id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
46613281|NCT03409796|82724565|FG000|Overall Study|Adverse Event|2|||
46613282|NCT03409796|82724566|FG001|Overall Study|Adverse Event|0|||
46613283|NCT03409796|82724565|FG000|Overall Study|Other|0|||
46613284|NCT03409796|82724566|FG001|Overall Study|Other|1|||
46613285|NCT02462928|82724575|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
46613286|NCT02462928|82724576|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
46613287|NCT02462928|82724577|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
46613288|NCT02462928|82724575|FG000|Overall Study|Adverse Event|47|||
46613289|NCT02462928|82724576|FG001|Overall Study|Adverse Event|51|||
46613290|NCT02462928|82724577|FG002|Overall Study|Adverse Event|25|||
46613291|NCT02462928|82724575|FG000|Overall Study|Lack of Efficacy|3|||
46613292|NCT02462928|82724576|FG001|Overall Study|Lack of Efficacy|8|||
46613293|NCT02462928|82724577|FG002|Overall Study|Lack of Efficacy|3|||
46613294|NCT02462928|82724575|FG000|Overall Study|Lost to Follow-up|4|||
46613295|NCT02462928|82724576|FG001|Overall Study|Lost to Follow-up|4|||
46613296|NCT02462928|82724577|FG002|Overall Study|Lost to Follow-up|1|||
46613297|NCT02462928|82724575|FG000|Overall Study|Withdrawal by Patient|31|||
46613298|NCT02462928|82724576|FG001|Overall Study|Withdrawal by Patient|21|||
46708297|NCT01179191|82923750|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
46708298|NCT01179191|82923750|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
46708299|NCT01179191|82923750|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
46708300|NCT01179191|82923750|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
46708301|NCT01179191|82923750|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
46708302|NCT01179191|82923750|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
46708303|NCT01179191|82923750|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
46708304|NCT01179191|82923750|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
46708305|NCT01179191|82923750|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
46897740|NCT03156504|83123456|FG000|Overall Study|Withdrawal by Subject|1|||
46897741|NCT03159468|83123466|FG000|Overall Study|Withdrawal by Subject|0|||
46897742|NCT03159468|83123467|FG001|Overall Study|Withdrawal by Subject|0|||
46897743|NCT03159468|83123468|FG002|Overall Study|Withdrawal by Subject|3|||
46897744|NCT03159468|83123469|FG003|Overall Study|Withdrawal by Subject|0|||
46897745|NCT03159468|83123470|FG004|Overall Study|Withdrawal by Subject|0|||
46897746|NCT03159468|83123471|FG005|Overall Study|Withdrawal by Subject|0|||
46897747|NCT03430063|83123488|FG000|Overall Study|Adverse Event|0|||
46708306|NCT01179191|82923750|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
46708307|NCT01179191|82923750|FG000|Maintenance Phase (8 Weeks)|Other|66|||
46708308|NCT01169844|82923756|FG000|Overall Study|Adverse Event|0|||
46708309|NCT01169844|82923757|FG001|Overall Study|Adverse Event|1|||
46708310|NCT01169844|82923756|FG000|Overall Study|Patient withdrew consent|4|||
46708311|NCT01169844|82923757|FG001|Overall Study|Patient withdrew consent|0|||
46897748|NCT03430063|83123489|FG001|Overall Study|Adverse Event|1|||
46897749|NCT03430063|83123490|FG002|Overall Study|Adverse Event|0|||
46897750|NCT03430063|83123488|FG000|Overall Study|Death|3|||
46897751|NCT03430063|83123489|FG001|Overall Study|Death|2|||
46897752|NCT03430063|83123490|FG002|Overall Study|Death|3|||
46613299|NCT02462928|82724577|FG002|Overall Study|Withdrawal by Patient|21|||
46613300|NCT02462928|82724575|FG000|Overall Study|Protocol Violation|0|||
46613301|NCT02462928|82724576|FG001|Overall Study|Protocol Violation|1|||
46897753|NCT03430063|83123488|FG000|Overall Study|Lost to Follow-up|0|||
46897754|NCT03430063|83123489|FG001|Overall Study|Lost to Follow-up|1|||
46897755|NCT03430063|83123490|FG002|Overall Study|Lost to Follow-up|0|||
46897756|NCT03430063|83123488|FG000|Overall Study|Withdrawal by Subject|0|||
46897757|NCT03430063|83123489|FG001|Overall Study|Withdrawal by Subject|0|||
46897758|NCT03430063|83123490|FG002|Overall Study|Withdrawal by Subject|1|||
46897759|NCT03430063|83123488|FG000|Overall Study|Withdrawal of consent|3|||
46897760|NCT03430063|83123489|FG001|Overall Study|Withdrawal of consent|1|||
46897761|NCT03430063|83123490|FG002|Overall Study|Withdrawal of consent|2|||
46897762|NCT03430063|83123488|FG000|Overall Study|Progressive disease|1|||
46897763|NCT03430063|83123489|FG001|Overall Study|Progressive disease|2|||
46613302|NCT02462928|82724577|FG002|Overall Study|Protocol Violation|0|||
46613303|NCT02462928|82724575|FG000|Overall Study|Reason not Specified|4|||
46613304|NCT02462928|82724576|FG001|Overall Study|Reason not Specified|6|||
46613305|NCT02462928|82724577|FG002|Overall Study|Reason not Specified|5|||
46613306|NCT00019604|82724594|FG000|Overall Study|Death|1|||
46613307|NCT00019604|82724594|FG000|Overall Study|Progressive disease|23|||
46613308|NCT00019604|82724594|FG000|Overall Study|Refused treatment|1|||
46613309|NCT00019604|82724594|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
46613310|NCT00019604|82724594|FG000|Overall Study|Going to have liver transplant|1|||
46613311|NCT00019604|82724594|FG000|Overall Study|Move to a different study|1|||
46613312|NCT00019604|82724594|FG000|Overall Study|Non compliant on systemic CH|1|||
46613313|NCT00019604|82724594|FG000|Overall Study|Non compliant|1|||
46613314|NCT00019604|82724594|FG000|Overall Study|Resectable disease|1|||
46897764|NCT03430063|83123490|FG002|Overall Study|Progressive disease|1|||
46897765|NCT03430063|83123488|FG000|Overall Study|Other un-specified|1|||
46613315|NCT00019604|82724594|FG000|Overall Study|Started new chemo regimen|1|||
46613316|NCT00019604|82724594|FG000|Overall Study|Pt going to immunotherapy study|1|||
46613317|NCT00019604|82724594|FG000|Overall Study|Too much disease|1|||
46613318|NCT00019604|82724594|FG000|Overall Study|Unable to evaluate|1|||
46613319|NCT00019604|82724594|FG000|Overall Study|Details for other not available|4|||
46613320|NCT02492958|82724610|FG000|Overall Study|Withdrawal by Subject|0|||
46613321|NCT02492958|82724611|FG001|Overall Study|Withdrawal by Subject|0|||
46613322|NCT02492958|82724612|FG002|Overall Study|Withdrawal by Subject|1|||
46613323|NCT02492958|82724613|FG003|Overall Study|Withdrawal by Subject|0|||
46613324|NCT02492958|82724610|FG000|Overall Study|Adverse Event|1|||
46613325|NCT02492958|82724611|FG001|Overall Study|Adverse Event|0|||
46613326|NCT02492958|82724612|FG002|Overall Study|Adverse Event|1|||
46613327|NCT02492958|82724613|FG003|Overall Study|Adverse Event|0|||
46613328|NCT02492880|82724623|FG000|Overall Study|Lost to Follow-up|1|||
46708312|NCT01169844|82923756|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46708313|NCT01169844|82923757|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46708314|NCT01132482|82923765|FG000|Overall Study|Adverse Event|1|||
46708315|NCT01132482|82923766|FG001|Overall Study|Adverse Event|0|||
46708316|NCT00931762|82923772|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
46708317|NCT00931762|82923772|FG000|Overall Study|Administrative Problems|5|||
46708318|NCT00931762|82923772|FG000|Overall Study|Death|1|||
46708319|NCT00931762|82923772|FG000|Overall Study|Disease Progression|3|||
46708320|NCT00931762|82923772|FG000|Overall Study|Adverse Event (s)|11|||
46708321|NCT00931762|82923772|FG000|Overall Study|Subject withdrew consent|13|||
46708322|NCT01178411|82923776|FG000|Overall Study|Adverse Event|5|||
46708323|NCT01178411|82923776|FG000|Overall Study|Withdrawal by Subject|4|||
46708324|NCT01178411|82923776|FG000|Overall Study|Protocol Violation|1|||
46708325|NCT01178411|82923776|FG000|Overall Study|Progressive disease per RECIST|32|||
46708326|NCT01178411|82923776|FG000|Overall Study|Progressive disease per clinician|9|||
46708327|NCT01178411|82923776|FG000|Overall Study|Physician Decision|6|||
46708328|NCT01178411|82923776|FG000|Overall Study|Death|1|||
46708329|NCT01178411|82923776|FG000|Overall Study|No reason provided|1|||
46708330|NCT01178411|82923776|FG000|Overall Study|Drug manufacturing ended|1|||
46708331|NCT01145508|82923782|FG000|Overall Study|Adverse Event|1|||
46708332|NCT01145508|82923783|FG001|Overall Study|Adverse Event|0|||
46708333|NCT01145508|82923782|FG000|Overall Study|Death|1|||
46708334|NCT01145508|82923783|FG001|Overall Study|Death|0|||
46708335|NCT01145508|82923782|FG000|Overall Study|Physician Decision|2|||
46708336|NCT01145508|82923783|FG001|Overall Study|Physician Decision|1|||
46708337|NCT01145508|82923782|FG000|Overall Study|Never started treatment|1|||
46708338|NCT01145508|82923783|FG001|Overall Study|Never started treatment|1|||
46708339|NCT00931528|82923791|FG000|Overall Study|Protocol Violation|9|||
46708340|NCT00931528|82923792|FG001|Overall Study|Protocol Violation|12|||
46708341|NCT00931528|82923791|FG000|Overall Study|Withdrawal by Subject|4|||
46708342|NCT00931528|82923792|FG001|Overall Study|Withdrawal by Subject|12|||
46708343|NCT00931528|82923791|FG000|Overall Study|Lost to Follow-up|6|||
46708344|NCT00931528|82923792|FG001|Overall Study|Lost to Follow-up|13|||
46708345|NCT00931528|82923791|FG000|Overall Study|Assessment outside of Time Frame|22|||
46708346|NCT00931528|82923792|FG001|Overall Study|Assessment outside of Time Frame|23|||
46708347|NCT00975195|82923801|FG000|Overall Study|Adverse Event|108|||
46613329|NCT02492880|82724623|FG000|Overall Study|Protocol Violation|1|||
46897766|NCT03430063|83123489|FG001|Overall Study|Other un-specified|1|||
46897767|NCT03430063|83123490|FG002|Overall Study|Other un-specified|0|||
46897768|NCT03430063|83123488|FG000|Overall Study|Randomized, but never treated|0|||
46897769|NCT03430063|83123489|FG001|Overall Study|Randomized, but never treated|0|||
46897770|NCT03430063|83123490|FG002|Overall Study|Randomized, but never treated|1|||
46897771|NCT03158220|83123501|FG000|Overall Study|Screen Failure|0|||
46897772|NCT03158220|83123502|FG001|Overall Study|Screen Failure|1|||
46897773|NCT03158220|83123501|FG000|Overall Study|Withdrawal by Subject|8|||
46897774|NCT03158220|83123502|FG001|Overall Study|Withdrawal by Subject|9|||
46897775|NCT03158220|83123501|FG000|Overall Study|Status unknown|0|||
46897776|NCT03158220|83123502|FG001|Overall Study|Status unknown|1|||
46897777|NCT03158220|83123501|FG000|Overall Study|Lost to Follow-up|8|||
46897778|NCT03158220|83123502|FG001|Overall Study|Lost to Follow-up|5|||
46613330|NCT02516592|82724629|FG000|Overall Study|Patient withdrew consent|5|||
46613331|NCT02516592|82724630|FG001|Overall Study|Patient withdrew consent|2|||
46613332|NCT02516592|82724629|FG000|Overall Study|Protocol deviation|4|||
46613333|NCT02516592|82724630|FG001|Overall Study|Protocol deviation|4|||
46613334|NCT02516592|82724629|FG000|Overall Study|Lost to Follow-up|2|||
46613335|NCT02516592|82724630|FG001|Overall Study|Lost to Follow-up|3|||
46897779|NCT03158220|83123501|FG000|Overall Study|Physician Decision|1|||
46613336|NCT02516592|82724629|FG000|Overall Study|Patient/guardian decision|2|||
46613337|NCT02516592|82724630|FG001|Overall Study|Patient/guardian decision|1|||
46613338|NCT02516592|82724629|FG000|Overall Study|Adverse Event|1|||
46613339|NCT02516592|82724630|FG001|Overall Study|Adverse Event|2|||
46613340|NCT02516592|82724629|FG000|Overall Study|Abnormal test procedure result|1|||
46708348|NCT00975195|82923802|FG001|Overall Study|Adverse Event|101|||
46708349|NCT00975195|82923801|FG000|Overall Study|Lack of Efficacy|6|||
46708350|NCT00975195|82923802|FG001|Overall Study|Lack of Efficacy|6|||
46708351|NCT00975195|82923801|FG000|Overall Study|Protocol Violation|27|||
46613341|NCT02516592|82724630|FG001|Overall Study|Abnormal test procedure result|0|||
46613342|NCT02516592|82724629|FG000|Overall Study|Death|1|||
46613343|NCT02516592|82724630|FG001|Overall Study|Death|1|||
46613344|NCT02492100|82724658|FG000|Overall Study|Death|1|||
46613345|NCT02461758|82724676|FG000|Overall Study|Lost to Follow-up|0|||
46613346|NCT02461758|82724677|FG001|Overall Study|Lost to Follow-up|1|||
46613347|NCT02461758|82724678|FG002|Overall Study|Lost to Follow-up|1|||
46613348|NCT02461758|82724679|FG003|Overall Study|Lost to Follow-up|0|||
46613349|NCT02461290|82724701|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
46613350|NCT02461290|82724701|FG000|Overall Study|Lost to Follow-up|3|||
46613351|NCT02461134|82724705|FG000|Overall Study|Adverse Event|1|||
46613352|NCT02460978|82724734|FG000|Overall Study|Adverse Event|17|||
46613353|NCT02460978|82724735|FG001|Overall Study|Adverse Event|11|||
46613354|NCT02460978|82724736|FG002|Overall Study|Adverse Event|11|||
46613355|NCT02460978|82724734|FG000|Overall Study|Withdrawal by Subject|5|||
46613356|NCT02460978|82724735|FG001|Overall Study|Withdrawal by Subject|5|||
46613357|NCT02460978|82724736|FG002|Overall Study|Withdrawal by Subject|14|||
46613358|NCT02460978|82724734|FG000|Overall Study|Lost to Follow-up|2|||
46613359|NCT02460978|82724735|FG001|Overall Study|Lost to Follow-up|3|||
46613360|NCT02460978|82724736|FG002|Overall Study|Lost to Follow-up|1|||
46613361|NCT02460978|82724734|FG000|Overall Study|Protocol Violation|1|||
46613362|NCT02460978|82724735|FG001|Overall Study|Protocol Violation|1|||
46613363|NCT02460978|82724736|FG002|Overall Study|Protocol Violation|1|||
46613364|NCT02460978|82724734|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
46613365|NCT02460978|82724735|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
46613366|NCT02460978|82724736|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
46613367|NCT02460978|82724734|FG000|Overall Study|Pregnancy|0|||
46897780|NCT03158220|83123502|FG001|Overall Study|Physician Decision|0|||
46897781|NCT03156270|83123508|FG000|Overall Study|Failed pre-treatment screening|1|||
46897782|NCT03156270|83123508|FG000|Overall Study|Lost to Follow-up|1|||
46897783|NCT03429049|83123516|FG000|Overall Study|Adverse Event|2|||
46897784|NCT03429049|83123517|FG001|Overall Study|Adverse Event|3|||
46897785|NCT03429049|83123516|FG000|Overall Study|Death|0|||
46897786|NCT03429049|83123517|FG001|Overall Study|Death|1|||
46897787|NCT03429049|83123516|FG000|Overall Study|Lack of Efficacy|4|||
46897788|NCT03429049|83123517|FG001|Overall Study|Lack of Efficacy|2|||
46897789|NCT03429049|83123516|FG000|Overall Study|Lost to Follow-up|9|||
46897790|NCT03429049|83123517|FG001|Overall Study|Lost to Follow-up|8|||
46897791|NCT03429049|83123516|FG000|Overall Study|Physician Decision|1|||
46897792|NCT03429049|83123517|FG001|Overall Study|Physician Decision|0|||
46897793|NCT03429049|83123516|FG000|Overall Study|Protocol Violation|3|||
46613368|NCT02460978|82724735|FG001|Overall Study|Pregnancy|0|||
46613369|NCT02460978|82724736|FG002|Overall Study|Pregnancy|2|||
46613370|NCT02489448|82724751|FG000|Overall Study|Death|3|||
46613371|NCT02489448|82724751|FG000|Overall Study|Withdrawal by Subject|2|||
46613372|NCT02488980|82724772|FG000|Overall Study|Protocol Violation|2|||
46613373|NCT02488980|82724773|FG001|Overall Study|Protocol Violation|2|||
46613374|NCT02488980|82724774|FG002|Overall Study|Protocol Violation|2|||
46613375|NCT02460822|82724786|FG000|Overall Study|Withdrawal by Subject|1|||
46613376|NCT02488824|82724792|FG000|Overall Study|Adverse Event|1|||
46613377|NCT02488824|82724793|FG001|Overall Study|Adverse Event|1|||
46613378|NCT02308241|82724905|FG000|Overall Study|Withdrawal by Subject|3|||
46613379|NCT02460198|82724944|FG000|Overall Study|Adverse Event|1|||
46613380|NCT02460198|82724945|FG001|Overall Study|Adverse Event|3|||
46613381|NCT02460198|82724944|FG000|Overall Study|Death|36|||
46613382|NCT02460198|82724945|FG001|Overall Study|Death|28|||
46613383|NCT02460198|82724944|FG000|Overall Study|Lost to Follow-up|1|||
46613384|NCT02460198|82724945|FG001|Overall Study|Lost to Follow-up|1|||
46613385|NCT02460198|82724944|FG000|Overall Study|Transferred to Extension Study|15|||
46613386|NCT02460198|82724945|FG001|Overall Study|Transferred to Extension Study|15|||
46613387|NCT02460198|82724944|FG000|Overall Study|Withdrawal by Subject|2|||
46613388|NCT02460198|82724945|FG001|Overall Study|Withdrawal by Subject|4|||
46613389|NCT02460198|82724944|FG000|Overall Study|Site Terminated By Sponsor|0|||
46613390|NCT02460198|82724945|FG001|Overall Study|Site Terminated By Sponsor|1|||
46613391|NCT02460198|82724944|FG000|Overall Study|Did Not Continue on Extension Study|6|||
46613392|NCT02460198|82724945|FG001|Overall Study|Did Not Continue on Extension Study|11|||
46613393|NCT02487810|82724965|FG000|Overall Study|Withdrawal by Subject|1|||
46613394|NCT02487810|82724966|FG001|Overall Study|Withdrawal by Subject|0|||
46708352|NCT00975195|82923802|FG001|Overall Study|Protocol Violation|23|||
46802979|NCT00680771|83022236|FG000|Overall Study|Withdrawal by Subject|1|||
46613395|NCT02452320|82724974|FG000|Overall Study|Adverse Event|0|||
46613396|NCT02452320|82724975|FG001|Overall Study|Adverse Event|1|||
46708353|NCT00975195|82923801|FG000|Overall Study|Lost to Follow-up|9|||
46802980|NCT00680771|83022237|FG001|Overall Study|Withdrawal by Subject|0|||
46613397|NCT02459964|82724984|FG000|Overall Study|Withdrawal by Subject|0|||
46613398|NCT02459964|82724985|FG001|Overall Study|Withdrawal by Subject|0|||
46897794|NCT03429049|83123517|FG001|Overall Study|Protocol Violation|0|||
46897795|NCT03429049|83123516|FG000|Overall Study|Sponsor Decision|2|||
46613399|NCT02459964|82724986|FG002|Overall Study|Withdrawal by Subject|1|||
46613400|NCT02459964|82724984|FG000|Overall Study|Abnormal EKG changes|0|||
46613401|NCT02459964|82724985|FG001|Overall Study|Abnormal EKG changes|0|||
46613402|NCT02459964|82724986|FG002|Overall Study|Abnormal EKG changes|1|||
46613403|NCT02451930|82725063|FG000|Overall Study|Death|0|||
46613404|NCT02451930|82725064|FG001|Overall Study|Death|15|||
46613405|NCT02451930|82725063|FG000|Overall Study|Lost to Follow-up|0|||
46613406|NCT02451930|82725064|FG001|Overall Study|Lost to Follow-up|3|||
46613407|NCT02451930|82725063|FG000|Overall Study|Sponsor Decision|2|||
46613408|NCT02451930|82725064|FG001|Overall Study|Sponsor Decision|10|||
46613409|NCT02451930|82725063|FG000|Overall Study|Withdrawal by Subject|0|||
46613410|NCT02451930|82725064|FG001|Overall Study|Withdrawal by Subject|1|||
46613411|NCT02451930|82725063|FG000|Overall Study|Other|0|||
46613412|NCT02451930|82725064|FG001|Overall Study|Other|1|||
46613413|NCT02451696|82725100|FG000|Overall Study|Surgery postponed|1|||
46613414|NCT02451696|82725101|FG001|Overall Study|Surgery postponed|0|||
46613415|NCT02459418|82725124|FG000|Overall Study|Exclusion Criteria|4|||
46613416|NCT02459418|82725125|FG001|Overall Study|Exclusion Criteria|0|||
46613417|NCT02459418|82725124|FG000|Overall Study|Protocol Violation|0|||
46613418|NCT02459418|82725125|FG001|Overall Study|Protocol Violation|2|||
46613419|NCT02459418|82725124|FG000|Overall Study|Physician Decision|0|||
46613420|NCT02459418|82725125|FG001|Overall Study|Physician Decision|2|||
46613421|NCT02459418|82725124|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
46613422|NCT02459418|82725125|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
46613423|NCT02459418|82725124|FG000|Overall Study|Adverse Event|0|||
46613424|NCT02459418|82725125|FG001|Overall Study|Adverse Event|1|||
46613425|NCT02459418|82725124|FG000|Overall Study|Withdrawal by Subject|1|||
46613426|NCT02459418|82725125|FG001|Overall Study|Withdrawal by Subject|1|||
46613427|NCT02459418|82725124|FG000|Overall Study|Elevated Creatine Kinase|1|||
46613428|NCT02459418|82725125|FG001|Overall Study|Elevated Creatine Kinase|0|||
46613429|NCT02459418|82725124|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
46613430|NCT02459418|82725125|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
46613431|NCT02487498|82725155|FG000|Period: Period 1|Adverse Event|2|||
46613432|NCT02487498|82725156|FG001|Period: Period 1|Adverse Event|4|||
46613433|NCT02487498|82725155|FG000|Period: Period 1|Subject/guardian decision|2|||
46613434|NCT02487498|82725156|FG001|Period: Period 1|Subject/guardian decision|4|||
46613435|NCT02487498|82725155|FG000|Period: Period 1|Lost to Follow-up|0|||
46613436|NCT02487498|82725156|FG001|Period: Period 1|Lost to Follow-up|2|||
46708354|NCT00975195|82923802|FG001|Overall Study|Lost to Follow-up|7|||
46708355|NCT00975195|82923801|FG000|Overall Study|Withdrawal by Subject|48|||
46708356|NCT00975195|82923802|FG001|Overall Study|Withdrawal by Subject|61|||
46708357|NCT00975195|82923801|FG000|Overall Study|Other reason not defined above|29|||
46708358|NCT00975195|82923802|FG001|Overall Study|Other reason not defined above|33|||
46708359|NCT00975195|82923801|FG000|Overall Study|Not treated|1|||
46708360|NCT00975195|82923802|FG001|Overall Study|Not treated|2|||
46708361|NCT01145352|82923808|FG000|Overall Study|Found to have been registered twice|6|||
46708362|NCT01145352|82923808|FG000|Overall Study|Treated before marketing approval|4|||
46708363|NCT01145352|82923808|FG000|Overall Study|Syringe formulation was used|1|||
46708364|NCT01178099|82923816|FG000|Overall Study|Physician Decision|0|||
46708365|NCT01178099|82923817|FG001|Overall Study|Physician Decision|1|||
46708366|NCT01169532|82923827|FG000|Overall Study|Withdrawal by Subject|1|||
46708367|NCT00928564|82923833|FG000|Overall Study|Lost to Follow-up|6|||
46708368|NCT00928564|82923834|FG001|Overall Study|Lost to Follow-up|0|||
46708369|NCT01177943|82923842|FG000|First Intervention|Withdrawal by Subject|2|||
46708370|NCT01177943|82923843|FG001|First Intervention|Withdrawal by Subject|0|||
46708371|NCT01131312|82923852|FG000|Overall Study|Lost to Follow-up|425|||
46708372|NCT01131312|82923853|FG001|Overall Study|Lost to Follow-up|229|||
46708373|NCT01131312|82923854|FG002|Overall Study|Lost to Follow-up|351|||
46708374|NCT01177787|82923862|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
46708375|NCT01177787|82923862|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
46708376|NCT01177787|82923862|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
46708377|NCT00928486|82923874|FG000|Overall Study|Adverse Event|2|||
46897796|NCT03429049|83123517|FG001|Overall Study|Sponsor Decision|0|||
46897797|NCT03429049|83123516|FG000|Overall Study|Withdrawal by Subject|4|||
46708378|NCT00928486|82923874|FG000|Overall Study|Disease Progression|7|||
46708379|NCT00928486|82923874|FG000|Overall Study|Withdrawal by Subject|1|||
46708380|NCT01168596|82923880|FG000|Overall Study|Withdrawal by Subject|3|||
46708381|NCT01168596|82923881|FG001|Overall Study|Withdrawal by Subject|1|||
46613437|NCT02487498|82725155|FG000|Period: Period 1|Lack of Efficacy|1|||
46613438|NCT02487498|82725156|FG001|Period: Period 1|Lack of Efficacy|0|||
46613439|NCT02487498|82725155|FG000|Period: Period 1|Physician Decision|0|||
46613440|NCT02487498|82725156|FG001|Period: Period 1|Physician Decision|1|||
46613441|NCT02487498|82725155|FG000|Period: Period 1|Protocol deviation|1|||
46613442|NCT02487498|82725156|FG001|Period: Period 1|Protocol deviation|0|||
46613443|NCT02487498|82725155|FG000|Period: Washout|Subject/guardian decision|0|||
46613444|NCT02487498|82725156|FG001|Period: Washout|Subject/guardian decision|5|||
46708382|NCT01177553|82923889|FG000|Overall Study|babies not yet 6 months of age|1|||
46708383|NCT01177553|82923890|FG001|Overall Study|babies not yet 6 months of age|0|||
46708384|NCT00928408|82923896|FG000|Overall Study|Other|2|||
46708385|NCT00928408|82923896|FG000|Overall Study|Withdrawal by Subject|4|||
46708386|NCT00928408|82923896|FG000|Overall Study|Death|5|||
46708387|NCT00928408|82923896|FG000|Overall Study|Lost to Follow-up|12|||
46897798|NCT03429049|83123517|FG001|Overall Study|Withdrawal by Subject|20|||
46897799|NCT03429049|83123516|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
46897800|NCT03429049|83123517|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
46897801|NCT03428815|83123525|FG000|Overall Study|Lost to Follow-up|2|||
46897802|NCT03428815|83123526|FG001|Overall Study|Lost to Follow-up|2|||
46897803|NCT03428815|83123525|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
46897804|NCT03428815|83123526|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
46897805|NCT03428815|83123525|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
46897806|NCT03428815|83123526|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
46897807|NCT03155724|83123532|FG000|Overall Study|Death|3|||
46897808|NCT03155724|83123532|FG000|Overall Study|Physician Decision|1|||
46897809|NCT03155724|83123532|FG000|Overall Study|Study closure|7|||
46897810|NCT03426787|83123536|FG000|Overall Study|Withdrawal by Subject|6|||
46897811|NCT03426787|83123536|FG000|Overall Study|Lost to Follow-up|7|||
46897812|NCT03426787|83123536|FG000|Overall Study|Unrelated to intervention death|1|||
46897813|NCT03426631|83123546|FG000|Overall Study|Lost to Follow-up|0|||
46708388|NCT00928252|82923900|FG000|Overall Study|Physician Decision|3|||
46708389|NCT01177007|82923906|FG000|Overall Study|Lost to Follow-up|2|||
46708390|NCT01177007|82923906|FG000|Overall Study|Death|4|||
46708391|NCT01177007|82923906|FG000|Overall Study|Entered hospice care|5|||
46708392|NCT01177007|82923906|FG000|Overall Study|Required additional Y90 treatment|6|||
46708393|NCT01177007|82923906|FG000|Overall Study|Change in treatment modality|21|||
46708394|NCT00930982|82923914|FG000|Overall Study|Adverse Event|19|||
46708395|NCT00930982|82923915|FG001|Overall Study|Adverse Event|23|||
46708396|NCT00930982|82923914|FG000|Overall Study|Protocol Violation|1|||
46708397|NCT00930982|82923915|FG001|Overall Study|Protocol Violation|5|||
46897814|NCT03426631|83123547|FG001|Overall Study|Lost to Follow-up|1|||
46897815|NCT03484429|83123555|FG000|Overall Study|Withdrawal by Subject|1|||
46897816|NCT03484429|83123556|FG001|Overall Study|Withdrawal by Subject|0|||
46897817|NCT03484429|83123555|FG000|Overall Study|Adverse Event|2|||
46897818|NCT03484429|83123556|FG001|Overall Study|Adverse Event|0|||
46897819|NCT03484273|83123562|FG000|Overall Study|Equipment Malfunction|1|||
46897820|NCT03484273|83123562|FG000|Overall Study|Data excluded from analysis|1|||
46897821|NCT02724592|83123576|FG000|Overall Study|Lost to Follow-up|4|||
46897822|NCT02724592|83123577|FG001|Overall Study|Lost to Follow-up|1|||
46897823|NCT03154476|83123585|FG000|Overall Study|Lost to Follow-up|4|||
46897824|NCT03154476|83123586|FG001|Overall Study|Lost to Follow-up|4|||
46897825|NCT02726074|83123592|FG000|Overall Study|Withdrawal by Subject|4|||
46897826|NCT02726074|83123592|FG000|Overall Study|Adverse Event|14|||
46897827|NCT02726074|83123592|FG000|Overall Study|Protocol Violation|3|||
46897828|NCT02726074|83123592|FG000|Overall Study|Lost to Follow-up|2|||
46708398|NCT00930982|82923914|FG000|Overall Study|Withdrawal by Subject|1|||
46708399|NCT00930982|82923915|FG001|Overall Study|Withdrawal by Subject|1|||
46708400|NCT01176773|82923921|FG000|Overall Study|Screen Failure|2|||
46708401|NCT01176773|82923921|FG000|Overall Study|Withdrew consent|1|||
46708402|NCT00928018|82923928|FG000|Overall Study|Withdrawal by Subject|1|||
46708403|NCT00928018|82923929|FG001|Overall Study|Withdrawal by Subject|0|||
46708404|NCT00927940|82923939|FG000|Overall Study|Death|1|||
46708405|NCT00927862|82923946|FG000|Overall Study|Missing data needed for endpt analyses|27|||
46708406|NCT00927862|82923947|FG001|Overall Study|Missing data needed for endpt analyses|45|||
46708407|NCT00976989|82923958|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
46897829|NCT02726074|83123592|FG000|Overall Study|Others|3|||
46897830|NCT03482635|83123600|FG000|Overall Study|Lack of Efficacy|0|||
46708408|NCT00976989|82923959|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
46708409|NCT00976989|82923960|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
46708410|NCT00976989|82923958|FG000|Overall Study|Death|5|||
46708411|NCT00976989|82923959|FG001|Overall Study|Death|7|||
46708412|NCT00976989|82923960|FG002|Overall Study|Death|10|||
46897831|NCT03482635|83123601|FG001|Overall Study|Lack of Efficacy|0|||
46897832|NCT03482635|83123602|FG002|Overall Study|Lack of Efficacy|1|||
46897833|NCT03482635|83123603|FG003|Overall Study|Lack of Efficacy|3|||
46897834|NCT03482635|83123600|FG000|Overall Study|Adverse Event|2|||
46897835|NCT03482635|83123601|FG001|Overall Study|Adverse Event|2|||
46897836|NCT03482635|83123602|FG002|Overall Study|Adverse Event|0|||
46897837|NCT03482635|83123603|FG003|Overall Study|Adverse Event|3|||
46708413|NCT00976989|82923958|FG000|Overall Study|Refused Treatment|4|||
46708414|NCT00976989|82923959|FG001|Overall Study|Refused Treatment|3|||
46708415|NCT00976989|82923960|FG002|Overall Study|Refused Treatment|5|||
46708416|NCT00976989|82923958|FG000|Overall Study|Failure to Return|2|||
46897838|NCT03482635|83123600|FG000|Overall Study|Withdrawal by Subject|2|||
46897839|NCT03482635|83123601|FG001|Overall Study|Withdrawal by Subject|1|||
46897840|NCT03482635|83123602|FG002|Overall Study|Withdrawal by Subject|0|||
46897841|NCT03482635|83123603|FG003|Overall Study|Withdrawal by Subject|1|||
46897842|NCT03482635|83123600|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
46897843|NCT03482635|83123601|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
46897844|NCT03482635|83123602|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
46897845|NCT03482635|83123603|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
46897846|NCT03482635|83123600|FG000|Overall Study|Not treated|0|||
46897847|NCT03482635|83123601|FG001|Overall Study|Not treated|0|||
46897848|NCT03482635|83123602|FG002|Overall Study|Not treated|0|||
46897849|NCT03482635|83123603|FG003|Overall Study|Not treated|1|||
46897850|NCT03712787|83123617|FG000|Overall Study|Adverse Event|2|||
46897851|NCT03712787|83123618|FG001|Overall Study|Adverse Event|3|||
46897852|NCT03712787|83123619|FG002|Overall Study|Adverse Event|0|||
46897853|NCT03712787|83123620|FG003|Overall Study|Adverse Event|4|||
46897854|NCT03712787|83123617|FG000|Overall Study|Withdrawal by Subject|4|||
46897855|NCT03712787|83123618|FG001|Overall Study|Withdrawal by Subject|14|||
46897856|NCT03712787|83123619|FG002|Overall Study|Withdrawal by Subject|12|||
46897857|NCT03712787|83123620|FG003|Overall Study|Withdrawal by Subject|8|||
46897858|NCT03712787|83123617|FG000|Overall Study|Lost to Follow-up|1|||
46897859|NCT03712787|83123618|FG001|Overall Study|Lost to Follow-up|1|||
46897860|NCT03712787|83123619|FG002|Overall Study|Lost to Follow-up|2|||
46897861|NCT03712787|83123620|FG003|Overall Study|Lost to Follow-up|1|||
46897862|NCT03712787|83123617|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
46897863|NCT03712787|83123618|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
46897864|NCT03712787|83123619|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
46897865|NCT03712787|83123620|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
46897866|NCT03712787|83123617|FG000|Overall Study|COVID-19 Infection|0|||
46897867|NCT03712787|83123618|FG001|Overall Study|COVID-19 Infection|1|||
46897868|NCT03712787|83123619|FG002|Overall Study|COVID-19 Infection|0|||
46897869|NCT03712787|83123620|FG003|Overall Study|COVID-19 Infection|0|||
46897870|NCT03712787|83123617|FG000|Overall Study|Other, Not Specified|79|||
46708417|NCT00976989|82923959|FG001|Overall Study|Failure to Return|1|||
46708418|NCT00976989|82923960|FG002|Overall Study|Failure to Return|0|||
46708419|NCT00976989|82923958|FG000|Overall Study|Recurrence of Disease|0|||
46708420|NCT00976989|82923959|FG001|Overall Study|Recurrence of Disease|1|||
46708421|NCT00976989|82923960|FG002|Overall Study|Recurrence of Disease|0|||
46708422|NCT00976989|82923958|FG000|Overall Study|Other|1|||
46708423|NCT00976989|82923959|FG001|Overall Study|Other|0|||
46708424|NCT00976989|82923960|FG002|Overall Study|Other|1|||
46708425|NCT00927784|82923970|FG000|Overall Study|Death|1|||
46708426|NCT00927784|82923971|FG001|Overall Study|Death|0|||
46708427|NCT00927784|82923970|FG000|Overall Study|Withdrawal by Subject|1|||
46708428|NCT00927784|82923971|FG001|Overall Study|Withdrawal by Subject|0|||
46708429|NCT05056987|82923988|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
46708430|NCT05056987|82923989|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
46708431|NCT05056987|82923988|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
46708432|NCT05056987|82923989|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
46708433|NCT03439852|82924009|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
46708434|NCT03439852|82924010|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
46708435|NCT03439852|82924009|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
46708436|NCT03439852|82924010|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
46708437|NCT03439852|82924009|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
46708438|NCT03439852|82924010|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
46708439|NCT03355300|82924021|FG000|Overall Study|Physician Decision|0|||
46708440|NCT03355300|82924022|FG001|Overall Study|Physician Decision|1|||
46708441|NCT03355300|82924021|FG000|Overall Study|Lack of Efficacy|2|||
46708442|NCT03355300|82924022|FG001|Overall Study|Lack of Efficacy|1|||
46708443|NCT03355300|82924021|FG000|Overall Study|Other reason|1|||
46708444|NCT03355300|82924022|FG001|Overall Study|Other reason|0|||
46708445|NCT03332056|82924030|FG000|Overall Study|Incomplete questionnaires|8|||
46708446|NCT03332056|82924031|FG001|Overall Study|Incomplete questionnaires|9|||
46708447|NCT03332056|82924030|FG000|Overall Study|Passed stone prior to surgery date|1|||
46708448|NCT03332056|82924031|FG001|Overall Study|Passed stone prior to surgery date|0|||
46708449|NCT03332056|82924030|FG000|Overall Study|Did not require a ureteral stent|0|||
46708450|NCT03332056|82924031|FG001|Overall Study|Did not require a ureteral stent|1|||
46708451|NCT03093350|82924037|FG000|Overall Study|Death|1|||
46708452|NCT03093350|82924037|FG000|Overall Study|Signed consent, never began treartment|1|||
46708453|NCT02901041|82924043|FG000|Overall Study|Withdrawal by PI|4|||
46708454|NCT02901041|82924044|FG001|Overall Study|Withdrawal by PI|8|||
46708455|NCT02901041|82924043|FG000|Overall Study|Withdrawal by Subject|7|||
46897871|NCT03712787|83123618|FG001|Overall Study|Other, Not Specified|77|||
46897872|NCT03712787|83123619|FG002|Overall Study|Other, Not Specified|74|||
46897873|NCT03712787|83123620|FG003|Overall Study|Other, Not Specified|78|||
46897874|NCT03048422|83123652|FG000|Overall Study|Death|1|||
46708456|NCT02901041|82924044|FG001|Overall Study|Withdrawal by Subject|3|||
46708457|NCT02547987|82924078|FG000|Overall Study|Withdrawal by Subject|1|||
46708458|NCT02547987|82924078|FG000|Overall Study|Adverse Event|2|||
46708459|NCT02513199|82924082|FG000|Treatment|Death|1|||
46708460|NCT02513199|82924082|FG000|Treatment|Lost to Follow-up|1|||
46708461|NCT02513199|82924082|FG000|Follow-Up|Death|11|||
46708462|NCT00999804|82924099|FG000|Overall Study|Lack of Efficacy|9|||
46708463|NCT00999804|82924100|FG001|Overall Study|Lack of Efficacy|2|||
46708464|NCT00999804|82924099|FG000|Overall Study|Adverse Event|4|||
46708465|NCT00999804|82924100|FG001|Overall Study|Adverse Event|3|||
46708466|NCT00999804|82924099|FG000|Overall Study|Withdrawal by Subject|4|||
46708467|NCT00999804|82924100|FG001|Overall Study|Withdrawal by Subject|0|||
46708468|NCT00999804|82924099|FG000|Overall Study|Death|1|||
46708469|NCT00999804|82924100|FG001|Overall Study|Death|0|||
46708470|NCT00999804|82924099|FG000|Overall Study|Ineligible|3|||
46708471|NCT00999804|82924100|FG001|Overall Study|Ineligible|0|||
46708472|NCT00927472|82924108|FG000|Overall Study|Withdrawal by Subject|10|||
46708473|NCT00927472|82924109|FG001|Overall Study|Withdrawal by Subject|11|||
46708474|NCT00927472|82924108|FG000|Overall Study|Lost to Follow-up|1|||
46708475|NCT00927472|82924109|FG001|Overall Study|Lost to Follow-up|6|||
46708476|NCT00927472|82924108|FG000|Overall Study|Protocol Violation|0|||
46708477|NCT00927472|82924109|FG001|Overall Study|Protocol Violation|1|||
46708478|NCT00927472|82924108|FG000|Overall Study|Post treatment Assessment out of window|0|||
46708479|NCT00927472|82924109|FG001|Overall Study|Post treatment Assessment out of window|4|||
46708480|NCT00927394|82924117|FG000|Overall Study|Adverse Event|14|||
46708481|NCT00927394|82924118|FG001|Overall Study|Adverse Event|9|||
46708482|NCT00927394|82924117|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
46708483|NCT00927394|82924118|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
46708484|NCT00927394|82924117|FG000|Overall Study|Withdrawal by Subject|20|||
46708485|NCT00927394|82924118|FG001|Overall Study|Withdrawal by Subject|24|||
46708486|NCT00927394|82924117|FG000|Overall Study|Lost to Follow-up|8|||
46708487|NCT00927394|82924118|FG001|Overall Study|Lost to Follow-up|14|||
46708488|NCT00927394|82924117|FG000|Overall Study|Administrative Problem|1|||
46708489|NCT00927394|82924118|FG001|Overall Study|Administrative Problem|0|||
46708490|NCT00927394|82924117|FG000|Overall Study|Death|1|||
46708491|NCT00927394|82924118|FG001|Overall Study|Death|1|||
46708492|NCT00927394|82924117|FG000|Overall Study|Protocol deviation|16|||
46708493|NCT00927394|82924118|FG001|Overall Study|Protocol deviation|13|||
46708494|NCT00927394|82924117|FG000|Overall Study|Randomized in error|0|||
46708495|NCT00927394|82924118|FG001|Overall Study|Randomized in error|1|||
46708496|NCT00976911|82924127|FG000|Overall Study|Withdrawal by Subject|4|||
46708497|NCT00976911|82924128|FG001|Overall Study|Withdrawal by Subject|6|||
46708498|NCT00976911|82924127|FG000|Overall Study|Death|138|||
46708499|NCT00976911|82924128|FG001|Overall Study|Death|126|||
46708500|NCT00976911|82924127|FG000|Overall Study|Adverse Event|0|||
46708501|NCT00976911|82924128|FG001|Overall Study|Adverse Event|1|||
46708502|NCT00976911|82924127|FG000|Overall Study|Protocol Violation|2|||
46708503|NCT00976911|82924128|FG001|Overall Study|Protocol Violation|0|||
46708504|NCT00976911|82924127|FG000|Overall Study|Other|8|||
46708505|NCT00976911|82924128|FG001|Overall Study|Other|9|||
46708506|NCT00976911|82924127|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
46708507|NCT00976911|82924128|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
46708508|NCT00934648|82924134|FG000|Overall Study|Failure to return|8|||
46708509|NCT00934648|82924134|FG000|Overall Study|Withdrawal by Subject|1|||
46708510|NCT01175213|82924142|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
46708511|NCT01175213|82924143|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
46708512|NCT01175213|82924142|FG000|IGSC, 10%/rHuPH20|Death|1|||
46708513|NCT01175213|82924143|FG001|IGSC, 10%/rHuPH20|Death|0|||
46708514|NCT01175213|82924142|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
46708515|NCT01175213|82924143|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
46708516|NCT01175213|82924142|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
46708517|NCT01175213|82924143|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
46708518|NCT01175213|82924142|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
46708519|NCT01175213|82924143|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
46708520|NCT01175213|82924142|FG000|Safety Follow-up|Adverse Event|1|||
46708521|NCT01175213|82924143|FG001|Safety Follow-up|Adverse Event|0|||
46708522|NCT00974259|82924154|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
46708523|NCT00974259|82924155|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
46708524|NCT00927082|82924165|FG000|Overall Study|Lost to Follow-up|9|||
46708525|NCT00927082|82924166|FG001|Overall Study|Lost to Follow-up|8|||
46708526|NCT00927082|82924167|FG002|Overall Study|Lost to Follow-up|12|||
46708527|NCT00927082|82924168|FG003|Overall Study|Lost to Follow-up|16|||
46708528|NCT00927082|82924165|FG000|Overall Study|Withdrawal by Subject|3|||
46708529|NCT00927082|82924166|FG001|Overall Study|Withdrawal by Subject|2|||
46708530|NCT00927082|82924167|FG002|Overall Study|Withdrawal by Subject|7|||
46708531|NCT00927082|82924168|FG003|Overall Study|Withdrawal by Subject|2|||
46708532|NCT00927082|82924165|FG000|Overall Study|Death|0|||
46708533|NCT00927082|82924166|FG001|Overall Study|Death|0|||
46708534|NCT00927082|82924167|FG002|Overall Study|Death|1|||
46708535|NCT00927082|82924168|FG003|Overall Study|Death|0|||
46708536|NCT00927082|82924165|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
46708537|NCT00927082|82924166|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
46708538|NCT00927082|82924167|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
46708539|NCT00927082|82924168|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
46708540|NCT00976677|82924184|FG000|Overall Study|Adverse Event|1|||
46708541|NCT00976677|82924185|FG001|Overall Study|Adverse Event|0|||
46708542|NCT00976677|82924184|FG000|Overall Study|Withdrawal by Subject|0|||
46708543|NCT00976677|82924185|FG001|Overall Study|Withdrawal by Subject|2|||
46708544|NCT00976677|82924184|FG000|Overall Study|Disease progression|1|||
46708545|NCT00976677|82924185|FG001|Overall Study|Disease progression|1|||
46708546|NCT00976677|82924184|FG000|Overall Study|Trial unblinded|2|||
46708547|NCT00976677|82924185|FG001|Overall Study|Trial unblinded|2|||
46708548|NCT00976677|82924184|FG000|Overall Study|Unknown/Missing|1|||
46708549|NCT00976677|82924185|FG001|Overall Study|Unknown/Missing|0|||
46802981|NCT00680771|83022236|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
46802982|NCT00680771|83022237|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
46802983|NCT00680771|83022236|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
46802984|NCT00680771|83022237|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
46802985|NCT00482703|83022245|FG000|Overall Study|Poor compliance|1|||
46802986|NCT00482703|83022246|FG001|Overall Study|Poor compliance|0|||
46802987|NCT00482391|83022259|FG000|Overall Study|Withdrawal by Subject|1|||
46802988|NCT00482391|83022259|FG000|Overall Study|Adverse Event|1|||
46802989|NCT00482391|83022259|FG000|Overall Study|Death|1|||
46802990|NCT00423046|83022266|FG000|Overall Study|Other|340|||
46802991|NCT00423046|83022267|FG001|Overall Study|Other|345|||
46802992|NCT00496587|83022275|FG000|Overall Study|Adverse Event|2|||
46802993|NCT00496587|83022275|FG000|Overall Study|Progressive Disease|24|||
46802994|NCT00496587|83022275|FG000|Overall Study|Withdrawal by Subject|2|||
46802995|NCT00496587|83022275|FG000|Overall Study|Death|1|||
46802996|NCT00496587|83022275|FG000|Overall Study|Complications unrelated|2|||
46802997|NCT00405652|83022279|FG000|Overall Study|Adverse Event|4|||
46802998|NCT00422734|83022285|FG000|Overall Study|Physician Decision|1|||
46802999|NCT00422734|83022286|FG001|Overall Study|Physician Decision|1|||
46803000|NCT00422734|83022285|FG000|Overall Study|Protocol Violation|1|||
46803001|NCT00422734|83022286|FG001|Overall Study|Protocol Violation|6|||
46803002|NCT00422734|83022285|FG000|Overall Study|Withdrawal by Subject|12|||
46803003|NCT00422734|83022286|FG001|Overall Study|Withdrawal by Subject|8|||
46803004|NCT00422734|83022285|FG000|Overall Study|Adverse Event|0|||
46803005|NCT00422734|83022286|FG001|Overall Study|Adverse Event|3|||
46803006|NCT00422734|83022285|FG000|Overall Study|Partner Decision|0|||
46803007|NCT00422734|83022286|FG001|Overall Study|Partner Decision|3|||
46803008|NCT00422422|83022292|FG000|Overall Study|Lack of Efficacy|1|||
46803009|NCT00422422|83022292|FG000|Overall Study|Protocol Violation|1|||
46803010|NCT00422422|83022292|FG000|Overall Study|Withdrawal by Subject|2|||
46803011|NCT00422422|83022292|FG000|Overall Study|SAE, non-fatal|1|||
46803012|NCT00422422|83022292|FG000|Overall Study|AE, non-serious non-fatal|5|||
46803013|NCT00413374|83022300|FG000|Overall Study|Ineligible due to screening criteria.|3|||
46803014|NCT00413374|83022301|FG001|Overall Study|Ineligible due to screening criteria.|0|||
46803015|NCT00413374|83022300|FG000|Overall Study|Adverse Event|1|||
46803016|NCT00413374|83022301|FG001|Overall Study|Adverse Event|0|||
46803017|NCT00413374|83022300|FG000|Overall Study|Lost to Follow-up|1|||
46803018|NCT00413374|83022301|FG001|Overall Study|Lost to Follow-up|0|||
46803019|NCT00413374|83022300|FG000|Overall Study|Surgery|1|||
46803020|NCT00413374|83022301|FG001|Overall Study|Surgery|0|||
46803021|NCT00682643|83022312|FG000|Overall Study|Adverse Event|12|||
46803022|NCT00682643|83022313|FG001|Overall Study|Adverse Event|23|||
46803023|NCT00682643|83022312|FG000|Overall Study|Lack of Efficacy|2|||
46803024|NCT00682643|83022313|FG001|Overall Study|Lack of Efficacy|0|||
46803025|NCT00682643|83022312|FG000|Overall Study|Protocol Violation|38|||
46803026|NCT00682643|83022313|FG001|Overall Study|Protocol Violation|76|||
46803027|NCT00682643|83022312|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
46803028|NCT00682643|83022313|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
46803029|NCT00682643|83022312|FG000|Overall Study|Lost to Follow-up|1|||
46803030|NCT00682643|83022313|FG001|Overall Study|Lost to Follow-up|6|||
46803031|NCT00682643|83022312|FG000|Overall Study|Physician Decision|2|||
46803032|NCT00682643|83022313|FG001|Overall Study|Physician Decision|6|||
46803033|NCT00682643|83022312|FG000|Overall Study|Withdrawal by Subject|19|||
46803034|NCT00682643|83022313|FG001|Overall Study|Withdrawal by Subject|53|||
46803035|NCT00682643|83022312|FG000|Overall Study|Did Not Receive Study Drug|1|||
46803036|NCT00682643|83022313|FG001|Overall Study|Did Not Receive Study Drug|1|||
46803037|NCT00421408|83022322|FG000|Overall Study|Lost to Follow-up|30|||
46803038|NCT00421408|83022323|FG001|Overall Study|Lost to Follow-up|20|||
46803039|NCT00421408|83022322|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
46803040|NCT00421408|83022323|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
46992562|NCT02518685|83239463|FG000|Overall Study|Adverse Event|29|||
46708550|NCT00926536|82924193|FG000|Overall Study|Physician Decision|1|||
46992563|NCT02518685|83239464|FG001|Overall Study|Adverse Event|1|||
46803041|NCT00679913|83022331|FG000|Overall Study|Protocol Violation|18|||
46803042|NCT00679913|83022332|FG001|Overall Study|Protocol Violation|13|||
46803043|NCT00482001|83022341|FG000|Overall Study|Protocol Violation|1|||
46803044|NCT00482001|83022342|FG001|Overall Study|Protocol Violation|1|||
46803045|NCT00490035|83022354|FG000|Overall Study|AE, non-serious non-fatal|3|||
46803046|NCT00490035|83022355|FG001|Overall Study|AE, non-serious non-fatal|4|||
46803047|NCT00490035|83022356|FG002|Overall Study|AE, non-serious non-fatal|4|||
46803048|NCT00490035|83022357|FG003|Overall Study|AE, non-serious non-fatal|5|||
46803049|NCT00490035|83022354|FG000|Overall Study|Lost to Follow-up|2|||
46803050|NCT00490035|83022355|FG001|Overall Study|Lost to Follow-up|0|||
46803051|NCT00490035|83022356|FG002|Overall Study|Lost to Follow-up|1|||
46803052|NCT00490035|83022357|FG003|Overall Study|Lost to Follow-up|0|||
46803053|NCT00490035|83022354|FG000|Overall Study|Withdrawal by Subject|2|||
46803054|NCT00490035|83022355|FG001|Overall Study|Withdrawal by Subject|1|||
46803055|NCT00490035|83022356|FG002|Overall Study|Withdrawal by Subject|1|||
46803056|NCT00490035|83022357|FG003|Overall Study|Withdrawal by Subject|0|||
46803057|NCT00490035|83022354|FG000|Overall Study|Other reason|0|||
46803058|NCT00490035|83022355|FG001|Overall Study|Other reason|1|||
46803059|NCT00490035|83022356|FG002|Overall Study|Other reason|3|||
46803060|NCT00490035|83022357|FG003|Overall Study|Other reason|1|||
46803061|NCT00490035|83022354|FG000|Overall Study|AE, serious fatal|1|||
46803062|NCT00490035|83022355|FG001|Overall Study|AE, serious fatal|0|||
46803063|NCT00490035|83022356|FG002|Overall Study|AE, serious fatal|0|||
46803064|NCT00490035|83022357|FG003|Overall Study|AE, serious fatal|0|||
46803065|NCT00490035|83022354|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
46803066|NCT00490035|83022355|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
46803067|NCT00490035|83022356|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
46803068|NCT00490035|83022357|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
46803069|NCT00490035|83022354|FG000|Overall Study|AE of unknown type|0|||
46803070|NCT00490035|83022355|FG001|Overall Study|AE of unknown type|0|||
46803071|NCT00490035|83022356|FG002|Overall Study|AE of unknown type|2|||
46803072|NCT00490035|83022357|FG003|Overall Study|AE of unknown type|0|||
46803073|NCT00404248|83022370|FG000|Overall Study|pts declining status|0|||
46803074|NCT00404248|83022371|FG001|Overall Study|pts declining status|1|||
46803075|NCT00404248|83022372|FG002|Overall Study|pts declining status|0|||
46803076|NCT00404248|83022373|FG003|Overall Study|pts declining status|0|||
46803077|NCT00404248|83022374|FG004|Overall Study|pts declining status|0|||
46803078|NCT00404248|83022375|FG005|Overall Study|pts declining status|0|||
46803079|NCT00404248|83022376|FG006|Overall Study|pts declining status|0|||
46803080|NCT00404248|83022377|FG007|Overall Study|pts declining status|0|||
46803081|NCT00404248|83022378|FG008|Overall Study|pts declining status|0|||
46803082|NCT00421174|83022406|FG000|Overall Study|Withdrawal by Subject|0|||
46803083|NCT00421174|83022407|FG001|Overall Study|Withdrawal by Subject|1|||
46803084|NCT00421174|83022406|FG000|Overall Study|Ineligible due to infection|2|||
46803085|NCT00421174|83022407|FG001|Overall Study|Ineligible due to infection|0|||
46803086|NCT00496197|83022413|FG000|Overall Study|Discontinued study due to death|43|||
46803087|NCT00496197|83022413|FG000|Overall Study|Adverse Event|13|||
46803088|NCT00496197|83022413|FG000|Overall Study|Does not meet entrance criteria|5|||
46803089|NCT00496197|83022413|FG000|Overall Study|Insufficient clinical response|3|||
46803090|NCT00496197|83022413|FG000|Overall Study|Insufficient bacteriological response|10|||
46803091|NCT00496197|83022413|FG000|Overall Study|Lost to Follow-up|11|||
46803092|NCT00496197|83022413|FG000|Overall Study|Withdrawal by Subject|11|||
46803093|NCT00496197|83022413|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
46803094|NCT00496197|83022413|FG000|Overall Study|Other|14|||
46803095|NCT00496197|83022413|FG000|Overall Study|Protocol Violation|8|||
46803096|NCT00495495|83022417|FG000|Overall Study|Protocol Violation|99|||
46803097|NCT00404092|83022426|FG000|Overall Study|Death|1|||
46803098|NCT00404092|83022427|FG001|Overall Study|Death|0|||
46803099|NCT00404092|83022428|FG002|Overall Study|Death|0|||
46803100|NCT00404092|83022429|FG003|Overall Study|Death|0|||
46803101|NCT00404092|83022426|FG000|Overall Study|Adverse Event|0|||
46803102|NCT00404092|83022427|FG001|Overall Study|Adverse Event|0|||
46803103|NCT00404092|83022428|FG002|Overall Study|Adverse Event|1|||
46897875|NCT03048422|83123653|FG001|Overall Study|Death|0|||
46803104|NCT00404092|83022429|FG003|Overall Study|Adverse Event|0|||
46803105|NCT00481767|83022441|FG000|Overall Study|Withdrawal by Subject|16|||
46803106|NCT00481767|83022442|FG001|Overall Study|Withdrawal by Subject|11|||
46803107|NCT00481767|83022441|FG000|Overall Study|Lost to Follow-up|16|||
46803108|NCT00481767|83022442|FG001|Overall Study|Lost to Follow-up|10|||
46803109|NCT00489489|83022451|FG000|Overall Study|Not treated due to protocol violation|0|||
46803110|NCT00489489|83022452|FG001|Overall Study|Not treated due to protocol violation|1|||
46803111|NCT00489489|83022453|FG002|Overall Study|Not treated due to protocol violation|1|||
46803112|NCT00489489|83022451|FG000|Overall Study|Adverse Event|1|||
46803113|NCT00489489|83022452|FG001|Overall Study|Adverse Event|1|||
46803114|NCT00489489|83022453|FG002|Overall Study|Adverse Event|1|||
46803115|NCT00489489|83022451|FG000|Overall Study|Protocol Violation|1|||
46803116|NCT00489489|83022452|FG001|Overall Study|Protocol Violation|0|||
46803117|NCT00489489|83022453|FG002|Overall Study|Protocol Violation|1|||
46803118|NCT00489489|83022451|FG000|Overall Study|Progressive disease|0|||
46803119|NCT00489489|83022452|FG001|Overall Study|Progressive disease|1|||
46803120|NCT00489489|83022453|FG002|Overall Study|Progressive disease|0|||
46803121|NCT00489489|83022451|FG000|Overall Study|Participant did not wish to continue|1|||
46803122|NCT00489489|83022452|FG001|Overall Study|Participant did not wish to continue|1|||
46803123|NCT00489489|83022453|FG002|Overall Study|Participant did not wish to continue|0|||
46803124|NCT00489489|83022451|FG000|Overall Study|Other than above|0|||
46803125|NCT00489489|83022452|FG001|Overall Study|Other than above|1|||
46803126|NCT00489489|83022453|FG002|Overall Study|Other than above|0|||
46803127|NCT00489411|83022465|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
46803128|NCT00489411|83022466|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
46803129|NCT00489411|83022465|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
46803130|NCT00489411|83022466|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
46803131|NCT00489411|83022465|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
46803132|NCT00489411|83022466|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
46803133|NCT00489411|83022465|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
46803134|NCT00489411|83022466|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
46803135|NCT00489411|83022465|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
46803136|NCT00489411|83022466|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
46803137|NCT00420784|83022476|FG000|Overall Study|Adverse Event|11|||
46803138|NCT00420784|83022477|FG001|Overall Study|Adverse Event|29|||
46803139|NCT00420784|83022478|FG002|Overall Study|Adverse Event|10|||
46803140|NCT00420784|83022479|FG003|Overall Study|Adverse Event|5|||
46803141|NCT00420784|83022476|FG000|Overall Study|Withdrawal by Subject|0|||
46803142|NCT00420784|83022477|FG001|Overall Study|Withdrawal by Subject|1|||
46803143|NCT00420784|83022478|FG002|Overall Study|Withdrawal by Subject|0|||
46803144|NCT00420784|83022479|FG003|Overall Study|Withdrawal by Subject|0|||
46803145|NCT00420784|83022476|FG000|Overall Study|Lost to Follow-up|0|||
46803146|NCT00420784|83022477|FG001|Overall Study|Lost to Follow-up|0|||
46803147|NCT00420784|83022478|FG002|Overall Study|Lost to Follow-up|2|||
46803148|NCT00420784|83022479|FG003|Overall Study|Lost to Follow-up|1|||
46803149|NCT00420784|83022476|FG000|Overall Study|Virologic Stopping Rule|17|||
46803150|NCT00420784|83022477|FG001|Overall Study|Virologic Stopping Rule|26|||
46803151|NCT00420784|83022478|FG002|Overall Study|Virologic Stopping Rule|41|||
46803152|NCT00420784|83022479|FG003|Overall Study|Virologic Stopping Rule|67|||
46803153|NCT00420784|83022476|FG000|Overall Study|Other|1|||
46803154|NCT00420784|83022477|FG001|Overall Study|Other|2|||
46803155|NCT00420784|83022478|FG002|Overall Study|Other|0|||
46803156|NCT00420784|83022479|FG003|Overall Study|Other|5|||
46803157|NCT00420628|83022492|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
46803158|NCT00420628|83022493|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
46803159|NCT00420628|83022492|FG000|Overall Study|Lost to Follow-up|3|||
46803160|NCT00420628|83022493|FG001|Overall Study|Lost to Follow-up|2|||
46992564|NCT02518685|83239463|FG000|Overall Study|Withdrawal by Subject|10|||
46992565|NCT02518685|83239464|FG001|Overall Study|Withdrawal by Subject|3|||
46992566|NCT02518685|83239463|FG000|Overall Study|relocation, study fatigue|7|||
46992567|NCT02518685|83239464|FG001|Overall Study|relocation, study fatigue|2|||
46992568|NCT02518685|83239463|FG000|Overall Study|Pregnancy|1|||
46992569|NCT02518685|83239464|FG001|Overall Study|Pregnancy|0|||
46992570|NCT02518685|83239463|FG000|Overall Study|Physician Decision|1|||
46992571|NCT02518685|83239464|FG001|Overall Study|Physician Decision|0|||
46992572|NCT02518685|83239463|FG000|Overall Study|Lost to Follow-up|1|||
46992573|NCT02518685|83239464|FG001|Overall Study|Lost to Follow-up|4|||
46992574|NCT02520089|83239473|FG000|Overall Study|Lost to Follow-up|3|||
46992575|NCT02520089|83239474|FG001|Overall Study|Lost to Follow-up|4|||
46803161|NCT00420628|83022492|FG000|Overall Study|Adverse Event|1|||
46803162|NCT00420628|83022493|FG001|Overall Study|Adverse Event|0|||
46803163|NCT00489255|83022501|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
46803164|NCT00489255|83022502|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
46803165|NCT00489255|83022501|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
46803166|NCT00489255|83022502|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
46803167|NCT00489255|83022501|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
46803168|NCT00489255|83022502|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
46803169|NCT00489255|83022501|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
46803170|NCT00489255|83022502|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
46803171|NCT00489255|83022501|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
46803172|NCT00489255|83022502|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
46803173|NCT00489255|83022501|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
46803174|NCT00489255|83022502|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
46803175|NCT00489255|83022501|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
46803176|NCT00489255|83022502|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
46803177|NCT00489255|83022501|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
46992576|NCT02105961|83239483|FG000|Overall Study|Adverse Event|18|||
46803178|NCT00489255|83022502|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
46803179|NCT00489255|83022501|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
46803180|NCT00489255|83022502|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
46803181|NCT00489255|83022501|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
46803182|NCT00489255|83022502|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
46803183|NCT00413218|83022510|FG000|Overall Study|Randomized but didn't receive study drug|2|||
46803184|NCT00413218|83022511|FG001|Overall Study|Randomized but didn't receive study drug|8|||
46803185|NCT00413218|83022510|FG000|Overall Study|Death|57|||
46803186|NCT00413218|83022511|FG001|Overall Study|Death|56|||
46803187|NCT00413218|83022510|FG000|Overall Study|Lost to Follow-up|14|||
46803188|NCT00413218|83022511|FG001|Overall Study|Lost to Follow-up|17|||
46803189|NCT00413218|83022510|FG000|Overall Study|Admin|20|||
46803190|NCT00413218|83022511|FG001|Overall Study|Admin|14|||
46803191|NCT00413218|83022510|FG000|Overall Study|Missing|1|||
46803192|NCT00413218|83022511|FG001|Overall Study|Missing|0|||
46803193|NCT00413218|83022510|FG000|Overall Study|Withdrawal by Subject|9|||
46803194|NCT00413218|83022511|FG001|Overall Study|Withdrawal by Subject|1|||
46803195|NCT00420316|83022520|FG000|Overall Study|Withdrawal by Subject|0|||
46803196|NCT00420316|83022521|FG001|Overall Study|Withdrawal by Subject|1|||
46803197|NCT00420316|83022520|FG000|Overall Study|Lost to Follow-up|12|||
46803198|NCT00420316|83022521|FG001|Overall Study|Lost to Follow-up|8|||
46803199|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
46803200|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
46803201|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
46803202|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
46803203|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Death|8|||
46803204|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Death|3|||
46803205|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
46803206|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
46803207|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
46803208|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
46803209|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
46803210|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
46803211|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
46803212|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
46803213|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
46803214|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
46803215|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
46803216|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
46803217|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
46803218|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
46803219|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
46803220|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
46803221|NCT00494871|83022529|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
46803222|NCT00494871|83022530|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
46803223|NCT00494871|83022529|FG000|Follow-up (FU) Period|Adverse Event|1|||
46803224|NCT00494871|83022530|FG001|Follow-up (FU) Period|Adverse Event|1|||
46803225|NCT00494871|83022529|FG000|Follow-up (FU) Period|Death|13|||
46803226|NCT00494871|83022530|FG001|Follow-up (FU) Period|Death|12|||
46803227|NCT00494871|83022529|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
46803228|NCT00494871|83022530|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
46803229|NCT00494871|83022529|FG000|Follow-up (FU) Period|Physician Decision|0|||
46803230|NCT00494871|83022530|FG001|Follow-up (FU) Period|Physician Decision|1|||
46803231|NCT00494871|83022529|FG000|Follow-up (FU) Period|Protocol Violation|1|||
46803232|NCT00494871|83022530|FG001|Follow-up (FU) Period|Protocol Violation|0|||
46803233|NCT00494871|83022529|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
46803234|NCT00494871|83022530|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
46803235|NCT00494871|83022529|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
46803236|NCT00494871|83022530|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
46803237|NCT00420238|83022540|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
46803238|NCT00420238|83022541|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
46803239|NCT00420238|83022540|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
46803240|NCT00420238|83022541|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
46803241|NCT00420238|83022540|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
46803242|NCT00420238|83022541|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
46803243|NCT00420238|83022540|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
46803244|NCT00420238|83022541|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
46803245|NCT00420238|83022540|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
46803246|NCT00420238|83022541|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
46803247|NCT00420238|83022540|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
46803248|NCT00420238|83022541|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
46803249|NCT00420004|83022556|FG000|Overall Study|Adverse Event|4|||
46803250|NCT00420004|83022557|FG001|Overall Study|Adverse Event|1|||
46803251|NCT00420004|83022558|FG002|Overall Study|Adverse Event|1|||
46803252|NCT00420004|83022556|FG000|Overall Study|Lack of Efficacy|5|||
46803253|NCT00420004|83022557|FG001|Overall Study|Lack of Efficacy|4|||
46803254|NCT00420004|83022558|FG002|Overall Study|Lack of Efficacy|1|||
46803255|NCT00420004|83022556|FG000|Overall Study|Lost to Follow-up|31|||
46803256|NCT00420004|83022557|FG001|Overall Study|Lost to Follow-up|12|||
46803257|NCT00420004|83022558|FG002|Overall Study|Lost to Follow-up|10|||
46803258|NCT00420004|83022556|FG000|Overall Study|Entry Criteria Not Met|0|||
46803259|NCT00420004|83022557|FG001|Overall Study|Entry Criteria Not Met|1|||
46803260|NCT00420004|83022558|FG002|Overall Study|Entry Criteria Not Met|0|||
46803261|NCT00420004|83022556|FG000|Overall Study|Physician Decision|14|||
46803262|NCT00420004|83022557|FG001|Overall Study|Physician Decision|4|||
46803263|NCT00420004|83022558|FG002|Overall Study|Physician Decision|2|||
46803264|NCT00420004|83022556|FG000|Overall Study|Protocol Violation|5|||
46803265|NCT00420004|83022557|FG001|Overall Study|Protocol Violation|4|||
46803266|NCT00420004|83022558|FG002|Overall Study|Protocol Violation|3|||
46803267|NCT00420004|83022556|FG000|Overall Study|Withdrawal by Subject|67|||
46803268|NCT00420004|83022557|FG001|Overall Study|Withdrawal by Subject|42|||
46803269|NCT00420004|83022558|FG002|Overall Study|Withdrawal by Subject|14|||
46803270|NCT00420004|83022556|FG000|Overall Study|Sponsor Decision|3|||
46803271|NCT00420004|83022557|FG001|Overall Study|Sponsor Decision|3|||
46803272|NCT00420004|83022558|FG002|Overall Study|Sponsor Decision|1|||
46803273|NCT00494481|83022572|FG000|Overall Study|Condition under investigation worsened|11|||
46803274|NCT00494481|83022573|FG001|Overall Study|Condition under investigation worsened|13|||
46803275|NCT00494481|83022572|FG000|Overall Study|Adverse Event|15|||
46803276|NCT00494481|83022573|FG001|Overall Study|Adverse Event|11|||
46708551|NCT00926536|82924194|FG001|Overall Study|Physician Decision|2|||
46708552|NCT00923260|82924202|FG000|Overall Study|Lost to Follow-up|1|||
46708553|NCT00923260|82924203|FG001|Overall Study|Lost to Follow-up|1|||
46708554|NCT00934102|82924209|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
46708555|NCT00934102|82924210|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
46708556|NCT00934102|82924211|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
46708557|NCT00970281|82924230|FG000|Overall Study|Lack of Efficacy|1|||
46708558|NCT00970281|82924231|FG001|Overall Study|Lack of Efficacy|14|||
46708559|NCT00970281|82924230|FG000|Overall Study|Withdrawal by Subject|0|||
46708560|NCT00970281|82924231|FG001|Overall Study|Withdrawal by Subject|1|||
46708561|NCT00970281|82924230|FG000|Overall Study|Physician Decision|1|||
46708562|NCT00970281|82924231|FG001|Overall Study|Physician Decision|1|||
46708563|NCT00976209|82924239|FG000|Treatment Period 1|Protocol Violation|1|||
46897876|NCT03048422|83123654|FG002|Overall Study|Death|0|||
46897877|NCT03048422|83123652|FG000|Overall Study|Lost to Follow-up|5|||
46897878|NCT03048422|83123653|FG001|Overall Study|Lost to Follow-up|0|||
46897879|NCT03048422|83123654|FG002|Overall Study|Lost to Follow-up|1|||
46897880|NCT03048422|83123652|FG000|Overall Study|Withdrawal by Subject|5|||
46897881|NCT03048422|83123653|FG001|Overall Study|Withdrawal by Subject|7|||
46897882|NCT03048422|83123654|FG002|Overall Study|Withdrawal by Subject|4|||
46897883|NCT03048422|83123652|FG000|Overall Study|Moved|3|||
46897884|NCT03048422|83123653|FG001|Overall Study|Moved|2|||
46897885|NCT03048422|83123654|FG002|Overall Study|Moved|2|||
46897886|NCT03048422|83123652|FG000|Overall Study|Noncompliant with Study Requirements|2|||
46897887|NCT03048422|83123653|FG001|Overall Study|Noncompliant with Study Requirements|1|||
46897888|NCT03048422|83123654|FG002|Overall Study|Noncompliant with Study Requirements|2|||
46897889|NCT03048422|83123652|FG000|Overall Study|Not Able to Get to Clinic|1|||
46897890|NCT03048422|83123653|FG001|Overall Study|Not Able to Get to Clinic|0|||
46897891|NCT03048422|83123654|FG002|Overall Study|Not Able to Get to Clinic|0|||
46897892|NCT04664855|83123674|FG000|Overall Study|Withdrawal by Subject|0|||
46897893|NCT04664855|83123675|FG001|Overall Study|Withdrawal by Subject|2|||
46897894|NCT04664153|83123685|FG000|Overall Study|Lack of Efficacy|0|||
46897895|NCT04664153|83123686|FG001|Overall Study|Lack of Efficacy|0|||
46897896|NCT04664153|83123687|FG002|Overall Study|Lack of Efficacy|1|||
46897897|NCT04664153|83123688|FG003|Overall Study|Lack of Efficacy|0|||
46897898|NCT04664153|83123685|FG000|Overall Study|Physician Decision|0|||
46897899|NCT04664153|83123686|FG001|Overall Study|Physician Decision|0|||
46897900|NCT04664153|83123687|FG002|Overall Study|Physician Decision|1|||
46897901|NCT04664153|83123688|FG003|Overall Study|Physician Decision|0|||
46897902|NCT04664153|83123685|FG000|Overall Study|Withdrawal by Subject|3|||
46708564|NCT00976209|82924240|FG001|Treatment Period 1|Protocol Violation|0|||
46708565|NCT00976209|82924239|FG000|Treatment Period 1|Lost to Follow-up|2|||
46708566|NCT00976209|82924240|FG001|Treatment Period 1|Lost to Follow-up|0|||
46708567|NCT00976209|82924239|FG000|Treatment Period 1|Other|0|||
46708568|NCT00976209|82924240|FG001|Treatment Period 1|Other|1|||
46803277|NCT00494481|83022572|FG000|Overall Study|Other|1|||
46803278|NCT00494481|83022573|FG001|Overall Study|Other|0|||
46897903|NCT04664153|83123686|FG001|Overall Study|Withdrawal by Subject|2|||
46897904|NCT04664153|83123687|FG002|Overall Study|Withdrawal by Subject|1|||
46897905|NCT04664153|83123688|FG003|Overall Study|Withdrawal by Subject|2|||
46897906|NCT04664153|83123685|FG000|Overall Study|Other|0|||
46897907|NCT04664153|83123686|FG001|Overall Study|Other|1|||
46897908|NCT04664153|83123687|FG002|Overall Study|Other|0|||
46897909|NCT04664153|83123688|FG003|Overall Study|Other|0|||
46897910|NCT04664153|83123685|FG000|Overall Study|Adverse Event|4|||
46897911|NCT04664153|83123686|FG001|Overall Study|Adverse Event|0|||
46897912|NCT04664153|83123687|FG002|Overall Study|Adverse Event|1|||
46897913|NCT04664153|83123688|FG003|Overall Study|Adverse Event|0|||
46897914|NCT04663295|83123700|FG000|Run-in Period|Withdrawal by Subject|3|||
46897915|NCT04663295|83123700|FG000|Overall Study Period|Pregnancy|1|||
46897916|NCT04663295|83123700|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
46897917|NCT04228445|83123711|FG000|Overall Study|Lost to Follow-up|1|||
46897918|NCT04228445|83123712|FG001|Overall Study|Lost to Follow-up|1|||
46897919|NCT04228445|83123711|FG000|Overall Study|Physician Decision|1|||
46897920|NCT04228445|83123712|FG001|Overall Study|Physician Decision|2|||
46897921|NCT04228445|83123711|FG000|Overall Study|Withdrawal by Subject|0|||
46897922|NCT04228445|83123712|FG001|Overall Study|Withdrawal by Subject|1|||
46897923|NCT04228445|83123711|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
46897924|NCT04228445|83123712|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
46897925|NCT04641299|83123724|FG000|Overall Study|Adverse Event|0|||
46897926|NCT04641299|83123725|FG001|Overall Study|Adverse Event|0|||
46897927|NCT04641299|83123726|FG002|Overall Study|Adverse Event|2|||
46897928|NCT04641299|83123727|FG003|Overall Study|Adverse Event|0|||
46897929|NCT04641299|83123724|FG000|Overall Study|Lost to Follow-up|0|||
46897930|NCT04641299|83123725|FG001|Overall Study|Lost to Follow-up|1|||
46897931|NCT04641299|83123726|FG002|Overall Study|Lost to Follow-up|0|||
46897932|NCT04641299|83123727|FG003|Overall Study|Lost to Follow-up|0|||
46897933|NCT04641299|83123724|FG000|Overall Study|Withdrawal by Subject|1|||
46897934|NCT04641299|83123725|FG001|Overall Study|Withdrawal by Subject|0|||
46897935|NCT04641299|83123726|FG002|Overall Study|Withdrawal by Subject|0|||
46897936|NCT04641299|83123727|FG003|Overall Study|Withdrawal by Subject|0|||
46897937|NCT04641299|83123724|FG000|Overall Study|Reason not given|1|||
46897938|NCT04641299|83123725|FG001|Overall Study|Reason not given|0|||
46897939|NCT04641299|83123726|FG002|Overall Study|Reason not given|0|||
46897940|NCT04641299|83123727|FG003|Overall Study|Reason not given|0|||
46897941|NCT03703817|83123743|FG000|Overall Study|Not meeting eligibility criteria|7|||
46897942|NCT03703817|83123744|FG001|Overall Study|Not meeting eligibility criteria|4|||
46897943|NCT03698591|83123752|FG000|Overall Study|Withdrawal by Subject|2|||
46897944|NCT03698591|83123753|FG001|Overall Study|Withdrawal by Subject|2|||
46897945|NCT03698591|83123752|FG000|Overall Study|Failed drug screen|1|||
46897946|NCT03698591|83123753|FG001|Overall Study|Failed drug screen|1|||
46897947|NCT03698591|83123752|FG000|Overall Study|Failed health screen|0|||
46897948|NCT03698591|83123753|FG001|Overall Study|Failed health screen|1|||
46897949|NCT03698591|83123752|FG000|Overall Study|Ineligible for financial compensation|1|||
46897950|NCT03698591|83123753|FG001|Overall Study|Ineligible for financial compensation|0|||
46897951|NCT03698591|83123752|FG000|Overall Study|Equipment Error|1|||
46897952|NCT03698591|83123753|FG001|Overall Study|Equipment Error|0|||
46897953|NCT03698591|83123752|FG000|Overall Study|Could not establish TMS dosage|0|||
46897954|NCT03698591|83123753|FG001|Overall Study|Could not establish TMS dosage|1|||
46897955|NCT04606199|83123759|FG000|Overall Study|Withdrawal by Subject|2|||
46897956|NCT05085665|83123765|FG000|Overall Study|Physician Decision|2|||
46897957|NCT05017493|83123771|FG000|Overall Study|Withdrawal by Subject|26|||
46897958|NCT05017493|83123772|FG001|Overall Study|Withdrawal by Subject|0|||
46897959|NCT05017493|83123771|FG000|Overall Study|Physician Decision|15|||
46897960|NCT05017493|83123772|FG001|Overall Study|Physician Decision|0|||
46897961|NCT05017493|83123771|FG000|Overall Study|Protocol Violation|81|||
46897962|NCT05017493|83123772|FG001|Overall Study|Protocol Violation|0|||
46897963|NCT04599803|83123778|FG000|Overall Study|Withdrawal by Subject|5|||
46897964|NCT04599803|83123778|FG000|Overall Study|Lost to Follow-up|26|||
46897965|NCT05002985|83123782|FG000|Overall Study|Withdrawal by Subject|1|||
46897966|NCT04580303|83123788|FG000|Overall Study|Adverse Event|0|||
46897967|NCT04580303|83123789|FG001|Overall Study|Adverse Event|1|||
46897968|NCT04580303|83123790|FG002|Overall Study|Adverse Event|0|||
46897969|NCT04580303|83123791|FG003|Overall Study|Adverse Event|0|||
46897970|NCT04580303|83123788|FG000|Overall Study|Withdrawal by Subject|0|||
46897971|NCT04580303|83123789|FG001|Overall Study|Withdrawal by Subject|0|||
46897972|NCT04580303|83123790|FG002|Overall Study|Withdrawal by Subject|1|||
46897973|NCT04580303|83123791|FG003|Overall Study|Withdrawal by Subject|0|||
46897974|NCT04577183|83123801|FG000|Overall Study|Death|1|||
46897975|NCT04577183|83123801|FG000|Overall Study|Withdrawal by Subject|3|||
46897976|NCT04577183|83123801|FG000|Overall Study|Early termination|2|||
46897977|NCT04574999|83123807|FG000|Overall Study|Adverse Event|1|||
46897978|NCT04574999|83123808|FG001|Overall Study|Adverse Event|0|||
46897979|NCT04574999|83123807|FG000|Overall Study|Lack of Efficacy|2|||
46897980|NCT04574999|83123808|FG001|Overall Study|Lack of Efficacy|3|||
46897981|NCT04574999|83123807|FG000|Overall Study|Protocol Violation|1|||
46897982|NCT04574999|83123808|FG001|Overall Study|Protocol Violation|0|||
46897983|NCT04574999|83123807|FG000|Overall Study|Withdrawal by Subject|2|||
46897984|NCT04574999|83123808|FG001|Overall Study|Withdrawal by Subject|2|||
46897985|NCT04574999|83123807|FG000|Overall Study|Lost to Follow-up|1|||
46897986|NCT04574999|83123808|FG001|Overall Study|Lost to Follow-up|0|||
46897987|NCT04574999|83123807|FG000|Overall Study|Personal problems|1|||
46897988|NCT04574999|83123808|FG001|Overall Study|Personal problems|0|||
46897989|NCT04574999|83123807|FG000|Overall Study|Previous planned surgery|1|||
46897990|NCT04574999|83123808|FG001|Overall Study|Previous planned surgery|0|||
46897991|NCT04565249|83123818|FG000|Overall Study|Death|0|||
46897992|NCT04565249|83123819|FG001|Overall Study|Death|0|||
46897993|NCT04565249|83123820|FG002|Overall Study|Death|0|||
46897994|NCT04565249|83123821|FG003|Overall Study|Death|1|||
46897995|NCT04942925|83123833|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
46897996|NCT04942925|83123834|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
46897997|NCT04942925|83123833|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
46897998|NCT04942925|83123834|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
46897999|NCT04854707|83123846|FG000|Overall Study|Lack of Efficacy|78|||
46898000|NCT04854707|83123847|FG001|Overall Study|Lack of Efficacy|59|||
46898001|NCT04854707|83123848|FG002|Overall Study|Lack of Efficacy|30|||
46898002|NCT04557371|83123863|FG000|Overall Study|Covid-19-related|0|||
46898003|NCT04557371|83123864|FG001|Overall Study|Covid-19-related|1|||
46898004|NCT04557371|83123865|FG002|Overall Study|Covid-19-related|0|||
46898005|NCT04557371|83123863|FG000|Overall Study|Withdrawal by Subject|0|||
46898006|NCT04557371|83123864|FG001|Overall Study|Withdrawal by Subject|1|||
46898007|NCT04557371|83123865|FG002|Overall Study|Withdrawal by Subject|0|||
46898008|NCT04557371|83123863|FG000|Overall Study|Adverse Event|1|||
46898009|NCT04557371|83123864|FG001|Overall Study|Adverse Event|0|||
46898010|NCT04557371|83123865|FG002|Overall Study|Adverse Event|0|||
46898011|NCT04821245|83123873|FG000|Overall Study|Withdrawal by Subject|3|||
46898012|NCT04821245|83123873|FG000|Overall Study|Physician Decision|1|||
46898013|NCT04821245|83123873|FG000|Overall Study|Protocol Violation|5|||
46898014|NCT04539275|83123881|FG000|Overall Study|Death|2|||
46898015|NCT04539275|83123882|FG001|Overall Study|Death|4|||
46898016|NCT04539275|83123881|FG000|Overall Study|Lost to Follow-up|1|||
46898017|NCT04539275|83123882|FG001|Overall Study|Lost to Follow-up|1|||
46898018|NCT04539275|83123881|FG000|Overall Study|Withdrawal by Subject|3|||
46898019|NCT04539275|83123882|FG001|Overall Study|Withdrawal by Subject|0|||
46898020|NCT04784897|83123891|FG000|Overall Study|Death|4|||
46898021|NCT04784897|83123892|FG001|Overall Study|Death|2|||
46898022|NCT04784897|83123893|FG002|Overall Study|Death|1|||
46898023|NCT04784897|83123891|FG000|Overall Study|Withdrawal by Subject|0|||
46898024|NCT04784897|83123892|FG001|Overall Study|Withdrawal by Subject|0|||
46898025|NCT04784897|83123893|FG002|Overall Study|Withdrawal by Subject|1|||
46898026|NCT04532099|83123907|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
46898027|NCT04532099|83123908|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
46898028|NCT04532099|83123909|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
46898029|NCT03041792|83123923|FG000|Overall Study|Adverse Event|4|||
46898030|NCT03041792|83123924|FG001|Overall Study|Adverse Event|0|||
46898031|NCT03041792|83123923|FG000|Overall Study|Death in the family|0|||
46898032|NCT03041792|83123924|FG001|Overall Study|Death in the family|2|||
46898033|NCT03041792|83123923|FG000|Overall Study|Randomized but not treated|0|||
46898034|NCT03041792|83123924|FG001|Overall Study|Randomized but not treated|1|||
46898035|NCT04507763|83123930|FG000|Overall Study|Participants did not meet entrance criteria|201|||
46898036|NCT03045302|83123937|FG000|Overall Study|Pre-treatment adverse event|1|||
46898037|NCT00705484|83123943|FG000|Overall Study|Adverse Event|28|||
46898038|NCT00705484|83123944|FG001|Overall Study|Adverse Event|27|||
46898039|NCT00705484|83123943|FG000|Overall Study|Lost to Follow-up|169|||
46898040|NCT00705484|83123944|FG001|Overall Study|Lost to Follow-up|250|||
46898041|NCT00705484|83123943|FG000|Overall Study|Withdrawal by Subject|96|||
46898042|NCT00705484|83123944|FG001|Overall Study|Withdrawal by Subject|72|||
46898043|NCT00705484|83123943|FG000|Overall Study|Administrative|89|||
46898044|NCT00705484|83123944|FG001|Overall Study|Administrative|59|||
46898045|NCT04523831|83123954|FG000|Overall Study|Lost to Follow-up|15|||
46898046|NCT04523831|83123955|FG001|Overall Study|Lost to Follow-up|17|||
46898047|NCT04523831|83123954|FG000|Overall Study|Death|0|||
46992577|NCT02105961|83239484|FG001|Overall Study|Adverse Event|7|||
46898048|NCT04523831|83123955|FG001|Overall Study|Death|3|||
46898049|NCT04523831|83123954|FG000|Overall Study|Adverse Event|2|||
46898050|NCT04523831|83123955|FG001|Overall Study|Adverse Event|0|||
46898051|NCT04707664|83123966|FG000|Overall Study|Adverse Event|2|||
46898052|NCT04707664|83123967|FG001|Overall Study|Adverse Event|0|||
46898053|NCT04707664|83123966|FG000|Overall Study|Death|1|||
46898054|NCT04707664|83123967|FG001|Overall Study|Death|2|||
46898055|NCT04707664|83123966|FG000|Overall Study|Withdrawal by Subject|13|||
46898056|NCT04707664|83123967|FG001|Overall Study|Withdrawal by Subject|21|||
46898057|NCT04707664|83123966|FG000|Overall Study|Lost to Follow-up|11|||
46898058|NCT04707664|83123967|FG001|Overall Study|Lost to Follow-up|13|||
46898059|NCT04707664|83123966|FG000|Overall Study|Not treated|2|||
46898060|NCT04707664|83123967|FG001|Overall Study|Not treated|0|||
46898061|NCT01316276|83123973|FG000|Overall Study|Death|1|||
46898062|NCT01316276|83123973|FG000|Overall Study|Adverse Event|19|||
46898063|NCT01316276|83123973|FG000|Overall Study|Withdrawal of consent|24|||
46898064|NCT01316276|83123973|FG000|Overall Study|Lost to Follow-up|1|||
46898065|NCT01316276|83123973|FG000|Overall Study|Other|22|||
46898066|NCT04668989|83123978|FG000|First Intervention|Covid-19 related self-isolation|0|||
46898067|NCT04668989|83123979|FG001|First Intervention|Covid-19 related self-isolation|1|||
46898068|NCT04668989|83123978|FG000|Second Intervention|Adverse Event|0|||
46898069|NCT04668989|83123979|FG001|Second Intervention|Adverse Event|1|||
46898070|NCT03700385|83123985|FG000|Overall Study|Lost to Follow-up|1|||
46898071|NCT04498403|83123991|FG000|Overall Study|Adverse Event|1|||
46898072|NCT04498403|83123992|FG001|Overall Study|Adverse Event|0|||
46898073|NCT04498403|83123991|FG000|Overall Study|Study Terminated By Sponsor|29|||
46898074|NCT04498403|83123992|FG001|Overall Study|Study Terminated By Sponsor|10|||
46898075|NCT04362137|83124000|FG000|Overall Study|Death|9|||
46898076|NCT04362137|83124001|FG001|Overall Study|Death|3|||
46898077|NCT04362137|83124000|FG000|Overall Study|Patient decision|6|||
46898078|NCT04362137|83124001|FG001|Overall Study|Patient decision|3|||
46898079|NCT04362137|83124000|FG000|Overall Study|Adverse Event|1|||
46898080|NCT04362137|83124001|FG001|Overall Study|Adverse Event|0|||
46898081|NCT04362137|83124000|FG000|Overall Study|Lost to Follow-up|1|||
46898082|NCT04362137|83124001|FG001|Overall Study|Lost to Follow-up|0|||
46898083|NCT04362137|83124000|FG000|Overall Study|Protocol deviation|1|||
46898084|NCT04362137|83124001|FG001|Overall Study|Protocol deviation|0|||
46898085|NCT05099380|83124009|FG000|Overall Study|Subject enrolled in error|1|||
46898086|NCT05099380|83124010|FG001|Overall Study|Subject enrolled in error|0|||
46898087|NCT05099380|83124009|FG000|Overall Study|Study Procedure|1|||
46898088|NCT05099380|83124010|FG001|Overall Study|Study Procedure|0|||
46898089|NCT05099380|83124009|FG000|Overall Study|Protocol Violation|1|||
46898090|NCT05099380|83124010|FG001|Overall Study|Protocol Violation|0|||
46898091|NCT05099380|83124009|FG000|Overall Study|Adverse Event|1|||
46898092|NCT05099380|83124010|FG001|Overall Study|Adverse Event|1|||
46898093|NCT05099380|83124009|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
46898094|NCT05099380|83124010|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
46898095|NCT03614728|83124020|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
46898096|NCT03614728|83124021|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
46898097|NCT03614728|83124022|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
46898098|NCT03614728|83124023|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
46898099|NCT03614728|83124020|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
46898100|NCT03614728|83124021|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
46898101|NCT03614728|83124022|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
46898102|NCT03614728|83124023|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
46898103|NCT03154086|83124046|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898104|NCT03154086|83124047|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898105|NCT03154086|83124048|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898106|NCT03154086|83124049|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
46898107|NCT03154086|83124050|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898108|NCT03154086|83124051|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898109|NCT03154086|83124052|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898110|NCT03154086|83124053|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898111|NCT03154086|83124054|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898112|NCT03154086|83124055|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898113|NCT03154086|83124056|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898114|NCT03154086|83124057|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898115|NCT03154086|83124058|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898116|NCT03154086|83124059|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898117|NCT03154086|83124060|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
46898118|NCT03154086|83124046|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898119|NCT03154086|83124047|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
46898120|NCT03154086|83124048|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898121|NCT03154086|83124049|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898122|NCT03154086|83124050|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898123|NCT03154086|83124051|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898124|NCT03154086|83124052|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898125|NCT03154086|83124053|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898126|NCT03154086|83124054|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46992578|NCT02105961|83239485|FG002|Overall Study|Adverse Event|13|||
46898127|NCT03154086|83124055|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898128|NCT03154086|83124056|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898129|NCT03154086|83124057|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898130|NCT03154086|83124058|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898131|NCT03154086|83124059|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898132|NCT03154086|83124060|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
46898133|NCT03154086|83124046|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898134|NCT03154086|83124047|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898135|NCT03154086|83124048|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
46898136|NCT03154086|83124049|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898137|NCT03154086|83124050|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898138|NCT03154086|83124051|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898139|NCT03154086|83124052|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898140|NCT03154086|83124053|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898141|NCT03154086|83124054|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898142|NCT03154086|83124055|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898143|NCT03154086|83124056|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898144|NCT03154086|83124057|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898145|NCT03154086|83124058|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898146|NCT03154086|83124059|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898147|NCT03154086|83124060|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
46898148|NCT03154086|83124046|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
46898149|NCT03154086|83124047|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898150|NCT03154086|83124048|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898151|NCT03154086|83124049|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898152|NCT03154086|83124050|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898153|NCT03154086|83124051|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898154|NCT03154086|83124052|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898155|NCT03154086|83124053|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898156|NCT03154086|83124054|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898157|NCT03154086|83124055|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898158|NCT03154086|83124056|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898159|NCT03154086|83124057|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898160|NCT03154086|83124058|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898161|NCT03154086|83124059|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898162|NCT03154086|83124060|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
46898163|NCT03154086|83124046|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898164|NCT03154086|83124047|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898165|NCT03154086|83124048|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898166|NCT03154086|83124049|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898167|NCT03154086|83124050|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898168|NCT03154086|83124051|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898169|NCT03154086|83124052|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898170|NCT03154086|83124053|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898171|NCT03154086|83124054|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
46898172|NCT03154086|83124055|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898173|NCT03154086|83124056|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898174|NCT03154086|83124057|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898175|NCT03154086|83124058|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898176|NCT03154086|83124059|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898177|NCT03154086|83124060|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
46898178|NCT03154086|83124046|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898179|NCT03154086|83124047|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898180|NCT03154086|83124048|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898181|NCT03154086|83124049|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898182|NCT03154086|83124050|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898183|NCT03154086|83124051|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898184|NCT03154086|83124052|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898185|NCT03154086|83124053|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
46898186|NCT03154086|83124054|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898187|NCT03154086|83124055|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898188|NCT03154086|83124056|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898189|NCT03154086|83124057|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898190|NCT03154086|83124058|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898191|NCT03154086|83124059|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46898192|NCT03154086|83124060|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
46708569|NCT00976209|82924239|FG000|Wash-out Period|Adverse Event|1|||
46708570|NCT00976209|82924240|FG001|Wash-out Period|Adverse Event|2|||
46898193|NCT03154086|83124046|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
46898194|NCT03154086|83124047|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
46898195|NCT03154086|83124048|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
46898196|NCT03154086|83124049|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
46898197|NCT03154086|83124050|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
46898198|NCT03154086|83124051|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
46898199|NCT03154086|83124052|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
46898200|NCT03154086|83124053|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
46898201|NCT03154086|83124054|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
46898202|NCT03154086|83124055|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
46898203|NCT03154086|83124056|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
46898204|NCT03154086|83124057|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
46898205|NCT03154086|83124058|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
46898206|NCT03154086|83124059|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
46898207|NCT03154086|83124060|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
46898208|NCT02723344|83124118|FG000|Overall Study|Lost to Follow-up|0|||
46708571|NCT00976209|82924239|FG000|Wash-out Period|Lost to Follow-up|1|||
46708572|NCT00976209|82924240|FG001|Wash-out Period|Lost to Follow-up|0|||
46708573|NCT00976209|82924239|FG000|Wash-out Period|Protocol Violation|1|||
46898209|NCT02723344|83124119|FG001|Overall Study|Lost to Follow-up|4|||
46898210|NCT02723188|83124128|FG000|Overall Study|Withdrawal by Subject|1|||
46898211|NCT02723188|83124129|FG001|Overall Study|Withdrawal by Subject|0|||
46898212|NCT02723188|83124130|FG002|Overall Study|Withdrawal by Subject|0|||
46898213|NCT00705406|83124140|FG000|Overall Study|Lost to Follow-up|3|||
46898214|NCT00705406|83124141|FG001|Overall Study|Lost to Follow-up|3|||
46898215|NCT00705406|83124140|FG000|Overall Study|Did not receive study drug|1|||
46898216|NCT00705406|83124141|FG001|Overall Study|Did not receive study drug|2|||
46898217|NCT03155178|83124152|FG000|Overall Study|Did not meet treatment day baseline|7|||
46898218|NCT03155178|83124153|FG001|Overall Study|Did not meet treatment day baseline|7|||
46898219|NCT03155178|83124154|FG002|Overall Study|Did not meet treatment day baseline|7|||
46708574|NCT00976209|82924240|FG001|Wash-out Period|Protocol Violation|0|||
46708575|NCT00976209|82924239|FG000|Wash-out Period|Other|1|||
46708576|NCT00976209|82924240|FG001|Wash-out Period|Other|0|||
46708577|NCT00976209|82924239|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46708578|NCT00976209|82924240|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46708579|NCT00976209|82924239|FG000|Treatment Period 2|Lost to Follow-up|0|||
46708580|NCT00976209|82924240|FG001|Treatment Period 2|Lost to Follow-up|1|||
46708581|NCT00925990|82924247|FG000|Overall Study|Adverse Event|1|||
46803279|NCT00494481|83022572|FG000|Overall Study|Never received IP|2|||
46803280|NCT00494481|83022573|FG001|Overall Study|Never received IP|0|||
46803281|NCT00097591|83022581|FG000|Overall Study|Withdrawal of consent|342|||
46803282|NCT00097591|83022582|FG001|Overall Study|Withdrawal of consent|323|||
46803283|NCT00097591|83022581|FG000|Overall Study|Less than 6 months on study drug|9|||
46803284|NCT00097591|83022582|FG001|Overall Study|Less than 6 months on study drug|7|||
46898220|NCT03155178|83124155|FG003|Overall Study|Did not meet treatment day baseline|7|||
46898221|NCT00705250|83124179|FG000|Overall Study|Withdrawal by Subject|1|||
46898222|NCT00705250|83124179|FG000|Overall Study|Patient died in car accident|1|||
46898223|NCT05553600|83124185|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
46898224|NCT05553600|83124186|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
46898225|NCT05553600|83124187|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
46898226|NCT05553600|83124188|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
46898227|NCT05553600|83124185|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
46898228|NCT05553600|83124186|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
46898229|NCT05553600|83124187|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
46898230|NCT05553600|83124188|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
46898231|NCT05553600|83124185|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
46898232|NCT05553600|83124186|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
46898233|NCT05553600|83124187|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
46898234|NCT05553600|83124188|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
46898235|NCT05553600|83124185|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
46898236|NCT05553600|83124186|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
46898237|NCT05553600|83124187|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
46898238|NCT05553600|83124188|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
46898239|NCT05553600|83124185|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
46898240|NCT05553600|83124186|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
46898241|NCT05553600|83124187|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
46803285|NCT00097591|83022581|FG000|Overall Study|Unable to attend termination visit|53|||
46898242|NCT05553600|83124188|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
46708582|NCT00925990|82924248|FG001|Overall Study|Adverse Event|3|||
46708583|NCT00925990|82924247|FG000|Overall Study|Withdrawal by Subject|2|||
46803286|NCT00097591|83022582|FG001|Overall Study|Unable to attend termination visit|51|||
46898243|NCT05553600|83124185|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
46898244|NCT05553600|83124186|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
46898245|NCT05553600|83124187|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
46898246|NCT05553600|83124188|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
46898247|NCT05553600|83124185|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
46898248|NCT05553600|83124186|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
46898249|NCT05553600|83124187|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
46898250|NCT05553600|83124188|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
46898251|NCT05553600|83124185|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
46898252|NCT05553600|83124186|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
46898253|NCT05553600|83124187|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
46898254|NCT05553600|83124188|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
46898255|NCT05553600|83124185|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
46898256|NCT05553600|83124186|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
46898257|NCT05553600|83124187|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
46898258|NCT05553600|83124188|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
46898259|NCT05553600|83124185|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
46898260|NCT05553600|83124186|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
46898261|NCT05553600|83124187|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
46898262|NCT05553600|83124188|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
46898263|NCT05553600|83124185|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
46898264|NCT05553600|83124186|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
46898265|NCT05553600|83124187|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
46898266|NCT05553600|83124188|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
46898267|NCT05553600|83124185|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
46898268|NCT05553600|83124186|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
46898269|NCT05553600|83124187|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
46898270|NCT05553600|83124188|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
46898271|NCT05451329|83124202|FG000|Overall Study|Adverse Event|1|||
46898272|NCT05451329|83124203|FG001|Overall Study|Adverse Event|1|||
46898273|NCT05451329|83124204|FG002|Overall Study|Adverse Event|0|||
46898274|NCT05451329|83124202|FG000|Overall Study|Withdrawal by Subject|1|||
46898275|NCT05451329|83124203|FG001|Overall Study|Withdrawal by Subject|0|||
46898276|NCT05451329|83124204|FG002|Overall Study|Withdrawal by Subject|0|||
46898277|NCT05451329|83124202|FG000|Overall Study|Investigational Product Lot exchange|1|||
46898278|NCT05451329|83124203|FG001|Overall Study|Investigational Product Lot exchange|1|||
46898279|NCT05451329|83124204|FG002|Overall Study|Investigational Product Lot exchange|0|||
46898280|NCT05013905|83124232|FG000|Overall Study|Adverse Event|1|||
46898281|NCT05013905|83124232|FG000|Overall Study|Lack of Efficacy|1|||
46898282|NCT04887506|83124242|FG000|Overall Study|Death|1|||
46898283|NCT04887506|83124243|FG001|Overall Study|Death|1|||
46898284|NCT04887506|83124242|FG000|Overall Study|Withdrawal by Subject|0|||
46898285|NCT04887506|83124243|FG001|Overall Study|Withdrawal by Subject|3|||
46898286|NCT04887506|83124242|FG000|Overall Study|Adverse Event|4|||
46898287|NCT04887506|83124243|FG001|Overall Study|Adverse Event|3|||
46898288|NCT04887506|83124242|FG000|Overall Study|Other - Not Reported|1|||
46898289|NCT04887506|83124243|FG001|Overall Study|Other - Not Reported|1|||
46898290|NCT04872569|83124253|FG000|Overall Study|Withdrawal by Subject|2|||
46992579|NCT02105961|83239483|FG000|Overall Study|Lack of Efficacy|3|||
46992580|NCT02105961|83239484|FG001|Overall Study|Lack of Efficacy|0|||
46992581|NCT02105961|83239485|FG002|Overall Study|Lack of Efficacy|3|||
46992582|NCT02105961|83239483|FG000|Overall Study|Lost to Follow-up|2|||
46992583|NCT02105961|83239484|FG001|Overall Study|Lost to Follow-up|0|||
46992584|NCT02105961|83239485|FG002|Overall Study|Lost to Follow-up|1|||
46992585|NCT02105961|83239483|FG000|Overall Study|Physician Decision|3|||
46992586|NCT02105961|83239484|FG001|Overall Study|Physician Decision|3|||
46992587|NCT02105961|83239485|FG002|Overall Study|Physician Decision|2|||
46992588|NCT02105961|83239483|FG000|Overall Study|Withdrawal by Subject|15|||
46992589|NCT02105961|83239484|FG001|Overall Study|Withdrawal by Subject|7|||
46992590|NCT02105961|83239485|FG002|Overall Study|Withdrawal by Subject|11|||
46992591|NCT02141997|83239498|FG000|Overall Study|Adverse Event|0|||
46992592|NCT02141997|83239499|FG001|Overall Study|Adverse Event|2|||
46992593|NCT02141997|83239500|FG002|Overall Study|Adverse Event|0|||
46992594|NCT02141997|83239501|FG003|Overall Study|Adverse Event|1|||
46992595|NCT02141997|83239498|FG000|Overall Study|Participant noncompliance|1|||
46992596|NCT02141997|83239499|FG001|Overall Study|Participant noncompliance|0|||
46992597|NCT02141997|83239500|FG002|Overall Study|Participant noncompliance|0|||
46992598|NCT02141997|83239501|FG003|Overall Study|Participant noncompliance|0|||
46992599|NCT02141997|83239498|FG000|Overall Study|Withdrew consent|1|||
46613445|NCT02487498|82725155|FG000|Period: Washout|Lack of Efficacy|1|||
46613446|NCT02487498|82725156|FG001|Period: Washout|Lack of Efficacy|1|||
46803287|NCT00097591|83022581|FG000|Overall Study|Lost to follow up|6|||
46803288|NCT00097591|83022582|FG001|Overall Study|Lost to follow up|10|||
46803289|NCT00097591|83022581|FG000|Overall Study|Other|0|||
46803290|NCT00097591|83022582|FG001|Overall Study|Other|3|||
46803291|NCT00419926|83022590|FG000|Overall Study|Withdrawal by Subject|7|||
46803292|NCT00419926|83022591|FG001|Overall Study|Withdrawal by Subject|3|||
46803293|NCT00419926|83022590|FG000|Overall Study|Administrative Problem|4|||
46803294|NCT00419926|83022591|FG001|Overall Study|Administrative Problem|4|||
46803295|NCT00419926|83022590|FG000|Overall Study|Lost to Follow-up|1|||
46803296|NCT00419926|83022591|FG001|Overall Study|Lost to Follow-up|2|||
46803297|NCT00419926|83022590|FG000|Overall Study|Death|2|||
46803298|NCT00419926|83022591|FG001|Overall Study|Death|1|||
46803299|NCT00080119|83022601|FG000|Overall Study|Discontinued because of study closure|0|||
46803300|NCT00080119|83022602|FG001|Overall Study|Discontinued because of study closure|0|||
46803301|NCT00080119|83022603|FG002|Overall Study|Discontinued because of study closure|130|||
46803302|NCT00080119|83022604|FG003|Overall Study|Discontinued because of study closure|141|||
46803303|NCT00080119|83022601|FG000|Overall Study|Unable to get to clinic|24|||
46803304|NCT00080119|83022602|FG001|Overall Study|Unable to get to clinic|24|||
46803305|NCT00080119|83022603|FG002|Overall Study|Unable to get to clinic|7|||
46803306|NCT00080119|83022604|FG003|Overall Study|Unable to get to clinic|1|||
46803307|NCT00080119|83022601|FG000|Overall Study|Consent withdrawn|13|||
46803308|NCT00080119|83022602|FG001|Overall Study|Consent withdrawn|17|||
46803309|NCT00080119|83022603|FG002|Overall Study|Consent withdrawn|4|||
46803310|NCT00080119|83022604|FG003|Overall Study|Consent withdrawn|6|||
46803311|NCT00080119|83022601|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
46803312|NCT00080119|83022602|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
46803313|NCT00080119|83022603|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
46803314|NCT00080119|83022604|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
46803315|NCT00080119|83022601|FG000|Overall Study|Lost to Follow-up|16|||
46803316|NCT00080119|83022602|FG001|Overall Study|Lost to Follow-up|19|||
46803317|NCT00080119|83022603|FG002|Overall Study|Lost to Follow-up|19|||
46803318|NCT00080119|83022604|FG003|Overall Study|Lost to Follow-up|14|||
46803319|NCT00419380|83022618|FG000|Overall Study|Lack of Efficacy|1|||
46803320|NCT00419380|83022619|FG001|Overall Study|Lack of Efficacy|7|||
46803321|NCT00419380|83022618|FG000|Overall Study|Physician Decision|0|||
46803322|NCT00419380|83022619|FG001|Overall Study|Physician Decision|1|||
46803323|NCT00419380|83022618|FG000|Overall Study|Lost to Follow-up|0|||
46803324|NCT00419380|83022619|FG001|Overall Study|Lost to Follow-up|1|||
46803325|NCT00419380|83022618|FG000|Overall Study|Withdrawal by Subject|0|||
46803326|NCT00419380|83022619|FG001|Overall Study|Withdrawal by Subject|1|||
46803327|NCT00413062|83022627|FG000|Overall Study|Adverse event/serious adverse event|289|||
46803328|NCT00413062|83022628|FG001|Overall Study|Adverse event/serious adverse event|56|||
46803329|NCT00413062|83022627|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
46803330|NCT00413062|83022628|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
46803331|NCT00413062|83022627|FG000|Overall Study|Withdrawal of informed consent|111|||
46803332|NCT00413062|83022628|FG001|Overall Study|Withdrawal of informed consent|36|||
46803333|NCT00413062|83022627|FG000|Overall Study|Pregnancy|15|||
46803334|NCT00413062|83022628|FG001|Overall Study|Pregnancy|5|||
46803335|NCT00413062|83022627|FG000|Overall Study|Pregnancy wish|17|||
46803336|NCT00413062|83022628|FG001|Overall Study|Pregnancy wish|6|||
46803337|NCT00413062|83022627|FG000|Overall Study|Lost to Follow-up|175|||
46803338|NCT00413062|83022628|FG001|Overall Study|Lost to Follow-up|73|||
46803339|NCT00413062|83022627|FG000|Overall Study|Other reason|70|||
46803340|NCT00413062|83022628|FG001|Overall Study|Other reason|34|||
46803341|NCT00494091|83022638|FG000|Overall Study|Death|5|||
46803342|NCT00494091|83022639|FG001|Overall Study|Death|54|||
46803343|NCT00494091|83022638|FG000|Overall Study|Lost to Follow-up|0|||
46803344|NCT00494091|83022639|FG001|Overall Study|Lost to Follow-up|4|||
46803345|NCT00494091|83022638|FG000|Overall Study|Other|1|||
46803346|NCT00494091|83022639|FG001|Overall Study|Other|11|||
46803347|NCT00494091|83022638|FG000|Overall Study|Withdrawal by Subject|0|||
46803348|NCT00494091|83022639|FG001|Overall Study|Withdrawal by Subject|7|||
46803349|NCT00494013|83022648|FG000|Overall Study|Adverse Event|0|||
46803350|NCT00494013|83022649|FG001|Overall Study|Adverse Event|1|||
46803351|NCT00494013|83022648|FG000|Overall Study|Entry Criteria Not Met|1|||
46803352|NCT00494013|83022649|FG001|Overall Study|Entry Criteria Not Met|4|||
46803353|NCT00494013|83022648|FG000|Overall Study|Lost to Follow-up|5|||
46803354|NCT00494013|83022649|FG001|Overall Study|Lost to Follow-up|6|||
46803355|NCT00494013|83022648|FG000|Overall Study|Physician Decision|3|||
46803356|NCT00494013|83022649|FG001|Overall Study|Physician Decision|5|||
46992600|NCT02141997|83239499|FG001|Overall Study|Withdrew consent|0|||
46803357|NCT00494013|83022648|FG000|Overall Study|Protocol Violation|8|||
46803358|NCT00494013|83022649|FG001|Overall Study|Protocol Violation|5|||
46803359|NCT00494013|83022648|FG000|Overall Study|Withdrawal by Subject|13|||
46803360|NCT00494013|83022649|FG001|Overall Study|Withdrawal by Subject|14|||
46803361|NCT00494013|83022648|FG000|Overall Study|Sponsor Decision|0|||
46803362|NCT00494013|83022649|FG001|Overall Study|Sponsor Decision|1|||
46803363|NCT00079339|83022658|FG000|Overall Study|Adverse Event|1|||
46803364|NCT00079339|83022659|FG001|Overall Study|Adverse Event|7|||
46803365|NCT00079339|83022660|FG002|Overall Study|Adverse Event|2|||
46803366|NCT00079339|83022658|FG000|Overall Study|Death|1|||
46803367|NCT00079339|83022659|FG001|Overall Study|Death|0|||
46803368|NCT00079339|83022660|FG002|Overall Study|Death|0|||
46803369|NCT00079339|83022658|FG000|Overall Study|Non-compliance|0|||
46803370|NCT00079339|83022659|FG001|Overall Study|Non-compliance|0|||
46803371|NCT00079339|83022660|FG002|Overall Study|Non-compliance|1|||
46803372|NCT00079339|83022658|FG000|Overall Study|Withdrawal by Subject|0|||
46803373|NCT00079339|83022659|FG001|Overall Study|Withdrawal by Subject|4|||
46803374|NCT00079339|83022660|FG002|Overall Study|Withdrawal by Subject|1|||
46803375|NCT00079339|83022658|FG000|Overall Study|Disease progression|3|||
46803376|NCT00079339|83022659|FG001|Overall Study|Disease progression|28|||
46898291|NCT04871776|83124261|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
46898292|NCT04871776|83124262|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
46898293|NCT04871776|83124263|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
46898294|NCT04871776|83124261|FG000|Overall Study|Did not meet eligibility criteria|1|||
46898295|NCT04871776|83124262|FG001|Overall Study|Did not meet eligibility criteria|1|||
46898296|NCT04871776|83124263|FG002|Overall Study|Did not meet eligibility criteria|1|||
46898297|NCT04854642|83124271|FG000|Overall Study|Adverse Event|1|||
46898298|NCT04854642|83124272|FG001|Overall Study|Adverse Event|2|||
46898299|NCT04854642|83124271|FG000|Overall Study|Withdrawal by Subject|0|||
46898300|NCT04854642|83124272|FG001|Overall Study|Withdrawal by Subject|1|||
46898301|NCT04832971|83124284|FG000|Overall Study|Death|1|||
46898302|NCT04832971|83124285|FG001|Overall Study|Death|0|||
46898303|NCT04832971|83124286|FG002|Overall Study|Death|0|||
46898304|NCT04832971|83124287|FG003|Overall Study|Death|0|||
46898305|NCT04832971|83124284|FG000|Overall Study|Lost to Follow-up|1|||
46898306|NCT04832971|83124285|FG001|Overall Study|Lost to Follow-up|1|||
46898307|NCT04832971|83124286|FG002|Overall Study|Lost to Follow-up|1|||
46898308|NCT04832971|83124287|FG003|Overall Study|Lost to Follow-up|0|||
46898309|NCT04832971|83124284|FG000|Overall Study|Withdrawal by Subject|1|||
46898310|NCT04832971|83124285|FG001|Overall Study|Withdrawal by Subject|3|||
46898311|NCT04832971|83124286|FG002|Overall Study|Withdrawal by Subject|2|||
46898312|NCT04832971|83124287|FG003|Overall Study|Withdrawal by Subject|2|||
46898313|NCT04832971|83124284|FG000|Overall Study|Other, Not Specified|0|||
46898314|NCT04832971|83124285|FG001|Overall Study|Other, Not Specified|0|||
46898315|NCT04832971|83124286|FG002|Overall Study|Other, Not Specified|1|||
46898316|NCT04832971|83124287|FG003|Overall Study|Other, Not Specified|0|||
46898317|NCT04824521|83124299|FG000|Overall Study|Lost to Follow-up|1|||
46898318|NCT04706091|83124305|FG000|Treatment 2|Withdrawal by Subject|1|||
46898319|NCT04706091|83124306|FG001|Treatment 2|Withdrawal by Subject|0|||
46898320|NCT04610580|83124312|FG000|Two-way Crossover Period|Adverse Event|1|||
46898321|NCT04610580|83124313|FG001|Two-way Crossover Period|Adverse Event|0|||
46898322|NCT04610580|83124314|FG002|Two-way Crossover Period|Adverse Event|0|||
46898323|NCT04610580|83124315|FG003|Two-way Crossover Period|Adverse Event|0|||
46898324|NCT04610580|83124316|FG004|Two-way Crossover Period|Adverse Event|0|||
46898325|NCT04610580|83124317|FG005|Two-way Crossover Period|Adverse Event|0|||
46898326|NCT04610580|83124312|FG000|Two-way Crossover Period|Physician Decision|1|||
46898327|NCT04610580|83124313|FG001|Two-way Crossover Period|Physician Decision|0|||
46898328|NCT04610580|83124314|FG002|Two-way Crossover Period|Physician Decision|0|||
46898329|NCT04610580|83124315|FG003|Two-way Crossover Period|Physician Decision|0|||
46898330|NCT04610580|83124316|FG004|Two-way Crossover Period|Physician Decision|0|||
46898331|NCT04610580|83124317|FG005|Two-way Crossover Period|Physician Decision|0|||
46898332|NCT04610580|83124312|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
46898333|NCT04610580|83124313|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
46898334|NCT04610580|83124314|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
46898335|NCT04610580|83124315|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
46898336|NCT04610580|83124316|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
46898337|NCT04610580|83124317|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
46898338|NCT04610580|83124312|FG000|Two-way Crossover Period|Other than specified|0|||
46898339|NCT04610580|83124313|FG001|Two-way Crossover Period|Other than specified|1|||
46898340|NCT04610580|83124314|FG002|Two-way Crossover Period|Other than specified|0|||
46898341|NCT04610580|83124315|FG003|Two-way Crossover Period|Other than specified|0|||
46898342|NCT04610580|83124316|FG004|Two-way Crossover Period|Other than specified|0|||
46898343|NCT04610580|83124317|FG005|Two-way Crossover Period|Other than specified|0|||
46898344|NCT04610580|83124312|FG000|Washout Before Extension Period|Other than specified|0|||
46898345|NCT04610580|83124313|FG001|Washout Before Extension Period|Other than specified|1|||
46898346|NCT04610580|83124314|FG002|Washout Before Extension Period|Other than specified|0|||
46898347|NCT04610580|83124315|FG003|Washout Before Extension Period|Other than specified|0|||
46898348|NCT04610580|83124316|FG004|Washout Before Extension Period|Other than specified|0|||
46992601|NCT02141997|83239500|FG002|Overall Study|Withdrew consent|3|||
46803377|NCT00079339|83022660|FG002|Overall Study|Disease progression|2|||
46803378|NCT00493779|83022673|FG000|Overall Study|Logistical issue at site|1|||
46898349|NCT04610580|83124317|FG005|Washout Before Extension Period|Other than specified|0|||
46898350|NCT04610580|83124312|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
46898351|NCT04610580|83124313|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
46898352|NCT04610580|83124314|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
46898353|NCT04610580|83124315|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
46898354|NCT04610580|83124316|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
46898355|NCT04610580|83124317|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
46898356|NCT04610580|83124312|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
46898357|NCT04610580|83124313|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
46898358|NCT04610580|83124314|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
46898359|NCT04610580|83124315|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
46898360|NCT04610580|83124316|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
46898361|NCT04610580|83124317|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
46898362|NCT04359758|83124370|FG000|Overall Study|Protocol Violation|3|||
46898363|NCT04359758|83124371|FG001|Overall Study|Protocol Violation|2|||
46898364|NCT04186871|83124394|FG000|Overall Study|Lack of Efficacy|0|||
46898365|NCT04186871|83124395|FG001|Overall Study|Lack of Efficacy|1|||
46898366|NCT04186871|83124396|FG002|Overall Study|Lack of Efficacy|0|||
46898367|NCT04186871|83124397|FG003|Overall Study|Lack of Efficacy|0|||
46898368|NCT04186871|83124398|FG004|Overall Study|Lack of Efficacy|1|||
46898369|NCT04186871|83124399|FG005|Overall Study|Lack of Efficacy|1|||
46898370|NCT04186871|83124394|FG000|Overall Study|Adverse Event|1|||
46898371|NCT04186871|83124395|FG001|Overall Study|Adverse Event|1|||
46898372|NCT04186871|83124396|FG002|Overall Study|Adverse Event|0|||
46898373|NCT04186871|83124397|FG003|Overall Study|Adverse Event|0|||
46898374|NCT04186871|83124398|FG004|Overall Study|Adverse Event|0|||
46898375|NCT04186871|83124399|FG005|Overall Study|Adverse Event|2|||
46898376|NCT04186871|83124394|FG000|Overall Study|Study terminated by sponsor|1|||
46898377|NCT04186871|83124395|FG001|Overall Study|Study terminated by sponsor|2|||
46898378|NCT04186871|83124396|FG002|Overall Study|Study terminated by sponsor|0|||
46898379|NCT04186871|83124397|FG003|Overall Study|Study terminated by sponsor|1|||
46898380|NCT04186871|83124398|FG004|Overall Study|Study terminated by sponsor|0|||
46898381|NCT04186871|83124399|FG005|Overall Study|Study terminated by sponsor|0|||
46898382|NCT04186871|83124394|FG000|Overall Study|Other reasons|0|||
46898383|NCT04186871|83124395|FG001|Overall Study|Other reasons|0|||
46898384|NCT04186871|83124396|FG002|Overall Study|Other reasons|0|||
46898385|NCT04186871|83124397|FG003|Overall Study|Other reasons|0|||
46898386|NCT04186871|83124398|FG004|Overall Study|Other reasons|0|||
46898387|NCT04186871|83124399|FG005|Overall Study|Other reasons|1|||
46898388|NCT04186871|83124394|FG000|Overall Study|Withdrawal by Subject|0|||
46898389|NCT04186871|83124395|FG001|Overall Study|Withdrawal by Subject|0|||
46898390|NCT04186871|83124396|FG002|Overall Study|Withdrawal by Subject|0|||
46898391|NCT04186871|83124397|FG003|Overall Study|Withdrawal by Subject|0|||
46898392|NCT04186871|83124398|FG004|Overall Study|Withdrawal by Subject|0|||
46898393|NCT04186871|83124399|FG005|Overall Study|Withdrawal by Subject|1|||
46898394|NCT04186871|83124394|FG000|Overall Study|Lost to Follow-up|0|||
46898395|NCT04186871|83124395|FG001|Overall Study|Lost to Follow-up|0|||
46898396|NCT04186871|83124396|FG002|Overall Study|Lost to Follow-up|0|||
46898397|NCT04186871|83124397|FG003|Overall Study|Lost to Follow-up|0|||
46898398|NCT04186871|83124398|FG004|Overall Study|Lost to Follow-up|0|||
46898399|NCT04186871|83124399|FG005|Overall Study|Lost to Follow-up|1|||
46898400|NCT04058366|83124414|FG000|Overall Study|Adverse Event|14|||
46898401|NCT04058366|83124414|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
46898402|NCT04058366|83124414|FG000|Overall Study|Commercial drug is available for participants|6|||
46898403|NCT04058366|83124414|FG000|Overall Study|Death|1|||
46898404|NCT04058366|83124414|FG000|Overall Study|Other non-compliance|2|||
46898405|NCT04058366|83124414|FG000|Overall Study|Other|6|||
46898406|NCT03840902|83124473|FG000|Overall Study|Randomized but not treated|1|||
46898407|NCT03840902|83124474|FG001|Overall Study|Randomized but not treated|1|||
46898408|NCT03775486|83124482|FG000|Initial Therapy Phase|Other reason provided|0|||
46898409|NCT03775486|83124483|FG001|Initial Therapy Phase|Other reason provided|15|||
46898410|NCT03775486|83124482|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
46898411|NCT03775486|83124483|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
46898412|NCT03775486|83124482|FG000|Initial Therapy Phase|Protocol Violation|0|||
46898413|NCT03775486|83124483|FG001|Initial Therapy Phase|Protocol Violation|2|||
46898414|NCT03775486|83124482|FG000|Initial Therapy Phase|Adverse Event|0|||
46898415|NCT03775486|83124483|FG001|Initial Therapy Phase|Adverse Event|34|||
46898416|NCT03775486|83124482|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
46898417|NCT03775486|83124483|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
46898418|NCT03775486|83124482|FG000|Maintenance Phase|Withdrawal by Subject|13|||
46898419|NCT03775486|83124483|FG001|Maintenance Phase|Withdrawal by Subject|12|||
46898420|NCT03775486|83124482|FG000|Maintenance Phase|Death|44|||
46898421|NCT03775486|83124483|FG001|Maintenance Phase|Death|45|||
46898422|NCT03675737|83124501|FG000|Overall Study|Death|593|||
46898423|NCT03675737|83124502|FG001|Overall Study|Death|660|||
46898424|NCT03675737|83124501|FG000|Overall Study|Lost to Follow-up|1|||
46898425|NCT03675737|83124502|FG001|Overall Study|Lost to Follow-up|5|||
46898426|NCT03675737|83124501|FG000|Overall Study|Physician Decision|1|||
46898427|NCT03675737|83124502|FG001|Overall Study|Physician Decision|0|||
46898428|NCT03675737|83124501|FG000|Overall Study|Withdrawal by Subject|14|||
46898429|NCT03675737|83124502|FG001|Overall Study|Withdrawal by Subject|12|||
46898430|NCT03675737|83124501|FG000|Overall Study|Ongoing in Study|181|||
46898431|NCT03675737|83124502|FG001|Overall Study|Ongoing in Study|112|||
46898432|NCT03643562|83124511|FG000|Overall Study|Adverse Event|1|||
46898433|NCT03643562|83124512|FG001|Overall Study|Adverse Event|0|||
46898434|NCT03643562|83124511|FG000|Overall Study|Lack of Efficacy|0|||
46898435|NCT03643562|83124512|FG001|Overall Study|Lack of Efficacy|1|||
46898436|NCT03643562|83124511|FG000|Overall Study|Physician Decision|0|||
46898437|NCT03643562|83124512|FG001|Overall Study|Physician Decision|1|||
46898438|NCT03643562|83124511|FG000|Overall Study|Study Terminated by Sponsor|2|||
46898439|NCT03643562|83124512|FG001|Overall Study|Study Terminated by Sponsor|10|||
46898440|NCT03643562|83124511|FG000|Overall Study|Withdrawal by Subject|2|||
46898441|NCT03643562|83124512|FG001|Overall Study|Withdrawal by Subject|2|||
46898442|NCT03643562|83124511|FG000|Overall Study|Other than specified|3|||
46898443|NCT03643562|83124512|FG001|Overall Study|Other than specified|2|||
46898444|NCT03635567|83124520|FG000|Overall Study|Lost to Follow-up|0|||
46898445|NCT03635567|83124521|FG001|Overall Study|Lost to Follow-up|2|||
46898446|NCT03635567|83124520|FG000|Overall Study|Withdrawal by Subject|9|||
46898447|NCT03635567|83124521|FG001|Overall Study|Withdrawal by Subject|10|||
46898448|NCT03635567|83124520|FG000|Overall Study|Ongoing in Study|125|||
46898449|NCT03635567|83124521|FG001|Overall Study|Ongoing in Study|76|||
46898450|NCT03635567|83124520|FG000|Overall Study|Death|174|||
46898451|NCT03635567|83124521|FG001|Overall Study|Death|221|||
46898452|NCT03606486|83124528|FG000|Overall Study|Unable to collect sample|5|||
46898453|NCT03578536|83124532|FG000|Overall Study|Lost to Follow-up|1|||
46898454|NCT03564496|83124539|FG000|Overall Study|Withdrawal by Subject|1|||
46898455|NCT03564496|83124540|FG001|Overall Study|Withdrawal by Subject|1|||
46898456|NCT03564496|83124541|FG002|Overall Study|Withdrawal by Subject|0|||
46898457|NCT03564496|83124539|FG000|Overall Study|Screen failure|0|||
46898458|NCT03564496|83124540|FG001|Overall Study|Screen failure|3|||
46898459|NCT03564496|83124541|FG002|Overall Study|Screen failure|0|||
46898460|NCT03562247|83124556|FG000|Overall Study|Lost to Follow-up|3|||
46898461|NCT03562247|83124557|FG001|Overall Study|Lost to Follow-up|1|||
46898462|NCT03562247|83124558|FG002|Overall Study|Lost to Follow-up|1|||
46898463|NCT03515837|83124568|FG000|Overall Study|Death|214|||
46898464|NCT03515837|83124569|FG001|Overall Study|Death|221|||
46898465|NCT03515837|83124568|FG000|Overall Study|Lost to Follow-up|0|||
46898466|NCT03515837|83124569|FG001|Overall Study|Lost to Follow-up|1|||
46898467|NCT03515837|83124568|FG000|Overall Study|Ongoing|31|||
46898468|NCT03515837|83124569|FG001|Overall Study|Ongoing|21|||
46898469|NCT03515837|83124568|FG000|Overall Study|Withdrawal by Subject|0|||
46898470|NCT03515837|83124569|FG001|Overall Study|Withdrawal by Subject|4|||
46898471|NCT03443973|83124582|FG000|Double-blind Treatment Period|Adverse Event|5|||
46898472|NCT03443973|83124583|FG001|Double-blind Treatment Period|Adverse Event|19|||
46898473|NCT03443973|83124584|FG002|Double-blind Treatment Period|Adverse Event|0|||
46898474|NCT03443973|83124585|FG003|Double-blind Treatment Period|Adverse Event|0|||
46898475|NCT03443973|83124582|FG000|Double-blind Treatment Period|Death|5|||
46898476|NCT03443973|83124583|FG001|Double-blind Treatment Period|Death|7|||
46898477|NCT03443973|83124584|FG002|Double-blind Treatment Period|Death|0|||
46898478|NCT03443973|83124585|FG003|Double-blind Treatment Period|Death|0|||
46898479|NCT03443973|83124582|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
46898480|NCT03443973|83124583|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
46898481|NCT03443973|83124584|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
46898482|NCT03443973|83124585|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
46898483|NCT03443973|83124582|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
46898484|NCT03443973|83124583|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
46898485|NCT03443973|83124584|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
46898486|NCT03443973|83124585|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
46898487|NCT03443973|83124582|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
46898488|NCT03443973|83124583|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
46898489|NCT03443973|83124584|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
46898490|NCT03443973|83124585|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
46898491|NCT03443973|83124582|FG000|Double-blind Treatment Period|Physician Decision|5|||
46898492|NCT03443973|83124583|FG001|Double-blind Treatment Period|Physician Decision|6|||
46898493|NCT03443973|83124584|FG002|Double-blind Treatment Period|Physician Decision|0|||
46898494|NCT03443973|83124585|FG003|Double-blind Treatment Period|Physician Decision|0|||
46898495|NCT03443973|83124582|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
46898496|NCT03443973|83124583|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
46898497|NCT03443973|83124584|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
46898498|NCT03443973|83124585|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
46898499|NCT03443973|83124582|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
46898500|NCT03443973|83124583|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
46898501|NCT03443973|83124584|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46898502|NCT03443973|83124585|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
46898503|NCT03443973|83124582|FG000|Open-label Extension Period|Reason Not Specified|0|||
46898504|NCT03443973|83124583|FG001|Open-label Extension Period|Reason Not Specified|0|||
46898505|NCT03443973|83124584|FG002|Open-label Extension Period|Reason Not Specified|3|||
46898506|NCT03443973|83124585|FG003|Open-label Extension Period|Reason Not Specified|0|||
46898507|NCT03443973|83124582|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
46898508|NCT03443973|83124583|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
46898509|NCT03443973|83124584|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
46898510|NCT03443973|83124585|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
46898511|NCT03361306|83124649|FG000|Overall Study|Death|5|||
46898512|NCT03361306|83124649|FG000|Overall Study|Still On Study (on study treatment)|3|||
46898513|NCT03361306|83124649|FG000|Overall Study|Still On Study (in follow up)|7|||
46898514|NCT03325439|83124653|FG000|Overall Study|Ineligibility|3|||
46898515|NCT03246347|83124665|FG000|Overall Study|On Study|23|||
46898516|NCT03141177|83124672|FG000|Overall Study|Death|62|||
46898517|NCT03141177|83124673|FG001|Overall Study|Death|13|||
46898518|NCT03141177|83124674|FG002|Overall Study|Death|84|||
46898519|NCT03141177|83124672|FG000|Overall Study|Participant withdrew consent|9|||
46898520|NCT03141177|83124673|FG001|Overall Study|Participant withdrew consent|2|||
46898521|NCT03141177|83124674|FG002|Overall Study|Participant withdrew consent|13|||
46898522|NCT03141177|83124672|FG000|Overall Study|Not reported|1|||
46898523|NCT03141177|83124673|FG001|Overall Study|Not reported|0|||
46898524|NCT03141177|83124674|FG002|Overall Study|Not reported|1|||
46898525|NCT03141177|83124672|FG000|Overall Study|Lost to Follow-up|2|||
46898526|NCT03141177|83124673|FG001|Overall Study|Lost to Follow-up|1|||
46898527|NCT03141177|83124674|FG002|Overall Study|Lost to Follow-up|1|||
46898528|NCT03141177|83124672|FG000|Overall Study|Other reasons|4|||
46898529|NCT03141177|83124673|FG001|Overall Study|Other reasons|0|||
46898530|NCT03141177|83124674|FG002|Overall Study|Other reasons|11|||
46898531|NCT03141177|83124672|FG000|Overall Study|Participants did not start treatment period|3|||
46898532|NCT03141177|83124673|FG001|Overall Study|Participants did not start treatment period|0|||
46898533|NCT03141177|83124674|FG002|Overall Study|Participants did not start treatment period|8|||
46898534|NCT03035864|83124685|FG000|Treatment Period|Adverse Event|1|||
46898535|NCT03035864|83124686|FG001|Treatment Period|Adverse Event|0|||
46898536|NCT03035864|83124685|FG000|Treatment Period|Other|3|||
46898537|NCT03035864|83124686|FG001|Treatment Period|Other|1|||
46898538|NCT03035864|83124685|FG000|Follow-up Period|Adverse Event|1|||
46898539|NCT03035864|83124686|FG001|Follow-up Period|Adverse Event|0|||
46898540|NCT03035864|83124685|FG000|Follow-up Period|Lost to Follow-up|6|||
46898541|NCT03035864|83124686|FG001|Follow-up Period|Lost to Follow-up|2|||
46898542|NCT03035864|83124685|FG000|Follow-up Period|Physician Decision|1|||
46898543|NCT03035864|83124686|FG001|Follow-up Period|Physician Decision|0|||
46898544|NCT03035864|83124685|FG000|Follow-up Period|Other|3|||
46898545|NCT03035864|83124686|FG001|Follow-up Period|Other|2|||
46898546|NCT02889809|83124694|FG000|Overall Study|Withdrawal by Subject|30|||
46898547|NCT02889809|83124695|FG001|Overall Study|Withdrawal by Subject|21|||
46898548|NCT02889809|83124694|FG000|Overall Study|Lost to Follow-up|1|||
46898549|NCT02889809|83124695|FG001|Overall Study|Lost to Follow-up|1|||
46898550|NCT02889809|83124694|FG000|Overall Study|Site Closed|12|||
46898551|NCT02889809|83124695|FG001|Overall Study|Site Closed|11|||
46898552|NCT02759107|83124719|FG000|Overall Study|Adverse Event|0|||
46898553|NCT02759107|83124720|FG001|Overall Study|Adverse Event|0|||
46898554|NCT02759107|83124721|FG002|Overall Study|Adverse Event|0|||
46898555|NCT02759107|83124722|FG003|Overall Study|Adverse Event|0|||
46898556|NCT02759107|83124723|FG004|Overall Study|Adverse Event|0|||
46898557|NCT02759107|83124724|FG005|Overall Study|Adverse Event|0|||
46898558|NCT02759107|83124725|FG006|Overall Study|Adverse Event|0|||
46898559|NCT02759107|83124726|FG007|Overall Study|Adverse Event|0|||
46898560|NCT02759107|83124727|FG008|Overall Study|Adverse Event|0|||
46898561|NCT02759107|83124728|FG009|Overall Study|Adverse Event|0|||
46898562|NCT02759107|83124729|FG010|Overall Study|Adverse Event|0|||
46898563|NCT02759107|83124730|FG011|Overall Study|Adverse Event|0|||
46898564|NCT02759107|83124731|FG012|Overall Study|Adverse Event|2|||
46898565|NCT02759107|83124732|FG013|Overall Study|Adverse Event|0|||
46898566|NCT02759107|83124733|FG014|Overall Study|Adverse Event|0|||
46898567|NCT02759107|83124734|FG015|Overall Study|Adverse Event|1|||
46898568|NCT02759107|83124735|FG016|Overall Study|Adverse Event|0|||
46898569|NCT02759107|83124736|FG017|Overall Study|Adverse Event|2|||
46898570|NCT02759107|83124719|FG000|Overall Study|Scheduling Conflict|0|||
46898571|NCT02759107|83124720|FG001|Overall Study|Scheduling Conflict|0|||
46898572|NCT02759107|83124721|FG002|Overall Study|Scheduling Conflict|0|||
46898573|NCT02759107|83124722|FG003|Overall Study|Scheduling Conflict|0|||
46898574|NCT02759107|83124723|FG004|Overall Study|Scheduling Conflict|0|||
46898575|NCT02759107|83124724|FG005|Overall Study|Scheduling Conflict|0|||
46898576|NCT02759107|83124725|FG006|Overall Study|Scheduling Conflict|0|||
46898577|NCT02759107|83124726|FG007|Overall Study|Scheduling Conflict|0|||
46898578|NCT02759107|83124727|FG008|Overall Study|Scheduling Conflict|0|||
46898579|NCT02759107|83124728|FG009|Overall Study|Scheduling Conflict|1|||
46898580|NCT02759107|83124729|FG010|Overall Study|Scheduling Conflict|0|||
46898581|NCT02759107|83124730|FG011|Overall Study|Scheduling Conflict|0|||
46898582|NCT02759107|83124731|FG012|Overall Study|Scheduling Conflict|0|||
46898583|NCT02759107|83124732|FG013|Overall Study|Scheduling Conflict|0|||
46898584|NCT02759107|83124733|FG014|Overall Study|Scheduling Conflict|0|||
46898585|NCT02759107|83124734|FG015|Overall Study|Scheduling Conflict|0|||
46898586|NCT02759107|83124735|FG016|Overall Study|Scheduling Conflict|0|||
46898587|NCT02759107|83124736|FG017|Overall Study|Scheduling Conflict|0|||
46898588|NCT02658968|83124782|FG000|Received Rituximab|Adverse Event|0|||
46898589|NCT02658968|83124783|FG001|Received Rituximab|Adverse Event|0|||
46898590|NCT02658968|83124784|FG002|Received Rituximab|Adverse Event|0|||
46898591|NCT02658968|83124785|FG003|Received Rituximab|Adverse Event|0|||
46898592|NCT02658968|83124786|FG004|Received Rituximab|Adverse Event|1|||
46898593|NCT02658968|83124782|FG000|Received Rituximab|Progressive disease|0|||
46898594|NCT02658968|83124783|FG001|Received Rituximab|Progressive disease|0|||
46898595|NCT02658968|83124784|FG002|Received Rituximab|Progressive disease|0|||
46898596|NCT02658968|83124785|FG003|Received Rituximab|Progressive disease|0|||
46898597|NCT02658968|83124786|FG004|Received Rituximab|Progressive disease|1|||
46898598|NCT02658968|83124782|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
46898599|NCT02658968|83124783|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
46898600|NCT02658968|83124784|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
46898601|NCT02658968|83124785|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
46898602|NCT02658968|83124786|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
46898603|NCT02658968|83124782|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
46898604|NCT02658968|83124783|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
46898605|NCT02658968|83124784|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
46898606|NCT02658968|83124785|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
46898607|NCT02658968|83124786|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
46898608|NCT02658968|83124782|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
46898609|NCT02658968|83124783|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
46898610|NCT02658968|83124784|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
46898611|NCT02658968|83124785|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
46898612|NCT02658968|83124786|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
46898613|NCT02658968|83124782|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
46898614|NCT02658968|83124783|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
46898615|NCT02658968|83124784|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
46898616|NCT02658968|83124785|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
46898617|NCT02658968|83124786|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
46898618|NCT02658968|83124782|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
46898619|NCT02658968|83124783|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
46898620|NCT02658968|83124784|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
46898621|NCT02658968|83124785|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
46898622|NCT02658968|83124786|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
46898623|NCT02385110|83124821|FG000|Overall Study|Early Death|1|||
46898624|NCT02385110|83124822|FG001|Overall Study|Early Death|0|||
46898625|NCT02138110|83124828|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
46898626|NCT02138110|83124828|FG000|Overall Scaffold Implantation|Death|3|||
46898627|NCT01898793|83124839|FG000|Overall Study|Death|2|||
46898628|NCT01898793|83124840|FG001|Overall Study|Death|1|||
46898629|NCT01898793|83124841|FG002|Overall Study|Death|4|||
46898630|NCT01898793|83124842|FG003|Overall Study|Death|0|||
46898631|NCT01898793|83124843|FG004|Overall Study|Death|0|||
46898632|NCT01898793|83124844|FG005|Overall Study|Death|0|||
46898633|NCT01898793|83124845|FG006|Overall Study|Death|0|||
46898634|NCT01857934|83124864|FG000|Overall Study|Relapse or progression|2|||
46898635|NCT01857934|83124864|FG000|Overall Study|Unacceptable toxicity|3|||
46898636|NCT01857934|83124864|FG000|Overall Study|Unwillingness or inability to comply|2|||
46898637|NCT01857934|83124864|FG000|Overall Study|Physician Decision|3|||
46898638|NCT01757665|83124890|FG000|Overall Study|Still on Study - Visit Completed|240|||
46898639|NCT01757665|83124891|FG001|Overall Study|Still on Study - Visit Completed|30|||
46898640|NCT01757665|83124890|FG000|Overall Study|Still on Study - Visit Pending|398|||
46898641|NCT01757665|83124891|FG001|Overall Study|Still on Study - Visit Pending|40|||
46898642|NCT01757665|83124890|FG000|Overall Study|Still on Study - Missed Visit|14|||
46898643|NCT01757665|83124891|FG001|Overall Study|Still on Study - Missed Visit|1|||
46898644|NCT01757665|83124890|FG000|Overall Study|Death|25|||
46898645|NCT01757665|83124891|FG001|Overall Study|Death|8|||
46898646|NCT01757665|83124890|FG000|Overall Study|Explant|1|||
46898647|NCT01757665|83124891|FG001|Overall Study|Explant|2|||
46898648|NCT01757665|83124890|FG000|Overall Study|Withdrawal by Subject|10|||
46898649|NCT01757665|83124891|FG001|Overall Study|Withdrawal by Subject|0|||
46898650|NCT01757665|83124890|FG000|Overall Study|Lost to Follow-up|1|||
46898651|NCT01757665|83124891|FG001|Overall Study|Lost to Follow-up|1|||
46898652|NCT01757665|83124890|FG000|Overall Study|Not Implanted with Device|5|||
46898653|NCT01757665|83124891|FG001|Overall Study|Not Implanted with Device|1|||
46992602|NCT02141997|83239501|FG003|Overall Study|Withdrew consent|0|||
46992603|NCT02141997|83239498|FG000|Overall Study|Other|1|||
46992604|NCT02141997|83239499|FG001|Overall Study|Other|4|||
46992605|NCT02141997|83239500|FG002|Overall Study|Other|0|||
46992606|NCT02141997|83239501|FG003|Overall Study|Other|0|||
46992607|NCT01628367|83239513|FG000|Overall Study|Adverse Event|1|||
46992608|NCT01628367|83239514|FG001|Overall Study|Adverse Event|0|||
46992609|NCT01627899|83239520|FG000|Overall Study|Study terminated early by sponsor.|5|||
46992610|NCT02519777|83239527|FG000|Overall Study|Death|1|||
46992611|NCT02519777|83239528|FG001|Overall Study|Death|0|||
46992612|NCT02519777|83239529|FG002|Overall Study|Death|0|||
46992613|NCT02519777|83239527|FG000|Overall Study|Lost to Follow-up|0|||
46992614|NCT02519777|83239528|FG001|Overall Study|Lost to Follow-up|4|||
46992615|NCT02519777|83239529|FG002|Overall Study|Lost to Follow-up|2|||
46992616|NCT02519777|83239527|FG000|Overall Study|Withdrawal by Subject|3|||
46992617|NCT02519777|83239528|FG001|Overall Study|Withdrawal by Subject|1|||
46992618|NCT02519777|83239529|FG002|Overall Study|Withdrawal by Subject|0|||
46992619|NCT02519777|83239527|FG000|Overall Study|Severe Debilitation|1|||
46992620|NCT02519777|83239528|FG001|Overall Study|Severe Debilitation|1|||
46992621|NCT02519777|83239529|FG002|Overall Study|Severe Debilitation|1|||
46992622|NCT02519777|83239527|FG000|Overall Study|Not able to get to clinic|1|||
46992623|NCT02519777|83239528|FG001|Overall Study|Not able to get to clinic|2|||
46992624|NCT02519777|83239529|FG002|Overall Study|Not able to get to clinic|1|||
46992625|NCT02515331|83239540|FG000|Overall Study|Withdrawal by Subject|0|||
46992626|NCT02515331|83239541|FG001|Overall Study|Withdrawal by Subject|0|||
46992627|NCT02515331|83239542|FG002|Overall Study|Withdrawal by Subject|1|||
46992628|NCT02515331|83239540|FG000|Overall Study|Protocol deviation|0|||
46992629|NCT02515331|83239541|FG001|Overall Study|Protocol deviation|0|||
46992630|NCT02515331|83239542|FG002|Overall Study|Protocol deviation|3|||
46992631|NCT02515331|83239540|FG000|Overall Study|Adverse Event|2|||
46992632|NCT02515331|83239541|FG001|Overall Study|Adverse Event|0|||
46992633|NCT02515331|83239542|FG002|Overall Study|Adverse Event|0|||
46992634|NCT02515097|83239552|FG000|Overall Study|Lost to Follow-up|4|||
46992635|NCT02515097|83239553|FG001|Overall Study|Lost to Follow-up|2|||
46992636|NCT02515097|83239552|FG000|Overall Study|Withdrawal by Subject|1|||
46992637|NCT02515097|83239553|FG001|Overall Study|Withdrawal by Subject|3|||
46992638|NCT02515097|83239552|FG000|Overall Study|Adverse Event|2|||
46992639|NCT02515097|83239553|FG001|Overall Study|Adverse Event|1|||
46992640|NCT02141295|83239562|FG000|Overall Study|Adverse Event|1|||
46992641|NCT02141295|83239563|FG001|Overall Study|Adverse Event|18|||
46992642|NCT02141295|83239564|FG002|Overall Study|Adverse Event|11|||
46992643|NCT02141295|83239562|FG000|Overall Study|Physician Decision|2|||
46992644|NCT02141295|83239563|FG001|Overall Study|Physician Decision|19|||
46992645|NCT02141295|83239564|FG002|Overall Study|Physician Decision|14|||
46992646|NCT02141295|83239562|FG000|Overall Study|Study terminated by sponsor|0|||
46992647|NCT02141295|83239563|FG001|Overall Study|Study terminated by sponsor|6|||
46992648|NCT02141295|83239564|FG002|Overall Study|Study terminated by sponsor|6|||
46992649|NCT02141295|83239562|FG000|Overall Study|Non-compliance|0|||
46992650|NCT02141295|83239563|FG001|Overall Study|Non-compliance|1|||
46992651|NCT02141295|83239564|FG002|Overall Study|Non-compliance|0|||
46992652|NCT02141295|83239562|FG000|Overall Study|Progressive disease|3|||
46992653|NCT02141295|83239563|FG001|Overall Study|Progressive disease|32|||
46992654|NCT02141295|83239564|FG002|Overall Study|Progressive disease|50|||
46992655|NCT02141295|83239562|FG000|Overall Study|Reason not specified|0|||
46992656|NCT02141295|83239563|FG001|Overall Study|Reason not specified|9|||
46992657|NCT02141295|83239564|FG002|Overall Study|Reason not specified|10|||
46992658|NCT02141295|83239562|FG000|Overall Study|Withdrawal by Subject|0|||
46992659|NCT02141295|83239563|FG001|Overall Study|Withdrawal by Subject|9|||
46992660|NCT02141295|83239564|FG002|Overall Study|Withdrawal by Subject|4|||
46992661|NCT02514551|83239576|FG000|Overall Study|Lost to Follow-up|0|||
46992662|NCT02514551|83239577|FG001|Overall Study|Lost to Follow-up|1|||
46992663|NCT02514551|83239576|FG000|Overall Study|Participant Never Treated|0|||
46992664|NCT02514551|83239577|FG001|Overall Study|Participant Never Treated|2|||
46992665|NCT02141217|83239586|FG000|Overall Study|Adverse Event|1|||
46992666|NCT02141217|83239587|FG001|Overall Study|Adverse Event|2|||
46992667|NCT02141217|83239586|FG000|Overall Study|Protocol Violation|1|||
46992668|NCT02141217|83239587|FG001|Overall Study|Protocol Violation|4|||
46992669|NCT02141217|83239586|FG000|Overall Study|Withdrawal by Subject|6|||
46898654|NCT01459497|83124927|FG000|Overall Study|Inability to meet trial constraints.|1|||
46898655|NCT01459497|83124928|FG001|Overall Study|Inability to meet trial constraints.|0|||
46898656|NCT01459497|83124927|FG000|Overall Study|Physician Decision|1|||
46898657|NCT01459497|83124928|FG001|Overall Study|Physician Decision|1|||
46898658|NCT01459497|83124927|FG000|Overall Study|Hospitalization.|0|||
46898659|NCT01459497|83124928|FG001|Overall Study|Hospitalization.|3|||
46898660|NCT01459497|83124927|FG000|Overall Study|Disease progression.|0|||
46992670|NCT02141217|83239587|FG001|Overall Study|Withdrawal by Subject|0|||
46992671|NCT02141217|83239586|FG000|Overall Study|Lost to Follow-up|1|||
46992672|NCT02141217|83239587|FG001|Overall Study|Lost to Follow-up|1|||
46992673|NCT02141217|83239586|FG000|Overall Study|Physician Decision|1|||
46992674|NCT02141217|83239587|FG001|Overall Study|Physician Decision|0|||
46992675|NCT02141217|83239586|FG000|Overall Study|Surgical Intervention|1|||
46992676|NCT02141217|83239587|FG001|Overall Study|Surgical Intervention|1|||
46992677|NCT02138253|83239598|FG000|Overall Study|Adverse Event|3|||
46992678|NCT02138253|83239599|FG001|Overall Study|Adverse Event|3|||
46992679|NCT02138253|83239598|FG000|Overall Study|Lost to Follow-up|2|||
46992680|NCT02138253|83239599|FG001|Overall Study|Lost to Follow-up|1|||
46992681|NCT02138253|83239598|FG000|Overall Study|Physician Decision|2|||
46992682|NCT02138253|83239599|FG001|Overall Study|Physician Decision|0|||
46992683|NCT02138253|83239598|FG000|Overall Study|Non compliance|1|||
46992684|NCT02138253|83239599|FG001|Overall Study|Non compliance|0|||
46992685|NCT02138253|83239598|FG000|Overall Study|Withdrawal by Subject|1|||
46992686|NCT02138253|83239599|FG001|Overall Study|Withdrawal by Subject|0|||
46992687|NCT02514473|83239607|FG000|Overall Study|Adverse Event|0|||
46992688|NCT02514473|83239608|FG001|Overall Study|Adverse Event|2|||
46992689|NCT02514473|83239607|FG000|Overall Study|Withdrawal by Subject|2|||
46992690|NCT02514473|83239608|FG001|Overall Study|Withdrawal by Subject|1|||
46992691|NCT02514473|83239607|FG000|Overall Study|Lost to Follow-up|0|||
46992692|NCT02514473|83239608|FG001|Overall Study|Lost to Follow-up|1|||
46992693|NCT02514473|83239607|FG000|Overall Study|Other|1|||
46992694|NCT02514473|83239608|FG001|Overall Study|Other|1|||
46992695|NCT02513771|83239617|FG000|Overall Study|Lost to Follow-up|1|||
46992696|NCT02513771|83239618|FG001|Overall Study|Lost to Follow-up|1|||
46992697|NCT02513771|83239617|FG000|Overall Study|Not being able to get to clinic|1|||
46992698|NCT02513771|83239618|FG001|Overall Study|Not being able to get to clinic|0|||
46992699|NCT02104947|83239626|FG000|Overall Study|Withdrawal by Subject|10|||
46992700|NCT02104947|83239627|FG001|Overall Study|Withdrawal by Subject|3|||
46992701|NCT02104947|83239626|FG000|Overall Study|Lost to Follow-up|4|||
46992702|NCT02104947|83239627|FG001|Overall Study|Lost to Follow-up|4|||
46992703|NCT02104947|83239626|FG000|Overall Study|Protocol Violation|6|||
46992704|NCT02104947|83239627|FG001|Overall Study|Protocol Violation|8|||
46992705|NCT02104947|83239626|FG000|Overall Study|Adverse Event|57|||
46992706|NCT02104947|83239627|FG001|Overall Study|Adverse Event|38|||
46992707|NCT02104947|83239626|FG000|Overall Study|Other than stated above|2|||
46992708|NCT02104947|83239627|FG001|Overall Study|Other than stated above|3|||
46992709|NCT02513459|83239637|FG000|Overall Study|Adverse Event|7|||
46992710|NCT02513459|83239637|FG000|Overall Study|Withdrew consent|5|||
46992711|NCT02513459|83239637|FG000|Overall Study|Loss of efficacy|2|||
46992712|NCT02513459|83239637|FG000|Overall Study|Pregnancy|2|||
46992713|NCT02513459|83239637|FG000|Overall Study|Subject decision|2|||
46992714|NCT02513459|83239637|FG000|Overall Study|Lack of response|1|||
46992715|NCT02513459|83239637|FG000|Overall Study|Reproductive plans|1|||
46992716|NCT02513459|83239637|FG000|Overall Study|Surgery planned-- not done|1|||
46992717|NCT02104557|83239646|FG000|Overall Study|Adverse Event|24|||
46992718|NCT02104557|83239646|FG000|Overall Study|Lost to Follow-up|34|||
46992719|NCT02104557|83239646|FG000|Overall Study|Violated the usage and dosage|14|||
46992720|NCT02104557|83239646|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
46992721|NCT02104557|83239646|FG000|Overall Study|Administered Sayana prior to the contract|1|||
46992722|NCT02104557|83239646|FG000|Overall Study|Other|17|||
46992723|NCT02104557|83239646|FG000|Overall Study|Change to other contraception methods|5|||
46992724|NCT02104557|83239646|FG000|Overall Study|Discontinuation due to no pain|1|||
46992725|NCT02104557|83239646|FG000|Overall Study|Withdrawal consent|2|||
46992726|NCT02104557|83239646|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
46992727|NCT02104557|83239646|FG000|Overall Study|Discontinuation of contraception|9|||
46992728|NCT02069379|83239652|FG000|Baseline Measurements|Lost to Follow-up|1|||
46992729|NCT02069379|83239653|FG001|Baseline Measurements|Lost to Follow-up|0|||
46992730|NCT02069379|83239654|FG002|Baseline Measurements|Lost to Follow-up|0|||
46992731|NCT02069379|83239655|FG003|Baseline Measurements|Lost to Follow-up|0|||
46992732|NCT02069379|83239652|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
46992733|NCT02069379|83239653|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
46992734|NCT02069379|83239654|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
46992735|NCT02069379|83239655|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
46992736|NCT02069379|83239652|FG000|First Treatment Arm|Lost to Follow-up|0|||
46992737|NCT02069379|83239653|FG001|First Treatment Arm|Lost to Follow-up|1|||
46992738|NCT02069379|83239654|FG002|First Treatment Arm|Lost to Follow-up|1|||
46992739|NCT02069379|83239655|FG003|First Treatment Arm|Lost to Follow-up|0|||
46992740|NCT02069379|83239652|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
46992741|NCT02069379|83239653|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
46992742|NCT02069379|83239654|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
46992743|NCT02069379|83239655|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
46992744|NCT02069379|83239652|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
46992745|NCT02069379|83239653|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
46992746|NCT02069379|83239654|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
46992747|NCT02069379|83239655|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
46992748|NCT02069379|83239652|FG000|Second Treatment Arm|Lost to Follow-up|0|||
46992749|NCT02069379|83239653|FG001|Second Treatment Arm|Lost to Follow-up|0|||
46992750|NCT02069379|83239654|FG002|Second Treatment Arm|Lost to Follow-up|1|||
46992751|NCT02069379|83239655|FG003|Second Treatment Arm|Lost to Follow-up|0|||
46992752|NCT02511431|83239671|FG000|Treatment|Lost to Follow-up|0|||
46992753|NCT02511431|83239672|FG001|Treatment|Lost to Follow-up|0|||
46992754|NCT02511431|83239673|FG002|Treatment|Lost to Follow-up|1|||
46992755|NCT02511431|83239674|FG003|Treatment|Lost to Follow-up|0|||
46992756|NCT02511431|83239675|FG004|Treatment|Lost to Follow-up|0|||
46992757|NCT02511431|83239676|FG005|Treatment|Lost to Follow-up|1|||
46992758|NCT02137785|83239693|FG000|Overall Study|Lost to Follow-up|1|||
46992759|NCT02137785|83239694|FG001|Overall Study|Lost to Follow-up|0|||
46992760|NCT02137785|83239693|FG000|Overall Study|Withdrawal by Subject|1|||
46992761|NCT02137785|83239694|FG001|Overall Study|Withdrawal by Subject|4|||
46992762|NCT02137785|83239693|FG000|Overall Study|subject moved out of state|1|||
46992763|NCT02137785|83239694|FG001|Overall Study|subject moved out of state|0|||
46992764|NCT01655069|83239704|FG000|Overall Study|Physician Decision|0|||
46992765|NCT01655069|83239705|FG001|Overall Study|Physician Decision|0|||
46992766|NCT01655069|83239706|FG002|Overall Study|Physician Decision|0|||
46992767|NCT01655069|83239707|FG003|Overall Study|Physician Decision|1|||
46992768|NCT01655069|83239704|FG000|Overall Study|Adverse Event|6|||
46992769|NCT01655069|83239705|FG001|Overall Study|Adverse Event|7|||
46992770|NCT01655069|83239706|FG002|Overall Study|Adverse Event|2|||
46992771|NCT01655069|83239707|FG003|Overall Study|Adverse Event|3|||
46992772|NCT01655069|83239704|FG000|Overall Study|Lack of Efficacy|0|||
46992773|NCT01655069|83239705|FG001|Overall Study|Lack of Efficacy|1|||
46992774|NCT01655069|83239706|FG002|Overall Study|Lack of Efficacy|0|||
46992775|NCT01655069|83239707|FG003|Overall Study|Lack of Efficacy|0|||
46992776|NCT01655069|83239704|FG000|Overall Study|No Treatment Needed|0|||
46992777|NCT01655069|83239705|FG001|Overall Study|No Treatment Needed|1|||
46992778|NCT01655069|83239706|FG002|Overall Study|No Treatment Needed|0|||
46992779|NCT01655069|83239707|FG003|Overall Study|No Treatment Needed|0|||
46992780|NCT01655069|83239704|FG000|Overall Study|Withdrawal by Subject|2|||
46992781|NCT01655069|83239705|FG001|Overall Study|Withdrawal by Subject|3|||
46992782|NCT01655069|83239706|FG002|Overall Study|Withdrawal by Subject|0|||
46992783|NCT01655069|83239707|FG003|Overall Study|Withdrawal by Subject|0|||
46992784|NCT02068599|83239718|FG000|Overall Study|Adverse Event|4|||
46992785|NCT02068599|83239719|FG001|Overall Study|Adverse Event|1|||
46992786|NCT02068599|83239720|FG002|Overall Study|Adverse Event|1|||
46992787|NCT02068599|83239718|FG000|Overall Study|Withdrawal by Subject|2|||
46992788|NCT02068599|83239719|FG001|Overall Study|Withdrawal by Subject|7|||
46992789|NCT02068599|83239720|FG002|Overall Study|Withdrawal by Subject|5|||
46992790|NCT02068599|83239718|FG000|Overall Study|Protocol Violation|4|||
46992791|NCT02068599|83239719|FG001|Overall Study|Protocol Violation|2|||
46992792|NCT02068599|83239720|FG002|Overall Study|Protocol Violation|3|||
46992793|NCT02068599|83239718|FG000|Overall Study|Lost to Follow-up|1|||
46992794|NCT02068599|83239719|FG001|Overall Study|Lost to Follow-up|0|||
46992795|NCT02068599|83239720|FG002|Overall Study|Lost to Follow-up|0|||
46992796|NCT02068599|83239718|FG000|Overall Study|Lack of Efficacy|0|||
46992797|NCT02068599|83239719|FG001|Overall Study|Lack of Efficacy|0|||
46992798|NCT02068599|83239720|FG002|Overall Study|Lack of Efficacy|3|||
46992799|NCT02068599|83239718|FG000|Overall Study|Noncompliance|0|||
46992800|NCT02068599|83239719|FG001|Overall Study|Noncompliance|0|||
46992801|NCT02068599|83239720|FG002|Overall Study|Noncompliance|1|||
46992802|NCT01654601|83239730|FG000|1st Administration|Withdrawal by Subject|2|||
46992803|NCT01654601|83239731|FG001|1st Administration|Withdrawal by Subject|0|||
46992804|NCT01654601|83239730|FG000|1st Administration|Protocol Violation|0|||
46992805|NCT01654601|83239731|FG001|1st Administration|Protocol Violation|2|||
46992806|NCT01654601|83239730|FG000|2nd Administration|Adverse Event|1|||
46992807|NCT01654601|83239731|FG001|2nd Administration|Adverse Event|0|||
46992808|NCT01654601|83239730|FG000|2nd Administration|Protocol Violation|0|||
46992809|NCT01654601|83239731|FG001|2nd Administration|Protocol Violation|1|||
46992810|NCT01654523|83239737|FG000|Overall Study|Withdrawal by Subject|1|||
46992811|NCT02508935|83239741|FG000|Overall Study|Withdrawal by Subject|1|||
46992812|NCT02508935|83239741|FG000|Overall Study|Withdrawal by Caregiver|8|||
46992813|NCT02508935|83239741|FG000|Overall Study|Pain Score <4|1|||
46992814|NCT02508935|83239741|FG000|Overall Study|Emesis|3|||
46992815|NCT02508935|83239741|FG000|Overall Study|Adverse Event|3|||
46708584|NCT00925990|82924248|FG001|Overall Study|Withdrawal by Subject|2|||
46992816|NCT02508935|83239741|FG000|Overall Study|Protocol Violation|1|||
46992817|NCT02508935|83239741|FG000|Overall Study|Physician Decision|1|||
46992818|NCT02508935|83239741|FG000|Overall Study|Trial terminated by sponsor|5|||
46992819|NCT02508701|83239751|FG000|Overall Study|Lost to Follow-up|9|||
46992820|NCT02508701|83239752|FG001|Overall Study|Lost to Follow-up|5|||
46992821|NCT02508701|83239753|FG002|Overall Study|Lost to Follow-up|5|||
46992822|NCT02508701|83239754|FG003|Overall Study|Lost to Follow-up|3|||
46992823|NCT02507375|83239770|FG000|Overall Study|Progressive Disease|4|||
46992824|NCT02507375|83239771|FG001|Overall Study|Progressive Disease|5|||
46992825|NCT02507375|83239770|FG000|Overall Study|Death|0|||
46992826|NCT02507375|83239771|FG001|Overall Study|Death|1|||
46992827|NCT02507375|83239770|FG000|Overall Study|Refused treatment|0|||
46992828|NCT02507375|83239771|FG001|Overall Study|Refused treatment|1|||
46992829|NCT02507375|83239770|FG000|Overall Study|Adverse Event|0|||
46992830|NCT02507375|83239771|FG001|Overall Study|Adverse Event|1|||
46992831|NCT02507219|83239781|FG000|Overall Study|Physician Decision|1|||
46992832|NCT02507219|83239782|FG001|Overall Study|Physician Decision|0|||
46992833|NCT02507219|83239783|FG002|Overall Study|Physician Decision|0|||
46992834|NCT02507219|83239784|FG003|Overall Study|Physician Decision|0|||
46992835|NCT02507219|83239785|FG004|Overall Study|Physician Decision|0|||
46992836|NCT02507219|83239786|FG005|Overall Study|Physician Decision|0|||
46992837|NCT02507219|83239781|FG000|Overall Study|Withdrawal by Subject|0|||
46992838|NCT02507219|83239782|FG001|Overall Study|Withdrawal by Subject|0|||
46992839|NCT02507219|83239783|FG002|Overall Study|Withdrawal by Subject|0|||
46992840|NCT02507219|83239784|FG003|Overall Study|Withdrawal by Subject|0|||
46992841|NCT02507219|83239785|FG004|Overall Study|Withdrawal by Subject|1|||
46992842|NCT02507219|83239786|FG005|Overall Study|Withdrawal by Subject|0|||
46992843|NCT02483975|83239796|FG000|Overall Study|Adverse Event|0|||
46992844|NCT02483975|83239797|FG001|Overall Study|Adverse Event|1|||
46992845|NCT02483975|83239796|FG000|Overall Study|Lost to Follow-up|0|||
46992846|NCT02483975|83239797|FG001|Overall Study|Lost to Follow-up|1|||
46992847|NCT02483975|83239796|FG000|Overall Study|Physician Decision|2|||
46992848|NCT02483975|83239797|FG001|Overall Study|Physician Decision|0|||
46992849|NCT02047227|83239808|FG000|Overall Study|Adverse Event|2|||
46992850|NCT02047227|83239809|FG001|Overall Study|Adverse Event|4|||
46992851|NCT02047227|83239808|FG000|Overall Study|Lost to Follow-up|0|||
46992852|NCT02047227|83239809|FG001|Overall Study|Lost to Follow-up|3|||
46992853|NCT02047227|83239808|FG000|Overall Study|Protocol Violation|1|||
46992854|NCT02047227|83239809|FG001|Overall Study|Protocol Violation|0|||
46992855|NCT02047227|83239808|FG000|Overall Study|Spontaneous pregnancy|1|||
46992856|NCT02047227|83239809|FG001|Overall Study|Spontaneous pregnancy|0|||
46992857|NCT02047227|83239808|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
46992858|NCT02047227|83239809|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
46992859|NCT02047227|83239808|FG000|Overall Study|No oocytes retrieved|21|||
46992860|NCT02047227|83239809|FG001|Overall Study|No oocytes retrieved|20|||
46992861|NCT02047227|83239808|FG000|Overall Study|No fertilization|61|||
46992862|NCT02047227|83239809|FG001|Overall Study|No fertilization|51|||
46992863|NCT02047227|83239808|FG000|Overall Study|Intention to freeze all embryos|1|||
46992864|NCT02047227|83239809|FG001|Overall Study|Intention to freeze all embryos|0|||
46992865|NCT02047227|83239808|FG000|Overall Study|All embryos discarded|12|||
46992866|NCT02047227|83239809|FG001|Overall Study|All embryos discarded|11|||
46992867|NCT02047227|83239808|FG000|Overall Study|Other|10|||
46992868|NCT02047227|83239809|FG001|Overall Study|Other|9|||
46992869|NCT02483585|83239817|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
46992870|NCT02483585|83239818|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
46992871|NCT02483585|83239817|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
46992872|NCT02483585|83239818|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
46992873|NCT02483585|83239817|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
46992874|NCT02483585|83239818|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
46992875|NCT02483585|83239817|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
46992876|NCT02483585|83239818|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
46992877|NCT02483585|83239817|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
46992878|NCT02483585|83239818|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
46992879|NCT02483585|83239817|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
46992880|NCT02483585|83239818|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
46992881|NCT02483585|83239817|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
46992882|NCT02483585|83239818|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
46992883|NCT02046993|83239830|FG000|Overall Study|Withdrawal by Subject|2|||
46992884|NCT02046993|83239831|FG001|Overall Study|Withdrawal by Subject|10|||
46992885|NCT02046993|83239830|FG000|Overall Study|Lost to Follow-up|1|||
46992886|NCT02046993|83239831|FG001|Overall Study|Lost to Follow-up|1|||
46992887|NCT02101983|83239841|FG000|Overall Study|Physician Decision|1|||
46992888|NCT02101983|83239842|FG001|Overall Study|Physician Decision|0|||
46992889|NCT02482805|83239851|FG000|Overall Study|Lost to Follow-up|4|||
46992890|NCT02482805|83239852|FG001|Overall Study|Lost to Follow-up|4|||
46992891|NCT02482805|83239853|FG002|Overall Study|Lost to Follow-up|0|||
46992892|NCT02503865|83239864|FG000|Overall Study|Moved out of area|1|||
46992893|NCT02503865|83239865|FG001|Overall Study|Moved out of area|8|||
46992894|NCT02503865|83239866|FG002|Overall Study|Moved out of area|0|||
46992895|NCT02503865|83239864|FG000|Overall Study|Refused treatment|4|||
46992896|NCT02503865|83239865|FG001|Overall Study|Refused treatment|39|||
46992897|NCT02503865|83239866|FG002|Overall Study|Refused treatment|2|||
46992898|NCT01623531|83239877|FG000|Overall Study|Death|1|||
46992899|NCT01623531|83239878|FG001|Overall Study|Death|0|||
46992900|NCT01623531|83239877|FG000|Overall Study|Protocol Violation|2|||
46992901|NCT01623531|83239878|FG001|Overall Study|Protocol Violation|1|||
46992902|NCT01623531|83239877|FG000|Overall Study|Missing data at primary outcome time poi|1|||
46992903|NCT01623531|83239878|FG001|Overall Study|Missing data at primary outcome time poi|1|||
46992904|NCT02503787|83239887|FG000|Enrollment|Withdrawal by Subject|6|||
46992905|NCT02503787|83239887|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
46992906|NCT02503787|83239887|FG000|Enrollment|Physician Decision|2|||
46992907|NCT02503787|83239887|FG000|Enrollment|Insurance issue|2|||
46992908|NCT02503787|83239887|FG000|Enrollment|Lost to Follow-up|1|||
46992909|NCT02503787|83239887|FG000|Enrollment|Study closure|1|||
46992910|NCT02503787|83239887|FG000|Enrollment|Adverse Event|1|||
46992911|NCT02503787|83239887|FG000|Enrollment|Protocol Violation|1|||
46992912|NCT02503787|83239887|FG000|Enrollment|Inability to implant system|1|||
46992913|NCT02503787|83239887|FG000|Enrollment|Unable to be programmed|1|||
46992914|NCT02503787|83239887|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
46992915|NCT02503787|83239887|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
46992916|NCT02503787|83239887|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
46992917|NCT02503787|83239887|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
46992918|NCT02503787|83239887|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
46992919|NCT02503787|83239887|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
46992920|NCT02482571|83239891|FG000|Overall Study|Adverse Event|1|||
46992921|NCT02482571|83239891|FG000|Overall Study|Scanner or Respiract failure|3|||
46992922|NCT02482571|83239891|FG000|Overall Study|Withdrawal by Subject|4|||
46992923|NCT02481947|83239898|FG000|Overall Study|Withdrawal by Subject|24|||
46992924|NCT02481947|83239899|FG001|Overall Study|Withdrawal by Subject|10|||
46992925|NCT02481947|83239898|FG000|Overall Study|Lost to Follow-up|11|||
46992926|NCT02481947|83239899|FG001|Overall Study|Lost to Follow-up|5|||
46992927|NCT02481947|83239898|FG000|Overall Study|Adverse Event|6|||
46992928|NCT02481947|83239899|FG001|Overall Study|Adverse Event|11|||
46992929|NCT02481947|83239898|FG000|Overall Study|Physician Decision|4|||
46992930|NCT02481947|83239899|FG001|Overall Study|Physician Decision|5|||
46992931|NCT02481947|83239898|FG000|Overall Study|Protocol Violation|1|||
46992932|NCT02481947|83239899|FG001|Overall Study|Protocol Violation|5|||
46992933|NCT02503085|83239905|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
46992934|NCT02503085|83239906|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
46992935|NCT02503085|83239907|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
46992936|NCT02503085|83239908|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
46992937|NCT02481869|83239917|FG000|Overall Study|Lost to Follow-up|3|||
46992938|NCT02481869|83239918|FG001|Overall Study|Lost to Follow-up|4|||
46992939|NCT02481869|83239917|FG000|Overall Study|Withdrawal by Subject|2|||
46992940|NCT02481869|83239918|FG001|Overall Study|Withdrawal by Subject|0|||
46992941|NCT02502149|83239925|FG000|Intermediate|Discontinued prematurely|1|||
46992942|NCT02502149|83239926|FG001|Intermediate|Discontinued prematurely|0|||
46992943|NCT02502149|83239927|FG002|Intermediate|Discontinued prematurely|0|||
46992944|NCT02502149|83239928|FG003|Intermediate|Discontinued prematurely|0|||
46992945|NCT02502149|83239929|FG004|Intermediate|Discontinued prematurely|0|||
46992946|NCT02480621|83239948|FG000|Randomization|Withdrawal by Subject|1|||
46992947|NCT02480621|83239949|FG001|Randomization|Withdrawal by Subject|0|||
46992948|NCT02480621|83239948|FG000|Randomization|Surgeon did not give intervention|0|||
46992949|NCT02480621|83239949|FG001|Randomization|Surgeon did not give intervention|1|||
46992950|NCT02480621|83239948|FG000|Follow Up|Lost to Follow-up|4|||
46992951|NCT02480621|83239949|FG001|Follow Up|Lost to Follow-up|2|||
46992952|NCT02046603|83239957|FG000|Overall Study|Other|11|||
46992953|NCT02046603|83239958|FG001|Overall Study|Other|66|||
46992954|NCT02046603|83239957|FG000|Overall Study|Protocol Violation|0|||
46992955|NCT02046603|83239958|FG001|Overall Study|Protocol Violation|1|||
46992956|NCT02046603|83239957|FG000|Overall Study|Participant/legal guardian decision|1|||
46992957|NCT02046603|83239958|FG001|Overall Study|Participant/legal guardian decision|3|||
46992958|NCT02046603|83239957|FG000|Overall Study|Physician Decision|2|||
46992959|NCT02046603|83239958|FG001|Overall Study|Physician Decision|1|||
46992960|NCT02046603|83239957|FG000|Overall Study|Lost to Follow-up|1|||
46992961|NCT02046603|83239958|FG001|Overall Study|Lost to Follow-up|2|||
46992962|NCT02046603|83239957|FG000|Overall Study|Death|0|||
46992963|NCT02046603|83239958|FG001|Overall Study|Death|1|||
46992964|NCT02046603|83239957|FG000|Overall Study|Adverse Event|0|||
46992965|NCT02046603|83239958|FG001|Overall Study|Adverse Event|1|||
46992966|NCT01885078|83239973|FG000|Treatment Period|Adverse Event|52|||
46992967|NCT01885078|83239974|FG001|Treatment Period|Adverse Event|136|||
46992968|NCT01885078|83239975|FG002|Treatment Period|Adverse Event|30|||
46992969|NCT01885078|83239976|FG003|Treatment Period|Adverse Event|73|||
46992970|NCT01885078|83239977|FG004|Treatment Period|Adverse Event|17|||
46992971|NCT01885078|83239978|FG005|Treatment Period|Adverse Event|72|||
46992972|NCT01885078|83239979|FG006|Treatment Period|Adverse Event|24|||
46992973|NCT01885078|83239980|FG007|Treatment Period|Adverse Event|5|||
46992974|NCT01885078|83239981|FG008|Treatment Period|Adverse Event|0|||
46992975|NCT01885078|83239982|FG009|Treatment Period|Adverse Event|0|||
46992976|NCT01885078|83239973|FG000|Treatment Period|Death|13|||
46992977|NCT01885078|83239974|FG001|Treatment Period|Death|33|||
46992978|NCT01885078|83239975|FG002|Treatment Period|Death|5|||
46992979|NCT01885078|83239976|FG003|Treatment Period|Death|9|||
46992980|NCT01885078|83239977|FG004|Treatment Period|Death|2|||
46992981|NCT01885078|83239978|FG005|Treatment Period|Death|10|||
46992982|NCT01885078|83239979|FG006|Treatment Period|Death|3|||
46992983|NCT01885078|83239980|FG007|Treatment Period|Death|2|||
46992984|NCT01885078|83239981|FG008|Treatment Period|Death|0|||
46992985|NCT01885078|83239982|FG009|Treatment Period|Death|0|||
46992986|NCT01885078|83239973|FG000|Treatment Period|Lack of Efficacy|12|||
46992987|NCT01885078|83239974|FG001|Treatment Period|Lack of Efficacy|33|||
46992988|NCT01885078|83239975|FG002|Treatment Period|Lack of Efficacy|10|||
46992989|NCT01885078|83239976|FG003|Treatment Period|Lack of Efficacy|23|||
46992990|NCT01885078|83239977|FG004|Treatment Period|Lack of Efficacy|24|||
46992991|NCT01885078|83239978|FG005|Treatment Period|Lack of Efficacy|58|||
46992992|NCT01885078|83239979|FG006|Treatment Period|Lack of Efficacy|9|||
46992993|NCT01885078|83239980|FG007|Treatment Period|Lack of Efficacy|5|||
46992994|NCT01885078|83239981|FG008|Treatment Period|Lack of Efficacy|0|||
46992995|NCT01885078|83239982|FG009|Treatment Period|Lack of Efficacy|0|||
46992996|NCT01885078|83239973|FG000|Treatment Period|Lost to Follow-up|16|||
46992997|NCT01885078|83239974|FG001|Treatment Period|Lost to Follow-up|19|||
46992998|NCT01885078|83239975|FG002|Treatment Period|Lost to Follow-up|7|||
46992999|NCT01885078|83239976|FG003|Treatment Period|Lost to Follow-up|9|||
46993000|NCT01885078|83239977|FG004|Treatment Period|Lost to Follow-up|2|||
46993001|NCT01885078|83239978|FG005|Treatment Period|Lost to Follow-up|8|||
46993002|NCT01885078|83239979|FG006|Treatment Period|Lost to Follow-up|2|||
46993003|NCT01885078|83239980|FG007|Treatment Period|Lost to Follow-up|0|||
46993004|NCT01885078|83239981|FG008|Treatment Period|Lost to Follow-up|0|||
46993005|NCT01885078|83239982|FG009|Treatment Period|Lost to Follow-up|0|||
46993006|NCT01885078|83239973|FG000|Treatment Period|Physician Decision|19|||
46993007|NCT01885078|83239974|FG001|Treatment Period|Physician Decision|21|||
46993008|NCT01885078|83239975|FG002|Treatment Period|Physician Decision|5|||
46993009|NCT01885078|83239976|FG003|Treatment Period|Physician Decision|12|||
46993010|NCT01885078|83239977|FG004|Treatment Period|Physician Decision|9|||
46993011|NCT01885078|83239978|FG005|Treatment Period|Physician Decision|24|||
46993012|NCT01885078|83239979|FG006|Treatment Period|Physician Decision|4|||
46993013|NCT01885078|83239980|FG007|Treatment Period|Physician Decision|3|||
46993014|NCT01885078|83239981|FG008|Treatment Period|Physician Decision|0|||
46993015|NCT01885078|83239982|FG009|Treatment Period|Physician Decision|0|||
46993016|NCT01885078|83239973|FG000|Treatment Period|Protocol Violation|3|||
46993017|NCT01885078|83239974|FG001|Treatment Period|Protocol Violation|5|||
46993018|NCT01885078|83239975|FG002|Treatment Period|Protocol Violation|0|||
46993019|NCT01885078|83239976|FG003|Treatment Period|Protocol Violation|3|||
46993020|NCT01885078|83239977|FG004|Treatment Period|Protocol Violation|1|||
46993021|NCT01885078|83239978|FG005|Treatment Period|Protocol Violation|6|||
46993022|NCT01885078|83239979|FG006|Treatment Period|Protocol Violation|0|||
46993023|NCT01885078|83239980|FG007|Treatment Period|Protocol Violation|0|||
46993024|NCT01885078|83239981|FG008|Treatment Period|Protocol Violation|0|||
46993025|NCT01885078|83239982|FG009|Treatment Period|Protocol Violation|0|||
46993026|NCT01885078|83239973|FG000|Treatment Period|Sponsor Decision|245|||
46993027|NCT01885078|83239974|FG001|Treatment Period|Sponsor Decision|648|||
46993028|NCT01885078|83239975|FG002|Treatment Period|Sponsor Decision|49|||
46993029|NCT01885078|83239976|FG003|Treatment Period|Sponsor Decision|90|||
46993030|NCT01885078|83239977|FG004|Treatment Period|Sponsor Decision|20|||
46993031|NCT01885078|83239978|FG005|Treatment Period|Sponsor Decision|38|||
46993032|NCT01885078|83239979|FG006|Treatment Period|Sponsor Decision|162|||
46993033|NCT01885078|83239980|FG007|Treatment Period|Sponsor Decision|3|||
46993034|NCT01885078|83239981|FG008|Treatment Period|Sponsor Decision|0|||
46993035|NCT01885078|83239982|FG009|Treatment Period|Sponsor Decision|0|||
46993036|NCT01885078|83239973|FG000|Treatment Period|Withdrawal by Subject|72|||
46993037|NCT01885078|83239974|FG001|Treatment Period|Withdrawal by Subject|132|||
46993038|NCT01885078|83239975|FG002|Treatment Period|Withdrawal by Subject|25|||
46993039|NCT01885078|83239976|FG003|Treatment Period|Withdrawal by Subject|63|||
46993040|NCT01885078|83239977|FG004|Treatment Period|Withdrawal by Subject|15|||
46993041|NCT01885078|83239978|FG005|Treatment Period|Withdrawal by Subject|34|||
46993042|NCT01885078|83239979|FG006|Treatment Period|Withdrawal by Subject|17|||
46993043|NCT01885078|83239980|FG007|Treatment Period|Withdrawal by Subject|10|||
46993044|NCT01885078|83239981|FG008|Treatment Period|Withdrawal by Subject|0|||
46993045|NCT01885078|83239982|FG009|Treatment Period|Withdrawal by Subject|0|||
46993046|NCT01885078|83239973|FG000|Treatment Period|Other|0|||
46993047|NCT01885078|83239974|FG001|Treatment Period|Other|0|||
46993048|NCT01885078|83239975|FG002|Treatment Period|Other|0|||
46993049|NCT01885078|83239976|FG003|Treatment Period|Other|1|||
46993050|NCT01885078|83239977|FG004|Treatment Period|Other|0|||
46993051|NCT01885078|83239978|FG005|Treatment Period|Other|0|||
46993052|NCT01885078|83239979|FG006|Treatment Period|Other|0|||
46993053|NCT01885078|83239980|FG007|Treatment Period|Other|0|||
46993054|NCT01885078|83239981|FG008|Treatment Period|Other|0|||
46993055|NCT01885078|83239982|FG009|Treatment Period|Other|0|||
46993056|NCT01885078|83239973|FG000|Step-down Period|Sponsor Decision|0|||
46993057|NCT01885078|83239974|FG001|Step-down Period|Sponsor Decision|0|||
46993058|NCT01885078|83239975|FG002|Step-down Period|Sponsor Decision|0|||
46993059|NCT01885078|83239976|FG003|Step-down Period|Sponsor Decision|0|||
46993060|NCT01885078|83239977|FG004|Step-down Period|Sponsor Decision|0|||
46993061|NCT01885078|83239978|FG005|Step-down Period|Sponsor Decision|0|||
46993062|NCT01885078|83239979|FG006|Step-down Period|Sponsor Decision|0|||
46993063|NCT01885078|83239980|FG007|Step-down Period|Sponsor Decision|0|||
46993064|NCT01885078|83239981|FG008|Step-down Period|Sponsor Decision|1|||
46993065|NCT01885078|83239982|FG009|Step-down Period|Sponsor Decision|1|||
46993066|NCT01885078|83239973|FG000|Step-down Period|Adverse Event|0|||
46993067|NCT01885078|83239974|FG001|Step-down Period|Adverse Event|0|||
46993068|NCT01885078|83239975|FG002|Step-down Period|Adverse Event|0|||
46993069|NCT01885078|83239976|FG003|Step-down Period|Adverse Event|0|||
46993070|NCT01885078|83239977|FG004|Step-down Period|Adverse Event|0|||
46993071|NCT01885078|83239978|FG005|Step-down Period|Adverse Event|0|||
46993072|NCT01885078|83239979|FG006|Step-down Period|Adverse Event|0|||
46993073|NCT01885078|83239980|FG007|Step-down Period|Adverse Event|0|||
46993074|NCT01885078|83239981|FG008|Step-down Period|Adverse Event|29|||
46993075|NCT01885078|83239982|FG009|Step-down Period|Adverse Event|38|||
46993076|NCT01885078|83239973|FG000|Step-down Period|Withdrawal by Subject|0|||
46993077|NCT01885078|83239974|FG001|Step-down Period|Withdrawal by Subject|0|||
46993078|NCT01885078|83239975|FG002|Step-down Period|Withdrawal by Subject|0|||
46993079|NCT01885078|83239976|FG003|Step-down Period|Withdrawal by Subject|0|||
46993080|NCT01885078|83239977|FG004|Step-down Period|Withdrawal by Subject|0|||
46993081|NCT01885078|83239978|FG005|Step-down Period|Withdrawal by Subject|0|||
46993082|NCT01885078|83239979|FG006|Step-down Period|Withdrawal by Subject|0|||
46993083|NCT01885078|83239980|FG007|Step-down Period|Withdrawal by Subject|0|||
46993084|NCT01885078|83239981|FG008|Step-down Period|Withdrawal by Subject|25|||
46993085|NCT01885078|83239982|FG009|Step-down Period|Withdrawal by Subject|15|||
46993086|NCT01885078|83239973|FG000|Step-down Period|Physician Decision|0|||
46993087|NCT01885078|83239974|FG001|Step-down Period|Physician Decision|0|||
46993088|NCT01885078|83239975|FG002|Step-down Period|Physician Decision|0|||
46993089|NCT01885078|83239976|FG003|Step-down Period|Physician Decision|0|||
46993090|NCT01885078|83239977|FG004|Step-down Period|Physician Decision|0|||
46993091|NCT01885078|83239978|FG005|Step-down Period|Physician Decision|0|||
46993092|NCT01885078|83239979|FG006|Step-down Period|Physician Decision|0|||
46993093|NCT01885078|83239980|FG007|Step-down Period|Physician Decision|0|||
46993094|NCT01885078|83239981|FG008|Step-down Period|Physician Decision|7|||
46993095|NCT01885078|83239982|FG009|Step-down Period|Physician Decision|2|||
46993096|NCT01885078|83239973|FG000|Step-down Period|Death|0|||
46993097|NCT01885078|83239974|FG001|Step-down Period|Death|0|||
46993098|NCT01885078|83239975|FG002|Step-down Period|Death|0|||
46993099|NCT01885078|83239976|FG003|Step-down Period|Death|0|||
46993100|NCT01885078|83239977|FG004|Step-down Period|Death|0|||
46993101|NCT01885078|83239978|FG005|Step-down Period|Death|0|||
46993102|NCT01885078|83239979|FG006|Step-down Period|Death|0|||
46993103|NCT01885078|83239980|FG007|Step-down Period|Death|0|||
46993104|NCT01885078|83239981|FG008|Step-down Period|Death|4|||
46993105|NCT01885078|83239982|FG009|Step-down Period|Death|3|||
46993106|NCT01885078|83239973|FG000|Step-down Period|Lost to Follow-up|0|||
46993107|NCT01885078|83239974|FG001|Step-down Period|Lost to Follow-up|0|||
46993108|NCT01885078|83239975|FG002|Step-down Period|Lost to Follow-up|0|||
46993109|NCT01885078|83239976|FG003|Step-down Period|Lost to Follow-up|0|||
46993110|NCT01885078|83239977|FG004|Step-down Period|Lost to Follow-up|0|||
46993111|NCT01885078|83239978|FG005|Step-down Period|Lost to Follow-up|0|||
46993112|NCT01885078|83239979|FG006|Step-down Period|Lost to Follow-up|0|||
46993113|NCT01885078|83239980|FG007|Step-down Period|Lost to Follow-up|0|||
46993114|NCT01885078|83239981|FG008|Step-down Period|Lost to Follow-up|1|||
46993115|NCT01885078|83239982|FG009|Step-down Period|Lost to Follow-up|1|||
46993116|NCT01885078|83239973|FG000|Step-down Period|Lack of Efficacy|0|||
46993117|NCT01885078|83239974|FG001|Step-down Period|Lack of Efficacy|0|||
46993118|NCT01885078|83239975|FG002|Step-down Period|Lack of Efficacy|0|||
46993119|NCT01885078|83239976|FG003|Step-down Period|Lack of Efficacy|0|||
46993120|NCT01885078|83239977|FG004|Step-down Period|Lack of Efficacy|0|||
46993121|NCT01885078|83239978|FG005|Step-down Period|Lack of Efficacy|0|||
46993122|NCT01885078|83239979|FG006|Step-down Period|Lack of Efficacy|0|||
46993123|NCT01885078|83239980|FG007|Step-down Period|Lack of Efficacy|0|||
46993124|NCT01885078|83239981|FG008|Step-down Period|Lack of Efficacy|1|||
46993125|NCT01885078|83239982|FG009|Step-down Period|Lack of Efficacy|0|||
46993126|NCT01885078|83239973|FG000|Step-down Period|Protocol Violation|0|||
46993127|NCT01885078|83239974|FG001|Step-down Period|Protocol Violation|0|||
46993128|NCT01885078|83239975|FG002|Step-down Period|Protocol Violation|0|||
46993129|NCT01885078|83239976|FG003|Step-down Period|Protocol Violation|0|||
46993130|NCT01885078|83239977|FG004|Step-down Period|Protocol Violation|0|||
46993131|NCT01885078|83239978|FG005|Step-down Period|Protocol Violation|0|||
46993132|NCT01885078|83239979|FG006|Step-down Period|Protocol Violation|0|||
46993133|NCT01885078|83239980|FG007|Step-down Period|Protocol Violation|0|||
46993134|NCT01885078|83239981|FG008|Step-down Period|Protocol Violation|1|||
46993135|NCT01885078|83239982|FG009|Step-down Period|Protocol Violation|1|||
46993136|NCT02046369|83240005|FG000|Overall Study|Adverse Event|3|||
46993137|NCT02046369|83240006|FG001|Overall Study|Adverse Event|3|||
46993138|NCT02046369|83240005|FG000|Overall Study|Lack of Efficacy|3|||
46993139|NCT02046369|83240006|FG001|Overall Study|Lack of Efficacy|3|||
46993140|NCT02046369|83240005|FG000|Overall Study|Lost to Follow-up|3|||
46993141|NCT02046369|83240006|FG001|Overall Study|Lost to Follow-up|3|||
46993142|NCT02046369|83240005|FG000|Overall Study|Protocol Violation|1|||
46993143|NCT02046369|83240006|FG001|Overall Study|Protocol Violation|2|||
46993144|NCT02046369|83240005|FG000|Overall Study|Withdrawal by Subject|3|||
46993145|NCT02046369|83240006|FG001|Overall Study|Withdrawal by Subject|6|||
46993146|NCT02046369|83240005|FG000|Overall Study|never received study drug|0|||
46993147|NCT02046369|83240006|FG001|Overall Study|never received study drug|1|||
46993148|NCT02046369|83240005|FG000|Overall Study|non compliance|1|||
46993149|NCT02046369|83240006|FG001|Overall Study|non compliance|0|||
46993150|NCT02101359|83240014|FG000|Overall Study|Not included|23|||
46993151|NCT02101359|83240015|FG001|Overall Study|Not included|13|||
46993152|NCT02101359|83240014|FG000|Overall Study|Withdrawal by Subject|5|||
46993153|NCT02101359|83240015|FG001|Overall Study|Withdrawal by Subject|4|||
46993154|NCT02101359|83240014|FG000|Overall Study|Lost to Follow-up|1|||
46993155|NCT02101359|83240015|FG001|Overall Study|Lost to Follow-up|0|||
46993156|NCT02101359|83240014|FG000|Overall Study|Protocol Violation|0|||
46993157|NCT02101359|83240015|FG001|Overall Study|Protocol Violation|2|||
46993158|NCT02100969|83240021|FG000|Overall Study|Did not pass screening phase|1|||
46993159|NCT01885000|83240028|FG000|Overall Study|Adverse Event|1|||
46993160|NCT01885000|83240029|FG001|Overall Study|Adverse Event|0|||
46993161|NCT01885000|83240028|FG000|Overall Study|Withdrawal by Subject|1|||
46993162|NCT01885000|83240029|FG001|Overall Study|Withdrawal by Subject|1|||
46993163|NCT01885000|83240028|FG000|Overall Study|Protocol Violation|0|||
46993164|NCT01885000|83240029|FG001|Overall Study|Protocol Violation|1|||
46993165|NCT01884688|83240035|FG000|Overall Study|Screen Failure|2|||
46993166|NCT01883362|83240041|FG000|Treatment|Adverse Event|1|||
46993167|NCT01883362|83240042|FG001|Treatment|Adverse Event|8|||
46993168|NCT01883362|83240041|FG000|Treatment|Withdrawal by Subject|6|||
46993169|NCT01883362|83240042|FG001|Treatment|Withdrawal by Subject|2|||
46993170|NCT01883362|83240041|FG000|Treatment|Administrative problems|4|||
46993171|NCT01883362|83240042|FG001|Treatment|Administrative problems|1|||
46993172|NCT01883362|83240041|FG000|Treatment|Relapse|4|||
46993173|NCT01883362|83240042|FG001|Treatment|Relapse|2|||
46993174|NCT01883362|83240041|FG000|Treatment|Randomized, not treated|1|||
46993175|NCT01883362|83240042|FG001|Treatment|Randomized, not treated|1|||
46993176|NCT01883362|83240041|FG000|Post Treatment Follow-up|Protocol Violation|0|||
46993177|NCT01883362|83240042|FG001|Post Treatment Follow-up|Protocol Violation|1|||
46993178|NCT01883362|83240041|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
46993179|NCT01883362|83240042|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
46993180|NCT01883362|83240041|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
46993181|NCT01883362|83240042|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
46993182|NCT01883362|83240041|FG000|Post Treatment Follow-up|Administrative problems|2|||
46993183|NCT01883362|83240042|FG001|Post Treatment Follow-up|Administrative problems|0|||
46993184|NCT01883362|83240041|FG000|Post Treatment Follow-up|Death|8|||
46993185|NCT01883362|83240042|FG001|Post Treatment Follow-up|Death|4|||
46993186|NCT01883362|83240041|FG000|Post Treatment Follow-up|Relapse|1|||
46993187|NCT01883362|83240042|FG001|Post Treatment Follow-up|Relapse|2|||
46993188|NCT02100813|83240060|FG000|Overall Study|Adverse Event|0|||
46993189|NCT02100813|83240061|FG001|Overall Study|Adverse Event|0|||
46993190|NCT02100813|83240062|FG002|Overall Study|Adverse Event|0|||
46993191|NCT02100813|83240063|FG003|Overall Study|Adverse Event|0|||
46993192|NCT02100813|83240064|FG004|Overall Study|Adverse Event|0|||
46993193|NCT02100813|83240065|FG005|Overall Study|Adverse Event|0|||
46993194|NCT02100813|83240066|FG006|Overall Study|Adverse Event|0|||
46993195|NCT02100813|83240067|FG007|Overall Study|Adverse Event|1|||
46993196|NCT01930162|83240089|FG000|Overall Study|Abnormal test procedure result(s)|4|||
46993197|NCT01930162|83240089|FG000|Overall Study|Death|1|||
46993198|NCT02045979|83240097|FG000|Overall Study|Informed Consent Withdrawn|2|||
46993199|NCT02045979|83240098|FG001|Overall Study|Informed Consent Withdrawn|0|||
46993200|NCT02045979|83240099|FG002|Overall Study|Informed Consent Withdrawn|1|||
46993201|NCT02045979|83240097|FG000|Overall Study|not specified above|0|||
46993202|NCT02045979|83240098|FG001|Overall Study|not specified above|1|||
46993203|NCT02045979|83240099|FG002|Overall Study|not specified above|0|||
46993204|NCT01929226|83240109|FG000|Overall Study|Lost to Follow-up|4|||
46993205|NCT01929226|83240110|FG001|Overall Study|Lost to Follow-up|0|||
46993206|NCT01929226|83240109|FG000|Overall Study|Withdrawal by Subject|1|||
46993207|NCT01929226|83240110|FG001|Overall Study|Withdrawal by Subject|1|||
46993208|NCT02045433|83240117|FG000|Overall Study|Withdrawal by Subject|1|||
46993209|NCT01911442|83240124|FG000|Overall Study|Adverse Event|2|||
46993210|NCT01911442|83240125|FG001|Overall Study|Adverse Event|2|||
46993211|NCT01911442|83240126|FG002|Overall Study|Adverse Event|4|||
46993212|NCT01911442|83240124|FG000|Overall Study|Lack of Efficacy|1|||
46993213|NCT01911442|83240125|FG001|Overall Study|Lack of Efficacy|1|||
46993214|NCT01911442|83240126|FG002|Overall Study|Lack of Efficacy|1|||
46993215|NCT01911442|83240124|FG000|Overall Study|Lost to Follow-up|2|||
46993216|NCT01911442|83240125|FG001|Overall Study|Lost to Follow-up|0|||
46993217|NCT01911442|83240126|FG002|Overall Study|Lost to Follow-up|1|||
46993218|NCT01911442|83240124|FG000|Overall Study|Withdrawal by Subject|1|||
46993219|NCT01911442|83240125|FG001|Overall Study|Withdrawal by Subject|0|||
46993220|NCT01911442|83240126|FG002|Overall Study|Withdrawal by Subject|6|||
46993221|NCT01911442|83240124|FG000|Overall Study|Mother's Work Schedule|0|||
46993222|NCT01911442|83240125|FG001|Overall Study|Mother's Work Schedule|1|||
46993223|NCT01911442|83240126|FG002|Overall Study|Mother's Work Schedule|0|||
46613447|NCT02487498|82725155|FG000|Period: Washout|Physician Decision|1|||
46613448|NCT02487498|82725156|FG001|Period: Washout|Physician Decision|0|||
46613449|NCT02487498|82725155|FG000|Period: Washout|Non-compliance with study treatment|0|||
46613450|NCT02487498|82725156|FG001|Period: Washout|Non-compliance with study treatment|1|||
46613451|NCT02487498|82725155|FG000|Period: Period 2|Adverse Event|2|||
46613452|NCT02487498|82725156|FG001|Period: Period 2|Adverse Event|2|||
46613453|NCT02487498|82725155|FG000|Period: Period 2|Subject/guardian decision|2|||
46613454|NCT02487498|82725156|FG001|Period: Period 2|Subject/guardian decision|1|||
46613455|NCT02487498|82725155|FG000|Period: Period 2|Lost to Follow-up|1|||
46613456|NCT02487498|82725156|FG001|Period: Period 2|Lost to Follow-up|1|||
46613457|NCT02487498|82725155|FG000|Period: Period 2|Death|0|||
46613458|NCT02487498|82725156|FG001|Period: Period 2|Death|1|||
46613459|NCT02487498|82725155|FG000|Period: Period 2|Physician Decision|1|||
46613460|NCT02487498|82725156|FG001|Period: Period 2|Physician Decision|0|||
46613461|NCT02487108|82725167|FG000|Overall Study|Adverse Event|1|||
46613462|NCT02487108|82725168|FG001|Overall Study|Adverse Event|6|||
46613463|NCT02487108|82725169|FG002|Overall Study|Adverse Event|12|||
46613464|NCT02487108|82725170|FG003|Overall Study|Adverse Event|6|||
46613465|NCT02487108|82725167|FG000|Overall Study|Withdrawal by Subject|8|||
46613466|NCT02487108|82725168|FG001|Overall Study|Withdrawal by Subject|5|||
46613467|NCT02487108|82725169|FG002|Overall Study|Withdrawal by Subject|5|||
46613468|NCT02487108|82725170|FG003|Overall Study|Withdrawal by Subject|0|||
46613469|NCT02487108|82725167|FG000|Overall Study|Non-compliance to study medication|3|||
46613470|NCT02487108|82725168|FG001|Overall Study|Non-compliance to study medication|2|||
46613471|NCT02487108|82725169|FG002|Overall Study|Non-compliance to study medication|5|||
46613472|NCT02487108|82725170|FG003|Overall Study|Non-compliance to study medication|4|||
46613473|NCT02487108|82725167|FG000|Overall Study|Protocol Violation|1|||
46613474|NCT02487108|82725168|FG001|Overall Study|Protocol Violation|1|||
46613475|NCT02487108|82725169|FG002|Overall Study|Protocol Violation|2|||
46613476|NCT02487108|82725170|FG003|Overall Study|Protocol Violation|0|||
46613477|NCT02487108|82725167|FG000|Overall Study|Non-compliance to study procedures|0|||
46613478|NCT02487108|82725168|FG001|Overall Study|Non-compliance to study procedures|0|||
46708585|NCT00925990|82924247|FG000|Overall Study|Lost to Follow-up|1|||
46708586|NCT00925990|82924248|FG001|Overall Study|Lost to Follow-up|3|||
46708587|NCT00925990|82924247|FG000|Overall Study|Physician Decision|1|||
46993224|NCT01928758|83240140|FG000|Overall Study|Lost to Follow-up|14|||
46993225|NCT01928758|83240141|FG001|Overall Study|Lost to Follow-up|9|||
46613479|NCT02487108|82725169|FG002|Overall Study|Non-compliance to study procedures|0|||
46613480|NCT02487108|82725170|FG003|Overall Study|Non-compliance to study procedures|1|||
46613481|NCT02487108|82725167|FG000|Overall Study|Other than specified|3|||
46613482|NCT02487108|82725168|FG001|Overall Study|Other than specified|2|||
46613483|NCT02487108|82725169|FG002|Overall Study|Other than specified|2|||
46613484|NCT02487108|82725170|FG003|Overall Study|Other than specified|0|||
46613485|NCT02487030|82725187|FG000|Overall Study|Lack of Efficacy|2|||
46613486|NCT02487030|82725188|FG001|Overall Study|Lack of Efficacy|4|||
46613487|NCT02487030|82725189|FG002|Overall Study|Lack of Efficacy|1|||
46613488|NCT02487030|82725190|FG003|Overall Study|Lack of Efficacy|0|||
46613489|NCT02487030|82725191|FG004|Overall Study|Lack of Efficacy|1|||
46613490|NCT02487030|82725192|FG005|Overall Study|Lack of Efficacy|0|||
46613491|NCT02487030|82725193|FG006|Overall Study|Lack of Efficacy|0|||
46613492|NCT02487030|82725187|FG000|Overall Study|Lost to Follow-up|0|||
46613493|NCT02487030|82725188|FG001|Overall Study|Lost to Follow-up|0|||
46613494|NCT02487030|82725189|FG002|Overall Study|Lost to Follow-up|1|||
46613495|NCT02487030|82725190|FG003|Overall Study|Lost to Follow-up|1|||
46613496|NCT02487030|82725191|FG004|Overall Study|Lost to Follow-up|0|||
46613497|NCT02487030|82725192|FG005|Overall Study|Lost to Follow-up|1|||
46613498|NCT02487030|82725193|FG006|Overall Study|Lost to Follow-up|0|||
46613499|NCT02487030|82725187|FG000|Overall Study|Adverse Event|0|||
46613500|NCT02487030|82725188|FG001|Overall Study|Adverse Event|0|||
46613501|NCT02487030|82725189|FG002|Overall Study|Adverse Event|0|||
46613502|NCT02487030|82725190|FG003|Overall Study|Adverse Event|1|||
46613503|NCT02487030|82725191|FG004|Overall Study|Adverse Event|0|||
46613504|NCT02487030|82725192|FG005|Overall Study|Adverse Event|0|||
46613505|NCT02487030|82725193|FG006|Overall Study|Adverse Event|0|||
46613506|NCT02487030|82725187|FG000|Overall Study|Death|0|||
46613507|NCT02487030|82725188|FG001|Overall Study|Death|0|||
46613508|NCT02487030|82725189|FG002|Overall Study|Death|0|||
46613509|NCT02487030|82725190|FG003|Overall Study|Death|0|||
46613510|NCT02487030|82725191|FG004|Overall Study|Death|1|||
46613511|NCT02487030|82725192|FG005|Overall Study|Death|0|||
46613512|NCT02487030|82725193|FG006|Overall Study|Death|0|||
46613513|NCT02486952|82725210|FG000|Overall Study|Not Started Induction Therapy|3|||
46613514|NCT02486952|82725210|FG000|Overall Study|Adverse Event|1|||
46613515|NCT02486952|82725210|FG000|Overall Study|Death|15|||
46613516|NCT02486952|82725210|FG000|Overall Study|Lack of Efficacy|3|||
46613517|NCT02486952|82725210|FG000|Overall Study|Lost to Follow-up|26|||
46613518|NCT02486952|82725210|FG000|Overall Study|Other|2|||
46613519|NCT02486796|82725216|FG000|Overall Study|Withdrawal by Subject|1|||
46613520|NCT02486796|82725217|FG001|Overall Study|Withdrawal by Subject|1|||
46613521|NCT02486796|82725216|FG000|Overall Study|Physician Decision|1|||
46613522|NCT02486796|82725217|FG001|Overall Study|Physician Decision|0|||
46613523|NCT02459262|82725234|FG000|Overall Study|Withdrawal by Subject|0|||
46613524|NCT02459262|82725235|FG001|Overall Study|Withdrawal by Subject|0|||
46613525|NCT02459262|82725236|FG002|Overall Study|Withdrawal by Subject|0|||
46613526|NCT02459262|82725237|FG003|Overall Study|Withdrawal by Subject|0|||
46613527|NCT02459262|82725238|FG004|Overall Study|Withdrawal by Subject|0|||
46613528|NCT02459262|82725239|FG005|Overall Study|Withdrawal by Subject|0|||
46613529|NCT02459262|82725240|FG006|Overall Study|Withdrawal by Subject|0|||
46613530|NCT02459262|82725241|FG007|Overall Study|Withdrawal by Subject|0|||
46613531|NCT02459262|82725242|FG008|Overall Study|Withdrawal by Subject|0|||
46613532|NCT02459262|82725243|FG009|Overall Study|Withdrawal by Subject|1|||
46613533|NCT02459262|82725244|FG010|Overall Study|Withdrawal by Subject|0|||
46613534|NCT02450526|82725328|FG000|DB Period (Cycle 1)|Adverse Event|0|||
46613535|NCT02450526|82725329|FG001|DB Period (Cycle 1)|Adverse Event|0|||
46613536|NCT02450526|82725330|FG002|DB Period (Cycle 1)|Adverse Event|2|||
46613537|NCT02450526|82725331|FG003|DB Period (Cycle 1)|Adverse Event|0|||
46613538|NCT02450526|82725332|FG004|DB Period (Cycle 1)|Adverse Event|0|||
46613539|NCT02450526|82725328|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
46613540|NCT02450526|82725329|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
46613541|NCT02450526|82725330|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
46613542|NCT02450526|82725331|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
46613543|NCT02450526|82725332|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
46613544|NCT02450526|82725328|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
46613545|NCT02450526|82725329|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
46613546|NCT02450526|82725330|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
46613547|NCT02450526|82725331|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
46613548|NCT02450526|82725332|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
46613549|NCT02450526|82725328|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
46613550|NCT02450526|82725329|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
46613551|NCT02450526|82725330|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
46613552|NCT02450526|82725331|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
46613553|NCT02450526|82725332|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
46613554|NCT02450526|82725328|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
46613555|NCT02450526|82725329|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
46613556|NCT02450526|82725330|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
46613557|NCT02450526|82725331|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
46613558|NCT02450526|82725332|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
46613559|NCT02450526|82725328|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
46613560|NCT02450526|82725329|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
46613561|NCT02450526|82725330|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
46613562|NCT02450526|82725331|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
46613563|NCT02450526|82725332|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
46613564|NCT02450526|82725328|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
46613565|NCT02450526|82725329|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
46613566|NCT02450526|82725330|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
46613567|NCT02450526|82725331|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
46613568|NCT02450526|82725332|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
46613569|NCT02450526|82725328|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
46613570|NCT02450526|82725329|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
46613571|NCT02450526|82725330|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
46613572|NCT02450526|82725331|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
46613573|NCT02450526|82725332|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
46613574|NCT02458638|82725399|FG000|Overall Study|Death|309|||
46613575|NCT02458638|82725399|FG000|Overall Study|End of Cohort/End of Study|67|||
46613576|NCT02458638|82725399|FG000|Overall Study|Lost to Follow-up|31|||
46613577|NCT02458638|82725399|FG000|Overall Study|Other Reasons|4|||
46613578|NCT02458638|82725399|FG000|Overall Study|Physician Decision|1|||
46613579|NCT02458638|82725399|FG000|Overall Study|Withdrawal by Subject|47|||
46613580|NCT02458092|82725537|FG000|Overall Study|Withdrawal by Subject|1|||
46613581|NCT02458092|82725538|FG001|Overall Study|Withdrawal by Subject|0|||
46613582|NCT02449902|82725561|FG000|Overall Study|Adverse Event|0|||
46613583|NCT02449902|82725562|FG001|Overall Study|Adverse Event|1|||
46613584|NCT02449902|82725561|FG000|Overall Study|Withdrawal by Subject|0|||
46613585|NCT02449902|82725562|FG001|Overall Study|Withdrawal by Subject|1|||
46613586|NCT02449044|82725570|FG000|Overall Study|Lost to Follow-up|2|||
46613587|NCT02449044|82725570|FG000|Overall Study|Withdrawal by Subject|13|||
46613588|NCT02449044|82725570|FG000|Overall Study|Adverse Event|30|||
46613589|NCT02449044|82725570|FG000|Overall Study|Met Withdrawal Criteria|7|||
46613590|NCT02449044|82725570|FG000|Overall Study|Physician Decision|9|||
46613591|NCT02449044|82725570|FG000|Overall Study|Sponsor Discontinued Trial|3|||
46613592|NCT02448810|82726423|FG000|Overall Study|Adverse Event|0|||
46613593|NCT02448810|82726424|FG001|Overall Study|Adverse Event|0|||
46613594|NCT02448810|82726425|FG002|Overall Study|Adverse Event|1|||
46613595|NCT02448810|82726426|FG003|Overall Study|Adverse Event|0|||
46613596|NCT02448810|82726427|FG004|Overall Study|Adverse Event|0|||
46613597|NCT02448810|82726428|FG005|Overall Study|Adverse Event|0|||
46613598|NCT02448810|82726429|FG006|Overall Study|Adverse Event|0|||
46613599|NCT02448810|82726430|FG007|Overall Study|Adverse Event|0|||
46613600|NCT02448810|82726423|FG000|Overall Study|Withdrawal by Subject|0|||
46613601|NCT02448810|82726424|FG001|Overall Study|Withdrawal by Subject|0|||
46613602|NCT02448810|82726425|FG002|Overall Study|Withdrawal by Subject|1|||
46613603|NCT02448810|82726426|FG003|Overall Study|Withdrawal by Subject|0|||
46613604|NCT02448810|82726427|FG004|Overall Study|Withdrawal by Subject|3|||
46613605|NCT02448810|82726428|FG005|Overall Study|Withdrawal by Subject|5|||
46613606|NCT02448810|82726429|FG006|Overall Study|Withdrawal by Subject|0|||
46613607|NCT02448810|82726430|FG007|Overall Study|Withdrawal by Subject|2|||
46613608|NCT02448810|82726423|FG000|Overall Study|Other (study terminated by sponsor)|0|||
46613609|NCT02448810|82726424|FG001|Overall Study|Other (study terminated by sponsor)|0|||
46613610|NCT02448810|82726425|FG002|Overall Study|Other (study terminated by sponsor)|0|||
46613611|NCT02448810|82726426|FG003|Overall Study|Other (study terminated by sponsor)|0|||
46613612|NCT02448810|82726427|FG004|Overall Study|Other (study terminated by sponsor)|4|||
46613613|NCT02448810|82726428|FG005|Overall Study|Other (study terminated by sponsor)|2|||
46613614|NCT02448810|82726429|FG006|Overall Study|Other (study terminated by sponsor)|2|||
46613615|NCT02448810|82726430|FG007|Overall Study|Other (study terminated by sponsor)|1|||
46613616|NCT02448810|82726423|FG000|Overall Study|Death|1|||
46613617|NCT02448810|82726424|FG001|Overall Study|Death|0|||
46613618|NCT02448810|82726425|FG002|Overall Study|Death|1|||
46613619|NCT02448810|82726426|FG003|Overall Study|Death|0|||
46613620|NCT02448810|82726427|FG004|Overall Study|Death|1|||
46613621|NCT02448810|82726428|FG005|Overall Study|Death|0|||
46613622|NCT02448810|82726429|FG006|Overall Study|Death|0|||
46613623|NCT02448810|82726430|FG007|Overall Study|Death|0|||
46613624|NCT02448810|82726423|FG000|Overall Study|Other (Progressive disease)|2|||
46613625|NCT02448810|82726424|FG001|Overall Study|Other (Progressive disease)|2|||
46613626|NCT02448810|82726425|FG002|Overall Study|Other (Progressive disease)|0|||
46613627|NCT02448810|82726426|FG003|Overall Study|Other (Progressive disease)|3|||
46613628|NCT02448810|82726427|FG004|Overall Study|Other (Progressive disease)|23|||
46613629|NCT02448810|82726428|FG005|Overall Study|Other (Progressive disease)|9|||
46613630|NCT02448810|82726429|FG006|Overall Study|Other (Progressive disease)|14|||
46613631|NCT02448810|82726430|FG007|Overall Study|Other (Progressive disease)|5|||
46613632|NCT02448810|82726423|FG000|Overall Study|Lost to Follow-up|0|||
46613633|NCT02448810|82726424|FG001|Overall Study|Lost to Follow-up|1|||
46613634|NCT02448810|82726425|FG002|Overall Study|Lost to Follow-up|0|||
46613635|NCT02448810|82726426|FG003|Overall Study|Lost to Follow-up|0|||
46613636|NCT02448810|82726427|FG004|Overall Study|Lost to Follow-up|0|||
46613637|NCT02448810|82726428|FG005|Overall Study|Lost to Follow-up|0|||
46613638|NCT02448810|82726429|FG006|Overall Study|Lost to Follow-up|0|||
46613639|NCT02448810|82726430|FG007|Overall Study|Lost to Follow-up|0|||
46613640|NCT02448810|82726423|FG000|Overall Study|Other (unspecified)|0|||
46613641|NCT02448810|82726424|FG001|Overall Study|Other (unspecified)|0|||
46613642|NCT02448810|82726425|FG002|Overall Study|Other (unspecified)|0|||
46613643|NCT02448810|82726426|FG003|Overall Study|Other (unspecified)|0|||
46613644|NCT02448810|82726427|FG004|Overall Study|Other (unspecified)|0|||
46613645|NCT02448810|82726428|FG005|Overall Study|Other (unspecified)|0|||
46613646|NCT02448810|82726429|FG006|Overall Study|Other (unspecified)|2|||
46613647|NCT02448810|82726430|FG007|Overall Study|Other (unspecified)|0|||
46613648|NCT02457546|82726503|FG000|Overall Study|Other reasons|4|||
46613649|NCT02457546|82726504|FG001|Overall Study|Other reasons|1|||
46613650|NCT02457546|82726503|FG000|Overall Study|Refused to complete study/procedures|1|||
46613651|NCT02457546|82726504|FG001|Overall Study|Refused to complete study/procedures|1|||
46613652|NCT02457546|82726503|FG000|Overall Study|Lost to Follow-up|4|||
46613653|NCT02457546|82726504|FG001|Overall Study|Lost to Follow-up|1|||
46613654|NCT02457546|82726503|FG000|Overall Study|Adverse Event|0|||
46613655|NCT02457546|82726504|FG001|Overall Study|Adverse Event|1|||
46613656|NCT02447952|82726525|FG000|Overall Study|Adverse Event|2|||
46613657|NCT02447952|82726525|FG000|Overall Study|Physician Decision|1|||
46613658|NCT02447952|82726525|FG000|Overall Study|Withdrawal by Subject|4|||
46613659|NCT02447718|82726559|FG000|Overall Study|Lost to Follow-up|8|||
46613660|NCT02447718|82726560|FG001|Overall Study|Lost to Follow-up|0|||
46613661|NCT02447718|82726559|FG000|Overall Study|Withdrawal by Subject|3|||
46613662|NCT02447718|82726560|FG001|Overall Study|Withdrawal by Subject|0|||
46613663|NCT02447718|82726559|FG000|Overall Study|Screen Failure|1|||
46613664|NCT02447718|82726560|FG001|Overall Study|Screen Failure|0|||
46613665|NCT02486406|82726737|FG000|Overall Study|Withdrew consent|1|||
46613666|NCT02486406|82726738|FG001|Overall Study|Withdrew consent|0|||
46613667|NCT02486406|82726739|FG002|Overall Study|Withdrew consent|0|||
46613668|NCT02486406|82726740|FG003|Overall Study|Withdrew consent|1|||
46613669|NCT02486406|82726737|FG000|Overall Study|Lost to Follow-up|1|||
46613670|NCT02486406|82726738|FG001|Overall Study|Lost to Follow-up|3|||
46613671|NCT02486406|82726739|FG002|Overall Study|Lost to Follow-up|1|||
46613672|NCT02486406|82726740|FG003|Overall Study|Lost to Follow-up|3|||
46613673|NCT02486406|82726737|FG000|Overall Study|Other, not specified|0|||
46613674|NCT02486406|82726738|FG001|Overall Study|Other, not specified|0|||
46613675|NCT02486406|82726739|FG002|Overall Study|Other, not specified|1|||
46613676|NCT02486406|82726740|FG003|Overall Study|Other, not specified|0|||
46613677|NCT02485704|82726812|FG000|Overall Study|Lost to Follow-up|4|||
46613678|NCT02485704|82726813|FG001|Overall Study|Lost to Follow-up|5|||
46613679|NCT02485704|82726812|FG000|Overall Study|Withdrawal by Subject|0|||
46613680|NCT02485704|82726813|FG001|Overall Study|Withdrawal by Subject|3|||
46613681|NCT02485704|82726812|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
46613682|NCT02485704|82726813|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
46613683|NCT02485158|82726823|FG000|Overall Study|Withdrawal by Subject|3|||
46613684|NCT02485158|82726823|FG000|Overall Study|expected drug side effect|1|||
46613685|NCT02455518|82726842|FG000|Overall Study|Protocol Violation|0|||
46613686|NCT02455518|82726843|FG001|Overall Study|Protocol Violation|1|||
46613687|NCT02455518|82726844|FG002|Overall Study|Protocol Violation|1|||
46613688|NCT02455518|82726845|FG003|Overall Study|Protocol Violation|3|||
46613689|NCT02240069|82727063|FG000|Overall Study|Withdrawal by Subject|5|||
46613690|NCT02240069|82727064|FG001|Overall Study|Withdrawal by Subject|5|||
46613691|NCT02240069|82727065|FG002|Overall Study|Withdrawal by Subject|2|||
46613692|NCT02484690|82727151|FG000|Overall Study|Adverse Event|1|||
46613693|NCT02484690|82727152|FG001|Overall Study|Adverse Event|3|||
46613694|NCT02484690|82727153|FG002|Overall Study|Adverse Event|0|||
46613695|NCT02484690|82727154|FG003|Overall Study|Adverse Event|0|||
46613696|NCT02484690|82727155|FG004|Overall Study|Adverse Event|5|||
46613697|NCT02484690|82727151|FG000|Overall Study|Death|0|||
46613698|NCT02484690|82727152|FG001|Overall Study|Death|0|||
46613699|NCT02484690|82727153|FG002|Overall Study|Death|0|||
46613700|NCT02484690|82727154|FG003|Overall Study|Death|0|||
46613701|NCT02484690|82727155|FG004|Overall Study|Death|1|||
46613702|NCT02484690|82727151|FG000|Overall Study|Withdrawal by Subject|1|||
46613703|NCT02484690|82727152|FG001|Overall Study|Withdrawal by Subject|3|||
46613704|NCT02484690|82727153|FG002|Overall Study|Withdrawal by Subject|1|||
46613705|NCT02484690|82727154|FG003|Overall Study|Withdrawal by Subject|2|||
46613706|NCT02484690|82727155|FG004|Overall Study|Withdrawal by Subject|0|||
46613707|NCT02484690|82727151|FG000|Overall Study|Physician Decision|2|||
46613708|NCT02484690|82727152|FG001|Overall Study|Physician Decision|0|||
46613709|NCT02484690|82727153|FG002|Overall Study|Physician Decision|1|||
46613710|NCT02484690|82727154|FG003|Overall Study|Physician Decision|0|||
46613711|NCT02484690|82727155|FG004|Overall Study|Physician Decision|0|||
46613712|NCT02484690|82727151|FG000|Overall Study|Lost to Follow-up|0|||
46613713|NCT02484690|82727152|FG001|Overall Study|Lost to Follow-up|0|||
46613714|NCT02484690|82727153|FG002|Overall Study|Lost to Follow-up|1|||
46613715|NCT02484690|82727154|FG003|Overall Study|Lost to Follow-up|0|||
46613716|NCT02484690|82727155|FG004|Overall Study|Lost to Follow-up|0|||
46613717|NCT01654224|82727179|FG000|Overall Study|Lost to Follow-up|2|||
46613718|NCT01654224|82727180|FG001|Overall Study|Lost to Follow-up|2|||
46613719|NCT01654224|82727179|FG000|Overall Study|Did not receive allocation|1|||
46613720|NCT01654224|82727180|FG001|Overall Study|Did not receive allocation|8|||
46613721|NCT01654224|82727179|FG000|Overall Study|Insufficient blood sample|3|||
46613722|NCT01654224|82727180|FG001|Overall Study|Insufficient blood sample|2|||
46613723|NCT02447328|82727186|FG000|Overall Study|Withdrawal by Subject|1|||
46613724|NCT02447250|82727190|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
46613725|NCT02447250|82727190|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
46613726|NCT02447250|82727190|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
46613727|NCT02447172|82727294|FG000|Overall Study|Adverse Event|11|||
46613728|NCT02447172|82727295|FG001|Overall Study|Adverse Event|8|||
46613729|NCT02447172|82727296|FG002|Overall Study|Adverse Event|7|||
46613730|NCT02447172|82727294|FG000|Overall Study|Death|3|||
46613731|NCT02447172|82727295|FG001|Overall Study|Death|1|||
46613732|NCT02447172|82727296|FG002|Overall Study|Death|0|||
46613733|NCT02447172|82727294|FG000|Overall Study|Protocol Violation|2|||
46613734|NCT02447172|82727295|FG001|Overall Study|Protocol Violation|1|||
46613735|NCT02447172|82727296|FG002|Overall Study|Protocol Violation|2|||
46613736|NCT02447172|82727294|FG000|Overall Study|Lost to Follow-up|7|||
46613737|NCT02447172|82727295|FG001|Overall Study|Lost to Follow-up|4|||
46613738|NCT02447172|82727296|FG002|Overall Study|Lost to Follow-up|4|||
46613739|NCT02447172|82727294|FG000|Overall Study|Withdrawal by Subject|5|||
46613740|NCT02447172|82727295|FG001|Overall Study|Withdrawal by Subject|1|||
46613741|NCT02447172|82727296|FG002|Overall Study|Withdrawal by Subject|3|||
46613742|NCT02447172|82727294|FG000|Overall Study|protocol specific treatment unrelated|3|||
46613743|NCT02447172|82727295|FG001|Overall Study|protocol specific treatment unrelated|0|||
46613744|NCT02447172|82727296|FG002|Overall Study|protocol specific treatment unrelated|2|||
46613745|NCT02455050|82727329|FG000|Treatment Period 1|Lost to Follow-up|1|||
46613746|NCT02455050|82727330|FG001|Treatment Period 1|Lost to Follow-up|1|||
46613747|NCT02455050|82727331|FG002|Treatment Period 1|Lost to Follow-up|1|||
46613748|NCT02455050|82727332|FG003|Treatment Period 1|Lost to Follow-up|2|||
46613749|NCT02455050|82727329|FG000|Treatment Period 2|Lost to Follow-up|1|||
46613750|NCT02455050|82727330|FG001|Treatment Period 2|Lost to Follow-up|0|||
46613751|NCT02455050|82727331|FG002|Treatment Period 2|Lost to Follow-up|2|||
46613752|NCT02455050|82727332|FG003|Treatment Period 2|Lost to Follow-up|1|||
46613753|NCT02418468|82727372|FG000|Overall Study|Adverse Event|1|||
46613754|NCT02418468|82727373|FG001|Overall Study|Adverse Event|0|||
46613755|NCT02418468|82727372|FG000|Overall Study|Withdrawal of informed consent|1|||
46613756|NCT02418468|82727373|FG001|Overall Study|Withdrawal of informed consent|1|||
46613757|NCT02418000|82727493|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
46613758|NCT02418000|82727494|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613759|NCT02418000|82727495|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613760|NCT02418000|82727496|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613761|NCT02418000|82727497|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613762|NCT02418000|82727493|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
46613763|NCT02418000|82727494|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
46613764|NCT02418000|82727495|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
46613765|NCT02418000|82727496|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
46613766|NCT02418000|82727497|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
46613767|NCT02418000|82727493|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
46613768|NCT02418000|82727494|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
46613769|NCT02418000|82727495|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
46613770|NCT02418000|82727496|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
46613771|NCT02418000|82727497|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
46613772|NCT02418000|82727493|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613773|NCT02418000|82727494|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
46613774|NCT02418000|82727495|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613775|NCT02418000|82727496|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613776|NCT02418000|82727497|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
46613777|NCT02418000|82727493|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
46613778|NCT02418000|82727494|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
46613779|NCT02418000|82727495|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
46613780|NCT02418000|82727496|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
46613781|NCT02418000|82727497|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
46613782|NCT02418000|82727493|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613783|NCT02418000|82727494|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613784|NCT02418000|82727495|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
46613785|NCT02418000|82727496|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613786|NCT02418000|82727497|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613787|NCT02418000|82727493|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613788|NCT02418000|82727494|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613789|NCT02418000|82727495|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613790|NCT02418000|82727496|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
46613791|NCT02418000|82727497|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613792|NCT02418000|82727493|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
46613793|NCT02418000|82727494|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
46613794|NCT02418000|82727495|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
46613795|NCT02418000|82727496|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
46613796|NCT02418000|82727497|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
46613797|NCT02418000|82727493|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613798|NCT02418000|82727494|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613799|NCT02418000|82727495|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613800|NCT02418000|82727496|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
46613801|NCT02418000|82727497|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
46613802|NCT02417064|82727601|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
46613803|NCT02417064|82727602|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
46613804|NCT02417064|82727603|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
46613805|NCT02417064|82727601|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
46613806|NCT02417064|82727602|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
46613807|NCT02417064|82727603|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
46613808|NCT02417064|82727601|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
46613809|NCT02417064|82727602|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
46613810|NCT02417064|82727603|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
46613811|NCT02417064|82727601|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
46613812|NCT02417064|82727602|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
46613813|NCT02417064|82727603|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
46613814|NCT02417064|82727601|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
46613815|NCT02417064|82727602|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
46613816|NCT02417064|82727603|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
46613817|NCT02417064|82727601|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
46613818|NCT02417064|82727602|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
46613819|NCT02417064|82727603|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
46613820|NCT02417064|82727601|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
46613821|NCT02417064|82727602|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
46613822|NCT02417064|82727603|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
46613823|NCT02417064|82727601|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
46613824|NCT02417064|82727602|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
46613825|NCT02417064|82727603|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
46613826|NCT02417064|82727601|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
46613827|NCT02417064|82727602|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
46613828|NCT02417064|82727603|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
46613829|NCT02417064|82727601|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
46613830|NCT02417064|82727602|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
46613831|NCT02417064|82727603|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
46613832|NCT02417064|82727601|FG000|Follow-up Phase (24 Weeks)|Other|2|||
46613833|NCT02417064|82727602|FG001|Follow-up Phase (24 Weeks)|Other|2|||
46613834|NCT02417064|82727603|FG002|Follow-up Phase (24 Weeks)|Other|3|||
46613835|NCT01653132|82727618|FG000|First Intervention|Protocol Violation|1|||
46613836|NCT01653132|82727619|FG001|First Intervention|Protocol Violation|0|||
46613837|NCT02453334|82727644|FG000|Overall Study|Death|15|||
46613838|NCT02453334|82727645|FG001|Overall Study|Death|13|||
46613839|NCT02453334|82727644|FG000|Overall Study|Adverse Event|2|||
46613840|NCT02453334|82727645|FG001|Overall Study|Adverse Event|1|||
46613841|NCT02453334|82727644|FG000|Overall Study|Lost to Follow-up|5|||
46613842|NCT02453334|82727645|FG001|Overall Study|Lost to Follow-up|9|||
46613843|NCT02453334|82727644|FG000|Overall Study|Physician Decision|1|||
46613844|NCT02453334|82727645|FG001|Overall Study|Physician Decision|0|||
46613845|NCT02453334|82727644|FG000|Overall Study|Withdrawal by Subject|17|||
46613846|NCT02453334|82727645|FG001|Overall Study|Withdrawal by Subject|13|||
46613847|NCT02453334|82727644|FG000|Overall Study|Other reason|1|||
46613848|NCT02453334|82727645|FG001|Overall Study|Other reason|4|||
46613849|NCT02443740|82727731|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613850|NCT02443740|82727732|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613851|NCT02443740|82727733|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613852|NCT02443740|82727734|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613853|NCT02443740|82727735|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613854|NCT02443740|82727736|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
46613855|NCT02443740|82727737|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613856|NCT02443740|82727738|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613857|NCT02443740|82727739|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613858|NCT02443740|82727740|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613859|NCT02443740|82727741|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
46613860|NCT02443740|82727731|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
46613861|NCT02443740|82727732|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613862|NCT02443740|82727733|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613863|NCT02443740|82727734|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613864|NCT02443740|82727735|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613865|NCT02443740|82727736|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613866|NCT02443740|82727737|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
46613867|NCT02443740|82727738|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613868|NCT02443740|82727739|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613869|NCT02443740|82727740|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613870|NCT02443740|82727741|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
46613871|NCT02443740|82727731|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613872|NCT02443740|82727732|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613873|NCT02443740|82727733|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613874|NCT02443740|82727734|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613875|NCT02443740|82727735|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613876|NCT02443740|82727736|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
46613877|NCT02443740|82727737|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613878|NCT02443740|82727738|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613879|NCT02443740|82727739|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613880|NCT02443740|82727740|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613881|NCT02443740|82727741|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
46613882|NCT02416908|82727972|FG000|Dose Escalation Phase|Adverse Event|0|||
46613883|NCT02416908|82727973|FG001|Dose Escalation Phase|Adverse Event|0|||
46613884|NCT02416908|82727974|FG002|Dose Escalation Phase|Adverse Event|3|||
46613885|NCT02416908|82727975|FG003|Dose Escalation Phase|Adverse Event|0|||
46613886|NCT02416908|82727972|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
46613887|NCT02416908|82727973|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
46613888|NCT02416908|82727974|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
46613889|NCT02416908|82727975|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
46613890|NCT02453256|82728065|FG000|Double Blind Period|Death|1|||
46613891|NCT02453256|82728066|FG001|Double Blind Period|Death|1|||
46613892|NCT02453256|82728065|FG000|Double Blind Period|Adverse Event|3|||
46613893|NCT02453256|82728066|FG001|Double Blind Period|Adverse Event|2|||
46613894|NCT02453256|82728065|FG000|Double Blind Period|Withdrawal by Subject|9|||
46613895|NCT02453256|82728066|FG001|Double Blind Period|Withdrawal by Subject|5|||
46613896|NCT02453256|82728065|FG000|Double Blind Period|Other|0|||
46613897|NCT02453256|82728066|FG001|Double Blind Period|Other|1|||
46613898|NCT02453256|82728065|FG000|Open Label Period|Adverse Event|1|||
46613899|NCT02453256|82728066|FG001|Open Label Period|Adverse Event|3|||
46613900|NCT02453256|82728065|FG000|Open Label Period|Death|0|||
46613901|NCT02453256|82728066|FG001|Open Label Period|Death|1|||
46613902|NCT02453256|82728065|FG000|Open Label Period|Lost to Follow-up|1|||
46613903|NCT02453256|82728066|FG001|Open Label Period|Lost to Follow-up|0|||
46613904|NCT02453256|82728065|FG000|Open Label Period|Other|0|||
46613905|NCT02453256|82728066|FG001|Open Label Period|Other|2|||
46613906|NCT02453256|82728065|FG000|Open Label Period|Withdrawal by Subject|5|||
46613907|NCT02453256|82728066|FG001|Open Label Period|Withdrawal by Subject|1|||
46613908|NCT02442804|82728081|FG000|Overall Study|Withdrawal by Subject|0|||
46613909|NCT02442804|82728082|FG001|Overall Study|Withdrawal by Subject|1|||
46613910|NCT02442804|82728081|FG000|Overall Study|Adverse Event|1|||
46613911|NCT02442804|82728082|FG001|Overall Study|Adverse Event|0|||
46613912|NCT02414958|82728171|FG000|Overall Study|Adverse Event|6|||
46613913|NCT02414958|82728172|FG001|Overall Study|Adverse Event|6|||
46613914|NCT02414958|82728173|FG002|Overall Study|Adverse Event|3|||
46613915|NCT02414958|82728171|FG000|Overall Study|Protocol Violation|10|||
46613916|NCT02414958|82728172|FG001|Overall Study|Protocol Violation|3|||
46613917|NCT02414958|82728173|FG002|Overall Study|Protocol Violation|1|||
46613918|NCT02414958|82728171|FG000|Overall Study|Lost to Follow-up|7|||
46613919|NCT02414958|82728172|FG001|Overall Study|Lost to Follow-up|4|||
46613920|NCT02414958|82728173|FG002|Overall Study|Lost to Follow-up|0|||
46613921|NCT02414958|82728171|FG000|Overall Study|Withdrawal by Subject|5|||
46613922|NCT02414958|82728172|FG001|Overall Study|Withdrawal by Subject|3|||
46613923|NCT02414958|82728173|FG002|Overall Study|Withdrawal by Subject|5|||
46613924|NCT02414958|82728171|FG000|Overall Study|Other than specified|4|||
46613925|NCT02414958|82728172|FG001|Overall Study|Other than specified|4|||
46613926|NCT02414958|82728173|FG002|Overall Study|Other than specified|5|||
46613927|NCT02452476|82728246|FG000|Overall Study|Death|4|||
46613928|NCT02452476|82728247|FG001|Overall Study|Death|7|||
46613929|NCT02452476|82728246|FG000|Overall Study|Lost to Follow-up|1|||
46613930|NCT02452476|82728247|FG001|Overall Study|Lost to Follow-up|1|||
46613931|NCT02452476|82728246|FG000|Overall Study|Physician Decision|1|||
46613932|NCT02452476|82728247|FG001|Overall Study|Physician Decision|1|||
46613933|NCT02452476|82728246|FG000|Overall Study|Not treated|5|||
46613934|NCT02452476|82728247|FG001|Overall Study|Not treated|1|||
46613935|NCT02442336|82728262|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
46613936|NCT02442336|82728262|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
46613937|NCT02442336|82728262|FG000|Overall Study|Lost to Follow-up|11|||
46613938|NCT02452398|82728266|FG000|Overall Study|Adverse Event|1|||
46613939|NCT02452398|82728266|FG000|Overall Study|Lost to Follow-up|28|||
46613940|NCT02452398|82728266|FG000|Overall Study|Physician Decision|2|||
46613941|NCT02452398|82728266|FG000|Overall Study|Withdrawal by Subject|6|||
46613942|NCT02452398|82728266|FG000|Overall Study|Moved away|4|||
46613943|NCT02413398|82728272|FG000|Overall Study|Lost to Follow-up|2|||
46613944|NCT02413398|82728273|FG001|Overall Study|Lost to Follow-up|4|||
46613945|NCT02413398|82728272|FG000|Overall Study|Withdrawal by Subject|1|||
46613946|NCT02413398|82728273|FG001|Overall Study|Withdrawal by Subject|1|||
46613947|NCT02413398|82728272|FG000|Overall Study|Other Eligibility criteria|1|||
46613948|NCT02413398|82728273|FG001|Overall Study|Other Eligibility criteria|2|||
46613949|NCT02441946|82728282|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
46613950|NCT02441946|82728283|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
46613951|NCT02441946|82728284|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
46613952|NCT02441946|82728282|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
46613953|NCT02441946|82728283|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
46613954|NCT02441946|82728284|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
46613955|NCT02441946|82728282|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
46613956|NCT02441946|82728283|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
46613957|NCT02441946|82728284|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
46613958|NCT02441946|82728282|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
46613959|NCT02441946|82728283|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
46613960|NCT02441946|82728284|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
46613961|NCT02441946|82728282|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
46613962|NCT02441946|82728283|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
46613963|NCT02441946|82728284|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
46613964|NCT02441946|82728282|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
46613965|NCT02441946|82728283|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
46613966|NCT02441946|82728284|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
46613967|NCT02441946|82728282|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
46613968|NCT02441946|82728283|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
46613969|NCT02441946|82728284|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
46613970|NCT02441946|82728282|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
46613971|NCT02441946|82728283|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
46613972|NCT02441946|82728284|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
46613973|NCT02441946|82728282|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
46613974|NCT02441946|82728283|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
46613975|NCT02441946|82728284|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
46613976|NCT02441946|82728282|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
46613977|NCT02441946|82728283|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
46613978|NCT02441946|82728284|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
46613979|NCT02441946|82728282|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
46613980|NCT02441946|82728283|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46613981|NCT02441946|82728284|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46613982|NCT02387580|82728318|FG000|Overall Study|Withdrawal by Subject|0|||
46613983|NCT02387580|82728319|FG001|Overall Study|Withdrawal by Subject|0|||
46613984|NCT02387580|82728320|FG002|Overall Study|Withdrawal by Subject|0|||
46613985|NCT02387580|82728321|FG003|Overall Study|Withdrawal by Subject|1|||
46613986|NCT02387580|82728322|FG004|Overall Study|Withdrawal by Subject|0|||
46613987|NCT02387580|82728323|FG005|Overall Study|Withdrawal by Subject|0|||
46613988|NCT02440854|82728339|FG000|Overall Study|Relocation of patient|1|||
46613989|NCT02440854|82728339|FG000|Overall Study|Death|6|||
46613990|NCT02440854|82728339|FG000|Overall Study|Lost to Follow-up|10|||
46613991|NCT02440854|82728339|FG000|Overall Study|Afatinib discontinuation|46|||
46613992|NCT02440854|82728339|FG000|Overall Study|stopped study at earlier timepoint|14|||
46613993|NCT02440854|82728339|FG000|Overall Study|Study medication not received|1|||
46613994|NCT02440854|82728339|FG000|Overall Study|Violation of inclusion criteria|2|||
46613995|NCT02412852|82728394|FG000|Overall Study|Withdrawal by Subject|0|||
46613996|NCT02412852|82728395|FG001|Overall Study|Withdrawal by Subject|1|||
46613997|NCT02412852|82728396|FG002|Overall Study|Withdrawal by Subject|0|||
46613998|NCT02412852|82728397|FG003|Overall Study|Withdrawal by Subject|0|||
46613999|NCT02412852|82728394|FG000|Overall Study|Physician Decision|0|||
46614000|NCT02412852|82728395|FG001|Overall Study|Physician Decision|0|||
46614001|NCT02412852|82728396|FG002|Overall Study|Physician Decision|0|||
46614002|NCT02412852|82728397|FG003|Overall Study|Physician Decision|1|||
46614003|NCT02386098|82728453|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
46614004|NCT02386098|82728454|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
46614005|NCT02386098|82728455|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
46614006|NCT02386098|82728456|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
46614007|NCT02386098|82728457|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
46614008|NCT02386098|82728453|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
46614009|NCT02386098|82728454|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
46614010|NCT02386098|82728455|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
46614011|NCT02386098|82728456|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
46614012|NCT02386098|82728457|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
46614013|NCT02386098|82728453|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
46614014|NCT02386098|82728454|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
46614015|NCT02386098|82728455|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
46614016|NCT02386098|82728456|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
46614017|NCT02386098|82728457|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
46614018|NCT02386098|82728453|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
46614019|NCT02386098|82728454|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
46614020|NCT02386098|82728455|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
46614021|NCT02386098|82728456|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
46614022|NCT02386098|82728457|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
46614023|NCT02386098|82728453|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
46614024|NCT02386098|82728454|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
46614025|NCT02386098|82728455|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
46614026|NCT02386098|82728456|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
46614027|NCT02386098|82728457|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
46614028|NCT02386098|82728453|FG000|Stage 1 (96 Weeks)|Other|1|||
46614029|NCT02386098|82728454|FG001|Stage 1 (96 Weeks)|Other|0|||
46614030|NCT02386098|82728455|FG002|Stage 1 (96 Weeks)|Other|0|||
46614031|NCT02386098|82728456|FG003|Stage 1 (96 Weeks)|Other|0|||
46614032|NCT02386098|82728457|FG004|Stage 1 (96 Weeks)|Other|0|||
46614033|NCT02386098|82728453|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
46614034|NCT02386098|82728454|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
46614035|NCT02386098|82728455|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
46614036|NCT02386098|82728456|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
46614037|NCT02386098|82728457|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
46614038|NCT02412618|82728500|FG000|Overall Study|Withdrawal by Subject|1|||
46614039|NCT02412618|82728501|FG001|Overall Study|Withdrawal by Subject|1|||
46614040|NCT02412618|82728500|FG000|Overall Study|Expulsion|1|||
46614041|NCT02412618|82728501|FG001|Overall Study|Expulsion|1|||
46614042|NCT00585195|82728698|FG000|Overall Study|Adverse Event|0|||
46614043|NCT00585195|82728699|FG001|Overall Study|Adverse Event|0|||
46614044|NCT00585195|82728700|FG002|Overall Study|Adverse Event|0|||
46614045|NCT00585195|82728701|FG003|Overall Study|Adverse Event|0|||
46614046|NCT00585195|82728702|FG004|Overall Study|Adverse Event|2|||
46614047|NCT00585195|82728703|FG005|Overall Study|Adverse Event|1|||
46614048|NCT00585195|82728704|FG006|Overall Study|Adverse Event|0|||
46614049|NCT00585195|82728705|FG007|Overall Study|Adverse Event|1|||
46614050|NCT00585195|82728706|FG008|Overall Study|Adverse Event|0|||
46614051|NCT00585195|82728707|FG009|Overall Study|Adverse Event|0|||
46614052|NCT00585195|82728708|FG010|Overall Study|Adverse Event|3|||
46614053|NCT00585195|82728709|FG011|Overall Study|Adverse Event|0|||
46614054|NCT00585195|82728710|FG012|Overall Study|Adverse Event|8|||
46614055|NCT00585195|82728711|FG013|Overall Study|Adverse Event|6|||
46614056|NCT00585195|82728712|FG014|Overall Study|Adverse Event|4|||
46614057|NCT00585195|82728713|FG015|Overall Study|Adverse Event|1|||
46614058|NCT00585195|82728714|FG016|Overall Study|Adverse Event|14|||
46614059|NCT00585195|82728715|FG017|Overall Study|Adverse Event|9|||
46614060|NCT00585195|82728716|FG018|Overall Study|Adverse Event|2|||
46614061|NCT00585195|82728717|FG019|Overall Study|Adverse Event|3|||
46614062|NCT00585195|82728718|FG020|Overall Study|Adverse Event|1|||
46614063|NCT00585195|82728698|FG000|Overall Study|Progressive Disease|2|||
46614064|NCT00585195|82728699|FG001|Overall Study|Progressive Disease|2|||
46614065|NCT00585195|82728700|FG002|Overall Study|Progressive Disease|5|||
46614066|NCT00585195|82728701|FG003|Overall Study|Progressive Disease|4|||
46614067|NCT00585195|82728702|FG004|Overall Study|Progressive Disease|6|||
46614068|NCT00585195|82728703|FG005|Overall Study|Progressive Disease|4|||
46614069|NCT00585195|82728704|FG006|Overall Study|Progressive Disease|6|||
46614070|NCT00585195|82728705|FG007|Overall Study|Progressive Disease|3|||
46614071|NCT00585195|82728706|FG008|Overall Study|Progressive Disease|0|||
46614072|NCT00585195|82728707|FG009|Overall Study|Progressive Disease|5|||
46614073|NCT00585195|82728708|FG010|Overall Study|Progressive Disease|2|||
46614074|NCT00585195|82728709|FG011|Overall Study|Progressive Disease|25|||
46614075|NCT00585195|82728710|FG012|Overall Study|Progressive Disease|29|||
46614076|NCT00585195|82728711|FG013|Overall Study|Progressive Disease|26|||
46614077|NCT00585195|82728712|FG014|Overall Study|Progressive Disease|21|||
46614078|NCT00585195|82728713|FG015|Overall Study|Progressive Disease|12|||
46614079|NCT00585195|82728714|FG016|Overall Study|Progressive Disease|94|||
46614080|NCT00585195|82728715|FG017|Overall Study|Progressive Disease|42|||
46614081|NCT00585195|82728716|FG018|Overall Study|Progressive Disease|4|||
46614082|NCT00585195|82728717|FG019|Overall Study|Progressive Disease|9|||
46614083|NCT00585195|82728718|FG020|Overall Study|Progressive Disease|8|||
46614084|NCT00585195|82728698|FG000|Overall Study|Withdrawal by Subject|1|||
46614085|NCT00585195|82728699|FG001|Overall Study|Withdrawal by Subject|1|||
46614086|NCT00585195|82728700|FG002|Overall Study|Withdrawal by Subject|2|||
46614087|NCT00585195|82728701|FG003|Overall Study|Withdrawal by Subject|2|||
46614088|NCT00585195|82728702|FG004|Overall Study|Withdrawal by Subject|0|||
46614089|NCT00585195|82728703|FG005|Overall Study|Withdrawal by Subject|0|||
46614090|NCT00585195|82728704|FG006|Overall Study|Withdrawal by Subject|0|||
46614091|NCT00585195|82728705|FG007|Overall Study|Withdrawal by Subject|1|||
46614092|NCT00585195|82728706|FG008|Overall Study|Withdrawal by Subject|0|||
46614093|NCT00585195|82728707|FG009|Overall Study|Withdrawal by Subject|0|||
46614094|NCT00585195|82728708|FG010|Overall Study|Withdrawal by Subject|3|||
46614095|NCT00585195|82728709|FG011|Overall Study|Withdrawal by Subject|8|||
46614096|NCT00585195|82728710|FG012|Overall Study|Withdrawal by Subject|15|||
46614097|NCT00585195|82728711|FG013|Overall Study|Withdrawal by Subject|0|||
46614098|NCT00585195|82728712|FG014|Overall Study|Withdrawal by Subject|3|||
46614099|NCT00585195|82728713|FG015|Overall Study|Withdrawal by Subject|0|||
46614100|NCT00585195|82728714|FG016|Overall Study|Withdrawal by Subject|7|||
46614101|NCT00585195|82728715|FG017|Overall Study|Withdrawal by Subject|1|||
46614102|NCT00585195|82728716|FG018|Overall Study|Withdrawal by Subject|2|||
46614103|NCT00585195|82728717|FG019|Overall Study|Withdrawal by Subject|2|||
46614104|NCT00585195|82728718|FG020|Overall Study|Withdrawal by Subject|0|||
46614105|NCT00585195|82728698|FG000|Overall Study|Other|0|||
46614106|NCT00585195|82728699|FG001|Overall Study|Other|1|||
46614107|NCT00585195|82728700|FG002|Overall Study|Other|1|||
46614108|NCT00585195|82728701|FG003|Overall Study|Other|1|||
46614109|NCT00585195|82728702|FG004|Overall Study|Other|0|||
46614110|NCT00585195|82728703|FG005|Overall Study|Other|1|||
46614111|NCT00585195|82728704|FG006|Overall Study|Other|0|||
46614112|NCT00585195|82728705|FG007|Overall Study|Other|0|||
46614113|NCT00585195|82728706|FG008|Overall Study|Other|2|||
46614114|NCT00585195|82728707|FG009|Overall Study|Other|1|||
46614115|NCT00585195|82728708|FG010|Overall Study|Other|0|||
46614116|NCT00585195|82728709|FG011|Overall Study|Other|19|||
46614117|NCT00585195|82728710|FG012|Overall Study|Other|24|||
46614118|NCT00585195|82728711|FG013|Overall Study|Other|7|||
46614119|NCT00585195|82728712|FG014|Overall Study|Other|11|||
46614120|NCT00585195|82728713|FG015|Overall Study|Other|3|||
46614121|NCT00585195|82728714|FG016|Overall Study|Other|28|||
46614122|NCT00585195|82728715|FG017|Overall Study|Other|12|||
46614123|NCT00585195|82728716|FG018|Overall Study|Other|10|||
46614124|NCT00585195|82728717|FG019|Overall Study|Other|4|||
46614125|NCT00585195|82728718|FG020|Overall Study|Other|2|||
46614126|NCT00585195|82728698|FG000|Overall Study|Randomized not treated|0|||
46614127|NCT00585195|82728699|FG001|Overall Study|Randomized not treated|0|||
46614128|NCT00585195|82728700|FG002|Overall Study|Randomized not treated|1|||
46614129|NCT00585195|82728701|FG003|Overall Study|Randomized not treated|0|||
46614130|NCT00585195|82728702|FG004|Overall Study|Randomized not treated|1|||
46614131|NCT00585195|82728703|FG005|Overall Study|Randomized not treated|0|||
46614132|NCT00585195|82728704|FG006|Overall Study|Randomized not treated|1|||
46614133|NCT00585195|82728705|FG007|Overall Study|Randomized not treated|0|||
46614134|NCT00585195|82728706|FG008|Overall Study|Randomized not treated|0|||
46614135|NCT00585195|82728707|FG009|Overall Study|Randomized not treated|0|||
46614136|NCT00585195|82728708|FG010|Overall Study|Randomized not treated|2|||
46614137|NCT00585195|82728709|FG011|Overall Study|Randomized not treated|0|||
46614138|NCT00585195|82728710|FG012|Overall Study|Randomized not treated|0|||
46614139|NCT00585195|82728711|FG013|Overall Study|Randomized not treated|0|||
46614140|NCT00585195|82728712|FG014|Overall Study|Randomized not treated|0|||
46614141|NCT00585195|82728713|FG015|Overall Study|Randomized not treated|1|||
46614142|NCT00585195|82728714|FG016|Overall Study|Randomized not treated|0|||
46614143|NCT00585195|82728715|FG017|Overall Study|Randomized not treated|1|||
46614144|NCT00585195|82728716|FG018|Overall Study|Randomized not treated|3|||
46614145|NCT00585195|82728717|FG019|Overall Study|Randomized not treated|0|||
46614146|NCT00585195|82728718|FG020|Overall Study|Randomized not treated|2|||
46614147|NCT00585195|82728698|FG000|Overall Study|Death|0|||
46614148|NCT00585195|82728699|FG001|Overall Study|Death|0|||
46614149|NCT00585195|82728700|FG002|Overall Study|Death|0|||
46614150|NCT00585195|82728701|FG003|Overall Study|Death|0|||
46614151|NCT00585195|82728702|FG004|Overall Study|Death|0|||
46614152|NCT00585195|82728703|FG005|Overall Study|Death|0|||
46614153|NCT00585195|82728704|FG006|Overall Study|Death|0|||
46614154|NCT00585195|82728705|FG007|Overall Study|Death|0|||
46614155|NCT00585195|82728706|FG008|Overall Study|Death|1|||
46614156|NCT00585195|82728707|FG009|Overall Study|Death|0|||
46614157|NCT00585195|82728708|FG010|Overall Study|Death|1|||
46614158|NCT00585195|82728709|FG011|Overall Study|Death|1|||
46614159|NCT00585195|82728710|FG012|Overall Study|Death|7|||
46614160|NCT00585195|82728711|FG013|Overall Study|Death|2|||
46614161|NCT00585195|82728712|FG014|Overall Study|Death|8|||
46614162|NCT00585195|82728713|FG015|Overall Study|Death|2|||
46614163|NCT00585195|82728714|FG016|Overall Study|Death|11|||
46614164|NCT00585195|82728715|FG017|Overall Study|Death|0|||
46614165|NCT00585195|82728716|FG018|Overall Study|Death|0|||
46614166|NCT00585195|82728717|FG019|Overall Study|Death|0|||
46614167|NCT00585195|82728718|FG020|Overall Study|Death|1|||
46614168|NCT00585195|82728698|FG000|Overall Study|Lost to Follow-up|0|||
46614169|NCT00585195|82728699|FG001|Overall Study|Lost to Follow-up|0|||
46614170|NCT00585195|82728700|FG002|Overall Study|Lost to Follow-up|0|||
46614171|NCT00585195|82728701|FG003|Overall Study|Lost to Follow-up|0|||
46614172|NCT00585195|82728702|FG004|Overall Study|Lost to Follow-up|0|||
46614173|NCT00585195|82728703|FG005|Overall Study|Lost to Follow-up|0|||
46614174|NCT00585195|82728704|FG006|Overall Study|Lost to Follow-up|0|||
46614175|NCT00585195|82728705|FG007|Overall Study|Lost to Follow-up|0|||
46614176|NCT00585195|82728706|FG008|Overall Study|Lost to Follow-up|0|||
46614177|NCT00585195|82728707|FG009|Overall Study|Lost to Follow-up|0|||
46614178|NCT00585195|82728708|FG010|Overall Study|Lost to Follow-up|0|||
46614179|NCT00585195|82728709|FG011|Overall Study|Lost to Follow-up|0|||
46614180|NCT00585195|82728710|FG012|Overall Study|Lost to Follow-up|1|||
46614181|NCT00585195|82728711|FG013|Overall Study|Lost to Follow-up|0|||
46614182|NCT00585195|82728712|FG014|Overall Study|Lost to Follow-up|0|||
46614183|NCT00585195|82728713|FG015|Overall Study|Lost to Follow-up|0|||
46614184|NCT00585195|82728714|FG016|Overall Study|Lost to Follow-up|0|||
46614185|NCT00585195|82728715|FG017|Overall Study|Lost to Follow-up|2|||
46614186|NCT00585195|82728716|FG018|Overall Study|Lost to Follow-up|0|||
46614187|NCT00585195|82728717|FG019|Overall Study|Lost to Follow-up|0|||
46614188|NCT00585195|82728718|FG020|Overall Study|Lost to Follow-up|0|||
46614189|NCT00585195|82728698|FG000|Overall Study|Site Terminated by Sponsor|0|||
46614190|NCT00585195|82728699|FG001|Overall Study|Site Terminated by Sponsor|0|||
46614191|NCT00585195|82728700|FG002|Overall Study|Site Terminated by Sponsor|0|||
46614192|NCT00585195|82728701|FG003|Overall Study|Site Terminated by Sponsor|0|||
46614193|NCT00585195|82728702|FG004|Overall Study|Site Terminated by Sponsor|0|||
46614194|NCT00585195|82728703|FG005|Overall Study|Site Terminated by Sponsor|0|||
46614195|NCT00585195|82728704|FG006|Overall Study|Site Terminated by Sponsor|0|||
46614196|NCT00585195|82728705|FG007|Overall Study|Site Terminated by Sponsor|0|||
46614197|NCT00585195|82728706|FG008|Overall Study|Site Terminated by Sponsor|0|||
46614198|NCT00585195|82728707|FG009|Overall Study|Site Terminated by Sponsor|0|||
46614199|NCT00585195|82728708|FG010|Overall Study|Site Terminated by Sponsor|0|||
46614200|NCT00585195|82728709|FG011|Overall Study|Site Terminated by Sponsor|0|||
46614201|NCT00585195|82728710|FG012|Overall Study|Site Terminated by Sponsor|1|||
46614202|NCT00585195|82728711|FG013|Overall Study|Site Terminated by Sponsor|0|||
46614203|NCT00585195|82728712|FG014|Overall Study|Site Terminated by Sponsor|0|||
46614204|NCT00585195|82728713|FG015|Overall Study|Site Terminated by Sponsor|0|||
46614205|NCT00585195|82728714|FG016|Overall Study|Site Terminated by Sponsor|0|||
46614206|NCT00585195|82728715|FG017|Overall Study|Site Terminated by Sponsor|0|||
46614207|NCT00585195|82728716|FG018|Overall Study|Site Terminated by Sponsor|0|||
46614208|NCT00585195|82728717|FG019|Overall Study|Site Terminated by Sponsor|0|||
46614209|NCT00585195|82728718|FG020|Overall Study|Site Terminated by Sponsor|0|||
46614210|NCT00585195|82728698|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
46614211|NCT00585195|82728699|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
46614212|NCT00585195|82728700|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
46614213|NCT00585195|82728701|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
46614214|NCT00585195|82728702|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
46614215|NCT00585195|82728703|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
46614216|NCT00585195|82728704|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
46614217|NCT00585195|82728705|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
46614218|NCT00585195|82728706|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
46614219|NCT00585195|82728707|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
46614220|NCT00585195|82728708|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
46614221|NCT00585195|82728709|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
46614222|NCT00585195|82728710|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
46614223|NCT00585195|82728711|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
46614224|NCT00585195|82728712|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
46614225|NCT00585195|82728713|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
46614226|NCT00585195|82728714|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
46614227|NCT00585195|82728715|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
46614228|NCT00585195|82728716|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
46614229|NCT00585195|82728717|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
46614230|NCT00585195|82728718|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
46614231|NCT02439216|82728890|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
46614232|NCT02439216|82728891|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614233|NCT02439216|82728892|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614234|NCT02439216|82728893|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614235|NCT02439216|82728894|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614236|NCT02439216|82728895|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614237|NCT02439216|82728896|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614238|NCT02439216|82728897|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614239|NCT02439216|82728898|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
46614240|NCT02439216|82728890|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614241|NCT02439216|82728891|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614242|NCT02439216|82728892|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614243|NCT02439216|82728893|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614244|NCT02439216|82728894|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614245|NCT02439216|82728895|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614246|NCT02439216|82728896|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614247|NCT02439216|82728897|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
46614248|NCT02439216|82728898|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
46614249|NCT02439216|82728890|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
46614250|NCT02439216|82728891|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
46614251|NCT02439216|82728892|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
46614252|NCT02439216|82728893|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
46614253|NCT02439216|82728894|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
46614254|NCT02439216|82728895|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
46614255|NCT02439216|82728896|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
46614256|NCT02439216|82728897|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
46614257|NCT02439216|82728898|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
46614258|NCT02439216|82728890|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614259|NCT02439216|82728891|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614260|NCT02439216|82728892|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614261|NCT02439216|82728893|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614262|NCT02439216|82728894|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614263|NCT02439216|82728895|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614264|NCT02439216|82728896|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614265|NCT02439216|82728897|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
46614266|NCT02439216|82728898|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
46614267|NCT02439216|82728890|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
46614268|NCT02439216|82728891|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
46614269|NCT02439216|82728892|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
46614270|NCT02439216|82728893|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
46614271|NCT02439216|82728894|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
46614272|NCT02439216|82728895|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
46614273|NCT02439216|82728896|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
46614274|NCT02439216|82728897|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
46614275|NCT02439216|82728898|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
46614276|NCT02439138|82728922|FG000|Overall Study|Adverse Event|1|||
46614277|NCT02439138|82728922|FG000|Overall Study|PI decision to terminate the study|2|||
46614278|NCT02438826|82729298|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
46614279|NCT02438826|82729299|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
46614280|NCT02438826|82729300|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
46614281|NCT02438826|82729301|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
46803379|NCT00541866|83022683|FG000|Overall Study|Adverse Event|3|||
46803380|NCT00541866|83022684|FG001|Overall Study|Adverse Event|0|||
46614282|NCT02438826|82729298|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
46614283|NCT02438826|82729299|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
46614284|NCT02438826|82729300|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
46614285|NCT02438826|82729301|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
46614286|NCT02438826|82729298|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
46614287|NCT02438826|82729299|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
46614288|NCT02438826|82729300|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
46614289|NCT02438826|82729301|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
46614290|NCT02438826|82729298|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
46614291|NCT02438826|82729299|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
46614292|NCT02438826|82729300|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
46614293|NCT02438826|82729301|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
46614294|NCT02438826|82729298|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
46614295|NCT02438826|82729299|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
46614296|NCT02438826|82729300|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
46614297|NCT02438826|82729301|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
46614298|NCT02438826|82729298|FG000|Open-Label Treatment Phase|Adverse Event|11|||
46614299|NCT02438826|82729299|FG001|Open-Label Treatment Phase|Adverse Event|6|||
46614300|NCT02438826|82729300|FG002|Open-Label Treatment Phase|Adverse Event|0|||
46614301|NCT02438826|82729301|FG003|Open-Label Treatment Phase|Adverse Event|0|||
46614302|NCT02438826|82729298|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
46614303|NCT02438826|82729299|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
46614304|NCT02438826|82729300|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
46614305|NCT02438826|82729301|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
46614306|NCT02438826|82729298|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
46614307|NCT02438826|82729299|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
46614308|NCT02438826|82729300|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
46614309|NCT02438826|82729301|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
46614310|NCT02438826|82729298|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
46614311|NCT02438826|82729299|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
46614312|NCT02438826|82729300|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
46614313|NCT02438826|82729301|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
46614314|NCT02438826|82729298|FG000|Post-Treatment Phase|Adverse Event|3|||
46614315|NCT02438826|82729299|FG001|Post-Treatment Phase|Adverse Event|0|||
46614316|NCT02438826|82729300|FG002|Post-Treatment Phase|Adverse Event|0|||
46614317|NCT02438826|82729301|FG003|Post-Treatment Phase|Adverse Event|0|||
46614318|NCT02438826|82729298|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
46614319|NCT02438826|82729299|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
46614320|NCT02438826|82729300|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
46614321|NCT02438826|82729301|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
46614322|NCT02438826|82729298|FG000|Post-Treatment Phase|Physician Decision|1|||
46614323|NCT02438826|82729299|FG001|Post-Treatment Phase|Physician Decision|0|||
46614324|NCT02438826|82729300|FG002|Post-Treatment Phase|Physician Decision|0|||
46614325|NCT02438826|82729301|FG003|Post-Treatment Phase|Physician Decision|0|||
46614326|NCT02438826|82729298|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
46614327|NCT02438826|82729299|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
46614328|NCT02438826|82729300|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
46614329|NCT02438826|82729301|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
46614330|NCT02438280|82729318|FG000|Overall Study|Physician Decision|1|||
46614331|NCT02438280|82729319|FG001|Overall Study|Physician Decision|0|||
46614332|NCT02385708|82729337|FG000|Overall Study|Withdrawal by Subject|0|||
46614333|NCT02385708|82729338|FG001|Overall Study|Withdrawal by Subject|2|||
46614334|NCT02385708|82729337|FG000|Overall Study|Withdrawn - surgery canceled|2|||
46614335|NCT02385708|82729338|FG001|Overall Study|Withdrawn - surgery canceled|5|||
46614336|NCT02385708|82729337|FG000|Overall Study|Investigator decision|5|||
46614337|NCT02385708|82729338|FG001|Overall Study|Investigator decision|7|||
46614338|NCT02385708|82729337|FG000|Overall Study|Protocol Violation|1|||
46614339|NCT02385708|82729338|FG001|Overall Study|Protocol Violation|1|||
46614340|NCT02385084|82730077|FG000|Period 2|Protocol Violation|0|||
46614341|NCT02385084|82730078|FG001|Period 2|Protocol Violation|0|||
46614342|NCT02385084|82730079|FG002|Period 2|Protocol Violation|1|||
46614343|NCT02385084|82730080|FG003|Period 2|Protocol Violation|0|||
46614344|NCT02385084|82730081|FG004|Period 2|Protocol Violation|0|||
46614345|NCT02385084|82730082|FG005|Period 2|Protocol Violation|0|||
46614346|NCT02411292|82730091|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
46614347|NCT02411292|82730091|FG000|Overall Study|Death|2|||
46614348|NCT02411292|82730091|FG000|Overall Study|Lost to Follow-up|3|||
46614349|NCT02384850|82730154|FG000|Overall Study|Withdrawal by Subject|2|||
46614350|NCT02384850|82730155|FG001|Overall Study|Withdrawal by Subject|2|||
46614351|NCT02437890|82730377|FG000|Overall Study|Non-compliance to study drug|0|||
46614352|NCT02437890|82730378|FG001|Overall Study|Non-compliance to study drug|1|||
46614353|NCT02437890|82730379|FG002|Overall Study|Non-compliance to study drug|0|||
46614354|NCT02437890|82730380|FG003|Overall Study|Non-compliance to study drug|0|||
46614355|NCT02437890|82730381|FG004|Overall Study|Non-compliance to study drug|1|||
46614356|NCT02437890|82730377|FG000|Overall Study|Sponsor's decision|1|||
46614357|NCT02437890|82730378|FG001|Overall Study|Sponsor's decision|1|||
46614358|NCT02437890|82730379|FG002|Overall Study|Sponsor's decision|4|||
46614359|NCT02437890|82730380|FG003|Overall Study|Sponsor's decision|0|||
46614360|NCT02437890|82730381|FG004|Overall Study|Sponsor's decision|2|||
46614361|NCT02437890|82730377|FG000|Overall Study|Physician Decision|0|||
46614362|NCT02437890|82730378|FG001|Overall Study|Physician Decision|0|||
46614363|NCT02437890|82730379|FG002|Overall Study|Physician Decision|0|||
46614364|NCT02437890|82730380|FG003|Overall Study|Physician Decision|1|||
46614365|NCT02437890|82730381|FG004|Overall Study|Physician Decision|0|||
46614366|NCT02437890|82730377|FG000|Overall Study|Unable to attend visit(s)|1|||
46614367|NCT02437890|82730378|FG001|Overall Study|Unable to attend visit(s)|0|||
46614368|NCT02437890|82730379|FG002|Overall Study|Unable to attend visit(s)|0|||
46614369|NCT02437890|82730380|FG003|Overall Study|Unable to attend visit(s)|0|||
46614370|NCT02437890|82730381|FG004|Overall Study|Unable to attend visit(s)|0|||
46614371|NCT02437890|82730377|FG000|Overall Study|Lack of Efficacy|1|||
46614372|NCT02437890|82730378|FG001|Overall Study|Lack of Efficacy|3|||
46614373|NCT02437890|82730379|FG002|Overall Study|Lack of Efficacy|0|||
46614374|NCT02437890|82730380|FG003|Overall Study|Lack of Efficacy|3|||
46614375|NCT02437890|82730381|FG004|Overall Study|Lack of Efficacy|1|||
46614376|NCT02437890|82730377|FG000|Overall Study|Adverse Event|4|||
46614377|NCT02437890|82730378|FG001|Overall Study|Adverse Event|9|||
46614378|NCT02437890|82730379|FG002|Overall Study|Adverse Event|5|||
46614379|NCT02437890|82730380|FG003|Overall Study|Adverse Event|11|||
46614380|NCT02437890|82730381|FG004|Overall Study|Adverse Event|7|||
46614381|NCT02437890|82730377|FG000|Overall Study|Withdrawal by Subject|1|||
46614382|NCT02437890|82730378|FG001|Overall Study|Withdrawal by Subject|2|||
46614383|NCT02437890|82730379|FG002|Overall Study|Withdrawal by Subject|6|||
46614384|NCT02437890|82730380|FG003|Overall Study|Withdrawal by Subject|5|||
46614385|NCT02437890|82730381|FG004|Overall Study|Withdrawal by Subject|5|||
46614386|NCT02437890|82730377|FG000|Overall Study|Death|0|||
46614387|NCT02437890|82730378|FG001|Overall Study|Death|0|||
46614388|NCT02437890|82730379|FG002|Overall Study|Death|0|||
46614389|NCT02437890|82730380|FG003|Overall Study|Death|2|||
46614390|NCT02437890|82730381|FG004|Overall Study|Death|0|||
46614391|NCT02384538|82730442|FG000|Overall Study|Adverse Event|1|||
46614392|NCT02384538|82730443|FG001|Overall Study|Adverse Event|4|||
46614393|NCT02384538|82730442|FG000|Overall Study|Lack of Efficacy|4|||
46614394|NCT02384538|82730443|FG001|Overall Study|Lack of Efficacy|4|||
46614395|NCT02384538|82730442|FG000|Overall Study|Withdrew Consent|0|||
46614396|NCT02384538|82730443|FG001|Overall Study|Withdrew Consent|4|||
46614397|NCT02384538|82730442|FG000|Overall Study|Other|1|||
46614398|NCT02384538|82730443|FG001|Overall Study|Other|3|||
46614399|NCT02410824|82730467|FG000|First Intervention (One Week)|Headache|0|||
46614400|NCT02410824|82730468|FG001|First Intervention (One Week)|Headache|1|||
46614401|NCT02384460|82730498|FG000|Overall Study|Protocol Violation|0|||
46614402|NCT02384460|82730499|FG001|Overall Study|Protocol Violation|1|||
46614403|NCT02384460|82730498|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
46614404|NCT02384460|82730499|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
46614405|NCT02384460|82730498|FG000|Overall Study|Adverse Event|5|||
46614406|NCT02384460|82730499|FG001|Overall Study|Adverse Event|2|||
46614407|NCT02384460|82730498|FG000|Overall Study|Withdrawal by Subject|0|||
46614408|NCT02384460|82730499|FG001|Overall Study|Withdrawal by Subject|3|||
46614409|NCT02384460|82730498|FG000|Overall Study|Elective medical treatment|1|||
46614410|NCT02384460|82730499|FG001|Overall Study|Elective medical treatment|0|||
46614411|NCT02384460|82730498|FG000|Overall Study|Non-compliance|1|||
46614412|NCT02384460|82730499|FG001|Overall Study|Non-compliance|0|||
46614413|NCT02384382|82730522|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
46614414|NCT02384382|82730522|FG000|Overall Study|Death|1|||
46614415|NCT02384382|82730522|FG000|Overall Study|Adverse Event|1|||
46614416|NCT02384382|82730522|FG000|Overall Study|Disease progression|16|||
46614417|NCT02437188|82730542|FG000|Overall Study|Randomized but did not receive surgery|4|||
46614418|NCT02437188|82730543|FG001|Overall Study|Randomized but did not receive surgery|8|||
46614419|NCT02437188|82730542|FG000|Overall Study|Adverse Event|0|||
46614420|NCT02437188|82730543|FG001|Overall Study|Adverse Event|1|||
46614421|NCT02383758|82730565|FG000|Overall Study|Withdrawal by Subject|0|||
46614422|NCT02383758|82730566|FG001|Overall Study|Withdrawal by Subject|2|||
46614423|NCT02410278|82730616|FG000|Run-in Period|Adverse Event|5|||
46614424|NCT02410278|82730617|FG001|Run-in Period|Adverse Event|0|||
46614425|NCT02410278|82730618|FG002|Run-in Period|Adverse Event|0|||
46614426|NCT02410278|82730616|FG000|Run-in Period|GSRS Threshold Not Met|30|||
46614427|NCT02410278|82730617|FG001|Run-in Period|GSRS Threshold Not Met|0|||
46614428|NCT02410278|82730618|FG002|Run-in Period|GSRS Threshold Not Met|0|||
46614429|NCT02410278|82730616|FG000|Run-in Period|Lost to Follow-up|1|||
46614430|NCT02410278|82730617|FG001|Run-in Period|Lost to Follow-up|0|||
46614431|NCT02410278|82730618|FG002|Run-in Period|Lost to Follow-up|0|||
46614432|NCT02410278|82730616|FG000|Run-in Period|Withdrawal by Subject|1|||
46614433|NCT02410278|82730617|FG001|Run-in Period|Withdrawal by Subject|0|||
46614434|NCT02410278|82730618|FG002|Run-in Period|Withdrawal by Subject|0|||
46614435|NCT02410278|82730616|FG000|Run-in Period|Pregnancy|1|||
46614436|NCT02410278|82730617|FG001|Run-in Period|Pregnancy|0|||
46614437|NCT02410278|82730618|FG002|Run-in Period|Pregnancy|0|||
46614438|NCT02410278|82730616|FG000|Study Treatment Period|Adverse Event|0|||
46614439|NCT02410278|82730617|FG001|Study Treatment Period|Adverse Event|6|||
46614440|NCT02410278|82730618|FG002|Study Treatment Period|Adverse Event|3|||
46614441|NCT02410278|82730616|FG000|Study Treatment Period|Physician Decision|0|||
46614442|NCT02410278|82730617|FG001|Study Treatment Period|Physician Decision|0|||
46614443|NCT02410278|82730618|FG002|Study Treatment Period|Physician Decision|1|||
46614444|NCT02410278|82730616|FG000|Study Treatment Period|Withdrawal by Subject|0|||
46614445|NCT02410278|82730617|FG001|Study Treatment Period|Withdrawal by Subject|1|||
46614446|NCT02410278|82730618|FG002|Study Treatment Period|Withdrawal by Subject|0|||
46614447|NCT02410278|82730616|FG000|Study Treatment Period|Other|0|||
46614448|NCT02410278|82730617|FG001|Study Treatment Period|Other|3|||
46614449|NCT02410278|82730618|FG002|Study Treatment Period|Other|0|||
46614450|NCT02410278|82730616|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
46614451|NCT02410278|82730617|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
46614452|NCT02410278|82730618|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
46614453|NCT02410200|82730651|FG000|Overall Study|Adverse Event|2|||
46614454|NCT02383056|82730670|FG000|Overall Study|Adverse Event|1|||
46614455|NCT02383056|82730671|FG001|Overall Study|Adverse Event|0|||
46614456|NCT02383056|82730670|FG000|Overall Study|Lost to Follow-up|0|||
46614457|NCT02383056|82730671|FG001|Overall Study|Lost to Follow-up|2|||
46614458|NCT02409732|82730677|FG000|Overall Study|Withdrawal by Subject|4|||
46614459|NCT02409732|82730677|FG000|Overall Study|Lost to Follow-up|2|||
46614460|NCT01650636|82730688|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
46614461|NCT01650636|82730689|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
46614462|NCT01650636|82730688|FG000|Washout up to 5 Months|Physician Decision|2|||
46614463|NCT01650636|82730689|FG001|Washout up to 5 Months|Physician Decision|2|||
46614464|NCT01650636|82730688|FG000|Washout up to 5 Months|Death|1|||
46614465|NCT01650636|82730689|FG001|Washout up to 5 Months|Death|0|||
46614466|NCT01650636|82730688|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
46614467|NCT01650636|82730689|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
46614468|NCT01650636|82730688|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
46614469|NCT01650636|82730689|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
46614470|NCT01650636|82730688|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
46614471|NCT01650636|82730689|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
46614472|NCT02436876|82730699|FG000|Overall Study|Lost to Follow-up|0|||
46614473|NCT02436876|82730700|FG001|Overall Study|Lost to Follow-up|1|||
46614474|NCT02436876|82730701|FG002|Overall Study|Lost to Follow-up|1|||
46614475|NCT02436876|82730702|FG003|Overall Study|Lost to Follow-up|1|||
46614476|NCT02436876|82730699|FG000|Overall Study|Withdrawal by Subject|1|||
46614477|NCT02436876|82730700|FG001|Overall Study|Withdrawal by Subject|0|||
46614478|NCT02436876|82730701|FG002|Overall Study|Withdrawal by Subject|0|||
46614479|NCT02436876|82730702|FG003|Overall Study|Withdrawal by Subject|1|||
46614480|NCT02436876|82730699|FG000|Overall Study|Physician Decision|0|||
46614481|NCT02436876|82730700|FG001|Overall Study|Physician Decision|2|||
46614482|NCT02436876|82730701|FG002|Overall Study|Physician Decision|1|||
46614483|NCT02436876|82730702|FG003|Overall Study|Physician Decision|0|||
46614484|NCT02436876|82730699|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
46614485|NCT02436876|82730700|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
46614486|NCT02436876|82730701|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
46614487|NCT02436876|82730702|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
46614488|NCT02382276|82730731|FG000|Overall Study|Withdrawal by Subject|4|||
46614489|NCT02382276|82730732|FG001|Overall Study|Withdrawal by Subject|8|||
46614490|NCT02382276|82730733|FG002|Overall Study|Withdrawal by Subject|5|||
46614491|NCT02382276|82730731|FG000|Overall Study|Adverse Event|7|||
46614492|NCT02382276|82730732|FG001|Overall Study|Adverse Event|2|||
46614493|NCT02382276|82730733|FG002|Overall Study|Adverse Event|32|||
46614494|NCT02382276|82730731|FG000|Overall Study|Physician Decision|0|||
46614495|NCT02382276|82730732|FG001|Overall Study|Physician Decision|0|||
46614496|NCT02382276|82730733|FG002|Overall Study|Physician Decision|2|||
46614497|NCT02436408|82730774|FG000|Overall Study|Death|1|||
46614498|NCT02436330|82730797|FG000|Cohort 1|Lost to Follow-up|5|||
46614499|NCT02436330|82730798|FG001|Cohort 1|Lost to Follow-up|2|||
46614500|NCT02436330|82730797|FG000|Cohort 1|Withdrawal by Subject|0|||
46614501|NCT02436330|82730798|FG001|Cohort 1|Withdrawal by Subject|1|||
46614502|NCT02436330|82730797|FG000|Cohort 2|Lost to Follow-up|2|||
46614503|NCT02436330|82730798|FG001|Cohort 2|Lost to Follow-up|0|||
46614504|NCT02436330|82730797|FG000|Cohort 2|Withdrawal by Subject|2|||
46614505|NCT02436330|82730798|FG001|Cohort 2|Withdrawal by Subject|3|||
46614506|NCT02436330|82730797|FG000|Cohort 3|Lost to Follow-up|1|||
46614507|NCT02436330|82730798|FG001|Cohort 3|Lost to Follow-up|0|||
46614508|NCT02436330|82730797|FG000|Cohort 3|Withdrawal by Subject|4|||
46614509|NCT02436330|82730798|FG001|Cohort 3|Withdrawal by Subject|0|||
46614510|NCT02436330|82730797|FG000|Cohort 4|Lost to Follow-up|1|||
46614511|NCT02436330|82730798|FG001|Cohort 4|Lost to Follow-up|0|||
46614512|NCT02436330|82730797|FG000|Cohort 4|Withdrawal by Subject|1|||
46614513|NCT02436330|82730798|FG001|Cohort 4|Withdrawal by Subject|0|||
46614514|NCT02436330|82730797|FG000|Cohort 5|Lost to Follow-up|3|||
46614515|NCT02436330|82730798|FG001|Cohort 5|Lost to Follow-up|2|||
46614516|NCT02436330|82730797|FG000|Cohort 5|Withdrawal by Subject|3|||
46614517|NCT02436330|82730798|FG001|Cohort 5|Withdrawal by Subject|2|||
46614518|NCT02436330|82730797|FG000|Cohort 6|Lost to Follow-up|2|||
46614519|NCT02436330|82730798|FG001|Cohort 6|Lost to Follow-up|0|||
46614520|NCT02436330|82730797|FG000|Cohort 6|Withdrawal by Subject|1|||
46614521|NCT02436330|82730798|FG001|Cohort 6|Withdrawal by Subject|1|||
46614522|NCT01650558|82730835|FG000|Overall Study|Migration out of study area|61|||
46614523|NCT01650558|82730836|FG001|Overall Study|Migration out of study area|71|||
46614524|NCT01650558|82730837|FG002|Overall Study|Migration out of study area|56|||
46614525|NCT01650558|82730835|FG000|Overall Study|Lost to Follow-up|10|||
46614526|NCT01650558|82730836|FG001|Overall Study|Lost to Follow-up|13|||
46614527|NCT01650558|82730837|FG002|Overall Study|Lost to Follow-up|6|||
46614528|NCT01650558|82730835|FG000|Overall Study|Death|10|||
46614529|NCT01650558|82730836|FG001|Overall Study|Death|6|||
46614530|NCT01650558|82730837|FG002|Overall Study|Death|8|||
46614531|NCT01650558|82730835|FG000|Overall Study|Withdrawal by Subject|1|||
46614532|NCT01650558|82730836|FG001|Overall Study|Withdrawal by Subject|1|||
46614533|NCT01650558|82730837|FG002|Overall Study|Withdrawal by Subject|3|||
46614534|NCT01650558|82730835|FG000|Overall Study|Non-compliant participant|1|||
46614535|NCT01650558|82730836|FG001|Overall Study|Non-compliant participant|0|||
46614536|NCT01650558|82730837|FG002|Overall Study|Non-compliant participant|2|||
46614537|NCT01650558|82730835|FG000|Overall Study|Physician Decision|0|||
46614538|NCT01650558|82730836|FG001|Overall Study|Physician Decision|1|||
46614539|NCT01650558|82730837|FG002|Overall Study|Physician Decision|0|||
46614540|NCT02408484|82730876|FG000|Overall Study|Withdrawal by Subject|3|||
46614541|NCT02408484|82730876|FG000|Overall Study|Not treated during study period|1|||
46614542|NCT02380248|82730904|FG000|Overall Study|Lost to Follow-up|11|||
46614543|NCT02380248|82730904|FG000|Overall Study|Withdrawal by Subject|3|||
46614544|NCT02408016|82730951|FG000|Overall Study|Death|6|||
46614545|NCT02408016|82730952|FG001|Overall Study|Death|1|||
46614546|NCT02408016|82730953|FG002|Overall Study|Death|0|||
46614547|NCT02408016|82730951|FG000|Overall Study|Physician Decision|0|||
46614548|NCT02408016|82730952|FG001|Overall Study|Physician Decision|2|||
46614549|NCT02408016|82730953|FG002|Overall Study|Physician Decision|0|||
46614550|NCT02407704|82731017|FG000|Overall Study|Lost to Follow-up|0|||
46614551|NCT02407704|82731018|FG001|Overall Study|Lost to Follow-up|0|||
46614552|NCT02407704|82731019|FG002|Overall Study|Lost to Follow-up|0|||
46614553|NCT02407704|82731020|FG003|Overall Study|Lost to Follow-up|2|||
46614554|NCT02407704|82731017|FG000|Overall Study|Protocol Violation|0|||
46614555|NCT02407704|82731018|FG001|Overall Study|Protocol Violation|0|||
46614556|NCT02407704|82731019|FG002|Overall Study|Protocol Violation|0|||
46614557|NCT02407704|82731020|FG003|Overall Study|Protocol Violation|1|||
46614558|NCT02407704|82731017|FG000|Overall Study|Withdrawal by Subject|0|||
46614559|NCT02407704|82731018|FG001|Overall Study|Withdrawal by Subject|0|||
46614560|NCT02407704|82731019|FG002|Overall Study|Withdrawal by Subject|1|||
46614561|NCT02407704|82731020|FG003|Overall Study|Withdrawal by Subject|0|||
46614562|NCT02406612|82731041|FG000|Overall Study|Screening Failure|3|||
46614563|NCT02406612|82731042|FG001|Overall Study|Screening Failure|0|||
46614564|NCT02406612|82731041|FG000|Overall Study|Intra-procedural Exclusion|1|||
46614565|NCT02406612|82731042|FG001|Overall Study|Intra-procedural Exclusion|3|||
46614566|NCT02406612|82731041|FG000|Overall Study|Guidewire Failure|0|||
46614567|NCT02406612|82731042|FG001|Overall Study|Guidewire Failure|1|||
46614568|NCT02405442|82731186|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
46614569|NCT02405442|82731187|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
46614570|NCT02405442|82731188|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
46614571|NCT02405442|82731189|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
46614572|NCT02405442|82731186|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
46614573|NCT02405442|82731187|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
46614574|NCT02405442|82731188|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
46614575|NCT02405442|82731189|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
46614576|NCT02405442|82731186|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
46614577|NCT02405442|82731187|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
46708588|NCT00925990|82924248|FG001|Overall Study|Physician Decision|1|||
46614578|NCT02405442|82731188|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
46614579|NCT02405442|82731189|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
46614580|NCT02405442|82731186|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
46614581|NCT02405442|82731187|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
46614582|NCT02405442|82731188|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
46614583|NCT02405442|82731189|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
46614584|NCT02405442|82731186|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
46614585|NCT02405442|82731187|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
46614586|NCT02405442|82731188|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
46614587|NCT02405442|82731189|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
46614588|NCT02405442|82731186|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
46614589|NCT02405442|82731187|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
46614590|NCT02405442|82731188|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
46614591|NCT02405442|82731189|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
46614592|NCT02405442|82731186|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
46614593|NCT02405442|82731187|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
46614594|NCT02405442|82731188|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
46614595|NCT02405442|82731189|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
46614596|NCT02405442|82731186|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
46614597|NCT02405442|82731187|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
46614598|NCT02405442|82731188|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
46614599|NCT02405442|82731189|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
46614600|NCT02405442|82731186|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
46614601|NCT02405442|82731187|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
46614602|NCT02405442|82731188|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
46614603|NCT02405442|82731189|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
46614604|NCT02405442|82731186|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
46614605|NCT02405442|82731187|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
46614606|NCT02405442|82731188|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
46614607|NCT02405442|82731189|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
46614608|NCT02405442|82731186|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
46614609|NCT02405442|82731187|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
46614610|NCT02405442|82731188|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
46614611|NCT02405442|82731189|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
46614612|NCT02405442|82731186|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
46614613|NCT02405442|82731187|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
46614614|NCT02405442|82731188|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
46614615|NCT02405442|82731189|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
46614616|NCT02405442|82731186|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
46614617|NCT02405442|82731187|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
46614618|NCT02405442|82731188|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
46614619|NCT02405442|82731189|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
46614620|NCT02405442|82731186|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
46614621|NCT02405442|82731187|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
46614622|NCT02405442|82731188|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
46614623|NCT02405442|82731189|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
46614624|NCT02404350|82731305|FG000|Overall Study|Adverse Event|2|||
46614625|NCT02404350|82731306|FG001|Overall Study|Adverse Event|2|||
46614626|NCT02404350|82731307|FG002|Overall Study|Adverse Event|3|||
46614627|NCT02404350|82731308|FG003|Overall Study|Adverse Event|9|||
46614628|NCT02404350|82731305|FG000|Overall Study|Lack of Efficacy|3|||
46614629|NCT02404350|82731306|FG001|Overall Study|Lack of Efficacy|1|||
46614630|NCT02404350|82731307|FG002|Overall Study|Lack of Efficacy|0|||
46614631|NCT02404350|82731308|FG003|Overall Study|Lack of Efficacy|3|||
46614632|NCT02404350|82731305|FG000|Overall Study|Lost to Follow-up|2|||
46614633|NCT02404350|82731306|FG001|Overall Study|Lost to Follow-up|0|||
46614634|NCT02404350|82731307|FG002|Overall Study|Lost to Follow-up|0|||
46614635|NCT02404350|82731308|FG003|Overall Study|Lost to Follow-up|1|||
46614636|NCT02404350|82731305|FG000|Overall Study|Physician Decision|1|||
46614637|NCT02404350|82731306|FG001|Overall Study|Physician Decision|0|||
46614638|NCT02404350|82731307|FG002|Overall Study|Physician Decision|0|||
46614639|NCT02404350|82731308|FG003|Overall Study|Physician Decision|2|||
46614640|NCT02404350|82731305|FG000|Overall Study|Pregnancy|0|||
46614641|NCT02404350|82731306|FG001|Overall Study|Pregnancy|0|||
46614642|NCT02404350|82731307|FG002|Overall Study|Pregnancy|0|||
46614643|NCT02404350|82731308|FG003|Overall Study|Pregnancy|1|||
46614644|NCT02404350|82731305|FG000|Overall Study|Withdrawal by Subject|7|||
46614645|NCT02404350|82731306|FG001|Overall Study|Withdrawal by Subject|3|||
46614646|NCT02404350|82731307|FG002|Overall Study|Withdrawal by Subject|3|||
46614647|NCT02404350|82731308|FG003|Overall Study|Withdrawal by Subject|19|||
46614648|NCT02404350|82731305|FG000|Overall Study|Due to Non-compliance with treatment|0|||
46614649|NCT02404350|82731306|FG001|Overall Study|Due to Non-compliance with treatment|0|||
46614650|NCT02404350|82731307|FG002|Overall Study|Due to Non-compliance with treatment|0|||
46614651|NCT02404350|82731308|FG003|Overall Study|Due to Non-compliance with treatment|1|||
46614652|NCT02404350|82731305|FG000|Overall Study|Due to Technical problems|0|||
46614653|NCT02404350|82731306|FG001|Overall Study|Due to Technical problems|0|||
46614654|NCT02404350|82731307|FG002|Overall Study|Due to Technical problems|0|||
46614655|NCT02404350|82731308|FG003|Overall Study|Due to Technical problems|1|||
46614656|NCT02434770|82731607|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
46614657|NCT02434770|82731608|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
46614658|NCT02434770|82731609|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
46614659|NCT02434770|82731607|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
46614660|NCT02434770|82731608|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
46614661|NCT02434770|82731609|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
46614662|NCT02434770|82731607|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
46614663|NCT02434770|82731608|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
46614664|NCT02434770|82731609|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
46614665|NCT02434770|82731607|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
46614666|NCT02434770|82731608|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
46614667|NCT02434770|82731609|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
46614668|NCT02434770|82731607|FG000|Week 1 to Week 18|Death|1|||
46614669|NCT02434770|82731608|FG001|Week 1 to Week 18|Death|0|||
46614670|NCT02434770|82731609|FG002|Week 1 to Week 18|Death|0|||
46614671|NCT02434770|82731607|FG000|Week 18 to Week|Lost to Follow-up|2|||
46614672|NCT02434770|82731608|FG001|Week 18 to Week|Lost to Follow-up|2|||
46614673|NCT02434770|82731609|FG002|Week 18 to Week|Lost to Follow-up|1|||
46614674|NCT02434770|82731607|FG000|Week 18 to Week|Withdrawal by Subject|0|||
46614675|NCT02434770|82731608|FG001|Week 18 to Week|Withdrawal by Subject|0|||
46614676|NCT02434770|82731609|FG002|Week 18 to Week|Withdrawal by Subject|2|||
46614677|NCT02434770|82731607|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
46614678|NCT02434770|82731608|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
46614679|NCT02434770|82731609|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
46614680|NCT02433834|82731640|FG000|Overall Study|Protocol-specified criteria|7|||
46614681|NCT02433834|82731640|FG000|Overall Study|Protocol Violation|3|||
46614682|NCT02433834|82731640|FG000|Overall Study|Lost to Follow-up|6|||
46614683|NCT02433834|82731640|FG000|Overall Study|Withdrawal by Subject|14|||
46614684|NCT02433834|82731640|FG000|Overall Study|Adverse Event|6|||
46614685|NCT02433834|82731640|FG000|Overall Study|Physician Decision|1|||
46614686|NCT02433678|82731684|FG000|Overall Study|Lost to Follow-up|1|||
46614687|NCT02433678|82731685|FG001|Overall Study|Lost to Follow-up|2|||
46614688|NCT02433288|82731698|FG000|Overall Study|Severe non-compliance to protocol|13|||
46614689|NCT02433288|82731699|FG001|Overall Study|Severe non-compliance to protocol|7|||
46614690|NCT02433288|82731698|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
46614691|NCT02433288|82731699|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
46614692|NCT02433288|82731698|FG000|Overall Study|Withdrawal by Subject|101|||
46614693|NCT02433288|82731699|FG001|Overall Study|Withdrawal by Subject|99|||
46614694|NCT02433288|82731698|FG000|Overall Study|Lost to Follow-up|2|||
46614695|NCT02433288|82731699|FG001|Overall Study|Lost to Follow-up|14|||
46614696|NCT02433288|82731698|FG000|Overall Study|Death|0|||
46614697|NCT02433288|82731699|FG001|Overall Study|Death|3|||
46614698|NCT02433210|82731719|FG000|Overall Study|Physician Decision|1|||
46614699|NCT02433210|82731720|FG001|Overall Study|Physician Decision|0|||
46614700|NCT02433210|82731721|FG002|Overall Study|Physician Decision|0|||
46614701|NCT02432040|82731856|FG000|Overall Study|Lack of Efficacy|3|||
46614702|NCT02432040|82731857|FG001|Overall Study|Lack of Efficacy|0|||
46614703|NCT02432040|82731856|FG000|Overall Study|Lost to Follow-up|4|||
46614704|NCT02432040|82731857|FG001|Overall Study|Lost to Follow-up|5|||
46614705|NCT02432040|82731856|FG000|Overall Study|Physician Decision|1|||
46614706|NCT02432040|82731857|FG001|Overall Study|Physician Decision|1|||
46614707|NCT04418076|82731903|FG000|Overall Study|Death|1|||
46614708|NCT04418076|82731904|FG001|Overall Study|Death|0|||
46614709|NCT04418076|82731905|FG002|Overall Study|Death|0|||
46614710|NCT04418076|82731906|FG003|Overall Study|Death|0|||
46614711|NCT04418076|82731903|FG000|Overall Study|Lost to Follow-up|2|||
46614712|NCT04418076|82731904|FG001|Overall Study|Lost to Follow-up|5|||
46614713|NCT04418076|82731905|FG002|Overall Study|Lost to Follow-up|1|||
46614714|NCT04418076|82731906|FG003|Overall Study|Lost to Follow-up|2|||
46614715|NCT04418076|82731903|FG000|Overall Study|Withdrawal by Subject|1|||
46614716|NCT04418076|82731904|FG001|Overall Study|Withdrawal by Subject|0|||
46614717|NCT04418076|82731905|FG002|Overall Study|Withdrawal by Subject|1|||
46614718|NCT04418076|82731906|FG003|Overall Study|Withdrawal by Subject|1|||
46614719|NCT04418076|82731903|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
46614720|NCT04418076|82731904|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
46614721|NCT04418076|82731905|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
46614722|NCT04418076|82731906|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
46614723|NCT04165824|82731916|FG000|Overall Study|Adverse Event|23|||
46614724|NCT04165824|82731916|FG000|Overall Study|Physician Decision|1|||
46614725|NCT04165824|82731916|FG000|Overall Study|Withdrawal by Subject|17|||
46614726|NCT04165824|82731916|FG000|Overall Study|Other|5|||
46614727|NCT03809039|82731929|FG000|Part 1|Withdrawal by Subject|1|||
46614728|NCT03809039|82731930|FG001|Part 1|Withdrawal by Subject|0|||
46614729|NCT03809039|82731931|FG002|Part 1|Withdrawal by Subject|0|||
46614730|NCT03809039|82731932|FG003|Part 1|Withdrawal by Subject|1|||
46614731|NCT03809039|82731933|FG004|Part 1|Withdrawal by Subject|0|||
46614732|NCT03809039|82731934|FG005|Part 1|Withdrawal by Subject|0|||
46614733|NCT03809039|82731935|FG006|Part 1|Withdrawal by Subject|0|||
46614734|NCT03809039|82731936|FG007|Part 1|Withdrawal by Subject|0|||
46614735|NCT03809039|82731937|FG008|Part 1|Withdrawal by Subject|0|||
46614736|NCT03809039|82731929|FG000|Part 3|Withdrawn by study termination|0|||
46614737|NCT03809039|82731930|FG001|Part 3|Withdrawn by study termination|0|||
46614738|NCT03809039|82731931|FG002|Part 3|Withdrawn by study termination|0|||
46614739|NCT03809039|82731932|FG003|Part 3|Withdrawn by study termination|0|||
46614740|NCT03809039|82731933|FG004|Part 3|Withdrawn by study termination|0|||
46614741|NCT03809039|82731934|FG005|Part 3|Withdrawn by study termination|0|||
46614742|NCT03809039|82731935|FG006|Part 3|Withdrawn by study termination|0|||
46614743|NCT03809039|82731936|FG007|Part 3|Withdrawn by study termination|2|||
46614744|NCT03809039|82731937|FG008|Part 3|Withdrawn by study termination|6|||
46614745|NCT03541200|82731970|FG000|Overall Study|Adverse Event|19|||
46614746|NCT03541200|82731970|FG000|Overall Study|Death|1|||
46614747|NCT03541200|82731970|FG000|Overall Study|Lost to Follow-up|10|||
46614748|NCT03541200|82731970|FG000|Overall Study|Physician Decision|1|||
46614749|NCT03541200|82731970|FG000|Overall Study|Protocol Violation|51|||
46614750|NCT03541200|82731970|FG000|Overall Study|Withdrawal by Subject|23|||
46614751|NCT03541200|82731970|FG000|Overall Study|other|8|||
46614752|NCT03505710|82731977|FG000|Overall Study|Progressive Disease|22|||
46614753|NCT03505710|82731978|FG001|Overall Study|Progressive Disease|9|||
46614754|NCT03505710|82731979|FG002|Overall Study|Progressive Disease|34|||
46614755|NCT03505710|82731977|FG000|Overall Study|Clinical Progression|6|||
46614756|NCT03505710|82731978|FG001|Overall Study|Clinical Progression|6|||
46614757|NCT03505710|82731979|FG002|Overall Study|Clinical Progression|3|||
46614758|NCT03505710|82731977|FG000|Overall Study|Adverse Event|12|||
46614759|NCT03505710|82731978|FG001|Overall Study|Adverse Event|5|||
46614760|NCT03505710|82731979|FG002|Overall Study|Adverse Event|27|||
46614761|NCT03505710|82731977|FG000|Overall Study|Withdrawal by Subject|1|||
46614762|NCT03505710|82731978|FG001|Overall Study|Withdrawal by Subject|3|||
46614763|NCT03505710|82731979|FG002|Overall Study|Withdrawal by Subject|3|||
46614764|NCT03505710|82731977|FG000|Overall Study|Physician Decision|1|||
46614765|NCT03505710|82731978|FG001|Overall Study|Physician Decision|0|||
46614766|NCT03505710|82731979|FG002|Overall Study|Physician Decision|2|||
46614767|NCT03505710|82731977|FG000|Overall Study|Death|4|||
46614768|NCT03505710|82731978|FG001|Overall Study|Death|3|||
46614769|NCT03505710|82731979|FG002|Overall Study|Death|6|||
46614770|NCT03505710|82731977|FG000|Overall Study|Other Reasons|1|||
46614771|NCT03505710|82731978|FG001|Overall Study|Other Reasons|1|||
46614772|NCT03505710|82731979|FG002|Overall Study|Other Reasons|1|||
46614773|NCT03291067|82731991|FG000|Overall Study|Adverse Event|0|||
46614774|NCT03291067|82731992|FG001|Overall Study|Adverse Event|2|||
46614775|NCT03291067|82731993|FG002|Overall Study|Adverse Event|17|||
46614776|NCT03291067|82731994|FG003|Overall Study|Adverse Event|3|||
46614777|NCT03291067|82731991|FG000|Overall Study|Lost to Follow-up|2|||
46614778|NCT03291067|82731992|FG001|Overall Study|Lost to Follow-up|1|||
46614779|NCT03291067|82731993|FG002|Overall Study|Lost to Follow-up|0|||
46614780|NCT03291067|82731994|FG003|Overall Study|Lost to Follow-up|1|||
46614781|NCT03291067|82731991|FG000|Overall Study|Physician Decision|0|||
46614782|NCT03291067|82731992|FG001|Overall Study|Physician Decision|0|||
46614783|NCT03291067|82731993|FG002|Overall Study|Physician Decision|1|||
46614784|NCT03291067|82731994|FG003|Overall Study|Physician Decision|0|||
46614785|NCT03291067|82731991|FG000|Overall Study|Protocol Violation|5|||
46614786|NCT03291067|82731992|FG001|Overall Study|Protocol Violation|3|||
46614787|NCT03291067|82731993|FG002|Overall Study|Protocol Violation|4|||
46614788|NCT03291067|82731994|FG003|Overall Study|Protocol Violation|2|||
46614789|NCT03291067|82731991|FG000|Overall Study|Withdrawal by Subject|3|||
46614790|NCT03291067|82731992|FG001|Overall Study|Withdrawal by Subject|4|||
46614791|NCT03291067|82731993|FG002|Overall Study|Withdrawal by Subject|7|||
46614792|NCT03291067|82731994|FG003|Overall Study|Withdrawal by Subject|5|||
46614793|NCT03291067|82731991|FG000|Overall Study|Other|0|||
46614794|NCT03291067|82731992|FG001|Overall Study|Other|4|||
46614795|NCT03291067|82731993|FG002|Overall Study|Other|4|||
46614796|NCT03291067|82731994|FG003|Overall Study|Other|6|||
46614797|NCT02841280|82732006|FG000|Overall Study|Adverse Event|2|||
46614798|NCT02841280|82732007|FG001|Overall Study|Adverse Event|1|||
46614799|NCT02841280|82732006|FG000|Overall Study|Death|1|||
46614800|NCT02841280|82732007|FG001|Overall Study|Death|0|||
46614801|NCT02841280|82732006|FG000|Overall Study|Lost to Follow-up|2|||
46614802|NCT02841280|82732007|FG001|Overall Study|Lost to Follow-up|2|||
46614803|NCT02841280|82732006|FG000|Overall Study|Withdrawal by Subject|7|||
46614804|NCT02841280|82732007|FG001|Overall Study|Withdrawal by Subject|3|||
46614805|NCT02841280|82732006|FG000|Overall Study|Stop Point: BP above threshold|2|||
46614806|NCT02841280|82732007|FG001|Overall Study|Stop Point: BP above threshold|0|||
46614807|NCT02345330|82732021|FG000|Overall Study|Death|1|||
46614808|NCT02345330|82732021|FG000|Overall Study|Progressive Disease|2|||
46614809|NCT01513343|82732036|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
46614810|NCT01513343|82732037|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
46614811|NCT01513343|82732036|FG000|Post Data Collection|Dropped/withdrew from study|7|||
46614812|NCT01513343|82732037|FG001|Post Data Collection|Dropped/withdrew from study|1|||
46614813|NCT01513343|82732036|FG000|Post Data Collection|Lost to Follow-up|10|||
46614814|NCT01513343|82732037|FG001|Post Data Collection|Lost to Follow-up|23|||
46614815|NCT01513343|82732036|FG000|6-month Follow-up|Lost to Follow-up|28|||
46614816|NCT01513343|82732037|FG001|6-month Follow-up|Lost to Follow-up|17|||
46614817|NCT01513343|82732036|FG000|12-month Follow-up|Lost to Follow-up|10|||
46614818|NCT01513343|82732037|FG001|12-month Follow-up|Lost to Follow-up|3|||
46614819|NCT01440816|82732064|FG000|Overall Study|Disease Progression|0|||
46614820|NCT01440816|82732065|FG001|Overall Study|Disease Progression|9|||
46614821|NCT01440816|82732064|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
46614822|NCT01440816|82732065|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
46614823|NCT01348919|82732076|FG000|Overall Study|Adverse Event|3|||
46614824|NCT01348919|82732077|FG001|Overall Study|Adverse Event|1|||
46614825|NCT01348919|82732078|FG002|Overall Study|Adverse Event|0|||
46614826|NCT01348919|82732076|FG000|Overall Study|Withdrawal by Subject|0|||
46614827|NCT01348919|82732077|FG001|Overall Study|Withdrawal by Subject|1|||
46614828|NCT01348919|82732078|FG002|Overall Study|Withdrawal by Subject|0|||
46614829|NCT01348919|82732076|FG000|Overall Study|Disease progression|0|||
46614830|NCT01348919|82732077|FG001|Overall Study|Disease progression|1|||
46614831|NCT01348919|82732078|FG002|Overall Study|Disease progression|1|||
46614832|NCT00966381|82732090|FG000|Overall Study|Withdrawal by Subject|2|||
46614833|NCT00966381|82732091|FG001|Overall Study|Withdrawal by Subject|2|||
46614834|NCT02431806|82732103|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
46614835|NCT02431806|82732104|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
46614836|NCT02431806|82732105|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
46614837|NCT02431806|82732106|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
46614838|NCT02431806|82732103|FG000|Double-blind Treatment Period|Adverse Event|4|||
46614839|NCT02431806|82732104|FG001|Double-blind Treatment Period|Adverse Event|7|||
46614840|NCT02431806|82732105|FG002|Double-blind Treatment Period|Adverse Event|11|||
46614841|NCT02431806|82732106|FG003|Double-blind Treatment Period|Adverse Event|7|||
46614842|NCT02431806|82732103|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
46614843|NCT02431806|82732104|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
46614844|NCT02431806|82732105|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
46614845|NCT02431806|82732106|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
46614846|NCT02431806|82732103|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
46614847|NCT02431806|82732104|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
46614848|NCT02431806|82732105|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
46614849|NCT02431806|82732106|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
46614850|NCT02431806|82732103|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
46614851|NCT02431806|82732104|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
46614852|NCT02431806|82732105|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
46614853|NCT02431806|82732106|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
46614854|NCT02431806|82732103|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
46614855|NCT02431806|82732104|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
46614856|NCT02431806|82732105|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
46614857|NCT02431806|82732106|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
46614858|NCT02431806|82732103|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
46614859|NCT02431806|82732104|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
46614860|NCT02431806|82732105|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
46614861|NCT02431806|82732106|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
46614862|NCT01650246|82732147|FG000|Overall Study|Adverse Event|23|||
46614863|NCT01650246|82732147|FG000|Overall Study|Protocol Violation|5|||
46614864|NCT01650246|82732147|FG000|Overall Study|Sponsor terminated study|53|||
46614865|NCT01650246|82732147|FG000|Overall Study|Lost to Follow-up|5|||
46614866|NCT01650246|82732147|FG000|Overall Study|Withdrawal by Subject|26|||
46614867|NCT01650246|82732147|FG000|Overall Study|Death|1|||
46614868|NCT01650246|82732147|FG000|Overall Study|Lack of Efficacy|30|||
46614869|NCT01652664|82732166|FG000|Overall Study|Treatment Failure|5|||
46614870|NCT01652664|82732167|FG001|Overall Study|Treatment Failure|1|||
46614871|NCT01652664|82732166|FG000|Overall Study|Inadequate IOP control|1|||
46614872|NCT01652664|82732167|FG001|Overall Study|Inadequate IOP control|0|||
46614873|NCT02379390|82732207|FG000|Overall Study|Adverse Event|1|||
46614874|NCT02379390|82732208|FG001|Overall Study|Adverse Event|1|||
46614875|NCT02379390|82732207|FG000|Overall Study|Investigator's decision|1|||
46614876|NCT02379390|82732208|FG001|Overall Study|Investigator's decision|0|||
46614877|NCT02379390|82732207|FG000|Overall Study|Study Termination|0|||
46614878|NCT02379390|82732208|FG001|Overall Study|Study Termination|1|||
46614879|NCT02379078|82732219|FG000|Overall Study|Lost to Follow-up|33|||
46614880|NCT02379078|82732220|FG001|Overall Study|Lost to Follow-up|30|||
46614881|NCT02379078|82732219|FG000|Overall Study|Withdrawal by Subject|6|||
46614882|NCT02379078|82732220|FG001|Overall Study|Withdrawal by Subject|5|||
46614883|NCT01714739|82732313|FG000|Overall Study|Disease progression|3|||
46614884|NCT01714739|82732314|FG001|Overall Study|Disease progression|5|||
46614885|NCT01714739|82732315|FG002|Overall Study|Disease progression|5|||
46614886|NCT01714739|82732316|FG003|Overall Study|Disease progression|204|||
46614887|NCT01714739|82732317|FG004|Overall Study|Disease progression|1|||
46614888|NCT01714739|82732318|FG005|Overall Study|Disease progression|3|||
46614889|NCT01714739|82732319|FG006|Overall Study|Disease progression|5|||
46614890|NCT01714739|82732313|FG000|Overall Study|Study drug toxicity|1|||
46614891|NCT01714739|82732314|FG001|Overall Study|Study drug toxicity|1|||
46614892|NCT01714739|82732315|FG002|Overall Study|Study drug toxicity|1|||
46614893|NCT01714739|82732316|FG003|Overall Study|Study drug toxicity|15|||
46614894|NCT01714739|82732317|FG004|Overall Study|Study drug toxicity|0|||
46614895|NCT01714739|82732318|FG005|Overall Study|Study drug toxicity|0|||
46614896|NCT01714739|82732319|FG006|Overall Study|Study drug toxicity|5|||
46614897|NCT01714739|82732313|FG000|Overall Study|Death|0|||
46614898|NCT01714739|82732314|FG001|Overall Study|Death|0|||
46614899|NCT01714739|82732315|FG002|Overall Study|Death|0|||
46614900|NCT01714739|82732316|FG003|Overall Study|Death|1|||
46614901|NCT01714739|82732317|FG004|Overall Study|Death|0|||
46614902|NCT01714739|82732318|FG005|Overall Study|Death|0|||
46614903|NCT01714739|82732319|FG006|Overall Study|Death|0|||
46614904|NCT01714739|82732313|FG000|Overall Study|Adverse Event unrelated to drug|0|||
46614905|NCT01714739|82732314|FG001|Overall Study|Adverse Event unrelated to drug|0|||
46614906|NCT01714739|82732315|FG002|Overall Study|Adverse Event unrelated to drug|3|||
46614907|NCT01714739|82732316|FG003|Overall Study|Adverse Event unrelated to drug|21|||
46614908|NCT01714739|82732317|FG004|Overall Study|Adverse Event unrelated to drug|0|||
46614909|NCT01714739|82732318|FG005|Overall Study|Adverse Event unrelated to drug|0|||
46614910|NCT01714739|82732319|FG006|Overall Study|Adverse Event unrelated to drug|0|||
46614911|NCT01714739|82732313|FG000|Overall Study|Participant request to stop therapy|0|||
46614912|NCT01714739|82732314|FG001|Overall Study|Participant request to stop therapy|1|||
46614913|NCT01714739|82732315|FG002|Overall Study|Participant request to stop therapy|0|||
46614914|NCT01714739|82732316|FG003|Overall Study|Participant request to stop therapy|6|||
46614915|NCT01714739|82732317|FG004|Overall Study|Participant request to stop therapy|0|||
46614916|NCT01714739|82732318|FG005|Overall Study|Participant request to stop therapy|0|||
46614917|NCT01714739|82732319|FG006|Overall Study|Participant request to stop therapy|0|||
46614918|NCT01714739|82732313|FG000|Overall Study|Participant withdrew consent|0|||
46614919|NCT01714739|82732314|FG001|Overall Study|Participant withdrew consent|1|||
46614920|NCT01714739|82732315|FG002|Overall Study|Participant withdrew consent|0|||
46614921|NCT01714739|82732316|FG003|Overall Study|Participant withdrew consent|8|||
46614922|NCT01714739|82732317|FG004|Overall Study|Participant withdrew consent|0|||
46614923|NCT01714739|82732318|FG005|Overall Study|Participant withdrew consent|0|||
46614924|NCT01714739|82732319|FG006|Overall Study|Participant withdrew consent|0|||
46614925|NCT01714739|82732313|FG000|Overall Study|Lost to Follow-up|0|||
46614926|NCT01714739|82732314|FG001|Overall Study|Lost to Follow-up|0|||
46614927|NCT01714739|82732315|FG002|Overall Study|Lost to Follow-up|0|||
46614928|NCT01714739|82732316|FG003|Overall Study|Lost to Follow-up|1|||
46614929|NCT01714739|82732317|FG004|Overall Study|Lost to Follow-up|0|||
46614930|NCT01714739|82732318|FG005|Overall Study|Lost to Follow-up|0|||
46614931|NCT01714739|82732319|FG006|Overall Study|Lost to Follow-up|0|||
46614932|NCT01714739|82732313|FG000|Overall Study|Maximum clinical benefit|0|||
46614933|NCT01714739|82732314|FG001|Overall Study|Maximum clinical benefit|1|||
46614934|NCT01714739|82732315|FG002|Overall Study|Maximum clinical benefit|1|||
46614935|NCT01714739|82732316|FG003|Overall Study|Maximum clinical benefit|3|||
46614936|NCT01714739|82732317|FG004|Overall Study|Maximum clinical benefit|0|||
46614937|NCT01714739|82732318|FG005|Overall Study|Maximum clinical benefit|0|||
46614938|NCT01714739|82732319|FG006|Overall Study|Maximum clinical benefit|0|||
46614939|NCT01714739|82732313|FG000|Overall Study|Poor/non-comliance|0|||
46614940|NCT01714739|82732314|FG001|Overall Study|Poor/non-comliance|1|||
46614941|NCT01714739|82732315|FG002|Overall Study|Poor/non-comliance|0|||
46614942|NCT01714739|82732316|FG003|Overall Study|Poor/non-comliance|1|||
46614943|NCT01714739|82732317|FG004|Overall Study|Poor/non-comliance|0|||
46614944|NCT01714739|82732318|FG005|Overall Study|Poor/non-comliance|0|||
46614945|NCT01714739|82732319|FG006|Overall Study|Poor/non-comliance|0|||
46614946|NCT01714739|82732313|FG000|Overall Study|No longer meets study criteria|0|||
46614947|NCT01714739|82732314|FG001|Overall Study|No longer meets study criteria|0|||
46614948|NCT01714739|82732315|FG002|Overall Study|No longer meets study criteria|0|||
46614949|NCT01714739|82732316|FG003|Overall Study|No longer meets study criteria|1|||
46614950|NCT01714739|82732317|FG004|Overall Study|No longer meets study criteria|0|||
46614951|NCT01714739|82732318|FG005|Overall Study|No longer meets study criteria|0|||
46614952|NCT01714739|82732319|FG006|Overall Study|No longer meets study criteria|0|||
46614953|NCT01714739|82732313|FG000|Overall Study|Other reason|0|||
46614954|NCT01714739|82732314|FG001|Overall Study|Other reason|0|||
46614955|NCT01714739|82732315|FG002|Overall Study|Other reason|0|||
46614956|NCT01714739|82732316|FG003|Overall Study|Other reason|3|||
46614957|NCT01714739|82732317|FG004|Overall Study|Other reason|1|||
46614958|NCT01714739|82732318|FG005|Overall Study|Other reason|0|||
46614959|NCT01714739|82732319|FG006|Overall Study|Other reason|0|||
46614960|NCT03823287|82734296|FG000|Overall Study|Withdrawal by Subject|25|||
46614961|NCT03823287|82734297|FG001|Overall Study|Withdrawal by Subject|17|||
46614962|NCT03823287|82734296|FG000|Overall Study|Death|13|||
46614963|NCT03823287|82734297|FG001|Overall Study|Death|7|||
46614964|NCT03823287|82734296|FG000|Overall Study|Lost to Follow-up|7|||
46614965|NCT03823287|82734297|FG001|Overall Study|Lost to Follow-up|8|||
46614966|NCT03823287|82734296|FG000|Overall Study|Adverse Event|6|||
46614967|NCT03823287|82734297|FG001|Overall Study|Adverse Event|8|||
46614968|NCT03823287|82734296|FG000|Overall Study|Physician Decision|5|||
46614969|NCT03823287|82734297|FG001|Overall Study|Physician Decision|2|||
46614970|NCT03823287|82734296|FG000|Overall Study|Lack of Efficacy|2|||
46614971|NCT03823287|82734297|FG001|Overall Study|Lack of Efficacy|0|||
46614972|NCT03823287|82734296|FG000|Overall Study|Other|2|||
46614973|NCT03823287|82734297|FG001|Overall Study|Other|4|||
46614974|NCT03707925|82734458|FG000|Overall Study|Inevaluable|1|||
46614975|NCT03461757|82734518|FG000|Overall Study|Adverse Event|1|||
46614976|NCT03461757|82734519|FG001|Overall Study|Adverse Event|0|||
46614977|NCT03461757|82734518|FG000|Overall Study|Lost to Follow-up|13|||
46614978|NCT03461757|82734519|FG001|Overall Study|Lost to Follow-up|7|||
46614979|NCT03461757|82734518|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
46614980|NCT03461757|82734519|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
46614981|NCT03461757|82734518|FG000|Overall Study|Non-compliance with study treatment|0|||
46614982|NCT03461757|82734519|FG001|Overall Study|Non-compliance with study treatment|1|||
46614983|NCT03461757|82734518|FG000|Overall Study|Pregnancy|2|||
46614984|NCT03461757|82734519|FG001|Overall Study|Pregnancy|0|||
46614985|NCT03461757|82734518|FG000|Overall Study|Protocol Violation|1|||
46614986|NCT03461757|82734519|FG001|Overall Study|Protocol Violation|1|||
46614987|NCT03461757|82734518|FG000|Overall Study|Withdrawal by Subject|7|||
46614988|NCT03461757|82734519|FG001|Overall Study|Withdrawal by Subject|7|||
46614989|NCT03461757|82734518|FG000|Overall Study|Other Reasons|1|||
46614990|NCT03461757|82734519|FG001|Overall Study|Other Reasons|4|||
46614991|NCT03235479|82735007|FG000|Overall Study|Lost to Follow-up|8|||
46614992|NCT03235479|82735008|FG001|Overall Study|Lost to Follow-up|11|||
46614993|NCT03235479|82735007|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
46614994|NCT03235479|82735008|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
46614995|NCT03235479|82735007|FG000|Overall Study|Pregnancy|1|||
46614996|NCT03235479|82735008|FG001|Overall Study|Pregnancy|0|||
46708589|NCT00925990|82924247|FG000|Overall Study|moved out of state, missed medication|0|||
46708590|NCT00925990|82924248|FG001|Overall Study|moved out of state, missed medication|2|||
46708591|NCT01131078|82924257|FG000|Overall Study|Adverse Event|22|||
46708592|NCT01131078|82924258|FG001|Overall Study|Adverse Event|12|||
46708593|NCT01131078|82924259|FG002|Overall Study|Adverse Event|17|||
46614997|NCT03235479|82735007|FG000|Overall Study|Protocol Deviation|1|||
46614998|NCT03235479|82735008|FG001|Overall Study|Protocol Deviation|3|||
46614999|NCT03235479|82735007|FG000|Overall Study|Technical Problems|3|||
46615000|NCT03235479|82735008|FG001|Overall Study|Technical Problems|2|||
46615001|NCT03235479|82735007|FG000|Overall Study|Withdrawal by Subject|2|||
46615002|NCT03235479|82735008|FG001|Overall Study|Withdrawal by Subject|2|||
46615003|NCT03235479|82735007|FG000|Overall Study|Other Reasons|3|||
46615004|NCT03235479|82735008|FG001|Overall Study|Other Reasons|5|||
46615005|NCT03193437|82735064|FG000|Overall Study|Adverse Event|4|||
46615006|NCT03193437|82735064|FG000|Overall Study|Withdrawal by Subject|2|||
46615007|NCT03193437|82735064|FG000|Overall Study|Disease Progression|2|||
46615008|NCT02906787|82735106|FG000|Overall Study|Withdrawal by Subject|12|||
46615009|NCT02906787|82735107|FG001|Overall Study|Withdrawal by Subject|10|||
46615010|NCT02906787|82735106|FG000|Overall Study|Missed|24|||
46615011|NCT02906787|82735107|FG001|Overall Study|Missed|22|||
46615012|NCT02107443|82735680|FG000|Overall Study|Death|42|||
46615013|NCT02107443|82735681|FG001|Overall Study|Death|30|||
46615014|NCT02107443|82735680|FG000|Overall Study|Study Protocol Violation|3|||
46615015|NCT02107443|82735681|FG001|Overall Study|Study Protocol Violation|1|||
46615016|NCT02107443|82735680|FG000|Overall Study|Registered but Not Eligible|0|||
46615017|NCT02107443|82735681|FG001|Overall Study|Registered but Not Eligible|1|||
46615018|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
46615019|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
46615020|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
46615021|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
46615022|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Changed Mind|2|||
46615023|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Changed Mind|0|||
46615024|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
46615025|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
46615026|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
46615027|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
46615028|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
46615029|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
46615030|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
46615031|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
46615032|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Other Medical|9|||
46615033|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Other Medical|5|||
46615034|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Disease Progression|4|||
46615035|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Disease Progression|2|||
46615036|NCT02107443|82735680|FG000|Overall Study|Withdrawal: Personal Issues|0|||
46615037|NCT02107443|82735681|FG001|Overall Study|Withdrawal: Personal Issues|3|||
46615038|NCT00559949|82736576|FG000|Overall Study|Progressive Disease during cycle 1|1|||
46615039|NCT00559949|82736576|FG000|Overall Study|Adverse Event|1|||
46615040|NCT00559949|82736576|FG000|Overall Study|Withdrawal by Subject|4|||
46615041|NCT00559949|82736576|FG000|Overall Study|No disease evaluation per protocol|1|||
46615042|NCT00559637|82736628|FG000|Overall Study|Adverse Event|22|||
46615043|NCT00559637|82736628|FG000|Overall Study|Withdrawal by Subject|4|||
46615044|NCT00559637|82736628|FG000|Overall Study|Protocol Violation|6|||
46615045|NCT00559637|82736628|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
46615046|NCT00559637|82736628|FG000|Overall Study|Failure to return|6|||
46615047|NCT00559637|82736628|FG000|Overall Study|Insufficient response|3|||
46615048|NCT00559637|82736628|FG000|Overall Study|Started requiring dialysis after month 7|2|||
46615049|NCT00559637|82736628|FG000|Overall Study|Suspected lung cancer|1|||
46615050|NCT00559637|82736628|FG000|Overall Study|Participation in another study|1|||
46615051|NCT00559637|82736628|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
46615052|NCT00559637|82736628|FG000|Overall Study|Change of center|1|||
46615053|NCT00559637|82736628|FG000|Overall Study|Change of home|1|||
46615054|NCT00559637|82736628|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
46615055|NCT02578641|82736701|FG000|Overall Study|Adverse Event|5|||
46615056|NCT02578641|82736702|FG001|Overall Study|Adverse Event|15|||
46615057|NCT02578641|82736701|FG000|Overall Study|Death|16|||
46615058|NCT02578641|82736702|FG001|Overall Study|Death|8|||
46615059|NCT02578641|82736701|FG000|Overall Study|Lost to Follow-up|0|||
46615060|NCT02578641|82736702|FG001|Overall Study|Lost to Follow-up|1|||
46615061|NCT02578641|82736701|FG000|Overall Study|Withdrawal by Subject|14|||
46615062|NCT02578641|82736702|FG001|Overall Study|Withdrawal by Subject|7|||
46615063|NCT02578641|82736701|FG000|Overall Study|Progressive Disease|69|||
46615064|NCT02578641|82736702|FG001|Overall Study|Progressive Disease|21|||
46615065|NCT02578641|82736701|FG000|Overall Study|No Study Drug|2|||
46615066|NCT02578641|82736702|FG001|Overall Study|No Study Drug|0|||
46615067|NCT02578641|82736701|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
46615068|NCT02578641|82736702|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
46615069|NCT02578641|82736701|FG000|Overall Study|Non-compliance with Study Schedule|1|||
46615070|NCT02578641|82736702|FG001|Overall Study|Non-compliance with Study Schedule|0|||
46615071|NCT02578641|82736701|FG000|Overall Study|Other|1|||
46615072|NCT02578641|82736702|FG001|Overall Study|Other|10|||
46615073|NCT02578641|82736701|FG000|Overall Study|Not treated|1|||
46615074|NCT02578641|82736702|FG001|Overall Study|Not treated|4|||
46615075|NCT02431260|82736730|FG000|Overall Study|Subject Decision|0|||
46615076|NCT02431260|82736731|FG001|Overall Study|Subject Decision|1|||
46615077|NCT02431260|82736732|FG002|Overall Study|Subject Decision|1|||
46615078|NCT02431260|82736733|FG003|Overall Study|Subject Decision|0|||
46615079|NCT02431260|82736734|FG004|Overall Study|Subject Decision|0|||
46615080|NCT02431260|82736735|FG005|Overall Study|Subject Decision|0|||
46615081|NCT02431260|82736736|FG006|Overall Study|Subject Decision|0|||
46615082|NCT02431260|82736737|FG007|Overall Study|Subject Decision|0|||
46615083|NCT02431260|82736738|FG008|Overall Study|Subject Decision|1|||
46615084|NCT02431260|82736739|FG009|Overall Study|Subject Decision|1|||
46615085|NCT02431260|82736740|FG010|Overall Study|Subject Decision|0|||
46615086|NCT02431260|82736741|FG011|Overall Study|Subject Decision|1|||
46615087|NCT02431260|82736742|FG012|Overall Study|Subject Decision|0|||
46615088|NCT02431260|82736743|FG013|Overall Study|Subject Decision|0|||
46615089|NCT02431260|82736730|FG000|Overall Study|Death|4|||
46615090|NCT02431260|82736731|FG001|Overall Study|Death|4|||
46615091|NCT02431260|82736732|FG002|Overall Study|Death|3|||
46615092|NCT02431260|82736733|FG003|Overall Study|Death|4|||
46615093|NCT02431260|82736734|FG004|Overall Study|Death|2|||
46615094|NCT02431260|82736735|FG005|Overall Study|Death|2|||
46615095|NCT02431260|82736736|FG006|Overall Study|Death|3|||
46615096|NCT02431260|82736737|FG007|Overall Study|Death|1|||
46615097|NCT02431260|82736738|FG008|Overall Study|Death|6|||
46615098|NCT02431260|82736739|FG009|Overall Study|Death|6|||
46615099|NCT02431260|82736740|FG010|Overall Study|Death|3|||
46615100|NCT02431260|82736741|FG011|Overall Study|Death|2|||
46615101|NCT02431260|82736742|FG012|Overall Study|Death|5|||
46615102|NCT02431260|82736743|FG013|Overall Study|Death|1|||
46615103|NCT02431260|82736730|FG000|Overall Study|Lost to Follow-up|0|||
46615104|NCT02431260|82736731|FG001|Overall Study|Lost to Follow-up|0|||
46615105|NCT02431260|82736732|FG002|Overall Study|Lost to Follow-up|0|||
46615106|NCT02431260|82736733|FG003|Overall Study|Lost to Follow-up|0|||
46615107|NCT02431260|82736734|FG004|Overall Study|Lost to Follow-up|0|||
46615108|NCT02431260|82736735|FG005|Overall Study|Lost to Follow-up|1|||
46615109|NCT02431260|82736736|FG006|Overall Study|Lost to Follow-up|0|||
46615110|NCT02431260|82736737|FG007|Overall Study|Lost to Follow-up|0|||
46615111|NCT02431260|82736738|FG008|Overall Study|Lost to Follow-up|0|||
46615112|NCT02431260|82736739|FG009|Overall Study|Lost to Follow-up|0|||
46615113|NCT02431260|82736740|FG010|Overall Study|Lost to Follow-up|0|||
46615114|NCT02431260|82736741|FG011|Overall Study|Lost to Follow-up|0|||
46615115|NCT02431260|82736742|FG012|Overall Study|Lost to Follow-up|0|||
46615116|NCT02431260|82736743|FG013|Overall Study|Lost to Follow-up|0|||
46615117|NCT02431260|82736730|FG000|Overall Study|Study Terminated by the Sponsor|0|||
46615118|NCT02431260|82736731|FG001|Overall Study|Study Terminated by the Sponsor|0|||
46615119|NCT02431260|82736732|FG002|Overall Study|Study Terminated by the Sponsor|2|||
46615120|NCT02431260|82736733|FG003|Overall Study|Study Terminated by the Sponsor|1|||
46615121|NCT02431260|82736734|FG004|Overall Study|Study Terminated by the Sponsor|1|||
46615122|NCT02431260|82736735|FG005|Overall Study|Study Terminated by the Sponsor|0|||
46615123|NCT02431260|82736736|FG006|Overall Study|Study Terminated by the Sponsor|1|||
46615124|NCT02431260|82736737|FG007|Overall Study|Study Terminated by the Sponsor|2|||
46615125|NCT02431260|82736738|FG008|Overall Study|Study Terminated by the Sponsor|1|||
46615126|NCT02431260|82736739|FG009|Overall Study|Study Terminated by the Sponsor|1|||
46615127|NCT02431260|82736740|FG010|Overall Study|Study Terminated by the Sponsor|1|||
46615128|NCT02431260|82736741|FG011|Overall Study|Study Terminated by the Sponsor|0|||
46615129|NCT02431260|82736742|FG012|Overall Study|Study Terminated by the Sponsor|4|||
46615130|NCT02431260|82736743|FG013|Overall Study|Study Terminated by the Sponsor|0|||
46615131|NCT02431260|82736730|FG000|Overall Study|Physician Decision|0|||
46615132|NCT02431260|82736731|FG001|Overall Study|Physician Decision|0|||
46615133|NCT02431260|82736732|FG002|Overall Study|Physician Decision|0|||
46615134|NCT02431260|82736733|FG003|Overall Study|Physician Decision|0|||
46615135|NCT02431260|82736734|FG004|Overall Study|Physician Decision|0|||
46615136|NCT02431260|82736735|FG005|Overall Study|Physician Decision|1|||
46615137|NCT02431260|82736736|FG006|Overall Study|Physician Decision|0|||
46615138|NCT02431260|82736737|FG007|Overall Study|Physician Decision|0|||
46615139|NCT02431260|82736738|FG008|Overall Study|Physician Decision|0|||
46615140|NCT02431260|82736739|FG009|Overall Study|Physician Decision|0|||
46615141|NCT02431260|82736740|FG010|Overall Study|Physician Decision|0|||
46615142|NCT02431260|82736741|FG011|Overall Study|Physician Decision|0|||
46615143|NCT02431260|82736742|FG012|Overall Study|Physician Decision|0|||
46615144|NCT02431260|82736743|FG013|Overall Study|Physician Decision|0|||
46615145|NCT02431260|82736730|FG000|Overall Study|Other Unspecified|0|||
46615146|NCT02431260|82736731|FG001|Overall Study|Other Unspecified|0|||
46615147|NCT02431260|82736732|FG002|Overall Study|Other Unspecified|0|||
46615148|NCT02431260|82736733|FG003|Overall Study|Other Unspecified|0|||
46615149|NCT02431260|82736734|FG004|Overall Study|Other Unspecified|0|||
46615150|NCT02431260|82736735|FG005|Overall Study|Other Unspecified|0|||
46615151|NCT02431260|82736736|FG006|Overall Study|Other Unspecified|0|||
46615152|NCT02431260|82736737|FG007|Overall Study|Other Unspecified|0|||
46615153|NCT02431260|82736738|FG008|Overall Study|Other Unspecified|0|||
46615154|NCT02431260|82736739|FG009|Overall Study|Other Unspecified|0|||
46615155|NCT02431260|82736740|FG010|Overall Study|Other Unspecified|0|||
46615156|NCT02431260|82736741|FG011|Overall Study|Other Unspecified|1|||
46615157|NCT02431260|82736742|FG012|Overall Study|Other Unspecified|1|||
46615158|NCT02431260|82736743|FG013|Overall Study|Other Unspecified|0|||
46615159|NCT02430870|82736938|FG000|Part 2|Voluntary Withdrawal|0|||
46615160|NCT02430870|82736939|FG001|Part 2|Voluntary Withdrawal|0|||
46615161|NCT02430870|82736940|FG002|Part 2|Voluntary Withdrawal|0|||
46615162|NCT02430870|82736941|FG003|Part 2|Voluntary Withdrawal|0|||
46615163|NCT02430870|82736942|FG004|Part 2|Voluntary Withdrawal|0|||
46615164|NCT02430870|82736943|FG005|Part 2|Voluntary Withdrawal|0|||
46615165|NCT02430870|82736944|FG006|Part 2|Voluntary Withdrawal|1|||
46615166|NCT02430870|82736945|FG007|Part 2|Voluntary Withdrawal|0|||
46615167|NCT02430870|82736938|FG000|Part 2|Other Reason Not Specified|0|||
46615168|NCT02430870|82736939|FG001|Part 2|Other Reason Not Specified|0|||
46615169|NCT02430870|82736940|FG002|Part 2|Other Reason Not Specified|0|||
46615170|NCT02430870|82736941|FG003|Part 2|Other Reason Not Specified|0|||
46615171|NCT02430870|82736942|FG004|Part 2|Other Reason Not Specified|0|||
46615172|NCT02430870|82736943|FG005|Part 2|Other Reason Not Specified|0|||
46615173|NCT02430870|82736944|FG006|Part 2|Other Reason Not Specified|0|||
46615174|NCT02430870|82736945|FG007|Part 2|Other Reason Not Specified|1|||
46615175|NCT02429934|82737011|FG000|Overall Study|Withdrawal by Subject|0|||
46615176|NCT02429934|82737012|FG001|Overall Study|Withdrawal by Subject|2|||
46615177|NCT02429934|82737011|FG000|Overall Study|Adverse Event|2|||
46615178|NCT02429934|82737012|FG001|Overall Study|Adverse Event|0|||
46615179|NCT02429934|82737011|FG000|Overall Study|Lost to Follow-up|1|||
46615180|NCT02429934|82737012|FG001|Overall Study|Lost to Follow-up|1|||
46615181|NCT02429934|82737011|FG000|Overall Study|Physician Decision|1|||
46615182|NCT02429934|82737012|FG001|Overall Study|Physician Decision|0|||
46615183|NCT02429856|82737026|FG000|Overall Study|Death|12|||
46615184|NCT02429856|82737027|FG001|Overall Study|Death|13|||
46615185|NCT02429856|82737026|FG000|Overall Study|Lost to Follow-up|6|||
46615186|NCT02429856|82737027|FG001|Overall Study|Lost to Follow-up|5|||
46615187|NCT02429856|82737026|FG000|Overall Study|Withdrawal by Subject|1|||
46615188|NCT02429856|82737027|FG001|Overall Study|Withdrawal by Subject|1|||
46615189|NCT02429778|82737037|FG000|Overall Study|Lost to Follow-up|2|||
46615190|NCT02429778|82737038|FG001|Overall Study|Lost to Follow-up|0|||
46615191|NCT02429778|82737037|FG000|Overall Study|Withdrawal by Subject|5|||
46615192|NCT02429778|82737038|FG001|Overall Study|Withdrawal by Subject|0|||
46615193|NCT02403180|82737046|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
46615194|NCT02403180|82737047|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
46615195|NCT02403180|82737046|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
46615196|NCT02403180|82737047|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
46615197|NCT00558467|82737081|FG000|Overall Study|Adverse Event|1|||
46615198|NCT00558467|82737082|FG001|Overall Study|Adverse Event|2|||
46615199|NCT00558467|82737081|FG000|Overall Study|Lack of Efficacy|0|||
46615200|NCT00558467|82737082|FG001|Overall Study|Lack of Efficacy|1|||
46615201|NCT00558467|82737081|FG000|Overall Study|Patient moving out of state|0|||
46615202|NCT00558467|82737082|FG001|Overall Study|Patient moving out of state|1|||
46615203|NCT02402166|82737088|FG000|Overall Study|Adverse Event|2|||
46615204|NCT02402166|82737088|FG000|Overall Study|Withdrawal by Subject|2|||
46615205|NCT02402166|82737088|FG000|Overall Study|Lost to Follow-up|1|||
46615206|NCT02378220|82737108|FG000|Overall Study|Death|6|||
46615207|NCT02378220|82737109|FG001|Overall Study|Death|1|||
46615208|NCT02401308|82737118|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
46615209|NCT02401308|82737119|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
46615210|NCT02401230|82737128|FG000|Overall Study|Adverse Event|3|||
46615211|NCT02401230|82737129|FG001|Overall Study|Adverse Event|2|||
46615212|NCT02401230|82737130|FG002|Overall Study|Adverse Event|0|||
46615213|NCT02401230|82737128|FG000|Overall Study|Withdrawal by Subject|2|||
46615214|NCT02401230|82737129|FG001|Overall Study|Withdrawal by Subject|1|||
46615215|NCT02401230|82737130|FG002|Overall Study|Withdrawal by Subject|1|||
46615216|NCT02401230|82737128|FG000|Overall Study|Lost to Follow-up|1|||
46615217|NCT02401230|82737129|FG001|Overall Study|Lost to Follow-up|3|||
46615218|NCT02401230|82737130|FG002|Overall Study|Lost to Follow-up|3|||
46615219|NCT02429310|82737171|FG000|Overall Study|Lost to Follow-up|1|||
46615220|NCT02429310|82737172|FG001|Overall Study|Lost to Follow-up|2|||
46615221|NCT02429310|82737171|FG000|Overall Study|Protocol Violation|1|||
46615222|NCT02429310|82737172|FG001|Overall Study|Protocol Violation|1|||
46615223|NCT02428608|82737198|FG000|Overall Study|Pregnancy|2|||
46615224|NCT02428608|82737198|FG000|Overall Study|Lost to Follow-up|37|||
46615225|NCT02428608|82737198|FG000|Overall Study|Withdrawal by Subject|2|||
46615226|NCT02428608|82737198|FG000|Overall Study|scheduling conflicts|15|||
46615227|NCT02428608|82737198|FG000|Overall Study|moved away|10|||
46615228|NCT02428608|82737198|FG000|Overall Study|Death|1|||
46615229|NCT02428608|82737198|FG000|Overall Study|various|16|||
46615230|NCT02428296|82737218|FG000|Overall Study|Adverse Event|7|||
46615231|NCT02428296|82737218|FG000|Overall Study|Withdrawal by Subject|2|||
46615232|NCT02427984|82737232|FG000|Overall Study|Lost to Follow-up|13|||
46615233|NCT02427984|82737233|FG001|Overall Study|Lost to Follow-up|5|||
46615234|NCT02427984|82737234|FG002|Overall Study|Lost to Follow-up|18|||
46615235|NCT00556673|82737452|FG000|Overall Study|Protocol deviation|3|||
46615236|NCT00556673|82737453|FG001|Overall Study|Protocol deviation|2|||
46615237|NCT02402322|82737477|FG000|Pretreatment|Withdrawal by Subject|3|||
46615238|NCT02402322|82737478|FG001|Pretreatment|Withdrawal by Subject|1|||
46615239|NCT02402322|82737479|FG002|Pretreatment|Withdrawal by Subject|1|||
46615240|NCT02402322|82737477|FG000|Follow-up|Withdrawal by Subject|6|||
46615241|NCT02402322|82737478|FG001|Follow-up|Withdrawal by Subject|3|||
46615242|NCT02402322|82737479|FG002|Follow-up|Withdrawal by Subject|24|||
46615243|NCT00555425|82737595|FG000|Overall Study|Missed Medication > 1 wk|34|||
46615244|NCT00555425|82737596|FG001|Overall Study|Missed Medication > 1 wk|15|||
46615245|NCT00555425|82737595|FG000|Overall Study|Missed 3 physician management visits|1|||
46615246|NCT00555425|82737596|FG001|Overall Study|Missed 3 physician management visits|0|||
46615247|NCT00555425|82737595|FG000|Overall Study|Met criteria for protective transfer|16|||
46615248|NCT00555425|82737596|FG001|Overall Study|Met criteria for protective transfer|3|||
46615249|NCT00555425|82737595|FG000|Overall Study|Became pregnant and transferred care|0|||
46615250|NCT00555425|82737596|FG001|Overall Study|Became pregnant and transferred care|1|||
46615251|NCT00554099|82737777|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
46615252|NCT00554099|82737778|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
46615253|NCT00554099|82737779|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
46615254|NCT00554099|82737777|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
46615255|NCT00554099|82737778|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
46615256|NCT00554099|82737779|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
46615257|NCT00554099|82737777|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
46615258|NCT00554099|82737778|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
46615259|NCT00554099|82737779|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
46615260|NCT00554099|82737777|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
46615261|NCT00554099|82737778|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
46615262|NCT00554099|82737779|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
46615263|NCT00554099|82737777|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
46615264|NCT00554099|82737778|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
46615265|NCT00554099|82737779|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
46615266|NCT00554099|82737777|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
46615267|NCT00554099|82737778|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
46615268|NCT00554099|82737779|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
46615269|NCT00554099|82737777|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
46615270|NCT00554099|82737778|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
46615271|NCT00554099|82737779|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
46615272|NCT00554099|82737777|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
46615273|NCT00554099|82737778|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
46615274|NCT00554099|82737779|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
46615275|NCT00554099|82737777|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
46615276|NCT00554099|82737778|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
46615277|NCT00554099|82737779|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
46615278|NCT02377362|82737813|FG000|Part A Second Treatment|Protocol Violation|0|||
46615279|NCT02377362|82737814|FG001|Part A Second Treatment|Protocol Violation|0|||
46615280|NCT02377362|82737815|FG002|Part A Second Treatment|Protocol Violation|0|||
46615281|NCT02377362|82737816|FG003|Part A Second Treatment|Protocol Violation|0|||
46615282|NCT02377362|82737817|FG004|Part A Second Treatment|Protocol Violation|1|||
46615283|NCT02377362|82737818|FG005|Part A Second Treatment|Protocol Violation|0|||
46615284|NCT02377362|82737819|FG006|Part A Second Treatment|Protocol Violation|0|||
46615285|NCT02377362|82737820|FG007|Part A Second Treatment|Protocol Violation|0|||
46615286|NCT02377362|82737821|FG008|Part A Second Treatment|Protocol Violation|0|||
46615287|NCT02377362|82737822|FG009|Part A Second Treatment|Protocol Violation|0|||
46615288|NCT02377362|82737823|FG010|Part A Second Treatment|Protocol Violation|0|||
46615289|NCT02377362|82737824|FG011|Part A Second Treatment|Protocol Violation|0|||
46615290|NCT02377362|82737825|FG012|Part A Second Treatment|Protocol Violation|0|||
46615291|NCT02377362|82737813|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615292|NCT02377362|82737814|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615293|NCT02377362|82737815|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615294|NCT02377362|82737816|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
46615295|NCT02377362|82737817|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
46615296|NCT02377362|82737818|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
46615297|NCT02377362|82737819|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615298|NCT02377362|82737820|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615299|NCT02377362|82737821|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615300|NCT02377362|82737822|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615301|NCT02377362|82737823|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615302|NCT02377362|82737824|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615303|NCT02377362|82737825|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
46615304|NCT02377362|82737813|FG000|Part B Overall|Protocol Violation|0|||
46615305|NCT02377362|82737814|FG001|Part B Overall|Protocol Violation|0|||
46615306|NCT02377362|82737815|FG002|Part B Overall|Protocol Violation|0|||
46615307|NCT02377362|82737816|FG003|Part B Overall|Protocol Violation|0|||
46615308|NCT02377362|82737817|FG004|Part B Overall|Protocol Violation|0|||
46615309|NCT02377362|82737818|FG005|Part B Overall|Protocol Violation|0|||
46615310|NCT02377362|82737819|FG006|Part B Overall|Protocol Violation|0|||
46615311|NCT02377362|82737820|FG007|Part B Overall|Protocol Violation|0|||
46615312|NCT02377362|82737821|FG008|Part B Overall|Protocol Violation|0|||
46615313|NCT02377362|82737822|FG009|Part B Overall|Protocol Violation|1|||
46615314|NCT02377362|82737823|FG010|Part B Overall|Protocol Violation|0|||
46615315|NCT02377362|82737824|FG011|Part B Overall|Protocol Violation|0|||
46615316|NCT02377362|82737825|FG012|Part B Overall|Protocol Violation|0|||
46615317|NCT02377362|82737813|FG000|Part B Overall|Adverse Event|0|||
46615318|NCT02377362|82737814|FG001|Part B Overall|Adverse Event|0|||
46615319|NCT02377362|82737815|FG002|Part B Overall|Adverse Event|0|||
46615320|NCT02377362|82737816|FG003|Part B Overall|Adverse Event|0|||
46615321|NCT02377362|82737817|FG004|Part B Overall|Adverse Event|0|||
46615322|NCT02377362|82737818|FG005|Part B Overall|Adverse Event|0|||
46615323|NCT02377362|82737819|FG006|Part B Overall|Adverse Event|1|||
46615324|NCT02377362|82737820|FG007|Part B Overall|Adverse Event|1|||
46615325|NCT02377362|82737821|FG008|Part B Overall|Adverse Event|0|||
46615326|NCT02377362|82737822|FG009|Part B Overall|Adverse Event|0|||
46615327|NCT02377362|82737823|FG010|Part B Overall|Adverse Event|0|||
46615328|NCT02377362|82737824|FG011|Part B Overall|Adverse Event|0|||
46615329|NCT02377362|82737825|FG012|Part B Overall|Adverse Event|0|||
46615330|NCT02377362|82737813|FG000|Part B Overall|Withdrawal by Subject|0|||
46615331|NCT02377362|82737814|FG001|Part B Overall|Withdrawal by Subject|0|||
46615332|NCT02377362|82737815|FG002|Part B Overall|Withdrawal by Subject|0|||
46615333|NCT02377362|82737816|FG003|Part B Overall|Withdrawal by Subject|0|||
46615334|NCT02377362|82737817|FG004|Part B Overall|Withdrawal by Subject|0|||
46615335|NCT02377362|82737818|FG005|Part B Overall|Withdrawal by Subject|0|||
46615336|NCT02377362|82737819|FG006|Part B Overall|Withdrawal by Subject|1|||
46615337|NCT02377362|82737820|FG007|Part B Overall|Withdrawal by Subject|0|||
46615338|NCT02377362|82737821|FG008|Part B Overall|Withdrawal by Subject|0|||
46615339|NCT02377362|82737822|FG009|Part B Overall|Withdrawal by Subject|0|||
46615340|NCT02377362|82737823|FG010|Part B Overall|Withdrawal by Subject|0|||
46615341|NCT02377362|82737824|FG011|Part B Overall|Withdrawal by Subject|1|||
46615342|NCT02377362|82737825|FG012|Part B Overall|Withdrawal by Subject|0|||
46615343|NCT00553631|82737865|FG000|Overall Study|Withdrawal by Subject|0|||
46615344|NCT00553631|82737866|FG001|Overall Study|Withdrawal by Subject|1|||
46615345|NCT00553631|82737865|FG000|Overall Study|Lost to Follow-up|1|||
46615346|NCT00553631|82737866|FG001|Overall Study|Lost to Follow-up|0|||
46615347|NCT00553319|82737875|FG000|Overall Study|Lost to Follow-up|10|||
46615348|NCT00553319|82737876|FG001|Overall Study|Lost to Follow-up|9|||
46615349|NCT00553319|82737877|FG002|Overall Study|Lost to Follow-up|5|||
46615350|NCT00553319|82737875|FG000|Overall Study|wanted treatment elsewhere|2|||
46615351|NCT00553319|82737876|FG001|Overall Study|wanted treatment elsewhere|1|||
46615352|NCT00553319|82737877|FG002|Overall Study|wanted treatment elsewhere|1|||
46615353|NCT00553319|82737875|FG000|Overall Study|non-compliance|0|||
46615354|NCT00553319|82737876|FG001|Overall Study|non-compliance|0|||
46615355|NCT00553319|82737877|FG002|Overall Study|non-compliance|2|||
46615356|NCT00553319|82737875|FG000|Overall Study|incarceration|1|||
46615357|NCT00553319|82737876|FG001|Overall Study|incarceration|0|||
46615358|NCT00553319|82737877|FG002|Overall Study|incarceration|0|||
46615359|NCT00553319|82737875|FG000|Overall Study|moved|1|||
46615360|NCT00553319|82737876|FG001|Overall Study|moved|0|||
46615361|NCT00553319|82737877|FG002|Overall Study|moved|1|||
46615362|NCT01649856|82738063|FG000|Overall Study|Withdrawal by Subject|14|||
46615363|NCT01649856|82738064|FG001|Overall Study|Withdrawal by Subject|14|||
46615364|NCT01649856|82738063|FG000|Overall Study|Protocol Violation|4|||
46615365|NCT01649856|82738064|FG001|Overall Study|Protocol Violation|4|||
46615366|NCT01649856|82738063|FG000|Overall Study|Treatment Failure|1|||
46615367|NCT01649856|82738064|FG001|Overall Study|Treatment Failure|1|||
46615368|NCT01649856|82738063|FG000|Overall Study|Death|69|||
46615369|NCT01649856|82738064|FG001|Overall Study|Death|34|||
46615370|NCT01649856|82738063|FG000|Overall Study|Stable or Progressed Disease|5|||
46615371|NCT01649856|82738064|FG001|Overall Study|Stable or Progressed Disease|3|||
46615372|NCT01649856|82738063|FG000|Overall Study|Lost to Follow-up|20|||
46615373|NCT01649856|82738064|FG001|Overall Study|Lost to Follow-up|16|||
46615374|NCT01649856|82738063|FG000|Overall Study|Lack of Compliance|6|||
46615375|NCT01649856|82738064|FG001|Overall Study|Lack of Compliance|1|||
46615376|NCT01649856|82738063|FG000|Overall Study|Other|20|||
46615377|NCT01649856|82738064|FG001|Overall Study|Other|5|||
46615378|NCT02375724|82738085|FG000|Overall Study|Lack of Efficacy|1|||
46615379|NCT02375724|82738086|FG001|Overall Study|Lack of Efficacy|1|||
46615380|NCT02375724|82738085|FG000|Overall Study|Withdrawal by Subject|1|||
46615381|NCT02375724|82738086|FG001|Overall Study|Withdrawal by Subject|1|||
46615382|NCT02375724|82738085|FG000|Overall Study|Lost to Follow-up|1|||
46615383|NCT02375724|82738086|FG001|Overall Study|Lost to Follow-up|0|||
46615384|NCT02375724|82738085|FG000|Overall Study|Protocol Violation|1|||
46615385|NCT02375724|82738086|FG001|Overall Study|Protocol Violation|0|||
46615386|NCT02375724|82738085|FG000|Overall Study|Adverse Event|2|||
46615387|NCT02375724|82738086|FG001|Overall Study|Adverse Event|4|||
46615388|NCT02398188|82738094|FG000|Overall Study|Adverse Event|2|||
46615389|NCT02398188|82738095|FG001|Overall Study|Adverse Event|3|||
46615390|NCT02398188|82738094|FG000|Overall Study|Lost to Follow-up|5|||
46615391|NCT02398188|82738095|FG001|Overall Study|Lost to Follow-up|0|||
46615392|NCT02398188|82738094|FG000|Overall Study|Non-compliance|4|||
46615393|NCT02398188|82738095|FG001|Overall Study|Non-compliance|4|||
46615394|NCT02398188|82738094|FG000|Overall Study|Protocol Violation|6|||
46615395|NCT02398188|82738095|FG001|Overall Study|Protocol Violation|10|||
46615396|NCT02398188|82738094|FG000|Overall Study|Sponsor Decision|2|||
46615397|NCT02398188|82738095|FG001|Overall Study|Sponsor Decision|1|||
46615398|NCT02398188|82738094|FG000|Overall Study|Pregnancy|1|||
46615399|NCT02398188|82738095|FG001|Overall Study|Pregnancy|0|||
46615400|NCT02398188|82738094|FG000|Overall Study|Withdrawal by Subject|7|||
46615401|NCT02398188|82738095|FG001|Overall Study|Withdrawal by Subject|16|||
46615402|NCT02426580|82738103|FG000|Overall Study|Death|2|||
46615403|NCT02426580|82738104|FG001|Overall Study|Death|2|||
46615404|NCT02426580|82738103|FG000|Overall Study|Lost to Follow-up|0|||
46615405|NCT02426580|82738104|FG001|Overall Study|Lost to Follow-up|9|||
46615406|NCT02426580|82738103|FG000|Overall Study|transfer to hemodialysis|5|||
46615407|NCT02426580|82738104|FG001|Overall Study|transfer to hemodialysis|5|||
46615408|NCT02426580|82738103|FG000|Overall Study|Kidney transplant|3|||
46615409|NCT02426580|82738104|FG001|Overall Study|Kidney transplant|0|||
46615410|NCT02426580|82738103|FG000|Overall Study|Allergic to egg white|1|||
46615411|NCT02426580|82738104|FG001|Overall Study|Allergic to egg white|0|||
46615412|NCT01651260|82738110|FG000|Overall Study|unable to apply product|3|||
46615413|NCT02425098|82738130|FG000|Overall Study|Lost to Follow-up|7|||
46615414|NCT02425098|82738131|FG001|Overall Study|Lost to Follow-up|7|||
46615415|NCT02425098|82738130|FG000|Overall Study|Withdrawal by Subject|4|||
46615416|NCT02425098|82738131|FG001|Overall Study|Withdrawal by Subject|8|||
46615417|NCT02425098|82738130|FG000|Overall Study|Pregnancy|2|||
46615418|NCT02425098|82738131|FG001|Overall Study|Pregnancy|0|||
46615419|NCT02425098|82738130|FG000|Overall Study|Reason not Specified|0|||
46615420|NCT02425098|82738131|FG001|Overall Study|Reason not Specified|1|||
46615421|NCT02424630|82738139|FG000|Overall Study|No rotator cuff tear|1|||
46615422|NCT02424630|82738140|FG001|Overall Study|No rotator cuff tear|2|||
46615423|NCT02424630|82738139|FG000|Overall Study|Open procedure|0|||
46615424|NCT02424630|82738140|FG001|Overall Study|Open procedure|1|||
46615425|NCT02397408|82738146|FG000|Overall Study|Physician Decision|4|||
46615426|NCT02397408|82738146|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
46615427|NCT02397096|82738152|FG000|Day 1 to Week 24|Adverse Event|7|||
46615428|NCT02397096|82738153|FG001|Day 1 to Week 24|Adverse Event|1|||
46615429|NCT02397096|82738152|FG000|Day 1 to Week 24|Death|1|||
46615430|NCT02397096|82738153|FG001|Day 1 to Week 24|Death|0|||
46615431|NCT02397096|82738152|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
46615432|NCT02397096|82738153|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
46615433|NCT02397096|82738152|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
46615434|NCT02397096|82738153|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
46615435|NCT02397096|82738152|FG000|Day 1 to Week 24|Physician Decision|2|||
46615436|NCT02397096|82738153|FG001|Day 1 to Week 24|Physician Decision|3|||
46615437|NCT02397096|82738152|FG000|Day 1 to Week 24|Protocol Violation|1|||
46615438|NCT02397096|82738153|FG001|Day 1 to Week 24|Protocol Violation|4|||
46615439|NCT02397096|82738152|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
46615440|NCT02397096|82738153|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
46615441|NCT02397096|82738152|FG000|Week 24 to Week 48|Adverse Event|6|||
46615442|NCT02397096|82738153|FG001|Week 24 to Week 48|Adverse Event|2|||
46615443|NCT02397096|82738152|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
46615444|NCT02397096|82738153|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
46615445|NCT02397096|82738152|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
46615446|NCT02397096|82738153|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
46615447|NCT02397096|82738152|FG000|Week 24 to Week 48|Physician Decision|2|||
46615448|NCT02397096|82738153|FG001|Week 24 to Week 48|Physician Decision|1|||
46615449|NCT02397096|82738152|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
46615450|NCT02397096|82738153|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
46615451|NCT02397096|82738152|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
46615452|NCT02397096|82738153|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
46615453|NCT02397096|82738152|FG000|Study Extensions|Ongoing|399|||
46615454|NCT02397096|82738153|FG001|Study Extensions|Ongoing|202|||
46615455|NCT02372058|82738163|FG000|Overall Study|Withdrawal by Subject|3|||
46615456|NCT02396316|82738171|FG000|Overall Study|Physician Decision|1|||
46615457|NCT02396316|82738172|FG001|Overall Study|Physician Decision|0|||
46615458|NCT02396316|82738171|FG000|Overall Study|Progressive disease|6|||
46615459|NCT02396316|82738172|FG001|Overall Study|Progressive disease|3|||
46615460|NCT02396316|82738171|FG000|Overall Study|Protocol Violation|0|||
46615461|NCT02396316|82738172|FG001|Overall Study|Protocol Violation|1|||
46615462|NCT02396316|82738171|FG000|Overall Study|Treatment unblinded|0|||
46615463|NCT02396316|82738172|FG001|Overall Study|Treatment unblinded|1|||
46615464|NCT02395536|82738182|FG000|Overall Study|Lost to Follow-up|4|||
46615465|NCT02395536|82738183|FG001|Overall Study|Lost to Follow-up|4|||
46615466|NCT02395536|82738182|FG000|Overall Study|Death|2|||
46615467|NCT02395536|82738183|FG001|Overall Study|Death|0|||
46615468|NCT02395536|82738182|FG000|Overall Study|Physician Decision|4|||
46615469|NCT02395536|82738183|FG001|Overall Study|Physician Decision|6|||
46615470|NCT02395536|82738182|FG000|Overall Study|Withdrawal by Subject|9|||
46615471|NCT02395536|82738183|FG001|Overall Study|Withdrawal by Subject|17|||
46615472|NCT02395536|82738182|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
46615473|NCT02395536|82738183|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
46615474|NCT02395536|82738182|FG000|Overall Study|Insurance issue|0|||
46615475|NCT02395536|82738183|FG001|Overall Study|Insurance issue|1|||
46615476|NCT00552929|82738199|FG000|Overall Study|Lost to Follow-up|0|||
46615477|NCT00552929|82738200|FG001|Overall Study|Lost to Follow-up|0|||
46615478|NCT00552929|82738201|FG002|Overall Study|Lost to Follow-up|0|||
46615479|NCT00552929|82738202|FG003|Overall Study|Lost to Follow-up|0|||
46615480|NCT00552929|82738203|FG004|Overall Study|Lost to Follow-up|0|||
46615481|NCT00552929|82738204|FG005|Overall Study|Lost to Follow-up|0|||
46615482|NCT00552929|82738205|FG006|Overall Study|Lost to Follow-up|0|||
46615483|NCT00552929|82738206|FG007|Overall Study|Lost to Follow-up|0|||
46615484|NCT00552929|82738207|FG008|Overall Study|Lost to Follow-up|1|||
46615485|NCT00552929|82738208|FG009|Overall Study|Lost to Follow-up|0|||
46615486|NCT00552929|82738199|FG000|Overall Study|Not Eligible|0|||
46615487|NCT00552929|82738200|FG001|Overall Study|Not Eligible|0|||
46615488|NCT00552929|82738201|FG002|Overall Study|Not Eligible|0|||
46615489|NCT00552929|82738202|FG003|Overall Study|Not Eligible|0|||
46615490|NCT00552929|82738203|FG004|Overall Study|Not Eligible|0|||
46615491|NCT00552929|82738204|FG005|Overall Study|Not Eligible|1|||
46615492|NCT00552929|82738205|FG006|Overall Study|Not Eligible|0|||
46615493|NCT00552929|82738206|FG007|Overall Study|Not Eligible|0|||
46615494|NCT00552929|82738207|FG008|Overall Study|Not Eligible|0|||
46615495|NCT00552929|82738208|FG009|Overall Study|Not Eligible|0|||
46615496|NCT02395302|82738230|FG000|Overall Study|Screen Failure|3|||
46615497|NCT02395302|82738230|FG000|Overall Study|Run In Failure|7|||
46615498|NCT02395302|82738230|FG000|Overall Study|Withdrawal by Subject|2|||
46615499|NCT02395302|82738230|FG000|Overall Study|Physician Decision|2|||
46615500|NCT02371980|82738264|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
46615501|NCT02371980|82738265|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
46615502|NCT02371980|82738266|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
46615503|NCT02371980|82738267|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
46615504|NCT02371980|82738268|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
46615505|NCT02371980|82738264|FG000|Open-label Period|Significant Protocol Deviation|19|||
46615506|NCT02371980|82738265|FG001|Open-label Period|Significant Protocol Deviation|0|||
46615507|NCT02371980|82738266|FG002|Open-label Period|Significant Protocol Deviation|0|||
46615508|NCT02371980|82738267|FG003|Open-label Period|Significant Protocol Deviation|0|||
46615509|NCT02371980|82738268|FG004|Open-label Period|Significant Protocol Deviation|0|||
46615510|NCT02371980|82738264|FG000|Open-label Period|Noncompliance with Study Drug|10|||
46615511|NCT02371980|82738265|FG001|Open-label Period|Noncompliance with Study Drug|0|||
46615512|NCT02371980|82738266|FG002|Open-label Period|Noncompliance with Study Drug|0|||
46615513|NCT02371980|82738267|FG003|Open-label Period|Noncompliance with Study Drug|0|||
46615514|NCT02371980|82738268|FG004|Open-label Period|Noncompliance with Study Drug|0|||
46615515|NCT02371980|82738264|FG000|Open-label Period|Lost to Follow-up|55|||
46615516|NCT02371980|82738265|FG001|Open-label Period|Lost to Follow-up|0|||
46615517|NCT02371980|82738266|FG002|Open-label Period|Lost to Follow-up|0|||
46615518|NCT02371980|82738267|FG003|Open-label Period|Lost to Follow-up|0|||
46615519|NCT02371980|82738268|FG004|Open-label Period|Lost to Follow-up|0|||
46615520|NCT02371980|82738264|FG000|Open-label Period|Voluntary Withdrawal|91|||
46615521|NCT02371980|82738265|FG001|Open-label Period|Voluntary Withdrawal|0|||
46615522|NCT02371980|82738266|FG002|Open-label Period|Voluntary Withdrawal|0|||
46615523|NCT02371980|82738267|FG003|Open-label Period|Voluntary Withdrawal|0|||
46615524|NCT02371980|82738268|FG004|Open-label Period|Voluntary Withdrawal|0|||
46615525|NCT02371980|82738264|FG000|Open-label Period|Pregnancy|1|||
46615526|NCT02371980|82738265|FG001|Open-label Period|Pregnancy|0|||
46615527|NCT02371980|82738266|FG002|Open-label Period|Pregnancy|0|||
46615528|NCT02371980|82738267|FG003|Open-label Period|Pregnancy|0|||
46615529|NCT02371980|82738268|FG004|Open-label Period|Pregnancy|0|||
46615530|NCT02371980|82738264|FG000|Open-label Period|Lack of Efficacy|116|||
46615531|NCT02371980|82738265|FG001|Open-label Period|Lack of Efficacy|0|||
46615532|NCT02371980|82738266|FG002|Open-label Period|Lack of Efficacy|0|||
46615533|NCT02371980|82738267|FG003|Open-label Period|Lack of Efficacy|0|||
46615534|NCT02371980|82738268|FG004|Open-label Period|Lack of Efficacy|0|||
46615535|NCT02371980|82738264|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
46615536|NCT02371980|82738265|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
46615537|NCT02371980|82738266|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
46615538|NCT02371980|82738267|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
46615539|NCT02371980|82738268|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
46615540|NCT02371980|82738264|FG000|Open-label Period|Reason not Specified|9|||
46615541|NCT02371980|82738265|FG001|Open-label Period|Reason not Specified|0|||
46615542|NCT02371980|82738266|FG002|Open-label Period|Reason not Specified|0|||
46615543|NCT02371980|82738267|FG003|Open-label Period|Reason not Specified|0|||
46615544|NCT02371980|82738268|FG004|Open-label Period|Reason not Specified|0|||
46615545|NCT02371980|82738264|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
46615546|NCT02371980|82738265|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
46615547|NCT02371980|82738266|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
46615548|NCT02371980|82738267|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
46615549|NCT02371980|82738268|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
46615550|NCT02371980|82738264|FG000|Double-blind Period|Significant Protocol Deviation|0|||
46615551|NCT02371980|82738265|FG001|Double-blind Period|Significant Protocol Deviation|2|||
46615552|NCT02371980|82738266|FG002|Double-blind Period|Significant Protocol Deviation|7|||
46615553|NCT02371980|82738267|FG003|Double-blind Period|Significant Protocol Deviation|3|||
46615554|NCT02371980|82738268|FG004|Double-blind Period|Significant Protocol Deviation|3|||
46615555|NCT02371980|82738264|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
46615556|NCT02371980|82738265|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
46615557|NCT02371980|82738266|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
46615558|NCT02371980|82738267|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
46615559|NCT02371980|82738268|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
46615560|NCT02371980|82738264|FG000|Double-blind Period|Lost to Follow-up|0|||
46615561|NCT02371980|82738265|FG001|Double-blind Period|Lost to Follow-up|8|||
46615562|NCT02371980|82738266|FG002|Double-blind Period|Lost to Follow-up|8|||
46615563|NCT02371980|82738267|FG003|Double-blind Period|Lost to Follow-up|6|||
46615564|NCT02371980|82738268|FG004|Double-blind Period|Lost to Follow-up|5|||
46615565|NCT02371980|82738264|FG000|Double-blind Period|Voluntary Withdrawal|0|||
46615566|NCT02371980|82738265|FG001|Double-blind Period|Voluntary Withdrawal|12|||
46615567|NCT02371980|82738266|FG002|Double-blind Period|Voluntary Withdrawal|8|||
46615568|NCT02371980|82738267|FG003|Double-blind Period|Voluntary Withdrawal|9|||
46615569|NCT02371980|82738268|FG004|Double-blind Period|Voluntary Withdrawal|11|||
46615570|NCT02371980|82738264|FG000|Double-blind Period|Relapse|0|||
46615571|NCT02371980|82738265|FG001|Double-blind Period|Relapse|50|||
46615572|NCT02371980|82738266|FG002|Double-blind Period|Relapse|25|||
46615573|NCT02371980|82738267|FG003|Double-blind Period|Relapse|25|||
46615574|NCT02371980|82738268|FG004|Double-blind Period|Relapse|26|||
46615575|NCT02371980|82738264|FG000|Double-blind Period|Reason not Specified|0|||
46615576|NCT02371980|82738265|FG001|Double-blind Period|Reason not Specified|3|||
46615577|NCT02371980|82738266|FG002|Double-blind Period|Reason not Specified|3|||
46615578|NCT02371980|82738267|FG003|Double-blind Period|Reason not Specified|2|||
46615579|NCT02371980|82738268|FG004|Double-blind Period|Reason not Specified|1|||
46615580|NCT02371980|82738264|FG000|Double-blind Period|Missing|0|||
46615581|NCT02371980|82738265|FG001|Double-blind Period|Missing|1|||
46615582|NCT02371980|82738266|FG002|Double-blind Period|Missing|0|||
46615583|NCT02371980|82738267|FG003|Double-blind Period|Missing|0|||
46615584|NCT02371980|82738268|FG004|Double-blind Period|Missing|0|||
46615585|NCT02371746|82738408|FG000|Overall Study|Consent withdrawn|0|||
46615586|NCT02371746|82738409|FG001|Overall Study|Consent withdrawn|0|||
46615587|NCT02371746|82738410|FG002|Overall Study|Consent withdrawn|0|||
46615588|NCT02371746|82738411|FG003|Overall Study|Consent withdrawn|0|||
46615589|NCT02371746|82738412|FG004|Overall Study|Consent withdrawn|0|||
46615590|NCT02371746|82738413|FG005|Overall Study|Consent withdrawn|0|||
46615591|NCT02371746|82738414|FG006|Overall Study|Consent withdrawn|1|||
46615592|NCT02421666|82738462|FG000|6-month Follow-up|Lost to Follow-up|8|||
46615593|NCT02421666|82738463|FG001|6-month Follow-up|Lost to Follow-up|7|||
46615594|NCT02421666|82738462|FG000|6-month Follow-up|Withdrawal by Subject|5|||
46615595|NCT02421666|82738463|FG001|6-month Follow-up|Withdrawal by Subject|6|||
46615596|NCT02421666|82738462|FG000|12-month Follow-up|Lost to Follow-up|5|||
46615597|NCT02421666|82738463|FG001|12-month Follow-up|Lost to Follow-up|5|||
46615598|NCT02421666|82738462|FG000|12-month Follow-up|Withdrawal by Subject|6|||
46615599|NCT02421666|82738463|FG001|12-month Follow-up|Withdrawal by Subject|11|||
46615600|NCT02394756|82738473|FG000|Period 1|Lens Discomfort|0|||
46615601|NCT02394756|82738474|FG001|Period 1|Lens Discomfort|0|||
46615602|NCT02394756|82738475|FG002|Period 1|Lens Discomfort|0|||
46615603|NCT02394756|82738476|FG003|Period 1|Lens Discomfort|0|||
46615604|NCT02394756|82738477|FG004|Period 1|Lens Discomfort|0|||
46615605|NCT02394756|82738478|FG005|Period 1|Lens Discomfort|1|||
46615606|NCT02394756|82738473|FG000|Period 1|Withdrawal by Subject|0|||
46615607|NCT02394756|82738474|FG001|Period 1|Withdrawal by Subject|1|||
46615608|NCT02394756|82738475|FG002|Period 1|Withdrawal by Subject|1|||
46615609|NCT02394756|82738476|FG003|Period 1|Withdrawal by Subject|1|||
46615610|NCT02394756|82738477|FG004|Period 1|Withdrawal by Subject|0|||
46615611|NCT02394756|82738478|FG005|Period 1|Withdrawal by Subject|0|||
46615612|NCT02394756|82738473|FG000|Period 2|Unsatisfactory Visual Response|0|||
46615613|NCT02394756|82738474|FG001|Period 2|Unsatisfactory Visual Response|0|||
46615614|NCT02394756|82738475|FG002|Period 2|Unsatisfactory Visual Response|0|||
46615615|NCT02394756|82738476|FG003|Period 2|Unsatisfactory Visual Response|0|||
46615616|NCT02394756|82738477|FG004|Period 2|Unsatisfactory Visual Response|1|||
46615617|NCT02394756|82738478|FG005|Period 2|Unsatisfactory Visual Response|0|||
46615618|NCT02370888|82738499|FG000|Overall Study|disease progression|2|||
46615619|NCT02370888|82738499|FG000|Overall Study|did not meet chimerism criteria|6|||
46615620|NCT02394600|82738523|FG000|Overall Study|Adverse Event|3|||
46615621|NCT02394600|82738524|FG001|Overall Study|Adverse Event|0|||
46615622|NCT02394600|82738523|FG000|Overall Study|Lost to Follow-up|0|||
46615623|NCT02394600|82738524|FG001|Overall Study|Lost to Follow-up|1|||
46615624|NCT02394600|82738523|FG000|Overall Study|Withdrawal by Subject|0|||
46615625|NCT02394600|82738524|FG001|Overall Study|Withdrawal by Subject|1|||
46615626|NCT02394600|82738523|FG000|Overall Study|Protocol Violation|1|||
46615627|NCT02394600|82738524|FG001|Overall Study|Protocol Violation|0|||
46615628|NCT04685499|82738540|FG000|Overall Study|Study Terminated Early|1|||
46615629|NCT02421588|82738616|FG000|Overall Study|Non-treatment-related AE|8|||
46615630|NCT02421588|82738617|FG001|Overall Study|Non-treatment-related AE|8|||
46615631|NCT02421588|82738616|FG000|Overall Study|Progressive disease|152|||
46615632|NCT02421588|82738617|FG001|Overall Study|Progressive disease|135|||
46615633|NCT02421588|82738616|FG000|Overall Study|Death|11|||
46615634|NCT02421588|82738617|FG001|Overall Study|Death|3|||
46615635|NCT02421588|82738616|FG000|Overall Study|Physician Decision|8|||
46615636|NCT02421588|82738617|FG001|Overall Study|Physician Decision|17|||
46615637|NCT02421588|82738616|FG000|Overall Study|Other reason not specified|3|||
46615638|NCT02421588|82738617|FG001|Overall Study|Other reason not specified|1|||
46615639|NCT02421588|82738616|FG000|Overall Study|Symptomatic deterioration|13|||
46615640|NCT02421588|82738617|FG001|Overall Study|Symptomatic deterioration|19|||
46615641|NCT02421588|82738616|FG000|Overall Study|Treatment-related AE|10|||
46615642|NCT02421588|82738617|FG001|Overall Study|Treatment-related AE|14|||
46615643|NCT02421588|82738616|FG000|Overall Study|Withdrawal by Subject|14|||
46615644|NCT02421588|82738617|FG001|Overall Study|Withdrawal by Subject|16|||
46615645|NCT02421588|82738616|FG000|Overall Study|Not treated|2|||
46615646|NCT02421588|82738617|FG001|Overall Study|Not treated|8|||
46615647|NCT02421510|82738626|FG000|Overall Study|Other|4|||
46615648|NCT02421510|82738627|FG001|Overall Study|Other|2|||
46615649|NCT02421510|82738628|FG002|Overall Study|Other|3|||
46615650|NCT02421510|82738626|FG000|Overall Study|Protocol Violation|1|||
46615651|NCT02421510|82738627|FG001|Overall Study|Protocol Violation|2|||
46615652|NCT02421510|82738628|FG002|Overall Study|Protocol Violation|0|||
46615653|NCT02421510|82738626|FG000|Overall Study|Death|1|||
46615654|NCT02421510|82738627|FG001|Overall Study|Death|0|||
46615655|NCT02421510|82738628|FG002|Overall Study|Death|0|||
46615656|NCT02421510|82738626|FG000|Overall Study|Noncompliance with study drug|1|||
46615657|NCT02421510|82738627|FG001|Overall Study|Noncompliance with study drug|0|||
46615658|NCT02421510|82738628|FG002|Overall Study|Noncompliance with study drug|0|||
46615659|NCT02421510|82738626|FG000|Overall Study|Physician Decision|1|||
46615660|NCT02421510|82738627|FG001|Overall Study|Physician Decision|1|||
46615661|NCT02421510|82738628|FG002|Overall Study|Physician Decision|3|||
46615662|NCT02421510|82738626|FG000|Overall Study|Adverse Event|9|||
46615663|NCT02421510|82738627|FG001|Overall Study|Adverse Event|10|||
46615664|NCT02421510|82738628|FG002|Overall Study|Adverse Event|18|||
46615665|NCT02421510|82738626|FG000|Overall Study|Pregnancy|1|||
46615666|NCT02421510|82738627|FG001|Overall Study|Pregnancy|1|||
46615667|NCT02421510|82738628|FG002|Overall Study|Pregnancy|0|||
46615668|NCT02421510|82738626|FG000|Overall Study|Withdrawal by Subject|14|||
46615669|NCT02421510|82738627|FG001|Overall Study|Withdrawal by Subject|18|||
46615670|NCT02421510|82738628|FG002|Overall Study|Withdrawal by Subject|12|||
46615671|NCT02421510|82738626|FG000|Overall Study|Lost to Follow-up|1|||
46615672|NCT02421510|82738627|FG001|Overall Study|Lost to Follow-up|1|||
46615673|NCT02421510|82738628|FG002|Overall Study|Lost to Follow-up|0|||
46615674|NCT00552617|82738646|FG000|Overall Study|Not Treated|0|||
46615675|NCT00552617|82738647|FG001|Overall Study|Not Treated|0|||
46615676|NCT00552617|82738648|FG002|Overall Study|Not Treated|1|||
46615677|NCT00552617|82738649|FG003|Overall Study|Not Treated|0|||
46615678|NCT00552617|82738650|FG004|Overall Study|Not Treated|0|||
46615679|NCT00552617|82738651|FG005|Overall Study|Not Treated|0|||
46615680|NCT00552617|82738652|FG006|Overall Study|Not Treated|0|||
46615681|NCT00552617|82738653|FG007|Overall Study|Not Treated|0|||
46615682|NCT00552617|82738654|FG008|Overall Study|Not Treated|0|||
46615683|NCT00552617|82738655|FG009|Overall Study|Not Treated|1|||
46615684|NCT00552617|82738646|FG000|Overall Study|Lost to Follow-up|0|||
46615685|NCT00552617|82738647|FG001|Overall Study|Lost to Follow-up|0|||
46615686|NCT00552617|82738648|FG002|Overall Study|Lost to Follow-up|0|||
46615687|NCT00552617|82738649|FG003|Overall Study|Lost to Follow-up|1|||
46615688|NCT00552617|82738650|FG004|Overall Study|Lost to Follow-up|0|||
46615689|NCT00552617|82738651|FG005|Overall Study|Lost to Follow-up|2|||
46615690|NCT00552617|82738652|FG006|Overall Study|Lost to Follow-up|0|||
46615691|NCT00552617|82738653|FG007|Overall Study|Lost to Follow-up|0|||
46615692|NCT00552617|82738654|FG008|Overall Study|Lost to Follow-up|2|||
46615693|NCT00552617|82738655|FG009|Overall Study|Lost to Follow-up|0|||
46615694|NCT02421120|82738677|FG000|Overall Study|Adverse Event|1|||
46615695|NCT02420262|82738683|FG000|Overall Study|Adverse Event|1|||
46615696|NCT02420262|82738684|FG001|Overall Study|Adverse Event|0|||
46615697|NCT02420262|82738683|FG000|Overall Study|Withdrawal by Subject|1|||
46615698|NCT02420262|82738684|FG001|Overall Study|Withdrawal by Subject|4|||
46615699|NCT02420262|82738683|FG000|Overall Study|Unclassified|0|||
46615700|NCT02420262|82738684|FG001|Overall Study|Unclassified|1|||
46615701|NCT00552305|82738690|FG000|Overall Study|Adverse Event|43|||
46615702|NCT00552305|82738690|FG000|Overall Study|Lack of Efficacy|120|||
46615703|NCT00552305|82738690|FG000|Overall Study|Lost to Follow-up|4|||
46615704|NCT00552305|82738690|FG000|Overall Study|Protocol Violation|3|||
46615705|NCT00552305|82738690|FG000|Overall Study|Withdrawal by Subject|44|||
46615706|NCT00552305|82738690|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
46615707|NCT00552305|82738690|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
46615708|NCT00552305|82738690|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
46615709|NCT00552305|82738690|FG000|Overall Study|Unsatisfactory compliance|11|||
46615710|NCT00552305|82738690|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
46615711|NCT00552305|82738690|FG000|Overall Study|AE/Other: prohibited drug required|1|||
46615712|NCT00552305|82738690|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
46615713|NCT00552305|82738690|FG000|Overall Study|Other: Site closed|4|||
46615714|NCT00552305|82738690|FG000|Overall Study|Other: Personal problems|1|||
46615715|NCT00552305|82738690|FG000|Overall Study|Other: Unable to attend visits|1|||
46615716|NCT00552305|82738690|FG000|Overall Study|Other: Subject underwent surgery|4|||
46615717|NCT00552305|82738690|FG000|Overall Study|Other: Subject became pregnant|1|||
46615718|NCT00552305|82738690|FG000|Overall Study|Other: Health problems, not drug related|1|||
46615719|NCT00552305|82738690|FG000|Overall Study|Other: Subject moved from area|2|||
46615720|NCT00552305|82738690|FG000|Overall Study|Other: Subject incarcerated|1|||
46615721|NCT00552305|82738690|FG000|Overall Study|Other: Subject went to rehab|1|||
46615722|NCT00552071|82738716|FG000|Overall Study|Adverse Event|1|||
46615723|NCT00552071|82738717|FG001|Overall Study|Adverse Event|0|||
46615724|NCT00552071|82738716|FG000|Overall Study|Lack of Efficacy|1|||
46615725|NCT00552071|82738717|FG001|Overall Study|Lack of Efficacy|0|||
46615726|NCT00552071|82738716|FG000|Overall Study|Physician Decision|1|||
46615727|NCT00552071|82738717|FG001|Overall Study|Physician Decision|0|||
46615728|NCT00552071|82738716|FG000|Overall Study|Pregnancy|1|||
46615729|NCT00552071|82738717|FG001|Overall Study|Pregnancy|0|||
46615730|NCT00552071|82738716|FG000|Overall Study|Death|0|||
46615731|NCT00552071|82738717|FG001|Overall Study|Death|1|||
46615732|NCT00552071|82738716|FG000|Overall Study|Withdrawal by Subject|0|||
46615733|NCT00552071|82738717|FG001|Overall Study|Withdrawal by Subject|1|||
46615734|NCT00551525|82738725|FG000|Overall Study|Protocol Violation|5|||
46615735|NCT02370498|82738752|FG000|Overall Study|Adverse Event|10|||
46615736|NCT02370498|82738753|FG001|Overall Study|Adverse Event|8|||
46615737|NCT02370498|82738752|FG000|Overall Study|Death|263|||
46615738|NCT02370498|82738753|FG001|Overall Study|Death|265|||
46615739|NCT02370498|82738752|FG000|Overall Study|Protocol Violation|1|||
46615740|NCT02370498|82738753|FG001|Overall Study|Protocol Violation|2|||
46615741|NCT02370498|82738752|FG000|Overall Study|Withdrawal by Subject|7|||
46615742|NCT02370498|82738753|FG001|Overall Study|Withdrawal by Subject|12|||
46615743|NCT02370498|82738752|FG000|Overall Study|Sponsor's decision|15|||
46615744|NCT02370498|82738753|FG001|Overall Study|Sponsor's decision|9|||
46615745|NCT02347332|82738778|FG000|Overall Study|Not treated|5|||
46615746|NCT02347332|82738779|FG001|Overall Study|Not treated|2|||
46615747|NCT02347332|82738778|FG000|Overall Study|Progressive disease|141|||
46615748|NCT02347332|82738779|FG001|Overall Study|Progressive disease|159|||
46615749|NCT02347332|82738778|FG000|Overall Study|Adverse Event|50|||
46615750|NCT02347332|82738779|FG001|Overall Study|Adverse Event|41|||
46615751|NCT02347332|82738778|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
46615752|NCT02347332|82738779|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
46615753|NCT02347332|82738778|FG000|Overall Study|Protocol Violation|1|||
46615754|NCT02347332|82738779|FG001|Overall Study|Protocol Violation|1|||
46615755|NCT02347332|82738778|FG000|Overall Study|Lost to Follow-up|2|||
46615756|NCT02347332|82738779|FG001|Overall Study|Lost to Follow-up|1|||
46615757|NCT02347332|82738778|FG000|Overall Study|Physician Decision|4|||
46615758|NCT02347332|82738779|FG001|Overall Study|Physician Decision|3|||
46615759|NCT02347332|82738778|FG000|Overall Study|Withdrawal by Subject|20|||
46615760|NCT02347332|82738779|FG001|Overall Study|Withdrawal by Subject|14|||
46615761|NCT02347332|82738778|FG000|Overall Study|Protocol requirement|1|||
46615762|NCT02347332|82738779|FG001|Overall Study|Protocol requirement|1|||
46615763|NCT02347332|82738778|FG000|Overall Study|Switch Post-Trial program|0|||
46615764|NCT02347332|82738779|FG001|Overall Study|Switch Post-Trial program|1|||
46615765|NCT02347176|82738802|FG000|Overall Study|Lost to Follow-up|2|||
46615766|NCT02347176|82738803|FG001|Overall Study|Lost to Follow-up|3|||
46615767|NCT02347176|82738804|FG002|Overall Study|Lost to Follow-up|1|||
46615768|NCT02347176|82738805|FG003|Overall Study|Lost to Follow-up|1|||
46615769|NCT02347176|82738802|FG000|Overall Study|Withdrawal by Subject|9|||
46615770|NCT02347176|82738803|FG001|Overall Study|Withdrawal by Subject|5|||
46615771|NCT02347176|82738804|FG002|Overall Study|Withdrawal by Subject|5|||
46615772|NCT02347176|82738805|FG003|Overall Study|Withdrawal by Subject|3|||
46615773|NCT02347176|82738802|FG000|Overall Study|Other|1|||
46615774|NCT02347176|82738803|FG001|Overall Study|Other|2|||
46615775|NCT02347176|82738804|FG002|Overall Study|Other|2|||
46615776|NCT02347176|82738805|FG003|Overall Study|Other|0|||
46615777|NCT02370420|82738817|FG000|Overall Study|Physician Decision|3|||
46615778|NCT02370420|82738818|FG001|Overall Study|Physician Decision|3|||
46615779|NCT02370420|82738817|FG000|Overall Study|Lost to Follow-up|11|||
46615780|NCT02370420|82738818|FG001|Overall Study|Lost to Follow-up|9|||
46615781|NCT02347098|82738840|FG000|Overall Study|Death|1|||
46615782|NCT02347098|82738841|FG001|Overall Study|Death|0|||
46615783|NCT02347098|82738840|FG000|Overall Study|Withdrawal by Subject|1|||
46615784|NCT02347098|82738841|FG001|Overall Study|Withdrawal by Subject|0|||
46615785|NCT02347098|82738840|FG000|Overall Study|Lost to Follow-up|2|||
46615786|NCT02347098|82738841|FG001|Overall Study|Lost to Follow-up|2|||
46615787|NCT02347098|82738840|FG000|Overall Study|Refuse Follow-up Visit|1|||
46615788|NCT02347098|82738841|FG001|Overall Study|Refuse Follow-up Visit|5|||
46615789|NCT02347098|82738840|FG000|Overall Study|no visit due to illness|2|||
46615790|NCT02347098|82738841|FG001|Overall Study|no visit due to illness|1|||
46615791|NCT02346708|82738858|FG000|Overall Study|Adverse Event|2|||
46615792|NCT02346708|82738859|FG001|Overall Study|Adverse Event|0|||
46615793|NCT02346708|82738858|FG000|Overall Study|Protocol Violation|0|||
46615794|NCT02346708|82738859|FG001|Overall Study|Protocol Violation|1|||
46615795|NCT02346240|82739349|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615796|NCT02346240|82739350|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
46615797|NCT02346240|82739351|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
46615798|NCT02346240|82739352|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
46615799|NCT02346240|82739353|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615800|NCT02346240|82739354|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615801|NCT02346240|82739355|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615802|NCT02346240|82739356|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615803|NCT02346240|82739357|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615804|NCT02346240|82739358|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615805|NCT02346240|82739359|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615806|NCT02346240|82739360|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615807|NCT02346240|82739361|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615808|NCT02346240|82739362|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615809|NCT02346240|82739363|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615810|NCT02346240|82739364|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615811|NCT02346240|82739365|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615812|NCT02346240|82739366|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615813|NCT02346240|82739367|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615814|NCT02346240|82739368|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615815|NCT02346240|82739369|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615816|NCT02346240|82739370|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615817|NCT02346240|82739371|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615818|NCT02346240|82739372|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
46615819|NCT02346240|82739349|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615820|NCT02346240|82739350|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
46615821|NCT02346240|82739351|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615822|NCT02346240|82739352|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615823|NCT02346240|82739353|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615824|NCT02346240|82739354|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615825|NCT02346240|82739355|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615826|NCT02346240|82739356|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615827|NCT02346240|82739357|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615828|NCT02346240|82739358|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615829|NCT02346240|82739359|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615830|NCT02346240|82739360|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615831|NCT02346240|82739361|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615832|NCT02346240|82739362|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615833|NCT02346240|82739363|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615834|NCT02346240|82739364|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615835|NCT02346240|82739365|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615836|NCT02346240|82739366|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615837|NCT02346240|82739367|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615838|NCT02346240|82739368|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615839|NCT02346240|82739369|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615840|NCT02346240|82739370|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615841|NCT02346240|82739371|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615842|NCT02346240|82739372|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
46615843|NCT02346240|82739349|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615844|NCT02346240|82739350|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
46615845|NCT02346240|82739351|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615846|NCT02346240|82739352|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615847|NCT02346240|82739353|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615848|NCT02346240|82739354|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615849|NCT02346240|82739355|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615850|NCT02346240|82739356|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615851|NCT02346240|82739357|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615852|NCT02346240|82739358|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615853|NCT02346240|82739359|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615854|NCT02346240|82739360|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615855|NCT02346240|82739361|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615856|NCT02346240|82739362|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615857|NCT02346240|82739363|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615858|NCT02346240|82739364|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615859|NCT02346240|82739365|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615860|NCT02346240|82739366|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615861|NCT02346240|82739367|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615862|NCT02346240|82739368|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615863|NCT02346240|82739369|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615864|NCT02346240|82739370|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615865|NCT02346240|82739371|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615866|NCT02346240|82739372|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
46615867|NCT02346240|82739349|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
46615868|NCT02346240|82739350|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
46615869|NCT02346240|82739351|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
46615870|NCT02346240|82739352|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
46615871|NCT02346240|82739353|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615872|NCT02346240|82739354|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615873|NCT02346240|82739355|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615874|NCT02346240|82739356|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615875|NCT02346240|82739357|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615876|NCT02346240|82739358|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615877|NCT02346240|82739359|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615878|NCT02346240|82739360|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615879|NCT02346240|82739361|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615880|NCT02346240|82739362|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615881|NCT02346240|82739363|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615882|NCT02346240|82739364|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615883|NCT02346240|82739365|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615884|NCT02346240|82739366|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615885|NCT02346240|82739367|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615886|NCT02346240|82739368|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615887|NCT02346240|82739369|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615888|NCT02346240|82739370|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615889|NCT02346240|82739371|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615890|NCT02346240|82739372|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
46615891|NCT02346240|82739349|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
46615892|NCT02346240|82739350|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
46615893|NCT02346240|82739351|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
46615894|NCT02346240|82739352|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
46615895|NCT02346240|82739353|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615896|NCT02346240|82739354|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615897|NCT02346240|82739355|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615898|NCT02346240|82739356|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615899|NCT02346240|82739357|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615900|NCT02346240|82739358|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615901|NCT02346240|82739359|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615902|NCT02346240|82739360|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615903|NCT02346240|82739361|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615904|NCT02346240|82739362|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615905|NCT02346240|82739363|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615906|NCT02346240|82739364|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615907|NCT02346240|82739365|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615908|NCT02346240|82739366|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615909|NCT02346240|82739367|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615910|NCT02346240|82739368|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615911|NCT02346240|82739369|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615912|NCT02346240|82739370|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615913|NCT02346240|82739371|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615914|NCT02346240|82739372|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
46615915|NCT02346240|82739349|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615916|NCT02346240|82739350|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
46615917|NCT02346240|82739351|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615918|NCT02346240|82739352|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
46615919|NCT02346240|82739353|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615920|NCT02346240|82739354|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615921|NCT02346240|82739355|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615922|NCT02346240|82739356|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615923|NCT02346240|82739357|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615924|NCT02346240|82739358|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615925|NCT02346240|82739359|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615926|NCT02346240|82739360|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615927|NCT02346240|82739361|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615928|NCT02346240|82739362|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615929|NCT02346240|82739363|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615930|NCT02346240|82739364|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615931|NCT02346240|82739365|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615932|NCT02346240|82739366|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615933|NCT02346240|82739367|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615934|NCT02346240|82739368|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615935|NCT02346240|82739369|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615936|NCT02346240|82739370|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615937|NCT02346240|82739371|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615938|NCT02346240|82739372|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
46615939|NCT02346240|82739349|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615940|NCT02346240|82739350|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615941|NCT02346240|82739351|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
46615942|NCT02346240|82739352|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615943|NCT02346240|82739353|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615944|NCT02346240|82739354|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615945|NCT02346240|82739355|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615946|NCT02346240|82739356|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615947|NCT02346240|82739357|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615948|NCT02346240|82739358|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615949|NCT02346240|82739359|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615950|NCT02346240|82739360|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615951|NCT02346240|82739361|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615952|NCT02346240|82739362|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615953|NCT02346240|82739363|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615954|NCT02346240|82739364|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615955|NCT02346240|82739365|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615956|NCT02346240|82739366|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615957|NCT02346240|82739367|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615958|NCT02346240|82739368|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615959|NCT02346240|82739369|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615960|NCT02346240|82739370|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615961|NCT02346240|82739371|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615962|NCT02346240|82739372|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
46615963|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615964|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615965|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615966|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615967|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615968|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615969|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615970|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
46615971|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
46615972|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615973|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615974|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615975|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615976|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
46615977|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
46615978|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
46615979|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
46615980|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615981|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615982|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615983|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615984|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615985|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615986|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46615987|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615988|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615989|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615990|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615991|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615992|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615993|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615994|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615995|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615996|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615997|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615998|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46615999|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616000|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
46616001|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616002|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
46616003|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616004|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616005|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616006|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616007|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616008|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616009|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616010|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46616011|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616012|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616013|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616014|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616015|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616016|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616017|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616018|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616019|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616020|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616021|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616022|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616023|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616024|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616025|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
46616026|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616027|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616028|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616029|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46708594|NCT01131078|82924257|FG000|Overall Study|Progressive Disease|58|||
46616030|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616031|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616032|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616033|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616034|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46616035|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616036|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616037|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616038|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616039|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616040|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46616041|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46616042|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46616043|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46616044|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616045|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46616046|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
46616047|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616048|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
46616049|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
46616050|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
46616051|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46616052|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616053|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616054|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616055|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616056|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616057|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616058|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46616059|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616060|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616061|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616062|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616063|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616064|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616065|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616066|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616067|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616068|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616069|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616070|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616071|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616072|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
46616073|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
46616074|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
46616075|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
46616076|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616077|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616078|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616079|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616080|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616081|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616082|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46616083|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616084|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616085|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616086|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616087|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616088|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616089|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
46616090|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616091|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616092|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616093|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616094|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616095|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616096|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616097|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616098|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616099|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616100|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616101|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616102|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616103|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616104|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616105|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616106|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
46616107|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616108|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616109|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616110|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616111|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616112|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616113|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616114|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616115|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
46616116|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616117|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616118|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
46616119|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616120|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
46616121|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
46616122|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616123|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616124|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616125|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616126|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616127|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616128|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616129|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616130|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
46616131|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616132|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616133|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616134|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616135|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616136|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616137|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616138|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616139|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616140|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
46616141|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616142|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616143|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616144|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616145|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616146|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616147|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46708595|NCT01131078|82924258|FG001|Overall Study|Progressive Disease|77|||
46616148|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616149|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616150|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616151|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616152|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616153|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616154|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
46616155|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616156|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616157|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616158|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616159|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616160|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616161|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616162|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616163|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616164|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616165|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
46616166|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616167|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616168|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616169|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616170|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616171|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616172|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616173|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616174|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616175|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616176|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616177|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616178|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
46616179|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616180|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616181|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616182|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616183|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616184|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616185|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616186|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616187|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616188|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616189|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616190|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616191|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616192|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616193|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
46616194|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616195|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616196|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616197|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616198|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616199|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616200|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616201|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616202|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
46616203|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46708596|NCT01131078|82924259|FG002|Overall Study|Progressive Disease|71|||
46708597|NCT01131078|82924257|FG000|Overall Study|Protocol Violation|1|||
46616204|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616205|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616206|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616207|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616208|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616209|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616210|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616211|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616212|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616213|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616214|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616215|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616216|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616217|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
46616218|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616219|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616220|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616221|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616222|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616223|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616224|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616225|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616226|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
46616227|NCT02346240|82739349|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616228|NCT02346240|82739350|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616229|NCT02346240|82739351|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616230|NCT02346240|82739352|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616231|NCT02346240|82739353|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616232|NCT02346240|82739354|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616233|NCT02346240|82739355|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616234|NCT02346240|82739356|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616235|NCT02346240|82739357|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616236|NCT02346240|82739358|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616237|NCT02346240|82739359|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616238|NCT02346240|82739360|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616239|NCT02346240|82739361|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616240|NCT02346240|82739362|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616241|NCT02346240|82739363|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
46616242|NCT02346240|82739364|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616243|NCT02346240|82739365|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616244|NCT02346240|82739366|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616245|NCT02346240|82739367|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616246|NCT02346240|82739368|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616247|NCT02346240|82739369|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616248|NCT02346240|82739370|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616249|NCT02346240|82739371|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616250|NCT02346240|82739372|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
46616251|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616252|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616253|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616254|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616255|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616256|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616257|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616258|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616259|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616260|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616261|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616262|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616263|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616264|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616265|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616266|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616267|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
46616268|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
46616269|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
46616270|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
46616271|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
46616272|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
46616273|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
46616274|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
46616275|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616276|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616277|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616278|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616279|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616280|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616281|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616282|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616283|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616284|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616285|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616286|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616287|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616288|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616289|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616290|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616291|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616292|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616293|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
46616294|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
46616295|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616296|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
46616297|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616298|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
46616299|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616300|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616301|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616302|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616303|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616304|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616305|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616306|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616307|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616308|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616309|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616310|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616311|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616312|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616313|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616314|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616315|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616316|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616317|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
46616318|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616319|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616320|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
46616321|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616322|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46616323|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616324|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616325|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616326|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616327|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616328|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46708598|NCT01131078|82924258|FG001|Overall Study|Protocol Violation|0|||
46616329|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616330|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616331|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616332|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616333|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616334|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616335|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616336|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616337|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616338|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616339|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616340|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616341|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616342|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616343|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616344|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
46616345|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616346|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
46616347|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616348|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616349|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616350|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616351|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616352|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616353|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616354|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616355|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616356|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616357|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616358|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616359|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616360|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616361|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616362|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616363|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616364|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
46616365|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
46616366|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
46616367|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46616368|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
46616369|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
46616370|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
46616371|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616372|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616373|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616374|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616375|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616376|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616377|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616378|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616379|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616380|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616381|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616382|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616383|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616384|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616385|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616386|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616387|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616388|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616389|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
46616390|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
46616391|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46616392|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
46616393|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
46616394|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
46616395|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616396|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616397|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616398|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616399|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616400|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616401|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616402|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616403|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616404|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616405|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616406|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616407|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616408|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616409|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616410|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616411|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616412|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616413|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
46616414|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616415|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
46616416|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
46616417|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
46616418|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
46616419|NCT02346240|82739349|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616420|NCT02346240|82739350|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616421|NCT02346240|82739351|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616422|NCT02346240|82739352|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616423|NCT02346240|82739353|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616424|NCT02346240|82739354|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616425|NCT02346240|82739355|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616426|NCT02346240|82739356|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616427|NCT02346240|82739357|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616428|NCT02346240|82739358|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616429|NCT02346240|82739359|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616430|NCT02346240|82739360|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616431|NCT02346240|82739361|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616432|NCT02346240|82739362|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616433|NCT02346240|82739363|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616434|NCT02346240|82739364|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616435|NCT02346240|82739365|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616436|NCT02346240|82739366|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616437|NCT02346240|82739367|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
46616438|NCT02346240|82739368|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616439|NCT02346240|82739369|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616440|NCT02346240|82739370|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616441|NCT02346240|82739371|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616442|NCT02346240|82739372|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
46616443|NCT02392104|82739423|FG000|Overall Study|discontinuation of warfarin|3|||
46616444|NCT02392104|82739423|FG000|Overall Study|bleeding event|1|||
46616445|NCT02392104|82739423|FG000|Overall Study|transferred care to another doctor|2|||
46616446|NCT02392104|82739423|FG000|Overall Study|INR goal range changed|1|||
46616447|NCT02392104|82739423|FG000|Overall Study|admitted to skilled nursing facility|3|||
46616448|NCT02392104|82739423|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
46616449|NCT02391948|82739441|FG000|6-month Assessment|Death|0|||
46616450|NCT02391948|82739442|FG001|6-month Assessment|Death|0|||
46616451|NCT02391948|82739443|FG002|6-month Assessment|Death|0|||
46616452|NCT02391948|82739444|FG003|6-month Assessment|Death|0|||
46616453|NCT02391948|82739445|FG004|6-month Assessment|Death|1|||
46708599|NCT01131078|82924259|FG002|Overall Study|Protocol Violation|0|||
46616454|NCT02391948|82739441|FG000|6-month Assessment|Withdrawal by Subject|0|||
46616455|NCT02391948|82739442|FG001|6-month Assessment|Withdrawal by Subject|0|||
46616456|NCT02391948|82739443|FG002|6-month Assessment|Withdrawal by Subject|1|||
46616457|NCT02391948|82739444|FG003|6-month Assessment|Withdrawal by Subject|2|||
46616458|NCT02391948|82739445|FG004|6-month Assessment|Withdrawal by Subject|0|||
46616459|NCT02391948|82739441|FG000|6-month Assessment|Lost to Follow-up|4|||
46616460|NCT02391948|82739442|FG001|6-month Assessment|Lost to Follow-up|5|||
46616461|NCT02391948|82739443|FG002|6-month Assessment|Lost to Follow-up|2|||
46616462|NCT02391948|82739444|FG003|6-month Assessment|Lost to Follow-up|3|||
46616463|NCT02391948|82739445|FG004|6-month Assessment|Lost to Follow-up|1|||
46616464|NCT02391948|82739441|FG000|6-month Assessment|Medical issue/illness|1|||
46616465|NCT02391948|82739442|FG001|6-month Assessment|Medical issue/illness|1|||
46616466|NCT02391948|82739443|FG002|6-month Assessment|Medical issue/illness|0|||
46616467|NCT02391948|82739444|FG003|6-month Assessment|Medical issue/illness|0|||
46616468|NCT02391948|82739445|FG004|6-month Assessment|Medical issue/illness|0|||
46616469|NCT02391948|82739441|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
46616470|NCT02391948|82739442|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
46616471|NCT02391948|82739443|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
46616472|NCT02391948|82739444|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
46616473|NCT02391948|82739445|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
46616474|NCT02391948|82739441|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
46616475|NCT02391948|82739442|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
46616476|NCT02391948|82739443|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
46616477|NCT02391948|82739444|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
46616478|NCT02391948|82739445|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
46616479|NCT02391948|82739441|FG000|12-month Assessment|Death|0|||
46616480|NCT02391948|82739442|FG001|12-month Assessment|Death|0|||
46616481|NCT02391948|82739443|FG002|12-month Assessment|Death|0|||
46616482|NCT02391948|82739444|FG003|12-month Assessment|Death|1|||
46616483|NCT02391948|82739445|FG004|12-month Assessment|Death|0|||
46616484|NCT02391948|82739441|FG000|12-month Assessment|Withdrawal by Subject|1|||
46616485|NCT02391948|82739442|FG001|12-month Assessment|Withdrawal by Subject|0|||
46616486|NCT02391948|82739443|FG002|12-month Assessment|Withdrawal by Subject|0|||
46616487|NCT02391948|82739444|FG003|12-month Assessment|Withdrawal by Subject|1|||
46616488|NCT02391948|82739445|FG004|12-month Assessment|Withdrawal by Subject|0|||
46616489|NCT02391948|82739441|FG000|12-month Assessment|Lost to Follow-up|5|||
46616490|NCT02391948|82739442|FG001|12-month Assessment|Lost to Follow-up|4|||
46616491|NCT02391948|82739443|FG002|12-month Assessment|Lost to Follow-up|4|||
46616492|NCT02391948|82739444|FG003|12-month Assessment|Lost to Follow-up|4|||
46616493|NCT02391948|82739445|FG004|12-month Assessment|Lost to Follow-up|5|||
46616494|NCT02391948|82739441|FG000|12-month Assessment|Medical issue/illness|0|||
46616495|NCT02391948|82739442|FG001|12-month Assessment|Medical issue/illness|1|||
46616496|NCT02391948|82739443|FG002|12-month Assessment|Medical issue/illness|0|||
46616497|NCT02391948|82739444|FG003|12-month Assessment|Medical issue/illness|1|||
46616498|NCT02391948|82739445|FG004|12-month Assessment|Medical issue/illness|0|||
46616499|NCT02391948|82739441|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
46616500|NCT02391948|82739442|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
46616501|NCT02391948|82739443|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
46616502|NCT02391948|82739444|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
46616503|NCT02391948|82739445|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
46616504|NCT02391948|82739441|FG000|18-month Assessment|Death|0|||
46616505|NCT02391948|82739442|FG001|18-month Assessment|Death|0|||
46616506|NCT02391948|82739443|FG002|18-month Assessment|Death|0|||
46616507|NCT02391948|82739444|FG003|18-month Assessment|Death|1|||
46616508|NCT02391948|82739445|FG004|18-month Assessment|Death|1|||
46616509|NCT02391948|82739441|FG000|18-month Assessment|Withdrawal by Subject|1|||
46616510|NCT02391948|82739442|FG001|18-month Assessment|Withdrawal by Subject|0|||
46616511|NCT02391948|82739443|FG002|18-month Assessment|Withdrawal by Subject|0|||
46616512|NCT02391948|82739444|FG003|18-month Assessment|Withdrawal by Subject|1|||
46616513|NCT02391948|82739445|FG004|18-month Assessment|Withdrawal by Subject|0|||
46616514|NCT02391948|82739441|FG000|18-month Assessment|Lost to Follow-up|2|||
46616515|NCT02391948|82739442|FG001|18-month Assessment|Lost to Follow-up|6|||
46616516|NCT02391948|82739443|FG002|18-month Assessment|Lost to Follow-up|2|||
46616517|NCT02391948|82739444|FG003|18-month Assessment|Lost to Follow-up|2|||
46616518|NCT02391948|82739445|FG004|18-month Assessment|Lost to Follow-up|3|||
46616519|NCT02391948|82739441|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
46616520|NCT02391948|82739442|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
46616521|NCT02391948|82739443|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
46616522|NCT02391948|82739444|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
46616523|NCT02391948|82739445|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
46616524|NCT02391948|82739441|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
46616525|NCT02391948|82739442|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
46708600|NCT01131078|82924257|FG000|Overall Study|Lost to Follow-up|1|||
46616526|NCT02391948|82739443|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
46616527|NCT02391948|82739444|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
46616528|NCT02391948|82739445|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
46616529|NCT02391948|82739441|FG000|24-month Assessment|Death|0|||
46616530|NCT02391948|82739442|FG001|24-month Assessment|Death|0|||
46616531|NCT02391948|82739443|FG002|24-month Assessment|Death|0|||
46616532|NCT02391948|82739444|FG003|24-month Assessment|Death|0|||
46616533|NCT02391948|82739445|FG004|24-month Assessment|Death|1|||
46616534|NCT02391948|82739441|FG000|24-month Assessment|Withdrawal by Subject|1|||
46616535|NCT02391948|82739442|FG001|24-month Assessment|Withdrawal by Subject|1|||
46616536|NCT02391948|82739443|FG002|24-month Assessment|Withdrawal by Subject|0|||
46616537|NCT02391948|82739444|FG003|24-month Assessment|Withdrawal by Subject|0|||
46616538|NCT02391948|82739445|FG004|24-month Assessment|Withdrawal by Subject|1|||
46616539|NCT02391948|82739441|FG000|24-month Assessment|Lost to Follow-up|5|||
46616540|NCT02391948|82739442|FG001|24-month Assessment|Lost to Follow-up|4|||
46616541|NCT02391948|82739443|FG002|24-month Assessment|Lost to Follow-up|0|||
46616542|NCT02391948|82739444|FG003|24-month Assessment|Lost to Follow-up|0|||
46616543|NCT02391948|82739445|FG004|24-month Assessment|Lost to Follow-up|0|||
46616544|NCT02391948|82739441|FG000|24-month Assessment|Medical issue/illness|0|||
46616545|NCT02391948|82739442|FG001|24-month Assessment|Medical issue/illness|0|||
46616546|NCT02391948|82739443|FG002|24-month Assessment|Medical issue/illness|1|||
46616547|NCT02391948|82739444|FG003|24-month Assessment|Medical issue/illness|0|||
46616548|NCT02391948|82739445|FG004|24-month Assessment|Medical issue/illness|0|||
46616549|NCT02391948|82739441|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
46616550|NCT02391948|82739442|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
46616551|NCT02391948|82739443|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
46616552|NCT02391948|82739444|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
46616553|NCT02391948|82739445|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
46616554|NCT02369874|82739688|FG000|Overall Study|Lost to Follow-up|2|||
46616555|NCT02369874|82739689|FG001|Overall Study|Lost to Follow-up|2|||
46616556|NCT02369874|82739690|FG002|Overall Study|Lost to Follow-up|2|||
46616557|NCT02369874|82739688|FG000|Overall Study|Withdrawal by Subject|7|||
46616558|NCT02369874|82739689|FG001|Overall Study|Withdrawal by Subject|9|||
46616559|NCT02369874|82739690|FG002|Overall Study|Withdrawal by Subject|27|||
46616560|NCT02369874|82739688|FG000|Overall Study|Miscellaneous|1|||
46616561|NCT02369874|82739689|FG001|Overall Study|Miscellaneous|1|||
46616562|NCT02369874|82739690|FG002|Overall Study|Miscellaneous|0|||
46616563|NCT02369874|82739688|FG000|Overall Study|On Treatment/Off Study|34|||
46616564|NCT02369874|82739689|FG001|Overall Study|On Treatment/Off Study|45|||
46616565|NCT02369874|82739690|FG002|Overall Study|On Treatment/Off Study|32|||
46616566|NCT02368314|82739833|FG000|Overall Study|Withdrawal by Subject|2|||
46616567|NCT02368314|82739834|FG001|Overall Study|Withdrawal by Subject|1|||
46616568|NCT02368314|82739833|FG000|Overall Study|Adverse Event|1|||
46616569|NCT02368314|82739834|FG001|Overall Study|Adverse Event|2|||
46616570|NCT02366910|82739844|FG000|Overall Study|Withdrawal by Subject|2|||
46616571|NCT02366910|82739844|FG000|Overall Study|Screen Failure|3|||
46616572|NCT05608629|82739955|FG000|Overall Study|Lost to Follow-up|2|||
46616573|NCT05180500|82739961|FG000|Overall Study|Adverse Event|1|||
46616574|NCT05180500|82739962|FG001|Overall Study|Adverse Event|0|||
46616575|NCT05180500|82739961|FG000|Overall Study|Withdrawal by Subject|2|||
46616576|NCT05180500|82739962|FG001|Overall Study|Withdrawal by Subject|0|||
46616577|NCT05001945|82739976|FG000|Overall Study|Adverse Event|0|||
46616578|NCT05001945|82739977|FG001|Overall Study|Adverse Event|0|||
46616579|NCT05001945|82739978|FG002|Overall Study|Adverse Event|0|||
46616580|NCT05001945|82739979|FG003|Overall Study|Adverse Event|1|||
46616581|NCT05001945|82739980|FG004|Overall Study|Adverse Event|0|||
46616582|NCT05001945|82739981|FG005|Overall Study|Adverse Event|0|||
46616583|NCT05001945|82739982|FG006|Overall Study|Adverse Event|0|||
46616584|NCT05001945|82739983|FG007|Overall Study|Adverse Event|0|||
46616585|NCT05001945|82739976|FG000|Overall Study|Lost to Follow-up|0|||
46616586|NCT05001945|82739977|FG001|Overall Study|Lost to Follow-up|1|||
46616587|NCT05001945|82739978|FG002|Overall Study|Lost to Follow-up|1|||
46616588|NCT05001945|82739979|FG003|Overall Study|Lost to Follow-up|2|||
46616589|NCT05001945|82739980|FG004|Overall Study|Lost to Follow-up|0|||
46616590|NCT05001945|82739981|FG005|Overall Study|Lost to Follow-up|1|||
46616591|NCT05001945|82739982|FG006|Overall Study|Lost to Follow-up|0|||
46616592|NCT05001945|82739983|FG007|Overall Study|Lost to Follow-up|0|||
46616593|NCT05001945|82739976|FG000|Overall Study|Protocol Violation|1|||
46616594|NCT05001945|82739977|FG001|Overall Study|Protocol Violation|0|||
46616595|NCT05001945|82739978|FG002|Overall Study|Protocol Violation|1|||
46616596|NCT05001945|82739979|FG003|Overall Study|Protocol Violation|1|||
46616597|NCT05001945|82739980|FG004|Overall Study|Protocol Violation|0|||
46616598|NCT05001945|82739981|FG005|Overall Study|Protocol Violation|1|||
46616599|NCT05001945|82739982|FG006|Overall Study|Protocol Violation|0|||
46616600|NCT05001945|82739983|FG007|Overall Study|Protocol Violation|0|||
46616601|NCT05001945|82739976|FG000|Overall Study|Withdrawal by Subject|0|||
46616602|NCT05001945|82739977|FG001|Overall Study|Withdrawal by Subject|0|||
46616603|NCT05001945|82739978|FG002|Overall Study|Withdrawal by Subject|0|||
46616604|NCT05001945|82739979|FG003|Overall Study|Withdrawal by Subject|1|||
46616605|NCT05001945|82739980|FG004|Overall Study|Withdrawal by Subject|1|||
46616606|NCT05001945|82739981|FG005|Overall Study|Withdrawal by Subject|1|||
46616607|NCT05001945|82739982|FG006|Overall Study|Withdrawal by Subject|0|||
46616608|NCT05001945|82739983|FG007|Overall Study|Withdrawal by Subject|1|||
46616609|NCT05001945|82739976|FG000|Overall Study|Not specified by Investigator|0|||
46616610|NCT05001945|82739977|FG001|Overall Study|Not specified by Investigator|3|||
46616611|NCT05001945|82739978|FG002|Overall Study|Not specified by Investigator|0|||
46616612|NCT05001945|82739979|FG003|Overall Study|Not specified by Investigator|0|||
46616613|NCT05001945|82739980|FG004|Overall Study|Not specified by Investigator|1|||
46616614|NCT05001945|82739981|FG005|Overall Study|Not specified by Investigator|0|||
46616615|NCT05001945|82739982|FG006|Overall Study|Not specified by Investigator|0|||
46616616|NCT05001945|82739983|FG007|Overall Study|Not specified by Investigator|0|||
46616617|NCT04955639|82740004|FG000|Overall Study|Withdrawal by Subject|2|||
46616618|NCT04955639|82740005|FG001|Overall Study|Withdrawal by Subject|2|||
46616619|NCT04955639|82740004|FG000|Overall Study|Week 26 survey not completed|2|||
46616620|NCT04955639|82740005|FG001|Overall Study|Week 26 survey not completed|2|||
46616621|NCT04919564|82740013|FG000|Overall Study|Lost to Follow-up|1|||
46616622|NCT04919564|82740014|FG001|Overall Study|Lost to Follow-up|0|||
46616623|NCT04919564|82740013|FG000|Overall Study|Physician Decision|1|||
46616624|NCT04919564|82740014|FG001|Overall Study|Physician Decision|1|||
46616625|NCT04908800|82740033|FG000|Overall Study|Adverse Event|0|||
46616626|NCT04908800|82740034|FG001|Overall Study|Adverse Event|0|||
46616627|NCT04908800|82740035|FG002|Overall Study|Adverse Event|0|||
46616628|NCT04908800|82740036|FG003|Overall Study|Adverse Event|0|||
46616629|NCT04908800|82740037|FG004|Overall Study|Adverse Event|0|||
46616630|NCT04908800|82740038|FG005|Overall Study|Adverse Event|0|||
46616631|NCT04908800|82740039|FG006|Overall Study|Adverse Event|0|||
46616632|NCT04908800|82740040|FG007|Overall Study|Adverse Event|0|||
46616633|NCT04908800|82740041|FG008|Overall Study|Adverse Event|0|||
46616634|NCT04908800|82740042|FG009|Overall Study|Adverse Event|0|||
46616635|NCT04908800|82740043|FG010|Overall Study|Adverse Event|1|||
46616636|NCT04908800|82740044|FG011|Overall Study|Adverse Event|0|||
46616637|NCT04908800|82740045|FG012|Overall Study|Adverse Event|0|||
46616638|NCT04889040|82740093|FG000|Overall Study|Withdrawal by Subject|3|||
46616639|NCT04889040|82740094|FG001|Overall Study|Withdrawal by Subject|3|||
46616640|NCT04889040|82740093|FG000|Overall Study|Lost to Follow-up|0|||
46616641|NCT04889040|82740094|FG001|Overall Study|Lost to Follow-up|1|||
46616642|NCT04889040|82740093|FG000|Overall Study|Adverse Event|2|||
46616643|NCT04889040|82740094|FG001|Overall Study|Adverse Event|1|||
46616644|NCT04794803|82740103|FG000|Overall Study|Death|1|||
46616645|NCT04794803|82740104|FG001|Overall Study|Death|3|||
46616646|NCT04794803|82740103|FG000|Overall Study|Lost to Follow-up|2|||
46616647|NCT04794803|82740104|FG001|Overall Study|Lost to Follow-up|2|||
46616648|NCT04794803|82740103|FG000|Overall Study|Withdrawal by Subject|1|||
46616649|NCT04794803|82740104|FG001|Overall Study|Withdrawal by Subject|0|||
46616650|NCT04794803|82740103|FG000|Overall Study|Physician Decision|1|||
46616651|NCT04794803|82740104|FG001|Overall Study|Physician Decision|1|||
46616652|NCT04794803|82740103|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
46616653|NCT04794803|82740104|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
46616654|NCT04794803|82740103|FG000|Overall Study|Refused to continue the treatment|1|||
46616655|NCT04794803|82740104|FG001|Overall Study|Refused to continue the treatment|0|||
46616656|NCT04794803|82740103|FG000|Overall Study|Patient admitted to ICU|0|||
46616657|NCT04794803|82740104|FG001|Overall Study|Patient admitted to ICU|1|||
46616658|NCT04676152|82740123|FG000|Overall Study|screen fail|9|||
46616659|NCT04546425|82740135|FG000|Overall Study|Protocol Violation|1|||
46616660|NCT04546425|82740136|FG001|Overall Study|Protocol Violation|1|||
46616661|NCT04546425|82740137|FG002|Overall Study|Protocol Violation|0|||
46616662|NCT04546425|82740138|FG003|Overall Study|Protocol Violation|0|||
46616663|NCT04546425|82740135|FG000|Overall Study|Adverse Event|3|||
46616664|NCT04546425|82740136|FG001|Overall Study|Adverse Event|0|||
46616665|NCT04546425|82740137|FG002|Overall Study|Adverse Event|0|||
46616666|NCT04546425|82740138|FG003|Overall Study|Adverse Event|0|||
46616667|NCT04546425|82740135|FG000|Overall Study|Lost to Follow-up|5|||
46616668|NCT04546425|82740136|FG001|Overall Study|Lost to Follow-up|4|||
46616669|NCT04546425|82740137|FG002|Overall Study|Lost to Follow-up|0|||
46616670|NCT04546425|82740138|FG003|Overall Study|Lost to Follow-up|0|||
46616671|NCT04546425|82740135|FG000|Overall Study|No Longer met eligibility criteria|3|||
46616672|NCT04546425|82740136|FG001|Overall Study|No Longer met eligibility criteria|3|||
46616673|NCT04546425|82740137|FG002|Overall Study|No Longer met eligibility criteria|1|||
46616674|NCT04546425|82740138|FG003|Overall Study|No Longer met eligibility criteria|1|||
46616675|NCT04546425|82740135|FG000|Overall Study|Withdrawal by parent/guardian|6|||
46616676|NCT04546425|82740136|FG001|Overall Study|Withdrawal by parent/guardian|5|||
46616677|NCT04546425|82740137|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46616678|NCT04546425|82740138|FG003|Overall Study|Withdrawal by parent/guardian|1|||
46616679|NCT04537949|82740156|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
46616680|NCT04537949|82740157|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
46616681|NCT04537949|82740158|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
46616682|NCT04537949|82740159|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
46616683|NCT04537949|82740160|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
46616684|NCT04537949|82740161|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
46616685|NCT04537949|82740162|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
46616686|NCT04537949|82740163|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
46616687|NCT04537949|82740156|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
46616688|NCT04537949|82740157|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
46616689|NCT04537949|82740158|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
46616690|NCT04537949|82740159|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
46616691|NCT04537949|82740160|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
46616692|NCT04537949|82740161|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
46616693|NCT04537949|82740162|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
46616694|NCT04537949|82740163|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
46616695|NCT04537949|82740156|FG000|Follow-up Phase|Lost to Follow-up|0|||
46616696|NCT04537949|82740157|FG001|Follow-up Phase|Lost to Follow-up|3|||
46616697|NCT04537949|82740158|FG002|Follow-up Phase|Lost to Follow-up|0|||
46616698|NCT04537949|82740159|FG003|Follow-up Phase|Lost to Follow-up|0|||
46616699|NCT04537949|82740160|FG004|Follow-up Phase|Lost to Follow-up|0|||
46616700|NCT04537949|82740161|FG005|Follow-up Phase|Lost to Follow-up|0|||
46616701|NCT04537949|82740162|FG006|Follow-up Phase|Lost to Follow-up|0|||
46616702|NCT04537949|82740163|FG007|Follow-up Phase|Lost to Follow-up|0|||
46616703|NCT04537949|82740156|FG000|Follow-up Phase|personal reasons|0|||
46616704|NCT04537949|82740157|FG001|Follow-up Phase|personal reasons|0|||
46616705|NCT04537949|82740158|FG002|Follow-up Phase|personal reasons|0|||
46616706|NCT04537949|82740159|FG003|Follow-up Phase|personal reasons|1|||
46616707|NCT04537949|82740160|FG004|Follow-up Phase|personal reasons|1|||
46616708|NCT04537949|82740161|FG005|Follow-up Phase|personal reasons|0|||
46616709|NCT04537949|82740162|FG006|Follow-up Phase|personal reasons|0|||
46616710|NCT04537949|82740163|FG007|Follow-up Phase|personal reasons|0|||
46616711|NCT04537949|82740156|FG000|Follow-up Phase|Withdrawal by Subject|0|||
46616712|NCT04537949|82740157|FG001|Follow-up Phase|Withdrawal by Subject|0|||
46616713|NCT04537949|82740158|FG002|Follow-up Phase|Withdrawal by Subject|0|||
46616714|NCT04537949|82740159|FG003|Follow-up Phase|Withdrawal by Subject|0|||
46616715|NCT04537949|82740160|FG004|Follow-up Phase|Withdrawal by Subject|1|||
46616716|NCT04537949|82740161|FG005|Follow-up Phase|Withdrawal by Subject|0|||
46616717|NCT04537949|82740162|FG006|Follow-up Phase|Withdrawal by Subject|0|||
46616718|NCT04537949|82740163|FG007|Follow-up Phase|Withdrawal by Subject|0|||
46616719|NCT04439201|82740181|FG000|Overall Study|Ineligible|2|||
46616720|NCT04439201|82740181|FG000|Overall Study|Never start protocol therapy|1|||
46616721|NCT04439201|82740181|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
46616722|NCT04439201|82740181|FG000|Overall Study|Mutation status not confirmed|4|||
46616723|NCT04439201|82740181|FG000|Overall Study|Adverse Event|1|||
46616724|NCT04439201|82740181|FG000|Overall Study|Death|7|||
46616725|NCT04439201|82740181|FG000|Overall Study|Withdrawal by Subject|2|||
46616726|NCT04439201|82740181|FG000|Overall Study|Disease progression|20|||
46616727|NCT04439201|82740181|FG000|Overall Study|Alternative therapy|1|||
46616728|NCT04439201|82740181|FG000|Overall Study|Physician Decision|1|||
46616729|NCT04425902|82740185|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
46616730|NCT04421586|82740198|FG000|Overall Study|Death|0|||
46616731|NCT04421586|82740199|FG001|Overall Study|Death|1|||
46616732|NCT04421586|82740198|FG000|Overall Study|Lost to Follow-up|2|||
46616733|NCT04421586|82740199|FG001|Overall Study|Lost to Follow-up|2|||
46616734|NCT04421586|82740198|FG000|Overall Study|Withdrawn by PI|1|||
46616735|NCT04421586|82740199|FG001|Overall Study|Withdrawn by PI|0|||
46616736|NCT04421586|82740198|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
46616737|NCT04421586|82740199|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
46616738|NCT04407234|82740207|FG000|Overall Study|Adverse Event|3|||
46616739|NCT04407234|82740208|FG001|Overall Study|Adverse Event|3|||
46616740|NCT04270747|82740226|FG000|Through Week 16|Adverse Event|1|||
46616741|NCT04270747|82740227|FG001|Through Week 16|Adverse Event|2|||
46616742|NCT04270747|82740228|FG002|Through Week 16|Adverse Event|0|||
46616743|NCT04270747|82740226|FG000|Through Week 16|Death|0|||
46616744|NCT04270747|82740227|FG001|Through Week 16|Death|2|||
46616745|NCT04270747|82740228|FG002|Through Week 16|Death|0|||
46616746|NCT04270747|82740226|FG000|Through Week 16|Consent Withdrawn|3|||
46616747|NCT04270747|82740227|FG001|Through Week 16|Consent Withdrawn|3|||
46616748|NCT04270747|82740228|FG002|Through Week 16|Consent Withdrawn|0|||
46616749|NCT04270747|82740226|FG000|Through Week 16|Physician Decision|1|||
46616750|NCT04270747|82740227|FG001|Through Week 16|Physician Decision|1|||
46616751|NCT04270747|82740228|FG002|Through Week 16|Physician Decision|0|||
46616752|NCT04270747|82740226|FG000|Through Week 16|Lost to Follow-up|2|||
46616753|NCT04270747|82740227|FG001|Through Week 16|Lost to Follow-up|0|||
46616754|NCT04270747|82740228|FG002|Through Week 16|Lost to Follow-up|0|||
46616755|NCT04270747|82740226|FG000|Through Week 16|Protocol Violation|1|||
46616756|NCT04270747|82740227|FG001|Through Week 16|Protocol Violation|2|||
46616757|NCT04270747|82740228|FG002|Through Week 16|Protocol Violation|0|||
46616758|NCT04270747|82740226|FG000|Through Week 16|Protocol Specified Criteria|6|||
46616759|NCT04270747|82740227|FG001|Through Week 16|Protocol Specified Criteria|7|||
46616760|NCT04270747|82740228|FG002|Through Week 16|Protocol Specified Criteria|0|||
46616761|NCT04270747|82740226|FG000|Through Week 16|Miscellaneous|1|||
46616762|NCT04270747|82740227|FG001|Through Week 16|Miscellaneous|1|||
46616763|NCT04270747|82740228|FG002|Through Week 16|Miscellaneous|0|||
46616764|NCT04270747|82740226|FG000|Post Week 16|Adverse Event|7|||
46616765|NCT04270747|82740227|FG001|Post Week 16|Adverse Event|5|||
46616766|NCT04270747|82740228|FG002|Post Week 16|Adverse Event|1|||
46616767|NCT04270747|82740226|FG000|Post Week 16|Death|2|||
46616768|NCT04270747|82740227|FG001|Post Week 16|Death|0|||
46616769|NCT04270747|82740228|FG002|Post Week 16|Death|2|||
46616770|NCT04270747|82740226|FG000|Post Week 16|Consent Withdrawn|4|||
46616771|NCT04270747|82740227|FG001|Post Week 16|Consent Withdrawn|3|||
46616772|NCT04270747|82740228|FG002|Post Week 16|Consent Withdrawn|6|||
46616773|NCT04270747|82740226|FG000|Post Week 16|Physician Decision|3|||
46616774|NCT04270747|82740227|FG001|Post Week 16|Physician Decision|1|||
46616775|NCT04270747|82740228|FG002|Post Week 16|Physician Decision|1|||
46616776|NCT04270747|82740226|FG000|Post Week 16|Lost to Follow-up|2|||
46616777|NCT04270747|82740227|FG001|Post Week 16|Lost to Follow-up|1|||
46616778|NCT04270747|82740228|FG002|Post Week 16|Lost to Follow-up|0|||
46616779|NCT04270747|82740226|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
46616780|NCT04270747|82740227|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
46616781|NCT04270747|82740228|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
46616782|NCT04270747|82740226|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
46616783|NCT04270747|82740227|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
46616784|NCT04270747|82740228|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
46616785|NCT04270747|82740226|FG000|Post Week 16|Miscellaneous|1|||
46616786|NCT04270747|82740227|FG001|Post Week 16|Miscellaneous|0|||
46616787|NCT04270747|82740228|FG002|Post Week 16|Miscellaneous|1|||
46616788|NCT04238728|82740259|FG000|Overall Study|Withdrawal by Subject|1|||
46616789|NCT04238728|82740259|FG000|Overall Study|Lost to Follow-up|2|||
46616790|NCT04106557|82740275|FG000|Overall Study|Physician Decision|0|||
46616791|NCT04106557|82740276|FG001|Overall Study|Physician Decision|1|||
46616792|NCT04106557|82740277|FG002|Overall Study|Physician Decision|0|||
46616793|NCT04106557|82740275|FG000|Overall Study|Protocol Violation|0|||
46616794|NCT04106557|82740276|FG001|Overall Study|Protocol Violation|1|||
46616795|NCT04106557|82740277|FG002|Overall Study|Protocol Violation|0|||
46616796|NCT04085614|82740286|FG000|Overall Study|Protocol Violation|9|||
46616797|NCT04085614|82740287|FG001|Overall Study|Protocol Violation|6|||
46616798|NCT04056455|82740295|FG000|Overall Study|Adverse Event|1|||
46616799|NCT04056455|82740296|FG001|Overall Study|Adverse Event|0|||
46616800|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
46616801|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
46616802|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
46616803|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
46616804|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
46616805|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
46616806|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
46616807|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
46616808|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
46616809|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
46616810|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
46616811|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
46616812|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
46616813|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
46616814|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
46616815|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
46616816|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
46616817|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
46616818|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
46616819|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
46616820|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
46616821|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
46616822|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
46616823|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
46616824|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
46616825|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
46616826|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
46616827|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
46616828|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
46616829|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
46616830|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
46616831|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
46616832|NCT03747939|82740304|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
46616833|NCT03747939|82740305|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
46616834|NCT03747939|82740306|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
46616835|NCT03747939|82740307|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
46616836|NCT03747939|82740304|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
46616837|NCT03747939|82740305|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
46616838|NCT03747939|82740306|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
46616839|NCT03747939|82740307|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
46616840|NCT03747939|82740304|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
46616841|NCT03747939|82740305|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
46616842|NCT03747939|82740306|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
46616843|NCT03747939|82740307|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
46616844|NCT03747939|82740304|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
46616845|NCT03747939|82740305|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
46616846|NCT03747939|82740306|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
46616847|NCT03747939|82740307|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
46616848|NCT03747939|82740304|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
46616849|NCT03747939|82740305|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
46616850|NCT03747939|82740306|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
46616851|NCT03747939|82740307|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
46616852|NCT03747939|82740304|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
46616853|NCT03747939|82740305|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
46616854|NCT03747939|82740306|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
46616855|NCT03747939|82740307|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
46616856|NCT03688620|82740326|FG000|Overall Study|Other|0|||
46616857|NCT03688620|82740327|FG001|Overall Study|Other|0|||
46616858|NCT03688620|82740328|FG002|Overall Study|Other|1|||
46616859|NCT03688620|82740326|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
46616860|NCT03688620|82740327|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
46616861|NCT03688620|82740328|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
46616862|NCT03688620|82740326|FG000|Overall Study|Lost to Follow-up|16|||
46616863|NCT03688620|82740327|FG001|Overall Study|Lost to Follow-up|0|||
46616864|NCT03688620|82740328|FG002|Overall Study|Lost to Follow-up|1|||
46616865|NCT03688620|82740326|FG000|Overall Study|Withdrawal by Subject|0|||
46616866|NCT03688620|82740327|FG001|Overall Study|Withdrawal by Subject|0|||
46616867|NCT03688620|82740328|FG002|Overall Study|Withdrawal by Subject|6|||
46616868|NCT03683173|82740340|FG000|Completed Follow-up|Unavailable|235|||
46616869|NCT03683173|82740341|FG001|Completed Follow-up|Unavailable|217|||
46616870|NCT03683173|82740340|FG000|Completed Follow-up|Refused|69|||
46616871|NCT03683173|82740341|FG001|Completed Follow-up|Refused|59|||
46616872|NCT03683173|82740340|FG000|Completed Follow-up|Disconnected phone|65|||
46616873|NCT03683173|82740341|FG001|Completed Follow-up|Disconnected phone|95|||
46616874|NCT03683173|82740340|FG000|Completed Follow-up|Health issue/deceased|10|||
46616875|NCT03683173|82740341|FG001|Completed Follow-up|Health issue/deceased|4|||
46616876|NCT03683173|82740340|FG000|Completed Follow-up|Moved away|8|||
46616877|NCT03683173|82740341|FG001|Completed Follow-up|Moved away|1|||
46616878|NCT03652961|82740360|FG000|Overall Study|Lost to Follow-up|3|||
46616879|NCT03652961|82740360|FG000|Overall Study|Screen Failure|1|||
46616880|NCT03484403|82740402|FG000|Overall Study|Withdrawal by Subject|6|||
46616881|NCT03484403|82740403|FG001|Overall Study|Withdrawal by Subject|4|||
46616882|NCT03299049|82740420|FG000|Overall Study|On-going|486|||
46616883|NCT03299049|82740421|FG001|Overall Study|On-going|481|||
46616884|NCT03299049|82740420|FG000|Overall Study|Withdrawal by Subject|6|||
46616885|NCT03299049|82740421|FG001|Overall Study|Withdrawal by Subject|21|||
46616886|NCT03299049|82740420|FG000|Overall Study|Physician Decision|5|||
46616887|NCT03299049|82740421|FG001|Overall Study|Physician Decision|1|||
46616888|NCT03299049|82740420|FG000|Overall Study|Lost to Follow-up|2|||
46616889|NCT03299049|82740421|FG001|Overall Study|Lost to Follow-up|0|||
46616890|NCT03299049|82740420|FG000|Overall Study|Pregnancy|1|||
46616891|NCT03299049|82740421|FG001|Overall Study|Pregnancy|3|||
46616892|NCT03299049|82740420|FG000|Overall Study|Protocol Violation|1|||
46616893|NCT03299049|82740421|FG001|Overall Study|Protocol Violation|1|||
46616894|NCT03299049|82740420|FG000|Overall Study|Lack of Efficacy|9|||
46616895|NCT03299049|82740421|FG001|Overall Study|Lack of Efficacy|3|||
46616896|NCT03299049|82740420|FG000|Overall Study|Adverse Event|12|||
46616897|NCT03299049|82740421|FG001|Overall Study|Adverse Event|13|||
46616898|NCT03298022|82740434|FG000|Overall Study|Lack of Efficacy|4|||
46616899|NCT03298022|82740434|FG000|Overall Study|Withdrawal by Subject|7|||
46616900|NCT03298022|82740434|FG000|Overall Study|Adverse Event|1|||
46616901|NCT03298022|82740434|FG000|Overall Study|disease relapse|1|||
46616902|NCT03277105|82740446|FG000|Overall Study|Death|129|||
46616903|NCT03277105|82740447|FG001|Overall Study|Death|124|||
46616904|NCT03277105|82740446|FG000|Overall Study|Lost to Follow-up|2|||
46616905|NCT03277105|82740447|FG001|Overall Study|Lost to Follow-up|4|||
46616906|NCT03277105|82740446|FG000|Overall Study|Withdrawal by Subject|10|||
46616907|NCT03277105|82740447|FG001|Overall Study|Withdrawal by Subject|10|||
46616908|NCT03277105|82740446|FG000|Overall Study|Other|118|||
46616909|NCT03277105|82740447|FG001|Overall Study|Other|125|||
46616910|NCT03247413|82740453|FG000|Overall Study|Lost to Follow-up|28|||
46616911|NCT03206203|82740461|FG000|Treatment|Death|38|||
46616912|NCT03206203|82740462|FG001|Treatment|Death|26|||
46616913|NCT03206203|82740463|FG002|Treatment|Death|0|||
46616914|NCT03206203|82740461|FG000|Treatment|Withdrawal by Subject|1|||
46616915|NCT03206203|82740462|FG001|Treatment|Withdrawal by Subject|0|||
46616916|NCT03206203|82740463|FG002|Treatment|Withdrawal by Subject|0|||
46616917|NCT03206203|82740461|FG000|Treatment|Lost to Follow-up|4|||
46616918|NCT03206203|82740462|FG001|Treatment|Lost to Follow-up|0|||
46616919|NCT03206203|82740463|FG002|Treatment|Lost to Follow-up|0|||
46616920|NCT03206203|82740461|FG000|Treatment|N/A in Follow-Up|8|||
46616921|NCT03206203|82740462|FG001|Treatment|N/A in Follow-Up|1|||
46616922|NCT03206203|82740463|FG002|Treatment|N/A in Follow-Up|0|||
46616923|NCT03206203|82740461|FG000|Treatment|Disease progression|0|||
46616924|NCT03206203|82740462|FG001|Treatment|Disease progression|1|||
46616925|NCT03206203|82740463|FG002|Treatment|Disease progression|0|||
46616926|NCT03206203|82740461|FG000|Treatment|Refused follow-up|0|||
46616927|NCT03206203|82740462|FG001|Treatment|Refused follow-up|1|||
46616928|NCT03206203|82740463|FG002|Treatment|Refused follow-up|0|||
46616929|NCT03206203|82740461|FG000|Treatment|Cross over to Arm 1|0|||
46616930|NCT03206203|82740462|FG001|Treatment|Cross over to Arm 1|19|||
46616931|NCT03206203|82740463|FG002|Treatment|Cross over to Arm 1|0|||
46616932|NCT03206203|82740461|FG000|Optional Cross-Over|Death|0|||
46616933|NCT03206203|82740462|FG001|Optional Cross-Over|Death|0|||
46616934|NCT03206203|82740463|FG002|Optional Cross-Over|Death|14|||
46616935|NCT03206203|82740461|FG000|Optional Cross-Over|Refused follow-up|0|||
46616936|NCT03206203|82740462|FG001|Optional Cross-Over|Refused follow-up|0|||
46616937|NCT03206203|82740463|FG002|Optional Cross-Over|Refused follow-up|2|||
46616938|NCT03126019|82740472|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
46616939|NCT03126019|82740473|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
46616940|NCT03126019|82740472|FG000|Overall Study|Death|2|||
46616941|NCT03126019|82740473|FG001|Overall Study|Death|7|||
46616942|NCT03126019|82740472|FG000|Overall Study|Lost to Follow-up|2|||
46616943|NCT03126019|82740473|FG001|Overall Study|Lost to Follow-up|3|||
46616944|NCT03126019|82740472|FG000|Overall Study|Withdrawal by Participant|1|||
46616945|NCT03126019|82740473|FG001|Overall Study|Withdrawal by Participant|3|||
46616946|NCT03126019|82740472|FG000|Overall Study|Reason not Specified|1|||
46616947|NCT03126019|82740473|FG001|Overall Study|Reason not Specified|3|||
46616948|NCT03072862|82740480|FG000|Overall Study|Withdrawal by Subject|4|||
46616949|NCT03072862|82740480|FG000|Overall Study|Lost to Follow-up|6|||
46616950|NCT03072862|82740480|FG000|Overall Study|Protocol Violation|4|||
46616951|NCT03072862|82740480|FG000|Overall Study|Physician Decision|2|||
46616952|NCT03072862|82740480|FG000|Overall Study|Death|1|||
46616953|NCT03072862|82740480|FG000|Overall Study|Adverse Event|1|||
46616954|NCT03055221|82740484|FG000|Overall Study|Adverse Event|2|||
46616955|NCT03055221|82740484|FG000|Overall Study|Withdrawal by Subject|4|||
46616956|NCT03055221|82740484|FG000|Overall Study|Death|6|||
46616957|NCT03055221|82740484|FG000|Overall Study|Physician Decision|1|||
46616958|NCT03055221|82740484|FG000|Overall Study|Study terminated by Sponsor|3|||
46616959|NCT03055221|82740484|FG000|Overall Study|Lost to Follow-up|4|||
46616960|NCT02913482|82740492|FG000|Overall Study|Death|0|||
46616961|NCT02913482|82740493|FG001|Overall Study|Death|2|||
46616962|NCT02913482|82740494|FG002|Overall Study|Death|2|||
46616963|NCT02913482|82740492|FG000|Overall Study|Progressive Disease|1|||
46616964|NCT02913482|82740493|FG001|Overall Study|Progressive Disease|1|||
46616965|NCT02913482|82740494|FG002|Overall Study|Progressive Disease|1|||
46616966|NCT02838420|82740506|FG000|Overall Study|Ongoing in Study|113|||
46616967|NCT02838420|82740507|FG001|Overall Study|Ongoing in Study|45|||
46616968|NCT02838420|82740506|FG000|Overall Study|Lost to Follow-up|1|||
46616969|NCT02838420|82740507|FG001|Overall Study|Lost to Follow-up|0|||
46616970|NCT02838420|82740506|FG000|Overall Study|Withdrawal by Subject|3|||
46616971|NCT02838420|82740507|FG001|Overall Study|Withdrawal by Subject|4|||
46616972|NCT02838420|82740506|FG000|Overall Study|Death|8|||
46616973|NCT02838420|82740507|FG001|Overall Study|Death|13|||
46616974|NCT02728076|82740513|FG000|Overall Study|Physician Decision|4|||
46616975|NCT02632409|82740519|FG000|Randomized|AE unrelated to study Drug|0|||
46616976|NCT02632409|82740520|FG001|Randomized|AE unrelated to study Drug|1|||
46616977|NCT02632409|82740519|FG000|Randomized|Participant withdrew consent|2|||
46616978|NCT02632409|82740520|FG001|Randomized|Participant withdrew consent|1|||
46616979|NCT02632409|82740519|FG000|Randomized|No Longer meets study criteria|5|||
46616980|NCT02632409|82740520|FG001|Randomized|No Longer meets study criteria|0|||
46616981|NCT02632409|82740519|FG000|Randomized|other reasons|1|||
46616982|NCT02632409|82740520|FG001|Randomized|other reasons|0|||
46616983|NCT02632409|82740519|FG000|Treatment Period|Ongoing Treatment|20|||
46616984|NCT02632409|82740520|FG001|Treatment Period|Ongoing Treatment|21|||
46616985|NCT02632409|82740519|FG000|Treatment Period|Disease Recurrence|147|||
46616986|NCT02632409|82740520|FG001|Treatment Period|Disease Recurrence|90|||
46616987|NCT02632409|82740519|FG000|Treatment Period|Study Drug Toxicity|8|||
46616988|NCT02632409|82740520|FG001|Treatment Period|Study Drug Toxicity|49|||
46616989|NCT02632409|82740519|FG000|Treatment Period|Death|1|||
46616990|NCT02632409|82740520|FG001|Treatment Period|Death|0|||
46616991|NCT02632409|82740519|FG000|Treatment Period|AE unrelated to study drug|15|||
46616992|NCT02632409|82740520|FG001|Treatment Period|AE unrelated to study drug|16|||
46616993|NCT02632409|82740519|FG000|Treatment Period|Request to discontinue treatment|4|||
46616994|NCT02632409|82740520|FG001|Treatment Period|Request to discontinue treatment|19|||
46616995|NCT02632409|82740519|FG000|Treatment Period|Participant withdrew consent|7|||
46616996|NCT02632409|82740520|FG001|Treatment Period|Participant withdrew consent|5|||
46616997|NCT02632409|82740519|FG000|Treatment Period|Lost to Follow-up|0|||
46616998|NCT02632409|82740520|FG001|Treatment Period|Lost to Follow-up|1|||
46616999|NCT02632409|82740519|FG000|Treatment Period|Maximum clinical benefit|1|||
46617000|NCT02632409|82740520|FG001|Treatment Period|Maximum clinical benefit|0|||
46617001|NCT02632409|82740519|FG000|Treatment Period|No longer meets study criteria|3|||
46617002|NCT02632409|82740520|FG001|Treatment Period|No longer meets study criteria|0|||
46617003|NCT02632409|82740519|FG000|Treatment Period|Administrative Reason by sponsor|0|||
46617004|NCT02632409|82740520|FG001|Treatment Period|Administrative Reason by sponsor|1|||
46617005|NCT02632409|82740519|FG000|Treatment Period|Other Reasons|10|||
46617006|NCT02632409|82740520|FG001|Treatment Period|Other Reasons|6|||
46617007|NCT02333227|82740537|FG000|Overall Study|Lost to Follow-up|137|||
46617008|NCT02333227|82740538|FG001|Overall Study|Lost to Follow-up|106|||
46617009|NCT02333227|82740537|FG000|Overall Study|Pregnancy Interrupted|42|||
46617010|NCT02333227|82740538|FG001|Overall Study|Pregnancy Interrupted|89|||
46617011|NCT02333227|82740537|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
46617012|NCT02333227|82740538|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
46993226|NCT01928758|83240140|FG000|Overall Study|Withdrawal by Subject|5|||
46993227|NCT01928758|83240141|FG001|Overall Study|Withdrawal by Subject|2|||
46993228|NCT01928758|83240140|FG000|Overall Study|Adverse Event|3|||
46993229|NCT01928758|83240141|FG001|Overall Study|Adverse Event|5|||
46993230|NCT01928758|83240140|FG000|Overall Study|Protocol Violation|3|||
46993231|NCT01928758|83240141|FG001|Overall Study|Protocol Violation|4|||
46993232|NCT01910116|83240150|FG000|Overall Study|Adverse Event|0|||
46993233|NCT01910116|83240151|FG001|Overall Study|Adverse Event|3|||
46993234|NCT01910116|83240150|FG000|Overall Study|Lack of Efficacy|3|||
46993235|NCT01910116|83240151|FG001|Overall Study|Lack of Efficacy|4|||
46993236|NCT01910116|83240150|FG000|Overall Study|Lost to Follow-up|1|||
46993237|NCT01910116|83240151|FG001|Overall Study|Lost to Follow-up|0|||
46993238|NCT01910116|83240150|FG000|Overall Study|Protocol Violation|1|||
46993239|NCT01910116|83240151|FG001|Overall Study|Protocol Violation|2|||
46993240|NCT01910116|83240150|FG000|Overall Study|Withdrawal by Subject|8|||
46993241|NCT01910116|83240151|FG001|Overall Study|Withdrawal by Subject|3|||
46993242|NCT01910116|83240150|FG000|Overall Study|uncertain allocation|1|||
46993243|NCT01910116|83240151|FG001|Overall Study|uncertain allocation|3|||
46993244|NCT01910116|83240150|FG000|Overall Study|incomplete data|0|||
46993245|NCT01910116|83240151|FG001|Overall Study|incomplete data|1|||
46993246|NCT01614886|83240159|FG000|Overall Study|Adverse Event|15|||
46993247|NCT01614886|83240160|FG001|Overall Study|Adverse Event|20|||
46993248|NCT01614886|83240159|FG000|Overall Study|Withdrawal by Subject|4|||
46617036|NCT01831635|82740560|FG000|Overall Study|Withdrawal by Subject|0|||
46617037|NCT01831635|82740561|FG001|Overall Study|Withdrawal by Subject|2|||
46617038|NCT01831635|82740562|FG002|Overall Study|Withdrawal by Subject|0|||
46617039|NCT01606878|82740581|FG000|Overall Study|Adverse Event|1|||
46617040|NCT01606878|82740582|FG001|Overall Study|Adverse Event|1|||
46617041|NCT01606878|82740583|FG002|Overall Study|Adverse Event|0|||
46617042|NCT01606878|82740584|FG003|Overall Study|Adverse Event|0|||
46617043|NCT01606878|82740585|FG004|Overall Study|Adverse Event|0|||
46617044|NCT01606878|82740586|FG005|Overall Study|Adverse Event|0|||
46617045|NCT01606878|82740587|FG006|Overall Study|Adverse Event|1|||
46617046|NCT01606878|82740588|FG007|Overall Study|Adverse Event|0|||
46617047|NCT01606878|82740589|FG008|Overall Study|Adverse Event|1|||
46617048|NCT01606878|82740590|FG009|Overall Study|Adverse Event|3|||
46617049|NCT01606878|82740591|FG010|Overall Study|Adverse Event|0|||
46617050|NCT01606878|82740581|FG000|Overall Study|Lack of Efficacy|1|||
46617051|NCT01606878|82740582|FG001|Overall Study|Lack of Efficacy|1|||
46617052|NCT01606878|82740583|FG002|Overall Study|Lack of Efficacy|1|||
46617053|NCT01606878|82740584|FG003|Overall Study|Lack of Efficacy|2|||
46617054|NCT01606878|82740585|FG004|Overall Study|Lack of Efficacy|1|||
46617055|NCT01606878|82740586|FG005|Overall Study|Lack of Efficacy|2|||
46617056|NCT01606878|82740587|FG006|Overall Study|Lack of Efficacy|1|||
46617057|NCT01606878|82740588|FG007|Overall Study|Lack of Efficacy|2|||
46617058|NCT01606878|82740589|FG008|Overall Study|Lack of Efficacy|2|||
46617059|NCT01606878|82740590|FG009|Overall Study|Lack of Efficacy|0|||
46617060|NCT01606878|82740591|FG010|Overall Study|Lack of Efficacy|1|||
46617061|NCT01606878|82740581|FG000|Overall Study|Physician Decision|1|||
46617062|NCT01606878|82740582|FG001|Overall Study|Physician Decision|0|||
46617063|NCT01606878|82740583|FG002|Overall Study|Physician Decision|2|||
46617064|NCT01606878|82740584|FG003|Overall Study|Physician Decision|1|||
46617065|NCT01606878|82740585|FG004|Overall Study|Physician Decision|1|||
46617066|NCT01606878|82740586|FG005|Overall Study|Physician Decision|1|||
46617067|NCT01606878|82740587|FG006|Overall Study|Physician Decision|2|||
46617068|NCT01606878|82740588|FG007|Overall Study|Physician Decision|0|||
46617069|NCT01606878|82740589|FG008|Overall Study|Physician Decision|1|||
46617070|NCT01606878|82740590|FG009|Overall Study|Physician Decision|0|||
46617071|NCT01606878|82740591|FG010|Overall Study|Physician Decision|0|||
46617072|NCT01606878|82740581|FG000|Overall Study|Withdrawal by Subject|3|||
46617073|NCT01606878|82740582|FG001|Overall Study|Withdrawal by Subject|2|||
46617074|NCT01606878|82740583|FG002|Overall Study|Withdrawal by Subject|2|||
46617075|NCT01606878|82740584|FG003|Overall Study|Withdrawal by Subject|0|||
46617076|NCT01606878|82740585|FG004|Overall Study|Withdrawal by Subject|1|||
46617077|NCT01606878|82740586|FG005|Overall Study|Withdrawal by Subject|1|||
46617078|NCT01606878|82740587|FG006|Overall Study|Withdrawal by Subject|2|||
46617079|NCT01606878|82740588|FG007|Overall Study|Withdrawal by Subject|1|||
46617080|NCT01606878|82740589|FG008|Overall Study|Withdrawal by Subject|2|||
46617081|NCT01606878|82740590|FG009|Overall Study|Withdrawal by Subject|0|||
46617082|NCT01606878|82740591|FG010|Overall Study|Withdrawal by Subject|2|||
46617083|NCT01175356|82740623|FG000|Overall Study|Death|1|||
46617084|NCT01175356|82740623|FG000|Overall Study|Lack of Efficacy|12|||
46617085|NCT01175356|82740623|FG000|Overall Study|Lost to Follow-up|1|||
46617086|NCT01175356|82740623|FG000|Overall Study|Physician Decision|23|||
46617087|NCT01175356|82740623|FG000|Overall Study|Ineligible|1|||
46617088|NCT01175356|82740623|FG000|Overall Study|Treatment Slot Not Available|18|||
46617089|NCT01175356|82740623|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
46617090|NCT01175356|82740623|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
46617091|NCT01175356|82740623|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
46617092|NCT01175356|82740623|FG000|Overall Study|Inadequate stem cell for transplant|1|||
46617093|NCT01175356|82740623|FG000|Overall Study|Initiation other tx prior to completion|9|||
46617094|NCT01005745|82740627|FG000|Overall Study|No TIL growth|1|||
46617095|NCT01005745|82740627|FG000|Overall Study|Disease progressed during TIL growth|3|||
46617096|NCT01005745|82740627|FG000|Overall Study|Death prior to treatment|1|||
46617097|NCT01005745|82740627|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
46617098|NCT02345226|82740837|FG000|Double-Blind Phase|Adverse Event|5|||
46617099|NCT02345226|82740838|FG001|Double-Blind Phase|Adverse Event|6|||
46617100|NCT02345226|82740837|FG000|Double-Blind Phase|Death|3|||
46617101|NCT02345226|82740838|FG001|Double-Blind Phase|Death|0|||
46617102|NCT02345226|82740837|FG000|Double-Blind Phase|Pregnancy|0|||
46617103|NCT02345226|82740838|FG001|Double-Blind Phase|Pregnancy|1|||
46617104|NCT02345226|82740837|FG000|Double-Blind Phase|Lack of Efficacy|1|||
46617105|NCT02345226|82740838|FG001|Double-Blind Phase|Lack of Efficacy|0|||
46617106|NCT02345226|82740837|FG000|Double-Blind Phase|Investigator's Discretion|4|||
46617107|NCT02345226|82740838|FG001|Double-Blind Phase|Investigator's Discretion|3|||
46617108|NCT02345226|82740837|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
46617109|NCT02345226|82740838|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
46617110|NCT02345226|82740837|FG000|Double-Blind Phase|Withdrew Consent|41|||
46617111|NCT02345226|82740838|FG001|Double-Blind Phase|Withdrew Consent|39|||
46617112|NCT02345226|82740837|FG000|Double-Blind Phase|Lost to Follow-up|12|||
46617113|NCT02345226|82740838|FG001|Double-Blind Phase|Lost to Follow-up|16|||
46617114|NCT02345226|82740837|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
46617115|NCT02345226|82740838|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
46617116|NCT02345226|82740837|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
46617117|NCT02345226|82740838|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
46617118|NCT00551369|82741409|FG000|Overall Study|Protocol Violation|5|||
46617119|NCT00551369|82741409|FG000|Overall Study|Withdrawal by Subject|1|||
46617120|NCT00551369|82741409|FG000|Overall Study|Not treated per protocol and re|1|||
46617121|NCT00551291|82741422|FG000|Overall Study|Physician Decision|1|||
46617122|NCT00551213|82741528|FG000|Overall Study|Adverse Event|6|||
46617123|NCT00551213|82741529|FG001|Overall Study|Adverse Event|3|||
46617124|NCT00551213|82741528|FG000|Overall Study|Progressive Disease|41|||
46617125|NCT00551213|82741529|FG001|Overall Study|Progressive Disease|12|||
46617126|NCT00551213|82741528|FG000|Overall Study|Withdrawal by Subject|2|||
46617127|NCT00551213|82741529|FG001|Overall Study|Withdrawal by Subject|0|||
46617128|NCT00551213|82741528|FG000|Overall Study|Not Treated|1|||
46617129|NCT00551213|82741529|FG001|Overall Study|Not Treated|2|||
46617130|NCT00550043|82741666|FG000|Overall Study|Adverse Event|0|||
46617131|NCT00550043|82741667|FG001|Overall Study|Adverse Event|0|||
46617132|NCT00550043|82741668|FG002|Overall Study|Adverse Event|0|||
46617133|NCT00550043|82741669|FG003|Overall Study|Adverse Event|1|||
46617134|NCT00550043|82741670|FG004|Overall Study|Adverse Event|1|||
46617135|NCT00550043|82741666|FG000|Overall Study|Subject Withdrew Consent|0|||
46617136|NCT00550043|82741667|FG001|Overall Study|Subject Withdrew Consent|2|||
46617137|NCT00550043|82741668|FG002|Overall Study|Subject Withdrew Consent|1|||
46617138|NCT00550043|82741669|FG003|Overall Study|Subject Withdrew Consent|0|||
46617139|NCT00550043|82741670|FG004|Overall Study|Subject Withdrew Consent|0|||
46617140|NCT00550043|82741666|FG000|Overall Study|Other Reasons- Unspecified|0|||
46617141|NCT00550043|82741667|FG001|Overall Study|Other Reasons- Unspecified|1|||
46617142|NCT00550043|82741668|FG002|Overall Study|Other Reasons- Unspecified|0|||
46617143|NCT00550043|82741669|FG003|Overall Study|Other Reasons- Unspecified|1|||
46617144|NCT00550043|82741670|FG004|Overall Study|Other Reasons- Unspecified|0|||
46617145|NCT03188822|82742389|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
46617146|NCT03188822|82742389|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
46617147|NCT04976777|82742523|FG000|Overall Study|COVID-19 Infection|1|||
46617148|NCT04976777|82742524|FG001|Overall Study|COVID-19 Infection|0|||
46617149|NCT00555971|82742698|FG000|Overall Study|Adverse Event|1|||
46617150|NCT00555971|82742699|FG001|Overall Study|Adverse Event|1|||
46617151|NCT02343120|82743566|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
46617152|NCT02343120|82743567|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
46617153|NCT02343120|82743568|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
46617154|NCT02343120|82743569|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
46617155|NCT02343120|82743570|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
46617156|NCT02343120|82743566|FG000|Part 1: Dose Escalation|Death|1|||
46617157|NCT02343120|82743567|FG001|Part 1: Dose Escalation|Death|2|||
46617158|NCT02343120|82743568|FG002|Part 1: Dose Escalation|Death|2|||
46617159|NCT02343120|82743569|FG003|Part 1: Dose Escalation|Death|2|||
46617160|NCT02343120|82743570|FG004|Part 1: Dose Escalation|Death|1|||
46617161|NCT02343120|82743566|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
46617162|NCT02343120|82743567|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
46617163|NCT02343120|82743568|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
46617164|NCT02343120|82743569|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
46617165|NCT02343120|82743570|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
46617166|NCT02343120|82743566|FG000|Part 2: Expansion|Sponsor decision|0|||
46617167|NCT02343120|82743567|FG001|Part 2: Expansion|Sponsor decision|0|||
46617168|NCT02343120|82743568|FG002|Part 2: Expansion|Sponsor decision|0|||
46617169|NCT02343120|82743569|FG003|Part 2: Expansion|Sponsor decision|165|||
46617170|NCT02343120|82743570|FG004|Part 2: Expansion|Sponsor decision|67|||
46617171|NCT02343120|82743566|FG000|Part 2: Expansion|Death|0|||
46617172|NCT02343120|82743567|FG001|Part 2: Expansion|Death|0|||
46617173|NCT02343120|82743568|FG002|Part 2: Expansion|Death|0|||
46617174|NCT02343120|82743569|FG003|Part 2: Expansion|Death|74|||
46617175|NCT02343120|82743570|FG004|Part 2: Expansion|Death|17|||
46617176|NCT02343120|82743566|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
46617177|NCT02343120|82743567|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
46617178|NCT02343120|82743568|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
46617179|NCT02343120|82743569|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
46617180|NCT02343120|82743570|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
46617181|NCT02343120|82743566|FG000|Part 2: Expansion|Lost to Follow-up|0|||
46617182|NCT02343120|82743567|FG001|Part 2: Expansion|Lost to Follow-up|0|||
46617183|NCT02343120|82743568|FG002|Part 2: Expansion|Lost to Follow-up|0|||
46617184|NCT02343120|82743569|FG003|Part 2: Expansion|Lost to Follow-up|5|||
46617185|NCT02343120|82743570|FG004|Part 2: Expansion|Lost to Follow-up|2|||
46617186|NCT02343120|82743566|FG000|Part 2: Expansion|Other|0|||
46617187|NCT02343120|82743567|FG001|Part 2: Expansion|Other|0|||
46617188|NCT02343120|82743568|FG002|Part 2: Expansion|Other|0|||
46617189|NCT02343120|82743569|FG003|Part 2: Expansion|Other|1|||
46617190|NCT02343120|82743570|FG004|Part 2: Expansion|Other|5|||
46617191|NCT02343120|82743566|FG000|Part 2: Expansion|Adverse Event|0|||
46617192|NCT02343120|82743567|FG001|Part 2: Expansion|Adverse Event|0|||
46617193|NCT02343120|82743568|FG002|Part 2: Expansion|Adverse Event|0|||
46617194|NCT02343120|82743569|FG003|Part 2: Expansion|Adverse Event|1|||
46617195|NCT02343120|82743570|FG004|Part 2: Expansion|Adverse Event|1|||
46617196|NCT02342886|82743827|FG000|Overall Study|Treatment non-compliance|1|||
46617197|NCT02342886|82743828|FG001|Overall Study|Treatment non-compliance|0|||
46617198|NCT02342886|82743829|FG002|Overall Study|Treatment non-compliance|0|||
46617199|NCT02342886|82743830|FG003|Overall Study|Treatment non-compliance|1|||
46617200|NCT02342886|82743831|FG004|Overall Study|Treatment non-compliance|0|||
46617201|NCT02342886|82743827|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
46617202|NCT02342886|82743828|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
46617203|NCT02342886|82743829|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
46617204|NCT02342886|82743830|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
46617205|NCT02342886|82743831|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
46617206|NCT02342886|82743827|FG000|Overall Study|Adverse event/specific toxicity|4|||
46617207|NCT02342886|82743828|FG001|Overall Study|Adverse event/specific toxicity|3|||
46617208|NCT02342886|82743829|FG002|Overall Study|Adverse event/specific toxicity|11|||
46617209|NCT02342886|82743830|FG003|Overall Study|Adverse event/specific toxicity|2|||
46617210|NCT02342886|82743831|FG004|Overall Study|Adverse event/specific toxicity|1|||
46617211|NCT02342886|82743827|FG000|Overall Study|Lost to Follow-up|1|||
46617212|NCT02342886|82743828|FG001|Overall Study|Lost to Follow-up|0|||
46617213|NCT02342886|82743829|FG002|Overall Study|Lost to Follow-up|0|||
46617214|NCT02342886|82743830|FG003|Overall Study|Lost to Follow-up|0|||
46617215|NCT02342886|82743831|FG004|Overall Study|Lost to Follow-up|0|||
46617216|NCT02342886|82743827|FG000|Overall Study|Death|1|||
46617217|NCT02342886|82743828|FG001|Overall Study|Death|2|||
46617218|NCT02342886|82743829|FG002|Overall Study|Death|1|||
46617219|NCT02342886|82743830|FG003|Overall Study|Death|0|||
46617220|NCT02342886|82743831|FG004|Overall Study|Death|1|||
46617221|NCT02342886|82743827|FG000|Overall Study|Withdrawal by Subject|0|||
46617222|NCT02342886|82743828|FG001|Overall Study|Withdrawal by Subject|1|||
46617223|NCT02342886|82743829|FG002|Overall Study|Withdrawal by Subject|0|||
46617224|NCT02342886|82743830|FG003|Overall Study|Withdrawal by Subject|1|||
46617225|NCT02342886|82743831|FG004|Overall Study|Withdrawal by Subject|0|||
46617226|NCT02342886|82743827|FG000|Overall Study|Investigator/sponsor decision|0|||
46617227|NCT02342886|82743828|FG001|Overall Study|Investigator/sponsor decision|2|||
46617228|NCT02342886|82743829|FG002|Overall Study|Investigator/sponsor decision|0|||
46617229|NCT02342886|82743830|FG003|Overall Study|Investigator/sponsor decision|3|||
46617230|NCT02342886|82743831|FG004|Overall Study|Investigator/sponsor decision|1|||
46617231|NCT02342886|82743827|FG000|Overall Study|Pregnancy|0|||
46617232|NCT02342886|82743828|FG001|Overall Study|Pregnancy|0|||
46617233|NCT02342886|82743829|FG002|Overall Study|Pregnancy|2|||
46617234|NCT02342886|82743830|FG003|Overall Study|Pregnancy|0|||
46617235|NCT02342886|82743831|FG004|Overall Study|Pregnancy|0|||
46617236|NCT02342886|82743827|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
46617237|NCT02342886|82743828|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
46617238|NCT02342886|82743829|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
46617239|NCT02342886|82743830|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
46617240|NCT02342886|82743831|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
46617241|NCT02342886|82743827|FG000|Overall Study|Protocol Violation|0|||
46617242|NCT02342886|82743828|FG001|Overall Study|Protocol Violation|0|||
46617243|NCT02342886|82743829|FG002|Overall Study|Protocol Violation|0|||
46617244|NCT02342886|82743830|FG003|Overall Study|Protocol Violation|2|||
46617245|NCT02342886|82743831|FG004|Overall Study|Protocol Violation|0|||
46617246|NCT02390076|82743867|FG000|Overall Study|Lost to Follow-up|2|||
46617247|NCT02390076|82743868|FG001|Overall Study|Lost to Follow-up|1|||
46617248|NCT02390076|82743869|FG002|Overall Study|Lost to Follow-up|4|||
46617249|NCT02389998|82743888|FG000|Overall Study|car accident|1|||
46617250|NCT02389998|82743889|FG001|Overall Study|car accident|0|||
46617251|NCT02389764|82743915|FG000|Overall Study|Lack of Efficacy|9|||
46617252|NCT02366130|82743986|FG000|Overall Study|Withdrawal by Subject|3|||
46617253|NCT02366130|82743986|FG000|Overall Study|Ineligible|6|||
46617254|NCT02389452|82744048|FG000|Overall Study|Lost to Follow-up|13|||
46617255|NCT02389452|82744048|FG000|Overall Study|Adverse Event|1|||
46617256|NCT02389452|82744048|FG000|Overall Study|Withdrawal by Subject|5|||
46617257|NCT02389452|82744048|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
46617258|NCT02365584|82744086|FG000|Overall Study|Adverse Event|2|||
46617259|NCT02365584|82744087|FG001|Overall Study|Adverse Event|2|||
46617260|NCT02365584|82744086|FG000|Overall Study|Withdrawal by Subject|1|||
46617261|NCT02365584|82744087|FG001|Overall Study|Withdrawal by Subject|0|||
46617262|NCT02365584|82744086|FG000|Overall Study|Disease Progression|9|||
46617263|NCT02365584|82744087|FG001|Overall Study|Disease Progression|12|||
46617264|NCT02342418|82744099|FG000|Overall Study|Adverse Event|0|||
46617265|NCT02342418|82744100|FG001|Overall Study|Adverse Event|1|||
46617266|NCT02365506|82744141|FG000|Overall Study|Investigator's Discretion|0|||
46617267|NCT02365506|82744142|FG001|Overall Study|Investigator's Discretion|0|||
46617268|NCT02365506|82744143|FG002|Overall Study|Investigator's Discretion|1|||
46617269|NCT02312934|82744180|FG000|Overall Study|Lost to Follow-up|1|||
46617270|NCT02312934|82744181|FG001|Overall Study|Lost to Follow-up|0|||
46617271|NCT02312934|82744180|FG000|Overall Study|Physician Decision|1|||
46617272|NCT02312934|82744181|FG001|Overall Study|Physician Decision|0|||
46617273|NCT02341482|82744215|FG000|Overall Study|Adverse Event|1|||
46617274|NCT02312856|82744255|FG000|Overall Study|Death|1|||
46617275|NCT02312856|82744255|FG000|Overall Study|Lost to Follow-up|3|||
46617276|NCT01602120|82744720|FG000|Overall Study|Adverse Event|3|||
46617277|NCT01602120|82744721|FG001|Overall Study|Adverse Event|6|||
46617278|NCT01602120|82744722|FG002|Overall Study|Adverse Event|0|||
46617279|NCT01602120|82744723|FG003|Overall Study|Adverse Event|2|||
46617280|NCT01602120|82744720|FG000|Overall Study|Death|0|||
46617281|NCT01602120|82744721|FG001|Overall Study|Death|4|||
46617282|NCT01602120|82744722|FG002|Overall Study|Death|0|||
46617283|NCT01602120|82744723|FG003|Overall Study|Death|0|||
46617284|NCT01602120|82744720|FG000|Overall Study|Lost to Follow-up|0|||
46617285|NCT01602120|82744721|FG001|Overall Study|Lost to Follow-up|1|||
46617286|NCT01602120|82744722|FG002|Overall Study|Lost to Follow-up|0|||
46617287|NCT01602120|82744723|FG003|Overall Study|Lost to Follow-up|1|||
46617288|NCT01602120|82744720|FG000|Overall Study|Protocol Violation|1|||
46617289|NCT01602120|82744721|FG001|Overall Study|Protocol Violation|1|||
46617290|NCT01602120|82744722|FG002|Overall Study|Protocol Violation|0|||
46617291|NCT01602120|82744723|FG003|Overall Study|Protocol Violation|0|||
46617292|NCT01602120|82744720|FG000|Overall Study|Non-compliance|0|||
46617293|NCT01602120|82744721|FG001|Overall Study|Non-compliance|3|||
46617294|NCT01602120|82744722|FG002|Overall Study|Non-compliance|0|||
46617295|NCT01602120|82744723|FG003|Overall Study|Non-compliance|1|||
46617296|NCT01602120|82744720|FG000|Overall Study|Withdrawal by Subject|8|||
46617297|NCT01602120|82744721|FG001|Overall Study|Withdrawal by Subject|17|||
46617298|NCT01602120|82744722|FG002|Overall Study|Withdrawal by Subject|0|||
46617299|NCT01602120|82744723|FG003|Overall Study|Withdrawal by Subject|3|||
46617300|NCT01602120|82744720|FG000|Overall Study|Study Terminated by Sponsor|12|||
46617301|NCT01602120|82744721|FG001|Overall Study|Study Terminated by Sponsor|24|||
46617302|NCT01602120|82744722|FG002|Overall Study|Study Terminated by Sponsor|17|||
46617303|NCT01602120|82744723|FG003|Overall Study|Study Terminated by Sponsor|44|||
46617304|NCT01602120|82744720|FG000|Overall Study|Physician Decision|2|||
46617305|NCT01602120|82744721|FG001|Overall Study|Physician Decision|3|||
46617306|NCT01602120|82744722|FG002|Overall Study|Physician Decision|0|||
46617307|NCT01602120|82744723|FG003|Overall Study|Physician Decision|0|||
46617308|NCT01602120|82744720|FG000|Overall Study|Unspecified Reason|3|||
46617309|NCT01602120|82744721|FG001|Overall Study|Unspecified Reason|1|||
46617310|NCT01602120|82744722|FG002|Overall Study|Unspecified Reason|0|||
46617311|NCT01602120|82744723|FG003|Overall Study|Unspecified Reason|2|||
46617312|NCT04543955|82745530|FG000|Overall Study|Company cancelled study|1|||
46617313|NCT04543955|82745531|FG001|Overall Study|Company cancelled study|0|||
46617314|NCT04436744|82746081|FG000|Overall Study|Adverse Event|1|||
46617315|NCT04436744|82746082|FG001|Overall Study|Adverse Event|1|||
46617316|NCT04436744|82746081|FG000|Overall Study|Death|1|||
46617317|NCT04436744|82746082|FG001|Overall Study|Death|0|||
46617318|NCT04436744|82746081|FG000|Overall Study|Lost to Follow-up|0|||
46617319|NCT04436744|82746082|FG001|Overall Study|Lost to Follow-up|2|||
46617320|NCT04436744|82746081|FG000|Overall Study|Physician Decision|0|||
46617321|NCT04436744|82746082|FG001|Overall Study|Physician Decision|1|||
46617322|NCT04436744|82746081|FG000|Overall Study|Progressive Disease|0|||
46617323|NCT04436744|82746082|FG001|Overall Study|Progressive Disease|4|||
46617324|NCT04436744|82746081|FG000|Overall Study|Protocol Deviation|1|||
46617325|NCT04436744|82746082|FG001|Overall Study|Protocol Deviation|1|||
46617326|NCT04436744|82746081|FG000|Overall Study|Withdrawal by Subject|1|||
46617327|NCT04436744|82746082|FG001|Overall Study|Withdrawal by Subject|2|||
46617328|NCT02243306|82746238|FG000|Overall Study|Adverse Event|0|||
46617329|NCT02243306|82746239|FG001|Overall Study|Adverse Event|1|||
46617330|NCT02243306|82746238|FG000|Overall Study|Other: Reached stopping criteria|0|||
46617331|NCT02243306|82746239|FG001|Overall Study|Other: Reached stopping criteria|1|||
46617332|NCT02243306|82746238|FG000|Overall Study|Physician Decision|0|||
46617333|NCT02243306|82746239|FG001|Overall Study|Physician Decision|1|||
46617334|NCT03214679|82746395|FG000|Overall Study|Lost to Follow-up|12|||
46617335|NCT03214679|82746396|FG001|Overall Study|Lost to Follow-up|14|||
46617336|NCT03214679|82746395|FG000|Overall Study|not eligible|2|||
46617337|NCT03214679|82746396|FG001|Overall Study|not eligible|0|||
46617338|NCT01349465|82747669|FG000|Overall Study|Adverse Event|1|||
46617339|NCT01349465|82747670|FG001|Overall Study|Adverse Event|0|||
46617340|NCT01349465|82747669|FG000|Overall Study|Death|3|||
46617341|NCT01349465|82747670|FG001|Overall Study|Death|0|||
46617342|NCT01349465|82747669|FG000|Overall Study|Lost to Follow-up|10|||
46617343|NCT01349465|82747670|FG001|Overall Study|Lost to Follow-up|1|||
46617344|NCT01349465|82747669|FG000|Overall Study|Withdrawal by Subject|4|||
46617345|NCT01349465|82747670|FG001|Overall Study|Withdrawal by Subject|2|||
46617346|NCT01349465|82747669|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
46617347|NCT01349465|82747670|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
46617348|NCT01648764|82748780|FG000|Overall Study|Progressive Disease|0|||
46617349|NCT01648764|82748781|FG001|Overall Study|Progressive Disease|1|||
46617350|NCT01648764|82748782|FG002|Overall Study|Progressive Disease|0|||
46617351|NCT01648764|82748783|FG003|Overall Study|Progressive Disease|0|||
46617352|NCT01648764|82748784|FG004|Overall Study|Progressive Disease|0|||
46617353|NCT01648764|82748785|FG005|Overall Study|Progressive Disease|1|||
46617354|NCT01648764|82748786|FG006|Overall Study|Progressive Disease|1|||
46617355|NCT01648764|82748787|FG007|Overall Study|Progressive Disease|0|||
46617356|NCT01648764|82748788|FG008|Overall Study|Progressive Disease|0|||
46617357|NCT01648764|82748789|FG009|Overall Study|Progressive Disease|2|||
46617358|NCT01648764|82748790|FG010|Overall Study|Progressive Disease|0|||
46617359|NCT01648764|82748791|FG011|Overall Study|Progressive Disease|1|||
46617360|NCT01648764|82748792|FG012|Overall Study|Progressive Disease|2|||
46617361|NCT01648764|82748793|FG013|Overall Study|Progressive Disease|1|||
46617362|NCT01648764|82748780|FG000|Overall Study|Adverse Event|0|||
46617363|NCT01648764|82748781|FG001|Overall Study|Adverse Event|0|||
46617364|NCT01648764|82748782|FG002|Overall Study|Adverse Event|0|||
46617365|NCT01648764|82748783|FG003|Overall Study|Adverse Event|0|||
46617366|NCT01648764|82748784|FG004|Overall Study|Adverse Event|0|||
46617367|NCT01648764|82748785|FG005|Overall Study|Adverse Event|1|||
46617368|NCT01648764|82748786|FG006|Overall Study|Adverse Event|0|||
46617369|NCT01648764|82748787|FG007|Overall Study|Adverse Event|0|||
46617370|NCT01648764|82748788|FG008|Overall Study|Adverse Event|0|||
46617371|NCT01648764|82748789|FG009|Overall Study|Adverse Event|1|||
46617372|NCT01648764|82748790|FG010|Overall Study|Adverse Event|0|||
46617373|NCT01648764|82748791|FG011|Overall Study|Adverse Event|3|||
46617374|NCT01648764|82748792|FG012|Overall Study|Adverse Event|1|||
46617375|NCT01648764|82748793|FG013|Overall Study|Adverse Event|1|||
46617376|NCT01648764|82748780|FG000|Overall Study|Death|0|||
46617377|NCT01648764|82748781|FG001|Overall Study|Death|0|||
46617378|NCT01648764|82748782|FG002|Overall Study|Death|0|||
46617379|NCT01648764|82748783|FG003|Overall Study|Death|0|||
46617380|NCT01648764|82748784|FG004|Overall Study|Death|0|||
46617381|NCT01648764|82748785|FG005|Overall Study|Death|0|||
46617382|NCT01648764|82748786|FG006|Overall Study|Death|1|||
46617383|NCT01648764|82748787|FG007|Overall Study|Death|0|||
46617384|NCT01648764|82748788|FG008|Overall Study|Death|0|||
46617385|NCT01648764|82748789|FG009|Overall Study|Death|0|||
46617386|NCT01648764|82748790|FG010|Overall Study|Death|0|||
46617387|NCT01648764|82748791|FG011|Overall Study|Death|0|||
46617388|NCT01648764|82748792|FG012|Overall Study|Death|0|||
46617389|NCT01648764|82748793|FG013|Overall Study|Death|1|||
46617390|NCT01648764|82748780|FG000|Overall Study|Withdrawal by Subject|0|||
46617391|NCT01648764|82748781|FG001|Overall Study|Withdrawal by Subject|0|||
46617392|NCT01648764|82748782|FG002|Overall Study|Withdrawal by Subject|0|||
46617393|NCT01648764|82748783|FG003|Overall Study|Withdrawal by Subject|0|||
46617394|NCT01648764|82748784|FG004|Overall Study|Withdrawal by Subject|0|||
46617395|NCT01648764|82748785|FG005|Overall Study|Withdrawal by Subject|0|||
46617396|NCT01648764|82748786|FG006|Overall Study|Withdrawal by Subject|2|||
46617397|NCT01648764|82748787|FG007|Overall Study|Withdrawal by Subject|0|||
46617398|NCT01648764|82748788|FG008|Overall Study|Withdrawal by Subject|0|||
46617399|NCT01648764|82748789|FG009|Overall Study|Withdrawal by Subject|0|||
46617400|NCT01648764|82748790|FG010|Overall Study|Withdrawal by Subject|0|||
46617401|NCT01648764|82748791|FG011|Overall Study|Withdrawal by Subject|0|||
46617402|NCT01648764|82748792|FG012|Overall Study|Withdrawal by Subject|1|||
46617403|NCT01648764|82748793|FG013|Overall Study|Withdrawal by Subject|0|||
46617404|NCT01648764|82748780|FG000|Overall Study|Investigator Decision|0|||
46617405|NCT01648764|82748781|FG001|Overall Study|Investigator Decision|0|||
46617406|NCT01648764|82748782|FG002|Overall Study|Investigator Decision|0|||
46617407|NCT01648764|82748783|FG003|Overall Study|Investigator Decision|0|||
46617408|NCT01648764|82748784|FG004|Overall Study|Investigator Decision|0|||
46617409|NCT01648764|82748785|FG005|Overall Study|Investigator Decision|0|||
46617410|NCT01648764|82748786|FG006|Overall Study|Investigator Decision|1|||
46617411|NCT01648764|82748787|FG007|Overall Study|Investigator Decision|0|||
46617412|NCT01648764|82748788|FG008|Overall Study|Investigator Decision|0|||
46617413|NCT01648764|82748789|FG009|Overall Study|Investigator Decision|0|||
46617414|NCT01648764|82748790|FG010|Overall Study|Investigator Decision|0|||
46617415|NCT01648764|82748791|FG011|Overall Study|Investigator Decision|1|||
46617416|NCT01648764|82748792|FG012|Overall Study|Investigator Decision|0|||
46617417|NCT01648764|82748793|FG013|Overall Study|Investigator Decision|0|||
46617418|NCT02364336|82748829|FG000|Overall Study|Adverse Event|0|||
46617419|NCT02364336|82748830|FG001|Overall Study|Adverse Event|1|||
46617420|NCT02810951|82749061|FG000|Overall Study|Adverse Event|1|||
46617421|NCT02310906|82749157|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
46617422|NCT02310906|82749158|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
46617423|NCT02310906|82749159|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
46617424|NCT02310906|82749160|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
46617425|NCT02310906|82749157|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
46617426|NCT02310906|82749158|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
46617427|NCT02310906|82749159|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
46617428|NCT02310906|82749160|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
46617429|NCT02310906|82749157|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
46617430|NCT02310906|82749158|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
46617431|NCT02310906|82749159|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
46617432|NCT02310906|82749160|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
46617433|NCT02310906|82749157|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
46617434|NCT02310906|82749158|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
46617435|NCT02310906|82749159|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
46617436|NCT02310906|82749160|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
46617437|NCT02340078|82749210|FG000|Overall Study|Protocol Violation|1|||
46617438|NCT02340000|82749226|FG000|Time Period 1|Withdrawal by Subject|6|||
46617439|NCT02340000|82749227|FG001|Time Period 1|Withdrawal by Subject|8|||
46617440|NCT02340000|82749226|FG000|Time Period 1|Lost to Follow-up|6|||
46617441|NCT02340000|82749227|FG001|Time Period 1|Lost to Follow-up|7|||
46617442|NCT02340000|82749226|FG000|Time Period 2|Withdrawal by Subject|9|||
46617443|NCT02340000|82749227|FG001|Time Period 2|Withdrawal by Subject|7|||
46617444|NCT02340000|82749226|FG000|Time Period 2|Lost to Follow-up|10|||
46617445|NCT02340000|82749227|FG001|Time Period 2|Lost to Follow-up|8|||
46617446|NCT02364180|82749258|FG000|Overall Study|Screen Fail|1|||
46617447|NCT02310750|82749887|FG000|HP Period 1|Lost to Follow-up|0|||
46617448|NCT02310750|82749888|FG001|HP Period 1|Lost to Follow-up|0|||
46617449|NCT02310750|82749889|FG002|HP Period 1|Lost to Follow-up|0|||
46617450|NCT02310750|82749890|FG003|HP Period 1|Lost to Follow-up|0|||
46617451|NCT02310750|82749891|FG004|HP Period 1|Lost to Follow-up|0|||
46617452|NCT02310750|82749892|FG005|HP Period 1|Lost to Follow-up|0|||
46617453|NCT02310750|82749893|FG006|HP Period 1|Lost to Follow-up|1|||
46617454|NCT02310750|82749894|FG007|HP Period 1|Lost to Follow-up|0|||
46617455|NCT02310750|82749895|FG008|HP Period 1|Lost to Follow-up|0|||
46617456|NCT02310750|82749896|FG009|HP Period 1|Lost to Follow-up|0|||
46617457|NCT02310750|82749897|FG010|HP Period 1|Lost to Follow-up|0|||
46617458|NCT02310750|82749898|FG011|HP Period 1|Lost to Follow-up|0|||
46617459|NCT02310750|82749899|FG012|HP Period 1|Lost to Follow-up|0|||
46617460|NCT02310750|82749900|FG013|HP Period 1|Lost to Follow-up|0|||
46617461|NCT02310750|82749901|FG014|HP Period 1|Lost to Follow-up|0|||
46617462|NCT02310750|82749902|FG015|HP Period 1|Lost to Follow-up|0|||
46617463|NCT02310750|82749887|FG000|HP Period 1|Withdrawal by Subject|1|||
46617464|NCT02310750|82749888|FG001|HP Period 1|Withdrawal by Subject|0|||
46617465|NCT02310750|82749889|FG002|HP Period 1|Withdrawal by Subject|0|||
46617466|NCT02310750|82749890|FG003|HP Period 1|Withdrawal by Subject|1|||
46617467|NCT02310750|82749891|FG004|HP Period 1|Withdrawal by Subject|0|||
46617468|NCT02310750|82749892|FG005|HP Period 1|Withdrawal by Subject|0|||
46617469|NCT02310750|82749893|FG006|HP Period 1|Withdrawal by Subject|0|||
46617470|NCT02310750|82749894|FG007|HP Period 1|Withdrawal by Subject|0|||
46617471|NCT02310750|82749895|FG008|HP Period 1|Withdrawal by Subject|0|||
46617472|NCT02310750|82749896|FG009|HP Period 1|Withdrawal by Subject|0|||
46617473|NCT02310750|82749897|FG010|HP Period 1|Withdrawal by Subject|0|||
46617474|NCT02310750|82749898|FG011|HP Period 1|Withdrawal by Subject|0|||
46617475|NCT02310750|82749899|FG012|HP Period 1|Withdrawal by Subject|0|||
46617476|NCT02310750|82749900|FG013|HP Period 1|Withdrawal by Subject|0|||
46617477|NCT02310750|82749901|FG014|HP Period 1|Withdrawal by Subject|0|||
46617478|NCT02310750|82749902|FG015|HP Period 1|Withdrawal by Subject|0|||
46617479|NCT02310750|82749887|FG000|HP Washout 1|Lost to Follow-up|0|||
46617480|NCT02310750|82749888|FG001|HP Washout 1|Lost to Follow-up|0|||
46617481|NCT02310750|82749889|FG002|HP Washout 1|Lost to Follow-up|1|||
46617482|NCT02310750|82749890|FG003|HP Washout 1|Lost to Follow-up|1|||
46617483|NCT02310750|82749891|FG004|HP Washout 1|Lost to Follow-up|2|||
46617484|NCT02310750|82749892|FG005|HP Washout 1|Lost to Follow-up|2|||
46617485|NCT02310750|82749893|FG006|HP Washout 1|Lost to Follow-up|3|||
46617486|NCT02310750|82749894|FG007|HP Washout 1|Lost to Follow-up|0|||
46617487|NCT02310750|82749895|FG008|HP Washout 1|Lost to Follow-up|0|||
46617488|NCT02310750|82749896|FG009|HP Washout 1|Lost to Follow-up|0|||
46617489|NCT02310750|82749897|FG010|HP Washout 1|Lost to Follow-up|0|||
46617490|NCT02310750|82749898|FG011|HP Washout 1|Lost to Follow-up|0|||
46617491|NCT02310750|82749899|FG012|HP Washout 1|Lost to Follow-up|0|||
46617492|NCT02310750|82749900|FG013|HP Washout 1|Lost to Follow-up|0|||
46617493|NCT02310750|82749901|FG014|HP Washout 1|Lost to Follow-up|0|||
46617494|NCT02310750|82749902|FG015|HP Washout 1|Lost to Follow-up|0|||
46617495|NCT02310750|82749887|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617496|NCT02310750|82749888|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617497|NCT02310750|82749889|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617498|NCT02310750|82749890|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
46617499|NCT02310750|82749891|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617500|NCT02310750|82749892|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
46617501|NCT02310750|82749893|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617502|NCT02310750|82749894|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617503|NCT02310750|82749895|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
46617504|NCT02310750|82749896|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
46617505|NCT02310750|82749897|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617506|NCT02310750|82749898|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617507|NCT02310750|82749899|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617508|NCT02310750|82749900|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617509|NCT02310750|82749901|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617510|NCT02310750|82749902|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
46617511|NCT02310750|82749887|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617512|NCT02310750|82749888|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617513|NCT02310750|82749889|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617514|NCT02310750|82749890|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617515|NCT02310750|82749891|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617516|NCT02310750|82749892|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617517|NCT02310750|82749893|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617518|NCT02310750|82749894|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617519|NCT02310750|82749895|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617520|NCT02310750|82749896|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
46617521|NCT02310750|82749897|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617522|NCT02310750|82749898|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617523|NCT02310750|82749899|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617524|NCT02310750|82749900|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617525|NCT02310750|82749901|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617526|NCT02310750|82749902|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
46617527|NCT02310750|82749887|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617528|NCT02310750|82749888|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617529|NCT02310750|82749889|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617530|NCT02310750|82749890|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617531|NCT02310750|82749891|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617532|NCT02310750|82749892|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617533|NCT02310750|82749893|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617534|NCT02310750|82749894|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
46617535|NCT02310750|82749895|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
46617536|NCT02310750|82749896|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
46617537|NCT02310750|82749897|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617538|NCT02310750|82749898|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617539|NCT02310750|82749899|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617540|NCT02310750|82749900|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617541|NCT02310750|82749901|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617542|NCT02310750|82749902|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
46617543|NCT02310750|82749887|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617544|NCT02310750|82749888|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617545|NCT02310750|82749889|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617546|NCT02310750|82749890|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617547|NCT02310750|82749891|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617548|NCT02310750|82749892|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617549|NCT02310750|82749893|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617550|NCT02310750|82749894|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
46617551|NCT02310750|82749895|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
46617552|NCT02310750|82749896|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617553|NCT02310750|82749897|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617554|NCT02310750|82749898|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617555|NCT02310750|82749899|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617556|NCT02310750|82749900|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617557|NCT02310750|82749901|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617558|NCT02310750|82749902|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
46617559|NCT02310750|82749887|FG000|HP Washout 2|Lost to Follow-up|0|||
46617560|NCT02310750|82749888|FG001|HP Washout 2|Lost to Follow-up|0|||
46617561|NCT02310750|82749889|FG002|HP Washout 2|Lost to Follow-up|0|||
46617562|NCT02310750|82749890|FG003|HP Washout 2|Lost to Follow-up|0|||
46617563|NCT02310750|82749891|FG004|HP Washout 2|Lost to Follow-up|1|||
46617564|NCT02310750|82749892|FG005|HP Washout 2|Lost to Follow-up|0|||
46617565|NCT02310750|82749893|FG006|HP Washout 2|Lost to Follow-up|7|||
46617566|NCT02310750|82749894|FG007|HP Washout 2|Lost to Follow-up|0|||
46617567|NCT02310750|82749895|FG008|HP Washout 2|Lost to Follow-up|0|||
46617568|NCT02310750|82749896|FG009|HP Washout 2|Lost to Follow-up|0|||
46617569|NCT02310750|82749897|FG010|HP Washout 2|Lost to Follow-up|0|||
46617570|NCT02310750|82749898|FG011|HP Washout 2|Lost to Follow-up|0|||
46617571|NCT02310750|82749899|FG012|HP Washout 2|Lost to Follow-up|0|||
46617572|NCT02310750|82749900|FG013|HP Washout 2|Lost to Follow-up|0|||
46617573|NCT02310750|82749901|FG014|HP Washout 2|Lost to Follow-up|0|||
46617574|NCT02310750|82749902|FG015|HP Washout 2|Lost to Follow-up|0|||
46617575|NCT02310672|82750007|FG000|Overall Study|Death|1|||
46617576|NCT02310672|82750007|FG000|Overall Study|Lost to Follow-up|1|||
46617577|NCT02310672|82750007|FG000|Overall Study|Withdrawal by Subject|1|||
46617578|NCT02310672|82750007|FG000|Overall Study|Sponsor's decision|12|||
46617579|NCT02363946|82750153|FG000|Overall Study|Lost to Follow-up|0|||
46617580|NCT02363946|82750154|FG001|Overall Study|Lost to Follow-up|0|||
46617581|NCT02363946|82750155|FG002|Overall Study|Lost to Follow-up|0|||
46617582|NCT02363946|82750156|FG003|Overall Study|Lost to Follow-up|0|||
46617583|NCT02363946|82750157|FG004|Overall Study|Lost to Follow-up|0|||
46617584|NCT02363946|82750158|FG005|Overall Study|Lost to Follow-up|0|||
46617585|NCT02363946|82750159|FG006|Overall Study|Lost to Follow-up|0|||
46617586|NCT02363946|82750160|FG007|Overall Study|Lost to Follow-up|1|||
46617587|NCT02363946|82750161|FG008|Overall Study|Lost to Follow-up|0|||
46617588|NCT02363946|82750162|FG009|Overall Study|Lost to Follow-up|0|||
46617589|NCT02363946|82750163|FG010|Overall Study|Lost to Follow-up|0|||
46617590|NCT02363946|82750164|FG011|Overall Study|Lost to Follow-up|0|||
46617591|NCT02363946|82750165|FG012|Overall Study|Lost to Follow-up|0|||
46617592|NCT02363478|82750193|FG000|Overall Study|Lost to Follow-up|4|||
46617593|NCT02363478|82750193|FG000|Overall Study|Adverse Event|4|||
46617594|NCT02310126|82750200|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
46617595|NCT02310126|82750201|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
46617596|NCT02310126|82750200|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
46617597|NCT02310126|82750201|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
46617598|NCT02338362|82750209|FG000|Overall Study|Withdrawal by Subject|1|||
46617599|NCT02338362|82750210|FG001|Overall Study|Withdrawal by Subject|1|||
46617600|NCT02363322|82750218|FG000|Overall Study|Lost to Follow-up|1|||
46617601|NCT02363322|82750219|FG001|Overall Study|Lost to Follow-up|0|||
46617602|NCT02361762|82750227|FG000|Overall Study|Withdrawal by Subject|0|||
46617603|NCT02361762|82750228|FG001|Overall Study|Withdrawal by Subject|1|||
46617604|NCT02361762|82750227|FG000|Overall Study|Lost to Follow-up|0|||
46617605|NCT02361762|82750228|FG001|Overall Study|Lost to Follow-up|1|||
46617606|NCT02337738|82750237|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
46617607|NCT02337738|82750238|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
46617608|NCT02337738|82750239|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
46617609|NCT02337738|82750237|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
46617610|NCT02337738|82750238|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
46617611|NCT02337738|82750239|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
46617612|NCT02337738|82750237|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
46617613|NCT02337738|82750238|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
46617614|NCT02337738|82750239|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
46617615|NCT02337738|82750237|FG000|Overall Study|Voluntary Withdrawal|10|||
46617616|NCT02337738|82750238|FG001|Overall Study|Voluntary Withdrawal|5|||
46617617|NCT02337738|82750239|FG002|Overall Study|Voluntary Withdrawal|2|||
46617618|NCT02337738|82750237|FG000|Overall Study|Lack of Efficacy|2|||
46617619|NCT02337738|82750238|FG001|Overall Study|Lack of Efficacy|4|||
46617620|NCT02337738|82750239|FG002|Overall Study|Lack of Efficacy|0|||
46617621|NCT02337738|82750237|FG000|Overall Study|Investigator's Judgment|1|||
46617622|NCT02337738|82750238|FG001|Overall Study|Investigator's Judgment|1|||
46617623|NCT02337738|82750239|FG002|Overall Study|Investigator's Judgment|3|||
46617624|NCT02309112|82750250|FG000|Overall Study|Withdrawal by Subject|1|||
46617625|NCT02309112|82750251|FG001|Overall Study|Withdrawal by Subject|0|||
46617626|NCT02309112|82750252|FG002|Overall Study|Withdrawal by Subject|1|||
46617627|NCT02309112|82750250|FG000|Overall Study|Lost to Follow-up|0|||
46617628|NCT02309112|82750251|FG001|Overall Study|Lost to Follow-up|1|||
46617629|NCT02309112|82750252|FG002|Overall Study|Lost to Follow-up|0|||
46617630|NCT02361216|82750264|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
46617631|NCT02361216|82750265|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
46617632|NCT02361216|82750264|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
46617633|NCT02361216|82750265|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
46617634|NCT02361216|82750264|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
46617635|NCT02361216|82750265|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
46617636|NCT02361216|82750264|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
46617637|NCT02361216|82750265|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
46617638|NCT02361216|82750264|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
46617639|NCT02361216|82750265|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
46617640|NCT02361216|82750264|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
46617641|NCT02361216|82750265|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
46617642|NCT00559988|82750698|FG000|Overall Study|Death|147|||
46617643|NCT00559988|82750699|FG001|Overall Study|Death|140|||
46617644|NCT00559988|82750698|FG000|Overall Study|Withdrawal by Subject|152|||
46617645|NCT00559988|82750699|FG001|Overall Study|Withdrawal by Subject|139|||
46617646|NCT00559988|82750698|FG000|Overall Study|Lost to Follow-up|42|||
46617647|NCT00559988|82750699|FG001|Overall Study|Lost to Follow-up|56|||
46617648|NCT00559988|82750698|FG000|Overall Study|ICD device explanted|10|||
46617649|NCT00559988|82750699|FG001|Overall Study|ICD device explanted|17|||
46617650|NCT00559754|82750761|FG000|Overall Study|Disease progression|1|||
46617651|NCT00559754|82750761|FG000|Overall Study|Adverse Event|5|||
46617652|NCT00559754|82750761|FG000|Overall Study|Protocol Violation|1|||
46617653|NCT00559754|82750761|FG000|Overall Study|Investigator criteria|2|||
46617654|NCT00559754|82750761|FG000|Overall Study|Withdrawal by Subject|2|||
46617655|NCT00559364|82750875|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
46617656|NCT00559364|82750876|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
46617657|NCT02308020|82750939|FG000|Overall Study|Lost to Follow-up|1|||
46617658|NCT02308020|82750940|FG001|Overall Study|Lost to Follow-up|7|||
46617659|NCT02308020|82750941|FG002|Overall Study|Lost to Follow-up|0|||
46617660|NCT02308020|82750942|FG003|Overall Study|Lost to Follow-up|0|||
46617661|NCT02308020|82750943|FG004|Overall Study|Lost to Follow-up|1|||
46617662|NCT02308020|82750944|FG005|Overall Study|Lost to Follow-up|2|||
46617663|NCT02308020|82750939|FG000|Overall Study|Sponsor Decision|0|||
46617664|NCT02308020|82750940|FG001|Overall Study|Sponsor Decision|8|||
46617665|NCT02308020|82750941|FG002|Overall Study|Sponsor Decision|0|||
46617666|NCT02308020|82750942|FG003|Overall Study|Sponsor Decision|2|||
46617667|NCT02308020|82750943|FG004|Overall Study|Sponsor Decision|2|||
46617668|NCT02308020|82750944|FG005|Overall Study|Sponsor Decision|1|||
46617669|NCT02308020|82750939|FG000|Overall Study|Withdrawal by Subject|3|||
46617670|NCT02308020|82750940|FG001|Overall Study|Withdrawal by Subject|5|||
46617671|NCT02308020|82750941|FG002|Overall Study|Withdrawal by Subject|3|||
46617672|NCT02308020|82750942|FG003|Overall Study|Withdrawal by Subject|2|||
46617673|NCT02308020|82750943|FG004|Overall Study|Withdrawal by Subject|1|||
46617674|NCT02308020|82750944|FG005|Overall Study|Withdrawal by Subject|2|||
46617675|NCT02359890|82750964|FG000|Overall Study|Not meeting eligibility|4|||
46617676|NCT02359890|82750964|FG000|Overall Study|Never treated with study catheter|6|||
46617677|NCT02306850|82750968|FG000|Overall Study|Lack of Efficacy|2|||
46617678|NCT02306694|82750973|FG000|Overall Study|Withdrawal by Subject|3|||
46617679|NCT02306694|82750973|FG000|Overall Study|Lost to Follow-up|1|||
46617680|NCT01648140|82750985|FG000|Overall Study|Physician Decision|1|||
46617681|NCT01648140|82750986|FG001|Overall Study|Physician Decision|0|||
46617682|NCT01648140|82750987|FG002|Overall Study|Physician Decision|0|||
46617683|NCT01648140|82750988|FG003|Overall Study|Physician Decision|0|||
46617684|NCT01648140|82750985|FG000|Overall Study|Lack of Efficacy|4|||
46617685|NCT01648140|82750986|FG001|Overall Study|Lack of Efficacy|7|||
46617686|NCT01648140|82750987|FG002|Overall Study|Lack of Efficacy|1|||
46617687|NCT01648140|82750988|FG003|Overall Study|Lack of Efficacy|0|||
46617688|NCT01648140|82750985|FG000|Overall Study|Adverse Event|3|||
46617689|NCT01648140|82750986|FG001|Overall Study|Adverse Event|1|||
46617690|NCT01648140|82750987|FG002|Overall Study|Adverse Event|2|||
46617691|NCT01648140|82750988|FG003|Overall Study|Adverse Event|0|||
46617692|NCT01648140|82750985|FG000|Overall Study|Withdrawal by Subject|2|||
46617693|NCT01648140|82750986|FG001|Overall Study|Withdrawal by Subject|3|||
46617694|NCT01648140|82750987|FG002|Overall Study|Withdrawal by Subject|3|||
46617695|NCT01648140|82750988|FG003|Overall Study|Withdrawal by Subject|2|||
46617696|NCT01648140|82750985|FG000|Overall Study|Lost to Follow-up|2|||
46617697|NCT01648140|82750986|FG001|Overall Study|Lost to Follow-up|1|||
46617698|NCT01648140|82750987|FG002|Overall Study|Lost to Follow-up|2|||
46617699|NCT01648140|82750988|FG003|Overall Study|Lost to Follow-up|0|||
46617700|NCT02336178|82751007|FG000|Overall Study|Lost to Follow-up|1|||
46617701|NCT02336178|82751007|FG000|Overall Study|Protocol Violation|1|||
46617702|NCT02336178|82751007|FG000|Overall Study|Withdrawal by Subject|1|||
46617703|NCT02336178|82751007|FG000|Overall Study|Other|1|||
46617704|NCT02357940|82751021|FG000|Overall Study|Adverse Event|0|||
46617705|NCT02357940|82751022|FG001|Overall Study|Adverse Event|1|||
46617706|NCT02357940|82751021|FG000|Overall Study|Investigator's judgement|0|||
46617707|NCT02357940|82751022|FG001|Overall Study|Investigator's judgement|1|||
46617708|NCT02335242|82751030|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
46617709|NCT02335242|82751031|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
46617710|NCT02335242|82751030|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
46617711|NCT02335242|82751031|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46617712|NCT02335242|82751030|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
46617713|NCT02335242|82751031|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
46617714|NCT02334384|82751043|FG000|Overall Study|Lost to Follow-up|1|||
46617715|NCT02334384|82751044|FG001|Overall Study|Lost to Follow-up|1|||
46617716|NCT02334306|82751052|FG000|Double-blind Period|Adverse Event|0|||
46617717|NCT02334306|82751053|FG001|Double-blind Period|Adverse Event|1|||
46617718|NCT02334306|82751052|FG000|Double-blind Period|Withdrawal by Subject|1|||
46617719|NCT02334306|82751053|FG001|Double-blind Period|Withdrawal by Subject|1|||
46617720|NCT02305758|82751062|FG000|Overall Study|Death|27|||
46617721|NCT02305758|82751063|FG001|Overall Study|Death|27|||
46617722|NCT02305758|82751062|FG000|Overall Study|Withdrew consent|9|||
46617723|NCT02305758|82751063|FG001|Overall Study|Withdrew consent|2|||
46617724|NCT02305758|82751062|FG000|Overall Study|Lost to Follow-up|6|||
46617725|NCT02305758|82751063|FG001|Overall Study|Lost to Follow-up|1|||
46617726|NCT02305758|82751062|FG000|Overall Study|Study Terminated by Sponsor|21|||
46617727|NCT02305758|82751063|FG001|Overall Study|Study Terminated by Sponsor|34|||
46617728|NCT02305758|82751062|FG000|Overall Study|Other, not specified|2|||
46617729|NCT02305758|82751063|FG001|Overall Study|Other, not specified|1|||
46617730|NCT02305446|82751069|FG000|Overall Study|Adverse Event|1|||
46617731|NCT02303574|82751206|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617732|NCT02303574|82751207|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617733|NCT02303574|82751208|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
46617734|NCT02303574|82751209|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617735|NCT02303574|82751210|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617736|NCT02303574|82751211|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617737|NCT02303574|82751212|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617738|NCT02303574|82751213|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617739|NCT02303574|82751214|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617740|NCT02303574|82751215|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
46617741|NCT02303574|82751206|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617742|NCT02303574|82751207|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617743|NCT02303574|82751208|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617744|NCT02303574|82751209|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617745|NCT02303574|82751210|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617746|NCT02303574|82751211|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617747|NCT02303574|82751212|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617748|NCT02303574|82751213|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
46617749|NCT02303574|82751214|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617750|NCT02303574|82751215|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
46617751|NCT02354976|82751251|FG000|Overall Study|Other - reason not specified|1|||
46617752|NCT02354976|82751252|FG001|Overall Study|Other - reason not specified|0|||
46617753|NCT02354976|82751253|FG002|Overall Study|Other - reason not specified|1|||
46617754|NCT02354976|82751251|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
46617755|NCT02354976|82751252|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
46617756|NCT02354976|82751253|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
46617757|NCT02354976|82751251|FG000|Overall Study|Adverse Event|1|||
46617758|NCT02354976|82751252|FG001|Overall Study|Adverse Event|0|||
46617759|NCT02354976|82751253|FG002|Overall Study|Adverse Event|2|||
46617760|NCT02303262|82751261|FG000|Overall Study|Withdrawal by Subject|2|||
46617761|NCT00558896|82751272|FG000|Overall Study|Adverse Event|1|||
46617762|NCT00558896|82751273|FG001|Overall Study|Adverse Event|1|||
46617763|NCT00558896|82751274|FG002|Overall Study|Adverse Event|1|||
46617764|NCT00558896|82751275|FG003|Overall Study|Adverse Event|3|||
46617765|NCT00558896|82751276|FG004|Overall Study|Adverse Event|4|||
46617766|NCT00558896|82751277|FG005|Overall Study|Adverse Event|10|||
46617767|NCT00558896|82751278|FG006|Overall Study|Adverse Event|3|||
46617768|NCT00558896|82751272|FG000|Overall Study|Death|3|||
46617769|NCT00558896|82751273|FG001|Overall Study|Death|0|||
46617770|NCT00558896|82751274|FG002|Overall Study|Death|2|||
46617771|NCT00558896|82751275|FG003|Overall Study|Death|3|||
46617772|NCT00558896|82751276|FG004|Overall Study|Death|2|||
46617773|NCT00558896|82751277|FG005|Overall Study|Death|2|||
46617774|NCT00558896|82751278|FG006|Overall Study|Death|6|||
46617775|NCT00558896|82751272|FG000|Overall Study|Withdrawal by Subject|2|||
46617776|NCT00558896|82751273|FG001|Overall Study|Withdrawal by Subject|1|||
46617777|NCT00558896|82751274|FG002|Overall Study|Withdrawal by Subject|1|||
46617778|NCT00558896|82751275|FG003|Overall Study|Withdrawal by Subject|1|||
46617779|NCT00558896|82751276|FG004|Overall Study|Withdrawal by Subject|1|||
46617780|NCT00558896|82751277|FG005|Overall Study|Withdrawal by Subject|5|||
46617781|NCT00558896|82751278|FG006|Overall Study|Withdrawal by Subject|5|||
46617782|NCT00558896|82751272|FG000|Overall Study|Alternative Treatment|2|||
46617783|NCT00558896|82751273|FG001|Overall Study|Alternative Treatment|2|||
46617784|NCT00558896|82751274|FG002|Overall Study|Alternative Treatment|0|||
46617785|NCT00558896|82751275|FG003|Overall Study|Alternative Treatment|2|||
46617786|NCT00558896|82751276|FG004|Overall Study|Alternative Treatment|6|||
46617787|NCT00558896|82751277|FG005|Overall Study|Alternative Treatment|7|||
46617788|NCT00558896|82751278|FG006|Overall Study|Alternative Treatment|1|||
46617789|NCT00558896|82751272|FG000|Overall Study|Physician discretion|3|||
46617790|NCT00558896|82751273|FG001|Overall Study|Physician discretion|2|||
46617791|NCT00558896|82751274|FG002|Overall Study|Physician discretion|1|||
46617792|NCT00558896|82751275|FG003|Overall Study|Physician discretion|2|||
46617793|NCT00558896|82751276|FG004|Overall Study|Physician discretion|1|||
46617794|NCT00558896|82751277|FG005|Overall Study|Physician discretion|3|||
46617795|NCT00558896|82751278|FG006|Overall Study|Physician discretion|3|||
46617796|NCT00558896|82751272|FG000|Overall Study|Continues on treatment|10|||
46617797|NCT00558896|82751273|FG001|Overall Study|Continues on treatment|1|||
46617798|NCT00558896|82751274|FG002|Overall Study|Continues on treatment|0|||
46617799|NCT00558896|82751275|FG003|Overall Study|Continues on treatment|1|||
46617800|NCT00558896|82751276|FG004|Overall Study|Continues on treatment|9|||
46617801|NCT00558896|82751277|FG005|Overall Study|Continues on treatment|25|||
46617802|NCT00558896|82751278|FG006|Overall Study|Continues on treatment|6|||
46617803|NCT00558428|82751412|FG000|Overall Study|Adverse Event|6|||
46617804|NCT00558428|82751413|FG001|Overall Study|Adverse Event|22|||
46617805|NCT00558428|82751414|FG002|Overall Study|Adverse Event|3|||
46617806|NCT00558428|82751415|FG003|Overall Study|Adverse Event|4|||
46617807|NCT00558428|82751412|FG000|Overall Study|Lost to Follow-up|0|||
46617808|NCT00558428|82751413|FG001|Overall Study|Lost to Follow-up|1|||
46617809|NCT00558428|82751414|FG002|Overall Study|Lost to Follow-up|0|||
46617810|NCT00558428|82751415|FG003|Overall Study|Lost to Follow-up|0|||
46617811|NCT00558428|82751412|FG000|Overall Study|Lack of Efficacy|0|||
46617812|NCT00558428|82751413|FG001|Overall Study|Lack of Efficacy|0|||
46617813|NCT00558428|82751414|FG002|Overall Study|Lack of Efficacy|1|||
46617814|NCT00558428|82751415|FG003|Overall Study|Lack of Efficacy|2|||
46617815|NCT00558428|82751412|FG000|Overall Study|Non compliant with protocol|1|||
46617816|NCT00558428|82751413|FG001|Overall Study|Non compliant with protocol|0|||
46617817|NCT00558428|82751414|FG002|Overall Study|Non compliant with protocol|0|||
46617818|NCT00558428|82751415|FG003|Overall Study|Non compliant with protocol|3|||
46617819|NCT00558428|82751412|FG000|Overall Study|Consent withdrawn|2|||
46617820|NCT00558428|82751413|FG001|Overall Study|Consent withdrawn|1|||
46617821|NCT00558428|82751414|FG002|Overall Study|Consent withdrawn|0|||
46617822|NCT00558428|82751415|FG003|Overall Study|Consent withdrawn|1|||
46617823|NCT00558428|82751412|FG000|Overall Study|Other|3|||
46617824|NCT00558428|82751413|FG001|Overall Study|Other|0|||
46617825|NCT00558428|82751414|FG002|Overall Study|Other|0|||
46617826|NCT00558428|82751415|FG003|Overall Study|Other|1|||
46617827|NCT00558272|82751454|FG000|Overall Study|Adverse Event|10|||
46617828|NCT00558272|82751455|FG001|Overall Study|Adverse Event|0|||
46617829|NCT00558272|82751454|FG000|Overall Study|Death|1|||
46617830|NCT00558272|82751455|FG001|Overall Study|Death|0|||
46617831|NCT00558272|82751454|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
46617832|NCT00558272|82751455|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
46617833|NCT00558272|82751454|FG000|Overall Study|AZ study team decision|0|||
46617834|NCT00558272|82751455|FG001|Overall Study|AZ study team decision|1|||
46617835|NCT00558272|82751454|FG000|Overall Study|Incorrectly enrolled|1|||
46617836|NCT00558272|82751455|FG001|Overall Study|Incorrectly enrolled|0|||
46617837|NCT00558272|82751454|FG000|Overall Study|Withdrawal by Subject|0|||
46617838|NCT00558272|82751455|FG001|Overall Study|Withdrawal by Subject|1|||
46617839|NCT00557492|82751600|FG000|Overall Study|Change in health insurance|1|||
46617840|NCT02354586|82751703|FG000|Overall Study|Death|230|||
46617841|NCT02354586|82751703|FG000|Overall Study|Withdrawal by Subject|59|||
46617842|NCT02354586|82751703|FG000|Overall Study|Lost to Follow-up|11|||
46617843|NCT02354586|82751703|FG000|Overall Study|Sponsor decision|51|||
46617844|NCT02354586|82751703|FG000|Overall Study|Site closure|2|||
46617845|NCT02354586|82751703|FG000|Overall Study|Intercurrent illness|1|||
46617846|NCT02354586|82751703|FG000|Overall Study|Protocol Violation|3|||
46617847|NCT02354586|82751703|FG000|Overall Study|Physician Decision|13|||
46617848|NCT02354586|82751703|FG000|Overall Study|Lack of Efficacy|86|||
46617849|NCT02354586|82751703|FG000|Overall Study|Adverse Event|7|||
46617850|NCT02332824|82751728|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
46617851|NCT02332824|82751729|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
46617852|NCT02332824|82751730|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
46617853|NCT02332824|82751731|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
46617854|NCT02332824|82751732|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
46617855|NCT02332824|82751733|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
46617856|NCT02332824|82751728|FG000|Overall Study|Voluntary Withdrawal|1|||
46617857|NCT02332824|82751729|FG001|Overall Study|Voluntary Withdrawal|0|||
46617858|NCT02332824|82751730|FG002|Overall Study|Voluntary Withdrawal|0|||
46617859|NCT02332824|82751731|FG003|Overall Study|Voluntary Withdrawal|0|||
46617860|NCT02332824|82751732|FG004|Overall Study|Voluntary Withdrawal|0|||
46617861|NCT02332824|82751733|FG005|Overall Study|Voluntary Withdrawal|0|||
46617862|NCT02332824|82751728|FG000|Overall Study|Inconvenient schedule|1|||
46617863|NCT02332824|82751729|FG001|Overall Study|Inconvenient schedule|1|||
46617864|NCT02332824|82751730|FG002|Overall Study|Inconvenient schedule|0|||
46617865|NCT02332824|82751731|FG003|Overall Study|Inconvenient schedule|0|||
46617866|NCT02332824|82751732|FG004|Overall Study|Inconvenient schedule|0|||
46617867|NCT02332824|82751733|FG005|Overall Study|Inconvenient schedule|0|||
46617868|NCT02332824|82751728|FG000|Overall Study|Transfer|0|||
46617869|NCT02332824|82751729|FG001|Overall Study|Transfer|0|||
46617870|NCT02332824|82751730|FG002|Overall Study|Transfer|1|||
46617871|NCT02332824|82751731|FG003|Overall Study|Transfer|1|||
46617872|NCT02332824|82751732|FG004|Overall Study|Transfer|0|||
46617873|NCT02332824|82751733|FG005|Overall Study|Transfer|0|||
46617874|NCT00556712|82751880|FG000|Overall Study|Adverse Event|7|||
46617875|NCT00556712|82751881|FG001|Overall Study|Adverse Event|19|||
46617876|NCT00556712|82751880|FG000|Overall Study|Death|5|||
46617877|NCT00556712|82751881|FG001|Overall Study|Death|10|||
46617878|NCT00556712|82751880|FG000|Overall Study|Progressive Disease|383|||
46617879|NCT00556712|82751881|FG001|Overall Study|Progressive Disease|320|||
46617880|NCT00556712|82751880|FG000|Overall Study|Protocol Violation|3|||
46617881|NCT00556712|82751881|FG001|Overall Study|Protocol Violation|2|||
46617882|NCT00556712|82751880|FG000|Overall Study|Refused Treatment|17|||
46617883|NCT00556712|82751881|FG001|Overall Study|Refused Treatment|16|||
46617884|NCT00556712|82751880|FG000|Overall Study|Failure to Return|2|||
46617885|NCT00556712|82751881|FG001|Overall Study|Failure to Return|3|||
46617886|NCT00556712|82751880|FG000|Overall Study|Other|2|||
46617887|NCT00556712|82751881|FG001|Overall Study|Other|2|||
46617888|NCT00556712|82751880|FG000|Overall Study|Ongoing at Data Cutoff|32|||
46617889|NCT00556712|82751881|FG001|Overall Study|Ongoing at Data Cutoff|66|||
46617890|NCT00556322|82751955|FG000|Overall Study|Insufficient therapeutic response|158|||
46617891|NCT00556322|82751956|FG001|Overall Study|Insufficient therapeutic response|168|||
46617892|NCT00556322|82751955|FG000|Overall Study|Adverse Event|7|||
46617893|NCT00556322|82751956|FG001|Overall Study|Adverse Event|4|||
46617894|NCT00556322|82751955|FG000|Overall Study|Other|4|||
46617895|NCT00556322|82751956|FG001|Overall Study|Other|1|||
46617896|NCT00556322|82751955|FG000|Overall Study|Lost to Follow-up|5|||
46617897|NCT00556322|82751956|FG001|Overall Study|Lost to Follow-up|3|||
46617898|NCT00556322|82751955|FG000|Overall Study|Withdrawal by Subject|19|||
46617899|NCT00556322|82751956|FG001|Overall Study|Withdrawal by Subject|7|||
46617900|NCT00556322|82751955|FG000|Overall Study|Protocol Violation|5|||
46617901|NCT00556322|82751956|FG001|Overall Study|Protocol Violation|1|||
46617902|NCT00556322|82751955|FG000|Overall Study|Ongoing at data cutoff|3|||
46617903|NCT00556322|82751956|FG001|Overall Study|Ongoing at data cutoff|5|||
46617904|NCT00556322|82751955|FG000|Overall Study|Death|20|||
46617905|NCT00556322|82751956|FG001|Overall Study|Death|14|||
46617906|NCT00556166|82751974|FG000|Overall Study|Withdrawal by Subject|1|||
46617907|NCT02332590|82752134|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
46617908|NCT02332590|82752135|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
46617909|NCT02332590|82752134|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
46617910|NCT02332590|82752135|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
46617911|NCT02332590|82752134|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
46617912|NCT02332590|82752135|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
46617913|NCT02332590|82752134|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
46617914|NCT02332590|82752135|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
46617915|NCT02332590|82752134|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
46617916|NCT02332590|82752135|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
46617917|NCT02332590|82752134|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
46617918|NCT02332590|82752135|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
46617919|NCT02332590|82752134|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
46617920|NCT02332590|82752135|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
46617921|NCT02332590|82752134|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
46617922|NCT02332590|82752135|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
46617923|NCT02332590|82752134|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
46617924|NCT02332590|82752135|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
46617925|NCT00554840|82752206|FG000|Overall Study|Physician Decision|0|||
46617926|NCT00554840|82752207|FG001|Overall Study|Physician Decision|1|||
46617927|NCT02302716|82752232|FG000|Overall Study|Adverse Event|1|||
46617928|NCT02302716|82752233|FG001|Overall Study|Adverse Event|1|||
46617929|NCT02302716|82752232|FG000|Overall Study|Death|0|||
46617930|NCT02302716|82752233|FG001|Overall Study|Death|1|||
46617931|NCT02302716|82752232|FG000|Overall Study|Lack of Efficacy|0|||
46617932|NCT02302716|82752233|FG001|Overall Study|Lack of Efficacy|1|||
46617933|NCT02302716|82752232|FG000|Overall Study|Lost to Follow-up|2|||
46617934|NCT02302716|82752233|FG001|Overall Study|Lost to Follow-up|4|||
46617935|NCT02302716|82752232|FG000|Overall Study|Physician Decision|3|||
46617936|NCT02302716|82752233|FG001|Overall Study|Physician Decision|4|||
46617937|NCT02302716|82752232|FG000|Overall Study|Withdrawal by Subject|13|||
46617938|NCT02302716|82752233|FG001|Overall Study|Withdrawal by Subject|7|||
46617939|NCT02302716|82752232|FG000|Overall Study|Protocol Violation|0|||
46617940|NCT02302716|82752233|FG001|Overall Study|Protocol Violation|1|||
46617941|NCT00554606|82752262|FG000|Overall Study|Adverse Event|3|||
46617942|NCT00554606|82752262|FG000|Overall Study|Abnormal laboratory values|1|||
46617943|NCT00554606|82752262|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
46617944|NCT00554606|82752262|FG000|Overall Study|Subject withdrew consent|2|||
46617945|NCT00554606|82752262|FG000|Overall Study|Lost to Follow-up|2|||
46617946|NCT00554606|82752262|FG000|Overall Study|Administrative problems|60|||
46617947|NCT00554606|82752262|FG000|Overall Study|Death|1|||
46617948|NCT00554606|82752262|FG000|Overall Study|Protocol deviation|2|||
46617949|NCT02354508|82752298|FG000|Period 1: Core Phase|Adverse Event|1|||
46617950|NCT02354508|82752299|FG001|Period 1: Core Phase|Adverse Event|1|||
46617951|NCT02354508|82752300|FG002|Period 1: Core Phase|Adverse Event|2|||
46617952|NCT02354508|82752298|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
46617953|NCT02354508|82752299|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
46617954|NCT02354508|82752300|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
46617955|NCT02354508|82752298|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
46617956|NCT02354508|82752299|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
46617957|NCT02354508|82752300|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
46617958|NCT02354508|82752298|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
46617959|NCT02354508|82752299|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
46617960|NCT02354508|82752300|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
46617961|NCT02354508|82752298|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
46617962|NCT02354508|82752299|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
46617963|NCT02354508|82752300|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
46617964|NCT02354508|82752298|FG000|Period 2: Extension Phase|Physician Decision|5|||
46617965|NCT02354508|82752299|FG001|Period 2: Extension Phase|Physician Decision|0|||
46617966|NCT02354508|82752300|FG002|Period 2: Extension Phase|Physician Decision|1|||
46617967|NCT02354508|82752298|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
46617968|NCT02354508|82752299|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
46617969|NCT02354508|82752300|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
46617970|NCT02354508|82752298|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
46617971|NCT02354508|82752299|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
46617972|NCT02354508|82752300|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
46617973|NCT02354508|82752298|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
46617974|NCT02354508|82752299|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
46617975|NCT02354508|82752300|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
46617976|NCT00554216|82752352|FG000|Overall Study|Lost to Follow-up|92|||
46617977|NCT00554216|82752353|FG001|Overall Study|Lost to Follow-up|31|||
46617978|NCT00554216|82752354|FG002|Overall Study|Lost to Follow-up|63|||
46617979|NCT00554216|82752352|FG000|Overall Study|Adverse Event|16|||
46617980|NCT00554216|82752353|FG001|Overall Study|Adverse Event|16|||
46617981|NCT00554216|82752354|FG002|Overall Study|Adverse Event|36|||
46617982|NCT00554216|82752352|FG000|Overall Study|Withdrawal by Subject|92|||
46617983|NCT00554216|82752353|FG001|Overall Study|Withdrawal by Subject|31|||
46617984|NCT00554216|82752354|FG002|Overall Study|Withdrawal by Subject|43|||
46617985|NCT00554216|82752352|FG000|Overall Study|Non compliance|10|||
46617986|NCT00554216|82752353|FG001|Overall Study|Non compliance|4|||
46617987|NCT00554216|82752354|FG002|Overall Study|Non compliance|5|||
46617988|NCT00554216|82752352|FG000|Overall Study|Pregnancy|2|||
46617989|NCT00554216|82752353|FG001|Overall Study|Pregnancy|1|||
46617990|NCT00554216|82752354|FG002|Overall Study|Pregnancy|14|||
46617991|NCT00554216|82752352|FG000|Overall Study|Restricted med|3|||
46617992|NCT00554216|82752353|FG001|Overall Study|Restricted med|1|||
46617993|NCT00554216|82752354|FG002|Overall Study|Restricted med|1|||
46617994|NCT00554216|82752352|FG000|Overall Study|Other|12|||
46617995|NCT00554216|82752353|FG001|Overall Study|Other|7|||
46617996|NCT00554216|82752354|FG002|Overall Study|Other|10|||
46617997|NCT00554216|82752352|FG000|Overall Study|Lack of Efficacy|15|||
46617998|NCT00554216|82752353|FG001|Overall Study|Lack of Efficacy|3|||
46617999|NCT00554216|82752354|FG002|Overall Study|Lack of Efficacy|0|||
46618000|NCT02353572|82752379|FG000|Overall Study|Withdrawal by Subject|1|||
46618001|NCT02353572|82752379|FG000|Overall Study|Study terminated|2|||
46618002|NCT00552578|82752391|FG000|Overall Study|Lost to Follow-up|1|||
46618003|NCT00552578|82752392|FG001|Overall Study|Lost to Follow-up|1|||
46618004|NCT02301936|82752400|FG000|Overall Study|Lost to Follow-up|1|||
46618005|NCT02301936|82752401|FG001|Overall Study|Lost to Follow-up|0|||
46618006|NCT00552344|82752440|FG000|Overall Study|Lack of Efficacy|55|||
46618007|NCT00552344|82752440|FG000|Overall Study|Loss of efficacy|75|||
46618008|NCT00552344|82752440|FG000|Overall Study|Lost to Follow-up|8|||
46618009|NCT00552344|82752440|FG000|Overall Study|Withdrawal by Subject|48|||
46618010|NCT00552344|82752440|FG000|Overall Study|SAE, non-fatal|6|||
46618011|NCT00552344|82752440|FG000|Overall Study|AE, non-serious non-fatal|38|||
46618012|NCT00552344|82752440|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
46618013|NCT00552344|82752440|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
46618014|NCT00552344|82752440|FG000|Overall Study|Other Reason|22|||
46618015|NCT00553514|82752477|FG000|Overall Study|Protocol deviation|0|||
46618016|NCT00553514|82752478|FG001|Overall Study|Protocol deviation|0|||
46618017|NCT00553514|82752479|FG002|Overall Study|Protocol deviation|0|||
46618018|NCT00553514|82752480|FG003|Overall Study|Protocol deviation|1|||
46618019|NCT00553514|82752481|FG004|Overall Study|Protocol deviation|0|||
46618020|NCT00553514|82752477|FG000|Overall Study|Lack of ovarian response|4|||
46618021|NCT00553514|82752478|FG001|Overall Study|Lack of ovarian response|5|||
46618022|NCT00553514|82752479|FG002|Overall Study|Lack of ovarian response|5|||
46618023|NCT00553514|82752480|FG003|Overall Study|Lack of ovarian response|5|||
46618024|NCT00553514|82752481|FG004|Overall Study|Lack of ovarian response|6|||
46618025|NCT00553514|82752477|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
46618026|NCT00553514|82752478|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
46618027|NCT00553514|82752479|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
46618028|NCT00553514|82752480|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
46618029|NCT00553514|82752481|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
46618030|NCT00553514|82752477|FG000|Overall Study|Risk of multiple pregnancy|0|||
46618031|NCT00553514|82752478|FG001|Overall Study|Risk of multiple pregnancy|2|||
46618032|NCT00553514|82752479|FG002|Overall Study|Risk of multiple pregnancy|0|||
46618033|NCT00553514|82752480|FG003|Overall Study|Risk of multiple pregnancy|1|||
46618034|NCT00553514|82752481|FG004|Overall Study|Risk of multiple pregnancy|0|||
46618035|NCT00553514|82752477|FG000|Overall Study|Other|1|||
46618036|NCT00553514|82752478|FG001|Overall Study|Other|1|||
46618037|NCT00553514|82752479|FG002|Overall Study|Other|0|||
46618038|NCT00553514|82752480|FG003|Overall Study|Other|0|||
46618039|NCT00553514|82752481|FG004|Overall Study|Other|1|||
46618040|NCT00553436|82752505|FG000|Overall Study|Conversion to another procedure|1|||
46618041|NCT00553202|82752536|FG000|Overall Study|Death|16|||
46618042|NCT00553202|82752536|FG000|Overall Study|Lost to Follow-up|1|||
46618043|NCT00553202|82752536|FG000|Overall Study|Physician Decision|28|||
46618044|NCT00553202|82752536|FG000|Overall Study|Withdrawal by Subject|1|||
46618045|NCT00553202|82752536|FG000|Overall Study|No donor identified|16|||
46618046|NCT00553202|82752536|FG000|Overall Study|Fails to meet organ function|6|||
46618047|NCT00552188|82752560|FG000|Overall Study|Adverse Event|0|||
46618048|NCT00552188|82752561|FG001|Overall Study|Adverse Event|2|||
46618049|NCT00552188|82752560|FG000|Overall Study|Lost to Follow-up|2|||
46618050|NCT00552188|82752561|FG001|Overall Study|Lost to Follow-up|1|||
46618051|NCT00552188|82752560|FG000|Overall Study|Withdrawal of consent|0|||
46618052|NCT00552188|82752561|FG001|Overall Study|Withdrawal of consent|1|||
46618053|NCT00552188|82752560|FG000|Overall Study|Subject returned to home country|0|||
46618054|NCT00552188|82752561|FG001|Overall Study|Subject returned to home country|1|||
46618055|NCT00552110|82752581|FG000|Overall Study|Serious or Life-Threatening AE|0|||
46618056|NCT00552110|82752582|FG001|Overall Study|Serious or Life-Threatening AE|0|||
46618057|NCT00552110|82752583|FG002|Overall Study|Serious or Life-Threatening AE|1|||
46618058|NCT00552110|82752584|FG003|Overall Study|Serious or Life-Threatening AE|0|||
46618059|NCT00552110|82752585|FG004|Overall Study|Serious or Life-Threatening AE|0|||
46708601|NCT01131078|82924258|FG001|Overall Study|Lost to Follow-up|1|||
46708602|NCT01131078|82924259|FG002|Overall Study|Lost to Follow-up|1|||
46708603|NCT01131078|82924257|FG000|Overall Study|Withdrawal by Subject|2|||
46708604|NCT01131078|82924258|FG001|Overall Study|Withdrawal by Subject|4|||
46708605|NCT01131078|82924259|FG002|Overall Study|Withdrawal by Subject|3|||
46708606|NCT01131078|82924257|FG000|Overall Study|Non-compliance|3|||
46708607|NCT01131078|82924258|FG001|Overall Study|Non-compliance|0|||
46708608|NCT01131078|82924259|FG002|Overall Study|Non-compliance|0|||
46618060|NCT00552110|82752581|FG000|Overall Study|Lack of Efficacy|1|||
46618061|NCT00552110|82752582|FG001|Overall Study|Lack of Efficacy|0|||
46618062|NCT00552110|82752583|FG002|Overall Study|Lack of Efficacy|0|||
46618063|NCT00552110|82752584|FG003|Overall Study|Lack of Efficacy|1|||
46618064|NCT00552110|82752585|FG004|Overall Study|Lack of Efficacy|4|||
46618065|NCT00552110|82752581|FG000|Overall Study|Withdrawal by Subject|0|||
46618066|NCT00552110|82752582|FG001|Overall Study|Withdrawal by Subject|2|||
46618067|NCT00552110|82752583|FG002|Overall Study|Withdrawal by Subject|0|||
46618068|NCT00552110|82752584|FG003|Overall Study|Withdrawal by Subject|3|||
46708609|NCT01131078|82924257|FG000|Overall Study|Physician Decision|10|||
46708610|NCT01131078|82924258|FG001|Overall Study|Physician Decision|6|||
46708611|NCT01131078|82924259|FG002|Overall Study|Physician Decision|8|||
46708612|NCT01131078|82924257|FG000|Overall Study|Death|4|||
46708613|NCT01131078|82924258|FG001|Overall Study|Death|0|||
46708614|NCT01131078|82924259|FG002|Overall Study|Death|2|||
46708615|NCT01131078|82924257|FG000|Overall Study|Other|0|||
46708616|NCT01131078|82924258|FG001|Overall Study|Other|1|||
46618069|NCT00552110|82752585|FG004|Overall Study|Withdrawal by Subject|2|||
46618070|NCT00552110|82752581|FG000|Overall Study|Lost to Follow-up|0|||
46618071|NCT00552110|82752582|FG001|Overall Study|Lost to Follow-up|0|||
46618072|NCT00552110|82752583|FG002|Overall Study|Lost to Follow-up|0|||
46618073|NCT00552110|82752584|FG003|Overall Study|Lost to Follow-up|1|||
46618074|NCT00552110|82752585|FG004|Overall Study|Lost to Follow-up|1|||
46708617|NCT01131078|82924259|FG002|Overall Study|Other|0|||
46618075|NCT00552110|82752581|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
46618076|NCT00552110|82752582|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
46618077|NCT00552110|82752583|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
46618078|NCT00552110|82752584|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
46618079|NCT00552110|82752585|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
46618080|NCT00552110|82752581|FG000|Overall Study|Withdrawn per Sponsor|0|||
46618081|NCT00552110|82752582|FG001|Overall Study|Withdrawn per Sponsor|1|||
46618082|NCT00552110|82752583|FG002|Overall Study|Withdrawn per Sponsor|0|||
46618083|NCT00552110|82752584|FG003|Overall Study|Withdrawn per Sponsor|0|||
46618084|NCT00552110|82752585|FG004|Overall Study|Withdrawn per Sponsor|1|||
46618085|NCT00552110|82752581|FG000|Overall Study|Use of Prohibited Medication|1|||
46618086|NCT00552110|82752582|FG001|Overall Study|Use of Prohibited Medication|1|||
46618087|NCT00552110|82752583|FG002|Overall Study|Use of Prohibited Medication|0|||
46618088|NCT00552110|82752584|FG003|Overall Study|Use of Prohibited Medication|0|||
46618089|NCT00552110|82752585|FG004|Overall Study|Use of Prohibited Medication|0|||
46618090|NCT00552110|82752581|FG000|Overall Study|Delay of Study due to Relabeling|0|||
46618091|NCT00552110|82752582|FG001|Overall Study|Delay of Study due to Relabeling|0|||
46618092|NCT00552110|82752583|FG002|Overall Study|Delay of Study due to Relabeling|0|||
46618093|NCT00552110|82752584|FG003|Overall Study|Delay of Study due to Relabeling|1|||
46618094|NCT00552110|82752585|FG004|Overall Study|Delay of Study due to Relabeling|0|||
46618095|NCT00552110|82752581|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
46618096|NCT00552110|82752582|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
46618097|NCT00552110|82752583|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
46618098|NCT00552110|82752584|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
46618099|NCT00552110|82752585|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
46618100|NCT00552110|82752581|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
46618101|NCT00552110|82752582|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
46618102|NCT00552110|82752583|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
46618103|NCT00552110|82752584|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
46618104|NCT00552110|82752585|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
46618105|NCT02301624|82752608|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
46618106|NCT02301624|82752609|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
46618107|NCT02301624|82752608|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
46618108|NCT02301624|82752609|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
46618109|NCT02301624|82752608|FG000|Open-label Maintenance Phase|Adverse Event|2|||
46618110|NCT02301624|82752609|FG001|Open-label Maintenance Phase|Adverse Event|5|||
46618111|NCT02301624|82752608|FG000|Open-label Maintenance Phase|Physician Decision|3|||
46618112|NCT02301624|82752609|FG001|Open-label Maintenance Phase|Physician Decision|3|||
46618113|NCT02301624|82752608|FG000|Open-label Maintenance Phase|Death|2|||
46618114|NCT02301624|82752609|FG001|Open-label Maintenance Phase|Death|1|||
46618115|NCT02301624|82752608|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
46618116|NCT02301624|82752609|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
46618117|NCT02301546|82752650|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
46708618|NCT01167582|82924271|FG000|Overall Study|Lost to Follow-up|0|||
46708619|NCT01167582|82924272|FG001|Overall Study|Lost to Follow-up|1|||
46708620|NCT01167426|82924278|FG000|Overall Study|Lost to Follow-up|6|||
46708621|NCT01167426|82924278|FG000|Overall Study|Protocol Violation|1|||
46708622|NCT01167426|82924278|FG000|Overall Study|Withdrawal by Subject|2|||
46708623|NCT01167426|82924278|FG000|Overall Study|Sponsor Decision|1|||
46708624|NCT00922636|82924288|FG000|Overall Study|Adverse Event|3|||
46618118|NCT02301546|82752651|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
46618119|NCT02301546|82752650|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
46618120|NCT02301546|82752651|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
46618121|NCT02301546|82752650|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
46618122|NCT02301546|82752651|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
46618123|NCT02301546|82752650|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
46618124|NCT02301546|82752651|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
46618125|NCT02301546|82752650|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
46618126|NCT02301546|82752651|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
46618127|NCT02301546|82752650|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
46618128|NCT02301546|82752651|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
46618129|NCT02301546|82752650|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
46618130|NCT02301546|82752651|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
46618131|NCT02351934|82752675|FG000|Allocation|POD weight<pre-op weight|3|||
46708625|NCT00922636|82924289|FG001|Overall Study|Adverse Event|3|||
46618132|NCT02351934|82752676|FG001|Allocation|POD weight<pre-op weight|0|||
46708626|NCT00922636|82924290|FG002|Overall Study|Adverse Event|2|||
46618133|NCT02351934|82752675|FG000|Allocation|Hypotension preventing administration|2|||
46708627|NCT00922636|82924291|FG003|Overall Study|Adverse Event|3|||
46708628|NCT00922636|82924292|FG004|Overall Study|Adverse Event|2|||
46708629|NCT00922636|82924288|FG000|Overall Study|Lack of Efficacy|1|||
46708630|NCT00922636|82924289|FG001|Overall Study|Lack of Efficacy|7|||
46708631|NCT00922636|82924290|FG002|Overall Study|Lack of Efficacy|3|||
46708632|NCT00922636|82924291|FG003|Overall Study|Lack of Efficacy|2|||
46618134|NCT02351934|82752676|FG001|Allocation|Hypotension preventing administration|0|||
46618135|NCT02351934|82752675|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
46708633|NCT00922636|82924292|FG004|Overall Study|Lack of Efficacy|4|||
46618136|NCT02351934|82752676|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
46618137|NCT02351934|82752675|FG000|Follow-Up|POD weight<pre-op weight|3|||
46618138|NCT02351934|82752676|FG001|Follow-Up|POD weight<pre-op weight|0|||
46618139|NCT02351934|82752675|FG000|Follow-Up|Acute Kidney Injury|1|||
46618140|NCT02351934|82752676|FG001|Follow-Up|Acute Kidney Injury|0|||
46618141|NCT02351934|82752675|FG000|Follow-Up|Early dismissal|3|||
46618142|NCT02351934|82752676|FG001|Follow-Up|Early dismissal|0|||
46708634|NCT00922636|82924288|FG000|Overall Study|Sponsor Decision|0|||
46708635|NCT00922636|82924289|FG001|Overall Study|Sponsor Decision|0|||
46708636|NCT00922636|82924290|FG002|Overall Study|Sponsor Decision|2|||
46708637|NCT00922636|82924291|FG003|Overall Study|Sponsor Decision|0|||
46708638|NCT00922636|82924292|FG004|Overall Study|Sponsor Decision|0|||
46708639|NCT00922636|82924288|FG000|Overall Study|Withdrawal by Subject|0|||
46708640|NCT00922636|82924289|FG001|Overall Study|Withdrawal by Subject|0|||
46708641|NCT00922636|82924290|FG002|Overall Study|Withdrawal by Subject|5|||
46708642|NCT00922636|82924291|FG003|Overall Study|Withdrawal by Subject|2|||
46708643|NCT00922636|82924292|FG004|Overall Study|Withdrawal by Subject|4|||
46708644|NCT00922636|82924288|FG000|Overall Study|Protocol Violation|0|||
46708645|NCT00922636|82924289|FG001|Overall Study|Protocol Violation|0|||
46708646|NCT00922636|82924290|FG002|Overall Study|Protocol Violation|2|||
46708647|NCT00922636|82924291|FG003|Overall Study|Protocol Violation|2|||
46708648|NCT00922636|82924292|FG004|Overall Study|Protocol Violation|0|||
46708649|NCT00922636|82924288|FG000|Overall Study|Entry Criteria Not Met|0|||
46708650|NCT00922636|82924289|FG001|Overall Study|Entry Criteria Not Met|0|||
46708651|NCT00922636|82924290|FG002|Overall Study|Entry Criteria Not Met|1|||
46708652|NCT00922636|82924291|FG003|Overall Study|Entry Criteria Not Met|1|||
46708653|NCT00922636|82924292|FG004|Overall Study|Entry Criteria Not Met|0|||
46708654|NCT00922636|82924288|FG000|Overall Study|Parent/Caregiver Decision|2|||
46708655|NCT00922636|82924289|FG001|Overall Study|Parent/Caregiver Decision|4|||
46708656|NCT00922636|82924290|FG002|Overall Study|Parent/Caregiver Decision|3|||
46708657|NCT00922636|82924291|FG003|Overall Study|Parent/Caregiver Decision|5|||
46708658|NCT00922636|82924292|FG004|Overall Study|Parent/Caregiver Decision|2|||
46708659|NCT00922636|82924288|FG000|Overall Study|Lost to Follow-up|1|||
46708660|NCT00922636|82924289|FG001|Overall Study|Lost to Follow-up|2|||
46708661|NCT00922636|82924290|FG002|Overall Study|Lost to Follow-up|2|||
46708662|NCT00922636|82924291|FG003|Overall Study|Lost to Follow-up|2|||
46708663|NCT00922636|82924292|FG004|Overall Study|Lost to Follow-up|4|||
46708664|NCT01175135|82924313|FG000|Overall Study|Adverse Event|2|||
46708665|NCT01175135|82924314|FG001|Overall Study|Adverse Event|5|||
46708666|NCT01175135|82924315|FG002|Overall Study|Adverse Event|3|||
46708667|NCT01175135|82924316|FG003|Overall Study|Adverse Event|4|||
46708668|NCT01175135|82924313|FG000|Overall Study|Death|1|||
46708669|NCT01175135|82924314|FG001|Overall Study|Death|0|||
46708670|NCT01175135|82924315|FG002|Overall Study|Death|0|||
46708671|NCT01175135|82924316|FG003|Overall Study|Death|0|||
46708672|NCT01175135|82924313|FG000|Overall Study|Lack of Efficacy|4|||
46708673|NCT01175135|82924314|FG001|Overall Study|Lack of Efficacy|5|||
46708674|NCT01175135|82924315|FG002|Overall Study|Lack of Efficacy|0|||
46708675|NCT01175135|82924316|FG003|Overall Study|Lack of Efficacy|5|||
46708676|NCT01175135|82924313|FG000|Overall Study|Lost to Follow-up|1|||
46708677|NCT01175135|82924314|FG001|Overall Study|Lost to Follow-up|2|||
46708678|NCT01175135|82924315|FG002|Overall Study|Lost to Follow-up|0|||
46708679|NCT01175135|82924316|FG003|Overall Study|Lost to Follow-up|0|||
46708680|NCT01175135|82924313|FG000|Overall Study|Protocol Violation|1|||
46708681|NCT01175135|82924314|FG001|Overall Study|Protocol Violation|1|||
46708682|NCT01175135|82924315|FG002|Overall Study|Protocol Violation|0|||
46618143|NCT02351934|82752675|FG000|Follow-Up|Hypotension|3|||
46708683|NCT01175135|82924316|FG003|Overall Study|Protocol Violation|0|||
46618144|NCT02351934|82752676|FG001|Follow-Up|Hypotension|0|||
46618145|NCT02351934|82752675|FG000|Follow-Up|No documentation|2|||
46618146|NCT02351934|82752676|FG001|Follow-Up|No documentation|0|||
46618147|NCT02351934|82752675|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
46708684|NCT01175135|82924313|FG000|Overall Study|Withdrawal by Subject|4|||
46708685|NCT01175135|82924314|FG001|Overall Study|Withdrawal by Subject|8|||
46708686|NCT01175135|82924315|FG002|Overall Study|Withdrawal by Subject|5|||
46708687|NCT01175135|82924316|FG003|Overall Study|Withdrawal by Subject|5|||
46708688|NCT01175135|82924313|FG000|Overall Study|Other|3|||
46618148|NCT02351934|82752676|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
46618149|NCT02351934|82752675|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
46708689|NCT01175135|82924314|FG001|Overall Study|Other|1|||
46708690|NCT01175135|82924315|FG002|Overall Study|Other|3|||
46708691|NCT01175135|82924316|FG003|Overall Study|Other|0|||
46618150|NCT02351934|82752676|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
46618151|NCT02351856|82752716|FG000|Overall Study|Adverse Event|2|||
46618152|NCT02351856|82752716|FG000|Overall Study|Physician Decision|5|||
46618153|NCT02351856|82752716|FG000|Overall Study|Study terminated by sponsor|1|||
46618154|NCT02349360|82752756|FG000|Overall Study|Withdrawal by Subject|0|||
46618155|NCT02349360|82752757|FG001|Overall Study|Withdrawal by Subject|1|||
46618156|NCT00551642|82752782|FG000|Treatment Period|Protocol Deviation|6|||
46618157|NCT00551642|82752783|FG001|Treatment Period|Protocol Deviation|11|||
46618158|NCT00551642|82752782|FG000|Treatment Period|Delivery device failure|1|||
46618159|NCT00551642|82752783|FG001|Treatment Period|Delivery device failure|3|||
46618160|NCT00551642|82752782|FG000|Treatment Period|Physician Decision|0|||
46618161|NCT00551642|82752783|FG001|Treatment Period|Physician Decision|1|||
46618162|NCT00551642|82752782|FG000|Treatment Period|Death|33|||
46618163|NCT00551642|82752783|FG001|Treatment Period|Death|31|||
46618164|NCT00551642|82752782|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
46618165|NCT00551642|82752783|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
46618166|NCT00551642|82752782|FG000|Treatment Period|Adverse Event|15|||
46618167|NCT00551642|82752783|FG001|Treatment Period|Adverse Event|12|||
46618168|NCT00551642|82752782|FG000|Treatment Period|Withdrawal by Subject|2|||
46618169|NCT00551642|82752783|FG001|Treatment Period|Withdrawal by Subject|1|||
46618170|NCT00550550|82752868|FG000|Overall Study|Adverse Event|13|||
46618171|NCT00550550|82752869|FG001|Overall Study|Adverse Event|5|||
46618172|NCT00550550|82752868|FG000|Overall Study|Treatment Failure|0|||
46618173|NCT00550550|82752869|FG001|Overall Study|Treatment Failure|1|||
46618174|NCT00550550|82752868|FG000|Overall Study|Lost to Follow-up|4|||
46618175|NCT00550550|82752869|FG001|Overall Study|Lost to Follow-up|0|||
46618176|NCT00550550|82752868|FG000|Overall Study|Withdrawal by Subject|10|||
46618177|NCT00550550|82752869|FG001|Overall Study|Withdrawal by Subject|8|||
46618178|NCT00550550|82752868|FG000|Overall Study|Protocol Violation|5|||
46618179|NCT00550550|82752869|FG001|Overall Study|Protocol Violation|14|||
46618180|NCT00550550|82752868|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
46618181|NCT00550550|82752869|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
46618182|NCT00550550|82752868|FG000|Overall Study|Randomized But Not Treated|1|||
46618183|NCT00550550|82752869|FG001|Overall Study|Randomized But Not Treated|0|||
46618184|NCT02301156|82752920|FG000|Overall Study|Adverse Event|13|||
46618185|NCT02301156|82752921|FG001|Overall Study|Adverse Event|14|||
46618186|NCT02301156|82752920|FG000|Overall Study|Death|1|||
46618187|NCT02301156|82752921|FG001|Overall Study|Death|5|||
46618188|NCT02301156|82752920|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
46618189|NCT02301156|82752921|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
46618190|NCT02301156|82752920|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
46618191|NCT02301156|82752921|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
46618192|NCT02301156|82752920|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
46618193|NCT02301156|82752921|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
46618194|NCT02301156|82752920|FG000|Overall Study|Reason not Specified|6|||
46618195|NCT02301156|82752921|FG001|Overall Study|Reason not Specified|3|||
46618196|NCT02301390|82753002|FG000|Overall Study|Withdrawal by Subject|3|||
46618197|NCT02301390|82753003|FG001|Overall Study|Withdrawal by Subject|5|||
46618198|NCT02301390|82753002|FG000|Overall Study|Protocol Violation|1|||
46618199|NCT02301390|82753003|FG001|Overall Study|Protocol Violation|0|||
46618200|NCT02301390|82753002|FG000|Overall Study|Physician Decision|1|||
46618201|NCT02301390|82753003|FG001|Overall Study|Physician Decision|0|||
46618202|NCT02301390|82753002|FG000|Overall Study|Lost to Follow-up|0|||
46618203|NCT02301390|82753003|FG001|Overall Study|Lost to Follow-up|1|||
46618204|NCT02301390|82753002|FG000|Overall Study|Death|2|||
46618205|NCT02301390|82753003|FG001|Overall Study|Death|2|||
46618206|NCT02301390|82753002|FG000|Overall Study|Procedure not completed|0|||
46618207|NCT02301390|82753003|FG001|Overall Study|Procedure not completed|4|||
46618208|NCT02301390|82753002|FG000|Overall Study|Missed multiple visits|1|||
46618209|NCT02301390|82753003|FG001|Overall Study|Missed multiple visits|1|||
46618210|NCT02301390|82753002|FG000|Overall Study|study terminated|2|||
46708692|NCT01175135|82924313|FG000|Overall Study|Randomized But Not Treated|0|||
46618211|NCT02301390|82753003|FG001|Overall Study|study terminated|0|||
46618212|NCT02300610|82753120|FG000|Overall Study|Withdrawal by Subject|1|||
46618213|NCT02300610|82753121|FG001|Overall Study|Withdrawal by Subject|0|||
46618214|NCT02300610|82753122|FG002|Overall Study|Withdrawal by Subject|1|||
46618215|NCT02300298|82753167|FG000|Disposition for Nintedanib|Progressive disease|10|||
46618216|NCT02300298|82753168|FG001|Disposition for Nintedanib|Progressive disease|0|||
46618217|NCT02300298|82753167|FG000|Disposition for Docetaxel|Progressive disease|0|||
46618218|NCT02300298|82753168|FG001|Disposition for Docetaxel|Progressive disease|6|||
46618219|NCT02300298|82753167|FG000|Disposition for Docetaxel|other adverse event|0|||
46618220|NCT02300298|82753168|FG001|Disposition for Docetaxel|other adverse event|4|||
46618221|NCT02300220|82753174|FG000|Overall Study|Lost to Follow-up|1|||
46618222|NCT02300220|82753175|FG001|Overall Study|Lost to Follow-up|2|||
46618223|NCT02300220|82753174|FG000|Overall Study|Death|1|||
46708693|NCT01175135|82924314|FG001|Overall Study|Randomized But Not Treated|0|||
46708694|NCT01175135|82924315|FG002|Overall Study|Randomized But Not Treated|1|||
46708695|NCT01175135|82924316|FG003|Overall Study|Randomized But Not Treated|0|||
46708696|NCT00922480|82924328|FG000|Main Study|Protocol Violation|3|||
46708697|NCT00922480|82924329|FG001|Main Study|Protocol Violation|6|||
46708698|NCT00922480|82924328|FG000|Main Study|Adverse Event|6|||
46708699|NCT00922480|82924329|FG001|Main Study|Adverse Event|7|||
46708700|NCT00922480|82924328|FG000|Main Study|Lack of Efficacy|3|||
46708701|NCT00922480|82924329|FG001|Main Study|Lack of Efficacy|0|||
46708702|NCT00922480|82924328|FG000|Main Study|Withdrawal by Subject|20|||
46708703|NCT00922480|82924329|FG001|Main Study|Withdrawal by Subject|15|||
46708704|NCT00922480|82924328|FG000|Main Study|Lost to Follow-up|5|||
46708705|NCT00922480|82924329|FG001|Main Study|Lost to Follow-up|0|||
46708706|NCT00922480|82924328|FG000|Main Study|Physician Decision|0|||
46708707|NCT00922480|82924329|FG001|Main Study|Physician Decision|1|||
46708708|NCT00922480|82924328|FG000|Extension Study|Protocol Violation|3|||
46708709|NCT00922480|82924329|FG001|Extension Study|Protocol Violation|0|||
46708710|NCT00922480|82924328|FG000|Extension Study|Adverse Event|1|||
46708711|NCT00922480|82924329|FG001|Extension Study|Adverse Event|1|||
46708712|NCT00922480|82924328|FG000|Extension Study|Withdrawal by Subject|1|||
46708713|NCT00922480|82924329|FG001|Extension Study|Withdrawal by Subject|1|||
46708714|NCT00922480|82924328|FG000|Extension Study|Others|0|||
46708715|NCT00922480|82924329|FG001|Extension Study|Others|1|||
46708716|NCT00973479|82924339|FG000|Overall Study|Lost to Follow-up|0|||
46708717|NCT00973479|82924340|FG001|Overall Study|Lost to Follow-up|3|||
46708718|NCT00973479|82924339|FG000|Overall Study|Death|2|||
46708719|NCT00973479|82924340|FG001|Overall Study|Death|2|||
46708720|NCT00973479|82924339|FG000|Overall Study|Withdrawal by Subject|15|||
46708721|NCT00973479|82924340|FG001|Overall Study|Withdrawal by Subject|16|||
46708722|NCT00973479|82924339|FG000|Overall Study|Lack of Efficacy|5|||
46708723|NCT00973479|82924340|FG001|Overall Study|Lack of Efficacy|7|||
46708724|NCT00973479|82924339|FG000|Overall Study|Adverse Event|12|||
46708725|NCT00973479|82924340|FG001|Overall Study|Adverse Event|32|||
46708726|NCT00973479|82924339|FG000|Overall Study|Protocol Violation|2|||
46708727|NCT00973479|82924340|FG001|Overall Study|Protocol Violation|2|||
46708728|NCT00973479|82924339|FG000|Overall Study|Other|1|||
46708729|NCT00973479|82924340|FG001|Overall Study|Other|7|||
46708730|NCT01173653|82924350|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
46708731|NCT01173653|82924351|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
46708732|NCT01172873|82924359|FG000|Overall Study|Withdrawal by Subject|3|||
46708733|NCT01172873|82924360|FG001|Overall Study|Withdrawal by Subject|2|||
46708734|NCT04995419|82924405|FG000|Overall Study|Withdrawal by Subject|3|||
46708735|NCT04995419|82924405|FG000|Overall Study|Progressive Disease|19|||
46708736|NCT04995419|82924405|FG000|Overall Study|Adverse Event|2|||
46708737|NCT04995419|82924405|FG000|Overall Study|Ongoing|16|||
46708738|NCT04934722|82924411|FG000|Overall Study|Death|4|||
46708739|NCT04934722|82924412|FG001|Overall Study|Death|3|||
46708740|NCT04934722|82924411|FG000|Overall Study|Participants Ongoing|88|||
46708741|NCT04934722|82924412|FG001|Overall Study|Participants Ongoing|91|||
46708742|NCT04786210|82924442|FG000|Overall Study|Lost to Follow-up|2|||
46708743|NCT04786210|82924442|FG000|Overall Study|Withdrawal by Subject|4|||
46708744|NCT04439266|82924542|FG000|Overall Study|Ineligible|1|||
46708745|NCT04439266|82924542|FG000|Overall Study|Adverse Event|1|||
46708746|NCT04439266|82924542|FG000|Overall Study|Death|1|||
46708747|NCT04439266|82924542|FG000|Overall Study|Disease progression|1|||
46708748|NCT04439266|82924542|FG000|Overall Study|Still on treatment|1|||
46708749|NCT04439253|82924546|FG000|Overall Study|Adverse Event|1|||
46708750|NCT04439253|82924546|FG000|Overall Study|Disease progression|2|||
46708751|NCT04439253|82924546|FG000|Overall Study|Complicating disease|1|||
46708752|NCT04248829|82924590|FG000|Overall Study|Disease progression|44|||
46708753|NCT04248829|82924591|FG001|Overall Study|Disease progression|109|||
46708754|NCT04248829|82924590|FG000|Overall Study|Adverse Event|19|||
46708755|NCT04248829|82924591|FG001|Overall Study|Adverse Event|18|||
46708756|NCT04248829|82924590|FG000|Overall Study|Withdrawal by Subject|11|||
46708757|NCT04248829|82924591|FG001|Overall Study|Withdrawal by Subject|2|||
46708758|NCT04248829|82924590|FG000|Overall Study|Lost to Follow-up|0|||
46708759|NCT04248829|82924591|FG001|Overall Study|Lost to Follow-up|1|||
46708760|NCT04248829|82924590|FG000|Overall Study|Death|12|||
46708761|NCT04248829|82924591|FG001|Overall Study|Death|14|||
46708762|NCT04248829|82924590|FG000|Overall Study|Physician Decision|2|||
46708763|NCT04248829|82924591|FG001|Overall Study|Physician Decision|4|||
46708764|NCT04248829|82924590|FG000|Overall Study|Any reason not specifically recorded|0|||
46708765|NCT04248829|82924591|FG001|Overall Study|Any reason not specifically recorded|2|||
46708766|NCT04225039|82924601|FG000|Overall Study|Withdrawal by Subject|1|||
46708767|NCT04225039|82924602|FG001|Overall Study|Withdrawal by Subject|0|||
46708768|NCT04225039|82924603|FG002|Overall Study|Withdrawal by Subject|0|||
46708769|NCT04225039|82924604|FG003|Overall Study|Withdrawal by Subject|1|||
46708770|NCT04225039|82924601|FG000|Overall Study|Currently active on study treatment|0|||
46708771|NCT04225039|82924602|FG001|Overall Study|Currently active on study treatment|1|||
46775674|NCT00694707|82994140|FG004|Overall Study|Death in the Family|0|||
46708772|NCT04225039|82924603|FG002|Overall Study|Currently active on study treatment|0|||
46708773|NCT04225039|82924604|FG003|Overall Study|Currently active on study treatment|0|||
46708774|NCT04225039|82924601|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
46708775|NCT04225039|82924602|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
46708776|NCT04225039|82924603|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
46708777|NCT04225039|82924604|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
46708778|NCT04225039|82924601|FG000|Overall Study|Ineligible for treatment|0|||
46708779|NCT04225039|82924602|FG001|Overall Study|Ineligible for treatment|0|||
46708780|NCT04225039|82924603|FG002|Overall Study|Ineligible for treatment|0|||
46708781|NCT04225039|82924604|FG003|Overall Study|Ineligible for treatment|4|||
46708782|NCT04194645|82924636|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708783|NCT04194645|82924637|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708784|NCT04194645|82924638|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708785|NCT04194645|82924639|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708786|NCT04194645|82924640|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708787|NCT04194645|82924641|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708788|NCT04194645|82924642|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708789|NCT04194645|82924643|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708790|NCT04194645|82924644|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708791|NCT04194645|82924645|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
46708792|NCT04194645|82924646|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708793|NCT04194645|82924647|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708794|NCT04194645|82924648|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708795|NCT04194645|82924649|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708796|NCT04194645|82924650|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
46708797|NCT04179032|82924688|FG000|Part B (Up to Week 52)|Adverse Event|1|||
46708798|NCT04179032|82924688|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
46708799|NCT04179032|82924688|FG000|Access Extension Phase|Ongoing|11|||
46708800|NCT04126031|82924698|FG000|Part A|Withdrawal by Subject|0|||
46708801|NCT04126031|82924699|FG001|Part A|Withdrawal by Subject|0|||
46708802|NCT04126031|82924700|FG002|Part A|Withdrawal by Subject|1|||
46708803|NCT04126031|82924701|FG003|Part A|Withdrawal by Subject|0|||
46708804|NCT04126031|82924702|FG004|Part A|Withdrawal by Subject|0|||
46708805|NCT04126031|82924703|FG005|Part A|Withdrawal by Subject|0|||
46708806|NCT04126031|82924698|FG000|Part A|Other|1|||
46708807|NCT04126031|82924699|FG001|Part A|Other|0|||
46708808|NCT04126031|82924700|FG002|Part A|Other|0|||
46708809|NCT04126031|82924701|FG003|Part A|Other|0|||
46708810|NCT04126031|82924702|FG004|Part A|Other|0|||
46708811|NCT04126031|82924703|FG005|Part A|Other|0|||
46708812|NCT04126031|82924698|FG000|Part B|Adverse Event|0|||
46708813|NCT04126031|82924699|FG001|Part B|Adverse Event|0|||
46708814|NCT04126031|82924700|FG002|Part B|Adverse Event|0|||
46708815|NCT04126031|82924701|FG003|Part B|Adverse Event|0|||
46708816|NCT04126031|82924702|FG004|Part B|Adverse Event|0|||
46708817|NCT04126031|82924703|FG005|Part B|Adverse Event|2|||
46708818|NCT04126031|82924698|FG000|Part B|Pre-existing hypertransaminasemia|0|||
46708819|NCT04126031|82924699|FG001|Part B|Pre-existing hypertransaminasemia|0|||
46708820|NCT04126031|82924700|FG002|Part B|Pre-existing hypertransaminasemia|0|||
46708821|NCT04126031|82924701|FG003|Part B|Pre-existing hypertransaminasemia|0|||
46708822|NCT04126031|82924702|FG004|Part B|Pre-existing hypertransaminasemia|1|||
46708823|NCT04126031|82924703|FG005|Part B|Pre-existing hypertransaminasemia|0|||
46708824|NCT04117347|82924720|FG000|Overall Study|Adverse Event|0|||
46803381|NCT00541866|83022685|FG002|Overall Study|Adverse Event|0|||
46803382|NCT00541866|83022686|FG003|Overall Study|Adverse Event|0|||
46803383|NCT00541866|83022687|FG004|Overall Study|Adverse Event|0|||
46803384|NCT00541866|83022683|FG000|Overall Study|Death|1|||
46803385|NCT00541866|83022684|FG001|Overall Study|Death|0|||
46803386|NCT00541866|83022685|FG002|Overall Study|Death|0|||
46803387|NCT00541866|83022686|FG003|Overall Study|Death|0|||
46803388|NCT00541866|83022687|FG004|Overall Study|Death|0|||
46803389|NCT00541866|83022683|FG000|Overall Study|Lack of Efficacy|19|||
46803390|NCT00541866|83022684|FG001|Overall Study|Lack of Efficacy|15|||
46803391|NCT00541866|83022685|FG002|Overall Study|Lack of Efficacy|10|||
46803392|NCT00541866|83022686|FG003|Overall Study|Lack of Efficacy|12|||
46803393|NCT00541866|83022687|FG004|Overall Study|Lack of Efficacy|14|||
46803394|NCT00541866|83022683|FG000|Overall Study|Not Reported or Other|11|||
46803395|NCT00541866|83022684|FG001|Overall Study|Not Reported or Other|3|||
46803396|NCT00541866|83022685|FG002|Overall Study|Not Reported or Other|3|||
46803397|NCT00541866|83022686|FG003|Overall Study|Not Reported or Other|3|||
46803398|NCT00541866|83022687|FG004|Overall Study|Not Reported or Other|1|||
46803399|NCT00541866|83022683|FG000|Overall Study|Physician Decision|0|||
46803400|NCT00541866|83022684|FG001|Overall Study|Physician Decision|0|||
46803401|NCT00541866|83022685|FG002|Overall Study|Physician Decision|2|||
46803402|NCT00541866|83022686|FG003|Overall Study|Physician Decision|1|||
46803403|NCT00541866|83022687|FG004|Overall Study|Physician Decision|0|||
46803404|NCT00493467|83022715|FG000|Overall Study|Death|1|||
46803405|NCT00090493|83022719|FG000|Overall Study|Physician Decision|2|||
46803406|NCT04329702|83022726|FG000|Overall Study|illness|3|||
46803407|NCT04329702|83022727|FG001|Overall Study|illness|4|||
46803408|NCT04329702|83022728|FG002|Overall Study|illness|0|||
46803409|NCT04329702|83022726|FG000|Overall Study|Lost to Follow-up|0|||
46803410|NCT04329702|83022727|FG001|Overall Study|Lost to Follow-up|0|||
46803411|NCT04329702|83022728|FG002|Overall Study|Lost to Follow-up|2|||
46803412|NCT04329702|83022726|FG000|Overall Study|Death|0|||
46803413|NCT04329702|83022727|FG001|Overall Study|Death|2|||
46803414|NCT04329702|83022728|FG002|Overall Study|Death|0|||
46803415|NCT00481065|83022749|FG000|Overall Study|Adverse event or death|1|||
46803416|NCT00481065|83022750|FG001|Overall Study|Adverse event or death|1|||
46803417|NCT00481065|83022751|FG002|Overall Study|Adverse event or death|3|||
46803418|NCT00481065|83022752|FG003|Overall Study|Adverse event or death|0|||
46803419|NCT00481065|83022753|FG004|Overall Study|Adverse event or death|2|||
46803420|NCT00481065|83022754|FG005|Overall Study|Adverse event or death|0|||
46803421|NCT00481065|83022755|FG006|Overall Study|Adverse event or death|1|||
46803422|NCT00481065|83022756|FG007|Overall Study|Adverse event or death|1|||
46803423|NCT00481065|83022749|FG000|Overall Study|Withdrawal by Subject|11|||
46803424|NCT00481065|83022750|FG001|Overall Study|Withdrawal by Subject|12|||
46803425|NCT00481065|83022751|FG002|Overall Study|Withdrawal by Subject|7|||
46803426|NCT00481065|83022752|FG003|Overall Study|Withdrawal by Subject|11|||
46618224|NCT02300220|82753175|FG001|Overall Study|Death|1|||
46803427|NCT00481065|83022753|FG004|Overall Study|Withdrawal by Subject|13|||
46803428|NCT00481065|83022754|FG005|Overall Study|Withdrawal by Subject|12|||
46803429|NCT00481065|83022755|FG006|Overall Study|Withdrawal by Subject|9|||
46803430|NCT00481065|83022756|FG007|Overall Study|Withdrawal by Subject|10|||
46803431|NCT00481065|83022749|FG000|Overall Study|Lost to Follow-up|4|||
46803432|NCT00481065|83022750|FG001|Overall Study|Lost to Follow-up|2|||
46803433|NCT00481065|83022751|FG002|Overall Study|Lost to Follow-up|4|||
46803434|NCT00481065|83022752|FG003|Overall Study|Lost to Follow-up|3|||
46803435|NCT00481065|83022753|FG004|Overall Study|Lost to Follow-up|3|||
46803436|NCT00481065|83022754|FG005|Overall Study|Lost to Follow-up|3|||
46803437|NCT00481065|83022755|FG006|Overall Study|Lost to Follow-up|2|||
46803438|NCT00481065|83022756|FG007|Overall Study|Lost to Follow-up|5|||
46803439|NCT00481065|83022749|FG000|Overall Study|Inappropriate enrollment|4|||
46803440|NCT00481065|83022750|FG001|Overall Study|Inappropriate enrollment|0|||
46803441|NCT00481065|83022751|FG002|Overall Study|Inappropriate enrollment|2|||
46803442|NCT00481065|83022752|FG003|Overall Study|Inappropriate enrollment|0|||
46803443|NCT00481065|83022753|FG004|Overall Study|Inappropriate enrollment|2|||
46803444|NCT00481065|83022754|FG005|Overall Study|Inappropriate enrollment|1|||
46803445|NCT00481065|83022755|FG006|Overall Study|Inappropriate enrollment|0|||
46803446|NCT00481065|83022756|FG007|Overall Study|Inappropriate enrollment|1|||
46803447|NCT00481065|83022749|FG000|Overall Study|Administrative reason|0|||
46803448|NCT00481065|83022750|FG001|Overall Study|Administrative reason|0|||
46803449|NCT00481065|83022751|FG002|Overall Study|Administrative reason|0|||
46803450|NCT00481065|83022752|FG003|Overall Study|Administrative reason|0|||
46803451|NCT00481065|83022753|FG004|Overall Study|Administrative reason|0|||
46803452|NCT00481065|83022754|FG005|Overall Study|Administrative reason|2|||
46803453|NCT00481065|83022755|FG006|Overall Study|Administrative reason|1|||
46803454|NCT00481065|83022756|FG007|Overall Study|Administrative reason|0|||
46803455|NCT00481065|83022749|FG000|Overall Study|Protocol Violation|2|||
46803456|NCT00481065|83022750|FG001|Overall Study|Protocol Violation|1|||
46803457|NCT00481065|83022751|FG002|Overall Study|Protocol Violation|1|||
46803458|NCT00481065|83022752|FG003|Overall Study|Protocol Violation|1|||
46618225|NCT02300220|82753174|FG000|Overall Study|Adverse Event|1|||
46618226|NCT02300220|82753175|FG001|Overall Study|Adverse Event|1|||
46618227|NCT02300220|82753174|FG000|Overall Study|Protocol Violation|1|||
46618228|NCT02300220|82753175|FG001|Overall Study|Protocol Violation|0|||
46618229|NCT02300220|82753174|FG000|Overall Study|Withdrawal by Subject|0|||
46618230|NCT02300220|82753175|FG001|Overall Study|Withdrawal by Subject|2|||
46618231|NCT02300220|82753174|FG000|Overall Study|Did not tolerate IMP|0|||
46618232|NCT02300220|82753175|FG001|Overall Study|Did not tolerate IMP|1|||
46618233|NCT02327130|82753199|FG000|Overall Study|Discharged in less than 5 days|5|||
46618234|NCT02327130|82753199|FG000|Overall Study|Physician Decision|2|||
46618235|NCT02327130|82753199|FG000|Overall Study|Unable to provide breath sample|1|||
46618236|NCT02327130|82753199|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
46618237|NCT02327130|82753199|FG000|Overall Study|Met exclusion criteria|3|||
46618238|NCT02326272|82753254|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46803459|NCT00481065|83022753|FG004|Overall Study|Protocol Violation|2|||
46803460|NCT00481065|83022754|FG005|Overall Study|Protocol Violation|6|||
46803461|NCT00481065|83022755|FG006|Overall Study|Protocol Violation|3|||
46803462|NCT00481065|83022756|FG007|Overall Study|Protocol Violation|2|||
46803463|NCT00481065|83022749|FG000|Overall Study|Unable to classify|0|||
46803464|NCT00481065|83022750|FG001|Overall Study|Unable to classify|1|||
46803465|NCT00481065|83022751|FG002|Overall Study|Unable to classify|2|||
46618239|NCT02326272|82753255|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
46618240|NCT02326272|82753256|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
46708825|NCT04117347|82924721|FG001|Overall Study|Adverse Event|0|||
46803466|NCT00481065|83022752|FG003|Overall Study|Unable to classify|0|||
46803467|NCT00481065|83022753|FG004|Overall Study|Unable to classify|1|||
46803468|NCT00481065|83022754|FG005|Overall Study|Unable to classify|0|||
46803469|NCT00481065|83022755|FG006|Overall Study|Unable to classify|0|||
46803470|NCT00481065|83022756|FG007|Overall Study|Unable to classify|0|||
46803471|NCT00493311|83022778|FG000|Overall Study|Need for rescue medication|2|||
46803472|NCT00493311|83022779|FG001|Overall Study|Need for rescue medication|2|||
46803473|NCT00571649|83022787|FG000|Treatment Period|Adverse Event|438|||
46803474|NCT00571649|83022788|FG001|Treatment Period|Adverse Event|385|||
46803475|NCT00571649|83022787|FG000|Treatment Period|Clinical endpoint reached|50|||
46803476|NCT00571649|83022788|FG001|Treatment Period|Clinical endpoint reached|56|||
46803477|NCT00571649|83022787|FG000|Treatment Period|Withdrawal by Subject|285|||
46803478|NCT00571649|83022788|FG001|Treatment Period|Withdrawal by Subject|255|||
46803479|NCT00571649|83022787|FG000|Treatment Period|Death|76|||
46803480|NCT00571649|83022788|FG001|Treatment Period|Death|59|||
46803481|NCT00571649|83022787|FG000|Treatment Period|Physician Decision|8|||
46803482|NCT00571649|83022788|FG001|Treatment Period|Physician Decision|9|||
46803483|NCT00571649|83022787|FG000|Treatment Period|Lost to Follow-up|43|||
46803484|NCT00571649|83022788|FG001|Treatment Period|Lost to Follow-up|41|||
46803485|NCT00571649|83022787|FG000|Treatment Period|Non-compliant with study medication|88|||
46803486|NCT00571649|83022788|FG001|Treatment Period|Non-compliant with study medication|89|||
46803487|NCT00571649|83022787|FG000|Treatment Period|Patient convenience|11|||
46803488|NCT00571649|83022788|FG001|Treatment Period|Patient convenience|13|||
46803489|NCT00571649|83022787|FG000|Treatment Period|Protocol Violation|90|||
46803490|NCT00571649|83022788|FG001|Treatment Period|Protocol Violation|92|||
46803491|NCT00571649|83022787|FG000|Treatment Period|Technical problems|3|||
46803492|NCT00571649|83022788|FG001|Treatment Period|Technical problems|5|||
46803493|NCT00571649|83022787|FG000|Follow-up Period|Adverse Event|46|||
46803494|NCT00571649|83022788|FG001|Follow-up Period|Adverse Event|40|||
46803495|NCT00571649|83022787|FG000|Follow-up Period|Clinical endpoint reached|5|||
46803496|NCT00571649|83022788|FG001|Follow-up Period|Clinical endpoint reached|2|||
46803497|NCT00571649|83022787|FG000|Follow-up Period|Withdrawal by Subject|119|||
46803498|NCT00571649|83022788|FG001|Follow-up Period|Withdrawal by Subject|115|||
46803499|NCT00571649|83022787|FG000|Follow-up Period|Death|132|||
46803500|NCT00571649|83022788|FG001|Follow-up Period|Death|133|||
46803501|NCT00571649|83022787|FG000|Follow-up Period|Physician Decision|7|||
46803502|NCT00571649|83022788|FG001|Follow-up Period|Physician Decision|13|||
46803503|NCT00571649|83022787|FG000|Follow-up Period|Lost to Follow-up|95|||
46803504|NCT00571649|83022788|FG001|Follow-up Period|Lost to Follow-up|92|||
46803505|NCT00571649|83022787|FG000|Follow-up Period|Patient convenience|136|||
46803506|NCT00571649|83022788|FG001|Follow-up Period|Patient convenience|121|||
46803507|NCT00571649|83022787|FG000|Follow-up Period|Protocol Violation|5|||
46803508|NCT00571649|83022788|FG001|Follow-up Period|Protocol Violation|12|||
46803509|NCT00546572|83022796|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
46803510|NCT00546572|83022797|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
46803511|NCT00546572|83022796|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
46803512|NCT00546572|83022797|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
46803513|NCT00546572|83022796|FG000|Vax 1 / Year 0|Protocol Violation|3|||
46803514|NCT00546572|83022797|FG001|Vax 1 / Year 0|Protocol Violation|4|||
46803515|NCT00546572|83022796|FG000|Vax 1 / Year 0|Death|2|||
46803516|NCT00546572|83022797|FG001|Vax 1 / Year 0|Death|2|||
46803517|NCT00546572|83022796|FG000|Vax 1 / Year 0|Adverse Event|0|||
46803518|NCT00546572|83022797|FG001|Vax 1 / Year 0|Adverse Event|1|||
46803519|NCT00546572|83022796|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
46803520|NCT00546572|83022797|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
46803521|NCT00546572|83022796|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
46803522|NCT00546572|83022797|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
46803523|NCT00546572|83022796|FG000|Vax 2 / Year 1|Other|1|||
46803524|NCT00546572|83022797|FG001|Vax 2 / Year 1|Other|1|||
46803525|NCT00546572|83022796|FG000|Vax 2 / Year 1|Adverse Event|1|||
46803526|NCT00546572|83022797|FG001|Vax 2 / Year 1|Adverse Event|0|||
46803527|NCT00546572|83022796|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
46803528|NCT00546572|83022797|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
46803529|NCT03917472|83022816|FG000|Overall Study|Physician Decision|4|||
46803530|NCT03917472|83022817|FG001|Overall Study|Physician Decision|0|||
46803531|NCT03917472|83022816|FG000|Overall Study|Adverse Event|3|||
46803532|NCT03917472|83022817|FG001|Overall Study|Adverse Event|1|||
46803533|NCT03917472|83022816|FG000|Overall Study|Death|7|||
46803534|NCT03917472|83022817|FG001|Overall Study|Death|5|||
46803535|NCT03917472|83022816|FG000|Overall Study|Withdrawal by Subject|11|||
46803536|NCT03917472|83022817|FG001|Overall Study|Withdrawal by Subject|4|||
46803537|NCT03917472|83022816|FG000|Overall Study|Lost to Follow-up|10|||
46803538|NCT03917472|83022817|FG001|Overall Study|Lost to Follow-up|5|||
46803539|NCT00681863|83022824|FG000|Overall Study|Adverse Event|1|||
46803540|NCT00681863|83022824|FG000|Overall Study|Lost to Follow-up|2|||
46803541|NCT00681863|83022824|FG000|Overall Study|Lack of Efficacy|2|||
46803542|NCT00681863|83022824|FG000|Overall Study|Other|18|||
46803543|NCT00681629|83022830|FG000|Overall Study|Study termination|4|||
46803544|NCT00681629|83022831|FG001|Overall Study|Study termination|2|||
46803545|NCT00681629|83022830|FG000|Overall Study|Adverse Event|1|||
46803546|NCT00681629|83022831|FG001|Overall Study|Adverse Event|0|||
46803547|NCT00679367|83022837|FG000|Overall Study|Adverse Event|7|||
46803548|NCT00679367|83022837|FG000|Overall Study|inability to swallow oral drugs|1|||
46803549|NCT00679367|83022837|FG000|Overall Study|Lack of Efficacy|3|||
46803550|NCT00679367|83022837|FG000|Overall Study|Withdrawal by Subject|1|||
46803551|NCT03937778|83022842|FG000|Overall Study|Withdrawal by Subject|1|||
46803552|NCT03937778|83022842|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
46803553|NCT03935126|83022846|FG000|Overall Study|Study termination by sponsor|3|||
46803554|NCT00545714|83022850|FG000|Induction Phase (6 Months)|Physician Decision|3|||
46803555|NCT00545714|83022850|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
46803556|NCT00545714|83022850|FG000|Induction Phase (6 Months)|Disease Progression|1|||
46803557|NCT00545714|83022850|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
46803558|NCT00545714|83022850|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
46803559|NCT00545714|83022850|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
46803560|NCT00545714|83022850|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
46803561|NCT00545714|83022850|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
46803562|NCT00545714|83022850|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
46803563|NCT00545714|83022850|FG000|Maintenance Phase (36 Months)|Death|2|||
46803564|NCT00539838|83022857|FG000|Overall Study|Fail to return|2|||
46803565|NCT00539838|83022858|FG001|Overall Study|Fail to return|0|||
46803566|NCT00539838|83022859|FG002|Overall Study|Fail to return|0|||
46803567|NCT00539838|83022857|FG000|Overall Study|Withdrawal by Subject|0|||
46803568|NCT00539838|83022858|FG001|Overall Study|Withdrawal by Subject|4|||
46803569|NCT00539838|83022859|FG002|Overall Study|Withdrawal by Subject|0|||
46803570|NCT00539838|83022857|FG000|Overall Study|Death|0|||
46803571|NCT00539838|83022858|FG001|Overall Study|Death|2|||
46803572|NCT00539838|83022859|FG002|Overall Study|Death|0|||
46803573|NCT00539838|83022857|FG000|Overall Study|Did not cooperate|1|||
46803574|NCT00539838|83022858|FG001|Overall Study|Did not cooperate|0|||
46803575|NCT00539838|83022859|FG002|Overall Study|Did not cooperate|1|||
46803576|NCT00539838|83022857|FG000|Overall Study|Administrative|4|||
46803577|NCT00539838|83022858|FG001|Overall Study|Administrative|0|||
46803578|NCT00539838|83022859|FG002|Overall Study|Administrative|8|||
46803579|NCT00679289|83022872|FG000|Overall Study|Progressive disease|4|||
46803580|NCT00679289|83022873|FG001|Overall Study|Progressive disease|5|||
46803581|NCT00679289|83022874|FG002|Overall Study|Progressive disease|18|||
46803582|NCT00679289|83022872|FG000|Overall Study|Withdrawal by Subject|0|||
46803583|NCT00679289|83022873|FG001|Overall Study|Withdrawal by Subject|1|||
46803584|NCT00679289|83022874|FG002|Overall Study|Withdrawal by Subject|1|||
46803585|NCT00679289|83022872|FG000|Overall Study|Adverse Event|0|||
46803586|NCT00679289|83022873|FG001|Overall Study|Adverse Event|0|||
46803587|NCT00679289|83022874|FG002|Overall Study|Adverse Event|3|||
46803588|NCT00679289|83022872|FG000|Overall Study|Physician Decision|1|||
46803589|NCT00679289|83022873|FG001|Overall Study|Physician Decision|0|||
46803590|NCT00679289|83022874|FG002|Overall Study|Physician Decision|1|||
46803591|NCT00679211|83022884|FG000|Overall Study|Progressive disease|82|||
46803592|NCT00679211|83022884|FG000|Overall Study|Adverse Event|7|||
46803593|NCT00679211|83022884|FG000|Overall Study|Withdrawal by Subject|2|||
46803594|NCT00679211|83022884|FG000|Overall Study|Physician Decision|5|||
46803595|NCT00679211|83022884|FG000|Overall Study|Refused to undergo protocol procedures|1|||
46803596|NCT00679211|83022884|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
46803597|NCT00679211|83022884|FG000|Overall Study|Other|1|||
46803598|NCT00545948|83022893|FG000|Overall Study|Not Treated|1|||
46803599|NCT00545948|83022894|FG001|Overall Study|Not Treated|1|||
46803600|NCT00545948|83022895|FG002|Overall Study|Not Treated|7|||
46803601|NCT00679055|83022906|FG000|Overall Study|Adverse Event|0|||
46803602|NCT00679055|83022907|FG001|Overall Study|Adverse Event|1|||
46803603|NCT00679055|83022906|FG000|Overall Study|Other|0|||
46803604|NCT00679055|83022907|FG001|Overall Study|Other|3|||
46803605|NCT00679055|83022906|FG000|Overall Study|Study Terminated|2|||
46803606|NCT00679055|83022907|FG001|Overall Study|Study Terminated|1|||
46803607|NCT03927950|83022913|FG000|Overall Study|Adverse Event|9|||
46803608|NCT00678899|83022918|FG000|Overall Study|Adverse Event|1|||
46803609|NCT00678587|83022925|FG000|Overall Study|Adverse Event|3|||
46803610|NCT00678587|83022926|FG001|Overall Study|Adverse Event|3|||
46803611|NCT00678587|83022925|FG000|Overall Study|Lack of Efficacy|1|||
46803612|NCT00678587|83022926|FG001|Overall Study|Lack of Efficacy|0|||
46803613|NCT00678587|83022925|FG000|Overall Study|Protocol Violation|2|||
46803614|NCT00678587|83022926|FG001|Overall Study|Protocol Violation|1|||
46803615|NCT00678587|83022925|FG000|Overall Study|Study Closed/Terminated|1|||
46803616|NCT00678587|83022926|FG001|Overall Study|Study Closed/Terminated|0|||
46803617|NCT00678587|83022925|FG000|Overall Study|Lost to Follow-up|3|||
46803618|NCT00678587|83022926|FG001|Overall Study|Lost to Follow-up|5|||
46803619|NCT00678587|83022925|FG000|Overall Study|Investigator Discretion|2|||
46803620|NCT00678587|83022926|FG001|Overall Study|Investigator Discretion|6|||
46898661|NCT01459497|83124928|FG001|Overall Study|Disease progression.|1|||
46898662|NCT01063751|83124934|FG000|Overall Study|Site terminated|45|||
46898663|NCT01063751|83124934|FG000|Overall Study|Lost to Follow-up|28|||
46898664|NCT01063751|83124934|FG000|Overall Study|Withdrawal by Subject|25|||
46898665|NCT01063751|83124934|FG000|Overall Study|Revision|6|||
46898666|NCT01063751|83124934|FG000|Overall Study|Death|12|||
46898667|NCT01063751|83124934|FG000|Overall Study|Physician Decision|4|||
46898668|NCT01063751|83124934|FG000|Overall Study|Active|91|||
46898669|NCT00680901|83124941|FG000|Overall Study|Lost to Follow-up|8|||
46898670|NCT00680901|83124942|FG001|Overall Study|Lost to Follow-up|8|||
46898671|NCT00680901|83124941|FG000|Overall Study|Withdrawal by Subject|4|||
46898672|NCT00680901|83124942|FG001|Overall Study|Withdrawal by Subject|13|||
46898673|NCT00680901|83124941|FG000|Overall Study|Physician Decision|0|||
46898674|NCT00680901|83124942|FG001|Overall Study|Physician Decision|1|||
46898675|NCT00680901|83124941|FG000|Overall Study|Ongoing: On Study Treatment|16|||
46898676|NCT00680901|83124942|FG001|Overall Study|Ongoing: On Study Treatment|13|||
46898677|NCT00680901|83124941|FG000|Overall Study|Ongoing: In Follow Up|45|||
46898678|NCT00680901|83124942|FG001|Overall Study|Ongoing: In Follow Up|41|||
46898679|NCT00557193|83124948|FG000|Induction|Adverse Event|2|||
46898680|NCT00557193|83124949|FG001|Induction|Adverse Event|0|||
46898681|NCT00557193|83124950|FG002|Induction|Adverse Event|0|||
46898682|NCT00557193|83124951|FG003|Induction|Adverse Event|0|||
46898683|NCT00557193|83124952|FG004|Induction|Adverse Event|0|||
46898684|NCT00557193|83124953|FG005|Induction|Adverse Event|0|||
46898685|NCT00557193|83124948|FG000|Induction|Death|6|||
46898686|NCT00557193|83124949|FG001|Induction|Death|0|||
46898687|NCT00557193|83124950|FG002|Induction|Death|0|||
46898688|NCT00557193|83124951|FG003|Induction|Death|0|||
46898689|NCT00557193|83124952|FG004|Induction|Death|0|||
46898690|NCT00557193|83124953|FG005|Induction|Death|0|||
46898691|NCT00557193|83124948|FG000|Induction|Physician Decision|3|||
46898692|NCT00557193|83124949|FG001|Induction|Physician Decision|0|||
46898693|NCT00557193|83124950|FG002|Induction|Physician Decision|0|||
46898694|NCT00557193|83124951|FG003|Induction|Physician Decision|0|||
46898695|NCT00557193|83124952|FG004|Induction|Physician Decision|0|||
46898696|NCT00557193|83124953|FG005|Induction|Physician Decision|0|||
46898697|NCT00557193|83124948|FG000|Induction|Withdrawal by Subject|1|||
46898698|NCT00557193|83124949|FG001|Induction|Withdrawal by Subject|0|||
46898699|NCT00557193|83124950|FG002|Induction|Withdrawal by Subject|0|||
46898700|NCT00557193|83124951|FG003|Induction|Withdrawal by Subject|0|||
46898701|NCT00557193|83124952|FG004|Induction|Withdrawal by Subject|0|||
46898702|NCT00557193|83124953|FG005|Induction|Withdrawal by Subject|0|||
46898703|NCT00557193|83124948|FG000|Induction|Refusal of Further Protocol Therapy|2|||
46898704|NCT00557193|83124949|FG001|Induction|Refusal of Further Protocol Therapy|0|||
46898705|NCT00557193|83124950|FG002|Induction|Refusal of Further Protocol Therapy|0|||
46898706|NCT00557193|83124951|FG003|Induction|Refusal of Further Protocol Therapy|0|||
46898707|NCT00557193|83124952|FG004|Induction|Refusal of Further Protocol Therapy|0|||
46898708|NCT00557193|83124953|FG005|Induction|Refusal of Further Protocol Therapy|0|||
46898709|NCT00557193|83124948|FG000|Induction|Ineligible|8|||
46898710|NCT00557193|83124949|FG001|Induction|Ineligible|0|||
46898711|NCT00557193|83124950|FG002|Induction|Ineligible|0|||
46898712|NCT00557193|83124951|FG003|Induction|Ineligible|0|||
46898713|NCT00557193|83124952|FG004|Induction|Ineligible|0|||
46898714|NCT00557193|83124953|FG005|Induction|Ineligible|0|||
46898715|NCT00557193|83124948|FG000|Induction|Inevaluable for post Induction|2|||
46898716|NCT00557193|83124949|FG001|Induction|Inevaluable for post Induction|0|||
46898717|NCT00557193|83124950|FG002|Induction|Inevaluable for post Induction|0|||
46898718|NCT00557193|83124951|FG003|Induction|Inevaluable for post Induction|0|||
46898719|NCT00557193|83124952|FG004|Induction|Inevaluable for post Induction|0|||
46898720|NCT00557193|83124953|FG005|Induction|Inevaluable for post Induction|0|||
46898721|NCT00557193|83124948|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
46898722|NCT00557193|83124949|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
46898723|NCT00557193|83124950|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
46898724|NCT00557193|83124951|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
46898725|NCT00557193|83124952|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
46898726|NCT00557193|83124953|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
46898727|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
46898728|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
46898729|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
46898730|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
46898731|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
46898732|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
46898733|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
46898734|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
46898735|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
46898736|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
46898737|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
46898738|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
46898739|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
46898740|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
46898741|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
46898742|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
46898743|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
46898744|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
46898745|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
46898746|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
46993249|NCT01614886|83240160|FG001|Overall Study|Withdrawal by Subject|4|||
46993250|NCT01614886|83240159|FG000|Overall Study|Death|1|||
46993251|NCT01614886|83240160|FG001|Overall Study|Death|0|||
46993252|NCT01614886|83240159|FG000|Overall Study|Protocol deviation|0|||
46993253|NCT01614886|83240160|FG001|Overall Study|Protocol deviation|2|||
46993254|NCT01880554|83240166|FG000|Overall Study|Protocol Violation|14|||
46993255|NCT01880554|83240166|FG000|Overall Study|Simon's design requirements|2|||
46993256|NCT02100657|83240174|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
46993257|NCT02100657|83240175|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
46993258|NCT02100657|83240176|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
46993259|NCT02100657|83240174|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
46993260|NCT02100657|83240175|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
46993261|NCT02100657|83240176|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
46993262|NCT02100657|83240174|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
46993263|NCT02100657|83240175|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
46993264|NCT02100657|83240176|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
46618241|NCT02326272|82753257|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618242|NCT02326272|82753258|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618243|NCT02326272|82753259|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618244|NCT02326272|82753260|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618245|NCT02326272|82753261|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618246|NCT02326272|82753262|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618247|NCT02326272|82753263|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618248|NCT02326272|82753264|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618249|NCT02326272|82753265|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618250|NCT02326272|82753266|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618251|NCT02326272|82753267|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618252|NCT02326272|82753268|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46618253|NCT02326272|82753254|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
46618254|NCT02326272|82753255|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
46618255|NCT02326272|82753256|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618256|NCT02326272|82753257|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618257|NCT02326272|82753258|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618258|NCT02326272|82753259|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618259|NCT02326272|82753260|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618260|NCT02326272|82753261|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618261|NCT02326272|82753262|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618262|NCT02326272|82753263|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618263|NCT02326272|82753264|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618264|NCT02326272|82753265|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618265|NCT02326272|82753266|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618266|NCT02326272|82753267|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618267|NCT02326272|82753268|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46618268|NCT02326272|82753254|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
46618269|NCT02326272|82753255|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
46618270|NCT02326272|82753256|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
46618271|NCT02326272|82753257|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618272|NCT02326272|82753258|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618273|NCT02326272|82753259|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618274|NCT02326272|82753260|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618275|NCT02326272|82753261|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618276|NCT02326272|82753262|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618277|NCT02326272|82753263|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618278|NCT02326272|82753264|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618279|NCT02326272|82753265|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46993265|NCT02100657|83240174|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
46993266|NCT02100657|83240175|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
46993267|NCT02100657|83240176|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
46993268|NCT02100657|83240174|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
46618280|NCT02326272|82753266|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618281|NCT02326272|82753267|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618282|NCT02326272|82753268|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46618283|NCT02326272|82753254|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618284|NCT02326272|82753255|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618285|NCT02326272|82753256|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
46618286|NCT02326272|82753257|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618287|NCT02326272|82753258|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618288|NCT02326272|82753259|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618289|NCT02326272|82753260|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618290|NCT02326272|82753261|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618291|NCT02326272|82753262|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618292|NCT02326272|82753263|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618293|NCT02326272|82753264|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618294|NCT02326272|82753265|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618295|NCT02326272|82753266|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618296|NCT02326272|82753267|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618297|NCT02326272|82753268|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
46618298|NCT02326272|82753254|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618299|NCT02326272|82753255|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618300|NCT02326272|82753256|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
46618301|NCT02326272|82753257|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618302|NCT02326272|82753258|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618303|NCT02326272|82753259|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618304|NCT02326272|82753260|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618305|NCT02326272|82753261|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618306|NCT02326272|82753262|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618307|NCT02326272|82753263|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618308|NCT02326272|82753264|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618309|NCT02326272|82753265|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618310|NCT02326272|82753266|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618311|NCT02326272|82753267|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618312|NCT02326272|82753268|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
46618313|NCT02326272|82753254|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618314|NCT02326272|82753255|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618315|NCT02326272|82753256|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
46618316|NCT02326272|82753257|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618317|NCT02326272|82753258|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618318|NCT02326272|82753259|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618319|NCT02326272|82753260|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618320|NCT02326272|82753261|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618321|NCT02326272|82753262|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618322|NCT02326272|82753263|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618323|NCT02326272|82753264|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618324|NCT02326272|82753265|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618325|NCT02326272|82753266|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618326|NCT02326272|82753267|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618327|NCT02326272|82753268|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
46618328|NCT02326272|82753254|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618329|NCT02326272|82753255|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618330|NCT02326272|82753256|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
46618331|NCT02326272|82753257|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618332|NCT02326272|82753258|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618333|NCT02326272|82753259|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618334|NCT02326272|82753260|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618335|NCT02326272|82753261|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618336|NCT02326272|82753262|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618337|NCT02326272|82753263|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46708826|NCT04117347|82924722|FG002|Overall Study|Adverse Event|1|||
46967452|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
46993269|NCT02100657|83240175|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
46993270|NCT02100657|83240176|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
46993271|NCT02100657|83240174|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
46993272|NCT02100657|83240175|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
46993273|NCT02100657|83240176|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
46993274|NCT02100657|83240174|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
46993275|NCT02100657|83240175|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
46993276|NCT02100657|83240176|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
46993277|NCT02100657|83240174|FG000|Cohort 3: Dose Level 3|Death|0|||
46993278|NCT02100657|83240175|FG001|Cohort 3: Dose Level 3|Death|0|||
46993279|NCT02100657|83240176|FG002|Cohort 3: Dose Level 3|Death|1|||
46993280|NCT02100657|83240174|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
46993281|NCT02100657|83240175|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
46993282|NCT02100657|83240176|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
46993283|NCT02100657|83240174|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
46993284|NCT02100657|83240175|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
46993285|NCT02100657|83240176|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
46993286|NCT02100657|83240174|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
46898747|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
46898748|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
46898749|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
46898750|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
46898751|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
46898752|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
46898753|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
46898754|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
46898755|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
46898756|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
46898757|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
46898758|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
46898759|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
46898760|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
46898761|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
46898762|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
46898763|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
46898764|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
46898765|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
46898766|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
46898767|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
46898768|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
46898769|NCT00557193|83124948|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
46898770|NCT00557193|83124949|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
46898771|NCT00557193|83124950|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
46898772|NCT00557193|83124951|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
46898773|NCT00557193|83124952|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
46898774|NCT00557193|83124953|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
46898775|NCT00186888|83125006|FG000|Overall Study|Toxicity|0|||
46898776|NCT00186888|83125007|FG001|Overall Study|Toxicity|1|||
46898777|NCT00186888|83125008|FG002|Overall Study|Toxicity|0|||
46898778|NCT00186888|83125006|FG000|Overall Study|Relapse or progression of disease|4|||
46898779|NCT00186888|83125007|FG001|Overall Study|Relapse or progression of disease|2|||
46898780|NCT00186888|83125008|FG002|Overall Study|Relapse or progression of disease|0|||
46898781|NCT03078192|83125045|FG000|Overall Study|Withdrawal by Subject|2|||
46898782|NCT03078192|83125046|FG001|Overall Study|Withdrawal by Subject|1|||
46898783|NCT03078192|83125045|FG000|Overall Study|screen failure|0|||
46898784|NCT03078192|83125046|FG001|Overall Study|screen failure|3|||
46898785|NCT00703846|83125052|FG000|Overall Study|Adverse Event|8|||
46898786|NCT00703846|83125052|FG000|Overall Study|Lost to Follow-up|55|||
46898787|NCT00703846|83125052|FG000|Overall Study|Lack of Efficacy|15|||
46898788|NCT00703846|83125052|FG000|Overall Study|Noncompliance with Study Treatment|2|||
46898789|NCT00703846|83125052|FG000|Overall Study|Withdrawal by Subject|40|||
46898790|NCT00703846|83125052|FG000|Overall Study|Death|1|||
46898791|NCT00703846|83125052|FG000|Overall Study|Other|14|||
46898792|NCT00703846|83125052|FG000|Overall Study|Did Not Receive Study Drug|2|||
46898793|NCT05372575|83125062|FG000|Overall Study|Protocol Violation|7|||
46898794|NCT05372575|83125063|FG001|Overall Study|Protocol Violation|16|||
46898795|NCT05132127|83125074|FG000|Overall Study|Adverse Event|1|||
46993287|NCT02100657|83240175|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
46993288|NCT02100657|83240176|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
46993289|NCT02100657|83240174|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
46993290|NCT02100657|83240175|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
46993291|NCT02100657|83240176|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
46993292|NCT02100657|83240174|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
46993293|NCT02100657|83240175|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
46993294|NCT02100657|83240176|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
46993295|NCT02067663|83240187|FG000|Overall Study|Lost to Follow-up|13|||
46993296|NCT02067663|83240188|FG001|Overall Study|Lost to Follow-up|14|||
46993297|NCT01909804|83240206|FG000|Overall Study|Randomized but Never Treated|0|||
46993298|NCT01909804|83240207|FG001|Overall Study|Randomized but Never Treated|0|||
46993299|NCT01909804|83240208|FG002|Overall Study|Randomized but Never Treated|0|||
46993300|NCT01909804|83240209|FG003|Overall Study|Randomized but Never Treated|0|||
46993301|NCT01909804|83240210|FG004|Overall Study|Randomized but Never Treated|0|||
46993302|NCT01909804|83240211|FG005|Overall Study|Randomized but Never Treated|0|||
46993303|NCT01909804|83240212|FG006|Overall Study|Randomized but Never Treated|1|||
46993304|NCT01909804|83240213|FG007|Overall Study|Randomized but Never Treated|0|||
46993305|NCT01909804|83240214|FG008|Overall Study|Randomized but Never Treated|0|||
46993306|NCT01909804|83240215|FG009|Overall Study|Randomized but Never Treated|0|||
46993307|NCT01909804|83240216|FG010|Overall Study|Randomized but Never Treated|0|||
46993308|NCT01909804|83240217|FG011|Overall Study|Randomized but Never Treated|1|||
46993309|NCT01909804|83240206|FG000|Overall Study|Death|0|||
46993310|NCT01909804|83240207|FG001|Overall Study|Death|0|||
46993311|NCT01909804|83240208|FG002|Overall Study|Death|0|||
46993312|NCT01909804|83240209|FG003|Overall Study|Death|0|||
46993313|NCT01909804|83240210|FG004|Overall Study|Death|0|||
46993314|NCT01909804|83240211|FG005|Overall Study|Death|0|||
46993315|NCT01909804|83240212|FG006|Overall Study|Death|0|||
46993316|NCT01909804|83240213|FG007|Overall Study|Death|0|||
46993317|NCT01909804|83240214|FG008|Overall Study|Death|0|||
46993318|NCT01909804|83240215|FG009|Overall Study|Death|0|||
46993319|NCT01909804|83240216|FG010|Overall Study|Death|1|||
46993320|NCT01909804|83240217|FG011|Overall Study|Death|0|||
46993321|NCT01909804|83240206|FG000|Overall Study|Lack of Efficacy|4|||
46993322|NCT01909804|83240207|FG001|Overall Study|Lack of Efficacy|1|||
46993323|NCT01909804|83240208|FG002|Overall Study|Lack of Efficacy|0|||
46993324|NCT01909804|83240209|FG003|Overall Study|Lack of Efficacy|0|||
46993325|NCT01909804|83240210|FG004|Overall Study|Lack of Efficacy|7|||
46993326|NCT01909804|83240211|FG005|Overall Study|Lack of Efficacy|3|||
46993327|NCT01909804|83240212|FG006|Overall Study|Lack of Efficacy|1|||
46993328|NCT01909804|83240213|FG007|Overall Study|Lack of Efficacy|1|||
46993329|NCT01909804|83240214|FG008|Overall Study|Lack of Efficacy|0|||
46993330|NCT01909804|83240215|FG009|Overall Study|Lack of Efficacy|1|||
46993331|NCT01909804|83240216|FG010|Overall Study|Lack of Efficacy|0|||
46993332|NCT01909804|83240217|FG011|Overall Study|Lack of Efficacy|1|||
46993333|NCT01909804|83240206|FG000|Overall Study|Withdrew Consent|0|||
46993334|NCT01909804|83240207|FG001|Overall Study|Withdrew Consent|0|||
46993335|NCT01909804|83240208|FG002|Overall Study|Withdrew Consent|0|||
46993336|NCT01909804|83240209|FG003|Overall Study|Withdrew Consent|0|||
46993337|NCT01909804|83240210|FG004|Overall Study|Withdrew Consent|1|||
46993338|NCT01909804|83240211|FG005|Overall Study|Withdrew Consent|1|||
46993339|NCT01909804|83240212|FG006|Overall Study|Withdrew Consent|0|||
46993340|NCT01909804|83240213|FG007|Overall Study|Withdrew Consent|0|||
46993341|NCT01909804|83240214|FG008|Overall Study|Withdrew Consent|0|||
46993342|NCT01909804|83240215|FG009|Overall Study|Withdrew Consent|0|||
46993343|NCT01909804|83240216|FG010|Overall Study|Withdrew Consent|0|||
46993344|NCT01909804|83240217|FG011|Overall Study|Withdrew Consent|0|||
46993345|NCT01909804|83240206|FG000|Overall Study|Protocol Violation|0|||
46993346|NCT01909804|83240207|FG001|Overall Study|Protocol Violation|0|||
46993347|NCT01909804|83240208|FG002|Overall Study|Protocol Violation|0|||
46993348|NCT01909804|83240209|FG003|Overall Study|Protocol Violation|0|||
46993349|NCT01909804|83240210|FG004|Overall Study|Protocol Violation|0|||
46993350|NCT01909804|83240211|FG005|Overall Study|Protocol Violation|0|||
46993351|NCT01909804|83240212|FG006|Overall Study|Protocol Violation|0|||
46993352|NCT01909804|83240213|FG007|Overall Study|Protocol Violation|0|||
46993353|NCT01909804|83240214|FG008|Overall Study|Protocol Violation|0|||
46898796|NCT04969276|83125101|FG000|Overall Study|Protocol Deviation|0|||
46898797|NCT04969276|83125102|FG001|Overall Study|Protocol Deviation|1|||
46898798|NCT04969276|83125103|FG002|Overall Study|Protocol Deviation|0|||
46898799|NCT04969276|83125101|FG000|Overall Study|Withdrawal by Subject|1|||
46898800|NCT04969276|83125102|FG001|Overall Study|Withdrawal by Subject|10|||
46898801|NCT04969276|83125103|FG002|Overall Study|Withdrawal by Subject|0|||
46898802|NCT04969276|83125101|FG000|Overall Study|Lost to Follow-up|0|||
46898803|NCT04969276|83125102|FG001|Overall Study|Lost to Follow-up|1|||
46898804|NCT04969276|83125103|FG002|Overall Study|Lost to Follow-up|0|||
46898805|NCT04969224|83125111|FG000|Overall Study|Adverse Event|1|||
46898806|NCT04969224|83125111|FG000|Overall Study|Enrolled but never dosed|1|||
46898807|NCT04507126|83125137|FG000|Overall Study|Withdrawal by Subject|1|||
46993354|NCT01909804|83240215|FG009|Overall Study|Protocol Violation|0|||
46993355|NCT01909804|83240216|FG010|Overall Study|Protocol Violation|0|||
46993356|NCT01909804|83240217|FG011|Overall Study|Protocol Violation|1|||
46993357|NCT01880086|83240241|FG000|Overall Study|Lost to Follow-up|1|||
46993358|NCT01880086|83240242|FG001|Overall Study|Lost to Follow-up|1|||
46993359|NCT01879852|83240250|FG000|Overall Study|Withdrawal by Subject|2|||
46993360|NCT01879852|83240251|FG001|Overall Study|Withdrawal by Subject|0|||
46993361|NCT01879618|83240257|FG000|Overall Study|Does not meet entrance criteria|1|||
46993362|NCT01879618|83240257|FG000|Overall Study|Withdrawal by Subject|1|||
46993363|NCT01879618|83240257|FG000|Overall Study|Surgery;changed schedule; not available|8|||
46993364|NCT01879618|83240257|FG000|Overall Study|Protocol Violation|6|||
46993365|NCT01879618|83240257|FG000|Overall Study|Adverse Event|5|||
46993366|NCT01926886|83240261|FG000|Overall Study|Administrative/other|1|||
46993367|NCT01926886|83240262|FG001|Overall Study|Administrative/other|0|||
46993368|NCT01926886|83240261|FG000|Overall Study|Adverse event/intercurrent illness|4|||
46993369|NCT01926886|83240262|FG001|Overall Study|Adverse event/intercurrent illness|0|||
46993370|NCT01926886|83240261|FG000|Overall Study|Disease progression/recurrence|4|||
46993371|NCT01926886|83240262|FG001|Overall Study|Disease progression/recurrence|0|||
46993372|NCT01926886|83240261|FG000|Overall Study|Withdrawal by Subject|15|||
46993373|NCT01926886|83240262|FG001|Overall Study|Withdrawal by Subject|0|||
46993374|NCT01926886|83240261|FG000|Overall Study|Failure to return|3|||
46993375|NCT01926886|83240262|FG001|Overall Study|Failure to return|0|||
46993376|NCT01926886|83240261|FG000|Overall Study|Recurrence of disease|1|||
46993377|NCT01926886|83240262|FG001|Overall Study|Recurrence of disease|0|||
46993378|NCT01926886|83240261|FG000|Overall Study|Progression of disease|2|||
46993379|NCT01926886|83240262|FG001|Overall Study|Progression of disease|0|||
46993380|NCT01926886|83240261|FG000|Overall Study|Death|1|||
46993381|NCT01926886|83240262|FG001|Overall Study|Death|0|||
46993382|NCT01926886|83240261|FG000|Overall Study|Did not cooperate|1|||
46993383|NCT01926886|83240262|FG001|Overall Study|Did not cooperate|0|||
46993384|NCT01909336|83240271|FG000|Overall Study|Lost to Follow-up|4|||
46993385|NCT01909336|83240272|FG001|Overall Study|Lost to Follow-up|2|||
46993386|NCT01909336|83240273|FG002|Overall Study|Lost to Follow-up|2|||
46993387|NCT01909336|83240271|FG000|Overall Study|Physician Decision|0|||
46993388|NCT01909336|83240272|FG001|Overall Study|Physician Decision|1|||
46993389|NCT01909336|83240273|FG002|Overall Study|Physician Decision|1|||
46993390|NCT01926028|83240284|FG000|Overall Study|Lost to Follow-up|7|||
46993391|NCT01926028|83240285|FG001|Overall Study|Lost to Follow-up|6|||
46993392|NCT01926028|83240286|FG002|Overall Study|Lost to Follow-up|0|||
46993393|NCT01926028|83240284|FG000|Overall Study|Physician Decision|1|||
46993394|NCT01926028|83240285|FG001|Overall Study|Physician Decision|5|||
46993395|NCT01926028|83240286|FG002|Overall Study|Physician Decision|0|||
46993396|NCT01926028|83240284|FG000|Overall Study|Withdrawal by Subject|9|||
46993397|NCT01926028|83240285|FG001|Overall Study|Withdrawal by Subject|9|||
46993398|NCT01926028|83240286|FG002|Overall Study|Withdrawal by Subject|2|||
46993399|NCT01926028|83240284|FG000|Overall Study|Non compliance or other reasons|4|||
46993400|NCT01926028|83240285|FG001|Overall Study|Non compliance or other reasons|2|||
46993401|NCT01926028|83240286|FG002|Overall Study|Non compliance or other reasons|0|||
46993402|NCT01925950|83240297|FG000|Part 2|Withdrawal by Subject|1|||
46993403|NCT01925950|83240298|FG001|Part 2|Withdrawal by Subject|0|||
46993404|NCT01878292|83240307|FG000|Randomized|Protocol Violation|1|||
46993405|NCT01878292|83240308|FG001|Randomized|Protocol Violation|0|||
46993406|NCT01878292|83240309|FG002|Randomized|Protocol Violation|0|||
46993407|NCT01878292|83240307|FG000|Randomized|Lost to Follow-up|1|||
46993408|NCT01878292|83240308|FG001|Randomized|Lost to Follow-up|0|||
46993409|NCT01878292|83240309|FG002|Randomized|Lost to Follow-up|0|||
46993410|NCT01878292|83240307|FG000|Randomized|Adverse Event|1|||
46993411|NCT01878292|83240308|FG001|Randomized|Adverse Event|0|||
46618338|NCT02326272|82753264|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618339|NCT02326272|82753265|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618340|NCT02326272|82753266|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618341|NCT02326272|82753267|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618342|NCT02326272|82753268|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
46618343|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618344|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618345|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618346|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618347|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
46618348|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
46993412|NCT01878292|83240309|FG002|Randomized|Adverse Event|0|||
46993413|NCT01878292|83240307|FG000|Double-blind Treatment Period|Other Reasons|2|||
46993414|NCT01878292|83240308|FG001|Double-blind Treatment Period|Other Reasons|0|||
46993415|NCT01878292|83240309|FG002|Double-blind Treatment Period|Other Reasons|0|||
46993416|NCT01878292|83240307|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
46993417|NCT01878292|83240308|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
46993418|NCT01878292|83240309|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
46993419|NCT01878292|83240307|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
46993420|NCT01878292|83240308|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
46993421|NCT01878292|83240309|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
46993422|NCT01878292|83240307|FG000|Double-blind Treatment Period|Protocol Violation|3|||
46993423|NCT01878292|83240308|FG001|Double-blind Treatment Period|Protocol Violation|4|||
46993424|NCT01878292|83240309|FG002|Double-blind Treatment Period|Protocol Violation|2|||
46993425|NCT01878292|83240307|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
46993426|NCT01878292|83240308|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
46993427|NCT01878292|83240309|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
46993428|NCT01878292|83240307|FG000|Double-blind Treatment Period|Adverse Event|4|||
46993429|NCT01878292|83240308|FG001|Double-blind Treatment Period|Adverse Event|9|||
46993430|NCT01878292|83240309|FG002|Double-blind Treatment Period|Adverse Event|8|||
46993431|NCT01878292|83240307|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
46993432|NCT01878292|83240308|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
46993433|NCT01878292|83240309|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
46993434|NCT01908634|83240317|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
46993435|NCT01908634|83240317|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
46993436|NCT01878214|83240327|FG000|Overall Study|Withdrawal by Subject|18|||
46993437|NCT01878214|83240328|FG001|Overall Study|Withdrawal by Subject|7|||
46993438|NCT01878214|83240327|FG000|Overall Study|Death|0|||
46993439|NCT01878214|83240328|FG001|Overall Study|Death|1|||
46993440|NCT01878214|83240327|FG000|Overall Study|Lost to Follow-up|35|||
46993441|NCT01878214|83240328|FG001|Overall Study|Lost to Follow-up|36|||
46993442|NCT01907854|83240336|FG000|Overall Study|Protocol Violation|1|||
46993443|NCT01907854|83240337|FG001|Overall Study|Protocol Violation|1|||
46993444|NCT01907854|83240336|FG000|Overall Study|Withdrawal by Subject|9|||
46993445|NCT01907854|83240337|FG001|Overall Study|Withdrawal by Subject|7|||
46993446|NCT01907854|83240336|FG000|Overall Study|Lost to Follow-up|2|||
46993447|NCT01907854|83240337|FG001|Overall Study|Lost to Follow-up|2|||
46993448|NCT01907854|83240336|FG000|Overall Study|Unclassified|4|||
46993449|NCT01907854|83240337|FG001|Overall Study|Unclassified|3|||
46993450|NCT02480153|83240345|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
46993451|NCT02480153|83240346|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
46993452|NCT02480153|83240347|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
46993453|NCT02480153|83240345|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
46993454|NCT02480153|83240346|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
46993455|NCT02480153|83240347|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
46993456|NCT02480153|83240345|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
46993457|NCT02480153|83240346|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
46993458|NCT02480153|83240347|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
46993459|NCT02480153|83240345|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
46993460|NCT02480153|83240346|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
46993461|NCT02480153|83240347|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
46993462|NCT02480153|83240345|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
46993463|NCT02480153|83240346|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
46993464|NCT02480153|83240347|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
46993465|NCT02480153|83240345|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
46993466|NCT02480153|83240346|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
46993467|NCT02480153|83240347|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
46993468|NCT02480153|83240345|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
46993469|NCT02480153|83240346|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
46993470|NCT02480153|83240347|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
46993471|NCT02480153|83240345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
46993472|NCT02480153|83240346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
46993473|NCT02480153|83240347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
46618349|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
46618350|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
46618351|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
46618352|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618353|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618354|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618355|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618356|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618357|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46618358|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618359|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46993474|NCT02480153|83240345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
46993475|NCT02480153|83240346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
46993476|NCT02480153|83240347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
46993477|NCT02480153|83240345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
46993478|NCT02480153|83240346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
46993479|NCT02480153|83240347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
46993480|NCT02480153|83240345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
46993481|NCT02480153|83240346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
46993482|NCT02480153|83240347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
46993483|NCT02480153|83240345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
46993484|NCT02480153|83240346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
46993485|NCT02480153|83240347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
46993486|NCT02480153|83240345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
46993487|NCT02480153|83240346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
46993488|NCT02480153|83240347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
46993489|NCT02480153|83240345|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
46993490|NCT02480153|83240346|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
46993491|NCT02480153|83240347|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
46993492|NCT02480153|83240345|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
46993493|NCT02480153|83240346|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
46993494|NCT02480153|83240347|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
46993495|NCT02480153|83240345|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
46993496|NCT02480153|83240346|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
46993497|NCT02480153|83240347|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
46993498|NCT02480153|83240345|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
46993499|NCT02480153|83240346|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
46993500|NCT02480153|83240347|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
46993501|NCT02480153|83240345|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
46993502|NCT02480153|83240346|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
46993503|NCT02480153|83240347|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
46993504|NCT02500979|83240372|FG000|Period 1|Hyperglycemia|1|||
46993505|NCT02500979|83240373|FG001|Period 1|Hyperglycemia|0|||
46993506|NCT02500979|83240372|FG000|Period 1|Severe non-compliance to protocol|0|||
46993507|NCT02500979|83240373|FG001|Period 1|Severe non-compliance to protocol|1|||
46993508|NCT02500979|83240372|FG000|Period 1|Adverse Event|1|||
46993509|NCT02500979|83240373|FG001|Period 1|Adverse Event|0|||
46993510|NCT02500979|83240372|FG000|Period 1|Subject decision|2|||
46993511|NCT02500979|83240373|FG001|Period 1|Subject decision|0|||
46993512|NCT02500979|83240372|FG000|Period 2|Change in risk|1|||
46993513|NCT02500979|83240373|FG001|Period 2|Change in risk|0|||
46993514|NCT02500901|83240379|FG000|Overall Study|Disease ProgressionDD|2|||
46993515|NCT02479139|83240389|FG000|Overall Study|Lost to Follow-up|2|||
46993516|NCT02479139|83240390|FG001|Overall Study|Lost to Follow-up|4|||
46993517|NCT02479139|83240391|FG002|Overall Study|Lost to Follow-up|4|||
46993518|NCT02479139|83240392|FG003|Overall Study|Lost to Follow-up|2|||
46993519|NCT02479139|83240393|FG004|Overall Study|Lost to Follow-up|3|||
46993520|NCT02479139|83240394|FG005|Overall Study|Lost to Follow-up|5|||
46993521|NCT02479139|83240389|FG000|Overall Study|Withdrew Consent|5|||
46993522|NCT02479139|83240390|FG001|Overall Study|Withdrew Consent|6|||
46993523|NCT02479139|83240391|FG002|Overall Study|Withdrew Consent|1|||
46993524|NCT02479139|83240392|FG003|Overall Study|Withdrew Consent|4|||
46993525|NCT02479139|83240393|FG004|Overall Study|Withdrew Consent|1|||
46993526|NCT02479139|83240394|FG005|Overall Study|Withdrew Consent|1|||
46993527|NCT02479139|83240389|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
46993528|NCT02479139|83240390|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
46993529|NCT02479139|83240391|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
46993530|NCT02479139|83240392|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
46993531|NCT02479139|83240393|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
46993532|NCT02479139|83240394|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
46993533|NCT02479139|83240389|FG000|Overall Study|Other Miscellaneous Reasons|1|||
46708827|NCT04117347|82924720|FG000|Overall Study|No time for study|0|||
46993534|NCT02479139|83240390|FG001|Overall Study|Other Miscellaneous Reasons|0|||
46993535|NCT02479139|83240391|FG002|Overall Study|Other Miscellaneous Reasons|1|||
46993536|NCT02479139|83240392|FG003|Overall Study|Other Miscellaneous Reasons|1|||
46993537|NCT02479139|83240393|FG004|Overall Study|Other Miscellaneous Reasons|1|||
46993538|NCT02479139|83240394|FG005|Overall Study|Other Miscellaneous Reasons|0|||
46993539|NCT02478359|83240410|FG000|Overall Study|Disenrolled from health plan|106|||
46993540|NCT02478359|83240411|FG001|Overall Study|Disenrolled from health plan|65|||
46993541|NCT01877668|83240424|FG000|Overall Study|Death|0|||
46993542|NCT01877668|83240425|FG001|Overall Study|Death|0|||
46993543|NCT01877668|83240426|FG002|Overall Study|Death|0|||
46993544|NCT01877668|83240427|FG003|Overall Study|Death|1|||
46993545|NCT01877668|83240428|FG004|Overall Study|Death|0|||
46993546|NCT01877668|83240424|FG000|Overall Study|No longer met study criteria|1|||
46993547|NCT01877668|83240425|FG001|Overall Study|No longer met study criteria|0|||
46993548|NCT01877668|83240426|FG002|Overall Study|No longer met study criteria|1|||
46993549|NCT01877668|83240427|FG003|Overall Study|No longer met study criteria|0|||
46993550|NCT01877668|83240428|FG004|Overall Study|No longer met study criteria|0|||
46993551|NCT01877668|83240424|FG000|Overall Study|Insufficient clinical response|0|||
46993552|NCT01877668|83240425|FG001|Overall Study|Insufficient clinical response|1|||
46993553|NCT01877668|83240426|FG002|Overall Study|Insufficient clinical response|2|||
46993554|NCT01877668|83240427|FG003|Overall Study|Insufficient clinical response|2|||
46993555|NCT01877668|83240428|FG004|Overall Study|Insufficient clinical response|0|||
46993556|NCT01877668|83240424|FG000|Overall Study|Lost to Follow-up|0|||
46993557|NCT01877668|83240425|FG001|Overall Study|Lost to Follow-up|2|||
46993558|NCT01877668|83240426|FG002|Overall Study|Lost to Follow-up|1|||
46993559|NCT01877668|83240427|FG003|Overall Study|Lost to Follow-up|0|||
46993560|NCT01877668|83240428|FG004|Overall Study|Lost to Follow-up|0|||
46993561|NCT01877668|83240424|FG000|Overall Study|Withdrawal by Subject|2|||
46993562|NCT01877668|83240425|FG001|Overall Study|Withdrawal by Subject|0|||
46993563|NCT01877668|83240426|FG002|Overall Study|Withdrawal by Subject|3|||
46993564|NCT01877668|83240427|FG003|Overall Study|Withdrawal by Subject|2|||
46993565|NCT01877668|83240428|FG004|Overall Study|Withdrawal by Subject|2|||
46993566|NCT01877668|83240424|FG000|Overall Study|Other|1|||
46993567|NCT01877668|83240425|FG001|Overall Study|Other|1|||
46993568|NCT01877668|83240426|FG002|Overall Study|Other|1|||
46993569|NCT01877668|83240427|FG003|Overall Study|Other|1|||
46993570|NCT01877668|83240428|FG004|Overall Study|Other|3|||
46993571|NCT01877668|83240424|FG000|Overall Study|Protocol Violation|1|||
46993572|NCT01877668|83240425|FG001|Overall Study|Protocol Violation|1|||
46993573|NCT01877668|83240426|FG002|Overall Study|Protocol Violation|0|||
46993574|NCT01877668|83240427|FG003|Overall Study|Protocol Violation|0|||
46993575|NCT01877668|83240428|FG004|Overall Study|Protocol Violation|3|||
46993576|NCT01877668|83240424|FG000|Overall Study|Adverse event related to study drug|2|||
46993577|NCT01877668|83240425|FG001|Overall Study|Adverse event related to study drug|2|||
46993578|NCT01877668|83240426|FG002|Overall Study|Adverse event related to study drug|2|||
46993579|NCT01877668|83240427|FG003|Overall Study|Adverse event related to study drug|2|||
46993580|NCT01877668|83240428|FG004|Overall Study|Adverse event related to study drug|1|||
46993581|NCT01877668|83240424|FG000|Overall Study|Adverse event unrelated to study drug|4|||
46993582|NCT01877668|83240425|FG001|Overall Study|Adverse event unrelated to study drug|1|||
46993583|NCT01877668|83240426|FG002|Overall Study|Adverse event unrelated to study drug|2|||
46993584|NCT01877668|83240427|FG003|Overall Study|Adverse event unrelated to study drug|0|||
46993585|NCT01877668|83240428|FG004|Overall Study|Adverse event unrelated to study drug|1|||
46993586|NCT01877278|83240446|FG000|Overall Study|Lost to Follow-up|3|||
46993587|NCT01877278|83240447|FG001|Overall Study|Lost to Follow-up|3|||
46993588|NCT01906372|83240453|FG000|Overall Study|Withdrawal by Subject|2|||
46993589|NCT01925170|83240458|FG000|Overall Study|Unverified cancer status|53|||
46993590|NCT01925014|83240466|FG000|Overall Study|Inappropriate enrollment|4|||
46993591|NCT01925014|83240467|FG001|Overall Study|Inappropriate enrollment|6|||
46993592|NCT01925014|83240466|FG000|Overall Study|Withdrawal by Subject|5|||
46993593|NCT01925014|83240467|FG001|Overall Study|Withdrawal by Subject|13|||
46993594|NCT01876810|83240473|FG000|Overall Study|Physician Decision|0|||
46993595|NCT01876810|83240474|FG001|Overall Study|Physician Decision|1|||
46993596|NCT01876732|83240483|FG000|Overall Study|MMA was not over 800mg/dL|75|||
46993597|NCT01905592|83240490|FG000|Overall Study|Disease Progression|51|||
46993598|NCT01905592|83240491|FG001|Overall Study|Disease Progression|110|||
46993599|NCT01905592|83240490|FG000|Overall Study|Toxicity|1|||
46993600|NCT01905592|83240491|FG001|Overall Study|Toxicity|16|||
46993601|NCT01905592|83240490|FG000|Overall Study|Physician Decision|0|||
46993602|NCT01905592|83240491|FG001|Overall Study|Physician Decision|2|||
46993603|NCT01905592|83240490|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
46993604|NCT01905592|83240491|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
46993605|NCT01905592|83240490|FG000|Overall Study|Protocol Violation|0|||
46993606|NCT01905592|83240491|FG001|Overall Study|Protocol Violation|1|||
46993607|NCT01905592|83240490|FG000|Overall Study|Sponsor's decision|1|||
46993608|NCT01905592|83240491|FG001|Overall Study|Sponsor's decision|1|||
46993609|NCT01905592|83240490|FG000|Overall Study|Not treated|7|||
46993610|NCT01905592|83240491|FG001|Overall Study|Not treated|3|||
46993611|NCT01905592|83240490|FG000|Overall Study|Withdrawal by Subject|10|||
46993612|NCT01905592|83240491|FG001|Overall Study|Withdrawal by Subject|2|||
46708828|NCT04117347|82924721|FG001|Overall Study|No time for study|2|||
46993613|NCT01876420|83240497|FG000|Overall Study|Missed 30 day visit|1|||
46993614|NCT01875874|83240501|FG000|Overall Study|Death|3|||
46993615|NCT02500121|83240508|FG000|Overall Study|Lost to Follow-up|0|||
46993616|NCT02500121|83240509|FG001|Overall Study|Lost to Follow-up|1|||
46993617|NCT02500121|83240508|FG000|Overall Study|Withdrawal by Subject|1|||
46993618|NCT02500121|83240509|FG001|Overall Study|Withdrawal by Subject|1|||
46993619|NCT02500121|83240508|FG000|Overall Study|Death|26|||
46993620|NCT02500121|83240509|FG001|Overall Study|Death|24|||
46993621|NCT01875250|83240519|FG000|Overall Study|Adverse Event|2|||
46993622|NCT01875250|83240520|FG001|Overall Study|Adverse Event|0|||
46993623|NCT01904032|83240530|FG000|Overall Study|Adverse Event|3|||
46993624|NCT01904032|83240531|FG001|Overall Study|Adverse Event|1|||
46993625|NCT01904032|83240530|FG000|Overall Study|Lost to Follow-up|4|||
46993626|NCT01904032|83240531|FG001|Overall Study|Lost to Follow-up|2|||
46993627|NCT01903876|83240539|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
46993628|NCT01903876|83240540|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
46993629|NCT01903876|83240539|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
46993630|NCT01903876|83240540|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
46993631|NCT01921348|83240548|FG000|Overall Study|Withdrawal by Subject|1|||
46993632|NCT01921348|83240549|FG001|Overall Study|Withdrawal by Subject|0|||
46993633|NCT01921348|83240548|FG000|Overall Study|Lost to Follow-up|0|||
46993634|NCT01921348|83240549|FG001|Overall Study|Lost to Follow-up|2|||
46993635|NCT01921270|83240555|FG000|Overall Study|Withdrawal by Subject|1|||
46993636|NCT02325739|83240570|FG000|Phase I Part|Adverse Event|1|||
46993637|NCT02325739|83240571|FG001|Phase I Part|Adverse Event|0|||
46993638|NCT02325739|83240572|FG002|Phase I Part|Adverse Event|1|||
46993639|NCT02325739|83240573|FG003|Phase I Part|Adverse Event|2|||
46993640|NCT02325739|83240574|FG004|Phase I Part|Adverse Event|3|||
46993641|NCT02325739|83240575|FG005|Phase I Part|Adverse Event|1|||
46993642|NCT02325739|83240576|FG006|Phase I Part|Adverse Event|0|||
46993643|NCT02325739|83240577|FG007|Phase I Part|Adverse Event|2|||
46993644|NCT02325739|83240578|FG008|Phase I Part|Adverse Event|0|||
46993645|NCT02325739|83240579|FG009|Phase I Part|Adverse Event|0|||
46993646|NCT02325739|83240580|FG010|Phase I Part|Adverse Event|0|||
46993647|NCT02325739|83240570|FG000|Phase I Part|Progressive disease|9|||
46993648|NCT02325739|83240571|FG001|Phase I Part|Progressive disease|6|||
46993649|NCT02325739|83240572|FG002|Phase I Part|Progressive disease|3|||
46993650|NCT02325739|83240573|FG003|Phase I Part|Progressive disease|23|||
46993651|NCT02325739|83240574|FG004|Phase I Part|Progressive disease|14|||
46993652|NCT02325739|83240575|FG005|Phase I Part|Progressive disease|6|||
46993653|NCT02325739|83240576|FG006|Phase I Part|Progressive disease|6|||
46993654|NCT02325739|83240577|FG007|Phase I Part|Progressive disease|3|||
46993655|NCT02325739|83240578|FG008|Phase I Part|Progressive disease|0|||
46993656|NCT02325739|83240579|FG009|Phase I Part|Progressive disease|0|||
46993657|NCT02325739|83240580|FG010|Phase I Part|Progressive disease|0|||
46993658|NCT02325739|83240570|FG000|Phase I Part|Subject/guardian decision|1|||
46993659|NCT02325739|83240571|FG001|Phase I Part|Subject/guardian decision|0|||
46993660|NCT02325739|83240572|FG002|Phase I Part|Subject/guardian decision|1|||
46993661|NCT02325739|83240573|FG003|Phase I Part|Subject/guardian decision|1|||
46993662|NCT02325739|83240574|FG004|Phase I Part|Subject/guardian decision|0|||
46618360|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618361|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618362|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618363|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
46618364|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
46618365|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618366|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
46618367|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
46618368|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618369|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618370|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618371|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46993663|NCT02325739|83240575|FG005|Phase I Part|Subject/guardian decision|0|||
46993664|NCT02325739|83240576|FG006|Phase I Part|Subject/guardian decision|0|||
46993665|NCT02325739|83240577|FG007|Phase I Part|Subject/guardian decision|1|||
46993666|NCT02325739|83240578|FG008|Phase I Part|Subject/guardian decision|0|||
46993667|NCT02325739|83240579|FG009|Phase I Part|Subject/guardian decision|0|||
46993668|NCT02325739|83240580|FG010|Phase I Part|Subject/guardian decision|0|||
46993669|NCT02325739|83240570|FG000|Phase I Part|Death|0|||
46993670|NCT02325739|83240571|FG001|Phase I Part|Death|0|||
46618372|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
46618373|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618374|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618375|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46993671|NCT02325739|83240572|FG002|Phase I Part|Death|0|||
46993672|NCT02325739|83240573|FG003|Phase I Part|Death|0|||
46993673|NCT02325739|83240574|FG004|Phase I Part|Death|2|||
46993674|NCT02325739|83240575|FG005|Phase I Part|Death|0|||
46993675|NCT02325739|83240576|FG006|Phase I Part|Death|0|||
46993676|NCT02325739|83240577|FG007|Phase I Part|Death|0|||
46993677|NCT02325739|83240578|FG008|Phase I Part|Death|0|||
46993678|NCT02325739|83240579|FG009|Phase I Part|Death|0|||
46993679|NCT02325739|83240580|FG010|Phase I Part|Death|0|||
46993680|NCT02325739|83240570|FG000|Phase II Part|Adverse Event|0|||
46993681|NCT02325739|83240571|FG001|Phase II Part|Adverse Event|0|||
46993682|NCT02325739|83240572|FG002|Phase II Part|Adverse Event|0|||
46993683|NCT02325739|83240573|FG003|Phase II Part|Adverse Event|0|||
46993684|NCT02325739|83240574|FG004|Phase II Part|Adverse Event|0|||
46993685|NCT02325739|83240575|FG005|Phase II Part|Adverse Event|0|||
46993686|NCT02325739|83240576|FG006|Phase II Part|Adverse Event|0|||
46993687|NCT02325739|83240577|FG007|Phase II Part|Adverse Event|0|||
46993688|NCT02325739|83240578|FG008|Phase II Part|Adverse Event|4|||
46993689|NCT02325739|83240579|FG009|Phase II Part|Adverse Event|5|||
46993690|NCT02325739|83240580|FG010|Phase II Part|Adverse Event|1|||
46993691|NCT02325739|83240570|FG000|Phase II Part|Physician Decision|0|||
46993692|NCT02325739|83240571|FG001|Phase II Part|Physician Decision|0|||
46993693|NCT02325739|83240572|FG002|Phase II Part|Physician Decision|0|||
46993694|NCT02325739|83240573|FG003|Phase II Part|Physician Decision|0|||
46993695|NCT02325739|83240574|FG004|Phase II Part|Physician Decision|0|||
46993696|NCT02325739|83240575|FG005|Phase II Part|Physician Decision|0|||
46993697|NCT02325739|83240576|FG006|Phase II Part|Physician Decision|0|||
46993698|NCT02325739|83240577|FG007|Phase II Part|Physician Decision|0|||
46993699|NCT02325739|83240578|FG008|Phase II Part|Physician Decision|0|||
46993700|NCT02325739|83240579|FG009|Phase II Part|Physician Decision|1|||
46993701|NCT02325739|83240580|FG010|Phase II Part|Physician Decision|0|||
46993702|NCT02325739|83240570|FG000|Phase II Part|Progressive disease|0|||
46993703|NCT02325739|83240571|FG001|Phase II Part|Progressive disease|0|||
46993704|NCT02325739|83240572|FG002|Phase II Part|Progressive disease|0|||
46993705|NCT02325739|83240573|FG003|Phase II Part|Progressive disease|0|||
46993706|NCT02325739|83240574|FG004|Phase II Part|Progressive disease|0|||
46993707|NCT02325739|83240575|FG005|Phase II Part|Progressive disease|0|||
46993708|NCT02325739|83240576|FG006|Phase II Part|Progressive disease|0|||
46993709|NCT02325739|83240577|FG007|Phase II Part|Progressive disease|0|||
46993710|NCT02325739|83240578|FG008|Phase II Part|Progressive disease|22|||
46993711|NCT02325739|83240579|FG009|Phase II Part|Progressive disease|29|||
46993712|NCT02325739|83240580|FG010|Phase II Part|Progressive disease|18|||
46993713|NCT02325739|83240570|FG000|Phase II Part|Subject/guardian decision|0|||
46993714|NCT02325739|83240571|FG001|Phase II Part|Subject/guardian decision|0|||
46993715|NCT02325739|83240572|FG002|Phase II Part|Subject/guardian decision|0|||
46993716|NCT02325739|83240573|FG003|Phase II Part|Subject/guardian decision|0|||
46993717|NCT02325739|83240574|FG004|Phase II Part|Subject/guardian decision|0|||
46993718|NCT02325739|83240575|FG005|Phase II Part|Subject/guardian decision|0|||
46993719|NCT02325739|83240576|FG006|Phase II Part|Subject/guardian decision|0|||
46993720|NCT02325739|83240577|FG007|Phase II Part|Subject/guardian decision|0|||
46993721|NCT02325739|83240578|FG008|Phase II Part|Subject/guardian decision|4|||
46993722|NCT02325739|83240579|FG009|Phase II Part|Subject/guardian decision|1|||
46993723|NCT02325739|83240580|FG010|Phase II Part|Subject/guardian decision|1|||
46993724|NCT01903720|83240625|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
46993725|NCT01903720|83240625|FG000|Overall Study|Adverse Event|1|||
46993726|NCT01903720|83240625|FG000|Overall Study|Rescinding of informed consent|2|||
46993727|NCT01903720|83240625|FG000|Overall Study|Lost to Follow-up|2|||
46993728|NCT01903720|83240625|FG000|Overall Study|Treatment with alternative drug|1|||
46993729|NCT02366689|83240632|FG000|Overall Study|Withdrawal by Subject|1|||
46993730|NCT02366689|83240633|FG001|Overall Study|Withdrawal by Subject|0|||
46993731|NCT02366689|83240634|FG002|Overall Study|Withdrawal by Subject|1|||
46993732|NCT02366689|83240632|FG000|Overall Study|Lost to Follow-up|3|||
46993733|NCT02366689|83240633|FG001|Overall Study|Lost to Follow-up|2|||
46993734|NCT02366689|83240634|FG002|Overall Study|Lost to Follow-up|0|||
46993735|NCT02366689|83240632|FG000|Overall Study|Pregnancy|0|||
46993736|NCT02366689|83240633|FG001|Overall Study|Pregnancy|1|||
46993737|NCT02366689|83240634|FG002|Overall Study|Pregnancy|1|||
46993738|NCT01903252|83240644|FG000|Double-Blind Induction|Adverse Event|20|||
46993739|NCT01903252|83240645|FG001|Double-Blind Induction|Adverse Event|18|||
46993740|NCT01903252|83240646|FG002|Double-Blind Induction|Adverse Event|0|||
46993741|NCT01903252|83240647|FG003|Double-Blind Induction|Adverse Event|0|||
46993742|NCT01903252|83240648|FG004|Double-Blind Induction|Adverse Event|0|||
46993743|NCT01903252|83240649|FG005|Double-Blind Induction|Adverse Event|0|||
46993744|NCT01903252|83240644|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
46993745|NCT01903252|83240645|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
46993746|NCT01903252|83240646|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
46993747|NCT01903252|83240647|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
46993748|NCT01903252|83240648|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
46993749|NCT01903252|83240649|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
46993750|NCT01903252|83240644|FG000|Double-Blind Induction|Physician Decision|2|||
46993751|NCT01903252|83240645|FG001|Double-Blind Induction|Physician Decision|3|||
46993752|NCT01903252|83240646|FG002|Double-Blind Induction|Physician Decision|0|||
46993753|NCT01903252|83240647|FG003|Double-Blind Induction|Physician Decision|0|||
46993754|NCT01903252|83240648|FG004|Double-Blind Induction|Physician Decision|0|||
46993755|NCT01903252|83240649|FG005|Double-Blind Induction|Physician Decision|0|||
46993756|NCT01903252|83240644|FG000|Double-Blind Induction|non-compliance,|7|||
46993757|NCT01903252|83240645|FG001|Double-Blind Induction|non-compliance,|7|||
46993758|NCT01903252|83240646|FG002|Double-Blind Induction|non-compliance,|0|||
46993759|NCT01903252|83240647|FG003|Double-Blind Induction|non-compliance,|0|||
46993760|NCT01903252|83240648|FG004|Double-Blind Induction|non-compliance,|0|||
46993761|NCT01903252|83240649|FG005|Double-Blind Induction|non-compliance,|0|||
46993762|NCT01903252|83240644|FG000|Extended Induction, Open-Label|Adverse Event|0|||
46993763|NCT01903252|83240645|FG001|Extended Induction, Open-Label|Adverse Event|0|||
46993764|NCT01903252|83240646|FG002|Extended Induction, Open-Label|Adverse Event|17|||
46993765|NCT01903252|83240647|FG003|Extended Induction, Open-Label|Adverse Event|0|||
46993766|NCT01903252|83240648|FG004|Extended Induction, Open-Label|Adverse Event|0|||
46993767|NCT01903252|83240649|FG005|Extended Induction, Open-Label|Adverse Event|0|||
46993768|NCT01903252|83240644|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
46993769|NCT01903252|83240645|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
46993770|NCT01903252|83240646|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
46993771|NCT01903252|83240647|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
46993772|NCT01903252|83240648|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
46993773|NCT01903252|83240649|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
46993774|NCT01903252|83240644|FG000|Extended Induction, Open-Label|Physician Decision|0|||
46993775|NCT01903252|83240645|FG001|Extended Induction, Open-Label|Physician Decision|0|||
46993776|NCT01903252|83240646|FG002|Extended Induction, Open-Label|Physician Decision|1|||
46993777|NCT01903252|83240647|FG003|Extended Induction, Open-Label|Physician Decision|0|||
46993778|NCT01903252|83240648|FG004|Extended Induction, Open-Label|Physician Decision|0|||
46993779|NCT01903252|83240649|FG005|Extended Induction, Open-Label|Physician Decision|0|||
46993780|NCT01903252|83240644|FG000|Maintenance, Open-Label|Adverse Event|0|||
46993781|NCT01903252|83240645|FG001|Maintenance, Open-Label|Adverse Event|0|||
46993782|NCT01903252|83240646|FG002|Maintenance, Open-Label|Adverse Event|0|||
46993783|NCT01903252|83240647|FG003|Maintenance, Open-Label|Adverse Event|3|||
46993784|NCT01903252|83240648|FG004|Maintenance, Open-Label|Adverse Event|9|||
46993785|NCT01903252|83240649|FG005|Maintenance, Open-Label|Adverse Event|14|||
46993786|NCT01903252|83240644|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
46993787|NCT01903252|83240645|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
46993788|NCT01903252|83240646|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
46993789|NCT01903252|83240647|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
46993790|NCT01903252|83240648|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
46993791|NCT01903252|83240649|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
46993792|NCT01903252|83240644|FG000|Maintenance, Open-Label|Other|0|||
46993793|NCT01903252|83240645|FG001|Maintenance, Open-Label|Other|0|||
46993794|NCT01903252|83240646|FG002|Maintenance, Open-Label|Other|0|||
46993795|NCT01903252|83240647|FG003|Maintenance, Open-Label|Other|2|||
46993796|NCT01903252|83240648|FG004|Maintenance, Open-Label|Other|6|||
46993797|NCT01903252|83240649|FG005|Maintenance, Open-Label|Other|2|||
46993798|NCT01920958|83240667|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
46993799|NCT01613716|83240671|FG000|Overall Study|screen failures|3|||
46993800|NCT01613716|83240671|FG000|Overall Study|Lost to Follow-up|4|||
46993801|NCT01872910|83240681|FG000|Overall Study|Lost to Follow-up|2|||
46993802|NCT01872910|83240682|FG001|Overall Study|Lost to Follow-up|0|||
46993803|NCT01872910|83240683|FG002|Overall Study|Lost to Follow-up|2|||
46993804|NCT01872910|83240684|FG003|Overall Study|Lost to Follow-up|0|||
46993805|NCT01872910|83240685|FG004|Overall Study|Lost to Follow-up|0|||
46993806|NCT01872910|83240686|FG005|Overall Study|Lost to Follow-up|0|||
46993807|NCT01920568|83240701|FG000|Overall Study|Adverse Event|27|||
46993808|NCT01920568|83240702|FG001|Overall Study|Adverse Event|8|||
46993809|NCT01920568|83240701|FG000|Overall Study|Protocol Violation|5|||
46993810|NCT01920568|83240702|FG001|Overall Study|Protocol Violation|3|||
46993811|NCT01920568|83240701|FG000|Overall Study|Lost to Follow-up|2|||
46993812|NCT01920568|83240702|FG001|Overall Study|Lost to Follow-up|2|||
46993813|NCT01920568|83240701|FG000|Overall Study|Physician Decision|13|||
46993814|NCT01920568|83240702|FG001|Overall Study|Physician Decision|4|||
46993815|NCT01920568|83240701|FG000|Overall Study|Withdrawal by Subject|79|||
46993816|NCT01920568|83240702|FG001|Overall Study|Withdrawal by Subject|55|||
46993817|NCT01920568|83240701|FG000|Overall Study|Death due to disease progression|25|||
46993818|NCT01920568|83240702|FG001|Overall Study|Death due to disease progression|12|||
46993819|NCT01902628|83240709|FG000|Overall Study|Withdrawal of participant's consent|7|||
46993820|NCT01902628|83240709|FG000|Overall Study|Adverse Event|41|||
46993821|NCT01902628|83240709|FG000|Overall Study|Lost to Follow-up|35|||
46993822|NCT01920178|83240715|FG000|Overall Study|Lost to Follow-up|2|||
46993823|NCT01920178|83240716|FG001|Overall Study|Lost to Follow-up|1|||
46993824|NCT01901848|83240724|FG000|Randomized and Treated|Lost to Follow-up|3|||
46993825|NCT01901848|83240725|FG001|Randomized and Treated|Lost to Follow-up|6|||
46993826|NCT01901848|83240724|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
46993827|NCT01901848|83240725|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
46993828|NCT01901614|83240733|FG000|Overall Study|Adverse Event|0|||
46993829|NCT01901614|83240734|FG001|Overall Study|Adverse Event|1|||
46993830|NCT01901614|83240733|FG000|Overall Study|Lost to Follow-up|1|||
46993831|NCT01901614|83240734|FG001|Overall Study|Lost to Follow-up|0|||
46993832|NCT01901614|83240733|FG000|Overall Study|Screen Fail|1|||
46993833|NCT01901614|83240734|FG001|Overall Study|Screen Fail|0|||
46993834|NCT01901302|83240742|FG000|Overall Study|Adverse Event|2|||
46993835|NCT01901302|83240743|FG001|Overall Study|Adverse Event|1|||
46993836|NCT01901302|83240742|FG000|Overall Study|Lack of Efficacy|0|||
46993837|NCT01901302|83240743|FG001|Overall Study|Lack of Efficacy|2|||
46993838|NCT01901302|83240742|FG000|Overall Study|Study Terminated by Sponsor|23|||
46993839|NCT01901302|83240743|FG001|Overall Study|Study Terminated by Sponsor|20|||
46993840|NCT01901302|83240742|FG000|Overall Study|Withdrawal by Subject|2|||
46993841|NCT01901302|83240743|FG001|Overall Study|Withdrawal by Subject|0|||
46993842|NCT01919398|83240752|FG000|Overall Study|Progressive Disease|0|||
46993843|NCT01919398|83240753|FG001|Overall Study|Progressive Disease|0|||
46993844|NCT01919398|83240754|FG002|Overall Study|Progressive Disease|4|||
46993845|NCT02500043|83240764|FG000|Overall Study|Randomized, but not Treated|2|||
46993846|NCT02500043|83240765|FG001|Overall Study|Randomized, but not Treated|2|||
46993847|NCT02500043|83240764|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
46993848|NCT02500043|83240765|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
46993849|NCT02500043|83240764|FG000|Overall Study|Adverse Event|33|||
46993850|NCT02500043|83240765|FG001|Overall Study|Adverse Event|11|||
46993851|NCT02500043|83240764|FG000|Overall Study|Clinical Progression|54|||
46993852|NCT02500043|83240765|FG001|Overall Study|Clinical Progression|35|||
46993853|NCT02500043|83240764|FG000|Overall Study|Radiological Progression|192|||
46993854|NCT02500043|83240765|FG001|Overall Study|Radiological Progression|110|||
46993855|NCT02500043|83240764|FG000|Overall Study|Physician's Decision|11|||
46993856|NCT02500043|83240765|FG001|Overall Study|Physician's Decision|3|||
46993857|NCT02500043|83240764|FG000|Overall Study|Withdrawal by Subject|14|||
46993858|NCT02500043|83240765|FG001|Overall Study|Withdrawal by Subject|4|||
46993859|NCT02500043|83240764|FG000|Overall Study|Death|11|||
46993860|NCT02500043|83240765|FG001|Overall Study|Death|2|||
46993861|NCT02500043|83240764|FG000|Overall Study|Protocol Deviation|1|||
46993862|NCT02500043|83240765|FG001|Overall Study|Protocol Deviation|0|||
46993863|NCT02499575|83240773|FG000|Overall Study|Protocol Violation|0|||
46993864|NCT02499575|83240774|FG001|Overall Study|Protocol Violation|1|||
46993865|NCT02065791|83240782|FG000|Overall Study|Closed Site|1|||
46993866|NCT02065791|83240783|FG001|Overall Study|Closed Site|1|||
46993867|NCT02065791|83240782|FG000|Overall Study|Withdrawal by Subject|11|||
46993868|NCT02065791|83240783|FG001|Overall Study|Withdrawal by Subject|5|||
46993869|NCT02065791|83240782|FG000|Overall Study|Lost to Follow-up|13|||
46993870|NCT02065791|83240783|FG001|Overall Study|Lost to Follow-up|9|||
46993871|NCT02499263|83240789|FG000|Overall Study|Lost to Follow-up|9|||
46993872|NCT02499263|83240789|FG000|Overall Study|Participant's withdrawal of consent|4|||
46993873|NCT02499263|83240789|FG000|Overall Study|Lack of Efficacy|22|||
46993874|NCT02499263|83240789|FG000|Overall Study|investigator's judgment|12|||
46993875|NCT02499263|83240789|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
46993876|NCT02499263|83240789|FG000|Overall Study|Participant's decision|3|||
46993877|NCT02499263|83240789|FG000|Overall Study|Pregnancy|1|||
46993878|NCT01654289|83240796|FG000|Overall Study|Withdrawal by Subject|10|||
46993879|NCT01654289|83240797|FG001|Overall Study|Withdrawal by Subject|8|||
46993880|NCT01654289|83240798|FG002|Overall Study|Withdrawal by Subject|5|||
46993881|NCT01654289|83240796|FG000|Overall Study|Withdrew from intervention only|17|||
46993882|NCT01654289|83240797|FG001|Overall Study|Withdrew from intervention only|20|||
46993883|NCT01654289|83240798|FG002|Overall Study|Withdrew from intervention only|0|||
46993884|NCT02499029|83240808|FG000|Overall Study|Lost to Follow-up|2|||
46993885|NCT02499029|83240809|FG001|Overall Study|Lost to Follow-up|2|||
46993886|NCT02499029|83240808|FG000|Overall Study|Physician Decision|2|||
46993887|NCT02499029|83240809|FG001|Overall Study|Physician Decision|1|||
46993888|NCT02499029|83240808|FG000|Overall Study|Death|1|||
46993889|NCT02499029|83240809|FG001|Overall Study|Death|0|||
46618376|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618377|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618378|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
46618379|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618380|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
46618381|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618382|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46993890|NCT04968353|83240819|FG000|Overall Study|Non-compliance|1|||
46993891|NCT04968353|83240820|FG001|Overall Study|Non-compliance|0|||
46993892|NCT04968353|83240821|FG002|Overall Study|Non-compliance|2|||
46993893|NCT04968353|83240822|FG003|Overall Study|Non-compliance|0|||
46618383|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618384|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46993894|NCT02065713|83240834|FG000|Overall Study|Adverse Event|0|||
46993895|NCT02065713|83240835|FG001|Overall Study|Adverse Event|1|||
46993896|NCT02065713|83240834|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46993897|NCT02065713|83240835|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46993898|NCT02497781|83240843|FG000|Overall Study|Withdrawal by Subject|2|||
46993899|NCT02497781|83240844|FG001|Overall Study|Withdrawal by Subject|0|||
46993900|NCT02497781|83240843|FG000|Overall Study|Lack of Efficacy|0|||
46993901|NCT02497781|83240844|FG001|Overall Study|Lack of Efficacy|1|||
46993902|NCT02497781|83240843|FG000|Overall Study|Randomised but not treated|1|||
46993903|NCT02497781|83240844|FG001|Overall Study|Randomised but not treated|1|||
46993904|NCT02497781|83240843|FG000|Overall Study|Lost to Follow-up|1|||
46993905|NCT02497781|83240844|FG001|Overall Study|Lost to Follow-up|1|||
46993906|NCT02497469|83240852|FG000|Overall Study|Randomized but not Treated|0|||
46993907|NCT02497469|83240853|FG001|Overall Study|Randomized but not Treated|2|||
46993908|NCT02497469|83240852|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
46993909|NCT02497469|83240853|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
46993910|NCT02497469|83240852|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
46993911|NCT02497469|83240853|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
46993912|NCT02497469|83240852|FG000|Overall Study|Significant Protocol Deviation|4|||
46993913|NCT02497469|83240853|FG001|Overall Study|Significant Protocol Deviation|5|||
46993914|NCT02497469|83240852|FG000|Overall Study|Lost to Follow-up|14|||
46993915|NCT02497469|83240853|FG001|Overall Study|Lost to Follow-up|4|||
46993916|NCT02497469|83240852|FG000|Overall Study|Voluntary Withdrawal|39|||
46993917|NCT02497469|83240853|FG001|Overall Study|Voluntary Withdrawal|41|||
46993918|NCT02497469|83240852|FG000|Overall Study|Pregnancy|1|||
46993919|NCT02497469|83240853|FG001|Overall Study|Pregnancy|1|||
46993920|NCT02497469|83240852|FG000|Overall Study|Lack of Efficacy|86|||
46993921|NCT02497469|83240853|FG001|Overall Study|Lack of Efficacy|40|||
46993922|NCT02497469|83240852|FG000|Overall Study|Reason not Specified|6|||
46993923|NCT02497469|83240853|FG001|Overall Study|Reason not Specified|6|||
46993924|NCT02497391|83240859|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
46993925|NCT02497391|83240860|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
46993926|NCT02497391|83240861|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
46993927|NCT02497391|83240862|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
46993928|NCT02497391|83240863|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
46993929|NCT02497391|83240864|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
46993930|NCT02497391|83240859|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
46993931|NCT02497391|83240860|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
46993932|NCT02497391|83240861|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
46993933|NCT02497391|83240862|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
46993934|NCT02497391|83240863|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
46993935|NCT02497391|83240864|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
46993936|NCT02497391|83240859|FG000|Period 3 (14 Days)|Adverse Event|0|||
46993937|NCT02497391|83240860|FG001|Period 3 (14 Days)|Adverse Event|1|||
46993938|NCT02497391|83240861|FG002|Period 3 (14 Days)|Adverse Event|0|||
46993939|NCT02497391|83240862|FG003|Period 3 (14 Days)|Adverse Event|0|||
46993940|NCT02497391|83240863|FG004|Period 3 (14 Days)|Adverse Event|0|||
46618385|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618386|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618387|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46618388|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618389|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618390|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618391|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46618392|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618393|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
46618394|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46618395|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46618396|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618397|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46618398|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618399|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618400|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618401|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618402|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46618403|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618404|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618405|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618406|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618407|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46993941|NCT02497391|83240864|FG005|Period 3 (14 Days)|Adverse Event|0|||
46993942|NCT02497391|83240859|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
46993943|NCT02497391|83240860|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
46993944|NCT02497391|83240861|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
46993945|NCT02497391|83240862|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
46993946|NCT02497391|83240863|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
46993947|NCT02497391|83240864|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
46993948|NCT02497391|83240859|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
46993949|NCT02497391|83240860|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
46618408|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618409|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46993950|NCT02497391|83240861|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
46993951|NCT02497391|83240862|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
46993952|NCT02497391|83240863|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
46993953|NCT02497391|83240864|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
46993954|NCT02476175|83240872|FG000|Overall Study|Adverse Event|2|||
46993955|NCT02065557|83240879|FG000|Induction Period|Withdrawal by Subject|2|||
46993956|NCT02065557|83240880|FG001|Induction Period|Withdrawal by Subject|1|||
46993957|NCT02065557|83240881|FG002|Induction Period|Withdrawal by Subject|0|||
46993958|NCT02065557|83240882|FG003|Induction Period|Withdrawal by Subject|0|||
46993959|NCT02065557|83240883|FG004|Induction Period|Withdrawal by Subject|0|||
46993960|NCT02065557|83240884|FG005|Induction Period|Withdrawal by Subject|0|||
46993961|NCT02065557|83240879|FG000|Induction Period|Lack of Efficacy|2|||
46993962|NCT02065557|83240880|FG001|Induction Period|Lack of Efficacy|1|||
46993963|NCT02065557|83240881|FG002|Induction Period|Lack of Efficacy|1|||
46993964|NCT02065557|83240882|FG003|Induction Period|Lack of Efficacy|0|||
46993965|NCT02065557|83240883|FG004|Induction Period|Lack of Efficacy|0|||
46993966|NCT02065557|83240884|FG005|Induction Period|Lack of Efficacy|0|||
46993967|NCT02065557|83240879|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
46993968|NCT02065557|83240880|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
46993969|NCT02065557|83240881|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
46993970|NCT02065557|83240882|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
46993971|NCT02065557|83240883|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
46993972|NCT02065557|83240884|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
46993973|NCT02065557|83240879|FG000|Induction Period|Non-Responder at Week 8|4|||
46993974|NCT02065557|83240880|FG001|Induction Period|Non-Responder at Week 8|4|||
46993975|NCT02065557|83240881|FG002|Induction Period|Non-Responder at Week 8|0|||
46993976|NCT02065557|83240882|FG003|Induction Period|Non-Responder at Week 8|0|||
46993977|NCT02065557|83240883|FG004|Induction Period|Non-Responder at Week 8|0|||
46993978|NCT02065557|83240884|FG005|Induction Period|Non-Responder at Week 8|0|||
46993979|NCT02065557|83240879|FG000|Induction Period|Adverse Event|1|||
46993980|NCT02065557|83240880|FG001|Induction Period|Adverse Event|1|||
46993981|NCT02065557|83240881|FG002|Induction Period|Adverse Event|0|||
46993982|NCT02065557|83240882|FG003|Induction Period|Adverse Event|0|||
46993983|NCT02065557|83240883|FG004|Induction Period|Adverse Event|0|||
46993984|NCT02065557|83240884|FG005|Induction Period|Adverse Event|0|||
46993985|NCT02065557|83240879|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
46993986|NCT02065557|83240880|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
46993987|NCT02065557|83240881|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
46618410|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
46708829|NCT04117347|82924722|FG002|Overall Study|No time for study|0|||
46898808|NCT04507126|83125137|FG000|Overall Study|Protocol Violation|2|||
46898809|NCT04507126|83125137|FG000|Overall Study|Physician Decision|1|||
46898810|NCT04498832|83125144|FG000|Overall Study|Adverse Event|1|||
46898811|NCT04498832|83125145|FG001|Overall Study|Adverse Event|3|||
46898812|NCT04498832|83125144|FG000|Overall Study|Withdrawal by Subject|0|||
46898813|NCT04498832|83125145|FG001|Overall Study|Withdrawal by Subject|1|||
46898814|NCT04490018|83125154|FG000|Overall Study|Protocol Violation|0|||
46898815|NCT04490018|83125155|FG001|Overall Study|Protocol Violation|2|||
46898816|NCT04490018|83125156|FG002|Overall Study|Protocol Violation|1|||
46898817|NCT04490018|83125154|FG000|Overall Study|Lost to Follow-up|2|||
46898818|NCT04490018|83125155|FG001|Overall Study|Lost to Follow-up|2|||
46898819|NCT04490018|83125156|FG002|Overall Study|Lost to Follow-up|0|||
46898820|NCT04490018|83125154|FG000|Overall Study|Withdrawal by Subject|2|||
46898821|NCT04490018|83125155|FG001|Overall Study|Withdrawal by Subject|1|||
46898822|NCT04490018|83125156|FG002|Overall Study|Withdrawal by Subject|0|||
46898823|NCT04490018|83125154|FG000|Overall Study|Withdrawal by parent/guardian|2|||
46898824|NCT04490018|83125155|FG001|Overall Study|Withdrawal by parent/guardian|3|||
46898825|NCT04490018|83125156|FG002|Overall Study|Withdrawal by parent/guardian|0|||
46898826|NCT03672461|83125219|FG000|Overall Study|COVID Related|4|||
46898827|NCT03672461|83125220|FG001|Overall Study|COVID Related|2|||
46898828|NCT03672461|83125219|FG000|Overall Study|Adverse Event|2|||
46898829|NCT03672461|83125220|FG001|Overall Study|Adverse Event|0|||
46898830|NCT03672461|83125219|FG000|Overall Study|Serious Adverse Event|0|||
46898831|NCT03672461|83125220|FG001|Overall Study|Serious Adverse Event|1|||
46898832|NCT03672461|83125219|FG000|Overall Study|Too Busy|3|||
46898833|NCT03672461|83125220|FG001|Overall Study|Too Busy|1|||
46898834|NCT03672461|83125219|FG000|Overall Study|Lost to Follow-up|1|||
46898835|NCT03672461|83125220|FG001|Overall Study|Lost to Follow-up|2|||
46898836|NCT03672461|83125219|FG000|Overall Study|Family|2|||
46898837|NCT03672461|83125220|FG001|Overall Study|Family|2|||
46898838|NCT03672461|83125219|FG000|Overall Study|No remote technology access|0|||
46898839|NCT03672461|83125220|FG001|Overall Study|No remote technology access|1|||
46898840|NCT03672461|83125219|FG000|Overall Study|Withdrawal by Subject|1|||
46993988|NCT02065557|83240882|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
46993989|NCT02065557|83240883|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
46993990|NCT02065557|83240884|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
46993991|NCT02065557|83240879|FG000|Maintenance Period|Withdrawal by Subject|0|||
46993992|NCT02065557|83240880|FG001|Maintenance Period|Withdrawal by Subject|0|||
46993993|NCT02065557|83240881|FG002|Maintenance Period|Withdrawal by Subject|0|||
46993994|NCT02065557|83240882|FG003|Maintenance Period|Withdrawal by Subject|0|||
46993995|NCT02065557|83240883|FG004|Maintenance Period|Withdrawal by Subject|2|||
46993996|NCT02065557|83240884|FG005|Maintenance Period|Withdrawal by Subject|1|||
46993997|NCT02065557|83240879|FG000|Maintenance Period|Lack of Efficacy|0|||
46993998|NCT02065557|83240880|FG001|Maintenance Period|Lack of Efficacy|0|||
46993999|NCT02065557|83240881|FG002|Maintenance Period|Lack of Efficacy|0|||
46994000|NCT02065557|83240882|FG003|Maintenance Period|Lack of Efficacy|0|||
46994001|NCT02065557|83240883|FG004|Maintenance Period|Lack of Efficacy|5|||
46994002|NCT02065557|83240884|FG005|Maintenance Period|Lack of Efficacy|2|||
46994003|NCT02065557|83240879|FG000|Maintenance Period|Subject Non-Compliance|0|||
46994004|NCT02065557|83240880|FG001|Maintenance Period|Subject Non-Compliance|0|||
46994005|NCT02065557|83240881|FG002|Maintenance Period|Subject Non-Compliance|0|||
46994006|NCT02065557|83240882|FG003|Maintenance Period|Subject Non-Compliance|0|||
46994007|NCT02065557|83240883|FG004|Maintenance Period|Subject Non-Compliance|0|||
46994008|NCT02065557|83240884|FG005|Maintenance Period|Subject Non-Compliance|1|||
46994009|NCT02065245|83240916|FG000|Infusion 1|Lost to Follow-up|0|||
46994010|NCT02065245|83240917|FG001|Infusion 1|Lost to Follow-up|0|||
46994011|NCT02065245|83240918|FG002|Infusion 1|Lost to Follow-up|0|||
46994012|NCT02065245|83240919|FG003|Infusion 1|Lost to Follow-up|0|||
46994013|NCT02065245|83240920|FG004|Infusion 1|Lost to Follow-up|0|||
46994014|NCT02065245|83240921|FG005|Infusion 1|Lost to Follow-up|0|||
46994015|NCT02065245|83240922|FG006|Infusion 1|Lost to Follow-up|1|||
46994016|NCT02065245|83240916|FG000|Infusion 1|Death|0|||
46994017|NCT02065245|83240917|FG001|Infusion 1|Death|0|||
46994018|NCT02065245|83240918|FG002|Infusion 1|Death|1|||
46994019|NCT02065245|83240919|FG003|Infusion 1|Death|0|||
46994020|NCT02065245|83240920|FG004|Infusion 1|Death|1|||
46994021|NCT02065245|83240921|FG005|Infusion 1|Death|0|||
46994022|NCT02065245|83240922|FG006|Infusion 1|Death|0|||
46994023|NCT02065245|83240916|FG000|Infusion 2|Death|0|||
46994024|NCT02065245|83240917|FG001|Infusion 2|Death|0|||
46994025|NCT02065245|83240918|FG002|Infusion 2|Death|0|||
46994026|NCT02065245|83240919|FG003|Infusion 2|Death|0|||
46994027|NCT02065245|83240920|FG004|Infusion 2|Death|0|||
46994028|NCT02065245|83240921|FG005|Infusion 2|Death|0|||
46994029|NCT02065245|83240922|FG006|Infusion 2|Death|1|||
46994030|NCT02065245|83240916|FG000|Infusion 3|Lost to Follow-up|1|||
46994031|NCT02065245|83240917|FG001|Infusion 3|Lost to Follow-up|1|||
46994032|NCT02065245|83240918|FG002|Infusion 3|Lost to Follow-up|0|||
46994033|NCT02065245|83240919|FG003|Infusion 3|Lost to Follow-up|0|||
46994034|NCT02065245|83240920|FG004|Infusion 3|Lost to Follow-up|0|||
46994035|NCT02065245|83240921|FG005|Infusion 3|Lost to Follow-up|0|||
46994036|NCT02065245|83240922|FG006|Infusion 3|Lost to Follow-up|0|||
46994037|NCT02043015|83240938|FG000|Overall Study|Lost to Follow-up|4|||
46994038|NCT02043015|83240938|FG000|Overall Study|Withdrawal by Subject|4|||
46994039|NCT02043015|83240938|FG000|Overall Study|Removed once target enrollment reached|15|||
46994040|NCT02043015|83240938|FG000|Overall Study|Participant moved away from study city|4|||
46994041|NCT02043015|83240938|FG000|Overall Study|Incarceration|1|||
46994042|NCT02064231|83240944|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
46994043|NCT02064231|83240945|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
46994044|NCT02064231|83240946|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
46994045|NCT02064231|83240947|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
46994046|NCT02064231|83240944|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
46994047|NCT02064231|83240945|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
46994048|NCT02064231|83240946|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
46994049|NCT02064231|83240947|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
46618411|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618412|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618413|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618414|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46994050|NCT02064231|83240944|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
46994051|NCT02064231|83240945|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
46994052|NCT02064231|83240946|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
46994053|NCT02064231|83240947|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
46994054|NCT02064231|83240944|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
46994055|NCT02064231|83240945|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
46994056|NCT02064231|83240946|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
46994057|NCT02064231|83240947|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
46994058|NCT02063217|83240962|FG000|Overall Study|Withdrawal by Subject|1|||
46618415|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618416|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618417|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
46618418|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618419|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618420|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618421|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618422|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618423|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618424|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
46618425|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618426|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618427|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618428|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618429|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618430|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618431|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618432|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46618433|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618434|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618435|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618436|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618437|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618438|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618439|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618440|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618441|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
46618442|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618443|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618444|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618445|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618446|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618447|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
46618448|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618449|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618450|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618451|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618452|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618453|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
46618454|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
46994059|NCT02063217|83240963|FG001|Overall Study|Withdrawal by Subject|0|||
46994060|NCT02063217|83240964|FG002|Overall Study|Withdrawal by Subject|0|||
46994061|NCT02497001|83240976|FG000|Overall Study|Lost to Follow-up|10|||
46994062|NCT02497001|83240977|FG001|Overall Study|Lost to Follow-up|2|||
46994063|NCT02497001|83240978|FG002|Overall Study|Lost to Follow-up|0|||
46994064|NCT02497001|83240979|FG003|Overall Study|Lost to Follow-up|2|||
46994065|NCT02497001|83240976|FG000|Overall Study|Adverse Event|28|||
46994066|NCT02497001|83240977|FG001|Overall Study|Adverse Event|30|||
46994067|NCT02497001|83240978|FG002|Overall Study|Adverse Event|11|||
46994068|NCT02497001|83240979|FG003|Overall Study|Adverse Event|11|||
46994069|NCT02497001|83240976|FG000|Overall Study|Withdrawal by Subject|14|||
46994070|NCT02497001|83240977|FG001|Overall Study|Withdrawal by Subject|37|||
46994071|NCT02497001|83240978|FG002|Overall Study|Withdrawal by Subject|19|||
46994072|NCT02497001|83240979|FG003|Overall Study|Withdrawal by Subject|15|||
46994073|NCT02497001|83240976|FG000|Overall Study|Physician Decision|5|||
46994074|NCT02497001|83240977|FG001|Overall Study|Physician Decision|11|||
46994075|NCT02497001|83240978|FG002|Overall Study|Physician Decision|5|||
46994076|NCT02497001|83240979|FG003|Overall Study|Physician Decision|1|||
46994077|NCT02497001|83240976|FG000|Overall Study|subjects that were not treated|1|||
46994078|NCT02497001|83240977|FG001|Overall Study|subjects that were not treated|2|||
46994079|NCT02497001|83240978|FG002|Overall Study|subjects that were not treated|2|||
46994080|NCT02497001|83240979|FG003|Overall Study|subjects that were not treated|1|||
46618455|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
46618456|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
46618457|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46898841|NCT03672461|83125220|FG001|Overall Study|Withdrawal by Subject|0|||
46994081|NCT02497001|83240976|FG000|Overall Study|Major Protocol Deviation|3|||
46994082|NCT02497001|83240977|FG001|Overall Study|Major Protocol Deviation|4|||
46994083|NCT02497001|83240978|FG002|Overall Study|Major Protocol Deviation|4|||
46994084|NCT02497001|83240979|FG003|Overall Study|Major Protocol Deviation|4|||
46994085|NCT02497001|83240976|FG000|Overall Study|Lack of Efficacy|10|||
46994086|NCT02497001|83240977|FG001|Overall Study|Lack of Efficacy|16|||
46994087|NCT02497001|83240978|FG002|Overall Study|Lack of Efficacy|6|||
46994088|NCT02497001|83240979|FG003|Overall Study|Lack of Efficacy|6|||
46994089|NCT02497001|83240976|FG000|Overall Study|Protocol Violation|3|||
46994090|NCT02497001|83240977|FG001|Overall Study|Protocol Violation|1|||
46994091|NCT02497001|83240978|FG002|Overall Study|Protocol Violation|3|||
46994092|NCT02497001|83240979|FG003|Overall Study|Protocol Violation|1|||
46994093|NCT02366143|83240995|FG000|Overall Study|Death|307|||
46994094|NCT02366143|83240996|FG001|Overall Study|Death|278|||
46994095|NCT02366143|83240997|FG002|Overall Study|Death|280|||
46994096|NCT02366143|83240995|FG000|Overall Study|Lost to Follow-up|2|||
46994097|NCT02366143|83240996|FG001|Overall Study|Lost to Follow-up|4|||
46994098|NCT02366143|83240997|FG002|Overall Study|Lost to Follow-up|2|||
46994099|NCT02366143|83240995|FG000|Overall Study|Physician Decision|1|||
46994100|NCT02366143|83240996|FG001|Overall Study|Physician Decision|2|||
46994101|NCT02366143|83240997|FG002|Overall Study|Physician Decision|1|||
46994102|NCT02366143|83240995|FG000|Overall Study|Protocol Violation|0|||
46994103|NCT02366143|83240996|FG001|Overall Study|Protocol Violation|0|||
46994104|NCT02366143|83240997|FG002|Overall Study|Protocol Violation|2|||
46994105|NCT02366143|83240995|FG000|Overall Study|Withdrawal by Subject|16|||
46994106|NCT02366143|83240996|FG001|Overall Study|Withdrawal by Subject|17|||
46994107|NCT02366143|83240997|FG002|Overall Study|Withdrawal by Subject|22|||
46994108|NCT02366143|83240995|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
46994109|NCT02366143|83240996|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
46994110|NCT02366143|83240997|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
46994111|NCT02366143|83240995|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
46994112|NCT02366143|83240996|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
46994113|NCT02366143|83240997|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
46994114|NCT02366143|83240995|FG000|Overall Study|Randomization Error|1|||
46994115|NCT02366143|83240996|FG001|Overall Study|Randomization Error|0|||
46994116|NCT02366143|83240997|FG002|Overall Study|Randomization Error|0|||
46994117|NCT02366143|83240995|FG000|Overall Study|PI Move and Site Closure|1|||
46994118|NCT02366143|83240996|FG001|Overall Study|PI Move and Site Closure|0|||
46994119|NCT02366143|83240997|FG002|Overall Study|PI Move and Site Closure|1|||
46994120|NCT02366143|83240995|FG000|Overall Study|Study Terminated By Sponsor|0|||
46994121|NCT02366143|83240996|FG001|Overall Study|Study Terminated By Sponsor|0|||
46994122|NCT02366143|83240997|FG002|Overall Study|Study Terminated By Sponsor|2|||
46994123|NCT02366143|83240995|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
46994124|NCT02366143|83240996|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
46994125|NCT02366143|83240997|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
46994126|NCT02366143|83240995|FG000|Overall Study|Patient moved to roll-over study|1|||
46994127|NCT02366143|83240996|FG001|Overall Study|Patient moved to roll-over study|19|||
46994128|NCT02366143|83240997|FG002|Overall Study|Patient moved to roll-over study|28|||
46994129|NCT02366143|83240995|FG000|Overall Study|Patient moved to commercial stock|0|||
46994130|NCT02366143|83240996|FG001|Overall Study|Patient moved to commercial stock|0|||
46994131|NCT02366143|83240997|FG002|Overall Study|Patient moved to commercial stock|1|||
46994132|NCT02366143|83240995|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
46994133|NCT02366143|83240996|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
46994134|NCT02366143|83240997|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
46994135|NCT02366143|83240995|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
46994136|NCT02366143|83240996|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
46994137|NCT02366143|83240997|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
46994138|NCT02366143|83240995|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
46994139|NCT02366143|83240996|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
46994140|NCT02366143|83240997|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
46618458|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618459|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618460|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618461|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618462|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
46618463|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46994141|NCT02366143|83240995|FG000|Overall Study|Requester's instructions|1|||
46994142|NCT02366143|83240996|FG001|Overall Study|Requester's instructions|1|||
46994143|NCT02366143|83240997|FG002|Overall Study|Requester's instructions|1|||
46994144|NCT02366143|83240995|FG000|Overall Study|Uneligible|0|||
46618464|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46994145|NCT02366143|83240996|FG001|Overall Study|Uneligible|1|||
46618465|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618466|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618467|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618468|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
46618469|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618470|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618471|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618472|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618473|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618474|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618475|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618476|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618477|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
46618478|NCT02326272|82753254|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618479|NCT02326272|82753255|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618480|NCT02326272|82753256|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46994146|NCT02366143|83240997|FG002|Overall Study|Uneligible|0|||
46994147|NCT02366143|83240995|FG000|Overall Study|Post Trial Migration|0|||
46994148|NCT02366143|83240996|FG001|Overall Study|Post Trial Migration|1|||
46994149|NCT02366143|83240997|FG002|Overall Study|Post Trial Migration|0|||
46994150|NCT02366143|83240995|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
46994151|NCT02366143|83240996|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
46994152|NCT02366143|83240997|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
46994153|NCT02366143|83240995|FG000|Overall Study|Patient switched to PTAP|0|||
46994154|NCT02366143|83240996|FG001|Overall Study|Patient switched to PTAP|1|||
46994155|NCT02366143|83240997|FG002|Overall Study|Patient switched to PTAP|0|||
46994156|NCT02366143|83240995|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
46994157|NCT02366143|83240996|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
46994158|NCT02366143|83240997|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
46994159|NCT02098395|83241013|FG000|Overall Study|Protocol Violation|2|||
46994160|NCT02098395|83241014|FG001|Overall Study|Protocol Violation|2|||
46994161|NCT02098395|83241015|FG002|Overall Study|Protocol Violation|0|||
46994162|NCT02098395|83241016|FG003|Overall Study|Protocol Violation|7|||
46994163|NCT02098395|83241013|FG000|Overall Study|Withdrawal by Subject|10|||
46994164|NCT02098395|83241014|FG001|Overall Study|Withdrawal by Subject|10|||
46994165|NCT02098395|83241015|FG002|Overall Study|Withdrawal by Subject|5|||
46994166|NCT02098395|83241016|FG003|Overall Study|Withdrawal by Subject|13|||
46994167|NCT02098395|83241013|FG000|Overall Study|Adverse Event|12|||
46994168|NCT02098395|83241014|FG001|Overall Study|Adverse Event|19|||
46994169|NCT02098395|83241015|FG002|Overall Study|Adverse Event|34|||
46994170|NCT02098395|83241016|FG003|Overall Study|Adverse Event|2|||
46994171|NCT02098395|83241013|FG000|Overall Study|Lost to Follow-up|2|||
46994172|NCT02098395|83241014|FG001|Overall Study|Lost to Follow-up|1|||
46994173|NCT02098395|83241015|FG002|Overall Study|Lost to Follow-up|0|||
46994174|NCT02098395|83241016|FG003|Overall Study|Lost to Follow-up|3|||
46994175|NCT02098395|83241013|FG000|Overall Study|Unclassified|0|||
46994176|NCT02098395|83241014|FG001|Overall Study|Unclassified|0|||
46994177|NCT02098395|83241015|FG002|Overall Study|Unclassified|3|||
46994178|NCT02098395|83241016|FG003|Overall Study|Unclassified|2|||
46994179|NCT02041923|83241028|FG000|Overall Study|Lost to Follow-up|26|||
46994180|NCT02041923|83241029|FG001|Overall Study|Lost to Follow-up|30|||
46994181|NCT02062437|83241037|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
46994182|NCT02062437|83241037|FG000|Overall Study|Patient not available for the 2y visit|18|||
46618481|NCT02326272|82753257|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618482|NCT02326272|82753258|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46994183|NCT02062437|83241037|FG000|Overall Study|Death|2|||
46994184|NCT02062437|83241037|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
46994185|NCT02365519|83241043|FG000|Randomized and Treated|Adverse Event|0|||
46994186|NCT02365519|83241044|FG001|Randomized and Treated|Adverse Event|1|||
46994187|NCT02365519|83241045|FG002|Randomized and Treated|Adverse Event|0|||
46994188|NCT02365519|83241043|FG000|Randomized and Treated|Withdrawal by Subject|0|||
46994189|NCT02365519|83241044|FG001|Randomized and Treated|Withdrawal by Subject|1|||
46994190|NCT02365519|83241045|FG002|Randomized and Treated|Withdrawal by Subject|1|||
46994191|NCT02061813|83241054|FG000|Overall Study|Withdrawal by Subject|1|||
46994192|NCT02061813|83241054|FG000|Overall Study|Protocol Violation|2|||
46994193|NCT02096835|83241064|FG000|Overall Study|Withdrawal by Subject|1|||
46994194|NCT02096835|83241065|FG001|Overall Study|Withdrawal by Subject|0|||
46994195|NCT02096835|83241066|FG002|Overall Study|Withdrawal by Subject|0|||
46994196|NCT02096835|83241064|FG000|Overall Study|converted to open procedures|1|||
46994197|NCT02096835|83241065|FG001|Overall Study|converted to open procedures|0|||
46994198|NCT02096835|83241066|FG002|Overall Study|converted to open procedures|0|||
46994199|NCT02096835|83241064|FG000|Overall Study|Lost to Follow-up|1|||
46994200|NCT02096835|83241065|FG001|Overall Study|Lost to Follow-up|0|||
46994201|NCT02096835|83241066|FG002|Overall Study|Lost to Follow-up|1|||
46994202|NCT02294773|83241076|FG000|Overall Study|Withdrawal by Subject|0|||
46994203|NCT02294773|83241077|FG001|Overall Study|Withdrawal by Subject|2|||
46994204|NCT02365285|83241087|FG000|Overall Study|Physician Decision|0|||
46994205|NCT02365285|83241088|FG001|Overall Study|Physician Decision|1|||
46994206|NCT02365285|83241089|FG002|Overall Study|Physician Decision|1|||
46994207|NCT02365285|83241090|FG003|Overall Study|Physician Decision|0|||
46994208|NCT02365285|83241087|FG000|Overall Study|Adverse Event|0|||
46994209|NCT02365285|83241088|FG001|Overall Study|Adverse Event|0|||
46994210|NCT02365285|83241089|FG002|Overall Study|Adverse Event|0|||
46994211|NCT02365285|83241090|FG003|Overall Study|Adverse Event|2|||
46994212|NCT02041299|83241104|FG000|Overall Study|Adverse Event|9|||
46994213|NCT02041299|83241105|FG001|Overall Study|Adverse Event|3|||
46994214|NCT02041299|83241104|FG000|Overall Study|Lost to Follow-up|4|||
46994215|NCT02041299|83241105|FG001|Overall Study|Lost to Follow-up|1|||
46994216|NCT02041299|83241104|FG000|Overall Study|Physician Decision|1|||
46994217|NCT02041299|83241105|FG001|Overall Study|Physician Decision|1|||
46994218|NCT02041299|83241104|FG000|Overall Study|Withdrawal by Subject|13|||
46994219|NCT02041299|83241105|FG001|Overall Study|Withdrawal by Subject|7|||
46994220|NCT02041299|83241104|FG000|Overall Study|Protocol Violation|11|||
46994221|NCT02041299|83241105|FG001|Overall Study|Protocol Violation|4|||
46994222|NCT02041299|83241104|FG000|Overall Study|Termination of the study|7|||
46994223|NCT02041299|83241105|FG001|Overall Study|Termination of the study|3|||
46994224|NCT02041299|83241104|FG000|Overall Study|Required bone marrow transplant|0|||
46994225|NCT02041299|83241105|FG001|Overall Study|Required bone marrow transplant|1|||
46994226|NCT02041299|83241104|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
46994227|NCT02041299|83241105|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
46994228|NCT01645735|83241117|FG000|Overall Study|Physician Decision|2|||
46994229|NCT01645735|83241118|FG001|Overall Study|Physician Decision|0|||
46994230|NCT01645735|83241117|FG000|Overall Study|Withdrawal by Subject|1|||
46994231|NCT01645735|83241118|FG001|Overall Study|Withdrawal by Subject|0|||
46994232|NCT01645735|83241117|FG000|Overall Study|Protocol Violation|1|||
46994233|NCT01645735|83241118|FG001|Overall Study|Protocol Violation|0|||
46994234|NCT01645735|83241117|FG000|Overall Study|Adverse Event|0|||
46994235|NCT01645735|83241118|FG001|Overall Study|Adverse Event|1|||
46994236|NCT02365207|83241125|FG000|Overall Study|Withdrawal by Subject|1|||
46994237|NCT02365207|83241125|FG000|Overall Study|Physician Decision|1|||
46994238|NCT01645111|83241129|FG000|Overall Study|Did not require Clevidipine|15|||
46994239|NCT02364037|83241135|FG000|Overall Study|Withdrawal by Subject|7|||
46994240|NCT02364037|83241136|FG001|Overall Study|Withdrawal by Subject|4|||
46994241|NCT02364037|83241135|FG000|Overall Study|Lost to Follow-up|37|||
46994242|NCT02364037|83241136|FG001|Overall Study|Lost to Follow-up|49|||
46994243|NCT01919164|83241147|FG000|Overall Study|Adverse Event|6|||
46994244|NCT01919164|83241148|FG001|Overall Study|Adverse Event|4|||
46994245|NCT01919164|83241149|FG002|Overall Study|Adverse Event|9|||
46994246|NCT01919164|83241150|FG003|Overall Study|Adverse Event|3|||
46994247|NCT01919164|83241151|FG004|Overall Study|Adverse Event|2|||
46994248|NCT01919164|83241147|FG000|Overall Study|Lost to Follow-up|2|||
46994249|NCT01919164|83241148|FG001|Overall Study|Lost to Follow-up|2|||
46994250|NCT01919164|83241149|FG002|Overall Study|Lost to Follow-up|2|||
46994251|NCT01919164|83241150|FG003|Overall Study|Lost to Follow-up|0|||
46994252|NCT01919164|83241151|FG004|Overall Study|Lost to Follow-up|4|||
46994253|NCT01919164|83241147|FG000|Overall Study|Death|1|||
46994254|NCT01919164|83241148|FG001|Overall Study|Death|0|||
46994255|NCT01919164|83241149|FG002|Overall Study|Death|0|||
46994256|NCT01919164|83241150|FG003|Overall Study|Death|0|||
46994257|NCT01919164|83241151|FG004|Overall Study|Death|0|||
46994258|NCT01919164|83241147|FG000|Overall Study|Protocol Violation|6|||
46994259|NCT01919164|83241148|FG001|Overall Study|Protocol Violation|0|||
46994260|NCT01919164|83241149|FG002|Overall Study|Protocol Violation|3|||
46994261|NCT01919164|83241150|FG003|Overall Study|Protocol Violation|2|||
46994262|NCT01919164|83241151|FG004|Overall Study|Protocol Violation|2|||
46994263|NCT01919164|83241147|FG000|Overall Study|Disease progression|2|||
46994264|NCT01919164|83241148|FG001|Overall Study|Disease progression|2|||
46994265|NCT01919164|83241149|FG002|Overall Study|Disease progression|1|||
46994266|NCT01919164|83241150|FG003|Overall Study|Disease progression|2|||
46994267|NCT01919164|83241151|FG004|Overall Study|Disease progression|1|||
46994268|NCT01919164|83241147|FG000|Overall Study|Withdrew consent|13|||
46994269|NCT01919164|83241148|FG001|Overall Study|Withdrew consent|13|||
46994270|NCT01919164|83241149|FG002|Overall Study|Withdrew consent|14|||
46994271|NCT01919164|83241150|FG003|Overall Study|Withdrew consent|14|||
46994272|NCT01919164|83241151|FG004|Overall Study|Withdrew consent|9|||
46994273|NCT01919164|83241147|FG000|Overall Study|Other Un-specified|13|||
46994274|NCT01919164|83241148|FG001|Overall Study|Other Un-specified|9|||
46994275|NCT01919164|83241149|FG002|Overall Study|Other Un-specified|8|||
46994276|NCT01919164|83241150|FG003|Overall Study|Other Un-specified|7|||
46994277|NCT01919164|83241151|FG004|Overall Study|Other Un-specified|15|||
46994278|NCT01901224|83241163|FG000|Overall Study|study was not funded and terminated|2|||
46994279|NCT01901146|83241169|FG000|Neoadjuvant Phase|Death|1|||
46994280|NCT01901146|83241170|FG001|Neoadjuvant Phase|Death|2|||
46994281|NCT01901146|83241171|FG002|Neoadjuvant Phase|Death|0|||
46994282|NCT01901146|83241172|FG003|Neoadjuvant Phase|Death|0|||
46994283|NCT01901146|83241173|FG004|Neoadjuvant Phase|Death|0|||
46994284|NCT01901146|83241169|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
46994285|NCT01901146|83241170|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
46994286|NCT01901146|83241171|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
46994287|NCT01901146|83241172|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
46994288|NCT01901146|83241173|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
46994289|NCT01901146|83241169|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
46994290|NCT01901146|83241170|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
46994291|NCT01901146|83241171|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
46994292|NCT01901146|83241172|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
46994293|NCT01901146|83241173|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
46994294|NCT01901146|83241169|FG000|Neoadjuvant Phase|Physician Decision|1|||
46994295|NCT01901146|83241170|FG001|Neoadjuvant Phase|Physician Decision|2|||
46994296|NCT01901146|83241171|FG002|Neoadjuvant Phase|Physician Decision|0|||
46994297|NCT01901146|83241172|FG003|Neoadjuvant Phase|Physician Decision|0|||
46994298|NCT01901146|83241173|FG004|Neoadjuvant Phase|Physician Decision|0|||
46994299|NCT01901146|83241169|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
46994300|NCT01901146|83241170|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
46994301|NCT01901146|83241171|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
46994302|NCT01901146|83241172|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
46994303|NCT01901146|83241173|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
46994304|NCT01901146|83241169|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
46994305|NCT01901146|83241170|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
46994306|NCT01901146|83241171|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
46994307|NCT01901146|83241172|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
46994308|NCT01901146|83241173|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
46994309|NCT01901146|83241169|FG000|Adjuvant Phase|Other|0|||
46994310|NCT01901146|83241170|FG001|Adjuvant Phase|Other|0|||
46994311|NCT01901146|83241171|FG002|Adjuvant Phase|Other|1|||
46994312|NCT01901146|83241172|FG003|Adjuvant Phase|Other|0|||
46994313|NCT01901146|83241173|FG004|Adjuvant Phase|Other|0|||
46994314|NCT01901146|83241169|FG000|Adjuvant Phase|Death|0|||
46994315|NCT01901146|83241170|FG001|Adjuvant Phase|Death|0|||
46994316|NCT01901146|83241171|FG002|Adjuvant Phase|Death|0|||
46994317|NCT01901146|83241172|FG003|Adjuvant Phase|Death|0|||
46994318|NCT01901146|83241173|FG004|Adjuvant Phase|Death|3|||
46994319|NCT01901146|83241169|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
46994320|NCT01901146|83241170|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
46994321|NCT01901146|83241171|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
46994322|NCT01901146|83241172|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
46994323|NCT01901146|83241173|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
46994324|NCT01901146|83241169|FG000|Adjuvant Phase|Physician Decision|0|||
46994325|NCT01901146|83241170|FG001|Adjuvant Phase|Physician Decision|0|||
46994326|NCT01901146|83241171|FG002|Adjuvant Phase|Physician Decision|9|||
46994327|NCT01901146|83241172|FG003|Adjuvant Phase|Physician Decision|2|||
46994328|NCT01901146|83241173|FG004|Adjuvant Phase|Physician Decision|4|||
46994329|NCT01901146|83241169|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
46994330|NCT01901146|83241170|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
46994331|NCT01901146|83241171|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
46994332|NCT01901146|83241172|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
46994333|NCT01901146|83241173|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
46994334|NCT01644643|83241186|FG000|Overall Study|Death|1|||
46994335|NCT01644643|83241187|FG001|Overall Study|Death|0|||
46994336|NCT01644643|83241188|FG002|Overall Study|Death|3|||
46994337|NCT01644643|83241189|FG003|Overall Study|Death|3|||
46994338|NCT01644643|83241186|FG000|Overall Study|Lost to Follow-up|0|||
46994339|NCT01644643|83241187|FG001|Overall Study|Lost to Follow-up|0|||
46994340|NCT01644643|83241188|FG002|Overall Study|Lost to Follow-up|0|||
46994341|NCT01644643|83241189|FG003|Overall Study|Lost to Follow-up|4|||
46994342|NCT01644643|83241186|FG000|Overall Study|Withdrawal by Subject|1|||
46994343|NCT01644643|83241187|FG001|Overall Study|Withdrawal by Subject|0|||
46994344|NCT01644643|83241188|FG002|Overall Study|Withdrawal by Subject|2|||
46994345|NCT01644643|83241189|FG003|Overall Study|Withdrawal by Subject|1|||
46994346|NCT01644643|83241186|FG000|Overall Study|Other Eligibility criteria|0|||
46618483|NCT02326272|82753259|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46994347|NCT01644643|83241187|FG001|Overall Study|Other Eligibility criteria|0|||
46994348|NCT01644643|83241188|FG002|Overall Study|Other Eligibility criteria|0|||
46994349|NCT01644643|83241189|FG003|Overall Study|Other Eligibility criteria|2|||
46994350|NCT01864564|83241207|FG000|Overall Study|Lost to Follow-up|17|||
46994351|NCT01864564|83241208|FG001|Overall Study|Lost to Follow-up|23|||
46994352|NCT01864564|83241207|FG000|Overall Study|Withdrawal by Subject|20|||
46994353|NCT01864564|83241208|FG001|Overall Study|Withdrawal by Subject|11|||
46994354|NCT01864564|83241207|FG000|Overall Study|Protocol Violation|0|||
46994355|NCT01864564|83241208|FG001|Overall Study|Protocol Violation|27|||
46994356|NCT01864564|83241207|FG000|Overall Study|not reported|0|||
46994357|NCT01864564|83241208|FG001|Overall Study|not reported|34|||
46994358|NCT01864174|83241216|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
46994359|NCT01864174|83241217|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
46994360|NCT01864174|83241216|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
46994361|NCT01864174|83241217|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
46994362|NCT01864174|83241216|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
46994363|NCT01864174|83241217|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
46994364|NCT01864174|83241216|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
46994365|NCT01864174|83241217|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
46994366|NCT01864174|83241216|FG000|Double Blind - Compliant Randomized|Death|1|||
46994367|NCT01864174|83241217|FG001|Double Blind - Compliant Randomized|Death|0|||
46994368|NCT01864174|83241216|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
46994369|NCT01864174|83241217|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
46994370|NCT01864174|83241216|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
46994371|NCT01864174|83241217|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
46994372|NCT01864174|83241216|FG000|Double Blind - Compliant Randomized|Other|6|||
46994373|NCT01864174|83241217|FG001|Double Blind - Compliant Randomized|Other|10|||
46994374|NCT01864174|83241216|FG000|Off Treatment Follow-Up|Other|2|||
46994375|NCT01864174|83241217|FG001|Off Treatment Follow-Up|Other|0|||
46994376|NCT01864174|83241216|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
46994377|NCT01864174|83241217|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
46994378|NCT01900444|83241223|FG000|Overall Study|Protocol Violation|2|||
46994379|NCT01900444|83241223|FG000|Overall Study|Lost to Follow-up|1|||
46994380|NCT02294227|83241230|FG000|Overall Study|Death|0|||
46994381|NCT02294227|83241231|FG001|Overall Study|Death|0|||
46994382|NCT02294227|83241232|FG002|Overall Study|Death|1|||
46994383|NCT02294227|83241230|FG000|Overall Study|Subject/Guardian Decision|6|||
46994384|NCT02294227|83241231|FG001|Overall Study|Subject/Guardian Decision|3|||
46994385|NCT02294227|83241232|FG002|Overall Study|Subject/Guardian Decision|7|||
46994386|NCT02294227|83241230|FG000|Overall Study|Physician Decision|1|||
46994387|NCT02294227|83241231|FG001|Overall Study|Physician Decision|2|||
46994388|NCT02294227|83241232|FG002|Overall Study|Physician Decision|1|||
46994389|NCT02294227|83241230|FG000|Overall Study|Lost to Follow-up|1|||
46994390|NCT02294227|83241231|FG001|Overall Study|Lost to Follow-up|0|||
46994391|NCT02294227|83241232|FG002|Overall Study|Lost to Follow-up|0|||
46994392|NCT02294227|83241230|FG000|Overall Study|Lack of Efficacy|11|||
46994393|NCT02294227|83241231|FG001|Overall Study|Lack of Efficacy|12|||
46994394|NCT02294227|83241232|FG002|Overall Study|Lack of Efficacy|8|||
46994395|NCT02294227|83241230|FG000|Overall Study|Adverse Event|6|||
46994396|NCT02294227|83241231|FG001|Overall Study|Adverse Event|8|||
46994397|NCT02294227|83241232|FG002|Overall Study|Adverse Event|2|||
46994398|NCT02496767|83241246|FG000|Open-label Lead-in Phase|Adverse Event|176|||
46994399|NCT02496767|83241247|FG001|Open-label Lead-in Phase|Adverse Event|0|||
46994400|NCT02496767|83241248|FG002|Open-label Lead-in Phase|Adverse Event|0|||
46994401|NCT02496767|83241249|FG003|Open-label Lead-in Phase|Adverse Event|0|||
46994402|NCT02496767|83241250|FG004|Open-label Lead-in Phase|Adverse Event|0|||
46994403|NCT02496767|83241251|FG005|Open-label Lead-in Phase|Adverse Event|0|||
46994404|NCT02496767|83241252|FG006|Open-label Lead-in Phase|Adverse Event|0|||
46994405|NCT02496767|83241253|FG007|Open-label Lead-in Phase|Adverse Event|0|||
46994406|NCT02496767|83241246|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
46994407|NCT02496767|83241247|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
46994408|NCT02496767|83241248|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
46994409|NCT02496767|83241249|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
46994410|NCT02496767|83241250|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
46994411|NCT02496767|83241251|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
46994412|NCT02496767|83241252|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
46994413|NCT02496767|83241253|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
46994414|NCT02496767|83241246|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
46994415|NCT02496767|83241247|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
46994416|NCT02496767|83241248|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
46994417|NCT02496767|83241249|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
46994418|NCT02496767|83241250|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
46994419|NCT02496767|83241251|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
46708830|NCT04117347|82924720|FG000|Overall Study|Family emergency|1|||
46994420|NCT02496767|83241252|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
46994421|NCT02496767|83241253|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
46994422|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
46994423|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
46994424|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
46994425|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
46994426|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
46994427|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
46618484|NCT02326272|82753260|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
46618485|NCT02326272|82753261|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618486|NCT02326272|82753262|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618487|NCT02326272|82753263|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46994428|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
46994429|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
46994430|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
46994431|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
46994432|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
46994433|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
46994434|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
46994435|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
46994436|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
46994437|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
46994438|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
46994439|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
46994440|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
46994441|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
46994442|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
46994443|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
46994444|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
46994445|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
46994446|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
46994447|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
46994448|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
46994449|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
46994450|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
46994451|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
46994452|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
46994453|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
46994454|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
46994455|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
46994456|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
46994457|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
46994458|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
46994459|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
46994460|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
46994461|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
46994462|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
46994463|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
46994464|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
46994465|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
46994466|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
46994467|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
46994468|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
46994469|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
46994470|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
46994471|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
46994472|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
46994473|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
46994474|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
46994475|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
46994476|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
46994477|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
46994478|NCT02496767|83241246|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
46994479|NCT02496767|83241247|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
46994480|NCT02496767|83241248|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
46994481|NCT02496767|83241249|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
46994482|NCT02496767|83241250|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
46994483|NCT02496767|83241251|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
46994484|NCT02496767|83241252|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
46994485|NCT02496767|83241253|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
46994486|NCT02496767|83241246|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
46994487|NCT02496767|83241247|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
46994488|NCT02496767|83241248|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
46994489|NCT02496767|83241249|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
46994490|NCT02496767|83241250|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
46994491|NCT02496767|83241251|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
46994492|NCT02496767|83241252|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
46994493|NCT02496767|83241253|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
46994494|NCT02496767|83241246|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
46994495|NCT02496767|83241247|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
46994496|NCT02496767|83241248|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
46994497|NCT02496767|83241249|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
46994498|NCT02496767|83241250|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
46994499|NCT02496767|83241251|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
46994500|NCT02496767|83241252|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
46994501|NCT02496767|83241253|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
46994502|NCT02496767|83241246|FG000|Double-blind, Withdrawal Phase|Death|0|||
46994503|NCT02496767|83241247|FG001|Double-blind, Withdrawal Phase|Death|0|||
46994504|NCT02496767|83241248|FG002|Double-blind, Withdrawal Phase|Death|0|||
46994505|NCT02496767|83241249|FG003|Double-blind, Withdrawal Phase|Death|0|||
46994506|NCT02496767|83241250|FG004|Double-blind, Withdrawal Phase|Death|0|||
46994507|NCT02496767|83241251|FG005|Double-blind, Withdrawal Phase|Death|0|||
46994508|NCT02496767|83241252|FG006|Double-blind, Withdrawal Phase|Death|1|||
46994509|NCT02496767|83241253|FG007|Double-blind, Withdrawal Phase|Death|2|||
46994510|NCT02496767|83241246|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
46994511|NCT02496767|83241247|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
46994512|NCT02496767|83241248|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
46994513|NCT02496767|83241249|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
46994514|NCT02496767|83241250|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
46994515|NCT02496767|83241251|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
46994516|NCT02496767|83241252|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
46994517|NCT02496767|83241253|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
46994518|NCT02496533|83241269|FG000|Overall Study|Lack of data on outcome|3|||
46994519|NCT02496533|83241270|FG001|Overall Study|Lack of data on outcome|0|||
46994520|NCT02496533|83241269|FG000|Overall Study|Patient did not complete all measures|0|||
46994521|NCT02496533|83241270|FG001|Overall Study|Patient did not complete all measures|4|||
46994522|NCT02496533|83241269|FG000|Overall Study|Late for radiologic testing|0|||
46994523|NCT02496533|83241270|FG001|Overall Study|Late for radiologic testing|2|||
46994524|NCT02496221|83241276|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
46994525|NCT02496221|83241277|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
46994526|NCT02496221|83241276|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
46994527|NCT02496221|83241277|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
46994528|NCT02496221|83241276|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
46994529|NCT02496221|83241277|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
46994530|NCT02475629|83241285|FG000|Overall Study|Adverse Event|1|||
46994531|NCT02475629|83241285|FG000|Overall Study|Death|4|||
46994532|NCT02475629|83241285|FG000|Overall Study|Physician Decision|1|||
46994533|NCT02475629|83241285|FG000|Overall Study|Withdrawal by Subject|1|||
46994534|NCT02475629|83241285|FG000|Overall Study|Lost to Follow-up|1|||
46994535|NCT02475629|83241285|FG000|Overall Study|Subject non-compliance|1|||
46994536|NCT02475395|83241291|FG000|Overall Study|Protocol Violation|30|||
46994537|NCT02475395|83241292|FG001|Overall Study|Protocol Violation|3|||
46994538|NCT01653743|83241300|FG000|Overall Study|Withdrawal by Subject|1|||
46994539|NCT01653743|83241301|FG001|Overall Study|Withdrawal by Subject|0|||
46618488|NCT02326272|82753264|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46994540|NCT01653743|83241300|FG000|Overall Study|Investigator discretion|3|||
46994541|NCT01653743|83241301|FG001|Overall Study|Investigator discretion|0|||
46994542|NCT02293993|83241311|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
46994543|NCT02293993|83241312|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
46618489|NCT02326272|82753265|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618490|NCT02326272|82753266|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618491|NCT02326272|82753267|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618492|NCT02326272|82753268|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
46618493|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
46618494|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
46994544|NCT02293993|83241313|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
46994545|NCT02293993|83241314|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
46994546|NCT02293993|83241311|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
46994547|NCT02293993|83241312|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
46994548|NCT02293993|83241313|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
46994549|NCT02293993|83241314|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
46994550|NCT02293993|83241311|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
46994551|NCT02293993|83241312|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
46994552|NCT02293993|83241313|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
46994553|NCT02293993|83241314|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
46994554|NCT02293993|83241311|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
46994555|NCT02293993|83241312|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
46994556|NCT02293993|83241313|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
46994557|NCT02293993|83241314|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
46994558|NCT02293993|83241311|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
46994559|NCT02293993|83241312|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
46994560|NCT02293993|83241313|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
46994561|NCT02293993|83241314|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
46994562|NCT02322775|83241334|FG000|Overall Study|Adverse Event|1|||
46994563|NCT02322775|83241335|FG001|Overall Study|Adverse Event|0|||
46994564|NCT02322775|83241334|FG000|Overall Study|Lost to Follow-up|0|||
46994565|NCT02322775|83241335|FG001|Overall Study|Lost to Follow-up|1|||
46994566|NCT02322775|83241334|FG000|Overall Study|Protocol Violation|1|||
46994567|NCT02322775|83241335|FG001|Overall Study|Protocol Violation|0|||
46994568|NCT02322775|83241334|FG000|Overall Study|Withdrawal by Subject|3|||
46994569|NCT02322775|83241335|FG001|Overall Study|Withdrawal by Subject|4|||
46994570|NCT02322775|83241334|FG000|Overall Study|Not willing to perform all FU visits|0|||
46994571|NCT02322775|83241335|FG001|Overall Study|Not willing to perform all FU visits|1|||
46994572|NCT02322229|83241341|FG000|Overall Study|Physician Decision|2|||
46994573|NCT02362789|83241348|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
46994574|NCT02362789|83241349|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
46994575|NCT02362789|83241350|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
46994576|NCT02362789|83241348|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
46994577|NCT02362789|83241349|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
46994578|NCT02362789|83241350|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
46994579|NCT02362789|83241348|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
46994580|NCT02362789|83241349|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
46994581|NCT02362789|83241350|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
46994582|NCT02362789|83241348|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
46994583|NCT02362789|83241349|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
46994584|NCT02362789|83241350|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
46994585|NCT02362789|83241348|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
46994586|NCT02362789|83241349|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
46994587|NCT02362789|83241350|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
46994588|NCT01646827|83241359|FG000|Overall Study|Lost to Follow-up|0|||
46994589|NCT01646827|83241360|FG001|Overall Study|Lost to Follow-up|3|||
46994590|NCT01646827|83241359|FG000|Overall Study|Physician Decision|1|||
46994591|NCT01646827|83241360|FG001|Overall Study|Physician Decision|2|||
46994592|NCT01646827|83241359|FG000|Overall Study|Withdrawal by Subject|1|||
46994593|NCT01646827|83241360|FG001|Overall Study|Withdrawal by Subject|0|||
46994594|NCT02293837|83241370|FG000|Overall Study|Lost to Follow-up|0|||
46994595|NCT02293837|83241371|FG001|Overall Study|Lost to Follow-up|2|||
46994596|NCT02293837|83241372|FG002|Overall Study|Lost to Follow-up|1|||
46994597|NCT02293837|83241373|FG003|Overall Study|Lost to Follow-up|0|||
46994598|NCT02293837|83241370|FG000|Overall Study|Withdrawal by Subject|2|||
46994599|NCT02293837|83241371|FG001|Overall Study|Withdrawal by Subject|1|||
46994600|NCT02293837|83241372|FG002|Overall Study|Withdrawal by Subject|2|||
46994601|NCT02293837|83241373|FG003|Overall Study|Withdrawal by Subject|1|||
46994602|NCT02293837|83241370|FG000|Overall Study|COVID-19 Related|1|||
46994603|NCT02293837|83241371|FG001|Overall Study|COVID-19 Related|1|||
46994604|NCT02293837|83241372|FG002|Overall Study|COVID-19 Related|0|||
46994605|NCT02293837|83241373|FG003|Overall Study|COVID-19 Related|0|||
46994606|NCT02293837|83241370|FG000|Overall Study|Participant ill and could not be infused|0|||
46994607|NCT02293837|83241371|FG001|Overall Study|Participant ill and could not be infused|0|||
46994608|NCT02293837|83241372|FG002|Overall Study|Participant ill and could not be infused|1|||
46994609|NCT02293837|83241373|FG003|Overall Study|Participant ill and could not be infused|0|||
46994610|NCT02361307|83241389|FG000|Overall Study|Unstable medical condition.|0|||
46994611|NCT02361307|83241390|FG001|Overall Study|Unstable medical condition.|1|||
46994612|NCT02320903|83241399|FG000|Overall Study|Withdrawal by Subject|0|||
46994613|NCT02320903|83241400|FG001|Overall Study|Withdrawal by Subject|9|||
46994614|NCT02320903|83241401|FG002|Overall Study|Withdrawal by Subject|9|||
46994615|NCT02320903|83241399|FG000|Overall Study|Exited therapy; no longer eligible|8|||
46994616|NCT02320903|83241400|FG001|Overall Study|Exited therapy; no longer eligible|2|||
46994617|NCT02320903|83241401|FG002|Overall Study|Exited therapy; no longer eligible|2|||
46994618|NCT02320903|83241399|FG000|Overall Study|Lost to Follow-up|0|||
46994619|NCT02320903|83241400|FG001|Overall Study|Lost to Follow-up|5|||
46994620|NCT02320903|83241401|FG002|Overall Study|Lost to Follow-up|5|||
46994621|NCT02320123|83241412|FG000|Overall Study|Lost to Follow-up|4|||
46994622|NCT02320123|83241413|FG001|Overall Study|Lost to Follow-up|6|||
46994623|NCT02320123|83241412|FG000|Overall Study|Death|6|||
46994624|NCT02320123|83241413|FG001|Overall Study|Death|5|||
46994625|NCT02360995|83241426|FG000|Overall Study|Lost to Follow-up|2|||
46994626|NCT02360995|83241427|FG001|Overall Study|Lost to Follow-up|0|||
46994627|NCT02360995|83241428|FG002|Overall Study|Lost to Follow-up|2|||
46994628|NCT02360995|83241426|FG000|Overall Study|Withdrawal by Subject|0|||
46994629|NCT02360995|83241427|FG001|Overall Study|Withdrawal by Subject|1|||
46994630|NCT02360995|83241428|FG002|Overall Study|Withdrawal by Subject|0|||
46994631|NCT02360605|83241438|FG000|Overall Study|Withdrawal by Subject|4|||
46994632|NCT02360605|83241439|FG001|Overall Study|Withdrawal by Subject|9|||
46994633|NCT02360605|83241438|FG000|Overall Study|Lost to Follow-up|7|||
46994634|NCT02360605|83241439|FG001|Overall Study|Lost to Follow-up|8|||
46994635|NCT02360605|83241438|FG000|Overall Study|Death|0|||
46994636|NCT02360605|83241439|FG001|Overall Study|Death|1|||
46994637|NCT02360293|83241449|FG000|Overall Study|Lost to Follow-up|73|||
46994638|NCT02360293|83241450|FG001|Overall Study|Lost to Follow-up|95|||
46994639|NCT02360293|83241449|FG000|Overall Study|Withdrawal by Subject|2|||
46994640|NCT02360293|83241450|FG001|Overall Study|Withdrawal by Subject|1|||
46994641|NCT02360293|83241449|FG000|Overall Study|Excluded|1|||
46994642|NCT02360293|83241450|FG001|Overall Study|Excluded|0|||
46994643|NCT02359903|83241458|FG000|Overall Study|Adverse Event|0|||
46994644|NCT02359903|83241459|FG001|Overall Study|Adverse Event|2|||
46994645|NCT02291419|83241467|FG000|Overall Study|Early study termination|1|||
46994646|NCT02291419|83241468|FG001|Overall Study|Early study termination|5|||
46994647|NCT02319031|83241476|FG000|Treatment Period|Death|1|||
46994648|NCT02319031|83241477|FG001|Treatment Period|Death|0|||
46994649|NCT02318797|83241485|FG000|Overall Study|Death|3|||
46994650|NCT02318797|83241486|FG001|Overall Study|Death|6|||
46994651|NCT02318797|83241485|FG000|Overall Study|Lost to Follow-up|85|||
46994652|NCT02318797|83241486|FG001|Overall Study|Lost to Follow-up|96|||
46994653|NCT02359435|83241494|FG000|Overall Study|Lost to Follow-up|4|||
46994654|NCT02359435|83241495|FG001|Overall Study|Lost to Follow-up|4|||
46994655|NCT02318719|83241505|FG000|Double-blind Phase|Adverse Event|7|||
46994656|NCT02318719|83241506|FG001|Double-blind Phase|Adverse Event|6|||
46994657|NCT02318719|83241507|FG002|Double-blind Phase|Adverse Event|12|||
46994658|NCT02318719|83241508|FG003|Double-blind Phase|Adverse Event|4|||
46994659|NCT02318719|83241509|FG004|Double-blind Phase|Adverse Event|0|||
46994660|NCT02318719|83241505|FG000|Double-blind Phase|Lack of Efficacy|5|||
46994661|NCT02318719|83241506|FG001|Double-blind Phase|Lack of Efficacy|0|||
46994662|NCT02318719|83241507|FG002|Double-blind Phase|Lack of Efficacy|1|||
46994663|NCT02318719|83241508|FG003|Double-blind Phase|Lack of Efficacy|1|||
46994664|NCT02318719|83241509|FG004|Double-blind Phase|Lack of Efficacy|0|||
46994665|NCT02318719|83241505|FG000|Double-blind Phase|Protocol Violation|0|||
46994666|NCT02318719|83241506|FG001|Double-blind Phase|Protocol Violation|1|||
46994667|NCT02318719|83241507|FG002|Double-blind Phase|Protocol Violation|3|||
46994668|NCT02318719|83241508|FG003|Double-blind Phase|Protocol Violation|0|||
46994669|NCT02318719|83241509|FG004|Double-blind Phase|Protocol Violation|0|||
46994670|NCT02318719|83241505|FG000|Double-blind Phase|Withdrawal by Subject|25|||
46994671|NCT02318719|83241506|FG001|Double-blind Phase|Withdrawal by Subject|7|||
46994672|NCT02318719|83241507|FG002|Double-blind Phase|Withdrawal by Subject|9|||
46994673|NCT02318719|83241508|FG003|Double-blind Phase|Withdrawal by Subject|10|||
46994674|NCT02318719|83241509|FG004|Double-blind Phase|Withdrawal by Subject|0|||
46994675|NCT02318719|83241505|FG000|Double-blind Phase|Other|1|||
46994676|NCT02318719|83241506|FG001|Double-blind Phase|Other|2|||
46994677|NCT02318719|83241507|FG002|Double-blind Phase|Other|0|||
46994678|NCT02318719|83241508|FG003|Double-blind Phase|Other|0|||
46994679|NCT02318719|83241509|FG004|Double-blind Phase|Other|0|||
46994680|NCT02318719|83241505|FG000|Open-label Extension Phase|Adverse Event|0|||
46994681|NCT02318719|83241506|FG001|Open-label Extension Phase|Adverse Event|0|||
46994682|NCT02318719|83241507|FG002|Open-label Extension Phase|Adverse Event|0|||
46994683|NCT02318719|83241508|FG003|Open-label Extension Phase|Adverse Event|0|||
46994684|NCT02318719|83241509|FG004|Open-label Extension Phase|Adverse Event|15|||
46994685|NCT02318719|83241505|FG000|Open-label Extension Phase|Death|0|||
46994686|NCT02318719|83241506|FG001|Open-label Extension Phase|Death|0|||
46994687|NCT02318719|83241507|FG002|Open-label Extension Phase|Death|0|||
46994688|NCT02318719|83241508|FG003|Open-label Extension Phase|Death|0|||
46994689|NCT02318719|83241509|FG004|Open-label Extension Phase|Death|1|||
46994690|NCT02318719|83241505|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
46994691|NCT02318719|83241506|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
46994692|NCT02318719|83241507|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
46994693|NCT02318719|83241508|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
46994694|NCT02318719|83241509|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
46994695|NCT02318719|83241505|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
46994696|NCT02318719|83241506|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
46994697|NCT02318719|83241507|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
46994698|NCT02318719|83241508|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
46994699|NCT02318719|83241509|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
46994700|NCT02318719|83241505|FG000|Open-label Extension Phase|Other|0|||
46994701|NCT02318719|83241506|FG001|Open-label Extension Phase|Other|0|||
46994702|NCT02318719|83241507|FG002|Open-label Extension Phase|Other|0|||
46994703|NCT02318719|83241508|FG003|Open-label Extension Phase|Other|0|||
46994704|NCT02318719|83241509|FG004|Open-label Extension Phase|Other|7|||
46994705|NCT01870726|83241528|FG000|Overall Study|Withdrawal of informed consent|0|||
46994706|NCT01870726|83241529|FG001|Overall Study|Withdrawal of informed consent|0|||
46994707|NCT01870726|83241530|FG002|Overall Study|Withdrawal of informed consent|0|||
46994708|NCT01870726|83241531|FG003|Overall Study|Withdrawal of informed consent|1|||
46994709|NCT01870726|83241532|FG004|Overall Study|Withdrawal of informed consent|0|||
46994710|NCT01870726|83241533|FG005|Overall Study|Withdrawal of informed consent|0|||
46994711|NCT01870726|83241534|FG006|Overall Study|Withdrawal of informed consent|0|||
46994712|NCT01870726|83241528|FG000|Overall Study|Withdrawal by Subject|0|||
46994713|NCT01870726|83241529|FG001|Overall Study|Withdrawal by Subject|1|||
46994714|NCT01870726|83241530|FG002|Overall Study|Withdrawal by Subject|0|||
46994715|NCT01870726|83241531|FG003|Overall Study|Withdrawal by Subject|0|||
46994716|NCT01870726|83241532|FG004|Overall Study|Withdrawal by Subject|0|||
46994717|NCT01870726|83241533|FG005|Overall Study|Withdrawal by Subject|0|||
46994718|NCT01870726|83241534|FG006|Overall Study|Withdrawal by Subject|0|||
46994719|NCT01870726|83241528|FG000|Overall Study|Adverse Event|0|||
46994720|NCT01870726|83241529|FG001|Overall Study|Adverse Event|0|||
46994721|NCT01870726|83241530|FG002|Overall Study|Adverse Event|0|||
46994722|NCT01870726|83241531|FG003|Overall Study|Adverse Event|0|||
46994723|NCT01870726|83241532|FG004|Overall Study|Adverse Event|1|||
46994724|NCT01870726|83241533|FG005|Overall Study|Adverse Event|1|||
46994725|NCT01870726|83241534|FG006|Overall Study|Adverse Event|0|||
46994726|NCT01870726|83241528|FG000|Overall Study|Progressive disease|5|||
46994727|NCT01870726|83241529|FG001|Overall Study|Progressive disease|5|||
46994728|NCT01870726|83241530|FG002|Overall Study|Progressive disease|4|||
46994729|NCT01870726|83241531|FG003|Overall Study|Progressive disease|5|||
46994730|NCT01870726|83241532|FG004|Overall Study|Progressive disease|6|||
46994731|NCT01870726|83241533|FG005|Overall Study|Progressive disease|4|||
46994732|NCT01870726|83241534|FG006|Overall Study|Progressive disease|10|||
46994733|NCT01900054|83241559|FG000|Overall Study|Physician Decision|1|||
46994734|NCT01900054|83241559|FG000|Overall Study|Withdrawal by Subject|1|||
46994735|NCT01612156|83241565|FG000|Overall Study|Protocol Violation|2|||
46994736|NCT01612156|83241566|FG001|Overall Study|Protocol Violation|0|||
46994737|NCT01899742|83241574|FG000|Overall Study|Adverse Event|5|||
46994738|NCT01899742|83241575|FG001|Overall Study|Adverse Event|4|||
46994739|NCT01899742|83241574|FG000|Overall Study|Lack of Efficacy|1|||
46994740|NCT01899742|83241575|FG001|Overall Study|Lack of Efficacy|5|||
46994741|NCT01899742|83241574|FG000|Overall Study|Protocol Violation|2|||
46994742|NCT01899742|83241575|FG001|Overall Study|Protocol Violation|2|||
46994743|NCT01899742|83241574|FG000|Overall Study|Withdrawal by Subject|9|||
46994744|NCT01899742|83241575|FG001|Overall Study|Withdrawal by Subject|5|||
46994745|NCT01615822|83241584|FG000|Period 1|Withdrawal by Subject|0|||
46994746|NCT01615822|83241585|FG001|Period 1|Withdrawal by Subject|1|||
46994747|NCT01615822|83241586|FG002|Period 1|Withdrawal by Subject|0|||
46994748|NCT01615822|83241584|FG000|Period 1|Adverse Event|1|||
46994749|NCT01615822|83241585|FG001|Period 1|Adverse Event|1|||
46994750|NCT01615822|83241586|FG002|Period 1|Adverse Event|0|||
46994751|NCT01615822|83241584|FG000|Period 2|Lost to Follow-up|0|||
46994752|NCT01615822|83241585|FG001|Period 2|Lost to Follow-up|1|||
46994753|NCT01615822|83241586|FG002|Period 2|Lost to Follow-up|2|||
46994754|NCT01898884|83241602|FG000|Multiple Dose Period|Adverse Event|0|||
46994755|NCT01898884|83241603|FG001|Multiple Dose Period|Adverse Event|0|||
46994756|NCT01898884|83241604|FG002|Multiple Dose Period|Adverse Event|0|||
46994757|NCT01898884|83241605|FG003|Multiple Dose Period|Adverse Event|0|||
46994758|NCT01898884|83241606|FG004|Multiple Dose Period|Adverse Event|0|||
46994759|NCT01898884|83241607|FG005|Multiple Dose Period|Adverse Event|0|||
46994760|NCT01898884|83241608|FG006|Multiple Dose Period|Adverse Event|1|||
46994761|NCT01898884|83241609|FG007|Multiple Dose Period|Adverse Event|0|||
46994762|NCT01898884|83241610|FG008|Multiple Dose Period|Adverse Event|0|||
46994763|NCT01898884|83241602|FG000|Multiple Dose Period|Randomized Not Treated|0|||
46994764|NCT01898884|83241603|FG001|Multiple Dose Period|Randomized Not Treated|0|||
46994765|NCT01898884|83241604|FG002|Multiple Dose Period|Randomized Not Treated|0|||
46994766|NCT01898884|83241605|FG003|Multiple Dose Period|Randomized Not Treated|0|||
46994767|NCT01898884|83241606|FG004|Multiple Dose Period|Randomized Not Treated|0|||
46994768|NCT01898884|83241607|FG005|Multiple Dose Period|Randomized Not Treated|0|||
46994769|NCT01898884|83241608|FG006|Multiple Dose Period|Randomized Not Treated|0|||
46994770|NCT01898884|83241609|FG007|Multiple Dose Period|Randomized Not Treated|0|||
46994771|NCT01898884|83241610|FG008|Multiple Dose Period|Randomized Not Treated|1|||
46994772|NCT01613326|83241648|FG000|Overall Study|Adverse Event|7|||
46994773|NCT01613326|83241649|FG001|Overall Study|Adverse Event|5|||
46994774|NCT01613326|83241648|FG000|Overall Study|Withdrawal by Subject|3|||
46994775|NCT01613326|83241649|FG001|Overall Study|Withdrawal by Subject|4|||
46994776|NCT01613326|83241648|FG000|Overall Study|Abnormal test procedure result(s)|2|||
46994777|NCT01613326|83241649|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46994778|NCT01613326|83241648|FG000|Overall Study|inability to use device|1|||
46994779|NCT01613326|83241649|FG001|Overall Study|inability to use device|0|||
46994780|NCT01613326|83241648|FG000|Overall Study|Lack of Efficacy|0|||
46994781|NCT01613326|83241649|FG001|Overall Study|Lack of Efficacy|1|||
46994782|NCT01613326|83241648|FG000|Overall Study|Lost to Follow-up|0|||
46994783|NCT01613326|83241649|FG001|Overall Study|Lost to Follow-up|1|||
46994784|NCT01613326|83241648|FG000|Overall Study|Administrative|0|||
46994785|NCT01613326|83241649|FG001|Overall Study|Administrative|2|||
46994786|NCT01613326|83241648|FG000|Overall Study|Protocol Violation|0|||
46994787|NCT01613326|83241649|FG001|Overall Study|Protocol Violation|1|||
46994788|NCT01613248|83241661|FG000|Overall Study|Adverse Event|0|||
46994789|NCT01613248|83241662|FG001|Overall Study|Adverse Event|0|||
46994790|NCT01613248|83241663|FG002|Overall Study|Adverse Event|0|||
46994791|NCT01613248|83241664|FG003|Overall Study|Adverse Event|1|||
46994792|NCT01613248|83241665|FG004|Overall Study|Adverse Event|0|||
46994793|NCT01613248|83241666|FG005|Overall Study|Adverse Event|0|||
46994794|NCT01613248|83241661|FG000|Overall Study|Withdrawal by Subject|3|||
46994795|NCT01613248|83241662|FG001|Overall Study|Withdrawal by Subject|2|||
46994796|NCT01613248|83241663|FG002|Overall Study|Withdrawal by Subject|2|||
46994797|NCT01613248|83241664|FG003|Overall Study|Withdrawal by Subject|5|||
46994798|NCT01613248|83241665|FG004|Overall Study|Withdrawal by Subject|0|||
46994799|NCT01613248|83241666|FG005|Overall Study|Withdrawal by Subject|1|||
46994800|NCT01613248|83241661|FG000|Overall Study|Lost to Follow-up|5|||
46994801|NCT01613248|83241662|FG001|Overall Study|Lost to Follow-up|7|||
46994802|NCT01613248|83241663|FG002|Overall Study|Lost to Follow-up|4|||
46994803|NCT01613248|83241664|FG003|Overall Study|Lost to Follow-up|8|||
46994804|NCT01613248|83241665|FG004|Overall Study|Lost to Follow-up|4|||
46994805|NCT01613248|83241666|FG005|Overall Study|Lost to Follow-up|2|||
46994806|NCT01613248|83241661|FG000|Overall Study|Study Terminated by Sponsor|4|||
46994807|NCT01613248|83241662|FG001|Overall Study|Study Terminated by Sponsor|6|||
46994808|NCT01613248|83241663|FG002|Overall Study|Study Terminated by Sponsor|8|||
46994809|NCT01613248|83241664|FG003|Overall Study|Study Terminated by Sponsor|8|||
46994810|NCT01613248|83241665|FG004|Overall Study|Study Terminated by Sponsor|9|||
46994811|NCT01613248|83241666|FG005|Overall Study|Study Terminated by Sponsor|11|||
46994812|NCT01613248|83241661|FG000|Overall Study|Physician Decision|8|||
46994813|NCT01613248|83241662|FG001|Overall Study|Physician Decision|8|||
46994814|NCT01613248|83241663|FG002|Overall Study|Physician Decision|9|||
46994815|NCT01613248|83241664|FG003|Overall Study|Physician Decision|4|||
46994816|NCT01613248|83241665|FG004|Overall Study|Physician Decision|7|||
46994817|NCT01613248|83241666|FG005|Overall Study|Physician Decision|6|||
46994818|NCT01613248|83241661|FG000|Overall Study|Lack of Qualifying Event|9|||
46994819|NCT01613248|83241662|FG001|Overall Study|Lack of Qualifying Event|11|||
46994820|NCT01613248|83241663|FG002|Overall Study|Lack of Qualifying Event|10|||
46994821|NCT01613248|83241664|FG003|Overall Study|Lack of Qualifying Event|11|||
46994822|NCT01613248|83241665|FG004|Overall Study|Lack of Qualifying Event|15|||
46994823|NCT01613248|83241666|FG005|Overall Study|Lack of Qualifying Event|18|||
46994824|NCT01613248|83241661|FG000|Overall Study|Pregnancy|0|||
46994825|NCT01613248|83241662|FG001|Overall Study|Pregnancy|0|||
46994826|NCT01613248|83241663|FG002|Overall Study|Pregnancy|0|||
46994827|NCT01613248|83241664|FG003|Overall Study|Pregnancy|1|||
46994828|NCT01613248|83241665|FG004|Overall Study|Pregnancy|0|||
46994829|NCT01613248|83241666|FG005|Overall Study|Pregnancy|0|||
46994830|NCT01898806|83241680|FG000|Overall Study|Withdrawal by Subject|2|||
46994831|NCT01898806|83241680|FG000|Overall Study|Physician Decision|1|||
46994832|NCT02291029|83241690|FG000|Overall Study|Withdrawal by Subject|0|||
46994833|NCT02291029|83241691|FG001|Overall Study|Withdrawal by Subject|0|||
46994834|NCT02291029|83241692|FG002|Overall Study|Withdrawal by Subject|1|||
46994835|NCT02291029|83241693|FG003|Overall Study|Withdrawal by Subject|0|||
46994836|NCT02291029|83241694|FG004|Overall Study|Withdrawal by Subject|0|||
46994837|NCT02291029|83241695|FG005|Overall Study|Withdrawal by Subject|0|||
46994838|NCT02291029|83241690|FG000|Overall Study|Adverse Event|0|||
46994839|NCT02291029|83241691|FG001|Overall Study|Adverse Event|1|||
46994840|NCT02291029|83241692|FG002|Overall Study|Adverse Event|0|||
46994841|NCT02291029|83241693|FG003|Overall Study|Adverse Event|0|||
46994842|NCT02291029|83241694|FG004|Overall Study|Adverse Event|0|||
46994843|NCT02291029|83241695|FG005|Overall Study|Adverse Event|0|||
46994844|NCT02290873|83241712|FG000|Overall Study|Withdrawal by Subject|0|||
46994845|NCT02290873|83241713|FG001|Overall Study|Withdrawal by Subject|1|||
46994846|NCT02290873|83241714|FG002|Overall Study|Withdrawal by Subject|1|||
46994847|NCT02290873|83241712|FG000|Overall Study|Nellcor device error|1|||
46994848|NCT02290873|83241713|FG001|Overall Study|Nellcor device error|0|||
46994849|NCT02290873|83241714|FG002|Overall Study|Nellcor device error|0|||
46994850|NCT02290873|83241712|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
46994851|NCT02290873|83241713|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
46994852|NCT02290873|83241714|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
46994853|NCT02290873|83241712|FG000|Overall Study|Protocol Violation|0|||
46994854|NCT02290873|83241713|FG001|Overall Study|Protocol Violation|0|||
46994855|NCT02290873|83241714|FG002|Overall Study|Protocol Violation|1|||
46994856|NCT02290405|83241725|FG000|Overall Study|Withdrawal by Subject|1|||
46994857|NCT02290405|83241726|FG001|Overall Study|Withdrawal by Subject|0|||
46994858|NCT02359045|83241734|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
46618495|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
46618496|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
46618497|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
46618498|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
46618499|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
46618500|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
46618501|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
46618502|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
46618503|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
46618504|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
46618505|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
46618506|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
46618507|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
46618508|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46618509|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46618510|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46618511|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46994859|NCT02359045|83241735|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
46994860|NCT02359045|83241734|FG000|Overall Study|Lost to Follow-up|1|||
46994861|NCT02359045|83241735|FG001|Overall Study|Lost to Follow-up|1|||
46994862|NCT02359045|83241734|FG000|Overall Study|Adverse Event|0|||
46994863|NCT02359045|83241735|FG001|Overall Study|Adverse Event|1|||
46994864|NCT02358343|83241756|FG000|Screening Intervention|Death|0|||
46994865|NCT02358343|83241757|FG001|Screening Intervention|Death|2|||
46994866|NCT02358343|83241758|FG002|Screening Intervention|Death|0|||
46994867|NCT02358343|83241759|FG003|Screening Intervention|Death|0|||
46994868|NCT02358343|83241760|FG004|Screening Intervention|Death|0|||
46994869|NCT02358343|83241756|FG000|Screening Intervention|Withdrawal by Subject|1|||
46994870|NCT02358343|83241757|FG001|Screening Intervention|Withdrawal by Subject|0|||
46994871|NCT02358343|83241758|FG002|Screening Intervention|Withdrawal by Subject|0|||
46994872|NCT02358343|83241759|FG003|Screening Intervention|Withdrawal by Subject|0|||
46994873|NCT02358343|83241760|FG004|Screening Intervention|Withdrawal by Subject|0|||
46994874|NCT02358343|83241756|FG000|Screening Intervention|Determined Ineligible|5|||
46994875|NCT02358343|83241757|FG001|Screening Intervention|Determined Ineligible|6|||
46994876|NCT02358343|83241758|FG002|Screening Intervention|Determined Ineligible|0|||
46994877|NCT02358343|83241759|FG003|Screening Intervention|Determined Ineligible|0|||
46994878|NCT02358343|83241760|FG004|Screening Intervention|Determined Ineligible|0|||
46994879|NCT02358343|83241756|FG000|Comparative Efficacy Trial / Observation|Death|0|||
46994880|NCT02358343|83241757|FG001|Comparative Efficacy Trial / Observation|Death|0|||
46994881|NCT02358343|83241758|FG002|Comparative Efficacy Trial / Observation|Death|2|||
46994882|NCT02358343|83241759|FG003|Comparative Efficacy Trial / Observation|Death|0|||
46994883|NCT02358343|83241760|FG004|Comparative Efficacy Trial / Observation|Death|0|||
46994884|NCT02358343|83241756|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
46994885|NCT02358343|83241757|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
46994886|NCT02358343|83241758|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
46618512|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46618513|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46708831|NCT04117347|82924721|FG001|Overall Study|Family emergency|0|||
46994887|NCT02358343|83241759|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
46994888|NCT02358343|83241760|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
46994889|NCT02358343|83241756|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
46994890|NCT02358343|83241757|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
46994891|NCT02358343|83241758|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
46994892|NCT02358343|83241759|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
46994893|NCT02358343|83241760|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
46994894|NCT02356783|83241773|FG000|Overall Study|Lost to Follow-up|1|||
46994895|NCT02356783|83241774|FG001|Overall Study|Lost to Follow-up|3|||
46994896|NCT02289469|83241782|FG000|Overall Study|Unable to match a control|6|||
46994897|NCT02289469|83241783|FG001|Overall Study|Unable to match a control|0|||
46994898|NCT02318095|83241789|FG000|Overall Study|Adverse Event|1|||
46994899|NCT02317705|83241794|FG000|Overall Study|Withdrawal by Subject|3|||
46994900|NCT02317705|83241794|FG000|Overall Study|Physician Decision|1|||
46994901|NCT02317705|83241794|FG000|Overall Study|Drug not usable|1|||
46994902|NCT02474069|83241798|FG000|Selection Phase (SP)|Adverse Event|8|||
46994903|NCT02474069|83241799|FG001|Selection Phase (SP)|Adverse Event|0|||
46994904|NCT02474069|83241800|FG002|Selection Phase (SP)|Adverse Event|0|||
46994905|NCT02474069|83241798|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
46994906|NCT02474069|83241799|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
46994907|NCT02474069|83241800|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
46994908|NCT02474069|83241798|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
46994909|NCT02474069|83241799|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
46994910|NCT02474069|83241800|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
46994911|NCT02474069|83241798|FG000|Selection Phase (SP)|Physician Decision|1|||
46994912|NCT02474069|83241799|FG001|Selection Phase (SP)|Physician Decision|0|||
46994913|NCT02474069|83241800|FG002|Selection Phase (SP)|Physician Decision|0|||
46994914|NCT02474069|83241798|FG000|Selection Phase (SP)|Protocol Violation|1|||
46994915|NCT02474069|83241799|FG001|Selection Phase (SP)|Protocol Violation|0|||
46994916|NCT02474069|83241800|FG002|Selection Phase (SP)|Protocol Violation|0|||
46994917|NCT02474069|83241798|FG000|Selection Phase (SP)|No longer requires treatment|1|||
46994918|NCT02474069|83241799|FG001|Selection Phase (SP)|No longer requires treatment|0|||
46994919|NCT02474069|83241800|FG002|Selection Phase (SP)|No longer requires treatment|0|||
46994920|NCT02474069|83241798|FG000|Selection Phase (SP)|Technical Problem|1|||
46994921|NCT02474069|83241799|FG001|Selection Phase (SP)|Technical Problem|0|||
46994922|NCT02474069|83241800|FG002|Selection Phase (SP)|Technical Problem|0|||
46994923|NCT02474069|83241798|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
46994924|NCT02474069|83241799|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
46994925|NCT02474069|83241800|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
46994926|NCT02474069|83241798|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
46994927|NCT02474069|83241799|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
46994928|NCT02474069|83241800|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
46994929|NCT02474069|83241798|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
46994930|NCT02474069|83241799|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
46994931|NCT02474069|83241800|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
46994932|NCT02474069|83241798|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
46994933|NCT02474069|83241799|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
46994934|NCT02474069|83241800|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
46994935|NCT02474069|83241798|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
46994936|NCT02474069|83241799|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
46994937|NCT02474069|83241800|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
46994938|NCT02474069|83241798|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
46994939|NCT02474069|83241799|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
46994940|NCT02474069|83241800|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
46994941|NCT02317627|83241813|FG000|Overall Study|Withdrawal by Subject|0|||
46994942|NCT02317627|83241814|FG001|Overall Study|Withdrawal by Subject|1|||
46994943|NCT02317627|83241815|FG002|Overall Study|Withdrawal by Subject|1|||
46994944|NCT02317627|83241813|FG000|Overall Study|Lost to Follow-up|2|||
46994945|NCT02317627|83241814|FG001|Overall Study|Lost to Follow-up|0|||
46994946|NCT02317627|83241815|FG002|Overall Study|Lost to Follow-up|0|||
46994947|NCT02317627|83241813|FG000|Overall Study|Stopped by Investigator|0|||
46994948|NCT02317627|83241814|FG001|Overall Study|Stopped by Investigator|1|||
46994949|NCT02317627|83241815|FG002|Overall Study|Stopped by Investigator|0|||
46994950|NCT02317627|83241813|FG000|Overall Study|Adverse Event|0|||
46994951|NCT02317627|83241814|FG001|Overall Study|Adverse Event|2|||
46994952|NCT02317627|83241815|FG002|Overall Study|Adverse Event|3|||
46994953|NCT02317627|83241813|FG000|Overall Study|Non-compliance with study drug|0|||
46994954|NCT02317627|83241814|FG001|Overall Study|Non-compliance with study drug|1|||
46994955|NCT02317627|83241815|FG002|Overall Study|Non-compliance with study drug|0|||
46994956|NCT02517905|83241831|FG000|Overall Study|Lost to Follow-up|4|||
46618514|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46994957|NCT02517905|83241832|FG001|Overall Study|Lost to Follow-up|0|||
46994958|NCT02517905|83241831|FG000|Overall Study|Withdrawal by Subject|4|||
46994959|NCT02517905|83241832|FG001|Overall Study|Withdrawal by Subject|0|||
46994960|NCT02517905|83241831|FG000|Overall Study|Screen failure|2|||
46618515|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46994961|NCT02517905|83241832|FG001|Overall Study|Screen failure|2|||
46994962|NCT02473913|83241840|FG000|Overall Study|Lost to Follow-up|3|||
46994963|NCT02473913|83241841|FG001|Overall Study|Lost to Follow-up|3|||
46994964|NCT02316847|83241849|FG000|Overall Study|Adverse Event|0|||
46994965|NCT02316847|83241850|FG001|Overall Study|Adverse Event|3|||
46994966|NCT02316847|83241849|FG000|Overall Study|Lost to Follow-up|0|||
46994967|NCT02316847|83241850|FG001|Overall Study|Lost to Follow-up|2|||
46994968|NCT02316847|83241849|FG000|Overall Study|Physician Decision|0|||
46994969|NCT02316847|83241850|FG001|Overall Study|Physician Decision|1|||
46994970|NCT02316847|83241849|FG000|Overall Study|Pregnancy|0|||
46994971|NCT02316847|83241850|FG001|Overall Study|Pregnancy|1|||
46994972|NCT02316847|83241849|FG000|Overall Study|Withdrawal by Subject|2|||
46994973|NCT02316847|83241850|FG001|Overall Study|Withdrawal by Subject|9|||
46994974|NCT02316847|83241849|FG000|Overall Study|Noncompliance with study drug|0|||
46994975|NCT02316847|83241850|FG001|Overall Study|Noncompliance with study drug|3|||
46994976|NCT02316847|83241849|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
46994977|NCT02316847|83241850|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
46994978|NCT02473523|83241858|FG000|Overall Study|Death|1|||
46994979|NCT02473523|83241858|FG000|Overall Study|Lost to Follow-up|1|||
46994980|NCT02316769|83241864|FG000|Overall Study|Physician Decision|1|||
46994981|NCT02316769|83241865|FG001|Overall Study|Physician Decision|0|||
46994982|NCT02316769|83241864|FG000|Overall Study|Withdrawal by Subject|1|||
46994983|NCT02316769|83241865|FG001|Overall Study|Withdrawal by Subject|0|||
46994984|NCT02473445|83241871|FG000|Overall Study|Withdrawal by Subject|2|||
46994985|NCT02473445|83241871|FG000|Overall Study|Sponsor Decision|20|||
46994986|NCT02473367|83241875|FG000|Wait 1|Withdrawal by Subject|1|||
46994987|NCT02473367|83241875|FG000|Period 4|Lost to Follow-up|1|||
46994988|NCT02316613|83241885|FG000|Overall Study|Death|63|||
46994989|NCT02316613|83241885|FG000|Overall Study|Lost to Follow-up|9|||
46994990|NCT02316613|83241885|FG000|Overall Study|Lymphoma transformation|2|||
46994991|NCT02316613|83241885|FG000|Overall Study|Participant moved/changed medical team|11|||
46994992|NCT02316613|83241885|FG000|Overall Study|No data and duplicate cases|5|||
46994993|NCT02316613|83241885|FG000|Overall Study|Did not met selection criteria|14|||
46994994|NCT02492165|83241904|FG000|Overall Study|Withdrawal by Subject|0|||
46994995|NCT02492165|83241905|FG001|Overall Study|Withdrawal by Subject|1|||
46994996|NCT02492165|83241906|FG002|Overall Study|Withdrawal by Subject|0|||
46994997|NCT02492165|83241907|FG003|Overall Study|Withdrawal by Subject|0|||
46994998|NCT02355691|83241919|FG000|Overall Study|Loss of Research Personnel|7|||
46994999|NCT02355691|83241920|FG001|Overall Study|Loss of Research Personnel|9|||
46995000|NCT02473289|83241928|FG000|Overall Study|Adverse Event|2|||
46995001|NCT02473289|83241929|FG001|Overall Study|Adverse Event|3|||
46995002|NCT02473289|83241928|FG000|Overall Study|Lost to Follow-up|1|||
46995003|NCT02473289|83241929|FG001|Overall Study|Lost to Follow-up|1|||
46995004|NCT02473289|83241928|FG000|Overall Study|Protocol Violation|0|||
46995005|NCT02473289|83241929|FG001|Overall Study|Protocol Violation|1|||
46995006|NCT02473289|83241928|FG000|Overall Study|Withdrawal of consent|6|||
46995007|NCT02473289|83241929|FG001|Overall Study|Withdrawal of consent|7|||
46995008|NCT02473289|83241928|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
46995009|NCT02473289|83241929|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
46995010|NCT02473289|83241928|FG000|Overall Study|Other|2|||
46995011|NCT02473289|83241929|FG001|Overall Study|Other|0|||
46995012|NCT02354599|83241941|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
46995013|NCT02354599|83241942|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
46995014|NCT02354599|83241943|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
46995015|NCT02354599|83241944|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
46995016|NCT02354599|83241945|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
46995017|NCT02354599|83241946|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
46995018|NCT02354599|83241941|FG000|Overall Study|Withdrawal by Subject|1|||
46995019|NCT02354599|83241942|FG001|Overall Study|Withdrawal by Subject|1|||
46995020|NCT02354599|83241943|FG002|Overall Study|Withdrawal by Subject|0|||
46995021|NCT02354599|83241944|FG003|Overall Study|Withdrawal by Subject|0|||
46995022|NCT02354599|83241945|FG004|Overall Study|Withdrawal by Subject|0|||
46995023|NCT02354599|83241946|FG005|Overall Study|Withdrawal by Subject|0|||
46995024|NCT02316223|83241969|FG000|Overall Study|Lack of Efficacy|0|||
46995025|NCT02316223|83241970|FG001|Overall Study|Lack of Efficacy|1|||
46995026|NCT02316223|83241971|FG002|Overall Study|Lack of Efficacy|1|||
46995027|NCT02316223|83241969|FG000|Overall Study|Lost to Follow-up|27|||
46995028|NCT02316223|83241970|FG001|Overall Study|Lost to Follow-up|34|||
46995029|NCT02316223|83241971|FG002|Overall Study|Lost to Follow-up|36|||
46995030|NCT02316223|83241969|FG000|Overall Study|COPD Diagnosis|3|||
46995031|NCT02316223|83241970|FG001|Overall Study|COPD Diagnosis|2|||
46995032|NCT02316223|83241971|FG002|Overall Study|COPD Diagnosis|3|||
46995033|NCT02316223|83241969|FG000|Overall Study|Reside outside study area|1|||
46995034|NCT02316223|83241970|FG001|Overall Study|Reside outside study area|1|||
46995035|NCT02316223|83241971|FG002|Overall Study|Reside outside study area|1|||
46995036|NCT02316223|83241969|FG000|Overall Study|No asthma|2|||
46995037|NCT02316223|83241970|FG001|Overall Study|No asthma|0|||
46995038|NCT02316223|83241971|FG002|Overall Study|No asthma|0|||
46995039|NCT02316223|83241969|FG000|Overall Study|Discontinued by PI|11|||
46995040|NCT02316223|83241970|FG001|Overall Study|Discontinued by PI|19|||
46995041|NCT02316223|83241971|FG002|Overall Study|Discontinued by PI|3|||
46995042|NCT02286895|83241981|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
46995043|NCT02286895|83241982|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
46995044|NCT02286895|83241981|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
46995045|NCT02286895|83241982|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
46995046|NCT02286895|83241981|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
46995047|NCT02286895|83241982|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
46995048|NCT02472977|83241991|FG000|Overall Study|Disease progression|4|||
46995049|NCT02472977|83241992|FG001|Overall Study|Disease progression|25|||
46995050|NCT02472977|83241993|FG002|Overall Study|Disease progression|6|||
46995051|NCT02472977|83241991|FG000|Overall Study|Withdrawal by Subject|0|||
46995052|NCT02472977|83241992|FG001|Overall Study|Withdrawal by Subject|1|||
46995053|NCT02472977|83241993|FG002|Overall Study|Withdrawal by Subject|0|||
46995054|NCT02472977|83241991|FG000|Overall Study|Study drug toxicity|2|||
46995055|NCT02472977|83241992|FG001|Overall Study|Study drug toxicity|0|||
46995056|NCT02472977|83241993|FG002|Overall Study|Study drug toxicity|2|||
46995057|NCT02472977|83241991|FG000|Overall Study|Subject request to discontinue treatment|0|||
46995058|NCT02472977|83241992|FG001|Overall Study|Subject request to discontinue treatment|1|||
46995059|NCT02472977|83241993|FG002|Overall Study|Subject request to discontinue treatment|0|||
46995060|NCT02060487|83242004|FG000|Overall Study|Other|1|||
46995061|NCT02060487|83242005|FG001|Overall Study|Other|2|||
46995062|NCT02060487|83242006|FG002|Overall Study|Other|1|||
46995063|NCT02060487|83242004|FG000|Overall Study|Lack of Efficacy|0|||
46995064|NCT02060487|83242005|FG001|Overall Study|Lack of Efficacy|1|||
46995065|NCT02060487|83242006|FG002|Overall Study|Lack of Efficacy|0|||
46995066|NCT02060487|83242004|FG000|Overall Study|Withdrawal by Subject|3|||
46995067|NCT02060487|83242005|FG001|Overall Study|Withdrawal by Subject|10|||
46995068|NCT02060487|83242006|FG002|Overall Study|Withdrawal by Subject|4|||
46995069|NCT02060487|83242004|FG000|Overall Study|Study Terminated By Sponsor|87|||
46995070|NCT02060487|83242005|FG001|Overall Study|Study Terminated By Sponsor|89|||
46995071|NCT02060487|83242006|FG002|Overall Study|Study Terminated By Sponsor|100|||
46995072|NCT02060487|83242004|FG000|Overall Study|Randomized in error|1|||
46995073|NCT02060487|83242005|FG001|Overall Study|Randomized in error|0|||
46995074|NCT02060487|83242006|FG002|Overall Study|Randomized in error|0|||
46995075|NCT02060487|83242004|FG000|Overall Study|Protocol Violation|0|||
46995076|NCT02060487|83242005|FG001|Overall Study|Protocol Violation|1|||
46995077|NCT02060487|83242006|FG002|Overall Study|Protocol Violation|1|||
46995078|NCT02060487|83242004|FG000|Overall Study|Lost to Follow-up|3|||
46995079|NCT02060487|83242005|FG001|Overall Study|Lost to Follow-up|0|||
46995080|NCT02060487|83242006|FG002|Overall Study|Lost to Follow-up|2|||
46995081|NCT02060487|83242004|FG000|Overall Study|Death|34|||
46995082|NCT02060487|83242005|FG001|Overall Study|Death|25|||
46995083|NCT02060487|83242006|FG002|Overall Study|Death|19|||
46995084|NCT02060487|83242004|FG000|Overall Study|Adverse Event|0|||
46995085|NCT02060487|83242005|FG001|Overall Study|Adverse Event|0|||
46995086|NCT02060487|83242006|FG002|Overall Study|Adverse Event|1|||
46995087|NCT02059395|83242016|FG000|Overall Study|Lost to Follow-up|2|||
46995088|NCT02059395|83242017|FG001|Overall Study|Lost to Follow-up|4|||
46995089|NCT02059239|83242025|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
46995090|NCT02059239|83242026|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
46995091|NCT02059239|83242025|FG000|Overall Study|Physician Decision|1|||
46995092|NCT02059239|83242026|FG001|Overall Study|Physician Decision|0|||
46995093|NCT02059161|83242035|FG000|Overall Study|Pregnancy|0|||
46995094|NCT02059161|83242036|FG001|Overall Study|Pregnancy|2|||
46995095|NCT02059161|83242035|FG000|Overall Study|Adverse Event|2|||
46995096|NCT02059161|83242036|FG001|Overall Study|Adverse Event|6|||
46995097|NCT02059161|83242035|FG000|Overall Study|Lost to Follow-up|20|||
46995098|NCT02059161|83242036|FG001|Overall Study|Lost to Follow-up|12|||
46995099|NCT02059161|83242035|FG000|Overall Study|Physician Decision|4|||
46995100|NCT02059161|83242036|FG001|Overall Study|Physician Decision|4|||
46995101|NCT02059161|83242035|FG000|Overall Study|Protocol Violation|1|||
46995102|NCT02059161|83242036|FG001|Overall Study|Protocol Violation|1|||
46995103|NCT02059161|83242035|FG000|Overall Study|Withdrawal by Subject|16|||
46995104|NCT02059161|83242036|FG001|Overall Study|Withdrawal by Subject|13|||
46995105|NCT02059161|83242035|FG000|Overall Study|Randomized in error, no study drug|0|||
46995106|NCT02059161|83242036|FG001|Overall Study|Randomized in error, no study drug|1|||
46995107|NCT02059161|83242035|FG000|Overall Study|Non-compliance with study drug|6|||
46995108|NCT02059161|83242036|FG001|Overall Study|Non-compliance with study drug|2|||
46995109|NCT01897714|83242048|FG000|Phase I (Dose Escalation)|Disease progression|3|||
46995110|NCT01897714|83242049|FG001|Phase I (Dose Escalation)|Disease progression|5|||
46995111|NCT01897714|83242050|FG002|Phase I (Dose Escalation)|Disease progression|1|||
46898842|NCT03672461|83125219|FG000|Overall Study|Cannot tolerate intervention|1|||
46898843|NCT03672461|83125220|FG001|Overall Study|Cannot tolerate intervention|0|||
46995112|NCT01897714|83242051|FG003|Phase I (Dose Escalation)|Disease progression|3|||
46995113|NCT01897714|83242052|FG004|Phase I (Dose Escalation)|Disease progression|0|||
46995114|NCT01897714|83242053|FG005|Phase I (Dose Escalation)|Disease progression|0|||
46995115|NCT01897714|83242048|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
46995116|NCT01897714|83242049|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
46995117|NCT01897714|83242050|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
46995118|NCT01897714|83242051|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
46995119|NCT01897714|83242052|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
46995120|NCT01897714|83242053|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
46995121|NCT01897714|83242048|FG000|Phase I (Dose Escalation)|Other|0|||
46995122|NCT01897714|83242049|FG001|Phase I (Dose Escalation)|Other|1|||
46995123|NCT01897714|83242050|FG002|Phase I (Dose Escalation)|Other|0|||
46995124|NCT01897714|83242051|FG003|Phase I (Dose Escalation)|Other|0|||
46995125|NCT01897714|83242052|FG004|Phase I (Dose Escalation)|Other|0|||
46995126|NCT01897714|83242053|FG005|Phase I (Dose Escalation)|Other|0|||
46995127|NCT01897714|83242048|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
46995128|NCT01897714|83242049|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
46995129|NCT01897714|83242050|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
46995130|NCT01897714|83242051|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
46995131|NCT01897714|83242052|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
46995132|NCT01897714|83242053|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
46995133|NCT01897714|83242048|FG000|Phase II (MTD)|Lost to Follow-up|0|||
46995134|NCT01897714|83242049|FG001|Phase II (MTD)|Lost to Follow-up|0|||
46995135|NCT01897714|83242050|FG002|Phase II (MTD)|Lost to Follow-up|0|||
46995136|NCT01897714|83242051|FG003|Phase II (MTD)|Lost to Follow-up|0|||
46995137|NCT01897714|83242052|FG004|Phase II (MTD)|Lost to Follow-up|1|||
46995138|NCT01897714|83242053|FG005|Phase II (MTD)|Lost to Follow-up|0|||
46995139|NCT01897714|83242048|FG000|Phase II (MTD)|Death|0|||
46995140|NCT01897714|83242049|FG001|Phase II (MTD)|Death|0|||
46995141|NCT01897714|83242050|FG002|Phase II (MTD)|Death|0|||
46995142|NCT01897714|83242051|FG003|Phase II (MTD)|Death|0|||
46995143|NCT01897714|83242052|FG004|Phase II (MTD)|Death|25|||
46995144|NCT01897714|83242053|FG005|Phase II (MTD)|Death|10|||
46995145|NCT01897714|83242048|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
46995146|NCT01897714|83242049|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
46995147|NCT01897714|83242050|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
46995148|NCT01897714|83242051|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
46995149|NCT01897714|83242052|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
46995150|NCT01897714|83242053|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
46995151|NCT01897714|83242048|FG000|Phase II (MTD)|Other|0|||
46995152|NCT01897714|83242049|FG001|Phase II (MTD)|Other|0|||
46995153|NCT01897714|83242050|FG002|Phase II (MTD)|Other|0|||
46995154|NCT01897714|83242051|FG003|Phase II (MTD)|Other|0|||
46995155|NCT01897714|83242052|FG004|Phase II (MTD)|Other|3|||
46995156|NCT01897714|83242053|FG005|Phase II (MTD)|Other|0|||
46995157|NCT01861522|83242071|FG000|Overall Study|Adverse Event|1|||
46995158|NCT01861522|83242072|FG001|Overall Study|Adverse Event|0|||
46995159|NCT01861522|83242071|FG000|Overall Study|Withdrawal by Subject|2|||
46995160|NCT01861522|83242072|FG001|Overall Study|Withdrawal by Subject|0|||
46995161|NCT01860976|83242080|FG000|Blinded Treatment|Adverse Event|1|||
46995162|NCT01860976|83242081|FG001|Blinded Treatment|Adverse Event|3|||
46995163|NCT01860976|83242080|FG000|Blinded Treatment|Lack of Efficacy|5|||
46995164|NCT01860976|83242081|FG001|Blinded Treatment|Lack of Efficacy|12|||
46995165|NCT01860976|83242080|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
46995166|NCT01860976|83242081|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
46995167|NCT01860976|83242080|FG000|Blinded Treatment|Withdrawal by Subject|3|||
46995168|NCT01860976|83242081|FG001|Blinded Treatment|Withdrawal by Subject|5|||
46995169|NCT01860976|83242080|FG000|Blinded Treatment|Subject no longer met criteria|1|||
46995170|NCT01860976|83242081|FG001|Blinded Treatment|Subject no longer met criteria|0|||
46995171|NCT01860976|83242080|FG000|Blinded Treatment|Entered Open-Label in error|0|||
46995172|NCT01860976|83242081|FG001|Blinded Treatment|Entered Open-Label in error|1|||
46995173|NCT01860976|83242080|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
46995174|NCT01860976|83242081|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
46995175|NCT01860976|83242080|FG000|Open-Label|Adverse Event|2|||
46995176|NCT01860976|83242081|FG001|Open-Label|Adverse Event|4|||
46995177|NCT01860976|83242080|FG000|Open-Label|Lack of Efficacy|16|||
46995178|NCT01860976|83242081|FG001|Open-Label|Lack of Efficacy|8|||
46995179|NCT01860976|83242080|FG000|Open-Label|Lost to Follow-up|1|||
46995180|NCT01860976|83242081|FG001|Open-Label|Lost to Follow-up|2|||
46618516|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46995181|NCT01860976|83242080|FG000|Open-Label|Subject request discontinue treatment|4|||
46995182|NCT01860976|83242081|FG001|Open-Label|Subject request discontinue treatment|3|||
46995183|NCT01860976|83242080|FG000|Open-Label|Withdrawal by Subject|4|||
46995184|NCT01860976|83242081|FG001|Open-Label|Withdrawal by Subject|1|||
46995185|NCT01860976|83242080|FG000|Open-Label|Other Reasons|1|||
46995186|NCT01860976|83242081|FG001|Open-Label|Other Reasons|1|||
46995187|NCT01860976|83242080|FG000|Long Term Extension|Adverse Event|4|||
46995188|NCT01860976|83242081|FG001|Long Term Extension|Adverse Event|0|||
46995189|NCT01860976|83242080|FG000|Long Term Extension|Lack of Efficacy|2|||
46995190|NCT01860976|83242081|FG001|Long Term Extension|Lack of Efficacy|0|||
46995191|NCT01860976|83242080|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
46995192|NCT01860976|83242081|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
46995193|NCT01860976|83242080|FG000|Long Term Extension|Lost to Follow-up|2|||
46995194|NCT01860976|83242081|FG001|Long Term Extension|Lost to Follow-up|0|||
46995195|NCT01860976|83242080|FG000|Long Term Extension|subject withdrew consent|7|||
46995196|NCT01860976|83242081|FG001|Long Term Extension|subject withdrew consent|0|||
46995197|NCT01860040|83242092|FG000|Overall Study|Withdrawal by Subject|1|||
46995198|NCT01860040|83242093|FG001|Overall Study|Withdrawal by Subject|0|||
46995199|NCT01896934|83242098|FG000|Overall Study|Adverse Event|1|||
46995200|NCT01896934|83242098|FG000|Overall Study|Withdrawal by Subject|1|||
46995201|NCT02039505|83242105|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
46995202|NCT02039505|83242106|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
46995203|NCT02039505|83242107|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
46995204|NCT02039505|83242108|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
46995205|NCT02039505|83242109|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
46995206|NCT02039505|83242110|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
46995207|NCT02039505|83242111|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
46995208|NCT02039505|83242105|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
46995209|NCT02039505|83242106|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
46995210|NCT02039505|83242107|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
46995211|NCT02039505|83242108|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
46995212|NCT02039505|83242109|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
46995213|NCT02039505|83242110|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
46995214|NCT02039505|83242111|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
46995215|NCT02039505|83242105|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
46995216|NCT02039505|83242106|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
46995217|NCT02039505|83242107|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
46995218|NCT02039505|83242108|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
46995219|NCT02039505|83242109|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
46995220|NCT02039505|83242110|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
46995221|NCT02039505|83242111|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
46995222|NCT02039505|83242105|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
46995223|NCT02039505|83242106|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
46995224|NCT02039505|83242107|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
46995225|NCT02039505|83242108|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
46995226|NCT02039505|83242109|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
46995227|NCT02039505|83242110|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
46995228|NCT02039505|83242111|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
46995229|NCT02039505|83242105|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
46995230|NCT02039505|83242106|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
46995231|NCT02039505|83242107|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
46995232|NCT02039505|83242108|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
46995233|NCT02039505|83242109|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
46995234|NCT02039505|83242110|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
46995235|NCT02039505|83242111|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
46995236|NCT02039505|83242105|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
46995237|NCT02039505|83242106|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
46995238|NCT02039505|83242107|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
46995239|NCT02039505|83242108|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
46995240|NCT02039505|83242109|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
46995241|NCT02039505|83242110|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
46995242|NCT02039505|83242111|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
46995243|NCT02039505|83242105|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
46995244|NCT02039505|83242106|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
46995245|NCT02039505|83242107|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
46995246|NCT02039505|83242108|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
46995247|NCT02039505|83242109|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
46618517|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46618518|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
46618519|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
46618520|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
46618521|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46618522|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
46995248|NCT02039505|83242110|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
46995249|NCT02039505|83242111|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
46995250|NCT02039505|83242105|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
46995251|NCT02039505|83242106|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
46995252|NCT02039505|83242107|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
46995253|NCT02039505|83242108|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
46995254|NCT02039505|83242109|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
46995255|NCT02039505|83242110|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
46995256|NCT02039505|83242111|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
46995257|NCT02039505|83242105|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
46995258|NCT02039505|83242106|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
46995259|NCT02039505|83242107|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
46995260|NCT02039505|83242108|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
46995261|NCT02039505|83242109|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
46995262|NCT02039505|83242110|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
46995263|NCT02039505|83242111|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
46995264|NCT02039505|83242105|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
46995265|NCT02039505|83242106|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
46995266|NCT02039505|83242107|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
46995267|NCT02039505|83242108|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
46995268|NCT02039505|83242109|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
46995269|NCT02039505|83242110|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
46995270|NCT02039505|83242111|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
46995271|NCT02039505|83242105|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
46995272|NCT02039505|83242106|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
46995273|NCT02039505|83242107|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
46995274|NCT02039505|83242108|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
46995275|NCT02039505|83242109|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
46995276|NCT02039505|83242110|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
46995277|NCT02039505|83242111|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
46995278|NCT02095197|83242133|FG000|Overall Study|Lost to Follow-up|0|||
46995279|NCT02095197|83242134|FG001|Overall Study|Lost to Follow-up|3|||
46995280|NCT02039427|83242144|FG000|Overall Study|Duration of surgery > 3h|1|||
46995281|NCT02039427|83242145|FG001|Overall Study|Duration of surgery > 3h|1|||
46995282|NCT02039427|83242146|FG002|Overall Study|Duration of surgery > 3h|0|||
46995283|NCT02039427|83242147|FG003|Overall Study|Duration of surgery > 3h|0|||
46995284|NCT02039427|83242144|FG000|Overall Study|Withdrawal on concent|0|||
46995285|NCT02039427|83242145|FG001|Overall Study|Withdrawal on concent|0|||
46995286|NCT02039427|83242146|FG002|Overall Study|Withdrawal on concent|0|||
46995287|NCT02039427|83242147|FG003|Overall Study|Withdrawal on concent|1|||
46995288|NCT02039427|83242144|FG000|Overall Study|Cancellation of surgery|0|||
46995289|NCT02039427|83242145|FG001|Overall Study|Cancellation of surgery|0|||
46995290|NCT02039427|83242146|FG002|Overall Study|Cancellation of surgery|1|||
46995291|NCT02039427|83242147|FG003|Overall Study|Cancellation of surgery|0|||
46995292|NCT02039427|83242144|FG000|Overall Study|Loss of follow - up|1|||
46995293|NCT02039427|83242145|FG001|Overall Study|Loss of follow - up|0|||
46995294|NCT02039427|83242146|FG002|Overall Study|Loss of follow - up|2|||
46995295|NCT02039427|83242147|FG003|Overall Study|Loss of follow - up|4|||
46995296|NCT02039427|83242144|FG000|Overall Study|Steroid Use|1|||
46995297|NCT02039427|83242145|FG001|Overall Study|Steroid Use|0|||
46995298|NCT02039427|83242146|FG002|Overall Study|Steroid Use|0|||
46995299|NCT02039427|83242147|FG003|Overall Study|Steroid Use|0|||
46995300|NCT02094885|83242163|FG000|Overall Study|Death|1|||
46995301|NCT02094885|83242164|FG001|Overall Study|Death|5|||
46995302|NCT02094885|83242163|FG000|Overall Study|Withdrawn due to age|1|||
46995303|NCT02094885|83242164|FG001|Overall Study|Withdrawn due to age|0|||
46995304|NCT01896856|83242176|FG000|Overall Study|Transportation issues / Non-compliance|0|||
46995305|NCT01896856|83242177|FG001|Overall Study|Transportation issues / Non-compliance|0|||
46995306|NCT01896856|83242178|FG002|Overall Study|Transportation issues / Non-compliance|1|||
46995307|NCT01896856|83242179|FG003|Overall Study|Transportation issues / Non-compliance|0|||
46995308|NCT01896856|83242180|FG004|Overall Study|Transportation issues / Non-compliance|0|||
46995309|NCT01896856|83242181|FG005|Overall Study|Transportation issues / Non-compliance|0|||
46995310|NCT02038959|83242198|FG000|Overall Study|Withdrawal by Subject|6|||
46995311|NCT02038959|83242199|FG001|Overall Study|Withdrawal by Subject|8|||
46995312|NCT01896700|83242207|FG000|Overall Study|Adverse Event|4|||
46995313|NCT01896700|83242208|FG001|Overall Study|Adverse Event|5|||
46995314|NCT01896700|83242207|FG000|Overall Study|Withdrawal by Subject|0|||
46995315|NCT01896700|83242208|FG001|Overall Study|Withdrawal by Subject|1|||
46995316|NCT02352493|83242232|FG000|Overall Study|Pregnancy|0|||
46995317|NCT02352493|83242233|FG001|Overall Study|Pregnancy|0|||
46995318|NCT02352493|83242234|FG002|Overall Study|Pregnancy|0|||
46995319|NCT02352493|83242235|FG003|Overall Study|Pregnancy|0|||
46995320|NCT02352493|83242236|FG004|Overall Study|Pregnancy|0|||
46995321|NCT02352493|83242237|FG005|Overall Study|Pregnancy|0|||
46995322|NCT02352493|83242238|FG006|Overall Study|Pregnancy|1|||
46995323|NCT02352493|83242239|FG007|Overall Study|Pregnancy|0|||
46995324|NCT02352493|83242240|FG008|Overall Study|Pregnancy|1|||
46995325|NCT02352493|83242241|FG009|Overall Study|Pregnancy|0|||
46995326|NCT02352493|83242242|FG010|Overall Study|Pregnancy|0|||
46995327|NCT02352493|83242243|FG011|Overall Study|Pregnancy|0|||
46995328|NCT02352493|83242244|FG012|Overall Study|Pregnancy|0|||
46995329|NCT02352493|83242245|FG013|Overall Study|Pregnancy|0|||
46995330|NCT02352493|83242246|FG014|Overall Study|Pregnancy|0|||
46995331|NCT02352493|83242247|FG015|Overall Study|Pregnancy|0|||
46995332|NCT02352493|83242248|FG016|Overall Study|Pregnancy|0|||
46995333|NCT02352493|83242249|FG017|Overall Study|Pregnancy|0|||
46995334|NCT02352493|83242232|FG000|Overall Study|Withdrawal by Subject|0|||
46995335|NCT02352493|83242233|FG001|Overall Study|Withdrawal by Subject|0|||
46995336|NCT02352493|83242234|FG002|Overall Study|Withdrawal by Subject|0|||
46995337|NCT02352493|83242235|FG003|Overall Study|Withdrawal by Subject|0|||
46995338|NCT02352493|83242236|FG004|Overall Study|Withdrawal by Subject|0|||
46995339|NCT02352493|83242237|FG005|Overall Study|Withdrawal by Subject|0|||
46995340|NCT02352493|83242238|FG006|Overall Study|Withdrawal by Subject|0|||
46995341|NCT02352493|83242239|FG007|Overall Study|Withdrawal by Subject|0|||
46995342|NCT02352493|83242240|FG008|Overall Study|Withdrawal by Subject|1|||
46995343|NCT02352493|83242241|FG009|Overall Study|Withdrawal by Subject|0|||
46995344|NCT02352493|83242242|FG010|Overall Study|Withdrawal by Subject|0|||
46995345|NCT02352493|83242243|FG011|Overall Study|Withdrawal by Subject|0|||
46995346|NCT02352493|83242244|FG012|Overall Study|Withdrawal by Subject|0|||
46995347|NCT02352493|83242245|FG013|Overall Study|Withdrawal by Subject|0|||
46995348|NCT02352493|83242246|FG014|Overall Study|Withdrawal by Subject|1|||
46995349|NCT02352493|83242247|FG015|Overall Study|Withdrawal by Subject|0|||
46995350|NCT02352493|83242248|FG016|Overall Study|Withdrawal by Subject|0|||
46995351|NCT02352493|83242249|FG017|Overall Study|Withdrawal by Subject|0|||
46995352|NCT02352493|83242232|FG000|Overall Study|Lost to Follow-up|0|||
46995353|NCT02352493|83242233|FG001|Overall Study|Lost to Follow-up|0|||
46995354|NCT02352493|83242234|FG002|Overall Study|Lost to Follow-up|0|||
46995355|NCT02352493|83242235|FG003|Overall Study|Lost to Follow-up|0|||
46995356|NCT02352493|83242236|FG004|Overall Study|Lost to Follow-up|0|||
46995357|NCT02352493|83242237|FG005|Overall Study|Lost to Follow-up|0|||
46995358|NCT02352493|83242238|FG006|Overall Study|Lost to Follow-up|0|||
46995359|NCT02352493|83242239|FG007|Overall Study|Lost to Follow-up|0|||
46995360|NCT02352493|83242240|FG008|Overall Study|Lost to Follow-up|0|||
46995361|NCT02352493|83242241|FG009|Overall Study|Lost to Follow-up|1|||
46995362|NCT02352493|83242242|FG010|Overall Study|Lost to Follow-up|0|||
46995363|NCT02352493|83242243|FG011|Overall Study|Lost to Follow-up|0|||
46995364|NCT02352493|83242244|FG012|Overall Study|Lost to Follow-up|1|||
46995365|NCT02352493|83242245|FG013|Overall Study|Lost to Follow-up|2|||
46995366|NCT02352493|83242246|FG014|Overall Study|Lost to Follow-up|0|||
46995367|NCT02352493|83242247|FG015|Overall Study|Lost to Follow-up|0|||
46995368|NCT02352493|83242248|FG016|Overall Study|Lost to Follow-up|0|||
46995369|NCT02352493|83242249|FG017|Overall Study|Lost to Follow-up|0|||
46995370|NCT02286193|83242304|FG000|Overall Study|Referred: CRS unable to make contact|62|||
46995371|NCT02286193|83242304|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
46995372|NCT02286193|83242304|FG000|Overall Study|Referred: Declined service|38|||
46995373|NCT01896232|83242311|FG000|Overall Study|Death|6|||
46995374|NCT01896232|83242312|FG001|Overall Study|Death|10|||
46995375|NCT01896232|83242311|FG000|Overall Study|Withdrawal by Subject|32|||
46995376|NCT01896232|83242312|FG001|Overall Study|Withdrawal by Subject|31|||
46995377|NCT01896232|83242311|FG000|Overall Study|Sponsor Decision|2|||
46995378|NCT01896232|83242312|FG001|Overall Study|Sponsor Decision|0|||
46995379|NCT01896232|83242311|FG000|Overall Study|Lost to Follow-up|9|||
46995380|NCT01896232|83242312|FG001|Overall Study|Lost to Follow-up|12|||
46995381|NCT02460224|83242347|FG000|Overall Study|Adverse Event|0|||
46995382|NCT02460224|83242348|FG001|Overall Study|Adverse Event|0|||
46995383|NCT02460224|83242349|FG002|Overall Study|Adverse Event|0|||
46995384|NCT02460224|83242350|FG003|Overall Study|Adverse Event|0|||
46995385|NCT02460224|83242351|FG004|Overall Study|Adverse Event|0|||
46995386|NCT02460224|83242352|FG005|Overall Study|Adverse Event|0|||
46995387|NCT02460224|83242353|FG006|Overall Study|Adverse Event|1|||
46995388|NCT02460224|83242354|FG007|Overall Study|Adverse Event|0|||
46995389|NCT02460224|83242355|FG008|Overall Study|Adverse Event|0|||
46995390|NCT02460224|83242356|FG009|Overall Study|Adverse Event|0|||
46995391|NCT02460224|83242357|FG010|Overall Study|Adverse Event|0|||
46995392|NCT02460224|83242358|FG011|Overall Study|Adverse Event|0|||
46995393|NCT02460224|83242359|FG012|Overall Study|Adverse Event|1|||
46995394|NCT02460224|83242360|FG013|Overall Study|Adverse Event|0|||
46995395|NCT02460224|83242361|FG014|Overall Study|Adverse Event|0|||
46995396|NCT02460224|83242362|FG015|Overall Study|Adverse Event|0|||
46995397|NCT02460224|83242363|FG016|Overall Study|Adverse Event|1|||
46995398|NCT02460224|83242364|FG017|Overall Study|Adverse Event|0|||
46995399|NCT02460224|83242365|FG018|Overall Study|Adverse Event|1|||
46995400|NCT02460224|83242366|FG019|Overall Study|Adverse Event|0|||
46995401|NCT02460224|83242367|FG020|Overall Study|Adverse Event|1|||
46995402|NCT02460224|83242368|FG021|Overall Study|Adverse Event|1|||
46995403|NCT02460224|83242369|FG022|Overall Study|Adverse Event|1|||
46995404|NCT02460224|83242370|FG023|Overall Study|Adverse Event|0|||
46995405|NCT02460224|83242371|FG024|Overall Study|Adverse Event|0|||
46995406|NCT02460224|83242372|FG025|Overall Study|Adverse Event|0|||
46995407|NCT02460224|83242373|FG026|Overall Study|Adverse Event|11|||
46995408|NCT02460224|83242374|FG027|Overall Study|Adverse Event|1|||
46995409|NCT02460224|83242375|FG028|Overall Study|Adverse Event|6|||
46995410|NCT02460224|83242347|FG000|Overall Study|Death|0|||
46995411|NCT02460224|83242348|FG001|Overall Study|Death|0|||
46995412|NCT02460224|83242349|FG002|Overall Study|Death|0|||
46995413|NCT02460224|83242350|FG003|Overall Study|Death|0|||
46995414|NCT02460224|83242351|FG004|Overall Study|Death|0|||
46995415|NCT02460224|83242352|FG005|Overall Study|Death|2|||
46995416|NCT02460224|83242353|FG006|Overall Study|Death|1|||
46995417|NCT02460224|83242354|FG007|Overall Study|Death|0|||
46995418|NCT02460224|83242355|FG008|Overall Study|Death|0|||
46995419|NCT02460224|83242356|FG009|Overall Study|Death|1|||
46995420|NCT02460224|83242357|FG010|Overall Study|Death|0|||
46995421|NCT02460224|83242358|FG011|Overall Study|Death|0|||
46995422|NCT02460224|83242359|FG012|Overall Study|Death|0|||
46995423|NCT02460224|83242360|FG013|Overall Study|Death|1|||
46995424|NCT02460224|83242361|FG014|Overall Study|Death|0|||
46995425|NCT02460224|83242362|FG015|Overall Study|Death|0|||
46995426|NCT02460224|83242363|FG016|Overall Study|Death|2|||
46995427|NCT02460224|83242364|FG017|Overall Study|Death|1|||
46995428|NCT02460224|83242365|FG018|Overall Study|Death|0|||
46995429|NCT02460224|83242366|FG019|Overall Study|Death|2|||
46995430|NCT02460224|83242367|FG020|Overall Study|Death|0|||
46995431|NCT02460224|83242368|FG021|Overall Study|Death|0|||
46995432|NCT02460224|83242369|FG022|Overall Study|Death|0|||
46995433|NCT02460224|83242370|FG023|Overall Study|Death|0|||
46995434|NCT02460224|83242371|FG024|Overall Study|Death|1|||
46995435|NCT02460224|83242372|FG025|Overall Study|Death|1|||
46995436|NCT02460224|83242373|FG026|Overall Study|Death|5|||
46995437|NCT02460224|83242374|FG027|Overall Study|Death|0|||
46995438|NCT02460224|83242375|FG028|Overall Study|Death|1|||
46995439|NCT02460224|83242347|FG000|Overall Study|Lost to Follow-up|0|||
46995440|NCT02460224|83242348|FG001|Overall Study|Lost to Follow-up|0|||
46995441|NCT02460224|83242349|FG002|Overall Study|Lost to Follow-up|0|||
46995442|NCT02460224|83242350|FG003|Overall Study|Lost to Follow-up|0|||
46995443|NCT02460224|83242351|FG004|Overall Study|Lost to Follow-up|0|||
46995444|NCT02460224|83242352|FG005|Overall Study|Lost to Follow-up|0|||
46995445|NCT02460224|83242353|FG006|Overall Study|Lost to Follow-up|0|||
46995446|NCT02460224|83242354|FG007|Overall Study|Lost to Follow-up|0|||
46995447|NCT02460224|83242355|FG008|Overall Study|Lost to Follow-up|0|||
46995448|NCT02460224|83242356|FG009|Overall Study|Lost to Follow-up|0|||
46995449|NCT02460224|83242357|FG010|Overall Study|Lost to Follow-up|0|||
46995450|NCT02460224|83242358|FG011|Overall Study|Lost to Follow-up|0|||
46995451|NCT02460224|83242359|FG012|Overall Study|Lost to Follow-up|0|||
46995452|NCT02460224|83242360|FG013|Overall Study|Lost to Follow-up|0|||
46995453|NCT02460224|83242361|FG014|Overall Study|Lost to Follow-up|0|||
46995454|NCT02460224|83242362|FG015|Overall Study|Lost to Follow-up|0|||
46995455|NCT02460224|83242363|FG016|Overall Study|Lost to Follow-up|0|||
46995456|NCT02460224|83242364|FG017|Overall Study|Lost to Follow-up|0|||
46995457|NCT02460224|83242365|FG018|Overall Study|Lost to Follow-up|0|||
46995458|NCT02460224|83242366|FG019|Overall Study|Lost to Follow-up|0|||
46995459|NCT02460224|83242367|FG020|Overall Study|Lost to Follow-up|0|||
46995460|NCT02460224|83242368|FG021|Overall Study|Lost to Follow-up|0|||
46995461|NCT02460224|83242369|FG022|Overall Study|Lost to Follow-up|1|||
46995462|NCT02460224|83242370|FG023|Overall Study|Lost to Follow-up|0|||
46995463|NCT02460224|83242371|FG024|Overall Study|Lost to Follow-up|0|||
46995464|NCT02460224|83242372|FG025|Overall Study|Lost to Follow-up|0|||
46995465|NCT02460224|83242373|FG026|Overall Study|Lost to Follow-up|0|||
46995466|NCT02460224|83242374|FG027|Overall Study|Lost to Follow-up|0|||
46995467|NCT02460224|83242375|FG028|Overall Study|Lost to Follow-up|0|||
46995468|NCT02460224|83242347|FG000|Overall Study|Physician Decision|0|||
46995469|NCT02460224|83242348|FG001|Overall Study|Physician Decision|1|||
46995470|NCT02460224|83242349|FG002|Overall Study|Physician Decision|0|||
46995471|NCT02460224|83242350|FG003|Overall Study|Physician Decision|0|||
46995472|NCT02460224|83242351|FG004|Overall Study|Physician Decision|1|||
46995473|NCT02460224|83242352|FG005|Overall Study|Physician Decision|0|||
46995474|NCT02460224|83242353|FG006|Overall Study|Physician Decision|0|||
46995475|NCT02460224|83242354|FG007|Overall Study|Physician Decision|1|||
46995476|NCT02460224|83242355|FG008|Overall Study|Physician Decision|0|||
46995477|NCT02460224|83242356|FG009|Overall Study|Physician Decision|0|||
46995478|NCT02460224|83242357|FG010|Overall Study|Physician Decision|0|||
46995479|NCT02460224|83242358|FG011|Overall Study|Physician Decision|1|||
46995480|NCT02460224|83242359|FG012|Overall Study|Physician Decision|0|||
46995481|NCT02460224|83242360|FG013|Overall Study|Physician Decision|1|||
46995482|NCT02460224|83242361|FG014|Overall Study|Physician Decision|0|||
46995483|NCT02460224|83242362|FG015|Overall Study|Physician Decision|0|||
46995484|NCT02460224|83242363|FG016|Overall Study|Physician Decision|2|||
46995485|NCT02460224|83242364|FG017|Overall Study|Physician Decision|1|||
46995486|NCT02460224|83242365|FG018|Overall Study|Physician Decision|1|||
46995487|NCT02460224|83242366|FG019|Overall Study|Physician Decision|2|||
46995488|NCT02460224|83242367|FG020|Overall Study|Physician Decision|1|||
46995489|NCT02460224|83242368|FG021|Overall Study|Physician Decision|1|||
46995490|NCT02460224|83242369|FG022|Overall Study|Physician Decision|0|||
46995491|NCT02460224|83242370|FG023|Overall Study|Physician Decision|0|||
46995492|NCT02460224|83242371|FG024|Overall Study|Physician Decision|1|||
46995493|NCT02460224|83242372|FG025|Overall Study|Physician Decision|0|||
46995494|NCT02460224|83242373|FG026|Overall Study|Physician Decision|14|||
46995495|NCT02460224|83242374|FG027|Overall Study|Physician Decision|1|||
46995496|NCT02460224|83242375|FG028|Overall Study|Physician Decision|6|||
46995497|NCT02460224|83242347|FG000|Overall Study|Progressive disease|15|||
46995498|NCT02460224|83242348|FG001|Overall Study|Progressive disease|11|||
46995499|NCT02460224|83242349|FG002|Overall Study|Progressive disease|5|||
46995500|NCT02460224|83242350|FG003|Overall Study|Progressive disease|6|||
46995501|NCT02460224|83242351|FG004|Overall Study|Progressive disease|3|||
46995502|NCT02460224|83242352|FG005|Overall Study|Progressive disease|26|||
46995503|NCT02460224|83242353|FG006|Overall Study|Progressive disease|28|||
46995504|NCT02460224|83242354|FG007|Overall Study|Progressive disease|4|||
46995505|NCT02460224|83242355|FG008|Overall Study|Progressive disease|5|||
46995506|NCT02460224|83242356|FG009|Overall Study|Progressive disease|9|||
46995507|NCT02460224|83242357|FG010|Overall Study|Progressive disease|5|||
46995508|NCT02460224|83242358|FG011|Overall Study|Progressive disease|4|||
46995509|NCT02460224|83242359|FG012|Overall Study|Progressive disease|5|||
46995510|NCT02460224|83242360|FG013|Overall Study|Progressive disease|4|||
46995511|NCT02460224|83242361|FG014|Overall Study|Progressive disease|5|||
46995512|NCT02460224|83242362|FG015|Overall Study|Progressive disease|5|||
46995513|NCT02460224|83242363|FG016|Overall Study|Progressive disease|15|||
46995514|NCT02460224|83242364|FG017|Overall Study|Progressive disease|3|||
46995515|NCT02460224|83242365|FG018|Overall Study|Progressive disease|8|||
46995516|NCT02460224|83242366|FG019|Overall Study|Progressive disease|3|||
46995517|NCT02460224|83242367|FG020|Overall Study|Progressive disease|4|||
46995518|NCT02460224|83242368|FG021|Overall Study|Progressive disease|9|||
46995519|NCT02460224|83242369|FG022|Overall Study|Progressive disease|4|||
46995520|NCT02460224|83242370|FG023|Overall Study|Progressive disease|11|||
46995521|NCT02460224|83242371|FG024|Overall Study|Progressive disease|4|||
46995522|NCT02460224|83242372|FG025|Overall Study|Progressive disease|5|||
46995523|NCT02460224|83242373|FG026|Overall Study|Progressive disease|85|||
46995524|NCT02460224|83242374|FG027|Overall Study|Progressive disease|17|||
46995525|NCT02460224|83242375|FG028|Overall Study|Progressive disease|77|||
46995526|NCT02460224|83242347|FG000|Overall Study|Subject/guardian decision|2|||
46995527|NCT02460224|83242348|FG001|Overall Study|Subject/guardian decision|0|||
46995528|NCT02460224|83242349|FG002|Overall Study|Subject/guardian decision|1|||
46995529|NCT02460224|83242350|FG003|Overall Study|Subject/guardian decision|0|||
46995530|NCT02460224|83242351|FG004|Overall Study|Subject/guardian decision|2|||
46995531|NCT02460224|83242352|FG005|Overall Study|Subject/guardian decision|2|||
46995532|NCT02460224|83242353|FG006|Overall Study|Subject/guardian decision|0|||
46995533|NCT02460224|83242354|FG007|Overall Study|Subject/guardian decision|0|||
46995534|NCT02460224|83242355|FG008|Overall Study|Subject/guardian decision|1|||
46995535|NCT02460224|83242356|FG009|Overall Study|Subject/guardian decision|1|||
46995536|NCT02460224|83242357|FG010|Overall Study|Subject/guardian decision|0|||
46995537|NCT02460224|83242358|FG011|Overall Study|Subject/guardian decision|1|||
46995538|NCT02460224|83242359|FG012|Overall Study|Subject/guardian decision|0|||
46995539|NCT02460224|83242360|FG013|Overall Study|Subject/guardian decision|0|||
46995540|NCT02460224|83242361|FG014|Overall Study|Subject/guardian decision|0|||
46995541|NCT02460224|83242362|FG015|Overall Study|Subject/guardian decision|1|||
46995542|NCT02460224|83242363|FG016|Overall Study|Subject/guardian decision|0|||
46995543|NCT02460224|83242364|FG017|Overall Study|Subject/guardian decision|1|||
46995544|NCT02460224|83242365|FG018|Overall Study|Subject/guardian decision|2|||
46618523|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46995545|NCT02460224|83242366|FG019|Overall Study|Subject/guardian decision|0|||
46995546|NCT02460224|83242367|FG020|Overall Study|Subject/guardian decision|0|||
46995547|NCT02460224|83242368|FG021|Overall Study|Subject/guardian decision|1|||
46995548|NCT02460224|83242369|FG022|Overall Study|Subject/guardian decision|0|||
46995549|NCT02460224|83242370|FG023|Overall Study|Subject/guardian decision|0|||
46995550|NCT02460224|83242371|FG024|Overall Study|Subject/guardian decision|0|||
46995551|NCT02460224|83242372|FG025|Overall Study|Subject/guardian decision|0|||
46995552|NCT02460224|83242373|FG026|Overall Study|Subject/guardian decision|6|||
46995553|NCT02460224|83242374|FG027|Overall Study|Subject/guardian decision|2|||
46995554|NCT02460224|83242375|FG028|Overall Study|Subject/guardian decision|3|||
46995555|NCT02094573|83242449|FG000|Overall Study|Adverse Event|4|||
46995556|NCT02094573|83242450|FG001|Overall Study|Adverse Event|14|||
46995557|NCT02094573|83242449|FG000|Overall Study|Clinical Progressive Disease|9|||
46995558|NCT02094573|83242450|FG001|Overall Study|Clinical Progressive Disease|13|||
46995559|NCT02094573|83242449|FG000|Overall Study|Death|11|||
46995560|NCT02094573|83242450|FG001|Overall Study|Death|3|||
46995561|NCT02094573|83242449|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
46995562|NCT02094573|83242450|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
46995563|NCT02094573|83242449|FG000|Overall Study|Non-compliance with Study Drug|1|||
46995564|NCT02094573|83242450|FG001|Overall Study|Non-compliance with Study Drug|1|||
46995565|NCT02094573|83242449|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
46995566|NCT02094573|83242450|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
46995567|NCT02094573|83242449|FG000|Overall Study|Physician Decision|4|||
46995568|NCT02094573|83242450|FG001|Overall Study|Physician Decision|4|||
46995569|NCT02094573|83242449|FG000|Overall Study|Site Terminated by Sponsor|10|||
46995570|NCT02094573|83242450|FG001|Overall Study|Site Terminated by Sponsor|17|||
46995571|NCT02094573|83242449|FG000|Overall Study|Withdrawal by Subject|6|||
46995572|NCT02094573|83242450|FG001|Overall Study|Withdrawal by Subject|8|||
46995573|NCT02094573|83242449|FG000|Overall Study|Randomized but not Treated|3|||
46995574|NCT02094573|83242450|FG001|Overall Study|Randomized but not Treated|0|||
46995575|NCT01859494|83242456|FG000|Overall Study|Adverse Event|1|||
46995576|NCT01858636|83242460|FG000|Overall Study|No Device Deployment Attempted|24|||
46995577|NCT01858636|83242460|FG000|Overall Study|Physician Decision|1|||
46995578|NCT01858636|83242460|FG000|Overall Study|Death|1|||
46995579|NCT01858636|83242460|FG000|Overall Study|Lost to Follow-up|1|||
46995580|NCT01858636|83242460|FG000|Overall Study|Withdrawal by Subject|1|||
46995581|NCT02058849|83242467|FG000|Overall Study|Hospitalization|1|||
46995582|NCT02058849|83242468|FG001|Overall Study|Hospitalization|1|||
46995583|NCT02058849|83242467|FG000|Overall Study|Death|1|||
46995584|NCT02058849|83242468|FG001|Overall Study|Death|0|||
46995585|NCT02058849|83242467|FG000|Overall Study|Lost to Follow-up|1|||
46995586|NCT02058849|83242468|FG001|Overall Study|Lost to Follow-up|0|||
46995587|NCT02058849|83242467|FG000|Overall Study|Withdrawal by Subject|4|||
46995588|NCT02058849|83242468|FG001|Overall Study|Withdrawal by Subject|0|||
46995589|NCT01858558|83242476|FG000|Overall Study|Death|1|||
46995590|NCT01858558|83242477|FG001|Overall Study|Death|1|||
46995591|NCT01858558|83242476|FG000|Overall Study|Lost to Follow-up|1|||
46995592|NCT01858558|83242477|FG001|Overall Study|Lost to Follow-up|0|||
46995593|NCT01858558|83242476|FG000|Overall Study|Disease progression|3|||
46995594|NCT01858558|83242477|FG001|Overall Study|Disease progression|1|||
46995595|NCT01858558|83242476|FG000|Overall Study|Product contamination|2|||
46995596|NCT01858558|83242477|FG001|Overall Study|Product contamination|0|||
46995597|NCT01858558|83242476|FG000|Overall Study|Failed expansion of cell product|2|||
46995598|NCT01858558|83242477|FG001|Overall Study|Failed expansion of cell product|0|||
46995599|NCT02058537|83242483|FG000|Overall Study|Withdrawal by Subject|1|||
46995600|NCT01612000|83242491|FG000|Overall Study|Lost to Follow-up|6|||
46995601|NCT01612000|83242492|FG001|Overall Study|Lost to Follow-up|4|||
46995602|NCT01612000|83242493|FG002|Overall Study|Lost to Follow-up|4|||
46995603|NCT01612000|83242494|FG003|Overall Study|Lost to Follow-up|8|||
46995604|NCT01612000|83242491|FG000|Overall Study|Physician Decision|0|||
46995605|NCT01612000|83242492|FG001|Overall Study|Physician Decision|0|||
46995606|NCT01612000|83242493|FG002|Overall Study|Physician Decision|1|||
46995607|NCT01612000|83242494|FG003|Overall Study|Physician Decision|0|||
46995608|NCT01612000|83242491|FG000|Overall Study|Withdrawal by Subject|3|||
46995609|NCT01612000|83242492|FG001|Overall Study|Withdrawal by Subject|1|||
46995610|NCT01612000|83242493|FG002|Overall Study|Withdrawal by Subject|2|||
46995611|NCT01612000|83242494|FG003|Overall Study|Withdrawal by Subject|2|||
46995612|NCT01895608|83242508|FG000|Overall Study|change in health status|0|||
46995613|NCT01895608|83242509|FG001|Overall Study|change in health status|1|||
46995614|NCT01895608|83242510|FG002|Overall Study|change in health status|1|||
46995615|NCT01895608|83242511|FG003|Overall Study|change in health status|0|||
46995616|NCT01895608|83242508|FG000|Overall Study|Withdrawal by Subject|0|||
46995617|NCT01895608|83242509|FG001|Overall Study|Withdrawal by Subject|0|||
46995618|NCT01895608|83242510|FG002|Overall Study|Withdrawal by Subject|2|||
46995619|NCT01895608|83242511|FG003|Overall Study|Withdrawal by Subject|0|||
46995620|NCT02409680|83242523|FG000|Overall Study|Lost to Follow-up|15|||
46995621|NCT02409680|83242524|FG001|Overall Study|Lost to Follow-up|30|||
46995622|NCT01895452|83242532|FG000|Overall Study|Adverse Event|1|||
46995623|NCT01895452|83242533|FG001|Overall Study|Adverse Event|4|||
46995624|NCT01895452|83242532|FG000|Overall Study|Lost to Follow-up|1|||
46995625|NCT01895452|83242533|FG001|Overall Study|Lost to Follow-up|5|||
46995626|NCT01895452|83242532|FG000|Overall Study|Pregnancy|0|||
46995627|NCT01895452|83242533|FG001|Overall Study|Pregnancy|1|||
46995628|NCT01895452|83242532|FG000|Overall Study|Withdrawal by Subject|2|||
46618524|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46995629|NCT01895452|83242533|FG001|Overall Study|Withdrawal by Subject|14|||
46995630|NCT01895452|83242532|FG000|Overall Study|Underlying disease|0|||
46995631|NCT01895452|83242533|FG001|Overall Study|Underlying disease|3|||
46995632|NCT01895452|83242532|FG000|Overall Study|Noncompliance with study drug|0|||
46995633|NCT01895452|83242533|FG001|Overall Study|Noncompliance with study drug|1|||
46995634|NCT02094417|83242543|FG000|Overall Study|Adverse Event|0|||
46995635|NCT02094417|83242544|FG001|Overall Study|Adverse Event|0|||
46995636|NCT02094417|83242545|FG002|Overall Study|Adverse Event|0|||
46995637|NCT02094417|83242546|FG003|Overall Study|Adverse Event|1|||
46995638|NCT02094417|83242543|FG000|Overall Study|Eligibility criteria|0|||
46995639|NCT02094417|83242544|FG001|Overall Study|Eligibility criteria|1|||
46995640|NCT02094417|83242545|FG002|Overall Study|Eligibility criteria|0|||
46995641|NCT02094417|83242546|FG003|Overall Study|Eligibility criteria|0|||
46995642|NCT02094417|83242543|FG000|Overall Study|No responder|4|||
46995643|NCT02094417|83242544|FG001|Overall Study|No responder|4|||
46995644|NCT02094417|83242545|FG002|Overall Study|No responder|4|||
46995645|NCT02094417|83242546|FG003|Overall Study|No responder|3|||
46995646|NCT02094417|83242543|FG000|Overall Study|Unable to conduct observations or assess|0|||
46995647|NCT02094417|83242544|FG001|Overall Study|Unable to conduct observations or assess|1|||
46995648|NCT02094417|83242545|FG002|Overall Study|Unable to conduct observations or assess|0|||
46995649|NCT02094417|83242546|FG003|Overall Study|Unable to conduct observations or assess|0|||
46995650|NCT02094417|83242543|FG000|Overall Study|Withdrawal by Subject|1|||
46995651|NCT02094417|83242544|FG001|Overall Study|Withdrawal by Subject|2|||
46995652|NCT02094417|83242545|FG002|Overall Study|Withdrawal by Subject|1|||
46995653|NCT02094417|83242546|FG003|Overall Study|Withdrawal by Subject|3|||
46995654|NCT01894984|83242558|FG000|Overall Study|Other|314|||
46995655|NCT01894984|83242559|FG001|Overall Study|Other|175|||
46995656|NCT02375672|83242565|FG000|Overall Study|remain on follow up|20|||
46995657|NCT01894516|83242573|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
46995658|NCT01894516|83242574|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
46995659|NCT01894516|83242575|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
46995660|NCT01894516|83242576|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
46995661|NCT01894516|83242573|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
46995662|NCT01894516|83242574|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
46995663|NCT01894516|83242575|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
46618525|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618526|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618527|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618528|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618529|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618530|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618531|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618532|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618533|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
46618534|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618535|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
46618536|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618537|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46618538|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618539|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618540|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618541|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618542|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618543|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618544|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618545|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618546|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618547|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46995664|NCT01894516|83242576|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
46995665|NCT01894516|83242573|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
46995666|NCT01894516|83242574|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
46995667|NCT01894516|83242575|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
46995668|NCT01894516|83242576|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
46995669|NCT01894516|83242573|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
46995670|NCT01894516|83242574|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
46995671|NCT01894516|83242575|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
46995672|NCT01894516|83242576|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
46995673|NCT01894516|83242573|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
46995674|NCT01894516|83242574|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
46995675|NCT01894516|83242575|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
46995676|NCT01894516|83242576|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
46618548|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618549|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
46618550|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618551|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618552|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46618553|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46995677|NCT01894516|83242573|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
46995678|NCT01894516|83242574|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
46995679|NCT01894516|83242575|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
46995680|NCT01894516|83242576|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
46995681|NCT01894516|83242573|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
46995682|NCT01894516|83242574|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
46995683|NCT01894516|83242575|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
46995684|NCT01894516|83242576|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
46995685|NCT01894516|83242573|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
46995686|NCT01894516|83242574|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
46995687|NCT01894516|83242575|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
46995688|NCT01894516|83242576|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
46995689|NCT02491463|83242594|FG000|Overall Study|Withdrawal by Subject|1|||
46995690|NCT02491463|83242595|FG001|Overall Study|Withdrawal by Subject|2|||
46995691|NCT02491463|83242596|FG002|Overall Study|Withdrawal by Subject|0|||
46995692|NCT02491463|83242597|FG003|Overall Study|Withdrawal by Subject|0|||
46995693|NCT02491463|83242594|FG000|Overall Study|Migrated/moved from study area|1|||
46995694|NCT02491463|83242595|FG001|Overall Study|Migrated/moved from study area|5|||
46995695|NCT02491463|83242596|FG002|Overall Study|Migrated/moved from study area|1|||
46995696|NCT02491463|83242597|FG003|Overall Study|Migrated/moved from study area|1|||
46995697|NCT02491463|83242594|FG000|Overall Study|Lost to Follow-up|0|||
46995698|NCT02491463|83242595|FG001|Overall Study|Lost to Follow-up|3|||
46995699|NCT02491463|83242596|FG002|Overall Study|Lost to Follow-up|3|||
46995700|NCT02491463|83242597|FG003|Overall Study|Lost to Follow-up|0|||
46995701|NCT02038881|83242610|FG000|Overall Study|Withdrawal by Subject|0|||
46995702|NCT02038881|83242611|FG001|Overall Study|Withdrawal by Subject|0|||
46995703|NCT02038881|83242612|FG002|Overall Study|Withdrawal by Subject|1|||
46995704|NCT02038881|83242610|FG000|Overall Study|Lost to Follow-up|2|||
46995705|NCT02038881|83242611|FG001|Overall Study|Lost to Follow-up|0|||
46995706|NCT02038881|83242612|FG002|Overall Study|Lost to Follow-up|0|||
46995707|NCT02038881|83242610|FG000|Overall Study|incarcerated|1|||
46995708|NCT02038881|83242611|FG001|Overall Study|incarcerated|0|||
46995709|NCT02038881|83242612|FG002|Overall Study|incarcerated|0|||
46995710|NCT01857622|83242625|FG000|Overall Study|Adverse Event|5|||
46995711|NCT01857622|83242626|FG001|Overall Study|Adverse Event|0|||
46995712|NCT01857622|83242627|FG002|Overall Study|Adverse Event|2|||
46995713|NCT01857622|83242625|FG000|Overall Study|Physician Decision|1|||
46995714|NCT01857622|83242626|FG001|Overall Study|Physician Decision|0|||
46995715|NCT01857622|83242627|FG002|Overall Study|Physician Decision|0|||
46995716|NCT01857622|83242625|FG000|Overall Study|Protocol Violation|4|||
46995717|NCT01857622|83242626|FG001|Overall Study|Protocol Violation|1|||
46995718|NCT01857622|83242627|FG002|Overall Study|Protocol Violation|0|||
46995719|NCT01857622|83242625|FG000|Overall Study|Withdrawal by Subject|1|||
46995720|NCT01857622|83242626|FG001|Overall Study|Withdrawal by Subject|0|||
46995721|NCT01857622|83242627|FG002|Overall Study|Withdrawal by Subject|0|||
46995722|NCT01857310|83242637|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
46995723|NCT01857310|83242638|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
46995724|NCT02472353|83242646|FG000|Overall Study|Lost to Follow-up|1|||
46995725|NCT02472353|83242647|FG001|Overall Study|Lost to Follow-up|1|||
46995726|NCT02472353|83242646|FG000|Overall Study|Withdrawal by Subject|2|||
46995727|NCT02472353|83242647|FG001|Overall Study|Withdrawal by Subject|1|||
46995728|NCT02472353|83242646|FG000|Overall Study|Study Termination|1|||
46995729|NCT02472353|83242647|FG001|Overall Study|Study Termination|4|||
46995730|NCT02491073|83242655|FG000|Overall Study|screen failure|1|||
46995731|NCT02491073|83242656|FG001|Overall Study|screen failure|0|||
46995732|NCT02314117|83242680|FG000|Overall Study|Lost to Follow-up|9|||
46995733|NCT02314117|83242681|FG001|Overall Study|Lost to Follow-up|14|||
46995734|NCT02314117|83242680|FG000|Overall Study|Withdrawal by Subject|3|||
46995735|NCT02314117|83242681|FG001|Overall Study|Withdrawal by Subject|2|||
46995736|NCT01893346|83242692|FG000|Overall Study|Lost to Follow-up|0|||
46618554|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46995737|NCT01893346|83242693|FG001|Overall Study|Lost to Follow-up|1|||
46995738|NCT01893346|83242694|FG002|Overall Study|Lost to Follow-up|0|||
46995739|NCT01893346|83242695|FG003|Overall Study|Lost to Follow-up|0|||
46995740|NCT01893346|83242692|FG000|Overall Study|Protocol Violation|1|||
46995741|NCT01893346|83242693|FG001|Overall Study|Protocol Violation|0|||
46995742|NCT01893346|83242694|FG002|Overall Study|Protocol Violation|0|||
46618555|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46618556|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46995743|NCT01893346|83242695|FG003|Overall Study|Protocol Violation|0|||
46995744|NCT01893346|83242692|FG000|Overall Study|Withdrawal by Subject|2|||
46995745|NCT01893346|83242693|FG001|Overall Study|Withdrawal by Subject|0|||
46995746|NCT01893346|83242694|FG002|Overall Study|Withdrawal by Subject|0|||
46995747|NCT01893346|83242695|FG003|Overall Study|Withdrawal by Subject|0|||
46995748|NCT02490371|83242707|FG000|Overall Study|Lost to Follow-up|1|||
46995749|NCT02490371|83242708|FG001|Overall Study|Lost to Follow-up|1|||
46995750|NCT02058147|83242717|FG000|Overall Study|Randomized but not treated|0|||
46995751|NCT02058147|83242718|FG001|Overall Study|Randomized but not treated|0|||
46995752|NCT02058147|83242719|FG002|Overall Study|Randomized but not treated|1|||
46995753|NCT02058147|83242717|FG000|Overall Study|Adverse Event|12|||
46995754|NCT02058147|83242718|FG001|Overall Study|Adverse Event|9|||
46995755|NCT02058147|83242719|FG002|Overall Study|Adverse Event|21|||
46995756|NCT02058147|83242717|FG000|Overall Study|Lack of Efficacy|1|||
46995757|NCT02058147|83242718|FG001|Overall Study|Lack of Efficacy|0|||
46995758|NCT02058147|83242719|FG002|Overall Study|Lack of Efficacy|3|||
46995759|NCT02058147|83242717|FG000|Overall Study|Poor compliance to protocol|8|||
46995760|NCT02058147|83242718|FG001|Overall Study|Poor compliance to protocol|9|||
46995761|NCT02058147|83242719|FG002|Overall Study|Poor compliance to protocol|4|||
46995762|NCT02058147|83242717|FG000|Overall Study|Other than specified|8|||
46995763|NCT02058147|83242718|FG001|Overall Study|Other than specified|9|||
46995764|NCT02058147|83242719|FG002|Overall Study|Other than specified|0|||
46995765|NCT02489981|83242727|FG000|Overall Study|Adverse Event|21|||
46995766|NCT02489981|83242727|FG000|Overall Study|Insufficient effectiveness|16|||
46995767|NCT02489981|83242727|FG000|Overall Study|Improved|31|||
46995768|NCT02489981|83242727|FG000|Overall Study|Lost to Follow-up|31|||
46995769|NCT02489981|83242727|FG000|Overall Study|Other than listed|28|||
46995770|NCT02471183|83242731|FG000|Main Treatment Period|Adverse Event|1|||
46995771|NCT02471183|83242731|FG000|Main Treatment Period|Withdrawal by Subject|1|||
46995772|NCT02471183|83242731|FG000|Extended Treatment Period|Lack of Efficacy|1|||
46995773|NCT01855828|83242735|FG000|Overall Study|Adverse Event|1|||
46995774|NCT01855828|83242735|FG000|Overall Study|Withdrawal by Subject|1|||
46995775|NCT02489279|83242746|FG000|Overall Study|Lost to Follow-up|12|||
46995776|NCT02489279|83242747|FG001|Overall Study|Lost to Follow-up|10|||
46995777|NCT02489045|83242753|FG000|Overall Study|unable to collect usable data|53|||
46995778|NCT02489045|83242753|FG000|Follow-up|Lost to Follow-up|10|||
46995779|NCT02488109|83242759|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
46995780|NCT02488109|83242760|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
46995781|NCT02488109|83242759|FG000|12-month Follow-Up|Lost to Follow-up|4|||
46995782|NCT02488109|83242760|FG001|12-month Follow-Up|Lost to Follow-up|7|||
46995783|NCT02351167|83242771|FG000|Overall Study|Withdrawal by Subject|19|||
46995784|NCT02351167|83242772|FG001|Overall Study|Withdrawal by Subject|18|||
46995785|NCT02351167|83242773|FG002|Overall Study|Withdrawal by Subject|21|||
46995786|NCT02350309|83242788|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
46995787|NCT02350309|83242789|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
46995788|NCT02350309|83242790|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
46995789|NCT02350309|83242791|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
46995790|NCT02350309|83242792|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
46995791|NCT02350309|83242793|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
46995792|NCT02350309|83242788|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
46995793|NCT02350309|83242789|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
46995794|NCT02350309|83242790|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
46995795|NCT02350309|83242791|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
46995796|NCT02350309|83242792|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
46995797|NCT02350309|83242793|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
46995798|NCT02038647|83242810|FG000|Overall Study|Progressive Disease|50|||
46995799|NCT02038647|83242811|FG001|Overall Study|Progressive Disease|59|||
46995800|NCT02038647|83242810|FG000|Overall Study|Adverse Event|18|||
46995801|NCT02038647|83242811|FG001|Overall Study|Adverse Event|10|||
46995802|NCT02038647|83242810|FG000|Overall Study|Symptomatic Deterioration|7|||
46995803|NCT02038647|83242811|FG001|Overall Study|Symptomatic Deterioration|7|||
46995804|NCT02038647|83242810|FG000|Overall Study|Withdrawal by Subject|5|||
46995805|NCT02038647|83242811|FG001|Overall Study|Withdrawal by Subject|2|||
46995806|NCT02038647|83242810|FG000|Overall Study|Not Reported|0|||
46995807|NCT02038647|83242811|FG001|Overall Study|Not Reported|1|||
46995808|NCT02038647|83242810|FG000|Overall Study|Ongoing at Datacut|9|||
46995809|NCT02038647|83242811|FG001|Overall Study|Ongoing at Datacut|10|||
46995810|NCT02058069|83242817|FG000|Overall Study|Exclusion due to implant size|5|||
46995811|NCT02058069|83242817|FG000|Overall Study|Withdrawal by Subject|6|||
46995812|NCT02057835|83242831|FG000|Overall Study|Withdrawal by Subject|0|||
46995813|NCT02057835|83242832|FG001|Overall Study|Withdrawal by Subject|2|||
46995814|NCT02057835|83242833|FG002|Overall Study|Withdrawal by Subject|0|||
46995815|NCT02057835|83242834|FG003|Overall Study|Withdrawal by Subject|0|||
46995816|NCT02057835|83242835|FG004|Overall Study|Withdrawal by Subject|0|||
46995817|NCT02057835|83242836|FG005|Overall Study|Withdrawal by Subject|0|||
46995818|NCT02057835|83242837|FG006|Overall Study|Withdrawal by Subject|0|||
46995819|NCT02057835|83242838|FG007|Overall Study|Withdrawal by Subject|0|||
46995820|NCT02057835|83242839|FG008|Overall Study|Withdrawal by Subject|0|||
46995821|NCT02057835|83242840|FG009|Overall Study|Withdrawal by Subject|0|||
46995822|NCT02057757|83242871|FG000|Overall Study|Withdrawal by Subject|3|||
46995823|NCT02057757|83242872|FG001|Overall Study|Withdrawal by Subject|5|||
46995824|NCT02057757|83242871|FG000|Overall Study|Death|2|||
46995825|NCT02057757|83242872|FG001|Overall Study|Death|0|||
46995826|NCT02057757|83242871|FG000|Overall Study|Lost to Follow-up|8|||
46995827|NCT02057757|83242872|FG001|Overall Study|Lost to Follow-up|3|||
46995828|NCT02057757|83242871|FG000|Overall Study|Non-compliance|1|||
46618557|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46618558|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46995829|NCT02057757|83242872|FG001|Overall Study|Non-compliance|0|||
46995830|NCT02037477|83242886|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
46995831|NCT02037477|83242887|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
46995832|NCT02037477|83242888|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
46995833|NCT02037477|83242889|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
46995834|NCT02057523|83242899|FG000|Overall Study|Withdrawal by Subject|1|||
46995835|NCT02057523|83242899|FG000|Overall Study|Lack of Efficacy|1|||
46995836|NCT02037165|83242908|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
46995837|NCT02037165|83242909|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
46995838|NCT02037165|83242910|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
46995839|NCT02037165|83242911|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
46995840|NCT02037165|83242912|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
46995841|NCT02470403|83242933|FG000|Overall Study|Adverse Event|1|||
46995842|NCT02470403|83242934|FG001|Overall Study|Adverse Event|0|||
46995843|NCT02470403|83242935|FG002|Overall Study|Adverse Event|0|||
46995844|NCT02470403|83242936|FG003|Overall Study|Adverse Event|0|||
46995845|NCT02470403|83242937|FG004|Overall Study|Adverse Event|0|||
46995846|NCT02470403|83242933|FG000|Overall Study|Lost to Follow-up|0|||
46995847|NCT02470403|83242934|FG001|Overall Study|Lost to Follow-up|1|||
46995848|NCT02470403|83242935|FG002|Overall Study|Lost to Follow-up|0|||
46995849|NCT02470403|83242936|FG003|Overall Study|Lost to Follow-up|0|||
46995850|NCT02470403|83242937|FG004|Overall Study|Lost to Follow-up|0|||
46995851|NCT02470403|83242933|FG000|Overall Study|Subject/guardian decision|1|||
46995852|NCT02470403|83242934|FG001|Overall Study|Subject/guardian decision|0|||
46995853|NCT02470403|83242935|FG002|Overall Study|Subject/guardian decision|0|||
46995854|NCT02470403|83242936|FG003|Overall Study|Subject/guardian decision|4|||
46995855|NCT02470403|83242937|FG004|Overall Study|Subject/guardian decision|0|||
46995856|NCT01855750|83242954|FG000|Overall Study|Death|78|||
46995857|NCT01855750|83242955|FG001|Overall Study|Death|78|||
46995858|NCT01855750|83242954|FG000|Overall Study|Lost to Follow-up|9|||
46995859|NCT01855750|83242955|FG001|Overall Study|Lost to Follow-up|23|||
46995860|NCT01855750|83242954|FG000|Overall Study|Withdrawal by Subject|35|||
46995861|NCT01855750|83242955|FG001|Overall Study|Withdrawal by Subject|28|||
46995862|NCT01855750|83242954|FG000|Overall Study|Sponsor ends the study|297|||
46995863|NCT01855750|83242955|FG001|Overall Study|Sponsor ends the study|290|||
46995864|NCT01855126|83242963|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
46995865|NCT01855126|83242964|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
46995866|NCT01855126|83242963|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
46995867|NCT01855126|83242964|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
46995868|NCT01622673|83242980|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46995869|NCT01622673|83242981|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46995870|NCT01622673|83242982|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46995871|NCT01622673|83242983|FG003|Treatment Period 1|Withdrawal by Subject|1|||
46995872|NCT01622673|83242984|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46995873|NCT01622673|83242985|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46995874|NCT01622673|83242980|FG000|Treatment Period 1|Protocol Violation|0|||
46995875|NCT01622673|83242981|FG001|Treatment Period 1|Protocol Violation|1|||
46995876|NCT01622673|83242982|FG002|Treatment Period 1|Protocol Violation|0|||
46995877|NCT01622673|83242983|FG003|Treatment Period 1|Protocol Violation|0|||
46995878|NCT01622673|83242984|FG004|Treatment Period 1|Protocol Violation|0|||
46995879|NCT01622673|83242985|FG005|Treatment Period 1|Protocol Violation|0|||
46995880|NCT01622673|83242980|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46995881|NCT01622673|83242981|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46995882|NCT01622673|83242982|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46995883|NCT01622673|83242983|FG003|Treatment Period 2|Withdrawal by Subject|1|||
46618559|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46995884|NCT01622673|83242984|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46995885|NCT01622673|83242985|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46995886|NCT01622673|83242980|FG000|Treatment Period 3|Protocol Violation|0|||
46995887|NCT01622673|83242981|FG001|Treatment Period 3|Protocol Violation|1|||
46995888|NCT01622673|83242982|FG002|Treatment Period 3|Protocol Violation|0|||
46995889|NCT01622673|83242983|FG003|Treatment Period 3|Protocol Violation|0|||
46995890|NCT01622673|83242984|FG004|Treatment Period 3|Protocol Violation|0|||
46995891|NCT01622673|83242985|FG005|Treatment Period 3|Protocol Violation|0|||
46995892|NCT01855048|83243010|FG000|Overall Study|Withdrawal by Subject|0|||
46995893|NCT01855048|83243011|FG001|Overall Study|Withdrawal by Subject|1|||
46995894|NCT01855048|83243012|FG002|Overall Study|Withdrawal by Subject|0|||
46995895|NCT01855048|83243013|FG003|Overall Study|Withdrawal by Subject|0|||
46618560|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46618561|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46618562|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46618563|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
46618564|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46618565|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
46618566|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46618567|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
46618568|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618569|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618570|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618571|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618572|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618573|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618574|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618575|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618576|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618577|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46898844|NCT03672461|83125219|FG000|Overall Study|Incomplete outcome data|6|||
46898845|NCT03672461|83125220|FG001|Overall Study|Incomplete outcome data|1|||
46995896|NCT01855048|83243014|FG004|Overall Study|Withdrawal by Subject|1|||
46995897|NCT01855048|83243015|FG005|Overall Study|Withdrawal by Subject|0|||
46995898|NCT02469857|83243041|FG000|Overall Study|Death|24|||
46995899|NCT02469857|83243042|FG001|Overall Study|Death|29|||
46995900|NCT02469857|83243041|FG000|Overall Study|Discontinuation|1|||
46995901|NCT02469857|83243042|FG001|Overall Study|Discontinuation|3|||
46995902|NCT02036853|83243052|FG000|Overall Study|Adverse Event|0|||
46995903|NCT02036853|83243053|FG001|Overall Study|Adverse Event|2|||
46995904|NCT02036853|83243052|FG000|Overall Study|Lack of Efficacy|0|||
46995905|NCT02036853|83243053|FG001|Overall Study|Lack of Efficacy|2|||
46995906|NCT02036853|83243052|FG000|Overall Study|Physician Decision|0|||
46995907|NCT02036853|83243053|FG001|Overall Study|Physician Decision|1|||
46995908|NCT02036853|83243052|FG000|Overall Study|Withdrawal by Subject|0|||
46898846|NCT03611556|83125233|FG000|Overall Study|Death|7|||
46898847|NCT03611556|83125234|FG001|Overall Study|Death|7|||
46898848|NCT03611556|83125235|FG002|Overall Study|Death|3|||
46898849|NCT03611556|83125236|FG003|Overall Study|Death|8|||
46898850|NCT03611556|83125237|FG004|Overall Study|Death|47|||
46898851|NCT03611556|83125238|FG005|Overall Study|Death|32|||
46898852|NCT03611556|83125239|FG006|Overall Study|Death|53|||
46898853|NCT03611556|83125233|FG000|Overall Study|Withdrawal by Subject|0|||
46898854|NCT03611556|83125234|FG001|Overall Study|Withdrawal by Subject|0|||
46898855|NCT03611556|83125235|FG002|Overall Study|Withdrawal by Subject|0|||
46898856|NCT03611556|83125236|FG003|Overall Study|Withdrawal by Subject|0|||
46898857|NCT03611556|83125237|FG004|Overall Study|Withdrawal by Subject|4|||
46898858|NCT03611556|83125238|FG005|Overall Study|Withdrawal by Subject|2|||
46898859|NCT03611556|83125239|FG006|Overall Study|Withdrawal by Subject|4|||
46898860|NCT03611556|83125233|FG000|Overall Study|Sponsor decision|0|||
46898861|NCT03611556|83125234|FG001|Overall Study|Sponsor decision|0|||
46898862|NCT03611556|83125235|FG002|Overall Study|Sponsor decision|0|||
46898863|NCT03611556|83125236|FG003|Overall Study|Sponsor decision|0|||
46898864|NCT03611556|83125237|FG004|Overall Study|Sponsor decision|9|||
46898865|NCT03611556|83125238|FG005|Overall Study|Sponsor decision|4|||
46898866|NCT03611556|83125239|FG006|Overall Study|Sponsor decision|12|||
46898867|NCT03611556|83125233|FG000|Overall Study|Reasons|0|||
46898868|NCT03611556|83125234|FG001|Overall Study|Reasons|0|||
46898869|NCT03611556|83125235|FG002|Overall Study|Reasons|0|||
46898870|NCT03611556|83125236|FG003|Overall Study|Reasons|0|||
46898871|NCT03611556|83125237|FG004|Overall Study|Reasons|2|||
46898872|NCT03611556|83125238|FG005|Overall Study|Reasons|0|||
46898873|NCT03611556|83125239|FG006|Overall Study|Reasons|1|||
46898874|NCT03309813|83125282|FG000|Main Randomized Study|Withdrawal by Subject|1|||
46995909|NCT02036853|83243053|FG001|Overall Study|Withdrawal by Subject|1|||
46995910|NCT02469623|83243059|FG000|Overall Study|Not consented for long-term follow-up|4|||
46995911|NCT02469623|83243059|FG000|Overall Study|Lost to Follow-up|4|||
46618578|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46708832|NCT04117347|82924722|FG002|Overall Study|Family emergency|0|||
46898875|NCT03309813|83125283|FG001|Main Randomized Study|Withdrawal by Subject|0|||
46898876|NCT02273388|83125336|FG000|Overall Study|Adverse Event|0|||
46995912|NCT02469623|83243059|FG000|Overall Study|Withdrawal by Subject|2|||
46995913|NCT02469623|83243059|FG000|Overall Study|Death|3|||
46995914|NCT02469077|83243066|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
46995915|NCT02469077|83243067|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
46995916|NCT02469077|83243066|FG000|Post Randomization/Intervention Period|Relocated|1|||
46995917|NCT02469077|83243067|FG001|Post Randomization/Intervention Period|Relocated|1|||
46995918|NCT02469077|83243066|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
46995919|NCT02469077|83243067|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
46995920|NCT02469077|83243066|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
46995921|NCT02469077|83243067|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
46995922|NCT02486627|83243079|FG000|Overall Study|Death|1|||
46995923|NCT02486627|83243080|FG001|Overall Study|Death|0|||
46995924|NCT02486627|83243079|FG000|Overall Study|Other Unspecified|0|||
46995925|NCT02486627|83243080|FG001|Overall Study|Other Unspecified|2|||
46995926|NCT02486627|83243079|FG000|Overall Study|Consent Withdrawn by Participant|4|||
46995927|NCT02486627|83243080|FG001|Overall Study|Consent Withdrawn by Participant|3|||
46995928|NCT02486627|83243079|FG000|Overall Study|Significant Participant Noncompliance|1|||
46995929|NCT02486627|83243080|FG001|Overall Study|Significant Participant Noncompliance|1|||
46995930|NCT02486627|83243079|FG000|Overall Study|Lost to Follow-up|1|||
46995931|NCT02486627|83243080|FG001|Overall Study|Lost to Follow-up|3|||
46995932|NCT01644565|83243086|FG000|Overall Study|Undisclosed Medical History|1|||
46618579|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
46618580|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618581|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46618582|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
46618583|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618584|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618585|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46995933|NCT01644565|83243087|FG001|Overall Study|Undisclosed Medical History|0|||
46995934|NCT01644565|83243088|FG002|Overall Study|Undisclosed Medical History|0|||
46995935|NCT01644565|83243089|FG003|Overall Study|Undisclosed Medical History|0|||
46995936|NCT01644565|83243090|FG004|Overall Study|Undisclosed Medical History|0|||
46995937|NCT01644565|83243091|FG005|Overall Study|Undisclosed Medical History|0|||
46995938|NCT01644565|83243092|FG006|Overall Study|Undisclosed Medical History|0|||
46995939|NCT01644565|83243093|FG007|Overall Study|Undisclosed Medical History|0|||
46995940|NCT01644565|83243094|FG008|Overall Study|Undisclosed Medical History|0|||
46995941|NCT01644565|83243086|FG000|Overall Study|Lost to Follow-up|0|||
46995942|NCT01644565|83243087|FG001|Overall Study|Lost to Follow-up|0|||
46995943|NCT01644565|83243088|FG002|Overall Study|Lost to Follow-up|0|||
46995944|NCT01644565|83243089|FG003|Overall Study|Lost to Follow-up|1|||
46995945|NCT01644565|83243090|FG004|Overall Study|Lost to Follow-up|0|||
46995946|NCT01644565|83243091|FG005|Overall Study|Lost to Follow-up|0|||
46995947|NCT01644565|83243092|FG006|Overall Study|Lost to Follow-up|0|||
46995948|NCT01644565|83243093|FG007|Overall Study|Lost to Follow-up|2|||
46995949|NCT01644565|83243094|FG008|Overall Study|Lost to Follow-up|0|||
46995950|NCT01644565|83243086|FG000|Overall Study|Family emergency|0|||
46995951|NCT01644565|83243087|FG001|Overall Study|Family emergency|0|||
46995952|NCT01644565|83243088|FG002|Overall Study|Family emergency|0|||
46995953|NCT01644565|83243089|FG003|Overall Study|Family emergency|0|||
46995954|NCT01644565|83243090|FG004|Overall Study|Family emergency|1|||
46995955|NCT01644565|83243091|FG005|Overall Study|Family emergency|0|||
46995956|NCT01644565|83243092|FG006|Overall Study|Family emergency|0|||
46995957|NCT01644565|83243093|FG007|Overall Study|Family emergency|0|||
46995958|NCT01644565|83243094|FG008|Overall Study|Family emergency|0|||
46995959|NCT01644565|83243086|FG000|Overall Study|Relocation|0|||
46618586|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618587|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618588|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618589|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618590|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618591|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618592|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618593|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46618594|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
46618595|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
46618596|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46995960|NCT01644565|83243087|FG001|Overall Study|Relocation|0|||
46995961|NCT01644565|83243088|FG002|Overall Study|Relocation|0|||
46995962|NCT01644565|83243089|FG003|Overall Study|Relocation|0|||
46995963|NCT01644565|83243090|FG004|Overall Study|Relocation|0|||
46995964|NCT01644565|83243091|FG005|Overall Study|Relocation|0|||
46995965|NCT01644565|83243092|FG006|Overall Study|Relocation|0|||
46995966|NCT01644565|83243093|FG007|Overall Study|Relocation|0|||
46995967|NCT01644565|83243094|FG008|Overall Study|Relocation|1|||
46995968|NCT02485925|83243114|FG000|Overall Study|Withdrawal by Subject|3|||
46995969|NCT02485925|83243114|FG000|Overall Study|Death|1|||
46995970|NCT02485925|83243114|FG000|Overall Study|Lost to Follow-up|11|||
46995971|NCT02282293|83243120|FG000|Overall Study|Lost to Follow-up|2|||
46995972|NCT02282293|83243121|FG001|Overall Study|Lost to Follow-up|2|||
46995973|NCT02282293|83243120|FG000|Overall Study|Unable to comply with study procedures|1|||
46995974|NCT02282293|83243121|FG001|Overall Study|Unable to comply with study procedures|0|||
46995975|NCT02282293|83243120|FG000|Overall Study|Moved out of study area|0|||
46995976|NCT02282293|83243121|FG001|Overall Study|Moved out of study area|1|||
46995977|NCT01854658|83243131|FG000|Overall Study|Protocol Violation|6|||
46995978|NCT01854658|83243132|FG001|Overall Study|Protocol Violation|2|||
46995979|NCT01854658|83243133|FG002|Overall Study|Protocol Violation|2|||
46995980|NCT01854658|83243134|FG003|Overall Study|Protocol Violation|1|||
46995981|NCT01854658|83243131|FG000|Overall Study|Physician Decision|7|||
46995982|NCT01854658|83243132|FG001|Overall Study|Physician Decision|5|||
46995983|NCT01854658|83243133|FG002|Overall Study|Physician Decision|2|||
46995984|NCT01854658|83243134|FG003|Overall Study|Physician Decision|4|||
46995985|NCT01854658|83243131|FG000|Overall Study|Lost to Follow-up|8|||
46995986|NCT01854658|83243132|FG001|Overall Study|Lost to Follow-up|9|||
46995987|NCT01854658|83243133|FG002|Overall Study|Lost to Follow-up|8|||
46995988|NCT01854658|83243134|FG003|Overall Study|Lost to Follow-up|4|||
46995989|NCT01854658|83243131|FG000|Overall Study|Withdrawal by Subject|28|||
46995990|NCT01854658|83243132|FG001|Overall Study|Withdrawal by Subject|21|||
46995991|NCT01854658|83243133|FG002|Overall Study|Withdrawal by Subject|29|||
46995992|NCT01854658|83243134|FG003|Overall Study|Withdrawal by Subject|15|||
46995993|NCT01854658|83243131|FG000|Overall Study|Protocol-specified criteria|15|||
46995994|NCT01854658|83243132|FG001|Overall Study|Protocol-specified criteria|15|||
46995995|NCT01854658|83243133|FG002|Overall Study|Protocol-specified criteria|10|||
46995996|NCT01854658|83243134|FG003|Overall Study|Protocol-specified criteria|7|||
46995997|NCT01854658|83243131|FG000|Overall Study|Lack of Efficacy|3|||
46995998|NCT01854658|83243132|FG001|Overall Study|Lack of Efficacy|8|||
46995999|NCT01854658|83243133|FG002|Overall Study|Lack of Efficacy|4|||
46996000|NCT01854658|83243134|FG003|Overall Study|Lack of Efficacy|7|||
46996001|NCT01854658|83243131|FG000|Overall Study|Adverse Event|21|||
46996002|NCT01854658|83243132|FG001|Overall Study|Adverse Event|14|||
46996003|NCT01854658|83243133|FG002|Overall Study|Adverse Event|23|||
46996004|NCT01854658|83243134|FG003|Overall Study|Adverse Event|19|||
46996005|NCT01854658|83243131|FG000|Overall Study|Administrative reasons|5|||
46996006|NCT01854658|83243132|FG001|Overall Study|Administrative reasons|1|||
46996007|NCT01854658|83243133|FG002|Overall Study|Administrative reasons|2|||
46996008|NCT01854658|83243134|FG003|Overall Study|Administrative reasons|2|||
46996009|NCT01892020|83243144|FG000|Period 1|Adverse Event|1|||
46996010|NCT01892020|83243145|FG001|Period 1|Adverse Event|1|||
46996011|NCT01892020|83243144|FG000|Period 1|Protocol Violation|2|||
46996012|NCT01892020|83243145|FG001|Period 1|Protocol Violation|4|||
46996013|NCT01892020|83243144|FG000|Period 1|Unclassified|0|||
46996014|NCT01892020|83243145|FG001|Period 1|Unclassified|1|||
46996015|NCT01892020|83243144|FG000|Period 2|Protocol Violation|1|||
46996016|NCT01892020|83243145|FG001|Period 2|Protocol Violation|0|||
46996017|NCT02485691|83243153|FG000|Overall Study|Adverse Event|25|||
46996018|NCT02485691|83243154|FG001|Overall Study|Adverse Event|11|||
46996019|NCT02485691|83243153|FG000|Overall Study|Poor compliance to protocol|0|||
46996020|NCT02485691|83243154|FG001|Overall Study|Poor compliance to protocol|1|||
46996021|NCT02485691|83243153|FG000|Overall Study|Disease progression|57|||
46996022|NCT02485691|83243154|FG001|Overall Study|Disease progression|92|||
46996023|NCT02485691|83243153|FG000|Overall Study|Investigator's decision|23|||
46996024|NCT02485691|83243154|FG001|Overall Study|Investigator's decision|5|||
46996025|NCT02485691|83243153|FG000|Overall Study|Participant's request|13|||
46996026|NCT02485691|83243154|FG001|Overall Study|Participant's request|6|||
46996027|NCT02485691|83243153|FG000|Overall Study|Other reason|8|||
46996028|NCT02485691|83243154|FG001|Overall Study|Other reason|9|||
46996029|NCT02485691|83243153|FG000|Overall Study|Randomized and not treated|3|||
46996030|NCT02485691|83243154|FG001|Overall Study|Randomized and not treated|2|||
46996031|NCT02517515|83243163|FG000|Overall Study|Adverse Event|0|||
46618597|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
46618598|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46996032|NCT02517515|83243164|FG001|Overall Study|Adverse Event|1|||
46996033|NCT02517515|83243163|FG000|Overall Study|Withdrew Consent|0|||
46996034|NCT02517515|83243164|FG001|Overall Study|Withdrew Consent|1|||
46996035|NCT02517515|83243163|FG000|Overall Study|Lost to Follow-up|1|||
46996036|NCT02517515|83243164|FG001|Overall Study|Lost to Follow-up|0|||
46996037|NCT02517515|83243163|FG000|Overall Study|Other|1|||
46996038|NCT02517515|83243164|FG001|Overall Study|Other|0|||
46996039|NCT02466659|83243173|FG000|Overall Study|Lost to Follow-up|5|||
46996040|NCT02466659|83243174|FG001|Overall Study|Lost to Follow-up|2|||
46996041|NCT01891864|83243182|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
46775675|NCT00694707|82994136|FG000|Overall Study|Arrest by Police|0|||
46996042|NCT01891864|83243183|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
46996043|NCT01891864|83243184|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
46996044|NCT01891864|83243185|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
46996045|NCT01891864|83243186|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
46996046|NCT01891864|83243187|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
46996047|NCT01891864|83243182|FG000|Treatment Period 1|Physician Decision|0|||
46996048|NCT01891864|83243183|FG001|Treatment Period 1|Physician Decision|1|||
46996049|NCT01891864|83243184|FG002|Treatment Period 1|Physician Decision|0|||
46996050|NCT01891864|83243185|FG003|Treatment Period 1|Physician Decision|0|||
46996051|NCT01891864|83243186|FG004|Treatment Period 1|Physician Decision|0|||
46996052|NCT01891864|83243187|FG005|Treatment Period 1|Physician Decision|0|||
46996053|NCT01891864|83243182|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
46996054|NCT01891864|83243183|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
46996055|NCT01891864|83243184|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
46996056|NCT01891864|83243185|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
46996057|NCT01891864|83243186|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
46996058|NCT01891864|83243187|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
46996059|NCT01891864|83243182|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
46996060|NCT01891864|83243183|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
46996061|NCT01891864|83243184|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
46996062|NCT01891864|83243185|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
46996063|NCT01891864|83243186|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
46996064|NCT01891864|83243187|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
46996065|NCT01891864|83243182|FG000|Treatment Period 1|Withdrawal by Subject|2|||
46996066|NCT01891864|83243183|FG001|Treatment Period 1|Withdrawal by Subject|5|||
46996067|NCT01891864|83243184|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46996068|NCT01891864|83243185|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46996069|NCT01891864|83243186|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46996070|NCT01891864|83243187|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46996071|NCT01891864|83243182|FG000|Treatment Period 1|Lost to Follow-up|1|||
46996072|NCT01891864|83243183|FG001|Treatment Period 1|Lost to Follow-up|0|||
46996073|NCT01891864|83243184|FG002|Treatment Period 1|Lost to Follow-up|0|||
46996074|NCT01891864|83243185|FG003|Treatment Period 1|Lost to Follow-up|0|||
46996075|NCT01891864|83243186|FG004|Treatment Period 1|Lost to Follow-up|0|||
46996076|NCT01891864|83243187|FG005|Treatment Period 1|Lost to Follow-up|0|||
46996077|NCT01891864|83243182|FG000|Treatment Period 2|Protocol Violation|0|||
46996078|NCT01891864|83243183|FG001|Treatment Period 2|Protocol Violation|0|||
46996079|NCT01891864|83243184|FG002|Treatment Period 2|Protocol Violation|0|||
46996080|NCT01891864|83243185|FG003|Treatment Period 2|Protocol Violation|1|||
46996081|NCT01891864|83243186|FG004|Treatment Period 2|Protocol Violation|0|||
46996082|NCT01891864|83243187|FG005|Treatment Period 2|Protocol Violation|0|||
46996083|NCT01891864|83243182|FG000|Treatment Period 2|Physician Decision|0|||
46996084|NCT01891864|83243183|FG001|Treatment Period 2|Physician Decision|0|||
46996085|NCT01891864|83243184|FG002|Treatment Period 2|Physician Decision|1|||
46996086|NCT01891864|83243185|FG003|Treatment Period 2|Physician Decision|0|||
46996087|NCT01891864|83243186|FG004|Treatment Period 2|Physician Decision|0|||
46996088|NCT01891864|83243187|FG005|Treatment Period 2|Physician Decision|0|||
46996089|NCT01891864|83243182|FG000|Treatment Period 2|Site Termination|0|||
46996090|NCT01891864|83243183|FG001|Treatment Period 2|Site Termination|0|||
46996091|NCT01891864|83243184|FG002|Treatment Period 2|Site Termination|1|||
46996092|NCT01891864|83243185|FG003|Treatment Period 2|Site Termination|2|||
46996093|NCT01891864|83243186|FG004|Treatment Period 2|Site Termination|0|||
46996094|NCT01891864|83243187|FG005|Treatment Period 2|Site Termination|0|||
46996095|NCT01891864|83243182|FG000|Treatment Period 2|Lack of Efficacy|0|||
46996096|NCT01891864|83243183|FG001|Treatment Period 2|Lack of Efficacy|0|||
46996097|NCT01891864|83243184|FG002|Treatment Period 2|Lack of Efficacy|1|||
46996098|NCT01891864|83243185|FG003|Treatment Period 2|Lack of Efficacy|0|||
46996099|NCT01891864|83243186|FG004|Treatment Period 2|Lack of Efficacy|1|||
46996100|NCT01891864|83243187|FG005|Treatment Period 2|Lack of Efficacy|0|||
46996101|NCT01891864|83243182|FG000|Treatment Period 2|Adverse Event|0|||
46996102|NCT01891864|83243183|FG001|Treatment Period 2|Adverse Event|0|||
46996103|NCT01891864|83243184|FG002|Treatment Period 2|Adverse Event|1|||
46996104|NCT01891864|83243185|FG003|Treatment Period 2|Adverse Event|2|||
46996105|NCT01891864|83243186|FG004|Treatment Period 2|Adverse Event|0|||
46996106|NCT01891864|83243187|FG005|Treatment Period 2|Adverse Event|4|||
46996107|NCT01891864|83243182|FG000|Treatment Period 2|Termination of Site|0|||
46996108|NCT01891864|83243183|FG001|Treatment Period 2|Termination of Site|0|||
46996109|NCT01891864|83243184|FG002|Treatment Period 2|Termination of Site|0|||
46996110|NCT01891864|83243185|FG003|Treatment Period 2|Termination of Site|0|||
46618599|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46996111|NCT01891864|83243186|FG004|Treatment Period 2|Termination of Site|2|||
46996112|NCT01891864|83243187|FG005|Treatment Period 2|Termination of Site|0|||
46996113|NCT01891864|83243182|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46996114|NCT01891864|83243183|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46996115|NCT01891864|83243184|FG002|Treatment Period 2|Withdrawal by Subject|3|||
46996116|NCT01891864|83243185|FG003|Treatment Period 2|Withdrawal by Subject|4|||
46996117|NCT01891864|83243186|FG004|Treatment Period 2|Withdrawal by Subject|1|||
46996118|NCT01891864|83243187|FG005|Treatment Period 2|Withdrawal by Subject|1|||
46996119|NCT01891864|83243182|FG000|Extension Period|Lack of Efficacy|0|||
46996120|NCT01891864|83243183|FG001|Extension Period|Lack of Efficacy|0|||
46996121|NCT01891864|83243184|FG002|Extension Period|Lack of Efficacy|0|||
46996122|NCT01891864|83243185|FG003|Extension Period|Lack of Efficacy|1|||
46996123|NCT01891864|83243186|FG004|Extension Period|Lack of Efficacy|1|||
46996124|NCT01891864|83243187|FG005|Extension Period|Lack of Efficacy|0|||
46996125|NCT01891864|83243182|FG000|Extension Period|Pregnancy|0|||
46996126|NCT01891864|83243183|FG001|Extension Period|Pregnancy|0|||
46996127|NCT01891864|83243184|FG002|Extension Period|Pregnancy|1|||
46996128|NCT01891864|83243185|FG003|Extension Period|Pregnancy|0|||
46996129|NCT01891864|83243186|FG004|Extension Period|Pregnancy|0|||
46996130|NCT01891864|83243187|FG005|Extension Period|Pregnancy|0|||
46996131|NCT01891864|83243182|FG000|Extension Period|Adverse Event|0|||
46996132|NCT01891864|83243183|FG001|Extension Period|Adverse Event|0|||
46996133|NCT01891864|83243184|FG002|Extension Period|Adverse Event|4|||
46996134|NCT01891864|83243185|FG003|Extension Period|Adverse Event|2|||
46996135|NCT01891864|83243186|FG004|Extension Period|Adverse Event|2|||
46996136|NCT01891864|83243187|FG005|Extension Period|Adverse Event|0|||
46996137|NCT01891864|83243182|FG000|Extension Period|Withdrawal by Subject|0|||
46996138|NCT01891864|83243183|FG001|Extension Period|Withdrawal by Subject|0|||
46996139|NCT01891864|83243184|FG002|Extension Period|Withdrawal by Subject|1|||
46996140|NCT01891864|83243185|FG003|Extension Period|Withdrawal by Subject|2|||
46996141|NCT01891864|83243186|FG004|Extension Period|Withdrawal by Subject|4|||
46996142|NCT01891864|83243187|FG005|Extension Period|Withdrawal by Subject|0|||
46996143|NCT01891864|83243182|FG000|Extension Period|Lost to Follow-up|0|||
46996144|NCT01891864|83243183|FG001|Extension Period|Lost to Follow-up|0|||
46996145|NCT01891864|83243184|FG002|Extension Period|Lost to Follow-up|2|||
46996146|NCT01891864|83243185|FG003|Extension Period|Lost to Follow-up|0|||
46996147|NCT01891864|83243186|FG004|Extension Period|Lost to Follow-up|0|||
46996148|NCT01891864|83243187|FG005|Extension Period|Lost to Follow-up|0|||
46996149|NCT02485301|83243201|FG000|Overall Study|Serious Adverse Events|2|||
46996150|NCT02485301|83243202|FG001|Overall Study|Serious Adverse Events|1|||
46996151|NCT02485301|83243201|FG000|Overall Study|Protocol Violation|0|||
46996152|NCT02485301|83243202|FG001|Overall Study|Protocol Violation|1|||
46996153|NCT02485301|83243201|FG000|Overall Study|Withdrawal by Subject|6|||
46996154|NCT02485301|83243202|FG001|Overall Study|Withdrawal by Subject|7|||
46996155|NCT02485301|83243201|FG000|Overall Study|Migrated/moved from study area|10|||
46996156|NCT02485301|83243202|FG001|Overall Study|Migrated/moved from study area|19|||
46996157|NCT02485301|83243201|FG000|Overall Study|Lost to Follow-up|17|||
46996158|NCT02485301|83243202|FG001|Overall Study|Lost to Follow-up|17|||
46996159|NCT02485301|83243201|FG000|Overall Study|Other|3|||
46996160|NCT02485301|83243202|FG001|Overall Study|Other|4|||
46996161|NCT02484911|83243210|FG000|Overall Study|Withdrawal by Subject|2|||
46618600|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618601|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618602|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618603|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618604|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618605|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618606|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618607|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618608|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618609|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
46618610|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618611|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618612|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
46618613|NCT02326272|82753254|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618614|NCT02326272|82753255|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618615|NCT02326272|82753256|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618616|NCT02326272|82753257|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46898877|NCT02273388|83125337|FG001|Overall Study|Adverse Event|0|||
46898878|NCT02273388|83125338|FG002|Overall Study|Adverse Event|0|||
46898879|NCT02273388|83125339|FG003|Overall Study|Adverse Event|0|||
46898880|NCT02273388|83125340|FG004|Overall Study|Adverse Event|0|||
46898881|NCT02273388|83125341|FG005|Overall Study|Adverse Event|0|||
46898882|NCT02273388|83125342|FG006|Overall Study|Adverse Event|1|||
46898883|NCT02273388|83125343|FG007|Overall Study|Adverse Event|2|||
46898884|NCT02273388|83125344|FG008|Overall Study|Adverse Event|0|||
46898885|NCT02273388|83125345|FG009|Overall Study|Adverse Event|0|||
46898886|NCT02273388|83125346|FG010|Overall Study|Adverse Event|0|||
46618617|NCT02326272|82753258|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618618|NCT02326272|82753259|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618619|NCT02326272|82753260|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618620|NCT02326272|82753261|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618621|NCT02326272|82753262|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618622|NCT02326272|82753263|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618623|NCT02326272|82753264|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618624|NCT02326272|82753265|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618625|NCT02326272|82753266|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
46618626|NCT02326272|82753267|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618627|NCT02326272|82753268|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
46618628|NCT02325414|82753305|FG000|Overall Study|Withdrawal by Subject|3|||
46618629|NCT02325414|82753306|FG001|Overall Study|Withdrawal by Subject|1|||
46618630|NCT02325414|82753305|FG000|Overall Study|Lost to Follow-up|5|||
46618631|NCT02325414|82753306|FG001|Overall Study|Lost to Follow-up|5|||
46618632|NCT02349048|82753324|FG000|Overall Study|Withdrawal by Subject|4|||
46618633|NCT02349048|82753325|FG001|Overall Study|Withdrawal by Subject|0|||
46996162|NCT02484911|83243211|FG001|Overall Study|Withdrawal by Subject|1|||
46996163|NCT02484911|83243210|FG000|Overall Study|Protocol Violation|2|||
46996164|NCT02484911|83243211|FG001|Overall Study|Protocol Violation|1|||
46996165|NCT02466425|83243220|FG000|Overall Study|Adverse Event|3|||
46996166|NCT02466425|83243221|FG001|Overall Study|Adverse Event|11|||
46996167|NCT02466425|83243220|FG000|Overall Study|Lack of Efficacy|4|||
46996168|NCT02466425|83243221|FG001|Overall Study|Lack of Efficacy|1|||
46996169|NCT02466425|83243220|FG000|Overall Study|Lost to Follow-up|3|||
46996170|NCT02466425|83243221|FG001|Overall Study|Lost to Follow-up|0|||
46996171|NCT02466425|83243220|FG000|Overall Study|Protocol Violation|1|||
46996172|NCT02466425|83243221|FG001|Overall Study|Protocol Violation|0|||
46996173|NCT02466425|83243220|FG000|Overall Study|Withdrawal by Subject|0|||
46996174|NCT02466425|83243221|FG001|Overall Study|Withdrawal by Subject|1|||
46996175|NCT02466425|83243220|FG000|Overall Study|Other|1|||
46996176|NCT02466425|83243221|FG001|Overall Study|Other|3|||
46996177|NCT02466425|83243220|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
46996178|NCT02466425|83243221|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46996179|NCT02451917|83243229|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
46996180|NCT02451917|83243230|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
46996181|NCT02451917|83243229|FG000|First Intervention (24 Weeks)|Death|0|||
46996182|NCT02451917|83243230|FG001|First Intervention (24 Weeks)|Death|1|||
46996183|NCT02451917|83243229|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
46996184|NCT02451917|83243230|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
46996185|NCT02349451|83243243|FG000|Overall Study|Withdrawal by Subject|0|||
46996186|NCT02349451|83243244|FG001|Overall Study|Withdrawal by Subject|1|||
46996187|NCT02349451|83243245|FG002|Overall Study|Withdrawal by Subject|2|||
46996188|NCT02349451|83243246|FG003|Overall Study|Withdrawal by Subject|1|||
46996189|NCT02409368|83243263|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
46996190|NCT02409368|83243264|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
46996191|NCT02409368|83243265|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
46996192|NCT02409368|83243266|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
46996193|NCT02409368|83243263|FG000|ECOG Reclassification|Death|1|||
46996194|NCT02409368|83243264|FG001|ECOG Reclassification|Death|5|||
46996195|NCT02409368|83243265|FG002|ECOG Reclassification|Death|0|||
46996196|NCT02409368|83243266|FG003|ECOG Reclassification|Death|0|||
46996197|NCT02409368|83243263|FG000|ECOG Reclassification|Disease Progression|113|||
46618634|NCT02349048|82753324|FG000|Overall Study|Lost to Follow-up|1|||
46618635|NCT02349048|82753325|FG001|Overall Study|Lost to Follow-up|0|||
46618636|NCT02299206|82753372|FG000|Overall Study|Lost to Follow-up|1|||
46618637|NCT02299206|82753372|FG000|Overall Study|Withdrawal by Subject|1|||
46618638|NCT02298192|82753391|FG000|Overall Study|Unclassified|3|||
46996198|NCT02409368|83243264|FG001|ECOG Reclassification|Disease Progression|382|||
46996199|NCT02409368|83243265|FG002|ECOG Reclassification|Disease Progression|70|||
46996200|NCT02409368|83243266|FG003|ECOG Reclassification|Disease Progression|1|||
46996201|NCT02409368|83243263|FG000|ECOG Reclassification|Lost to Follow-up|1|||
46996202|NCT02409368|83243264|FG001|ECOG Reclassification|Lost to Follow-up|5|||
46996203|NCT02409368|83243265|FG002|ECOG Reclassification|Lost to Follow-up|0|||
46996204|NCT02409368|83243266|FG003|ECOG Reclassification|Lost to Follow-up|0|||
46996205|NCT02409368|83243263|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
46996206|NCT02409368|83243264|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
46996207|NCT02409368|83243265|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
46996208|NCT02409368|83243266|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
46996209|NCT02409368|83243263|FG000|ECOG Reclassification|Poor/non-compliance|0|||
46996210|NCT02409368|83243264|FG001|ECOG Reclassification|Poor/non-compliance|3|||
46618639|NCT02298192|82753392|FG001|Overall Study|Unclassified|2|||
46618640|NCT02298192|82753391|FG000|Overall Study|Withdrawal criteria|2|||
46618641|NCT02298192|82753392|FG001|Overall Study|Withdrawal criteria|0|||
46618642|NCT02298192|82753391|FG000|Overall Study|Withdrawal by Subject|6|||
46618643|NCT02298192|82753392|FG001|Overall Study|Withdrawal by Subject|1|||
46618644|NCT02298192|82753391|FG000|Overall Study|Lost to Follow-up|2|||
46618645|NCT02298192|82753392|FG001|Overall Study|Lost to Follow-up|1|||
46618646|NCT02298192|82753391|FG000|Overall Study|Adverse Event|6|||
46618647|NCT02298192|82753392|FG001|Overall Study|Adverse Event|2|||
46618648|NCT02280408|82753518|FG000|Overall Study|Lost to Follow-up|0|||
46618649|NCT02280408|82753519|FG001|Overall Study|Lost to Follow-up|2|||
46618650|NCT02280408|82753520|FG002|Overall Study|Lost to Follow-up|0|||
46618651|NCT02280408|82753521|FG003|Overall Study|Lost to Follow-up|0|||
46618652|NCT02296476|82753588|FG000|Overall Study|Disease Progression|6|||
46618653|NCT02296476|82753589|FG001|Overall Study|Disease Progression|4|||
46618654|NCT02296476|82753590|FG002|Overall Study|Disease Progression|2|||
46618655|NCT00552032|82753631|FG000|Overall Study|Withdrawal by Subject|2|||
46618656|NCT00552032|82753632|FG001|Overall Study|Withdrawal by Subject|2|||
46618657|NCT00552032|82753631|FG000|Overall Study|Protocol Violation|7|||
46618658|NCT00552032|82753632|FG001|Overall Study|Protocol Violation|12|||
46618659|NCT00552032|82753631|FG000|Overall Study|Lost to Follow-up|8|||
46618660|NCT00552032|82753632|FG001|Overall Study|Lost to Follow-up|5|||
46618661|NCT03312530|82754418|FG000|Overall Study|Death|5|||
46618662|NCT03312530|82754419|FG001|Overall Study|Death|5|||
46618663|NCT03312530|82754420|FG002|Overall Study|Death|4|||
46618664|NCT03312530|82754421|FG003|Overall Study|Death|10|||
46618665|NCT03312530|82754422|FG004|Overall Study|Death|8|||
46618666|NCT03312530|82754418|FG000|Overall Study|Lost to Follow-up|0|||
46618667|NCT03312530|82754419|FG001|Overall Study|Lost to Follow-up|0|||
46618668|NCT03312530|82754420|FG002|Overall Study|Lost to Follow-up|0|||
46618669|NCT03312530|82754421|FG003|Overall Study|Lost to Follow-up|1|||
46618670|NCT03312530|82754422|FG004|Overall Study|Lost to Follow-up|0|||
46618671|NCT03312530|82754418|FG000|Overall Study|Participant in another sponsor study.|0|||
46618672|NCT03312530|82754419|FG001|Overall Study|Participant in another sponsor study.|0|||
46618673|NCT03312530|82754420|FG002|Overall Study|Participant in another sponsor study.|0|||
46618674|NCT03312530|82754421|FG003|Overall Study|Participant in another sponsor study.|1|||
46618675|NCT03312530|82754422|FG004|Overall Study|Participant in another sponsor study.|0|||
46618676|NCT03312530|82754418|FG000|Overall Study|Study terminated by sponsor|1|||
46618677|NCT03312530|82754419|FG001|Overall Study|Study terminated by sponsor|0|||
46618678|NCT03312530|82754420|FG002|Overall Study|Study terminated by sponsor|2|||
46618679|NCT03312530|82754421|FG003|Overall Study|Study terminated by sponsor|3|||
46618680|NCT03312530|82754422|FG004|Overall Study|Study terminated by sponsor|7|||
46618681|NCT03312530|82754418|FG000|Overall Study|Withdrawal by Subject|0|||
46618682|NCT03312530|82754419|FG001|Overall Study|Withdrawal by Subject|1|||
46618683|NCT03312530|82754420|FG002|Overall Study|Withdrawal by Subject|0|||
46618684|NCT03312530|82754421|FG003|Overall Study|Withdrawal by Subject|0|||
46618685|NCT03312530|82754422|FG004|Overall Study|Withdrawal by Subject|0|||
46618686|NCT03312530|82754418|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
46618687|NCT03312530|82754419|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
46618688|NCT03312530|82754420|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
46618689|NCT03312530|82754421|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
46618690|NCT03312530|82754422|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
46618691|NCT02296320|82754540|FG000|Overall Study|Withdrawal by Subject|4|||
46618692|NCT02296320|82754541|FG001|Overall Study|Withdrawal by Subject|0|||
46618693|NCT02296320|82754542|FG002|Overall Study|Withdrawal by Subject|2|||
46618694|NCT02296320|82754540|FG000|Overall Study|Death|24|||
46618695|NCT02296320|82754541|FG001|Overall Study|Death|3|||
46618696|NCT02296320|82754542|FG002|Overall Study|Death|27|||
46618697|NCT02296320|82754540|FG000|Overall Study|Lost to Follow-up|5|||
46618698|NCT02296320|82754541|FG001|Overall Study|Lost to Follow-up|2|||
46618699|NCT02296320|82754542|FG002|Overall Study|Lost to Follow-up|7|||
46618700|NCT02296320|82754540|FG000|Overall Study|Not treated|2|||
46618701|NCT02296320|82754541|FG001|Overall Study|Not treated|0|||
46618702|NCT02296320|82754542|FG002|Overall Study|Not treated|0|||
46618703|NCT02296320|82754540|FG000|Overall Study|Not - specified|0|||
46618704|NCT02296320|82754541|FG001|Overall Study|Not - specified|0|||
46618705|NCT02296320|82754542|FG002|Overall Study|Not - specified|1|||
46618706|NCT02296242|82754594|FG000|Overall Study|Death|1|||
46618707|NCT02296242|82754595|FG001|Overall Study|Death|1|||
46618708|NCT02296242|82754596|FG002|Overall Study|Death|1|||
46618709|NCT02296242|82754597|FG003|Overall Study|Death|1|||
46618710|NCT02296242|82754598|FG004|Overall Study|Death|1|||
46618711|NCT02296242|82754594|FG000|Overall Study|Withdrawal by Subject|0|||
46618712|NCT02296242|82754595|FG001|Overall Study|Withdrawal by Subject|0|||
46618713|NCT02296242|82754596|FG002|Overall Study|Withdrawal by Subject|1|||
46618714|NCT02296242|82754597|FG003|Overall Study|Withdrawal by Subject|1|||
46618715|NCT02296242|82754598|FG004|Overall Study|Withdrawal by Subject|3|||
46618716|NCT02296242|82754594|FG000|Overall Study|Disease Progression|1|||
46618717|NCT02296242|82754595|FG001|Overall Study|Disease Progression|3|||
46618718|NCT02296242|82754596|FG002|Overall Study|Disease Progression|2|||
46618719|NCT02296242|82754597|FG003|Overall Study|Disease Progression|8|||
46618720|NCT02296242|82754598|FG004|Overall Study|Disease Progression|11|||
46618721|NCT02296242|82754594|FG000|Overall Study|Unacceptable Toxicity|0|||
46996211|NCT02409368|83243265|FG002|ECOG Reclassification|Poor/non-compliance|2|||
46618722|NCT02296242|82754595|FG001|Overall Study|Unacceptable Toxicity|0|||
46618723|NCT02296242|82754596|FG002|Overall Study|Unacceptable Toxicity|0|||
46618724|NCT02296242|82754597|FG003|Overall Study|Unacceptable Toxicity|0|||
46618725|NCT02296242|82754598|FG004|Overall Study|Unacceptable Toxicity|1|||
46618726|NCT02296242|82754594|FG000|Overall Study|Patient Condition Changed|0|||
46618727|NCT02296242|82754595|FG001|Overall Study|Patient Condition Changed|0|||
46618728|NCT02296242|82754596|FG002|Overall Study|Patient Condition Changed|2|||
46618729|NCT02296242|82754597|FG003|Overall Study|Patient Condition Changed|0|||
46996212|NCT02409368|83243266|FG003|ECOG Reclassification|Poor/non-compliance|0|||
46996213|NCT02409368|83243263|FG000|ECOG Reclassification|Study drug toxicity|17|||
46996214|NCT02409368|83243264|FG001|ECOG Reclassification|Study drug toxicity|42|||
46996215|NCT02409368|83243265|FG002|ECOG Reclassification|Study drug toxicity|7|||
46996216|NCT02409368|83243266|FG003|ECOG Reclassification|Study drug toxicity|0|||
46996217|NCT02409368|83243263|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
46618730|NCT02296242|82754598|FG004|Overall Study|Patient Condition Changed|1|||
46618731|NCT02296242|82754594|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
46618732|NCT02296242|82754595|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
46618733|NCT02296242|82754596|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
46618734|NCT02296242|82754597|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
46618735|NCT02296242|82754598|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
46618736|NCT02296242|82754594|FG000|Overall Study|Lost to Follow-up|1|||
46618737|NCT02296242|82754595|FG001|Overall Study|Lost to Follow-up|0|||
46618738|NCT02296242|82754596|FG002|Overall Study|Lost to Follow-up|0|||
46618739|NCT02296242|82754597|FG003|Overall Study|Lost to Follow-up|0|||
46618740|NCT02296242|82754598|FG004|Overall Study|Lost to Follow-up|0|||
46618741|NCT02296242|82754594|FG000|Overall Study|Need for Hydroxyurea|2|||
46618742|NCT02296242|82754595|FG001|Overall Study|Need for Hydroxyurea|0|||
46618743|NCT02296242|82754596|FG002|Overall Study|Need for Hydroxyurea|0|||
46618744|NCT02296242|82754597|FG003|Overall Study|Need for Hydroxyurea|0|||
46618745|NCT02296242|82754598|FG004|Overall Study|Need for Hydroxyurea|0|||
46618746|NCT02296242|82754594|FG000|Overall Study|Screened for Other Protocol|0|||
46618747|NCT02296242|82754595|FG001|Overall Study|Screened for Other Protocol|1|||
46618748|NCT02296242|82754596|FG002|Overall Study|Screened for Other Protocol|0|||
46618749|NCT02296242|82754597|FG003|Overall Study|Screened for Other Protocol|0|||
46618750|NCT02296242|82754598|FG004|Overall Study|Screened for Other Protocol|0|||
46618751|NCT02296242|82754594|FG000|Overall Study|Physician Decision|0|||
46618752|NCT02296242|82754595|FG001|Overall Study|Physician Decision|1|||
46618753|NCT02296242|82754596|FG002|Overall Study|Physician Decision|0|||
46618754|NCT02296242|82754597|FG003|Overall Study|Physician Decision|1|||
46618755|NCT02296242|82754598|FG004|Overall Study|Physician Decision|0|||
46618756|NCT02296242|82754594|FG000|Overall Study|Alternative Treatment|0|||
46618757|NCT02296242|82754595|FG001|Overall Study|Alternative Treatment|0|||
46618758|NCT02296242|82754596|FG002|Overall Study|Alternative Treatment|0|||
46618759|NCT02296242|82754597|FG003|Overall Study|Alternative Treatment|1|||
46618760|NCT02296242|82754598|FG004|Overall Study|Alternative Treatment|0|||
46618761|NCT02296242|82754594|FG000|Overall Study|Adverse Event|0|||
46618762|NCT02296242|82754595|FG001|Overall Study|Adverse Event|0|||
46618763|NCT02296242|82754596|FG002|Overall Study|Adverse Event|0|||
46618764|NCT02296242|82754597|FG003|Overall Study|Adverse Event|1|||
46618765|NCT02296242|82754598|FG004|Overall Study|Adverse Event|0|||
46618766|NCT02296242|82754594|FG000|Overall Study|Lack of Efficacy|0|||
46618767|NCT02296242|82754595|FG001|Overall Study|Lack of Efficacy|0|||
46618768|NCT02296242|82754596|FG002|Overall Study|Lack of Efficacy|0|||
46618769|NCT02296242|82754597|FG003|Overall Study|Lack of Efficacy|0|||
46618770|NCT02296242|82754598|FG004|Overall Study|Lack of Efficacy|3|||
46618771|NCT02295774|82754618|FG000|Overall Study|Physician Decision|1|||
46996218|NCT02409368|83243264|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
46618772|NCT02295774|82754618|FG000|Overall Study|Withdrawal by Subject|2|||
46996219|NCT02409368|83243265|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
46618773|NCT02294682|82754633|FG000|Overall Study|Could not swallow pills|1|||
46618774|NCT02294682|82754634|FG001|Overall Study|Could not swallow pills|0|||
46618775|NCT02294604|82754643|FG000|Overall Study|Did not provide samples for culture|0|||
46618776|NCT02294604|82754644|FG001|Overall Study|Did not provide samples for culture|1|||
46618777|NCT02294604|82754645|FG002|Overall Study|Did not provide samples for culture|0|||
46618778|NCT02294604|82754643|FG000|Overall Study|Culture contamination|1|||
46618779|NCT02294604|82754644|FG001|Overall Study|Culture contamination|2|||
46618780|NCT02294604|82754645|FG002|Overall Study|Culture contamination|0|||
46618781|NCT01645176|82754664|FG000|Overall Study|Lack of Efficacy|4|||
46618782|NCT01645176|82754664|FG000|Overall Study|did not complete final MRI|1|||
46618783|NCT02322216|82754679|FG000|Overall Study|Adverse Event|1|||
46618784|NCT02322216|82754680|FG001|Overall Study|Adverse Event|0|||
46618785|NCT02322216|82754679|FG000|Overall Study|Withdrawal by Subject|1|||
46618786|NCT02322216|82754680|FG001|Overall Study|Withdrawal by Subject|4|||
46618787|NCT01647516|82754721|FG000|Induction Period (IP)|Physician Decision|2|||
46618788|NCT01647516|82754722|FG001|Induction Period (IP)|Physician Decision|0|||
46618789|NCT01647516|82754723|FG002|Induction Period (IP)|Physician Decision|0|||
46618790|NCT01647516|82754724|FG003|Induction Period (IP)|Physician Decision|0|||
46618791|NCT01647516|82754725|FG004|Induction Period (IP)|Physician Decision|0|||
46618792|NCT01647516|82754726|FG005|Induction Period (IP)|Physician Decision|0|||
46618793|NCT01647516|82754721|FG000|Induction Period (IP)|Adverse Event|1|||
46618794|NCT01647516|82754722|FG001|Induction Period (IP)|Adverse Event|2|||
46618795|NCT01647516|82754723|FG002|Induction Period (IP)|Adverse Event|0|||
46618796|NCT01647516|82754724|FG003|Induction Period (IP)|Adverse Event|0|||
46618797|NCT01647516|82754725|FG004|Induction Period (IP)|Adverse Event|0|||
46618798|NCT01647516|82754726|FG005|Induction Period (IP)|Adverse Event|0|||
46618799|NCT01647516|82754721|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
46618800|NCT01647516|82754722|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
46618801|NCT01647516|82754723|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
46618802|NCT01647516|82754724|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
46618803|NCT01647516|82754725|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
46618804|NCT01647516|82754726|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
46618805|NCT01647516|82754721|FG000|Induction Period (IP)|Participant Choice|0|||
46618806|NCT01647516|82754722|FG001|Induction Period (IP)|Participant Choice|0|||
46618807|NCT01647516|82754723|FG002|Induction Period (IP)|Participant Choice|1|||
46618808|NCT01647516|82754724|FG003|Induction Period (IP)|Participant Choice|0|||
46618809|NCT01647516|82754725|FG004|Induction Period (IP)|Participant Choice|0|||
46618810|NCT01647516|82754726|FG005|Induction Period (IP)|Participant Choice|0|||
46618811|NCT01647516|82754721|FG000|Induction Period (IP)|Lack of Efficacy|1|||
46618812|NCT01647516|82754722|FG001|Induction Period (IP)|Lack of Efficacy|0|||
46618813|NCT01647516|82754723|FG002|Induction Period (IP)|Lack of Efficacy|0|||
46618814|NCT01647516|82754724|FG003|Induction Period (IP)|Lack of Efficacy|0|||
46618815|NCT01647516|82754725|FG004|Induction Period (IP)|Lack of Efficacy|0|||
46618816|NCT01647516|82754726|FG005|Induction Period (IP)|Lack of Efficacy|0|||
46618817|NCT01647516|82754721|FG000|Induction Period (IP)|No study drug received|1|||
46618818|NCT01647516|82754722|FG001|Induction Period (IP)|No study drug received|1|||
46618819|NCT01647516|82754723|FG002|Induction Period (IP)|No study drug received|0|||
46618820|NCT01647516|82754724|FG003|Induction Period (IP)|No study drug received|0|||
46618821|NCT01647516|82754725|FG004|Induction Period (IP)|No study drug received|0|||
46618822|NCT01647516|82754726|FG005|Induction Period (IP)|No study drug received|0|||
46618823|NCT01647516|82754721|FG000|Maintenance Period (MP)|Adverse Event|2|||
46618824|NCT01647516|82754722|FG001|Maintenance Period (MP)|Adverse Event|1|||
46618825|NCT01647516|82754723|FG002|Maintenance Period (MP)|Adverse Event|0|||
46618826|NCT01647516|82754724|FG003|Maintenance Period (MP)|Adverse Event|0|||
46618827|NCT01647516|82754725|FG004|Maintenance Period (MP)|Adverse Event|0|||
46618828|NCT01647516|82754726|FG005|Maintenance Period (MP)|Adverse Event|0|||
46618829|NCT01647516|82754721|FG000|Maintenance Period (MP)|Non-compliance|1|||
46618830|NCT01647516|82754722|FG001|Maintenance Period (MP)|Non-compliance|0|||
46618831|NCT01647516|82754723|FG002|Maintenance Period (MP)|Non-compliance|0|||
46618832|NCT01647516|82754724|FG003|Maintenance Period (MP)|Non-compliance|0|||
46618833|NCT01647516|82754725|FG004|Maintenance Period (MP)|Non-compliance|0|||
46618834|NCT01647516|82754726|FG005|Maintenance Period (MP)|Non-compliance|0|||
46618835|NCT01647516|82754721|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
46996220|NCT02409368|83243266|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
46996221|NCT02409368|83243263|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
46996222|NCT02409368|83243264|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
46996223|NCT02409368|83243265|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
46618836|NCT01647516|82754722|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
46618837|NCT01647516|82754723|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
46618838|NCT01647516|82754724|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
46618839|NCT01647516|82754725|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
46996224|NCT02409368|83243266|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
46618840|NCT01647516|82754726|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
46618841|NCT01647516|82754721|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
46618842|NCT01647516|82754722|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
46618843|NCT01647516|82754723|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
46618844|NCT01647516|82754724|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
46618845|NCT01647516|82754725|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
46618846|NCT01647516|82754726|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
46618847|NCT01647516|82754721|FG000|Open-Label Period|Adverse Event|0|||
46618848|NCT01647516|82754722|FG001|Open-Label Period|Adverse Event|0|||
46618849|NCT01647516|82754723|FG002|Open-Label Period|Adverse Event|0|||
46618850|NCT01647516|82754724|FG003|Open-Label Period|Adverse Event|5|||
46618851|NCT01647516|82754725|FG004|Open-Label Period|Adverse Event|6|||
46898887|NCT02273388|83125347|FG011|Overall Study|Adverse Event|0|||
46618852|NCT01647516|82754726|FG005|Open-Label Period|Adverse Event|3|||
46618853|NCT01647516|82754721|FG000|Open-Label Period|Pregnancy|0|||
46618854|NCT01647516|82754722|FG001|Open-Label Period|Pregnancy|0|||
46618855|NCT01647516|82754723|FG002|Open-Label Period|Pregnancy|0|||
46618856|NCT01647516|82754724|FG003|Open-Label Period|Pregnancy|0|||
46618857|NCT01647516|82754725|FG004|Open-Label Period|Pregnancy|0|||
46618858|NCT01647516|82754726|FG005|Open-Label Period|Pregnancy|1|||
46618859|NCT01647516|82754721|FG000|Open-Label Period|Non-compliance|0|||
46618860|NCT01647516|82754722|FG001|Open-Label Period|Non-compliance|0|||
46618861|NCT01647516|82754723|FG002|Open-Label Period|Non-compliance|0|||
46618862|NCT01647516|82754724|FG003|Open-Label Period|Non-compliance|1|||
46618863|NCT01647516|82754725|FG004|Open-Label Period|Non-compliance|0|||
46618864|NCT01647516|82754726|FG005|Open-Label Period|Non-compliance|1|||
46618865|NCT01647516|82754721|FG000|Open-Label Period|Physician Decision|0|||
46618866|NCT01647516|82754722|FG001|Open-Label Period|Physician Decision|0|||
46618867|NCT01647516|82754723|FG002|Open-Label Period|Physician Decision|0|||
46618868|NCT01647516|82754724|FG003|Open-Label Period|Physician Decision|1|||
46618869|NCT01647516|82754725|FG004|Open-Label Period|Physician Decision|1|||
46618870|NCT01647516|82754726|FG005|Open-Label Period|Physician Decision|0|||
46618871|NCT01647516|82754721|FG000|Open-Label Period|Withdrawal by Subject|0|||
46618872|NCT01647516|82754722|FG001|Open-Label Period|Withdrawal by Subject|0|||
46996225|NCT02409368|83243263|FG000|ECOG Reclassification|Participant withdrew consent|2|||
46996226|NCT02409368|83243264|FG001|ECOG Reclassification|Participant withdrew consent|3|||
46996227|NCT02409368|83243265|FG002|ECOG Reclassification|Participant withdrew consent|4|||
46996228|NCT02409368|83243266|FG003|ECOG Reclassification|Participant withdrew consent|0|||
46996229|NCT02409368|83243263|FG000|ECOG Reclassification|Other Reasons|5|||
46618873|NCT01647516|82754723|FG002|Open-Label Period|Withdrawal by Subject|0|||
46996230|NCT02409368|83243264|FG001|ECOG Reclassification|Other Reasons|26|||
46618874|NCT01647516|82754724|FG003|Open-Label Period|Withdrawal by Subject|9|||
46618875|NCT01647516|82754725|FG004|Open-Label Period|Withdrawal by Subject|11|||
46618876|NCT01647516|82754726|FG005|Open-Label Period|Withdrawal by Subject|6|||
46618877|NCT01647516|82754721|FG000|Open-Label Period|Lost to Follow-up|0|||
46618878|NCT01647516|82754722|FG001|Open-Label Period|Lost to Follow-up|0|||
46618879|NCT01647516|82754723|FG002|Open-Label Period|Lost to Follow-up|0|||
46618880|NCT01647516|82754724|FG003|Open-Label Period|Lost to Follow-up|1|||
46618881|NCT01647516|82754725|FG004|Open-Label Period|Lost to Follow-up|0|||
46618882|NCT01647516|82754726|FG005|Open-Label Period|Lost to Follow-up|1|||
46618883|NCT01647516|82754721|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
46618884|NCT01647516|82754722|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
46618885|NCT01647516|82754723|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
46618886|NCT01647516|82754724|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
46618887|NCT01647516|82754725|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
46618888|NCT01647516|82754726|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
46618889|NCT01647516|82754721|FG000|Open-Label Period|Lack of Efficacy|0|||
46618890|NCT01647516|82754722|FG001|Open-Label Period|Lack of Efficacy|0|||
46618891|NCT01647516|82754723|FG002|Open-Label Period|Lack of Efficacy|0|||
46618892|NCT01647516|82754724|FG003|Open-Label Period|Lack of Efficacy|7|||
46618893|NCT01647516|82754725|FG004|Open-Label Period|Lack of Efficacy|9|||
46618894|NCT01647516|82754726|FG005|Open-Label Period|Lack of Efficacy|10|||
46618895|NCT01647516|82754721|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
46618896|NCT01647516|82754722|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
46618897|NCT01647516|82754723|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
46618898|NCT01647516|82754724|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
46618899|NCT01647516|82754725|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
46618900|NCT01647516|82754726|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
46618901|NCT01647516|82754721|FG000|Open-Label Period|No completion / discontinuation visit|0|||
46618902|NCT01647516|82754722|FG001|Open-Label Period|No completion / discontinuation visit|0|||
46618903|NCT01647516|82754723|FG002|Open-Label Period|No completion / discontinuation visit|0|||
46618904|NCT01647516|82754724|FG003|Open-Label Period|No completion / discontinuation visit|0|||
46618905|NCT01647516|82754725|FG004|Open-Label Period|No completion / discontinuation visit|2|||
46618906|NCT01647516|82754726|FG005|Open-Label Period|No completion / discontinuation visit|1|||
46618907|NCT01647282|82754743|FG000|Overall Study|Physician Decision|7|||
46618908|NCT01647282|82754744|FG001|Overall Study|Physician Decision|5|||
46618909|NCT02321436|82754752|FG000|Overall Study|Withdrawal by Subject|1|||
46618910|NCT02321436|82754753|FG001|Overall Study|Withdrawal by Subject|0|||
46618911|NCT02321436|82754752|FG000|Overall Study|Lost to Follow-up|0|||
46618912|NCT02321436|82754753|FG001|Overall Study|Lost to Follow-up|1|||
46618913|NCT02319642|82754762|FG000|Overall Study|Adverse Event|2|||
46618914|NCT02319642|82754763|FG001|Overall Study|Adverse Event|4|||
46618915|NCT02319642|82754762|FG000|Overall Study|Lack of Efficacy|1|||
46618916|NCT02319642|82754763|FG001|Overall Study|Lack of Efficacy|1|||
46618917|NCT02319642|82754762|FG000|Overall Study|Withdrawal by Subject|1|||
46618918|NCT02319642|82754763|FG001|Overall Study|Withdrawal by Subject|1|||
46618919|NCT02280096|82754773|FG000|Overall Study|Pregnancy|1|||
46618920|NCT02280096|82754774|FG001|Overall Study|Pregnancy|0|||
46618921|NCT02280096|82754773|FG000|Overall Study|Functional neurological disorder|1|||
46618922|NCT02280096|82754774|FG001|Overall Study|Functional neurological disorder|0|||
46618923|NCT02280096|82754773|FG000|Overall Study|Lack of attachment|0|||
46618924|NCT02280096|82754774|FG001|Overall Study|Lack of attachment|1|||
46618925|NCT02279862|82754791|FG000|Overall Study|Study drug toxicity|3|||
46618926|NCT02279862|82754792|FG001|Overall Study|Study drug toxicity|6|||
46618927|NCT02279862|82754791|FG000|Overall Study|No longer meets criteria|0|||
46618928|NCT02279862|82754792|FG001|Overall Study|No longer meets criteria|1|||
46618929|NCT02279862|82754791|FG000|Overall Study|Administrative reason by sponsor|0|||
46618930|NCT02279862|82754792|FG001|Overall Study|Administrative reason by sponsor|1|||
46618931|NCT02279862|82754791|FG000|Overall Study|Disease progression|5|||
46618932|NCT02279862|82754792|FG001|Overall Study|Disease progression|2|||
46618933|NCT02279862|82754791|FG000|Overall Study|Study closed by sponsor|16|||
46618934|NCT02279862|82754792|FG001|Overall Study|Study closed by sponsor|13|||
46618935|NCT02279862|82754791|FG000|Overall Study|Other|1|||
46618936|NCT02279862|82754792|FG001|Overall Study|Other|2|||
46618937|NCT02279862|82754791|FG000|Overall Study|Withdrawal by Subject|1|||
46618938|NCT02279862|82754792|FG001|Overall Study|Withdrawal by Subject|0|||
46618939|NCT02318940|82754800|FG000|Overall Study|lost the record|1|||
46618940|NCT02318940|82754801|FG001|Overall Study|lost the record|0|||
46618941|NCT02294058|82754810|FG000|Overall Study|Adverse Event|16|||
46618942|NCT02294058|82754811|FG001|Overall Study|Adverse Event|7|||
46618943|NCT02294058|82754812|FG002|Overall Study|Adverse Event|13|||
46618944|NCT02294058|82754810|FG000|Overall Study|Lack of Efficacy|3|||
46618945|NCT02294058|82754811|FG001|Overall Study|Lack of Efficacy|3|||
46618946|NCT02294058|82754812|FG002|Overall Study|Lack of Efficacy|0|||
46618947|NCT02294058|82754810|FG000|Overall Study|Lost to Follow-up|1|||
46618948|NCT02294058|82754811|FG001|Overall Study|Lost to Follow-up|0|||
46618949|NCT02294058|82754812|FG002|Overall Study|Lost to Follow-up|2|||
46618950|NCT02294058|82754810|FG000|Overall Study|Withdrawal by Subject|10|||
46618951|NCT02294058|82754811|FG001|Overall Study|Withdrawal by Subject|14|||
46618952|NCT02294058|82754812|FG002|Overall Study|Withdrawal by Subject|13|||
46618953|NCT02294058|82754810|FG000|Overall Study|Physician Decision|2|||
46618954|NCT02294058|82754811|FG001|Overall Study|Physician Decision|1|||
46618955|NCT02294058|82754812|FG002|Overall Study|Physician Decision|0|||
46618956|NCT02294058|82754810|FG000|Overall Study|Miscellaneous|4|||
46618957|NCT02294058|82754811|FG001|Overall Study|Miscellaneous|1|||
46618958|NCT02294058|82754812|FG002|Overall Study|Miscellaneous|1|||
46618959|NCT02293902|82754824|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
46618960|NCT02293902|82754825|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
46618961|NCT02293902|82754826|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
46618962|NCT02293902|82754827|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
46618963|NCT02293902|82754828|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
46618964|NCT02293902|82754824|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
46618965|NCT02293902|82754825|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
46618966|NCT02293902|82754826|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
46618967|NCT02293902|82754827|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
46618968|NCT02293902|82754828|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
46618969|NCT02293902|82754824|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
46618970|NCT02293902|82754825|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
46618971|NCT02293902|82754826|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
46618972|NCT02293902|82754827|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
46618973|NCT02293902|82754828|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
46618974|NCT02293902|82754824|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
46618975|NCT02293902|82754825|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
46618976|NCT02293902|82754826|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
46618977|NCT02293902|82754827|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
46618978|NCT02293902|82754828|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
46996231|NCT02409368|83243265|FG002|ECOG Reclassification|Other Reasons|2|||
46996232|NCT02409368|83243266|FG003|ECOG Reclassification|Other Reasons|0|||
46996233|NCT02409368|83243263|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
46618979|NCT02293902|82754824|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
46618980|NCT02293902|82754825|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
46618981|NCT02293902|82754826|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
46618982|NCT02293902|82754827|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
46618983|NCT02293902|82754828|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
46618984|NCT02278614|82754848|FG000|Overall Study|Withdrawal by Subject|3|||
46618985|NCT02278614|82754849|FG001|Overall Study|Withdrawal by Subject|5|||
46618986|NCT02278614|82754848|FG000|Overall Study|Adverse Event|1|||
46618987|NCT02278614|82754849|FG001|Overall Study|Adverse Event|0|||
46996234|NCT02409368|83243264|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
46996235|NCT02409368|83243265|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
46996236|NCT02409368|83243266|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
46996237|NCT01853878|83243279|FG000|Overall Study|Recurrence|2|||
46996238|NCT01853878|83243280|FG001|Overall Study|Recurrence|0|||
46996239|NCT01853878|83243279|FG000|Overall Study|Adverse Event|2|||
46996240|NCT01853878|83243280|FG001|Overall Study|Adverse Event|0|||
46996241|NCT01853878|83243279|FG000|Overall Study|Withdrawal by Subject|3|||
46996242|NCT01853878|83243280|FG001|Overall Study|Withdrawal by Subject|1|||
46996243|NCT01853878|83243279|FG000|Overall Study|Migrated/moved from the study area|1|||
46996244|NCT01853878|83243280|FG001|Overall Study|Migrated/moved from the study area|0|||
46996245|NCT01853878|83243279|FG000|Overall Study|Other|55|||
46996246|NCT01853878|83243280|FG001|Overall Study|Other|43|||
46996247|NCT02342678|83243288|FG000|Overall Study|Lost to Follow-up|0|||
46996248|NCT02342678|83243289|FG001|Overall Study|Lost to Follow-up|1|||
46996249|NCT02342678|83243288|FG000|Overall Study|Too busy to complete study|0|||
46996250|NCT02342678|83243289|FG001|Overall Study|Too busy to complete study|2|||
46996251|NCT02342678|83243288|FG000|Overall Study|Family illness/emergency|0|||
46996252|NCT02342678|83243289|FG001|Overall Study|Family illness/emergency|1|||
46996253|NCT02342678|83243288|FG000|Overall Study|Illness/medical reason|1|||
46996254|NCT02342678|83243289|FG001|Overall Study|Illness/medical reason|1|||
46996255|NCT02342288|83243297|FG000|Overall Study|no protocol anesthesiologist available|3|||
46996256|NCT02342288|83243298|FG001|Overall Study|no protocol anesthesiologist available|2|||
46996257|NCT02342288|83243297|FG000|Overall Study|anesthesia leak in system|1|||
46618988|NCT02278614|82754848|FG000|Overall Study|left eye was not eligible|1|||
46618989|NCT02278614|82754849|FG001|Overall Study|left eye was not eligible|0|||
46618990|NCT02318706|82754859|FG000|Double-blind Phase|Adverse Event|7|||
46618991|NCT02318706|82754860|FG001|Double-blind Phase|Adverse Event|4|||
46618992|NCT02318706|82754861|FG002|Double-blind Phase|Adverse Event|3|||
46618993|NCT02318706|82754862|FG003|Double-blind Phase|Adverse Event|10|||
46618994|NCT02318706|82754863|FG004|Double-blind Phase|Adverse Event|0|||
46618995|NCT02318706|82754859|FG000|Double-blind Phase|Lost to Follow-up|1|||
46618996|NCT02318706|82754860|FG001|Double-blind Phase|Lost to Follow-up|0|||
46618997|NCT02318706|82754861|FG002|Double-blind Phase|Lost to Follow-up|0|||
46618998|NCT02318706|82754862|FG003|Double-blind Phase|Lost to Follow-up|0|||
46618999|NCT02318706|82754863|FG004|Double-blind Phase|Lost to Follow-up|0|||
46619000|NCT02318706|82754859|FG000|Double-blind Phase|Protocol Violation|4|||
46619001|NCT02318706|82754860|FG001|Double-blind Phase|Protocol Violation|2|||
46619002|NCT02318706|82754861|FG002|Double-blind Phase|Protocol Violation|4|||
46619003|NCT02318706|82754862|FG003|Double-blind Phase|Protocol Violation|3|||
46619004|NCT02318706|82754863|FG004|Double-blind Phase|Protocol Violation|0|||
46619005|NCT02318706|82754859|FG000|Double-blind Phase|Withdrawal by Subject|9|||
46619006|NCT02318706|82754860|FG001|Double-blind Phase|Withdrawal by Subject|5|||
46619007|NCT02318706|82754861|FG002|Double-blind Phase|Withdrawal by Subject|7|||
46619008|NCT02318706|82754862|FG003|Double-blind Phase|Withdrawal by Subject|10|||
46996258|NCT02342288|83243298|FG001|Overall Study|anesthesia leak in system|0|||
46996259|NCT02342288|83243297|FG000|Overall Study|Withdrawal by Subject|1|||
46996260|NCT02342288|83243298|FG001|Overall Study|Withdrawal by Subject|0|||
46996261|NCT02342288|83243297|FG000|Overall Study|coordinator contaminated with blood|0|||
46996262|NCT02342288|83243298|FG001|Overall Study|coordinator contaminated with blood|1|||
46996263|NCT02342288|83243297|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
46996264|NCT02342288|83243298|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
46996265|NCT02342288|83243297|FG000|Overall Study|coordinator not available|0|||
46996266|NCT02342288|83243298|FG001|Overall Study|coordinator not available|2|||
46996267|NCT01853644|83243304|FG000|Registration and Treatment Start|Did not start treatment|1|||
46996268|NCT01853644|83243304|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
46996269|NCT01853644|83243304|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
46996270|NCT01853644|83243304|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
46996271|NCT01853644|83243304|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
46619009|NCT02318706|82754863|FG004|Double-blind Phase|Withdrawal by Subject|0|||
46619010|NCT02318706|82754859|FG000|Double-blind Phase|Other|4|||
46996272|NCT01853644|83243304|FG000|Continued Treatment After First Response|Adverse Event|2|||
46996273|NCT01853644|83243304|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
46619011|NCT02318706|82754860|FG001|Double-blind Phase|Other|1|||
46619012|NCT02318706|82754861|FG002|Double-blind Phase|Other|2|||
46619013|NCT02318706|82754862|FG003|Double-blind Phase|Other|1|||
46996274|NCT02374346|83243308|FG000|Overall Study|operated or discharged during weekend|48|||
46619014|NCT02318706|82754863|FG004|Double-blind Phase|Other|0|||
46996275|NCT01853254|83243314|FG000|Overall Study|Abnormal Laboratory Test|1|||
46996276|NCT01853254|83243314|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
46996277|NCT01853254|83243314|FG000|Overall Study|Death|1|||
46619015|NCT02318706|82754859|FG000|Double-blind Phase|Death|0|||
46619016|NCT02318706|82754860|FG001|Double-blind Phase|Death|0|||
46619017|NCT02318706|82754861|FG002|Double-blind Phase|Death|2|||
46996278|NCT01853254|83243314|FG000|Overall Study|Failure to Return|43|||
46996279|NCT01853254|83243314|FG000|Overall Study|Insufficient Therapeutic Response|22|||
46996280|NCT01853254|83243314|FG000|Overall Study|Refusal of Treatment|1|||
46996281|NCT01853254|83243314|FG000|Overall Study|Other Protocol Violation|1|||
46996282|NCT01853254|83243314|FG000|Overall Study|Withdrawal of Consent|16|||
46996283|NCT01853254|83243314|FG000|Overall Study|Administrative/Other|16|||
46996284|NCT02373098|83243320|FG000|Overall Study|Lost to Follow-up|1|||
46996285|NCT02373098|83243321|FG001|Overall Study|Lost to Follow-up|0|||
46996286|NCT02373098|83243320|FG000|Overall Study|Protocol Violation|3|||
46996287|NCT02373098|83243321|FG001|Overall Study|Protocol Violation|0|||
46996288|NCT02373098|83243320|FG000|Overall Study|Withdrawal by Subject|5|||
46996289|NCT02373098|83243321|FG001|Overall Study|Withdrawal by Subject|0|||
46996290|NCT02373098|83243320|FG000|Overall Study|Adverse Event|3|||
46996291|NCT02373098|83243321|FG001|Overall Study|Adverse Event|0|||
46996292|NCT01853176|83243335|FG000|Overall Study|Study terminated|4|||
46996293|NCT01853176|83243336|FG001|Overall Study|Study terminated|0|||
46619018|NCT02318706|82754862|FG003|Double-blind Phase|Death|0|||
46619019|NCT02318706|82754863|FG004|Double-blind Phase|Death|0|||
46619020|NCT02318706|82754859|FG000|Open-label Extension Phase|Adverse Event|0|||
46619021|NCT02318706|82754860|FG001|Open-label Extension Phase|Adverse Event|0|||
46619022|NCT02318706|82754861|FG002|Open-label Extension Phase|Adverse Event|0|||
46619023|NCT02318706|82754862|FG003|Open-label Extension Phase|Adverse Event|0|||
46619024|NCT02318706|82754863|FG004|Open-label Extension Phase|Adverse Event|21|||
46619025|NCT02318706|82754859|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
46619026|NCT02318706|82754860|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
46619027|NCT02318706|82754861|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
46619028|NCT02318706|82754862|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
46619029|NCT02318706|82754863|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
46619030|NCT02318706|82754859|FG000|Open-label Extension Phase|Death|0|||
46619031|NCT02318706|82754860|FG001|Open-label Extension Phase|Death|0|||
46619032|NCT02318706|82754861|FG002|Open-label Extension Phase|Death|0|||
46619033|NCT02318706|82754862|FG003|Open-label Extension Phase|Death|0|||
46619034|NCT02318706|82754863|FG004|Open-label Extension Phase|Death|1|||
46619035|NCT02318706|82754859|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
46619036|NCT02318706|82754860|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
46619037|NCT02318706|82754861|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
46619038|NCT02318706|82754862|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
46619039|NCT02318706|82754863|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
46619040|NCT04583280|82754914|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
46619041|NCT04583280|82754915|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
46996294|NCT02372396|83243344|FG000|Overall Study|Lost to Follow-up|7|||
46996295|NCT02372396|83243345|FG001|Overall Study|Lost to Follow-up|9|||
46996296|NCT01835548|83243353|FG000|Dose Optimization Period|Adverse Event|0|||
46996297|NCT01835548|83243354|FG001|Dose Optimization Period|Adverse Event|0|||
46996298|NCT01835548|83243355|FG002|Dose Optimization Period|Adverse Event|1|||
46996299|NCT01835548|83243353|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
46996300|NCT01835548|83243354|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
46996301|NCT01835548|83243355|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
46996302|NCT01835548|83243353|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46996303|NCT01835548|83243354|FG001|Double-Blind Treatment Period|Adverse Event|1|||
46996304|NCT01835548|83243355|FG002|Double-Blind Treatment Period|Adverse Event|0|||
46996305|NCT01835548|83243353|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46996306|NCT01835548|83243354|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46996307|NCT01835548|83243355|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46996308|NCT01852942|83243369|FG000|Overall Study|Physician Decision|1|||
46996309|NCT01852942|83243370|FG001|Overall Study|Physician Decision|0|||
46996310|NCT01852942|83243369|FG000|Overall Study|Death|1|||
46996311|NCT01852942|83243370|FG001|Overall Study|Death|1|||
46996312|NCT01852942|83243369|FG000|Overall Study|Withdrawal by Subject|2|||
46996313|NCT01852942|83243370|FG001|Overall Study|Withdrawal by Subject|3|||
46996314|NCT01852942|83243369|FG000|Overall Study|Lost to Follow-up|1|||
46996315|NCT01852942|83243370|FG001|Overall Study|Lost to Follow-up|2|||
46619042|NCT04489940|82754934|FG000|Overall Study|Other|2|||
46619043|NCT04489940|82754934|FG000|Overall Study|Withdrawal by Subject|2|||
46619044|NCT04489940|82754934|FG000|Overall Study|Death|5|||
46619045|NCT04489940|82754934|FG000|Overall Study|Lost to Follow-up|1|||
46619046|NCT04365257|82754940|FG000|Overall Study|Physician Decision|1|||
46619047|NCT04365257|82754941|FG001|Overall Study|Physician Decision|0|||
46619048|NCT04365257|82754940|FG000|Overall Study|Patient Noncompliance|1|||
46619049|NCT04365257|82754941|FG001|Overall Study|Patient Noncompliance|0|||
46619050|NCT04365257|82754940|FG000|Overall Study|Withdrawal by Subject|0|||
46619051|NCT04365257|82754941|FG001|Overall Study|Withdrawal by Subject|1|||
46619052|NCT03395223|82754973|FG000|Overall Study|Lost to Follow-up|3|||
46619053|NCT03395223|82754973|FG000|Overall Study|Other|1|||
46775676|NCT00694707|82994137|FG001|Overall Study|Arrest by Police|1|||
46996316|NCT01852162|83243379|FG000|Overall Study|Adverse Event|1|||
46619054|NCT02864940|82755003|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
46619055|NCT02864940|82755004|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
46619056|NCT02756611|82755023|FG000|Overall Study|Death|70|||
46619057|NCT02756611|82755023|FG000|Overall Study|Withdrawal by Subject|2|||
46619058|NCT02756611|82755023|FG000|Overall Study|Lost to Follow-up|3|||
46619059|NCT02756611|82755023|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
46619060|NCT02756611|82755023|FG000|Overall Study|Other|10|||
46619061|NCT02624518|82755027|FG000|Overall Study|Physician Decision|1|||
46619062|NCT02287623|82755033|FG000|Overall Study|Protocol Violation|0|||
46619063|NCT02287623|82755034|FG001|Overall Study|Protocol Violation|1|||
46996317|NCT01852162|83243380|FG001|Overall Study|Adverse Event|0|||
46996318|NCT01852162|83243379|FG000|Overall Study|Withdrawal by Subject|3|||
46996319|NCT01852162|83243380|FG001|Overall Study|Withdrawal by Subject|1|||
46996320|NCT01835470|83243386|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
46996321|NCT01835470|83243386|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
46996322|NCT02451137|83243393|FG000|Overall Study|Randomized but not treated|19|||
46996323|NCT02451137|83243394|FG001|Overall Study|Randomized but not treated|27|||
46996324|NCT02451137|83243393|FG000|Overall Study|Adverse Event|43|||
46996325|NCT02451137|83243394|FG001|Overall Study|Adverse Event|42|||
46996326|NCT02451137|83243393|FG000|Overall Study|Lack of Efficacy|4|||
46996327|NCT02451137|83243394|FG001|Overall Study|Lack of Efficacy|9|||
46996328|NCT02451137|83243393|FG000|Overall Study|Participant decision:discontinue insulin|41|||
46996329|NCT02451137|83243394|FG001|Overall Study|Participant decision:discontinue insulin|43|||
46996330|NCT02451137|83243393|FG000|Overall Study|Hypoglycemia|2|||
46996331|NCT02451137|83243394|FG001|Overall Study|Hypoglycemia|1|||
46996332|NCT02451137|83243393|FG000|Overall Study|Investigator's decision|23|||
46996333|NCT02451137|83243394|FG001|Overall Study|Investigator's decision|19|||
46996334|NCT02451137|83243393|FG000|Overall Study|Lost to Follow-up|53|||
46996335|NCT02451137|83243394|FG001|Overall Study|Lost to Follow-up|61|||
46996336|NCT02451137|83243393|FG000|Overall Study|Physician Decision|6|||
46996337|NCT02451137|83243394|FG001|Overall Study|Physician Decision|5|||
46996338|NCT02451137|83243393|FG000|Overall Study|Sponsor decision|13|||
46996339|NCT02451137|83243394|FG001|Overall Study|Sponsor decision|25|||
46996340|NCT02451137|83243393|FG000|Overall Study|Withdrawal by Subject|40|||
46996341|NCT02451137|83243394|FG001|Overall Study|Withdrawal by Subject|63|||
46996342|NCT02451137|83243393|FG000|Overall Study|Other than specified above|2|||
46996343|NCT02451137|83243394|FG001|Overall Study|Other than specified above|3|||
46996344|NCT02372006|83243403|FG000|Overall Study|Progressive disease|8|||
46996345|NCT02372006|83243404|FG001|Overall Study|Progressive disease|7|||
46996346|NCT02372006|83243405|FG002|Overall Study|Progressive disease|34|||
46996347|NCT02372006|83243403|FG000|Overall Study|Dose limiting toxicity|0|||
46996348|NCT02372006|83243404|FG001|Overall Study|Dose limiting toxicity|1|||
46996349|NCT02372006|83243405|FG002|Overall Study|Dose limiting toxicity|0|||
46996350|NCT02372006|83243403|FG000|Overall Study|Adverse Event|0|||
46996351|NCT02372006|83243404|FG001|Overall Study|Adverse Event|0|||
46619064|NCT01794520|82755056|FG000|Overall Study|Adverse events- related to progression|0|||
46619065|NCT01794520|82755057|FG001|Overall Study|Adverse events- related to progression|0|||
46619066|NCT01794520|82755058|FG002|Overall Study|Adverse events- related to progression|1|||
46619067|NCT01794520|82755059|FG003|Overall Study|Adverse events- related to progression|2|||
46619068|NCT01794520|82755060|FG004|Overall Study|Adverse events- related to progression|0|||
46619069|NCT01794520|82755061|FG005|Overall Study|Adverse events- related to progression|1|||
46619070|NCT01794520|82755062|FG006|Overall Study|Adverse events- related to progression|0|||
46619071|NCT01794520|82755056|FG000|Overall Study|Adverse event- not related to progression|1|||
46619072|NCT01794520|82755057|FG001|Overall Study|Adverse event- not related to progression|1|||
46619073|NCT01794520|82755058|FG002|Overall Study|Adverse event- not related to progression|0|||
46619074|NCT01794520|82755059|FG003|Overall Study|Adverse event- not related to progression|0|||
46619075|NCT01794520|82755060|FG004|Overall Study|Adverse event- not related to progression|2|||
46619076|NCT01794520|82755061|FG005|Overall Study|Adverse event- not related to progression|0|||
46619077|NCT01794520|82755062|FG006|Overall Study|Adverse event- not related to progression|0|||
46619078|NCT01794520|82755056|FG000|Overall Study|Progressive disease|5|||
46619079|NCT01794520|82755057|FG001|Overall Study|Progressive disease|6|||
46619080|NCT01794520|82755058|FG002|Overall Study|Progressive disease|2|||
46619081|NCT01794520|82755059|FG003|Overall Study|Progressive disease|5|||
46619082|NCT01794520|82755060|FG004|Overall Study|Progressive disease|27|||
46619083|NCT01794520|82755061|FG005|Overall Study|Progressive disease|18|||
46996352|NCT02372006|83243405|FG002|Overall Study|Adverse Event|3|||
46996353|NCT02372006|83243403|FG000|Overall Study|Withdrawal by Subject|0|||
46996354|NCT02372006|83243404|FG001|Overall Study|Withdrawal by Subject|1|||
46619084|NCT01794520|82755062|FG006|Overall Study|Progressive disease|0|||
46619085|NCT01794520|82755056|FG000|Overall Study|Withdrew consent|0|||
46996355|NCT02372006|83243405|FG002|Overall Study|Withdrawal by Subject|1|||
46996356|NCT02372006|83243403|FG000|Overall Study|Other reason for not completing|0|||
46996357|NCT02372006|83243404|FG001|Overall Study|Other reason for not completing|0|||
46619086|NCT01794520|82755057|FG001|Overall Study|Withdrew consent|0|||
46619087|NCT01794520|82755058|FG002|Overall Study|Withdrew consent|1|||
46619088|NCT01794520|82755059|FG003|Overall Study|Withdrew consent|1|||
46619089|NCT01794520|82755060|FG004|Overall Study|Withdrew consent|0|||
46619090|NCT01794520|82755061|FG005|Overall Study|Withdrew consent|0|||
46619091|NCT01794520|82755062|FG006|Overall Study|Withdrew consent|0|||
46619092|NCT01794520|82755056|FG000|Overall Study|Lost to Follow-up|0|||
46619093|NCT01794520|82755057|FG001|Overall Study|Lost to Follow-up|0|||
46619094|NCT01794520|82755058|FG002|Overall Study|Lost to Follow-up|0|||
46619095|NCT01794520|82755059|FG003|Overall Study|Lost to Follow-up|0|||
46619096|NCT01794520|82755060|FG004|Overall Study|Lost to Follow-up|1|||
46619097|NCT01794520|82755061|FG005|Overall Study|Lost to Follow-up|0|||
46619098|NCT01794520|82755062|FG006|Overall Study|Lost to Follow-up|0|||
46619099|NCT01794520|82755056|FG000|Overall Study|Toxicity|0|||
46619100|NCT01794520|82755057|FG001|Overall Study|Toxicity|2|||
46619101|NCT01794520|82755058|FG002|Overall Study|Toxicity|0|||
46619102|NCT01794520|82755059|FG003|Overall Study|Toxicity|0|||
46619103|NCT01794520|82755060|FG004|Overall Study|Toxicity|0|||
46619104|NCT01794520|82755061|FG005|Overall Study|Toxicity|0|||
46619105|NCT01794520|82755062|FG006|Overall Study|Toxicity|0|||
46619106|NCT01794520|82755056|FG000|Overall Study|Study terminated by sponsor|0|||
46619107|NCT01794520|82755057|FG001|Overall Study|Study terminated by sponsor|0|||
46619108|NCT01794520|82755058|FG002|Overall Study|Study terminated by sponsor|1|||
46619109|NCT01794520|82755059|FG003|Overall Study|Study terminated by sponsor|0|||
46619110|NCT01794520|82755060|FG004|Overall Study|Study terminated by sponsor|1|||
46996358|NCT02372006|83243405|FG002|Overall Study|Other reason for not completing|1|||
46996359|NCT02406248|83243414|FG000|Overall Study|Death|7|||
46996360|NCT02406248|83243414|FG000|Overall Study|Withdrawal by Subject|2|||
46996361|NCT02450903|83243418|FG000|Overall Study|Adverse Event|3|||
46996362|NCT02450903|83243418|FG000|Overall Study|Progressive disease|15|||
46996363|NCT02450903|83243418|FG000|Overall Study|Switched to commercial drug|1|||
46996364|NCT02450903|83243418|FG000|Overall Study|Subject/guardian decision|1|||
46996365|NCT02371616|83243424|FG000|Overall Study|Protocol Violation|2|||
46996366|NCT02371616|83243425|FG001|Overall Study|Protocol Violation|1|||
46996367|NCT02371616|83243424|FG000|Overall Study|Adverse Event|0|||
46996368|NCT02371616|83243425|FG001|Overall Study|Adverse Event|1|||
46996369|NCT02371616|83243424|FG000|Overall Study|Withdrawal of Consent|1|||
46996370|NCT02371616|83243425|FG001|Overall Study|Withdrawal of Consent|0|||
46996371|NCT02371616|83243424|FG000|Overall Study|Other (Not specified)|1|||
46996372|NCT02371616|83243425|FG001|Overall Study|Other (Not specified)|5|||
46996373|NCT02370914|83243431|FG000|Overall Study|Protocol Violation|2|||
46996374|NCT02370602|83243441|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
46996375|NCT02370602|83243442|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
46996376|NCT02370602|83243443|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
46996377|NCT02370602|83243444|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
46996378|NCT02370602|83243445|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
46996379|NCT02370602|83243446|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
46996380|NCT02370368|83243465|FG000|Overall Study|Adverse Event|1|||
46996381|NCT02370368|83243466|FG001|Overall Study|Adverse Event|2|||
46996382|NCT02370368|83243465|FG000|Overall Study|Withdrawal by Subject|5|||
46996383|NCT02370368|83243466|FG001|Overall Study|Withdrawal by Subject|4|||
46619111|NCT01794520|82755061|FG005|Overall Study|Study terminated by sponsor|0|||
46619112|NCT01794520|82755062|FG006|Overall Study|Study terminated by sponsor|7|||
46619113|NCT01794520|82755056|FG000|Overall Study|Death|0|||
46619114|NCT01794520|82755057|FG001|Overall Study|Death|0|||
46619115|NCT01794520|82755058|FG002|Overall Study|Death|0|||
46619116|NCT01794520|82755059|FG003|Overall Study|Death|0|||
46619117|NCT01794520|82755060|FG004|Overall Study|Death|1|||
46619118|NCT01794520|82755061|FG005|Overall Study|Death|0|||
46619119|NCT01794520|82755062|FG006|Overall Study|Death|22|||
46619120|NCT01794520|82755056|FG000|Overall Study|Other, not specified|0|||
46619121|NCT01794520|82755057|FG001|Overall Study|Other, not specified|0|||
46619122|NCT01794520|82755058|FG002|Overall Study|Other, not specified|1|||
46619123|NCT01794520|82755059|FG003|Overall Study|Other, not specified|1|||
46619124|NCT01794520|82755060|FG004|Overall Study|Other, not specified|4|||
46619125|NCT01794520|82755061|FG005|Overall Study|Other, not specified|1|||
46619126|NCT01794520|82755062|FG006|Overall Study|Other, not specified|2|||
46619127|NCT01774019|82755085|FG000|Overall Study|No longer meets protocol criteria|2|||
46619128|NCT01774019|82755086|FG001|Overall Study|No longer meets protocol criteria|0|||
46996384|NCT02340806|83243474|FG000|Overall Study|Protocol Violation|2|||
46619129|NCT01774019|82755085|FG000|Overall Study|Withdrawal by Subject|1|||
46619130|NCT01774019|82755086|FG001|Overall Study|Withdrawal by Subject|0|||
46619131|NCT01774019|82755085|FG000|Overall Study|Surgery delayed > 120 days|1|||
46619132|NCT01774019|82755086|FG001|Overall Study|Surgery delayed > 120 days|0|||
46619133|NCT01774019|82755085|FG000|Overall Study|Patient refused surgery|1|||
46996385|NCT02340806|83243475|FG001|Overall Study|Protocol Violation|0|||
46996386|NCT02340806|83243474|FG000|Overall Study|epidural catheter replaced|2|||
46619134|NCT01774019|82755086|FG001|Overall Study|Patient refused surgery|1|||
46619135|NCT01774019|82755085|FG000|Overall Study|Unable to implant study device|1|||
46619136|NCT01774019|82755086|FG001|Overall Study|Unable to implant study device|0|||
46619137|NCT01774019|82755085|FG000|Overall Study|Lost to Follow-up|0|||
46619138|NCT01774019|82755086|FG001|Overall Study|Lost to Follow-up|3|||
46619139|NCT03251924|82755448|FG000|Overall Study|Disease Progression|6|||
46619140|NCT03251924|82755449|FG001|Overall Study|Disease Progression|6|||
46619141|NCT03251924|82755450|FG002|Overall Study|Disease Progression|7|||
46619142|NCT03251924|82755451|FG003|Overall Study|Disease Progression|8|||
46619143|NCT03251924|82755452|FG004|Overall Study|Disease Progression|8|||
46619144|NCT03251924|82755453|FG005|Overall Study|Disease Progression|7|||
46619145|NCT03251924|82755454|FG006|Overall Study|Disease Progression|6|||
46619146|NCT03251924|82755455|FG007|Overall Study|Disease Progression|10|||
46619147|NCT03251924|82755456|FG008|Overall Study|Disease Progression|6|||
46619148|NCT03251924|82755448|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
46619149|NCT03251924|82755449|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
46619150|NCT03251924|82755450|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
46619151|NCT03251924|82755451|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
46619152|NCT03251924|82755452|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
46619153|NCT03251924|82755453|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
46619154|NCT03251924|82755454|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
46619155|NCT03251924|82755455|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
46619156|NCT03251924|82755456|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
46619157|NCT03251924|82755448|FG000|Overall Study|Death|0|||
46619158|NCT03251924|82755449|FG001|Overall Study|Death|1|||
46619159|NCT03251924|82755450|FG002|Overall Study|Death|0|||
46619160|NCT03251924|82755451|FG003|Overall Study|Death|1|||
46619161|NCT03251924|82755452|FG004|Overall Study|Death|1|||
46619162|NCT03251924|82755453|FG005|Overall Study|Death|1|||
46619163|NCT03251924|82755454|FG006|Overall Study|Death|0|||
46619164|NCT03251924|82755455|FG007|Overall Study|Death|0|||
46619165|NCT03251924|82755456|FG008|Overall Study|Death|0|||
46619166|NCT03251924|82755448|FG000|Overall Study|Study Drug Toxicity|0|||
46619167|NCT03251924|82755449|FG001|Overall Study|Study Drug Toxicity|0|||
46619168|NCT03251924|82755450|FG002|Overall Study|Study Drug Toxicity|0|||
46619169|NCT03251924|82755451|FG003|Overall Study|Study Drug Toxicity|1|||
46619170|NCT03251924|82755452|FG004|Overall Study|Study Drug Toxicity|0|||
46619171|NCT03251924|82755453|FG005|Overall Study|Study Drug Toxicity|0|||
46619172|NCT03251924|82755454|FG006|Overall Study|Study Drug Toxicity|0|||
46619173|NCT03251924|82755455|FG007|Overall Study|Study Drug Toxicity|0|||
46619174|NCT03251924|82755456|FG008|Overall Study|Study Drug Toxicity|1|||
46619175|NCT03251924|82755448|FG000|Overall Study|Other Reasons|0|||
46619176|NCT03251924|82755449|FG001|Overall Study|Other Reasons|0|||
46619177|NCT03251924|82755450|FG002|Overall Study|Other Reasons|0|||
46619178|NCT03251924|82755451|FG003|Overall Study|Other Reasons|0|||
46619179|NCT03251924|82755452|FG004|Overall Study|Other Reasons|0|||
46619180|NCT03251924|82755453|FG005|Overall Study|Other Reasons|0|||
46619181|NCT03251924|82755454|FG006|Overall Study|Other Reasons|0|||
46619182|NCT03251924|82755455|FG007|Overall Study|Other Reasons|0|||
46619183|NCT03251924|82755456|FG008|Overall Study|Other Reasons|1|||
46619184|NCT03251924|82755448|FG000|Overall Study|Participant request to discontinue study treatment|0|||
46619185|NCT03251924|82755449|FG001|Overall Study|Participant request to discontinue study treatment|0|||
46619186|NCT03251924|82755450|FG002|Overall Study|Participant request to discontinue study treatment|0|||
46619187|NCT03251924|82755451|FG003|Overall Study|Participant request to discontinue study treatment|0|||
46619188|NCT03251924|82755452|FG004|Overall Study|Participant request to discontinue study treatment|0|||
46619189|NCT03251924|82755453|FG005|Overall Study|Participant request to discontinue study treatment|0|||
46619190|NCT03251924|82755454|FG006|Overall Study|Participant request to discontinue study treatment|0|||
46619191|NCT03251924|82755455|FG007|Overall Study|Participant request to discontinue study treatment|1|||
46619192|NCT03251924|82755456|FG008|Overall Study|Participant request to discontinue study treatment|0|||
46619193|NCT03723707|82755544|FG000|Overall Study|Death|32|||
46619194|NCT03723707|82755545|FG001|Overall Study|Death|32|||
46619195|NCT03723707|82755544|FG000|Overall Study|Admitted to long term care|12|||
46619196|NCT03723707|82755545|FG001|Overall Study|Admitted to long term care|12|||
46619197|NCT03723707|82755544|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
46619198|NCT03723707|82755545|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
46619199|NCT03723707|82755544|FG000|Overall Study|Lost to Follow-up|40|||
46619200|NCT03723707|82755545|FG001|Overall Study|Lost to Follow-up|22|||
46619201|NCT03723707|82755544|FG000|Overall Study|Discontinued after study closure|24|||
46619202|NCT03723707|82755545|FG001|Overall Study|Discontinued after study closure|12|||
46619203|NCT01350141|82755655|FG000|Overall Study|Lost to Follow-up|1|||
46619204|NCT01350141|82755656|FG001|Overall Study|Lost to Follow-up|0|||
46619205|NCT01350141|82755657|FG002|Overall Study|Lost to Follow-up|1|||
46619206|NCT01350141|82755655|FG000|Overall Study|Withdrawal by Subject|1|||
46619207|NCT01350141|82755656|FG001|Overall Study|Withdrawal by Subject|0|||
46619208|NCT01350141|82755657|FG002|Overall Study|Withdrawal by Subject|0|||
46619209|NCT01350141|82755655|FG000|Overall Study|Randomized but not treated|1|||
46619210|NCT01350141|82755656|FG001|Overall Study|Randomized but not treated|0|||
46619211|NCT01350141|82755657|FG002|Overall Study|Randomized but not treated|0|||
46619212|NCT05045625|82756196|FG000|Overall Study|Lost to Follow-up|3|||
46619213|NCT04830969|82756578|FG000|Overall Study|Withdrawal by Subject|6|||
46619214|NCT04830969|82756579|FG001|Overall Study|Withdrawal by Subject|2|||
46619215|NCT04830969|82756578|FG000|Overall Study|Protocol Violation|3|||
46619216|NCT04830969|82756579|FG001|Overall Study|Protocol Violation|9|||
46619217|NCT04830969|82756578|FG000|Overall Study|Lost to Follow-up|4|||
46619218|NCT04830969|82756579|FG001|Overall Study|Lost to Follow-up|4|||
46619219|NCT02384993|82756890|FG000|Overall Study|Adverse Event|0|||
46619220|NCT02384993|82756891|FG001|Overall Study|Adverse Event|1|||
46619221|NCT01352117|82756935|FG000|Overall Study|Death|15|||
46619222|NCT01352117|82756936|FG001|Overall Study|Death|16|||
46619223|NCT01352117|82756935|FG000|Overall Study|Withdrawal by Subject|1|||
46619224|NCT01352117|82756936|FG001|Overall Study|Withdrawal by Subject|0|||
46619225|NCT01352117|82756935|FG000|Overall Study|Lost to Follow-up|2|||
46619226|NCT01352117|82756936|FG001|Overall Study|Lost to Follow-up|7|||
46619227|NCT01352117|82756935|FG000|Overall Study|Non-adherent to study requirements|1|||
46619228|NCT01352117|82756936|FG001|Overall Study|Non-adherent to study requirements|1|||
46619229|NCT01352117|82756935|FG000|Overall Study|Did not initiate study treatment|1|||
46619230|NCT01352117|82756936|FG001|Overall Study|Did not initiate study treatment|0|||
46619231|NCT01352117|82756935|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
46619232|NCT01352117|82756936|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
46619233|NCT03578237|82757007|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
46619234|NCT03578237|82757008|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
46619235|NCT02220725|82757091|FG000|Overall Study|Lost to Follow-up|0|||
46619236|NCT02220725|82757092|FG001|Overall Study|Lost to Follow-up|0|||
46619237|NCT02220725|82757093|FG002|Overall Study|Lost to Follow-up|0|||
46619238|NCT02220725|82757094|FG003|Overall Study|Lost to Follow-up|1|||
46619239|NCT02220725|82757091|FG000|Overall Study|Withdrawal by Subject|0|||
46619240|NCT02220725|82757092|FG001|Overall Study|Withdrawal by Subject|0|||
46619241|NCT02220725|82757093|FG002|Overall Study|Withdrawal by Subject|0|||
46619242|NCT02220725|82757094|FG003|Overall Study|Withdrawal by Subject|1|||
46619243|NCT02259517|82757136|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
46619244|NCT02259517|82757137|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
46619245|NCT02259517|82757138|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
46619246|NCT02259517|82757136|FG000|Overall Study|Withdrawal by Subject|0|||
46619247|NCT02259517|82757137|FG001|Overall Study|Withdrawal by Subject|0|||
46619248|NCT02259517|82757138|FG002|Overall Study|Withdrawal by Subject|3|||
46619249|NCT02277990|82757181|FG000|Overall Study|Death|170|||
46619250|NCT02277990|82757182|FG001|Overall Study|Death|188|||
46619251|NCT02277990|82757181|FG000|Overall Study|Withdrawal by Subject|64|||
46619252|NCT02277990|82757182|FG001|Overall Study|Withdrawal by Subject|53|||
46619253|NCT02277990|82757181|FG000|Overall Study|Physician Decision|40|||
46619254|NCT02277990|82757182|FG001|Overall Study|Physician Decision|34|||
46619255|NCT02277990|82757181|FG000|Overall Study|Lost to Follow-up|66|||
46619256|NCT02277990|82757182|FG001|Overall Study|Lost to Follow-up|69|||
46619257|NCT02277990|82757181|FG000|Overall Study|Had other reason|26|||
46619258|NCT02277990|82757182|FG001|Overall Study|Had other reason|32|||
46619259|NCT02317614|82757204|FG000|Overall Study|Lost to Follow-up|1|||
46619260|NCT02317614|82757205|FG001|Overall Study|Lost to Follow-up|1|||
46619261|NCT02317614|82757204|FG000|Overall Study|Withdrawal by Subject|1|||
46619262|NCT02317614|82757205|FG001|Overall Study|Withdrawal by Subject|0|||
46619263|NCT02317614|82757204|FG000|Overall Study|Death|1|||
46619264|NCT02317614|82757205|FG001|Overall Study|Death|1|||
46619265|NCT02276040|82757218|FG000|Overall Study|Physician Decision|15|||
46619266|NCT02315664|82757224|FG000|Overall Study|Lost to Follow-up|1|||
46619267|NCT02315664|82757225|FG001|Overall Study|Lost to Follow-up|1|||
46619268|NCT02315664|82757224|FG000|Overall Study|Withdrawal by Subject|0|||
46619269|NCT02315664|82757225|FG001|Overall Study|Withdrawal by Subject|3|||
46619270|NCT02314728|82757253|FG000|Overall Study|Protocol Violation|1|||
46619271|NCT02314728|82757254|FG001|Overall Study|Protocol Violation|0|||
46619272|NCT02314728|82757253|FG000|Overall Study|Lost to Follow-up|0|||
46619273|NCT02314728|82757254|FG001|Overall Study|Lost to Follow-up|1|||
46619274|NCT02275338|82757273|FG000|Overall Study|Adverse Event|15|||
46619275|NCT02275338|82757273|FG000|Overall Study|Lack of Efficacy|3|||
46619276|NCT02275338|82757273|FG000|Overall Study|Withdrawal by Subject|4|||
46619277|NCT02275338|82757273|FG000|Overall Study|Disease progression (death)|1|||
46619278|NCT02275338|82757273|FG000|Overall Study|Ineligible to start Phase 2|4|||
46619279|NCT02275338|82757273|FG000|Overall Study|Reason not specified|5|||
46619280|NCT02275338|82757273|FG000|Overall Study|Does not meet entry criteria|1|||
46619281|NCT02313558|82757280|FG000|Overall Study|Withdrawal by Subject|2|||
46619282|NCT02313558|82757281|FG001|Overall Study|Withdrawal by Subject|0|||
46619283|NCT02313558|82757280|FG000|Overall Study|Lost to Follow-up|4|||
46619284|NCT02313558|82757281|FG001|Overall Study|Lost to Follow-up|4|||
46619285|NCT01646268|82757309|FG000|Overall Study|Adverse Event|6|||
46619286|NCT01646268|82757310|FG001|Overall Study|Adverse Event|7|||
46619287|NCT01646268|82757309|FG000|Overall Study|Lack of Efficacy|1|||
46619288|NCT01646268|82757310|FG001|Overall Study|Lack of Efficacy|3|||
46619289|NCT01646268|82757309|FG000|Overall Study|Protocol Violation|0|||
46619290|NCT01646268|82757310|FG001|Overall Study|Protocol Violation|1|||
46619291|NCT01646268|82757309|FG000|Overall Study|Withdrawal by Subject|2|||
46619292|NCT01646268|82757310|FG001|Overall Study|Withdrawal by Subject|5|||
46619293|NCT01646268|82757309|FG000|Overall Study|Other|2|||
46619294|NCT01646268|82757310|FG001|Overall Study|Other|0|||
46619295|NCT02275026|82757316|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
46619296|NCT02275026|82757316|FG000|Overall Study|Withdrawal by Subject|4|||
46619297|NCT02275026|82757316|FG000|Overall Study|Ineligible due to medical history|13|||
46619298|NCT02275026|82757316|FG000|Overall Study|MRI malfunction precluded testing|1|||
46619299|NCT02275026|82757316|FG000|Overall Study|Ineligible after MRI findings|1|||
46619300|NCT02275026|82757316|FG000|Overall Study|Lost to Follow-up|2|||
46619301|NCT02275026|82757316|FG000|Overall Study|Scanner failure|1|||
46619302|NCT04579250|82757419|FG000|Overall Study|Withdrawal by Subject|1|||
46619303|NCT04579250|82757420|FG001|Overall Study|Withdrawal by Subject|1|||
46619304|NCT04579250|82757421|FG002|Overall Study|Withdrawal by Subject|0|||
46619305|NCT04579250|82757419|FG000|Overall Study|Lost to Follow-up|1|||
46619306|NCT04579250|82757420|FG001|Overall Study|Lost to Follow-up|1|||
46619307|NCT04579250|82757421|FG002|Overall Study|Lost to Follow-up|0|||
46619308|NCT04579250|82757419|FG000|Overall Study|Moved from area|0|||
46619309|NCT04579250|82757420|FG001|Overall Study|Moved from area|1|||
46619310|NCT04579250|82757421|FG002|Overall Study|Moved from area|2|||
46619311|NCT03175367|82757448|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
46619312|NCT03175367|82757449|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
46619313|NCT03175367|82757450|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
46619314|NCT03175367|82757451|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
46619315|NCT03175367|82757452|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
46619316|NCT03175367|82757453|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
46619317|NCT03175367|82757454|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
46619318|NCT03175367|82757448|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
46619319|NCT03175367|82757449|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
46619320|NCT03175367|82757450|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
46619321|NCT03175367|82757451|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
46619322|NCT03175367|82757452|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
46619323|NCT03175367|82757453|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
46619324|NCT03175367|82757454|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
46619325|NCT03175367|82757448|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
46619326|NCT03175367|82757449|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
46619327|NCT03175367|82757450|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
46619328|NCT03175367|82757451|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
46619329|NCT03175367|82757452|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46619330|NCT03175367|82757453|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
46619331|NCT03175367|82757454|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46619332|NCT03175367|82757448|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
46619333|NCT03175367|82757449|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
46619334|NCT03175367|82757450|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
46619335|NCT03175367|82757451|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
46619336|NCT03175367|82757452|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
46619337|NCT03175367|82757453|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
46619338|NCT03175367|82757454|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
46619339|NCT03175367|82757448|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46619340|NCT03175367|82757449|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46619341|NCT03175367|82757450|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
46619342|NCT03175367|82757451|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46619343|NCT03175367|82757452|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
46619344|NCT03175367|82757453|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46619345|NCT03175367|82757454|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46619346|NCT03175367|82757448|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
46619347|NCT03175367|82757449|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
46619348|NCT03175367|82757450|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
46619349|NCT03175367|82757451|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
46619350|NCT03175367|82757452|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
46619351|NCT03175367|82757453|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
46619352|NCT03175367|82757454|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
46619353|NCT03175367|82757448|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46619354|NCT03175367|82757449|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46619355|NCT03175367|82757450|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46619356|NCT03175367|82757451|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46708833|NCT04071366|82924735|FG000|Part 1: Open-label (29 Days)|Death|4|||
46708834|NCT04071366|82924736|FG001|Part 1: Open-label (29 Days)|Death|2|||
46708835|NCT04071366|82924737|FG002|Part 1: Open-label (29 Days)|Death|8|||
46708836|NCT04071366|82924738|FG003|Part 1: Open-label (29 Days)|Death|0|||
46708837|NCT04071366|82924739|FG004|Part 1: Open-label (29 Days)|Death|0|||
46708838|NCT04071366|82924735|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
46708839|NCT04071366|82924736|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
46619357|NCT03175367|82757452|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46619358|NCT03175367|82757453|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
46619359|NCT03175367|82757454|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
46619360|NCT03990363|82757583|FG000|Overall Study|Withdrawal by Subject|10|||
46619361|NCT03990363|82757584|FG001|Overall Study|Withdrawal by Subject|9|||
46619362|NCT03990363|82757585|FG002|Overall Study|Withdrawal by Subject|18|||
46619363|NCT03990363|82757586|FG003|Overall Study|Withdrawal by Subject|11|||
46619364|NCT03990363|82757587|FG004|Overall Study|Withdrawal by Subject|9|||
46619365|NCT03990363|82757583|FG000|Overall Study|Physician Decision|1|||
46619366|NCT03990363|82757584|FG001|Overall Study|Physician Decision|0|||
46619367|NCT03990363|82757585|FG002|Overall Study|Physician Decision|0|||
46619368|NCT03990363|82757586|FG003|Overall Study|Physician Decision|0|||
46619369|NCT03990363|82757587|FG004|Overall Study|Physician Decision|0|||
46619370|NCT03990363|82757583|FG000|Overall Study|Adverse Event|1|||
46619371|NCT03990363|82757584|FG001|Overall Study|Adverse Event|3|||
46619372|NCT03990363|82757585|FG002|Overall Study|Adverse Event|2|||
46619373|NCT03990363|82757586|FG003|Overall Study|Adverse Event|2|||
46619374|NCT03990363|82757587|FG004|Overall Study|Adverse Event|0|||
46619375|NCT03990363|82757583|FG000|Overall Study|Death|14|||
46619376|NCT03990363|82757584|FG001|Overall Study|Death|8|||
46619377|NCT03990363|82757585|FG002|Overall Study|Death|14|||
46619378|NCT03990363|82757586|FG003|Overall Study|Death|10|||
46619379|NCT03990363|82757587|FG004|Overall Study|Death|11|||
46619380|NCT03990363|82757583|FG000|Overall Study|Failure to meet randomization criteria|0|||
46619381|NCT03990363|82757584|FG001|Overall Study|Failure to meet randomization criteria|1|||
46619382|NCT03990363|82757585|FG002|Overall Study|Failure to meet randomization criteria|1|||
46619383|NCT03990363|82757586|FG003|Overall Study|Failure to meet randomization criteria|0|||
46619384|NCT03990363|82757587|FG004|Overall Study|Failure to meet randomization criteria|0|||
46619385|NCT03990363|82757583|FG000|Overall Study|Lost to Follow-up|0|||
46619386|NCT03990363|82757584|FG001|Overall Study|Lost to Follow-up|0|||
46619387|NCT03990363|82757585|FG002|Overall Study|Lost to Follow-up|0|||
46619388|NCT03990363|82757586|FG003|Overall Study|Lost to Follow-up|1|||
46619389|NCT03990363|82757587|FG004|Overall Study|Lost to Follow-up|2|||
46619390|NCT03990363|82757583|FG000|Overall Study|Non-compliance with study drug|2|||
46619391|NCT03990363|82757584|FG001|Overall Study|Non-compliance with study drug|1|||
46619392|NCT03990363|82757585|FG002|Overall Study|Non-compliance with study drug|2|||
46619393|NCT03990363|82757586|FG003|Overall Study|Non-compliance with study drug|0|||
46619394|NCT03990363|82757587|FG004|Overall Study|Non-compliance with study drug|0|||
46619395|NCT03990363|82757583|FG000|Overall Study|Study terminated by sponsor|0|||
46619396|NCT03990363|82757584|FG001|Overall Study|Study terminated by sponsor|1|||
46619397|NCT03990363|82757585|FG002|Overall Study|Study terminated by sponsor|0|||
46619398|NCT03990363|82757586|FG003|Overall Study|Study terminated by sponsor|0|||
46619399|NCT03990363|82757587|FG004|Overall Study|Study terminated by sponsor|0|||
46619400|NCT03990363|82757583|FG000|Overall Study|Site terminated by sponsor|2|||
46619401|NCT03990363|82757584|FG001|Overall Study|Site terminated by sponsor|1|||
46619402|NCT03990363|82757585|FG002|Overall Study|Site terminated by sponsor|2|||
46619403|NCT03990363|82757586|FG003|Overall Study|Site terminated by sponsor|0|||
46619404|NCT03990363|82757587|FG004|Overall Study|Site terminated by sponsor|2|||
46619405|NCT03990363|82757583|FG000|Overall Study|Not categorized|5|||
46619406|NCT03990363|82757584|FG001|Overall Study|Not categorized|5|||
46619407|NCT03990363|82757585|FG002|Overall Study|Not categorized|3|||
46619408|NCT03990363|82757586|FG003|Overall Study|Not categorized|2|||
46619409|NCT03990363|82757587|FG004|Overall Study|Not categorized|2|||
46619410|NCT02240485|82757744|FG000|3 Months Post-admission|Lost to Follow-up|1|||
46619411|NCT02240485|82757745|FG001|3 Months Post-admission|Lost to Follow-up|5|||
46619412|NCT02240485|82757744|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
46619413|NCT02240485|82757745|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
46619414|NCT02240485|82757744|FG000|9 Months Post-admission|Lost to Follow-up|3|||
46619415|NCT02240485|82757745|FG001|9 Months Post-admission|Lost to Follow-up|1|||
46619416|NCT02240485|82757744|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
46619417|NCT02240485|82757745|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
46619418|NCT02240485|82757744|FG000|18 Months Post-admission|Lost to Follow-up|1|||
46619419|NCT02240485|82757745|FG001|18 Months Post-admission|Lost to Follow-up|1|||
46619420|NCT02240485|82757744|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
46619421|NCT02240485|82757745|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
46619422|NCT04149535|82757768|FG000|Overall Study|Death|11|||
46619423|NCT04149535|82757769|FG001|Overall Study|Death|7|||
46619424|NCT04149535|82757768|FG000|Overall Study|Physician Decision|10|||
46619425|NCT04149535|82757769|FG001|Overall Study|Physician Decision|4|||
46619426|NCT04149535|82757768|FG000|Overall Study|Withdrawal by Subject|6|||
46619427|NCT04149535|82757769|FG001|Overall Study|Withdrawal by Subject|7|||
46619428|NCT04149535|82757768|FG000|Overall Study|Not described|2|||
46619429|NCT04149535|82757769|FG001|Overall Study|Not described|0|||
46619430|NCT02210559|82757787|FG000|Overall Study|Progressive Disease|3|||
46619431|NCT02210559|82757788|FG001|Overall Study|Progressive Disease|2|||
46619432|NCT02210559|82757787|FG000|Overall Study|Adverse Event|2|||
46619433|NCT02210559|82757788|FG001|Overall Study|Adverse Event|2|||
46619434|NCT02210559|82757787|FG000|Overall Study|Physician Decision|1|||
46619435|NCT02210559|82757788|FG001|Overall Study|Physician Decision|0|||
46619436|NCT02210559|82757787|FG000|Overall Study|Withdrawal by Subject|0|||
46619437|NCT02210559|82757788|FG001|Overall Study|Withdrawal by Subject|1|||
46619438|NCT02210559|82757787|FG000|Overall Study|Other than specified|0|||
46619439|NCT02210559|82757788|FG001|Overall Study|Other than specified|1|||
46619440|NCT02073279|82757945|FG000|Double-blind Period|Adverse Event|1|||
46619441|NCT02073279|82757946|FG001|Double-blind Period|Adverse Event|1|||
46619442|NCT02073279|82757945|FG000|Double-blind Period|Switched to another treatment|1|||
46619443|NCT02073279|82757946|FG001|Double-blind Period|Switched to another treatment|2|||
46619444|NCT02073279|82757945|FG000|Double-blind Period|Protocol Violation|0|||
46619445|NCT02073279|82757946|FG001|Double-blind Period|Protocol Violation|1|||
46619446|NCT02073279|82757945|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
46619447|NCT02073279|82757946|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
46619448|NCT02073279|82757945|FG000|Double-blind Period|Withdrawal by Subject|2|||
46619449|NCT02073279|82757946|FG001|Double-blind Period|Withdrawal by Subject|2|||
46619450|NCT02073279|82757945|FG000|Open-label Extension Period|Adverse Event|1|||
46619451|NCT02073279|82757946|FG001|Open-label Extension Period|Adverse Event|0|||
46619452|NCT02073279|82757945|FG000|Open-label Extension Period|Lack of Efficacy|1|||
46619453|NCT02073279|82757946|FG001|Open-label Extension Period|Lack of Efficacy|0|||
46619454|NCT02073279|82757945|FG000|Open-label Extension Period|Lost to Follow-up|0|||
46619455|NCT02073279|82757946|FG001|Open-label Extension Period|Lost to Follow-up|4|||
46619456|NCT02073279|82757945|FG000|Open-label Extension Period|Switched to another treatment|1|||
46619457|NCT02073279|82757946|FG001|Open-label Extension Period|Switched to another treatment|4|||
46619458|NCT02073279|82757945|FG000|Open-label Extension Period|Protocol Violation|0|||
46619459|NCT02073279|82757946|FG001|Open-label Extension Period|Protocol Violation|1|||
46619460|NCT02073279|82757945|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
46619461|NCT02073279|82757946|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
46619462|NCT02073279|82757945|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
46619463|NCT02073279|82757946|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
46619464|NCT01673867|82758202|FG000|Randomization|Adverse event unrelated to study drug|1|||
46619465|NCT01673867|82758203|FG001|Randomization|Adverse event unrelated to study drug|0|||
46619466|NCT01673867|82758202|FG000|Randomization|Participant request to discontinue study treatment|0|||
46619467|NCT01673867|82758203|FG001|Randomization|Participant request to discontinue study treatment|4|||
46619468|NCT01673867|82758202|FG000|Randomization|Withdrawal by participant|0|||
46619469|NCT01673867|82758203|FG001|Randomization|Withdrawal by participant|12|||
46619470|NCT01673867|82758202|FG000|Randomization|Lost to Follow-up|0|||
46619471|NCT01673867|82758203|FG001|Randomization|Lost to Follow-up|1|||
46619472|NCT01673867|82758202|FG000|Randomization|Participant no longer meets study criteria|4|||
46619473|NCT01673867|82758203|FG001|Randomization|Participant no longer meets study criteria|5|||
46619474|NCT01673867|82758202|FG000|Treatment|Disease Progression|208|||
46619475|NCT01673867|82758203|FG001|Treatment|Disease Progression|178|||
46619476|NCT01673867|82758202|FG000|Treatment|Study Drug Toxicity|23|||
46619477|NCT01673867|82758203|FG001|Treatment|Study Drug Toxicity|43|||
46619478|NCT01673867|82758202|FG000|Treatment|Death|2|||
46619479|NCT01673867|82758203|FG001|Treatment|Death|3|||
46619480|NCT01673867|82758202|FG000|Treatment|Adverse event unrelated to study drug|23|||
46619481|NCT01673867|82758203|FG001|Treatment|Adverse event unrelated to study drug|10|||
46619482|NCT01673867|82758202|FG000|Treatment|Participant request to discontinue study treatment|7|||
46619483|NCT01673867|82758203|FG001|Treatment|Participant request to discontinue study treatment|17|||
46619484|NCT01673867|82758202|FG000|Treatment|Withdrawal by participant|5|||
46619485|NCT01673867|82758203|FG001|Treatment|Withdrawal by participant|5|||
46619486|NCT01673867|82758202|FG000|Treatment|Maximum clinical benefit|1|||
46619487|NCT01673867|82758203|FG001|Treatment|Maximum clinical benefit|10|||
46619488|NCT01673867|82758202|FG000|Treatment|Participant no longer meets study criteria|2|||
46619489|NCT01673867|82758203|FG001|Treatment|Participant no longer meets study criteria|0|||
46619490|NCT01673867|82758202|FG000|Treatment|Administrative reason by sponsor|3|||
46619491|NCT01673867|82758203|FG001|Treatment|Administrative reason by sponsor|0|||
46619492|NCT01673867|82758202|FG000|Treatment|Other reason|11|||
46898888|NCT02273388|83125336|FG000|Overall Study|Adverse Event study disease worse|4|||
46619493|NCT01673867|82758203|FG001|Treatment|Other reason|2|||
46619494|NCT02041533|82758299|FG000|Pre-Treatment Period|Disease Progression|1|||
46619495|NCT02041533|82758300|FG001|Pre-Treatment Period|Disease Progression|1|||
46619496|NCT02041533|82758299|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
46619497|NCT02041533|82758300|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
46619498|NCT02041533|82758299|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
46619499|NCT02041533|82758300|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
46619500|NCT02041533|82758299|FG000|Treatment Period|Disease progression|189|||
46619501|NCT02041533|82758300|FG001|Treatment Period|Disease progression|146|||
46619502|NCT02041533|82758299|FG000|Treatment Period|Study drug toxicity|30|||
46619503|NCT02041533|82758300|FG001|Treatment Period|Study drug toxicity|34|||
46619504|NCT02041533|82758299|FG000|Treatment Period|Death|1|||
46619505|NCT02041533|82758300|FG001|Treatment Period|Death|0|||
46619506|NCT02041533|82758299|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
46619507|NCT02041533|82758300|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
46619508|NCT02041533|82758299|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
46619509|NCT02041533|82758300|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
46619510|NCT02041533|82758299|FG000|Treatment Period|Participant withdrew consent|2|||
46619511|NCT02041533|82758300|FG001|Treatment Period|Participant withdrew consent|2|||
46619512|NCT02041533|82758299|FG000|Treatment Period|Maximum clinical benefit|0|||
46619513|NCT02041533|82758300|FG001|Treatment Period|Maximum clinical benefit|18|||
46619514|NCT02041533|82758299|FG000|Treatment Period|Poor/Non-compliance|1|||
46619515|NCT02041533|82758300|FG001|Treatment Period|Poor/Non-compliance|0|||
46619516|NCT02041533|82758299|FG000|Treatment Period|Administrative reason by sponsor|1|||
46619517|NCT02041533|82758300|FG001|Treatment Period|Administrative reason by sponsor|0|||
46619518|NCT02041533|82758299|FG000|Treatment Period|Other reasons|9|||
46619519|NCT02041533|82758300|FG001|Treatment Period|Other reasons|2|||
46619520|NCT02041533|82758299|FG000|Treatment Period|Not Reported|0|||
46619521|NCT02041533|82758300|FG001|Treatment Period|Not Reported|1|||
46619522|NCT02907203|82758307|FG000|Overall Study|Death|1|||
46619523|NCT02907203|82758307|FG000|Overall Study|Lost to Follow-up|3|||
46619524|NCT02907203|82758307|FG000|Overall Study|Withdrawal by Subject|3|||
46619525|NCT02907203|82758307|FG000|Overall Study|Surgical bypass|1|||
46619526|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
46619527|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
46619528|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
46619529|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
46619530|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
46619531|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
46619532|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
46619533|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
46619534|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Death|1|||
46619535|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Death|1|||
46619536|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
46619537|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
46619538|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
46619539|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
46619540|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
46619541|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
46619542|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
46619543|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
46619544|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
46619545|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
46619546|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
46619547|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
46619548|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
46619549|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
46619550|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
46619551|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
46619552|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
46619553|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
46619554|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
46619555|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
46619556|NCT00559585|82759403|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
46619557|NCT00559585|82759404|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
46619558|NCT00559585|82759403|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
46619559|NCT00559585|82759404|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
46619560|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
46619561|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
46619562|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
46619563|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
46619564|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
46619565|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
46619566|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
46619567|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
46619568|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
46619569|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
46619570|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
46619571|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
46619572|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
46619573|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
46619574|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
46619575|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
46619576|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
46619577|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
46619578|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
46619579|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
46619580|NCT00559585|82759403|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
46619581|NCT00559585|82759404|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
46619582|NCT00559507|82759444|FG000|Overall Study|Not treated, patient ineligible|3|||
46619583|NCT00559273|82759700|FG000|Correction Period (20 Weeks)|Death|3|||
46619584|NCT00559273|82759701|FG001|Correction Period (20 Weeks)|Death|4|||
46619585|NCT00559273|82759700|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
46619586|NCT00559273|82759701|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
46619587|NCT00559273|82759700|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
46619588|NCT00559273|82759701|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
46619589|NCT00559273|82759700|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
46619590|NCT00559273|82759701|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
46619591|NCT00559273|82759700|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
46619592|NCT00559273|82759701|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
46619593|NCT00559273|82759700|FG000|Evaluation Period (8 Weeks)|Death|1|||
46619594|NCT00559273|82759701|FG001|Evaluation Period (8 Weeks)|Death|3|||
46619595|NCT00559273|82759700|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
46619596|NCT00559273|82759701|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
46619597|NCT00559273|82759700|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
46619598|NCT00559273|82759701|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
46619599|NCT00559273|82759700|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
46619600|NCT00559273|82759701|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
46619601|NCT00558259|82759756|FG000|Overall Study|Adverse Event|50|||
46619602|NCT00558259|82759757|FG001|Overall Study|Adverse Event|81|||
46619603|NCT00558259|82759756|FG000|Overall Study|Protocol Violation|9|||
46619604|NCT00558259|82759757|FG001|Overall Study|Protocol Violation|5|||
46619605|NCT00558259|82759756|FG000|Overall Study|Withdrawal by Subject|12|||
46619606|NCT00558259|82759757|FG001|Overall Study|Withdrawal by Subject|13|||
46619607|NCT00558103|82759904|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
46619608|NCT00558103|82759905|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
46619609|NCT00558103|82759906|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
46619610|NCT00558103|82759907|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
46619611|NCT00558103|82759908|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
46619612|NCT00558103|82759909|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
46619613|NCT00558103|82759904|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
46619614|NCT00558103|82759905|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
46619615|NCT00558103|82759906|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
46619616|NCT00558103|82759907|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
46619617|NCT00558103|82759908|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
46619618|NCT00558103|82759909|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
46619619|NCT00558103|82759904|FG000|Randomized Treatment Phase|Disease Progression|1|||
46619620|NCT00558103|82759905|FG001|Randomized Treatment Phase|Disease Progression|0|||
46619621|NCT00558103|82759906|FG002|Randomized Treatment Phase|Disease Progression|1|||
46619622|NCT00558103|82759907|FG003|Randomized Treatment Phase|Disease Progression|0|||
46619623|NCT00558103|82759908|FG004|Randomized Treatment Phase|Disease Progression|0|||
46619624|NCT00558103|82759909|FG005|Randomized Treatment Phase|Disease Progression|0|||
46619625|NCT00558103|82759904|FG000|Randomized Treatment Phase|Adverse Event|0|||
46619626|NCT00558103|82759905|FG001|Randomized Treatment Phase|Adverse Event|0|||
46619627|NCT00558103|82759906|FG002|Randomized Treatment Phase|Adverse Event|0|||
46619628|NCT00558103|82759907|FG003|Randomized Treatment Phase|Adverse Event|1|||
46619629|NCT00558103|82759908|FG004|Randomized Treatment Phase|Adverse Event|1|||
46619630|NCT00558103|82759909|FG005|Randomized Treatment Phase|Adverse Event|0|||
46619631|NCT00558103|82759904|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
46619632|NCT00558103|82759905|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
46619633|NCT00558103|82759906|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
46619634|NCT00558103|82759907|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
46619635|NCT00558103|82759908|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
46619636|NCT00558103|82759909|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
46619637|NCT00558103|82759904|FG000|Monotherapy Extension Phase|Disease Progression|0|||
46619638|NCT00558103|82759905|FG001|Monotherapy Extension Phase|Disease Progression|0|||
46619639|NCT00558103|82759906|FG002|Monotherapy Extension Phase|Disease Progression|0|||
46619640|NCT00558103|82759907|FG003|Monotherapy Extension Phase|Disease Progression|0|||
46619641|NCT00558103|82759908|FG004|Monotherapy Extension Phase|Disease Progression|0|||
46619642|NCT00558103|82759909|FG005|Monotherapy Extension Phase|Disease Progression|8|||
46619643|NCT00558025|82759946|FG000|Overall Study|Adverse Event|1|||
46619644|NCT00558025|82759947|FG001|Overall Study|Adverse Event|1|||
46619645|NCT00558025|82759946|FG000|Overall Study|Withdrawal by Subject|2|||
46619646|NCT00558025|82759947|FG001|Overall Study|Withdrawal by Subject|2|||
46619647|NCT00558025|82759946|FG000|Overall Study|Protocol Violation|1|||
46619648|NCT00558025|82759947|FG001|Overall Study|Protocol Violation|0|||
46619649|NCT00557323|82760000|FG000|Overall Study|Death|3|||
46619650|NCT00557323|82760000|FG000|Overall Study|Withdrawal by Subject|2|||
46619651|NCT00557323|82760000|FG000|Overall Study|Administrative change|2|||
46619652|NCT00557245|82760034|FG000|Overall Study|Lost to Follow-up|7|||
46619653|NCT00557245|82760035|FG001|Overall Study|Lost to Follow-up|8|||
46619654|NCT00557245|82760036|FG002|Overall Study|Lost to Follow-up|10|||
46619655|NCT00557245|82760034|FG000|Overall Study|Ineligible|5|||
46619656|NCT00557245|82760035|FG001|Overall Study|Ineligible|4|||
46619657|NCT00557245|82760036|FG002|Overall Study|Ineligible|2|||
46619658|NCT00556075|82760097|FG000|Overall Study|Lost to Follow-up|3|||
46619659|NCT00556075|82760098|FG001|Overall Study|Lost to Follow-up|0|||
46619660|NCT00556075|82760099|FG002|Overall Study|Lost to Follow-up|3|||
46996387|NCT02340806|83243475|FG001|Overall Study|epidural catheter replaced|1|||
46996388|NCT02340806|83243474|FG000|Overall Study|history of chronic pain medication|1|||
46996389|NCT02340806|83243475|FG001|Overall Study|history of chronic pain medication|0|||
46996390|NCT02340806|83243474|FG000|Overall Study|re-dose < 90 min of CSE|1|||
46996391|NCT02340806|83243475|FG001|Overall Study|re-dose < 90 min of CSE|3|||
46996392|NCT02338154|83243481|FG000|Overall Study|Death|46|||
46996393|NCT02338154|83243481|FG000|Overall Study|Valve Implant Failure|17|||
46996394|NCT02338154|83243481|FG000|Overall Study|Valve Explant|11|||
46996395|NCT02338154|83243481|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
46996396|NCT02338154|83243481|FG000|Overall Study|Lost to Follow-up|8|||
46996397|NCT02338154|83243481|FG000|Overall Study|Other Reason|3|||
46619661|NCT00556075|82760097|FG000|Overall Study|Withdrawal by Subject|3|||
46619662|NCT00556075|82760098|FG001|Overall Study|Withdrawal by Subject|3|||
46619663|NCT00556075|82760099|FG002|Overall Study|Withdrawal by Subject|0|||
46619664|NCT00556075|82760097|FG000|Overall Study|Protocol Violation|1|||
46619665|NCT00556075|82760098|FG001|Overall Study|Protocol Violation|1|||
46619666|NCT00556075|82760099|FG002|Overall Study|Protocol Violation|3|||
46619667|NCT00556075|82760097|FG000|Overall Study|Not eligible|1|||
46619668|NCT00556075|82760098|FG001|Overall Study|Not eligible|1|||
46619669|NCT00556075|82760099|FG002|Overall Study|Not eligible|2|||
46619670|NCT00556075|82760097|FG000|Overall Study|Adverse Event|1|||
46619671|NCT00556075|82760098|FG001|Overall Study|Adverse Event|2|||
46619672|NCT00556075|82760099|FG002|Overall Study|Adverse Event|0|||
46619673|NCT00556075|82760097|FG000|Overall Study|Personal issues|4|||
46619674|NCT00556075|82760098|FG001|Overall Study|Personal issues|1|||
46619675|NCT00556075|82760099|FG002|Overall Study|Personal issues|0|||
46619676|NCT00556075|82760097|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
46619677|NCT00556075|82760098|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
46619678|NCT00556075|82760099|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
46619679|NCT02289690|82760130|FG000|Overall Study|Adverse Event Related to Progression|0|||
46619680|NCT02289690|82760131|FG001|Overall Study|Adverse Event Related to Progression|1|||
46619681|NCT02289690|82760132|FG002|Overall Study|Adverse Event Related to Progression|1|||
46619682|NCT02289690|82760133|FG003|Overall Study|Adverse Event Related to Progression|0|||
46619683|NCT02289690|82760134|FG004|Overall Study|Adverse Event Related to Progression|1|||
46619684|NCT02289690|82760135|FG005|Overall Study|Adverse Event Related to Progression|0|||
46619685|NCT02289690|82760136|FG006|Overall Study|Adverse Event Related to Progression|1|||
46619686|NCT02289690|82760137|FG007|Overall Study|Adverse Event Related to Progression|0|||
46619687|NCT02289690|82760138|FG008|Overall Study|Adverse Event Related to Progression|0|||
46619688|NCT02289690|82760139|FG009|Overall Study|Adverse Event Related to Progression|0|||
46619689|NCT02289690|82760130|FG000|Overall Study|Withdrawal by Subject|1|||
46619690|NCT02289690|82760131|FG001|Overall Study|Withdrawal by Subject|0|||
46619691|NCT02289690|82760132|FG002|Overall Study|Withdrawal by Subject|0|||
46619692|NCT02289690|82760133|FG003|Overall Study|Withdrawal by Subject|0|||
46619693|NCT02289690|82760134|FG004|Overall Study|Withdrawal by Subject|1|||
46619694|NCT02289690|82760135|FG005|Overall Study|Withdrawal by Subject|1|||
46619695|NCT02289690|82760136|FG006|Overall Study|Withdrawal by Subject|0|||
46619696|NCT02289690|82760137|FG007|Overall Study|Withdrawal by Subject|0|||
46619697|NCT02289690|82760138|FG008|Overall Study|Withdrawal by Subject|4|||
46619698|NCT02289690|82760139|FG009|Overall Study|Withdrawal by Subject|2|||
46619699|NCT02289690|82760130|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
46619700|NCT02289690|82760131|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
46619701|NCT02289690|82760132|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
46619702|NCT02289690|82760133|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
46619703|NCT02289690|82760134|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
46619704|NCT02289690|82760135|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
46619705|NCT02289690|82760136|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
46619706|NCT02289690|82760137|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
46619707|NCT02289690|82760138|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
46619708|NCT02289690|82760139|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
46619709|NCT02289690|82760130|FG000|Overall Study|Lost to Follow-up|0|||
46619710|NCT02289690|82760131|FG001|Overall Study|Lost to Follow-up|0|||
46619711|NCT02289690|82760132|FG002|Overall Study|Lost to Follow-up|0|||
46619712|NCT02289690|82760133|FG003|Overall Study|Lost to Follow-up|0|||
46619713|NCT02289690|82760134|FG004|Overall Study|Lost to Follow-up|0|||
46619714|NCT02289690|82760135|FG005|Overall Study|Lost to Follow-up|0|||
46619715|NCT02289690|82760136|FG006|Overall Study|Lost to Follow-up|0|||
46619716|NCT02289690|82760137|FG007|Overall Study|Lost to Follow-up|1|||
46619717|NCT02289690|82760138|FG008|Overall Study|Lost to Follow-up|0|||
46619718|NCT02289690|82760139|FG009|Overall Study|Lost to Follow-up|2|||
46619719|NCT02289690|82760130|FG000|Overall Study|Death|0|||
46619720|NCT02289690|82760131|FG001|Overall Study|Death|0|||
46619721|NCT02289690|82760132|FG002|Overall Study|Death|0|||
46619722|NCT02289690|82760133|FG003|Overall Study|Death|0|||
46619723|NCT02289690|82760134|FG004|Overall Study|Death|0|||
46619724|NCT02289690|82760135|FG005|Overall Study|Death|0|||
46619725|NCT02289690|82760136|FG006|Overall Study|Death|0|||
46619726|NCT02289690|82760137|FG007|Overall Study|Death|49|||
46619727|NCT02289690|82760138|FG008|Overall Study|Death|45|||
46619728|NCT02289690|82760139|FG009|Overall Study|Death|41|||
46619729|NCT02289690|82760130|FG000|Overall Study|Sponsor Discontinued Study|0|||
46619730|NCT02289690|82760131|FG001|Overall Study|Sponsor Discontinued Study|0|||
46619731|NCT02289690|82760132|FG002|Overall Study|Sponsor Discontinued Study|0|||
46619732|NCT02289690|82760133|FG003|Overall Study|Sponsor Discontinued Study|0|||
46619733|NCT02289690|82760134|FG004|Overall Study|Sponsor Discontinued Study|0|||
46619734|NCT02289690|82760135|FG005|Overall Study|Sponsor Discontinued Study|0|||
46619735|NCT02289690|82760136|FG006|Overall Study|Sponsor Discontinued Study|0|||
46619736|NCT02289690|82760137|FG007|Overall Study|Sponsor Discontinued Study|9|||
46619737|NCT02289690|82760138|FG008|Overall Study|Sponsor Discontinued Study|7|||
46619738|NCT02289690|82760139|FG009|Overall Study|Sponsor Discontinued Study|15|||
46619739|NCT02289690|82760130|FG000|Overall Study|Other|0|||
46619740|NCT02289690|82760131|FG001|Overall Study|Other|0|||
46619741|NCT02289690|82760132|FG002|Overall Study|Other|0|||
46619742|NCT02289690|82760133|FG003|Overall Study|Other|1|||
46619743|NCT02289690|82760134|FG004|Overall Study|Other|1|||
46619744|NCT02289690|82760135|FG005|Overall Study|Other|0|||
46619745|NCT02289690|82760136|FG006|Overall Study|Other|1|||
46619746|NCT02289690|82760137|FG007|Overall Study|Other|2|||
46619747|NCT02289690|82760138|FG008|Overall Study|Other|3|||
46619748|NCT02289690|82760139|FG009|Overall Study|Other|1|||
46619749|NCT02289456|82760242|FG000|Induction Period|Death|2|||
46619750|NCT02289456|82760242|FG000|Induction Period|Adverse Event|11|||
46619751|NCT02289456|82760242|FG000|Induction Period|Progressive Disease (PD)|4|||
46619752|NCT02289456|82760242|FG000|Induction Period|Symptomatic Deterioration|4|||
46619753|NCT02289456|82760242|FG000|Induction Period|Withdrawal by Subject|2|||
46619754|NCT02289456|82760242|FG000|Induction Period|Miscellaneous|1|||
46619755|NCT02289456|82760242|FG000|Monotherapy Period|Death|1|||
46619756|NCT02289456|82760242|FG000|Monotherapy Period|Adverse Event|1|||
46619757|NCT02289456|82760242|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
46619758|NCT02289456|82760242|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
46619759|NCT02289456|82760242|FG000|Monotherapy Period|Withdrawal by Subject|2|||
46619760|NCT02289456|82760242|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
46898889|NCT02273388|83125337|FG001|Overall Study|Adverse Event study disease worse|3|||
46619761|NCT02289456|82760242|FG000|Monotherapy Period|Miscellaneous|1|||
46619762|NCT02274948|82760291|FG000|Overall Study|Lost to Follow-up|28|||
46619763|NCT02274948|82760292|FG001|Overall Study|Lost to Follow-up|25|||
46619764|NCT02274948|82760291|FG000|Overall Study|Withdrawal by Subject|64|||
46619765|NCT02274948|82760292|FG001|Overall Study|Withdrawal by Subject|58|||
46619766|NCT02274948|82760291|FG000|Overall Study|Stopped on family Practitioner advice|2|||
46619767|NCT02274948|82760292|FG001|Overall Study|Stopped on family Practitioner advice|5|||
46619768|NCT02274948|82760291|FG000|Overall Study|Left the area|4|||
46619769|NCT02274948|82760292|FG001|Overall Study|Left the area|3|||
46619770|NCT02274792|82760308|FG000|Overall Study|Withdrawal by Subject|13|||
46619771|NCT02274792|82760308|FG000|Overall Study|Lost to Follow-up|8|||
46619772|NCT02274792|82760308|FG000|Overall Study|Protocol Specified Criteria|2|||
46619773|NCT02274792|82760308|FG000|Overall Study|Sponsor Decision|2|||
46619774|NCT02274558|82760338|FG000|Overall Study|Adverse Event|2|||
46619775|NCT02274558|82760339|FG001|Overall Study|Adverse Event|4|||
46619776|NCT02274558|82760340|FG002|Overall Study|Adverse Event|2|||
46619777|NCT02274558|82760338|FG000|Overall Study|Non-compliance|2|||
46619778|NCT02274558|82760339|FG001|Overall Study|Non-compliance|1|||
46619779|NCT02274558|82760340|FG002|Overall Study|Non-compliance|0|||
46619780|NCT02274558|82760338|FG000|Overall Study|Withdrawal by Subject|1|||
46619781|NCT02274558|82760339|FG001|Overall Study|Withdrawal by Subject|5|||
46619782|NCT02274558|82760340|FG002|Overall Study|Withdrawal by Subject|4|||
46619783|NCT02274558|82760338|FG000|Overall Study|Death|0|||
46619784|NCT02274558|82760339|FG001|Overall Study|Death|0|||
46619785|NCT02274558|82760340|FG002|Overall Study|Death|1|||
46619786|NCT02274558|82760338|FG000|Overall Study|Lost to Follow-up|2|||
46619787|NCT02274558|82760339|FG001|Overall Study|Lost to Follow-up|1|||
46619788|NCT02274558|82760340|FG002|Overall Study|Lost to Follow-up|1|||
46619789|NCT02274558|82760338|FG000|Overall Study|Physician Decision|0|||
46619790|NCT02274558|82760339|FG001|Overall Study|Physician Decision|2|||
46619791|NCT02274558|82760340|FG002|Overall Study|Physician Decision|1|||
46619792|NCT02287896|82760357|FG000|Second Injection Visit|Withdrawal by Subject|0|||
46619793|NCT02287896|82760358|FG001|Second Injection Visit|Withdrawal by Subject|1|||
46619794|NCT00553501|82760416|FG000|Overall Study|Adverse Event|2|||
46619795|NCT00553501|82760416|FG000|Overall Study|Death|1|||
46619796|NCT00553501|82760416|FG000|Overall Study|Progression|1|||
46619797|NCT02287584|82760444|FG000|the Double-blind Phase|Adverse Event|17|||
46619798|NCT02287584|82760445|FG001|the Double-blind Phase|Adverse Event|17|||
46619799|NCT02287584|82760446|FG002|the Double-blind Phase|Adverse Event|12|||
46619800|NCT02287584|82760447|FG003|the Double-blind Phase|Adverse Event|0|||
46619801|NCT02287584|82760448|FG004|the Double-blind Phase|Adverse Event|0|||
46619802|NCT02287584|82760449|FG005|the Double-blind Phase|Adverse Event|0|||
46619803|NCT02287584|82760444|FG000|the Double-blind Phase|Lack of Efficacy|18|||
46619804|NCT02287584|82760445|FG001|the Double-blind Phase|Lack of Efficacy|8|||
46619805|NCT02287584|82760446|FG002|the Double-blind Phase|Lack of Efficacy|8|||
46619806|NCT02287584|82760447|FG003|the Double-blind Phase|Lack of Efficacy|0|||
46619807|NCT02287584|82760448|FG004|the Double-blind Phase|Lack of Efficacy|0|||
46619808|NCT02287584|82760449|FG005|the Double-blind Phase|Lack of Efficacy|0|||
46619809|NCT02287584|82760444|FG000|the Double-blind Phase|Lost to Follow-up|0|||
46619810|NCT02287584|82760445|FG001|the Double-blind Phase|Lost to Follow-up|1|||
46619811|NCT02287584|82760446|FG002|the Double-blind Phase|Lost to Follow-up|1|||
46619812|NCT02287584|82760447|FG003|the Double-blind Phase|Lost to Follow-up|0|||
46619813|NCT02287584|82760448|FG004|the Double-blind Phase|Lost to Follow-up|0|||
46619814|NCT02287584|82760449|FG005|the Double-blind Phase|Lost to Follow-up|0|||
46619815|NCT02287584|82760444|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
46619816|NCT02287584|82760445|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
46619817|NCT02287584|82760446|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
46619818|NCT02287584|82760447|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
46619819|NCT02287584|82760448|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
46619820|NCT02287584|82760449|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
46619821|NCT02287584|82760444|FG000|the Double-blind Phase|Pregnancy|0|||
46619822|NCT02287584|82760445|FG001|the Double-blind Phase|Pregnancy|1|||
46619823|NCT02287584|82760446|FG002|the Double-blind Phase|Pregnancy|0|||
46619824|NCT02287584|82760447|FG003|the Double-blind Phase|Pregnancy|0|||
46619825|NCT02287584|82760448|FG004|the Double-blind Phase|Pregnancy|0|||
46619826|NCT02287584|82760449|FG005|the Double-blind Phase|Pregnancy|0|||
46619827|NCT02287584|82760444|FG000|the Double-blind Phase|Protocol Violation|0|||
46619828|NCT02287584|82760445|FG001|the Double-blind Phase|Protocol Violation|3|||
46619829|NCT02287584|82760446|FG002|the Double-blind Phase|Protocol Violation|0|||
46619830|NCT02287584|82760447|FG003|the Double-blind Phase|Protocol Violation|0|||
46619831|NCT02287584|82760448|FG004|the Double-blind Phase|Protocol Violation|0|||
46619832|NCT02287584|82760449|FG005|the Double-blind Phase|Protocol Violation|0|||
46619833|NCT02287584|82760444|FG000|the Double-blind Phase|other reasons|0|||
46619834|NCT02287584|82760445|FG001|the Double-blind Phase|other reasons|0|||
46619835|NCT02287584|82760446|FG002|the Double-blind Phase|other reasons|1|||
46619836|NCT02287584|82760447|FG003|the Double-blind Phase|other reasons|0|||
46619837|NCT02287584|82760448|FG004|the Double-blind Phase|other reasons|0|||
46619838|NCT02287584|82760449|FG005|the Double-blind Phase|other reasons|0|||
46619839|NCT02287584|82760444|FG000|the Open-label Phase|Did not receive drug|0|||
46619840|NCT02287584|82760445|FG001|the Open-label Phase|Did not receive drug|0|||
46619841|NCT02287584|82760446|FG002|the Open-label Phase|Did not receive drug|0|||
46619842|NCT02287584|82760447|FG003|the Open-label Phase|Did not receive drug|7|||
46619843|NCT02287584|82760448|FG004|the Open-label Phase|Did not receive drug|6|||
46619844|NCT02287584|82760449|FG005|the Open-label Phase|Did not receive drug|4|||
46619845|NCT02287584|82760444|FG000|the Open-label Phase|Adverse Event|0|||
46619846|NCT02287584|82760445|FG001|the Open-label Phase|Adverse Event|0|||
46619847|NCT02287584|82760446|FG002|the Open-label Phase|Adverse Event|0|||
46619848|NCT02287584|82760447|FG003|the Open-label Phase|Adverse Event|15|||
46619849|NCT02287584|82760448|FG004|the Open-label Phase|Adverse Event|12|||
46619850|NCT02287584|82760449|FG005|the Open-label Phase|Adverse Event|16|||
46619851|NCT02287584|82760444|FG000|the Open-label Phase|Lack of Efficacy|0|||
46619852|NCT02287584|82760445|FG001|the Open-label Phase|Lack of Efficacy|0|||
46619853|NCT02287584|82760446|FG002|the Open-label Phase|Lack of Efficacy|0|||
46619854|NCT02287584|82760447|FG003|the Open-label Phase|Lack of Efficacy|8|||
46619855|NCT02287584|82760448|FG004|the Open-label Phase|Lack of Efficacy|3|||
46619856|NCT02287584|82760449|FG005|the Open-label Phase|Lack of Efficacy|7|||
46619857|NCT02287584|82760444|FG000|the Open-label Phase|Lost to Follow-up|0|||
46619858|NCT02287584|82760445|FG001|the Open-label Phase|Lost to Follow-up|0|||
46619859|NCT02287584|82760446|FG002|the Open-label Phase|Lost to Follow-up|0|||
46619860|NCT02287584|82760447|FG003|the Open-label Phase|Lost to Follow-up|4|||
46619861|NCT02287584|82760448|FG004|the Open-label Phase|Lost to Follow-up|1|||
46619862|NCT02287584|82760449|FG005|the Open-label Phase|Lost to Follow-up|2|||
46619863|NCT02287584|82760444|FG000|the Open-label Phase|Withdrawal by Subject|0|||
46619864|NCT02287584|82760445|FG001|the Open-label Phase|Withdrawal by Subject|0|||
46619865|NCT02287584|82760446|FG002|the Open-label Phase|Withdrawal by Subject|0|||
46619866|NCT02287584|82760447|FG003|the Open-label Phase|Withdrawal by Subject|18|||
46619867|NCT02287584|82760448|FG004|the Open-label Phase|Withdrawal by Subject|29|||
46619868|NCT02287584|82760449|FG005|the Open-label Phase|Withdrawal by Subject|21|||
46619869|NCT02287584|82760444|FG000|the Open-label Phase|non-compliance|0|||
46619870|NCT02287584|82760445|FG001|the Open-label Phase|non-compliance|0|||
46619871|NCT02287584|82760446|FG002|the Open-label Phase|non-compliance|0|||
46619872|NCT02287584|82760447|FG003|the Open-label Phase|non-compliance|2|||
46619873|NCT02287584|82760448|FG004|the Open-label Phase|non-compliance|5|||
46619874|NCT02287584|82760449|FG005|the Open-label Phase|non-compliance|1|||
46619875|NCT02287584|82760444|FG000|the Open-label Phase|other reasons|0|||
46619876|NCT02287584|82760445|FG001|the Open-label Phase|other reasons|0|||
46619877|NCT02287584|82760446|FG002|the Open-label Phase|other reasons|0|||
46619878|NCT02287584|82760447|FG003|the Open-label Phase|other reasons|3|||
46619879|NCT02287584|82760448|FG004|the Open-label Phase|other reasons|6|||
46619880|NCT02287584|82760449|FG005|the Open-label Phase|other reasons|6|||
46619881|NCT00553267|82760482|FG000|Overall Study|Adverse Event|8|||
46619882|NCT00553267|82760483|FG001|Overall Study|Adverse Event|10|||
46619883|NCT00553267|82760484|FG002|Overall Study|Adverse Event|5|||
46619884|NCT00553267|82760482|FG000|Overall Study|Non compliant with protocol|3|||
46619885|NCT00553267|82760483|FG001|Overall Study|Non compliant with protocol|3|||
46619886|NCT00553267|82760484|FG002|Overall Study|Non compliant with protocol|2|||
46619887|NCT00553267|82760482|FG000|Overall Study|Lost to Follow-up|0|||
46619888|NCT00553267|82760483|FG001|Overall Study|Lost to Follow-up|0|||
46619889|NCT00553267|82760484|FG002|Overall Study|Lost to Follow-up|1|||
46619890|NCT00553267|82760482|FG000|Overall Study|Consent withdrawn|2|||
46619891|NCT00553267|82760483|FG001|Overall Study|Consent withdrawn|3|||
46619892|NCT00553267|82760484|FG002|Overall Study|Consent withdrawn|1|||
46619893|NCT00553267|82760482|FG000|Overall Study|Specified category|1|||
46619894|NCT00553267|82760483|FG001|Overall Study|Specified category|2|||
46619895|NCT00553267|82760484|FG002|Overall Study|Specified category|1|||
46619896|NCT02271984|82760498|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619897|NCT02271984|82760499|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619898|NCT02271984|82760500|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619899|NCT02271984|82760501|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619900|NCT02271984|82760502|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619901|NCT02271984|82760503|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
46619902|NCT02271984|82760504|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619903|NCT02271984|82760505|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
46619904|NCT02271984|82760506|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619905|NCT02271984|82760507|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619906|NCT02271984|82760508|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619907|NCT02271984|82760509|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46619908|NCT02287038|82760560|FG000|Overall Study|Stopped attending appointments|3|||
46619909|NCT02287038|82760561|FG001|Overall Study|Stopped attending appointments|2|||
46619910|NCT02287038|82760560|FG000|Overall Study|Anxiety after starting medication|0|||
46619911|NCT02287038|82760561|FG001|Overall Study|Anxiety after starting medication|1|||
46619912|NCT02287038|82760560|FG000|Overall Study|Nausea after starting medication|1|||
46619913|NCT02287038|82760561|FG001|Overall Study|Nausea after starting medication|0|||
46619914|NCT02287038|82760560|FG000|Overall Study|Abnormal ECG after starting medication|1|||
46619915|NCT02287038|82760561|FG001|Overall Study|Abnormal ECG after starting medication|0|||
46619916|NCT02286960|82760571|FG000|Overall Study|Lost to Follow-up|3|||
46619917|NCT02286960|82760572|FG001|Overall Study|Lost to Follow-up|3|||
46619918|NCT02286102|82760589|FG000|Overall Study|Screen Failure|1|||
46619919|NCT02286102|82760590|FG001|Overall Study|Screen Failure|1|||
46619920|NCT02285166|82760596|FG000|Overall Study|Case Report Forms Uncollected|564|||
46619921|NCT02285166|82760596|FG000|Overall Study|Protocol Deviation|402|||
46619922|NCT00555061|82760659|FG000|Overall Study|Adverse Event|3|||
46619923|NCT00555061|82760659|FG000|Overall Study|Protocol Violation|1|||
46619924|NCT00555061|82760659|FG000|Overall Study|Lost to Follow-up|2|||
46619925|NCT00555061|82760659|FG000|Overall Study|Withdrawal by Subject|2|||
46619926|NCT00555061|82760659|FG000|Overall Study|Participant enrolled, but never treated|1|||
46619927|NCT01642212|82760677|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
46619928|NCT01642212|82760678|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
46619929|NCT01642212|82760679|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
46619930|NCT01642212|82760680|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
46619931|NCT01642212|82760681|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
46619932|NCT01642212|82760677|FG000|Double-blind Treatment|Other|0|||
46619933|NCT01642212|82760678|FG001|Double-blind Treatment|Other|2|||
46619934|NCT01642212|82760679|FG002|Double-blind Treatment|Other|1|||
46619935|NCT01642212|82760680|FG003|Double-blind Treatment|Other|0|||
46619936|NCT01642212|82760681|FG004|Double-blind Treatment|Other|0|||
46619937|NCT01642212|82760677|FG000|Double-blind Treatment|Non-compliance|0|||
46619938|NCT01642212|82760678|FG001|Double-blind Treatment|Non-compliance|1|||
46619939|NCT01642212|82760679|FG002|Double-blind Treatment|Non-compliance|0|||
46619940|NCT01642212|82760680|FG003|Double-blind Treatment|Non-compliance|0|||
46619941|NCT01642212|82760681|FG004|Double-blind Treatment|Non-compliance|0|||
46619942|NCT01642212|82760677|FG000|Double-blind Treatment|Adverse Event|0|||
46619943|NCT01642212|82760678|FG001|Double-blind Treatment|Adverse Event|0|||
46619944|NCT01642212|82760679|FG002|Double-blind Treatment|Adverse Event|1|||
46619945|NCT01642212|82760680|FG003|Double-blind Treatment|Adverse Event|0|||
46619946|NCT01642212|82760681|FG004|Double-blind Treatment|Adverse Event|0|||
46619947|NCT01642212|82760677|FG000|Open-label Extension|Adverse Event|0|||
46619948|NCT01642212|82760678|FG001|Open-label Extension|Adverse Event|0|||
46619949|NCT01642212|82760679|FG002|Open-label Extension|Adverse Event|0|||
46619950|NCT01642212|82760680|FG003|Open-label Extension|Adverse Event|3|||
46619951|NCT01642212|82760681|FG004|Open-label Extension|Adverse Event|0|||
46619952|NCT01642212|82760677|FG000|Open-label Extension|Sponsor Decision|0|||
46619953|NCT01642212|82760678|FG001|Open-label Extension|Sponsor Decision|0|||
46619954|NCT01642212|82760679|FG002|Open-label Extension|Sponsor Decision|0|||
46619955|NCT01642212|82760680|FG003|Open-label Extension|Sponsor Decision|7|||
46619956|NCT01642212|82760681|FG004|Open-label Extension|Sponsor Decision|4|||
46619957|NCT01642212|82760677|FG000|Open-label Extension|Consent Withdrawn|0|||
46619958|NCT01642212|82760678|FG001|Open-label Extension|Consent Withdrawn|0|||
46619959|NCT01642212|82760679|FG002|Open-label Extension|Consent Withdrawn|0|||
46619960|NCT01642212|82760680|FG003|Open-label Extension|Consent Withdrawn|0|||
46619961|NCT01642212|82760681|FG004|Open-label Extension|Consent Withdrawn|2|||
46619962|NCT01642212|82760677|FG000|Open-label Extension|Lost to Follow-up|0|||
46619963|NCT01642212|82760678|FG001|Open-label Extension|Lost to Follow-up|0|||
46619964|NCT01642212|82760679|FG002|Open-label Extension|Lost to Follow-up|0|||
46619965|NCT01642212|82760680|FG003|Open-label Extension|Lost to Follow-up|0|||
46619966|NCT01642212|82760681|FG004|Open-label Extension|Lost to Follow-up|1|||
46619967|NCT01642212|82760677|FG000|Open-label Extension|Other|0|||
46619968|NCT01642212|82760678|FG001|Open-label Extension|Other|0|||
46619969|NCT01642212|82760679|FG002|Open-label Extension|Other|0|||
46619970|NCT01642212|82760680|FG003|Open-label Extension|Other|0|||
46619971|NCT01642212|82760681|FG004|Open-label Extension|Other|1|||
46619972|NCT00552175|82760706|FG000|Overall Study|Lack of Efficacy|2|||
46619973|NCT00552175|82760707|FG001|Overall Study|Lack of Efficacy|0|||
46619974|NCT00552175|82760708|FG002|Overall Study|Lack of Efficacy|1|||
46619975|NCT00552175|82760706|FG000|Overall Study|Adverse Event|9|||
46619976|NCT00552175|82760707|FG001|Overall Study|Adverse Event|9|||
46619977|NCT00552175|82760708|FG002|Overall Study|Adverse Event|10|||
46619978|NCT00552175|82760706|FG000|Overall Study|Withdrawal by Subject|2|||
46619979|NCT00552175|82760707|FG001|Overall Study|Withdrawal by Subject|2|||
46619980|NCT00552175|82760708|FG002|Overall Study|Withdrawal by Subject|1|||
46619981|NCT00552175|82760706|FG000|Overall Study|Lost to Follow-up|0|||
46619982|NCT00552175|82760707|FG001|Overall Study|Lost to Follow-up|0|||
46619983|NCT00552175|82760708|FG002|Overall Study|Lost to Follow-up|1|||
46619984|NCT00552175|82760706|FG000|Overall Study|Entry Criteria Not Met|1|||
46619985|NCT00552175|82760707|FG001|Overall Study|Entry Criteria Not Met|1|||
46619986|NCT00552175|82760708|FG002|Overall Study|Entry Criteria Not Met|0|||
46619987|NCT00552175|82760706|FG000|Overall Study|Reason Not Specified|3|||
46619988|NCT00552175|82760707|FG001|Overall Study|Reason Not Specified|1|||
46619989|NCT00552175|82760708|FG002|Overall Study|Reason Not Specified|1|||
46619990|NCT01644474|82760719|FG000|Overall Study|Poor compliance to protocol|1|||
46619991|NCT01644474|82760720|FG001|Overall Study|Poor compliance to protocol|0|||
46619992|NCT01644474|82760719|FG000|Overall Study|Consent withdrawn by participant|0|||
46619993|NCT01644474|82760720|FG001|Overall Study|Consent withdrawn by participant|1|||
46619994|NCT01644474|82760719|FG000|Overall Study|Participant moved|0|||
46619995|NCT01644474|82760720|FG001|Overall Study|Participant moved|1|||
46619996|NCT01644474|82760719|FG000|Overall Study|Adverse Event|4|||
46619997|NCT01644474|82760720|FG001|Overall Study|Adverse Event|5|||
46619998|NCT01644474|82760719|FG000|Overall Study|Site scheduling error|1|||
46619999|NCT01644474|82760720|FG001|Overall Study|Site scheduling error|1|||
46620000|NCT01644474|82760719|FG000|Overall Study|Protocol Violation|1|||
46620001|NCT01644474|82760720|FG001|Overall Study|Protocol Violation|0|||
46620002|NCT02285010|82760755|FG000|Overall Study|not abdominal hysterectomy|2|||
46620003|NCT02285010|82760756|FG001|Overall Study|not abdominal hysterectomy|0|||
46620004|NCT02285010|82760755|FG000|Overall Study|Not spinal anesthesia|3|||
46620005|NCT02285010|82760756|FG001|Overall Study|Not spinal anesthesia|1|||
46620006|NCT00551161|82760800|FG000|Overall Study|Withdrawal by Subject|1|||
46620007|NCT00550771|82760836|FG000|Overall Study|Adverse Event|11|||
46620008|NCT00550771|82760837|FG001|Overall Study|Adverse Event|3|||
46620009|NCT00550771|82760836|FG000|Overall Study|Discontinued for study-related reasons|0|||
46620010|NCT00550771|82760837|FG001|Overall Study|Discontinued for study-related reasons|1|||
46620011|NCT00550771|82760836|FG000|Overall Study|Physician Decision|2|||
46620012|NCT00550771|82760837|FG001|Overall Study|Physician Decision|0|||
46620013|NCT00550771|82760836|FG000|Overall Study|Withdrawal by Subject|0|||
46620014|NCT00550771|82760837|FG001|Overall Study|Withdrawal by Subject|1|||
46620015|NCT00550771|82760836|FG000|Overall Study|Protocol Violation|4|||
46620016|NCT00550771|82760837|FG001|Overall Study|Protocol Violation|5|||
46620017|NCT00550537|82760870|FG000|Overall Study|Death|18|||
46620018|NCT00550537|82760870|FG000|Overall Study|Adverse Event|20|||
46620019|NCT00550537|82760870|FG000|Overall Study|Disease progression before|46|||
46620020|NCT00550537|82760870|FG000|Overall Study|Withdrawal by Subject|7|||
46620021|NCT00550537|82760870|FG000|Overall Study|Change in treatment plan|4|||
46620022|NCT00550537|82760870|FG000|Overall Study|Other complicating ilness|3|||
46620023|NCT00550537|82760870|FG000|Overall Study|Declining performance status|2|||
46620024|NCT00550537|82760870|FG000|Overall Study|Treated closer to home|4|||
46620025|NCT00550147|82760888|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
46620026|NCT00550147|82760888|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
46620027|NCT00550147|82760888|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
46620028|NCT00550147|82760888|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
46620029|NCT00550147|82760888|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
46620030|NCT00550459|82761099|FG000|Overall Study|Adverse Event|0|||
46620031|NCT00550459|82761100|FG001|Overall Study|Adverse Event|2|||
46620032|NCT00550459|82761099|FG000|Overall Study|Withdrawal by Subject|1|||
46620033|NCT00550459|82761100|FG001|Overall Study|Withdrawal by Subject|1|||
46620034|NCT02823145|82761135|FG000|Enrollment|Other|1|||
46620035|NCT02823145|82761136|FG001|Enrollment|Other|0|||
46620036|NCT02823145|82761135|FG000|Treatment|Adverse Event|0|||
46620037|NCT02823145|82761136|FG001|Treatment|Adverse Event|11|||
46620038|NCT02823145|82761135|FG000|Treatment|Death|0|||
46620039|NCT02823145|82761136|FG001|Treatment|Death|3|||
46620040|NCT02823145|82761135|FG000|Treatment|Family Decision|0|||
46620041|NCT02823145|82761136|FG001|Treatment|Family Decision|1|||
46620042|NCT02823145|82761135|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
46620043|NCT02823145|82761136|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
46620044|NCT02823145|82761135|FG000|Treatment|Lack of Efficacy|0|||
46620045|NCT02823145|82761136|FG001|Treatment|Lack of Efficacy|48|||
46620046|NCT02823145|82761135|FG000|Treatment|Non-Compliance With E-Diary|0|||
46620047|NCT02823145|82761136|FG001|Treatment|Non-Compliance With E-Diary|1|||
46620048|NCT02823145|82761135|FG000|Treatment|Physician Decision|0|||
46620049|NCT02823145|82761136|FG001|Treatment|Physician Decision|2|||
46620050|NCT02823145|82761135|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
46620051|NCT02823145|82761136|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
46620052|NCT02823145|82761135|FG000|Treatment|Subject needed to take prohibited medication|0|||
46620053|NCT02823145|82761136|FG001|Treatment|Subject needed to take prohibited medication|1|||
46620054|NCT02823145|82761135|FG000|Treatment|Subject transferred to direct access programme|0|||
46620055|NCT02823145|82761136|FG001|Treatment|Subject transferred to direct access programme|1|||
46620056|NCT02823145|82761135|FG000|Treatment|Switching to commercially available drug|0|||
46620057|NCT02823145|82761136|FG001|Treatment|Switching to commercially available drug|11|||
46620058|NCT02823145|82761135|FG000|Treatment|Transitioned to commercial supply of medication|0|||
46620059|NCT02823145|82761136|FG001|Treatment|Transitioned to commercial supply of medication|1|||
46620060|NCT02823145|82761135|FG000|Treatment|Withdrawal By Caregiver|0|||
46620061|NCT02823145|82761136|FG001|Treatment|Withdrawal By Caregiver|1|||
46996398|NCT02338154|83243481|FG000|Overall Study|Patients Without Exit Form|47|||
46996399|NCT02338154|83243481|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
46620062|NCT02823145|82761135|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
46620063|NCT02823145|82761136|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
46620064|NCT02823145|82761135|FG000|Treatment|Withdrawal by Subject|0|||
46620065|NCT02823145|82761136|FG001|Treatment|Withdrawal by Subject|16|||
46620066|NCT02823145|82761135|FG000|Treatment|Reason unknown|0|||
46996400|NCT01835158|83243495|FG000|Overall Study|Withdrawal by Subject|1|||
46620067|NCT02823145|82761136|FG001|Treatment|Reason unknown|1|||
46620068|NCT01643928|82761400|FG000|Overall Study|Lost to Follow-up|1|||
46620069|NCT01643928|82761401|FG001|Overall Study|Lost to Follow-up|0|||
46996401|NCT01835158|83243496|FG001|Overall Study|Withdrawal by Subject|6|||
46620070|NCT01643928|82761402|FG002|Overall Study|Lost to Follow-up|2|||
46620071|NCT01643928|82761403|FG003|Overall Study|Lost to Follow-up|0|||
46620072|NCT01643928|82761404|FG004|Overall Study|Lost to Follow-up|0|||
46620073|NCT01643928|82761400|FG000|Overall Study|Withdrawal by Subject|2|||
46620074|NCT01643928|82761401|FG001|Overall Study|Withdrawal by Subject|0|||
46620075|NCT01643928|82761402|FG002|Overall Study|Withdrawal by Subject|0|||
46620076|NCT01643928|82761403|FG003|Overall Study|Withdrawal by Subject|1|||
46620077|NCT01643928|82761404|FG004|Overall Study|Withdrawal by Subject|0|||
46620078|NCT01643928|82761400|FG000|Overall Study|Pregnancy|0|||
46620079|NCT01643928|82761401|FG001|Overall Study|Pregnancy|0|||
46620080|NCT01643928|82761402|FG002|Overall Study|Pregnancy|0|||
46620081|NCT01643928|82761403|FG003|Overall Study|Pregnancy|1|||
46620082|NCT01643928|82761404|FG004|Overall Study|Pregnancy|0|||
46620083|NCT01643928|82761400|FG000|Overall Study|Other|5|||
46620084|NCT01643928|82761401|FG001|Overall Study|Other|1|||
46620085|NCT01643928|82761402|FG002|Overall Study|Other|1|||
46620086|NCT01643928|82761403|FG003|Overall Study|Other|0|||
46620087|NCT01643928|82761404|FG004|Overall Study|Other|0|||
46620088|NCT01643928|82761400|FG000|Overall Study|Adverse Event|2|||
46620089|NCT01643928|82761401|FG001|Overall Study|Adverse Event|1|||
46620090|NCT01643928|82761402|FG002|Overall Study|Adverse Event|0|||
46620091|NCT01643928|82761403|FG003|Overall Study|Adverse Event|1|||
46620092|NCT01643928|82761404|FG004|Overall Study|Adverse Event|2|||
46620093|NCT03237845|82761615|FG000|Overall Study|Adverse Event|0|||
46620094|NCT03237845|82761616|FG001|Overall Study|Adverse Event|1|||
46620095|NCT03237845|82761615|FG000|Overall Study|Lost to Follow-up|13|||
46620096|NCT03237845|82761616|FG001|Overall Study|Lost to Follow-up|10|||
46620097|NCT03237845|82761615|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
46620098|NCT03237845|82761616|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
46620099|NCT03237845|82761615|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
46620100|NCT03237845|82761616|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
46620101|NCT03237845|82761615|FG000|Overall Study|Physician Decision|1|||
46620102|NCT03237845|82761616|FG001|Overall Study|Physician Decision|2|||
46620103|NCT03237845|82761615|FG000|Overall Study|Pregnancy|1|||
46620104|NCT03237845|82761616|FG001|Overall Study|Pregnancy|0|||
46620105|NCT03237845|82761615|FG000|Overall Study|Protocol Deviation|0|||
46620106|NCT03237845|82761616|FG001|Overall Study|Protocol Deviation|1|||
46620107|NCT03237845|82761615|FG000|Overall Study|Technical Problems|8|||
46620108|NCT03237845|82761616|FG001|Overall Study|Technical Problems|1|||
46620109|NCT03237845|82761615|FG000|Overall Study|Withdrawal by Subject|3|||
46620110|NCT03237845|82761616|FG001|Overall Study|Withdrawal by Subject|3|||
46620111|NCT03237845|82761615|FG000|Overall Study|Other Reasons|4|||
46620112|NCT03237845|82761616|FG001|Overall Study|Other Reasons|0|||
46620113|NCT01643850|82761703|FG000|Overall Study|Withdrawal by Subject|0|||
46620114|NCT01643850|82761704|FG001|Overall Study|Withdrawal by Subject|0|||
46620115|NCT01643850|82761705|FG002|Overall Study|Withdrawal by Subject|0|||
46620116|NCT01643850|82761706|FG003|Overall Study|Withdrawal by Subject|0|||
46620117|NCT01643850|82761707|FG004|Overall Study|Withdrawal by Subject|1|||
46620118|NCT01643850|82761708|FG005|Overall Study|Withdrawal by Subject|0|||
46620119|NCT01643850|82761709|FG006|Overall Study|Withdrawal by Subject|0|||
46620120|NCT01643850|82761710|FG007|Overall Study|Withdrawal by Subject|0|||
46620121|NCT01643850|82761711|FG008|Overall Study|Withdrawal by Subject|0|||
46620122|NCT01643850|82761703|FG000|Overall Study|Lost to Follow-up|0|||
46620123|NCT01643850|82761704|FG001|Overall Study|Lost to Follow-up|0|||
46620124|NCT01643850|82761705|FG002|Overall Study|Lost to Follow-up|0|||
46620125|NCT01643850|82761706|FG003|Overall Study|Lost to Follow-up|0|||
46620126|NCT01643850|82761707|FG004|Overall Study|Lost to Follow-up|0|||
46620127|NCT01643850|82761708|FG005|Overall Study|Lost to Follow-up|0|||
46620128|NCT01643850|82761709|FG006|Overall Study|Lost to Follow-up|1|||
46620129|NCT01643850|82761710|FG007|Overall Study|Lost to Follow-up|0|||
46620130|NCT01643850|82761711|FG008|Overall Study|Lost to Follow-up|1|||
46620131|NCT01643850|82761703|FG000|Overall Study|Adverse Event|0|||
46620132|NCT01643850|82761704|FG001|Overall Study|Adverse Event|0|||
46620133|NCT01643850|82761705|FG002|Overall Study|Adverse Event|0|||
46620134|NCT01643850|82761706|FG003|Overall Study|Adverse Event|0|||
46620135|NCT01643850|82761707|FG004|Overall Study|Adverse Event|1|||
46708840|NCT04071366|82924737|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
46708841|NCT04071366|82924738|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
46708842|NCT04071366|82924739|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
46708843|NCT04071366|82924735|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
46708844|NCT04071366|82924736|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
46708845|NCT04071366|82924737|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
46708846|NCT04071366|82924738|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
46708847|NCT04071366|82924739|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
46620136|NCT01643850|82761708|FG005|Overall Study|Adverse Event|0|||
46620137|NCT01643850|82761709|FG006|Overall Study|Adverse Event|0|||
46620138|NCT01643850|82761710|FG007|Overall Study|Adverse Event|0|||
46620139|NCT01643850|82761711|FG008|Overall Study|Adverse Event|0|||
46996402|NCT02337764|83243502|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
46996403|NCT02337764|83243502|FG000|Overall Study|Voluntary Withdrawal|12|||
46996404|NCT02337764|83243502|FG000|Overall Study|Lack of Efficacy|2|||
46996405|NCT01834222|83243506|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
46708848|NCT04071366|82924735|FG000|Part 2: Randomized (29 Days)|Death|0|||
46708849|NCT04071366|82924736|FG001|Part 2: Randomized (29 Days)|Death|0|||
46708850|NCT04071366|82924737|FG002|Part 2: Randomized (29 Days)|Death|0|||
46708851|NCT04071366|82924738|FG003|Part 2: Randomized (29 Days)|Death|2|||
46708852|NCT04071366|82924739|FG004|Part 2: Randomized (29 Days)|Death|2|||
46708853|NCT04071366|82924735|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
46708854|NCT04071366|82924736|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
46708855|NCT04071366|82924737|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
46708856|NCT04071366|82924738|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
46708857|NCT04071366|82924739|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
46708858|NCT04071366|82924735|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
46708859|NCT04071366|82924736|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
46708860|NCT04071366|82924737|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
46708861|NCT04071366|82924738|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
46708862|NCT04071366|82924739|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
46708863|NCT04071366|82924735|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
46708864|NCT04071366|82924736|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
46708865|NCT04071366|82924737|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
46708866|NCT04071366|82924738|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
46708867|NCT04071366|82924739|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
46708868|NCT04071366|82924735|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
46708869|NCT04071366|82924736|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
46708870|NCT04071366|82924737|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
46708871|NCT04071366|82924738|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
46708872|NCT04071366|82924739|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
46708873|NCT04071366|82924735|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
46708874|NCT04071366|82924736|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
46708875|NCT04071366|82924737|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
46708876|NCT04071366|82924738|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
46708877|NCT04071366|82924739|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
46708878|NCT04071366|82924735|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
46708879|NCT04071366|82924736|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
46708880|NCT04071366|82924737|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
46708881|NCT04071366|82924738|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
46708882|NCT04071366|82924739|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
46708883|NCT04068181|82924756|FG000|Overall Study|Withdrawal by Subject|2|||
46708884|NCT04068181|82924757|FG001|Overall Study|Withdrawal by Subject|0|||
46708885|NCT04068181|82924758|FG002|Overall Study|Withdrawal by Subject|0|||
46708886|NCT04068181|82924759|FG003|Overall Study|Withdrawal by Subject|0|||
46708887|NCT04068181|82924756|FG000|Overall Study|Lost to Follow-up|1|||
46708888|NCT04068181|82924757|FG001|Overall Study|Lost to Follow-up|0|||
46708889|NCT04068181|82924758|FG002|Overall Study|Lost to Follow-up|0|||
46708890|NCT04068181|82924759|FG003|Overall Study|Lost to Follow-up|0|||
46708891|NCT04068181|82924756|FG000|Overall Study|Death|8|||
46708892|NCT04068181|82924757|FG001|Overall Study|Death|8|||
46708893|NCT04068181|82924758|FG002|Overall Study|Death|4|||
46708894|NCT04068181|82924759|FG003|Overall Study|Death|2|||
46708895|NCT04068181|82924756|FG000|Overall Study|Continuing Study|16|||
46708896|NCT04068181|82924757|FG001|Overall Study|Continuing Study|7|||
46708897|NCT04068181|82924758|FG002|Overall Study|Continuing Study|11|||
46708898|NCT04068181|82924759|FG003|Overall Study|Continuing Study|13|||
46708899|NCT04058158|82924771|FG000|Period 1|Death|1|||
46708900|NCT04058158|82924772|FG001|Period 1|Death|0|||
46708901|NCT04058158|82924771|FG000|Period 1|Adverse Event|1|||
46708902|NCT04058158|82924772|FG001|Period 1|Adverse Event|1|||
46708903|NCT04058158|82924771|FG000|Period 1|Pregnancy|0|||
46708904|NCT04058158|82924772|FG001|Period 1|Pregnancy|1|||
46708905|NCT04027946|82924778|FG000|Overall Study|Screen failures|3|||
46708906|NCT04004611|82924791|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708907|NCT04004611|82924792|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708908|NCT04004611|82924793|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708909|NCT04004611|82924794|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708910|NCT04004611|82924795|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708911|NCT04004611|82924796|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708912|NCT04004611|82924797|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708913|NCT04004611|82924798|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
46708914|NCT04004611|82924799|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
46708915|NCT04004611|82924791|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
46708916|NCT04004611|82924792|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
46708917|NCT04004611|82924793|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
46708918|NCT04004611|82924794|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
46708919|NCT04004611|82924795|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
46708920|NCT04004611|82924796|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
46708921|NCT04004611|82924797|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
46708922|NCT04004611|82924798|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
46708923|NCT04004611|82924799|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
46898890|NCT02273388|83125338|FG002|Overall Study|Adverse Event study disease worse|3|||
46898891|NCT02273388|83125339|FG003|Overall Study|Adverse Event study disease worse|2|||
46898892|NCT02273388|83125340|FG004|Overall Study|Adverse Event study disease worse|4|||
46898893|NCT02273388|83125341|FG005|Overall Study|Adverse Event study disease worse|3|||
46898894|NCT02273388|83125342|FG006|Overall Study|Adverse Event study disease worse|14|||
46898895|NCT02273388|83125343|FG007|Overall Study|Adverse Event study disease worse|6|||
46898896|NCT02273388|83125344|FG008|Overall Study|Adverse Event study disease worse|6|||
46898897|NCT02273388|83125345|FG009|Overall Study|Adverse Event study disease worse|5|||
46898898|NCT02273388|83125346|FG010|Overall Study|Adverse Event study disease worse|10|||
46898899|NCT02273388|83125347|FG011|Overall Study|Adverse Event study disease worse|1|||
46898900|NCT02273388|83125336|FG000|Overall Study|Sponsor decision|0|||
46898901|NCT02273388|83125337|FG001|Overall Study|Sponsor decision|0|||
46898902|NCT02273388|83125338|FG002|Overall Study|Sponsor decision|0|||
46898903|NCT02273388|83125339|FG003|Overall Study|Sponsor decision|0|||
46898904|NCT02273388|83125340|FG004|Overall Study|Sponsor decision|0|||
46898905|NCT02273388|83125341|FG005|Overall Study|Sponsor decision|0|||
46898906|NCT02273388|83125342|FG006|Overall Study|Sponsor decision|0|||
46898907|NCT02273388|83125343|FG007|Overall Study|Sponsor decision|0|||
46898908|NCT02273388|83125344|FG008|Overall Study|Sponsor decision|0|||
46898909|NCT02273388|83125345|FG009|Overall Study|Sponsor decision|0|||
46898910|NCT02273388|83125346|FG010|Overall Study|Sponsor decision|0|||
46898911|NCT02273388|83125347|FG011|Overall Study|Sponsor decision|1|||
46898912|NCT02272790|83125382|FG000|Overall Study|Physician Decision|0|||
46898913|NCT02272790|83125383|FG001|Overall Study|Physician Decision|1|||
46898914|NCT02272790|83125384|FG002|Overall Study|Physician Decision|0|||
46898915|NCT02272790|83125385|FG003|Overall Study|Physician Decision|0|||
46898916|NCT02272790|83125386|FG004|Overall Study|Physician Decision|0|||
46898917|NCT02272790|83125387|FG005|Overall Study|Physician Decision|0|||
46898918|NCT02100956|83125409|FG000|At Least One Week Between Injections|Adverse Event|0|||
46898919|NCT02100956|83125410|FG001|At Least One Week Between Injections|Adverse Event|1|||
46898920|NCT01438411|83125416|FG000|Overall Study|Adverse Event|8|||
46898921|NCT01438411|83125416|FG000|Overall Study|Lost to Follow-up|1|||
46898922|NCT01438411|83125416|FG000|Overall Study|Lack of Efficacy|1|||
46898923|NCT01438411|83125416|FG000|Overall Study|Withdrawal by Subject|3|||
46898924|NCT01302834|83125422|FG000|Overall Study|Protocol Violation|17|||
46996406|NCT01833832|83243510|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
46996407|NCT01833520|83243516|FG000|Overall Study|Lack of Efficacy|3|||
46898925|NCT01302834|83125423|FG001|Overall Study|Protocol Violation|23|||
46898926|NCT01302834|83125422|FG000|Overall Study|HIV positive|1|||
46898927|NCT01302834|83125423|FG001|Overall Study|HIV positive|3|||
46898928|NCT01153698|83125429|FG000|Overall Study|Adverse Event|12|||
46898929|NCT01153698|83125429|FG000|Overall Study|Lost to Follow-up|4|||
46898930|NCT01153698|83125429|FG000|Overall Study|Withdrawal by Subject|2|||
46898931|NCT01153698|83125429|FG000|Overall Study|Switch to other anticoagulants|4|||
46898932|NCT01153698|83125429|FG000|Overall Study|Other|2|||
46898933|NCT01153698|83125429|FG000|Overall Study|Not treated with Pradaxa|5|||
46898934|NCT00804856|83125462|FG000|Overall Study|Progressive Disease|3|||
46898935|NCT00804856|83125463|FG001|Overall Study|Progressive Disease|2|||
46898936|NCT00804856|83125464|FG002|Overall Study|Progressive Disease|4|||
46898937|NCT00804856|83125465|FG003|Overall Study|Progressive Disease|6|||
46898938|NCT00804856|83125466|FG004|Overall Study|Progressive Disease|4|||
46898939|NCT00804856|83125467|FG005|Overall Study|Progressive Disease|1|||
46898940|NCT00804856|83125468|FG006|Overall Study|Progressive Disease|8|||
46898941|NCT00804856|83125469|FG007|Overall Study|Progressive Disease|2|||
46898942|NCT00804856|83125470|FG008|Overall Study|Progressive Disease|4|||
46898943|NCT00804856|83125471|FG009|Overall Study|Progressive Disease|5|||
46898944|NCT00804856|83125472|FG010|Overall Study|Progressive Disease|12|||
46996408|NCT01833520|83243517|FG001|Overall Study|Lack of Efficacy|3|||
46898945|NCT00804856|83125473|FG011|Overall Study|Progressive Disease|2|||
46898946|NCT00804856|83125474|FG012|Overall Study|Progressive Disease|2|||
46898947|NCT00804856|83125475|FG013|Overall Study|Progressive Disease|26|||
46898948|NCT00804856|83125476|FG014|Overall Study|Progressive Disease|20|||
46898949|NCT00804856|83125462|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898950|NCT00804856|83125463|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898951|NCT00804856|83125464|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898952|NCT00804856|83125465|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898953|NCT00804856|83125466|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
46898954|NCT00804856|83125467|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898955|NCT00804856|83125468|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898956|NCT00804856|83125469|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898957|NCT00804856|83125470|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898958|NCT00804856|83125471|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898959|NCT00804856|83125472|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898960|NCT00804856|83125473|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898961|NCT00804856|83125474|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898962|NCT00804856|83125475|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46898963|NCT00804856|83125476|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
46898964|NCT00804856|83125462|FG000|Overall Study|Other Adverse Event|1|||
46996409|NCT01833520|83243518|FG002|Overall Study|Lack of Efficacy|8|||
46996410|NCT01833520|83243519|FG003|Overall Study|Lack of Efficacy|3|||
46996411|NCT01850602|83243533|FG000|Overall Study|Adverse Event|7|||
46996412|NCT01850602|83243534|FG001|Overall Study|Adverse Event|10|||
46996413|NCT01850602|83243533|FG000|Overall Study|Physician Decision|2|||
46996414|NCT01850602|83243534|FG001|Overall Study|Physician Decision|1|||
46996415|NCT01850602|83243533|FG000|Overall Study|Withdrawal by Subject|2|||
46996416|NCT01850602|83243534|FG001|Overall Study|Withdrawal by Subject|4|||
46996417|NCT01850602|83243533|FG000|Overall Study|Decrease in serum calcium|2|||
46996418|NCT01850602|83243534|FG001|Overall Study|Decrease in serum calcium|3|||
46996419|NCT01850602|83243533|FG000|Overall Study|Increase in serum ferritin|1|||
46996420|NCT01850602|83243534|FG001|Overall Study|Increase in serum ferritin|0|||
46996421|NCT01832818|83243540|FG000|Overall Study|Lost to Follow-up|6|||
46996422|NCT02405780|83243548|FG000|Period I|Adverse Event|8|||
46996423|NCT02405780|83243549|FG001|Period I|Adverse Event|0|||
46996424|NCT02405780|83243550|FG002|Period I|Adverse Event|3|||
46996425|NCT02405780|83243551|FG003|Period I|Adverse Event|7|||
46996426|NCT02405780|83243548|FG000|Period I|Medical reasons|1|||
46996427|NCT02405780|83243549|FG001|Period I|Medical reasons|1|||
46996428|NCT02405780|83243550|FG002|Period I|Medical reasons|0|||
46996429|NCT02405780|83243551|FG003|Period I|Medical reasons|1|||
46996430|NCT02405780|83243548|FG000|Period I|Screening Failure|1|||
46996431|NCT02405780|83243549|FG001|Period I|Screening Failure|0|||
46996432|NCT02405780|83243550|FG002|Period I|Screening Failure|1|||
46996433|NCT02405780|83243551|FG003|Period I|Screening Failure|0|||
46996434|NCT02405780|83243548|FG000|Period I|Withdrawal by Subject|9|||
46996435|NCT02405780|83243549|FG001|Period I|Withdrawal by Subject|1|||
46996436|NCT02405780|83243550|FG002|Period I|Withdrawal by Subject|3|||
46996437|NCT02405780|83243551|FG003|Period I|Withdrawal by Subject|4|||
46996438|NCT02405780|83243548|FG000|Period I|Non-compliance with study procedures|8|||
46996439|NCT02405780|83243549|FG001|Period I|Non-compliance with study procedures|6|||
46996440|NCT02405780|83243550|FG002|Period I|Non-compliance with study procedures|8|||
46996441|NCT02405780|83243551|FG003|Period I|Non-compliance with study procedures|11|||
46996442|NCT02405780|83243548|FG000|Period II|Adverse Event|3|||
46898965|NCT00804856|83125463|FG001|Overall Study|Other Adverse Event|1|||
46898966|NCT00804856|83125464|FG002|Overall Study|Other Adverse Event|1|||
46898967|NCT00804856|83125465|FG003|Overall Study|Other Adverse Event|2|||
46898968|NCT00804856|83125466|FG004|Overall Study|Other Adverse Event|2|||
46898969|NCT00804856|83125467|FG005|Overall Study|Other Adverse Event|1|||
46898970|NCT00804856|83125468|FG006|Overall Study|Other Adverse Event|3|||
46898971|NCT00804856|83125469|FG007|Overall Study|Other Adverse Event|0|||
46898972|NCT00804856|83125470|FG008|Overall Study|Other Adverse Event|0|||
46898973|NCT00804856|83125471|FG009|Overall Study|Other Adverse Event|1|||
46898974|NCT00804856|83125472|FG010|Overall Study|Other Adverse Event|5|||
46898975|NCT00804856|83125473|FG011|Overall Study|Other Adverse Event|2|||
46898976|NCT00804856|83125474|FG012|Overall Study|Other Adverse Event|0|||
46898977|NCT00804856|83125475|FG013|Overall Study|Other Adverse Event|6|||
46898978|NCT00804856|83125476|FG014|Overall Study|Other Adverse Event|13|||
46898979|NCT00804856|83125462|FG000|Overall Study|Non compliance with protocol|0|||
46898980|NCT00804856|83125463|FG001|Overall Study|Non compliance with protocol|0|||
46898981|NCT00804856|83125464|FG002|Overall Study|Non compliance with protocol|0|||
46898982|NCT00804856|83125465|FG003|Overall Study|Non compliance with protocol|0|||
46898983|NCT00804856|83125466|FG004|Overall Study|Non compliance with protocol|0|||
46898984|NCT00804856|83125467|FG005|Overall Study|Non compliance with protocol|0|||
46898985|NCT00804856|83125468|FG006|Overall Study|Non compliance with protocol|0|||
46898986|NCT00804856|83125469|FG007|Overall Study|Non compliance with protocol|0|||
46898987|NCT00804856|83125470|FG008|Overall Study|Non compliance with protocol|0|||
46898988|NCT00804856|83125471|FG009|Overall Study|Non compliance with protocol|0|||
46898989|NCT00804856|83125472|FG010|Overall Study|Non compliance with protocol|0|||
46996443|NCT02405780|83243549|FG001|Period II|Adverse Event|5|||
46996444|NCT02405780|83243550|FG002|Period II|Adverse Event|4|||
46996445|NCT02405780|83243551|FG003|Period II|Adverse Event|11|||
46996446|NCT02405780|83243548|FG000|Period II|Medical reason|0|||
46996447|NCT02405780|83243549|FG001|Period II|Medical reason|1|||
46898990|NCT00804856|83125473|FG011|Overall Study|Non compliance with protocol|0|||
46898991|NCT00804856|83125474|FG012|Overall Study|Non compliance with protocol|0|||
46898992|NCT00804856|83125475|FG013|Overall Study|Non compliance with protocol|2|||
46898993|NCT00804856|83125476|FG014|Overall Study|Non compliance with protocol|0|||
46898994|NCT00804856|83125462|FG000|Overall Study|Refused to continue medication|0|||
46898995|NCT00804856|83125463|FG001|Overall Study|Refused to continue medication|0|||
46898996|NCT00804856|83125464|FG002|Overall Study|Refused to continue medication|0|||
46898997|NCT00804856|83125465|FG003|Overall Study|Refused to continue medication|1|||
46898998|NCT00804856|83125466|FG004|Overall Study|Refused to continue medication|1|||
46898999|NCT00804856|83125467|FG005|Overall Study|Refused to continue medication|0|||
46899000|NCT00804856|83125468|FG006|Overall Study|Refused to continue medication|0|||
46899001|NCT00804856|83125469|FG007|Overall Study|Refused to continue medication|0|||
46899002|NCT00804856|83125470|FG008|Overall Study|Refused to continue medication|0|||
46899003|NCT00804856|83125471|FG009|Overall Study|Refused to continue medication|0|||
46899004|NCT00804856|83125472|FG010|Overall Study|Refused to continue medication|3|||
46899005|NCT00804856|83125473|FG011|Overall Study|Refused to continue medication|0|||
46899006|NCT00804856|83125474|FG012|Overall Study|Refused to continue medication|1|||
46899007|NCT00804856|83125475|FG013|Overall Study|Refused to continue medication|1|||
46899008|NCT00804856|83125476|FG014|Overall Study|Refused to continue medication|5|||
46899009|NCT00804856|83125462|FG000|Overall Study|Other reason than listed above|0|||
46899010|NCT00804856|83125463|FG001|Overall Study|Other reason than listed above|0|||
46899011|NCT00804856|83125464|FG002|Overall Study|Other reason than listed above|0|||
46899012|NCT00804856|83125465|FG003|Overall Study|Other reason than listed above|0|||
46899013|NCT00804856|83125466|FG004|Overall Study|Other reason than listed above|0|||
46899014|NCT00804856|83125467|FG005|Overall Study|Other reason than listed above|1|||
46899015|NCT00804856|83125468|FG006|Overall Study|Other reason than listed above|0|||
46899016|NCT00804856|83125469|FG007|Overall Study|Other reason than listed above|0|||
46899017|NCT00804856|83125470|FG008|Overall Study|Other reason than listed above|1|||
46996448|NCT02405780|83243550|FG002|Period II|Medical reason|0|||
46996449|NCT02405780|83243551|FG003|Period II|Medical reason|0|||
46996450|NCT02405780|83243548|FG000|Period II|Pregnancy|0|||
46996451|NCT02405780|83243549|FG001|Period II|Pregnancy|0|||
46996452|NCT02405780|83243550|FG002|Period II|Pregnancy|1|||
46996453|NCT02405780|83243551|FG003|Period II|Pregnancy|0|||
46996454|NCT02405780|83243548|FG000|Period II|Withdrawal by Subject|7|||
46899018|NCT00804856|83125471|FG009|Overall Study|Other reason than listed above|0|||
46996455|NCT02405780|83243549|FG001|Period II|Withdrawal by Subject|4|||
46899019|NCT00804856|83125472|FG010|Overall Study|Other reason than listed above|3|||
46996456|NCT02405780|83243550|FG002|Period II|Withdrawal by Subject|0|||
46996457|NCT02405780|83243551|FG003|Period II|Withdrawal by Subject|3|||
46996458|NCT02405780|83243548|FG000|Period II|Non-compliance with study procedures|5|||
46996459|NCT02405780|83243549|FG001|Period II|Non-compliance with study procedures|2|||
46996460|NCT02405780|83243550|FG002|Period II|Non-compliance with study procedures|7|||
46996461|NCT02405780|83243551|FG003|Period II|Non-compliance with study procedures|4|||
46996462|NCT02369510|83243579|FG000|Overall Study|Spilled Medication|1|||
46996463|NCT02369510|83243580|FG001|Overall Study|Spilled Medication|2|||
46996464|NCT02369510|83243581|FG002|Overall Study|Spilled Medication|1|||
46996465|NCT02369510|83243579|FG000|Overall Study|Epidural Activation|1|||
46996466|NCT02369510|83243580|FG001|Overall Study|Epidural Activation|1|||
46996467|NCT02369510|83243581|FG002|Overall Study|Epidural Activation|5|||
46996468|NCT01650194|83243589|FG000|Overall Study|Progressive Disease (PD)|35|||
46996469|NCT01650194|83243589|FG000|Overall Study|Withdrawal by Subject|2|||
46996470|NCT01650194|83243589|FG000|Overall Study|Miscellaneous|10|||
46996471|NCT02367716|83243594|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
46996472|NCT02366936|83243599|FG000|Overall Study|Withdrawal by Subject|2|||
46996473|NCT02366936|83243599|FG000|Overall Study|Lost to Follow-up|4|||
46996474|NCT02366936|83243599|FG000|Overall Study|Physician Decision|2|||
46996475|NCT01648166|83243605|FG000|Overall Study|inadequate toenail samples|53|||
46899020|NCT00804856|83125473|FG011|Overall Study|Other reason than listed above|1|||
46899021|NCT00804856|83125474|FG012|Overall Study|Other reason than listed above|1|||
46708924|NCT04004611|82924791|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46708925|NCT04004611|82924792|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46899022|NCT00804856|83125475|FG013|Overall Study|Other reason than listed above|10|||
46899023|NCT00804856|83125476|FG014|Overall Study|Other reason than listed above|3|||
46899024|NCT01314872|83125564|FG000|Treatment Period 1|Protocol Violation|2|||
46899025|NCT01314872|83125565|FG001|Treatment Period 1|Protocol Violation|1|||
46899026|NCT01314872|83125566|FG002|Treatment Period 1|Protocol Violation|1|||
46899027|NCT01314872|83125567|FG003|Treatment Period 1|Protocol Violation|0|||
46996476|NCT01648166|83243606|FG001|Overall Study|inadequate toenail samples|100|||
46996477|NCT02404220|83243616|FG000|Overall Study|Adverse Event|0|||
46996478|NCT02404220|83243617|FG001|Overall Study|Adverse Event|0|||
46996479|NCT02404220|83243618|FG002|Overall Study|Adverse Event|1|||
46996480|NCT02404220|83243619|FG003|Overall Study|Adverse Event|0|||
46899028|NCT01314872|83125568|FG004|Treatment Period 1|Protocol Violation|1|||
46899029|NCT01314872|83125569|FG005|Treatment Period 1|Protocol Violation|0|||
46899030|NCT01314872|83125570|FG006|Treatment Period 1|Protocol Violation|0|||
46899031|NCT01314872|83125571|FG007|Treatment Period 1|Protocol Violation|0|||
46899032|NCT01314872|83125572|FG008|Treatment Period 1|Protocol Violation|0|||
46899033|NCT01314872|83125573|FG009|Treatment Period 1|Protocol Violation|1|||
46899034|NCT01314872|83125574|FG010|Treatment Period 1|Protocol Violation|1|||
46899035|NCT01314872|83125575|FG011|Treatment Period 1|Protocol Violation|0|||
46899036|NCT01314872|83125576|FG012|Treatment Period 1|Protocol Violation|0|||
46899037|NCT01314872|83125577|FG013|Treatment Period 1|Protocol Violation|0|||
46899038|NCT01314872|83125578|FG014|Treatment Period 1|Protocol Violation|0|||
46899039|NCT01314872|83125564|FG000|Treatment Period 1|Physician Decision|0|||
46899040|NCT01314872|83125565|FG001|Treatment Period 1|Physician Decision|1|||
46899041|NCT01314872|83125566|FG002|Treatment Period 1|Physician Decision|0|||
46899042|NCT01314872|83125567|FG003|Treatment Period 1|Physician Decision|1|||
46899043|NCT01314872|83125568|FG004|Treatment Period 1|Physician Decision|0|||
46899044|NCT01314872|83125569|FG005|Treatment Period 1|Physician Decision|0|||
46899045|NCT01314872|83125570|FG006|Treatment Period 1|Physician Decision|0|||
46899046|NCT01314872|83125571|FG007|Treatment Period 1|Physician Decision|0|||
46899047|NCT01314872|83125572|FG008|Treatment Period 1|Physician Decision|0|||
46899048|NCT01314872|83125573|FG009|Treatment Period 1|Physician Decision|1|||
46899049|NCT01314872|83125574|FG010|Treatment Period 1|Physician Decision|0|||
46899050|NCT01314872|83125575|FG011|Treatment Period 1|Physician Decision|0|||
46899051|NCT01314872|83125576|FG012|Treatment Period 1|Physician Decision|0|||
46899052|NCT01314872|83125577|FG013|Treatment Period 1|Physician Decision|0|||
46899053|NCT01314872|83125578|FG014|Treatment Period 1|Physician Decision|0|||
46899054|NCT01314872|83125564|FG000|Treatment Period 1|Lack of Efficacy|1|||
46899055|NCT01314872|83125565|FG001|Treatment Period 1|Lack of Efficacy|0|||
46899056|NCT01314872|83125566|FG002|Treatment Period 1|Lack of Efficacy|0|||
46899057|NCT01314872|83125567|FG003|Treatment Period 1|Lack of Efficacy|0|||
46899058|NCT01314872|83125568|FG004|Treatment Period 1|Lack of Efficacy|0|||
46899059|NCT01314872|83125569|FG005|Treatment Period 1|Lack of Efficacy|1|||
46899060|NCT01314872|83125570|FG006|Treatment Period 1|Lack of Efficacy|0|||
46899061|NCT01314872|83125571|FG007|Treatment Period 1|Lack of Efficacy|2|||
46899062|NCT01314872|83125572|FG008|Treatment Period 1|Lack of Efficacy|0|||
46899063|NCT01314872|83125573|FG009|Treatment Period 1|Lack of Efficacy|0|||
46899064|NCT01314872|83125574|FG010|Treatment Period 1|Lack of Efficacy|0|||
46899065|NCT01314872|83125575|FG011|Treatment Period 1|Lack of Efficacy|0|||
46899066|NCT01314872|83125576|FG012|Treatment Period 1|Lack of Efficacy|0|||
46899067|NCT01314872|83125577|FG013|Treatment Period 1|Lack of Efficacy|0|||
46899068|NCT01314872|83125578|FG014|Treatment Period 1|Lack of Efficacy|0|||
46899069|NCT01314872|83125564|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
46899070|NCT01314872|83125565|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
46899071|NCT01314872|83125566|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
46899072|NCT01314872|83125567|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
46899073|NCT01314872|83125568|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
46899074|NCT01314872|83125569|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
46899075|NCT01314872|83125570|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
46899076|NCT01314872|83125571|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
46899077|NCT01314872|83125572|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
46899078|NCT01314872|83125573|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
46899079|NCT01314872|83125574|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
46899080|NCT01314872|83125575|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
46996481|NCT02404220|83243616|FG000|Overall Study|Death|5|||
46996482|NCT02404220|83243617|FG001|Overall Study|Death|5|||
46996483|NCT02404220|83243618|FG002|Overall Study|Death|3|||
46996484|NCT02404220|83243619|FG003|Overall Study|Death|8|||
46996485|NCT02404220|83243616|FG000|Overall Study|Progressive Disease|0|||
46996486|NCT02404220|83243617|FG001|Overall Study|Progressive Disease|0|||
46899081|NCT01314872|83125576|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
46899082|NCT01314872|83125577|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
46899083|NCT01314872|83125578|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
46899084|NCT01314872|83125564|FG000|Treatment Period 1|Withdrawal by Subject|3|||
46899085|NCT01314872|83125565|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46899086|NCT01314872|83125566|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46899087|NCT01314872|83125567|FG003|Treatment Period 1|Withdrawal by Subject|2|||
46899088|NCT01314872|83125568|FG004|Treatment Period 1|Withdrawal by Subject|3|||
46899089|NCT01314872|83125569|FG005|Treatment Period 1|Withdrawal by Subject|1|||
46996487|NCT02404220|83243618|FG002|Overall Study|Progressive Disease|1|||
46996488|NCT02404220|83243619|FG003|Overall Study|Progressive Disease|1|||
46899090|NCT01314872|83125570|FG006|Treatment Period 1|Withdrawal by Subject|3|||
46899091|NCT01314872|83125571|FG007|Treatment Period 1|Withdrawal by Subject|2|||
46899092|NCT01314872|83125572|FG008|Treatment Period 1|Withdrawal by Subject|2|||
46899093|NCT01314872|83125573|FG009|Treatment Period 1|Withdrawal by Subject|2|||
46996489|NCT02404220|83243616|FG000|Overall Study|Study Terminated by Sponsor|0|||
46899094|NCT01314872|83125574|FG010|Treatment Period 1|Withdrawal by Subject|1|||
46899095|NCT01314872|83125575|FG011|Treatment Period 1|Withdrawal by Subject|0|||
46899096|NCT01314872|83125576|FG012|Treatment Period 1|Withdrawal by Subject|0|||
46899097|NCT01314872|83125577|FG013|Treatment Period 1|Withdrawal by Subject|0|||
46899098|NCT01314872|83125578|FG014|Treatment Period 1|Withdrawal by Subject|0|||
46899099|NCT01314872|83125564|FG000|Treatment Period 1|Lost to Follow-up|0|||
46899100|NCT01314872|83125565|FG001|Treatment Period 1|Lost to Follow-up|1|||
46899101|NCT01314872|83125566|FG002|Treatment Period 1|Lost to Follow-up|2|||
46899102|NCT01314872|83125567|FG003|Treatment Period 1|Lost to Follow-up|2|||
46899103|NCT01314872|83125568|FG004|Treatment Period 1|Lost to Follow-up|1|||
46899104|NCT01314872|83125569|FG005|Treatment Period 1|Lost to Follow-up|1|||
46899105|NCT01314872|83125570|FG006|Treatment Period 1|Lost to Follow-up|1|||
46899106|NCT01314872|83125571|FG007|Treatment Period 1|Lost to Follow-up|1|||
46899107|NCT01314872|83125572|FG008|Treatment Period 1|Lost to Follow-up|1|||
46899108|NCT01314872|83125573|FG009|Treatment Period 1|Lost to Follow-up|0|||
46899109|NCT01314872|83125574|FG010|Treatment Period 1|Lost to Follow-up|0|||
46899110|NCT01314872|83125575|FG011|Treatment Period 1|Lost to Follow-up|0|||
46899111|NCT01314872|83125576|FG012|Treatment Period 1|Lost to Follow-up|0|||
46899112|NCT01314872|83125577|FG013|Treatment Period 1|Lost to Follow-up|0|||
46899113|NCT01314872|83125578|FG014|Treatment Period 1|Lost to Follow-up|0|||
46899114|NCT01314872|83125564|FG000|Period 2|Protocol Violation|0|||
46899115|NCT01314872|83125565|FG001|Period 2|Protocol Violation|0|||
46899116|NCT01314872|83125566|FG002|Period 2|Protocol Violation|0|||
46899117|NCT01314872|83125567|FG003|Period 2|Protocol Violation|0|||
46899118|NCT01314872|83125568|FG004|Period 2|Protocol Violation|0|||
46899119|NCT01314872|83125569|FG005|Period 2|Protocol Violation|0|||
46899120|NCT01314872|83125570|FG006|Period 2|Protocol Violation|0|||
46899121|NCT01314872|83125571|FG007|Period 2|Protocol Violation|0|||
46899122|NCT01314872|83125572|FG008|Period 2|Protocol Violation|0|||
46899123|NCT01314872|83125573|FG009|Period 2|Protocol Violation|0|||
46899124|NCT01314872|83125574|FG010|Period 2|Protocol Violation|0|||
46899125|NCT01314872|83125575|FG011|Period 2|Protocol Violation|3|||
46899126|NCT01314872|83125576|FG012|Period 2|Protocol Violation|3|||
46899127|NCT01314872|83125577|FG013|Period 2|Protocol Violation|2|||
46899128|NCT01314872|83125578|FG014|Period 2|Protocol Violation|0|||
46899129|NCT01314872|83125564|FG000|Period 2|Non-compliance with study drug|0|||
46899130|NCT01314872|83125565|FG001|Period 2|Non-compliance with study drug|0|||
46899131|NCT01314872|83125566|FG002|Period 2|Non-compliance with study drug|0|||
46899132|NCT01314872|83125567|FG003|Period 2|Non-compliance with study drug|0|||
46899133|NCT01314872|83125568|FG004|Period 2|Non-compliance with study drug|0|||
46899134|NCT01314872|83125569|FG005|Period 2|Non-compliance with study drug|0|||
46708926|NCT04004611|82924793|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46708927|NCT04004611|82924794|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46708928|NCT04004611|82924795|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
46708929|NCT04004611|82924796|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46708930|NCT04004611|82924797|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46708931|NCT04004611|82924798|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46708932|NCT04004611|82924799|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
46708933|NCT04004611|82924791|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
46708934|NCT04004611|82924792|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
46708935|NCT04004611|82924793|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
46708936|NCT04004611|82924794|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
46708937|NCT04004611|82924795|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
46708938|NCT04004611|82924796|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
46708939|NCT04004611|82924797|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
46708940|NCT04004611|82924798|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
46708941|NCT04004611|82924799|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
46708942|NCT04004611|82924791|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
46708943|NCT04004611|82924792|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
46708944|NCT04004611|82924793|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
46708945|NCT04004611|82924794|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
46708946|NCT04004611|82924795|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
46708947|NCT04004611|82924796|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
46708948|NCT04004611|82924797|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
46708949|NCT04004611|82924798|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
46708950|NCT04004611|82924799|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
46708951|NCT04004611|82924791|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46708952|NCT04004611|82924792|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
46708953|NCT04004611|82924793|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46899135|NCT01314872|83125570|FG006|Period 2|Non-compliance with study drug|0|||
46899136|NCT01314872|83125571|FG007|Period 2|Non-compliance with study drug|0|||
46899137|NCT01314872|83125572|FG008|Period 2|Non-compliance with study drug|0|||
46899138|NCT01314872|83125573|FG009|Period 2|Non-compliance with study drug|0|||
46899139|NCT01314872|83125574|FG010|Period 2|Non-compliance with study drug|0|||
46899140|NCT01314872|83125575|FG011|Period 2|Non-compliance with study drug|3|||
46899141|NCT01314872|83125576|FG012|Period 2|Non-compliance with study drug|3|||
46899142|NCT01314872|83125577|FG013|Period 2|Non-compliance with study drug|1|||
46899143|NCT01314872|83125578|FG014|Period 2|Non-compliance with study drug|2|||
46899144|NCT01314872|83125564|FG000|Period 2|Lack of Efficacy|0|||
46899145|NCT01314872|83125565|FG001|Period 2|Lack of Efficacy|0|||
46899146|NCT01314872|83125566|FG002|Period 2|Lack of Efficacy|0|||
46899147|NCT01314872|83125567|FG003|Period 2|Lack of Efficacy|0|||
46899148|NCT01314872|83125568|FG004|Period 2|Lack of Efficacy|0|||
46899149|NCT01314872|83125569|FG005|Period 2|Lack of Efficacy|0|||
46899150|NCT01314872|83125570|FG006|Period 2|Lack of Efficacy|0|||
46899151|NCT01314872|83125571|FG007|Period 2|Lack of Efficacy|0|||
46899152|NCT01314872|83125572|FG008|Period 2|Lack of Efficacy|0|||
46899153|NCT01314872|83125573|FG009|Period 2|Lack of Efficacy|0|||
46899154|NCT01314872|83125574|FG010|Period 2|Lack of Efficacy|0|||
46899155|NCT01314872|83125575|FG011|Period 2|Lack of Efficacy|7|||
46996490|NCT02404220|83243617|FG001|Overall Study|Study Terminated by Sponsor|0|||
46996491|NCT02404220|83243618|FG002|Overall Study|Study Terminated by Sponsor|2|||
46996492|NCT02404220|83243619|FG003|Overall Study|Study Terminated by Sponsor|1|||
46996493|NCT02404220|83243616|FG000|Overall Study|Withdrawal by Subject|0|||
46996494|NCT02404220|83243617|FG001|Overall Study|Withdrawal by Subject|1|||
46996495|NCT02404220|83243618|FG002|Overall Study|Withdrawal by Subject|0|||
46996496|NCT02404220|83243619|FG003|Overall Study|Withdrawal by Subject|0|||
46996497|NCT02404220|83243616|FG000|Overall Study|Enrolled but Never Treated|0|||
46996498|NCT02404220|83243617|FG001|Overall Study|Enrolled but Never Treated|2|||
46996499|NCT02404220|83243618|FG002|Overall Study|Enrolled but Never Treated|0|||
46996500|NCT02404220|83243619|FG003|Overall Study|Enrolled but Never Treated|0|||
46996501|NCT02335658|83243631|FG000|Overall Study|Adverse Event|18|||
46996502|NCT02335658|83243632|FG001|Overall Study|Adverse Event|12|||
46996503|NCT02335658|83243631|FG000|Overall Study|Lack of Efficacy|4|||
46708954|NCT04004611|82924794|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46708955|NCT04004611|82924795|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46708956|NCT04004611|82924796|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46708957|NCT04004611|82924797|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46708958|NCT04004611|82924798|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46708959|NCT04004611|82924799|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
46708960|NCT03716726|82924835|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
46708961|NCT03716726|82924836|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
46708962|NCT03716726|82924835|FG000|12 Months Followup|Lost to Follow-up|10|||
46708963|NCT03716726|82924836|FG001|12 Months Followup|Lost to Follow-up|17|||
46996504|NCT02335658|83243632|FG001|Overall Study|Lack of Efficacy|5|||
46996505|NCT02335658|83243631|FG000|Overall Study|Pregnancy|1|||
46996506|NCT02335658|83243632|FG001|Overall Study|Pregnancy|0|||
46996507|NCT02335658|83243631|FG000|Overall Study|Withdrawal by Subject|13|||
46996508|NCT02335658|83243632|FG001|Overall Study|Withdrawal by Subject|21|||
46996509|NCT02335658|83243631|FG000|Overall Study|non-compliance|2|||
46996510|NCT02335658|83243632|FG001|Overall Study|non-compliance|3|||
46708964|NCT03539952|82924844|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
46708965|NCT03539952|82924845|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
46899156|NCT01314872|83125576|FG012|Period 2|Lack of Efficacy|12|||
46899157|NCT01314872|83125577|FG013|Period 2|Lack of Efficacy|9|||
46899158|NCT01314872|83125578|FG014|Period 2|Lack of Efficacy|2|||
46996511|NCT02335658|83243631|FG000|Overall Study|other reason|2|||
46996512|NCT02335658|83243632|FG001|Overall Study|other reason|3|||
46996513|NCT02366468|83243642|FG000|Overall Study|Adverse Event|2|||
46620140|NCT01643850|82761703|FG000|Overall Study|Administrative Problems|0|||
46620141|NCT01643850|82761704|FG001|Overall Study|Administrative Problems|0|||
46620142|NCT01643850|82761705|FG002|Overall Study|Administrative Problems|1|||
46620143|NCT01643850|82761706|FG003|Overall Study|Administrative Problems|0|||
46620144|NCT01643850|82761707|FG004|Overall Study|Administrative Problems|1|||
46620145|NCT01643850|82761708|FG005|Overall Study|Administrative Problems|0|||
46620146|NCT01643850|82761709|FG006|Overall Study|Administrative Problems|0|||
46620147|NCT01643850|82761710|FG007|Overall Study|Administrative Problems|0|||
46620148|NCT01643850|82761711|FG008|Overall Study|Administrative Problems|0|||
46620149|NCT02271594|82761779|FG000|Overall Study|Study closed; recruiting failure|19|||
46620150|NCT02271594|82761780|FG001|Overall Study|Study closed; recruiting failure|12|||
46620151|NCT02535923|82761799|FG000|Overall Study|Lost to Follow-up|5|||
46708966|NCT03539952|82924844|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
46708967|NCT03539952|82924845|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
46708968|NCT03539952|82924844|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
46708969|NCT03539952|82924845|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
46708970|NCT03539952|82924844|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
46708971|NCT03539952|82924845|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
46708972|NCT03539952|82924844|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
46708973|NCT03539952|82924845|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
46708974|NCT03539952|82924844|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
46708975|NCT03539952|82924845|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
46708976|NCT03539952|82924844|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
46708977|NCT03539952|82924845|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
46708978|NCT03504774|82924863|FG000|Overall Study|Adverse Event|2|||
46708979|NCT03504774|82924864|FG001|Overall Study|Adverse Event|0|||
46708980|NCT03504774|82924863|FG000|Overall Study|Lost to Follow-up|0|||
46708981|NCT03504774|82924864|FG001|Overall Study|Lost to Follow-up|1|||
46708982|NCT03504774|82924863|FG000|Overall Study|Protocol Violation|11|||
46708983|NCT03504774|82924864|FG001|Overall Study|Protocol Violation|3|||
46708984|NCT03504774|82924863|FG000|Overall Study|failed wk 52 DBPCFC|1|||
46708985|NCT03504774|82924864|FG001|Overall Study|failed wk 52 DBPCFC|0|||
46708986|NCT03499249|82924871|FG000|Overall Study|Physician Decision|1|||
46708987|NCT03459846|82924877|FG000|Overall Study|Death|52|||
46996514|NCT02366468|83243643|FG001|Overall Study|Adverse Event|0|||
46996515|NCT02366468|83243642|FG000|Overall Study|Withdrawal by Subject|1|||
46996516|NCT02366468|83243643|FG001|Overall Study|Withdrawal by Subject|5|||
46996517|NCT02366468|83243642|FG000|Overall Study|Lost to Follow-up|2|||
46996518|NCT02366468|83243643|FG001|Overall Study|Lost to Follow-up|0|||
46996519|NCT02366468|83243642|FG000|Overall Study|Death|1|||
46996520|NCT02366468|83243643|FG001|Overall Study|Death|2|||
46996521|NCT02366468|83243642|FG000|Overall Study|Other|0|||
46996522|NCT02366468|83243643|FG001|Overall Study|Other|2|||
46996523|NCT02366312|83243651|FG000|Overall Study|Lost to Follow-up|0|||
46996524|NCT02366312|83243652|FG001|Overall Study|Lost to Follow-up|1|||
46996525|NCT02335346|83243658|FG000|Overall Study|Adverse Event|11|||
46996526|NCT02335346|83243658|FG000|Overall Study|Withdrawal by Subject|1|||
46996527|NCT02403206|83243664|FG000|Overall Study|Lost to Follow-up|4|||
46996528|NCT02403206|83243665|FG001|Overall Study|Lost to Follow-up|3|||
46996529|NCT02403206|83243664|FG000|Overall Study|Physician Decision|2|||
46996530|NCT02403206|83243665|FG001|Overall Study|Physician Decision|0|||
46996531|NCT02403206|83243664|FG000|Overall Study|Withdrawal by Subject|3|||
46996532|NCT02403206|83243665|FG001|Overall Study|Withdrawal by Subject|3|||
46996533|NCT02403206|83243664|FG000|Overall Study|Reason not given|2|||
46996534|NCT02403206|83243665|FG001|Overall Study|Reason not given|4|||
46996535|NCT02333630|83243674|FG000|Overall Study|Lost to Follow-up|5|||
46996536|NCT02333630|83243675|FG001|Overall Study|Lost to Follow-up|2|||
46996537|NCT02401412|83243687|FG000|Overall Study|Lost to Follow-up|1|||
46996538|NCT02401412|83243688|FG001|Overall Study|Lost to Follow-up|0|||
46996539|NCT02401412|83243687|FG000|Overall Study|Discontinued Intervention|15|||
46996540|NCT02401412|83243688|FG001|Overall Study|Discontinued Intervention|21|||
46996541|NCT02401412|83243687|FG000|Overall Study|Withdrawal by Subject|4|||
46996542|NCT02401412|83243688|FG001|Overall Study|Withdrawal by Subject|4|||
46996543|NCT02401412|83243687|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
46996544|NCT02401412|83243688|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
46708988|NCT03459846|82924878|FG001|Overall Study|Death|46|||
46708989|NCT03459846|82924877|FG000|Overall Study|Study terminated by sponsor|24|||
46708990|NCT03459846|82924878|FG001|Overall Study|Study terminated by sponsor|28|||
46708991|NCT03459846|82924877|FG000|Overall Study|Withdrawal by Subject|2|||
46708992|NCT03459846|82924878|FG001|Overall Study|Withdrawal by Subject|2|||
46708993|NCT03404960|82924886|FG000|Overall Study|Adverse Event|0|||
46708994|NCT03404960|82924887|FG001|Overall Study|Adverse Event|2|||
46708995|NCT03404960|82924886|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
46708996|NCT03404960|82924887|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
46708997|NCT03404960|82924886|FG000|Overall Study|Bowel obstruction|0|||
46708998|NCT03404960|82924887|FG001|Overall Study|Bowel obstruction|1|||
46708999|NCT03404960|82924886|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
46709000|NCT03404960|82924887|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
46709001|NCT03290079|82924893|FG000|Overall Study|Death|2|||
46709002|NCT03125902|82924899|FG000|Overall Study|Adverse Event|0|||
46709003|NCT03125902|82924900|FG001|Overall Study|Adverse Event|1|||
46709004|NCT03125902|82924899|FG000|Overall Study|Death|119|||
46709005|NCT03125902|82924900|FG001|Overall Study|Death|229|||
46996545|NCT02401412|83243687|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
46996546|NCT02401412|83243688|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
46996547|NCT02365298|83243694|FG000|Period 2|incorrect Rx dispensed|1|||
46709006|NCT03125902|82924899|FG000|Overall Study|Lost to Follow-up|4|||
46709007|NCT03125902|82924900|FG001|Overall Study|Lost to Follow-up|13|||
46709008|NCT03125902|82924899|FG000|Overall Study|Other|0|||
46709009|NCT03125902|82924900|FG001|Overall Study|Other|4|||
46709010|NCT03125902|82924899|FG000|Overall Study|Physician Decision|2|||
46709011|NCT03125902|82924900|FG001|Overall Study|Physician Decision|1|||
46709012|NCT03125902|82924899|FG000|Overall Study|Progressive Disease|0|||
46709013|NCT03125902|82924900|FG001|Overall Study|Progressive Disease|3|||
46709014|NCT03125902|82924899|FG000|Overall Study|Study Terminated By Sponsor|74|||
46709015|NCT03125902|82924900|FG001|Overall Study|Study Terminated By Sponsor|143|||
46709016|NCT03125902|82924899|FG000|Overall Study|Withdrawal by Subject|21|||
46709017|NCT03125902|82924900|FG001|Overall Study|Withdrawal by Subject|37|||
46709018|NCT03064126|82924911|FG000|Overall Study|Death|6|||
46709019|NCT03064126|82924912|FG001|Overall Study|Death|2|||
46709020|NCT03064126|82924913|FG002|Overall Study|Death|2|||
46709021|NCT03064126|82924914|FG003|Overall Study|Death|1|||
46709022|NCT03064126|82924911|FG000|Overall Study|Investigator Discretion|1|||
46709023|NCT03064126|82924912|FG001|Overall Study|Investigator Discretion|0|||
46709024|NCT03064126|82924913|FG002|Overall Study|Investigator Discretion|0|||
46709025|NCT03064126|82924914|FG003|Overall Study|Investigator Discretion|0|||
46709026|NCT03064126|82924911|FG000|Overall Study|Withdrawal by Subject|7|||
46709027|NCT03064126|82924912|FG001|Overall Study|Withdrawal by Subject|4|||
46709028|NCT03064126|82924913|FG002|Overall Study|Withdrawal by Subject|0|||
46709029|NCT03064126|82924914|FG003|Overall Study|Withdrawal by Subject|0|||
46709030|NCT03064126|82924911|FG000|Overall Study|Subject moved|1|||
46709031|NCT03064126|82924912|FG001|Overall Study|Subject moved|0|||
46899159|NCT01314872|83125564|FG000|Period 2|Pregnancy|0|||
46899160|NCT01314872|83125565|FG001|Period 2|Pregnancy|0|||
46899161|NCT01314872|83125566|FG002|Period 2|Pregnancy|0|||
46899162|NCT01314872|83125567|FG003|Period 2|Pregnancy|0|||
46899163|NCT01314872|83125568|FG004|Period 2|Pregnancy|0|||
46899164|NCT01314872|83125569|FG005|Period 2|Pregnancy|0|||
46899165|NCT01314872|83125570|FG006|Period 2|Pregnancy|0|||
46899166|NCT01314872|83125571|FG007|Period 2|Pregnancy|0|||
46899167|NCT01314872|83125572|FG008|Period 2|Pregnancy|0|||
46899168|NCT01314872|83125573|FG009|Period 2|Pregnancy|0|||
46899169|NCT01314872|83125574|FG010|Period 2|Pregnancy|0|||
46899170|NCT01314872|83125575|FG011|Period 2|Pregnancy|0|||
46899171|NCT01314872|83125576|FG012|Period 2|Pregnancy|0|||
46899172|NCT01314872|83125577|FG013|Period 2|Pregnancy|0|||
46899173|NCT01314872|83125578|FG014|Period 2|Pregnancy|1|||
46899174|NCT01314872|83125564|FG000|Period 2|Study terminated by Sponsor|0|||
46899175|NCT01314872|83125565|FG001|Period 2|Study terminated by Sponsor|0|||
46899176|NCT01314872|83125566|FG002|Period 2|Study terminated by Sponsor|0|||
46899177|NCT01314872|83125567|FG003|Period 2|Study terminated by Sponsor|0|||
46899178|NCT01314872|83125568|FG004|Period 2|Study terminated by Sponsor|0|||
46899179|NCT01314872|83125569|FG005|Period 2|Study terminated by Sponsor|0|||
46899180|NCT01314872|83125570|FG006|Period 2|Study terminated by Sponsor|0|||
46899181|NCT01314872|83125571|FG007|Period 2|Study terminated by Sponsor|0|||
46899182|NCT01314872|83125572|FG008|Period 2|Study terminated by Sponsor|0|||
46899183|NCT01314872|83125573|FG009|Period 2|Study terminated by Sponsor|0|||
46899184|NCT01314872|83125574|FG010|Period 2|Study terminated by Sponsor|0|||
46899185|NCT01314872|83125575|FG011|Period 2|Study terminated by Sponsor|2|||
46899186|NCT01314872|83125576|FG012|Period 2|Study terminated by Sponsor|2|||
46899187|NCT01314872|83125577|FG013|Period 2|Study terminated by Sponsor|3|||
46899188|NCT01314872|83125578|FG014|Period 2|Study terminated by Sponsor|0|||
46899189|NCT01314872|83125564|FG000|Period 2|Adverse event, non-fatal|0|||
46899190|NCT01314872|83125565|FG001|Period 2|Adverse event, non-fatal|0|||
46899191|NCT01314872|83125566|FG002|Period 2|Adverse event, non-fatal|0|||
46996548|NCT02365298|83243695|FG001|Period 2|incorrect Rx dispensed|0|||
46899192|NCT01314872|83125567|FG003|Period 2|Adverse event, non-fatal|0|||
46899193|NCT01314872|83125568|FG004|Period 2|Adverse event, non-fatal|0|||
46709032|NCT03064126|82924913|FG002|Overall Study|Subject moved|0|||
46709033|NCT03064126|82924914|FG003|Overall Study|Subject moved|0|||
46709034|NCT03064126|82924911|FG000|Overall Study|Protocol Violation|11|||
46709035|NCT03064126|82924912|FG001|Overall Study|Protocol Violation|1|||
46709036|NCT03064126|82924913|FG002|Overall Study|Protocol Violation|1|||
46709037|NCT03064126|82924914|FG003|Overall Study|Protocol Violation|0|||
46709038|NCT02929589|82924929|FG000|Overall Study|Withdrawal by Subject|1|||
46709039|NCT02929589|82924930|FG001|Overall Study|Withdrawal by Subject|0|||
46899194|NCT01314872|83125569|FG005|Period 2|Adverse event, non-fatal|0|||
46899195|NCT01314872|83125570|FG006|Period 2|Adverse event, non-fatal|0|||
46899196|NCT01314872|83125571|FG007|Period 2|Adverse event, non-fatal|0|||
46899197|NCT01314872|83125572|FG008|Period 2|Adverse event, non-fatal|0|||
46899198|NCT01314872|83125573|FG009|Period 2|Adverse event, non-fatal|0|||
46899199|NCT01314872|83125574|FG010|Period 2|Adverse event, non-fatal|0|||
46709040|NCT02929589|82924931|FG002|Overall Study|Withdrawal by Subject|0|||
46899200|NCT01314872|83125575|FG011|Period 2|Adverse event, non-fatal|13|||
46899201|NCT01314872|83125576|FG012|Period 2|Adverse event, non-fatal|16|||
46899202|NCT01314872|83125577|FG013|Period 2|Adverse event, non-fatal|24|||
46899203|NCT01314872|83125578|FG014|Period 2|Adverse event, non-fatal|9|||
46899204|NCT01314872|83125564|FG000|Period 2|Withdrawal by Subject|0|||
46899205|NCT01314872|83125565|FG001|Period 2|Withdrawal by Subject|0|||
46899206|NCT01314872|83125566|FG002|Period 2|Withdrawal by Subject|0|||
46899207|NCT01314872|83125567|FG003|Period 2|Withdrawal by Subject|0|||
46899208|NCT01314872|83125568|FG004|Period 2|Withdrawal by Subject|0|||
46899209|NCT01314872|83125569|FG005|Period 2|Withdrawal by Subject|0|||
46899210|NCT01314872|83125570|FG006|Period 2|Withdrawal by Subject|0|||
46899211|NCT01314872|83125571|FG007|Period 2|Withdrawal by Subject|0|||
46899212|NCT01314872|83125572|FG008|Period 2|Withdrawal by Subject|0|||
46899213|NCT01314872|83125573|FG009|Period 2|Withdrawal by Subject|0|||
46899214|NCT01314872|83125574|FG010|Period 2|Withdrawal by Subject|0|||
46899215|NCT01314872|83125575|FG011|Period 2|Withdrawal by Subject|14|||
46899216|NCT01314872|83125576|FG012|Period 2|Withdrawal by Subject|17|||
46899217|NCT01314872|83125577|FG013|Period 2|Withdrawal by Subject|12|||
46899218|NCT01314872|83125578|FG014|Period 2|Withdrawal by Subject|4|||
46899219|NCT01314872|83125564|FG000|Period 2|Lost to Follow-up|0|||
46899220|NCT01314872|83125565|FG001|Period 2|Lost to Follow-up|0|||
46899221|NCT01314872|83125566|FG002|Period 2|Lost to Follow-up|0|||
46899222|NCT01314872|83125567|FG003|Period 2|Lost to Follow-up|0|||
46899223|NCT01314872|83125568|FG004|Period 2|Lost to Follow-up|0|||
46899224|NCT01314872|83125569|FG005|Period 2|Lost to Follow-up|0|||
46899225|NCT01314872|83125570|FG006|Period 2|Lost to Follow-up|0|||
46899226|NCT01314872|83125571|FG007|Period 2|Lost to Follow-up|0|||
46899227|NCT01314872|83125572|FG008|Period 2|Lost to Follow-up|0|||
46899228|NCT01314872|83125573|FG009|Period 2|Lost to Follow-up|0|||
46899229|NCT01314872|83125574|FG010|Period 2|Lost to Follow-up|0|||
46899230|NCT01314872|83125575|FG011|Period 2|Lost to Follow-up|6|||
46899231|NCT01314872|83125576|FG012|Period 2|Lost to Follow-up|7|||
46899232|NCT01314872|83125577|FG013|Period 2|Lost to Follow-up|2|||
46899233|NCT01314872|83125578|FG014|Period 2|Lost to Follow-up|6|||
46899234|NCT00703924|83125612|FG000|Overall Study|Withdrawal by Subject|1|||
46899235|NCT00703924|83125613|FG001|Overall Study|Withdrawal by Subject|1|||
46899236|NCT03152526|83125625|FG000|Overall Study|Withdrawal by Subject|0|||
46899237|NCT03152526|83125626|FG001|Overall Study|Withdrawal by Subject|1|||
46899238|NCT03149328|83125634|FG000|Overall Study|Withdrawal by Subject|30|||
46899239|NCT03149328|83125635|FG001|Overall Study|Withdrawal by Subject|26|||
46899240|NCT03149328|83125634|FG000|Overall Study|Changed Dialysis Modality|18|||
46899241|NCT03149328|83125635|FG001|Overall Study|Changed Dialysis Modality|1|||
46899242|NCT03149328|83125634|FG000|Overall Study|Transplant|9|||
46899243|NCT03149328|83125635|FG001|Overall Study|Transplant|1|||
46899244|NCT03149328|83125634|FG000|Overall Study|Lost to Follow-up|25|||
46899245|NCT03149328|83125635|FG001|Overall Study|Lost to Follow-up|16|||
46899246|NCT03149328|83125634|FG000|Overall Study|Left Study Site|1|||
46899247|NCT03149328|83125635|FG001|Overall Study|Left Study Site|2|||
46899248|NCT03149328|83125634|FG000|Overall Study|Language Barrier|1|||
46899249|NCT03149328|83125635|FG001|Overall Study|Language Barrier|0|||
46899250|NCT04296942|83125684|FG000|Overall Study|Study closure by sponsor|1|||
46899251|NCT04296942|83125685|FG001|Overall Study|Study closure by sponsor|0|||
46899252|NCT04296942|83125686|FG002|Overall Study|Study closure by sponsor|0|||
46899253|NCT01315028|83125742|FG000|Overall Study|Lost to Follow-up|1|||
46899254|NCT01315028|83125743|FG001|Overall Study|Lost to Follow-up|0|||
46899255|NCT01315028|83125742|FG000|Overall Study|Death|0|||
46899256|NCT01315028|83125743|FG001|Overall Study|Death|1|||
46899257|NCT02720536|83125749|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
46899258|NCT02720536|83125749|FG000|Overall Study|PR - pregnancy|2|||
46899259|NCT02720536|83125749|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
46899260|NCT02720536|83125749|FG000|Overall Study|PR - death|1|||
46899261|NCT02720536|83125749|FG000|Overall Study|PR - adverse event|1|||
46899262|NCT02720536|83125749|FG000|Overall Study|PR - abnormal lab value(s)|1|||
46899263|NCT02720536|83125749|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
46899264|NCT03168438|83125761|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
46899265|NCT03168438|83125762|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
46899266|NCT03137784|83125769|FG000|Overall Study|Adverse Event|1|||
46899267|NCT03137784|83125770|FG001|Overall Study|Adverse Event|1|||
46899268|NCT03137784|83125771|FG002|Overall Study|Adverse Event|0|||
46899269|NCT03137784|83125772|FG003|Overall Study|Adverse Event|0|||
46899270|NCT03137784|83125773|FG004|Overall Study|Adverse Event|0|||
46899271|NCT03137784|83125774|FG005|Overall Study|Adverse Event|0|||
46899272|NCT03137784|83125769|FG000|Overall Study|Subject/guardian decision|1|||
46899273|NCT03137784|83125770|FG001|Overall Study|Subject/guardian decision|0|||
46899274|NCT03137784|83125771|FG002|Overall Study|Subject/guardian decision|0|||
46899275|NCT03137784|83125772|FG003|Overall Study|Subject/guardian decision|0|||
46899276|NCT03137784|83125773|FG004|Overall Study|Subject/guardian decision|0|||
46899277|NCT03137784|83125774|FG005|Overall Study|Subject/guardian decision|0|||
46899278|NCT03137784|83125769|FG000|Overall Study|Non-compliance with study treatment|0|||
46899279|NCT03137784|83125770|FG001|Overall Study|Non-compliance with study treatment|0|||
46899280|NCT03137784|83125771|FG002|Overall Study|Non-compliance with study treatment|0|||
46899281|NCT03137784|83125772|FG003|Overall Study|Non-compliance with study treatment|0|||
46899282|NCT03137784|83125773|FG004|Overall Study|Non-compliance with study treatment|1|||
46899283|NCT03137784|83125774|FG005|Overall Study|Non-compliance with study treatment|0|||
46899284|NCT01314716|83125784|FG000|Double-Blind Phase|Randomized but not treated|1|||
46899285|NCT01314716|83125785|FG001|Double-Blind Phase|Randomized but not treated|1|||
46899286|NCT01314716|83125784|FG000|Double-Blind Phase|Adverse Event|10|||
46899287|NCT01314716|83125785|FG001|Double-Blind Phase|Adverse Event|4|||
46899288|NCT01314716|83125784|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
46899289|NCT01314716|83125785|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
46899290|NCT01314716|83125784|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46899291|NCT01314716|83125785|FG001|Double-Blind Phase|Lost to Follow-up|1|||
46899292|NCT01314716|83125784|FG000|Double-Blind Phase|Sponsor request|1|||
46899293|NCT01314716|83125785|FG001|Double-Blind Phase|Sponsor request|2|||
46899294|NCT01314716|83125784|FG000|Double-Blind Phase|Physician Decision|0|||
46899295|NCT01314716|83125785|FG001|Double-Blind Phase|Physician Decision|1|||
46899296|NCT01314716|83125784|FG000|Open-Label Phase|Adverse Event|4|||
46899297|NCT01314716|83125785|FG001|Open-Label Phase|Adverse Event|6|||
46899298|NCT01314716|83125784|FG000|Open-Label Phase|Withdrawal by Subject|1|||
46899299|NCT01314716|83125785|FG001|Open-Label Phase|Withdrawal by Subject|2|||
46899300|NCT01314716|83125784|FG000|Open-Label Phase|Physician Decision|5|||
46899301|NCT01314716|83125785|FG001|Open-Label Phase|Physician Decision|4|||
46899302|NCT03144180|83125795|FG000|Overall Study|STAT Delivery|1|||
46899303|NCT03144180|83125796|FG001|Overall Study|STAT Delivery|1|||
46899304|NCT03144180|83125795|FG000|Overall Study|Provider forgot to fill out forms|1|||
46899305|NCT03144180|83125796|FG001|Overall Study|Provider forgot to fill out forms|3|||
46899306|NCT03144180|83125795|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
46899307|NCT03144180|83125796|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
46899308|NCT03144180|83125795|FG000|Overall Study|Scrub tech removed tube cap|0|||
46899309|NCT03144180|83125796|FG001|Overall Study|Scrub tech removed tube cap|1|||
46899310|NCT01465334|83125806|FG000|Overall Study|Disease Progression|1|||
46899311|NCT01465334|83125807|FG001|Overall Study|Disease Progression|0|||
46899312|NCT01465334|83125806|FG000|Overall Study|Adverse Event|1|||
46899313|NCT01465334|83125807|FG001|Overall Study|Adverse Event|0|||
46899314|NCT01465334|83125806|FG000|Overall Study|Richter's transformation|0|||
46899315|NCT01465334|83125807|FG001|Overall Study|Richter's transformation|3|||
46899316|NCT01465334|83125806|FG000|Overall Study|Refractory Disease|0|||
46899317|NCT01465334|83125807|FG001|Overall Study|Refractory Disease|3|||
46899318|NCT00702208|83125813|FG000|Overall Study|Lost to Follow-up|28|||
46899319|NCT00702208|83125813|FG000|Overall Study|Did not self-lavage|1|||
46899320|NCT00702208|83125813|FG000|Overall Study|Unsatisfactory colposcopy|2|||
46899321|NCT02718898|83125830|FG000|Blinded Treatment Period|Adverse Event|5|||
46899322|NCT02718898|83125831|FG001|Blinded Treatment Period|Adverse Event|1|||
46899323|NCT02718898|83125832|FG002|Blinded Treatment Period|Adverse Event|0|||
46899324|NCT02718898|83125833|FG003|Blinded Treatment Period|Adverse Event|0|||
46899325|NCT02718898|83125834|FG004|Blinded Treatment Period|Adverse Event|0|||
46899326|NCT02718898|83125835|FG005|Blinded Treatment Period|Adverse Event|0|||
46899327|NCT02718898|83125836|FG006|Blinded Treatment Period|Adverse Event|0|||
46899328|NCT02718898|83125830|FG000|Blinded Treatment Period|Physician Decision|1|||
46899329|NCT02718898|83125831|FG001|Blinded Treatment Period|Physician Decision|0|||
46899330|NCT02718898|83125832|FG002|Blinded Treatment Period|Physician Decision|0|||
46899331|NCT02718898|83125833|FG003|Blinded Treatment Period|Physician Decision|0|||
46899332|NCT02718898|83125834|FG004|Blinded Treatment Period|Physician Decision|0|||
46899333|NCT02718898|83125835|FG005|Blinded Treatment Period|Physician Decision|0|||
46899334|NCT02718898|83125836|FG006|Blinded Treatment Period|Physician Decision|0|||
46899335|NCT02718898|83125830|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
46899336|NCT02718898|83125831|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
46899337|NCT02718898|83125832|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
46899338|NCT02718898|83125833|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
46709041|NCT02929589|82924932|FG003|Overall Study|Withdrawal by Subject|0|||
46899339|NCT02718898|83125834|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
46899340|NCT02718898|83125835|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
46899341|NCT02718898|83125836|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
46899342|NCT02718898|83125830|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
46996549|NCT02365298|83243694|FG000|Period 2|Discontinued at request of Sponsor|1|||
46709042|NCT02929589|82924929|FG000|Overall Study|Physician Decision|2|||
46899343|NCT02718898|83125831|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
46899344|NCT02718898|83125832|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
46899345|NCT02718898|83125833|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
46899346|NCT02718898|83125834|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
46899347|NCT02718898|83125835|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
46899348|NCT02718898|83125836|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
46899349|NCT02718898|83125830|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
46899350|NCT02718898|83125831|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
46899351|NCT02718898|83125832|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
46899352|NCT02718898|83125833|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
46899353|NCT02718898|83125834|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
46620152|NCT02535923|82761800|FG001|Overall Study|Lost to Follow-up|5|||
46620153|NCT02535923|82761799|FG000|Overall Study|Withdrawal by Subject|4|||
46620154|NCT02535923|82761800|FG001|Overall Study|Withdrawal by Subject|3|||
46899354|NCT02718898|83125835|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
46899355|NCT02718898|83125836|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
46899356|NCT02718898|83125830|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
46899357|NCT02718898|83125831|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
46899358|NCT02718898|83125832|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
46899359|NCT02718898|83125833|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
46899360|NCT02718898|83125834|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
46899361|NCT02718898|83125835|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
46899362|NCT02718898|83125836|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
46899363|NCT02718898|83125830|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46899364|NCT02718898|83125831|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46899365|NCT02718898|83125832|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
46899366|NCT02718898|83125833|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
46899367|NCT02718898|83125834|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46899368|NCT02718898|83125835|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46899369|NCT02718898|83125836|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46899370|NCT02718898|83125830|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
46899371|NCT02718898|83125831|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
46899372|NCT02718898|83125832|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
46899373|NCT02718898|83125833|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
46899374|NCT02718898|83125834|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
46899375|NCT02718898|83125835|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
46899376|NCT02718898|83125836|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
46899377|NCT02718898|83125830|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
46899378|NCT02718898|83125831|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
46899379|NCT02718898|83125832|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
46899380|NCT02718898|83125833|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
46899381|NCT02718898|83125834|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
46899382|NCT02718898|83125835|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
46899383|NCT02718898|83125836|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
46899384|NCT02718898|83125830|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
46899385|NCT02718898|83125831|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
46899386|NCT02718898|83125832|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
46899387|NCT02718898|83125833|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
46899388|NCT02718898|83125834|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
46899389|NCT02718898|83125835|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
46899390|NCT02718898|83125836|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
46899391|NCT02718898|83125830|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
46899392|NCT02718898|83125831|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
46899393|NCT02718898|83125832|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
46899394|NCT02718898|83125833|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
46899395|NCT02718898|83125834|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
46899396|NCT02718898|83125835|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
46899397|NCT02718898|83125836|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
46899398|NCT02718898|83125830|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
46899399|NCT02718898|83125831|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
46899400|NCT02718898|83125832|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
46899401|NCT02718898|83125833|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
46899402|NCT02718898|83125834|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
46620155|NCT02270736|82761809|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
46620156|NCT02270736|82761810|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
46899403|NCT02718898|83125835|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
46899404|NCT02718898|83125836|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
46899405|NCT02718898|83125830|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46899406|NCT02718898|83125831|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46899407|NCT02718898|83125832|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46899408|NCT02718898|83125833|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46899409|NCT02718898|83125834|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46899410|NCT02718898|83125835|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
46899411|NCT02718898|83125836|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
46899412|NCT03143166|83125853|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
46899413|NCT02879994|83125859|FG000|Overall Study|off treatment early|7|||
46899414|NCT02879994|83125859|FG000|Overall Study|Adverse Event|2|||
46899415|NCT02879994|83125859|FG000|Overall Study|Death|2|||
46899416|NCT03142932|83125865|FG000|Overall Study|Lost to Follow-up|2|||
46899417|NCT03142932|83125866|FG001|Overall Study|Lost to Follow-up|11|||
46899418|NCT00702052|83125872|FG000|Overall Study|Adverse Event|23|||
46899419|NCT00702052|83125872|FG000|Overall Study|Disease Progression|30|||
46899420|NCT00702052|83125872|FG000|Overall Study|Withdrawal by Subject|5|||
46899421|NCT03140280|83125876|FG000|Overall Study|Physician Decision|5|||
46899422|NCT03136380|83125882|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
46899423|NCT03136380|83125883|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
46899424|NCT03136380|83125884|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
46899425|NCT03136380|83125885|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
46899426|NCT03136380|83125886|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
46899427|NCT03136068|83125906|FG000|Overall Study|Lost to Follow-up|1|||
46899428|NCT03136068|83125907|FG001|Overall Study|Lost to Follow-up|1|||
46899429|NCT03136068|83125906|FG000|Overall Study|Protocol Violation|1|||
46899430|NCT03136068|83125907|FG001|Overall Study|Protocol Violation|0|||
46899431|NCT02585232|83125915|FG000|Overall Study|Lost to Follow-up|8|||
46899432|NCT02585232|83125916|FG001|Overall Study|Lost to Follow-up|8|||
46899433|NCT02585232|83125915|FG000|Overall Study|Withdrawal by Subject|4|||
46899434|NCT02585232|83125916|FG001|Overall Study|Withdrawal by Subject|8|||
46899435|NCT03377790|83125945|FG000|Overall Study|Withdrawal by Subject|1|||
46899436|NCT03377790|83125946|FG001|Overall Study|Withdrawal by Subject|0|||
46899437|NCT03377790|83125945|FG000|Overall Study|Adverse Event|1|||
46899438|NCT03377790|83125946|FG001|Overall Study|Adverse Event|0|||
46899439|NCT03377790|83125945|FG000|Overall Study|Lost to Follow-up|0|||
46899440|NCT03377790|83125946|FG001|Overall Study|Lost to Follow-up|2|||
46899441|NCT03377790|83125945|FG000|Overall Study|Randomized but not treated|1|||
46899442|NCT03377790|83125946|FG001|Overall Study|Randomized but not treated|0|||
46899443|NCT03377790|83125945|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
46899444|NCT03377790|83125946|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
46899445|NCT02717494|83125955|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
46899446|NCT02717494|83125956|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
46899447|NCT02717494|83125957|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
46899448|NCT02717494|83125955|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
46899449|NCT02717494|83125956|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
46899450|NCT02717494|83125957|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
46899451|NCT02717494|83125955|FG000|First Intervention (Step 1)|Death|0|||
46899452|NCT02717494|83125956|FG001|First Intervention (Step 1)|Death|0|||
46899453|NCT02717494|83125957|FG002|First Intervention (Step 1)|Death|1|||
46899454|NCT02717494|83125955|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
46899455|NCT02717494|83125956|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
46899456|NCT02717494|83125957|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
46899457|NCT01844856|83125985|FG000|Overall Study|Lost to Follow-up|15|||
46899458|NCT01844856|83125986|FG001|Overall Study|Lost to Follow-up|3|||
46996550|NCT02365298|83243695|FG001|Period 2|Discontinued at request of Sponsor|0|||
46899459|NCT01844856|83125985|FG000|Overall Study|Adverse Event|3|||
46899460|NCT01844856|83125986|FG001|Overall Study|Adverse Event|6|||
46899461|NCT01844856|83125985|FG000|Overall Study|Withdrawal by Subject|3|||
46899462|NCT01844856|83125986|FG001|Overall Study|Withdrawal by Subject|2|||
46899463|NCT01844856|83125985|FG000|Overall Study|Noncompliance|2|||
46899464|NCT01844856|83125986|FG001|Overall Study|Noncompliance|3|||
46899465|NCT01844856|83125985|FG000|Overall Study|Enterococcus Resistant|0|||
46899466|NCT01844856|83125986|FG001|Overall Study|Enterococcus Resistant|1|||
46899467|NCT01844856|83125985|FG000|Overall Study|Inadvertently Not Scheduled|1|||
46899468|NCT01844856|83125986|FG001|Overall Study|Inadvertently Not Scheduled|0|||
46899469|NCT01844856|83125985|FG000|Overall Study|Randomized but was a Screen Failure|0|||
46899470|NCT01844856|83125986|FG001|Overall Study|Randomized but was a Screen Failure|1|||
46899471|NCT03135210|83126022|FG000|Overall Study|Death|0|||
46899472|NCT03135210|83126023|FG001|Overall Study|Death|1|||
46899473|NCT00701662|83126029|FG000|Overall Study|Lack of Efficacy|1|||
46899474|NCT02878590|83126033|FG000|Overall Study|Withdrawal by Subject|2|||
46899475|NCT04634409|83126064|FG000|Overall Study|Death|0|||
46899476|NCT04634409|83126065|FG001|Overall Study|Death|0|||
46899477|NCT04634409|83126066|FG002|Overall Study|Death|0|||
46899478|NCT04634409|83126067|FG003|Overall Study|Death|0|||
46899479|NCT04634409|83126068|FG004|Overall Study|Death|0|||
46899480|NCT04634409|83126069|FG005|Overall Study|Death|0|||
46899481|NCT04634409|83126070|FG006|Overall Study|Death|0|||
46899482|NCT04634409|83126071|FG007|Overall Study|Death|0|||
46899483|NCT04634409|83126072|FG008|Overall Study|Death|0|||
46899484|NCT04634409|83126073|FG009|Overall Study|Death|0|||
46899485|NCT04634409|83126074|FG010|Overall Study|Death|1|||
46899486|NCT04634409|83126075|FG011|Overall Study|Death|0|||
46899487|NCT04634409|83126076|FG012|Overall Study|Death|1|||
46899488|NCT04634409|83126077|FG013|Overall Study|Death|0|||
46899489|NCT04634409|83126078|FG014|Overall Study|Death|0|||
46899490|NCT04634409|83126079|FG015|Overall Study|Death|0|||
46899491|NCT04634409|83126080|FG016|Overall Study|Death|0|||
46996551|NCT02365298|83243694|FG000|Period 2|Test Article longer available|0|||
46996552|NCT02365298|83243695|FG001|Period 2|Test Article longer available|1|||
46996553|NCT02365298|83243694|FG000|Period 2|Protocol Violation|0|||
46996554|NCT02365298|83243695|FG001|Period 2|Protocol Violation|1|||
46996555|NCT02365064|83243703|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
46996556|NCT02365064|83243704|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
46996557|NCT02365064|83243703|FG000|Overall Study|Withdrawal by Subject|6|||
46996558|NCT02365064|83243704|FG001|Overall Study|Withdrawal by Subject|9|||
46996559|NCT02365064|83243703|FG000|Overall Study|Treatment intolerance|2|||
46996560|NCT02365064|83243704|FG001|Overall Study|Treatment intolerance|4|||
46899492|NCT04634409|83126081|FG017|Overall Study|Death|0|||
46899493|NCT04634409|83126082|FG018|Overall Study|Death|0|||
46899494|NCT04634409|83126083|FG019|Overall Study|Death|0|||
46899495|NCT04634409|83126084|FG020|Overall Study|Death|0|||
46899496|NCT04634409|83126085|FG021|Overall Study|Death|0|||
46899497|NCT04634409|83126086|FG022|Overall Study|Death|0|||
46899498|NCT04634409|83126087|FG023|Overall Study|Death|0|||
46899499|NCT04634409|83126088|FG024|Overall Study|Death|0|||
46899500|NCT04634409|83126089|FG025|Overall Study|Death|0|||
46899501|NCT04634409|83126090|FG026|Overall Study|Death|0|||
46899502|NCT04634409|83126064|FG000|Overall Study|Adverse Event|0|||
46899503|NCT04634409|83126065|FG001|Overall Study|Adverse Event|0|||
46899504|NCT04634409|83126066|FG002|Overall Study|Adverse Event|1|||
46899505|NCT04634409|83126067|FG003|Overall Study|Adverse Event|0|||
46899506|NCT04634409|83126068|FG004|Overall Study|Adverse Event|0|||
46899507|NCT04634409|83126069|FG005|Overall Study|Adverse Event|1|||
46899508|NCT04634409|83126070|FG006|Overall Study|Adverse Event|0|||
46899509|NCT04634409|83126071|FG007|Overall Study|Adverse Event|0|||
46899510|NCT04634409|83126072|FG008|Overall Study|Adverse Event|0|||
46899511|NCT04634409|83126073|FG009|Overall Study|Adverse Event|0|||
46899512|NCT04634409|83126074|FG010|Overall Study|Adverse Event|0|||
46899513|NCT04634409|83126075|FG011|Overall Study|Adverse Event|0|||
46899514|NCT04634409|83126076|FG012|Overall Study|Adverse Event|0|||
46996561|NCT02401256|83243710|FG000|Overall Study|Adverse Event|5|||
46996562|NCT02401256|83243710|FG000|Overall Study|Withdrawal by Subject|12|||
46996563|NCT02349295|83243719|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
46996564|NCT02349295|83243720|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
46996565|NCT02349295|83243721|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
46996566|NCT02349295|83243722|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996567|NCT02349295|83243723|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996568|NCT02349295|83243724|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996569|NCT02349295|83243725|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996570|NCT02349295|83243726|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996571|NCT02349295|83243727|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996572|NCT02349295|83243728|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46899515|NCT04634409|83126077|FG013|Overall Study|Adverse Event|0|||
46899516|NCT04634409|83126078|FG014|Overall Study|Adverse Event|0|||
46899517|NCT04634409|83126079|FG015|Overall Study|Adverse Event|0|||
46996573|NCT02349295|83243729|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996574|NCT02349295|83243730|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46899518|NCT04634409|83126080|FG016|Overall Study|Adverse Event|0|||
46899519|NCT04634409|83126081|FG017|Overall Study|Adverse Event|0|||
46899520|NCT04634409|83126082|FG018|Overall Study|Adverse Event|0|||
46899521|NCT04634409|83126083|FG019|Overall Study|Adverse Event|0|||
46899522|NCT04634409|83126084|FG020|Overall Study|Adverse Event|0|||
46899523|NCT04634409|83126085|FG021|Overall Study|Adverse Event|0|||
46899524|NCT04634409|83126086|FG022|Overall Study|Adverse Event|0|||
46899525|NCT04634409|83126087|FG023|Overall Study|Adverse Event|0|||
46899526|NCT04634409|83126088|FG024|Overall Study|Adverse Event|0|||
46899527|NCT04634409|83126089|FG025|Overall Study|Adverse Event|0|||
46899528|NCT04634409|83126090|FG026|Overall Study|Adverse Event|0|||
46899529|NCT04634409|83126064|FG000|Overall Study|Lost to Follow-up|3|||
46899530|NCT04634409|83126065|FG001|Overall Study|Lost to Follow-up|1|||
46899531|NCT04634409|83126066|FG002|Overall Study|Lost to Follow-up|1|||
46899532|NCT04634409|83126067|FG003|Overall Study|Lost to Follow-up|3|||
46899533|NCT04634409|83126068|FG004|Overall Study|Lost to Follow-up|1|||
46899534|NCT04634409|83126069|FG005|Overall Study|Lost to Follow-up|1|||
46899535|NCT04634409|83126070|FG006|Overall Study|Lost to Follow-up|1|||
46899536|NCT04634409|83126071|FG007|Overall Study|Lost to Follow-up|3|||
46899537|NCT04634409|83126072|FG008|Overall Study|Lost to Follow-up|3|||
46899538|NCT04634409|83126073|FG009|Overall Study|Lost to Follow-up|11|||
46899539|NCT04634409|83126074|FG010|Overall Study|Lost to Follow-up|8|||
46899540|NCT04634409|83126075|FG011|Overall Study|Lost to Follow-up|15|||
46899541|NCT04634409|83126076|FG012|Overall Study|Lost to Follow-up|3|||
46899542|NCT04634409|83126077|FG013|Overall Study|Lost to Follow-up|2|||
46899543|NCT04634409|83126078|FG014|Overall Study|Lost to Follow-up|7|||
46899544|NCT04634409|83126079|FG015|Overall Study|Lost to Follow-up|0|||
46899545|NCT04634409|83126080|FG016|Overall Study|Lost to Follow-up|0|||
46899546|NCT04634409|83126081|FG017|Overall Study|Lost to Follow-up|0|||
46899547|NCT04634409|83126082|FG018|Overall Study|Lost to Follow-up|0|||
46899548|NCT04634409|83126083|FG019|Overall Study|Lost to Follow-up|0|||
46899549|NCT04634409|83126084|FG020|Overall Study|Lost to Follow-up|0|||
46899550|NCT04634409|83126085|FG021|Overall Study|Lost to Follow-up|0|||
46899551|NCT04634409|83126086|FG022|Overall Study|Lost to Follow-up|0|||
46899552|NCT04634409|83126087|FG023|Overall Study|Lost to Follow-up|0|||
46899553|NCT04634409|83126088|FG024|Overall Study|Lost to Follow-up|0|||
46899554|NCT04634409|83126089|FG025|Overall Study|Lost to Follow-up|0|||
46899555|NCT04634409|83126090|FG026|Overall Study|Lost to Follow-up|0|||
46899556|NCT04634409|83126064|FG000|Overall Study|Withdrawal by Subject|3|||
46899557|NCT04634409|83126065|FG001|Overall Study|Withdrawal by Subject|1|||
46899558|NCT04634409|83126066|FG002|Overall Study|Withdrawal by Subject|6|||
46899559|NCT04634409|83126067|FG003|Overall Study|Withdrawal by Subject|4|||
46899560|NCT04634409|83126068|FG004|Overall Study|Withdrawal by Subject|2|||
46899561|NCT04634409|83126069|FG005|Overall Study|Withdrawal by Subject|0|||
46899562|NCT04634409|83126070|FG006|Overall Study|Withdrawal by Subject|0|||
46996575|NCT02349295|83243731|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996576|NCT02349295|83243732|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
46996577|NCT02349295|83243719|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
46996578|NCT02349295|83243720|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
46996579|NCT02349295|83243721|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
46996580|NCT02349295|83243722|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996581|NCT02349295|83243723|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996582|NCT02349295|83243724|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996583|NCT02349295|83243725|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996584|NCT02349295|83243726|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996585|NCT02349295|83243727|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996586|NCT02349295|83243728|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996587|NCT02349295|83243729|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996588|NCT02349295|83243730|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46996589|NCT02349295|83243731|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46899563|NCT04634409|83126071|FG007|Overall Study|Withdrawal by Subject|2|||
46899564|NCT04634409|83126072|FG008|Overall Study|Withdrawal by Subject|3|||
46899565|NCT04634409|83126073|FG009|Overall Study|Withdrawal by Subject|2|||
46899566|NCT04634409|83126074|FG010|Overall Study|Withdrawal by Subject|3|||
46899567|NCT04634409|83126075|FG011|Overall Study|Withdrawal by Subject|2|||
46899568|NCT04634409|83126076|FG012|Overall Study|Withdrawal by Subject|2|||
46899569|NCT04634409|83126077|FG013|Overall Study|Withdrawal by Subject|1|||
46899570|NCT04634409|83126078|FG014|Overall Study|Withdrawal by Subject|5|||
46899571|NCT04634409|83126079|FG015|Overall Study|Withdrawal by Subject|0|||
46899572|NCT04634409|83126080|FG016|Overall Study|Withdrawal by Subject|0|||
46899573|NCT04634409|83126081|FG017|Overall Study|Withdrawal by Subject|1|||
46899574|NCT04634409|83126082|FG018|Overall Study|Withdrawal by Subject|0|||
46620157|NCT02270736|82761811|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
46899575|NCT04634409|83126083|FG019|Overall Study|Withdrawal by Subject|0|||
46899576|NCT04634409|83126084|FG020|Overall Study|Withdrawal by Subject|0|||
46620158|NCT02270736|82761812|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
46620159|NCT02270736|82761813|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
46899577|NCT04634409|83126085|FG021|Overall Study|Withdrawal by Subject|0|||
46899578|NCT04634409|83126086|FG022|Overall Study|Withdrawal by Subject|0|||
46899579|NCT04634409|83126087|FG023|Overall Study|Withdrawal by Subject|1|||
46899580|NCT04634409|83126088|FG024|Overall Study|Withdrawal by Subject|0|||
46899581|NCT04634409|83126089|FG025|Overall Study|Withdrawal by Subject|0|||
46899582|NCT04634409|83126090|FG026|Overall Study|Withdrawal by Subject|0|||
46899583|NCT04634409|83126064|FG000|Overall Study|Other - As reported by Investigator|1|||
46899584|NCT04634409|83126065|FG001|Overall Study|Other - As reported by Investigator|0|||
46899585|NCT04634409|83126066|FG002|Overall Study|Other - As reported by Investigator|0|||
46899586|NCT04634409|83126067|FG003|Overall Study|Other - As reported by Investigator|0|||
46899587|NCT04634409|83126068|FG004|Overall Study|Other - As reported by Investigator|0|||
46899588|NCT04634409|83126069|FG005|Overall Study|Other - As reported by Investigator|0|||
46899589|NCT04634409|83126070|FG006|Overall Study|Other - As reported by Investigator|0|||
46899590|NCT04634409|83126071|FG007|Overall Study|Other - As reported by Investigator|6|||
46899591|NCT04634409|83126072|FG008|Overall Study|Other - As reported by Investigator|4|||
46899592|NCT04634409|83126073|FG009|Overall Study|Other - As reported by Investigator|0|||
46899593|NCT04634409|83126074|FG010|Overall Study|Other - As reported by Investigator|1|||
46899594|NCT04634409|83126075|FG011|Overall Study|Other - As reported by Investigator|2|||
46899595|NCT04634409|83126076|FG012|Overall Study|Other - As reported by Investigator|2|||
46899596|NCT04634409|83126077|FG013|Overall Study|Other - As reported by Investigator|1|||
46899597|NCT04634409|83126078|FG014|Overall Study|Other - As reported by Investigator|0|||
46899598|NCT04634409|83126079|FG015|Overall Study|Other - As reported by Investigator|0|||
46899599|NCT04634409|83126080|FG016|Overall Study|Other - As reported by Investigator|0|||
46899600|NCT04634409|83126081|FG017|Overall Study|Other - As reported by Investigator|0|||
46899601|NCT04634409|83126082|FG018|Overall Study|Other - As reported by Investigator|0|||
46899602|NCT04634409|83126083|FG019|Overall Study|Other - As reported by Investigator|0|||
46899603|NCT04634409|83126084|FG020|Overall Study|Other - As reported by Investigator|0|||
46899604|NCT04634409|83126085|FG021|Overall Study|Other - As reported by Investigator|0|||
46899605|NCT04634409|83126086|FG022|Overall Study|Other - As reported by Investigator|0|||
46899606|NCT04634409|83126087|FG023|Overall Study|Other - As reported by Investigator|0|||
46899607|NCT04634409|83126088|FG024|Overall Study|Other - As reported by Investigator|0|||
46899608|NCT04634409|83126089|FG025|Overall Study|Other - As reported by Investigator|0|||
46899609|NCT04634409|83126090|FG026|Overall Study|Other - As reported by Investigator|0|||
46899610|NCT00005780|83126168|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
46899611|NCT01978938|83126177|FG000|Overall Study|Lost to Follow-up|12|||
46899612|NCT01978938|83126178|FG001|Overall Study|Lost to Follow-up|6|||
46899613|NCT01978938|83126177|FG000|Overall Study|Withdrawal by Subject|8|||
46899614|NCT01978938|83126178|FG001|Overall Study|Withdrawal by Subject|4|||
46899615|NCT01978938|83126177|FG000|Overall Study|Adverse Event, non-fatal|2|||
46899616|NCT01978938|83126178|FG001|Overall Study|Adverse Event, non-fatal|1|||
46899617|NCT01978938|83126177|FG000|Overall Study|Participant noncompliance|1|||
46899618|NCT01978938|83126178|FG001|Overall Study|Participant noncompliance|1|||
46899619|NCT01978938|83126177|FG000|Overall Study|Did not meet inclusion criteria|0|||
46899620|NCT01978938|83126178|FG001|Overall Study|Did not meet inclusion criteria|1|||
46899621|NCT01978938|83126177|FG000|Overall Study|Previously scheduled procedure|0|||
46899622|NCT01978938|83126178|FG001|Overall Study|Previously scheduled procedure|1|||
46899623|NCT03041090|83126186|FG000|Overall Study|technical error|0|||
46899624|NCT03041090|83126187|FG001|Overall Study|technical error|3|||
46899625|NCT00116142|83126195|FG000|Overall Study|Adverse Event|8|||
46899626|NCT00116142|83126196|FG001|Overall Study|Adverse Event|7|||
46899627|NCT00116142|83126195|FG000|Overall Study|Protocol Violation|2|||
46899628|NCT00116142|83126196|FG001|Overall Study|Protocol Violation|1|||
46899629|NCT00116142|83126195|FG000|Overall Study|Withdrawal by Subject|5|||
46899630|NCT00116142|83126196|FG001|Overall Study|Withdrawal by Subject|5|||
46899631|NCT00116142|83126195|FG000|Overall Study|Physician Decision|3|||
46899632|NCT00116142|83126196|FG001|Overall Study|Physician Decision|1|||
46899633|NCT00116142|83126195|FG000|Overall Study|Delayed Radiation Therapy|1|||
46899634|NCT00116142|83126196|FG001|Overall Study|Delayed Radiation Therapy|0|||
46899635|NCT00116142|83126195|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
46899636|NCT00116142|83126196|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
46899637|NCT00116142|83126195|FG000|Overall Study|Patient stopped due to depression|0|||
46899638|NCT00116142|83126196|FG001|Overall Study|Patient stopped due to depression|1|||
46899639|NCT00116142|83126195|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
46899640|NCT00116142|83126196|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
46899641|NCT00116142|83126195|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
46899642|NCT00116142|83126196|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
46899643|NCT00116142|83126195|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
46899644|NCT00116142|83126196|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
46899645|NCT03135522|83126207|FG000|Overall Study|Adverse Event|1|||
46899646|NCT03135522|83126208|FG001|Overall Study|Adverse Event|0|||
46899647|NCT02875080|83126231|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
46899648|NCT02875080|83126232|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
46899649|NCT02875080|83126233|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
46899650|NCT03129360|83126244|FG000|Overall Study|Did not meet entry criteria|0|||
46899651|NCT03129360|83126245|FG001|Overall Study|Did not meet entry criteria|2|||
46899652|NCT03129360|83126246|FG002|Overall Study|Did not meet entry criteria|1|||
46899653|NCT03129360|83126244|FG000|Overall Study|Excluded due to motion in scanner|1|||
46899654|NCT03129360|83126245|FG001|Overall Study|Excluded due to motion in scanner|0|||
46899655|NCT03129360|83126246|FG002|Overall Study|Excluded due to motion in scanner|0|||
46899656|NCT03165045|83126254|FG000|Visit 1|No registration after visit 1|9|||
46899657|NCT03165045|83126254|FG000|Visit 1|No treatment documented|10|||
46899658|NCT03165045|83126254|FG000|Visit 1|No visit 1|10|||
46899659|NCT03165045|83126254|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
46899660|NCT03165045|83126254|FG000|Visit 2|No available total CCQ score at all|29|||
46899661|NCT03165045|83126254|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
46899662|NCT01928199|83126262|FG000|Overall Study|Lost to Follow-up|2|||
46899663|NCT01928199|83126263|FG001|Overall Study|Lost to Follow-up|1|||
46899664|NCT01928199|83126262|FG000|Overall Study|Withdrawal by Subject|3|||
46899665|NCT01928199|83126263|FG001|Overall Study|Withdrawal by Subject|5|||
46899666|NCT03128892|83126269|FG000|Overall Study|Withdrawal by Subject|2|||
46899667|NCT03128892|83126269|FG000|Overall Study|Physician Decision|1|||
46899668|NCT03039686|83126285|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
46899669|NCT03039686|83126286|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
46899670|NCT03039686|83126287|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
46899671|NCT03039686|83126285|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
46899672|NCT03039686|83126286|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
46899673|NCT03039686|83126287|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
46899674|NCT03039686|83126285|FG000|Double-blind Period|Withdrawal by Subject|2|||
46899675|NCT03039686|83126286|FG001|Double-blind Period|Withdrawal by Subject|2|||
46899676|NCT03039686|83126287|FG002|Double-blind Period|Withdrawal by Subject|1|||
46899677|NCT03039686|83126285|FG000|Double-blind Period|Death|0|||
46899678|NCT03039686|83126286|FG001|Double-blind Period|Death|0|||
46899679|NCT03039686|83126287|FG002|Double-blind Period|Death|1|||
46899680|NCT03039686|83126285|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
46899681|NCT03039686|83126286|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
46899682|NCT03039686|83126287|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
46899683|NCT03039686|83126285|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
46899684|NCT03039686|83126286|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
46899685|NCT03039686|83126287|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
46899686|NCT03039686|83126285|FG000|Open Label Period|Withdrawal by Subject|0|||
46899687|NCT03039686|83126286|FG001|Open Label Period|Withdrawal by Subject|3|||
46899688|NCT03039686|83126287|FG002|Open Label Period|Withdrawal by Subject|1|||
46899689|NCT01822275|83126305|FG000|Overall Study|Withdrawal by Subject|3|||
46899690|NCT01822275|83126305|FG000|Overall Study|Adverse Event|3|||
46899691|NCT01822275|83126305|FG000|Overall Study|Progression|14|||
46899692|NCT01822275|83126305|FG000|Overall Study|Physician Decision|2|||
46899693|NCT01656434|83126317|FG000|Overall Study|Adverse Event|199|||
46899694|NCT01656434|83126318|FG001|Overall Study|Adverse Event|63|||
46899695|NCT01656434|83126317|FG000|Overall Study|Enrollment terminated at trial site|2|||
46899696|NCT01656434|83126318|FG001|Overall Study|Enrollment terminated at trial site|0|||
46899697|NCT01656434|83126317|FG000|Overall Study|Lost to Follow-up|309|||
46899698|NCT01656434|83126318|FG001|Overall Study|Lost to Follow-up|76|||
46899699|NCT01656434|83126317|FG000|Overall Study|Site discontinued study participation|24|||
46899700|NCT01656434|83126318|FG001|Overall Study|Site discontinued study participation|9|||
46899701|NCT01656434|83126317|FG000|Overall Study|Screen failure|2|||
46899702|NCT01656434|83126318|FG001|Overall Study|Screen failure|0|||
46899703|NCT01656434|83126317|FG000|Overall Study|Protocol Violation|7|||
46899704|NCT01656434|83126318|FG001|Overall Study|Protocol Violation|0|||
46899705|NCT01656434|83126317|FG000|Overall Study|Pregnancy wish|18|||
46899706|NCT01656434|83126318|FG001|Overall Study|Pregnancy wish|6|||
46899707|NCT01656434|83126317|FG000|Overall Study|Pregnancy|45|||
46899708|NCT01656434|83126318|FG001|Overall Study|Pregnancy|10|||
46899709|NCT01656434|83126317|FG000|Overall Study|Physician Decision|7|||
46899710|NCT01656434|83126318|FG001|Overall Study|Physician Decision|2|||
46899711|NCT01656434|83126317|FG000|Overall Study|Non-compliance with study drug|48|||
46899712|NCT01656434|83126318|FG001|Overall Study|Non-compliance with study drug|9|||
46899713|NCT01656434|83126317|FG000|Overall Study|Study terminated by sponsor|1501|||
46899714|NCT01656434|83126318|FG001|Overall Study|Study terminated by sponsor|348|||
46899715|NCT01656434|83126317|FG000|Overall Study|Participant discontinued; drug related|13|||
46899716|NCT01656434|83126318|FG001|Overall Study|Participant discontinued; drug related|4|||
46899717|NCT01656434|83126317|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
46899718|NCT01656434|83126318|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
46899719|NCT01656434|83126317|FG000|Overall Study|Non-compliance with protocol|39|||
46899720|NCT01656434|83126318|FG001|Overall Study|Non-compliance with protocol|15|||
46899721|NCT01656434|83126317|FG000|Overall Study|Participant moved|40|||
46899722|NCT01656434|83126318|FG001|Overall Study|Participant moved|12|||
46899723|NCT01656434|83126317|FG000|Overall Study|Participant withdrew consent|28|||
46899724|NCT01656434|83126318|FG001|Overall Study|Participant withdrew consent|9|||
46899725|NCT01656434|83126317|FG000|Overall Study|Withdrawal by Subject|64|||
46899726|NCT01656434|83126318|FG001|Overall Study|Withdrawal by Subject|7|||
46899727|NCT02931396|83126326|FG000|Overall Study|Lost to Follow-up|3|||
46899728|NCT02931396|83126327|FG001|Overall Study|Lost to Follow-up|0|||
46899729|NCT02931396|83126326|FG000|Overall Study|Withdrawal by Subject|2|||
46899730|NCT02931396|83126327|FG001|Overall Study|Withdrawal by Subject|0|||
46899731|NCT03037580|83126335|FG000|Overall Study|Withdrawal by Subject|3|||
46899732|NCT03037580|83126336|FG001|Overall Study|Withdrawal by Subject|0|||
46899733|NCT03037580|83126335|FG000|Overall Study|Adverse Event|1|||
46899734|NCT03037580|83126336|FG001|Overall Study|Adverse Event|0|||
46899735|NCT03037580|83126335|FG000|Overall Study|Study Terminated by Sponsor|12|||
46899736|NCT03037580|83126336|FG001|Overall Study|Study Terminated by Sponsor|15|||
46899737|NCT03037580|83126335|FG000|Overall Study|Death|0|||
46899738|NCT03037580|83126336|FG001|Overall Study|Death|1|||
46709043|NCT02929589|82924930|FG001|Overall Study|Physician Decision|0|||
46709044|NCT02929589|82924931|FG002|Overall Study|Physician Decision|0|||
46709045|NCT02929589|82924932|FG003|Overall Study|Physician Decision|0|||
46709046|NCT02807480|82924944|FG000|Overall Study|Withdrawal by Subject|14|||
46709047|NCT02807480|82924945|FG001|Overall Study|Withdrawal by Subject|10|||
46709048|NCT02545868|82924992|FG000|Overall Study|Lack of Efficacy|1|||
46709049|NCT02545868|82924993|FG001|Overall Study|Lack of Efficacy|1|||
46709050|NCT02545868|82924994|FG002|Overall Study|Lack of Efficacy|0|||
46709051|NCT02545868|82924992|FG000|Overall Study|Lost to Follow-up|1|||
46709052|NCT02545868|82924993|FG001|Overall Study|Lost to Follow-up|5|||
46709053|NCT02545868|82924994|FG002|Overall Study|Lost to Follow-up|1|||
46709054|NCT02545868|82924992|FG000|Overall Study|Non-compliance|1|||
46899739|NCT00897104|83126345|FG000|Overall Study|Lost to Follow-up|12|||
46899740|NCT00897104|83126346|FG001|Overall Study|Lost to Follow-up|17|||
46899741|NCT00897104|83126347|FG002|Overall Study|Lost to Follow-up|2|||
46899742|NCT00897104|83126345|FG000|Overall Study|Pregnancy|0|||
46899743|NCT00897104|83126346|FG001|Overall Study|Pregnancy|1|||
46899744|NCT00897104|83126347|FG002|Overall Study|Pregnancy|0|||
46899745|NCT00897104|83126345|FG000|Overall Study|Protocol Violation|0|||
46899746|NCT00897104|83126346|FG001|Overall Study|Protocol Violation|1|||
46899747|NCT00897104|83126347|FG002|Overall Study|Protocol Violation|0|||
46899748|NCT00897104|83126345|FG000|Overall Study|Withdrawal by Subject|23|||
46899749|NCT00897104|83126346|FG001|Overall Study|Withdrawal by Subject|27|||
46899750|NCT00897104|83126347|FG002|Overall Study|Withdrawal by Subject|3|||
46899751|NCT00897104|83126345|FG000|Overall Study|Abnormal Prestudy Labs|2|||
46899752|NCT00897104|83126346|FG001|Overall Study|Abnormal Prestudy Labs|0|||
46899753|NCT00897104|83126347|FG002|Overall Study|Abnormal Prestudy Labs|0|||
46899754|NCT00897104|83126345|FG000|Overall Study|Abnormal Baseline ECG|2|||
46899755|NCT00897104|83126346|FG001|Overall Study|Abnormal Baseline ECG|2|||
46899756|NCT00897104|83126347|FG002|Overall Study|Abnormal Baseline ECG|0|||
46899757|NCT00897104|83126345|FG000|Overall Study|Need for Concom. Med.|0|||
46899758|NCT00897104|83126346|FG001|Overall Study|Need for Concom. Med.|1|||
46899759|NCT00897104|83126347|FG002|Overall Study|Need for Concom. Med.|1|||
46899760|NCT00897104|83126345|FG000|Overall Study|Lack of Migraine Attack|20|||
46899761|NCT00897104|83126346|FG001|Overall Study|Lack of Migraine Attack|22|||
46899762|NCT00897104|83126347|FG002|Overall Study|Lack of Migraine Attack|1|||
46899763|NCT00897104|83126345|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
46899764|NCT00897104|83126346|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46899765|NCT00897104|83126347|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46899766|NCT00897104|83126345|FG000|Overall Study|Other|3|||
46899767|NCT00897104|83126346|FG001|Overall Study|Other|0|||
46899768|NCT00897104|83126347|FG002|Overall Study|Other|0|||
46899769|NCT00897104|83126345|FG000|Overall Study|Protocol Violation|1|||
46899770|NCT00897104|83126346|FG001|Overall Study|Protocol Violation|0|||
46899771|NCT00897104|83126347|FG002|Overall Study|Protocol Violation|0|||
46899772|NCT00897104|83126345|FG000|Overall Study|Withdrawal by Subject|0|||
46899773|NCT00897104|83126346|FG001|Overall Study|Withdrawal by Subject|0|||
46899774|NCT00897104|83126347|FG002|Overall Study|Withdrawal by Subject|1|||
46899775|NCT01339689|83126357|FG000|Overall Study|Adverse Event|1|||
46899776|NCT01339689|83126358|FG001|Overall Study|Adverse Event|2|||
46899777|NCT01339689|83126357|FG000|Overall Study|Lost to Follow-up|9|||
46899778|NCT01339689|83126358|FG001|Overall Study|Lost to Follow-up|3|||
46899779|NCT01339689|83126357|FG000|Overall Study|Withdrawal by Subject|3|||
46899780|NCT01339689|83126358|FG001|Overall Study|Withdrawal by Subject|0|||
46899781|NCT01339689|83126357|FG000|Overall Study|Noncompliance|1|||
46899782|NCT01339689|83126358|FG001|Overall Study|Noncompliance|0|||
46899783|NCT01339689|83126357|FG000|Overall Study|Relocated out of area|0|||
46996590|NCT02349295|83243732|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
46899784|NCT01339689|83126358|FG001|Overall Study|Relocated out of area|1|||
46899785|NCT01339689|83126357|FG000|Overall Study|Other|2|||
46899786|NCT01339689|83126358|FG001|Overall Study|Other|2|||
46899787|NCT01339689|83126357|FG000|Overall Study|multiple reasons|1|||
46899788|NCT01339689|83126358|FG001|Overall Study|multiple reasons|1|||
46709055|NCT02545868|82924993|FG001|Overall Study|Non-compliance|1|||
46899789|NCT03038126|83126366|FG000|Overall Study|Death|1|||
46899790|NCT03038126|83126367|FG001|Overall Study|Death|1|||
46899791|NCT03038126|83126366|FG000|Overall Study|Withdrawal by Subject|5|||
46899792|NCT03038126|83126367|FG001|Overall Study|Withdrawal by Subject|0|||
46899793|NCT03038126|83126366|FG000|Overall Study|Lost to Follow-up|0|||
46899794|NCT03038126|83126367|FG001|Overall Study|Lost to Follow-up|1|||
46899795|NCT03038126|83126366|FG000|Overall Study|Long Term Hospitalization|2|||
46899796|NCT03038126|83126367|FG001|Overall Study|Long Term Hospitalization|0|||
46899797|NCT03038126|83126366|FG000|Overall Study|Too Ill to Participate|1|||
46899798|NCT03038126|83126367|FG001|Overall Study|Too Ill to Participate|2|||
46899799|NCT00696878|83126373|FG000|Overall Study|Adverse Event|8|||
46899800|NCT00696878|83126373|FG000|Overall Study|Withdrawal by Subject|87|||
46899801|NCT00696878|83126373|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
46899802|NCT00696878|83126373|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
46899803|NCT00696878|83126373|FG000|Overall Study|Trial stopped|32|||
46899804|NCT00696878|83126373|FG000|Overall Study|Other reason (not specified)|55|||
46899805|NCT00696800|83126379|FG000|Overall Study|Adverse Event|16|||
46899806|NCT00696800|83126380|FG001|Overall Study|Adverse Event|3|||
46899807|NCT00696800|83126379|FG000|Overall Study|Insufficient compliance with medication|2|||
46899808|NCT00696800|83126380|FG001|Overall Study|Insufficient compliance with medication|1|||
46899809|NCT00696800|83126379|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
46899810|NCT00696800|83126380|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
46899811|NCT00696800|83126379|FG000|Overall Study|Insufficient ovarian response|4|||
46899812|NCT00696800|83126380|FG001|Overall Study|Insufficient ovarian response|1|||
46899813|NCT00696800|83126379|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
46899814|NCT00696800|83126380|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
46899815|NCT00696800|83126379|FG000|Overall Study|Too high ovarian response|6|||
46899816|NCT00696800|83126380|FG001|Overall Study|Too high ovarian response|1|||
46899817|NCT00696800|83126379|FG000|Overall Study|No/too few/bad quality oocytes|4|||
46899818|NCT00696800|83126380|FG001|Overall Study|No/too few/bad quality oocytes|3|||
46899819|NCT00696800|83126379|FG000|Overall Study|No/abnormal fertilization|11|||
46899820|NCT00696800|83126380|FG001|Overall Study|No/abnormal fertilization|13|||
46899821|NCT00696800|83126379|FG000|Overall Study|No/too few/bad quality embryos|24|||
46899822|NCT00696800|83126380|FG001|Overall Study|No/too few/bad quality embryos|18|||
46899823|NCT00696800|83126379|FG000|Overall Study|Other Reasons|5|||
46899824|NCT00696800|83126380|FG001|Overall Study|Other Reasons|3|||
46899825|NCT00696800|83126379|FG000|Overall Study|Not treated|1|||
46899826|NCT00696800|83126380|FG001|Overall Study|Not treated|2|||
46899827|NCT00289874|83126388|FG000|Overall Study|Adverse Event|1|||
46899828|NCT00289874|83126389|FG001|Overall Study|Adverse Event|5|||
46899829|NCT00289874|83126388|FG000|Overall Study|Lost to Follow-up|1|||
46899830|NCT00289874|83126389|FG001|Overall Study|Lost to Follow-up|1|||
46899831|NCT00289874|83126388|FG000|Overall Study|Protocol Violation|3|||
46899832|NCT00289874|83126389|FG001|Overall Study|Protocol Violation|2|||
46899833|NCT00289874|83126388|FG000|Overall Study|Did not meet eligibility|1|||
46899834|NCT00289874|83126389|FG001|Overall Study|Did not meet eligibility|0|||
46899835|NCT00245570|83126395|FG000|Washout Between Periods III and IV|Adverse Event|0|||
46899836|NCT00245570|83126396|FG001|Washout Between Periods III and IV|Adverse Event|1|||
46899837|NCT00245570|83126397|FG002|Washout Between Periods III and IV|Adverse Event|0|||
46899838|NCT00245570|83126398|FG003|Washout Between Periods III and IV|Adverse Event|0|||
46899839|NCT00245570|83126399|FG004|Washout Between Periods III and IV|Adverse Event|0|||
46899840|NCT00245570|83126400|FG005|Washout Between Periods III and IV|Adverse Event|0|||
46899841|NCT04638660|83126436|FG000|Overall Study|Withdrawal by Subject|2|||
46899842|NCT04638660|83126437|FG001|Overall Study|Withdrawal by Subject|0|||
46899843|NCT04638660|83126436|FG000|Overall Study|Lost to Follow-up|1|||
46899844|NCT04638660|83126437|FG001|Overall Study|Lost to Follow-up|0|||
46899845|NCT04367480|83126446|FG000|Overall Study|Adverse Event|1|||
46899846|NCT04367480|83126447|FG001|Overall Study|Adverse Event|1|||
46899847|NCT04367480|83126446|FG000|Overall Study|Death|1|||
46899848|NCT04367480|83126447|FG001|Overall Study|Death|0|||
46899849|NCT04367480|83126446|FG000|Overall Study|Lost to Follow-up|1|||
46899850|NCT04367480|83126447|FG001|Overall Study|Lost to Follow-up|1|||
46899851|NCT04367480|83126446|FG000|Overall Study|Withdrawal by Subject|0|||
46899852|NCT04367480|83126447|FG001|Overall Study|Withdrawal by Subject|3|||
46899853|NCT04367480|83126446|FG000|Overall Study|App glitch during the study|1|||
46899854|NCT04367480|83126447|FG001|Overall Study|App glitch during the study|0|||
46899855|NCT04367480|83126446|FG000|Overall Study|Device Distribution Error|0|||
46899856|NCT04367480|83126447|FG001|Overall Study|Device Distribution Error|2|||
46899857|NCT04367480|83126446|FG000|Overall Study|Ineligible after Randomization|0|||
46899858|NCT04367480|83126447|FG001|Overall Study|Ineligible after Randomization|1|||
46899859|NCT04367480|83126446|FG000|Overall Study|Other Medical Reasons|0|||
46899860|NCT04367480|83126447|FG001|Overall Study|Other Medical Reasons|2|||
46899861|NCT04137731|83126470|FG000|Overall Study|Surgery Cancellation|1|||
46709056|NCT02545868|82924994|FG002|Overall Study|Non-compliance|1|||
46899862|NCT04137731|83126471|FG001|Overall Study|Surgery Cancellation|2|||
46899863|NCT04137731|83126470|FG000|Overall Study|Withdrawal by Subject|2|||
46899864|NCT04137731|83126471|FG001|Overall Study|Withdrawal by Subject|0|||
46899865|NCT04137731|83126470|FG000|Overall Study|Protocol Violation|0|||
46899866|NCT04137731|83126471|FG001|Overall Study|Protocol Violation|1|||
46709057|NCT02545868|82924992|FG000|Overall Study|Treatment change|21|||
46899867|NCT04088760|83126486|FG000|Overall Study|Physician Decision|1|||
46899868|NCT03813238|83126505|FG000|Overall Study|Adverse Event|0|||
46899869|NCT03813238|83126506|FG001|Overall Study|Adverse Event|6|||
46899870|NCT03813238|83126505|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46899871|NCT03813238|83126506|FG001|Overall Study|Withdrawal by parent/guardian|2|||
46899872|NCT03813238|83126505|FG000|Overall Study|Lost to Follow-up|0|||
46899873|NCT03813238|83126506|FG001|Overall Study|Lost to Follow-up|1|||
46899874|NCT03813238|83126505|FG000|Overall Study|Other than specified|1|||
46899875|NCT03813238|83126506|FG001|Overall Study|Other than specified|2|||
46899876|NCT03737240|83126514|FG000|Overall Study|Lost to Follow-up|16|||
46899877|NCT03737240|83126515|FG001|Overall Study|Lost to Follow-up|15|||
46899878|NCT03532178|83126523|FG000|First Period|Withdrawal by Subject|1|||
46899879|NCT03532178|83126524|FG001|First Period|Withdrawal by Subject|3|||
46899880|NCT03532178|83126523|FG000|First Period|technical issues in data collection Technical issues|0|||
46899881|NCT03532178|83126524|FG001|First Period|technical issues in data collection Technical issues|1|||
46899882|NCT03532178|83126523|FG000|Second Period|Withdrawal by Subject|1|||
46899883|NCT03532178|83126524|FG001|Second Period|Withdrawal by Subject|1|||
46899884|NCT03532178|83126523|FG000|Second Period|Technical issues|0|||
46899885|NCT03532178|83126524|FG001|Second Period|Technical issues|1|||
46899886|NCT03526549|83126532|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
46899887|NCT03526549|83126533|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
46899888|NCT03526549|83126532|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
46899889|NCT03526549|83126533|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
46899890|NCT03526549|83126532|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
46899891|NCT03526549|83126533|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
46899892|NCT03526549|83126532|FG000|Open-label Phase|Adverse Event|4|||
46899893|NCT03526549|83126533|FG001|Open-label Phase|Adverse Event|0|||
46899894|NCT03526549|83126532|FG000|Open-label Phase|Withdrawal by Subject|54|||
46899895|NCT03526549|83126533|FG001|Open-label Phase|Withdrawal by Subject|0|||
46899896|NCT03526549|83126532|FG000|Open-label Phase|Lost to Follow-up|35|||
46899897|NCT03526549|83126533|FG001|Open-label Phase|Lost to Follow-up|0|||
46899898|NCT03526549|83126532|FG000|Open-label Phase|Other than Specified|5|||
46899899|NCT03526549|83126533|FG001|Open-label Phase|Other than Specified|0|||
46899900|NCT03449901|83126547|FG000|Overall Study|Progression|57|||
46899901|NCT03449901|83126548|FG001|Overall Study|Progression|12|||
46899902|NCT03449901|83126547|FG000|Overall Study|Adverse Event|3|||
46899903|NCT03449901|83126548|FG001|Overall Study|Adverse Event|0|||
46899904|NCT03449901|83126547|FG000|Overall Study|Death|6|||
46899905|NCT03449901|83126548|FG001|Overall Study|Death|2|||
46899906|NCT03449901|83126547|FG000|Overall Study|Withdrawal by Subject|12|||
46899907|NCT03449901|83126548|FG001|Overall Study|Withdrawal by Subject|1|||
46899908|NCT03449901|83126547|FG000|Overall Study|Physician Decision|1|||
46899909|NCT03449901|83126548|FG001|Overall Study|Physician Decision|0|||
46899910|NCT03449901|83126547|FG000|Overall Study|Patient elected for surgical intervention|1|||
46899911|NCT03449901|83126548|FG001|Overall Study|Patient elected for surgical intervention|0|||
46899912|NCT03449901|83126547|FG000|Overall Study|Patient off for other complicating disease|1|||
46899913|NCT03449901|83126548|FG001|Overall Study|Patient off for other complicating disease|0|||
46899914|NCT03435380|83126563|FG000|Overall Study|Death|1|||
46899915|NCT03435380|83126564|FG001|Overall Study|Death|2|||
46899916|NCT03435380|83126565|FG002|Overall Study|Death|1|||
46899917|NCT03435380|83126563|FG000|Overall Study|Lost to Follow-up|12|||
46899918|NCT03435380|83126564|FG001|Overall Study|Lost to Follow-up|8|||
46899919|NCT03435380|83126565|FG002|Overall Study|Lost to Follow-up|6|||
46899920|NCT03435380|83126563|FG000|Overall Study|Physician Decision|1|||
46899921|NCT03435380|83126564|FG001|Overall Study|Physician Decision|0|||
46899922|NCT03435380|83126565|FG002|Overall Study|Physician Decision|0|||
46899923|NCT03435380|83126563|FG000|Overall Study|Withdrawal by Subject|0|||
46899924|NCT03435380|83126564|FG001|Overall Study|Withdrawal by Subject|1|||
46996591|NCT02349295|83243719|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
46996592|NCT02349295|83243720|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
46996593|NCT02349295|83243721|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
46996594|NCT02349295|83243722|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996595|NCT02349295|83243723|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46899925|NCT03435380|83126565|FG002|Overall Study|Withdrawal by Subject|1|||
46899926|NCT03435380|83126563|FG000|Overall Study|Ineligible|0|||
46899927|NCT03435380|83126564|FG001|Overall Study|Ineligible|1|||
46899928|NCT03435380|83126565|FG002|Overall Study|Ineligible|1|||
46899929|NCT03363659|83126573|FG000|Overall Study|Adverse Event|1|||
46899930|NCT03363659|83126573|FG000|Overall Study|Screen fail|1|||
46899931|NCT03363659|83126573|FG000|Overall Study|Withdrawal by Subject|1|||
46899932|NCT03299166|83126579|FG000|Overall Study|Adverse Event|9|||
46899933|NCT03299166|83126580|FG001|Overall Study|Adverse Event|4|||
46899934|NCT03299166|83126579|FG000|Overall Study|Withdrawal by Subject|6|||
46899935|NCT03299166|83126580|FG001|Overall Study|Withdrawal by Subject|5|||
46899936|NCT03299166|83126579|FG000|Overall Study|Physician Decision|1|||
46899937|NCT03299166|83126580|FG001|Overall Study|Physician Decision|1|||
46899938|NCT03299166|83126579|FG000|Overall Study|Sponsor Decision|3|||
46899939|NCT03299166|83126580|FG001|Overall Study|Sponsor Decision|0|||
46899940|NCT03299166|83126579|FG000|Overall Study|Lost to Follow-up|2|||
46899941|NCT03299166|83126580|FG001|Overall Study|Lost to Follow-up|4|||
46899942|NCT03299166|83126579|FG000|Overall Study|Randomization Error|0|||
46899943|NCT03299166|83126580|FG001|Overall Study|Randomization Error|1|||
46899944|NCT03299166|83126579|FG000|Overall Study|Subject unable to return due to COVID|1|||
46899945|NCT03299166|83126580|FG001|Overall Study|Subject unable to return due to COVID|0|||
46899946|NCT03299166|83126579|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
46899947|NCT03299166|83126580|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
46899948|NCT03204812|83126586|FG000|Overall Study|Adverse Event|3|||
46899949|NCT03201250|83126593|FG000|Overall Study|screen failures|3|||
46899950|NCT03201250|83126594|FG001|Overall Study|screen failures|0|||
46899951|NCT03201250|83126595|FG002|Overall Study|screen failures|0|||
46899952|NCT02853305|83126607|FG000|Overall Study|Death|287|||
46899953|NCT02853305|83126608|FG001|Overall Study|Death|249|||
46899954|NCT02853305|83126609|FG002|Overall Study|Death|300|||
46899955|NCT02853305|83126607|FG000|Overall Study|Withdrawal by Subject|2|||
46899956|NCT02853305|83126608|FG001|Overall Study|Withdrawal by Subject|8|||
46899957|NCT02853305|83126609|FG002|Overall Study|Withdrawal by Subject|3|||
46899958|NCT02853305|83126607|FG000|Overall Study|Transferred to Extension Study|46|||
46899959|NCT02853305|83126608|FG001|Overall Study|Transferred to Extension Study|30|||
46899960|NCT02853305|83126609|FG002|Overall Study|Transferred to Extension Study|25|||
46899961|NCT02853305|83126607|FG000|Overall Study|Did Not Continue on Extension Study|16|||
46899962|NCT02853305|83126608|FG001|Overall Study|Did Not Continue on Extension Study|20|||
46899963|NCT02853305|83126609|FG002|Overall Study|Did Not Continue on Extension Study|24|||
46899964|NCT02524275|83126619|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
46899965|NCT02499120|83126625|FG000|Overall Study|Death|52|||
46899966|NCT02499120|83126626|FG001|Overall Study|Death|43|||
46899967|NCT02499120|83126625|FG000|Overall Study|Lost to Follow-up|1|||
46899968|NCT02499120|83126626|FG001|Overall Study|Lost to Follow-up|2|||
46899969|NCT02499120|83126625|FG000|Overall Study|Participant refused further follow-up|1|||
46899970|NCT02499120|83126626|FG001|Overall Study|Participant refused further follow-up|0|||
46899971|NCT02499120|83126625|FG000|Overall Study|Withdrawal by Subject|2|||
46899972|NCT02499120|83126626|FG001|Overall Study|Withdrawal by Subject|5|||
46899973|NCT02499120|83126625|FG000|Overall Study|Other|9|||
46899974|NCT02499120|83126626|FG001|Overall Study|Other|10|||
46899975|NCT02227992|83126634|FG000|Overall Study|Lost to Follow-up|1|||
46899976|NCT02227992|83126635|FG001|Overall Study|Lost to Follow-up|1|||
46899977|NCT01027143|83126647|FG000|Overall Study|Lost to Follow-up|9|||
46899978|NCT01027143|83126648|FG001|Overall Study|Lost to Follow-up|4|||
46899979|NCT00981656|83126654|FG000|Overall Study|Protocol Violation|1|||
46899980|NCT00981656|83126654|FG000|Overall Study|Did not start protocol treatment|2|||
46899981|NCT00895622|83126661|FG000|Overall Study|Protocol Violation|5|||
46899982|NCT00895622|83126662|FG001|Overall Study|Protocol Violation|4|||
46899983|NCT00895622|83126663|FG002|Overall Study|Protocol Violation|4|||
46899984|NCT00847535|83126679|FG000|Overall Study|Withdrawal by Subject|2|||
46899985|NCT00847535|83126680|FG001|Overall Study|Withdrawal by Subject|1|||
46899986|NCT00847535|83126681|FG002|Overall Study|Withdrawal by Subject|1|||
46899987|NCT00847535|83126679|FG000|Overall Study|Lost to Follow-up|0|||
46899988|NCT00847535|83126680|FG001|Overall Study|Lost to Follow-up|1|||
46899989|NCT00847535|83126681|FG002|Overall Study|Lost to Follow-up|0|||
46899990|NCT00539591|83126693|FG000|Overall Study|Toxicity|3|||
46899991|NCT00539591|83126694|FG001|Overall Study|Toxicity|0|||
46899992|NCT00539591|83126695|FG002|Overall Study|Toxicity|0|||
46899993|NCT00539591|83126693|FG000|Overall Study|Disease progression|2|||
46899994|NCT00539591|83126694|FG001|Overall Study|Disease progression|2|||
46899995|NCT00539591|83126695|FG002|Overall Study|Disease progression|3|||
46899996|NCT03512210|83126735|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
46899997|NCT03512210|83126735|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
46996596|NCT02349295|83243724|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996597|NCT02349295|83243725|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996598|NCT02349295|83243726|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46709058|NCT02545868|82924993|FG001|Overall Study|Treatment change|19|||
46899998|NCT03512210|83126735|FG000|Step 2:Post-MINMON|Death|2|||
46899999|NCT03512210|83126735|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
46900000|NCT03512210|83126735|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
46900001|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
46900002|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
46900003|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
46900004|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
46900005|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
46900006|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
46900007|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
46900008|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
46900009|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
46900010|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
46900011|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
46900012|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
46900013|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
46900014|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
46900015|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
46900016|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
46900017|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
46900018|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
46900019|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
46900020|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
46900021|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
46900022|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
46900023|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
46900024|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
46900025|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
46900026|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
46709059|NCT02545868|82924994|FG002|Overall Study|Treatment change|22|||
46709060|NCT02545868|82924992|FG000|Overall Study|Physician Decision|1|||
46709061|NCT02545868|82924993|FG001|Overall Study|Physician Decision|1|||
46709062|NCT02545868|82924994|FG002|Overall Study|Physician Decision|1|||
46900027|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
46900028|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
46900029|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
46900030|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
46900031|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
46900032|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
46900033|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
46900034|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
46900035|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
46900036|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
46900037|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
46900038|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
46900039|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
46900040|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
46900041|NCT00383721|83126744|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
46900042|NCT00383721|83126745|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
46900043|NCT00383721|83126746|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
46900044|NCT00383721|83126747|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
46900045|NCT00383721|83126748|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
46900046|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
46900047|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
46900048|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
46900049|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
46900050|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
46900051|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
46900052|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
46900053|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
46900054|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
46900055|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
46900056|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
46900057|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
46996599|NCT02349295|83243727|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996600|NCT02349295|83243728|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996601|NCT02349295|83243729|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996602|NCT02349295|83243730|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996603|NCT02349295|83243731|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996604|NCT02349295|83243732|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
46996605|NCT02349295|83243719|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
46996606|NCT02349295|83243720|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
46709063|NCT02545868|82924992|FG000|Overall Study|Withdrawal by Subject|6|||
46709064|NCT02545868|82924993|FG001|Overall Study|Withdrawal by Subject|7|||
46709065|NCT02545868|82924994|FG002|Overall Study|Withdrawal by Subject|9|||
46996607|NCT02349295|83243721|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
46996608|NCT02349295|83243722|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996609|NCT02349295|83243723|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996610|NCT02349295|83243724|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996611|NCT02349295|83243725|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996612|NCT02349295|83243726|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996613|NCT02349295|83243727|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996614|NCT02349295|83243728|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996615|NCT02349295|83243729|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996616|NCT02349295|83243730|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996617|NCT02349295|83243731|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996618|NCT02349295|83243732|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
46996619|NCT02349295|83243719|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996620|NCT02349295|83243720|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
46996621|NCT02349295|83243721|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
46996622|NCT02349295|83243722|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996623|NCT02349295|83243723|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996624|NCT02349295|83243724|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996625|NCT02349295|83243725|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996626|NCT02349295|83243726|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46900058|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
46900059|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
46900060|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
46900061|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
46900062|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
46900063|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
46900064|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
46900065|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
46900066|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
46900067|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
46900068|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
46900069|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
46900070|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
46900071|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
46900072|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
46900073|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
46900074|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
46900075|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
46900076|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
46900077|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
46900078|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
46900079|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
46900080|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
46900081|NCT00383721|83126744|FG000|26-Week Treatment Safety Extension|Administrative|1|||
46900082|NCT00383721|83126745|FG001|26-Week Treatment Safety Extension|Administrative|2|||
46900083|NCT00383721|83126746|FG002|26-Week Treatment Safety Extension|Administrative|3|||
46900084|NCT00383721|83126747|FG003|26-Week Treatment Safety Extension|Administrative|1|||
46900085|NCT00383721|83126748|FG004|26-Week Treatment Safety Extension|Administrative|0|||
46900086|NCT03035942|83126776|FG000|Overall Study|Adverse Event|8|||
46900087|NCT03035942|83126777|FG001|Overall Study|Adverse Event|4|||
46900088|NCT03035942|83126778|FG002|Overall Study|Adverse Event|5|||
46900089|NCT02616146|83126790|FG000|Overall Study|Adverse Event|64|||
46900090|NCT02616146|83126791|FG001|Overall Study|Adverse Event|24|||
46900091|NCT02616146|83126790|FG000|Overall Study|Lost to Follow-up|23|||
46900092|NCT02616146|83126791|FG001|Overall Study|Lost to Follow-up|13|||
46900093|NCT02616146|83126790|FG000|Overall Study|Non-compliance with study protocol|2|||
46900094|NCT02616146|83126791|FG001|Overall Study|Non-compliance with study protocol|0|||
46900095|NCT02616146|83126790|FG000|Overall Study|Non-compliance with study drug|4|||
46900096|NCT02616146|83126791|FG001|Overall Study|Non-compliance with study drug|2|||
46900097|NCT02616146|83126790|FG000|Overall Study|Pregnancy|2|||
46900098|NCT02616146|83126791|FG001|Overall Study|Pregnancy|2|||
46900099|NCT02616146|83126790|FG000|Overall Study|Pregnancy wish|3|||
46900100|NCT02616146|83126791|FG001|Overall Study|Pregnancy wish|0|||
46900101|NCT02616146|83126790|FG000|Overall Study|Protocol Violation|6|||
46900102|NCT02616146|83126791|FG001|Overall Study|Protocol Violation|3|||
46900103|NCT02616146|83126790|FG000|Overall Study|Study terminated by sponsor|1372|||
46900104|NCT02616146|83126791|FG001|Overall Study|Study terminated by sponsor|432|||
46900105|NCT02616146|83126790|FG000|Overall Study|Participant moved|4|||
46900106|NCT02616146|83126791|FG001|Overall Study|Participant moved|3|||
46900107|NCT02616146|83126790|FG000|Overall Study|Withdrawal by Subject|30|||
46900108|NCT02616146|83126791|FG001|Overall Study|Withdrawal by Subject|24|||
46900109|NCT02616146|83126790|FG000|Overall Study|Physician Decision|2|||
46900110|NCT02616146|83126791|FG001|Overall Study|Physician Decision|1|||
46900111|NCT04850313|83126799|FG000|Overall Study|Withdrawal by Subject|0|||
46900112|NCT04850313|83126800|FG001|Overall Study|Withdrawal by Subject|1|||
46900113|NCT02885181|83126818|FG000|Overall Study|Investigator's Discretion|0|||
46900114|NCT02885181|83126819|FG001|Overall Study|Investigator's Discretion|1|||
46900115|NCT02885181|83126820|FG002|Overall Study|Investigator's Discretion|0|||
46900116|NCT02885181|83126821|FG003|Overall Study|Investigator's Discretion|1|||
46900117|NCT02885181|83126818|FG000|Overall Study|Adverse Event|0|||
46900118|NCT02885181|83126819|FG001|Overall Study|Adverse Event|0|||
46900119|NCT02885181|83126820|FG002|Overall Study|Adverse Event|0|||
46900120|NCT02885181|83126821|FG003|Overall Study|Adverse Event|1|||
46900121|NCT02885181|83126818|FG000|Overall Study|Withdrawal by Subject|0|||
46900122|NCT02885181|83126819|FG001|Overall Study|Withdrawal by Subject|0|||
46900123|NCT02885181|83126820|FG002|Overall Study|Withdrawal by Subject|0|||
46900124|NCT02885181|83126821|FG003|Overall Study|Withdrawal by Subject|1|||
46900125|NCT02884089|83126835|FG000|Period 1|Dosing error|2|||
46900126|NCT02884089|83126836|FG001|Period 1|Dosing error|2|||
46900127|NCT02884089|83126837|FG002|Period 1|Dosing error|0|||
46900128|NCT02884089|83126838|FG003|Period 1|Dosing error|0|||
46900129|NCT02884089|83126835|FG000|Washout Period 1|Lost to Follow-up|0|||
46900130|NCT02884089|83126836|FG001|Washout Period 1|Lost to Follow-up|1|||
46900131|NCT02884089|83126837|FG002|Washout Period 1|Lost to Follow-up|0|||
46900132|NCT02884089|83126838|FG003|Washout Period 1|Lost to Follow-up|1|||
46900133|NCT02884089|83126835|FG000|Washout Period 1|Withdrawal by Subject|0|||
46900134|NCT02884089|83126836|FG001|Washout Period 1|Withdrawal by Subject|1|||
46900135|NCT02884089|83126837|FG002|Washout Period 1|Withdrawal by Subject|0|||
46900136|NCT02884089|83126838|FG003|Washout Period 1|Withdrawal by Subject|0|||
46900137|NCT02884089|83126835|FG000|Period 2|Adverse Event|1|||
46900138|NCT02884089|83126836|FG001|Period 2|Adverse Event|0|||
46900139|NCT02884089|83126837|FG002|Period 2|Adverse Event|0|||
46900140|NCT02884089|83126838|FG003|Period 2|Adverse Event|0|||
46900141|NCT02884089|83126835|FG000|Period 3|Withdrawal by Subject|0|||
46900142|NCT02884089|83126836|FG001|Period 3|Withdrawal by Subject|0|||
46900143|NCT02884089|83126837|FG002|Period 3|Withdrawal by Subject|1|||
46900144|NCT02884089|83126838|FG003|Period 3|Withdrawal by Subject|0|||
46900145|NCT02884089|83126835|FG000|Washout Period 3|Withdrawal by Subject|0|||
46900146|NCT02884089|83126836|FG001|Washout Period 3|Withdrawal by Subject|0|||
46900147|NCT02884089|83126837|FG002|Washout Period 3|Withdrawal by Subject|1|||
46900148|NCT02884089|83126838|FG003|Washout Period 3|Withdrawal by Subject|0|||
46900149|NCT02884089|83126835|FG000|Washout Period 3|Lost to Follow-up|0|||
46900150|NCT02884089|83126836|FG001|Washout Period 3|Lost to Follow-up|0|||
46900151|NCT02884089|83126837|FG002|Washout Period 3|Lost to Follow-up|0|||
46900152|NCT02884089|83126838|FG003|Washout Period 3|Lost to Follow-up|1|||
46900153|NCT02884089|83126835|FG000|Period 4|Withdrawal by Subject|0|||
46900154|NCT02884089|83126836|FG001|Period 4|Withdrawal by Subject|1|||
46900155|NCT02884089|83126837|FG002|Period 4|Withdrawal by Subject|0|||
46900156|NCT02884089|83126838|FG003|Period 4|Withdrawal by Subject|0|||
46900157|NCT02884089|83126835|FG000|Period 4|Lost to Follow-up|1|||
46900158|NCT02884089|83126836|FG001|Period 4|Lost to Follow-up|0|||
46900159|NCT02884089|83126837|FG002|Period 4|Lost to Follow-up|0|||
46900160|NCT02884089|83126838|FG003|Period 4|Lost to Follow-up|0|||
46900161|NCT02884089|83126835|FG000|Follow-up Visit|Withdrawal by Subject|1|||
46900162|NCT02884089|83126836|FG001|Follow-up Visit|Withdrawal by Subject|0|||
46900163|NCT02884089|83126837|FG002|Follow-up Visit|Withdrawal by Subject|0|||
46900164|NCT02884089|83126838|FG003|Follow-up Visit|Withdrawal by Subject|1|||
46900165|NCT02809677|83126848|FG000|Overall Study|Withdrawal by Subject|8|||
46900166|NCT02881047|83126853|FG000|Overall Study|Adverse Event|1|||
46900167|NCT02881047|83126853|FG000|Overall Study|Withdrawal by Subject|1|||
46900168|NCT03157089|83126859|FG000|Overall Study|Treated only with pembrolizumab|1|||
46900169|NCT03157089|83126860|FG001|Overall Study|Treated only with pembrolizumab|0|||
46900170|NCT03157089|83126859|FG000|Overall Study|Adverse Event|5|||
46996627|NCT02349295|83243727|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46709066|NCT02232399|82925021|FG000|Overall Study|Adverse Event|1|||
46900171|NCT03157089|83126860|FG001|Overall Study|Adverse Event|4|||
46900172|NCT03157089|83126859|FG000|Overall Study|Progressive disease|6|||
46900173|NCT03157089|83126860|FG001|Overall Study|Progressive disease|8|||
46900174|NCT03158727|83126869|FG000|Overall Study|Withdrawal by Subject|2|||
46900175|NCT03158727|83126870|FG001|Overall Study|Withdrawal by Subject|6|||
46900176|NCT03158727|83126869|FG000|Overall Study|Death|11|||
46900177|NCT03158727|83126870|FG001|Overall Study|Death|12|||
46900178|NCT03158727|83126869|FG000|Overall Study|Lost to Follow-up|1|||
46900179|NCT03158727|83126870|FG001|Overall Study|Lost to Follow-up|0|||
46900180|NCT03158727|83126869|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
46900181|NCT03158727|83126870|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
46900182|NCT03158727|83126869|FG000|Overall Study|Visit 11 not done by mistake|0|||
46900183|NCT03158727|83126870|FG001|Overall Study|Visit 11 not done by mistake|1|||
46900184|NCT03158727|83126869|FG000|Overall Study|Enrolled, not treated|1|||
46900185|NCT03158727|83126870|FG001|Overall Study|Enrolled, not treated|0|||
46900186|NCT00089895|83126878|FG000|Overall Study|Consent Withdrawn|11|||
46900187|NCT00089895|83126879|FG001|Overall Study|Consent Withdrawn|14|||
46900188|NCT00089895|83126878|FG000|Overall Study|Technical reason|7|||
46900189|NCT00089895|83126879|FG001|Overall Study|Technical reason|2|||
46900190|NCT00089895|83126878|FG000|Overall Study|Surgery|0|||
46900191|NCT00089895|83126879|FG001|Overall Study|Surgery|1|||
46900192|NCT00089895|83126878|FG000|Overall Study|Bleeding|0|||
46900193|NCT00089895|83126879|FG001|Overall Study|Bleeding|2|||
46900194|NCT00089895|83126878|FG000|Overall Study|Physician Decision|3|||
46900195|NCT00089895|83126879|FG001|Overall Study|Physician Decision|7|||
46900196|NCT00089895|83126878|FG000|Overall Study|Exclusion criteria met|6|||
46900197|NCT00089895|83126879|FG001|Overall Study|Exclusion criteria met|6|||
46900198|NCT00089895|83126878|FG000|Overall Study|Not otherwise specified|4|||
46900199|NCT00089895|83126879|FG001|Overall Study|Not otherwise specified|8|||
46900200|NCT00089895|83126878|FG000|Overall Study|Missing|4|||
46900201|NCT00089895|83126879|FG001|Overall Study|Missing|2|||
46900202|NCT02714218|83126888|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46900203|NCT02714218|83126889|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
46900204|NCT02714218|83126890|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46900205|NCT02714218|83126888|FG000|Pre-Treatment Period|Other reasons|0|||
46900206|NCT02714218|83126889|FG001|Pre-Treatment Period|Other reasons|1|||
46900207|NCT02714218|83126890|FG002|Pre-Treatment Period|Other reasons|0|||
46900208|NCT02714218|83126888|FG000|Treatment Period|Disease Progression|55|||
46900209|NCT02714218|83126889|FG001|Treatment Period|Disease Progression|52|||
46900210|NCT02714218|83126890|FG002|Treatment Period|Disease Progression|14|||
46900211|NCT02714218|83126888|FG000|Treatment Period|Study drug toxicity|46|||
46900212|NCT02714218|83126889|FG001|Treatment Period|Study drug toxicity|70|||
46900213|NCT02714218|83126890|FG002|Treatment Period|Study drug toxicity|6|||
46900214|NCT02714218|83126888|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
46900215|NCT02714218|83126889|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
46900216|NCT02714218|83126890|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
46900217|NCT02714218|83126888|FG000|Treatment Period|Request to discontinue treatment|1|||
46900218|NCT02714218|83126889|FG001|Treatment Period|Request to discontinue treatment|4|||
46900219|NCT02714218|83126890|FG002|Treatment Period|Request to discontinue treatment|1|||
46900220|NCT02714218|83126888|FG000|Treatment Period|Participant withdrew consent|2|||
46900221|NCT02714218|83126889|FG001|Treatment Period|Participant withdrew consent|2|||
46900222|NCT02714218|83126890|FG002|Treatment Period|Participant withdrew consent|0|||
46900223|NCT02714218|83126888|FG000|Treatment Period|Maximum clinical benefit|4|||
46900224|NCT02714218|83126889|FG001|Treatment Period|Maximum clinical benefit|2|||
46900225|NCT02714218|83126890|FG002|Treatment Period|Maximum clinical benefit|0|||
46900226|NCT02714218|83126888|FG000|Treatment Period|Administrative reason by sponsor|2|||
46900227|NCT02714218|83126889|FG001|Treatment Period|Administrative reason by sponsor|1|||
46900228|NCT02714218|83126890|FG002|Treatment Period|Administrative reason by sponsor|0|||
46900229|NCT02714218|83126888|FG000|Treatment Period|Other reasons|6|||
46900230|NCT02714218|83126889|FG001|Treatment Period|Other reasons|6|||
46900231|NCT02714218|83126890|FG002|Treatment Period|Other reasons|0|||
46900232|NCT02714218|83126888|FG000|Treatment Period|Completed treatment as per protocol|36|||
46900233|NCT02714218|83126889|FG001|Treatment Period|Completed treatment as per protocol|27|||
46709067|NCT02232399|82925022|FG001|Overall Study|Adverse Event|0|||
46709068|NCT02232399|82925021|FG000|Overall Study|Withdrawal by Subject|0|||
46709069|NCT02232399|82925022|FG001|Overall Study|Withdrawal by Subject|1|||
46709070|NCT02141074|82925029|FG000|Pre-prophylaxis|Adverse Event|3|||
46709071|NCT02141074|82925030|FG001|Pre-prophylaxis|Adverse Event|0|||
46709072|NCT02141074|82925029|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
46709073|NCT02141074|82925030|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
46709074|NCT02141074|82925029|FG000|Prophylaxis|Adverse Event|0|||
46709075|NCT02141074|82925030|FG001|Prophylaxis|Adverse Event|4|||
46709076|NCT02141074|82925029|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
46900234|NCT02714218|83126890|FG002|Treatment Period|Completed treatment as per protocol|3|||
46900235|NCT02714218|83126888|FG000|Treatment Period|Not reported|9|||
46900236|NCT02714218|83126889|FG001|Treatment Period|Not reported|6|||
46900237|NCT02714218|83126890|FG002|Treatment Period|Not reported|0|||
46709077|NCT02141074|82925030|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
46709078|NCT02141074|82925029|FG000|Prophylaxis|Withdrawal by Subject|0|||
46709079|NCT02141074|82925030|FG001|Prophylaxis|Withdrawal by Subject|1|||
46900238|NCT03154047|83126897|FG000|Overall Study|Death|1|||
46900239|NCT03154047|83126897|FG000|Overall Study|Study terminated by sponsor|76|||
46900240|NCT03154047|83126897|FG000|Overall Study|Withdrawal by Subject|3|||
46900241|NCT03156621|83126903|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
46900242|NCT03156621|83126904|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
46900243|NCT03156621|83126903|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
46900244|NCT03156621|83126904|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
46900245|NCT03156543|83126915|FG000|Overall Study|Withdrawal by Subject|1|||
46900246|NCT03156543|83126916|FG001|Overall Study|Withdrawal by Subject|0|||
46900247|NCT02713594|83126924|FG000|Overall Study|Withdrawal by Subject|32|||
46900248|NCT02713594|83126925|FG001|Overall Study|Withdrawal by Subject|22|||
46900249|NCT02713594|83126924|FG000|Overall Study|Lost to Follow-up|358|||
46900250|NCT02713594|83126925|FG001|Overall Study|Lost to Follow-up|374|||
46900251|NCT03152019|83126935|FG000|Overall Study|Adverse Event|0|||
46900252|NCT03152019|83126936|FG001|Overall Study|Adverse Event|1|||
46900253|NCT02714062|83126949|FG000|Overall Study|Adverse Event|0|||
46900254|NCT02714062|83126950|FG001|Overall Study|Adverse Event|0|||
46900255|NCT02714062|83126951|FG002|Overall Study|Adverse Event|2|||
46900256|NCT02714062|83126949|FG000|Overall Study|Withdrawal by Subject|1|||
46900257|NCT02714062|83126950|FG001|Overall Study|Withdrawal by Subject|0|||
46900258|NCT02714062|83126951|FG002|Overall Study|Withdrawal by Subject|1|||
46900259|NCT02714062|83126949|FG000|Overall Study|Protocol Violation|0|||
46900260|NCT02714062|83126950|FG001|Overall Study|Protocol Violation|1|||
46900261|NCT02714062|83126951|FG002|Overall Study|Protocol Violation|0|||
46900262|NCT03151395|83126961|FG000|Overall Study|Adverse Event|2|||
46900263|NCT03151395|83126961|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
46900264|NCT03151395|83126961|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
46900265|NCT03151395|83126961|FG000|Overall Study|Unspecified reason|4|||
46900266|NCT02713828|83126967|FG000|Overall Study|Death|2|||
46900267|NCT02713828|83126968|FG001|Overall Study|Death|0|||
46900268|NCT02713828|83126967|FG000|Overall Study|Withdrawal by Subject|1|||
46900269|NCT02713828|83126968|FG001|Overall Study|Withdrawal by Subject|0|||
46900270|NCT02713828|83126967|FG000|Overall Study|study terminated but patient allowed to|2|||
46900271|NCT02713828|83126968|FG001|Overall Study|study terminated but patient allowed to|0|||
46900272|NCT02875860|83126975|FG000|Overall Study|Withdrawal by Subject|0|||
46900273|NCT02875860|83126976|FG001|Overall Study|Withdrawal by Subject|1|||
46900274|NCT02875392|83126984|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
46900275|NCT02875392|83126985|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
46900276|NCT03127644|83126994|FG000|Overall Study|Study-specific withdrawal criteria|0|||
46900277|NCT03127644|83126995|FG001|Overall Study|Study-specific withdrawal criteria|0|||
46900278|NCT03127644|83126996|FG002|Overall Study|Study-specific withdrawal criteria|2|||
46900279|NCT03965962|83127010|FG000|Overall Study|Adverse Event|1|||
46900280|NCT03965962|83127011|FG001|Overall Study|Adverse Event|0|||
46900281|NCT03965962|83127012|FG002|Overall Study|Adverse Event|0|||
46900282|NCT03965962|83127013|FG003|Overall Study|Adverse Event|0|||
46900283|NCT03965962|83127010|FG000|Overall Study|Protocol Violation|21|||
46900284|NCT03965962|83127011|FG001|Overall Study|Protocol Violation|4|||
46900285|NCT03965962|83127012|FG002|Overall Study|Protocol Violation|10|||
46900286|NCT03965962|83127013|FG003|Overall Study|Protocol Violation|5|||
46900287|NCT03965962|83127010|FG000|Overall Study|Lost to Follow-up|0|||
46900288|NCT03965962|83127011|FG001|Overall Study|Lost to Follow-up|1|||
46900289|NCT03965962|83127012|FG002|Overall Study|Lost to Follow-up|0|||
46900290|NCT03965962|83127013|FG003|Overall Study|Lost to Follow-up|0|||
46900291|NCT03965962|83127010|FG000|Overall Study|Withdrawal by Subject|3|||
46900292|NCT03965962|83127011|FG001|Overall Study|Withdrawal by Subject|0|||
46900293|NCT03965962|83127012|FG002|Overall Study|Withdrawal by Subject|0|||
46900294|NCT03965962|83127013|FG003|Overall Study|Withdrawal by Subject|1|||
46900295|NCT03151551|83127025|FG000|Open-Label Treatment Period|Adverse Event|0|||
46900296|NCT03151551|83127026|FG001|Open-Label Treatment Period|Adverse Event|2|||
46900297|NCT03151551|83127025|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
46900298|NCT03151551|83127026|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
46900299|NCT03151551|83127025|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
46900300|NCT03151551|83127026|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
46900301|NCT03151551|83127025|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
46900302|NCT03151551|83127026|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
46900303|NCT03151551|83127025|FG000|Open-Label Treatment Period|Physician Decision|3|||
46900304|NCT03151551|83127026|FG001|Open-Label Treatment Period|Physician Decision|0|||
46900305|NCT03151551|83127025|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
46900306|NCT03151551|83127026|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
46900307|NCT03151551|83127025|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
46900308|NCT03151551|83127026|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
46900309|NCT03151551|83127025|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
46900310|NCT03151551|83127026|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
46900311|NCT03151551|83127025|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
46900312|NCT03151551|83127026|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
46775677|NCT00694707|82994138|FG002|Overall Study|Arrest by Police|0|||
46900313|NCT03151551|83127025|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
46900314|NCT03151551|83127026|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
46900315|NCT03147495|83127036|FG000|Overall Study|Physician Decision|0|||
46900316|NCT03147495|83127037|FG001|Overall Study|Physician Decision|6|||
46900317|NCT03126786|83127045|FG000|Overall Study|Adverse Event|3|||
46900318|NCT03126786|83127046|FG001|Overall Study|Adverse Event|0|||
46900319|NCT03126786|83127045|FG000|Overall Study|Lost to Follow-up|0|||
46900320|NCT03126786|83127046|FG001|Overall Study|Lost to Follow-up|1|||
46900321|NCT03126786|83127045|FG000|Overall Study|Withdrawal by Subject|3|||
46900322|NCT03126786|83127046|FG001|Overall Study|Withdrawal by Subject|1|||
46900323|NCT03146403|83127054|FG000|Overall Study|Withdrawal by Subject|0|||
46709082|NCT01962948|82925051|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
46709083|NCT01962948|82925052|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
46900324|NCT03146403|83127055|FG001|Overall Study|Withdrawal by Subject|3|||
46900325|NCT03146403|83127054|FG000|Overall Study|Lost to Follow-up|2|||
46900326|NCT03146403|83127055|FG001|Overall Study|Lost to Follow-up|0|||
46900327|NCT02713204|83127064|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
46900328|NCT02713204|83127065|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
46900329|NCT02713204|83127066|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
46900330|NCT02713204|83127067|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
46900331|NCT02713204|83127068|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
46900332|NCT02713204|83127069|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
46900333|NCT02713204|83127070|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
46900334|NCT02713204|83127071|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
46900335|NCT02713204|83127064|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46900336|NCT02713204|83127065|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46900337|NCT02713204|83127066|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
46900338|NCT02713204|83127067|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46900339|NCT02713204|83127068|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46900340|NCT02713204|83127069|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46900341|NCT02713204|83127070|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46900342|NCT02713204|83127071|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46900343|NCT02713204|83127064|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46900344|NCT02713204|83127065|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
46709084|NCT01962948|82925053|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
46709085|NCT01962948|82925054|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
46709086|NCT01897571|82925072|FG000|Overall Study|Lost to Follow-up|3|||
46900345|NCT02713204|83127066|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46900346|NCT02713204|83127067|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46900347|NCT02713204|83127068|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46900348|NCT02713204|83127069|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46709087|NCT01897571|82925073|FG001|Overall Study|Lost to Follow-up|0|||
46709088|NCT01897571|82925074|FG002|Overall Study|Lost to Follow-up|0|||
46709089|NCT01897571|82925075|FG003|Overall Study|Lost to Follow-up|0|||
46900349|NCT02713204|83127070|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46900350|NCT02713204|83127071|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46900351|NCT02713204|83127064|FG000|From Week 12 up to Week 36|Adverse Event|1|||
46900352|NCT02713204|83127065|FG001|From Week 12 up to Week 36|Adverse Event|0|||
46900353|NCT02713204|83127066|FG002|From Week 12 up to Week 36|Adverse Event|0|||
46900354|NCT02713204|83127067|FG003|From Week 12 up to Week 36|Adverse Event|1|||
46900355|NCT02713204|83127068|FG004|From Week 12 up to Week 36|Adverse Event|1|||
46900356|NCT02713204|83127069|FG005|From Week 12 up to Week 36|Adverse Event|0|||
46900357|NCT02713204|83127070|FG006|From Week 12 up to Week 36|Adverse Event|2|||
46900358|NCT02713204|83127071|FG007|From Week 12 up to Week 36|Adverse Event|1|||
46900359|NCT02713204|83127064|FG000|From Week 12 up to Week 36|Death|0|||
46900360|NCT02713204|83127065|FG001|From Week 12 up to Week 36|Death|0|||
46900361|NCT02713204|83127066|FG002|From Week 12 up to Week 36|Death|0|||
46900362|NCT02713204|83127067|FG003|From Week 12 up to Week 36|Death|1|||
46900363|NCT02713204|83127068|FG004|From Week 12 up to Week 36|Death|0|||
46900364|NCT02713204|83127069|FG005|From Week 12 up to Week 36|Death|1|||
46900365|NCT02713204|83127070|FG006|From Week 12 up to Week 36|Death|0|||
46900366|NCT02713204|83127071|FG007|From Week 12 up to Week 36|Death|3|||
46900367|NCT02713204|83127064|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
46900368|NCT02713204|83127065|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
46900369|NCT02713204|83127066|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
46900370|NCT02713204|83127067|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
46900371|NCT02713204|83127068|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
46900372|NCT02713204|83127069|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
46900373|NCT02713204|83127070|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
46996628|NCT02349295|83243728|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996629|NCT02349295|83243729|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996630|NCT02349295|83243730|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996631|NCT02349295|83243731|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996632|NCT02349295|83243732|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
46996633|NCT02349295|83243719|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
46996634|NCT02349295|83243720|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
46996635|NCT02349295|83243721|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
46996636|NCT02349295|83243722|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
46996637|NCT02349295|83243723|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
46996638|NCT02349295|83243724|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
46996639|NCT02349295|83243725|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
46996640|NCT02349295|83243726|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
46996641|NCT02349295|83243727|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
46996642|NCT02349295|83243728|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
46996643|NCT02349295|83243729|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
46996644|NCT02349295|83243730|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
46996645|NCT02349295|83243731|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
46996646|NCT02349295|83243732|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
46996647|NCT02349295|83243719|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996648|NCT02349295|83243720|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996649|NCT02349295|83243721|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46709090|NCT01897571|82925076|FG004|Overall Study|Lost to Follow-up|2|||
46900374|NCT02713204|83127071|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
46900375|NCT02713204|83127064|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
46900376|NCT02713204|83127065|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
46900377|NCT02713204|83127066|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
46900378|NCT02713204|83127067|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
46900379|NCT02713204|83127068|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
46900380|NCT02713204|83127069|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
46900381|NCT02713204|83127070|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
46900382|NCT02713204|83127071|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
46900383|NCT03695172|83127091|FG000|Overall Study|Withdrawal by Subject|1|||
46900384|NCT03695172|83127092|FG001|Overall Study|Withdrawal by Subject|1|||
46900385|NCT03695172|83127093|FG002|Overall Study|Withdrawal by Subject|0|||
46900386|NCT03721107|83127105|FG000|Overall Study|Adverse Event|1|||
46900387|NCT03721107|83127106|FG001|Overall Study|Adverse Event|1|||
46900388|NCT03721107|83127107|FG002|Overall Study|Adverse Event|6|||
46900389|NCT03721107|83127108|FG003|Overall Study|Adverse Event|5|||
46900390|NCT03721107|83127105|FG000|Overall Study|Lost to Follow-up|2|||
46900391|NCT03721107|83127106|FG001|Overall Study|Lost to Follow-up|0|||
46900392|NCT03721107|83127107|FG002|Overall Study|Lost to Follow-up|3|||
46900393|NCT03721107|83127108|FG003|Overall Study|Lost to Follow-up|0|||
46900394|NCT03721107|83127105|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
46900395|NCT03721107|83127106|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
46900396|NCT03721107|83127107|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
46900397|NCT03721107|83127108|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
46900398|NCT03721107|83127105|FG000|Overall Study|Physician Decision|0|||
46900399|NCT03721107|83127106|FG001|Overall Study|Physician Decision|1|||
46900400|NCT03721107|83127107|FG002|Overall Study|Physician Decision|0|||
46900401|NCT03721107|83127108|FG003|Overall Study|Physician Decision|0|||
46900402|NCT03721107|83127105|FG000|Overall Study|Pregnancy|0|||
46900403|NCT03721107|83127106|FG001|Overall Study|Pregnancy|0|||
46900404|NCT03721107|83127107|FG002|Overall Study|Pregnancy|1|||
46900405|NCT03721107|83127108|FG003|Overall Study|Pregnancy|0|||
46900406|NCT03721107|83127105|FG000|Overall Study|Withdrawal by Subject|1|||
46900407|NCT03721107|83127106|FG001|Overall Study|Withdrawal by Subject|1|||
46900408|NCT03721107|83127107|FG002|Overall Study|Withdrawal by Subject|5|||
46900409|NCT03721107|83127108|FG003|Overall Study|Withdrawal by Subject|5|||
46900410|NCT03721107|83127105|FG000|Overall Study|Other|1|||
46900411|NCT03721107|83127106|FG001|Overall Study|Other|0|||
46900412|NCT03721107|83127107|FG002|Overall Study|Other|0|||
46900413|NCT03721107|83127108|FG003|Overall Study|Other|1|||
46900414|NCT03052920|83127127|FG000|Overall Study|Withdrawal by Subject|1|||
46900415|NCT02930226|83127137|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
46900416|NCT02930226|83127138|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
46900417|NCT02930226|83127139|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
46900418|NCT02930226|83127140|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
46900419|NCT02930226|83127141|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
46996650|NCT02349295|83243722|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996651|NCT02349295|83243723|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46709091|NCT01897571|82925077|FG005|Overall Study|Lost to Follow-up|0|||
46900420|NCT02930226|83127142|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
46900421|NCT02722434|83127179|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
46900422|NCT02722434|83127180|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
46900423|NCT02722434|83127179|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
46900424|NCT02722434|83127180|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
46900425|NCT03539601|83127190|FG000|Overall Study|Withdraw by parent/guardian|1|||
46900426|NCT03539601|83127191|FG001|Overall Study|Withdraw by parent/guardian|0|||
46900427|NCT03539601|83127192|FG002|Overall Study|Withdraw by parent/guardian|1|||
46900428|NCT03539601|83127193|FG003|Overall Study|Withdraw by parent/guardian|0|||
46900429|NCT03539601|83127190|FG000|Overall Study|Adverse Event|0|||
46900430|NCT03539601|83127191|FG001|Overall Study|Adverse Event|2|||
46900431|NCT03539601|83127192|FG002|Overall Study|Adverse Event|0|||
46900432|NCT03539601|83127193|FG003|Overall Study|Adverse Event|0|||
46900433|NCT03539601|83127190|FG000|Overall Study|Lost to Follow-up|2|||
46900434|NCT03539601|83127191|FG001|Overall Study|Lost to Follow-up|4|||
46900435|NCT03539601|83127192|FG002|Overall Study|Lost to Follow-up|5|||
46900436|NCT03539601|83127193|FG003|Overall Study|Lost to Follow-up|0|||
46900437|NCT03539601|83127190|FG000|Overall Study|Withdrawal by Subject|2|||
46900438|NCT03539601|83127191|FG001|Overall Study|Withdrawal by Subject|0|||
46900439|NCT03539601|83127192|FG002|Overall Study|Withdrawal by Subject|0|||
46900440|NCT03539601|83127193|FG003|Overall Study|Withdrawal by Subject|1|||
46900441|NCT03539601|83127190|FG000|Overall Study|Randomized but not treated|1|||
46900442|NCT03539601|83127191|FG001|Overall Study|Randomized but not treated|1|||
46900443|NCT03539601|83127192|FG002|Overall Study|Randomized but not treated|0|||
46900444|NCT03539601|83127193|FG003|Overall Study|Randomized but not treated|0|||
46900445|NCT00700804|83127213|FG000|Overall Study|Withdrawal by Subject|1|||
46900446|NCT00700804|83127214|FG001|Overall Study|Withdrawal by Subject|2|||
46900447|NCT00700804|83127213|FG000|Overall Study|Protocol Violation|1|||
46900448|NCT00700804|83127214|FG001|Overall Study|Protocol Violation|1|||
46900449|NCT00700804|83127213|FG000|Overall Study|Loose Stools|1|||
46900450|NCT00700804|83127214|FG001|Overall Study|Loose Stools|1|||
46900451|NCT02903823|83127220|FG000|Overall Study|Physician Decision|5|||
46900452|NCT02903823|83127220|FG000|Overall Study|Could not advance catheter|1|||
46900453|NCT02903823|83127220|FG000|Overall Study|Catheter dislodgement|1|||
46900454|NCT00832455|83127249|FG000|Overall Study|Adverse Event|13|||
46900455|NCT00832455|83127249|FG000|Overall Study|Lost to Follow-up|26|||
46900456|NCT00832455|83127249|FG000|Overall Study|Protocol Violation|4|||
46900457|NCT00832455|83127249|FG000|Overall Study|Withdrawal by Subject|17|||
46900458|NCT00832455|83127249|FG000|Overall Study|Screening Failure|2|||
46900459|NCT00832455|83127249|FG000|Overall Study|Stopped Medication|4|||
46900460|NCT00832455|83127249|FG000|Overall Study|Parent misunderstood study|1|||
46900461|NCT00832455|83127249|FG000|Overall Study|Parent dissatisfied|1|||
46900462|NCT00832455|83127249|FG000|Overall Study|No improvement|3|||
46900463|NCT00832455|83127249|FG000|Overall Study|Patient moved|1|||
46900464|NCT00687531|83127262|FG000|Overall Study|Did not meet protocol eligibility|104|||
46900465|NCT00687531|83127262|FG000|Overall Study|Adverse Event|5|||
46996652|NCT02349295|83243724|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996653|NCT02349295|83243725|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996654|NCT02349295|83243726|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
46996655|NCT02349295|83243727|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
46996656|NCT02349295|83243728|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
46996657|NCT02349295|83243729|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
46996658|NCT02349295|83243730|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996659|NCT02349295|83243731|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996660|NCT02349295|83243732|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
46996661|NCT02349295|83243719|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996662|NCT02349295|83243720|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996663|NCT02349295|83243721|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996664|NCT02349295|83243722|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996665|NCT02349295|83243723|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996666|NCT02349295|83243724|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996667|NCT02349295|83243725|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996668|NCT02349295|83243726|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
46996669|NCT02349295|83243727|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
46900466|NCT00687531|83127262|FG000|Overall Study|Lost to Follow-up|26|||
46900467|NCT00423579|83127268|FG000|Overall Study|Lost to Follow-up|3|||
46900468|NCT00423579|83127269|FG001|Overall Study|Lost to Follow-up|0|||
46900469|NCT00423579|83127268|FG000|Overall Study|Protocol Violation|1|||
46900470|NCT00423579|83127269|FG001|Overall Study|Protocol Violation|3|||
46900471|NCT00423579|83127268|FG000|Overall Study|Diagnosis of diabetes|0|||
46900472|NCT00423579|83127269|FG001|Overall Study|Diagnosis of diabetes|1|||
46900473|NCT03268005|83127282|FG000|Overall Study|Death|2|||
46900474|NCT03268005|83127283|FG001|Overall Study|Death|1|||
46900475|NCT03268005|83127282|FG000|Overall Study|Lost to Follow-up|2|||
46900476|NCT03268005|83127283|FG001|Overall Study|Lost to Follow-up|2|||
46900477|NCT03268005|83127282|FG000|Overall Study|Withdrawal by Subject|11|||
46900478|NCT03268005|83127283|FG001|Overall Study|Withdrawal by Subject|11|||
46900479|NCT03149055|83127289|FG000|Overall Study|Not treated|4|||
46900480|NCT03137121|83127304|FG000|Overall Study|Withdrawal by Subject|0|||
46900481|NCT03137121|83127305|FG001|Overall Study|Withdrawal by Subject|1|||
46900482|NCT00700570|83127348|FG000|Overall Study|Adverse Event|2|||
46900483|NCT00700570|83127349|FG001|Overall Study|Adverse Event|6|||
46900484|NCT00700570|83127348|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
46900485|NCT00700570|83127349|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
46900486|NCT00700570|83127348|FG000|Overall Study|Disease Progression|8|||
46900487|NCT00700570|83127349|FG001|Overall Study|Disease Progression|11|||
46900488|NCT00700570|83127348|FG000|Overall Study|Withdrawal by Subject|1|||
46900489|NCT00700570|83127349|FG001|Overall Study|Withdrawal by Subject|6|||
46900490|NCT02874924|83127367|FG000|Overall Study|Adverse Event|2|||
46900491|NCT02874924|83127368|FG001|Overall Study|Adverse Event|0|||
46900492|NCT02874924|83127369|FG002|Overall Study|Adverse Event|0|||
46900493|NCT02874924|83127367|FG000|Overall Study|Withdrawal by Subject|1|||
46900494|NCT02874924|83127368|FG001|Overall Study|Withdrawal by Subject|0|||
46900495|NCT02874924|83127369|FG002|Overall Study|Withdrawal by Subject|0|||
46900496|NCT04425863|83127380|FG000|Overall Study|Death|0|||
46900497|NCT04425863|83127381|FG001|Overall Study|Death|0|||
46900498|NCT04425863|83127382|FG002|Overall Study|Death|1|||
46900499|NCT04360187|83127404|FG000|Double-Blind Treatment|Adverse Event|9|||
46900500|NCT04360187|83127405|FG001|Double-Blind Treatment|Adverse Event|11|||
46900501|NCT04360187|83127404|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
46900502|NCT04360187|83127405|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
46900503|NCT04360187|83127404|FG000|Double-Blind Treatment|Physician Decision|1|||
46900504|NCT04360187|83127405|FG001|Double-Blind Treatment|Physician Decision|0|||
46900505|NCT04360187|83127404|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
46900506|NCT04360187|83127405|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
46900507|NCT04360187|83127404|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
46900508|NCT04360187|83127405|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
46900509|NCT04360187|83127404|FG000|Follow-Up|Lost to Follow-up|1|||
46900510|NCT04360187|83127405|FG001|Follow-Up|Lost to Follow-up|0|||
46900511|NCT04498169|83127413|FG000|Study Completion|Adverse Event|1|||
46900512|NCT04498169|83127414|FG001|Study Completion|Adverse Event|1|||
46900513|NCT03695393|83127422|FG000|Overall Study|Death|3|||
46900514|NCT03695393|83127423|FG001|Overall Study|Death|1|||
46900515|NCT03695393|83127422|FG000|Overall Study|Lost to Follow-up|0|||
46900516|NCT03695393|83127423|FG001|Overall Study|Lost to Follow-up|1|||
46709092|NCT01897571|82925078|FG006|Overall Study|Lost to Follow-up|0|||
46900517|NCT03694925|83127432|FG000|Overall Study|Inadequate laboratory testing|0|||
46900518|NCT03694925|83127433|FG001|Overall Study|Inadequate laboratory testing|3|||
46900519|NCT03694925|83127434|FG002|Overall Study|Inadequate laboratory testing|0|||
46900520|NCT04258020|83127446|FG000|Overall Study|Withdrawal by Subject|1|||
46900521|NCT04258020|83127447|FG001|Overall Study|Withdrawal by Subject|0|||
46900522|NCT04495283|83127456|FG000|Overall Study|Physician Decision|0|||
46900523|NCT04495283|83127457|FG001|Overall Study|Physician Decision|0|||
46900524|NCT04495283|83127458|FG002|Overall Study|Physician Decision|1|||
46900525|NCT04495283|83127456|FG000|Overall Study|Withdrawal by Subject|0|||
46900526|NCT04495283|83127457|FG001|Overall Study|Withdrawal by Subject|1|||
46900527|NCT04495283|83127458|FG002|Overall Study|Withdrawal by Subject|1|||
46900528|NCT04495283|83127456|FG000|Overall Study|Other|1|||
46900529|NCT04495283|83127457|FG001|Overall Study|Other|0|||
46900530|NCT04495283|83127458|FG002|Overall Study|Other|1|||
46900531|NCT03117738|83127471|FG000|Overall Study|Withdrawal by Subject|3|||
46900532|NCT03117738|83127472|FG001|Overall Study|Withdrawal by Subject|1|||
46900533|NCT03117738|83127471|FG000|Overall Study|Lost to Follow-up|1|||
46900534|NCT03117738|83127472|FG001|Overall Study|Lost to Follow-up|4|||
46900535|NCT04234464|83127480|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
46996670|NCT02349295|83243728|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
46996671|NCT02349295|83243729|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
46996672|NCT02349295|83243730|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996673|NCT02349295|83243731|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46900536|NCT04234464|83127481|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
46900537|NCT03123588|83127489|FG000|Overall Study|Study Terminated by Sponsor|2|||
46900538|NCT03123588|83127490|FG001|Overall Study|Study Terminated by Sponsor|5|||
46900539|NCT03123588|83127489|FG000|Overall Study|Withdrawal by Subject|1|||
46900540|NCT03123588|83127490|FG001|Overall Study|Withdrawal by Subject|0|||
46900541|NCT03123588|83127489|FG000|Overall Study|Adverse Event|1|||
46996674|NCT02349295|83243732|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
46996675|NCT02349295|83243719|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46900542|NCT03123588|83127490|FG001|Overall Study|Adverse Event|0|||
46709093|NCT01897571|82925079|FG007|Overall Study|Lost to Follow-up|0|||
46900543|NCT03123588|83127489|FG000|Overall Study|Physician Decision|2|||
46900544|NCT03123588|83127490|FG001|Overall Study|Physician Decision|1|||
46900545|NCT03123354|83127497|FG000|Overall Study|Physician Decision|6|||
46900546|NCT04421027|83127503|FG000|Treatment Period|Adverse Event|5|||
46900547|NCT04421027|83127504|FG001|Treatment Period|Adverse Event|3|||
46900548|NCT04421027|83127505|FG002|Treatment Period|Adverse Event|0|||
46900549|NCT04421027|83127506|FG003|Treatment Period|Adverse Event|0|||
46900550|NCT04421027|83127503|FG000|Treatment Period|Death|98|||
46900551|NCT04421027|83127504|FG001|Treatment Period|Death|61|||
46900552|NCT04421027|83127505|FG002|Treatment Period|Death|0|||
46900553|NCT04421027|83127506|FG003|Treatment Period|Death|0|||
46900554|NCT04421027|83127503|FG000|Treatment Period|Lost to Follow-up|22|||
46900555|NCT04421027|83127504|FG001|Treatment Period|Lost to Follow-up|20|||
46900556|NCT04421027|83127505|FG002|Treatment Period|Lost to Follow-up|0|||
46900557|NCT04421027|83127506|FG003|Treatment Period|Lost to Follow-up|0|||
46900558|NCT04421027|83127503|FG000|Treatment Period|Other-Unknown|15|||
46900559|NCT04421027|83127504|FG001|Treatment Period|Other-Unknown|9|||
46900560|NCT04421027|83127505|FG002|Treatment Period|Other-Unknown|0|||
46900561|NCT04421027|83127506|FG003|Treatment Period|Other-Unknown|0|||
46900562|NCT04421027|83127503|FG000|Treatment Period|Physician Decision|1|||
46900563|NCT04421027|83127504|FG001|Treatment Period|Physician Decision|1|||
46900564|NCT04421027|83127505|FG002|Treatment Period|Physician Decision|0|||
46900565|NCT04421027|83127506|FG003|Treatment Period|Physician Decision|0|||
46900566|NCT04421027|83127503|FG000|Treatment Period|Withdrawal by Subject|7|||
46900567|NCT04421027|83127504|FG001|Treatment Period|Withdrawal by Subject|12|||
46900568|NCT04421027|83127505|FG002|Treatment Period|Withdrawal by Subject|0|||
46900569|NCT04421027|83127506|FG003|Treatment Period|Withdrawal by Subject|0|||
46900570|NCT04421027|83127503|FG000|Treatment Period|Randomized Not Dosed|9|||
46900571|NCT04421027|83127504|FG001|Treatment Period|Randomized Not Dosed|14|||
46900572|NCT04421027|83127505|FG002|Treatment Period|Randomized Not Dosed|0|||
46900573|NCT04421027|83127506|FG003|Treatment Period|Randomized Not Dosed|0|||
46900574|NCT04421027|83127503|FG000|Follow-Up Period|Adverse Event|0|||
46900575|NCT04421027|83127504|FG001|Follow-Up Period|Adverse Event|0|||
46900576|NCT04421027|83127505|FG002|Follow-Up Period|Adverse Event|0|||
46900577|NCT04421027|83127506|FG003|Follow-Up Period|Adverse Event|3|||
46900578|NCT04421027|83127503|FG000|Follow-Up Period|Death|0|||
46900579|NCT04421027|83127504|FG001|Follow-Up Period|Death|0|||
46900580|NCT04421027|83127505|FG002|Follow-Up Period|Death|16|||
46900581|NCT04421027|83127506|FG003|Follow-Up Period|Death|17|||
46900582|NCT04421027|83127503|FG000|Follow-Up Period|Lost to Follow-up|0|||
46900583|NCT04421027|83127504|FG001|Follow-Up Period|Lost to Follow-up|0|||
46900584|NCT04421027|83127505|FG002|Follow-Up Period|Lost to Follow-up|7|||
46900585|NCT04421027|83127506|FG003|Follow-Up Period|Lost to Follow-up|7|||
46900586|NCT04421027|83127503|FG000|Follow-Up Period|Protocol Deviation|0|||
46900587|NCT04421027|83127504|FG001|Follow-Up Period|Protocol Deviation|0|||
46900588|NCT04421027|83127505|FG002|Follow-Up Period|Protocol Deviation|1|||
46900589|NCT04421027|83127506|FG003|Follow-Up Period|Protocol Deviation|0|||
46900590|NCT04421027|83127503|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
46900591|NCT04421027|83127504|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
46900592|NCT04421027|83127505|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
46900593|NCT04421027|83127506|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
46900594|NCT04421027|83127503|FG000|Follow-Up Period|Left message, participant did not call back|0|||
46900595|NCT04421027|83127504|FG001|Follow-Up Period|Left message, participant did not call back|0|||
46900596|NCT04421027|83127505|FG002|Follow-Up Period|Left message, participant did not call back|0|||
46900597|NCT04421027|83127506|FG003|Follow-Up Period|Left message, participant did not call back|1|||
46900598|NCT04421027|83127503|FG000|Follow-Up Period|Participant died|0|||
46900599|NCT04421027|83127504|FG001|Follow-Up Period|Participant died|0|||
46900600|NCT04421027|83127505|FG002|Follow-Up Period|Participant died|0|||
46900601|NCT04421027|83127506|FG003|Follow-Up Period|Participant died|1|||
46900602|NCT04421027|83127503|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
46900603|NCT04421027|83127504|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
46900604|NCT04421027|83127505|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
46900605|NCT04421027|83127506|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
46900606|NCT04419311|83127516|FG000|Overall Study|Lost to Follow-up|1|||
46900607|NCT04419311|83127517|FG001|Overall Study|Lost to Follow-up|0|||
46900608|NCT04411667|83127527|FG000|Overall Study|Physician Decision|1|||
46900609|NCT04411667|83127528|FG001|Overall Study|Physician Decision|0|||
46900610|NCT04358549|83127536|FG000|Overall Study|Adverse Event|0|||
46900611|NCT04358549|83127537|FG001|Overall Study|Adverse Event|1|||
46900612|NCT04358549|83127536|FG000|Overall Study|Death|1|||
46900613|NCT04358549|83127537|FG001|Overall Study|Death|0|||
46709094|NCT01897571|82925080|FG008|Overall Study|Lost to Follow-up|1|||
46900614|NCT04358549|83127536|FG000|Overall Study|Lost to Follow-up|2|||
46900615|NCT04358549|83127537|FG001|Overall Study|Lost to Follow-up|1|||
46900616|NCT04358549|83127536|FG000|Overall Study|Withdrawal by Subject|6|||
46900617|NCT04358549|83127537|FG001|Overall Study|Withdrawal by Subject|6|||
46900618|NCT04358549|83127536|FG000|Overall Study|Start remdesivir|1|||
46900619|NCT04358549|83127537|FG001|Overall Study|Start remdesivir|0|||
46900620|NCT00700180|83127545|FG000|Overall Study|Death|99|||
46900621|NCT00700180|83127546|FG001|Overall Study|Death|114|||
46900622|NCT00700180|83127545|FG000|Overall Study|Alive on treatment|5|||
46900623|NCT00700180|83127546|FG001|Overall Study|Alive on treatment|3|||
46900624|NCT00700180|83127545|FG000|Overall Study|Alive in follow-up|46|||
46900625|NCT00700180|83127546|FG001|Overall Study|Alive in follow-up|27|||
46900626|NCT00700180|83127545|FG000|Overall Study|Lost to Follow-up|4|||
46900627|NCT00700180|83127546|FG001|Overall Study|Lost to Follow-up|5|||
46900628|NCT00238420|83127554|FG000|Overall Study|Protocol Violation|1|||
46900629|NCT00238420|83127555|FG001|Overall Study|Protocol Violation|1|||
46900630|NCT04492475|83127563|FG000|Overall Study|Enrolled but not treated|8|||
46900631|NCT04492475|83127564|FG001|Overall Study|Enrolled but not treated|8|||
46900632|NCT04492475|83127563|FG000|Overall Study|Withdrawal by Subject|4|||
46900633|NCT04492475|83127564|FG001|Overall Study|Withdrawal by Subject|0|||
46900634|NCT04492475|83127563|FG000|Overall Study|Became ineligible after enrollment|2|||
46900635|NCT04492475|83127564|FG001|Overall Study|Became ineligible after enrollment|0|||
46900636|NCT04486235|83127579|FG000|Overall Study|Pregnancy|1|||
46900637|NCT04486235|83127580|FG001|Overall Study|Pregnancy|0|||
46900638|NCT04486235|83127579|FG000|Overall Study|Lost to Follow-up|1|||
46900639|NCT04486235|83127580|FG001|Overall Study|Lost to Follow-up|0|||
46900640|NCT04358081|83127590|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
46900641|NCT04358081|83127591|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
46900642|NCT04358081|83127592|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
46900643|NCT04358081|83127590|FG000|Treatment Phase of Study|Adverse Event|1|||
46900644|NCT04358081|83127591|FG001|Treatment Phase of Study|Adverse Event|0|||
46900645|NCT04358081|83127592|FG002|Treatment Phase of Study|Adverse Event|1|||
46900646|NCT04358081|83127590|FG000|Treatment Phase of Study|Physician Decision|2|||
46900647|NCT04358081|83127591|FG001|Treatment Phase of Study|Physician Decision|0|||
46900648|NCT04358081|83127592|FG002|Treatment Phase of Study|Physician Decision|1|||
46900649|NCT04358081|83127590|FG000|Treatment Phase of Study|Protocol Violation|1|||
46900650|NCT04358081|83127591|FG001|Treatment Phase of Study|Protocol Violation|0|||
46900651|NCT04358081|83127592|FG002|Treatment Phase of Study|Protocol Violation|0|||
46900652|NCT04358081|83127590|FG000|Study Completion Phase|Death|0|||
46900653|NCT04358081|83127591|FG001|Study Completion Phase|Death|0|||
46900654|NCT04358081|83127592|FG002|Study Completion Phase|Death|1|||
46900655|NCT04358081|83127590|FG000|Study Completion Phase|Lost to Follow-up|1|||
46900656|NCT04358081|83127591|FG001|Study Completion Phase|Lost to Follow-up|0|||
46900657|NCT04358081|83127592|FG002|Study Completion Phase|Lost to Follow-up|1|||
46900658|NCT04355663|83127605|FG000|Overall Study|Physician Decision|2|||
46900659|NCT04355663|83127606|FG001|Overall Study|Physician Decision|7|||
46900660|NCT04355663|83127607|FG002|Overall Study|Physician Decision|0|||
46900661|NCT04355663|83127605|FG000|Overall Study|Adverse Event|0|||
46900662|NCT04355663|83127606|FG001|Overall Study|Adverse Event|0|||
46900663|NCT04355663|83127607|FG002|Overall Study|Adverse Event|1|||
46900664|NCT04355663|83127605|FG000|Overall Study|Withdrawal by Subject|0|||
46900665|NCT04355663|83127606|FG001|Overall Study|Withdrawal by Subject|8|||
46900666|NCT04355663|83127607|FG002|Overall Study|Withdrawal by Subject|3|||
46900667|NCT04345367|83127617|FG000|Overall Study|Other|3|||
46900668|NCT04345367|83127618|FG001|Overall Study|Other|4|||
46900669|NCT04345367|83127617|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
46900670|NCT04345367|83127618|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
46900671|NCT04345367|83127617|FG000|Overall Study|Withdrawal by Subject|11|||
46900672|NCT04345367|83127618|FG001|Overall Study|Withdrawal by Subject|11|||
46900673|NCT04345367|83127617|FG000|Overall Study|Protocol Violation|4|||
46900674|NCT04345367|83127618|FG001|Overall Study|Protocol Violation|3|||
46900675|NCT04345367|83127617|FG000|Overall Study|Lost to Follow-up|2|||
46900676|NCT04345367|83127618|FG001|Overall Study|Lost to Follow-up|4|||
46900677|NCT04345367|83127617|FG000|Overall Study|Lack of Efficacy|2|||
46900678|NCT04345367|83127618|FG001|Overall Study|Lack of Efficacy|0|||
46900679|NCT04345367|83127617|FG000|Overall Study|Death|2|||
46900680|NCT04345367|83127618|FG001|Overall Study|Death|0|||
46900681|NCT04345367|83127617|FG000|Overall Study|Adverse Event|10|||
46900682|NCT04345367|83127618|FG001|Overall Study|Adverse Event|9|||
46900683|NCT04404725|83127624|FG000|First Intervention|Withdrawal by Subject|0|||
46900684|NCT04404725|83127625|FG001|First Intervention|Withdrawal by Subject|2|||
46900685|NCT04404725|83127624|FG000|Second Intervention|Adverse Event|1|||
46900686|NCT04404725|83127625|FG001|Second Intervention|Adverse Event|1|||
46900687|NCT04404725|83127624|FG000|Second Intervention|Withdrawal by Subject|0|||
46900688|NCT04404725|83127625|FG001|Second Intervention|Withdrawal by Subject|1|||
46900689|NCT04343261|83127631|FG000|Overall Study|Adverse Event|1|||
46900690|NCT04343261|83127631|FG000|Overall Study|received inadequate amount of antibodies|7|||
46900691|NCT04336475|83127637|FG000|Overall Study|pain|1|||
46900692|NCT04336475|83127638|FG001|Overall Study|pain|0|||
46900693|NCT04336475|83127637|FG000|Overall Study|upper respiratory infection|1|||
46900694|NCT04336475|83127638|FG001|Overall Study|upper respiratory infection|0|||
46900695|NCT04336475|83127637|FG000|Overall Study|Lost to Follow-up|0|||
46900696|NCT04336475|83127638|FG001|Overall Study|Lost to Follow-up|2|||
46900697|NCT04335929|83127644|FG000|Overall Study|Lost to Follow-up|10|||
46900698|NCT04333199|83127651|FG000|Evaluated Patients|Lost to Follow-up|0|||
46900699|NCT04333199|83127652|FG001|Evaluated Patients|Lost to Follow-up|1|||
46900700|NCT04333199|83127653|FG002|Evaluated Patients|Lost to Follow-up|2|||
46900701|NCT04332419|83127662|FG000|Overall Study|Withdrawal by Subject|1|||
46900702|NCT04330157|83127666|FG000|Overall Study|Protocol Violation|4|||
46900703|NCT04330157|83127666|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
46996676|NCT02349295|83243720|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996677|NCT02349295|83243721|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46900704|NCT04329923|83127681|FG000|Overall Study|Withdrawal by Subject|1|||
46900705|NCT04329923|83127682|FG001|Overall Study|Withdrawal by Subject|4|||
46900706|NCT04329923|83127683|FG002|Overall Study|Withdrawal by Subject|1|||
46900707|NCT04329923|83127684|FG003|Overall Study|Withdrawal by Subject|1|||
46900708|NCT04329923|83127685|FG004|Overall Study|Withdrawal by Subject|1|||
46900709|NCT04329923|83127686|FG005|Overall Study|Withdrawal by Subject|1|||
46900710|NCT04329923|83127681|FG000|Overall Study|early termination of study|0|||
46900711|NCT04329923|83127682|FG001|Overall Study|early termination of study|0|||
46900712|NCT04329923|83127683|FG002|Overall Study|early termination of study|0|||
46900713|NCT04329923|83127684|FG003|Overall Study|early termination of study|0|||
46900714|NCT04329923|83127685|FG004|Overall Study|early termination of study|1|||
46900715|NCT04329923|83127686|FG005|Overall Study|early termination of study|2|||
46900716|NCT04329923|83127681|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
46900717|NCT04329923|83127682|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
46900718|NCT04329923|83127683|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
46900719|NCT04329923|83127684|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
46900720|NCT04329923|83127685|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
46900721|NCT04329923|83127686|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
46900722|NCT04403399|83127702|FG000|Period 2|Physician Decision|0|||
46900723|NCT04403399|83127703|FG001|Period 2|Physician Decision|1|||
46900724|NCT04401293|83127711|FG000|Overall Study|Withdrawal by Subject|1|||
46900725|NCT04401293|83127712|FG001|Overall Study|Withdrawal by Subject|3|||
46900726|NCT04319159|83127720|FG000|Overall Study|Screening failure|13|||
46900727|NCT04319159|83127720|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
46900728|NCT04319159|83127720|FG000|Overall Study|Withdrawal by Subject|1|||
46900729|NCT04318535|83127726|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
46900730|NCT04318535|83127727|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
46900731|NCT04318535|83127728|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
46900732|NCT04454567|83127739|FG000|Overall Study|Study Terminated by Sponsor|1|||
46900733|NCT04454567|83127740|FG001|Overall Study|Study Terminated by Sponsor|1|||
46900734|NCT04449341|83127748|FG000|Overall Study|Protocol Violation|1|||
46900735|NCT04449341|83127749|FG001|Overall Study|Protocol Violation|0|||
46900736|NCT04448561|83127757|FG000|Overall Study|Noncompliance|1|||
46900737|NCT04448561|83127758|FG001|Overall Study|Noncompliance|0|||
46900738|NCT04308239|83127774|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
46900739|NCT04308239|83127775|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
46900740|NCT04308239|83127774|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
46900741|NCT04308239|83127775|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
46900742|NCT04308239|83127774|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
46900743|NCT04308239|83127775|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
46996678|NCT02349295|83243722|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996679|NCT02349295|83243723|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996680|NCT02349295|83243724|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996681|NCT02349295|83243725|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46900744|NCT04308239|83127774|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
46900745|NCT04308239|83127775|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
46900746|NCT04302545|83127787|FG000|Overall Study|Lost to Follow-up|3|||
46900747|NCT04302545|83127788|FG001|Overall Study|Lost to Follow-up|4|||
46900748|NCT04297241|83127805|FG000|Overall Study|Withdrawal by Subject|1|||
46900749|NCT04297241|83127805|FG000|Overall Study|Adverse Event|1|||
46900750|NCT04297241|83127805|FG000|Overall Study|Physician Decision|3|||
46709095|NCT01897571|82925081|FG009|Overall Study|Lost to Follow-up|2|||
46900751|NCT04292171|83127821|FG000|Overall Study|Pharmacy error|2|||
46900752|NCT04292171|83127822|FG001|Overall Study|Pharmacy error|0|||
46900753|NCT04292171|83127821|FG000|Overall Study|Delivered prior to procedure|0|||
46900754|NCT04292171|83127822|FG001|Overall Study|Delivered prior to procedure|1|||
46900755|NCT04393493|83127830|FG000|First 4 Days of Intervention|Early improvement|5|||
46900756|NCT04393493|83127831|FG001|First 4 Days of Intervention|Early improvement|7|||
46900757|NCT04280705|83127841|FG000|Overall Study|Enrolled but not treated|4|||
46900758|NCT04280705|83127842|FG001|Overall Study|Enrolled but not treated|10|||
46900759|NCT04280705|83127841|FG000|Overall Study|Physician Decision|1|||
46900760|NCT04280705|83127842|FG001|Overall Study|Physician Decision|0|||
46900761|NCT04280705|83127841|FG000|Overall Study|Withdrawal by Subject|7|||
46900762|NCT04280705|83127842|FG001|Overall Study|Withdrawal by Subject|9|||
46900763|NCT04280705|83127841|FG000|Overall Study|Adverse Event|0|||
46900764|NCT04280705|83127842|FG001|Overall Study|Adverse Event|4|||
46900765|NCT04280705|83127841|FG000|Overall Study|Transferred to another hospital|1|||
46900766|NCT04280705|83127842|FG001|Overall Study|Transferred to another hospital|1|||
46900767|NCT02077166|83127855|FG000|Overall Study|Death|6|||
46996682|NCT02349295|83243726|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
46996683|NCT02349295|83243727|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996684|NCT02349295|83243728|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
46996685|NCT02349295|83243729|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996686|NCT02349295|83243730|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996687|NCT02349295|83243731|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996688|NCT02349295|83243732|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
46996689|NCT02349295|83243719|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
46996690|NCT02349295|83243720|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
46996691|NCT02349295|83243721|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
46996692|NCT02349295|83243722|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
46996693|NCT02349295|83243723|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
46996694|NCT02349295|83243724|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
46996695|NCT02349295|83243725|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
46996696|NCT02349295|83243726|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
46996697|NCT02349295|83243727|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
46996698|NCT02349295|83243728|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
46996699|NCT02349295|83243729|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
46996700|NCT02349295|83243730|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
46996701|NCT02349295|83243731|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
46709096|NCT01897571|82925082|FG010|Overall Study|Lost to Follow-up|4|||
46709097|NCT01897571|82925072|FG000|Overall Study|Withdrawal by Subject|0|||
46709098|NCT01897571|82925073|FG001|Overall Study|Withdrawal by Subject|0|||
46709099|NCT01897571|82925074|FG002|Overall Study|Withdrawal by Subject|0|||
46709100|NCT01897571|82925075|FG003|Overall Study|Withdrawal by Subject|0|||
46709101|NCT01897571|82925076|FG004|Overall Study|Withdrawal by Subject|0|||
46709102|NCT01897571|82925077|FG005|Overall Study|Withdrawal by Subject|0|||
46709103|NCT01897571|82925078|FG006|Overall Study|Withdrawal by Subject|0|||
46709104|NCT01897571|82925079|FG007|Overall Study|Withdrawal by Subject|1|||
46709105|NCT01897571|82925080|FG008|Overall Study|Withdrawal by Subject|4|||
46709106|NCT01897571|82925081|FG009|Overall Study|Withdrawal by Subject|3|||
46709107|NCT01897571|82925082|FG010|Overall Study|Withdrawal by Subject|1|||
46709108|NCT01897571|82925072|FG000|Overall Study|Other|1|||
46709109|NCT01897571|82925073|FG001|Overall Study|Other|0|||
46709110|NCT01897571|82925074|FG002|Overall Study|Other|0|||
46709111|NCT01897571|82925075|FG003|Overall Study|Other|3|||
46709112|NCT01897571|82925076|FG004|Overall Study|Other|3|||
46709113|NCT01897571|82925077|FG005|Overall Study|Other|4|||
46709114|NCT01897571|82925078|FG006|Overall Study|Other|7|||
46709115|NCT01897571|82925079|FG007|Overall Study|Other|0|||
46709116|NCT01897571|82925080|FG008|Overall Study|Other|0|||
46709117|NCT01897571|82925081|FG009|Overall Study|Other|0|||
46709118|NCT01897571|82925082|FG010|Overall Study|Other|0|||
46709119|NCT01897571|82925072|FG000|Overall Study|Enrolled in rollover study|0|||
46709120|NCT01897571|82925073|FG001|Overall Study|Enrolled in rollover study|0|||
46709121|NCT01897571|82925074|FG002|Overall Study|Enrolled in rollover study|0|||
46709122|NCT01897571|82925075|FG003|Overall Study|Enrolled in rollover study|0|||
46709123|NCT01897571|82925076|FG004|Overall Study|Enrolled in rollover study|0|||
46709124|NCT01897571|82925077|FG005|Overall Study|Enrolled in rollover study|0|||
46709125|NCT01897571|82925078|FG006|Overall Study|Enrolled in rollover study|0|||
46709126|NCT01897571|82925079|FG007|Overall Study|Enrolled in rollover study|9|||
46709127|NCT01897571|82925080|FG008|Overall Study|Enrolled in rollover study|7|||
46709128|NCT01897571|82925081|FG009|Overall Study|Enrolled in rollover study|9|||
46709129|NCT01897571|82925082|FG010|Overall Study|Enrolled in rollover study|1|||
46709130|NCT01897571|82925072|FG000|Overall Study|Death|2|||
46709131|NCT01897571|82925073|FG001|Overall Study|Death|2|||
46900768|NCT02077166|83127856|FG001|Overall Study|Death|7|||
46900769|NCT02077166|83127857|FG002|Overall Study|Death|5|||
46709132|NCT01897571|82925074|FG002|Overall Study|Death|3|||
46996702|NCT02349295|83243732|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
46900770|NCT02077166|83127858|FG003|Overall Study|Death|6|||
46900771|NCT02077166|83127859|FG004|Overall Study|Death|4|||
46900772|NCT02077166|83127860|FG005|Overall Study|Death|32|||
46900773|NCT02077166|83127861|FG006|Overall Study|Death|22|||
46900774|NCT02077166|83127855|FG000|Overall Study|Study Closure by Sponsor|3|||
46900775|NCT02077166|83127856|FG001|Overall Study|Study Closure by Sponsor|0|||
46900776|NCT02077166|83127857|FG002|Overall Study|Study Closure by Sponsor|2|||
46900777|NCT02077166|83127858|FG003|Overall Study|Study Closure by Sponsor|2|||
46900778|NCT02077166|83127859|FG004|Overall Study|Study Closure by Sponsor|2|||
46900779|NCT02077166|83127860|FG005|Overall Study|Study Closure by Sponsor|12|||
46900780|NCT02077166|83127861|FG006|Overall Study|Study Closure by Sponsor|4|||
46900781|NCT02077166|83127855|FG000|Overall Study|Lost to Follow-up|0|||
46900782|NCT02077166|83127856|FG001|Overall Study|Lost to Follow-up|0|||
46900783|NCT02077166|83127857|FG002|Overall Study|Lost to Follow-up|0|||
46900784|NCT02077166|83127858|FG003|Overall Study|Lost to Follow-up|0|||
46900785|NCT02077166|83127859|FG004|Overall Study|Lost to Follow-up|0|||
46900786|NCT02077166|83127860|FG005|Overall Study|Lost to Follow-up|1|||
46900787|NCT02077166|83127861|FG006|Overall Study|Lost to Follow-up|0|||
46900788|NCT02077166|83127855|FG000|Overall Study|Withdrawal by Subject|3|||
46900789|NCT02077166|83127856|FG001|Overall Study|Withdrawal by Subject|0|||
46900790|NCT02077166|83127857|FG002|Overall Study|Withdrawal by Subject|1|||
46900791|NCT02077166|83127858|FG003|Overall Study|Withdrawal by Subject|1|||
46900792|NCT02077166|83127859|FG004|Overall Study|Withdrawal by Subject|1|||
46900793|NCT02077166|83127860|FG005|Overall Study|Withdrawal by Subject|3|||
46900794|NCT02077166|83127861|FG006|Overall Study|Withdrawal by Subject|0|||
46900795|NCT02077166|83127855|FG000|Overall Study|Other, Not Specified|0|||
46900796|NCT02077166|83127856|FG001|Overall Study|Other, Not Specified|0|||
46900797|NCT02077166|83127857|FG002|Overall Study|Other, Not Specified|1|||
46900798|NCT02077166|83127858|FG003|Overall Study|Other, Not Specified|0|||
46900799|NCT02077166|83127859|FG004|Overall Study|Other, Not Specified|1|||
46900800|NCT02077166|83127860|FG005|Overall Study|Other, Not Specified|7|||
46900801|NCT02077166|83127861|FG006|Overall Study|Other, Not Specified|8|||
46900802|NCT04273217|83127888|FG000|Overall Study|Lost to Follow-up|0|||
46900803|NCT04273217|83127889|FG001|Overall Study|Lost to Follow-up|0|||
46900804|NCT04273217|83127890|FG002|Overall Study|Lost to Follow-up|0|||
46900805|NCT04273217|83127891|FG003|Overall Study|Lost to Follow-up|0|||
46900806|NCT04273217|83127892|FG004|Overall Study|Lost to Follow-up|0|||
46900807|NCT04273217|83127893|FG005|Overall Study|Lost to Follow-up|1|||
46900808|NCT04273217|83127888|FG000|Overall Study|Participant non-compliance|0|||
46900809|NCT04273217|83127889|FG001|Overall Study|Participant non-compliance|0|||
46900810|NCT04273217|83127890|FG002|Overall Study|Participant non-compliance|0|||
46900811|NCT04273217|83127891|FG003|Overall Study|Participant non-compliance|0|||
46900812|NCT04273217|83127892|FG004|Overall Study|Participant non-compliance|1|||
46900813|NCT04273217|83127893|FG005|Overall Study|Participant non-compliance|0|||
46900814|NCT04273217|83127888|FG000|Overall Study|Positive urine drug screen|1|||
46900815|NCT04273217|83127889|FG001|Overall Study|Positive urine drug screen|0|||
46900816|NCT04273217|83127890|FG002|Overall Study|Positive urine drug screen|1|||
46900817|NCT04273217|83127891|FG003|Overall Study|Positive urine drug screen|0|||
46900818|NCT04273217|83127892|FG004|Overall Study|Positive urine drug screen|0|||
46900819|NCT04273217|83127893|FG005|Overall Study|Positive urine drug screen|1|||
46900820|NCT04384523|83127913|FG000|Overall Study|Lost to Follow-up|0|||
46900821|NCT04384523|83127914|FG001|Overall Study|Lost to Follow-up|0|||
46900822|NCT04384523|83127915|FG002|Overall Study|Lost to Follow-up|0|||
46900823|NCT04384523|83127916|FG003|Overall Study|Lost to Follow-up|0|||
46900824|NCT04384523|83127917|FG004|Overall Study|Lost to Follow-up|0|||
46900825|NCT04384523|83127918|FG005|Overall Study|Lost to Follow-up|1|||
46900826|NCT04384523|83127913|FG000|Overall Study|Protocol Violation|0|||
46900827|NCT04384523|83127914|FG001|Overall Study|Protocol Violation|1|||
46900828|NCT04384523|83127915|FG002|Overall Study|Protocol Violation|0|||
46900829|NCT04384523|83127916|FG003|Overall Study|Protocol Violation|0|||
46900830|NCT04384523|83127917|FG004|Overall Study|Protocol Violation|0|||
46900831|NCT04384523|83127918|FG005|Overall Study|Protocol Violation|0|||
46900832|NCT04384523|83127913|FG000|Overall Study|Withdrawal by Subject|1|||
46900833|NCT04384523|83127914|FG001|Overall Study|Withdrawal by Subject|0|||
46900834|NCT04384523|83127915|FG002|Overall Study|Withdrawal by Subject|0|||
46996703|NCT02349295|83243719|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46900835|NCT04384523|83127916|FG003|Overall Study|Withdrawal by Subject|0|||
46900836|NCT04384523|83127917|FG004|Overall Study|Withdrawal by Subject|0|||
46900837|NCT04384523|83127918|FG005|Overall Study|Withdrawal by Subject|0|||
46900838|NCT04382651|83127953|FG000|Overall Study|Death|26|||
46900839|NCT04382651|83127954|FG001|Overall Study|Death|23|||
46900840|NCT04382651|83127953|FG000|Overall Study|Lost to Follow-up|3|||
46900841|NCT04382651|83127954|FG001|Overall Study|Lost to Follow-up|4|||
46900842|NCT04382651|83127953|FG000|Overall Study|Withdrawal by Subject|2|||
46900843|NCT04382651|83127954|FG001|Overall Study|Withdrawal by Subject|0|||
46900844|NCT04382651|83127953|FG000|Overall Study|Physician Decision|0|||
46900845|NCT04382651|83127954|FG001|Overall Study|Physician Decision|1|||
46900846|NCT03442088|83127966|FG000|Overall Study|Adverse Event|1|||
46900847|NCT03442088|83127966|FG000|Overall Study|Lack of Efficacy|2|||
46900848|NCT03442088|83127966|FG000|Overall Study|Lost to Follow-up|2|||
46900849|NCT04223687|83127972|FG000|Overall Study|Missing primary outcome|1|||
46900850|NCT04223687|83127973|FG001|Overall Study|Missing primary outcome|0|||
46900851|NCT03722576|83127979|FG000|Overall Study|Withdrawal by Subject|3|||
46900852|NCT03722576|83127979|FG000|Overall Study|Adverse Event|2|||
46900853|NCT03722576|83127979|FG000|Overall Study|Physician Decision|1|||
46900854|NCT03722576|83127979|FG000|Overall Study|Lost to Follow-up|1|||
46996704|NCT02349295|83243720|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996705|NCT02349295|83243721|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996706|NCT02349295|83243722|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996707|NCT02349295|83243723|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996708|NCT02349295|83243724|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996709|NCT02349295|83243725|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996710|NCT02349295|83243726|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
46996711|NCT02349295|83243727|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
46996712|NCT02349295|83243728|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
46996713|NCT02349295|83243729|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
46996714|NCT02349295|83243730|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996715|NCT02349295|83243731|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996716|NCT02349295|83243732|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
46996717|NCT02349295|83243719|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996718|NCT02349295|83243720|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996719|NCT02349295|83243721|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996720|NCT02349295|83243722|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996721|NCT02349295|83243723|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996722|NCT02349295|83243724|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996723|NCT02349295|83243725|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996724|NCT02349295|83243726|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
46996725|NCT02349295|83243727|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
46996726|NCT02349295|83243728|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996727|NCT02349295|83243729|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996728|NCT02349295|83243730|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996729|NCT02349295|83243731|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996730|NCT02349295|83243732|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
46996731|NCT02349295|83243719|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996732|NCT02349295|83243720|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996733|NCT02349295|83243721|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996734|NCT02349295|83243722|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996735|NCT02349295|83243723|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996736|NCT02349295|83243724|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996737|NCT02349295|83243725|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996738|NCT02349295|83243726|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
46996739|NCT02349295|83243727|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
46996740|NCT02349295|83243728|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996741|NCT02349295|83243729|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996742|NCT02349295|83243730|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996743|NCT02349295|83243731|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996744|NCT02349295|83243732|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
46996745|NCT02349295|83243719|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996746|NCT02349295|83243720|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996747|NCT02349295|83243721|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996748|NCT02349295|83243722|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996749|NCT02349295|83243723|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996750|NCT02349295|83243724|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996751|NCT02349295|83243725|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46709133|NCT01897571|82925075|FG003|Overall Study|Death|6|||
46709134|NCT01897571|82925076|FG004|Overall Study|Death|7|||
46709135|NCT01897571|82925077|FG005|Overall Study|Death|9|||
46709136|NCT01897571|82925078|FG006|Overall Study|Death|5|||
46709137|NCT01897571|82925079|FG007|Overall Study|Death|22|||
46709138|NCT01897571|82925080|FG008|Overall Study|Death|23|||
46900855|NCT03693989|83127985|FG000|Overall Study|Protocol Violation|3|||
46900856|NCT03693989|83127986|FG001|Overall Study|Protocol Violation|4|||
46900857|NCT04206293|83127992|FG000|Overall Study|Consent withdrawal|1|||
46900858|NCT02727998|83127999|FG000|Overall Study|Lost to Follow-up|3|||
46900859|NCT02727998|83128000|FG001|Overall Study|Lost to Follow-up|3|||
46900860|NCT02727998|83127999|FG000|Overall Study|Withdrawal by Subject|0|||
46900861|NCT02727998|83128000|FG001|Overall Study|Withdrawal by Subject|1|||
46900862|NCT02636270|83128009|FG000|Overall Study|Adverse Event|1|||
46900863|NCT02636270|83128010|FG001|Overall Study|Adverse Event|0|||
46900864|NCT02636270|83128011|FG002|Overall Study|Adverse Event|0|||
46900865|NCT02636270|83128009|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
46900866|NCT02636270|83128010|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
46900867|NCT02636270|83128011|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
46900868|NCT04366349|83128051|FG000|Overall Study|Withdrawal by Subject|1|||
46900869|NCT04366349|83128052|FG001|Overall Study|Withdrawal by Subject|0|||
46900870|NCT04366349|83128053|FG002|Overall Study|Withdrawal by Subject|0|||
46900871|NCT04366349|83128054|FG003|Overall Study|Withdrawal by Subject|0|||
46900872|NCT04366349|83128055|FG004|Overall Study|Withdrawal by Subject|0|||
46900873|NCT04366349|83128056|FG005|Overall Study|Withdrawal by Subject|0|||
46900874|NCT04179461|83128074|FG000|Overall Study|Lost to Follow-up|4|||
46900875|NCT04017611|83128078|FG000|Overall Study|Withdrawn prior to completion|1|||
46900876|NCT04172831|83128093|FG000|Overall Study|Adverse Event|21|||
46900877|NCT04172831|83128094|FG001|Overall Study|Adverse Event|9|||
46900878|NCT04172831|83128093|FG000|Overall Study|Lack of Efficacy|2|||
46900879|NCT04172831|83128094|FG001|Overall Study|Lack of Efficacy|8|||
46900880|NCT04172831|83128093|FG000|Overall Study|Physician Decision|0|||
46900881|NCT04172831|83128094|FG001|Overall Study|Physician Decision|1|||
46900882|NCT04172831|83128093|FG000|Overall Study|Withdrawal by Subject|12|||
46900883|NCT04172831|83128094|FG001|Overall Study|Withdrawal by Subject|11|||
46900884|NCT04172831|83128093|FG000|Overall Study|Lost to Follow-up|4|||
46900885|NCT04172831|83128094|FG001|Overall Study|Lost to Follow-up|9|||
46900886|NCT04172831|83128093|FG000|Overall Study|COVID-19 related crisis|3|||
46900887|NCT04172831|83128094|FG001|Overall Study|COVID-19 related crisis|3|||
46900888|NCT04172831|83128093|FG000|Overall Study|Subject non-compliance|1|||
46900889|NCT04172831|83128094|FG001|Overall Study|Subject non-compliance|1|||
46900890|NCT04172831|83128093|FG000|Overall Study|Family emergency|1|||
46900891|NCT04172831|83128094|FG001|Overall Study|Family emergency|0|||
46900892|NCT04165031|83128111|FG000|Overall Study|Adverse Event|1|||
46900893|NCT04165031|83128112|FG001|Overall Study|Adverse Event|1|||
46900894|NCT04165031|83128113|FG002|Overall Study|Adverse Event|0|||
46900895|NCT04165031|83128114|FG003|Overall Study|Adverse Event|0|||
46900896|NCT04165031|83128115|FG004|Overall Study|Adverse Event|0|||
46900897|NCT04165031|83128116|FG005|Overall Study|Adverse Event|0|||
46900898|NCT04165031|83128111|FG000|Overall Study|Withdrawal by Subject|0|||
46900899|NCT04165031|83128112|FG001|Overall Study|Withdrawal by Subject|0|||
46900900|NCT04165031|83128113|FG002|Overall Study|Withdrawal by Subject|1|||
46900901|NCT04165031|83128114|FG003|Overall Study|Withdrawal by Subject|0|||
46996752|NCT02349295|83243726|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996753|NCT02349295|83243727|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46900902|NCT04165031|83128115|FG004|Overall Study|Withdrawal by Subject|0|||
46900903|NCT04165031|83128116|FG005|Overall Study|Withdrawal by Subject|0|||
46900904|NCT02712424|83128133|FG000|Overall Study|Lost to Follow-up|34|||
46900905|NCT02712424|83128134|FG001|Overall Study|Lost to Follow-up|32|||
46900906|NCT03034772|83128142|FG000|Overall Study|Adverse Event|0|||
46900907|NCT03034772|83128143|FG001|Overall Study|Adverse Event|1|||
46900908|NCT03034772|83128142|FG000|Overall Study|Withdrawal by Subject|0|||
46900909|NCT03034772|83128143|FG001|Overall Study|Withdrawal by Subject|1|||
46900910|NCT03032198|83128149|FG000|Overall Study|Screen Fail|1|||
46900911|NCT02431364|83128158|FG000|Overall Study|Adverse Event|0|||
46996754|NCT02349295|83243728|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996755|NCT02349295|83243729|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
46996756|NCT02349295|83243730|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
46996757|NCT02349295|83243731|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
46996758|NCT02349295|83243732|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
46996759|NCT02349295|83243719|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46900912|NCT02431364|83128159|FG001|Overall Study|Adverse Event|1|||
46900913|NCT02431364|83128160|FG002|Overall Study|Adverse Event|0|||
46900914|NCT02431364|83128161|FG003|Overall Study|Adverse Event|0|||
46900915|NCT02431364|83128162|FG004|Overall Study|Adverse Event|0|||
46996760|NCT02349295|83243720|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996761|NCT02349295|83243721|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46900916|NCT02431364|83128158|FG000|Overall Study|Randomized but never treated|0|||
46900917|NCT02431364|83128159|FG001|Overall Study|Randomized but never treated|0|||
46900918|NCT02431364|83128160|FG002|Overall Study|Randomized but never treated|0|||
46900919|NCT02431364|83128161|FG003|Overall Study|Randomized but never treated|1|||
46900920|NCT02431364|83128162|FG004|Overall Study|Randomized but never treated|0|||
46900921|NCT03034460|83128180|FG000|Overall Study|Adverse Event|0|||
46900922|NCT03034460|83128181|FG001|Overall Study|Adverse Event|1|||
46900923|NCT03034460|83128180|FG000|Overall Study|Withdrawal by Subject|2|||
46900924|NCT03034460|83128181|FG001|Overall Study|Withdrawal by Subject|2|||
46900925|NCT03034460|83128180|FG000|Overall Study|Personal Reasons|1|||
46900926|NCT03034460|83128181|FG001|Overall Study|Personal Reasons|0|||
46900927|NCT04162769|83128194|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
46900928|NCT04162769|83128195|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
46900929|NCT04162769|83128196|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
46900930|NCT04162769|83128197|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
46900931|NCT04162769|83128194|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
46900932|NCT04162769|83128195|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
46900933|NCT04162769|83128196|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
46900934|NCT04162769|83128197|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
46900935|NCT04162769|83128194|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
46900936|NCT04162769|83128195|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
46900937|NCT04162769|83128196|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
46900938|NCT04162769|83128197|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
46900939|NCT04162769|83128194|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
46900940|NCT04162769|83128195|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
46900941|NCT04162769|83128196|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
46900942|NCT04162769|83128197|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
46900943|NCT04162769|83128194|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
46900944|NCT04162769|83128195|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
46900945|NCT04162769|83128196|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
46900946|NCT04162769|83128197|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
46900947|NCT04162769|83128194|FG000|Double-blind Treatment (12-Week)|Other|0|||
46900948|NCT04162769|83128195|FG001|Double-blind Treatment (12-Week)|Other|1|||
46900949|NCT04162769|83128196|FG002|Double-blind Treatment (12-Week)|Other|1|||
46900950|NCT04162769|83128197|FG003|Double-blind Treatment (12-Week)|Other|0|||
46900951|NCT04162769|83128194|FG000|OLE Period (52-Week)|Adverse Event|0|||
46900952|NCT04162769|83128195|FG001|OLE Period (52-Week)|Adverse Event|0|||
46900953|NCT04162769|83128196|FG002|OLE Period (52-Week)|Adverse Event|0|||
46900954|NCT04162769|83128197|FG003|OLE Period (52-Week)|Adverse Event|5|||
46900955|NCT04162769|83128194|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
46900956|NCT04162769|83128195|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
46900957|NCT04162769|83128196|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
46900958|NCT04162769|83128197|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
46900959|NCT04162769|83128194|FG000|OLE Period (52-Week)|Physician Decision|0|||
46900960|NCT04162769|83128195|FG001|OLE Period (52-Week)|Physician Decision|0|||
46900961|NCT04162769|83128196|FG002|OLE Period (52-Week)|Physician Decision|0|||
46900962|NCT04162769|83128197|FG003|OLE Period (52-Week)|Physician Decision|1|||
46900963|NCT04162769|83128194|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
46900964|NCT04162769|83128195|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
46900965|NCT04162769|83128196|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
46900966|NCT04162769|83128197|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
46900967|NCT04162769|83128194|FG000|OLE Period (52-Week)|Protocol deviation|0|||
46900968|NCT04162769|83128195|FG001|OLE Period (52-Week)|Protocol deviation|0|||
46900969|NCT04162769|83128196|FG002|OLE Period (52-Week)|Protocol deviation|0|||
46900970|NCT04162769|83128197|FG003|OLE Period (52-Week)|Protocol deviation|2|||
46900971|NCT04161131|83128208|FG000|Overall Study|Ineligible|2|||
46900972|NCT04161131|83128208|FG000|Overall Study|Lost to Follow-up|4|||
46900973|NCT04155047|83128214|FG000|Overall Study|Adverse Event|1|||
46996762|NCT02349295|83243722|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996763|NCT02349295|83243723|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996764|NCT02349295|83243724|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996765|NCT02349295|83243725|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996766|NCT02349295|83243726|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996767|NCT02349295|83243727|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996768|NCT02349295|83243728|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46900974|NCT04155047|83128215|FG001|Overall Study|Adverse Event|0|||
46900975|NCT04155047|83128214|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
46900976|NCT04155047|83128215|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
46900977|NCT04152083|83128223|FG000|Overall Study|Lost to Follow-up|2|||
46900978|NCT04152083|83128224|FG001|Overall Study|Lost to Follow-up|1|||
46900979|NCT04152083|83128223|FG000|Overall Study|Adverse Event|1|||
46900980|NCT04152083|83128224|FG001|Overall Study|Adverse Event|0|||
46996769|NCT02349295|83243729|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46900981|NCT04152083|83128223|FG000|Overall Study|Randomized but not treated|3|||
46900982|NCT04152083|83128224|FG001|Overall Study|Randomized but not treated|2|||
46900983|NCT02711956|83128245|FG000|Overall Study|Adverse Event|0|||
46900984|NCT02711956|83128246|FG001|Overall Study|Adverse Event|0|||
46900985|NCT02711956|83128247|FG002|Overall Study|Adverse Event|0|||
46900986|NCT02711956|83128248|FG003|Overall Study|Adverse Event|1|||
46900987|NCT02711956|83128249|FG004|Overall Study|Adverse Event|2|||
46900988|NCT02711956|83128250|FG005|Overall Study|Adverse Event|0|||
46900989|NCT02711956|83128251|FG006|Overall Study|Adverse Event|0|||
46900990|NCT02711956|83128252|FG007|Overall Study|Adverse Event|1|||
46900991|NCT02711956|83128253|FG008|Overall Study|Adverse Event|1|||
46900992|NCT02711956|83128254|FG009|Overall Study|Adverse Event|1|||
46900993|NCT02711956|83128255|FG010|Overall Study|Adverse Event|1|||
46900994|NCT02711956|83128256|FG011|Overall Study|Adverse Event|0|||
46900995|NCT02711956|83128257|FG012|Overall Study|Adverse Event|0|||
46900996|NCT02711956|83128258|FG013|Overall Study|Adverse Event|0|||
46900997|NCT02711956|83128259|FG014|Overall Study|Adverse Event|2|||
46900998|NCT02711956|83128245|FG000|Overall Study|Physician Decision|0|||
46900999|NCT02711956|83128246|FG001|Overall Study|Physician Decision|0|||
46901000|NCT02711956|83128247|FG002|Overall Study|Physician Decision|0|||
46901001|NCT02711956|83128248|FG003|Overall Study|Physician Decision|2|||
46901002|NCT02711956|83128249|FG004|Overall Study|Physician Decision|0|||
46901003|NCT02711956|83128250|FG005|Overall Study|Physician Decision|0|||
46901004|NCT02711956|83128251|FG006|Overall Study|Physician Decision|0|||
46901005|NCT02711956|83128252|FG007|Overall Study|Physician Decision|0|||
46901006|NCT02711956|83128253|FG008|Overall Study|Physician Decision|0|||
46901007|NCT02711956|83128254|FG009|Overall Study|Physician Decision|0|||
46901008|NCT02711956|83128255|FG010|Overall Study|Physician Decision|0|||
46901009|NCT02711956|83128256|FG011|Overall Study|Physician Decision|0|||
46901010|NCT02711956|83128257|FG012|Overall Study|Physician Decision|0|||
46901011|NCT02711956|83128258|FG013|Overall Study|Physician Decision|0|||
46901012|NCT02711956|83128259|FG014|Overall Study|Physician Decision|0|||
46901013|NCT02711956|83128245|FG000|Overall Study|Withdrawal by Subject|0|||
46901014|NCT02711956|83128246|FG001|Overall Study|Withdrawal by Subject|0|||
46901015|NCT02711956|83128247|FG002|Overall Study|Withdrawal by Subject|0|||
46901016|NCT02711956|83128248|FG003|Overall Study|Withdrawal by Subject|0|||
46901017|NCT02711956|83128249|FG004|Overall Study|Withdrawal by Subject|0|||
46901018|NCT02711956|83128250|FG005|Overall Study|Withdrawal by Subject|0|||
46901019|NCT02711956|83128251|FG006|Overall Study|Withdrawal by Subject|1|||
46901020|NCT02711956|83128252|FG007|Overall Study|Withdrawal by Subject|0|||
46901021|NCT02711956|83128253|FG008|Overall Study|Withdrawal by Subject|0|||
46996770|NCT02349295|83243730|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
46996771|NCT02349295|83243731|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
46996772|NCT02349295|83243732|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
46996773|NCT02349295|83243719|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996774|NCT02349295|83243720|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996775|NCT02349295|83243721|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996776|NCT02349295|83243722|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996777|NCT02349295|83243723|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996778|NCT02349295|83243724|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996779|NCT02349295|83243725|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996780|NCT02349295|83243726|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996781|NCT02349295|83243727|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996782|NCT02349295|83243728|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996783|NCT02349295|83243729|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996784|NCT02349295|83243730|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
46996785|NCT02349295|83243731|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
46996786|NCT02349295|83243732|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
46996787|NCT02349295|83243719|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46901022|NCT02711956|83128254|FG009|Overall Study|Withdrawal by Subject|0|||
46901023|NCT02711956|83128255|FG010|Overall Study|Withdrawal by Subject|0|||
46901024|NCT02711956|83128256|FG011|Overall Study|Withdrawal by Subject|1|||
46901025|NCT02711956|83128257|FG012|Overall Study|Withdrawal by Subject|6|||
46901026|NCT02711956|83128258|FG013|Overall Study|Withdrawal by Subject|0|||
46901027|NCT02711956|83128259|FG014|Overall Study|Withdrawal by Subject|1|||
46901028|NCT02711956|83128245|FG000|Overall Study|Clinical progression|1|||
46901029|NCT02711956|83128246|FG001|Overall Study|Clinical progression|0|||
46901030|NCT02711956|83128247|FG002|Overall Study|Clinical progression|0|||
46901031|NCT02711956|83128248|FG003|Overall Study|Clinical progression|0|||
46901032|NCT02711956|83128249|FG004|Overall Study|Clinical progression|0|||
46901033|NCT02711956|83128250|FG005|Overall Study|Clinical progression|0|||
46901034|NCT02711956|83128251|FG006|Overall Study|Clinical progression|1|||
46901035|NCT02711956|83128252|FG007|Overall Study|Clinical progression|0|||
46996788|NCT02349295|83243720|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996789|NCT02349295|83243721|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996790|NCT02349295|83243722|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996791|NCT02349295|83243723|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996792|NCT02349295|83243724|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46901036|NCT02711956|83128253|FG008|Overall Study|Clinical progression|1|||
46901037|NCT02711956|83128254|FG009|Overall Study|Clinical progression|0|||
46901038|NCT02711956|83128255|FG010|Overall Study|Clinical progression|0|||
46901039|NCT02711956|83128256|FG011|Overall Study|Clinical progression|2|||
46901040|NCT02711956|83128257|FG012|Overall Study|Clinical progression|4|||
46901041|NCT02711956|83128258|FG013|Overall Study|Clinical progression|1|||
46901042|NCT02711956|83128259|FG014|Overall Study|Clinical progression|1|||
46901043|NCT02711956|83128245|FG000|Overall Study|Radiographic progression|1|||
46901044|NCT02711956|83128246|FG001|Overall Study|Radiographic progression|1|||
46901045|NCT02711956|83128247|FG002|Overall Study|Radiographic progression|2|||
46901046|NCT02711956|83128248|FG003|Overall Study|Radiographic progression|0|||
46901047|NCT02711956|83128249|FG004|Overall Study|Radiographic progression|1|||
46901048|NCT02711956|83128250|FG005|Overall Study|Radiographic progression|0|||
46901049|NCT02711956|83128251|FG006|Overall Study|Radiographic progression|0|||
46901050|NCT02711956|83128252|FG007|Overall Study|Radiographic progression|0|||
46901051|NCT02711956|83128253|FG008|Overall Study|Radiographic progression|2|||
46901052|NCT02711956|83128254|FG009|Overall Study|Radiographic progression|1|||
46901053|NCT02711956|83128255|FG010|Overall Study|Radiographic progression|0|||
46901054|NCT02711956|83128256|FG011|Overall Study|Radiographic progression|5|||
46901055|NCT02711956|83128257|FG012|Overall Study|Radiographic progression|3|||
46901056|NCT02711956|83128258|FG013|Overall Study|Radiographic progression|0|||
46901057|NCT02711956|83128259|FG014|Overall Study|Radiographic progression|1|||
46901058|NCT02711956|83128245|FG000|Overall Study|PSA progression with clinical progression|0|||
46901059|NCT02711956|83128246|FG001|Overall Study|PSA progression with clinical progression|0|||
46901060|NCT02711956|83128247|FG002|Overall Study|PSA progression with clinical progression|0|||
46901061|NCT02711956|83128248|FG003|Overall Study|PSA progression with clinical progression|0|||
46901062|NCT02711956|83128249|FG004|Overall Study|PSA progression with clinical progression|1|||
46901063|NCT02711956|83128250|FG005|Overall Study|PSA progression with clinical progression|0|||
46901064|NCT02711956|83128251|FG006|Overall Study|PSA progression with clinical progression|0|||
46901065|NCT02711956|83128252|FG007|Overall Study|PSA progression with clinical progression|0|||
46901066|NCT02711956|83128253|FG008|Overall Study|PSA progression with clinical progression|0|||
46901067|NCT02711956|83128254|FG009|Overall Study|PSA progression with clinical progression|0|||
46901068|NCT02711956|83128255|FG010|Overall Study|PSA progression with clinical progression|0|||
46901069|NCT02711956|83128256|FG011|Overall Study|PSA progression with clinical progression|0|||
46901070|NCT02711956|83128257|FG012|Overall Study|PSA progression with clinical progression|1|||
46901071|NCT02711956|83128258|FG013|Overall Study|PSA progression with clinical progression|1|||
46901072|NCT02711956|83128259|FG014|Overall Study|PSA progression with clinical progression|0|||
46901073|NCT02711956|83128245|FG000|Overall Study|PSA progression with radiographic progression|0|||
46901074|NCT02711956|83128246|FG001|Overall Study|PSA progression with radiographic progression|1|||
46901075|NCT02711956|83128247|FG002|Overall Study|PSA progression with radiographic progression|0|||
46901076|NCT02711956|83128248|FG003|Overall Study|PSA progression with radiographic progression|0|||
46901077|NCT02711956|83128249|FG004|Overall Study|PSA progression with radiographic progression|0|||
46901078|NCT02711956|83128250|FG005|Overall Study|PSA progression with radiographic progression|2|||
46901079|NCT02711956|83128251|FG006|Overall Study|PSA progression with radiographic progression|2|||
46901080|NCT02711956|83128252|FG007|Overall Study|PSA progression with radiographic progression|1|||
46901081|NCT02711956|83128253|FG008|Overall Study|PSA progression with radiographic progression|0|||
46901082|NCT02711956|83128254|FG009|Overall Study|PSA progression with radiographic progression|1|||
46901083|NCT02711956|83128255|FG010|Overall Study|PSA progression with radiographic progression|0|||
46901084|NCT02711956|83128256|FG011|Overall Study|PSA progression with radiographic progression|1|||
46901085|NCT02711956|83128257|FG012|Overall Study|PSA progression with radiographic progression|2|||
46901086|NCT02711956|83128258|FG013|Overall Study|PSA progression with radiographic progression|3|||
46901087|NCT02711956|83128259|FG014|Overall Study|PSA progression with radiographic progression|3|||
46901088|NCT04149353|83128300|FG000|Overall Study|Study terminated|1|||
46901089|NCT02711800|83128305|FG000|Overall Study|Lost to Follow-up|1|||
46901090|NCT02711800|83128305|FG000|Overall Study|Withdrawal by Subject|1|||
46901091|NCT03031496|83128309|FG000|Period 1|Adverse Event|2|||
46901092|NCT03031496|83128310|FG001|Period 1|Adverse Event|0|||
46901093|NCT03031496|83128309|FG000|Period 1|Withdrawal by Subject|0|||
46901094|NCT03031496|83128310|FG001|Period 1|Withdrawal by Subject|2|||
46901095|NCT02659020|83128323|FG000|Overall Study|Adverse Event|0|||
46901096|NCT02659020|83128324|FG001|Overall Study|Adverse Event|0|||
46901097|NCT02659020|83128325|FG002|Overall Study|Adverse Event|0|||
46901098|NCT02659020|83128326|FG003|Overall Study|Adverse Event|2|||
46996793|NCT02349295|83243725|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46901099|NCT02659020|83128327|FG004|Overall Study|Adverse Event|0|||
46901100|NCT02659020|83128328|FG005|Overall Study|Adverse Event|0|||
46901101|NCT02659020|83128329|FG006|Overall Study|Adverse Event|2|||
46901102|NCT02659020|83128323|FG000|Overall Study|Lost to Follow-up|1|||
46901103|NCT02659020|83128324|FG001|Overall Study|Lost to Follow-up|2|||
46901104|NCT02659020|83128325|FG002|Overall Study|Lost to Follow-up|1|||
46901105|NCT02659020|83128326|FG003|Overall Study|Lost to Follow-up|6|||
46901106|NCT02659020|83128327|FG004|Overall Study|Lost to Follow-up|1|||
46901107|NCT02659020|83128328|FG005|Overall Study|Lost to Follow-up|5|||
46901108|NCT02659020|83128329|FG006|Overall Study|Lost to Follow-up|0|||
46901109|NCT02659020|83128323|FG000|Overall Study|Physician Decision|0|||
46901110|NCT02659020|83128324|FG001|Overall Study|Physician Decision|0|||
46901111|NCT02659020|83128325|FG002|Overall Study|Physician Decision|0|||
46901112|NCT02659020|83128326|FG003|Overall Study|Physician Decision|1|||
46901113|NCT02659020|83128327|FG004|Overall Study|Physician Decision|1|||
46901114|NCT02659020|83128328|FG005|Overall Study|Physician Decision|0|||
46901115|NCT02659020|83128329|FG006|Overall Study|Physician Decision|1|||
46901116|NCT02659020|83128323|FG000|Overall Study|Withdrawal by Subject|2|||
46901117|NCT02659020|83128324|FG001|Overall Study|Withdrawal by Subject|1|||
46901118|NCT02659020|83128325|FG002|Overall Study|Withdrawal by Subject|0|||
46901119|NCT02659020|83128326|FG003|Overall Study|Withdrawal by Subject|3|||
46901120|NCT02659020|83128327|FG004|Overall Study|Withdrawal by Subject|3|||
46901121|NCT02659020|83128328|FG005|Overall Study|Withdrawal by Subject|6|||
46901122|NCT02659020|83128329|FG006|Overall Study|Withdrawal by Subject|3|||
46901123|NCT02659020|83128323|FG000|Overall Study|Progressive Disease|0|||
46901124|NCT02659020|83128324|FG001|Overall Study|Progressive Disease|0|||
46901125|NCT02659020|83128325|FG002|Overall Study|Progressive Disease|0|||
46901126|NCT02659020|83128326|FG003|Overall Study|Progressive Disease|4|||
46901127|NCT02659020|83128327|FG004|Overall Study|Progressive Disease|1|||
46901128|NCT02659020|83128328|FG005|Overall Study|Progressive Disease|0|||
46901129|NCT02659020|83128329|FG006|Overall Study|Progressive Disease|2|||
46901130|NCT03482011|83128354|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
46901131|NCT03482011|83128355|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
46901132|NCT03482011|83128356|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
46901133|NCT03482011|83128357|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
46901134|NCT03482011|83128358|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
46901135|NCT03482011|83128359|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
46901136|NCT03482011|83128360|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
46901137|NCT03482011|83128361|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
46901138|NCT03482011|83128354|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
46901139|NCT03482011|83128355|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
46901140|NCT03482011|83128356|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46901141|NCT03482011|83128357|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46901142|NCT03482011|83128358|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46901143|NCT03482011|83128359|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46901144|NCT03482011|83128360|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46901145|NCT03482011|83128361|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46901146|NCT03482011|83128354|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
46901147|NCT03482011|83128355|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
46901148|NCT03482011|83128356|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
46901149|NCT03482011|83128357|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
46901150|NCT03482011|83128358|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
46901151|NCT03482011|83128359|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
46901152|NCT03482011|83128360|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
46901153|NCT03482011|83128361|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
46901154|NCT03482011|83128354|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
46901155|NCT03482011|83128355|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
46901156|NCT03482011|83128356|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
46901157|NCT03482011|83128357|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
46901158|NCT03482011|83128358|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
46901159|NCT03482011|83128359|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
46901160|NCT03482011|83128360|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
46901161|NCT03482011|83128361|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
46901162|NCT03482011|83128354|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
46901163|NCT03482011|83128355|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
46901164|NCT03482011|83128356|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46901165|NCT03482011|83128357|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46901166|NCT03482011|83128358|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46901167|NCT03482011|83128359|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46901168|NCT03482011|83128360|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46901169|NCT03482011|83128361|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46901170|NCT03482011|83128354|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
46901171|NCT03482011|83128355|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
46901172|NCT03482011|83128356|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
46901173|NCT03482011|83128357|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
46901174|NCT03482011|83128358|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
46901175|NCT03482011|83128359|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
46901176|NCT03482011|83128360|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
46901177|NCT03482011|83128361|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
46901178|NCT03482011|83128354|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
46901179|NCT03482011|83128355|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
46901180|NCT03482011|83128356|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
46901181|NCT03482011|83128357|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
46901182|NCT03482011|83128358|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
46901183|NCT03482011|83128359|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
46901184|NCT03482011|83128360|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
46901185|NCT03482011|83128361|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
46901186|NCT03482011|83128354|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46901187|NCT03482011|83128355|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46901188|NCT03482011|83128356|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46901189|NCT03482011|83128357|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46901190|NCT03482011|83128358|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
46901191|NCT03482011|83128359|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46901192|NCT03482011|83128360|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46901193|NCT03482011|83128361|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
46901194|NCT03482011|83128354|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
46901195|NCT03482011|83128355|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
46901196|NCT03482011|83128356|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
46901197|NCT03482011|83128357|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
46901198|NCT03482011|83128358|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
46901199|NCT03482011|83128359|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
46901200|NCT03482011|83128360|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
46901201|NCT03482011|83128361|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
46901202|NCT03482011|83128354|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46901203|NCT03482011|83128355|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46901204|NCT03482011|83128356|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46901205|NCT03482011|83128357|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
46901206|NCT03482011|83128358|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
46901207|NCT03482011|83128359|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
46901208|NCT03482011|83128360|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
46901209|NCT03482011|83128361|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
46901210|NCT03482011|83128354|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46901211|NCT03482011|83128355|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46901212|NCT03482011|83128356|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46901213|NCT03482011|83128357|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
46901214|NCT03482011|83128358|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46901215|NCT03482011|83128359|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
46901216|NCT03482011|83128360|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
46901217|NCT03482011|83128361|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
46901218|NCT03482011|83128354|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
46901219|NCT03482011|83128355|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
46901220|NCT03482011|83128356|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
46901221|NCT03482011|83128357|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
46901222|NCT03482011|83128358|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
46901223|NCT03482011|83128359|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
46901224|NCT03482011|83128360|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
46901225|NCT03482011|83128361|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
46901226|NCT03482011|83128354|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
46996794|NCT02349295|83243726|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996795|NCT02349295|83243727|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46901227|NCT03482011|83128355|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
46901228|NCT03482011|83128356|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
46901229|NCT03482011|83128357|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
46901230|NCT03482011|83128358|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
46901231|NCT03482011|83128359|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
46901232|NCT03482011|83128360|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
46901233|NCT03482011|83128361|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
46901234|NCT03482011|83128354|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
46901235|NCT03482011|83128355|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
46901236|NCT03482011|83128356|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
46901237|NCT03482011|83128357|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
46901238|NCT03482011|83128358|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
46901239|NCT03482011|83128359|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
46901240|NCT03482011|83128360|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
46901241|NCT03482011|83128361|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
46901242|NCT03482011|83128354|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46901243|NCT03482011|83128355|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46901244|NCT03482011|83128356|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46901245|NCT03482011|83128357|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46901246|NCT03482011|83128358|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46901247|NCT03482011|83128359|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46901248|NCT03482011|83128360|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
46901249|NCT03482011|83128361|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
46901250|NCT03481309|83128392|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
46901251|NCT03481309|83128393|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
46901252|NCT03481309|83128394|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
46901253|NCT03481309|83128395|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
46901254|NCT03481309|83128396|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
46901255|NCT03481309|83128397|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
46901256|NCT03480841|83128405|FG000|Overall Study|Lost to Follow-up|2|||
46901257|NCT02709538|83128412|FG000|Overall Study|Adverse Event|13|||
46901258|NCT02709538|83128413|FG001|Overall Study|Adverse Event|2|||
46901259|NCT02709538|83128414|FG002|Overall Study|Adverse Event|3|||
46901260|NCT02709538|83128412|FG000|Overall Study|Lack of Efficacy|1|||
46901261|NCT02709538|83128413|FG001|Overall Study|Lack of Efficacy|0|||
46901262|NCT02709538|83128414|FG002|Overall Study|Lack of Efficacy|0|||
46901263|NCT02709538|83128412|FG000|Overall Study|Lost to Follow-up|24|||
46901264|NCT02709538|83128413|FG001|Overall Study|Lost to Follow-up|8|||
46901265|NCT02709538|83128414|FG002|Overall Study|Lost to Follow-up|4|||
46901266|NCT02709538|83128412|FG000|Overall Study|Physician Decision|1|||
46901267|NCT02709538|83128413|FG001|Overall Study|Physician Decision|0|||
46901268|NCT02709538|83128414|FG002|Overall Study|Physician Decision|0|||
46901269|NCT02709538|83128412|FG000|Overall Study|Withdrawal by Subject|40|||
46901270|NCT02709538|83128413|FG001|Overall Study|Withdrawal by Subject|7|||
46901271|NCT02709538|83128414|FG002|Overall Study|Withdrawal by Subject|4|||
46901272|NCT02709538|83128412|FG000|Overall Study|Non-compliance with study procedures|5|||
46901273|NCT02709538|83128413|FG001|Overall Study|Non-compliance with study procedures|0|||
46901274|NCT02709538|83128414|FG002|Overall Study|Non-compliance with study procedures|0|||
46901275|NCT02709538|83128412|FG000|Overall Study|Non-compliance with study drug|2|||
46901276|NCT02709538|83128413|FG001|Overall Study|Non-compliance with study drug|0|||
46901277|NCT02709538|83128414|FG002|Overall Study|Non-compliance with study drug|0|||
46901278|NCT02709538|83128412|FG000|Overall Study|Protocol deviation|10|||
46901279|NCT02709538|83128413|FG001|Overall Study|Protocol deviation|4|||
46901280|NCT02709538|83128414|FG002|Overall Study|Protocol deviation|4|||
46901281|NCT02709538|83128412|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
46901282|NCT02709538|83128413|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
46901283|NCT02709538|83128414|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
46901284|NCT02709538|83128412|FG000|Overall Study|Other|16|||
46901285|NCT02709538|83128413|FG001|Overall Study|Other|7|||
46901286|NCT02709538|83128414|FG002|Overall Study|Other|5|||
46901287|NCT00511134|83128428|FG000|Overall Study|Withdrawal by Subject|0|||
46901288|NCT00511134|83128429|FG001|Overall Study|Withdrawal by Subject|2|||
46901289|NCT01372384|83128435|FG000|Overall Study|Progression of disease|3|||
46901290|NCT03115476|83128442|FG000|LP0084-1369|Death|1|||
46901291|NCT03115476|83128443|FG001|LP0084-1369|Death|0|||
46901292|NCT03115476|83128444|FG002|LP0084-1369|Death|2|||
46901293|NCT03115476|83128442|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
46901294|NCT03115476|83128443|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
46901295|NCT03115476|83128444|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
46901296|NCT03480763|83128454|FG000|Overall Study|Withdrawal by Subject|18|||
46901297|NCT03480763|83128455|FG001|Overall Study|Withdrawal by Subject|10|||
46901298|NCT03480763|83128454|FG000|Overall Study|Lost to Follow-up|4|||
46901299|NCT03480763|83128455|FG001|Overall Study|Lost to Follow-up|7|||
46901300|NCT03480763|83128454|FG000|Overall Study|non-study pneumococcal vaccine|1|||
46901301|NCT03480763|83128455|FG001|Overall Study|non-study pneumococcal vaccine|0|||
46901302|NCT03480763|83128454|FG000|Overall Study|oncological treatment|0|||
46901303|NCT03480763|83128455|FG001|Overall Study|oncological treatment|2|||
46901304|NCT03480763|83128454|FG000|Overall Study|pain with vaccination|1|||
46901305|NCT03480763|83128455|FG001|Overall Study|pain with vaccination|0|||
46901306|NCT03123120|83128469|FG000|Overall Study|Lost to Follow-up|0|||
46901307|NCT03123120|83128470|FG001|Overall Study|Lost to Follow-up|1|||
46901308|NCT03123120|83128469|FG000|Overall Study|Withdrawal by Subject|0|||
46901309|NCT03123120|83128470|FG001|Overall Study|Withdrawal by Subject|1|||
46901310|NCT01319994|83128480|FG000|Overall Study|Protocol Violation|7|||
46901311|NCT01319994|83128481|FG001|Overall Study|Protocol Violation|6|||
46901312|NCT03453151|83128491|FG000|Overall Study|Withdrawal by Subject|1|||
46901313|NCT03453151|83128491|FG000|Overall Study|Physician Decision|3|||
46901314|NCT03452527|83128497|FG000|Overall Study|Withdrawal by Subject|1|||
46901315|NCT03452527|83128498|FG001|Overall Study|Withdrawal by Subject|1|||
46901316|NCT03452527|83128497|FG000|Overall Study|Study Terminated|2|||
46901317|NCT03452527|83128498|FG001|Overall Study|Study Terminated|3|||
46901318|NCT03028142|83128504|FG000|Overall Study|Adverse Event|1|||
46901319|NCT03028142|83128505|FG001|Overall Study|Adverse Event|1|||
46901320|NCT03028142|83128506|FG002|Overall Study|Adverse Event|0|||
46901321|NCT03028142|83128507|FG003|Overall Study|Adverse Event|0|||
46901322|NCT03028142|83128508|FG004|Overall Study|Adverse Event|0|||
46901323|NCT03028142|83128509|FG005|Overall Study|Adverse Event|1|||
46901324|NCT03028142|83128504|FG000|Overall Study|Withdrawal by Subject|0|||
46901325|NCT03028142|83128505|FG001|Overall Study|Withdrawal by Subject|0|||
46901326|NCT03028142|83128506|FG002|Overall Study|Withdrawal by Subject|0|||
46901327|NCT03028142|83128507|FG003|Overall Study|Withdrawal by Subject|0|||
46901328|NCT03028142|83128508|FG004|Overall Study|Withdrawal by Subject|1|||
46901329|NCT03028142|83128509|FG005|Overall Study|Withdrawal by Subject|0|||
46901330|NCT02708524|83128522|FG000|Overall Study|Adverse Event|0|||
46901331|NCT02708524|83128523|FG001|Overall Study|Adverse Event|1|||
46901332|NCT02708524|83128524|FG002|Overall Study|Adverse Event|0|||
46901333|NCT02708524|83128525|FG003|Overall Study|Adverse Event|0|||
46901334|NCT02708524|83128522|FG000|Overall Study|Lens Discomfort|1|||
46901335|NCT02708524|83128523|FG001|Overall Study|Lens Discomfort|0|||
46901336|NCT02708524|83128524|FG002|Overall Study|Lens Discomfort|1|||
46901337|NCT02708524|83128525|FG003|Overall Study|Lens Discomfort|0|||
46901338|NCT02708524|83128522|FG000|Overall Study|Lost to Follow-up|1|||
46901339|NCT02708524|83128523|FG001|Overall Study|Lost to Follow-up|1|||
46901340|NCT02708524|83128524|FG002|Overall Study|Lost to Follow-up|1|||
46901341|NCT02708524|83128525|FG003|Overall Study|Lost to Follow-up|0|||
46901342|NCT02708524|83128522|FG000|Overall Study|Protocol Violation|0|||
46901343|NCT02708524|83128523|FG001|Overall Study|Protocol Violation|1|||
46901344|NCT02708524|83128524|FG002|Overall Study|Protocol Violation|0|||
46901345|NCT02708524|83128525|FG003|Overall Study|Protocol Violation|0|||
46901346|NCT02708524|83128522|FG000|Overall Study|Withdrawal by Subject|1|||
46901347|NCT02708524|83128523|FG001|Overall Study|Withdrawal by Subject|1|||
46901348|NCT02708524|83128524|FG002|Overall Study|Withdrawal by Subject|0|||
46901349|NCT02708524|83128525|FG003|Overall Study|Withdrawal by Subject|0|||
46901350|NCT02708524|83128522|FG000|Overall Study|Dispensed incorrect study lens|0|||
46901351|NCT02708524|83128523|FG001|Overall Study|Dispensed incorrect study lens|1|||
46901352|NCT02708524|83128524|FG002|Overall Study|Dispensed incorrect study lens|1|||
46901353|NCT02708524|83128525|FG003|Overall Study|Dispensed incorrect study lens|0|||
46901354|NCT02708524|83128522|FG000|Overall Study|Did not wear lens at final visit|0|||
46901355|NCT02708524|83128523|FG001|Overall Study|Did not wear lens at final visit|1|||
46901356|NCT02708524|83128524|FG002|Overall Study|Did not wear lens at final visit|0|||
46901357|NCT02708524|83128525|FG003|Overall Study|Did not wear lens at final visit|0|||
46901358|NCT02708524|83128522|FG000|Overall Study|Subject lost study lens|1|||
46901359|NCT02708524|83128523|FG001|Overall Study|Subject lost study lens|0|||
46901360|NCT02708524|83128524|FG002|Overall Study|Subject lost study lens|0|||
46901361|NCT02708524|83128525|FG003|Overall Study|Subject lost study lens|0|||
46901362|NCT03418675|83128537|FG000|Overall Study|Lost to Follow-up|13|||
46901363|NCT03418675|83128538|FG001|Overall Study|Lost to Follow-up|10|||
46901364|NCT03418675|83128537|FG000|Overall Study|Adverse Event|2|||
46901365|NCT03418675|83128538|FG001|Overall Study|Adverse Event|0|||
46901366|NCT03417505|83128555|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
46901367|NCT03417505|83128556|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
46901368|NCT02953639|83128565|FG000|Overall Study|Adverse Event|2|||
46901369|NCT02953639|83128566|FG001|Overall Study|Adverse Event|0|||
46901370|NCT02953639|83128567|FG002|Overall Study|Adverse Event|1|||
46901371|NCT02953639|83128565|FG000|Overall Study|Lost to Follow-up|8|||
46901372|NCT02953639|83128566|FG001|Overall Study|Lost to Follow-up|4|||
46901373|NCT02953639|83128567|FG002|Overall Study|Lost to Follow-up|3|||
46901374|NCT02953639|83128565|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46901375|NCT02953639|83128566|FG001|Overall Study|Non-Compliance With Study Drug|2|||
46901376|NCT02953639|83128567|FG002|Overall Study|Non-Compliance With Study Drug|1|||
46901377|NCT02953639|83128565|FG000|Overall Study|Multiple Reasons|1|||
46901378|NCT02953639|83128566|FG001|Overall Study|Multiple Reasons|0|||
46901379|NCT02953639|83128567|FG002|Overall Study|Multiple Reasons|1|||
46901380|NCT02953639|83128565|FG000|Overall Study|Physician Decision|1|||
46901381|NCT02953639|83128566|FG001|Overall Study|Physician Decision|0|||
46901382|NCT02953639|83128567|FG002|Overall Study|Physician Decision|0|||
46901383|NCT02953639|83128565|FG000|Overall Study|Withdrawal by Subject|7|||
46901384|NCT02953639|83128566|FG001|Overall Study|Withdrawal by Subject|8|||
46901385|NCT02953639|83128567|FG002|Overall Study|Withdrawal by Subject|10|||
46901386|NCT02953639|83128565|FG000|Overall Study|Completed or Discontinued information is missing|1|||
46901387|NCT02953639|83128566|FG001|Overall Study|Completed or Discontinued information is missing|0|||
46901388|NCT02953639|83128567|FG002|Overall Study|Completed or Discontinued information is missing|0|||
46901389|NCT04147715|83128589|FG000|Overall Study|Adverse Event|0|||
46901390|NCT04147715|83128590|FG001|Overall Study|Adverse Event|0|||
46901391|NCT04147715|83128591|FG002|Overall Study|Adverse Event|0|||
46901392|NCT04147715|83128592|FG003|Overall Study|Adverse Event|0|||
46901393|NCT04147715|83128593|FG004|Overall Study|Adverse Event|0|||
46901394|NCT04147715|83128594|FG005|Overall Study|Adverse Event|0|||
46901395|NCT04147715|83128595|FG006|Overall Study|Adverse Event|0|||
46901396|NCT04147715|83128596|FG007|Overall Study|Adverse Event|2|||
46901397|NCT04147715|83128597|FG008|Overall Study|Adverse Event|1|||
46901398|NCT04147715|83128598|FG009|Overall Study|Adverse Event|0|||
46901399|NCT04147715|83128599|FG010|Overall Study|Adverse Event|0|||
46901400|NCT04147715|83128600|FG011|Overall Study|Adverse Event|0|||
46901401|NCT02452554|83128687|FG000|Overall Study|Death|2|||
46901402|NCT02452554|83128688|FG001|Overall Study|Death|1|||
46901403|NCT02452554|83128689|FG002|Overall Study|Death|0|||
46901404|NCT02452554|83128690|FG003|Overall Study|Death|0|||
46901405|NCT02452554|83128691|FG004|Overall Study|Death|0|||
46901406|NCT02452554|83128692|FG005|Overall Study|Death|0|||
46901407|NCT02452554|83128687|FG000|Overall Study|Lack of Efficacy|13|||
46901408|NCT02452554|83128688|FG001|Overall Study|Lack of Efficacy|14|||
46901409|NCT02452554|83128689|FG002|Overall Study|Lack of Efficacy|9|||
46901410|NCT02452554|83128690|FG003|Overall Study|Lack of Efficacy|1|||
46901411|NCT02452554|83128691|FG004|Overall Study|Lack of Efficacy|5|||
46901412|NCT02452554|83128692|FG005|Overall Study|Lack of Efficacy|8|||
46901413|NCT02452554|83128687|FG000|Overall Study|Physician Decision|0|||
46901414|NCT02452554|83128688|FG001|Overall Study|Physician Decision|1|||
46901415|NCT02452554|83128689|FG002|Overall Study|Physician Decision|0|||
46901416|NCT02452554|83128690|FG003|Overall Study|Physician Decision|0|||
46901417|NCT02452554|83128691|FG004|Overall Study|Physician Decision|0|||
46901418|NCT02452554|83128692|FG005|Overall Study|Physician Decision|0|||
46901419|NCT02452554|83128687|FG000|Overall Study|Withdrawal by Subject|1|||
46901420|NCT02452554|83128688|FG001|Overall Study|Withdrawal by Subject|0|||
46901421|NCT02452554|83128689|FG002|Overall Study|Withdrawal by Subject|2|||
46901422|NCT02452554|83128690|FG003|Overall Study|Withdrawal by Subject|0|||
46901423|NCT02452554|83128691|FG004|Overall Study|Withdrawal by Subject|0|||
46901424|NCT02452554|83128692|FG005|Overall Study|Withdrawal by Subject|1|||
46901425|NCT02452554|83128687|FG000|Overall Study|Ineligible|0|||
46901426|NCT02452554|83128688|FG001|Overall Study|Ineligible|1|||
46901427|NCT02452554|83128689|FG002|Overall Study|Ineligible|0|||
46901428|NCT02452554|83128690|FG003|Overall Study|Ineligible|0|||
46901429|NCT02452554|83128691|FG004|Overall Study|Ineligible|0|||
46901430|NCT02452554|83128692|FG005|Overall Study|Ineligible|0|||
46901431|NCT02452554|83128687|FG000|Overall Study|Never Received Treatment|1|||
46901432|NCT02452554|83128688|FG001|Overall Study|Never Received Treatment|0|||
46901433|NCT02452554|83128689|FG002|Overall Study|Never Received Treatment|0|||
46901434|NCT02452554|83128690|FG003|Overall Study|Never Received Treatment|0|||
46901435|NCT02452554|83128691|FG004|Overall Study|Never Received Treatment|0|||
46901436|NCT02452554|83128692|FG005|Overall Study|Never Received Treatment|0|||
46901437|NCT04009577|83128711|FG000|Core Study|Adverse Event|1|||
46901438|NCT04009577|83128712|FG001|Core Study|Adverse Event|0|||
46901439|NCT04009577|83128713|FG002|Core Study|Adverse Event|2|||
46996796|NCT02349295|83243728|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996797|NCT02349295|83243729|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996798|NCT02349295|83243730|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
46996799|NCT02349295|83243731|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996800|NCT02349295|83243732|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
46996801|NCT02349295|83243719|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996802|NCT02349295|83243720|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996803|NCT02349295|83243721|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996804|NCT02349295|83243722|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996805|NCT02349295|83243723|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996806|NCT02349295|83243724|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996807|NCT02349295|83243725|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996808|NCT02349295|83243726|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996809|NCT02349295|83243727|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996810|NCT02349295|83243728|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996811|NCT02349295|83243729|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996812|NCT02349295|83243730|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
46996813|NCT02349295|83243731|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996814|NCT02349295|83243732|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
46996815|NCT02281357|83243759|FG000|Overall Study|Adverse Event|2|||
46996816|NCT02281357|83243760|FG001|Overall Study|Adverse Event|1|||
46996817|NCT02281357|83243759|FG000|Overall Study|Lost to Follow-up|1|||
46996818|NCT02281357|83243760|FG001|Overall Study|Lost to Follow-up|0|||
46901440|NCT04009577|83128714|FG003|Core Study|Adverse Event|4|||
46901441|NCT04009577|83128711|FG000|Core Study|Withdrawal by Subject|0|||
46901442|NCT04009577|83128712|FG001|Core Study|Withdrawal by Subject|0|||
46901443|NCT04009577|83128713|FG002|Core Study|Withdrawal by Subject|2|||
46901444|NCT04009577|83128714|FG003|Core Study|Withdrawal by Subject|0|||
46901445|NCT04009577|83128711|FG000|Core Study|Other|0|||
46901446|NCT04009577|83128712|FG001|Core Study|Other|0|||
46901447|NCT04009577|83128713|FG002|Core Study|Other|0|||
46901448|NCT04009577|83128714|FG003|Core Study|Other|1|||
46901449|NCT04009577|83128711|FG000|Extension Phase|Adverse Event|0|||
46901450|NCT04009577|83128712|FG001|Extension Phase|Adverse Event|0|||
46901451|NCT04009577|83128713|FG002|Extension Phase|Adverse Event|0|||
46901452|NCT04009577|83128714|FG003|Extension Phase|Adverse Event|1|||
46901453|NCT04009577|83128711|FG000|Extension Phase|Inadequate therapeutic effect|0|||
46901454|NCT04009577|83128712|FG001|Extension Phase|Inadequate therapeutic effect|0|||
46901455|NCT04009577|83128713|FG002|Extension Phase|Inadequate therapeutic effect|1|||
46901456|NCT04009577|83128714|FG003|Extension Phase|Inadequate therapeutic effect|0|||
46901457|NCT04009577|83128711|FG000|Extension Phase|Withdrawal by Subject|0|||
46901458|NCT04009577|83128712|FG001|Extension Phase|Withdrawal by Subject|0|||
46901459|NCT04009577|83128713|FG002|Extension Phase|Withdrawal by Subject|1|||
46901460|NCT04009577|83128714|FG003|Extension Phase|Withdrawal by Subject|0|||
46901461|NCT04009577|83128711|FG000|Extension Phase|Not Treated|0|||
46901462|NCT04009577|83128712|FG001|Extension Phase|Not Treated|0|||
46901463|NCT04009577|83128713|FG002|Extension Phase|Not Treated|2|||
46901464|NCT04009577|83128714|FG003|Extension Phase|Not Treated|0|||
46901465|NCT04146467|83128742|FG000|Overall Study|Adverse Event|0|||
46901466|NCT04146467|83128743|FG001|Overall Study|Adverse Event|1|||
46901467|NCT04146467|83128742|FG000|Overall Study|Lost to Follow-up|0|||
46901468|NCT04146467|83128743|FG001|Overall Study|Lost to Follow-up|2|||
46901469|NCT02705716|83128754|FG000|Overall Study|Adverse Event|0|||
46901470|NCT02705716|83128755|FG001|Overall Study|Adverse Event|1|||
46996819|NCT02281357|83243759|FG000|Overall Study|Withdrawal by Subject|4|||
46996820|NCT02281357|83243760|FG001|Overall Study|Withdrawal by Subject|3|||
46996821|NCT02284243|83243768|FG000|Overall Study|Lack of Efficacy|3|||
46996822|NCT02284243|83243769|FG001|Overall Study|Lack of Efficacy|3|||
46996823|NCT02284243|83243768|FG000|Overall Study|Adverse Event|1|||
46996824|NCT02284243|83243769|FG001|Overall Study|Adverse Event|0|||
46996825|NCT02284009|83243777|FG000|Overall Study|Adverse Event|3|||
46996826|NCT02284009|83243778|FG001|Overall Study|Adverse Event|0|||
46996827|NCT02284009|83243777|FG000|Overall Study|Lost to Follow-up|1|||
46996828|NCT02284009|83243778|FG001|Overall Study|Lost to Follow-up|3|||
46996829|NCT02284009|83243777|FG000|Overall Study|Physician Decision|0|||
46996830|NCT02284009|83243778|FG001|Overall Study|Physician Decision|2|||
46996831|NCT02284009|83243777|FG000|Overall Study|Withdrawal by Subject|2|||
46996832|NCT02284009|83243778|FG001|Overall Study|Withdrawal by Subject|5|||
46996833|NCT02280499|83243786|FG000|Overall Study|Death|14|||
46996834|NCT02280499|83243786|FG000|Overall Study|Lost to Follow-up|42|||
46996835|NCT02280499|83243786|FG000|Overall Study|Adverse Event|5|||
46996836|NCT02400476|83243796|FG000|Overall Study|Adverse Event|57|||
46996837|NCT02400476|83243797|FG001|Overall Study|Adverse Event|10|||
46996838|NCT02400476|83243798|FG002|Overall Study|Adverse Event|22|||
46901471|NCT02705716|83128754|FG000|Overall Study|Protocol Violation|3|||
46901472|NCT02705716|83128755|FG001|Overall Study|Protocol Violation|0|||
46901473|NCT02705716|83128754|FG000|Overall Study|Withdrawal of Consent|1|||
46901474|NCT02705716|83128755|FG001|Overall Study|Withdrawal of Consent|1|||
46901475|NCT04138043|83128763|FG000|Overall Study|Withdrawal by Subject|0|||
46901476|NCT04138043|83128764|FG001|Overall Study|Withdrawal by Subject|1|||
46901477|NCT03443713|83128783|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
46901478|NCT03443713|83128784|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
46901479|NCT03443713|83128785|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
46901480|NCT04133519|83128799|FG000|Overall Study|Withdrawal by Subject|5|||
46901481|NCT04133519|83128800|FG001|Overall Study|Withdrawal by Subject|4|||
46901482|NCT04133519|83128799|FG000|Overall Study|Protocol Violation|0|||
46901483|NCT04133519|83128800|FG001|Overall Study|Protocol Violation|1|||
46901484|NCT04133519|83128799|FG000|Overall Study|Never started treatment|1|||
46901485|NCT04133519|83128800|FG001|Overall Study|Never started treatment|1|||
46901486|NCT04007159|83128806|FG000|Induction Phase|(missed study visits)|16|||
46996839|NCT02400476|83243799|FG003|Overall Study|Adverse Event|19|||
46996840|NCT02400476|83243800|FG004|Overall Study|Adverse Event|5|||
46996841|NCT02400476|83243801|FG005|Overall Study|Adverse Event|8|||
46996842|NCT02400476|83243796|FG000|Overall Study|Withdrawal by Subject|4|||
46996843|NCT02400476|83243797|FG001|Overall Study|Withdrawal by Subject|1|||
46901487|NCT04007159|83128806|FG000|Induction Phase|Withdrawal by Subject|4|||
46901488|NCT04007159|83128806|FG000|Induction Phase|Adverse Event|2|||
46901489|NCT04007159|83128806|FG000|Challenge Phase|missed study visits|3|||
46901490|NCT03119688|83128817|FG000|Overall Study|Adverse Event|4|||
46901491|NCT03389893|83128836|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
46996844|NCT02400476|83243798|FG002|Overall Study|Withdrawal by Subject|12|||
46996845|NCT02400476|83243799|FG003|Overall Study|Withdrawal by Subject|7|||
46996846|NCT02400476|83243800|FG004|Overall Study|Withdrawal by Subject|5|||
46901492|NCT03389893|83128837|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
46901493|NCT03389893|83128838|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
46901494|NCT03389893|83128839|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
46996847|NCT02400476|83243801|FG005|Overall Study|Withdrawal by Subject|5|||
46996848|NCT02400476|83243796|FG000|Overall Study|Lost to Follow-up|0|||
46901495|NCT03389893|83128836|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
46901496|NCT03389893|83128837|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
46901497|NCT03389893|83128838|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
46901498|NCT03389893|83128839|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
46901499|NCT03389893|83128836|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
46901500|NCT03389893|83128837|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
46901501|NCT03389893|83128838|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
46901502|NCT03389893|83128839|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
46901503|NCT03389893|83128836|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
46901504|NCT03389893|83128837|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
46901505|NCT03389893|83128838|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
46901506|NCT03389893|83128839|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
46901507|NCT04128293|83128849|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
46901508|NCT04128293|83128850|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
46901509|NCT04128293|83128851|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
46901510|NCT04128293|83128852|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
46901511|NCT00787176|83128871|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
46901512|NCT00787176|83128872|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
46901513|NCT00787176|83128873|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
46901514|NCT00787176|83128874|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
46901515|NCT03691571|83128887|FG000|Overall Study|Withdrawal by Subject|9|||
46901516|NCT03691571|83128888|FG001|Overall Study|Withdrawal by Subject|2|||
46901517|NCT03113916|83128897|FG000|Overall Study|Withdrawal by Subject|9|||
46901518|NCT03113916|83128898|FG001|Overall Study|Withdrawal by Subject|7|||
46901519|NCT03113916|83128897|FG000|Overall Study|Pregnancy|1|||
46901520|NCT03113916|83128898|FG001|Overall Study|Pregnancy|3|||
46901521|NCT03113916|83128897|FG000|Overall Study|Lost to Follow-up|1|||
46901522|NCT03113916|83128898|FG001|Overall Study|Lost to Follow-up|2|||
46901523|NCT02925494|83128913|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
46901524|NCT02925494|83128914|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
46901525|NCT02925494|83128915|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
46901526|NCT02925494|83128916|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
46901527|NCT02925494|83128913|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
46901528|NCT02925494|83128914|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
46901529|NCT02925494|83128915|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
46901530|NCT02925494|83128916|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
46901531|NCT02925494|83128913|FG000|Post-Treatment Follow-Up Period|Other|1|||
46901532|NCT02925494|83128914|FG001|Post-Treatment Follow-Up Period|Other|4|||
46901533|NCT02925494|83128915|FG002|Post-Treatment Follow-Up Period|Other|3|||
46901534|NCT02925494|83128916|FG003|Post-Treatment Follow-Up Period|Other|6|||
46901535|NCT02925494|83128913|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
46901536|NCT02925494|83128914|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
46901537|NCT02925494|83128915|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
46901538|NCT02925494|83128916|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
46901539|NCT02925494|83128913|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
46901540|NCT02925494|83128914|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
46901541|NCT02925494|83128915|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
46901542|NCT02925494|83128916|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
46901543|NCT02925494|83128913|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
46901544|NCT02925494|83128914|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
46901545|NCT02925494|83128915|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
46901546|NCT02925494|83128916|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
46901547|NCT02925494|83128913|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
46901548|NCT02925494|83128914|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
46901549|NCT02925494|83128915|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
46901550|NCT02925494|83128916|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
46901551|NCT04006145|83128929|FG000|Overall Study|Lost to Follow-up|0|||
46901552|NCT04006145|83128930|FG001|Overall Study|Lost to Follow-up|1|||
46901553|NCT04006145|83128929|FG000|Overall Study|Other|1|||
46901554|NCT04006145|83128930|FG001|Overall Study|Other|2|||
46901555|NCT03386773|83128938|FG000|Overall Study|Lost to Follow-up|24|||
46901556|NCT03386773|83128939|FG001|Overall Study|Lost to Follow-up|33|||
46901557|NCT03386773|83128938|FG000|Overall Study|Withdrawal by Subject|3|||
46901558|NCT03386773|83128939|FG001|Overall Study|Withdrawal by Subject|2|||
46901559|NCT04126343|83128951|FG000|Overall Study|Adverse Event|0|||
46901560|NCT04126343|83128952|FG001|Overall Study|Adverse Event|0|||
46901561|NCT04126343|83128953|FG002|Overall Study|Adverse Event|0|||
46901562|NCT04126343|83128954|FG003|Overall Study|Adverse Event|0|||
46901563|NCT04126343|83128955|FG004|Overall Study|Adverse Event|0|||
46901564|NCT04126343|83128956|FG005|Overall Study|Adverse Event|1|||
46901565|NCT04126343|83128951|FG000|Overall Study|Withdrawal by Subject|0|||
46901566|NCT04126343|83128952|FG001|Overall Study|Withdrawal by Subject|0|||
46901567|NCT04126343|83128953|FG002|Overall Study|Withdrawal by Subject|0|||
46901568|NCT04126343|83128954|FG003|Overall Study|Withdrawal by Subject|1|||
46901569|NCT04126343|83128955|FG004|Overall Study|Withdrawal by Subject|0|||
46901570|NCT04126343|83128956|FG005|Overall Study|Withdrawal by Subject|0|||
46901571|NCT04126343|83128951|FG000|Overall Study|Related to COVID-19 pandemic|3|||
46901572|NCT04126343|83128952|FG001|Overall Study|Related to COVID-19 pandemic|4|||
46901573|NCT04126343|83128953|FG002|Overall Study|Related to COVID-19 pandemic|3|||
46901574|NCT04126343|83128954|FG003|Overall Study|Related to COVID-19 pandemic|3|||
46901575|NCT04126343|83128955|FG004|Overall Study|Related to COVID-19 pandemic|3|||
46901576|NCT04126343|83128956|FG005|Overall Study|Related to COVID-19 pandemic|3|||
46901577|NCT02952313|83128971|FG000|Primary Endpoint|Lost to Follow-up|4|||
46901578|NCT02952313|83128971|FG000|Primary Endpoint|Withdrawal by Subject|1|||
46901579|NCT02952313|83128971|FG000|Primary Endpoint|Lack of Efficacy|1|||
46901580|NCT02952313|83128971|FG000|Primary Endpoint|Missed visit|1|||
46901581|NCT02952313|83128971|FG000|Long-term Follow-up|Lost to Follow-up|12|||
46901582|NCT02952313|83128971|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
46901583|NCT02952313|83128971|FG000|Long-term Follow-up|Lack of Efficacy|6|||
46901584|NCT02952313|83128971|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
46901585|NCT02952313|83128971|FG000|Long-term Follow-up|Physician Decision|1|||
46901586|NCT02952313|83128971|FG000|Long-term Follow-up|Death|1|||
46901587|NCT03119610|83128978|FG000|Overall Study|Adverse Event|1|||
46901588|NCT03119610|83128979|FG001|Overall Study|Adverse Event|0|||
46901589|NCT03119610|83128978|FG000|Overall Study|Lost to Follow-up|0|||
46901590|NCT03119610|83128979|FG001|Overall Study|Lost to Follow-up|1|||
46901591|NCT04005755|83128985|FG000|Overall Study|Adverse Event|6|||
46901592|NCT04005755|83128985|FG000|Overall Study|Physician Decision|3|||
46901593|NCT04005755|83128985|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
46901594|NCT04005755|83128985|FG000|Overall Study|Withdrawal by Subject|3|||
46901595|NCT04005755|83128985|FG000|Overall Study|Lost to Follow-up|1|||
46901596|NCT03442777|83128992|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
46901597|NCT03442777|83128993|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
46901598|NCT03442777|83128994|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
46901599|NCT03401749|83129003|FG000|Overall Study|Lost to Follow-up|20|||
46901600|NCT03401749|83129004|FG001|Overall Study|Lost to Follow-up|16|||
46901601|NCT03401749|83129005|FG002|Overall Study|Lost to Follow-up|26|||
46901602|NCT03029624|83129013|FG000|Overall Study|Adverse Event|1|||
46901603|NCT03029624|83129013|FG000|Overall Study|Withdrawal by Subject|1|||
46901604|NCT03029624|83129013|FG000|Overall Study|Lack of Efficacy|1|||
46901605|NCT03029624|83129013|FG000|Overall Study|MRI need|2|||
46901606|NCT02952001|83129021|FG000|Overall Study|Adverse Event|3|||
46901607|NCT02952001|83129022|FG001|Overall Study|Adverse Event|0|||
46901608|NCT02952001|83129021|FG000|Overall Study|Prohibited therapy|10|||
46901609|NCT02952001|83129022|FG001|Overall Study|Prohibited therapy|3|||
46901610|NCT02952001|83129021|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
46901611|NCT02952001|83129022|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
46901612|NCT04123067|83129031|FG000|Overall Study|Lost to Follow-up|0|||
46901613|NCT04123067|83129032|FG001|Overall Study|Lost to Follow-up|1|||
46901614|NCT04117607|83129041|FG000|Overall Study|Early Termination|0|||
46901615|NCT04117607|83129042|FG001|Overall Study|Early Termination|1|||
46901616|NCT04117607|83129043|FG002|Overall Study|Early Termination|0|||
46901617|NCT04117607|83129044|FG003|Overall Study|Early Termination|0|||
46901618|NCT04117607|83129045|FG004|Overall Study|Early Termination|0|||
46901619|NCT04117607|83129046|FG005|Overall Study|Early Termination|0|||
46901620|NCT04117607|83129047|FG006|Overall Study|Early Termination|1|||
46901621|NCT04117607|83129048|FG007|Overall Study|Early Termination|0|||
46901622|NCT04117607|83129049|FG008|Overall Study|Early Termination|0|||
46901623|NCT04117607|83129050|FG009|Overall Study|Early Termination|0|||
46901624|NCT04117607|83129051|FG010|Overall Study|Early Termination|0|||
46901625|NCT04117607|83129052|FG011|Overall Study|Early Termination|0|||
46901626|NCT04117607|83129053|FG012|Overall Study|Early Termination|0|||
46901627|NCT04117607|83129054|FG013|Overall Study|Early Termination|0|||
46901628|NCT04112303|83129070|FG000|Overall Study|Death|1|||
46901629|NCT03998189|83129076|FG000|Overall Study|Lack of Efficacy|0|||
46901630|NCT03998189|83129077|FG001|Overall Study|Lack of Efficacy|1|||
46620160|NCT02270736|82761809|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
46620161|NCT02270736|82761810|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
46620162|NCT02270736|82761811|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
46620163|NCT02270736|82761812|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
46901631|NCT04099277|83129083|FG000|Overall Study|Physician Decision|1|||
46901632|NCT04099277|83129083|FG000|Overall Study|Withdrawal by Subject|1|||
46901633|NCT03990389|83129089|FG000|Overall Study|Lost to Follow-up|3|||
46901634|NCT03990389|83129090|FG001|Overall Study|Lost to Follow-up|0|||
46709139|NCT01897571|82925081|FG009|Overall Study|Death|129|||
46901635|NCT03988907|83129098|FG000|Overall Study|Unable to complete visit|0|||
46620164|NCT02270736|82761813|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
46620165|NCT02270736|82761809|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
46620166|NCT02270736|82761810|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
46620167|NCT02270736|82761811|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
46620168|NCT02270736|82761812|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
46620169|NCT02270736|82761813|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
46620170|NCT02270736|82761809|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
46620171|NCT02270736|82761810|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
46620172|NCT02270736|82761811|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
46620173|NCT02270736|82761812|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
46901636|NCT03988907|83129099|FG001|Overall Study|Unable to complete visit|1|||
46901637|NCT03987191|83129113|FG000|Overall Study|COVID-19 related research disruption|0|||
46901638|NCT03987191|83129114|FG001|Overall Study|COVID-19 related research disruption|2|||
46901639|NCT04098809|83129122|FG000|Overall Study|Withdrawal by Subject|1|||
46901640|NCT04098809|83129123|FG001|Overall Study|Withdrawal by Subject|3|||
46901641|NCT04098809|83129122|FG000|Overall Study|Physician Decision|2|||
46901642|NCT04098809|83129123|FG001|Overall Study|Physician Decision|1|||
46901643|NCT03122184|83129131|FG000|Overall Study|Lost to Follow-up|4|||
46901644|NCT03122184|83129132|FG001|Overall Study|Lost to Follow-up|6|||
46901645|NCT03122184|83129131|FG000|Overall Study|Withdrawal by Subject|3|||
46901646|NCT03122184|83129132|FG001|Overall Study|Withdrawal by Subject|0|||
46901647|NCT03122184|83129131|FG000|Overall Study|Terminated due to cognitive problem|1|||
46901648|NCT03122184|83129132|FG001|Overall Study|Terminated due to cognitive problem|0|||
46901649|NCT04091087|83129157|FG000|Overall Study|Not treated|1|||
46901650|NCT04091087|83129158|FG001|Overall Study|Not treated|0|||
46901651|NCT04091087|83129157|FG000|Overall Study|Adverse Event|4|||
46901652|NCT04091087|83129158|FG001|Overall Study|Adverse Event|4|||
46901653|NCT04091087|83129157|FG000|Overall Study|Protocol Violation|0|||
46901654|NCT04091087|83129158|FG001|Overall Study|Protocol Violation|1|||
46901655|NCT04091087|83129157|FG000|Overall Study|Withdrawal by Subject|5|||
46901656|NCT04091087|83129158|FG001|Overall Study|Withdrawal by Subject|2|||
46901657|NCT03400033|83129176|FG000|Overall Study|Withdrawal by Subject|1|||
46901658|NCT03400033|83129177|FG001|Overall Study|Withdrawal by Subject|2|||
46901659|NCT04089761|83129192|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
46901660|NCT04089761|83129192|FG000|"Run In Phase"|Lost to Follow-up|1|||
46901661|NCT04089761|83129192|FG000|"Treatment Phase"|No evaluable data|5|||
46901662|NCT04089761|83129192|FG000|"Treatment Phase"|Lost to Follow-up|1|||
46901663|NCT03118518|83129198|FG000|Overall Study|Early Exit after treatment|2|||
46901664|NCT03118518|83129199|FG001|Overall Study|Early Exit after treatment|8|||
46901665|NCT03118518|83129198|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
46901666|NCT03118518|83129199|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
46901667|NCT03984305|83129207|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
46901668|NCT03984305|83129208|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
46901669|NCT03984305|83129207|FG000|Overall Study|Withdrawal by Subject|3|||
46901670|NCT03984305|83129208|FG001|Overall Study|Withdrawal by Subject|3|||
46901671|NCT03984305|83129207|FG000|Overall Study|Lost to Follow-up|1|||
46901672|NCT03984305|83129208|FG001|Overall Study|Lost to Follow-up|0|||
46901673|NCT03397771|83129216|FG000|Overall Study|2 erroneously randomized, never treated|3|||
46901674|NCT03397771|83129217|FG001|Overall Study|2 erroneously randomized, never treated|1|||
46901675|NCT03397771|83129216|FG000|Overall Study|Withdrawal by Subject|1|||
46901676|NCT03397771|83129217|FG001|Overall Study|Withdrawal by Subject|3|||
46901677|NCT03397771|83129216|FG000|Overall Study|Protocol Violation|2|||
46901678|NCT03397771|83129217|FG001|Overall Study|Protocol Violation|2|||
46901679|NCT03397771|83129216|FG000|Overall Study|Adverse Event|2|||
46901680|NCT03397771|83129217|FG001|Overall Study|Adverse Event|1|||
46901681|NCT02876835|83129225|FG000|Treatment Period (51.1 Month)|Other|1|||
46901682|NCT02876835|83129226|FG001|Treatment Period (51.1 Month)|Other|0|||
46901683|NCT02876835|83129225|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
46901684|NCT02876835|83129226|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
46901685|NCT02876835|83129225|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
46901686|NCT02876835|83129226|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
46901687|NCT02876835|83129225|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
46901688|NCT02876835|83129226|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
46901689|NCT04086641|83129235|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
46901690|NCT04086641|83129236|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
46901691|NCT03503318|83129245|FG000|Overall Study|Death|1|||
46901692|NCT03503318|83129246|FG001|Overall Study|Death|0|||
46901693|NCT03503318|83129247|FG002|Overall Study|Death|4|||
46901694|NCT03503318|83129245|FG000|Overall Study|Adverse Event|3|||
46901695|NCT03503318|83129246|FG001|Overall Study|Adverse Event|4|||
46901696|NCT03503318|83129247|FG002|Overall Study|Adverse Event|2|||
46620174|NCT02270736|82761813|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
46620175|NCT02270736|82761809|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
46901697|NCT03503318|83129245|FG000|Overall Study|Withdrawal by Subject|12|||
46901698|NCT03503318|83129246|FG001|Overall Study|Withdrawal by Subject|17|||
46901699|NCT03503318|83129247|FG002|Overall Study|Withdrawal by Subject|16|||
46901700|NCT03503318|83129245|FG000|Overall Study|Protocol Violation|5|||
46901701|NCT03503318|83129246|FG001|Overall Study|Protocol Violation|0|||
46901702|NCT03503318|83129247|FG002|Overall Study|Protocol Violation|3|||
46901703|NCT03503318|83129245|FG000|Overall Study|Lost to Follow-up|17|||
46901704|NCT03503318|83129246|FG001|Overall Study|Lost to Follow-up|15|||
46901705|NCT03503318|83129247|FG002|Overall Study|Lost to Follow-up|12|||
46901706|NCT03503318|83129245|FG000|Overall Study|Other than specified|1|||
46901707|NCT03503318|83129246|FG001|Overall Study|Other than specified|3|||
46901708|NCT03503318|83129247|FG002|Overall Study|Other than specified|3|||
46901709|NCT03396913|83129257|FG000|Overall Study|Lost to Follow-up|0|||
46901710|NCT03396913|83129258|FG001|Overall Study|Lost to Follow-up|6|||
46901711|NCT03982433|83129264|FG000|Overall Study|Lost to Follow-up|1|||
46901712|NCT03396835|83129268|FG000|Overall Study|Withdrawn prior to completion|1|||
46901713|NCT03396835|83129268|FG000|Overall Study|Did not meet criteria for data analysis|1|||
46901714|NCT03121950|83129274|FG000|Overall Study|Withdrawal by Subject|11|||
46901715|NCT03121950|83129275|FG001|Overall Study|Withdrawal by Subject|2|||
46901716|NCT03395353|83129283|FG000|Overall Study|Adverse Event|20|||
46901717|NCT03395353|83129283|FG000|Overall Study|Protocol Violation|1|||
46901718|NCT03395353|83129283|FG000|Overall Study|Lack of Efficacy|3|||
46901719|NCT03395353|83129283|FG000|Overall Study|Withdrawal by Subject|24|||
46901720|NCT03395353|83129283|FG000|Overall Study|Discontinued visit|1|||
46901721|NCT03395353|83129283|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
46901722|NCT03395353|83129283|FG000|Overall Study|Physician Decision|4|||
46901723|NCT03395353|83129283|FG000|Overall Study|Early termination of overall study|33|||
46901724|NCT04082663|83129291|FG000|Overall Study|Adverse Event|6|||
46901725|NCT04082663|83129291|FG000|Overall Study|Lost to Follow-up|1|||
46901726|NCT03682367|83129297|FG000|Overall Study|Protocol Violation|2|||
46901727|NCT03682367|83129298|FG001|Overall Study|Protocol Violation|1|||
46901728|NCT03682367|83129297|FG000|Overall Study|Closed Study Early|0|||
46901729|NCT03682367|83129298|FG001|Overall Study|Closed Study Early|3|||
46901730|NCT03681353|83129304|FG000|Overall Study|Lost to Follow-up|2|||
46901731|NCT03681353|83129304|FG000|Overall Study|Withdrawal by Subject|3|||
46901732|NCT03681353|83129304|FG000|Overall Study|withdrawn by PI|2|||
46901733|NCT03394885|83129308|FG000|Overall Study|Adverse Event|4|||
46901734|NCT03394885|83129308|FG000|Overall Study|Lack of Efficacy|1|||
46901735|NCT03394885|83129308|FG000|Overall Study|Physician Decision|1|||
46901736|NCT03394885|83129308|FG000|Overall Study|Withdrawal by Subject|8|||
46901737|NCT03394885|83129308|FG000|Overall Study|Alternative Therapy|1|||
46901738|NCT02877927|83129314|FG000|Overall Study|Adverse Event|1|||
46901739|NCT02877927|83129315|FG001|Overall Study|Adverse Event|0|||
46901740|NCT02877927|83129314|FG000|Overall Study|Lost to Follow-up|37|||
46901741|NCT02877927|83129315|FG001|Overall Study|Lost to Follow-up|38|||
46901742|NCT02877927|83129314|FG000|Overall Study|Withdrawal by Subject|11|||
46901743|NCT02877927|83129315|FG001|Overall Study|Withdrawal by Subject|12|||
46901744|NCT02877927|83129314|FG000|Overall Study|Physician Decision|0|||
46901745|NCT02877927|83129315|FG001|Overall Study|Physician Decision|1|||
46901746|NCT02877927|83129314|FG000|Overall Study|Missed EOT/PTE Visit|5|||
46901747|NCT02877927|83129315|FG001|Overall Study|Missed EOT/PTE Visit|6|||
46901748|NCT02706886|83129330|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
46901749|NCT02706886|83129331|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
46901750|NCT02706886|83129332|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
46901751|NCT02706886|83129333|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
46901752|NCT02706886|83129334|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
46901753|NCT02706886|83129335|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
46901754|NCT02706886|83129336|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
46901755|NCT02706886|83129337|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
46996849|NCT02400476|83243797|FG001|Overall Study|Lost to Follow-up|0|||
46996850|NCT02400476|83243798|FG002|Overall Study|Lost to Follow-up|0|||
46901756|NCT02706886|83129338|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
46996851|NCT02400476|83243799|FG003|Overall Study|Lost to Follow-up|1|||
46996852|NCT02400476|83243800|FG004|Overall Study|Lost to Follow-up|3|||
46901757|NCT04069715|83129392|FG000|Overall Study|Lost to Follow-up|1|||
46901758|NCT04069715|83129393|FG001|Overall Study|Lost to Follow-up|1|||
46901759|NCT04069715|83129392|FG000|Overall Study|Physician Decision|1|||
46901760|NCT04069715|83129393|FG001|Overall Study|Physician Decision|1|||
46901761|NCT04069715|83129392|FG000|Overall Study|Withdrawal by Subject|3|||
46901762|NCT04069715|83129393|FG001|Overall Study|Withdrawal by Subject|3|||
46901763|NCT03681119|83129401|FG000|Overall Study|No specific reason|4|||
46901764|NCT03681119|83129402|FG001|Overall Study|No specific reason|0|||
46901765|NCT03681119|83129401|FG000|Overall Study|Sickness|2|||
46901766|NCT03681119|83129402|FG001|Overall Study|Sickness|0|||
46901767|NCT03111108|83129408|FG000|Overall Study|Death|0|||
46901768|NCT03111108|83129409|FG001|Overall Study|Death|1|||
46901769|NCT03111108|83129408|FG000|Overall Study|Withdrawal by Subject|1|||
46901770|NCT03111108|83129409|FG001|Overall Study|Withdrawal by Subject|0|||
46996853|NCT02400476|83243801|FG005|Overall Study|Lost to Follow-up|1|||
46901771|NCT03677375|83129415|FG000|Overall Study|Incomplete procedure|8|||
46901772|NCT03677375|83129415|FG000|Overall Study|Adverse Event|3|||
46901773|NCT03677375|83129415|FG000|Overall Study|Physician Decision|1|||
46901774|NCT00702520|83129421|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
46901775|NCT00702520|83129422|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
46901776|NCT00702520|83129423|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
46620176|NCT02270736|82761810|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
46620177|NCT02270736|82761811|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
46620178|NCT02270736|82761812|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
46620179|NCT02270736|82761813|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
46901777|NCT00702520|83129424|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
46901778|NCT00702520|83129421|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
46901779|NCT00702520|83129422|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
46901780|NCT00702520|83129423|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
46901781|NCT00702520|83129424|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
46901782|NCT00702520|83129421|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
46901783|NCT00702520|83129422|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
46901784|NCT00702520|83129423|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
46901785|NCT00702520|83129424|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
46901786|NCT04067141|83129434|FG000|First Intervention|Withdrawal by Subject|0|||
46901787|NCT04067141|83129435|FG001|First Intervention|Withdrawal by Subject|1|||
46901788|NCT04067141|83129434|FG000|Second Intervention|Adverse Event|0|||
46901789|NCT04067141|83129435|FG001|Second Intervention|Adverse Event|2|||
46901790|NCT02876601|83129445|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
46901791|NCT02876601|83129446|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
46901792|NCT02876601|83129447|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
46901793|NCT02876601|83129448|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
46901794|NCT04054193|83129493|FG000|Cycle 1|Physician Decision|1|||
46901795|NCT04054193|83129493|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
46901796|NCT04054193|83129493|FG000|Cycle 1|Allocated but not treated|3|||
46901797|NCT04054193|83129493|FG000|Cycles 2-3|Physician Decision|2|||
46901798|NCT04054193|83129493|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
46901799|NCT04054193|83129493|FG000|Cycles 2-3|Various reasons|17|||
46901800|NCT03394027|83129501|FG000|Overall Study|Ineligible|3|||
46901801|NCT03394027|83129502|FG001|Overall Study|Ineligible|1|||
46901802|NCT03394027|83129503|FG002|Overall Study|Ineligible|3|||
46901803|NCT03394027|83129501|FG000|Overall Study|Participant declined to participate before treatment started|0|||
46901804|NCT03394027|83129502|FG001|Overall Study|Participant declined to participate before treatment started|0|||
46901805|NCT03394027|83129503|FG002|Overall Study|Participant declined to participate before treatment started|1|||
46901806|NCT03136107|83129529|FG000|Overall Study|Other (Not specified)|1|||
46901807|NCT02916056|83129537|FG000|Overall Study|Adverse Event|6|||
46901808|NCT02916056|83129537|FG000|Overall Study|Lost to Follow-up|1|||
46901809|NCT02916056|83129537|FG000|Overall Study|Other|12|||
46901810|NCT02916056|83129537|FG000|Overall Study|Protocol Violation|1|||
46901811|NCT02916056|83129537|FG000|Overall Study|Withdrawal by Subject|8|||
46901812|NCT02916056|83129537|FG000|Overall Study|Study Terminated by Sponsor|269|||
46901813|NCT03384745|83129547|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
46901814|NCT03384745|83129548|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
46901815|NCT03384745|83129549|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
46901816|NCT03384745|83129550|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
46901817|NCT03384745|83129551|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
46901818|NCT03384745|83129552|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
46901819|NCT03384745|83129547|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
46901820|NCT03384745|83129548|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
46901821|NCT03384745|83129549|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
46901822|NCT03384745|83129550|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
46901823|NCT03384745|83129551|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
46901824|NCT03384745|83129552|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
46901825|NCT03384745|83129547|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
46901826|NCT03384745|83129548|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
46901827|NCT03384745|83129549|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
46901828|NCT03384745|83129550|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
46901829|NCT03384745|83129551|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
46901830|NCT03384745|83129552|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
46996854|NCT02400476|83243796|FG000|Overall Study|Physician Decision|0|||
46620180|NCT02270736|82761809|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
46901831|NCT03384745|83129547|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
46901832|NCT03384745|83129548|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
46996855|NCT02400476|83243797|FG001|Overall Study|Physician Decision|0|||
46901833|NCT03384745|83129549|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
46901834|NCT03384745|83129550|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
46901835|NCT03384745|83129551|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
46901836|NCT03384745|83129552|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
46901837|NCT03384745|83129547|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
46901838|NCT03384745|83129548|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
46901839|NCT03384745|83129549|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
46901840|NCT03384745|83129550|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
46901841|NCT03384745|83129551|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
46901842|NCT03384745|83129552|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
46901843|NCT03384745|83129547|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
46901844|NCT03384745|83129548|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
46901845|NCT03384745|83129549|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
46901846|NCT03384745|83129550|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
46901847|NCT03384745|83129551|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
46901848|NCT03384745|83129552|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
46901849|NCT03384745|83129547|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
46901850|NCT03384745|83129548|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
46901851|NCT03384745|83129549|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
46901852|NCT03384745|83129550|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
46901853|NCT03384745|83129551|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
46901854|NCT03384745|83129552|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
46901855|NCT03384745|83129547|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
46901856|NCT03384745|83129548|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
46901857|NCT03384745|83129549|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
46901858|NCT03384745|83129550|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
46901859|NCT03384745|83129551|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
46901860|NCT03384745|83129552|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
46901861|NCT03384745|83129547|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
46901862|NCT03384745|83129548|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
46901863|NCT03384745|83129549|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
46901864|NCT03384745|83129550|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
46901865|NCT03384745|83129551|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
46901866|NCT03384745|83129552|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
46901867|NCT03384745|83129547|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
46901868|NCT03384745|83129548|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
46901869|NCT03384745|83129549|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
46901870|NCT03384745|83129550|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
46901871|NCT03384745|83129551|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
46901872|NCT03384745|83129552|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
46901873|NCT03384745|83129547|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
46901874|NCT03384745|83129548|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
46901875|NCT03384745|83129549|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
46901876|NCT03384745|83129550|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
46901877|NCT03384745|83129551|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
46901878|NCT03384745|83129552|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
46901879|NCT03383887|83129572|FG000|Overall Study|Lost to Follow-up|0|||
46901880|NCT03383887|83129573|FG001|Overall Study|Lost to Follow-up|1|||
46901881|NCT03379753|83129581|FG000|Overall Study|Withdrawal by Subject|2|||
46901882|NCT03379753|83129582|FG001|Overall Study|Withdrawal by Subject|1|||
46901883|NCT03379753|83129581|FG000|Overall Study|not having correct procedure|1|||
46901884|NCT03379753|83129582|FG001|Overall Study|not having correct procedure|2|||
46901885|NCT03379753|83129581|FG000|Overall Study|No primary outcome|12|||
46901886|NCT03379753|83129582|FG001|Overall Study|No primary outcome|22|||
46901887|NCT03379675|83129591|FG000|Overall Study|Lost to Follow-up|0|||
46901888|NCT03379675|83129592|FG001|Overall Study|Lost to Follow-up|1|||
46901889|NCT03379675|83129593|FG002|Overall Study|Lost to Follow-up|0|||
46901890|NCT03379675|83129591|FG000|Overall Study|Adverse Event|2|||
46901891|NCT03379675|83129592|FG001|Overall Study|Adverse Event|0|||
46901892|NCT03379675|83129593|FG002|Overall Study|Adverse Event|0|||
46901893|NCT03379675|83129591|FG000|Overall Study|Withdrawal by Subject|2|||
46901894|NCT03379675|83129592|FG001|Overall Study|Withdrawal by Subject|1|||
46901895|NCT03379675|83129593|FG002|Overall Study|Withdrawal by Subject|2|||
46709140|NCT01897571|82925082|FG010|Overall Study|Death|59|||
46709141|NCT01559935|82925114|FG000|Car Phase|Toxicity|4|||
46901896|NCT02930889|83129601|FG000|Overall Study|Lost to Follow-up|2|||
46901897|NCT02930889|83129601|FG000|Overall Study|Withdrawal by Subject|6|||
46996856|NCT02400476|83243798|FG002|Overall Study|Physician Decision|1|||
46709142|NCT01559935|82925114|FG000|Car Phase|Death|1|||
46709143|NCT01559935|82925114|FG000|Car Phase|Lack of Efficacy|2|||
46709144|NCT01559935|82925114|FG000|Car Phase|Lost to Follow-up|1|||
46901898|NCT02930889|83129601|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
46901899|NCT02875977|83129607|FG000|Overall Study|Lost to Follow-up|42|||
46901900|NCT02875977|83129608|FG001|Overall Study|Lost to Follow-up|29|||
46901901|NCT02703532|83129627|FG000|Overall Study|Withdrawal by Subject|0|||
46901902|NCT02703532|83129628|FG001|Overall Study|Withdrawal by Subject|1|||
46901903|NCT02703532|83129629|FG002|Overall Study|Withdrawal by Subject|0|||
46901904|NCT02703532|83129630|FG003|Overall Study|Withdrawal by Subject|1|||
46901905|NCT02703532|83129627|FG000|Overall Study|Lost to Follow-up|2|||
46901906|NCT02703532|83129628|FG001|Overall Study|Lost to Follow-up|0|||
46901907|NCT02703532|83129629|FG002|Overall Study|Lost to Follow-up|2|||
46901908|NCT02703532|83129630|FG003|Overall Study|Lost to Follow-up|0|||
46901909|NCT02930343|83129663|FG000|Overall Study|Lost to Follow-up|9|||
46901910|NCT02930343|83129664|FG001|Overall Study|Lost to Follow-up|7|||
46901911|NCT02703454|83129672|FG000|Overall Study|Not treated|1|||
46901912|NCT02703454|83129673|FG001|Overall Study|Not treated|3|||
46901913|NCT02703454|83129672|FG000|Overall Study|Withdrawal by Subject|4|||
46901914|NCT02703454|83129673|FG001|Overall Study|Withdrawal by Subject|3|||
46901915|NCT02703454|83129672|FG000|Overall Study|Lost to Follow-up|1|||
46901916|NCT02703454|83129673|FG001|Overall Study|Lost to Follow-up|2|||
46901917|NCT02703454|83129672|FG000|Overall Study|Study discontinuation|5|||
46901918|NCT02703454|83129673|FG001|Overall Study|Study discontinuation|8|||
46901919|NCT03103542|83129679|FG000|Overall Study|Physician Decision|2|||
46901920|NCT03103542|83129679|FG000|Overall Study|Adverse Event|2|||
46901921|NCT03103542|83129679|FG000|Overall Study|Other|2|||
46901922|NCT03103542|83129679|FG000|Overall Study|Withdrawal by Subject|1|||
46901923|NCT03376321|83129706|FG000|Overall Study|Other|5|||
46901924|NCT03376321|83129707|FG001|Overall Study|Other|1|||
46901925|NCT03376321|83129706|FG000|Overall Study|Withdrawal by Subject|8|||
46901926|NCT03376321|83129707|FG001|Overall Study|Withdrawal by Subject|14|||
46901927|NCT03376321|83129706|FG000|Overall Study|Lost to Follow-up|1|||
46901928|NCT03376321|83129707|FG001|Overall Study|Lost to Follow-up|7|||
46901929|NCT03376321|83129706|FG000|Overall Study|Death|4|||
46901930|NCT03376321|83129707|FG001|Overall Study|Death|0|||
46901931|NCT03376321|83129706|FG000|Overall Study|Randomized, not treated|5|||
46901932|NCT03376321|83129707|FG001|Overall Study|Randomized, not treated|3|||
46901933|NCT03374995|83129715|FG000|Overall Study|Withdrawal by Subject|0|||
46901934|NCT03374995|83129716|FG001|Overall Study|Withdrawal by Subject|1|||
46901935|NCT02828982|83129722|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46901936|NCT02828982|83129723|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46901937|NCT03133767|83129733|FG000|Overall Study|Lost to Follow-up|38|||
46901938|NCT03133767|83129734|FG001|Overall Study|Lost to Follow-up|24|||
46901939|NCT03133767|83129733|FG000|Overall Study|Protocol Violation|0|||
46901940|NCT03133767|83129734|FG001|Overall Study|Protocol Violation|1|||
46901941|NCT03391765|83129744|FG000|Overall Study|Adverse Event|2|||
46901942|NCT03391765|83129745|FG001|Overall Study|Adverse Event|0|||
46901943|NCT03391765|83129746|FG002|Overall Study|Adverse Event|0|||
46901944|NCT03391765|83129747|FG003|Overall Study|Adverse Event|2|||
46996857|NCT02400476|83243799|FG003|Overall Study|Physician Decision|1|||
46996858|NCT02400476|83243800|FG004|Overall Study|Physician Decision|0|||
46996859|NCT02400476|83243801|FG005|Overall Study|Physician Decision|1|||
46996860|NCT02400476|83243796|FG000|Overall Study|Other, Disease Progression|0|||
46996861|NCT02400476|83243797|FG001|Overall Study|Other, Disease Progression|1|||
46996862|NCT02400476|83243798|FG002|Overall Study|Other, Disease Progression|2|||
46996863|NCT02400476|83243799|FG003|Overall Study|Other, Disease Progression|1|||
46996864|NCT02400476|83243800|FG004|Overall Study|Other, Disease Progression|2|||
46996865|NCT02400476|83243801|FG005|Overall Study|Other, Disease Progression|1|||
46996866|NCT02400476|83243796|FG000|Overall Study|Other, Decreased Quality of Life|0|||
46996867|NCT02400476|83243797|FG001|Overall Study|Other, Decreased Quality of Life|0|||
46901945|NCT03391765|83129744|FG000|Overall Study|Withdrew consent|5|||
46901946|NCT03391765|83129745|FG001|Overall Study|Withdrew consent|7|||
46901947|NCT03391765|83129746|FG002|Overall Study|Withdrew consent|2|||
46901948|NCT03391765|83129747|FG003|Overall Study|Withdrew consent|5|||
46901949|NCT03391765|83129744|FG000|Overall Study|Other, not specified|44|||
46901950|NCT03391765|83129745|FG001|Overall Study|Other, not specified|38|||
46901951|NCT03391765|83129746|FG002|Overall Study|Other, not specified|21|||
46901952|NCT03391765|83129747|FG003|Overall Study|Other, not specified|16|||
46996868|NCT02400476|83243798|FG002|Overall Study|Other, Decreased Quality of Life|2|||
46996869|NCT02400476|83243799|FG003|Overall Study|Other, Decreased Quality of Life|0|||
46901953|NCT02802228|83129759|FG000|Overall Study|Withdrawal by Subject|2|||
46901954|NCT02802228|83129760|FG001|Overall Study|Withdrawal by Subject|0|||
46901955|NCT02802228|83129759|FG000|Overall Study|Lost to Follow-up|1|||
46901956|NCT02802228|83129760|FG001|Overall Study|Lost to Follow-up|0|||
46901957|NCT02802228|83129759|FG000|Overall Study|Adverse Event|1|||
46996870|NCT02400476|83243800|FG004|Overall Study|Other, Decreased Quality of Life|0|||
46996871|NCT02400476|83243801|FG005|Overall Study|Other, Decreased Quality of Life|0|||
46996872|NCT02400476|83243796|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
46901958|NCT02802228|83129760|FG001|Overall Study|Adverse Event|0|||
46901959|NCT02802228|83129759|FG000|Overall Study|Physician Decision|1|||
46901960|NCT02802228|83129760|FG001|Overall Study|Physician Decision|0|||
46901961|NCT03130257|83129769|FG000|Overall Study|Withdrawal by Subject|1|||
46901962|NCT03130257|83129770|FG001|Overall Study|Withdrawal by Subject|0|||
46901963|NCT03130257|83129771|FG002|Overall Study|Withdrawal by Subject|2|||
46901964|NCT03674177|83129783|FG000|Overall Study|Lost to Follow-up|2|||
46901965|NCT03674177|83129784|FG001|Overall Study|Lost to Follow-up|1|||
46901966|NCT03674177|83129785|FG002|Overall Study|Lost to Follow-up|0|||
46901967|NCT03674177|83129786|FG003|Overall Study|Lost to Follow-up|2|||
46901968|NCT03354637|83129812|FG000|Double-blind Period|Protocol Violation|2|||
46901969|NCT03354637|83129813|FG001|Double-blind Period|Protocol Violation|0|||
46901970|NCT03354637|83129814|FG002|Double-blind Period|Protocol Violation|0|||
46901971|NCT03354637|83129812|FG000|Double-blind Period|Adverse Event|1|||
46901972|NCT03354637|83129813|FG001|Double-blind Period|Adverse Event|2|||
46901973|NCT03354637|83129814|FG002|Double-blind Period|Adverse Event|0|||
46901974|NCT03354637|83129812|FG000|Double-blind Period|Lost to Follow-up|3|||
46901975|NCT03354637|83129813|FG001|Double-blind Period|Lost to Follow-up|4|||
46901976|NCT03354637|83129814|FG002|Double-blind Period|Lost to Follow-up|3|||
46901977|NCT03354637|83129812|FG000|Double-blind Period|Withdrawal by Subject|10|||
46901978|NCT03354637|83129813|FG001|Double-blind Period|Withdrawal by Subject|6|||
46901979|NCT03354637|83129814|FG002|Double-blind Period|Withdrawal by Subject|4|||
46901980|NCT03354637|83129812|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
46901981|NCT03354637|83129813|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
46901982|NCT03354637|83129814|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
46901983|NCT03354637|83129812|FG000|Open Label Extension|Adverse Event|0|||
46901984|NCT03354637|83129813|FG001|Open Label Extension|Adverse Event|0|||
46901985|NCT03354637|83129814|FG002|Open Label Extension|Adverse Event|1|||
46901986|NCT03354637|83129812|FG000|Open Label Extension|Lost to Follow-up|0|||
46901987|NCT03354637|83129813|FG001|Open Label Extension|Lost to Follow-up|0|||
46901988|NCT03354637|83129814|FG002|Open Label Extension|Lost to Follow-up|2|||
46901989|NCT03354637|83129812|FG000|Open Label Extension|Withdrawal by Subject|0|||
46901990|NCT03354637|83129813|FG001|Open Label Extension|Withdrawal by Subject|0|||
46901991|NCT03354637|83129814|FG002|Open Label Extension|Withdrawal by Subject|5|||
46901992|NCT03354637|83129812|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
46901993|NCT03354637|83129813|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
46901994|NCT03354637|83129814|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
46901995|NCT03354637|83129812|FG000|Open Label Extension|Subject Noncompliance|0|||
46901996|NCT03354637|83129813|FG001|Open Label Extension|Subject Noncompliance|0|||
46901997|NCT03354637|83129814|FG002|Open Label Extension|Subject Noncompliance|1|||
46901998|NCT03354637|83129812|FG000|Open Label Extension|Lack of Efficacy|0|||
46996873|NCT02400476|83243797|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
46996874|NCT02400476|83243798|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
46996875|NCT02400476|83243799|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
46901999|NCT03354637|83129813|FG001|Open Label Extension|Lack of Efficacy|0|||
46902000|NCT03354637|83129814|FG002|Open Label Extension|Lack of Efficacy|1|||
46902001|NCT03354637|83129812|FG000|Open Label Extension|Physician Decision|0|||
46902002|NCT03354637|83129813|FG001|Open Label Extension|Physician Decision|0|||
46902003|NCT03354637|83129814|FG002|Open Label Extension|Physician Decision|1|||
46902004|NCT04053023|83129825|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
46902005|NCT04053023|83129826|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
46902006|NCT03352453|83129838|FG000|Overall Study|Miscellaneous Reasons|1|||
46902007|NCT03352453|83129839|FG001|Overall Study|Miscellaneous Reasons|2|||
46902008|NCT03352453|83129838|FG000|Overall Study|Lack of Efficacy|1|||
46902009|NCT03352453|83129839|FG001|Overall Study|Lack of Efficacy|0|||
46902010|NCT03352453|83129838|FG000|Overall Study|Withdrawal by Subject|8|||
46902011|NCT03352453|83129839|FG001|Overall Study|Withdrawal by Subject|14|||
46902012|NCT03352453|83129838|FG000|Overall Study|Study Terminated by Sponsor|2|||
46902013|NCT03352453|83129839|FG001|Overall Study|Study Terminated by Sponsor|1|||
46902014|NCT03352453|83129838|FG000|Overall Study|Protocol Deviation|1|||
46902015|NCT03352453|83129839|FG001|Overall Study|Protocol Deviation|0|||
46902016|NCT03352453|83129838|FG000|Overall Study|Lost to Follow-up|7|||
46902017|NCT03352453|83129839|FG001|Overall Study|Lost to Follow-up|6|||
46902018|NCT03352453|83129838|FG000|Overall Study|Adverse Event|2|||
46902019|NCT03352453|83129839|FG001|Overall Study|Adverse Event|9|||
46902020|NCT03128931|83129845|FG000|Overall Study|Physician Decision|1|||
46902021|NCT03128931|83129845|FG000|Overall Study|Equipment Issues|3|||
46902022|NCT03107052|83129852|FG000|Overall Study|Adverse Event|6|||
46902023|NCT03107052|83129853|FG001|Overall Study|Adverse Event|1|||
46902024|NCT03107052|83129854|FG002|Overall Study|Adverse Event|2|||
46902025|NCT03107052|83129852|FG000|Overall Study|Withdrawal by Subject|9|||
46902026|NCT03107052|83129853|FG001|Overall Study|Withdrawal by Subject|5|||
46902027|NCT03107052|83129854|FG002|Overall Study|Withdrawal by Subject|8|||
46902028|NCT03107052|83129852|FG000|Overall Study|Protocol Violation|6|||
46902029|NCT03107052|83129853|FG001|Overall Study|Protocol Violation|0|||
46709145|NCT01559935|82925114|FG000|Car Phase|Physician Decision|1|||
46902030|NCT03107052|83129854|FG002|Overall Study|Protocol Violation|3|||
46902031|NCT03107052|83129852|FG000|Overall Study|Lost to Follow-up|4|||
46902032|NCT03107052|83129853|FG001|Overall Study|Lost to Follow-up|0|||
46902033|NCT03107052|83129854|FG002|Overall Study|Lost to Follow-up|1|||
46902034|NCT03107052|83129852|FG000|Overall Study|Lack of Efficacy|23|||
46902035|NCT03107052|83129853|FG001|Overall Study|Lack of Efficacy|7|||
46902036|NCT03107052|83129854|FG002|Overall Study|Lack of Efficacy|4|||
46902037|NCT03107052|83129852|FG000|Overall Study|Other than specified|4|||
46902038|NCT03107052|83129853|FG001|Overall Study|Other than specified|2|||
46902039|NCT03107052|83129854|FG002|Overall Study|Other than specified|0|||
46902040|NCT03107052|83129852|FG000|Overall Study|Study terminated due to futility|67|||
46902041|NCT03107052|83129853|FG001|Overall Study|Study terminated due to futility|31|||
46902042|NCT03107052|83129854|FG002|Overall Study|Study terminated due to futility|23|||
46902043|NCT04050371|83129864|FG000|Overall Study|Withdrawal by Subject|1|||
46902044|NCT04050371|83129865|FG001|Overall Study|Withdrawal by Subject|0|||
46902045|NCT04447287|83129874|FG000|Period 1: Run-in Period|Adverse Event|3|||
46902046|NCT04447287|83129875|FG001|Period 1: Run-in Period|Adverse Event|0|||
46902047|NCT04447287|83129876|FG002|Period 1: Run-in Period|Adverse Event|0|||
46902048|NCT04447287|83129874|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
46902049|NCT04447287|83129875|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
46902050|NCT04447287|83129876|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
46902051|NCT04447287|83129874|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
46902052|NCT04447287|83129875|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
46902053|NCT04447287|83129876|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
46902054|NCT01879319|83129897|FG000|Overall Study|Withdrawal by Subject|1|||
46902055|NCT01879319|83129898|FG001|Overall Study|Withdrawal by Subject|0|||
46902056|NCT01879319|83129897|FG000|Overall Study|Lost to Follow-up|1|||
46902057|NCT01879319|83129898|FG001|Overall Study|Lost to Follow-up|5|||
46902058|NCT03102918|83129906|FG000|Overall Study|Protocol Violation|1|||
46902059|NCT03102918|83129907|FG001|Overall Study|Protocol Violation|0|||
46902060|NCT03128307|83129913|FG000|Overall Study|Lost to Follow-up|29|||
46902061|NCT03128307|83129913|FG000|Overall Study|Withdrawal by Subject|5|||
46902062|NCT03102762|83129919|FG000|Overall Study|Lost to Follow-up|1|||
46902063|NCT03102762|83129920|FG001|Overall Study|Lost to Follow-up|0|||
46902064|NCT01346475|83129933|FG000|First Intervention|Lost to Follow-up|4|||
46902065|NCT01346475|83129934|FG001|First Intervention|Lost to Follow-up|3|||
46902066|NCT01338636|83129940|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
46902067|NCT00322218|83129946|FG000|Overall Study|Death|3|||
46902068|NCT00322218|83129947|FG001|Overall Study|Death|6|||
46902069|NCT02873754|83129953|FG000|Overall Study|Lost to Follow-up|5|||
46902070|NCT02873754|83129953|FG000|Overall Study|Couldn't complete study procedures|1|||
46902071|NCT03287414|83129959|FG000|Treatment Epoch|Adverse Event|0|||
46902072|NCT03287414|83129960|FG001|Treatment Epoch|Adverse Event|1|||
46902073|NCT03287414|83129959|FG000|Treatment Epoch|Study terminated by sponsor|2|||
46902074|NCT03287414|83129960|FG001|Treatment Epoch|Study terminated by sponsor|2|||
46902075|NCT03287414|83129959|FG000|Treatment Epoch|Subject/Guardian decision|4|||
46902076|NCT03287414|83129960|FG001|Treatment Epoch|Subject/Guardian decision|0|||
46902077|NCT03287414|83129959|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
46902078|NCT03287414|83129960|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
46902079|NCT03287414|83129959|FG000|Treatment Epoch|Withdrawal by Subject|1|||
46902080|NCT03287414|83129960|FG001|Treatment Epoch|Withdrawal by Subject|0|||
46902081|NCT03287414|83129959|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
46996876|NCT02400476|83243800|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
46902082|NCT03287414|83129960|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
46902083|NCT03287414|83129959|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
46902084|NCT03287414|83129960|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
46902085|NCT03101592|83129990|FG000|Overall Study|participant files could not be located|111|||
46902086|NCT03101592|83129991|FG001|Overall Study|participant files could not be located|170|||
46902087|NCT03101592|83129992|FG002|Overall Study|participant files could not be located|118|||
46902088|NCT04046939|83130010|FG000|Primary Assessment Period|Adverse Event|1|||
46902089|NCT04046939|83130011|FG001|Primary Assessment Period|Adverse Event|0|||
46902090|NCT04046939|83130012|FG002|Primary Assessment Period|Adverse Event|0|||
46996877|NCT02400476|83243801|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
46996878|NCT02363738|83243817|FG000|Overall Study|Adverse Event|5|||
46996879|NCT02363738|83243818|FG001|Overall Study|Adverse Event|2|||
46996880|NCT02363738|83243817|FG000|Overall Study|Lack of Efficacy|1|||
46996881|NCT02363738|83243818|FG001|Overall Study|Lack of Efficacy|2|||
46902091|NCT04046939|83130013|FG003|Primary Assessment Period|Adverse Event|0|||
46902092|NCT04046939|83130010|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
46996882|NCT02363738|83243817|FG000|Overall Study|Lost to Follow-up|2|||
46902093|NCT04046939|83130011|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
46902094|NCT04046939|83130012|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
46902095|NCT04046939|83130013|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
46902096|NCT04046939|83130010|FG000|Primary Assessment Period|Physician Decision|0|||
46902097|NCT04046939|83130011|FG001|Primary Assessment Period|Physician Decision|0|||
46902098|NCT04046939|83130012|FG002|Primary Assessment Period|Physician Decision|1|||
46902099|NCT04046939|83130013|FG003|Primary Assessment Period|Physician Decision|0|||
46902100|NCT04046939|83130010|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
46902101|NCT04046939|83130011|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
46902102|NCT04046939|83130012|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
46902103|NCT04046939|83130013|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
46902104|NCT04042103|83130029|FG000|Overall Study|Lost to Follow-up|1|||
46902105|NCT04042103|83130029|FG000|Overall Study|Withdrawal by Subject|1|||
46902106|NCT02955797|83130037|FG000|Overall Study|Protocol Violation|1|||
46902107|NCT02955797|83130038|FG001|Overall Study|Protocol Violation|0|||
46902108|NCT02955797|83130039|FG002|Overall Study|Protocol Violation|0|||
46902109|NCT02955797|83130040|FG003|Overall Study|Protocol Violation|1|||
46902110|NCT02955797|83130037|FG000|Overall Study|Withdrawal by Subject|2|||
46902111|NCT02955797|83130038|FG001|Overall Study|Withdrawal by Subject|2|||
46902112|NCT02955797|83130039|FG002|Overall Study|Withdrawal by Subject|0|||
46902113|NCT02955797|83130040|FG003|Overall Study|Withdrawal by Subject|1|||
46902114|NCT02955797|83130037|FG000|Overall Study|Lost to Follow-up|0|||
46902115|NCT02955797|83130038|FG001|Overall Study|Lost to Follow-up|1|||
46902116|NCT02955797|83130039|FG002|Overall Study|Lost to Follow-up|0|||
46902117|NCT02955797|83130040|FG003|Overall Study|Lost to Follow-up|0|||
46902118|NCT03101514|83130053|FG000|Overall Study|Withdrawal by Subject|4|||
46902119|NCT03101514|83130053|FG000|Overall Study|Protocol Violation|2|||
46902120|NCT03101514|83130053|FG000|Overall Study|patient's information was incomplete|1|||
46902121|NCT02702518|83130059|FG000|Overall Study|Lost to Follow-up|3|||
46902122|NCT02702518|83130060|FG001|Overall Study|Lost to Follow-up|4|||
46902123|NCT04039503|83130070|FG000|Overall Study|Adverse Event|3|||
46902124|NCT04039503|83130071|FG001|Overall Study|Adverse Event|0|||
46902125|NCT04039503|83130072|FG002|Overall Study|Adverse Event|2|||
46902126|NCT04039503|83130073|FG003|Overall Study|Adverse Event|0|||
46902127|NCT04039503|83130070|FG000|Overall Study|Lost to Follow-up|0|||
46902128|NCT04039503|83130071|FG001|Overall Study|Lost to Follow-up|0|||
46902129|NCT04039503|83130072|FG002|Overall Study|Lost to Follow-up|1|||
46902130|NCT04039503|83130073|FG003|Overall Study|Lost to Follow-up|0|||
46902131|NCT04039503|83130070|FG000|Overall Study|Protocol Violation|0|||
46902132|NCT04039503|83130071|FG001|Overall Study|Protocol Violation|1|||
46902133|NCT04039503|83130072|FG002|Overall Study|Protocol Violation|2|||
46902134|NCT04039503|83130073|FG003|Overall Study|Protocol Violation|1|||
46902135|NCT04039503|83130070|FG000|Overall Study|Withdrawal by Subject|4|||
46902136|NCT04039503|83130071|FG001|Overall Study|Withdrawal by Subject|3|||
46902137|NCT04039503|83130072|FG002|Overall Study|Withdrawal by Subject|5|||
46902138|NCT04039503|83130073|FG003|Overall Study|Withdrawal by Subject|2|||
46902139|NCT03131895|83130110|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
46902140|NCT03131895|83130111|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
46902141|NCT03131895|83130112|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
46902142|NCT03131895|83130113|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
46902143|NCT03131895|83130110|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
46902144|NCT03131895|83130111|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
46902145|NCT03131895|83130112|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
46902146|NCT03131895|83130113|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
46902147|NCT03131895|83130110|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46902148|NCT03131895|83130111|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
46902149|NCT03131895|83130112|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46902150|NCT03131895|83130113|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
46902151|NCT03131895|83130110|FG000|Washout Period (at Least 5 Days)|Other|0|||
46902152|NCT03131895|83130111|FG001|Washout Period (at Least 5 Days)|Other|0|||
46902153|NCT03131895|83130112|FG002|Washout Period (at Least 5 Days)|Other|2|||
46902154|NCT03131895|83130113|FG003|Washout Period (at Least 5 Days)|Other|0|||
46902155|NCT03131895|83130110|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
46902156|NCT03131895|83130111|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
46902157|NCT03131895|83130112|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
46902158|NCT03131895|83130113|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
46902159|NCT03131895|83130110|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
46902160|NCT03131895|83130111|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
46902161|NCT03131895|83130112|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
46902162|NCT03131895|83130113|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
46902163|NCT04039919|83130128|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46902164|NCT04039919|83130129|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46902165|NCT04039919|83130130|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46902166|NCT04039919|83130131|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46902167|NCT04039919|83130132|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46902168|NCT04039919|83130128|FG000|Treatment Period 1|Sponsor's decision|0|||
46902169|NCT04039919|83130129|FG001|Treatment Period 1|Sponsor's decision|0|||
46902170|NCT04039919|83130130|FG002|Treatment Period 1|Sponsor's decision|0|||
46902171|NCT04039919|83130131|FG003|Treatment Period 1|Sponsor's decision|0|||
46902172|NCT04039919|83130132|FG004|Treatment Period 1|Sponsor's decision|16|||
46902173|NCT04039919|83130128|FG000|Treatment Period 5|Withdrawal by Subject|1|||
46902174|NCT04039919|83130129|FG001|Treatment Period 5|Withdrawal by Subject|0|||
46902175|NCT04039919|83130130|FG002|Treatment Period 5|Withdrawal by Subject|0|||
46902176|NCT04039919|83130131|FG003|Treatment Period 5|Withdrawal by Subject|0|||
46902177|NCT04039919|83130132|FG004|Treatment Period 5|Withdrawal by Subject|0|||
46902178|NCT04035473|83130168|FG000|Screening/Baseline|Death|0|||
46902179|NCT04035473|83130169|FG001|Screening/Baseline|Death|1|||
46902180|NCT04035473|83130168|FG000|Screening/Baseline|Adverse Event|0|||
46902181|NCT04035473|83130169|FG001|Screening/Baseline|Adverse Event|1|||
46902182|NCT04035473|83130168|FG000|Follow-up Period|Adverse Event|2|||
46902183|NCT04035473|83130169|FG001|Follow-up Period|Adverse Event|0|||
46902184|NCT04032977|83130177|FG000|Overall Study|Withdrawal by Subject|6|||
46902185|NCT04032977|83130178|FG001|Overall Study|Withdrawal by Subject|1|||
46902186|NCT04032977|83130177|FG000|Overall Study|Lost to Follow-up|2|||
46902187|NCT04032977|83130178|FG001|Overall Study|Lost to Follow-up|7|||
46902188|NCT04032977|83130177|FG000|Overall Study|Pregnancy|1|||
46902189|NCT04032977|83130178|FG001|Overall Study|Pregnancy|0|||
46902190|NCT04030247|83130184|FG000|Overall Study|Withdrawal by Subject|4|||
46902191|NCT04030247|83130184|FG000|Overall Study|Lost to Follow-up|13|||
46902192|NCT02915978|83130191|FG000|Overall Study|Adverse Event|2|||
46902193|NCT02915978|83130192|FG001|Overall Study|Adverse Event|1|||
46902194|NCT02915978|83130193|FG002|Overall Study|Adverse Event|0|||
46902195|NCT02701192|83130201|FG000|Overall Study|Protocol Violation|2|||
46902196|NCT02701192|83130201|FG000|Overall Study|Lost to Follow-up|4|||
46902197|NCT03101358|83130209|FG000|Overall Study|Non-compliance with study schedule|1|||
46902198|NCT03101358|83130210|FG001|Overall Study|Non-compliance with study schedule|0|||
46902199|NCT03101358|83130211|FG002|Overall Study|Non-compliance with study schedule|0|||
46902200|NCT03101358|83130212|FG003|Overall Study|Non-compliance with study schedule|1|||
46902201|NCT03101358|83130209|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
46902202|NCT03101358|83130210|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
46902203|NCT03101358|83130211|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
46902204|NCT03101358|83130212|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
46902205|NCT03101358|83130209|FG000|Overall Study|Physician Decision|1|||
46902206|NCT03101358|83130210|FG001|Overall Study|Physician Decision|0|||
46902207|NCT03101358|83130211|FG002|Overall Study|Physician Decision|0|||
46902208|NCT03101358|83130212|FG003|Overall Study|Physician Decision|3|||
46902209|NCT03101358|83130209|FG000|Overall Study|Adverse Event|0|||
46902210|NCT03101358|83130210|FG001|Overall Study|Adverse Event|0|||
46902211|NCT03101358|83130211|FG002|Overall Study|Adverse Event|1|||
46902212|NCT03101358|83130212|FG003|Overall Study|Adverse Event|0|||
46902213|NCT03101358|83130209|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
46902214|NCT03101358|83130210|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
46902215|NCT03101358|83130211|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
46902216|NCT03101358|83130212|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
46902217|NCT03101358|83130209|FG000|Overall Study|Lost to Follow-up|1|||
46902218|NCT03101358|83130210|FG001|Overall Study|Lost to Follow-up|0|||
46902219|NCT03101358|83130211|FG002|Overall Study|Lost to Follow-up|0|||
46902220|NCT03101358|83130212|FG003|Overall Study|Lost to Follow-up|1|||
46902221|NCT03657095|83130225|FG000|Overall Study|Withdrawal by Subject|1|||
46902222|NCT03657095|83130226|FG001|Overall Study|Withdrawal by Subject|1|||
46902223|NCT03657095|83130225|FG000|Overall Study|Adverse Event|0|||
46902224|NCT03657095|83130226|FG001|Overall Study|Adverse Event|3|||
46902225|NCT03657095|83130225|FG000|Overall Study|Study Terminated by Sponsor|58|||
46902226|NCT03657095|83130226|FG001|Overall Study|Study Terminated by Sponsor|49|||
46902227|NCT03100344|83130236|FG000|Overall Study|Adverse Event|0|||
46902228|NCT03100344|83130237|FG001|Overall Study|Adverse Event|3|||
46902229|NCT03100344|83130238|FG002|Overall Study|Adverse Event|2|||
46902230|NCT03100344|83130239|FG003|Overall Study|Adverse Event|3|||
46902231|NCT03100344|83130236|FG000|Overall Study|Lack of Efficacy|2|||
46902232|NCT03100344|83130237|FG001|Overall Study|Lack of Efficacy|0|||
46902233|NCT03100344|83130238|FG002|Overall Study|Lack of Efficacy|0|||
46902234|NCT03100344|83130239|FG003|Overall Study|Lack of Efficacy|0|||
46902235|NCT03100344|83130236|FG000|Overall Study|Protocol Violation|1|||
46709146|NCT01559935|82925114|FG000|Car Phase|Withdrawal by Subject|2|||
46902236|NCT03100344|83130237|FG001|Overall Study|Protocol Violation|0|||
46902237|NCT03100344|83130238|FG002|Overall Study|Protocol Violation|0|||
46902238|NCT03100344|83130239|FG003|Overall Study|Protocol Violation|0|||
46902239|NCT03100344|83130236|FG000|Overall Study|Withdrawal by Subject|10|||
46902240|NCT03100344|83130237|FG001|Overall Study|Withdrawal by Subject|7|||
46902241|NCT03100344|83130238|FG002|Overall Study|Withdrawal by Subject|4|||
46902242|NCT03100344|83130239|FG003|Overall Study|Withdrawal by Subject|8|||
46902243|NCT03100344|83130236|FG000|Overall Study|Lost to Follow-up|1|||
46902244|NCT03100344|83130237|FG001|Overall Study|Lost to Follow-up|1|||
46902245|NCT03100344|83130238|FG002|Overall Study|Lost to Follow-up|1|||
46902246|NCT03100344|83130239|FG003|Overall Study|Lost to Follow-up|1|||
46902247|NCT02951533|83130252|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
46902248|NCT02951533|83130253|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
46902249|NCT02951533|83130254|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
46902250|NCT02951533|83130252|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
46902251|NCT02951533|83130253|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
46902252|NCT02951533|83130254|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
46902253|NCT02951533|83130252|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
46902254|NCT02951533|83130253|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
46902255|NCT02951533|83130254|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
46902256|NCT02951533|83130252|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
46902257|NCT02951533|83130253|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
46902258|NCT02951533|83130254|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
46902259|NCT02951533|83130252|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
46902260|NCT02951533|83130253|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
46902261|NCT02951533|83130254|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
46902262|NCT02951533|83130252|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
46902263|NCT02951533|83130253|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
46902264|NCT02951533|83130254|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
46902265|NCT02951533|83130252|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
46902266|NCT02951533|83130253|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
46902267|NCT02951533|83130254|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
46902268|NCT02951533|83130252|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
46902269|NCT02951533|83130253|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
46902270|NCT02951533|83130254|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
46902271|NCT02951533|83130252|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
46902272|NCT02951533|83130253|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
46902273|NCT02951533|83130254|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
46902274|NCT02951533|83130252|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
46902275|NCT02951533|83130253|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
46902276|NCT02951533|83130254|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
46902277|NCT02951533|83130252|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
46902278|NCT02951533|83130253|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
46902279|NCT02951533|83130254|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
46902280|NCT02700412|83130271|FG000|Overall Study|Adverse Event|6|||
46902281|NCT02700412|83130271|FG000|Overall Study|Death|1|||
46902282|NCT02700412|83130271|FG000|Overall Study|Lack of Efficacy|19|||
46902283|NCT02700412|83130271|FG000|Overall Study|Protocol Violation|5|||
46902284|NCT02700412|83130271|FG000|Overall Study|Withdrawal by Subject|2|||
46902285|NCT03665441|83130277|FG000|Overall Study|survival follow up ongoing|23|||
46902286|NCT03665441|83130278|FG001|Overall Study|survival follow up ongoing|0|||
46902287|NCT03665441|83130277|FG000|Overall Study|Patients ongoing on treatment|9|||
46902288|NCT03665441|83130278|FG001|Overall Study|Patients ongoing on treatment|6|||
46902289|NCT03665441|83130277|FG000|Overall Study|Randomized but not treated|7|||
46902290|NCT03665441|83130278|FG001|Overall Study|Randomized but not treated|11|||
46902291|NCT02699866|83130284|FG000|Overall Study|Withdrawal by Subject|3|||
46902292|NCT02699866|83130284|FG000|Overall Study|Physician Decision|2|||
46902293|NCT02699866|83130284|FG000|Overall Study|Adverse Event|3|||
46902294|NCT03663569|83130288|FG000|Overall Study|Discontinuation of study|11|||
46902295|NCT03663569|83130288|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
46902296|NCT03663569|83130288|FG000|Overall Study|Deceased patient|6|||
46902297|NCT03663569|83130288|FG000|Overall Study|Lost to Follow-up|18|||
46996883|NCT02363738|83243818|FG001|Overall Study|Lost to Follow-up|1|||
46996884|NCT02331680|83243827|FG000|Overall Study|Adverse Event|3|||
46996885|NCT02331680|83243828|FG001|Overall Study|Adverse Event|0|||
46996886|NCT02331680|83243829|FG002|Overall Study|Adverse Event|2|||
46902298|NCT03663569|83130288|FG000|Overall Study|Withdrawal of consent|5|||
46902299|NCT03663569|83130288|FG000|Overall Study|Patient's request|11|||
46902300|NCT03663569|83130288|FG000|Overall Study|Adverse Event|4|||
46902301|NCT03663569|83130288|FG000|Overall Study|Not come to second visit|3|||
46996887|NCT02331680|83243827|FG000|Overall Study|Physician Decision|1|||
46996888|NCT02331680|83243828|FG001|Overall Study|Physician Decision|1|||
46902302|NCT03663569|83130288|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
46902303|NCT03663569|83130288|FG000|Overall Study|Serious adverse event|1|||
46902304|NCT03596762|83130297|FG000|Overall Study|Protocol Violation|0|||
46902305|NCT03596762|83130298|FG001|Overall Study|Protocol Violation|0|||
46902306|NCT03596762|83130299|FG002|Overall Study|Protocol Violation|0|||
46902307|NCT03596762|83130300|FG003|Overall Study|Protocol Violation|0|||
46902308|NCT03596762|83130301|FG004|Overall Study|Protocol Violation|1|||
46902309|NCT03596762|83130297|FG000|Overall Study|Adverse Event|2|||
46902310|NCT03596762|83130298|FG001|Overall Study|Adverse Event|0|||
46902311|NCT03596762|83130299|FG002|Overall Study|Adverse Event|1|||
46902312|NCT03596762|83130300|FG003|Overall Study|Adverse Event|0|||
46902313|NCT03596762|83130301|FG004|Overall Study|Adverse Event|5|||
46902314|NCT03596762|83130297|FG000|Overall Study|Withdrawal by Subject|2|||
46902315|NCT03596762|83130298|FG001|Overall Study|Withdrawal by Subject|1|||
46902316|NCT03596762|83130299|FG002|Overall Study|Withdrawal by Subject|0|||
46902317|NCT03596762|83130300|FG003|Overall Study|Withdrawal by Subject|1|||
46902318|NCT03596762|83130301|FG004|Overall Study|Withdrawal by Subject|1|||
46902319|NCT03663179|83130319|FG000|Overall Study|Withdrawal by Subject|2|||
46902320|NCT03663179|83130320|FG001|Overall Study|Withdrawal by Subject|0|||
46902321|NCT03663179|83130319|FG000|Overall Study|Lost to Follow-up|1|||
46902322|NCT03663179|83130320|FG001|Overall Study|Lost to Follow-up|1|||
46902323|NCT03663179|83130319|FG000|Overall Study|Revealed exclusionary condition|1|||
46902324|NCT03663179|83130320|FG001|Overall Study|Revealed exclusionary condition|0|||
46902325|NCT03662789|83130328|FG000|Overall Study|Lost to Follow-up|1|||
46902326|NCT03662789|83130329|FG001|Overall Study|Lost to Follow-up|2|||
46902327|NCT03662789|83130328|FG000|Overall Study|Could not perform treadmill test|4|||
46902328|NCT03662789|83130329|FG001|Overall Study|Could not perform treadmill test|4|||
46902329|NCT03662789|83130328|FG000|Overall Study|Death|0|||
46902330|NCT03662789|83130329|FG001|Overall Study|Death|1|||
46902331|NCT03658889|83130337|FG000|Overall Study|Protocol Violation|2|||
46902332|NCT03658889|83130338|FG001|Overall Study|Protocol Violation|0|||
46902333|NCT03655691|83130346|FG000|Overall Study|Adverse Event|0|||
46902334|NCT03655691|83130347|FG001|Overall Study|Adverse Event|0|||
46902335|NCT03655691|83130348|FG002|Overall Study|Adverse Event|1|||
46902336|NCT03655691|83130346|FG000|Overall Study|Lost to Follow-up|1|||
46902337|NCT03655691|83130347|FG001|Overall Study|Lost to Follow-up|1|||
46902338|NCT03655691|83130348|FG002|Overall Study|Lost to Follow-up|2|||
46902339|NCT03655691|83130346|FG000|Overall Study|Protocol Violation|0|||
46902340|NCT03655691|83130347|FG001|Overall Study|Protocol Violation|1|||
46902341|NCT03655691|83130348|FG002|Overall Study|Protocol Violation|0|||
46902342|NCT03655691|83130346|FG000|Overall Study|Withdrawal by Subject|1|||
46902343|NCT03655691|83130347|FG001|Overall Study|Withdrawal by Subject|1|||
46902344|NCT03655691|83130348|FG002|Overall Study|Withdrawal by Subject|0|||
46902345|NCT03658811|83130356|FG000|Overall Study|Lost to Follow-up|3|||
46902346|NCT03631355|83130366|FG000|Overall Study|Lost to Follow-up|1|||
46902347|NCT03631355|83130367|FG001|Overall Study|Lost to Follow-up|2|||
46902348|NCT03629249|83130376|FG000|Overall Study|Study terminated by sponsor|197|||
46902349|NCT03629249|83130377|FG001|Overall Study|Study terminated by sponsor|197|||
46902350|NCT03629249|83130378|FG002|Overall Study|Study terminated by sponsor|194|||
46902351|NCT03629249|83130376|FG000|Overall Study|Protocol deviation|0|||
46902352|NCT03629249|83130377|FG001|Overall Study|Protocol deviation|2|||
46902353|NCT03629249|83130378|FG002|Overall Study|Protocol deviation|5|||
46902354|NCT03629249|83130376|FG000|Overall Study|Subject decision|1|||
46902355|NCT03629249|83130377|FG001|Overall Study|Subject decision|1|||
46902356|NCT03629249|83130378|FG002|Overall Study|Subject decision|3|||
46902357|NCT03629249|83130376|FG000|Overall Study|Adverse Event|1|||
46902358|NCT03629249|83130377|FG001|Overall Study|Adverse Event|1|||
46902359|NCT03629249|83130378|FG002|Overall Study|Adverse Event|0|||
46902360|NCT03629249|83130376|FG000|Overall Study|Death|1|||
46902361|NCT03629249|83130377|FG001|Overall Study|Death|0|||
46902362|NCT03629249|83130378|FG002|Overall Study|Death|0|||
46902363|NCT03629249|83130376|FG000|Overall Study|Physician Decision|1|||
46902364|NCT03629249|83130377|FG001|Overall Study|Physician Decision|0|||
46902365|NCT03629249|83130378|FG002|Overall Study|Physician Decision|0|||
46996889|NCT02331680|83243829|FG002|Overall Study|Physician Decision|2|||
46902366|NCT03628781|83130388|FG000|Overall Study|Lost to Follow-up|16|||
46902367|NCT03628781|83130389|FG001|Overall Study|Lost to Follow-up|8|||
46902368|NCT03628781|83130388|FG000|Overall Study|Withdrawal by Subject|16|||
46902369|NCT03628781|83130389|FG001|Overall Study|Withdrawal by Subject|1|||
46902370|NCT03371251|83130401|FG000|Overall Study|Withdrawal by Subject|1|||
46902371|NCT03371251|83130402|FG001|Overall Study|Withdrawal by Subject|0|||
46902372|NCT03371251|83130403|FG002|Overall Study|Withdrawal by Subject|1|||
46902373|NCT03371251|83130404|FG003|Overall Study|Withdrawal by Subject|0|||
46902374|NCT03371251|83130405|FG004|Overall Study|Withdrawal by Subject|2|||
46902375|NCT03371251|83130406|FG005|Overall Study|Withdrawal by Subject|2|||
46902376|NCT03371251|83130401|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
46902377|NCT03371251|83130402|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
46967453|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
46902378|NCT03371251|83130403|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
46902379|NCT03371251|83130404|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
46902380|NCT03371251|83130405|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
46902381|NCT03371251|83130406|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
46902382|NCT03371251|83130401|FG000|Overall Study|Adverse Event|0|||
46902383|NCT03371251|83130402|FG001|Overall Study|Adverse Event|0|||
46902384|NCT03371251|83130403|FG002|Overall Study|Adverse Event|0|||
46902385|NCT03371251|83130404|FG003|Overall Study|Adverse Event|0|||
46902386|NCT03371251|83130405|FG004|Overall Study|Adverse Event|1|||
46902387|NCT03371251|83130406|FG005|Overall Study|Adverse Event|0|||
46902388|NCT03371251|83130401|FG000|Overall Study|Decision by Sponsor|0|||
46902389|NCT03371251|83130402|FG001|Overall Study|Decision by Sponsor|0|||
46902390|NCT03371251|83130403|FG002|Overall Study|Decision by Sponsor|0|||
46902391|NCT03371251|83130404|FG003|Overall Study|Decision by Sponsor|0|||
46902392|NCT03371251|83130405|FG004|Overall Study|Decision by Sponsor|2|||
46902393|NCT03371251|83130406|FG005|Overall Study|Decision by Sponsor|0|||
46902394|NCT03370471|83130425|FG000|Overall Study|Withdrawal by Subject|6|||
46902395|NCT03370471|83130426|FG001|Overall Study|Withdrawal by Subject|1|||
46902396|NCT03370471|83130425|FG000|Overall Study|Unable to access veins for blood draw|0|||
46902397|NCT03370471|83130426|FG001|Overall Study|Unable to access veins for blood draw|1|||
46902398|NCT03370471|83130425|FG000|Overall Study|Screen fail|1|||
46902399|NCT03370471|83130426|FG001|Overall Study|Screen fail|0|||
46902400|NCT03349645|83130434|FG000|Overall Study|Sponsor Terminated Study|75|||
46902401|NCT03349645|83130434|FG000|Overall Study|Withdrawal by Subject|4|||
46902402|NCT03349645|83130434|FG000|Overall Study|Protocol Violation|1|||
46902403|NCT03349645|83130434|FG000|Overall Study|Other|2|||
46902404|NCT03349333|83130438|FG000|Overall Study|Progression of Disease|36|||
46902405|NCT03349333|83130438|FG000|Overall Study|Adverse Event|11|||
46902406|NCT03349333|83130438|FG000|Overall Study|Other|6|||
46902407|NCT03349333|83130438|FG000|Overall Study|Withdrawal by Subject|5|||
46902408|NCT03349333|83130438|FG000|Overall Study|Conditions interfere with participation|2|||
46902409|NCT03349333|83130438|FG000|Overall Study|Physician Decision|2|||
46902410|NCT03349333|83130438|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
46902411|NCT03349333|83130438|FG000|Overall Study|Patients in treatment less than 24 month|8|||
46902412|NCT03349099|83130444|FG000|Overall Study|Physician Decision|3|||
46902413|NCT03349099|83130445|FG001|Overall Study|Physician Decision|4|||
46902414|NCT03349099|83130444|FG000|Overall Study|Stone migrated from the kidney|1|||
46902415|NCT03349099|83130445|FG001|Overall Study|Stone migrated from the kidney|0|||
46902416|NCT03348163|83130453|FG000|Overall Study|Withdrawal by Subject|2|||
46902417|NCT03348163|83130454|FG001|Overall Study|Withdrawal by Subject|0|||
46902418|NCT03347695|83130462|FG000|Overall Study|Death|0|||
46902419|NCT03347695|83130463|FG001|Overall Study|Death|4|||
46902420|NCT03347695|83130462|FG000|Overall Study|Lost to Follow-up|0|||
46902421|NCT03347695|83130463|FG001|Overall Study|Lost to Follow-up|1|||
46902422|NCT02892019|83130473|FG000|Overall Study|randomized but not treated|0|||
46902423|NCT02892019|83130474|FG001|Overall Study|randomized but not treated|1|||
46902424|NCT02892019|83130473|FG000|Overall Study|Withdrawal by Subject|0|||
46902425|NCT02892019|83130474|FG001|Overall Study|Withdrawal by Subject|1|||
46902426|NCT02892019|83130473|FG000|Overall Study|Adverse Event|1|||
46902427|NCT02892019|83130474|FG001|Overall Study|Adverse Event|1|||
46902428|NCT03365791|83130480|FG000|Overall Study|Adverse Event|5|||
46902429|NCT03365791|83130480|FG000|Overall Study|Death|1|||
46902430|NCT03365791|83130480|FG000|Overall Study|Lost to Follow-up|1|||
46902431|NCT03365791|83130480|FG000|Overall Study|Physician Decision|9|||
46996890|NCT02331680|83243827|FG000|Overall Study|Withdrawal by Subject|0|||
46996891|NCT02331680|83243828|FG001|Overall Study|Withdrawal by Subject|1|||
46996892|NCT02331680|83243829|FG002|Overall Study|Withdrawal by Subject|2|||
46996893|NCT02331680|83243827|FG000|Overall Study|Met withdrawal criteria|2|||
46996894|NCT02331680|83243828|FG001|Overall Study|Met withdrawal criteria|2|||
46996895|NCT02331680|83243829|FG002|Overall Study|Met withdrawal criteria|5|||
46996896|NCT02331680|83243827|FG000|Overall Study|Non-compliance with study drug|0|||
46996897|NCT02331680|83243828|FG001|Overall Study|Non-compliance with study drug|0|||
46996898|NCT02331680|83243829|FG002|Overall Study|Non-compliance with study drug|1|||
46996899|NCT02331680|83243827|FG000|Overall Study|Protocol Violation|0|||
46996900|NCT02331680|83243828|FG001|Overall Study|Protocol Violation|0|||
46996901|NCT02331680|83243829|FG002|Overall Study|Protocol Violation|3|||
46996902|NCT02331446|83243841|FG000|Overall Study|Lost to Follow-up|2|||
46996903|NCT02331446|83243842|FG001|Overall Study|Lost to Follow-up|1|||
46902432|NCT03365791|83130480|FG000|Overall Study|Progressive disease|51|||
46902433|NCT03365791|83130480|FG000|Overall Study|Subject/guardian decision|5|||
46902434|NCT03365011|83130487|FG000|Overall Study|Withdrawal by Subject|1|||
46902435|NCT03365011|83130488|FG001|Overall Study|Withdrawal by Subject|2|||
46902436|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
46902437|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
46902438|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
46996904|NCT02331446|83243843|FG002|Overall Study|Lost to Follow-up|0|||
46996905|NCT02331446|83243844|FG003|Overall Study|Lost to Follow-up|1|||
46996906|NCT02331446|83243841|FG000|Overall Study|Personal Problem|2|||
46902439|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
46902440|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
46902441|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
46902442|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
46902443|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
46902444|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
46902445|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
46902446|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
46902447|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
46902448|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
46902449|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
46902450|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
46902451|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
46902452|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
46902453|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
46902454|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
46902455|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
46902456|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
46902457|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
46902458|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
46902459|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
46902460|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
46902461|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
46902462|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
46902463|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
46902464|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
46902465|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
46902466|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
46902467|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
46902468|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
46902469|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
46902470|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
46902471|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
46902472|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
46902473|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
46902474|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
46902475|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
46902476|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
46902477|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
46902478|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
46902479|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
46902480|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
46902481|NCT03627767|83130497|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
46902482|NCT03627767|83130498|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
46902483|NCT03627767|83130499|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
46902484|NCT03627767|83130500|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
46902485|NCT03627767|83130501|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
46902486|NCT03627767|83130497|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
46902487|NCT03627767|83130498|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
46902488|NCT03627767|83130499|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
46902489|NCT03627767|83130500|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
46902490|NCT03627767|83130501|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
46996907|NCT02331446|83243842|FG001|Overall Study|Personal Problem|0|||
46996908|NCT02331446|83243843|FG002|Overall Study|Personal Problem|0|||
46996909|NCT02331446|83243844|FG003|Overall Study|Personal Problem|0|||
46996910|NCT02331446|83243841|FG000|Overall Study|Disease|0|||
46996911|NCT02331446|83243842|FG001|Overall Study|Disease|2|||
46996912|NCT02331446|83243843|FG002|Overall Study|Disease|2|||
46996913|NCT02331446|83243844|FG003|Overall Study|Disease|1|||
46996914|NCT02331446|83243841|FG000|Overall Study|Physician Decision|0|||
46996915|NCT02331446|83243842|FG001|Overall Study|Physician Decision|1|||
46996916|NCT02331446|83243843|FG002|Overall Study|Physician Decision|0|||
46902491|NCT03627767|83130497|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
46902492|NCT03627767|83130498|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
46902493|NCT03627767|83130499|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
46902494|NCT03627767|83130500|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
46902495|NCT03627767|83130501|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
46902496|NCT03627767|83130497|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
46902497|NCT03627767|83130498|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
46902498|NCT03627767|83130499|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
46902499|NCT03627767|83130500|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
46902500|NCT03627767|83130501|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
46902501|NCT03627767|83130497|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
46902502|NCT03627767|83130498|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
46902503|NCT03627767|83130499|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
46902504|NCT03627767|83130500|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
46902505|NCT03627767|83130501|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
46902506|NCT03627767|83130497|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
46902507|NCT03627767|83130498|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
46902508|NCT03627767|83130499|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
46902509|NCT03627767|83130500|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
46902510|NCT03627767|83130501|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
46902511|NCT03627767|83130497|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
46902512|NCT03627767|83130498|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
46902513|NCT03627767|83130499|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
46902514|NCT03627767|83130500|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
46902515|NCT03627767|83130501|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
46902516|NCT03627767|83130497|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
46902517|NCT03627767|83130498|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
46902518|NCT03627767|83130499|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
46902519|NCT03627767|83130500|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
46902520|NCT03627767|83130501|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
46902521|NCT03627767|83130497|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
46902522|NCT03627767|83130498|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
46902523|NCT03627767|83130499|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
46902524|NCT03627767|83130500|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
46902525|NCT03627767|83130501|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
46902526|NCT03627767|83130497|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
46902527|NCT03627767|83130498|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
46902528|NCT03627767|83130499|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
46902529|NCT03627767|83130500|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
46902530|NCT03627767|83130501|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
46902531|NCT03627767|83130497|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
46902532|NCT03627767|83130498|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
46902533|NCT03627767|83130499|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
46902534|NCT03627767|83130500|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
46902535|NCT03627767|83130501|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
46902536|NCT03627065|83130512|FG000|Overall Study|Study Terminated by sponsor|1|||
46902537|NCT03627065|83130512|FG000|Overall Study|Withdrawal by Subject|2|||
46902538|NCT02142738|83130518|FG000|Overall Study|Adverse Event|13|||
46902539|NCT02142738|83130519|FG001|Overall Study|Adverse Event|9|||
46902540|NCT02142738|83130518|FG000|Overall Study|Death|92|||
46902541|NCT02142738|83130519|FG001|Overall Study|Death|112|||
46902542|NCT02142738|83130518|FG000|Overall Study|Lost to Follow-up|0|||
46902543|NCT02142738|83130519|FG001|Overall Study|Lost to Follow-up|3|||
46902544|NCT02142738|83130518|FG000|Overall Study|Withdrawal by Subject|6|||
46902545|NCT02142738|83130519|FG001|Overall Study|Withdrawal by Subject|7|||
46902546|NCT02142738|83130518|FG000|Overall Study|Follow up ended by sponsor|43|||
46902547|NCT02142738|83130519|FG001|Overall Study|Follow up ended by sponsor|20|||
46902548|NCT03617861|83130530|FG000|Second Intervention (1 Day)|Adverse Event|0|||
46902549|NCT03617861|83130531|FG001|Second Intervention (1 Day)|Adverse Event|0|||
46902550|NCT03617861|83130532|FG002|Second Intervention (1 Day)|Adverse Event|1|||
46902551|NCT03617861|83130533|FG003|Second Intervention (1 Day)|Adverse Event|0|||
46902552|NCT03614975|83130545|FG000|Overall Study|Physician Decision|7|||
46902553|NCT03614975|83130546|FG001|Overall Study|Physician Decision|5|||
46902554|NCT03614975|83130545|FG000|Overall Study|Withdrawal by Subject|2|||
46902555|NCT03614975|83130546|FG001|Overall Study|Withdrawal by Subject|2|||
46902556|NCT03614975|83130545|FG000|Overall Study|Specimens not in lab batch shipment|1|||
46709147|NCT01559935|82925114|FG000|Car Phase|Per protocol|1|||
46902557|NCT03614975|83130546|FG001|Overall Study|Specimens not in lab batch shipment|1|||
46902558|NCT03613649|83130564|FG000|Second Treatment|Lost to Follow-up|0|||
46902559|NCT03613649|83130565|FG001|Second Treatment|Lost to Follow-up|0|||
46902560|NCT03613649|83130566|FG002|Second Treatment|Lost to Follow-up|1|||
46902561|NCT03613649|83130567|FG003|Second Treatment|Lost to Follow-up|0|||
46902562|NCT03613649|83130568|FG004|Second Treatment|Lost to Follow-up|0|||
46902563|NCT03613649|83130569|FG005|Second Treatment|Lost to Follow-up|0|||
46902564|NCT03613649|83130570|FG006|Second Treatment|Lost to Follow-up|0|||
46902565|NCT03613649|83130571|FG007|Second Treatment|Lost to Follow-up|0|||
46902566|NCT03613649|83130572|FG008|Second Treatment|Lost to Follow-up|0|||
46902567|NCT03613649|83130573|FG009|Second Treatment|Lost to Follow-up|0|||
46902568|NCT03613649|83130574|FG010|Second Treatment|Lost to Follow-up|0|||
46902569|NCT03613649|83130575|FG011|Second Treatment|Lost to Follow-up|0|||
46902570|NCT03613649|83130564|FG000|Second Treatment|Withdrawal by Subject|0|||
46902571|NCT03613649|83130565|FG001|Second Treatment|Withdrawal by Subject|0|||
46902572|NCT03613649|83130566|FG002|Second Treatment|Withdrawal by Subject|0|||
46902573|NCT03613649|83130567|FG003|Second Treatment|Withdrawal by Subject|0|||
46902574|NCT03613649|83130568|FG004|Second Treatment|Withdrawal by Subject|1|||
46902575|NCT03613649|83130569|FG005|Second Treatment|Withdrawal by Subject|0|||
46902576|NCT03613649|83130570|FG006|Second Treatment|Withdrawal by Subject|0|||
46902577|NCT03613649|83130571|FG007|Second Treatment|Withdrawal by Subject|0|||
46902578|NCT03613649|83130572|FG008|Second Treatment|Withdrawal by Subject|0|||
46902579|NCT03613649|83130573|FG009|Second Treatment|Withdrawal by Subject|0|||
46902580|NCT03613649|83130574|FG010|Second Treatment|Withdrawal by Subject|0|||
46902581|NCT03613649|83130575|FG011|Second Treatment|Withdrawal by Subject|0|||
46902582|NCT03613649|83130564|FG000|Third Treatment|Lost to Follow-up|0|||
46902583|NCT03613649|83130565|FG001|Third Treatment|Lost to Follow-up|0|||
46902584|NCT03613649|83130566|FG002|Third Treatment|Lost to Follow-up|0|||
46902585|NCT03613649|83130567|FG003|Third Treatment|Lost to Follow-up|0|||
46902586|NCT03613649|83130568|FG004|Third Treatment|Lost to Follow-up|1|||
46902587|NCT03613649|83130569|FG005|Third Treatment|Lost to Follow-up|0|||
46902588|NCT03613649|83130570|FG006|Third Treatment|Lost to Follow-up|0|||
46902589|NCT03613649|83130571|FG007|Third Treatment|Lost to Follow-up|0|||
46902590|NCT03613649|83130572|FG008|Third Treatment|Lost to Follow-up|0|||
46902591|NCT03613649|83130573|FG009|Third Treatment|Lost to Follow-up|0|||
46902592|NCT03613649|83130574|FG010|Third Treatment|Lost to Follow-up|0|||
46902593|NCT03613649|83130575|FG011|Third Treatment|Lost to Follow-up|1|||
46902594|NCT03613649|83130564|FG000|Third Treatment|Protocol Violation|0|||
46902595|NCT03613649|83130565|FG001|Third Treatment|Protocol Violation|0|||
46902596|NCT03613649|83130566|FG002|Third Treatment|Protocol Violation|0|||
46902597|NCT03613649|83130567|FG003|Third Treatment|Protocol Violation|0|||
46902598|NCT03613649|83130568|FG004|Third Treatment|Protocol Violation|0|||
46902599|NCT03613649|83130569|FG005|Third Treatment|Protocol Violation|0|||
46902600|NCT03613649|83130570|FG006|Third Treatment|Protocol Violation|1|||
46902601|NCT03613649|83130571|FG007|Third Treatment|Protocol Violation|0|||
46902602|NCT03613649|83130572|FG008|Third Treatment|Protocol Violation|0|||
46902603|NCT03613649|83130573|FG009|Third Treatment|Protocol Violation|0|||
46902604|NCT03613649|83130574|FG010|Third Treatment|Protocol Violation|0|||
46902605|NCT03613649|83130575|FG011|Third Treatment|Protocol Violation|1|||
46902606|NCT03613649|83130564|FG000|Fourth Treatment|Protocol Violation|1|||
46902607|NCT03613649|83130565|FG001|Fourth Treatment|Protocol Violation|0|||
46902608|NCT03613649|83130566|FG002|Fourth Treatment|Protocol Violation|0|||
46902609|NCT03613649|83130567|FG003|Fourth Treatment|Protocol Violation|0|||
46902610|NCT03613649|83130568|FG004|Fourth Treatment|Protocol Violation|1|||
46902611|NCT03613649|83130569|FG005|Fourth Treatment|Protocol Violation|0|||
46902612|NCT03613649|83130570|FG006|Fourth Treatment|Protocol Violation|0|||
46902613|NCT03613649|83130571|FG007|Fourth Treatment|Protocol Violation|0|||
46902614|NCT03613649|83130572|FG008|Fourth Treatment|Protocol Violation|0|||
46902615|NCT03613649|83130573|FG009|Fourth Treatment|Protocol Violation|0|||
46902616|NCT03613649|83130574|FG010|Fourth Treatment|Protocol Violation|0|||
46902617|NCT03613649|83130575|FG011|Fourth Treatment|Protocol Violation|0|||
46902618|NCT03613649|83130564|FG000|Fourth Treatment|Physician Decision|0|||
46902619|NCT03613649|83130565|FG001|Fourth Treatment|Physician Decision|0|||
46996917|NCT02331446|83243844|FG003|Overall Study|Physician Decision|1|||
46996918|NCT02331446|83243841|FG000|Overall Study|Lost before baseline analysis|0|||
46996919|NCT02331446|83243842|FG001|Overall Study|Lost before baseline analysis|1|||
46996920|NCT02331446|83243843|FG002|Overall Study|Lost before baseline analysis|1|||
46996921|NCT02331446|83243844|FG003|Overall Study|Lost before baseline analysis|0|||
46996922|NCT02349061|83243856|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
46902620|NCT03613649|83130566|FG002|Fourth Treatment|Physician Decision|0|||
46902621|NCT03613649|83130567|FG003|Fourth Treatment|Physician Decision|0|||
46902622|NCT03613649|83130568|FG004|Fourth Treatment|Physician Decision|0|||
46996923|NCT02349061|83243857|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
46996924|NCT02349061|83243858|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
46902623|NCT03613649|83130569|FG005|Fourth Treatment|Physician Decision|0|||
46902624|NCT03613649|83130570|FG006|Fourth Treatment|Physician Decision|1|||
46902625|NCT03613649|83130571|FG007|Fourth Treatment|Physician Decision|0|||
46902626|NCT03613649|83130572|FG008|Fourth Treatment|Physician Decision|0|||
46902627|NCT03613649|83130573|FG009|Fourth Treatment|Physician Decision|0|||
46902628|NCT03613649|83130574|FG010|Fourth Treatment|Physician Decision|0|||
46902629|NCT03613649|83130575|FG011|Fourth Treatment|Physician Decision|0|||
46902630|NCT03096288|83130597|FG000|Overall Study|Withdrawal by Subject|0|||
46902631|NCT03096288|83130598|FG001|Overall Study|Withdrawal by Subject|1|||
46902632|NCT03096288|83130599|FG002|Overall Study|Withdrawal by Subject|0|||
46902633|NCT03096288|83130600|FG003|Overall Study|Withdrawal by Subject|1|||
46902634|NCT03611075|83130619|FG000|Overall Study|Physician Decision|0|||
46902635|NCT03611075|83130620|FG001|Overall Study|Physician Decision|1|||
46902636|NCT03611075|83130621|FG002|Overall Study|Physician Decision|1|||
46902637|NCT03611075|83130622|FG003|Overall Study|Physician Decision|0|||
46902638|NCT03611075|83130623|FG004|Overall Study|Physician Decision|0|||
46902639|NCT03611075|83130624|FG005|Overall Study|Physician Decision|0|||
46902640|NCT03611075|83130625|FG006|Overall Study|Physician Decision|0|||
46902641|NCT03611075|83130626|FG007|Overall Study|Physician Decision|0|||
46902642|NCT03611075|83130627|FG008|Overall Study|Physician Decision|0|||
46902643|NCT03611075|83130619|FG000|Overall Study|Lost to Follow-up|1|||
46902644|NCT03611075|83130620|FG001|Overall Study|Lost to Follow-up|0|||
46902645|NCT03611075|83130621|FG002|Overall Study|Lost to Follow-up|0|||
46902646|NCT03611075|83130622|FG003|Overall Study|Lost to Follow-up|2|||
46902647|NCT03611075|83130623|FG004|Overall Study|Lost to Follow-up|0|||
46902648|NCT03611075|83130624|FG005|Overall Study|Lost to Follow-up|0|||
46902649|NCT03611075|83130625|FG006|Overall Study|Lost to Follow-up|0|||
46902650|NCT03611075|83130626|FG007|Overall Study|Lost to Follow-up|0|||
46902651|NCT03611075|83130627|FG008|Overall Study|Lost to Follow-up|0|||
46902652|NCT03611075|83130619|FG000|Overall Study|Withdrawal by Subject|0|||
46902653|NCT03611075|83130620|FG001|Overall Study|Withdrawal by Subject|1|||
46902654|NCT03611075|83130621|FG002|Overall Study|Withdrawal by Subject|1|||
46902655|NCT03611075|83130622|FG003|Overall Study|Withdrawal by Subject|1|||
46902656|NCT03611075|83130623|FG004|Overall Study|Withdrawal by Subject|0|||
46902657|NCT03611075|83130624|FG005|Overall Study|Withdrawal by Subject|0|||
46902658|NCT03611075|83130625|FG006|Overall Study|Withdrawal by Subject|1|||
46902659|NCT03611075|83130626|FG007|Overall Study|Withdrawal by Subject|0|||
46902660|NCT03611075|83130627|FG008|Overall Study|Withdrawal by Subject|0|||
46902661|NCT03611075|83130619|FG000|Overall Study|Reason unknown|0|||
46902662|NCT03611075|83130620|FG001|Overall Study|Reason unknown|0|||
46902663|NCT03611075|83130621|FG002|Overall Study|Reason unknown|0|||
46902664|NCT03611075|83130622|FG003|Overall Study|Reason unknown|1|||
46902665|NCT03611075|83130623|FG004|Overall Study|Reason unknown|0|||
46902666|NCT03611075|83130624|FG005|Overall Study|Reason unknown|0|||
46902667|NCT03611075|83130625|FG006|Overall Study|Reason unknown|1|||
46902668|NCT03611075|83130626|FG007|Overall Study|Reason unknown|0|||
46902669|NCT03611075|83130627|FG008|Overall Study|Reason unknown|0|||
46902670|NCT03095508|83130672|FG000|Overall Study|Adverse Event|0|||
46902671|NCT03095508|83130673|FG001|Overall Study|Adverse Event|1|||
46902672|NCT03607487|83130683|FG000|Overall Study|Withdrawal by Subject|2|||
46902673|NCT03607487|83130684|FG001|Overall Study|Withdrawal by Subject|0|||
46902674|NCT03607487|83130685|FG002|Overall Study|Withdrawal by Subject|0|||
46902675|NCT03607487|83130686|FG003|Overall Study|Withdrawal by Subject|1|||
46902676|NCT03605693|83130700|FG000|Overall Study|Lost to Follow-up|4|||
46902677|NCT03605693|83130701|FG001|Overall Study|Lost to Follow-up|0|||
46902678|NCT03605693|83130700|FG000|Overall Study|Physician Decision|1|||
46902679|NCT03605693|83130701|FG001|Overall Study|Physician Decision|0|||
46902680|NCT03605303|83130707|FG000|Period 1|Study Terminated|2|||
46902681|NCT03605303|83130708|FG001|Period 1|Study Terminated|1|||
46902682|NCT03604523|83130716|FG000|Overall Study|Physician Decision|1|||
46902683|NCT03604523|83130717|FG001|Overall Study|Physician Decision|0|||
46902684|NCT03602339|83130723|FG000|Overall Study|Withdrawal by Subject|9|||
46902685|NCT03602339|83130723|FG000|Overall Study|Physician Decision|2|||
46902686|NCT03602339|83130723|FG000|Overall Study|Other reason|4|||
46620181|NCT02270736|82761810|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
46620182|NCT02270736|82761811|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
46902687|NCT03653429|83130732|FG000|Overall Study|Physician Decision|4|||
46902688|NCT03653429|83130733|FG001|Overall Study|Physician Decision|10|||
46902689|NCT03601715|83130742|FG000|Second Intervention|Lost to Follow-up|1|||
46902690|NCT03601715|83130743|FG001|Second Intervention|Lost to Follow-up|1|||
46902691|NCT03601715|83130744|FG002|Second Intervention|Lost to Follow-up|0|||
46902692|NCT03594227|83130760|FG000|Overall Study|Adverse Event|2|||
46902693|NCT03594227|83130761|FG001|Overall Study|Adverse Event|1|||
46902694|NCT03594227|83130762|FG002|Overall Study|Adverse Event|0|||
46902695|NCT03594227|83130763|FG003|Overall Study|Adverse Event|2|||
46902696|NCT03594227|83130760|FG000|Overall Study|Lost to Follow-up|1|||
46620183|NCT02270736|82761812|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
46620184|NCT02270736|82761813|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
46902697|NCT03594227|83130761|FG001|Overall Study|Lost to Follow-up|1|||
46902698|NCT03594227|83130762|FG002|Overall Study|Lost to Follow-up|1|||
46902699|NCT03594227|83130763|FG003|Overall Study|Lost to Follow-up|0|||
46902700|NCT03594227|83130760|FG000|Overall Study|Withdrawal by Subject|1|||
46902701|NCT03594227|83130761|FG001|Overall Study|Withdrawal by Subject|1|||
46902702|NCT03594227|83130762|FG002|Overall Study|Withdrawal by Subject|1|||
46902703|NCT03594227|83130763|FG003|Overall Study|Withdrawal by Subject|1|||
46902704|NCT03594227|83130760|FG000|Overall Study|Pregnancy|0|||
46902705|NCT03594227|83130761|FG001|Overall Study|Pregnancy|1|||
46902706|NCT03594227|83130762|FG002|Overall Study|Pregnancy|0|||
46902707|NCT03594227|83130763|FG003|Overall Study|Pregnancy|0|||
46902708|NCT03594227|83130760|FG000|Overall Study|Sponsor Decision|0|||
46902709|NCT03594227|83130761|FG001|Overall Study|Sponsor Decision|0|||
46902710|NCT03594227|83130762|FG002|Overall Study|Sponsor Decision|0|||
46902711|NCT03594227|83130763|FG003|Overall Study|Sponsor Decision|1|||
46902712|NCT03594227|83130760|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
46902713|NCT03594227|83130761|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
46902714|NCT03594227|83130762|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
46902715|NCT03594227|83130763|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
46902716|NCT03098550|83130787|FG000|Overall Study|Disease Progression|30|||
46902717|NCT03098550|83130788|FG001|Overall Study|Disease Progression|19|||
46902718|NCT03098550|83130789|FG002|Overall Study|Disease Progression|41|||
46902719|NCT03098550|83130787|FG000|Overall Study|Study Drug Toxicity|2|||
46902720|NCT03098550|83130788|FG001|Overall Study|Study Drug Toxicity|1|||
46902721|NCT03098550|83130789|FG002|Overall Study|Study Drug Toxicity|0|||
46902722|NCT03098550|83130787|FG000|Overall Study|Death|1|||
46902723|NCT03098550|83130788|FG001|Overall Study|Death|0|||
46902724|NCT03098550|83130789|FG002|Overall Study|Death|0|||
46902725|NCT03098550|83130787|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
46902726|NCT03098550|83130788|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
46902727|NCT03098550|83130789|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
46902728|NCT03098550|83130787|FG000|Overall Study|Administrative reason by sponsor|0|||
46902729|NCT03098550|83130788|FG001|Overall Study|Administrative reason by sponsor|0|||
46902730|NCT03098550|83130789|FG002|Overall Study|Administrative reason by sponsor|1|||
46902731|NCT03098550|83130787|FG000|Overall Study|Other reasons|2|||
46902732|NCT03098550|83130788|FG001|Overall Study|Other reasons|0|||
46902733|NCT03098550|83130789|FG002|Overall Study|Other reasons|0|||
46902734|NCT03095118|83130801|FG000|Overall Study|Adverse Event|1|||
46902735|NCT03095118|83130801|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
46902736|NCT03594071|83130805|FG000|Overall Study|Re-operation|3|||
46902737|NCT03594071|83130805|FG000|Overall Study|Missed visit|2|||
46902738|NCT02696902|83130812|FG000|Overall Study|Lost to Follow-up|0|||
46902739|NCT02696902|83130813|FG001|Overall Study|Lost to Follow-up|1|||
46902740|NCT02696902|83130814|FG002|Overall Study|Lost to Follow-up|1|||
46902741|NCT02696902|83130812|FG000|Overall Study|Withdrawal by Subject|0|||
46902742|NCT02696902|83130813|FG001|Overall Study|Withdrawal by Subject|0|||
46902743|NCT02696902|83130814|FG002|Overall Study|Withdrawal by Subject|1|||
46902744|NCT02696902|83130812|FG000|Overall Study|Death|19|||
46902745|NCT02696902|83130813|FG001|Overall Study|Death|3|||
46902746|NCT02696902|83130814|FG002|Overall Study|Death|24|||
46902747|NCT02696902|83130812|FG000|Overall Study|Participant not fit post-randomization|0|||
46902748|NCT02696902|83130813|FG001|Overall Study|Participant not fit post-randomization|0|||
46902749|NCT02696902|83130814|FG002|Overall Study|Participant not fit post-randomization|1|||
46902750|NCT02696902|83130812|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
46902751|NCT02696902|83130813|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
46902752|NCT02696902|83130814|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
46902753|NCT02696902|83130812|FG000|Overall Study|Principal investigator's decision|1|||
46902754|NCT02696902|83130813|FG001|Overall Study|Principal investigator's decision|0|||
46902755|NCT02696902|83130814|FG002|Overall Study|Principal investigator's decision|0|||
46996925|NCT02349061|83243856|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
46996926|NCT02349061|83243857|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
46996927|NCT02349061|83243858|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
46996928|NCT02349061|83243856|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
46902756|NCT02696902|83130812|FG000|Overall Study|Sponsor's decision|1|||
46902757|NCT02696902|83130813|FG001|Overall Study|Sponsor's decision|0|||
46902758|NCT02696902|83130814|FG002|Overall Study|Sponsor's decision|0|||
46902759|NCT02696902|83130812|FG000|Overall Study|Transferred to other hospital|1|||
46902760|NCT02696902|83130813|FG001|Overall Study|Transferred to other hospital|0|||
46902761|NCT02696902|83130814|FG002|Overall Study|Transferred to other hospital|0|||
46996929|NCT02349061|83243857|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
46996930|NCT02349061|83243858|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
46996931|NCT02349061|83243856|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
46996932|NCT02349061|83243857|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
46996933|NCT02349061|83243858|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
46902762|NCT02694562|83130824|FG000|Overall Study|Death|8|||
46902763|NCT02694562|83130824|FG000|Overall Study|Protocol Violation|4|||
46902764|NCT02694562|83130824|FG000|Overall Study|Lost to Follow-up|3|||
46902765|NCT02694562|83130824|FG000|Overall Study|Screen Failure|2|||
46902766|NCT02694562|83130824|FG000|Overall Study|Physician Decision|1|||
46902767|NCT02874534|83130830|FG000|Overall Study|Withdrawal by Subject|5|||
46902768|NCT02874534|83130831|FG001|Overall Study|Withdrawal by Subject|8|||
46902769|NCT02874534|83130830|FG000|Overall Study|Lost to Follow-up|2|||
46902770|NCT02874534|83130831|FG001|Overall Study|Lost to Follow-up|2|||
46902771|NCT02874534|83130830|FG000|Overall Study|Ongoing in study|1|||
46902772|NCT02874534|83130831|FG001|Overall Study|Ongoing in study|1|||
46902773|NCT03097614|83130837|FG000|Overall Study|Adverse Event|3|||
46902774|NCT03364309|83130844|FG000|Induction Period|Adverse Event|4|||
46902775|NCT03364309|83130845|FG001|Induction Period|Adverse Event|0|||
46902776|NCT03364309|83130846|FG002|Induction Period|Adverse Event|1|||
46902777|NCT03364309|83130847|FG003|Induction Period|Adverse Event|0|||
46902778|NCT03364309|83130848|FG004|Induction Period|Adverse Event|0|||
46902779|NCT03364309|83130849|FG005|Induction Period|Adverse Event|0|||
46902780|NCT03364309|83130850|FG006|Induction Period|Adverse Event|0|||
46902781|NCT03364309|83130851|FG007|Induction Period|Adverse Event|0|||
46902782|NCT03364309|83130852|FG008|Induction Period|Adverse Event|0|||
46902783|NCT03364309|83130853|FG009|Induction Period|Adverse Event|0|||
46902784|NCT03364309|83130854|FG010|Induction Period|Adverse Event|0|||
46902785|NCT03364309|83130855|FG011|Induction Period|Adverse Event|0|||
46902786|NCT03364309|83130856|FG012|Induction Period|Adverse Event|0|||
46902787|NCT03364309|83130857|FG013|Induction Period|Adverse Event|0|||
46902788|NCT03364309|83130858|FG014|Induction Period|Adverse Event|0|||
46902789|NCT03364309|83130859|FG015|Induction Period|Adverse Event|0|||
46902790|NCT03364309|83130860|FG016|Induction Period|Adverse Event|0|||
46902791|NCT03364309|83130861|FG017|Induction Period|Adverse Event|0|||
46902792|NCT03364309|83130862|FG018|Induction Period|Adverse Event|0|||
46902793|NCT03364309|83130844|FG000|Induction Period|Withdrawal by Subject|1|||
46902794|NCT03364309|83130845|FG001|Induction Period|Withdrawal by Subject|3|||
46902795|NCT03364309|83130846|FG002|Induction Period|Withdrawal by Subject|0|||
46902796|NCT03364309|83130847|FG003|Induction Period|Withdrawal by Subject|0|||
46902797|NCT03364309|83130848|FG004|Induction Period|Withdrawal by Subject|0|||
46902798|NCT03364309|83130849|FG005|Induction Period|Withdrawal by Subject|0|||
46902799|NCT03364309|83130850|FG006|Induction Period|Withdrawal by Subject|0|||
46902800|NCT03364309|83130851|FG007|Induction Period|Withdrawal by Subject|0|||
46902801|NCT03364309|83130852|FG008|Induction Period|Withdrawal by Subject|0|||
46902802|NCT03364309|83130853|FG009|Induction Period|Withdrawal by Subject|0|||
46902803|NCT03364309|83130854|FG010|Induction Period|Withdrawal by Subject|0|||
46902804|NCT03364309|83130855|FG011|Induction Period|Withdrawal by Subject|0|||
46902805|NCT03364309|83130856|FG012|Induction Period|Withdrawal by Subject|0|||
46902806|NCT03364309|83130857|FG013|Induction Period|Withdrawal by Subject|0|||
46902807|NCT03364309|83130858|FG014|Induction Period|Withdrawal by Subject|0|||
46902808|NCT03364309|83130859|FG015|Induction Period|Withdrawal by Subject|0|||
46902809|NCT03364309|83130860|FG016|Induction Period|Withdrawal by Subject|0|||
46902810|NCT03364309|83130861|FG017|Induction Period|Withdrawal by Subject|0|||
46902811|NCT03364309|83130862|FG018|Induction Period|Withdrawal by Subject|0|||
46902812|NCT03364309|83130844|FG000|Induction Period|Lost to Follow-up|1|||
46902813|NCT03364309|83130845|FG001|Induction Period|Lost to Follow-up|0|||
46902814|NCT03364309|83130846|FG002|Induction Period|Lost to Follow-up|0|||
46902815|NCT03364309|83130847|FG003|Induction Period|Lost to Follow-up|0|||
46902816|NCT03364309|83130848|FG004|Induction Period|Lost to Follow-up|0|||
46902817|NCT03364309|83130849|FG005|Induction Period|Lost to Follow-up|0|||
46902818|NCT03364309|83130850|FG006|Induction Period|Lost to Follow-up|0|||
46902819|NCT03364309|83130851|FG007|Induction Period|Lost to Follow-up|0|||
46902820|NCT03364309|83130852|FG008|Induction Period|Lost to Follow-up|0|||
46902821|NCT03364309|83130853|FG009|Induction Period|Lost to Follow-up|0|||
46902822|NCT03364309|83130854|FG010|Induction Period|Lost to Follow-up|0|||
46902823|NCT03364309|83130855|FG011|Induction Period|Lost to Follow-up|0|||
46902824|NCT03364309|83130856|FG012|Induction Period|Lost to Follow-up|0|||
46902825|NCT03364309|83130857|FG013|Induction Period|Lost to Follow-up|0|||
46902826|NCT03364309|83130858|FG014|Induction Period|Lost to Follow-up|0|||
46902827|NCT03364309|83130859|FG015|Induction Period|Lost to Follow-up|0|||
46902828|NCT03364309|83130860|FG016|Induction Period|Lost to Follow-up|0|||
46902829|NCT03364309|83130861|FG017|Induction Period|Lost to Follow-up|0|||
46902830|NCT03364309|83130862|FG018|Induction Period|Lost to Follow-up|0|||
46902831|NCT03364309|83130844|FG000|Induction Period|Physician Decision|0|||
46902832|NCT03364309|83130845|FG001|Induction Period|Physician Decision|1|||
46902833|NCT03364309|83130846|FG002|Induction Period|Physician Decision|0|||
46902834|NCT03364309|83130847|FG003|Induction Period|Physician Decision|0|||
46902835|NCT03364309|83130848|FG004|Induction Period|Physician Decision|0|||
46902836|NCT03364309|83130849|FG005|Induction Period|Physician Decision|0|||
46902837|NCT03364309|83130850|FG006|Induction Period|Physician Decision|0|||
46902838|NCT03364309|83130851|FG007|Induction Period|Physician Decision|0|||
46902839|NCT03364309|83130852|FG008|Induction Period|Physician Decision|0|||
46902840|NCT03364309|83130853|FG009|Induction Period|Physician Decision|0|||
46902841|NCT03364309|83130854|FG010|Induction Period|Physician Decision|0|||
46902842|NCT03364309|83130855|FG011|Induction Period|Physician Decision|0|||
46902843|NCT03364309|83130856|FG012|Induction Period|Physician Decision|0|||
46902844|NCT03364309|83130857|FG013|Induction Period|Physician Decision|0|||
46902845|NCT03364309|83130858|FG014|Induction Period|Physician Decision|0|||
46902846|NCT03364309|83130859|FG015|Induction Period|Physician Decision|0|||
46902847|NCT03364309|83130860|FG016|Induction Period|Physician Decision|0|||
46902848|NCT03364309|83130861|FG017|Induction Period|Physician Decision|0|||
46902849|NCT03364309|83130862|FG018|Induction Period|Physician Decision|0|||
46902850|NCT03364309|83130844|FG000|Maintenance Period|Withdrawal by Subject|0|||
46902851|NCT03364309|83130845|FG001|Maintenance Period|Withdrawal by Subject|0|||
46902852|NCT03364309|83130846|FG002|Maintenance Period|Withdrawal by Subject|0|||
46902853|NCT03364309|83130847|FG003|Maintenance Period|Withdrawal by Subject|1|||
46902854|NCT03364309|83130848|FG004|Maintenance Period|Withdrawal by Subject|3|||
46902855|NCT03364309|83130849|FG005|Maintenance Period|Withdrawal by Subject|1|||
46902856|NCT03364309|83130850|FG006|Maintenance Period|Withdrawal by Subject|3|||
46902857|NCT03364309|83130851|FG007|Maintenance Period|Withdrawal by Subject|0|||
46902858|NCT03364309|83130852|FG008|Maintenance Period|Withdrawal by Subject|1|||
46902859|NCT03364309|83130853|FG009|Maintenance Period|Withdrawal by Subject|1|||
46902860|NCT03364309|83130854|FG010|Maintenance Period|Withdrawal by Subject|2|||
46902861|NCT03364309|83130855|FG011|Maintenance Period|Withdrawal by Subject|0|||
46902862|NCT03364309|83130856|FG012|Maintenance Period|Withdrawal by Subject|0|||
46902863|NCT03364309|83130857|FG013|Maintenance Period|Withdrawal by Subject|0|||
46902864|NCT03364309|83130858|FG014|Maintenance Period|Withdrawal by Subject|0|||
46996934|NCT02349061|83243856|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
46996935|NCT02349061|83243857|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
46996936|NCT02349061|83243858|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
46996937|NCT02349061|83243856|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
46996938|NCT02349061|83243857|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
46996939|NCT02349061|83243858|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
46996940|NCT02349061|83243856|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
46996941|NCT02349061|83243857|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
46996942|NCT02349061|83243858|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
46996943|NCT02349061|83243856|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
46996944|NCT02349061|83243857|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
46996945|NCT02349061|83243858|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
46996946|NCT02349061|83243856|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
46996947|NCT02349061|83243857|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
46996948|NCT02349061|83243858|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
46996949|NCT02349061|83243856|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
46996950|NCT02349061|83243857|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
46996951|NCT02349061|83243858|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
46996952|NCT02349061|83243856|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
46996953|NCT02349061|83243857|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
46996954|NCT02349061|83243858|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
46996955|NCT02349061|83243856|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
46996956|NCT02349061|83243857|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
46996957|NCT02349061|83243858|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
46996958|NCT02349061|83243856|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
46996959|NCT02349061|83243857|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
46996960|NCT02349061|83243858|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
46996961|NCT02331368|83243868|FG000|Overall Study|Withdrawal by Subject|3|||
46902865|NCT03364309|83130859|FG015|Maintenance Period|Withdrawal by Subject|0|||
46902866|NCT03364309|83130860|FG016|Maintenance Period|Withdrawal by Subject|0|||
46902867|NCT03364309|83130861|FG017|Maintenance Period|Withdrawal by Subject|0|||
46902868|NCT03364309|83130862|FG018|Maintenance Period|Withdrawal by Subject|0|||
46902869|NCT03364309|83130844|FG000|Maintenance Period|Adverse Event|0|||
46902870|NCT03364309|83130845|FG001|Maintenance Period|Adverse Event|0|||
46902871|NCT03364309|83130846|FG002|Maintenance Period|Adverse Event|0|||
46902872|NCT03364309|83130847|FG003|Maintenance Period|Adverse Event|0|||
46996962|NCT02362724|83243874|FG000|Overall Study|Withdrawal by Subject|3|||
46902873|NCT03364309|83130848|FG004|Maintenance Period|Adverse Event|2|||
46902874|NCT03364309|83130849|FG005|Maintenance Period|Adverse Event|0|||
46996963|NCT02362724|83243875|FG001|Overall Study|Withdrawal by Subject|1|||
46996964|NCT02362724|83243874|FG000|Overall Study|Adverse Event|3|||
46996965|NCT02362724|83243875|FG001|Overall Study|Adverse Event|0|||
46996966|NCT02362646|83243883|FG000|Overall Study|Death|15|||
46902875|NCT03364309|83130850|FG006|Maintenance Period|Adverse Event|3|||
46902876|NCT03364309|83130851|FG007|Maintenance Period|Adverse Event|0|||
46902877|NCT03364309|83130852|FG008|Maintenance Period|Adverse Event|1|||
46709148|NCT01559935|82925114|FG000|Car Phase|Insurance|1|||
46902878|NCT03364309|83130853|FG009|Maintenance Period|Adverse Event|0|||
46902879|NCT03364309|83130854|FG010|Maintenance Period|Adverse Event|2|||
46902880|NCT03364309|83130855|FG011|Maintenance Period|Adverse Event|0|||
46902881|NCT03364309|83130856|FG012|Maintenance Period|Adverse Event|0|||
46902882|NCT03364309|83130857|FG013|Maintenance Period|Adverse Event|0|||
46902883|NCT03364309|83130858|FG014|Maintenance Period|Adverse Event|0|||
46902884|NCT03364309|83130859|FG015|Maintenance Period|Adverse Event|0|||
46902885|NCT03364309|83130860|FG016|Maintenance Period|Adverse Event|0|||
46902886|NCT03364309|83130861|FG017|Maintenance Period|Adverse Event|0|||
46902887|NCT03364309|83130862|FG018|Maintenance Period|Adverse Event|0|||
46902888|NCT03364309|83130844|FG000|Maintenance Period|Relapsed|0|||
46902889|NCT03364309|83130845|FG001|Maintenance Period|Relapsed|0|||
46902890|NCT03364309|83130846|FG002|Maintenance Period|Relapsed|0|||
46902891|NCT03364309|83130847|FG003|Maintenance Period|Relapsed|43|||
46902892|NCT03364309|83130848|FG004|Maintenance Period|Relapsed|7|||
46902893|NCT03364309|83130849|FG005|Maintenance Period|Relapsed|45|||
46902894|NCT03364309|83130850|FG006|Maintenance Period|Relapsed|10|||
46902895|NCT03364309|83130851|FG007|Maintenance Period|Relapsed|2|||
46902896|NCT03364309|83130852|FG008|Maintenance Period|Relapsed|0|||
46902897|NCT03364309|83130853|FG009|Maintenance Period|Relapsed|0|||
46902898|NCT03364309|83130854|FG010|Maintenance Period|Relapsed|0|||
46902899|NCT03364309|83130855|FG011|Maintenance Period|Relapsed|0|||
46902900|NCT03364309|83130856|FG012|Maintenance Period|Relapsed|0|||
46902901|NCT03364309|83130857|FG013|Maintenance Period|Relapsed|0|||
46902902|NCT03364309|83130858|FG014|Maintenance Period|Relapsed|0|||
46902903|NCT03364309|83130859|FG015|Maintenance Period|Relapsed|0|||
46902904|NCT03364309|83130860|FG016|Maintenance Period|Relapsed|0|||
46902905|NCT03364309|83130861|FG017|Maintenance Period|Relapsed|0|||
46902906|NCT03364309|83130862|FG018|Maintenance Period|Relapsed|0|||
46902907|NCT03364309|83130844|FG000|Maintenance Period|Lack of Efficacy|0|||
46902908|NCT03364309|83130845|FG001|Maintenance Period|Lack of Efficacy|0|||
46902909|NCT03364309|83130846|FG002|Maintenance Period|Lack of Efficacy|0|||
46902910|NCT03364309|83130847|FG003|Maintenance Period|Lack of Efficacy|0|||
46902911|NCT03364309|83130848|FG004|Maintenance Period|Lack of Efficacy|0|||
46902912|NCT03364309|83130849|FG005|Maintenance Period|Lack of Efficacy|0|||
46902913|NCT03364309|83130850|FG006|Maintenance Period|Lack of Efficacy|0|||
46902914|NCT03364309|83130851|FG007|Maintenance Period|Lack of Efficacy|0|||
46902915|NCT03364309|83130852|FG008|Maintenance Period|Lack of Efficacy|1|||
46902916|NCT03364309|83130853|FG009|Maintenance Period|Lack of Efficacy|3|||
46902917|NCT03364309|83130854|FG010|Maintenance Period|Lack of Efficacy|2|||
46902918|NCT03364309|83130855|FG011|Maintenance Period|Lack of Efficacy|0|||
46902919|NCT03364309|83130856|FG012|Maintenance Period|Lack of Efficacy|0|||
46902920|NCT03364309|83130857|FG013|Maintenance Period|Lack of Efficacy|0|||
46902921|NCT03364309|83130858|FG014|Maintenance Period|Lack of Efficacy|0|||
46902922|NCT03364309|83130859|FG015|Maintenance Period|Lack of Efficacy|0|||
46902923|NCT03364309|83130860|FG016|Maintenance Period|Lack of Efficacy|0|||
46902924|NCT03364309|83130861|FG017|Maintenance Period|Lack of Efficacy|0|||
46902925|NCT03364309|83130862|FG018|Maintenance Period|Lack of Efficacy|0|||
46902926|NCT03364309|83130844|FG000|Maintenance Period|Death|0|||
46902927|NCT03364309|83130845|FG001|Maintenance Period|Death|0|||
46902928|NCT03364309|83130846|FG002|Maintenance Period|Death|0|||
46902929|NCT03364309|83130847|FG003|Maintenance Period|Death|0|||
46902930|NCT03364309|83130848|FG004|Maintenance Period|Death|0|||
46902931|NCT03364309|83130849|FG005|Maintenance Period|Death|0|||
46902932|NCT03364309|83130850|FG006|Maintenance Period|Death|0|||
46902933|NCT03364309|83130851|FG007|Maintenance Period|Death|0|||
46902934|NCT03364309|83130852|FG008|Maintenance Period|Death|1|||
46902935|NCT03364309|83130853|FG009|Maintenance Period|Death|0|||
46902936|NCT03364309|83130854|FG010|Maintenance Period|Death|0|||
46902937|NCT03364309|83130855|FG011|Maintenance Period|Death|0|||
46902938|NCT03364309|83130856|FG012|Maintenance Period|Death|0|||
46902939|NCT03364309|83130857|FG013|Maintenance Period|Death|0|||
46902940|NCT03364309|83130858|FG014|Maintenance Period|Death|0|||
46902941|NCT03364309|83130859|FG015|Maintenance Period|Death|0|||
46620185|NCT02270736|82761809|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
46902942|NCT03364309|83130860|FG016|Maintenance Period|Death|0|||
46902943|NCT03364309|83130861|FG017|Maintenance Period|Death|0|||
46902944|NCT03364309|83130862|FG018|Maintenance Period|Death|0|||
46902945|NCT03364309|83130844|FG000|Maintenance Period|Lost to Follow-up|0|||
46902946|NCT03364309|83130845|FG001|Maintenance Period|Lost to Follow-up|0|||
46620186|NCT02270736|82761810|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
46902947|NCT03364309|83130846|FG002|Maintenance Period|Lost to Follow-up|0|||
46902948|NCT03364309|83130847|FG003|Maintenance Period|Lost to Follow-up|0|||
46902949|NCT03364309|83130848|FG004|Maintenance Period|Lost to Follow-up|0|||
46902950|NCT03364309|83130849|FG005|Maintenance Period|Lost to Follow-up|0|||
46902951|NCT03364309|83130850|FG006|Maintenance Period|Lost to Follow-up|0|||
46902952|NCT03364309|83130851|FG007|Maintenance Period|Lost to Follow-up|0|||
46902953|NCT03364309|83130852|FG008|Maintenance Period|Lost to Follow-up|1|||
46902954|NCT03364309|83130853|FG009|Maintenance Period|Lost to Follow-up|0|||
46902955|NCT03364309|83130854|FG010|Maintenance Period|Lost to Follow-up|0|||
46902956|NCT03364309|83130855|FG011|Maintenance Period|Lost to Follow-up|0|||
46902957|NCT03364309|83130856|FG012|Maintenance Period|Lost to Follow-up|0|||
46902958|NCT03364309|83130857|FG013|Maintenance Period|Lost to Follow-up|0|||
46902959|NCT03364309|83130858|FG014|Maintenance Period|Lost to Follow-up|0|||
46902960|NCT03364309|83130859|FG015|Maintenance Period|Lost to Follow-up|0|||
46902961|NCT03364309|83130860|FG016|Maintenance Period|Lost to Follow-up|0|||
46902962|NCT03364309|83130861|FG017|Maintenance Period|Lost to Follow-up|0|||
46902963|NCT03364309|83130862|FG018|Maintenance Period|Lost to Follow-up|0|||
46902964|NCT03364309|83130844|FG000|Maintenance Period|Miscellaneous|0|||
46902965|NCT03364309|83130845|FG001|Maintenance Period|Miscellaneous|0|||
46902966|NCT03364309|83130846|FG002|Maintenance Period|Miscellaneous|0|||
46902967|NCT03364309|83130847|FG003|Maintenance Period|Miscellaneous|0|||
46902968|NCT03364309|83130848|FG004|Maintenance Period|Miscellaneous|0|||
46902969|NCT03364309|83130849|FG005|Maintenance Period|Miscellaneous|0|||
46902970|NCT03364309|83130850|FG006|Maintenance Period|Miscellaneous|0|||
46902971|NCT03364309|83130851|FG007|Maintenance Period|Miscellaneous|0|||
46902972|NCT03364309|83130852|FG008|Maintenance Period|Miscellaneous|1|||
46902973|NCT03364309|83130853|FG009|Maintenance Period|Miscellaneous|0|||
46902974|NCT03364309|83130854|FG010|Maintenance Period|Miscellaneous|0|||
46902975|NCT03364309|83130855|FG011|Maintenance Period|Miscellaneous|0|||
46902976|NCT03364309|83130856|FG012|Maintenance Period|Miscellaneous|0|||
46902977|NCT03364309|83130857|FG013|Maintenance Period|Miscellaneous|0|||
46902978|NCT03364309|83130858|FG014|Maintenance Period|Miscellaneous|0|||
46902979|NCT03364309|83130859|FG015|Maintenance Period|Miscellaneous|0|||
46902980|NCT03364309|83130860|FG016|Maintenance Period|Miscellaneous|0|||
46902981|NCT03364309|83130861|FG017|Maintenance Period|Miscellaneous|0|||
46902982|NCT03364309|83130862|FG018|Maintenance Period|Miscellaneous|0|||
46902983|NCT03364309|83130844|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902984|NCT03364309|83130845|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902985|NCT03364309|83130846|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902986|NCT03364309|83130847|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902987|NCT03364309|83130848|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902988|NCT03364309|83130849|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902989|NCT03364309|83130850|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902990|NCT03364309|83130851|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902991|NCT03364309|83130852|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902992|NCT03364309|83130853|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902993|NCT03364309|83130854|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902994|NCT03364309|83130855|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902995|NCT03364309|83130856|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46902996|NCT03364309|83130857|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
46902997|NCT03364309|83130858|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
46902998|NCT03364309|83130859|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
46902999|NCT03364309|83130860|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46903000|NCT03364309|83130861|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46903001|NCT03364309|83130862|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
46903002|NCT03364309|83130844|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903003|NCT03364309|83130845|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903004|NCT03364309|83130846|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903005|NCT03364309|83130847|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903006|NCT03364309|83130848|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903007|NCT03364309|83130849|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903008|NCT03364309|83130850|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903009|NCT03364309|83130851|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903010|NCT03364309|83130852|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903011|NCT03364309|83130853|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903012|NCT03364309|83130854|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903013|NCT03364309|83130855|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903014|NCT03364309|83130856|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903015|NCT03364309|83130857|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903016|NCT03364309|83130858|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
46903017|NCT03364309|83130859|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903018|NCT03364309|83130860|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903019|NCT03364309|83130861|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903020|NCT03364309|83130862|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
46903021|NCT03364309|83130844|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
46903022|NCT03364309|83130845|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
46903023|NCT03364309|83130846|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
46903024|NCT03364309|83130847|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
46903025|NCT03364309|83130848|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
46903026|NCT03364309|83130849|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
46903027|NCT03364309|83130850|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
46903028|NCT03364309|83130851|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
46903029|NCT03364309|83130852|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
46903030|NCT03364309|83130853|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
46903031|NCT03364309|83130854|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
46903032|NCT03364309|83130855|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
46903033|NCT03364309|83130856|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
46903034|NCT03364309|83130857|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
46903035|NCT03364309|83130858|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
46903036|NCT03364309|83130859|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
46903037|NCT03364309|83130860|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
46903038|NCT03364309|83130861|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
46903039|NCT03364309|83130862|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
46903040|NCT03364309|83130844|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903041|NCT03364309|83130845|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903042|NCT03364309|83130846|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903043|NCT03364309|83130847|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903044|NCT03364309|83130848|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903045|NCT03364309|83130849|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903046|NCT03364309|83130850|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903047|NCT03364309|83130851|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903048|NCT03364309|83130852|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903049|NCT03364309|83130853|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903050|NCT03364309|83130854|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903051|NCT03364309|83130855|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903052|NCT03364309|83130856|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903053|NCT03364309|83130857|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903054|NCT03364309|83130858|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903055|NCT03364309|83130859|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46903056|NCT03364309|83130860|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
46903057|NCT03364309|83130861|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
46903058|NCT03364309|83130862|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
46903059|NCT03364309|83130844|FG000|Post-Treatment Followup Period|Adverse Event|0|||
46903060|NCT03364309|83130845|FG001|Post-Treatment Followup Period|Adverse Event|0|||
46903061|NCT03364309|83130846|FG002|Post-Treatment Followup Period|Adverse Event|0|||
46903062|NCT03364309|83130847|FG003|Post-Treatment Followup Period|Adverse Event|0|||
46903063|NCT03364309|83130848|FG004|Post-Treatment Followup Period|Adverse Event|0|||
46903064|NCT03364309|83130849|FG005|Post-Treatment Followup Period|Adverse Event|0|||
46903065|NCT03364309|83130850|FG006|Post-Treatment Followup Period|Adverse Event|0|||
46903066|NCT03364309|83130851|FG007|Post-Treatment Followup Period|Adverse Event|0|||
46903067|NCT03364309|83130852|FG008|Post-Treatment Followup Period|Adverse Event|0|||
46903068|NCT03364309|83130853|FG009|Post-Treatment Followup Period|Adverse Event|0|||
46903069|NCT03364309|83130854|FG010|Post-Treatment Followup Period|Adverse Event|0|||
46903070|NCT03364309|83130855|FG011|Post-Treatment Followup Period|Adverse Event|0|||
46903071|NCT03364309|83130856|FG012|Post-Treatment Followup Period|Adverse Event|0|||
46903072|NCT03364309|83130857|FG013|Post-Treatment Followup Period|Adverse Event|0|||
46903073|NCT03364309|83130858|FG014|Post-Treatment Followup Period|Adverse Event|0|||
46903074|NCT03364309|83130859|FG015|Post-Treatment Followup Period|Adverse Event|0|||
46903075|NCT03364309|83130860|FG016|Post-Treatment Followup Period|Adverse Event|2|||
46903076|NCT03364309|83130861|FG017|Post-Treatment Followup Period|Adverse Event|6|||
46903077|NCT03364309|83130862|FG018|Post-Treatment Followup Period|Adverse Event|1|||
46903078|NCT03364309|83130844|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903079|NCT03364309|83130845|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903080|NCT03364309|83130846|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903081|NCT03364309|83130847|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903082|NCT03364309|83130848|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
46996967|NCT02362646|83243884|FG001|Overall Study|Death|8|||
46996968|NCT02362646|83243883|FG000|Overall Study|Withdrawal by Subject|2|||
46903083|NCT03364309|83130849|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903084|NCT03364309|83130850|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903085|NCT03364309|83130851|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903086|NCT03364309|83130852|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903087|NCT03364309|83130853|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903088|NCT03364309|83130854|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903089|NCT03364309|83130855|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
46996969|NCT02362646|83243884|FG001|Overall Study|Withdrawal by Subject|2|||
46996970|NCT02362646|83243883|FG000|Overall Study|received transplant|21|||
46996971|NCT02362646|83243884|FG001|Overall Study|received transplant|14|||
46620187|NCT02270736|82761811|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
46620188|NCT02270736|82761812|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
46620189|NCT02270736|82761813|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
46903090|NCT03364309|83130856|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903091|NCT03364309|83130857|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903092|NCT03364309|83130858|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903093|NCT03364309|83130859|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903094|NCT03364309|83130860|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903095|NCT03364309|83130861|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
46903096|NCT03364309|83130862|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
46903097|NCT03364309|83130844|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
46903098|NCT03364309|83130845|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
46903099|NCT03364309|83130846|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
46903100|NCT03364309|83130847|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
46903101|NCT03364309|83130848|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
46903102|NCT03364309|83130849|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
46903103|NCT03364309|83130850|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
46903104|NCT03364309|83130851|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
46903105|NCT03364309|83130852|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
46903106|NCT03364309|83130853|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
46903107|NCT03364309|83130854|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
46903108|NCT03364309|83130855|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
46903109|NCT03364309|83130856|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
46903110|NCT03364309|83130857|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
46903111|NCT03364309|83130858|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
46903112|NCT03364309|83130859|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
46903113|NCT03364309|83130860|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
46903114|NCT03364309|83130861|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
46903115|NCT03364309|83130862|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
46903116|NCT03334903|83130888|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
46903117|NCT03334903|83130889|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
46903118|NCT03334903|83130888|FG000|Overall Study|Protocol Violation|1|||
46903119|NCT03334903|83130889|FG001|Overall Study|Protocol Violation|3|||
46903120|NCT03334903|83130888|FG000|Overall Study|Surgery postponed|1|||
46903121|NCT03334903|83130889|FG001|Overall Study|Surgery postponed|0|||
46903122|NCT03334903|83130888|FG000|Overall Study|Adverse Event|1|||
46903123|NCT03334903|83130889|FG001|Overall Study|Adverse Event|1|||
46903124|NCT03334903|83130888|FG000|Overall Study|Withdrawal by Subject|0|||
46903125|NCT03334903|83130889|FG001|Overall Study|Withdrawal by Subject|1|||
46903126|NCT01353664|83130895|FG000|Overall Study|Other|3|||
46903127|NCT01353664|83130895|FG000|Overall Study|Disease Progression|16|||
46903128|NCT02694328|83130901|FG000|Overall Study|Adverse Event|27|||
46903129|NCT02694328|83130902|FG001|Overall Study|Adverse Event|33|||
46903130|NCT02694328|83130901|FG000|Overall Study|Withdrawal by Subject|27|||
46903131|NCT02694328|83130902|FG001|Overall Study|Withdrawal by Subject|23|||
46903132|NCT02694328|83130901|FG000|Overall Study|Lost to Follow-up|26|||
46903133|NCT02694328|83130902|FG001|Overall Study|Lost to Follow-up|22|||
46903134|NCT02694328|83130901|FG000|Overall Study|Noncompliant with study drug|11|||
46903135|NCT02694328|83130902|FG001|Overall Study|Noncompliant with study drug|8|||
46903136|NCT02694328|83130901|FG000|Overall Study|Incarceration|1|||
46903137|NCT02694328|83130902|FG001|Overall Study|Incarceration|1|||
46903138|NCT02694328|83130901|FG000|Overall Study|Lack of Efficacy|1|||
46903139|NCT02694328|83130902|FG001|Overall Study|Lack of Efficacy|2|||
46903140|NCT02694328|83130901|FG000|Overall Study|Pregnancy|1|||
46903141|NCT02694328|83130902|FG001|Overall Study|Pregnancy|1|||
46903142|NCT02694328|83130901|FG000|Overall Study|Protocol Violation|6|||
46903143|NCT02694328|83130902|FG001|Overall Study|Protocol Violation|5|||
46903144|NCT02694328|83130901|FG000|Overall Study|Abnormal Laboratory Value|0|||
46903145|NCT02694328|83130902|FG001|Overall Study|Abnormal Laboratory Value|3|||
46903146|NCT03334747|83130917|FG000|Treatment Phase|Technical problems|0|||
46903147|NCT03334747|83130918|FG001|Treatment Phase|Technical problems|0|||
46903148|NCT03334747|83130919|FG002|Treatment Phase|Technical problems|0|||
46903149|NCT03334747|83130920|FG003|Treatment Phase|Technical problems|0|||
46620190|NCT02270736|82761809|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
46903150|NCT03334747|83130921|FG004|Treatment Phase|Technical problems|1|||
46903151|NCT03334747|83130922|FG005|Treatment Phase|Technical problems|0|||
46903152|NCT03334747|83130923|FG006|Treatment Phase|Technical problems|0|||
46903153|NCT03334747|83130924|FG007|Treatment Phase|Technical problems|0|||
46903154|NCT03334747|83130925|FG008|Treatment Phase|Technical problems|0|||
46903155|NCT03334747|83130917|FG000|Treatment Phase|Subject/guardian decision|1|||
46903156|NCT03334747|83130918|FG001|Treatment Phase|Subject/guardian decision|0|||
46903157|NCT03334747|83130919|FG002|Treatment Phase|Subject/guardian decision|0|||
46903158|NCT03334747|83130920|FG003|Treatment Phase|Subject/guardian decision|0|||
46903159|NCT03334747|83130921|FG004|Treatment Phase|Subject/guardian decision|0|||
46903160|NCT03334747|83130922|FG005|Treatment Phase|Subject/guardian decision|1|||
46903161|NCT03334747|83130923|FG006|Treatment Phase|Subject/guardian decision|0|||
46903162|NCT03334747|83130924|FG007|Treatment Phase|Subject/guardian decision|0|||
46903163|NCT03334747|83130925|FG008|Treatment Phase|Subject/guardian decision|0|||
46903164|NCT03334747|83130917|FG000|Follow-Up Phase|Subject/guardian decision|0|||
46903165|NCT03334747|83130918|FG001|Follow-Up Phase|Subject/guardian decision|0|||
46903166|NCT03334747|83130919|FG002|Follow-Up Phase|Subject/guardian decision|0|||
46903167|NCT03334747|83130920|FG003|Follow-Up Phase|Subject/guardian decision|0|||
46903168|NCT03334747|83130921|FG004|Follow-Up Phase|Subject/guardian decision|0|||
46903169|NCT03334747|83130922|FG005|Follow-Up Phase|Subject/guardian decision|0|||
46903170|NCT03334747|83130923|FG006|Follow-Up Phase|Subject/guardian decision|1|||
46903171|NCT03334747|83130924|FG007|Follow-Up Phase|Subject/guardian decision|0|||
46903172|NCT03334747|83130925|FG008|Follow-Up Phase|Subject/guardian decision|1|||
46903173|NCT03346759|83130947|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
46903174|NCT03346759|83130948|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
46903175|NCT03346759|83130947|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
46903176|NCT03346759|83130948|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
46903177|NCT03346759|83130947|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
46903178|NCT03346759|83130948|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
46903179|NCT04576988|83131159|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
46903180|NCT04576988|83131160|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
46903181|NCT04576988|83131159|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
46903182|NCT04576988|83131160|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
46903183|NCT04576988|83131159|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
46903184|NCT04576988|83131160|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
46903185|NCT04576988|83131159|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
46903186|NCT04576988|83131160|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
46903187|NCT04576988|83131159|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
46903188|NCT04576988|83131160|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
46903189|NCT04576988|83131159|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
46903190|NCT04576988|83131160|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
46903191|NCT04576988|83131159|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
46903192|NCT04576988|83131160|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
46903193|NCT04576988|83131159|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
46903194|NCT04576988|83131160|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
46903195|NCT04576988|83131159|FG000|Long Term Double Blind (LTDB)|Death|2|||
46903196|NCT04576988|83131160|FG001|Long Term Double Blind (LTDB)|Death|1|||
46903197|NCT04576988|83131159|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
46903198|NCT04576988|83131160|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
46903199|NCT04575467|83131176|FG000|Overall Study|Adverse Event|0|||
46903200|NCT04575467|83131177|FG001|Overall Study|Adverse Event|1|||
46903201|NCT04575467|83131178|FG002|Overall Study|Adverse Event|0|||
46903202|NCT04575467|83131179|FG003|Overall Study|Adverse Event|0|||
46903203|NCT04573972|83131196|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
46903204|NCT04573972|83131197|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
46903205|NCT04565951|83131205|FG000|Overall Study|Lost to Follow-up|66|||
46903206|NCT04565951|83131206|FG001|Overall Study|Lost to Follow-up|38|||
46903207|NCT04565951|83131205|FG000|Overall Study|Withdrawal by Subject|14|||
46903208|NCT04565951|83131206|FG001|Overall Study|Withdrawal by Subject|7|||
46903209|NCT04565951|83131205|FG000|Overall Study|Death|0|||
46903210|NCT04565951|83131206|FG001|Overall Study|Death|1|||
46903211|NCT04445155|83131218|FG000|Overall Study|Lost to Follow-up|11|||
46903212|NCT04445155|83131219|FG001|Overall Study|Lost to Follow-up|2|||
46903213|NCT04445155|83131220|FG002|Overall Study|Lost to Follow-up|3|||
46903214|NCT04445155|83131221|FG003|Overall Study|Lost to Follow-up|0|||
46903215|NCT04445155|83131218|FG000|Overall Study|Withdrawal by Subject|8|||
46903216|NCT04445155|83131219|FG001|Overall Study|Withdrawal by Subject|0|||
46903217|NCT04445155|83131220|FG002|Overall Study|Withdrawal by Subject|0|||
46903218|NCT04445155|83131221|FG003|Overall Study|Withdrawal by Subject|0|||
46903219|NCT04445155|83131218|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
46903220|NCT04445155|83131219|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
46903221|NCT04445155|83131220|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
46903222|NCT04445155|83131221|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
46903223|NCT04445155|83131218|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
46903224|NCT04445155|83131219|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
46903225|NCT04445155|83131220|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
46903226|NCT04445155|83131221|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
46903227|NCT04394624|83131231|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
46903228|NCT04394624|83131231|FG000|Overall Study|Adverse Event|5|||
46903229|NCT04394624|83131231|FG000|Overall Study|Progressive disease|20|||
46903230|NCT04288089|83131240|FG000|Overall Study|Ongoing Treatment|2|||
46903231|NCT04288089|83131241|FG001|Overall Study|Ongoing Treatment|1|||
46903232|NCT04288089|83131242|FG002|Overall Study|Ongoing Treatment|1|||
46903233|NCT04288089|83131243|FG003|Overall Study|Ongoing Treatment|4|||
46903234|NCT04223778|83131327|FG000|Overall Study|Ongoing|322|||
46903235|NCT04223778|83131328|FG001|Overall Study|Ongoing|326|||
46903236|NCT04223778|83131327|FG000|Overall Study|Death|0|||
46903237|NCT04223778|83131328|FG001|Overall Study|Death|1|||
46903238|NCT04223778|83131327|FG000|Overall Study|Lost to Follow-up|1|||
46903239|NCT04223778|83131328|FG001|Overall Study|Lost to Follow-up|5|||
46903240|NCT04223778|83131327|FG000|Overall Study|Physician Decision|3|||
46903241|NCT04223778|83131328|FG001|Overall Study|Physician Decision|1|||
46903242|NCT04223778|83131327|FG000|Overall Study|Withdrawal by Subject|10|||
46903243|NCT04223778|83131328|FG001|Overall Study|Withdrawal by Subject|1|||
46903244|NCT04223778|83131327|FG000|Overall Study|Lack of Efficacy|0|||
46903245|NCT04223778|83131328|FG001|Overall Study|Lack of Efficacy|2|||
46903246|NCT04052997|83131345|FG000|Overall Study|Withdrawal by Subject|17|||
46903247|NCT04052997|83131345|FG000|Overall Study|Physician Decision|50|||
46903248|NCT04052997|83131345|FG000|Overall Study|Death|43|||
46903249|NCT04052997|83131345|FG000|Overall Study|Lost to Follow-up|5|||
46903250|NCT04052997|83131345|FG000|Overall Study|Progression of Disease|1|||
46903251|NCT03904693|83131366|FG000|Overall Study|Death|0|||
46903252|NCT03904693|83131367|FG001|Overall Study|Death|0|||
46903253|NCT03904693|83131368|FG002|Overall Study|Death|3|||
46903254|NCT03904693|83131366|FG000|Overall Study|Physician Decision|0|||
46903255|NCT03904693|83131367|FG001|Overall Study|Physician Decision|0|||
46903256|NCT03904693|83131368|FG002|Overall Study|Physician Decision|2|||
46903257|NCT03904693|83131366|FG000|Overall Study|Withdrawal by Subject|0|||
46903258|NCT03904693|83131367|FG001|Overall Study|Withdrawal by Subject|1|||
46903259|NCT03904693|83131368|FG002|Overall Study|Withdrawal by Subject|4|||
46903260|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
46903261|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
46903262|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
46903263|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
46903264|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
46903265|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
46903266|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
46996972|NCT02280421|83243894|FG000|Washout (2 Weeks)|Adverse Event|0|||
46996973|NCT02280421|83243895|FG001|Washout (2 Weeks)|Adverse Event|1|||
46996974|NCT02280421|83243894|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
46996975|NCT02280421|83243895|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
46996976|NCT02362412|83243913|FG000|Treatment Period III|Lost to Follow-up|0|||
46996977|NCT02362412|83243914|FG001|Treatment Period III|Lost to Follow-up|1|||
46996978|NCT02280187|83243926|FG000|Overall Study|Lost to Follow-up|218|||
46996979|NCT02347813|83243932|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
46996980|NCT02347813|83243933|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
46996981|NCT02347813|83243932|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
46903267|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
46903268|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
46903269|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
46903270|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
46903271|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
46903272|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
46903273|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
46903274|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
46903275|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
46903276|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
46903277|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
46903278|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
46903279|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
46903280|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
46903281|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
46903282|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
46903283|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
46903284|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
46903285|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
46903286|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
46903287|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
46903288|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
46903289|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
46903290|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
46903291|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
46903292|NCT03818035|83131378|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
46903293|NCT03818035|83131379|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
46903294|NCT03818035|83131380|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
46996982|NCT02347813|83243933|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
46903295|NCT03818035|83131381|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
46903296|NCT03818035|83131378|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
46903297|NCT03818035|83131379|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
46903298|NCT03818035|83131380|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
46903299|NCT03818035|83131381|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
46903300|NCT03818035|83131378|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
46903301|NCT03818035|83131379|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
46903302|NCT03818035|83131380|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
46903303|NCT03818035|83131381|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
46903304|NCT03818035|83131378|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
46903305|NCT03818035|83131379|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
46903306|NCT03818035|83131380|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
46903307|NCT03818035|83131381|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
46903308|NCT03818035|83131378|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
46903309|NCT03818035|83131379|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
46903310|NCT03818035|83131380|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
46903311|NCT03818035|83131381|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
46903312|NCT03818035|83131378|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
46903313|NCT03818035|83131379|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
46903314|NCT03818035|83131380|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
46903315|NCT03818035|83131381|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
46903316|NCT03818035|83131378|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
46903317|NCT03818035|83131379|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
46903318|NCT03818035|83131380|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
46903319|NCT03818035|83131381|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
46903320|NCT03748641|83131395|FG000|Overall Study|Ongoing|155|||
46903321|NCT03748641|83131396|FG001|Overall Study|Ongoing|148|||
46903322|NCT03748641|83131397|FG002|Overall Study|Ongoing|66|||
46903323|NCT03748641|83131398|FG003|Overall Study|Ongoing|79|||
46903324|NCT03748641|83131399|FG004|Overall Study|Ongoing|84|||
46903325|NCT03748641|83131395|FG000|Overall Study|Death|54|||
46903326|NCT03748641|83131396|FG001|Overall Study|Death|59|||
46903327|NCT03748641|83131397|FG002|Overall Study|Death|51|||
46903328|NCT03748641|83131398|FG003|Overall Study|Death|42|||
46903329|NCT03748641|83131399|FG004|Overall Study|Death|9|||
46903330|NCT03748641|83131395|FG000|Overall Study|Lost to Follow-up|0|||
46903331|NCT03748641|83131396|FG001|Overall Study|Lost to Follow-up|2|||
46903332|NCT03748641|83131397|FG002|Overall Study|Lost to Follow-up|1|||
46903333|NCT03748641|83131398|FG003|Overall Study|Lost to Follow-up|0|||
46903334|NCT03748641|83131399|FG004|Overall Study|Lost to Follow-up|0|||
46903335|NCT03748641|83131395|FG000|Overall Study|Withdrawal by Subject|3|||
46903336|NCT03748641|83131396|FG001|Overall Study|Withdrawal by Subject|2|||
46903337|NCT03748641|83131397|FG002|Overall Study|Withdrawal by Subject|5|||
46903338|NCT03748641|83131398|FG003|Overall Study|Withdrawal by Subject|3|||
46903339|NCT03748641|83131399|FG004|Overall Study|Withdrawal by Subject|2|||
46903340|NCT03499119|83131412|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
46903341|NCT03499119|83131413|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
46903342|NCT03499119|83131414|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
46903343|NCT03499119|83131415|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
46903344|NCT03499119|83131412|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
46903345|NCT03499119|83131413|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
46903346|NCT03499119|83131414|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
46903347|NCT03499119|83131415|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
46903348|NCT03499119|83131412|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
46903349|NCT03499119|83131413|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
46903350|NCT03499119|83131414|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
46903351|NCT03499119|83131415|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
46903352|NCT03499119|83131412|FG000|Optional Extension Phase|Lost to Follow-up|0|||
46903353|NCT03499119|83131413|FG001|Optional Extension Phase|Lost to Follow-up|0|||
46903354|NCT03499119|83131414|FG002|Optional Extension Phase|Lost to Follow-up|0|||
46903355|NCT03499119|83131415|FG003|Optional Extension Phase|Lost to Follow-up|1|||
46903356|NCT03499119|83131412|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
46996983|NCT02329730|83243943|FG000|Overall Study|Protocol Violation|0|||
46903357|NCT03499119|83131413|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
46903358|NCT03499119|83131414|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
46903359|NCT03499119|83131415|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
46903360|NCT03499119|83131412|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
46903361|NCT03499119|83131413|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
46903362|NCT03499119|83131414|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
46903363|NCT03499119|83131415|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
46903364|NCT03492177|83131432|FG000|Overall Study|Adverse Event|1|||
46996984|NCT02329730|83243944|FG001|Overall Study|Protocol Violation|0|||
46709149|NCT01559935|82925114|FG000|Car Phase|non-compliance|1|||
46903365|NCT03492177|83131433|FG001|Overall Study|Adverse Event|0|||
46903366|NCT03492177|83131434|FG002|Overall Study|Adverse Event|0|||
46903367|NCT03492177|83131432|FG000|Overall Study|Death|3|||
46903368|NCT03492177|83131433|FG001|Overall Study|Death|0|||
46903369|NCT03492177|83131434|FG002|Overall Study|Death|3|||
46903370|NCT03492177|83131432|FG000|Overall Study|Lack of Efficacy|1|||
46903371|NCT03492177|83131433|FG001|Overall Study|Lack of Efficacy|2|||
46903372|NCT03492177|83131434|FG002|Overall Study|Lack of Efficacy|0|||
46903373|NCT03492177|83131432|FG000|Overall Study|Other|1|||
46903374|NCT03492177|83131433|FG001|Overall Study|Other|0|||
46903375|NCT03492177|83131434|FG002|Overall Study|Other|0|||
46903376|NCT03492177|83131432|FG000|Overall Study|Ongoing|16|||
46903377|NCT03492177|83131433|FG001|Overall Study|Ongoing|19|||
46903378|NCT03492177|83131434|FG002|Overall Study|Ongoing|17|||
46903379|NCT03473743|83131450|FG000|Overall Study|Withdrawal by Subject|0|||
46903380|NCT03473743|83131451|FG001|Overall Study|Withdrawal by Subject|0|||
46903381|NCT03473743|83131452|FG002|Overall Study|Withdrawal by Subject|0|||
46903382|NCT03473743|83131453|FG003|Overall Study|Withdrawal by Subject|0|||
46903383|NCT03473743|83131454|FG004|Overall Study|Withdrawal by Subject|0|||
46903384|NCT03473743|83131455|FG005|Overall Study|Withdrawal by Subject|0|||
46903385|NCT03473743|83131456|FG006|Overall Study|Withdrawal by Subject|0|||
46903386|NCT03473743|83131457|FG007|Overall Study|Withdrawal by Subject|3|||
46903387|NCT03473743|83131450|FG000|Overall Study|Other|0|||
46996985|NCT02329730|83243945|FG002|Overall Study|Protocol Violation|0|||
46996986|NCT02329730|83243946|FG003|Overall Study|Protocol Violation|0|||
46996987|NCT02329730|83243947|FG004|Overall Study|Protocol Violation|2|||
46996988|NCT02329730|83243948|FG005|Overall Study|Protocol Violation|2|||
46996989|NCT02329730|83243949|FG006|Overall Study|Protocol Violation|0|||
46996990|NCT02329730|83243950|FG007|Overall Study|Protocol Violation|0|||
46996991|NCT02329730|83243951|FG008|Overall Study|Protocol Violation|0|||
46996992|NCT02329730|83243952|FG009|Overall Study|Protocol Violation|0|||
46996993|NCT02329730|83243953|FG010|Overall Study|Protocol Violation|0|||
46996994|NCT02329730|83243954|FG011|Overall Study|Protocol Violation|0|||
46996995|NCT02329730|83243943|FG000|Overall Study|Withdrawal by Subject|0|||
46996996|NCT02329730|83243944|FG001|Overall Study|Withdrawal by Subject|0|||
46996997|NCT02329730|83243945|FG002|Overall Study|Withdrawal by Subject|0|||
46996998|NCT02329730|83243946|FG003|Overall Study|Withdrawal by Subject|0|||
46996999|NCT02329730|83243947|FG004|Overall Study|Withdrawal by Subject|1|||
46997000|NCT02329730|83243948|FG005|Overall Study|Withdrawal by Subject|0|||
46997001|NCT02329730|83243949|FG006|Overall Study|Withdrawal by Subject|1|||
46997002|NCT02329730|83243950|FG007|Overall Study|Withdrawal by Subject|1|||
46997003|NCT02329730|83243951|FG008|Overall Study|Withdrawal by Subject|1|||
46997004|NCT02329730|83243952|FG009|Overall Study|Withdrawal by Subject|1|||
46997005|NCT02329730|83243953|FG010|Overall Study|Withdrawal by Subject|0|||
46997006|NCT02329730|83243954|FG011|Overall Study|Withdrawal by Subject|0|||
46997007|NCT02328326|83243974|FG000|Overall Study|Withdrawal by Subject|10|||
46997008|NCT02328326|83243975|FG001|Overall Study|Withdrawal by Subject|3|||
46997009|NCT02328326|83243974|FG000|Overall Study|Death|2|||
46997010|NCT02328326|83243975|FG001|Overall Study|Death|1|||
46997011|NCT02328326|83243974|FG000|Overall Study|Lost to Follow-up|10|||
46997012|NCT02328326|83243975|FG001|Overall Study|Lost to Follow-up|4|||
46997013|NCT01649804|83243983|FG000|Overall Study|Administrative/Other|8|||
46997014|NCT02397278|83243989|FG000|Overall Study|Withdrawal by Subject|0|||
46997015|NCT02397278|83243990|FG001|Overall Study|Withdrawal by Subject|2|||
46997016|NCT02397278|83243989|FG000|Overall Study|Deemed ineligible following surgery|1|||
46997017|NCT02397278|83243990|FG001|Overall Study|Deemed ineligible following surgery|1|||
46997018|NCT02360228|83243999|FG000|Overall Study|Withdrawal by Subject|1|||
46997019|NCT02360228|83244000|FG001|Overall Study|Withdrawal by Subject|0|||
46997020|NCT02360228|83244001|FG002|Overall Study|Withdrawal by Subject|0|||
46903388|NCT03473743|83131451|FG001|Overall Study|Other|0|||
46903389|NCT03473743|83131452|FG002|Overall Study|Other|0|||
46903390|NCT03473743|83131453|FG003|Overall Study|Other|1|||
46903391|NCT03473743|83131454|FG004|Overall Study|Other|0|||
46997021|NCT02360228|83243999|FG000|Overall Study|Self-discontinued medication|0|||
46997022|NCT02360228|83244000|FG001|Overall Study|Self-discontinued medication|1|||
46997023|NCT02360228|83244001|FG002|Overall Study|Self-discontinued medication|0|||
46997024|NCT02360228|83243999|FG000|Overall Study|Unstable symptoms during screening|0|||
46997025|NCT02360228|83244000|FG001|Overall Study|Unstable symptoms during screening|0|||
46903392|NCT03473743|83131455|FG005|Overall Study|Other|0|||
46903393|NCT03473743|83131456|FG006|Overall Study|Other|0|||
46903394|NCT03473743|83131457|FG007|Overall Study|Other|0|||
46903395|NCT03473743|83131450|FG000|Overall Study|Ongoing|0|||
46903396|NCT03473743|83131451|FG001|Overall Study|Ongoing|0|||
46903397|NCT03473743|83131452|FG002|Overall Study|Ongoing|6|||
46903398|NCT03473743|83131453|FG003|Overall Study|Ongoing|8|||
46903399|NCT03473743|83131454|FG004|Overall Study|Ongoing|1|||
46997026|NCT02360228|83244001|FG002|Overall Study|Unstable symptoms during screening|1|||
46997027|NCT02359994|83244011|FG000|Overall Population Study|Adverse Event|1|||
46997028|NCT02359994|83244012|FG001|Overall Population Study|Adverse Event|1|||
46997029|NCT02359994|83244011|FG000|Overall Population Study|Death|1|||
46997030|NCT02359994|83244012|FG001|Overall Population Study|Death|5|||
46997031|NCT02359994|83244011|FG000|Overall Population Study|Lost to Follow-up|1|||
46997032|NCT02359994|83244012|FG001|Overall Population Study|Lost to Follow-up|1|||
46997033|NCT02359994|83244011|FG000|Overall Population Study|Withdrawal by Subject|1|||
46997034|NCT02359994|83244012|FG001|Overall Population Study|Withdrawal by Subject|0|||
46997035|NCT02359994|83244011|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
46997036|NCT02359994|83244012|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
46997037|NCT02359994|83244011|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
46997038|NCT02359994|83244012|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
46997039|NCT02359994|83244011|FG000|Extended Oncology 24-Month Survival|Death|19|||
46997040|NCT02359994|83244012|FG001|Extended Oncology 24-Month Survival|Death|21|||
46997041|NCT02359994|83244011|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
46997042|NCT02359994|83244012|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
46997043|NCT02326298|83244021|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997044|NCT02326298|83244022|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997045|NCT02326298|83244023|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
46997046|NCT02326298|83244024|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997047|NCT02326298|83244025|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997048|NCT02326298|83244026|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997049|NCT02326298|83244027|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997050|NCT02326298|83244028|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997051|NCT02326298|83244029|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46903400|NCT03473743|83131455|FG005|Overall Study|Ongoing|1|||
46903401|NCT03473743|83131456|FG006|Overall Study|Ongoing|22|||
46903402|NCT03473743|83131457|FG007|Overall Study|Ongoing|24|||
46903403|NCT03473743|83131450|FG000|Overall Study|Randomized but not treated|0|||
46903404|NCT03473743|83131451|FG001|Overall Study|Randomized but not treated|0|||
46903405|NCT03473743|83131452|FG002|Overall Study|Randomized but not treated|0|||
46903406|NCT03473743|83131453|FG003|Overall Study|Randomized but not treated|0|||
46903407|NCT03473743|83131454|FG004|Overall Study|Randomized but not treated|0|||
46903408|NCT03473743|83131455|FG005|Overall Study|Randomized but not treated|0|||
46903409|NCT03473743|83131456|FG006|Overall Study|Randomized but not treated|1|||
46903410|NCT03473743|83131457|FG007|Overall Study|Randomized but not treated|1|||
46903411|NCT03462719|83131477|FG000|Overall Study|Withdrawal by Subject|4|||
46903412|NCT03462719|83131478|FG001|Overall Study|Withdrawal by Subject|3|||
46903413|NCT03462719|83131477|FG000|Overall Study|Ongoing|87|||
46903414|NCT03462719|83131478|FG001|Overall Study|Ongoing|72|||
46903415|NCT03459690|83131486|FG000|Overall Study|Lost to Follow-up|0|||
46903416|NCT03459690|83131487|FG001|Overall Study|Lost to Follow-up|1|||
46903417|NCT03459690|83131486|FG000|Overall Study|Withdrawal by Subject|1|||
46903418|NCT03459690|83131487|FG001|Overall Study|Withdrawal by Subject|1|||
46903419|NCT03431350|83131505|FG000|Overall Study|ONGOING|0|||
46903420|NCT03431350|83131506|FG001|Overall Study|ONGOING|0|||
46903421|NCT03431350|83131507|FG002|Overall Study|ONGOING|2|||
46903422|NCT03431350|83131508|FG003|Overall Study|ONGOING|0|||
46903423|NCT03431350|83131509|FG004|Overall Study|ONGOING|1|||
46903424|NCT03431350|83131510|FG005|Overall Study|ONGOING|3|||
46903425|NCT03431350|83131511|FG006|Overall Study|ONGOING|0|||
46903426|NCT03431350|83131512|FG007|Overall Study|ONGOING|1|||
46903427|NCT03431350|83131513|FG008|Overall Study|ONGOING|3|||
46903428|NCT03431350|83131514|FG009|Overall Study|ONGOING|4|||
46903429|NCT03431350|83131515|FG010|Overall Study|ONGOING|2|||
46903430|NCT03431350|83131516|FG011|Overall Study|ONGOING|1|||
46903431|NCT03431350|83131505|FG000|Overall Study|Death|6|||
46903432|NCT03431350|83131506|FG001|Overall Study|Death|5|||
46903433|NCT03431350|83131507|FG002|Overall Study|Death|18|||
46903434|NCT03431350|83131508|FG003|Overall Study|Death|7|||
46997052|NCT02326298|83244030|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997053|NCT02326298|83244031|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997054|NCT02326298|83244032|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997055|NCT02326298|83244033|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46997056|NCT02326298|83244034|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46903435|NCT03431350|83131509|FG004|Overall Study|Death|4|||
46903436|NCT03431350|83131510|FG005|Overall Study|Death|3|||
46903437|NCT03431350|83131511|FG006|Overall Study|Death|2|||
46903438|NCT03431350|83131512|FG007|Overall Study|Death|0|||
46903439|NCT03431350|83131513|FG008|Overall Study|Death|0|||
46903440|NCT03431350|83131514|FG009|Overall Study|Death|0|||
46903441|NCT03431350|83131515|FG010|Overall Study|Death|4|||
46903442|NCT03431350|83131516|FG011|Overall Study|Death|0|||
46903443|NCT03431350|83131505|FG000|Overall Study|Lost to Follow-up|0|||
46903444|NCT03431350|83131506|FG001|Overall Study|Lost to Follow-up|1|||
46903445|NCT03431350|83131507|FG002|Overall Study|Lost to Follow-up|0|||
46903446|NCT03431350|83131508|FG003|Overall Study|Lost to Follow-up|0|||
46903447|NCT03431350|83131509|FG004|Overall Study|Lost to Follow-up|0|||
46903448|NCT03431350|83131510|FG005|Overall Study|Lost to Follow-up|0|||
46903449|NCT03431350|83131511|FG006|Overall Study|Lost to Follow-up|0|||
46903450|NCT03431350|83131512|FG007|Overall Study|Lost to Follow-up|0|||
46903451|NCT03431350|83131513|FG008|Overall Study|Lost to Follow-up|0|||
46903452|NCT03431350|83131514|FG009|Overall Study|Lost to Follow-up|0|||
46903453|NCT03431350|83131515|FG010|Overall Study|Lost to Follow-up|0|||
46903454|NCT03431350|83131516|FG011|Overall Study|Lost to Follow-up|0|||
46903455|NCT03431350|83131505|FG000|Overall Study|Withdrawal by Subject|0|||
46903456|NCT03431350|83131506|FG001|Overall Study|Withdrawal by Subject|0|||
46903457|NCT03431350|83131507|FG002|Overall Study|Withdrawal by Subject|0|||
46903458|NCT03431350|83131508|FG003|Overall Study|Withdrawal by Subject|1|||
46903459|NCT03431350|83131509|FG004|Overall Study|Withdrawal by Subject|1|||
46903460|NCT03431350|83131510|FG005|Overall Study|Withdrawal by Subject|1|||
46903461|NCT03431350|83131511|FG006|Overall Study|Withdrawal by Subject|0|||
46903462|NCT03431350|83131512|FG007|Overall Study|Withdrawal by Subject|0|||
46903463|NCT03431350|83131513|FG008|Overall Study|Withdrawal by Subject|0|||
46903464|NCT03431350|83131514|FG009|Overall Study|Withdrawal by Subject|2|||
46903465|NCT03431350|83131515|FG010|Overall Study|Withdrawal by Subject|0|||
46903466|NCT03431350|83131516|FG011|Overall Study|Withdrawal by Subject|1|||
46903467|NCT03431350|83131505|FG000|Overall Study|Other|0|||
46903468|NCT03431350|83131506|FG001|Overall Study|Other|0|||
46903469|NCT03431350|83131507|FG002|Overall Study|Other|1|||
46903470|NCT03431350|83131508|FG003|Overall Study|Other|3|||
46903471|NCT03431350|83131509|FG004|Overall Study|Other|2|||
46903472|NCT03431350|83131510|FG005|Overall Study|Other|2|||
46903473|NCT03431350|83131511|FG006|Overall Study|Other|4|||
46903474|NCT03431350|83131512|FG007|Overall Study|Other|0|||
46903475|NCT03431350|83131513|FG008|Overall Study|Other|14|||
46903476|NCT03431350|83131514|FG009|Overall Study|Other|11|||
46903477|NCT03431350|83131515|FG010|Overall Study|Other|11|||
46903478|NCT03431350|83131516|FG011|Overall Study|Other|15|||
46903479|NCT03294135|83131544|FG000|Overall Study|Serious Adverse Event|1|||
46903480|NCT03294135|83131545|FG001|Overall Study|Serious Adverse Event|0|||
46903481|NCT03294135|83131546|FG002|Overall Study|Serious Adverse Event|0|||
46903482|NCT03294135|83131544|FG000|Overall Study|Lost to Follow-up|1|||
46903483|NCT03294135|83131545|FG001|Overall Study|Lost to Follow-up|0|||
46903484|NCT03294135|83131546|FG002|Overall Study|Lost to Follow-up|1|||
46903485|NCT03294135|83131544|FG000|Overall Study|Withdrawal by Subject|0|||
46903486|NCT03294135|83131545|FG001|Overall Study|Withdrawal by Subject|0|||
46903487|NCT03294135|83131546|FG002|Overall Study|Withdrawal by Subject|1|||
46903488|NCT03294135|83131544|FG000|Overall Study|Other|2|||
46903489|NCT03294135|83131545|FG001|Overall Study|Other|0|||
46903490|NCT03294135|83131546|FG002|Overall Study|Other|0|||
46903491|NCT03288493|83131561|FG000|Overall Study|Withdrawal by Subject|4|||
46903492|NCT03288493|83131562|FG001|Overall Study|Withdrawal by Subject|0|||
46903493|NCT03288493|83131563|FG002|Overall Study|Withdrawal by Subject|0|||
46903494|NCT03288493|83131564|FG003|Overall Study|Withdrawal by Subject|0|||
46903495|NCT03288493|83131565|FG004|Overall Study|Withdrawal by Subject|0|||
46903496|NCT03288493|83131566|FG005|Overall Study|Withdrawal by Subject|2|||
46903497|NCT03288493|83131567|FG006|Overall Study|Withdrawal by Subject|0|||
46903498|NCT03288493|83131561|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
46903499|NCT03288493|83131562|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
46903500|NCT03288493|83131563|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
46903501|NCT03288493|83131564|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
46903502|NCT03288493|83131565|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
46903503|NCT03288493|83131566|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
46903504|NCT03288493|83131567|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
46903505|NCT03288493|83131561|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
46903506|NCT03288493|83131562|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
46903507|NCT03288493|83131563|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
46903508|NCT03288493|83131564|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
46903509|NCT03288493|83131565|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
46903510|NCT03288493|83131566|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
46903511|NCT03288493|83131567|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
46903512|NCT03288493|83131561|FG000|Overall Study|Death|2|||
46903513|NCT03288493|83131562|FG001|Overall Study|Death|0|||
46903514|NCT03288493|83131563|FG002|Overall Study|Death|0|||
46903515|NCT03288493|83131564|FG003|Overall Study|Death|0|||
46709150|NCT01559935|82925114|FG000|BiRD Phase|Toxicity|1|||
46903516|NCT03288493|83131565|FG004|Overall Study|Death|0|||
46903517|NCT03288493|83131566|FG005|Overall Study|Death|0|||
46903518|NCT03288493|83131567|FG006|Overall Study|Death|0|||
46903519|NCT03288493|83131561|FG000|Overall Study|other reason not listed above|2|||
46903520|NCT03288493|83131562|FG001|Overall Study|other reason not listed above|0|||
46903521|NCT03288493|83131563|FG002|Overall Study|other reason not listed above|0|||
46903522|NCT03288493|83131564|FG003|Overall Study|other reason not listed above|0|||
46903523|NCT03288493|83131565|FG004|Overall Study|other reason not listed above|0|||
46903524|NCT03288493|83131566|FG005|Overall Study|other reason not listed above|0|||
46903525|NCT03288493|83131567|FG006|Overall Study|other reason not listed above|0|||
46903526|NCT03201965|83131588|FG000|Overall Study|Death|5|||
46903527|NCT03201965|83131589|FG001|Overall Study|Death|27|||
46903528|NCT03201965|83131590|FG002|Overall Study|Death|27|||
46903529|NCT03201965|83131588|FG000|Overall Study|Lost to Follow-up|0|||
46903530|NCT03201965|83131589|FG001|Overall Study|Lost to Follow-up|1|||
46903531|NCT03201965|83131590|FG002|Overall Study|Lost to Follow-up|0|||
46903532|NCT03201965|83131588|FG000|Overall Study|Withdrawal by Subject|3|||
46903533|NCT03201965|83131589|FG001|Overall Study|Withdrawal by Subject|13|||
46903534|NCT03201965|83131590|FG002|Overall Study|Withdrawal by Subject|4|||
46903535|NCT03201965|83131588|FG000|Overall Study|Ongoing|20|||
46903536|NCT03201965|83131589|FG001|Overall Study|Ongoing|152|||
46903537|NCT03201965|83131590|FG002|Overall Study|Ongoing|164|||
46903538|NCT02951767|83131601|FG000|Overall Study|Study Terminated By Sponsor|9|||
46903539|NCT02951767|83131601|FG000|Overall Study|Withdrawal by Subject|11|||
46903540|NCT02951767|83131601|FG000|Overall Study|Death|96|||
46903541|NCT02951767|83131601|FG000|Overall Study|Lost to Follow-up|2|||
46903542|NCT02951767|83131601|FG000|Overall Study|Physician Decision|1|||
46903543|NCT02873715|83131607|FG000|Overall Study|Lost to Follow-up|84|||
46903544|NCT02873715|83131608|FG001|Overall Study|Lost to Follow-up|94|||
46903545|NCT02873715|83131607|FG000|Overall Study|Withdrawal by Subject|7|||
46903546|NCT02873715|83131608|FG001|Overall Study|Withdrawal by Subject|26|||
46903547|NCT02489318|83131616|FG000|Randomized|Withdrawal by Subject|0|||
46903548|NCT02489318|83131617|FG001|Randomized|Withdrawal by Subject|1|||
46903549|NCT02489318|83131616|FG000|Treated|Adverse Event|19|||
46903550|NCT02489318|83131617|FG001|Treated|Adverse Event|62|||
46903551|NCT02489318|83131616|FG000|Treated|Death|13|||
46903552|NCT02489318|83131617|FG001|Treated|Death|11|||
46903553|NCT02489318|83131616|FG000|Treated|Physician Decision|4|||
46903554|NCT02489318|83131617|FG001|Treated|Physician Decision|6|||
46903555|NCT02489318|83131616|FG000|Treated|Protocol Violation|1|||
46903556|NCT02489318|83131617|FG001|Treated|Protocol Violation|2|||
46903557|NCT02489318|83131616|FG000|Treated|Withdrawal by Subject|37|||
46903558|NCT02489318|83131617|FG001|Treated|Withdrawal by Subject|36|||
46903559|NCT02489318|83131616|FG000|Treated|Other: Progressive Disease|245|||
46903560|NCT02489318|83131617|FG001|Treated|Other: Progressive Disease|138|||
46903561|NCT02489318|83131616|FG000|Treated|Other|0|||
46903562|NCT02489318|83131617|FG001|Treated|Other|2|||
46903563|NCT02489318|83131616|FG000|Treated|Ongoing|0|||
46903564|NCT02489318|83131617|FG001|Treated|Ongoing|267|||
46903565|NCT02277444|83131624|FG000|Overall Study|Adverse Event|10|||
46903566|NCT02277444|83131624|FG000|Overall Study|Withdrawal by Subject|3|||
46903567|NCT02277444|83131624|FG000|Overall Study|Other|1|||
46903568|NCT02277444|83131624|FG000|Overall Study|Enrolled and not Treated|3|||
46903569|NCT02277444|83131624|FG000|Overall Study|Ongoing|113|||
46903570|NCT02257736|83131630|FG000|Overall Study|Progressive disease|365|||
46903571|NCT02257736|83131631|FG001|Overall Study|Progressive disease|327|||
46997057|NCT02326298|83244021|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
46620191|NCT02270736|82761810|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
46620192|NCT02270736|82761811|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
46903572|NCT02257736|83131630|FG000|Overall Study|Adverse Event|45|||
46903573|NCT02257736|83131631|FG001|Overall Study|Adverse Event|56|||
46903574|NCT02257736|83131630|FG000|Overall Study|Withdrawal by Subject|21|||
46903575|NCT02257736|83131631|FG001|Overall Study|Withdrawal by Subject|38|||
46903576|NCT02257736|83131630|FG000|Overall Study|Death|11|||
46903577|NCT02257736|83131631|FG001|Overall Study|Death|6|||
46903578|NCT02257736|83131630|FG000|Overall Study|Physician Decision|5|||
46903579|NCT02257736|83131631|FG001|Overall Study|Physician Decision|9|||
46903580|NCT02257736|83131630|FG000|Overall Study|Non-Compliance with study drug|1|||
46903581|NCT02257736|83131631|FG001|Overall Study|Non-Compliance with study drug|2|||
46903582|NCT02257736|83131630|FG000|Overall Study|Protocol Violation|1|||
46903583|NCT02257736|83131631|FG001|Overall Study|Protocol Violation|0|||
46903584|NCT02257736|83131630|FG000|Overall Study|Other|1|||
46903585|NCT02257736|83131631|FG001|Overall Study|Other|7|||
46903586|NCT02257736|83131630|FG000|Overall Study|Randomized, not treated|1|||
46903587|NCT02257736|83131631|FG001|Overall Study|Randomized, not treated|2|||
46903588|NCT02252172|83131639|FG000|Overall Study|Lost to Follow-up|3|||
46903589|NCT02252172|83131640|FG001|Overall Study|Lost to Follow-up|1|||
46903590|NCT02252172|83131639|FG000|Overall Study|Ongoing|276|||
46903591|NCT02252172|83131640|FG001|Overall Study|Ongoing|298|||
46903592|NCT02108652|83131646|FG000|Overall Study|Death|253|||
46903593|NCT02108652|83131646|FG000|Overall Study|Lost to Follow-up|2|||
46903594|NCT02108652|83131646|FG000|Overall Study|Withdrawal by Subject|16|||
46903595|NCT02108652|83131646|FG000|Overall Study|Study Terminated By Sponsor|31|||
46903596|NCT02108652|83131646|FG000|Overall Study|Non-Compliance|1|||
46903597|NCT02108652|83131646|FG000|Overall Study|Physician Decision|6|||
46903598|NCT02108652|83131646|FG000|Overall Study|Progression Of Disease|1|||
46903599|NCT02076009|83131652|FG000|Overall Study|Death|172|||
46903600|NCT02076009|83131653|FG001|Overall Study|Death|153|||
46903601|NCT02076009|83131652|FG000|Overall Study|Withdrawal by Subject|16|||
46903602|NCT02076009|83131653|FG001|Overall Study|Withdrawal by Subject|12|||
46903603|NCT02076009|83131652|FG000|Overall Study|Lost to Follow-up|4|||
46903604|NCT02076009|83131653|FG001|Overall Study|Lost to Follow-up|2|||
46903605|NCT02076009|83131652|FG000|Overall Study|Progressive Disease|1|||
46903606|NCT02076009|83131653|FG001|Overall Study|Progressive Disease|0|||
46903607|NCT02076009|83131652|FG000|Overall Study|Physician Decision|0|||
46903608|NCT02076009|83131653|FG001|Overall Study|Physician Decision|1|||
46903609|NCT02076009|83131652|FG000|Overall Study|End of data collection|90|||
46903610|NCT02076009|83131653|FG001|Overall Study|End of data collection|118|||
46903611|NCT01946204|83131661|FG000|Overall Study|Death|38|||
46903612|NCT01946204|83131662|FG001|Overall Study|Death|59|||
46903613|NCT01946204|83131661|FG000|Overall Study|Withdrawal by Subject|37|||
46903614|NCT01946204|83131662|FG001|Overall Study|Withdrawal by Subject|50|||
46903615|NCT01946204|83131661|FG000|Overall Study|Lost to Follow-up|3|||
46903616|NCT01946204|83131662|FG001|Overall Study|Lost to Follow-up|7|||
46903617|NCT01946204|83131661|FG000|Overall Study|Ongoing|316|||
46903618|NCT01946204|83131662|FG001|Overall Study|Ongoing|687|||
46903619|NCT01946204|83131661|FG000|Overall Study|Other|7|||
46903620|NCT01946204|83131662|FG001|Overall Study|Other|3|||
46903621|NCT01776840|83131670|FG000|Overall Study|Lost to Follow-up|4|||
46903622|NCT01776840|83131671|FG001|Overall Study|Lost to Follow-up|4|||
46903623|NCT01776840|83131670|FG000|Overall Study|Withdrawal by Subject|42|||
46903624|NCT01776840|83131671|FG001|Overall Study|Withdrawal by Subject|22|||
46903625|NCT01776840|83131670|FG000|Overall Study|Ongoing|112|||
46903626|NCT01776840|83131671|FG001|Overall Study|Ongoing|129|||
46903627|NCT01615029|83131682|FG000|Overall Study|Adverse Event|0|||
46903628|NCT01615029|83131683|FG001|Overall Study|Adverse Event|0|||
46903629|NCT01615029|83131684|FG002|Overall Study|Adverse Event|0|||
46903630|NCT01615029|83131685|FG003|Overall Study|Adverse Event|0|||
46903631|NCT01615029|83131686|FG004|Overall Study|Adverse Event|1|||
46903632|NCT01615029|83131682|FG000|Overall Study|Death|0|||
46903633|NCT01615029|83131683|FG001|Overall Study|Death|0|||
46903634|NCT01615029|83131684|FG002|Overall Study|Death|0|||
46903635|NCT01615029|83131685|FG003|Overall Study|Death|0|||
46903636|NCT01615029|83131686|FG004|Overall Study|Death|1|||
46903637|NCT01615029|83131682|FG000|Overall Study|Lost to Follow-up|0|||
46903638|NCT01615029|83131683|FG001|Overall Study|Lost to Follow-up|0|||
46903639|NCT01615029|83131684|FG002|Overall Study|Lost to Follow-up|0|||
46903640|NCT01615029|83131685|FG003|Overall Study|Lost to Follow-up|0|||
46903641|NCT01615029|83131686|FG004|Overall Study|Lost to Follow-up|1|||
46903642|NCT01615029|83131682|FG000|Overall Study|Progressive disease|2|||
46903643|NCT01615029|83131683|FG001|Overall Study|Progressive disease|1|||
46903644|NCT01615029|83131684|FG002|Overall Study|Progressive disease|1|||
46903645|NCT01615029|83131685|FG003|Overall Study|Progressive disease|1|||
46903646|NCT01615029|83131686|FG004|Overall Study|Progressive disease|5|||
46903647|NCT01615029|83131682|FG000|Overall Study|Physician Decision|0|||
46903648|NCT01615029|83131683|FG001|Overall Study|Physician Decision|0|||
46903649|NCT01615029|83131684|FG002|Overall Study|Physician Decision|0|||
46620193|NCT02270736|82761812|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
46903650|NCT01615029|83131685|FG003|Overall Study|Physician Decision|0|||
46903651|NCT01615029|83131686|FG004|Overall Study|Physician Decision|1|||
46903652|NCT01615029|83131682|FG000|Overall Study|Ongoing|1|||
46903653|NCT01615029|83131683|FG001|Overall Study|Ongoing|2|||
46903654|NCT01615029|83131684|FG002|Overall Study|Ongoing|3|||
46903655|NCT01615029|83131685|FG003|Overall Study|Ongoing|2|||
46903656|NCT01615029|83131686|FG004|Overall Study|Ongoing|23|||
46903657|NCT01314118|83131698|FG000|Overall Study|Adverse Event|9|||
46903658|NCT01314118|83131698|FG000|Overall Study|Progressive disease|27|||
46903659|NCT01314118|83131698|FG000|Overall Study|Physician Decision|11|||
46903660|NCT01314118|83131698|FG000|Overall Study|Death|4|||
46903661|NCT01314118|83131698|FG000|Overall Study|Protocol Violation|5|||
46903662|NCT01314118|83131698|FG000|Overall Study|Withdrawal by Subject|11|||
46903663|NCT01314118|83131698|FG000|Overall Study|Other|2|||
46903664|NCT01314118|83131698|FG000|Overall Study|Ongoing|62|||
46903665|NCT01171898|83131706|FG000|Overall Study|Death|0|||
46903666|NCT01171898|83131707|FG001|Overall Study|Death|0|||
46903667|NCT01171898|83131708|FG002|Overall Study|Death|2|||
46903668|NCT01171898|83131709|FG003|Overall Study|Death|0|||
46903669|NCT01171898|83131706|FG000|Overall Study|Lost to Follow-up|0|||
46903670|NCT01171898|83131707|FG001|Overall Study|Lost to Follow-up|1|||
46903671|NCT01171898|83131708|FG002|Overall Study|Lost to Follow-up|1|||
46903672|NCT01171898|83131709|FG003|Overall Study|Lost to Follow-up|1|||
46903673|NCT01171898|83131706|FG000|Overall Study|Withdrawal by Subject|1|||
46903674|NCT01171898|83131707|FG001|Overall Study|Withdrawal by Subject|4|||
46903675|NCT01171898|83131708|FG002|Overall Study|Withdrawal by Subject|6|||
46903676|NCT01171898|83131709|FG003|Overall Study|Withdrawal by Subject|3|||
46903677|NCT01171898|83131706|FG000|Overall Study|Terminated by Sponsor|1|||
46903678|NCT01171898|83131707|FG001|Overall Study|Terminated by Sponsor|0|||
46903679|NCT01171898|83131708|FG002|Overall Study|Terminated by Sponsor|0|||
46903680|NCT01171898|83131709|FG003|Overall Study|Terminated by Sponsor|0|||
46997058|NCT02326298|83244022|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997059|NCT02326298|83244023|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997060|NCT02326298|83244024|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997061|NCT02326298|83244025|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997062|NCT02326298|83244026|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997063|NCT02326298|83244027|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997064|NCT02326298|83244028|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997065|NCT02326298|83244029|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997066|NCT02326298|83244030|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997067|NCT02326298|83244031|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997068|NCT02326298|83244032|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997069|NCT02326298|83244033|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997070|NCT02326298|83244034|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
46997071|NCT02326298|83244021|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
46903681|NCT01171898|83131706|FG000|Overall Study|Ongoing|1|||
46903682|NCT01171898|83131707|FG001|Overall Study|Ongoing|9|||
46903683|NCT01171898|83131708|FG002|Overall Study|Ongoing|3|||
46903684|NCT01171898|83131709|FG003|Overall Study|Ongoing|0|||
46903685|NCT01171898|83131706|FG000|Overall Study|Other|1|||
46903686|NCT01171898|83131707|FG001|Overall Study|Other|5|||
46903687|NCT01171898|83131708|FG002|Overall Study|Other|0|||
46903688|NCT01171898|83131709|FG003|Overall Study|Other|2|||
46903689|NCT00980538|83131731|FG000|Overall Study|Lost to Follow-up|20|||
46903690|NCT00980538|83131731|FG000|Overall Study|Sponsor's Decision|4|||
46903691|NCT00980538|83131731|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
46903692|NCT00980538|83131731|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
46903693|NCT00980538|83131731|FG000|Overall Study|Switch to Commercially Available Medication|25|||
46903694|NCT00980538|83131731|FG000|Overall Study|Participant Non-Compliant|9|||
46903695|NCT00980538|83131731|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
46903696|NCT00980538|83131731|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
46903697|NCT00980538|83131731|FG000|Overall Study|Other|60|||
46903698|NCT00980538|83131731|FG000|Overall Study|Other|1|||
46967454|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
46967455|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
46967456|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
46967457|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
46967458|NCT02128763|83209996|FG000|Overall Study|Death|1|||
46967459|NCT02128763|83209997|FG001|Overall Study|Death|0|||
46967460|NCT02128763|83209996|FG000|Overall Study|Lost to Follow-up|19|||
46967461|NCT02128763|83209997|FG001|Overall Study|Lost to Follow-up|16|||
46967462|NCT02124772|83210019|FG000|Overall Study|Lack of Efficacy|2|||
46967463|NCT02124772|83210020|FG001|Overall Study|Lack of Efficacy|0|||
46967464|NCT02124772|83210021|FG002|Overall Study|Lack of Efficacy|0|||
46967465|NCT02124772|83210022|FG003|Overall Study|Lack of Efficacy|1|||
46967466|NCT02124772|83210023|FG004|Overall Study|Lack of Efficacy|2|||
46967467|NCT02124772|83210024|FG005|Overall Study|Lack of Efficacy|3|||
46967468|NCT02124772|83210025|FG006|Overall Study|Lack of Efficacy|0|||
46997072|NCT02326298|83244022|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
46997073|NCT02326298|83244023|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997074|NCT02326298|83244024|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997075|NCT02326298|83244025|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997076|NCT02326298|83244026|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997077|NCT02326298|83244027|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46967469|NCT02124772|83210026|FG007|Overall Study|Lack of Efficacy|2|||
46967470|NCT02124772|83210027|FG008|Overall Study|Lack of Efficacy|0|||
46967471|NCT02124772|83210028|FG009|Overall Study|Lack of Efficacy|1|||
46967472|NCT02124772|83210029|FG010|Overall Study|Lack of Efficacy|0|||
46967473|NCT02124772|83210030|FG011|Overall Study|Lack of Efficacy|0|||
46967474|NCT02124772|83210031|FG012|Overall Study|Lack of Efficacy|1|||
46967475|NCT02124772|83210019|FG000|Overall Study|Adverse Event|1|||
46967476|NCT02124772|83210020|FG001|Overall Study|Adverse Event|4|||
46967477|NCT02124772|83210021|FG002|Overall Study|Adverse Event|1|||
46967478|NCT02124772|83210022|FG003|Overall Study|Adverse Event|5|||
46967479|NCT02124772|83210023|FG004|Overall Study|Adverse Event|2|||
46967480|NCT02124772|83210024|FG005|Overall Study|Adverse Event|1|||
46967481|NCT02124772|83210025|FG006|Overall Study|Adverse Event|1|||
46967482|NCT02124772|83210026|FG007|Overall Study|Adverse Event|5|||
46903699|NCT03361423|83131737|FG000|Overall Study|Withdrawal by Subject|4|||
46903700|NCT03361423|83131738|FG001|Overall Study|Withdrawal by Subject|3|||
46903701|NCT03361423|83131737|FG000|Overall Study|Did not treat|19|||
46903702|NCT03361423|83131738|FG001|Overall Study|Did not treat|18|||
46903703|NCT03361423|83131737|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
46903704|NCT03361423|83131738|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
46903705|NCT03361423|83131737|FG000|Overall Study|Missing data|4|||
46903706|NCT03361423|83131738|FG001|Overall Study|Missing data|1|||
46903707|NCT02693002|83131746|FG000|Overall Study|Withdrawal by Subject|1|||
46903708|NCT02693002|83131747|FG001|Overall Study|Withdrawal by Subject|0|||
46903709|NCT03093870|83131756|FG000|Overall Study|Withdrawal by Subject|2|||
46903710|NCT03093870|83131757|FG001|Overall Study|Withdrawal by Subject|6|||
46903711|NCT03093870|83131758|FG002|Overall Study|Withdrawal by Subject|5|||
46903712|NCT03093870|83131756|FG000|Overall Study|Death|1|||
46903713|NCT03093870|83131757|FG001|Overall Study|Death|35|||
46903714|NCT03093870|83131758|FG002|Overall Study|Death|35|||
46903715|NCT03093870|83131756|FG000|Overall Study|Radiographic disease progression|10|||
46903716|NCT03093870|83131757|FG001|Overall Study|Radiographic disease progression|0|||
46903717|NCT03093870|83131758|FG002|Overall Study|Radiographic disease progression|0|||
46903718|NCT03093870|83131756|FG000|Overall Study|Clinical disease progression|1|||
46903719|NCT03093870|83131757|FG001|Overall Study|Clinical disease progression|0|||
46903720|NCT03093870|83131758|FG002|Overall Study|Clinical disease progression|0|||
46903721|NCT03093870|83131756|FG000|Overall Study|Physician Decision|2|||
46903722|NCT03093870|83131757|FG001|Overall Study|Physician Decision|0|||
46903723|NCT03093870|83131758|FG002|Overall Study|Physician Decision|0|||
46903724|NCT03093870|83131756|FG000|Overall Study|Adverse Event|7|||
46903725|NCT03093870|83131757|FG001|Overall Study|Adverse Event|0|||
46903726|NCT03093870|83131758|FG002|Overall Study|Adverse Event|0|||
46903727|NCT03093870|83131756|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
46903728|NCT03093870|83131757|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
46903729|NCT03093870|83131758|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
46903730|NCT03093870|83131756|FG000|Overall Study|Lost to Follow-up|0|||
46903731|NCT03093870|83131757|FG001|Overall Study|Lost to Follow-up|0|||
46903732|NCT03093870|83131758|FG002|Overall Study|Lost to Follow-up|1|||
46903733|NCT03346057|83131781|FG000|Overall Study|Death|1|||
46903734|NCT03346057|83131782|FG001|Overall Study|Death|2|||
46903735|NCT03346057|83131783|FG002|Overall Study|Death|0|||
46903736|NCT03346057|83131784|FG003|Overall Study|Death|0|||
46903737|NCT03346057|83131781|FG000|Overall Study|Lost to Follow-up|0|||
46903738|NCT03346057|83131782|FG001|Overall Study|Lost to Follow-up|2|||
46997078|NCT02326298|83244028|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997079|NCT02326298|83244029|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997080|NCT02326298|83244030|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997081|NCT02326298|83244031|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997082|NCT02326298|83244032|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997083|NCT02326298|83244033|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997084|NCT02326298|83244034|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
46997085|NCT02326298|83244021|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
46997086|NCT02326298|83244022|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
46997087|NCT02326298|83244023|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997088|NCT02326298|83244024|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997089|NCT02326298|83244025|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997090|NCT02326298|83244026|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997091|NCT02326298|83244027|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997092|NCT02326298|83244028|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997093|NCT02326298|83244029|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997094|NCT02326298|83244030|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997095|NCT02326298|83244031|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997096|NCT02326298|83244032|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46903739|NCT03346057|83131783|FG002|Overall Study|Lost to Follow-up|1|||
46903740|NCT03346057|83131784|FG003|Overall Study|Lost to Follow-up|0|||
46903741|NCT03346057|83131781|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
46903742|NCT03346057|83131782|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
46903743|NCT03346057|83131783|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
46903744|NCT03346057|83131784|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
46903745|NCT03346057|83131781|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
46903746|NCT03346057|83131782|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
46903747|NCT03346057|83131783|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
46903748|NCT03346057|83131784|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
46903749|NCT03346057|83131781|FG000|Overall Study|Physician Decision|3|||
46903750|NCT03346057|83131782|FG001|Overall Study|Physician Decision|2|||
46903751|NCT03346057|83131783|FG002|Overall Study|Physician Decision|0|||
46903752|NCT03346057|83131784|FG003|Overall Study|Physician Decision|2|||
46903753|NCT03346057|83131781|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
46903754|NCT03346057|83131782|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
46903755|NCT03346057|83131783|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
46903756|NCT03346057|83131784|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
46903757|NCT03346057|83131781|FG000|Overall Study|Withdrawal by Subject|1|||
46903758|NCT03346057|83131782|FG001|Overall Study|Withdrawal by Subject|0|||
46903759|NCT03346057|83131783|FG002|Overall Study|Withdrawal by Subject|0|||
46903760|NCT03346057|83131784|FG003|Overall Study|Withdrawal by Subject|0|||
46903761|NCT03345979|83131796|FG000|Overall Study|Withdrawal by Subject|20|||
46903762|NCT03345979|83131797|FG001|Overall Study|Withdrawal by Subject|31|||
46903763|NCT03345979|83131796|FG000|Overall Study|Adverse Event|10|||
46903764|NCT03345979|83131797|FG001|Overall Study|Adverse Event|11|||
46903765|NCT03345979|83131796|FG000|Overall Study|Lost to Follow-up|8|||
46903766|NCT03345979|83131797|FG001|Overall Study|Lost to Follow-up|9|||
46903767|NCT03345979|83131796|FG000|Overall Study|Lack of Efficacy|4|||
46903768|NCT03345979|83131797|FG001|Overall Study|Lack of Efficacy|2|||
46903769|NCT03345979|83131796|FG000|Overall Study|Protocol Violation|1|||
46903770|NCT03345979|83131797|FG001|Overall Study|Protocol Violation|3|||
46903771|NCT03345979|83131796|FG000|Overall Study|Physician Decision|0|||
46903772|NCT03345979|83131797|FG001|Overall Study|Physician Decision|2|||
46903773|NCT02696434|83131805|FG000|Overall Study|Adverse Event|3|||
46903774|NCT02696434|83131806|FG001|Overall Study|Adverse Event|1|||
46903775|NCT02696434|83131805|FG000|Overall Study|Lost to Follow-up|5|||
46903776|NCT02696434|83131806|FG001|Overall Study|Lost to Follow-up|4|||
46903777|NCT02696434|83131805|FG000|Overall Study|Withdrawal by Subject|14|||
46903778|NCT02696434|83131806|FG001|Overall Study|Withdrawal by Subject|12|||
46903779|NCT02696434|83131805|FG000|Overall Study|Physician Decision|0|||
46903780|NCT02696434|83131806|FG001|Overall Study|Physician Decision|1|||
46903781|NCT03345901|83131812|FG000|Overall Study|The study was terminated|18|||
46903782|NCT02950831|83131817|FG000|Overall Study|Lost to Follow-up|1|||
46903783|NCT02950831|83131817|FG000|Overall Study|Withdrawal by Subject|3|||
46903784|NCT02950831|83131817|FG000|Overall Study|stimulation trail failure|5|||
46903785|NCT03593681|83131821|FG000|Overall Study|Inadequate sample collected|12|||
46903786|NCT03593681|83131821|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
46903787|NCT03593681|83131821|FG000|Overall Study|Protocol Violation|3|||
46903788|NCT03593681|83131821|FG000|Overall Study|Withdrawal by Subject|3|||
46903789|NCT03593681|83131821|FG000|Overall Study|Procedure not attempted|3|||
46903790|NCT03593681|83131821|FG000|Overall Study|Adverse Event|2|||
46903791|NCT03593681|83131821|FG000|Overall Study|Physician Decision|1|||
46903792|NCT03592745|83131844|FG000|Overall Study|Adverse Event|0|||
46903793|NCT03592745|83131845|FG001|Overall Study|Adverse Event|2|||
46903794|NCT03592745|83131844|FG000|Overall Study|Lost to Follow-up|2|||
46903795|NCT03592745|83131845|FG001|Overall Study|Lost to Follow-up|0|||
46903796|NCT03592745|83131844|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
46903797|NCT03592745|83131845|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
46903798|NCT03592277|83131853|FG000|Overall Study|Withdrawal by Subject|6|||
46903799|NCT03592277|83131854|FG001|Overall Study|Withdrawal by Subject|8|||
46903800|NCT03401112|83131865|FG000|Overall Study|Adverse Event|1|||
46903801|NCT03401112|83131866|FG001|Overall Study|Adverse Event|2|||
46903802|NCT03401112|83131867|FG002|Overall Study|Adverse Event|3|||
46903803|NCT03401112|83131868|FG003|Overall Study|Adverse Event|2|||
46903804|NCT03401112|83131869|FG004|Overall Study|Adverse Event|0|||
46903805|NCT03401112|83131865|FG000|Overall Study|Lost to Follow-up|1|||
46903806|NCT03401112|83131866|FG001|Overall Study|Lost to Follow-up|0|||
46903807|NCT03401112|83131867|FG002|Overall Study|Lost to Follow-up|0|||
46903808|NCT03401112|83131868|FG003|Overall Study|Lost to Follow-up|0|||
46903809|NCT03401112|83131869|FG004|Overall Study|Lost to Follow-up|0|||
46903810|NCT03401112|83131865|FG000|Overall Study|Noncompliance|1|||
46903811|NCT03401112|83131866|FG001|Overall Study|Noncompliance|2|||
46903812|NCT03401112|83131867|FG002|Overall Study|Noncompliance|3|||
46903813|NCT03401112|83131868|FG003|Overall Study|Noncompliance|0|||
46903814|NCT03401112|83131869|FG004|Overall Study|Noncompliance|0|||
46903815|NCT03401112|83131865|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
46903816|NCT03401112|83131866|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
46903817|NCT03401112|83131867|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
46903818|NCT03401112|83131868|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
46903819|NCT03401112|83131869|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
46903820|NCT03401112|83131865|FG000|Overall Study|Withdrawal by Subject|0|||
46903821|NCT03401112|83131866|FG001|Overall Study|Withdrawal by Subject|3|||
46903822|NCT03401112|83131867|FG002|Overall Study|Withdrawal by Subject|2|||
46903823|NCT03401112|83131868|FG003|Overall Study|Withdrawal by Subject|1|||
46903824|NCT03401112|83131869|FG004|Overall Study|Withdrawal by Subject|0|||
46903825|NCT03401112|83131865|FG000|Overall Study|Physician Decision|0|||
46903826|NCT03401112|83131866|FG001|Overall Study|Physician Decision|0|||
46903827|NCT03401112|83131867|FG002|Overall Study|Physician Decision|0|||
46903828|NCT03401112|83131868|FG003|Overall Study|Physician Decision|2|||
46903829|NCT03401112|83131869|FG004|Overall Study|Physician Decision|0|||
46903830|NCT03401112|83131865|FG000|Overall Study|Study was Terminated by Sponsor|0|||
46903831|NCT03401112|83131866|FG001|Overall Study|Study was Terminated by Sponsor|0|||
46903832|NCT03401112|83131867|FG002|Overall Study|Study was Terminated by Sponsor|0|||
46903833|NCT03401112|83131868|FG003|Overall Study|Study was Terminated by Sponsor|1|||
46903834|NCT03401112|83131869|FG004|Overall Study|Study was Terminated by Sponsor|0|||
46903835|NCT03401112|83131865|FG000|Overall Study|Day 1 Assessment not Done|1|||
46903836|NCT03401112|83131866|FG001|Overall Study|Day 1 Assessment not Done|0|||
46903837|NCT03401112|83131867|FG002|Overall Study|Day 1 Assessment not Done|0|||
46903838|NCT03401112|83131868|FG003|Overall Study|Day 1 Assessment not Done|0|||
46903839|NCT03401112|83131869|FG004|Overall Study|Day 1 Assessment not Done|0|||
46903840|NCT03401112|83131865|FG000|Overall Study|Not Dosed|0|||
46903841|NCT03401112|83131866|FG001|Overall Study|Not Dosed|0|||
46903842|NCT03401112|83131867|FG002|Overall Study|Not Dosed|1|||
46903843|NCT03401112|83131868|FG003|Overall Study|Not Dosed|0|||
46903844|NCT03401112|83131869|FG004|Overall Study|Not Dosed|0|||
46903845|NCT03401112|83131865|FG000|Overall Study|Missed Clinical Visit|0|||
46903846|NCT03401112|83131866|FG001|Overall Study|Missed Clinical Visit|0|||
46903847|NCT03401112|83131867|FG002|Overall Study|Missed Clinical Visit|1|||
46903848|NCT03401112|83131868|FG003|Overall Study|Missed Clinical Visit|0|||
46903849|NCT03401112|83131869|FG004|Overall Study|Missed Clinical Visit|0|||
46903850|NCT03401112|83131865|FG000|Overall Study|Missed Doses|0|||
46903851|NCT03401112|83131866|FG001|Overall Study|Missed Doses|0|||
46903852|NCT03401112|83131867|FG002|Overall Study|Missed Doses|1|||
46903853|NCT03401112|83131868|FG003|Overall Study|Missed Doses|0|||
46903854|NCT03401112|83131869|FG004|Overall Study|Missed Doses|0|||
46903855|NCT02697916|83131898|FG000|Overall Study|Death|357|||
46903856|NCT02697916|83131899|FG001|Overall Study|Death|315|||
46903857|NCT02697916|83131898|FG000|Overall Study|Withdrawal by Subject|221|||
46903858|NCT02697916|83131899|FG001|Overall Study|Withdrawal by Subject|393|||
46903859|NCT03359473|83131918|FG000|Overall Study|Adverse Event|0|||
46903860|NCT03359473|83131919|FG001|Overall Study|Adverse Event|2|||
46903861|NCT03359473|83131920|FG002|Overall Study|Adverse Event|5|||
46903862|NCT03359473|83131921|FG003|Overall Study|Adverse Event|3|||
46903863|NCT03359473|83131918|FG000|Overall Study|Lost to Follow-up|0|||
46903864|NCT03359473|83131919|FG001|Overall Study|Lost to Follow-up|1|||
46903865|NCT03359473|83131920|FG002|Overall Study|Lost to Follow-up|0|||
46903866|NCT03359473|83131921|FG003|Overall Study|Lost to Follow-up|0|||
46903867|NCT03359473|83131918|FG000|Overall Study|Physician Decision|0|||
46903868|NCT03359473|83131919|FG001|Overall Study|Physician Decision|1|||
46903869|NCT03359473|83131920|FG002|Overall Study|Physician Decision|0|||
46903870|NCT03359473|83131921|FG003|Overall Study|Physician Decision|1|||
46903871|NCT03359473|83131918|FG000|Overall Study|Withdrawal by Subject|1|||
46903872|NCT03359473|83131919|FG001|Overall Study|Withdrawal by Subject|2|||
46903873|NCT03359473|83131920|FG002|Overall Study|Withdrawal by Subject|1|||
46903874|NCT03359473|83131921|FG003|Overall Study|Withdrawal by Subject|0|||
46903875|NCT03359473|83131918|FG000|Overall Study|Protocol-defined stopping criteria|1|||
46903876|NCT03359473|83131919|FG001|Overall Study|Protocol-defined stopping criteria|0|||
46903877|NCT03359473|83131920|FG002|Overall Study|Protocol-defined stopping criteria|0|||
46903878|NCT03359473|83131921|FG003|Overall Study|Protocol-defined stopping criteria|1|||
46903879|NCT03589469|83131934|FG000|Overall Study|Withdrawal by Subject|8|||
46903880|NCT03589469|83131934|FG000|Overall Study|Physician Decision|20|||
46903881|NCT03589469|83131934|FG000|Overall Study|Death|97|||
46903882|NCT03589469|83131934|FG000|Overall Study|Lost to Follow-up|8|||
46903883|NCT03589469|83131934|FG000|Overall Study|Miscellaneous|1|||
46903884|NCT03359395|83131940|FG000|First Intervention A / B|Withdrawal by Subject|1|||
46903885|NCT03359395|83131941|FG001|First Intervention A / B|Withdrawal by Subject|0|||
46903886|NCT03359395|83131940|FG000|First Intervention A / B|Lost to Follow-up|2|||
46903887|NCT03359395|83131941|FG001|First Intervention A / B|Lost to Follow-up|3|||
46903888|NCT03359395|83131940|FG000|Second Intervention B/A|Exclusion criteria|0|||
46903889|NCT03359395|83131941|FG001|Second Intervention B/A|Exclusion criteria|1|||
46903890|NCT03359395|83131940|FG000|Second Intervention B/A|Lost to Follow-up|3|||
46903891|NCT03359395|83131941|FG001|Second Intervention B/A|Lost to Follow-up|2|||
46903892|NCT03586427|83131952|FG000|Overall Study|Lost to Follow-up|0|||
46903893|NCT03586427|83131953|FG001|Overall Study|Lost to Follow-up|3|||
46903894|NCT03586427|83131954|FG002|Overall Study|Lost to Follow-up|1|||
46903895|NCT03586427|83131955|FG003|Overall Study|Lost to Follow-up|3|||
46903896|NCT03586427|83131956|FG004|Overall Study|Lost to Follow-up|3|||
46903897|NCT03586427|83131952|FG000|Overall Study|Withdrawal by Subject|0|||
46903898|NCT03586427|83131953|FG001|Overall Study|Withdrawal by Subject|1|||
46903899|NCT03586427|83131954|FG002|Overall Study|Withdrawal by Subject|2|||
46903900|NCT03586427|83131955|FG003|Overall Study|Withdrawal by Subject|1|||
46903901|NCT03586427|83131956|FG004|Overall Study|Withdrawal by Subject|1|||
46903902|NCT03586427|83131952|FG000|Overall Study|Adverse Event|0|||
46903903|NCT03586427|83131953|FG001|Overall Study|Adverse Event|0|||
46903904|NCT03586427|83131954|FG002|Overall Study|Adverse Event|1|||
46903905|NCT03586427|83131955|FG003|Overall Study|Adverse Event|0|||
46903906|NCT03586427|83131956|FG004|Overall Study|Adverse Event|0|||
46903907|NCT03586427|83131952|FG000|Overall Study|Protocol Violation|0|||
46903908|NCT03586427|83131953|FG001|Overall Study|Protocol Violation|0|||
46903909|NCT03586427|83131954|FG002|Overall Study|Protocol Violation|1|||
46903910|NCT03586427|83131955|FG003|Overall Study|Protocol Violation|0|||
46903911|NCT03586427|83131956|FG004|Overall Study|Protocol Violation|1|||
46903912|NCT03586427|83131952|FG000|Overall Study|Noncompliance with study drug|0|||
46903913|NCT03586427|83131953|FG001|Overall Study|Noncompliance with study drug|0|||
46903914|NCT03586427|83131954|FG002|Overall Study|Noncompliance with study drug|1|||
46903915|NCT03586427|83131955|FG003|Overall Study|Noncompliance with study drug|0|||
46903916|NCT03586427|83131956|FG004|Overall Study|Noncompliance with study drug|0|||
46903917|NCT03648983|83131973|FG000|Overall Study|Study was terminated due to PI departure|95|||
46903918|NCT02695420|83131982|FG000|Overall Study|Death|0|||
46903919|NCT02695420|83131983|FG001|Overall Study|Death|1|||
46903920|NCT02695420|83131984|FG002|Overall Study|Death|0|||
46903921|NCT02695420|83131985|FG003|Overall Study|Death|0|||
46903922|NCT03358147|83132003|FG000|Overall Study|Withdrawal by Subject|13|||
46903923|NCT03358147|83132004|FG001|Overall Study|Withdrawal by Subject|19|||
46903924|NCT03358147|83132005|FG002|Overall Study|Withdrawal by Subject|16|||
46903925|NCT03358147|83132006|FG003|Overall Study|Withdrawal by Subject|10|||
46903926|NCT03358147|83132007|FG004|Overall Study|Withdrawal by Subject|5|||
46903927|NCT03358147|83132003|FG000|Overall Study|Adverse Event|3|||
46903928|NCT03358147|83132004|FG001|Overall Study|Adverse Event|9|||
46903929|NCT03358147|83132005|FG002|Overall Study|Adverse Event|7|||
46903930|NCT03358147|83132006|FG003|Overall Study|Adverse Event|5|||
46903931|NCT03358147|83132007|FG004|Overall Study|Adverse Event|2|||
46903932|NCT03358147|83132003|FG000|Overall Study|Lost to Follow-up|4|||
46903933|NCT03358147|83132004|FG001|Overall Study|Lost to Follow-up|3|||
46903934|NCT03358147|83132005|FG002|Overall Study|Lost to Follow-up|7|||
46903935|NCT03358147|83132006|FG003|Overall Study|Lost to Follow-up|6|||
46903936|NCT03358147|83132007|FG004|Overall Study|Lost to Follow-up|4|||
46903937|NCT03358147|83132003|FG000|Overall Study|Major Protocol Deviation|11|||
46903938|NCT03358147|83132004|FG001|Overall Study|Major Protocol Deviation|3|||
46903939|NCT03358147|83132005|FG002|Overall Study|Major Protocol Deviation|2|||
46903940|NCT03358147|83132006|FG003|Overall Study|Major Protocol Deviation|3|||
46903941|NCT03358147|83132007|FG004|Overall Study|Major Protocol Deviation|1|||
46903942|NCT03358147|83132003|FG000|Overall Study|Protocol specified criteria|2|||
46903943|NCT03358147|83132004|FG001|Overall Study|Protocol specified criteria|3|||
46903944|NCT03358147|83132005|FG002|Overall Study|Protocol specified criteria|0|||
46903945|NCT03358147|83132006|FG003|Overall Study|Protocol specified criteria|3|||
46903946|NCT03358147|83132007|FG004|Overall Study|Protocol specified criteria|1|||
46903947|NCT03358147|83132003|FG000|Overall Study|Physician Decision|1|||
46903948|NCT03358147|83132004|FG001|Overall Study|Physician Decision|0|||
46903949|NCT03358147|83132005|FG002|Overall Study|Physician Decision|1|||
46903950|NCT03358147|83132006|FG003|Overall Study|Physician Decision|6|||
46903951|NCT03358147|83132007|FG004|Overall Study|Physician Decision|1|||
46903952|NCT03358147|83132003|FG000|Overall Study|Administrative reasons|0|||
46903953|NCT03358147|83132004|FG001|Overall Study|Administrative reasons|1|||
46903954|NCT03358147|83132005|FG002|Overall Study|Administrative reasons|0|||
46903955|NCT03358147|83132006|FG003|Overall Study|Administrative reasons|3|||
46903956|NCT03358147|83132007|FG004|Overall Study|Administrative reasons|0|||
46903957|NCT03358147|83132003|FG000|Overall Study|Lack of Efficacy|0|||
46903958|NCT03358147|83132004|FG001|Overall Study|Lack of Efficacy|1|||
46903959|NCT03358147|83132005|FG002|Overall Study|Lack of Efficacy|1|||
46903960|NCT03358147|83132006|FG003|Overall Study|Lack of Efficacy|0|||
46903961|NCT03358147|83132007|FG004|Overall Study|Lack of Efficacy|0|||
46903962|NCT03093402|83132023|FG000|Overall Study|Lost to Follow-up|1|||
46903963|NCT03093402|83132024|FG001|Overall Study|Lost to Follow-up|0|||
46903964|NCT03093402|83132025|FG002|Overall Study|Lost to Follow-up|0|||
46903965|NCT03093402|83132026|FG003|Overall Study|Lost to Follow-up|0|||
46620194|NCT02270736|82761813|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
46903966|NCT03093402|83132023|FG000|Overall Study|Withdrawal by Subject|3|||
46903967|NCT03093402|83132024|FG001|Overall Study|Withdrawal by Subject|3|||
46903968|NCT03093402|83132025|FG002|Overall Study|Withdrawal by Subject|0|||
46903969|NCT03093402|83132026|FG003|Overall Study|Withdrawal by Subject|1|||
46903970|NCT03093402|83132023|FG000|Overall Study|Withdrew prior to dosing|2|||
46903971|NCT03093402|83132024|FG001|Overall Study|Withdrew prior to dosing|1|||
46903972|NCT03093402|83132025|FG002|Overall Study|Withdrew prior to dosing|2|||
46903973|NCT03093402|83132026|FG003|Overall Study|Withdrew prior to dosing|3|||
46903974|NCT03093402|83132023|FG000|Overall Study|Ineligible for study|1|||
46903975|NCT03093402|83132024|FG001|Overall Study|Ineligible for study|0|||
46903976|NCT03093402|83132025|FG002|Overall Study|Ineligible for study|0|||
46903977|NCT03093402|83132026|FG003|Overall Study|Ineligible for study|0|||
46903978|NCT03093402|83132023|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
46903979|NCT03093402|83132024|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
46903980|NCT03093402|83132025|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
46967483|NCT02124772|83210027|FG008|Overall Study|Adverse Event|0|||
46903981|NCT03093402|83132026|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
46903982|NCT03585959|83132036|FG000|Overall Study|Physician Decision|1|||
46903983|NCT03585959|83132036|FG000|Overall Study|Unsuccessful Procedure|2|||
46903984|NCT03584789|83132045|FG000|Overall Study|refused EHR permission|19|||
46903985|NCT03584789|83132046|FG001|Overall Study|refused EHR permission|28|||
46903986|NCT03584789|83132047|FG002|Overall Study|refused EHR permission|23|||
46903987|NCT03584789|83132045|FG000|Overall Study|patients tied to a provider who retired|0|||
46903988|NCT03584789|83132046|FG001|Overall Study|patients tied to a provider who retired|0|||
46903989|NCT03584789|83132047|FG002|Overall Study|patients tied to a provider who retired|3|||
46903990|NCT03343639|83132057|FG000|Overall Study|Withdrawal by Subject|10|||
46903991|NCT03343639|83132058|FG001|Overall Study|Withdrawal by Subject|6|||
46903992|NCT03343639|83132057|FG000|Overall Study|Lost to Follow-up|4|||
46903993|NCT03343639|83132058|FG001|Overall Study|Lost to Follow-up|5|||
46903994|NCT03343639|83132057|FG000|Overall Study|Protocol Violation|0|||
46903995|NCT03343639|83132058|FG001|Overall Study|Protocol Violation|1|||
46903996|NCT03647267|83132066|FG000|Overall Study|Lost to Follow-up|1|||
46903997|NCT03647267|83132067|FG001|Overall Study|Lost to Follow-up|0|||
46903998|NCT03356977|83132075|FG000|Overall Study|Lost to Follow-up|3|||
46903999|NCT03356977|83132075|FG000|Overall Study|Withdrawal by parent/guardian|2|||
46904000|NCT02690974|83132079|FG000|Overall Study|Adverse Event|16|||
46904001|NCT02690974|83132079|FG000|Overall Study|Death|9|||
46904002|NCT02690974|83132079|FG000|Overall Study|Subject/guardian decision|4|||
46904003|NCT02690974|83132079|FG000|Overall Study|Lost to Follow-up|3|||
46904004|NCT02690974|83132079|FG000|Overall Study|Withdrawal of Informed Consent|3|||
46904005|NCT02690974|83132079|FG000|Overall Study|Physician Decision|2|||
46904006|NCT02690974|83132079|FG000|Overall Study|Non-compliance with study treatment|1|||
46904007|NCT02690974|83132079|FG000|Overall Study|Protocol-defined stopping criteria|1|||
46904008|NCT02690974|83132079|FG000|Overall Study|Protocol Deviation|1|||
46904009|NCT03093324|83132085|FG000|Overall Study|Adverse Event|4|||
46904010|NCT03093324|83132086|FG001|Overall Study|Adverse Event|15|||
46904011|NCT03093324|83132085|FG000|Overall Study|Lost to Follow-up|1|||
46904012|NCT03093324|83132086|FG001|Overall Study|Lost to Follow-up|0|||
46904013|NCT03093324|83132085|FG000|Overall Study|Protocol Deviation|2|||
46904014|NCT03093324|83132086|FG001|Overall Study|Protocol Deviation|2|||
46904015|NCT03093324|83132085|FG000|Overall Study|Withdrawal by Subject|2|||
46904016|NCT03093324|83132086|FG001|Overall Study|Withdrawal by Subject|2|||
46904017|NCT03584009|83132094|FG000|Overall Study|Death|25|||
46904018|NCT03584009|83132095|FG001|Overall Study|Death|18|||
46904019|NCT03584009|83132094|FG000|Overall Study|Lost to Follow-up|0|||
46904020|NCT03584009|83132095|FG001|Overall Study|Lost to Follow-up|1|||
46904021|NCT03584009|83132094|FG000|Overall Study|Physician Decision|1|||
46904022|NCT03584009|83132095|FG001|Overall Study|Physician Decision|1|||
46904023|NCT03584009|83132094|FG000|Overall Study|Study Terminated by Sponsor|22|||
46904024|NCT03584009|83132095|FG001|Overall Study|Study Terminated by Sponsor|30|||
46904025|NCT03584009|83132094|FG000|Overall Study|Withdrawal by Subject|3|||
46904026|NCT03584009|83132095|FG001|Overall Study|Withdrawal by Subject|2|||
46904027|NCT04167462|83132106|FG000|Overall Study|Other reasons|3|||
46904028|NCT04167462|83132107|FG001|Overall Study|Other reasons|2|||
46904029|NCT04167462|83132106|FG000|Overall Study|Withdrawal by Subject|6|||
46904030|NCT04167462|83132107|FG001|Overall Study|Withdrawal by Subject|7|||
46904031|NCT04167462|83132106|FG000|Overall Study|Adverse Event|4|||
46904032|NCT04167462|83132107|FG001|Overall Study|Adverse Event|0|||
46904033|NCT04167462|83132106|FG000|Overall Study|Pregnancy|1|||
46904034|NCT04167462|83132107|FG001|Overall Study|Pregnancy|0|||
46904035|NCT04167462|83132106|FG000|Overall Study|Lack of Efficacy|0|||
46904036|NCT04167462|83132107|FG001|Overall Study|Lack of Efficacy|1|||
46904037|NCT03583385|83132114|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46904038|NCT03583385|83132115|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46904039|NCT03583385|83132114|FG000|Treatment Period 2|Adverse Event|1|||
46904040|NCT03583385|83132115|FG001|Treatment Period 2|Adverse Event|0|||
46904041|NCT04350372|83132121|FG000|Overall Study|Death|1|||
46904042|NCT02949973|83132125|FG000|Overall Study|Physician Decision|1|||
46904043|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
46904044|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
46904045|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Adverse Event|2|||
46904046|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Adverse Event|5|||
46904047|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
46904048|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
46904049|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
46904050|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
46709151|NCT01559935|82925114|FG000|BiRD Phase|Lack of Efficacy|1|||
46904051|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Randomized by error|0|||
46904052|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Randomized by error|5|||
46904053|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
46904054|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
46904055|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
46904056|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
46904057|NCT02948959|83132131|FG000|52 Weeks Treatment Period|Change of residence location|0|||
46904058|NCT02948959|83132132|FG001|52 Weeks Treatment Period|Change of residence location|1|||
46904059|NCT02948959|83132131|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
46904060|NCT02948959|83132132|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
46904061|NCT02948959|83132131|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
46904062|NCT02948959|83132132|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
46904063|NCT02948959|83132131|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
46904064|NCT02948959|83132132|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
46904065|NCT02948959|83132131|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
46904066|NCT02948959|83132132|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
46904067|NCT02948959|83132131|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
46904068|NCT02948959|83132132|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
46904069|NCT02948959|83132131|FG000|12 Weeks Follow-up Period|Study site closure|1|||
46904070|NCT02948959|83132132|FG001|12 Weeks Follow-up Period|Study site closure|0|||
46997097|NCT02326298|83244033|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46904071|NCT03582215|83132154|FG000|Overall Study|Adverse Event|1|||
46904072|NCT03582215|83132155|FG001|Overall Study|Adverse Event|0|||
46904073|NCT03582215|83132156|FG002|Overall Study|Adverse Event|0|||
46904074|NCT03582215|83132157|FG003|Overall Study|Adverse Event|0|||
46904075|NCT03582215|83132158|FG004|Overall Study|Adverse Event|0|||
46904076|NCT03582215|83132159|FG005|Overall Study|Adverse Event|0|||
46904077|NCT03582215|83132160|FG006|Overall Study|Adverse Event|2|||
46904078|NCT03582215|83132161|FG007|Overall Study|Adverse Event|2|||
46904079|NCT03089580|83132190|FG000|Overall Study|Lost to Follow-up|2|||
46904080|NCT03645395|83132200|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
46904081|NCT03645395|83132201|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
46904082|NCT03645395|83132202|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
46904083|NCT03645395|83132203|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
46904084|NCT03645395|83132200|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
46904085|NCT03645395|83132201|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
46904086|NCT03645395|83132202|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
46904087|NCT03645395|83132203|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
46904088|NCT03645395|83132200|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
46904089|NCT03645395|83132201|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
46904090|NCT03645395|83132202|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
46904091|NCT03645395|83132203|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
46904092|NCT03645395|83132200|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
46904093|NCT03645395|83132201|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
46904094|NCT03645395|83132202|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
46904095|NCT03645395|83132203|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
46904096|NCT03342469|83132216|FG000|Overall Study|Withdrawal by Subject|0|||
46904097|NCT03342469|83132217|FG001|Overall Study|Withdrawal by Subject|1|||
46904098|NCT03342469|83132218|FG002|Overall Study|Withdrawal by Subject|0|||
46904099|NCT03342469|83132219|FG003|Overall Study|Withdrawal by Subject|0|||
46904100|NCT03581825|83132230|FG000|Period 1|Lens Discomfort|1|||
46904101|NCT03581825|83132231|FG001|Period 1|Lens Discomfort|0|||
46904102|NCT03581825|83132230|FG000|Period 2|Unsatisfactory Vision to Test|0|||
46904103|NCT03581825|83132231|FG001|Period 2|Unsatisfactory Vision to Test|1|||
46904104|NCT03342001|83132237|FG000|Overall Study|Adverse Event|1|||
46904105|NCT03342001|83132237|FG000|Overall Study|Lost to Follow-up|1|||
46904106|NCT03341923|83132241|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
46904107|NCT03341923|83132242|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
46904108|NCT03579719|83132250|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
46904109|NCT03341533|83132256|FG000|Overall Study|Withdrawal by Subject|1|||
46904110|NCT03341533|83132257|FG001|Overall Study|Withdrawal by Subject|1|||
46904111|NCT03341533|83132256|FG000|Overall Study|Not eligible after randomization|2|||
46904112|NCT03341533|83132257|FG001|Overall Study|Not eligible after randomization|1|||
46997098|NCT02326298|83244034|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46997099|NCT02326298|83244021|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997100|NCT02326298|83244022|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997101|NCT02326298|83244023|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
46997102|NCT02326298|83244024|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46620195|NCT02270736|82761809|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
46620196|NCT02270736|82761810|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
46904113|NCT02688088|83132263|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
46904114|NCT02688088|83132264|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
46904115|NCT02688088|83132265|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
46904116|NCT02688088|83132266|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
46904117|NCT02688088|83132267|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
46904118|NCT02688088|83132263|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
46904119|NCT02688088|83132264|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
46904120|NCT02688088|83132265|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
46904121|NCT02688088|83132266|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
46904122|NCT02688088|83132267|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
46904123|NCT02688088|83132263|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
46904124|NCT02688088|83132264|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
46904125|NCT02688088|83132265|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
46904126|NCT02688088|83132266|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
46904127|NCT02688088|83132267|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
46904128|NCT02688088|83132263|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
46904129|NCT02688088|83132264|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
46904130|NCT02688088|83132265|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
46904131|NCT02688088|83132266|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
46904132|NCT02688088|83132267|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
46904133|NCT02688088|83132263|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
46904134|NCT02688088|83132264|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
46904135|NCT02688088|83132265|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
46904136|NCT02688088|83132266|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
46904137|NCT02688088|83132267|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
46904138|NCT02688088|83132263|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
46904139|NCT02688088|83132264|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
46904140|NCT02688088|83132265|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
46904141|NCT02688088|83132266|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
46904142|NCT02688088|83132267|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
46904143|NCT02688088|83132263|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
46904144|NCT02688088|83132264|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
46904145|NCT02688088|83132265|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
46904146|NCT02688088|83132266|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
46904147|NCT02688088|83132267|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
46904148|NCT02688088|83132263|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
46904149|NCT02688088|83132264|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
46904150|NCT02688088|83132265|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
46904151|NCT02688088|83132266|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
46904152|NCT02688088|83132267|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
46904153|NCT02688088|83132263|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
46904154|NCT02688088|83132264|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
46904155|NCT02688088|83132265|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
46904156|NCT02688088|83132266|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
46904157|NCT02688088|83132267|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
46904158|NCT03641651|83132292|FG000|Overall Study|organizational issues at one study site|1|||
46904159|NCT03341299|83132296|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
46904160|NCT03341299|83132297|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
46904161|NCT03341299|83132298|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
46904162|NCT03341299|83132299|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
46904163|NCT02949271|83132313|FG000|Overall Study|Lack of Efficacy|5|||
46904164|NCT02949271|83132314|FG001|Overall Study|Lack of Efficacy|4|||
46904165|NCT02949271|83132313|FG000|Overall Study|Lost to Follow-up|3|||
46904166|NCT02949271|83132314|FG001|Overall Study|Lost to Follow-up|6|||
46904167|NCT02949271|83132313|FG000|Overall Study|Physician Decision|5|||
46904168|NCT02949271|83132314|FG001|Overall Study|Physician Decision|5|||
46904169|NCT02949271|83132313|FG000|Overall Study|Protocol Violation|6|||
46904170|NCT02949271|83132314|FG001|Overall Study|Protocol Violation|3|||
46904171|NCT02949271|83132313|FG000|Overall Study|Withdrawal by Subject|1|||
46904172|NCT02949271|83132314|FG001|Overall Study|Withdrawal by Subject|0|||
46904173|NCT02949271|83132313|FG000|Overall Study|Delivered prior to intervention|7|||
46904174|NCT02949271|83132314|FG001|Overall Study|Delivered prior to intervention|9|||
46904175|NCT02949271|83132313|FG000|Overall Study|Outside the window for cervical dilation|2|||
46904176|NCT02949271|83132314|FG001|Overall Study|Outside the window for cervical dilation|3|||
46904177|NCT03640559|83132322|FG000|Overall Study|Physician Decision|1|||
46904178|NCT03640559|83132323|FG001|Overall Study|Physician Decision|1|||
46904179|NCT03640559|83132322|FG000|Overall Study|Withdrawal by Subject|1|||
46904180|NCT03640559|83132323|FG001|Overall Study|Withdrawal by Subject|0|||
46904181|NCT03339583|83132331|FG000|First Intervention (14 Days)|Adverse Event|1|||
46904182|NCT03339583|83132332|FG001|First Intervention (14 Days)|Adverse Event|0|||
46904183|NCT03339583|83132331|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
46904184|NCT03339583|83132332|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
46904185|NCT03339583|83132331|FG000|Second Intervention (14 Days)|Adverse Event|0|||
46904186|NCT03339583|83132332|FG001|Second Intervention (14 Days)|Adverse Event|1|||
46904187|NCT03339583|83132331|FG000|Follow-up (14 Days)|Physician Decision|6|||
46904188|NCT03339583|83132332|FG001|Follow-up (14 Days)|Physician Decision|3|||
46904189|NCT03639779|83132340|FG000|Overall Study|Lost to Follow-up|1|||
46904190|NCT03575975|83132349|FG000|Overall Study|Lost to Follow-up|1|||
46904191|NCT03575975|83132350|FG001|Overall Study|Lost to Follow-up|0|||
46904192|NCT03575975|83132351|FG002|Overall Study|Lost to Follow-up|0|||
46904193|NCT03636893|83132359|FG000|Overall Study|Death|0|||
46904194|NCT03636893|83132360|FG001|Overall Study|Death|1|||
46904195|NCT03636893|83132359|FG000|Overall Study|Protocol Violation|0|||
46904196|NCT03636893|83132360|FG001|Overall Study|Protocol Violation|3|||
46904197|NCT03636893|83132359|FG000|Overall Study|Withdrawal by Subject|1|||
46904198|NCT03636893|83132360|FG001|Overall Study|Withdrawal by Subject|2|||
46904199|NCT03636893|83132359|FG000|Overall Study|Refusal to surgery|4|||
46904200|NCT03636893|83132360|FG001|Overall Study|Refusal to surgery|3|||
46904201|NCT03636893|83132359|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
46904202|NCT03636893|83132360|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
46904203|NCT03636893|83132359|FG000|Overall Study|Adverse Event|1|||
46904204|NCT03636893|83132360|FG001|Overall Study|Adverse Event|1|||
46904205|NCT01353586|83132368|FG000|Overall Study|Procedure terminated prior to ablation|3|||
46904206|NCT01353586|83132369|FG001|Overall Study|Procedure terminated prior to ablation|0|||
46904207|NCT01353586|83132368|FG000|Overall Study|Never had insertion of study catheter|4|||
46904208|NCT01353586|83132369|FG001|Overall Study|Never had insertion of study catheter|1|||
46904209|NCT01353586|83132368|FG000|Overall Study|Neurological exam not done|0|||
46904210|NCT01353586|83132369|FG001|Overall Study|Neurological exam not done|1|||
46904211|NCT03091920|83132381|FG000|Overall Study|Adverse Event|0|||
46904212|NCT03091920|83132382|FG001|Overall Study|Adverse Event|1|||
46904213|NCT03091920|83132383|FG002|Overall Study|Adverse Event|0|||
46904214|NCT03338569|83132399|FG000|Overall Study|Physician Decision|8|||
46904215|NCT03338569|83132400|FG001|Overall Study|Physician Decision|3|||
46904216|NCT03338569|83132399|FG000|Overall Study|Withdrawal by Subject|0|||
46904217|NCT03338569|83132400|FG001|Overall Study|Withdrawal by Subject|1|||
46904218|NCT03338569|83132399|FG000|Overall Study|Lost to Follow-up|0|||
46904219|NCT03338569|83132400|FG001|Overall Study|Lost to Follow-up|1|||
46904220|NCT03338023|83132408|FG000|Overall Study|Withdrawal by Subject|3|||
46904221|NCT03338023|83132409|FG001|Overall Study|Withdrawal by Subject|4|||
46904222|NCT03338023|83132408|FG000|Overall Study|Protocol Violation|3|||
46904223|NCT03338023|83132409|FG001|Overall Study|Protocol Violation|3|||
46904224|NCT03338023|83132408|FG000|Overall Study|Lost to Follow-up|2|||
46904225|NCT03338023|83132409|FG001|Overall Study|Lost to Follow-up|1|||
46904226|NCT03338023|83132408|FG000|Overall Study|Physician Decision|1|||
46904227|NCT03338023|83132409|FG001|Overall Study|Physician Decision|2|||
46904228|NCT03337477|83132417|FG000|Overall Study|not categorized into the listed ones|11|||
46904229|NCT03337477|83132418|FG001|Overall Study|not categorized into the listed ones|9|||
46904230|NCT03337477|83132417|FG000|Overall Study|Withdrawal by Subject|0|||
46904231|NCT03337477|83132418|FG001|Overall Study|Withdrawal by Subject|1|||
46904232|NCT03337477|83132417|FG000|Overall Study|Death|0|||
46904233|NCT03337477|83132418|FG001|Overall Study|Death|1|||
46904234|NCT03337477|83132417|FG000|Overall Study|Lost to Follow-up|0|||
46904235|NCT03337477|83132418|FG001|Overall Study|Lost to Follow-up|2|||
46904236|NCT02687542|83132431|FG000|Overall Study|Medication error without associated AEs|0|||
46904237|NCT02687542|83132432|FG001|Overall Study|Medication error without associated AEs|0|||
46904238|NCT02687542|83132433|FG002|Overall Study|Medication error without associated AEs|0|||
46904239|NCT02687542|83132434|FG003|Overall Study|Medication error without associated AEs|0|||
46904240|NCT02687542|83132435|FG004|Overall Study|Medication error without associated AEs|1|||
46904241|NCT02687542|83132431|FG000|Overall Study|Lost to Follow-up|0|||
46904242|NCT02687542|83132432|FG001|Overall Study|Lost to Follow-up|0|||
46904243|NCT02687542|83132433|FG002|Overall Study|Lost to Follow-up|0|||
46904244|NCT02687542|83132434|FG003|Overall Study|Lost to Follow-up|0|||
46904245|NCT02687542|83132435|FG004|Overall Study|Lost to Follow-up|1|||
46904246|NCT02687542|83132431|FG000|Overall Study|Protocol Violation|0|||
46904247|NCT02687542|83132432|FG001|Overall Study|Protocol Violation|1|||
46904248|NCT02687542|83132433|FG002|Overall Study|Protocol Violation|0|||
46904249|NCT02687542|83132434|FG003|Overall Study|Protocol Violation|0|||
46904250|NCT02687542|83132435|FG004|Overall Study|Protocol Violation|0|||
46904251|NCT02687542|83132431|FG000|Overall Study|Other|5|||
46904252|NCT02687542|83132432|FG001|Overall Study|Other|9|||
46904253|NCT02687542|83132433|FG002|Overall Study|Other|10|||
46904254|NCT02687542|83132434|FG003|Overall Study|Other|6|||
46904255|NCT02687542|83132435|FG004|Overall Study|Other|5|||
46904256|NCT02687542|83132431|FG000|Overall Study|Adverse Event|3|||
46904257|NCT02687542|83132432|FG001|Overall Study|Adverse Event|1|||
46904258|NCT02687542|83132433|FG002|Overall Study|Adverse Event|3|||
46904259|NCT02687542|83132434|FG003|Overall Study|Adverse Event|2|||
46904260|NCT02687542|83132435|FG004|Overall Study|Adverse Event|9|||
46904261|NCT02687542|83132431|FG000|Overall Study|Withdrawal by Subject|0|||
46904262|NCT02687542|83132432|FG001|Overall Study|Withdrawal by Subject|1|||
46904263|NCT02687542|83132433|FG002|Overall Study|Withdrawal by Subject|1|||
46904264|NCT02687542|83132434|FG003|Overall Study|Withdrawal by Subject|2|||
46904265|NCT02687542|83132435|FG004|Overall Study|Withdrawal by Subject|4|||
46904266|NCT03336619|83132449|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
46904267|NCT03336619|83132450|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
46904268|NCT03336619|83132449|FG000|Overall Study|Withdrawal by Subject|17|||
46904269|NCT03336619|83132450|FG001|Overall Study|Withdrawal by Subject|16|||
46904270|NCT03336619|83132449|FG000|Overall Study|Adverse Event|2|||
46904271|NCT03336619|83132450|FG001|Overall Study|Adverse Event|5|||
46904272|NCT03336619|83132449|FG000|Overall Study|Physician Decision|3|||
46904273|NCT03336619|83132450|FG001|Overall Study|Physician Decision|0|||
46904274|NCT01353508|83132472|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
46904275|NCT01353508|83132473|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
46904276|NCT01353508|83132474|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
46904277|NCT01353508|83132475|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
46904278|NCT01353508|83132472|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
46904279|NCT01353508|83132473|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
46904280|NCT01353508|83132474|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
46904281|NCT01353508|83132475|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
46904282|NCT03636269|83132487|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
46904283|NCT03636269|83132488|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
46904284|NCT03636269|83132489|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
46904285|NCT03636269|83132487|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
46904286|NCT03636269|83132488|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
46904287|NCT03636269|83132489|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
46904288|NCT03636269|83132487|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
46904289|NCT03636269|83132488|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
46904290|NCT03636269|83132489|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
46904291|NCT03636269|83132487|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
46904292|NCT03636269|83132488|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
46904293|NCT03636269|83132489|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
46904294|NCT03636269|83132487|FG000|Period 1: Double-blind Phase|Other|6|||
46904295|NCT03636269|83132488|FG001|Period 1: Double-blind Phase|Other|3|||
46904296|NCT03636269|83132489|FG002|Period 1: Double-blind Phase|Other|0|||
46904297|NCT03636269|83132487|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
46904298|NCT03636269|83132488|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
46904299|NCT03636269|83132489|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
46904300|NCT03636269|83132487|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
46904301|NCT03636269|83132488|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
46904302|NCT03636269|83132489|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
46904303|NCT03636269|83132487|FG000|Period 2: Open-label Phase|Adverse Event|0|||
46904304|NCT03636269|83132488|FG001|Period 2: Open-label Phase|Adverse Event|0|||
46904305|NCT03636269|83132489|FG002|Period 2: Open-label Phase|Adverse Event|21|||
46904306|NCT03636269|83132487|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
46904307|NCT03636269|83132488|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
46904308|NCT03636269|83132489|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
46904309|NCT03636269|83132487|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
46904310|NCT03636269|83132488|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
46904311|NCT03636269|83132489|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
46904312|NCT03636269|83132487|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
46904313|NCT03636269|83132488|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
46904314|NCT03636269|83132489|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
46904315|NCT03636269|83132487|FG000|Period 2: Open-label Phase|Administrative|0|||
46904316|NCT03636269|83132488|FG001|Period 2: Open-label Phase|Administrative|0|||
46904317|NCT03636269|83132489|FG002|Period 2: Open-label Phase|Administrative|36|||
46904318|NCT03636269|83132487|FG000|Period 2: Open-label Phase|Other|0|||
46904319|NCT03636269|83132488|FG001|Period 2: Open-label Phase|Other|0|||
46904320|NCT03636269|83132489|FG002|Period 2: Open-label Phase|Other|9|||
46904321|NCT03636269|83132487|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
46904322|NCT03636269|83132488|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
46904323|NCT03636269|83132489|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
46904324|NCT02685202|83132498|FG000|Overall Study|Lost to Follow-up|9|||
46904325|NCT03087786|83132504|FG000|Overall Study|Withdrawal by Subject|2|||
46904326|NCT03087786|83132505|FG001|Overall Study|Withdrawal by Subject|0|||
46904327|NCT03635957|83132511|FG000|Run-In Period|Lost to Follow-up|1|||
46904328|NCT03635957|83132511|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
46904329|NCT01353274|83132516|FG000|Overall Study|No case report form (CRF) collected|28|||
46904330|NCT02690194|83132523|FG000|Overall Study|Withdrawal by Subject|1|||
46904331|NCT02690194|83132524|FG001|Overall Study|Withdrawal by Subject|4|||
46904332|NCT02690194|83132525|FG002|Overall Study|Withdrawal by Subject|0|||
46904333|NCT02684344|83132535|FG000|Overall Study|Withdrawal by Subject|0|||
46904334|NCT02684344|83132536|FG001|Overall Study|Withdrawal by Subject|1|||
46904335|NCT02683876|83132544|FG000|Overall Study|samples damaged during shipping|2|||
46904336|NCT02683876|83132545|FG001|Overall Study|samples damaged during shipping|0|||
46904337|NCT03974100|83132555|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
46904338|NCT03974100|83132556|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
46904339|NCT03974100|83132557|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
46904340|NCT03974100|83132558|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
46904341|NCT03974100|83132559|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
46904342|NCT03974100|83132555|FG000|TP1 - Day 1 to Week 52|Death|1|||
46904343|NCT03974100|83132556|FG001|TP1 - Day 1 to Week 52|Death|0|||
46904344|NCT03974100|83132557|FG002|TP1 - Day 1 to Week 52|Death|0|||
46904345|NCT03974100|83132558|FG003|TP1 - Day 1 to Week 52|Death|0|||
46904346|NCT03974100|83132559|FG004|TP1 - Day 1 to Week 52|Death|0|||
46904347|NCT03974100|83132555|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
46904348|NCT03974100|83132556|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
46904349|NCT03974100|83132557|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
46904350|NCT03974100|83132558|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
46904351|NCT03974100|83132559|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
46904352|NCT03974100|83132555|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
46904353|NCT03974100|83132556|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
46904354|NCT03974100|83132557|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
46904355|NCT03974100|83132558|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
46904356|NCT03974100|83132559|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
46904357|NCT03974100|83132555|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
46904358|NCT03974100|83132556|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
46904359|NCT03974100|83132557|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
46904360|NCT03974100|83132558|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
46904361|NCT03974100|83132559|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
46904362|NCT03974100|83132555|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
46904363|NCT03974100|83132556|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
46904364|NCT03974100|83132557|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
46904365|NCT03974100|83132558|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
46904366|NCT03974100|83132559|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
46904367|NCT03974100|83132555|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
46904368|NCT03974100|83132556|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
46904369|NCT03974100|83132557|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
46904370|NCT03974100|83132558|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
46904371|NCT03974100|83132559|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
46904372|NCT02689804|83132573|FG000|Overall Study|Withdrawal by Subject|2|||
46904373|NCT02689804|83132574|FG001|Overall Study|Withdrawal by Subject|0|||
46904374|NCT02946931|83132583|FG000|Overall Study|Did not require collection of CRFs|588|||
46904375|NCT02946931|83132583|FG000|Overall Study|Other than listed|37|||
46904376|NCT02946931|83132583|FG000|Overall Study|Discharge from hospital|118|||
46904377|NCT02946931|83132583|FG000|Overall Study|Adverse Event|81|||
46904378|NCT02946931|83132583|FG000|Overall Study|CRFs not valid|1|||
46904379|NCT02946931|83132583|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
46904380|NCT02689492|83132587|FG000|Overall Study|Lost to Follow-up|61|||
46904381|NCT02689492|83132587|FG000|Overall Study|Withdrawal by Subject|11|||
46904382|NCT02689492|83132587|FG000|Overall Study|Death|9|||
46904383|NCT02689492|83132587|FG000|Overall Study|Physician Decision|2|||
46904384|NCT02689492|83132587|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
46904385|NCT02689492|83132587|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
46904386|NCT02689492|83132587|FG000|Overall Study|Other than listed|1|||
46904387|NCT01374568|83132605|FG000|Overall Study|Lab unable to analyze BTM|0|||
46904388|NCT01374568|83132606|FG001|Overall Study|Lab unable to analyze BTM|2|||
46904389|NCT02682784|83132616|FG000|Overall Study|Withdrawal by Subject|0|||
46904390|NCT02682784|83132617|FG001|Overall Study|Withdrawal by Subject|2|||
46904391|NCT02682784|83132618|FG002|Overall Study|Withdrawal by Subject|1|||
46904392|NCT02682784|83132619|FG003|Overall Study|Withdrawal by Subject|2|||
46904393|NCT02682784|83132616|FG000|Overall Study|Physician Decision|1|||
46904394|NCT02682784|83132617|FG001|Overall Study|Physician Decision|0|||
46997103|NCT02326298|83244025|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997104|NCT02326298|83244026|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997105|NCT02326298|83244027|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46904395|NCT02682784|83132618|FG002|Overall Study|Physician Decision|1|||
46904396|NCT02682784|83132619|FG003|Overall Study|Physician Decision|1|||
46904397|NCT03387852|83132633|FG000|Overall Study|Adverse event (AE)|3|||
46904398|NCT03387852|83132634|FG001|Overall Study|Adverse event (AE)|0|||
46904399|NCT03387852|83132635|FG002|Overall Study|Adverse event (AE)|2|||
46904400|NCT03387852|83132636|FG003|Overall Study|Adverse event (AE)|0|||
46904401|NCT03387852|83132633|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
46904402|NCT03387852|83132634|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
46904403|NCT03387852|83132635|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
46904404|NCT03387852|83132636|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
46904405|NCT03387852|83132633|FG000|Overall Study|Withdrawal by participant|1|||
46904406|NCT03387852|83132634|FG001|Overall Study|Withdrawal by participant|1|||
46904407|NCT03387852|83132635|FG002|Overall Study|Withdrawal by participant|3|||
46904408|NCT03387852|83132636|FG003|Overall Study|Withdrawal by participant|2|||
46904409|NCT03387852|83132633|FG000|Overall Study|Other- Unspecified|1|||
46904410|NCT03387852|83132634|FG001|Overall Study|Other- Unspecified|1|||
46904411|NCT03387852|83132635|FG002|Overall Study|Other- Unspecified|2|||
46904412|NCT03387852|83132636|FG003|Overall Study|Other- Unspecified|1|||
46904413|NCT03387852|83132633|FG000|Overall Study|Poor compliance to protocol|0|||
46904414|NCT03387852|83132634|FG001|Overall Study|Poor compliance to protocol|0|||
46904415|NCT03387852|83132635|FG002|Overall Study|Poor compliance to protocol|0|||
46904416|NCT03387852|83132636|FG003|Overall Study|Poor compliance to protocol|1|||
46997106|NCT02326298|83244028|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997107|NCT02326298|83244029|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997108|NCT02326298|83244030|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997109|NCT02326298|83244031|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997110|NCT02326298|83244032|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997111|NCT02326298|83244033|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997112|NCT02326298|83244034|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
46997113|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997114|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997115|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997116|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997117|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997118|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46997119|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
46997120|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46997121|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46997122|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
46997123|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997124|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997125|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46997126|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
46620197|NCT02270736|82761811|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
46620198|NCT02270736|82761812|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
46904417|NCT03387852|83132633|FG000|Overall Study|Randomized and not treated|0|||
46997127|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997128|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997129|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997130|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997131|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997132|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
46997133|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
46997134|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997135|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
46997136|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997137|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997138|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997139|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997140|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
46997141|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997142|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997143|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997144|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997145|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997146|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
46997147|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997148|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997149|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997150|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997151|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997152|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997153|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997154|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
46997155|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997156|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997157|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997158|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997159|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997160|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997161|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
46997162|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997163|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46904418|NCT03387852|83132634|FG001|Overall Study|Randomized and not treated|0|||
46904419|NCT03387852|83132635|FG002|Overall Study|Randomized and not treated|0|||
46904420|NCT03387852|83132636|FG003|Overall Study|Randomized and not treated|1|||
46904421|NCT02679274|83132649|FG000|Overall Study|Withdrawal by Subject|1|||
46904422|NCT02679274|83132650|FG001|Overall Study|Withdrawal by Subject|0|||
46904423|NCT04969861|83132658|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
46904424|NCT04969861|83132659|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
46904425|NCT02678416|83132667|FG000|Part 1|Withdrawal by Subject|1|||
46904426|NCT02678416|83132667|FG000|Part 2|Adverse Event|2|||
46904427|NCT02678416|83132667|FG000|Part 2|Withdrawal by Subject|1|||
46904428|NCT02680834|83132687|FG000|Overall Study|Physician Decision|5|||
46904429|NCT02680834|83132688|FG001|Overall Study|Physician Decision|2|||
46904430|NCT02680834|83132687|FG000|Overall Study|Withdrawal by Subject|6|||
46904431|NCT02680834|83132688|FG001|Overall Study|Withdrawal by Subject|0|||
46904432|NCT02680834|83132687|FG000|Overall Study|Lost to Follow-up|0|||
46904433|NCT02680834|83132688|FG001|Overall Study|Lost to Follow-up|1|||
46904434|NCT03343704|83132696|FG000|Overall Study|Refused to complete follow up|0|||
46904435|NCT03343704|83132697|FG001|Overall Study|Refused to complete follow up|1|||
46904436|NCT03343704|83132696|FG000|Overall Study|Death|0|||
46997164|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997165|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997166|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997167|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997168|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
46997169|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46904437|NCT03343704|83132697|FG001|Overall Study|Death|1|||
46904438|NCT03343704|83132696|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
46904439|NCT03343704|83132697|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
46904440|NCT02680756|83132707|FG000|Overall Study|Adverse Event|10|||
46904441|NCT02680756|83132708|FG001|Overall Study|Adverse Event|2|||
46904442|NCT02680756|83132707|FG000|Overall Study|Lost to Follow-up|7|||
46904443|NCT02680756|83132708|FG001|Overall Study|Lost to Follow-up|6|||
46904444|NCT02680756|83132707|FG000|Overall Study|Withdrawal by Subject|5|||
46904445|NCT02680756|83132708|FG001|Overall Study|Withdrawal by Subject|5|||
46904446|NCT02680756|83132707|FG000|Overall Study|Physician Decision|4|||
46904447|NCT02680756|83132708|FG001|Overall Study|Physician Decision|1|||
46904448|NCT02680756|83132707|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
46904449|NCT02680756|83132708|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
46904450|NCT02680756|83132707|FG000|Overall Study|Blood transfusion for any reason|0|||
46904451|NCT02680756|83132708|FG001|Overall Study|Blood transfusion for any reason|1|||
46904452|NCT02680756|83132707|FG000|Overall Study|Death|1|||
46904453|NCT02680756|83132708|FG001|Overall Study|Death|0|||
46904454|NCT02680756|83132707|FG000|Overall Study|Protocol Violation|1|||
46904455|NCT02680756|83132708|FG001|Overall Study|Protocol Violation|0|||
46904456|NCT02680756|83132707|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
46904457|NCT02680756|83132708|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
46904458|NCT02680756|83132707|FG000|Overall Study|None of above or not recorded|3|||
46904459|NCT02680756|83132708|FG001|Overall Study|None of above or not recorded|2|||
46904460|NCT03086460|83132714|FG000|Study Participants|Lost to Follow-up|2|||
46904461|NCT03086460|83132714|FG000|Study Participants|Protocol Violation|1|||
46904462|NCT03086460|83132714|FG000|Study Participants|Withdrawal by Subject|6|||
46904463|NCT03086460|83132714|FG000|Treatment A|Lost to Follow-up|1|||
46904464|NCT03086460|83132714|FG000|Treatment A|Protocol Violation|1|||
46904465|NCT03086460|83132714|FG000|Treatment A|Withdrawal by Subject|2|||
46904466|NCT03086460|83132714|FG000|Treatment C|Withdrawal by Subject|2|||
46904467|NCT03086460|83132714|FG000|Treatment E|Lost to Follow-up|1|||
46904468|NCT03086460|83132714|FG000|Treatment E|Withdrawal by Subject|3|||
46904469|NCT02677714|83132740|FG000|Overall Study|Withdrawal by Subject|2|||
46904470|NCT02677714|83132741|FG001|Overall Study|Withdrawal by Subject|0|||
46904471|NCT02677324|83132747|FG000|Overall Study|Disease Progression|6|||
46904472|NCT02677324|83132747|FG000|Overall Study|Inability to Swallow pills|1|||
46904473|NCT02677324|83132747|FG000|Overall Study|Non-compliance|1|||
46904474|NCT02677324|83132747|FG000|Overall Study|Lack of Efficacy|1|||
46904475|NCT02677324|83132747|FG000|Overall Study|Medical insurance coverage|1|||
46904476|NCT02677324|83132747|FG000|Overall Study|Adverse Event|1|||
46904477|NCT02677324|83132747|FG000|Overall Study|IgM Myeloma diagnosis|1|||
46904478|NCT01971008|83132755|FG000|Overall Study|Protocol Violation|2|||
46904479|NCT01971008|83132756|FG001|Overall Study|Protocol Violation|1|||
46904480|NCT01374178|83132765|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
46904481|NCT01374178|83132766|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
46904482|NCT01374178|83132765|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
46904483|NCT01374178|83132766|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
46904484|NCT03025542|83132774|FG000|Overall Study|Adverse Event|0|||
46904485|NCT03025542|83132775|FG001|Overall Study|Adverse Event|2|||
46904486|NCT03025542|83132774|FG000|Overall Study|Lost to Follow-up|1|||
46904487|NCT03025542|83132775|FG001|Overall Study|Lost to Follow-up|0|||
46904488|NCT03025542|83132774|FG000|Overall Study|Withdrawal by Subject|1|||
46904489|NCT03025542|83132775|FG001|Overall Study|Withdrawal by Subject|0|||
46904490|NCT03022370|83132789|FG000|Overall Study|Death|6|||
46904491|NCT03022370|83132790|FG001|Overall Study|Death|12|||
46904492|NCT03022370|83132789|FG000|Overall Study|Lost to Follow-up|174|||
46904493|NCT03022370|83132790|FG001|Overall Study|Lost to Follow-up|109|||
46904494|NCT03021668|83132802|FG000|Overall Study|Physician Decision|0|||
46904495|NCT03021668|83132803|FG001|Overall Study|Physician Decision|1|||
46904496|NCT03020888|83132809|FG000|Overall Study|Physician Decision|4|||
46997170|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997171|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46904497|NCT03020888|83132809|FG000|Overall Study|Withdrawal by Subject|6|||
46904498|NCT03020888|83132809|FG000|Overall Study|Insurance coverage|2|||
47073109|NCT01045161|83361495|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
46904499|NCT03020888|83132809|FG000|Overall Study|Lost to Follow-up|1|||
46904500|NCT02250300|83132817|FG000|Expansion Phase|Death|6|||
46904501|NCT02250300|83132818|FG001|Expansion Phase|Death|7|||
46904502|NCT02250300|83132819|FG002|Expansion Phase|Death|0|||
46904503|NCT02250300|83132820|FG003|Expansion Phase|Death|0|||
46904504|NCT03020966|83132833|FG000|Overall Study|Withdrawal by Subject|2|||
46904505|NCT03020966|83132834|FG001|Overall Study|Withdrawal by Subject|0|||
46904506|NCT03020576|83132842|FG000|Overall Study|Withdrawal by Subject|1|||
46904507|NCT03020576|83132843|FG001|Overall Study|Withdrawal by Subject|2|||
46904508|NCT03017612|83132849|FG000|Overall Study|Adverse Event|2|||
46904509|NCT03635099|83132861|FG000|Period 1|Adverse Event|1|||
46904510|NCT03635099|83132862|FG001|Period 1|Adverse Event|0|||
46997172|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997173|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997174|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997175|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997176|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
46997177|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997178|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997179|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997180|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997181|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997182|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
46997183|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997184|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997185|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997186|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997187|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997188|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997189|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
46997190|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
46997191|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46904511|NCT03635099|83132863|FG002|Period 1|Adverse Event|0|||
46904512|NCT03635099|83132864|FG003|Period 1|Adverse Event|1|||
46904513|NCT03635099|83132865|FG004|Period 1|Adverse Event|0|||
46904514|NCT03635099|83132866|FG005|Period 1|Adverse Event|0|||
46904515|NCT03635099|83132867|FG006|Period 1|Adverse Event|0|||
46904516|NCT03635099|83132868|FG007|Period 1|Adverse Event|0|||
46904517|NCT03635099|83132861|FG000|Period 1|Protocol Violation|0|||
46904518|NCT03635099|83132862|FG001|Period 1|Protocol Violation|0|||
46904519|NCT03635099|83132863|FG002|Period 1|Protocol Violation|1|||
46904520|NCT03635099|83132864|FG003|Period 1|Protocol Violation|0|||
46904521|NCT03635099|83132865|FG004|Period 1|Protocol Violation|0|||
46904522|NCT03635099|83132866|FG005|Period 1|Protocol Violation|0|||
46904523|NCT03635099|83132867|FG006|Period 1|Protocol Violation|0|||
46904524|NCT03635099|83132868|FG007|Period 1|Protocol Violation|0|||
46904525|NCT03635099|83132861|FG000|Period 1|Lost to Follow-up|0|||
46904526|NCT03635099|83132862|FG001|Period 1|Lost to Follow-up|0|||
46904527|NCT03635099|83132863|FG002|Period 1|Lost to Follow-up|1|||
46904528|NCT03635099|83132864|FG003|Period 1|Lost to Follow-up|2|||
46904529|NCT03635099|83132865|FG004|Period 1|Lost to Follow-up|1|||
46904530|NCT03635099|83132866|FG005|Period 1|Lost to Follow-up|0|||
46904531|NCT03635099|83132867|FG006|Period 1|Lost to Follow-up|1|||
46904532|NCT03635099|83132868|FG007|Period 1|Lost to Follow-up|2|||
46904533|NCT03635099|83132861|FG000|Period 1|Withdrawal by Subject|3|||
46904534|NCT03635099|83132862|FG001|Period 1|Withdrawal by Subject|3|||
46904535|NCT03635099|83132863|FG002|Period 1|Withdrawal by Subject|5|||
46904536|NCT03635099|83132864|FG003|Period 1|Withdrawal by Subject|2|||
46904537|NCT03635099|83132865|FG004|Period 1|Withdrawal by Subject|2|||
46904538|NCT03635099|83132866|FG005|Period 1|Withdrawal by Subject|0|||
46904539|NCT03635099|83132867|FG006|Period 1|Withdrawal by Subject|3|||
46904540|NCT03635099|83132868|FG007|Period 1|Withdrawal by Subject|0|||
46904541|NCT03635099|83132861|FG000|Period 1|History of suicidal ideation|0|||
46904542|NCT03635099|83132862|FG001|Period 1|History of suicidal ideation|0|||
46904543|NCT03635099|83132863|FG002|Period 1|History of suicidal ideation|1|||
46904544|NCT03635099|83132864|FG003|Period 1|History of suicidal ideation|0|||
46904545|NCT03635099|83132865|FG004|Period 1|History of suicidal ideation|0|||
46904546|NCT03635099|83132866|FG005|Period 1|History of suicidal ideation|0|||
46904547|NCT03635099|83132867|FG006|Period 1|History of suicidal ideation|0|||
46904548|NCT03635099|83132868|FG007|Period 1|History of suicidal ideation|0|||
46904549|NCT03635099|83132861|FG000|Period 1|pursue other treatment options|0|||
46904550|NCT03635099|83132862|FG001|Period 1|pursue other treatment options|0|||
46904551|NCT03635099|83132863|FG002|Period 1|pursue other treatment options|0|||
46904552|NCT03635099|83132864|FG003|Period 1|pursue other treatment options|0|||
46904553|NCT03635099|83132865|FG004|Period 1|pursue other treatment options|0|||
46904554|NCT03635099|83132866|FG005|Period 1|pursue other treatment options|1|||
46904555|NCT03635099|83132867|FG006|Period 1|pursue other treatment options|0|||
46904556|NCT03635099|83132868|FG007|Period 1|pursue other treatment options|0|||
46904557|NCT03635099|83132861|FG000|Not Eligible for Period 2|Pregnancy|0|||
46904558|NCT03635099|83132862|FG001|Not Eligible for Period 2|Pregnancy|0|||
46904559|NCT03635099|83132863|FG002|Not Eligible for Period 2|Pregnancy|0|||
46904560|NCT03635099|83132864|FG003|Not Eligible for Period 2|Pregnancy|1|||
46904561|NCT03635099|83132865|FG004|Not Eligible for Period 2|Pregnancy|0|||
46904562|NCT03635099|83132866|FG005|Not Eligible for Period 2|Pregnancy|0|||
46904563|NCT03635099|83132867|FG006|Not Eligible for Period 2|Pregnancy|0|||
46904564|NCT03635099|83132868|FG007|Not Eligible for Period 2|Pregnancy|0|||
46904565|NCT03635099|83132861|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
46904566|NCT03635099|83132862|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
46904567|NCT03635099|83132863|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
46904568|NCT03635099|83132864|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
46904569|NCT03635099|83132865|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
46904570|NCT03635099|83132866|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
46904571|NCT03635099|83132867|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
46904572|NCT03635099|83132868|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
46904573|NCT03635099|83132861|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
46904574|NCT03635099|83132862|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
46904575|NCT03635099|83132863|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
46904576|NCT03635099|83132864|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
46904577|NCT03635099|83132865|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
46904578|NCT03635099|83132866|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
46904579|NCT03635099|83132867|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
46904580|NCT03635099|83132868|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
46904581|NCT03635099|83132861|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
46904582|NCT03635099|83132862|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
46904583|NCT03635099|83132863|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
46904584|NCT03635099|83132864|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
46904585|NCT03635099|83132865|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
46904586|NCT03635099|83132866|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
46904587|NCT03635099|83132867|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
46904588|NCT03635099|83132868|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
46904589|NCT03635099|83132861|FG000|Period 2|Adverse Event|0|||
46904590|NCT03635099|83132862|FG001|Period 2|Adverse Event|0|||
46904591|NCT03635099|83132863|FG002|Period 2|Adverse Event|1|||
46904592|NCT03635099|83132864|FG003|Period 2|Adverse Event|0|||
46904593|NCT03635099|83132865|FG004|Period 2|Adverse Event|1|||
46904594|NCT03635099|83132866|FG005|Period 2|Adverse Event|0|||
46904595|NCT03635099|83132867|FG006|Period 2|Adverse Event|0|||
46904596|NCT03635099|83132868|FG007|Period 2|Adverse Event|0|||
46904597|NCT03635099|83132861|FG000|Period 2|Lost to Follow-up|0|||
46904598|NCT03635099|83132862|FG001|Period 2|Lost to Follow-up|0|||
46904599|NCT03635099|83132863|FG002|Period 2|Lost to Follow-up|1|||
46904600|NCT03635099|83132864|FG003|Period 2|Lost to Follow-up|0|||
46904601|NCT03635099|83132865|FG004|Period 2|Lost to Follow-up|4|||
46904602|NCT03635099|83132866|FG005|Period 2|Lost to Follow-up|0|||
46904603|NCT03635099|83132867|FG006|Period 2|Lost to Follow-up|0|||
46904604|NCT03635099|83132868|FG007|Period 2|Lost to Follow-up|0|||
46904605|NCT03635099|83132861|FG000|Period 2|Withdrawal by Subject|0|||
46904606|NCT03635099|83132862|FG001|Period 2|Withdrawal by Subject|0|||
46904607|NCT03635099|83132863|FG002|Period 2|Withdrawal by Subject|7|||
46904608|NCT03635099|83132864|FG003|Period 2|Withdrawal by Subject|4|||
46904609|NCT03635099|83132865|FG004|Period 2|Withdrawal by Subject|7|||
46904610|NCT03635099|83132866|FG005|Period 2|Withdrawal by Subject|0|||
46904611|NCT03635099|83132867|FG006|Period 2|Withdrawal by Subject|0|||
46904612|NCT03635099|83132868|FG007|Period 2|Withdrawal by Subject|0|||
46904613|NCT03634085|83132896|FG000|Overall Study|Adverse Event|1|||
46904614|NCT03634085|83132897|FG001|Overall Study|Adverse Event|0|||
46904615|NCT03634085|83132896|FG000|Overall Study|Withdrawal by Subject|0|||
46904616|NCT03634085|83132897|FG001|Overall Study|Withdrawal by Subject|2|||
46904617|NCT02676778|83132913|FG000|Overall Study|Disease Progression|7|||
46904618|NCT02676778|83132914|FG001|Overall Study|Disease Progression|3|||
46904619|NCT02676778|83132915|FG002|Overall Study|Disease Progression|1|||
46904620|NCT02676778|83132913|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
46904621|NCT02676778|83132914|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
46904622|NCT02676778|83132915|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
46904623|NCT02676778|83132913|FG000|Overall Study|Withdrawal by Subject|3|||
46904624|NCT02676778|83132914|FG001|Overall Study|Withdrawal by Subject|2|||
46904625|NCT02676778|83132915|FG002|Overall Study|Withdrawal by Subject|0|||
46904626|NCT02676778|83132913|FG000|Overall Study|Other|4|||
46904627|NCT02676778|83132914|FG001|Overall Study|Other|3|||
46904628|NCT02676778|83132915|FG002|Overall Study|Other|0|||
46904629|NCT02676778|83132913|FG000|Overall Study|Adverse Event|2|||
46904630|NCT02676778|83132914|FG001|Overall Study|Adverse Event|3|||
46904631|NCT02676778|83132915|FG002|Overall Study|Adverse Event|0|||
46904632|NCT02946385|83132930|FG000|Overall Study|Lost to Follow-up|0|||
46904633|NCT02946385|83132931|FG001|Overall Study|Lost to Follow-up|0|||
46904634|NCT02946385|83132932|FG002|Overall Study|Lost to Follow-up|3|||
46904635|NCT02946385|83132933|FG003|Overall Study|Lost to Follow-up|0|||
46904636|NCT02946385|83132934|FG004|Overall Study|Lost to Follow-up|2|||
46904637|NCT02946385|83132935|FG005|Overall Study|Lost to Follow-up|1|||
46904638|NCT02694718|83132955|FG000|Overall Study|Death|1|||
46904639|NCT02694718|83132955|FG000|Overall Study|Withdrawal by Subject|1|||
46904640|NCT02944513|83132961|FG000|Overall Study|Withdrawal by Subject|4|||
46904641|NCT02944513|83132962|FG001|Overall Study|Withdrawal by Subject|1|||
46904642|NCT03018938|83132990|FG000|Overall Study|Death|0|||
46904643|NCT03018938|83132991|FG001|Overall Study|Death|1|||
46904644|NCT03018938|83132990|FG000|Overall Study|Lost to Follow-up|21|||
46904645|NCT03018938|83132991|FG001|Overall Study|Lost to Follow-up|32|||
46904646|NCT03018938|83132990|FG000|Overall Study|Withdrawal by Subject|38|||
46904647|NCT03018938|83132991|FG001|Overall Study|Withdrawal by Subject|45|||
46904648|NCT03018938|83132990|FG000|Overall Study|Physician Decision|3|||
46904649|NCT03018938|83132991|FG001|Overall Study|Physician Decision|2|||
46904650|NCT03018938|83132990|FG000|Overall Study|Sponsor Decision|0|||
46904651|NCT03018938|83132991|FG001|Overall Study|Sponsor Decision|1|||
46904652|NCT03018938|83132990|FG000|Overall Study|Screen failure-After randomization|4|||
46904653|NCT03018938|83132991|FG001|Overall Study|Screen failure-After randomization|2|||
46904654|NCT03018938|83132990|FG000|Overall Study|Not recorded|0|||
46904655|NCT03018938|83132991|FG001|Overall Study|Not recorded|2|||
46904656|NCT02943577|83132999|FG000|Overall Study|Protocol Violation|0|||
46904657|NCT02943577|83133000|FG001|Overall Study|Protocol Violation|1|||
46904658|NCT02943577|83132999|FG000|Overall Study|Adverse Event|3|||
46904659|NCT02943577|83133000|FG001|Overall Study|Adverse Event|2|||
46904660|NCT02943577|83132999|FG000|Overall Study|Lost to Follow-up|0|||
46904661|NCT02943577|83133000|FG001|Overall Study|Lost to Follow-up|1|||
46904662|NCT02943577|83132999|FG000|Overall Study|Withdrawal by Subject|1|||
46904663|NCT02943577|83133000|FG001|Overall Study|Withdrawal by Subject|1|||
46904664|NCT02943577|83132999|FG000|Overall Study|Pregnancy|1|||
46904665|NCT02943577|83133000|FG001|Overall Study|Pregnancy|0|||
46904666|NCT03016598|83133008|FG000|Overall Study|Lost to Follow-up|0|||
46904667|NCT03016598|83133009|FG001|Overall Study|Lost to Follow-up|2|||
46904668|NCT03017846|83133015|FG000|Overall Study|Lost to Follow-up|3|||
46904669|NCT03017846|83133015|FG000|Overall Study|Adverse Event|2|||
46904670|NCT03014180|83133021|FG000|Overall Study|Protocol Violation|2|||
46904671|NCT03011840|83133031|FG000|Overall Study|Not received PIL in post PIL phase|0|||
46904672|NCT03011840|83133032|FG001|Overall Study|Not received PIL in post PIL phase|21|||
46904673|NCT02942485|83133040|FG000|Overall Study|Lost to Follow-up|1|||
46904674|NCT02942485|83133041|FG001|Overall Study|Lost to Follow-up|0|||
46904675|NCT02942407|83133049|FG000|Overall Study|Lost to Follow-up|3|||
46904676|NCT02942407|83133050|FG001|Overall Study|Lost to Follow-up|2|||
46904677|NCT02942407|83133049|FG000|Overall Study|Withdrawal by Subject|7|||
46904678|NCT02942407|83133050|FG001|Overall Study|Withdrawal by Subject|9|||
46904679|NCT02942407|83133049|FG000|Overall Study|Death|16|||
46904680|NCT02942407|83133050|FG001|Overall Study|Death|13|||
46904681|NCT03009344|83133064|FG000|Overall Study|Lack of Efficacy|5|||
46904682|NCT03009344|83133064|FG000|Overall Study|Withdrawal by Subject|1|||
46904683|NCT03009344|83133064|FG000|Overall Study|Adverse Event|1|||
46904684|NCT03322423|83133068|FG000|Period 1|Subject no longer eligible|0|||
46904685|NCT03322423|83133069|FG001|Period 1|Subject no longer eligible|1|||
46904686|NCT03322423|83133068|FG000|Period 1|Withdrawal by Subject|0|||
46904687|NCT03322423|83133069|FG001|Period 1|Withdrawal by Subject|1|||
46904688|NCT03322423|83133068|FG000|Period 1|Incorrect Lens Dispensed|1|||
46904689|NCT03322423|83133069|FG001|Period 1|Incorrect Lens Dispensed|0|||
46904690|NCT03322423|83133068|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
46904691|NCT03322423|83133069|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
46904692|NCT03322423|83133068|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
46904693|NCT03322423|83133069|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
46904694|NCT03322423|83133068|FG000|Period 2|Protocol Violation|1|||
46904695|NCT03322423|83133069|FG001|Period 2|Protocol Violation|0|||
46904696|NCT03322423|83133068|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
46904697|NCT03322423|83133069|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
46904698|NCT03007472|83133075|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
46904699|NCT03007472|83133075|FG000|Overall Study|Death|2|||
46904700|NCT03007472|83133075|FG000|Overall Study|Loss to Follow Up|1|||
46904701|NCT03321721|83133082|FG000|Overall Study|Lost to Follow-up|4|||
46904702|NCT03321721|83133083|FG001|Overall Study|Lost to Follow-up|8|||
46904703|NCT03321721|83133084|FG002|Overall Study|Lost to Follow-up|11|||
46904704|NCT03015116|83133096|FG000|Overall Study|Lost to Follow-up|3|||
46904705|NCT03015116|83133097|FG001|Overall Study|Lost to Follow-up|0|||
46904706|NCT03015116|83133098|FG002|Overall Study|Lost to Follow-up|2|||
46904707|NCT03015116|83133096|FG000|Overall Study|Withdrawal by Subject|3|||
46904708|NCT03015116|83133097|FG001|Overall Study|Withdrawal by Subject|1|||
46904709|NCT03015116|83133098|FG002|Overall Study|Withdrawal by Subject|0|||
46904710|NCT03015116|83133096|FG000|Overall Study|Subject has New Medical Status|1|||
46904711|NCT03015116|83133097|FG001|Overall Study|Subject has New Medical Status|0|||
46904712|NCT03015116|83133098|FG002|Overall Study|Subject has New Medical Status|0|||
46904713|NCT03015116|83133096|FG000|Overall Study|Physician Decision|0|||
46904714|NCT03015116|83133097|FG001|Overall Study|Physician Decision|1|||
46904715|NCT03015116|83133098|FG002|Overall Study|Physician Decision|0|||
46904716|NCT03006458|83133108|FG000|First Intervention|Unsatisfied Vision|0|||
46904717|NCT03006458|83133109|FG001|First Intervention|Unsatisfied Vision|3|||
46904718|NCT03320941|83133120|FG000|Overall Study|subject/guardian decision|0|||
46904719|NCT03320941|83133121|FG001|Overall Study|subject/guardian decision|0|||
46904720|NCT03320941|83133122|FG002|Overall Study|subject/guardian decision|0|||
46904721|NCT03320941|83133123|FG003|Overall Study|subject/guardian decision|1|||
46904722|NCT03320941|83133124|FG004|Overall Study|subject/guardian decision|0|||
46904723|NCT03005288|83133138|FG000|Overall Study|Withdrawal by Subject|7|||
46904724|NCT03005288|83133139|FG001|Overall Study|Withdrawal by Subject|5|||
46904725|NCT03005288|83133138|FG000|Overall Study|Lost to Follow-up|0|||
46904726|NCT03005288|83133139|FG001|Overall Study|Lost to Follow-up|1|||
46904727|NCT03005288|83133138|FG000|Overall Study|Adverse Event|5|||
46904728|NCT03005288|83133139|FG001|Overall Study|Adverse Event|0|||
46904729|NCT03005288|83133138|FG000|Overall Study|Protocol deviation|0|||
46904730|NCT03005288|83133139|FG001|Overall Study|Protocol deviation|1|||
46904731|NCT03005288|83133138|FG000|Overall Study|Physician Decision|0|||
46904732|NCT03005288|83133139|FG001|Overall Study|Physician Decision|1|||
46904733|NCT03003494|83133145|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
46904734|NCT03559699|83133149|FG000|Overall Study|Withdrawal by Subject|6|||
46904735|NCT03559699|83133149|FG000|Overall Study|Lost to Follow-up|1|||
46904736|NCT03935880|83133165|FG000|Overall Study|Lost to Follow-up|0|||
46904737|NCT03935880|83133166|FG001|Overall Study|Lost to Follow-up|1|||
46904738|NCT03315793|83133174|FG000|Overall Study|Adverse Event|4|||
46904739|NCT03315793|83133175|FG001|Overall Study|Adverse Event|2|||
46904740|NCT03315793|83133174|FG000|Overall Study|Protocol Deviation|1|||
46904741|NCT03315793|83133175|FG001|Overall Study|Protocol Deviation|0|||
46904742|NCT03315793|83133174|FG000|Overall Study|Difficult for regular visit|0|||
46904743|NCT03315793|83133175|FG001|Overall Study|Difficult for regular visit|1|||
46904744|NCT02676466|83133191|FG000|Overall Study|Death|0|||
46904745|NCT02676466|83133192|FG001|Overall Study|Death|2|||
46904746|NCT02676466|83133193|FG002|Overall Study|Death|1|||
46904747|NCT02676466|83133194|FG003|Overall Study|Death|0|||
46904748|NCT02676466|83133195|FG004|Overall Study|Death|0|||
46904749|NCT02676466|83133196|FG005|Overall Study|Death|0|||
46904750|NCT02676466|83133197|FG006|Overall Study|Death|0|||
46904751|NCT02676466|83133198|FG007|Overall Study|Death|0|||
46904752|NCT02676466|83133191|FG000|Overall Study|Withdrawal by Subject|4|||
46904753|NCT02676466|83133192|FG001|Overall Study|Withdrawal by Subject|3|||
46904754|NCT02676466|83133193|FG002|Overall Study|Withdrawal by Subject|1|||
46904755|NCT02676466|83133194|FG003|Overall Study|Withdrawal by Subject|0|||
46904756|NCT02676466|83133195|FG004|Overall Study|Withdrawal by Subject|3|||
46904757|NCT02676466|83133196|FG005|Overall Study|Withdrawal by Subject|1|||
46904758|NCT02676466|83133197|FG006|Overall Study|Withdrawal by Subject|1|||
46904759|NCT02676466|83133198|FG007|Overall Study|Withdrawal by Subject|1|||
46904760|NCT03633695|83133222|FG000|Overall Study|Lost to Follow-up|4|||
46904761|NCT03633695|83133223|FG001|Overall Study|Lost to Follow-up|5|||
46904762|NCT03633695|83133222|FG000|Overall Study|Discontinued|8|||
46904763|NCT03633695|83133223|FG001|Overall Study|Discontinued|4|||
46904764|NCT03314233|83133245|FG000|Overall Study|No longer eligible at time of delivery|1|||
46904765|NCT02675998|83133253|FG000|8-Week Treatment Period|Adverse Event|6|||
46904766|NCT02675998|83133254|FG001|8-Week Treatment Period|Adverse Event|5|||
46904767|NCT02675998|83133255|FG002|8-Week Treatment Period|Adverse Event|6|||
46904768|NCT02675998|83133256|FG003|8-Week Treatment Period|Adverse Event|0|||
46904769|NCT02675998|83133253|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
46904770|NCT02675998|83133254|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
46904771|NCT02675998|83133255|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
46904772|NCT02675998|83133256|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
46904773|NCT02675998|83133253|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
46904774|NCT02675998|83133254|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
46904775|NCT02675998|83133255|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
46904776|NCT02675998|83133256|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
46904777|NCT02675998|83133253|FG000|8-Week Treatment Period|Physician Decision|1|||
46904778|NCT02675998|83133254|FG001|8-Week Treatment Period|Physician Decision|0|||
46904779|NCT02675998|83133255|FG002|8-Week Treatment Period|Physician Decision|2|||
46904780|NCT02675998|83133256|FG003|8-Week Treatment Period|Physician Decision|0|||
46904781|NCT02675998|83133253|FG000|8-Week Treatment Period|GI side Effects|1|||
46904782|NCT02675998|83133254|FG001|8-Week Treatment Period|GI side Effects|4|||
46904783|NCT02675998|83133255|FG002|8-Week Treatment Period|GI side Effects|2|||
46904784|NCT02675998|83133256|FG003|8-Week Treatment Period|GI side Effects|0|||
46904785|NCT02675998|83133253|FG000|8-Week Treatment Period|Protocol Violation|1|||
46904786|NCT02675998|83133254|FG001|8-Week Treatment Period|Protocol Violation|1|||
46904787|NCT02675998|83133255|FG002|8-Week Treatment Period|Protocol Violation|1|||
46904788|NCT02675998|83133256|FG003|8-Week Treatment Period|Protocol Violation|0|||
46904789|NCT02675998|83133253|FG000|8-Week Treatment Period|Other|3|||
46904790|NCT02675998|83133254|FG001|8-Week Treatment Period|Other|1|||
46904791|NCT02675998|83133255|FG002|8-Week Treatment Period|Other|2|||
46904792|NCT02675998|83133256|FG003|8-Week Treatment Period|Other|0|||
46904793|NCT02675998|83133253|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
46904794|NCT02675998|83133254|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
46904795|NCT02675998|83133255|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
46904796|NCT02675998|83133256|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
46904797|NCT02675998|83133253|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
46904798|NCT02675998|83133254|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
46904799|NCT02675998|83133255|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
46904800|NCT02675998|83133256|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
46904801|NCT02675998|83133253|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
46904802|NCT02675998|83133254|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
46904803|NCT02675998|83133255|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
46904804|NCT02675998|83133256|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
46904805|NCT02675998|83133253|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
46904806|NCT02675998|83133254|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
46904807|NCT02675998|83133255|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
46904808|NCT02675998|83133256|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
46904809|NCT02675998|83133253|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
46904810|NCT02675998|83133254|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
46904811|NCT02675998|83133255|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
46904812|NCT02675998|83133256|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
46904813|NCT02674204|83133272|FG000|Overall Study|Adverse Event|1|||
46904814|NCT02674204|83133273|FG001|Overall Study|Adverse Event|0|||
46904815|NCT02941627|83133279|FG000|Overall Study|Death|1|||
46904816|NCT02941627|83133279|FG000|Overall Study|Surgical failure|1|||
46904817|NCT02941627|83133279|FG000|Overall Study|cholesteatoma prevented implantation|1|||
46904818|NCT03521934|83133291|FG000|Overall Study|Death|65|||
46904819|NCT03521934|83133292|FG001|Overall Study|Death|73|||
46904820|NCT03521934|83133291|FG000|Overall Study|Withdrawal by Subject|18|||
46904821|NCT03521934|83133292|FG001|Overall Study|Withdrawal by Subject|23|||
46904822|NCT03521934|83133291|FG000|Overall Study|Site Terminated by Sponsor|39|||
46904823|NCT03521934|83133292|FG001|Overall Study|Site Terminated by Sponsor|35|||
46904824|NCT03521934|83133291|FG000|Overall Study|Study Terminated by Sponsor|483|||
46904825|NCT03521934|83133292|FG001|Overall Study|Study Terminated by Sponsor|477|||
46904826|NCT03521934|83133291|FG000|Overall Study|Reason not Specified|3|||
46904827|NCT03521934|83133292|FG001|Overall Study|Reason not Specified|6|||
46904828|NCT03434353|83133303|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
46904829|NCT03434353|83133304|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
46904830|NCT03434353|83133305|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
46904831|NCT03434353|83133306|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
46904832|NCT03434353|83133307|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
46904833|NCT03434353|83133303|FG000|Overall Study|Withdrew consent|1|||
46904834|NCT03434353|83133304|FG001|Overall Study|Withdrew consent|0|||
46904835|NCT03434353|83133305|FG002|Overall Study|Withdrew consent|3|||
46904836|NCT03434353|83133306|FG003|Overall Study|Withdrew consent|0|||
46904837|NCT03434353|83133307|FG004|Overall Study|Withdrew consent|0|||
46904838|NCT03434353|83133303|FG000|Overall Study|Adverse Event|1|||
46904839|NCT03434353|83133304|FG001|Overall Study|Adverse Event|0|||
46904840|NCT03434353|83133305|FG002|Overall Study|Adverse Event|0|||
46904841|NCT03434353|83133306|FG003|Overall Study|Adverse Event|0|||
46904842|NCT03434353|83133307|FG004|Overall Study|Adverse Event|1|||
46904843|NCT03434353|83133303|FG000|Overall Study|Lost to Follow-up|2|||
46904844|NCT03434353|83133304|FG001|Overall Study|Lost to Follow-up|0|||
46904845|NCT03434353|83133305|FG002|Overall Study|Lost to Follow-up|0|||
46904846|NCT03434353|83133306|FG003|Overall Study|Lost to Follow-up|0|||
46904847|NCT03434353|83133307|FG004|Overall Study|Lost to Follow-up|0|||
46904848|NCT02914184|83133323|FG000|Overall Study|Lost to Follow-up|7|||
46904849|NCT02914184|83133324|FG001|Overall Study|Lost to Follow-up|10|||
46997192|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997193|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997194|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46709152|NCT01559935|82925114|FG000|BiRD Phase|Withdrawal by Subject|2|||
46904850|NCT02914184|83133325|FG002|Overall Study|Lost to Follow-up|8|||
46904851|NCT02914184|83133326|FG003|Overall Study|Lost to Follow-up|7|||
46904852|NCT02914184|83133323|FG000|Overall Study|Withdrawal by Subject|4|||
46904853|NCT02914184|83133324|FG001|Overall Study|Withdrawal by Subject|2|||
46904854|NCT02914184|83133325|FG002|Overall Study|Withdrawal by Subject|7|||
46904855|NCT02914184|83133326|FG003|Overall Study|Withdrawal by Subject|3|||
46904856|NCT02914184|83133323|FG000|Overall Study|Other|1|||
46904857|NCT02914184|83133324|FG001|Overall Study|Other|0|||
46904858|NCT02914184|83133325|FG002|Overall Study|Other|0|||
46904859|NCT02914184|83133326|FG003|Overall Study|Other|0|||
46904860|NCT02914184|83133323|FG000|Overall Study|Migrated/moved from the study area|2|||
46904861|NCT02914184|83133324|FG001|Overall Study|Migrated/moved from the study area|1|||
46904862|NCT02914184|83133325|FG002|Overall Study|Migrated/moved from the study area|2|||
46904863|NCT02914184|83133326|FG003|Overall Study|Migrated/moved from the study area|1|||
46904864|NCT03633227|83133340|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
46904865|NCT03633227|83133341|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
46904866|NCT03633227|83133340|FG000|Double Blind (DB), up to Week 48|Death|2|||
46904867|NCT03633227|83133341|FG001|Double Blind (DB), up to Week 48|Death|1|||
46904868|NCT03633227|83133340|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
46904869|NCT03633227|83133341|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
46904870|NCT03633227|83133340|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
46904871|NCT03633227|83133341|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
46904872|NCT03633227|83133340|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
46904873|NCT03633227|83133341|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
46904874|NCT03633227|83133340|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
46904875|NCT03633227|83133341|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
46904876|NCT03633227|83133340|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
46904877|NCT03633227|83133341|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
46904878|NCT03633227|83133340|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
46904879|NCT03633227|83133341|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
46904880|NCT03633227|83133340|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
46904881|NCT03633227|83133341|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
46904882|NCT03633227|83133340|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
46904883|NCT03633227|83133341|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
46904884|NCT03633227|83133340|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
46904885|NCT03633227|83133341|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
46904886|NCT03633227|83133340|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
46904887|NCT03633227|83133341|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
46904888|NCT02913326|83133354|FG000|Overall Study|Reason not listed|0|||
46904889|NCT02913326|83133355|FG001|Overall Study|Reason not listed|1|||
46904890|NCT02913326|83133354|FG000|Overall Study|Lost to Follow-up|0|||
46904891|NCT02913326|83133355|FG001|Overall Study|Lost to Follow-up|1|||
46904892|NCT02913326|83133354|FG000|Overall Study|Adverse Event|1|||
46904893|NCT02913326|83133355|FG001|Overall Study|Adverse Event|0|||
46904894|NCT02912468|83133363|FG000|Overall Study|Adverse Event|3|||
46904895|NCT02912468|83133364|FG001|Overall Study|Adverse Event|2|||
46904896|NCT02912468|83133363|FG000|Overall Study|Withdrawal by Subject|6|||
46904897|NCT02912468|83133364|FG001|Overall Study|Withdrawal by Subject|2|||
46904898|NCT02912468|83133363|FG000|Overall Study|Randomized and not treated|0|||
46904899|NCT02912468|83133364|FG001|Overall Study|Randomized and not treated|1|||
46904900|NCT04438499|83133371|FG000|Overall Study|Lack of Efficacy|2|||
46904901|NCT00002874|83133377|FG000|Overall Study|Withdrawal by Subject|1|||
46904902|NCT00002874|83133378|FG001|Overall Study|Withdrawal by Subject|1|||
46904903|NCT00002874|83133377|FG000|Overall Study|Protocol Violation|44|||
46904904|NCT00002874|83133378|FG001|Overall Study|Protocol Violation|34|||
46904905|NCT03001076|83133386|FG000|Overall Study|Withdrawal by patient|2|||
46904906|NCT03001076|83133387|FG001|Overall Study|Withdrawal by patient|0|||
46904907|NCT03001076|83133386|FG000|Overall Study|Other|1|||
46904908|NCT03001076|83133387|FG001|Overall Study|Other|0|||
46904909|NCT03001076|83133386|FG000|Overall Study|Adverse Event|3|||
46904910|NCT03001076|83133387|FG001|Overall Study|Adverse Event|3|||
46904911|NCT03001076|83133386|FG000|Overall Study|Sponsor decision|1|||
46904912|NCT03001076|83133387|FG001|Overall Study|Sponsor decision|0|||
46904913|NCT03001076|83133386|FG000|Overall Study|Lost to Follow-up|0|||
46904914|NCT03001076|83133387|FG001|Overall Study|Lost to Follow-up|2|||
46904915|NCT03555305|83133393|FG000|Period 1|Physician Decision|0|||
46904916|NCT03555305|83133394|FG001|Period 1|Physician Decision|1|||
46904917|NCT03555305|83133393|FG000|Period 1|Adverse Event|0|||
46904918|NCT03555305|83133394|FG001|Period 1|Adverse Event|1|||
46904919|NCT03553823|83133402|FG000|Overall Study|Physician Decision|0|||
46904920|NCT03553823|83133403|FG001|Overall Study|Physician Decision|1|||
46904921|NCT03000686|83133411|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
46904922|NCT03000686|83133412|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
46904923|NCT03000686|83133413|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
46904924|NCT03000686|83133414|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
46904925|NCT02493660|83133432|FG000|Overall Study|Physician Decision|0|||
46904926|NCT02493660|83133433|FG001|Overall Study|Physician Decision|1|||
46904927|NCT02493660|83133432|FG000|Overall Study|Adverse Event|4|||
46904928|NCT02493660|83133433|FG001|Overall Study|Adverse Event|2|||
46904929|NCT02493660|83133432|FG000|Overall Study|Withdrawal by Subject|2|||
46904930|NCT02493660|83133433|FG001|Overall Study|Withdrawal by Subject|3|||
46904931|NCT02493660|83133432|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
46904932|NCT02493660|83133433|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
46904933|NCT02493660|83133432|FG000|Overall Study|Protocol Violation|0|||
46904934|NCT02493660|83133433|FG001|Overall Study|Protocol Violation|1|||
46904935|NCT02493660|83133432|FG000|Overall Study|Death|0|||
46904936|NCT02493660|83133433|FG001|Overall Study|Death|1|||
46904937|NCT02493660|83133432|FG000|Overall Study|Lost to Follow-up|2|||
46904938|NCT02493660|83133433|FG001|Overall Study|Lost to Follow-up|4|||
46904939|NCT03552029|83133443|FG000|Overall Study|Death|3|||
46904940|NCT03552029|83133444|FG001|Overall Study|Death|0|||
46904941|NCT03552029|83133443|FG000|Overall Study|Adverse Event|1|||
46904942|NCT03552029|83133444|FG001|Overall Study|Adverse Event|0|||
46997195|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997196|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
46997197|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997198|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46904943|NCT03552029|83133443|FG000|Overall Study|Lack of Efficacy|0|||
46904944|NCT03552029|83133444|FG001|Overall Study|Lack of Efficacy|2|||
46904945|NCT03552029|83133443|FG000|Overall Study|Physician Decision|0|||
46904946|NCT03552029|83133444|FG001|Overall Study|Physician Decision|1|||
46904947|NCT03552029|83133443|FG000|Overall Study|Study terminated by Sponsor|0|||
46904948|NCT03552029|83133444|FG001|Overall Study|Study terminated by Sponsor|1|||
46904949|NCT03552029|83133443|FG000|Overall Study|Other|0|||
46904950|NCT03552029|83133444|FG001|Overall Study|Other|2|||
46904951|NCT05395104|83133450|FG000|Overall Study|Met Liver Stopping Criteria|1|||
46904952|NCT05395104|83133450|FG000|Overall Study|Withdrawal by Subject|1|||
46904953|NCT05327491|83133456|FG000|Periods 1 & 2|Miscellaneous|0|||
46904954|NCT05327491|83133457|FG001|Periods 1 & 2|Miscellaneous|1|||
46904955|NCT05327491|83133458|FG002|Periods 1 & 2|Miscellaneous|0|||
46904956|NCT05327491|83133459|FG003|Periods 1 & 2|Miscellaneous|0|||
46904957|NCT05327491|83133456|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
46904958|NCT05327491|83133457|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
46904959|NCT05327491|83133458|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
46904960|NCT05327491|83133459|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
46904961|NCT05299892|83133477|FG000|Overall Study|Withdrawal by Subject|2|||
46904962|NCT04983940|83133482|FG000|Overall Study|Lost to Follow-up|14|||
46904963|NCT04983940|83133482|FG000|Overall Study|Lack of Efficacy|2|||
46904964|NCT04966910|83133490|FG000|Baseline|Participant did not complete measure|0|||
46904965|NCT04966910|83133491|FG001|Baseline|Participant did not complete measure|0|||
46904966|NCT04966910|83133492|FG002|Baseline|Participant did not complete measure|1|||
46904967|NCT04966910|83133493|FG003|Baseline|Participant did not complete measure|0|||
46904968|NCT04966910|83133490|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
46904969|NCT04966910|83133491|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
46904970|NCT04966910|83133492|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
46904971|NCT04966910|83133493|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
46904972|NCT04966910|83133490|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
46904973|NCT04966910|83133491|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
46904974|NCT04966910|83133492|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
46904975|NCT04966910|83133493|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
46904976|NCT04966910|83133490|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
46904977|NCT04966910|83133491|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
46904978|NCT04966910|83133492|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
46904979|NCT04966910|83133493|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
46904980|NCT04900038|83133509|FG000|Overall Study|Adverse Event|1|||
46904981|NCT04900038|83133510|FG001|Overall Study|Adverse Event|0|||
46904982|NCT04900038|83133511|FG002|Overall Study|Adverse Event|1|||
46904983|NCT04900038|83133512|FG003|Overall Study|Adverse Event|1|||
46904984|NCT04900038|83133509|FG000|Overall Study|Withdrawal by Subject|0|||
46904985|NCT04900038|83133510|FG001|Overall Study|Withdrawal by Subject|1|||
46904986|NCT04900038|83133511|FG002|Overall Study|Withdrawal by Subject|0|||
46904987|NCT04900038|83133512|FG003|Overall Study|Withdrawal by Subject|0|||
46904988|NCT04900038|83133509|FG000|Overall Study|Study terminated by sponsor|18|||
46904989|NCT04900038|83133510|FG001|Overall Study|Study terminated by sponsor|15|||
46904990|NCT04900038|83133511|FG002|Overall Study|Study terminated by sponsor|17|||
46904991|NCT04900038|83133512|FG003|Overall Study|Study terminated by sponsor|14|||
46904992|NCT04900038|83133509|FG000|Overall Study|Protocol Deviation|1|||
46997199|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997200|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997201|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46620199|NCT02270736|82761813|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
46620200|NCT02269098|82761828|FG000|Overall Study|Lost to Follow-up|14|||
46904993|NCT04900038|83133510|FG001|Overall Study|Protocol Deviation|1|||
46904994|NCT04900038|83133511|FG002|Overall Study|Protocol Deviation|0|||
46904995|NCT04900038|83133512|FG003|Overall Study|Protocol Deviation|0|||
46904996|NCT04900038|83133509|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
46904997|NCT04900038|83133510|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
46904998|NCT04900038|83133511|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
46904999|NCT04900038|83133512|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
46905000|NCT04900038|83133509|FG000|Overall Study|Lost to Follow-up|0|||
46905001|NCT04900038|83133510|FG001|Overall Study|Lost to Follow-up|0|||
46905002|NCT04900038|83133511|FG002|Overall Study|Lost to Follow-up|0|||
46905003|NCT04900038|83133512|FG003|Overall Study|Lost to Follow-up|1|||
46905004|NCT04880642|83133524|FG000|Randomization|Withdrawal by Subject|2|||
46905005|NCT04880642|83133525|FG001|Randomization|Withdrawal by Subject|3|||
46905006|NCT04880642|83133524|FG000|Treatment Period|Adverse Event|0|||
46905007|NCT04880642|83133525|FG001|Treatment Period|Adverse Event|1|||
46905008|NCT04880642|83133524|FG000|Treatment Period|Death|6|||
46905009|NCT04880642|83133525|FG001|Treatment Period|Death|6|||
46905010|NCT04880642|83133524|FG000|Treatment Period|Lost to Follow-up|1|||
46905011|NCT04880642|83133525|FG001|Treatment Period|Lost to Follow-up|0|||
46905012|NCT04880642|83133524|FG000|Treatment Period|Protocol Violation|0|||
46905013|NCT04880642|83133525|FG001|Treatment Period|Protocol Violation|1|||
46905014|NCT04880642|83133524|FG000|Treatment Period|Withdrawal by Subject|5|||
46905015|NCT04880642|83133525|FG001|Treatment Period|Withdrawal by Subject|3|||
46905016|NCT04880642|83133524|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
46905017|NCT04880642|83133525|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
46905018|NCT04880642|83133524|FG000|Follow-up|Death|4|||
46905019|NCT04880642|83133525|FG001|Follow-up|Death|3|||
46905020|NCT04880642|83133524|FG000|Follow-up|Withdrawal by Subject|1|||
46905021|NCT04880642|83133525|FG001|Follow-up|Withdrawal by Subject|0|||
46905022|NCT04578535|83133537|FG000|Overall Study|Lost to Follow-up|1|||
46905023|NCT04578535|83133538|FG001|Overall Study|Lost to Follow-up|0|||
46905024|NCT04578535|83133539|FG002|Overall Study|Lost to Follow-up|0|||
46905025|NCT04578535|83133540|FG003|Overall Study|Lost to Follow-up|1|||
46905026|NCT04578535|83133541|FG004|Overall Study|Lost to Follow-up|0|||
46905027|NCT04578535|83133542|FG005|Overall Study|Lost to Follow-up|2|||
46905028|NCT04578535|83133537|FG000|Overall Study|Pregnancy|1|||
46905029|NCT04578535|83133538|FG001|Overall Study|Pregnancy|0|||
46905030|NCT04578535|83133539|FG002|Overall Study|Pregnancy|0|||
46905031|NCT04578535|83133540|FG003|Overall Study|Pregnancy|0|||
46905032|NCT04578535|83133541|FG004|Overall Study|Pregnancy|0|||
46905033|NCT04578535|83133542|FG005|Overall Study|Pregnancy|0|||
46905034|NCT04578535|83133537|FG000|Overall Study|Withdrawal by Subject|0|||
46905035|NCT04578535|83133538|FG001|Overall Study|Withdrawal by Subject|0|||
46905036|NCT04578535|83133539|FG002|Overall Study|Withdrawal by Subject|0|||
46905037|NCT04578535|83133540|FG003|Overall Study|Withdrawal by Subject|1|||
46905038|NCT04578535|83133541|FG004|Overall Study|Withdrawal by Subject|1|||
46905039|NCT04578535|83133542|FG005|Overall Study|Withdrawal by Subject|5|||
46905040|NCT04578535|83133537|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
46905041|NCT04578535|83133538|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
46905042|NCT04578535|83133539|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
46905043|NCT04578535|83133540|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
46905044|NCT04578535|83133541|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
46905045|NCT04578535|83133542|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
46905046|NCT04574362|83133562|FG000|Overall Study|Other|0|||
46905047|NCT04574362|83133563|FG001|Overall Study|Other|5|||
46905048|NCT04574362|83133562|FG000|Overall Study|COVID-19|0|||
46905049|NCT04574362|83133563|FG001|Overall Study|COVID-19|1|||
46905050|NCT04574362|83133562|FG000|Overall Study|Adverse Event|1|||
46905051|NCT04574362|83133563|FG001|Overall Study|Adverse Event|1|||
46905052|NCT04574362|83133562|FG000|Overall Study|Withdrawal by Subject|2|||
46905053|NCT04574362|83133563|FG001|Overall Study|Withdrawal by Subject|4|||
46905054|NCT04574362|83133562|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
46905055|NCT04574362|83133563|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
46905056|NCT04574362|83133562|FG000|Overall Study|Participant refused to come to the hospital|1|||
46905057|NCT04574362|83133563|FG001|Overall Study|Participant refused to come to the hospital|0|||
46905058|NCT04574362|83133562|FG000|Overall Study|Participant refused the visit|1|||
46905059|NCT04574362|83133563|FG001|Overall Study|Participant refused the visit|0|||
46997202|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997203|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46905060|NCT04574362|83133562|FG000|Overall Study|Participant quit early because of business trip|1|||
46905061|NCT04574362|83133563|FG001|Overall Study|Participant quit early because of business trip|0|||
46905062|NCT04470908|83133569|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
46905063|NCT04399837|83133583|FG000|Overall Study|Other than listed|0|||
46905064|NCT04399837|83133584|FG001|Overall Study|Other than listed|2|||
46905065|NCT04399837|83133585|FG002|Overall Study|Other than listed|2|||
46997204|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
46905066|NCT04399837|83133586|FG003|Overall Study|Other than listed|3|||
46905067|NCT04399837|83133583|FG000|Overall Study|Withdrawal by Subject|1|||
46905068|NCT04399837|83133584|FG001|Overall Study|Withdrawal by Subject|2|||
46905069|NCT04399837|83133585|FG002|Overall Study|Withdrawal by Subject|1|||
46905070|NCT04399837|83133586|FG003|Overall Study|Withdrawal by Subject|1|||
46905071|NCT04364269|83133609|FG000|Overall Study|Adverse Event|1|||
46905072|NCT04364269|83133610|FG001|Overall Study|Adverse Event|0|||
46905073|NCT04364269|83133611|FG002|Overall Study|Adverse Event|0|||
46905074|NCT04364269|83133609|FG000|Overall Study|Withdrawal by Subject|0|||
46905075|NCT04364269|83133610|FG001|Overall Study|Withdrawal by Subject|1|||
46905076|NCT04364269|83133611|FG002|Overall Study|Withdrawal by Subject|0|||
46905077|NCT04299048|83133619|FG000|Overall Study|Death|1|||
46905078|NCT04299048|83133619|FG000|Overall Study|Global deterioration of health status|2|||
46905079|NCT04299048|83133619|FG000|Overall Study|Enrolled and not treated|1|||
46905080|NCT03673462|83133651|FG000|Overall Study|Adverse Event|11|||
46905081|NCT03673462|83133652|FG001|Overall Study|Adverse Event|1|||
46905082|NCT03673462|83133651|FG000|Overall Study|Protocol Violation|25|||
46905083|NCT03673462|83133652|FG001|Overall Study|Protocol Violation|11|||
46905084|NCT03673462|83133651|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
46905085|NCT03673462|83133652|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
46905086|NCT03673462|83133651|FG000|Overall Study|Lost to Follow-up|102|||
46905087|NCT03673462|83133652|FG001|Overall Study|Lost to Follow-up|19|||
46905088|NCT03432364|83133661|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
46905089|NCT03307785|83133677|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
46905090|NCT03307785|83133678|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
46905091|NCT03307785|83133679|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
46905092|NCT03307785|83133680|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
46905093|NCT03307785|83133681|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
46905094|NCT03307785|83133682|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
46905095|NCT03307785|83133683|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
46905096|NCT03307785|83133684|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
46905097|NCT03307785|83133685|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
46905098|NCT03307785|83133686|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
46905099|NCT03307785|83133687|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
46905100|NCT03307785|83133677|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
46905101|NCT03307785|83133678|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
46905102|NCT03307785|83133679|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905103|NCT03307785|83133680|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905104|NCT03307785|83133681|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905105|NCT03307785|83133682|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905106|NCT03307785|83133683|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905107|NCT03307785|83133684|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905108|NCT03307785|83133685|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905109|NCT03307785|83133686|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905110|NCT03307785|83133687|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
46905111|NCT03307785|83133677|FG000|Part A: Up to 28.5 Months|Death|4|||
46905112|NCT03307785|83133678|FG001|Part A: Up to 28.5 Months|Death|4|||
46905113|NCT03307785|83133679|FG002|Part A: Up to 28.5 Months|Death|0|||
46905114|NCT03307785|83133680|FG003|Part A: Up to 28.5 Months|Death|0|||
46905115|NCT03307785|83133681|FG004|Part A: Up to 28.5 Months|Death|0|||
46905116|NCT03307785|83133682|FG005|Part A: Up to 28.5 Months|Death|0|||
46905117|NCT03307785|83133683|FG006|Part A: Up to 28.5 Months|Death|0|||
46905118|NCT03307785|83133684|FG007|Part A: Up to 28.5 Months|Death|0|||
46905119|NCT03307785|83133685|FG008|Part A: Up to 28.5 Months|Death|0|||
46905120|NCT03307785|83133686|FG009|Part A: Up to 28.5 Months|Death|0|||
46905121|NCT03307785|83133687|FG010|Part A: Up to 28.5 Months|Death|0|||
46905122|NCT03307785|83133677|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
46905123|NCT03307785|83133678|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
46905124|NCT03307785|83133679|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
46905125|NCT03307785|83133680|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
46905126|NCT03307785|83133681|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
46905127|NCT03307785|83133682|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
46905128|NCT03307785|83133683|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
46905129|NCT03307785|83133684|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
46905130|NCT03307785|83133685|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
46997205|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997206|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997207|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46905131|NCT03307785|83133686|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
46997208|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46905132|NCT03307785|83133687|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
46905133|NCT03307785|83133677|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
46620201|NCT02269098|82761829|FG001|Overall Study|Lost to Follow-up|9|||
46905134|NCT03307785|83133678|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
46905135|NCT03307785|83133679|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
46905136|NCT03307785|83133680|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
46905137|NCT03307785|83133681|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
46905138|NCT03307785|83133682|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
46905139|NCT03307785|83133683|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
46905140|NCT03307785|83133684|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
46905141|NCT03307785|83133685|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
46905142|NCT03307785|83133686|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
46905143|NCT03307785|83133687|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
46905144|NCT03307785|83133677|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
46905145|NCT03307785|83133678|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
46905146|NCT03307785|83133679|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
46905147|NCT03307785|83133680|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
46905148|NCT03307785|83133681|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
46905149|NCT03307785|83133682|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
46905150|NCT03307785|83133683|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
46905151|NCT03307785|83133684|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
46905152|NCT03307785|83133685|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
46905153|NCT03307785|83133686|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
46905154|NCT03307785|83133687|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
46905155|NCT03307785|83133677|FG000|Part B: Up to 28.5 Months|Death|0|||
46905156|NCT03307785|83133678|FG001|Part B: Up to 28.5 Months|Death|0|||
46905157|NCT03307785|83133679|FG002|Part B: Up to 28.5 Months|Death|7|||
46905158|NCT03307785|83133680|FG003|Part B: Up to 28.5 Months|Death|0|||
46905159|NCT03307785|83133681|FG004|Part B: Up to 28.5 Months|Death|0|||
46905160|NCT03307785|83133682|FG005|Part B: Up to 28.5 Months|Death|0|||
46905161|NCT03307785|83133683|FG006|Part B: Up to 28.5 Months|Death|0|||
46905162|NCT03307785|83133684|FG007|Part B: Up to 28.5 Months|Death|0|||
46905163|NCT03307785|83133685|FG008|Part B: Up to 28.5 Months|Death|0|||
46905164|NCT03307785|83133686|FG009|Part B: Up to 28.5 Months|Death|0|||
46905165|NCT03307785|83133687|FG010|Part B: Up to 28.5 Months|Death|0|||
46905166|NCT03307785|83133677|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905167|NCT03307785|83133678|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905168|NCT03307785|83133679|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
46905169|NCT03307785|83133680|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905170|NCT03307785|83133681|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905171|NCT03307785|83133682|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905172|NCT03307785|83133683|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905173|NCT03307785|83133684|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905174|NCT03307785|83133685|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905175|NCT03307785|83133686|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905176|NCT03307785|83133687|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
46905177|NCT03307785|83133677|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905178|NCT03307785|83133678|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905179|NCT03307785|83133679|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
46905180|NCT03307785|83133680|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905181|NCT03307785|83133681|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46967484|NCT02124772|83210028|FG009|Overall Study|Adverse Event|3|||
46967485|NCT02124772|83210029|FG010|Overall Study|Adverse Event|1|||
46967486|NCT02124772|83210030|FG011|Overall Study|Adverse Event|3|||
46967487|NCT02124772|83210031|FG012|Overall Study|Adverse Event|1|||
46967488|NCT02124772|83210019|FG000|Overall Study|Withdrawal consent|0|||
46967489|NCT02124772|83210020|FG001|Overall Study|Withdrawal consent|1|||
46967490|NCT02124772|83210021|FG002|Overall Study|Withdrawal consent|1|||
46967491|NCT02124772|83210022|FG003|Overall Study|Withdrawal consent|1|||
46967492|NCT02124772|83210023|FG004|Overall Study|Withdrawal consent|0|||
46967493|NCT02124772|83210024|FG005|Overall Study|Withdrawal consent|1|||
46967494|NCT02124772|83210025|FG006|Overall Study|Withdrawal consent|1|||
46967495|NCT02124772|83210026|FG007|Overall Study|Withdrawal consent|0|||
46967496|NCT02124772|83210027|FG008|Overall Study|Withdrawal consent|0|||
46967497|NCT02124772|83210028|FG009|Overall Study|Withdrawal consent|1|||
46967498|NCT02124772|83210029|FG010|Overall Study|Withdrawal consent|0|||
46967499|NCT02124772|83210030|FG011|Overall Study|Withdrawal consent|1|||
46967500|NCT02124772|83210031|FG012|Overall Study|Withdrawal consent|0|||
46905182|NCT03307785|83133682|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905183|NCT03307785|83133683|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905184|NCT03307785|83133684|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905185|NCT03307785|83133685|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905186|NCT03307785|83133686|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905187|NCT03307785|83133687|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
46905188|NCT03307785|83133677|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
46905189|NCT03307785|83133678|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
46905190|NCT03307785|83133679|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
46905191|NCT03307785|83133680|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
46905192|NCT03307785|83133681|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
46905193|NCT03307785|83133682|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
46905194|NCT03307785|83133683|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
46905195|NCT03307785|83133684|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
46905196|NCT03307785|83133685|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
46905197|NCT03307785|83133686|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
46905198|NCT03307785|83133687|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
46905199|NCT03307785|83133677|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
46905200|NCT03307785|83133678|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
46905201|NCT03307785|83133679|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
46905202|NCT03307785|83133680|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
46905203|NCT03307785|83133681|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
46905204|NCT03307785|83133682|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
46905205|NCT03307785|83133683|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
46905206|NCT03307785|83133684|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
46905207|NCT03307785|83133685|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
46905208|NCT03307785|83133686|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
46905209|NCT03307785|83133687|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
46905210|NCT03307785|83133677|FG000|Part C: Up to 22.5 Months|Death|0|||
46905211|NCT03307785|83133678|FG001|Part C: Up to 22.5 Months|Death|0|||
46905212|NCT03307785|83133679|FG002|Part C: Up to 22.5 Months|Death|0|||
46905213|NCT03307785|83133680|FG003|Part C: Up to 22.5 Months|Death|1|||
46905214|NCT03307785|83133681|FG004|Part C: Up to 22.5 Months|Death|4|||
46905215|NCT03307785|83133682|FG005|Part C: Up to 22.5 Months|Death|0|||
46905216|NCT03307785|83133683|FG006|Part C: Up to 22.5 Months|Death|0|||
46905217|NCT03307785|83133684|FG007|Part C: Up to 22.5 Months|Death|0|||
46905218|NCT03307785|83133685|FG008|Part C: Up to 22.5 Months|Death|0|||
46905219|NCT03307785|83133686|FG009|Part C: Up to 22.5 Months|Death|0|||
46905220|NCT03307785|83133687|FG010|Part C: Up to 22.5 Months|Death|0|||
46905221|NCT03307785|83133677|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905222|NCT03307785|83133678|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905223|NCT03307785|83133679|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905224|NCT03307785|83133680|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
46905225|NCT03307785|83133681|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905226|NCT03307785|83133682|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905227|NCT03307785|83133683|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905228|NCT03307785|83133684|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905229|NCT03307785|83133685|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905230|NCT03307785|83133686|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905231|NCT03307785|83133687|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
46905232|NCT03307785|83133677|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905233|NCT03307785|83133678|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905234|NCT03307785|83133679|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905235|NCT03307785|83133680|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
46997209|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997210|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
46997211|NCT02326298|83244021|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997212|NCT02326298|83244022|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997213|NCT02326298|83244023|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997214|NCT02326298|83244024|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997215|NCT02326298|83244025|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997216|NCT02326298|83244026|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
46905236|NCT03307785|83133681|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
46905237|NCT03307785|83133682|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905238|NCT03307785|83133683|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905239|NCT03307785|83133684|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905240|NCT03307785|83133685|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905241|NCT03307785|83133686|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905242|NCT03307785|83133687|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
46905243|NCT03307785|83133677|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
46905244|NCT03307785|83133678|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
46905245|NCT03307785|83133679|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
46905246|NCT03307785|83133680|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
46905247|NCT03307785|83133681|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
46905248|NCT03307785|83133682|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
46905249|NCT03307785|83133683|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
46905250|NCT03307785|83133684|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
46709153|NCT01559935|82925114|FG000|Maintenance Phase|Remains on study|28|||
46709154|NCT01559935|82925114|FG000|Maintenance Phase|Toxicity|1|||
46709155|NCT01559935|82925114|FG000|Maintenance Phase|Lack of Efficacy|18|||
46905251|NCT03307785|83133685|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
46905252|NCT03307785|83133686|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
46905253|NCT03307785|83133687|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
46905254|NCT03307785|83133677|FG000|Part D: Up to 9.5 Months|Death|0|||
46905255|NCT03307785|83133678|FG001|Part D: Up to 9.5 Months|Death|0|||
46905256|NCT03307785|83133679|FG002|Part D: Up to 9.5 Months|Death|0|||
46905257|NCT03307785|83133680|FG003|Part D: Up to 9.5 Months|Death|0|||
46905258|NCT03307785|83133681|FG004|Part D: Up to 9.5 Months|Death|0|||
46905259|NCT03307785|83133682|FG005|Part D: Up to 9.5 Months|Death|1|||
46905260|NCT03307785|83133683|FG006|Part D: Up to 9.5 Months|Death|0|||
46905261|NCT03307785|83133684|FG007|Part D: Up to 9.5 Months|Death|0|||
46905262|NCT03307785|83133685|FG008|Part D: Up to 9.5 Months|Death|0|||
46905263|NCT03307785|83133686|FG009|Part D: Up to 9.5 Months|Death|0|||
46905264|NCT03307785|83133687|FG010|Part D: Up to 9.5 Months|Death|0|||
46905265|NCT03307785|83133677|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905266|NCT03307785|83133678|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905267|NCT03307785|83133679|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905268|NCT03307785|83133680|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905269|NCT03307785|83133681|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905270|NCT03307785|83133682|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
46905271|NCT03307785|83133683|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905272|NCT03307785|83133684|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905273|NCT03307785|83133685|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905274|NCT03307785|83133686|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905275|NCT03307785|83133687|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
46905276|NCT03307785|83133677|FG000|Part E: Up to 4.4 Months|Death|0|||
46905277|NCT03307785|83133678|FG001|Part E: Up to 4.4 Months|Death|0|||
46905278|NCT03307785|83133679|FG002|Part E: Up to 4.4 Months|Death|0|||
46905279|NCT03307785|83133680|FG003|Part E: Up to 4.4 Months|Death|0|||
46905280|NCT03307785|83133681|FG004|Part E: Up to 4.4 Months|Death|0|||
46905281|NCT03307785|83133682|FG005|Part E: Up to 4.4 Months|Death|0|||
46905282|NCT03307785|83133683|FG006|Part E: Up to 4.4 Months|Death|1|||
46905283|NCT03307785|83133684|FG007|Part E: Up to 4.4 Months|Death|0|||
46905284|NCT03307785|83133685|FG008|Part E: Up to 4.4 Months|Death|0|||
46905285|NCT03307785|83133686|FG009|Part E: Up to 4.4 Months|Death|0|||
46905286|NCT03307785|83133687|FG010|Part E: Up to 4.4 Months|Death|0|||
46905287|NCT03307785|83133677|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
46905288|NCT03307785|83133678|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
46905289|NCT03307785|83133679|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
46905290|NCT03307785|83133680|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
46905291|NCT03307785|83133681|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
46905292|NCT03307785|83133682|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
46905293|NCT03307785|83133683|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
46905294|NCT03307785|83133684|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
46709156|NCT01559935|82925114|FG000|Maintenance Phase|Withdrawal by Subject|5|||
46709157|NCT01559935|82925114|FG000|Maintenance Phase|Non-compliance|2|||
46709158|NCT00740870|82925135|FG000|Overall Study|Not Catheterized|4|||
46709159|NCT00740870|82925135|FG000|Overall Study|Further testing contraindicated implant|17|||
46997217|NCT02326298|83244027|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46709160|NCT00701909|82925144|FG000|Overall Study|Withdrawal by Subject|0|||
46709161|NCT00701909|82925145|FG001|Overall Study|Withdrawal by Subject|1|||
46905295|NCT03307785|83133685|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
46905296|NCT03307785|83133686|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
46905297|NCT03307785|83133687|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
46905298|NCT03307785|83133677|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
46905299|NCT03307785|83133678|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
46905300|NCT03307785|83133679|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
46905301|NCT03307785|83133680|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
46905302|NCT03307785|83133681|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
46905303|NCT03307785|83133682|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
46905304|NCT03307785|83133683|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
46905305|NCT03307785|83133684|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
46905306|NCT03307785|83133685|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
46905307|NCT03307785|83133686|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
46905308|NCT03307785|83133687|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
46905309|NCT03199040|83133710|FG000|Overall Study|Lack of Efficacy|2|||
46905310|NCT03199040|83133711|FG001|Overall Study|Lack of Efficacy|0|||
46905311|NCT03199040|83133710|FG000|Overall Study|Withdrawal by Subject|2|||
46905312|NCT03199040|83133711|FG001|Overall Study|Withdrawal by Subject|0|||
46905313|NCT03199040|83133710|FG000|Overall Study|Adverse Event|0|||
46905314|NCT03199040|83133711|FG001|Overall Study|Adverse Event|1|||
46905315|NCT02408549|83133843|FG000|Overall Study|Adverse Event|15|||
46905316|NCT02408549|83133843|FG000|Overall Study|Death|4|||
46905317|NCT02408549|83133843|FG000|Overall Study|Lack of Efficacy|17|||
46905318|NCT02408549|83133843|FG000|Overall Study|Protocol Violation|4|||
46905319|NCT02408549|83133843|FG000|Overall Study|Lost to Follow-up|6|||
46905320|NCT02408549|83133843|FG000|Overall Study|Consent withdrawn|30|||
46905321|NCT02408549|83133843|FG000|Overall Study|Neurology research program closing at site|1|||
46905322|NCT02408549|83133843|FG000|Overall Study|Site closure|1|||
46905323|NCT02408549|83133843|FG000|Overall Study|Pregnancy|1|||
46905324|NCT02408549|83133843|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
46905325|NCT02408549|83133843|FG000|Overall Study|Subject moved to another place, far from site|1|||
46905326|NCT02408549|83133843|FG000|Overall Study|Study terminated at site|1|||
46905327|NCT01523002|83133858|FG000|Period 1|Withdrawal by Subject|1|||
46905328|NCT01523002|83133859|FG001|Period 1|Withdrawal by Subject|3|||
46905329|NCT01523002|83133858|FG000|Period 1|Lost to Follow-up|1|||
46905330|NCT01523002|83133859|FG001|Period 1|Lost to Follow-up|0|||
46905331|NCT01523002|83133858|FG000|Period 1|Adverse Event|0|||
46905332|NCT01523002|83133859|FG001|Period 1|Adverse Event|8|||
46905333|NCT01523002|83133858|FG000|Period 2|Withdrawal by Subject|4|||
46905334|NCT01523002|83133859|FG001|Period 2|Withdrawal by Subject|1|||
46905335|NCT01523002|83133858|FG000|Period 2|Adverse Event|2|||
46905336|NCT01523002|83133859|FG001|Period 2|Adverse Event|5|||
46905337|NCT01523002|83133858|FG000|Period 3|Withdrawal by Subject|1|||
46905338|NCT01523002|83133859|FG001|Period 3|Withdrawal by Subject|0|||
46905339|NCT01523002|83133858|FG000|Period 3|Adverse Event|3|||
46905340|NCT01523002|83133859|FG001|Period 3|Adverse Event|0|||
46905341|NCT00489307|83133867|FG000|Overall Study|Death|1|||
46905342|NCT00489307|83133868|FG001|Overall Study|Death|1|||
46905343|NCT00489307|83133867|FG000|Overall Study|Lost to Follow-up|2|||
46905344|NCT00489307|83133868|FG001|Overall Study|Lost to Follow-up|2|||
46905345|NCT00489307|83133867|FG000|Overall Study|Physician Decision|1|||
46905346|NCT00489307|83133868|FG001|Overall Study|Physician Decision|0|||
46905347|NCT00489307|83133867|FG000|Overall Study|Withdrawal by Subject|2|||
46905348|NCT00489307|83133868|FG001|Overall Study|Withdrawal by Subject|4|||
46905349|NCT00489307|83133867|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
46905350|NCT00489307|83133868|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
46905351|NCT00489307|83133867|FG000|Overall Study|Surgery after assignment|1|||
46905352|NCT00489307|83133868|FG001|Overall Study|Surgery after assignment|0|||
46905353|NCT00489307|83133867|FG000|Overall Study|Did not fill up the forms|2|||
46905354|NCT00489307|83133868|FG001|Overall Study|Did not fill up the forms|1|||
46905355|NCT00489307|83133867|FG000|Overall Study|Patient or family refusal|5|||
46905356|NCT00489307|83133868|FG001|Overall Study|Patient or family refusal|9|||
46905357|NCT03521141|83133877|FG000|Overall Study|Death|1|||
46905358|NCT03521141|83133878|FG001|Overall Study|Death|0|||
46905359|NCT03521141|83133879|FG002|Overall Study|Death|1|||
46905360|NCT02997176|83133891|FG000|Overall Study|Adverse Event|0|||
46905361|NCT02997176|83133892|FG001|Overall Study|Adverse Event|0|||
46905362|NCT02997176|83133893|FG002|Overall Study|Adverse Event|0|||
46905363|NCT02997176|83133894|FG003|Overall Study|Adverse Event|8|||
46905364|NCT02997176|83133891|FG000|Overall Study|Progressive Disease|1|||
46905365|NCT02997176|83133892|FG001|Overall Study|Progressive Disease|0|||
46905366|NCT02997176|83133893|FG002|Overall Study|Progressive Disease|1|||
46905367|NCT02997176|83133894|FG003|Overall Study|Progressive Disease|1|||
46905368|NCT02997176|83133891|FG000|Overall Study|Death|0|||
46905369|NCT02997176|83133892|FG001|Overall Study|Death|0|||
46905370|NCT02997176|83133893|FG002|Overall Study|Death|1|||
46905371|NCT02997176|83133894|FG003|Overall Study|Death|1|||
46905372|NCT02997176|83133891|FG000|Overall Study|Withdrawal by Subject|0|||
46905373|NCT02997176|83133892|FG001|Overall Study|Withdrawal by Subject|2|||
46905374|NCT02997176|83133893|FG002|Overall Study|Withdrawal by Subject|0|||
46905375|NCT02997176|83133894|FG003|Overall Study|Withdrawal by Subject|1|||
46905376|NCT03000452|83133904|FG000|Treatment Period|Death|1|||
46905377|NCT03000452|83133904|FG000|Treatment Period|Progressive Disease (PD)|14|||
46905378|NCT03000452|83133904|FG000|Treatment Period|Physician Decision|1|||
46905379|NCT03000452|83133904|FG000|Treatment Period|Miscellaneous|2|||
46905380|NCT03000452|83133904|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
46905381|NCT03000452|83133904|FG000|Follow-Up Period|Death|3|||
46905382|NCT03000452|83133904|FG000|Follow-Up Period|Withdrawal by Subject|3|||
46905383|NCT01373164|83133913|FG000|Overall Study|Lost to Follow-up|0|||
46905384|NCT01373164|83133914|FG001|Overall Study|Lost to Follow-up|0|||
46905385|NCT01373164|83133915|FG002|Overall Study|Lost to Follow-up|1|||
46905386|NCT01373164|83133916|FG003|Overall Study|Lost to Follow-up|2|||
46905387|NCT01373164|83133917|FG004|Overall Study|Lost to Follow-up|0|||
46905388|NCT01373164|83133913|FG000|Overall Study|Withdrawal by Subject|0|||
46905389|NCT01373164|83133914|FG001|Overall Study|Withdrawal by Subject|1|||
46905390|NCT01373164|83133915|FG002|Overall Study|Withdrawal by Subject|0|||
46905391|NCT01373164|83133916|FG003|Overall Study|Withdrawal by Subject|10|||
46905392|NCT01373164|83133917|FG004|Overall Study|Withdrawal by Subject|2|||
46905393|NCT02999984|83133932|FG000|Overall Study|Treatment Failure|1|||
46905394|NCT03550313|83133939|FG000|Overall Study|Adverse Event|0|||
46905395|NCT03550313|83133940|FG001|Overall Study|Adverse Event|1|||
46905396|NCT03550313|83133941|FG002|Overall Study|Adverse Event|0|||
46905397|NCT03550313|83133939|FG000|Overall Study|Lost to Follow-up|5|||
46905398|NCT03550313|83133940|FG001|Overall Study|Lost to Follow-up|7|||
46905399|NCT03550313|83133941|FG002|Overall Study|Lost to Follow-up|12|||
46905400|NCT03550313|83133939|FG000|Overall Study|Study terminated by sponsor|44|||
46905401|NCT03550313|83133940|FG001|Overall Study|Study terminated by sponsor|37|||
46905402|NCT03550313|83133941|FG002|Overall Study|Study terminated by sponsor|48|||
46905403|NCT03550313|83133939|FG000|Overall Study|No longer met eligibility criteria|3|||
46905404|NCT03550313|83133940|FG001|Overall Study|No longer met eligibility criteria|5|||
46905405|NCT03550313|83133941|FG002|Overall Study|No longer met eligibility criteria|6|||
46905406|NCT03550313|83133939|FG000|Overall Study|Withdrawal by parent/guardian|20|||
46905407|NCT03550313|83133940|FG001|Overall Study|Withdrawal by parent/guardian|18|||
46905408|NCT03550313|83133941|FG002|Overall Study|Withdrawal by parent/guardian|26|||
46905409|NCT03550313|83133939|FG000|Overall Study|Other|4|||
46905410|NCT03550313|83133940|FG001|Overall Study|Other|2|||
46905411|NCT03550313|83133941|FG002|Overall Study|Other|2|||
46905412|NCT03550313|83133939|FG000|Overall Study|Randomized but not vaccinated|3|||
46905413|NCT03550313|83133940|FG001|Overall Study|Randomized but not vaccinated|23|||
46905414|NCT03550313|83133941|FG002|Overall Study|Randomized but not vaccinated|2|||
46905415|NCT03550313|83133939|FG000|Overall Study|Sites terminated due to quality issues|18|||
46905416|NCT03550313|83133940|FG001|Overall Study|Sites terminated due to quality issues|17|||
46905417|NCT03550313|83133941|FG002|Overall Study|Sites terminated due to quality issues|18|||
46905418|NCT03312907|83133953|FG000|Overall Study|Adverse Event|1|||
46905419|NCT03312907|83133954|FG001|Overall Study|Adverse Event|6|||
46905420|NCT03312907|83133955|FG002|Overall Study|Adverse Event|1|||
46905421|NCT03312907|83133953|FG000|Overall Study|Protocol Violation|2|||
46905422|NCT03312907|83133954|FG001|Overall Study|Protocol Violation|3|||
46905423|NCT03312907|83133955|FG002|Overall Study|Protocol Violation|4|||
46905424|NCT03312907|83133953|FG000|Overall Study|Lost to Follow-up|2|||
46905425|NCT03312907|83133954|FG001|Overall Study|Lost to Follow-up|3|||
46905426|NCT03312907|83133955|FG002|Overall Study|Lost to Follow-up|2|||
46905427|NCT03312907|83133953|FG000|Overall Study|Physician Decision|3|||
46905428|NCT03312907|83133954|FG001|Overall Study|Physician Decision|4|||
46905429|NCT03312907|83133955|FG002|Overall Study|Physician Decision|2|||
46905430|NCT03312907|83133953|FG000|Overall Study|Withdrawal by Subject|9|||
46905431|NCT03312907|83133954|FG001|Overall Study|Withdrawal by Subject|14|||
46905432|NCT03312907|83133955|FG002|Overall Study|Withdrawal by Subject|10|||
46905433|NCT02999672|83133965|FG000|Overall Study|Death|0|||
46905434|NCT02999672|83133966|FG001|Overall Study|Death|1|||
46905435|NCT02999672|83133965|FG000|Overall Study|Study Terminated by Sponsor|0|||
46905436|NCT02999672|83133966|FG001|Overall Study|Study Terminated by Sponsor|1|||
46905437|NCT02999672|83133965|FG000|Overall Study|Progressive Disease|9|||
46905438|NCT02999672|83133966|FG001|Overall Study|Progressive Disease|5|||
46905439|NCT02999672|83133965|FG000|Overall Study|Adverse Event|4|||
46905440|NCT02999672|83133966|FG001|Overall Study|Adverse Event|0|||
46905441|NCT01911676|83133976|FG000|Period 1 of Study|Withdrawal by Subject|4|||
46905442|NCT01911676|83133977|FG001|Period 1 of Study|Withdrawal by Subject|2|||
46905443|NCT01911676|83133978|FG002|Period 1 of Study|Withdrawal by Subject|1|||
46905444|NCT01911676|83133979|FG003|Period 1 of Study|Withdrawal by Subject|2|||
46905445|NCT01911676|83133976|FG000|Period 1 of Study|Physician Decision|2|||
46905446|NCT01911676|83133977|FG001|Period 1 of Study|Physician Decision|0|||
46905447|NCT01911676|83133978|FG002|Period 1 of Study|Physician Decision|0|||
46905448|NCT01911676|83133979|FG003|Period 1 of Study|Physician Decision|1|||
46905449|NCT01911676|83133976|FG000|Period 2 of Study|Physician Decision|2|||
46905450|NCT01911676|83133977|FG001|Period 2 of Study|Physician Decision|0|||
46905451|NCT01911676|83133978|FG002|Period 2 of Study|Physician Decision|0|||
46905452|NCT01911676|83133979|FG003|Period 2 of Study|Physician Decision|1|||
46905453|NCT01911676|83133976|FG000|Period 2 of Study|Lost to Follow-up|0|||
46905454|NCT01911676|83133977|FG001|Period 2 of Study|Lost to Follow-up|0|||
46905455|NCT01911676|83133978|FG002|Period 2 of Study|Lost to Follow-up|0|||
46905456|NCT01911676|83133979|FG003|Period 2 of Study|Lost to Follow-up|1|||
46905457|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
46905458|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
46905459|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
46905460|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
46905461|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
46905462|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
46905463|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
46905464|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
46905465|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
46905466|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
46905467|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
46905468|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
46905469|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
46905470|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
46905471|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
46905472|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
46905473|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
46905474|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
46905475|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
46905476|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
46905477|NCT03573323|83133996|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
46905478|NCT03573323|83133997|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
46905479|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
46905480|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
46905481|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
46905482|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
46905483|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
46905484|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
46905485|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
46905486|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
46905487|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
46905488|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
46905489|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
46905490|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
46905491|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
46905492|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
46905493|NCT03573323|83133996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
46905494|NCT03573323|83133997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
46905495|NCT03306043|83134023|FG000|Overall Study|Adverse Event|1|||
46905496|NCT03306043|83134023|FG000|Overall Study|Lost to Follow-up|1|||
46905497|NCT03306043|83134023|FG000|Overall Study|Withdrawal by Subject|2|||
46905498|NCT01069172|83134027|FG000|Overall Study|Withdrawal by Subject|1|||
46905499|NCT01069172|83134028|FG001|Overall Study|Withdrawal by Subject|0|||
46905500|NCT02911688|83134037|FG000|Washout|Lost to Follow-up|1|||
46905501|NCT02911688|83134038|FG001|Washout|Lost to Follow-up|1|||
46905502|NCT02911688|83134037|FG000|Washout|Withdrawal by Subject|0|||
46905503|NCT02911688|83134038|FG001|Washout|Withdrawal by Subject|1|||
46905504|NCT02670928|83134048|FG000|Overall Study|Adverse Event|3|||
46905505|NCT02670928|83134049|FG001|Overall Study|Adverse Event|1|||
46905506|NCT02670928|83134048|FG000|Overall Study|Withdrawal by Subject|4|||
46905507|NCT02670928|83134049|FG001|Overall Study|Withdrawal by Subject|0|||
46905508|NCT02670928|83134048|FG000|Overall Study|Lost to Follow-up|1|||
46905509|NCT02670928|83134049|FG001|Overall Study|Lost to Follow-up|0|||
46905510|NCT02670928|83134048|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
46905511|NCT02670928|83134049|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
46905512|NCT03305809|83134059|FG000|Overall Study|Adverse Event|2|||
46905513|NCT03305809|83134060|FG001|Overall Study|Adverse Event|2|||
46905514|NCT03305809|83134061|FG002|Overall Study|Adverse Event|6|||
46905515|NCT03305809|83134062|FG003|Overall Study|Adverse Event|6|||
46905516|NCT03305809|83134059|FG000|Overall Study|Death|0|||
46905517|NCT03305809|83134060|FG001|Overall Study|Death|0|||
46905518|NCT03305809|83134061|FG002|Overall Study|Death|1|||
46905519|NCT03305809|83134062|FG003|Overall Study|Death|1|||
46905520|NCT03305809|83134059|FG000|Overall Study|Lost to Follow-up|1|||
46905521|NCT03305809|83134060|FG001|Overall Study|Lost to Follow-up|2|||
46905522|NCT03305809|83134061|FG002|Overall Study|Lost to Follow-up|0|||
46905523|NCT03305809|83134062|FG003|Overall Study|Lost to Follow-up|0|||
46905524|NCT03305809|83134059|FG000|Overall Study|Sponsor Decision|1|||
46905525|NCT03305809|83134060|FG001|Overall Study|Sponsor Decision|0|||
46905526|NCT03305809|83134061|FG002|Overall Study|Sponsor Decision|1|||
46905527|NCT03305809|83134062|FG003|Overall Study|Sponsor Decision|8|||
46905528|NCT03305809|83134059|FG000|Overall Study|Physician Decision|0|||
46905529|NCT03305809|83134060|FG001|Overall Study|Physician Decision|0|||
46905530|NCT03305809|83134061|FG002|Overall Study|Physician Decision|2|||
46905531|NCT03305809|83134062|FG003|Overall Study|Physician Decision|4|||
46905532|NCT03305809|83134059|FG000|Overall Study|Progressive Disease|0|||
46905533|NCT03305809|83134060|FG001|Overall Study|Progressive Disease|0|||
46905534|NCT03305809|83134061|FG002|Overall Study|Progressive Disease|1|||
46905535|NCT03305809|83134062|FG003|Overall Study|Progressive Disease|0|||
46905536|NCT03305809|83134059|FG000|Overall Study|Protocol Violation|1|||
46905537|NCT03305809|83134060|FG001|Overall Study|Protocol Violation|0|||
46905538|NCT03305809|83134061|FG002|Overall Study|Protocol Violation|2|||
46905539|NCT03305809|83134062|FG003|Overall Study|Protocol Violation|3|||
46905540|NCT03305809|83134059|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
46905541|NCT03305809|83134060|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
46905542|NCT03305809|83134061|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
46905543|NCT03305809|83134062|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
46905544|NCT03305809|83134059|FG000|Overall Study|Withdrawal by Subject|2|||
46905545|NCT03305809|83134060|FG001|Overall Study|Withdrawal by Subject|4|||
46905546|NCT03305809|83134061|FG002|Overall Study|Withdrawal by Subject|5|||
46905547|NCT03305809|83134062|FG003|Overall Study|Withdrawal by Subject|2|||
46905548|NCT03305809|83134059|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
46905549|NCT03305809|83134060|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
46905550|NCT03305809|83134061|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
46905551|NCT03305809|83134062|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
46905552|NCT02994056|83134075|FG000|Overall Study|Death|8|||
46905553|NCT02994056|83134075|FG000|Overall Study|Withdrew Consent|1|||
46905554|NCT03548051|83134094|FG000|Overall Study|Death|1|||
46905555|NCT03548051|83134095|FG001|Overall Study|Death|1|||
46905556|NCT03548051|83134094|FG000|Overall Study|Withdrawal by Subject|1|||
46905557|NCT03548051|83134095|FG001|Overall Study|Withdrawal by Subject|0|||
46905558|NCT03305731|83134101|FG000|Overall Study|Protocol Violation|1|||
46905559|NCT03305575|83134107|FG000|Overall Study|Physician Decision|1|||
46905560|NCT03305575|83134108|FG001|Overall Study|Physician Decision|0|||
46905561|NCT02993822|83134118|FG000|Overall Study|Lack of Efficacy|1|||
46905562|NCT02993822|83134119|FG001|Overall Study|Lack of Efficacy|1|||
46905563|NCT02993822|83134120|FG002|Overall Study|Lack of Efficacy|0|||
46905564|NCT02993822|83134121|FG003|Overall Study|Lack of Efficacy|0|||
46905565|NCT02993822|83134118|FG000|Overall Study|Protocol Violation|1|||
46905566|NCT02993822|83134119|FG001|Overall Study|Protocol Violation|0|||
46905567|NCT02993822|83134120|FG002|Overall Study|Protocol Violation|0|||
46905568|NCT02993822|83134121|FG003|Overall Study|Protocol Violation|0|||
46905569|NCT02993822|83134118|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
46905570|NCT02993822|83134119|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
46905571|NCT02993822|83134120|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
46905572|NCT02993822|83134121|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
46905573|NCT02993822|83134118|FG000|Overall Study|Adverse Event|3|||
46905574|NCT02993822|83134119|FG001|Overall Study|Adverse Event|1|||
46905575|NCT02993822|83134120|FG002|Overall Study|Adverse Event|7|||
46905576|NCT02993822|83134121|FG003|Overall Study|Adverse Event|0|||
46905577|NCT02993822|83134118|FG000|Overall Study|Withdrawal by Subject|4|||
46905578|NCT02993822|83134119|FG001|Overall Study|Withdrawal by Subject|2|||
46905579|NCT02993822|83134120|FG002|Overall Study|Withdrawal by Subject|2|||
46905580|NCT02993822|83134121|FG003|Overall Study|Withdrawal by Subject|3|||
46905581|NCT02993822|83134118|FG000|Overall Study|Lost to Follow-up|1|||
46905582|NCT02993822|83134119|FG001|Overall Study|Lost to Follow-up|0|||
46905583|NCT02993822|83134120|FG002|Overall Study|Lost to Follow-up|1|||
46905584|NCT02993822|83134121|FG003|Overall Study|Lost to Follow-up|0|||
46905585|NCT01068860|83134141|FG000|Overall Study|Withdrawal by Subject|0|||
46905586|NCT01068860|83134142|FG001|Overall Study|Withdrawal by Subject|0|||
46905587|NCT01068860|83134143|FG002|Overall Study|Withdrawal by Subject|0|||
46905588|NCT01068860|83134144|FG003|Overall Study|Withdrawal by Subject|0|||
46905589|NCT01068860|83134145|FG004|Overall Study|Withdrawal by Subject|0|||
46905590|NCT01068860|83134146|FG005|Overall Study|Withdrawal by Subject|2|||
46905591|NCT01068860|83134147|FG006|Overall Study|Withdrawal by Subject|0|||
46905592|NCT01068860|83134148|FG007|Overall Study|Withdrawal by Subject|0|||
46905593|NCT01068860|83134149|FG008|Overall Study|Withdrawal by Subject|0|||
46905594|NCT01068860|83134150|FG009|Overall Study|Withdrawal by Subject|3|||
46905595|NCT01068860|83134141|FG000|Overall Study|Administrative problems; misrandomized|0|||
46905596|NCT01068860|83134142|FG001|Overall Study|Administrative problems; misrandomized|0|||
46905597|NCT01068860|83134143|FG002|Overall Study|Administrative problems; misrandomized|0|||
46905598|NCT01068860|83134144|FG003|Overall Study|Administrative problems; misrandomized|1|||
46905599|NCT01068860|83134145|FG004|Overall Study|Administrative problems; misrandomized|0|||
46905600|NCT01068860|83134146|FG005|Overall Study|Administrative problems; misrandomized|0|||
46905601|NCT01068860|83134147|FG006|Overall Study|Administrative problems; misrandomized|0|||
46905602|NCT01068860|83134148|FG007|Overall Study|Administrative problems; misrandomized|0|||
46905603|NCT01068860|83134149|FG008|Overall Study|Administrative problems; misrandomized|0|||
46905604|NCT01068860|83134150|FG009|Overall Study|Administrative problems; misrandomized|1|||
46905605|NCT01068860|83134141|FG000|Overall Study|Lost to Follow-up|0|||
46905606|NCT01068860|83134142|FG001|Overall Study|Lost to Follow-up|1|||
46905607|NCT01068860|83134143|FG002|Overall Study|Lost to Follow-up|0|||
46905608|NCT01068860|83134144|FG003|Overall Study|Lost to Follow-up|0|||
46905609|NCT01068860|83134145|FG004|Overall Study|Lost to Follow-up|0|||
46905610|NCT01068860|83134146|FG005|Overall Study|Lost to Follow-up|0|||
46905611|NCT01068860|83134147|FG006|Overall Study|Lost to Follow-up|0|||
46905612|NCT01068860|83134148|FG007|Overall Study|Lost to Follow-up|0|||
46905613|NCT01068860|83134149|FG008|Overall Study|Lost to Follow-up|0|||
46905614|NCT01068860|83134150|FG009|Overall Study|Lost to Follow-up|0|||
46905615|NCT02989610|83134172|FG000|Overall Study|Withdrawal/Other reasons|39|||
46905616|NCT01372774|83134178|FG000|Overall Study|Withdrawal prior to treatment|4|||
46905617|NCT01372774|83134179|FG001|Overall Study|Withdrawal prior to treatment|5|||
46905618|NCT02670538|83134190|FG000|Overall Study|Withdrawal of Consent|8|||
46905619|NCT02670538|83134191|FG001|Overall Study|Withdrawal of Consent|6|||
46905620|NCT02670538|83134192|FG002|Overall Study|Withdrawal of Consent|5|||
46905621|NCT02670538|83134190|FG000|Overall Study|Lost to Follow-up|8|||
46905622|NCT02670538|83134191|FG001|Overall Study|Lost to Follow-up|12|||
46905623|NCT02670538|83134192|FG002|Overall Study|Lost to Follow-up|7|||
46905624|NCT02670538|83134190|FG000|Overall Study|Adverse Event|5|||
46905625|NCT02670538|83134191|FG001|Overall Study|Adverse Event|5|||
46905626|NCT02670538|83134192|FG002|Overall Study|Adverse Event|11|||
46905627|NCT02670538|83134190|FG000|Overall Study|Lack of Efficacy|7|||
46905628|NCT02670538|83134191|FG001|Overall Study|Lack of Efficacy|1|||
46905629|NCT02670538|83134192|FG002|Overall Study|Lack of Efficacy|2|||
46905630|NCT02670538|83134190|FG000|Overall Study|Protocol Violation|3|||
46905631|NCT02670538|83134191|FG001|Overall Study|Protocol Violation|4|||
46905632|NCT02670538|83134192|FG002|Overall Study|Protocol Violation|1|||
46905633|NCT02670538|83134190|FG000|Overall Study|Noncompliance with Study Drug|1|||
46905634|NCT02670538|83134191|FG001|Overall Study|Noncompliance with Study Drug|3|||
46905635|NCT02670538|83134192|FG002|Overall Study|Noncompliance with Study Drug|2|||
46905636|NCT02670538|83134190|FG000|Overall Study|Other Miscellaneous Reasons|0|||
46905637|NCT02670538|83134191|FG001|Overall Study|Other Miscellaneous Reasons|1|||
46905638|NCT02670538|83134192|FG002|Overall Study|Other Miscellaneous Reasons|2|||
46905639|NCT03547583|83134203|FG000|Overall Study|Adverse Event|16|||
46905640|NCT03547583|83134204|FG001|Overall Study|Adverse Event|11|||
46905641|NCT03547583|83134205|FG002|Overall Study|Adverse Event|10|||
46905642|NCT03547583|83134203|FG000|Overall Study|Death|11|||
46905643|NCT03547583|83134204|FG001|Overall Study|Death|7|||
46905644|NCT03547583|83134205|FG002|Overall Study|Death|4|||
46905645|NCT03547583|83134203|FG000|Overall Study|Lost to Follow-up|1|||
46905646|NCT03547583|83134204|FG001|Overall Study|Lost to Follow-up|0|||
46905647|NCT03547583|83134205|FG002|Overall Study|Lost to Follow-up|0|||
46905648|NCT03547583|83134203|FG000|Overall Study|Non-compliance with study drug|0|||
46905649|NCT03547583|83134204|FG001|Overall Study|Non-compliance with study drug|0|||
46905650|NCT03547583|83134205|FG002|Overall Study|Non-compliance with study drug|1|||
46905651|NCT03547583|83134203|FG000|Overall Study|Physician Decision|1|||
46905652|NCT03547583|83134204|FG001|Overall Study|Physician Decision|0|||
46905653|NCT03547583|83134205|FG002|Overall Study|Physician Decision|3|||
46905654|NCT03547583|83134203|FG000|Overall Study|Protocol Violation|2|||
46905655|NCT03547583|83134204|FG001|Overall Study|Protocol Violation|1|||
46905656|NCT03547583|83134205|FG002|Overall Study|Protocol Violation|1|||
46905657|NCT03547583|83134203|FG000|Overall Study|Withdrawal by Subject|12|||
46905658|NCT03547583|83134204|FG001|Overall Study|Withdrawal by Subject|19|||
46905659|NCT03547583|83134205|FG002|Overall Study|Withdrawal by Subject|10|||
46905660|NCT03547583|83134203|FG000|Overall Study|Other|2|||
46905661|NCT03547583|83134204|FG001|Overall Study|Other|2|||
46905662|NCT03547583|83134205|FG002|Overall Study|Other|3|||
46905663|NCT02670382|83134216|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
46905664|NCT02670382|83134217|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
46905665|NCT02991482|83134227|FG000|Overall Study|Disease progression|56|||
46905666|NCT02991482|83134228|FG001|Overall Study|Disease progression|47|||
46905667|NCT02991482|83134227|FG000|Overall Study|Death|4|||
46905668|NCT02991482|83134228|FG001|Overall Study|Death|4|||
46905669|NCT02991482|83134227|FG000|Overall Study|Adverse Event|1|||
46905670|NCT02991482|83134228|FG001|Overall Study|Adverse Event|6|||
46905671|NCT02991482|83134227|FG000|Overall Study|Patient decision|1|||
46905672|NCT02991482|83134228|FG001|Overall Study|Patient decision|1|||
46905673|NCT02991482|83134227|FG000|Overall Study|Physician Decision|0|||
46905674|NCT02991482|83134228|FG001|Overall Study|Physician Decision|6|||
46709162|NCT00381680|82925155|FG000|Overall Study|Adverse Event|9|||
46905675|NCT02991482|83134227|FG000|Overall Study|Clinical deterioration|1|||
46905676|NCT02991482|83134228|FG001|Overall Study|Clinical deterioration|0|||
46905677|NCT02991482|83134227|FG000|Overall Study|Patient feeling too unwell|1|||
46905678|NCT02991482|83134228|FG001|Overall Study|Patient feeling too unwell|0|||
46905679|NCT02991482|83134227|FG000|Overall Study|Worsening of performance status|0|||
46905680|NCT02991482|83134228|FG001|Overall Study|Worsening of performance status|1|||
46905681|NCT02991482|83134227|FG000|Overall Study|Death prior to study drug initiation|1|||
46905682|NCT02991482|83134228|FG001|Overall Study|Death prior to study drug initiation|0|||
46905683|NCT02991482|83134227|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
46905684|NCT02991482|83134228|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
46905685|NCT02674750|83134237|FG000|Overall Study|Death|4|||
46905686|NCT02674750|83134238|FG001|Overall Study|Death|5|||
46905687|NCT02674750|83134239|FG002|Overall Study|Death|8|||
46905688|NCT02674750|83134237|FG000|Overall Study|Lost to Follow-up|0|||
46905689|NCT02674750|83134238|FG001|Overall Study|Lost to Follow-up|8|||
46905690|NCT02674750|83134239|FG002|Overall Study|Lost to Follow-up|0|||
46905691|NCT02674750|83134237|FG000|Overall Study|Lack of Efficacy|1|||
46905692|NCT02674750|83134238|FG001|Overall Study|Lack of Efficacy|17|||
46905693|NCT02674750|83134239|FG002|Overall Study|Lack of Efficacy|3|||
46905694|NCT02674750|83134237|FG000|Overall Study|Withdrawal by Subject|0|||
46905695|NCT02674750|83134238|FG001|Overall Study|Withdrawal by Subject|7|||
46905696|NCT02674750|83134239|FG002|Overall Study|Withdrawal by Subject|1|||
46905697|NCT02674750|83134237|FG000|Overall Study|Other|0|||
46905698|NCT02674750|83134238|FG001|Overall Study|Other|8|||
46905699|NCT02674750|83134239|FG002|Overall Study|Other|0|||
46905700|NCT02987972|83134268|FG000|Overall Study|Adverse Event|1|||
46905701|NCT02987972|83134269|FG001|Overall Study|Adverse Event|1|||
46905702|NCT02987972|83134270|FG002|Overall Study|Adverse Event|0|||
46905703|NCT02987972|83134268|FG000|Overall Study|Death|1|||
46905704|NCT02987972|83134269|FG001|Overall Study|Death|0|||
46905705|NCT02987972|83134270|FG002|Overall Study|Death|0|||
46905706|NCT02987972|83134268|FG000|Overall Study|Lack of Efficacy|9|||
46905707|NCT02987972|83134269|FG001|Overall Study|Lack of Efficacy|12|||
46905708|NCT02987972|83134270|FG002|Overall Study|Lack of Efficacy|12|||
46905709|NCT02987972|83134268|FG000|Overall Study|Lost to Follow-up|7|||
46905710|NCT02987972|83134269|FG001|Overall Study|Lost to Follow-up|8|||
46905711|NCT02987972|83134270|FG002|Overall Study|Lost to Follow-up|4|||
46905712|NCT02987972|83134268|FG000|Overall Study|Physician Decision|1|||
46905713|NCT02987972|83134269|FG001|Overall Study|Physician Decision|6|||
46905714|NCT02987972|83134270|FG002|Overall Study|Physician Decision|0|||
46905715|NCT02987972|83134268|FG000|Overall Study|Protocol Violation|2|||
46905716|NCT02987972|83134269|FG001|Overall Study|Protocol Violation|1|||
46905717|NCT02987972|83134270|FG002|Overall Study|Protocol Violation|5|||
46905718|NCT02987972|83134268|FG000|Overall Study|Withdrawal by Subject|22|||
46905719|NCT02987972|83134269|FG001|Overall Study|Withdrawal by Subject|17|||
46905720|NCT02987972|83134270|FG002|Overall Study|Withdrawal by Subject|21|||
46905721|NCT01372618|83134278|FG000|Overall Study|PI Died. Study Terminated|9|||
46905722|NCT03304873|83134284|FG000|Overall Study|Lost to Follow-up|1|||
46905723|NCT03304873|83134285|FG001|Overall Study|Lost to Follow-up|8|||
46905724|NCT02669758|83134291|FG000|Overall Study|Withdrawal by Subject|43|||
46905725|NCT02669758|83134291|FG000|Overall Study|Lost to Follow-up|19|||
46905726|NCT02669758|83134291|FG000|Overall Study|Adverse Event|16|||
46905727|NCT02669758|83134291|FG000|Overall Study|Non-Compliance with Study Drug|8|||
46905728|NCT02669758|83134291|FG000|Overall Study|Lack of Efficacy|5|||
46905729|NCT02669758|83134291|FG000|Overall Study|Pregnancy|1|||
46905730|NCT02669758|83134291|FG000|Overall Study|Study noncompliance|1|||
46905731|NCT02669758|83134291|FG000|Overall Study|Protocol Violation|1|||
46905732|NCT02987660|83134297|FG000|Overall Study|Study terminated by sponsor|10|||
46905733|NCT02987660|83134298|FG001|Overall Study|Study terminated by sponsor|10|||
46905734|NCT04528069|83134304|FG000|Overall Study|Adverse Event|1|||
46905735|NCT04528069|83134304|FG000|Overall Study|Lost to Follow-up|1|||
46905736|NCT04528069|83134304|FG000|Overall Study|Patient Unable to Come|1|||
46905737|NCT04528069|83134304|FG000|Overall Study|Patient Unable to Attend|1|||
46905738|NCT03303469|83134320|FG000|Overall Study|Lost to Follow-up|2|||
46905739|NCT02990000|83134326|FG000|Overall Study|Failed to provide data beyond baseline|36|||
46905740|NCT02990000|83134327|FG001|Overall Study|Failed to provide data beyond baseline|34|||
46905741|NCT01068626|83134335|FG000|Overall Study|Adverse Event|3|||
46997218|NCT02326298|83244028|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997219|NCT02326298|83244029|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46905742|NCT01068626|83134336|FG001|Overall Study|Adverse Event|0|||
46905743|NCT01068626|83134335|FG000|Overall Study|Withdrawal by Subject|0|||
46997220|NCT02326298|83244030|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997221|NCT02326298|83244031|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46905744|NCT01068626|83134336|FG001|Overall Study|Withdrawal by Subject|2|||
46905745|NCT02921750|83134344|FG000|Overall Study|Adverse Event|1|||
46905746|NCT02921750|83134345|FG001|Overall Study|Adverse Event|2|||
46905747|NCT02921750|83134344|FG000|Overall Study|Withdrawal by Subject|1|||
46905748|NCT02921750|83134345|FG001|Overall Study|Withdrawal by Subject|1|||
46905749|NCT02921750|83134344|FG000|Overall Study|Lost to Follow-up|3|||
46905750|NCT02921750|83134345|FG001|Overall Study|Lost to Follow-up|3|||
46905751|NCT02921750|83134344|FG000|Overall Study|Wound healed|3|||
46905752|NCT02921750|83134345|FG001|Overall Study|Wound healed|3|||
46905753|NCT02921750|83134344|FG000|Overall Study|Serious Adverse Event|1|||
46905754|NCT02921750|83134345|FG001|Overall Study|Serious Adverse Event|2|||
46905755|NCT02920970|83134354|FG000|First Intervention|Protocol Violation|0|||
46905756|NCT02920970|83134355|FG001|First Intervention|Protocol Violation|1|||
46905757|NCT02920970|83134354|FG000|First Intervention|Adverse Event|0|||
46905758|NCT02920970|83134355|FG001|First Intervention|Adverse Event|1|||
46905759|NCT02920970|83134354|FG000|Second Intervention|Poor Lens Fit|1|||
46905760|NCT02920970|83134355|FG001|Second Intervention|Poor Lens Fit|0|||
46905761|NCT01068158|83134365|FG000|Overall Study|Withdrawal by Subject|1|||
46905762|NCT01068158|83134366|FG001|Overall Study|Withdrawal by Subject|2|||
46905763|NCT01068158|83134365|FG000|Overall Study|Lost to Follow-up|7|||
46905764|NCT01068158|83134366|FG001|Overall Study|Lost to Follow-up|0|||
46905765|NCT01068158|83134365|FG000|Overall Study|Protocol Violation|0|||
46905766|NCT01068158|83134366|FG001|Overall Study|Protocol Violation|2|||
46905767|NCT03303079|83134375|FG000|Overall Study|Adverse Event|0|||
46905768|NCT03303079|83134376|FG001|Overall Study|Adverse Event|1|||
46905769|NCT03303079|83134377|FG002|Overall Study|Adverse Event|3|||
46905770|NCT03303079|83134375|FG000|Overall Study|Protocol Violation|5|||
46905771|NCT03303079|83134376|FG001|Overall Study|Protocol Violation|4|||
46905772|NCT03303079|83134377|FG002|Overall Study|Protocol Violation|7|||
46905773|NCT03303079|83134375|FG000|Overall Study|Withdrawal by Subject|2|||
46905774|NCT03303079|83134376|FG001|Overall Study|Withdrawal by Subject|4|||
46905775|NCT03303079|83134377|FG002|Overall Study|Withdrawal by Subject|2|||
46905776|NCT03303079|83134375|FG000|Overall Study|Other than specified|0|||
46905777|NCT03303079|83134376|FG001|Overall Study|Other than specified|2|||
46905778|NCT03303079|83134377|FG002|Overall Study|Other than specified|0|||
46905779|NCT01067846|83134387|FG000|Overall Study|Lost to Follow-up|17|||
46905780|NCT01067846|83134388|FG001|Overall Study|Lost to Follow-up|19|||
46905781|NCT01067846|83134387|FG000|Overall Study|Withdrawal by Subject|1|||
46905782|NCT01067846|83134388|FG001|Overall Study|Withdrawal by Subject|0|||
46905783|NCT01067846|83134387|FG000|Overall Study|participation in other tx study|1|||
46905784|NCT01067846|83134388|FG001|Overall Study|participation in other tx study|0|||
46905785|NCT03311659|83134394|FG000|Overall Study|Protocol Violation|1|||
46905786|NCT03874234|83134411|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905787|NCT03874234|83134412|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905788|NCT03874234|83134413|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905789|NCT03874234|83134414|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
46905790|NCT03874234|83134415|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905791|NCT03874234|83134416|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905792|NCT03874234|83134417|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905793|NCT03874234|83134418|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905794|NCT03874234|83134419|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905795|NCT03874234|83134420|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905796|NCT03874234|83134421|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905797|NCT03874234|83134422|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905798|NCT03874234|83134423|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
46905799|NCT03874234|83134411|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
46905800|NCT03874234|83134412|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905801|NCT03874234|83134413|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905802|NCT03874234|83134414|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905803|NCT03874234|83134415|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905804|NCT03874234|83134416|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46997222|NCT02326298|83244032|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46905805|NCT03874234|83134417|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905806|NCT03874234|83134418|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905807|NCT03874234|83134419|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46997223|NCT02326298|83244033|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997224|NCT02326298|83244034|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
46997225|NCT02326298|83244021|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
46997226|NCT02326298|83244022|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
46997227|NCT02326298|83244023|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
46997228|NCT02326298|83244024|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
46997229|NCT02326298|83244025|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
46709163|NCT00381680|82925156|FG001|Overall Study|Adverse Event|3|||
46905808|NCT03874234|83134420|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905809|NCT03874234|83134421|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905810|NCT03874234|83134422|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905811|NCT03874234|83134423|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
46905812|NCT03874234|83134411|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905813|NCT03874234|83134412|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905814|NCT03874234|83134413|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905815|NCT03874234|83134414|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
46905816|NCT03874234|83134415|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905817|NCT03874234|83134416|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905818|NCT03874234|83134417|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905819|NCT03874234|83134418|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905820|NCT03874234|83134419|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905821|NCT03874234|83134420|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905822|NCT03874234|83134421|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905823|NCT03874234|83134422|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905824|NCT03874234|83134423|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
46905825|NCT03874234|83134411|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905826|NCT03874234|83134412|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905827|NCT03874234|83134413|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905828|NCT03874234|83134414|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905829|NCT03874234|83134415|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
46905830|NCT03874234|83134416|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905831|NCT03874234|83134417|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905832|NCT03874234|83134418|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905833|NCT03874234|83134419|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905834|NCT03874234|83134420|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905835|NCT03874234|83134421|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905836|NCT03874234|83134422|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905837|NCT03874234|83134423|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
46905838|NCT03874234|83134411|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905839|NCT03874234|83134412|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905840|NCT03874234|83134413|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905841|NCT03874234|83134414|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905842|NCT03874234|83134415|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905843|NCT03874234|83134416|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905844|NCT03874234|83134417|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905845|NCT03874234|83134418|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
46905846|NCT03874234|83134419|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905847|NCT03874234|83134420|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905848|NCT03874234|83134421|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905849|NCT03874234|83134422|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905850|NCT03874234|83134423|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
46905851|NCT03874234|83134411|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905852|NCT03874234|83134412|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905853|NCT03874234|83134413|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905854|NCT03874234|83134414|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905855|NCT03874234|83134415|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
46905856|NCT03874234|83134416|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
46905857|NCT03874234|83134417|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905858|NCT03874234|83134418|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905859|NCT03874234|83134419|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905860|NCT03874234|83134420|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905861|NCT03874234|83134421|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905862|NCT03874234|83134422|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46997230|NCT02326298|83244026|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
46997231|NCT02326298|83244027|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
46997232|NCT02326298|83244028|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
46997233|NCT02326298|83244029|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
46620202|NCT02283762|82761962|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
46620203|NCT02283762|82761963|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
46620204|NCT02283762|82761962|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
46620205|NCT02283762|82761963|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
46905863|NCT03874234|83134423|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
46905864|NCT03874234|83134411|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905865|NCT03874234|83134412|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905866|NCT03874234|83134413|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905867|NCT03874234|83134414|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46997234|NCT02326298|83244030|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
46905868|NCT03874234|83134415|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905869|NCT03874234|83134416|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905870|NCT03874234|83134417|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
46905871|NCT03874234|83134418|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905872|NCT03874234|83134419|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905873|NCT03874234|83134420|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905874|NCT03874234|83134421|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905875|NCT03874234|83134422|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905876|NCT03874234|83134423|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
46905877|NCT03874234|83134411|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905878|NCT03874234|83134412|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905879|NCT03874234|83134413|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905880|NCT03874234|83134414|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905881|NCT03874234|83134415|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
46905882|NCT03874234|83134416|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905883|NCT03874234|83134417|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905884|NCT03874234|83134418|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905885|NCT03874234|83134419|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905886|NCT03874234|83134420|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905887|NCT03874234|83134421|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905888|NCT03874234|83134422|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905889|NCT03874234|83134423|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
46905890|NCT02985398|83134459|FG000|Overall Study|Adverse Event|1|||
46905891|NCT02985398|83134459|FG000|Overall Study|Lost to Follow-up|4|||
46905892|NCT02985398|83134459|FG000|Overall Study|Withdrawal by Subject|8|||
46905893|NCT02985398|83134459|FG000|Overall Study|Study Burden|9|||
46905894|NCT03310723|83134465|FG000|Overall Study|Withdrawal by Subject|0|||
46905895|NCT03310723|83134466|FG001|Overall Study|Withdrawal by Subject|1|||
46905896|NCT03310723|83134465|FG000|Overall Study|Protocol Violation|0|||
46905897|NCT03310723|83134466|FG001|Overall Study|Protocol Violation|2|||
46905898|NCT02663674|83134474|FG000|Overall Study|Lost to Follow-up|5|||
46905899|NCT02663674|83134475|FG001|Overall Study|Lost to Follow-up|4|||
46905900|NCT02663674|83134474|FG000|Overall Study|Withdrawal by Subject|1|||
46905901|NCT02663674|83134475|FG001|Overall Study|Withdrawal by Subject|4|||
46905902|NCT02663674|83134474|FG000|Overall Study|Physician Decision|1|||
46905903|NCT02663674|83134475|FG001|Overall Study|Physician Decision|1|||
46905904|NCT02663674|83134474|FG000|Overall Study|Other Event (Health Related)|0|||
46905905|NCT02663674|83134475|FG001|Overall Study|Other Event (Health Related)|1|||
46905906|NCT02908880|83134481|FG000|Overall Study|Lost to Follow-up|4|||
46905907|NCT02908880|83134481|FG000|Overall Study|Explantation of the device|1|||
46905908|NCT02908880|83134481|FG000|Overall Study|Withdrawal by Subject|17|||
46905909|NCT02908880|83134481|FG000|Overall Study|Death|5|||
46905910|NCT03310411|83134485|FG000|Period 1|Adverse Event|0|||
46905911|NCT03310411|83134486|FG001|Period 1|Adverse Event|0|||
46905912|NCT03310411|83134487|FG002|Period 1|Adverse Event|0|||
46905913|NCT03310411|83134488|FG003|Period 1|Adverse Event|1|||
46905914|NCT03301831|83134506|FG000|Overall Study|Lost to Follow-up|5|||
46905915|NCT03301831|83134507|FG001|Overall Study|Lost to Follow-up|3|||
46905916|NCT03301831|83134506|FG000|Overall Study|Protocol Violation|4|||
46905917|NCT03301831|83134507|FG001|Overall Study|Protocol Violation|0|||
46905918|NCT03301831|83134506|FG000|Overall Study|Withdrawal by Subject|11|||
46905919|NCT03301831|83134507|FG001|Overall Study|Withdrawal by Subject|0|||
46905920|NCT02909504|83134513|FG000|Overall Study|Adverse Event|2|||
46905921|NCT02909504|83134513|FG000|Overall Study|Lack of Efficacy|3|||
46905922|NCT02909504|83134513|FG000|Overall Study|Withdrawal by Subject|4|||
46709164|NCT00381680|82925155|FG000|Overall Study|Death|10|||
46905923|NCT02909504|83134513|FG000|Overall Study|Pregnancy|1|||
46905924|NCT02909504|83134513|FG000|Overall Study|Subject moved|1|||
46905925|NCT02909504|83134513|FG000|Overall Study|Lost to Follow-up|1|||
46905926|NCT02199691|83134522|FG000|Overall Study|Protocol Violation|3|||
46905927|NCT02199691|83134523|FG001|Overall Study|Protocol Violation|3|||
46905928|NCT02199691|83134524|FG002|Overall Study|Protocol Violation|6|||
46905929|NCT02199691|83134525|FG003|Overall Study|Protocol Violation|7|||
46905930|NCT02199691|83134522|FG000|Overall Study|Withdrawal by Subject|5|||
46905931|NCT02199691|83134523|FG001|Overall Study|Withdrawal by Subject|3|||
46905932|NCT02199691|83134524|FG002|Overall Study|Withdrawal by Subject|12|||
46905933|NCT02199691|83134525|FG003|Overall Study|Withdrawal by Subject|13|||
46905934|NCT02199691|83134522|FG000|Overall Study|Lost to Follow-up|2|||
46905935|NCT02199691|83134523|FG001|Overall Study|Lost to Follow-up|1|||
46905936|NCT02199691|83134524|FG002|Overall Study|Lost to Follow-up|9|||
46905937|NCT02199691|83134525|FG003|Overall Study|Lost to Follow-up|10|||
46905938|NCT03299881|83134539|FG000|Overall Study|Study Termination|17|||
46905939|NCT03299881|83134540|FG001|Overall Study|Study Termination|13|||
46905940|NCT03299101|83134546|FG000|Overall Study|Lost to Follow-up|1|||
46905941|NCT03299101|83134546|FG000|Overall Study|Withdrawal by Subject|5|||
46905942|NCT03299101|83134546|FG000|Overall Study|Surgery was changed|3|||
46905943|NCT03299101|83134546|FG000|Overall Study|Not enough time to complete prehab|1|||
46905944|NCT02663128|83134552|FG000|Period 2|Physician Decision|0|||
46905945|NCT02663128|83134553|FG001|Period 2|Physician Decision|0|||
46905946|NCT02663128|83134554|FG002|Period 2|Physician Decision|0|||
46905947|NCT02663128|83134555|FG003|Period 2|Physician Decision|0|||
46905948|NCT02663128|83134556|FG004|Period 2|Physician Decision|1|||
46905949|NCT02663128|83134557|FG005|Period 2|Physician Decision|0|||
46905950|NCT03298867|83134568|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
46905951|NCT03298867|83134569|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
46905952|NCT03298867|83134568|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
46905953|NCT03298867|83134569|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
46905954|NCT03298867|83134568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
46905955|NCT03298867|83134569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
46905956|NCT03298867|83134568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
46905957|NCT03298867|83134569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
46905958|NCT03298867|83134568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
46905959|NCT03298867|83134569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
46905960|NCT03298867|83134568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
46905961|NCT03298867|83134569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
46905962|NCT03298867|83134568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
46905963|NCT03298867|83134569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
46905964|NCT03298867|83134568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
46905965|NCT03298867|83134569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
46905966|NCT03298867|83134568|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
46905967|NCT03298867|83134569|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
46905968|NCT02906930|83134579|FG000|Overall Study|Withdrawal by Subject|0|||
46905969|NCT02906930|83134580|FG001|Overall Study|Withdrawal by Subject|5|||
46905970|NCT02906930|83134581|FG002|Overall Study|Withdrawal by Subject|5|||
46905971|NCT02906930|83134582|FG003|Overall Study|Withdrawal by Subject|4|||
46905972|NCT02906930|83134579|FG000|Overall Study|Lost to Follow-up|5|||
46905973|NCT02906930|83134580|FG001|Overall Study|Lost to Follow-up|7|||
46905974|NCT02906930|83134581|FG002|Overall Study|Lost to Follow-up|5|||
46905975|NCT02906930|83134582|FG003|Overall Study|Lost to Follow-up|2|||
46905976|NCT02906930|83134579|FG000|Overall Study|Death|0|||
46905977|NCT02906930|83134580|FG001|Overall Study|Death|0|||
46905978|NCT02906930|83134581|FG002|Overall Study|Death|1|||
46905979|NCT02906930|83134582|FG003|Overall Study|Death|0|||
46905980|NCT02906930|83134579|FG000|Overall Study|Other|1|||
46905981|NCT02906930|83134580|FG001|Overall Study|Other|2|||
46905982|NCT02906930|83134581|FG002|Overall Study|Other|1|||
46905983|NCT02906930|83134582|FG003|Overall Study|Other|2|||
46905984|NCT02983604|83134596|FG000|Overall Study|Enrolled but not Treated|0|||
46905985|NCT02983604|83134597|FG001|Overall Study|Enrolled but not Treated|0|||
46905986|NCT02983604|83134598|FG002|Overall Study|Enrolled but not Treated|1|||
46905987|NCT02983604|83134599|FG003|Overall Study|Enrolled but not Treated|0|||
46905988|NCT02662582|83134611|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
46905989|NCT02662582|83134612|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
46905990|NCT02662582|83134611|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
46905991|NCT02662582|83134612|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
46905992|NCT02662582|83134611|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
46905993|NCT02662582|83134612|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
46905994|NCT02662582|83134611|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
46905995|NCT02662582|83134612|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
46905996|NCT02908100|83134622|FG000|Overall Study|Adverse Event|7|||
46905997|NCT02908100|83134623|FG001|Overall Study|Adverse Event|6|||
46905998|NCT02908100|83134624|FG002|Overall Study|Adverse Event|9|||
46905999|NCT02908100|83134622|FG000|Overall Study|Death|2|||
46906000|NCT02908100|83134623|FG001|Overall Study|Death|0|||
46906001|NCT02908100|83134624|FG002|Overall Study|Death|0|||
46906002|NCT02908100|83134622|FG000|Overall Study|Lack of Efficacy|2|||
46906003|NCT02908100|83134623|FG001|Overall Study|Lack of Efficacy|3|||
46906004|NCT02908100|83134624|FG002|Overall Study|Lack of Efficacy|3|||
46906005|NCT02908100|83134622|FG000|Overall Study|Lost to Follow-up|0|||
46906006|NCT02908100|83134623|FG001|Overall Study|Lost to Follow-up|1|||
46906007|NCT02908100|83134624|FG002|Overall Study|Lost to Follow-up|2|||
46906008|NCT02908100|83134622|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46906009|NCT02908100|83134623|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46906010|NCT02908100|83134624|FG002|Overall Study|Non-Compliance With Study Drug|2|||
46906011|NCT02908100|83134622|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
46906012|NCT02908100|83134623|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
46906013|NCT02908100|83134624|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
46906014|NCT02908100|83134622|FG000|Overall Study|Physician Decision|0|||
46906015|NCT02908100|83134623|FG001|Overall Study|Physician Decision|1|||
46906016|NCT02908100|83134624|FG002|Overall Study|Physician Decision|0|||
46906017|NCT02908100|83134622|FG000|Overall Study|Pregnancy|1|||
46906018|NCT02908100|83134623|FG001|Overall Study|Pregnancy|2|||
46906019|NCT02908100|83134624|FG002|Overall Study|Pregnancy|0|||
46906020|NCT02908100|83134622|FG000|Overall Study|Withdrawal by Subject|8|||
46906021|NCT02908100|83134623|FG001|Overall Study|Withdrawal by Subject|7|||
46906022|NCT02908100|83134624|FG002|Overall Study|Withdrawal by Subject|5|||
46906023|NCT02908100|83134622|FG000|Overall Study|Randomised in Error|1|||
46906024|NCT02908100|83134623|FG001|Overall Study|Randomised in Error|0|||
46906025|NCT02908100|83134624|FG002|Overall Study|Randomised in Error|0|||
46906026|NCT02982590|83134648|FG000|Overall Study|Lost to Follow-up|0|||
46906027|NCT02982590|83134649|FG001|Overall Study|Lost to Follow-up|1|||
46906028|NCT02982590|83134648|FG000|Overall Study|Death|4|||
46906029|NCT02982590|83134649|FG001|Overall Study|Death|0|||
46906030|NCT03310021|83134675|FG000|Overall Study|Withdrawal by Subject|0|||
46906031|NCT03310021|83134676|FG001|Overall Study|Withdrawal by Subject|0|||
46906032|NCT03310021|83134677|FG002|Overall Study|Withdrawal by Subject|0|||
46906033|NCT03310021|83134678|FG003|Overall Study|Withdrawal by Subject|0|||
46906034|NCT03310021|83134679|FG004|Overall Study|Withdrawal by Subject|0|||
46906035|NCT03310021|83134680|FG005|Overall Study|Withdrawal by Subject|0|||
46906036|NCT03310021|83134681|FG006|Overall Study|Withdrawal by Subject|1|||
46906037|NCT03310021|83134682|FG007|Overall Study|Withdrawal by Subject|0|||
46906038|NCT03310021|83134683|FG008|Overall Study|Withdrawal by Subject|0|||
46906039|NCT03310021|83134684|FG009|Overall Study|Withdrawal by Subject|0|||
46906040|NCT03310021|83134685|FG010|Overall Study|Withdrawal by Subject|0|||
46906041|NCT03310021|83134686|FG011|Overall Study|Withdrawal by Subject|0|||
46906042|NCT03310021|83134687|FG012|Overall Study|Withdrawal by Subject|0|||
46906043|NCT03310021|83134688|FG013|Overall Study|Withdrawal by Subject|0|||
46906044|NCT03310021|83134689|FG014|Overall Study|Withdrawal by Subject|0|||
46906045|NCT03310021|83134690|FG015|Overall Study|Withdrawal by Subject|0|||
46906046|NCT03310021|83134691|FG016|Overall Study|Withdrawal by Subject|0|||
46906047|NCT03310021|83134692|FG017|Overall Study|Withdrawal by Subject|0|||
46906048|NCT03310021|83134693|FG018|Overall Study|Withdrawal by Subject|0|||
46906049|NCT03310021|83134694|FG019|Overall Study|Withdrawal by Subject|0|||
46906050|NCT03310021|83134675|FG000|Overall Study|Lost to Follow-up|0|||
46906051|NCT03310021|83134676|FG001|Overall Study|Lost to Follow-up|0|||
46906052|NCT03310021|83134677|FG002|Overall Study|Lost to Follow-up|0|||
46997235|NCT02326298|83244031|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
46997236|NCT02326298|83244032|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
46997237|NCT02326298|83244033|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
46906053|NCT03310021|83134678|FG003|Overall Study|Lost to Follow-up|0|||
46906054|NCT03310021|83134679|FG004|Overall Study|Lost to Follow-up|0|||
46906055|NCT03310021|83134680|FG005|Overall Study|Lost to Follow-up|0|||
46906056|NCT03310021|83134681|FG006|Overall Study|Lost to Follow-up|0|||
46906057|NCT03310021|83134682|FG007|Overall Study|Lost to Follow-up|0|||
46906058|NCT03310021|83134683|FG008|Overall Study|Lost to Follow-up|0|||
46906059|NCT03310021|83134684|FG009|Overall Study|Lost to Follow-up|0|||
46906060|NCT03310021|83134685|FG010|Overall Study|Lost to Follow-up|1|||
46906061|NCT03310021|83134686|FG011|Overall Study|Lost to Follow-up|0|||
46906062|NCT03310021|83134687|FG012|Overall Study|Lost to Follow-up|0|||
46906063|NCT03310021|83134688|FG013|Overall Study|Lost to Follow-up|0|||
46906064|NCT03310021|83134689|FG014|Overall Study|Lost to Follow-up|0|||
46906065|NCT03310021|83134690|FG015|Overall Study|Lost to Follow-up|0|||
46906066|NCT03310021|83134691|FG016|Overall Study|Lost to Follow-up|0|||
46906067|NCT03310021|83134692|FG017|Overall Study|Lost to Follow-up|0|||
46906068|NCT03310021|83134693|FG018|Overall Study|Lost to Follow-up|0|||
46906069|NCT03310021|83134694|FG019|Overall Study|Lost to Follow-up|0|||
46906070|NCT03333109|83134739|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
46997238|NCT02326298|83244034|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
46906071|NCT03333109|83134740|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
46906072|NCT03333109|83134741|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
46906073|NCT03333109|83134739|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46906074|NCT03333109|83134740|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46906075|NCT03333109|83134741|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
46906076|NCT03333109|83134739|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
46906077|NCT03333109|83134740|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
46906078|NCT03333109|83134741|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
46906079|NCT03333109|83134739|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
46906080|NCT03333109|83134740|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
46906081|NCT03333109|83134741|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
46906082|NCT03333109|83134739|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
46906083|NCT03333109|83134740|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
46906084|NCT03333109|83134741|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
46906085|NCT03333109|83134739|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
46906086|NCT03333109|83134740|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
46906087|NCT03333109|83134741|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
46906088|NCT03333109|83134739|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
46906089|NCT03333109|83134740|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
46906090|NCT03333109|83134741|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
46906091|NCT03333109|83134739|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
46906092|NCT03333109|83134740|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
46906093|NCT03333109|83134741|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
46906094|NCT02940223|83134751|FG000|Overall Study|Failed Requirement|2|||
46906095|NCT02940223|83134752|FG001|Overall Study|Failed Requirement|0|||
46906096|NCT03295201|83134760|FG000|Overall Study|Lost to Follow-up|1|||
46906097|NCT03295201|83134761|FG001|Overall Study|Lost to Follow-up|1|||
46906098|NCT03295201|83134760|FG000|Overall Study|Hospital admission|0|||
46906099|NCT03295201|83134761|FG001|Overall Study|Hospital admission|1|||
46906100|NCT03293485|83134767|FG000|Overall Study|Death|1|||
46906101|NCT03293485|83134767|FG000|Overall Study|Screen Failure|2|||
46906102|NCT03293485|83134767|FG000|Overall Study|Withdrawal by Subject|2|||
46906103|NCT03309943|83134775|FG000|Overall Study|Withdrawal by Subject|0|||
46906104|NCT03309943|83134776|FG001|Overall Study|Withdrawal by Subject|1|||
46906105|NCT03309943|83134775|FG000|Overall Study|Inappropriate behavior towards staff|0|||
46906106|NCT03309943|83134776|FG001|Overall Study|Inappropriate behavior towards staff|1|||
46906107|NCT01732627|83134784|FG000|Overall Study|Withdrawal by Subject|1|||
46906108|NCT01732627|83134785|FG001|Overall Study|Withdrawal by Subject|0|||
46906109|NCT03307837|83134797|FG000|Overall Study|Withdrawal by Subject|0|||
46906110|NCT03307837|83134798|FG001|Overall Study|Withdrawal by Subject|0|||
46906111|NCT03307837|83134799|FG002|Overall Study|Withdrawal by Subject|1|||
46906112|NCT03307837|83134800|FG003|Overall Study|Withdrawal by Subject|0|||
46906113|NCT03307837|83134801|FG004|Overall Study|Withdrawal by Subject|0|||
46906114|NCT03307837|83134802|FG005|Overall Study|Withdrawal by Subject|1|||
46906115|NCT03307837|83134797|FG000|Overall Study|Lost to Follow-up|1|||
46906116|NCT03307837|83134798|FG001|Overall Study|Lost to Follow-up|1|||
46906117|NCT03307837|83134799|FG002|Overall Study|Lost to Follow-up|0|||
46906118|NCT03307837|83134800|FG003|Overall Study|Lost to Follow-up|0|||
46906119|NCT03307837|83134801|FG004|Overall Study|Lost to Follow-up|0|||
46906120|NCT03307837|83134802|FG005|Overall Study|Lost to Follow-up|1|||
46906121|NCT03331315|83134823|FG000|Overall Study|Physician Decision|18|||
46906122|NCT03331315|83134824|FG001|Overall Study|Physician Decision|14|||
46906123|NCT03329989|83134832|FG000|Overall Study|Withdrawal by Subject|9|||
46906124|NCT03329989|83134832|FG000|Overall Study|Lost to Follow-up|8|||
46906125|NCT03329989|83134832|FG000|Overall Study|Adverse Event|5|||
46906126|NCT03329989|83134832|FG000|Overall Study|Protocol Violation|1|||
46906127|NCT03287869|83134838|FG000|Overall Study|Adverse Event|14|||
46906128|NCT03287869|83134839|FG001|Overall Study|Adverse Event|12|||
46906129|NCT03287869|83134838|FG000|Overall Study|Lack of Efficacy|1|||
46997239|NCT02326298|83244021|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997240|NCT02326298|83244022|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997241|NCT02326298|83244023|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997242|NCT02326298|83244024|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997243|NCT02326298|83244025|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997244|NCT02326298|83244026|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46906130|NCT03287869|83134839|FG001|Overall Study|Lack of Efficacy|0|||
46906131|NCT03287869|83134838|FG000|Overall Study|Lost to Follow-up|13|||
46906132|NCT03287869|83134839|FG001|Overall Study|Lost to Follow-up|19|||
46906133|NCT03287869|83134838|FG000|Overall Study|Non-Compliance With Study Drug|5|||
46906134|NCT03287869|83134839|FG001|Overall Study|Non-Compliance With Study Drug|9|||
46906135|NCT03287869|83134838|FG000|Overall Study|Progressive Disease|1|||
46906136|NCT03287869|83134839|FG001|Overall Study|Progressive Disease|0|||
46906137|NCT03287869|83134838|FG000|Overall Study|Protocol Deviation|2|||
46906138|NCT03287869|83134839|FG001|Overall Study|Protocol Deviation|1|||
46906139|NCT03287869|83134838|FG000|Overall Study|Withdrawal by Subject|36|||
46906140|NCT03287869|83134839|FG001|Overall Study|Withdrawal by Subject|43|||
46906141|NCT03287869|83134838|FG000|Overall Study|Early Closure of the Site|0|||
46906142|NCT03287869|83134839|FG001|Overall Study|Early Closure of the Site|1|||
46906143|NCT03287869|83134838|FG000|Overall Study|Physician Decision|5|||
46906144|NCT03287869|83134839|FG001|Overall Study|Physician Decision|5|||
46906145|NCT03287869|83134838|FG000|Overall Study|Reason not Specified|6|||
46906146|NCT03287869|83134839|FG001|Overall Study|Reason not Specified|3|||
46906147|NCT02661490|83134850|FG000|Overall Study|Lost to Follow-up|0|||
46906148|NCT02661490|83134851|FG001|Overall Study|Lost to Follow-up|1|||
46906149|NCT02661490|83134852|FG002|Overall Study|Lost to Follow-up|0|||
46906150|NCT02661490|83134853|FG003|Overall Study|Lost to Follow-up|0|||
46906151|NCT02661490|83134854|FG004|Overall Study|Lost to Follow-up|2|||
46906152|NCT02661490|83134850|FG000|Overall Study|Withdrawal by Subject|2|||
46906153|NCT02661490|83134851|FG001|Overall Study|Withdrawal by Subject|0|||
46906154|NCT02661490|83134852|FG002|Overall Study|Withdrawal by Subject|2|||
46906155|NCT02661490|83134853|FG003|Overall Study|Withdrawal by Subject|0|||
46906156|NCT02661490|83134854|FG004|Overall Study|Withdrawal by Subject|0|||
46906157|NCT02661490|83134850|FG000|Overall Study|Death|1|||
46906158|NCT02661490|83134851|FG001|Overall Study|Death|1|||
46906159|NCT02661490|83134852|FG002|Overall Study|Death|0|||
46906160|NCT02661490|83134853|FG003|Overall Study|Death|1|||
46906161|NCT02661490|83134854|FG004|Overall Study|Death|0|||
46906162|NCT02661490|83134850|FG000|Overall Study|Reason not Specified|0|||
46906163|NCT02661490|83134851|FG001|Overall Study|Reason not Specified|0|||
46906164|NCT02661490|83134852|FG002|Overall Study|Reason not Specified|0|||
46906165|NCT02661490|83134853|FG003|Overall Study|Reason not Specified|0|||
46906166|NCT02661490|83134854|FG004|Overall Study|Reason not Specified|1|||
46906167|NCT03287791|83134869|FG000|Overall Study|Insufficient Therapeutic Response|0|||
46906168|NCT03287791|83134870|FG001|Overall Study|Insufficient Therapeutic Response|0|||
46906169|NCT03287791|83134871|FG002|Overall Study|Insufficient Therapeutic Response|1|||
46906170|NCT03287791|83134869|FG000|Overall Study|Adverse Event|0|||
46906171|NCT03287791|83134870|FG001|Overall Study|Adverse Event|4|||
46906172|NCT03287791|83134871|FG002|Overall Study|Adverse Event|3|||
46906173|NCT03287791|83134869|FG000|Overall Study|Withdrawal by Subject|12|||
46906174|NCT03287791|83134870|FG001|Overall Study|Withdrawal by Subject|12|||
46906175|NCT03287791|83134871|FG002|Overall Study|Withdrawal by Subject|17|||
46906176|NCT03287791|83134869|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
46906177|NCT03287791|83134870|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
46906178|NCT03287791|83134871|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
46906179|NCT03287791|83134869|FG000|Overall Study|Lost to Follow-up|8|||
46906180|NCT03287791|83134870|FG001|Overall Study|Lost to Follow-up|14|||
46906181|NCT03287791|83134871|FG002|Overall Study|Lost to Follow-up|11|||
46906182|NCT03287791|83134869|FG000|Overall Study|Protocol Violation|7|||
46906183|NCT03287791|83134870|FG001|Overall Study|Protocol Violation|2|||
46906184|NCT03287791|83134871|FG002|Overall Study|Protocol Violation|1|||
46906185|NCT03287791|83134869|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
46906186|NCT03287791|83134870|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
46906187|NCT03287791|83134871|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
46906188|NCT03287791|83134869|FG000|Overall Study|Too much time between 2 visits|0|||
46906189|NCT03287791|83134870|FG001|Overall Study|Too much time between 2 visits|1|||
46906190|NCT03287791|83134871|FG002|Overall Study|Too much time between 2 visits|0|||
46906191|NCT03287791|83134869|FG000|Overall Study|Non-compliance|0|||
46906192|NCT03287791|83134870|FG001|Overall Study|Non-compliance|1|||
46906193|NCT03287791|83134871|FG002|Overall Study|Non-compliance|0|||
46906194|NCT03287791|83134869|FG000|Overall Study|Did not meet inclusion criteria|1|||
46906195|NCT03287791|83134870|FG001|Overall Study|Did not meet inclusion criteria|0|||
46906196|NCT03287791|83134871|FG002|Overall Study|Did not meet inclusion criteria|0|||
46906197|NCT03287635|83134879|FG000|Overall Study|Lost to Follow-up|5|||
46906198|NCT03287635|83134879|FG000|Overall Study|Withdrawal by Subject|1|||
46906199|NCT03287635|83134879|FG000|Overall Study|Physician Decision|1|||
46906200|NCT03287089|83134885|FG000|Overall Study|Lost to Follow-up|0|||
46906201|NCT03287089|83134886|FG001|Overall Study|Lost to Follow-up|2|||
46906202|NCT03287089|83134885|FG000|Overall Study|Physician Decision|0|||
46906203|NCT03287089|83134886|FG001|Overall Study|Physician Decision|2|||
46906204|NCT03287089|83134885|FG000|Overall Study|Withdrawal by Subject|0|||
46906205|NCT03287089|83134886|FG001|Overall Study|Withdrawal by Subject|2|||
46906206|NCT03286543|83134894|FG000|Consented|Screen failure before randomization|2|||
46906207|NCT03286543|83134895|FG001|Consented|Screen failure before randomization|0|||
46906208|NCT03286543|83134896|FG002|Consented|Screen failure before randomization|0|||
46906209|NCT03286543|83134894|FG000|Consented|Screen failure before enrollment|4|||
46906210|NCT03286543|83134895|FG001|Consented|Screen failure before enrollment|0|||
46906211|NCT03286543|83134896|FG002|Consented|Screen failure before enrollment|0|||
46906212|NCT03286543|83134894|FG000|Consented|TKA cancelled after enrollment|1|||
46906213|NCT03286543|83134895|FG001|Consented|TKA cancelled after enrollment|0|||
46906214|NCT03286543|83134896|FG002|Consented|TKA cancelled after enrollment|0|||
46906215|NCT03286543|83134894|FG000|Consented|Withdrawn from study|12|||
46906216|NCT03286543|83134895|FG001|Consented|Withdrawn from study|0|||
46906217|NCT03286543|83134896|FG002|Consented|Withdrawn from study|0|||
46906218|NCT03286543|83134894|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
46906219|NCT03286543|83134895|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
46906220|NCT03286543|83134896|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
46906221|NCT03286543|83134894|FG000|Study Enrollment|Withdrawn from study|0|||
46906222|NCT03286543|83134895|FG001|Study Enrollment|Withdrawn from study|6|||
46906223|NCT03286543|83134896|FG002|Study Enrollment|Withdrawn from study|6|||
46906224|NCT03306433|83134902|FG000|Overall Study|Lost to Follow-up|3|||
46906225|NCT03306433|83134902|FG000|Overall Study|Patient did not have teeth extracted|1|||
46906226|NCT03306433|83134902|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
46906227|NCT02940691|83134910|FG000|Overall Study|Lost to Follow-up|5|||
46906228|NCT02940691|83134910|FG000|Overall Study|Incarceration|1|||
46906229|NCT03306277|83134948|FG000|Overall Study|Death|1|||
46906230|NCT03306277|83134948|FG000|Overall Study|Adverse Event|1|||
46906231|NCT03306277|83134948|FG000|Overall Study|Withdrawal by Subject|1|||
46906232|NCT03130959|83134962|FG000|Overall Study|Disease progression|19|||
46906233|NCT03130959|83134963|FG001|Overall Study|Disease progression|7|||
46906234|NCT03130959|83134964|FG002|Overall Study|Disease progression|12|||
46906235|NCT03130959|83134965|FG003|Overall Study|Disease progression|7|||
46906236|NCT03130959|83134966|FG004|Overall Study|Disease progression|12|||
46906237|NCT03130959|83134967|FG005|Overall Study|Disease progression|3|||
46906238|NCT03130959|83134968|FG006|Overall Study|Disease progression|6|||
46906239|NCT03130959|83134969|FG007|Overall Study|Disease progression|3|||
46906240|NCT03130959|83134970|FG008|Overall Study|Disease progression|15|||
46906241|NCT03130959|83134971|FG009|Overall Study|Disease progression|8|||
46906242|NCT03130959|83134962|FG000|Overall Study|Study drug toxicity|2|||
46906243|NCT03130959|83134963|FG001|Overall Study|Study drug toxicity|2|||
46906244|NCT03130959|83134964|FG002|Overall Study|Study drug toxicity|1|||
46906245|NCT03130959|83134965|FG003|Overall Study|Study drug toxicity|2|||
46906246|NCT03130959|83134966|FG004|Overall Study|Study drug toxicity|1|||
46906247|NCT03130959|83134967|FG005|Overall Study|Study drug toxicity|1|||
46906248|NCT03130959|83134968|FG006|Overall Study|Study drug toxicity|3|||
46906249|NCT03130959|83134969|FG007|Overall Study|Study drug toxicity|0|||
46906250|NCT03130959|83134970|FG008|Overall Study|Study drug toxicity|3|||
46906251|NCT03130959|83134971|FG009|Overall Study|Study drug toxicity|3|||
46906252|NCT03130959|83134962|FG000|Overall Study|Other reasons|0|||
46906253|NCT03130959|83134963|FG001|Overall Study|Other reasons|0|||
46906254|NCT03130959|83134964|FG002|Overall Study|Other reasons|0|||
46906255|NCT03130959|83134965|FG003|Overall Study|Other reasons|0|||
46906256|NCT03130959|83134966|FG004|Overall Study|Other reasons|0|||
46906257|NCT03130959|83134967|FG005|Overall Study|Other reasons|1|||
46906258|NCT03130959|83134968|FG006|Overall Study|Other reasons|1|||
46906259|NCT03130959|83134969|FG007|Overall Study|Other reasons|0|||
46906260|NCT03130959|83134970|FG008|Overall Study|Other reasons|0|||
46906261|NCT03130959|83134971|FG009|Overall Study|Other reasons|0|||
46906262|NCT03130959|83134962|FG000|Overall Study|Subject request to discontinue therapy|0|||
46906263|NCT03130959|83134963|FG001|Overall Study|Subject request to discontinue therapy|0|||
46906264|NCT03130959|83134964|FG002|Overall Study|Subject request to discontinue therapy|1|||
46906265|NCT03130959|83134965|FG003|Overall Study|Subject request to discontinue therapy|1|||
46906266|NCT03130959|83134966|FG004|Overall Study|Subject request to discontinue therapy|0|||
46906267|NCT03130959|83134967|FG005|Overall Study|Subject request to discontinue therapy|0|||
46906268|NCT03130959|83134968|FG006|Overall Study|Subject request to discontinue therapy|1|||
46906269|NCT03130959|83134969|FG007|Overall Study|Subject request to discontinue therapy|1|||
46906270|NCT03130959|83134970|FG008|Overall Study|Subject request to discontinue therapy|0|||
46906271|NCT03130959|83134971|FG009|Overall Study|Subject request to discontinue therapy|0|||
46906272|NCT03130959|83134962|FG000|Overall Study|Not reported|0|||
46906273|NCT03130959|83134963|FG001|Overall Study|Not reported|0|||
46906274|NCT03130959|83134964|FG002|Overall Study|Not reported|0|||
46906275|NCT03130959|83134965|FG003|Overall Study|Not reported|1|||
46906276|NCT03130959|83134966|FG004|Overall Study|Not reported|0|||
46906277|NCT03130959|83134967|FG005|Overall Study|Not reported|1|||
46997245|NCT02326298|83244027|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46906278|NCT03130959|83134968|FG006|Overall Study|Not reported|0|||
46906279|NCT03130959|83134969|FG007|Overall Study|Not reported|0|||
46906280|NCT03130959|83134970|FG008|Overall Study|Not reported|0|||
46906281|NCT03130959|83134971|FG009|Overall Study|Not reported|1|||
46906282|NCT03130959|83134962|FG000|Overall Study|Adverse Event unrelated to drug|0|||
46906283|NCT03130959|83134963|FG001|Overall Study|Adverse Event unrelated to drug|0|||
46906284|NCT03130959|83134964|FG002|Overall Study|Adverse Event unrelated to drug|1|||
46906285|NCT03130959|83134965|FG003|Overall Study|Adverse Event unrelated to drug|1|||
46906286|NCT03130959|83134966|FG004|Overall Study|Adverse Event unrelated to drug|1|||
46906287|NCT03130959|83134967|FG005|Overall Study|Adverse Event unrelated to drug|0|||
46906288|NCT03130959|83134968|FG006|Overall Study|Adverse Event unrelated to drug|1|||
46906289|NCT03130959|83134969|FG007|Overall Study|Adverse Event unrelated to drug|0|||
46906290|NCT03130959|83134970|FG008|Overall Study|Adverse Event unrelated to drug|1|||
46906291|NCT03130959|83134971|FG009|Overall Study|Adverse Event unrelated to drug|1|||
46906292|NCT03130959|83134962|FG000|Overall Study|Participant withdrew consent|0|||
46906293|NCT03130959|83134963|FG001|Overall Study|Participant withdrew consent|1|||
46906294|NCT03130959|83134964|FG002|Overall Study|Participant withdrew consent|0|||
46906295|NCT03130959|83134965|FG003|Overall Study|Participant withdrew consent|2|||
46906296|NCT03130959|83134966|FG004|Overall Study|Participant withdrew consent|1|||
46906297|NCT03130959|83134967|FG005|Overall Study|Participant withdrew consent|0|||
46906298|NCT03130959|83134968|FG006|Overall Study|Participant withdrew consent|0|||
46906299|NCT03130959|83134969|FG007|Overall Study|Participant withdrew consent|0|||
46906300|NCT03130959|83134970|FG008|Overall Study|Participant withdrew consent|0|||
46906301|NCT03130959|83134971|FG009|Overall Study|Participant withdrew consent|2|||
46906302|NCT03130959|83134962|FG000|Overall Study|Administrative reason by sponsor|1|||
46906303|NCT03130959|83134963|FG001|Overall Study|Administrative reason by sponsor|0|||
46906304|NCT03130959|83134964|FG002|Overall Study|Administrative reason by sponsor|1|||
46906305|NCT03130959|83134965|FG003|Overall Study|Administrative reason by sponsor|0|||
46906306|NCT03130959|83134966|FG004|Overall Study|Administrative reason by sponsor|0|||
46906307|NCT03130959|83134967|FG005|Overall Study|Administrative reason by sponsor|0|||
46906308|NCT03130959|83134968|FG006|Overall Study|Administrative reason by sponsor|0|||
46906309|NCT03130959|83134969|FG007|Overall Study|Administrative reason by sponsor|0|||
46906310|NCT03130959|83134970|FG008|Overall Study|Administrative reason by sponsor|0|||
46906311|NCT03130959|83134971|FG009|Overall Study|Administrative reason by sponsor|0|||
46906312|NCT03130959|83134962|FG000|Overall Study|Lost to Follow-up|1|||
46906313|NCT03130959|83134963|FG001|Overall Study|Lost to Follow-up|0|||
46906314|NCT03130959|83134964|FG002|Overall Study|Lost to Follow-up|0|||
46906315|NCT03130959|83134965|FG003|Overall Study|Lost to Follow-up|0|||
46906316|NCT03130959|83134966|FG004|Overall Study|Lost to Follow-up|0|||
46906317|NCT03130959|83134967|FG005|Overall Study|Lost to Follow-up|0|||
46906318|NCT03130959|83134968|FG006|Overall Study|Lost to Follow-up|0|||
46906319|NCT03130959|83134969|FG007|Overall Study|Lost to Follow-up|0|||
46906320|NCT03130959|83134970|FG008|Overall Study|Lost to Follow-up|0|||
46906321|NCT03130959|83134971|FG009|Overall Study|Lost to Follow-up|0|||
46906322|NCT02929407|83135006|FG000|Overall Study|Adverse Event|1|||
46906323|NCT03123939|83135010|FG000|Overall Study|Lack of Efficacy|6|||
46906324|NCT03123939|83135010|FG000|Overall Study|Death|5|||
46906325|NCT03123939|83135010|FG000|Overall Study|Physician Decision|2|||
46906326|NCT03123939|83135010|FG000|Overall Study|Subject/guardian decision|2|||
46906327|NCT03123939|83135010|FG000|Overall Study|Lost to Follow-up|1|||
46906328|NCT03123939|83135010|FG000|Overall Study|New therapy for study indication|1|||
46906329|NCT03123939|83135010|FG000|Overall Study|Protocol deviation|1|||
46906330|NCT03123939|83135010|FG000|Overall Study|Progressive disease|18|||
46906331|NCT03123939|83135010|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
46906332|NCT03123939|83135010|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
46906333|NCT03123861|83135025|FG000|Overall Study|Protocol Violation|1|||
46906334|NCT03123861|83135026|FG001|Overall Study|Protocol Violation|1|||
46906335|NCT03123861|83135025|FG000|Overall Study|Withdrawal by Subject|2|||
46906336|NCT03123861|83135026|FG001|Overall Study|Withdrawal by Subject|2|||
46906337|NCT03123471|83135034|FG000|Placebo-controlled Phase|Adverse Event|3|||
46906338|NCT03123471|83135035|FG001|Placebo-controlled Phase|Adverse Event|8|||
46906339|NCT03123471|83135034|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
46906340|NCT03123471|83135035|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
46906341|NCT03123471|83135034|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
46906342|NCT03123471|83135035|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
46906343|NCT03123471|83135034|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
46906344|NCT03123471|83135035|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
46906345|NCT03123471|83135034|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
46906346|NCT03123471|83135035|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
46906347|NCT03123471|83135034|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
46906348|NCT03123471|83135035|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
46906349|NCT03123471|83135034|FG000|Placebo-controlled Phase|Miscellaneous|0|||
46906350|NCT03123471|83135035|FG001|Placebo-controlled Phase|Miscellaneous|1|||
46906351|NCT03123471|83135034|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
46906352|NCT03123471|83135035|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
46906353|NCT03123471|83135034|FG000|Apremilast Extension Phase|Adverse Event|1|||
46906354|NCT03123471|83135035|FG001|Apremilast Extension Phase|Adverse Event|5|||
46906355|NCT03123471|83135034|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
46906356|NCT03123471|83135035|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
46997246|NCT02326298|83244028|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997247|NCT02326298|83244029|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46906357|NCT03123471|83135034|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
46906358|NCT03123471|83135035|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
46906359|NCT02661178|83135062|FG000|Part 1|Protocol Violation|1|||
46906360|NCT02661178|83135063|FG001|Part 1|Protocol Violation|0|||
46906361|NCT02661178|83135064|FG002|Part 1|Protocol Violation|0|||
46906362|NCT02661178|83135065|FG003|Part 1|Protocol Violation|0|||
46906363|NCT02661178|83135066|FG004|Part 1|Protocol Violation|0|||
46620206|NCT02283762|82761962|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
46906364|NCT02661178|83135067|FG005|Part 1|Protocol Violation|0|||
46906365|NCT02661178|83135068|FG006|Part 1|Protocol Violation|0|||
46906366|NCT02661178|83135069|FG007|Part 1|Protocol Violation|0|||
46906367|NCT02661178|83135070|FG008|Part 1|Protocol Violation|0|||
46906368|NCT02661178|83135071|FG009|Part 1|Protocol Violation|0|||
46906369|NCT02661178|83135072|FG010|Part 1|Protocol Violation|0|||
46906370|NCT02661178|83135073|FG011|Part 1|Protocol Violation|0|||
46906371|NCT02661178|83135074|FG012|Part 1|Protocol Violation|0|||
46906372|NCT02661178|83135075|FG013|Part 1|Protocol Violation|0|||
46906373|NCT02661178|83135076|FG014|Part 1|Protocol Violation|0|||
46906374|NCT02660944|83135128|FG000|Overall Study|Adverse Event|3|||
46906375|NCT02660944|83135129|FG001|Overall Study|Adverse Event|4|||
46906376|NCT02660944|83135128|FG000|Overall Study|Physician Decision|3|||
46906377|NCT02660944|83135129|FG001|Overall Study|Physician Decision|1|||
46906378|NCT02660944|83135128|FG000|Overall Study|Withdrawal by Subject|5|||
46906379|NCT02660944|83135129|FG001|Overall Study|Withdrawal by Subject|3|||
46906380|NCT02660944|83135128|FG000|Overall Study|Lost to Follow-up|4|||
46906381|NCT02660944|83135129|FG001|Overall Study|Lost to Follow-up|1|||
46906382|NCT02660944|83135128|FG000|Overall Study|Subject schedule|0|||
46906383|NCT02660944|83135129|FG001|Overall Study|Subject schedule|1|||
46906384|NCT02660944|83135128|FG000|Overall Study|Exclusion criteria met|2|||
46906385|NCT02660944|83135129|FG001|Overall Study|Exclusion criteria met|0|||
46906386|NCT02975336|83135139|FG000|DBPC (52 Weeks)|Adverse Event|16|||
46906387|NCT02975336|83135140|FG001|DBPC (52 Weeks)|Adverse Event|17|||
46906388|NCT02975336|83135141|FG002|DBPC (52 Weeks)|Adverse Event|13|||
46906389|NCT02975336|83135142|FG003|DBPC (52 Weeks)|Adverse Event|18|||
46906390|NCT02975336|83135143|FG004|DBPC (52 Weeks)|Adverse Event|0|||
46906391|NCT02975336|83135144|FG005|DBPC (52 Weeks)|Adverse Event|0|||
46906392|NCT02975336|83135145|FG006|DBPC (52 Weeks)|Adverse Event|0|||
46906393|NCT02975336|83135146|FG007|DBPC (52 Weeks)|Adverse Event|0|||
46906394|NCT02975336|83135139|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
46906395|NCT02975336|83135140|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
46906396|NCT02975336|83135141|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
46906397|NCT02975336|83135142|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
46906398|NCT02975336|83135143|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
46906399|NCT02975336|83135144|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
46906400|NCT02975336|83135145|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
46906401|NCT02975336|83135146|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
46906402|NCT02975336|83135139|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
46906403|NCT02975336|83135140|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
46906404|NCT02975336|83135141|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
46906405|NCT02975336|83135142|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
46906406|NCT02975336|83135143|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
46906407|NCT02975336|83135144|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
46906408|NCT02975336|83135145|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
46620207|NCT02283762|82761963|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
46620208|NCT02283762|82761962|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
46620209|NCT02283762|82761963|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
46620210|NCT02283762|82761962|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
46620211|NCT02283762|82761963|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
46620212|NCT02283762|82761962|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
46620213|NCT02283762|82761963|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
46620214|NCT02283762|82761962|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
46620215|NCT02283762|82761963|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
46620216|NCT02283762|82761962|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
46620217|NCT02283762|82761963|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
46620218|NCT02283762|82761962|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
46620219|NCT02283762|82761963|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
46620220|NCT02283762|82761962|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
46906409|NCT02975336|83135146|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
46906410|NCT02975336|83135139|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
46906411|NCT02975336|83135140|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
46906412|NCT02975336|83135141|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
46906413|NCT02975336|83135142|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
46906414|NCT02975336|83135143|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
46906415|NCT02975336|83135144|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
46906416|NCT02975336|83135145|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
46906417|NCT02975336|83135146|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
46906418|NCT02975336|83135139|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
46997248|NCT02326298|83244030|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46906419|NCT02975336|83135140|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
46906420|NCT02975336|83135141|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
46906421|NCT02975336|83135142|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
46906422|NCT02975336|83135143|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
46906423|NCT02975336|83135144|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
46906424|NCT02975336|83135145|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
46906425|NCT02975336|83135146|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
46906426|NCT02975336|83135139|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
46906427|NCT02975336|83135140|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
46906428|NCT02975336|83135141|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
46906429|NCT02975336|83135142|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
46906430|NCT02975336|83135143|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
46906431|NCT02975336|83135144|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
46906432|NCT02975336|83135145|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
46906433|NCT02975336|83135146|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
46906434|NCT02975336|83135139|FG000|LTE (104 Weeks)|Adverse Event|0|||
46906435|NCT02975336|83135140|FG001|LTE (104 Weeks)|Adverse Event|0|||
46906436|NCT02975336|83135141|FG002|LTE (104 Weeks)|Adverse Event|0|||
46906437|NCT02975336|83135142|FG003|LTE (104 Weeks)|Adverse Event|0|||
46906438|NCT02975336|83135143|FG004|LTE (104 Weeks)|Adverse Event|7|||
46906439|NCT02975336|83135144|FG005|LTE (104 Weeks)|Adverse Event|4|||
46906440|NCT02975336|83135145|FG006|LTE (104 Weeks)|Adverse Event|2|||
46906441|NCT02975336|83135146|FG007|LTE (104 Weeks)|Adverse Event|0|||
46906442|NCT02975336|83135139|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
46906443|NCT02975336|83135140|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
46906444|NCT02975336|83135141|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
46906445|NCT02975336|83135142|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
46906446|NCT02975336|83135143|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
46906447|NCT02975336|83135144|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
46906448|NCT02975336|83135145|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
46906449|NCT02975336|83135146|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
46906450|NCT02975336|83135139|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
46906451|NCT02975336|83135140|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
46906452|NCT02975336|83135141|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
46906453|NCT02975336|83135142|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
46906454|NCT02975336|83135143|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
46906455|NCT02975336|83135144|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
46906456|NCT02975336|83135145|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
46906457|NCT02975336|83135146|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
46906458|NCT02975336|83135139|FG000|LTE (104 Weeks)|Other|0|||
46906459|NCT02975336|83135140|FG001|LTE (104 Weeks)|Other|0|||
46906460|NCT02975336|83135141|FG002|LTE (104 Weeks)|Other|0|||
46906461|NCT02975336|83135142|FG003|LTE (104 Weeks)|Other|0|||
46906462|NCT02975336|83135143|FG004|LTE (104 Weeks)|Other|55|||
46906463|NCT02975336|83135144|FG005|LTE (104 Weeks)|Other|63|||
46906464|NCT02975336|83135145|FG006|LTE (104 Weeks)|Other|76|||
46906465|NCT02975336|83135146|FG007|LTE (104 Weeks)|Other|72|||
46906466|NCT03124563|83135162|FG000|Overall Study|Lost to Follow-up|1|||
46906467|NCT03124563|83135163|FG001|Overall Study|Lost to Follow-up|1|||
46906468|NCT03124563|83135162|FG000|Overall Study|Withdrawal by Subject|1|||
46906469|NCT03124563|83135163|FG001|Overall Study|Withdrawal by Subject|1|||
46906470|NCT03079869|83135171|FG000|Overall Study|Adverse Event|6|||
46906471|NCT03079869|83135172|FG001|Overall Study|Adverse Event|8|||
46906472|NCT03079869|83135171|FG000|Overall Study|Withdrawal by Subject|4|||
46906473|NCT03079869|83135172|FG001|Overall Study|Withdrawal by Subject|1|||
46906474|NCT03079869|83135171|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
46906475|NCT03079869|83135172|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
46906476|NCT03085914|83135185|FG000|Overall Study|Death|6|||
46906477|NCT03085914|83135186|FG001|Overall Study|Death|6|||
46906478|NCT03085914|83135187|FG002|Overall Study|Death|4|||
46906479|NCT03085914|83135188|FG003|Overall Study|Death|1|||
46906480|NCT03085914|83135189|FG004|Overall Study|Death|5|||
46906481|NCT03085914|83135190|FG005|Overall Study|Death|2|||
46906482|NCT03085914|83135191|FG006|Overall Study|Death|2|||
46906483|NCT03085914|83135185|FG000|Overall Study|Withdrawal by Subject|1|||
46906484|NCT03085914|83135186|FG001|Overall Study|Withdrawal by Subject|1|||
46906485|NCT03085914|83135187|FG002|Overall Study|Withdrawal by Subject|2|||
46906486|NCT03085914|83135188|FG003|Overall Study|Withdrawal by Subject|2|||
46906487|NCT03085914|83135189|FG004|Overall Study|Withdrawal by Subject|2|||
46906488|NCT03085914|83135190|FG005|Overall Study|Withdrawal by Subject|0|||
46906489|NCT03085914|83135191|FG006|Overall Study|Withdrawal by Subject|1|||
46906490|NCT03085914|83135185|FG000|Overall Study|Lost to Follow-up|0|||
46906491|NCT03085914|83135186|FG001|Overall Study|Lost to Follow-up|0|||
46906492|NCT03085914|83135187|FG002|Overall Study|Lost to Follow-up|1|||
46906493|NCT03085914|83135188|FG003|Overall Study|Lost to Follow-up|0|||
46906494|NCT03085914|83135189|FG004|Overall Study|Lost to Follow-up|0|||
46906495|NCT03085914|83135190|FG005|Overall Study|Lost to Follow-up|1|||
46906496|NCT03085914|83135191|FG006|Overall Study|Lost to Follow-up|1|||
46906497|NCT03085914|83135185|FG000|Overall Study|Reason was not specified,|2|||
46906498|NCT03085914|83135186|FG001|Overall Study|Reason was not specified,|2|||
46906499|NCT03085914|83135187|FG002|Overall Study|Reason was not specified,|2|||
46906500|NCT03085914|83135188|FG003|Overall Study|Reason was not specified,|3|||
46906501|NCT03085914|83135189|FG004|Overall Study|Reason was not specified,|3|||
46906502|NCT03085914|83135190|FG005|Overall Study|Reason was not specified,|3|||
46906503|NCT03085914|83135191|FG006|Overall Study|Reason was not specified,|6|||
46906504|NCT03085914|83135185|FG000|Overall Study|Progressive Disease|0|||
46906505|NCT03085914|83135186|FG001|Overall Study|Progressive Disease|0|||
46906506|NCT03085914|83135187|FG002|Overall Study|Progressive Disease|2|||
46906507|NCT03085914|83135188|FG003|Overall Study|Progressive Disease|2|||
46906508|NCT03085914|83135189|FG004|Overall Study|Progressive Disease|1|||
46906509|NCT03085914|83135190|FG005|Overall Study|Progressive Disease|1|||
46906510|NCT03085914|83135191|FG006|Overall Study|Progressive Disease|1|||
46906511|NCT03085914|83135185|FG000|Overall Study|Study Terminated by the Sponsor|0|||
46906512|NCT03085914|83135186|FG001|Overall Study|Study Terminated by the Sponsor|0|||
46906513|NCT03085914|83135187|FG002|Overall Study|Study Terminated by the Sponsor|0|||
46906514|NCT03085914|83135188|FG003|Overall Study|Study Terminated by the Sponsor|1|||
46906515|NCT03085914|83135189|FG004|Overall Study|Study Terminated by the Sponsor|2|||
46906516|NCT03085914|83135190|FG005|Overall Study|Study Terminated by the Sponsor|1|||
46906517|NCT03085914|83135191|FG006|Overall Study|Study Terminated by the Sponsor|0|||
46906518|NCT03078582|83135219|FG000|Overall Study|Adverse Event|0|||
46906519|NCT03078582|83135220|FG001|Overall Study|Adverse Event|8|||
46906520|NCT03077724|83135228|FG000|Overall Study|Lost to Follow-up|5|||
46906521|NCT03077724|83135229|FG001|Overall Study|Lost to Follow-up|1|||
46906522|NCT03077724|83135228|FG000|Overall Study|Withdrawal by Subject|3|||
46906523|NCT03077724|83135229|FG001|Overall Study|Withdrawal by Subject|1|||
46906524|NCT00979212|83135237|FG000|Overall Study|Protocol Violation|1|||
46906525|NCT00979212|83135238|FG001|Overall Study|Protocol Violation|8|||
46906526|NCT00979212|83135237|FG000|Overall Study|No protocol therapy received|1|||
46906527|NCT00979212|83135238|FG001|Overall Study|No protocol therapy received|0|||
46906528|NCT03080454|83135244|FG000|Baseline|Adverse Event|2|||
46906529|NCT03080454|83135244|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
46906530|NCT03080454|83135244|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
46906531|NCT02981342|83135268|FG000|Overall Study|Adverse Event|0|||
46906532|NCT02981342|83135269|FG001|Overall Study|Adverse Event|0|||
46906533|NCT02981342|83135270|FG002|Overall Study|Adverse Event|0|||
46906534|NCT02981342|83135271|FG003|Overall Study|Adverse Event|1|||
46906535|NCT02981342|83135268|FG000|Overall Study|Death|0|||
46906536|NCT02981342|83135269|FG001|Overall Study|Death|9|||
46906537|NCT02981342|83135270|FG002|Overall Study|Death|9|||
46906538|NCT02981342|83135271|FG003|Overall Study|Death|4|||
46906539|NCT02981342|83135268|FG000|Overall Study|Withdrawal by Subject|0|||
46906540|NCT02981342|83135269|FG001|Overall Study|Withdrawal by Subject|0|||
46906541|NCT02981342|83135270|FG002|Overall Study|Withdrawal by Subject|3|||
46906542|NCT02981342|83135271|FG003|Overall Study|Withdrawal by Subject|1|||
46906543|NCT02981342|83135268|FG000|Overall Study|Study closed by sponsor|0|||
46906544|NCT02981342|83135269|FG001|Overall Study|Study closed by sponsor|0|||
46906545|NCT02981342|83135270|FG002|Overall Study|Study closed by sponsor|1|||
46906546|NCT02981342|83135271|FG003|Overall Study|Study closed by sponsor|1|||
46906547|NCT02981342|83135268|FG000|Overall Study|Randomized, Never Treated|0|||
46906548|NCT02981342|83135269|FG001|Overall Study|Randomized, Never Treated|1|||
46906549|NCT02981342|83135270|FG002|Overall Study|Randomized, Never Treated|0|||
46906550|NCT02981342|83135271|FG003|Overall Study|Randomized, Never Treated|7|||
46906551|NCT02981342|83135268|FG000|Overall Study|Lost to Follow-up|0|||
46906552|NCT02981342|83135269|FG001|Overall Study|Lost to Follow-up|1|||
46620221|NCT02283762|82761963|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
46906553|NCT02981342|83135270|FG002|Overall Study|Lost to Follow-up|0|||
46906554|NCT02981342|83135271|FG003|Overall Study|Lost to Follow-up|0|||
46906555|NCT02794246|83135283|FG000|Overall Study|Withdrawal by Subject|2|||
46906556|NCT02794246|83135283|FG000|Overall Study|Physician Decision|4|||
46906557|NCT03428100|83135291|FG000|Overall Study|Adverse Event|1|||
46906558|NCT03428100|83135292|FG001|Overall Study|Adverse Event|0|||
46906559|NCT03428100|83135293|FG002|Overall Study|Adverse Event|3|||
46906560|NCT03428100|83135294|FG003|Overall Study|Adverse Event|1|||
46906561|NCT03428100|83135291|FG000|Overall Study|Lack of Efficacy|16|||
46906562|NCT03428100|83135292|FG001|Overall Study|Lack of Efficacy|10|||
46906563|NCT03428100|83135293|FG002|Overall Study|Lack of Efficacy|7|||
46906564|NCT03428100|83135294|FG003|Overall Study|Lack of Efficacy|6|||
46906565|NCT03428100|83135291|FG000|Overall Study|Protocol Deviation|0|||
46906566|NCT03428100|83135292|FG001|Overall Study|Protocol Deviation|2|||
46906567|NCT03428100|83135293|FG002|Overall Study|Protocol Deviation|2|||
46906568|NCT03428100|83135294|FG003|Overall Study|Protocol Deviation|0|||
46906569|NCT03428100|83135291|FG000|Overall Study|Withdrawal by Subject|4|||
46906570|NCT03428100|83135292|FG001|Overall Study|Withdrawal by Subject|0|||
46906571|NCT03428100|83135293|FG002|Overall Study|Withdrawal by Subject|0|||
46906572|NCT03428100|83135294|FG003|Overall Study|Withdrawal by Subject|0|||
46906573|NCT03428100|83135291|FG000|Overall Study|Physician Decision|0|||
46906574|NCT03428100|83135292|FG001|Overall Study|Physician Decision|1|||
46906575|NCT03428100|83135293|FG002|Overall Study|Physician Decision|0|||
46906576|NCT03428100|83135294|FG003|Overall Study|Physician Decision|0|||
46906577|NCT02980874|83135316|FG000|Overall Study|Adverse Event|2|||
46906578|NCT02980874|83135317|FG001|Overall Study|Adverse Event|7|||
46906579|NCT02980874|83135316|FG000|Overall Study|Withdrawal by Subject|7|||
46906580|NCT02980874|83135317|FG001|Overall Study|Withdrawal by Subject|2|||
46906581|NCT02980874|83135316|FG000|Overall Study|Lost to Follow-up|5|||
46906582|NCT02980874|83135317|FG001|Overall Study|Lost to Follow-up|5|||
46906583|NCT02980874|83135316|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
46906584|NCT02980874|83135317|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
46906585|NCT02980874|83135316|FG000|Overall Study|Unknown study completion status|1|||
46906586|NCT02980874|83135317|FG001|Overall Study|Unknown study completion status|0|||
46906587|NCT01066052|83135325|FG000|Overall Study|Enrolled But Not Treated|3|||
46906588|NCT01066052|83135326|FG001|Overall Study|Enrolled But Not Treated|0|||
46906589|NCT03077646|83135343|FG000|Overall Study|Lost to Follow-up|29|||
46906590|NCT03077646|83135344|FG001|Overall Study|Lost to Follow-up|30|||
46906591|NCT03077646|83135345|FG002|Overall Study|Lost to Follow-up|31|||
46906592|NCT02892149|83135355|FG000|Overall Study|Death|262|||
46906593|NCT02892149|83135356|FG001|Overall Study|Death|278|||
46906594|NCT02892149|83135355|FG000|Overall Study|Withdrawal by Subject|53|||
46906595|NCT02892149|83135356|FG001|Overall Study|Withdrawal by Subject|47|||
46906596|NCT02892149|83135355|FG000|Overall Study|Lost to Follow-up|37|||
46906597|NCT02892149|83135356|FG001|Overall Study|Lost to Follow-up|31|||
46906598|NCT04187092|83135364|FG000|Overall Study|Lost to Follow-up|1|||
46906599|NCT04187092|83135365|FG001|Overall Study|Lost to Follow-up|1|||
46906600|NCT04187092|83135364|FG000|Overall Study|Withdrawal by Subject|1|||
46906601|NCT04187092|83135365|FG001|Overall Study|Withdrawal by Subject|1|||
46906602|NCT04187092|83135364|FG000|Overall Study|Adverse Event|0|||
46906603|NCT04187092|83135365|FG001|Overall Study|Adverse Event|1|||
46906604|NCT02896127|83135373|FG000|COMPLETED WEEK 52|Adverse Event|9|||
46906605|NCT02896127|83135374|FG001|COMPLETED WEEK 52|Adverse Event|2|||
46906606|NCT02896127|83135373|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
46906607|NCT02896127|83135374|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
46906608|NCT02896127|83135373|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
46906609|NCT02896127|83135374|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
46906610|NCT02896127|83135373|FG000|COMPLETED WEEK 52|Physician Decision|1|||
46906611|NCT02896127|83135374|FG001|COMPLETED WEEK 52|Physician Decision|1|||
46906612|NCT02896127|83135373|FG000|COMPLETED WEEK 52|Pregnancy|2|||
46906613|NCT02896127|83135374|FG001|COMPLETED WEEK 52|Pregnancy|0|||
46906614|NCT02896127|83135373|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
46906615|NCT02896127|83135374|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
46906616|NCT02896127|83135373|FG000|COMPLETED WEEK 52|Technical problems|1|||
46906617|NCT02896127|83135374|FG001|COMPLETED WEEK 52|Technical problems|0|||
46906618|NCT02896127|83135373|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
46997249|NCT02326298|83244031|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997250|NCT02326298|83244032|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
46997251|NCT02326298|83244033|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
46997252|NCT02326298|83244034|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
46997253|NCT02326298|83244021|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46997254|NCT02326298|83244022|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46997255|NCT02326298|83244023|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46997256|NCT02326298|83244024|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46620222|NCT02283762|82761962|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
46906619|NCT02896127|83135374|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
46906620|NCT02896127|83135373|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
46906621|NCT02896127|83135374|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
46906622|NCT02896127|83135373|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
46906623|NCT02896127|83135374|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
46997257|NCT02326298|83244025|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46906624|NCT02896127|83135373|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
46906625|NCT02896127|83135374|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
46906626|NCT02896127|83135373|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
46906627|NCT02896127|83135374|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
46906628|NCT03546647|83135380|FG000|Overall Study|Adverse Event|1|||
46906629|NCT03546647|83135381|FG001|Overall Study|Adverse Event|0|||
46906630|NCT03077412|83135390|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
46906631|NCT03077412|83135391|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
46906632|NCT03077412|83135392|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
46906633|NCT03077412|83135390|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
46906634|NCT03077412|83135391|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
46906635|NCT03077412|83135392|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
46906636|NCT03077412|83135390|FG000|Overall Study|Adverse Event|1|||
46906637|NCT03077412|83135391|FG001|Overall Study|Adverse Event|2|||
46906638|NCT03077412|83135392|FG002|Overall Study|Adverse Event|2|||
46906639|NCT03077412|83135390|FG000|Overall Study|Investigator's Discretion|0|||
46906640|NCT03077412|83135391|FG001|Overall Study|Investigator's Discretion|1|||
46906641|NCT03077412|83135392|FG002|Overall Study|Investigator's Discretion|1|||
46906642|NCT03077412|83135390|FG000|Overall Study|Withdrew Consent|0|||
46906643|NCT03077412|83135391|FG001|Overall Study|Withdrew Consent|2|||
46906644|NCT03077412|83135392|FG002|Overall Study|Withdrew Consent|0|||
46906645|NCT03544229|83135404|FG000|Overall Study|Adverse Event|1|||
46906646|NCT03544229|83135405|FG001|Overall Study|Adverse Event|0|||
46906647|NCT03544229|83135406|FG002|Overall Study|Adverse Event|1|||
46906648|NCT03544229|83135407|FG003|Overall Study|Adverse Event|0|||
46906649|NCT03544229|83135404|FG000|Overall Study|Protocol Deviation|0|||
46906650|NCT03544229|83135405|FG001|Overall Study|Protocol Deviation|0|||
46906651|NCT03544229|83135406|FG002|Overall Study|Protocol Deviation|1|||
46906652|NCT03544229|83135407|FG003|Overall Study|Protocol Deviation|0|||
46906653|NCT03544229|83135404|FG000|Overall Study|Lost to Follow-up|3|||
46906654|NCT03544229|83135405|FG001|Overall Study|Lost to Follow-up|0|||
46906655|NCT03544229|83135406|FG002|Overall Study|Lost to Follow-up|0|||
46906656|NCT03544229|83135407|FG003|Overall Study|Lost to Follow-up|2|||
46906657|NCT03544229|83135404|FG000|Overall Study|Voluntary Withdrawal|2|||
46906658|NCT03544229|83135405|FG001|Overall Study|Voluntary Withdrawal|1|||
46906659|NCT03544229|83135406|FG002|Overall Study|Voluntary Withdrawal|3|||
46906660|NCT03544229|83135407|FG003|Overall Study|Voluntary Withdrawal|0|||
46906661|NCT03544229|83135404|FG000|Overall Study|Lack of Efficacy|0|||
46906662|NCT03544229|83135405|FG001|Overall Study|Lack of Efficacy|1|||
46906663|NCT03544229|83135406|FG002|Overall Study|Lack of Efficacy|0|||
46906664|NCT03544229|83135407|FG003|Overall Study|Lack of Efficacy|0|||
46906665|NCT03078816|83135417|FG000|Overall Study|Withdrawal by Subject|1|||
46906666|NCT03510455|83135421|FG000|Overall Study|Physician Decision|1|||
46906667|NCT03509675|83135429|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
46906668|NCT03509675|83135430|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
46906669|NCT03509675|83135429|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
46906670|NCT03509675|83135430|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
46997258|NCT02326298|83244026|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46997259|NCT02326298|83244027|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46997260|NCT02326298|83244028|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46620223|NCT02283762|82761963|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
46620224|NCT02283762|82761962|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
46709165|NCT00381680|82925156|FG001|Overall Study|Death|7|||
46709166|NCT00381680|82925155|FG000|Overall Study|Lost to Follow-up|3|||
46620225|NCT02283762|82761963|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
46620226|NCT02283294|82762063|FG000|Overall Study|Lost to Follow-up|1|||
46620227|NCT02283294|82762064|FG001|Overall Study|Lost to Follow-up|1|||
46709167|NCT00381680|82925156|FG001|Overall Study|Lost to Follow-up|2|||
46709168|NCT00381680|82925155|FG000|Overall Study|Physician Decision|25|||
46709169|NCT00381680|82925156|FG001|Overall Study|Physician Decision|6|||
46709170|NCT00381680|82925155|FG000|Overall Study|Withdrawal by Subject|3|||
46709171|NCT00381680|82925156|FG001|Overall Study|Withdrawal by Subject|1|||
46709172|NCT00381680|82925155|FG000|Overall Study|Entry onto another COG Trial|1|||
46906671|NCT03509675|83135429|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
46906672|NCT03509675|83135430|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
46620228|NCT02283294|82762063|FG000|Overall Study|Withdrawal by Subject|1|||
46620229|NCT02283294|82762064|FG001|Overall Study|Withdrawal by Subject|6|||
46620230|NCT02283294|82762063|FG000|Overall Study|Protocol Violation|1|||
46620231|NCT02283294|82762064|FG001|Overall Study|Protocol Violation|0|||
46906673|NCT03509675|83135429|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
46906674|NCT03509675|83135430|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
46906675|NCT03509207|83135436|FG000|Overall Study|Death|2|||
46906676|NCT03543137|83135440|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
46906677|NCT03543137|83135441|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
46906678|NCT03543137|83135440|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
46620232|NCT02283294|82762063|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
46620233|NCT02283294|82762064|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
46775678|NCT00694707|82994139|FG003|Overall Study|Arrest by Police|0|||
46620234|NCT02282982|82762080|FG000|Overall Study|Lost to Follow-up|15|||
46620235|NCT02282982|82762080|FG000|Overall Study|Withdrew consent|2|||
46620236|NCT02282982|82762080|FG000|Overall Study|Death|4|||
46620237|NCT02282982|82762080|FG000|Overall Study|Lack of product|156|||
46620238|NCT02282982|82762080|FG000|Overall Study|Palivizumab is ended|11|||
46620239|NCT02282982|82762080|FG000|Overall Study|Other, not specified|18|||
46620240|NCT02268864|82762122|FG000|Overall Study|Withdrawal by Subject|2|||
46620241|NCT02268864|82762123|FG001|Overall Study|Withdrawal by Subject|0|||
46620242|NCT02268864|82762124|FG002|Overall Study|Withdrawal by Subject|0|||
46620243|NCT02268864|82762122|FG000|Overall Study|Death|0|||
46620244|NCT02268864|82762123|FG001|Overall Study|Death|1|||
46620245|NCT02268864|82762124|FG002|Overall Study|Death|0|||
46620246|NCT02268786|82762153|FG000|Overall Study|No Euploid Embryos available|42|||
46620247|NCT02268786|82762154|FG001|Overall Study|No Euploid Embryos available|0|||
46620248|NCT02268786|82762153|FG000|Overall Study|Withdrawal by Subject|7|||
46620249|NCT02268786|82762154|FG001|Overall Study|Withdrawal by Subject|14|||
46620250|NCT02268786|82762153|FG000|Overall Study|Thaw Failure|6|||
46620251|NCT02268786|82762154|FG001|Overall Study|Thaw Failure|4|||
46620252|NCT02268786|82762153|FG000|Overall Study|Protocol Violation|1|||
46620253|NCT02268786|82762154|FG001|Overall Study|Protocol Violation|0|||
46620254|NCT02268396|82762169|FG000|Overall Study|Adverse Event|3|||
46620255|NCT02268396|82762169|FG000|Overall Study|Administrative|2|||
46620256|NCT02268396|82762169|FG000|Overall Study|Withdrawal by Subject|1|||
46620257|NCT02268396|82762169|FG000|Overall Study|Lost to Follow-up|2|||
46620258|NCT02268396|82762169|FG000|Overall Study|Protocol-Specified Criteria|2|||
46620259|NCT02268396|82762169|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
46620260|NCT02268084|82762175|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
46620261|NCT02268084|82762176|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
46620262|NCT02268084|82762175|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
46620263|NCT02268084|82762176|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
46620264|NCT01643772|82762205|FG000|Overall Study|Protocol Violation|0|||
46620265|NCT01643772|82762206|FG001|Overall Study|Protocol Violation|0|||
46620266|NCT01643772|82762207|FG002|Overall Study|Protocol Violation|0|||
46620267|NCT01643772|82762208|FG003|Overall Study|Protocol Violation|1|||
46620268|NCT01643772|82762205|FG000|Overall Study|Adverse Event|0|||
46620269|NCT01643772|82762206|FG001|Overall Study|Adverse Event|0|||
46620270|NCT01643772|82762207|FG002|Overall Study|Adverse Event|0|||
46620271|NCT01643772|82762208|FG003|Overall Study|Adverse Event|1|||
46620272|NCT02265744|82762311|FG000|Overall Study|Poor/Non-compliance|1|||
46620273|NCT02265744|82762312|FG001|Overall Study|Poor/Non-compliance|1|||
46620274|NCT02265744|82762313|FG002|Overall Study|Poor/Non-compliance|0|||
46620275|NCT02265744|82762314|FG003|Overall Study|Poor/Non-compliance|0|||
46620276|NCT02265744|82762315|FG004|Overall Study|Poor/Non-compliance|2|||
46620277|NCT02265744|82762311|FG000|Overall Study|Lost to Follow-up|0|||
46620278|NCT02265744|82762312|FG001|Overall Study|Lost to Follow-up|0|||
46620279|NCT02265744|82762313|FG002|Overall Study|Lost to Follow-up|0|||
46620280|NCT02265744|82762314|FG003|Overall Study|Lost to Follow-up|1|||
46620281|NCT02265744|82762315|FG004|Overall Study|Lost to Follow-up|0|||
46620282|NCT02265744|82762311|FG000|Overall Study|Death|0|||
46620283|NCT02265744|82762312|FG001|Overall Study|Death|0|||
46620284|NCT02265744|82762313|FG002|Overall Study|Death|0|||
46620285|NCT02265744|82762314|FG003|Overall Study|Death|2|||
46620286|NCT02265744|82762315|FG004|Overall Study|Death|0|||
46620287|NCT02265744|82762311|FG000|Overall Study|Withdrawal by Subject|2|||
46620288|NCT02265744|82762312|FG001|Overall Study|Withdrawal by Subject|0|||
46620289|NCT02265744|82762313|FG002|Overall Study|Withdrawal by Subject|0|||
46620290|NCT02265744|82762314|FG003|Overall Study|Withdrawal by Subject|2|||
46620291|NCT02265744|82762315|FG004|Overall Study|Withdrawal by Subject|0|||
46997261|NCT02326298|83244029|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46997262|NCT02326298|83244030|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46997263|NCT02326298|83244031|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46620292|NCT02265744|82762311|FG000|Overall Study|Participant request to discontinue|2|||
46620293|NCT02265744|82762312|FG001|Overall Study|Participant request to discontinue|2|||
46620294|NCT02265744|82762313|FG002|Overall Study|Participant request to discontinue|2|||
46620295|NCT02265744|82762314|FG003|Overall Study|Participant request to discontinue|0|||
46620296|NCT02265744|82762315|FG004|Overall Study|Participant request to discontinue|0|||
46620297|NCT02265744|82762311|FG000|Overall Study|Adverse Event|8|||
46620298|NCT02265744|82762312|FG001|Overall Study|Adverse Event|4|||
46620299|NCT02265744|82762313|FG002|Overall Study|Adverse Event|9|||
46620300|NCT02265744|82762314|FG003|Overall Study|Adverse Event|8|||
46997264|NCT02326298|83244032|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
46620301|NCT02265744|82762315|FG004|Overall Study|Adverse Event|2|||
46620302|NCT02265744|82762311|FG000|Overall Study|Lack of Efficacy|2|||
46620303|NCT02265744|82762312|FG001|Overall Study|Lack of Efficacy|4|||
46620304|NCT02265744|82762313|FG002|Overall Study|Lack of Efficacy|3|||
46620305|NCT02265744|82762314|FG003|Overall Study|Lack of Efficacy|4|||
46620306|NCT02265744|82762315|FG004|Overall Study|Lack of Efficacy|5|||
46620307|NCT02265744|82762311|FG000|Overall Study|Reason not provided by Investigator|1|||
46620308|NCT02265744|82762312|FG001|Overall Study|Reason not provided by Investigator|0|||
46620309|NCT02265744|82762313|FG002|Overall Study|Reason not provided by Investigator|0|||
46620310|NCT02265744|82762314|FG003|Overall Study|Reason not provided by Investigator|2|||
46620311|NCT02265744|82762315|FG004|Overall Study|Reason not provided by Investigator|0|||
46620312|NCT02265744|82762311|FG000|Overall Study|Administrative reason by sponsor|3|||
46620313|NCT02265744|82762312|FG001|Overall Study|Administrative reason by sponsor|2|||
46620314|NCT02265744|82762313|FG002|Overall Study|Administrative reason by sponsor|2|||
46620315|NCT02265744|82762314|FG003|Overall Study|Administrative reason by sponsor|3|||
46620316|NCT02265744|82762315|FG004|Overall Study|Administrative reason by sponsor|3|||
46620317|NCT02265744|82762311|FG000|Overall Study|Subject no longer meets study criteria|0|||
46620318|NCT02265744|82762312|FG001|Overall Study|Subject no longer meets study criteria|0|||
46620319|NCT02265744|82762313|FG002|Overall Study|Subject no longer meets study criteria|0|||
46620320|NCT02265744|82762314|FG003|Overall Study|Subject no longer meets study criteria|0|||
46620321|NCT02265744|82762315|FG004|Overall Study|Subject no longer meets study criteria|1|||
46620322|NCT02265744|82762311|FG000|Overall Study|Pregnancy|1|||
46620323|NCT02265744|82762312|FG001|Overall Study|Pregnancy|2|||
46620324|NCT02265744|82762313|FG002|Overall Study|Pregnancy|1|||
46620325|NCT02265744|82762314|FG003|Overall Study|Pregnancy|1|||
46620326|NCT02265744|82762315|FG004|Overall Study|Pregnancy|0|||
46620327|NCT00085735|82762344|FG000|Overall Study|Adverse Event|1|||
46620328|NCT00085735|82762345|FG001|Overall Study|Adverse Event|0|||
46620329|NCT00085735|82762346|FG002|Overall Study|Adverse Event|0|||
46620330|NCT00085735|82762347|FG003|Overall Study|Adverse Event|0|||
46620331|NCT00085735|82762348|FG004|Overall Study|Adverse Event|0|||
46620332|NCT00085735|82762349|FG005|Overall Study|Adverse Event|0|||
46620333|NCT00085735|82762344|FG000|Overall Study|Lack of Efficacy|2|||
46620334|NCT00085735|82762345|FG001|Overall Study|Lack of Efficacy|4|||
46620335|NCT00085735|82762346|FG002|Overall Study|Lack of Efficacy|6|||
46620336|NCT00085735|82762347|FG003|Overall Study|Lack of Efficacy|3|||
46620337|NCT00085735|82762348|FG004|Overall Study|Lack of Efficacy|4|||
46620338|NCT00085735|82762349|FG005|Overall Study|Lack of Efficacy|3|||
46620339|NCT00085735|82762344|FG000|Overall Study|Lost to Follow-up|0|||
46620340|NCT00085735|82762345|FG001|Overall Study|Lost to Follow-up|1|||
46620341|NCT00085735|82762346|FG002|Overall Study|Lost to Follow-up|0|||
46620342|NCT00085735|82762347|FG003|Overall Study|Lost to Follow-up|0|||
46620343|NCT00085735|82762348|FG004|Overall Study|Lost to Follow-up|1|||
46620344|NCT00085735|82762349|FG005|Overall Study|Lost to Follow-up|0|||
46620345|NCT00085735|82762344|FG000|Overall Study|Physician Decision|2|||
46620346|NCT00085735|82762345|FG001|Overall Study|Physician Decision|3|||
46620347|NCT00085735|82762346|FG002|Overall Study|Physician Decision|2|||
46620348|NCT00085735|82762347|FG003|Overall Study|Physician Decision|3|||
46620349|NCT00085735|82762348|FG004|Overall Study|Physician Decision|11|||
46620350|NCT00085735|82762349|FG005|Overall Study|Physician Decision|8|||
46620351|NCT00085735|82762344|FG000|Overall Study|Protocol Violation|1|||
46620352|NCT00085735|82762345|FG001|Overall Study|Protocol Violation|0|||
46620353|NCT00085735|82762346|FG002|Overall Study|Protocol Violation|0|||
46620354|NCT00085735|82762347|FG003|Overall Study|Protocol Violation|0|||
46620355|NCT00085735|82762348|FG004|Overall Study|Protocol Violation|0|||
46620356|NCT00085735|82762349|FG005|Overall Study|Protocol Violation|0|||
46620357|NCT00085735|82762344|FG000|Overall Study|Withdrawal by Subject|1|||
46620358|NCT00085735|82762345|FG001|Overall Study|Withdrawal by Subject|0|||
46620359|NCT00085735|82762346|FG002|Overall Study|Withdrawal by Subject|4|||
46620360|NCT00085735|82762347|FG003|Overall Study|Withdrawal by Subject|5|||
46906679|NCT03543137|83135441|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
46906680|NCT03543137|83135440|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
46906681|NCT03543137|83135441|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
46620361|NCT00085735|82762348|FG004|Overall Study|Withdrawal by Subject|7|||
46620362|NCT00085735|82762349|FG005|Overall Study|Withdrawal by Subject|8|||
46620363|NCT00085735|82762344|FG000|Overall Study|Patient ineligible|1|||
46620364|NCT00085735|82762345|FG001|Overall Study|Patient ineligible|0|||
46620365|NCT00085735|82762346|FG002|Overall Study|Patient ineligible|3|||
46620366|NCT00085735|82762347|FG003|Overall Study|Patient ineligible|7|||
46620367|NCT00085735|82762348|FG004|Overall Study|Patient ineligible|17|||
46620368|NCT00085735|82762349|FG005|Overall Study|Patient ineligible|8|||
46620369|NCT00085735|82762344|FG000|Overall Study|Excess residual disease|2|||
46620370|NCT00085735|82762345|FG001|Overall Study|Excess residual disease|2|||
46620371|NCT00085735|82762346|FG002|Overall Study|Excess residual disease|1|||
46620372|NCT00085735|82762347|FG003|Overall Study|Excess residual disease|1|||
46620373|NCT00085735|82762348|FG004|Overall Study|Excess residual disease|1|||
46906682|NCT02895347|83135451|FG000|Overall Study|Withdrawal by Subject|3|||
46906683|NCT02895347|83135452|FG001|Overall Study|Withdrawal by Subject|1|||
46906684|NCT03539549|83135459|FG000|Overall Study|Adverse Event|12|||
46906685|NCT03539549|83135459|FG000|Overall Study|Lost to Follow-up|1|||
46906686|NCT03539549|83135459|FG000|Overall Study|Death|2|||
46906687|NCT03539549|83135459|FG000|Overall Study|Progressive Disease|1|||
46906688|NCT03539549|83135459|FG000|Overall Study|Reason not Specified|1|||
46906689|NCT03506477|83135465|FG000|Overall Study|Withdrawal by Subject|1|||
46906690|NCT03506477|83135466|FG001|Overall Study|Withdrawal by Subject|0|||
46906691|NCT03073980|83135475|FG000|Overall Study|Lost to Follow-up|10|||
46906692|NCT03073980|83135476|FG001|Overall Study|Lost to Follow-up|2|||
46906693|NCT03073980|83135477|FG002|Overall Study|Lost to Follow-up|9|||
46906694|NCT03073980|83135475|FG000|Overall Study|No post-procedure data|0|||
46906695|NCT03073980|83135476|FG001|Overall Study|No post-procedure data|0|||
46906696|NCT03073980|83135477|FG002|Overall Study|No post-procedure data|2|||
46906697|NCT03930186|83135489|FG000|Weeks 0 to 16|Adverse Event|6|||
46906698|NCT03930186|83135489|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
46906699|NCT03930186|83135489|FG000|Weeks 16 to 32|Adverse Event|1|||
46906700|NCT03930186|83135489|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
46906701|NCT03504917|83135495|FG000|Blinded Treatment Period|Protocol Violation|1|||
46906702|NCT03504917|83135496|FG001|Blinded Treatment Period|Protocol Violation|0|||
46906703|NCT03504917|83135495|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
46906704|NCT03504917|83135496|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
46906705|NCT03504917|83135495|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
46906706|NCT03504917|83135496|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
46906707|NCT03504917|83135495|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
46906708|NCT03504917|83135496|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
46906709|NCT03504917|83135495|FG000|Blinded Treatment Period|Adverse Event|4|||
46906710|NCT03504917|83135496|FG001|Blinded Treatment Period|Adverse Event|4|||
46906711|NCT03504917|83135495|FG000|Blinded Treatment Period|Physician Decision|1|||
46906712|NCT03504917|83135496|FG001|Blinded Treatment Period|Physician Decision|0|||
46906713|NCT03504917|83135495|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
46906714|NCT03504917|83135496|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
46906715|NCT03504917|83135495|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
46906716|NCT03504917|83135496|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
46906717|NCT03504917|83135495|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
46906718|NCT03504917|83135496|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
46906719|NCT03504917|83135495|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
46906720|NCT03504917|83135496|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
46906721|NCT03504917|83135495|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
46906722|NCT03504917|83135496|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
46906723|NCT03504917|83135495|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
46906724|NCT03504917|83135496|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
46906725|NCT03504917|83135495|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
46906726|NCT03504917|83135496|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
46906727|NCT03504917|83135495|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
46906728|NCT03504917|83135496|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
46906729|NCT03504917|83135495|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
46906730|NCT03504917|83135496|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
46906731|NCT03504917|83135495|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
46906732|NCT03504917|83135496|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
46906733|NCT03536663|83135508|FG000|Endexo|Protocol Violation|1|||
46906734|NCT03565211|83135517|FG000|Overall Study|Withdrawal by Subject|2|||
46906735|NCT03565211|83135517|FG000|Overall Study|Lost to Follow-up|1|||
46906736|NCT03565211|83135517|FG000|Overall Study|Adverse Event|44|||
46906737|NCT03565211|83135517|FG000|Overall Study|Personal issues|1|||
46997265|NCT02326298|83244033|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
46906738|NCT03531905|83135524|FG000|Overall Study|Withdrawal by Subject|3|||
46906739|NCT03531905|83135525|FG001|Overall Study|Withdrawal by Subject|3|||
46906740|NCT03531905|83135526|FG002|Overall Study|Withdrawal by Subject|2|||
46906741|NCT03531905|83135524|FG000|Overall Study|Lost to Follow-up|2|||
46906742|NCT03531905|83135525|FG001|Overall Study|Lost to Follow-up|2|||
46906743|NCT03531905|83135526|FG002|Overall Study|Lost to Follow-up|1|||
46906744|NCT03531905|83135524|FG000|Overall Study|Participant was out of town|1|||
46906745|NCT03531905|83135525|FG001|Overall Study|Participant was out of town|0|||
46906746|NCT03531905|83135526|FG002|Overall Study|Participant was out of town|0|||
46906747|NCT03531905|83135524|FG000|Overall Study|Could not speak with the participant|1|||
46906748|NCT03531905|83135525|FG001|Overall Study|Could not speak with the participant|0|||
46906749|NCT03531905|83135526|FG002|Overall Study|Could not speak with the participant|0|||
46906750|NCT03531827|83135536|FG000|Overall Study|Adverse Event|2|||
46906751|NCT03531827|83135537|FG001|Overall Study|Adverse Event|0|||
46906752|NCT03531827|83135536|FG000|Overall Study|Progressive disease|1|||
46906753|NCT03531827|83135537|FG001|Overall Study|Progressive disease|0|||
46906754|NCT03530345|83135566|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
46906755|NCT03530345|83135567|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
46906756|NCT03530345|83135566|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
46906757|NCT03530345|83135567|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
46906758|NCT03530345|83135566|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
46906759|NCT03530345|83135567|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
46906760|NCT03530345|83135566|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
46906761|NCT03530345|83135567|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
46906762|NCT03500159|83135581|FG000|Overall Study|Study Terminated|2|||
46906763|NCT03500159|83135582|FG001|Overall Study|Study Terminated|1|||
46906764|NCT03785340|83135590|FG000|Overall Study|Lost to Follow-up|2|||
46906765|NCT03785340|83135591|FG001|Overall Study|Lost to Follow-up|0|||
46906766|NCT03785340|83135590|FG000|Overall Study|Adverse Event|1|||
46906767|NCT03785340|83135591|FG001|Overall Study|Adverse Event|0|||
46906768|NCT03499067|83135597|FG000|First Intervention|Physician Decision|2|||
46906769|NCT03499067|83135598|FG001|First Intervention|Physician Decision|1|||
46906770|NCT03499067|83135597|FG000|First Intervention|Withdrawal by Subject|3|||
46906771|NCT03499067|83135598|FG001|First Intervention|Withdrawal by Subject|6|||
46906772|NCT03562481|83135606|FG000|First Intervention|Lost to Follow-up|1|||
46906773|NCT03562481|83135607|FG001|First Intervention|Lost to Follow-up|0|||
46906774|NCT03529409|83135633|FG000|Randomized|Lost to Follow-up|0|||
46906775|NCT03529409|83135634|FG001|Randomized|Lost to Follow-up|0|||
46906776|NCT03529409|83135635|FG002|Randomized|Lost to Follow-up|4|||
46906777|NCT03529409|83135633|FG000|Randomized|Excluded|0|||
46906778|NCT03529409|83135634|FG001|Randomized|Excluded|0|||
46906779|NCT03529409|83135635|FG002|Randomized|Excluded|1|||
46906780|NCT03529409|83135633|FG000|Post-treatment Assessment|Death|1|||
46906781|NCT03529409|83135634|FG001|Post-treatment Assessment|Death|0|||
46906782|NCT03529409|83135635|FG002|Post-treatment Assessment|Death|0|||
46906783|NCT03529409|83135633|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
46906784|NCT03529409|83135634|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
46906785|NCT03529409|83135635|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
46906786|NCT03529409|83135633|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
46906787|NCT03529409|83135634|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
46906788|NCT03529409|83135635|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
46906789|NCT03529409|83135633|FG000|Follow-up Assessment|Death|1|||
46906790|NCT03529409|83135634|FG001|Follow-up Assessment|Death|0|||
46906791|NCT03529409|83135635|FG002|Follow-up Assessment|Death|0|||
46906792|NCT03529409|83135633|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
46906793|NCT03529409|83135634|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
46906794|NCT03529409|83135635|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
46906795|NCT03498287|83135644|FG000|Overall Study|Withdrawal by Subject|3|||
46906796|NCT03498287|83135645|FG001|Overall Study|Withdrawal by Subject|0|||
46906797|NCT03498287|83135644|FG000|Overall Study|Protocol Violation|0|||
46906798|NCT03498287|83135645|FG001|Overall Study|Protocol Violation|4|||
46906799|NCT03498287|83135644|FG000|Overall Study|Adverse Event|0|||
46906800|NCT03498287|83135645|FG001|Overall Study|Adverse Event|1|||
46906801|NCT03497429|83135653|FG000|Overall Study|Progressive disease|3|||
46906802|NCT03497429|83135654|FG001|Overall Study|Progressive disease|4|||
46906803|NCT03497429|83135653|FG000|Overall Study|Adverse Event|0|||
46906804|NCT03497429|83135654|FG001|Overall Study|Adverse Event|2|||
46906805|NCT03497039|83135662|FG000|Overall Study|Withdrawal by Subject|1|||
46906806|NCT03497039|83135663|FG001|Overall Study|Withdrawal by Subject|0|||
46997266|NCT02326298|83244034|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
46906807|NCT03497039|83135662|FG000|Overall Study|Protocol Violation|0|||
46906808|NCT03497039|83135663|FG001|Overall Study|Protocol Violation|1|||
46906809|NCT03495869|83135682|FG000|Overall Study|Lost to Follow-up|4|||
46906810|NCT03495869|83135683|FG001|Overall Study|Lost to Follow-up|17|||
46906811|NCT03495869|83135684|FG002|Overall Study|Lost to Follow-up|8|||
46906812|NCT03495869|83135685|FG003|Overall Study|Lost to Follow-up|14|||
46906813|NCT03495869|83135682|FG000|Overall Study|Withdrawal by Subject|0|||
46906814|NCT03495869|83135683|FG001|Overall Study|Withdrawal by Subject|3|||
46906815|NCT03495869|83135684|FG002|Overall Study|Withdrawal by Subject|0|||
46906816|NCT03495869|83135685|FG003|Overall Study|Withdrawal by Subject|3|||
46906817|NCT03495869|83135682|FG000|Overall Study|Dropped from study|0|||
46906818|NCT03495869|83135683|FG001|Overall Study|Dropped from study|7|||
46906819|NCT03495869|83135684|FG002|Overall Study|Dropped from study|2|||
46906820|NCT03495869|83135685|FG003|Overall Study|Dropped from study|4|||
46906821|NCT03071094|83135706|FG000|Overall Study|Death|1|||
46906822|NCT03071094|83135707|FG001|Overall Study|Death|1|||
46906823|NCT03071094|83135706|FG000|Overall Study|Adverse Event|1|||
46906824|NCT03071094|83135707|FG001|Overall Study|Adverse Event|0|||
46906825|NCT03559517|83135716|FG000|Overall Study|Withdrawal by Subject|1|||
46906826|NCT03559517|83135717|FG001|Overall Study|Withdrawal by Subject|0|||
46906827|NCT03559517|83135718|FG002|Overall Study|Withdrawal by Subject|0|||
46906828|NCT02509494|83135735|FG000|Overall Study|Lost to Follow-up|8|||
46906829|NCT02509494|83135736|FG001|Overall Study|Lost to Follow-up|47|||
46906830|NCT02509494|83135737|FG002|Overall Study|Lost to Follow-up|19|||
46906831|NCT02509494|83135738|FG003|Overall Study|Lost to Follow-up|6|||
46906832|NCT02509494|83135739|FG004|Overall Study|Lost to Follow-up|3|||
46906833|NCT02509494|83135740|FG005|Overall Study|Lost to Follow-up|3|||
46906834|NCT02509494|83135741|FG006|Overall Study|Lost to Follow-up|1|||
46906835|NCT02509494|83135742|FG007|Overall Study|Lost to Follow-up|3|||
46906836|NCT02509494|83135743|FG008|Overall Study|Lost to Follow-up|1|||
46906837|NCT02509494|83135735|FG000|Overall Study|Physician Decision|2|||
46906838|NCT02509494|83135736|FG001|Overall Study|Physician Decision|1|||
46906839|NCT02509494|83135737|FG002|Overall Study|Physician Decision|0|||
46906840|NCT02509494|83135738|FG003|Overall Study|Physician Decision|0|||
46906841|NCT02509494|83135739|FG004|Overall Study|Physician Decision|0|||
46906842|NCT02509494|83135740|FG005|Overall Study|Physician Decision|0|||
46906843|NCT02509494|83135741|FG006|Overall Study|Physician Decision|0|||
46906844|NCT02509494|83135742|FG007|Overall Study|Physician Decision|0|||
46906845|NCT02509494|83135743|FG008|Overall Study|Physician Decision|0|||
46906846|NCT02509494|83135735|FG000|Overall Study|Withdrawal by Subject|4|||
46906847|NCT02509494|83135736|FG001|Overall Study|Withdrawal by Subject|17|||
46906848|NCT02509494|83135737|FG002|Overall Study|Withdrawal by Subject|7|||
46906849|NCT02509494|83135738|FG003|Overall Study|Withdrawal by Subject|5|||
46906850|NCT02509494|83135739|FG004|Overall Study|Withdrawal by Subject|0|||
46906851|NCT02509494|83135740|FG005|Overall Study|Withdrawal by Subject|6|||
46906852|NCT02509494|83135741|FG006|Overall Study|Withdrawal by Subject|1|||
46906853|NCT02509494|83135742|FG007|Overall Study|Withdrawal by Subject|2|||
46906854|NCT02509494|83135743|FG008|Overall Study|Withdrawal by Subject|1|||
46906855|NCT02509494|83135735|FG000|Overall Study|Death|0|||
46906856|NCT02509494|83135736|FG001|Overall Study|Death|1|||
46906857|NCT02509494|83135737|FG002|Overall Study|Death|0|||
46906858|NCT02509494|83135738|FG003|Overall Study|Death|0|||
46906859|NCT02509494|83135739|FG004|Overall Study|Death|1|||
46906860|NCT02509494|83135740|FG005|Overall Study|Death|0|||
46906861|NCT02509494|83135741|FG006|Overall Study|Death|0|||
46906862|NCT02509494|83135742|FG007|Overall Study|Death|1|||
46906863|NCT02509494|83135743|FG008|Overall Study|Death|0|||
46906864|NCT02509494|83135735|FG000|Overall Study|Other|0|||
46906865|NCT02509494|83135736|FG001|Overall Study|Other|4|||
46906866|NCT02509494|83135737|FG002|Overall Study|Other|5|||
46906867|NCT02509494|83135738|FG003|Overall Study|Other|0|||
46906868|NCT02509494|83135739|FG004|Overall Study|Other|0|||
46906869|NCT02509494|83135740|FG005|Overall Study|Other|0|||
46906870|NCT02509494|83135741|FG006|Overall Study|Other|0|||
46906871|NCT02509494|83135742|FG007|Overall Study|Other|0|||
46906872|NCT02509494|83135743|FG008|Overall Study|Other|0|||
46906873|NCT02509494|83135735|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46906874|NCT02509494|83135736|FG001|Overall Study|Non-Compliance With Study Drug|11|||
46906875|NCT02509494|83135737|FG002|Overall Study|Non-Compliance With Study Drug|7|||
46906876|NCT02509494|83135738|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46906877|NCT02509494|83135739|FG004|Overall Study|Non-Compliance With Study Drug|1|||
46906878|NCT02509494|83135740|FG005|Overall Study|Non-Compliance With Study Drug|2|||
46906879|NCT02509494|83135741|FG006|Overall Study|Non-Compliance With Study Drug|1|||
46906880|NCT02509494|83135742|FG007|Overall Study|Non-Compliance With Study Drug|1|||
46997267|NCT02326298|83244021|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46906881|NCT02509494|83135743|FG008|Overall Study|Non-Compliance With Study Drug|0|||
46906882|NCT03493451|83135780|FG000|Overall Study|Death|11|||
46906883|NCT03493451|83135781|FG001|Overall Study|Death|26|||
46906884|NCT03493451|83135782|FG002|Overall Study|Death|3|||
46906885|NCT03493451|83135780|FG000|Overall Study|Lost to Follow-up|1|||
46906886|NCT03493451|83135781|FG001|Overall Study|Lost to Follow-up|4|||
46906887|NCT03493451|83135782|FG002|Overall Study|Lost to Follow-up|1|||
46906888|NCT03493451|83135780|FG000|Overall Study|Withdrawal by Subject|1|||
46906889|NCT03493451|83135781|FG001|Overall Study|Withdrawal by Subject|1|||
46906890|NCT03493451|83135782|FG002|Overall Study|Withdrawal by Subject|2|||
46906891|NCT03493451|83135780|FG000|Overall Study|Progressive Disease|1|||
46906892|NCT03493451|83135781|FG001|Overall Study|Progressive Disease|0|||
46906893|NCT03493451|83135782|FG002|Overall Study|Progressive Disease|0|||
46906894|NCT03493451|83135780|FG000|Overall Study|Transferred to long term extension study|8|||
46906895|NCT03493451|83135781|FG001|Overall Study|Transferred to long term extension study|13|||
46906896|NCT03493451|83135782|FG002|Overall Study|Transferred to long term extension study|5|||
46906897|NCT03492281|83135793|FG000|Overall Study|Withdrawal by Subject|21|||
46906898|NCT03492281|83135794|FG001|Overall Study|Withdrawal by Subject|14|||
46906899|NCT03492281|83135795|FG002|Overall Study|Withdrawal by Subject|13|||
46906900|NCT03492281|83135793|FG000|Overall Study|Lost to Follow-up|14|||
46906901|NCT03492281|83135794|FG001|Overall Study|Lost to Follow-up|15|||
46906902|NCT03492281|83135795|FG002|Overall Study|Lost to Follow-up|10|||
46906903|NCT03492281|83135793|FG000|Overall Study|Adverse Event|6|||
46906904|NCT03492281|83135794|FG001|Overall Study|Adverse Event|8|||
46906905|NCT03492281|83135795|FG002|Overall Study|Adverse Event|13|||
46906906|NCT03492281|83135793|FG000|Overall Study|Lack of Efficacy|3|||
46906907|NCT03492281|83135794|FG001|Overall Study|Lack of Efficacy|0|||
46906908|NCT03492281|83135795|FG002|Overall Study|Lack of Efficacy|1|||
46906909|NCT03492281|83135793|FG000|Overall Study|Physician Decision|1|||
46906910|NCT03492281|83135794|FG001|Overall Study|Physician Decision|0|||
46997268|NCT02326298|83244022|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997269|NCT02326298|83244023|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997270|NCT02326298|83244024|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997271|NCT02326298|83244025|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997272|NCT02326298|83244026|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997273|NCT02326298|83244027|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997274|NCT02326298|83244028|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997275|NCT02326298|83244029|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997276|NCT02326298|83244030|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997277|NCT02326298|83244031|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997278|NCT02326298|83244032|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46997279|NCT02326298|83244033|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
46709173|NCT00381680|82925156|FG001|Overall Study|Entry onto another COG Trial|2|||
46709174|NCT00381680|82925155|FG000|Overall Study|Alternative Therapy|11|||
46709175|NCT00381680|82925156|FG001|Overall Study|Alternative Therapy|5|||
46709176|NCT00381680|82925155|FG000|Overall Study|Secondary Malignancy|3|||
46709177|NCT00381680|82925156|FG001|Overall Study|Secondary Malignancy|0|||
46709178|NCT00381680|82925155|FG000|Overall Study|Delay initiation|1|||
46709179|NCT00381680|82925156|FG001|Overall Study|Delay initiation|0|||
46709180|NCT00381680|82925155|FG000|Overall Study|Stem Cell Transplant|26|||
46709181|NCT00381680|82925156|FG001|Overall Study|Stem Cell Transplant|10|||
46709182|NCT00381680|82925155|FG000|Overall Study|Relapse|18|||
46709183|NCT00381680|82925156|FG001|Overall Study|Relapse|9|||
46709184|NCT00381680|82925155|FG000|Overall Study|Induction Failure|4|||
46709185|NCT00381680|82925156|FG001|Overall Study|Induction Failure|1|||
46997280|NCT02326298|83244034|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
46997281|NCT02326298|83244021|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997282|NCT02326298|83244022|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997283|NCT02326298|83244023|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997284|NCT02326298|83244024|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997285|NCT02326298|83244025|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997286|NCT02326298|83244026|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997287|NCT02326298|83244027|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997288|NCT02326298|83244028|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46709186|NCT00381680|82925155|FG000|Overall Study|Progression|1|||
46709187|NCT00381680|82925156|FG001|Overall Study|Progression|1|||
46709188|NCT00381680|82925155|FG000|Overall Study|Other not otherwise specified|7|||
46709189|NCT00381680|82925156|FG001|Overall Study|Other not otherwise specified|2|||
46709190|NCT00381680|82925155|FG000|Overall Study|Ineligible|3|||
46709191|NCT00381680|82925156|FG001|Overall Study|Ineligible|1|||
46775679|NCT00694707|82994140|FG004|Overall Study|Arrest by Police|0|||
46775680|NCT00694707|82994136|FG000|Overall Study|Administrative Reasons|0|||
46775681|NCT00694707|82994137|FG001|Overall Study|Administrative Reasons|1|||
46775682|NCT00694707|82994138|FG002|Overall Study|Administrative Reasons|0|||
46775683|NCT00694707|82994139|FG003|Overall Study|Administrative Reasons|2|||
46775684|NCT00694707|82994140|FG004|Overall Study|Administrative Reasons|0|||
46775685|NCT00694707|82994136|FG000|Overall Study|Notification of Past Head Injury|0|||
46775686|NCT00694707|82994137|FG001|Overall Study|Notification of Past Head Injury|0|||
46775687|NCT00694707|82994138|FG002|Overall Study|Notification of Past Head Injury|0|||
46775688|NCT00694707|82994139|FG003|Overall Study|Notification of Past Head Injury|1|||
46775689|NCT00694707|82994140|FG004|Overall Study|Notification of Past Head Injury|0|||
46775690|NCT00692913|82994154|FG000|Overall Study|Adverse Event|8|||
46775691|NCT00692913|82994155|FG001|Overall Study|Adverse Event|4|||
46775692|NCT00692913|82994154|FG000|Overall Study|Lost to Follow-up|3|||
46906911|NCT03492281|83135795|FG002|Overall Study|Physician Decision|3|||
46906912|NCT03492281|83135793|FG000|Overall Study|Protocol Violation|0|||
46906913|NCT03492281|83135794|FG001|Overall Study|Protocol Violation|2|||
46775693|NCT00692913|82994155|FG001|Overall Study|Lost to Follow-up|5|||
46775694|NCT00692913|82994154|FG000|Overall Study|Physician Decision|2|||
46775695|NCT00692913|82994155|FG001|Overall Study|Physician Decision|0|||
46775696|NCT00692913|82994154|FG000|Overall Study|Protocol Violation|1|||
46775697|NCT00692913|82994155|FG001|Overall Study|Protocol Violation|1|||
46906914|NCT03492281|83135795|FG002|Overall Study|Protocol Violation|1|||
46997289|NCT02326298|83244029|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997290|NCT02326298|83244030|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997291|NCT02326298|83244031|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
46997292|NCT02326298|83244032|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
46997293|NCT02326298|83244033|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
46997294|NCT02326298|83244034|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
46997295|NCT02326298|83244021|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997296|NCT02326298|83244022|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997297|NCT02326298|83244023|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997298|NCT02326298|83244024|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997299|NCT02326298|83244025|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997300|NCT02326298|83244026|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997301|NCT02326298|83244027|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997302|NCT02326298|83244028|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997303|NCT02326298|83244029|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997304|NCT02326298|83244030|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997305|NCT02326298|83244031|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
46997306|NCT02326298|83244032|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
46997307|NCT02326298|83244033|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
46997308|NCT02326298|83244034|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
46997309|NCT02326298|83244021|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997310|NCT02326298|83244022|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997311|NCT02326298|83244023|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997312|NCT02326298|83244024|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997313|NCT02326298|83244025|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997314|NCT02326298|83244026|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997315|NCT02326298|83244027|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997316|NCT02326298|83244028|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997317|NCT02326298|83244029|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997318|NCT02326298|83244030|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997319|NCT02326298|83244031|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
46997320|NCT02326298|83244032|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
46997321|NCT02326298|83244033|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
46997322|NCT02326298|83244034|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
46997323|NCT02396420|83244043|FG000|Overall Study|Death|1|||
46997324|NCT02279719|83244055|FG000|Overall Study|Patients randomized but never treated|0|||
46997325|NCT02279719|83244056|FG001|Overall Study|Patients randomized but never treated|0|||
46997326|NCT02279719|83244057|FG002|Overall Study|Patients randomized but never treated|0|||
46997327|NCT02279719|83244058|FG003|Overall Study|Patients randomized but never treated|0|||
46997328|NCT02279719|83244059|FG004|Overall Study|Patients randomized but never treated|3|||
46997329|NCT02279719|83244060|FG005|Overall Study|Patients randomized but never treated|0|||
46997330|NCT02279719|83244061|FG006|Overall Study|Patients randomized but never treated|3|||
46997331|NCT02279407|83244098|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
46997332|NCT02279407|83244099|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
46997333|NCT02279407|83244100|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
46997334|NCT02279407|83244101|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
46997335|NCT02279407|83244098|FG000|Overall Study|Withdrawal by Subject|1|||
46997336|NCT02279407|83244099|FG001|Overall Study|Withdrawal by Subject|0|||
46997337|NCT02279407|83244100|FG002|Overall Study|Withdrawal by Subject|1|||
46997338|NCT02279407|83244101|FG003|Overall Study|Withdrawal by Subject|1|||
46997339|NCT02279407|83244098|FG000|Overall Study|Adverse Event|1|||
46620374|NCT00085735|82762349|FG005|Overall Study|Excess residual disease|4|||
46906915|NCT03492281|83135793|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
46906916|NCT03492281|83135794|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
46906917|NCT03492281|83135795|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
46906918|NCT03492281|83135793|FG000|Overall Study|Death|0|||
46906919|NCT03492281|83135794|FG001|Overall Study|Death|0|||
46906920|NCT03492281|83135795|FG002|Overall Study|Death|1|||
46906921|NCT03492281|83135793|FG000|Overall Study|Captured as Other in Database|8|||
46906922|NCT03492281|83135794|FG001|Overall Study|Captured as Other in Database|6|||
46906923|NCT03492281|83135795|FG002|Overall Study|Captured as Other in Database|3|||
46906924|NCT03070782|83135812|FG000|Overall Study|Adverse Event|3|||
46906925|NCT03070782|83135813|FG001|Overall Study|Adverse Event|0|||
46997340|NCT02279407|83244099|FG001|Overall Study|Adverse Event|1|||
46906926|NCT03070782|83135814|FG002|Overall Study|Adverse Event|3|||
46906927|NCT03070782|83135815|FG003|Overall Study|Adverse Event|1|||
46906928|NCT03070782|83135816|FG004|Overall Study|Adverse Event|6|||
46906929|NCT03070782|83135817|FG005|Overall Study|Adverse Event|2|||
46997341|NCT02279407|83244100|FG002|Overall Study|Adverse Event|2|||
46997342|NCT02279407|83244101|FG003|Overall Study|Adverse Event|0|||
46997343|NCT02326220|83244113|FG000|Double-blind Treatment Period|Adverse Event|1|||
46997344|NCT02326220|83244114|FG001|Double-blind Treatment Period|Adverse Event|2|||
46997345|NCT02326220|83244115|FG002|Double-blind Treatment Period|Adverse Event|0|||
46997346|NCT02326220|83244113|FG000|Double-blind Treatment Period|Protocol Violation|0|||
46997347|NCT02326220|83244114|FG001|Double-blind Treatment Period|Protocol Violation|1|||
46997348|NCT02326220|83244115|FG002|Double-blind Treatment Period|Protocol Violation|0|||
46997349|NCT02326220|83244113|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
46997350|NCT02326220|83244114|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
46997351|NCT02326220|83244115|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46997352|NCT02326220|83244113|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
46997353|NCT02326220|83244114|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
46997354|NCT02326220|83244115|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
46997355|NCT02326220|83244113|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
46997356|NCT02326220|83244114|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
46997357|NCT02326220|83244115|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
46997358|NCT02279173|83244125|FG000|Overall Study|Protocol-specified Criteria|67|||
46997359|NCT02279173|83244125|FG000|Overall Study|Withdrawal by Subject|20|||
46997360|NCT02279173|83244125|FG000|Overall Study|Decision by Sponsor|4|||
46997361|NCT02279173|83244125|FG000|Overall Study|Lost to Follow-up|3|||
46997362|NCT02282917|83244131|FG000|Overall Study|Withdrawal by Subject|1|||
46997363|NCT02282917|83244131|FG000|Overall Study|Screen Failure/Not Eligible|1|||
46997364|NCT02358668|83244138|FG000|Overall Study|Adverse Event|2|||
46997365|NCT02358668|83244139|FG001|Overall Study|Adverse Event|0|||
46997366|NCT02358668|83244140|FG002|Overall Study|Adverse Event|0|||
46997367|NCT02358668|83244138|FG000|Overall Study|Withdrawal by Subject|0|||
46997368|NCT02358668|83244139|FG001|Overall Study|Withdrawal by Subject|1|||
46997369|NCT02358668|83244140|FG002|Overall Study|Withdrawal by Subject|0|||
46997370|NCT02282605|83244151|FG000|Overall Study|negative SA result on Day -1|3|||
46997371|NCT02282605|83244152|FG001|Overall Study|negative SA result on Day -1|0|||
46997372|NCT02282605|83244153|FG002|Overall Study|negative SA result on Day -1|0|||
46997373|NCT02282527|83244163|FG000|Overall Study|Lost to Follow-up|0|||
46997374|NCT02282527|83244164|FG001|Overall Study|Lost to Follow-up|1|||
46997375|NCT02282527|83244163|FG000|Overall Study|Lack of home health aid|1|||
46709192|NCT00925600|82925168|FG000|Overall Study|Withdrawal by Subject|16|||
46709193|NCT00925600|82925169|FG001|Overall Study|Withdrawal by Subject|14|||
46906930|NCT03070782|83135812|FG000|Overall Study|Withdrawal by Subject|2|||
46906931|NCT03070782|83135813|FG001|Overall Study|Withdrawal by Subject|1|||
46906932|NCT03070782|83135814|FG002|Overall Study|Withdrawal by Subject|1|||
46906933|NCT03070782|83135815|FG003|Overall Study|Withdrawal by Subject|0|||
46906934|NCT03070782|83135816|FG004|Overall Study|Withdrawal by Subject|4|||
46906935|NCT03070782|83135817|FG005|Overall Study|Withdrawal by Subject|3|||
46906936|NCT03070782|83135812|FG000|Overall Study|Reason Not Specified|2|||
46906937|NCT03070782|83135813|FG001|Overall Study|Reason Not Specified|0|||
46906938|NCT03070782|83135814|FG002|Overall Study|Reason Not Specified|0|||
46906939|NCT03070782|83135815|FG003|Overall Study|Reason Not Specified|1|||
46906940|NCT03070782|83135816|FG004|Overall Study|Reason Not Specified|2|||
46906941|NCT03070782|83135817|FG005|Overall Study|Reason Not Specified|1|||
46906942|NCT03070782|83135812|FG000|Overall Study|Ineligibility|0|||
46906943|NCT03070782|83135813|FG001|Overall Study|Ineligibility|0|||
46906944|NCT03070782|83135814|FG002|Overall Study|Ineligibility|0|||
46906945|NCT03070782|83135815|FG003|Overall Study|Ineligibility|1|||
46906946|NCT03070782|83135816|FG004|Overall Study|Ineligibility|0|||
46906947|NCT03070782|83135817|FG005|Overall Study|Ineligibility|1|||
46906948|NCT03070782|83135812|FG000|Overall Study|Pregnancy|0|||
46906949|NCT03070782|83135813|FG001|Overall Study|Pregnancy|0|||
46906950|NCT03070782|83135814|FG002|Overall Study|Pregnancy|0|||
46906951|NCT03070782|83135815|FG003|Overall Study|Pregnancy|1|||
46906952|NCT03070782|83135816|FG004|Overall Study|Pregnancy|0|||
46906953|NCT03070782|83135817|FG005|Overall Study|Pregnancy|0|||
46906954|NCT03070782|83135812|FG000|Overall Study|Investigator Judgement|0|||
46997376|NCT02282527|83244164|FG001|Overall Study|Lack of home health aid|0|||
46997377|NCT02278939|83244175|FG000|Overall Study|lack of time|1|||
46997378|NCT02278939|83244176|FG001|Overall Study|lack of time|0|||
46997379|NCT02278939|83244175|FG000|Overall Study|Lost to Follow-up|1|||
46997380|NCT02278939|83244176|FG001|Overall Study|Lost to Follow-up|1|||
46709194|NCT00925600|82925168|FG000|Overall Study|Death|4|||
46906955|NCT03070782|83135813|FG001|Overall Study|Investigator Judgement|0|||
46906956|NCT03070782|83135814|FG002|Overall Study|Investigator Judgement|0|||
46906957|NCT03070782|83135815|FG003|Overall Study|Investigator Judgement|1|||
46906958|NCT03070782|83135816|FG004|Overall Study|Investigator Judgement|0|||
46906959|NCT03070782|83135817|FG005|Overall Study|Investigator Judgement|0|||
46906960|NCT03525119|83135853|FG000|Overall Study|Adverse Event|0|||
46997381|NCT02278939|83244175|FG000|Overall Study|death in family|1|||
46997382|NCT02278939|83244176|FG001|Overall Study|death in family|0|||
46997383|NCT02278939|83244175|FG000|Overall Study|family emergency unable to commit|2|||
46997384|NCT02278939|83244176|FG001|Overall Study|family emergency unable to commit|0|||
46997385|NCT02278471|83244184|FG000|Overall Study|Lost to Follow-up|6|||
46997386|NCT02278471|83244185|FG001|Overall Study|Lost to Follow-up|15|||
46997387|NCT02278471|83244184|FG000|Overall Study|Death|2|||
46997388|NCT02278471|83244185|FG001|Overall Study|Death|2|||
46997389|NCT02278471|83244184|FG000|Overall Study|Withdrawal by Subject|0|||
46997390|NCT02278471|83244185|FG001|Overall Study|Withdrawal by Subject|3|||
46997391|NCT02278003|83244194|FG000|Overall Study|Withdrawal by Subject|11|||
46997392|NCT02278003|83244195|FG001|Overall Study|Withdrawal by Subject|0|||
46997393|NCT02278003|83244194|FG000|Overall Study|Not Treated|1|||
46997394|NCT02278003|83244195|FG001|Overall Study|Not Treated|0|||
46997395|NCT02278003|83244194|FG000|Overall Study|Recognition task improperly completed|7|||
46997396|NCT02278003|83244195|FG001|Overall Study|Recognition task improperly completed|0|||
46997397|NCT02277769|83244204|FG000|Overall Study|Protocol Violation|3|||
46997398|NCT02277769|83244205|FG001|Overall Study|Protocol Violation|3|||
46997399|NCT02277769|83244206|FG002|Overall Study|Protocol Violation|5|||
46997400|NCT02277769|83244204|FG000|Overall Study|Lack of Efficacy|17|||
46997401|NCT02277769|83244205|FG001|Overall Study|Lack of Efficacy|0|||
46997402|NCT02277769|83244206|FG002|Overall Study|Lack of Efficacy|4|||
46997403|NCT02277769|83244204|FG000|Overall Study|Adverse Event|14|||
46997404|NCT02277769|83244205|FG001|Overall Study|Adverse Event|2|||
46997405|NCT02277769|83244206|FG002|Overall Study|Adverse Event|4|||
46997406|NCT02277769|83244204|FG000|Overall Study|Other than specified above|12|||
46997407|NCT02277769|83244205|FG001|Overall Study|Other than specified above|8|||
46997408|NCT02277769|83244206|FG002|Overall Study|Other than specified above|5|||
46997409|NCT01641991|83244218|FG000|Overall Study|Physician Decision|0|||
46997410|NCT01641991|83244219|FG001|Overall Study|Physician Decision|1|||
46997411|NCT01641991|83244220|FG002|Overall Study|Physician Decision|7|||
46997412|NCT01641991|83244221|FG003|Overall Study|Physician Decision|5|||
46997413|NCT01641991|83244218|FG000|Overall Study|Withdrawal by Subject|4|||
46997414|NCT01641991|83244219|FG001|Overall Study|Withdrawal by Subject|2|||
46997415|NCT01641991|83244220|FG002|Overall Study|Withdrawal by Subject|1|||
46997416|NCT01641991|83244221|FG003|Overall Study|Withdrawal by Subject|5|||
46997417|NCT01641991|83244218|FG000|Overall Study|Adverse Event|2|||
46997418|NCT01641991|83244219|FG001|Overall Study|Adverse Event|1|||
46997419|NCT01641991|83244220|FG002|Overall Study|Adverse Event|2|||
46997420|NCT01641991|83244221|FG003|Overall Study|Adverse Event|1|||
46997421|NCT01641991|83244218|FG000|Overall Study|Lost to Follow-up|0|||
46997422|NCT01641991|83244219|FG001|Overall Study|Lost to Follow-up|2|||
46997423|NCT01641991|83244220|FG002|Overall Study|Lost to Follow-up|3|||
46997424|NCT01641991|83244221|FG003|Overall Study|Lost to Follow-up|1|||
46997425|NCT01641991|83244218|FG000|Overall Study|Protocol Violation|1|||
46997426|NCT01641991|83244219|FG001|Overall Study|Protocol Violation|1|||
46997427|NCT01641991|83244220|FG002|Overall Study|Protocol Violation|3|||
46997428|NCT01641991|83244221|FG003|Overall Study|Protocol Violation|0|||
46997429|NCT01641991|83244218|FG000|Overall Study|Pregnancy|0|||
46997430|NCT01641991|83244219|FG001|Overall Study|Pregnancy|0|||
46997431|NCT01641991|83244220|FG002|Overall Study|Pregnancy|1|||
46997432|NCT01641991|83244221|FG003|Overall Study|Pregnancy|0|||
46997433|NCT01641991|83244218|FG000|Overall Study|no longer eligible|2|||
46997434|NCT01641991|83244219|FG001|Overall Study|no longer eligible|1|||
46997435|NCT01641991|83244220|FG002|Overall Study|no longer eligible|0|||
46997436|NCT01641991|83244221|FG003|Overall Study|no longer eligible|4|||
46997437|NCT02277691|83244234|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
46997438|NCT02277691|83244234|FG000|Overall Study|Voluntary Withdrawal|7|||
46997439|NCT02277691|83244234|FG000|Overall Study|Lack of Efficacy|5|||
46997440|NCT02277691|83244234|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
46997441|NCT02395172|83244240|FG000|Overall Study|Participants randomized but not treated|3|||
46997442|NCT02395172|83244241|FG001|Overall Study|Participants randomized but not treated|31|||
46997443|NCT02276053|83244247|FG000|Overall Study|Death|2|||
46997444|NCT02276053|83244247|FG000|Overall Study|Adverse Event|5|||
46997445|NCT02276053|83244247|FG000|Overall Study|Lack of Efficacy|2|||
46997446|NCT02276053|83244247|FG000|Overall Study|Withdrawal by Subject|1|||
46997447|NCT02276053|83244247|FG000|Overall Study|Patient does not meet selection criteria|3|||
46997448|NCT02276053|83244247|FG000|Overall Study|Patient needs to increase baseline AED|1|||
46997449|NCT02275819|83244254|FG000|Overall Study|Adverse Event|0|||
46997450|NCT02275819|83244255|FG001|Overall Study|Adverse Event|1|||
46997451|NCT02358044|83244263|FG000|Overall Study|Adverse Event|0|||
46997452|NCT02358044|83244264|FG001|Overall Study|Adverse Event|1|||
46997453|NCT02358044|83244263|FG000|Overall Study|Lost to Follow-up|2|||
46997454|NCT02358044|83244264|FG001|Overall Study|Lost to Follow-up|1|||
46709195|NCT00925600|82925169|FG001|Overall Study|Death|3|||
46997455|NCT02358044|83244263|FG000|Overall Study|Physician Decision|0|||
46997456|NCT02358044|83244264|FG001|Overall Study|Physician Decision|1|||
46997457|NCT02358044|83244263|FG000|Overall Study|Withdrawal by Subject|0|||
46997458|NCT02358044|83244264|FG001|Overall Study|Withdrawal by Subject|4|||
46997459|NCT02275117|83244275|FG000|Overall Study|Adverse Event|0|||
46997460|NCT02275117|83244276|FG001|Overall Study|Adverse Event|0|||
46997461|NCT02275117|83244277|FG002|Overall Study|Adverse Event|0|||
46997462|NCT02275117|83244278|FG003|Overall Study|Adverse Event|0|||
46997463|NCT02275117|83244279|FG004|Overall Study|Adverse Event|1|||
46997464|NCT02275117|83244275|FG000|Overall Study|Lack of Efficacy|6|||
46997465|NCT02275117|83244276|FG001|Overall Study|Lack of Efficacy|7|||
46997466|NCT02275117|83244277|FG002|Overall Study|Lack of Efficacy|5|||
46997467|NCT02275117|83244278|FG003|Overall Study|Lack of Efficacy|2|||
46997468|NCT02275117|83244279|FG004|Overall Study|Lack of Efficacy|10|||
46997469|NCT02275117|83244275|FG000|Overall Study|Lost to Follow-up|11|||
46997470|NCT02275117|83244276|FG001|Overall Study|Lost to Follow-up|16|||
46997471|NCT02275117|83244277|FG002|Overall Study|Lost to Follow-up|15|||
46997472|NCT02275117|83244278|FG003|Overall Study|Lost to Follow-up|16|||
46997473|NCT02275117|83244279|FG004|Overall Study|Lost to Follow-up|8|||
46997474|NCT02275117|83244275|FG000|Overall Study|Physician Decision|0|||
46997475|NCT02275117|83244276|FG001|Overall Study|Physician Decision|1|||
46997476|NCT02275117|83244277|FG002|Overall Study|Physician Decision|1|||
46997477|NCT02275117|83244278|FG003|Overall Study|Physician Decision|0|||
46997478|NCT02275117|83244279|FG004|Overall Study|Physician Decision|1|||
46997479|NCT02275117|83244275|FG000|Overall Study|Protocol Violation|1|||
46997480|NCT02275117|83244276|FG001|Overall Study|Protocol Violation|0|||
46997481|NCT02275117|83244277|FG002|Overall Study|Protocol Violation|1|||
46997482|NCT02275117|83244278|FG003|Overall Study|Protocol Violation|1|||
46997483|NCT02275117|83244279|FG004|Overall Study|Protocol Violation|0|||
46997484|NCT02275117|83244275|FG000|Overall Study|Withdrawal by Subject|6|||
46997485|NCT02275117|83244276|FG001|Overall Study|Withdrawal by Subject|4|||
46997486|NCT02275117|83244277|FG002|Overall Study|Withdrawal by Subject|7|||
46997487|NCT02275117|83244278|FG003|Overall Study|Withdrawal by Subject|3|||
46997488|NCT02275117|83244279|FG004|Overall Study|Withdrawal by Subject|3|||
46997489|NCT02275117|83244275|FG000|Overall Study|Terminated by Sponsor|4|||
46997490|NCT02275117|83244276|FG001|Overall Study|Terminated by Sponsor|4|||
46997491|NCT02275117|83244277|FG002|Overall Study|Terminated by Sponsor|4|||
46997492|NCT02275117|83244278|FG003|Overall Study|Terminated by Sponsor|6|||
46997493|NCT02275117|83244279|FG004|Overall Study|Terminated by Sponsor|4|||
46997494|NCT02275117|83244275|FG000|Overall Study|Worsening of Study Indication|0|||
46997495|NCT02275117|83244276|FG001|Overall Study|Worsening of Study Indication|1|||
46997496|NCT02275117|83244277|FG002|Overall Study|Worsening of Study Indication|2|||
46997497|NCT02275117|83244278|FG003|Overall Study|Worsening of Study Indication|0|||
46997498|NCT02275117|83244279|FG004|Overall Study|Worsening of Study Indication|0|||
46997499|NCT02275117|83244275|FG000|Overall Study|Study Burden|5|||
46997500|NCT02275117|83244276|FG001|Overall Study|Study Burden|4|||
46997501|NCT02275117|83244277|FG002|Overall Study|Study Burden|7|||
46997502|NCT02275117|83244278|FG003|Overall Study|Study Burden|5|||
46997503|NCT02275117|83244279|FG004|Overall Study|Study Burden|7|||
46997504|NCT02275117|83244275|FG000|Overall Study|Other|1|||
46997505|NCT02275117|83244276|FG001|Overall Study|Other|0|||
46997506|NCT02275117|83244277|FG002|Overall Study|Other|0|||
46997507|NCT02275117|83244278|FG003|Overall Study|Other|0|||
46997508|NCT02275117|83244279|FG004|Overall Study|Other|2|||
46997509|NCT02274493|83244291|FG000|Overall Study|Withdrawal by Subject|1|||
46997510|NCT02273167|83244298|FG000|Overall Study|Adverse Event|1|||
46997511|NCT02273167|83244299|FG001|Overall Study|Adverse Event|0|||
46906961|NCT03525119|83135854|FG001|Overall Study|Adverse Event|1|||
46906962|NCT03525119|83135855|FG002|Overall Study|Adverse Event|0|||
46906963|NCT03525119|83135853|FG000|Overall Study|Lost to Follow-up|32|||
46906964|NCT03525119|83135854|FG001|Overall Study|Lost to Follow-up|33|||
46906965|NCT03525119|83135855|FG002|Overall Study|Lost to Follow-up|37|||
46906966|NCT03525119|83135853|FG000|Overall Study|Withdrawal by Subject|5|||
46906967|NCT03525119|83135854|FG001|Overall Study|Withdrawal by Subject|4|||
46906968|NCT03525119|83135855|FG002|Overall Study|Withdrawal by Subject|2|||
46906969|NCT03525119|83135853|FG000|Overall Study|Reason not Specified|2|||
46906970|NCT03525119|83135854|FG001|Overall Study|Reason not Specified|1|||
46906971|NCT03525119|83135855|FG002|Overall Study|Reason not Specified|2|||
46997512|NCT02273167|83244300|FG002|Overall Study|Adverse Event|0|||
46906972|NCT03525119|83135853|FG000|Overall Study|Randomized but not Vaccinated|1|||
46906973|NCT03525119|83135854|FG001|Overall Study|Randomized but not Vaccinated|0|||
46997513|NCT02273167|83244298|FG000|Overall Study|Protocol Violation|3|||
46997514|NCT02273167|83244299|FG001|Overall Study|Protocol Violation|1|||
46997515|NCT02273167|83244300|FG002|Overall Study|Protocol Violation|1|||
46997516|NCT02273167|83244298|FG000|Overall Study|Lost to Follow-up|0|||
46997517|NCT02273167|83244299|FG001|Overall Study|Lost to Follow-up|1|||
46997518|NCT02273167|83244300|FG002|Overall Study|Lost to Follow-up|1|||
46997519|NCT02273167|83244298|FG000|Overall Study|Withdrawal by Subject|10|||
46997520|NCT02273167|83244299|FG001|Overall Study|Withdrawal by Subject|12|||
46997521|NCT02273167|83244300|FG002|Overall Study|Withdrawal by Subject|11|||
46997522|NCT02273167|83244298|FG000|Overall Study|Various|10|||
46997523|NCT02273167|83244299|FG001|Overall Study|Various|9|||
46997524|NCT02273167|83244300|FG002|Overall Study|Various|8|||
46997525|NCT02272777|83244311|FG000|Overall Study|Adverse Event|0|||
46997526|NCT02272777|83244312|FG001|Overall Study|Adverse Event|1|||
46997527|NCT02272777|83244311|FG000|Overall Study|Withdrawal by Subject|0|||
46997528|NCT02272777|83244312|FG001|Overall Study|Withdrawal by Subject|3|||
46997529|NCT02272777|83244311|FG000|Overall Study|Lost to Follow-up|2|||
46997530|NCT02272777|83244312|FG001|Overall Study|Lost to Follow-up|0|||
46997531|NCT02272777|83244311|FG000|Overall Study|Other|2|||
46997532|NCT02272777|83244312|FG001|Overall Study|Other|0|||
46997533|NCT02357810|83244318|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
46997534|NCT02357810|83244318|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
46997535|NCT02357810|83244318|FG000|Reached 12 Weeks Response|Adverse Event|5|||
46997536|NCT02357810|83244318|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
46997537|NCT02357810|83244318|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
46997538|NCT02357810|83244318|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
46997539|NCT02357810|83244318|FG000|Reached 12 Weeks Response|Death|1|||
46997540|NCT02357810|83244318|FG000|Reached 12 Weeks Response|Physician Decision|1|||
46997541|NCT02357810|83244318|FG000|Reached 12 Weeks Response|Other|1|||
46997542|NCT02357810|83244318|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
46997543|NCT02357810|83244318|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
46997544|NCT02357810|83244318|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
46997545|NCT02357810|83244318|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
46997546|NCT02357810|83244318|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
46997547|NCT02357810|83244318|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
46997548|NCT02357576|83244324|FG000|Treatment Period|Withdrawal by Subject|0|||
46997549|NCT02357576|83244325|FG001|Treatment Period|Withdrawal by Subject|1|||
46997550|NCT02357576|83244324|FG000|Treatment Period|Physician Decision|0|||
46997551|NCT02357576|83244325|FG001|Treatment Period|Physician Decision|1|||
46997552|NCT02357576|83244324|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
46997553|NCT02357576|83244325|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
46997554|NCT02357576|83244324|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
46997555|NCT02357576|83244325|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
46997556|NCT02357576|83244324|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
46997557|NCT02357576|83244325|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
46997558|NCT02357576|83244324|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
46997559|NCT02357576|83244325|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
46997560|NCT01850446|83244333|FG000|Overall Study|Lack of Efficacy|1|||
46997561|NCT01850446|83244334|FG001|Overall Study|Lack of Efficacy|0|||
46997562|NCT01850446|83244333|FG000|Overall Study|Withdrawal by Subject|4|||
46997563|NCT01850446|83244334|FG001|Overall Study|Withdrawal by Subject|0|||
46997564|NCT01850446|83244333|FG000|Overall Study|Protocol Violation|0|||
46997565|NCT01850446|83244334|FG001|Overall Study|Protocol Violation|2|||
46997566|NCT02465567|83244344|FG000|Overall Study|Adverse Event|118|||
46997567|NCT02465567|83244345|FG001|Overall Study|Adverse Event|113|||
46997568|NCT02465567|83244346|FG002|Overall Study|Adverse Event|147|||
46997569|NCT02465567|83244347|FG003|Overall Study|Adverse Event|138|||
46997570|NCT02465567|83244344|FG000|Overall Study|Lack of Efficacy|103|||
46997571|NCT02465567|83244345|FG001|Overall Study|Lack of Efficacy|102|||
46997572|NCT02465567|83244346|FG002|Overall Study|Lack of Efficacy|171|||
46997573|NCT02465567|83244347|FG003|Overall Study|Lack of Efficacy|135|||
46997574|NCT02465567|83244344|FG000|Overall Study|Withdrawal by Subject|104|||
46997575|NCT02465567|83244345|FG001|Overall Study|Withdrawal by Subject|94|||
46997576|NCT02465567|83244346|FG002|Overall Study|Withdrawal by Subject|123|||
46997577|NCT02465567|83244347|FG003|Overall Study|Withdrawal by Subject|130|||
46997578|NCT02465567|83244344|FG000|Overall Study|Physician Decision|23|||
46997579|NCT02465567|83244345|FG001|Overall Study|Physician Decision|33|||
46997580|NCT02465567|83244346|FG002|Overall Study|Physician Decision|38|||
46997581|NCT02465567|83244347|FG003|Overall Study|Physician Decision|28|||
46997582|NCT02465567|83244344|FG000|Overall Study|Major Protocol Deviation|24|||
46997583|NCT02465567|83244345|FG001|Overall Study|Major Protocol Deviation|26|||
46997584|NCT02465567|83244346|FG002|Overall Study|Major Protocol Deviation|22|||
46997585|NCT02465567|83244347|FG003|Overall Study|Major Protocol Deviation|25|||
46997586|NCT02465567|83244344|FG000|Overall Study|Lost to Follow-up|25|||
46997587|NCT02465567|83244345|FG001|Overall Study|Lost to Follow-up|21|||
46997588|NCT02465567|83244346|FG002|Overall Study|Lost to Follow-up|19|||
46997589|NCT02465567|83244347|FG003|Overall Study|Lost to Follow-up|15|||
46997590|NCT02465567|83244344|FG000|Overall Study|Protocol Specified Criteria|20|||
46997591|NCT02465567|83244345|FG001|Overall Study|Protocol Specified Criteria|10|||
46997592|NCT02465567|83244346|FG002|Overall Study|Protocol Specified Criteria|9|||
46997593|NCT02465567|83244347|FG003|Overall Study|Protocol Specified Criteria|12|||
46997594|NCT02465567|83244344|FG000|Overall Study|Administrative Reasons|12|||
46997595|NCT02465567|83244345|FG001|Overall Study|Administrative Reasons|9|||
46997596|NCT02465567|83244346|FG002|Overall Study|Administrative Reasons|11|||
46997597|NCT02465567|83244347|FG003|Overall Study|Administrative Reasons|5|||
46997598|NCT02465567|83244344|FG000|Overall Study|Randomized but not treated|1|||
46997599|NCT02465567|83244345|FG001|Overall Study|Randomized but not treated|5|||
46997600|NCT02465567|83244346|FG002|Overall Study|Randomized but not treated|4|||
46997601|NCT02465567|83244347|FG003|Overall Study|Randomized but not treated|5|||
46997602|NCT02465567|83244344|FG000|Overall Study|enrolled in >1 studies|18|||
46997603|NCT02465567|83244345|FG001|Overall Study|enrolled in >1 studies|11|||
46997604|NCT02465567|83244346|FG002|Overall Study|enrolled in >1 studies|19|||
46997605|NCT02465567|83244347|FG003|Overall Study|enrolled in >1 studies|15|||
46997606|NCT02465567|83244344|FG000|Overall Study|missing PI Signature|1|||
46997607|NCT02465567|83244345|FG001|Overall Study|missing PI Signature|0|||
46997608|NCT02465567|83244346|FG002|Overall Study|missing PI Signature|0|||
46997609|NCT02465567|83244347|FG003|Overall Study|missing PI Signature|0|||
46997610|NCT01644175|83244359|FG000|Overall Study|Randomized But Not Treated|0|||
46997611|NCT01644175|83244360|FG001|Overall Study|Randomized But Not Treated|2|||
46997612|NCT01644175|83244359|FG000|Overall Study|Adverse Event|8|||
46997613|NCT01644175|83244360|FG001|Overall Study|Adverse Event|13|||
46997614|NCT01644175|83244359|FG000|Overall Study|Death|1|||
46997615|NCT01644175|83244360|FG001|Overall Study|Death|2|||
46997616|NCT01644175|83244359|FG000|Overall Study|Poor compliance to protocol|9|||
46997617|NCT01644175|83244360|FG001|Overall Study|Poor compliance to protocol|10|||
46997618|NCT01644175|83244359|FG000|Overall Study|Physician Decision|1|||
46997619|NCT01644175|83244360|FG001|Overall Study|Physician Decision|2|||
46997620|NCT01644175|83244359|FG000|Overall Study|Participant Moved|1|||
46997621|NCT01644175|83244360|FG001|Overall Study|Participant Moved|2|||
46997622|NCT01644175|83244359|FG000|Overall Study|Consent withdrawn by participant|3|||
46997623|NCT01644175|83244360|FG001|Overall Study|Consent withdrawn by participant|4|||
46997624|NCT01644175|83244359|FG000|Overall Study|Related to Autoinjector Administration|2|||
46997625|NCT01644175|83244360|FG001|Overall Study|Related to Autoinjector Administration|1|||
46997626|NCT01644175|83244359|FG000|Overall Study|Last visit outside protocol visit window|4|||
46997627|NCT01644175|83244360|FG001|Overall Study|Last visit outside protocol visit window|11|||
46997628|NCT01644175|83244359|FG000|Overall Study|Selection criteria finally not met|0|||
46997629|NCT01644175|83244360|FG001|Overall Study|Selection criteria finally not met|1|||
46997630|NCT01644175|83244359|FG000|Overall Study|Site closure|2|||
46997631|NCT01644175|83244360|FG001|Overall Study|Site closure|2|||
46997632|NCT01644175|83244359|FG000|Overall Study|Lost to Follow-up|1|||
46997633|NCT01644175|83244360|FG001|Overall Study|Lost to Follow-up|0|||
46997634|NCT01644175|83244359|FG000|Overall Study|Other than specified above|0|||
46997635|NCT01644175|83244360|FG001|Overall Study|Other than specified above|3|||
46997636|NCT02357420|83244370|FG000|Overall Study|Adverse Event|3|||
46997637|NCT02357420|83244371|FG001|Overall Study|Adverse Event|3|||
46997638|NCT02357420|83244372|FG002|Overall Study|Adverse Event|8|||
46997639|NCT02357420|83244373|FG003|Overall Study|Adverse Event|9|||
46997640|NCT02357420|83244370|FG000|Overall Study|Investigator Decision|1|||
46997641|NCT02357420|83244371|FG001|Overall Study|Investigator Decision|0|||
46997642|NCT02357420|83244372|FG002|Overall Study|Investigator Decision|0|||
46997643|NCT02357420|83244373|FG003|Overall Study|Investigator Decision|0|||
46997644|NCT02357420|83244370|FG000|Overall Study|Prohibited Medication|1|||
46997645|NCT02357420|83244371|FG001|Overall Study|Prohibited Medication|1|||
46997646|NCT02357420|83244372|FG002|Overall Study|Prohibited Medication|0|||
46997647|NCT02357420|83244373|FG003|Overall Study|Prohibited Medication|0|||
46997648|NCT02357420|83244370|FG000|Overall Study|Protocol Non-compliance|0|||
46997649|NCT02357420|83244371|FG001|Overall Study|Protocol Non-compliance|0|||
46997650|NCT02357420|83244372|FG002|Overall Study|Protocol Non-compliance|0|||
46997651|NCT02357420|83244373|FG003|Overall Study|Protocol Non-compliance|1|||
46997652|NCT02357420|83244370|FG000|Overall Study|Withdrawn Consent|4|||
46997653|NCT02357420|83244371|FG001|Overall Study|Withdrawn Consent|8|||
46997654|NCT02357420|83244372|FG002|Overall Study|Withdrawn Consent|6|||
46997655|NCT02357420|83244373|FG003|Overall Study|Withdrawn Consent|6|||
46997656|NCT02357420|83244370|FG000|Overall Study|Lost to Follow-up|3|||
46997657|NCT02357420|83244371|FG001|Overall Study|Lost to Follow-up|0|||
46997658|NCT02357420|83244372|FG002|Overall Study|Lost to Follow-up|2|||
46997659|NCT02357420|83244373|FG003|Overall Study|Lost to Follow-up|3|||
46997660|NCT01832038|83244383|FG000|Overall Study|Death|5|||
46997661|NCT01832038|83244383|FG000|Overall Study|Adverse Event|50|||
46997662|NCT01832038|83244383|FG000|Overall Study|Lack of Efficacy|81|||
46709196|NCT00925600|82925168|FG000|Overall Study|Lost to Follow-up|2|||
46709197|NCT00925600|82925169|FG001|Overall Study|Lost to Follow-up|2|||
46997663|NCT01832038|83244383|FG000|Overall Study|Protocol Violation|7|||
46997664|NCT01832038|83244383|FG000|Overall Study|Lost to Follow-up|10|||
46997665|NCT01832038|83244383|FG000|Overall Study|Withdrawal by Subject|49|||
46997666|NCT01832038|83244383|FG000|Overall Study|Visit non-compliance|2|||
46997667|NCT01832038|83244383|FG000|Overall Study|Subject refused to return visit|2|||
46997668|NCT01832038|83244383|FG000|Overall Study|Not convenient to come back to site|2|||
46997669|NCT01832038|83244383|FG000|Overall Study|Participant was asked to quit|5|||
46997670|NCT01832038|83244383|FG000|Overall Study|Back home|1|||
46997671|NCT01832038|83244383|FG000|Overall Study|Pregnancy|1|||
46997672|NCT01832038|83244383|FG000|Overall Study|Low compliance|3|||
46997673|NCT01832038|83244383|FG000|Overall Study|Prohibit procedure|2|||
46997674|NCT01832038|83244383|FG000|Overall Study|Not possible to visit the hospital|1|||
46997675|NCT01832038|83244383|FG000|Overall Study|Changes of implementation system|3|||
46997676|NCT01832038|83244383|FG000|Overall Study|Plan to pregnancy|7|||
46997677|NCT01832038|83244383|FG000|Overall Study|Bad mood and has suicidal thought|1|||
46997678|NCT01832038|83244383|FG000|Overall Study|Prohibited concomitant medication|1|||
46997679|NCT01832038|83244383|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
46997680|NCT01832038|83244383|FG000|Overall Study|Subject considered the efficacy was poor|1|||
46997681|NCT01849588|83244388|FG000|Overall Study|Lack of Efficacy|3|||
46997682|NCT02357342|83244394|FG000|First 6 Months|Death|2|||
46997683|NCT02357342|83244395|FG001|First 6 Months|Death|0|||
46997684|NCT02271529|83244401|FG000|Overall Study|Withdrawal by Subject|1|||
46997685|NCT02325518|83244407|FG000|Overall Study|Adverse Event|4|||
46997686|NCT02325518|83244408|FG001|Overall Study|Adverse Event|1|||
46997687|NCT02325518|83244407|FG000|Overall Study|Physician Decision|0|||
46997688|NCT02325518|83244408|FG001|Overall Study|Physician Decision|1|||
46997689|NCT02325518|83244407|FG000|Overall Study|Withdrawal by Subject|0|||
46997690|NCT02325518|83244408|FG001|Overall Study|Withdrawal by Subject|1|||
46997691|NCT02270983|83244418|FG000|Overall Study|Adverse Event|3|||
46997692|NCT02270983|83244419|FG001|Overall Study|Adverse Event|2|||
46997693|NCT02270983|83244420|FG002|Overall Study|Adverse Event|6|||
46997694|NCT02270983|83244418|FG000|Overall Study|Lack of Efficacy|2|||
46997695|NCT02270983|83244419|FG001|Overall Study|Lack of Efficacy|1|||
46997696|NCT02270983|83244420|FG002|Overall Study|Lack of Efficacy|1|||
46997697|NCT02270983|83244418|FG000|Overall Study|Withdrawal by Subject|1|||
46997698|NCT02270983|83244419|FG001|Overall Study|Withdrawal by Subject|0|||
46997699|NCT02270983|83244420|FG002|Overall Study|Withdrawal by Subject|2|||
46997700|NCT02270983|83244418|FG000|Overall Study|Lost to Follow-up|1|||
46997701|NCT02270983|83244419|FG001|Overall Study|Lost to Follow-up|1|||
46997702|NCT02270983|83244420|FG002|Overall Study|Lost to Follow-up|2|||
46997703|NCT02270983|83244418|FG000|Overall Study|Protocol Violation|1|||
46997704|NCT02270983|83244419|FG001|Overall Study|Protocol Violation|1|||
46997705|NCT02270983|83244420|FG002|Overall Study|Protocol Violation|1|||
46997706|NCT02270983|83244418|FG000|Overall Study|family emergency|0|||
46997707|NCT02270983|83244419|FG001|Overall Study|family emergency|1|||
46997708|NCT02270983|83244420|FG002|Overall Study|family emergency|0|||
46997709|NCT02270983|83244418|FG000|Overall Study|study procedure non-compliance|1|||
46997710|NCT02270983|83244419|FG001|Overall Study|study procedure non-compliance|0|||
46997711|NCT02270983|83244420|FG002|Overall Study|study procedure non-compliance|0|||
46997712|NCT02270983|83244418|FG000|Overall Study|moved away from study site|0|||
46997713|NCT02270983|83244419|FG001|Overall Study|moved away from study site|1|||
46997714|NCT02270983|83244420|FG002|Overall Study|moved away from study site|0|||
46997715|NCT02449889|83244431|FG000|Overall Study|Adverse Event|1|||
46997716|NCT02449889|83244432|FG001|Overall Study|Adverse Event|2|||
46997717|NCT02449889|83244433|FG002|Overall Study|Adverse Event|0|||
46997718|NCT02449889|83244431|FG000|Overall Study|Protocol Violation|0|||
46997719|NCT02449889|83244432|FG001|Overall Study|Protocol Violation|4|||
46997720|NCT02449889|83244433|FG002|Overall Study|Protocol Violation|1|||
46997721|NCT01831804|83244450|FG000|Overall Study|Adverse Event|0|||
46997722|NCT01831804|83244451|FG001|Overall Study|Adverse Event|0|||
46997723|NCT01831804|83244452|FG002|Overall Study|Adverse Event|0|||
46997724|NCT01831804|83244453|FG003|Overall Study|Adverse Event|0|||
46997725|NCT01831804|83244454|FG004|Overall Study|Adverse Event|0|||
46997726|NCT01831804|83244455|FG005|Overall Study|Adverse Event|0|||
46997727|NCT01831804|83244456|FG006|Overall Study|Adverse Event|1|||
46997728|NCT01831804|83244457|FG007|Overall Study|Adverse Event|0|||
46997729|NCT01831804|83244458|FG008|Overall Study|Adverse Event|1|||
46997730|NCT01831804|83244450|FG000|Overall Study|Protocol Violation|0|||
46997731|NCT01831804|83244451|FG001|Overall Study|Protocol Violation|0|||
46997732|NCT01831804|83244452|FG002|Overall Study|Protocol Violation|2|||
46997733|NCT01831804|83244453|FG003|Overall Study|Protocol Violation|0|||
46997734|NCT01831804|83244454|FG004|Overall Study|Protocol Violation|0|||
46997735|NCT01831804|83244455|FG005|Overall Study|Protocol Violation|0|||
46997736|NCT01831804|83244456|FG006|Overall Study|Protocol Violation|0|||
46997737|NCT01831804|83244457|FG007|Overall Study|Protocol Violation|0|||
46997738|NCT01831804|83244458|FG008|Overall Study|Protocol Violation|0|||
46997739|NCT01831804|83244450|FG000|Overall Study|Protocol defined stopping criteria|1|||
46997740|NCT01831804|83244451|FG001|Overall Study|Protocol defined stopping criteria|1|||
46997741|NCT01831804|83244452|FG002|Overall Study|Protocol defined stopping criteria|3|||
46997742|NCT01831804|83244453|FG003|Overall Study|Protocol defined stopping criteria|0|||
46997743|NCT01831804|83244454|FG004|Overall Study|Protocol defined stopping criteria|1|||
46997744|NCT01831804|83244455|FG005|Overall Study|Protocol defined stopping criteria|0|||
46997745|NCT01831804|83244456|FG006|Overall Study|Protocol defined stopping criteria|0|||
46997746|NCT01831804|83244457|FG007|Overall Study|Protocol defined stopping criteria|0|||
46997747|NCT01831804|83244458|FG008|Overall Study|Protocol defined stopping criteria|0|||
46997748|NCT01831804|83244450|FG000|Overall Study|Lost to Follow-up|0|||
46997749|NCT01831804|83244451|FG001|Overall Study|Lost to Follow-up|0|||
46997750|NCT01831804|83244452|FG002|Overall Study|Lost to Follow-up|1|||
46997751|NCT01831804|83244453|FG003|Overall Study|Lost to Follow-up|0|||
46997752|NCT01831804|83244454|FG004|Overall Study|Lost to Follow-up|0|||
46997753|NCT01831804|83244455|FG005|Overall Study|Lost to Follow-up|0|||
46997754|NCT01831804|83244456|FG006|Overall Study|Lost to Follow-up|0|||
46997755|NCT01831804|83244457|FG007|Overall Study|Lost to Follow-up|0|||
46997756|NCT01831804|83244458|FG008|Overall Study|Lost to Follow-up|1|||
46997757|NCT01831804|83244450|FG000|Overall Study|Investigator discretion|0|||
46997758|NCT01831804|83244451|FG001|Overall Study|Investigator discretion|0|||
46997759|NCT01831804|83244452|FG002|Overall Study|Investigator discretion|0|||
46997760|NCT01831804|83244453|FG003|Overall Study|Investigator discretion|0|||
46997761|NCT01831804|83244454|FG004|Overall Study|Investigator discretion|1|||
46997762|NCT01831804|83244455|FG005|Overall Study|Investigator discretion|0|||
46997763|NCT01831804|83244456|FG006|Overall Study|Investigator discretion|0|||
46997764|NCT01831804|83244457|FG007|Overall Study|Investigator discretion|1|||
46997765|NCT01831804|83244458|FG008|Overall Study|Investigator discretion|0|||
46997766|NCT01831804|83244450|FG000|Overall Study|Withdrew Consent|0|||
46997767|NCT01831804|83244451|FG001|Overall Study|Withdrew Consent|1|||
46997768|NCT01831804|83244452|FG002|Overall Study|Withdrew Consent|0|||
46997769|NCT01831804|83244453|FG003|Overall Study|Withdrew Consent|0|||
46997770|NCT01831804|83244454|FG004|Overall Study|Withdrew Consent|0|||
46997771|NCT01831804|83244455|FG005|Overall Study|Withdrew Consent|0|||
46997772|NCT01831804|83244456|FG006|Overall Study|Withdrew Consent|0|||
46997773|NCT01831804|83244457|FG007|Overall Study|Withdrew Consent|2|||
46997774|NCT01831804|83244458|FG008|Overall Study|Withdrew Consent|0|||
46997775|NCT02270671|83244489|FG000|Overall Study|Withdrawal by Subject|1|||
46997776|NCT02270671|83244490|FG001|Overall Study|Withdrawal by Subject|1|||
46997777|NCT02270671|83244489|FG000|Overall Study|Protocol Violation|0|||
46997778|NCT02270671|83244490|FG001|Overall Study|Protocol Violation|1|||
46997779|NCT02270671|83244489|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
46997780|NCT02270671|83244490|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
46997781|NCT02270671|83244489|FG000|Overall Study|Lost to Follow-up|2|||
46997782|NCT02270671|83244490|FG001|Overall Study|Lost to Follow-up|1|||
46997783|NCT02324270|83244499|FG000|Overall Study|Withdrawal by Subject|0|||
46997784|NCT02324270|83244500|FG001|Overall Study|Withdrawal by Subject|1|||
46997785|NCT02324270|83244501|FG002|Overall Study|Withdrawal by Subject|0|||
46997786|NCT02324270|83244499|FG000|Overall Study|Lost to Follow-up|4|||
46997787|NCT02324270|83244500|FG001|Overall Study|Lost to Follow-up|3|||
46997788|NCT02324270|83244501|FG002|Overall Study|Lost to Follow-up|4|||
46997789|NCT02324270|83244499|FG000|Overall Study|Protocol Violation|0|||
46997790|NCT02324270|83244500|FG001|Overall Study|Protocol Violation|1|||
46997791|NCT02324270|83244501|FG002|Overall Study|Protocol Violation|1|||
46997792|NCT02324270|83244499|FG000|Overall Study|Non Compliance with Study Drug|1|||
46997793|NCT02324270|83244500|FG001|Overall Study|Non Compliance with Study Drug|2|||
46997794|NCT02324270|83244501|FG002|Overall Study|Non Compliance with Study Drug|0|||
46997795|NCT02270515|83244509|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
46997796|NCT02270515|83244509|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
46997797|NCT02270515|83244509|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
46997798|NCT02270515|83244509|FG000|Intervention Period 1: 0-6 Months|Death|7|||
46997799|NCT02270515|83244509|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
46906974|NCT03525119|83135855|FG002|Overall Study|Randomized but not Vaccinated|2|||
46906975|NCT03558503|83135863|FG000|Overall Study|Adverse Event|1|||
46906976|NCT03558503|83135863|FG000|Overall Study|Death|1|||
46906977|NCT03558503|83135863|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
46906978|NCT03489863|83135869|FG000|Overall Study|Withdrawal by Subject|0|||
46906979|NCT03489863|83135870|FG001|Overall Study|Withdrawal by Subject|1|||
46997800|NCT02270515|83244509|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
46997801|NCT02270515|83244509|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
46997802|NCT02270515|83244509|FG000|Intervention Period 2: 6-12 Months|Death|5|||
46997803|NCT02270515|83244509|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
46997804|NCT02270515|83244509|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
46997805|NCT02270515|83244509|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
46997806|NCT02270515|83244509|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
46997807|NCT02270515|83244509|FG000|Intervention Period 3: 12-18 Months|Death|3|||
46906980|NCT03489551|83135876|FG000|Overall Study|Withdrawal by Subject|2|||
46906981|NCT03557801|83135883|FG000|Overall Study|Protocol Violation|1|||
46997808|NCT02270515|83244509|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
46997809|NCT02448875|83244523|FG000|Overall Study|Adverse Event|2|||
46997810|NCT02448875|83244524|FG001|Overall Study|Adverse Event|1|||
46997811|NCT02448875|83244525|FG002|Overall Study|Adverse Event|0|||
46997812|NCT02448875|83244523|FG000|Overall Study|Lost to Follow-up|1|||
46997813|NCT02448875|83244524|FG001|Overall Study|Lost to Follow-up|0|||
46997814|NCT02448875|83244525|FG002|Overall Study|Lost to Follow-up|0|||
46997815|NCT02448875|83244523|FG000|Overall Study|Investigator Decision|3|||
46709198|NCT00925600|82925168|FG000|Overall Study|Disease Progression|1|||
46906982|NCT03557801|83135884|FG001|Overall Study|Protocol Violation|0|||
46906983|NCT03557801|83135885|FG002|Overall Study|Protocol Violation|0|||
46906984|NCT03557801|83135883|FG000|Overall Study|Withdrawal by Subject|1|||
46906985|NCT03557801|83135884|FG001|Overall Study|Withdrawal by Subject|0|||
46906986|NCT03557801|83135885|FG002|Overall Study|Withdrawal by Subject|3|||
46906987|NCT03557801|83135883|FG000|Overall Study|Lost to Follow-up|0|||
46906988|NCT03557801|83135884|FG001|Overall Study|Lost to Follow-up|1|||
46906989|NCT03557801|83135885|FG002|Overall Study|Lost to Follow-up|0|||
46906990|NCT04210180|83135893|FG000|Overall Study|Withdrawal by Subject|2|||
46906991|NCT03523871|83135897|FG000|Overall Study|Death|1|||
46906992|NCT03523715|83135903|FG000|Overall Study|Lost to Follow-up|11|||
46906993|NCT03523715|83135904|FG001|Overall Study|Lost to Follow-up|14|||
46906994|NCT03523715|83135903|FG000|Overall Study|Did not meet inclusion criteria|1|||
46906995|NCT03523715|83135904|FG001|Overall Study|Did not meet inclusion criteria|0|||
46906996|NCT03523715|83135903|FG000|Overall Study|Internally inconsistent reporting|0|||
46906997|NCT03523715|83135904|FG001|Overall Study|Internally inconsistent reporting|2|||
46906998|NCT03980730|83135912|FG000|Overall Study|Study Terminated by Sponsor|0|||
46906999|NCT03980730|83135913|FG001|Overall Study|Study Terminated by Sponsor|3|||
46907000|NCT03980730|83135912|FG000|Overall Study|Adverse Event|2|||
46907001|NCT03980730|83135913|FG001|Overall Study|Adverse Event|0|||
46907002|NCT03980730|83135912|FG000|Overall Study|Sponsor Request|0|||
46907003|NCT03980730|83135913|FG001|Overall Study|Sponsor Request|1|||
46907004|NCT03523091|83135921|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
46907005|NCT03523091|83135922|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
46907006|NCT03523091|83135921|FG000|Overall Study|Withdrawal by Subject|0|||
46907007|NCT03523091|83135922|FG001|Overall Study|Withdrawal by Subject|3|||
46907008|NCT03523091|83135921|FG000|Overall Study|Increase Botox dose|0|||
46907009|NCT03523091|83135922|FG001|Overall Study|Increase Botox dose|1|||
46907010|NCT03438383|83135943|FG000|Overall Study|Protocol Violation|9|||
46907011|NCT03438383|83135944|FG001|Overall Study|Protocol Violation|3|||
46907012|NCT03478787|83135952|FG000|Overall Study|Adverse Event|5|||
46907013|NCT03478787|83135953|FG001|Overall Study|Adverse Event|1|||
46907014|NCT03478787|83135952|FG000|Overall Study|Protocol Violation|3|||
46907015|NCT03478787|83135953|FG001|Overall Study|Protocol Violation|0|||
46907016|NCT03478787|83135952|FG000|Overall Study|Lack of Efficacy|7|||
46907017|NCT03478787|83135953|FG001|Overall Study|Lack of Efficacy|1|||
46907018|NCT03478787|83135952|FG000|Overall Study|Lost to Follow-up|9|||
46907019|NCT03478787|83135953|FG001|Overall Study|Lost to Follow-up|5|||
46907020|NCT03478787|83135952|FG000|Overall Study|Withdrawal by Subject|2|||
46907021|NCT03478787|83135953|FG001|Overall Study|Withdrawal by Subject|6|||
46907022|NCT03478787|83135952|FG000|Overall Study|Other, Not Specified|3|||
46907023|NCT03478787|83135953|FG001|Overall Study|Other, Not Specified|0|||
46907024|NCT03488927|83135962|FG000|Overall Study|Withdrawal by Subject|44|||
46907025|NCT03488927|83135963|FG001|Overall Study|Withdrawal by Subject|118|||
46907026|NCT03488927|83135964|FG002|Overall Study|Withdrawal by Subject|217|||
46907027|NCT03437447|83135975|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46907028|NCT03437447|83135976|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46907029|NCT03437447|83135977|FG002|Treatment Period 1|Withdrawal by Subject|1|||
46907030|NCT03487445|83136000|FG000|Randomization|Not treated for administrative reasons|1|||
46907031|NCT03487445|83136001|FG001|Randomization|Not treated for administrative reasons|0|||
46907032|NCT02109172|83136007|FG000|Overall Study|Withdrawal by Subject|1|||
46907033|NCT02109172|83136008|FG001|Overall Study|Withdrawal by Subject|0|||
46997816|NCT02448875|83244524|FG001|Overall Study|Investigator Decision|0|||
46997817|NCT02448875|83244525|FG002|Overall Study|Investigator Decision|1|||
46997818|NCT02448875|83244523|FG000|Overall Study|Withdrawal by Subject|1|||
46997819|NCT02448875|83244524|FG001|Overall Study|Withdrawal by Subject|0|||
46907034|NCT02109172|83136009|FG002|Overall Study|Withdrawal by Subject|0|||
46907035|NCT02109172|83136010|FG003|Overall Study|Withdrawal by Subject|1|||
46907036|NCT02109172|83136011|FG004|Overall Study|Withdrawal by Subject|0|||
46907037|NCT02109172|83136012|FG005|Overall Study|Withdrawal by Subject|0|||
46907038|NCT02109172|83136007|FG000|Overall Study|Adverse Event|0|||
46907039|NCT02109172|83136008|FG001|Overall Study|Adverse Event|0|||
46997820|NCT02448875|83244525|FG002|Overall Study|Withdrawal by Subject|0|||
46997821|NCT01831726|83244536|FG000|Overall Study|Adverse Event|16|||
46907040|NCT02109172|83136009|FG002|Overall Study|Adverse Event|1|||
46907041|NCT02109172|83136010|FG003|Overall Study|Adverse Event|0|||
46907042|NCT02109172|83136011|FG004|Overall Study|Adverse Event|0|||
46907043|NCT02109172|83136012|FG005|Overall Study|Adverse Event|1|||
46907044|NCT02109172|83136007|FG000|Overall Study|Death|0|||
46907045|NCT02109172|83136008|FG001|Overall Study|Death|0|||
46997822|NCT01831726|83244536|FG000|Overall Study|Death|7|||
46997823|NCT01831726|83244536|FG000|Overall Study|Disease Progression|49|||
46997824|NCT01831726|83244536|FG000|Overall Study|Physician Decision|1|||
46997825|NCT01831726|83244536|FG000|Overall Study|Subject/guardian decision|7|||
46997826|NCT01831258|83244540|FG000|Overall Study|Withdrawal by Subject|2|||
46997827|NCT01831258|83244541|FG001|Overall Study|Withdrawal by Subject|1|||
46997828|NCT01831258|83244540|FG000|Overall Study|Lost to Follow-up|3|||
46997829|NCT01831258|83244541|FG001|Overall Study|Lost to Follow-up|2|||
46997830|NCT01849276|83244549|FG000|Followed for Survival for 5 Years|Death|1|||
46997831|NCT01849276|83244549|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
46997832|NCT02465489|83244553|FG000|Overall Study|Adverse Event|5|||
46997833|NCT01829464|83244568|FG000|Overall Study|Adverse Event|1|||
46997834|NCT01829464|83244569|FG001|Overall Study|Adverse Event|0|||
46997835|NCT01829464|83244570|FG002|Overall Study|Adverse Event|0|||
46997836|NCT01829464|83244568|FG000|Overall Study|Lost to Follow-up|0|||
46997837|NCT01829464|83244569|FG001|Overall Study|Lost to Follow-up|0|||
46997838|NCT01829464|83244570|FG002|Overall Study|Lost to Follow-up|1|||
46997839|NCT01829464|83244568|FG000|Overall Study|Withdrawal by Subject|2|||
46997840|NCT01829464|83244569|FG001|Overall Study|Withdrawal by Subject|0|||
46997841|NCT01829464|83244570|FG002|Overall Study|Withdrawal by Subject|0|||
46997842|NCT01829464|83244568|FG000|Overall Study|Study terminated by sponsor|25|||
46997843|NCT01829464|83244569|FG001|Overall Study|Study terminated by sponsor|28|||
46997844|NCT01829464|83244570|FG002|Overall Study|Study terminated by sponsor|25|||
46997845|NCT01829464|83244568|FG000|Overall Study|Lack of Efficacy|0|||
46997846|NCT01829464|83244569|FG001|Overall Study|Lack of Efficacy|1|||
46997847|NCT01829464|83244570|FG002|Overall Study|Lack of Efficacy|0|||
46997848|NCT01847092|83244580|FG000|Overall Study|Adverse Event|12|||
46997849|NCT01847092|83244581|FG001|Overall Study|Adverse Event|3|||
46997850|NCT01847092|83244580|FG000|Overall Study|Withdrawal by Subject|5|||
46997851|NCT01847092|83244581|FG001|Overall Study|Withdrawal by Subject|5|||
46997852|NCT01847092|83244580|FG000|Overall Study|Protocol Specified|8|||
46997853|NCT01847092|83244581|FG001|Overall Study|Protocol Specified|0|||
46997854|NCT01847092|83244580|FG000|Overall Study|Physician Decision|1|||
46997855|NCT01847092|83244581|FG001|Overall Study|Physician Decision|1|||
46997856|NCT01847092|83244580|FG000|Overall Study|Protocol Violation|0|||
46997857|NCT01847092|83244581|FG001|Overall Study|Protocol Violation|2|||
46997858|NCT01601821|83244589|FG000|Overall Study|Death|2|||
46997859|NCT01601821|83244590|FG001|Overall Study|Death|5|||
46997860|NCT01601821|83244589|FG000|Overall Study|Protocol Violation|2|||
46997861|NCT01601821|83244590|FG001|Overall Study|Protocol Violation|2|||
46997862|NCT01601821|83244589|FG000|Overall Study|Lost to Follow-up|6|||
46997863|NCT01601821|83244590|FG001|Overall Study|Lost to Follow-up|14|||
46997864|NCT01601821|83244589|FG000|Overall Study|Withdrawal by Subject|1|||
46997865|NCT01601821|83244590|FG001|Overall Study|Withdrawal by Subject|0|||
46997866|NCT01601821|83244589|FG000|Overall Study|Graft Loss|6|||
46997867|NCT01601821|83244590|FG001|Overall Study|Graft Loss|6|||
46997868|NCT01601821|83244589|FG000|Overall Study|Study Events|7|||
46997869|NCT01601821|83244590|FG001|Overall Study|Study Events|1|||
46997870|NCT01601821|83244589|FG000|Overall Study|Other|5|||
46907046|NCT02109172|83136009|FG002|Overall Study|Death|0|||
46907047|NCT02109172|83136010|FG003|Overall Study|Death|0|||
46907048|NCT02109172|83136011|FG004|Overall Study|Death|1|||
46907049|NCT02109172|83136012|FG005|Overall Study|Death|0|||
46907050|NCT02974868|83136023|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
46907051|NCT02974868|83136024|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
46907052|NCT02974868|83136025|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
46907053|NCT02974868|83136026|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
46907054|NCT02974868|83136023|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
46907055|NCT02974868|83136024|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
46907056|NCT02974868|83136025|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
46907057|NCT02974868|83136026|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
46907058|NCT02974868|83136023|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
46907059|NCT02974868|83136024|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
46907060|NCT02974868|83136025|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
46907061|NCT02974868|83136026|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
46907062|NCT02974868|83136023|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
46907063|NCT02974868|83136024|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
46907064|NCT02974868|83136025|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
46997871|NCT01601821|83244590|FG001|Overall Study|Other|1|||
46997872|NCT02323646|83244599|FG000|Treatment Course 1|Adverse Event|1|||
46997873|NCT02323646|83244600|FG001|Treatment Course 1|Adverse Event|0|||
46997874|NCT02323646|83244601|FG002|Treatment Course 1|Adverse Event|1|||
46997875|NCT02323646|83244599|FG000|Treatment Course 1|Heavy Bleeding|1|||
46997876|NCT02323646|83244600|FG001|Treatment Course 1|Heavy Bleeding|1|||
46997877|NCT02323646|83244601|FG002|Treatment Course 1|Heavy Bleeding|0|||
46907065|NCT02974868|83136026|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
46907066|NCT03486899|83136071|FG000|Overall Study|Lost to Follow-up|4|||
46907067|NCT03486899|83136072|FG001|Overall Study|Lost to Follow-up|1|||
46907068|NCT03486899|83136073|FG002|Overall Study|Lost to Follow-up|4|||
46907069|NCT03486899|83136074|FG003|Overall Study|Lost to Follow-up|3|||
46907070|NCT03486899|83136071|FG000|Overall Study|Death|1|||
46907071|NCT03486899|83136072|FG001|Overall Study|Death|0|||
46907072|NCT03486899|83136073|FG002|Overall Study|Death|0|||
46907073|NCT03486899|83136074|FG003|Overall Study|Death|1|||
46907074|NCT03486899|83136071|FG000|Overall Study|Adverse Event|0|||
46907075|NCT03486899|83136072|FG001|Overall Study|Adverse Event|2|||
46907076|NCT03486899|83136073|FG002|Overall Study|Adverse Event|0|||
46907077|NCT03486899|83136074|FG003|Overall Study|Adverse Event|2|||
46907078|NCT03486899|83136071|FG000|Overall Study|Withdrawal by Subject|3|||
46907079|NCT03486899|83136072|FG001|Overall Study|Withdrawal by Subject|7|||
46907080|NCT03486899|83136073|FG002|Overall Study|Withdrawal by Subject|4|||
46907081|NCT03486899|83136074|FG003|Overall Study|Withdrawal by Subject|3|||
46907082|NCT03486899|83136071|FG000|Overall Study|Other Reasons|0|||
46907083|NCT03486899|83136072|FG001|Overall Study|Other Reasons|1|||
46907084|NCT03486899|83136073|FG002|Overall Study|Other Reasons|0|||
46907085|NCT03486899|83136074|FG003|Overall Study|Other Reasons|1|||
46907086|NCT02918552|83136086|FG000|Overall Study|Failed Pharmacokinetics|1|||
46907087|NCT02918552|83136087|FG001|Overall Study|Failed Pharmacokinetics|0|||
46907088|NCT02918552|83136086|FG000|Overall Study|Withdrawal by Subject|0|||
46907089|NCT02918552|83136087|FG001|Overall Study|Withdrawal by Subject|1|||
46907090|NCT02918552|83136086|FG000|Overall Study|Lost to Follow-up|0|||
46907091|NCT02918552|83136087|FG001|Overall Study|Lost to Follow-up|1|||
46907092|NCT03485495|83136095|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
46907093|NCT03485495|83136096|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
46907094|NCT01065818|83136102|FG000|Overall Study|Withdrawal by Subject|1|||
46907095|NCT01065818|83136102|FG000|Overall Study|Not a candidate for surgery|1|||
46907096|NCT03483623|83136106|FG000|Overall Study|43 complete sets achieved|1|||
46907097|NCT02318277|83136118|FG000|Overall Study|Physician Decision|0|||
46907098|NCT02318277|83136119|FG001|Overall Study|Physician Decision|0|||
46907099|NCT02318277|83136120|FG002|Overall Study|Physician Decision|0|||
46907100|NCT02318277|83136121|FG003|Overall Study|Physician Decision|0|||
46907101|NCT02318277|83136122|FG004|Overall Study|Physician Decision|0|||
46907102|NCT02318277|83136123|FG005|Overall Study|Physician Decision|0|||
46907103|NCT02318277|83136124|FG006|Overall Study|Physician Decision|0|||
46907104|NCT02318277|83136125|FG007|Overall Study|Physician Decision|1|||
46907105|NCT02318277|83136118|FG000|Overall Study|Other|0|||
46907106|NCT02318277|83136119|FG001|Overall Study|Other|0|||
46907107|NCT02318277|83136120|FG002|Overall Study|Other|0|||
46907108|NCT02318277|83136121|FG003|Overall Study|Other|0|||
46907109|NCT02318277|83136122|FG004|Overall Study|Other|0|||
46907110|NCT02318277|83136123|FG005|Overall Study|Other|0|||
46907111|NCT02318277|83136124|FG006|Overall Study|Other|1|||
46907112|NCT02318277|83136125|FG007|Overall Study|Other|0|||
46907113|NCT02318277|83136118|FG000|Overall Study|Withdrawal by Subject|0|||
46907114|NCT02318277|83136119|FG001|Overall Study|Withdrawal by Subject|0|||
46907115|NCT02318277|83136120|FG002|Overall Study|Withdrawal by Subject|1|||
46907116|NCT02318277|83136121|FG003|Overall Study|Withdrawal by Subject|0|||
46907117|NCT02318277|83136122|FG004|Overall Study|Withdrawal by Subject|1|||
46907118|NCT02318277|83136123|FG005|Overall Study|Withdrawal by Subject|1|||
46907119|NCT02318277|83136124|FG006|Overall Study|Withdrawal by Subject|6|||
46907120|NCT02318277|83136125|FG007|Overall Study|Withdrawal by Subject|14|||
46907121|NCT02318277|83136118|FG000|Overall Study|Participant trial terminated by sponsor|0|||
46907122|NCT02318277|83136119|FG001|Overall Study|Participant trial terminated by sponsor|0|||
46907123|NCT02318277|83136120|FG002|Overall Study|Participant trial terminated by sponsor|1|||
46907124|NCT02318277|83136121|FG003|Overall Study|Participant trial terminated by sponsor|0|||
46907125|NCT02318277|83136122|FG004|Overall Study|Participant trial terminated by sponsor|1|||
46907126|NCT02318277|83136123|FG005|Overall Study|Participant trial terminated by sponsor|2|||
46907127|NCT02318277|83136124|FG006|Overall Study|Participant trial terminated by sponsor|5|||
46907128|NCT02318277|83136125|FG007|Overall Study|Participant trial terminated by sponsor|16|||
46907129|NCT02318277|83136118|FG000|Overall Study|Lost to Follow-up|1|||
46907130|NCT02318277|83136119|FG001|Overall Study|Lost to Follow-up|0|||
46907131|NCT02318277|83136120|FG002|Overall Study|Lost to Follow-up|1|||
46997878|NCT02323646|83244599|FG000|Treatment Course 1|Lost to Follow-up|1|||
46907132|NCT02318277|83136121|FG003|Overall Study|Lost to Follow-up|0|||
46907133|NCT02318277|83136122|FG004|Overall Study|Lost to Follow-up|0|||
46907134|NCT02318277|83136123|FG005|Overall Study|Lost to Follow-up|0|||
46907135|NCT02318277|83136124|FG006|Overall Study|Lost to Follow-up|3|||
46907136|NCT02318277|83136125|FG007|Overall Study|Lost to Follow-up|4|||
46907137|NCT02318277|83136118|FG000|Overall Study|Death|5|||
46907138|NCT02318277|83136119|FG001|Overall Study|Death|3|||
46907139|NCT02318277|83136120|FG002|Overall Study|Death|1|||
46907140|NCT02318277|83136121|FG003|Overall Study|Death|4|||
46997879|NCT02323646|83244600|FG001|Treatment Course 1|Lost to Follow-up|0|||
46997880|NCT02323646|83244601|FG002|Treatment Course 1|Lost to Follow-up|2|||
46997881|NCT02323646|83244599|FG000|Treatment Course 1|Withdrawal by Subject|0|||
46997882|NCT02323646|83244600|FG001|Treatment Course 1|Withdrawal by Subject|2|||
46997883|NCT02323646|83244601|FG002|Treatment Course 1|Withdrawal by Subject|0|||
46997884|NCT02323646|83244599|FG000|Treatment Course 2|Adverse Event|1|||
46997885|NCT02323646|83244600|FG001|Treatment Course 2|Adverse Event|0|||
46997886|NCT02323646|83244601|FG002|Treatment Course 2|Adverse Event|1|||
46997887|NCT02323646|83244599|FG000|Treatment Course 2|Lost to Follow-up|0|||
46997888|NCT02323646|83244600|FG001|Treatment Course 2|Lost to Follow-up|0|||
46997889|NCT02323646|83244601|FG002|Treatment Course 2|Lost to Follow-up|1|||
46997890|NCT02323646|83244599|FG000|Treatment Course 2|Non-compliance|0|||
46997891|NCT02323646|83244600|FG001|Treatment Course 2|Non-compliance|1|||
46997892|NCT02323646|83244601|FG002|Treatment Course 2|Non-compliance|1|||
46997893|NCT01846624|83244609|FG000|Overall Study|Died during induction, no midostaurin|1|||
46997894|NCT01829230|83244615|FG000|Overall Study|Protocol Violation|0|||
46997895|NCT01829230|83244616|FG001|Overall Study|Protocol Violation|2|||
46997896|NCT01829230|83244615|FG000|Overall Study|Withdrawal by Subject|0|||
46997897|NCT01829230|83244616|FG001|Overall Study|Withdrawal by Subject|1|||
46997898|NCT01829230|83244615|FG000|Overall Study|Lost to Follow-up|1|||
46997899|NCT01829230|83244616|FG001|Overall Study|Lost to Follow-up|1|||
46997900|NCT02269657|83244622|FG000|Overall Study|Protocol Violation|3|||
46997901|NCT02269423|83244632|FG000|Overall Study|Discontinued due to change in residence|0|||
46997902|NCT02269423|83244633|FG001|Overall Study|Discontinued due to change in residence|1|||
46997903|NCT02269423|83244634|FG002|Overall Study|Discontinued due to change in residence|0|||
46997904|NCT02269423|83244635|FG003|Overall Study|Discontinued due to change in residence|1|||
46997905|NCT01827670|83244647|FG000|Overall Study|Withdrawal of Consent|3|||
46997906|NCT01827670|83244648|FG001|Overall Study|Withdrawal of Consent|2|||
46997907|NCT01827670|83244647|FG000|Overall Study|Lost to Follow-up|0|||
46997908|NCT01827670|83244648|FG001|Overall Study|Lost to Follow-up|1|||
46997909|NCT02267317|83244662|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
46997910|NCT02267317|83244663|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
46997911|NCT02267317|83244664|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
46997912|NCT02267317|83244665|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
46997913|NCT02267317|83244666|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
46997914|NCT02267317|83244667|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
46997915|NCT02267317|83244662|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
46997916|NCT02267317|83244663|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
46997917|NCT02267317|83244664|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
46997918|NCT02267317|83244665|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
46997919|NCT02267317|83244666|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
46997920|NCT02267317|83244667|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
46997921|NCT01844830|83244683|FG000|Overall Study|Withdrawal by Subject|1|||
46997922|NCT01844830|83244684|FG001|Overall Study|Withdrawal by Subject|0|||
46997923|NCT01827592|83244693|FG000|Overall Study|Adverse Event|11|||
46997924|NCT01827592|83244694|FG001|Overall Study|Adverse Event|9|||
46997925|NCT01827592|83244695|FG002|Overall Study|Adverse Event|2|||
46997926|NCT01827592|83244693|FG000|Overall Study|Physician Decision|0|||
46997927|NCT01827592|83244694|FG001|Overall Study|Physician Decision|2|||
46997928|NCT01827592|83244695|FG002|Overall Study|Physician Decision|1|||
46997929|NCT01827592|83244693|FG000|Overall Study|Protocol Violation|2|||
46997930|NCT01827592|83244694|FG001|Overall Study|Protocol Violation|1|||
46997931|NCT01827592|83244695|FG002|Overall Study|Protocol Violation|0|||
46997932|NCT01827592|83244693|FG000|Overall Study|Lost to Follow-up|1|||
46997933|NCT01827592|83244694|FG001|Overall Study|Lost to Follow-up|2|||
46997934|NCT01827592|83244695|FG002|Overall Study|Lost to Follow-up|2|||
46997935|NCT01827592|83244693|FG000|Overall Study|Withdrawal by Subject|12|||
46997936|NCT01827592|83244694|FG001|Overall Study|Withdrawal by Subject|11|||
46997937|NCT01827592|83244695|FG002|Overall Study|Withdrawal by Subject|11|||
46997938|NCT01827592|83244693|FG000|Overall Study|Patient's substantial non-compliance|1|||
46997939|NCT01827592|83244694|FG001|Overall Study|Patient's substantial non-compliance|1|||
46997940|NCT01827592|83244695|FG002|Overall Study|Patient's substantial non-compliance|6|||
46997941|NCT01827592|83244693|FG000|Overall Study|Trial terminated by Sponsor|47|||
46997942|NCT01827592|83244694|FG001|Overall Study|Trial terminated by Sponsor|53|||
46997943|NCT01827592|83244695|FG002|Overall Study|Trial terminated by Sponsor|51|||
46997944|NCT01827592|83244693|FG000|Overall Study|Others|0|||
46997945|NCT01827592|83244694|FG001|Overall Study|Others|1|||
46997946|NCT01827592|83244695|FG002|Overall Study|Others|3|||
46997947|NCT02323334|83244713|FG000|Period 3|Lost to Follow-up|0|||
46997948|NCT02323334|83244714|FG001|Period 3|Lost to Follow-up|0|||
46997949|NCT02323334|83244715|FG002|Period 3|Lost to Follow-up|1|||
46997950|NCT02323334|83244716|FG003|Period 3|Lost to Follow-up|0|||
46997951|NCT02323334|83244717|FG004|Period 3|Lost to Follow-up|0|||
46997952|NCT02323334|83244718|FG005|Period 3|Lost to Follow-up|0|||
46997953|NCT02323334|83244719|FG006|Period 3|Lost to Follow-up|0|||
46997954|NCT02323334|83244720|FG007|Period 3|Lost to Follow-up|0|||
46997955|NCT02323334|83244721|FG008|Period 3|Lost to Follow-up|0|||
46997956|NCT02323334|83244722|FG009|Period 3|Lost to Follow-up|0|||
46997957|NCT02323334|83244723|FG010|Period 3|Lost to Follow-up|0|||
46997958|NCT02323334|83244724|FG011|Period 3|Lost to Follow-up|0|||
46997959|NCT02323334|83244725|FG012|Period 3|Lost to Follow-up|0|||
46997960|NCT02323334|83244726|FG013|Period 3|Lost to Follow-up|0|||
46997961|NCT02323334|83244727|FG014|Period 3|Lost to Follow-up|0|||
46997962|NCT02323334|83244728|FG015|Period 3|Lost to Follow-up|0|||
46997963|NCT02323334|83244729|FG016|Period 3|Lost to Follow-up|0|||
46997964|NCT02323334|83244713|FG000|Period 3|Withdrawal by Subject|1|||
46997965|NCT02323334|83244714|FG001|Period 3|Withdrawal by Subject|0|||
46997966|NCT02323334|83244715|FG002|Period 3|Withdrawal by Subject|0|||
46997967|NCT02323334|83244716|FG003|Period 3|Withdrawal by Subject|0|||
46997968|NCT02323334|83244717|FG004|Period 3|Withdrawal by Subject|0|||
46997969|NCT02323334|83244718|FG005|Period 3|Withdrawal by Subject|0|||
46997970|NCT02323334|83244719|FG006|Period 3|Withdrawal by Subject|0|||
46997971|NCT02323334|83244720|FG007|Period 3|Withdrawal by Subject|0|||
46997972|NCT02323334|83244721|FG008|Period 3|Withdrawal by Subject|0|||
46997973|NCT02323334|83244722|FG009|Period 3|Withdrawal by Subject|0|||
46997974|NCT02323334|83244723|FG010|Period 3|Withdrawal by Subject|0|||
46997975|NCT02323334|83244724|FG011|Period 3|Withdrawal by Subject|0|||
46997976|NCT02323334|83244725|FG012|Period 3|Withdrawal by Subject|0|||
46997977|NCT02323334|83244726|FG013|Period 3|Withdrawal by Subject|0|||
46997978|NCT02323334|83244727|FG014|Period 3|Withdrawal by Subject|0|||
46997979|NCT02323334|83244728|FG015|Period 3|Withdrawal by Subject|0|||
46997980|NCT02323334|83244729|FG016|Period 3|Withdrawal by Subject|0|||
46997981|NCT02448719|83244802|FG000|Overall Study|Withdrawal by Subject|0|||
46997982|NCT02448719|83244803|FG001|Overall Study|Withdrawal by Subject|0|||
46997983|NCT02448719|83244804|FG002|Overall Study|Withdrawal by Subject|0|||
46997984|NCT02448719|83244805|FG003|Overall Study|Withdrawal by Subject|0|||
46997985|NCT02448719|83244806|FG004|Overall Study|Withdrawal by Subject|1|||
46997986|NCT02448719|83244807|FG005|Overall Study|Withdrawal by Subject|0|||
46997987|NCT02448719|83244808|FG006|Overall Study|Withdrawal by Subject|0|||
46997988|NCT02448719|83244809|FG007|Overall Study|Withdrawal by Subject|0|||
46997989|NCT02448719|83244810|FG008|Overall Study|Withdrawal by Subject|0|||
46997990|NCT02448719|83244811|FG009|Overall Study|Withdrawal by Subject|0|||
46997991|NCT02448719|83244812|FG010|Overall Study|Withdrawal by Subject|0|||
46997992|NCT02322866|83244875|FG000|Overall Study|Adverse Event|6|||
46997993|NCT02322866|83244876|FG001|Overall Study|Adverse Event|11|||
46997994|NCT02322866|83244875|FG000|Overall Study|Withdrawal of Consent|16|||
46997995|NCT02322866|83244876|FG001|Overall Study|Withdrawal of Consent|25|||
46997996|NCT02322866|83244875|FG000|Overall Study|Lost to Follow-up|36|||
46997997|NCT02322866|83244876|FG001|Overall Study|Lost to Follow-up|39|||
46997998|NCT02322866|83244875|FG000|Overall Study|Protocol Violation|1|||
46907141|NCT02318277|83136122|FG004|Overall Study|Death|6|||
46907142|NCT02318277|83136123|FG005|Overall Study|Death|5|||
46907143|NCT02318277|83136124|FG006|Overall Study|Death|34|||
46907144|NCT02318277|83136125|FG007|Overall Study|Death|58|||
46907145|NCT02318277|83136118|FG000|Overall Study|Transitioned to Hospice|0|||
46907146|NCT02318277|83136119|FG001|Overall Study|Transitioned to Hospice|0|||
46907147|NCT02318277|83136120|FG002|Overall Study|Transitioned to Hospice|0|||
46907148|NCT02318277|83136121|FG003|Overall Study|Transitioned to Hospice|0|||
46907149|NCT02318277|83136122|FG004|Overall Study|Transitioned to Hospice|0|||
46907150|NCT02318277|83136123|FG005|Overall Study|Transitioned to Hospice|1|||
46907151|NCT02318277|83136124|FG006|Overall Study|Transitioned to Hospice|0|||
46907152|NCT02318277|83136125|FG007|Overall Study|Transitioned to Hospice|0|||
46907153|NCT01063868|83136170|FG000|Overall Study|Adverse Event|9|||
46907154|NCT01063868|83136171|FG001|Overall Study|Adverse Event|7|||
46907155|NCT01063868|83136170|FG000|Overall Study|Withdrawal by Subject|3|||
46907156|NCT01063868|83136171|FG001|Overall Study|Withdrawal by Subject|1|||
46907157|NCT01063868|83136170|FG000|Overall Study|Study Terminated By Sponsor|23|||
46907158|NCT01063868|83136171|FG001|Overall Study|Study Terminated By Sponsor|4|||
46907159|NCT02385045|83136177|FG000|Overall Study|Endoscopy could not be completed|4|||
46907160|NCT02974010|83136185|FG000|Overall Study|Lost to Follow-up|3|||
46907161|NCT02974010|83136186|FG001|Overall Study|Lost to Follow-up|1|||
46907162|NCT02974010|83136187|FG002|Overall Study|Lost to Follow-up|0|||
46907163|NCT02974010|83136188|FG003|Overall Study|Lost to Follow-up|0|||
46907164|NCT02974010|83136185|FG000|Overall Study|Withdrawal by Subject|2|||
46907165|NCT02974010|83136186|FG001|Overall Study|Withdrawal by Subject|1|||
46907166|NCT02974010|83136187|FG002|Overall Study|Withdrawal by Subject|0|||
46907167|NCT02974010|83136188|FG003|Overall Study|Withdrawal by Subject|0|||
46907168|NCT02974010|83136185|FG000|Overall Study|Adverse Event|0|||
46907169|NCT02974010|83136186|FG001|Overall Study|Adverse Event|1|||
46907170|NCT02974010|83136187|FG002|Overall Study|Adverse Event|0|||
46907171|NCT02974010|83136188|FG003|Overall Study|Adverse Event|0|||
46907172|NCT02974010|83136185|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
46907173|NCT02974010|83136186|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
46907174|NCT02974010|83136187|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
46907175|NCT02974010|83136188|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
46907176|NCT02974010|83136185|FG000|Overall Study|Lack of Efficacy|0|||
46907177|NCT02974010|83136186|FG001|Overall Study|Lack of Efficacy|0|||
46907178|NCT02974010|83136187|FG002|Overall Study|Lack of Efficacy|1|||
46907179|NCT02974010|83136188|FG003|Overall Study|Lack of Efficacy|0|||
46907180|NCT02030938|83136198|FG000|Overall Study|Lost to Follow-up|4|||
46907181|NCT02030938|83136198|FG000|Overall Study|Withdrawal by Subject|1|||
46907182|NCT03122535|83136206|FG000|Overall Study|Lost to Follow-up|68|||
46907183|NCT03122535|83136207|FG001|Overall Study|Lost to Follow-up|68|||
46907184|NCT03122535|83136206|FG000|Overall Study|Physician Decision|3|||
46907185|NCT03122535|83136207|FG001|Overall Study|Physician Decision|3|||
46907186|NCT03122535|83136206|FG000|Overall Study|Withdrawal by Subject|2|||
46907187|NCT03122535|83136207|FG001|Overall Study|Withdrawal by Subject|2|||
46907188|NCT01061606|83136213|FG000|Overall Study|Adverse Event|1|||
46907189|NCT01061606|83136213|FG000|Overall Study|Death|1|||
46907190|NCT01061606|83136213|FG000|Overall Study|Disease Progression|4|||
46907191|NCT01061606|83136213|FG000|Overall Study|alternative therapy|2|||
46907192|NCT03122457|83136217|FG000|Overall Study|Withdrawal by Subject|6|||
46907193|NCT03482453|83136233|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907194|NCT03482453|83136234|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907195|NCT03482453|83136235|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907196|NCT03482453|83136236|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907197|NCT03482453|83136237|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907198|NCT03482453|83136238|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907199|NCT03482453|83136239|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907200|NCT03482453|83136240|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907201|NCT03482453|83136241|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907202|NCT03482453|83136242|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907203|NCT03482453|83136243|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
46907204|NCT03482453|83136244|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
46907205|NCT03480425|83136280|FG000|Overall Study|Force transducer technical failure|1|||
46907206|NCT03472547|83136284|FG000|Overall Study|Withdrawal by Subject|30|||
46907207|NCT00799396|83136288|FG000|Clopidogrel Treatment|Adverse Event|6|||
46907208|NCT00799396|83136288|FG000|Clopidogrel Treatment|Physician Decision|5|||
46907209|NCT00799396|83136288|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
46907210|NCT00799396|83136288|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
46907211|NCT00799396|83136288|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
46907212|NCT03469349|83136294|FG000|Overall Study|Withdrawal by Subject|1|||
46997999|NCT02322866|83244876|FG001|Overall Study|Protocol Violation|0|||
46907213|NCT03469349|83136295|FG001|Overall Study|Withdrawal by Subject|3|||
46907214|NCT03469349|83136294|FG000|Overall Study|Progressive Disease|0|||
46998000|NCT02322866|83244875|FG000|Overall Study|Noncompliance with Treatment|3|||
46998001|NCT02322866|83244876|FG001|Overall Study|Noncompliance with Treatment|4|||
46998002|NCT02322866|83244875|FG000|Overall Study|Lack of Efficacy|3|||
46998003|NCT02322866|83244876|FG001|Overall Study|Lack of Efficacy|1|||
46998004|NCT02322866|83244875|FG000|Overall Study|Other Miscellaneous Reasons|6|||
46998005|NCT02322866|83244876|FG001|Overall Study|Other Miscellaneous Reasons|6|||
46998006|NCT01640353|83244882|FG000|Overall Study|Withdrew prior to treatment|10|||
46998007|NCT01640353|83244882|FG000|Overall Study|Withdrawn from analysis at term site|12|||
46998008|NCT01640353|83244882|FG000|Overall Study|Withdrawal by Subject|5|||
46998009|NCT01640353|83244882|FG000|Overall Study|Death|2|||
46998010|NCT01640353|83244882|FG000|Overall Study|Early site termination|3|||
46998011|NCT01640353|83244882|FG000|Overall Study|Lost to Follow-up|12|||
46998012|NCT01640353|83244882|FG000|Overall Study|Physician Decision|1|||
46998013|NCT02463071|83244889|FG000|Overall Study|Adverse Event|3|||
46998014|NCT02463071|83244890|FG001|Overall Study|Adverse Event|5|||
46998015|NCT02463071|83244891|FG002|Overall Study|Adverse Event|1|||
46998016|NCT02463071|83244889|FG000|Overall Study|Death|1|||
46998017|NCT02463071|83244890|FG001|Overall Study|Death|0|||
46998018|NCT02463071|83244891|FG002|Overall Study|Death|0|||
46998019|NCT02463071|83244889|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
46998020|NCT02463071|83244890|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46998021|NCT02463071|83244891|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
46998022|NCT02463071|83244889|FG000|Overall Study|Reason not specified|7|||
46998023|NCT02463071|83244890|FG001|Overall Study|Reason not specified|9|||
46998024|NCT02463071|83244891|FG002|Overall Study|Reason not specified|4|||
46998025|NCT02463071|83244889|FG000|Overall Study|Protocol Violation|0|||
46998026|NCT02463071|83244890|FG001|Overall Study|Protocol Violation|2|||
46998027|NCT02463071|83244891|FG002|Overall Study|Protocol Violation|0|||
46998028|NCT02463071|83244889|FG000|Overall Study|Lost to Follow-up|0|||
46998029|NCT02463071|83244890|FG001|Overall Study|Lost to Follow-up|0|||
46998030|NCT02463071|83244891|FG002|Overall Study|Lost to Follow-up|1|||
46998031|NCT02266381|83244902|FG000|Overall Study|Physician Decision|3|||
46998032|NCT02266381|83244903|FG001|Overall Study|Physician Decision|5|||
46998033|NCT02266381|83244904|FG002|Overall Study|Physician Decision|4|||
46998034|NCT01827046|83244916|FG000|Overall Study|Lost to Follow-up|1|||
46998035|NCT01827046|83244917|FG001|Overall Study|Lost to Follow-up|5|||
46998036|NCT01827046|83244916|FG000|Overall Study|Withdrawal by Subject|0|||
46998037|NCT01827046|83244917|FG001|Overall Study|Withdrawal by Subject|4|||
46998038|NCT02356562|83244925|FG000|Overall Study|Withdrawal by Subject|0|||
46998039|NCT02356562|83244926|FG001|Overall Study|Withdrawal by Subject|1|||
46998040|NCT02356562|83244925|FG000|Overall Study|Re-entered treatment in a previous study|1|||
46998041|NCT02356562|83244926|FG001|Overall Study|Re-entered treatment in a previous study|0|||
46998042|NCT02356562|83244925|FG000|Overall Study|site closure|1|||
46998043|NCT02356562|83244926|FG001|Overall Study|site closure|0|||
46998044|NCT02448563|83244937|FG000|Overall Study|Lost to Follow-up|16|||
46998045|NCT02448563|83244938|FG001|Overall Study|Lost to Follow-up|10|||
46998046|NCT02448563|83244937|FG000|Overall Study|Withdrawal by Subject|0|||
46998047|NCT02448563|83244938|FG001|Overall Study|Withdrawal by Subject|1|||
46998048|NCT02266225|83244948|FG000|Overall Study|Lost to Follow-up|2|||
46998049|NCT02266225|83244948|FG000|Overall Study|Death|1|||
46998050|NCT02266225|83244948|FG000|Overall Study|Withdrawal by Subject|13|||
46998051|NCT02354690|83244953|FG000|Overall Study|Physician Decision|1|||
46998052|NCT02354222|83244959|FG000|Overall Study|Adverse Event|0|||
46998053|NCT02354222|83244960|FG001|Overall Study|Adverse Event|3|||
46998054|NCT02354222|83244959|FG000|Overall Study|Physician Decision|1|||
46998055|NCT02354222|83244960|FG001|Overall Study|Physician Decision|1|||
46998056|NCT02354222|83244959|FG000|Overall Study|Pregnancy|1|||
46998057|NCT02354222|83244960|FG001|Overall Study|Pregnancy|0|||
46998058|NCT02354222|83244959|FG000|Overall Study|Withdrawal by Subject|2|||
46998059|NCT02354222|83244960|FG001|Overall Study|Withdrawal by Subject|3|||
46998060|NCT02354222|83244959|FG000|Overall Study|Conflict with the stopping criteria|0|||
46998061|NCT02354222|83244960|FG001|Overall Study|Conflict with the stopping criteria|4|||
46998062|NCT02353442|83244968|FG000|Overall Study|Withdrawal by Subject|3|||
46709199|NCT00925600|82925169|FG001|Overall Study|Disease Progression|3|||
46998063|NCT02353442|83244969|FG001|Overall Study|Withdrawal by Subject|4|||
46998064|NCT02351960|83244977|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
46998065|NCT02351960|83244978|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
46998066|NCT02351960|83244977|FG000|Overall Study|Voluntary Withdrawal|5|||
46998067|NCT02351960|83244978|FG001|Overall Study|Voluntary Withdrawal|4|||
46998068|NCT02351960|83244977|FG000|Overall Study|Significant Protocol Deviation|0|||
46998069|NCT02351960|83244978|FG001|Overall Study|Significant Protocol Deviation|5|||
46998070|NCT02351180|83244987|FG000|Overall Study|Withdrawal by Subject|1|||
46998071|NCT02351180|83244988|FG001|Overall Study|Withdrawal by Subject|0|||
46998072|NCT02350478|83244996|FG000|Overall Study|Lost to Follow-up|5|||
46998073|NCT02350478|83244997|FG001|Overall Study|Lost to Follow-up|1|||
46998074|NCT02349542|83245003|FG000|Overall Study|Withdrawal by Subject|5|||
46998075|NCT02321930|83245007|FG000|Overall Study|Lost to Follow-up|1|||
46998076|NCT01647542|83245014|FG000|Overall Study|Major Protocol Deviation|1|||
46998077|NCT01647542|83245015|FG001|Overall Study|Major Protocol Deviation|0|||
46998078|NCT01647542|83245016|FG002|Overall Study|Major Protocol Deviation|0|||
46998079|NCT01647542|83245014|FG000|Overall Study|Adverse Event|4|||
46998080|NCT01647542|83245015|FG001|Overall Study|Adverse Event|5|||
46998081|NCT01647542|83245016|FG002|Overall Study|Adverse Event|4|||
46998082|NCT01647542|83245014|FG000|Overall Study|Lost to Follow-up|0|||
46998083|NCT01647542|83245015|FG001|Overall Study|Lost to Follow-up|2|||
46998084|NCT01647542|83245016|FG002|Overall Study|Lost to Follow-up|2|||
46998085|NCT01647542|83245014|FG000|Overall Study|Withdrawal by Subject|6|||
46998086|NCT01647542|83245015|FG001|Overall Study|Withdrawal by Subject|4|||
46998087|NCT01647542|83245016|FG002|Overall Study|Withdrawal by Subject|0|||
46998088|NCT01647542|83245014|FG000|Overall Study|Study Termination|64|||
46998089|NCT01647542|83245015|FG001|Overall Study|Study Termination|61|||
46998090|NCT01647542|83245016|FG002|Overall Study|Study Termination|65|||
46998091|NCT01647542|83245014|FG000|Overall Study|Lack of Efficacy|1|||
46998092|NCT01647542|83245015|FG001|Overall Study|Lack of Efficacy|1|||
46998093|NCT01647542|83245016|FG002|Overall Study|Lack of Efficacy|0|||
46998094|NCT01647542|83245014|FG000|Overall Study|Death|0|||
46998095|NCT01647542|83245015|FG001|Overall Study|Death|0|||
46998096|NCT01647542|83245016|FG002|Overall Study|Death|1|||
46998097|NCT02321462|83245026|FG000|Overall Study|Withdrawal by Subject|5|||
46998098|NCT02321462|83245027|FG001|Overall Study|Withdrawal by Subject|2|||
46998099|NCT02321462|83245026|FG000|Overall Study|Subject withdrawn before any treatment|1|||
46998100|NCT02321462|83245027|FG001|Overall Study|Subject withdrawn before any treatment|1|||
46998101|NCT02391584|83245036|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
46998102|NCT02391584|83245037|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
46998103|NCT02391584|83245036|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
46998104|NCT02391584|83245037|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
46998105|NCT02391584|83245036|FG000|3 Month|Lost to Follow-up|1|||
46998106|NCT02391584|83245037|FG001|3 Month|Lost to Follow-up|0|||
46998107|NCT02391584|83245036|FG000|6 Month|Withdrawal by Subject|1|||
46998108|NCT02391584|83245037|FG001|6 Month|Withdrawal by Subject|0|||
46998109|NCT02391584|83245036|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
46998110|NCT02391584|83245037|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
46998111|NCT02266147|83245050|FG000|PART 1: Dose Escalation|Physician Decision|0|||
46998112|NCT02266147|83245051|FG001|PART 1: Dose Escalation|Physician Decision|0|||
46998113|NCT02266147|83245052|FG002|PART 1: Dose Escalation|Physician Decision|1|||
46998114|NCT02266147|83245053|FG003|PART 1: Dose Escalation|Physician Decision|0|||
46907215|NCT03469349|83136295|FG001|Overall Study|Progressive Disease|1|||
46907216|NCT03469349|83136294|FG000|Overall Study|Lost to Follow-up|2|||
46907217|NCT03469349|83136295|FG001|Overall Study|Lost to Follow-up|2|||
46907218|NCT03469349|83136294|FG000|Overall Study|Adverse Event|2|||
46907219|NCT03469349|83136295|FG001|Overall Study|Adverse Event|4|||
46907220|NCT03467945|83136305|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46907221|NCT03467945|83136306|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46907222|NCT03467945|83136307|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46907223|NCT03467945|83136308|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46907224|NCT03467945|83136305|FG000|Treatment Period 3|Withdrawal by Subject|1|||
46907225|NCT03467945|83136306|FG001|Treatment Period 3|Withdrawal by Subject|0|||
46907226|NCT03467945|83136307|FG002|Treatment Period 3|Withdrawal by Subject|2|||
46907227|NCT03467945|83136308|FG003|Treatment Period 3|Withdrawal by Subject|1|||
46907228|NCT00069238|83136319|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
46907229|NCT00069238|83136320|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
46998115|NCT02266147|83245050|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
46998116|NCT02266147|83245051|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
46907230|NCT00069238|83136321|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
46998117|NCT02266147|83245052|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
46998118|NCT02266147|83245053|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
46998119|NCT02266147|83245050|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
46998120|NCT02266147|83245051|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
46907231|NCT00069238|83136319|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
46907232|NCT00069238|83136320|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
46907233|NCT00069238|83136321|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
46907234|NCT00069238|83136319|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
46907235|NCT00069238|83136320|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
46907236|NCT00069238|83136321|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
46907237|NCT03435497|83136328|FG000|Overall Study|Lost to Follow-up|1|||
46907238|NCT03435497|83136329|FG001|Overall Study|Lost to Follow-up|0|||
46907239|NCT03435497|83136328|FG000|Overall Study|Death|1|||
46907240|NCT03435497|83136329|FG001|Overall Study|Death|0|||
46907241|NCT03435497|83136328|FG000|Overall Study|Withdrawal by Subject|0|||
46907242|NCT03435497|83136329|FG001|Overall Study|Withdrawal by Subject|4|||
46907243|NCT03435497|83136328|FG000|Overall Study|Wrong survey administered|0|||
46907244|NCT03435497|83136329|FG001|Overall Study|Wrong survey administered|2|||
46907245|NCT03073200|83136338|FG000|Double Blind Treatment Period|Protocol Violation|1|||
46907246|NCT03073200|83136339|FG001|Double Blind Treatment Period|Protocol Violation|0|||
46907247|NCT03073200|83136340|FG002|Double Blind Treatment Period|Protocol Violation|0|||
46907248|NCT03073200|83136341|FG003|Double Blind Treatment Period|Protocol Violation|0|||
46907249|NCT03073200|83136342|FG004|Double Blind Treatment Period|Protocol Violation|0|||
46907250|NCT03073200|83136343|FG005|Double Blind Treatment Period|Protocol Violation|0|||
46907251|NCT03073200|83136344|FG006|Double Blind Treatment Period|Protocol Violation|0|||
46907252|NCT03073200|83136345|FG007|Double Blind Treatment Period|Protocol Violation|0|||
46907253|NCT03073200|83136346|FG008|Double Blind Treatment Period|Protocol Violation|0|||
46907254|NCT03073200|83136347|FG009|Double Blind Treatment Period|Protocol Violation|0|||
46907255|NCT03073200|83136348|FG010|Double Blind Treatment Period|Protocol Violation|0|||
46907256|NCT03073200|83136349|FG011|Double Blind Treatment Period|Protocol Violation|0|||
46907257|NCT03073200|83136350|FG012|Double Blind Treatment Period|Protocol Violation|0|||
46907258|NCT03073200|83136351|FG013|Double Blind Treatment Period|Protocol Violation|0|||
46907259|NCT03073200|83136352|FG014|Double Blind Treatment Period|Protocol Violation|0|||
46907260|NCT03073200|83136338|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907261|NCT03073200|83136339|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
46907262|NCT03073200|83136340|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907263|NCT03073200|83136341|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907264|NCT03073200|83136342|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907265|NCT03073200|83136343|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907266|NCT03073200|83136344|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907267|NCT03073200|83136345|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907268|NCT03073200|83136346|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907269|NCT03073200|83136347|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907270|NCT03073200|83136348|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907271|NCT03073200|83136349|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907272|NCT03073200|83136350|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907273|NCT03073200|83136351|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907274|NCT03073200|83136352|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
46907275|NCT03073200|83136338|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
46907276|NCT03073200|83136339|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907277|NCT03073200|83136340|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907278|NCT03073200|83136341|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907279|NCT03073200|83136342|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907280|NCT03073200|83136343|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907281|NCT03073200|83136344|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907282|NCT03073200|83136345|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907283|NCT03073200|83136346|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907284|NCT03073200|83136347|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907285|NCT03073200|83136348|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907286|NCT03073200|83136349|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907287|NCT03073200|83136350|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907288|NCT03073200|83136351|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907289|NCT03073200|83136352|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
46907290|NCT03073200|83136338|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907291|NCT03073200|83136339|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907292|NCT03073200|83136340|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907293|NCT03073200|83136341|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
46907294|NCT03073200|83136342|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
46907295|NCT03073200|83136343|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907296|NCT03073200|83136344|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907297|NCT03073200|83136345|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907298|NCT03073200|83136346|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907299|NCT03073200|83136347|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907300|NCT03073200|83136348|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907301|NCT03073200|83136349|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907302|NCT03073200|83136350|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907303|NCT03073200|83136351|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907304|NCT03073200|83136352|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
46907305|NCT03073200|83136338|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
46907306|NCT03073200|83136339|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
46907307|NCT03073200|83136340|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
46907308|NCT03073200|83136341|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
46907309|NCT03073200|83136342|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
46907310|NCT03073200|83136343|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
46907311|NCT03073200|83136344|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
46907312|NCT03073200|83136345|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
46907313|NCT03073200|83136346|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
46907314|NCT03073200|83136347|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
46907315|NCT03073200|83136348|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
46907316|NCT03073200|83136349|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
46907317|NCT03073200|83136350|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
46907318|NCT03073200|83136351|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
46907319|NCT03073200|83136352|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
46907320|NCT03073200|83136338|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907321|NCT03073200|83136339|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907322|NCT03073200|83136340|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907323|NCT03073200|83136341|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907324|NCT03073200|83136342|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
46907325|NCT03073200|83136343|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907326|NCT03073200|83136344|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907327|NCT03073200|83136345|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907328|NCT03073200|83136346|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907329|NCT03073200|83136347|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907330|NCT03073200|83136348|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907331|NCT03073200|83136349|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907332|NCT03073200|83136350|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907333|NCT03073200|83136351|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907334|NCT03073200|83136352|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
46907335|NCT03073200|83136338|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907336|NCT03073200|83136339|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907337|NCT03073200|83136340|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907338|NCT03073200|83136341|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
46907339|NCT03073200|83136342|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
46907340|NCT03073200|83136343|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907341|NCT03073200|83136344|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907342|NCT03073200|83136345|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907343|NCT03073200|83136346|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907344|NCT03073200|83136347|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907345|NCT03073200|83136348|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907346|NCT03073200|83136349|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907347|NCT03073200|83136350|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907348|NCT03073200|83136351|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907349|NCT03073200|83136352|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
46907350|NCT03073200|83136338|FG000|Extension Period|Lost to Follow-up|0|||
46907351|NCT03073200|83136339|FG001|Extension Period|Lost to Follow-up|0|||
46907352|NCT03073200|83136340|FG002|Extension Period|Lost to Follow-up|0|||
46907353|NCT03073200|83136341|FG003|Extension Period|Lost to Follow-up|0|||
46907354|NCT03073200|83136342|FG004|Extension Period|Lost to Follow-up|0|||
46907355|NCT03073200|83136343|FG005|Extension Period|Lost to Follow-up|0|||
46907356|NCT03073200|83136344|FG006|Extension Period|Lost to Follow-up|1|||
46907357|NCT03073200|83136345|FG007|Extension Period|Lost to Follow-up|1|||
46907358|NCT03073200|83136346|FG008|Extension Period|Lost to Follow-up|0|||
46907359|NCT03073200|83136347|FG009|Extension Period|Lost to Follow-up|0|||
46907360|NCT03073200|83136348|FG010|Extension Period|Lost to Follow-up|0|||
46907361|NCT03073200|83136349|FG011|Extension Period|Lost to Follow-up|0|||
46907362|NCT03073200|83136350|FG012|Extension Period|Lost to Follow-up|0|||
46907363|NCT03073200|83136351|FG013|Extension Period|Lost to Follow-up|0|||
46907364|NCT03073200|83136352|FG014|Extension Period|Lost to Follow-up|0|||
46907365|NCT03073200|83136338|FG000|Extension Period|Sponsor Decision|0|||
46907366|NCT03073200|83136339|FG001|Extension Period|Sponsor Decision|0|||
46907367|NCT03073200|83136340|FG002|Extension Period|Sponsor Decision|0|||
46907368|NCT03073200|83136341|FG003|Extension Period|Sponsor Decision|0|||
46907369|NCT03073200|83136342|FG004|Extension Period|Sponsor Decision|0|||
46907370|NCT03073200|83136343|FG005|Extension Period|Sponsor Decision|0|||
46907371|NCT03073200|83136344|FG006|Extension Period|Sponsor Decision|0|||
46907372|NCT03073200|83136345|FG007|Extension Period|Sponsor Decision|0|||
46907373|NCT03073200|83136346|FG008|Extension Period|Sponsor Decision|1|||
46907374|NCT03073200|83136347|FG009|Extension Period|Sponsor Decision|0|||
46907375|NCT03073200|83136348|FG010|Extension Period|Sponsor Decision|0|||
46907376|NCT03073200|83136349|FG011|Extension Period|Sponsor Decision|0|||
46907377|NCT03073200|83136350|FG012|Extension Period|Sponsor Decision|0|||
46907378|NCT03073200|83136351|FG013|Extension Period|Sponsor Decision|0|||
46907379|NCT03073200|83136352|FG014|Extension Period|Sponsor Decision|0|||
46907380|NCT03073200|83136338|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
46907381|NCT03073200|83136339|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
46907382|NCT03073200|83136340|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
46907383|NCT03073200|83136341|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
46907384|NCT03073200|83136342|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
46907385|NCT03073200|83136343|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
46907386|NCT03073200|83136344|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
46907387|NCT03073200|83136345|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
46907388|NCT03073200|83136346|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
46907389|NCT03073200|83136347|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
46907390|NCT03073200|83136348|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
46907391|NCT03073200|83136349|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
46907392|NCT03073200|83136350|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
46907393|NCT03073200|83136351|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
46907394|NCT03073200|83136352|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
46907395|NCT03073200|83136338|FG000|Extension Period|Withdrawal by Subject|0|||
46907396|NCT03073200|83136339|FG001|Extension Period|Withdrawal by Subject|0|||
46907397|NCT03073200|83136340|FG002|Extension Period|Withdrawal by Subject|0|||
46907398|NCT03073200|83136341|FG003|Extension Period|Withdrawal by Subject|0|||
46907399|NCT03073200|83136342|FG004|Extension Period|Withdrawal by Subject|0|||
46907400|NCT03073200|83136343|FG005|Extension Period|Withdrawal by Subject|0|||
46907401|NCT03073200|83136344|FG006|Extension Period|Withdrawal by Subject|1|||
46907402|NCT03073200|83136345|FG007|Extension Period|Withdrawal by Subject|2|||
46907403|NCT03073200|83136346|FG008|Extension Period|Withdrawal by Subject|0|||
46907404|NCT03073200|83136347|FG009|Extension Period|Withdrawal by Subject|0|||
46907405|NCT03073200|83136348|FG010|Extension Period|Withdrawal by Subject|0|||
46907406|NCT03073200|83136349|FG011|Extension Period|Withdrawal by Subject|0|||
46907407|NCT03073200|83136350|FG012|Extension Period|Withdrawal by Subject|0|||
46907408|NCT03073200|83136351|FG013|Extension Period|Withdrawal by Subject|0|||
46907409|NCT03073200|83136352|FG014|Extension Period|Withdrawal by Subject|0|||
46907410|NCT03073200|83136338|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907411|NCT03073200|83136339|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907412|NCT03073200|83136340|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907413|NCT03073200|83136341|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907414|NCT03073200|83136342|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907415|NCT03073200|83136343|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907416|NCT03073200|83136344|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907417|NCT03073200|83136345|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907418|NCT03073200|83136346|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907419|NCT03073200|83136347|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907420|NCT03073200|83136348|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907421|NCT03073200|83136349|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
46907422|NCT03073200|83136350|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907423|NCT03073200|83136351|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907424|NCT03073200|83136352|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
46907425|NCT03073200|83136338|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907426|NCT03073200|83136339|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907427|NCT03073200|83136340|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907428|NCT03073200|83136341|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907429|NCT03073200|83136342|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907430|NCT03073200|83136343|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46620375|NCT00085735|82762344|FG000|Overall Study|Reason not documented|1|||
46803621|NCT00678587|83022925|FG000|Overall Study|Withdrew Consent|8|||
46907431|NCT03073200|83136344|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907432|NCT03073200|83136345|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907433|NCT03073200|83136346|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46998121|NCT02266147|83245052|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
46998122|NCT02266147|83245053|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
46998123|NCT02266147|83245050|FG000|PART 1: Dose Escalation|Other|1|||
46998124|NCT02266147|83245051|FG001|PART 1: Dose Escalation|Other|1|||
46998125|NCT02266147|83245052|FG002|PART 1: Dose Escalation|Other|0|||
46998126|NCT02266147|83245053|FG003|PART 1: Dose Escalation|Other|0|||
46998127|NCT02266147|83245050|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
46998128|NCT02266147|83245051|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
46998129|NCT02266147|83245052|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
46998130|NCT02266147|83245053|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
46998131|NCT02266147|83245050|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
46998132|NCT02266147|83245051|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
46998133|NCT02266147|83245052|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
46907434|NCT03073200|83136347|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907435|NCT03073200|83136348|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907436|NCT03073200|83136349|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
46907437|NCT03073200|83136350|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907438|NCT03073200|83136351|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907439|NCT03073200|83136352|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
46907440|NCT03073200|83136338|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907441|NCT03073200|83136339|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907442|NCT03073200|83136340|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907443|NCT03073200|83136341|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907444|NCT03073200|83136342|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907445|NCT03073200|83136343|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907446|NCT03073200|83136344|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907447|NCT03073200|83136345|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907448|NCT03073200|83136346|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46620376|NCT00085735|82762345|FG001|Overall Study|Reason not documented|0|||
46907449|NCT03073200|83136347|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907450|NCT03073200|83136348|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
46907451|NCT03073200|83136349|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
46907452|NCT03073200|83136350|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907453|NCT03073200|83136351|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907454|NCT03073200|83136352|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46907455|NCT03073200|83136338|FG000|Randomized Withdrawal Period|Adverse Event|0|||
46907456|NCT03073200|83136339|FG001|Randomized Withdrawal Period|Adverse Event|0|||
46907457|NCT03073200|83136340|FG002|Randomized Withdrawal Period|Adverse Event|0|||
46907458|NCT03073200|83136341|FG003|Randomized Withdrawal Period|Adverse Event|0|||
46907459|NCT03073200|83136342|FG004|Randomized Withdrawal Period|Adverse Event|0|||
46907460|NCT03073200|83136343|FG005|Randomized Withdrawal Period|Adverse Event|0|||
46907461|NCT03073200|83136344|FG006|Randomized Withdrawal Period|Adverse Event|0|||
46907462|NCT03073200|83136345|FG007|Randomized Withdrawal Period|Adverse Event|0|||
46907463|NCT03073200|83136346|FG008|Randomized Withdrawal Period|Adverse Event|0|||
46907464|NCT03073200|83136347|FG009|Randomized Withdrawal Period|Adverse Event|0|||
46907465|NCT03073200|83136348|FG010|Randomized Withdrawal Period|Adverse Event|1|||
46907466|NCT03073200|83136349|FG011|Randomized Withdrawal Period|Adverse Event|0|||
46907467|NCT03073200|83136350|FG012|Randomized Withdrawal Period|Adverse Event|0|||
46907468|NCT03073200|83136351|FG013|Randomized Withdrawal Period|Adverse Event|0|||
46907469|NCT03073200|83136352|FG014|Randomized Withdrawal Period|Adverse Event|0|||
46907470|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907471|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907472|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907473|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907474|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907475|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907476|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
46620377|NCT00085735|82762346|FG002|Overall Study|Reason not documented|1|||
46907477|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907478|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
46998134|NCT02266147|83245053|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
46998135|NCT02264977|83245065|FG000|Overall Study|Death|3|||
46998136|NCT02264977|83245065|FG000|Overall Study|Physician Decision|1|||
46998137|NCT02264977|83245065|FG000|Overall Study|Refuse to return|1|||
46803622|NCT00678587|83022926|FG001|Overall Study|Withdrew Consent|3|||
46998138|NCT02264821|83245072|FG000|Overall Study|Protocol Violation|1|||
46998139|NCT02264821|83245073|FG001|Overall Study|Protocol Violation|3|||
46998140|NCT02264821|83245074|FG002|Overall Study|Protocol Violation|6|||
46998141|NCT02261467|83245084|FG000|Overall Study|Enrolled in Error|1|||
46998142|NCT02261467|83245085|FG001|Overall Study|Enrolled in Error|0|||
46998143|NCT02261467|83245084|FG000|Overall Study|Protocol Violation|0|||
46998144|NCT02261467|83245085|FG001|Overall Study|Protocol Violation|1|||
46998145|NCT02261467|83245084|FG000|Overall Study|Personal Reasons|17|||
46998146|NCT02261467|83245085|FG001|Overall Study|Personal Reasons|22|||
46998147|NCT02261467|83245084|FG000|Overall Study|Lost to Follow-up|2|||
46998148|NCT02261467|83245085|FG001|Overall Study|Lost to Follow-up|13|||
46998149|NCT02261467|83245084|FG000|Overall Study|Adverse Event|1|||
46998150|NCT02261467|83245085|FG001|Overall Study|Adverse Event|1|||
46998151|NCT01643473|83245093|FG000|Overall Study|Lost to Follow-up|1|||
46998152|NCT01643473|83245094|FG001|Overall Study|Lost to Follow-up|0|||
46998153|NCT02320058|83245102|FG000|Overall Study|Death|25|||
46998154|NCT02320058|83245103|FG001|Overall Study|Death|10|||
46998155|NCT02320058|83245102|FG000|Overall Study|Lost to Follow-up|4|||
46998156|NCT02320058|83245103|FG001|Overall Study|Lost to Follow-up|0|||
46998157|NCT02320058|83245102|FG000|Overall Study|Other reasons|4|||
46998158|NCT02320058|83245103|FG001|Overall Study|Other reasons|1|||
46998159|NCT02320058|83245102|FG000|Overall Study|Withdrawal by Subject|8|||
46998160|NCT02320058|83245103|FG001|Overall Study|Withdrawal by Subject|2|||
46998161|NCT02320058|83245102|FG000|Overall Study|Not reported|1|||
46998162|NCT02320058|83245103|FG001|Overall Study|Not reported|0|||
46998163|NCT02319668|83245111|FG000|Overall Study|Other (Not specified)|0|||
46998164|NCT02319668|83245112|FG001|Overall Study|Other (Not specified)|2|||
46998165|NCT02092467|83245124|FG000|Overall Study|Death|49|||
46998166|NCT02092467|83245125|FG001|Overall Study|Death|66|||
46998167|NCT02092467|83245126|FG002|Overall Study|Death|38|||
46998168|NCT02092467|83245124|FG000|Overall Study|Lost to Follow-up|38|||
46998169|NCT02092467|83245125|FG001|Overall Study|Lost to Follow-up|35|||
46998170|NCT02092467|83245126|FG002|Overall Study|Lost to Follow-up|40|||
46998171|NCT02092467|83245124|FG000|Overall Study|Global Deterioration of Health Status|1|||
46998172|NCT02092467|83245125|FG001|Overall Study|Global Deterioration of Health Status|0|||
46998173|NCT02092467|83245126|FG002|Overall Study|Global Deterioration of Health Status|0|||
46998174|NCT02092467|83245124|FG000|Overall Study|Other|32|||
46998175|NCT02092467|83245125|FG001|Overall Study|Other|30|||
46998176|NCT02092467|83245126|FG002|Overall Study|Other|24|||
46998177|NCT02092467|83245124|FG000|Overall Study|Withdrawal by Subject|282|||
46998178|NCT02092467|83245125|FG001|Overall Study|Withdrawal by Subject|327|||
46998179|NCT02092467|83245126|FG002|Overall Study|Withdrawal by Subject|289|||
46998180|NCT02092467|83245124|FG000|Overall Study|Randomized but not treated|2|||
46998181|NCT02092467|83245125|FG001|Overall Study|Randomized but not treated|1|||
46998182|NCT02092467|83245126|FG002|Overall Study|Randomized but not treated|7|||
46998183|NCT02462759|83245138|FG000|Part 1: Double Blind|Death|1|||
46998184|NCT02462759|83245139|FG001|Part 1: Double Blind|Death|0|||
46998185|NCT02462759|83245140|FG002|Part 1: Double Blind|Death|0|||
46998186|NCT02349386|83245155|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
46709200|NCT00925600|82925168|FG000|Overall Study|Administrative Decision|1|||
46907479|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907480|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907481|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907482|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907483|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
46907484|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
46907485|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907486|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907487|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907488|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907489|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907490|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907491|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907492|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907493|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46998187|NCT02349386|83245156|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
46998188|NCT02349386|83245157|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
46998189|NCT02349386|83245158|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
46998190|NCT02349386|83245155|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
46998191|NCT02349386|83245156|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
46998192|NCT02349386|83245157|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
46998193|NCT02349386|83245158|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
46998194|NCT02349386|83245155|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
46709201|NCT00925600|82925169|FG001|Overall Study|Administrative Decision|1|||
46998195|NCT02349386|83245156|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
46998196|NCT02349386|83245157|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
46998197|NCT02349386|83245158|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
46998198|NCT02349386|83245155|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
46998199|NCT02349386|83245156|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
46998200|NCT02349386|83245157|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
46998201|NCT02349386|83245158|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
46998202|NCT02349386|83245155|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
46998203|NCT02349386|83245156|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
46998204|NCT02349386|83245157|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
46998205|NCT02349386|83245158|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
46998206|NCT02349386|83245155|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
46998207|NCT02349386|83245156|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
46998208|NCT02349386|83245157|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
46998209|NCT02349386|83245158|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
46998210|NCT02036775|83245168|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
46998211|NCT02036775|83245169|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
46998212|NCT02036775|83245170|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
46998213|NCT02036775|83245171|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
46998214|NCT02036775|83245172|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
46998215|NCT02036775|83245173|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
46998216|NCT02092389|83245181|FG000|Overall Study|Adverse Event|1|||
46998217|NCT02092389|83245181|FG000|Overall Study|Other|5|||
46998218|NCT02034591|83245185|FG000|Overall Study|Withdrawal by Subject|0|||
46998219|NCT02034591|83245186|FG001|Overall Study|Withdrawal by Subject|0|||
46998220|NCT02034591|83245187|FG002|Overall Study|Withdrawal by Subject|0|||
46998221|NCT02034591|83245188|FG003|Overall Study|Withdrawal by Subject|0|||
46998222|NCT02034591|83245189|FG004|Overall Study|Withdrawal by Subject|1|||
46998223|NCT02034591|83245190|FG005|Overall Study|Withdrawal by Subject|0|||
46998224|NCT02391116|83245199|FG000|Treatment|Withdrawal by Subject|1|||
46998225|NCT02391116|83245199|FG000|Treatment|Protocol Violation|1|||
46998226|NCT02391116|83245199|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
46998227|NCT02391116|83245199|FG000|Treatment|AE with Clinical PD|3|||
46998228|NCT02391116|83245199|FG000|Safety Follow-up|Adverse Event|1|||
46998229|NCT02391116|83245199|FG000|Safety Follow-up|Withdrawal by Subject|4|||
46998230|NCT02391116|83245199|FG000|Safety Follow-up|Switching to Other Therapy|4|||
46998231|NCT02391116|83245199|FG000|Safety Follow-up|No Follow Up|1|||
46998232|NCT02391116|83245199|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
46998233|NCT02391116|83245199|FG000|Active Follow-up|Withdrawal by Subject|1|||
46998234|NCT02391116|83245199|FG000|Active Follow-up|Switching to Other Therapy|2|||
46998235|NCT02391116|83245199|FG000|Survival Follow-up|Withdrawal by Subject|3|||
46998236|NCT02391116|83245199|FG000|Survival Follow-up|Switching to Other Therapy|1|||
46998237|NCT02091921|83245210|FG000|Overall Study|Adverse Event|3|||
46998238|NCT02447081|83245217|FG000|Overall Study|Death|161|||
46998239|NCT02447081|83245217|FG000|Overall Study|Lost to Follow-up|36|||
46998240|NCT02447081|83245217|FG000|Overall Study|Visit not completed|17|||
46998241|NCT02447081|83245217|FG000|Overall Study|unsuccessful implant procedure|10|||
46998242|NCT02391038|83245221|FG000|Overall Study|Progressive disease|3|||
46998243|NCT02391038|83245222|FG001|Overall Study|Progressive disease|3|||
46998244|NCT02391038|83245223|FG002|Overall Study|Progressive disease|6|||
46998245|NCT02260921|83245234|FG000|Overall Study|Adverse Event|1|||
46998246|NCT02260921|83245235|FG001|Overall Study|Adverse Event|0|||
46998247|NCT02260921|83245234|FG000|Overall Study|Lost to Follow-up|4|||
46998248|NCT02260921|83245235|FG001|Overall Study|Lost to Follow-up|3|||
46998249|NCT02260921|83245234|FG000|Overall Study|Withdraw Consent|4|||
46998250|NCT02260921|83245235|FG001|Overall Study|Withdraw Consent|1|||
46998251|NCT02260921|83245234|FG000|Overall Study|Death|1|||
46998252|NCT02260921|83245235|FG001|Overall Study|Death|0|||
46998253|NCT02260921|83245234|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
46998254|NCT02260921|83245235|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
46998255|NCT02462603|83245241|FG000|Overall Study|Investigator Decision|1|||
46998256|NCT02462603|83245241|FG000|Overall Study|Non-Compliance|1|||
46998257|NCT02462603|83245241|FG000|Overall Study|Withdrawal by Subject|2|||
46998258|NCT02034513|83245247|FG000|Overall Study|Adverse Event|11|||
46998259|NCT02034513|83245248|FG001|Overall Study|Adverse Event|10|||
46998260|NCT02034513|83245247|FG000|Overall Study|Lack of Efficacy|0|||
46998261|NCT02034513|83245248|FG001|Overall Study|Lack of Efficacy|1|||
46998262|NCT02034513|83245247|FG000|Overall Study|Lost to Follow-up|6|||
46998263|NCT02034513|83245248|FG001|Overall Study|Lost to Follow-up|7|||
46998264|NCT02034513|83245247|FG000|Overall Study|Pregnancy|0|||
46998265|NCT02034513|83245248|FG001|Overall Study|Pregnancy|3|||
46998266|NCT02034513|83245247|FG000|Overall Study|Protocol Violation|7|||
46998267|NCT02034513|83245248|FG001|Overall Study|Protocol Violation|10|||
46998268|NCT02034513|83245247|FG000|Overall Study|Withdrawal by Subject|25|||
46998269|NCT02034513|83245248|FG001|Overall Study|Withdrawal by Subject|25|||
46998270|NCT02034513|83245247|FG000|Overall Study|Unclassified|0|||
46998271|NCT02034513|83245248|FG001|Overall Study|Unclassified|1|||
46998272|NCT02348840|83245260|FG000|Overall Study|Withdrawal by Subject|2|||
46998273|NCT02348840|83245261|FG001|Overall Study|Withdrawal by Subject|1|||
46998274|NCT02348840|83245262|FG002|Overall Study|Withdrawal by Subject|0|||
46998275|NCT02348840|83245263|FG003|Overall Study|Withdrawal by Subject|0|||
46998276|NCT02462057|83245278|FG000|Overall Study|Left Vitality|32|||
46907494|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907495|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907496|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907497|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907498|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
46907499|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46907500|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907501|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907502|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907503|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907504|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907505|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907506|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907507|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907508|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907509|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907510|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907511|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907512|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907513|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
46907514|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
46907515|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907516|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907517|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907518|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907519|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907520|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907521|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907522|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907523|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907524|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907525|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907526|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907527|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907528|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
46907529|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46907530|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907531|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907532|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907533|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907534|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907535|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907536|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907537|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907538|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907539|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907540|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907541|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46998277|NCT02462057|83245279|FG001|Overall Study|Left Vitality|27|||
46998278|NCT02462057|83245280|FG002|Overall Study|Left Vitality|23|||
46998279|NCT02462057|83245281|FG003|Overall Study|Left Vitality|35|||
46998280|NCT02462057|83245282|FG004|Overall Study|Left Vitality|33|||
46998281|NCT02462057|83245278|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
46998282|NCT02462057|83245279|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
46998283|NCT02462057|83245280|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
46998284|NCT02462057|83245281|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
46907542|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907543|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
46907544|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
46907545|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46709202|NCT00925600|82925168|FG000|Overall Study|Noncompliance|2|||
46709203|NCT00925600|82925169|FG001|Overall Study|Noncompliance|0|||
46709204|NCT00925600|82925168|FG000|Overall Study|Ineligibility Determined|2|||
46709205|NCT00925600|82925169|FG001|Overall Study|Ineligibility Determined|0|||
46709206|NCT00925600|82925168|FG000|Overall Study|Protocol Deviation|0|||
46709207|NCT00925600|82925169|FG001|Overall Study|Protocol Deviation|1|||
46709208|NCT00925600|82925168|FG000|Overall Study|Requirement for Alternative Therapy|0|||
46709209|NCT00925600|82925169|FG001|Overall Study|Requirement for Alternative Therapy|1|||
46709210|NCT00925600|82925168|FG000|Overall Study|Other|3|||
46709211|NCT00925600|82925169|FG001|Overall Study|Other|1|||
46709212|NCT00925600|82925168|FG000|Overall Study|Adverse Event|1|||
46709213|NCT00925600|82925169|FG001|Overall Study|Adverse Event|2|||
46709214|NCT00968253|82925182|FG000|Overall Study|Death|0|||
46709215|NCT00968253|82925183|FG001|Overall Study|Death|0|||
46709216|NCT00968253|82925184|FG002|Overall Study|Death|2|||
46709217|NCT00968253|82925182|FG000|Overall Study|Withdrawal by Subject|0|||
46709218|NCT00968253|82925183|FG001|Overall Study|Withdrawal by Subject|0|||
46907546|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907547|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907548|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907549|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907550|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907551|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907552|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907553|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907554|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907555|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907556|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907557|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907558|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
46907559|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
46907560|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907561|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907562|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907563|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907564|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907565|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907566|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907567|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907568|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907569|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907570|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907571|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907572|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907573|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
46907574|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46907575|NCT03073200|83136338|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907576|NCT03073200|83136339|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907577|NCT03073200|83136340|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907578|NCT03073200|83136341|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907579|NCT03073200|83136342|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907580|NCT03073200|83136343|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907581|NCT03073200|83136344|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907582|NCT03073200|83136345|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907583|NCT03073200|83136346|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907584|NCT03073200|83136347|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907585|NCT03073200|83136348|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907586|NCT03073200|83136349|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46709219|NCT00968253|82925184|FG002|Overall Study|Withdrawal by Subject|1|||
46709220|NCT00968253|82925182|FG000|Overall Study|Disease Progression|0|||
46709221|NCT00968253|82925183|FG001|Overall Study|Disease Progression|3|||
46709222|NCT00968253|82925184|FG002|Overall Study|Disease Progression|3|||
46709223|NCT00968253|82925182|FG000|Overall Study|Adverse Event|0|||
46709224|NCT00968253|82925183|FG001|Overall Study|Adverse Event|0|||
46709225|NCT00968253|82925184|FG002|Overall Study|Adverse Event|1|||
46907587|NCT03073200|83136350|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907588|NCT03073200|83136351|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
46907589|NCT03073200|83136352|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
46907590|NCT03290781|83136381|FG000|Overall Study|Adverse Event|5|||
46907591|NCT03290781|83136382|FG001|Overall Study|Adverse Event|7|||
46907592|NCT03290781|83136383|FG002|Overall Study|Adverse Event|4|||
46907593|NCT03290781|83136384|FG003|Overall Study|Adverse Event|1|||
46907594|NCT03290781|83136385|FG004|Overall Study|Adverse Event|0|||
46907595|NCT03290781|83136386|FG005|Overall Study|Adverse Event|0|||
46907596|NCT03290781|83136387|FG006|Overall Study|Adverse Event|0|||
46907597|NCT03290781|83136381|FG000|Overall Study|Death|0|||
46907598|NCT03290781|83136382|FG001|Overall Study|Death|0|||
46907599|NCT03290781|83136383|FG002|Overall Study|Death|1|||
46907600|NCT03290781|83136384|FG003|Overall Study|Death|0|||
46907601|NCT03290781|83136385|FG004|Overall Study|Death|1|||
46907602|NCT03290781|83136386|FG005|Overall Study|Death|0|||
46907603|NCT03290781|83136387|FG006|Overall Study|Death|0|||
46907604|NCT03290781|83136381|FG000|Overall Study|Withdrawal by Subject|6|||
46907605|NCT03290781|83136382|FG001|Overall Study|Withdrawal by Subject|5|||
46907606|NCT03290781|83136383|FG002|Overall Study|Withdrawal by Subject|9|||
46907607|NCT03290781|83136384|FG003|Overall Study|Withdrawal by Subject|10|||
46907608|NCT03290781|83136385|FG004|Overall Study|Withdrawal by Subject|1|||
46907609|NCT03290781|83136386|FG005|Overall Study|Withdrawal by Subject|2|||
46907610|NCT03290781|83136387|FG006|Overall Study|Withdrawal by Subject|0|||
46907611|NCT03290781|83136381|FG000|Overall Study|Physician Decision|0|||
46907612|NCT03290781|83136382|FG001|Overall Study|Physician Decision|1|||
46907613|NCT03290781|83136383|FG002|Overall Study|Physician Decision|0|||
46907614|NCT03290781|83136384|FG003|Overall Study|Physician Decision|0|||
46907615|NCT03290781|83136385|FG004|Overall Study|Physician Decision|0|||
46907616|NCT03290781|83136386|FG005|Overall Study|Physician Decision|0|||
46907617|NCT03290781|83136387|FG006|Overall Study|Physician Decision|0|||
46907618|NCT03290781|83136381|FG000|Overall Study|Site Terminated by Sponsor|1|||
46907619|NCT03290781|83136382|FG001|Overall Study|Site Terminated by Sponsor|0|||
46907620|NCT03290781|83136383|FG002|Overall Study|Site Terminated by Sponsor|2|||
46907621|NCT03290781|83136384|FG003|Overall Study|Site Terminated by Sponsor|1|||
46907622|NCT03290781|83136385|FG004|Overall Study|Site Terminated by Sponsor|0|||
46907623|NCT03290781|83136386|FG005|Overall Study|Site Terminated by Sponsor|0|||
46907624|NCT03290781|83136387|FG006|Overall Study|Site Terminated by Sponsor|0|||
46907625|NCT03290781|83136381|FG000|Overall Study|Lost to Follow-up|0|||
46907626|NCT03290781|83136382|FG001|Overall Study|Lost to Follow-up|0|||
46907627|NCT03290781|83136383|FG002|Overall Study|Lost to Follow-up|0|||
46907628|NCT03290781|83136384|FG003|Overall Study|Lost to Follow-up|1|||
46907629|NCT03290781|83136385|FG004|Overall Study|Lost to Follow-up|0|||
46907630|NCT03290781|83136386|FG005|Overall Study|Lost to Follow-up|0|||
46907631|NCT03290781|83136387|FG006|Overall Study|Lost to Follow-up|0|||
46907632|NCT03290781|83136381|FG000|Overall Study|Protocol Deviation|2|||
46907633|NCT03290781|83136382|FG001|Overall Study|Protocol Deviation|0|||
46907634|NCT03290781|83136383|FG002|Overall Study|Protocol Deviation|0|||
46907635|NCT03290781|83136384|FG003|Overall Study|Protocol Deviation|1|||
46907636|NCT03290781|83136385|FG004|Overall Study|Protocol Deviation|0|||
46907637|NCT03290781|83136386|FG005|Overall Study|Protocol Deviation|0|||
46907638|NCT03290781|83136387|FG006|Overall Study|Protocol Deviation|0|||
46907639|NCT03290781|83136381|FG000|Overall Study|Disease Relapse|32|||
46907640|NCT03290781|83136382|FG001|Overall Study|Disease Relapse|5|||
46907641|NCT03290781|83136383|FG002|Overall Study|Disease Relapse|38|||
46907642|NCT03290781|83136384|FG003|Overall Study|Disease Relapse|7|||
46907643|NCT03290781|83136385|FG004|Overall Study|Disease Relapse|3|||
46907644|NCT03290781|83136386|FG005|Overall Study|Disease Relapse|1|||
46907645|NCT03290781|83136387|FG006|Overall Study|Disease Relapse|4|||
46907646|NCT03290781|83136381|FG000|Overall Study|Other|3|||
46907647|NCT03290781|83136382|FG001|Overall Study|Other|0|||
46907648|NCT03290781|83136383|FG002|Overall Study|Other|2|||
46907649|NCT03290781|83136384|FG003|Overall Study|Other|2|||
46907650|NCT03290781|83136385|FG004|Overall Study|Other|0|||
46907651|NCT03290781|83136386|FG005|Overall Study|Other|0|||
46907652|NCT03290781|83136387|FG006|Overall Study|Other|0|||
46907653|NCT03466073|83136416|FG000|Overall Study|Death|1|||
46907654|NCT03466073|83136417|FG001|Overall Study|Death|0|||
46907655|NCT03466073|83136418|FG002|Overall Study|Death|0|||
46907656|NCT03466073|83136419|FG003|Overall Study|Death|0|||
46907657|NCT03466073|83136420|FG004|Overall Study|Death|0|||
46998285|NCT02462057|83245282|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
46998286|NCT02461745|83245296|FG000|Overall Study|Lack of Efficacy|9|||
46998287|NCT02461745|83245297|FG001|Overall Study|Lack of Efficacy|1|||
46998288|NCT02461745|83245296|FG000|Overall Study|Lost to Follow-up|2|||
46998289|NCT02461745|83245297|FG001|Overall Study|Lost to Follow-up|2|||
46998290|NCT02461745|83245296|FG000|Overall Study|Withdrawal by Subject|3|||
46998291|NCT02461745|83245297|FG001|Overall Study|Withdrawal by Subject|1|||
46998292|NCT02034435|83245307|FG000|Overall Study|Withdrawal by Subject|1|||
46998293|NCT02034435|83245308|FG001|Overall Study|Withdrawal by Subject|0|||
46998294|NCT02034435|83245309|FG002|Overall Study|Withdrawal by Subject|0|||
46998295|NCT02034435|83245310|FG003|Overall Study|Withdrawal by Subject|0|||
46998296|NCT02034435|83245307|FG000|Overall Study|Illness|0|||
46998297|NCT02034435|83245308|FG001|Overall Study|Illness|2|||
46998298|NCT02034435|83245309|FG002|Overall Study|Illness|0|||
46998299|NCT02034435|83245310|FG003|Overall Study|Illness|0|||
46998300|NCT02034435|83245307|FG000|Overall Study|Inadequate IV access|1|||
46998301|NCT02034435|83245308|FG001|Overall Study|Inadequate IV access|0|||
46998302|NCT02034435|83245309|FG002|Overall Study|Inadequate IV access|0|||
46998303|NCT02034435|83245310|FG003|Overall Study|Inadequate IV access|1|||
46998304|NCT02033889|83245323|FG000|Overall Study|Adverse Event|3|||
46998305|NCT02033889|83245324|FG001|Overall Study|Adverse Event|1|||
46998306|NCT02033889|83245325|FG002|Overall Study|Adverse Event|3|||
46998307|NCT02033889|83245323|FG000|Overall Study|Death|3|||
46998308|NCT02033889|83245324|FG001|Overall Study|Death|1|||
46998309|NCT02033889|83245325|FG002|Overall Study|Death|2|||
46998310|NCT02033889|83245323|FG000|Overall Study|Excluded Medication|1|||
46998311|NCT02033889|83245324|FG001|Overall Study|Excluded Medication|1|||
46998312|NCT02033889|83245325|FG002|Overall Study|Excluded Medication|0|||
46998313|NCT02033889|83245323|FG000|Overall Study|Lost to Follow-up|8|||
46998314|NCT02033889|83245324|FG001|Overall Study|Lost to Follow-up|5|||
46998315|NCT02033889|83245325|FG002|Overall Study|Lost to Follow-up|6|||
46998316|NCT02033889|83245323|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46998317|NCT02033889|83245324|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46998318|NCT02033889|83245325|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46998319|NCT02033889|83245323|FG000|Overall Study|Physician Decision|0|||
46998320|NCT02033889|83245324|FG001|Overall Study|Physician Decision|1|||
46998321|NCT02033889|83245325|FG002|Overall Study|Physician Decision|1|||
46998322|NCT02033889|83245323|FG000|Overall Study|Participant moved|0|||
46998323|NCT02033889|83245324|FG001|Overall Study|Participant moved|1|||
46998324|NCT02033889|83245325|FG002|Overall Study|Participant moved|0|||
46998325|NCT02033889|83245323|FG000|Overall Study|Withdrawal by Subject|18|||
46998326|NCT02033889|83245324|FG001|Overall Study|Withdrawal by Subject|10|||
46998327|NCT02033889|83245325|FG002|Overall Study|Withdrawal by Subject|13|||
46998328|NCT02447003|83245335|FG000|Overall Study|Other|0|||
46998329|NCT02447003|83245336|FG001|Overall Study|Other|4|||
46998330|NCT02447003|83245335|FG000|Overall Study|Site discontinued|0|||
46998331|NCT02447003|83245336|FG001|Overall Study|Site discontinued|2|||
46998332|NCT02447003|83245335|FG000|Overall Study|Physician Decision|0|||
46998333|NCT02447003|83245336|FG001|Overall Study|Physician Decision|1|||
46998334|NCT02447003|83245335|FG000|Overall Study|Withdrawal by Subject|4|||
46998335|NCT02447003|83245336|FG001|Overall Study|Withdrawal by Subject|3|||
46998336|NCT02447003|83245335|FG000|Overall Study|Sponsor Decision|6|||
46998337|NCT02447003|83245336|FG001|Overall Study|Sponsor Decision|11|||
46998338|NCT02447003|83245335|FG000|Overall Study|Progressive Disease|1|||
46998339|NCT02447003|83245336|FG001|Overall Study|Progressive Disease|0|||
46998340|NCT02447003|83245335|FG000|Overall Study|Lost to Follow-up|5|||
46998341|NCT02447003|83245336|FG001|Overall Study|Lost to Follow-up|0|||
46709226|NCT00964743|82925193|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
46998342|NCT02447003|83245335|FG000|Overall Study|Death|154|||
46998343|NCT02447003|83245336|FG001|Overall Study|Death|63|||
46998344|NCT01844284|83245346|FG000|Overall Study|Lost to Follow-up|12|||
46998345|NCT01844284|83245347|FG001|Overall Study|Lost to Follow-up|7|||
46998346|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Refused|1|||
46998347|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Refused|3|||
46998348|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Medical|0|||
46998349|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Medical|1|||
46998350|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
46998351|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
46998352|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
46998353|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
46709227|NCT00925522|82925197|FG000|Overall Study|study closed -- business decision|20|||
46998354|NCT02054715|83245355|FG000|Baseline/Follow-up 1|No Reason|0|||
46998355|NCT02054715|83245356|FG001|Baseline/Follow-up 1|No Reason|1|||
46998356|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
46998357|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
46998358|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Ineligible|3|||
46998359|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Ineligible|0|||
46998360|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Hospitalization|1|||
46998361|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Hospitalization|0|||
46907658|NCT03466073|83136421|FG005|Overall Study|Death|1|||
46907659|NCT03412019|83136444|FG000|Overall Study|Withdrawal by Subject|1|||
46907660|NCT03412019|83136445|FG001|Overall Study|Withdrawal by Subject|1|||
46907661|NCT03070002|83136451|FG000|Follow up for 2 Years|Death|1|||
46907662|NCT02918318|83136459|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
46998362|NCT02054715|83245355|FG000|Baseline/Follow-up 1|Changed Mind|1|||
46998363|NCT02054715|83245356|FG001|Baseline/Follow-up 1|Changed Mind|0|||
46998364|NCT02054715|83245355|FG000|Follow-up 2|Lost to Followup|3|||
46998365|NCT02054715|83245356|FG001|Follow-up 2|Lost to Followup|1|||
46998366|NCT02054715|83245355|FG000|Follow-up 2|Refused|3|||
46620378|NCT00085735|82762347|FG003|Overall Study|Reason not documented|0|||
46620379|NCT00085735|82762348|FG004|Overall Study|Reason not documented|1|||
46907663|NCT02918318|83136460|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
46907664|NCT02918318|83136461|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
46907665|NCT02918318|83136462|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
46907666|NCT02918318|83136463|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
46907667|NCT02918318|83136459|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
46907668|NCT02918318|83136460|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
46907669|NCT02918318|83136461|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
46907670|NCT02918318|83136462|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
46907671|NCT02918318|83136463|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
46907672|NCT02918318|83136459|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
46907673|NCT02918318|83136460|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
46907674|NCT02918318|83136461|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
46907675|NCT02918318|83136462|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
46907676|NCT02918318|83136463|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
46907677|NCT02918318|83136459|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
46907678|NCT02918318|83136460|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
46907679|NCT02918318|83136461|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
46907680|NCT02918318|83136462|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
46907681|NCT02918318|83136463|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
46907682|NCT02918318|83136459|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
46907683|NCT02918318|83136460|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
46907684|NCT02918318|83136461|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
46907685|NCT02918318|83136462|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
46907686|NCT02918318|83136463|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
46907687|NCT02918318|83136459|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
46907688|NCT02918318|83136460|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
46907689|NCT02918318|83136461|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
46907690|NCT02918318|83136462|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
46907691|NCT02918318|83136463|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
46907692|NCT02918318|83136459|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
46907693|NCT02918318|83136460|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
46907694|NCT02918318|83136461|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
46907695|NCT02918318|83136462|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
46907696|NCT02918318|83136463|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
46907697|NCT02918318|83136459|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
46907698|NCT02918318|83136460|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
46907699|NCT02918318|83136461|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
46907700|NCT02918318|83136462|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
46907701|NCT02918318|83136463|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
46907702|NCT02918318|83136459|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
46907703|NCT02918318|83136460|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
46907704|NCT02918318|83136461|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
46907705|NCT02918318|83136462|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
46907706|NCT02918318|83136463|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
46907707|NCT02918318|83136459|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
46907708|NCT02918318|83136460|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
46907709|NCT02918318|83136461|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
46907710|NCT02918318|83136462|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
46907711|NCT02918318|83136463|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
46907712|NCT02918318|83136459|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
46907713|NCT02918318|83136460|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
46907714|NCT02918318|83136461|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
46907715|NCT02918318|83136462|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
46907716|NCT02918318|83136463|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
46998367|NCT02054715|83245356|FG001|Follow-up 2|Refused|2|||
46998368|NCT02054715|83245355|FG000|Follow-up 2|Followup Not Completed|3|||
46998369|NCT02054715|83245356|FG001|Follow-up 2|Followup Not Completed|4|||
46998370|NCT02054715|83245355|FG000|Follow-up 2|Ineligible|4|||
46998371|NCT02054715|83245356|FG001|Follow-up 2|Ineligible|5|||
46998372|NCT02054715|83245355|FG000|Follow-up 2|Death|3|||
46998373|NCT02054715|83245356|FG001|Follow-up 2|Death|3|||
46998374|NCT02054715|83245355|FG000|Follow-up 2|Hospitalization|0|||
46998375|NCT02054715|83245356|FG001|Follow-up 2|Hospitalization|2|||
46998376|NCT02054715|83245355|FG000|Follow-up 2|Changed MD/Facility|0|||
46998377|NCT02054715|83245356|FG001|Follow-up 2|Changed MD/Facility|1|||
46998378|NCT02054715|83245355|FG000|Follow-up 2|Changed Mind|0|||
46998379|NCT02054715|83245356|FG001|Follow-up 2|Changed Mind|1|||
46998380|NCT02054715|83245355|FG000|Follow-up 2|No Reason|2|||
46998381|NCT02054715|83245356|FG001|Follow-up 2|No Reason|0|||
46998382|NCT02054715|83245355|FG000|Follow-up 2|Treatment Change or Delay|1|||
46998383|NCT02054715|83245356|FG001|Follow-up 2|Treatment Change or Delay|0|||
46998384|NCT02446769|83245362|FG000|Screening Period|Screen Failure|11|||
46998385|NCT02446769|83245363|FG001|Screening Period|Screen Failure|0|||
46998386|NCT02446769|83245364|FG002|Screening Period|Screen Failure|0|||
46998387|NCT02446769|83245362|FG000|Study Period|Randomized in Error|0|||
46998388|NCT02446769|83245363|FG001|Study Period|Randomized in Error|2|||
46998389|NCT02446769|83245364|FG002|Study Period|Randomized in Error|0|||
46998390|NCT02420093|83245373|FG000|Overall Study|Withdrawal by Subject|1|||
46998391|NCT02420093|83245374|FG001|Overall Study|Withdrawal by Subject|1|||
46998392|NCT02419937|83245382|FG000|Overall Study|Lost to Follow-up|1|||
46998393|NCT02419937|83245383|FG001|Overall Study|Lost to Follow-up|0|||
46998394|NCT02054481|83245393|FG000|Overall Study|Adverse Event|1|||
46998395|NCT02054481|83245394|FG001|Overall Study|Adverse Event|1|||
46998396|NCT02054481|83245395|FG002|Overall Study|Adverse Event|0|||
46998397|NCT02054481|83245396|FG003|Overall Study|Adverse Event|1|||
46998398|NCT02054481|83245393|FG000|Overall Study|Lost to Follow-up|1|||
46998399|NCT02054481|83245394|FG001|Overall Study|Lost to Follow-up|0|||
46998400|NCT02054481|83245395|FG002|Overall Study|Lost to Follow-up|0|||
46998401|NCT02054481|83245396|FG003|Overall Study|Lost to Follow-up|0|||
46998402|NCT02054481|83245393|FG000|Overall Study|Other reason|2|||
46998403|NCT02054481|83245394|FG001|Overall Study|Other reason|1|||
46998404|NCT02054481|83245395|FG002|Overall Study|Other reason|2|||
46998405|NCT02054481|83245396|FG003|Overall Study|Other reason|0|||
46998406|NCT01610752|83245410|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
46998407|NCT01610752|83245411|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
46998408|NCT01610752|83245412|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
46998409|NCT02054325|83245422|FG000|Overall Study|Lost to Follow-up|8|||
46998410|NCT02054325|83245423|FG001|Overall Study|Lost to Follow-up|5|||
46998411|NCT02446691|83245429|FG000|Overall Study|Withdrawal by Subject|2|||
46998412|NCT02446691|83245429|FG000|Overall Study|Lost to Follow-up|8|||
46998413|NCT02446691|83245429|FG000|Overall Study|Protocol Violation|1|||
46998414|NCT02091375|83245435|FG000|Overall Study|Adverse Event|8|||
46998415|NCT02091375|83245436|FG001|Overall Study|Adverse Event|1|||
46998416|NCT02091375|83245435|FG000|Overall Study|Lost to Follow-up|0|||
46998417|NCT02091375|83245436|FG001|Overall Study|Lost to Follow-up|1|||
46998418|NCT02091375|83245435|FG000|Overall Study|Withdrawal by Subject|0|||
46998419|NCT02091375|83245436|FG001|Overall Study|Withdrawal by Subject|1|||
46998420|NCT02091375|83245435|FG000|Overall Study|Withdrawn by the investigator|1|||
46998421|NCT02091375|83245436|FG001|Overall Study|Withdrawn by the investigator|0|||
46998422|NCT02032875|83245444|FG000|Treatment Period|Adverse Event|1|||
46998423|NCT02032875|83245445|FG001|Treatment Period|Adverse Event|0|||
46998424|NCT02032875|83245444|FG000|Treatment Period|Liver transplant, No extension needed|0|||
46998425|NCT02032875|83245445|FG001|Treatment Period|Liver transplant, No extension needed|1|||
46998426|NCT02032875|83245444|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
46998427|NCT02032875|83245445|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
46998428|NCT02032875|83245444|FG000|Follow-up Period|Death|0|||
46998429|NCT02032875|83245445|FG001|Follow-up Period|Death|1|||
46998430|NCT02032875|83245444|FG000|Follow-up Period|Virologic Relapse|3|||
46998431|NCT02032875|83245445|FG001|Follow-up Period|Virologic Relapse|10|||
46998432|NCT02032407|83245452|FG000|Overall Study|Lost to Follow-up|2|||
46998433|NCT02032407|83245452|FG000|Overall Study|Pregnancy|1|||
46998434|NCT02032407|83245452|FG000|Overall Study|Other Miscellaneous Reasons|2|||
46998435|NCT01843972|83245470|FG000|Overall Study|Withdrawal by Subject|0|||
46998436|NCT01843972|83245471|FG001|Overall Study|Withdrawal by Subject|0|||
46998437|NCT01843972|83245472|FG002|Overall Study|Withdrawal by Subject|0|||
46998438|NCT01843972|83245473|FG003|Overall Study|Withdrawal by Subject|0|||
46998439|NCT01843972|83245474|FG004|Overall Study|Withdrawal by Subject|1|||
46998440|NCT01843972|83245475|FG005|Overall Study|Withdrawal by Subject|0|||
46998441|NCT01843972|83245476|FG006|Overall Study|Withdrawal by Subject|0|||
46998442|NCT01843972|83245477|FG007|Overall Study|Withdrawal by Subject|0|||
46998443|NCT01843972|83245478|FG008|Overall Study|Withdrawal by Subject|0|||
46998444|NCT01843972|83245479|FG009|Overall Study|Withdrawal by Subject|0|||
46998445|NCT01826422|83245517|FG000|Overall Study|Withdrawal by Subject|1|||
46998446|NCT01826422|83245518|FG001|Overall Study|Withdrawal by Subject|3|||
46998447|NCT01843660|83245524|FG000|Overall Study|Other|30|||
46998448|NCT02090283|83245531|FG000|Overall Study|Withdrawal by Subject|6|||
46998449|NCT02090283|83245532|FG001|Overall Study|Withdrawal by Subject|6|||
46998450|NCT02090283|83245533|FG002|Overall Study|Withdrawal by Subject|6|||
46998451|NCT02090283|83245531|FG000|Overall Study|Sponsor Terminated Study|6|||
46998452|NCT02090283|83245532|FG001|Overall Study|Sponsor Terminated Study|6|||
46998453|NCT02090283|83245533|FG002|Overall Study|Sponsor Terminated Study|1|||
46998454|NCT02090283|83245531|FG000|Overall Study|Lost to Follow-up|2|||
46998455|NCT02090283|83245532|FG001|Overall Study|Lost to Follow-up|2|||
46998456|NCT02090283|83245533|FG002|Overall Study|Lost to Follow-up|3|||
46998457|NCT02090283|83245531|FG000|Overall Study|Adverse Event|1|||
46998458|NCT02090283|83245532|FG001|Overall Study|Adverse Event|1|||
46998459|NCT02090283|83245533|FG002|Overall Study|Adverse Event|0|||
46998460|NCT02090283|83245531|FG000|Overall Study|Protocol Violation|2|||
46998461|NCT02090283|83245532|FG001|Overall Study|Protocol Violation|0|||
46998462|NCT02090283|83245533|FG002|Overall Study|Protocol Violation|0|||
46998463|NCT02032173|83245541|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
46998464|NCT02031471|83245545|FG000|24 Week Treatment Period|Adverse Event|6|||
46998465|NCT02031471|83245545|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
46998466|NCT02031471|83245545|FG000|24 Week Treatment Period|Protocol Violation|1|||
46998467|NCT02031471|83245545|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
46998468|NCT02031471|83245545|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
46998469|NCT02031471|83245545|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
46998470|NCT02031471|83245545|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
46998471|NCT02461589|83245559|FG000|Overall Study|Withdrawal by Subject|5|||
46998472|NCT02461589|83245560|FG001|Overall Study|Withdrawal by Subject|1|||
46998473|NCT02461589|83245561|FG002|Overall Study|Withdrawal by Subject|3|||
46998474|NCT02461589|83245562|FG003|Overall Study|Withdrawal by Subject|2|||
46998475|NCT02461589|83245563|FG004|Overall Study|Withdrawal by Subject|1|||
46998476|NCT02461589|83245564|FG005|Overall Study|Withdrawal by Subject|2|||
46998477|NCT02461589|83245565|FG006|Overall Study|Withdrawal by Subject|1|||
46998478|NCT02461589|83245566|FG007|Overall Study|Withdrawal by Subject|3|||
46998479|NCT02461589|83245567|FG008|Overall Study|Withdrawal by Subject|3|||
46998480|NCT02461589|83245568|FG009|Overall Study|Withdrawal by Subject|1|||
46998481|NCT02461589|83245559|FG000|Overall Study|Lost to Follow-up|0|||
46998482|NCT02461589|83245560|FG001|Overall Study|Lost to Follow-up|0|||
46998483|NCT02461589|83245561|FG002|Overall Study|Lost to Follow-up|2|||
46998484|NCT02461589|83245562|FG003|Overall Study|Lost to Follow-up|3|||
46998485|NCT02461589|83245563|FG004|Overall Study|Lost to Follow-up|1|||
46998486|NCT02461589|83245564|FG005|Overall Study|Lost to Follow-up|1|||
46998487|NCT02461589|83245565|FG006|Overall Study|Lost to Follow-up|3|||
46998488|NCT02461589|83245566|FG007|Overall Study|Lost to Follow-up|1|||
46998489|NCT02461589|83245567|FG008|Overall Study|Lost to Follow-up|3|||
46907717|NCT02918318|83136459|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
46907718|NCT02918318|83136460|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
46907719|NCT02918318|83136461|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
46907720|NCT02918318|83136462|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
46907721|NCT02918318|83136463|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
46907722|NCT03411863|83136508|FG000|Overall Study|Withdrawal by Subject|3|||
46907723|NCT03411863|83136509|FG001|Overall Study|Withdrawal by Subject|1|||
46907724|NCT03411863|83136508|FG000|Overall Study|Physician Decision|0|||
46907725|NCT03411863|83136509|FG001|Overall Study|Physician Decision|1|||
46907726|NCT01065350|83136518|FG000|Overall Study|Received incorrect drug allocation|0|||
46907727|NCT01065350|83136519|FG001|Overall Study|Received incorrect drug allocation|1|||
46907728|NCT03434249|83136527|FG000|Overall Study|Adverse Event|1|||
46907729|NCT03434249|83136528|FG001|Overall Study|Adverse Event|0|||
46907730|NCT03434249|83136527|FG000|Overall Study|Lost to Follow-up|0|||
46907731|NCT03434249|83136528|FG001|Overall Study|Lost to Follow-up|1|||
46907732|NCT03434249|83136527|FG000|Overall Study|Non-compliance of family|2|||
46998490|NCT02461589|83245568|FG009|Overall Study|Lost to Follow-up|1|||
46998491|NCT02461589|83245559|FG000|Overall Study|Death|0|||
46998492|NCT02461589|83245560|FG001|Overall Study|Death|0|||
46998493|NCT02461589|83245561|FG002|Overall Study|Death|0|||
46998494|NCT02461589|83245562|FG003|Overall Study|Death|0|||
46998495|NCT02461589|83245563|FG004|Overall Study|Death|0|||
46998496|NCT02461589|83245564|FG005|Overall Study|Death|0|||
46998497|NCT02461589|83245565|FG006|Overall Study|Death|0|||
46998498|NCT02461589|83245566|FG007|Overall Study|Death|1|||
46998499|NCT02461589|83245567|FG008|Overall Study|Death|0|||
46998500|NCT02461589|83245568|FG009|Overall Study|Death|0|||
46998501|NCT02461589|83245559|FG000|Overall Study|Unclassified|0|||
46998502|NCT02461589|83245560|FG001|Overall Study|Unclassified|0|||
46998503|NCT02461589|83245561|FG002|Overall Study|Unclassified|0|||
46998504|NCT02461589|83245562|FG003|Overall Study|Unclassified|0|||
46998505|NCT02461589|83245563|FG004|Overall Study|Unclassified|0|||
46998506|NCT02461589|83245564|FG005|Overall Study|Unclassified|0|||
46998507|NCT02461589|83245565|FG006|Overall Study|Unclassified|1|||
46998508|NCT02461589|83245566|FG007|Overall Study|Unclassified|0|||
46998509|NCT02461589|83245567|FG008|Overall Study|Unclassified|0|||
46998510|NCT02461589|83245568|FG009|Overall Study|Unclassified|2|||
46998511|NCT02461589|83245559|FG000|Overall Study|Missing follow-up information|1|||
46998512|NCT02461589|83245560|FG001|Overall Study|Missing follow-up information|1|||
46998513|NCT02461589|83245561|FG002|Overall Study|Missing follow-up information|0|||
46998514|NCT02461589|83245562|FG003|Overall Study|Missing follow-up information|0|||
46998515|NCT02461589|83245563|FG004|Overall Study|Missing follow-up information|0|||
46998516|NCT02461589|83245564|FG005|Overall Study|Missing follow-up information|0|||
46998517|NCT02461589|83245565|FG006|Overall Study|Missing follow-up information|1|||
46998518|NCT02461589|83245566|FG007|Overall Study|Missing follow-up information|0|||
46998519|NCT02461589|83245567|FG008|Overall Study|Missing follow-up information|0|||
46907733|NCT03434249|83136528|FG001|Overall Study|Non-compliance of family|1|||
46907734|NCT03434249|83136527|FG000|Overall Study|Difficulties in completing daily diary|2|||
46907735|NCT03434249|83136528|FG001|Overall Study|Difficulties in completing daily diary|1|||
46907736|NCT03114969|83136543|FG000|Overall Study|Lost to Follow-up|0|||
46907737|NCT03114969|83136544|FG001|Overall Study|Lost to Follow-up|0|||
46907738|NCT03114969|83136545|FG002|Overall Study|Lost to Follow-up|3|||
46907739|NCT03114969|83136546|FG003|Overall Study|Lost to Follow-up|2|||
46907740|NCT03114969|83136547|FG004|Overall Study|Lost to Follow-up|0|||
46998520|NCT02461589|83245568|FG009|Overall Study|Missing follow-up information|0|||
46998521|NCT02461589|83245559|FG000|Overall Study|Withdrawal from trial before exposure|0|||
46998522|NCT02461589|83245560|FG001|Overall Study|Withdrawal from trial before exposure|0|||
46998523|NCT02461589|83245561|FG002|Overall Study|Withdrawal from trial before exposure|0|||
46998524|NCT02461589|83245562|FG003|Overall Study|Withdrawal from trial before exposure|0|||
46998525|NCT02461589|83245563|FG004|Overall Study|Withdrawal from trial before exposure|0|||
46998526|NCT02461589|83245564|FG005|Overall Study|Withdrawal from trial before exposure|0|||
46998527|NCT02461589|83245565|FG006|Overall Study|Withdrawal from trial before exposure|0|||
46998528|NCT02461589|83245566|FG007|Overall Study|Withdrawal from trial before exposure|0|||
46998529|NCT02461589|83245567|FG008|Overall Study|Withdrawal from trial before exposure|0|||
46998530|NCT02461589|83245568|FG009|Overall Study|Withdrawal from trial before exposure|1|||
46998531|NCT02089737|83245590|FG000|Overall Study|Survey form not completed|5|||
46998532|NCT02089737|83245590|FG000|Overall Study|Not treated|1|||
46998533|NCT02460575|83245597|FG000|Overall Study|Lost to Follow-up|1|||
46998534|NCT02460575|83245598|FG001|Overall Study|Lost to Follow-up|0|||
46998535|NCT02089347|83245606|FG000|Overall Study|Protocol Violation|1|||
46998536|NCT02089347|83245607|FG001|Overall Study|Protocol Violation|0|||
46998537|NCT02445755|83245613|FG000|Overall Study|Withdrawal by Subject|2|||
46998538|NCT02445755|83245613|FG000|Overall Study|Protocol Violation|6|||
46709228|NCT01130532|82925204|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
46709229|NCT01130532|82925205|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
46803623|NCT03523728|83022938|FG000|Stage 1 (24 Months)|Adverse Event|2|||
46907741|NCT03114969|83136548|FG005|Overall Study|Lost to Follow-up|0|||
46907742|NCT03114969|83136549|FG006|Overall Study|Lost to Follow-up|0|||
46907743|NCT03114969|83136550|FG007|Overall Study|Lost to Follow-up|0|||
46907744|NCT03114969|83136551|FG008|Overall Study|Lost to Follow-up|0|||
46907745|NCT03114969|83136543|FG000|Overall Study|Adverse Event|0|||
46907746|NCT03114969|83136544|FG001|Overall Study|Adverse Event|0|||
46907747|NCT03114969|83136545|FG002|Overall Study|Adverse Event|1|||
46907748|NCT03114969|83136546|FG003|Overall Study|Adverse Event|0|||
46907749|NCT03114969|83136547|FG004|Overall Study|Adverse Event|0|||
46907750|NCT03114969|83136548|FG005|Overall Study|Adverse Event|1|||
46907751|NCT03114969|83136549|FG006|Overall Study|Adverse Event|1|||
46907752|NCT03114969|83136550|FG007|Overall Study|Adverse Event|0|||
46907753|NCT03114969|83136551|FG008|Overall Study|Adverse Event|2|||
46907754|NCT02046096|83136580|FG000|Overall Study|Death|28|||
46907755|NCT02046096|83136581|FG001|Overall Study|Death|45|||
46907756|NCT02046096|83136580|FG000|Overall Study|Lost to Follow-up|9|||
46907757|NCT02046096|83136581|FG001|Overall Study|Lost to Follow-up|20|||
46907758|NCT02046096|83136580|FG000|Overall Study|Withdrawal by Subject|5|||
46907759|NCT02046096|83136581|FG001|Overall Study|Withdrawal by Subject|17|||
46907760|NCT02046096|83136580|FG000|Overall Study|Other endpoint|2|||
46998539|NCT02445755|83245613|FG000|Overall Study|Screen Failure|5|||
46998540|NCT02419469|83245620|FG000|Overall Study|Withdrawal by Subject|1|||
46998541|NCT02419313|83245624|FG000|First Intervention|Lost to Follow-up|2|||
46998542|NCT02419313|83245625|FG001|First Intervention|Lost to Follow-up|0|||
46998543|NCT02419313|83245624|FG000|Second Intervention|Lost to Follow-up|1|||
46998544|NCT02419313|83245625|FG001|Second Intervention|Lost to Follow-up|0|||
46998545|NCT02419001|83245633|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
46998546|NCT02419001|83245634|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
46998547|NCT02031237|83245642|FG000|Overall Study|Death|1|||
46998548|NCT02031237|83245643|FG001|Overall Study|Death|5|||
46998549|NCT02031237|83245644|FG002|Overall Study|Death|0|||
46998550|NCT02031237|83245642|FG000|Overall Study|Physician Decision|0|||
46998551|NCT02031237|83245643|FG001|Overall Study|Physician Decision|1|||
46998552|NCT02031237|83245644|FG002|Overall Study|Physician Decision|0|||
46998553|NCT02031237|83245642|FG000|Overall Study|Withdrawal by Subject|2|||
46998554|NCT02031237|83245643|FG001|Overall Study|Withdrawal by Subject|2|||
46998555|NCT02031237|83245644|FG002|Overall Study|Withdrawal by Subject|0|||
46998556|NCT02031237|83245642|FG000|Overall Study|Protocol Violation|2|||
46998557|NCT02031237|83245643|FG001|Overall Study|Protocol Violation|6|||
46998558|NCT02031237|83245644|FG002|Overall Study|Protocol Violation|0|||
46998559|NCT02031237|83245642|FG000|Overall Study|Alternate Treatment Given|0|||
46998560|NCT02031237|83245643|FG001|Overall Study|Alternate Treatment Given|0|||
46998561|NCT02031237|83245644|FG002|Overall Study|Alternate Treatment Given|3|||
46998562|NCT02088957|83245651|FG000|Overall Study|Lack of Efficacy|1|||
46998563|NCT02088957|83245652|FG001|Overall Study|Lack of Efficacy|0|||
46998564|NCT02418845|83245660|FG000|Overall Study|Lost to Follow-up|7|||
46998565|NCT02418845|83245661|FG001|Overall Study|Lost to Follow-up|2|||
46998566|NCT02418845|83245660|FG000|Overall Study|Lack of Efficacy|0|||
46998567|NCT02418845|83245661|FG001|Overall Study|Lack of Efficacy|3|||
46998568|NCT02418845|83245660|FG000|Overall Study|Physician Decision|5|||
46998569|NCT02418845|83245661|FG001|Overall Study|Physician Decision|5|||
46998570|NCT02418845|83245660|FG000|Overall Study|Protocol Violation|1|||
46998571|NCT02418845|83245661|FG001|Overall Study|Protocol Violation|0|||
46998572|NCT02418845|83245660|FG000|Overall Study|Withdrawal by Subject|3|||
46998573|NCT02418845|83245661|FG001|Overall Study|Withdrawal by Subject|2|||
46998574|NCT02088177|83245667|FG000|Overall Study|Lost to Follow-up|3|||
46998575|NCT02030535|83245671|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
46998576|NCT02029989|83245687|FG000|Overall Study|Withdrawal by Subject|1|||
46998577|NCT02029989|83245688|FG001|Overall Study|Withdrawal by Subject|0|||
46998578|NCT02029989|83245687|FG000|Overall Study|Withdrawal: Fear of needles|1|||
46998579|NCT02029989|83245688|FG001|Overall Study|Withdrawal: Fear of needles|0|||
46998580|NCT02029989|83245687|FG000|Overall Study|Change of location|2|||
46998581|NCT02029989|83245688|FG001|Overall Study|Change of location|3|||
46998582|NCT02029989|83245687|FG000|Overall Study|Physician Decision|2|||
46998583|NCT02029989|83245688|FG001|Overall Study|Physician Decision|0|||
46998584|NCT02029989|83245687|FG000|Overall Study|Lost to Follow-up|9|||
46998585|NCT02029989|83245688|FG001|Overall Study|Lost to Follow-up|7|||
46998586|NCT02029989|83245687|FG000|Overall Study|Death|0|||
46998587|NCT02029989|83245688|FG001|Overall Study|Death|1|||
46998588|NCT02029989|83245687|FG000|Overall Study|Protocol Violation|1|||
46998589|NCT02029989|83245688|FG001|Overall Study|Protocol Violation|0|||
46998590|NCT02048241|83245696|FG000|Overall Study|Withdrawal by Subject|0|||
46998591|NCT02048241|83245697|FG001|Overall Study|Withdrawal by Subject|1|||
46998592|NCT02087943|83245706|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
46998593|NCT02087943|83245707|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
46998594|NCT02087943|83245708|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
46998595|NCT02087943|83245709|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
46998596|NCT02087943|83245710|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
46998597|NCT02087943|83245706|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
46998598|NCT02087943|83245707|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
46998599|NCT02087943|83245708|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
46998600|NCT02087943|83245709|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
46998601|NCT02087943|83245710|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
46998602|NCT02087943|83245706|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
46998603|NCT02087943|83245707|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
46998604|NCT02087943|83245708|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
46998605|NCT02087943|83245709|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
46998606|NCT02087943|83245710|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
46998607|NCT02087943|83245706|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
46620380|NCT00085735|82762349|FG005|Overall Study|Reason not documented|0|||
46803624|NCT03523728|83022939|FG001|Stage 1 (24 Months)|Adverse Event|2|||
46998608|NCT02087943|83245707|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
46998609|NCT02087943|83245708|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
46998610|NCT02087943|83245709|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
46998611|NCT02087943|83245710|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
46998612|NCT02087943|83245706|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
46998613|NCT02087943|83245707|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
46998614|NCT02087943|83245708|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
46998615|NCT02087943|83245709|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
46620381|NCT00085735|82762344|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
46998616|NCT02087943|83245710|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
46998617|NCT02087943|83245706|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
46998618|NCT02087943|83245707|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
46998619|NCT02087943|83245708|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
46998620|NCT02087943|83245709|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
46998621|NCT02087943|83245710|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
46998622|NCT02087943|83245706|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
46998623|NCT02087943|83245707|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
46998624|NCT02087943|83245708|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
46998625|NCT02087943|83245709|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
46998626|NCT02087943|83245710|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
46998627|NCT02087943|83245706|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
46998628|NCT02087943|83245707|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
46998629|NCT02087943|83245708|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
46998630|NCT02087943|83245709|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
46998631|NCT02087943|83245710|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
46998632|NCT02087943|83245706|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
46998633|NCT02087943|83245707|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
46998634|NCT02087943|83245708|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
46998635|NCT02087943|83245709|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
46998636|NCT02087943|83245710|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
46998637|NCT02087943|83245706|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
46998638|NCT02087943|83245707|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
46998639|NCT02087943|83245708|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
46998640|NCT02087943|83245709|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
46998641|NCT02087943|83245710|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
46998642|NCT02029521|83245724|FG000|Overall Study|Protocol Violation|1|||
46998643|NCT02029521|83245725|FG001|Overall Study|Protocol Violation|0|||
46998644|NCT02029521|83245724|FG000|Overall Study|Withdrawal by Subject|1|||
46998645|NCT02029521|83245725|FG001|Overall Study|Withdrawal by Subject|1|||
46998646|NCT02443883|83245746|FG000|Overall Study|Adverse Event|0|||
46998647|NCT02443883|83245747|FG001|Overall Study|Adverse Event|1|||
46998648|NCT02443883|83245748|FG002|Overall Study|Adverse Event|0|||
46998649|NCT02443883|83245749|FG003|Overall Study|Adverse Event|0|||
46998650|NCT02443883|83245746|FG000|Overall Study|Lost to Follow-up|3|||
46998651|NCT02443883|83245747|FG001|Overall Study|Lost to Follow-up|2|||
46998652|NCT02443883|83245748|FG002|Overall Study|Lost to Follow-up|1|||
46998653|NCT02443883|83245749|FG003|Overall Study|Lost to Follow-up|0|||
46998654|NCT02443883|83245746|FG000|Overall Study|Physician Decision|1|||
46998655|NCT02443883|83245747|FG001|Overall Study|Physician Decision|1|||
46998656|NCT02443883|83245748|FG002|Overall Study|Physician Decision|0|||
46998657|NCT02443883|83245749|FG003|Overall Study|Physician Decision|3|||
46998658|NCT02443883|83245746|FG000|Overall Study|Withdrawal by Subject|1|||
46998659|NCT02443883|83245747|FG001|Overall Study|Withdrawal by Subject|0|||
46998660|NCT02443883|83245748|FG002|Overall Study|Withdrawal by Subject|0|||
46998661|NCT02443883|83245749|FG003|Overall Study|Withdrawal by Subject|2|||
46998662|NCT02443883|83245746|FG000|Overall Study|Randomized, but never treated|1|||
46998663|NCT02443883|83245747|FG001|Overall Study|Randomized, but never treated|0|||
46998664|NCT02443883|83245748|FG002|Overall Study|Randomized, but never treated|0|||
46998665|NCT02443883|83245749|FG003|Overall Study|Randomized, but never treated|0|||
46998666|NCT02460263|83245759|FG000|Transition Period|Withdrawal by Subject|1|||
46998667|NCT02460263|83245759|FG000|Transition Period|Death|1|||
46998668|NCT02443805|83245769|FG000|Overall Study|Adverse Event|100|||
46998669|NCT02443805|83245770|FG001|Overall Study|Adverse Event|18|||
46998670|NCT02443805|83245769|FG000|Overall Study|Withdrawal by Subject|73|||
46998671|NCT02443805|83245770|FG001|Overall Study|Withdrawal by Subject|74|||
46998672|NCT02443805|83245769|FG000|Overall Study|Lost to Follow-up|19|||
46998673|NCT02443805|83245770|FG001|Overall Study|Lost to Follow-up|14|||
46998674|NCT02443805|83245769|FG000|Overall Study|Pregnancy|6|||
46998675|NCT02443805|83245770|FG001|Overall Study|Pregnancy|5|||
46998676|NCT02443805|83245769|FG000|Overall Study|Protocol Violation|2|||
46998677|NCT02443805|83245770|FG001|Overall Study|Protocol Violation|4|||
46998678|NCT02443805|83245769|FG000|Overall Study|Lack of Efficacy|1|||
46998679|NCT02443805|83245770|FG001|Overall Study|Lack of Efficacy|1|||
46998680|NCT02443805|83245769|FG000|Overall Study|Non-compliance with study drug|6|||
46998681|NCT02443805|83245770|FG001|Overall Study|Non-compliance with study drug|4|||
46998682|NCT02443805|83245769|FG000|Overall Study|Withdrawal by parent/guardian|3|||
46998683|NCT02443805|83245770|FG001|Overall Study|Withdrawal by parent/guardian|5|||
46998684|NCT02443805|83245769|FG000|Overall Study|Any other reason not above-mentioned|3|||
46998685|NCT02443805|83245770|FG001|Overall Study|Any other reason not above-mentioned|2|||
46998686|NCT01652885|83245776|FG000|Overall Study|Adverse Event|1|||
46998687|NCT02459951|83245780|FG000|Overall Study|Unable to meet holding requirement|1|||
46803625|NCT03523728|83022940|FG002|Stage 1 (24 Months)|Adverse Event|4|||
46998688|NCT02087241|83245789|FG000|Overall Study|Death|2|||
46998689|NCT02087241|83245790|FG001|Overall Study|Death|1|||
46998690|NCT02087241|83245791|FG002|Overall Study|Death|1|||
46998691|NCT02087241|83245792|FG003|Overall Study|Death|1|||
46998692|NCT02087241|83245789|FG000|Overall Study|Withdrawal by Subject|1|||
46998693|NCT02087241|83245790|FG001|Overall Study|Withdrawal by Subject|0|||
46998694|NCT02087241|83245791|FG002|Overall Study|Withdrawal by Subject|0|||
46998695|NCT02087241|83245792|FG003|Overall Study|Withdrawal by Subject|1|||
46998696|NCT02087241|83245789|FG000|Overall Study|Progressive Disease|0|||
46998697|NCT02087241|83245790|FG001|Overall Study|Progressive Disease|0|||
46998698|NCT02087241|83245791|FG002|Overall Study|Progressive Disease|0|||
46998699|NCT02087241|83245792|FG003|Overall Study|Progressive Disease|1|||
46998700|NCT02087241|83245789|FG000|Overall Study|Study Terminated by Sponsor|0|||
46998701|NCT02087241|83245790|FG001|Overall Study|Study Terminated by Sponsor|2|||
46998702|NCT02087241|83245791|FG002|Overall Study|Study Terminated by Sponsor|0|||
46998703|NCT02087241|83245792|FG003|Overall Study|Study Terminated by Sponsor|4|||
46998704|NCT02087085|83245808|FG000|Overall Study|Adverse Event|10|||
46998705|NCT02087085|83245809|FG001|Overall Study|Adverse Event|14|||
46998706|NCT02087085|83245808|FG000|Overall Study|Lack of Efficacy|4|||
46998707|NCT02087085|83245809|FG001|Overall Study|Lack of Efficacy|3|||
46998708|NCT02087085|83245808|FG000|Overall Study|Lost to Follow-up|6|||
46998709|NCT02087085|83245809|FG001|Overall Study|Lost to Follow-up|4|||
46998710|NCT02087085|83245808|FG000|Overall Study|Withdrawal by Subject|9|||
46998711|NCT02087085|83245809|FG001|Overall Study|Withdrawal by Subject|11|||
46998712|NCT02087085|83245808|FG000|Overall Study|Protocol Violation|1|||
46998713|NCT02087085|83245809|FG001|Overall Study|Protocol Violation|0|||
46998714|NCT02087085|83245808|FG000|Overall Study|Study Terminated by Sponsor|87|||
46998715|NCT02087085|83245809|FG001|Overall Study|Study Terminated by Sponsor|80|||
46998716|NCT02087085|83245808|FG000|Overall Study|Other Miscellaneous Reasons|3|||
46709230|NCT01130532|82925206|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
46907761|NCT02046096|83136581|FG001|Overall Study|Other endpoint|19|||
46907762|NCT03463577|83136595|FG000|Overall Study|Lost to Follow-up|238|||
46907763|NCT03463577|83136596|FG001|Overall Study|Lost to Follow-up|435|||
46907764|NCT03463577|83136597|FG002|Overall Study|Lost to Follow-up|0|||
46907765|NCT03463577|83136598|FG003|Overall Study|Lost to Follow-up|0|||
46907766|NCT03463577|83136599|FG004|Overall Study|Lost to Follow-up|0|||
46907767|NCT03463577|83136600|FG005|Overall Study|Lost to Follow-up|0|||
46907768|NCT03463577|83136595|FG000|Overall Study|With unknown pregnancy outcome|0|||
46907769|NCT03463577|83136596|FG001|Overall Study|With unknown pregnancy outcome|5|||
46907770|NCT03463577|83136597|FG002|Overall Study|With unknown pregnancy outcome|0|||
46998717|NCT02087085|83245809|FG001|Overall Study|Other Miscellaneous Reasons|4|||
46709231|NCT01130532|82925207|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
46709232|NCT01130532|82925204|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
46709233|NCT01130532|82925205|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
46709234|NCT01130532|82925206|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
46709235|NCT01130532|82925207|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
46709236|NCT01130532|82925204|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
46709237|NCT01130532|82925205|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
46709238|NCT01130532|82925206|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
46709239|NCT01130532|82925207|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
46709240|NCT01130532|82925204|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
46709241|NCT01130532|82925205|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
46709242|NCT01130532|82925206|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
46709243|NCT01130532|82925207|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
46709244|NCT01130532|82925204|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
46709245|NCT01130532|82925205|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
46709246|NCT01130532|82925206|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
46709247|NCT01130532|82925207|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
46709248|NCT01130532|82925204|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
46709249|NCT01130532|82925205|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
46907771|NCT03463577|83136598|FG003|Overall Study|With unknown pregnancy outcome|0|||
46907772|NCT03463577|83136599|FG004|Overall Study|With unknown pregnancy outcome|0|||
46907773|NCT03463577|83136600|FG005|Overall Study|With unknown pregnancy outcome|0|||
46907774|NCT03463577|83136595|FG000|Overall Study|Maternal death|2|||
46998718|NCT02443337|83245817|FG000|Overall Study|Adverse Event|0|||
46998719|NCT02443337|83245818|FG001|Overall Study|Adverse Event|1|||
46998720|NCT02443337|83245817|FG000|Overall Study|Clinical Progressive Disease|3|||
46998721|NCT02443337|83245818|FG001|Overall Study|Clinical Progressive Disease|0|||
46998722|NCT02443337|83245817|FG000|Overall Study|Withdrawal by Subject|2|||
46998723|NCT02443337|83245818|FG001|Overall Study|Withdrawal by Subject|1|||
46998724|NCT02443103|83245829|FG000|Overall Study|Adverse Event|2|||
46998725|NCT02443103|83245829|FG000|Overall Study|Noncompliance|1|||
46998726|NCT02022657|83245833|FG000|Overall Study|Withdrawal by Subject|2|||
46709250|NCT01130532|82925206|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
46709251|NCT01130532|82925207|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
46907775|NCT03463577|83136596|FG001|Overall Study|Maternal death|0|||
46998727|NCT02022657|83245834|FG001|Overall Study|Withdrawal by Subject|0|||
46998728|NCT02022657|83245835|FG002|Overall Study|Withdrawal by Subject|1|||
46998729|NCT02022657|83245836|FG003|Overall Study|Withdrawal by Subject|0|||
46998730|NCT02022657|83245837|FG004|Overall Study|Withdrawal by Subject|0|||
46998731|NCT02022657|83245838|FG005|Overall Study|Withdrawal by Subject|0|||
46998732|NCT02022657|83245833|FG000|Overall Study|Physician Decision|0|||
46998733|NCT02022657|83245834|FG001|Overall Study|Physician Decision|0|||
46998734|NCT02022657|83245835|FG002|Overall Study|Physician Decision|0|||
46998735|NCT02022657|83245836|FG003|Overall Study|Physician Decision|0|||
46998736|NCT02022657|83245837|FG004|Overall Study|Physician Decision|0|||
46998737|NCT02022657|83245838|FG005|Overall Study|Physician Decision|1|||
46998738|NCT02418455|83245844|FG000|48-Week Treatment Period|Other- Not Specified|1|||
46998739|NCT02418455|83245844|FG000|Continuation Period|Sponsor Decision|7|||
46998740|NCT02417753|83245850|FG000|Overall Study|Death|1|||
46998741|NCT02417441|83245856|FG000|Overall Study|Inconclusive due to missing data|52|||
46998742|NCT02417441|83245857|FG001|Overall Study|Inconclusive due to missing data|19|||
46998743|NCT02021643|83245870|FG000|Overall Study|Enrolled but Never Treated|1|||
46998744|NCT02021643|83245871|FG001|Overall Study|Enrolled but Never Treated|0|||
46998745|NCT02021643|83245872|FG002|Overall Study|Enrolled but Never Treated|0|||
46998746|NCT02021643|83245873|FG003|Overall Study|Enrolled but Never Treated|0|||
46998747|NCT02021643|83245870|FG000|Overall Study|Adverse Event|0|||
46998748|NCT02021643|83245871|FG001|Overall Study|Adverse Event|1|||
46998749|NCT02021643|83245872|FG002|Overall Study|Adverse Event|0|||
46998750|NCT02021643|83245873|FG003|Overall Study|Adverse Event|0|||
46998751|NCT02021643|83245870|FG000|Overall Study|Death|0|||
46998752|NCT02021643|83245871|FG001|Overall Study|Death|1|||
46998753|NCT02021643|83245872|FG002|Overall Study|Death|0|||
46998754|NCT02021643|83245873|FG003|Overall Study|Death|0|||
46998755|NCT02021643|83245870|FG000|Overall Study|Investigator's Discretion|1|||
46998756|NCT02021643|83245871|FG001|Overall Study|Investigator's Discretion|0|||
46998757|NCT02021643|83245872|FG002|Overall Study|Investigator's Discretion|0|||
46998758|NCT02021643|83245873|FG003|Overall Study|Investigator's Discretion|0|||
46998759|NCT02021643|83245870|FG000|Overall Study|Lack of Efficacy|7|||
46998760|NCT02021643|83245871|FG001|Overall Study|Lack of Efficacy|6|||
46998761|NCT02021643|83245872|FG002|Overall Study|Lack of Efficacy|0|||
46998762|NCT02021643|83245873|FG003|Overall Study|Lack of Efficacy|12|||
46998763|NCT02021643|83245870|FG000|Overall Study|Lost to Follow-up|0|||
46998764|NCT02021643|83245871|FG001|Overall Study|Lost to Follow-up|1|||
46998765|NCT02021643|83245872|FG002|Overall Study|Lost to Follow-up|0|||
46998766|NCT02021643|83245873|FG003|Overall Study|Lost to Follow-up|0|||
46998767|NCT02021643|83245870|FG000|Overall Study|Withdrew Consent|0|||
46998768|NCT02021643|83245871|FG001|Overall Study|Withdrew Consent|1|||
46998769|NCT02021643|83245872|FG002|Overall Study|Withdrew Consent|0|||
46998770|NCT02021643|83245873|FG003|Overall Study|Withdrew Consent|0|||
46998771|NCT02415959|83245894|FG000|Overall Study|Adverse Event|0|||
46998772|NCT02415959|83245895|FG001|Overall Study|Adverse Event|1|||
46620382|NCT00085735|82762345|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
46620383|NCT00085735|82762346|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
46907776|NCT03463577|83136597|FG002|Overall Study|Maternal death|0|||
46907777|NCT03463577|83136598|FG003|Overall Study|Maternal death|0|||
46907778|NCT03463577|83136599|FG004|Overall Study|Maternal death|0|||
46907779|NCT03463577|83136600|FG005|Overall Study|Maternal death|0|||
46998773|NCT02415959|83245896|FG002|Overall Study|Adverse Event|0|||
46998774|NCT02415959|83245897|FG003|Overall Study|Adverse Event|0|||
46998775|NCT02415959|83245898|FG004|Overall Study|Adverse Event|0|||
46998776|NCT02415959|83245894|FG000|Overall Study|Protocol Violation|0|||
46907780|NCT03463577|83136595|FG000|Overall Study|Neonatal death|0|||
46907781|NCT03463577|83136596|FG001|Overall Study|Neonatal death|0|||
46907782|NCT03463577|83136597|FG002|Overall Study|Neonatal death|0|||
46907783|NCT03463577|83136598|FG003|Overall Study|Neonatal death|15|||
46907784|NCT03463577|83136599|FG004|Overall Study|Neonatal death|17|||
46998777|NCT02415959|83245895|FG001|Overall Study|Protocol Violation|0|||
46998778|NCT02415959|83245896|FG002|Overall Study|Protocol Violation|0|||
46998779|NCT02415959|83245897|FG003|Overall Study|Protocol Violation|1|||
46998780|NCT02415959|83245898|FG004|Overall Study|Protocol Violation|0|||
46620384|NCT00085735|82762347|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
46907785|NCT03463577|83136600|FG005|Overall Study|Neonatal death|0|||
46907786|NCT03122145|83136616|FG000|Overall Study|Concurrent respiratory disease|3|||
46998781|NCT02021565|83245912|FG000|Baseline Through Intervention|Death|0|||
46998782|NCT02021565|83245913|FG001|Baseline Through Intervention|Death|1|||
46998783|NCT02021565|83245912|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
46998784|NCT02021565|83245913|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
46998785|NCT02021565|83245912|FG000|Baseline Through Intervention|Protocol Violation|0|||
46998786|NCT02021565|83245913|FG001|Baseline Through Intervention|Protocol Violation|7|||
46998787|NCT02021565|83245912|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
46998788|NCT02021565|83245913|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
46998789|NCT02021565|83245912|FG000|3-month Follow-up|Death|3|||
46998790|NCT02021565|83245913|FG001|3-month Follow-up|Death|0|||
46998791|NCT02021565|83245912|FG000|3-month Follow-up|Withdrawal by Subject|4|||
46998792|NCT02021565|83245913|FG001|3-month Follow-up|Withdrawal by Subject|0|||
46998793|NCT02021565|83245912|FG000|3-month Follow-up|Protocol Violation|3|||
46998794|NCT02021565|83245913|FG001|3-month Follow-up|Protocol Violation|2|||
46998795|NCT02021331|83245923|FG000|Overall Study|Adverse Event|0|||
46998796|NCT02021331|83245924|FG001|Overall Study|Adverse Event|2|||
46998797|NCT02085135|83245932|FG000|Overall Study|Adverse Event|4|||
46998798|NCT02085135|83245933|FG001|Overall Study|Adverse Event|7|||
46998799|NCT02085135|83245932|FG000|Overall Study|Lost to Follow-up|2|||
46998800|NCT02085135|83245933|FG001|Overall Study|Lost to Follow-up|2|||
46998801|NCT02085135|83245932|FG000|Overall Study|Withdrawal by Subject|3|||
46998802|NCT02085135|83245933|FG001|Overall Study|Withdrawal by Subject|0|||
46998803|NCT02085135|83245932|FG000|Overall Study|Lack of Efficacy|2|||
46998804|NCT02085135|83245933|FG001|Overall Study|Lack of Efficacy|0|||
46998805|NCT02441309|83245942|FG000|Overall Study|Disease progression|2|||
46998806|NCT02441309|83245943|FG001|Overall Study|Disease progression|1|||
46998807|NCT02441309|83245944|FG002|Overall Study|Disease progression|2|||
46998808|NCT02441309|83245942|FG000|Overall Study|Adverse Event|0|||
46998809|NCT02441309|83245943|FG001|Overall Study|Adverse Event|1|||
46998810|NCT02441309|83245944|FG002|Overall Study|Adverse Event|0|||
46998811|NCT02441309|83245942|FG000|Overall Study|Withdrawal by Subject|1|||
46998812|NCT02441309|83245943|FG001|Overall Study|Withdrawal by Subject|0|||
46998813|NCT02441309|83245944|FG002|Overall Study|Withdrawal by Subject|1|||
46998814|NCT02027025|83245958|FG000|Overall Study|Adverse Event|0|||
46998815|NCT02027025|83245959|FG001|Overall Study|Adverse Event|1|||
46998816|NCT02027025|83245960|FG002|Overall Study|Adverse Event|1|||
46998817|NCT02027025|83245958|FG000|Overall Study|Protocol Violation|1|||
46998818|NCT02027025|83245959|FG001|Overall Study|Protocol Violation|0|||
46998819|NCT02027025|83245960|FG002|Overall Study|Protocol Violation|0|||
46998820|NCT02027025|83245958|FG000|Overall Study|Lost to Follow-up|0|||
46998821|NCT02027025|83245959|FG001|Overall Study|Lost to Follow-up|2|||
46998822|NCT02027025|83245960|FG002|Overall Study|Lost to Follow-up|0|||
46998823|NCT02027025|83245958|FG000|Overall Study|Withdrawal by Subject|0|||
46998824|NCT02027025|83245959|FG001|Overall Study|Withdrawal by Subject|1|||
46998825|NCT02027025|83245960|FG002|Overall Study|Withdrawal by Subject|0|||
46998826|NCT02027025|83245958|FG000|Overall Study|Sponsor's decision|0|||
46998827|NCT02027025|83245959|FG001|Overall Study|Sponsor's decision|1|||
46998828|NCT02027025|83245960|FG002|Overall Study|Sponsor's decision|0|||
46998829|NCT01652729|83245982|FG000|Overall Study|Withdrawal by Subject|14|||
46998830|NCT01652729|83245983|FG001|Overall Study|Withdrawal by Subject|7|||
46998831|NCT01652729|83245984|FG002|Overall Study|Withdrawal by Subject|7|||
46998832|NCT01652729|83245982|FG000|Overall Study|Adverse Event|4|||
46998833|NCT01652729|83245983|FG001|Overall Study|Adverse Event|0|||
46998834|NCT01652729|83245984|FG002|Overall Study|Adverse Event|3|||
46998835|NCT01652729|83245982|FG000|Overall Study|Physician Decision|1|||
46998836|NCT01652729|83245983|FG001|Overall Study|Physician Decision|0|||
46998837|NCT01652729|83245984|FG002|Overall Study|Physician Decision|1|||
46998838|NCT01652729|83245982|FG000|Overall Study|Protocol Violation|1|||
46998839|NCT01652729|83245983|FG001|Overall Study|Protocol Violation|0|||
46998840|NCT01652729|83245984|FG002|Overall Study|Protocol Violation|0|||
46998841|NCT01652729|83245982|FG000|Overall Study|Lost to Follow-up|6|||
46998842|NCT01652729|83245983|FG001|Overall Study|Lost to Follow-up|6|||
46620385|NCT00085735|82762348|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
46907787|NCT03122145|83136617|FG001|Overall Study|Concurrent respiratory disease|0|||
46907788|NCT03114657|83136625|FG000|Overall Study|Adverse Event|9|||
46907789|NCT03114657|83136626|FG001|Overall Study|Adverse Event|6|||
46907790|NCT03114657|83136625|FG000|Overall Study|Death|4|||
46907791|NCT03114657|83136626|FG001|Overall Study|Death|0|||
46907792|NCT03114657|83136625|FG000|Overall Study|Multiple Reasons|1|||
46907793|NCT03114657|83136626|FG001|Overall Study|Multiple Reasons|2|||
46907794|NCT03114657|83136625|FG000|Overall Study|Physician Decision|2|||
46907795|NCT03114657|83136626|FG001|Overall Study|Physician Decision|2|||
46907796|NCT03114657|83136625|FG000|Overall Study|Study Terminated By Sponsor|355|||
46907797|NCT03114657|83136626|FG001|Overall Study|Study Terminated By Sponsor|374|||
46907798|NCT03114657|83136625|FG000|Overall Study|Symptomatic Deterioration|0|||
46907799|NCT03114657|83136626|FG001|Overall Study|Symptomatic Deterioration|1|||
46907800|NCT03114657|83136625|FG000|Overall Study|Withdrawal by Subject|28|||
46907801|NCT03114657|83136626|FG001|Overall Study|Withdrawal by Subject|22|||
46998843|NCT01652729|83245984|FG002|Overall Study|Lost to Follow-up|3|||
46998844|NCT01652729|83245982|FG000|Overall Study|Administrative|1|||
46907802|NCT02926950|83136635|FG000|Overall Study|Adverse Event|4|||
46907803|NCT02926950|83136636|FG001|Overall Study|Adverse Event|6|||
46998845|NCT01652729|83245983|FG001|Overall Study|Administrative|0|||
46803626|NCT03523728|83022941|FG003|Stage 1 (24 Months)|Adverse Event|0|||
46998846|NCT01652729|83245984|FG002|Overall Study|Administrative|0|||
46998847|NCT02083965|83245994|FG000|Treatment Period|Other|1|||
46998848|NCT02083965|83245995|FG001|Treatment Period|Other|0|||
46998849|NCT02438813|83246003|FG000|Overall Study|Patient Decision|59|||
46907804|NCT02926950|83136635|FG000|Overall Study|At the participant's own request|21|||
46907805|NCT02926950|83136636|FG001|Overall Study|At the participant's own request|25|||
46907806|NCT02926950|83136635|FG000|Overall Study|Reason not Specified|17|||
46907807|NCT02926950|83136636|FG001|Overall Study|Reason not Specified|9|||
46907808|NCT02926950|83136635|FG000|Overall Study|Lost to Follow-up|7|||
46907809|NCT02926950|83136636|FG001|Overall Study|Lost to Follow-up|8|||
46907810|NCT03410693|83136645|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
46907811|NCT03410693|83136646|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
46907812|NCT03410693|83136645|FG000|Overall Study|Disc trt: Lost to follow up|0|||
46907813|NCT03410693|83136646|FG001|Overall Study|Disc trt: Lost to follow up|1|||
46907814|NCT03410693|83136645|FG000|Overall Study|Disc trt: radiological progression|58|||
46907815|NCT03410693|83136646|FG001|Overall Study|Disc trt: radiological progression|50|||
46907816|NCT03410693|83136645|FG000|Overall Study|Disc trt: Other|1|||
46907817|NCT03410693|83136646|FG001|Overall Study|Disc trt: Other|0|||
46907818|NCT03410693|83136645|FG000|Overall Study|Study drug never administered|1|||
46907819|NCT03410693|83136646|FG001|Overall Study|Study drug never administered|6|||
46907820|NCT03410693|83136645|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
46907821|NCT03410693|83136646|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
46907822|NCT03410693|83136645|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
46907823|NCT03410693|83136646|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
46907824|NCT03410693|83136645|FG000|Overall Study|Disc trt: Physician decision|0|||
46907825|NCT03410693|83136646|FG001|Overall Study|Disc trt: Physician decision|5|||
46907826|NCT03410693|83136645|FG000|Overall Study|Disc trt: clinical progression|1|||
46907827|NCT03410693|83136646|FG001|Overall Study|Disc trt: clinical progression|5|||
46907828|NCT03410693|83136645|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
46907829|NCT03410693|83136646|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
46907830|NCT01064414|83136661|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
46907831|NCT01064414|83136662|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
46907832|NCT01064414|83136663|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
46907833|NCT01064414|83136661|FG000|Core Period: Baseline to Week 26|Death|0|||
46907834|NCT01064414|83136662|FG001|Core Period: Baseline to Week 26|Death|1|||
46907835|NCT01064414|83136663|FG002|Core Period: Baseline to Week 26|Death|0|||
46907836|NCT01064414|83136661|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
46907837|NCT01064414|83136662|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
46907838|NCT01064414|83136663|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
46907839|NCT01064414|83136661|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
46907840|NCT01064414|83136662|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
46907841|NCT01064414|83136663|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
46907842|NCT01064414|83136661|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46907843|NCT01064414|83136662|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
46907844|NCT01064414|83136663|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46907845|NCT01064414|83136661|FG000|Core Period: Baseline to Week 26|Other|4|||
46907846|NCT01064414|83136662|FG001|Core Period: Baseline to Week 26|Other|7|||
46907847|NCT01064414|83136663|FG002|Core Period: Baseline to Week 26|Other|2|||
46907848|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
46907849|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
46907850|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
46907851|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Death|0|||
46907852|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Death|1|||
46907853|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Death|0|||
46907854|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
46907855|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46907856|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46907857|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
46907858|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46907859|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46907860|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46907861|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
46907862|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46907863|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
46907864|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
46907865|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
46907866|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
46907867|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
46907868|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
46907869|NCT01064414|83136661|FG000|Extension Period: Week 26 to Week 52|Other|5|||
46907870|NCT01064414|83136662|FG001|Extension Period: Week 26 to Week 52|Other|2|||
46907871|NCT01064414|83136663|FG002|Extension Period: Week 26 to Week 52|Other|1|||
46998850|NCT02438813|83246003|FG000|Overall Study|Patient Lost to Follow-Up|137|||
46998851|NCT02438813|83246003|FG000|Overall Study|Study Ended by Sponsor|80|||
46907872|NCT03433703|83136674|FG000|Overall Study|Study terminated by Sponsor|2|||
46907873|NCT03463031|83136684|FG000|Overall Study|Withdrawal by Subject|4|||
46907874|NCT03463031|83136685|FG001|Overall Study|Withdrawal by Subject|2|||
46907875|NCT03463031|83136684|FG000|Overall Study|Investigator/Sponsor Decision|0|||
46907876|NCT03463031|83136685|FG001|Overall Study|Investigator/Sponsor Decision|1|||
46907877|NCT03463031|83136684|FG000|Overall Study|Lost to Follow-up|1|||
46907878|NCT03463031|83136685|FG001|Overall Study|Lost to Follow-up|1|||
46907879|NCT03463031|83136684|FG000|Overall Study|Adverse Event|4|||
46998852|NCT02438813|83246003|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
46998853|NCT02437409|83246017|FG000|Overall Study|Withdrawal by Subject|3|||
46998854|NCT02437409|83246017|FG000|Overall Study|Screening failure|12|||
46998855|NCT02459093|83246024|FG000|Overall Study|Protocol Violation|6|||
46998856|NCT02459093|83246025|FG001|Overall Study|Protocol Violation|11|||
46998857|NCT02459093|83246024|FG000|Overall Study|Lost to Follow-up|6|||
46998858|NCT02459093|83246025|FG001|Overall Study|Lost to Follow-up|7|||
46998859|NCT02458469|83246031|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
46998860|NCT02458469|83246032|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
46998861|NCT02458469|83246033|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
46998862|NCT02458469|83246034|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
46998863|NCT02458469|83246035|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
46907880|NCT03463031|83136685|FG001|Overall Study|Adverse Event|1|||
46907881|NCT03463031|83136684|FG000|Overall Study|Use of prohibited medication by subject|1|||
46907882|NCT03463031|83136685|FG001|Overall Study|Use of prohibited medication by subject|0|||
46907883|NCT03462641|83136693|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
46907884|NCT03462641|83136694|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
46907885|NCT03462641|83136693|FG000|Visit 2|Withdrawal by Subject|0|||
46907886|NCT03462641|83136694|FG001|Visit 2|Withdrawal by Subject|1|||
46907887|NCT02974634|83136704|FG000|Overall Study|Advanced disease|12|||
46907888|NCT02974634|83136705|FG001|Overall Study|Advanced disease|3|||
46907889|NCT02974634|83136704|FG000|Overall Study|Noncompliance|3|||
46907890|NCT02974634|83136705|FG001|Overall Study|Noncompliance|7|||
46907891|NCT02974634|83136704|FG000|Overall Study|intervention technology related issues|5|||
46907892|NCT02974634|83136705|FG001|Overall Study|intervention technology related issues|0|||
46907893|NCT02974634|83136704|FG000|Overall Study|Death|8|||
46907894|NCT02974634|83136705|FG001|Overall Study|Death|11|||
46907895|NCT01060670|83136714|FG000|Run In|screen failure|0|||
46907896|NCT01060670|83136715|FG001|Run In|screen failure|238|||
46907897|NCT02971670|83136727|FG000|Overall Study|Withdrawal by Subject|4|||
46907898|NCT02971670|83136728|FG001|Overall Study|Withdrawal by Subject|1|||
46907899|NCT02971670|83136729|FG002|Overall Study|Withdrawal by Subject|1|||
46907900|NCT02971670|83136730|FG003|Overall Study|Withdrawal by Subject|2|||
46907901|NCT02971202|83136743|FG000|Overall Study|Pregnancy|1|||
46907902|NCT02971202|83136744|FG001|Overall Study|Pregnancy|0|||
46907903|NCT02971202|83136745|FG002|Overall Study|Pregnancy|0|||
46907904|NCT02971202|83136743|FG000|Overall Study|screen fail after consent|1|||
46907905|NCT02971202|83136744|FG001|Overall Study|screen fail after consent|0|||
46907906|NCT02971202|83136745|FG002|Overall Study|screen fail after consent|1|||
46907907|NCT02926638|83136755|FG000|Overall Study|Progression|2|||
46907908|NCT02926638|83136756|FG001|Overall Study|Progression|5|||
46907909|NCT02926638|83136755|FG000|Overall Study|Ineligible|1|||
46907910|NCT02926638|83136756|FG001|Overall Study|Ineligible|0|||
46907911|NCT02926638|83136755|FG000|Overall Study|Not protocol specified|1|||
46907912|NCT02926638|83136756|FG001|Overall Study|Not protocol specified|0|||
46907913|NCT02903030|83136764|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
46907914|NCT02903030|83136765|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
46907915|NCT02969408|83136774|FG000|Overall Study|Adverse Event|2|||
46907916|NCT02969408|83136774|FG000|Overall Study|Withdrawal by Subject|8|||
46998864|NCT02458469|83246036|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
46998865|NCT02458469|83246031|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
46998866|NCT02458469|83246032|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
46907917|NCT02969408|83136774|FG000|Overall Study|Lost to Follow-up|4|||
46907918|NCT02969408|83136774|FG000|Overall Study|Protocol Violation|1|||
46907919|NCT02969408|83136774|FG000|Overall Study|Other than specified|1|||
46907920|NCT03462563|83136780|FG000|Overall Study|Death|1|||
46907921|NCT03462563|83136781|FG001|Overall Study|Death|1|||
46907922|NCT03462563|83136780|FG000|Overall Study|Termination of study|2|||
46907923|NCT03462563|83136781|FG001|Overall Study|Termination of study|1|||
46907924|NCT03462563|83136780|FG000|Overall Study|Adverse Event|1|||
46907925|NCT03462563|83136781|FG001|Overall Study|Adverse Event|3|||
46907926|NCT03462563|83136780|FG000|Overall Study|Unspecified reason|10|||
46907927|NCT03462563|83136781|FG001|Overall Study|Unspecified reason|12|||
46907928|NCT03462563|83136780|FG000|Overall Study|Physician Decision|1|||
46998867|NCT02458469|83246033|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
46998868|NCT02458469|83246034|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
46998869|NCT02458469|83246035|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
46998870|NCT02458469|83246036|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
46998871|NCT02458469|83246031|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998872|NCT02458469|83246032|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998873|NCT02458469|83246033|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998874|NCT02458469|83246034|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998875|NCT02458469|83246035|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998876|NCT02458469|83246036|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
46998877|NCT01843348|83246047|FG000|Overall Study|Withdrawal by Subject|4|||
46998878|NCT01843348|83246048|FG001|Overall Study|Withdrawal by Subject|16|||
46998879|NCT01843348|83246049|FG002|Overall Study|Withdrawal by Subject|18|||
46998880|NCT01843348|83246047|FG000|Overall Study|Lost to Follow-up|5|||
46998881|NCT01843348|83246048|FG001|Overall Study|Lost to Follow-up|4|||
46998882|NCT01843348|83246049|FG002|Overall Study|Lost to Follow-up|2|||
46998883|NCT01843348|83246047|FG000|Overall Study|Death|5|||
46998884|NCT01843348|83246048|FG001|Overall Study|Death|3|||
46998885|NCT01843348|83246049|FG002|Overall Study|Death|4|||
46998886|NCT01843348|83246047|FG000|Overall Study|Graft loss/retransplantation|5|||
46998887|NCT01843348|83246048|FG001|Overall Study|Graft loss/retransplantation|8|||
46998888|NCT01843348|83246049|FG002|Overall Study|Graft loss/retransplantation|11|||
46998889|NCT01843348|83246047|FG000|Overall Study|Various reasons|4|||
46998890|NCT01843348|83246048|FG001|Overall Study|Various reasons|9|||
46998891|NCT01843348|83246049|FG002|Overall Study|Various reasons|6|||
46998892|NCT01843192|83246062|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
46998893|NCT01843192|83246063|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
46998894|NCT01843192|83246064|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
46998895|NCT01825876|83246072|FG000|Period 2|Withdrawal by Subject|0|||
46998896|NCT01825876|83246073|FG001|Period 2|Withdrawal by Subject|1|||
46998897|NCT01842958|83246084|FG000|Overall Study|Lost to Follow-up|1|||
46998898|NCT01842958|83246085|FG001|Overall Study|Lost to Follow-up|1|||
46998899|NCT02413229|83246099|FG000|Overall Study|Adverse Event|0|||
46998900|NCT02413229|83246100|FG001|Overall Study|Adverse Event|0|||
46998901|NCT02413229|83246101|FG002|Overall Study|Adverse Event|0|||
46998902|NCT02413229|83246102|FG003|Overall Study|Adverse Event|1|||
46998903|NCT02413229|83246103|FG004|Overall Study|Adverse Event|0|||
46998904|NCT02413229|83246104|FG005|Overall Study|Adverse Event|0|||
46998905|NCT02413229|83246105|FG006|Overall Study|Adverse Event|0|||
46998906|NCT02413229|83246106|FG007|Overall Study|Adverse Event|1|||
46998907|NCT02413229|83246099|FG000|Overall Study|Lost to Follow-up|0|||
46998908|NCT02413229|83246100|FG001|Overall Study|Lost to Follow-up|0|||
46998909|NCT02413229|83246101|FG002|Overall Study|Lost to Follow-up|1|||
46998910|NCT02413229|83246102|FG003|Overall Study|Lost to Follow-up|0|||
46998911|NCT02413229|83246103|FG004|Overall Study|Lost to Follow-up|2|||
46998912|NCT02413229|83246104|FG005|Overall Study|Lost to Follow-up|0|||
46998913|NCT02413229|83246105|FG006|Overall Study|Lost to Follow-up|0|||
46998914|NCT02413229|83246106|FG007|Overall Study|Lost to Follow-up|0|||
46998915|NCT02413229|83246099|FG000|Overall Study|Withdrawal by Subject|1|||
46998916|NCT02413229|83246100|FG001|Overall Study|Withdrawal by Subject|1|||
46907929|NCT03462563|83136781|FG001|Overall Study|Physician Decision|0|||
46907930|NCT01060124|83136787|FG000|Overall Study|Other|16|||
46907931|NCT01060124|83136787|FG000|Overall Study|Adverse Event|14|||
46907932|NCT01060124|83136787|FG000|Overall Study|Withdrawal by Subject|7|||
46907933|NCT03461003|83136793|FG000|Overall Study|Lost to Follow-up|2|||
46907934|NCT03461003|83136794|FG001|Overall Study|Lost to Follow-up|2|||
46907935|NCT03461003|83136793|FG000|Overall Study|Withdrawal by Subject|3|||
46907936|NCT03461003|83136794|FG001|Overall Study|Withdrawal by Subject|1|||
46907937|NCT02904902|83136800|FG000|Overall Study|Withdrawal by Subject|1|||
46907938|NCT04425720|83136806|FG000|Overall Study|Withdrawal by Subject|0|||
46907939|NCT04425720|83136807|FG001|Overall Study|Withdrawal by Subject|20|||
46907940|NCT02904512|83136816|FG000|Overall Study|Withdrawal by Subject|1|||
46907941|NCT02904512|83136817|FG001|Overall Study|Withdrawal by Subject|0|||
46907942|NCT02904512|83136816|FG000|Overall Study|Transferred to ICU|1|||
46907943|NCT02904512|83136817|FG001|Overall Study|Transferred to ICU|0|||
46907944|NCT02904512|83136816|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
46907945|NCT02904512|83136817|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
46998917|NCT02413229|83246101|FG002|Overall Study|Withdrawal by Subject|0|||
46907946|NCT02904200|83136823|FG000|Overall Study|Withdrawal by Subject|1|||
46998918|NCT02413229|83246102|FG003|Overall Study|Withdrawal by Subject|0|||
46907947|NCT02904200|83136824|FG001|Overall Study|Withdrawal by Subject|0|||
46907948|NCT03432533|83136830|FG000|Overall Study|Lost to Follow-up|1|||
46907949|NCT03432533|83136831|FG001|Overall Study|Lost to Follow-up|2|||
46907950|NCT03432533|83136830|FG000|Overall Study|Withdrawal by Subject|14|||
46998919|NCT02413229|83246103|FG004|Overall Study|Withdrawal by Subject|1|||
46998920|NCT02413229|83246104|FG005|Overall Study|Withdrawal by Subject|0|||
46998921|NCT02413229|83246105|FG006|Overall Study|Withdrawal by Subject|0|||
46998922|NCT02413229|83246106|FG007|Overall Study|Withdrawal by Subject|2|||
46998923|NCT02413229|83246099|FG000|Overall Study|Progressive Disease|0|||
46998924|NCT02413229|83246100|FG001|Overall Study|Progressive Disease|0|||
46998925|NCT02413229|83246101|FG002|Overall Study|Progressive Disease|0|||
46998926|NCT02413229|83246102|FG003|Overall Study|Progressive Disease|0|||
46998927|NCT02413229|83246103|FG004|Overall Study|Progressive Disease|0|||
46998928|NCT02413229|83246104|FG005|Overall Study|Progressive Disease|0|||
46998929|NCT02413229|83246105|FG006|Overall Study|Progressive Disease|0|||
46998930|NCT02413229|83246106|FG007|Overall Study|Progressive Disease|1|||
46998931|NCT01825798|83246126|FG000|Overall Study|Adverse Event|1|||
46998932|NCT01825798|83246127|FG001|Overall Study|Adverse Event|5|||
46998933|NCT01825798|83246126|FG000|Overall Study|Lost to Follow-up|1|||
46998934|NCT01825798|83246127|FG001|Overall Study|Lost to Follow-up|0|||
46998935|NCT01824472|83246136|FG000|Overall Study|Lost to Follow-up|0|||
46998936|NCT01824472|83246137|FG001|Overall Study|Lost to Follow-up|0|||
46998937|NCT01824472|83246138|FG002|Overall Study|Lost to Follow-up|1|||
46998938|NCT01824472|83246136|FG000|Overall Study|Withdrawal by Subject|1|||
46998939|NCT01824472|83246137|FG001|Overall Study|Withdrawal by Subject|5|||
46998940|NCT01824472|83246138|FG002|Overall Study|Withdrawal by Subject|3|||
46998941|NCT01824472|83246136|FG000|Overall Study|Ineligible post randomization&screening|0|||
46998942|NCT01824472|83246137|FG001|Overall Study|Ineligible post randomization&screening|2|||
46998943|NCT01824472|83246138|FG002|Overall Study|Ineligible post randomization&screening|0|||
46998944|NCT02412761|83246146|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998945|NCT02412761|83246147|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
46998946|NCT02412761|83246148|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
46998947|NCT02412761|83246149|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998948|NCT02412761|83246150|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46998949|NCT02412761|83246151|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
46998950|NCT01842334|83246161|FG000|Overall Study|Withdrawal by Subject|3|||
46998951|NCT01842334|83246162|FG001|Overall Study|Withdrawal by Subject|3|||
46998952|NCT01842334|83246161|FG000|Overall Study|Moved away mid-study|0|||
46998953|NCT01842334|83246162|FG001|Overall Study|Moved away mid-study|1|||
46998954|NCT02457611|83246168|FG000|Overall Study|Lost to Follow-up|3|||
46998955|NCT02457065|83246174|FG000|Overall Study|Lost to Follow-up|9|||
46998956|NCT02457065|83246175|FG001|Overall Study|Lost to Follow-up|11|||
46998957|NCT02083653|83246184|FG000|Overall Study|Randomized but not Treated|0|||
46998958|NCT02083653|83246185|FG001|Overall Study|Randomized but not Treated|2|||
46998959|NCT02083653|83246186|FG002|Overall Study|Randomized but not Treated|7|||
46998960|NCT02083653|83246184|FG000|Overall Study|Adverse Event|12|||
46998961|NCT02083653|83246185|FG001|Overall Study|Adverse Event|5|||
46998962|NCT02083653|83246186|FG002|Overall Study|Adverse Event|4|||
46998963|NCT02083653|83246184|FG000|Overall Study|Lost to Follow-up|1|||
46998964|NCT02083653|83246185|FG001|Overall Study|Lost to Follow-up|0|||
46998965|NCT02083653|83246186|FG002|Overall Study|Lost to Follow-up|0|||
46998966|NCT02083653|83246184|FG000|Overall Study|Death|2|||
46998967|NCT02083653|83246185|FG001|Overall Study|Death|2|||
46998968|NCT02083653|83246186|FG002|Overall Study|Death|2|||
46998969|NCT02083653|83246184|FG000|Overall Study|Progressive Disease|65|||
46998970|NCT02083653|83246185|FG001|Overall Study|Progressive Disease|73|||
46998971|NCT02083653|83246186|FG002|Overall Study|Progressive Disease|63|||
46998972|NCT02083653|83246184|FG000|Overall Study|Withdrawal by Subject|2|||
46998973|NCT02083653|83246185|FG001|Overall Study|Withdrawal by Subject|1|||
46998974|NCT02083653|83246186|FG002|Overall Study|Withdrawal by Subject|2|||
46998975|NCT02083653|83246184|FG000|Overall Study|Other Events|0|||
46998976|NCT02083653|83246185|FG001|Overall Study|Other Events|2|||
46998977|NCT02083653|83246186|FG002|Overall Study|Other Events|2|||
46998978|NCT02083653|83246184|FG000|Overall Study|Reason Missing|0|||
46998979|NCT02083653|83246185|FG001|Overall Study|Reason Missing|0|||
46998980|NCT02083653|83246186|FG002|Overall Study|Reason Missing|4|||
46998981|NCT02436239|83246198|FG000|Open-Lable Treatment Period|Adverse Event|12|||
46998982|NCT02436239|83246199|FG001|Open-Lable Treatment Period|Adverse Event|3|||
46998983|NCT02436239|83246200|FG002|Open-Lable Treatment Period|Adverse Event|4|||
46998984|NCT02436239|83246201|FG003|Open-Lable Treatment Period|Adverse Event|2|||
46998985|NCT02436239|83246198|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
46998986|NCT02436239|83246199|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
46998987|NCT02436239|83246200|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
46998988|NCT02436239|83246201|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
46998989|NCT02436239|83246198|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
46998990|NCT02436239|83246199|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
46998991|NCT02436239|83246200|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
46998992|NCT02436239|83246201|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
46998993|NCT02436239|83246198|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
46998994|NCT02436239|83246199|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
46998995|NCT02436239|83246200|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
46998996|NCT02436239|83246201|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
46998997|NCT02436239|83246198|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
46998998|NCT02436239|83246199|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
46907951|NCT03432533|83136831|FG001|Overall Study|Withdrawal by Subject|9|||
46907952|NCT02901548|83136837|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
46709252|NCT01130532|82925204|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
46907953|NCT02903966|83136843|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
46998999|NCT02436239|83246200|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
46999000|NCT02436239|83246201|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
46620386|NCT00085735|82762349|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
46620387|NCT04537793|82762634|FG000|Part B (24 Weeks)|Adverse Event|0|||
46620388|NCT04537793|82762635|FG001|Part B (24 Weeks)|Adverse Event|1|||
46620389|NCT01938001|82763884|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
46620390|NCT01938001|82763885|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
46620391|NCT01938001|82763884|FG000|Pre-Treatment|Death|1|||
46620392|NCT01938001|82763885|FG001|Pre-Treatment|Death|0|||
46620393|NCT01938001|82763884|FG000|Treatment|Death|2|||
46907954|NCT02903966|83136844|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
46907955|NCT02903966|83136843|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
46907956|NCT02903966|83136844|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
46907957|NCT02903966|83136843|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
46907958|NCT02903966|83136844|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
46907959|NCT03457727|83136860|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
46907960|NCT03457727|83136861|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
46907961|NCT03457727|83136862|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
46907962|NCT03457727|83136863|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
46907963|NCT03431441|83136895|FG000|Overall Study|Withdrawal by Subject|2|||
46907964|NCT03431441|83136895|FG000|Overall Study|Adverse Event|2|||
46907965|NCT03431441|83136895|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
46907966|NCT03457103|83136901|FG000|Overall Study|illness/hospitalization|4|||
46907967|NCT03457103|83136902|FG001|Overall Study|illness/hospitalization|2|||
46907968|NCT03457103|83136901|FG000|Overall Study|Lost to Follow-up|2|||
46907969|NCT03457103|83136902|FG001|Overall Study|Lost to Follow-up|1|||
46907970|NCT03457103|83136901|FG000|Overall Study|Withdrawal by Subject|1|||
46907971|NCT03457103|83136902|FG001|Overall Study|Withdrawal by Subject|2|||
46907972|NCT03457103|83136901|FG000|Overall Study|financial/ insurance issues|1|||
46907973|NCT03457103|83136902|FG001|Overall Study|financial/ insurance issues|1|||
46907974|NCT03455543|83136910|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
46620394|NCT01938001|82763885|FG001|Treatment|Death|0|||
46907975|NCT03455543|83136911|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
46999001|NCT02436239|83246198|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
46999002|NCT02436239|83246199|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
46999003|NCT02436239|83246200|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
46999004|NCT02436239|83246201|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
46999005|NCT02436239|83246198|FG000|Open-Lable Treatment Period|Other Reason|1|||
46999006|NCT02436239|83246199|FG001|Open-Lable Treatment Period|Other Reason|1|||
46999007|NCT02436239|83246200|FG002|Open-Lable Treatment Period|Other Reason|0|||
46999008|NCT02436239|83246201|FG003|Open-Lable Treatment Period|Other Reason|0|||
46999009|NCT02436239|83246198|FG000|Down-Taper Period|Withdrawal by Subject|4|||
46999010|NCT02436239|83246199|FG001|Down-Taper Period|Withdrawal by Subject|4|||
46999011|NCT02436239|83246200|FG002|Down-Taper Period|Withdrawal by Subject|1|||
46999012|NCT02436239|83246201|FG003|Down-Taper Period|Withdrawal by Subject|2|||
46999013|NCT02026011|83246213|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
46999014|NCT02026011|83246214|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
46999015|NCT02026011|83246213|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
46999016|NCT02026011|83246214|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
46999017|NCT02026011|83246213|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
46999018|NCT02026011|83246214|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
46999019|NCT02026011|83246213|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
46999020|NCT02026011|83246214|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
46999021|NCT02436005|83246223|FG000|Second Intervention|Adverse Event|0|||
46999022|NCT02436005|83246224|FG001|Second Intervention|Adverse Event|1|||
46999023|NCT02456909|83246232|FG000|Overall Study|Did not receive allocated intervention|24|||
46999024|NCT02456909|83246233|FG001|Overall Study|Did not receive allocated intervention|26|||
46999025|NCT02456909|83246232|FG000|Overall Study|Did not complete the primary outcome|0|||
46999026|NCT02456909|83246233|FG001|Overall Study|Did not complete the primary outcome|1|||
46999027|NCT02025621|83246241|FG000|Overall Study|Withdrawal by Subject|1|||
46999028|NCT02025621|83246242|FG001|Overall Study|Withdrawal by Subject|0|||
46999029|NCT02025621|83246241|FG000|Overall Study|Death|0|||
46999030|NCT02025621|83246242|FG001|Overall Study|Death|1|||
46999031|NCT02025621|83246241|FG000|Overall Study|No longer eligible|10|||
46999032|NCT02025621|83246242|FG001|Overall Study|No longer eligible|15|||
46999033|NCT02025621|83246241|FG000|Overall Study|Surgery initiated before infusion|3|||
46999034|NCT02025621|83246242|FG001|Overall Study|Surgery initiated before infusion|3|||
46999035|NCT02020941|83246248|FG000|Overall Study|Adverse Event|1|||
46999036|NCT02020941|83246248|FG000|Overall Study|Physician Decision|2|||
46999037|NCT02020941|83246248|FG000|Overall Study|Withdrawal by Subject|1|||
46999038|NCT02020941|83246248|FG000|Overall Study|Disease Progression|4|||
46999039|NCT02024529|83246254|FG000|Overall Study|Withdrawal by Subject|11|||
46999040|NCT02024529|83246255|FG001|Overall Study|Withdrawal by Subject|21|||
46999041|NCT02024529|83246254|FG000|Overall Study|Lost to Follow-up|2|||
46999042|NCT02024529|83246255|FG001|Overall Study|Lost to Follow-up|4|||
46999043|NCT02020863|83246263|FG000|Overall Study|Discovery of Metastatic disease|4|||
46999044|NCT02020863|83246263|FG000|Overall Study|Team chose not to place an a line|1|||
46999045|NCT01824394|83246270|FG000|Overall Study|Early Termination|1|||
46999046|NCT01824394|83246271|FG001|Overall Study|Early Termination|1|||
46999047|NCT01824394|83246272|FG002|Overall Study|Early Termination|3|||
46999048|NCT01824394|83246270|FG000|Overall Study|Withdrawn due to Study Termination|91|||
46999049|NCT01824394|83246271|FG001|Overall Study|Withdrawn due to Study Termination|83|||
46999050|NCT01824394|83246272|FG002|Overall Study|Withdrawn due to Study Termination|41|||
46999051|NCT01824394|83246270|FG000|Overall Study|Lost to Follow-up|0|||
46999052|NCT01824394|83246271|FG001|Overall Study|Lost to Follow-up|9|||
46999053|NCT01824394|83246272|FG002|Overall Study|Lost to Follow-up|3|||
46999054|NCT01824394|83246270|FG000|Overall Study|Death|3|||
46999055|NCT01824394|83246271|FG001|Overall Study|Death|2|||
46999056|NCT01824394|83246272|FG002|Overall Study|Death|4|||
46999057|NCT01824394|83246270|FG000|Overall Study|Discontinued Subjects|1|||
46999058|NCT01824394|83246271|FG001|Overall Study|Discontinued Subjects|1|||
46999059|NCT01824394|83246272|FG002|Overall Study|Discontinued Subjects|2|||
46999060|NCT01824394|83246270|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
46999061|NCT01824394|83246271|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
46999062|NCT01824394|83246272|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
46999063|NCT01823536|83246286|FG000|Overall Study|Lost to Follow-up|1|||
46999064|NCT01823536|83246287|FG001|Overall Study|Lost to Follow-up|0|||
46999065|NCT01823536|83246288|FG002|Overall Study|Lost to Follow-up|0|||
46999066|NCT01823536|83246289|FG003|Overall Study|Lost to Follow-up|1|||
46999067|NCT01823536|83246290|FG004|Overall Study|Lost to Follow-up|1|||
46999068|NCT01823536|83246291|FG005|Overall Study|Lost to Follow-up|0|||
46999069|NCT01823536|83246286|FG000|Overall Study|Protocol Violation|0|||
46999070|NCT01823536|83246287|FG001|Overall Study|Protocol Violation|1|||
46999071|NCT01823536|83246288|FG002|Overall Study|Protocol Violation|0|||
46999072|NCT01823536|83246289|FG003|Overall Study|Protocol Violation|0|||
46999073|NCT01823536|83246290|FG004|Overall Study|Protocol Violation|0|||
46999074|NCT01823536|83246291|FG005|Overall Study|Protocol Violation|0|||
46999075|NCT01823536|83246286|FG000|Overall Study|Withdrawal by Subject|1|||
46999076|NCT01823536|83246287|FG001|Overall Study|Withdrawal by Subject|1|||
46999077|NCT01823536|83246288|FG002|Overall Study|Withdrawal by Subject|0|||
46999078|NCT01823536|83246289|FG003|Overall Study|Withdrawal by Subject|0|||
46999079|NCT01823536|83246290|FG004|Overall Study|Withdrawal by Subject|0|||
46999080|NCT01823536|83246291|FG005|Overall Study|Withdrawal by Subject|0|||
46999081|NCT01823536|83246286|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
46999082|NCT01823536|83246287|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
46999083|NCT01823536|83246288|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
46999084|NCT01823536|83246289|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
46999085|NCT01823536|83246290|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
46999086|NCT01823536|83246291|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
46999087|NCT01823536|83246286|FG000|Overall Study|Met exclusion criterion No 6|0|||
46999088|NCT01823536|83246287|FG001|Overall Study|Met exclusion criterion No 6|0|||
46999089|NCT01823536|83246288|FG002|Overall Study|Met exclusion criterion No 6|0|||
46999090|NCT01823536|83246289|FG003|Overall Study|Met exclusion criterion No 6|1|||
46999091|NCT01823536|83246290|FG004|Overall Study|Met exclusion criterion No 6|0|||
46999092|NCT01823536|83246291|FG005|Overall Study|Met exclusion criterion No 6|0|||
46999093|NCT01823536|83246286|FG000|Overall Study|Subject moved out of the state|0|||
46999094|NCT01823536|83246287|FG001|Overall Study|Subject moved out of the state|0|||
46999095|NCT01823536|83246288|FG002|Overall Study|Subject moved out of the state|0|||
46999096|NCT01823536|83246289|FG003|Overall Study|Subject moved out of the state|0|||
46999097|NCT01823536|83246290|FG004|Overall Study|Subject moved out of the state|1|||
46999098|NCT01823536|83246291|FG005|Overall Study|Subject moved out of the state|0|||
46999099|NCT01841554|83246304|FG000|Overall Study|Death|7|||
46999100|NCT01841554|83246304|FG000|Overall Study|No Implantation|1|||
46999101|NCT01841554|83246304|FG000|Overall Study|Discontinued Follow Up|5|||
46999102|NCT01841554|83246304|FG000|Overall Study|Study exit due to secondary intervention|6|||
46999103|NCT01823224|83246310|FG000|Overall Study|Lost to Follow-up|5|||
46999104|NCT01823224|83246311|FG001|Overall Study|Lost to Follow-up|6|||
46999105|NCT01823224|83246310|FG000|Overall Study|didn't qualify|1|||
46999106|NCT01823224|83246311|FG001|Overall Study|didn't qualify|2|||
46999107|NCT01823224|83246310|FG000|Overall Study|pharmacy error|0|||
46999108|NCT01823224|83246311|FG001|Overall Study|pharmacy error|1|||
46999109|NCT01823224|83246310|FG000|Overall Study|missed med dose|0|||
46999110|NCT01823224|83246311|FG001|Overall Study|missed med dose|1|||
46999111|NCT01823224|83246310|FG000|Overall Study|Withdrawal by Subject|0|||
46999112|NCT01823224|83246311|FG001|Overall Study|Withdrawal by Subject|1|||
46999113|NCT01840228|83246321|FG000|Overall Study|Lost to Follow-up|1|||
46999114|NCT01840228|83246322|FG001|Overall Study|Lost to Follow-up|1|||
46999115|NCT01839916|83246332|FG000|Overall Study|Death|9|||
46999116|NCT01839916|83246332|FG000|Overall Study|Physician Decision|17|||
46999117|NCT01839916|83246332|FG000|Overall Study|Relapse|12|||
46999118|NCT01839916|83246332|FG000|Overall Study|GVHD|2|||
46999119|NCT01839916|83246332|FG000|Overall Study|Graft Failure|1|||
46999120|NCT01823146|83246338|FG000|Overall Study|Withdrawal by Subject|0|||
46999121|NCT01823146|83246339|FG001|Overall Study|Withdrawal by Subject|1|||
46999122|NCT01823146|83246338|FG000|Overall Study|Lost to Follow-up|2|||
46999123|NCT01823146|83246339|FG001|Overall Study|Lost to Follow-up|1|||
46999124|NCT02083185|83246348|FG000|Overall Study|Lost to Follow-up|0|||
46999125|NCT02083185|83246349|FG001|Overall Study|Lost to Follow-up|3|||
46999126|NCT02083185|83246350|FG002|Overall Study|Lost to Follow-up|0|||
46999127|NCT02083185|83246348|FG000|Overall Study|Withdrawal by Subject|9|||
46999128|NCT02083185|83246349|FG001|Overall Study|Withdrawal by Subject|15|||
46999129|NCT02083185|83246350|FG002|Overall Study|Withdrawal by Subject|1|||
46999130|NCT02083185|83246348|FG000|Overall Study|Death|2|||
46999131|NCT02083185|83246349|FG001|Overall Study|Death|2|||
46999132|NCT02083185|83246350|FG002|Overall Study|Death|1|||
46999133|NCT02083185|83246348|FG000|Overall Study|Reason not Specified|9|||
46999134|NCT02083185|83246349|FG001|Overall Study|Reason not Specified|6|||
46999135|NCT02083185|83246350|FG002|Overall Study|Reason not Specified|5|||
46999136|NCT02083185|83246348|FG000|Overall Study|Study Terminated by Sponsor|0|||
46999137|NCT02083185|83246349|FG001|Overall Study|Study Terminated by Sponsor|1|||
46999138|NCT02083185|83246350|FG002|Overall Study|Study Terminated by Sponsor|0|||
46999139|NCT02083185|83246348|FG000|Overall Study|Did not Receive Study Drug|0|||
46999140|NCT02083185|83246349|FG001|Overall Study|Did not Receive Study Drug|2|||
46999141|NCT02083185|83246350|FG002|Overall Study|Did not Receive Study Drug|0|||
46999142|NCT02019927|83246364|FG000|Overall Study|Lost to Follow-up|2|||
46999143|NCT02019927|83246365|FG001|Overall Study|Lost to Follow-up|4|||
46999144|NCT02019927|83246366|FG002|Overall Study|Lost to Follow-up|1|||
46999145|NCT02019927|83246367|FG003|Overall Study|Lost to Follow-up|2|||
46999146|NCT02019927|83246368|FG004|Overall Study|Lost to Follow-up|3|||
46999147|NCT02019927|83246369|FG005|Overall Study|Lost to Follow-up|1|||
46999148|NCT02412371|83246393|FG000|Overall Study|Withdrawal by Subject|0|||
46999149|NCT02412371|83246394|FG001|Overall Study|Withdrawal by Subject|2|||
46999150|NCT02412371|83246395|FG002|Overall Study|Withdrawal by Subject|0|||
46999151|NCT02412371|83246396|FG003|Overall Study|Withdrawal by Subject|1|||
46999152|NCT02412371|83246397|FG004|Overall Study|Withdrawal by Subject|1|||
46999153|NCT02412371|83246398|FG005|Overall Study|Withdrawal by Subject|0|||
46999154|NCT02412371|83246393|FG000|Overall Study|Sponsor Discontinued Study|1|||
46999155|NCT02412371|83246394|FG001|Overall Study|Sponsor Discontinued Study|4|||
46999156|NCT02412371|83246395|FG002|Overall Study|Sponsor Discontinued Study|6|||
46999157|NCT02412371|83246396|FG003|Overall Study|Sponsor Discontinued Study|4|||
46999158|NCT02412371|83246397|FG004|Overall Study|Sponsor Discontinued Study|5|||
46999159|NCT02412371|83246398|FG005|Overall Study|Sponsor Discontinued Study|0|||
46999160|NCT02412371|83246393|FG000|Overall Study|Death|4|||
46999161|NCT02412371|83246394|FG001|Overall Study|Death|2|||
46709253|NCT01130532|82925205|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
46999162|NCT02412371|83246395|FG002|Overall Study|Death|1|||
46999163|NCT02412371|83246396|FG003|Overall Study|Death|3|||
46999164|NCT02412371|83246397|FG004|Overall Study|Death|5|||
46999165|NCT02412371|83246398|FG005|Overall Study|Death|2|||
46999166|NCT02412371|83246393|FG000|Overall Study|Other|2|||
46999167|NCT02412371|83246394|FG001|Overall Study|Other|1|||
46999168|NCT02412371|83246395|FG002|Overall Study|Other|0|||
46999169|NCT02412371|83246396|FG003|Overall Study|Other|0|||
46999170|NCT02412371|83246397|FG004|Overall Study|Other|1|||
46999171|NCT02412371|83246398|FG005|Overall Study|Other|3|||
46999172|NCT02411747|83246415|FG000|Overall Study|Withdrawal by Subject|1|||
46999173|NCT02411747|83246416|FG001|Overall Study|Withdrawal by Subject|0|||
46999174|NCT02411747|83246415|FG000|Overall Study|Protocol Violation|2|||
46999175|NCT02411747|83246416|FG001|Overall Study|Protocol Violation|4|||
46999176|NCT01822756|83246427|FG000|Overall Study|Adverse Event|0|||
46999177|NCT01822756|83246428|FG001|Overall Study|Adverse Event|0|||
46999178|NCT01822756|83246429|FG002|Overall Study|Adverse Event|0|||
46999179|NCT01822756|83246430|FG003|Overall Study|Adverse Event|2|||
46999180|NCT01822756|83246431|FG004|Overall Study|Adverse Event|0|||
46999181|NCT01822756|83246427|FG000|Overall Study|Disease progression|11|||
46999182|NCT01822756|83246428|FG001|Overall Study|Disease progression|1|||
46999183|NCT01822756|83246429|FG002|Overall Study|Disease progression|7|||
46999184|NCT01822756|83246430|FG003|Overall Study|Disease progression|2|||
46999185|NCT01822756|83246431|FG004|Overall Study|Disease progression|6|||
46999186|NCT01822756|83246427|FG000|Overall Study|Death|2|||
46999187|NCT01822756|83246428|FG001|Overall Study|Death|2|||
46999188|NCT01822756|83246429|FG002|Overall Study|Death|1|||
46999189|NCT01822756|83246430|FG003|Overall Study|Death|0|||
46999190|NCT01822756|83246431|FG004|Overall Study|Death|0|||
46999191|NCT01822756|83246427|FG000|Overall Study|Lost to Follow-up|1|||
46999192|NCT01822756|83246428|FG001|Overall Study|Lost to Follow-up|0|||
46999193|NCT01822756|83246429|FG002|Overall Study|Lost to Follow-up|1|||
46999194|NCT01822756|83246430|FG003|Overall Study|Lost to Follow-up|0|||
46999195|NCT01822756|83246431|FG004|Overall Study|Lost to Follow-up|1|||
46999196|NCT01822756|83246427|FG000|Overall Study|Physician Decision|0|||
46999197|NCT01822756|83246428|FG001|Overall Study|Physician Decision|1|||
46999198|NCT01822756|83246429|FG002|Overall Study|Physician Decision|0|||
46999199|NCT01822756|83246430|FG003|Overall Study|Physician Decision|0|||
46999200|NCT01822756|83246431|FG004|Overall Study|Physician Decision|0|||
46999201|NCT01822756|83246427|FG000|Overall Study|disease progression & patient preference|2|||
46999202|NCT01822756|83246428|FG001|Overall Study|disease progression & patient preference|0|||
46999203|NCT01822756|83246429|FG002|Overall Study|disease progression & patient preference|1|||
46999204|NCT01822756|83246430|FG003|Overall Study|disease progression & patient preference|0|||
46999205|NCT01822756|83246431|FG004|Overall Study|disease progression & patient preference|0|||
46999206|NCT01822678|83246446|FG000|Overall Study|Withdrawal by Subject|5|||
46999207|NCT01822678|83246447|FG001|Overall Study|Withdrawal by Subject|4|||
46620395|NCT01938001|82763884|FG000|Treatment|Adverse Event|14|||
46620396|NCT01938001|82763885|FG001|Treatment|Adverse Event|8|||
46999208|NCT01822678|83246448|FG002|Overall Study|Withdrawal by Subject|4|||
46999209|NCT01822678|83246446|FG000|Overall Study|Adverse Event|4|||
46620397|NCT01938001|82763884|FG000|Treatment|Progressive Disease|21|||
46999210|NCT01822678|83246447|FG001|Overall Study|Adverse Event|3|||
46999211|NCT01822678|83246448|FG002|Overall Study|Adverse Event|1|||
46999212|NCT01822678|83246446|FG000|Overall Study|Lack of Efficacy|3|||
46999213|NCT01822678|83246447|FG001|Overall Study|Lack of Efficacy|6|||
46999214|NCT01822678|83246448|FG002|Overall Study|Lack of Efficacy|5|||
46999215|NCT01822678|83246446|FG000|Overall Study|Lost to Follow-up|0|||
46999216|NCT01822678|83246447|FG001|Overall Study|Lost to Follow-up|2|||
46999217|NCT01822678|83246448|FG002|Overall Study|Lost to Follow-up|1|||
46999218|NCT01822366|83246460|FG000|Overall Study|Lost to Follow-up|5|||
46999219|NCT01822366|83246461|FG001|Overall Study|Lost to Follow-up|1|||
46999220|NCT01822366|83246462|FG002|Overall Study|Lost to Follow-up|5|||
46999221|NCT01822366|83246463|FG003|Overall Study|Lost to Follow-up|1|||
46999222|NCT01822366|83246460|FG000|Overall Study|Withdrawal by Subject|0|||
46999223|NCT01822366|83246461|FG001|Overall Study|Withdrawal by Subject|6|||
46999224|NCT01822366|83246462|FG002|Overall Study|Withdrawal by Subject|0|||
46999225|NCT01822366|83246463|FG003|Overall Study|Withdrawal by Subject|6|||
46999226|NCT01822366|83246460|FG000|Overall Study|Partial Intervention Completion|0|||
46999227|NCT01822366|83246461|FG001|Overall Study|Partial Intervention Completion|15|||
46999228|NCT01822366|83246462|FG002|Overall Study|Partial Intervention Completion|0|||
46999229|NCT01822366|83246463|FG003|Overall Study|Partial Intervention Completion|15|||
46999230|NCT01838590|83246495|FG000|Overall Study|Lack of Efficacy|12|||
46999231|NCT01838590|83246496|FG001|Overall Study|Lack of Efficacy|4|||
46999232|NCT01838590|83246495|FG000|Overall Study|Lost to Follow-up|0|||
46999233|NCT01838590|83246496|FG001|Overall Study|Lost to Follow-up|1|||
46999234|NCT01611454|83246508|FG000|Overall Study|Lack of Efficacy|18|||
46999235|NCT01611454|83246509|FG001|Overall Study|Lack of Efficacy|10|||
46999236|NCT01611298|83246519|FG000|Overall Study|Relapsed|2|||
46999237|NCT01822132|83246525|FG000|Overall Study|Lost to Follow-up|4|||
46999238|NCT01822132|83246526|FG001|Overall Study|Lost to Follow-up|2|||
46999239|NCT01821898|83246540|FG000|Overall Study|Withdrawal by Subject|2|||
46999240|NCT01821898|83246541|FG001|Overall Study|Withdrawal by Subject|1|||
46999241|NCT02411591|83246551|FG000|Overall Study|Adverse Event|0|||
46999242|NCT02411591|83246552|FG001|Overall Study|Adverse Event|4|||
46999243|NCT02411591|83246553|FG002|Overall Study|Adverse Event|2|||
46999244|NCT02411591|83246551|FG000|Overall Study|Withdrawal by Subject|0|||
46999245|NCT02411591|83246552|FG001|Overall Study|Withdrawal by Subject|3|||
46999246|NCT02411591|83246553|FG002|Overall Study|Withdrawal by Subject|0|||
46620398|NCT01938001|82763885|FG001|Treatment|Progressive Disease|54|||
46907976|NCT03455543|83136912|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
46907977|NCT03455543|83136910|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
46907978|NCT03455543|83136911|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
46907979|NCT03455543|83136912|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
46907980|NCT03455543|83136910|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
46907981|NCT03455543|83136911|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
46907982|NCT03455543|83136912|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
46907983|NCT03455543|83136910|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
46907984|NCT03455543|83136911|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
46907985|NCT03455543|83136912|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
46907986|NCT03455543|83136910|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
46907987|NCT03455543|83136911|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
46907988|NCT03455543|83136912|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
46907989|NCT03455543|83136910|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
46907990|NCT03455543|83136911|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
46907991|NCT03455543|83136912|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
46907992|NCT03455543|83136910|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
46907993|NCT03455543|83136911|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
46907994|NCT03455543|83136912|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
46907995|NCT03455543|83136910|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
46907996|NCT03455543|83136911|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
46907997|NCT03455543|83136912|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
46907998|NCT03455543|83136910|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
46907999|NCT03455543|83136911|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
46908000|NCT03455543|83136912|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
46908001|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
46908002|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
46908003|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
46908004|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
46908005|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Death|2|||
46908006|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Death|2|||
46908007|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Death|0|||
46908008|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Death|0|||
46908009|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
46908010|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
46908011|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
46908012|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
46908013|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
46908014|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
46908015|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
46908016|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
46908017|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
46999247|NCT02411591|83246551|FG000|Overall Study|Physician Decision|0|||
46999248|NCT02411591|83246552|FG001|Overall Study|Physician Decision|3|||
46999249|NCT02411591|83246553|FG002|Overall Study|Physician Decision|1|||
46620399|NCT01938001|82763884|FG000|Treatment|Withdrawal by Subject|13|||
46999250|NCT02454959|83246569|FG000|Overall Study|Protocol-Specified Criteria|3|||
46999251|NCT02454959|83246569|FG000|Overall Study|Physician Decision|1|||
46999252|NCT02454959|83246569|FG000|Overall Study|Withdrawal by Subject|3|||
46999253|NCT02454959|83246569|FG000|Overall Study|Adverse Event|2|||
46999254|NCT01821118|83246577|FG000|Overall Study|Death|0|||
46999255|NCT01821118|83246578|FG001|Overall Study|Death|1|||
46999256|NCT01650779|83246584|FG000|Overall Study|Withdrawal by Subject|1|||
46999257|NCT02411201|83246588|FG000|Overall Study|Adverse Event|2|||
46999258|NCT02411201|83246588|FG000|Overall Study|Withdrawal by Subject|2|||
46999259|NCT02411201|83246588|FG000|Overall Study|Age group completed|2|||
46999260|NCT01838044|83246596|FG000|Overall Study|Adverse Event|4|||
46999261|NCT01838044|83246597|FG001|Overall Study|Adverse Event|6|||
46999262|NCT01838044|83246596|FG000|Overall Study|Protocol Violation|3|||
46999263|NCT01838044|83246597|FG001|Overall Study|Protocol Violation|3|||
46999264|NCT01838044|83246596|FG000|Overall Study|Withdrawal by Subject|0|||
46999265|NCT01838044|83246597|FG001|Overall Study|Withdrawal by Subject|2|||
46999266|NCT01838044|83246596|FG000|Overall Study|Insufficient clinical response|1|||
46999267|NCT01838044|83246597|FG001|Overall Study|Insufficient clinical response|2|||
46999268|NCT01838044|83246596|FG000|Overall Study|Medication error without associated AE|0|||
46999269|NCT01838044|83246597|FG001|Overall Study|Medication error without associated AE|1|||
46999270|NCT01838044|83246596|FG000|Overall Study|Lost to Follow-up|0|||
46999271|NCT01838044|83246597|FG001|Overall Study|Lost to Follow-up|2|||
46999272|NCT02410811|83246608|FG000|Overall Study|Withdrawal by Subject|0|||
46999273|NCT02410811|83246609|FG001|Overall Study|Withdrawal by Subject|0|||
46999274|NCT02410811|83246610|FG002|Overall Study|Withdrawal by Subject|1|||
46999275|NCT02410811|83246611|FG003|Overall Study|Withdrawal by Subject|0|||
46999276|NCT02435381|83246621|FG000|Overall Study|Lost to Follow-up|2|||
46999277|NCT02435381|83246622|FG001|Overall Study|Lost to Follow-up|1|||
46999278|NCT01837966|83246638|FG000|Overall Study|Withdrawal by Subject|2|||
46999279|NCT01837966|83246639|FG001|Overall Study|Withdrawal by Subject|1|||
46999280|NCT02435147|83246645|FG000|Overall Study|non-evaluable DXA scan|11|||
46999281|NCT02435069|83246649|FG000|Dose Response - First Intervention|Adverse Event|0|||
46999282|NCT02435069|83246650|FG001|Dose Response - First Intervention|Adverse Event|1|||
46999283|NCT02435069|83246651|FG002|Dose Response - First Intervention|Adverse Event|1|||
46999284|NCT02435069|83246652|FG003|Dose Response - First Intervention|Adverse Event|0|||
46999285|NCT02435069|83246653|FG004|Dose Response - First Intervention|Adverse Event|0|||
46999286|NCT02435069|83246649|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
46999287|NCT02435069|83246650|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
46999288|NCT02435069|83246651|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
46999289|NCT02435069|83246652|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
46999290|NCT02435069|83246653|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
46999291|NCT02454101|83246675|FG000|Overall Study|Adverse Event|2|||
46999292|NCT02454101|83246676|FG001|Overall Study|Adverse Event|3|||
46999293|NCT02454101|83246675|FG000|Overall Study|Lost to Follow-up|3|||
46999294|NCT02454101|83246676|FG001|Overall Study|Lost to Follow-up|4|||
46999295|NCT02409719|83246684|FG000|Overall Study|Lost to Follow-up|3|||
46999296|NCT02409719|83246685|FG001|Overall Study|Lost to Follow-up|3|||
46999297|NCT01820572|83246693|FG000|Randomization|Not Treated|2|||
46999298|NCT01820572|83246694|FG001|Randomization|Not Treated|1|||
46999299|NCT01820572|83246693|FG000|Treatment Period|Adverse Event|12|||
46999300|NCT01820572|83246694|FG001|Treatment Period|Adverse Event|7|||
46999301|NCT01820572|83246693|FG000|Treatment Period|Death|3|||
46999302|NCT01820572|83246694|FG001|Treatment Period|Death|3|||
46999303|NCT01820572|83246693|FG000|Treatment Period|Lack of Efficacy|1|||
46999304|NCT01820572|83246694|FG001|Treatment Period|Lack of Efficacy|0|||
46999305|NCT01820572|83246693|FG000|Treatment Period|poor/non compliance|0|||
46999306|NCT01820572|83246694|FG001|Treatment Period|poor/non compliance|3|||
46999307|NCT01820572|83246693|FG000|Treatment Period|request to discontinue|6|||
46999308|NCT01820572|83246694|FG001|Treatment Period|request to discontinue|11|||
46999309|NCT01820572|83246693|FG000|Treatment Period|No longer meets study criteria|3|||
46999310|NCT01820572|83246694|FG001|Treatment Period|No longer meets study criteria|10|||
46999311|NCT01820572|83246693|FG000|Treatment Period|withdrew consent|1|||
46999312|NCT01820572|83246694|FG001|Treatment Period|withdrew consent|2|||
46999313|NCT01820260|83246714|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999314|NCT01820260|83246715|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999315|NCT01820260|83246716|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999316|NCT01820260|83246717|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999317|NCT01820260|83246718|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999318|NCT01820260|83246719|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999319|NCT01820260|83246720|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
46999320|NCT01820260|83246721|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999321|NCT01820260|83246722|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
47073110|NCT01045161|83361496|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
46709254|NCT01130532|82925206|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
46709255|NCT01130532|82925207|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
46709256|NCT01130532|82925204|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
46709257|NCT01130532|82925205|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
46908018|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
46908019|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
46908020|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
46908021|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
46908022|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
46908023|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
46908024|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
46999322|NCT01820260|83246723|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999323|NCT01820260|83246724|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999324|NCT01820260|83246725|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999325|NCT01820260|83246726|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999326|NCT01820260|83246727|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
46999327|NCT01820260|83246714|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999328|NCT01820260|83246715|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999329|NCT01820260|83246716|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999330|NCT01820260|83246717|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999331|NCT01820260|83246718|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999332|NCT01820260|83246719|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999333|NCT01820260|83246720|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999334|NCT01820260|83246721|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999335|NCT01820260|83246722|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999336|NCT01820260|83246723|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
46999337|NCT01820260|83246724|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999338|NCT01820260|83246725|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999339|NCT01820260|83246726|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999340|NCT01820260|83246727|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
46999341|NCT01610596|83246765|FG000|Overall Study|Lost to Follow-up|0|||
46999342|NCT01610596|83246766|FG001|Overall Study|Lost to Follow-up|1|||
46999343|NCT01818700|83246772|FG000|Overall Study|Adverse Event|67|||
46999344|NCT01818700|83246772|FG000|Overall Study|Lack of Efficacy|2|||
46709258|NCT01130532|82925206|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
46709259|NCT01130532|82925207|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
46620400|NCT01938001|82763885|FG001|Treatment|Withdrawal by Subject|7|||
46908025|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
46620401|NCT01938001|82763884|FG000|Treatment|Other reasons|2|||
46620402|NCT01938001|82763885|FG001|Treatment|Other reasons|1|||
46709260|NCT01130532|82925204|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
46709261|NCT01130532|82925205|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
46999345|NCT01818700|83246772|FG000|Overall Study|Lost to Follow-up|5|||
46999346|NCT01818700|83246772|FG000|Overall Study|Withdrawal by Subject|27|||
46999347|NCT01818700|83246772|FG000|Overall Study|Protocol Violation|2|||
46999348|NCT01818700|83246772|FG000|Overall Study|Other|1|||
46999349|NCT01817764|83246780|FG000|Overall Study|Adverse Event|7|||
46999350|NCT01817764|83246781|FG001|Overall Study|Adverse Event|10|||
46999351|NCT01817764|83246780|FG000|Overall Study|Lack of Efficacy|9|||
46999352|NCT01817764|83246781|FG001|Overall Study|Lack of Efficacy|7|||
46999353|NCT01817764|83246780|FG000|Overall Study|Protocol Violation|7|||
46999354|NCT01817764|83246781|FG001|Overall Study|Protocol Violation|5|||
46999355|NCT01817764|83246780|FG000|Overall Study|Lost to Follow-up|1|||
46999356|NCT01817764|83246781|FG001|Overall Study|Lost to Follow-up|4|||
46999357|NCT01817764|83246780|FG000|Overall Study|Withdrawal by Subject|10|||
46999358|NCT01817764|83246781|FG001|Overall Study|Withdrawal by Subject|12|||
46999359|NCT01803880|83246790|FG000|Overall Study|Adverse Event|1|||
46999360|NCT01803880|83246791|FG001|Overall Study|Adverse Event|0|||
46999361|NCT01803880|83246792|FG002|Overall Study|Adverse Event|0|||
46999362|NCT01803880|83246790|FG000|Overall Study|Withdrawal by Subject|1|||
46999363|NCT01803880|83246791|FG001|Overall Study|Withdrawal by Subject|1|||
46999364|NCT01803880|83246792|FG002|Overall Study|Withdrawal by Subject|4|||
46999365|NCT01803880|83246790|FG000|Overall Study|Physician Decision|0|||
46999366|NCT01803880|83246791|FG001|Overall Study|Physician Decision|0|||
46999367|NCT01803880|83246792|FG002|Overall Study|Physician Decision|1|||
46999368|NCT01803880|83246790|FG000|Overall Study|Unable to return for follow-up visits|0|||
46999369|NCT01803880|83246791|FG001|Overall Study|Unable to return for follow-up visits|1|||
46999370|NCT01803880|83246792|FG002|Overall Study|Unable to return for follow-up visits|2|||
46999371|NCT01803880|83246790|FG000|Overall Study|Lost to Follow-up|1|||
46999372|NCT01803880|83246791|FG001|Overall Study|Lost to Follow-up|2|||
46999373|NCT01803880|83246792|FG002|Overall Study|Lost to Follow-up|3|||
46999374|NCT01803880|83246790|FG000|Overall Study|Protocol Violation|1|||
46999375|NCT01803880|83246791|FG001|Overall Study|Protocol Violation|0|||
46999376|NCT01803880|83246792|FG002|Overall Study|Protocol Violation|0|||
46999377|NCT01803880|83246790|FG000|Overall Study|Early study termination|0|||
46999378|NCT01803880|83246791|FG001|Overall Study|Early study termination|6|||
46999379|NCT01803880|83246792|FG002|Overall Study|Early study termination|5|||
46999380|NCT01803880|83246790|FG000|Overall Study|Incomplete data entry by sites|2|||
46999381|NCT01803880|83246791|FG001|Overall Study|Incomplete data entry by sites|0|||
46999382|NCT01803880|83246792|FG002|Overall Study|Incomplete data entry by sites|0|||
46999383|NCT01803646|83246804|FG000|Overall Study|Protocol Violation|1|||
46999384|NCT01803646|83246805|FG001|Overall Study|Protocol Violation|0|||
46999385|NCT01803646|83246804|FG000|Overall Study|Adverse Event|1|||
46999386|NCT01803646|83246805|FG001|Overall Study|Adverse Event|1|||
46999387|NCT01803646|83246804|FG000|Overall Study|Withdrawal by Subject|9|||
46999388|NCT01803646|83246805|FG001|Overall Study|Withdrawal by Subject|6|||
46999389|NCT01803646|83246804|FG000|Overall Study|Randomization error|1|||
46999390|NCT01803646|83246805|FG001|Overall Study|Randomization error|2|||
46999391|NCT01803646|83246804|FG000|Overall Study|Lost to Follow-up|5|||
46999392|NCT01803646|83246805|FG001|Overall Study|Lost to Follow-up|1|||
46999393|NCT01817530|83246819|FG000|Overall Study|Exclusionary Medication Received|0|||
46999394|NCT01817530|83246820|FG001|Overall Study|Exclusionary Medication Received|0|||
46999395|NCT01817530|83246821|FG002|Overall Study|Exclusionary Medication Received|0|||
46999396|NCT01817530|83246822|FG003|Overall Study|Exclusionary Medication Received|0|||
46999397|NCT01817530|83246823|FG004|Overall Study|Exclusionary Medication Received|1|||
46999398|NCT01817530|83246824|FG005|Overall Study|Exclusionary Medication Received|0|||
46999399|NCT01817530|83246825|FG006|Overall Study|Exclusionary Medication Received|0|||
46999400|NCT01817530|83246826|FG007|Overall Study|Exclusionary Medication Received|0|||
46999401|NCT01817530|83246819|FG000|Overall Study|Adverse Event|6|||
46999402|NCT01817530|83246820|FG001|Overall Study|Adverse Event|3|||
46999403|NCT01817530|83246821|FG002|Overall Study|Adverse Event|2|||
46999404|NCT01817530|83246822|FG003|Overall Study|Adverse Event|5|||
46999405|NCT01817530|83246823|FG004|Overall Study|Adverse Event|0|||
46999406|NCT01817530|83246824|FG005|Overall Study|Adverse Event|10|||
46999407|NCT01817530|83246825|FG006|Overall Study|Adverse Event|5|||
46999408|NCT01817530|83246826|FG007|Overall Study|Adverse Event|8|||
46999409|NCT01817530|83246819|FG000|Overall Study|Subject Noncompliant|3|||
46999410|NCT01817530|83246820|FG001|Overall Study|Subject Noncompliant|1|||
46999411|NCT01817530|83246821|FG002|Overall Study|Subject Noncompliant|0|||
46999412|NCT01817530|83246822|FG003|Overall Study|Subject Noncompliant|4|||
46999413|NCT01817530|83246823|FG004|Overall Study|Subject Noncompliant|0|||
46999414|NCT01817530|83246824|FG005|Overall Study|Subject Noncompliant|1|||
46999415|NCT01817530|83246825|FG006|Overall Study|Subject Noncompliant|1|||
46999416|NCT01817530|83246826|FG007|Overall Study|Subject Noncompliant|1|||
46999417|NCT01817530|83246819|FG000|Overall Study|Lack of Efficacy|1|||
46999418|NCT01817530|83246820|FG001|Overall Study|Lack of Efficacy|0|||
46999419|NCT01817530|83246821|FG002|Overall Study|Lack of Efficacy|0|||
46999420|NCT01817530|83246822|FG003|Overall Study|Lack of Efficacy|0|||
46999421|NCT01817530|83246823|FG004|Overall Study|Lack of Efficacy|0|||
46999422|NCT01817530|83246824|FG005|Overall Study|Lack of Efficacy|1|||
46999423|NCT01817530|83246825|FG006|Overall Study|Lack of Efficacy|0|||
46999424|NCT01817530|83246826|FG007|Overall Study|Lack of Efficacy|1|||
46999425|NCT01817530|83246819|FG000|Overall Study|Pregnancy|0|||
46999426|NCT01817530|83246820|FG001|Overall Study|Pregnancy|0|||
46999427|NCT01817530|83246821|FG002|Overall Study|Pregnancy|0|||
46999428|NCT01817530|83246822|FG003|Overall Study|Pregnancy|0|||
46999429|NCT01817530|83246823|FG004|Overall Study|Pregnancy|0|||
46999430|NCT01817530|83246824|FG005|Overall Study|Pregnancy|1|||
46999431|NCT01817530|83246825|FG006|Overall Study|Pregnancy|0|||
46999432|NCT01817530|83246826|FG007|Overall Study|Pregnancy|0|||
46999433|NCT01817530|83246819|FG000|Overall Study|Other|0|||
46999434|NCT01817530|83246820|FG001|Overall Study|Other|1|||
46999435|NCT01817530|83246821|FG002|Overall Study|Other|0|||
46999436|NCT01817530|83246822|FG003|Overall Study|Other|0|||
46999437|NCT01817530|83246823|FG004|Overall Study|Other|1|||
46999438|NCT01817530|83246824|FG005|Overall Study|Other|0|||
46999439|NCT01817530|83246825|FG006|Overall Study|Other|5|||
46999440|NCT01817530|83246826|FG007|Overall Study|Other|0|||
46999441|NCT01817530|83246819|FG000|Overall Study|Surgery or Invasive Intervention|1|||
46620403|NCT01066663|82764046|FG000|Overall Study|Adverse Event|0|||
46620404|NCT01066663|82764047|FG001|Overall Study|Adverse Event|0|||
46999442|NCT01817530|83246820|FG001|Overall Study|Surgery or Invasive Intervention|0|||
46999443|NCT01817530|83246821|FG002|Overall Study|Surgery or Invasive Intervention|0|||
46999444|NCT01817530|83246822|FG003|Overall Study|Surgery or Invasive Intervention|0|||
46999445|NCT01817530|83246823|FG004|Overall Study|Surgery or Invasive Intervention|1|||
46999446|NCT01817530|83246824|FG005|Overall Study|Surgery or Invasive Intervention|1|||
46999447|NCT01817530|83246825|FG006|Overall Study|Surgery or Invasive Intervention|1|||
46999448|NCT01817530|83246826|FG007|Overall Study|Surgery or Invasive Intervention|0|||
46999449|NCT01817530|83246819|FG000|Overall Study|Consent Withdrawn by Subject|3|||
46999450|NCT01817530|83246820|FG001|Overall Study|Consent Withdrawn by Subject|4|||
46999451|NCT01817530|83246821|FG002|Overall Study|Consent Withdrawn by Subject|7|||
46999452|NCT01817530|83246822|FG003|Overall Study|Consent Withdrawn by Subject|3|||
46999453|NCT01817530|83246823|FG004|Overall Study|Consent Withdrawn by Subject|5|||
46999454|NCT01817530|83246824|FG005|Overall Study|Consent Withdrawn by Subject|3|||
46620405|NCT01066663|82764048|FG002|Overall Study|Adverse Event|1|||
46709262|NCT01130532|82925206|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
46908026|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
46908027|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
46908028|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
46908029|NCT03068754|83136922|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
46908030|NCT03068754|83136923|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
46908031|NCT03068754|83136924|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
46908032|NCT03068754|83136925|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
46999455|NCT01817530|83246825|FG006|Overall Study|Consent Withdrawn by Subject|3|||
46999456|NCT01817530|83246826|FG007|Overall Study|Consent Withdrawn by Subject|10|||
46999457|NCT01817530|83246819|FG000|Overall Study|Lost to Follow-up|1|||
46999458|NCT01817530|83246820|FG001|Overall Study|Lost to Follow-up|4|||
46999459|NCT01817530|83246821|FG002|Overall Study|Lost to Follow-up|2|||
46999460|NCT01817530|83246822|FG003|Overall Study|Lost to Follow-up|1|||
46999461|NCT01817530|83246823|FG004|Overall Study|Lost to Follow-up|3|||
46999462|NCT01817530|83246824|FG005|Overall Study|Lost to Follow-up|2|||
46999463|NCT01817530|83246825|FG006|Overall Study|Lost to Follow-up|8|||
46999464|NCT01817530|83246826|FG007|Overall Study|Lost to Follow-up|4|||
46999465|NCT01816984|83246844|FG000|Overall Study|declining health status|1|||
46999466|NCT01816906|83246850|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
46999467|NCT01816906|83246851|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
46999468|NCT01816906|83246850|FG000|Six Months|Lost to Follow-up|14|||
46999469|NCT01816906|83246851|FG001|Six Months|Lost to Follow-up|16|||
46999470|NCT01816906|83246850|FG000|12 Months|Adverse Event|2|||
46999471|NCT01816906|83246851|FG001|12 Months|Adverse Event|2|||
46999472|NCT01816906|83246850|FG000|12 Months|Death|0|||
46999473|NCT01816906|83246851|FG001|12 Months|Death|2|||
46999474|NCT01816906|83246850|FG000|12 Months|Lost to Follow-up|2|||
46999475|NCT01816906|83246851|FG001|12 Months|Lost to Follow-up|1|||
46999476|NCT01816594|83246860|FG000|Overall Study|Local Progress|0|||
46999477|NCT01816594|83246861|FG001|Overall Study|Local Progress|2|||
46999478|NCT01816594|83246860|FG000|Overall Study|Adverse Event|9|||
46999479|NCT01816594|83246861|FG001|Overall Study|Adverse Event|0|||
46999480|NCT01816594|83246860|FG000|Overall Study|Withdrawal by Subject|1|||
46999481|NCT01816594|83246861|FG001|Overall Study|Withdrawal by Subject|0|||
46999482|NCT01816594|83246860|FG000|Overall Study|Physician Decision|1|||
46999483|NCT01816594|83246861|FG001|Overall Study|Physician Decision|0|||
46999484|NCT01802320|83246873|FG000|Overall Study|Death|1|||
46999485|NCT01802320|83246873|FG000|Overall Study|Withdrawal by Subject|1|||
46999486|NCT02453711|83246886|FG000|Overall Study|Withdrawal by Subject|5|||
46999487|NCT02453711|83246887|FG001|Overall Study|Withdrawal by Subject|4|||
46999488|NCT02453711|83246888|FG002|Overall Study|Withdrawal by Subject|6|||
46999489|NCT02453711|83246889|FG003|Overall Study|Withdrawal by Subject|4|||
46999490|NCT02453711|83246890|FG004|Overall Study|Withdrawal by Subject|1|||
46999491|NCT02453711|83246891|FG005|Overall Study|Withdrawal by Subject|1|||
46999492|NCT02453711|83246892|FG006|Overall Study|Withdrawal by Subject|0|||
46999493|NCT02453711|83246893|FG007|Overall Study|Withdrawal by Subject|1|||
46999494|NCT02453711|83246894|FG008|Overall Study|Withdrawal by Subject|7|||
46999495|NCT02453711|83246886|FG000|Overall Study|Lost to Follow-up|5|||
46999496|NCT02453711|83246887|FG001|Overall Study|Lost to Follow-up|3|||
46999497|NCT02453711|83246888|FG002|Overall Study|Lost to Follow-up|2|||
46999498|NCT02453711|83246889|FG003|Overall Study|Lost to Follow-up|3|||
46999499|NCT02453711|83246890|FG004|Overall Study|Lost to Follow-up|1|||
46999500|NCT02453711|83246891|FG005|Overall Study|Lost to Follow-up|5|||
46999501|NCT02453711|83246892|FG006|Overall Study|Lost to Follow-up|2|||
46999502|NCT02453711|83246893|FG007|Overall Study|Lost to Follow-up|6|||
46999503|NCT02453711|83246894|FG008|Overall Study|Lost to Follow-up|6|||
46999504|NCT02453711|83246886|FG000|Overall Study|Death|0|||
46999505|NCT02453711|83246887|FG001|Overall Study|Death|0|||
46999506|NCT02453711|83246888|FG002|Overall Study|Death|0|||
46999507|NCT02453711|83246889|FG003|Overall Study|Death|0|||
46999508|NCT02453711|83246890|FG004|Overall Study|Death|0|||
46999509|NCT02453711|83246891|FG005|Overall Study|Death|0|||
46999510|NCT02453711|83246892|FG006|Overall Study|Death|1|||
46999511|NCT02453711|83246893|FG007|Overall Study|Death|0|||
46999512|NCT02453711|83246894|FG008|Overall Study|Death|0|||
46999513|NCT02453711|83246886|FG000|Overall Study|Unclassified|1|||
46999514|NCT02453711|83246887|FG001|Overall Study|Unclassified|0|||
46999515|NCT02453711|83246888|FG002|Overall Study|Unclassified|1|||
46999516|NCT02453711|83246889|FG003|Overall Study|Unclassified|0|||
46999517|NCT02453711|83246890|FG004|Overall Study|Unclassified|0|||
46999518|NCT02453711|83246891|FG005|Overall Study|Unclassified|0|||
46999519|NCT02453711|83246892|FG006|Overall Study|Unclassified|0|||
46999520|NCT02453711|83246893|FG007|Overall Study|Unclassified|0|||
46999521|NCT02453711|83246894|FG008|Overall Study|Unclassified|0|||
46999522|NCT02453555|83246916|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
46999523|NCT02453555|83246917|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
46999524|NCT02453555|83246918|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
46999525|NCT02453555|83246919|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
46999526|NCT02453555|83246920|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
46999527|NCT02453555|83246921|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
46999528|NCT02453555|83246916|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
46999529|NCT02453555|83246917|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
46999530|NCT02453555|83246918|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
46999531|NCT02453555|83246919|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
46999532|NCT02453555|83246920|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
46999533|NCT02453555|83246921|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
46999534|NCT02453555|83246916|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
46999535|NCT02453555|83246917|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
46999536|NCT02453555|83246918|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
46999537|NCT02453555|83246919|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
46999538|NCT02453555|83246920|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
46999539|NCT02453555|83246921|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
46999540|NCT02453555|83246916|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
46999541|NCT02453555|83246917|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
46999542|NCT02453555|83246918|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
46999543|NCT02453555|83246919|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
46999544|NCT02453555|83246920|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
46999545|NCT02453555|83246921|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
46999546|NCT02453555|83246916|FG000|Extension Period|Adverse Event|0|||
46999547|NCT02453555|83246917|FG001|Extension Period|Adverse Event|0|||
46999548|NCT02453555|83246918|FG002|Extension Period|Adverse Event|1|||
46999549|NCT02453555|83246919|FG003|Extension Period|Adverse Event|2|||
46999550|NCT02453555|83246920|FG004|Extension Period|Adverse Event|1|||
46999551|NCT02453555|83246921|FG005|Extension Period|Adverse Event|1|||
46999552|NCT02453555|83246916|FG000|Extension Period|Protocol Violation|0|||
46999553|NCT02453555|83246917|FG001|Extension Period|Protocol Violation|0|||
46999554|NCT02453555|83246918|FG002|Extension Period|Protocol Violation|1|||
46999555|NCT02453555|83246919|FG003|Extension Period|Protocol Violation|0|||
46999556|NCT02453555|83246920|FG004|Extension Period|Protocol Violation|0|||
46999557|NCT02453555|83246921|FG005|Extension Period|Protocol Violation|0|||
46999558|NCT02453555|83246916|FG000|Extension Period|Withdrawal by Subject|0|||
46999559|NCT02453555|83246917|FG001|Extension Period|Withdrawal by Subject|0|||
46999560|NCT02453555|83246918|FG002|Extension Period|Withdrawal by Subject|1|||
46999561|NCT02453555|83246919|FG003|Extension Period|Withdrawal by Subject|0|||
46999562|NCT02453555|83246920|FG004|Extension Period|Withdrawal by Subject|0|||
46999563|NCT02453555|83246921|FG005|Extension Period|Withdrawal by Subject|0|||
46999564|NCT02453321|83246934|FG000|Overall Study|Weakness|1|||
46999565|NCT02453321|83246935|FG001|Overall Study|Weakness|1|||
46999566|NCT02453321|83246936|FG002|Overall Study|Weakness|2|||
46999567|NCT02453321|83246934|FG000|Overall Study|Deep Venous Thrombosis|0|||
46999568|NCT02453321|83246935|FG001|Overall Study|Deep Venous Thrombosis|1|||
46999569|NCT02453321|83246936|FG002|Overall Study|Deep Venous Thrombosis|0|||
46999570|NCT01610284|83246949|FG000|Randomization Phase|Adverse Event|1|||
46999571|NCT01610284|83246950|FG001|Randomization Phase|Adverse Event|0|||
46999572|NCT01610284|83246949|FG000|Randomization Phase|Physician Decision|1|||
46999573|NCT01610284|83246950|FG001|Randomization Phase|Physician Decision|1|||
46999574|NCT01610284|83246949|FG000|Randomization Phase|Death|0|||
46999575|NCT01610284|83246950|FG001|Randomization Phase|Death|1|||
46999576|NCT01610284|83246949|FG000|Treatment Phase|Adverse Event|80|||
46999577|NCT01610284|83246950|FG001|Treatment Phase|Adverse Event|12|||
46999578|NCT01610284|83246949|FG000|Treatment Phase|Lost to Follow-up|1|||
46999579|NCT01610284|83246950|FG001|Treatment Phase|Lost to Follow-up|0|||
46999580|NCT01610284|83246949|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
46999581|NCT01610284|83246950|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
46999582|NCT01610284|83246949|FG000|Treatment Phase|Physician Decision|27|||
46999583|NCT01610284|83246950|FG001|Treatment Phase|Physician Decision|24|||
46999584|NCT01610284|83246949|FG000|Treatment Phase|Progressive Disease|377|||
46999585|NCT01610284|83246950|FG001|Treatment Phase|Progressive Disease|486|||
46999586|NCT01610284|83246949|FG000|Treatment Phase|Protocol Deviation|2|||
46709263|NCT01130532|82925207|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
46803627|NCT03523728|83022942|FG004|Stage 1 (24 Months)|Adverse Event|0|||
46999587|NCT01610284|83246950|FG001|Treatment Phase|Protocol Deviation|3|||
46999588|NCT01610284|83246949|FG000|Treatment Phase|Study terminated by Sponsor|18|||
46999589|NCT01610284|83246950|FG001|Treatment Phase|Study terminated by Sponsor|15|||
46999590|NCT01610284|83246949|FG000|Treatment Phase|Subject/Guardian Decision|55|||
46999591|NCT01610284|83246950|FG001|Treatment Phase|Subject/Guardian Decision|23|||
46999592|NCT01610284|83246949|FG000|Treatment Phase|Death|6|||
46999593|NCT01610284|83246950|FG001|Treatment Phase|Death|5|||
46999594|NCT01610284|83246949|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
46999595|NCT01610284|83246950|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
46999596|NCT01610284|83246949|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
46999597|NCT01610284|83246950|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
46999598|NCT01610284|83246949|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
46999599|NCT01610284|83246950|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
46999600|NCT01610284|83246949|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
46999601|NCT01610284|83246950|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
46999602|NCT01610284|83246949|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
46999603|NCT01610284|83246950|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
46999604|NCT01610284|83246949|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
46999605|NCT01610284|83246950|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
46999606|NCT02452463|83246959|FG000|Overall Study|Death|1|||
46999607|NCT02452463|83246960|FG001|Overall Study|Death|0|||
46999608|NCT02452463|83246961|FG002|Overall Study|Death|0|||
46999609|NCT02452463|83246959|FG000|Overall Study|Study Suspended|1|||
46999610|NCT02452463|83246960|FG001|Overall Study|Study Suspended|0|||
46999611|NCT02452463|83246961|FG002|Overall Study|Study Suspended|0|||
46999612|NCT02452463|83246959|FG000|Overall Study|Recommended by DSMB|0|||
46999613|NCT02452463|83246960|FG001|Overall Study|Recommended by DSMB|1|||
46999614|NCT02452463|83246961|FG002|Overall Study|Recommended by DSMB|0|||
46999615|NCT02452463|83246959|FG000|Overall Study|Withdrawal by Subject|0|||
46999616|NCT02452463|83246960|FG001|Overall Study|Withdrawal by Subject|1|||
46999617|NCT02452463|83246961|FG002|Overall Study|Withdrawal by Subject|0|||
46999618|NCT02432105|83246972|FG000|Overall Study|Lost to Follow-up|1|||
46999619|NCT02432105|83246973|FG001|Overall Study|Lost to Follow-up|1|||
46999620|NCT02432105|83246974|FG002|Overall Study|Lost to Follow-up|0|||
46999621|NCT02432105|83246972|FG000|Overall Study|Withdrawal by Subject|1|||
46999622|NCT02432105|83246973|FG001|Overall Study|Withdrawal by Subject|0|||
46999623|NCT02432105|83246974|FG002|Overall Study|Withdrawal by Subject|1|||
46999624|NCT02432105|83246972|FG000|Overall Study|Culture positive for yeast|0|||
46999625|NCT02432105|83246973|FG001|Overall Study|Culture positive for yeast|1|||
46999626|NCT02432105|83246974|FG002|Overall Study|Culture positive for yeast|0|||
46999627|NCT02432105|83246972|FG000|Overall Study|Randomized in error|0|||
46999628|NCT02432105|83246973|FG001|Overall Study|Randomized in error|0|||
46999629|NCT02432105|83246974|FG002|Overall Study|Randomized in error|2|||
46999630|NCT02431793|83246986|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
46999631|NCT02431793|83246987|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
46999632|NCT02431793|83246988|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
46999633|NCT02431793|83246986|FG000|Overall Study|Withdrawal by Subject|7|||
46999634|NCT02431793|83246987|FG001|Overall Study|Withdrawal by Subject|5|||
46999635|NCT02431793|83246988|FG002|Overall Study|Withdrawal by Subject|5|||
46999636|NCT02431793|83246986|FG000|Overall Study|Lost to Follow-up|101|||
46999637|NCT02431793|83246987|FG001|Overall Study|Lost to Follow-up|122|||
46999638|NCT02431793|83246988|FG002|Overall Study|Lost to Follow-up|104|||
46999639|NCT01801930|83247000|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
46999640|NCT01801930|83247001|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
46999641|NCT01801930|83247002|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
46999642|NCT01801930|83247003|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
46999643|NCT01801930|83247000|FG000|Overall Study|DLT occurs|0|||
46999644|NCT01801930|83247001|FG001|Overall Study|DLT occurs|1|||
46999645|NCT01801930|83247002|FG002|Overall Study|DLT occurs|0|||
46999646|NCT01801930|83247003|FG003|Overall Study|DLT occurs|0|||
46999647|NCT01610206|83247015|FG000|Overall Study|Adverse Event|10|||
46709264|NCT01130532|82925204|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
46709265|NCT01130532|82925205|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
46999648|NCT01610206|83247016|FG001|Overall Study|Adverse Event|30|||
46999649|NCT01816048|83247022|FG000|Overall Study|Adverse Event|1|||
46999650|NCT01816048|83247022|FG000|Overall Study|Death|1|||
46999651|NCT01816048|83247022|FG000|Overall Study|Withdrawal by Subject|1|||
46999652|NCT01816048|83247022|FG000|Overall Study|Disease Progression|3|||
46999653|NCT01612858|83247029|FG000|Overall Study|Withdrawal by Subject|5|||
46999654|NCT01612858|83247030|FG001|Overall Study|Withdrawal by Subject|1|||
46999655|NCT01612780|83247036|FG000|Overall Study|Treatment not completed|1|||
46999656|NCT01612780|83247036|FG000|Overall Study|Withdrawal by Subject|5|||
46999657|NCT01612702|83247042|FG000|Overall Study|Protocol Violation|11|||
46999658|NCT01612702|83247043|FG001|Overall Study|Protocol Violation|11|||
46999659|NCT02431559|83247053|FG000|Overall Study|Adverse Event|0|||
46999660|NCT02431559|83247054|FG001|Overall Study|Adverse Event|1|||
46999661|NCT02431559|83247055|FG002|Overall Study|Adverse Event|0|||
46999662|NCT02431559|83247056|FG003|Overall Study|Adverse Event|4|||
46999663|NCT02431559|83247053|FG000|Overall Study|Progressive disease|2|||
46999664|NCT02431559|83247054|FG001|Overall Study|Progressive disease|1|||
46999665|NCT02431559|83247055|FG002|Overall Study|Progressive disease|4|||
46999666|NCT02431559|83247056|FG003|Overall Study|Progressive disease|22|||
46999667|NCT02431559|83247053|FG000|Overall Study|Withdrawal by Subject|0|||
46999668|NCT02431559|83247054|FG001|Overall Study|Withdrawal by Subject|1|||
46999669|NCT02431559|83247055|FG002|Overall Study|Withdrawal by Subject|0|||
46999670|NCT02431559|83247056|FG003|Overall Study|Withdrawal by Subject|4|||
46999671|NCT02431559|83247053|FG000|Overall Study|Physician Decision|0|||
46999672|NCT02431559|83247054|FG001|Overall Study|Physician Decision|0|||
46999673|NCT02431559|83247055|FG002|Overall Study|Physician Decision|0|||
46999674|NCT02431559|83247056|FG003|Overall Study|Physician Decision|1|||
46999675|NCT02388269|83247070|FG000|Overall Study|Adverse Event|2|||
46999676|NCT02388269|83247071|FG001|Overall Study|Adverse Event|0|||
46999677|NCT02388269|83247072|FG002|Overall Study|Adverse Event|0|||
46999678|NCT02388269|83247070|FG000|Overall Study|Withdrawal by Subject|1|||
46999679|NCT02388269|83247071|FG001|Overall Study|Withdrawal by Subject|2|||
46999680|NCT02388269|83247072|FG002|Overall Study|Withdrawal by Subject|0|||
46999681|NCT02388269|83247070|FG000|Overall Study|less than 50% stimulations|1|||
46999682|NCT02388269|83247071|FG001|Overall Study|less than 50% stimulations|0|||
46999683|NCT02388269|83247072|FG002|Overall Study|less than 50% stimulations|0|||
46999684|NCT02388269|83247070|FG000|Overall Study|no diary data|3|||
46908033|NCT03068754|83136922|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
46908034|NCT03068754|83136923|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
46908035|NCT03068754|83136924|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
46908036|NCT03068754|83136925|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
46908037|NCT03068754|83136922|FG000|Open Label Extension Period (OLE)|Death|0|||
46908038|NCT03068754|83136923|FG001|Open Label Extension Period (OLE)|Death|0|||
46908039|NCT03068754|83136924|FG002|Open Label Extension Period (OLE)|Death|0|||
46908040|NCT03068754|83136925|FG003|Open Label Extension Period (OLE)|Death|1|||
46908041|NCT03068754|83136922|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
46908042|NCT03068754|83136923|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
46908043|NCT03068754|83136924|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
46908044|NCT03068754|83136925|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
46908045|NCT03068754|83136922|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
46908046|NCT03068754|83136923|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
46908047|NCT03068754|83136924|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
46908048|NCT03068754|83136925|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
46908049|NCT03068754|83136922|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
46908050|NCT03068754|83136923|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
46908051|NCT03068754|83136924|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
46908052|NCT03068754|83136925|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
46908053|NCT03068754|83136922|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
46908054|NCT03068754|83136923|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
46908055|NCT03068754|83136924|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
46908056|NCT03068754|83136925|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
46908057|NCT02965820|83136935|FG000|Period 2, Second 30 Days|Adverse Event|1|||
46908058|NCT02965820|83136936|FG001|Period 2, Second 30 Days|Adverse Event|1|||
46908059|NCT03430895|83136942|FG000|Overall Study|Not Treated|2|||
46908060|NCT03452189|83136946|FG000|First Intervention (3 Months)|Adverse Event|1|||
46908061|NCT03452189|83136947|FG001|First Intervention (3 Months)|Adverse Event|0|||
46908062|NCT03452189|83136946|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
46908063|NCT03452189|83136947|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
46908064|NCT03451721|83136953|FG000|Overall Study|Death|1|||
46908065|NCT00603954|83136959|FG000|Overall Study|Protocol Violation|1|||
46999685|NCT02388269|83247071|FG001|Overall Study|no diary data|0|||
46999686|NCT02388269|83247072|FG002|Overall Study|no diary data|0|||
46999687|NCT02388269|83247070|FG000|Overall Study|Protocol Violation|2|||
46620406|NCT03930745|82766246|FG000|Overall Study|Lost to Follow-up|10|||
46999688|NCT02388269|83247071|FG001|Overall Study|Protocol Violation|0|||
46999689|NCT02388269|83247072|FG002|Overall Study|Protocol Violation|0|||
46999690|NCT02388269|83247070|FG000|Overall Study|Screen Failure|0|||
46999691|NCT02388269|83247071|FG001|Overall Study|Screen Failure|0|||
46999692|NCT02388269|83247072|FG002|Overall Study|Screen Failure|10|||
46999693|NCT01652573|83247098|FG000|Overall Study|Adverse Event|0|||
46999694|NCT01652573|83247099|FG001|Overall Study|Adverse Event|1|||
46999695|NCT02388191|83247107|FG000|Overall Study|Patient did not receive IUD|1|||
46999696|NCT02388191|83247108|FG001|Overall Study|Patient did not receive IUD|0|||
46999697|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
46999698|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
46999699|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
46999700|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
46999701|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
46999702|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
46999703|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
46999704|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
46999705|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
46999706|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
46999707|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
46999708|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
46999709|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
46999710|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
46999711|NCT01815736|83247116|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
46999712|NCT01815736|83247117|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
46999713|NCT01815736|83247116|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
46999714|NCT01815736|83247117|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
46999715|NCT01815736|83247116|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
46999716|NCT01815736|83247117|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
46999717|NCT01815736|83247116|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
46999718|NCT01815736|83247117|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
46999719|NCT01815736|83247116|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
46999720|NCT01815736|83247117|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
46999721|NCT01815736|83247116|FG000|Extension Treatment Phase- After Week 96|Death|1|||
46999722|NCT01815736|83247117|FG001|Extension Treatment Phase- After Week 96|Death|0|||
46999723|NCT01651949|83247128|FG000|Overall Study|Unknown status|4|||
46999724|NCT01651949|83247129|FG001|Overall Study|Unknown status|4|||
46999725|NCT01651949|83247130|FG002|Overall Study|Unknown status|0|||
46999726|NCT01651949|83247128|FG000|Overall Study|Lost to Follow-up|30|||
46999727|NCT01651949|83247129|FG001|Overall Study|Lost to Follow-up|56|||
46999728|NCT01651949|83247130|FG002|Overall Study|Lost to Follow-up|20|||
46999729|NCT01651949|83247128|FG000|Overall Study|Protocol Violation|0|||
46999730|NCT01651949|83247129|FG001|Overall Study|Protocol Violation|2|||
46999731|NCT01651949|83247130|FG002|Overall Study|Protocol Violation|1|||
46999732|NCT01651949|83247128|FG000|Overall Study|Physician Decision|0|||
46999733|NCT01651949|83247129|FG001|Overall Study|Physician Decision|2|||
46999734|NCT01651949|83247130|FG002|Overall Study|Physician Decision|0|||
46999735|NCT01651949|83247128|FG000|Overall Study|Adverse Event|0|||
46999736|NCT01651949|83247129|FG001|Overall Study|Adverse Event|2|||
46908066|NCT00603954|83136960|FG001|Overall Study|Protocol Violation|2|||
46908067|NCT03427619|83136967|FG000|Overall Study|Physician Decision|3|||
46908068|NCT03427619|83136967|FG000|Overall Study|Withdrawal by Subject|4|||
46908069|NCT03427619|83136967|FG000|Overall Study|Lost to Follow-up|5|||
46908070|NCT03427619|83136967|FG000|Overall Study|Administrative|4|||
46908071|NCT03427619|83136967|FG000|Overall Study|Other|2|||
46908072|NCT03427619|83136967|FG000|Overall Study|Unknown or Missing Completion Status|48|||
46908073|NCT03407729|83136973|FG000|Overall Study|Lost to Follow-up|2|||
46908074|NCT03407729|83136974|FG001|Overall Study|Lost to Follow-up|0|||
46908075|NCT03407729|83136973|FG000|Overall Study|Unable to schedule|0|||
46908076|NCT03407729|83136974|FG001|Overall Study|Unable to schedule|3|||
46908077|NCT02435433|83136985|FG000|Overall Study|Withdrawal by Subject|2|||
46908078|NCT02435433|83136986|FG001|Overall Study|Withdrawal by Subject|3|||
46908079|NCT02435433|83136987|FG002|Overall Study|Withdrawal by Subject|1|||
46908080|NCT02435433|83136988|FG003|Overall Study|Withdrawal by Subject|0|||
46908081|NCT02435433|83136989|FG004|Overall Study|Withdrawal by Subject|0|||
46908082|NCT02435433|83136985|FG000|Overall Study|Lost to Follow-up|2|||
46908083|NCT02435433|83136986|FG001|Overall Study|Lost to Follow-up|2|||
46908084|NCT02435433|83136987|FG002|Overall Study|Lost to Follow-up|4|||
46999737|NCT01651949|83247130|FG002|Overall Study|Adverse Event|1|||
46999738|NCT01651949|83247128|FG000|Overall Study|Screen failure|2|||
46908085|NCT02435433|83136988|FG003|Overall Study|Lost to Follow-up|1|||
46999739|NCT01651949|83247129|FG001|Overall Study|Screen failure|2|||
46999740|NCT01651949|83247130|FG002|Overall Study|Screen failure|0|||
46999741|NCT01651949|83247128|FG000|Overall Study|Withdrawal by Subject|17|||
46999742|NCT01651949|83247129|FG001|Overall Study|Withdrawal by Subject|18|||
46999743|NCT01651949|83247130|FG002|Overall Study|Withdrawal by Subject|9|||
46999744|NCT01800916|83247138|FG000|Test Period 1 (1 Week)|Convex product user|0|||
46999745|NCT01800916|83247139|FG001|Test Period 1 (1 Week)|Convex product user|0|||
46999746|NCT01800916|83247140|FG002|Test Period 1 (1 Week)|Convex product user|0|||
46999747|NCT01800916|83247141|FG003|Test Period 1 (1 Week)|Convex product user|1|||
46999748|NCT01800916|83247142|FG004|Test Period 1 (1 Week)|Convex product user|0|||
46999749|NCT01800916|83247143|FG005|Test Period 1 (1 Week)|Convex product user|0|||
46999750|NCT01800916|83247144|FG006|Test Period 1 (1 Week)|Convex product user|0|||
46999751|NCT01800916|83247145|FG007|Test Period 1 (1 Week)|Convex product user|0|||
46999752|NCT01800916|83247146|FG008|Test Period 1 (1 Week)|Convex product user|0|||
46999753|NCT01800916|83247138|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
46999754|NCT01800916|83247139|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
46999755|NCT01800916|83247140|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
46999756|NCT01800916|83247141|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
46999757|NCT01800916|83247142|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
46999758|NCT01800916|83247143|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
46999759|NCT01800916|83247144|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
46999760|NCT01800916|83247145|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
46999761|NCT01800916|83247146|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
46999762|NCT01800058|83247156|FG000|Overall Study|Lost to Follow-up|1|||
46999763|NCT01815580|83247163|FG000|Overall Study|Lost to Follow-up|4|||
46999764|NCT01815580|83247164|FG001|Overall Study|Lost to Follow-up|7|||
46999765|NCT01815580|83247163|FG000|Overall Study|Withdrawal by Subject|3|||
46999766|NCT01815580|83247164|FG001|Overall Study|Withdrawal by Subject|4|||
46999767|NCT01815580|83247163|FG000|Overall Study|Excluded from analysis|5|||
46999768|NCT01815580|83247164|FG001|Overall Study|Excluded from analysis|4|||
46999769|NCT01799590|83247178|FG000|Overall Study|Adverse Event|13|||
46999770|NCT01799590|83247179|FG001|Overall Study|Adverse Event|7|||
46999771|NCT01799590|83247180|FG002|Overall Study|Adverse Event|5|||
46999772|NCT01799590|83247178|FG000|Overall Study|Pregnancy|2|||
46999773|NCT01799590|83247179|FG001|Overall Study|Pregnancy|0|||
46999774|NCT01799590|83247180|FG002|Overall Study|Pregnancy|0|||
46999775|NCT01799590|83247178|FG000|Overall Study|Lack of Efficacy|3|||
46999776|NCT01799590|83247179|FG001|Overall Study|Lack of Efficacy|1|||
46999777|NCT01799590|83247180|FG002|Overall Study|Lack of Efficacy|3|||
46999778|NCT01799590|83247178|FG000|Overall Study|Participants convenience|4|||
46999779|NCT01799590|83247179|FG001|Overall Study|Participants convenience|4|||
46999780|NCT01799590|83247180|FG002|Overall Study|Participants convenience|2|||
46999781|NCT01799590|83247178|FG000|Overall Study|Aggravation of complications|0|||
46999782|NCT01799590|83247179|FG001|Overall Study|Aggravation of complications|1|||
46999783|NCT01799590|83247180|FG002|Overall Study|Aggravation of complications|1|||
46999784|NCT01799590|83247178|FG000|Overall Study|Using drugs with restricted days of use|0|||
46999785|NCT01799590|83247179|FG001|Overall Study|Using drugs with restricted days of use|3|||
46999786|NCT01799590|83247180|FG002|Overall Study|Using drugs with restricted days of use|2|||
46999787|NCT01799590|83247178|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
46999788|NCT01799590|83247179|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
46999789|NCT01799590|83247180|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
46999790|NCT01799590|83247178|FG000|Overall Study|Other|3|||
46999791|NCT01799590|83247179|FG001|Overall Study|Other|0|||
46999792|NCT01799590|83247180|FG002|Overall Study|Other|1|||
46999793|NCT01815424|83247191|FG000|Week 0 to 16|Adverse Event|1|||
46999794|NCT01815424|83247192|FG001|Week 0 to 16|Adverse Event|3|||
46999795|NCT01815424|83247193|FG002|Week 0 to 16|Adverse Event|3|||
46999796|NCT01815424|83247194|FG003|Week 0 to 16|Adverse Event|0|||
46999797|NCT01815424|83247195|FG004|Week 0 to 16|Adverse Event|0|||
46999798|NCT01815424|83247191|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
46999799|NCT01815424|83247192|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
46999800|NCT01815424|83247193|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
46620407|NCT03930745|82766247|FG001|Overall Study|Lost to Follow-up|5|||
46999801|NCT01815424|83247194|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
46620408|NCT03930745|82766246|FG000|Overall Study|Withdrawal by Subject|1|||
46620409|NCT03930745|82766247|FG001|Overall Study|Withdrawal by Subject|2|||
46620410|NCT03930745|82766246|FG000|Overall Study|Protocol Violation|2|||
46999802|NCT01815424|83247195|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
46999803|NCT01815424|83247191|FG000|Week 0 to 16|Lost to Follow-up|0|||
46999804|NCT01815424|83247192|FG001|Week 0 to 16|Lost to Follow-up|1|||
46999805|NCT01815424|83247193|FG002|Week 0 to 16|Lost to Follow-up|0|||
46999806|NCT01815424|83247194|FG003|Week 0 to 16|Lost to Follow-up|0|||
46999807|NCT01815424|83247195|FG004|Week 0 to 16|Lost to Follow-up|0|||
46999808|NCT01815424|83247191|FG000|Week 0 to 16|Withdrawal by Subject|0|||
46999809|NCT01815424|83247192|FG001|Week 0 to 16|Withdrawal by Subject|0|||
46999810|NCT01815424|83247193|FG002|Week 0 to 16|Withdrawal by Subject|1|||
46999811|NCT01815424|83247194|FG003|Week 0 to 16|Withdrawal by Subject|0|||
46999812|NCT01815424|83247195|FG004|Week 0 to 16|Withdrawal by Subject|0|||
46999813|NCT01815424|83247191|FG000|Week 0 to 16|Other|1|||
46999814|NCT01815424|83247192|FG001|Week 0 to 16|Other|0|||
46999815|NCT01815424|83247193|FG002|Week 0 to 16|Other|3|||
46999816|NCT01815424|83247194|FG003|Week 0 to 16|Other|0|||
46999817|NCT01815424|83247195|FG004|Week 0 to 16|Other|0|||
46999818|NCT01815424|83247191|FG000|Week 0 to 16|Protocol Violation|1|||
46999819|NCT01815424|83247192|FG001|Week 0 to 16|Protocol Violation|0|||
46999820|NCT01815424|83247193|FG002|Week 0 to 16|Protocol Violation|0|||
46999821|NCT01815424|83247194|FG003|Week 0 to 16|Protocol Violation|0|||
46999822|NCT01815424|83247195|FG004|Week 0 to 16|Protocol Violation|0|||
46999823|NCT01815424|83247191|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
46999824|NCT01815424|83247192|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
46999825|NCT01815424|83247193|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
46999826|NCT01815424|83247194|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
46999827|NCT01815424|83247195|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
46999828|NCT01815424|83247191|FG000|Week 16 to 52|Other|0|||
46999829|NCT01815424|83247192|FG001|Week 16 to 52|Other|1|||
46999830|NCT01815424|83247193|FG002|Week 16 to 52|Other|0|||
46999831|NCT01815424|83247194|FG003|Week 16 to 52|Other|0|||
46999832|NCT01815424|83247195|FG004|Week 16 to 52|Other|0|||
46999833|NCT01815424|83247191|FG000|Week 16 to 52|Adverse Event|0|||
46999834|NCT01815424|83247192|FG001|Week 16 to 52|Adverse Event|0|||
46999835|NCT01815424|83247193|FG002|Week 16 to 52|Adverse Event|0|||
46999836|NCT01815424|83247194|FG003|Week 16 to 52|Adverse Event|0|||
46999837|NCT01815424|83247195|FG004|Week 16 to 52|Adverse Event|1|||
46999838|NCT01815424|83247191|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
46999839|NCT01815424|83247192|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
46999840|NCT01815424|83247193|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
46999841|NCT01815424|83247194|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
46999842|NCT01815424|83247195|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
46999843|NCT01815424|83247191|FG000|Week 16 to 52|Lost to Follow-up|0|||
46999844|NCT01815424|83247192|FG001|Week 16 to 52|Lost to Follow-up|2|||
46999845|NCT01815424|83247193|FG002|Week 16 to 52|Lost to Follow-up|0|||
46999846|NCT01815424|83247194|FG003|Week 16 to 52|Lost to Follow-up|2|||
46999847|NCT01815424|83247195|FG004|Week 16 to 52|Lost to Follow-up|1|||
46999848|NCT01815424|83247191|FG000|Week 16 to 52|Withdrawal by Subject|1|||
46999849|NCT01815424|83247192|FG001|Week 16 to 52|Withdrawal by Subject|2|||
46999850|NCT01815424|83247193|FG002|Week 16 to 52|Withdrawal by Subject|0|||
46999851|NCT01815424|83247194|FG003|Week 16 to 52|Withdrawal by Subject|0|||
46999852|NCT01815424|83247195|FG004|Week 16 to 52|Withdrawal by Subject|0|||
46999853|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
46999854|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
46999855|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
46999856|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
46999857|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
46999858|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
46999859|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
46999860|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
46999861|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
46999862|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
46999863|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
46999864|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
46999865|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
46999866|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
46999867|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
46999868|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
46999869|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
46999870|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
46999871|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
46999872|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
46999873|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
46999874|NCT02431247|83247210|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
46999875|NCT02431247|83247211|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
46999876|NCT02431247|83247212|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
46999877|NCT02431247|83247210|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
46999878|NCT02431247|83247211|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
46999879|NCT02431247|83247212|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
46999880|NCT02431247|83247210|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
46999881|NCT02431247|83247211|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
46999882|NCT02431247|83247212|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
46999883|NCT02431247|83247210|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
46999884|NCT02431247|83247211|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
46999885|NCT02431247|83247212|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
46709266|NCT01130532|82925206|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
46908086|NCT02435433|83136989|FG004|Overall Study|Lost to Follow-up|0|||
46908087|NCT03120351|83137002|FG000|Overall Study|Physician Decision|1|||
46908088|NCT03120351|83137003|FG001|Overall Study|Physician Decision|1|||
46908089|NCT02354703|83137013|FG000|Overall Study|Withdrawal by Subject|1|||
46908090|NCT02354703|83137014|FG001|Overall Study|Withdrawal by Subject|1|||
46908091|NCT02354703|83137015|FG002|Overall Study|Withdrawal by Subject|1|||
46908092|NCT02354703|83137016|FG003|Overall Study|Withdrawal by Subject|1|||
46908093|NCT02354703|83137013|FG000|Overall Study|Lost to Follow-up|2|||
46908094|NCT02354703|83137014|FG001|Overall Study|Lost to Follow-up|7|||
46908095|NCT02354703|83137015|FG002|Overall Study|Lost to Follow-up|9|||
46908096|NCT02354703|83137016|FG003|Overall Study|Lost to Follow-up|2|||
46908097|NCT02354703|83137013|FG000|Overall Study|Adverse Event|0|||
46908098|NCT02354703|83137014|FG001|Overall Study|Adverse Event|0|||
46908099|NCT02354703|83137015|FG002|Overall Study|Adverse Event|1|||
46908100|NCT02354703|83137016|FG003|Overall Study|Adverse Event|0|||
46908101|NCT00384111|83137032|FG000|Overall Study|Disease Progression|3|||
46908102|NCT00384111|83137032|FG000|Overall Study|Adverse Event|1|||
46908103|NCT00384111|83137032|FG000|Overall Study|Investigator Decision|3|||
46908104|NCT00384111|83137032|FG000|Overall Study|Study Terminated by the Sponsor|19|||
46908105|NCT03113409|83137036|FG000|Overall Study|Withdrawal by Subject|5|||
46908106|NCT03113409|83137037|FG001|Overall Study|Withdrawal by Subject|0|||
46908107|NCT03113409|83137038|FG002|Overall Study|Withdrawal by Subject|0|||
46908108|NCT01319877|83137044|FG000|Overall Study|Lost to Follow-up|100|||
46908109|NCT01319877|83137045|FG001|Overall Study|Lost to Follow-up|37|||
46908110|NCT01319877|83137044|FG000|Overall Study|Physician Decision|2|||
46908111|NCT01319877|83137045|FG001|Overall Study|Physician Decision|0|||
46908112|NCT01319877|83137044|FG000|Overall Study|Disease Progression|2|||
46908113|NCT01319877|83137045|FG001|Overall Study|Disease Progression|2|||
46908114|NCT01319877|83137044|FG000|Overall Study|Withdrawal by Subject|0|||
46908115|NCT01319877|83137045|FG001|Overall Study|Withdrawal by Subject|1|||
46908116|NCT01319877|83137044|FG000|Overall Study|Reason Not Specified|4|||
46908117|NCT01319877|83137045|FG001|Overall Study|Reason Not Specified|5|||
46908118|NCT03427073|83137058|FG000|Overall Study|Disease Progression|1|||
46908119|NCT03427073|83137059|FG001|Overall Study|Disease Progression|1|||
46908120|NCT03427073|83137060|FG002|Overall Study|Disease Progression|1|||
46908121|NCT03427073|83137061|FG003|Overall Study|Disease Progression|3|||
46908122|NCT03427073|83137062|FG004|Overall Study|Disease Progression|3|||
46908123|NCT03427073|83137063|FG005|Overall Study|Disease Progression|4|||
46908124|NCT03427073|83137064|FG006|Overall Study|Disease Progression|2|||
46908125|NCT03427073|83137065|FG007|Overall Study|Disease Progression|3|||
46908126|NCT03427073|83137058|FG000|Overall Study|Physician Decision|0|||
46908127|NCT03427073|83137059|FG001|Overall Study|Physician Decision|0|||
46908128|NCT03427073|83137060|FG002|Overall Study|Physician Decision|0|||
46908129|NCT03427073|83137061|FG003|Overall Study|Physician Decision|0|||
46908130|NCT03427073|83137062|FG004|Overall Study|Physician Decision|0|||
46908131|NCT03427073|83137063|FG005|Overall Study|Physician Decision|0|||
46908132|NCT03427073|83137064|FG006|Overall Study|Physician Decision|1|||
46908133|NCT03427073|83137065|FG007|Overall Study|Physician Decision|1|||
46908134|NCT03066804|83137085|FG000|Overall Study|Physician Decision|0|||
46908135|NCT03066804|83137086|FG001|Overall Study|Physician Decision|4|||
46908136|NCT03066804|83137085|FG000|Overall Study|Death|23|||
46908137|NCT03066804|83137086|FG001|Overall Study|Death|17|||
46908138|NCT03066804|83137085|FG000|Overall Study|Withdrawal by Subject|19|||
46908139|NCT03066804|83137086|FG001|Overall Study|Withdrawal by Subject|25|||
46908140|NCT03066804|83137085|FG000|Overall Study|Lost to Follow-up|2|||
46908141|NCT03066804|83137086|FG001|Overall Study|Lost to Follow-up|0|||
46908142|NCT03066804|83137085|FG000|Overall Study|Adverse Event|2|||
46908143|NCT03066804|83137086|FG001|Overall Study|Adverse Event|3|||
46999886|NCT02431247|83247210|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
46999887|NCT02431247|83247211|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
46999888|NCT02431247|83247212|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
46999889|NCT02431247|83247210|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
46999890|NCT02431247|83247211|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
46908144|NCT03066804|83137085|FG000|Overall Study|Technical problems|5|||
46908145|NCT03066804|83137086|FG001|Overall Study|Technical problems|1|||
46908146|NCT02954237|83137093|FG000|Overall Study|Withdrawal by Subject|25|||
46908147|NCT02954237|83137093|FG000|Overall Study|Missed visit|16|||
46908148|NCT02954237|83137093|FG000|Overall Study|Death|2|||
46908149|NCT04250337|83137099|FG000|Overall Study|Adverse Event|0|||
46908150|NCT04250337|83137100|FG001|Overall Study|Adverse Event|3|||
46908151|NCT04250337|83137099|FG000|Overall Study|Lack of Efficacy|1|||
46908152|NCT04250337|83137100|FG001|Overall Study|Lack of Efficacy|3|||
46908153|NCT04250337|83137099|FG000|Overall Study|Physician Decision|1|||
46999891|NCT02431247|83247212|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
46999892|NCT02431247|83247210|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
46999893|NCT02431247|83247211|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
46999894|NCT02431247|83247212|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
46999895|NCT01814878|83247226|FG000|Overall Study|Adverse Event|16|||
46999896|NCT01814878|83247227|FG001|Overall Study|Adverse Event|5|||
46999897|NCT01814878|83247226|FG000|Overall Study|Withdrawal by Subject|20|||
46999898|NCT01814878|83247227|FG001|Overall Study|Withdrawal by Subject|16|||
46999899|NCT01814878|83247226|FG000|Overall Study|Protocol Violation|5|||
46999900|NCT01814878|83247227|FG001|Overall Study|Protocol Violation|5|||
46999901|NCT01814878|83247226|FG000|Overall Study|Physician Decision|3|||
46999902|NCT01814878|83247227|FG001|Overall Study|Physician Decision|1|||
46999903|NCT01814878|83247226|FG000|Overall Study|Screening failure (drop-out)|0|||
46999904|NCT01814878|83247227|FG001|Overall Study|Screening failure (drop-out)|3|||
46999905|NCT01814878|83247226|FG000|Overall Study|Other|2|||
46999906|NCT01814878|83247227|FG001|Overall Study|Other|0|||
46999907|NCT02407457|83247235|FG000|1 Month|Death|3|||
46999908|NCT02407457|83247236|FG001|1 Month|Death|0|||
46999909|NCT02407457|83247235|FG000|1 Month|Lost to Follow-up|1|||
46999910|NCT02407457|83247236|FG001|1 Month|Lost to Follow-up|1|||
46999911|NCT02407457|83247235|FG000|1 Month|missed visit|2|||
46999912|NCT02407457|83247236|FG001|1 Month|missed visit|6|||
46999913|NCT02407457|83247235|FG000|6-Month|Death|2|||
46999914|NCT02407457|83247236|FG001|6-Month|Death|8|||
46999915|NCT02407457|83247235|FG000|6-Month|Lost to Follow-up|2|||
46999916|NCT02407457|83247236|FG001|6-Month|Lost to Follow-up|2|||
46999917|NCT02407457|83247235|FG000|6-Month|missed visit|15|||
46999918|NCT02407457|83247236|FG001|6-Month|missed visit|12|||
46999919|NCT02407457|83247235|FG000|6-Month|Over Due|1|||
46999920|NCT02407457|83247236|FG001|6-Month|Over Due|2|||
46999921|NCT02407457|83247235|FG000|6-Month|Open Repair|0|||
46999922|NCT02407457|83247236|FG001|6-Month|Open Repair|1|||
46999923|NCT02407457|83247235|FG000|1 Year|Death|6|||
46999924|NCT02407457|83247236|FG001|1 Year|Death|11|||
46999925|NCT02407457|83247235|FG000|1 Year|Lost to Follow-up|3|||
46999926|NCT02407457|83247236|FG001|1 Year|Lost to Follow-up|2|||
46999927|NCT02407457|83247235|FG000|1 Year|Missed Visit|18|||
46999928|NCT02407457|83247236|FG001|1 Year|Missed Visit|10|||
46999929|NCT02407457|83247235|FG000|1 Year|Over Due|6|||
46999930|NCT02407457|83247236|FG001|1 Year|Over Due|4|||
46999931|NCT02407457|83247235|FG000|1 Year|Open Repair|0|||
46999932|NCT02407457|83247236|FG001|1 Year|Open Repair|1|||
46999933|NCT02407457|83247235|FG000|2-year|Death|14|||
46999934|NCT02407457|83247236|FG001|2-year|Death|8|||
46999935|NCT02407457|83247235|FG000|2-year|Lost to Follow-up|6|||
46999936|NCT02407457|83247236|FG001|2-year|Lost to Follow-up|9|||
46999937|NCT02407457|83247235|FG000|2-year|Missed Visit|13|||
46999938|NCT02407457|83247236|FG001|2-year|Missed Visit|11|||
46999939|NCT02407457|83247235|FG000|2-year|Over Due|1|||
46999940|NCT02407457|83247236|FG001|2-year|Over Due|5|||
46999941|NCT02407457|83247235|FG000|2-year|Open Repair|0|||
46999942|NCT02407457|83247236|FG001|2-year|Open Repair|2|||
46999943|NCT02407457|83247235|FG000|3-year|Death|11|||
46999944|NCT02407457|83247236|FG001|3-year|Death|10|||
46999945|NCT02407457|83247235|FG000|3-year|Lost to Follow-up|6|||
46999946|NCT02407457|83247236|FG001|3-year|Lost to Follow-up|9|||
46999947|NCT02407457|83247235|FG000|3-year|Missed Visit|21|||
46999948|NCT02407457|83247236|FG001|3-year|Missed Visit|16|||
46999949|NCT02407457|83247235|FG000|3-year|Over Due|4|||
46999950|NCT02407457|83247236|FG001|3-year|Over Due|3|||
46999951|NCT02407457|83247235|FG000|4-year|Death|14|||
46999952|NCT02407457|83247236|FG001|4-year|Death|7|||
46999953|NCT02407457|83247235|FG000|4-year|Lost to Follow-up|9|||
46999954|NCT02407457|83247236|FG001|4-year|Lost to Follow-up|12|||
46999955|NCT02407457|83247235|FG000|4-year|Over Due|10|||
46999956|NCT02407457|83247236|FG001|4-year|Over Due|5|||
46999957|NCT02407457|83247235|FG000|4-year|Missed Visit|13|||
46999958|NCT02407457|83247236|FG001|4-year|Missed Visit|13|||
46999959|NCT02407457|83247235|FG000|4-year|Pending visit|19|||
46999960|NCT02407457|83247236|FG001|4-year|Pending visit|14|||
46999961|NCT02407457|83247235|FG000|4-year|Not Due|16|||
46999962|NCT02407457|83247236|FG001|4-year|Not Due|10|||
46709267|NCT01130532|82925207|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
46999963|NCT02407457|83247235|FG000|5-year|Death|6|||
46999964|NCT02407457|83247236|FG001|5-year|Death|1|||
46999965|NCT02407457|83247235|FG000|5-year|Lost to Follow-up|4|||
46999966|NCT02407457|83247236|FG001|5-year|Lost to Follow-up|4|||
46999967|NCT02407457|83247235|FG000|5-year|Missed Visit|10|||
46999968|NCT02407457|83247236|FG001|5-year|Missed Visit|9|||
46999969|NCT02407457|83247235|FG000|5-year|Pending Visit|18|||
46999970|NCT02407457|83247236|FG001|5-year|Pending Visit|17|||
46999971|NCT02407457|83247235|FG000|5-year|Not Due|54|||
46999972|NCT02407457|83247236|FG001|5-year|Not Due|46|||
46999973|NCT01814800|83247242|FG000|Overall Study|Adverse Event|2|||
46999974|NCT01814800|83247242|FG000|Overall Study|Pregnancy|1|||
46999975|NCT01814800|83247242|FG000|Overall Study|Sponsor decision|1|||
46999976|NCT01814800|83247242|FG000|Overall Study|Subject relocation|1|||
46999977|NCT01814332|83247248|FG000|Overall Study|Adverse Event|8|||
46908154|NCT04250337|83137100|FG001|Overall Study|Physician Decision|0|||
46908155|NCT04250337|83137099|FG000|Overall Study|Protocol Deviation|2|||
46908156|NCT04250337|83137100|FG001|Overall Study|Protocol Deviation|2|||
46908157|NCT04250337|83137099|FG000|Overall Study|Withdrawal by Subject|4|||
46908158|NCT04250337|83137100|FG001|Overall Study|Withdrawal by Subject|3|||
46908159|NCT03118947|83137107|FG000|Overall Study|Adverse Event|7|||
46908160|NCT03118947|83137107|FG000|Overall Study|Death|3|||
46908161|NCT03118947|83137107|FG000|Overall Study|Lack of Efficacy|4|||
46908162|NCT03118947|83137107|FG000|Overall Study|Non-compliance with study drug|1|||
46908163|NCT03118947|83137107|FG000|Overall Study|Protocol Violation|2|||
46908164|NCT03118947|83137107|FG000|Overall Study|Withdrawal by Subject|3|||
46908165|NCT03118947|83137107|FG000|Overall Study|Withdrawal by caregiver|3|||
46908166|NCT03118947|83137107|FG000|Overall Study|Change in patient's living situation|4|||
46908167|NCT03118947|83137107|FG000|Overall Study|Lost to Follow-up|2|||
46908168|NCT03953079|83137114|FG000|Core Study|Withdrawal by Subject|1|||
46908169|NCT03953079|83137115|FG001|Core Study|Withdrawal by Subject|2|||
46908170|NCT03953079|83137116|FG002|Core Study|Withdrawal by Subject|1|||
46908171|NCT03953079|83137114|FG000|Core Study|COVID-19|0|||
46908172|NCT03953079|83137115|FG001|Core Study|COVID-19|1|||
46908173|NCT03953079|83137116|FG002|Core Study|COVID-19|0|||
46908174|NCT03953079|83137114|FG000|Core Study|Difficulties leaving the house|0|||
46908175|NCT03953079|83137115|FG001|Core Study|Difficulties leaving the house|1|||
46908176|NCT03953079|83137116|FG002|Core Study|Difficulties leaving the house|0|||
46908177|NCT03953079|83137114|FG000|Extension Study|Withdrawal by Subject|1|||
46908178|NCT03953079|83137115|FG001|Extension Study|Withdrawal by Subject|0|||
46908179|NCT03953079|83137116|FG002|Extension Study|Withdrawal by Subject|0|||
46908180|NCT03953079|83137114|FG000|Extension Study|Received Rescue Treatment|5|||
46908181|NCT03953079|83137115|FG001|Extension Study|Received Rescue Treatment|6|||
46908182|NCT03953079|83137116|FG002|Extension Study|Received Rescue Treatment|5|||
46908183|NCT03885999|83137129|FG000|Overall Study|Adverse Event|1|||
46908184|NCT03108027|83137143|FG000|Period 1|Subject/Guardian Decision|0|||
46908185|NCT03108027|83137144|FG001|Period 1|Subject/Guardian Decision|0|||
46908186|NCT03108027|83137145|FG002|Period 1|Subject/Guardian Decision|0|||
46908187|NCT03108027|83137146|FG003|Period 1|Subject/Guardian Decision|2|||
46908188|NCT03108027|83137147|FG004|Period 1|Subject/Guardian Decision|0|||
46908189|NCT03108027|83137148|FG005|Period 1|Subject/Guardian Decision|0|||
46908190|NCT03108027|83137143|FG000|Period 3|Adverse Event|0|||
46908191|NCT03108027|83137144|FG001|Period 3|Adverse Event|1|||
46908192|NCT03108027|83137145|FG002|Period 3|Adverse Event|0|||
46908193|NCT03108027|83137146|FG003|Period 3|Adverse Event|0|||
46908194|NCT03108027|83137147|FG004|Period 3|Adverse Event|0|||
46908195|NCT03108027|83137148|FG005|Period 3|Adverse Event|0|||
46908196|NCT03107715|83137164|FG000|Overall Study|did not deliver at the home hospital|4|||
46908197|NCT03107715|83137165|FG001|Overall Study|did not deliver at the home hospital|6|||
46908198|NCT03107715|83137164|FG000|Overall Study|infant stillborn|0|||
46908199|NCT03107715|83137165|FG001|Overall Study|infant stillborn|1|||
46908200|NCT03567057|83137174|FG000|Overall Study|Adverse Event|56|||
46908201|NCT03567057|83137175|FG001|Overall Study|Adverse Event|53|||
46908202|NCT03567057|83137176|FG002|Overall Study|Adverse Event|28|||
46908203|NCT03567057|83137174|FG000|Overall Study|Withdrawal by Subject|22|||
46908204|NCT03567057|83137175|FG001|Overall Study|Withdrawal by Subject|24|||
46908205|NCT03567057|83137176|FG002|Overall Study|Withdrawal by Subject|13|||
46908206|NCT03567057|83137174|FG000|Overall Study|Lost to Follow-up|3|||
46908207|NCT03567057|83137175|FG001|Overall Study|Lost to Follow-up|5|||
46908208|NCT03567057|83137176|FG002|Overall Study|Lost to Follow-up|2|||
46908209|NCT03567057|83137174|FG000|Overall Study|COVID-19 pandemic|4|||
46908210|NCT03567057|83137175|FG001|Overall Study|COVID-19 pandemic|3|||
46908211|NCT03567057|83137176|FG002|Overall Study|COVID-19 pandemic|0|||
46908212|NCT03567057|83137174|FG000|Overall Study|Non-compliance with study drug|4|||
46908213|NCT03567057|83137175|FG001|Overall Study|Non-compliance with study drug|2|||
46908214|NCT03567057|83137176|FG002|Overall Study|Non-compliance with study drug|0|||
46620411|NCT03930745|82766247|FG001|Overall Study|Protocol Violation|2|||
46908215|NCT03567057|83137174|FG000|Overall Study|Lack of Efficacy|3|||
46908216|NCT03567057|83137175|FG001|Overall Study|Lack of Efficacy|0|||
46908217|NCT03567057|83137176|FG002|Overall Study|Lack of Efficacy|1|||
46908218|NCT03567057|83137174|FG000|Overall Study|Death|1|||
46908219|NCT03567057|83137175|FG001|Overall Study|Death|0|||
46908220|NCT03567057|83137176|FG002|Overall Study|Death|0|||
46908221|NCT03567057|83137174|FG000|Overall Study|Physician Decision|1|||
46908222|NCT03567057|83137175|FG001|Overall Study|Physician Decision|0|||
46908223|NCT03567057|83137176|FG002|Overall Study|Physician Decision|0|||
46908224|NCT03567057|83137174|FG000|Overall Study|Unstable medical condition|1|||
46908225|NCT03567057|83137175|FG001|Overall Study|Unstable medical condition|0|||
46908226|NCT03567057|83137176|FG002|Overall Study|Unstable medical condition|0|||
46908227|NCT03567057|83137174|FG000|Overall Study|Medical history event|0|||
46908228|NCT03567057|83137175|FG001|Overall Study|Medical history event|0|||
46999978|NCT01814332|83247249|FG001|Overall Study|Adverse Event|3|||
46999979|NCT01814332|83247248|FG000|Overall Study|Withdrawal by Subject|3|||
46999980|NCT01814332|83247249|FG001|Overall Study|Withdrawal by Subject|8|||
46999981|NCT01814332|83247248|FG000|Overall Study|Protocol Violation|0|||
46999982|NCT01814332|83247249|FG001|Overall Study|Protocol Violation|4|||
46999983|NCT01814332|83247248|FG000|Overall Study|Lost to Follow-up|5|||
46999984|NCT01814332|83247249|FG001|Overall Study|Lost to Follow-up|1|||
46999985|NCT02407223|83247258|FG000|Overall Study|Adverse Event|1|||
46999986|NCT02407223|83247259|FG001|Overall Study|Adverse Event|0|||
46999987|NCT02407223|83247260|FG002|Overall Study|Adverse Event|1|||
46999988|NCT02407223|83247258|FG000|Overall Study|Lack of Efficacy|6|||
46999989|NCT02407223|83247259|FG001|Overall Study|Lack of Efficacy|6|||
46999990|NCT02407223|83247260|FG002|Overall Study|Lack of Efficacy|4|||
46999991|NCT02407223|83247258|FG000|Overall Study|Lost to Follow-up|1|||
46999992|NCT02407223|83247259|FG001|Overall Study|Lost to Follow-up|0|||
46999993|NCT02407223|83247260|FG002|Overall Study|Lost to Follow-up|2|||
46999994|NCT02407223|83247258|FG000|Overall Study|Withdrawal by Subject|2|||
46999995|NCT02407223|83247259|FG001|Overall Study|Withdrawal by Subject|4|||
46999996|NCT02407223|83247260|FG002|Overall Study|Withdrawal by Subject|4|||
46999997|NCT02407223|83247258|FG000|Overall Study|Study Terminated by Sponsor|77|||
46999998|NCT02407223|83247259|FG001|Overall Study|Study Terminated by Sponsor|80|||
46999999|NCT02407223|83247260|FG002|Overall Study|Study Terminated by Sponsor|86|||
47000000|NCT02407223|83247258|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
47000001|NCT02407223|83247259|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
47000002|NCT02407223|83247260|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
47000003|NCT02407223|83247258|FG000|Overall Study|Other|29|||
47000004|NCT02407223|83247259|FG001|Overall Study|Other|27|||
47000005|NCT02407223|83247260|FG002|Overall Study|Other|25|||
47000006|NCT01797562|83247270|FG000|Overall Study|Protocol Violation|5|||
47000007|NCT01813474|83247278|FG000|Overall Study|Withdrawal by Subject|0|||
47000008|NCT01813474|83247279|FG001|Overall Study|Withdrawal by Subject|0|||
47000009|NCT01813474|83247280|FG002|Overall Study|Withdrawal by Subject|1|||
47000010|NCT01813474|83247278|FG000|Overall Study|Adverse Event|1|||
47000011|NCT01813474|83247279|FG001|Overall Study|Adverse Event|1|||
47000012|NCT01813474|83247280|FG002|Overall Study|Adverse Event|0|||
47000013|NCT01813474|83247278|FG000|Overall Study|Lack of Efficacy|2|||
47000014|NCT01813474|83247279|FG001|Overall Study|Lack of Efficacy|6|||
47000015|NCT01813474|83247280|FG002|Overall Study|Lack of Efficacy|9|||
47000016|NCT01813474|83247278|FG000|Overall Study|Death|0|||
47000017|NCT01813474|83247279|FG001|Overall Study|Death|0|||
47000018|NCT01813474|83247280|FG002|Overall Study|Death|1|||
47000019|NCT01868542|83247291|FG000|Overall Study|Protocol Violation|0|||
47000020|NCT01868542|83247292|FG001|Overall Study|Protocol Violation|1|||
47000021|NCT01868542|83247291|FG000|Overall Study|Unclassified|0|||
47000022|NCT01868542|83247292|FG001|Overall Study|Unclassified|1|||
47000023|NCT01797094|83247300|FG000|Overall Study|Adverse Event|1|||
47000024|NCT01797094|83247301|FG001|Overall Study|Adverse Event|1|||
47000025|NCT01797094|83247300|FG000|Overall Study|Personal Reasons|4|||
47000026|NCT01797094|83247301|FG001|Overall Study|Personal Reasons|0|||
46908229|NCT03567057|83137176|FG002|Overall Study|Medical history event|1|||
46908230|NCT03567057|83137174|FG000|Overall Study|Other|0|||
46908231|NCT03567057|83137175|FG001|Overall Study|Other|0|||
46908232|NCT03567057|83137176|FG002|Overall Study|Other|1|||
46908233|NCT04388787|83137184|FG000|Blinded Period|Patient could not follow instructions|1|||
46908234|NCT04388787|83137184|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
46908235|NCT03057600|83137196|FG000|Overall Study|Adverse Event|0|||
46908236|NCT03057600|83137197|FG001|Overall Study|Adverse Event|0|||
46908237|NCT03057600|83137198|FG002|Overall Study|Adverse Event|4|||
46908238|NCT03057600|83137199|FG003|Overall Study|Adverse Event|0|||
46908239|NCT03057600|83137196|FG000|Overall Study|Radiologic Disease Progression|8|||
47000027|NCT01797094|83247300|FG000|Overall Study|Protocol Violation|0|||
47000028|NCT01797094|83247301|FG001|Overall Study|Protocol Violation|1|||
47000029|NCT01797094|83247300|FG000|Overall Study|Other Miscellaneous Reasons|1|||
46709268|NCT01130532|82925204|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
47000030|NCT01797094|83247301|FG001|Overall Study|Other Miscellaneous Reasons|0|||
47000031|NCT02383589|83247309|FG000|Treatment Period|Adverse Event|1|||
46908240|NCT03057600|83137197|FG001|Overall Study|Radiologic Disease Progression|7|||
46908241|NCT03057600|83137198|FG002|Overall Study|Radiologic Disease Progression|13|||
46908242|NCT03057600|83137199|FG003|Overall Study|Radiologic Disease Progression|10|||
46908243|NCT03057600|83137196|FG000|Overall Study|Symptomatic Deterioration|0|||
46908244|NCT03057600|83137197|FG001|Overall Study|Symptomatic Deterioration|1|||
47000032|NCT02383589|83247310|FG001|Treatment Period|Adverse Event|3|||
47000033|NCT02383589|83247309|FG000|Treatment Period|Lost to Follow-up|0|||
47000034|NCT02383589|83247310|FG001|Treatment Period|Lost to Follow-up|1|||
47000035|NCT02383589|83247309|FG000|Treatment Period|Withdrawal by Subject|0|||
47000036|NCT02383589|83247310|FG001|Treatment Period|Withdrawal by Subject|5|||
47000037|NCT02383589|83247309|FG000|Treatment Period|Non-compliance with study drug|0|||
47000038|NCT02383589|83247310|FG001|Treatment Period|Non-compliance with study drug|1|||
47000039|NCT02383589|83247309|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
47000040|NCT02383589|83247310|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
47000041|NCT02383589|83247309|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
47000042|NCT02383589|83247310|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
47000043|NCT02383589|83247309|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
47000044|NCT02383589|83247310|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
47000045|NCT01810432|83247318|FG000|Washout|Protocol Violation|0|||
47000046|NCT01810432|83247319|FG001|Washout|Protocol Violation|1|||
47000047|NCT01810432|83247318|FG000|Washout|Adverse Event|1|||
47000048|NCT01810432|83247319|FG001|Washout|Adverse Event|0|||
47000049|NCT01810432|83247318|FG000|Period 2|Withdrawal by Subject|2|||
47000050|NCT01810432|83247319|FG001|Period 2|Withdrawal by Subject|1|||
47000051|NCT01810432|83247318|FG000|Period 2|Physician Decision|1|||
47000052|NCT01810432|83247319|FG001|Period 2|Physician Decision|0|||
47000053|NCT01810432|83247318|FG000|Period 2|Lost to Follow-up|1|||
47000054|NCT01810432|83247319|FG001|Period 2|Lost to Follow-up|1|||
47000055|NCT01796860|83247325|FG000|Overall Study|Withdrawal by Subject|3|||
47000056|NCT01796548|83247329|FG000|Overall Study|Lost to Follow-up|1|||
47000057|NCT01796548|83247329|FG000|Overall Study|Other|2|||
47000058|NCT02406677|83247335|FG000|Overall Study|Death|16|||
47000059|NCT02406677|83247336|FG001|Overall Study|Death|8|||
47000060|NCT02406677|83247335|FG000|Overall Study|Discharged without P2Y12|1|||
47000061|NCT02406677|83247336|FG001|Overall Study|Discharged without P2Y12|3|||
47000062|NCT02406677|83247335|FG000|Overall Study|Discharged on prasugrel|283|||
47000063|NCT02406677|83247336|FG001|Overall Study|Discharged on prasugrel|587|||
47000064|NCT02406677|83247335|FG000|Overall Study|Withdrawal by Subject|1|||
47000065|NCT02406677|83247336|FG001|Overall Study|Withdrawal by Subject|0|||
47000066|NCT02404805|83247352|FG000|Overall Study|Withdrawal by Subject|1|||
47000067|NCT02404805|83247353|FG001|Overall Study|Withdrawal by Subject|0|||
47000068|NCT02404805|83247354|FG002|Overall Study|Withdrawal by Subject|0|||
47000069|NCT02404805|83247355|FG003|Overall Study|Withdrawal by Subject|0|||
47000070|NCT02404805|83247356|FG004|Overall Study|Withdrawal by Subject|0|||
47000071|NCT02404805|83247357|FG005|Overall Study|Withdrawal by Subject|0|||
47000072|NCT02430311|83247368|FG000|Part A|Adverse Event|0|||
47000073|NCT02430311|83247369|FG001|Part A|Adverse Event|1|||
47000074|NCT02430311|83247368|FG000|Part A|Withdrawal by Subject|1|||
47000075|NCT02430311|83247369|FG001|Part A|Withdrawal by Subject|0|||
47000076|NCT02430311|83247368|FG000|Part B|Meet study-specific withdrawal criteria|6|||
47000077|NCT02430311|83247369|FG001|Part B|Meet study-specific withdrawal criteria|6|||
47000078|NCT02430311|83247368|FG000|Part B|Withdrawal by Subject|2|||
47000079|NCT02430311|83247369|FG001|Part B|Withdrawal by Subject|2|||
47000080|NCT02430311|83247368|FG000|Part B|Adverse Event|1|||
46709269|NCT01130532|82925205|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
46709270|NCT01130532|82925206|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
46709271|NCT01130532|82925207|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
46908245|NCT03057600|83137198|FG002|Overall Study|Symptomatic Deterioration|1|||
46908246|NCT03057600|83137199|FG003|Overall Study|Symptomatic Deterioration|0|||
46908247|NCT03057600|83137196|FG000|Overall Study|Investigator Decision|0|||
46908248|NCT03057600|83137197|FG001|Overall Study|Investigator Decision|0|||
46908249|NCT03057600|83137198|FG002|Overall Study|Investigator Decision|1|||
46908250|NCT03057600|83137199|FG003|Overall Study|Investigator Decision|0|||
46908251|NCT03057600|83137196|FG000|Overall Study|Study Termination by Sponsor|0|||
46908252|NCT03057600|83137197|FG001|Overall Study|Study Termination by Sponsor|0|||
46908253|NCT03057600|83137198|FG002|Overall Study|Study Termination by Sponsor|0|||
46908254|NCT03057600|83137199|FG003|Overall Study|Study Termination by Sponsor|2|||
46908255|NCT03057600|83137196|FG000|Overall Study|Withdrawal by Subject|0|||
46908256|NCT03057600|83137197|FG001|Overall Study|Withdrawal by Subject|1|||
46908257|NCT03057600|83137198|FG002|Overall Study|Withdrawal by Subject|0|||
46908258|NCT03057600|83137199|FG003|Overall Study|Withdrawal by Subject|0|||
46908259|NCT03057600|83137196|FG000|Overall Study|Other, Not Specified|1|||
46908260|NCT03057600|83137197|FG001|Overall Study|Other, Not Specified|1|||
46908261|NCT03057600|83137198|FG002|Overall Study|Other, Not Specified|1|||
47000081|NCT02430311|83247369|FG001|Part B|Adverse Event|0|||
47000082|NCT02430311|83247368|FG000|Part B|Death|1|||
47000083|NCT02430311|83247369|FG001|Part B|Death|0|||
47000084|NCT02404649|83247386|FG000|Overall Study|Adverse Event|1|||
47000085|NCT02404649|83247387|FG001|Overall Study|Adverse Event|2|||
46908262|NCT03057600|83137199|FG003|Overall Study|Other, Not Specified|1|||
46908263|NCT03371823|83137229|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
46908264|NCT03371823|83137230|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
46908265|NCT02966301|83137245|FG000|Overall Study|Death|2|||
47000086|NCT02383355|83247395|FG000|Overall Study|Adverse Event|2|||
47000087|NCT02383355|83247396|FG001|Overall Study|Adverse Event|0|||
47000088|NCT02381795|83247402|FG000|Overall Study|Withdrawal by Subject|1|||
47000089|NCT02381795|83247402|FG000|Overall Study|Study Terminated|2|||
47000090|NCT02404493|83247408|FG000|Overall Study|Adverse Event|1|||
47000091|NCT02404493|83247409|FG001|Overall Study|Adverse Event|1|||
47000092|NCT02380859|83247417|FG000|Overall Study|Withdrawal by Subject|2|||
47000093|NCT02380859|83247418|FG001|Overall Study|Withdrawal by Subject|0|||
47000094|NCT02380703|83247426|FG000|Overall Study|Withdrawal by Subject|12|||
47000095|NCT02380703|83247427|FG001|Overall Study|Withdrawal by Subject|9|||
47000096|NCT02380703|83247426|FG000|Overall Study|Lost to Follow-up|12|||
47000097|NCT02380703|83247427|FG001|Overall Study|Lost to Follow-up|12|||
47000098|NCT02380703|83247426|FG000|Overall Study|Caregiver death|1|||
47000099|NCT02380703|83247427|FG001|Overall Study|Caregiver death|0|||
47000100|NCT02380703|83247426|FG000|Overall Study|Person with dementia (PWD) death|7|||
47000101|NCT02380703|83247427|FG001|Overall Study|Person with dementia (PWD) death|8|||
47000102|NCT02380703|83247426|FG000|Overall Study|Entered Long-term Care|4|||
47000103|NCT02380703|83247427|FG001|Overall Study|Entered Long-term Care|7|||
47000104|NCT02379923|83247433|FG000|Overall Study|Death|5|||
47000105|NCT02379221|83247440|FG000|Overall Study|Lost to Follow-up|1|||
47000106|NCT02404103|83247451|FG000|Overall Study|Adverse Event|1|||
47000107|NCT02404103|83247452|FG001|Overall Study|Adverse Event|0|||
47000108|NCT02404103|83247451|FG000|Overall Study|Lost to Follow-up|3|||
47000109|NCT02404103|83247452|FG001|Overall Study|Lost to Follow-up|3|||
47000110|NCT02404025|83247468|FG000|Overall Study|Adverse Event|1|||
47000111|NCT02404025|83247468|FG000|Overall Study|Lack of Efficacy|3|||
47000112|NCT02377817|83247474|FG000|Overall Study|Transportation/childcare barriers.|2|||
47000113|NCT02377817|83247475|FG001|Overall Study|Transportation/childcare barriers.|0|||
47000114|NCT02377817|83247474|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
47000115|NCT02377817|83247475|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
47000116|NCT02403635|83247483|FG000|Overall Study|Not eligible|9|||
47000117|NCT02402933|83247503|FG000|Overall Study|Withdrawal by Subject|4|||
47000118|NCT02402933|83247503|FG000|Overall Study|Discontinued; Site Termination|10|||
47000119|NCT01796470|83247512|FG000|Overall Study|Adverse Event|4|||
47000120|NCT01796470|83247513|FG001|Overall Study|Adverse Event|2|||
47000121|NCT01796470|83247514|FG002|Overall Study|Adverse Event|2|||
47000122|NCT01796470|83247515|FG003|Overall Study|Adverse Event|1|||
47000123|NCT01796470|83247516|FG004|Overall Study|Adverse Event|3|||
47000124|NCT01796470|83247512|FG000|Overall Study|Death|2|||
47000125|NCT01796470|83247513|FG001|Overall Study|Death|0|||
47000126|NCT01796470|83247514|FG002|Overall Study|Death|0|||
47000127|NCT01796470|83247515|FG003|Overall Study|Death|0|||
47000128|NCT01796470|83247516|FG004|Overall Study|Death|1|||
47000129|NCT01796470|83247512|FG000|Overall Study|Initiated New Therapy|9|||
47000130|NCT01796470|83247513|FG001|Overall Study|Initiated New Therapy|0|||
47000131|NCT01796470|83247514|FG002|Overall Study|Initiated New Therapy|0|||
47000132|NCT01796470|83247515|FG003|Overall Study|Initiated New Therapy|0|||
47000133|NCT01796470|83247516|FG004|Overall Study|Initiated New Therapy|2|||
47000134|NCT01796470|83247512|FG000|Overall Study|Lost to Follow-up|0|||
47000135|NCT01796470|83247513|FG001|Overall Study|Lost to Follow-up|1|||
47000136|NCT01796470|83247514|FG002|Overall Study|Lost to Follow-up|0|||
47000137|NCT01796470|83247515|FG003|Overall Study|Lost to Follow-up|0|||
47000138|NCT01796470|83247516|FG004|Overall Study|Lost to Follow-up|0|||
47000139|NCT01796470|83247512|FG000|Overall Study|Physician Decision|5|||
47000140|NCT01796470|83247513|FG001|Overall Study|Physician Decision|4|||
47000141|NCT01796470|83247514|FG002|Overall Study|Physician Decision|1|||
47000142|NCT01796470|83247515|FG003|Overall Study|Physician Decision|0|||
47000143|NCT01796470|83247516|FG004|Overall Study|Physician Decision|1|||
47000144|NCT01796470|83247512|FG000|Overall Study|Progressive Disease|7|||
47000145|NCT01796470|83247513|FG001|Overall Study|Progressive Disease|7|||
47000146|NCT01796470|83247514|FG002|Overall Study|Progressive Disease|3|||
47000147|NCT01796470|83247515|FG003|Overall Study|Progressive Disease|2|||
47000148|NCT01796470|83247516|FG004|Overall Study|Progressive Disease|0|||
47000149|NCT01796470|83247512|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
47000150|NCT01796470|83247513|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
47000151|NCT01796470|83247514|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
47000152|NCT01796470|83247515|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
47000153|NCT01796470|83247516|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
47000154|NCT01796470|83247512|FG000|Overall Study|Withdrawal by Subject|7|||
47000155|NCT01796470|83247513|FG001|Overall Study|Withdrawal by Subject|0|||
47000156|NCT01796470|83247514|FG002|Overall Study|Withdrawal by Subject|0|||
47000157|NCT01796470|83247515|FG003|Overall Study|Withdrawal by Subject|0|||
47000158|NCT01796470|83247516|FG004|Overall Study|Withdrawal by Subject|1|||
47000159|NCT01868074|83247534|FG000|Overall Study|Lost to Follow-up|3|||
46709272|NCT00972777|82925221|FG000|Overall Study|Adverse Event|3|||
47000160|NCT01868074|83247535|FG001|Overall Study|Lost to Follow-up|2|||
47000161|NCT01868074|83247534|FG000|Overall Study|Withdrawal by Subject|4|||
47000162|NCT01868074|83247535|FG001|Overall Study|Withdrawal by Subject|2|||
47000163|NCT01810042|83247541|FG000|Overall Study|Lost to Follow-up|10|||
47000164|NCT02424539|83247548|FG000|Overall Study|Adverse Event|0|||
47000165|NCT02424539|83247549|FG001|Overall Study|Adverse Event|0|||
47000166|NCT02424539|83247550|FG002|Overall Study|Adverse Event|1|||
47000167|NCT02424539|83247548|FG000|Overall Study|Physician Decision|0|||
47000168|NCT02424539|83247549|FG001|Overall Study|Physician Decision|0|||
47000169|NCT02424539|83247550|FG002|Overall Study|Physician Decision|1|||
47000170|NCT02424539|83247548|FG000|Overall Study|Withdrawal by Subject|3|||
47000171|NCT02424539|83247549|FG001|Overall Study|Withdrawal by Subject|1|||
47000172|NCT02424539|83247550|FG002|Overall Study|Withdrawal by Subject|0|||
47000173|NCT02424539|83247548|FG000|Overall Study|Other: Reached stopping criteria|11|||
47000174|NCT02424539|83247549|FG001|Overall Study|Other: Reached stopping criteria|7|||
47000175|NCT02424539|83247550|FG002|Overall Study|Other: Reached stopping criteria|6|||
47000176|NCT01809262|83247558|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000177|NCT01809262|83247559|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000178|NCT01809262|83247560|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000179|NCT01809262|83247561|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000180|NCT01809262|83247562|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
47000181|NCT01809262|83247563|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000182|NCT01809262|83247564|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000183|NCT01809262|83247565|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000184|NCT01809262|83247566|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000185|NCT01809262|83247567|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
47000186|NCT01809262|83247558|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000187|NCT01809262|83247559|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
47000188|NCT01809262|83247560|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000189|NCT01809262|83247561|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000190|NCT01809262|83247562|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000191|NCT01809262|83247563|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000192|NCT01809262|83247564|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000193|NCT01809262|83247565|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000194|NCT01809262|83247566|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000195|NCT01809262|83247567|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
47000196|NCT01808248|83247581|FG000|Overall Study|Lack of Efficacy|3|||
47000197|NCT01808248|83247581|FG000|Overall Study|Withdrawal by Subject|1|||
47000198|NCT01808248|83247581|FG000|Overall Study|Lost to Follow-up|1|||
47000199|NCT02424383|83247587|FG000|Overall Study|Withdrawal by Subject|32|||
47000200|NCT02424383|83247587|FG000|Overall Study|Death|170|||
47000201|NCT02424383|83247587|FG000|Overall Study|Sponsor's decision|3|||
47000202|NCT02424383|83247587|FG000|Overall Study|Investigator's decision|44|||
47000203|NCT02424383|83247587|FG000|Overall Study|Lost to Follow-up|81|||
47000204|NCT02424383|83247587|FG000|Overall Study|Other|7|||
47000205|NCT02424383|83247587|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
47000206|NCT01867294|83247595|FG000|Overall Study|Withdrawal by Subject|1|||
47000207|NCT01867294|83247596|FG001|Overall Study|Withdrawal by Subject|1|||
47000208|NCT01867294|83247597|FG002|Overall Study|Withdrawal by Subject|0|||
47000209|NCT01867294|83247598|FG003|Overall Study|Withdrawal by Subject|0|||
47000210|NCT02424149|83247608|FG000|Overall Study|surgery cancelled|2|||
47000211|NCT02424149|83247609|FG001|Overall Study|surgery cancelled|0|||
47000212|NCT02424149|83247608|FG000|Overall Study|Withdrawal by Subject|0|||
47000213|NCT02424149|83247609|FG001|Overall Study|Withdrawal by Subject|1|||
47000214|NCT02423291|83247615|FG000|Overall Study|Lack of Efficacy|14|||
47000215|NCT02423291|83247615|FG000|Overall Study|Adverse Event|1|||
47000216|NCT02401529|83247621|FG000|Overall Study|Lost to Follow-up|2|||
47000217|NCT02401529|83247622|FG001|Overall Study|Lost to Follow-up|1|||
47000218|NCT02401529|83247621|FG000|Overall Study|Physician Decision|2|||
47000219|NCT02401529|83247622|FG001|Overall Study|Physician Decision|6|||
47000220|NCT02401529|83247621|FG000|Overall Study|Protocol Violation|5|||
47000221|NCT02401529|83247622|FG001|Overall Study|Protocol Violation|0|||
47000222|NCT01867216|83247636|FG000|Overall Study|Withdrawal by Subject|2|||
47000223|NCT01867216|83247637|FG001|Overall Study|Withdrawal by Subject|0|||
47000224|NCT01867216|83247638|FG002|Overall Study|Withdrawal by Subject|0|||
47000225|NCT01867216|83247639|FG003|Overall Study|Withdrawal by Subject|0|||
47000226|NCT01867216|83247640|FG004|Overall Study|Withdrawal by Subject|1|||
47000227|NCT01867216|83247641|FG005|Overall Study|Withdrawal by Subject|0|||
47000228|NCT01867216|83247642|FG006|Overall Study|Withdrawal by Subject|1|||
47000229|NCT01867216|83247636|FG000|Overall Study|Physician Decision|1|||
47000230|NCT01867216|83247637|FG001|Overall Study|Physician Decision|0|||
47000231|NCT01867216|83247638|FG002|Overall Study|Physician Decision|0|||
47000232|NCT01867216|83247639|FG003|Overall Study|Physician Decision|0|||
47000233|NCT01867216|83247640|FG004|Overall Study|Physician Decision|0|||
47000234|NCT01867216|83247641|FG005|Overall Study|Physician Decision|0|||
47000235|NCT01867216|83247642|FG006|Overall Study|Physician Decision|0|||
47000236|NCT01867216|83247636|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
47000237|NCT01867216|83247637|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
47000238|NCT01867216|83247638|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
47000239|NCT01867216|83247639|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
47000240|NCT01867216|83247640|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
47000241|NCT01867216|83247641|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
47000242|NCT01867216|83247642|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
47000243|NCT01866826|83247664|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
47000244|NCT01866826|83247665|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
47000245|NCT01866826|83247664|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
47000246|NCT01866826|83247665|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
47000247|NCT01866826|83247664|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
47000248|NCT01866826|83247665|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
47000249|NCT01791244|83247682|FG000|Overall Study|Adverse Event|5|||
47000250|NCT01791244|83247683|FG001|Overall Study|Adverse Event|7|||
47000251|NCT01791244|83247682|FG000|Overall Study|Insufficient clinical response|10|||
47000252|NCT01791244|83247683|FG001|Overall Study|Insufficient clinical response|10|||
47000253|NCT01791244|83247682|FG000|Overall Study|Laboratory Abnormality|0|||
47000254|NCT01791244|83247683|FG001|Overall Study|Laboratory Abnormality|1|||
47000255|NCT01865812|83247691|FG000|Primary Treatment Phase|Adverse Event|2|||
47000256|NCT01865812|83247692|FG001|Primary Treatment Phase|Adverse Event|0|||
47000257|NCT01865812|83247691|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
47000258|NCT01865812|83247692|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
47000259|NCT01865812|83247691|FG000|Long-term Safety Extension Phase|Pruritus|0|||
47000260|NCT01865812|83247692|FG001|Long-term Safety Extension Phase|Pruritus|3|||
47000261|NCT01865812|83247691|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
47000262|NCT01865812|83247692|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
47000263|NCT01865812|83247691|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
47000264|NCT01865812|83247692|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
47000265|NCT01808092|83247701|FG000|Overall Study|Death|39|||
47000266|NCT01808092|83247702|FG001|Overall Study|Death|29|||
47000267|NCT01808092|83247701|FG000|Overall Study|Lost to Follow-up|3|||
47000268|NCT01808092|83247702|FG001|Overall Study|Lost to Follow-up|7|||
47000269|NCT01808092|83247701|FG000|Overall Study|Withdrawal by Subject|9|||
47000270|NCT01808092|83247702|FG001|Overall Study|Withdrawal by Subject|4|||
47000271|NCT01808092|83247701|FG000|Overall Study|Other Eligibility criteria|3|||
47000272|NCT01808092|83247702|FG001|Overall Study|Other Eligibility criteria|5|||
47000273|NCT01774084|83247710|FG000|Overall Study|Personal reasons|1|||
47000274|NCT01774084|83247711|FG001|Overall Study|Personal reasons|0|||
47000275|NCT01807234|83247723|FG000|Overall Study|Lost to Follow-up|2|||
47000276|NCT01807234|83247724|FG001|Overall Study|Lost to Follow-up|5|||
47000277|NCT01807234|83247725|FG002|Overall Study|Lost to Follow-up|1|||
47000278|NCT01807234|83247726|FG003|Overall Study|Lost to Follow-up|1|||
47000279|NCT01807234|83247727|FG004|Overall Study|Lost to Follow-up|1|||
47000280|NCT01807234|83247728|FG005|Overall Study|Lost to Follow-up|2|||
47000281|NCT01807234|83247723|FG000|Overall Study|Withdrawal by Subject|3|||
47000282|NCT01807234|83247724|FG001|Overall Study|Withdrawal by Subject|1|||
47000283|NCT01807234|83247725|FG002|Overall Study|Withdrawal by Subject|1|||
47000284|NCT01807234|83247726|FG003|Overall Study|Withdrawal by Subject|1|||
47000285|NCT01807234|83247727|FG004|Overall Study|Withdrawal by Subject|2|||
47000286|NCT01807234|83247728|FG005|Overall Study|Withdrawal by Subject|1|||
47000287|NCT01807234|83247723|FG000|Overall Study|Lack of Efficacy|0|||
47000288|NCT01807234|83247724|FG001|Overall Study|Lack of Efficacy|0|||
47000289|NCT01807234|83247725|FG002|Overall Study|Lack of Efficacy|0|||
47000290|NCT01807234|83247726|FG003|Overall Study|Lack of Efficacy|0|||
47000291|NCT01807234|83247727|FG004|Overall Study|Lack of Efficacy|1|||
47000292|NCT01807234|83247728|FG005|Overall Study|Lack of Efficacy|1|||
47000293|NCT01790932|83247738|FG000|Overall Study|Disease Progression|41|||
47000294|NCT01790932|83247738|FG000|Overall Study|Adverse Event|7|||
47000295|NCT01790932|83247738|FG000|Overall Study|Physician Decision|1|||
47000296|NCT01790932|83247738|FG000|Overall Study|Withdrawal by Subject|1|||
47000297|NCT02377427|83247744|FG000|Part A (Up to Week 20)|Physician Decision|1|||
47000298|NCT02377427|83247745|FG001|Part A (Up to Week 20)|Physician Decision|0|||
47000299|NCT02377427|83247746|FG002|Part A (Up to Week 20)|Physician Decision|0|||
47000300|NCT02377427|83247747|FG003|Part A (Up to Week 20)|Physician Decision|0|||
47000301|NCT02377427|83247748|FG004|Part A (Up to Week 20)|Physician Decision|0|||
47000302|NCT02377427|83247744|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
46908266|NCT02966301|83137245|FG000|Overall Study|Withdrawal by Subject|1|||
46908267|NCT03107091|83137249|FG000|Overall Study|Physician Decision|1|||
46908268|NCT03065400|83137263|FG000|Overall Study|Adverse Event|1|||
46908269|NCT03065400|83137263|FG000|Overall Study|Physician Decision|3|||
46908270|NCT03065400|83137263|FG000|Overall Study|Withdrawal by Subject|1|||
46908271|NCT03065400|83137263|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
46908272|NCT03085095|83137269|FG000|Overall Study|Adverse Event|23|||
46908273|NCT03085095|83137270|FG001|Overall Study|Adverse Event|8|||
47000303|NCT02377427|83247745|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
47000304|NCT02377427|83247746|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
47000305|NCT02377427|83247747|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
47000306|NCT02377427|83247748|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
47000307|NCT02377427|83247744|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
47000308|NCT02377427|83247745|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
47000309|NCT02377427|83247746|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
47000310|NCT02377427|83247747|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
47000311|NCT02377427|83247748|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
47000312|NCT02377427|83247744|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
47000313|NCT02377427|83247745|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
47000314|NCT02377427|83247746|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
47000315|NCT02377427|83247747|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
47000316|NCT02377427|83247748|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
47000317|NCT02421887|83247763|FG000|Overall Study|Lost to Follow-up|5|||
47000318|NCT02421887|83247764|FG001|Overall Study|Lost to Follow-up|0|||
47000319|NCT02421887|83247763|FG000|Overall Study|Withdrawal by Subject|8|||
47000320|NCT02421887|83247764|FG001|Overall Study|Withdrawal by Subject|5|||
47000321|NCT02421887|83247763|FG000|Overall Study|Physician Decision|2|||
47000322|NCT02421887|83247764|FG001|Overall Study|Physician Decision|4|||
47000323|NCT02421887|83247763|FG000|Overall Study|Adverse Event|2|||
47000324|NCT02421887|83247764|FG001|Overall Study|Adverse Event|0|||
47000325|NCT01609582|83247772|FG000|Overall Study|Adverse Event|20|||
47000326|NCT01609582|83247773|FG001|Overall Study|Adverse Event|18|||
47000327|NCT01609582|83247772|FG000|Overall Study|Lost to Follow-up|10|||
47000328|NCT01609582|83247773|FG001|Overall Study|Lost to Follow-up|10|||
47000329|NCT01609582|83247772|FG000|Overall Study|Withdrawal by Subject|21|||
47000330|NCT01609582|83247773|FG001|Overall Study|Withdrawal by Subject|15|||
47000331|NCT01609582|83247772|FG000|Overall Study|Study Terminated by Sponsor|1543|||
47000332|NCT01609582|83247773|FG001|Overall Study|Study Terminated by Sponsor|1548|||
47000333|NCT01609582|83247772|FG000|Overall Study|Other|9|||
47000334|NCT01609582|83247773|FG001|Overall Study|Other|10|||
47000335|NCT01609582|83247772|FG000|Overall Study|Randomized, but not treated|0|||
47000336|NCT01609582|83247773|FG001|Overall Study|Randomized, but not treated|3|||
47000337|NCT01789606|83247781|FG000|Overall Study|Participant not Purchased the Product|0|||
47000338|NCT01789606|83247782|FG001|Overall Study|Participant not Purchased the Product|20|||
47000339|NCT01789606|83247781|FG000|Overall Study|Withdrawal by Subject|0|||
47000340|NCT01789606|83247782|FG001|Overall Study|Withdrawal by Subject|1|||
47000341|NCT01789606|83247781|FG000|Overall Study|Ineligible|6|||
47000342|NCT01789606|83247782|FG001|Overall Study|Ineligible|2|||
47000343|NCT01789606|83247781|FG000|Overall Study|Administrative Reasons|17|||
47000344|NCT01789606|83247782|FG001|Overall Study|Administrative Reasons|6|||
47000345|NCT01789606|83247781|FG000|Overall Study|No Study Medication Taken|0|||
47000346|NCT01789606|83247782|FG001|Overall Study|No Study Medication Taken|1|||
47000347|NCT01789606|83247781|FG000|Overall Study|Protocol Violation|0|||
47000348|NCT01789606|83247782|FG001|Overall Study|Protocol Violation|55|||
47000349|NCT01789606|83247781|FG000|Overall Study|Adverse Event|0|||
47000350|NCT01789606|83247782|FG001|Overall Study|Adverse Event|3|||
47000351|NCT01789606|83247781|FG000|Overall Study|Lost to Follow-up|0|||
47000352|NCT01789606|83247782|FG001|Overall Study|Lost to Follow-up|14|||
47000353|NCT01789606|83247781|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
47000354|NCT01789606|83247782|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
47000355|NCT01788358|83247787|FG000|Overall Study|Other|11|||
47000356|NCT01788358|83247787|FG000|Overall Study|Logistical difficulties|1|||
47000357|NCT01788358|83247787|FG000|Overall Study|Lost to Follow-up|5|||
47000358|NCT01788358|83247787|FG000|Overall Study|Protocol Violation|3|||
47000359|NCT01788358|83247787|FG000|Overall Study|Withdrawal by Subject|26|||
47000360|NCT01788358|83247787|FG000|Overall Study|Lack of Efficacy|1|||
47000361|NCT01788358|83247787|FG000|Overall Study|Adverse Event|51|||
47000362|NCT01773226|83247791|FG000|Overall Study|Withdrawal by Subject|1|||
47000363|NCT01773070|83247795|FG000|Overall Study|Withdrawal by Subject|24|||
47000364|NCT01773070|83247795|FG000|Overall Study|Lost to Follow-up|39|||
47000365|NCT01773070|83247795|FG000|Overall Study|Other|15|||
47000366|NCT01773070|83247795|FG000|Overall Study|Death (unrelated to study procedures)|3|||
47000367|NCT01772368|83247799|FG000|Overall Study|Adverse Event|1|||
47000368|NCT01772368|83247799|FG000|Overall Study|Withdrawal by Subject|3|||
47000369|NCT01772368|83247799|FG000|Overall Study|Protocol Violation|2|||
47000370|NCT01772368|83247799|FG000|Overall Study|Other|1|||
47000371|NCT01788046|83247817|FG000|Overall Study|Withdrawal by Subject|12|||
47000372|NCT01788046|83247818|FG001|Overall Study|Withdrawal by Subject|12|||
47000373|NCT01788046|83247817|FG000|Overall Study|Lost to Follow-up|12|||
47000374|NCT01788046|83247818|FG001|Overall Study|Lost to Follow-up|19|||
47000375|NCT01788046|83247817|FG000|Overall Study|Death|7|||
46620412|NCT03930745|82766246|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
47000376|NCT01788046|83247818|FG001|Overall Study|Death|5|||
47000377|NCT01788046|83247817|FG000|Overall Study|Protocol Specified Criteria|25|||
47000378|NCT01788046|83247818|FG001|Overall Study|Protocol Specified Criteria|1|||
47000379|NCT01806298|83247824|FG000|Overall Study|Adverse Event|3|||
47000380|NCT01806298|83247824|FG000|Overall Study|Protocol Non-compliance|1|||
47000381|NCT01806298|83247824|FG000|Overall Study|Withdrawal by Subject|1|||
46709273|NCT00972777|82925222|FG001|Overall Study|Adverse Event|2|||
46709274|NCT00972777|82925221|FG000|Overall Study|Lost to Follow-up|0|||
46709275|NCT00972777|82925222|FG001|Overall Study|Lost to Follow-up|4|||
46709276|NCT00972777|82925221|FG000|Overall Study|Withdrawal by Subject|4|||
46709277|NCT00972777|82925222|FG001|Overall Study|Withdrawal by Subject|5|||
46709278|NCT00972777|82925221|FG000|Overall Study|Physician Decision|4|||
46709279|NCT00972777|82925222|FG001|Overall Study|Physician Decision|0|||
46709280|NCT00972777|82925221|FG000|Overall Study|Protocol Violation|0|||
46709281|NCT00972777|82925222|FG001|Overall Study|Protocol Violation|2|||
46709282|NCT00972777|82925221|FG000|Overall Study|Screening Failure|2|||
46908274|NCT03085095|83137269|FG000|Overall Study|Protocol Violation|0|||
46908275|NCT03085095|83137270|FG001|Overall Study|Protocol Violation|1|||
46908276|NCT03085095|83137269|FG000|Overall Study|Lost to Follow-up|2|||
46908277|NCT03085095|83137270|FG001|Overall Study|Lost to Follow-up|1|||
46908278|NCT03085095|83137269|FG000|Overall Study|Withdrawal by Subject|17|||
46908279|NCT03085095|83137270|FG001|Overall Study|Withdrawal by Subject|6|||
46908280|NCT03085095|83137269|FG000|Overall Study|Physician Decision|9|||
46908281|NCT03085095|83137270|FG001|Overall Study|Physician Decision|3|||
46908282|NCT03085095|83137269|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
46908283|NCT03085095|83137270|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
46908284|NCT03085095|83137269|FG000|Overall Study|Did not Receive Study Drug|2|||
46908285|NCT03085095|83137270|FG001|Overall Study|Did not Receive Study Drug|2|||
46908286|NCT03085095|83137269|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
46908287|NCT03085095|83137270|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
46908288|NCT04097301|83137279|FG000|Overall Study|Death|1|||
46908289|NCT04097301|83137279|FG000|Overall Study|Withdrawal by Subject|1|||
46908290|NCT04097301|83137279|FG000|Overall Study|Screening Failure|5|||
46908291|NCT02276547|83137285|FG000|Overall Study|Death|2|||
46908292|NCT02276547|83137285|FG000|Overall Study|Explant|2|||
46908293|NCT02966834|83137295|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
46908294|NCT02966834|83137296|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
46908295|NCT02966834|83137297|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
46908296|NCT02966834|83137298|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
46908297|NCT02966834|83137299|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
46908298|NCT02966834|83137300|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
46908299|NCT02966834|83137295|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
46908300|NCT02966834|83137296|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
46908301|NCT02966834|83137297|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
46908302|NCT02966834|83137298|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
46908303|NCT02966834|83137299|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
46908304|NCT02966834|83137300|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
46908305|NCT02966834|83137295|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
46908306|NCT02966834|83137296|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
46908307|NCT02966834|83137297|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
46908308|NCT02966834|83137298|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
46908309|NCT02966834|83137299|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
46908310|NCT02966834|83137300|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
46908311|NCT02966834|83137295|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
46908312|NCT02966834|83137296|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
46908313|NCT02966834|83137297|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
46908314|NCT02966834|83137298|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
46908315|NCT02966834|83137299|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
46908316|NCT02966834|83137300|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
46709283|NCT00972777|82925222|FG001|Overall Study|Screening Failure|1|||
46709284|NCT00972777|82925221|FG000|Overall Study|Missed visit|1|||
46709285|NCT00972777|82925222|FG001|Overall Study|Missed visit|0|||
46709286|NCT00918736|82925228|FG000|Overall Study|Withdrawal by Subject|4|||
46709287|NCT01172639|82925237|FG000|Overall Study|Death|1|||
46709288|NCT01172639|82925238|FG001|Overall Study|Death|1|||
46709289|NCT01172639|82925239|FG002|Overall Study|Death|0|||
46709290|NCT01172639|82925240|FG003|Overall Study|Death|0|||
46709291|NCT01172639|82925241|FG004|Overall Study|Death|0|||
46709292|NCT01172639|82925237|FG000|Overall Study|Lost to Follow-up|9|||
46709293|NCT01172639|82925238|FG001|Overall Study|Lost to Follow-up|7|||
46709294|NCT01172639|82925239|FG002|Overall Study|Lost to Follow-up|11|||
46709295|NCT01172639|82925240|FG003|Overall Study|Lost to Follow-up|6|||
46709296|NCT01172639|82925241|FG004|Overall Study|Lost to Follow-up|6|||
46709297|NCT01172639|82925237|FG000|Overall Study|Withdrawal by Subject|3|||
46908317|NCT02966834|83137295|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
46908318|NCT02966834|83137296|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
47000382|NCT01806298|83247824|FG000|Overall Study|Other|5|||
46709298|NCT01172639|82925238|FG001|Overall Study|Withdrawal by Subject|3|||
46709299|NCT01172639|82925239|FG002|Overall Study|Withdrawal by Subject|5|||
47000383|NCT01772134|83247831|FG000|Overall Study|Adverse Event|6|||
47000384|NCT01772134|83247832|FG001|Overall Study|Adverse Event|5|||
47000385|NCT01772134|83247833|FG002|Overall Study|Adverse Event|10|||
47000386|NCT01772134|83247831|FG000|Overall Study|Withdrew Consent|3|||
47000387|NCT01772134|83247832|FG001|Overall Study|Withdrew Consent|1|||
47000388|NCT01772134|83247833|FG002|Overall Study|Withdrew Consent|5|||
47000389|NCT01772134|83247831|FG000|Overall Study|Lost to Follow-up|2|||
47000390|NCT01772134|83247832|FG001|Overall Study|Lost to Follow-up|0|||
47000391|NCT01772134|83247833|FG002|Overall Study|Lost to Follow-up|0|||
47000392|NCT01772134|83247831|FG000|Overall Study|Protocol Deviation|4|||
47000393|NCT01772134|83247832|FG001|Overall Study|Protocol Deviation|3|||
47000394|NCT01772134|83247833|FG002|Overall Study|Protocol Deviation|3|||
47000395|NCT01772134|83247831|FG000|Overall Study|Lack of Efficacy|11|||
47000396|NCT01772134|83247832|FG001|Overall Study|Lack of Efficacy|5|||
47000397|NCT01772134|83247833|FG002|Overall Study|Lack of Efficacy|3|||
47000398|NCT01772134|83247831|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
47000399|NCT01772134|83247832|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
47000400|NCT01772134|83247833|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
47000401|NCT01772134|83247831|FG000|Overall Study|Randomized Study Medication Not Received|2|||
47000402|NCT01772134|83247832|FG001|Overall Study|Randomized Study Medication Not Received|0|||
47000403|NCT01772134|83247833|FG002|Overall Study|Randomized Study Medication Not Received|1|||
47000404|NCT01994889|83247844|FG000|Overall Study|Adverse Event|5|||
47000405|NCT01994889|83247845|FG001|Overall Study|Adverse Event|12|||
47000406|NCT01994889|83247846|FG002|Overall Study|Adverse Event|11|||
47000407|NCT01994889|83247844|FG000|Overall Study|Cardiac Device Implantation|0|||
47000408|NCT01994889|83247845|FG001|Overall Study|Cardiac Device Implantation|2|||
47000409|NCT01994889|83247846|FG002|Overall Study|Cardiac Device Implantation|0|||
47000410|NCT01994889|83247844|FG000|Overall Study|Organ Transplantation|1|||
47000411|NCT01994889|83247845|FG001|Overall Study|Organ Transplantation|5|||
47000412|NCT01994889|83247846|FG002|Overall Study|Organ Transplantation|5|||
47000413|NCT01994889|83247844|FG000|Overall Study|No longer willing to participate|8|||
47000414|NCT01994889|83247845|FG001|Overall Study|No longer willing to participate|17|||
47000415|NCT01994889|83247846|FG002|Overall Study|No longer willing to participate|37|||
46908319|NCT02966834|83137297|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
46908320|NCT02966834|83137298|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
46908321|NCT02966834|83137299|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
46908322|NCT02966834|83137300|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
46908323|NCT02966834|83137295|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
46908324|NCT02966834|83137296|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
46908325|NCT02966834|83137297|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
46908326|NCT02966834|83137298|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
46908327|NCT02966834|83137299|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
46908328|NCT02966834|83137300|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
46908329|NCT03106077|83137349|FG000|Overall Study|Screen Failure|94|||
46908330|NCT03106077|83137350|FG001|Overall Study|Screen Failure|0|||
46908331|NCT03105297|83137355|FG000|Baseline Phase (Day 1)|Other|21|||
46908332|NCT03105297|83137355|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
46908333|NCT03105297|83137355|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
46908334|NCT03426995|83137385|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908335|NCT03426995|83137386|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908336|NCT03426995|83137387|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
46908337|NCT03426995|83137388|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908338|NCT03426995|83137389|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908339|NCT03426995|83137390|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908340|NCT03426995|83137391|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908341|NCT03426995|83137392|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908342|NCT03426995|83137393|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
47000416|NCT01994889|83247844|FG000|Overall Study|Lost to Follow-up|0|||
47000417|NCT01994889|83247845|FG001|Overall Study|Lost to Follow-up|1|||
47000418|NCT01994889|83247846|FG002|Overall Study|Lost to Follow-up|0|||
47000419|NCT01994889|83247844|FG000|Overall Study|Protocol Violation|0|||
47000420|NCT01994889|83247845|FG001|Overall Study|Protocol Violation|1|||
47000421|NCT01994889|83247846|FG002|Overall Study|Protocol Violation|1|||
46908343|NCT03426995|83137394|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908344|NCT03426995|83137395|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908345|NCT03426995|83137396|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908346|NCT03426995|83137397|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908347|NCT03426995|83137398|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908348|NCT03426995|83137399|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
47000422|NCT01994889|83247844|FG000|Overall Study|Death|14|||
47000423|NCT01994889|83247845|FG001|Overall Study|Death|25|||
47000424|NCT01994889|83247846|FG002|Overall Study|Death|38|||
47000425|NCT02082483|83247855|FG000|Overall Study|Lost to Follow-up|1|||
47000426|NCT02082483|83247856|FG001|Overall Study|Lost to Follow-up|1|||
47000427|NCT02082483|83247855|FG000|Overall Study|Withdrawal by Subject|2|||
47000428|NCT02082483|83247856|FG001|Overall Study|Withdrawal by Subject|1|||
47000429|NCT02082483|83247855|FG000|Overall Study|Physician Decision|1|||
47000430|NCT02082483|83247856|FG001|Overall Study|Physician Decision|1|||
47000431|NCT02082483|83247855|FG000|Overall Study|Death|2|||
47000432|NCT02082483|83247856|FG001|Overall Study|Death|3|||
47000433|NCT02017899|83247869|FG000|Overall Study|Withdrawal by Subject|0|||
47000434|NCT02017899|83247870|FG001|Overall Study|Withdrawal by Subject|0|||
47000435|NCT02017899|83247871|FG002|Overall Study|Withdrawal by Subject|0|||
47000436|NCT02017899|83247872|FG003|Overall Study|Withdrawal by Subject|1|||
47000437|NCT02017899|83247873|FG004|Overall Study|Withdrawal by Subject|1|||
47000438|NCT02017899|83247874|FG005|Overall Study|Withdrawal by Subject|0|||
47000439|NCT01993329|83247894|FG000|Period 2|Adverse Event|0|||
47000440|NCT01993329|83247895|FG001|Period 2|Adverse Event|0|||
47000441|NCT01993329|83247896|FG002|Period 2|Adverse Event|0|||
47000442|NCT01993329|83247897|FG003|Period 2|Adverse Event|0|||
47000443|NCT01993329|83247898|FG004|Period 2|Adverse Event|0|||
47000444|NCT01993329|83247899|FG005|Period 2|Adverse Event|1|||
47000445|NCT01993329|83247894|FG000|Wash-out|Personal reasons|0|||
47000446|NCT01993329|83247895|FG001|Wash-out|Personal reasons|1|||
47000447|NCT01993329|83247896|FG002|Wash-out|Personal reasons|0|||
47000448|NCT01993329|83247897|FG003|Wash-out|Personal reasons|0|||
47000449|NCT01993329|83247898|FG004|Wash-out|Personal reasons|0|||
47000450|NCT01993329|83247899|FG005|Wash-out|Personal reasons|0|||
47000451|NCT02016183|83247911|FG000|Overall Study|Case Report Forms Uncollected|13|||
47000452|NCT02016183|83247911|FG000|Overall Study|Protocol Violation|52|||
47000453|NCT02377349|83247917|FG000|Overall Study|Serious Adverse Event|1|||
47000454|NCT02377349|83247918|FG001|Overall Study|Serious Adverse Event|0|||
46908349|NCT03426995|83137400|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908350|NCT03426995|83137401|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
47000455|NCT02377349|83247917|FG000|Overall Study|Protocol Violation|3|||
47000456|NCT02377349|83247918|FG001|Overall Study|Protocol Violation|2|||
47000457|NCT02377349|83247917|FG000|Overall Study|Withdrawal by Subject|5|||
47000458|NCT02377349|83247918|FG001|Overall Study|Withdrawal by Subject|3|||
46908351|NCT03426995|83137402|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908352|NCT03426995|83137403|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
46908353|NCT03426995|83137385|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
47000459|NCT02377349|83247917|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
47000460|NCT02377349|83247918|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
47000461|NCT02377349|83247917|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
47000462|NCT02377349|83247918|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
47000463|NCT02377349|83247917|FG000|Overall Study|Other|0|||
47000464|NCT02377349|83247918|FG001|Overall Study|Other|1|||
47000465|NCT02421419|83247936|FG000|Overall Study|Physician Decision|0|||
47000466|NCT02421419|83247937|FG001|Overall Study|Physician Decision|0|||
47000467|NCT02421419|83247938|FG002|Overall Study|Physician Decision|1|||
47000468|NCT02016105|83247948|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
47000469|NCT02016105|83247949|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
47000470|NCT02016105|83247950|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
47000471|NCT02016105|83247951|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
47000472|NCT02016105|83247952|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
47000473|NCT02016105|83247953|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
47000474|NCT02016105|83247948|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
47000475|NCT02016105|83247949|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
47000476|NCT02016105|83247950|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
47000477|NCT02016105|83247951|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
47000478|NCT02016105|83247952|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
47000479|NCT02016105|83247953|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
47000480|NCT02016105|83247948|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
47000481|NCT02016105|83247949|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
47000482|NCT02016105|83247950|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
47000483|NCT02016105|83247951|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
47000484|NCT02016105|83247952|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
47000485|NCT02016105|83247953|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
47000486|NCT02016105|83247948|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
47000487|NCT02016105|83247949|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
47000488|NCT02016105|83247950|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
47000489|NCT02016105|83247951|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
47000490|NCT02016105|83247952|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
47000491|NCT02016105|83247953|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
47000492|NCT02016105|83247948|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
47000493|NCT02016105|83247949|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
47000494|NCT02016105|83247950|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
47000495|NCT02016105|83247951|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
47000496|NCT02016105|83247952|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
47000497|NCT02016105|83247953|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
47000498|NCT02016105|83247948|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
47000499|NCT02016105|83247949|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
47000500|NCT02016105|83247950|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
47000501|NCT02016105|83247951|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
47000502|NCT02016105|83247952|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
47000503|NCT02016105|83247953|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
47000504|NCT02016105|83247948|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
47000505|NCT02016105|83247949|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
47000506|NCT02016105|83247950|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
47000507|NCT02016105|83247951|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
47000508|NCT02016105|83247952|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
47000509|NCT02016105|83247953|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
47000510|NCT02016105|83247948|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
47000511|NCT02016105|83247949|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
47000512|NCT02016105|83247950|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
47000513|NCT02016105|83247951|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
47000514|NCT02016105|83247952|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
47000515|NCT02016105|83247953|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
47000516|NCT02016105|83247948|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
47000517|NCT02016105|83247949|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
47000518|NCT02016105|83247950|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
47000519|NCT02016105|83247951|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
47000520|NCT02016105|83247952|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
47000521|NCT02016105|83247953|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
47000522|NCT02016105|83247948|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
47000523|NCT02016105|83247949|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
47000524|NCT02016105|83247950|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
47000525|NCT02016105|83247951|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
47000526|NCT02016105|83247952|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
47000527|NCT02016105|83247953|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
47000528|NCT02016105|83247948|FG000|TREATMENT PERIOD 2|Death|0|||
46908354|NCT03426995|83137386|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908355|NCT03426995|83137387|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908356|NCT03426995|83137388|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908357|NCT03426995|83137389|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908358|NCT03426995|83137390|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
46908359|NCT03426995|83137391|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908360|NCT03426995|83137392|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908361|NCT03426995|83137393|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
47000529|NCT02016105|83247949|FG001|TREATMENT PERIOD 2|Death|0|||
47000530|NCT02016105|83247950|FG002|TREATMENT PERIOD 2|Death|0|||
46908362|NCT03426995|83137394|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908363|NCT03426995|83137395|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908364|NCT03426995|83137396|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908365|NCT03426995|83137397|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908366|NCT03426995|83137398|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908367|NCT03426995|83137399|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908368|NCT03426995|83137400|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908369|NCT03426995|83137401|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908370|NCT03426995|83137402|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908371|NCT03426995|83137403|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
46908372|NCT03426995|83137385|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908373|NCT03426995|83137386|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908374|NCT03426995|83137387|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908375|NCT03426995|83137388|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908376|NCT03426995|83137389|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
46908377|NCT03426995|83137390|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
46908378|NCT03426995|83137391|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908379|NCT03426995|83137392|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908380|NCT03426995|83137393|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908381|NCT03426995|83137394|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908382|NCT03426995|83137395|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908383|NCT03426995|83137396|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908384|NCT03426995|83137397|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908385|NCT03426995|83137398|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908386|NCT03426995|83137399|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908387|NCT03426995|83137400|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908388|NCT03426995|83137401|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908389|NCT03426995|83137402|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908390|NCT03426995|83137403|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
46908391|NCT03426995|83137385|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908392|NCT03426995|83137386|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908393|NCT03426995|83137387|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908394|NCT03426995|83137388|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908395|NCT03426995|83137389|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908396|NCT03426995|83137390|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908397|NCT03426995|83137391|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908398|NCT03426995|83137392|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908399|NCT03426995|83137393|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908400|NCT03426995|83137394|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908401|NCT03426995|83137395|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
46908402|NCT03426995|83137396|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908403|NCT03426995|83137397|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908404|NCT03426995|83137398|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908405|NCT03426995|83137399|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908406|NCT03426995|83137400|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908407|NCT03426995|83137401|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908408|NCT03426995|83137402|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908409|NCT03426995|83137403|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
46908410|NCT03426995|83137385|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908411|NCT03426995|83137386|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908412|NCT03426995|83137387|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908413|NCT03426995|83137388|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908414|NCT03426995|83137389|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908415|NCT03426995|83137390|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908416|NCT03426995|83137391|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908417|NCT03426995|83137392|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
46908418|NCT03426995|83137393|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908419|NCT03426995|83137394|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908420|NCT03426995|83137395|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908421|NCT03426995|83137396|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908422|NCT03426995|83137397|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908423|NCT03426995|83137398|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908424|NCT03426995|83137399|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908425|NCT03426995|83137400|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908426|NCT03426995|83137401|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908427|NCT03426995|83137402|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
47000531|NCT02016105|83247951|FG003|TREATMENT PERIOD 2|Death|0|||
47000532|NCT02016105|83247952|FG004|TREATMENT PERIOD 2|Death|0|||
47000533|NCT02016105|83247953|FG005|TREATMENT PERIOD 2|Death|1|||
47000534|NCT02016105|83247948|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
47000535|NCT02016105|83247949|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
47000536|NCT02016105|83247950|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
47000537|NCT02016105|83247951|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
47000538|NCT02016105|83247952|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
47000539|NCT02016105|83247953|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
47000540|NCT02016105|83247948|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
47000541|NCT02016105|83247949|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
47000542|NCT02016105|83247950|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
47000543|NCT02016105|83247951|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
47000544|NCT02016105|83247952|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
47000545|NCT02016105|83247953|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
47000546|NCT02016105|83247948|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
47000547|NCT02016105|83247949|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
47000548|NCT02016105|83247950|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
47000549|NCT02016105|83247951|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
47000550|NCT02016105|83247952|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
47000551|NCT02016105|83247953|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
47000552|NCT02016105|83247948|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
47000553|NCT02016105|83247949|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
47000554|NCT02016105|83247950|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
47000555|NCT02016105|83247951|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
47000556|NCT02016105|83247952|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
47000557|NCT02016105|83247953|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
47000558|NCT02016105|83247948|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
47000559|NCT02016105|83247949|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
47000560|NCT02016105|83247950|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
47000561|NCT02016105|83247951|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
47000562|NCT02016105|83247952|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
47000563|NCT02016105|83247953|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
47000564|NCT02016105|83247948|FG000|EXTENSION PERIOD|Adverse Event|0|||
47000565|NCT02016105|83247949|FG001|EXTENSION PERIOD|Adverse Event|0|||
47000566|NCT02016105|83247950|FG002|EXTENSION PERIOD|Adverse Event|2|||
47000567|NCT02016105|83247951|FG003|EXTENSION PERIOD|Adverse Event|0|||
47000568|NCT02016105|83247952|FG004|EXTENSION PERIOD|Adverse Event|1|||
47000569|NCT02016105|83247953|FG005|EXTENSION PERIOD|Adverse Event|0|||
47000570|NCT02016105|83247948|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
47000571|NCT02016105|83247949|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
47000572|NCT02016105|83247950|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
47000573|NCT02016105|83247951|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
47000574|NCT02016105|83247952|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
47000575|NCT02016105|83247953|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
47000576|NCT02016105|83247948|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
47000577|NCT02016105|83247949|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
47000578|NCT02016105|83247950|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
47000579|NCT02016105|83247951|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
47000580|NCT02016105|83247952|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
47000581|NCT02016105|83247953|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
47000582|NCT02016105|83247948|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
47000583|NCT02016105|83247949|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
47000584|NCT02016105|83247950|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
47000585|NCT02016105|83247951|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
47000586|NCT02016105|83247952|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
47000587|NCT02016105|83247953|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
47000588|NCT02400905|83247967|FG000|Overall Study|Death|24|||
47000589|NCT02400905|83247967|FG000|Overall Study|Lost to Follow-up|18|||
47000590|NCT02400905|83247967|FG000|Overall Study|Withdrawal by Subject|16|||
47000591|NCT02400905|83247967|FG000|Overall Study|Physician Decision|4|||
46908428|NCT03426995|83137403|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
46908429|NCT03426995|83137385|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908430|NCT03426995|83137386|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908431|NCT03426995|83137387|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908432|NCT03426995|83137388|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908433|NCT03426995|83137389|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908434|NCT03426995|83137390|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908435|NCT03426995|83137391|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908436|NCT03426995|83137392|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908437|NCT03426995|83137393|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
47000592|NCT02400905|83247967|FG000|Overall Study|Other|1|||
47000593|NCT02400749|83247974|FG000|Week 0 -16|Withdrawal by Subject|5|||
47000594|NCT02400749|83247975|FG001|Week 0 -16|Withdrawal by Subject|5|||
47000595|NCT02400749|83247974|FG000|Week 0 -16|Adverse Event|3|||
47000596|NCT02400749|83247975|FG001|Week 0 -16|Adverse Event|1|||
47000597|NCT02400749|83247974|FG000|Week 0 -16|Lost to Follow-up|2|||
47000598|NCT02400749|83247975|FG001|Week 0 -16|Lost to Follow-up|0|||
47000599|NCT02400749|83247974|FG000|Week 0 -16|Protocol Violation|1|||
47000600|NCT02400749|83247975|FG001|Week 0 -16|Protocol Violation|0|||
47000601|NCT02400749|83247974|FG000|Week 17 - 32|Withdrawal by Subject|3|||
47000602|NCT02400749|83247975|FG001|Week 17 - 32|Withdrawal by Subject|2|||
47000603|NCT02400749|83247974|FG000|Week 17 - 32|Adverse Event|2|||
47000604|NCT02400749|83247975|FG001|Week 17 - 32|Adverse Event|1|||
47000605|NCT02420327|83247981|FG000|Overall Study|Adverse Event|7|||
47000606|NCT02420327|83247981|FG000|Overall Study|Pregnancy|1|||
47000607|NCT02420327|83247981|FG000|Overall Study|Withdrawal by Subject|6|||
47000608|NCT02420327|83247981|FG000|Overall Study|Lost to Follow-up|1|||
47000609|NCT02420327|83247981|FG000|Overall Study|Protocol Violation|1|||
47000610|NCT02374853|83247993|FG000|Overall Study|Surgery Cancelled|5|||
47000611|NCT02374853|83247994|FG001|Overall Study|Surgery Cancelled|11|||
47000612|NCT02015793|83248002|FG000|Overall Study|Adverse Event|3|||
47000613|NCT02015793|83248003|FG001|Overall Study|Adverse Event|3|||
47000614|NCT02015793|83248002|FG000|Overall Study|Withdrawal by Subject|1|||
47000615|NCT02015793|83248003|FG001|Overall Study|Withdrawal by Subject|1|||
47000616|NCT02347631|83248017|FG000|First Intervention (2 Months)|Adverse Event|1|||
47000617|NCT02347631|83248018|FG001|First Intervention (2 Months)|Adverse Event|1|||
47000618|NCT02347631|83248017|FG000|First Intervention (2 Months)|Pregnancy|1|||
47000619|NCT02347631|83248018|FG001|First Intervention (2 Months)|Pregnancy|0|||
47000620|NCT02347631|83248017|FG000|First Intervention (2 Months)|Moved out of area|0|||
47000621|NCT02347631|83248018|FG001|First Intervention (2 Months)|Moved out of area|2|||
47000622|NCT02347631|83248017|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
47000623|NCT02347631|83248018|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
47000624|NCT02347631|83248017|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
47000625|NCT02347631|83248018|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
47000626|NCT02347631|83248017|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
47000627|NCT02347631|83248018|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
47000628|NCT02347631|83248017|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
47000629|NCT02347631|83248018|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
47000630|NCT02347631|83248017|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
47000631|NCT02347631|83248018|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
47000632|NCT02015637|83248028|FG000|Overall Study|Lost to Follow-up|3|||
47000633|NCT02015637|83248029|FG001|Overall Study|Lost to Follow-up|5|||
47000634|NCT02015637|83248028|FG000|Overall Study|Adverse Event|3|||
47000635|NCT02015637|83248029|FG001|Overall Study|Adverse Event|0|||
47000636|NCT02015637|83248028|FG000|Overall Study|Did not take study drug|2|||
47000637|NCT02015637|83248029|FG001|Overall Study|Did not take study drug|0|||
47000638|NCT02347085|83248035|FG000|Overall Study|Adverse Event|2|||
47000639|NCT02347085|83248035|FG000|Overall Study|Lack of Efficacy|1|||
47000640|NCT02347085|83248035|FG000|Overall Study|Withdrawal by Subject|4|||
47000641|NCT02347085|83248035|FG000|Overall Study|Lost to Follow-up|1|||
47000642|NCT02347085|83248035|FG000|Overall Study|Protocol Criteria|2|||
47000643|NCT02374463|83248043|FG000|Overall Study|Withdrawal by Subject|3|||
47000644|NCT02374463|83248044|FG001|Overall Study|Withdrawal by Subject|3|||
47000645|NCT02015481|83248051|FG000|Overall Study|Death|1|||
47000646|NCT02374307|83248058|FG000|3-months Follow-up|Lost to Follow-up|1|||
47000647|NCT02374307|83248059|FG001|3-months Follow-up|Lost to Follow-up|2|||
47000648|NCT02374307|83248058|FG000|3-months Follow-up|Withdrawal by Subject|1|||
47000649|NCT02374307|83248059|FG001|3-months Follow-up|Withdrawal by Subject|4|||
47000650|NCT02374307|83248058|FG000|3-months Follow-up|Death|1|||
47000651|NCT02374307|83248059|FG001|3-months Follow-up|Death|2|||
47000652|NCT02374307|83248058|FG000|3-months Follow-up|Missed first follow-up|5|||
47000653|NCT02374307|83248059|FG001|3-months Follow-up|Missed first follow-up|1|||
47000654|NCT02374307|83248058|FG000|6-months Follow-up|Lost to Follow-up|1|||
47000655|NCT02374307|83248059|FG001|6-months Follow-up|Lost to Follow-up|2|||
47000656|NCT02374307|83248058|FG000|6-months Follow-up|Death|2|||
47000657|NCT02374307|83248059|FG001|6-months Follow-up|Death|1|||
47000658|NCT02374307|83248058|FG000|6-months Follow-up|Withdrawal by Subject|0|||
47000659|NCT02374307|83248059|FG001|6-months Follow-up|Withdrawal by Subject|3|||
47000660|NCT02397473|83248067|FG000|Treatment Phase|Adverse Event|1|||
47000661|NCT02397473|83248068|FG001|Treatment Phase|Adverse Event|2|||
47000662|NCT02397473|83248067|FG000|Treatment Phase|Lack of Efficacy|8|||
47000663|NCT02397473|83248068|FG001|Treatment Phase|Lack of Efficacy|1|||
47000664|NCT02397473|83248067|FG000|Treatment Phase|Lost to Follow-up|1|||
47000665|NCT02397473|83248068|FG001|Treatment Phase|Lost to Follow-up|0|||
47000666|NCT02397473|83248067|FG000|Treatment Phase|Withdrawal by Subject|2|||
47000667|NCT02397473|83248068|FG001|Treatment Phase|Withdrawal by Subject|1|||
47000668|NCT02397473|83248067|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
47000669|NCT02397473|83248068|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
47000670|NCT02397473|83248067|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
47000671|NCT02397473|83248068|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
47000672|NCT02397473|83248067|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
47000673|NCT02397473|83248068|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
47000674|NCT02397473|83248067|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
47000675|NCT02397473|83248068|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
47000676|NCT02397473|83248067|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
47000677|NCT02397473|83248068|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
47000678|NCT02344745|83248079|FG000|Overall Study|Data collection sheets were lost|2|||
47000679|NCT02344745|83248080|FG001|Overall Study|Data collection sheets were lost|0|||
47000680|NCT02370641|83248088|FG000|Overall Study|dropped study|4|||
47000681|NCT02370641|83248089|FG001|Overall Study|dropped study|2|||
47000682|NCT01621191|83248095|FG000|Overall Study|Adverse Event|9|||
47000683|NCT01621191|83248095|FG000|Overall Study|Withdrawal by Subject|8|||
47000684|NCT01621191|83248095|FG000|Overall Study|Lack of Efficacy|6|||
47000685|NCT01621191|83248095|FG000|Overall Study|Lost to Follow-up|1|||
47000686|NCT01621191|83248095|FG000|Overall Study|Site Removed From Study|1|||
47000687|NCT02343263|83248103|FG000|Overall Study|Physician Decision|5|||
47000688|NCT02343263|83248104|FG001|Overall Study|Physician Decision|3|||
47000689|NCT02343263|83248105|FG002|Overall Study|Physician Decision|1|||
47000690|NCT02081859|83248119|FG000|Overall Study|No fertilization|2|||
47000691|NCT02081859|83248120|FG001|Overall Study|No fertilization|2|||
47000692|NCT02081859|83248119|FG000|Overall Study|No sperm|1|||
47000693|NCT02081859|83248120|FG001|Overall Study|No sperm|0|||
47000694|NCT02081859|83248119|FG000|Overall Study|Unanticipated freeze all cycle|2|||
47000695|NCT02081859|83248120|FG001|Overall Study|Unanticipated freeze all cycle|6|||
47000696|NCT02081859|83248119|FG000|Overall Study|< 4 embryos|27|||
47000697|NCT02081859|83248120|FG001|Overall Study|< 4 embryos|23|||
47000698|NCT02081859|83248119|FG000|Overall Study|Other reasons|2|||
47000699|NCT02081859|83248120|FG001|Overall Study|Other reasons|0|||
47000700|NCT02342639|83248128|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
47000701|NCT02342639|83248129|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
47000702|NCT02342639|83248128|FG000|Overall Study|Protocol Violation|0|||
47000703|NCT02342639|83248129|FG001|Overall Study|Protocol Violation|2|||
47000704|NCT01625091|83248139|FG000|Intervention|Death|1|||
47000705|NCT01625091|83248140|FG001|Intervention|Death|1|||
47000706|NCT01625091|83248139|FG000|Intervention|Withdrawal by Subject|4|||
47000707|NCT01625091|83248140|FG001|Intervention|Withdrawal by Subject|1|||
47000708|NCT01625091|83248139|FG000|Intervention|Adverse Event|0|||
47000709|NCT01625091|83248140|FG001|Intervention|Adverse Event|2|||
47000710|NCT01625091|83248139|FG000|Intervention|Lost to Follow-up|4|||
47000711|NCT01625091|83248140|FG001|Intervention|Lost to Follow-up|4|||
47000712|NCT01625091|83248139|FG000|Intervention|Study termination|2|||
47000713|NCT01625091|83248140|FG001|Intervention|Study termination|3|||
47000714|NCT01625091|83248139|FG000|Post-intervention|Death|0|||
47000715|NCT01625091|83248140|FG001|Post-intervention|Death|1|||
47000716|NCT01625091|83248139|FG000|Post-intervention|Lost to Follow-up|2|||
47000717|NCT01625091|83248140|FG001|Post-intervention|Lost to Follow-up|0|||
47000718|NCT01625091|83248139|FG000|Post-intervention|Study termination|2|||
47000719|NCT01625091|83248140|FG001|Post-intervention|Study termination|1|||
47000720|NCT02396849|83248148|FG000|Overall Study|Lost to Follow-up|1|||
47000721|NCT02396849|83248149|FG001|Overall Study|Lost to Follow-up|1|||
47000722|NCT02396849|83248148|FG000|Overall Study|Did not tolerate intervention|1|||
46620413|NCT03930745|82766247|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
47000723|NCT02396849|83248149|FG001|Overall Study|Did not tolerate intervention|1|||
47000724|NCT02370251|83248157|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
47000725|NCT02370251|83248157|FG000|Overall Study|Death|4|||
47000726|NCT02396537|83248163|FG000|Overall Study|Protocol Violation|0|||
47000727|NCT02396537|83248164|FG001|Overall Study|Protocol Violation|1|||
47000728|NCT02342171|83248172|FG000|Overall Study|Death|4|||
47000729|NCT02342171|83248173|FG001|Overall Study|Death|87|||
47000730|NCT02342171|83248172|FG000|Overall Study|Received favipiravir|10|||
47000731|NCT02342171|83248173|FG001|Overall Study|Received favipiravir|0|||
47000732|NCT02342171|83248172|FG000|Overall Study|Missing cycle treshold value|1|||
47000733|NCT02342171|83248173|FG001|Overall Study|Missing cycle treshold value|0|||
47000734|NCT02342171|83248172|FG000|Overall Study|Unknown outcome|0|||
47000735|NCT02342171|83248173|FG001|Overall Study|Unknown outcome|1|||
47000736|NCT02342171|83248172|FG000|Overall Study|Missing age data|0|||
47000737|NCT02342171|83248173|FG001|Overall Study|Missing age data|1|||
47000738|NCT01624467|83248178|FG000|Overall Study|Withdrawal by Subject|2|||
47000739|NCT01624467|83248178|FG000|Overall Study|Lost to Follow-up|1|||
46908438|NCT03426995|83137394|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908439|NCT03426995|83137395|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908440|NCT03426995|83137396|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908441|NCT03426995|83137397|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908442|NCT03426995|83137398|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908443|NCT03426995|83137399|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
46908444|NCT03426995|83137400|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
46908445|NCT03426995|83137401|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908446|NCT03426995|83137402|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908447|NCT03426995|83137403|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
46908448|NCT03426995|83137385|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908449|NCT03426995|83137386|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908450|NCT03426995|83137387|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908451|NCT03426995|83137388|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908452|NCT03426995|83137389|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908453|NCT03426995|83137390|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908454|NCT03426995|83137391|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908455|NCT03426995|83137392|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908456|NCT03426995|83137393|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908457|NCT03426995|83137394|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908458|NCT03426995|83137395|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908459|NCT03426995|83137396|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908460|NCT03426995|83137397|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908461|NCT03426995|83137398|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908462|NCT03426995|83137399|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
46908463|NCT03426995|83137400|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
46908464|NCT03426995|83137401|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908465|NCT03426995|83137402|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908466|NCT03426995|83137403|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
46908467|NCT03424265|83137452|FG000|Overall Study|screening failure|1|||
46908468|NCT03424265|83137453|FG001|Overall Study|screening failure|0|||
46908469|NCT03424265|83137452|FG000|Overall Study|Withdrawal by Subject|0|||
46908470|NCT03424265|83137453|FG001|Overall Study|Withdrawal by Subject|2|||
46908471|NCT03322566|83137462|FG000|Overall Study|Death|34|||
46908472|NCT03322566|83137463|FG001|Overall Study|Death|35|||
46908473|NCT03322566|83137464|FG002|Overall Study|Death|23|||
46908474|NCT03322566|83137462|FG000|Overall Study|Physician Decision|6|||
46908475|NCT03322566|83137463|FG001|Overall Study|Physician Decision|7|||
46908476|NCT03322566|83137464|FG002|Overall Study|Physician Decision|2|||
46908477|NCT03322566|83137462|FG000|Overall Study|Withdrawal by Subject|4|||
46908478|NCT03322566|83137463|FG001|Overall Study|Withdrawal by Subject|3|||
46908479|NCT03322566|83137464|FG002|Overall Study|Withdrawal by Subject|6|||
46908480|NCT03322566|83137462|FG000|Overall Study|Lost to Follow-up|0|||
46908481|NCT03322566|83137463|FG001|Overall Study|Lost to Follow-up|0|||
46908482|NCT03322566|83137464|FG002|Overall Study|Lost to Follow-up|1|||
46908483|NCT03322566|83137462|FG000|Overall Study|Study terminated by sponsor|1|||
46908484|NCT03322566|83137463|FG001|Overall Study|Study terminated by sponsor|0|||
46908485|NCT03322566|83137464|FG002|Overall Study|Study terminated by sponsor|1|||
46908486|NCT02969018|83137480|FG000|Overall Study|Adverse Event|2|||
46908487|NCT02969018|83137481|FG001|Overall Study|Adverse Event|4|||
46908488|NCT02969018|83137482|FG002|Overall Study|Adverse Event|1|||
46908489|NCT02969018|83137483|FG003|Overall Study|Adverse Event|2|||
46908490|NCT02969018|83137484|FG004|Overall Study|Adverse Event|0|||
46908491|NCT02969018|83137485|FG005|Overall Study|Adverse Event|1|||
46908492|NCT02969018|83137486|FG006|Overall Study|Adverse Event|2|||
46908493|NCT02969018|83137487|FG007|Overall Study|Adverse Event|0|||
46908494|NCT02969018|83137480|FG000|Overall Study|Lack of Efficacy|0|||
46908495|NCT02969018|83137481|FG001|Overall Study|Lack of Efficacy|1|||
46908496|NCT02969018|83137482|FG002|Overall Study|Lack of Efficacy|0|||
46908497|NCT02969018|83137483|FG003|Overall Study|Lack of Efficacy|0|||
46908498|NCT02969018|83137484|FG004|Overall Study|Lack of Efficacy|1|||
46908499|NCT02969018|83137485|FG005|Overall Study|Lack of Efficacy|1|||
47000740|NCT01624467|83248178|FG000|Overall Study|Adverse Event|7|||
46908500|NCT02969018|83137486|FG006|Overall Study|Lack of Efficacy|1|||
46908501|NCT02969018|83137487|FG007|Overall Study|Lack of Efficacy|1|||
47000741|NCT01624467|83248178|FG000|Overall Study|Progressive Disease|19|||
47000742|NCT01624467|83248178|FG000|Overall Study|Per Sponsor Requirement|1|||
47000743|NCT01624467|83248178|FG000|Overall Study|Subject Withdrew from Treatment|1|||
47000744|NCT01624233|83248184|FG000|Period 2 - Induction|Adverse Event|1|||
47000745|NCT01624233|83248184|FG000|Period 3 - Maintenance|Adverse Event|2|||
46908502|NCT02969018|83137480|FG000|Overall Study|Lost to Follow-up|1|||
46908503|NCT02969018|83137481|FG001|Overall Study|Lost to Follow-up|2|||
47000746|NCT01624233|83248184|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
47000747|NCT01624233|83248184|FG000|Period 3 - Maintenance|Physician Decision|2|||
47000748|NCT01624233|83248184|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
47000749|NCT01624233|83248184|FG000|Period 4 - Drug Free Period|Relapsed|61|||
47000750|NCT01624233|83248184|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
47000751|NCT01624233|83248184|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
47000752|NCT01624233|83248184|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
47000753|NCT01624233|83248184|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
47000754|NCT01624233|83248184|FG000|Period 6: Follow-up|Adverse Event|3|||
47000755|NCT01624233|83248184|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
47000756|NCT01624233|83248184|FG000|Period 6: Follow-up|Physician Decision|1|||
47000757|NCT01624233|83248184|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
47000758|NCT01993017|83248195|FG000|Overall Study|Death|23|||
47000759|NCT01993017|83248196|FG001|Overall Study|Death|26|||
47000760|NCT01993017|83248197|FG002|Overall Study|Death|18|||
47000761|NCT01993017|83248195|FG000|Overall Study|Could not be contacted|43|||
47000762|NCT01993017|83248196|FG001|Overall Study|Could not be contacted|42|||
47000763|NCT01993017|83248197|FG002|Overall Study|Could not be contacted|38|||
47000764|NCT01993017|83248195|FG000|Overall Study|Dropped out|19|||
47000765|NCT01993017|83248196|FG001|Overall Study|Dropped out|6|||
47000766|NCT01993017|83248197|FG002|Overall Study|Dropped out|11|||
47000767|NCT01993017|83248195|FG000|Overall Study|Other reasons|17|||
47000768|NCT01993017|83248196|FG001|Overall Study|Other reasons|11|||
47000769|NCT01993017|83248197|FG002|Overall Study|Other reasons|7|||
47000770|NCT01993017|83248195|FG000|Overall Study|Ineligible after randomization|4|||
47000771|NCT01993017|83248196|FG001|Overall Study|Ineligible after randomization|5|||
47000772|NCT01993017|83248197|FG002|Overall Study|Ineligible after randomization|5|||
47000773|NCT01992549|83248206|FG000|Overall Study|Lost to Follow-up|2|||
47000774|NCT01992549|83248206|FG000|Overall Study|Serious Adverse Event|1|||
47000775|NCT01992549|83248206|FG000|Overall Study|Product Switch to Extend Half Life|1|||
47000776|NCT01992159|83248220|FG000|Overall Study|Withdrawal by Subject|4|||
47000777|NCT01992159|83248221|FG001|Overall Study|Withdrawal by Subject|7|||
47000778|NCT01992159|83248222|FG002|Overall Study|Withdrawal by Subject|0|||
47000779|NCT01992159|83248223|FG003|Overall Study|Withdrawal by Subject|3|||
47000780|NCT01992159|83248220|FG000|Overall Study|Adverse Event|0|||
47000781|NCT01992159|83248221|FG001|Overall Study|Adverse Event|1|||
47000782|NCT01992159|83248222|FG002|Overall Study|Adverse Event|0|||
47000783|NCT01992159|83248223|FG003|Overall Study|Adverse Event|1|||
47000784|NCT01992159|83248220|FG000|Overall Study|Death|0|||
47000785|NCT01992159|83248221|FG001|Overall Study|Death|0|||
47000786|NCT01992159|83248222|FG002|Overall Study|Death|1|||
47000787|NCT01992159|83248223|FG003|Overall Study|Death|0|||
47000788|NCT01988493|83248238|FG000|Overall Study|Randomized but not treated|0|||
47000789|NCT01988493|83248239|FG001|Overall Study|Randomized but not treated|0|||
47000790|NCT01988493|83248240|FG002|Overall Study|Randomized but not treated|0|||
47000791|NCT01988493|83248241|FG003|Overall Study|Randomized but not treated|0|||
47000792|NCT01988493|83248242|FG004|Overall Study|Randomized but not treated|1|||
47000793|NCT02081079|83248258|FG000|Overall Study|Lack of Efficacy|3|||
47000794|NCT02081079|83248259|FG001|Overall Study|Lack of Efficacy|2|||
47000795|NCT02081079|83248258|FG000|Overall Study|Lost to Follow-up|1|||
47000796|NCT02081079|83248259|FG001|Overall Study|Lost to Follow-up|0|||
47000797|NCT02081001|83248271|FG000|Overall Study|Adverse Event|0|||
47000798|NCT02081001|83248272|FG001|Overall Study|Adverse Event|0|||
47000799|NCT02081001|83248273|FG002|Overall Study|Adverse Event|0|||
47000800|NCT02081001|83248274|FG003|Overall Study|Adverse Event|0|||
47000801|NCT02081001|83248275|FG004|Overall Study|Adverse Event|1|||
46620414|NCT03930745|82766246|FG000|Overall Study|Adverse Event|0|||
47000802|NCT02081001|83248276|FG005|Overall Study|Adverse Event|0|||
47000803|NCT02081001|83248277|FG006|Overall Study|Adverse Event|0|||
47000804|NCT02081001|83248278|FG007|Overall Study|Adverse Event|0|||
47000805|NCT02081001|83248279|FG008|Overall Study|Adverse Event|0|||
47000806|NCT02081001|83248280|FG009|Overall Study|Adverse Event|0|||
47000807|NCT02081001|83248281|FG010|Overall Study|Adverse Event|0|||
47000808|NCT02081001|83248282|FG011|Overall Study|Adverse Event|0|||
47000809|NCT02080221|83248293|FG000|Overall Study|Withdrawal by Subject|1|||
47000810|NCT02080221|83248293|FG000|Overall Study|Clinical Progression of Disease|1|||
47000811|NCT02079909|83248300|FG000|Overall Study|Adverse Event|23|||
47000812|NCT02079909|83248301|FG001|Overall Study|Adverse Event|23|||
47000813|NCT02079909|83248302|FG002|Overall Study|Adverse Event|7|||
47000814|NCT02079909|83248300|FG000|Overall Study|Withdrawal by Subject|9|||
47000815|NCT02079909|83248301|FG001|Overall Study|Withdrawal by Subject|17|||
46908504|NCT02969018|83137482|FG002|Overall Study|Lost to Follow-up|2|||
46908505|NCT02969018|83137483|FG003|Overall Study|Lost to Follow-up|0|||
46908506|NCT02969018|83137484|FG004|Overall Study|Lost to Follow-up|1|||
46908507|NCT02969018|83137485|FG005|Overall Study|Lost to Follow-up|1|||
46908508|NCT02969018|83137486|FG006|Overall Study|Lost to Follow-up|0|||
46908509|NCT02969018|83137487|FG007|Overall Study|Lost to Follow-up|1|||
46908510|NCT02969018|83137480|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
46908511|NCT02969018|83137481|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46908512|NCT02969018|83137482|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
46908513|NCT02969018|83137483|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
46908514|NCT02969018|83137484|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
46908515|NCT02969018|83137485|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
46908516|NCT02969018|83137486|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
46908517|NCT02969018|83137487|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
46908518|NCT02969018|83137480|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46908519|NCT02969018|83137481|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46908520|NCT02969018|83137482|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46908521|NCT02969018|83137483|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46908522|NCT02969018|83137484|FG004|Overall Study|Non-Compliance With Study Drug|0|||
46908523|NCT02969018|83137485|FG005|Overall Study|Non-Compliance With Study Drug|0|||
46908524|NCT02969018|83137486|FG006|Overall Study|Non-Compliance With Study Drug|0|||
46908525|NCT02969018|83137487|FG007|Overall Study|Non-Compliance With Study Drug|0|||
46908526|NCT02969018|83137480|FG000|Overall Study|Other|0|||
46908527|NCT02969018|83137481|FG001|Overall Study|Other|0|||
46908528|NCT02969018|83137482|FG002|Overall Study|Other|0|||
46908529|NCT02969018|83137483|FG003|Overall Study|Other|1|||
46908530|NCT02969018|83137484|FG004|Overall Study|Other|0|||
46908531|NCT02969018|83137485|FG005|Overall Study|Other|0|||
46908532|NCT02969018|83137486|FG006|Overall Study|Other|0|||
46908533|NCT02969018|83137487|FG007|Overall Study|Other|2|||
46908534|NCT02969018|83137480|FG000|Overall Study|Pregnancy|0|||
46908535|NCT02969018|83137481|FG001|Overall Study|Pregnancy|0|||
46908536|NCT02969018|83137482|FG002|Overall Study|Pregnancy|0|||
46908537|NCT02969018|83137483|FG003|Overall Study|Pregnancy|0|||
46908538|NCT02969018|83137484|FG004|Overall Study|Pregnancy|0|||
46908539|NCT02969018|83137485|FG005|Overall Study|Pregnancy|1|||
46908540|NCT02969018|83137486|FG006|Overall Study|Pregnancy|0|||
46908541|NCT02969018|83137487|FG007|Overall Study|Pregnancy|0|||
46908542|NCT02969018|83137480|FG000|Overall Study|Protocol Violation|0|||
46908543|NCT02969018|83137481|FG001|Overall Study|Protocol Violation|0|||
46908544|NCT02969018|83137482|FG002|Overall Study|Protocol Violation|1|||
46908545|NCT02969018|83137483|FG003|Overall Study|Protocol Violation|1|||
46908546|NCT02969018|83137484|FG004|Overall Study|Protocol Violation|0|||
46908547|NCT02969018|83137485|FG005|Overall Study|Protocol Violation|0|||
46908548|NCT02969018|83137486|FG006|Overall Study|Protocol Violation|0|||
46908549|NCT02969018|83137487|FG007|Overall Study|Protocol Violation|0|||
46908550|NCT02969018|83137480|FG000|Overall Study|Withdrawal by Subject|0|||
46908551|NCT02969018|83137481|FG001|Overall Study|Withdrawal by Subject|1|||
46908552|NCT02969018|83137482|FG002|Overall Study|Withdrawal by Subject|2|||
46908553|NCT02969018|83137483|FG003|Overall Study|Withdrawal by Subject|1|||
46908554|NCT02969018|83137484|FG004|Overall Study|Withdrawal by Subject|0|||
46908555|NCT02969018|83137485|FG005|Overall Study|Withdrawal by Subject|4|||
46908556|NCT02969018|83137486|FG006|Overall Study|Withdrawal by Subject|4|||
46908557|NCT02969018|83137487|FG007|Overall Study|Withdrawal by Subject|3|||
46908558|NCT01319721|83137510|FG000|Overall Study|Lost to Follow-up|1|||
46908559|NCT01319721|83137511|FG001|Overall Study|Lost to Follow-up|6|||
46908560|NCT02905032|83137520|FG000|Overall Study|Withdrawal by Subject|2|||
46908561|NCT02905032|83137521|FG001|Overall Study|Withdrawal by Subject|0|||
46908562|NCT02905032|83137522|FG002|Overall Study|Withdrawal by Subject|0|||
46908563|NCT02905032|83137520|FG000|Overall Study|Protocol Violation|6|||
46908564|NCT02905032|83137521|FG001|Overall Study|Protocol Violation|12|||
46908565|NCT02905032|83137522|FG002|Overall Study|Protocol Violation|0|||
46908566|NCT03259425|83137529|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
46908567|NCT03101241|83137535|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
46908568|NCT03101241|83137536|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
46908569|NCT03101241|83137535|FG000|Overall Study|Participant withdrew consent|3|||
46908570|NCT03101241|83137536|FG001|Overall Study|Participant withdrew consent|1|||
46908571|NCT03101241|83137535|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
46620415|NCT03930745|82766247|FG001|Overall Study|Adverse Event|1|||
46908572|NCT03101241|83137536|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
46908573|NCT03101241|83137535|FG000|Overall Study|Lost to Follow-up|2|||
46908574|NCT03101241|83137536|FG001|Overall Study|Lost to Follow-up|0|||
46908575|NCT03101241|83137535|FG000|Overall Study|Lack of Efficacy|0|||
46908576|NCT03101241|83137536|FG001|Overall Study|Lack of Efficacy|1|||
46908577|NCT03101241|83137535|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
47000816|NCT02079909|83248302|FG002|Overall Study|Withdrawal by Subject|4|||
47000817|NCT02079909|83248300|FG000|Overall Study|Lost to Follow-up|2|||
47000818|NCT02079909|83248301|FG001|Overall Study|Lost to Follow-up|3|||
47000819|NCT02079909|83248302|FG002|Overall Study|Lost to Follow-up|1|||
47000820|NCT02079909|83248300|FG000|Overall Study|Death|2|||
47000821|NCT02079909|83248301|FG001|Overall Study|Death|2|||
47000822|NCT02079909|83248302|FG002|Overall Study|Death|0|||
47000823|NCT02079909|83248300|FG000|Overall Study|Lack of Efficacy|0|||
47000824|NCT02079909|83248301|FG001|Overall Study|Lack of Efficacy|0|||
47000825|NCT02079909|83248302|FG002|Overall Study|Lack of Efficacy|1|||
47000826|NCT02079909|83248300|FG000|Overall Study|Protocol Violation|0|||
47000827|NCT02079909|83248301|FG001|Overall Study|Protocol Violation|1|||
47000828|NCT02079909|83248302|FG002|Overall Study|Protocol Violation|1|||
47000829|NCT02079909|83248300|FG000|Overall Study|Physician Decision|0|||
47000830|NCT02079909|83248301|FG001|Overall Study|Physician Decision|1|||
47000831|NCT02079909|83248302|FG002|Overall Study|Physician Decision|1|||
47000832|NCT02079909|83248300|FG000|Overall Study|Relocation etc.|2|||
47000833|NCT02079909|83248301|FG001|Overall Study|Relocation etc.|2|||
47000834|NCT02079909|83248302|FG002|Overall Study|Relocation etc.|3|||
47000835|NCT02014467|83248312|FG000|Overall Study|Adverse Event|4|||
47000836|NCT02014467|83248313|FG001|Overall Study|Adverse Event|0|||
47000837|NCT02014467|83248312|FG000|Overall Study|Protocol Violation|3|||
47000838|NCT02014467|83248313|FG001|Overall Study|Protocol Violation|0|||
47000839|NCT02014467|83248312|FG000|Overall Study|Physician Decision|2|||
47000840|NCT02014467|83248313|FG001|Overall Study|Physician Decision|3|||
47000841|NCT02014467|83248312|FG000|Overall Study|Withdrawal by Subject|16|||
47000842|NCT02014467|83248313|FG001|Overall Study|Withdrawal by Subject|4|||
47000843|NCT02013765|83248319|FG000|Overall Study|Trial was terminated by sponsor|1|||
47000844|NCT02013687|83248327|FG000|Overall Study|Lost to Follow-up|0|||
47000845|NCT02013687|83248328|FG001|Overall Study|Lost to Follow-up|0|||
47000846|NCT02013687|83248329|FG002|Overall Study|Lost to Follow-up|1|||
47000847|NCT02013687|83248330|FG003|Overall Study|Lost to Follow-up|0|||
47000848|NCT02013687|83248327|FG000|Overall Study|Protocol Violation|0|||
47000849|NCT02013687|83248328|FG001|Overall Study|Protocol Violation|0|||
47000850|NCT02013687|83248329|FG002|Overall Study|Protocol Violation|0|||
47000851|NCT02013687|83248330|FG003|Overall Study|Protocol Violation|1|||
47000852|NCT02013687|83248327|FG000|Overall Study|Withdrawal by Subject|0|||
47000853|NCT02013687|83248328|FG001|Overall Study|Withdrawal by Subject|0|||
47000854|NCT02013687|83248329|FG002|Overall Study|Withdrawal by Subject|0|||
47000855|NCT02013687|83248330|FG003|Overall Study|Withdrawal by Subject|1|||
47000856|NCT02013687|83248327|FG000|Overall Study|Missed visits due to patient travel|0|||
47000857|NCT02013687|83248328|FG001|Overall Study|Missed visits due to patient travel|0|||
47000858|NCT02013687|83248329|FG002|Overall Study|Missed visits due to patient travel|1|||
47000859|NCT02013687|83248330|FG003|Overall Study|Missed visits due to patient travel|0|||
47000860|NCT02013609|83248344|FG000|Overall Study|Withdrawal by Subject|9|||
47000861|NCT02013609|83248344|FG000|Overall Study|Lost to Follow-up|3|||
47000862|NCT02013609|83248344|FG000|Overall Study|Adverse Event|3|||
47000863|NCT02013609|83248344|FG000|Overall Study|Met Withdrawal Criteria|3|||
47000864|NCT01988337|83248348|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
47000865|NCT02013531|83248354|FG000|Overall Study|Lost to Follow-up|3|||
47000866|NCT02013531|83248354|FG000|Overall Study|Met Withdrawal Criteria|1|||
47000867|NCT02013531|83248354|FG000|Overall Study|Withdrawal by Subject|1|||
47000868|NCT01988103|83248361|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
47000869|NCT01988103|83248362|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
47000870|NCT01988103|83248363|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
47000871|NCT01988103|83248364|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
47000872|NCT01988103|83248365|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
46620416|NCT03930745|82766246|FG000|Overall Study|Pregnancy|0|||
46620417|NCT03930745|82766247|FG001|Overall Study|Pregnancy|1|||
46620418|NCT04473326|82768992|FG000|Overall Study|Death|0|||
47000873|NCT01988103|83248361|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
47000874|NCT01988103|83248362|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
47000875|NCT01988103|83248363|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
47000876|NCT01988103|83248364|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
47000877|NCT01988103|83248365|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
47000878|NCT01988103|83248361|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
47000879|NCT01988103|83248362|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
47000880|NCT01988103|83248363|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
47000881|NCT01988103|83248364|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
47000882|NCT01988103|83248365|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
47000883|NCT01988103|83248361|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
47000884|NCT01988103|83248362|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
47000885|NCT01988103|83248363|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
47000886|NCT01988103|83248364|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
47000887|NCT01988103|83248365|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
47000888|NCT01988103|83248361|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
47000889|NCT01988103|83248362|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
47000890|NCT01988103|83248363|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
47000891|NCT01988103|83248364|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
47000892|NCT01988103|83248365|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
47000893|NCT01988103|83248361|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
47000894|NCT01988103|83248362|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
47000895|NCT01988103|83248363|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
47000896|NCT01988103|83248364|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
47000897|NCT01988103|83248365|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
47000898|NCT01988103|83248361|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
47000899|NCT01988103|83248362|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
47000900|NCT01988103|83248363|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
47000901|NCT01988103|83248364|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
47000902|NCT01988103|83248365|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
47000903|NCT02013375|83248380|FG000|Overall Study|Did not engraft|1|||
47000904|NCT02013375|83248380|FG000|Overall Study|Did not engraft|1|||
47000905|NCT02079519|83248385|FG000|Overall Study|Disease Progression|9|||
47000906|NCT02079519|83248385|FG000|Overall Study|Adverse Event|1|||
47000907|NCT01987557|83248392|FG000|Overall Study|Protocol Violation|1|||
47000908|NCT01987557|83248393|FG001|Overall Study|Protocol Violation|0|||
47000909|NCT01987557|83248394|FG002|Overall Study|Protocol Violation|1|||
47000910|NCT01987557|83248392|FG000|Overall Study|Withdrawal by Subject|2|||
47000911|NCT01987557|83248393|FG001|Overall Study|Withdrawal by Subject|1|||
47000912|NCT01987557|83248394|FG002|Overall Study|Withdrawal by Subject|2|||
47000913|NCT01987557|83248392|FG000|Overall Study|Adverse Event|0|||
47000914|NCT01987557|83248393|FG001|Overall Study|Adverse Event|2|||
47000915|NCT01987557|83248394|FG002|Overall Study|Adverse Event|0|||
47000916|NCT02078817|83248402|FG000|Overall Study|Withdrawal by Subject|1|||
47000917|NCT02011893|83248406|FG000|Enrollment to Randomization|Adverse Event|2|||
47000918|NCT02011893|83248407|FG001|Enrollment to Randomization|Adverse Event|0|||
47000919|NCT02011893|83248408|FG002|Enrollment to Randomization|Adverse Event|0|||
47000920|NCT02011893|83248406|FG000|Enrollment to Randomization|Physician Decision|10|||
47000921|NCT02011893|83248407|FG001|Enrollment to Randomization|Physician Decision|0|||
47000922|NCT02011893|83248408|FG002|Enrollment to Randomization|Physician Decision|0|||
47000923|NCT02011893|83248406|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
47000924|NCT02011893|83248407|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
47000925|NCT02011893|83248408|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
47000926|NCT02011893|83248406|FG000|Enrollment to Randomization|Screening Failure|29|||
47000927|NCT02011893|83248407|FG001|Enrollment to Randomization|Screening Failure|0|||
47000928|NCT02011893|83248408|FG002|Enrollment to Randomization|Screening Failure|0|||
47000929|NCT02011893|83248406|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
47000930|NCT02011893|83248407|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
47000931|NCT02011893|83248408|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
47000932|NCT02011893|83248406|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
47000933|NCT02011893|83248407|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
47000934|NCT02011893|83248408|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
47000935|NCT02011893|83248406|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
47000936|NCT02011893|83248407|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
47000937|NCT02011893|83248408|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
47000938|NCT02011893|83248406|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
47000939|NCT02011893|83248407|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
47000940|NCT02011893|83248408|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
47000941|NCT02011893|83248406|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
47000942|NCT02011893|83248407|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
47000943|NCT02011893|83248408|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
47000944|NCT02011113|83248413|FG000|Overall Study|Adverse Event|4|||
47000945|NCT02011113|83248413|FG000|Overall Study|Disease Progression (DP)|16|||
46620419|NCT04473326|82768993|FG001|Overall Study|Death|1|||
46620420|NCT04473326|82768992|FG000|Overall Study|Withdrawal by Subject|1|||
46620421|NCT04473326|82768993|FG001|Overall Study|Withdrawal by Subject|2|||
47000946|NCT02011113|83248413|FG000|Overall Study|Death|1|||
47000947|NCT02011113|83248413|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
47000948|NCT02011113|83248413|FG000|Overall Study|Investigator's judgement- DP|3|||
47000949|NCT02011113|83248413|FG000|Overall Study|Study terminated by sponsor|11|||
47000950|NCT01807156|83248418|FG000|Overall Study|Physician Decision|1|||
47000951|NCT01987479|83248422|FG000|Overall Study|Protocol Violation|1|||
47000952|NCT01987479|83248422|FG000|Overall Study|Physician Decision|2|||
47000953|NCT01987479|83248422|FG000|Overall Study|Participant/legal guardian decision|1|||
47000954|NCT01987479|83248422|FG000|Overall Study|Other|5|||
47000955|NCT01987479|83248422|FG000|Overall Study|Lost to Follow-up|1|||
47000956|NCT01987479|83248422|FG000|Overall Study|Adverse Event|7|||
47000957|NCT01620489|83248428|FG000|Overall Study|Adverse Event|17|||
47000958|NCT01620489|83248429|FG001|Overall Study|Adverse Event|4|||
47000959|NCT01620489|83248428|FG000|Overall Study|Protocol Violation|0|||
47000960|NCT01620489|83248429|FG001|Overall Study|Protocol Violation|3|||
47000961|NCT01620489|83248428|FG000|Overall Study|Withdrawal Criteria|17|||
47000962|NCT01620489|83248429|FG001|Overall Study|Withdrawal Criteria|25|||
47000963|NCT01620489|83248428|FG000|Overall Study|Unclassified|1|||
47000964|NCT01620489|83248429|FG001|Overall Study|Unclassified|2|||
47000965|NCT02076165|83248437|FG000|Overall Study|Lost to Follow-up|7|||
47000966|NCT02076165|83248438|FG001|Overall Study|Lost to Follow-up|5|||
47000967|NCT02076165|83248437|FG000|Overall Study|Refused follow-up assessment|1|||
47000968|NCT02076165|83248438|FG001|Overall Study|Refused follow-up assessment|1|||
47000969|NCT01620255|83248449|FG000|Overall Study|Withdrawal by Subject|4|||
47000970|NCT01620255|83248450|FG001|Overall Study|Withdrawal by Subject|1|||
47000971|NCT01620255|83248451|FG002|Overall Study|Withdrawal by Subject|1|||
47000972|NCT01620255|83248452|FG003|Overall Study|Withdrawal by Subject|2|||
47000973|NCT01620255|83248453|FG004|Overall Study|Withdrawal by Subject|4|||
47000974|NCT01620255|83248449|FG000|Overall Study|Participant underwent fecal transplant|0|||
47000975|NCT01620255|83248450|FG001|Overall Study|Participant underwent fecal transplant|0|||
47000976|NCT01620255|83248451|FG002|Overall Study|Participant underwent fecal transplant|1|||
47000977|NCT01620255|83248452|FG003|Overall Study|Participant underwent fecal transplant|0|||
47000978|NCT01620255|83248453|FG004|Overall Study|Participant underwent fecal transplant|0|||
47000979|NCT01620255|83248449|FG000|Overall Study|Non-compliance|0|||
47000980|NCT01620255|83248450|FG001|Overall Study|Non-compliance|1|||
47000981|NCT01620255|83248451|FG002|Overall Study|Non-compliance|0|||
47000982|NCT01620255|83248452|FG003|Overall Study|Non-compliance|0|||
47000983|NCT01620255|83248453|FG004|Overall Study|Non-compliance|0|||
47000984|NCT01620255|83248449|FG000|Overall Study|Adverse Event|0|||
47000985|NCT01620255|83248450|FG001|Overall Study|Adverse Event|4|||
47000986|NCT01620255|83248451|FG002|Overall Study|Adverse Event|0|||
47000987|NCT01620255|83248452|FG003|Overall Study|Adverse Event|1|||
47000988|NCT01620255|83248453|FG004|Overall Study|Adverse Event|1|||
47000989|NCT01620255|83248449|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
47000990|NCT01620255|83248450|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
47000991|NCT01620255|83248451|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
47000992|NCT01620255|83248452|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
47000993|NCT01620255|83248453|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
47000994|NCT02010567|83248470|FG000|Overall Study|Adverse Event|0|||
46709300|NCT01172639|82925240|FG003|Overall Study|Withdrawal by Subject|5|||
46709301|NCT01172639|82925241|FG004|Overall Study|Withdrawal by Subject|0|||
47000995|NCT02010567|83248471|FG001|Overall Study|Adverse Event|0|||
47000996|NCT02010567|83248472|FG002|Overall Study|Adverse Event|1|||
47000997|NCT02010567|83248473|FG003|Overall Study|Adverse Event|0|||
47000998|NCT02010567|83248474|FG004|Overall Study|Adverse Event|1|||
47000999|NCT01806064|83248489|FG000|Overall Study|Randomized Not Enrolled|0|||
47001000|NCT01806064|83248490|FG001|Overall Study|Randomized Not Enrolled|0|||
47001001|NCT01806064|83248491|FG002|Overall Study|Randomized Not Enrolled|0|||
47001002|NCT01806064|83248492|FG003|Overall Study|Randomized Not Enrolled|1|||
47001003|NCT01806064|83248493|FG004|Overall Study|Randomized Not Enrolled|2|||
47001004|NCT01804582|83248511|FG000|Overall Study|Lost to Follow-up|47|||
47001005|NCT01804582|83248512|FG001|Overall Study|Lost to Follow-up|56|||
47001006|NCT01804582|83248511|FG000|Overall Study|Physician Decision|2|||
46709302|NCT01144182|82925255|FG000|Overall Study|Death|5|||
46709303|NCT01144182|82925256|FG001|Overall Study|Death|6|||
47001007|NCT01804582|83248512|FG001|Overall Study|Physician Decision|0|||
47001008|NCT01787188|83248522|FG000|Overall Study|Adverse Event|2|||
47001009|NCT01787188|83248523|FG001|Overall Study|Adverse Event|4|||
47001010|NCT01787188|83248524|FG002|Overall Study|Adverse Event|6|||
47001011|NCT01787188|83248522|FG000|Overall Study|Lack of Efficacy|7|||
47001012|NCT01787188|83248523|FG001|Overall Study|Lack of Efficacy|3|||
47001013|NCT01787188|83248524|FG002|Overall Study|Lack of Efficacy|5|||
47001014|NCT01787188|83248522|FG000|Overall Study|Non-compliance with Study Drug|0|||
47001015|NCT01787188|83248523|FG001|Overall Study|Non-compliance with Study Drug|1|||
47001016|NCT01787188|83248524|FG002|Overall Study|Non-compliance with Study Drug|0|||
47001017|NCT01787188|83248522|FG000|Overall Study|Withdrawal by Subject|4|||
47001018|NCT01787188|83248523|FG001|Overall Study|Withdrawal by Subject|3|||
47001019|NCT01787188|83248524|FG002|Overall Study|Withdrawal by Subject|2|||
47001020|NCT01787188|83248522|FG000|Overall Study|Protocol Violation|3|||
47001021|NCT01787188|83248523|FG001|Overall Study|Protocol Violation|2|||
47001022|NCT01787188|83248524|FG002|Overall Study|Protocol Violation|3|||
47001023|NCT01787188|83248522|FG000|Overall Study|Lost to Follow-up|1|||
47001024|NCT01787188|83248523|FG001|Overall Study|Lost to Follow-up|2|||
47001025|NCT01787188|83248524|FG002|Overall Study|Lost to Follow-up|2|||
47001026|NCT01787188|83248522|FG000|Overall Study|Other, including patient moved|0|||
47001027|NCT01787188|83248523|FG001|Overall Study|Other, including patient moved|3|||
47001028|NCT01787188|83248524|FG002|Overall Study|Other, including patient moved|0|||
47001029|NCT01787032|83248538|FG000|Overall Study|Protocol Violation|0|||
47001030|NCT01787032|83248539|FG001|Overall Study|Protocol Violation|0|||
47001031|NCT01787032|83248540|FG002|Overall Study|Protocol Violation|0|||
47001032|NCT01787032|83248541|FG003|Overall Study|Protocol Violation|0|||
47001033|NCT01787032|83248542|FG004|Overall Study|Protocol Violation|1|||
47001034|NCT01787032|83248543|FG005|Overall Study|Protocol Violation|1|||
47001035|NCT01737268|83248553|FG000|Overall Study|Adverse Event|6|||
47001036|NCT01737268|83248553|FG000|Overall Study|Worsening of Target Disease|2|||
47001037|NCT01737268|83248553|FG000|Overall Study|In consideration of the patient's safety|1|||
47001038|NCT01769404|83248558|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
47001039|NCT01769404|83248559|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
47001040|NCT01769404|83248558|FG000|Treatment Period 1|Withdrawal by Subject|3|||
47001041|NCT01769404|83248559|FG001|Treatment Period 1|Withdrawal by Subject|0|||
47001042|NCT01769404|83248558|FG000|Treatment Period 1|Sponsor decision|1|||
47001043|NCT01769404|83248559|FG001|Treatment Period 1|Sponsor decision|0|||
47001044|NCT01769404|83248558|FG000|Treatment Period 2|Sponsor decision|7|||
47001045|NCT01769404|83248559|FG001|Treatment Period 2|Sponsor decision|0|||
47001046|NCT01769326|83248571|FG000|Overall Study|Lost to Follow-up|1|||
47001047|NCT01769326|83248572|FG001|Overall Study|Lost to Follow-up|2|||
47001048|NCT01769326|83248573|FG002|Overall Study|Lost to Follow-up|0|||
47001049|NCT01769326|83248574|FG003|Overall Study|Lost to Follow-up|0|||
47001050|NCT01769326|83248571|FG000|Overall Study|unrelated injry|1|||
47001051|NCT01769326|83248572|FG001|Overall Study|unrelated injry|1|||
47001052|NCT01769326|83248573|FG002|Overall Study|unrelated injry|0|||
47001053|NCT01769326|83248574|FG003|Overall Study|unrelated injry|0|||
46620422|NCT05993299|82769344|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
46620423|NCT05993299|82769344|FG000|Overall Study|Ongoing|4|||
46709304|NCT01144182|82925255|FG000|Overall Study|Withdrawal by Subject|3|||
46908578|NCT03101241|83137536|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
46908579|NCT03061188|83137546|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
46908580|NCT03061188|83137547|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
46908581|NCT03061188|83137548|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
46908582|NCT03061188|83137549|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
46908583|NCT03061188|83137546|FG000|On Follow-up for 3 Years|Death|0|||
46908584|NCT03061188|83137547|FG001|On Follow-up for 3 Years|Death|3|||
46908585|NCT03061188|83137548|FG002|On Follow-up for 3 Years|Death|5|||
46908586|NCT03061188|83137549|FG003|On Follow-up for 3 Years|Death|2|||
46908587|NCT03061188|83137546|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
46908588|NCT03061188|83137547|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
47001054|NCT01769326|83248571|FG000|Overall Study|got a job|0|||
46709305|NCT01144182|82925256|FG001|Overall Study|Withdrawal by Subject|6|||
46709306|NCT01144182|82925255|FG000|Overall Study|Lost to Follow-up|9|||
46709307|NCT01144182|82925256|FG001|Overall Study|Lost to Follow-up|9|||
46709308|NCT01225562|82925266|FG000|Overall Study|Withdrawal by Subject|52|||
46709309|NCT01225562|82925267|FG001|Overall Study|Withdrawal by Subject|50|||
46709310|NCT01225562|82925268|FG002|Overall Study|Withdrawal by Subject|52|||
46709311|NCT01225562|82925266|FG000|Overall Study|Lost to Follow-up|3|||
46709312|NCT01225562|82925267|FG001|Overall Study|Lost to Follow-up|6|||
46709313|NCT01225562|82925268|FG002|Overall Study|Lost to Follow-up|1|||
46709314|NCT00925288|82925278|FG000|Overall Study|Lost to Follow-up|9|||
46709315|NCT00925288|82925279|FG001|Overall Study|Lost to Follow-up|7|||
46709316|NCT01143714|82925289|FG000|Overall Study|Adverse Event|4|||
46709317|NCT01143714|82925290|FG001|Overall Study|Adverse Event|2|||
46709318|NCT01143714|82925289|FG000|Overall Study|Withdrawal by Subject|1|||
46709319|NCT01143714|82925290|FG001|Overall Study|Withdrawal by Subject|0|||
46908589|NCT03061188|83137548|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
46908590|NCT03061188|83137549|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
47001055|NCT01769326|83248572|FG001|Overall Study|got a job|1|||
47001056|NCT01769326|83248573|FG002|Overall Study|got a job|0|||
47001057|NCT01769326|83248574|FG003|Overall Study|got a job|0|||
47001058|NCT01769326|83248571|FG000|Overall Study|Got sick and could not complete study|0|||
47001059|NCT01769326|83248572|FG001|Overall Study|Got sick and could not complete study|0|||
47001060|NCT01769326|83248573|FG002|Overall Study|Got sick and could not complete study|1|||
46620424|NCT05239598|82769401|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
46620425|NCT05239598|82769402|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
46620426|NCT05239598|82769401|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
46620427|NCT05239598|82769402|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
46620428|NCT05010070|82769445|FG000|Overall Study|Lost to Follow-up|1|||
47001061|NCT01769326|83248574|FG003|Overall Study|Got sick and could not complete study|0|||
47001062|NCT01786564|83248584|FG000|Overall Study|Lost to Follow-up|47|||
47001063|NCT01786564|83248584|FG000|Overall Study|Ineligible|17|||
47001064|NCT01786330|83248590|FG000|Overall Study|Withdrawal by Subject|0|||
47001065|NCT01786330|83248591|FG001|Overall Study|Withdrawal by Subject|1|||
47001066|NCT01786330|83248590|FG000|Overall Study|Lost to Follow-up|0|||
47001067|NCT01786330|83248591|FG001|Overall Study|Lost to Follow-up|1|||
47001068|NCT01786330|83248590|FG000|Overall Study|Excluded intraoperatively|0|||
47001069|NCT01786330|83248591|FG001|Overall Study|Excluded intraoperatively|1|||
47001070|NCT01786330|83248590|FG000|Overall Study|Protocol Violation|1|||
47001071|NCT01786330|83248591|FG001|Overall Study|Protocol Violation|0|||
47001072|NCT01786174|83248599|FG000|Overall Study|Discontinued Study Drug|2|||
47001073|NCT01786174|83248600|FG001|Overall Study|Discontinued Study Drug|0|||
47001074|NCT01736566|83248611|FG000|Long Term Follow-up|Still collecting data|42|||
47001075|NCT01736566|83248612|FG001|Long Term Follow-up|Still collecting data|0|||
47001076|NCT01736566|83248613|FG002|Long Term Follow-up|Still collecting data|49|||
47001077|NCT01736566|83248614|FG003|Long Term Follow-up|Still collecting data|0|||
47001078|NCT01736566|83248615|FG004|Long Term Follow-up|Still collecting data|1|||
47001079|NCT01768858|83248640|FG000|Overall Study|Lost to Follow-up|9|||
47001080|NCT01768858|83248640|FG000|Overall Study|Lack of Efficacy|8|||
47001081|NCT01768858|83248640|FG000|Overall Study|Serious Adverse Event|1|||
47001082|NCT01768858|83248640|FG000|Overall Study|Participant moved to Germany|1|||
47001083|NCT01768858|83248640|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
47001084|NCT01768858|83248640|FG000|Overall Study|Exanthema|1|||
47001085|NCT01768858|83248640|FG000|Overall Study|Withdrawal by Subject|1|||
47001086|NCT01736254|83248644|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
47001087|NCT01736254|83248644|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
47001088|NCT01767376|83248655|FG000|Overall Study|Lost to Follow-up|3|||
47001089|NCT01767376|83248656|FG001|Overall Study|Lost to Follow-up|2|||
47001090|NCT01767376|83248657|FG002|Overall Study|Lost to Follow-up|0|||
47001091|NCT01767376|83248655|FG000|Overall Study|Withdrawal by Subject|1|||
47001092|NCT01767376|83248656|FG001|Overall Study|Withdrawal by Subject|1|||
47001093|NCT01767376|83248657|FG002|Overall Study|Withdrawal by Subject|0|||
47001094|NCT01767142|83248667|FG000|Overall Study|Lost to Follow-up|3|||
47001095|NCT01785628|83248673|FG000|Overall Study|Lost to Follow-up|2|||
47001096|NCT01785628|83248674|FG001|Overall Study|Lost to Follow-up|3|||
47001097|NCT01785472|83248683|FG000|Overall Study|Adverse Event|5|||
47001098|NCT01785472|83248684|FG001|Overall Study|Adverse Event|4|||
47001099|NCT01785472|83248685|FG002|Overall Study|Adverse Event|6|||
47001100|NCT01785472|83248683|FG000|Overall Study|Lack of Efficacy|2|||
47001101|NCT01785472|83248684|FG001|Overall Study|Lack of Efficacy|0|||
47001102|NCT01785472|83248685|FG002|Overall Study|Lack of Efficacy|1|||
47001103|NCT01785472|83248683|FG000|Overall Study|Lost to Follow-up|1|||
47001104|NCT01785472|83248684|FG001|Overall Study|Lost to Follow-up|2|||
47001105|NCT01785472|83248685|FG002|Overall Study|Lost to Follow-up|0|||
47001106|NCT01785472|83248683|FG000|Overall Study|Physician Decision|1|||
46908591|NCT03449147|83137567|FG000|52-week Treatment Period|Death|0|||
46908592|NCT03449147|83137568|FG001|52-week Treatment Period|Death|1|||
46908593|NCT03449147|83137569|FG002|52-week Treatment Period|Death|0|||
46908594|NCT03449147|83137567|FG000|52-week Treatment Period|Lost to Follow-up|6|||
46908595|NCT03449147|83137568|FG001|52-week Treatment Period|Lost to Follow-up|2|||
46908596|NCT03449147|83137569|FG002|52-week Treatment Period|Lost to Follow-up|5|||
46908597|NCT03449147|83137567|FG000|52-week Treatment Period|Other|0|||
46908598|NCT03449147|83137568|FG001|52-week Treatment Period|Other|1|||
46908599|NCT03449147|83137569|FG002|52-week Treatment Period|Other|2|||
46908600|NCT03449147|83137567|FG000|52-week Treatment Period|Physician Decision|1|||
47001107|NCT01785472|83248684|FG001|Overall Study|Physician Decision|1|||
47001108|NCT01785472|83248685|FG002|Overall Study|Physician Decision|1|||
47001109|NCT01785472|83248683|FG000|Overall Study|Protocol deviation|0|||
47001110|NCT01785472|83248684|FG001|Overall Study|Protocol deviation|2|||
47001111|NCT01785472|83248685|FG002|Overall Study|Protocol deviation|2|||
47001112|NCT01785472|83248683|FG000|Overall Study|Subject/guardian decision|15|||
46908601|NCT03449147|83137568|FG001|52-week Treatment Period|Physician Decision|0|||
47001113|NCT01785472|83248684|FG001|Overall Study|Subject/guardian decision|10|||
47001114|NCT01785472|83248685|FG002|Overall Study|Subject/guardian decision|11|||
47001115|NCT01785472|83248683|FG000|Overall Study|Technical problems|0|||
47001116|NCT01785472|83248684|FG001|Overall Study|Technical problems|0|||
47001117|NCT01785472|83248685|FG002|Overall Study|Technical problems|1|||
47001118|NCT01785160|83248695|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
47001119|NCT01785160|83248695|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
47001120|NCT01736176|83248701|FG000|Overall Study|Adverse Event|3|||
47001121|NCT01736176|83248701|FG000|Overall Study|Withdrawal by Subject|4|||
47001122|NCT01736176|83248701|FG000|Overall Study|Lack of Efficacy|3|||
47001123|NCT01736176|83248701|FG000|Overall Study|Unable to Complete PEG Placement|1|||
47001124|NCT01735630|83248711|FG000|Overall Study|Adverse Event|8|||
47001125|NCT01735630|83248712|FG001|Overall Study|Adverse Event|7|||
47001126|NCT01735630|83248711|FG000|Overall Study|Lost to Follow-up|1|||
47001127|NCT01735630|83248712|FG001|Overall Study|Lost to Follow-up|0|||
47001128|NCT01735630|83248711|FG000|Overall Study|Physician Decision|0|||
47001129|NCT01735630|83248712|FG001|Overall Study|Physician Decision|1|||
47001130|NCT01735630|83248711|FG000|Overall Study|Sponsor Decision|2|||
47001131|NCT01735630|83248712|FG001|Overall Study|Sponsor Decision|1|||
47001132|NCT01735630|83248711|FG000|Overall Study|Withdrawal by Subject|7|||
47001133|NCT01735630|83248712|FG001|Overall Study|Withdrawal by Subject|9|||
47001134|NCT01735396|83248718|FG000|Overall Study|not evaluable|1|||
47001135|NCT01766206|83248722|FG000|Overall Study|Withdrawal by Subject|22|||
47001136|NCT01766206|83248722|FG000|Overall Study|Lost to Follow-up|10|||
47001137|NCT01766206|83248722|FG000|Overall Study|Inappropriate enrollment|18|||
47001138|NCT01766206|83248722|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
47001139|NCT01734850|83248729|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
47001140|NCT01734850|83248730|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
47001141|NCT01734850|83248731|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
47001142|NCT01734850|83248729|FG000|Overall Study|Not infused due to manufacturing failure|0|||
47001143|NCT01734850|83248730|FG001|Overall Study|Not infused due to manufacturing failure|0|||
47001144|NCT01734850|83248731|FG002|Overall Study|Not infused due to manufacturing failure|1|||
47001145|NCT01766050|83248742|FG000|Overall Study|Adverse Event|1|||
47001146|NCT01766050|83248742|FG000|Overall Study|Lost to Follow-up|1|||
47001147|NCT01766050|83248742|FG000|Overall Study|Withdrawal by Subject|2|||
47001148|NCT02341625|83248770|FG000|Overall Study|Disease Progression|2|||
47001149|NCT02341625|83248771|FG001|Overall Study|Disease Progression|2|||
47001150|NCT02341625|83248772|FG002|Overall Study|Disease Progression|3|||
47001151|NCT02341625|83248773|FG003|Overall Study|Disease Progression|6|||
47001152|NCT02341625|83248774|FG004|Overall Study|Disease Progression|7|||
47001153|NCT02341625|83248775|FG005|Overall Study|Disease Progression|7|||
47001154|NCT02341625|83248776|FG006|Overall Study|Disease Progression|28|||
47001155|NCT02341625|83248777|FG007|Overall Study|Disease Progression|5|||
47001156|NCT02341625|83248778|FG008|Overall Study|Disease Progression|4|||
47001157|NCT02341625|83248779|FG009|Overall Study|Disease Progression|19|||
47001158|NCT02341625|83248770|FG000|Overall Study|Study Drug Toxicity|0|||
47001159|NCT02341625|83248771|FG001|Overall Study|Study Drug Toxicity|0|||
47001160|NCT02341625|83248772|FG002|Overall Study|Study Drug Toxicity|0|||
47001161|NCT02341625|83248773|FG003|Overall Study|Study Drug Toxicity|1|||
47001162|NCT02341625|83248774|FG004|Overall Study|Study Drug Toxicity|0|||
47001163|NCT02341625|83248775|FG005|Overall Study|Study Drug Toxicity|3|||
47001164|NCT02341625|83248776|FG006|Overall Study|Study Drug Toxicity|10|||
47001165|NCT02341625|83248777|FG007|Overall Study|Study Drug Toxicity|0|||
47001166|NCT02341625|83248778|FG008|Overall Study|Study Drug Toxicity|0|||
47001167|NCT02341625|83248779|FG009|Overall Study|Study Drug Toxicity|3|||
47001168|NCT02341625|83248770|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
47001169|NCT02341625|83248771|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
47001170|NCT02341625|83248772|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
47001171|NCT02341625|83248773|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
46620429|NCT05010070|82769445|FG000|Overall Study|Withdrawal by Subject|1|||
46709320|NCT01143714|82925289|FG000|Overall Study|Subject non-compliance|0|||
47001172|NCT02341625|83248774|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
47001173|NCT02341625|83248775|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
47001174|NCT02341625|83248776|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
47001175|NCT02341625|83248777|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
47001176|NCT02341625|83248778|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
47001177|NCT02341625|83248779|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
47001178|NCT02341625|83248770|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001179|NCT02341625|83248771|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001180|NCT02341625|83248772|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001181|NCT02341625|83248773|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001182|NCT02341625|83248774|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001183|NCT02341625|83248775|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001184|NCT02341625|83248776|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
47001185|NCT02341625|83248777|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
47001186|NCT02341625|83248778|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001187|NCT02341625|83248779|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
47001188|NCT02341625|83248770|FG000|Overall Study|Participant Withdrew Consent|0|||
47001189|NCT02341625|83248771|FG001|Overall Study|Participant Withdrew Consent|0|||
47001190|NCT02341625|83248772|FG002|Overall Study|Participant Withdrew Consent|0|||
47001191|NCT02341625|83248773|FG003|Overall Study|Participant Withdrew Consent|1|||
47001192|NCT02341625|83248774|FG004|Overall Study|Participant Withdrew Consent|0|||
47001193|NCT02341625|83248775|FG005|Overall Study|Participant Withdrew Consent|0|||
47001194|NCT02341625|83248776|FG006|Overall Study|Participant Withdrew Consent|0|||
47001195|NCT02341625|83248777|FG007|Overall Study|Participant Withdrew Consent|0|||
47001196|NCT02341625|83248778|FG008|Overall Study|Participant Withdrew Consent|0|||
47001197|NCT02341625|83248779|FG009|Overall Study|Participant Withdrew Consent|0|||
47001198|NCT02341625|83248770|FG000|Overall Study|Completed Treatment as per Protocol|0|||
47001199|NCT02341625|83248771|FG001|Overall Study|Completed Treatment as per Protocol|0|||
47001200|NCT02341625|83248772|FG002|Overall Study|Completed Treatment as per Protocol|0|||
47001201|NCT02341625|83248773|FG003|Overall Study|Completed Treatment as per Protocol|0|||
47001202|NCT02341625|83248774|FG004|Overall Study|Completed Treatment as per Protocol|0|||
47001203|NCT02341625|83248775|FG005|Overall Study|Completed Treatment as per Protocol|0|||
47001204|NCT02341625|83248776|FG006|Overall Study|Completed Treatment as per Protocol|0|||
47001205|NCT02341625|83248777|FG007|Overall Study|Completed Treatment as per Protocol|0|||
47001206|NCT02341625|83248778|FG008|Overall Study|Completed Treatment as per Protocol|0|||
47001207|NCT02341625|83248779|FG009|Overall Study|Completed Treatment as per Protocol|1|||
47001208|NCT02341625|83248770|FG000|Overall Study|Other Reasons|0|||
47001209|NCT02341625|83248771|FG001|Overall Study|Other Reasons|0|||
47001210|NCT02341625|83248772|FG002|Overall Study|Other Reasons|0|||
47001211|NCT02341625|83248773|FG003|Overall Study|Other Reasons|0|||
47001212|NCT02341625|83248774|FG004|Overall Study|Other Reasons|1|||
47001213|NCT02341625|83248775|FG005|Overall Study|Other Reasons|0|||
47001214|NCT02341625|83248776|FG006|Overall Study|Other Reasons|5|||
47001215|NCT02341625|83248777|FG007|Overall Study|Other Reasons|0|||
47001216|NCT02341625|83248778|FG008|Overall Study|Other Reasons|0|||
47001217|NCT02341625|83248779|FG009|Overall Study|Other Reasons|2|||
47001218|NCT02341625|83248770|FG000|Overall Study|Not Reported|0|||
47001219|NCT02341625|83248771|FG001|Overall Study|Not Reported|0|||
47001220|NCT02341625|83248772|FG002|Overall Study|Not Reported|0|||
47001221|NCT02341625|83248773|FG003|Overall Study|Not Reported|0|||
47001222|NCT02341625|83248774|FG004|Overall Study|Not Reported|0|||
47001223|NCT02341625|83248775|FG005|Overall Study|Not Reported|0|||
47001224|NCT02341625|83248776|FG006|Overall Study|Not Reported|0|||
47001225|NCT02341625|83248777|FG007|Overall Study|Not Reported|0|||
47001226|NCT02341625|83248778|FG008|Overall Study|Not Reported|0|||
47001227|NCT02341625|83248779|FG009|Overall Study|Not Reported|3|||
47001228|NCT02370095|83248826|FG000|Overall Study|Withdrawal by Subject|0|||
47001229|NCT02370095|83248827|FG001|Overall Study|Withdrawal by Subject|1|||
47001230|NCT01783678|83248839|FG000|Overall Study|Randomized but Not Treated|0|||
47001231|NCT01783678|83248840|FG001|Overall Study|Randomized but Not Treated|0|||
47001232|NCT01783678|83248841|FG002|Overall Study|Randomized but Not Treated|0|||
47001233|NCT01783678|83248842|FG003|Overall Study|Randomized but Not Treated|1|||
47001234|NCT01783678|83248843|FG004|Overall Study|Randomized but Not Treated|0|||
47001235|NCT01783678|83248844|FG005|Overall Study|Randomized but Not Treated|0|||
47001236|NCT01783678|83248839|FG000|Overall Study|Lack of Efficacy|1|||
47001237|NCT01783678|83248840|FG001|Overall Study|Lack of Efficacy|13|||
47001238|NCT01783678|83248841|FG002|Overall Study|Lack of Efficacy|1|||
47001239|NCT01783678|83248842|FG003|Overall Study|Lack of Efficacy|3|||
47001240|NCT01783678|83248843|FG004|Overall Study|Lack of Efficacy|6|||
47001241|NCT01783678|83248844|FG005|Overall Study|Lack of Efficacy|5|||
47001242|NCT01783678|83248839|FG000|Overall Study|Lost to Follow-up|0|||
47001243|NCT01783678|83248840|FG001|Overall Study|Lost to Follow-up|4|||
47001244|NCT01783678|83248841|FG002|Overall Study|Lost to Follow-up|0|||
47001245|NCT01783678|83248842|FG003|Overall Study|Lost to Follow-up|2|||
47001246|NCT01783678|83248843|FG004|Overall Study|Lost to Follow-up|1|||
47001247|NCT01783678|83248844|FG005|Overall Study|Lost to Follow-up|0|||
47001248|NCT01783678|83248839|FG000|Overall Study|Withdrew Consent|1|||
47001249|NCT01783678|83248840|FG001|Overall Study|Withdrew Consent|1|||
47001250|NCT01783678|83248841|FG002|Overall Study|Withdrew Consent|0|||
47001251|NCT01783678|83248842|FG003|Overall Study|Withdrew Consent|2|||
47001252|NCT01783678|83248843|FG004|Overall Study|Withdrew Consent|0|||
47001253|NCT01783678|83248844|FG005|Overall Study|Withdrew Consent|0|||
47001254|NCT01734772|83248861|FG000|Overall Study|Adverse Event|1|||
47001255|NCT01734772|83248862|FG001|Overall Study|Adverse Event|2|||
47001256|NCT01734772|83248861|FG000|Overall Study|Withdrawal by Subject|0|||
47001257|NCT01734772|83248862|FG001|Overall Study|Withdrawal by Subject|1|||
47001258|NCT02340221|83248876|FG000|Overall Study|Death|100|||
47001259|NCT02340221|83248877|FG001|Overall Study|Death|197|||
47001260|NCT02340221|83248876|FG000|Overall Study|Withdrawal by Participant|24|||
47001261|NCT02340221|83248877|FG001|Overall Study|Withdrawal by Participant|37|||
47001262|NCT02340221|83248876|FG000|Overall Study|Lost to Follow-up|4|||
46908602|NCT03449147|83137569|FG002|52-week Treatment Period|Physician Decision|3|||
46908603|NCT03449147|83137567|FG000|52-week Treatment Period|Screen Failure|1|||
46908604|NCT03449147|83137568|FG001|52-week Treatment Period|Screen Failure|2|||
46908605|NCT03449147|83137569|FG002|52-week Treatment Period|Screen Failure|0|||
46908606|NCT03449147|83137567|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
46908607|NCT03449147|83137568|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
46908608|NCT03449147|83137569|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
46908609|NCT03449147|83137567|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
46908610|NCT03449147|83137568|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
46908611|NCT03449147|83137569|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
46908612|NCT03449147|83137567|FG000|12-Week Off-Treatment Durability Period|Other|0|||
46908613|NCT03449147|83137568|FG001|12-Week Off-Treatment Durability Period|Other|1|||
46908614|NCT03449147|83137569|FG002|12-Week Off-Treatment Durability Period|Other|0|||
46908615|NCT03423173|83137594|FG000|Overall Study|Randomized but not vaccinated|1|||
46908616|NCT03423173|83137595|FG001|Overall Study|Randomized but not vaccinated|0|||
46908617|NCT03423173|83137596|FG002|Overall Study|Randomized but not vaccinated|2|||
46908618|NCT03423173|83137597|FG003|Overall Study|Randomized but not vaccinated|1|||
46908619|NCT03423173|83137594|FG000|Overall Study|Adverse Event|1|||
46908620|NCT03423173|83137595|FG001|Overall Study|Adverse Event|1|||
46908621|NCT03423173|83137596|FG002|Overall Study|Adverse Event|1|||
46908622|NCT03423173|83137597|FG003|Overall Study|Adverse Event|1|||
46908623|NCT03423173|83137594|FG000|Overall Study|Lost to Follow-up|10|||
46908624|NCT03423173|83137595|FG001|Overall Study|Lost to Follow-up|19|||
46908625|NCT03423173|83137596|FG002|Overall Study|Lost to Follow-up|17|||
46908626|NCT03423173|83137597|FG003|Overall Study|Lost to Follow-up|22|||
46908627|NCT03423173|83137594|FG000|Overall Study|Withdrawal of consent|4|||
46908628|NCT03423173|83137595|FG001|Overall Study|Withdrawal of consent|10|||
46908629|NCT03423173|83137596|FG002|Overall Study|Withdrawal of consent|4|||
46908630|NCT03423173|83137597|FG003|Overall Study|Withdrawal of consent|5|||
46908631|NCT03423173|83137594|FG000|Overall Study|Death|1|||
46908632|NCT03423173|83137595|FG001|Overall Study|Death|0|||
46908633|NCT03423173|83137596|FG002|Overall Study|Death|0|||
46908634|NCT03423173|83137597|FG003|Overall Study|Death|0|||
46908635|NCT03423173|83137594|FG000|Overall Study|Reason not Specified|2|||
46908636|NCT03423173|83137595|FG001|Overall Study|Reason not Specified|5|||
46908637|NCT03423173|83137596|FG002|Overall Study|Reason not Specified|3|||
46908638|NCT03423173|83137597|FG003|Overall Study|Reason not Specified|1|||
46908639|NCT03447821|83137610|FG000|Overall Study|Withdrawal by Subject|1|||
46908640|NCT03447821|83137611|FG001|Overall Study|Withdrawal by Subject|1|||
46908641|NCT03447821|83137612|FG002|Overall Study|Withdrawal by Subject|0|||
46908642|NCT03447821|83137610|FG000|Overall Study|Lost to Follow-up|0|||
46908643|NCT03447821|83137611|FG001|Overall Study|Lost to Follow-up|0|||
46908644|NCT03447821|83137612|FG002|Overall Study|Lost to Follow-up|1|||
46908645|NCT03447353|83137626|FG000|Overall Study|Failure at Screening Visit|2|||
46908646|NCT03447353|83137626|FG000|Overall Study|Lost to Follow-up|4|||
46908647|NCT03447353|83137626|FG000|Overall Study|Scheduling Conflicts|3|||
46620430|NCT04523480|82769470|FG000|Overall Study|Lost to Follow-up|30|||
46908648|NCT03447353|83137626|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
46908649|NCT03446885|83137636|FG000|Overall Study|Lost to Follow-up|1|||
46908650|NCT03446885|83137637|FG001|Overall Study|Lost to Follow-up|0|||
46908651|NCT03446885|83137636|FG000|Overall Study|Did not complete entire visit|1|||
46908652|NCT03446885|83137637|FG001|Overall Study|Did not complete entire visit|0|||
46908653|NCT00710970|83137645|FG000|Overall Study|Never took drug|3|||
46908654|NCT03421379|83137651|FG000|Period 1|Withdrawal by Subject|0|||
46908655|NCT03421379|83137652|FG001|Period 1|Withdrawal by Subject|1|||
47001263|NCT02340221|83248877|FG001|Overall Study|Lost to Follow-up|15|||
47001264|NCT02340221|83248876|FG000|Overall Study|Reason Not Specified|85|||
47001265|NCT02340221|83248877|FG001|Overall Study|Reason Not Specified|165|||
47001266|NCT02340221|83248876|FG000|Overall Study|Study Terminated by Sponsor|1|||
47001267|NCT02340221|83248877|FG001|Overall Study|Study Terminated by Sponsor|3|||
47001268|NCT02395133|83248888|FG000|Overall Study|Adverse Event|4|||
47001269|NCT02395133|83248889|FG001|Overall Study|Adverse Event|1|||
47001270|NCT02395133|83248890|FG002|Overall Study|Adverse Event|3|||
47001271|NCT02395133|83248891|FG003|Overall Study|Adverse Event|0|||
47001272|NCT02395133|83248888|FG000|Overall Study|Lack of Efficacy|1|||
47001273|NCT02395133|83248889|FG001|Overall Study|Lack of Efficacy|0|||
47001274|NCT02395133|83248890|FG002|Overall Study|Lack of Efficacy|1|||
47001275|NCT02395133|83248891|FG003|Overall Study|Lack of Efficacy|1|||
47001276|NCT02395133|83248888|FG000|Overall Study|Protocol Violation|1|||
47001277|NCT02395133|83248889|FG001|Overall Study|Protocol Violation|1|||
47001278|NCT02395133|83248890|FG002|Overall Study|Protocol Violation|0|||
47001279|NCT02395133|83248891|FG003|Overall Study|Protocol Violation|3|||
47001280|NCT02395133|83248888|FG000|Overall Study|Lost to Follow-up|0|||
47001281|NCT02395133|83248889|FG001|Overall Study|Lost to Follow-up|1|||
47001282|NCT02395133|83248890|FG002|Overall Study|Lost to Follow-up|1|||
47001283|NCT02395133|83248891|FG003|Overall Study|Lost to Follow-up|0|||
47001284|NCT02395133|83248888|FG000|Overall Study|Pregnancy|0|||
47001285|NCT02395133|83248889|FG001|Overall Study|Pregnancy|0|||
47001286|NCT02395133|83248890|FG002|Overall Study|Pregnancy|3|||
47001287|NCT02395133|83248891|FG003|Overall Study|Pregnancy|0|||
47001288|NCT02395133|83248888|FG000|Overall Study|Consent withdrawn with no reason given|1|||
47001289|NCT02395133|83248889|FG001|Overall Study|Consent withdrawn with no reason given|3|||
47001290|NCT02395133|83248890|FG002|Overall Study|Consent withdrawn with no reason given|0|||
47001291|NCT02395133|83248891|FG003|Overall Study|Consent withdrawn with no reason given|2|||
47001292|NCT02395133|83248888|FG000|Overall Study|Consent withdrawn with personal reason|0|||
47001293|NCT02395133|83248889|FG001|Overall Study|Consent withdrawn with personal reason|1|||
47001294|NCT02395133|83248890|FG002|Overall Study|Consent withdrawn with personal reason|0|||
47001295|NCT02395133|83248891|FG003|Overall Study|Consent withdrawn with personal reason|3|||
47001296|NCT02395133|83248888|FG000|Overall Study|Sponsor decision|2|||
47001297|NCT02395133|83248889|FG001|Overall Study|Sponsor decision|0|||
47001298|NCT02395133|83248890|FG002|Overall Study|Sponsor decision|0|||
47001299|NCT02395133|83248891|FG003|Overall Study|Sponsor decision|1|||
47001300|NCT02395133|83248888|FG000|Overall Study|Other than specified above|5|||
47001301|NCT02395133|83248889|FG001|Overall Study|Other than specified above|2|||
47001302|NCT02395133|83248890|FG002|Overall Study|Other than specified above|2|||
47001303|NCT02395133|83248891|FG003|Overall Study|Other than specified above|4|||
47001304|NCT02395055|83248903|FG000|Overall Study|Withdrawal by Subject|7|||
47001305|NCT02395055|83248904|FG001|Overall Study|Withdrawal by Subject|3|||
47001306|NCT02369159|83248912|FG000|Overall Study|Adverse Event|0|||
47001307|NCT02369159|83248913|FG001|Overall Study|Adverse Event|1|||
47001308|NCT02369159|83248912|FG000|Overall Study|Lost to Follow-up|1|||
47001309|NCT02369159|83248913|FG001|Overall Study|Lost to Follow-up|1|||
47001310|NCT02369159|83248912|FG000|Overall Study|Withdrawal by Subject|7|||
47001311|NCT02369159|83248913|FG001|Overall Study|Withdrawal by Subject|0|||
47001312|NCT02368691|83248930|FG000|Overall Study|Death|13|||
47001313|NCT02368691|83248930|FG000|Overall Study|Lack of Efficacy|15|||
47001314|NCT02368691|83248930|FG000|Overall Study|Physician Decision|4|||
46620431|NCT04523480|82769471|FG001|Overall Study|Lost to Follow-up|35|||
46908656|NCT03421379|83137651|FG000|Period 1|Physician Decision|1|||
46908657|NCT03421379|83137652|FG001|Period 1|Physician Decision|1|||
46908658|NCT03421379|83137651|FG000|Period 1|Did not receive treatment|1|||
46908659|NCT03421379|83137652|FG001|Period 1|Did not receive treatment|2|||
46908660|NCT02900378|83137660|FG000|Randomization (Visit 2)|Adverse Event|14|||
46908661|NCT02900378|83137661|FG001|Randomization (Visit 2)|Adverse Event|11|||
46908662|NCT02900378|83137660|FG000|Randomization (Visit 2)|Death|1|||
46908663|NCT02900378|83137661|FG001|Randomization (Visit 2)|Death|4|||
46908664|NCT02900378|83137660|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
46908665|NCT02900378|83137661|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
46908666|NCT02900378|83137660|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
46908667|NCT02900378|83137661|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
46908668|NCT02900378|83137660|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
47001315|NCT02394665|83248937|FG000|Overall Study|Physician Decision|1|||
47001316|NCT02394665|83248938|FG001|Overall Study|Physician Decision|0|||
47001317|NCT02394665|83248939|FG002|Overall Study|Physician Decision|0|||
47001318|NCT02367911|83248949|FG000|Overall Study|Withdrawal by Subject|3|||
47001319|NCT02367911|83248950|FG001|Overall Study|Withdrawal by Subject|2|||
47001320|NCT02367911|83248949|FG000|Overall Study|Lost to Follow-up|2|||
47001321|NCT02367911|83248950|FG001|Overall Study|Lost to Follow-up|2|||
47001322|NCT02339285|83248959|FG000|Overall Study|Withdrawal by Subject|0|||
47001323|NCT02339285|83248960|FG001|Overall Study|Withdrawal by Subject|1|||
47001324|NCT02339285|83248961|FG002|Overall Study|Withdrawal by Subject|1|||
47001325|NCT02339285|83248959|FG000|Overall Study|Lost to Follow-up|1|||
47001326|NCT02339285|83248960|FG001|Overall Study|Lost to Follow-up|1|||
47001327|NCT02339285|83248961|FG002|Overall Study|Lost to Follow-up|1|||
47001328|NCT02339285|83248959|FG000|Overall Study|Protocol Deviation|0|||
47001329|NCT02339285|83248960|FG001|Overall Study|Protocol Deviation|1|||
47001330|NCT02339285|83248961|FG002|Overall Study|Protocol Deviation|0|||
46908669|NCT02900378|83137661|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
46908670|NCT02900378|83137660|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
46908671|NCT02900378|83137661|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
46908672|NCT02900378|83137660|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
46908673|NCT02900378|83137661|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
47001331|NCT02367833|83248972|FG000|Overall Study|Withdrawal by Subject|1|||
47001332|NCT02367833|83248973|FG001|Overall Study|Withdrawal by Subject|1|||
47001333|NCT02367833|83248974|FG002|Overall Study|Withdrawal by Subject|0|||
47001334|NCT02367521|83248984|FG000|Overall Study|severe headache after intervention|2|||
47001335|NCT02367521|83248985|FG001|Overall Study|severe headache after intervention|0|||
47001336|NCT02367521|83248984|FG000|Overall Study|unable to find transportation|2|||
47001337|NCT02367521|83248985|FG001|Overall Study|unable to find transportation|0|||
46908674|NCT03058692|83137669|FG000|Overall Study|Lost to Follow-up|2|||
46908675|NCT03058692|83137670|FG001|Overall Study|Lost to Follow-up|1|||
46908676|NCT03058692|83137669|FG000|Overall Study|Withdrawal by Subject|1|||
46908677|NCT03058692|83137670|FG001|Overall Study|Withdrawal by Subject|1|||
46908678|NCT02964338|83137680|FG000|Overall Study|Sponsor terminated study for futility|12|||
46908679|NCT02964338|83137681|FG001|Overall Study|Sponsor terminated study for futility|15|||
46908680|NCT02964338|83137682|FG002|Overall Study|Sponsor terminated study for futility|14|||
46908681|NCT02964338|83137680|FG000|Overall Study|Lack of Efficacy|0|||
46908682|NCT02964338|83137681|FG001|Overall Study|Lack of Efficacy|3|||
46908683|NCT02964338|83137682|FG002|Overall Study|Lack of Efficacy|0|||
46908684|NCT02964338|83137680|FG000|Overall Study|Lost to Follow-up|1|||
46908685|NCT02964338|83137681|FG001|Overall Study|Lost to Follow-up|0|||
46908686|NCT02964338|83137682|FG002|Overall Study|Lost to Follow-up|3|||
46908687|NCT02964338|83137680|FG000|Overall Study|Protocol Violation|0|||
46908688|NCT02964338|83137681|FG001|Overall Study|Protocol Violation|1|||
46908689|NCT02964338|83137682|FG002|Overall Study|Protocol Violation|0|||
46908690|NCT02964338|83137680|FG000|Overall Study|Withdrawal by Subject|1|||
47001338|NCT02338193|83248994|FG000|Overall Study|Withdrawal by Subject|0|||
47001339|NCT02338193|83248995|FG001|Overall Study|Withdrawal by Subject|0|||
47001340|NCT02338193|83248996|FG002|Overall Study|Withdrawal by Subject|2|||
47001341|NCT02338193|83248994|FG000|Overall Study|Pregnancy|0|||
47001342|NCT02338193|83248995|FG001|Overall Study|Pregnancy|1|||
47001343|NCT02338193|83248996|FG002|Overall Study|Pregnancy|1|||
46709321|NCT01143714|82925290|FG001|Overall Study|Subject non-compliance|1|||
47001344|NCT02338193|83248994|FG000|Overall Study|Noncompliant with visits|2|||
47001345|NCT02338193|83248995|FG001|Overall Study|Noncompliant with visits|2|||
47001346|NCT02338193|83248996|FG002|Overall Study|Noncompliant with visits|7|||
47001347|NCT02338193|83248994|FG000|Overall Study|moved out of state|0|||
47001348|NCT02338193|83248995|FG001|Overall Study|moved out of state|1|||
47001349|NCT02338193|83248996|FG002|Overall Study|moved out of state|0|||
47001350|NCT02338193|83248994|FG000|Overall Study|intolerant of side effects|1|||
47001351|NCT02338193|83248995|FG001|Overall Study|intolerant of side effects|0|||
47001352|NCT02338193|83248996|FG002|Overall Study|intolerant of side effects|0|||
47001353|NCT01783444|83249007|FG000|Treatment Phase|Adverse Event|9|||
47001354|NCT01783444|83249008|FG001|Treatment Phase|Adverse Event|20|||
47001355|NCT01783444|83249009|FG002|Treatment Phase|Adverse Event|19|||
47001356|NCT01783444|83249007|FG000|Treatment Phase|Disease Progression|76|||
47001357|NCT01783444|83249008|FG001|Treatment Phase|Disease Progression|66|||
47001358|NCT01783444|83249009|FG002|Treatment Phase|Disease Progression|64|||
47001359|NCT01783444|83249007|FG000|Treatment Phase|Death|2|||
47001360|NCT01783444|83249008|FG001|Treatment Phase|Death|2|||
47001361|NCT01783444|83249009|FG002|Treatment Phase|Death|2|||
47001362|NCT01783444|83249007|FG000|Treatment Phase|Protocol Violation|1|||
47001363|NCT01783444|83249008|FG001|Treatment Phase|Protocol Violation|1|||
46908691|NCT02964338|83137681|FG001|Overall Study|Withdrawal by Subject|3|||
46908692|NCT02964338|83137682|FG002|Overall Study|Withdrawal by Subject|1|||
46908693|NCT02964338|83137680|FG000|Overall Study|Adverse Event|2|||
46908694|NCT02964338|83137681|FG001|Overall Study|Adverse Event|1|||
46908695|NCT02964338|83137682|FG002|Overall Study|Adverse Event|1|||
46908696|NCT02964338|83137680|FG000|Overall Study|Non-compliant with e-diary|0|||
46908697|NCT02964338|83137681|FG001|Overall Study|Non-compliant with e-diary|1|||
46908698|NCT02964338|83137682|FG002|Overall Study|Non-compliant with e-diary|0|||
46908699|NCT02964338|83137680|FG000|Overall Study|Did not meet criteria|1|||
46908700|NCT02964338|83137681|FG001|Overall Study|Did not meet criteria|0|||
46908701|NCT02964338|83137682|FG002|Overall Study|Did not meet criteria|0|||
46908702|NCT03056352|83137690|FG000|Overall Study|Lost to Follow-up|1|||
46908703|NCT02898662|83137696|FG000|Overall Study|Adverse Event|1|||
46908704|NCT02898662|83137697|FG001|Overall Study|Adverse Event|0|||
46908705|NCT02898662|83137696|FG000|Overall Study|Loss of asthma control|23|||
46908706|NCT02898662|83137697|FG001|Overall Study|Loss of asthma control|24|||
46908707|NCT02898662|83137696|FG000|Overall Study|Withdrawal by Subject|4|||
46908708|NCT02898662|83137697|FG001|Overall Study|Withdrawal by Subject|1|||
46908709|NCT02898662|83137696|FG000|Overall Study|Technical issue|0|||
46908710|NCT02898662|83137697|FG001|Overall Study|Technical issue|1|||
46908711|NCT02898662|83137696|FG000|Overall Study|Randomized in error|0|||
46908712|NCT02898662|83137697|FG001|Overall Study|Randomized in error|1|||
46908713|NCT02898662|83137696|FG000|Overall Study|Subject decision|1|||
46908714|NCT02898662|83137697|FG001|Overall Study|Subject decision|0|||
46908715|NCT02898662|83137696|FG000|Overall Study|Other|0|||
46908716|NCT02898662|83137697|FG001|Overall Study|Other|1|||
46908717|NCT03055338|83137706|FG000|Overall Study|Lost to Follow-up|9|||
46908718|NCT03055338|83137707|FG001|Overall Study|Lost to Follow-up|2|||
46908719|NCT03055338|83137708|FG002|Overall Study|Lost to Follow-up|3|||
46908720|NCT03055338|83137706|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
46908721|NCT03055338|83137707|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
46908722|NCT03055338|83137708|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
46908723|NCT03055338|83137706|FG000|Overall Study|Physician Decision|0|||
46908724|NCT03055338|83137707|FG001|Overall Study|Physician Decision|0|||
46908725|NCT03055338|83137708|FG002|Overall Study|Physician Decision|2|||
46908726|NCT03055338|83137706|FG000|Overall Study|Withdrawal by Subject|9|||
46908727|NCT03055338|83137707|FG001|Overall Study|Withdrawal by Subject|8|||
46908728|NCT03055338|83137708|FG002|Overall Study|Withdrawal by Subject|7|||
46908729|NCT03913130|83137716|FG000|Overall Study|Sponsor Decision|1|||
46908730|NCT03419741|83137722|FG000|Overall Study|Adverse Event|1|||
46908731|NCT03419741|83137723|FG001|Overall Study|Adverse Event|0|||
46908732|NCT03419741|83137722|FG000|Overall Study|Withdrawal by Subject|1|||
46908733|NCT03419741|83137723|FG001|Overall Study|Withdrawal by Subject|2|||
46908734|NCT02896400|83137745|FG000|1 Month Follow-up|Lost to Follow-up|7|||
46908735|NCT02896400|83137746|FG001|1 Month Follow-up|Lost to Follow-up|7|||
46908736|NCT02896400|83137747|FG002|1 Month Follow-up|Lost to Follow-up|5|||
46908737|NCT02896400|83137748|FG003|1 Month Follow-up|Lost to Follow-up|8|||
46908738|NCT02896400|83137749|FG004|1 Month Follow-up|Lost to Follow-up|9|||
46908739|NCT02896400|83137750|FG005|1 Month Follow-up|Lost to Follow-up|6|||
46908740|NCT02896400|83137751|FG006|1 Month Follow-up|Lost to Follow-up|5|||
46908741|NCT02896400|83137752|FG007|1 Month Follow-up|Lost to Follow-up|6|||
47001364|NCT01783444|83249009|FG002|Treatment Phase|Protocol Violation|2|||
47001365|NCT01783444|83249007|FG000|Treatment Phase|Withdrawal by Subject|6|||
47001366|NCT01783444|83249008|FG001|Treatment Phase|Withdrawal by Subject|8|||
47001367|NCT01783444|83249009|FG002|Treatment Phase|Withdrawal by Subject|9|||
47001368|NCT01783444|83249007|FG000|Treatment Phase|Administrative problems|2|||
47001369|NCT01783444|83249008|FG001|Treatment Phase|Administrative problems|0|||
47001370|NCT01783444|83249009|FG002|Treatment Phase|Administrative problems|1|||
47001371|NCT01783444|83249007|FG000|Treatment Phase|Physician Decision|8|||
46908742|NCT02896400|83137753|FG008|1 Month Follow-up|Lost to Follow-up|4|||
46908743|NCT02896400|83137754|FG009|1 Month Follow-up|Lost to Follow-up|7|||
46908744|NCT02896400|83137755|FG010|1 Month Follow-up|Lost to Follow-up|5|||
46908745|NCT02896400|83137756|FG011|1 Month Follow-up|Lost to Follow-up|5|||
47001372|NCT01783444|83249008|FG001|Treatment Phase|Physician Decision|6|||
47001373|NCT01783444|83249009|FG002|Treatment Phase|Physician Decision|5|||
47001374|NCT01783444|83249007|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
47001375|NCT01783444|83249008|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
47001376|NCT01783444|83249009|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
47001377|NCT01783444|83249007|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
47001378|NCT01783444|83249008|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
47001379|NCT01783444|83249009|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
47001380|NCT01783444|83249007|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
47001381|NCT01783444|83249008|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
47001382|NCT01783444|83249009|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
47001383|NCT01783444|83249007|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
47001384|NCT01783444|83249008|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
47001385|NCT01783444|83249009|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
47001386|NCT01783444|83249007|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
47001387|NCT01783444|83249008|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
47001388|NCT01783444|83249009|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
47001389|NCT01783444|83249007|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
47001390|NCT01783444|83249008|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
47001391|NCT01783444|83249009|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
47001392|NCT02394275|83249018|FG000|Overall Study|Adverse Event|22|||
47001393|NCT02394275|83249018|FG000|Overall Study|Lost to Follow-up|7|||
47001394|NCT01608724|83249023|FG000|Overall Study|Withdrawal by Subject|131|||
47001395|NCT01608724|83249023|FG000|Overall Study|Lost to Follow-up|41|||
47001396|NCT01608724|83249023|FG000|Overall Study|Study-specific discontinuation criteria|32|||
47001397|NCT01608724|83249023|FG000|Overall Study|Adverse Event|29|||
47001398|NCT01608724|83249023|FG000|Overall Study|Protocol Violation|6|||
47001399|NCT01608724|83249023|FG000|Overall Study|bood sugar too high, etc.|3|||
47001400|NCT01608724|83249023|FG000|Overall Study|Safety reasons|1|||
47001401|NCT02366195|83249027|FG000|Overall Study|Protocol-specified criteria|3|||
47001402|NCT02366195|83249027|FG000|Overall Study|Withdrawal by Subject|9|||
47001403|NCT02366195|83249027|FG000|Overall Study|Lost to Follow-up|1|||
47001404|NCT02366195|83249027|FG000|Overall Study|Death|41|||
47001405|NCT02364947|83249034|FG000|Overall Study|Withdrawal by Subject|10|||
47001406|NCT02364947|83249035|FG001|Overall Study|Withdrawal by Subject|8|||
47001407|NCT02364947|83249036|FG002|Overall Study|Withdrawal by Subject|9|||
47001408|NCT02364947|83249034|FG000|Overall Study|Adverse Event|45|||
47001409|NCT02364947|83249035|FG001|Overall Study|Adverse Event|33|||
47001410|NCT02364947|83249036|FG002|Overall Study|Adverse Event|11|||
47001411|NCT02364947|83249034|FG000|Overall Study|Protocol Violation|1|||
47001412|NCT02364947|83249035|FG001|Overall Study|Protocol Violation|1|||
47001413|NCT02364947|83249036|FG002|Overall Study|Protocol Violation|1|||
47001414|NCT02364947|83249034|FG000|Overall Study|Physician Decision|3|||
47001415|NCT02364947|83249035|FG001|Overall Study|Physician Decision|2|||
47001416|NCT02364947|83249036|FG002|Overall Study|Physician Decision|5|||
47001417|NCT02364947|83249034|FG000|Overall Study|Death|0|||
47001418|NCT02364947|83249035|FG001|Overall Study|Death|1|||
47001419|NCT02364947|83249036|FG002|Overall Study|Death|0|||
47001420|NCT02392481|83249048|FG000|Overall Study|Adverse Event|0|||
47001421|NCT02392481|83249049|FG001|Overall Study|Adverse Event|0|||
47001422|NCT02392481|83249050|FG002|Overall Study|Adverse Event|1|||
47001423|NCT02392481|83249051|FG003|Overall Study|Adverse Event|2|||
47001424|NCT02392481|83249048|FG000|Overall Study|Withdrawal by Subject|0|||
47001425|NCT02392481|83249049|FG001|Overall Study|Withdrawal by Subject|0|||
47001426|NCT02392481|83249050|FG002|Overall Study|Withdrawal by Subject|1|||
47001427|NCT02392481|83249051|FG003|Overall Study|Withdrawal by Subject|0|||
47001428|NCT02392403|83249061|FG000|Overall Study|Adverse Event|1|||
47001429|NCT02392403|83249061|FG000|Overall Study|Death|1|||
47001430|NCT02392403|83249061|FG000|Overall Study|Withdrawal by Subject|1|||
47001431|NCT02392247|83249065|FG000|Overall Study|Withdrawal by Subject|1|||
46620432|NCT04523480|82769472|FG002|Overall Study|Lost to Follow-up|0|||
46709322|NCT01143714|82925289|FG000|Overall Study|wound closed = deemed healed|1|||
47001432|NCT02392247|83249065|FG000|Overall Study|Surgery cancelled; no data|1|||
47001433|NCT02337725|83249071|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
46620433|NCT04454125|82769482|FG000|Overall Study|Lost to Follow-up|0|||
47001434|NCT02337725|83249072|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
47001435|NCT02337725|83249071|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
47001436|NCT02337725|83249072|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
47001437|NCT02337725|83249071|FG000|Overall Study|Major Protocol Deviation|0|||
47001438|NCT02337725|83249072|FG001|Overall Study|Major Protocol Deviation|1|||
47001439|NCT02337725|83249071|FG000|Overall Study|Voluntary Withdrawal|14|||
47001440|NCT02337725|83249072|FG001|Overall Study|Voluntary Withdrawal|3|||
47001441|NCT02337725|83249071|FG000|Overall Study|Lack of Efficacy|4|||
46620434|NCT04454125|82769483|FG001|Overall Study|Lost to Follow-up|1|||
46908746|NCT02896400|83137757|FG012|1 Month Follow-up|Lost to Follow-up|3|||
46908747|NCT02896400|83137758|FG013|1 Month Follow-up|Lost to Follow-up|4|||
46908748|NCT02896400|83137759|FG014|1 Month Follow-up|Lost to Follow-up|1|||
46908749|NCT02896400|83137760|FG015|1 Month Follow-up|Lost to Follow-up|2|||
46908750|NCT02896400|83137745|FG000|1 Month Follow-up|Death|0|||
46908751|NCT02896400|83137746|FG001|1 Month Follow-up|Death|0|||
46908752|NCT02896400|83137747|FG002|1 Month Follow-up|Death|0|||
46908753|NCT02896400|83137748|FG003|1 Month Follow-up|Death|0|||
46908754|NCT02896400|83137749|FG004|1 Month Follow-up|Death|0|||
46908755|NCT02896400|83137750|FG005|1 Month Follow-up|Death|0|||
46908756|NCT02896400|83137751|FG006|1 Month Follow-up|Death|0|||
46908757|NCT02896400|83137752|FG007|1 Month Follow-up|Death|0|||
46908758|NCT02896400|83137753|FG008|1 Month Follow-up|Death|0|||
46908759|NCT02896400|83137754|FG009|1 Month Follow-up|Death|0|||
46908760|NCT02896400|83137755|FG010|1 Month Follow-up|Death|0|||
46908761|NCT02896400|83137756|FG011|1 Month Follow-up|Death|0|||
46908762|NCT02896400|83137757|FG012|1 Month Follow-up|Death|0|||
46908763|NCT02896400|83137758|FG013|1 Month Follow-up|Death|0|||
46908764|NCT02896400|83137759|FG014|1 Month Follow-up|Death|0|||
46908765|NCT02896400|83137760|FG015|1 Month Follow-up|Death|1|||
46908766|NCT02896400|83137745|FG000|3 Month Follow-up|Lost to Follow-up|6|||
46908767|NCT02896400|83137746|FG001|3 Month Follow-up|Lost to Follow-up|3|||
46908768|NCT02896400|83137747|FG002|3 Month Follow-up|Lost to Follow-up|6|||
46908769|NCT02896400|83137748|FG003|3 Month Follow-up|Lost to Follow-up|11|||
46908770|NCT02896400|83137749|FG004|3 Month Follow-up|Lost to Follow-up|12|||
46908771|NCT02896400|83137750|FG005|3 Month Follow-up|Lost to Follow-up|6|||
46908772|NCT02896400|83137751|FG006|3 Month Follow-up|Lost to Follow-up|4|||
46908773|NCT02896400|83137752|FG007|3 Month Follow-up|Lost to Follow-up|3|||
46908774|NCT02896400|83137753|FG008|3 Month Follow-up|Lost to Follow-up|6|||
46908775|NCT02896400|83137754|FG009|3 Month Follow-up|Lost to Follow-up|5|||
46908776|NCT02896400|83137755|FG010|3 Month Follow-up|Lost to Follow-up|6|||
46908777|NCT02896400|83137756|FG011|3 Month Follow-up|Lost to Follow-up|6|||
46908778|NCT02896400|83137757|FG012|3 Month Follow-up|Lost to Follow-up|3|||
46908779|NCT02896400|83137758|FG013|3 Month Follow-up|Lost to Follow-up|5|||
46908780|NCT02896400|83137759|FG014|3 Month Follow-up|Lost to Follow-up|3|||
46908781|NCT02896400|83137760|FG015|3 Month Follow-up|Lost to Follow-up|2|||
46908782|NCT02896400|83137745|FG000|3 Month Follow-up|Death|0|||
46908783|NCT02896400|83137746|FG001|3 Month Follow-up|Death|0|||
46908784|NCT02896400|83137747|FG002|3 Month Follow-up|Death|0|||
46908785|NCT02896400|83137748|FG003|3 Month Follow-up|Death|0|||
46908786|NCT02896400|83137749|FG004|3 Month Follow-up|Death|0|||
46908787|NCT02896400|83137750|FG005|3 Month Follow-up|Death|0|||
46908788|NCT02896400|83137751|FG006|3 Month Follow-up|Death|0|||
46908789|NCT02896400|83137752|FG007|3 Month Follow-up|Death|0|||
46908790|NCT02896400|83137753|FG008|3 Month Follow-up|Death|0|||
46908791|NCT02896400|83137754|FG009|3 Month Follow-up|Death|0|||
46908792|NCT02896400|83137755|FG010|3 Month Follow-up|Death|0|||
46908793|NCT02896400|83137756|FG011|3 Month Follow-up|Death|0|||
46908794|NCT02896400|83137757|FG012|3 Month Follow-up|Death|0|||
46908795|NCT02896400|83137758|FG013|3 Month Follow-up|Death|1|||
46908796|NCT02896400|83137759|FG014|3 Month Follow-up|Death|1|||
46908797|NCT02896400|83137760|FG015|3 Month Follow-up|Death|0|||
46908798|NCT02896400|83137745|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908799|NCT02896400|83137746|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
46908800|NCT02896400|83137747|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908801|NCT02896400|83137748|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908802|NCT02896400|83137749|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
46908803|NCT02896400|83137750|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908804|NCT02896400|83137751|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
46908805|NCT02896400|83137752|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
46908806|NCT02896400|83137753|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908807|NCT02896400|83137754|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908808|NCT02896400|83137755|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
46908809|NCT02896400|83137756|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
46908810|NCT02896400|83137757|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908811|NCT02896400|83137758|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
46908812|NCT02896400|83137759|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
46908813|NCT02896400|83137760|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
46908814|NCT02896400|83137745|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
46908815|NCT02896400|83137746|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
46908816|NCT02896400|83137747|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
46908817|NCT02896400|83137748|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
46908818|NCT02896400|83137749|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
47001442|NCT02337725|83249072|FG001|Overall Study|Lack of Efficacy|0|||
47001443|NCT02337491|83249080|FG000|Overall Study|Death|1|||
47001444|NCT02337491|83249081|FG001|Overall Study|Death|1|||
47001445|NCT02337491|83249080|FG000|Overall Study|Adverse Event|0|||
47001446|NCT02337491|83249081|FG001|Overall Study|Adverse Event|1|||
47001447|NCT02337491|83249080|FG000|Overall Study|Withdrawal by Subject|3|||
47001448|NCT02337491|83249081|FG001|Overall Study|Withdrawal by Subject|0|||
47001449|NCT02337491|83249080|FG000|Overall Study|Progressive Disease|44|||
47001450|NCT02337491|83249081|FG001|Overall Study|Progressive Disease|28|||
47001451|NCT02337491|83249080|FG000|Overall Study|On Treatment|2|||
47001452|NCT02337491|83249081|FG001|Overall Study|On Treatment|0|||
47001453|NCT01765582|83249091|FG000|Overall Study|Other|3|||
47001454|NCT01765582|83249092|FG001|Overall Study|Other|6|||
47001455|NCT01765582|83249093|FG002|Overall Study|Other|9|||
47001456|NCT01765582|83249091|FG000|Overall Study|Lost to Follow-up|2|||
47001457|NCT01765582|83249092|FG001|Overall Study|Lost to Follow-up|2|||
47001458|NCT01765582|83249093|FG002|Overall Study|Lost to Follow-up|1|||
47001459|NCT01765582|83249091|FG000|Overall Study|Death|31|||
47001460|NCT01765582|83249092|FG001|Overall Study|Death|36|||
47001461|NCT01765582|83249093|FG002|Overall Study|Death|33|||
47001462|NCT01765582|83249091|FG000|Overall Study|Sponsor Decision|46|||
47001463|NCT01765582|83249092|FG001|Overall Study|Sponsor Decision|42|||
47001464|NCT01765582|83249093|FG002|Overall Study|Sponsor Decision|42|||
47001465|NCT01765582|83249091|FG000|Overall Study|Withdrawal of Consent|11|||
47001466|NCT01765582|83249092|FG001|Overall Study|Withdrawal of Consent|6|||
47001467|NCT01765582|83249093|FG002|Overall Study|Withdrawal of Consent|10|||
47001468|NCT01649375|83249105|FG000|Up to Week 16|Adverse Event|2|||
47001469|NCT01649375|83249106|FG001|Up to Week 16|Adverse Event|5|||
47001470|NCT01649375|83249107|FG002|Up to Week 16|Adverse Event|4|||
47001471|NCT01649375|83249108|FG003|Up to Week 16|Adverse Event|0|||
47001472|NCT01649375|83249109|FG004|Up to Week 16|Adverse Event|0|||
47001473|NCT01649375|83249105|FG000|Up to Week 16|Lack of Efficacy|0|||
47001474|NCT01649375|83249106|FG001|Up to Week 16|Lack of Efficacy|0|||
47001475|NCT01649375|83249107|FG002|Up to Week 16|Lack of Efficacy|1|||
47001476|NCT01649375|83249108|FG003|Up to Week 16|Lack of Efficacy|0|||
47001477|NCT01649375|83249109|FG004|Up to Week 16|Lack of Efficacy|0|||
47001478|NCT01649375|83249105|FG000|Up to Week 16|Physician Decision|0|||
47001479|NCT01649375|83249106|FG001|Up to Week 16|Physician Decision|0|||
47001480|NCT01649375|83249107|FG002|Up to Week 16|Physician Decision|1|||
47001481|NCT01649375|83249108|FG003|Up to Week 16|Physician Decision|0|||
47001482|NCT01649375|83249109|FG004|Up to Week 16|Physician Decision|0|||
47001483|NCT01649375|83249105|FG000|Up to Week 16|Withdrawal by Subject|2|||
47001484|NCT01649375|83249106|FG001|Up to Week 16|Withdrawal by Subject|1|||
47001485|NCT01649375|83249107|FG002|Up to Week 16|Withdrawal by Subject|2|||
47001486|NCT01649375|83249108|FG003|Up to Week 16|Withdrawal by Subject|0|||
47001487|NCT01649375|83249109|FG004|Up to Week 16|Withdrawal by Subject|0|||
47001488|NCT01649375|83249105|FG000|Up to Week 16|Death|1|||
47001489|NCT01649375|83249106|FG001|Up to Week 16|Death|0|||
47001490|NCT01649375|83249107|FG002|Up to Week 16|Death|0|||
47001491|NCT01649375|83249108|FG003|Up to Week 16|Death|0|||
47001492|NCT01649375|83249109|FG004|Up to Week 16|Death|0|||
47001493|NCT01649375|83249105|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
47001494|NCT01649375|83249106|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
47001495|NCT01649375|83249107|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
47001496|NCT01649375|83249108|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
47001497|NCT01649375|83249109|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
47001498|NCT01649375|83249105|FG000|Week 16 up to Week 260|Non-compliance|0|||
47001499|NCT01649375|83249106|FG001|Week 16 up to Week 260|Non-compliance|1|||
47001500|NCT01649375|83249107|FG002|Week 16 up to Week 260|Non-compliance|0|||
47001501|NCT01649375|83249108|FG003|Week 16 up to Week 260|Non-compliance|1|||
47001502|NCT01649375|83249109|FG004|Week 16 up to Week 260|Non-compliance|0|||
47001503|NCT01649375|83249105|FG000|Week 16 up to Week 260|Physician Decision|0|||
47001504|NCT01649375|83249106|FG001|Week 16 up to Week 260|Physician Decision|2|||
47001505|NCT01649375|83249107|FG002|Week 16 up to Week 260|Physician Decision|0|||
47001506|NCT01649375|83249108|FG003|Week 16 up to Week 260|Physician Decision|0|||
47001507|NCT01649375|83249109|FG004|Week 16 up to Week 260|Physician Decision|0|||
47001508|NCT01649375|83249105|FG000|Week 16 up to Week 260|Technical issues|0|||
47001509|NCT01649375|83249106|FG001|Week 16 up to Week 260|Technical issues|1|||
47001510|NCT01649375|83249107|FG002|Week 16 up to Week 260|Technical issues|0|||
47001511|NCT01649375|83249108|FG003|Week 16 up to Week 260|Technical issues|1|||
47001512|NCT01649375|83249109|FG004|Week 16 up to Week 260|Technical issues|0|||
47001513|NCT01649375|83249105|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
47001514|NCT01649375|83249106|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
47001515|NCT01649375|83249107|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
47001516|NCT01649375|83249108|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
47001517|NCT01649375|83249109|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
47001518|NCT01649375|83249105|FG000|Week 16 up to Week 260|Death|1|||
47001519|NCT01649375|83249106|FG001|Week 16 up to Week 260|Death|1|||
47001520|NCT01649375|83249107|FG002|Week 16 up to Week 260|Death|0|||
47001521|NCT01649375|83249108|FG003|Week 16 up to Week 260|Death|0|||
47001522|NCT01649375|83249109|FG004|Week 16 up to Week 260|Death|0|||
47001523|NCT01649375|83249105|FG000|Week 16 up to Week 260|Adverse Event|5|||
47001524|NCT01649375|83249106|FG001|Week 16 up to Week 260|Adverse Event|2|||
47001525|NCT01649375|83249107|FG002|Week 16 up to Week 260|Adverse Event|0|||
47001526|NCT01649375|83249108|FG003|Week 16 up to Week 260|Adverse Event|3|||
47001527|NCT01649375|83249109|FG004|Week 16 up to Week 260|Adverse Event|2|||
47001528|NCT02336555|83249119|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
47001529|NCT02336555|83249120|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
47001530|NCT02336555|83249119|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
47001531|NCT02336555|83249120|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
47001532|NCT02336555|83249119|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
47001533|NCT02336555|83249120|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
47001534|NCT01648283|83249126|FG000|Overall Study|Withdrawal by Subject|14|||
47001535|NCT01649297|83249137|FG000|Overall Study|Adverse Event|5|||
47001536|NCT01649297|83249138|FG001|Overall Study|Adverse Event|5|||
47001537|NCT01649297|83249139|FG002|Overall Study|Adverse Event|4|||
47001538|NCT01649297|83249140|FG003|Overall Study|Adverse Event|13|||
47001539|NCT01649297|83249141|FG004|Overall Study|Adverse Event|1|||
47001540|NCT01649297|83249137|FG000|Overall Study|Lack of Efficacy|0|||
47001541|NCT01649297|83249138|FG001|Overall Study|Lack of Efficacy|0|||
47001542|NCT01649297|83249139|FG002|Overall Study|Lack of Efficacy|0|||
47001543|NCT01649297|83249140|FG003|Overall Study|Lack of Efficacy|0|||
47001544|NCT01649297|83249141|FG004|Overall Study|Lack of Efficacy|1|||
47001545|NCT01649297|83249137|FG000|Overall Study|Non compliant with Protocol|1|||
47001546|NCT01649297|83249138|FG001|Overall Study|Non compliant with Protocol|0|||
47001547|NCT01649297|83249139|FG002|Overall Study|Non compliant with Protocol|3|||
47001548|NCT01649297|83249140|FG003|Overall Study|Non compliant with Protocol|2|||
47001549|NCT01649297|83249141|FG004|Overall Study|Non compliant with Protocol|1|||
47001550|NCT01649297|83249137|FG000|Overall Study|Lost to Follow-up|1|||
47001551|NCT01649297|83249138|FG001|Overall Study|Lost to Follow-up|1|||
47001552|NCT01649297|83249139|FG002|Overall Study|Lost to Follow-up|4|||
47001553|NCT01649297|83249140|FG003|Overall Study|Lost to Follow-up|3|||
47001554|NCT01649297|83249141|FG004|Overall Study|Lost to Follow-up|0|||
47001555|NCT01649297|83249137|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
47001556|NCT01649297|83249138|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
47001557|NCT01649297|83249139|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
47001558|NCT01649297|83249140|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
47001559|NCT01649297|83249141|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
47001560|NCT01649297|83249137|FG000|Overall Study|For other reason|4|||
47001561|NCT01649297|83249138|FG001|Overall Study|For other reason|1|||
47001562|NCT01649297|83249139|FG002|Overall Study|For other reason|2|||
47001563|NCT01649297|83249140|FG003|Overall Study|For other reason|0|||
47001564|NCT01649297|83249141|FG004|Overall Study|For other reason|0|||
47001565|NCT01648205|83249153|FG000|Placebo|Pregnancy|1|||
47001566|NCT01648205|83249153|FG000|Placebo|Withdrawal by Subject|1|||
47001567|NCT01648205|83249153|FG000|Placebo|Protocol Violation|2|||
47001568|NCT01648205|83249153|FG000|Ranolazine|Death|1|||
47001569|NCT01648205|83249153|FG000|Ranolazine|Withdrawal by Subject|1|||
47001570|NCT01648205|83249153|FG000|Ranolazine|Protocol Violation|3|||
47001571|NCT02362451|83249163|FG000|Overall Study|Withdrawal by Subject|0|||
47001572|NCT02362451|83249164|FG001|Overall Study|Withdrawal by Subject|1|||
47001573|NCT02362451|83249163|FG000|Overall Study|Lack of Efficacy|2|||
47001574|NCT02362451|83249164|FG001|Overall Study|Lack of Efficacy|0|||
47001575|NCT02362451|83249163|FG000|Overall Study|Progression|1|||
47001576|NCT02362451|83249164|FG001|Overall Study|Progression|0|||
47001577|NCT02362451|83249163|FG000|Overall Study|Participant chose other therapy.|1|||
47001578|NCT02362451|83249164|FG001|Overall Study|Participant chose other therapy.|0|||
47001579|NCT01734382|83249173|FG000|Part 1|Adverse Event|2|||
47001580|NCT01734382|83249174|FG001|Part 1|Adverse Event|0|||
47001581|NCT01734382|83249175|FG002|Part 1|Adverse Event|0|||
47001582|NCT01734382|83249173|FG000|Part 2|Adverse Event|0|||
47001583|NCT01734382|83249174|FG001|Part 2|Adverse Event|0|||
47001584|NCT01734382|83249175|FG002|Part 2|Adverse Event|1|||
47001585|NCT01734382|83249173|FG000|Part 2|Lack of Efficacy|0|||
47001586|NCT01734382|83249174|FG001|Part 2|Lack of Efficacy|1|||
47001587|NCT01734382|83249175|FG002|Part 2|Lack of Efficacy|1|||
47001588|NCT01734382|83249173|FG000|Part 2|Other|0|||
47001589|NCT01734382|83249174|FG001|Part 2|Other|0|||
46620435|NCT04307446|82769495|FG000|Overall Study|Lost to Follow-up|2|||
47001590|NCT01734382|83249175|FG002|Part 2|Other|1|||
47001591|NCT01734382|83249173|FG000|Part 2|Physician Decision|0|||
47001592|NCT01734382|83249174|FG001|Part 2|Physician Decision|0|||
47001593|NCT01734382|83249175|FG002|Part 2|Physician Decision|3|||
47001594|NCT01734382|83249173|FG000|Part 2|Protocol Violation|0|||
47001595|NCT01734382|83249174|FG001|Part 2|Protocol Violation|1|||
47001596|NCT01734382|83249175|FG002|Part 2|Protocol Violation|0|||
47001597|NCT01734382|83249173|FG000|Part 2|Withdrawal by Subject|0|||
47001598|NCT01734382|83249174|FG001|Part 2|Withdrawal by Subject|0|||
47001599|NCT01734382|83249175|FG002|Part 2|Withdrawal by Subject|1|||
47001600|NCT02391311|83249189|FG000|Overall Study|Lost to Follow-up|2|||
47001601|NCT02391311|83249190|FG001|Overall Study|Lost to Follow-up|1|||
47001602|NCT02391311|83249189|FG000|Overall Study|deemed ineligible after baseline|1|||
47001603|NCT02391311|83249190|FG001|Overall Study|deemed ineligible after baseline|1|||
47001604|NCT01765426|83249200|FG000|Overall Study|Lost to Follow-up|0|||
47001605|NCT01765426|83249201|FG001|Overall Study|Lost to Follow-up|1|||
47001606|NCT01765426|83249202|FG002|Overall Study|Lost to Follow-up|0|||
47001607|NCT01765426|83249203|FG003|Overall Study|Lost to Follow-up|0|||
47001608|NCT01765270|83249215|FG000|Overall Study|Physician Decision|1|||
47001609|NCT01765270|83249216|FG001|Overall Study|Physician Decision|0|||
47001610|NCT01765270|83249215|FG000|Overall Study|Withdrawal by Subject|0|||
47001611|NCT01765270|83249216|FG001|Overall Study|Withdrawal by Subject|1|||
47001612|NCT01733758|83249227|FG000|Overall Study|Adverse Event|5|||
47001613|NCT01733758|83249228|FG001|Overall Study|Adverse Event|7|||
47001614|NCT01733758|83249229|FG002|Overall Study|Adverse Event|8|||
47001615|NCT01733758|83249230|FG003|Overall Study|Adverse Event|1|||
47001616|NCT01733758|83249227|FG000|Overall Study|Withdrawal by Subject|1|||
47001617|NCT01733758|83249228|FG001|Overall Study|Withdrawal by Subject|1|||
47001618|NCT01733758|83249229|FG002|Overall Study|Withdrawal by Subject|5|||
47001619|NCT01733758|83249230|FG003|Overall Study|Withdrawal by Subject|3|||
47001620|NCT01733758|83249227|FG000|Overall Study|Persistent Hyperglycemia|3|||
47001621|NCT01733758|83249228|FG001|Overall Study|Persistent Hyperglycemia|2|||
47001622|NCT01733758|83249229|FG002|Overall Study|Persistent Hyperglycemia|0|||
47001623|NCT01733758|83249230|FG003|Overall Study|Persistent Hyperglycemia|0|||
47001624|NCT01733758|83249227|FG000|Overall Study|Protocol Violation|0|||
47001625|NCT01733758|83249228|FG001|Overall Study|Protocol Violation|1|||
47001626|NCT01733758|83249229|FG002|Overall Study|Protocol Violation|2|||
47001627|NCT01733758|83249230|FG003|Overall Study|Protocol Violation|2|||
47001628|NCT01733758|83249227|FG000|Overall Study|Non-compliance|1|||
47001629|NCT01733758|83249228|FG001|Overall Study|Non-compliance|0|||
47001630|NCT01733758|83249229|FG002|Overall Study|Non-compliance|0|||
47001631|NCT01733758|83249230|FG003|Overall Study|Non-compliance|0|||
47001632|NCT01733758|83249227|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
47001633|NCT01733758|83249228|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
47001634|NCT01733758|83249229|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
47001635|NCT01733758|83249230|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
47001636|NCT01733758|83249227|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
47001637|NCT01733758|83249228|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
47001638|NCT01733758|83249229|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
47001639|NCT01733758|83249230|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
47001640|NCT01607554|83249242|FG000|Overall Study|Disease progression|2|||
47001641|NCT01607476|83249249|FG000|Overall Study|Withdrawal by Subject|1|||
47001642|NCT01607476|83249250|FG001|Overall Study|Withdrawal by Subject|0|||
47001643|NCT01607476|83249251|FG002|Overall Study|Withdrawal by Subject|1|||
47001644|NCT01607476|83249249|FG000|Overall Study|Lost to Follow-up|0|||
47001645|NCT01607476|83249250|FG001|Overall Study|Lost to Follow-up|0|||
47001646|NCT01607476|83249251|FG002|Overall Study|Lost to Follow-up|2|||
47001647|NCT01765192|83249261|FG000|Treatment Period 1|Adverse Event|0|||
47001648|NCT01765192|83249262|FG001|Treatment Period 1|Adverse Event|1|||
47001649|NCT01765192|83249261|FG000|Washout Period|Voluntary Withdrawal|1|||
47001650|NCT01765192|83249262|FG001|Washout Period|Voluntary Withdrawal|1|||
47001651|NCT01765192|83249261|FG000|Washout Period|Reason not specified|1|||
47001652|NCT01765192|83249262|FG001|Washout Period|Reason not specified|0|||
47001653|NCT01765192|83249261|FG000|Treatment Period 2|Reason not specified|0|||
47001654|NCT01765192|83249262|FG001|Treatment Period 2|Reason not specified|2|||
47001655|NCT01765192|83249261|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
47001656|NCT01765192|83249262|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
46908819|NCT02896400|83137750|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
46908820|NCT02896400|83137751|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
46908821|NCT02896400|83137752|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
46908822|NCT02896400|83137753|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
46908823|NCT02896400|83137754|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
46908824|NCT02896400|83137755|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
47001657|NCT01733680|83249270|FG000|Overall Study|Withdrawal by Subject|0|||
47001658|NCT01733680|83249271|FG001|Overall Study|Withdrawal by Subject|1|||
47001659|NCT02336165|83249286|FG000|Overall Study|Death|3|||
47001660|NCT02336165|83249287|FG001|Overall Study|Death|0|||
47001661|NCT02336165|83249288|FG002|Overall Study|Death|0|||
47001662|NCT02336165|83249289|FG003|Overall Study|Death|0|||
47001663|NCT02336165|83249290|FG004|Overall Study|Death|1|||
47001664|NCT02336165|83249286|FG000|Overall Study|Physician Decision|2|||
47001665|NCT02336165|83249287|FG001|Overall Study|Physician Decision|2|||
47001666|NCT02336165|83249288|FG002|Overall Study|Physician Decision|1|||
47001667|NCT02336165|83249289|FG003|Overall Study|Physician Decision|1|||
47001668|NCT02336165|83249290|FG004|Overall Study|Physician Decision|0|||
46908825|NCT02896400|83137756|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
47001669|NCT02336165|83249286|FG000|Overall Study|Withdrawal by Subject|0|||
47001670|NCT02336165|83249287|FG001|Overall Study|Withdrawal by Subject|0|||
47001671|NCT02336165|83249288|FG002|Overall Study|Withdrawal by Subject|1|||
47001672|NCT02336165|83249289|FG003|Overall Study|Withdrawal by Subject|0|||
47001673|NCT02336165|83249290|FG004|Overall Study|Withdrawal by Subject|1|||
47001674|NCT02336165|83249286|FG000|Overall Study|Adverse Event|4|||
47001675|NCT02336165|83249287|FG001|Overall Study|Adverse Event|1|||
47001676|NCT02336165|83249288|FG002|Overall Study|Adverse Event|2|||
47001677|NCT02336165|83249289|FG003|Overall Study|Adverse Event|4|||
47001678|NCT02336165|83249290|FG004|Overall Study|Adverse Event|1|||
47001679|NCT02336165|83249286|FG000|Overall Study|Progressive disease|23|||
47001680|NCT02336165|83249287|FG001|Overall Study|Progressive disease|22|||
47001681|NCT02336165|83249288|FG002|Overall Study|Progressive disease|27|||
47001682|NCT02336165|83249289|FG003|Overall Study|Progressive disease|24|||
47001683|NCT02336165|83249290|FG004|Overall Study|Progressive disease|19|||
47001684|NCT02336165|83249286|FG000|Overall Study|Non-compliance|1|||
47001685|NCT02336165|83249287|FG001|Overall Study|Non-compliance|0|||
47001686|NCT02336165|83249288|FG002|Overall Study|Non-compliance|0|||
47001687|NCT02336165|83249289|FG003|Overall Study|Non-compliance|1|||
47001688|NCT02336165|83249290|FG004|Overall Study|Non-compliance|0|||
47001689|NCT02336165|83249286|FG000|Overall Study|Other|1|||
47001690|NCT02336165|83249287|FG001|Overall Study|Other|0|||
47001691|NCT02336165|83249288|FG002|Overall Study|Other|0|||
47001692|NCT02336165|83249289|FG003|Overall Study|Other|1|||
47001693|NCT02336165|83249290|FG004|Overall Study|Other|0|||
47001694|NCT02360111|83249306|FG000|Overall Study|Death|2|||
47001695|NCT02334683|83249312|FG000|First 12 Week Period|Lost to Follow-up|1|||
47001696|NCT02334683|83249313|FG001|First 12 Week Period|Lost to Follow-up|0|||
47001697|NCT02334683|83249312|FG000|Second 12 Week Period|Adverse Event|0|||
47001698|NCT02334683|83249313|FG001|Second 12 Week Period|Adverse Event|1|||
47001699|NCT02319044|83249322|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
47001700|NCT02319044|83249323|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
47001701|NCT02319044|83249324|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
47001702|NCT02319044|83249322|FG000|Overall Study|Withdrawal by Subject|3|||
47001703|NCT02319044|83249323|FG001|Overall Study|Withdrawal by Subject|3|||
47001704|NCT02319044|83249324|FG002|Overall Study|Withdrawal by Subject|6|||
47001705|NCT02319044|83249322|FG000|Overall Study|Condition under investigation worsened|100|||
47001706|NCT02319044|83249323|FG001|Overall Study|Condition under investigation worsened|50|||
47001707|NCT02319044|83249324|FG002|Overall Study|Condition under investigation worsened|46|||
47001708|NCT02319044|83249322|FG000|Overall Study|Adverse Event|17|||
47001709|NCT02319044|83249323|FG001|Overall Study|Adverse Event|2|||
47001710|NCT02319044|83249324|FG002|Overall Study|Adverse Event|8|||
47001711|NCT02319044|83249322|FG000|Overall Study|Study specific discontinuation criteria|2|||
47001712|NCT02319044|83249323|FG001|Overall Study|Study specific discontinuation criteria|2|||
46908826|NCT02896400|83137757|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
46908827|NCT02896400|83137758|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
46908828|NCT02896400|83137759|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
46908829|NCT02896400|83137760|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
46908830|NCT03405935|83137786|FG000|Overall Study|Adverse Event|3|||
46908831|NCT03405935|83137786|FG000|Overall Study|Death|2|||
46908832|NCT03405935|83137786|FG000|Overall Study|Withdrawal by Subject|1|||
46908833|NCT03405935|83137786|FG000|Overall Study|Lost to Follow-up|2|||
46908834|NCT03055260|83137792|FG000|Overall Study|Withdrawal by Subject|1|||
47001713|NCT02319044|83249324|FG002|Overall Study|Study specific discontinuation criteria|1|||
47001714|NCT02319044|83249322|FG000|Overall Study|Not treated|0|||
47001715|NCT02319044|83249323|FG001|Overall Study|Not treated|2|||
47001716|NCT02319044|83249324|FG002|Overall Study|Not treated|2|||
47001717|NCT01649765|83249335|FG000|Overall Study|Adverse Event|5|||
47001718|NCT01649765|83249336|FG001|Overall Study|Adverse Event|3|||
47001719|NCT01649765|83249335|FG000|Overall Study|Lack of Efficacy|1|||
47001720|NCT01649765|83249336|FG001|Overall Study|Lack of Efficacy|1|||
47001721|NCT01649765|83249335|FG000|Overall Study|Physician Decision|0|||
46709323|NCT01143714|82925290|FG001|Overall Study|wound closed = deemed healed|0|||
47001722|NCT01649765|83249336|FG001|Overall Study|Physician Decision|3|||
47001723|NCT01649765|83249335|FG000|Overall Study|Protocol Violation|1|||
47001724|NCT01649765|83249336|FG001|Overall Study|Protocol Violation|0|||
47001725|NCT01649765|83249335|FG000|Overall Study|Withdrawal by Subject|2|||
47001726|NCT01649765|83249336|FG001|Overall Study|Withdrawal by Subject|1|||
47001727|NCT02317562|83249343|FG000|Overall Study|Physician Decision|1|||
47001728|NCT02317562|83249343|FG000|Overall Study|early termination of the study|8|||
47001729|NCT02317562|83249343|FG000|Overall Study|Lack of Efficacy|4|||
47001730|NCT02317562|83249343|FG000|Overall Study|Withdrawal by Subject|1|||
47001731|NCT02317016|83249347|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
47001732|NCT02317016|83249347|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
47001733|NCT02317016|83249347|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
47001734|NCT02317016|83249347|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
47001735|NCT02317016|83249347|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
47001736|NCT02317016|83249347|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
47001737|NCT02317016|83249347|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
47001738|NCT02311478|83249355|FG000|Overall Study|Withdrawal by Subject|1|||
47001739|NCT02311478|83249355|FG000|Overall Study|Lost to Follow-up|5|||
47001740|NCT02311478|83249355|FG000|Overall Study|Failed IUD Insertion|1|||
47001741|NCT02388932|83249360|FG000|Overall Study|Death|1|||
47001742|NCT02388776|83249365|FG000|Overall Study|Death|1|||
47001743|NCT02388776|83249365|FG000|Overall Study|Lost to Follow-up|1|||
47001744|NCT02316548|83249372|FG000|Overall Study|Protocol Violation|0|||
47001745|NCT02316548|83249373|FG001|Overall Study|Protocol Violation|1|||
47001746|NCT02281760|83249379|FG000|Overall Study|Withdrawal by Subject|1|||
47001747|NCT02390531|83249391|FG000|Overall Study|Death|0|||
47001748|NCT02390531|83249392|FG001|Overall Study|Death|2|||
47001749|NCT02390531|83249393|FG002|Overall Study|Death|0|||
47001750|NCT02390531|83249394|FG003|Overall Study|Death|1|||
47001751|NCT02390531|83249395|FG004|Overall Study|Death|0|||
47001752|NCT02390531|83249396|FG005|Overall Study|Death|0|||
47001753|NCT02390531|83249397|FG006|Overall Study|Death|0|||
47001754|NCT02390531|83249398|FG007|Overall Study|Death|1|||
47001755|NCT02390531|83249391|FG000|Overall Study|Protocol Violation|0|||
47001756|NCT02390531|83249392|FG001|Overall Study|Protocol Violation|0|||
47001757|NCT02390531|83249393|FG002|Overall Study|Protocol Violation|0|||
47001758|NCT02390531|83249394|FG003|Overall Study|Protocol Violation|0|||
47001759|NCT02390531|83249395|FG004|Overall Study|Protocol Violation|1|||
47001760|NCT02390531|83249396|FG005|Overall Study|Protocol Violation|0|||
47001761|NCT02390531|83249397|FG006|Overall Study|Protocol Violation|2|||
47001762|NCT02390531|83249398|FG007|Overall Study|Protocol Violation|0|||
47001763|NCT02390219|83249434|FG000|Overall Study|Death|1|||
47001764|NCT02390219|83249434|FG000|Overall Study|Physician Decision|1|||
47001765|NCT02390219|83249434|FG000|Overall Study|Adverse Event|6|||
47001766|NCT02390219|83249434|FG000|Overall Study|Withdrawal by Subject|1|||
47001767|NCT02390219|83249434|FG000|Overall Study|Lost to Follow-up|2|||
47001768|NCT02390219|83249434|FG000|Overall Study|Other|2|||
47001769|NCT02334215|83249441|FG000|Overall Study|Death|1|||
47001770|NCT02334215|83249442|FG001|Overall Study|Death|1|||
47001771|NCT02334215|83249443|FG002|Overall Study|Death|0|||
47001772|NCT02334215|83249441|FG000|Overall Study|Lost to Follow-up|1|||
46620436|NCT04307446|82769496|FG001|Overall Study|Lost to Follow-up|0|||
46908835|NCT03055260|83137793|FG001|Overall Study|Withdrawal by Subject|0|||
46908836|NCT03404843|83137801|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
46908837|NCT03404843|83137802|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
46908838|NCT03444155|83137826|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
46908839|NCT03444155|83137827|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
46908840|NCT02898116|83137833|FG000|Overall Study|Adverse Event|1|||
46908841|NCT02898116|83137833|FG000|Overall Study|Progressive disease|1|||
46908842|NCT03422159|83137839|FG000|Overall Study|Exclusion due to terminal disease|2|||
46908843|NCT03422159|83137840|FG001|Overall Study|Exclusion due to terminal disease|1|||
46908844|NCT03403751|83137854|FG000|Overall Study|Death|5|||
46908845|NCT03403751|83137855|FG001|Overall Study|Death|6|||
46908846|NCT03403751|83137854|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
46908847|NCT03403751|83137855|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
47001773|NCT02334215|83249442|FG001|Overall Study|Lost to Follow-up|0|||
47001774|NCT02334215|83249443|FG002|Overall Study|Lost to Follow-up|4|||
46620437|NCT04143009|82769518|FG000|Pilot Trial|Lost to Follow-up|0|||
46620438|NCT04143009|82769519|FG001|Pilot Trial|Lost to Follow-up|1|||
47001775|NCT02334215|83249441|FG000|Overall Study|Withdrawal by Subject|2|||
47001776|NCT02334215|83249442|FG001|Overall Study|Withdrawal by Subject|2|||
47001777|NCT02334215|83249443|FG002|Overall Study|Withdrawal by Subject|1|||
47001778|NCT02334215|83249441|FG000|Overall Study|Not released from incarceration on time|3|||
47001779|NCT02334215|83249442|FG001|Overall Study|Not released from incarceration on time|3|||
47001780|NCT02334215|83249443|FG002|Overall Study|Not released from incarceration on time|3|||
47001781|NCT02334215|83249441|FG000|Overall Study|Incarcerated|0|||
47001782|NCT02334215|83249442|FG001|Overall Study|Incarcerated|0|||
47001783|NCT02334215|83249443|FG002|Overall Study|Incarcerated|7|||
47001784|NCT02359877|83249455|FG000|Overall Study|Withdrawal by Subject|1|||
46908848|NCT02297412|83137865|FG000|Overall Study|Canceled|1|||
47001785|NCT02359877|83249456|FG001|Overall Study|Withdrawal by Subject|0|||
47001786|NCT02359877|83249457|FG002|Overall Study|Withdrawal by Subject|0|||
47001787|NCT02359877|83249458|FG003|Overall Study|Withdrawal by Subject|2|||
47001788|NCT02359877|83249455|FG000|Overall Study|Adverse Event|0|||
47001789|NCT02359877|83249456|FG001|Overall Study|Adverse Event|0|||
47001790|NCT02359877|83249457|FG002|Overall Study|Adverse Event|0|||
47001791|NCT02359877|83249458|FG003|Overall Study|Adverse Event|1|||
47001792|NCT02389829|83249488|FG000|Overall Study|Lost to Follow-up|0|||
47001793|NCT02389829|83249489|FG001|Overall Study|Lost to Follow-up|1|||
47001794|NCT02358863|83249495|FG000|Overall Study|Physician Decision|3|||
47001795|NCT02358473|83249499|FG000|Overall Study|Disease Progession|6|||
47001796|NCT02358473|83249499|FG000|Overall Study|Adverse Event|3|||
47001797|NCT02358473|83249499|FG000|Overall Study|Withdrawal by Subject|2|||
47001798|NCT02358473|83249499|FG000|Overall Study|Physician Decision|2|||
47001799|NCT02357459|83249506|FG000|Overall Study|Adverse Event|0|||
47001800|NCT02357459|83249507|FG001|Overall Study|Adverse Event|1|||
47001801|NCT02357459|83249508|FG002|Overall Study|Adverse Event|1|||
47001802|NCT02357459|83249506|FG000|Overall Study|Withdrawal by Subject|5|||
47001803|NCT02357459|83249507|FG001|Overall Study|Withdrawal by Subject|3|||
47001804|NCT02357459|83249508|FG002|Overall Study|Withdrawal by Subject|3|||
47001805|NCT02357459|83249506|FG000|Overall Study|Physician Decision|0|||
47001806|NCT02357459|83249507|FG001|Overall Study|Physician Decision|2|||
47001807|NCT02357459|83249508|FG002|Overall Study|Physician Decision|0|||
47001808|NCT02357459|83249506|FG000|Overall Study|Protocol Violation|1|||
47001809|NCT02357459|83249507|FG001|Overall Study|Protocol Violation|1|||
47001810|NCT02357459|83249508|FG002|Overall Study|Protocol Violation|0|||
47001811|NCT02357459|83249506|FG000|Overall Study|Lost to Follow-up|1|||
47001812|NCT02357459|83249507|FG001|Overall Study|Lost to Follow-up|3|||
47001813|NCT02357459|83249508|FG002|Overall Study|Lost to Follow-up|0|||
47001814|NCT02357459|83249506|FG000|Overall Study|Lack of Efficacy|7|||
47001815|NCT02357459|83249507|FG001|Overall Study|Lack of Efficacy|4|||
47001816|NCT02357459|83249508|FG002|Overall Study|Lack of Efficacy|4|||
47001817|NCT02357459|83249506|FG000|Overall Study|Patient Relocated|2|||
47001818|NCT02357459|83249507|FG001|Overall Study|Patient Relocated|0|||
47001819|NCT02357459|83249508|FG002|Overall Study|Patient Relocated|0|||
47001820|NCT02357459|83249506|FG000|Overall Study|Instruction from PCP|1|||
47001821|NCT02357459|83249507|FG001|Overall Study|Instruction from PCP|0|||
47001822|NCT02357459|83249508|FG002|Overall Study|Instruction from PCP|0|||
47001823|NCT02357459|83249506|FG000|Overall Study|Incarceration|0|||
47001824|NCT02357459|83249507|FG001|Overall Study|Incarceration|0|||
47001825|NCT02357459|83249508|FG002|Overall Study|Incarceration|1|||
47001826|NCT02357459|83249506|FG000|Overall Study|Pre-planned Knee surgery|0|||
47001827|NCT02357459|83249507|FG001|Overall Study|Pre-planned Knee surgery|0|||
47001828|NCT02357459|83249508|FG002|Overall Study|Pre-planned Knee surgery|2|||
47001829|NCT02357459|83249506|FG000|Overall Study|Job Commitments|0|||
47001830|NCT02357459|83249507|FG001|Overall Study|Job Commitments|0|||
47001831|NCT02357459|83249508|FG002|Overall Study|Job Commitments|1|||
47001832|NCT02332889|83249519|FG000|Overall Study|Physician Decision|1|||
47001833|NCT02357147|83249525|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
47001834|NCT02357147|83249526|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
47001835|NCT02357147|83249525|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
47001836|NCT02357147|83249526|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
47001837|NCT02357147|83249525|FG000|Combination Treatment Phase|Investigator Discretion|1|||
47001838|NCT02357147|83249526|FG001|Combination Treatment Phase|Investigator Discretion|1|||
47001839|NCT02357147|83249525|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
47001840|NCT02357147|83249526|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
47001841|NCT02357147|83249525|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
47001842|NCT02357147|83249526|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
47001843|NCT02357147|83249525|FG000|Combination Treatment Phase|Adverse Event|12|||
47001844|NCT02357147|83249526|FG001|Combination Treatment Phase|Adverse Event|4|||
47001845|NCT02357147|83249525|FG000|Combination Treatment Phase|Death|1|||
47001846|NCT02357147|83249526|FG001|Combination Treatment Phase|Death|1|||
47001847|NCT02357147|83249525|FG000|Combination Treatment Phase|Sponsor Decision|0|||
47001848|NCT02357147|83249526|FG001|Combination Treatment Phase|Sponsor Decision|12|||
47001849|NCT02357147|83249525|FG000|Combination Treatment Phase|Other|1|||
47001850|NCT02357147|83249526|FG001|Combination Treatment Phase|Other|0|||
47001851|NCT02357147|83249525|FG000|Combination Treatment Phase|Not treated|0|||
47001852|NCT02357147|83249526|FG001|Combination Treatment Phase|Not treated|2|||
47001853|NCT02357147|83249525|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
47001854|NCT02357147|83249526|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
47001855|NCT02357147|83249525|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
47001856|NCT02357147|83249526|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
47001857|NCT02357147|83249525|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
47001858|NCT02357147|83249526|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
47001859|NCT02357147|83249525|FG000|Maintenance Treatment Phase|Adverse Event|0|||
47001860|NCT02357147|83249526|FG001|Maintenance Treatment Phase|Adverse Event|3|||
47001861|NCT02357147|83249525|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
47001862|NCT02357147|83249526|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
47001863|NCT02357147|83249525|FG000|Maintenance Treatment Phase|Not Treated|1|||
47001864|NCT02357147|83249526|FG001|Maintenance Treatment Phase|Not Treated|0|||
47001865|NCT02356211|83249538|FG000|Overall Study|Withdrawal by Subject|2|||
47001866|NCT02356211|83249539|FG001|Overall Study|Withdrawal by Subject|2|||
47001867|NCT02356211|83249538|FG000|Overall Study|ineligible|1|||
47001868|NCT02356211|83249539|FG001|Overall Study|ineligible|8|||
47001869|NCT02332655|83249545|FG000|Overall Study|Lack of Efficacy|1|||
47001870|NCT02388737|83249552|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
47001871|NCT02388737|83249553|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
47001872|NCT02388737|83249554|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
47001873|NCT02388737|83249552|FG000|Overall Study|Major Protocol Deviation|18|||
47001874|NCT02388737|83249553|FG001|Overall Study|Major Protocol Deviation|25|||
47001875|NCT02388737|83249554|FG002|Overall Study|Major Protocol Deviation|22|||
47001876|NCT02388737|83249552|FG000|Overall Study|Lost to Follow-up|5|||
47001877|NCT02388737|83249553|FG001|Overall Study|Lost to Follow-up|1|||
47001878|NCT02388737|83249554|FG002|Overall Study|Lost to Follow-up|4|||
47001879|NCT02388737|83249552|FG000|Overall Study|Voluntary Withdrawal|10|||
47001880|NCT02388737|83249553|FG001|Overall Study|Voluntary Withdrawal|18|||
47001881|NCT02388737|83249554|FG002|Overall Study|Voluntary Withdrawal|17|||
47001882|NCT02388737|83249552|FG000|Overall Study|Lack of Efficacy|3|||
47001883|NCT02388737|83249553|FG001|Overall Study|Lack of Efficacy|0|||
47001884|NCT02388737|83249554|FG002|Overall Study|Lack of Efficacy|3|||
47001885|NCT02388737|83249552|FG000|Overall Study|Reason Not Specified|5|||
47001886|NCT02388737|83249553|FG001|Overall Study|Reason Not Specified|5|||
47001887|NCT02388737|83249554|FG002|Overall Study|Reason Not Specified|4|||
47001888|NCT02355743|83249562|FG000|Overall Study|Withdrawal by Subject|1|||
47001889|NCT02355743|83249562|FG000|Overall Study|Lost to Follow-up|1|||
47001890|NCT02388347|83249571|FG000|Overall Study|Withdrawal by Subject|0|||
47001891|NCT02388347|83249572|FG001|Overall Study|Withdrawal by Subject|0|||
47001892|NCT02388347|83249573|FG002|Overall Study|Withdrawal by Subject|1|||
47001893|NCT02388347|83249574|FG003|Overall Study|Withdrawal by Subject|0|||
47001894|NCT02388347|83249575|FG004|Overall Study|Withdrawal by Subject|0|||
47001895|NCT02355665|83249593|FG000|Overall Study|Adverse Event|16|||
47001896|NCT02355665|83249594|FG001|Overall Study|Adverse Event|24|||
47001897|NCT02355665|83249593|FG000|Overall Study|Protocol Violation|2|||
47001898|NCT02355665|83249594|FG001|Overall Study|Protocol Violation|0|||
47001899|NCT02355665|83249593|FG000|Overall Study|Withdrawal by Subject|90|||
47001900|NCT02355665|83249594|FG001|Overall Study|Withdrawal by Subject|100|||
47001901|NCT02355665|83249593|FG000|Overall Study|Lost to Follow-up|131|||
47001902|NCT02355665|83249594|FG001|Overall Study|Lost to Follow-up|103|||
47001903|NCT02355665|83249593|FG000|Overall Study|Death|4|||
47001904|NCT02355665|83249594|FG001|Overall Study|Death|2|||
47001905|NCT02355665|83249593|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
47001906|NCT02355665|83249594|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
47001907|NCT02010255|83249614|FG000|Overall Study|Death|0|||
47001908|NCT02010255|83249615|FG001|Overall Study|Death|1|||
47001909|NCT02010255|83249616|FG002|Overall Study|Death|4|||
47001910|NCT02010255|83249617|FG003|Overall Study|Death|4|||
47001911|NCT02010255|83249618|FG004|Overall Study|Death|2|||
47001912|NCT02010255|83249619|FG005|Overall Study|Death|0|||
47001913|NCT02010255|83249620|FG006|Overall Study|Death|1|||
47001914|NCT02010255|83249621|FG007|Overall Study|Death|1|||
47001915|NCT02010255|83249622|FG008|Overall Study|Death|1|||
47001916|NCT02010255|83249623|FG009|Overall Study|Death|0|||
47001917|NCT02010255|83249624|FG010|Overall Study|Death|1|||
47001918|NCT02010255|83249625|FG011|Overall Study|Death|1|||
47001919|NCT02010255|83249626|FG012|Overall Study|Death|0|||
47001920|NCT02010255|83249627|FG013|Overall Study|Death|0|||
47001921|NCT02010255|83249614|FG000|Overall Study|Lack of Efficacy|4|||
47001922|NCT02010255|83249615|FG001|Overall Study|Lack of Efficacy|1|||
47001923|NCT02010255|83249616|FG002|Overall Study|Lack of Efficacy|2|||
47001924|NCT02010255|83249617|FG003|Overall Study|Lack of Efficacy|1|||
47001925|NCT02010255|83249618|FG004|Overall Study|Lack of Efficacy|1|||
47001926|NCT02010255|83249619|FG005|Overall Study|Lack of Efficacy|0|||
47001927|NCT02010255|83249620|FG006|Overall Study|Lack of Efficacy|0|||
47001928|NCT02010255|83249621|FG007|Overall Study|Lack of Efficacy|0|||
46620439|NCT04143009|82769520|FG002|Pilot Trial|Lost to Follow-up|1|||
47001929|NCT02010255|83249622|FG008|Overall Study|Lack of Efficacy|0|||
47001930|NCT02010255|83249623|FG009|Overall Study|Lack of Efficacy|0|||
47001931|NCT02010255|83249624|FG010|Overall Study|Lack of Efficacy|1|||
47001932|NCT02010255|83249625|FG011|Overall Study|Lack of Efficacy|0|||
47001933|NCT02010255|83249626|FG012|Overall Study|Lack of Efficacy|0|||
47001934|NCT02010255|83249627|FG013|Overall Study|Lack of Efficacy|0|||
47001935|NCT02010255|83249614|FG000|Overall Study|Withdrew Consent|1|||
47001936|NCT02010255|83249615|FG001|Overall Study|Withdrew Consent|0|||
47001937|NCT02010255|83249616|FG002|Overall Study|Withdrew Consent|0|||
47001938|NCT02010255|83249617|FG003|Overall Study|Withdrew Consent|1|||
47001939|NCT02010255|83249618|FG004|Overall Study|Withdrew Consent|0|||
47001940|NCT02010255|83249619|FG005|Overall Study|Withdrew Consent|0|||
47001941|NCT02010255|83249620|FG006|Overall Study|Withdrew Consent|0|||
47001942|NCT02010255|83249621|FG007|Overall Study|Withdrew Consent|0|||
47001943|NCT02010255|83249622|FG008|Overall Study|Withdrew Consent|0|||
47001944|NCT02010255|83249623|FG009|Overall Study|Withdrew Consent|0|||
47001945|NCT02010255|83249624|FG010|Overall Study|Withdrew Consent|0|||
47001946|NCT02010255|83249625|FG011|Overall Study|Withdrew Consent|0|||
47001947|NCT02010255|83249626|FG012|Overall Study|Withdrew Consent|0|||
47001948|NCT02010255|83249627|FG013|Overall Study|Withdrew Consent|0|||
47001949|NCT02010255|83249614|FG000|Overall Study|Adverse Event|1|||
47001950|NCT02010255|83249615|FG001|Overall Study|Adverse Event|0|||
47001951|NCT02010255|83249616|FG002|Overall Study|Adverse Event|0|||
47001952|NCT02010255|83249617|FG003|Overall Study|Adverse Event|0|||
47001953|NCT02010255|83249618|FG004|Overall Study|Adverse Event|0|||
47001954|NCT02010255|83249619|FG005|Overall Study|Adverse Event|0|||
47001955|NCT02010255|83249620|FG006|Overall Study|Adverse Event|0|||
47001956|NCT02010255|83249621|FG007|Overall Study|Adverse Event|0|||
47001957|NCT02010255|83249622|FG008|Overall Study|Adverse Event|0|||
47001958|NCT02010255|83249623|FG009|Overall Study|Adverse Event|0|||
47001959|NCT02010255|83249624|FG010|Overall Study|Adverse Event|0|||
47001960|NCT02010255|83249625|FG011|Overall Study|Adverse Event|0|||
47001961|NCT02010255|83249626|FG012|Overall Study|Adverse Event|0|||
47001962|NCT02010255|83249627|FG013|Overall Study|Adverse Event|0|||
47001963|NCT02010255|83249614|FG000|Overall Study|Lost to Follow-up|0|||
47001964|NCT02010255|83249615|FG001|Overall Study|Lost to Follow-up|0|||
47001965|NCT02010255|83249616|FG002|Overall Study|Lost to Follow-up|1|||
47001966|NCT02010255|83249617|FG003|Overall Study|Lost to Follow-up|0|||
47001967|NCT02010255|83249618|FG004|Overall Study|Lost to Follow-up|1|||
47001968|NCT02010255|83249619|FG005|Overall Study|Lost to Follow-up|0|||
47001969|NCT02010255|83249620|FG006|Overall Study|Lost to Follow-up|0|||
47001970|NCT02010255|83249621|FG007|Overall Study|Lost to Follow-up|0|||
47001971|NCT02010255|83249622|FG008|Overall Study|Lost to Follow-up|0|||
47001972|NCT02010255|83249623|FG009|Overall Study|Lost to Follow-up|0|||
47001973|NCT02010255|83249624|FG010|Overall Study|Lost to Follow-up|0|||
47001974|NCT02010255|83249625|FG011|Overall Study|Lost to Follow-up|0|||
47001975|NCT02010255|83249626|FG012|Overall Study|Lost to Follow-up|0|||
47001976|NCT02010255|83249627|FG013|Overall Study|Lost to Follow-up|0|||
47001977|NCT02010255|83249614|FG000|Overall Study|Randomized but Not Treated|0|||
47001978|NCT02010255|83249615|FG001|Overall Study|Randomized but Not Treated|0|||
47001979|NCT02010255|83249616|FG002|Overall Study|Randomized but Not Treated|0|||
47001980|NCT02010255|83249617|FG003|Overall Study|Randomized but Not Treated|0|||
47001981|NCT02010255|83249618|FG004|Overall Study|Randomized but Not Treated|0|||
47001982|NCT02010255|83249619|FG005|Overall Study|Randomized but Not Treated|0|||
47001983|NCT02010255|83249620|FG006|Overall Study|Randomized but Not Treated|0|||
47001984|NCT02010255|83249621|FG007|Overall Study|Randomized but Not Treated|0|||
47001985|NCT02010255|83249622|FG008|Overall Study|Randomized but Not Treated|0|||
47001986|NCT02010255|83249623|FG009|Overall Study|Randomized but Not Treated|0|||
47001987|NCT02010255|83249624|FG010|Overall Study|Randomized but Not Treated|0|||
47001988|NCT02010255|83249625|FG011|Overall Study|Randomized but Not Treated|0|||
47001989|NCT02010255|83249626|FG012|Overall Study|Randomized but Not Treated|0|||
47001990|NCT02010255|83249627|FG013|Overall Study|Randomized but Not Treated|1|||
47001991|NCT02354417|83249682|FG000|Overall Study|Physician Decision|1|||
47001992|NCT02332187|83249688|FG000|Overall Study|Withdrawal by Subject|2|||
47001993|NCT02332187|83249689|FG001|Overall Study|Withdrawal by Subject|2|||
47001994|NCT02332187|83249688|FG000|Overall Study|Adverse Event|0|||
47001995|NCT02332187|83249689|FG001|Overall Study|Adverse Event|1|||
47001996|NCT02330549|83249697|FG000|Overall Study|Adverse Event|1|||
47001997|NCT02330549|83249698|FG001|Overall Study|Adverse Event|0|||
47001998|NCT02330549|83249697|FG000|Overall Study|Subject withdrew consent|2|||
47001999|NCT02330549|83249698|FG001|Overall Study|Subject withdrew consent|1|||
47002000|NCT02330549|83249697|FG000|Overall Study|Failure to meet randomization criteria|1|||
47002001|NCT02330549|83249698|FG001|Overall Study|Failure to meet randomization criteria|0|||
47002002|NCT02009865|83249706|FG000|Overall Study|Adverse Event|0|||
47002003|NCT02009865|83249707|FG001|Overall Study|Adverse Event|2|||
46709324|NCT01143714|82925289|FG000|Overall Study|wound size increased|1|||
47002004|NCT02009865|83249706|FG000|Overall Study|Protocol Violation|0|||
47002005|NCT02009865|83249707|FG001|Overall Study|Protocol Violation|2|||
46908849|NCT02297412|83137866|FG001|Overall Study|Canceled|1|||
46908850|NCT03418727|83137875|FG000|Overall Study|Adverse Event|1|||
46908851|NCT03418727|83137876|FG001|Overall Study|Adverse Event|2|||
46908852|NCT03418727|83137877|FG002|Overall Study|Adverse Event|0|||
46908853|NCT03418727|83137875|FG000|Overall Study|Withdrawal by Subject|0|||
46908854|NCT03418727|83137876|FG001|Overall Study|Withdrawal by Subject|0|||
46908855|NCT03418727|83137877|FG002|Overall Study|Withdrawal by Subject|2|||
46908856|NCT03418571|83137887|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
47002006|NCT02009865|83249706|FG000|Overall Study|Withdrawal by Subject|1|||
47002007|NCT02009865|83249707|FG001|Overall Study|Withdrawal by Subject|1|||
47002008|NCT01620177|83249713|FG000|Overall Study|Failure at Screening Visit|43|||
47002009|NCT01620177|83249713|FG000|Overall Study|Withdrawal by Subject|26|||
47002010|NCT01620177|83249713|FG000|Overall Study|Lost to Follow-up|7|||
47002011|NCT01620177|83249713|FG000|Overall Study|Physician Decision|2|||
47002012|NCT01620177|83249713|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
47002013|NCT02075541|83249732|FG000|Overall Study|Serious Adverse Event|1|||
47002014|NCT02075541|83249733|FG001|Overall Study|Serious Adverse Event|4|||
47002015|NCT02075541|83249732|FG000|Overall Study|Protocol Violation|1|||
47002016|NCT02075541|83249733|FG001|Overall Study|Protocol Violation|0|||
47002017|NCT02075541|83249732|FG000|Overall Study|Withdrawal by Subject|1|||
47002018|NCT02075541|83249733|FG001|Overall Study|Withdrawal by Subject|3|||
47002019|NCT02075541|83249732|FG000|Overall Study|Sponsor study termination|0|||
47002020|NCT02075541|83249733|FG001|Overall Study|Sponsor study termination|1|||
47002021|NCT02075541|83249732|FG000|Overall Study|Other- unable to perform study procedure|1|||
47002022|NCT02075541|83249733|FG001|Overall Study|Other- unable to perform study procedure|0|||
47002023|NCT02330081|83249739|FG000|Overall Study|Adverse Event|1|||
47002024|NCT02330081|83249739|FG000|Overall Study|Donation did not meet criteria|1|||
47002025|NCT02330081|83249739|FG000|Overall Study|Protocol Violation|6|||
47002026|NCT01986855|83249749|FG000|Overall Study|Adverse Event|1|||
47002027|NCT01986855|83249750|FG001|Overall Study|Adverse Event|0|||
47002028|NCT01986855|83249751|FG002|Overall Study|Adverse Event|0|||
47002029|NCT01986855|83249749|FG000|Overall Study|Death|3|||
47002030|NCT01986855|83249750|FG001|Overall Study|Death|4|||
47002031|NCT01986855|83249751|FG002|Overall Study|Death|4|||
47002032|NCT01986855|83249749|FG000|Overall Study|Lost to Follow-up|2|||
47002033|NCT01986855|83249750|FG001|Overall Study|Lost to Follow-up|1|||
47002034|NCT01986855|83249751|FG002|Overall Study|Lost to Follow-up|0|||
47002035|NCT01986855|83249749|FG000|Overall Study|Screen Failure|0|||
47002036|NCT01986855|83249750|FG001|Overall Study|Screen Failure|1|||
47002037|NCT01986855|83249751|FG002|Overall Study|Screen Failure|0|||
47002038|NCT01986855|83249749|FG000|Overall Study|Participant Moved|0|||
47002039|NCT01986855|83249750|FG001|Overall Study|Participant Moved|0|||
47002040|NCT01986855|83249751|FG002|Overall Study|Participant Moved|2|||
47002041|NCT01986855|83249749|FG000|Overall Study|Withdrawal by Subject|7|||
47002042|NCT01986855|83249750|FG001|Overall Study|Withdrawal by Subject|8|||
47002043|NCT01986855|83249751|FG002|Overall Study|Withdrawal by Subject|5|||
47002044|NCT02075463|83249759|FG000|Overall Study|Adverse Event|3|||
47002045|NCT02075463|83249759|FG000|Overall Study|Par. reached stopping criteria|4|||
47002046|NCT02075463|83249759|FG000|Overall Study|Withdrawal by Subject|1|||
47002047|NCT02353871|83249766|FG000|Overall Study|Protocol deviation|0|||
47002048|NCT02353871|83249767|FG001|Overall Study|Protocol deviation|1|||
47002049|NCT02353871|83249766|FG000|Overall Study|Consent withdrawn|1|||
47002050|NCT02353871|83249767|FG001|Overall Study|Consent withdrawn|8|||
47002051|NCT02353871|83249766|FG000|Overall Study|Lost to Follow-up|2|||
47002052|NCT02353871|83249767|FG001|Overall Study|Lost to Follow-up|0|||
47002053|NCT02009397|83249773|FG000|Overall Study|Protocol Violation|6|||
47002054|NCT02009397|83249773|FG000|Overall Study|Death|8|||
47002055|NCT02009397|83249773|FG000|Overall Study|Lost to Follow-up|6|||
47002056|NCT02312219|83249779|FG000|Overall Study|Withdrawal by Subject|1|||
47002057|NCT02312219|83249780|FG001|Overall Study|Withdrawal by Subject|2|||
47002058|NCT02312219|83249779|FG000|Overall Study|could not schedule imaging in time|0|||
47002059|NCT02312219|83249780|FG001|Overall Study|could not schedule imaging in time|2|||
47002060|NCT02312219|83249779|FG000|Overall Study|Other|0|||
47002061|NCT02312219|83249780|FG001|Overall Study|Other|1|||
47002062|NCT02312219|83249779|FG000|Overall Study|Not randomized. Ineligible|0|||
47002063|NCT02312219|83249780|FG001|Overall Study|Not randomized. Ineligible|1|||
47002064|NCT01986231|83249786|FG000|Overall Study|Adverse Event|1|||
47002065|NCT02312063|83249792|FG000|Overall Study|Withdrawal by Subject|0|||
47002066|NCT02312063|83249793|FG001|Overall Study|Withdrawal by Subject|1|||
47002067|NCT02353169|83249804|FG000|Overall Study|QTc > 450 msec|1|||
47002068|NCT02353169|83249805|FG001|Overall Study|QTc > 450 msec|1|||
47002069|NCT02353169|83249806|FG002|Overall Study|QTc > 450 msec|1|||
47002070|NCT02353169|83249807|FG003|Overall Study|QTc > 450 msec|1|||
47002071|NCT02353169|83249804|FG000|Overall Study|OR team declined|2|||
47002072|NCT02353169|83249805|FG001|Overall Study|OR team declined|0|||
47002073|NCT02353169|83249806|FG002|Overall Study|OR team declined|0|||
47002074|NCT02353169|83249807|FG003|Overall Study|OR team declined|0|||
47002075|NCT02353169|83249804|FG000|Overall Study|Inhalational induction|0|||
47002076|NCT02353169|83249805|FG001|Overall Study|Inhalational induction|2|||
47002077|NCT02353169|83249806|FG002|Overall Study|Inhalational induction|0|||
47002078|NCT02353169|83249807|FG003|Overall Study|Inhalational induction|0|||
47002079|NCT02353169|83249804|FG000|Overall Study|ECG data error|0|||
47002080|NCT02353169|83249805|FG001|Overall Study|ECG data error|3|||
47002081|NCT02353169|83249806|FG002|Overall Study|ECG data error|2|||
47002082|NCT02353169|83249807|FG003|Overall Study|ECG data error|2|||
47002083|NCT02353169|83249804|FG000|Overall Study|Pre-op medication|0|||
47002084|NCT02353169|83249805|FG001|Overall Study|Pre-op medication|0|||
47002085|NCT02353169|83249806|FG002|Overall Study|Pre-op medication|1|||
47002086|NCT02353169|83249807|FG003|Overall Study|Pre-op medication|0|||
47002087|NCT02009163|83249817|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
47002088|NCT02009163|83249818|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
47002089|NCT02009163|83249819|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
47002090|NCT02009163|83249817|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
47002091|NCT02009163|83249818|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
47002092|NCT02009163|83249819|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
47002093|NCT02009163|83249817|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
47002094|NCT02009163|83249818|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
47002095|NCT02009163|83249819|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
47002096|NCT02009163|83249817|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
47002097|NCT02009163|83249818|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
47002098|NCT02009163|83249819|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
47002099|NCT02009163|83249817|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
47002100|NCT02009163|83249818|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
47002101|NCT02009163|83249819|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
47002102|NCT02009163|83249817|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
47002103|NCT02009163|83249818|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
47002104|NCT02009163|83249819|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
47002105|NCT02009163|83249817|FG000|Open-label Period (Non-randomized)|Other|13|||
47002106|NCT02009163|83249818|FG001|Open-label Period (Non-randomized)|Other|0|||
47002107|NCT02009163|83249819|FG002|Open-label Period (Non-randomized)|Other|0|||
47002108|NCT02009163|83249817|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
47002109|NCT02009163|83249818|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
47002110|NCT02009163|83249819|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
47002111|NCT02009163|83249817|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
47002112|NCT02009163|83249818|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
47002113|NCT02009163|83249819|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
47002114|NCT02009163|83249817|FG000|Randomized-withdrawal Period|Adverse Event|0|||
47002115|NCT02009163|83249818|FG001|Randomized-withdrawal Period|Adverse Event|0|||
47002116|NCT02009163|83249819|FG002|Randomized-withdrawal Period|Adverse Event|6|||
47002117|NCT02009163|83249817|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
47002118|NCT02009163|83249818|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
46709325|NCT01143714|82925290|FG001|Overall Study|wound size increased|0|||
46709326|NCT00972543|82925311|FG000|Overall Study|Adverse Event|1|||
46908857|NCT03418571|83137888|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
46908858|NCT03402893|83137894|FG000|Overall Study|Withdrawal by Subject|1|||
46908859|NCT03442985|83137902|FG000|Overall Study|Sponsor Request|55|||
46908860|NCT03442985|83137903|FG001|Overall Study|Sponsor Request|60|||
46908861|NCT03442985|83137904|FG002|Overall Study|Sponsor Request|54|||
46908862|NCT03442985|83137902|FG000|Overall Study|Lost to Follow-up|5|||
46908863|NCT03442985|83137903|FG001|Overall Study|Lost to Follow-up|2|||
46908864|NCT03442985|83137904|FG002|Overall Study|Lost to Follow-up|7|||
46908865|NCT03442985|83137902|FG000|Overall Study|Withdrawal by Subject|2|||
46908866|NCT03442985|83137903|FG001|Overall Study|Withdrawal by Subject|3|||
46908867|NCT03442985|83137904|FG002|Overall Study|Withdrawal by Subject|4|||
46709327|NCT00972543|82925312|FG001|Overall Study|Adverse Event|0|||
46709328|NCT00972543|82925311|FG000|Overall Study|Early study termination by sponsor|4|||
46709329|NCT00972543|82925312|FG001|Overall Study|Early study termination by sponsor|1|||
46908868|NCT03442985|83137902|FG000|Overall Study|Adverse Event|0|||
46908869|NCT03442985|83137903|FG001|Overall Study|Adverse Event|1|||
46908870|NCT03442985|83137904|FG002|Overall Study|Adverse Event|0|||
46908871|NCT01318122|83137916|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46620440|NCT04126317|82769530|FG000|Overall Study|Adverse Event|0|||
46620441|NCT04126317|82769531|FG001|Overall Study|Adverse Event|1|||
46620442|NCT04126317|82769530|FG000|Overall Study|Withdrawal by Subject|4|||
46620443|NCT04126317|82769531|FG001|Overall Study|Withdrawal by Subject|1|||
46620444|NCT04066894|82769537|FG000|Overall Study|Lack of Efficacy|1|||
46620445|NCT04066894|82769537|FG000|Overall Study|Screen Failure|1|||
46620446|NCT03929913|82769563|FG000|Overall Study|Death|4|||
46620447|NCT03929913|82769563|FG000|Overall Study|Lost to Follow-up|1|||
46620448|NCT03929913|82769563|FG000|Overall Study|Failed Procedure|2|||
46908872|NCT01318122|83137917|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46620449|NCT03832192|82769578|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
46620450|NCT03832192|82769579|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
46709330|NCT00925132|82925318|FG000|Overall Study|Withdrawal by Subject|2|||
47002119|NCT02009163|83249819|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
47002120|NCT02009163|83249817|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
47002121|NCT02009163|83249818|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
47002122|NCT02009163|83249819|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
47002123|NCT02009163|83249817|FG000|Randomized-withdrawal Period|Pregnancy|0|||
47002124|NCT02009163|83249818|FG001|Randomized-withdrawal Period|Pregnancy|0|||
47002125|NCT02009163|83249819|FG002|Randomized-withdrawal Period|Pregnancy|2|||
47002126|NCT02009163|83249817|FG000|Randomized-withdrawal Period|Other|0|||
47002127|NCT02009163|83249818|FG001|Randomized-withdrawal Period|Other|9|||
47002128|NCT02009163|83249819|FG002|Randomized-withdrawal Period|Other|5|||
47002129|NCT01983969|83249832|FG000|Overall Study|Disease Progression|0|||
47002130|NCT01983969|83249833|FG001|Overall Study|Disease Progression|1|||
47002131|NCT01983969|83249834|FG002|Overall Study|Disease Progression|0|||
47002132|NCT02008773|83249850|FG000|Overall Study|Adverse Event|3|||
47002133|NCT02008773|83249851|FG001|Overall Study|Adverse Event|3|||
47002134|NCT02008773|83249852|FG002|Overall Study|Adverse Event|1|||
47002135|NCT02008773|83249853|FG003|Overall Study|Adverse Event|2|||
47002136|NCT02008773|83249850|FG000|Overall Study|Medication Non-compliance|2|||
47002137|NCT02008773|83249851|FG001|Overall Study|Medication Non-compliance|1|||
47002138|NCT02008773|83249852|FG002|Overall Study|Medication Non-compliance|3|||
47002139|NCT02008773|83249853|FG003|Overall Study|Medication Non-compliance|2|||
47002140|NCT02008773|83249850|FG000|Overall Study|Withdrawal by Subject|8|||
47002141|NCT02008773|83249851|FG001|Overall Study|Withdrawal by Subject|4|||
47002142|NCT02008773|83249852|FG002|Overall Study|Withdrawal by Subject|7|||
47002143|NCT02008773|83249853|FG003|Overall Study|Withdrawal by Subject|6|||
47002144|NCT02008773|83249850|FG000|Overall Study|Lost to Follow-up|0|||
47002145|NCT02008773|83249851|FG001|Overall Study|Lost to Follow-up|1|||
47002146|NCT02008773|83249852|FG002|Overall Study|Lost to Follow-up|3|||
47002147|NCT02008773|83249853|FG003|Overall Study|Lost to Follow-up|2|||
47002148|NCT02257567|83249872|FG000|Overall Study|Adverse Event|0|||
47002149|NCT02257567|83249873|FG001|Overall Study|Adverse Event|0|||
47002150|NCT02257567|83249874|FG002|Overall Study|Adverse Event|0|||
47002151|NCT02257567|83249875|FG003|Overall Study|Adverse Event|1|||
47002152|NCT02257567|83249876|FG004|Overall Study|Adverse Event|1|||
47002153|NCT02257567|83249877|FG005|Overall Study|Adverse Event|0|||
47002154|NCT02257567|83249878|FG006|Overall Study|Adverse Event|0|||
47002155|NCT02257567|83249879|FG007|Overall Study|Adverse Event|0|||
47002156|NCT02257567|83249880|FG008|Overall Study|Adverse Event|1|||
47002157|NCT02257567|83249881|FG009|Overall Study|Adverse Event|0|||
47002158|NCT02257567|83249882|FG010|Overall Study|Adverse Event|0|||
47002159|NCT02257567|83249872|FG000|Overall Study|Death|2|||
47002160|NCT02257567|83249873|FG001|Overall Study|Death|2|||
47002161|NCT02257567|83249874|FG002|Overall Study|Death|2|||
47002162|NCT02257567|83249875|FG003|Overall Study|Death|4|||
47002163|NCT02257567|83249876|FG004|Overall Study|Death|15|||
47002164|NCT02257567|83249877|FG005|Overall Study|Death|11|||
47002165|NCT02257567|83249878|FG006|Overall Study|Death|26|||
47002166|NCT02257567|83249879|FG007|Overall Study|Death|30|||
47002167|NCT02257567|83249880|FG008|Overall Study|Death|2|||
47002168|NCT02257567|83249881|FG009|Overall Study|Death|18|||
47002169|NCT02257567|83249882|FG010|Overall Study|Death|65|||
47002170|NCT02257567|83249872|FG000|Overall Study|Lost to Follow-up|0|||
47002171|NCT02257567|83249873|FG001|Overall Study|Lost to Follow-up|0|||
47002172|NCT02257567|83249874|FG002|Overall Study|Lost to Follow-up|0|||
47002173|NCT02257567|83249875|FG003|Overall Study|Lost to Follow-up|0|||
47002174|NCT02257567|83249876|FG004|Overall Study|Lost to Follow-up|2|||
47002175|NCT02257567|83249877|FG005|Overall Study|Lost to Follow-up|2|||
47002176|NCT02257567|83249878|FG006|Overall Study|Lost to Follow-up|0|||
47002177|NCT02257567|83249879|FG007|Overall Study|Lost to Follow-up|0|||
47002178|NCT02257567|83249880|FG008|Overall Study|Lost to Follow-up|0|||
47002179|NCT02257567|83249881|FG009|Overall Study|Lost to Follow-up|1|||
47002180|NCT02257567|83249882|FG010|Overall Study|Lost to Follow-up|1|||
47002181|NCT02257567|83249872|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002182|NCT02257567|83249873|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002183|NCT02257567|83249874|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002184|NCT02257567|83249875|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002185|NCT02257567|83249876|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
47002186|NCT02257567|83249877|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002187|NCT02257567|83249878|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
47002188|NCT02257567|83249879|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002189|NCT02257567|83249880|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002190|NCT02257567|83249881|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002191|NCT02257567|83249882|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
47002192|NCT02257567|83249872|FG000|Overall Study|Physician Decision|0|||
47002193|NCT02257567|83249873|FG001|Overall Study|Physician Decision|0|||
47002194|NCT02257567|83249874|FG002|Overall Study|Physician Decision|0|||
47002195|NCT02257567|83249875|FG003|Overall Study|Physician Decision|0|||
47002196|NCT02257567|83249876|FG004|Overall Study|Physician Decision|0|||
47002197|NCT02257567|83249877|FG005|Overall Study|Physician Decision|0|||
47002198|NCT02257567|83249878|FG006|Overall Study|Physician Decision|0|||
47002199|NCT02257567|83249879|FG007|Overall Study|Physician Decision|2|||
47002200|NCT02257567|83249880|FG008|Overall Study|Physician Decision|0|||
47002201|NCT02257567|83249881|FG009|Overall Study|Physician Decision|1|||
47002202|NCT02257567|83249882|FG010|Overall Study|Physician Decision|0|||
47002203|NCT02257567|83249872|FG000|Overall Study|Withdrawal by Subject|0|||
47002204|NCT02257567|83249873|FG001|Overall Study|Withdrawal by Subject|0|||
47002205|NCT02257567|83249874|FG002|Overall Study|Withdrawal by Subject|2|||
47002206|NCT02257567|83249875|FG003|Overall Study|Withdrawal by Subject|0|||
47002207|NCT02257567|83249876|FG004|Overall Study|Withdrawal by Subject|0|||
47002208|NCT02257567|83249877|FG005|Overall Study|Withdrawal by Subject|6|||
47002209|NCT02257567|83249878|FG006|Overall Study|Withdrawal by Subject|6|||
47002210|NCT02257567|83249879|FG007|Overall Study|Withdrawal by Subject|6|||
47002211|NCT02257567|83249880|FG008|Overall Study|Withdrawal by Subject|1|||
47002212|NCT02257567|83249881|FG009|Overall Study|Withdrawal by Subject|1|||
47002213|NCT02257567|83249882|FG010|Overall Study|Withdrawal by Subject|10|||
47002214|NCT01642615|83249939|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
47002215|NCT01642615|83249940|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
47002216|NCT01642615|83249941|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
47002217|NCT01642615|83249939|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
47002218|NCT01642615|83249940|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
47002219|NCT01642615|83249941|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
47002220|NCT01642615|83249939|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
47002221|NCT01642615|83249940|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
47002222|NCT01642615|83249941|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
47002223|NCT01642615|83249939|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
47002224|NCT01642615|83249940|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
46908873|NCT01318122|83137918|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
46908874|NCT01318122|83137919|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
46908875|NCT01318122|83137916|FG000|Enrolled - Long-Term Extension Study|Other|1|||
46908876|NCT01318122|83137917|FG001|Enrolled - Long-Term Extension Study|Other|0|||
46908877|NCT01318122|83137918|FG002|Enrolled - Long-Term Extension Study|Other|0|||
46908878|NCT01318122|83137919|FG003|Enrolled - Long-Term Extension Study|Other|0|||
46908879|NCT01318122|83137916|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
46908880|NCT01318122|83137917|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
46908881|NCT01318122|83137918|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
46908882|NCT01318122|83137919|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
46908883|NCT01318122|83137916|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
46908884|NCT01318122|83137917|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46908885|NCT01318122|83137918|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46908886|NCT01318122|83137919|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46908887|NCT01318122|83137916|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46908888|NCT01318122|83137917|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
46908889|NCT01318122|83137918|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46908890|NCT01318122|83137919|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
46908891|NCT01318122|83137916|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
46908892|NCT01318122|83137917|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
46908893|NCT01318122|83137918|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
46908894|NCT01318122|83137919|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
46908895|NCT02954159|83137927|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
46908896|NCT02954159|83137928|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
46908897|NCT02954159|83137927|FG000|Overall Study|Withdrawal by Subject|0|||
46908898|NCT02954159|83137928|FG001|Overall Study|Withdrawal by Subject|1|||
46908899|NCT03442829|83137936|FG000|Overall Study|Scheduling clash|3|||
46908900|NCT03442829|83137937|FG001|Overall Study|Scheduling clash|1|||
46908901|NCT03442829|83137936|FG000|Overall Study|Illness unrelated to study|1|||
46908902|NCT03442829|83137937|FG001|Overall Study|Illness unrelated to study|1|||
46908903|NCT03442595|83137945|FG000|Overall Study|Lost to Follow-up|94|||
46908904|NCT03442595|83137946|FG001|Overall Study|Lost to Follow-up|0|||
46908905|NCT03440411|83137955|FG000|Overall Study|Adverse Event|0|||
46908906|NCT03440411|83137956|FG001|Overall Study|Adverse Event|0|||
47002225|NCT01642615|83249941|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
47002226|NCT01642615|83249939|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
47002227|NCT01642615|83249940|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
47002228|NCT01642615|83249941|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
46709331|NCT00925132|82925319|FG001|Overall Study|Withdrawal by Subject|0|||
47002229|NCT01642615|83249939|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
47002230|NCT01642615|83249940|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
47002231|NCT01642615|83249941|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
47002232|NCT01642615|83249939|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
47002233|NCT01642615|83249940|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
47002234|NCT01642615|83249941|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
47002235|NCT01642615|83249939|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
47002236|NCT01642615|83249940|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
47002237|NCT01642615|83249941|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
47002238|NCT01642615|83249939|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
47002239|NCT01642615|83249940|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
47002240|NCT01642615|83249941|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
47002241|NCT02311361|83249953|FG000|Overall Study|Did not receive treatment|0|||
47002242|NCT02311361|83249954|FG001|Overall Study|Did not receive treatment|1|||
47002243|NCT02311361|83249955|FG002|Overall Study|Did not receive treatment|0|||
47002244|NCT02311361|83249956|FG003|Overall Study|Did not receive treatment|1|||
47002245|NCT02352779|83249973|FG000|Overall Study|Personal Issues|1|||
47002246|NCT02352779|83249974|FG001|Overall Study|Personal Issues|1|||
46709332|NCT00925132|82925320|FG002|Overall Study|Withdrawal by Subject|0|||
46709333|NCT00925132|82925321|FG003|Overall Study|Withdrawal by Subject|0|||
46709334|NCT00925132|82925322|FG004|Overall Study|Withdrawal by Subject|1|||
46709335|NCT00925132|82925318|FG000|Overall Study|Removed due to disease progression|0|||
46709336|NCT00925132|82925319|FG001|Overall Study|Removed due to disease progression|0|||
46908907|NCT03440411|83137957|FG002|Overall Study|Adverse Event|1|||
46709337|NCT00925132|82925320|FG002|Overall Study|Removed due to disease progression|0|||
46709338|NCT00925132|82925321|FG003|Overall Study|Removed due to disease progression|0|||
46709339|NCT00925132|82925322|FG004|Overall Study|Removed due to disease progression|4|||
46709340|NCT01143402|82925331|FG000|Overall Study|Rapid clinical decline|1|||
46709341|NCT01143402|82925332|FG001|Overall Study|Rapid clinical decline|1|||
46709342|NCT01143402|82925333|FG002|Overall Study|Rapid clinical decline|0|||
46709343|NCT01143402|82925331|FG000|Overall Study|Not Treated|0|||
46709344|NCT01143402|82925332|FG001|Overall Study|Not Treated|0|||
46709345|NCT01143402|82925333|FG002|Overall Study|Not Treated|1|||
46709346|NCT01171625|82925340|FG000|Overall Study|On-Protocol|67|||
46709347|NCT01171625|82925340|FG000|Overall Study|Death|38|||
46709348|NCT01171625|82925340|FG000|Overall Study|Withdrawal by Subject|31|||
46709349|NCT01171625|82925340|FG000|Overall Study|Explanted|10|||
46709350|NCT01171625|82925340|FG000|Overall Study|Lost to Follow-up|5|||
46709351|NCT01171625|82925340|FG000|Overall Study|Patient received valve-in-valve|3|||
46709352|NCT01171625|82925340|FG000|Overall Study|Other|1|||
46709353|NCT01171625|82925340|FG000|Overall Study|Consented but did not receive device|25|||
46709354|NCT00924898|82925352|FG000|Overall Study|Withdrawal by Subject|2|||
46709355|NCT01167192|82925361|FG000|Overall Study|Adverse Event|1|||
46908908|NCT03440411|83137958|FG003|Overall Study|Adverse Event|0|||
46908909|NCT03440411|83137955|FG000|Overall Study|PD|2|||
46908910|NCT03440411|83137956|FG001|Overall Study|PD|1|||
46908911|NCT03440411|83137957|FG002|Overall Study|PD|1|||
46908912|NCT03440411|83137958|FG003|Overall Study|PD|1|||
46908913|NCT03440411|83137955|FG000|Overall Study|Withdrawal by Subject|1|||
46908914|NCT03440411|83137956|FG001|Overall Study|Withdrawal by Subject|0|||
46908915|NCT03440411|83137957|FG002|Overall Study|Withdrawal by Subject|0|||
47002247|NCT02352779|83249975|FG002|Overall Study|Personal Issues|0|||
47002248|NCT02352779|83249973|FG000|Overall Study|Too Many Forms|2|||
47002249|NCT02352779|83249974|FG001|Overall Study|Too Many Forms|0|||
47002250|NCT02352779|83249975|FG002|Overall Study|Too Many Forms|0|||
47002251|NCT02352779|83249973|FG000|Overall Study|Feeling Overwhelmed|1|||
47002252|NCT02352779|83249974|FG001|Overall Study|Feeling Overwhelmed|0|||
47002253|NCT02352779|83249975|FG002|Overall Study|Feeling Overwhelmed|0|||
47002254|NCT02352779|83249973|FG000|Overall Study|Disliked Intervention|1|||
47002255|NCT02352779|83249974|FG001|Overall Study|Disliked Intervention|0|||
46908916|NCT03440411|83137958|FG003|Overall Study|Withdrawal by Subject|0|||
47002256|NCT02352779|83249975|FG002|Overall Study|Disliked Intervention|0|||
47002257|NCT02352779|83249973|FG000|Overall Study|Changed Mind|1|||
47002258|NCT02352779|83249974|FG001|Overall Study|Changed Mind|0|||
47002259|NCT02352779|83249975|FG002|Overall Study|Changed Mind|0|||
46908917|NCT03440411|83137955|FG000|Overall Study|Closed study by sponsor|0|||
46908918|NCT03440411|83137956|FG001|Overall Study|Closed study by sponsor|0|||
46709356|NCT01167192|82925361|FG000|Overall Study|Death|1|||
46709357|NCT01167192|82925361|FG000|Overall Study|Withdrawal by Subject|1|||
46709358|NCT01167192|82925361|FG000|Overall Study|Insurance denial|1|||
46709359|NCT01166958|82925367|FG000|Overall Study|Withdrawal by Subject|1|||
46709360|NCT01166958|82925368|FG001|Overall Study|Withdrawal by Subject|0|||
47002260|NCT02352779|83249973|FG000|Overall Study|Study Related Symptoms|1|||
47002261|NCT02352779|83249974|FG001|Overall Study|Study Related Symptoms|0|||
47002262|NCT02352779|83249975|FG002|Overall Study|Study Related Symptoms|0|||
47002263|NCT02352779|83249973|FG000|Overall Study|Absence of Symptoms|1|||
47002264|NCT02352779|83249974|FG001|Overall Study|Absence of Symptoms|0|||
47002265|NCT02352779|83249975|FG002|Overall Study|Absence of Symptoms|0|||
47002266|NCT02352779|83249973|FG000|Overall Study|Other Medical Reason|0|||
47002267|NCT02352779|83249974|FG001|Overall Study|Other Medical Reason|0|||
47002268|NCT02352779|83249975|FG002|Overall Study|Other Medical Reason|1|||
47002269|NCT02352779|83249973|FG000|Overall Study|No Reason|0|||
47002270|NCT02352779|83249974|FG001|Overall Study|No Reason|0|||
47002271|NCT02352779|83249975|FG002|Overall Study|No Reason|1|||
47002272|NCT02257489|83249992|FG000|Overall Study|Withdrawal by Subject|0|||
47002273|NCT02257489|83249993|FG001|Overall Study|Withdrawal by Subject|0|||
47002274|NCT02257489|83249994|FG002|Overall Study|Withdrawal by Subject|0|||
47002275|NCT02257489|83249995|FG003|Overall Study|Withdrawal by Subject|1|||
47002276|NCT02257489|83249996|FG004|Overall Study|Withdrawal by Subject|0|||
47002277|NCT02257489|83249997|FG005|Overall Study|Withdrawal by Subject|0|||
47002278|NCT02257489|83249998|FG006|Overall Study|Withdrawal by Subject|0|||
47002279|NCT02257489|83249999|FG007|Overall Study|Withdrawal by Subject|0|||
47002280|NCT02257489|83250000|FG008|Overall Study|Withdrawal by Subject|0|||
47002281|NCT02329223|83250023|FG000|Overall Study|Withdrawal by Subject|1|||
47002282|NCT02329223|83250024|FG001|Overall Study|Withdrawal by Subject|2|||
47002283|NCT02329223|83250025|FG002|Overall Study|Withdrawal by Subject|5|||
47002284|NCT02329223|83250023|FG000|Overall Study|Physician Decision|0|||
47002285|NCT02329223|83250024|FG001|Overall Study|Physician Decision|0|||
47002286|NCT02329223|83250025|FG002|Overall Study|Physician Decision|1|||
47002287|NCT02329223|83250023|FG000|Overall Study|Adverse Event|0|||
47002288|NCT02329223|83250024|FG001|Overall Study|Adverse Event|1|||
47002289|NCT02329223|83250025|FG002|Overall Study|Adverse Event|0|||
47002290|NCT01641601|83250035|FG000|Overall Study|Study discontinued.|3|||
47002291|NCT01641601|83250036|FG001|Overall Study|Study discontinued.|5|||
47002292|NCT02350127|83250044|FG000|4-Month Assessment|Withdrawal by Subject|10|||
47002293|NCT02350127|83250045|FG001|4-Month Assessment|Withdrawal by Subject|9|||
47002294|NCT02350127|83250044|FG000|4-Month Assessment|Death|1|||
47002295|NCT02350127|83250045|FG001|4-Month Assessment|Death|0|||
47002296|NCT02350127|83250044|FG000|8-Month Assessment|Death|1|||
47002297|NCT02350127|83250045|FG001|8-Month Assessment|Death|1|||
47002298|NCT02350127|83250044|FG000|8-Month Assessment|Withdrawal by Subject|5|||
47002299|NCT02350127|83250045|FG001|8-Month Assessment|Withdrawal by Subject|8|||
47002300|NCT02256553|83250052|FG000|Period I|Adverse Event|5|||
47002301|NCT02256553|83250052|FG000|Period I|Protocol Violation|1|||
47002302|NCT02256553|83250052|FG000|Period II|Adverse Event|1|||
47002303|NCT02256553|83250052|FG000|Period II|Subject Moved|1|||
47002304|NCT02256553|83250052|FG000|Period III|Adverse Event|3|||
47002305|NCT02349425|83250062|FG000|Period 1|Adverse Event|1|||
47002306|NCT02349425|83250063|FG001|Period 1|Adverse Event|1|||
47002307|NCT02349425|83250064|FG002|Period 1|Adverse Event|0|||
47002308|NCT02349425|83250065|FG003|Period 1|Adverse Event|0|||
47002309|NCT02349425|83250062|FG000|Period 2|Adverse Event|0|||
47002310|NCT02349425|83250063|FG001|Period 2|Adverse Event|1|||
47002311|NCT02349425|83250064|FG002|Period 2|Adverse Event|1|||
47002312|NCT02349425|83250065|FG003|Period 2|Adverse Event|0|||
47002313|NCT02310581|83250107|FG000|Overall Study|Adverse Event|1|||
47002314|NCT02310581|83250108|FG001|Overall Study|Adverse Event|1|||
47002315|NCT02310581|83250109|FG002|Overall Study|Adverse Event|1|||
47002316|NCT02310581|83250110|FG003|Overall Study|Adverse Event|0|||
47002317|NCT02310581|83250107|FG000|Overall Study|Withdrawal by Subject|2|||
47002318|NCT02310581|83250108|FG001|Overall Study|Withdrawal by Subject|1|||
47002319|NCT02310581|83250109|FG002|Overall Study|Withdrawal by Subject|0|||
47002320|NCT02310581|83250110|FG003|Overall Study|Withdrawal by Subject|1|||
47002321|NCT02309723|83250123|FG000|Overall Study|Withdrawal by Subject|24|||
47002322|NCT02309723|83250124|FG001|Overall Study|Withdrawal by Subject|23|||
47002323|NCT02309723|83250125|FG002|Overall Study|Withdrawal by Subject|24|||
47002324|NCT02309411|83250136|FG000|Overall Study|Physician Decision|1|||
47002325|NCT02309411|83250137|FG001|Overall Study|Physician Decision|0|||
47002326|NCT02309411|83250138|FG002|Overall Study|Physician Decision|0|||
47002327|NCT02309411|83250136|FG000|Overall Study|Withdrawal by Subject|1|||
47002328|NCT02309411|83250137|FG001|Overall Study|Withdrawal by Subject|1|||
47002329|NCT02309411|83250138|FG002|Overall Study|Withdrawal by Subject|0|||
47002330|NCT02008227|83250147|FG000|Overall Study|Lost to Follow-up|7|||
47002331|NCT02008227|83250148|FG001|Overall Study|Lost to Follow-up|9|||
47002332|NCT02008227|83250147|FG000|Overall Study|Death|494|||
47002333|NCT02008227|83250148|FG001|Overall Study|Death|485|||
47002334|NCT02008227|83250147|FG000|Overall Study|Withdrawal by Subject|67|||
47002335|NCT02008227|83250148|FG001|Overall Study|Withdrawal by Subject|36|||
47002336|NCT02008227|83250147|FG000|Overall Study|Study Terminated By Sponsor|44|||
47002337|NCT02008227|83250148|FG001|Overall Study|Study Terminated By Sponsor|83|||
47002338|NCT02006979|83250157|FG000|Overall Study|Withdrawal by Subject|1|||
47002339|NCT02006979|83250158|FG001|Overall Study|Withdrawal by Subject|1|||
47002340|NCT02006979|83250157|FG000|Overall Study|Protocol Violation|0|||
47002341|NCT02006979|83250158|FG001|Overall Study|Protocol Violation|1|||
47002342|NCT02348723|83250166|FG000|Overall Study|No ablation|21|||
47002343|NCT02348723|83250167|FG001|Overall Study|No ablation|20|||
47002344|NCT02348723|83250166|FG000|Overall Study|Non-compliant with Protocol|1|||
47002345|NCT02348723|83250167|FG001|Overall Study|Non-compliant with Protocol|0|||
47002346|NCT02348723|83250166|FG000|Overall Study|Lost to Follow-up|1|||
47002347|NCT02348723|83250167|FG001|Overall Study|Lost to Follow-up|1|||
47002348|NCT02348723|83250166|FG000|Overall Study|Consent withdrawn|1|||
47002349|NCT02348723|83250167|FG001|Overall Study|Consent withdrawn|3|||
47002350|NCT02348723|83250166|FG000|Overall Study|Reason other than specified|1|||
47002351|NCT02348723|83250167|FG001|Overall Study|Reason other than specified|1|||
47002352|NCT02348723|83250166|FG000|Overall Study|Adverse Event|3|||
47002353|NCT02348723|83250167|FG001|Overall Study|Adverse Event|1|||
47002354|NCT01967277|83250175|FG000|Overall Study|Lost to Follow-up|1|||
47002355|NCT01967277|83250176|FG001|Overall Study|Lost to Follow-up|2|||
47002356|NCT01967277|83250175|FG000|Overall Study|Unrelated illness|0|||
47002357|NCT01967277|83250176|FG001|Overall Study|Unrelated illness|1|||
47002358|NCT02326883|83250185|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
47002359|NCT02326883|83250186|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
47002360|NCT02326883|83250187|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
47002361|NCT02006667|83250195|FG000|Overall Study|Adverse Event|3|||
47002362|NCT02006667|83250195|FG000|Overall Study|Death|2|||
47002363|NCT02006667|83250195|FG000|Overall Study|Withdrawal by Subject|1|||
47002364|NCT01983111|83250201|FG000|Overall Study|Withdrawal by Subject|8|||
47002365|NCT01983111|83250202|FG001|Overall Study|Withdrawal by Subject|6|||
47002366|NCT01983111|83250201|FG000|Overall Study|Adverse Event|4|||
47002367|NCT01983111|83250202|FG001|Overall Study|Adverse Event|0|||
47002368|NCT01983111|83250201|FG000|Overall Study|Protocol Violation|0|||
46908919|NCT03440411|83137957|FG002|Overall Study|Closed study by sponsor|0|||
46908920|NCT03440411|83137958|FG003|Overall Study|Closed study by sponsor|1|||
46908921|NCT03438539|83137979|FG000|Overall Study|Lost to Follow-up|8|||
46908922|NCT03438539|83137980|FG001|Overall Study|Lost to Follow-up|4|||
46908923|NCT03438539|83137981|FG002|Overall Study|Lost to Follow-up|10|||
46908924|NCT03438539|83137982|FG003|Overall Study|Lost to Follow-up|9|||
46908925|NCT03438539|83137983|FG004|Overall Study|Lost to Follow-up|3|||
46908926|NCT03438539|83137984|FG005|Overall Study|Lost to Follow-up|8|||
46908927|NCT03400787|83138000|FG000|Overall Study|Lost to Follow-up|1|||
46908928|NCT03400787|83138001|FG001|Overall Study|Lost to Follow-up|0|||
46908929|NCT03400787|83138000|FG000|Overall Study|Death|1|||
46908930|NCT03400787|83138001|FG001|Overall Study|Death|0|||
46908931|NCT03400787|83138000|FG000|Overall Study|Protocol Violation|0|||
46908932|NCT03400787|83138001|FG001|Overall Study|Protocol Violation|2|||
46908933|NCT03400787|83138000|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
46908934|NCT03400787|83138001|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
46908935|NCT03417245|83138009|FG000|Overall Study|Adverse Event|1|||
46908936|NCT03417245|83138010|FG001|Overall Study|Adverse Event|0|||
46908937|NCT03417245|83138009|FG000|Overall Study|Protocol Violation|1|||
46908938|NCT03417245|83138010|FG001|Overall Study|Protocol Violation|0|||
46908939|NCT03417245|83138009|FG000|Overall Study|Withdrawal by Subject|1|||
46908940|NCT03417245|83138010|FG001|Overall Study|Withdrawal by Subject|1|||
46908941|NCT03389555|83138018|FG000|Overall Study|Protocol Violation|1|||
46908942|NCT03389555|83138019|FG001|Overall Study|Protocol Violation|3|||
46908943|NCT03389555|83138018|FG000|Overall Study|Death|1|||
46908944|NCT03389555|83138019|FG001|Overall Study|Death|0|||
46908945|NCT03395639|83138027|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
46908946|NCT03395639|83138028|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
46908947|NCT03395639|83138029|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
46908948|NCT03395639|83138027|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
46908949|NCT03395639|83138028|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
46908950|NCT03395639|83138029|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
46908951|NCT03395639|83138027|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
47002369|NCT01983111|83250202|FG001|Overall Study|Protocol Violation|1|||
46908952|NCT03395639|83138028|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
46908953|NCT03395639|83138029|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
46908954|NCT03395639|83138027|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
47002370|NCT02348489|83250210|FG000|Overall Study|Death|336|||
47002371|NCT02348489|83250211|FG001|Overall Study|Death|335|||
46908955|NCT03395639|83138028|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
46908956|NCT03395639|83138029|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
47002372|NCT02348489|83250210|FG000|Overall Study|Withdrawal by Subject|14|||
47002373|NCT02348489|83250211|FG001|Overall Study|Withdrawal by Subject|27|||
47002374|NCT02348489|83250210|FG000|Overall Study|Lost to Follow-up|3|||
46908957|NCT03395639|83138027|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
46908958|NCT03395639|83138028|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
46908959|NCT03395639|83138029|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
46908960|NCT03353922|83138036|FG000|Overall Study|Withdrawal by Subject|1|||
46908961|NCT03353922|83138037|FG001|Overall Study|Withdrawal by Subject|0|||
46908962|NCT03353922|83138038|FG002|Overall Study|Withdrawal by Subject|1|||
46908963|NCT03353922|83138039|FG003|Overall Study|Withdrawal by Subject|1|||
46908964|NCT03353922|83138040|FG004|Overall Study|Withdrawal by Subject|0|||
46908965|NCT03353922|83138041|FG005|Overall Study|Withdrawal by Subject|0|||
46908966|NCT03353922|83138036|FG000|Overall Study|Adverse Event|0|||
46908967|NCT03353922|83138037|FG001|Overall Study|Adverse Event|1|||
46908968|NCT03353922|83138038|FG002|Overall Study|Adverse Event|0|||
46908969|NCT03353922|83138039|FG003|Overall Study|Adverse Event|0|||
46908970|NCT03353922|83138040|FG004|Overall Study|Adverse Event|0|||
46908971|NCT03353922|83138041|FG005|Overall Study|Adverse Event|0|||
46908972|NCT03387683|83138054|FG000|Overall Study|In receipt of disallowed medication|1|||
46908973|NCT03387683|83138055|FG001|Overall Study|In receipt of disallowed medication|0|||
46908974|NCT03387683|83138054|FG000|Overall Study|Did not receive treatment|1|||
46908975|NCT03387683|83138055|FG001|Overall Study|Did not receive treatment|0|||
46908976|NCT03387059|83138063|FG000|Overall Study|Study termination|5|||
46908977|NCT03387059|83138064|FG001|Overall Study|Study termination|4|||
46908978|NCT02942004|83138073|FG000|Overall Study|Withdrawal by Subject|0|||
46908979|NCT02942004|83138074|FG001|Overall Study|Withdrawal by Subject|2|||
46908980|NCT02942004|83138075|FG002|Overall Study|Withdrawal by Subject|3|||
46908981|NCT02942004|83138073|FG000|Overall Study|Lost to Follow-up|1|||
46908982|NCT02942004|83138074|FG001|Overall Study|Lost to Follow-up|1|||
46908983|NCT02942004|83138075|FG002|Overall Study|Lost to Follow-up|2|||
46908984|NCT02942004|83138073|FG000|Overall Study|Randomized but not dosed|3|||
46908985|NCT02942004|83138074|FG001|Overall Study|Randomized but not dosed|9|||
46908986|NCT02942004|83138075|FG002|Overall Study|Randomized but not dosed|4|||
46908987|NCT03394391|83138085|FG000|Overall Study|Lost to Follow-up|1|||
46908988|NCT03394391|83138086|FG001|Overall Study|Lost to Follow-up|2|||
46908989|NCT03386435|83138094|FG000|Overall Study|Protocol Violation|5|||
46908990|NCT03386435|83138095|FG001|Overall Study|Protocol Violation|7|||
46908991|NCT02726880|83138103|FG000|Overall Study|Withdrawal by Subject|2|||
46908992|NCT02726880|83138104|FG001|Overall Study|Withdrawal by Subject|0|||
46908993|NCT02726880|83138103|FG000|Overall Study|Lost to Follow-up|1|||
46908994|NCT02726880|83138104|FG001|Overall Study|Lost to Follow-up|3|||
46908995|NCT03275389|83138121|FG000|Overall Study|Lost to Follow-up|10|||
46908996|NCT03275389|83138122|FG001|Overall Study|Lost to Follow-up|10|||
46908997|NCT03275389|83138123|FG002|Overall Study|Lost to Follow-up|19|||
46908998|NCT03275389|83138124|FG003|Overall Study|Lost to Follow-up|12|||
46908999|NCT03275389|83138125|FG004|Overall Study|Lost to Follow-up|11|||
46909000|NCT03275389|83138126|FG005|Overall Study|Lost to Follow-up|12|||
46909001|NCT03275389|83138127|FG006|Overall Study|Lost to Follow-up|21|||
46909002|NCT03275389|83138128|FG007|Overall Study|Lost to Follow-up|15|||
47002375|NCT02348489|83250211|FG001|Overall Study|Lost to Follow-up|5|||
47002376|NCT02309099|83250221|FG000|Overall Study|Adverse Event|2|||
47002377|NCT02309099|83250222|FG001|Overall Study|Adverse Event|0|||
47002378|NCT01966107|83250230|FG000|Overall Study|excluded from FAS|21|||
47002379|NCT01966107|83250231|FG001|Overall Study|excluded from FAS|20|||
47002380|NCT01966107|83250230|FG000|Overall Study|discontinued treatment|345|||
47002381|NCT01966107|83250231|FG001|Overall Study|discontinued treatment|372|||
47002382|NCT01966107|83250230|FG000|Overall Study|due to study closure|164|||
47002383|NCT01966107|83250231|FG001|Overall Study|due to study closure|186|||
47002384|NCT01966107|83250230|FG000|Overall Study|withdrew from the study|272|||
47002385|NCT01966107|83250231|FG001|Overall Study|withdrew from the study|303|||
47002386|NCT02347943|83250240|FG000|Overall Study|Study was cancelled|140|||
47002387|NCT02347943|83250241|FG001|Overall Study|Study was cancelled|67|||
47002388|NCT02347943|83250242|FG002|Overall Study|Study was cancelled|45|||
47002389|NCT01982331|83250252|FG000|Received Vaccination 2|Adverse Event|1|||
46709361|NCT01170221|82925376|FG000|Overall Study|Lost to Follow-up|22|||
47002390|NCT01982331|83250253|FG001|Received Vaccination 2|Adverse Event|2|||
47002391|NCT01982331|83250252|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
46709362|NCT01170221|82925377|FG001|Overall Study|Lost to Follow-up|21|||
46909003|NCT03275389|83138129|FG008|Overall Study|Lost to Follow-up|12|||
46909004|NCT03275389|83138130|FG009|Overall Study|Lost to Follow-up|14|||
46909005|NCT03275389|83138121|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
46909006|NCT03275389|83138122|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
46909007|NCT03275389|83138123|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
46909008|NCT03275389|83138124|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
46909009|NCT03275389|83138125|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
46909010|NCT03275389|83138126|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
46909011|NCT03275389|83138127|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
47002392|NCT01982331|83250253|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
47002393|NCT01982331|83250252|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
47002394|NCT01982331|83250253|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
47002395|NCT02326025|83250261|FG000|Overall Study|Adverse Event|3|||
47002396|NCT02326025|83250262|FG001|Overall Study|Adverse Event|0|||
47002397|NCT02326025|83250261|FG000|Overall Study|Physician Decision|1|||
47002398|NCT02326025|83250262|FG001|Overall Study|Physician Decision|2|||
47002399|NCT02326025|83250261|FG000|Overall Study|Physician and Participant Decision|1|||
47002400|NCT02326025|83250262|FG001|Overall Study|Physician and Participant Decision|0|||
47002401|NCT02326025|83250261|FG000|Overall Study|Withdrawal by Subject|0|||
47002402|NCT02326025|83250262|FG001|Overall Study|Withdrawal by Subject|2|||
47002403|NCT02326025|83250261|FG000|Overall Study|Protocol Violation|0|||
47002404|NCT02326025|83250262|FG001|Overall Study|Protocol Violation|1|||
47002405|NCT01619865|83250281|FG000|Overall Study|Adverse Event|1|||
47002406|NCT01619865|83250281|FG000|Overall Study|Death|2|||
47002407|NCT01619865|83250281|FG000|Overall Study|subject not able to comply|1|||
47002408|NCT02006121|83250288|FG000|Double Blind Phase|Adverse Event|6|||
47002409|NCT02006121|83250289|FG001|Double Blind Phase|Adverse Event|0|||
47002410|NCT02006121|83250288|FG000|Double Blind Phase|Lack of Efficacy|1|||
47002411|NCT02006121|83250289|FG001|Double Blind Phase|Lack of Efficacy|16|||
47002412|NCT02006121|83250288|FG000|Double Blind Phase|Withdrawal by Subject|3|||
47002413|NCT02006121|83250289|FG001|Double Blind Phase|Withdrawal by Subject|4|||
47002414|NCT02006121|83250288|FG000|Double Blind Phase|Non-compliance with study drug|1|||
47002415|NCT02006121|83250289|FG001|Double Blind Phase|Non-compliance with study drug|3|||
47002416|NCT02006121|83250288|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
47002417|NCT02006121|83250289|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
47002418|NCT02006121|83250288|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
47002419|NCT02006121|83250289|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
47002420|NCT02006121|83250288|FG000|Open Label Phase|Adverse Event|15|||
47002421|NCT02006121|83250289|FG001|Open Label Phase|Adverse Event|0|||
47002422|NCT02006121|83250288|FG000|Open Label Phase|Lack of Efficacy|2|||
47002423|NCT02006121|83250289|FG001|Open Label Phase|Lack of Efficacy|0|||
47002424|NCT02006121|83250288|FG000|Open Label Phase|Protocol Violation|2|||
47002425|NCT02006121|83250289|FG001|Open Label Phase|Protocol Violation|0|||
47002426|NCT02006121|83250288|FG000|Open Label Phase|Withdrawal by Subject|3|||
47002427|NCT02006121|83250289|FG001|Open Label Phase|Withdrawal by Subject|0|||
47002428|NCT02006121|83250288|FG000|Open Label Phase|Non-compliance with study drug|3|||
47002429|NCT02006121|83250289|FG001|Open Label Phase|Non-compliance with study drug|0|||
47002430|NCT02005887|83250301|FG000|Overall Study|Protocol Violation|0|||
47002431|NCT02005887|83250302|FG001|Overall Study|Protocol Violation|2|||
47002432|NCT01982253|83250311|FG000|Overall Study|Withdrawal by Subject|1|||
47002433|NCT01982253|83250312|FG001|Overall Study|Withdrawal by Subject|0|||
47002434|NCT01982253|83250313|FG002|Overall Study|Withdrawal by Subject|0|||
47002435|NCT01982253|83250311|FG000|Overall Study|Study terminated by sponsor|1|||
47002436|NCT01982253|83250312|FG001|Overall Study|Study terminated by sponsor|4|||
47002437|NCT01982253|83250313|FG002|Overall Study|Study terminated by sponsor|4|||
47002438|NCT01619787|83250323|FG000|Overall Study|Lost to Follow-up|5|||
47002439|NCT01981473|83250332|FG000|Overall Study|Incorrect diagnosis of RA|0|||
47002440|NCT01981473|83250333|FG001|Overall Study|Incorrect diagnosis of RA|0|||
47002441|NCT01981473|83250334|FG002|Overall Study|Incorrect diagnosis of RA|1|||
47002442|NCT01981473|83250332|FG000|Overall Study|Received treatment for < 6 months|0|||
47002443|NCT01981473|83250333|FG001|Overall Study|Received treatment for < 6 months|0|||
47002444|NCT01981473|83250334|FG002|Overall Study|Received treatment for < 6 months|1|||
47002445|NCT01981473|83250332|FG000|Overall Study|Received treatment for >24 months|2|||
47002446|NCT01981473|83250333|FG001|Overall Study|Received treatment for >24 months|0|||
47002447|NCT01981473|83250334|FG002|Overall Study|Received treatment for >24 months|6|||
47002448|NCT02005029|83250347|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
47002449|NCT02005029|83250348|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
47002450|NCT02325791|83250376|FG000|Overall Study|Adverse Event|0|||
47002451|NCT02325791|83250377|FG001|Overall Study|Adverse Event|1|||
47002452|NCT02325791|83250378|FG002|Overall Study|Adverse Event|1|||
47002453|NCT02325791|83250379|FG003|Overall Study|Adverse Event|0|||
47002454|NCT02325791|83250376|FG000|Overall Study|Death|0|||
47002455|NCT02325791|83250377|FG001|Overall Study|Death|3|||
47002456|NCT02325791|83250378|FG002|Overall Study|Death|0|||
47002457|NCT02325791|83250379|FG003|Overall Study|Death|1|||
47002458|NCT02325791|83250376|FG000|Overall Study|Lost to Follow-up|0|||
47002459|NCT02325791|83250377|FG001|Overall Study|Lost to Follow-up|15|||
47002460|NCT02325791|83250378|FG002|Overall Study|Lost to Follow-up|14|||
47002461|NCT02325791|83250379|FG003|Overall Study|Lost to Follow-up|9|||
47002462|NCT02325791|83250376|FG000|Overall Study|Physician Decision|0|||
47002463|NCT02325791|83250377|FG001|Overall Study|Physician Decision|1|||
47002464|NCT02325791|83250378|FG002|Overall Study|Physician Decision|1|||
47002465|NCT02325791|83250379|FG003|Overall Study|Physician Decision|0|||
47002466|NCT02325791|83250376|FG000|Overall Study|Protocol Violation|0|||
47002467|NCT02325791|83250377|FG001|Overall Study|Protocol Violation|0|||
47002468|NCT02325791|83250378|FG002|Overall Study|Protocol Violation|1|||
47002469|NCT02325791|83250379|FG003|Overall Study|Protocol Violation|0|||
47002470|NCT02325791|83250376|FG000|Overall Study|Withdrawal by Subject|0|||
47002471|NCT02325791|83250377|FG001|Overall Study|Withdrawal by Subject|5|||
47002472|NCT02325791|83250378|FG002|Overall Study|Withdrawal by Subject|8|||
47002473|NCT02325791|83250379|FG003|Overall Study|Withdrawal by Subject|16|||
47002474|NCT02004873|83250392|FG000|Overall Study|Implant unsuccessful|6|||
47002475|NCT02004873|83250392|FG000|Overall Study|Awaiting 6-month visit|390|||
46909012|NCT03275389|83138128|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
46909013|NCT03275389|83138129|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
46909014|NCT03275389|83138130|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
46909015|NCT03275389|83138121|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
46909016|NCT03275389|83138122|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46909017|NCT03275389|83138123|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46909018|NCT03275389|83138124|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
46909019|NCT03275389|83138125|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
46909020|NCT03275389|83138126|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
46909021|NCT03275389|83138127|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
46909022|NCT03275389|83138128|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
46909023|NCT03275389|83138129|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
46909024|NCT03275389|83138130|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
46909025|NCT03275389|83138121|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46909026|NCT03275389|83138122|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
46909027|NCT03275389|83138123|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46909028|NCT03275389|83138124|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
46909029|NCT03275389|83138125|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46909030|NCT03275389|83138126|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46909031|NCT03275389|83138127|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46909032|NCT03275389|83138128|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46909033|NCT03275389|83138129|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46909034|NCT03275389|83138130|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46909035|NCT03275389|83138121|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909036|NCT03275389|83138122|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909037|NCT03275389|83138123|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
46909038|NCT03275389|83138124|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909039|NCT03275389|83138125|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909040|NCT03275389|83138126|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909041|NCT03275389|83138127|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909042|NCT03275389|83138128|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909043|NCT03275389|83138129|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46909044|NCT03275389|83138130|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
46909045|NCT03275389|83138121|FG000|Overall Study|Other|0|||
46909046|NCT03275389|83138122|FG001|Overall Study|Other|4|||
46909047|NCT03275389|83138123|FG002|Overall Study|Other|3|||
46909048|NCT03275389|83138124|FG003|Overall Study|Other|2|||
46909049|NCT03275389|83138125|FG004|Overall Study|Other|2|||
46909050|NCT03275389|83138126|FG005|Overall Study|Other|2|||
46909051|NCT03275389|83138127|FG006|Overall Study|Other|0|||
46909052|NCT03275389|83138128|FG007|Overall Study|Other|0|||
46909053|NCT03275389|83138129|FG008|Overall Study|Other|1|||
46909054|NCT03275389|83138130|FG009|Overall Study|Other|0|||
46909055|NCT03414359|83138154|FG000|Overall Study|Lack of Efficacy|1|||
46909056|NCT03414359|83138155|FG001|Overall Study|Lack of Efficacy|1|||
46909057|NCT03414359|83138154|FG000|Overall Study|Protocol Violation|0|||
46909058|NCT03414359|83138155|FG001|Overall Study|Protocol Violation|1|||
46909059|NCT03285295|83138166|FG000|Alinity s HBsAg|Protocol Violation|11|||
46909060|NCT03285295|83138167|FG001|Alinity s HBsAg|Protocol Violation|0|||
46909061|NCT03285295|83138168|FG002|Alinity s HBsAg|Protocol Violation|0|||
46909062|NCT03285295|83138169|FG003|Alinity s HBsAg|Protocol Violation|0|||
46909063|NCT03285295|83138170|FG004|Alinity s HBsAg|Protocol Violation|0|||
46909064|NCT03285295|83138166|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
46909065|NCT03285295|83138167|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
46909066|NCT03285295|83138168|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
46909067|NCT03285295|83138169|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
46909068|NCT03285295|83138170|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
46909069|NCT03285295|83138166|FG000|Alinity s HBsAg|No Results Generated|74|||
46909070|NCT03285295|83138167|FG001|Alinity s HBsAg|No Results Generated|6|||
46620451|NCT03738800|82769595|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
46909071|NCT03285295|83138168|FG002|Alinity s HBsAg|No Results Generated|0|||
46909072|NCT03285295|83138169|FG003|Alinity s HBsAg|No Results Generated|0|||
47002476|NCT02004873|83250392|FG000|Overall Study|Missed 6-month visit|4|||
47002477|NCT02004873|83250392|FG000|Overall Study|Death|23|||
47002478|NCT02004873|83250392|FG000|Overall Study|Withdrawal by Subject|1|||
47002479|NCT02347787|83250401|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
47002480|NCT02347787|83250402|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
47002481|NCT02347787|83250401|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
47002482|NCT02347787|83250402|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
47002483|NCT02347787|83250401|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
47002484|NCT02347787|83250402|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
47002485|NCT02347787|83250401|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
47002486|NCT02347787|83250402|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
47002487|NCT01979835|83250413|FG000|Primary Outcome SA Measurment|failed insertion|18|||
47002488|NCT01979835|83250413|FG000|Follow-up|Lost to Follow-up|32|||
47002489|NCT02282345|83250419|FG000|Overall Study|Progression|0|||
47002490|NCT02282345|83250420|FG001|Overall Study|Progression|1|||
47002491|NCT01732822|83250431|FG000|Overall Study|Withdrawal by Subject|123|||
47002492|NCT01732822|83250432|FG001|Overall Study|Withdrawal by Subject|113|||
47002493|NCT02004093|83250462|FG000|Overall Study|Death|2|||
47002494|NCT02004093|83250463|FG001|Overall Study|Death|1|||
47002495|NCT02004093|83250462|FG000|Overall Study|Lack of Efficacy|66|||
47002496|NCT02004093|83250463|FG001|Overall Study|Lack of Efficacy|62|||
47002497|NCT02004093|83250462|FG000|Overall Study|Protocol Violation|0|||
47002498|NCT02004093|83250463|FG001|Overall Study|Protocol Violation|1|||
47002499|NCT02004093|83250462|FG000|Overall Study|Lost to Follow-up|0|||
47002500|NCT02004093|83250463|FG001|Overall Study|Lost to Follow-up|1|||
47002501|NCT02004093|83250462|FG000|Overall Study|Withdrawal by Subject|3|||
47002502|NCT02004093|83250463|FG001|Overall Study|Withdrawal by Subject|7|||
47002503|NCT02004093|83250462|FG000|Overall Study|Other|3|||
47002504|NCT02004093|83250463|FG001|Overall Study|Other|1|||
47002505|NCT01641367|83250478|FG000|Cohorts|Death|18|||
47002506|NCT01641367|83250479|FG001|Cohorts|Death|1|||
47002507|NCT01641367|83250480|FG002|Cohorts|Death|2|||
47002508|NCT01641367|83250481|FG003|Cohorts|Death|0|||
47002509|NCT01641367|83250482|FG004|Cohorts|Death|1|||
47002510|NCT01641367|83250483|FG005|Cohorts|Death|1|||
47002511|NCT01641367|83250484|FG006|Cohorts|Death|0|||
47002512|NCT01641367|83250485|FG007|Cohorts|Death|0|||
47002513|NCT01641367|83250478|FG000|Cohorts|Lost to Follow-up|16|||
47002514|NCT01641367|83250479|FG001|Cohorts|Lost to Follow-up|0|||
47002515|NCT01641367|83250480|FG002|Cohorts|Lost to Follow-up|2|||
47002516|NCT01641367|83250481|FG003|Cohorts|Lost to Follow-up|0|||
47002517|NCT01641367|83250482|FG004|Cohorts|Lost to Follow-up|2|||
47002518|NCT01641367|83250483|FG005|Cohorts|Lost to Follow-up|0|||
47002519|NCT01641367|83250484|FG006|Cohorts|Lost to Follow-up|0|||
47002520|NCT01641367|83250485|FG007|Cohorts|Lost to Follow-up|0|||
47002521|NCT01641367|83250478|FG000|Randomized Adherence Intervention|Death|0|||
47002522|NCT01641367|83250479|FG001|Randomized Adherence Intervention|Death|0|||
47002523|NCT01641367|83250480|FG002|Randomized Adherence Intervention|Death|0|||
47002524|NCT01641367|83250481|FG003|Randomized Adherence Intervention|Death|0|||
47002525|NCT01641367|83250482|FG004|Randomized Adherence Intervention|Death|0|||
47002526|NCT01641367|83250483|FG005|Randomized Adherence Intervention|Death|0|||
47002527|NCT01641367|83250484|FG006|Randomized Adherence Intervention|Death|11|||
47002528|NCT01641367|83250485|FG007|Randomized Adherence Intervention|Death|12|||
47002529|NCT01641367|83250478|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
47002530|NCT01641367|83250479|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
47002531|NCT01641367|83250480|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
47002532|NCT01641367|83250481|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
47002533|NCT01641367|83250482|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
47002534|NCT01641367|83250483|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
47002535|NCT01641367|83250484|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
47002536|NCT01641367|83250485|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
47002537|NCT02325713|83250524|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
46620452|NCT03738800|82769596|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
46620453|NCT03738800|82769597|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
47002538|NCT02325713|83250525|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002539|NCT02325713|83250526|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002540|NCT02325713|83250527|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002541|NCT02325713|83250528|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002542|NCT02325713|83250529|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002543|NCT02325713|83250530|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002544|NCT02325713|83250531|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002545|NCT02325713|83250532|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002546|NCT02325713|83250533|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002547|NCT02325713|83250534|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
47002548|NCT02325713|83250535|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002549|NCT02325713|83250536|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002550|NCT02325713|83250537|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002551|NCT02325713|83250538|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002552|NCT02325713|83250539|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
47002553|NCT02325713|83250524|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
47002554|NCT02325713|83250525|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002555|NCT02325713|83250526|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002556|NCT02325713|83250527|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002557|NCT02325713|83250528|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002558|NCT02325713|83250529|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002559|NCT02325713|83250530|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002560|NCT02325713|83250531|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002561|NCT02325713|83250532|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002562|NCT02325713|83250533|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002563|NCT02325713|83250534|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002564|NCT02325713|83250535|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002565|NCT02325713|83250536|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002566|NCT02325713|83250537|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002567|NCT02325713|83250538|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002568|NCT02325713|83250539|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
47002569|NCT02325713|83250524|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002570|NCT02325713|83250525|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002571|NCT02325713|83250526|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002572|NCT02325713|83250527|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002573|NCT02325713|83250528|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002574|NCT02325713|83250529|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002575|NCT02325713|83250530|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002576|NCT02325713|83250531|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002577|NCT02325713|83250532|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002578|NCT02325713|83250533|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
47002579|NCT02325713|83250534|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002580|NCT02325713|83250535|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002581|NCT02325713|83250536|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002582|NCT02325713|83250537|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002583|NCT02325713|83250538|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002584|NCT02325713|83250539|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
47002585|NCT02325401|83250554|FG000|Overall Study|Withdrawal by Subject|0|||
47002586|NCT02325401|83250555|FG001|Overall Study|Withdrawal by Subject|1|||
47002587|NCT02325401|83250556|FG002|Overall Study|Withdrawal by Subject|1|||
47002588|NCT02324699|83250570|FG000|Overall Study|study terminated|1|||
47002589|NCT01764256|83250578|FG000|Received All Vaccinations|Adverse Event|1|||
47002590|NCT01764256|83250579|FG001|Received All Vaccinations|Adverse Event|1|||
47002591|NCT01764256|83250580|FG002|Received All Vaccinations|Adverse Event|0|||
47002592|NCT01764256|83250581|FG003|Received All Vaccinations|Adverse Event|0|||
47002593|NCT01764256|83250578|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
47002594|NCT01764256|83250579|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
47002595|NCT01764256|83250580|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
47002596|NCT01764256|83250581|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
47002597|NCT01764256|83250578|FG000|Received All Vaccinations|Lost to Follow-up|1|||
47002598|NCT01764256|83250579|FG001|Received All Vaccinations|Lost to Follow-up|0|||
47002599|NCT01764256|83250580|FG002|Received All Vaccinations|Lost to Follow-up|0|||
47002600|NCT01764256|83250581|FG003|Received All Vaccinations|Lost to Follow-up|0|||
47002601|NCT01764256|83250578|FG000|Completed Study|Lost to Follow-up|0|||
47002602|NCT01764256|83250579|FG001|Completed Study|Lost to Follow-up|0|||
47002603|NCT01764256|83250580|FG002|Completed Study|Lost to Follow-up|0|||
47002604|NCT01764256|83250581|FG003|Completed Study|Lost to Follow-up|1|||
47002605|NCT01979523|83250597|FG000|Overall Study|Withdrawal by Subject|1|||
47002606|NCT01979523|83250598|FG001|Overall Study|Withdrawal by Subject|0|||
47002607|NCT02255461|83250610|FG000|Overall Study|Adverse Event|0|||
47002608|NCT02255461|83250611|FG001|Overall Study|Adverse Event|1|||
47002609|NCT02255461|83250612|FG002|Overall Study|Adverse Event|0|||
47002610|NCT02255461|83250613|FG003|Overall Study|Adverse Event|0|||
47002611|NCT02255461|83250614|FG004|Overall Study|Adverse Event|1|||
47002612|NCT02255461|83250610|FG000|Overall Study|Withdrawal by Subject|0|||
47002613|NCT02255461|83250611|FG001|Overall Study|Withdrawal by Subject|0|||
47002614|NCT02255461|83250612|FG002|Overall Study|Withdrawal by Subject|1|||
46709363|NCT01170221|82925376|FG000|Overall Study|Withdrawal by Subject|9|||
47002615|NCT02255461|83250613|FG003|Overall Study|Withdrawal by Subject|0|||
47002616|NCT02255461|83250614|FG004|Overall Study|Withdrawal by Subject|1|||
46709364|NCT01170221|82925377|FG001|Overall Study|Withdrawal by Subject|7|||
47002617|NCT02255461|83250610|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
47002618|NCT02255461|83250611|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
47002619|NCT02255461|83250612|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
47002620|NCT02255461|83250613|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
47002621|NCT02255461|83250614|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
47002622|NCT01764022|83250633|FG000|Overall Study|Death|3|||
47002623|NCT01764022|83250634|FG001|Overall Study|Death|5|||
46709365|NCT01170221|82925376|FG000|Overall Study|Subject completed only screening and LFU|1|||
46909073|NCT03285295|83138170|FG004|Alinity s HBsAg|No Results Generated|0|||
46909074|NCT03285295|83138166|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
46909075|NCT03285295|83138167|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
46909076|NCT03285295|83138168|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
46909077|NCT03285295|83138169|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
46909078|NCT03285295|83138170|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
46909079|NCT03285295|83138166|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
46909080|NCT03285295|83138167|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
46909081|NCT03285295|83138168|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
46909082|NCT03285295|83138169|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
46909083|NCT03285295|83138170|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
46909084|NCT03285295|83138166|FG000|Alinity s HTLV I/II|No Results Generated|70|||
46909085|NCT03285295|83138167|FG001|Alinity s HTLV I/II|No Results Generated|0|||
46909086|NCT03285295|83138168|FG002|Alinity s HTLV I/II|No Results Generated|0|||
46909087|NCT03285295|83138169|FG003|Alinity s HTLV I/II|No Results Generated|0|||
46909088|NCT03285295|83138170|FG004|Alinity s HTLV I/II|No Results Generated|0|||
46909089|NCT03285295|83138166|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
46909090|NCT03285295|83138167|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
46909091|NCT03285295|83138168|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
46909092|NCT03285295|83138169|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
46909093|NCT03285295|83138170|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
46909094|NCT03285295|83138166|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
46909095|NCT03285295|83138167|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
46909096|NCT03285295|83138168|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
46909097|NCT03285295|83138169|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
46909098|NCT03285295|83138170|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
46909099|NCT03285295|83138166|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
46909100|NCT03285295|83138167|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
46909101|NCT03285295|83138168|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
46909102|NCT03285295|83138169|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
46909103|NCT03285295|83138170|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
46909104|NCT03285295|83138166|FG000|Alinity s Anti-HCV|No Results Generated|71|||
46909105|NCT03285295|83138167|FG001|Alinity s Anti-HCV|No Results Generated|0|||
46909106|NCT03285295|83138168|FG002|Alinity s Anti-HCV|No Results Generated|0|||
46909107|NCT03285295|83138169|FG003|Alinity s Anti-HCV|No Results Generated|0|||
46909108|NCT03285295|83138170|FG004|Alinity s Anti-HCV|No Results Generated|0|||
46909109|NCT03285295|83138166|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
46909110|NCT03285295|83138167|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
46909111|NCT03285295|83138168|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
46909112|NCT03285295|83138169|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
46909113|NCT03285295|83138170|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
46909114|NCT03285295|83138166|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
46909115|NCT03285295|83138167|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
46909116|NCT03285295|83138168|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
46909117|NCT03285295|83138169|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
46909118|NCT03285295|83138170|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
46909119|NCT03285295|83138166|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
46909120|NCT03285295|83138167|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
46909121|NCT03285295|83138168|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
46909122|NCT03285295|83138169|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
46909123|NCT03285295|83138170|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
46909124|NCT03285295|83138166|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
46909125|NCT03285295|83138167|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
46909126|NCT03285295|83138168|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
46909127|NCT03285295|83138169|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
46909128|NCT03285295|83138170|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
46909129|NCT03285295|83138166|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
46909130|NCT03285295|83138167|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
46909131|NCT03285295|83138168|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
46909132|NCT03285295|83138169|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
46909133|NCT03285295|83138170|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
46909134|NCT03285295|83138166|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
47002624|NCT01764022|83250633|FG000|Overall Study|Withdrawal by Subject|2|||
46709366|NCT01170221|82925377|FG001|Overall Study|Subject completed only screening and LFU|0|||
46909135|NCT03285295|83138167|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
46909136|NCT03285295|83138168|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
46909137|NCT03285295|83138169|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
46909138|NCT03285295|83138170|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
46909139|NCT03285295|83138166|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
46909140|NCT03285295|83138167|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
46909141|NCT03285295|83138168|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
46909142|NCT03285295|83138169|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
46909143|NCT03285295|83138170|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
46909144|NCT03285295|83138166|FG000|Alinity s Anti-HBc|No Results Generated|70|||
46909145|NCT03285295|83138167|FG001|Alinity s Anti-HBc|No Results Generated|0|||
46909146|NCT03285295|83138168|FG002|Alinity s Anti-HBc|No Results Generated|0|||
46909147|NCT03285295|83138169|FG003|Alinity s Anti-HBc|No Results Generated|0|||
46909148|NCT03285295|83138170|FG004|Alinity s Anti-HBc|No Results Generated|0|||
46909149|NCT03285295|83138166|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
46909150|NCT03285295|83138167|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
46909151|NCT03285295|83138168|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
46909152|NCT03285295|83138169|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
46909153|NCT03285295|83138170|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
46909154|NCT03285295|83138166|FG000|Alinity s Chagas|Protocol Violation|76|||
46909155|NCT03285295|83138167|FG001|Alinity s Chagas|Protocol Violation|0|||
46909156|NCT03285295|83138168|FG002|Alinity s Chagas|Protocol Violation|0|||
46909157|NCT03285295|83138169|FG003|Alinity s Chagas|Protocol Violation|0|||
46909158|NCT03285295|83138170|FG004|Alinity s Chagas|Protocol Violation|0|||
46909159|NCT03285295|83138166|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
46909160|NCT03285295|83138167|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
46909161|NCT03285295|83138168|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
46909162|NCT03285295|83138169|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
46909163|NCT03285295|83138170|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
46909164|NCT03285295|83138166|FG000|Alinity s Chagas|No Results Generated|105|||
46909165|NCT03285295|83138167|FG001|Alinity s Chagas|No Results Generated|0|||
46909166|NCT03285295|83138168|FG002|Alinity s Chagas|No Results Generated|0|||
46909167|NCT03285295|83138169|FG003|Alinity s Chagas|No Results Generated|0|||
46909168|NCT03285295|83138170|FG004|Alinity s Chagas|No Results Generated|0|||
46909169|NCT03285295|83138166|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
46909170|NCT03285295|83138167|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
46909171|NCT03285295|83138168|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
46909172|NCT03285295|83138169|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
46909173|NCT03285295|83138170|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
46909174|NCT02583048|83138202|FG000|Overall Study|Withdrawal by Subject|0|||
46909175|NCT02583048|83138203|FG001|Overall Study|Withdrawal by Subject|1|||
46909176|NCT02583048|83138204|FG002|Overall Study|Withdrawal by Subject|0|||
46909177|NCT02583048|83138202|FG000|Overall Study|Failed to meet eligibility criterion|0|||
46909178|NCT02583048|83138203|FG001|Overall Study|Failed to meet eligibility criterion|0|||
46909179|NCT02583048|83138204|FG002|Overall Study|Failed to meet eligibility criterion|1|||
46909180|NCT02939599|83138217|FG000|Overall Study|Adverse Event|1|||
46909181|NCT02939599|83138218|FG001|Overall Study|Adverse Event|0|||
46909182|NCT02939599|83138217|FG000|Overall Study|Study Terminated By Sponsor|2|||
46909183|NCT02939599|83138218|FG001|Overall Study|Study Terminated By Sponsor|2|||
46909184|NCT01318512|83138225|FG000|Maintenance Period (6 Months)|Death|2|||
46909185|NCT01318512|83138225|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
46909186|NCT03274687|83138246|FG000|Overall Study|Protocol Violation|1|||
46909187|NCT03274687|83138247|FG001|Overall Study|Protocol Violation|1|||
46909188|NCT04651218|83138253|FG000|Overall Study|Withdrawal by Subject|0|||
46909189|NCT04651218|83138254|FG001|Overall Study|Withdrawal by Subject|2|||
46909190|NCT03274453|83138264|FG000|Overall Study|Lost to Follow-up|2|||
46909191|NCT03274453|83138265|FG001|Overall Study|Lost to Follow-up|5|||
46909192|NCT03274453|83138266|FG002|Overall Study|Lost to Follow-up|4|||
46909193|NCT03274453|83138267|FG003|Overall Study|Lost to Follow-up|1|||
46909194|NCT03274453|83138264|FG000|Overall Study|Physician Decision|2|||
46909195|NCT03274453|83138265|FG001|Overall Study|Physician Decision|0|||
46909196|NCT03274453|83138266|FG002|Overall Study|Physician Decision|0|||
46909197|NCT03274453|83138267|FG003|Overall Study|Physician Decision|3|||
46909198|NCT03274453|83138264|FG000|Overall Study|Surgery Cancelled|0|||
46909199|NCT03274453|83138265|FG001|Overall Study|Surgery Cancelled|1|||
46909200|NCT03274453|83138266|FG002|Overall Study|Surgery Cancelled|0|||
46909201|NCT03274453|83138267|FG003|Overall Study|Surgery Cancelled|0|||
46909202|NCT00659646|83138293|FG000|Overall Study|Protocol Violation|12|||
46909203|NCT00659646|83138294|FG001|Overall Study|Protocol Violation|8|||
46909204|NCT00659646|83138293|FG000|Overall Study|Adverse Event|1|||
46909205|NCT00659646|83138294|FG001|Overall Study|Adverse Event|0|||
46909206|NCT00659646|83138293|FG000|Overall Study|Lost to Follow-up|1|||
47002625|NCT01764022|83250634|FG001|Overall Study|Withdrawal by Subject|6|||
47002626|NCT01764022|83250633|FG000|Overall Study|Lack of Efficacy|0|||
47002627|NCT01764022|83250634|FG001|Overall Study|Lack of Efficacy|1|||
47002628|NCT01764022|83250633|FG000|Overall Study|Physician Decision|0|||
47002629|NCT01764022|83250634|FG001|Overall Study|Physician Decision|2|||
47002630|NCT01764022|83250633|FG000|Overall Study|Lost to Follow-up|2|||
47002631|NCT01764022|83250634|FG001|Overall Study|Lost to Follow-up|0|||
47002632|NCT01764022|83250633|FG000|Overall Study|Protocol Violation|1|||
47002633|NCT01764022|83250634|FG001|Overall Study|Protocol Violation|0|||
47002634|NCT02003391|83250644|FG000|Overall Study|Withdrawal by Subject|2|||
47002635|NCT02003391|83250645|FG001|Overall Study|Withdrawal by Subject|1|||
47002636|NCT02003391|83250644|FG000|Overall Study|Protocol Violation|0|||
47002637|NCT02003391|83250645|FG001|Overall Study|Protocol Violation|1|||
47002638|NCT02003391|83250644|FG000|Overall Study|Adverse Event|1|||
47002639|NCT02003391|83250645|FG001|Overall Study|Adverse Event|0|||
47002640|NCT02254681|83250651|FG000|Overall Study|Lack of Efficacy|6|||
47002641|NCT01965327|83250656|FG000|Overall Study|Physician Decision|2|||
47002642|NCT02002689|83250660|FG000|Overall Study|Disease Progression|7|||
47002643|NCT02002689|83250660|FG000|Overall Study|Adverse Event|3|||
47002644|NCT01639729|83250664|FG000|Overall Study|Withdrawal by Subject|1|||
47002645|NCT01639729|83250665|FG001|Overall Study|Withdrawal by Subject|0|||
47002646|NCT01639729|83250666|FG002|Overall Study|Withdrawal by Subject|1|||
47002647|NCT01639729|83250667|FG003|Overall Study|Withdrawal by Subject|1|||
47002648|NCT01639729|83250668|FG004|Overall Study|Withdrawal by Subject|0|||
47002649|NCT01639729|83250669|FG005|Overall Study|Withdrawal by Subject|0|||
47002650|NCT02002533|83250681|FG000|Overall Study|Withdrawal by Subject|6|||
47002651|NCT02002533|83250682|FG001|Overall Study|Withdrawal by Subject|13|||
47002652|NCT02002533|83250681|FG000|Overall Study|Protocol Violation|0|||
47002653|NCT02002533|83250682|FG001|Overall Study|Protocol Violation|1|||
47002654|NCT02002533|83250681|FG000|Overall Study|Adverse Event|0|||
47002655|NCT02002533|83250682|FG001|Overall Study|Adverse Event|3|||
47002656|NCT02002533|83250681|FG000|Overall Study|Lost to Follow-up|0|||
47002657|NCT02002533|83250682|FG001|Overall Study|Lost to Follow-up|1|||
47002658|NCT02002221|83250691|FG000|Overall Study|Adverse Event|2|||
47002659|NCT02002221|83250692|FG001|Overall Study|Adverse Event|1|||
47002660|NCT02002221|83250691|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
47002661|NCT02002221|83250692|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
47002662|NCT02002221|83250691|FG000|Overall Study|Patient withdrew consent|0|||
47002663|NCT02002221|83250692|FG001|Overall Study|Patient withdrew consent|1|||
47002664|NCT01639495|83250698|FG000|Overall Study|Lost to Follow-up|6|||
47002665|NCT01639495|83250698|FG000|Overall Study|Consented but didn't have study catheter|4|||
47002666|NCT01639495|83250698|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
47002667|NCT01639495|83250698|FG000|Overall Study|No radiofrequency energy applied|2|||
47002668|NCT02001987|83250702|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
47002669|NCT02001987|83250702|FG000|Core Study Period (24 Weeks)|Death|1|||
47002670|NCT02001987|83250702|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
47002671|NCT02001987|83250702|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
47002672|NCT02001987|83250702|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
47002673|NCT02001987|83250702|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
47002674|NCT02001987|83250702|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
46909207|NCT00659646|83138294|FG001|Overall Study|Lost to Follow-up|0|||
46909208|NCT00659646|83138293|FG000|Overall Study|protocol noncompliance after randomized|1|||
46909209|NCT00659646|83138294|FG001|Overall Study|protocol noncompliance after randomized|0|||
46909210|NCT02236572|83138302|FG000|Overall Study|Withdrawal by Subject|1|||
46909211|NCT02236572|83138302|FG000|Overall Study|Protocol Violation|1|||
46909212|NCT02236572|83138302|FG000|Overall Study|Lost to Follow-up|1|||
46909213|NCT03054870|83138306|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
46909214|NCT03054870|83138306|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
46909215|NCT03414047|83138325|FG000|Overall Study|Adverse Event|0|||
46909216|NCT03414047|83138326|FG001|Overall Study|Adverse Event|0|||
46909217|NCT03414047|83138327|FG002|Overall Study|Adverse Event|1|||
46909218|NCT03414047|83138328|FG003|Overall Study|Adverse Event|1|||
46909219|NCT03414047|83138325|FG000|Overall Study|Physician Decision|1|||
46909220|NCT03414047|83138326|FG001|Overall Study|Physician Decision|0|||
46909221|NCT03414047|83138327|FG002|Overall Study|Physician Decision|0|||
46909222|NCT03414047|83138328|FG003|Overall Study|Physician Decision|1|||
46909223|NCT03414047|83138325|FG000|Overall Study|Withdrawal by Subject|1|||
46909224|NCT03414047|83138326|FG001|Overall Study|Withdrawal by Subject|0|||
46909225|NCT03414047|83138327|FG002|Overall Study|Withdrawal by Subject|2|||
46909226|NCT03414047|83138328|FG003|Overall Study|Withdrawal by Subject|0|||
46909227|NCT03351335|83138342|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
46909228|NCT03351335|83138343|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
46909229|NCT03351335|83138344|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
46909230|NCT03055806|83138356|FG000|Overall Study|Adverse Event|0|||
46909231|NCT03055806|83138357|FG001|Overall Study|Adverse Event|0|||
46909232|NCT03055806|83138358|FG002|Overall Study|Adverse Event|1|||
46909233|NCT03055806|83138359|FG003|Overall Study|Adverse Event|1|||
46909234|NCT03055806|83138356|FG000|Overall Study|Lost to Follow-up|0|||
46909235|NCT03055806|83138357|FG001|Overall Study|Lost to Follow-up|3|||
46909236|NCT03055806|83138358|FG002|Overall Study|Lost to Follow-up|6|||
46909237|NCT03055806|83138359|FG003|Overall Study|Lost to Follow-up|7|||
46909238|NCT03055806|83138356|FG000|Overall Study|Physician Decision|1|||
46909239|NCT03055806|83138357|FG001|Overall Study|Physician Decision|0|||
46909240|NCT03055806|83138358|FG002|Overall Study|Physician Decision|0|||
46909241|NCT03055806|83138359|FG003|Overall Study|Physician Decision|1|||
46909242|NCT03055806|83138356|FG000|Overall Study|Protocol Violation|1|||
46909243|NCT03055806|83138357|FG001|Overall Study|Protocol Violation|0|||
46909244|NCT03055806|83138358|FG002|Overall Study|Protocol Violation|0|||
46909245|NCT03055806|83138359|FG003|Overall Study|Protocol Violation|0|||
46909246|NCT03055806|83138356|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
46909247|NCT03055806|83138357|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
46909248|NCT03055806|83138358|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
46909249|NCT03055806|83138359|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
46909250|NCT03055806|83138356|FG000|Overall Study|Withdrawal of consent to continue study|2|||
46909251|NCT03055806|83138357|FG001|Overall Study|Withdrawal of consent to continue study|3|||
46909252|NCT03055806|83138358|FG002|Overall Study|Withdrawal of consent to continue study|4|||
46909253|NCT03055806|83138359|FG003|Overall Study|Withdrawal of consent to continue study|6|||
46909254|NCT03055806|83138356|FG000|Overall Study|Partner not willing to try intercourse|1|||
46909255|NCT03055806|83138357|FG001|Overall Study|Partner not willing to try intercourse|0|||
46909256|NCT03055806|83138358|FG002|Overall Study|Partner not willing to try intercourse|0|||
46909257|NCT03055806|83138359|FG003|Overall Study|Partner not willing to try intercourse|0|||
46909258|NCT04620798|83138371|FG000|Overall Study|Lost to Follow-up|126|||
46909259|NCT04620798|83138372|FG001|Overall Study|Lost to Follow-up|138|||
46909260|NCT03052764|83138380|FG000|Double-Blind Treatment Period|Adverse Event|2|||
46909261|NCT03052764|83138381|FG001|Double-Blind Treatment Period|Adverse Event|0|||
46909262|NCT03052764|83138380|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
46909263|NCT03052764|83138381|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
46909264|NCT03052764|83138380|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
46909265|NCT03052764|83138381|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
46909266|NCT03052764|83138380|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
46909267|NCT03052764|83138381|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46909268|NCT03052764|83138380|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
46909269|NCT03052764|83138381|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
46909270|NCT02951819|83138391|FG000|Overall Study|Death|9|||
46909271|NCT02951819|83138392|FG001|Overall Study|Death|7|||
46909272|NCT02951819|83138391|FG000|Overall Study|Withdrawal by Subject|3|||
46909273|NCT02951819|83138392|FG001|Overall Study|Withdrawal by Subject|0|||
46909274|NCT02951819|83138391|FG000|Overall Study|Adverse Event|1|||
46909275|NCT02951819|83138392|FG001|Overall Study|Adverse Event|0|||
46909276|NCT02951819|83138391|FG000|Overall Study|Lack of Efficacy|4|||
46909277|NCT02951819|83138392|FG001|Overall Study|Lack of Efficacy|0|||
46909278|NCT02951819|83138391|FG000|Overall Study|Lost to Follow-up|1|||
46909279|NCT02951819|83138392|FG001|Overall Study|Lost to Follow-up|0|||
46909280|NCT02951819|83138391|FG000|Overall Study|Progressive Disease|1|||
46909281|NCT02951819|83138392|FG001|Overall Study|Progressive Disease|0|||
46909282|NCT02951819|83138391|FG000|Overall Study|Other|9|||
46909283|NCT02951819|83138392|FG001|Overall Study|Other|0|||
46909284|NCT03383783|83138398|FG000|Overall Study|Withdrawal by Subject|2|||
46909285|NCT03334721|83138416|FG000|Overall Study|Withdrawal by Subject|1|||
47002675|NCT02001987|83250702|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
47002676|NCT02001987|83250702|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
47002677|NCT02001987|83250702|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
47002678|NCT02001987|83250702|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
47002679|NCT02001987|83250702|FG000|LTE Period (52 Weeks)|Other|3|||
47002680|NCT01363765|83250713|FG000|Overall Study|non-diagnostic|2621|||
47002681|NCT01363765|83250714|FG001|Overall Study|non-diagnostic|1124|||
47002682|NCT01363765|83250713|FG000|Overall Study|duplicate records|736|||
47002683|NCT01363765|83250714|FG001|Overall Study|duplicate records|3177|||
46909286|NCT03334721|83138417|FG001|Overall Study|Withdrawal by Subject|0|||
46909287|NCT03334721|83138416|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
46909288|NCT03334721|83138417|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
46909289|NCT03515551|83138430|FG000|Overall Study|Death|4|||
46909290|NCT03515551|83138431|FG001|Overall Study|Death|1|||
46909291|NCT03515551|83138432|FG002|Overall Study|Death|2|||
46909292|NCT03515551|83138433|FG003|Overall Study|Death|2|||
46909293|NCT03515551|83138434|FG004|Overall Study|Death|2|||
47002684|NCT01363765|83250713|FG000|Overall Study|non-resident|156|||
47002685|NCT01363765|83250714|FG001|Overall Study|non-resident|76|||
47002686|NCT01363765|83250713|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
47002687|NCT01363765|83250714|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
47002688|NCT01363765|83250713|FG000|Overall Study|smear during intervention|2170|||
47002689|NCT01363765|83250714|FG001|Overall Study|smear during intervention|0|||
47002690|NCT02001051|83250724|FG000|Overall Study|Deemed not eligible following enrollment|0|||
47002691|NCT02001051|83250725|FG001|Overall Study|Deemed not eligible following enrollment|1|||
47002692|NCT01763164|83250733|FG000|Treatment Phase|Participant/Guardian decision|26|||
47002693|NCT01763164|83250734|FG001|Treatment Phase|Participant/Guardian decision|14|||
46909294|NCT03515551|83138435|FG005|Overall Study|Death|4|||
46909295|NCT03515551|83138436|FG006|Overall Study|Death|1|||
46909296|NCT03515551|83138430|FG000|Overall Study|Lost to Follow-up|0|||
46909297|NCT03515551|83138431|FG001|Overall Study|Lost to Follow-up|0|||
46909298|NCT03515551|83138432|FG002|Overall Study|Lost to Follow-up|1|||
46909299|NCT03515551|83138433|FG003|Overall Study|Lost to Follow-up|0|||
46909300|NCT03515551|83138434|FG004|Overall Study|Lost to Follow-up|0|||
46909301|NCT03515551|83138435|FG005|Overall Study|Lost to Follow-up|0|||
46909302|NCT03515551|83138436|FG006|Overall Study|Lost to Follow-up|0|||
46909303|NCT03515551|83138430|FG000|Overall Study|Withdrawal by Subject|0|||
46909304|NCT03515551|83138431|FG001|Overall Study|Withdrawal by Subject|1|||
46909305|NCT03515551|83138432|FG002|Overall Study|Withdrawal by Subject|0|||
46909306|NCT03515551|83138433|FG003|Overall Study|Withdrawal by Subject|0|||
46909307|NCT03515551|83138434|FG004|Overall Study|Withdrawal by Subject|0|||
46909308|NCT03515551|83138435|FG005|Overall Study|Withdrawal by Subject|0|||
46909309|NCT03515551|83138436|FG006|Overall Study|Withdrawal by Subject|1|||
46909310|NCT03515551|83138430|FG000|Overall Study|Study ended by sponsor|0|||
46909311|NCT03515551|83138431|FG001|Overall Study|Study ended by sponsor|0|||
46909312|NCT03515551|83138432|FG002|Overall Study|Study ended by sponsor|2|||
46909313|NCT03515551|83138433|FG003|Overall Study|Study ended by sponsor|1|||
46909314|NCT03515551|83138434|FG004|Overall Study|Study ended by sponsor|3|||
46909315|NCT03515551|83138435|FG005|Overall Study|Study ended by sponsor|0|||
46909316|NCT03515551|83138436|FG006|Overall Study|Study ended by sponsor|3|||
46909317|NCT03515551|83138430|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
46909318|NCT03515551|83138431|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
46909319|NCT03515551|83138432|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
46909320|NCT03515551|83138433|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
46909321|NCT03515551|83138434|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
46909322|NCT03515551|83138435|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
46909323|NCT03515551|83138436|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
46909324|NCT03380429|83138462|FG000|Overall Study|Physician Decision|0|||
46909325|NCT03380429|83138463|FG001|Overall Study|Physician Decision|1|||
46909326|NCT03380429|83138464|FG002|Overall Study|Physician Decision|0|||
46909327|NCT03380429|83138465|FG003|Overall Study|Physician Decision|1|||
46909328|NCT03380429|83138466|FG004|Overall Study|Physician Decision|1|||
46909329|NCT03380429|83138462|FG000|Overall Study|Withdrawal by Subject|3|||
46909330|NCT03380429|83138463|FG001|Overall Study|Withdrawal by Subject|3|||
46909331|NCT03380429|83138464|FG002|Overall Study|Withdrawal by Subject|5|||
46909332|NCT03380429|83138465|FG003|Overall Study|Withdrawal by Subject|2|||
46909333|NCT03380429|83138466|FG004|Overall Study|Withdrawal by Subject|1|||
46909334|NCT03380429|83138462|FG000|Overall Study|Lost to Follow-up|0|||
46909335|NCT03380429|83138463|FG001|Overall Study|Lost to Follow-up|2|||
46909336|NCT03380429|83138464|FG002|Overall Study|Lost to Follow-up|4|||
46909337|NCT03380429|83138465|FG003|Overall Study|Lost to Follow-up|3|||
46909338|NCT03380429|83138466|FG004|Overall Study|Lost to Follow-up|1|||
46909339|NCT03380429|83138462|FG000|Overall Study|Protocol Violation|1|||
46909340|NCT03380429|83138463|FG001|Overall Study|Protocol Violation|0|||
46909341|NCT03380429|83138464|FG002|Overall Study|Protocol Violation|1|||
46909342|NCT03380429|83138465|FG003|Overall Study|Protocol Violation|0|||
46909343|NCT03380429|83138466|FG004|Overall Study|Protocol Violation|1|||
46909344|NCT03380429|83138462|FG000|Overall Study|Lack of Efficacy|0|||
46909345|NCT03380429|83138463|FG001|Overall Study|Lack of Efficacy|0|||
46909346|NCT03380429|83138464|FG002|Overall Study|Lack of Efficacy|0|||
46909347|NCT03380429|83138465|FG003|Overall Study|Lack of Efficacy|2|||
46909348|NCT03380429|83138466|FG004|Overall Study|Lack of Efficacy|1|||
46909349|NCT03380429|83138462|FG000|Overall Study|Adverse Event|1|||
46909350|NCT03380429|83138463|FG001|Overall Study|Adverse Event|1|||
46909351|NCT03380429|83138464|FG002|Overall Study|Adverse Event|1|||
46909352|NCT03380429|83138465|FG003|Overall Study|Adverse Event|2|||
46909353|NCT03380429|83138466|FG004|Overall Study|Adverse Event|0|||
46909354|NCT03280615|83138485|FG000|Overall Study|Lost to Follow-up|1|||
46909355|NCT03280615|83138486|FG001|Overall Study|Lost to Follow-up|2|||
47002694|NCT01763164|83250733|FG000|Treatment Phase|Protocol Violation|1|||
46909356|NCT03280615|83138485|FG000|Overall Study|Adverse Event|1|||
46909357|NCT03280615|83138486|FG001|Overall Study|Adverse Event|1|||
46909358|NCT03280615|83138485|FG000|Overall Study|Withdrawal by Subject|2|||
47002695|NCT01763164|83250734|FG001|Treatment Phase|Protocol Violation|1|||
47002696|NCT01763164|83250733|FG000|Treatment Phase|Progressive Disease|142|||
47002697|NCT01763164|83250734|FG001|Treatment Phase|Progressive Disease|76|||
47002698|NCT01763164|83250733|FG000|Treatment Phase|Physician Decision|24|||
47002699|NCT01763164|83250734|FG001|Treatment Phase|Physician Decision|13|||
47002700|NCT01763164|83250733|FG000|Treatment Phase|Death|10|||
47002701|NCT01763164|83250734|FG001|Treatment Phase|Death|1|||
47002702|NCT01763164|83250733|FG000|Treatment Phase|Adverse Event|66|||
47002703|NCT01763164|83250734|FG001|Treatment Phase|Adverse Event|8|||
47002704|NCT01763164|83250733|FG000|Treatment Phase|Randomized but not Treated|0|||
47002705|NCT01763164|83250734|FG001|Treatment Phase|Randomized but not Treated|19|||
47002706|NCT01763164|83250733|FG000|Treatment Phase|Other|0|||
47002707|NCT01763164|83250734|FG001|Treatment Phase|Other|1|||
47002708|NCT01763164|83250733|FG000|Follow up Phase|New therapy for study indication|12|||
47002709|NCT01763164|83250734|FG001|Follow up Phase|New therapy for study indication|3|||
47002710|NCT01763164|83250733|FG000|Follow up Phase|Death|21|||
47002711|NCT01763164|83250734|FG001|Follow up Phase|Death|4|||
47002712|NCT01763164|83250733|FG000|Follow up Phase|Subject/guardian decision|9|||
47002713|NCT01763164|83250734|FG001|Follow up Phase|Subject/guardian decision|2|||
47002714|NCT01763164|83250733|FG000|Follow up Phase|Progressive disease|127|||
47002715|NCT01763164|83250734|FG001|Follow up Phase|Progressive disease|62|||
47002716|NCT01763164|83250733|FG000|Follow up Phase|Physician Decision|10|||
47002717|NCT01763164|83250734|FG001|Follow up Phase|Physician Decision|3|||
47002718|NCT01763164|83250733|FG000|Follow up Phase|Lost to Follow-up|1|||
47002719|NCT01763164|83250734|FG001|Follow up Phase|Lost to Follow-up|0|||
47002720|NCT01763164|83250733|FG000|Follow up Phase|Adverse Event|17|||
47002721|NCT01763164|83250734|FG001|Follow up Phase|Adverse Event|1|||
47002722|NCT01782742|83250742|FG000|Double-blind Treatment Phase|Adverse Event|1|||
47002723|NCT01782742|83250743|FG001|Double-blind Treatment Phase|Adverse Event|0|||
47002724|NCT01782664|83250757|FG000|Overall Study|Adverse Event|2|||
47002725|NCT01782664|83250758|FG001|Overall Study|Adverse Event|2|||
47002726|NCT01782664|83250759|FG002|Overall Study|Adverse Event|2|||
47002727|NCT01782664|83250760|FG003|Overall Study|Adverse Event|2|||
47002728|NCT01782664|83250761|FG004|Overall Study|Adverse Event|0|||
47002729|NCT01782664|83250762|FG005|Overall Study|Adverse Event|0|||
47002730|NCT01782664|83250757|FG000|Overall Study|Lack of Efficacy|2|||
47002731|NCT01782664|83250758|FG001|Overall Study|Lack of Efficacy|0|||
47002732|NCT01782664|83250759|FG002|Overall Study|Lack of Efficacy|2|||
47002733|NCT01782664|83250760|FG003|Overall Study|Lack of Efficacy|2|||
47002734|NCT01782664|83250761|FG004|Overall Study|Lack of Efficacy|0|||
47002735|NCT01782664|83250762|FG005|Overall Study|Lack of Efficacy|0|||
47002736|NCT01782664|83250757|FG000|Overall Study|Protocol Violation|0|||
47002737|NCT01782664|83250758|FG001|Overall Study|Protocol Violation|1|||
47002738|NCT01782664|83250759|FG002|Overall Study|Protocol Violation|0|||
47002739|NCT01782664|83250760|FG003|Overall Study|Protocol Violation|1|||
47002740|NCT01782664|83250761|FG004|Overall Study|Protocol Violation|0|||
47002741|NCT01782664|83250762|FG005|Overall Study|Protocol Violation|0|||
47002742|NCT01782664|83250757|FG000|Overall Study|Withdrawal by Subject|2|||
47002743|NCT01782664|83250758|FG001|Overall Study|Withdrawal by Subject|2|||
47002744|NCT01782664|83250759|FG002|Overall Study|Withdrawal by Subject|0|||
47002745|NCT01782664|83250760|FG003|Overall Study|Withdrawal by Subject|0|||
47002746|NCT01782664|83250761|FG004|Overall Study|Withdrawal by Subject|0|||
47002747|NCT01782664|83250762|FG005|Overall Study|Withdrawal by Subject|0|||
47002748|NCT01732588|83250779|FG000|First Intervention (7 Days)|Adverse Event|0|||
47002749|NCT01732588|83250780|FG001|First Intervention (7 Days)|Adverse Event|1|||
47002750|NCT01732588|83250781|FG002|First Intervention (7 Days)|Adverse Event|0|||
47002751|NCT01781962|83250789|FG000|Overall Study|Other Miscellaneous Reasons|5|||
47002752|NCT01639339|83250795|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
47002753|NCT01639339|83250796|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
47002754|NCT01639339|83250795|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
47002755|NCT01639339|83250796|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
47002756|NCT01639339|83250795|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
47002757|NCT01639339|83250796|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
47002758|NCT01639339|83250795|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
47002759|NCT01639339|83250796|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
47002760|NCT01639339|83250795|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
47002761|NCT01639339|83250796|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
47002762|NCT01639339|83250795|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
47002763|NCT01639339|83250796|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
47002764|NCT01639339|83250795|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
47002765|NCT01639339|83250796|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
47002766|NCT01639339|83250795|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
47002767|NCT01639339|83250796|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
47002768|NCT01639339|83250795|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
47002769|NCT01639339|83250796|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
47002770|NCT01639339|83250795|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
47002771|NCT01639339|83250796|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
47002772|NCT02000817|83250810|FG000|Overall Study|Withdrawal by Subject|2|||
47002773|NCT02000817|83250811|FG001|Overall Study|Withdrawal by Subject|0|||
47002774|NCT02000817|83250812|FG002|Overall Study|Withdrawal by Subject|0|||
47002775|NCT02000817|83250813|FG003|Overall Study|Withdrawal by Subject|0|||
47002776|NCT02000817|83250810|FG000|Overall Study|Adverse Event|0|||
47002777|NCT02000817|83250811|FG001|Overall Study|Adverse Event|1|||
47002778|NCT02000817|83250812|FG002|Overall Study|Adverse Event|0|||
47002779|NCT02000817|83250813|FG003|Overall Study|Adverse Event|0|||
47002780|NCT02000817|83250810|FG000|Overall Study|Lost to Follow-up|0|||
47002781|NCT02000817|83250811|FG001|Overall Study|Lost to Follow-up|0|||
47002782|NCT02000817|83250812|FG002|Overall Study|Lost to Follow-up|1|||
47002783|NCT02000817|83250813|FG003|Overall Study|Lost to Follow-up|0|||
47002784|NCT01641133|83250829|FG000|Overall Study|Protocol Violation|0|||
47002785|NCT01641133|83250830|FG001|Overall Study|Protocol Violation|1|||
47002786|NCT01641133|83250831|FG002|Overall Study|Protocol Violation|1|||
47002787|NCT01641133|83250829|FG000|Overall Study|Migrated/moved from study area|5|||
47002788|NCT01641133|83250830|FG001|Overall Study|Migrated/moved from study area|3|||
47002789|NCT01641133|83250831|FG002|Overall Study|Migrated/moved from study area|1|||
47002790|NCT01641133|83250829|FG000|Overall Study|Adverse Event|0|||
47002791|NCT01641133|83250830|FG001|Overall Study|Adverse Event|0|||
47002792|NCT01641133|83250831|FG002|Overall Study|Adverse Event|1|||
47002793|NCT01641133|83250829|FG000|Overall Study|Withdrawal by Subject|5|||
47002794|NCT01641133|83250830|FG001|Overall Study|Withdrawal by Subject|3|||
47002795|NCT01641133|83250831|FG002|Overall Study|Withdrawal by Subject|3|||
47002796|NCT01641133|83250829|FG000|Overall Study|Lost to Follow-up|0|||
47002797|NCT01641133|83250830|FG001|Overall Study|Lost to Follow-up|2|||
47002798|NCT01641133|83250831|FG002|Overall Study|Lost to Follow-up|2|||
47002799|NCT01600885|83250839|FG000|First Period|Adverse Event|1|||
47002800|NCT01600885|83250840|FG001|First Period|Adverse Event|1|||
47002801|NCT01600885|83250839|FG000|First Period|moved out of area|1|||
47002802|NCT01600885|83250840|FG001|First Period|moved out of area|0|||
47002803|NCT01732510|83250853|FG000|Overall Study|Adverse Event|0|||
47002804|NCT01732510|83250854|FG001|Overall Study|Adverse Event|1|||
47002805|NCT01732510|83250855|FG002|Overall Study|Adverse Event|1|||
47002806|NCT01732510|83250856|FG003|Overall Study|Adverse Event|0|||
47002807|NCT01732510|83250857|FG004|Overall Study|Adverse Event|0|||
47002808|NCT01732510|83250858|FG005|Overall Study|Adverse Event|0|||
47002809|NCT01732510|83250859|FG006|Overall Study|Adverse Event|1|||
47002810|NCT01732510|83250853|FG000|Overall Study|Protocol Violation|0|||
47002811|NCT01732510|83250854|FG001|Overall Study|Protocol Violation|0|||
47002812|NCT01732510|83250855|FG002|Overall Study|Protocol Violation|0|||
47002813|NCT01732510|83250856|FG003|Overall Study|Protocol Violation|1|||
47002814|NCT01732510|83250857|FG004|Overall Study|Protocol Violation|0|||
47002815|NCT01732510|83250858|FG005|Overall Study|Protocol Violation|0|||
47002816|NCT01732510|83250859|FG006|Overall Study|Protocol Violation|0|||
47002817|NCT01732510|83250853|FG000|Overall Study|Withdrawal by Subject|1|||
47002818|NCT01732510|83250854|FG001|Overall Study|Withdrawal by Subject|3|||
47002819|NCT01732510|83250855|FG002|Overall Study|Withdrawal by Subject|2|||
47002820|NCT01732510|83250856|FG003|Overall Study|Withdrawal by Subject|1|||
47002821|NCT01732510|83250857|FG004|Overall Study|Withdrawal by Subject|5|||
47002822|NCT01732510|83250858|FG005|Overall Study|Withdrawal by Subject|0|||
47002823|NCT01732510|83250859|FG006|Overall Study|Withdrawal by Subject|1|||
47002824|NCT01732510|83250853|FG000|Overall Study|Lost to Follow-up|0|||
47002825|NCT01732510|83250854|FG001|Overall Study|Lost to Follow-up|0|||
47002826|NCT01732510|83250855|FG002|Overall Study|Lost to Follow-up|1|||
47002827|NCT01732510|83250856|FG003|Overall Study|Lost to Follow-up|1|||
47002828|NCT01732510|83250857|FG004|Overall Study|Lost to Follow-up|0|||
47002829|NCT01732510|83250858|FG005|Overall Study|Lost to Follow-up|1|||
47002830|NCT01732510|83250859|FG006|Overall Study|Lost to Follow-up|0|||
47002831|NCT01732510|83250853|FG000|Overall Study|Physician Decision|0|||
47002832|NCT01732510|83250854|FG001|Overall Study|Physician Decision|1|||
47002833|NCT01732510|83250855|FG002|Overall Study|Physician Decision|0|||
47002834|NCT01732510|83250856|FG003|Overall Study|Physician Decision|0|||
47002835|NCT01732510|83250857|FG004|Overall Study|Physician Decision|0|||
47002836|NCT01732510|83250858|FG005|Overall Study|Physician Decision|0|||
47002837|NCT01732510|83250859|FG006|Overall Study|Physician Decision|0|||
47002838|NCT01732510|83250853|FG000|Overall Study|Pregnancy|0|||
47002839|NCT01732510|83250854|FG001|Overall Study|Pregnancy|0|||
47002840|NCT01732510|83250855|FG002|Overall Study|Pregnancy|0|||
47002841|NCT01732510|83250856|FG003|Overall Study|Pregnancy|1|||
47002842|NCT01732510|83250857|FG004|Overall Study|Pregnancy|0|||
47002843|NCT01732510|83250858|FG005|Overall Study|Pregnancy|0|||
47002844|NCT01732510|83250859|FG006|Overall Study|Pregnancy|0|||
47002845|NCT01732510|83250853|FG000|Overall Study|Study Terminated By Sponsor|0|||
47002846|NCT01732510|83250854|FG001|Overall Study|Study Terminated By Sponsor|0|||
47002847|NCT01732510|83250855|FG002|Overall Study|Study Terminated By Sponsor|0|||
47002848|NCT01732510|83250856|FG003|Overall Study|Study Terminated By Sponsor|1|||
47002849|NCT01732510|83250857|FG004|Overall Study|Study Terminated By Sponsor|0|||
47002850|NCT01732510|83250858|FG005|Overall Study|Study Terminated By Sponsor|12|||
47002851|NCT01732510|83250859|FG006|Overall Study|Study Terminated By Sponsor|6|||
47002852|NCT01637077|83250880|FG000|Overall Study|Cancel|1|||
47002853|NCT01637077|83250881|FG001|Overall Study|Cancel|1|||
47002854|NCT01637077|83250880|FG000|Overall Study|Withdrawal by Subject|1|||
47002855|NCT01637077|83250881|FG001|Overall Study|Withdrawal by Subject|0|||
47002856|NCT01637077|83250880|FG000|Overall Study|No cycle 1 questionnaire data|2|||
47002857|NCT01637077|83250881|FG001|Overall Study|No cycle 1 questionnaire data|0|||
47002858|NCT02308163|83250891|FG000|Overall Study|Not fulfill eligible criteria|1|||
47002859|NCT02308163|83250892|FG001|Overall Study|Not fulfill eligible criteria|2|||
47002860|NCT02308163|83250893|FG002|Overall Study|Not fulfill eligible criteria|0|||
47002861|NCT02308163|83250894|FG003|Overall Study|Not fulfill eligible criteria|1|||
47002862|NCT02308163|83250895|FG004|Overall Study|Not fulfill eligible criteria|1|||
47002863|NCT02308163|83250891|FG000|Overall Study|Adverse Event|9|||
47002864|NCT02308163|83250892|FG001|Overall Study|Adverse Event|5|||
47002865|NCT02308163|83250893|FG002|Overall Study|Adverse Event|2|||
47002866|NCT02308163|83250894|FG003|Overall Study|Adverse Event|2|||
47002867|NCT02308163|83250895|FG004|Overall Study|Adverse Event|11|||
47002868|NCT02308163|83250891|FG000|Overall Study|Lack of Efficacy|11|||
47002869|NCT02308163|83250892|FG001|Overall Study|Lack of Efficacy|3|||
47002870|NCT02308163|83250893|FG002|Overall Study|Lack of Efficacy|8|||
47002871|NCT02308163|83250894|FG003|Overall Study|Lack of Efficacy|4|||
47002872|NCT02308163|83250895|FG004|Overall Study|Lack of Efficacy|6|||
47002873|NCT02308163|83250891|FG000|Overall Study|Withdrawal of consent|2|||
47002874|NCT02308163|83250892|FG001|Overall Study|Withdrawal of consent|3|||
47002875|NCT02308163|83250893|FG002|Overall Study|Withdrawal of consent|0|||
47002876|NCT02308163|83250894|FG003|Overall Study|Withdrawal of consent|2|||
47002877|NCT02308163|83250895|FG004|Overall Study|Withdrawal of consent|6|||
47002878|NCT02308163|83250891|FG000|Overall Study|Protocol Violation|3|||
47002879|NCT02308163|83250892|FG001|Overall Study|Protocol Violation|3|||
47002880|NCT02308163|83250893|FG002|Overall Study|Protocol Violation|3|||
47002881|NCT02308163|83250894|FG003|Overall Study|Protocol Violation|2|||
47002882|NCT02308163|83250895|FG004|Overall Study|Protocol Violation|5|||
47002883|NCT02308163|83250891|FG000|Overall Study|Lab data met discontinuation criteria|3|||
47002884|NCT02308163|83250892|FG001|Overall Study|Lab data met discontinuation criteria|0|||
47002885|NCT02308163|83250893|FG002|Overall Study|Lab data met discontinuation criteria|0|||
47002886|NCT02308163|83250894|FG003|Overall Study|Lab data met discontinuation criteria|2|||
47002887|NCT02308163|83250895|FG004|Overall Study|Lab data met discontinuation criteria|0|||
46709367|NCT01170221|82925376|FG000|Overall Study|Randomized but not treated|1|||
46709368|NCT01170221|82925377|FG001|Overall Study|Randomized but not treated|0|||
46709369|NCT01166646|82925385|FG000|Overall Study|Protocol Violation|0|||
46709370|NCT01166646|82925386|FG001|Overall Study|Protocol Violation|1|||
47002888|NCT02308163|83250891|FG000|Overall Study|Miscellaneous|2|||
47002889|NCT02308163|83250892|FG001|Overall Study|Miscellaneous|2|||
47002890|NCT02308163|83250893|FG002|Overall Study|Miscellaneous|1|||
47002891|NCT02308163|83250894|FG003|Overall Study|Miscellaneous|0|||
47002892|NCT02308163|83250895|FG004|Overall Study|Miscellaneous|5|||
47002893|NCT01999335|83250927|FG000|Overall Study|Discontinued before receiving treatment|0|||
47002894|NCT01999335|83250928|FG001|Overall Study|Discontinued before receiving treatment|0|||
47002895|NCT01999335|83250929|FG002|Overall Study|Discontinued before receiving treatment|0|||
47002896|NCT01999335|83250930|FG003|Overall Study|Discontinued before receiving treatment|0|||
47002897|NCT01999335|83250931|FG004|Overall Study|Discontinued before receiving treatment|2|||
47002898|NCT01978119|83250946|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
47002899|NCT01978119|83250947|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
47002900|NCT01978119|83250946|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
47002901|NCT01978119|83250947|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
47002902|NCT01978119|83250946|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
47002903|NCT01978119|83250947|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
47002904|NCT01999179|83250953|FG000|Overall Study|Adverse Event|1|||
47002905|NCT01999179|83250953|FG000|Overall Study|Lost to Follow-up|1|||
47002906|NCT01999179|83250953|FG000|Overall Study|Change in Therapy|3|||
47002907|NCT01999179|83250953|FG000|Overall Study|New catheter|2|||
47002908|NCT01977729|83250957|FG000|Overall Study|Study terminated|1|||
47002909|NCT01998477|83250965|FG000|Overall Study|Lost to Follow-up|4|||
47002910|NCT01998477|83250966|FG001|Overall Study|Lost to Follow-up|5|||
47002911|NCT01998477|83250965|FG000|Overall Study|Withdrawal by Subject|6|||
47002912|NCT01998477|83250966|FG001|Overall Study|Withdrawal by Subject|0|||
47002913|NCT01998399|83250999|FG000|Overall Study|Lost to Follow-up|1|||
47002914|NCT01998399|83251000|FG001|Overall Study|Lost to Follow-up|3|||
47002915|NCT01998399|83250999|FG000|Overall Study|Death|4|||
47002916|NCT01998399|83251000|FG001|Overall Study|Death|2|||
47002917|NCT01998399|83250999|FG000|Overall Study|Study stopped before dosing completed|3|||
47002918|NCT01998399|83251000|FG001|Overall Study|Study stopped before dosing completed|3|||
47002919|NCT01998399|83250999|FG000|Overall Study|Withdrawal by Subject|0|||
47002920|NCT01998399|83251000|FG001|Overall Study|Withdrawal by Subject|1|||
47002921|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
47002922|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
47002923|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
47002924|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
47002925|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
47002926|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
47002927|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
47002928|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
47002929|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
47002930|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
47002931|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
47002932|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
47002933|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
47002934|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
47002935|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
47002936|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
47002937|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
47002938|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
47002939|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
47002940|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
47002941|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
47002942|NCT01781572|83251017|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
47002943|NCT01781572|83251018|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
47002944|NCT01781572|83251019|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
47002945|NCT01781572|83251017|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
47002946|NCT01781572|83251018|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
47002947|NCT01781572|83251019|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
47002948|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
47002949|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
47002950|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
47002951|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
47002952|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
47002953|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
47002954|NCT01781572|83251017|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
47002955|NCT01781572|83251018|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
47002956|NCT01781572|83251019|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
47002957|NCT01781572|83251017|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
47002958|NCT01781572|83251018|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
47002959|NCT01781572|83251019|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
47002960|NCT01781572|83251017|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
47002961|NCT01781572|83251018|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
47002962|NCT01781572|83251019|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
47002963|NCT01781572|83251017|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
47002964|NCT01781572|83251018|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
47002965|NCT01781572|83251019|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
47002966|NCT01781572|83251017|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
47002967|NCT01781572|83251018|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
47002968|NCT01781572|83251019|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
47002969|NCT01781572|83251017|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
47002970|NCT01781572|83251018|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
47002971|NCT01781572|83251019|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
47002972|NCT01781572|83251017|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
47002973|NCT01781572|83251018|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
47002974|NCT01781572|83251019|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
47002975|NCT01998243|83251050|FG000|Overall Study|Pregnancy|0|||
47002976|NCT01998243|83251051|FG001|Overall Study|Pregnancy|1|||
47002977|NCT01998243|83251050|FG000|Overall Study|Protocol Violation|5|||
47002978|NCT01998243|83251051|FG001|Overall Study|Protocol Violation|2|||
47002979|NCT01998243|83251050|FG000|Overall Study|Withdrawal by Subject|3|||
47002980|NCT01998243|83251051|FG001|Overall Study|Withdrawal by Subject|4|||
47002981|NCT01977573|83251063|FG000|Overall Study|Adverse Event|7|||
47002982|NCT01977573|83251064|FG001|Overall Study|Adverse Event|0|||
47002983|NCT01977573|83251065|FG002|Overall Study|Adverse Event|2|||
47002984|NCT01977573|83251066|FG003|Overall Study|Adverse Event|1|||
47002985|NCT01977573|83251063|FG000|Overall Study|Lost to Follow-up|1|||
47002986|NCT01977573|83251064|FG001|Overall Study|Lost to Follow-up|0|||
47002987|NCT01977573|83251065|FG002|Overall Study|Lost to Follow-up|0|||
47002988|NCT01977573|83251066|FG003|Overall Study|Lost to Follow-up|1|||
47002989|NCT01977573|83251063|FG000|Overall Study|Physician Decision|1|||
47002990|NCT01977573|83251064|FG001|Overall Study|Physician Decision|0|||
47002991|NCT01977573|83251065|FG002|Overall Study|Physician Decision|0|||
47002992|NCT01977573|83251066|FG003|Overall Study|Physician Decision|0|||
47002993|NCT01977573|83251063|FG000|Overall Study|Protocol Violation|3|||
47002994|NCT01977573|83251064|FG001|Overall Study|Protocol Violation|1|||
47002995|NCT01977573|83251065|FG002|Overall Study|Protocol Violation|0|||
47002996|NCT01977573|83251066|FG003|Overall Study|Protocol Violation|0|||
47002997|NCT01977573|83251063|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
47002998|NCT01977573|83251064|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
46709371|NCT01166646|82925385|FG000|Overall Study|Adverse Event|1|||
46709372|NCT01166646|82925386|FG001|Overall Study|Adverse Event|0|||
46709373|NCT01129284|82925395|FG000|Overall Study|Adverse Event|2|||
46709374|NCT01129284|82925396|FG001|Overall Study|Adverse Event|0|||
46709375|NCT01129284|82925397|FG002|Overall Study|Adverse Event|1|||
46709376|NCT01166568|82925408|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
46709377|NCT01166568|82925409|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
46709378|NCT01166568|82925410|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
46709379|NCT01166568|82925408|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
47002999|NCT01977573|83251065|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
47003000|NCT01977573|83251066|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
47003001|NCT01977573|83251063|FG000|Overall Study|Withdrawal by Subject|6|||
47003002|NCT01977573|83251064|FG001|Overall Study|Withdrawal by Subject|1|||
47003003|NCT01977573|83251065|FG002|Overall Study|Withdrawal by Subject|1|||
47003004|NCT01977573|83251066|FG003|Overall Study|Withdrawal by Subject|1|||
47003005|NCT01963767|83251079|FG000|Overall Study|Withdrawal by Subject|4|||
47003006|NCT01963767|83251080|FG001|Overall Study|Withdrawal by Subject|2|||
47003007|NCT01963767|83251079|FG000|Overall Study|Adverse Event|2|||
47003008|NCT01963767|83251080|FG001|Overall Study|Adverse Event|0|||
47003009|NCT01731886|83251088|FG000|Overall Study|Death|1|||
47003010|NCT01731886|83251089|FG001|Overall Study|Death|0|||
47003011|NCT01731886|83251088|FG000|Overall Study|Never started treatment|0|||
47003012|NCT01731886|83251089|FG001|Overall Study|Never started treatment|1|||
47003013|NCT01731886|83251088|FG000|Overall Study|Non-compliant|1|||
47003014|NCT01731886|83251089|FG001|Overall Study|Non-compliant|0|||
47003015|NCT01759420|83251096|FG000|Overall Study|Screen failure|5|||
47003016|NCT01759420|83251096|FG000|Overall Study|Inaccurate EKG machine readings|1|||
47003017|NCT01781026|83251100|FG000|Overall Study|Lack of Efficacy|2|||
47003018|NCT01607398|83251106|FG000|Overall Study|Adverse Event|0|||
47003019|NCT01607398|83251107|FG001|Overall Study|Adverse Event|2|||
47003020|NCT01607398|83251106|FG000|Overall Study|Severe COPD|2|||
47003021|NCT01607398|83251107|FG001|Overall Study|Severe COPD|0|||
47003022|NCT01779856|83251113|FG000|Overall Study|Withdrawal by Subject|15|||
47003023|NCT01779856|83251113|FG000|Overall Study|Death|3|||
47003024|NCT01779856|83251113|FG000|Overall Study|Physician Decision|1|||
47003025|NCT01779856|83251113|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
47003026|NCT01779856|83251113|FG000|Overall Study|Delays in scheduling implant|1|||
47003027|NCT01779856|83251113|FG000|Overall Study|Subject ineligible for Implant|2|||
47003028|NCT01729156|83251127|FG000|Overall Study|Withdrawal by Subject|1|||
47003029|NCT01729156|83251128|FG001|Overall Study|Withdrawal by Subject|0|||
47003030|NCT01729156|83251129|FG002|Overall Study|Withdrawal by Subject|0|||
47003031|NCT01779700|83251140|FG000|Overall Study|Adverse Event|4|||
47003032|NCT01779700|83251141|FG001|Overall Study|Adverse Event|3|||
47003033|NCT01779700|83251140|FG000|Overall Study|Withdrawal by Subject|0|||
47003034|NCT01779700|83251141|FG001|Overall Study|Withdrawal by Subject|2|||
47003035|NCT01778530|83251147|FG000|Overall Study|Progression on study|1|||
47003036|NCT01778530|83251147|FG000|Overall Study|Adverse event/side effect|1|||
47003037|NCT01778062|83251153|FG000|Overall Study|Adverse Event|1|||
47003038|NCT01778062|83251154|FG001|Overall Study|Adverse Event|3|||
47003039|NCT01778062|83251153|FG000|Overall Study|Consent Withdrawal|1|||
47003040|NCT01778062|83251154|FG001|Overall Study|Consent Withdrawal|5|||
47003041|NCT01778062|83251153|FG000|Overall Study|major protocol deviation|4|||
47003042|NCT01778062|83251154|FG001|Overall Study|major protocol deviation|3|||
47003043|NCT01759264|83251160|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
47003044|NCT01759264|83251160|FG000|Overall Study|Adverse Event|1|||
47003045|NCT01759264|83251160|FG000|Overall Study|Other|2|||
47003046|NCT01759264|83251160|FG000|Overall Study|Lost to Follow-up|2|||
47003047|NCT01759264|83251160|FG000|Overall Study|Withdrawal by Subject|3|||
47003048|NCT01759264|83251160|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
47003049|NCT01757704|83251167|FG000|Overall Study|Protocol Violation|1|||
47003050|NCT01757704|83251168|FG001|Overall Study|Protocol Violation|3|||
47003051|NCT01757392|83251174|FG000|Overall Study|Withdrawal by Subject|1|||
47003052|NCT01757392|83251174|FG000|Overall Study|Screen Fail|3|||
47003053|NCT01756846|83251180|FG000|Overall Study|Lost to Follow-up|5|||
47003054|NCT01756846|83251181|FG001|Overall Study|Lost to Follow-up|10|||
46709380|NCT01166568|82925409|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
47003055|NCT01756846|83251180|FG000|Overall Study|Withdrawal by Subject|1|||
47003056|NCT01756846|83251181|FG001|Overall Study|Withdrawal by Subject|2|||
47003057|NCT01963611|83251192|FG000|Overall Study|Adverse Event|1|||
47003058|NCT01963611|83251193|FG001|Overall Study|Adverse Event|1|||
47003059|NCT01963611|83251194|FG002|Overall Study|Adverse Event|3|||
47003060|NCT01963611|83251195|FG003|Overall Study|Adverse Event|4|||
47003061|NCT01963611|83251196|FG004|Overall Study|Adverse Event|3|||
47003062|NCT01963611|83251192|FG000|Overall Study|Protocol Violation|0|||
47003063|NCT01963611|83251193|FG001|Overall Study|Protocol Violation|0|||
47003064|NCT01963611|83251194|FG002|Overall Study|Protocol Violation|0|||
47003065|NCT01963611|83251195|FG003|Overall Study|Protocol Violation|1|||
47003066|NCT01963611|83251196|FG004|Overall Study|Protocol Violation|0|||
47003067|NCT01963611|83251192|FG000|Overall Study|Lack of Efficacy|0|||
47003068|NCT01963611|83251193|FG001|Overall Study|Lack of Efficacy|0|||
47003069|NCT01963611|83251194|FG002|Overall Study|Lack of Efficacy|0|||
47003070|NCT01963611|83251195|FG003|Overall Study|Lack of Efficacy|1|||
47003071|NCT01963611|83251196|FG004|Overall Study|Lack of Efficacy|0|||
47003072|NCT01963611|83251192|FG000|Overall Study|Withdrawal by Subject|3|||
47003073|NCT01963611|83251193|FG001|Overall Study|Withdrawal by Subject|2|||
47003074|NCT01963611|83251194|FG002|Overall Study|Withdrawal by Subject|1|||
47003075|NCT01963611|83251195|FG003|Overall Study|Withdrawal by Subject|1|||
47003076|NCT01963611|83251196|FG004|Overall Study|Withdrawal by Subject|3|||
47003077|NCT01963611|83251192|FG000|Overall Study|Other|47|||
47003078|NCT01963611|83251193|FG001|Overall Study|Other|46|||
47003079|NCT01963611|83251194|FG002|Overall Study|Other|48|||
47003080|NCT01963611|83251195|FG003|Overall Study|Other|45|||
47003081|NCT01963611|83251196|FG004|Overall Study|Other|45|||
47003082|NCT01975701|83251209|FG000|Overall Study|Lost to Follow-up|1|||
47003083|NCT01975701|83251209|FG000|Overall Study|Death|23|||
47003084|NCT01975701|83251209|FG000|Overall Study|Physician Decision|1|||
47003085|NCT01962987|83251216|FG000|Overall Study|Adverse Event|4|||
47003086|NCT01962987|83251217|FG001|Overall Study|Adverse Event|4|||
47003087|NCT01962987|83251218|FG002|Overall Study|Adverse Event|0|||
47003088|NCT01962987|83251216|FG000|Overall Study|Lost to Follow-up|0|||
47003089|NCT01962987|83251217|FG001|Overall Study|Lost to Follow-up|0|||
47003090|NCT01962987|83251218|FG002|Overall Study|Lost to Follow-up|1|||
46909359|NCT03280615|83138486|FG001|Overall Study|Withdrawal by Subject|2|||
46909360|NCT03280537|83138494|FG000|Overall Study|Withdrawal by Subject|2|||
46909361|NCT03280537|83138495|FG001|Overall Study|Withdrawal by Subject|4|||
46909362|NCT03280381|83138503|FG000|Overall Study|Physician Decision|0|||
46909363|NCT03280381|83138504|FG001|Overall Study|Physician Decision|2|||
46909364|NCT03270085|83138513|FG000|Overall Study|Withdrawal by Subject|1|||
46909365|NCT03270085|83138514|FG001|Overall Study|Withdrawal by Subject|0|||
46909366|NCT03267511|83138524|FG000|Overall Study|Lost to Follow-up|0|||
46909367|NCT03267511|83138525|FG001|Overall Study|Lost to Follow-up|0|||
46909368|NCT03267511|83138526|FG002|Overall Study|Lost to Follow-up|0|||
46909369|NCT03267511|83138527|FG003|Overall Study|Lost to Follow-up|1|||
46909370|NCT03379259|83138554|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
46909371|NCT03379259|83138555|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
46909372|NCT03379259|83138556|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
46909373|NCT03379259|83138557|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
46909374|NCT03379259|83138558|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
46909375|NCT03379259|83138559|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
46909376|NCT03379259|83138554|FG000|Overall Study|Death|0|||
46909377|NCT03379259|83138555|FG001|Overall Study|Death|1|||
46909378|NCT03379259|83138556|FG002|Overall Study|Death|2|||
46909379|NCT03379259|83138557|FG003|Overall Study|Death|1|||
46909380|NCT03379259|83138558|FG004|Overall Study|Death|4|||
46909381|NCT03379259|83138559|FG005|Overall Study|Death|2|||
46909382|NCT03379259|83138554|FG000|Overall Study|Withdrawal by Subject|0|||
46909383|NCT03379259|83138555|FG001|Overall Study|Withdrawal by Subject|0|||
46909384|NCT03379259|83138556|FG002|Overall Study|Withdrawal by Subject|1|||
46909385|NCT03379259|83138557|FG003|Overall Study|Withdrawal by Subject|0|||
46909386|NCT03379259|83138558|FG004|Overall Study|Withdrawal by Subject|2|||
46909387|NCT03379259|83138559|FG005|Overall Study|Withdrawal by Subject|0|||
46909388|NCT03379259|83138554|FG000|Overall Study|Study terminated by sponsor|0|||
46909389|NCT03379259|83138555|FG001|Overall Study|Study terminated by sponsor|0|||
46909390|NCT03379259|83138556|FG002|Overall Study|Study terminated by sponsor|0|||
46909391|NCT03379259|83138557|FG003|Overall Study|Study terminated by sponsor|1|||
46909392|NCT03379259|83138558|FG004|Overall Study|Study terminated by sponsor|1|||
46909393|NCT03379259|83138559|FG005|Overall Study|Study terminated by sponsor|4|||
46909394|NCT03379259|83138554|FG000|Overall Study|Disease progression|0|||
47003091|NCT01962987|83251216|FG000|Overall Study|Non compliance with dosing requirements|4|||
47003092|NCT01962987|83251217|FG001|Overall Study|Non compliance with dosing requirements|2|||
47003093|NCT01962987|83251218|FG002|Overall Study|Non compliance with dosing requirements|0|||
47003094|NCT01962987|83251216|FG000|Overall Study|Miscellaneous|1|||
47003095|NCT01962987|83251217|FG001|Overall Study|Miscellaneous|9|||
47003096|NCT01962987|83251218|FG002|Overall Study|Miscellaneous|2|||
46909395|NCT03379259|83138555|FG001|Overall Study|Disease progression|0|||
46909396|NCT03379259|83138556|FG002|Overall Study|Disease progression|0|||
46909397|NCT03379259|83138557|FG003|Overall Study|Disease progression|1|||
46909398|NCT03379259|83138558|FG004|Overall Study|Disease progression|0|||
46909399|NCT03379259|83138559|FG005|Overall Study|Disease progression|1|||
46909400|NCT03379259|83138554|FG000|Overall Study|Lost to Follow-up|0|||
47003097|NCT01962987|83251216|FG000|Overall Study|Restricted medication|5|||
47003098|NCT01962987|83251217|FG001|Overall Study|Restricted medication|1|||
47003099|NCT01962987|83251218|FG002|Overall Study|Restricted medication|1|||
47003100|NCT01962987|83251216|FG000|Overall Study|Serious Adverse Event|1|||
47003101|NCT01962987|83251217|FG001|Overall Study|Serious Adverse Event|0|||
47003102|NCT01962987|83251218|FG002|Overall Study|Serious Adverse Event|0|||
47003103|NCT01962987|83251216|FG000|Overall Study|Withdrawal by Subject|11|||
47003104|NCT01962987|83251217|FG001|Overall Study|Withdrawal by Subject|10|||
47003105|NCT01962987|83251218|FG002|Overall Study|Withdrawal by Subject|6|||
47003106|NCT01962987|83251216|FG000|Overall Study|Randomized in Error|4|||
47003107|NCT01962987|83251217|FG001|Overall Study|Randomized in Error|2|||
47003108|NCT01962987|83251218|FG002|Overall Study|Randomized in Error|2|||
47003109|NCT01962441|83251229|FG000|Randomized Period|Randomized but Never Treated|4|||
47003110|NCT01962441|83251230|FG001|Randomized Period|Randomized but Never Treated|2|||
47003111|NCT01962441|83251231|FG002|Randomized Period|Randomized but Never Treated|3|||
47003112|NCT01962441|83251229|FG000|Randomized Period|Lost to Follow-up|2|||
47003113|NCT01962441|83251230|FG001|Randomized Period|Lost to Follow-up|4|||
47003114|NCT01962441|83251231|FG002|Randomized Period|Lost to Follow-up|4|||
47003115|NCT01962441|83251229|FG000|Randomized Period|Withdrew Consent|3|||
47003116|NCT01962441|83251230|FG001|Randomized Period|Withdrew Consent|3|||
47003117|NCT01962441|83251231|FG002|Randomized Period|Withdrew Consent|2|||
47003118|NCT01962441|83251229|FG000|Randomized Period|Adverse Event|1|||
47003119|NCT01962441|83251230|FG001|Randomized Period|Adverse Event|1|||
47003120|NCT01962441|83251231|FG002|Randomized Period|Adverse Event|0|||
47003121|NCT01962441|83251229|FG000|Randomized Period|Death|0|||
47003122|NCT01962441|83251230|FG001|Randomized Period|Death|0|||
47003123|NCT01962441|83251231|FG002|Randomized Period|Death|2|||
47003124|NCT01962441|83251229|FG000|Randomized Period|Protocol Violation|0|||
47003125|NCT01962441|83251230|FG001|Randomized Period|Protocol Violation|1|||
47003126|NCT01962441|83251231|FG002|Randomized Period|Protocol Violation|0|||
47003127|NCT01962441|83251229|FG000|Retreatment Substudy|Lack of Efficacy|1|||
47003128|NCT01962441|83251230|FG001|Retreatment Substudy|Lack of Efficacy|0|||
47003129|NCT01962441|83251231|FG002|Retreatment Substudy|Lack of Efficacy|0|||
47003130|NCT01962441|83251229|FG000|Retreatment Substudy|Lost to Follow-up|1|||
47003131|NCT01962441|83251230|FG001|Retreatment Substudy|Lost to Follow-up|0|||
47003132|NCT01962441|83251231|FG002|Retreatment Substudy|Lost to Follow-up|0|||
47003133|NCT01638013|83251243|FG000|Overall Study|Adverse Event|36|||
47003134|NCT01638013|83251244|FG001|Overall Study|Adverse Event|29|||
47003135|NCT01638013|83251245|FG002|Overall Study|Adverse Event|48|||
47003136|NCT01638013|83251243|FG000|Overall Study|Lack of Efficacy|39|||
47003137|NCT01638013|83251244|FG001|Overall Study|Lack of Efficacy|11|||
47003138|NCT01638013|83251245|FG002|Overall Study|Lack of Efficacy|14|||
47003139|NCT01638013|83251243|FG000|Overall Study|Protocol Violation|10|||
47003140|NCT01638013|83251244|FG001|Overall Study|Protocol Violation|7|||
46909401|NCT03379259|83138555|FG001|Overall Study|Lost to Follow-up|0|||
46909402|NCT03379259|83138556|FG002|Overall Study|Lost to Follow-up|0|||
46909403|NCT03379259|83138557|FG003|Overall Study|Lost to Follow-up|0|||
46909404|NCT03379259|83138558|FG004|Overall Study|Lost to Follow-up|1|||
46909405|NCT03379259|83138559|FG005|Overall Study|Lost to Follow-up|0|||
46909406|NCT03379259|83138554|FG000|Overall Study|Deteriorating condition|0|||
46909407|NCT03379259|83138555|FG001|Overall Study|Deteriorating condition|0|||
46909408|NCT03379259|83138556|FG002|Overall Study|Deteriorating condition|0|||
46909409|NCT03379259|83138557|FG003|Overall Study|Deteriorating condition|0|||
46909410|NCT03379259|83138558|FG004|Overall Study|Deteriorating condition|1|||
46909411|NCT03379259|83138559|FG005|Overall Study|Deteriorating condition|0|||
46909412|NCT03328897|83138579|FG000|Randomized-treatment Epoch|Adverse Event|4|||
46909413|NCT03328897|83138580|FG001|Randomized-treatment Epoch|Adverse Event|1|||
46909414|NCT03328897|83138581|FG002|Randomized-treatment Epoch|Adverse Event|1|||
46909415|NCT03328897|83138579|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
46909416|NCT03328897|83138580|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
46909417|NCT03328897|83138581|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
46909418|NCT03328897|83138579|FG000|Randomized-treatment Epoch|Pregnancy|3|||
46909419|NCT03328897|83138580|FG001|Randomized-treatment Epoch|Pregnancy|0|||
46909420|NCT03328897|83138581|FG002|Randomized-treatment Epoch|Pregnancy|0|||
47003141|NCT01638013|83251245|FG002|Overall Study|Protocol Violation|11|||
47003142|NCT01638013|83251243|FG000|Overall Study|Met discontinuation criteria|4|||
47003143|NCT01638013|83251244|FG001|Overall Study|Met discontinuation criteria|0|||
47003144|NCT01638013|83251245|FG002|Overall Study|Met discontinuation criteria|7|||
47003145|NCT01638013|83251243|FG000|Overall Study|Subject Lost to Follow up|1|||
47003146|NCT01638013|83251244|FG001|Overall Study|Subject Lost to Follow up|0|||
47003147|NCT01638013|83251245|FG002|Overall Study|Subject Lost to Follow up|1|||
46909421|NCT03328897|83138579|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
46909422|NCT03328897|83138580|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
47003148|NCT01638013|83251243|FG000|Overall Study|Miscellaneous|25|||
47003149|NCT01638013|83251244|FG001|Overall Study|Miscellaneous|19|||
46909423|NCT03328897|83138581|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
47003150|NCT01638013|83251245|FG002|Overall Study|Miscellaneous|23|||
47003151|NCT01638013|83251243|FG000|Overall Study|Withdrawal of Consent|16|||
47003152|NCT01638013|83251244|FG001|Overall Study|Withdrawal of Consent|12|||
47003153|NCT01638013|83251245|FG002|Overall Study|Withdrawal of Consent|16|||
47003154|NCT01638013|83251243|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
47003155|NCT01638013|83251244|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
47003156|NCT01638013|83251245|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
47003157|NCT01637623|83251260|FG000|Overall Study|Lost to Follow-up|0|||
47003158|NCT01637623|83251261|FG001|Overall Study|Lost to Follow-up|0|||
47003159|NCT01637623|83251262|FG002|Overall Study|Lost to Follow-up|2|||
47003160|NCT01637623|83251260|FG000|Overall Study|Physician Decision|1|||
47003161|NCT01637623|83251261|FG001|Overall Study|Physician Decision|0|||
47003162|NCT01637623|83251262|FG002|Overall Study|Physician Decision|1|||
47003163|NCT01962207|83251274|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
47003164|NCT01962207|83251275|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
47003165|NCT01962207|83251276|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
47003166|NCT01962207|83251277|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
47003167|NCT01962207|83251274|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
47003168|NCT01962207|83251275|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
47003169|NCT01962207|83251276|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
47003170|NCT01962207|83251277|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
47003171|NCT01962207|83251274|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
47003172|NCT01962207|83251275|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
47003173|NCT01962207|83251276|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
47003174|NCT01962207|83251277|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
47003175|NCT01962207|83251274|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
47003176|NCT01962207|83251275|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
47003177|NCT01962207|83251276|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
47003178|NCT01962207|83251277|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
47003179|NCT01962207|83251274|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
47003180|NCT01962207|83251275|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
47003181|NCT01962207|83251276|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
47003182|NCT01962207|83251277|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
47003183|NCT01962207|83251274|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
47003184|NCT01962207|83251275|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
47003185|NCT01962207|83251276|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
47003186|NCT01962207|83251277|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
47003187|NCT01995825|83251293|FG000|Overall Study|Withdrawal by Subject|1|||
47003188|NCT01995825|83251294|FG001|Overall Study|Withdrawal by Subject|0|||
47003189|NCT01995357|83251300|FG000|Period 5|Lack of Efficacy|1|||
47003190|NCT01995357|83251301|FG001|Period 5|Lack of Efficacy|0|||
46709381|NCT01166568|82925410|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
46909424|NCT03328897|83138579|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
46909425|NCT03328897|83138580|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
46909426|NCT03328897|83138581|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
46909427|NCT03328897|83138579|FG000|Follow-up Epoch|Adverse Event|4|||
46909428|NCT03328897|83138580|FG001|Follow-up Epoch|Adverse Event|0|||
46909429|NCT03328897|83138581|FG002|Follow-up Epoch|Adverse Event|1|||
46909430|NCT03328897|83138579|FG000|Follow-up Epoch|Lack of Efficacy|1|||
46909431|NCT03328897|83138580|FG001|Follow-up Epoch|Lack of Efficacy|1|||
46909432|NCT03328897|83138581|FG002|Follow-up Epoch|Lack of Efficacy|1|||
46909433|NCT03328897|83138579|FG000|Follow-up Epoch|Lost to Follow-up|0|||
46909434|NCT03328897|83138580|FG001|Follow-up Epoch|Lost to Follow-up|1|||
46909435|NCT03328897|83138581|FG002|Follow-up Epoch|Lost to Follow-up|0|||
46909436|NCT03328897|83138579|FG000|Follow-up Epoch|Pregnancy|1|||
46909437|NCT03328897|83138580|FG001|Follow-up Epoch|Pregnancy|0|||
46909438|NCT03328897|83138581|FG002|Follow-up Epoch|Pregnancy|0|||
46909439|NCT03328897|83138579|FG000|Follow-up Epoch|Patient/guardian decision|2|||
46909440|NCT03328897|83138580|FG001|Follow-up Epoch|Patient/guardian decision|1|||
46909441|NCT03328897|83138581|FG002|Follow-up Epoch|Patient/guardian decision|0|||
46909442|NCT03266107|83138589|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
46909443|NCT03266107|83138589|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
47003191|NCT01995357|83251302|FG002|Period 5|Lack of Efficacy|0|||
46909444|NCT03266107|83138589|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
46909445|NCT03266107|83138589|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
46909446|NCT03378635|83138598|FG000|Overall Study|Adverse Event|1|||
47003192|NCT01995357|83251303|FG003|Period 5|Lack of Efficacy|0|||
47003193|NCT01995357|83251304|FG004|Period 5|Lack of Efficacy|0|||
47003194|NCT01995357|83251305|FG005|Period 5|Lack of Efficacy|0|||
46909447|NCT03378635|83138599|FG001|Overall Study|Adverse Event|0|||
47003195|NCT01995357|83251300|FG000|Period 5|Adverse Event|1|||
47003196|NCT01995357|83251301|FG001|Period 5|Adverse Event|0|||
46709382|NCT01166568|82925408|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
46709383|NCT01166568|82925409|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
46709384|NCT01166568|82925410|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
46709385|NCT01166178|82925418|FG000|Overall Study|Withdrawal by Subject|1|||
46709386|NCT01166178|82925419|FG001|Overall Study|Withdrawal by Subject|0|||
46709387|NCT01166178|82925418|FG000|Overall Study|Study was terminated|20|||
46709388|NCT01166178|82925419|FG001|Overall Study|Study was terminated|8|||
46909448|NCT03378635|83138600|FG002|Overall Study|Adverse Event|0|||
47003197|NCT01995357|83251302|FG002|Period 5|Adverse Event|1|||
47003198|NCT01995357|83251303|FG003|Period 5|Adverse Event|0|||
47003199|NCT01995357|83251304|FG004|Period 5|Adverse Event|0|||
47003200|NCT01995357|83251305|FG005|Period 5|Adverse Event|0|||
47003201|NCT01638559|83251321|FG000|Overall Study|Lost to Follow-up|1|||
47003202|NCT01638559|83251321|FG000|Overall Study|Withdrawal by Subject|1|||
47003203|NCT01638559|83251321|FG000|Overall Study|Subject declined to travel for biopsy|1|||
47003204|NCT01756300|83251336|FG000|Overall Study|Death|1|||
47003205|NCT01756300|83251336|FG000|Overall Study|Withdrawal by Subject|1|||
47003206|NCT01995201|83251359|FG000|From Baseline Until Week 24|Adverse Event|4|||
47003207|NCT01995201|83251360|FG001|From Baseline Until Week 24|Adverse Event|15|||
47003208|NCT01995201|83251361|FG002|From Baseline Until Week 24|Adverse Event|0|||
47003209|NCT01995201|83251362|FG003|From Baseline Until Week 24|Adverse Event|0|||
47003210|NCT01995201|83251363|FG004|From Baseline Until Week 24|Adverse Event|0|||
47003211|NCT01995201|83251364|FG005|From Baseline Until Week 24|Adverse Event|0|||
47003212|NCT01995201|83251365|FG006|From Baseline Until Week 24|Adverse Event|0|||
47003213|NCT01995201|83251359|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
47003214|NCT01995201|83251360|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
47003215|NCT01995201|83251361|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
47003216|NCT01995201|83251362|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
47003217|NCT01995201|83251363|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
47003218|NCT01995201|83251364|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
47003219|NCT01995201|83251365|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
47003220|NCT01995201|83251359|FG000|From Baseline Until Week 24|Death|0|||
47003221|NCT01995201|83251360|FG001|From Baseline Until Week 24|Death|1|||
47003222|NCT01995201|83251361|FG002|From Baseline Until Week 24|Death|0|||
47003223|NCT01995201|83251362|FG003|From Baseline Until Week 24|Death|0|||
47003224|NCT01995201|83251363|FG004|From Baseline Until Week 24|Death|0|||
47003225|NCT01995201|83251364|FG005|From Baseline Until Week 24|Death|0|||
47003226|NCT01995201|83251365|FG006|From Baseline Until Week 24|Death|0|||
47003227|NCT01995201|83251359|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
47003228|NCT01995201|83251360|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
47003229|NCT01995201|83251361|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
47003230|NCT01995201|83251362|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
47003231|NCT01995201|83251363|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
47003232|NCT01995201|83251364|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
47003233|NCT01995201|83251365|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
47003234|NCT01995201|83251359|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
47003235|NCT01995201|83251360|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
47003236|NCT01995201|83251361|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
47003237|NCT01995201|83251362|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
47003238|NCT01995201|83251363|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
47003239|NCT01995201|83251364|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
47003240|NCT01995201|83251365|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
46909449|NCT03378635|83138598|FG000|Overall Study|Withdrawal by Subject|1|||
46909450|NCT03378635|83138599|FG001|Overall Study|Withdrawal by Subject|0|||
46909451|NCT03378635|83138600|FG002|Overall Study|Withdrawal by Subject|0|||
46909452|NCT03326869|83138611|FG000|Overall Study|Study data has been lost to natural disa|1|||
46909453|NCT03326869|83138612|FG001|Overall Study|Study data has been lost to natural disa|1|||
46909454|NCT03334409|83138624|FG000|Overall Study|Did not meet inclusion criteria|1|||
46909455|NCT03334409|83138625|FG001|Overall Study|Did not meet inclusion criteria|0|||
46909456|NCT02891915|83138633|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
47003241|NCT01995201|83251359|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
47003242|NCT01995201|83251360|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
47003243|NCT01995201|83251361|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
47003244|NCT01995201|83251362|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
47003245|NCT01995201|83251363|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
47003246|NCT01995201|83251364|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
47003247|NCT01995201|83251365|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
47003248|NCT01995201|83251359|FG000|From Baseline Until Week 24|Physician Decision|0|||
47003249|NCT01995201|83251360|FG001|From Baseline Until Week 24|Physician Decision|2|||
47003250|NCT01995201|83251361|FG002|From Baseline Until Week 24|Physician Decision|0|||
47003251|NCT01995201|83251362|FG003|From Baseline Until Week 24|Physician Decision|0|||
47003252|NCT01995201|83251363|FG004|From Baseline Until Week 24|Physician Decision|0|||
47003253|NCT01995201|83251364|FG005|From Baseline Until Week 24|Physician Decision|0|||
47003254|NCT01995201|83251365|FG006|From Baseline Until Week 24|Physician Decision|0|||
47003255|NCT01995201|83251359|FG000|From Baseline Until Week 24|Protocol Violation|0|||
47003256|NCT01995201|83251360|FG001|From Baseline Until Week 24|Protocol Violation|9|||
47003257|NCT01995201|83251361|FG002|From Baseline Until Week 24|Protocol Violation|0|||
47003258|NCT01995201|83251362|FG003|From Baseline Until Week 24|Protocol Violation|0|||
47003259|NCT01995201|83251363|FG004|From Baseline Until Week 24|Protocol Violation|0|||
47003260|NCT01995201|83251364|FG005|From Baseline Until Week 24|Protocol Violation|0|||
47003261|NCT01995201|83251365|FG006|From Baseline Until Week 24|Protocol Violation|0|||
47003262|NCT01995201|83251359|FG000|From Week 24 Until Week 48|Adverse Event|0|||
47003263|NCT01995201|83251360|FG001|From Week 24 Until Week 48|Adverse Event|0|||
47003264|NCT01995201|83251361|FG002|From Week 24 Until Week 48|Adverse Event|2|||
47003265|NCT01995201|83251362|FG003|From Week 24 Until Week 48|Adverse Event|1|||
47003266|NCT01995201|83251363|FG004|From Week 24 Until Week 48|Adverse Event|1|||
47003267|NCT01995201|83251364|FG005|From Week 24 Until Week 48|Adverse Event|3|||
47003268|NCT01995201|83251365|FG006|From Week 24 Until Week 48|Adverse Event|1|||
47003269|NCT01995201|83251359|FG000|From Week 24 Until Week 48|Death|0|||
47003270|NCT01995201|83251360|FG001|From Week 24 Until Week 48|Death|0|||
47003271|NCT01995201|83251361|FG002|From Week 24 Until Week 48|Death|0|||
47003272|NCT01995201|83251362|FG003|From Week 24 Until Week 48|Death|0|||
47003273|NCT01995201|83251363|FG004|From Week 24 Until Week 48|Death|0|||
47003274|NCT01995201|83251364|FG005|From Week 24 Until Week 48|Death|2|||
47003275|NCT01995201|83251365|FG006|From Week 24 Until Week 48|Death|0|||
47003276|NCT01995201|83251359|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
47003277|NCT01995201|83251360|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
47003278|NCT01995201|83251361|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
47003279|NCT01995201|83251362|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
47003280|NCT01995201|83251363|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
47003281|NCT01995201|83251364|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
47003282|NCT01995201|83251365|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
47003283|NCT01995201|83251359|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
47003284|NCT01995201|83251360|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
47003285|NCT01995201|83251361|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
47003286|NCT01995201|83251362|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
47003287|NCT01995201|83251363|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
47003288|NCT01995201|83251364|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
47003289|NCT01995201|83251365|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
47003290|NCT01995201|83251359|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
47003291|NCT01995201|83251360|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
47003292|NCT01995201|83251361|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
47003293|NCT01995201|83251362|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
47003294|NCT01995201|83251363|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
47003295|NCT01995201|83251364|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
47003296|NCT01995201|83251365|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
47003297|NCT01995201|83251359|FG000|From Week 24 Until Week 48|Physician Decision|0|||
47003298|NCT01995201|83251360|FG001|From Week 24 Until Week 48|Physician Decision|0|||
47003299|NCT01995201|83251361|FG002|From Week 24 Until Week 48|Physician Decision|0|||
47003300|NCT01995201|83251362|FG003|From Week 24 Until Week 48|Physician Decision|0|||
47003301|NCT01995201|83251363|FG004|From Week 24 Until Week 48|Physician Decision|1|||
47003302|NCT01995201|83251364|FG005|From Week 24 Until Week 48|Physician Decision|0|||
47003303|NCT01995201|83251365|FG006|From Week 24 Until Week 48|Physician Decision|0|||
47003304|NCT01995201|83251359|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
47003305|NCT01995201|83251360|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
46620454|NCT03738800|82769595|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
46620455|NCT03738800|82769596|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
46620456|NCT03738800|82769597|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
46620457|NCT03738800|82769595|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
46620458|NCT03738800|82769596|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
47003306|NCT01995201|83251361|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
47003307|NCT01995201|83251362|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
47003308|NCT01995201|83251363|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
47003309|NCT01995201|83251364|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
46620459|NCT03738800|82769597|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
46620460|NCT03682055|82769616|FG000|Overall Study|Lack of Efficacy|1|||
46620461|NCT03682055|82769617|FG001|Overall Study|Lack of Efficacy|2|||
47003310|NCT01995201|83251365|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
47003311|NCT01728454|83251389|FG000|Stage 1 and 2|Pregnancy|1|||
47003312|NCT01728454|83251390|FG001|Stage 1 and 2|Pregnancy|0|||
47003313|NCT01728454|83251391|FG002|Stage 1 and 2|Pregnancy|0|||
47003314|NCT01728454|83251389|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
47003315|NCT01728454|83251390|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
47003316|NCT01728454|83251391|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
47003317|NCT01728454|83251389|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
47003318|NCT01728454|83251390|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
47003319|NCT01728454|83251391|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
47003320|NCT01728454|83251389|FG000|Stage 1 and 2|Lost to Follow-up|1|||
47003321|NCT01728454|83251390|FG001|Stage 1 and 2|Lost to Follow-up|1|||
47003322|NCT01728454|83251391|FG002|Stage 1 and 2|Lost to Follow-up|0|||
47003323|NCT01728454|83251389|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
47003324|NCT01728454|83251390|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
47003325|NCT01728454|83251391|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
47003326|NCT01728454|83251389|FG000|Stage 3|Reason Missing|0|||
47003327|NCT01728454|83251390|FG001|Stage 3|Reason Missing|0|||
47003328|NCT01728454|83251391|FG002|Stage 3|Reason Missing|1|||
47003329|NCT01728454|83251389|FG000|Stage 3|Subject Required Other Treatment|0|||
47003330|NCT01728454|83251390|FG001|Stage 3|Subject Required Other Treatment|1|||
47003331|NCT01728454|83251391|FG002|Stage 3|Subject Required Other Treatment|0|||
47003332|NCT01728454|83251389|FG000|Stage 3|Pregnancy|1|||
47003333|NCT01728454|83251390|FG001|Stage 3|Pregnancy|0|||
47003334|NCT01728454|83251391|FG002|Stage 3|Pregnancy|0|||
47003335|NCT01728454|83251389|FG000|Stage 3|Withdrew Consent|1|||
47003336|NCT01728454|83251390|FG001|Stage 3|Withdrew Consent|0|||
47003337|NCT01728454|83251391|FG002|Stage 3|Withdrew Consent|1|||
47003338|NCT01728454|83251389|FG000|Stage 3|Non-compliance with Protocol|0|||
47003339|NCT01728454|83251390|FG001|Stage 3|Non-compliance with Protocol|0|||
47003340|NCT01728454|83251391|FG002|Stage 3|Non-compliance with Protocol|1|||
47003341|NCT01728454|83251389|FG000|Stage 3|Lost to Follow-up|0|||
47003342|NCT01728454|83251390|FG001|Stage 3|Lost to Follow-up|3|||
47003343|NCT01728454|83251391|FG002|Stage 3|Lost to Follow-up|1|||
47003344|NCT01728454|83251389|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
47003345|NCT01728454|83251390|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
47003346|NCT01728454|83251391|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
47003347|NCT01636687|83251405|FG000|Induction Period|Withdrawal by Subject|1|||
47003348|NCT01636687|83251406|FG001|Induction Period|Withdrawal by Subject|0|||
47003349|NCT01636687|83251407|FG002|Induction Period|Withdrawal by Subject|0|||
47003350|NCT01636687|83251408|FG003|Induction Period|Withdrawal by Subject|0|||
47003351|NCT01636687|83251409|FG004|Induction Period|Withdrawal by Subject|0|||
47003352|NCT01636687|83251405|FG000|Induction Period|Adverse Event|1|||
47003353|NCT01636687|83251406|FG001|Induction Period|Adverse Event|0|||
47003354|NCT01636687|83251407|FG002|Induction Period|Adverse Event|0|||
47003355|NCT01636687|83251408|FG003|Induction Period|Adverse Event|0|||
47003356|NCT01636687|83251409|FG004|Induction Period|Adverse Event|1|||
47003357|NCT01636687|83251405|FG000|Induction Period|Lack of Efficacy|0|||
47003358|NCT01636687|83251406|FG001|Induction Period|Lack of Efficacy|0|||
47003359|NCT01636687|83251407|FG002|Induction Period|Lack of Efficacy|0|||
47003360|NCT01636687|83251408|FG003|Induction Period|Lack of Efficacy|0|||
47003361|NCT01636687|83251409|FG004|Induction Period|Lack of Efficacy|1|||
47003362|NCT01636687|83251405|FG000|Induction Period|Physician Decision|1|||
47003363|NCT01636687|83251406|FG001|Induction Period|Physician Decision|0|||
47003364|NCT01636687|83251407|FG002|Induction Period|Physician Decision|0|||
47003365|NCT01636687|83251408|FG003|Induction Period|Physician Decision|0|||
47003366|NCT01636687|83251409|FG004|Induction Period|Physician Decision|0|||
47003367|NCT01636687|83251405|FG000|Maintenance Period|Withdrawal by Subject|2|||
47003368|NCT01636687|83251406|FG001|Maintenance Period|Withdrawal by Subject|0|||
47003369|NCT01636687|83251407|FG002|Maintenance Period|Withdrawal by Subject|2|||
47003370|NCT01636687|83251408|FG003|Maintenance Period|Withdrawal by Subject|0|||
47003371|NCT01636687|83251409|FG004|Maintenance Period|Withdrawal by Subject|0|||
46909457|NCT02891915|83138634|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
46909458|NCT02891915|83138633|FG000|Overall Study|Withdrawal by Subject|3|||
47003372|NCT01636687|83251405|FG000|Maintenance Period|Adverse Event|1|||
46909459|NCT02891915|83138634|FG001|Overall Study|Withdrawal by Subject|3|||
46909460|NCT02891915|83138633|FG000|Overall Study|Became Ineligible After Enrollment|2|||
46909461|NCT02891915|83138634|FG001|Overall Study|Became Ineligible After Enrollment|1|||
46909462|NCT02891915|83138633|FG000|Overall Study|Lost to Follow-up|1|||
46909463|NCT02891915|83138634|FG001|Overall Study|Lost to Follow-up|4|||
46909464|NCT02891915|83138633|FG000|Overall Study|Physician Decision|1|||
46909465|NCT02891915|83138634|FG001|Overall Study|Physician Decision|0|||
46909466|NCT02891681|83138643|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
46909467|NCT02891681|83138644|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
47003373|NCT01636687|83251406|FG001|Maintenance Period|Adverse Event|0|||
47003374|NCT01636687|83251407|FG002|Maintenance Period|Adverse Event|0|||
47003375|NCT01636687|83251408|FG003|Maintenance Period|Adverse Event|0|||
47003376|NCT01636687|83251409|FG004|Maintenance Period|Adverse Event|0|||
47003377|NCT01636687|83251405|FG000|Maintenance Period|Lack of Efficacy|4|||
47003378|NCT01636687|83251406|FG001|Maintenance Period|Lack of Efficacy|1|||
47003379|NCT01636687|83251407|FG002|Maintenance Period|Lack of Efficacy|0|||
47003380|NCT01636687|83251408|FG003|Maintenance Period|Lack of Efficacy|0|||
47003381|NCT01636687|83251409|FG004|Maintenance Period|Lack of Efficacy|0|||
47003382|NCT01636687|83251405|FG000|Maintenance Period|Lost to Follow-up|1|||
47003383|NCT01636687|83251406|FG001|Maintenance Period|Lost to Follow-up|1|||
47003384|NCT01636687|83251407|FG002|Maintenance Period|Lost to Follow-up|0|||
47003385|NCT01636687|83251408|FG003|Maintenance Period|Lost to Follow-up|0|||
47003386|NCT01636687|83251409|FG004|Maintenance Period|Lost to Follow-up|1|||
47003387|NCT01636687|83251405|FG000|Maintenance Period|Physician Decision|0|||
47003388|NCT01636687|83251406|FG001|Maintenance Period|Physician Decision|0|||
47003389|NCT01636687|83251407|FG002|Maintenance Period|Physician Decision|0|||
47003390|NCT01636687|83251408|FG003|Maintenance Period|Physician Decision|0|||
47003391|NCT01636687|83251409|FG004|Maintenance Period|Physician Decision|1|||
47003392|NCT01636687|83251405|FG000|Extension Period|technical problems|0|||
47003393|NCT01636687|83251406|FG001|Extension Period|technical problems|1|||
47003394|NCT01636687|83251407|FG002|Extension Period|technical problems|2|||
47003395|NCT01636687|83251408|FG003|Extension Period|technical problems|1|||
47003396|NCT01636687|83251409|FG004|Extension Period|technical problems|0|||
47003397|NCT01636687|83251405|FG000|Extension Period|Adverse Event|4|||
47003398|NCT01636687|83251406|FG001|Extension Period|Adverse Event|3|||
47003399|NCT01636687|83251407|FG002|Extension Period|Adverse Event|2|||
47003400|NCT01636687|83251408|FG003|Extension Period|Adverse Event|1|||
47003401|NCT01636687|83251409|FG004|Extension Period|Adverse Event|0|||
47003402|NCT01636687|83251405|FG000|Extension Period|Lack of Efficacy|7|||
47003403|NCT01636687|83251406|FG001|Extension Period|Lack of Efficacy|0|||
47003404|NCT01636687|83251407|FG002|Extension Period|Lack of Efficacy|2|||
47003405|NCT01636687|83251408|FG003|Extension Period|Lack of Efficacy|1|||
46909468|NCT02891681|83138645|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
46909469|NCT02891681|83138643|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
46909470|NCT02891681|83138644|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
46909471|NCT02891681|83138645|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
46909472|NCT02891681|83138643|FG000|Overall Study|Taken off study after first imaging appointment|1|||
46909473|NCT02891681|83138644|FG001|Overall Study|Taken off study after first imaging appointment|0|||
46909474|NCT02891681|83138645|FG002|Overall Study|Taken off study after first imaging appointment|0|||
46909475|NCT04671342|83138653|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
46909476|NCT04671342|83138653|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
46909477|NCT04671342|83138653|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
46909478|NCT04671342|83138653|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
47003406|NCT01636687|83251409|FG004|Extension Period|Lack of Efficacy|0|||
47003407|NCT01636687|83251405|FG000|Extension Period|Lost to Follow-up|1|||
47003408|NCT01636687|83251406|FG001|Extension Period|Lost to Follow-up|0|||
47003409|NCT01636687|83251407|FG002|Extension Period|Lost to Follow-up|1|||
47003410|NCT01636687|83251408|FG003|Extension Period|Lost to Follow-up|0|||
47003411|NCT01636687|83251409|FG004|Extension Period|Lost to Follow-up|0|||
47003412|NCT01636687|83251405|FG000|Extension Period|Physician Decision|1|||
47003413|NCT01636687|83251406|FG001|Extension Period|Physician Decision|0|||
47003414|NCT01636687|83251407|FG002|Extension Period|Physician Decision|0|||
47003415|NCT01636687|83251408|FG003|Extension Period|Physician Decision|1|||
47003416|NCT01636687|83251409|FG004|Extension Period|Physician Decision|0|||
47003417|NCT01636687|83251405|FG000|Extension Period|study terminated by sponsor|33|||
47003418|NCT01636687|83251406|FG001|Extension Period|study terminated by sponsor|50|||
47003419|NCT01636687|83251407|FG002|Extension Period|study terminated by sponsor|17|||
47003420|NCT01636687|83251408|FG003|Extension Period|study terminated by sponsor|23|||
47003421|NCT01636687|83251409|FG004|Extension Period|study terminated by sponsor|0|||
47003422|NCT01636687|83251405|FG000|Extension Period|Withdrawal by Subject|1|||
47003423|NCT01636687|83251406|FG001|Extension Period|Withdrawal by Subject|0|||
47003424|NCT01636687|83251407|FG002|Extension Period|Withdrawal by Subject|1|||
47003425|NCT01636687|83251408|FG003|Extension Period|Withdrawal by Subject|1|||
46620462|NCT03682055|82769618|FG002|Overall Study|Lack of Efficacy|1|||
46620463|NCT03682055|82769619|FG003|Overall Study|Lack of Efficacy|2|||
47003426|NCT01636687|83251409|FG004|Extension Period|Withdrawal by Subject|0|||
47003427|NCT01636687|83251405|FG000|Follow-up Period|Withdrawal by Subject|1|||
47003428|NCT01636687|83251406|FG001|Follow-up Period|Withdrawal by Subject|0|||
47003429|NCT01636687|83251407|FG002|Follow-up Period|Withdrawal by Subject|0|||
47003430|NCT01636687|83251408|FG003|Follow-up Period|Withdrawal by Subject|0|||
47003431|NCT01636687|83251409|FG004|Follow-up Period|Withdrawal by Subject|1|||
47003432|NCT01634659|83251429|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
47003433|NCT01634659|83251430|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
46620464|NCT03682055|82769620|FG004|Overall Study|Lack of Efficacy|1|||
46620465|NCT03682055|82769621|FG005|Overall Study|Lack of Efficacy|3|||
46620466|NCT03682055|82769616|FG000|Overall Study|Withdrawal by Subject|0|||
46620467|NCT03682055|82769617|FG001|Overall Study|Withdrawal by Subject|0|||
46620468|NCT03682055|82769618|FG002|Overall Study|Withdrawal by Subject|0|||
47003434|NCT01634659|83251429|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
47003435|NCT01634659|83251430|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
47003436|NCT04863248|83251442|FG000|Overall Study|Sponsor Terminated|4|||
47003437|NCT04863248|83251443|FG001|Overall Study|Sponsor Terminated|1|||
47003438|NCT04863248|83251442|FG000|Overall Study|Death|0|||
47003439|NCT04863248|83251443|FG001|Overall Study|Death|1|||
47003440|NCT04863248|83251442|FG000|Overall Study|Withdrawal by Subject|0|||
47003441|NCT04863248|83251443|FG001|Overall Study|Withdrawal by Subject|1|||
47003442|NCT04285229|83251451|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
47003443|NCT04285229|83251452|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
47003444|NCT04285229|83251453|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
47003445|NCT04285229|83251454|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
47003446|NCT04285229|83251455|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
47003447|NCT04285229|83251456|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46709389|NCT00924820|82925425|FG000|Overall Study|Death|2|||
46709390|NCT00924820|82925425|FG000|Overall Study|Ineligible, Screen Failure|5|||
46709391|NCT01225172|82925431|FG000|Overall Study|Subject decision to stop|1|||
46709392|NCT01225172|82925432|FG001|Overall Study|Subject decision to stop|0|||
46709393|NCT01225172|82925431|FG000|Overall Study|Subject request to discontinue treatment|3|||
46709394|NCT01225172|82925432|FG001|Overall Study|Subject request to discontinue treatment|1|||
46709395|NCT01225172|82925431|FG000|Overall Study|Subject no longer meets study criteria|1|||
46709396|NCT01225172|82925432|FG001|Overall Study|Subject no longer meets study criteria|0|||
46709397|NCT01225172|82925431|FG000|Overall Study|Withdrawal by Subject|1|||
46709398|NCT01225172|82925432|FG001|Overall Study|Withdrawal by Subject|0|||
47003448|NCT04285229|83251451|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
47003449|NCT04285229|83251452|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
47003450|NCT04285229|83251453|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
47003451|NCT04285229|83251454|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
47003452|NCT04285229|83251455|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
47003453|NCT04285229|83251456|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
46909479|NCT04671342|83138653|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
46909480|NCT04671342|83138653|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
46909481|NCT03051217|83138660|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
46909482|NCT03051217|83138661|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46909483|NCT03051217|83138662|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
46909484|NCT03051217|83138663|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46909485|NCT03051217|83138664|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46909486|NCT03051217|83138665|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46909487|NCT03051217|83138666|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
46909488|NCT03051217|83138660|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
46909489|NCT03051217|83138661|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
46909490|NCT03051217|83138662|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
46909491|NCT03051217|83138663|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
46909492|NCT03051217|83138664|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
46909493|NCT03051217|83138665|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
46909494|NCT03051217|83138666|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
46909495|NCT03051217|83138660|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
46909496|NCT03051217|83138661|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
46909497|NCT03051217|83138662|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
46909498|NCT03051217|83138663|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46909499|NCT03051217|83138664|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46909500|NCT03051217|83138665|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46909501|NCT03051217|83138666|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
46909502|NCT03051217|83138660|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
46909503|NCT03051217|83138661|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
46909504|NCT03051217|83138662|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
46909505|NCT03051217|83138663|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
46909506|NCT03051217|83138664|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
46909507|NCT03051217|83138665|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
46909508|NCT03051217|83138666|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
46909509|NCT03051217|83138660|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
46909510|NCT03051217|83138661|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
46909511|NCT03051217|83138662|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
46909512|NCT03051217|83138663|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
46909513|NCT03051217|83138664|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
47003454|NCT04285229|83251451|FG000|Extended Treatment Period|Adverse Event|0|||
47003455|NCT04285229|83251452|FG001|Extended Treatment Period|Adverse Event|0|||
46709399|NCT01143324|82925438|FG000|Overall Study|Lost to Follow-up|11|||
46909514|NCT03051217|83138665|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
47003456|NCT04285229|83251453|FG002|Extended Treatment Period|Adverse Event|0|||
46709400|NCT01143324|82925438|FG000|Overall Study|Withdrawal by Subject|4|||
47003457|NCT04285229|83251454|FG003|Extended Treatment Period|Adverse Event|1|||
47003458|NCT04285229|83251455|FG004|Extended Treatment Period|Adverse Event|0|||
47003459|NCT04285229|83251456|FG005|Extended Treatment Period|Adverse Event|0|||
47003460|NCT04285229|83251451|FG000|Extended Treatment Period|Physician Decision|0|||
47003461|NCT04285229|83251452|FG001|Extended Treatment Period|Physician Decision|0|||
47003462|NCT04285229|83251453|FG002|Extended Treatment Period|Physician Decision|1|||
47003463|NCT04285229|83251454|FG003|Extended Treatment Period|Physician Decision|0|||
47003464|NCT04285229|83251455|FG004|Extended Treatment Period|Physician Decision|0|||
47003465|NCT04285229|83251456|FG005|Extended Treatment Period|Physician Decision|0|||
47003466|NCT04285229|83251451|FG000|Follow-up Period|Adverse Event|0|||
47003467|NCT04285229|83251452|FG001|Follow-up Period|Adverse Event|0|||
47003468|NCT04285229|83251453|FG002|Follow-up Period|Adverse Event|0|||
47003469|NCT04285229|83251454|FG003|Follow-up Period|Adverse Event|0|||
47003470|NCT04285229|83251455|FG004|Follow-up Period|Adverse Event|1|||
47003471|NCT04285229|83251456|FG005|Follow-up Period|Adverse Event|4|||
47003472|NCT04285229|83251451|FG000|Follow-up Period|Withdrawal by Subject|0|||
47003473|NCT04285229|83251452|FG001|Follow-up Period|Withdrawal by Subject|0|||
47003474|NCT04285229|83251453|FG002|Follow-up Period|Withdrawal by Subject|0|||
47003475|NCT04285229|83251454|FG003|Follow-up Period|Withdrawal by Subject|0|||
47003476|NCT04285229|83251455|FG004|Follow-up Period|Withdrawal by Subject|0|||
47003477|NCT04285229|83251456|FG005|Follow-up Period|Withdrawal by Subject|5|||
47003478|NCT04285229|83251451|FG000|Follow-up Period|Covid-19|0|||
47003479|NCT04285229|83251452|FG001|Follow-up Period|Covid-19|0|||
47003480|NCT04285229|83251453|FG002|Follow-up Period|Covid-19|0|||
47003481|NCT04285229|83251454|FG003|Follow-up Period|Covid-19|0|||
47003482|NCT04285229|83251455|FG004|Follow-up Period|Covid-19|0|||
47003483|NCT04285229|83251456|FG005|Follow-up Period|Covid-19|2|||
47003484|NCT04285229|83251451|FG000|Follow-up Period|Physician Decision|0|||
47003485|NCT04285229|83251452|FG001|Follow-up Period|Physician Decision|0|||
46909515|NCT03051217|83138666|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
46909516|NCT03051217|83138660|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
46909517|NCT03051217|83138661|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
46909518|NCT03051217|83138662|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
46909519|NCT03051217|83138663|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
46909520|NCT03051217|83138664|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
46909521|NCT03051217|83138665|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
46909522|NCT03051217|83138666|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
46909523|NCT03051217|83138660|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
46909524|NCT03051217|83138661|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
46909525|NCT03051217|83138662|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
46909526|NCT03051217|83138663|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
46909527|NCT03051217|83138664|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
46909528|NCT03051217|83138665|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
46909529|NCT03051217|83138666|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
46909530|NCT03051217|83138660|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
46909531|NCT03051217|83138661|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
46909532|NCT03051217|83138662|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
46909533|NCT03051217|83138663|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
46909534|NCT03051217|83138664|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
46909535|NCT03051217|83138665|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
46909536|NCT03051217|83138666|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
46909537|NCT03046056|83138692|FG000|Overall Study|Non-responder at Week 10|6|||
46909538|NCT03046056|83138693|FG001|Overall Study|Non-responder at Week 10|6|||
46909539|NCT03046056|83138694|FG002|Overall Study|Non-responder at Week 10|4|||
46909540|NCT03046056|83138692|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
46909541|NCT03046056|83138693|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
46909542|NCT03046056|83138694|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
46909543|NCT03046056|83138692|FG000|Overall Study|Adverse Event|1|||
46909544|NCT03046056|83138693|FG001|Overall Study|Adverse Event|5|||
46909545|NCT03046056|83138694|FG002|Overall Study|Adverse Event|0|||
46909546|NCT03046056|83138692|FG000|Overall Study|Non-compliance With Study Drug|0|||
46909547|NCT03046056|83138693|FG001|Overall Study|Non-compliance With Study Drug|0|||
46909548|NCT03046056|83138694|FG002|Overall Study|Non-compliance With Study Drug|2|||
46909549|NCT03046056|83138692|FG000|Overall Study|Protocol Violation|1|||
47003486|NCT04285229|83251453|FG002|Follow-up Period|Physician Decision|0|||
47003487|NCT04285229|83251454|FG003|Follow-up Period|Physician Decision|0|||
47003488|NCT04285229|83251455|FG004|Follow-up Period|Physician Decision|0|||
47003489|NCT04285229|83251456|FG005|Follow-up Period|Physician Decision|1|||
47003490|NCT04263454|83251473|FG000|Overall Study|Adverse Event|0|||
47003491|NCT04263454|83251474|FG001|Overall Study|Adverse Event|2|||
47003492|NCT04263454|83251473|FG000|Overall Study|Physician Decision|3|||
47003493|NCT04263454|83251474|FG001|Overall Study|Physician Decision|5|||
47003494|NCT04263454|83251473|FG000|Overall Study|Poor Data Quality|0|||
47003495|NCT04263454|83251474|FG001|Overall Study|Poor Data Quality|1|||
47003496|NCT04155463|83251484|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
47003497|NCT04155463|83251485|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
47003498|NCT04056611|83251491|FG000|Overall Study|Physician Decision|1|||
47003499|NCT04001803|83251495|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
47003500|NCT04001803|83251495|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
47003501|NCT04001803|83251495|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
47003502|NCT04001803|83251495|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
47003503|NCT04001803|83251495|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
47003504|NCT04001803|83251495|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
47003505|NCT04001803|83251495|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
47003506|NCT04001803|83251495|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
47003507|NCT04001803|83251495|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
47003508|NCT04001803|83251495|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
47003509|NCT03768427|83251504|FG000|Overall Study|Death|0|||
47003510|NCT03768427|83251505|FG001|Overall Study|Death|0|||
47003511|NCT03768427|83251506|FG002|Overall Study|Death|1|||
47003512|NCT03768427|83251507|FG003|Overall Study|Death|0|||
47003513|NCT03768427|83251504|FG000|Overall Study|Lost to Follow-up|2|||
47003514|NCT03768427|83251505|FG001|Overall Study|Lost to Follow-up|0|||
47003515|NCT03768427|83251506|FG002|Overall Study|Lost to Follow-up|0|||
47003516|NCT03768427|83251507|FG003|Overall Study|Lost to Follow-up|0|||
47003517|NCT03768427|83251504|FG000|Overall Study|Physician Decision|3|||
47003518|NCT03768427|83251505|FG001|Overall Study|Physician Decision|2|||
47003519|NCT03768427|83251506|FG002|Overall Study|Physician Decision|4|||
47003520|NCT03768427|83251507|FG003|Overall Study|Physician Decision|4|||
47003521|NCT03768427|83251504|FG000|Overall Study|Withdrawal by Subject|7|||
47003522|NCT03768427|83251505|FG001|Overall Study|Withdrawal by Subject|2|||
47003523|NCT03768427|83251506|FG002|Overall Study|Withdrawal by Subject|6|||
47003524|NCT03768427|83251507|FG003|Overall Study|Withdrawal by Subject|7|||
47003525|NCT03595228|83251521|FG000|Overall Study|Death|2|||
47003526|NCT03595228|83251521|FG000|Overall Study|Lack of Efficacy|13|||
47003527|NCT03595228|83251521|FG000|Overall Study|Withdrawal by Subject|3|||
47003528|NCT03595228|83251521|FG000|Overall Study|Withdrawal by Sponsor|1|||
47003529|NCT03572933|83251527|FG000|Overall Study|Adverse Event|4|||
47003530|NCT03572933|83251528|FG001|Overall Study|Adverse Event|1|||
47003531|NCT03572933|83251527|FG000|Overall Study|Withdrawal by Subject|0|||
47003532|NCT03572933|83251528|FG001|Overall Study|Withdrawal by Subject|1|||
47003533|NCT03558152|83251539|FG000|Overall Study|Adverse Event|0|||
47003534|NCT03558152|83251540|FG001|Overall Study|Adverse Event|0|||
47003535|NCT03558152|83251541|FG002|Overall Study|Adverse Event|1|||
47003536|NCT03558152|83251542|FG003|Overall Study|Adverse Event|1|||
47003537|NCT03558152|83251543|FG004|Overall Study|Adverse Event|2|||
47003538|NCT03558152|83251544|FG005|Overall Study|Adverse Event|1|||
47003539|NCT03558152|83251545|FG006|Overall Study|Adverse Event|1|||
47003540|NCT03558152|83251546|FG007|Overall Study|Adverse Event|0|||
47003541|NCT03558152|83251539|FG000|Overall Study|Death|0|||
47003542|NCT03558152|83251540|FG001|Overall Study|Death|0|||
47003543|NCT03558152|83251541|FG002|Overall Study|Death|0|||
47003544|NCT03558152|83251542|FG003|Overall Study|Death|0|||
47003545|NCT03558152|83251543|FG004|Overall Study|Death|1|||
47003546|NCT03558152|83251544|FG005|Overall Study|Death|0|||
47003547|NCT03558152|83251545|FG006|Overall Study|Death|0|||
47003548|NCT03558152|83251546|FG007|Overall Study|Death|0|||
47003549|NCT03558152|83251539|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
47003550|NCT03558152|83251540|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
47003551|NCT03558152|83251541|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
47003552|NCT03558152|83251542|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
47003553|NCT03558152|83251543|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
47003554|NCT03558152|83251544|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
47003555|NCT03558152|83251545|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
47003556|NCT03558152|83251546|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
47003557|NCT03558152|83251539|FG000|Overall Study|Miscalculation in mmcs|0|||
47003558|NCT03558152|83251540|FG001|Overall Study|Miscalculation in mmcs|0|||
47003559|NCT03558152|83251541|FG002|Overall Study|Miscalculation in mmcs|0|||
47003560|NCT03558152|83251542|FG003|Overall Study|Miscalculation in mmcs|0|||
47003561|NCT03558152|83251543|FG004|Overall Study|Miscalculation in mmcs|0|||
47003562|NCT03558152|83251544|FG005|Overall Study|Miscalculation in mmcs|0|||
47003563|NCT03558152|83251545|FG006|Overall Study|Miscalculation in mmcs|1|||
47003564|NCT03558152|83251546|FG007|Overall Study|Miscalculation in mmcs|0|||
47003565|NCT03558152|83251539|FG000|Overall Study|Mistake in calculation|0|||
47003566|NCT03558152|83251540|FG001|Overall Study|Mistake in calculation|0|||
47003567|NCT03558152|83251541|FG002|Overall Study|Mistake in calculation|0|||
47003568|NCT03558152|83251542|FG003|Overall Study|Mistake in calculation|1|||
47003569|NCT03558152|83251543|FG004|Overall Study|Mistake in calculation|0|||
47003570|NCT03558152|83251544|FG005|Overall Study|Mistake in calculation|0|||
47003571|NCT03558152|83251545|FG006|Overall Study|Mistake in calculation|0|||
47003572|NCT03558152|83251546|FG007|Overall Study|Mistake in calculation|0|||
47003573|NCT03558152|83251539|FG000|Overall Study|Mistake in evaluation of disease status|0|||
47003574|NCT03558152|83251540|FG001|Overall Study|Mistake in evaluation of disease status|0|||
47003575|NCT03558152|83251541|FG002|Overall Study|Mistake in evaluation of disease status|0|||
47003576|NCT03558152|83251542|FG003|Overall Study|Mistake in evaluation of disease status|0|||
47003577|NCT03558152|83251543|FG004|Overall Study|Mistake in evaluation of disease status|0|||
47003578|NCT03558152|83251544|FG005|Overall Study|Mistake in evaluation of disease status|0|||
47003579|NCT03558152|83251545|FG006|Overall Study|Mistake in evaluation of disease status|0|||
47003580|NCT03558152|83251546|FG007|Overall Study|Mistake in evaluation of disease status|1|||
47003581|NCT03558152|83251539|FG000|Overall Study|Physician Decision|0|||
47003582|NCT03558152|83251540|FG001|Overall Study|Physician Decision|0|||
47003583|NCT03558152|83251541|FG002|Overall Study|Physician Decision|0|||
47003584|NCT03558152|83251542|FG003|Overall Study|Physician Decision|0|||
47003585|NCT03558152|83251543|FG004|Overall Study|Physician Decision|0|||
47003586|NCT03558152|83251544|FG005|Overall Study|Physician Decision|0|||
47003587|NCT03558152|83251545|FG006|Overall Study|Physician Decision|1|||
47003588|NCT03558152|83251546|FG007|Overall Study|Physician Decision|0|||
47003589|NCT03558152|83251539|FG000|Overall Study|Withdrawal by Subject|2|||
47003590|NCT03558152|83251540|FG001|Overall Study|Withdrawal by Subject|3|||
47003591|NCT03558152|83251541|FG002|Overall Study|Withdrawal by Subject|2|||
47003592|NCT03558152|83251542|FG003|Overall Study|Withdrawal by Subject|1|||
47003593|NCT03558152|83251543|FG004|Overall Study|Withdrawal by Subject|1|||
47003594|NCT03558152|83251544|FG005|Overall Study|Withdrawal by Subject|1|||
47003595|NCT03558152|83251545|FG006|Overall Study|Withdrawal by Subject|3|||
47003596|NCT03558152|83251546|FG007|Overall Study|Withdrawal by Subject|2|||
47003597|NCT03558152|83251539|FG000|Overall Study|Lack of Efficacy|11|||
47003598|NCT03558152|83251540|FG001|Overall Study|Lack of Efficacy|11|||
47003599|NCT03558152|83251541|FG002|Overall Study|Lack of Efficacy|10|||
47003600|NCT03558152|83251542|FG003|Overall Study|Lack of Efficacy|11|||
47003601|NCT03558152|83251543|FG004|Overall Study|Lack of Efficacy|14|||
46709401|NCT01143324|82925438|FG000|Overall Study|Explant of the device|4|||
46709402|NCT01224782|82925442|FG000|Overall Study|Lost to Follow-up|177|||
46709403|NCT01224782|82925442|FG000|Overall Study|Withdrawal by Subject|16|||
46709404|NCT01224782|82925442|FG000|Overall Study|Death|14|||
46709405|NCT01224782|82925442|FG000|Overall Study|Improvement|13|||
46709406|NCT01224782|82925442|FG000|Overall Study|Adverse Event|12|||
46709407|NCT01224782|82925442|FG000|Overall Study|Adverse Reaction|11|||
46709408|NCT01224782|82925442|FG000|Overall Study|Noncompliance|10|||
46909550|NCT03046056|83138693|FG001|Overall Study|Protocol Violation|1|||
46909551|NCT03046056|83138694|FG002|Overall Study|Protocol Violation|0|||
46909552|NCT03046056|83138692|FG000|Overall Study|Investigator's Discretion|0|||
46909553|NCT03046056|83138693|FG001|Overall Study|Investigator's Discretion|1|||
46909554|NCT03046056|83138694|FG002|Overall Study|Investigator's Discretion|0|||
46909555|NCT03046056|83138692|FG000|Overall Study|Withdrew Consent|1|||
46909556|NCT03046056|83138693|FG001|Overall Study|Withdrew Consent|0|||
46909557|NCT03046056|83138694|FG002|Overall Study|Withdrew Consent|0|||
46909558|NCT02849587|83138705|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
46909559|NCT02849587|83138706|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
46909560|NCT02849587|83138707|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
46909561|NCT02849587|83138705|FG000|Overall Study|Withdrawal by Subject|0|||
46909562|NCT02849587|83138706|FG001|Overall Study|Withdrawal by Subject|1|||
46909563|NCT02849587|83138707|FG002|Overall Study|Withdrawal by Subject|0|||
46909564|NCT03347279|83138721|FG000|Overall Study|Withdrawal by Subject|8|||
46909565|NCT03347279|83138722|FG001|Overall Study|Withdrawal by Subject|15|||
46909566|NCT03347279|83138721|FG000|Overall Study|Death|0|||
46909567|NCT03347279|83138722|FG001|Overall Study|Death|2|||
46909568|NCT03347279|83138721|FG000|Overall Study|Lost to Follow-up|5|||
46909569|NCT03347279|83138722|FG001|Overall Study|Lost to Follow-up|2|||
46909570|NCT03347279|83138721|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
47003602|NCT03558152|83251544|FG005|Overall Study|Lack of Efficacy|12|||
47003603|NCT03558152|83251545|FG006|Overall Study|Lack of Efficacy|14|||
47003604|NCT03558152|83251546|FG007|Overall Study|Lack of Efficacy|13|||
47003605|NCT03558152|83251539|FG000|Overall Study|Protocol Violation|1|||
47003606|NCT03558152|83251540|FG001|Overall Study|Protocol Violation|1|||
46709409|NCT01224782|82925442|FG000|Overall Study|Other|4|||
46709410|NCT01224782|82925442|FG000|Overall Study|Start of Dialysis|3|||
46709411|NCT01224782|82925442|FG000|Overall Study|Change of Treatment|1|||
46709412|NCT01224782|82925442|FG000|Overall Study|Financial Reasons|1|||
46709413|NCT01224782|82925442|FG000|Overall Study|Deterioration|1|||
46709414|NCT01224782|82925442|FG000|Overall Study|Transplantation|1|||
46709415|NCT01224158|82925448|FG000|Overall Study|Withdrawal by Subject|1|||
46709416|NCT01224158|82925449|FG001|Overall Study|Withdrawal by Subject|0|||
46709417|NCT01129128|82925458|FG000|Overall Study|Lost to Follow-up|2|||
46709418|NCT01129128|82925459|FG001|Overall Study|Lost to Follow-up|2|||
46709419|NCT01129128|82925460|FG002|Overall Study|Lost to Follow-up|1|||
46709420|NCT01129128|82925458|FG000|Overall Study|Protocol Violation|0|||
46709421|NCT01129128|82925459|FG001|Overall Study|Protocol Violation|1|||
46709422|NCT01129128|82925460|FG002|Overall Study|Protocol Violation|0|||
46709423|NCT01129128|82925458|FG000|Overall Study|Withdrawal by Subject|0|||
46709424|NCT01129128|82925459|FG001|Overall Study|Withdrawal by Subject|1|||
46709425|NCT01129128|82925460|FG002|Overall Study|Withdrawal by Subject|3|||
46709426|NCT01129128|82925458|FG000|Overall Study|Physician Decision|1|||
46709427|NCT01129128|82925459|FG001|Overall Study|Physician Decision|0|||
46709428|NCT01129128|82925460|FG002|Overall Study|Physician Decision|0|||
47003607|NCT03558152|83251541|FG002|Overall Study|Protocol Violation|0|||
47003608|NCT03558152|83251542|FG003|Overall Study|Protocol Violation|1|||
47003609|NCT03558152|83251543|FG004|Overall Study|Protocol Violation|1|||
47003610|NCT03558152|83251544|FG005|Overall Study|Protocol Violation|0|||
47003611|NCT03558152|83251545|FG006|Overall Study|Protocol Violation|2|||
47003612|NCT03558152|83251546|FG007|Overall Study|Protocol Violation|0|||
47003613|NCT03461406|83251586|FG000|Overall Study|Death|1|||
47003614|NCT03461406|83251587|FG001|Overall Study|Death|2|||
47003615|NCT03461406|83251586|FG000|Overall Study|Consent Withdrawn by Participant|0|||
47003616|NCT03461406|83251587|FG001|Overall Study|Consent Withdrawn by Participant|1|||
47003617|NCT03461406|83251586|FG000|Overall Study|Screen Failure|3|||
47003618|NCT03461406|83251587|FG001|Overall Study|Screen Failure|1|||
47003619|NCT03461406|83251586|FG000|Overall Study|Reason not Specified|1|||
47003620|NCT03461406|83251587|FG001|Overall Study|Reason not Specified|3|||
47003621|NCT03461406|83251586|FG000|Overall Study|Lost to Follow-up|3|||
47003622|NCT03461406|83251587|FG001|Overall Study|Lost to Follow-up|0|||
47003623|NCT03408899|83251602|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
47003624|NCT02528643|83251623|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
47003625|NCT02528643|83251624|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
47003626|NCT02528643|83251623|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
47003627|NCT02528643|83251624|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
47003628|NCT02528643|83251623|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
47003629|NCT02528643|83251624|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
47003630|NCT02528643|83251623|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
47003631|NCT02528643|83251624|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
47003632|NCT02528643|83251623|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
47003633|NCT02528643|83251624|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
47003634|NCT02528643|83251623|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
47003635|NCT02528643|83251624|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
47003636|NCT02528643|83251623|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
47003637|NCT02528643|83251624|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
47003638|NCT02175680|83251636|FG000|Overall Study|non-compliance|1|||
47003639|NCT02175680|83251636|FG000|Overall Study|other non-medical reason|1|||
47003640|NCT01983462|83251650|FG000|Overall Study|Adverse Event|1|||
47003641|NCT01983462|83251651|FG001|Overall Study|Adverse Event|0|||
47003642|NCT01983462|83251652|FG002|Overall Study|Adverse Event|0|||
47003643|NCT00565851|83251679|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
47003644|NCT00565851|83251680|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
47003645|NCT00565851|83251681|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
47003646|NCT00565851|83251682|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
47003647|NCT00565851|83251683|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
47003648|NCT00565851|83251684|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
47003649|NCT00565851|83251685|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
47003650|NCT00565851|83251686|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
47003651|NCT00565851|83251679|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
47003652|NCT00565851|83251680|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
47003653|NCT00565851|83251681|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
47003654|NCT00565851|83251682|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
47003655|NCT00565851|83251683|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
47003656|NCT00565851|83251684|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
47003657|NCT00565851|83251685|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
46709429|NCT01222520|82925470|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
46709430|NCT01222520|82925471|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
47003658|NCT00565851|83251686|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
47003659|NCT00305227|83251710|FG000|Overall Study|Lost to Follow-up|7|||
47003660|NCT00305227|83251711|FG001|Overall Study|Lost to Follow-up|6|||
47003661|NCT01599793|83251719|FG000|Overall Study|Adverse Event|2|||
47003662|NCT01755598|83251734|FG000|Overall Study|Other|109|||
47003663|NCT01755598|83251735|FG001|Overall Study|Other|109|||
47003664|NCT01755598|83251734|FG000|Overall Study|Lost to Follow-up|32|||
47003665|NCT01755598|83251735|FG001|Overall Study|Lost to Follow-up|43|||
47003666|NCT01755598|83251734|FG000|Overall Study|Migrated/moved from study area|76|||
47003667|NCT01755598|83251735|FG001|Overall Study|Migrated/moved from study area|65|||
47003668|NCT01755598|83251734|FG000|Overall Study|Withdrawal by Subject|22|||
47003669|NCT01755598|83251735|FG001|Overall Study|Withdrawal by Subject|31|||
47003670|NCT01755598|83251734|FG000|Overall Study|Protocol Violation|7|||
47003671|NCT01755598|83251735|FG001|Overall Study|Protocol Violation|7|||
47003672|NCT01755598|83251734|FG000|Overall Study|Adverse Event|19|||
47003673|NCT01755598|83251735|FG001|Overall Study|Adverse Event|28|||
47003674|NCT01606306|83251747|FG000|Overall Study|Lack of Efficacy|2|||
47003675|NCT01606306|83251748|FG001|Overall Study|Lack of Efficacy|1|||
47003676|NCT01606306|83251749|FG002|Overall Study|Lack of Efficacy|4|||
47003677|NCT01606306|83251750|FG003|Overall Study|Lack of Efficacy|4|||
47003678|NCT01606306|83251751|FG004|Overall Study|Lack of Efficacy|1|||
47003679|NCT01606306|83251752|FG005|Overall Study|Lack of Efficacy|2|||
47003680|NCT01606306|83251747|FG000|Overall Study|Adverse Event|1|||
47003681|NCT01606306|83251748|FG001|Overall Study|Adverse Event|0|||
47003682|NCT01606306|83251749|FG002|Overall Study|Adverse Event|1|||
47003683|NCT01606306|83251750|FG003|Overall Study|Adverse Event|1|||
47003684|NCT01606306|83251751|FG004|Overall Study|Adverse Event|2|||
47003685|NCT01606306|83251752|FG005|Overall Study|Adverse Event|0|||
47003686|NCT01606306|83251747|FG000|Overall Study|Lost to Follow-up|7|||
47003687|NCT01606306|83251748|FG001|Overall Study|Lost to Follow-up|4|||
47003688|NCT01606306|83251749|FG002|Overall Study|Lost to Follow-up|5|||
47003689|NCT01606306|83251750|FG003|Overall Study|Lost to Follow-up|4|||
47003690|NCT01606306|83251751|FG004|Overall Study|Lost to Follow-up|3|||
47003691|NCT01606306|83251752|FG005|Overall Study|Lost to Follow-up|5|||
47003692|NCT01606306|83251747|FG000|Overall Study|Withdrawal by Subject|4|||
47003693|NCT01606306|83251748|FG001|Overall Study|Withdrawal by Subject|3|||
47003694|NCT01606306|83251749|FG002|Overall Study|Withdrawal by Subject|4|||
47003695|NCT01606306|83251750|FG003|Overall Study|Withdrawal by Subject|4|||
47003696|NCT01606306|83251751|FG004|Overall Study|Withdrawal by Subject|5|||
47003697|NCT01606306|83251752|FG005|Overall Study|Withdrawal by Subject|4|||
47003698|NCT01606306|83251747|FG000|Overall Study|Physician Decision|1|||
47003699|NCT01606306|83251748|FG001|Overall Study|Physician Decision|2|||
47003700|NCT01606306|83251749|FG002|Overall Study|Physician Decision|0|||
47003701|NCT01606306|83251750|FG003|Overall Study|Physician Decision|0|||
46909571|NCT03347279|83138722|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
46909572|NCT03262441|83138728|FG000|Overall Study|Withdrawal by Subject|1|||
46909573|NCT04580394|83138732|FG000|First Intervention|Incorrectly Randomized|1|||
46909574|NCT04580394|83138732|FG000|First Intervention|Physician Decision|1|||
46909575|NCT04580394|83138732|FG000|First Intervention|Lost to Follow-up|1|||
46909576|NCT04580394|83138732|FG000|Washout (One Week)|Withdrawal by Subject|1|||
46909577|NCT04580394|83138732|FG000|Washout (One Week)|Adverse Event|1|||
46909578|NCT04580394|83138732|FG000|Washout (One Week)|Withdrawal by Subject|2|||
46909579|NCT04580394|83138732|FG000|Third Intervention|Adverse Event|1|||
46909580|NCT04580394|83138732|FG000|Third Intervention|Withdrawal by Subject|1|||
46909581|NCT04580394|83138732|FG000|Washout (One Week)|Withdrawal by Subject|2|||
46909582|NCT02781727|83138744|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
46909583|NCT02781727|83138745|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
46909584|NCT02781727|83138744|FG000|Treatment Period|Withdrawal by Subject|1|||
46909585|NCT02781727|83138745|FG001|Treatment Period|Withdrawal by Subject|0|||
46909586|NCT02781727|83138744|FG000|Treatment Period|Lost to Follow-up|0|||
46909587|NCT02781727|83138745|FG001|Treatment Period|Lost to Follow-up|1|||
46909588|NCT01343082|83138751|FG000|The run-in Period|Not meeting criteria|3|||
46909589|NCT01343082|83138752|FG001|The run-in Period|Not meeting criteria|4|||
46909590|NCT01343082|83138753|FG002|The run-in Period|Not meeting criteria|5|||
46909591|NCT01343082|83138751|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
46909592|NCT01343082|83138752|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
46909593|NCT01343082|83138753|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
46909594|NCT01343082|83138751|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
46909595|NCT01343082|83138752|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
46909596|NCT01343082|83138753|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
46909597|NCT01343082|83138751|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
47003702|NCT01606306|83251751|FG004|Overall Study|Physician Decision|0|||
47003703|NCT01606306|83251752|FG005|Overall Study|Physician Decision|0|||
47003704|NCT01754194|83251760|FG000|Overall Study|Lost to Follow-up|39|||
47003705|NCT01754194|83251761|FG001|Overall Study|Lost to Follow-up|14|||
47003706|NCT01754194|83251760|FG000|Overall Study|Withdrawal by Subject|4|||
47003707|NCT01754194|83251761|FG001|Overall Study|Withdrawal by Subject|5|||
47003708|NCT01754194|83251760|FG000|Overall Study|Other|9|||
47003709|NCT01754194|83251761|FG001|Overall Study|Other|8|||
47003710|NCT01753570|83251772|FG000|Overall Study|Adverse Event|1|||
47003711|NCT01753570|83251773|FG001|Overall Study|Adverse Event|0|||
47003712|NCT01753570|83251774|FG002|Overall Study|Adverse Event|1|||
47003713|NCT01753570|83251772|FG000|Overall Study|Physician Decision|0|||
47003714|NCT01753570|83251773|FG001|Overall Study|Physician Decision|1|||
47003715|NCT01753570|83251774|FG002|Overall Study|Physician Decision|0|||
47003716|NCT01753570|83251772|FG000|Overall Study|Withdrawal by Subject|1|||
47003717|NCT01753570|83251773|FG001|Overall Study|Withdrawal by Subject|4|||
47003718|NCT01753570|83251774|FG002|Overall Study|Withdrawal by Subject|0|||
47003719|NCT01753336|83251783|FG000|Overall Study|Patient decision|12|||
47003720|NCT01753336|83251783|FG000|Overall Study|Lost to Follow-up|3|||
47003721|NCT01753336|83251783|FG000|Overall Study|Physician Decision|2|||
47003722|NCT01753336|83251783|FG000|Overall Study|Sponsor's decision|2|||
47003723|NCT01753336|83251783|FG000|Overall Study|Withdrawal by Subject|1|||
47003724|NCT01777282|83251792|FG000|Overall Study|Persistent Hyperglycemia|0|||
47003725|NCT01777282|83251793|FG001|Overall Study|Persistent Hyperglycemia|0|||
47003726|NCT01777282|83251794|FG002|Overall Study|Persistent Hyperglycemia|1|||
47003727|NCT01777282|83251795|FG003|Overall Study|Persistent Hyperglycemia|0|||
47003728|NCT01777282|83251796|FG004|Overall Study|Persistent Hyperglycemia|0|||
47003729|NCT01777282|83251792|FG000|Overall Study|New Antidiabetic Medication|0|||
47003730|NCT01777282|83251793|FG001|Overall Study|New Antidiabetic Medication|0|||
47003731|NCT01777282|83251794|FG002|Overall Study|New Antidiabetic Medication|1|||
47003732|NCT01777282|83251795|FG003|Overall Study|New Antidiabetic Medication|0|||
47003733|NCT01777282|83251796|FG004|Overall Study|New Antidiabetic Medication|0|||
47003734|NCT01777282|83251792|FG000|Overall Study|Adverse Event|4|||
47003735|NCT01777282|83251793|FG001|Overall Study|Adverse Event|4|||
47003736|NCT01777282|83251794|FG002|Overall Study|Adverse Event|2|||
47003737|NCT01777282|83251795|FG003|Overall Study|Adverse Event|1|||
47003738|NCT01777282|83251796|FG004|Overall Study|Adverse Event|3|||
47003739|NCT01777282|83251792|FG000|Overall Study|Withdrawal by Subject|4|||
47003740|NCT01777282|83251793|FG001|Overall Study|Withdrawal by Subject|0|||
47003741|NCT01777282|83251794|FG002|Overall Study|Withdrawal by Subject|0|||
47003742|NCT01777282|83251795|FG003|Overall Study|Withdrawal by Subject|1|||
47003743|NCT01777282|83251796|FG004|Overall Study|Withdrawal by Subject|2|||
47003744|NCT01777282|83251792|FG000|Overall Study|Protocol Violation|2|||
47003745|NCT01777282|83251793|FG001|Overall Study|Protocol Violation|0|||
47003746|NCT01777282|83251794|FG002|Overall Study|Protocol Violation|1|||
47003747|NCT01777282|83251795|FG003|Overall Study|Protocol Violation|0|||
47003748|NCT01777282|83251796|FG004|Overall Study|Protocol Violation|2|||
47003749|NCT01777282|83251792|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
47003750|NCT01777282|83251793|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
47003751|NCT01777282|83251794|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
47003752|NCT01777282|83251795|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
47003753|NCT01777282|83251796|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
47003754|NCT01975389|83251810|FG000|Overall Study|Adverse Event|10|||
47003755|NCT01975389|83251811|FG001|Overall Study|Adverse Event|6|||
47003756|NCT01975389|83251810|FG000|Overall Study|Death|61|||
47003757|NCT01975389|83251811|FG001|Overall Study|Death|54|||
47003758|NCT01975389|83251810|FG000|Overall Study|Lost to Follow-up|81|||
47003759|NCT01975389|83251811|FG001|Overall Study|Lost to Follow-up|86|||
47003760|NCT01975389|83251810|FG000|Overall Study|Withdrawal by Subject|90|||
47003761|NCT01975389|83251811|FG001|Overall Study|Withdrawal by Subject|76|||
47003762|NCT01975389|83251810|FG000|Overall Study|Other|6|||
47003763|NCT01975389|83251811|FG001|Overall Study|Other|9|||
47003764|NCT01975389|83251810|FG000|Overall Study|Randomized, not treated|4|||
47003765|NCT01975389|83251811|FG001|Overall Study|Randomized, not treated|5|||
47003766|NCT01974141|83251819|FG000|Overall Study|Other Reasons|28|||
47003767|NCT01974141|83251820|FG001|Overall Study|Other Reasons|18|||
47003768|NCT01974141|83251819|FG000|Overall Study|Protocol Violation|2|||
46620469|NCT03682055|82769619|FG003|Overall Study|Withdrawal by Subject|0|||
47003769|NCT01974141|83251820|FG001|Overall Study|Protocol Violation|6|||
47003770|NCT01974141|83251819|FG000|Overall Study|Personal Reasons|21|||
47003771|NCT01974141|83251820|FG001|Overall Study|Personal Reasons|20|||
47003772|NCT01974141|83251819|FG000|Overall Study|Lost to Follow-up|38|||
47003773|NCT01974141|83251820|FG001|Overall Study|Lost to Follow-up|29|||
47003774|NCT01974141|83251819|FG000|Overall Study|Pregnancy|3|||
47003775|NCT01974141|83251820|FG001|Overall Study|Pregnancy|3|||
47003776|NCT01974141|83251819|FG000|Overall Study|Lack of Efficacy|0|||
47003777|NCT01974141|83251820|FG001|Overall Study|Lack of Efficacy|1|||
47003778|NCT01974141|83251819|FG000|Overall Study|Adverse Event|4|||
47003779|NCT01974141|83251820|FG001|Overall Study|Adverse Event|5|||
47003780|NCT01945593|83251830|FG000|Overall Study|Adverse Event|0|||
47003781|NCT01945593|83251831|FG001|Overall Study|Adverse Event|0|||
47003782|NCT01945593|83251832|FG002|Overall Study|Adverse Event|0|||
47003783|NCT01945593|83251833|FG003|Overall Study|Adverse Event|5|||
47003784|NCT01945593|83251830|FG000|Overall Study|Physician Decision|0|||
47003785|NCT01945593|83251831|FG001|Overall Study|Physician Decision|0|||
47003786|NCT01945593|83251832|FG002|Overall Study|Physician Decision|1|||
47003787|NCT01945593|83251833|FG003|Overall Study|Physician Decision|1|||
47003788|NCT01945593|83251830|FG000|Overall Study|Withdrawal by Subject|0|||
47003789|NCT01945593|83251831|FG001|Overall Study|Withdrawal by Subject|2|||
47003790|NCT01945593|83251832|FG002|Overall Study|Withdrawal by Subject|0|||
47003791|NCT01945593|83251833|FG003|Overall Study|Withdrawal by Subject|4|||
47003792|NCT01945593|83251830|FG000|Overall Study|Protocol Violation|0|||
47003793|NCT01945593|83251831|FG001|Overall Study|Protocol Violation|2|||
47003794|NCT01945593|83251832|FG002|Overall Study|Protocol Violation|1|||
47003795|NCT01945593|83251833|FG003|Overall Study|Protocol Violation|3|||
47003796|NCT01945593|83251830|FG000|Overall Study|Death|0|||
47003797|NCT01945593|83251831|FG001|Overall Study|Death|0|||
47003798|NCT01945593|83251832|FG002|Overall Study|Death|1|||
47003799|NCT01945593|83251833|FG003|Overall Study|Death|0|||
47003800|NCT01945593|83251830|FG000|Overall Study|Other: Terminated|0|||
47003801|NCT01945593|83251831|FG001|Overall Study|Other: Terminated|0|||
47003802|NCT01945593|83251832|FG002|Overall Study|Other: Terminated|0|||
47003803|NCT01945593|83251833|FG003|Overall Study|Other: Terminated|1|||
47003804|NCT01945593|83251830|FG000|Overall Study|Other: Surgical Procedure|0|||
47003805|NCT01945593|83251831|FG001|Overall Study|Other: Surgical Procedure|2|||
47003806|NCT01945593|83251832|FG002|Overall Study|Other: Surgical Procedure|0|||
47003807|NCT01945593|83251833|FG003|Overall Study|Other: Surgical Procedure|6|||
47003808|NCT01945593|83251830|FG000|Overall Study|Other: Screen Failure|0|||
47003809|NCT01945593|83251831|FG001|Overall Study|Other: Screen Failure|2|||
47003810|NCT01945593|83251832|FG002|Overall Study|Other: Screen Failure|0|||
47003811|NCT01945593|83251833|FG003|Overall Study|Other: Screen Failure|0|||
47003812|NCT01945281|83251850|FG000|Overall Study|Adverse Event|1|||
47003813|NCT01945281|83251851|FG001|Overall Study|Adverse Event|0|||
47003814|NCT01945281|83251850|FG000|Overall Study|Death|3|||
47003815|NCT01945281|83251851|FG001|Overall Study|Death|3|||
47003816|NCT01945281|83251850|FG000|Overall Study|Physician Decision|1|||
47003817|NCT01945281|83251851|FG001|Overall Study|Physician Decision|1|||
47003818|NCT01945281|83251850|FG000|Overall Study|Technical Problems|1|||
47003819|NCT01945281|83251851|FG001|Overall Study|Technical Problems|0|||
47003820|NCT01961349|83251860|FG000|Overall Study|Withdrawal by Subject|1|||
47003821|NCT01961349|83251861|FG001|Overall Study|Withdrawal by Subject|4|||
47003822|NCT01961349|83251862|FG002|Overall Study|Withdrawal by Subject|0|||
47003823|NCT01961349|83251860|FG000|Overall Study|Adverse Event|0|||
47003824|NCT01961349|83251861|FG001|Overall Study|Adverse Event|0|||
47003825|NCT01961349|83251862|FG002|Overall Study|Adverse Event|1|||
47003826|NCT01961349|83251860|FG000|Overall Study|registration error, personal reason etc|2|||
47003827|NCT01961349|83251861|FG001|Overall Study|registration error, personal reason etc|2|||
47003828|NCT01961349|83251862|FG002|Overall Study|registration error, personal reason etc|1|||
46909598|NCT01343082|83138752|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
46909599|NCT01343082|83138753|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
46909600|NCT01343082|83138751|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
46909601|NCT01343082|83138752|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
46909602|NCT01343082|83138753|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
46909603|NCT03374189|83138759|FG000|Overall Study|Lost to Follow-up|1|||
46909604|NCT03374189|83138760|FG001|Overall Study|Lost to Follow-up|0|||
46909605|NCT03261037|83138770|FG000|Overall Study|Withdrawal by Subject|2|||
46909606|NCT03261037|83138771|FG001|Overall Study|Withdrawal by Subject|13|||
46909607|NCT03261037|83138772|FG002|Overall Study|Withdrawal by Subject|0|||
46909608|NCT03261037|83138773|FG003|Overall Study|Withdrawal by Subject|18|||
46909609|NCT03261037|83138770|FG000|Overall Study|Non-compliance with study procedures|0|||
46909610|NCT03261037|83138771|FG001|Overall Study|Non-compliance with study procedures|2|||
46909611|NCT03261037|83138772|FG002|Overall Study|Non-compliance with study procedures|0|||
46909612|NCT03261037|83138773|FG003|Overall Study|Non-compliance with study procedures|6|||
46909613|NCT03261037|83138770|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
47003829|NCT01973595|83251874|FG000|Washout|Withdrawal by Subject|1|||
47003830|NCT01973595|83251875|FG001|Washout|Withdrawal by Subject|0|||
47003831|NCT01973595|83251876|FG002|Washout|Withdrawal by Subject|1|||
46909614|NCT03261037|83138771|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
46909615|NCT03261037|83138772|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
47003832|NCT01973595|83251877|FG003|Washout|Withdrawal by Subject|0|||
47003833|NCT01944969|83251888|FG000|Overall Study|Adverse Event|1|||
47003834|NCT01944969|83251888|FG000|Overall Study|Lack of Efficacy|1|||
47003835|NCT01944969|83251888|FG000|Overall Study|Non-compliance with IMP|1|||
47003836|NCT01944969|83251888|FG000|Overall Study|Administrative or other reasons|23|||
47003837|NCT01961115|83251897|FG000|Overall Study|Disease Progression|1|||
46909616|NCT03261037|83138773|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
47003838|NCT01961115|83251898|FG001|Overall Study|Disease Progression|0|||
47003839|NCT01961115|83251899|FG002|Overall Study|Disease Progression|3|||
47003840|NCT01961115|83251897|FG000|Overall Study|Adverse Event|1|||
47003841|NCT01961115|83251898|FG001|Overall Study|Adverse Event|0|||
47003842|NCT01961115|83251899|FG002|Overall Study|Adverse Event|1|||
47003843|NCT01973439|83251907|FG000|Overall Study|Lost samples from one PK Day|2|||
47003844|NCT01973439|83251907|FG000|Overall Study|Vomiting after commencing once daily|1|||
47003845|NCT01973439|83251907|FG000|Overall Study|PK curve incomplete|2|||
47003846|NCT01973283|83251911|FG000|Overall Study|Lost to Follow-up|4|||
47003847|NCT01943799|83251921|FG000|Overall Study|Lost to Follow-up|0|||
47003848|NCT01943799|83251922|FG001|Overall Study|Lost to Follow-up|1|||
47003849|NCT01943799|83251923|FG002|Overall Study|Lost to Follow-up|1|||
47003850|NCT01943799|83251924|FG003|Overall Study|Lost to Follow-up|0|||
47003851|NCT01943799|83251921|FG000|Overall Study|Protocol Violation|1|||
47003852|NCT01943799|83251922|FG001|Overall Study|Protocol Violation|0|||
47003853|NCT01943799|83251923|FG002|Overall Study|Protocol Violation|0|||
47003854|NCT01943799|83251924|FG003|Overall Study|Protocol Violation|0|||
47003855|NCT01943799|83251921|FG000|Overall Study|Withdrawal by Subject|4|||
47003856|NCT01943799|83251922|FG001|Overall Study|Withdrawal by Subject|2|||
47003857|NCT01943799|83251923|FG002|Overall Study|Withdrawal by Subject|1|||
47003858|NCT01943799|83251924|FG003|Overall Study|Withdrawal by Subject|0|||
47003859|NCT01972659|83251936|FG000|Overall Study|Protocol Violation|2|||
47003860|NCT01972659|83251937|FG001|Overall Study|Protocol Violation|2|||
47003861|NCT01972659|83251936|FG000|Overall Study|problems realted to acceleromyograph|2|||
47003862|NCT01972659|83251937|FG001|Overall Study|problems realted to acceleromyograph|1|||
47003863|NCT01971723|83251945|FG000|Overall Study|Withdrawal by Subject|1|||
47003864|NCT01971723|83251946|FG001|Overall Study|Withdrawal by Subject|1|||
47003865|NCT01971723|83251945|FG000|Overall Study|Protocol Violation|1|||
47003866|NCT01971723|83251946|FG001|Overall Study|Protocol Violation|2|||
47003867|NCT01942785|83251952|FG000|Overall Study|Adverse Event|2|||
47003868|NCT01942785|83251952|FG000|Overall Study|Withdrawal by Subject|1|||
47003869|NCT01942785|83251952|FG000|Overall Study|Protocol Violation|1|||
47003870|NCT01774786|83251960|FG000|Overall Study|Death|300|||
47003871|NCT01774786|83251961|FG001|Overall Study|Death|319|||
47003872|NCT01774786|83251960|FG000|Overall Study|Lost to Follow-up|6|||
47003873|NCT01774786|83251961|FG001|Overall Study|Lost to Follow-up|7|||
46909617|NCT03261037|83138770|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
47003874|NCT01774786|83251960|FG000|Overall Study|Withdrawal by Subject|18|||
47003875|NCT01774786|83251961|FG001|Overall Study|Withdrawal by Subject|14|||
47003876|NCT01774786|83251960|FG000|Overall Study|Physician Decision|2|||
47003877|NCT01774786|83251961|FG001|Overall Study|Physician Decision|0|||
47003878|NCT01774786|83251960|FG000|Overall Study|Non-compliance|0|||
46909618|NCT03261037|83138771|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
46909619|NCT03261037|83138772|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
46909620|NCT03261037|83138773|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
46909621|NCT03261037|83138770|FG000|Overall Study|Diagnosed but protocol deviation|1|||
46909622|NCT03261037|83138771|FG001|Overall Study|Diagnosed but protocol deviation|0|||
46909623|NCT03261037|83138772|FG002|Overall Study|Diagnosed but protocol deviation|0|||
46909624|NCT03261037|83138773|FG003|Overall Study|Diagnosed but protocol deviation|0|||
46909625|NCT03261037|83138770|FG000|Overall Study|Participant did not want to continue the study|0|||
46909626|NCT03261037|83138771|FG001|Overall Study|Participant did not want to continue the study|1|||
46909627|NCT03261037|83138772|FG002|Overall Study|Participant did not want to continue the study|0|||
46909628|NCT03261037|83138773|FG003|Overall Study|Participant did not want to continue the study|0|||
46909629|NCT03261037|83138770|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
46909630|NCT03261037|83138771|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
46909631|NCT03261037|83138772|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
46909632|NCT03261037|83138773|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
46909633|NCT03261037|83138770|FG000|Overall Study|Participant presented clinical improvement|0|||
46909634|NCT03261037|83138771|FG001|Overall Study|Participant presented clinical improvement|2|||
46909635|NCT03261037|83138772|FG002|Overall Study|Participant presented clinical improvement|0|||
46909636|NCT03261037|83138773|FG003|Overall Study|Participant presented clinical improvement|0|||
46909637|NCT03261037|83138770|FG000|Overall Study|Technical difficulties|0|||
46909638|NCT03261037|83138771|FG001|Overall Study|Technical difficulties|0|||
46909639|NCT03261037|83138772|FG002|Overall Study|Technical difficulties|0|||
46909640|NCT03261037|83138773|FG003|Overall Study|Technical difficulties|1|||
46909641|NCT03261037|83138770|FG000|Overall Study|Equipment failed to work|0|||
46909642|NCT03261037|83138771|FG001|Overall Study|Equipment failed to work|0|||
46909643|NCT03261037|83138772|FG002|Overall Study|Equipment failed to work|0|||
47003879|NCT01774786|83251961|FG001|Overall Study|Non-compliance|1|||
47003880|NCT01774786|83251960|FG000|Overall Study|Reason Not Specified|2|||
47003881|NCT01774786|83251961|FG001|Overall Study|Reason Not Specified|5|||
47003882|NCT01960725|83251969|FG000|Overall Study|Lost to Follow-up|4|||
47003883|NCT01960725|83251970|FG001|Overall Study|Lost to Follow-up|3|||
47003884|NCT01960725|83251969|FG000|Overall Study|Withdrawal by Subject|1|||
47003885|NCT01960725|83251970|FG001|Overall Study|Withdrawal by Subject|0|||
47003886|NCT01960725|83251969|FG000|Overall Study|unable to obtain blood sample|1|||
47003887|NCT01960725|83251970|FG001|Overall Study|unable to obtain blood sample|2|||
47003888|NCT01942161|83251979|FG000|Overall Study|Adverse Event|1|||
47003889|NCT01942161|83251980|FG001|Overall Study|Adverse Event|2|||
47003890|NCT01942161|83251981|FG002|Overall Study|Adverse Event|5|||
47003891|NCT01942161|83251979|FG000|Overall Study|Physician Decision|3|||
47003892|NCT01942161|83251980|FG001|Overall Study|Physician Decision|1|||
47003893|NCT01942161|83251981|FG002|Overall Study|Physician Decision|0|||
47003894|NCT01942161|83251979|FG000|Overall Study|Protocol Violation|1|||
47003895|NCT01942161|83251980|FG001|Overall Study|Protocol Violation|0|||
47003896|NCT01942161|83251981|FG002|Overall Study|Protocol Violation|0|||
47003897|NCT01942161|83251979|FG000|Overall Study|Withdrawal by Subject|3|||
47003898|NCT01942161|83251980|FG001|Overall Study|Withdrawal by Subject|3|||
47003899|NCT01942161|83251981|FG002|Overall Study|Withdrawal by Subject|1|||
47003900|NCT01971645|83251992|FG000|Overall Study|Adverse Event|1|||
47003901|NCT01971645|83251993|FG001|Overall Study|Adverse Event|0|||
47003902|NCT01971645|83251994|FG002|Overall Study|Adverse Event|0|||
47003903|NCT01971645|83251992|FG000|Overall Study|Lost to Follow-up|1|||
47003904|NCT01971645|83251993|FG001|Overall Study|Lost to Follow-up|0|||
47003905|NCT01971645|83251994|FG002|Overall Study|Lost to Follow-up|1|||
47003906|NCT01971645|83251992|FG000|Overall Study|Protocol Violation|0|||
47003907|NCT01971645|83251993|FG001|Overall Study|Protocol Violation|0|||
47003908|NCT01971645|83251994|FG002|Overall Study|Protocol Violation|1|||
47003909|NCT01941537|83252004|FG000|Overall Study|Lack of Efficacy|1|||
47003910|NCT01941537|83252005|FG001|Overall Study|Lack of Efficacy|2|||
47003911|NCT01941537|83252004|FG000|Overall Study|Lost to Follow-up|1|||
47003912|NCT01941537|83252005|FG001|Overall Study|Lost to Follow-up|0|||
47003913|NCT01941537|83252004|FG000|Overall Study|Pregnancy|1|||
47003914|NCT01941537|83252005|FG001|Overall Study|Pregnancy|0|||
47003915|NCT01941537|83252004|FG000|Overall Study|Adverse Event|1|||
47003916|NCT01941537|83252005|FG001|Overall Study|Adverse Event|0|||
47003917|NCT01941537|83252004|FG000|Overall Study|Withdrawal by Subject|0|||
47003918|NCT01941537|83252005|FG001|Overall Study|Withdrawal by Subject|1|||
47003919|NCT01971567|83252014|FG000|Overall Study|Withdrawal by Subject|3|||
47003920|NCT01971567|83252015|FG001|Overall Study|Withdrawal by Subject|2|||
47003921|NCT01971567|83252014|FG000|Overall Study|Lost to Follow-up|1|||
47003922|NCT01971567|83252015|FG001|Overall Study|Lost to Follow-up|0|||
47003923|NCT01960413|83252023|FG000|Overall Study|Withdrawal by Subject|1|||
47003924|NCT01960413|83252024|FG001|Overall Study|Withdrawal by Subject|1|||
47003925|NCT01960413|83252023|FG000|Overall Study|Physician Decision|1|||
47003926|NCT01960413|83252024|FG001|Overall Study|Physician Decision|0|||
47003927|NCT01960413|83252023|FG000|Overall Study|Lost to Follow-up|2|||
47003928|NCT01960413|83252024|FG001|Overall Study|Lost to Follow-up|0|||
47003929|NCT01970475|83252032|FG000|Overall Study|Withdrawal by Subject|11|||
47003930|NCT01970475|83252033|FG001|Overall Study|Withdrawal by Subject|6|||
47003931|NCT01970475|83252032|FG000|Overall Study|Adverse Event|7|||
47003932|NCT01970475|83252033|FG001|Overall Study|Adverse Event|3|||
47003933|NCT01970475|83252032|FG000|Overall Study|Lost to Follow-up|2|||
47003934|NCT01970475|83252033|FG001|Overall Study|Lost to Follow-up|2|||
47003935|NCT01970475|83252032|FG000|Overall Study|Protocol Violation|1|||
47003936|NCT01970475|83252033|FG001|Overall Study|Protocol Violation|0|||
47003937|NCT01939977|83252041|FG000|Overall Study|Adverse Event|4|||
47003938|NCT01939977|83252042|FG001|Overall Study|Adverse Event|3|||
47003939|NCT01939977|83252041|FG000|Overall Study|Lack of Efficacy|3|||
47003940|NCT01939977|83252042|FG001|Overall Study|Lack of Efficacy|0|||
47003941|NCT01939977|83252041|FG000|Overall Study|Physician Decision|1|||
47003942|NCT01939977|83252042|FG001|Overall Study|Physician Decision|1|||
47003943|NCT01939977|83252041|FG000|Overall Study|Withdrawal by Subject|0|||
47003944|NCT01939977|83252042|FG001|Overall Study|Withdrawal by Subject|2|||
47003945|NCT01939977|83252041|FG000|Overall Study|Did not meet inclusion criteria|1|||
47003946|NCT01939977|83252042|FG001|Overall Study|Did not meet inclusion criteria|0|||
47003947|NCT01939977|83252041|FG000|Overall Study|Did not receive study medication|0|||
47003948|NCT01939977|83252042|FG001|Overall Study|Did not receive study medication|1|||
47003949|NCT01939899|83252053|FG000|Lead-in Dose Finding Phase|Death|0|||
47003950|NCT01939899|83252054|FG001|Lead-in Dose Finding Phase|Death|3|||
47003951|NCT01939899|83252055|FG002|Lead-in Dose Finding Phase|Death|1|||
47003952|NCT01939899|83252056|FG003|Lead-in Dose Finding Phase|Death|0|||
46709431|NCT01222520|82925470|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
46709432|NCT01222520|82925471|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
47003953|NCT01939899|83252057|FG004|Lead-in Dose Finding Phase|Death|0|||
47003954|NCT01939899|83252053|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
47003955|NCT01939899|83252054|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
47003956|NCT01939899|83252055|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
47003957|NCT01939899|83252056|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
47003958|NCT01939899|83252057|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
47003959|NCT01939899|83252053|FG000|Lead-in Dose Finding Phase|Other|0|||
47003960|NCT01939899|83252054|FG001|Lead-in Dose Finding Phase|Other|0|||
47003961|NCT01939899|83252055|FG002|Lead-in Dose Finding Phase|Other|1|||
47003962|NCT01939899|83252056|FG003|Lead-in Dose Finding Phase|Other|0|||
47003963|NCT01939899|83252057|FG004|Lead-in Dose Finding Phase|Other|0|||
47003964|NCT01939899|83252053|FG000|Phase 2|Withdrawal by Subject|0|||
47003965|NCT01939899|83252054|FG001|Phase 2|Withdrawal by Subject|0|||
47003966|NCT01939899|83252055|FG002|Phase 2|Withdrawal by Subject|0|||
47003967|NCT01939899|83252056|FG003|Phase 2|Withdrawal by Subject|2|||
47003968|NCT01939899|83252057|FG004|Phase 2|Withdrawal by Subject|0|||
47003969|NCT01939899|83252053|FG000|Phase 2|Disease Progression|0|||
47003970|NCT01939899|83252054|FG001|Phase 2|Disease Progression|0|||
47003971|NCT01939899|83252055|FG002|Phase 2|Disease Progression|0|||
47003972|NCT01939899|83252056|FG003|Phase 2|Disease Progression|9|||
47003973|NCT01939899|83252057|FG004|Phase 2|Disease Progression|1|||
47003974|NCT01970397|83252077|FG000|Overall Study|Adverse Event|0|||
47003975|NCT01970397|83252078|FG001|Overall Study|Adverse Event|1|||
46620470|NCT03682055|82769620|FG004|Overall Study|Withdrawal by Subject|0|||
46909644|NCT03261037|83138773|FG003|Overall Study|Equipment failed to work|1|||
46909645|NCT03261037|83138770|FG000|Overall Study|End of study for participant and no follow up|0|||
46909646|NCT03261037|83138771|FG001|Overall Study|End of study for participant and no follow up|0|||
46909647|NCT03261037|83138772|FG002|Overall Study|End of study for participant and no follow up|0|||
46909648|NCT03261037|83138773|FG003|Overall Study|End of study for participant and no follow up|1|||
46909649|NCT03261037|83138770|FG000|Overall Study|Participant was too weak to continue in study|1|||
46909650|NCT03261037|83138771|FG001|Overall Study|Participant was too weak to continue in study|0|||
46909651|NCT03261037|83138772|FG002|Overall Study|Participant was too weak to continue in study|0|||
46909652|NCT03261037|83138773|FG003|Overall Study|Participant was too weak to continue in study|0|||
46909653|NCT03372551|83138784|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
46909654|NCT03372551|83138785|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
46909655|NCT03326323|83138798|FG000|Overall Study|Unable to receive ANH protocol|3|||
46909656|NCT03259789|83138809|FG000|Overall Study|Adverse Event|3|||
46909657|NCT03259789|83138810|FG001|Overall Study|Adverse Event|2|||
46909658|NCT03259789|83138811|FG002|Overall Study|Adverse Event|1|||
46909659|NCT03259789|83138809|FG000|Overall Study|Withdrawal by Subject|9|||
46909660|NCT03259789|83138810|FG001|Overall Study|Withdrawal by Subject|5|||
46909661|NCT03259789|83138811|FG002|Overall Study|Withdrawal by Subject|1|||
46909662|NCT03259789|83138809|FG000|Overall Study|Lost to Follow-up|5|||
46909663|NCT03259789|83138810|FG001|Overall Study|Lost to Follow-up|9|||
46909664|NCT03259789|83138811|FG002|Overall Study|Lost to Follow-up|4|||
46909665|NCT03259789|83138809|FG000|Overall Study|Physician Decision|0|||
46909666|NCT03259789|83138810|FG001|Overall Study|Physician Decision|1|||
46909667|NCT03259789|83138811|FG002|Overall Study|Physician Decision|0|||
46909668|NCT03259555|83138822|FG000|Overall Study|Adverse Event|6|||
46909669|NCT03259555|83138823|FG001|Overall Study|Adverse Event|4|||
46909670|NCT03259555|83138822|FG000|Overall Study|Lack of Efficacy|6|||
46909671|NCT03259555|83138823|FG001|Overall Study|Lack of Efficacy|4|||
46909672|NCT03259555|83138822|FG000|Overall Study|Lost to Follow-up|0|||
46909673|NCT03259555|83138823|FG001|Overall Study|Lost to Follow-up|2|||
46909674|NCT03259555|83138822|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46909675|NCT03259555|83138823|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46909676|NCT03259555|83138822|FG000|Overall Study|Progressive Disease|0|||
46909677|NCT03259555|83138823|FG001|Overall Study|Progressive Disease|2|||
46909678|NCT03259555|83138822|FG000|Overall Study|Withdrawal by Subject|19|||
46909679|NCT03259555|83138823|FG001|Overall Study|Withdrawal by Subject|16|||
46909680|NCT03259555|83138822|FG000|Overall Study|Physician Decision|1|||
46909681|NCT03259555|83138823|FG001|Overall Study|Physician Decision|2|||
46909682|NCT03259555|83138822|FG000|Overall Study|Other|1|||
46909683|NCT03259555|83138823|FG001|Overall Study|Other|0|||
46909684|NCT03259087|83138834|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
46909685|NCT03259087|83138835|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
46909686|NCT03259087|83138836|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
46909687|NCT03259087|83138837|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
46909688|NCT03259087|83138838|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
46909689|NCT03259087|83138834|FG000|Period 2 of Part 2|Adverse Event|0|||
46909690|NCT03259087|83138835|FG001|Period 2 of Part 2|Adverse Event|0|||
46909691|NCT03259087|83138836|FG002|Period 2 of Part 2|Adverse Event|0|||
46909692|NCT03259087|83138837|FG003|Period 2 of Part 2|Adverse Event|0|||
46909693|NCT03259087|83138838|FG004|Period 2 of Part 2|Adverse Event|1|||
46909694|NCT03257995|83138860|FG000|Overall Study|Adverse Event|0|||
46909695|NCT03257995|83138861|FG001|Overall Study|Adverse Event|1|||
46909696|NCT03257995|83138862|FG002|Overall Study|Adverse Event|0|||
46909697|NCT03257995|83138863|FG003|Overall Study|Adverse Event|0|||
46909698|NCT03257995|83138864|FG004|Overall Study|Adverse Event|0|||
46909699|NCT03257995|83138865|FG005|Overall Study|Adverse Event|0|||
46909700|NCT03257995|83138860|FG000|Overall Study|Protocol deviation|0|||
46909701|NCT03257995|83138861|FG001|Overall Study|Protocol deviation|0|||
47003976|NCT01970397|83252077|FG000|Overall Study|Lost to Follow-up|0|||
47003977|NCT01970397|83252078|FG001|Overall Study|Lost to Follow-up|1|||
47003978|NCT01970397|83252077|FG000|Overall Study|Personal Reasons|1|||
47003979|NCT01970397|83252078|FG001|Overall Study|Personal Reasons|2|||
47003980|NCT01970397|83252077|FG000|Overall Study|Protocol Violation|1|||
47003981|NCT01970397|83252078|FG001|Overall Study|Protocol Violation|1|||
47003982|NCT01970241|83252086|FG000|Overall Study|Withdrawal by Subject|2|||
47003983|NCT01970241|83252087|FG001|Overall Study|Withdrawal by Subject|0|||
47003984|NCT01970241|83252086|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
47003985|NCT01970241|83252087|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
47003986|NCT01939353|83252095|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
47003987|NCT01939353|83252095|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
47003988|NCT01939353|83252095|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
47003989|NCT01939353|83252095|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
47003990|NCT01939353|83252095|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
47003991|NCT01970007|83252099|FG000|Overall Study|Death|5|||
47003992|NCT01970007|83252099|FG000|Overall Study|Withdrawal by Subject|23|||
47003993|NCT01970007|83252099|FG000|Overall Study|Lost to Follow-up|24|||
46909702|NCT03257995|83138862|FG002|Overall Study|Protocol deviation|0|||
46909703|NCT03257995|83138863|FG003|Overall Study|Protocol deviation|0|||
47003994|NCT01970007|83252099|FG000|Overall Study|"Other endpoint"|3|||
47003995|NCT01728376|83252109|FG000|Overall Study|Adverse Event|1|||
47003996|NCT01728376|83252110|FG001|Overall Study|Adverse Event|1|||
47003997|NCT01728376|83252111|FG002|Overall Study|Adverse Event|1|||
47003998|NCT01728376|83252112|FG003|Overall Study|Adverse Event|1|||
47003999|NCT01728376|83252113|FG004|Overall Study|Adverse Event|1|||
47004000|NCT01728376|83252114|FG005|Overall Study|Adverse Event|0|||
47004001|NCT01728376|83252109|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
47004002|NCT01728376|83252110|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
47004003|NCT01728376|83252111|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
47004004|NCT01728376|83252112|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
47004005|NCT01728376|83252113|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
47004006|NCT01728376|83252114|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
47004007|NCT01728376|83252109|FG000|Overall Study|No relevant bacteria|2|||
47004008|NCT01728376|83252110|FG001|Overall Study|No relevant bacteria|0|||
46909704|NCT03257995|83138864|FG004|Overall Study|Protocol deviation|0|||
46909705|NCT03257995|83138865|FG005|Overall Study|Protocol deviation|2|||
46909706|NCT03049488|83138883|FG000|Overall Study|Lost to Follow-up|1|||
46909707|NCT03049488|83138884|FG001|Overall Study|Lost to Follow-up|1|||
46909708|NCT03049488|83138885|FG002|Overall Study|Lost to Follow-up|0|||
46909709|NCT03049488|83138886|FG003|Overall Study|Lost to Follow-up|0|||
46909710|NCT03049488|83138887|FG004|Overall Study|Lost to Follow-up|0|||
46909711|NCT03049488|83138888|FG005|Overall Study|Lost to Follow-up|0|||
46909712|NCT03049488|83138883|FG000|Overall Study|Moved from Area|1|||
46909713|NCT03049488|83138884|FG001|Overall Study|Moved from Area|0|||
46909714|NCT03049488|83138885|FG002|Overall Study|Moved from Area|0|||
46909715|NCT03049488|83138886|FG003|Overall Study|Moved from Area|1|||
46909716|NCT03049488|83138887|FG004|Overall Study|Moved from Area|1|||
46909717|NCT03049488|83138888|FG005|Overall Study|Moved from Area|0|||
46909718|NCT03049488|83138883|FG000|Overall Study|Physician Decision|0|||
46909719|NCT03049488|83138884|FG001|Overall Study|Physician Decision|1|||
46909720|NCT03049488|83138885|FG002|Overall Study|Physician Decision|0|||
46909721|NCT03049488|83138886|FG003|Overall Study|Physician Decision|0|||
46909722|NCT03049488|83138887|FG004|Overall Study|Physician Decision|0|||
46909723|NCT03049488|83138888|FG005|Overall Study|Physician Decision|0|||
46909724|NCT03049488|83138883|FG000|Overall Study|Withdrawal by Subject|0|||
46909725|NCT03049488|83138884|FG001|Overall Study|Withdrawal by Subject|0|||
46909726|NCT03049488|83138885|FG002|Overall Study|Withdrawal by Subject|0|||
46909727|NCT03049488|83138886|FG003|Overall Study|Withdrawal by Subject|1|||
46909728|NCT03049488|83138887|FG004|Overall Study|Withdrawal by Subject|1|||
46909729|NCT03049488|83138888|FG005|Overall Study|Withdrawal by Subject|0|||
46909730|NCT03257371|83138903|FG000|Overall Study|Lost to Follow-up|1|||
46909731|NCT03242863|83138907|FG000|Study Week 1|Withdrawal by Subject|0|||
46909732|NCT03242863|83138908|FG001|Study Week 1|Withdrawal by Subject|1|||
46909733|NCT03242863|83138909|FG002|Study Week 1|Withdrawal by Subject|0|||
46909734|NCT03242863|83138910|FG003|Study Week 1|Withdrawal by Subject|0|||
46909735|NCT03242863|83138911|FG004|Study Week 1|Withdrawal by Subject|3|||
46909736|NCT03242863|83138912|FG005|Study Week 1|Withdrawal by Subject|0|||
46909737|NCT03044106|83138920|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
46909738|NCT03044106|83138921|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
46909739|NCT03043560|83138947|FG000|Overall Study|Discontinued Intervention|1|||
46909740|NCT03043560|83138948|FG001|Overall Study|Discontinued Intervention|2|||
46909741|NCT03043560|83138947|FG000|Overall Study|Lost to Follow-up|0|||
47004009|NCT01728376|83252111|FG002|Overall Study|No relevant bacteria|0|||
46909742|NCT03043560|83138948|FG001|Overall Study|Lost to Follow-up|1|||
47004010|NCT01728376|83252112|FG003|Overall Study|No relevant bacteria|0|||
47004011|NCT01728376|83252113|FG004|Overall Study|No relevant bacteria|1|||
47004012|NCT01728376|83252114|FG005|Overall Study|No relevant bacteria|1|||
47004013|NCT01728376|83252109|FG000|Overall Study|Did not receive treatment|0|||
47004014|NCT01728376|83252110|FG001|Overall Study|Did not receive treatment|1|||
47004015|NCT01728376|83252111|FG002|Overall Study|Did not receive treatment|0|||
47004016|NCT01728376|83252112|FG003|Overall Study|Did not receive treatment|0|||
47004017|NCT01728376|83252113|FG004|Overall Study|Did not receive treatment|0|||
47004018|NCT01728376|83252114|FG005|Overall Study|Did not receive treatment|0|||
47004019|NCT01728376|83252109|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
47004020|NCT01728376|83252110|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
47004021|NCT01728376|83252111|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
47004022|NCT01728376|83252112|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
47004023|NCT01728376|83252113|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
47004024|NCT01728376|83252114|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
47004025|NCT01708174|83252131|FG000|Treatment Period|Withdrawal by Subject|1|||
47004026|NCT01708174|83252132|FG001|Treatment Period|Withdrawal by Subject|0|||
47004027|NCT01708174|83252133|FG002|Treatment Period|Withdrawal by Subject|0|||
47004028|NCT01708174|83252131|FG000|Treatment Period|Progressive disease|0|||
47004029|NCT01708174|83252132|FG001|Treatment Period|Progressive disease|1|||
47004030|NCT01708174|83252133|FG002|Treatment Period|Progressive disease|0|||
47004031|NCT01708174|83252131|FG000|Treatment Period|Death|0|||
47004032|NCT01708174|83252132|FG001|Treatment Period|Death|0|||
47004033|NCT01708174|83252133|FG002|Treatment Period|Death|1|||
47004034|NCT01708174|83252131|FG000|Treatment Period|Adverse Event|0|||
47004035|NCT01708174|83252132|FG001|Treatment Period|Adverse Event|1|||
47004036|NCT01708174|83252133|FG002|Treatment Period|Adverse Event|0|||
47004037|NCT01605916|83252147|FG000|Overall Study|Adverse Event|1|||
47004038|NCT01605916|83252148|FG001|Overall Study|Adverse Event|0|||
47004039|NCT01605916|83252149|FG002|Overall Study|Adverse Event|0|||
47004040|NCT01605916|83252150|FG003|Overall Study|Adverse Event|1|||
47004041|NCT01605916|83252151|FG004|Overall Study|Adverse Event|0|||
47004042|NCT01605916|83252147|FG000|Overall Study|Lack of Efficacy|2|||
47004043|NCT01605916|83252148|FG001|Overall Study|Lack of Efficacy|3|||
47004044|NCT01605916|83252149|FG002|Overall Study|Lack of Efficacy|3|||
47004045|NCT01605916|83252150|FG003|Overall Study|Lack of Efficacy|5|||
47004046|NCT01605916|83252151|FG004|Overall Study|Lack of Efficacy|4|||
47004047|NCT01605916|83252147|FG000|Overall Study|Withdrawal by Subject|1|||
47004048|NCT01605916|83252148|FG001|Overall Study|Withdrawal by Subject|1|||
47004049|NCT01605916|83252149|FG002|Overall Study|Withdrawal by Subject|0|||
47004050|NCT01605916|83252150|FG003|Overall Study|Withdrawal by Subject|0|||
47004051|NCT01605916|83252151|FG004|Overall Study|Withdrawal by Subject|2|||
47004052|NCT01635283|83252164|FG000|Overall Study|Tumor Progression|3|||
47004053|NCT01635283|83252164|FG000|Overall Study|Lost to Follow-up|1|||
47004054|NCT01707004|83252171|FG000|Overall Study|Physician Decision|3|||
47004055|NCT01939197|83252183|FG000|Overall Study|Withdrawal by Subject|1|||
47004056|NCT01939197|83252184|FG001|Overall Study|Withdrawal by Subject|0|||
47004057|NCT01939197|83252185|FG002|Overall Study|Withdrawal by Subject|0|||
47004058|NCT01939197|83252186|FG003|Overall Study|Withdrawal by Subject|0|||
47004059|NCT01939197|83252187|FG004|Overall Study|Withdrawal by Subject|1|||
47004060|NCT01939197|83252188|FG005|Overall Study|Withdrawal by Subject|0|||
47004061|NCT01939197|83252189|FG006|Overall Study|Withdrawal by Subject|0|||
47004062|NCT01939197|83252183|FG000|Overall Study|Lost to Follow-up|0|||
47004063|NCT01939197|83252184|FG001|Overall Study|Lost to Follow-up|1|||
47004064|NCT01939197|83252185|FG002|Overall Study|Lost to Follow-up|0|||
46620471|NCT03682055|82769621|FG005|Overall Study|Withdrawal by Subject|1|||
46709433|NCT01222520|82925470|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
46909743|NCT03255733|83138974|FG000|Overall Study|Lost to Follow-up|4|||
46909744|NCT03255655|83138980|FG000|Overall Study|Lost to Follow-up|7|||
46909745|NCT03255655|83138981|FG001|Overall Study|Lost to Follow-up|4|||
46909746|NCT02899988|83138991|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
46909747|NCT02899988|83138992|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
46909748|NCT02899988|83138993|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909749|NCT02899988|83138994|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909750|NCT02899988|83138995|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909751|NCT02899988|83138996|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909752|NCT02899988|83138997|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909753|NCT02899988|83138998|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909754|NCT02899988|83138999|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909755|NCT02899988|83139000|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909756|NCT02899988|83139001|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46909757|NCT02899988|83138991|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
47004065|NCT01939197|83252186|FG003|Overall Study|Lost to Follow-up|1|||
47004066|NCT01939197|83252187|FG004|Overall Study|Lost to Follow-up|3|||
47004067|NCT01939197|83252188|FG005|Overall Study|Lost to Follow-up|1|||
47004068|NCT01939197|83252189|FG006|Overall Study|Lost to Follow-up|2|||
47004069|NCT01969851|83252222|FG000|Overall Study|Adverse Event|0|||
47004070|NCT01969851|83252223|FG001|Overall Study|Adverse Event|0|||
47004071|NCT01969851|83252224|FG002|Overall Study|Adverse Event|3|||
47004072|NCT01969851|83252222|FG000|Overall Study|Lack of Efficacy|0|||
47004073|NCT01969851|83252223|FG001|Overall Study|Lack of Efficacy|3|||
47004074|NCT01969851|83252224|FG002|Overall Study|Lack of Efficacy|1|||
47004075|NCT01969851|83252222|FG000|Overall Study|Withdrawal by Subject|1|||
47004076|NCT01969851|83252223|FG001|Overall Study|Withdrawal by Subject|0|||
47004077|NCT01969851|83252224|FG002|Overall Study|Withdrawal by Subject|1|||
47004078|NCT01969851|83252222|FG000|Overall Study|No effective dose in Titration period|0|||
47004079|NCT01969851|83252223|FG001|Overall Study|No effective dose in Titration period|0|||
47004080|NCT01969851|83252224|FG002|Overall Study|No effective dose in Titration period|1|||
47004081|NCT01969851|83252222|FG000|Overall Study|Sponsor decision|0|||
47004082|NCT01969851|83252223|FG001|Overall Study|Sponsor decision|0|||
47004083|NCT01969851|83252224|FG002|Overall Study|Sponsor decision|1|||
47004084|NCT01938573|83252232|FG000|Overall Study|Lack of Efficacy|1|||
47004085|NCT01938573|83252233|FG001|Overall Study|Lack of Efficacy|0|||
47004086|NCT01938573|83252232|FG000|Overall Study|Operation at other hospital|1|||
47004087|NCT01938573|83252233|FG001|Overall Study|Operation at other hospital|0|||
47004088|NCT01937871|83252241|FG000|Overall Study|Adverse Event|6|||
47004089|NCT01937871|83252242|FG001|Overall Study|Adverse Event|6|||
47004090|NCT01937871|83252243|FG002|Overall Study|Adverse Event|2|||
47004091|NCT01937871|83252241|FG000|Overall Study|Lost to Follow-up|8|||
47004092|NCT01937871|83252242|FG001|Overall Study|Lost to Follow-up|2|||
47004093|NCT01937871|83252243|FG002|Overall Study|Lost to Follow-up|4|||
47004094|NCT01937871|83252241|FG000|Overall Study|Withdrawal by Subject|9|||
47004095|NCT01937871|83252242|FG001|Overall Study|Withdrawal by Subject|6|||
47004096|NCT01937871|83252243|FG002|Overall Study|Withdrawal by Subject|4|||
47004097|NCT01937871|83252241|FG000|Overall Study|Physician Decision|0|||
47004098|NCT01937871|83252242|FG001|Overall Study|Physician Decision|1|||
47004099|NCT01937871|83252243|FG002|Overall Study|Physician Decision|0|||
47004100|NCT01937871|83252241|FG000|Overall Study|Entry Criteria Not Met|1|||
47004101|NCT01937871|83252242|FG001|Overall Study|Entry Criteria Not Met|2|||
47004102|NCT01937871|83252243|FG002|Overall Study|Entry Criteria Not Met|1|||
47004103|NCT01269463|83252254|FG000|First Intervention|Withdrawal by Subject|1|||
47004104|NCT01269463|83252255|FG001|First Intervention|Withdrawal by Subject|0|||
47004105|NCT01269463|83252254|FG000|First Intervention|Adverse Event|1|||
47004106|NCT01269463|83252255|FG001|First Intervention|Adverse Event|0|||
47004107|NCT01269463|83252254|FG000|First Intervention|Lack of Efficacy|0|||
47004108|NCT01269463|83252255|FG001|First Intervention|Lack of Efficacy|1|||
47004109|NCT01269463|83252254|FG000|First Intervention|Physician Decision|0|||
47004110|NCT01269463|83252255|FG001|First Intervention|Physician Decision|1|||
47004111|NCT01706926|83252270|FG000|Overall Study|Lost to Follow-up|0|||
47004112|NCT01706926|83252271|FG001|Overall Study|Lost to Follow-up|0|||
46909758|NCT02899988|83138992|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
46909759|NCT02899988|83138993|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
47004113|NCT01706926|83252272|FG002|Overall Study|Lost to Follow-up|1|||
47004114|NCT01706926|83252273|FG003|Overall Study|Lost to Follow-up|0|||
47004115|NCT01706926|83252270|FG000|Overall Study|Withdrawal by Subject|2|||
47004116|NCT01706926|83252271|FG001|Overall Study|Withdrawal by Subject|0|||
47004117|NCT01706926|83252272|FG002|Overall Study|Withdrawal by Subject|1|||
47004118|NCT01706926|83252273|FG003|Overall Study|Withdrawal by Subject|2|||
47004119|NCT01706926|83252270|FG000|Overall Study|Other|4|||
47004120|NCT01706926|83252271|FG001|Overall Study|Other|4|||
47004121|NCT01706926|83252272|FG002|Overall Study|Other|4|||
47004122|NCT01706926|83252273|FG003|Overall Study|Other|3|||
46909760|NCT02899988|83138994|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
46909761|NCT02899988|83138995|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
46909762|NCT02899988|83138996|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
46909763|NCT02899988|83138997|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
46909764|NCT02899988|83138998|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
46909765|NCT02899988|83138999|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
46909766|NCT02899988|83139000|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
46909767|NCT02899988|83139001|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
46909768|NCT02899988|83138991|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
46909769|NCT02899988|83138992|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
47004123|NCT01634113|83252289|FG000|Overall Study|Not treated|0|||
47004124|NCT01634113|83252290|FG001|Overall Study|Not treated|0|||
47004125|NCT01634113|83252291|FG002|Overall Study|Not treated|1|||
47004126|NCT01706770|83252301|FG000|Overall Study|Lost to Follow-up|1|||
47004127|NCT01706770|83252302|FG001|Overall Study|Lost to Follow-up|0|||
47004128|NCT01706770|83252301|FG000|Overall Study|Physician Decision|1|||
47004129|NCT01706770|83252302|FG001|Overall Study|Physician Decision|0|||
47004130|NCT01937715|83252313|FG000|Overall Study|Death|0|||
47004131|NCT01937715|83252314|FG001|Overall Study|Death|0|||
46909770|NCT02899988|83138993|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
47004132|NCT01937715|83252315|FG002|Overall Study|Death|0|||
47004133|NCT01937715|83252316|FG003|Overall Study|Death|1|||
47004134|NCT01937715|83252317|FG004|Overall Study|Death|0|||
47004135|NCT01937715|83252313|FG000|Overall Study|Withdrawal by Subject|0|||
47004136|NCT01937715|83252314|FG001|Overall Study|Withdrawal by Subject|1|||
47004137|NCT01937715|83252315|FG002|Overall Study|Withdrawal by Subject|0|||
47004138|NCT01937715|83252316|FG003|Overall Study|Withdrawal by Subject|0|||
47004139|NCT01937715|83252317|FG004|Overall Study|Withdrawal by Subject|2|||
47004140|NCT01937715|83252313|FG000|Overall Study|Other|0|||
47004141|NCT01937715|83252314|FG001|Overall Study|Other|0|||
47004142|NCT01937715|83252315|FG002|Overall Study|Other|0|||
47004143|NCT01937715|83252316|FG003|Overall Study|Other|3|||
47004144|NCT01937715|83252317|FG004|Overall Study|Other|0|||
47004145|NCT01937559|83252332|FG000|Overall Study|Physician Decision|3|||
47004146|NCT01937559|83252333|FG001|Overall Study|Physician Decision|3|||
47004147|NCT01937559|83252334|FG002|Overall Study|Physician Decision|0|||
47004148|NCT01937559|83252332|FG000|Overall Study|Withdrawal by Subject|6|||
47004149|NCT01937559|83252333|FG001|Overall Study|Withdrawal by Subject|4|||
47004150|NCT01937559|83252334|FG002|Overall Study|Withdrawal by Subject|0|||
47004151|NCT01937559|83252332|FG000|Overall Study|screen fail|2|||
47004152|NCT01937559|83252333|FG001|Overall Study|screen fail|4|||
47004153|NCT01937559|83252334|FG002|Overall Study|screen fail|0|||
47004154|NCT01960257|83252346|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
47004155|NCT01960257|83252347|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
47004156|NCT01960257|83252348|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
47004157|NCT01960257|83252346|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
47004158|NCT01960257|83252347|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
47004159|NCT01960257|83252348|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
47004160|NCT01960257|83252346|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
47004161|NCT01960257|83252347|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
47004162|NCT01960257|83252348|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
47004163|NCT01918371|83252360|FG000|Overall Study|Missing Data|1|||
47004164|NCT01918371|83252361|FG001|Overall Study|Missing Data|1|||
47004165|NCT01917747|83252369|FG000|Overall Study|Withdrawal by Subject|1|||
47004166|NCT01917747|83252370|FG001|Overall Study|Withdrawal by Subject|2|||
47004167|NCT01917747|83252369|FG000|Overall Study|Lost to Follow-up|18|||
47004168|NCT01917747|83252370|FG001|Overall Study|Lost to Follow-up|9|||
47004169|NCT01597791|83252382|FG000|Overall Study|Physician Decision|2|||
47004170|NCT01597791|83252383|FG001|Overall Study|Physician Decision|1|||
47004171|NCT01597791|83252382|FG000|Overall Study|Cesarean Section|6|||
47004172|NCT01597791|83252383|FG001|Overall Study|Cesarean Section|7|||
47004173|NCT01597791|83252382|FG000|Overall Study|Subject withdrawal|0|||
47004174|NCT01597791|83252383|FG001|Overall Study|Subject withdrawal|1|||
47004175|NCT01597791|83252382|FG000|Overall Study|Protocol Violation|0|||
47004176|NCT01597791|83252383|FG001|Overall Study|Protocol Violation|1|||
47004177|NCT01916967|83252392|FG000|Overall Study|Adverse Event|0|||
47004178|NCT01916967|83252393|FG001|Overall Study|Adverse Event|0|||
47004179|NCT01916967|83252394|FG002|Overall Study|Adverse Event|2|||
47004180|NCT01916967|83252392|FG000|Overall Study|Lack of Efficacy|0|||
47004181|NCT01916967|83252393|FG001|Overall Study|Lack of Efficacy|0|||
47004182|NCT01916967|83252394|FG002|Overall Study|Lack of Efficacy|6|||
47004183|NCT01916967|83252392|FG000|Overall Study|Physician Decision|0|||
47004184|NCT01916967|83252393|FG001|Overall Study|Physician Decision|0|||
47004185|NCT01916967|83252394|FG002|Overall Study|Physician Decision|1|||
47004186|NCT01916967|83252392|FG000|Overall Study|Protocol Violation|0|||
47004187|NCT01916967|83252393|FG001|Overall Study|Protocol Violation|1|||
47004188|NCT01916967|83252394|FG002|Overall Study|Protocol Violation|0|||
47004189|NCT01936623|83252406|FG000|Overall Study|Lost to Follow-up|0|||
47004190|NCT01936623|83252407|FG001|Overall Study|Lost to Follow-up|5|||
47004191|NCT01959243|83252415|FG000|Overall Study|Investigator Decision|3|||
47004192|NCT01959243|83252416|FG001|Overall Study|Investigator Decision|0|||
47004193|NCT01959243|83252415|FG000|Overall Study|Adverse Event|5|||
47004194|NCT01959243|83252416|FG001|Overall Study|Adverse Event|2|||
47004195|NCT01959243|83252415|FG000|Overall Study|Administrative reasons|2|||
47004196|NCT01959243|83252416|FG001|Overall Study|Administrative reasons|1|||
47004197|NCT01959243|83252415|FG000|Overall Study|Lost to Follow-up|3|||
47004198|NCT01959243|83252416|FG001|Overall Study|Lost to Follow-up|1|||
47004199|NCT01959165|83252426|FG000|Overall Study|Adverse Event|0|||
47004200|NCT01959165|83252427|FG001|Overall Study|Adverse Event|0|||
47004201|NCT01959165|83252428|FG002|Overall Study|Adverse Event|0|||
47004202|NCT01959165|83252429|FG003|Overall Study|Adverse Event|1|||
47004203|NCT01959165|83252426|FG000|Overall Study|Lack of Efficacy|1|||
47004204|NCT01959165|83252427|FG001|Overall Study|Lack of Efficacy|0|||
47004205|NCT01959165|83252428|FG002|Overall Study|Lack of Efficacy|0|||
47004206|NCT01959165|83252429|FG003|Overall Study|Lack of Efficacy|0|||
47004207|NCT01959165|83252426|FG000|Overall Study|overdose|0|||
47004208|NCT01959165|83252427|FG001|Overall Study|overdose|0|||
47004209|NCT01959165|83252428|FG002|Overall Study|overdose|0|||
47004210|NCT01959165|83252429|FG003|Overall Study|overdose|1|||
47004211|NCT01959165|83252426|FG000|Overall Study|Welfare recipient|0|||
47004212|NCT01959165|83252427|FG001|Overall Study|Welfare recipient|1|||
47004213|NCT01959165|83252428|FG002|Overall Study|Welfare recipient|0|||
47004214|NCT01959165|83252429|FG003|Overall Study|Welfare recipient|0|||
47004215|NCT01916109|83252439|FG000|Overall Study|Withdrawal by Subject|1|||
47004216|NCT01915095|83252450|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
47004217|NCT01915095|83252451|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
47004218|NCT01915095|83252452|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
47004219|NCT01915095|83252453|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
47004220|NCT01915095|83252454|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
47004221|NCT01958619|83252479|FG000|Overall Study|Protocol Violation|2|||
47004222|NCT01958619|83252480|FG001|Overall Study|Protocol Violation|0|||
47004223|NCT01958619|83252481|FG002|Overall Study|Protocol Violation|1|||
47004224|NCT01958619|83252482|FG003|Overall Study|Protocol Violation|0|||
47004225|NCT01752634|83252498|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
47004226|NCT01752634|83252499|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
47004227|NCT01752634|83252500|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
47004228|NCT01752634|83252501|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
47004229|NCT01752634|83252502|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
47004230|NCT01752634|83252503|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
47004231|NCT01752634|83252498|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
47004232|NCT01752634|83252499|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
47004233|NCT01752634|83252500|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
47004234|NCT01752634|83252501|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
47004235|NCT01752634|83252502|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
47004236|NCT01752634|83252503|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
47004237|NCT01752634|83252498|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
47004238|NCT01752634|83252499|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
47004239|NCT01752634|83252500|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
47004240|NCT01752634|83252501|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
47004241|NCT01752634|83252502|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
47004242|NCT01752634|83252503|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
47004243|NCT01752634|83252498|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
47004244|NCT01752634|83252499|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
47004245|NCT01752634|83252500|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
47004246|NCT01752634|83252501|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
47004247|NCT01752634|83252502|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
47004248|NCT01752634|83252503|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
47004249|NCT01752634|83252498|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
47004250|NCT01752634|83252499|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
47004251|NCT01752634|83252500|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
47004252|NCT01752634|83252501|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
47004253|NCT01752634|83252502|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
47004254|NCT01752634|83252503|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
47004255|NCT01752634|83252498|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
47004256|NCT01752634|83252499|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
47004257|NCT01752634|83252500|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
47004258|NCT01752634|83252501|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
47004259|NCT01752634|83252502|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
47004260|NCT01752634|83252503|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
47004261|NCT01752634|83252498|FG000|Week 24 to Week 260|Physician Decision|1|||
47004262|NCT01752634|83252499|FG001|Week 24 to Week 260|Physician Decision|2|||
47004263|NCT01752634|83252500|FG002|Week 24 to Week 260|Physician Decision|4|||
47004264|NCT01752634|83252501|FG003|Week 24 to Week 260|Physician Decision|2|||
47004265|NCT01752634|83252502|FG004|Week 24 to Week 260|Physician Decision|1|||
47004266|NCT01752634|83252503|FG005|Week 24 to Week 260|Physician Decision|0|||
47004267|NCT01752634|83252498|FG000|Week 24 to Week 260|Death|0|||
47004268|NCT01752634|83252499|FG001|Week 24 to Week 260|Death|1|||
47004269|NCT01752634|83252500|FG002|Week 24 to Week 260|Death|0|||
47004270|NCT01752634|83252501|FG003|Week 24 to Week 260|Death|0|||
47004271|NCT01752634|83252502|FG004|Week 24 to Week 260|Death|0|||
47004272|NCT01752634|83252503|FG005|Week 24 to Week 260|Death|0|||
47004273|NCT01752634|83252498|FG000|Week 24 to Week 260|Pregnancy|0|||
47004274|NCT01752634|83252499|FG001|Week 24 to Week 260|Pregnancy|0|||
47004275|NCT01752634|83252500|FG002|Week 24 to Week 260|Pregnancy|1|||
47004276|NCT01752634|83252501|FG003|Week 24 to Week 260|Pregnancy|0|||
47004277|NCT01752634|83252502|FG004|Week 24 to Week 260|Pregnancy|0|||
47004278|NCT01752634|83252503|FG005|Week 24 to Week 260|Pregnancy|0|||
47004279|NCT01752634|83252498|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
47004280|NCT01752634|83252499|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
47004281|NCT01752634|83252500|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
47004282|NCT01752634|83252501|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
46909771|NCT02899988|83138994|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
46909772|NCT02899988|83138995|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
46909773|NCT02899988|83138996|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
46909774|NCT02899988|83138997|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
46909775|NCT02899988|83138998|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
46909776|NCT02899988|83138999|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
46909777|NCT02899988|83139000|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
46909778|NCT02899988|83139001|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
46909779|NCT02899988|83138991|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
46909780|NCT02899988|83138992|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
47004283|NCT01752634|83252502|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
47004284|NCT01752634|83252503|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
47004285|NCT01752634|83252498|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
47004286|NCT01752634|83252499|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
47004287|NCT01752634|83252500|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
47004288|NCT01752634|83252501|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
47004289|NCT01752634|83252502|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
47004290|NCT01752634|83252503|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
47004291|NCT01752634|83252498|FG000|Week 24 to Week 260|Adverse Event|4|||
47004292|NCT01752634|83252499|FG001|Week 24 to Week 260|Adverse Event|8|||
47004293|NCT01752634|83252500|FG002|Week 24 to Week 260|Adverse Event|8|||
47004294|NCT01752634|83252501|FG003|Week 24 to Week 260|Adverse Event|4|||
47004295|NCT01752634|83252502|FG004|Week 24 to Week 260|Adverse Event|2|||
47004296|NCT01752634|83252503|FG005|Week 24 to Week 260|Adverse Event|0|||
47004297|NCT01726270|83252513|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
47004298|NCT01726270|83252513|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
47004299|NCT01726270|83252513|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
47004300|NCT01726270|83252513|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
47004301|NCT01726270|83252513|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
47004302|NCT01726270|83252513|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
47004303|NCT01914393|83252522|FG000|Overall Study|Protocol Violation|11|||
47004304|NCT01914393|83252523|FG001|Overall Study|Protocol Violation|3|||
47004305|NCT01914393|83252524|FG002|Overall Study|Protocol Violation|19|||
47004306|NCT01914393|83252522|FG000|Overall Study|Lack of Efficacy|11|||
47004307|NCT01914393|83252523|FG001|Overall Study|Lack of Efficacy|16|||
47004308|NCT01914393|83252524|FG002|Overall Study|Lack of Efficacy|5|||
47004309|NCT01914393|83252522|FG000|Overall Study|no reason given|14|||
47004310|NCT01914393|83252523|FG001|Overall Study|no reason given|8|||
47004311|NCT01914393|83252524|FG002|Overall Study|no reason given|16|||
47004312|NCT01914393|83252522|FG000|Overall Study|Adverse Event|29|||
47004313|NCT01914393|83252523|FG001|Overall Study|Adverse Event|18|||
47004314|NCT01914393|83252524|FG002|Overall Study|Adverse Event|31|||
47004315|NCT01914393|83252522|FG000|Overall Study|Withdrawal by Subject|38|||
47004316|NCT01914393|83252523|FG001|Overall Study|Withdrawal by Subject|20|||
47004317|NCT01914393|83252524|FG002|Overall Study|Withdrawal by Subject|47|||
47004318|NCT01914393|83252522|FG000|Overall Study|Lost to Follow-up|12|||
47004319|NCT01914393|83252523|FG001|Overall Study|Lost to Follow-up|6|||
47004320|NCT01914393|83252524|FG002|Overall Study|Lost to Follow-up|19|||
47004321|NCT01914393|83252522|FG000|Overall Study|subject never dosed|0|||
47004322|NCT01914393|83252523|FG001|Overall Study|subject never dosed|0|||
47004323|NCT01914393|83252524|FG002|Overall Study|subject never dosed|1|||
47004324|NCT01931865|83252536|FG000|Overall Study|Lost to Follow-up|2|||
47004325|NCT01931865|83252536|FG000|Overall Study|Withdrawal by Subject|2|||
47004326|NCT01617447|83252543|FG000|Overall Study|Adverse Event|0|||
47004327|NCT01617447|83252544|FG001|Overall Study|Adverse Event|1|||
47004328|NCT01617447|83252543|FG000|Overall Study|Physician Decision|0|||
47004329|NCT01617447|83252544|FG001|Overall Study|Physician Decision|2|||
47004330|NCT00432679|83252552|FG000|Overall Study|Adverse Event|2|||
47004331|NCT00432679|83252553|FG001|Overall Study|Adverse Event|1|||
47004332|NCT00432679|83252552|FG000|Overall Study|Withdrawal by Subject|3|||
47004333|NCT00432679|83252553|FG001|Overall Study|Withdrawal by Subject|2|||
47004334|NCT01600105|83252561|FG000|Total Participants|Withdrawal by Subject|1|||
47004335|NCT01600105|83252562|FG001|Total Participants|Withdrawal by Subject|0|||
47004336|NCT01600105|83252561|FG000|Total Participants|No images in PACS|10|||
47004337|NCT01600105|83252562|FG001|Total Participants|No images in PACS|0|||
47004338|NCT01600105|83252561|FG000|Total Participants|Insufficient image quality|30|||
47004339|NCT01600105|83252562|FG001|Total Participants|Insufficient image quality|10|||
47004340|NCT01600105|83252561|FG000|Sub Study I|Insufficient image quality|0|||
47004341|NCT01600105|83252562|FG001|Sub Study I|Insufficient image quality|10|||
46909781|NCT02899988|83138993|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
46909782|NCT02899988|83138994|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
47004342|NCT01600105|83252561|FG000|Sub Study II|Withdrawal by Subject|1|||
47004343|NCT01600105|83252562|FG001|Sub Study II|Withdrawal by Subject|0|||
47004344|NCT01600105|83252561|FG000|Sub Study II|No images in PACS|1|||
47004345|NCT01600105|83252562|FG001|Sub Study II|No images in PACS|0|||
47004346|NCT01600105|83252561|FG000|Sub Study II|Insufficient image quality|3|||
47004347|NCT01600105|83252562|FG001|Sub Study II|Insufficient image quality|0|||
47004348|NCT01600105|83252561|FG000|Sub Study III|Insufficient image quality|5|||
47004349|NCT01600105|83252562|FG001|Sub Study III|Insufficient image quality|0|||
47004350|NCT01600105|83252561|FG000|Sub Study V|Poor Image Quality|2|||
47004351|NCT01600105|83252562|FG001|Sub Study V|Poor Image Quality|0|||
47004352|NCT02246647|83252574|FG000|Overall Study|Withdrawal by Subject|1|||
47004353|NCT02246647|83252575|FG001|Overall Study|Withdrawal by Subject|1|||
47004354|NCT01933113|83252595|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
47004355|NCT02244619|83252601|FG000|Overall Study|Did not receive study intervention|8|||
47004356|NCT02244619|83252602|FG001|Overall Study|Did not receive study intervention|21|||
47004357|NCT02243371|83252610|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
47004358|NCT02243371|83252611|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
47004359|NCT02243371|83252610|FG000|Overall Study|Death (unrelated)|2|||
47004360|NCT02243371|83252611|FG001|Overall Study|Death (unrelated)|4|||
47004361|NCT02243371|83252610|FG000|Overall Study|Adverse Event (unrelated)|0|||
47004362|NCT02243371|83252611|FG001|Overall Study|Adverse Event (unrelated)|1|||
47004363|NCT02243371|83252610|FG000|Overall Study|Lack of Clinical Benefit|0|||
47004364|NCT02243371|83252611|FG001|Overall Study|Lack of Clinical Benefit|1|||
47004365|NCT02243371|83252610|FG000|Overall Study|Withdrawal by Subject|0|||
47004366|NCT02243371|83252611|FG001|Overall Study|Withdrawal by Subject|2|||
47004367|NCT01931475|83252619|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
47004368|NCT01931475|83252620|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
47004369|NCT01931475|83252619|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
47004370|NCT01931475|83252620|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
47004371|NCT01931475|83252619|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
47004372|NCT01931475|83252620|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
47004373|NCT01931475|83252619|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
47004374|NCT01931475|83252620|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
47004375|NCT01931475|83252619|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
47004376|NCT01931475|83252620|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
47004377|NCT01931475|83252619|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
47004378|NCT01931475|83252620|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
47004379|NCT01931475|83252619|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
47004380|NCT01931475|83252620|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
47004381|NCT01931475|83252619|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
47004382|NCT01931475|83252620|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
47004383|NCT01931475|83252619|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
46709434|NCT01222520|82925471|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
46709435|NCT01222520|82925470|FG000|Double-blind Period|Adverse Event|0|||
47004384|NCT01931475|83252620|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
47004385|NCT01931475|83252619|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
47004386|NCT01931475|83252620|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
47004387|NCT01931475|83252619|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
47004388|NCT01931475|83252620|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
47004389|NCT01931397|83252631|FG000|Overall Study|Physician Decision|2|||
47004390|NCT01931397|83252631|FG000|Overall Study|Withdrawal by Subject|8|||
47004391|NCT01931397|83252631|FG000|Overall Study|moved out of state|1|||
47004392|NCT01929993|83252641|FG000|Overall Study|Protocol Violation|4|||
47004393|NCT01929993|83252642|FG001|Overall Study|Protocol Violation|6|||
47004394|NCT01929993|83252641|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
47004395|NCT01929993|83252642|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
47004396|NCT01912599|83252650|FG000|Overall Study|Withdrawal by Subject|0|||
47004397|NCT01912599|83252651|FG001|Overall Study|Withdrawal by Subject|1|||
47004398|NCT01929681|83252659|FG000|Overall Study|Withdrawal by Subject|1|||
47004399|NCT01929681|83252660|FG001|Overall Study|Withdrawal by Subject|0|||
47004400|NCT01929681|83252659|FG000|Overall Study|Physician Decision|1|||
47004401|NCT01929681|83252660|FG001|Overall Study|Physician Decision|1|||
47004402|NCT01646177|83252670|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
47004403|NCT01646177|83252671|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
47004404|NCT01646177|83252672|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
47004405|NCT01646177|83252673|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
46620472|NCT03682055|82769616|FG000|Overall Study|Termination of Study by Sponsor|0|||
46709436|NCT01222520|82925471|FG001|Double-blind Period|Adverse Event|1|||
47004406|NCT01646177|83252674|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004407|NCT01646177|83252675|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004408|NCT01646177|83252676|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004409|NCT01646177|83252677|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004410|NCT01646177|83252678|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004411|NCT01646177|83252679|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004412|NCT01646177|83252680|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004413|NCT01646177|83252681|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
47004414|NCT01646177|83252670|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
47004415|NCT01646177|83252671|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
47004416|NCT01646177|83252672|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
47004417|NCT01646177|83252673|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
47004418|NCT01646177|83252674|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004419|NCT01646177|83252675|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004420|NCT01646177|83252676|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004421|NCT01646177|83252677|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004422|NCT01646177|83252678|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004423|NCT01646177|83252679|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004424|NCT01646177|83252680|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004425|NCT01646177|83252681|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
47004426|NCT01646177|83252670|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
47004427|NCT01646177|83252671|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
47004428|NCT01646177|83252672|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
47004429|NCT01646177|83252673|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
47004430|NCT01646177|83252674|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004431|NCT01646177|83252675|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004432|NCT01646177|83252676|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004433|NCT01646177|83252677|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004434|NCT01646177|83252678|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004435|NCT01646177|83252679|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004436|NCT01646177|83252680|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004437|NCT01646177|83252681|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
47004438|NCT01646177|83252670|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
47004439|NCT01646177|83252671|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
47004440|NCT01646177|83252672|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
47004441|NCT01646177|83252673|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
47004442|NCT01646177|83252674|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004443|NCT01646177|83252675|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004444|NCT01646177|83252676|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004445|NCT01646177|83252677|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004446|NCT01646177|83252678|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004447|NCT01646177|83252679|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004448|NCT01646177|83252680|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004449|NCT01646177|83252681|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
47004450|NCT01646177|83252670|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004451|NCT01646177|83252671|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004452|NCT01646177|83252672|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
47004453|NCT01646177|83252673|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
47004454|NCT01646177|83252674|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004455|NCT01646177|83252675|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004456|NCT01646177|83252676|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004457|NCT01646177|83252677|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004458|NCT01646177|83252678|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004459|NCT01646177|83252679|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004460|NCT01646177|83252680|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004461|NCT01646177|83252681|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
47004462|NCT01646177|83252670|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
47004463|NCT01646177|83252671|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
47004464|NCT01646177|83252672|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
47004465|NCT01646177|83252673|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004466|NCT01646177|83252674|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004467|NCT01646177|83252675|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004468|NCT01646177|83252676|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004469|NCT01646177|83252677|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004470|NCT01646177|83252678|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004471|NCT01646177|83252679|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004472|NCT01646177|83252680|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004473|NCT01646177|83252681|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
47004474|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004475|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004476|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004477|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004478|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
47004479|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
47004480|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
47004481|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
47004482|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004483|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004484|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004485|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
47004486|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004487|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004488|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004489|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004490|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
47004491|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
47004492|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
47004493|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
47004494|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004495|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004496|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004497|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
47004498|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004499|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004500|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004501|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004502|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
47004503|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
47004504|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
47004505|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
47004506|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004507|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004508|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004509|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
47004510|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004511|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004512|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004513|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004514|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
47004515|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
47004516|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
47004517|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
47004518|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004519|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004520|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004521|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
47004522|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004523|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004524|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004525|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004526|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
47004527|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
47004528|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
47004529|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
47004530|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004531|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004532|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004533|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
47004534|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004535|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004536|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004537|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004538|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
47004539|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
46709437|NCT01222520|82925470|FG000|Double-blind Period|Lack of Efficacy|0|||
46709438|NCT01222520|82925471|FG001|Double-blind Period|Lack of Efficacy|1|||
47004540|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004541|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
47004542|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004543|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004544|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004545|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
47004546|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
47004547|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
46709439|NCT01222520|82925470|FG000|Double-blind Period|Study medication stolen|1|||
46709440|NCT01222520|82925471|FG001|Double-blind Period|Study medication stolen|0|||
47004548|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
47004549|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
47004550|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
47004551|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
47004552|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
47004553|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
47004554|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
47004555|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
47004556|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
47004557|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
47004558|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
47004559|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
47004560|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
47004561|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
47004562|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
47004563|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
47004564|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
47004565|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
47004566|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
47004567|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
47004568|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
47004569|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
46709441|NCT01221350|82925479|FG000|Overall Study|Discontinued intervention (GERD)|1|||
46909783|NCT02899988|83138995|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
46909784|NCT02899988|83138996|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
46909785|NCT02899988|83138997|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
46909786|NCT02899988|83138998|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
46909787|NCT02899988|83138999|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
46909788|NCT02899988|83139000|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
46909789|NCT02899988|83139001|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
46909790|NCT02899988|83138991|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909791|NCT02899988|83138992|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909792|NCT02899988|83138993|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909793|NCT02899988|83138994|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
47004570|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004571|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004572|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004573|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004574|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
47004575|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
47004576|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
47004577|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
47004578|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004579|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004580|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004581|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
47004582|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004583|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004584|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004585|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004586|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004587|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004588|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004589|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
47004590|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004591|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004592|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004593|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
47004594|NCT01646177|83252670|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004595|NCT01646177|83252671|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004596|NCT01646177|83252672|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004597|NCT01646177|83252673|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004598|NCT01646177|83252674|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004599|NCT01646177|83252675|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
47004600|NCT01646177|83252676|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
47004601|NCT01646177|83252677|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
47004602|NCT01646177|83252678|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004603|NCT01646177|83252679|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004604|NCT01646177|83252680|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004605|NCT01646177|83252681|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
47004606|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
46620473|NCT03682055|82769617|FG001|Overall Study|Termination of Study by Sponsor|0|||
46909794|NCT02899988|83138995|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909795|NCT02899988|83138996|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
46909796|NCT02899988|83138997|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909797|NCT02899988|83138998|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
46909798|NCT02899988|83138999|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909799|NCT02899988|83139000|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909800|NCT02899988|83139001|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
46909801|NCT02899988|83138991|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
46909802|NCT02899988|83138992|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
46909803|NCT02899988|83138993|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
46909804|NCT02899988|83138994|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
46909805|NCT02899988|83138995|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
46909806|NCT02899988|83138996|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
46909807|NCT02899988|83138997|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
46909808|NCT02899988|83138998|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
46909809|NCT02899988|83138999|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
46909810|NCT02899988|83139000|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
46909811|NCT02899988|83139001|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
46909812|NCT02939131|83139035|FG000|Overall Study|Unable to get to clinic|6|||
46909813|NCT02939131|83139036|FG001|Overall Study|Unable to get to clinic|4|||
46909814|NCT02939131|83139035|FG000|Overall Study|Lost to Follow-up|2|||
46909815|NCT02939131|83139036|FG001|Overall Study|Lost to Follow-up|4|||
46909816|NCT02939131|83139035|FG000|Overall Study|severe debilitation|1|||
46909817|NCT02939131|83139036|FG001|Overall Study|severe debilitation|0|||
46909818|NCT02939131|83139035|FG000|Overall Study|Other|0|||
46909819|NCT02939131|83139036|FG001|Overall Study|Other|1|||
46909820|NCT02939131|83139035|FG000|Overall Study|not willing to adhere to protocol|2|||
47004607|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
47004608|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
47004609|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
47004610|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
47004611|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
47004612|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
47004613|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
47004614|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
47004615|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
47004616|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
47004617|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
47004618|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004619|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004620|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004621|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004622|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004623|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004624|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004625|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
47004626|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
47004627|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
47004628|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
47004629|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
47004630|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
47004631|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
46909821|NCT02939131|83139036|FG001|Overall Study|not willing to adhere to protocol|0|||
46909822|NCT03345407|83139050|FG000|Overall Study|Withdrawal by Subject|11|||
46909823|NCT03345407|83139051|FG001|Overall Study|Withdrawal by Subject|1|||
46909824|NCT03345407|83139052|FG002|Overall Study|Withdrawal by Subject|5|||
46909825|NCT03345407|83139053|FG003|Overall Study|Withdrawal by Subject|6|||
46909826|NCT03345407|83139054|FG004|Overall Study|Withdrawal by Subject|3|||
46909827|NCT03345407|83139055|FG005|Overall Study|Withdrawal by Subject|6|||
46909828|NCT03345407|83139056|FG006|Overall Study|Withdrawal by Subject|16|||
46909829|NCT03345407|83139050|FG000|Overall Study|Physician Decision|3|||
46909830|NCT03345407|83139051|FG001|Overall Study|Physician Decision|1|||
46909831|NCT03345407|83139052|FG002|Overall Study|Physician Decision|0|||
46909832|NCT03345407|83139053|FG003|Overall Study|Physician Decision|0|||
46909833|NCT03345407|83139054|FG004|Overall Study|Physician Decision|1|||
46909834|NCT03345407|83139055|FG005|Overall Study|Physician Decision|2|||
46909835|NCT03345407|83139056|FG006|Overall Study|Physician Decision|3|||
46909836|NCT03345407|83139050|FG000|Overall Study|Lost to Follow-up|2|||
46909837|NCT03345407|83139051|FG001|Overall Study|Lost to Follow-up|0|||
46909838|NCT03345407|83139052|FG002|Overall Study|Lost to Follow-up|1|||
46909839|NCT03345407|83139053|FG003|Overall Study|Lost to Follow-up|0|||
46909840|NCT03345407|83139054|FG004|Overall Study|Lost to Follow-up|1|||
46909841|NCT03345407|83139055|FG005|Overall Study|Lost to Follow-up|2|||
46909842|NCT03345407|83139056|FG006|Overall Study|Lost to Follow-up|3|||
46909843|NCT03345407|83139050|FG000|Overall Study|Protocol-defined stopping criteria|9|||
46909844|NCT03345407|83139051|FG001|Overall Study|Protocol-defined stopping criteria|0|||
46909845|NCT03345407|83139052|FG002|Overall Study|Protocol-defined stopping criteria|0|||
46909846|NCT03345407|83139053|FG003|Overall Study|Protocol-defined stopping criteria|0|||
46909847|NCT03345407|83139054|FG004|Overall Study|Protocol-defined stopping criteria|2|||
46909848|NCT03345407|83139055|FG005|Overall Study|Protocol-defined stopping criteria|1|||
46909849|NCT03345407|83139056|FG006|Overall Study|Protocol-defined stopping criteria|1|||
46909850|NCT03345407|83139050|FG000|Overall Study|Protocol Violation|2|||
46909851|NCT03345407|83139051|FG001|Overall Study|Protocol Violation|0|||
46909852|NCT03345407|83139052|FG002|Overall Study|Protocol Violation|0|||
46909853|NCT03345407|83139053|FG003|Overall Study|Protocol Violation|0|||
46909854|NCT03345407|83139054|FG004|Overall Study|Protocol Violation|1|||
46909855|NCT03345407|83139055|FG005|Overall Study|Protocol Violation|0|||
47004632|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
47004633|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
47004634|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
47004635|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
47004636|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
47004637|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
47004638|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
47004639|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
47004640|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
47004641|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
47004642|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
46709442|NCT01221350|82925480|FG001|Overall Study|Discontinued intervention (GERD)|0|||
47004643|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
47004644|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
47004645|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
47004646|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
47004647|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
47004648|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
47004649|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
47004650|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
47004651|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
47004652|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
47004653|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
47004654|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004655|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004656|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004657|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004658|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004659|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004660|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004661|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
47004662|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
47004663|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
47004664|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
47004665|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
47004666|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004667|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004668|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004669|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004670|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004671|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004672|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004673|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
47004674|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
47004675|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
47004676|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
47004677|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
47004678|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004679|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004680|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004681|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004682|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004683|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004684|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004685|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
47004686|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
46709443|NCT01221350|82925479|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
46709444|NCT01221350|82925480|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
47004687|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
47004688|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
47004689|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
47004690|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
46709445|NCT01221350|82925479|FG000|Overall Study|Withdrawal by Subject|4|||
47004691|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004692|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004693|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004694|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004695|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004696|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004697|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004698|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
47004699|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
47004700|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
47004701|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
47004702|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004703|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004704|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004705|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004706|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004707|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004708|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004709|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004710|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
47004711|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
47004712|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
47004713|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
47004714|NCT01646177|83252670|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004715|NCT01646177|83252671|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004716|NCT01646177|83252672|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004717|NCT01646177|83252673|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004718|NCT01646177|83252674|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004719|NCT01646177|83252675|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004720|NCT01646177|83252676|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004721|NCT01646177|83252677|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004722|NCT01646177|83252678|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004723|NCT01646177|83252679|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
47004724|NCT01646177|83252680|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
47004725|NCT01646177|83252681|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
47004726|NCT01912287|83252704|FG000|Overall Study|Ineligible|1|||
47004727|NCT01912287|83252705|FG001|Overall Study|Ineligible|0|||
47004728|NCT01912287|83252706|FG002|Overall Study|Ineligible|1|||
47004729|NCT01912287|83252704|FG000|Overall Study|No-show|0|||
47004730|NCT01912287|83252705|FG001|Overall Study|No-show|0|||
47004731|NCT01912287|83252706|FG002|Overall Study|No-show|1|||
47004732|NCT01912287|83252704|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
47004733|NCT01912287|83252705|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
47004734|NCT01912287|83252706|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
47004735|NCT01912287|83252704|FG000|Overall Study|Felt treatment no longer needed|0|||
47004736|NCT01912287|83252705|FG001|Overall Study|Felt treatment no longer needed|1|||
47004737|NCT01912287|83252706|FG002|Overall Study|Felt treatment no longer needed|0|||
47004738|NCT01912287|83252704|FG000|Overall Study|Life circumstances|4|||
47004739|NCT01912287|83252705|FG001|Overall Study|Life circumstances|2|||
47004740|NCT01912287|83252706|FG002|Overall Study|Life circumstances|0|||
47004741|NCT01912287|83252704|FG000|Overall Study|Lost Interest|1|||
47004742|NCT01912287|83252705|FG001|Overall Study|Lost Interest|0|||
47004743|NCT01912287|83252706|FG002|Overall Study|Lost Interest|0|||
47004744|NCT01912287|83252704|FG000|Overall Study|Uknown reason - subject drop out|5|||
47004745|NCT01912287|83252705|FG001|Overall Study|Uknown reason - subject drop out|7|||
47004746|NCT01912287|83252706|FG002|Overall Study|Uknown reason - subject drop out|3|||
47004747|NCT01912287|83252704|FG000|Overall Study|Missed Assesment|1|||
47004748|NCT01912287|83252705|FG001|Overall Study|Missed Assesment|1|||
47004749|NCT01912287|83252706|FG002|Overall Study|Missed Assesment|1|||
47004750|NCT01912287|83252704|FG000|Overall Study|Scheduling/change in availability|17|||
47004751|NCT01912287|83252705|FG001|Overall Study|Scheduling/change in availability|10|||
47004752|NCT01912287|83252706|FG002|Overall Study|Scheduling/change in availability|8|||
46709446|NCT01221350|82925480|FG001|Overall Study|Withdrawal by Subject|2|||
47004753|NCT01929135|83252716|FG000|Overall Study|Lost to Follow-up|1|||
47004754|NCT01929135|83252717|FG001|Overall Study|Lost to Follow-up|1|||
47004755|NCT01911819|83252728|FG000|Overall Study|Adverse Event|0|||
47004756|NCT01911819|83252729|FG001|Overall Study|Adverse Event|1|||
46709447|NCT01221272|82925488|FG000|Period 1|Adverse Event|2|||
47004757|NCT01911819|83252730|FG002|Overall Study|Adverse Event|0|||
47004758|NCT01911819|83252728|FG000|Overall Study|Withdrawal by Subject|1|||
47004759|NCT01911819|83252729|FG001|Overall Study|Withdrawal by Subject|1|||
47004760|NCT01911819|83252730|FG002|Overall Study|Withdrawal by Subject|0|||
47004761|NCT02280863|83252740|FG000|Integrated Platform|Met stopping criteria|0|||
47004762|NCT02280863|83252741|FG001|Integrated Platform|Met stopping criteria|1|||
47004763|NCT01911429|83252754|FG000|Overall Study|Adverse Event|5|||
47004764|NCT01911429|83252755|FG001|Overall Study|Adverse Event|3|||
47004765|NCT01911429|83252756|FG002|Overall Study|Adverse Event|9|||
47004766|NCT01911429|83252754|FG000|Overall Study|Lack of Efficacy|1|||
47004767|NCT01911429|83252755|FG001|Overall Study|Lack of Efficacy|2|||
47004768|NCT01911429|83252756|FG002|Overall Study|Lack of Efficacy|4|||
47004769|NCT01911429|83252754|FG000|Overall Study|Lost to Follow-up|0|||
47004770|NCT01911429|83252755|FG001|Overall Study|Lost to Follow-up|0|||
47004771|NCT01911429|83252756|FG002|Overall Study|Lost to Follow-up|1|||
47004772|NCT01911429|83252754|FG000|Overall Study|Protocol Violation|0|||
47004773|NCT01911429|83252755|FG001|Overall Study|Protocol Violation|0|||
47004774|NCT01911429|83252756|FG002|Overall Study|Protocol Violation|1|||
47004775|NCT01911429|83252754|FG000|Overall Study|Withdrawal by Subject|5|||
47004776|NCT01911429|83252755|FG001|Overall Study|Withdrawal by Subject|5|||
47004777|NCT01911429|83252756|FG002|Overall Study|Withdrawal by Subject|4|||
47004778|NCT01911429|83252754|FG000|Overall Study|Accidental randomization|0|||
47004779|NCT01911429|83252755|FG001|Overall Study|Accidental randomization|0|||
47004780|NCT01911429|83252756|FG002|Overall Study|Accidental randomization|1|||
47004781|NCT01911429|83252754|FG000|Overall Study|subject left study|1|||
47004782|NCT01911429|83252755|FG001|Overall Study|subject left study|0|||
47004783|NCT01911429|83252756|FG002|Overall Study|subject left study|0|||
47004784|NCT02324465|83252766|FG000|Overall Study|device failure|0|||
47004785|NCT02324465|83252767|FG001|Overall Study|device failure|1|||
47004786|NCT02324153|83252775|FG000|Overall Study|Withdrawal by Subject|4|||
47004787|NCT02324153|83252776|FG001|Overall Study|Withdrawal by Subject|1|||
47004788|NCT02324153|83252775|FG000|Overall Study|Surgery postponed after randomization|3|||
47004789|NCT02324153|83252776|FG001|Overall Study|Surgery postponed after randomization|0|||
47004790|NCT02324153|83252775|FG000|Overall Study|Developed delirium preoperatively|1|||
47004791|NCT02324153|83252776|FG001|Overall Study|Developed delirium preoperatively|0|||
47004792|NCT02280473|83252784|FG000|Overall Study|Adverse Event|1|||
47004793|NCT02280473|83252785|FG001|Overall Study|Adverse Event|1|||
47004794|NCT02280473|83252784|FG000|Overall Study|Lack of Efficacy|0|||
47004795|NCT02280473|83252785|FG001|Overall Study|Lack of Efficacy|1|||
47004796|NCT02280473|83252784|FG000|Overall Study|Lost to Follow-up|0|||
47004797|NCT02280473|83252785|FG001|Overall Study|Lost to Follow-up|1|||
47004798|NCT01911273|83252793|FG000|Overall Study|Progression of Disease|1|||
47004799|NCT01911273|83252794|FG001|Overall Study|Progression of Disease|0|||
47004800|NCT01911273|83252793|FG000|Overall Study|Withdrawal by Subject|0|||
47004801|NCT01911273|83252794|FG001|Overall Study|Withdrawal by Subject|2|||
47004802|NCT02308007|83252803|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
47004803|NCT02308007|83252804|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
47004804|NCT02308007|83252805|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
47004805|NCT02308007|83252803|FG000|Overall Study|Positive for STD at Baseline|7|||
47004806|NCT02308007|83252804|FG001|Overall Study|Positive for STD at Baseline|11|||
47004807|NCT02308007|83252805|FG002|Overall Study|Positive for STD at Baseline|7|||
47004808|NCT02308007|83252803|FG000|Overall Study|Lost to Follow-up|3|||
47004809|NCT02308007|83252804|FG001|Overall Study|Lost to Follow-up|0|||
47004810|NCT02308007|83252805|FG002|Overall Study|Lost to Follow-up|1|||
47004811|NCT02278367|83252815|FG000|Overall Study|Physician Decision|5|||
47004812|NCT02278367|83252816|FG001|Overall Study|Physician Decision|0|||
47004813|NCT02278367|83252815|FG000|Overall Study|Withdrawal by Subject|5|||
47004814|NCT02278367|83252816|FG001|Overall Study|Withdrawal by Subject|0|||
47004815|NCT01910181|83252822|FG000|Overall Study|Death|37|||
47004816|NCT01910181|83252822|FG000|Overall Study|Lost to Follow-up|3|||
47004817|NCT01910181|83252822|FG000|Overall Study|Study Terminated by Sponsor|6|||
47004818|NCT01957215|83252829|FG000|Overall Study|Adverse Event|2|||
47004819|NCT01957215|83252830|FG001|Overall Study|Adverse Event|2|||
47004820|NCT01957215|83252829|FG000|Overall Study|Lost to Follow-up|3|||
47004821|NCT01957215|83252830|FG001|Overall Study|Lost to Follow-up|3|||
47004822|NCT01957215|83252829|FG000|Overall Study|Protocol Violation|1|||
46709448|NCT01221272|82925489|FG001|Period 1|Adverse Event|0|||
47004823|NCT01957215|83252830|FG001|Overall Study|Protocol Violation|2|||
47004824|NCT01957215|83252829|FG000|Overall Study|Withdrawal by Subject|7|||
47004825|NCT01957215|83252830|FG001|Overall Study|Withdrawal by Subject|5|||
47004826|NCT02322749|83252840|FG000|Period 2|Adverse Event|0|||
47004827|NCT02322749|83252841|FG001|Period 2|Adverse Event|0|||
47004828|NCT02322749|83252842|FG002|Period 2|Adverse Event|0|||
47004829|NCT02322749|83252843|FG003|Period 2|Adverse Event|1|||
47004830|NCT02322749|83252844|FG004|Period 2|Adverse Event|0|||
47004831|NCT02322749|83252845|FG005|Period 2|Adverse Event|0|||
47004832|NCT02322749|83252840|FG000|Period 2|Withdrawal by Subject|0|||
47004833|NCT02322749|83252841|FG001|Period 2|Withdrawal by Subject|0|||
47004834|NCT02322749|83252842|FG002|Period 2|Withdrawal by Subject|0|||
47004835|NCT02322749|83252843|FG003|Period 2|Withdrawal by Subject|1|||
47004836|NCT02322749|83252844|FG004|Period 2|Withdrawal by Subject|0|||
47004837|NCT02322749|83252845|FG005|Period 2|Withdrawal by Subject|0|||
47004838|NCT02322749|83252840|FG000|Period 3|Withdrawal by Subject|0|||
47004839|NCT02322749|83252841|FG001|Period 3|Withdrawal by Subject|0|||
47004840|NCT02322749|83252842|FG002|Period 3|Withdrawal by Subject|1|||
47004841|NCT02322749|83252843|FG003|Period 3|Withdrawal by Subject|0|||
47004842|NCT02322749|83252844|FG004|Period 3|Withdrawal by Subject|0|||
47004843|NCT02322749|83252845|FG005|Period 3|Withdrawal by Subject|0|||
47004844|NCT01957137|83252854|FG000|Randomized Portion|Adverse Event|1|||
47004845|NCT01957137|83252854|FG000|Randomized Portion|Withdrawal by Subject|1|||
47004846|NCT01928433|83252869|FG000|Overall Study|Adverse Event|5|||
47004847|NCT01928433|83252870|FG001|Overall Study|Adverse Event|2|||
47004848|NCT01928433|83252871|FG002|Overall Study|Adverse Event|5|||
47004849|NCT01928433|83252869|FG000|Overall Study|Protocol Violation|0|||
47004850|NCT01928433|83252870|FG001|Overall Study|Protocol Violation|0|||
47004851|NCT01928433|83252871|FG002|Overall Study|Protocol Violation|2|||
47004852|NCT01928433|83252869|FG000|Overall Study|Lack of Efficacy|5|||
47004853|NCT01928433|83252870|FG001|Overall Study|Lack of Efficacy|4|||
47004854|NCT01928433|83252871|FG002|Overall Study|Lack of Efficacy|4|||
47004855|NCT01928433|83252869|FG000|Overall Study|Withdrawal by Subject|0|||
47004856|NCT01928433|83252870|FG001|Overall Study|Withdrawal by Subject|4|||
47004857|NCT01928433|83252871|FG002|Overall Study|Withdrawal by Subject|0|||
47004858|NCT01928433|83252869|FG000|Overall Study|Negative screening urine culture|7|||
47004859|NCT01928433|83252870|FG001|Overall Study|Negative screening urine culture|6|||
47004860|NCT01928433|83252871|FG002|Overall Study|Negative screening urine culture|10|||
47004861|NCT01928433|83252869|FG000|Overall Study|Lost to Follow-up|0|||
47004862|NCT01928433|83252870|FG001|Overall Study|Lost to Follow-up|2|||
47004863|NCT01928433|83252871|FG002|Overall Study|Lost to Follow-up|3|||
47004864|NCT01928433|83252869|FG000|Overall Study|Other reasons|3|||
47004865|NCT01928433|83252870|FG001|Overall Study|Other reasons|3|||
47004866|NCT01928433|83252871|FG002|Overall Study|Other reasons|4|||
47004867|NCT02322281|83252885|FG000|Overall Study|Progressive Disease|42|||
47004868|NCT02322281|83252886|FG001|Overall Study|Progressive Disease|14|||
47004869|NCT02322281|83252887|FG002|Overall Study|Progressive Disease|49|||
47004870|NCT02322281|83252885|FG000|Overall Study|Adverse Event|3|||
47004871|NCT02322281|83252886|FG001|Overall Study|Adverse Event|4|||
47004872|NCT02322281|83252887|FG002|Overall Study|Adverse Event|6|||
47004873|NCT02322281|83252885|FG000|Overall Study|Death|3|||
47004874|NCT02322281|83252886|FG001|Overall Study|Death|3|||
47004875|NCT02322281|83252887|FG002|Overall Study|Death|3|||
47004876|NCT02322281|83252885|FG000|Overall Study|Withdrawal by Subject|1|||
47004877|NCT02322281|83252886|FG001|Overall Study|Withdrawal by Subject|1|||
47004878|NCT02322281|83252887|FG002|Overall Study|Withdrawal by Subject|6|||
47004879|NCT02322281|83252885|FG000|Overall Study|Physician Decision|2|||
47004880|NCT02322281|83252886|FG001|Overall Study|Physician Decision|0|||
47004881|NCT02322281|83252887|FG002|Overall Study|Physician Decision|5|||
47004882|NCT02322281|83252885|FG000|Overall Study|Study Terminated by Sponsor|2|||
47004883|NCT02322281|83252886|FG001|Overall Study|Study Terminated by Sponsor|0|||
46909856|NCT03345407|83139056|FG006|Overall Study|Protocol Violation|3|||
46909857|NCT03345407|83139050|FG000|Overall Study|Lack of Efficacy|1|||
46909858|NCT03345407|83139051|FG001|Overall Study|Lack of Efficacy|1|||
46909859|NCT03345407|83139052|FG002|Overall Study|Lack of Efficacy|1|||
46909860|NCT03345407|83139053|FG003|Overall Study|Lack of Efficacy|1|||
46909861|NCT03345407|83139054|FG004|Overall Study|Lack of Efficacy|1|||
46909862|NCT03345407|83139055|FG005|Overall Study|Lack of Efficacy|0|||
46909863|NCT03345407|83139056|FG006|Overall Study|Lack of Efficacy|3|||
46909864|NCT03345407|83139050|FG000|Overall Study|Adverse Event|4|||
46909865|NCT03345407|83139051|FG001|Overall Study|Adverse Event|0|||
46909866|NCT03345407|83139052|FG002|Overall Study|Adverse Event|5|||
46909867|NCT03345407|83139053|FG003|Overall Study|Adverse Event|4|||
46909868|NCT03345407|83139054|FG004|Overall Study|Adverse Event|6|||
46909869|NCT03345407|83139055|FG005|Overall Study|Adverse Event|5|||
46909870|NCT03345407|83139056|FG006|Overall Study|Adverse Event|16|||
47004884|NCT02322281|83252887|FG002|Overall Study|Study Terminated by Sponsor|0|||
47004885|NCT02322281|83252885|FG000|Overall Study|Missing|0|||
47004886|NCT02322281|83252886|FG001|Overall Study|Missing|0|||
47004887|NCT02322281|83252887|FG002|Overall Study|Missing|1|||
47004888|NCT02322281|83252885|FG000|Overall Study|Miscellaneous|0|||
47004889|NCT02322281|83252886|FG001|Overall Study|Miscellaneous|0|||
47004890|NCT02322281|83252887|FG002|Overall Study|Miscellaneous|4|||
47004891|NCT02322125|83252897|FG000|Overall Study|Withdrawal by Subject|2|||
46620474|NCT03682055|82769618|FG002|Overall Study|Termination of Study by Sponsor|0|||
46909871|NCT03255187|83139080|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
46909872|NCT03255187|83139081|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
46909873|NCT03255187|83139080|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
47004892|NCT02243293|83252918|FG000|Overall Study|Adverse Event|1|||
47004893|NCT02243293|83252919|FG001|Overall Study|Adverse Event|0|||
47004894|NCT02243293|83252920|FG002|Overall Study|Adverse Event|0|||
47004895|NCT02243293|83252921|FG003|Overall Study|Adverse Event|0|||
47004896|NCT02243293|83252922|FG004|Overall Study|Adverse Event|0|||
47004897|NCT02243293|83252923|FG005|Overall Study|Adverse Event|0|||
47004898|NCT02243293|83252924|FG006|Overall Study|Adverse Event|0|||
47004899|NCT02243293|83252925|FG007|Overall Study|Adverse Event|0|||
47004900|NCT02243293|83252926|FG008|Overall Study|Adverse Event|0|||
47004901|NCT02243293|83252927|FG009|Overall Study|Adverse Event|0|||
47004902|NCT02243293|83252928|FG010|Overall Study|Adverse Event|0|||
47004903|NCT02243293|83252929|FG011|Overall Study|Adverse Event|0|||
47004904|NCT02243293|83252930|FG012|Overall Study|Adverse Event|0|||
47004905|NCT02243293|83252931|FG013|Overall Study|Adverse Event|0|||
47004906|NCT02243293|83252932|FG014|Overall Study|Adverse Event|0|||
47004907|NCT02243293|83252933|FG015|Overall Study|Adverse Event|1|||
47004908|NCT02243293|83252934|FG016|Overall Study|Adverse Event|0|||
47004909|NCT02243293|83252935|FG017|Overall Study|Adverse Event|0|||
47004910|NCT02243293|83252936|FG018|Overall Study|Adverse Event|0|||
47004911|NCT02243293|83252937|FG019|Overall Study|Adverse Event|0|||
47004912|NCT02243293|83252938|FG020|Overall Study|Adverse Event|1|||
47004913|NCT02243293|83252939|FG021|Overall Study|Adverse Event|0|||
47004914|NCT02243293|83252918|FG000|Overall Study|Withdrawal by Subject|1|||
47004915|NCT02243293|83252919|FG001|Overall Study|Withdrawal by Subject|0|||
47004916|NCT02243293|83252920|FG002|Overall Study|Withdrawal by Subject|0|||
47004917|NCT02243293|83252921|FG003|Overall Study|Withdrawal by Subject|0|||
47004918|NCT02243293|83252922|FG004|Overall Study|Withdrawal by Subject|0|||
47004919|NCT02243293|83252923|FG005|Overall Study|Withdrawal by Subject|0|||
47004920|NCT02243293|83252924|FG006|Overall Study|Withdrawal by Subject|0|||
47004921|NCT02243293|83252925|FG007|Overall Study|Withdrawal by Subject|0|||
47004922|NCT02243293|83252926|FG008|Overall Study|Withdrawal by Subject|0|||
47004923|NCT02243293|83252927|FG009|Overall Study|Withdrawal by Subject|1|||
47004924|NCT02243293|83252928|FG010|Overall Study|Withdrawal by Subject|0|||
47004925|NCT02243293|83252929|FG011|Overall Study|Withdrawal by Subject|1|||
47004926|NCT02243293|83252930|FG012|Overall Study|Withdrawal by Subject|0|||
47004927|NCT02243293|83252931|FG013|Overall Study|Withdrawal by Subject|0|||
47004928|NCT02243293|83252932|FG014|Overall Study|Withdrawal by Subject|0|||
47004929|NCT02243293|83252933|FG015|Overall Study|Withdrawal by Subject|0|||
47004930|NCT02243293|83252934|FG016|Overall Study|Withdrawal by Subject|0|||
47004931|NCT02243293|83252935|FG017|Overall Study|Withdrawal by Subject|0|||
47004932|NCT02243293|83252936|FG018|Overall Study|Withdrawal by Subject|0|||
47004933|NCT02243293|83252937|FG019|Overall Study|Withdrawal by Subject|0|||
47004934|NCT02243293|83252938|FG020|Overall Study|Withdrawal by Subject|0|||
47004935|NCT02243293|83252939|FG021|Overall Study|Withdrawal by Subject|1|||
47004936|NCT02243293|83252918|FG000|Overall Study|Lost to Follow-up|0|||
47004937|NCT02243293|83252919|FG001|Overall Study|Lost to Follow-up|1|||
47004938|NCT02243293|83252920|FG002|Overall Study|Lost to Follow-up|1|||
47004939|NCT02243293|83252921|FG003|Overall Study|Lost to Follow-up|1|||
47004940|NCT02243293|83252922|FG004|Overall Study|Lost to Follow-up|0|||
47004941|NCT02243293|83252923|FG005|Overall Study|Lost to Follow-up|0|||
47004942|NCT02243293|83252924|FG006|Overall Study|Lost to Follow-up|3|||
47004943|NCT02243293|83252925|FG007|Overall Study|Lost to Follow-up|0|||
47004944|NCT02243293|83252926|FG008|Overall Study|Lost to Follow-up|0|||
47004945|NCT02243293|83252927|FG009|Overall Study|Lost to Follow-up|0|||
47004946|NCT02243293|83252928|FG010|Overall Study|Lost to Follow-up|0|||
47004947|NCT02243293|83252929|FG011|Overall Study|Lost to Follow-up|2|||
47004948|NCT02243293|83252930|FG012|Overall Study|Lost to Follow-up|0|||
47004949|NCT02243293|83252931|FG013|Overall Study|Lost to Follow-up|0|||
47004950|NCT02243293|83252932|FG014|Overall Study|Lost to Follow-up|0|||
47004951|NCT02243293|83252933|FG015|Overall Study|Lost to Follow-up|0|||
47004952|NCT02243293|83252934|FG016|Overall Study|Lost to Follow-up|3|||
47004953|NCT02243293|83252935|FG017|Overall Study|Lost to Follow-up|1|||
47004954|NCT02243293|83252936|FG018|Overall Study|Lost to Follow-up|0|||
47004955|NCT02243293|83252937|FG019|Overall Study|Lost to Follow-up|0|||
47004956|NCT02243293|83252938|FG020|Overall Study|Lost to Follow-up|1|||
47004957|NCT02243293|83252939|FG021|Overall Study|Lost to Follow-up|2|||
47004958|NCT02243293|83252918|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
47004959|NCT02243293|83252919|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
47004960|NCT02243293|83252920|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
47004961|NCT02243293|83252921|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
47004962|NCT02243293|83252922|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
46709449|NCT01221272|82925488|FG000|Period 1|Consent Withdrawal|0|||
47004963|NCT02243293|83252923|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
47004964|NCT02243293|83252924|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
47004965|NCT02243293|83252925|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
47004966|NCT02243293|83252926|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
47004967|NCT02243293|83252927|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
47004968|NCT02243293|83252928|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
47004969|NCT02243293|83252929|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
47004970|NCT02243293|83252930|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
47004971|NCT02243293|83252931|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
47004972|NCT02243293|83252932|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
47004973|NCT02243293|83252933|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
47004974|NCT02243293|83252934|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
47004975|NCT02243293|83252935|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
47004976|NCT02243293|83252936|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
47004977|NCT02243293|83252937|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
47004978|NCT02243293|83252938|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
47004979|NCT02243293|83252939|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
47004980|NCT02243293|83252918|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
47004981|NCT02243293|83252919|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
47004982|NCT02243293|83252920|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
47004983|NCT02243293|83252921|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
47004984|NCT02243293|83252922|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
47004985|NCT02243293|83252923|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
47004986|NCT02243293|83252924|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
47004987|NCT02243293|83252925|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
47004988|NCT02243293|83252926|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
47004989|NCT02243293|83252927|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
47004990|NCT02243293|83252928|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
47004991|NCT02243293|83252929|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
47004992|NCT02243293|83252930|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
47004993|NCT02243293|83252931|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
47004994|NCT02243293|83252932|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
47004995|NCT02243293|83252933|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
47004996|NCT02243293|83252934|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
47004997|NCT02243293|83252935|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
47004998|NCT02243293|83252936|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
47004999|NCT02243293|83252937|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
47005000|NCT02243293|83252938|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
47005001|NCT02243293|83252939|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
47005002|NCT02322047|83252980|FG000|Overall Study|Physician Decision|1|||
47005003|NCT02322047|83252981|FG001|Overall Study|Physician Decision|0|||
47005004|NCT02322047|83252982|FG002|Overall Study|Physician Decision|0|||
47005005|NCT02322047|83252983|FG003|Overall Study|Physician Decision|0|||
47005006|NCT02322047|83252980|FG000|Overall Study|Withdrawal by Subject|1|||
47005007|NCT02322047|83252981|FG001|Overall Study|Withdrawal by Subject|0|||
47005008|NCT02322047|83252982|FG002|Overall Study|Withdrawal by Subject|0|||
47005009|NCT02322047|83252983|FG003|Overall Study|Withdrawal by Subject|1|||
47005010|NCT02322047|83252980|FG000|Overall Study|Adverse Event|0|||
47005011|NCT02322047|83252981|FG001|Overall Study|Adverse Event|1|||
47005012|NCT02322047|83252982|FG002|Overall Study|Adverse Event|0|||
47005013|NCT02322047|83252983|FG003|Overall Study|Adverse Event|0|||
47005014|NCT02322047|83252980|FG000|Overall Study|Lost to Follow-up|0|||
47005015|NCT02322047|83252981|FG001|Overall Study|Lost to Follow-up|0|||
47005016|NCT02322047|83252982|FG002|Overall Study|Lost to Follow-up|1|||
47005017|NCT02322047|83252983|FG003|Overall Study|Lost to Follow-up|1|||
47005018|NCT02254291|83252996|FG000|Overall Study|Withdrawal by Subject|0|||
47005019|NCT02254291|83252997|FG001|Overall Study|Withdrawal by Subject|3|||
47005020|NCT02254291|83252998|FG002|Overall Study|Withdrawal by Subject|1|||
47005021|NCT02254291|83252996|FG000|Overall Study|Missing follow-up information|0|||
47005022|NCT02254291|83252997|FG001|Overall Study|Missing follow-up information|0|||
47005023|NCT02254291|83252998|FG002|Overall Study|Missing follow-up information|1|||
47005024|NCT02253433|83253008|FG000|Overall Study|Unable to Contact|9|||
47005025|NCT02253433|83253009|FG001|Overall Study|Unable to Contact|16|||
47005026|NCT02253433|83253008|FG000|Overall Study|Death|1|||
47005027|NCT02253433|83253009|FG001|Overall Study|Death|1|||
47005028|NCT02253433|83253008|FG000|Overall Study|No Longer Interested|3|||
47005029|NCT02253433|83253009|FG001|Overall Study|No Longer Interested|15|||
47005030|NCT02253433|83253008|FG000|Overall Study|Out of Study Area|2|||
47005031|NCT02253433|83253009|FG001|Overall Study|Out of Study Area|7|||
47005032|NCT02253433|83253008|FG000|Overall Study|Uncomfortable with home visitors|0|||
47005033|NCT02253433|83253009|FG001|Overall Study|Uncomfortable with home visitors|3|||
47005034|NCT02253433|83253008|FG000|Overall Study|Unstable Housing/Homeless|0|||
47005035|NCT02253433|83253009|FG001|Overall Study|Unstable Housing/Homeless|7|||
47005036|NCT02253433|83253008|FG000|Overall Study|Too Busy|0|||
47005037|NCT02253433|83253009|FG001|Overall Study|Too Busy|4|||
47005038|NCT02253433|83253008|FG000|Overall Study|Medical or Other Concerns|1|||
46709450|NCT01221272|82925489|FG001|Period 1|Consent Withdrawal|1|||
47005039|NCT02253433|83253009|FG001|Overall Study|Medical or Other Concerns|2|||
47005040|NCT02242981|83253016|FG000|Overall Study|Withdrawal by Subject|1|||
47005041|NCT02277743|83253023|FG000|Overall Study|Protocol Violation|1|||
47005042|NCT02277743|83253024|FG001|Overall Study|Protocol Violation|1|||
47005043|NCT02277743|83253025|FG002|Overall Study|Protocol Violation|1|||
47005044|NCT02277743|83253023|FG000|Overall Study|Adverse Event|10|||
47005045|NCT02277743|83253024|FG001|Overall Study|Adverse Event|6|||
47005046|NCT02277743|83253025|FG002|Overall Study|Adverse Event|6|||
47005047|NCT02277743|83253023|FG000|Overall Study|Lack of Efficacy|11|||
47005048|NCT02277743|83253024|FG001|Overall Study|Lack of Efficacy|4|||
47005049|NCT02277743|83253025|FG002|Overall Study|Lack of Efficacy|3|||
47005050|NCT02277743|83253023|FG000|Overall Study|Other than specified above|18|||
47005051|NCT02277743|83253024|FG001|Overall Study|Other than specified above|5|||
47005052|NCT02277743|83253025|FG002|Overall Study|Other than specified above|16|||
47005053|NCT02242903|83253040|FG000|Overall Study|Withdrawal by Subject|1|||
47005054|NCT02242903|83253041|FG001|Overall Study|Withdrawal by Subject|0|||
47005055|NCT02242903|83253042|FG002|Overall Study|Withdrawal by Subject|0|||
47005056|NCT02242903|83253043|FG003|Overall Study|Withdrawal by Subject|0|||
47005057|NCT02242903|83253044|FG004|Overall Study|Withdrawal by Subject|0|||
47005058|NCT02242903|83253045|FG005|Overall Study|Withdrawal by Subject|0|||
47005059|NCT02242903|83253046|FG006|Overall Study|Withdrawal by Subject|0|||
47005060|NCT02320721|83253070|FG000|Overall Study|Adverse Event|6|||
47005061|NCT02320721|83253071|FG001|Overall Study|Adverse Event|6|||
47005062|NCT02320721|83253070|FG000|Overall Study|Lack of Efficacy|2|||
47005063|NCT02320721|83253071|FG001|Overall Study|Lack of Efficacy|0|||
47005064|NCT02320721|83253070|FG000|Overall Study|Poor compliance to protocol|3|||
47005065|NCT02320721|83253071|FG001|Overall Study|Poor compliance to protocol|7|||
47005066|NCT02320721|83253070|FG000|Overall Study|Randomized but not treated|0|||
47005067|NCT02320721|83253071|FG001|Overall Study|Randomized but not treated|1|||
47005068|NCT02320721|83253070|FG000|Overall Study|Hypoglycemia|1|||
47005069|NCT02320721|83253071|FG001|Overall Study|Hypoglycemia|0|||
47005070|NCT02320721|83253070|FG000|Overall Study|Other than specified above|15|||
47005071|NCT02320721|83253071|FG001|Overall Study|Other than specified above|20|||
47005072|NCT02320487|83253077|FG000|Overall Study|Reason not Specified|1|||
47005073|NCT02320487|83253077|FG000|Overall Study|Physician Decision|5|||
47005074|NCT02320487|83253077|FG000|Overall Study|Withdrawal by Subject|1|||
47005075|NCT02320487|83253077|FG000|Overall Study|Death|3|||
46620475|NCT03682055|82769619|FG003|Overall Study|Termination of Study by Sponsor|0|||
46909874|NCT03255187|83139081|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
46909875|NCT02929329|83139089|FG000|Overall Study|Withdrawal by Subject|24|||
46909876|NCT02929329|83139090|FG001|Overall Study|Withdrawal by Subject|21|||
46909877|NCT02929329|83139089|FG000|Overall Study|Lost to Follow-up|26|||
46909878|NCT02929329|83139090|FG001|Overall Study|Lost to Follow-up|20|||
46909879|NCT02929329|83139089|FG000|Overall Study|Death|1054|||
46909880|NCT02929329|83139090|FG001|Overall Study|Death|1051|||
46909881|NCT03240133|83139103|FG000|Overall Study|Withdrawal by Subject|0|||
46909882|NCT03240133|83139104|FG001|Overall Study|Withdrawal by Subject|1|||
46909883|NCT03240133|83139105|FG002|Overall Study|Withdrawal by Subject|0|||
46909884|NCT03240133|83139103|FG000|Overall Study|Adverse Event|1|||
46909885|NCT03240133|83139104|FG001|Overall Study|Adverse Event|1|||
46909886|NCT03240133|83139105|FG002|Overall Study|Adverse Event|0|||
46909887|NCT03240133|83139103|FG000|Overall Study|Rash|1|||
46909888|NCT03240133|83139104|FG001|Overall Study|Rash|0|||
46909889|NCT03240133|83139105|FG002|Overall Study|Rash|0|||
46909890|NCT03240133|83139103|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
46909891|NCT03240133|83139104|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
46909892|NCT03240133|83139105|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
46909893|NCT03240133|83139103|FG000|Overall Study|Intercurrent illness.|0|||
46909894|NCT03240133|83139104|FG001|Overall Study|Intercurrent illness.|1|||
46909895|NCT03240133|83139105|FG002|Overall Study|Intercurrent illness.|0|||
46909896|NCT03240133|83139103|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
46909897|NCT03240133|83139104|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
46909898|NCT03240133|83139105|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
46909899|NCT03372083|83139129|FG000|Overall Study|Adverse Event|3|||
46909900|NCT03372083|83139129|FG000|Overall Study|Physician Decision|1|||
46909901|NCT03372083|83139129|FG000|Overall Study|Withdrawal by Subject|1|||
47005076|NCT02320487|83253077|FG000|Overall Study|Adverse Event|11|||
46909902|NCT03044886|83139136|FG000|Overall Study|Lost to Follow-up|15|||
47005077|NCT02277119|83253084|FG000|Overall Study|Lack of Efficacy|1|||
47005078|NCT02277119|83253085|FG001|Overall Study|Lack of Efficacy|1|||
47005079|NCT02277119|83253086|FG002|Overall Study|Lack of Efficacy|1|||
46620476|NCT03682055|82769620|FG004|Overall Study|Termination of Study by Sponsor|0|||
46909903|NCT03044886|83139137|FG001|Overall Study|Lost to Follow-up|10|||
46909904|NCT03044886|83139138|FG002|Overall Study|Lost to Follow-up|12|||
46909905|NCT02961764|83139148|FG000|Overall Study|Protocol Violation|0|||
46909906|NCT02961764|83139149|FG001|Overall Study|Protocol Violation|1|||
46909907|NCT02961764|83139148|FG000|Overall Study|Death|2|||
47005080|NCT02277119|83253084|FG000|Overall Study|Protocol Violation|2|||
47005081|NCT02277119|83253085|FG001|Overall Study|Protocol Violation|3|||
47005082|NCT02277119|83253086|FG002|Overall Study|Protocol Violation|7|||
47005083|NCT02320253|83253097|FG000|Overall Study|Withdrawal by Subject|3|||
46909908|NCT02961764|83139149|FG001|Overall Study|Death|0|||
46909909|NCT02961764|83139148|FG000|Overall Study|Lost to Follow-up|35|||
46909910|NCT02961764|83139149|FG001|Overall Study|Lost to Follow-up|24|||
46909911|NCT02961764|83139148|FG000|Overall Study|Withdrawal by Subject|2|||
46909912|NCT02961764|83139149|FG001|Overall Study|Withdrawal by Subject|0|||
46909913|NCT03371459|83139155|FG000|Washout|Lost to Follow-up|0|||
46909914|NCT03371459|83139156|FG001|Washout|Lost to Follow-up|1|||
46909915|NCT02961920|83139164|FG000|Overall Study|did not achive stydy protocol schedule|1|||
46909916|NCT02961920|83139165|FG001|Overall Study|did not achive stydy protocol schedule|1|||
46909917|NCT03371381|83139171|FG000|Overall Study|Death|5|||
46909918|NCT03371381|83139171|FG000|Overall Study|Study terminated by sponsor|3|||
46909919|NCT03371381|83139171|FG000|Overall Study|Other|4|||
46909920|NCT03044730|83139175|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
46909921|NCT03044730|83139175|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
46909922|NCT03044730|83139175|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
46909923|NCT03044730|83139175|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
46909924|NCT03044730|83139175|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
46909925|NCT03044730|83139175|FG000|Cycles 4 and Beyond|Adverse Event|1|||
46909926|NCT03044730|83139175|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
46909927|NCT03044730|83139175|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
46909928|NCT03044730|83139175|FG000|On Follow-up for 2 Years|Death|17|||
46909929|NCT02961374|83139180|FG000|Overall Study|Adverse Event|4|||
46909930|NCT02951429|83139186|FG000|Overall Study|Adverse Event|3|||
46909931|NCT02951429|83139187|FG001|Overall Study|Adverse Event|7|||
46909932|NCT02951429|83139186|FG000|Overall Study|Death|28|||
46909933|NCT02951429|83139187|FG001|Overall Study|Death|36|||
46909934|NCT02951429|83139186|FG000|Overall Study|Lack of Efficacy|0|||
46909935|NCT02951429|83139187|FG001|Overall Study|Lack of Efficacy|1|||
46909936|NCT02951429|83139186|FG000|Overall Study|Lost to Follow-up|0|||
46909937|NCT02951429|83139187|FG001|Overall Study|Lost to Follow-up|1|||
46909938|NCT02951429|83139186|FG000|Overall Study|Lung Transplantation|9|||
46909939|NCT02951429|83139187|FG001|Overall Study|Lung Transplantation|6|||
46909940|NCT02951429|83139186|FG000|Overall Study|Other|1|||
46909941|NCT02951429|83139187|FG001|Overall Study|Other|3|||
46909942|NCT02951429|83139186|FG000|Overall Study|Progressive Disease|1|||
46909943|NCT02951429|83139187|FG001|Overall Study|Progressive Disease|1|||
46909944|NCT02951429|83139186|FG000|Overall Study|Withdrawal by Subject|7|||
46909945|NCT02951429|83139187|FG001|Overall Study|Withdrawal by Subject|11|||
46909946|NCT02951429|83139186|FG000|Overall Study|Participant ongoing in the study|23|||
46909947|NCT02951429|83139187|FG001|Overall Study|Participant ongoing in the study|17|||
46909948|NCT03343067|83139200|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
46909949|NCT03343067|83139201|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
46909950|NCT03343067|83139202|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
46909951|NCT03103503|83139210|FG000|Overall Study|Death|64|||
46909952|NCT03103503|83139210|FG000|Overall Study|Physician Decision|57|||
46909953|NCT03103503|83139210|FG000|Overall Study|Withdrawal by Subject|10|||
46909954|NCT03103503|83139210|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
46909955|NCT03103503|83139210|FG000|Overall Study|Lost to Follow-up|3|||
46909956|NCT03103503|83139210|FG000|Overall Study|Study Closure|757|||
46909957|NCT02961218|83139216|FG000|Overall Study|Lost to Follow-up|0|||
46909958|NCT02961218|83139217|FG001|Overall Study|Lost to Follow-up|2|||
46909959|NCT02961218|83139216|FG000|Overall Study|Physician Decision|0|||
46909960|NCT02961218|83139217|FG001|Overall Study|Physician Decision|2|||
46909961|NCT02961218|83139216|FG000|Overall Study|Subject/Guardian Decision|3|||
46909962|NCT02961218|83139217|FG001|Overall Study|Subject/Guardian Decision|1|||
46909963|NCT02949947|83139227|FG000|Overall Study|Non Compliance|0|||
46909964|NCT02949947|83139228|FG001|Overall Study|Non Compliance|1|||
46909965|NCT02949947|83139227|FG000|Overall Study|Insurance change|1|||
46909966|NCT02949947|83139228|FG001|Overall Study|Insurance change|0|||
46909967|NCT03341507|83139234|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
46909968|NCT01345058|83139240|FG000|Overall Study|Withdrawal by Subject|1|||
46909969|NCT01345058|83139241|FG001|Overall Study|Withdrawal by Subject|0|||
46909970|NCT01345058|83139240|FG000|Overall Study|Participant Reported Increase in Events|1|||
46909971|NCT01345058|83139241|FG001|Overall Study|Participant Reported Increase in Events|0|||
46909972|NCT01345058|83139240|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
46909973|NCT01345058|83139241|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
46909974|NCT01345058|83139240|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
46909975|NCT01345058|83139241|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
47005084|NCT02320253|83253098|FG001|Overall Study|Withdrawal by Subject|0|||
46909976|NCT01345058|83139240|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
47005085|NCT02320253|83253099|FG002|Overall Study|Withdrawal by Subject|0|||
47005086|NCT02320253|83253097|FG000|Overall Study|Lost to Follow-up|2|||
47005087|NCT02320253|83253098|FG001|Overall Study|Lost to Follow-up|2|||
47005088|NCT02320253|83253099|FG002|Overall Study|Lost to Follow-up|1|||
47005089|NCT02320253|83253097|FG000|Overall Study|Death|1|||
47005090|NCT02320253|83253098|FG001|Overall Study|Death|0|||
47005091|NCT02320253|83253099|FG002|Overall Study|Death|1|||
47005092|NCT02276807|83253109|FG000|Overall Study|Withdrawal by Subject|8|||
47005093|NCT02276807|83253110|FG001|Overall Study|Withdrawal by Subject|7|||
47005094|NCT02276807|83253109|FG000|Overall Study|Lost to Follow-up|10|||
47005095|NCT02276807|83253110|FG001|Overall Study|Lost to Follow-up|10|||
47005096|NCT02252965|83253118|FG000|Overall Study|Adverse Event|9|||
47005097|NCT02252965|83253119|FG001|Overall Study|Adverse Event|14|||
47005098|NCT02252965|83253118|FG000|Overall Study|Lost to Follow-up|16|||
47005099|NCT02252965|83253119|FG001|Overall Study|Lost to Follow-up|8|||
47005100|NCT02252965|83253118|FG000|Overall Study|Protocol Violation|4|||
47005101|NCT02252965|83253119|FG001|Overall Study|Protocol Violation|5|||
47005102|NCT02252965|83253118|FG000|Overall Study|Lack of Efficacy|0|||
47005103|NCT02252965|83253119|FG001|Overall Study|Lack of Efficacy|2|||
47005104|NCT02252965|83253118|FG000|Overall Study|Withdrawal by Subject|7|||
47005105|NCT02252965|83253119|FG001|Overall Study|Withdrawal by Subject|9|||
47005106|NCT02252965|83253118|FG000|Overall Study|Other|4|||
47005107|NCT02252965|83253119|FG001|Overall Study|Other|5|||
47005108|NCT02242435|83253129|FG000|Overall Study|Lost to Follow-up|3|||
47005109|NCT02242435|83253130|FG001|Overall Study|Lost to Follow-up|4|||
47005110|NCT02242435|83253129|FG000|Overall Study|Adverse Event|3|||
47005111|NCT02242435|83253130|FG001|Overall Study|Adverse Event|2|||
47005112|NCT02242435|83253129|FG000|Overall Study|Withdrawal by Subject|13|||
47005113|NCT02242435|83253130|FG001|Overall Study|Withdrawal by Subject|8|||
47005114|NCT02242435|83253129|FG000|Overall Study|Death|0|||
47005115|NCT02242435|83253130|FG001|Overall Study|Death|1|||
47005116|NCT02242435|83253129|FG000|Overall Study|Protocol Violation|1|||
47005117|NCT02242435|83253130|FG001|Overall Study|Protocol Violation|0|||
47005118|NCT02242435|83253129|FG000|Overall Study|Physician Decision|0|||
47005119|NCT02242435|83253130|FG001|Overall Study|Physician Decision|1|||
47005120|NCT02251717|83253138|FG000|Overall Study|Adverse Event|0|||
47005121|NCT02251717|83253139|FG001|Overall Study|Adverse Event|1|||
47005122|NCT02251717|83253138|FG000|Overall Study|Withdrew Consent|1|||
47005123|NCT02251717|83253139|FG001|Overall Study|Withdrew Consent|0|||
47005124|NCT02242201|83253148|FG000|Overall Study|preoperative identified neuropathy|2|||
47005125|NCT02242201|83253149|FG001|Overall Study|preoperative identified neuropathy|0|||
47005126|NCT02242201|83253150|FG002|Overall Study|preoperative identified neuropathy|0|||
47005127|NCT02242201|83253148|FG000|Overall Study|planned post-op anticoagulation|1|||
47005128|NCT02242201|83253149|FG001|Overall Study|planned post-op anticoagulation|0|||
47005129|NCT02242201|83253150|FG002|Overall Study|planned post-op anticoagulation|0|||
47005130|NCT02242201|83253148|FG000|Overall Study|changed surgical procedure|1|||
47005131|NCT02242201|83253149|FG001|Overall Study|changed surgical procedure|0|||
47005132|NCT02242201|83253150|FG002|Overall Study|changed surgical procedure|0|||
47005133|NCT02242201|83253148|FG000|Overall Study|postponed surgery|0|||
47005134|NCT02242201|83253149|FG001|Overall Study|postponed surgery|0|||
47005135|NCT02242201|83253150|FG002|Overall Study|postponed surgery|1|||
47005136|NCT02242201|83253148|FG000|Overall Study|preoperative opioid consumption|0|||
47005137|NCT02242201|83253149|FG001|Overall Study|preoperative opioid consumption|1|||
47005138|NCT02242201|83253150|FG002|Overall Study|preoperative opioid consumption|0|||
47005139|NCT02242045|83253158|FG000|Overall Study|Investigator's Discretion|1|||
47005140|NCT02242045|83253158|FG000|Overall Study|Progressive Disease|2|||
47005141|NCT02242045|83253158|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
47005142|NCT02242045|83253158|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
47005143|NCT02241889|83253162|FG000|Overall Study|device issues|0|||
47005144|NCT02241889|83253163|FG001|Overall Study|device issues|0|||
47005145|NCT02241889|83253164|FG002|Overall Study|device issues|1|||
47005146|NCT02241889|83253165|FG003|Overall Study|device issues|0|||
47005147|NCT02241889|83253166|FG004|Overall Study|device issues|0|||
47005148|NCT02241889|83253167|FG005|Overall Study|device issues|0|||
47005149|NCT02241889|83253162|FG000|Overall Study|Withdrawal by Subject|0|||
47005150|NCT02241889|83253163|FG001|Overall Study|Withdrawal by Subject|0|||
47005151|NCT02241889|83253164|FG002|Overall Study|Withdrawal by Subject|0|||
47005152|NCT02241889|83253165|FG003|Overall Study|Withdrawal by Subject|0|||
47005153|NCT02241889|83253166|FG004|Overall Study|Withdrawal by Subject|0|||
47005154|NCT02241889|83253167|FG005|Overall Study|Withdrawal by Subject|1|||
47005155|NCT02241733|83253177|FG000|Overall Study|Lost to Follow-up|9|||
47005156|NCT02241733|83253178|FG001|Overall Study|Lost to Follow-up|4|||
47005157|NCT02241733|83253177|FG000|Overall Study|Physician Decision|6|||
47005158|NCT02241733|83253178|FG001|Overall Study|Physician Decision|2|||
47005159|NCT02241733|83253177|FG000|Overall Study|Withdrawal by Subject|0|||
47005160|NCT02241733|83253178|FG001|Overall Study|Withdrawal by Subject|2|||
47005161|NCT02241733|83253177|FG000|Overall Study|Death|0|||
47005162|NCT02241733|83253178|FG001|Overall Study|Death|2|||
47005163|NCT02241343|83253184|FG000|Overall Study|Adverse Event|1|||
47005164|NCT02241187|83253189|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
47005165|NCT02249767|83253196|FG000|Overall Study|Did not use medication|8|||
47005166|NCT02249767|83253197|FG001|Overall Study|Did not use medication|9|||
47005167|NCT02249767|83253198|FG002|Overall Study|Did not use medication|8|||
47005168|NCT02239939|83253208|FG000|Overall Study|Adverse Event|1|||
47005169|NCT02239939|83253209|FG001|Overall Study|Adverse Event|0|||
47005170|NCT02239939|83253208|FG000|Overall Study|Withdrawal by Subject|1|||
47005171|NCT02239939|83253209|FG001|Overall Study|Withdrawal by Subject|1|||
47005172|NCT02239939|83253208|FG000|Overall Study|Lost to Follow-up|0|||
47005173|NCT02239939|83253209|FG001|Overall Study|Lost to Follow-up|1|||
47005174|NCT02248675|83253219|FG000|Overall Study|Lost to Follow-up|3|||
47005175|NCT02248675|83253220|FG001|Overall Study|Lost to Follow-up|1|||
47005176|NCT02238379|83253228|FG000|Overall Study|Lost to Follow-up|1|||
47005177|NCT02238379|83253229|FG001|Overall Study|Lost to Follow-up|0|||
47005178|NCT02238067|83253235|FG000|Overall Study|Not completed survey at Month 6|45|||
47005179|NCT02237911|83253242|FG000|Overall Study|Withdrawal by Subject|4|||
47005180|NCT02237911|83253243|FG001|Overall Study|Withdrawal by Subject|7|||
47005181|NCT02237911|83253244|FG002|Overall Study|Withdrawal by Subject|2|||
47005182|NCT02237911|83253242|FG000|Overall Study|Lost to Follow-up|3|||
47005183|NCT02237911|83253243|FG001|Overall Study|Lost to Follow-up|1|||
47005184|NCT02237911|83253244|FG002|Overall Study|Lost to Follow-up|1|||
47005185|NCT02234479|83253254|FG000|Overall Study|Withdrawal by Subject|1|||
47005186|NCT02234479|83253255|FG001|Overall Study|Withdrawal by Subject|3|||
47005187|NCT02207491|83253263|FG000|Overall Study|Adverse Event|20|||
47005188|NCT02207491|83253264|FG001|Overall Study|Adverse Event|4|||
47005189|NCT02207491|83253263|FG000|Overall Study|Withdrawal by Subject|3|||
47005190|NCT02207491|83253264|FG001|Overall Study|Withdrawal by Subject|2|||
47005191|NCT02207491|83253263|FG000|Overall Study|Non-compliant|0|||
47005192|NCT02207491|83253264|FG001|Overall Study|Non-compliant|1|||
47005193|NCT02207491|83253263|FG000|Overall Study|Lost to Follow-up|0|||
47005194|NCT02207491|83253264|FG001|Overall Study|Lost to Follow-up|1|||
47005195|NCT02207491|83253263|FG000|Overall Study|Lack of Efficacy|3|||
47005196|NCT02207491|83253264|FG001|Overall Study|Lack of Efficacy|0|||
47005197|NCT02207491|83253263|FG000|Overall Study|Physician Decision|2|||
47005198|NCT02207491|83253264|FG001|Overall Study|Physician Decision|0|||
47005199|NCT02207491|83253263|FG000|Overall Study|Protocol Violation|3|||
47005200|NCT02207491|83253264|FG001|Overall Study|Protocol Violation|5|||
47005201|NCT02315066|83253284|FG000|Overall Study|Lost to Follow-up|0|||
47005202|NCT02315066|83253285|FG001|Overall Study|Lost to Follow-up|1|||
47005203|NCT02315066|83253286|FG002|Overall Study|Lost to Follow-up|1|||
47005204|NCT02315066|83253287|FG003|Overall Study|Lost to Follow-up|0|||
47005205|NCT02315066|83253288|FG004|Overall Study|Lost to Follow-up|1|||
47005206|NCT02315066|83253289|FG005|Overall Study|Lost to Follow-up|0|||
47005207|NCT02315066|83253290|FG006|Overall Study|Lost to Follow-up|2|||
47005208|NCT02315066|83253291|FG007|Overall Study|Lost to Follow-up|1|||
47005209|NCT02315066|83253292|FG008|Overall Study|Lost to Follow-up|0|||
47005210|NCT02315066|83253293|FG009|Overall Study|Lost to Follow-up|0|||
47005211|NCT02315066|83253294|FG010|Overall Study|Lost to Follow-up|1|||
47005212|NCT02315066|83253295|FG011|Overall Study|Lost to Follow-up|2|||
47005213|NCT02315066|83253296|FG012|Overall Study|Lost to Follow-up|0|||
47005214|NCT02315066|83253297|FG013|Overall Study|Lost to Follow-up|4|||
47005215|NCT02315066|83253284|FG000|Overall Study|Death|2|||
47005216|NCT02315066|83253285|FG001|Overall Study|Death|7|||
47005217|NCT02315066|83253286|FG002|Overall Study|Death|6|||
47005218|NCT02315066|83253287|FG003|Overall Study|Death|11|||
47005219|NCT02315066|83253288|FG004|Overall Study|Death|10|||
47005220|NCT02315066|83253289|FG005|Overall Study|Death|3|||
47005221|NCT02315066|83253290|FG006|Overall Study|Death|9|||
47005222|NCT02315066|83253291|FG007|Overall Study|Death|9|||
47005223|NCT02315066|83253292|FG008|Overall Study|Death|10|||
47005224|NCT02315066|83253293|FG009|Overall Study|Death|8|||
47005225|NCT02315066|83253294|FG010|Overall Study|Death|10|||
47005226|NCT02315066|83253295|FG011|Overall Study|Death|7|||
47005227|NCT02315066|83253296|FG012|Overall Study|Death|8|||
47005228|NCT02315066|83253297|FG013|Overall Study|Death|21|||
47005229|NCT02315066|83253284|FG000|Overall Study|Other|0|||
47005230|NCT02315066|83253285|FG001|Overall Study|Other|0|||
47005231|NCT02315066|83253286|FG002|Overall Study|Other|0|||
47005232|NCT02315066|83253287|FG003|Overall Study|Other|0|||
47005233|NCT02315066|83253288|FG004|Overall Study|Other|0|||
47005234|NCT02315066|83253289|FG005|Overall Study|Other|0|||
47005235|NCT02315066|83253290|FG006|Overall Study|Other|0|||
47005236|NCT02315066|83253291|FG007|Overall Study|Other|1|||
47005237|NCT02315066|83253292|FG008|Overall Study|Other|1|||
47005238|NCT02315066|83253293|FG009|Overall Study|Other|2|||
47005239|NCT02315066|83253294|FG010|Overall Study|Other|0|||
47005240|NCT02315066|83253295|FG011|Overall Study|Other|0|||
47005241|NCT02315066|83253296|FG012|Overall Study|Other|0|||
47005242|NCT02315066|83253297|FG013|Overall Study|Other|0|||
47005243|NCT02315066|83253284|FG000|Overall Study|Subject refused further follow-up|0|||
47005244|NCT02315066|83253285|FG001|Overall Study|Subject refused further follow-up|2|||
47005245|NCT02315066|83253286|FG002|Overall Study|Subject refused further follow-up|2|||
47005246|NCT02315066|83253287|FG003|Overall Study|Subject refused further follow-up|0|||
47005247|NCT02315066|83253288|FG004|Overall Study|Subject refused further follow-up|0|||
47005248|NCT02315066|83253289|FG005|Overall Study|Subject refused further follow-up|0|||
47005249|NCT02315066|83253290|FG006|Overall Study|Subject refused further follow-up|2|||
47005250|NCT02315066|83253291|FG007|Overall Study|Subject refused further follow-up|3|||
47005251|NCT02315066|83253292|FG008|Overall Study|Subject refused further follow-up|0|||
47005252|NCT02315066|83253293|FG009|Overall Study|Subject refused further follow-up|1|||
47005253|NCT02315066|83253294|FG010|Overall Study|Subject refused further follow-up|1|||
47005254|NCT02315066|83253295|FG011|Overall Study|Subject refused further follow-up|2|||
47005255|NCT02315066|83253296|FG012|Overall Study|Subject refused further follow-up|2|||
47005256|NCT02315066|83253297|FG013|Overall Study|Subject refused further follow-up|4|||
47005257|NCT02315066|83253284|FG000|Overall Study|Study ongoing at date of cut-off|0|||
47005258|NCT02315066|83253285|FG001|Overall Study|Study ongoing at date of cut-off|0|||
47005259|NCT02315066|83253286|FG002|Overall Study|Study ongoing at date of cut-off|0|||
47005260|NCT02315066|83253287|FG003|Overall Study|Study ongoing at date of cut-off|0|||
47005261|NCT02315066|83253288|FG004|Overall Study|Study ongoing at date of cut-off|0|||
47005262|NCT02315066|83253289|FG005|Overall Study|Study ongoing at date of cut-off|0|||
47005263|NCT02315066|83253290|FG006|Overall Study|Study ongoing at date of cut-off|0|||
47005264|NCT02315066|83253291|FG007|Overall Study|Study ongoing at date of cut-off|0|||
47005265|NCT02315066|83253292|FG008|Overall Study|Study ongoing at date of cut-off|0|||
47005266|NCT02315066|83253293|FG009|Overall Study|Study ongoing at date of cut-off|0|||
47005267|NCT02315066|83253294|FG010|Overall Study|Study ongoing at date of cut-off|0|||
47005268|NCT02315066|83253295|FG011|Overall Study|Study ongoing at date of cut-off|0|||
47005269|NCT02315066|83253296|FG012|Overall Study|Study ongoing at date of cut-off|0|||
47005270|NCT02315066|83253297|FG013|Overall Study|Study ongoing at date of cut-off|1|||
47005271|NCT02207413|83253333|FG000|Overall Study|Withdrawal by Subject|1|||
47005272|NCT02207413|83253334|FG001|Overall Study|Withdrawal by Subject|0|||
47005273|NCT02207413|83253335|FG002|Overall Study|Withdrawal by Subject|0|||
47005274|NCT02207413|83253336|FG003|Overall Study|Withdrawal by Subject|0|||
47005275|NCT02207413|83253337|FG004|Overall Study|Withdrawal by Subject|3|||
47005276|NCT02207413|83253338|FG005|Overall Study|Withdrawal by Subject|7|||
47005277|NCT02207413|83253333|FG000|Overall Study|Lost to Follow-up|0|||
47005278|NCT02207413|83253334|FG001|Overall Study|Lost to Follow-up|0|||
47005279|NCT02207413|83253335|FG002|Overall Study|Lost to Follow-up|0|||
47005280|NCT02207413|83253336|FG003|Overall Study|Lost to Follow-up|1|||
47005281|NCT02207413|83253337|FG004|Overall Study|Lost to Follow-up|1|||
47005282|NCT02207413|83253338|FG005|Overall Study|Lost to Follow-up|5|||
47005283|NCT02207413|83253333|FG000|Overall Study|Adverse Event|0|||
47005284|NCT02207413|83253334|FG001|Overall Study|Adverse Event|0|||
47005285|NCT02207413|83253335|FG002|Overall Study|Adverse Event|0|||
47005286|NCT02207413|83253336|FG003|Overall Study|Adverse Event|0|||
47005287|NCT02207413|83253337|FG004|Overall Study|Adverse Event|2|||
47005288|NCT02207413|83253338|FG005|Overall Study|Adverse Event|1|||
47005289|NCT02207413|83253333|FG000|Overall Study|Migrated/moved from study area|0|||
47005290|NCT02207413|83253334|FG001|Overall Study|Migrated/moved from study area|0|||
47005291|NCT02207413|83253335|FG002|Overall Study|Migrated/moved from study area|0|||
47005292|NCT02207413|83253336|FG003|Overall Study|Migrated/moved from study area|0|||
47005293|NCT02207413|83253337|FG004|Overall Study|Migrated/moved from study area|1|||
47005294|NCT02207413|83253338|FG005|Overall Study|Migrated/moved from study area|0|||
47005295|NCT02309372|83253360|FG000|Overall Study|Lost to Follow-up|3|||
47005296|NCT02309372|83253361|FG001|Overall Study|Lost to Follow-up|2|||
47005297|NCT02276027|83253371|FG000|Overall Study|Death|1|||
47005298|NCT02276027|83253372|FG001|Overall Study|Death|0|||
47005299|NCT02276027|83253373|FG002|Overall Study|Death|0|||
47005300|NCT02276027|83253374|FG003|Overall Study|Death|2|||
47005301|NCT02276027|83253371|FG000|Overall Study|Physician Decision|0|||
47005302|NCT02276027|83253372|FG001|Overall Study|Physician Decision|0|||
47005303|NCT02276027|83253373|FG002|Overall Study|Physician Decision|0|||
47005304|NCT02276027|83253374|FG003|Overall Study|Physician Decision|1|||
47005305|NCT02276027|83253371|FG000|Overall Study|Progressive disease|1|||
47005306|NCT02276027|83253372|FG001|Overall Study|Progressive disease|13|||
47005307|NCT02276027|83253373|FG002|Overall Study|Progressive disease|12|||
47005308|NCT02276027|83253374|FG003|Overall Study|Progressive disease|14|||
47005309|NCT02276027|83253371|FG000|Overall Study|Subject/guardian decision|0|||
47005310|NCT02276027|83253372|FG001|Overall Study|Subject/guardian decision|1|||
47005311|NCT02276027|83253373|FG002|Overall Study|Subject/guardian decision|0|||
47005312|NCT02276027|83253374|FG003|Overall Study|Subject/guardian decision|3|||
47005313|NCT02276027|83253371|FG000|Overall Study|Adverse Event|0|||
47005314|NCT02276027|83253372|FG001|Overall Study|Adverse Event|2|||
46709451|NCT01221272|82925488|FG000|Period 1|Significant Dosing Noncompliance|0|||
46709452|NCT01221272|82925489|FG001|Period 1|Significant Dosing Noncompliance|1|||
46709453|NCT01221272|82925488|FG000|Period 2|Adverse Event|0|||
47005315|NCT02276027|83253373|FG002|Overall Study|Adverse Event|8|||
47005316|NCT02276027|83253374|FG003|Overall Study|Adverse Event|2|||
47005317|NCT02309294|83253384|FG000|Overall Study|Withdrawal by Subject|2|||
47005318|NCT02233543|83253388|FG000|Period 1|Withdrawal by Subject|1|||
47005319|NCT02233543|83253389|FG001|Period 1|Withdrawal by Subject|0|||
47005320|NCT02233543|83253388|FG000|Period 1|Participants required other treatment.|2|||
46709454|NCT01221272|82925489|FG001|Period 2|Adverse Event|2|||
47005321|NCT02233543|83253389|FG001|Period 1|Participants required other treatment.|3|||
47005322|NCT02233543|83253388|FG000|Period 2|Adverse Event|1|||
47005323|NCT02233543|83253389|FG001|Period 2|Adverse Event|0|||
47005324|NCT02233543|83253388|FG000|Period 2|Participant required other treatment.|0|||
47005325|NCT02233543|83253389|FG001|Period 2|Participant required other treatment.|1|||
47005326|NCT02233543|83253388|FG000|Period 2|COPD exacerbation|1|||
47005327|NCT02233543|83253389|FG001|Period 2|COPD exacerbation|0|||
47005328|NCT02309138|83253397|FG000|Overall Study|Withdrawal by Subject|44|||
47005329|NCT02309138|83253398|FG001|Overall Study|Withdrawal by Subject|15|||
47005330|NCT02309138|83253397|FG000|Overall Study|Protocol Violation|4|||
47005331|NCT02309138|83253398|FG001|Overall Study|Protocol Violation|2|||
47005332|NCT02309138|83253397|FG000|Overall Study|delivered before visit 2|0|||
47005333|NCT02309138|83253398|FG001|Overall Study|delivered before visit 2|1|||
47005334|NCT02233309|83253414|FG000|Overall Study|Physician Decision|5|||
47005335|NCT02204917|83253418|FG000|Overall Study|Protocol Violation|1|||
47005336|NCT02280044|83253427|FG000|Overall Study|Planned alternate|0|||
46709455|NCT01220414|82925500|FG000|Overall Study|Withdrawal by Subject|1|||
46709456|NCT01220414|82925501|FG001|Overall Study|Withdrawal by Subject|0|||
46709457|NCT01220414|82925502|FG002|Overall Study|Withdrawal by Subject|0|||
47005337|NCT02280044|83253428|FG001|Overall Study|Planned alternate|2|||
47005338|NCT02308748|83253434|FG000|Period 1|Withdrawal by Subject|0|||
47005339|NCT02308748|83253435|FG001|Period 1|Withdrawal by Subject|0|||
47005340|NCT02308748|83253436|FG002|Period 1|Withdrawal by Subject|1|||
47005341|NCT02308748|83253437|FG003|Period 1|Withdrawal by Subject|0|||
47005342|NCT02308748|83253438|FG004|Period 1|Withdrawal by Subject|0|||
47005343|NCT02308748|83253439|FG005|Period 1|Withdrawal by Subject|0|||
47005344|NCT02308748|83253440|FG006|Period 1|Withdrawal by Subject|0|||
47005345|NCT02308748|83253441|FG007|Period 1|Withdrawal by Subject|0|||
47005346|NCT02308748|83253442|FG008|Period 1|Withdrawal by Subject|0|||
47005347|NCT02308748|83253443|FG009|Period 1|Withdrawal by Subject|0|||
47005348|NCT02308748|83253434|FG000|Period 2|Adverse Event|0|||
47005349|NCT02308748|83253435|FG001|Period 2|Adverse Event|0|||
47005350|NCT02308748|83253436|FG002|Period 2|Adverse Event|0|||
47005351|NCT02308748|83253437|FG003|Period 2|Adverse Event|0|||
47005352|NCT02308748|83253438|FG004|Period 2|Adverse Event|0|||
47005353|NCT02308748|83253439|FG005|Period 2|Adverse Event|0|||
47005354|NCT02308748|83253440|FG006|Period 2|Adverse Event|0|||
47005355|NCT02308748|83253441|FG007|Period 2|Adverse Event|1|||
47005356|NCT02308748|83253442|FG008|Period 2|Adverse Event|0|||
47005357|NCT02308748|83253443|FG009|Period 2|Adverse Event|0|||
47005358|NCT02308748|83253434|FG000|Period 3|Protocol Violation|0|||
47005359|NCT02308748|83253435|FG001|Period 3|Protocol Violation|0|||
47005360|NCT02308748|83253436|FG002|Period 3|Protocol Violation|0|||
47005361|NCT02308748|83253437|FG003|Period 3|Protocol Violation|0|||
47005362|NCT02308748|83253438|FG004|Period 3|Protocol Violation|0|||
47005363|NCT02308748|83253439|FG005|Period 3|Protocol Violation|0|||
47005364|NCT02308748|83253440|FG006|Period 3|Protocol Violation|0|||
47005365|NCT02308748|83253441|FG007|Period 3|Protocol Violation|0|||
47005366|NCT02308748|83253442|FG008|Period 3|Protocol Violation|0|||
47005367|NCT02308748|83253443|FG009|Period 3|Protocol Violation|1|||
47005368|NCT02308748|83253434|FG000|Period 5|Adverse Event|1|||
47005369|NCT02308748|83253435|FG001|Period 5|Adverse Event|0|||
47005370|NCT02308748|83253436|FG002|Period 5|Adverse Event|0|||
47005371|NCT02308748|83253437|FG003|Period 5|Adverse Event|0|||
47005372|NCT02308748|83253438|FG004|Period 5|Adverse Event|0|||
47005373|NCT02308748|83253439|FG005|Period 5|Adverse Event|0|||
47005374|NCT02308748|83253440|FG006|Period 5|Adverse Event|0|||
47005375|NCT02308748|83253441|FG007|Period 5|Adverse Event|0|||
47005376|NCT02308748|83253442|FG008|Period 5|Adverse Event|1|||
47005377|NCT02308748|83253443|FG009|Period 5|Adverse Event|0|||
47005378|NCT01646216|83253457|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
47005379|NCT01646216|83253458|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
47005380|NCT01646216|83253457|FG000|Overall Study|Did not complete training|0|||
47005381|NCT01646216|83253458|FG001|Overall Study|Did not complete training|2|||
47005382|NCT01646216|83253457|FG000|Overall Study|Investigator decision|1|||
47005383|NCT01646216|83253458|FG001|Overall Study|Investigator decision|1|||
47005384|NCT02308124|83253471|FG000|Overall Study|Lost to Follow-up|6|||
47005385|NCT02308124|83253472|FG001|Overall Study|Lost to Follow-up|6|||
47005386|NCT02308124|83253473|FG002|Overall Study|Lost to Follow-up|6|||
46709458|NCT01220414|82925503|FG003|Overall Study|Withdrawal by Subject|1|||
46709459|NCT01128894|82925512|FG000|Overall Study|Adverse Event|31|||
47005387|NCT02308124|83253471|FG000|Overall Study|Adverse Event|0|||
47005388|NCT02308124|83253472|FG001|Overall Study|Adverse Event|2|||
47005389|NCT02308124|83253473|FG002|Overall Study|Adverse Event|2|||
47005390|NCT02232061|83253481|FG000|Overall Study|Administrative problems|1|||
47005391|NCT02232061|83253481|FG000|Overall Study|Withdrawal by Subject|1|||
47005392|NCT02275481|83253487|FG000|Overall Study|Death|2|||
47005393|NCT02275481|83253488|FG001|Overall Study|Death|1|||
47005394|NCT02275481|83253487|FG000|Overall Study|Lost to Follow-up|2|||
47005395|NCT02275481|83253488|FG001|Overall Study|Lost to Follow-up|0|||
47005396|NCT02275481|83253487|FG000|Overall Study|Withdrawal by Subject|3|||
47005397|NCT02275481|83253488|FG001|Overall Study|Withdrawal by Subject|0|||
47005398|NCT02275481|83253487|FG000|Overall Study|all other reasons combined|2|||
47005399|NCT02275481|83253488|FG001|Overall Study|all other reasons combined|1|||
47005400|NCT02275481|83253487|FG000|Overall Study|Physician Decision|0|||
47005401|NCT02275481|83253488|FG001|Overall Study|Physician Decision|1|||
47005402|NCT02204449|83253496|FG000|Overall Study|Lost to Follow-up|7|||
47005403|NCT02204449|83253497|FG001|Overall Study|Lost to Follow-up|9|||
47005404|NCT02204449|83253496|FG000|Overall Study|Death|0|||
47005405|NCT02204449|83253497|FG001|Overall Study|Death|1|||
47005406|NCT02204449|83253496|FG000|Overall Study|Withdrawal by Subject|0|||
47005407|NCT02204449|83253497|FG001|Overall Study|Withdrawal by Subject|1|||
47005408|NCT02308046|83253505|FG000|Overall Study|Negative yeast culture at Baseline|32|||
47005409|NCT02308046|83253506|FG001|Overall Study|Negative yeast culture at Baseline|33|||
47005410|NCT02308046|83253505|FG000|Overall Study|Positive for STD at Baseline|1|||
47005411|NCT02308046|83253506|FG001|Overall Study|Positive for STD at Baseline|2|||
47005412|NCT02308046|83253505|FG000|Overall Study|Lost to Follow-up|1|||
47005413|NCT02308046|83253506|FG001|Overall Study|Lost to Follow-up|3|||
47005414|NCT02318693|83253514|FG000|Overall Study|Protocol Violation|0|||
47005415|NCT02318693|83253515|FG001|Overall Study|Protocol Violation|1|||
47005416|NCT02230891|83253524|FG000|Baseline|Did not meet inclusion|0|||
47005417|NCT02230891|83253525|FG001|Baseline|Did not meet inclusion|1|||
47005418|NCT02230891|83253526|FG002|Baseline|Did not meet inclusion|1|||
47005419|NCT02230891|83253524|FG000|2 Week|Withdrawal by Subject|2|||
47005420|NCT02230891|83253525|FG001|2 Week|Withdrawal by Subject|2|||
47005421|NCT02230891|83253526|FG002|2 Week|Withdrawal by Subject|0|||
47005422|NCT02230891|83253524|FG000|2 Week|Consent withdrawn|1|||
47005423|NCT02230891|83253525|FG001|2 Week|Consent withdrawn|0|||
47005424|NCT02230891|83253526|FG002|2 Week|Consent withdrawn|0|||
47005425|NCT02230891|83253524|FG000|6 Month|Withdrawal by Subject|1|||
47005426|NCT02230891|83253525|FG001|6 Month|Withdrawal by Subject|1|||
47005427|NCT02230891|83253526|FG002|6 Month|Withdrawal by Subject|1|||
47005428|NCT02230891|83253524|FG000|6 Month|Physician Decision|0|||
47005429|NCT02230891|83253525|FG001|6 Month|Physician Decision|2|||
47005430|NCT02230891|83253526|FG002|6 Month|Physician Decision|0|||
47005431|NCT02230891|83253524|FG000|12 Month|Death|1|||
47005432|NCT02230891|83253525|FG001|12 Month|Death|0|||
47005433|NCT02230891|83253526|FG002|12 Month|Death|0|||
47005434|NCT02230891|83253524|FG000|12 Month|Lost to Follow-up|0|||
47005435|NCT02230891|83253525|FG001|12 Month|Lost to Follow-up|1|||
47005436|NCT02230891|83253526|FG002|12 Month|Lost to Follow-up|0|||
47005437|NCT02230891|83253524|FG000|12 Month|Withdrawal by Subject|0|||
47005438|NCT02230891|83253525|FG001|12 Month|Withdrawal by Subject|2|||
47005439|NCT02230891|83253526|FG002|12 Month|Withdrawal by Subject|0|||
47005440|NCT02230891|83253524|FG000|18 Month End of Study|Death|0|||
47005441|NCT02230891|83253525|FG001|18 Month End of Study|Death|0|||
47005442|NCT02230891|83253526|FG002|18 Month End of Study|Death|1|||
47005443|NCT02230891|83253524|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
47005444|NCT02230891|83253525|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
47005445|NCT02230891|83253526|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
47005446|NCT01646138|83253541|FG000|Overall Study|Lost to Follow-up|0|||
47005447|NCT01646138|83253542|FG001|Overall Study|Lost to Follow-up|0|||
47005448|NCT01646138|83253543|FG002|Overall Study|Lost to Follow-up|0|||
47005449|NCT01646138|83253544|FG003|Overall Study|Lost to Follow-up|0|||
47005450|NCT01646138|83253545|FG004|Overall Study|Lost to Follow-up|2|||
47005451|NCT02204371|83253557|FG000|Overall Study|Adverse Event|1|||
47005452|NCT02274857|83253563|FG000|Overall Study|Adverse Event|1|||
47005453|NCT02274857|83253564|FG001|Overall Study|Adverse Event|0|||
47005454|NCT02274857|83253563|FG000|Overall Study|Death|1|||
47005455|NCT02274857|83253564|FG001|Overall Study|Death|2|||
47005456|NCT02274857|83253563|FG000|Overall Study|Lost to Follow-up|3|||
47005457|NCT02274857|83253564|FG001|Overall Study|Lost to Follow-up|0|||
46709460|NCT01128894|82925513|FG001|Overall Study|Adverse Event|41|||
47005458|NCT02274857|83253563|FG000|Overall Study|Physician Decision|2|||
47005459|NCT02274857|83253564|FG001|Overall Study|Physician Decision|0|||
47005460|NCT02274857|83253563|FG000|Overall Study|Trial screen failure|0|||
47005461|NCT02274857|83253564|FG001|Overall Study|Trial screen failure|2|||
47005462|NCT02274857|83253563|FG000|Overall Study|Withdrawal by Subject|11|||
47005463|NCT02274857|83253564|FG001|Overall Study|Withdrawal by Subject|2|||
47005464|NCT02274857|83253563|FG000|Overall Study|Other|2|||
47005465|NCT02274857|83253564|FG001|Overall Study|Other|0|||
47005466|NCT02302859|83253573|FG000|Overall Study|Lost Phone|1|||
47005467|NCT02302859|83253574|FG001|Overall Study|Lost Phone|1|||
47005468|NCT02302859|83253573|FG000|Overall Study|Withdrawal by Subject|0|||
47005469|NCT02302859|83253574|FG001|Overall Study|Withdrawal by Subject|1|||
47005470|NCT02274311|83253580|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
47005471|NCT02316353|83253588|FG000|Overall Study|Pregnancy|1|||
47005472|NCT02316353|83253589|FG001|Overall Study|Pregnancy|3|||
47005473|NCT02316353|83253588|FG000|Overall Study|Adverse Event|1|||
47005474|NCT02316353|83253589|FG001|Overall Study|Adverse Event|3|||
47005475|NCT02316353|83253588|FG000|Overall Study|Withdrawal by Subject|6|||
47005476|NCT02316353|83253589|FG001|Overall Study|Withdrawal by Subject|2|||
47005477|NCT02273141|83253600|FG000|Overall Study|Adverse Event|0|||
47005478|NCT02273141|83253601|FG001|Overall Study|Adverse Event|1|||
47005479|NCT02273141|83253600|FG000|Overall Study|Lost to Follow-up|1|||
47005480|NCT02273141|83253601|FG001|Overall Study|Lost to Follow-up|3|||
47005481|NCT02273141|83253600|FG000|Overall Study|Withdrawal by Subject|10|||
47005482|NCT02273141|83253601|FG001|Overall Study|Withdrawal by Subject|15|||
47005483|NCT02273141|83253600|FG000|Overall Study|Various|6|||
47005484|NCT02273141|83253601|FG001|Overall Study|Various|6|||
47005485|NCT02314052|83253607|FG000|Cycle One|Adverse Event|0|||
47005486|NCT02314052|83253608|FG001|Cycle One|Adverse Event|0|||
47005487|NCT02314052|83253609|FG002|Cycle One|Adverse Event|0|||
47005488|NCT02314052|83253610|FG003|Cycle One|Adverse Event|1|||
47005489|NCT02314052|83253611|FG004|Cycle One|Adverse Event|0|||
47005490|NCT02314052|83253612|FG005|Cycle One|Adverse Event|0|||
47005491|NCT02279732|83253628|FG000|Overall Study|Death|23|||
47005492|NCT02279732|83253629|FG001|Overall Study|Death|20|||
47005493|NCT02279732|83253628|FG000|Overall Study|Disease Progression|13|||
47005494|NCT02279732|83253629|FG001|Overall Study|Disease Progression|3|||
47005495|NCT02279732|83253628|FG000|Overall Study|Withdrawal by Subject|2|||
47005496|NCT02279732|83253629|FG001|Overall Study|Withdrawal by Subject|7|||
47005497|NCT02279732|83253628|FG000|Overall Study|Adverse Event|1|||
47005498|NCT02279732|83253629|FG001|Overall Study|Adverse Event|2|||
47005499|NCT02279732|83253628|FG000|Overall Study|Administrative Reason By Sponsor|0|||
47005500|NCT02279732|83253629|FG001|Overall Study|Administrative Reason By Sponsor|2|||
47005501|NCT02279732|83253628|FG000|Overall Study|Study Drug Toxicity|2|||
47005502|NCT02279732|83253629|FG001|Overall Study|Study Drug Toxicity|0|||
47005503|NCT02279732|83253628|FG000|Overall Study|Lost to Follow-up|0|||
47005504|NCT02279732|83253629|FG001|Overall Study|Lost to Follow-up|1|||
47005505|NCT02279732|83253628|FG000|Overall Study|Maximum Clinical Benefit|1|||
47005506|NCT02279732|83253629|FG001|Overall Study|Maximum Clinical Benefit|0|||
47005507|NCT02279732|83253628|FG000|Overall Study|Subject Requested to Discontinue|0|||
47005508|NCT02279732|83253629|FG001|Overall Study|Subject Requested to Discontinue|1|||
47005509|NCT02279732|83253628|FG000|Overall Study|Other|53|||
47005510|NCT02279732|83253629|FG001|Overall Study|Other|67|||
47005511|NCT02279732|83253628|FG000|Overall Study|Other|3|||
47005512|NCT02279732|83253629|FG001|Overall Study|Other|3|||
47005513|NCT02279498|83253637|FG000|Overall Study|Adverse Event|3|||
47005514|NCT02279498|83253638|FG001|Overall Study|Adverse Event|0|||
47005515|NCT02279498|83253637|FG000|Overall Study|Lack of Efficacy|4|||
47005516|NCT02279498|83253638|FG001|Overall Study|Lack of Efficacy|0|||
47005517|NCT02279498|83253637|FG000|Overall Study|Lost to Follow-up|0|||
47005518|NCT02279498|83253638|FG001|Overall Study|Lost to Follow-up|1|||
47005519|NCT02279498|83253637|FG000|Overall Study|Withdrawal by Subject|9|||
47005520|NCT02279498|83253638|FG001|Overall Study|Withdrawal by Subject|2|||
47005521|NCT02279498|83253637|FG000|Overall Study|Undefined|2|||
47005522|NCT02279498|83253638|FG001|Overall Study|Undefined|1|||
47005523|NCT02307266|83253648|FG000|Overall Study|Adverse Event|3|||
47005524|NCT02307266|83253649|FG001|Overall Study|Adverse Event|1|||
47005525|NCT02307266|83253650|FG002|Overall Study|Adverse Event|5|||
47005526|NCT02307266|83253648|FG000|Overall Study|Withdrawal by Subject|2|||
47005527|NCT02307266|83253649|FG001|Overall Study|Withdrawal by Subject|0|||
47005528|NCT02307266|83253650|FG002|Overall Study|Withdrawal by Subject|1|||
47005529|NCT02307266|83253648|FG000|Overall Study|Lost to Follow-up|3|||
47005530|NCT02307266|83253649|FG001|Overall Study|Lost to Follow-up|0|||
47005531|NCT02307266|83253650|FG002|Overall Study|Lost to Follow-up|0|||
47005532|NCT02279420|83253658|FG000|Overall Study|Lost to Follow-up|23|||
47005533|NCT02278952|83253662|FG000|Overall Study|Insufficient Sample|6|||
47005534|NCT02278328|83253672|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
47005535|NCT02278328|83253673|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
47005536|NCT02278328|83253674|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
47005537|NCT02278328|83253672|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
47005538|NCT02278328|83253673|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
47005539|NCT02278328|83253674|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
47005540|NCT02278328|83253672|FG000|Neuropsych Screening|incomplete consent|0|||
47005541|NCT02278328|83253673|FG001|Neuropsych Screening|incomplete consent|0|||
47005542|NCT02278328|83253674|FG002|Neuropsych Screening|incomplete consent|2|||
47005543|NCT02314637|83253682|FG000|Overall Study|Adverse Event|4|||
47005544|NCT02314637|83253683|FG001|Overall Study|Adverse Event|8|||
47005545|NCT02314637|83253682|FG000|Overall Study|Lack of Efficacy|1|||
47005546|NCT02314637|83253683|FG001|Overall Study|Lack of Efficacy|0|||
47005547|NCT02314637|83253682|FG000|Overall Study|Physician Decision|5|||
47005548|NCT02314637|83253683|FG001|Overall Study|Physician Decision|2|||
47005549|NCT02314637|83253682|FG000|Overall Study|Withdrawal by Subject|5|||
47005550|NCT02314637|83253683|FG001|Overall Study|Withdrawal by Subject|4|||
47005551|NCT02314637|83253682|FG000|Overall Study|Other Reason|1|||
47005552|NCT02314637|83253683|FG001|Overall Study|Other Reason|0|||
47005553|NCT01646645|83253689|FG000|Overall Study|No Treated|1|||
47005554|NCT01646645|83253689|FG000|Overall Study|Inevaluable Donor|29|||
47005555|NCT02272985|83253693|FG000|Overall Study|Withdrawal by Subject|1|||
47005556|NCT02272985|83253693|FG000|Overall Study|hip fracture|1|||
47005557|NCT02272985|83253693|FG000|Overall Study|kidney transplantation|1|||
47005558|NCT01644149|83253700|FG000|Overall Study|Withdrawal by Subject|1|||
47005559|NCT01644149|83253701|FG001|Overall Study|Withdrawal by Subject|0|||
47005560|NCT01644149|83253700|FG000|Overall Study|Lost to Follow-up|3|||
47005561|NCT01644149|83253701|FG001|Overall Study|Lost to Follow-up|1|||
47005562|NCT02313233|83253710|FG000|Overall Study|Withdrawal by Subject|1|||
47005563|NCT02313233|83253711|FG001|Overall Study|Withdrawal by Subject|2|||
47005564|NCT02313233|83253710|FG000|Overall Study|Administrative reason|1|||
47005565|NCT02313233|83253711|FG001|Overall Study|Administrative reason|1|||
47005566|NCT02313155|83253721|FG000|Overall Study|Lost to Follow-up|0|||
46909977|NCT01345058|83139241|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
47005567|NCT02313155|83253722|FG001|Overall Study|Lost to Follow-up|1|||
47005568|NCT02204293|83253730|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
47005569|NCT02204293|83253731|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
47005570|NCT02204293|83253732|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
47005571|NCT02204293|83253733|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
47005572|NCT02204293|83253734|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
47005573|NCT02204293|83253735|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
47005574|NCT02204293|83253730|FG000|Core Study Part I|Adverse Event|1|||
47005575|NCT02204293|83253731|FG001|Core Study Part I|Adverse Event|0|||
47005576|NCT02204293|83253732|FG002|Core Study Part I|Adverse Event|0|||
47005577|NCT02204293|83253733|FG003|Core Study Part I|Adverse Event|0|||
47005578|NCT02204293|83253734|FG004|Core Study Part I|Adverse Event|0|||
47005579|NCT02204293|83253735|FG005|Core Study Part I|Adverse Event|0|||
47005580|NCT02204293|83253730|FG000|Core Study Part I|Physician Decision|0|||
47005581|NCT02204293|83253731|FG001|Core Study Part I|Physician Decision|3|||
47005582|NCT02204293|83253732|FG002|Core Study Part I|Physician Decision|0|||
47005583|NCT02204293|83253733|FG003|Core Study Part I|Physician Decision|0|||
47005584|NCT02204293|83253734|FG004|Core Study Part I|Physician Decision|0|||
47005585|NCT02204293|83253735|FG005|Core Study Part I|Physician Decision|0|||
47005586|NCT02204293|83253730|FG000|LTE Phase|Study Suspended|0|||
47005587|NCT02204293|83253731|FG001|LTE Phase|Study Suspended|0|||
47005588|NCT02204293|83253732|FG002|LTE Phase|Study Suspended|0|||
47005589|NCT02204293|83253733|FG003|LTE Phase|Study Suspended|0|||
47005590|NCT02204293|83253734|FG004|LTE Phase|Study Suspended|0|||
47005591|NCT02204293|83253735|FG005|LTE Phase|Study Suspended|7|||
47005592|NCT02304926|83253751|FG000|Overall Study|Lost to Follow-up|2|||
47005593|NCT02304926|83253752|FG001|Overall Study|Lost to Follow-up|1|||
47005594|NCT01646255|83253762|FG000|Overall Study|Adverse Event|7|||
47005595|NCT01646255|83253763|FG001|Overall Study|Adverse Event|8|||
47005596|NCT01646255|83253762|FG000|Overall Study|Lack of Efficacy|2|||
47005597|NCT01646255|83253763|FG001|Overall Study|Lack of Efficacy|0|||
47005598|NCT01646255|83253762|FG000|Overall Study|Withdrawal by Subject|10|||
47005599|NCT01646255|83253763|FG001|Overall Study|Withdrawal by Subject|6|||
47005600|NCT01646255|83253762|FG000|Overall Study|Compliance is not well|1|||
47005601|NCT01646255|83253763|FG001|Overall Study|Compliance is not well|0|||
47005602|NCT01646255|83253762|FG000|Overall Study|Inclusion Criteria Deviation|1|||
47005603|NCT01646255|83253763|FG001|Overall Study|Inclusion Criteria Deviation|0|||
47005604|NCT02304380|83253776|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
47005605|NCT02304380|83253777|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
47005606|NCT02304380|83253778|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
47005607|NCT02304380|83253779|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
47005608|NCT02304380|83253780|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
47005609|NCT02304380|83253781|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
47005610|NCT02203591|83253803|FG000|Overall Study|Did not meet treatment day baseline|147|||
47005611|NCT02203591|83253804|FG001|Overall Study|Did not meet treatment day baseline|141|||
47005612|NCT02203591|83253805|FG002|Overall Study|Did not meet treatment day baseline|150|||
47005613|NCT02203591|83253806|FG003|Overall Study|Did not meet treatment day baseline|45|||
46620477|NCT03682055|82769621|FG005|Overall Study|Termination of Study by Sponsor|3|||
46709461|NCT01128894|82925512|FG000|Overall Study|Protocol Violation|2|||
46709462|NCT01128894|82925513|FG001|Overall Study|Protocol Violation|1|||
46709463|NCT01128894|82925512|FG000|Overall Study|Noncompliance|4|||
47005614|NCT02203591|83253807|FG004|Overall Study|Did not meet treatment day baseline|33|||
47005615|NCT02203591|83253808|FG005|Overall Study|Did not meet treatment day baseline|35|||
47005616|NCT02203591|83253809|FG006|Overall Study|Did not meet treatment day baseline|29|||
47005617|NCT02203591|83253810|FG007|Overall Study|Did not meet treatment day baseline|12|||
47005618|NCT02203591|83253803|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
47005619|NCT02203591|83253804|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
47005620|NCT02203591|83253805|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
47005621|NCT02203591|83253806|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
46709464|NCT01128894|82925513|FG001|Overall Study|Noncompliance|5|||
47005622|NCT02203591|83253807|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
47005623|NCT02203591|83253808|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
47005624|NCT02203591|83253809|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
47005625|NCT02203591|83253810|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
47005626|NCT01642277|83253834|FG000|Overall Study|Adverse Event|10|||
47005627|NCT01642277|83253835|FG001|Overall Study|Adverse Event|0|||
47005628|NCT01642277|83253834|FG000|Overall Study|Physician Decision|2|||
47005629|NCT01642277|83253835|FG001|Overall Study|Physician Decision|0|||
47005630|NCT01642277|83253834|FG000|Overall Study|Protocol Violation|1|||
47005631|NCT01642277|83253835|FG001|Overall Study|Protocol Violation|0|||
47005632|NCT01642277|83253834|FG000|Overall Study|Withdrawal by Subject|11|||
47005633|NCT01642277|83253835|FG001|Overall Study|Withdrawal by Subject|0|||
47005634|NCT02230189|83253845|FG000|Overall Study|Withdrawal by Subject|3|||
46709465|NCT01128894|82925512|FG000|Overall Study|Lost to Follow-up|8|||
46709466|NCT01128894|82925513|FG001|Overall Study|Lost to Follow-up|8|||
46709467|NCT01128894|82925512|FG000|Overall Study|Withdrawal by Subject|10|||
46709468|NCT01128894|82925513|FG001|Overall Study|Withdrawal by Subject|12|||
46709469|NCT01128894|82925512|FG000|Overall Study|Physician Decision|2|||
46709470|NCT01128894|82925513|FG001|Overall Study|Physician Decision|1|||
46709471|NCT01128894|82925512|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
47005635|NCT02230189|83253846|FG001|Overall Study|Withdrawal by Subject|0|||
47005636|NCT02230189|83253847|FG002|Overall Study|Withdrawal by Subject|1|||
47005637|NCT02230189|83253845|FG000|Overall Study|Lost to Follow-up|1|||
47005638|NCT02230189|83253846|FG001|Overall Study|Lost to Follow-up|0|||
47005639|NCT02230189|83253847|FG002|Overall Study|Lost to Follow-up|0|||
47005640|NCT02230189|83253845|FG000|Overall Study|Physician Decision|1|||
47005641|NCT02230189|83253846|FG001|Overall Study|Physician Decision|0|||
47005642|NCT02230189|83253847|FG002|Overall Study|Physician Decision|0|||
47005643|NCT02304302|83253858|FG000|Overall Study|Adverse Event|2|||
47005644|NCT02304302|83253859|FG001|Overall Study|Adverse Event|3|||
47005645|NCT02304302|83253858|FG000|Overall Study|Lost to Follow-up|1|||
47005646|NCT02304302|83253859|FG001|Overall Study|Lost to Follow-up|4|||
47005647|NCT02304302|83253858|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
47005648|NCT02304302|83253859|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
47005649|NCT02276612|83253871|FG000|Overall Study|Death|1|||
47005650|NCT02276612|83253872|FG001|Overall Study|Death|0|||
47005651|NCT02276612|83253871|FG000|Overall Study|Pregnancy|1|||
47005652|NCT02276612|83253872|FG001|Overall Study|Pregnancy|0|||
47005653|NCT02276612|83253871|FG000|Overall Study|Withdrew Consent|1|||
47005654|NCT02276612|83253872|FG001|Overall Study|Withdrew Consent|0|||
47005655|NCT02276612|83253871|FG000|Overall Study|Lost to Follow-up|1|||
47005656|NCT02276612|83253872|FG001|Overall Study|Lost to Follow-up|0|||
47005657|NCT02301143|83253878|FG000|Induction Period|Enrolled But Not Treated|1|||
47005658|NCT02301143|83253879|FG001|Induction Period|Enrolled But Not Treated|0|||
47005659|NCT02301143|83253878|FG000|Induction Period|Death|1|||
47005660|NCT02301143|83253879|FG001|Induction Period|Death|0|||
47005661|NCT02301143|83253878|FG000|Induction Period|Adverse Event|22|||
47005662|NCT02301143|83253879|FG001|Induction Period|Adverse Event|0|||
47005663|NCT02301143|83253878|FG000|Induction Period|Progressive Disease|8|||
47005664|NCT02301143|83253879|FG001|Induction Period|Progressive Disease|0|||
47005665|NCT02301143|83253878|FG000|Induction Period|Withdrawal by Subject|3|||
47005666|NCT02301143|83253879|FG001|Induction Period|Withdrawal by Subject|0|||
47005667|NCT02301143|83253878|FG000|Induction Period|Noncompliance with Study Drug|1|||
47005668|NCT02301143|83253879|FG001|Induction Period|Noncompliance with Study Drug|0|||
47005669|NCT02301143|83253878|FG000|Induction Period|Physician Decision|4|||
47005670|NCT02301143|83253879|FG001|Induction Period|Physician Decision|0|||
47005671|NCT02301143|83253878|FG000|Induction Period|Symptomatic Deterioration|2|||
47005672|NCT02301143|83253879|FG001|Induction Period|Symptomatic Deterioration|0|||
47005673|NCT02301143|83253878|FG000|Induction Period|Protocol Violation|2|||
47005674|NCT02301143|83253879|FG001|Induction Period|Protocol Violation|0|||
47005675|NCT02301143|83253878|FG000|Induction Period|Other|1|||
47005676|NCT02301143|83253879|FG001|Induction Period|Other|0|||
47005677|NCT02301143|83253878|FG000|Investigator's Choice|Adverse Event|0|||
47005678|NCT02301143|83253879|FG001|Investigator's Choice|Adverse Event|3|||
47005679|NCT02301143|83253878|FG000|Investigator's Choice|Progressive Disease|0|||
47005680|NCT02301143|83253879|FG001|Investigator's Choice|Progressive Disease|3|||
47005681|NCT02301143|83253878|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
47005682|NCT02301143|83253879|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
47005683|NCT02301143|83253878|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
47005684|NCT02301143|83253879|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
47005685|NCT02301143|83253878|FG000|Investigator's Choice|Other|0|||
47005686|NCT02301143|83253879|FG001|Investigator's Choice|Other|1|||
47005687|NCT02301143|83253878|FG000|Investigator's Choice|Unresectable Surgery|0|||
46709472|NCT01128894|82925513|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
46709473|NCT01220180|82925522|FG000|Overall Study|Lost to Follow-up|76|||
47005688|NCT02301143|83253879|FG001|Investigator's Choice|Unresectable Surgery|1|||
47005689|NCT02276222|83253892|FG000|Overall Study|Adverse Event|62|||
47005690|NCT02276222|83253893|FG001|Overall Study|Adverse Event|11|||
47005691|NCT02276222|83253892|FG000|Overall Study|Death|3|||
47005692|NCT02276222|83253893|FG001|Overall Study|Death|4|||
47005693|NCT02276222|83253892|FG000|Overall Study|Lack of Efficacy|13|||
47005694|NCT02276222|83253893|FG001|Overall Study|Lack of Efficacy|3|||
47005695|NCT02276222|83253892|FG000|Overall Study|Protocol Violation|3|||
47005696|NCT02276222|83253893|FG001|Overall Study|Protocol Violation|2|||
47005697|NCT02276222|83253892|FG000|Overall Study|Withdrawal by Subject|79|||
47005698|NCT02276222|83253893|FG001|Overall Study|Withdrawal by Subject|33|||
47005699|NCT02276222|83253892|FG000|Overall Study|non compliance with study medication|6|||
47005700|NCT02276222|83253893|FG001|Overall Study|non compliance with study medication|2|||
47005701|NCT02276222|83253892|FG000|Overall Study|sponsor decision|0|||
47005702|NCT02276222|83253893|FG001|Overall Study|sponsor decision|3|||
47005703|NCT02276222|83253892|FG000|Overall Study|Lost to Follow-up|15|||
47005704|NCT02276222|83253893|FG001|Overall Study|Lost to Follow-up|5|||
47005705|NCT02276222|83253892|FG000|Overall Study|Physician Decision|2|||
47005706|NCT02276222|83253893|FG001|Overall Study|Physician Decision|1|||
47005707|NCT02276222|83253892|FG000|Overall Study|sheduling conflict|1|||
47005708|NCT02276222|83253893|FG001|Overall Study|sheduling conflict|0|||
47005709|NCT02276222|83253892|FG000|Overall Study|subject withdrew after randomization|1|||
47005710|NCT02276222|83253893|FG001|Overall Study|subject withdrew after randomization|0|||
47005711|NCT02275364|83253899|FG000|Period 1|Withdrawal by Subject|1|||
47005712|NCT02275364|83253900|FG001|Period 1|Withdrawal by Subject|0|||
47005713|NCT02275364|83253899|FG000|Period 1|Other reason|1|||
47005714|NCT02275364|83253900|FG001|Period 1|Other reason|0|||
47005715|NCT02275052|83253917|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
47005716|NCT02275052|83253918|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
47005717|NCT02275052|83253919|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
47005718|NCT02275052|83253920|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
47005719|NCT02275052|83253917|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
47005720|NCT02275052|83253918|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
47005721|NCT02275052|83253919|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
47005722|NCT02275052|83253920|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
47005723|NCT02275052|83253917|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
47005724|NCT02275052|83253918|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
47005725|NCT02275052|83253919|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
47005726|NCT02275052|83253920|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
47005727|NCT02275052|83253917|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
47005728|NCT02275052|83253918|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
47005729|NCT02275052|83253919|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
47005730|NCT02275052|83253920|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
47005731|NCT02275052|83253917|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
47005732|NCT02275052|83253918|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
47005733|NCT02275052|83253919|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
47005734|NCT02275052|83253920|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
47005735|NCT02275052|83253917|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
47005736|NCT02275052|83253918|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
47005737|NCT02275052|83253919|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
47005738|NCT02275052|83253920|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
47005739|NCT02275052|83253917|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
47005740|NCT02275052|83253918|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
47005741|NCT02275052|83253919|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
47005742|NCT02275052|83253920|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
47005743|NCT02275052|83253917|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
47005744|NCT02275052|83253918|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
47005745|NCT02275052|83253919|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
47005746|NCT02275052|83253920|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
47005747|NCT02275052|83253917|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
47005748|NCT02275052|83253918|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46709474|NCT01220180|82925522|FG000|Overall Study|Other|72|||
46709475|NCT01220180|82925522|FG000|Overall Study|Adverse Event|35|||
46709476|NCT01220180|82925522|FG000|Overall Study|Lack of Efficacy|22|||
46709477|NCT01220180|82925522|FG000|Overall Study|Death|1|||
47005749|NCT02275052|83253919|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
47005750|NCT02275052|83253920|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
47005751|NCT02275052|83253917|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
47005752|NCT02275052|83253918|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
47005753|NCT02275052|83253919|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
47005754|NCT02275052|83253920|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
47005755|NCT02275052|83253917|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
47005756|NCT02275052|83253918|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
47005757|NCT02275052|83253919|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
47005758|NCT02275052|83253920|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
47005759|NCT02274038|83253926|FG000|Overall Study|Death|1|||
47005760|NCT02300558|83253932|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
47005761|NCT02300558|83253932|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
47005762|NCT02300558|83253932|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
47005763|NCT02300558|83253932|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
47005764|NCT02273960|83253944|FG000|Short Term Period|Lost to Follow-up|1|||
47005765|NCT02273960|83253945|FG001|Short Term Period|Lost to Follow-up|0|||
47005766|NCT02273960|83253946|FG002|Short Term Period|Lost to Follow-up|0|||
47005767|NCT02273960|83253947|FG003|Short Term Period|Lost to Follow-up|0|||
47005768|NCT02273960|83253944|FG000|Short Term Period|Lack of Efficacy|0|||
47005769|NCT02273960|83253945|FG001|Short Term Period|Lack of Efficacy|0|||
47005770|NCT02273960|83253946|FG002|Short Term Period|Lack of Efficacy|0|||
47005771|NCT02273960|83253947|FG003|Short Term Period|Lack of Efficacy|1|||
47005772|NCT02273960|83253944|FG000|Short Term Period|ST complete, not entering LTE|4|||
47005773|NCT02273960|83253945|FG001|Short Term Period|ST complete, not entering LTE|6|||
47005774|NCT02273960|83253946|FG002|Short Term Period|ST complete, not entering LTE|4|||
47005775|NCT02273960|83253947|FG003|Short Term Period|ST complete, not entering LTE|5|||
47005776|NCT02273960|83253944|FG000|Long Term Extension|Death|0|||
47005777|NCT02273960|83253945|FG001|Long Term Extension|Death|0|||
47005778|NCT02273960|83253946|FG002|Long Term Extension|Death|0|||
47005779|NCT02273960|83253947|FG003|Long Term Extension|Death|1|||
47005780|NCT01646021|83253959|FG000|Overall Study|Death|77|||
47005781|NCT01646021|83253960|FG001|Overall Study|Death|83|||
47005782|NCT01646021|83253959|FG000|Overall Study|Study Terminated by Sponsor|50|||
47005783|NCT01646021|83253960|FG001|Overall Study|Study Terminated by Sponsor|41|||
47005784|NCT01646021|83253959|FG000|Overall Study|Lost to Follow-up|2|||
47005785|NCT01646021|83253960|FG001|Overall Study|Lost to Follow-up|2|||
47005786|NCT01646021|83253959|FG000|Overall Study|Withdrawal by Subject|10|||
47005787|NCT01646021|83253960|FG001|Overall Study|Withdrawal by Subject|15|||
47005788|NCT01750918|83253977|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
47005789|NCT01750918|83253978|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
47005790|NCT01750918|83253979|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
47005791|NCT01750918|83253980|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
47005792|NCT01750918|83253981|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
47005793|NCT01750918|83253982|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
47005794|NCT01750918|83253983|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
47005795|NCT01750918|83253984|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
47005796|NCT01750918|83253977|FG000|Overall Study|Lost to Follow-up|0|||
47005797|NCT01750918|83253978|FG001|Overall Study|Lost to Follow-up|0|||
47005798|NCT01750918|83253979|FG002|Overall Study|Lost to Follow-up|2|||
47005799|NCT01750918|83253980|FG003|Overall Study|Lost to Follow-up|2|||
47005800|NCT01750918|83253981|FG004|Overall Study|Lost to Follow-up|0|||
47005801|NCT01750918|83253982|FG005|Overall Study|Lost to Follow-up|0|||
47005802|NCT01750918|83253983|FG006|Overall Study|Lost to Follow-up|0|||
47005803|NCT01750918|83253984|FG007|Overall Study|Lost to Follow-up|1|||
47005804|NCT01750918|83253977|FG000|Overall Study|Withdrawal by Subject|0|||
47005805|NCT01750918|83253978|FG001|Overall Study|Withdrawal by Subject|0|||
47005806|NCT01750918|83253979|FG002|Overall Study|Withdrawal by Subject|1|||
47005807|NCT01750918|83253980|FG003|Overall Study|Withdrawal by Subject|2|||
47005808|NCT01750918|83253981|FG004|Overall Study|Withdrawal by Subject|1|||
47005809|NCT01750918|83253982|FG005|Overall Study|Withdrawal by Subject|1|||
47005810|NCT01750918|83253983|FG006|Overall Study|Withdrawal by Subject|2|||
47005811|NCT01750918|83253984|FG007|Overall Study|Withdrawal by Subject|2|||
47005812|NCT02300987|83254016|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
46620478|NCT03547518|82769637|FG000|Overall Study|Lost to Follow-up|2|||
47005813|NCT02300987|83254017|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
47005814|NCT02300987|83254016|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
47005815|NCT02300987|83254017|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
47005816|NCT02300987|83254016|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
47005817|NCT02300987|83254017|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
47005818|NCT02300987|83254016|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
47005819|NCT02300987|83254017|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
47005820|NCT02300987|83254016|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
47005821|NCT02300987|83254017|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
47005822|NCT01750840|83254024|FG000|Overall Study|Lost to Follow-up|4|||
47005823|NCT01606228|83254029|FG000|Overall Study|Lost to Follow-up|20|||
47005824|NCT01606228|83254029|FG000|Overall Study|Withdrawal by Subject|3|||
46709478|NCT01220180|82925522|FG000|Overall Study|Randomized but not treated|1|||
47005825|NCT01606228|83254029|FG000|Overall Study|Non-compliant|3|||
47005826|NCT01606228|83254029|FG000|Overall Study|Lack of Efficacy|2|||
47005827|NCT01606228|83254029|FG000|Overall Study|Adverse Event|1|||
47005828|NCT01706536|83254038|FG000|Overall Study|Withdrawal by Subject|1|||
47005829|NCT01706536|83254039|FG001|Overall Study|Withdrawal by Subject|0|||
47005830|NCT01706536|83254040|FG002|Overall Study|Withdrawal by Subject|1|||
47005831|NCT01706536|83254041|FG003|Overall Study|Withdrawal by Subject|0|||
47005832|NCT01706536|83254042|FG004|Overall Study|Withdrawal by Subject|0|||
47005833|NCT01706536|83254038|FG000|Overall Study|Adverse Event|2|||
47005834|NCT01706536|83254039|FG001|Overall Study|Adverse Event|3|||
47005835|NCT01706536|83254040|FG002|Overall Study|Adverse Event|4|||
47005836|NCT01706536|83254041|FG003|Overall Study|Adverse Event|3|||
47005837|NCT01706536|83254042|FG004|Overall Study|Adverse Event|2|||
47005838|NCT01706536|83254038|FG000|Overall Study|Lack of Efficacy|1|||
47005839|NCT01706536|83254039|FG001|Overall Study|Lack of Efficacy|0|||
47005840|NCT01706536|83254040|FG002|Overall Study|Lack of Efficacy|0|||
47005841|NCT01706536|83254041|FG003|Overall Study|Lack of Efficacy|1|||
47005842|NCT01706536|83254042|FG004|Overall Study|Lack of Efficacy|0|||
47005843|NCT01706536|83254038|FG000|Overall Study|non compliance|0|||
47005844|NCT01706536|83254039|FG001|Overall Study|non compliance|1|||
47005845|NCT01706536|83254040|FG002|Overall Study|non compliance|0|||
47005846|NCT01706536|83254041|FG003|Overall Study|non compliance|0|||
47005847|NCT01706536|83254042|FG004|Overall Study|non compliance|0|||
47005848|NCT02269943|83254057|FG000|Treatment Period|Death|0|||
47005849|NCT02269943|83254058|FG001|Treatment Period|Death|1|||
47005850|NCT02269943|83254057|FG000|Treatment Period|Adverse Event|1|||
47005851|NCT02269943|83254058|FG001|Treatment Period|Adverse Event|10|||
47005852|NCT02269943|83254057|FG000|Treatment Period|Progressive Disease|5|||
47005853|NCT02269943|83254058|FG001|Treatment Period|Progressive Disease|17|||
47005854|NCT02269943|83254057|FG000|Treatment Period|Symptomatic Deterioration|0|||
47005855|NCT02269943|83254058|FG001|Treatment Period|Symptomatic Deterioration|2|||
46620479|NCT03547518|82769638|FG001|Overall Study|Lost to Follow-up|0|||
46620480|NCT03519347|82769649|FG000|Interventional Crossover Period 1|Death|0|||
46620481|NCT03519347|82769650|FG001|Interventional Crossover Period 1|Death|0|||
46620482|NCT03519347|82769651|FG002|Interventional Crossover Period 1|Death|0|||
46620483|NCT03519347|82769652|FG003|Interventional Crossover Period 1|Death|1|||
46620484|NCT03199638|82769690|FG000|Overall Study|inability to drink glutamine during regularly|0|||
46620485|NCT03199638|82769691|FG001|Overall Study|inability to drink glutamine during regularly|2|||
46620486|NCT03015194|82769710|FG000|Overall Study|Death|10|||
46620487|NCT03015194|82769710|FG000|Overall Study|Withdrawal by Subject|2|||
47005856|NCT02269943|83254057|FG000|Follow-Up Survival Period|Death|3|||
47005857|NCT02269943|83254058|FG001|Follow-Up Survival Period|Death|16|||
47005858|NCT02269943|83254057|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
47005859|NCT02269943|83254058|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
46620492|NCT02536300|82769740|FG000|Overall Study|Investigator's Discretion|17|||
46620493|NCT02536300|82769741|FG001|Overall Study|Investigator's Discretion|11|||
46620494|NCT02536300|82769742|FG002|Overall Study|Investigator's Discretion|2|||
46620495|NCT02536300|82769740|FG000|Overall Study|Progressive Disease|11|||
46620496|NCT02536300|82769741|FG001|Overall Study|Progressive Disease|7|||
46620497|NCT02536300|82769742|FG002|Overall Study|Progressive Disease|6|||
46620498|NCT02536300|82769740|FG000|Overall Study|Study Terminated by Sponsor|6|||
46620499|NCT02536300|82769741|FG001|Overall Study|Study Terminated by Sponsor|4|||
46620500|NCT02536300|82769742|FG002|Overall Study|Study Terminated by Sponsor|7|||
46620501|NCT02536300|82769740|FG000|Overall Study|Death|7|||
46620502|NCT02536300|82769741|FG001|Overall Study|Death|0|||
46709479|NCT01220024|82925528|FG000|Overall Study|Lost to Follow-up|1|||
47005860|NCT02269943|83254057|FG000|Follow-Up Survival Period|Alive|2|||
47005861|NCT02269943|83254058|FG001|Follow-Up Survival Period|Alive|8|||
47005862|NCT01706458|83254066|FG000|Overall Study|Physician Decision|3|||
47005863|NCT01706458|83254067|FG001|Overall Study|Physician Decision|4|||
47005864|NCT02269787|83254075|FG000|Overall Study|Lost to Follow-up|20|||
47005865|NCT02269787|83254076|FG001|Overall Study|Lost to Follow-up|6|||
47005866|NCT02269787|83254075|FG000|Overall Study|Death|2|||
47005867|NCT02269787|83254076|FG001|Overall Study|Death|3|||
47005868|NCT02269787|83254075|FG000|Overall Study|Incapacitated|0|||
47005869|NCT02269787|83254076|FG001|Overall Study|Incapacitated|1|||
47005870|NCT01605370|83254084|FG000|Overall Study|Adverse Event|1|||
47005871|NCT01605370|83254085|FG001|Overall Study|Adverse Event|0|||
47005872|NCT02269709|83254091|FG000|Time of Enrollment|Withdrawal by Subject|3|||
47005873|NCT02269709|83254091|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
47005874|NCT02269709|83254091|FG000|Six Month Follow-up|Lost to Follow-up|12|||
47005875|NCT02269475|83254098|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
47005876|NCT02269475|83254099|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
47005877|NCT02269475|83254098|FG000|Overall Study|Withdrawal by Subject|0|||
47005878|NCT02269475|83254099|FG001|Overall Study|Withdrawal by Subject|1|||
47005879|NCT01605136|83254108|FG000|Study Period|Withdrawal by Subject|2|||
47005880|NCT01605136|83254109|FG001|Study Period|Withdrawal by Subject|0|||
47005881|NCT01605136|83254108|FG000|Study Period|Physician Decision|1|||
47005882|NCT01605136|83254109|FG001|Study Period|Physician Decision|1|||
47005883|NCT01605136|83254108|FG000|Study Period|Lost to Follow-up|0|||
47005884|NCT01605136|83254109|FG001|Study Period|Lost to Follow-up|2|||
47005885|NCT01605136|83254108|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
47005886|NCT01605136|83254109|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
47005887|NCT01706146|83254115|FG000|Overall Study|Withdrawal by Subject|1|||
47005888|NCT01706146|83254115|FG000|Overall Study|Adverse Event|3|||
47005889|NCT01706146|83254115|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
47005890|NCT02269241|83254119|FG000|Overall Study|Lost to Follow-up|269|||
47005891|NCT02269241|83254119|FG000|Overall Study|Withdrawal by Subject|155|||
47005892|NCT02269241|83254119|FG000|Overall Study|Protocol Violation|1|||
47005893|NCT02269241|83254119|FG000|Overall Study|Physician Decision|7|||
47005894|NCT02269241|83254119|FG000|Overall Study|Pregnancy|15|||
47005895|NCT02269241|83254119|FG000|Overall Study|Wish for pregnancy|5|||
47005896|NCT02269241|83254119|FG000|Overall Study|Development of an exclusion criteria|16|||
47005897|NCT02269241|83254119|FG000|Overall Study|Adverse Event|113|||
47005898|NCT02269241|83254119|FG000|Overall Study|At the specific request of the sponsor|20|||
47005899|NCT02269241|83254119|FG000|Overall Study|Several reasons not classified|53|||
47005900|NCT02269241|83254119|FG000|Overall Study|Screening failures|546|||
47005901|NCT01750684|83254126|FG000|Overall Study|Death|1|||
47005902|NCT01750684|83254127|FG001|Overall Study|Death|0|||
47005903|NCT01750684|83254126|FG000|Overall Study|Non-compliance with Study Drug|0|||
47005904|NCT01750684|83254127|FG001|Overall Study|Non-compliance with Study Drug|1|||
47005905|NCT01750684|83254126|FG000|Overall Study|Withdrawn by Sponsor|0|||
47005906|NCT01750684|83254127|FG001|Overall Study|Withdrawn by Sponsor|1|||
47005907|NCT01750684|83254126|FG000|Overall Study|Protocol Violation|1|||
47005908|NCT01750684|83254127|FG001|Overall Study|Protocol Violation|0|||
47005909|NCT01750294|83254134|FG000|Overall Study|Withdrawal by Subject|1|||
47005910|NCT01750294|83254134|FG000|Overall Study|Safety Endpoint|1|||
47005911|NCT01749982|83254142|FG000|Overall Study|Physician Decision|0|||
47005912|NCT01749982|83254143|FG001|Overall Study|Physician Decision|0|||
47005913|NCT01749982|83254144|FG002|Overall Study|Physician Decision|0|||
47005914|NCT01749982|83254145|FG003|Overall Study|Physician Decision|1|||
47005915|NCT01749982|83254142|FG000|Overall Study|Lost to Follow-up|0|||
47005916|NCT01749982|83254143|FG001|Overall Study|Lost to Follow-up|0|||
47005917|NCT01749982|83254144|FG002|Overall Study|Lost to Follow-up|0|||
47005918|NCT01749982|83254145|FG003|Overall Study|Lost to Follow-up|1|||
47005919|NCT01749982|83254142|FG000|Overall Study|Withdrawal by Subject|0|||
47005920|NCT01749982|83254143|FG001|Overall Study|Withdrawal by Subject|0|||
47005921|NCT01749982|83254144|FG002|Overall Study|Withdrawal by Subject|0|||
47005922|NCT01749982|83254145|FG003|Overall Study|Withdrawal by Subject|1|||
47005923|NCT02269163|83254157|FG000|Overall Study|Lost to Follow-up|1|||
47005924|NCT02269163|83254158|FG001|Overall Study|Lost to Follow-up|0|||
47005925|NCT02269163|83254157|FG000|Overall Study|Major protocol violation|0|||
47005926|NCT02269163|83254158|FG001|Overall Study|Major protocol violation|1|||
47005927|NCT02269163|83254157|FG000|Overall Study|Other|2|||
47005928|NCT02269163|83254158|FG001|Overall Study|Other|2|||
47005929|NCT02269163|83254157|FG000|Overall Study|Withdrawal by Subject|0|||
47005930|NCT02269163|83254158|FG001|Overall Study|Withdrawal by Subject|3|||
47005931|NCT02269163|83254157|FG000|Overall Study|Physician Decision|0|||
47005932|NCT02269163|83254158|FG001|Overall Study|Physician Decision|1|||
47005933|NCT01749826|83254168|FG000|Overall Study|Study Terminated|20|||
47005934|NCT01749826|83254169|FG001|Overall Study|Study Terminated|0|||
47005935|NCT02300129|83254175|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
47005936|NCT02300129|83254176|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
47005937|NCT02300129|83254177|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
47005938|NCT02300129|83254178|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
47005939|NCT02300129|83254175|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
47005940|NCT02300129|83254176|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
47005941|NCT02300129|83254177|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
47005942|NCT02300129|83254178|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
47005943|NCT02300129|83254175|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
47005944|NCT02300129|83254176|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
47005945|NCT02300129|83254177|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
47005946|NCT02300129|83254178|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
47005947|NCT02267135|83254190|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
47005948|NCT02267135|83254191|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
47005949|NCT02267135|83254190|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
47005950|NCT02267135|83254191|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
47005951|NCT02267135|83254190|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
47005952|NCT02267135|83254191|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
47005953|NCT02267135|83254190|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
47005954|NCT02267135|83254191|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
47005955|NCT02267135|83254190|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
47005956|NCT02267135|83254191|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
47005957|NCT02299427|83254202|FG000|Overall Study|Withdrawal by Subject|1|||
47005958|NCT02299427|83254203|FG001|Overall Study|Withdrawal by Subject|0|||
47005959|NCT02299427|83254202|FG000|Overall Study|Lost to Follow-up|1|||
47005960|NCT02299427|83254203|FG001|Overall Study|Lost to Follow-up|3|||
47005961|NCT02299427|83254202|FG000|Overall Study|not adherent to dog website use|21|||
47005962|NCT02299427|83254203|FG001|Overall Study|not adherent to dog website use|0|||
47005963|NCT01724866|83254213|FG000|Overall Study|Adverse Event|0|||
47005964|NCT01724866|83254214|FG001|Overall Study|Adverse Event|0|||
47005965|NCT01724866|83254215|FG002|Overall Study|Adverse Event|1|||
47005966|NCT01724866|83254216|FG003|Overall Study|Adverse Event|1|||
47005967|NCT01724866|83254213|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
47005968|NCT01724866|83254214|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
47005969|NCT01724866|83254215|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
47005970|NCT01724866|83254216|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
47005971|NCT01724866|83254213|FG000|Overall Study|Investigator's Discretion|0|||
47005972|NCT01724866|83254214|FG001|Overall Study|Investigator's Discretion|1|||
47005973|NCT01724866|83254215|FG002|Overall Study|Investigator's Discretion|1|||
47005974|NCT01724866|83254216|FG003|Overall Study|Investigator's Discretion|0|||
47005975|NCT01724866|83254213|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
47005976|NCT01724866|83254214|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
47005977|NCT01724866|83254215|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
47005978|NCT01724866|83254216|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
47005979|NCT01724866|83254213|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
47005980|NCT01724866|83254214|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
47005981|NCT01724866|83254215|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
47005982|NCT01724866|83254216|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
47005983|NCT02266433|83254228|FG000|Overall Study|Lost to Follow-up|54|||
47005984|NCT02266433|83254229|FG001|Overall Study|Lost to Follow-up|46|||
47005985|NCT02266433|83254228|FG000|Overall Study|Withdrawal by Subject|5|||
47005986|NCT02266433|83254229|FG001|Overall Study|Withdrawal by Subject|7|||
47005987|NCT01748890|83254236|FG000|Overall Study|Insufficient recruitment for analysis|4|||
47005988|NCT01747876|83254243|FG000|Overall Study|Adverse Event|1|||
47005989|NCT01747876|83254244|FG001|Overall Study|Adverse Event|0|||
47005990|NCT01747876|83254245|FG002|Overall Study|Adverse Event|2|||
47005991|NCT01747876|83254243|FG000|Overall Study|Withdrawal by Subject|0|||
47005992|NCT01747876|83254244|FG001|Overall Study|Withdrawal by Subject|1|||
47005993|NCT01747876|83254245|FG002|Overall Study|Withdrawal by Subject|1|||
47005994|NCT01747876|83254243|FG000|Overall Study|Disease progression|4|||
47005995|NCT01747876|83254244|FG001|Overall Study|Disease progression|13|||
47005996|NCT01747876|83254245|FG002|Overall Study|Disease progression|8|||
47005997|NCT01747876|83254243|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
47005998|NCT01747876|83254244|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
47005999|NCT01747876|83254245|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
47006000|NCT02273726|83254258|FG000|Overall Study|Death|70|||
47006001|NCT02273726|83254259|FG001|Overall Study|Death|62|||
47006002|NCT02273726|83254258|FG000|Overall Study|Withdrawal by Subject|41|||
46620503|NCT02536300|82769742|FG002|Overall Study|Death|5|||
47006003|NCT02273726|83254259|FG001|Overall Study|Withdrawal by Subject|29|||
47006004|NCT02273726|83254258|FG000|Overall Study|Kidney transplant|31|||
47006005|NCT02273726|83254259|FG001|Overall Study|Kidney transplant|39|||
47006006|NCT02273726|83254258|FG000|Overall Study|Physician Decision|30|||
47006007|NCT02273726|83254259|FG001|Overall Study|Physician Decision|15|||
47006008|NCT02273726|83254258|FG000|Overall Study|Adverse Event|27|||
47006009|NCT02273726|83254259|FG001|Overall Study|Adverse Event|9|||
47006010|NCT02273726|83254258|FG000|Overall Study|Lost to Follow-up|6|||
47006011|NCT02273726|83254259|FG001|Overall Study|Lost to Follow-up|3|||
47006012|NCT02273726|83254258|FG000|Overall Study|Lack of Efficacy|6|||
47006013|NCT02273726|83254259|FG001|Overall Study|Lack of Efficacy|1|||
47006014|NCT02273726|83254258|FG000|Overall Study|Protocol Violation|4|||
47006015|NCT02273726|83254259|FG001|Overall Study|Protocol Violation|0|||
47006016|NCT02273726|83254258|FG000|Overall Study|Other than specified|28|||
47006017|NCT02273726|83254259|FG001|Overall Study|Other than specified|30|||
47006018|NCT01723228|83254267|FG000|Overall Study|Adverse Event|2|||
47006019|NCT01723228|83254268|FG001|Overall Study|Adverse Event|6|||
47006020|NCT01723228|83254267|FG000|Overall Study|Withdrawal by Subject|2|||
47006021|NCT01723228|83254268|FG001|Overall Study|Withdrawal by Subject|1|||
47006022|NCT01723228|83254267|FG000|Overall Study|Protocol Violation|0|||
47006023|NCT01723228|83254268|FG001|Overall Study|Protocol Violation|2|||
47006024|NCT01723228|83254267|FG000|Overall Study|Lost to Follow-up|2|||
47006025|NCT01723228|83254268|FG001|Overall Study|Lost to Follow-up|1|||
47006026|NCT01723228|83254267|FG000|Overall Study|Other|2|||
47006027|NCT01723228|83254268|FG001|Overall Study|Other|1|||
47006028|NCT02273180|83254276|FG000|Overall Study|Adverse Event|2|||
47006029|NCT02273180|83254277|FG001|Overall Study|Adverse Event|2|||
47006030|NCT02273180|83254276|FG000|Overall Study|Lack of Efficacy|1|||
47006031|NCT02273180|83254277|FG001|Overall Study|Lack of Efficacy|0|||
47006032|NCT02273180|83254276|FG000|Overall Study|Protocol Violation|1|||
47006033|NCT02273180|83254277|FG001|Overall Study|Protocol Violation|7|||
47006034|NCT02273180|83254276|FG000|Overall Study|Randomized but not treated|1|||
47006035|NCT02273180|83254277|FG001|Overall Study|Randomized but not treated|0|||
47006036|NCT02273180|83254276|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
47006037|NCT02273180|83254277|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
47006038|NCT02273180|83254276|FG000|Overall Study|Other than specified above|21|||
47006039|NCT02273180|83254277|FG001|Overall Study|Other than specified above|10|||
47006040|NCT01746862|83254285|FG000|Overall Study|Withdrawal by Subject|1|||
47006041|NCT01746862|83254286|FG001|Overall Study|Withdrawal by Subject|1|||
47006042|NCT01746862|83254285|FG000|Overall Study|Protocol Violation|1|||
47006043|NCT01746862|83254286|FG001|Overall Study|Protocol Violation|0|||
47006044|NCT01746862|83254285|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
47006045|NCT01746862|83254286|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
47006046|NCT01746862|83254285|FG000|Overall Study|Entered puberty during the study|1|||
47006047|NCT01746862|83254286|FG001|Overall Study|Entered puberty during the study|0|||
47006048|NCT01745848|83254293|FG000|Overall Study|Adverse Event|6|||
47006049|NCT01745380|83254299|FG000|Overall Study|Lost to Follow-up|1|||
47006050|NCT01745380|83254300|FG001|Overall Study|Lost to Follow-up|0|||
47006051|NCT01745380|83254299|FG000|Overall Study|Lack of Efficacy|0|||
47006052|NCT01745380|83254300|FG001|Overall Study|Lack of Efficacy|1|||
47006053|NCT01745146|83254308|FG000|Overall Study|Withdrawal by Subject|1|||
47006054|NCT01745146|83254309|FG001|Overall Study|Withdrawal by Subject|3|||
47006055|NCT01745146|83254308|FG000|Overall Study|Lost to Follow-up|2|||
47006056|NCT01745146|83254309|FG001|Overall Study|Lost to Follow-up|0|||
47006057|NCT02203513|83254321|FG000|Overall Study|Refused further treatment|2|||
47006058|NCT02203513|83254322|FG001|Overall Study|Refused further treatment|0|||
47006059|NCT02203513|83254323|FG002|Overall Study|Refused further treatment|1|||
47006060|NCT02203513|83254324|FG003|Overall Study|Refused further treatment|0|||
47006061|NCT02203513|83254325|FG004|Overall Study|Refused further treatment|0|||
47006062|NCT02203513|83254321|FG000|Overall Study|Switched to alternative treatment|3|||
47006063|NCT02203513|83254322|FG001|Overall Study|Switched to alternative treatment|4|||
47006064|NCT02203513|83254323|FG002|Overall Study|Switched to alternative treatment|0|||
47006065|NCT02203513|83254324|FG003|Overall Study|Switched to alternative treatment|0|||
47006066|NCT02203513|83254325|FG004|Overall Study|Switched to alternative treatment|4|||
46709480|NCT01220024|82925529|FG001|Overall Study|Lost to Follow-up|1|||
46909978|NCT01345292|83139250|FG000|Overall Study|Withdrawal by Subject|2|||
46909979|NCT01345292|83139251|FG001|Overall Study|Withdrawal by Subject|0|||
46909980|NCT01345292|83139252|FG002|Overall Study|Withdrawal by Subject|1|||
46909981|NCT03340961|83139264|FG000|Overall Study|Adverse Event|1|||
46909982|NCT03340961|83139265|FG001|Overall Study|Adverse Event|3|||
46909983|NCT03340961|83139266|FG002|Overall Study|Adverse Event|2|||
46909984|NCT03340961|83139267|FG003|Overall Study|Adverse Event|4|||
46909985|NCT03340961|83139264|FG000|Overall Study|Lost to Follow-up|0|||
46909986|NCT03340961|83139265|FG001|Overall Study|Lost to Follow-up|1|||
46909987|NCT03340961|83139266|FG002|Overall Study|Lost to Follow-up|0|||
46909988|NCT03340961|83139267|FG003|Overall Study|Lost to Follow-up|1|||
47006067|NCT02203513|83254321|FG000|Overall Study|Did not receive investigational product (IP)|0|||
47006068|NCT02203513|83254322|FG001|Overall Study|Did not receive investigational product (IP)|1|||
47006069|NCT02203513|83254323|FG002|Overall Study|Did not receive investigational product (IP)|0|||
47006070|NCT02203513|83254324|FG003|Overall Study|Did not receive investigational product (IP)|0|||
47006071|NCT02203513|83254325|FG004|Overall Study|Did not receive investigational product (IP)|0|||
47006072|NCT02203513|83254321|FG000|Overall Study|Death (unrelated to study therapy)|1|||
47006073|NCT02203513|83254322|FG001|Overall Study|Death (unrelated to study therapy)|3|||
47006074|NCT02203513|83254323|FG002|Overall Study|Death (unrelated to study therapy)|1|||
47006075|NCT02203513|83254324|FG003|Overall Study|Death (unrelated to study therapy)|0|||
47006076|NCT02203513|83254325|FG004|Overall Study|Death (unrelated to study therapy)|2|||
47006077|NCT02203513|83254321|FG000|Overall Study|Lost to Follow-up|0|||
47006078|NCT02203513|83254322|FG001|Overall Study|Lost to Follow-up|0|||
47006079|NCT02203513|83254323|FG002|Overall Study|Lost to Follow-up|1|||
47006080|NCT02203513|83254324|FG003|Overall Study|Lost to Follow-up|1|||
47006081|NCT02203513|83254325|FG004|Overall Study|Lost to Follow-up|0|||
47006082|NCT02299934|83254339|FG000|Overall Study|Termination of study|13|||
47006083|NCT01703260|83254346|FG000|Overall Study|Adverse Event|1|||
47006084|NCT01703260|83254347|FG001|Overall Study|Adverse Event|2|||
46909989|NCT03340961|83139264|FG000|Overall Study|Withdrawal by Subject|3|||
46909990|NCT03340961|83139265|FG001|Overall Study|Withdrawal by Subject|2|||
46909991|NCT03340961|83139266|FG002|Overall Study|Withdrawal by Subject|4|||
46909992|NCT03340961|83139267|FG003|Overall Study|Withdrawal by Subject|7|||
46909993|NCT03340961|83139264|FG000|Overall Study|Use of prohibited treatment|0|||
46909994|NCT03340961|83139265|FG001|Overall Study|Use of prohibited treatment|3|||
47006085|NCT01703260|83254348|FG002|Overall Study|Adverse Event|2|||
47006086|NCT01703260|83254346|FG000|Overall Study|Lost to Follow-up|1|||
46620504|NCT02536300|82769740|FG000|Overall Study|Withdrew Consent|4|||
46709481|NCT01128738|82925537|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
46909995|NCT03340961|83139266|FG002|Overall Study|Use of prohibited treatment|2|||
46909996|NCT03340961|83139267|FG003|Overall Study|Use of prohibited treatment|4|||
46909997|NCT03340961|83139264|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
46909998|NCT03340961|83139265|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
46909999|NCT03340961|83139266|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
47006087|NCT01703260|83254347|FG001|Overall Study|Lost to Follow-up|0|||
47006088|NCT01703260|83254348|FG002|Overall Study|Lost to Follow-up|0|||
47006089|NCT01703260|83254346|FG000|Overall Study|Withdrawal by Subject|0|||
47006090|NCT01703260|83254347|FG001|Overall Study|Withdrawal by Subject|0|||
47006091|NCT01703260|83254348|FG002|Overall Study|Withdrawal by Subject|1|||
47006092|NCT01703260|83254346|FG000|Overall Study|Study Termination|1|||
47006093|NCT01703260|83254347|FG001|Overall Study|Study Termination|2|||
47006094|NCT01703260|83254348|FG002|Overall Study|Study Termination|0|||
47006095|NCT02203357|83254359|FG000|Overall Study|Lost to Follow-up|58|||
47006096|NCT02203357|83254360|FG001|Overall Study|Lost to Follow-up|66|||
47006097|NCT02203357|83254361|FG002|Overall Study|Lost to Follow-up|70|||
47006098|NCT02299388|83254374|FG000|Overall Study|Withdrawal by Subject|0|||
47006099|NCT02299388|83254375|FG001|Overall Study|Withdrawal by Subject|1|||
47006100|NCT02202577|83254383|FG000|Overall Study|Lost to Follow-up|6|||
47006101|NCT02202577|83254384|FG001|Overall Study|Lost to Follow-up|16|||
47006102|NCT02202577|83254383|FG000|Overall Study|Protocol Violation|7|||
47006103|NCT02202577|83254384|FG001|Overall Study|Protocol Violation|3|||
47006104|NCT02299076|83254392|FG000|Overall Study|Fraudulent Entries|20|||
47006105|NCT02299076|83254393|FG001|Overall Study|Fraudulent Entries|14|||
47006106|NCT01723072|83254401|FG000|Overall Study|Withdrawal by Subject|7|||
47006107|NCT01723072|83254402|FG001|Overall Study|Withdrawal by Subject|13|||
47006108|NCT01723072|83254401|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
47006109|NCT01723072|83254402|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
47006110|NCT01723072|83254401|FG000|Overall Study|Other|4|||
46620505|NCT02536300|82769741|FG001|Overall Study|Withdrew Consent|2|||
47006111|NCT01723072|83254402|FG001|Overall Study|Other|3|||
47006112|NCT01722994|83254410|FG000|Overall Study|Missing data|25|||
47006113|NCT01722994|83254411|FG001|Overall Study|Missing data|17|||
47006114|NCT02228395|83254419|FG000|First Intervention Period|No longer willing to participate|1|||
47006115|NCT02228395|83254420|FG001|First Intervention Period|No longer willing to participate|0|||
47006116|NCT02228395|83254421|FG002|First Intervention Period|No longer willing to participate|0|||
47006117|NCT02228395|83254419|FG000|First Intervention Period|Unable to comply with study dates|0|||
47006118|NCT02228395|83254420|FG001|First Intervention Period|Unable to comply with study dates|1|||
47006119|NCT02228395|83254421|FG002|First Intervention Period|Unable to comply with study dates|1|||
47006120|NCT02170051|83254433|FG000|Overall Study|Withdrawal by Subject|10|||
47006121|NCT02170051|83254434|FG001|Overall Study|Withdrawal by Subject|10|||
47006122|NCT02170051|83254433|FG000|Overall Study|Lost to Follow-up|1|||
47006123|NCT02170051|83254434|FG001|Overall Study|Lost to Follow-up|3|||
46709482|NCT01128738|82925538|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
46709483|NCT01128738|82925537|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
46709484|NCT01128738|82925538|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
46709485|NCT01128738|82925537|FG000|Second TP|Lost to Follow-up|0|||
46709486|NCT01128738|82925538|FG001|Second TP|Lost to Follow-up|1|||
46709487|NCT01128738|82925537|FG000|Second TP|Withdrawal by Subject|0|||
46709488|NCT01128738|82925538|FG001|Second TP|Withdrawal by Subject|2|||
46709489|NCT01143090|82925545|FG000|Overall Study|Lack of Efficacy|2|||
46620506|NCT02536300|82769742|FG002|Overall Study|Withdrew Consent|0|||
46709490|NCT01143090|82925545|FG000|Overall Study|Adverse Event|17|||
47006124|NCT02169739|83254442|FG000|Overall Study|Lost to Follow-up|0|||
47006125|NCT02169739|83254443|FG001|Overall Study|Lost to Follow-up|4|||
47006126|NCT02169505|83254450|FG000|Overall Study|Withdrawal by Subject|1|||
47006127|NCT01909791|83254457|FG000|Overall Study|Death|9|||
47006128|NCT01909791|83254458|FG001|Overall Study|Death|8|||
47006129|NCT01909791|83254459|FG002|Overall Study|Death|4|||
47006130|NCT01909791|83254457|FG000|Overall Study|Withdrawal by Subject|5|||
47006131|NCT01909791|83254458|FG001|Overall Study|Withdrawal by Subject|9|||
47006132|NCT01909791|83254459|FG002|Overall Study|Withdrawal by Subject|13|||
47006133|NCT01909791|83254457|FG000|Overall Study|Lost to Follow-up|5|||
47006134|NCT01909791|83254458|FG001|Overall Study|Lost to Follow-up|11|||
47006135|NCT01909791|83254459|FG002|Overall Study|Lost to Follow-up|10|||
47006136|NCT01909791|83254457|FG000|Overall Study|Missed Visit|2|||
47006137|NCT01909791|83254458|FG001|Overall Study|Missed Visit|0|||
47006138|NCT01909791|83254459|FG002|Overall Study|Missed Visit|1|||
47006139|NCT02202499|83254475|FG000|Overall Study|Cancer diagnosis|0|||
47006140|NCT02202499|83254476|FG001|Overall Study|Cancer diagnosis|0|||
47006141|NCT02202499|83254477|FG002|Overall Study|Cancer diagnosis|1|||
47006142|NCT02202499|83254475|FG000|Overall Study|Moved from area|0|||
47006143|NCT02202499|83254476|FG001|Overall Study|Moved from area|0|||
47006144|NCT02202499|83254477|FG002|Overall Study|Moved from area|1|||
47006145|NCT02202499|83254475|FG000|Overall Study|Declined before randomization|1|||
47006146|NCT02202499|83254476|FG001|Overall Study|Declined before randomization|0|||
47006147|NCT02202499|83254477|FG002|Overall Study|Declined before randomization|0|||
47006148|NCT02202499|83254475|FG000|Overall Study|Auto accident|1|||
47006149|NCT02202499|83254476|FG001|Overall Study|Auto accident|0|||
47006150|NCT02202499|83254477|FG002|Overall Study|Auto accident|0|||
47006151|NCT02202109|83254492|FG000|Overall Study|Lost to Follow-up|88|||
47006152|NCT02202109|83254493|FG001|Overall Study|Lost to Follow-up|87|||
47006153|NCT02202109|83254492|FG000|Overall Study|Withdrawal by Subject|2|||
47006154|NCT02202109|83254493|FG001|Overall Study|Withdrawal by Subject|0|||
47006155|NCT02227849|83254499|FG000|Overall Study|Adverse Event|4|||
47006156|NCT02227849|83254499|FG000|Overall Study|Physician Decision|1|||
47006157|NCT02227849|83254499|FG000|Overall Study|Withdrawal by Subject|3|||
47006158|NCT01927497|83254505|FG000|Overall Study|Death|0|||
47006159|NCT01927497|83254506|FG001|Overall Study|Death|1|||
47006160|NCT01927497|83254505|FG000|Overall Study|Protocol Violation|2|||
46709491|NCT01143090|82925545|FG000|Overall Study|Lost to Follow-up|9|||
47006161|NCT01927497|83254506|FG001|Overall Study|Protocol Violation|0|||
47006162|NCT02169271|83254514|FG000|Overall Study|Protocol Violation|1|||
47006163|NCT02169271|83254515|FG001|Overall Study|Protocol Violation|2|||
47006164|NCT02202031|83254523|FG000|Overall Study|Lost to Follow-up|1|||
47006165|NCT02202031|83254524|FG001|Overall Study|Lost to Follow-up|0|||
47006166|NCT02202031|83254523|FG000|Overall Study|Too Busy|1|||
47006167|NCT02202031|83254524|FG001|Overall Study|Too Busy|3|||
47006168|NCT02202031|83254523|FG000|Overall Study|Illness/Medical Reason|0|||
47006169|NCT02202031|83254524|FG001|Overall Study|Illness/Medical Reason|2|||
47006170|NCT02202031|83254523|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
47006171|NCT02202031|83254524|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
47006172|NCT01644188|83254532|FG000|Overall Study|Adverse Event|44|||
47006173|NCT01644188|83254533|FG001|Overall Study|Adverse Event|20|||
47006174|NCT01644188|83254532|FG000|Overall Study|Poor compliance to protocol|26|||
47006175|NCT01644188|83254533|FG001|Overall Study|Poor compliance to protocol|14|||
47006176|NCT01644188|83254532|FG000|Overall Study|Physician Decision|1|||
47006177|NCT01644188|83254533|FG001|Overall Study|Physician Decision|3|||
47006178|NCT01644188|83254532|FG000|Overall Study|Participant moved|7|||
47006179|NCT01644188|83254533|FG001|Overall Study|Participant moved|2|||
47006180|NCT01644188|83254532|FG000|Overall Study|Related to auto-injector administration|2|||
47006181|NCT01644188|83254533|FG001|Overall Study|Related to auto-injector administration|2|||
47006182|NCT01644188|83254532|FG000|Overall Study|Consent withdrawn by participant|14|||
47006183|NCT01644188|83254533|FG001|Overall Study|Consent withdrawn by participant|7|||
47006184|NCT01644188|83254532|FG000|Overall Study|Selection criteria finally not met|2|||
47006185|NCT01644188|83254533|FG001|Overall Study|Selection criteria finally not met|0|||
47006186|NCT01644188|83254532|FG000|Overall Study|Lost to Follow-up|1|||
47006187|NCT01644188|83254533|FG001|Overall Study|Lost to Follow-up|0|||
47006188|NCT01644188|83254532|FG000|Overall Study|Death|4|||
47006189|NCT01644188|83254533|FG001|Overall Study|Death|3|||
47006190|NCT01644188|83254532|FG000|Overall Study|Last visit outside protocol visit window|14|||
47006191|NCT01644188|83254533|FG001|Overall Study|Last visit outside protocol visit window|16|||
47006192|NCT01644188|83254532|FG000|Overall Study|Site closure|1|||
47006193|NCT01644188|83254533|FG001|Overall Study|Site closure|1|||
47006194|NCT01644188|83254532|FG000|Overall Study|Other than specified above|6|||
47006195|NCT01644188|83254533|FG001|Overall Study|Other than specified above|7|||
47006196|NCT02201953|83254541|FG000|Overall Study|Randomized but Never Treated|1|||
47006197|NCT02201953|83254542|FG001|Overall Study|Randomized but Never Treated|5|||
47006198|NCT02201953|83254541|FG000|Overall Study|Lack of Efficacy|9|||
47006199|NCT02201953|83254542|FG001|Overall Study|Lack of Efficacy|30|||
47006200|NCT02201953|83254541|FG000|Overall Study|Lost to Follow-up|8|||
47006201|NCT02201953|83254542|FG001|Overall Study|Lost to Follow-up|8|||
47006202|NCT02201953|83254541|FG000|Overall Study|Withdrew Consent|2|||
47006203|NCT02201953|83254542|FG001|Overall Study|Withdrew Consent|5|||
47006204|NCT02201953|83254541|FG000|Overall Study|Adverse Event|0|||
47006205|NCT02201953|83254542|FG001|Overall Study|Adverse Event|5|||
47006206|NCT02201953|83254541|FG000|Overall Study|Death|0|||
47006207|NCT02201953|83254542|FG001|Overall Study|Death|3|||
47006208|NCT02271854|83254548|FG000|Overall Study|Withdrawal by Subject|2|||
47006209|NCT02271854|83254548|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
47006210|NCT02271854|83254548|FG000|Overall Study|Lost to Follow-up|1|||
47006211|NCT02296892|83254556|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
47006212|NCT02296892|83254557|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
47006213|NCT02296892|83254558|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
47006214|NCT02296892|83254556|FG000|Overall Study|Lost to Follow-up|5|||
47006215|NCT02296892|83254557|FG001|Overall Study|Lost to Follow-up|0|||
47006216|NCT02296892|83254558|FG002|Overall Study|Lost to Follow-up|1|||
47006217|NCT02270684|83254568|FG000|Overall Study|Lost to Follow-up|0|||
47006218|NCT02270684|83254569|FG001|Overall Study|Lost to Follow-up|3|||
47006219|NCT02270684|83254568|FG000|Overall Study|Study terminated|1|||
47006220|NCT02270684|83254569|FG001|Overall Study|Study terminated|0|||
47006221|NCT02168803|83254578|FG000|Overall Study|Lost to Follow-up|1|||
47006222|NCT02168803|83254579|FG001|Overall Study|Lost to Follow-up|0|||
47006223|NCT02168803|83254580|FG002|Overall Study|Lost to Follow-up|1|||
47006224|NCT02168803|83254578|FG000|Overall Study|Withdrawal by Subject|1|||
47006225|NCT02168803|83254579|FG001|Overall Study|Withdrawal by Subject|1|||
47006226|NCT02168803|83254580|FG002|Overall Study|Withdrawal by Subject|2|||
47006227|NCT02168803|83254578|FG000|Overall Study|Physician Decision|0|||
47006228|NCT02168803|83254579|FG001|Overall Study|Physician Decision|1|||
47006229|NCT02168803|83254580|FG002|Overall Study|Physician Decision|0|||
47006230|NCT02168803|83254578|FG000|Overall Study|Adverse Event|0|||
47006231|NCT02168803|83254579|FG001|Overall Study|Adverse Event|1|||
47006232|NCT02168803|83254580|FG002|Overall Study|Adverse Event|1|||
47006233|NCT02168803|83254578|FG000|Overall Study|Death|0|||
47006234|NCT02168803|83254579|FG001|Overall Study|Death|0|||
47006235|NCT02168803|83254580|FG002|Overall Study|Death|1|||
47006236|NCT02168803|83254578|FG000|Overall Study|Sponsor Decision|0|||
47006237|NCT02168803|83254579|FG001|Overall Study|Sponsor Decision|0|||
47006238|NCT02168803|83254580|FG002|Overall Study|Sponsor Decision|1|||
47006239|NCT02201329|83254595|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
47006240|NCT02201329|83254595|FG000|Overall Study|Withdrawal by Subject|2|||
47006241|NCT01927419|83254601|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
47006242|NCT01927419|83254602|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
47006243|NCT01927419|83254601|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
47006244|NCT01927419|83254602|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
47006245|NCT01927419|83254601|FG000|Treatment Period|Disease progression|17|||
47006246|NCT01927419|83254602|FG001|Treatment Period|Disease progression|20|||
47006247|NCT01927419|83254601|FG000|Treatment Period|Study drug toxicity|48|||
47006248|NCT01927419|83254602|FG001|Treatment Period|Study drug toxicity|10|||
47006249|NCT01927419|83254601|FG000|Treatment Period|Death|0|||
47006250|NCT01927419|83254602|FG001|Treatment Period|Death|1|||
46709492|NCT01143090|82925545|FG000|Overall Study|Protocol Violation|2|||
46709493|NCT01143090|82925545|FG000|Overall Study|Withdrawal by Subject|18|||
46709494|NCT01143090|82925545|FG000|Overall Study|Non-compliance with study drug|1|||
46709495|NCT01143090|82925545|FG000|Overall Study|Failure to meet eligibility criteria|1|||
46709496|NCT01143090|82925545|FG000|Overall Study|Administrative|1|||
46709497|NCT01165554|82925549|FG000|Overall Study|Withdrawal by Subject|23|||
46709498|NCT01218308|82925558|FG000|Overall Study|Adverse Event|1|||
46709499|NCT01218308|82925559|FG001|Overall Study|Adverse Event|2|||
47006251|NCT01927419|83254601|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
47006252|NCT01927419|83254602|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
47006253|NCT01927419|83254601|FG000|Treatment Period|Participant request to discontinue|12|||
47006254|NCT01927419|83254602|FG001|Treatment Period|Participant request to discontinue|4|||
47006255|NCT01927419|83254601|FG000|Treatment Period|Withdrawal by Subject|1|||
47006256|NCT01927419|83254602|FG001|Treatment Period|Withdrawal by Subject|1|||
47006257|NCT01927419|83254601|FG000|Treatment Period|Maximum Clinical Benefit|6|||
47006258|NCT01927419|83254602|FG001|Treatment Period|Maximum Clinical Benefit|2|||
47006259|NCT01927419|83254601|FG000|Treatment Period|Other reasons|3|||
47006260|NCT01927419|83254602|FG001|Treatment Period|Other reasons|4|||
47006261|NCT01927419|83254601|FG000|Treatment Period|Not Reported|1|||
47006262|NCT01927419|83254602|FG001|Treatment Period|Not Reported|1|||
47006263|NCT02168491|83254608|FG000|Overall Study|Withdrawal by Subject|1|||
47006264|NCT02225743|83254612|FG000|Overall Study|Withdrawal by Subject|18|||
47006265|NCT01721746|83254618|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
47006266|NCT01721746|83254619|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
47006267|NCT01721746|83254618|FG000|Pre-Treatment|Withdrawal by Subject|1|||
47006268|NCT01721746|83254619|FG001|Pre-Treatment|Withdrawal by Subject|16|||
47006269|NCT01721746|83254618|FG000|Pre-Treatment|Poor/Non-compliance|1|||
47006270|NCT01721746|83254619|FG001|Pre-Treatment|Poor/Non-compliance|0|||
47006271|NCT01721746|83254618|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
47006272|NCT01721746|83254619|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
47006273|NCT01721746|83254618|FG000|Treatment|Disease Progression|192|||
47006274|NCT01721746|83254619|FG001|Treatment|Disease Progression|74|||
47006275|NCT01721746|83254618|FG000|Treatment|Study Drug Toxicity|19|||
47006276|NCT01721746|83254619|FG001|Treatment|Study Drug Toxicity|11|||
47006277|NCT01721746|83254618|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
47006278|NCT01721746|83254619|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
47006279|NCT01721746|83254618|FG000|Treatment|Participant request to discontinue Study treatment|26|||
47006280|NCT01721746|83254619|FG001|Treatment|Participant request to discontinue Study treatment|7|||
47006281|NCT01721746|83254618|FG000|Treatment|Participant withdrew consent|4|||
47006282|NCT01721746|83254619|FG001|Treatment|Participant withdrew consent|2|||
47006283|NCT01721746|83254618|FG000|Treatment|Maximum Clinical Benefit|9|||
47006284|NCT01721746|83254619|FG001|Treatment|Maximum Clinical Benefit|3|||
47006285|NCT01721746|83254618|FG000|Treatment|Poor/Non-compliance|2|||
47006286|NCT01721746|83254619|FG001|Treatment|Poor/Non-compliance|0|||
47006287|NCT01721746|83254618|FG000|Treatment|Participant no longer met Study criteria|4|||
47006288|NCT01721746|83254619|FG001|Treatment|Participant no longer met Study criteria|0|||
47006289|NCT01721746|83254618|FG000|Treatment|Other reasons|6|||
47006290|NCT01721746|83254619|FG001|Treatment|Other reasons|2|||
47006291|NCT02225665|83254628|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
47006292|NCT02225665|83254629|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
47006293|NCT02225665|83254628|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
47006294|NCT02225665|83254629|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
47006295|NCT01721200|83254637|FG000|Overall Study|Lost to Follow-up|3|||
47006296|NCT01721200|83254638|FG001|Overall Study|Lost to Follow-up|5|||
47006297|NCT02225587|83254651|FG000|Overall Study|Adverse Event|5|||
47006298|NCT02225587|83254652|FG001|Overall Study|Adverse Event|5|||
47006299|NCT02225587|83254651|FG000|Overall Study|Lost to Follow-up|5|||
47006300|NCT02225587|83254652|FG001|Overall Study|Lost to Follow-up|5|||
47006301|NCT02225587|83254651|FG000|Overall Study|Non-Compliance With Study Drug|1|||
47006302|NCT02225587|83254652|FG001|Overall Study|Non-Compliance With Study Drug|0|||
47006303|NCT02225587|83254651|FG000|Overall Study|Physician Decision|2|||
47006304|NCT02225587|83254652|FG001|Overall Study|Physician Decision|0|||
47006305|NCT02225587|83254651|FG000|Overall Study|Protocol Violation|1|||
47006306|NCT02225587|83254652|FG001|Overall Study|Protocol Violation|0|||
47006307|NCT02225587|83254651|FG000|Overall Study|Participant Moved|1|||
47006308|NCT02225587|83254652|FG001|Overall Study|Participant Moved|0|||
47006309|NCT02225587|83254651|FG000|Overall Study|Withdrawal by Subject|13|||
47006310|NCT02225587|83254652|FG001|Overall Study|Withdrawal by Subject|28|||
47006311|NCT02296424|83254660|FG000|Part 1|New therapy for study indication|0|||
47006312|NCT02296424|83254661|FG001|Part 1|New therapy for study indication|1|||
47006313|NCT02296424|83254662|FG002|Part 1|New therapy for study indication|0|||
47006314|NCT02296424|83254663|FG003|Part 1|New therapy for study indication|0|||
47006315|NCT02296424|83254660|FG000|Part 1|Protocol Violation|0|||
47006316|NCT02296424|83254661|FG001|Part 1|Protocol Violation|1|||
47006317|NCT02296424|83254662|FG002|Part 1|Protocol Violation|0|||
47006318|NCT02296424|83254663|FG003|Part 1|Protocol Violation|0|||
47006319|NCT02296424|83254660|FG000|Part 1|Withdrawal by Subject|0|||
47006320|NCT02296424|83254661|FG001|Part 1|Withdrawal by Subject|2|||
47006321|NCT02296424|83254662|FG002|Part 1|Withdrawal by Subject|0|||
47006322|NCT02296424|83254663|FG003|Part 1|Withdrawal by Subject|0|||
47006323|NCT02296424|83254660|FG000|Part 1|Study terminated by sponsor|0|||
47006324|NCT02296424|83254661|FG001|Part 1|Study terminated by sponsor|1|||
47006325|NCT02296424|83254662|FG002|Part 1|Study terminated by sponsor|0|||
46709500|NCT01218308|82925558|FG000|Overall Study|Protocol Violation|0|||
47006326|NCT02296424|83254663|FG003|Part 1|Study terminated by sponsor|0|||
47006327|NCT02296424|83254660|FG000|Part 1|Adverse Event|2|||
47006328|NCT02296424|83254661|FG001|Part 1|Adverse Event|11|||
47006329|NCT02296424|83254662|FG002|Part 1|Adverse Event|0|||
47006330|NCT02296424|83254663|FG003|Part 1|Adverse Event|0|||
47006331|NCT02296424|83254660|FG000|Part 1|Lack of Efficacy|5|||
47006332|NCT02296424|83254661|FG001|Part 1|Lack of Efficacy|17|||
47006333|NCT02296424|83254662|FG002|Part 1|Lack of Efficacy|0|||
47006334|NCT02296424|83254663|FG003|Part 1|Lack of Efficacy|0|||
47006335|NCT02296424|83254660|FG000|Part 1|16 directly started part II|16|||
47006336|NCT02296424|83254661|FG001|Part 1|16 directly started part II|0|||
47006337|NCT02296424|83254662|FG002|Part 1|16 directly started part II|0|||
47006338|NCT02296424|83254663|FG003|Part 1|16 directly started part II|0|||
47006339|NCT02296424|83254660|FG000|Part 2|Lack of Efficacy|0|||
47006340|NCT02296424|83254661|FG001|Part 2|Lack of Efficacy|0|||
47006341|NCT02296424|83254662|FG002|Part 2|Lack of Efficacy|1|||
47006342|NCT02296424|83254663|FG003|Part 2|Lack of Efficacy|0|||
47006343|NCT02296424|83254660|FG000|Part 2|Adverse Event|0|||
47006344|NCT02296424|83254661|FG001|Part 2|Adverse Event|0|||
47006345|NCT02296424|83254662|FG002|Part 2|Adverse Event|1|||
47006346|NCT02296424|83254663|FG003|Part 2|Adverse Event|0|||
47006347|NCT02296424|83254660|FG000|Part 2|Lost to Follow-up|0|||
47006348|NCT02296424|83254661|FG001|Part 2|Lost to Follow-up|0|||
47006349|NCT02296424|83254662|FG002|Part 2|Lost to Follow-up|1|||
47006350|NCT02296424|83254663|FG003|Part 2|Lost to Follow-up|0|||
47006351|NCT02296190|83254677|FG000|Overall Study|Lost to Follow-up|0|||
47006352|NCT02296190|83254678|FG001|Overall Study|Lost to Follow-up|0|||
47006353|NCT02296190|83254679|FG002|Overall Study|Lost to Follow-up|0|||
47006354|NCT02296190|83254680|FG003|Overall Study|Lost to Follow-up|0|||
47006355|NCT02296190|83254681|FG004|Overall Study|Lost to Follow-up|1|||
47006356|NCT02296190|83254682|FG005|Overall Study|Lost to Follow-up|0|||
47006357|NCT02296190|83254677|FG000|Overall Study|Failure to induce PSVT|6|||
47006358|NCT02296190|83254678|FG001|Overall Study|Failure to induce PSVT|10|||
47006359|NCT02296190|83254679|FG002|Overall Study|Failure to induce PSVT|5|||
47006360|NCT02296190|83254680|FG003|Overall Study|Failure to induce PSVT|13|||
47006361|NCT02296190|83254681|FG004|Overall Study|Failure to induce PSVT|8|||
47006362|NCT02296190|83254682|FG005|Overall Study|Failure to induce PSVT|0|||
47006363|NCT02296190|83254677|FG000|Overall Study|Physician Decision|1|||
47006364|NCT02296190|83254678|FG001|Overall Study|Physician Decision|1|||
47006365|NCT02296190|83254679|FG002|Overall Study|Physician Decision|0|||
47006366|NCT02296190|83254680|FG003|Overall Study|Physician Decision|1|||
47006367|NCT02296190|83254681|FG004|Overall Study|Physician Decision|2|||
47006368|NCT02296190|83254682|FG005|Overall Study|Physician Decision|0|||
47006369|NCT02296190|83254677|FG000|Overall Study|Withdrawal by Subject|0|||
47006370|NCT02296190|83254678|FG001|Overall Study|Withdrawal by Subject|1|||
47006371|NCT02296190|83254679|FG002|Overall Study|Withdrawal by Subject|0|||
47006372|NCT02296190|83254680|FG003|Overall Study|Withdrawal by Subject|0|||
47006373|NCT02296190|83254681|FG004|Overall Study|Withdrawal by Subject|0|||
47006374|NCT02296190|83254682|FG005|Overall Study|Withdrawal by Subject|0|||
47006375|NCT02296190|83254677|FG000|Overall Study|PSVT < 5 minutes|5|||
47006376|NCT02296190|83254678|FG001|Overall Study|PSVT < 5 minutes|6|||
47006377|NCT02296190|83254679|FG002|Overall Study|PSVT < 5 minutes|6|||
47006378|NCT02296190|83254680|FG003|Overall Study|PSVT < 5 minutes|6|||
47006379|NCT02296190|83254681|FG004|Overall Study|PSVT < 5 minutes|5|||
47006380|NCT02296190|83254682|FG005|Overall Study|PSVT < 5 minutes|0|||
47006381|NCT02296190|83254677|FG000|Overall Study|Patient was given Propofol|0|||
47006382|NCT02296190|83254678|FG001|Overall Study|Patient was given Propofol|1|||
47006383|NCT02296190|83254679|FG002|Overall Study|Patient was given Propofol|0|||
47006384|NCT02296190|83254680|FG003|Overall Study|Patient was given Propofol|1|||
47006385|NCT02296190|83254681|FG004|Overall Study|Patient was given Propofol|0|||
47006386|NCT02296190|83254682|FG005|Overall Study|Patient was given Propofol|0|||
47006387|NCT02296190|83254677|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
47006388|NCT02296190|83254678|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
47006389|NCT02296190|83254679|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
47006390|NCT02296190|83254680|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
47006391|NCT02296190|83254681|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
47006392|NCT02296190|83254682|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
47006393|NCT02296190|83254677|FG000|Overall Study|Blood pressure <100 after sedation|0|||
47006394|NCT02296190|83254678|FG001|Overall Study|Blood pressure <100 after sedation|0|||
47006395|NCT02296190|83254679|FG002|Overall Study|Blood pressure <100 after sedation|0|||
47006396|NCT02296190|83254680|FG003|Overall Study|Blood pressure <100 after sedation|1|||
47006397|NCT02296190|83254681|FG004|Overall Study|Blood pressure <100 after sedation|0|||
47006398|NCT02296190|83254682|FG005|Overall Study|Blood pressure <100 after sedation|0|||
47006399|NCT02296190|83254677|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
47006400|NCT02296190|83254678|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
47006401|NCT02296190|83254679|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
47006402|NCT02296190|83254680|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
47006403|NCT02296190|83254681|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
47006404|NCT02296190|83254682|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
47006405|NCT02296190|83254677|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
47006406|NCT02296190|83254678|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
47006407|NCT02296190|83254679|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
47006408|NCT02296190|83254680|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
47006409|NCT02296190|83254681|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
47006410|NCT02296190|83254682|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
47006411|NCT02296190|83254677|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
47006412|NCT02296190|83254678|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
47006413|NCT02296190|83254679|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
47006414|NCT02296190|83254680|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
47006415|NCT02296190|83254681|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
47006416|NCT02296190|83254682|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
47006417|NCT02296190|83254677|FG000|Overall Study|Lab result not available in time|1|||
47006418|NCT02296190|83254678|FG001|Overall Study|Lab result not available in time|0|||
47006419|NCT02296190|83254679|FG002|Overall Study|Lab result not available in time|0|||
47006420|NCT02296190|83254680|FG003|Overall Study|Lab result not available in time|0|||
47006421|NCT02296190|83254681|FG004|Overall Study|Lab result not available in time|0|||
47006422|NCT02296190|83254682|FG005|Overall Study|Lab result not available in time|0|||
47006423|NCT02296112|83254695|FG000|Overall Study|Disease progression|7|||
47006424|NCT02296112|83254695|FG000|Overall Study|Toxicity|1|||
47006425|NCT02296112|83254695|FG000|Overall Study|Began an alternate therapy|1|||
47006426|NCT02295644|83254708|FG000|Overall Study|Did not meet inclusion criterion|0|||
47006427|NCT02295644|83254709|FG001|Overall Study|Did not meet inclusion criterion|0|||
47006428|NCT02295644|83254710|FG002|Overall Study|Did not meet inclusion criterion|1|||
47006429|NCT02295644|83254711|FG003|Overall Study|Did not meet inclusion criterion|2|||
47006430|NCT02269670|83254721|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
47006431|NCT02225353|83254728|FG000|Overall Study|Lost to Follow-up|0|||
47006432|NCT02225353|83254729|FG001|Overall Study|Lost to Follow-up|1|||
47006433|NCT02225353|83254730|FG002|Overall Study|Lost to Follow-up|3|||
47006434|NCT02225353|83254728|FG000|Overall Study|Protocol Violation|4|||
47006435|NCT02225353|83254729|FG001|Overall Study|Protocol Violation|5|||
47006436|NCT02225353|83254730|FG002|Overall Study|Protocol Violation|12|||
47006437|NCT01641926|83254745|FG000|Overall Study|Adverse Event|5|||
47006438|NCT01641926|83254746|FG001|Overall Study|Adverse Event|2|||
47006439|NCT01641926|83254747|FG002|Overall Study|Adverse Event|3|||
47006440|NCT01641926|83254748|FG003|Overall Study|Adverse Event|1|||
47006441|NCT01641926|83254745|FG000|Overall Study|Lost to Follow-up|2|||
47006442|NCT01641926|83254746|FG001|Overall Study|Lost to Follow-up|2|||
47006443|NCT01641926|83254747|FG002|Overall Study|Lost to Follow-up|1|||
47006444|NCT01641926|83254748|FG003|Overall Study|Lost to Follow-up|0|||
47006445|NCT01641926|83254745|FG000|Overall Study|Physician Decision|6|||
47006446|NCT01641926|83254746|FG001|Overall Study|Physician Decision|5|||
47006447|NCT01641926|83254747|FG002|Overall Study|Physician Decision|0|||
47006448|NCT01641926|83254748|FG003|Overall Study|Physician Decision|1|||
47006449|NCT01641926|83254745|FG000|Overall Study|Protocol Violation|1|||
47006450|NCT01641926|83254746|FG001|Overall Study|Protocol Violation|0|||
47006451|NCT01641926|83254747|FG002|Overall Study|Protocol Violation|0|||
47006452|NCT01641926|83254748|FG003|Overall Study|Protocol Violation|1|||
47006453|NCT01641926|83254745|FG000|Overall Study|Withdrawal by Subject|13|||
47006454|NCT01641926|83254746|FG001|Overall Study|Withdrawal by Subject|5|||
47006455|NCT01641926|83254747|FG002|Overall Study|Withdrawal by Subject|6|||
47006456|NCT01641926|83254748|FG003|Overall Study|Withdrawal by Subject|1|||
47006457|NCT01641926|83254745|FG000|Overall Study|Not Treated|1|||
47006458|NCT01641926|83254746|FG001|Overall Study|Not Treated|1|||
47006459|NCT01641926|83254747|FG002|Overall Study|Not Treated|1|||
47006460|NCT01641926|83254748|FG003|Overall Study|Not Treated|0|||
47006461|NCT02295020|83254760|FG000|Overall Study|Adverse Event|0|||
47006462|NCT02295020|83254761|FG001|Overall Study|Adverse Event|1|||
47006463|NCT02295020|83254760|FG000|Overall Study|Withdrawal by Subject|3|||
47006464|NCT02295020|83254761|FG001|Overall Study|Withdrawal by Subject|2|||
47006465|NCT02200939|83254775|FG000|Overall Study|Participant withdrew consent|0|||
47006466|NCT02200939|83254776|FG001|Overall Study|Participant withdrew consent|1|||
47006467|NCT02200939|83254775|FG000|Overall Study|Lost to Follow-up|2|||
47006468|NCT02200939|83254776|FG001|Overall Study|Lost to Follow-up|9|||
47006469|NCT02200939|83254775|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
47006470|NCT02200939|83254776|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
47006471|NCT02294786|83254788|FG000|Overall Study|Withdrawal by Subject|0|||
47006472|NCT02294786|83254789|FG001|Overall Study|Withdrawal by Subject|1|||
47006473|NCT02294786|83254788|FG000|Overall Study|Physician Decision|6|||
47006474|NCT02294786|83254789|FG001|Overall Study|Physician Decision|7|||
47006475|NCT02294786|83254788|FG000|Overall Study|Lost to Follow-up|1|||
47006476|NCT02294786|83254789|FG001|Overall Study|Lost to Follow-up|2|||
47006477|NCT02294786|83254788|FG000|Overall Study|Protocol Violation|1|||
47006478|NCT02294786|83254789|FG001|Overall Study|Protocol Violation|0|||
47006479|NCT02294786|83254788|FG000|Overall Study|Adverse Event|1|||
47006480|NCT02294786|83254789|FG001|Overall Study|Adverse Event|1|||
47006481|NCT02294786|83254788|FG000|Overall Study|Death|2|||
47006482|NCT02294786|83254789|FG001|Overall Study|Death|3|||
47006483|NCT02269124|83254798|FG000|Overall Study|Lost to Follow-up|1|||
46709501|NCT01218308|82925559|FG001|Overall Study|Protocol Violation|2|||
47006484|NCT02269124|83254799|FG001|Overall Study|Lost to Follow-up|0|||
47006485|NCT02269124|83254798|FG000|Overall Study|Withdrawal by Subject|0|||
47006486|NCT02269124|83254799|FG001|Overall Study|Withdrawal by Subject|2|||
47006487|NCT01927341|83254811|FG000|Phase 1b|Lost to Follow-up|1|||
47006488|NCT01927341|83254812|FG001|Phase 1b|Lost to Follow-up|0|||
47006489|NCT01927341|83254813|FG002|Phase 1b|Lost to Follow-up|0|||
47006490|NCT01927341|83254814|FG003|Phase 1b|Lost to Follow-up|0|||
47006491|NCT01927341|83254815|FG004|Phase 1b|Lost to Follow-up|0|||
47006492|NCT01927341|83254811|FG000|Phase 1b|Death|2|||
47006493|NCT01927341|83254812|FG001|Phase 1b|Death|0|||
47006494|NCT01927341|83254813|FG002|Phase 1b|Death|0|||
47006495|NCT01927341|83254814|FG003|Phase 1b|Death|0|||
47006496|NCT01927341|83254815|FG004|Phase 1b|Death|0|||
47006497|NCT01927341|83254811|FG000|Phase 1b|Follow-up completed|7|||
47006498|NCT01927341|83254812|FG001|Phase 1b|Follow-up completed|0|||
47006499|NCT01927341|83254813|FG002|Phase 1b|Follow-up completed|0|||
47006500|NCT01927341|83254814|FG003|Phase 1b|Follow-up completed|0|||
47006501|NCT01927341|83254815|FG004|Phase 1b|Follow-up completed|0|||
47006502|NCT01927341|83254811|FG000|Phase 2|Lost to Follow-up|0|||
47006503|NCT01927341|83254812|FG001|Phase 2|Lost to Follow-up|1|||
47006504|NCT01927341|83254813|FG002|Phase 2|Lost to Follow-up|0|||
47006505|NCT01927341|83254814|FG003|Phase 2|Lost to Follow-up|0|||
47006506|NCT01927341|83254815|FG004|Phase 2|Lost to Follow-up|0|||
47006507|NCT01927341|83254811|FG000|Phase 2|Participant withdrew consent|0|||
47006508|NCT01927341|83254812|FG001|Phase 2|Participant withdrew consent|2|||
47006509|NCT01927341|83254813|FG002|Phase 2|Participant withdrew consent|1|||
47006510|NCT01927341|83254814|FG003|Phase 2|Participant withdrew consent|2|||
47006511|NCT01927341|83254815|FG004|Phase 2|Participant withdrew consent|3|||
47006512|NCT01927341|83254811|FG000|Phase 2|Death|0|||
47006513|NCT01927341|83254812|FG001|Phase 2|Death|4|||
47006514|NCT01927341|83254813|FG002|Phase 2|Death|0|||
47006515|NCT01927341|83254814|FG003|Phase 2|Death|3|||
47006516|NCT01927341|83254815|FG004|Phase 2|Death|2|||
47006517|NCT01927341|83254811|FG000|Phase 2|New cancer therapy|0|||
47006518|NCT01927341|83254812|FG001|Phase 2|New cancer therapy|1|||
47006519|NCT01927341|83254813|FG002|Phase 2|New cancer therapy|0|||
47006520|NCT01927341|83254814|FG003|Phase 2|New cancer therapy|4|||
47006521|NCT01927341|83254815|FG004|Phase 2|New cancer therapy|1|||
47006522|NCT01927341|83254811|FG000|Phase 2|Disease progression|0|||
47006523|NCT01927341|83254812|FG001|Phase 2|Disease progression|1|||
47006524|NCT01927341|83254813|FG002|Phase 2|Disease progression|1|||
47006525|NCT01927341|83254814|FG003|Phase 2|Disease progression|1|||
47006526|NCT01927341|83254815|FG004|Phase 2|Disease progression|0|||
47006527|NCT01927341|83254811|FG000|Phase 2|Follow-up completed|0|||
47006528|NCT01927341|83254812|FG001|Phase 2|Follow-up completed|6|||
47006529|NCT01927341|83254813|FG002|Phase 2|Follow-up completed|3|||
47006530|NCT01927341|83254814|FG003|Phase 2|Follow-up completed|5|||
47006531|NCT01927341|83254815|FG004|Phase 2|Follow-up completed|2|||
47006532|NCT02294474|83254833|FG000|Overall Study|Adverse Event|7|||
47006533|NCT02294474|83254834|FG001|Overall Study|Adverse Event|7|||
47006534|NCT02294474|83254833|FG000|Overall Study|Lack of Efficacy|2|||
47006535|NCT02294474|83254834|FG001|Overall Study|Lack of Efficacy|1|||
47006536|NCT02294474|83254833|FG000|Overall Study|Protocol Violation|4|||
47006537|NCT02294474|83254834|FG001|Overall Study|Protocol Violation|2|||
47006538|NCT02294474|83254833|FG000|Overall Study|Other than specified above|12|||
47006539|NCT02294474|83254834|FG001|Overall Study|Other than specified above|12|||
47006540|NCT02168101|83254844|FG000|Overall Study|Death|2|||
47006541|NCT02168101|83254845|FG001|Overall Study|Death|2|||
47006542|NCT02168101|83254846|FG002|Overall Study|Death|1|||
47006543|NCT02298179|83254867|FG000|Overall Study|Lost to Follow-up|0|||
47006544|NCT02298179|83254868|FG001|Overall Study|Lost to Follow-up|0|||
47006545|NCT02298179|83254869|FG002|Overall Study|Lost to Follow-up|1|||
47006546|NCT02298179|83254870|FG003|Overall Study|Lost to Follow-up|0|||
47006547|NCT02298179|83254871|FG004|Overall Study|Lost to Follow-up|0|||
47006548|NCT02298179|83254872|FG005|Overall Study|Lost to Follow-up|0|||
47006549|NCT02298179|83254873|FG006|Overall Study|Lost to Follow-up|0|||
47006550|NCT02298179|83254874|FG007|Overall Study|Lost to Follow-up|1|||
47006551|NCT02298179|83254875|FG008|Overall Study|Lost to Follow-up|0|||
47006552|NCT02298179|83254876|FG009|Overall Study|Lost to Follow-up|0|||
47006553|NCT02298179|83254877|FG010|Overall Study|Lost to Follow-up|0|||
47006554|NCT02298179|83254878|FG011|Overall Study|Lost to Follow-up|0|||
47006555|NCT02298023|83254907|FG000|Overall Study|Withdrawal by Subject|1|||
47006556|NCT02298023|83254908|FG001|Overall Study|Withdrawal by Subject|0|||
47006557|NCT02298023|83254909|FG002|Overall Study|Withdrawal by Subject|0|||
47006558|NCT02296931|83254922|FG000|Overall Study|Protocol Violation|0|||
47006559|NCT02296931|83254923|FG001|Overall Study|Protocol Violation|2|||
47006560|NCT02166697|83254929|FG000|Overall Study|Protocol Violation|347|||
47006561|NCT01909479|83254935|FG000|From Baseline to Week 26|Adverse Event|3|||
47006562|NCT01909479|83254936|FG001|From Baseline to Week 26|Adverse Event|2|||
47006563|NCT01909479|83254935|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
47006564|NCT01909479|83254936|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
47006565|NCT01909479|83254935|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
47006566|NCT01909479|83254936|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
47006567|NCT01909479|83254935|FG000|26 - 52 Weeks|Adverse Event|0|||
47006568|NCT01909479|83254936|FG001|26 - 52 Weeks|Adverse Event|1|||
47006569|NCT01909479|83254935|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
47006570|NCT01909479|83254936|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
47006571|NCT01909479|83254935|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
47006572|NCT01909479|83254936|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
47006573|NCT01909479|83254935|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
47006574|NCT01909479|83254936|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
47006575|NCT01909479|83254935|FG000|52 Weeks to End of Study|Adverse Event|2|||
47006576|NCT01909479|83254936|FG001|52 Weeks to End of Study|Adverse Event|1|||
47006577|NCT01909479|83254935|FG000|52 Weeks to End of Study|Death|0|||
47006578|NCT01909479|83254936|FG001|52 Weeks to End of Study|Death|1|||
47006579|NCT01909479|83254935|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
47006580|NCT01909479|83254936|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
47006581|NCT01909479|83254935|FG000|52 Weeks to End of Study|Protocol Violation|1|||
47006582|NCT01909479|83254936|FG001|52 Weeks to End of Study|Protocol Violation|0|||
47006583|NCT01909479|83254935|FG000|52 Weeks to End of Study|Progressive disease|1|||
47006584|NCT01909479|83254936|FG001|52 Weeks to End of Study|Progressive disease|1|||
47006585|NCT01909479|83254935|FG000|52 Weeks to End of Study|Personal reasons|2|||
47006586|NCT01909479|83254936|FG001|52 Weeks to End of Study|Personal reasons|1|||
47006587|NCT01909479|83254935|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
47006588|NCT01909479|83254936|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
47006589|NCT01909479|83254935|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
47006590|NCT01909479|83254936|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
47006591|NCT01909479|83254935|FG000|52 Weeks to End of Study|Lack of contact|1|||
47006592|NCT01909479|83254936|FG001|52 Weeks to End of Study|Lack of contact|0|||
47006593|NCT01909479|83254935|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
47006594|NCT01909479|83254936|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
47006595|NCT01909479|83254935|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
47006596|NCT01909479|83254936|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
47006597|NCT01955733|83254949|FG000|Period 1|Lost to Follow-up|1|||
47006598|NCT01955733|83254950|FG001|Period 1|Lost to Follow-up|0|||
47006599|NCT01955733|83254951|FG002|Period 1|Lost to Follow-up|0|||
47006600|NCT01955733|83254949|FG000|Period 2|Adverse Event|1|||
47006601|NCT01955733|83254950|FG001|Period 2|Adverse Event|0|||
47006602|NCT01955733|83254951|FG002|Period 2|Adverse Event|0|||
47006603|NCT01955733|83254949|FG000|Period 2|Physician Decision|0|||
47006604|NCT01955733|83254950|FG001|Period 2|Physician Decision|0|||
47006605|NCT01955733|83254951|FG002|Period 2|Physician Decision|1|||
47006606|NCT01955733|83254949|FG000|Period 2|Withdrawal by Subject|1|||
47006607|NCT01955733|83254950|FG001|Period 2|Withdrawal by Subject|3|||
47006608|NCT01955733|83254951|FG002|Period 2|Withdrawal by Subject|2|||
47006609|NCT01955733|83254949|FG000|Period 2|Study terminated by sponsor|8|||
47006610|NCT01955733|83254950|FG001|Period 2|Study terminated by sponsor|14|||
47006611|NCT01955733|83254951|FG002|Period 2|Study terminated by sponsor|16|||
47006612|NCT01955733|83254949|FG000|Period 2|Lost to Follow-up|2|||
47006613|NCT01955733|83254950|FG001|Period 2|Lost to Follow-up|0|||
47006614|NCT01955733|83254951|FG002|Period 2|Lost to Follow-up|0|||
47006615|NCT01955733|83254949|FG000|Period 2|Other not defined above|0|||
47006616|NCT01955733|83254950|FG001|Period 2|Other not defined above|2|||
47006617|NCT01955733|83254951|FG002|Period 2|Other not defined above|2|||
47006618|NCT02197897|83254959|FG000|Overall Study|not eligible|1|||
47006619|NCT02223793|83254966|FG000|Overall Study|Lost to Follow-up|10|||
47006620|NCT02223793|83254967|FG001|Overall Study|Lost to Follow-up|1|||
47006621|NCT02223793|83254968|FG002|Overall Study|Lost to Follow-up|2|||
47006622|NCT02223793|83254966|FG000|Overall Study|Withdrawal by Subject|3|||
47006623|NCT02223793|83254967|FG001|Overall Study|Withdrawal by Subject|2|||
47006624|NCT02223793|83254968|FG002|Overall Study|Withdrawal by Subject|3|||
47006625|NCT02223793|83254966|FG000|Overall Study|Moved/studycenter unable to participate|4|||
47006626|NCT02223793|83254967|FG001|Overall Study|Moved/studycenter unable to participate|6|||
47006627|NCT02223793|83254968|FG002|Overall Study|Moved/studycenter unable to participate|8|||
47006628|NCT01926015|83254978|FG000|Overall Study|Withdrawal by parent/guardian|0|||
47006629|NCT01926015|83254979|FG001|Overall Study|Withdrawal by parent/guardian|1|||
47006630|NCT01926015|83254978|FG000|Overall Study|Randomized not treated|2|||
47006631|NCT01926015|83254979|FG001|Overall Study|Randomized not treated|0|||
47006632|NCT02223715|83254985|FG000|Overall Study|Death|31|||
47006633|NCT02223715|83254985|FG000|Overall Study|Lost to Follow-up|73|||
47006634|NCT02196259|83254995|FG000|Overall Study|Researcher choice|0|||
47006635|NCT02196259|83254996|FG001|Overall Study|Researcher choice|0|||
47006636|NCT02196259|83254997|FG002|Overall Study|Researcher choice|1|||
47006637|NCT02196259|83254995|FG000|Overall Study|Partial data analysis|0|||
47006638|NCT02196259|83254996|FG001|Overall Study|Partial data analysis|3|||
47006639|NCT02196259|83254997|FG002|Overall Study|Partial data analysis|0|||
47006640|NCT02294396|83255008|FG000|Overall Study|Adverse Event|26|||
47006641|NCT02294396|83255009|FG001|Overall Study|Adverse Event|25|||
47006642|NCT02294396|83255010|FG002|Overall Study|Adverse Event|21|||
47006643|NCT02294396|83255011|FG003|Overall Study|Adverse Event|24|||
47006644|NCT02294396|83255008|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
47006645|NCT02294396|83255009|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
47006646|NCT02294396|83255010|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
47006647|NCT02294396|83255011|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
47006648|NCT02294396|83255008|FG000|Overall Study|Withdrawal by Subject|8|||
47006649|NCT02294396|83255009|FG001|Overall Study|Withdrawal by Subject|6|||
47006650|NCT02294396|83255010|FG002|Overall Study|Withdrawal by Subject|6|||
47006651|NCT02294396|83255011|FG003|Overall Study|Withdrawal by Subject|8|||
47006652|NCT02294396|83255008|FG000|Overall Study|Lost to Follow-up|0|||
47006653|NCT02294396|83255009|FG001|Overall Study|Lost to Follow-up|0|||
47006654|NCT02294396|83255010|FG002|Overall Study|Lost to Follow-up|1|||
47006655|NCT02294396|83255011|FG003|Overall Study|Lost to Follow-up|1|||
47006656|NCT02294396|83255008|FG000|Overall Study|Protocol Deviation|3|||
47006657|NCT02294396|83255009|FG001|Overall Study|Protocol Deviation|2|||
47006658|NCT02294396|83255010|FG002|Overall Study|Protocol Deviation|2|||
47006659|NCT02294396|83255011|FG003|Overall Study|Protocol Deviation|1|||
47006660|NCT02294396|83255008|FG000|Overall Study|Miscellaneous|2|||
47006661|NCT02294396|83255009|FG001|Overall Study|Miscellaneous|0|||
47006662|NCT02294396|83255010|FG002|Overall Study|Miscellaneous|5|||
47006663|NCT02294396|83255011|FG003|Overall Study|Miscellaneous|2|||
47006664|NCT01721044|83255024|FG000|Treatment Period|Adverse Event|7|||
47006665|NCT01721044|83255025|FG001|Treatment Period|Adverse Event|7|||
47006666|NCT01721044|83255026|FG002|Treatment Period|Adverse Event|10|||
47006667|NCT01721044|83255024|FG000|Treatment Period|Death|0|||
47006668|NCT01721044|83255025|FG001|Treatment Period|Death|0|||
47006669|NCT01721044|83255026|FG002|Treatment Period|Death|1|||
47006670|NCT01721044|83255024|FG000|Treatment Period|Lack of Efficacy|16|||
47006671|NCT01721044|83255025|FG001|Treatment Period|Lack of Efficacy|4|||
47006672|NCT01721044|83255026|FG002|Treatment Period|Lack of Efficacy|4|||
47006673|NCT01721044|83255024|FG000|Treatment Period|Lost to Follow-up|0|||
47006674|NCT01721044|83255025|FG001|Treatment Period|Lost to Follow-up|0|||
47006675|NCT01721044|83255026|FG002|Treatment Period|Lost to Follow-up|1|||
47006676|NCT01721044|83255024|FG000|Treatment Period|Physician Decision|1|||
47006677|NCT01721044|83255025|FG001|Treatment Period|Physician Decision|0|||
47006678|NCT01721044|83255026|FG002|Treatment Period|Physician Decision|2|||
47006679|NCT01721044|83255024|FG000|Treatment Period|Protocol Violation|1|||
47006680|NCT01721044|83255025|FG001|Treatment Period|Protocol Violation|0|||
47006681|NCT01721044|83255026|FG002|Treatment Period|Protocol Violation|0|||
47006682|NCT01721044|83255024|FG000|Treatment Period|Withdrawal by Subject|7|||
47006683|NCT01721044|83255025|FG001|Treatment Period|Withdrawal by Subject|6|||
47006684|NCT01721044|83255026|FG002|Treatment Period|Withdrawal by Subject|1|||
47006685|NCT02164981|83255048|FG000|Started|Withdrawal by Subject|2|||
47006686|NCT02164981|83255049|FG001|Started|Withdrawal by Subject|1|||
47006687|NCT02164981|83255050|FG002|Started|Withdrawal by Subject|0|||
47006688|NCT02164981|83255048|FG000|Started|Protocol Violation|2|||
47006689|NCT02164981|83255049|FG001|Started|Protocol Violation|0|||
47006690|NCT02164981|83255050|FG002|Started|Protocol Violation|0|||
47006691|NCT02164981|83255048|FG000|Started|Adverse Event|1|||
47006692|NCT02164981|83255049|FG001|Started|Adverse Event|2|||
47006693|NCT02164981|83255050|FG002|Started|Adverse Event|0|||
47006694|NCT02164981|83255048|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
47006695|NCT02164981|83255049|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
47006696|NCT02164981|83255050|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
47006697|NCT02164981|83255048|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
47006698|NCT02164981|83255049|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
47006699|NCT02164981|83255050|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
47006700|NCT02164981|83255048|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
47006701|NCT02164981|83255049|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
47006702|NCT02164981|83255050|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
47006703|NCT02195869|83255071|FG000|Overall Study|cGVHD Progression|5|||
47006704|NCT02195869|83255071|FG000|Overall Study|Malignancy Progression/relapse|2|||
47006705|NCT02195869|83255071|FG000|Overall Study|Adverse Event|15|||
47006706|NCT02195869|83255071|FG000|Overall Study|Withdrawal by Subject|7|||
47006707|NCT02195869|83255071|FG000|Overall Study|Physician Decision|4|||
47006708|NCT02195869|83255071|FG000|Overall Study|Study Terminated by Sponsor|7|||
47006709|NCT02195869|83255071|FG000|Overall Study|Noncompliance with study drug|2|||
47006710|NCT01908699|83255080|FG000|Overall Study|Adverse Event|8|||
47006711|NCT01908699|83255081|FG001|Overall Study|Adverse Event|12|||
47006712|NCT01908699|83255080|FG000|Overall Study|Lack of Efficacy|2|||
47006713|NCT01908699|83255081|FG001|Overall Study|Lack of Efficacy|2|||
47006714|NCT01908699|83255080|FG000|Overall Study|Lost to Follow-up|2|||
47006715|NCT01908699|83255081|FG001|Overall Study|Lost to Follow-up|4|||
47006716|NCT01908699|83255080|FG000|Overall Study|Physician Decision|8|||
47006717|NCT01908699|83255081|FG001|Overall Study|Physician Decision|8|||
47006718|NCT01908699|83255080|FG000|Overall Study|Withdrawal by Subject|15|||
47006719|NCT01908699|83255081|FG001|Overall Study|Withdrawal by Subject|10|||
47006720|NCT01908699|83255080|FG000|Overall Study|Pregnancy|0|||
47006721|NCT01908699|83255081|FG001|Overall Study|Pregnancy|1|||
47006722|NCT01908699|83255080|FG000|Overall Study|Randomized in Error|1|||
47006723|NCT01908699|83255081|FG001|Overall Study|Randomized in Error|0|||
47006724|NCT01908699|83255080|FG000|Overall Study|Death|9|||
47006725|NCT01908699|83255081|FG001|Overall Study|Death|12|||
47006726|NCT01908699|83255080|FG000|Overall Study|Progressive Disease|30|||
47006727|NCT01908699|83255081|FG001|Overall Study|Progressive Disease|29|||
47006728|NCT01599637|83255090|FG000|Overall Study|administrative problems|0|||
47006729|NCT01599637|83255091|FG001|Overall Study|administrative problems|2|||
47006730|NCT01599637|83255092|FG002|Overall Study|administrative problems|0|||
47006731|NCT01599637|83255090|FG000|Overall Study|Adverse Event|1|||
47006732|NCT01599637|83255091|FG001|Overall Study|Adverse Event|0|||
47006733|NCT01599637|83255092|FG002|Overall Study|Adverse Event|0|||
47006734|NCT02264639|83255107|FG000|Overall Study|Death (after completing single-dose phase)|1|||
47006735|NCT02264639|83255108|FG001|Overall Study|Death (after completing single-dose phase)|0|||
47006736|NCT02264639|83255109|FG002|Overall Study|Death (after completing single-dose phase)|0|||
47006737|NCT02264639|83255110|FG003|Overall Study|Death (after completing single-dose phase)|0|||
47006738|NCT02264639|83255111|FG004|Overall Study|Death (after completing single-dose phase)|0|||
47006739|NCT02264639|83255107|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
47006740|NCT02264639|83255108|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
47006741|NCT02264639|83255109|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
47006742|NCT02264639|83255110|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
47006743|NCT02264639|83255111|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
47006744|NCT02264639|83255107|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
47006745|NCT02264639|83255108|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
47006746|NCT02264639|83255109|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
47006747|NCT02264639|83255110|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
47006748|NCT02264639|83255111|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
47006749|NCT02264639|83255107|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
47006750|NCT02264639|83255108|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
47006751|NCT02264639|83255109|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
47006752|NCT02264639|83255110|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
47006753|NCT02264639|83255111|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
47006754|NCT01363011|83255128|FG000|Main Study|Adverse Event|2|||
47006755|NCT01363011|83255129|FG001|Main Study|Adverse Event|3|||
47006756|NCT01363011|83255128|FG000|Main Study|Investigator's Discretion|1|||
47006757|NCT01363011|83255129|FG001|Main Study|Investigator's Discretion|1|||
47006758|NCT01363011|83255128|FG000|Main Study|Withdrew Consent|1|||
47006759|NCT01363011|83255129|FG001|Main Study|Withdrew Consent|4|||
47006760|NCT01363011|83255128|FG000|Main Study|Protocol Violation|0|||
47006761|NCT01363011|83255129|FG001|Main Study|Protocol Violation|1|||
47006762|NCT01363011|83255128|FG000|Extension Phase|Adverse Event|1|||
47006763|NCT01363011|83255129|FG001|Extension Phase|Adverse Event|1|||
47006764|NCT01363011|83255128|FG000|Extension Phase|Lack of Efficacy|0|||
47006765|NCT01363011|83255129|FG001|Extension Phase|Lack of Efficacy|1|||
47006766|NCT01363011|83255128|FG000|Extension Phase|Investigator's Discretion|2|||
47006767|NCT01363011|83255129|FG001|Extension Phase|Investigator's Discretion|2|||
47006768|NCT01363011|83255128|FG000|Extension Phase|Withdrew Consent|0|||
47006769|NCT01363011|83255129|FG001|Extension Phase|Withdrew Consent|1|||
47006770|NCT01363011|83255128|FG000|Extension Phase|Lost to Follow-up|0|||
47006771|NCT01363011|83255129|FG001|Extension Phase|Lost to Follow-up|2|||
47006772|NCT01363011|83255128|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
47006773|NCT01363011|83255129|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
47006774|NCT02263547|83255135|FG000|Overall Study|Adverse Event|1|||
47006775|NCT02263547|83255135|FG000|Overall Study|Lost to Follow-up|2|||
47006776|NCT01925703|83255139|FG000|Overall Study|Physician Decision|1|||
47006777|NCT01925703|83255139|FG000|Overall Study|Lost to Follow-up|2|||
47006778|NCT01925703|83255139|FG000|Overall Study|Discharge prior to full iron repletion|1|||
47006779|NCT01617681|83255147|FG000|Period 1 Double Blind|Adverse Event|2|||
47006780|NCT01617681|83255148|FG001|Period 1 Double Blind|Adverse Event|0|||
47006781|NCT01617681|83255149|FG002|Period 1 Double Blind|Adverse Event|0|||
47006782|NCT01617681|83255150|FG003|Period 1 Double Blind|Adverse Event|2|||
47006783|NCT01617681|83255151|FG004|Period 1 Double Blind|Adverse Event|0|||
47006784|NCT01617681|83255147|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
47006785|NCT01617681|83255148|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
47006786|NCT01617681|83255149|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
47006787|NCT01617681|83255150|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
47006788|NCT01617681|83255151|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
47006789|NCT01617681|83255147|FG000|Period 2 Open Label|Adverse Event|0|||
47006790|NCT01617681|83255148|FG001|Period 2 Open Label|Adverse Event|0|||
47006791|NCT01617681|83255149|FG002|Period 2 Open Label|Adverse Event|0|||
47006792|NCT01617681|83255150|FG003|Period 2 Open Label|Adverse Event|0|||
47006793|NCT01617681|83255151|FG004|Period 2 Open Label|Adverse Event|3|||
47006794|NCT01617681|83255147|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
47006795|NCT01617681|83255148|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
47006796|NCT01617681|83255149|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
47006797|NCT01617681|83255150|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
47006798|NCT01617681|83255151|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
47006799|NCT02263079|83255163|FG000|Overall Study|Physician Decision|1|||
47006800|NCT02263079|83255164|FG001|Overall Study|Physician Decision|0|||
47006801|NCT02263079|83255165|FG002|Overall Study|Physician Decision|0|||
47006802|NCT02263079|83255163|FG000|Overall Study|Withdrawal by Subject|2|||
47006803|NCT02263079|83255164|FG001|Overall Study|Withdrawal by Subject|8|||
47006804|NCT02263079|83255165|FG002|Overall Study|Withdrawal by Subject|0|||
47006805|NCT02295995|83255175|FG000|Overall Study|Lost to Follow-up|5|||
47006806|NCT02295995|83255176|FG001|Overall Study|Lost to Follow-up|1|||
47006807|NCT02294981|83255183|FG000|Overall Study|Lost to Follow-up|1|||
47006808|NCT02262377|83255189|FG000|Overall Study|Lost to Follow-up|5|||
47006809|NCT02262377|83255190|FG001|Overall Study|Lost to Follow-up|6|||
47006810|NCT02262377|83255189|FG000|Overall Study|Found ineligible after enrollment|3|||
47006811|NCT02262377|83255190|FG001|Overall Study|Found ineligible after enrollment|0|||
47006812|NCT02262377|83255189|FG000|Overall Study|Withdrawal by Subject|4|||
47006813|NCT02262377|83255190|FG001|Overall Study|Withdrawal by Subject|0|||
47006814|NCT02260817|83255199|FG000|Overall Study|Lost to Follow-up|0|||
47006815|NCT02260817|83255200|FG001|Overall Study|Lost to Follow-up|14|||
47006816|NCT02260817|83255199|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
47006817|NCT02260817|83255200|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
47006818|NCT02260817|83255199|FG000|Overall Study|Observation, no biopsy|0|||
47006819|NCT02260817|83255200|FG001|Overall Study|Observation, no biopsy|1|||
47006820|NCT02260817|83255199|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
47006821|NCT02260817|83255200|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
47006822|NCT02260817|83255199|FG000|Overall Study|Protocol Violation|0|||
47006823|NCT02260817|83255200|FG001|Overall Study|Protocol Violation|14|||
47006824|NCT01642589|83255208|FG000|Overall Study|Withdrawal by Subject|1|||
47006825|NCT01642589|83255209|FG001|Overall Study|Withdrawal by Subject|1|||
47006826|NCT02268812|83255219|FG000|Overall Study|Adverse Event|8|||
47006827|NCT02268812|83255220|FG001|Overall Study|Adverse Event|26|||
47006828|NCT02268812|83255221|FG002|Overall Study|Adverse Event|7|||
47006829|NCT02268812|83255222|FG003|Overall Study|Adverse Event|10|||
47006830|NCT02268812|83255219|FG000|Overall Study|Protocol deviation|0|||
47006831|NCT02268812|83255220|FG001|Overall Study|Protocol deviation|0|||
47006832|NCT02268812|83255221|FG002|Overall Study|Protocol deviation|1|||
47006833|NCT02268812|83255222|FG003|Overall Study|Protocol deviation|0|||
47006834|NCT02268812|83255219|FG000|Overall Study|Withdrawal by Subject|0|||
47006835|NCT02268812|83255220|FG001|Overall Study|Withdrawal by Subject|1|||
47006836|NCT02268812|83255221|FG002|Overall Study|Withdrawal by Subject|0|||
47006837|NCT02268812|83255222|FG003|Overall Study|Withdrawal by Subject|0|||
47006838|NCT02268812|83255219|FG000|Overall Study|Physician Decision|3|||
46709502|NCT01218308|82925558|FG000|Overall Study|Withdrawal by Subject|61|||
46709503|NCT01218308|82925559|FG001|Overall Study|Withdrawal by Subject|64|||
46709504|NCT01218308|82925558|FG000|Overall Study|Lost to Follow-up|27|||
46709505|NCT01218308|82925559|FG001|Overall Study|Lost to Follow-up|31|||
46709506|NCT01218308|82925558|FG000|Overall Study|Other|14|||
46709507|NCT01218308|82925559|FG001|Overall Study|Other|21|||
46709508|NCT01165320|82925567|FG000|Overall Study|Clinical adverse experience|2|||
47006839|NCT02268812|83255220|FG001|Overall Study|Physician Decision|1|||
47006840|NCT02268812|83255221|FG002|Overall Study|Physician Decision|0|||
47006841|NCT02268812|83255222|FG003|Overall Study|Physician Decision|1|||
46709509|NCT01165320|82925568|FG001|Overall Study|Clinical adverse experience|1|||
46709510|NCT01165320|82925569|FG002|Overall Study|Clinical adverse experience|0|||
46709511|NCT01165320|82925567|FG000|Overall Study|Laboratory adverse experience|1|||
47006842|NCT02268812|83255219|FG000|Overall Study|Other|5|||
47006843|NCT02268812|83255220|FG001|Overall Study|Other|4|||
47006844|NCT02268812|83255221|FG002|Overall Study|Other|1|||
47006845|NCT02268812|83255222|FG003|Overall Study|Other|3|||
47006846|NCT01954251|83255234|FG000|Overall Study|Adverse Event|5|||
47006847|NCT01954251|83255235|FG001|Overall Study|Adverse Event|7|||
47006848|NCT01954251|83255234|FG000|Overall Study|Lost to Follow-up|6|||
47006849|NCT01954251|83255235|FG001|Overall Study|Lost to Follow-up|6|||
47006850|NCT01954251|83255234|FG000|Overall Study|Withdrawal by Subject|2|||
47006851|NCT01954251|83255235|FG001|Overall Study|Withdrawal by Subject|6|||
47006852|NCT01644617|83255245|FG000|Overall Study|Withdrawal by Subject|3|||
47006853|NCT01644617|83255246|FG001|Overall Study|Withdrawal by Subject|4|||
47006854|NCT01644617|83255247|FG002|Overall Study|Withdrawal by Subject|1|||
47006855|NCT01644617|83255245|FG000|Overall Study|Lost to Follow-up|0|||
47006856|NCT01644617|83255246|FG001|Overall Study|Lost to Follow-up|1|||
47006857|NCT01644617|83255247|FG002|Overall Study|Lost to Follow-up|0|||
47006858|NCT01644617|83255245|FG000|Overall Study|Adverse Event|3|||
47006859|NCT01644617|83255246|FG001|Overall Study|Adverse Event|0|||
47006860|NCT01644617|83255247|FG002|Overall Study|Adverse Event|6|||
47006861|NCT02294318|83255257|FG000|Overall Study|Worsening of drinking|3|||
47006862|NCT02294318|83255258|FG001|Overall Study|Worsening of drinking|0|||
47006863|NCT02294318|83255257|FG000|Overall Study|Not exposed to intervention|0|||
47006864|NCT02294318|83255258|FG001|Overall Study|Not exposed to intervention|2|||
47006865|NCT02293499|83255267|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
47006866|NCT02293499|83255268|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
47006867|NCT02293499|83255269|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
47006868|NCT02293499|83255267|FG000|Intervention - Camp|Withdrawal by Subject|3|||
47006869|NCT02293499|83255268|FG001|Intervention - Camp|Withdrawal by Subject|6|||
47006870|NCT02293499|83255269|FG002|Intervention - Camp|Withdrawal by Subject|2|||
47006871|NCT02293499|83255267|FG000|Intervention - Camp|these are those not showing up at camp|24|||
47006872|NCT02293499|83255268|FG001|Intervention - Camp|these are those not showing up at camp|28|||
47006873|NCT02293499|83255269|FG002|Intervention - Camp|these are those not showing up at camp|4|||
47006874|NCT02293499|83255267|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
47006875|NCT02293499|83255268|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
47006876|NCT02293499|83255269|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
47006877|NCT02293499|83255267|FG000|3 Month Follow Up|Lost to Follow-up|14|||
47006878|NCT02293499|83255268|FG001|3 Month Follow Up|Lost to Follow-up|15|||
47006879|NCT02293499|83255269|FG002|3 Month Follow Up|Lost to Follow-up|6|||
47006880|NCT02293499|83255267|FG000|6 Month Follow Up|Lost to Follow-up|17|||
47006881|NCT02293499|83255268|FG001|6 Month Follow Up|Lost to Follow-up|27|||
47006882|NCT02293499|83255269|FG002|6 Month Follow Up|Lost to Follow-up|6|||
47006883|NCT02293499|83255267|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
47006884|NCT02293499|83255268|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
47006885|NCT02293499|83255269|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
47006886|NCT02293499|83255267|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
47006887|NCT02293499|83255268|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
47006888|NCT02293499|83255269|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
47006889|NCT02293499|83255267|FG000|9 Month Follow Up|Lost to Follow-up|24|||
47006890|NCT02293499|83255268|FG001|9 Month Follow Up|Lost to Follow-up|28|||
47006891|NCT02293499|83255269|FG002|9 Month Follow Up|Lost to Follow-up|4|||
47006892|NCT02293499|83255267|FG000|12 Month Follow Up|Lost to Follow-up|26|||
47006893|NCT02293499|83255268|FG001|12 Month Follow Up|Lost to Follow-up|25|||
47006894|NCT02293499|83255269|FG002|12 Month Follow Up|Lost to Follow-up|6|||
47006895|NCT02293499|83255267|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
47006896|NCT02293499|83255268|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
47006897|NCT02293499|83255269|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
47006898|NCT02293499|83255267|FG000|15 Month Follow Up|Lost to Follow-up|22|||
47006899|NCT02293499|83255268|FG001|15 Month Follow Up|Lost to Follow-up|22|||
47006900|NCT02293499|83255269|FG002|15 Month Follow Up|Lost to Follow-up|7|||
47006901|NCT02257385|83255280|FG000|Overall Study|Adverse Event|12|||
47006902|NCT02257385|83255281|FG001|Overall Study|Adverse Event|8|||
47006903|NCT02257385|83255280|FG000|Overall Study|Lack of Efficacy|1|||
47006904|NCT02257385|83255281|FG001|Overall Study|Lack of Efficacy|2|||
47006905|NCT02257385|83255280|FG000|Overall Study|Protocol Violation|5|||
47006906|NCT02257385|83255281|FG001|Overall Study|Protocol Violation|7|||
47006907|NCT02257385|83255280|FG000|Overall Study|Lost to Follow-up|0|||
47006908|NCT02257385|83255281|FG001|Overall Study|Lost to Follow-up|1|||
47006909|NCT02257385|83255280|FG000|Overall Study|Withdrawal by Subject|4|||
47006910|NCT02257385|83255281|FG001|Overall Study|Withdrawal by Subject|4|||
47006911|NCT01629667|83255290|FG000|Overall Study|Lost to Follow-up|0|||
47006912|NCT01629667|83255291|FG001|Overall Study|Lost to Follow-up|1|||
47006913|NCT01629667|83255292|FG002|Overall Study|Lost to Follow-up|1|||
47006914|NCT01629667|83255290|FG000|Overall Study|Withdrawal by Subject|31|||
47006915|NCT01629667|83255291|FG001|Overall Study|Withdrawal by Subject|20|||
47006916|NCT01629667|83255292|FG002|Overall Study|Withdrawal by Subject|28|||
47006917|NCT01629667|83255290|FG000|Overall Study|Death|1|||
47006918|NCT01629667|83255291|FG001|Overall Study|Death|5|||
47006919|NCT01629667|83255292|FG002|Overall Study|Death|3|||
47006920|NCT01629667|83255290|FG000|Overall Study|Randomized, not treated|2|||
47006921|NCT01629667|83255291|FG001|Overall Study|Randomized, not treated|1|||
47006922|NCT01629667|83255292|FG002|Overall Study|Randomized, not treated|0|||
47006923|NCT01629667|83255290|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
47006924|NCT01629667|83255291|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
47006925|NCT01629667|83255292|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
47006926|NCT01629667|83255290|FG000|Overall Study|Requiring lung transplant|2|||
47006927|NCT01629667|83255291|FG001|Overall Study|Requiring lung transplant|1|||
47006928|NCT01629667|83255292|FG002|Overall Study|Requiring lung transplant|3|||
47006929|NCT01629667|83255290|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
47006930|NCT01629667|83255291|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
47006931|NCT01629667|83255292|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
47006932|NCT01629667|83255290|FG000|Overall Study|Started other medicine|1|||
47006933|NCT01629667|83255291|FG001|Overall Study|Started other medicine|0|||
47006934|NCT01629667|83255292|FG002|Overall Study|Started other medicine|1|||
47006935|NCT01629667|83255290|FG000|Overall Study|Site error in safety follow-up|0|||
47006936|NCT01629667|83255291|FG001|Overall Study|Site error in safety follow-up|0|||
47006937|NCT01629667|83255292|FG002|Overall Study|Site error in safety follow-up|1|||
47006938|NCT01629667|83255290|FG000|Overall Study|Enrolled in another clinical study|0|||
47006939|NCT01629667|83255291|FG001|Overall Study|Enrolled in another clinical study|1|||
47006940|NCT01629667|83255292|FG002|Overall Study|Enrolled in another clinical study|0|||
47006941|NCT01629667|83255290|FG000|Overall Study|Code break|1|||
47006942|NCT01629667|83255291|FG001|Overall Study|Code break|0|||
47006943|NCT01629667|83255292|FG002|Overall Study|Code break|0|||
47006944|NCT01645280|83255307|FG000|Overall Study|Death|0|||
47006945|NCT01645280|83255308|FG001|Overall Study|Death|1|||
47006946|NCT01645280|83255309|FG002|Overall Study|Death|0|||
47006947|NCT01645280|83255310|FG003|Overall Study|Death|0|||
47006948|NCT01645280|83255311|FG004|Overall Study|Death|0|||
47006949|NCT01645280|83255307|FG000|Overall Study|Withdrawal by Subject|4|||
47006950|NCT01645280|83255308|FG001|Overall Study|Withdrawal by Subject|0|||
47006951|NCT01645280|83255309|FG002|Overall Study|Withdrawal by Subject|2|||
47006952|NCT01645280|83255310|FG003|Overall Study|Withdrawal by Subject|4|||
47006953|NCT01645280|83255311|FG004|Overall Study|Withdrawal by Subject|5|||
47006954|NCT01645280|83255307|FG000|Overall Study|Lost to Follow-up|0|||
47006955|NCT01645280|83255308|FG001|Overall Study|Lost to Follow-up|0|||
47006956|NCT01645280|83255309|FG002|Overall Study|Lost to Follow-up|0|||
47006957|NCT01645280|83255310|FG003|Overall Study|Lost to Follow-up|2|||
47006958|NCT01645280|83255311|FG004|Overall Study|Lost to Follow-up|1|||
47006959|NCT01645280|83255307|FG000|Overall Study|Other|1|||
47006960|NCT01645280|83255308|FG001|Overall Study|Other|1|||
47006961|NCT01645280|83255309|FG002|Overall Study|Other|2|||
47006962|NCT01645280|83255310|FG003|Overall Study|Other|0|||
47006963|NCT01645280|83255311|FG004|Overall Study|Other|0|||
47006964|NCT01645280|83255307|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
47006965|NCT01645280|83255308|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
47006966|NCT01645280|83255309|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
47006967|NCT01645280|83255310|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
47006968|NCT01645280|83255311|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
47006969|NCT02256917|83255324|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
47006970|NCT02256917|83255324|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
47006971|NCT02256917|83255324|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
47006972|NCT02256917|83255324|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
47006973|NCT02256917|83255324|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
47006974|NCT01629589|83255337|FG000|Overall Study|Protocol Violation|4|||
47006975|NCT01629589|83255338|FG001|Overall Study|Protocol Violation|2|||
47006976|NCT01629589|83255337|FG000|Overall Study|Lost to Follow-up|2|||
47006977|NCT01629589|83255338|FG001|Overall Study|Lost to Follow-up|1|||
47006978|NCT01629589|83255337|FG000|Overall Study|Withdrawal by Subject|2|||
47006979|NCT01629589|83255338|FG001|Overall Study|Withdrawal by Subject|3|||
47006980|NCT01629589|83255337|FG000|Overall Study|Did not receive study vaccine|0|||
47006981|NCT01629589|83255338|FG001|Overall Study|Did not receive study vaccine|1|||
46709512|NCT01165320|82925568|FG001|Overall Study|Laboratory adverse experience|0|||
46709513|NCT01165320|82925569|FG002|Overall Study|Laboratory adverse experience|0|||
47006982|NCT02256839|83255346|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
47006983|NCT02256839|83255347|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
47006984|NCT02220907|83255353|FG000|Overall Study|Adverse Event|7|||
47006985|NCT02220907|83255353|FG000|Overall Study|Physician Decision|1|||
47006986|NCT02220907|83255353|FG000|Overall Study|Withdrawal by Subject|2|||
47006987|NCT02220907|83255353|FG000|Overall Study|Conflict with the stopping criteria|1|||
47006988|NCT02255981|83255357|FG000|Overall Study|Lost to Follow-up|3|||
47006989|NCT02255981|83255357|FG000|Overall Study|Withdrawal by Subject|1|||
47006990|NCT01601873|83255369|FG000|Overall Study|Lost to Follow-up|2|||
47006991|NCT01601873|83255370|FG001|Overall Study|Lost to Follow-up|3|||
47006992|NCT02194933|83255378|FG000|Overall Study|Lost to Follow-up|1|||
47006993|NCT02194933|83255379|FG001|Overall Study|Lost to Follow-up|2|||
47006994|NCT02194933|83255378|FG000|Overall Study|Participant met withdrawal criteria|1|||
47006995|NCT02194933|83255379|FG001|Overall Study|Participant met withdrawal criteria|3|||
47006996|NCT02194933|83255378|FG000|Overall Study|Withdrawal by Subject|0|||
47006997|NCT02194933|83255379|FG001|Overall Study|Withdrawal by Subject|2|||
47006998|NCT02194933|83255378|FG000|Overall Study|Lack of Efficacy|1|||
47006999|NCT02194933|83255379|FG001|Overall Study|Lack of Efficacy|2|||
47007000|NCT01644890|83255389|FG000|Overall Study|Adverse Event|7|||
47007001|NCT01644890|83255390|FG001|Overall Study|Adverse Event|20|||
47007002|NCT01644890|83255389|FG000|Overall Study|Death|1|||
47007003|NCT01644890|83255390|FG001|Overall Study|Death|3|||
47007004|NCT01644890|83255389|FG000|Overall Study|Physician Decision|3|||
47007005|NCT01644890|83255390|FG001|Overall Study|Physician Decision|9|||
47007006|NCT01644890|83255389|FG000|Overall Study|Protocol Violation|6|||
47007007|NCT01644890|83255390|FG001|Overall Study|Protocol Violation|7|||
47007008|NCT01644890|83255389|FG000|Overall Study|Withdrawal by Subject|19|||
47007009|NCT01644890|83255390|FG001|Overall Study|Withdrawal by Subject|27|||
47007010|NCT01644890|83255389|FG000|Overall Study|Progression Disease|160|||
47007011|NCT01644890|83255390|FG001|Overall Study|Progression Disease|131|||
47007012|NCT01644890|83255389|FG000|Overall Study|Clinical Progression|6|||
47007013|NCT01644890|83255390|FG001|Overall Study|Clinical Progression|6|||
47007014|NCT01644890|83255389|FG000|Overall Study|> 28 days since last dose of study drug|6|||
47007015|NCT01644890|83255390|FG001|Overall Study|> 28 days since last dose of study drug|3|||
47007016|NCT01644890|83255389|FG000|Overall Study|Other|8|||
47007017|NCT01644890|83255390|FG001|Overall Study|Other|9|||
47007018|NCT01628965|83255396|FG000|Overall Study|Adverse Event|30|||
47007019|NCT01628965|83255396|FG000|Overall Study|Lack of Efficacy|7|||
47007020|NCT01628965|83255396|FG000|Overall Study|Withdrawal by Subject|3|||
47007021|NCT01628965|83255396|FG000|Overall Study|Lost to Follow-up|1|||
47007022|NCT01628965|83255396|FG000|Overall Study|Discontinuation criteria|8|||
47007023|NCT01644734|83255400|FG000|Overall Study|Adverse Event|4|||
47007024|NCT01644734|83255400|FG000|Overall Study|Lost to Follow-up|17|||
47007025|NCT01644734|83255400|FG000|Overall Study|Reasons other than stated above|7|||
47007026|NCT01644734|83255400|FG000|Overall Study|Missing documentation|238|||
47007027|NCT02255279|83255406|FG000|Overall Study|Lost to Follow-up|2|||
47007028|NCT02255279|83255407|FG001|Overall Study|Lost to Follow-up|2|||
47007029|NCT02255279|83255406|FG000|Overall Study|Protocol Violation|0|||
47007030|NCT02255279|83255407|FG001|Overall Study|Protocol Violation|1|||
47007031|NCT02255279|83255406|FG000|Overall Study|Withdrawal by Subject|3|||
47007032|NCT02255279|83255407|FG001|Overall Study|Withdrawal by Subject|6|||
47007033|NCT01643798|83255427|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
47007034|NCT01643798|83255428|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
47007035|NCT02194699|83255441|FG000|Randomised|Did not receive treatment|1|||
47007036|NCT02194699|83255442|FG001|Randomised|Did not receive treatment|5|||
47007037|NCT02194699|83255441|FG000|Randomised|Without potential for 52 weeks of IP|5|||
47007038|NCT02194699|83255442|FG001|Randomised|Without potential for 52 weeks of IP|5|||
47007039|NCT02194699|83255441|FG000|Randomised|Duplicate patient|2|||
47007040|NCT02194699|83255442|FG001|Randomised|Duplicate patient|1|||
47007041|NCT02194699|83255441|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
47007042|NCT02194699|83255442|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
47007043|NCT02194699|83255441|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
47007044|NCT02194699|83255442|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
47007045|NCT02194699|83255441|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
47007046|NCT02194699|83255442|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
47007047|NCT02194699|83255441|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
47007048|NCT02194699|83255442|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
47007049|NCT02194699|83255441|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
47007050|NCT02194699|83255442|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
47007051|NCT02194699|83255441|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
46709514|NCT01165320|82925567|FG000|Overall Study|Lack of Efficacy|0|||
46709515|NCT01165320|82925568|FG001|Overall Study|Lack of Efficacy|2|||
47007052|NCT02194699|83255442|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
47007053|NCT02293538|83255458|FG000|Overall Study|Adverse Event|0|||
47007054|NCT02293538|83255459|FG001|Overall Study|Adverse Event|1|||
47007055|NCT02293538|83255458|FG000|Overall Study|Lost to Follow-up|1|||
47007056|NCT02293538|83255459|FG001|Overall Study|Lost to Follow-up|0|||
47007057|NCT02293538|83255458|FG000|Overall Study|Withdrawal by Subject|0|||
47007058|NCT02293538|83255459|FG001|Overall Study|Withdrawal by Subject|1|||
47007059|NCT02194621|83255469|FG000|Overall Study|6 withdrew prior to randomization|2|||
47007060|NCT02194621|83255470|FG001|Overall Study|6 withdrew prior to randomization|2|||
47007061|NCT02194621|83255471|FG002|Overall Study|6 withdrew prior to randomization|2|||
47007062|NCT02194621|83255469|FG000|Overall Study|Withdrawal by Subject|4|||
47007063|NCT02194621|83255470|FG001|Overall Study|Withdrawal by Subject|4|||
47007064|NCT02194621|83255471|FG002|Overall Study|Withdrawal by Subject|7|||
47007065|NCT02220205|83255481|FG000|Overall Study|Withdrawal by Subject|1|||
47007066|NCT02220205|83255482|FG001|Overall Study|Withdrawal by Subject|0|||
47007067|NCT02266706|83255497|FG000|Overall Study|Withdrawal by Subject|0|||
47007068|NCT02266706|83255498|FG001|Overall Study|Withdrawal by Subject|1|||
47007069|NCT02266706|83255499|FG002|Overall Study|Withdrawal by Subject|1|||
47007070|NCT02266706|83255500|FG003|Overall Study|Withdrawal by Subject|0|||
47007071|NCT02266706|83255501|FG004|Overall Study|Withdrawal by Subject|0|||
47007072|NCT02266706|83255502|FG005|Overall Study|Withdrawal by Subject|1|||
47007073|NCT02266706|83255503|FG006|Overall Study|Withdrawal by Subject|0|||
47007074|NCT02266706|83255504|FG007|Overall Study|Withdrawal by Subject|0|||
47007075|NCT02266706|83255505|FG008|Overall Study|Withdrawal by Subject|0|||
47007076|NCT02266706|83255497|FG000|Overall Study|Screen failure|0|||
47007077|NCT02266706|83255498|FG001|Overall Study|Screen failure|0|||
47007078|NCT02266706|83255499|FG002|Overall Study|Screen failure|0|||
47007079|NCT02266706|83255500|FG003|Overall Study|Screen failure|0|||
47007080|NCT02266706|83255501|FG004|Overall Study|Screen failure|0|||
47007081|NCT02266706|83255502|FG005|Overall Study|Screen failure|1|||
47007082|NCT02266706|83255503|FG006|Overall Study|Screen failure|1|||
47007083|NCT02266706|83255504|FG007|Overall Study|Screen failure|0|||
47007084|NCT02266706|83255505|FG008|Overall Study|Screen failure|0|||
47007085|NCT02266706|83255497|FG000|Overall Study|Enrollment in another study|0|||
47007086|NCT02266706|83255498|FG001|Overall Study|Enrollment in another study|0|||
47007087|NCT02266706|83255499|FG002|Overall Study|Enrollment in another study|0|||
47007088|NCT02266706|83255500|FG003|Overall Study|Enrollment in another study|1|||
47007089|NCT02266706|83255501|FG004|Overall Study|Enrollment in another study|0|||
47007090|NCT02266706|83255502|FG005|Overall Study|Enrollment in another study|0|||
47007091|NCT02266706|83255503|FG006|Overall Study|Enrollment in another study|0|||
47007092|NCT02266706|83255504|FG007|Overall Study|Enrollment in another study|0|||
47007093|NCT02266706|83255505|FG008|Overall Study|Enrollment in another study|0|||
47007094|NCT02293460|83255525|FG000|Overall Study|Protocol Violation|1|||
47007095|NCT02293460|83255525|FG000|Overall Study|Lack of Efficacy|2|||
47007096|NCT02293460|83255525|FG000|Overall Study|Adverse Event|2|||
47007097|NCT02293460|83255525|FG000|Overall Study|Withdrawal by Subject|1|||
47007098|NCT02266004|83255529|FG000|Overall Study|unrelated adverse event|1|||
47007099|NCT02266004|83255529|FG000|Overall Study|Physician Decision|1|||
47007100|NCT02292719|83255539|FG000|Overall Study|Withdrawal by Subject|0|||
47007101|NCT02292719|83255540|FG001|Overall Study|Withdrawal by Subject|0|||
47007102|NCT02292719|83255541|FG002|Overall Study|Withdrawal by Subject|0|||
47007103|NCT02292719|83255542|FG003|Overall Study|Withdrawal by Subject|1|||
47007104|NCT02292719|83255543|FG004|Overall Study|Withdrawal by Subject|1|||
47007105|NCT02292719|83255544|FG005|Overall Study|Withdrawal by Subject|0|||
47007106|NCT02292719|83255539|FG000|Overall Study|Subject enrolled in new study.|0|||
47007107|NCT02292719|83255540|FG001|Overall Study|Subject enrolled in new study.|0|||
47007108|NCT02292719|83255541|FG002|Overall Study|Subject enrolled in new study.|1|||
47007109|NCT02292719|83255542|FG003|Overall Study|Subject enrolled in new study.|0|||
47007110|NCT02292719|83255543|FG004|Overall Study|Subject enrolled in new study.|0|||
47007111|NCT02292719|83255544|FG005|Overall Study|Subject enrolled in new study.|0|||
47007112|NCT02291861|83255562|FG000|Overall Study|Adverse Event|2|||
47007113|NCT02291861|83255563|FG001|Overall Study|Adverse Event|4|||
47007114|NCT02291861|83255564|FG002|Overall Study|Adverse Event|1|||
47007115|NCT02291861|83255565|FG003|Overall Study|Adverse Event|2|||
47007116|NCT02291861|83255562|FG000|Overall Study|Death|0|||
47007117|NCT02291861|83255563|FG001|Overall Study|Death|0|||
47007118|NCT02291861|83255564|FG002|Overall Study|Death|1|||
47007119|NCT02291861|83255565|FG003|Overall Study|Death|1|||
47007120|NCT02291861|83255562|FG000|Overall Study|Protocol Violation|1|||
47007121|NCT02291861|83255563|FG001|Overall Study|Protocol Violation|0|||
47007122|NCT02291861|83255564|FG002|Overall Study|Protocol Violation|0|||
47007123|NCT02291861|83255565|FG003|Overall Study|Protocol Violation|1|||
46709516|NCT01165320|82925569|FG002|Overall Study|Lack of Efficacy|0|||
47007124|NCT02291861|83255562|FG000|Overall Study|Withdrawal by Subject|1|||
47007125|NCT02291861|83255563|FG001|Overall Study|Withdrawal by Subject|2|||
47007126|NCT02291861|83255564|FG002|Overall Study|Withdrawal by Subject|1|||
46709517|NCT01165320|82925567|FG000|Overall Study|Reason unknown|0|||
47007127|NCT02291861|83255565|FG003|Overall Study|Withdrawal by Subject|4|||
47007128|NCT02291861|83255562|FG000|Overall Study|Noncompliance|1|||
47007129|NCT02291861|83255563|FG001|Overall Study|Noncompliance|1|||
47007130|NCT02291861|83255564|FG002|Overall Study|Noncompliance|2|||
47007131|NCT02291861|83255565|FG003|Overall Study|Noncompliance|1|||
47007132|NCT02291861|83255562|FG000|Overall Study|Lost to Follow-up|2|||
47007133|NCT02291861|83255563|FG001|Overall Study|Lost to Follow-up|1|||
47007134|NCT02291861|83255564|FG002|Overall Study|Lost to Follow-up|4|||
47007135|NCT02291861|83255565|FG003|Overall Study|Lost to Follow-up|0|||
47007136|NCT02291861|83255562|FG000|Overall Study|Other|0|||
47007137|NCT02291861|83255563|FG001|Overall Study|Other|0|||
47007138|NCT02291861|83255564|FG002|Overall Study|Other|0|||
47007139|NCT02291861|83255565|FG003|Overall Study|Other|1|||
47007140|NCT02291549|83255577|FG000|Overall Study|Lost to Follow-up|1|||
47007141|NCT02291549|83255578|FG001|Overall Study|Lost to Follow-up|0|||
47007142|NCT02291549|83255577|FG000|Overall Study|Withdrawal by Subject|0|||
47007143|NCT02291549|83255578|FG001|Overall Study|Withdrawal by Subject|1|||
47007144|NCT02264990|83255588|FG000|Overall Study|Death|255|||
47007145|NCT02264990|83255589|FG001|Overall Study|Death|250|||
47007146|NCT02264990|83255588|FG000|Overall Study|Withdrawal by Subject|4|||
47007147|NCT02264990|83255589|FG001|Overall Study|Withdrawal by Subject|5|||
47007148|NCT02264990|83255588|FG000|Overall Study|Lost to Follow-up|1|||
47007149|NCT02264990|83255589|FG001|Overall Study|Lost to Follow-up|3|||
47007150|NCT02264990|83255588|FG000|Overall Study|Other|0|||
47007151|NCT02264990|83255589|FG001|Overall Study|Other|1|||
47007152|NCT02291237|83255598|FG000|Overall Study|Study Terminated by Sponsor|72|||
47007153|NCT02291237|83255599|FG001|Overall Study|Study Terminated by Sponsor|67|||
47007154|NCT02291237|83255598|FG000|Overall Study|Adverse Event|1|||
47007155|NCT02291237|83255599|FG001|Overall Study|Adverse Event|3|||
47007156|NCT02291237|83255598|FG000|Overall Study|Investigator's Discretion|0|||
47007157|NCT02291237|83255599|FG001|Overall Study|Investigator's Discretion|3|||
47007158|NCT02291237|83255598|FG000|Overall Study|Withdrew Consent|11|||
47007159|NCT02291237|83255599|FG001|Overall Study|Withdrew Consent|11|||
47007160|NCT02291237|83255598|FG000|Overall Study|Lost to Follow-up|0|||
47007161|NCT02291237|83255599|FG001|Overall Study|Lost to Follow-up|2|||
47007162|NCT02291237|83255598|FG000|Overall Study|Subject Required Prohibited Medication|2|||
47007163|NCT02291237|83255599|FG001|Overall Study|Subject Required Prohibited Medication|0|||
47007164|NCT02292446|83255605|FG000|Overall Study|Adverse Event|12|||
47007165|NCT02292446|83255605|FG000|Overall Study|Death|1|||
47007166|NCT02292446|83255605|FG000|Overall Study|Disease progression|2|||
47007167|NCT02292446|83255605|FG000|Overall Study|Subject/guardian decision|2|||
47007168|NCT02292446|83255605|FG000|Overall Study|Withdrawal by Subject|3|||
47007169|NCT02290925|83255614|FG000|First Period of Three Months|Lost to Follow-up|2|||
47007170|NCT02290925|83255615|FG001|First Period of Three Months|Lost to Follow-up|1|||
47007171|NCT02290925|83255614|FG000|First Period of Three Months|Death|1|||
47007172|NCT02290925|83255615|FG001|First Period of Three Months|Death|0|||
47007173|NCT02290925|83255614|FG000|First Period of Three Months|Insulin Started|1|||
47007174|NCT02290925|83255615|FG001|First Period of Three Months|Insulin Started|1|||
47007175|NCT02290925|83255614|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
47007176|NCT02290925|83255615|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
47007177|NCT02290925|83255614|FG000|Second Period of 3 Months|insulin started|0|||
47007178|NCT02290925|83255615|FG001|Second Period of 3 Months|insulin started|1|||
47007179|NCT02290691|83255625|FG000|Overall Study|Noncompliance|0|||
47007180|NCT02290691|83255626|FG001|Overall Study|Noncompliance|1|||
47007181|NCT02290691|83255625|FG000|Overall Study|Withdrawal by Subject|1|||
47007182|NCT02290691|83255626|FG001|Overall Study|Withdrawal by Subject|1|||
47007183|NCT02290691|83255625|FG000|Overall Study|Lost to Follow-up|7|||
47007184|NCT02290691|83255626|FG001|Overall Study|Lost to Follow-up|7|||
47007185|NCT02292212|83255632|FG000|ViE Phase|Withdrawal by Subject|1|||
47007186|NCT02292212|83255632|FG000|ViE Phase|Protocol Violation|2|||
47007187|NCT02291510|83255647|FG000|Overall Study|Adverse Event|0|||
47007188|NCT02291510|83255648|FG001|Overall Study|Adverse Event|0|||
47007189|NCT02291510|83255649|FG002|Overall Study|Adverse Event|0|||
47007190|NCT02291510|83255650|FG003|Overall Study|Adverse Event|1|||
47007191|NCT02290223|83255662|FG000|6 Months|Lost to Follow-up|9|||
47007192|NCT02290223|83255663|FG001|6 Months|Lost to Follow-up|6|||
47007193|NCT02290223|83255662|FG000|6 Months|Withdrawal by Subject|5|||
47007194|NCT02290223|83255663|FG001|6 Months|Withdrawal by Subject|0|||
47007195|NCT02290223|83255662|FG000|6 Months|deceased (not related to study)|2|||
47007196|NCT02290223|83255663|FG001|6 Months|deceased (not related to study)|0|||
47007197|NCT02290223|83255662|FG000|12 Months|Lost to Follow-up|16|||
47007198|NCT02290223|83255663|FG001|12 Months|Lost to Follow-up|10|||
47007199|NCT02290223|83255662|FG000|12 Months|Refusal|0|||
47007200|NCT02290223|83255663|FG001|12 Months|Refusal|1|||
47007201|NCT02289833|83255671|FG000|Overall Study|Study discontinuation|0|||
47007202|NCT02289833|83255672|FG001|Overall Study|Study discontinuation|1|||
47007203|NCT02289833|83255671|FG000|Overall Study|Lost to Follow-up|4|||
47007204|NCT02289833|83255672|FG001|Overall Study|Lost to Follow-up|0|||
47007205|NCT02289833|83255671|FG000|Overall Study|Death|23|||
47007206|NCT02289833|83255672|FG001|Overall Study|Death|16|||
47007207|NCT01702558|83255685|FG000|Overall Study|Withdrawal by Subject|0|||
47007208|NCT01702558|83255686|FG001|Overall Study|Withdrawal by Subject|0|||
47007209|NCT01702558|83255687|FG002|Overall Study|Withdrawal by Subject|0|||
47007210|NCT01702558|83255688|FG003|Overall Study|Withdrawal by Subject|12|||
47007211|NCT01702558|83255689|FG004|Overall Study|Withdrawal by Subject|4|||
47007212|NCT01702558|83255685|FG000|Overall Study|Lost to Follow-up|0|||
47007213|NCT01702558|83255686|FG001|Overall Study|Lost to Follow-up|0|||
47007214|NCT01702558|83255687|FG002|Overall Study|Lost to Follow-up|0|||
47007215|NCT01702558|83255688|FG003|Overall Study|Lost to Follow-up|3|||
47007216|NCT01702558|83255689|FG004|Overall Study|Lost to Follow-up|0|||
47007217|NCT01702558|83255685|FG000|Overall Study|Death|4|||
47007218|NCT01702558|83255686|FG001|Overall Study|Death|3|||
47007219|NCT01702558|83255687|FG002|Overall Study|Death|3|||
47007220|NCT01702558|83255688|FG003|Overall Study|Death|16|||
47007221|NCT01702558|83255689|FG004|Overall Study|Death|20|||
47007222|NCT01702558|83255685|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
47007223|NCT01702558|83255686|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
47007224|NCT01702558|83255687|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
47007225|NCT01702558|83255688|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
47007226|NCT01702558|83255689|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
47007227|NCT01702558|83255685|FG000|Overall Study|Study Terminated by Sponsor|0|||
47007228|NCT01702558|83255686|FG001|Overall Study|Study Terminated by Sponsor|1|||
47007229|NCT01702558|83255687|FG002|Overall Study|Study Terminated by Sponsor|0|||
47007230|NCT01702558|83255688|FG003|Overall Study|Study Terminated by Sponsor|0|||
47007231|NCT01702558|83255689|FG004|Overall Study|Study Terminated by Sponsor|1|||
47007232|NCT01702558|83255685|FG000|Overall Study|Other|0|||
47007233|NCT01702558|83255686|FG001|Overall Study|Other|0|||
47007234|NCT01702558|83255687|FG002|Overall Study|Other|0|||
47007235|NCT01702558|83255688|FG003|Overall Study|Other|16|||
47007236|NCT01702558|83255689|FG004|Overall Study|Other|17|||
47007237|NCT02287883|83255704|FG000|Overall Study|Death|8|||
47007238|NCT02287883|83255705|FG001|Overall Study|Death|7|||
47007239|NCT02287883|83255704|FG000|Overall Study|No longer eligible|222|||
47007240|NCT02287883|83255705|FG001|Overall Study|No longer eligible|182|||
47007241|NCT02287883|83255704|FG000|Overall Study|Non-response to survey|229|||
47007242|NCT02287883|83255705|FG001|Overall Study|Non-response to survey|237|||
47007243|NCT01743040|83255711|FG000|Overall Study|Death|1|||
47007244|NCT01743040|83255711|FG000|Overall Study|Lost to Follow-up|66|||
47007245|NCT01743040|83255711|FG000|Overall Study|Physician Decision|40|||
47007246|NCT01743040|83255711|FG000|Overall Study|Protocol Violation|1|||
47007247|NCT01743040|83255711|FG000|Overall Study|Withdrawal by Subject|121|||
47007248|NCT02194465|83255722|FG000|Overall Study|Adverse Event|6|||
47007249|NCT02194465|83255723|FG001|Overall Study|Adverse Event|1|||
47007250|NCT02194465|83255724|FG002|Overall Study|Adverse Event|4|||
47007251|NCT02194465|83255725|FG003|Overall Study|Adverse Event|4|||
47007252|NCT02194465|83255726|FG004|Overall Study|Adverse Event|4|||
47007253|NCT02194465|83255727|FG005|Overall Study|Adverse Event|2|||
47007254|NCT02194465|83255728|FG006|Overall Study|Adverse Event|0|||
47007255|NCT02194465|83255722|FG000|Overall Study|Lost to Follow-up|0|||
47007256|NCT02194465|83255723|FG001|Overall Study|Lost to Follow-up|0|||
47007257|NCT02194465|83255724|FG002|Overall Study|Lost to Follow-up|0|||
47007258|NCT02194465|83255725|FG003|Overall Study|Lost to Follow-up|1|||
47007259|NCT02194465|83255726|FG004|Overall Study|Lost to Follow-up|0|||
47007260|NCT02194465|83255727|FG005|Overall Study|Lost to Follow-up|1|||
47007261|NCT02194465|83255728|FG006|Overall Study|Lost to Follow-up|0|||
47007262|NCT02194465|83255722|FG000|Overall Study|Physician Decision|1|||
47007263|NCT02194465|83255723|FG001|Overall Study|Physician Decision|0|||
47007264|NCT02194465|83255724|FG002|Overall Study|Physician Decision|0|||
47007265|NCT02194465|83255725|FG003|Overall Study|Physician Decision|0|||
47007266|NCT02194465|83255726|FG004|Overall Study|Physician Decision|0|||
47007267|NCT02194465|83255727|FG005|Overall Study|Physician Decision|0|||
47007268|NCT02194465|83255728|FG006|Overall Study|Physician Decision|0|||
46709518|NCT01165320|82925568|FG001|Overall Study|Reason unknown|1|||
46709519|NCT01165320|82925569|FG002|Overall Study|Reason unknown|0|||
46709520|NCT01217606|82925577|FG000|Initial Treatment Phase|Other Reasons|0|||
46709521|NCT01217606|82925578|FG001|Initial Treatment Phase|Other Reasons|2|||
47007269|NCT02194465|83255722|FG000|Overall Study|Protocol Violation|1|||
47007270|NCT02194465|83255723|FG001|Overall Study|Protocol Violation|1|||
47007271|NCT02194465|83255724|FG002|Overall Study|Protocol Violation|2|||
47007272|NCT02194465|83255725|FG003|Overall Study|Protocol Violation|1|||
47007273|NCT02194465|83255726|FG004|Overall Study|Protocol Violation|1|||
47007274|NCT02194465|83255727|FG005|Overall Study|Protocol Violation|0|||
47007275|NCT02194465|83255728|FG006|Overall Study|Protocol Violation|0|||
47007276|NCT02194465|83255722|FG000|Overall Study|Withdrawal by Subject|1|||
47007277|NCT02194465|83255723|FG001|Overall Study|Withdrawal by Subject|3|||
47007278|NCT02194465|83255724|FG002|Overall Study|Withdrawal by Subject|1|||
47007279|NCT02194465|83255725|FG003|Overall Study|Withdrawal by Subject|2|||
47007280|NCT02194465|83255726|FG004|Overall Study|Withdrawal by Subject|2|||
47007281|NCT02194465|83255727|FG005|Overall Study|Withdrawal by Subject|1|||
47007282|NCT02194465|83255728|FG006|Overall Study|Withdrawal by Subject|2|||
47007283|NCT02194465|83255722|FG000|Overall Study|Discontinued follow-up period|0|||
47007284|NCT02194465|83255723|FG001|Overall Study|Discontinued follow-up period|2|||
47007285|NCT02194465|83255724|FG002|Overall Study|Discontinued follow-up period|1|||
47007286|NCT02194465|83255725|FG003|Overall Study|Discontinued follow-up period|0|||
47007287|NCT02194465|83255726|FG004|Overall Study|Discontinued follow-up period|2|||
47007288|NCT02194465|83255727|FG005|Overall Study|Discontinued follow-up period|0|||
47007289|NCT02194465|83255728|FG006|Overall Study|Discontinued follow-up period|0|||
47007290|NCT02287025|83255750|FG000|Overall Study|Not treated|2|||
47007291|NCT02287025|83255751|FG001|Overall Study|Not treated|0|||
47007292|NCT02287025|83255750|FG000|Overall Study|Progression of disease|3|||
47007293|NCT02287025|83255751|FG001|Overall Study|Progression of disease|2|||
47007294|NCT02287025|83255750|FG000|Overall Study|Adverse Event|2|||
47007295|NCT02287025|83255751|FG001|Overall Study|Adverse Event|4|||
47007296|NCT02287025|83255750|FG000|Overall Study|Withdrawal by Subject|2|||
47007297|NCT02287025|83255751|FG001|Overall Study|Withdrawal by Subject|2|||
47007298|NCT02287025|83255750|FG000|Overall Study|Screening failed|1|||
47007299|NCT02287025|83255751|FG001|Overall Study|Screening failed|1|||
47007300|NCT01720264|83255755|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
47007301|NCT01720264|83255755|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
47007302|NCT01720264|83255755|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
47007303|NCT01702246|83255759|FG000|Overall Study|Lost to Follow-up|2|||
47007304|NCT01702246|83255759|FG000|Overall Study|Withdrawal by Subject|2|||
47007305|NCT01702246|83255759|FG000|Overall Study|Physician Decision|1|||
47007306|NCT01631227|83255768|FG000|Overall Study|withdrawn consent|27|||
47007307|NCT01631227|83255769|FG001|Overall Study|withdrawn consent|21|||
47007308|NCT01631227|83255768|FG000|Overall Study|Adverse Event|1|||
47007309|NCT01631227|83255769|FG001|Overall Study|Adverse Event|0|||
47007310|NCT01631227|83255768|FG000|Overall Study|administrative|2|||
47007311|NCT01631227|83255769|FG001|Overall Study|administrative|1|||
47007312|NCT01719172|83255775|FG000|Overall Study|Lost to Follow-up|1|||
47007313|NCT01719172|83255775|FG000|Overall Study|Death|1|||
47007314|NCT02286947|83255779|FG000|Overall Study|Withdrawal by Subject|2|||
47007315|NCT02286713|83255787|FG000|One Week Follow-Up|Death|1|||
47007316|NCT02286713|83255788|FG001|One Week Follow-Up|Death|0|||
47007317|NCT02286713|83255787|FG000|One Week Follow-Up|Lost to Follow-up|17|||
47007318|NCT02286713|83255788|FG001|One Week Follow-Up|Lost to Follow-up|21|||
47007319|NCT02286713|83255787|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
47007320|NCT02286713|83255788|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
47007321|NCT02286713|83255787|FG000|Three Month Follow-Up|Death|1|||
47007322|NCT02286713|83255788|FG001|Three Month Follow-Up|Death|1|||
47007323|NCT02286713|83255787|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
47007324|NCT02286713|83255788|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
47007325|NCT02286713|83255787|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
47007326|NCT02286713|83255788|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
47007327|NCT02286713|83255787|FG000|Six Month Follow-Up|Death|2|||
47007328|NCT02286713|83255788|FG001|Six Month Follow-Up|Death|0|||
47007329|NCT02286713|83255787|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
47007330|NCT02286713|83255788|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
47007331|NCT02285855|83255796|FG000|Overall Study|Withdrawal by Subject|2|||
47007332|NCT02285855|83255797|FG001|Overall Study|Withdrawal by Subject|1|||
47007333|NCT02285777|83255805|FG000|Overall Study|Withdrawal by Subject|1|||
46709522|NCT01217606|82925577|FG000|Initial Treatment Phase|Protocol Violation|3|||
47007334|NCT02285777|83255806|FG001|Overall Study|Withdrawal by Subject|1|||
47007335|NCT02285777|83255805|FG000|Overall Study|Lost to Follow-up|4|||
47007336|NCT02285777|83255806|FG001|Overall Study|Lost to Follow-up|2|||
47007337|NCT02285153|83255814|FG000|Overall Study|Adverse Event|1|||
47007338|NCT02285153|83255815|FG001|Overall Study|Adverse Event|0|||
47007339|NCT02284373|83255824|FG000|Overall Study|Withdrawal by Subject|0|||
47007340|NCT02284373|83255825|FG001|Overall Study|Withdrawal by Subject|1|||
47007341|NCT02284373|83255826|FG002|Overall Study|Withdrawal by Subject|0|||
47007342|NCT02284373|83255824|FG000|Overall Study|Other|0|||
47007343|NCT02284373|83255825|FG001|Overall Study|Other|1|||
47007344|NCT02284373|83255826|FG002|Overall Study|Other|0|||
47007345|NCT02284373|83255824|FG000|Overall Study|Lost to Follow-up|0|||
47007346|NCT02284373|83255825|FG001|Overall Study|Lost to Follow-up|1|||
47007347|NCT02284373|83255826|FG002|Overall Study|Lost to Follow-up|0|||
47007348|NCT01632241|83255836|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
47007349|NCT01632241|83255837|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
47007350|NCT01632241|83255836|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
47007351|NCT01632241|83255837|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
47007352|NCT01632241|83255836|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
47007353|NCT01632241|83255837|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
47007354|NCT01632241|83255836|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
47007355|NCT01632241|83255837|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
47007356|NCT01632241|83255836|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
47007357|NCT01632241|83255837|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
47007358|NCT01632241|83255836|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
47007359|NCT01632241|83255837|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
47007360|NCT01632241|83255836|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
47007361|NCT01632241|83255837|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
47007362|NCT01632241|83255836|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
47007363|NCT01632241|83255837|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
47007364|NCT01632241|83255836|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
47007365|NCT01632241|83255837|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
47007366|NCT01632241|83255836|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
47007367|NCT01632241|83255837|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
47007368|NCT01632241|83255836|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
47007369|NCT01632241|83255837|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
47007370|NCT01632241|83255836|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
47007371|NCT01632241|83255837|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
47007372|NCT01632241|83255836|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
47007373|NCT01632241|83255837|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
47007374|NCT01632241|83255836|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
47007375|NCT01632241|83255837|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
47007376|NCT02263508|83255852|FG000|Overall Study|Withdrawal by Subject|1|||
47007377|NCT02263508|83255853|FG001|Overall Study|Withdrawal by Subject|23|||
47007378|NCT02263508|83255854|FG002|Overall Study|Withdrawal by Subject|17|||
47007379|NCT02263508|83255852|FG000|Overall Study|Sponsor Decision|12|||
47007380|NCT02263508|83255853|FG001|Overall Study|Sponsor Decision|165|||
47007381|NCT02263508|83255854|FG002|Overall Study|Sponsor Decision|182|||
47007382|NCT02263508|83255852|FG000|Overall Study|Lost to Follow-up|2|||
47007383|NCT02263508|83255853|FG001|Overall Study|Lost to Follow-up|7|||
47007384|NCT02263508|83255854|FG002|Overall Study|Lost to Follow-up|7|||
47007385|NCT02263508|83255852|FG000|Overall Study|Death|6|||
47007386|NCT02263508|83255853|FG001|Overall Study|Death|151|||
47007387|NCT02263508|83255854|FG002|Overall Study|Death|140|||
47007388|NCT02291432|83255865|FG000|Overall Study|Withdrawal by Subject|2|||
47007389|NCT02290340|83255873|FG000|Overall Study|Lost to Follow-up|0|||
47007390|NCT02290340|83255874|FG001|Overall Study|Lost to Follow-up|0|||
47007391|NCT02290340|83255875|FG002|Overall Study|Lost to Follow-up|0|||
47007392|NCT02290340|83255876|FG003|Overall Study|Lost to Follow-up|1|||
47007393|NCT02290340|83255873|FG000|Overall Study|Withdrawal by Subject|1|||
47007394|NCT02290340|83255874|FG001|Overall Study|Withdrawal by Subject|0|||
47007395|NCT02290340|83255875|FG002|Overall Study|Withdrawal by Subject|0|||
47007396|NCT02290340|83255876|FG003|Overall Study|Withdrawal by Subject|0|||
47007397|NCT02290340|83255873|FG000|Overall Study|Other|1|||
47007398|NCT02290340|83255874|FG001|Overall Study|Other|0|||
47007399|NCT02290340|83255875|FG002|Overall Study|Other|0|||
47007400|NCT02290340|83255876|FG003|Overall Study|Other|1|||
47007401|NCT02290028|83255889|FG000|Overall Study|Death|217|||
46910000|NCT03340961|83139267|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
46910001|NCT03340961|83139264|FG000|Overall Study|Subject developed an exclusion criterion|0|||
46910002|NCT03340961|83139265|FG001|Overall Study|Subject developed an exclusion criterion|1|||
46910003|NCT03340961|83139266|FG002|Overall Study|Subject developed an exclusion criterion|0|||
46910004|NCT03340961|83139267|FG003|Overall Study|Subject developed an exclusion criterion|0|||
46910005|NCT03340961|83139264|FG000|Overall Study|Protocol Violation|1|||
47007402|NCT02290028|83255889|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
47007403|NCT02290028|83255889|FG000|Overall Study|No longer under care of study physician|76|||
47007404|NCT02290028|83255889|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
47007405|NCT02290028|83255889|FG000|Overall Study|Withdrawal by Subject|52|||
47007406|NCT02290028|83255889|FG000|Overall Study|Study site closure|44|||
47007407|NCT02290028|83255889|FG000|Overall Study|Lost to Follow-up|34|||
47007408|NCT02290028|83255889|FG000|Overall Study|Miscellaneous|10|||
47007409|NCT02290028|83255889|FG000|Overall Study|Transition to EP PASSION|1295|||
47007410|NCT02290028|83255889|FG000|Overall Study|Planned study completion at 12 months|257|||
47007411|NCT01741792|83255899|FG000|Overall Study|Death|6|||
47007412|NCT01741792|83255900|FG001|Overall Study|Death|1|||
47007413|NCT01741792|83255901|FG002|Overall Study|Death|12|||
47007414|NCT02289950|83255917|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
47007415|NCT02289950|83255918|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
47007416|NCT02289950|83255917|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
47007417|NCT02289950|83255918|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
47007418|NCT02289950|83255917|FG000|Overall Study|Lost to Follow-up|1|||
47007419|NCT02289950|83255918|FG001|Overall Study|Lost to Follow-up|0|||
47007420|NCT02289950|83255917|FG000|Overall Study|Physician Decision|9|||
47007421|NCT02289950|83255918|FG001|Overall Study|Physician Decision|3|||
47007422|NCT02289950|83255917|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
47007423|NCT02289950|83255918|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
47007424|NCT02289950|83255917|FG000|Overall Study|Withdrawal by Subject|1|||
47007425|NCT02289950|83255918|FG001|Overall Study|Withdrawal by Subject|3|||
47007426|NCT02289950|83255917|FG000|Overall Study|Test article held for greater than 28 days|0|||
47007427|NCT02289950|83255918|FG001|Overall Study|Test article held for greater than 28 days|1|||
47007428|NCT02289950|83255917|FG000|Overall Study|Adverse Event|11|||
47007429|NCT02289950|83255918|FG001|Overall Study|Adverse Event|3|||
47007430|NCT02289950|83255917|FG000|Overall Study|Death|1|||
47007431|NCT02289950|83255918|FG001|Overall Study|Death|1|||
47007432|NCT02289950|83255917|FG000|Overall Study|Other|5|||
46910006|NCT03340961|83139265|FG001|Overall Study|Protocol Violation|0|||
46910007|NCT03340961|83139266|FG002|Overall Study|Protocol Violation|1|||
46910008|NCT03340961|83139267|FG003|Overall Study|Protocol Violation|0|||
46910009|NCT03340961|83139264|FG000|Overall Study|Adverse Event|1|||
46910010|NCT03340961|83139265|FG001|Overall Study|Adverse Event|1|||
46910011|NCT03340961|83139266|FG002|Overall Study|Adverse Event|0|||
46910012|NCT03340961|83139267|FG003|Overall Study|Adverse Event|0|||
46910013|NCT03340961|83139264|FG000|Overall Study|Lack of Efficacy|0|||
46910014|NCT03340961|83139265|FG001|Overall Study|Lack of Efficacy|0|||
46910015|NCT03340961|83139266|FG002|Overall Study|Lack of Efficacy|0|||
47007433|NCT02289950|83255918|FG001|Overall Study|Other|2|||
47007434|NCT02289950|83255917|FG000|Overall Study|Not Treated|2|||
47007435|NCT02289950|83255918|FG001|Overall Study|Not Treated|1|||
47007436|NCT01741012|83255924|FG000|Overall Study|Lost to Follow-up|1|||
47007437|NCT01741012|83255924|FG000|Overall Study|Withdrawal by Subject|2|||
47007438|NCT02288312|83255932|FG000|Overall Study|Pregnancy|1|||
47007439|NCT02288312|83255933|FG001|Overall Study|Pregnancy|0|||
47007440|NCT02288312|83255934|FG002|Overall Study|Pregnancy|0|||
47007441|NCT01740388|83255944|FG000|Overall Study|Withdrawal by Subject|1|||
47007442|NCT01740388|83255945|FG001|Overall Study|Withdrawal by Subject|2|||
47007443|NCT01740388|83255944|FG000|Overall Study|Lost to Follow-up|2|||
47007444|NCT01740388|83255945|FG001|Overall Study|Lost to Follow-up|0|||
47007445|NCT01740388|83255944|FG000|Overall Study|Physician Decision|2|||
47007446|NCT01740388|83255945|FG001|Overall Study|Physician Decision|6|||
47007447|NCT01740388|83255944|FG000|Overall Study|Subjects missing data, completed|41|||
47007448|NCT01740388|83255945|FG001|Overall Study|Subjects missing data, completed|36|||
47007449|NCT01740154|83255951|FG000|Overall Study|Adverse Event|1|||
47007450|NCT02287922|83255959|FG000|Overall Study|Adverse Event|1|||
47007451|NCT02287922|83255960|FG001|Overall Study|Adverse Event|1|||
47007452|NCT02287922|83255961|FG002|Overall Study|Adverse Event|3|||
47007453|NCT02287922|83255962|FG003|Overall Study|Adverse Event|4|||
47007454|NCT02287922|83255959|FG000|Overall Study|Withdrawal by Subject|1|||
47007455|NCT02287922|83255960|FG001|Overall Study|Withdrawal by Subject|1|||
47007456|NCT02287922|83255961|FG002|Overall Study|Withdrawal by Subject|1|||
47007457|NCT02287922|83255962|FG003|Overall Study|Withdrawal by Subject|2|||
47007458|NCT02287922|83255959|FG000|Overall Study|Lost to Follow-up|0|||
47007459|NCT02287922|83255960|FG001|Overall Study|Lost to Follow-up|0|||
47007460|NCT02287922|83255961|FG002|Overall Study|Lost to Follow-up|1|||
47007461|NCT02287922|83255962|FG003|Overall Study|Lost to Follow-up|0|||
47007462|NCT02287922|83255959|FG000|Overall Study|Sponsor's decision|0|||
47007463|NCT02287922|83255960|FG001|Overall Study|Sponsor's decision|0|||
47007464|NCT02287922|83255961|FG002|Overall Study|Sponsor's decision|0|||
47007465|NCT02287922|83255962|FG003|Overall Study|Sponsor's decision|1|||
47007466|NCT02287922|83255959|FG000|Overall Study|Other|1|||
47007467|NCT02287922|83255960|FG001|Overall Study|Other|0|||
47007468|NCT02287922|83255961|FG002|Overall Study|Other|2|||
47007469|NCT02287922|83255962|FG003|Overall Study|Other|0|||
47007470|NCT02287610|83255973|FG000|Overall Study|Lost to Follow-up|3|||
47007471|NCT02287610|83255973|FG000|Overall Study|Withdrawal by Subject|8|||
47007472|NCT02287610|83255973|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
47007473|NCT02262728|83255979|FG000|Follow-up Phase (3 Years)|Death|0|||
47007474|NCT02262728|83255980|FG001|Follow-up Phase (3 Years)|Death|1|||
47007475|NCT02262728|83255979|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
47007476|NCT02262728|83255980|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
47007477|NCT02262728|83255979|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
47007478|NCT02262728|83255980|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
47007479|NCT02262260|83255988|FG000|Overall Study|Adverse Event|4|||
47007480|NCT02262260|83255989|FG001|Overall Study|Adverse Event|1|||
47007481|NCT02262260|83255988|FG000|Overall Study|Withdrawal of consent|4|||
47007482|NCT02262260|83255989|FG001|Overall Study|Withdrawal of consent|2|||
47007483|NCT02262260|83255988|FG000|Overall Study|Lost to Follow-up|1|||
47007484|NCT02262260|83255989|FG001|Overall Study|Lost to Follow-up|2|||
47007485|NCT02262260|83255988|FG000|Overall Study|Protocol deviation|2|||
47007486|NCT02262260|83255989|FG001|Overall Study|Protocol deviation|5|||
47007487|NCT02285270|83255995|FG000|Overall Study|Lost to Follow-up|1|||
47007488|NCT02285270|83255995|FG000|Overall Study|Physician Decision|3|||
47007489|NCT02285270|83255995|FG000|Overall Study|Determined to be ineligible|1|||
47007490|NCT01717768|83256009|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007491|NCT01717768|83256010|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
47007492|NCT01717768|83256011|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007493|NCT01717768|83256012|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007494|NCT01717768|83256013|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007495|NCT01717768|83256014|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007496|NCT01717768|83256015|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007497|NCT01717768|83256016|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007498|NCT01717768|83256017|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007499|NCT01717768|83256018|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007500|NCT01717768|83256019|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007501|NCT01717768|83256020|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
47007502|NCT01717768|83256009|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007503|NCT01717768|83256010|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007504|NCT01717768|83256011|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
46910016|NCT03340961|83139267|FG003|Overall Study|Lack of Efficacy|1|||
47007505|NCT01717768|83256012|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007506|NCT01717768|83256013|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007507|NCT01717768|83256014|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007508|NCT01717768|83256015|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007509|NCT01717768|83256016|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007510|NCT01717768|83256017|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007511|NCT01717768|83256018|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007512|NCT01717768|83256019|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
47007513|NCT01717768|83256020|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
47007514|NCT01717768|83256009|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007515|NCT01717768|83256010|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007516|NCT01717768|83256011|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007517|NCT01717768|83256012|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007518|NCT01717768|83256013|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007519|NCT01717768|83256014|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007520|NCT01717768|83256015|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007521|NCT01717768|83256016|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
47007522|NCT01717768|83256017|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007523|NCT01717768|83256018|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007524|NCT01717768|83256019|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007525|NCT01717768|83256020|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
47007526|NCT01717768|83256009|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007527|NCT01717768|83256010|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007528|NCT01717768|83256011|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007529|NCT01717768|83256012|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007530|NCT01717768|83256013|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007531|NCT01717768|83256014|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007532|NCT01717768|83256015|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007533|NCT01717768|83256016|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007534|NCT01717768|83256017|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007535|NCT01717768|83256018|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
47007536|NCT01717768|83256019|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007537|NCT01717768|83256020|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
47007538|NCT02260934|83256048|FG000|Overall Study|Lost to Follow-up|2|||
47007539|NCT02260934|83256049|FG001|Overall Study|Lost to Follow-up|1|||
47007540|NCT02260934|83256048|FG000|Overall Study|Withdrawal by Subject|0|||
47007541|NCT02260934|83256049|FG001|Overall Study|Withdrawal by Subject|2|||
47007542|NCT02260934|83256048|FG000|Overall Study|Participant Relocated|1|||
47007543|NCT02260934|83256049|FG001|Overall Study|Participant Relocated|0|||
47007544|NCT02260934|83256048|FG000|Overall Study|Site error|0|||
47007545|NCT02260934|83256049|FG001|Overall Study|Site error|1|||
47007546|NCT02260388|83256066|FG000|Overall Study|Lost to Follow-up|2|||
47007547|NCT02260388|83256067|FG001|Overall Study|Lost to Follow-up|8|||
47007548|NCT02260388|83256068|FG002|Overall Study|Lost to Follow-up|3|||
47007549|NCT02260388|83256069|FG003|Overall Study|Lost to Follow-up|4|||
47007550|NCT02260154|83256079|FG000|Overall Study|Screening failure|2|||
47007551|NCT02284178|83256086|FG000|Overall Study|Met exclusion criteria|49|||
47007552|NCT02284178|83256087|FG001|Overall Study|Met exclusion criteria|54|||
47007553|NCT01643408|83256093|FG000|Overall Study|Adverse Event|12|||
47007554|NCT01643408|83256093|FG000|Overall Study|Other|2|||
47007555|NCT02283788|83256101|FG000|Overall Study|Adverse Event|1|||
47007556|NCT02283788|83256102|FG001|Overall Study|Adverse Event|3|||
47007557|NCT02283788|83256103|FG002|Overall Study|Adverse Event|5|||
47007558|NCT02283788|83256104|FG003|Overall Study|Adverse Event|1|||
47007559|NCT02283788|83256101|FG000|Overall Study|Withdrawal by Subject|0|||
47007560|NCT02283788|83256102|FG001|Overall Study|Withdrawal by Subject|1|||
47007561|NCT02283788|83256103|FG002|Overall Study|Withdrawal by Subject|0|||
47007562|NCT02283788|83256104|FG003|Overall Study|Withdrawal by Subject|1|||
47007563|NCT01739764|83256117|FG000|Overall Study|Adverse Event|0|||
47007564|NCT01739764|83256118|FG001|Overall Study|Adverse Event|3|||
47007565|NCT01739764|83256119|FG002|Overall Study|Adverse Event|4|||
47007566|NCT01739764|83256117|FG000|Overall Study|Death|4|||
47007567|NCT01739764|83256118|FG001|Overall Study|Death|6|||
47007568|NCT01739764|83256119|FG002|Overall Study|Death|38|||
47007569|NCT01739764|83256117|FG000|Overall Study|Lost to Follow-up|0|||
47007570|NCT01739764|83256118|FG001|Overall Study|Lost to Follow-up|0|||
47007571|NCT01739764|83256119|FG002|Overall Study|Lost to Follow-up|5|||
47007572|NCT01739764|83256117|FG000|Overall Study|Non-Compliance|0|||
47007573|NCT01739764|83256118|FG001|Overall Study|Non-Compliance|0|||
47007574|NCT01739764|83256119|FG002|Overall Study|Non-Compliance|1|||
47007575|NCT01739764|83256117|FG000|Overall Study|Multiple Reasons|3|||
47007576|NCT01739764|83256118|FG001|Overall Study|Multiple Reasons|2|||
47007577|NCT01739764|83256119|FG002|Overall Study|Multiple Reasons|3|||
47007578|NCT01739764|83256117|FG000|Overall Study|Physician Decision|2|||
47007579|NCT01739764|83256118|FG001|Overall Study|Physician Decision|2|||
47007580|NCT01739764|83256119|FG002|Overall Study|Physician Decision|4|||
47007581|NCT01739764|83256117|FG000|Overall Study|Progressive Disease|3|||
47007582|NCT01739764|83256118|FG001|Overall Study|Progressive Disease|5|||
47007583|NCT01739764|83256119|FG002|Overall Study|Progressive Disease|16|||
47007584|NCT01739764|83256117|FG000|Overall Study|Protocol Violation|0|||
47007585|NCT01739764|83256118|FG001|Overall Study|Protocol Violation|0|||
47007586|NCT01739764|83256119|FG002|Overall Study|Protocol Violation|2|||
47007587|NCT01739764|83256117|FG000|Overall Study|Study Terminated by Sponsor|8|||
47007588|NCT01739764|83256118|FG001|Overall Study|Study Terminated by Sponsor|13|||
47007589|NCT01739764|83256119|FG002|Overall Study|Study Terminated by Sponsor|26|||
47007590|NCT01739764|83256117|FG000|Overall Study|Withdrawal by Subject|6|||
47007591|NCT01739764|83256118|FG001|Overall Study|Withdrawal by Subject|5|||
47007592|NCT01739764|83256119|FG002|Overall Study|Withdrawal by Subject|27|||
47007593|NCT01700530|83256130|FG000|Overall Study|Withdrawal by Subject|0|||
47007594|NCT01700530|83256131|FG001|Overall Study|Withdrawal by Subject|3|||
47007595|NCT01700530|83256132|FG002|Overall Study|Withdrawal by Subject|1|||
47007596|NCT01700140|83256143|FG000|Overall Study|Use of rescue drugs|3|||
47007597|NCT01700140|83256144|FG001|Overall Study|Use of rescue drugs|3|||
47007598|NCT01700140|83256145|FG002|Overall Study|Use of rescue drugs|1|||
47007599|NCT01700140|83256143|FG000|Overall Study|Discontinuation of radiotherapy|1|||
47007600|NCT01700140|83256144|FG001|Overall Study|Discontinuation of radiotherapy|0|||
47007601|NCT01700140|83256145|FG002|Overall Study|Discontinuation of radiotherapy|0|||
47007602|NCT01700140|83256143|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
47007603|NCT01700140|83256144|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
47007604|NCT01700140|83256145|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
47007605|NCT01700140|83256143|FG000|Overall Study|Aggravation of symptoms|1|||
47007606|NCT01700140|83256144|FG001|Overall Study|Aggravation of symptoms|0|||
47007607|NCT01700140|83256145|FG002|Overall Study|Aggravation of symptoms|0|||
47007608|NCT01700140|83256143|FG000|Overall Study|Adverse Event|0|||
47007609|NCT01700140|83256144|FG001|Overall Study|Adverse Event|1|||
47007610|NCT01700140|83256145|FG002|Overall Study|Adverse Event|0|||
47007611|NCT01700140|83256143|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
47007612|NCT01700140|83256144|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
47007613|NCT01700140|83256145|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
47007614|NCT01717456|83256158|FG000|End of Treatment|Physician Decision|0|||
47007615|NCT01717456|83256159|FG001|End of Treatment|Physician Decision|1|||
47007616|NCT01717456|83256158|FG000|End of Treatment|Lost to Follow-up|0|||
47007617|NCT01717456|83256159|FG001|End of Treatment|Lost to Follow-up|1|||
47007618|NCT01717456|83256158|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
47007619|NCT01717456|83256159|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
47007620|NCT01699750|83256168|FG000|Overall Study|Withdrew Consent|0|||
47007621|NCT01699750|83256169|FG001|Overall Study|Withdrew Consent|1|||
47007622|NCT01699750|83256168|FG000|Overall Study|Other|0|||
47007623|NCT01699750|83256169|FG001|Overall Study|Other|2|||
47007624|NCT01716754|83256183|FG000|Overall Study|Death|0|||
47007625|NCT01716754|83256184|FG001|Overall Study|Death|0|||
47007626|NCT01716754|83256185|FG002|Overall Study|Death|0|||
47007627|NCT01716754|83256186|FG003|Overall Study|Death|1|||
47007628|NCT01716754|83256183|FG000|Overall Study|Protocol deviation|0|||
47007629|NCT01716754|83256184|FG001|Overall Study|Protocol deviation|2|||
47007630|NCT01716754|83256185|FG002|Overall Study|Protocol deviation|7|||
47007631|NCT01716754|83256186|FG003|Overall Study|Protocol deviation|2|||
47007632|NCT01716754|83256183|FG000|Overall Study|Non-compliance with study treatment|0|||
47007633|NCT01716754|83256184|FG001|Overall Study|Non-compliance with study treatment|0|||
47007634|NCT01716754|83256185|FG002|Overall Study|Non-compliance with study treatment|1|||
47007635|NCT01716754|83256186|FG003|Overall Study|Non-compliance with study treatment|0|||
47007636|NCT01716754|83256183|FG000|Overall Study|Physician Decision|1|||
47007637|NCT01716754|83256184|FG001|Overall Study|Physician Decision|0|||
47007638|NCT01716754|83256185|FG002|Overall Study|Physician Decision|0|||
47007639|NCT01716754|83256186|FG003|Overall Study|Physician Decision|0|||
47007640|NCT01716754|83256183|FG000|Overall Study|Lost to Follow-up|1|||
47007641|NCT01716754|83256184|FG001|Overall Study|Lost to Follow-up|0|||
47007642|NCT01716754|83256185|FG002|Overall Study|Lost to Follow-up|0|||
47007643|NCT01716754|83256186|FG003|Overall Study|Lost to Follow-up|1|||
47007644|NCT01716754|83256183|FG000|Overall Study|Adverse Event|4|||
47007645|NCT01716754|83256184|FG001|Overall Study|Adverse Event|2|||
47007646|NCT01716754|83256185|FG002|Overall Study|Adverse Event|2|||
47007647|NCT01716754|83256186|FG003|Overall Study|Adverse Event|1|||
47007648|NCT01716754|83256183|FG000|Overall Study|Withdrawal by Subject|5|||
47007649|NCT01716754|83256184|FG001|Overall Study|Withdrawal by Subject|0|||
47007650|NCT01716754|83256185|FG002|Overall Study|Withdrawal by Subject|4|||
47007651|NCT01716754|83256186|FG003|Overall Study|Withdrawal by Subject|3|||
47007652|NCT01698814|83256197|FG000|Overall Study|Adverse Event|0|||
46910017|NCT03340025|83139279|FG000|Overall Study|Lost to Follow-up|2|||
47007653|NCT01698814|83256198|FG001|Overall Study|Adverse Event|2|||
47007654|NCT01698814|83256197|FG000|Overall Study|Lost to Follow-up|0|||
47007655|NCT01698814|83256198|FG001|Overall Study|Lost to Follow-up|1|||
47007656|NCT01698814|83256197|FG000|Overall Study|Pregnancy|1|||
47007657|NCT01698814|83256198|FG001|Overall Study|Pregnancy|0|||
47007658|NCT01698814|83256197|FG000|Overall Study|Randomized in error|1|||
47007659|NCT01698814|83256198|FG001|Overall Study|Randomized in error|0|||
47007660|NCT01738984|83256206|FG000|Overall Study|Pregnancy|4|||
47007661|NCT01738984|83256207|FG001|Overall Study|Pregnancy|0|||
47007662|NCT01738984|83256206|FG000|Overall Study|Withdrawal by Subject|1|||
47007663|NCT01738984|83256207|FG001|Overall Study|Withdrawal by Subject|0|||
47007664|NCT01738984|83256206|FG000|Overall Study|Lost to Follow-up|59|||
47007665|NCT01738984|83256207|FG001|Overall Study|Lost to Follow-up|39|||
47007666|NCT01738594|83256216|FG000|Registration and Treatment Start|Adverse Event|0|||
47007667|NCT01738594|83256217|FG001|Registration and Treatment Start|Adverse Event|1|||
47007668|NCT01738594|83256218|FG002|Registration and Treatment Start|Adverse Event|0|||
47007669|NCT01738594|83256219|FG003|Registration and Treatment Start|Adverse Event|0|||
47007670|NCT01738594|83256220|FG004|Registration and Treatment Start|Adverse Event|0|||
47007671|NCT01738594|83256221|FG005|Registration and Treatment Start|Adverse Event|0|||
47007672|NCT01738594|83256222|FG006|Registration and Treatment Start|Adverse Event|0|||
47007673|NCT01738594|83256223|FG007|Registration and Treatment Start|Adverse Event|0|||
47007674|NCT01738594|83256216|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
47007675|NCT01738594|83256217|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
47007676|NCT01738594|83256218|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
47007677|NCT01738594|83256219|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
47007678|NCT01738594|83256220|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
47007679|NCT01738594|83256221|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
47007680|NCT01738594|83256222|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
47007681|NCT01738594|83256223|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
47007682|NCT01738594|83256216|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
47007683|NCT01738594|83256217|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
47007684|NCT01738594|83256218|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
47007685|NCT01738594|83256219|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
47007686|NCT01738594|83256220|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
47007687|NCT01738594|83256221|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
47007688|NCT01738594|83256222|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
47007689|NCT01738594|83256223|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
47007690|NCT01738594|83256216|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
47007691|NCT01738594|83256217|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
47007692|NCT01738594|83256218|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
47007693|NCT01738594|83256219|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
47007694|NCT01738594|83256220|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
47007695|NCT01738594|83256221|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
47007696|NCT01738594|83256222|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
47007697|NCT01738594|83256223|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
47007698|NCT01738594|83256216|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
47007699|NCT01738594|83256217|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
47007700|NCT01738594|83256218|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
47007701|NCT01738594|83256219|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
47007702|NCT01738594|83256220|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
47007703|NCT01738594|83256221|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
47007704|NCT01738594|83256222|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
47007705|NCT01738594|83256223|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
47007706|NCT01738594|83256216|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
47007707|NCT01738594|83256217|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
47007708|NCT01738594|83256218|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
47007709|NCT01738594|83256219|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
47007710|NCT01738594|83256220|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
47007711|NCT01738594|83256221|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
47007712|NCT01738594|83256222|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
47007713|NCT01738594|83256223|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
47007714|NCT01738594|83256216|FG000|Follow up for 1 Year|Death|0|||
47007715|NCT01738594|83256217|FG001|Follow up for 1 Year|Death|0|||
47007716|NCT01738594|83256218|FG002|Follow up for 1 Year|Death|0|||
47007717|NCT01738594|83256219|FG003|Follow up for 1 Year|Death|0|||
47007718|NCT01738594|83256220|FG004|Follow up for 1 Year|Death|0|||
47007719|NCT01738594|83256221|FG005|Follow up for 1 Year|Death|1|||
47007720|NCT01738594|83256222|FG006|Follow up for 1 Year|Death|0|||
47007721|NCT01738594|83256223|FG007|Follow up for 1 Year|Death|0|||
47007722|NCT01738594|83256216|FG000|Follow up for 1 Year|Other|0|||
47007723|NCT01738594|83256217|FG001|Follow up for 1 Year|Other|0|||
47007724|NCT01738594|83256218|FG002|Follow up for 1 Year|Other|0|||
47007725|NCT01738594|83256219|FG003|Follow up for 1 Year|Other|0|||
47007726|NCT01738594|83256220|FG004|Follow up for 1 Year|Other|0|||
47007727|NCT01738594|83256221|FG005|Follow up for 1 Year|Other|2|||
47007728|NCT01738594|83256222|FG006|Follow up for 1 Year|Other|0|||
47007729|NCT01738594|83256223|FG007|Follow up for 1 Year|Other|0|||
47007730|NCT01738438|83256233|FG000|Overall Study|Disease Progression|32|||
47007731|NCT01738438|83256233|FG000|Overall Study|Adverse Event|3|||
47007732|NCT01716520|83256237|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
47007733|NCT01716520|83256238|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
47007734|NCT01716520|83256239|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
47007735|NCT01716520|83256240|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
47007736|NCT01716520|83256241|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
47007737|NCT01716520|83256242|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
47007738|NCT01716520|83256237|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
47007739|NCT01716520|83256238|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
47007740|NCT01716520|83256239|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
47007741|NCT01716520|83256240|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
47007742|NCT01716520|83256241|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
47007743|NCT01716520|83256242|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
47007744|NCT01716520|83256237|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47007745|NCT01716520|83256238|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
47007746|NCT01716520|83256239|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47007747|NCT01716520|83256240|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47007748|NCT01716520|83256241|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47007749|NCT01716520|83256242|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47007750|NCT01716520|83256237|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
47007751|NCT01716520|83256238|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
47007752|NCT01716520|83256239|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
47007753|NCT01716520|83256240|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
47007754|NCT01716520|83256241|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
47007755|NCT01716520|83256242|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
47007756|NCT01716520|83256237|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
47007757|NCT01716520|83256238|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
47007758|NCT01716520|83256239|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
47007759|NCT01716520|83256240|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
47007760|NCT01716520|83256241|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
47007761|NCT01716520|83256242|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
47007762|NCT01716520|83256237|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
47007763|NCT01716520|83256238|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
47007764|NCT01716520|83256239|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
47007765|NCT01716520|83256240|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
47007766|NCT01716520|83256241|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
47007767|NCT01716520|83256242|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
47007768|NCT01716520|83256237|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
47007769|NCT01716520|83256238|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
47007770|NCT01716520|83256239|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
47007771|NCT01716520|83256240|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
47007772|NCT01716520|83256241|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
47007773|NCT01716520|83256242|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
47007774|NCT01716520|83256237|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
47007775|NCT01716520|83256238|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
47007776|NCT01716520|83256239|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
47007777|NCT01716520|83256240|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
47007778|NCT01716520|83256241|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
47007779|NCT01716520|83256242|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
47007780|NCT01716520|83256237|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
46709523|NCT01217606|82925578|FG001|Initial Treatment Phase|Protocol Violation|2|||
46709524|NCT01217606|82925577|FG000|Initial Treatment Phase|Personal Reasons|0|||
47007781|NCT01716520|83256238|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
47007782|NCT01716520|83256239|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
47007783|NCT01716520|83256240|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
47007784|NCT01716520|83256241|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
46709525|NCT01217606|82925578|FG001|Initial Treatment Phase|Personal Reasons|2|||
47007785|NCT01716520|83256242|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
47007786|NCT01716520|83256237|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
47007787|NCT01716520|83256238|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
47007788|NCT01716520|83256239|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
47007789|NCT01716520|83256240|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
47007790|NCT01716520|83256241|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
47007791|NCT01716520|83256242|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
47007792|NCT01716520|83256237|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
47007793|NCT01716520|83256238|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
47007794|NCT01716520|83256239|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
47007795|NCT01716520|83256240|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
47007796|NCT01716520|83256241|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
47007797|NCT01716520|83256242|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
47007798|NCT01716520|83256237|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
47007799|NCT01716520|83256238|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
47007800|NCT01716520|83256239|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
47007801|NCT01716520|83256240|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
47007802|NCT01716520|83256241|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
47007803|NCT01716520|83256242|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
47007804|NCT01716520|83256237|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
47007805|NCT01716520|83256238|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
47007806|NCT01716520|83256239|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
47007807|NCT01716520|83256240|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
47007808|NCT01716520|83256241|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
47007809|NCT01716520|83256242|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
47007810|NCT01716520|83256237|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47007811|NCT01716520|83256238|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47007812|NCT01716520|83256239|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47007813|NCT01716520|83256240|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47007814|NCT01716520|83256241|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47007815|NCT01716520|83256242|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
47007816|NCT01716520|83256237|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
47007817|NCT01716520|83256238|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
47007818|NCT01716520|83256239|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
47007819|NCT01716520|83256240|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
47007820|NCT01716520|83256241|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
47007821|NCT01716520|83256242|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
47007822|NCT01698268|83256252|FG000|Overall Study|Physician Decision|2|||
47007823|NCT01698268|83256253|FG001|Overall Study|Physician Decision|1|||
47007824|NCT01697956|83256261|FG000|Overall Study|Protocol Violation|1|||
47007825|NCT01697956|83256262|FG001|Overall Study|Protocol Violation|1|||
47007826|NCT01697800|83256276|FG000|Overall Study|Death|0|||
47007827|NCT01697800|83256277|FG001|Overall Study|Death|1|||
47007828|NCT01644500|83256286|FG000|Overall Study|Adverse Event|6|||
47007829|NCT01644500|83256287|FG001|Overall Study|Adverse Event|1|||
47007830|NCT01644500|83256288|FG002|Overall Study|Adverse Event|2|||
47007831|NCT01644500|83256286|FG000|Overall Study|Death|0|||
47007832|NCT01644500|83256287|FG001|Overall Study|Death|1|||
47007833|NCT01644500|83256288|FG002|Overall Study|Death|0|||
47007834|NCT01644500|83256286|FG000|Overall Study|Lost to Follow-up|3|||
47007835|NCT01644500|83256287|FG001|Overall Study|Lost to Follow-up|8|||
47007836|NCT01644500|83256288|FG002|Overall Study|Lost to Follow-up|0|||
47007837|NCT01644500|83256286|FG000|Overall Study|Protocol Violation|1|||
47007838|NCT01644500|83256287|FG001|Overall Study|Protocol Violation|1|||
47007839|NCT01644500|83256288|FG002|Overall Study|Protocol Violation|0|||
47007840|NCT01644500|83256286|FG000|Overall Study|Withdrawal by Subject|11|||
47007841|NCT01644500|83256287|FG001|Overall Study|Withdrawal by Subject|12|||
47007842|NCT01644500|83256288|FG002|Overall Study|Withdrawal by Subject|12|||
47007843|NCT01644500|83256286|FG000|Overall Study|Physician Decision|1|||
47007844|NCT01644500|83256287|FG001|Overall Study|Physician Decision|1|||
47007845|NCT01644500|83256288|FG002|Overall Study|Physician Decision|1|||
47007846|NCT01604824|83256300|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
47007847|NCT01604824|83256301|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
47007848|NCT01604824|83256302|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
46709526|NCT01217606|82925577|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
47007849|NCT01604824|83256303|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
47007850|NCT01604824|83256304|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
47007851|NCT01604824|83256305|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
47007852|NCT01604824|83256300|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
47007853|NCT01604824|83256301|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
47007854|NCT01604824|83256302|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
47007855|NCT01604824|83256303|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
47007856|NCT01604824|83256304|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
47007857|NCT01604824|83256305|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
47007858|NCT01716052|83256319|FG000|Overall Study|Withdrawal of funding|1|||
47007859|NCT01716052|83256320|FG001|Overall Study|Withdrawal of funding|1|||
47007860|NCT01641692|83256326|FG000|Treatment Period 1|Adverse Event|1|||
47007861|NCT01641692|83256327|FG001|Treatment Period 1|Adverse Event|0|||
47007862|NCT01641692|83256328|FG002|Treatment Period 1|Adverse Event|0|||
47007863|NCT01641692|83256329|FG003|Treatment Period 1|Adverse Event|0|||
47007864|NCT01641692|83256330|FG004|Treatment Period 1|Adverse Event|0|||
47007865|NCT01641692|83256331|FG005|Treatment Period 1|Adverse Event|0|||
47007866|NCT01641692|83256332|FG006|Treatment Period 1|Adverse Event|0|||
47007867|NCT01641692|83256333|FG007|Treatment Period 1|Adverse Event|0|||
47007868|NCT01641692|83256326|FG000|Treatment Period 1|Lack of Efficacy|0|||
47007869|NCT01641692|83256327|FG001|Treatment Period 1|Lack of Efficacy|0|||
47007870|NCT01641692|83256328|FG002|Treatment Period 1|Lack of Efficacy|0|||
47007871|NCT01641692|83256329|FG003|Treatment Period 1|Lack of Efficacy|0|||
47007872|NCT01641692|83256330|FG004|Treatment Period 1|Lack of Efficacy|0|||
47007873|NCT01641692|83256331|FG005|Treatment Period 1|Lack of Efficacy|0|||
47007874|NCT01641692|83256332|FG006|Treatment Period 1|Lack of Efficacy|0|||
47007875|NCT01641692|83256333|FG007|Treatment Period 1|Lack of Efficacy|1|||
47007876|NCT01641692|83256326|FG000|Treatment Period 1|Protocol Violation|1|||
47007877|NCT01641692|83256327|FG001|Treatment Period 1|Protocol Violation|0|||
47007878|NCT01641692|83256328|FG002|Treatment Period 1|Protocol Violation|0|||
47007879|NCT01641692|83256329|FG003|Treatment Period 1|Protocol Violation|0|||
47007880|NCT01641692|83256330|FG004|Treatment Period 1|Protocol Violation|2|||
47007881|NCT01641692|83256331|FG005|Treatment Period 1|Protocol Violation|0|||
47007882|NCT01641692|83256332|FG006|Treatment Period 1|Protocol Violation|0|||
47007883|NCT01641692|83256333|FG007|Treatment Period 1|Protocol Violation|0|||
47007884|NCT01641692|83256326|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
47007885|NCT01641692|83256327|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
47007886|NCT01641692|83256328|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
47007887|NCT01641692|83256329|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
47007888|NCT01641692|83256330|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
47007889|NCT01641692|83256331|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
47007890|NCT01641692|83256332|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
47007891|NCT01641692|83256333|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
47007892|NCT01641692|83256326|FG000|Treatment Period 1|Lost to Follow-up|0|||
47007893|NCT01641692|83256327|FG001|Treatment Period 1|Lost to Follow-up|0|||
47007894|NCT01641692|83256328|FG002|Treatment Period 1|Lost to Follow-up|1|||
47007895|NCT01641692|83256329|FG003|Treatment Period 1|Lost to Follow-up|0|||
47007896|NCT01641692|83256330|FG004|Treatment Period 1|Lost to Follow-up|0|||
47007897|NCT01641692|83256331|FG005|Treatment Period 1|Lost to Follow-up|0|||
47007898|NCT01641692|83256332|FG006|Treatment Period 1|Lost to Follow-up|0|||
47007899|NCT01641692|83256333|FG007|Treatment Period 1|Lost to Follow-up|0|||
47007900|NCT01641692|83256326|FG000|Treatment Period 1|Physician Decision|0|||
47007901|NCT01641692|83256327|FG001|Treatment Period 1|Physician Decision|0|||
47007902|NCT01641692|83256328|FG002|Treatment Period 1|Physician Decision|0|||
47007903|NCT01641692|83256329|FG003|Treatment Period 1|Physician Decision|0|||
47007904|NCT01641692|83256330|FG004|Treatment Period 1|Physician Decision|1|||
47007905|NCT01641692|83256331|FG005|Treatment Period 1|Physician Decision|0|||
47007906|NCT01641692|83256332|FG006|Treatment Period 1|Physician Decision|0|||
47007907|NCT01641692|83256333|FG007|Treatment Period 1|Physician Decision|0|||
47007908|NCT01641692|83256326|FG000|Treatment Period 1|Withdrawal by Subject|0|||
47007909|NCT01641692|83256327|FG001|Treatment Period 1|Withdrawal by Subject|0|||
47007910|NCT01641692|83256328|FG002|Treatment Period 1|Withdrawal by Subject|0|||
47007911|NCT01641692|83256329|FG003|Treatment Period 1|Withdrawal by Subject|0|||
47007912|NCT01641692|83256330|FG004|Treatment Period 1|Withdrawal by Subject|0|||
47007913|NCT01641692|83256331|FG005|Treatment Period 1|Withdrawal by Subject|2|||
47007914|NCT01641692|83256332|FG006|Treatment Period 1|Withdrawal by Subject|0|||
47007915|NCT01641692|83256333|FG007|Treatment Period 1|Withdrawal by Subject|1|||
47007916|NCT01641692|83256326|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
47007917|NCT01641692|83256327|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
47007918|NCT01641692|83256328|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
47007919|NCT01641692|83256329|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
47007920|NCT01641692|83256330|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
47007921|NCT01641692|83256331|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
47007922|NCT01641692|83256332|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
47007923|NCT01641692|83256333|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
47007924|NCT01641692|83256326|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47007925|NCT01641692|83256327|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47007926|NCT01641692|83256328|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47007927|NCT01641692|83256329|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47007928|NCT01641692|83256330|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47007929|NCT01641692|83256331|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47007930|NCT01641692|83256332|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
47007931|NCT01641692|83256333|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47007932|NCT01641692|83256326|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
47007933|NCT01641692|83256327|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007934|NCT01641692|83256328|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
47007935|NCT01641692|83256329|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
47007936|NCT01641692|83256330|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
47007937|NCT01641692|83256331|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007938|NCT01641692|83256332|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007939|NCT01641692|83256333|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
47007940|NCT01641692|83256326|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
47007941|NCT01641692|83256327|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
47007942|NCT01641692|83256328|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47007943|NCT01641692|83256329|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
47007944|NCT01641692|83256330|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
47007945|NCT01641692|83256331|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47007946|NCT01641692|83256332|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
47007947|NCT01641692|83256333|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47007948|NCT01641692|83256326|FG000|Treatment Period 2|Lack of Efficacy|1|||
47007949|NCT01641692|83256327|FG001|Treatment Period 2|Lack of Efficacy|0|||
47007950|NCT01641692|83256328|FG002|Treatment Period 2|Lack of Efficacy|0|||
47007951|NCT01641692|83256329|FG003|Treatment Period 2|Lack of Efficacy|0|||
47007952|NCT01641692|83256330|FG004|Treatment Period 2|Lack of Efficacy|0|||
47007953|NCT01641692|83256331|FG005|Treatment Period 2|Lack of Efficacy|0|||
47007954|NCT01641692|83256332|FG006|Treatment Period 2|Lack of Efficacy|0|||
47007955|NCT01641692|83256333|FG007|Treatment Period 2|Lack of Efficacy|0|||
47007956|NCT01641692|83256326|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
47007957|NCT01641692|83256327|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
47007958|NCT01641692|83256328|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
47007959|NCT01641692|83256329|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
47007960|NCT01641692|83256330|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
47007961|NCT01641692|83256331|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
47007962|NCT01641692|83256332|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
47007963|NCT01641692|83256333|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
47007964|NCT01641692|83256326|FG000|Treatment Period 2|Lost to Follow-up|0|||
47007965|NCT01641692|83256327|FG001|Treatment Period 2|Lost to Follow-up|0|||
47007966|NCT01641692|83256328|FG002|Treatment Period 2|Lost to Follow-up|0|||
47007967|NCT01641692|83256329|FG003|Treatment Period 2|Lost to Follow-up|0|||
47007968|NCT01641692|83256330|FG004|Treatment Period 2|Lost to Follow-up|0|||
47007969|NCT01641692|83256331|FG005|Treatment Period 2|Lost to Follow-up|1|||
47007970|NCT01641692|83256332|FG006|Treatment Period 2|Lost to Follow-up|0|||
47007971|NCT01641692|83256333|FG007|Treatment Period 2|Lost to Follow-up|0|||
47007972|NCT01641692|83256326|FG000|Treatment Period 2|Withdrawal by Subject|1|||
47007973|NCT01641692|83256327|FG001|Treatment Period 2|Withdrawal by Subject|0|||
47007974|NCT01641692|83256328|FG002|Treatment Period 2|Withdrawal by Subject|0|||
47007975|NCT01641692|83256329|FG003|Treatment Period 2|Withdrawal by Subject|0|||
47007976|NCT01641692|83256330|FG004|Treatment Period 2|Withdrawal by Subject|0|||
47007977|NCT01641692|83256331|FG005|Treatment Period 2|Withdrawal by Subject|1|||
47007978|NCT01641692|83256332|FG006|Treatment Period 2|Withdrawal by Subject|0|||
47007979|NCT01641692|83256333|FG007|Treatment Period 2|Withdrawal by Subject|1|||
46620507|NCT02536300|82769740|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
47007980|NCT01641692|83256326|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007981|NCT01641692|83256327|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007982|NCT01641692|83256328|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007983|NCT01641692|83256329|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007984|NCT01641692|83256330|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
47007985|NCT01641692|83256331|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007986|NCT01641692|83256332|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
47007987|NCT01641692|83256333|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
47007988|NCT01641692|83256326|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47007989|NCT01641692|83256327|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47007990|NCT01641692|83256328|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
47007991|NCT01641692|83256329|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47007992|NCT01641692|83256330|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47007993|NCT01641692|83256331|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
47007994|NCT01641692|83256332|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47007995|NCT01641692|83256333|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
47007996|NCT01641692|83256326|FG000|Treatment Period 3|Adverse Event|0|||
47007997|NCT01641692|83256327|FG001|Treatment Period 3|Adverse Event|0|||
47007998|NCT01641692|83256328|FG002|Treatment Period 3|Adverse Event|0|||
47007999|NCT01641692|83256329|FG003|Treatment Period 3|Adverse Event|0|||
47008000|NCT01641692|83256330|FG004|Treatment Period 3|Adverse Event|0|||
47008001|NCT01641692|83256331|FG005|Treatment Period 3|Adverse Event|0|||
47008002|NCT01641692|83256332|FG006|Treatment Period 3|Adverse Event|1|||
47008003|NCT01641692|83256333|FG007|Treatment Period 3|Adverse Event|0|||
47008004|NCT01641692|83256326|FG000|Treatment Period 3|Protocol Violation|0|||
47008005|NCT01641692|83256327|FG001|Treatment Period 3|Protocol Violation|0|||
47008006|NCT01641692|83256328|FG002|Treatment Period 3|Protocol Violation|1|||
47008007|NCT01641692|83256329|FG003|Treatment Period 3|Protocol Violation|0|||
47008008|NCT01641692|83256330|FG004|Treatment Period 3|Protocol Violation|0|||
47008009|NCT01641692|83256331|FG005|Treatment Period 3|Protocol Violation|0|||
47008010|NCT01641692|83256332|FG006|Treatment Period 3|Protocol Violation|0|||
47008011|NCT01641692|83256333|FG007|Treatment Period 3|Protocol Violation|0|||
47008012|NCT01641692|83256326|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
47008013|NCT01641692|83256327|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
47008014|NCT01641692|83256328|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
47008015|NCT01641692|83256329|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
47008016|NCT01641692|83256330|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
47008017|NCT01641692|83256331|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
47008018|NCT01641692|83256332|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
47008019|NCT01641692|83256333|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
47008020|NCT01641692|83256326|FG000|Treatment Period 3|Lost to Follow-up|0|||
47008021|NCT01641692|83256327|FG001|Treatment Period 3|Lost to Follow-up|1|||
47008022|NCT01641692|83256328|FG002|Treatment Period 3|Lost to Follow-up|0|||
47008023|NCT01641692|83256329|FG003|Treatment Period 3|Lost to Follow-up|0|||
47008024|NCT01641692|83256330|FG004|Treatment Period 3|Lost to Follow-up|0|||
47008025|NCT01641692|83256331|FG005|Treatment Period 3|Lost to Follow-up|0|||
47008026|NCT01641692|83256332|FG006|Treatment Period 3|Lost to Follow-up|0|||
47008027|NCT01641692|83256333|FG007|Treatment Period 3|Lost to Follow-up|0|||
47008028|NCT01641692|83256326|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
47008029|NCT01641692|83256327|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
47008030|NCT01641692|83256328|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
47008031|NCT01641692|83256329|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
47008032|NCT01641692|83256330|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
47008033|NCT01641692|83256331|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
47008034|NCT01641692|83256332|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
47008035|NCT01641692|83256333|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
47008036|NCT01641692|83256326|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
47008037|NCT01641692|83256327|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
47008038|NCT01641692|83256328|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
47008039|NCT01641692|83256329|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
47008040|NCT01641692|83256330|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
47008041|NCT01641692|83256331|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
47008042|NCT01641692|83256332|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
47008043|NCT01641692|83256333|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
47008044|NCT01682512|83256355|FG000|Overall Study|Adverse Event|6|||
47008045|NCT01682512|83256356|FG001|Overall Study|Adverse Event|5|||
47008046|NCT01682512|83256357|FG002|Overall Study|Adverse Event|2|||
47008047|NCT01682512|83256355|FG000|Overall Study|Withdrawal by Subject|2|||
47008048|NCT01682512|83256356|FG001|Overall Study|Withdrawal by Subject|6|||
47008049|NCT01682512|83256357|FG002|Overall Study|Withdrawal by Subject|3|||
47008050|NCT01682512|83256355|FG000|Overall Study|Physician Decision|0|||
47008051|NCT01682512|83256356|FG001|Overall Study|Physician Decision|2|||
47008052|NCT01682512|83256357|FG002|Overall Study|Physician Decision|0|||
47008053|NCT01682512|83256355|FG000|Overall Study|Study terminated by sponsor|46|||
47008054|NCT01682512|83256356|FG001|Overall Study|Study terminated by sponsor|43|||
47008055|NCT01682512|83256357|FG002|Overall Study|Study terminated by sponsor|0|||
47008056|NCT01682512|83256355|FG000|Overall Study|Lost to Follow-up|3|||
47008057|NCT01682512|83256356|FG001|Overall Study|Lost to Follow-up|0|||
47008058|NCT01682512|83256357|FG002|Overall Study|Lost to Follow-up|2|||
47008059|NCT01682512|83256355|FG000|Overall Study|Protocol Violation|2|||
47008060|NCT01682512|83256356|FG001|Overall Study|Protocol Violation|3|||
47008061|NCT01682512|83256357|FG002|Overall Study|Protocol Violation|2|||
47008062|NCT01682512|83256355|FG000|Overall Study|Primary lack of efficacy|10|||
47008063|NCT01682512|83256356|FG001|Overall Study|Primary lack of efficacy|7|||
47008064|NCT01682512|83256357|FG002|Overall Study|Primary lack of efficacy|7|||
47008065|NCT01682512|83256355|FG000|Overall Study|Secondary lack of efficacy|1|||
47008066|NCT01682512|83256356|FG001|Overall Study|Secondary lack of efficacy|1|||
47008067|NCT01682512|83256357|FG002|Overall Study|Secondary lack of efficacy|0|||
47008068|NCT01682512|83256355|FG000|Overall Study|Other than stated above|2|||
47008069|NCT01682512|83256356|FG001|Overall Study|Other than stated above|4|||
47008070|NCT01682512|83256357|FG002|Overall Study|Other than stated above|2|||
47008071|NCT02256488|83256369|FG000|Overall Study|Lost to Follow-up|6|||
47008072|NCT02256488|83256370|FG001|Overall Study|Lost to Follow-up|6|||
47008073|NCT02256488|83256371|FG002|Overall Study|Lost to Follow-up|9|||
47008074|NCT02256488|83256372|FG003|Overall Study|Lost to Follow-up|3|||
47008075|NCT02256488|83256369|FG000|Overall Study|OTHER|1|||
47008076|NCT02256488|83256370|FG001|Overall Study|OTHER|0|||
47008077|NCT02256488|83256371|FG002|Overall Study|OTHER|1|||
47008078|NCT02256488|83256372|FG003|Overall Study|OTHER|1|||
47008079|NCT02256488|83256369|FG000|Overall Study|Withdrawal by Subject|1|||
47008080|NCT02256488|83256370|FG001|Overall Study|Withdrawal by Subject|0|||
47008081|NCT02256488|83256371|FG002|Overall Study|Withdrawal by Subject|0|||
47008082|NCT02256488|83256372|FG003|Overall Study|Withdrawal by Subject|2|||
47008083|NCT01715896|83256385|FG000|Overall Study|Lost to Follow-up|0|||
47008084|NCT01715896|83256386|FG001|Overall Study|Lost to Follow-up|2|||
47008085|NCT01715896|83256385|FG000|Overall Study|Withdrawal by Subject|1|||
47008086|NCT01715896|83256386|FG001|Overall Study|Withdrawal by Subject|4|||
47008087|NCT01715896|83256385|FG000|Overall Study|Other|2|||
47008088|NCT01715896|83256386|FG001|Overall Study|Other|5|||
47008089|NCT02255552|83256395|FG000|Overall Study|Participants enrolled into another study|0|||
47008090|NCT02255552|83256396|FG001|Overall Study|Participants enrolled into another study|11|||
47008091|NCT02255552|83256395|FG000|Overall Study|Withdrawal by Subject|1|||
47008092|NCT02255552|83256396|FG001|Overall Study|Withdrawal by Subject|4|||
47008093|NCT01714726|83256404|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
47008094|NCT01714726|83256405|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
47008095|NCT01714726|83256406|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
47008096|NCT01714726|83256407|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
47008097|NCT01714726|83256404|FG000|Double-Blinded Induction Period|Adverse Event|0|||
47008098|NCT01714726|83256405|FG001|Double-Blinded Induction Period|Adverse Event|1|||
47008099|NCT01714726|83256406|FG002|Double-Blinded Induction Period|Adverse Event|0|||
47008100|NCT01714726|83256407|FG003|Double-Blinded Induction Period|Adverse Event|0|||
47008101|NCT01714726|83256404|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
47008102|NCT01714726|83256405|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
46709527|NCT01217606|82925578|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
46709528|NCT01217606|82925577|FG000|Initial Treatment Phase|Adverse Event|10|||
46709529|NCT01217606|82925578|FG001|Initial Treatment Phase|Adverse Event|6|||
46709530|NCT01217606|82925577|FG000|9-Month Masked Extension|Adverse Event|3|||
47008103|NCT01714726|83256406|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
47008104|NCT01714726|83256407|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
47008105|NCT01714726|83256404|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
47008106|NCT01714726|83256405|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
47008107|NCT01714726|83256406|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
47008108|NCT01714726|83256407|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
47008109|NCT01714726|83256404|FG000|Open-Label Period|Other|0|||
47008110|NCT01714726|83256405|FG001|Open-Label Period|Other|0|||
47008111|NCT01714726|83256406|FG002|Open-Label Period|Other|1|||
47008112|NCT01714726|83256407|FG003|Open-Label Period|Other|3|||
47008113|NCT01714726|83256404|FG000|Open-Label Period|Adverse Event|0|||
47008114|NCT01714726|83256405|FG001|Open-Label Period|Adverse Event|0|||
47008115|NCT01714726|83256406|FG002|Open-Label Period|Adverse Event|1|||
47008116|NCT01714726|83256407|FG003|Open-Label Period|Adverse Event|0|||
47008117|NCT01714726|83256404|FG000|Open-Label Period|Withdrawal by Subject|0|||
47008118|NCT01714726|83256405|FG001|Open-Label Period|Withdrawal by Subject|0|||
47008119|NCT01714726|83256406|FG002|Open-Label Period|Withdrawal by Subject|9|||
47008120|NCT01714726|83256407|FG003|Open-Label Period|Withdrawal by Subject|19|||
47008121|NCT01714726|83256404|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
47008122|NCT01714726|83256405|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
47008123|NCT01714726|83256406|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
47008124|NCT01714726|83256407|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
47008125|NCT01714726|83256404|FG000|Open-Label Period|Lost to Follow-up|0|||
47008126|NCT01714726|83256405|FG001|Open-Label Period|Lost to Follow-up|0|||
47008127|NCT01714726|83256406|FG002|Open-Label Period|Lost to Follow-up|3|||
47008128|NCT01714726|83256407|FG003|Open-Label Period|Lost to Follow-up|4|||
47008129|NCT02255474|83256420|FG000|Overall Study|Lost to Follow-up|1|||
47008130|NCT02255474|83256421|FG001|Overall Study|Lost to Follow-up|1|||
47008131|NCT02255474|83256422|FG002|Overall Study|Lost to Follow-up|3|||
47008132|NCT02255474|83256420|FG000|Overall Study|Withdrawal by Subject|1|||
47008133|NCT02255474|83256421|FG001|Overall Study|Withdrawal by Subject|1|||
47008134|NCT02255474|83256422|FG002|Overall Study|Withdrawal by Subject|0|||
47008135|NCT02254772|83256431|FG000|Overall Study|Ineligible|1|||
47008136|NCT02254772|83256431|FG000|Overall Study|Withdrawal by Subject|1|||
47008137|NCT02254460|83256435|FG000|Overall Study|Adverse Event|1|||
47008138|NCT02254460|83256436|FG001|Overall Study|Adverse Event|0|||
47008139|NCT01682044|83256442|FG000|Overall Study|Death|1|||
47008140|NCT01682044|83256442|FG000|Overall Study|Progression|3|||
47008141|NCT01696942|83256448|FG000|Overall Study|Withdrawal by Subject|1|||
47008142|NCT01696942|83256449|FG001|Overall Study|Withdrawal by Subject|0|||
47008143|NCT01696942|83256448|FG000|Overall Study|Protocol Violation|1|||
47008144|NCT01696942|83256449|FG001|Overall Study|Protocol Violation|2|||
47008145|NCT01696942|83256448|FG000|Overall Study|screen failure|0|||
47008146|NCT01696942|83256449|FG001|Overall Study|screen failure|1|||
47008147|NCT01640366|83256455|FG000|Overall Study|Withdrawal by Subject|1|||
47008148|NCT01640366|83256455|FG000|Overall Study|Protocol Violation|16|||
47008149|NCT01640366|83256455|FG000|Overall Study|Lost to Follow-up|5|||
47008150|NCT01640288|83256463|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
47008151|NCT01640288|83256464|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
47008152|NCT01640288|83256463|FG000|Overall Study|Screen Failure|20|||
47008153|NCT01640288|83256464|FG001|Overall Study|Screen Failure|18|||
47008154|NCT01640288|83256463|FG000|Overall Study|Withdrawn by PI|5|||
47008155|NCT01640288|83256464|FG001|Overall Study|Withdrawn by PI|0|||
47008156|NCT01640288|83256463|FG000|Overall Study|Withdrawal by Subject|1|||
47008157|NCT01640288|83256464|FG001|Overall Study|Withdrawal by Subject|0|||
47008158|NCT01639040|83256473|FG000|Overall Study|Adverse Event|1|||
47008159|NCT01639040|83256474|FG001|Overall Study|Adverse Event|0|||
47008160|NCT01640054|83256483|FG000|Overall Study|Study-specific disc criteria|1|||
47008161|NCT01640054|83256483|FG000|Overall Study|Lack of Efficacy|3|||
47008162|NCT01640054|83256483|FG000|Overall Study|Adverse Event|2|||
47008163|NCT01600586|83256489|FG000|Overall Study|Physician Decision|3|||
47008164|NCT01600586|83256490|FG001|Overall Study|Physician Decision|3|||
47008165|NCT01639742|83256503|FG000|Overall Study|Study Ongoing|17|||
47008166|NCT01639742|83256503|FG000|Overall Study|Lost to Follow-up|1|||
47008167|NCT02164513|83256510|FG000|Overall Study|Adverse Event|162|||
47008168|NCT02164513|83256511|FG001|Overall Study|Adverse Event|180|||
47008169|NCT02164513|83256512|FG002|Overall Study|Adverse Event|111|||
47008170|NCT02164513|83256510|FG000|Overall Study|Other: Study Closed or terminated|5|||
47008171|NCT02164513|83256511|FG001|Overall Study|Other: Study Closed or terminated|2|||
47008172|NCT02164513|83256512|FG002|Overall Study|Other: Study Closed or terminated|4|||
47008173|NCT02164513|83256510|FG000|Overall Study|Lost to Follow-up|30|||
47008174|NCT02164513|83256511|FG001|Overall Study|Lost to Follow-up|36|||
47008175|NCT02164513|83256512|FG002|Overall Study|Lost to Follow-up|22|||
47008176|NCT02164513|83256510|FG000|Overall Study|Physician Decision|47|||
47008177|NCT02164513|83256511|FG001|Overall Study|Physician Decision|57|||
47008178|NCT02164513|83256512|FG002|Overall Study|Physician Decision|28|||
47008179|NCT02164513|83256510|FG000|Overall Study|Withdrawal by Subject|192|||
47008180|NCT02164513|83256511|FG001|Overall Study|Withdrawal by Subject|261|||
47008181|NCT02164513|83256512|FG002|Overall Study|Withdrawal by Subject|130|||
47008182|NCT02164513|83256510|FG000|Overall Study|Other: Reason not provided by site|1|||
47008183|NCT02164513|83256511|FG001|Overall Study|Other: Reason not provided by site|0|||
47008184|NCT02164513|83256512|FG002|Overall Study|Other: Reason not provided by site|0|||
47008185|NCT02218489|83256532|FG000|Overall Study|Withdrawal by Subject|4|||
47008186|NCT02218489|83256533|FG001|Overall Study|Withdrawal by Subject|3|||
47008187|NCT02218489|83256532|FG000|Overall Study|Lost to Follow-up|1|||
47008188|NCT02218489|83256533|FG001|Overall Study|Lost to Follow-up|0|||
47008189|NCT02192905|83256540|FG000|Overall Study|Lost to Follow-up|1|||
47008190|NCT01713946|83256548|FG000|Overall Study|Death|0|||
47008191|NCT01713946|83256549|FG001|Overall Study|Death|2|||
47008192|NCT01713946|83256550|FG002|Overall Study|Death|2|||
47008193|NCT01713946|83256548|FG000|Overall Study|Adverse Event|19|||
47008194|NCT01713946|83256549|FG001|Overall Study|Adverse Event|14|||
47008195|NCT01713946|83256550|FG002|Overall Study|Adverse Event|13|||
47008196|NCT01713946|83256548|FG000|Overall Study|Withdrawal by Subject|12|||
47008197|NCT01713946|83256549|FG001|Overall Study|Withdrawal by Subject|12|||
47008198|NCT01713946|83256550|FG002|Overall Study|Withdrawal by Subject|8|||
47008199|NCT01713946|83256548|FG000|Overall Study|Lack of Efficacy|8|||
47008200|NCT01713946|83256549|FG001|Overall Study|Lack of Efficacy|8|||
47008201|NCT01713946|83256550|FG002|Overall Study|Lack of Efficacy|14|||
47008202|NCT01713946|83256548|FG000|Overall Study|Protocol Violation|2|||
47008203|NCT01713946|83256549|FG001|Overall Study|Protocol Violation|4|||
47008204|NCT01713946|83256550|FG002|Overall Study|Protocol Violation|1|||
47008205|NCT01713946|83256548|FG000|Overall Study|Lost to Follow-up|0|||
47008206|NCT01713946|83256549|FG001|Overall Study|Lost to Follow-up|0|||
47008207|NCT01713946|83256550|FG002|Overall Study|Lost to Follow-up|1|||
47008208|NCT01713946|83256548|FG000|Overall Study|Administrative problems|1|||
47008209|NCT01713946|83256549|FG001|Overall Study|Administrative problems|0|||
47008210|NCT01713946|83256550|FG002|Overall Study|Administrative problems|0|||
47008211|NCT01713946|83256548|FG000|Overall Study|Did not continue in Ext|0|||
47008212|NCT01713946|83256549|FG001|Overall Study|Did not continue in Ext|3|||
47008213|NCT01713946|83256550|FG002|Overall Study|Did not continue in Ext|0|||
47008214|NCT01713946|83256548|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
47008215|NCT01713946|83256549|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
47008216|NCT01713946|83256550|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
47008217|NCT01713946|83256548|FG000|Overall Study|Patients never switched to everolimus|0|||
47008218|NCT01713946|83256549|FG001|Overall Study|Patients never switched to everolimus|0|||
47008219|NCT01713946|83256550|FG002|Overall Study|Patients never switched to everolimus|5|||
47008220|NCT02163499|83256576|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
47008221|NCT02163499|83256576|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
47008222|NCT02163499|83256576|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
47008223|NCT02163499|83256576|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
47008224|NCT02163499|83256576|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
47008225|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
47008226|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
47008227|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
47008228|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
47008229|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
47008230|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
47008231|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
47008232|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
47008233|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
47008234|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Death|8|||
47008235|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
47008236|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
47008237|NCT02163499|83256576|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
47008238|NCT02163187|83256586|FG000|Overall Study|Device removed|1|||
47008239|NCT02163187|83256587|FG001|Overall Study|Device removed|0|||
47008240|NCT02163187|83256586|FG000|Overall Study|Progressive disease|1|||
47008241|NCT02163187|83256587|FG001|Overall Study|Progressive disease|0|||
47008242|NCT02191579|83256595|FG000|Treatment 1|Multiple Reasons Specified|27|||
47008243|NCT02191579|83256596|FG001|Treatment 1|Multiple Reasons Specified|58|||
47008244|NCT02191579|83256595|FG000|Treatment 2|Multiple Reasons Specified|0|||
47008245|NCT02191579|83256596|FG001|Treatment 2|Multiple Reasons Specified|25|||
47008246|NCT01363700|83256605|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
47008247|NCT01363700|83256606|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
47008248|NCT01363700|83256607|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
47008249|NCT01363700|83256608|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
47008250|NCT01363700|83256609|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
47008251|NCT01637402|83256620|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
46910018|NCT03340025|83139280|FG001|Overall Study|Lost to Follow-up|2|||
47008252|NCT01637402|83256621|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
47008253|NCT01637402|83256620|FG000|Standard Dose Regimen|Adverse Event|1|||
47008254|NCT01637402|83256621|FG001|Standard Dose Regimen|Adverse Event|0|||
47008255|NCT01637402|83256620|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
47008256|NCT01637402|83256621|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
47008257|NCT01637402|83256620|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
47008258|NCT01637402|83256621|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
47008259|NCT01637402|83256620|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
47008260|NCT01637402|83256621|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
47008261|NCT01637402|83256620|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
47008262|NCT01637402|83256621|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
47008263|NCT02217475|83256649|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
47008264|NCT02217475|83256650|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
47008265|NCT02217475|83256651|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
47008266|NCT02217475|83256649|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
47008267|NCT02217475|83256650|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
47008268|NCT02217475|83256651|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
47008269|NCT02217475|83256649|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
47008270|NCT02217475|83256650|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
47008271|NCT02217475|83256651|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
47008272|NCT02217475|83256649|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
47008273|NCT02217475|83256650|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
47008274|NCT02217475|83256651|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
47008275|NCT02217475|83256649|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
47008276|NCT02217475|83256650|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
47008277|NCT02217475|83256651|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
47008278|NCT02217475|83256649|FG000|Discontinued After Period 1|Adverse Event|1|||
47008279|NCT02217475|83256650|FG001|Discontinued After Period 1|Adverse Event|2|||
47008280|NCT02217475|83256651|FG002|Discontinued After Period 1|Adverse Event|0|||
47008281|NCT02217475|83256649|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
47008282|NCT02217475|83256650|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
47008283|NCT02217475|83256651|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
47008284|NCT02217475|83256649|FG000|Discontinued After Period 1|Physician Decision|0|||
47008285|NCT02217475|83256650|FG001|Discontinued After Period 1|Physician Decision|0|||
47008286|NCT02217475|83256651|FG002|Discontinued After Period 1|Physician Decision|1|||
47008287|NCT02217475|83256649|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
47008288|NCT02217475|83256650|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
47008289|NCT02217475|83256651|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
47008290|NCT02217475|83256649|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
47008291|NCT02217475|83256650|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
47008292|NCT02217475|83256651|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
47008293|NCT02217475|83256649|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
47008294|NCT02217475|83256650|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
47008295|NCT02217475|83256651|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
47008296|NCT02217475|83256649|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
47008297|NCT02217475|83256650|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
47008298|NCT02217475|83256651|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
47008299|NCT02217475|83256649|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
47008300|NCT02217475|83256650|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
47008301|NCT02217475|83256651|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
47008302|NCT02191267|83256671|FG000|Overall Study|Withdrawal by Subject|1|||
47008303|NCT02191267|83256672|FG001|Overall Study|Withdrawal by Subject|0|||
47008304|NCT02191267|83256673|FG002|Overall Study|Withdrawal by Subject|0|||
47008305|NCT02189941|83256681|FG000|Overall Study|Non-compliance|0|||
47008306|NCT02189941|83256682|FG001|Overall Study|Non-compliance|0|||
47008307|NCT02189941|83256683|FG002|Overall Study|Non-compliance|1|||
47008308|NCT02216773|83256693|FG000|Overall Study|Disease progression|4|||
47008309|NCT02216773|83256694|FG001|Overall Study|Disease progression|2|||
47008310|NCT02216773|83256693|FG000|Overall Study|Insufficient FLRV|4|||
47008311|NCT02216773|83256694|FG001|Overall Study|Insufficient FLRV|0|||
47008312|NCT02216773|83256693|FG000|Overall Study|Abandoned|4|||
47008313|NCT02216773|83256694|FG001|Overall Study|Abandoned|3|||
47008314|NCT01601132|83256700|FG000|Overall Study|Patient withdrew consent|1|||
47008315|NCT01601132|83256700|FG000|Overall Study|Protocol deviation|1|||
47008316|NCT02162719|83256709|FG000|Overall Study|Death|41|||
47008317|NCT02162719|83256710|FG001|Overall Study|Death|46|||
47008318|NCT02162719|83256709|FG000|Overall Study|Lost to Follow-up|1|||
47008319|NCT02162719|83256710|FG001|Overall Study|Lost to Follow-up|3|||
47008320|NCT02162719|83256709|FG000|Overall Study|Disease Progression|2|||
47008321|NCT02162719|83256710|FG001|Overall Study|Disease Progression|1|||
46910019|NCT03339713|83139288|FG000|Overall Study|Lost to Follow-up|2|||
47008322|NCT02162719|83256709|FG000|Overall Study|Withdrawal by Subject|8|||
47008323|NCT02162719|83256710|FG001|Overall Study|Withdrawal by Subject|2|||
47008324|NCT02162719|83256709|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
47008325|NCT02162719|83256710|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
47008326|NCT02161549|83256718|FG000|Overall Study|Physician Decision|6|||
47008327|NCT02161549|83256719|FG001|Overall Study|Physician Decision|2|||
47008328|NCT02189863|83256725|FG000|First 2 Weeks|Motion Sickness|4|||
47008329|NCT02189863|83256726|FG001|First 2 Weeks|Motion Sickness|2|||
47008330|NCT02189473|83256737|FG000|Overall Study|Death|22|||
47008331|NCT02189473|83256738|FG001|Overall Study|Death|23|||
47008332|NCT02189473|83256737|FG000|Overall Study|Lost to Follow-up|1|||
47008333|NCT02189473|83256738|FG001|Overall Study|Lost to Follow-up|2|||
47008334|NCT02188849|83256746|FG000|Overall Study|Lost to Follow-up|3|||
47008335|NCT02188849|83256747|FG001|Overall Study|Lost to Follow-up|8|||
47008336|NCT01636076|83256755|FG000|Overall Study|Terminated by sponsor|1|||
47008337|NCT01636076|83256756|FG001|Overall Study|Terminated by sponsor|1|||
47008338|NCT01636076|83256755|FG000|Overall Study|Lack of Efficacy|0|||
47008339|NCT01636076|83256756|FG001|Overall Study|Lack of Efficacy|1|||
47008340|NCT01636076|83256755|FG000|Overall Study|Lost to Follow-up|1|||
47008341|NCT01636076|83256756|FG001|Overall Study|Lost to Follow-up|0|||
47008342|NCT01636076|83256755|FG000|Overall Study|Physician Decision|1|||
47008343|NCT01636076|83256756|FG001|Overall Study|Physician Decision|1|||
47008344|NCT01636076|83256755|FG000|Overall Study|Non-compliance with study treatment|1|||
47008345|NCT01636076|83256756|FG001|Overall Study|Non-compliance with study treatment|1|||
47008346|NCT01636076|83256755|FG000|Overall Study|Adverse Event|6|||
47008347|NCT01636076|83256756|FG001|Overall Study|Adverse Event|11|||
47008348|NCT01636076|83256755|FG000|Overall Study|Withdrawal by Subject|7|||
47008349|NCT01636076|83256756|FG001|Overall Study|Withdrawal by Subject|10|||
47008350|NCT01635998|83256771|FG000|Overall Study|Death|1|||
47008351|NCT01635998|83256772|FG001|Overall Study|Death|1|||
47008352|NCT01635998|83256771|FG000|Overall Study|Lost to Follow-up|2|||
47008353|NCT01635998|83256772|FG001|Overall Study|Lost to Follow-up|1|||
47008354|NCT01635998|83256771|FG000|Overall Study|Withdrawal by Subject|1|||
47008355|NCT01635998|83256772|FG001|Overall Study|Withdrawal by Subject|5|||
47008356|NCT01635920|83256780|FG000|Overall Study|Adverse Event|1|||
47008357|NCT01635920|83256781|FG001|Overall Study|Adverse Event|0|||
47008358|NCT01635920|83256780|FG000|Overall Study|Lost to Follow-up|0|||
47008359|NCT01635920|83256781|FG001|Overall Study|Lost to Follow-up|1|||
47008360|NCT01635920|83256780|FG000|Overall Study|Subject decision|2|||
47008361|NCT01635920|83256781|FG001|Overall Study|Subject decision|0|||
47008362|NCT02160145|83256798|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
47008363|NCT02160145|83256799|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
47008364|NCT02160145|83256800|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
47008365|NCT02160145|83256798|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
47008366|NCT02160145|83256799|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
47008367|NCT02160145|83256800|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
47008368|NCT02160145|83256798|FG000|Randomized Double-blind Period|Subject decision|0|||
47008369|NCT02160145|83256799|FG001|Randomized Double-blind Period|Subject decision|21|||
47008370|NCT02160145|83256800|FG002|Randomized Double-blind Period|Subject decision|20|||
47008371|NCT02160145|83256798|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
47008372|NCT02160145|83256799|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
47008373|NCT02160145|83256800|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
47008374|NCT02160145|83256798|FG000|Randomized Double-blind Period|Physician Decision|0|||
47008375|NCT02160145|83256799|FG001|Randomized Double-blind Period|Physician Decision|7|||
47008376|NCT02160145|83256800|FG002|Randomized Double-blind Period|Physician Decision|5|||
47008377|NCT01696396|83256811|FG000|Overall Study|Withdrawal by Subject|19|||
47008378|NCT01696396|83256812|FG001|Overall Study|Withdrawal by Subject|5|||
47008379|NCT01696396|83256813|FG002|Overall Study|Withdrawal by Subject|19|||
47008380|NCT01696396|83256814|FG003|Overall Study|Withdrawal by Subject|11|||
47008381|NCT01696396|83256811|FG000|Overall Study|Decision by Sponsor|3|||
46910020|NCT03339713|83139289|FG001|Overall Study|Lost to Follow-up|1|||
47008382|NCT01696396|83256812|FG001|Overall Study|Decision by Sponsor|1|||
47008383|NCT01696396|83256813|FG002|Overall Study|Decision by Sponsor|2|||
47008384|NCT01696396|83256814|FG003|Overall Study|Decision by Sponsor|2|||
47008385|NCT01696396|83256811|FG000|Overall Study|Lost to Follow-up|9|||
47008386|NCT01696396|83256812|FG001|Overall Study|Lost to Follow-up|1|||
47008387|NCT01696396|83256813|FG002|Overall Study|Lost to Follow-up|4|||
47008388|NCT01696396|83256814|FG003|Overall Study|Lost to Follow-up|1|||
47008389|NCT01696396|83256811|FG000|Overall Study|Death|0|||
47008390|NCT01696396|83256812|FG001|Overall Study|Death|0|||
47008391|NCT01696396|83256813|FG002|Overall Study|Death|1|||
47008392|NCT01696396|83256814|FG003|Overall Study|Death|0|||
47008393|NCT02216071|83256830|FG000|Overall Study|Withdrawal by Subject|7|||
47008394|NCT02216071|83256831|FG001|Overall Study|Withdrawal by Subject|2|||
47008395|NCT02216071|83256830|FG000|Overall Study|Lost to Follow-up|3|||
47008396|NCT02216071|83256831|FG001|Overall Study|Lost to Follow-up|3|||
47008397|NCT02216071|83256830|FG000|Overall Study|Protocol Violation|3|||
47008398|NCT02216071|83256831|FG001|Overall Study|Protocol Violation|5|||
47008399|NCT02216071|83256830|FG000|Overall Study|Other|2|||
47008400|NCT02216071|83256831|FG001|Overall Study|Other|2|||
47008401|NCT01681576|83256839|FG000|Period 1|Adverse Event|1|||
47008402|NCT01681576|83256840|FG001|Period 1|Adverse Event|0|||
47008403|NCT01681576|83256839|FG000|Period 1|Protocol Deviation|1|||
47008404|NCT01681576|83256840|FG001|Period 1|Protocol Deviation|0|||
47008405|NCT01681576|83256839|FG000|Period 2|subject/guardian decision|3|||
47008406|NCT01681576|83256840|FG001|Period 2|subject/guardian decision|1|||
47008407|NCT01681576|83256839|FG000|Period 2|Non-compliance with study treatment|1|||
47008408|NCT01681576|83256840|FG001|Period 2|Non-compliance with study treatment|0|||
47008409|NCT02188459|83256850|FG000|Overall Study|Lost to Follow-up|3|||
47008410|NCT02188459|83256851|FG001|Overall Study|Lost to Follow-up|4|||
47008411|NCT02188459|83256850|FG000|Overall Study|Early Termination|0|||
47008412|NCT02188459|83256851|FG001|Overall Study|Early Termination|3|||
47008413|NCT02214121|83256873|FG000|Part A|Patient decision|2|||
47008414|NCT02214121|83256874|FG001|Part A|Patient decision|0|||
47008415|NCT02214121|83256875|FG002|Part A|Patient decision|0|||
47008416|NCT02214121|83256873|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
47008417|NCT02214121|83256874|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
47008418|NCT02214121|83256875|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
47008419|NCT02214121|83256873|FG000|Part A|Other|1|||
47008420|NCT02214121|83256874|FG001|Part A|Other|0|||
47008421|NCT02214121|83256875|FG002|Part A|Other|0|||
47008422|NCT02214121|83256873|FG000|Part B|Patient decision|0|||
47008423|NCT02214121|83256874|FG001|Part B|Patient decision|1|||
47008424|NCT02214121|83256875|FG002|Part B|Patient decision|0|||
47008425|NCT02214121|83256873|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
47008426|NCT02214121|83256874|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
47008427|NCT02214121|83256875|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
47008428|NCT02214121|83256873|FG000|Part B|Lost to Follow-up|0|||
47008429|NCT02214121|83256874|FG001|Part B|Lost to Follow-up|0|||
47008430|NCT02214121|83256875|FG002|Part B|Lost to Follow-up|1|||
47008431|NCT01681186|83256903|FG000|Washout Period From Second Intervention|Adverse Event|0|||
46910021|NCT03339713|83139288|FG000|Overall Study|Protocol Violation|1|||
46910022|NCT03339713|83139289|FG001|Overall Study|Protocol Violation|0|||
46910023|NCT03339713|83139288|FG000|Overall Study|Withdrawal by Subject|1|||
46910024|NCT03339713|83139289|FG001|Overall Study|Withdrawal by Subject|1|||
46910025|NCT03254485|83139301|FG000|Overall Study|Adverse Event|3|||
46910026|NCT03254485|83139302|FG001|Overall Study|Adverse Event|0|||
46910027|NCT03254485|83139303|FG002|Overall Study|Adverse Event|0|||
46910028|NCT03254485|83139304|FG003|Overall Study|Adverse Event|6|||
46910029|NCT03254485|83139301|FG000|Overall Study|Protocol Violation|6|||
46910030|NCT03254485|83139302|FG001|Overall Study|Protocol Violation|0|||
46910031|NCT03254485|83139303|FG002|Overall Study|Protocol Violation|0|||
46910032|NCT03254485|83139304|FG003|Overall Study|Protocol Violation|2|||
46910033|NCT03254485|83139301|FG000|Overall Study|Withdrawal by Subject|1|||
46910034|NCT03254485|83139302|FG001|Overall Study|Withdrawal by Subject|0|||
46910035|NCT03254485|83139303|FG002|Overall Study|Withdrawal by Subject|0|||
46910036|NCT03254485|83139304|FG003|Overall Study|Withdrawal by Subject|4|||
46910037|NCT03254485|83139301|FG000|Overall Study|Death|0|||
46910038|NCT03254485|83139302|FG001|Overall Study|Death|0|||
46910039|NCT03254485|83139303|FG002|Overall Study|Death|0|||
46910040|NCT03254485|83139304|FG003|Overall Study|Death|1|||
46910041|NCT03254485|83139301|FG000|Overall Study|Lost to Follow-up|1|||
46910042|NCT03254485|83139302|FG001|Overall Study|Lost to Follow-up|0|||
47008432|NCT01681186|83256904|FG001|Washout Period From Second Intervention|Adverse Event|0|||
47008433|NCT01681186|83256905|FG002|Washout Period From Second Intervention|Adverse Event|0|||
47008434|NCT01681186|83256906|FG003|Washout Period From Second Intervention|Adverse Event|0|||
47008435|NCT01681186|83256907|FG004|Washout Period From Second Intervention|Adverse Event|0|||
46910043|NCT03254485|83139303|FG002|Overall Study|Lost to Follow-up|0|||
47008436|NCT01681186|83256908|FG005|Washout Period From Second Intervention|Adverse Event|0|||
47008437|NCT01681186|83256909|FG006|Washout Period From Second Intervention|Adverse Event|1|||
47008438|NCT01681186|83256910|FG007|Washout Period From Second Intervention|Adverse Event|0|||
47008439|NCT01681186|83256903|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
47008440|NCT01681186|83256904|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
47008441|NCT01681186|83256905|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
47008442|NCT01681186|83256906|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
47008443|NCT01681186|83256907|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
47008444|NCT01681186|83256908|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
47008445|NCT01681186|83256909|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
47008446|NCT01681186|83256910|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
47008447|NCT01681186|83256903|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
47008448|NCT01681186|83256904|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
47008449|NCT01681186|83256905|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
47008450|NCT01681186|83256906|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
47008451|NCT01681186|83256907|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
47008452|NCT01681186|83256908|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
47008453|NCT01681186|83256909|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
47008454|NCT01681186|83256910|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
47008455|NCT01681186|83256903|FG000|Fourth Intervention|Protocol Violation|0|||
47008456|NCT01681186|83256904|FG001|Fourth Intervention|Protocol Violation|0|||
47008457|NCT01681186|83256905|FG002|Fourth Intervention|Protocol Violation|0|||
47008458|NCT01681186|83256906|FG003|Fourth Intervention|Protocol Violation|0|||
47008459|NCT01681186|83256907|FG004|Fourth Intervention|Protocol Violation|0|||
47008460|NCT01681186|83256908|FG005|Fourth Intervention|Protocol Violation|0|||
47008461|NCT01681186|83256909|FG006|Fourth Intervention|Protocol Violation|0|||
47008462|NCT01681186|83256910|FG007|Fourth Intervention|Protocol Violation|1|||
47008463|NCT03597464|83256942|FG000|Overall Study|Withdrawal by Subject|4|||
47008464|NCT03597464|83256943|FG001|Overall Study|Withdrawal by Subject|5|||
47008465|NCT03597464|83256942|FG000|Overall Study|Lost to Follow-up|3|||
47008466|NCT03597464|83256943|FG001|Overall Study|Lost to Follow-up|1|||
47008467|NCT03597464|83256942|FG000|Overall Study|Pregnancy|3|||
47008468|NCT03597464|83256943|FG001|Overall Study|Pregnancy|1|||
47008469|NCT03597464|83256942|FG000|Overall Study|Lack of Efficacy|2|||
47008470|NCT03597464|83256943|FG001|Overall Study|Lack of Efficacy|0|||
47008471|NCT03597464|83256942|FG000|Overall Study|Physician Decision|2|||
47008472|NCT03597464|83256943|FG001|Overall Study|Physician Decision|2|||
47008473|NCT03597464|83256942|FG000|Overall Study|Protocol Violation|1|||
47008474|NCT03597464|83256943|FG001|Overall Study|Protocol Violation|1|||
47008475|NCT03597464|83256942|FG000|Overall Study|Adverse Event|0|||
47008476|NCT03597464|83256943|FG001|Overall Study|Adverse Event|2|||
47008477|NCT03597464|83256942|FG000|Overall Study|Death|0|||
47008478|NCT03597464|83256943|FG001|Overall Study|Death|3|||
47008479|NCT01695772|83256951|FG000|Overall Study|Withdrawal by Subject|18|||
47008480|NCT01695772|83256951|FG000|Overall Study|Progressive Disease|8|||
47008481|NCT01695772|83256951|FG000|Overall Study|Investigator Decision|5|||
47008482|NCT01695772|83256951|FG000|Overall Study|Lost to Follow-up|4|||
47008483|NCT01695772|83256951|FG000|Overall Study|Protocol Violation|2|||
47008484|NCT01695772|83256951|FG000|Overall Study|Unspecified Reason|1|||
47008485|NCT02159521|83256955|FG000|Overall Study|Enrolled but not treated|3|||
47008486|NCT02159521|83256955|FG000|Overall Study|Withdrawal by Subject|7|||
47008487|NCT02159521|83256955|FG000|Overall Study|Lost to Follow-up|6|||
47008488|NCT02159521|83256955|FG000|Overall Study|Death|1|||
47008489|NCT02159521|83256955|FG000|Overall Study|Other than specified|1|||
47008490|NCT01636934|83256961|FG000|Overall Study|Withdrawal by Subject|3|||
47008491|NCT01636934|83256962|FG001|Overall Study|Withdrawal by Subject|2|||
47008492|NCT01636934|83256961|FG000|Overall Study|Chemo cancel|1|||
47008493|NCT01636934|83256962|FG001|Overall Study|Chemo cancel|0|||
47008494|NCT01636934|83256961|FG000|Overall Study|Too ill to continue|1|||
47008495|NCT01636934|83256962|FG001|Overall Study|Too ill to continue|0|||
47008496|NCT01636934|83256961|FG000|Overall Study|Never started study medication|1|||
47008497|NCT01636934|83256962|FG001|Overall Study|Never started study medication|1|||
46910044|NCT03254485|83139304|FG003|Overall Study|Lost to Follow-up|0|||
47008498|NCT01712854|83256968|FG000|Overall Study|Physician Decision|1|||
47008499|NCT01693120|83256972|FG000|Enrollment|Lost to Follow-up|1|||
47008500|NCT01693120|83256972|FG000|Enrollment|Withdrawal by Subject|10|||
47008501|NCT01693120|83256972|FG000|Enrollment|Protocol Violation|46|||
47008502|NCT01693120|83256972|FG000|Enrollment|Physician Decision|3|||
47008503|NCT01693120|83256972|FG000|Enrollment|Adverse Event|1|||
47008504|NCT01693120|83256972|FG000|Enrollment|Study closed|8|||
47008505|NCT01693120|83256972|FG000|Enrollment|Other|1|||
47008506|NCT01693120|83256972|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
47008507|NCT01693120|83256972|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
47008508|NCT01693120|83256972|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
47008509|NCT01693120|83256972|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
47008510|NCT01693120|83256972|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
47008511|NCT02159365|83256976|FG000|Overall Study|Disease Progression|23|||
47008512|NCT02159365|83256976|FG000|Overall Study|Other reasons|11|||
47008513|NCT02159365|83256976|FG000|Overall Study|Administrative reason by Sponsor|9|||
47008514|NCT02159365|83256976|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
47008515|NCT02159365|83256976|FG000|Overall Study|Study drug toxicity|7|||
47008516|NCT02159365|83256976|FG000|Overall Study|Maximum clinical benefit|3|||
47008517|NCT02159365|83256976|FG000|Overall Study|Subject request to discontinue treatment|3|||
47008518|NCT02159365|83256976|FG000|Overall Study|Subject withdrew consent|3|||
47008519|NCT02159365|83256976|FG000|Overall Study|Death|1|||
47008520|NCT02159365|83256976|FG000|Overall Study|Lost to Follow-up|1|||
47008521|NCT01712074|83256983|FG000|Placebo Run-in Period|Adverse Event|2|||
47008522|NCT01712074|83256984|FG001|Placebo Run-in Period|Adverse Event|0|||
47008523|NCT01712074|83256985|FG002|Placebo Run-in Period|Adverse Event|0|||
47008524|NCT01712074|83256983|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
47008525|NCT01712074|83256984|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
47008526|NCT01712074|83256985|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
47008527|NCT01712074|83256983|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
47008528|NCT01712074|83256984|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
47008529|NCT01712074|83256985|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
47008530|NCT01712074|83256983|FG000|Placebo Run-in Period|Other|1|||
47008531|NCT01712074|83256984|FG001|Placebo Run-in Period|Other|0|||
47008532|NCT01712074|83256985|FG002|Placebo Run-in Period|Other|0|||
47008533|NCT01712074|83256983|FG000|Placebo Run-in Period|No longer willing to participate|1|||
47008534|NCT01712074|83256984|FG001|Placebo Run-in Period|No longer willing to participate|0|||
47008535|NCT01712074|83256985|FG002|Placebo Run-in Period|No longer willing to participate|0|||
47008536|NCT01712074|83256983|FG000|Double Blind Period|Adverse Event|0|||
47008537|NCT01712074|83256984|FG001|Double Blind Period|Adverse Event|2|||
47008538|NCT01712074|83256985|FG002|Double Blind Period|Adverse Event|1|||
47008539|NCT01712074|83256983|FG000|Double Blind Period|No longer willing to participate|0|||
47008540|NCT01712074|83256984|FG001|Double Blind Period|No longer willing to participate|2|||
47008541|NCT01712074|83256985|FG002|Double Blind Period|No longer willing to participate|4|||
47008542|NCT01712074|83256983|FG000|Double Blind Period|Death|0|||
47008543|NCT01712074|83256984|FG001|Double Blind Period|Death|1|||
47008544|NCT01712074|83256985|FG002|Double Blind Period|Death|0|||
47008545|NCT01712074|83256983|FG000|Double Blind Period|Lost to Follow-up|0|||
47008546|NCT01712074|83256984|FG001|Double Blind Period|Lost to Follow-up|2|||
47008547|NCT01712074|83256985|FG002|Double Blind Period|Lost to Follow-up|1|||
47008548|NCT01712074|83256983|FG000|Double Blind Period|Other|0|||
47008549|NCT01712074|83256984|FG001|Double Blind Period|Other|4|||
47008550|NCT01712074|83256985|FG002|Double Blind Period|Other|1|||
47008551|NCT01712074|83256983|FG000|Double Blind Period|Protocol Violation|0|||
47008552|NCT01712074|83256984|FG001|Double Blind Period|Protocol Violation|0|||
47008553|NCT01712074|83256985|FG002|Double Blind Period|Protocol Violation|1|||
47008554|NCT01712074|83256983|FG000|Double Blind Period|No longer met eligibility criteria|0|||
47008555|NCT01712074|83256984|FG001|Double Blind Period|No longer met eligibility criteria|3|||
47008556|NCT01712074|83256985|FG002|Double Blind Period|No longer met eligibility criteria|0|||
47008557|NCT01711216|83257000|FG000|Overall Study|Adverse Event|4|||
47008558|NCT01711216|83257000|FG000|Overall Study|Pregnancy|56|||
47008559|NCT01711216|83257000|FG000|Overall Study|Withdrawal by Subject|6|||
47008560|NCT01711216|83257000|FG000|Overall Study|Lost to Follow-up|46|||
47008561|NCT01711216|83257000|FG000|Overall Study|variety of other minor reasons|83|||
47008562|NCT01711216|83257000|FG000|Overall Study|no reason specified|22|||
47008563|NCT01692730|83257010|FG000|Overall Study|Lost to Follow-up|225|||
47008564|NCT01692730|83257011|FG001|Overall Study|Lost to Follow-up|227|||
47008565|NCT01691794|83257020|FG000|Overall Study|Poor/Non-Compliance|1|||
47008566|NCT01691794|83257021|FG001|Overall Study|Poor/Non-Compliance|4|||
47008567|NCT01691794|83257022|FG002|Overall Study|Poor/Non-Compliance|1|||
47008568|NCT01691794|83257020|FG000|Overall Study|Death|0|||
47008569|NCT01691794|83257021|FG001|Overall Study|Death|0|||
47008570|NCT01691794|83257022|FG002|Overall Study|Death|1|||
47008571|NCT01691794|83257020|FG000|Overall Study|Lack of Efficacy|0|||
47008572|NCT01691794|83257021|FG001|Overall Study|Lack of Efficacy|7|||
47008573|NCT01691794|83257022|FG002|Overall Study|Lack of Efficacy|1|||
47008574|NCT01691794|83257020|FG000|Overall Study|Participant request to discontinue|0|||
47008575|NCT01691794|83257021|FG001|Overall Study|Participant request to discontinue|1|||
47008576|NCT01691794|83257022|FG002|Overall Study|Participant request to discontinue|0|||
47008577|NCT01691794|83257020|FG000|Overall Study|Adverse Event|0|||
47008578|NCT01691794|83257021|FG001|Overall Study|Adverse Event|1|||
47008579|NCT01691794|83257022|FG002|Overall Study|Adverse Event|1|||
47008580|NCT01691794|83257020|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
47008581|NCT01691794|83257021|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
47008582|NCT01691794|83257022|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
47008583|NCT01691794|83257020|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
47008584|NCT01691794|83257021|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
47008585|NCT01691794|83257022|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
47008586|NCT01710514|83257032|FG000|Overall Study|Adverse Event|6|||
47008587|NCT01710514|83257033|FG001|Overall Study|Adverse Event|7|||
47008588|NCT01710514|83257032|FG000|Overall Study|Withdrawal by Subject|1|||
47008589|NCT01710514|83257033|FG001|Overall Study|Withdrawal by Subject|0|||
47008590|NCT01592344|83257044|FG000|Overall Study|Adverse Event|1|||
47008591|NCT01592344|83257045|FG001|Overall Study|Adverse Event|1|||
47008592|NCT01592344|83257044|FG000|Overall Study|Lack of Efficacy|1|||
47008593|NCT01592344|83257045|FG001|Overall Study|Lack of Efficacy|0|||
47008594|NCT01592344|83257044|FG000|Overall Study|not available at primary outcome visit|2|||
47008595|NCT01592344|83257045|FG001|Overall Study|not available at primary outcome visit|4|||
47008596|NCT01636778|83257051|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
47008597|NCT01636778|83257052|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
47008598|NCT01636778|83257053|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
47008599|NCT01636778|83257051|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
47008600|NCT01636778|83257052|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
47008601|NCT01636778|83257053|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
47008602|NCT01636778|83257051|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
47008603|NCT01636778|83257052|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
47008604|NCT01636778|83257053|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
47008605|NCT01636778|83257051|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
47008606|NCT01636778|83257052|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
47008607|NCT01636778|83257053|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
47008608|NCT01636778|83257051|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
47008609|NCT01636778|83257052|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
47008610|NCT01636778|83257053|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
47008611|NCT01636778|83257051|FG000|Follow-up Period After Part 2|Other|0|||
47008612|NCT01636778|83257052|FG001|Follow-up Period After Part 2|Other|0|||
47008613|NCT01636778|83257053|FG002|Follow-up Period After Part 2|Other|1|||
47008614|NCT01636778|83257051|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
47008615|NCT01636778|83257052|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
47008616|NCT01636778|83257053|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
47008617|NCT01636778|83257051|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
47008618|NCT01636778|83257052|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
47008619|NCT01636778|83257053|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
47008620|NCT02159053|83257064|FG000|Overall Study|Death|2|||
47008621|NCT02159053|83257065|FG001|Overall Study|Death|0|||
47008622|NCT02159053|83257066|FG002|Overall Study|Death|1|||
47008623|NCT02159053|83257064|FG000|Overall Study|Physician Decision|0|||
47008624|NCT02159053|83257065|FG001|Overall Study|Physician Decision|1|||
47008625|NCT02159053|83257066|FG002|Overall Study|Physician Decision|1|||
47008626|NCT02159053|83257064|FG000|Overall Study|Lack of Efficacy|3|||
47008627|NCT02159053|83257065|FG001|Overall Study|Lack of Efficacy|4|||
47008628|NCT02159053|83257066|FG002|Overall Study|Lack of Efficacy|7|||
47008629|NCT02159053|83257064|FG000|Overall Study|Adverse Event|7|||
47008630|NCT02159053|83257065|FG001|Overall Study|Adverse Event|6|||
47008631|NCT02159053|83257066|FG002|Overall Study|Adverse Event|5|||
47008632|NCT02159053|83257064|FG000|Overall Study|Participants/guardian decision|8|||
47008633|NCT02159053|83257065|FG001|Overall Study|Participants/guardian decision|10|||
47008634|NCT02159053|83257066|FG002|Overall Study|Participants/guardian decision|6|||
47008635|NCT02158975|83257076|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
47008636|NCT02158663|83257083|FG000|Overall Study|Withdrawal by Subject|5|||
47008637|NCT02158663|83257084|FG001|Overall Study|Withdrawal by Subject|4|||
47008638|NCT02158039|83257092|FG000|Overall Study|Withdrawal by Subject|1|||
47008639|NCT02158039|83257092|FG000|Overall Study|Screen Failure|9|||
47008640|NCT01635764|83257110|FG000|Overall Study|Adverse Event|46|||
47008641|NCT01635764|83257110|FG000|Overall Study|Lack of Efficacy|76|||
47008642|NCT01635764|83257110|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
46910045|NCT03254485|83139301|FG000|Overall Study|Other|1|||
47008643|NCT01635764|83257110|FG000|Overall Study|Protocol Deviation|1|||
47008644|NCT01635764|83257110|FG000|Overall Study|Withdrew Consent|67|||
47008645|NCT01635764|83257110|FG000|Overall Study|Lost to Follow-up|53|||
47008646|NCT01635764|83257110|FG000|Overall Study|Other|28|||
47008647|NCT03432260|83257126|FG000|Overall Study|Lost to Follow-up|1|||
47008648|NCT03432260|83257127|FG001|Overall Study|Lost to Follow-up|1|||
47008649|NCT03432260|83257128|FG002|Overall Study|Lost to Follow-up|0|||
47008650|NCT03432260|83257129|FG003|Overall Study|Lost to Follow-up|0|||
47008651|NCT03432260|83257130|FG004|Overall Study|Lost to Follow-up|1|||
47008652|NCT01634360|83257144|FG000|Overall Study|Adverse Event|10|||
47008653|NCT01634360|83257145|FG001|Overall Study|Adverse Event|34|||
47008654|NCT01634360|83257144|FG000|Overall Study|subject withdrew consent|13|||
47008655|NCT01634360|83257145|FG001|Overall Study|subject withdrew consent|23|||
47008656|NCT01634360|83257144|FG000|Overall Study|Protocol Violation|1|||
47008657|NCT01634360|83257145|FG001|Overall Study|Protocol Violation|1|||
47008658|NCT01634360|83257144|FG000|Overall Study|Lack of Efficacy|4|||
47008659|NCT01634360|83257145|FG001|Overall Study|Lack of Efficacy|14|||
47008660|NCT01634360|83257144|FG000|Overall Study|Other|3|||
47008661|NCT01634360|83257145|FG001|Overall Study|Other|20|||
47008662|NCT01634360|83257144|FG000|Overall Study|Study termination by sponsor|18|||
47008663|NCT01634360|83257145|FG001|Overall Study|Study termination by sponsor|44|||
47008664|NCT01635218|83257162|FG000|Overall Study|Lost to Follow-up|3|||
47008665|NCT01635218|83257163|FG001|Overall Study|Lost to Follow-up|7|||
47008666|NCT01635218|83257164|FG002|Overall Study|Lost to Follow-up|6|||
47008667|NCT02049866|83257172|FG000|Overall Study|Withdrawal by Subject|1|||
47008668|NCT04307186|83257176|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
47008669|NCT04307186|83257176|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
47008670|NCT04307186|83257176|FG000|Washout 3-14 Days|Progressive disease|1|||
47008671|NCT04307186|83257176|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
47008672|NCT04307186|83257176|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
47008673|NCT04274894|83257188|FG000|Overall Study|Adverse Event|7|||
47008674|NCT04274894|83257188|FG000|Overall Study|Withdrew consent|5|||
47008675|NCT04274894|83257188|FG000|Overall Study|Lost to Follow-up|9|||
47008676|NCT04274894|83257188|FG000|Overall Study|COVID-19 infection|1|||
47008677|NCT04274894|83257188|FG000|Overall Study|Other, not specified|20|||
47008678|NCT02213263|83257194|FG000|Overall Study|Insufficient clinical response|4|||
47008679|NCT02213263|83257195|FG001|Overall Study|Insufficient clinical response|3|||
47008680|NCT02213263|83257194|FG000|Overall Study|Lost to Follow-up|0|||
47008681|NCT02213263|83257195|FG001|Overall Study|Lost to Follow-up|1|||
47008682|NCT02213263|83257194|FG000|Overall Study|No longer willing to participate|3|||
47008683|NCT02213263|83257195|FG001|Overall Study|No longer willing to participate|4|||
47008684|NCT02213263|83257194|FG000|Overall Study|Progressive disease|20|||
47008685|NCT02213263|83257195|FG001|Overall Study|Progressive disease|14|||
47008686|NCT02213263|83257194|FG000|Overall Study|Protocol Violation|0|||
47008687|NCT02213263|83257195|FG001|Overall Study|Protocol Violation|1|||
47008688|NCT02213263|83257194|FG000|Overall Study|Adverse Event|1|||
47008689|NCT02213263|83257195|FG001|Overall Study|Adverse Event|3|||
47008690|NCT02211313|83257203|FG000|Overall Study|Treatment Failure|5|||
47008691|NCT02211313|83257204|FG001|Overall Study|Treatment Failure|2|||
47008692|NCT02211313|83257203|FG000|Overall Study|No Follow up Questionnaires|1|||
47008693|NCT02211313|83257204|FG001|Overall Study|No Follow up Questionnaires|1|||
47008694|NCT02210689|83257213|FG000|Overall Study|Withdrawal by Subject|7|||
47008695|NCT02210689|83257214|FG001|Overall Study|Withdrawal by Subject|4|||
47008696|NCT02210689|83257215|FG002|Overall Study|Withdrawal by Subject|2|||
47008697|NCT02210689|83257213|FG000|Overall Study|Adverse Event|0|||
47008698|NCT02210689|83257214|FG001|Overall Study|Adverse Event|1|||
47008699|NCT02210689|83257215|FG002|Overall Study|Adverse Event|0|||
47008700|NCT02210689|83257213|FG000|Overall Study|Protocol Violation|1|||
47008701|NCT02210689|83257214|FG001|Overall Study|Protocol Violation|0|||
47008702|NCT02210689|83257215|FG002|Overall Study|Protocol Violation|0|||
47008703|NCT02210689|83257213|FG000|Overall Study|Lost to Follow-up|11|||
47008704|NCT02210689|83257214|FG001|Overall Study|Lost to Follow-up|9|||
47008705|NCT02210689|83257215|FG002|Overall Study|Lost to Follow-up|5|||
47008706|NCT02210689|83257213|FG000|Overall Study|Pregnancy|0|||
47008707|NCT02210689|83257214|FG001|Overall Study|Pregnancy|1|||
47008708|NCT02210689|83257215|FG002|Overall Study|Pregnancy|0|||
47008709|NCT02210689|83257213|FG000|Overall Study|Lack of Efficacy|0|||
47008710|NCT02210689|83257214|FG001|Overall Study|Lack of Efficacy|1|||
47008711|NCT02210689|83257215|FG002|Overall Study|Lack of Efficacy|5|||
47008712|NCT02210689|83257213|FG000|Overall Study|Prohibited medication|2|||
47008713|NCT02210689|83257214|FG001|Overall Study|Prohibited medication|8|||
47008714|NCT02210689|83257215|FG002|Overall Study|Prohibited medication|1|||
47008715|NCT02210689|83257213|FG000|Overall Study|Negative Nugent score at baseline|6|||
47008716|NCT02210689|83257214|FG001|Overall Study|Negative Nugent score at baseline|2|||
47008717|NCT02210689|83257215|FG002|Overall Study|Negative Nugent score at baseline|2|||
46620508|NCT02536300|82769741|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
47008718|NCT02210689|83257213|FG000|Overall Study|Other|25|||
47008719|NCT02210689|83257214|FG001|Overall Study|Other|21|||
47008720|NCT02210689|83257215|FG002|Overall Study|Other|8|||
47008721|NCT02209597|83257223|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
47008722|NCT02209597|83257223|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
47008723|NCT02209597|83257223|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
47008724|NCT02209597|83257223|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
47008725|NCT02188303|83257252|FG000|Overall Study|Adverse Event|0|||
47008726|NCT02188303|83257253|FG001|Overall Study|Adverse Event|0|||
47008727|NCT02188303|83257254|FG002|Overall Study|Adverse Event|0|||
47008728|NCT02188303|83257255|FG003|Overall Study|Adverse Event|0|||
47008729|NCT02188303|83257256|FG004|Overall Study|Adverse Event|0|||
47008730|NCT02188303|83257257|FG005|Overall Study|Adverse Event|2|||
47008731|NCT02188303|83257258|FG006|Overall Study|Adverse Event|0|||
47008732|NCT02188303|83257259|FG007|Overall Study|Adverse Event|2|||
47008733|NCT02188303|83257252|FG000|Overall Study|Dose Termination Criteria Met|0|||
47008734|NCT02188303|83257253|FG001|Overall Study|Dose Termination Criteria Met|0|||
47008735|NCT02188303|83257254|FG002|Overall Study|Dose Termination Criteria Met|0|||
47008736|NCT02188303|83257255|FG003|Overall Study|Dose Termination Criteria Met|0|||
47008737|NCT02188303|83257256|FG004|Overall Study|Dose Termination Criteria Met|0|||
47008738|NCT02188303|83257257|FG005|Overall Study|Dose Termination Criteria Met|0|||
47008739|NCT02188303|83257258|FG006|Overall Study|Dose Termination Criteria Met|2|||
47008740|NCT02188303|83257259|FG007|Overall Study|Dose Termination Criteria Met|4|||
47008741|NCT04867382|83257285|FG000|Overall Study|Did not complete the survey|2|||
47008742|NCT04867382|83257286|FG001|Overall Study|Did not complete the survey|1|||
47008743|NCT02187055|83257295|FG000|Overall Study|Lack of Efficacy|10|||
47008744|NCT02187055|83257296|FG001|Overall Study|Lack of Efficacy|3|||
47008745|NCT02187055|83257297|FG002|Overall Study|Lack of Efficacy|7|||
47008746|NCT02187055|83257295|FG000|Overall Study|Lost to Follow-up|2|||
47008747|NCT02187055|83257296|FG001|Overall Study|Lost to Follow-up|7|||
47008748|NCT02187055|83257297|FG002|Overall Study|Lost to Follow-up|3|||
47008749|NCT02187055|83257295|FG000|Overall Study|No longer meets eligibility criteria|0|||
47008750|NCT02187055|83257296|FG001|Overall Study|No longer meets eligibility criteria|2|||
47008751|NCT02187055|83257297|FG002|Overall Study|No longer meets eligibility criteria|0|||
47008752|NCT02187055|83257295|FG000|Overall Study|No longer willing to participate|6|||
47008753|NCT02187055|83257296|FG001|Overall Study|No longer willing to participate|8|||
47008754|NCT02187055|83257297|FG002|Overall Study|No longer willing to participate|10|||
47008755|NCT02187055|83257295|FG000|Overall Study|Other|5|||
47008756|NCT02187055|83257296|FG001|Overall Study|Other|6|||
47008757|NCT02187055|83257297|FG002|Overall Study|Other|3|||
47008758|NCT02187055|83257295|FG000|Overall Study|Protocol Violation|9|||
47008759|NCT02187055|83257296|FG001|Overall Study|Protocol Violation|9|||
47008760|NCT02187055|83257297|FG002|Overall Study|Protocol Violation|4|||
47008761|NCT02187055|83257295|FG000|Overall Study|Pregnancy|3|||
47008762|NCT02187055|83257296|FG001|Overall Study|Pregnancy|1|||
47008763|NCT02187055|83257297|FG002|Overall Study|Pregnancy|0|||
47008764|NCT02187055|83257295|FG000|Overall Study|Withdrawal by Subject|11|||
47008765|NCT02187055|83257296|FG001|Overall Study|Withdrawal by Subject|11|||
47008766|NCT02187055|83257297|FG002|Overall Study|Withdrawal by Subject|11|||
47008767|NCT02187055|83257295|FG000|Overall Study|Adverse Event|21|||
47008768|NCT02187055|83257296|FG001|Overall Study|Adverse Event|26|||
47008769|NCT02187055|83257297|FG002|Overall Study|Adverse Event|36|||
47008770|NCT02187055|83257295|FG000|Overall Study|Death|2|||
47008771|NCT02187055|83257296|FG001|Overall Study|Death|0|||
47008772|NCT02187055|83257297|FG002|Overall Study|Death|0|||
47008773|NCT02246660|83257337|FG000|Overall Study|Withdrawal by Subject|0|||
47008774|NCT02246660|83257338|FG001|Overall Study|Withdrawal by Subject|1|||
47008775|NCT02246660|83257339|FG002|Overall Study|Withdrawal by Subject|0|||
47008776|NCT02246660|83257337|FG000|Overall Study|Death|0|||
47008777|NCT02246660|83257338|FG001|Overall Study|Death|0|||
47008778|NCT02246660|83257339|FG002|Overall Study|Death|1|||
47008779|NCT02246582|83257347|FG000|Overall Study|Withdrawal by Subject|3|||
47008780|NCT02246582|83257348|FG001|Overall Study|Withdrawal by Subject|4|||
47008781|NCT02137369|83257354|FG000|Overall Study|Withdrawal by Subject|3|||
47008782|NCT02137369|83257355|FG001|Overall Study|Withdrawal by Subject|2|||
47008783|NCT02137369|83257354|FG000|Overall Study|Adverse Event|2|||
47008784|NCT02137369|83257355|FG001|Overall Study|Adverse Event|0|||
47008785|NCT02137369|83257354|FG000|Overall Study|Lost to Follow-up|1|||
47008786|NCT02137369|83257355|FG001|Overall Study|Lost to Follow-up|0|||
47008787|NCT02137369|83257354|FG000|Overall Study|Moved away|2|||
47008788|NCT02137369|83257355|FG001|Overall Study|Moved away|0|||
47008789|NCT02155309|83257364|FG000|Overall Study|Protocol Violation|0|||
47008790|NCT02155309|83257365|FG001|Overall Study|Protocol Violation|0|||
47008791|NCT02155309|83257366|FG002|Overall Study|Protocol Violation|1|||
47008792|NCT02186821|83257373|FG000|Overall Study|Adverse Event|9|||
47008793|NCT02186821|83257373|FG000|Overall Study|Death|2|||
46641220|NCT01105975|82820480|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
47008794|NCT02186821|83257373|FG000|Overall Study|Disease progression|32|||
47008795|NCT02186821|83257373|FG000|Overall Study|Protocol Violation|1|||
47008796|NCT02186821|83257373|FG000|Overall Study|Physician Decision|1|||
47008797|NCT02186821|83257373|FG000|Overall Study|Study terminated by sponsor|2|||
47008798|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
47008799|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
47008800|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
47008801|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
47008802|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
47008803|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
47008804|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
47008805|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
47008806|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
47008807|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
47008808|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
47008809|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
47008810|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
47008811|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
47008812|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
47008813|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
47008814|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
47008815|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
47008816|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
47008817|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
47008818|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
47008819|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
47008820|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
47008821|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
47008822|NCT01710358|83257380|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
47008823|NCT01710358|83257381|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
47008824|NCT01710358|83257382|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
47008825|NCT01710358|83257380|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
47008826|NCT01710358|83257381|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
47008827|NCT01710358|83257382|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
47008828|NCT01710358|83257380|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
47008829|NCT01710358|83257381|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
47008830|NCT01710358|83257382|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
47008831|NCT01710358|83257380|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
47008832|NCT01710358|83257381|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
47008833|NCT01710358|83257382|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
47008834|NCT01710358|83257380|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
47008835|NCT01710358|83257381|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
47008836|NCT01710358|83257382|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
47008837|NCT01710358|83257380|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
47008838|NCT01710358|83257381|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
47008839|NCT01710358|83257382|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
47008840|NCT01710358|83257380|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
47008841|NCT01710358|83257381|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
47008842|NCT01710358|83257382|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
47008843|NCT01710358|83257380|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
47008844|NCT01710358|83257381|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
47008845|NCT01710358|83257382|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
47008846|NCT01710358|83257380|FG000|Rescue Period|Adverse Event|0|||
47008847|NCT01710358|83257381|FG001|Rescue Period|Adverse Event|15|||
47008848|NCT01710358|83257382|FG002|Rescue Period|Adverse Event|0|||
47008849|NCT01710358|83257380|FG000|Rescue Period|Death|0|||
47008850|NCT01710358|83257381|FG001|Rescue Period|Death|1|||
47008851|NCT01710358|83257382|FG002|Rescue Period|Death|0|||
47008852|NCT01710358|83257380|FG000|Rescue Period|Lack of Efficacy|0|||
47008853|NCT01710358|83257381|FG001|Rescue Period|Lack of Efficacy|7|||
47008854|NCT01710358|83257382|FG002|Rescue Period|Lack of Efficacy|0|||
47008855|NCT01710358|83257380|FG000|Rescue Period|Withdrawal by Subject|0|||
47008856|NCT01710358|83257381|FG001|Rescue Period|Withdrawal by Subject|8|||
47008857|NCT01710358|83257382|FG002|Rescue Period|Withdrawal by Subject|0|||
47008858|NCT01633112|83257406|FG000|Overall Study|Lack of Efficacy|1|||
47008859|NCT01633112|83257407|FG001|Overall Study|Lack of Efficacy|6|||
47008860|NCT01633112|83257408|FG002|Overall Study|Lack of Efficacy|13|||
47008861|NCT01633112|83257406|FG000|Overall Study|Abnormal laboratory value(s)|3|||
47008862|NCT01633112|83257407|FG001|Overall Study|Abnormal laboratory value(s)|1|||
47008863|NCT01633112|83257408|FG002|Overall Study|Abnormal laboratory value(s)|0|||
47008864|NCT01633112|83257406|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46709531|NCT01217606|82925578|FG001|9-Month Masked Extension|Adverse Event|6|||
47008865|NCT01633112|83257407|FG001|Overall Study|Abnormal test procedure result(s)|1|||
47008866|NCT01633112|83257408|FG002|Overall Study|Abnormal test procedure result(s)|0|||
47008867|NCT01633112|83257406|FG000|Overall Study|Administrative problems|1|||
47008868|NCT01633112|83257407|FG001|Overall Study|Administrative problems|2|||
47008869|NCT01633112|83257408|FG002|Overall Study|Administrative problems|5|||
47008870|NCT01633112|83257406|FG000|Overall Study|Adverse Event|16|||
47008871|NCT01633112|83257407|FG001|Overall Study|Adverse Event|18|||
47008872|NCT01633112|83257408|FG002|Overall Study|Adverse Event|20|||
47008873|NCT01633112|83257406|FG000|Overall Study|Lost to Follow-up|7|||
47008874|NCT01633112|83257407|FG001|Overall Study|Lost to Follow-up|19|||
47008875|NCT01633112|83257408|FG002|Overall Study|Lost to Follow-up|6|||
47008876|NCT01633112|83257406|FG000|Overall Study|Protocol Violation|4|||
47008877|NCT01633112|83257407|FG001|Overall Study|Protocol Violation|0|||
47008878|NCT01633112|83257408|FG002|Overall Study|Protocol Violation|2|||
47008879|NCT01633112|83257406|FG000|Overall Study|Subject no longer requires study drug|0|||
47008880|NCT01633112|83257407|FG001|Overall Study|Subject no longer requires study drug|0|||
47008881|NCT01633112|83257408|FG002|Overall Study|Subject no longer requires study drug|1|||
47008882|NCT01633112|83257406|FG000|Overall Study|Withdrawal by Subject|20|||
47008883|NCT01633112|83257407|FG001|Overall Study|Withdrawal by Subject|12|||
47008884|NCT01633112|83257408|FG002|Overall Study|Withdrawal by Subject|41|||
47008885|NCT01633112|83257406|FG000|Overall Study|missing Study Completion CRF|1|||
47008886|NCT01633112|83257407|FG001|Overall Study|missing Study Completion CRF|1|||
47008887|NCT01633112|83257408|FG002|Overall Study|missing Study Completion CRF|4|||
47008888|NCT01691482|83257417|FG000|Treatment Period 2|Adverse Event|0|||
47008889|NCT01691482|83257418|FG001|Treatment Period 2|Adverse Event|1|||
47008890|NCT01691482|83257417|FG000|Treatment Period 2|Protocol Violation|1|||
47008891|NCT01691482|83257418|FG001|Treatment Period 2|Protocol Violation|1|||
47008892|NCT02246114|83257427|FG000|Overall Study|miscarriage|1|||
47008893|NCT02246114|83257428|FG001|Overall Study|miscarriage|0|||
47008894|NCT01710046|83257436|FG000|Overall Study|Lost to Follow-up|1|||
47008895|NCT01710046|83257437|FG001|Overall Study|Lost to Follow-up|0|||
47008896|NCT02154529|83257447|FG000|Overall Study|Death|1|||
47008897|NCT02154529|83257448|FG001|Overall Study|Death|1|||
47008898|NCT02154529|83257449|FG002|Overall Study|Death|5|||
47008899|NCT02154529|83257450|FG003|Overall Study|Death|1|||
47008900|NCT02154529|83257447|FG000|Overall Study|Termination of study by sponsor|2|||
47008901|NCT02154529|83257448|FG001|Overall Study|Termination of study by sponsor|2|||
47008902|NCT02154529|83257449|FG002|Overall Study|Termination of study by sponsor|3|||
47008903|NCT02154529|83257450|FG003|Overall Study|Termination of study by sponsor|1|||
47008904|NCT02154529|83257447|FG000|Overall Study|Lost to Follow-up|1|||
47008905|NCT02154529|83257448|FG001|Overall Study|Lost to Follow-up|0|||
47008906|NCT02154529|83257449|FG002|Overall Study|Lost to Follow-up|0|||
47008907|NCT02154529|83257450|FG003|Overall Study|Lost to Follow-up|0|||
47008908|NCT01954017|83257465|FG000|Overall Study|Adverse Event|0|||
47008909|NCT01954017|83257466|FG001|Overall Study|Adverse Event|0|||
47008910|NCT01954017|83257467|FG002|Overall Study|Adverse Event|1|||
47008911|NCT01954017|83257465|FG000|Overall Study|Death|2|||
47008912|NCT01954017|83257466|FG001|Overall Study|Death|1|||
47008913|NCT01954017|83257467|FG002|Overall Study|Death|1|||
47008914|NCT01954017|83257465|FG000|Overall Study|Withdrawal by Subject|0|||
47008915|NCT01954017|83257466|FG001|Overall Study|Withdrawal by Subject|1|||
47008916|NCT01954017|83257467|FG002|Overall Study|Withdrawal by Subject|0|||
47008917|NCT01954017|83257465|FG000|Overall Study|Protocol Violation|0|||
47008918|NCT01954017|83257466|FG001|Overall Study|Protocol Violation|3|||
47008919|NCT01954017|83257467|FG002|Overall Study|Protocol Violation|2|||
47008920|NCT01954017|83257465|FG000|Overall Study|Necrotizing enterocolitis|1|||
47008921|NCT01954017|83257466|FG001|Overall Study|Necrotizing enterocolitis|0|||
47008922|NCT01954017|83257467|FG002|Overall Study|Necrotizing enterocolitis|1|||
47008923|NCT01954017|83257465|FG000|Overall Study|Enteral intake stopped >7 days|0|||
47008924|NCT01954017|83257466|FG001|Overall Study|Enteral intake stopped >7 days|1|||
47008925|NCT01954017|83257467|FG002|Overall Study|Enteral intake stopped >7 days|1|||
47008926|NCT01954017|83257465|FG000|Overall Study|All other reasons|2|||
47008927|NCT01954017|83257466|FG001|Overall Study|All other reasons|2|||
47008928|NCT01954017|83257467|FG002|Overall Study|All other reasons|7|||
46709532|NCT01217606|82925577|FG000|9-Month Masked Extension|Other Reasons|4|||
47008929|NCT02154139|83257501|FG000|Overall Study|Injection not administered|2|||
47008930|NCT02154139|83257501|FG000|Overall Study|Other|2|||
47008931|NCT02154139|83257501|FG000|Overall Study|Investigator transferred|3|||
47008932|NCT02245568|83257505|FG000|Overall Study|Study terminated by Sponsor|346|||
47008933|NCT02245568|83257505|FG000|Overall Study|Adverse Event|144|||
47008934|NCT02245568|83257505|FG000|Overall Study|Lack of Efficacy|98|||
46641221|NCT00831623|82820521|FG000|Overall Study|Withdrawal by Subject|9|||
47008935|NCT02245568|83257505|FG000|Overall Study|Withdrawal by Caregiver|85|||
47008936|NCT02245568|83257505|FG000|Overall Study|Withdrawal by Subject|77|||
47008937|NCT02245568|83257505|FG000|Overall Study|Withdrawal by Legal Representative|31|||
47008938|NCT02245568|83257505|FG000|Overall Study|Missing (Site closure)|16|||
47008939|NCT02245568|83257505|FG000|Overall Study|Physician Decision|14|||
47008940|NCT02245568|83257505|FG000|Overall Study|Non-compliance with study drug|11|||
47008941|NCT02245568|83257505|FG000|Overall Study|Death|9|||
47008942|NCT02245568|83257505|FG000|Overall Study|Blue staining|6|||
47008943|NCT02245568|83257505|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
47008944|NCT02245568|83257505|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
47008945|NCT02245568|83257505|FG000|Overall Study|Lost to Follow-up|5|||
47008946|NCT02154061|83257511|FG000|Overall Study|Pregnancy|1|||
47008947|NCT02154061|83257512|FG001|Overall Study|Pregnancy|0|||
47008948|NCT02154061|83257511|FG000|Overall Study|enrolled but not vaccinated|1|||
47008949|NCT02154061|83257512|FG001|Overall Study|enrolled but not vaccinated|0|||
47008950|NCT01907217|83257520|FG000|Overall Study|Withdrawal by Subject|0|||
47008951|NCT01907217|83257521|FG001|Overall Study|Withdrawal by Subject|2|||
47008952|NCT01953783|83257529|FG000|Overall Study|Progressive disease|2|||
47008953|NCT02134015|83257535|FG000|Overall Study|Protocol Violation|0|||
47008954|NCT02134015|83257536|FG001|Overall Study|Protocol Violation|1|||
47008955|NCT02134015|83257535|FG000|Overall Study|Death|2|||
47008956|NCT02134015|83257536|FG001|Overall Study|Death|1|||
47008957|NCT02134015|83257535|FG000|Overall Study|Reason not provided|1|||
47008958|NCT02134015|83257536|FG001|Overall Study|Reason not provided|2|||
47008959|NCT02134015|83257535|FG000|Overall Study|Clinical progression|14|||
47008960|NCT02134015|83257536|FG001|Overall Study|Clinical progression|7|||
47008961|NCT02134015|83257535|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
47008962|NCT02134015|83257536|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
47008963|NCT02134015|83257535|FG000|Overall Study|Study terminated by sponsor|2|||
47008964|NCT02134015|83257536|FG001|Overall Study|Study terminated by sponsor|3|||
47008965|NCT02134015|83257535|FG000|Overall Study|Adverse Event|9|||
47008966|NCT02134015|83257536|FG001|Overall Study|Adverse Event|10|||
47008967|NCT02134015|83257535|FG000|Overall Study|Withdrawal by Subject|3|||
47008968|NCT02134015|83257536|FG001|Overall Study|Withdrawal by Subject|7|||
47008969|NCT01924845|83257542|FG000|Overall Study|Adverse Event|3|||
47008970|NCT01924845|83257542|FG000|Overall Study|Withdrawal by Subject|2|||
47008971|NCT01924845|83257542|FG000|Overall Study|Protocol Violation|1|||
47008972|NCT01630135|83257548|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
47008973|NCT01630135|83257549|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
47008974|NCT01691248|83257557|FG000|Overall Study|Protocol Violation|43|||
47008975|NCT01691248|83257558|FG001|Overall Study|Protocol Violation|27|||
47008976|NCT01691248|83257557|FG000|Overall Study|Adverse Event|24|||
47008977|NCT01691248|83257558|FG001|Overall Study|Adverse Event|22|||
47008978|NCT01691248|83257557|FG000|Overall Study|Withdrawal by Subject|20|||
47008979|NCT01691248|83257558|FG001|Overall Study|Withdrawal by Subject|18|||
47008980|NCT01691248|83257557|FG000|Overall Study|Confirmed CDAD|14|||
47008981|NCT01691248|83257558|FG001|Overall Study|Confirmed CDAD|31|||
47008982|NCT01691248|83257557|FG000|Overall Study|Lost to Follow-up|2|||
47008983|NCT01691248|83257558|FG001|Overall Study|Lost to Follow-up|5|||
47008984|NCT01691248|83257557|FG000|Overall Study|Reason not provided|4|||
47008985|NCT01691248|83257558|FG001|Overall Study|Reason not provided|4|||
47008986|NCT01691248|83257557|FG000|Overall Study|Not Treated|4|||
47008987|NCT01691248|83257558|FG001|Overall Study|Not Treated|7|||
47008988|NCT01924767|83257569|FG000|Overall Study|Adverse Event|1|||
47008989|NCT01924767|83257570|FG001|Overall Study|Adverse Event|0|||
47008990|NCT01924767|83257571|FG002|Overall Study|Adverse Event|1|||
47008991|NCT01924767|83257572|FG003|Overall Study|Adverse Event|0|||
47008992|NCT01924767|83257573|FG004|Overall Study|Adverse Event|0|||
47008993|NCT01691092|83257590|FG000|Overall Study|Lost to Follow-up|10|||
47008994|NCT01691092|83257590|FG000|Overall Study|Physician Decision|4|||
47008995|NCT01691092|83257590|FG000|Overall Study|Withdrawal by Subject|3|||
47008996|NCT01691092|83257590|FG000|Overall Study|non-compliance|3|||
47008997|NCT01691092|83257590|FG000|Overall Study|used for different study|2|||
47008998|NCT01691092|83257590|FG000|Overall Study|screen fail|19|||
47008999|NCT02133001|83257596|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
47009000|NCT02133001|83257597|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
47009001|NCT02133001|83257596|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
47009002|NCT02133001|83257597|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
47009003|NCT02133001|83257596|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
47009004|NCT02133001|83257597|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
47009005|NCT02133001|83257596|FG000|Double Blind (Day 1-25)|Other|2|||
47009006|NCT02133001|83257597|FG001|Double Blind (Day 1-25)|Other|2|||
47009007|NCT02133001|83257596|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
47009008|NCT02133001|83257597|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
47009009|NCT02133001|83257596|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
46641222|NCT00831623|82820521|FG000|Overall Study|Lost to Follow-up|1|||
47009010|NCT02133001|83257597|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
47009011|NCT02133001|83257596|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
47009012|NCT02133001|83257597|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
47009013|NCT02133001|83257596|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
47009014|NCT02133001|83257597|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
47009015|NCT01709578|83257608|FG000|Overall Study|Rescued and entered in long term safety|63|||
47009016|NCT01709578|83257609|FG001|Overall Study|Rescued and entered in long term safety|25|||
47009017|NCT01709578|83257610|FG002|Overall Study|Rescued and entered in long term safety|26|||
47009018|NCT01709578|83257608|FG000|Overall Study|Adverse Event|9|||
47009019|NCT01709578|83257609|FG001|Overall Study|Adverse Event|18|||
47009020|NCT01709578|83257610|FG002|Overall Study|Adverse Event|17|||
47009021|NCT01709578|83257608|FG000|Overall Study|Lack of Efficacy|5|||
47009022|NCT01709578|83257609|FG001|Overall Study|Lack of Efficacy|4|||
47009023|NCT01709578|83257610|FG002|Overall Study|Lack of Efficacy|2|||
47009024|NCT01709578|83257608|FG000|Overall Study|Poor compliance to protocol|1|||
47009025|NCT01709578|83257609|FG001|Overall Study|Poor compliance to protocol|2|||
47009026|NCT01709578|83257610|FG002|Overall Study|Poor compliance to protocol|1|||
47009027|NCT01709578|83257608|FG000|Overall Study|Other, not related to safety or efficacy|2|||
47009028|NCT01709578|83257609|FG001|Overall Study|Other, not related to safety or efficacy|7|||
47009029|NCT01709578|83257610|FG002|Overall Study|Other, not related to safety or efficacy|5|||
47009030|NCT02132767|83257620|FG000|Overall Study|Death|3|||
47009031|NCT02132767|83257621|FG001|Overall Study|Death|2|||
47009032|NCT02132767|83257620|FG000|Overall Study|Withdrawal by Subject|10|||
47009033|NCT02132767|83257621|FG001|Overall Study|Withdrawal by Subject|9|||
47009034|NCT02132767|83257620|FG000|Overall Study|Lost to Follow-up|4|||
47009035|NCT02132767|83257621|FG001|Overall Study|Lost to Follow-up|4|||
47009036|NCT02153905|83257629|FG000|Overall Study|Death|1|||
47009037|NCT02153905|83257630|FG001|Overall Study|Death|0|||
47009038|NCT02153827|83257638|FG000|Overall Study|Lost to Follow-up|3|||
47009039|NCT02153827|83257639|FG001|Overall Study|Lost to Follow-up|9|||
47009040|NCT02153359|83257645|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
47009041|NCT02153359|83257646|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
47009042|NCT01691014|83257659|FG000|Overall Study|Premature Termination|1|||
47009043|NCT01691014|83257660|FG001|Overall Study|Premature Termination|6|||
47009044|NCT01691014|83257661|FG002|Overall Study|Premature Termination|0|||
47009045|NCT01691014|83257662|FG003|Overall Study|Premature Termination|3|||
47009046|NCT01691014|83257659|FG000|Overall Study|Other|0|||
47009047|NCT01691014|83257660|FG001|Overall Study|Other|0|||
47009048|NCT01691014|83257661|FG002|Overall Study|Other|2|||
47009049|NCT01691014|83257662|FG003|Overall Study|Other|0|||
47009050|NCT01691014|83257659|FG000|Overall Study|Withdrawal by Subject|0|||
47009051|NCT01691014|83257660|FG001|Overall Study|Withdrawal by Subject|1|||
47009052|NCT01691014|83257661|FG002|Overall Study|Withdrawal by Subject|1|||
47009053|NCT01691014|83257662|FG003|Overall Study|Withdrawal by Subject|1|||
47009054|NCT01691014|83257659|FG000|Overall Study|Adverse Event|0|||
47009055|NCT01691014|83257660|FG001|Overall Study|Adverse Event|5|||
47009056|NCT01691014|83257661|FG002|Overall Study|Adverse Event|1|||
47009057|NCT01691014|83257662|FG003|Overall Study|Adverse Event|1|||
47009058|NCT01691014|83257659|FG000|Overall Study|Lack of Efficacy|2|||
47009059|NCT01691014|83257660|FG001|Overall Study|Lack of Efficacy|3|||
47009060|NCT01691014|83257661|FG002|Overall Study|Lack of Efficacy|7|||
47009061|NCT01691014|83257662|FG003|Overall Study|Lack of Efficacy|0|||
47009062|NCT02245412|83257675|FG000|Treatment Period|Death|1|||
47009063|NCT02245412|83257676|FG001|Treatment Period|Death|1|||
47009064|NCT02245412|83257677|FG002|Treatment Period|Death|0|||
47009065|NCT02245412|83257675|FG000|Treatment Period|Physician Decision|1|||
47009066|NCT02245412|83257676|FG001|Treatment Period|Physician Decision|1|||
47009067|NCT02245412|83257677|FG002|Treatment Period|Physician Decision|0|||
47009068|NCT02245412|83257675|FG000|Treatment Period|Withdrawal by Subject|2|||
47009069|NCT02245412|83257676|FG001|Treatment Period|Withdrawal by Subject|1|||
47009070|NCT02245412|83257677|FG002|Treatment Period|Withdrawal by Subject|0|||
47009071|NCT02245412|83257675|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
47009072|NCT02245412|83257676|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
47009073|NCT02245412|83257677|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
47009074|NCT02245412|83257675|FG000|Follow-Up Period|Death|4|||
47009075|NCT02245412|83257676|FG001|Follow-Up Period|Death|2|||
47009076|NCT02245412|83257677|FG002|Follow-Up Period|Death|1|||
47009077|NCT02245412|83257675|FG000|Follow-Up Period|Physician Decision|1|||
47009078|NCT02245412|83257676|FG001|Follow-Up Period|Physician Decision|0|||
47009079|NCT02245412|83257677|FG002|Follow-Up Period|Physician Decision|0|||
47009080|NCT02245412|83257675|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
47009081|NCT02245412|83257676|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
47009082|NCT02245412|83257677|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
47009083|NCT02244944|83257685|FG000|Overall Study|Withdrawal by Subject|1|||
47009084|NCT02244944|83257685|FG000|Overall Study|Study Terminated|1|||
47009085|NCT01689532|83257691|FG000|Overall Study|Adverse Event|9|||
47009086|NCT01689532|83257692|FG001|Overall Study|Adverse Event|5|||
47009087|NCT01689532|83257691|FG000|Overall Study|Lack of Efficacy|2|||
47009088|NCT01689532|83257692|FG001|Overall Study|Lack of Efficacy|2|||
47009089|NCT01689532|83257691|FG000|Overall Study|Withdrawal by Subject|1|||
47009090|NCT01689532|83257692|FG001|Overall Study|Withdrawal by Subject|2|||
47009091|NCT01689532|83257691|FG000|Overall Study|Physician Decision|2|||
47009092|NCT01689532|83257692|FG001|Overall Study|Physician Decision|0|||
47009093|NCT01924689|83257704|FG000|Overall Study|Death|0|||
47009094|NCT01924689|83257705|FG001|Overall Study|Death|1|||
47009095|NCT01924689|83257706|FG002|Overall Study|Death|0|||
47009096|NCT01924689|83257707|FG003|Overall Study|Death|1|||
47009097|NCT01924689|83257708|FG004|Overall Study|Death|0|||
47009098|NCT01924689|83257709|FG005|Overall Study|Death|0|||
47009099|NCT01924689|83257704|FG000|Overall Study|Disease progression|0|||
47009100|NCT01924689|83257705|FG001|Overall Study|Disease progression|0|||
47009101|NCT01924689|83257706|FG002|Overall Study|Disease progression|2|||
47009102|NCT01924689|83257707|FG003|Overall Study|Disease progression|0|||
47009103|NCT01924689|83257708|FG004|Overall Study|Disease progression|3|||
47009104|NCT01924689|83257709|FG005|Overall Study|Disease progression|2|||
47009105|NCT01924689|83257704|FG000|Overall Study|New therapy or study|3|||
47009106|NCT01924689|83257705|FG001|Overall Study|New therapy or study|2|||
47009107|NCT01924689|83257706|FG002|Overall Study|New therapy or study|1|||
47009108|NCT01924689|83257707|FG003|Overall Study|New therapy or study|4|||
47009109|NCT01924689|83257708|FG004|Overall Study|New therapy or study|2|||
47009110|NCT01924689|83257709|FG005|Overall Study|New therapy or study|0|||
47009111|NCT01924689|83257704|FG000|Overall Study|Withdrawal of consent|0|||
47009112|NCT01924689|83257705|FG001|Overall Study|Withdrawal of consent|0|||
47009113|NCT01924689|83257706|FG002|Overall Study|Withdrawal of consent|1|||
47009114|NCT01924689|83257707|FG003|Overall Study|Withdrawal of consent|1|||
47009115|NCT01924689|83257708|FG004|Overall Study|Withdrawal of consent|0|||
47009116|NCT01924689|83257709|FG005|Overall Study|Withdrawal of consent|0|||
47009117|NCT01924689|83257704|FG000|Overall Study|Other|0|||
47009118|NCT01924689|83257705|FG001|Overall Study|Other|0|||
47009119|NCT01924689|83257706|FG002|Overall Study|Other|0|||
47009120|NCT01924689|83257707|FG003|Overall Study|Other|0|||
47009121|NCT01924689|83257708|FG004|Overall Study|Other|1|||
47009122|NCT01924689|83257709|FG005|Overall Study|Other|0|||
47009123|NCT01591330|83257727|FG000|Period 1|Adverse Event|1|||
47009124|NCT01591330|83257728|FG001|Period 1|Adverse Event|0|||
47009125|NCT01591330|83257729|FG002|Period 1|Adverse Event|0|||
47009126|NCT01591330|83257730|FG003|Period 1|Adverse Event|0|||
47009127|NCT01591330|83257727|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
47009128|NCT01591330|83257728|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
47009129|NCT01591330|83257729|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
47009130|NCT01591330|83257730|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
47009131|NCT01591330|83257727|FG000|Period 2|Adverse Event|1|||
47009132|NCT01591330|83257728|FG001|Period 2|Adverse Event|0|||
47009133|NCT01591330|83257729|FG002|Period 2|Adverse Event|0|||
47009134|NCT01591330|83257730|FG003|Period 2|Adverse Event|0|||
47009135|NCT01591096|83257740|FG000|Overall Study|Adverse Event|1|||
47009136|NCT01953003|83257746|FG000|Overall Study|Not treated|0|||
47009137|NCT01953003|83257747|FG001|Overall Study|Not treated|1|||
47009138|NCT01953003|83257746|FG000|Overall Study|Progressive disease|35|||
47009139|NCT01953003|83257747|FG001|Overall Study|Progressive disease|45|||
47009140|NCT01953003|83257746|FG000|Overall Study|Related Adverse events|7|||
47009141|NCT01953003|83257747|FG001|Overall Study|Related Adverse events|2|||
47009142|NCT01953003|83257746|FG000|Overall Study|Non-related adverse events|0|||
47009143|NCT01953003|83257747|FG001|Overall Study|Non-related adverse events|2|||
47009144|NCT01953003|83257746|FG000|Overall Study|Protocol Violation|0|||
47009145|NCT01953003|83257747|FG001|Overall Study|Protocol Violation|1|||
47009146|NCT01953003|83257746|FG000|Overall Study|Withdrawal by Subject|14|||
47009147|NCT01953003|83257747|FG001|Overall Study|Withdrawal by Subject|4|||
47009148|NCT01952691|83257753|FG000|Overall Study|Lost to Follow-up|2|||
47009149|NCT01709500|83257759|FG000|Overall Study|Randomized but not treated|0|||
47009150|NCT01709500|83257760|FG001|Overall Study|Randomized but not treated|1|||
47009151|NCT01709500|83257759|FG000|Overall Study|Adverse Event|5|||
47009152|NCT01709500|83257760|FG001|Overall Study|Adverse Event|1|||
47009153|NCT01709500|83257759|FG000|Overall Study|Poor compliance to protocol|2|||
47009154|NCT01709500|83257760|FG001|Overall Study|Poor compliance to protocol|1|||
47009155|NCT01709500|83257759|FG000|Overall Study|Other|3|||
47009156|NCT01709500|83257760|FG001|Overall Study|Other|1|||
47009157|NCT01709500|83257759|FG000|Overall Study|Related to IMP administration|1|||
47009158|NCT01709500|83257760|FG001|Overall Study|Related to IMP administration|0|||
47009159|NCT01709500|83257759|FG000|Overall Study|Treatment ongoing|156|||
47009160|NCT01709500|83257760|FG001|Overall Study|Treatment ongoing|78|||
47009161|NCT01599806|83257768|FG000|Overall Study|Lost to Follow-up|20|||
47009162|NCT01599806|83257769|FG001|Overall Study|Lost to Follow-up|20|||
47009163|NCT01599806|83257768|FG000|Overall Study|Withdrawal by Subject|12|||
47009164|NCT01599806|83257769|FG001|Overall Study|Withdrawal by Subject|12|||
46910046|NCT03254485|83139302|FG001|Overall Study|Other|0|||
47009165|NCT01599806|83257768|FG000|Overall Study|Other Eligibility criteria|11|||
47009166|NCT01599806|83257769|FG001|Overall Study|Other Eligibility criteria|9|||
47009167|NCT01599325|83257775|FG000|Primary Parent Phase|Adverse Event|5|||
47009168|NCT01599325|83257775|FG000|Primary Parent Phase|Disease Progression|7|||
47009169|NCT01599325|83257775|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
47009170|NCT01599325|83257775|FG000|Primary Parent Phase|Death|13|||
47009171|NCT01599325|83257775|FG000|Primary Parent Phase|Protocol Violation|1|||
47009172|NCT01599325|83257775|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
47009173|NCT01599325|83257775|FG000|Primary Parent Phase|Other|2|||
47009174|NCT01599325|83257775|FG000|Extension Phase|Study Closure|1|||
47009175|NCT01599325|83257775|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
47009176|NCT01599325|83257775|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
47009177|NCT01599325|83257775|FG000|Extension Phase|Disease Progression|1|||
47009178|NCT01599325|83257775|FG000|Extension Phase|Withdrawal by Subject|8|||
47009179|NCT01924299|83257782|FG000|Period 2|Withdrawal by Subject|1|||
47009180|NCT01924299|83257783|FG001|Period 2|Withdrawal by Subject|0|||
47009181|NCT01924299|83257782|FG000|Period 2|Adverse Event|0|||
47009182|NCT01924299|83257783|FG001|Period 2|Adverse Event|1|||
47009183|NCT02182999|83257797|FG000|Overall Study|Adverse Event|4|||
47009184|NCT02182999|83257798|FG001|Overall Study|Adverse Event|3|||
47009185|NCT02182999|83257797|FG000|Overall Study|Physician Decision|1|||
47009186|NCT02182999|83257798|FG001|Overall Study|Physician Decision|0|||
47009187|NCT02243696|83257804|FG000|Overall Study|Death|282|||
47009188|NCT02243696|83257804|FG000|Overall Study|Withdrawal by Subject|79|||
47009189|NCT02243696|83257804|FG000|Overall Study|Lost to Follow-up|57|||
47009190|NCT02243696|83257804|FG000|Overall Study|Subject No Longer has Study System|42|||
47009191|NCT02243696|83257804|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
47009192|NCT02243696|83257804|FG000|Overall Study|Study Terminated for EP PASSION|961|||
47009193|NCT01598311|83257810|FG000|Overall Study|Physician Decision|4|||
47009194|NCT01598311|83257811|FG001|Overall Study|Physician Decision|5|||
47009195|NCT01598311|83257810|FG000|Overall Study|Adverse Event|9|||
47009196|NCT01598311|83257811|FG001|Overall Study|Adverse Event|13|||
47009197|NCT01598311|83257810|FG000|Overall Study|Lost to Follow-up|7|||
47009198|NCT01598311|83257811|FG001|Overall Study|Lost to Follow-up|12|||
47009199|NCT01598311|83257810|FG000|Overall Study|Withdrawal by Subject|9|||
47009200|NCT01598311|83257811|FG001|Overall Study|Withdrawal by Subject|13|||
47009201|NCT01598311|83257810|FG000|Overall Study|No reason provided.|0|||
47009202|NCT01598311|83257811|FG001|Overall Study|No reason provided.|5|||
47009203|NCT01598311|83257810|FG000|Overall Study|Randomized but never treated|8|||
47009204|NCT01598311|83257811|FG001|Overall Study|Randomized but never treated|5|||
47009205|NCT01598311|83257810|FG000|Overall Study|Treated but no confirmed CDAD|9|||
47009206|NCT01598311|83257811|FG001|Overall Study|Treated but no confirmed CDAD|8|||
47009207|NCT01598311|83257810|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
47009208|NCT01598311|83257811|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
47009209|NCT02182843|83257817|FG000|Overall Study|Withdrawal by Subject|7|||
47009210|NCT02182843|83257817|FG000|Overall Study|Lost to Follow-up|2|||
47009211|NCT02182843|83257817|FG000|Overall Study|Adverse Event|1|||
47009212|NCT02208050|83257823|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
47009213|NCT02208050|83257824|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
47009214|NCT02978222|83257846|FG000|Overall Study|Withdrawal by Subject|2|||
47009215|NCT02978222|83257847|FG001|Overall Study|Withdrawal by Subject|2|||
47009216|NCT02978222|83257846|FG000|Overall Study|Physician Decision|2|||
47009217|NCT02978222|83257847|FG001|Overall Study|Physician Decision|0|||
47009218|NCT02978222|83257846|FG000|Overall Study|Adverse Event|0|||
47009219|NCT02978222|83257847|FG001|Overall Study|Adverse Event|1|||
47009220|NCT02978222|83257846|FG000|Overall Study|Death|1|||
47009221|NCT02978222|83257847|FG001|Overall Study|Death|0|||
47009222|NCT02978222|83257846|FG000|Overall Study|Disease Progression|32|||
47009223|NCT02978222|83257847|FG001|Overall Study|Disease Progression|32|||
47009224|NCT02978222|83257846|FG000|Overall Study|Early Study Termination|24|||
47009225|NCT02978222|83257847|FG001|Overall Study|Early Study Termination|21|||
47009226|NCT02181673|83257855|FG000|Up to Week 24|Adverse Event|2|||
47009227|NCT02181673|83257856|FG001|Up to Week 24|Adverse Event|0|||
47009228|NCT02181673|83257857|FG002|Up to Week 24|Adverse Event|3|||
47009229|NCT02181673|83257855|FG000|Up to Week 24|Death|1|||
47009230|NCT02181673|83257856|FG001|Up to Week 24|Death|0|||
47009231|NCT02181673|83257857|FG002|Up to Week 24|Death|0|||
47009232|NCT02181673|83257855|FG000|Up to Week 24|Lack of Efficacy|1|||
47009233|NCT02181673|83257856|FG001|Up to Week 24|Lack of Efficacy|0|||
47009234|NCT02181673|83257857|FG002|Up to Week 24|Lack of Efficacy|0|||
47009235|NCT02181673|83257855|FG000|Up to Week 24|Lost to Follow-up|1|||
47009236|NCT02181673|83257856|FG001|Up to Week 24|Lost to Follow-up|0|||
47009237|NCT02181673|83257857|FG002|Up to Week 24|Lost to Follow-up|0|||
47009238|NCT02181673|83257855|FG000|Up to Week 24|Physician Decision|0|||
47009239|NCT02181673|83257856|FG001|Up to Week 24|Physician Decision|0|||
47009240|NCT02181673|83257857|FG002|Up to Week 24|Physician Decision|3|||
47009241|NCT02181673|83257855|FG000|Up to Week 24|Withdrawal by Subject|10|||
47009242|NCT02181673|83257856|FG001|Up to Week 24|Withdrawal by Subject|0|||
47009243|NCT02181673|83257857|FG002|Up to Week 24|Withdrawal by Subject|1|||
47009244|NCT02181673|83257855|FG000|Up to Week 24|Other|2|||
46709533|NCT01217606|82925578|FG001|9-Month Masked Extension|Other Reasons|4|||
47009245|NCT02181673|83257856|FG001|Up to Week 24|Other|0|||
47009246|NCT02181673|83257857|FG002|Up to Week 24|Other|3|||
47009247|NCT02181673|83257855|FG000|Up to Week 24|Randomized not Treated|0|||
47009248|NCT02181673|83257856|FG001|Up to Week 24|Randomized not Treated|0|||
47009249|NCT02181673|83257857|FG002|Up to Week 24|Randomized not Treated|1|||
47009250|NCT02181673|83257855|FG000|Week 24-Week 60|Adverse Event|0|||
47009251|NCT02181673|83257856|FG001|Week 24-Week 60|Adverse Event|4|||
47009252|NCT02181673|83257857|FG002|Week 24-Week 60|Adverse Event|10|||
47009253|NCT02181673|83257855|FG000|Week 24-Week 60|Other|0|||
47009254|NCT02181673|83257856|FG001|Week 24-Week 60|Other|2|||
47009255|NCT02181673|83257857|FG002|Week 24-Week 60|Other|1|||
47009256|NCT02181673|83257855|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
47009257|NCT02181673|83257856|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
47009258|NCT02181673|83257857|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
47009259|NCT02181673|83257855|FG000|Week 24-Week 60|Pregnancy|0|||
47009260|NCT02181673|83257856|FG001|Week 24-Week 60|Pregnancy|0|||
47009261|NCT02181673|83257857|FG002|Week 24-Week 60|Pregnancy|1|||
47009262|NCT02181673|83257855|FG000|Week 24-Week 60|Lack of Efficacy|0|||
47009263|NCT02181673|83257856|FG001|Week 24-Week 60|Lack of Efficacy|0|||
47009264|NCT02181673|83257857|FG002|Week 24-Week 60|Lack of Efficacy|1|||
47009265|NCT02181673|83257855|FG000|Week 24-Week 60|Lost to Follow-up|0|||
47009266|NCT02181673|83257856|FG001|Week 24-Week 60|Lost to Follow-up|0|||
47009267|NCT02181673|83257857|FG002|Week 24-Week 60|Lost to Follow-up|1|||
47009268|NCT02181673|83257855|FG000|Week 24-Week 60|Physician Decision|0|||
47009269|NCT02181673|83257856|FG001|Week 24-Week 60|Physician Decision|0|||
47009270|NCT02181673|83257857|FG002|Week 24-Week 60|Physician Decision|1|||
47009271|NCT02131129|83257866|FG000|Overall Study|Withdrawal by Subject|1|||
47009272|NCT02131129|83257867|FG001|Overall Study|Withdrawal by Subject|0|||
47009273|NCT02152345|83257875|FG000|Overall Study|Case Cancellations|2|||
47009274|NCT02152345|83257876|FG001|Overall Study|Case Cancellations|4|||
47009275|NCT02152345|83257875|FG000|Overall Study|Withdrawal by Subject|2|||
47009276|NCT02152345|83257876|FG001|Overall Study|Withdrawal by Subject|1|||
47009277|NCT02180659|83257884|FG000|Overall Study|Adverse Event|1|||
47009278|NCT02180659|83257885|FG001|Overall Study|Adverse Event|0|||
47009279|NCT02180659|83257884|FG000|Overall Study|Lost to Follow-up|4|||
47009280|NCT02180659|83257885|FG001|Overall Study|Lost to Follow-up|2|||
47009281|NCT02180659|83257884|FG000|Overall Study|Subject incarcerated during conduct|1|||
47009282|NCT02180659|83257885|FG001|Overall Study|Subject incarcerated during conduct|0|||
47009283|NCT02180659|83257884|FG000|Overall Study|Withdrawal by Subject|0|||
47009284|NCT02180659|83257885|FG001|Overall Study|Withdrawal by Subject|2|||
47009285|NCT02180659|83257884|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
47009286|NCT02180659|83257885|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
47009287|NCT02130427|83257891|FG000|Overall Study|Imaging results not interpretable|30|||
47009288|NCT02207816|83257898|FG000|Overall Study|Serious Adverse Event|0|||
47009289|NCT02207816|83257899|FG001|Overall Study|Serious Adverse Event|5|||
47009290|NCT02207816|83257900|FG002|Overall Study|Serious Adverse Event|2|||
47009291|NCT02207816|83257898|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
47009292|NCT02207816|83257899|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
47009293|NCT02207816|83257900|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
47009294|NCT02207816|83257898|FG000|Overall Study|Withdrawal by Subject|4|||
47009295|NCT02207816|83257899|FG001|Overall Study|Withdrawal by Subject|9|||
47009296|NCT02207816|83257900|FG002|Overall Study|Withdrawal by Subject|7|||
47009297|NCT02207816|83257898|FG000|Overall Study|Migrated/Moved From Study Area|41|||
47009298|NCT02207816|83257899|FG001|Overall Study|Migrated/Moved From Study Area|60|||
47009299|NCT02207816|83257900|FG002|Overall Study|Migrated/Moved From Study Area|51|||
47009300|NCT02207816|83257898|FG000|Overall Study|Lost to Follow-up|3|||
47009301|NCT02207816|83257899|FG001|Overall Study|Lost to Follow-up|9|||
47009302|NCT02207816|83257900|FG002|Overall Study|Lost to Follow-up|1|||
47009303|NCT02207816|83257898|FG000|Overall Study|Other|1|||
47009304|NCT02207816|83257899|FG001|Overall Study|Other|2|||
47009305|NCT02207816|83257900|FG002|Overall Study|Other|4|||
47009306|NCT02241512|83257913|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
47009307|NCT02241512|83257914|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
47009308|NCT02205476|83257922|FG000|Overall Study|Study termination by Sponsor|7|||
47009309|NCT02205476|83257923|FG001|Overall Study|Study termination by Sponsor|3|||
47009310|NCT01709110|83257937|FG000|Overall Study|Adverse Event|56|||
47009311|NCT01709110|83257938|FG001|Overall Study|Adverse Event|48|||
47009312|NCT01709110|83257937|FG000|Overall Study|Death|14|||
47009313|NCT01709110|83257938|FG001|Overall Study|Death|6|||
47009314|NCT01709110|83257937|FG000|Overall Study|Lost to Follow-up|7|||
47009315|NCT01709110|83257938|FG001|Overall Study|Lost to Follow-up|5|||
47009316|NCT01709110|83257937|FG000|Overall Study|Protocol Violation|4|||
47009317|NCT01709110|83257938|FG001|Overall Study|Protocol Violation|6|||
47009318|NCT01709110|83257937|FG000|Overall Study|Withdrawal by Subject|96|||
47009319|NCT01709110|83257938|FG001|Overall Study|Withdrawal by Subject|89|||
47009320|NCT01709110|83257937|FG000|Overall Study|Physician Decision|4|||
47009321|NCT01709110|83257938|FG001|Overall Study|Physician Decision|10|||
47009322|NCT01709110|83257937|FG000|Overall Study|Sponsor Decision|2|||
47009323|NCT01709110|83257938|FG001|Overall Study|Sponsor Decision|2|||
47009324|NCT01709110|83257937|FG000|Overall Study|Lack of Efficacy|1|||
47009325|NCT01709110|83257938|FG001|Overall Study|Lack of Efficacy|1|||
47009326|NCT01709110|83257937|FG000|Overall Study|Caregiver Decision|1|||
47009327|NCT01709110|83257938|FG001|Overall Study|Caregiver Decision|1|||
47009328|NCT02240108|83257946|FG000|Overall Study|Other than specified|8|||
47009329|NCT02240108|83257947|FG001|Overall Study|Other than specified|6|||
47009330|NCT02240108|83257946|FG000|Overall Study|Adverse Event|1|||
47009331|NCT02240108|83257947|FG001|Overall Study|Adverse Event|9|||
46910047|NCT03254485|83139303|FG002|Overall Study|Other|0|||
46910048|NCT03254485|83139304|FG003|Overall Study|Other|2|||
46910049|NCT03339401|83139317|FG000|Overall Study|Death|2|||
46910050|NCT03339401|83139318|FG001|Overall Study|Death|1|||
46910051|NCT03339401|83139317|FG000|Overall Study|Withdrawal by Subject|2|||
46910052|NCT03339401|83139318|FG001|Overall Study|Withdrawal by Subject|0|||
46910053|NCT03339401|83139317|FG000|Overall Study|Study terminated|4|||
46910054|NCT03339401|83139318|FG001|Overall Study|Study terminated|3|||
46910055|NCT03339401|83139317|FG000|Overall Study|Investigator Decision|1|||
46910056|NCT03339401|83139318|FG001|Overall Study|Investigator Decision|0|||
46910057|NCT03370289|83139324|FG000|Overall Study|Screen Failure|1|||
46910058|NCT03370289|83139324|FG000|Overall Study|Sample Size Sufficient|4|||
46910059|NCT01344824|83139328|FG000|Overall Study|Adverse Event|15|||
46910060|NCT01344824|83139328|FG000|Overall Study|Withdrawal by Subject|6|||
46910061|NCT01344824|83139328|FG000|Overall Study|Other complicating disease|1|||
46910062|NCT01344824|83139328|FG000|Overall Study|Progression|15|||
46910063|NCT03339245|83139335|FG000|Overall Study|Adverse Event|1|||
46910064|NCT03339245|83139336|FG001|Overall Study|Adverse Event|1|||
46910065|NCT03339245|83139335|FG000|Overall Study|Withdrawal by Subject|1|||
46910066|NCT03339245|83139336|FG001|Overall Study|Withdrawal by Subject|0|||
46910067|NCT03044574|83139344|FG000|Overall Study|Lost to Follow-up|37|||
46910068|NCT03044574|83139345|FG001|Overall Study|Lost to Follow-up|45|||
46910069|NCT02959892|83139353|FG000|Overall Study|PET tracer synthesis failure|1|||
46910070|NCT02959892|83139354|FG001|Overall Study|PET tracer synthesis failure|0|||
47009332|NCT02240108|83257946|FG000|Overall Study|Pregnancy|1|||
47009333|NCT02240108|83257947|FG001|Overall Study|Pregnancy|0|||
46910071|NCT02959892|83139353|FG000|Overall Study|Study termination|0|||
47009334|NCT02240108|83257946|FG000|Overall Study|Withdrawal by Subject|4|||
47009335|NCT02240108|83257947|FG001|Overall Study|Withdrawal by Subject|9|||
47009336|NCT02240108|83257946|FG000|Overall Study|StudyTerminated by Sponsor|0|||
47009337|NCT02240108|83257947|FG001|Overall Study|StudyTerminated by Sponsor|1|||
47009338|NCT02239640|83257953|FG000|Overall Study|Withdrawal by Subject|3|||
47009339|NCT02239640|83257953|FG000|Overall Study|Lost to Follow-up|72|||
47009340|NCT02239640|83257953|FG000|Overall Study|Death|142|||
47009341|NCT01590628|83257965|FG000|Overall Study|Death|2|||
47009342|NCT01590628|83257966|FG001|Overall Study|Death|0|||
47009343|NCT02130193|83257978|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
46709534|NCT01217606|82925577|FG000|9-Month Masked Extension|Personal Reasons|2|||
46910072|NCT02959892|83139354|FG001|Overall Study|Study termination|1|||
46910073|NCT03252145|83139362|FG000|Overall Study|Withdrawal by Subject|1|||
46910074|NCT03252145|83139363|FG001|Overall Study|Withdrawal by Subject|0|||
46910075|NCT03252145|83139362|FG000|Overall Study|Complicating Disease|1|||
46910076|NCT03252145|83139363|FG001|Overall Study|Complicating Disease|2|||
46910077|NCT02959814|83139369|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
46910078|NCT02959814|83139369|FG000|Overall Study|Excluded based on anatomical criteria|2|||
46910079|NCT02959814|83139369|FG000|Overall Study|Protocol Violation|7|||
46910080|NCT02959814|83139369|FG000|Overall Study|FFR not measured|2|||
46910081|NCT02959814|83139369|FG000|Overall Study|In-procedure QFR not computed|6|||
46910082|NCT02959814|83139369|FG000|Overall Study|Excluded by FFR core-lab|24|||
46910083|NCT03666624|83139376|FG000|Overall Study|participant grieving over recent death of parent|1|||
46910084|NCT03666624|83139377|FG001|Overall Study|participant grieving over recent death of parent|0|||
46910085|NCT03368807|83139383|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
46910086|NCT03368807|83139383|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
46910087|NCT03368807|83139383|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
46910088|NCT03368807|83139383|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
46910089|NCT03338855|83139391|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
46910090|NCT03338855|83139392|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
46910091|NCT03367793|83139404|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
46910092|NCT03367793|83139405|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
46910093|NCT03367793|83139406|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
46910094|NCT03367793|83139407|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
46910095|NCT03367793|83139408|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
46910096|NCT03367793|83139409|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
46910097|NCT01347307|83139431|FG000|Overall Study|Death|0|||
46910098|NCT01347307|83139432|FG001|Overall Study|Death|4|||
46910099|NCT01347307|83139431|FG000|Overall Study|Physician Decision|0|||
46910100|NCT01347307|83139432|FG001|Overall Study|Physician Decision|1|||
46910101|NCT03247543|83139489|FG000|Overall Study|Adverse Event|3|||
46910102|NCT03247543|83139490|FG001|Overall Study|Adverse Event|6|||
46910103|NCT03247543|83139491|FG002|Overall Study|Adverse Event|4|||
46910104|NCT03247543|83139489|FG000|Overall Study|Lost to Follow-up|10|||
46910105|NCT03247543|83139490|FG001|Overall Study|Lost to Follow-up|7|||
46910106|NCT03247543|83139491|FG002|Overall Study|Lost to Follow-up|8|||
46910107|NCT03247543|83139489|FG000|Overall Study|Consent withdrawn by caregiver|2|||
46910108|NCT03247543|83139490|FG001|Overall Study|Consent withdrawn by caregiver|2|||
46910109|NCT03247543|83139491|FG002|Overall Study|Consent withdrawn by caregiver|9|||
46910110|NCT03247543|83139489|FG000|Overall Study|Withdrawal by Subject|0|||
46910111|NCT03247543|83139490|FG001|Overall Study|Withdrawal by Subject|0|||
46910112|NCT03247543|83139491|FG002|Overall Study|Withdrawal by Subject|1|||
46910113|NCT03247543|83139489|FG000|Overall Study|Failure to Follow study procedures|1|||
46910114|NCT03247543|83139490|FG001|Overall Study|Failure to Follow study procedures|3|||
46910115|NCT03247543|83139491|FG002|Overall Study|Failure to Follow study procedures|1|||
47009344|NCT02130193|83257979|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
46910116|NCT03247543|83139489|FG000|Overall Study|Lack of Efficacy|1|||
46910117|NCT03247543|83139490|FG001|Overall Study|Lack of Efficacy|0|||
46910118|NCT03247543|83139491|FG002|Overall Study|Lack of Efficacy|0|||
46910119|NCT03247543|83139489|FG000|Overall Study|Non-compliance with study visits|0|||
46709535|NCT01217606|82925578|FG001|9-Month Masked Extension|Personal Reasons|1|||
47009345|NCT02130193|83257980|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
47009346|NCT02130193|83257978|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
47009347|NCT02130193|83257979|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
47009348|NCT02130193|83257980|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
47009349|NCT02130193|83257978|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
47009350|NCT02130193|83257979|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
47009351|NCT02130193|83257980|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
47009352|NCT02130193|83257978|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
47009353|NCT02130193|83257979|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
47009354|NCT02130193|83257980|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
47009355|NCT01590082|83257991|FG000|Overall Study|Withdrawal by Subject|1|||
47009356|NCT01590082|83257992|FG001|Overall Study|Withdrawal by Subject|0|||
47009357|NCT01590082|83257991|FG000|Overall Study|Ineligible|1|||
47009358|NCT01590082|83257992|FG001|Overall Study|Ineligible|0|||
47009359|NCT01631474|83258003|FG000|Overall Study|Lost to Follow-up|8|||
47009360|NCT01631474|83258004|FG001|Overall Study|Lost to Follow-up|5|||
47009361|NCT01631474|83258005|FG002|Overall Study|Lost to Follow-up|7|||
47009362|NCT01631474|83258006|FG003|Overall Study|Lost to Follow-up|5|||
47009363|NCT01631474|83258007|FG004|Overall Study|Lost to Follow-up|5|||
47009364|NCT01631474|83258003|FG000|Overall Study|Withdrawal by Subject|4|||
47009365|NCT01631474|83258004|FG001|Overall Study|Withdrawal by Subject|4|||
47009366|NCT01631474|83258005|FG002|Overall Study|Withdrawal by Subject|2|||
47009367|NCT01631474|83258006|FG003|Overall Study|Withdrawal by Subject|6|||
47009368|NCT01631474|83258007|FG004|Overall Study|Withdrawal by Subject|5|||
47009369|NCT01631474|83258003|FG000|Overall Study|Lack of Efficacy|2|||
47009370|NCT01631474|83258004|FG001|Overall Study|Lack of Efficacy|2|||
47009371|NCT01631474|83258005|FG002|Overall Study|Lack of Efficacy|0|||
47009372|NCT01631474|83258006|FG003|Overall Study|Lack of Efficacy|0|||
47009373|NCT01631474|83258007|FG004|Overall Study|Lack of Efficacy|2|||
47009374|NCT01631474|83258003|FG000|Overall Study|Noncompliance with Study Drug|0|||
47009375|NCT01631474|83258004|FG001|Overall Study|Noncompliance with Study Drug|0|||
47009376|NCT01631474|83258005|FG002|Overall Study|Noncompliance with Study Drug|0|||
47009377|NCT01631474|83258006|FG003|Overall Study|Noncompliance with Study Drug|0|||
47009378|NCT01631474|83258007|FG004|Overall Study|Noncompliance with Study Drug|1|||
47009379|NCT01631474|83258003|FG000|Overall Study|Adverse Event|0|||
47009380|NCT01631474|83258004|FG001|Overall Study|Adverse Event|1|||
47009381|NCT01631474|83258005|FG002|Overall Study|Adverse Event|0|||
47009382|NCT01631474|83258006|FG003|Overall Study|Adverse Event|0|||
47009383|NCT01631474|83258007|FG004|Overall Study|Adverse Event|0|||
47009384|NCT02203916|83258022|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
47009385|NCT02203916|83258023|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
47009386|NCT02203916|83258024|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
47009387|NCT02203916|83258022|FG000|Overall Study|Major Protocol Deviation|1|||
47009388|NCT02203916|83258023|FG001|Overall Study|Major Protocol Deviation|1|||
47009389|NCT02203916|83258024|FG002|Overall Study|Major Protocol Deviation|0|||
47009390|NCT02203916|83258022|FG000|Overall Study|Lost to Follow-up|0|||
47009391|NCT02203916|83258023|FG001|Overall Study|Lost to Follow-up|1|||
47009392|NCT02203916|83258024|FG002|Overall Study|Lost to Follow-up|0|||
47009393|NCT02203916|83258022|FG000|Overall Study|Voluntary Withdrawal|3|||
47009394|NCT02203916|83258023|FG001|Overall Study|Voluntary Withdrawal|3|||
47009395|NCT02203916|83258024|FG002|Overall Study|Voluntary Withdrawal|8|||
47009396|NCT02203916|83258022|FG000|Overall Study|Lack of Efficacy|3|||
47009397|NCT02203916|83258023|FG001|Overall Study|Lack of Efficacy|0|||
47009398|NCT02203916|83258024|FG002|Overall Study|Lack of Efficacy|0|||
47009399|NCT02203916|83258022|FG000|Overall Study|Reason Not Specified|0|||
47009400|NCT02203916|83258023|FG001|Overall Study|Reason Not Specified|2|||
47009401|NCT02203916|83258024|FG002|Overall Study|Reason Not Specified|1|||
47009402|NCT02179177|83258048|FG000|Overall Study|Lost to Follow-up|1|||
47009403|NCT02179177|83258049|FG001|Overall Study|Lost to Follow-up|1|||
47009404|NCT02179177|83258048|FG000|Overall Study|Withdrawal by Subject|1|||
47009405|NCT02179177|83258049|FG001|Overall Study|Withdrawal by Subject|1|||
47009406|NCT02239328|83258055|FG000|Overall Study|Benign disease noted at time of surgery|6|||
47009407|NCT02239328|83258055|FG000|Overall Study|Equipment or website malfunction|2|||
47009408|NCT02129803|83258061|FG000|Overall Study|Protocol Violation|4|||
47009409|NCT02129803|83258062|FG001|Overall Study|Protocol Violation|0|||
47009410|NCT02129803|83258061|FG000|Overall Study|Physician Decision|0|||
47009411|NCT02129803|83258062|FG001|Overall Study|Physician Decision|1|||
47009412|NCT02129803|83258061|FG000|Overall Study|Difficulty sleeping|1|||
47009413|NCT02129803|83258062|FG001|Overall Study|Difficulty sleeping|0|||
47009414|NCT02129803|83258061|FG000|Overall Study|Morning headache|0|||
46709536|NCT01217606|82925577|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
47009415|NCT02129803|83258062|FG001|Overall Study|Morning headache|1|||
47009416|NCT02129803|83258061|FG000|Overall Study|Withdrawal by Subject|1|||
47009417|NCT02129803|83258062|FG001|Overall Study|Withdrawal by Subject|1|||
47009418|NCT02239094|83258068|FG000|Overall Study|Withdrawal by Subject|1|||
47009419|NCT02239094|83258068|FG000|Overall Study|Remitted before started|1|||
47009420|NCT02129647|83258072|FG000|Overall Study|Adverse Event|2|||
47009421|NCT02129647|83258072|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
47009422|NCT02238626|83258080|FG000|Overall Study|Adverse Event|3|||
47009423|NCT02238626|83258081|FG001|Overall Study|Adverse Event|5|||
47009424|NCT02238626|83258082|FG002|Overall Study|Adverse Event|0|||
47009425|NCT02238626|83258083|FG003|Overall Study|Adverse Event|3|||
47009426|NCT02238626|83258080|FG000|Overall Study|Lost to Follow-up|2|||
47009427|NCT02238626|83258081|FG001|Overall Study|Lost to Follow-up|4|||
47009428|NCT02238626|83258082|FG002|Overall Study|Lost to Follow-up|2|||
47009429|NCT02238626|83258083|FG003|Overall Study|Lost to Follow-up|2|||
47009430|NCT02238626|83258080|FG000|Overall Study|Withdrawal by Subject|0|||
47009431|NCT02238626|83258081|FG001|Overall Study|Withdrawal by Subject|3|||
47009432|NCT02238626|83258082|FG002|Overall Study|Withdrawal by Subject|0|||
47009433|NCT02238626|83258083|FG003|Overall Study|Withdrawal by Subject|1|||
47009434|NCT02238626|83258080|FG000|Overall Study|Death|0|||
47009435|NCT02238626|83258081|FG001|Overall Study|Death|0|||
47009436|NCT02238626|83258082|FG002|Overall Study|Death|1|||
47009437|NCT02238626|83258083|FG003|Overall Study|Death|1|||
47009438|NCT02238626|83258080|FG000|Overall Study|Other|0|||
47009439|NCT02238626|83258081|FG001|Overall Study|Other|2|||
47009440|NCT02238626|83258082|FG002|Overall Study|Other|0|||
47009441|NCT02238626|83258083|FG003|Overall Study|Other|0|||
47009442|NCT02151643|83258109|FG000|Overall Study|Adverse Event|2|||
46910120|NCT03247543|83139490|FG001|Overall Study|Non-compliance with study visits|1|||
46910121|NCT03247543|83139491|FG002|Overall Study|Non-compliance with study visits|0|||
46910122|NCT01347073|83139501|FG000|Overall Study|Adverse Event|1|||
46910123|NCT01347073|83139501|FG000|Overall Study|Liver Transplant|1|||
46910124|NCT01315236|83139513|FG000|Double-blind Phase|Death|1|||
46910125|NCT01315236|83139514|FG001|Double-blind Phase|Death|0|||
46910126|NCT01315236|83139513|FG000|Double-blind Phase|Adverse Event|1|||
46910127|NCT01315236|83139514|FG001|Double-blind Phase|Adverse Event|0|||
46910128|NCT01315236|83139513|FG000|Double-blind Phase|Withdrawal of Consent|1|||
46910129|NCT01315236|83139514|FG001|Double-blind Phase|Withdrawal of Consent|0|||
46910130|NCT01315236|83139513|FG000|Double-blind Phase|Lost to Follow-up|1|||
46910131|NCT01315236|83139514|FG001|Double-blind Phase|Lost to Follow-up|0|||
46910132|NCT01315236|83139513|FG000|Open-label Phase|Death|1|||
46910133|NCT01315236|83139514|FG001|Open-label Phase|Death|0|||
46910134|NCT01315236|83139513|FG000|Open-label Phase|Adverse Event|0|||
46910135|NCT01315236|83139514|FG001|Open-label Phase|Adverse Event|1|||
46910136|NCT01315236|83139513|FG000|Open-label Phase|Other|0|||
46910137|NCT01315236|83139514|FG001|Open-label Phase|Other|1|||
46910138|NCT01315236|83139513|FG000|12-Month Follow-up Period|Death|0|||
46910139|NCT01315236|83139514|FG001|12-Month Follow-up Period|Death|1|||
46910140|NCT01315236|83139513|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
46910141|NCT01315236|83139514|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
46910142|NCT03232567|83139526|FG000|Overall Study|Withdrawal by Subject|0|||
46910143|NCT03232567|83139527|FG001|Overall Study|Withdrawal by Subject|1|||
46910144|NCT03232567|83139528|FG002|Overall Study|Withdrawal by Subject|0|||
46910145|NCT03232567|83139529|FG003|Overall Study|Withdrawal by Subject|0|||
46910146|NCT01348490|83139539|FG000|Overall Study|Death|1|||
46910147|NCT01348490|83139539|FG000|Overall Study|Adverse Event|3|||
46910148|NCT01348490|83139539|FG000|Overall Study|Consent withdrawn|7|||
46910149|NCT01348490|83139539|FG000|Overall Study|Disease progression|3|||
46910150|NCT01348490|83139539|FG000|Overall Study|Lost to Follow-up|1|||
46910151|NCT01348490|83139539|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
46910152|NCT01348490|83139539|FG000|Overall Study|Other Unspecified|8|||
46910153|NCT03040674|83139560|FG000|Overall Study|Lost to Follow-up|225|||
46910154|NCT03040674|83139560|FG000|Overall Study|Death|23|||
46910155|NCT03232333|83139565|FG000|Overall Study|Infection or Osteomyelitis|9|||
46910156|NCT03232333|83139565|FG000|Overall Study|Lost to Follow-up|4|||
46910157|NCT03232333|83139565|FG000|Overall Study|Withdrawal by Subject|2|||
46910158|NCT03364049|83139573|FG000|Overall Study|Death|6|||
46910159|NCT03364049|83139574|FG001|Overall Study|Death|4|||
46910160|NCT03364049|83139575|FG002|Overall Study|Death|5|||
46910161|NCT03364049|83139576|FG003|Overall Study|Death|14|||
46910162|NCT03364049|83139573|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
46910163|NCT03364049|83139574|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
46910164|NCT03364049|83139575|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
46910165|NCT03364049|83139576|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
46910166|NCT03364049|83139573|FG000|Overall Study|Withdrawal by Subject|0|||
46910167|NCT03364049|83139574|FG001|Overall Study|Withdrawal by Subject|1|||
46910168|NCT03364049|83139575|FG002|Overall Study|Withdrawal by Subject|1|||
46910169|NCT03364049|83139576|FG003|Overall Study|Withdrawal by Subject|1|||
47009443|NCT02151643|83258110|FG001|Overall Study|Adverse Event|0|||
47009444|NCT02151643|83258111|FG002|Overall Study|Adverse Event|1|||
47009445|NCT02151643|83258112|FG003|Overall Study|Adverse Event|4|||
47009446|NCT02151643|83258113|FG004|Overall Study|Adverse Event|0|||
47009447|NCT02151643|83258109|FG000|Overall Study|Withdrawal by Subject|0|||
47009448|NCT02151643|83258110|FG001|Overall Study|Withdrawal by Subject|1|||
47009449|NCT02151643|83258111|FG002|Overall Study|Withdrawal by Subject|1|||
47009450|NCT02151643|83258112|FG003|Overall Study|Withdrawal by Subject|1|||
47009451|NCT02151643|83258113|FG004|Overall Study|Withdrawal by Subject|1|||
47009452|NCT02151643|83258109|FG000|Overall Study|Hyperphosphataemia|1|||
47009453|NCT02151643|83258110|FG001|Overall Study|Hyperphosphataemia|0|||
47009454|NCT02151643|83258111|FG002|Overall Study|Hyperphosphataemia|0|||
47009455|NCT02151643|83258112|FG003|Overall Study|Hyperphosphataemia|0|||
47009456|NCT02151643|83258113|FG004|Overall Study|Hyperphosphataemia|1|||
47009457|NCT02151643|83258109|FG000|Overall Study|High Ferritin levels|3|||
47009458|NCT02151643|83258110|FG001|Overall Study|High Ferritin levels|3|||
47009459|NCT02151643|83258111|FG002|Overall Study|High Ferritin levels|2|||
47009460|NCT02151643|83258112|FG003|Overall Study|High Ferritin levels|2|||
47009461|NCT02151643|83258113|FG004|Overall Study|High Ferritin levels|1|||
47009462|NCT02203838|83258129|FG000|Overall Study|Lack of Efficacy|7|||
47009463|NCT02203838|83258130|FG001|Overall Study|Lack of Efficacy|0|||
47009464|NCT02203838|83258131|FG002|Overall Study|Lack of Efficacy|1|||
47009465|NCT02203838|83258132|FG003|Overall Study|Lack of Efficacy|1|||
47009466|NCT02203838|83258129|FG000|Overall Study|Adverse Event|46|||
47009467|NCT02203838|83258130|FG001|Overall Study|Adverse Event|6|||
47009468|NCT02203838|83258131|FG002|Overall Study|Adverse Event|3|||
47009469|NCT02203838|83258132|FG003|Overall Study|Adverse Event|2|||
47009470|NCT02203838|83258129|FG000|Overall Study|Lost to Follow-up|39|||
47009471|NCT02203838|83258130|FG001|Overall Study|Lost to Follow-up|3|||
47009472|NCT02203838|83258131|FG002|Overall Study|Lost to Follow-up|2|||
47009473|NCT02203838|83258132|FG003|Overall Study|Lost to Follow-up|1|||
47009474|NCT02203838|83258129|FG000|Overall Study|Protocol Violation|7|||
47009475|NCT02203838|83258130|FG001|Overall Study|Protocol Violation|3|||
47009476|NCT02203838|83258131|FG002|Overall Study|Protocol Violation|0|||
47009477|NCT02203838|83258132|FG003|Overall Study|Protocol Violation|0|||
47009478|NCT02203838|83258129|FG000|Overall Study|Withdrawal by Subject|83|||
47009479|NCT02203838|83258130|FG001|Overall Study|Withdrawal by Subject|10|||
47009480|NCT02203838|83258131|FG002|Overall Study|Withdrawal by Subject|8|||
47009481|NCT02203838|83258132|FG003|Overall Study|Withdrawal by Subject|11|||
47009482|NCT02203838|83258129|FG000|Overall Study|Physician Decision|27|||
47009483|NCT02203838|83258130|FG001|Overall Study|Physician Decision|0|||
47009484|NCT02203838|83258131|FG002|Overall Study|Physician Decision|2|||
47009485|NCT02203838|83258132|FG003|Overall Study|Physician Decision|3|||
47009486|NCT02203838|83258129|FG000|Overall Study|Other|1|||
47009487|NCT02203838|83258130|FG001|Overall Study|Other|0|||
47009488|NCT02203838|83258131|FG002|Overall Study|Other|0|||
47009489|NCT02203838|83258132|FG003|Overall Study|Other|0|||
47009490|NCT02178787|83258144|FG000|Overall Study|Lost to Follow-up|1|||
47009491|NCT02178787|83258145|FG001|Overall Study|Lost to Follow-up|0|||
47009492|NCT02178787|83258144|FG000|Overall Study|Withdrawal by Subject|0|||
47009493|NCT02178787|83258145|FG001|Overall Study|Withdrawal by Subject|2|||
47009494|NCT02178787|83258144|FG000|Overall Study|No TCD window|3|||
47009495|NCT02178787|83258145|FG001|Overall Study|No TCD window|7|||
47009496|NCT02178787|83258144|FG000|Overall Study|Physician Decision|1|||
47009497|NCT02178787|83258145|FG001|Overall Study|Physician Decision|0|||
47009498|NCT02178709|83258153|FG000|Overall Study|Adverse Event|5|||
47009499|NCT02178709|83258153|FG000|Overall Study|Death|2|||
47009500|NCT02178709|83258153|FG000|Overall Study|Withdrawal by Subject|2|||
47009501|NCT02178709|83258153|FG000|Overall Study|Physician Decision|2|||
47009502|NCT02178709|83258153|FG000|Overall Study|Disease Progression|5|||
47009503|NCT02238080|83258157|FG000|Overall Study|Death|13|||
47009504|NCT02238080|83258157|FG000|Overall Study|Treatment interrupted|6|||
47009505|NCT02238080|83258157|FG000|Overall Study|Withdrawal by Subject|2|||
47009506|NCT02238080|83258157|FG000|Overall Study|Other|4|||
47009507|NCT02150863|83258164|FG000|Overall Study|Lost to Follow-up|0|||
47009508|NCT02150863|83258165|FG001|Overall Study|Lost to Follow-up|1|||
47009509|NCT02150863|83258166|FG002|Overall Study|Lost to Follow-up|0|||
47009510|NCT02178553|83258176|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
47009511|NCT02178553|83258177|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
47009512|NCT02178553|83258176|FG000|Overall Study|Physician Decision|0|||
47009513|NCT02178553|83258177|FG001|Overall Study|Physician Decision|4|||
47009514|NCT02178553|83258176|FG000|Overall Study|Technical problem with injection|1|||
47009515|NCT02178553|83258177|FG001|Overall Study|Technical problem with injection|3|||
47009516|NCT01627327|83258185|FG000|Overall Study|Adverse Event|6|||
47009517|NCT01627327|83258186|FG001|Overall Study|Adverse Event|12|||
47009518|NCT01627327|83258185|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
47009519|NCT01627327|83258186|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
47009520|NCT01627327|83258185|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
47009521|NCT01627327|83258186|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
47009522|NCT01627327|83258185|FG000|Overall Study|Protocol Violation|4|||
47009523|NCT01627327|83258186|FG001|Overall Study|Protocol Violation|10|||
47009524|NCT01627327|83258185|FG000|Overall Study|Lost to Follow-up|1|||
47009525|NCT01627327|83258186|FG001|Overall Study|Lost to Follow-up|3|||
47009526|NCT01627327|83258185|FG000|Overall Study|Physician Decision|1|||
47009527|NCT01627327|83258186|FG001|Overall Study|Physician Decision|0|||
47009528|NCT01627327|83258185|FG000|Overall Study|Withdrawal by Subject|3|||
47009529|NCT01627327|83258186|FG001|Overall Study|Withdrawal by Subject|3|||
47009530|NCT01627249|83258195|FG000|Overall Study|Death|3|||
47009531|NCT01627249|83258196|FG001|Overall Study|Death|5|||
47009532|NCT01627249|83258197|FG002|Overall Study|Death|3|||
47009533|NCT01627249|83258195|FG000|Overall Study|Withdrawal by Subject|12|||
47009534|NCT01627249|83258196|FG001|Overall Study|Withdrawal by Subject|6|||
47009535|NCT01627249|83258197|FG002|Overall Study|Withdrawal by Subject|9|||
47009536|NCT01627249|83258195|FG000|Overall Study|Missed Visit|1|||
47009537|NCT01627249|83258196|FG001|Overall Study|Missed Visit|1|||
47009538|NCT01627249|83258197|FG002|Overall Study|Missed Visit|0|||
47009539|NCT01688830|83258226|FG000|Overall Study|Lost to Follow-up|0|||
47009540|NCT01688830|83258227|FG001|Overall Study|Lost to Follow-up|0|||
47009541|NCT01688830|83258228|FG002|Overall Study|Lost to Follow-up|0|||
47009542|NCT01688830|83258229|FG003|Overall Study|Lost to Follow-up|0|||
47009543|NCT01688830|83258230|FG004|Overall Study|Lost to Follow-up|0|||
47009544|NCT01688830|83258231|FG005|Overall Study|Lost to Follow-up|0|||
47009545|NCT01688830|83258232|FG006|Overall Study|Lost to Follow-up|0|||
47009546|NCT01688830|83258233|FG007|Overall Study|Lost to Follow-up|0|||
47009547|NCT01688830|83258234|FG008|Overall Study|Lost to Follow-up|0|||
47009548|NCT01688830|83258235|FG009|Overall Study|Lost to Follow-up|0|||
47009549|NCT01688830|83258236|FG010|Overall Study|Lost to Follow-up|1|||
47009550|NCT01688830|83258237|FG011|Overall Study|Lost to Follow-up|0|||
47009551|NCT01688830|83258238|FG012|Overall Study|Lost to Follow-up|0|||
47009552|NCT01688830|83258239|FG013|Overall Study|Lost to Follow-up|0|||
47009553|NCT01688830|83258240|FG014|Overall Study|Lost to Follow-up|0|||
47009554|NCT01688830|83258241|FG015|Overall Study|Lost to Follow-up|0|||
47009555|NCT01688830|83258242|FG016|Overall Study|Lost to Follow-up|0|||
47009556|NCT01688830|83258243|FG017|Overall Study|Lost to Follow-up|0|||
47009557|NCT01688830|83258244|FG018|Overall Study|Lost to Follow-up|0|||
47009558|NCT01688830|83258245|FG019|Overall Study|Lost to Follow-up|0|||
47009559|NCT01688830|83258246|FG020|Overall Study|Lost to Follow-up|0|||
47009560|NCT02178475|83258330|FG000|Overall Study|Withdrawal by Subject|7|||
47009561|NCT02178475|83258330|FG000|Overall Study|Lost to Follow-up|10|||
47009562|NCT02178475|83258330|FG000|Overall Study|Death|13|||
47009563|NCT02178475|83258330|FG000|Overall Study|Protocol-specified Criteria|99|||
47009564|NCT01569022|83258334|FG000|First Intervention|Lost to Follow-up|2|||
47009565|NCT01569022|83258335|FG001|First Intervention|Lost to Follow-up|1|||
47009566|NCT01569022|83258334|FG000|Second Intervention|Lost to Follow-up|2|||
47009567|NCT01569022|83258335|FG001|Second Intervention|Lost to Follow-up|2|||
47009568|NCT01629823|83258346|FG000|Trial Period|Missed visit|11|||
47009569|NCT01629823|83258347|FG001|Trial Period|Missed visit|9|||
47009570|NCT01629823|83258348|FG002|Trial Period|Missed visit|8|||
47009571|NCT01629823|83258346|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
47009572|NCT01629823|83258347|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
47009573|NCT01629823|83258348|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
47009574|NCT01629823|83258346|FG000|Trial Period|Pregnancy|1|||
47009575|NCT01629823|83258347|FG001|Trial Period|Pregnancy|0|||
47009576|NCT01629823|83258348|FG002|Trial Period|Pregnancy|0|||
47009577|NCT01629823|83258346|FG000|Trial Period|Adverse Event|0|||
47009578|NCT01629823|83258347|FG001|Trial Period|Adverse Event|1|||
47009579|NCT01629823|83258348|FG002|Trial Period|Adverse Event|0|||
47009580|NCT01629823|83258346|FG000|Trial Period|Out-of-window visit|0|||
47009581|NCT01629823|83258347|FG001|Trial Period|Out-of-window visit|2|||
47009582|NCT01629823|83258348|FG002|Trial Period|Out-of-window visit|0|||
47009583|NCT01629823|83258346|FG000|Trial Period|Failed to hold medication|0|||
47009584|NCT01629823|83258347|FG001|Trial Period|Failed to hold medication|0|||
47009585|NCT01629823|83258348|FG002|Trial Period|Failed to hold medication|1|||
47009586|NCT01629823|83258346|FG000|Washout Period|Safety|2|||
47009587|NCT01629823|83258347|FG001|Washout Period|Safety|5|||
47009588|NCT01629823|83258348|FG002|Washout Period|Safety|0|||
47009589|NCT01629823|83258346|FG000|Washout Period|Pregnancy|1|||
47009590|NCT01629823|83258347|FG001|Washout Period|Pregnancy|0|||
47009591|NCT01629823|83258348|FG002|Washout Period|Pregnancy|0|||
47009592|NCT01629823|83258346|FG000|Washout Period|Protocol Violation|0|||
47009593|NCT01629823|83258347|FG001|Washout Period|Protocol Violation|1|||
47009594|NCT01629823|83258348|FG002|Washout Period|Protocol Violation|0|||
47009595|NCT01688050|83258356|FG000|Overall Study|Death|7|||
47009596|NCT01688050|83258356|FG000|Overall Study|Conversion to open repair|1|||
47009597|NCT01688050|83258356|FG000|Overall Study|Lost to Follow-up|13|||
47009598|NCT01688050|83258356|FG000|Overall Study|Withdrawal by Subject|10|||
47009599|NCT01604278|83258362|FG000|Overall Study|Lack of Efficacy|0|||
47009600|NCT01604278|83258363|FG001|Overall Study|Lack of Efficacy|1|||
47009601|NCT01604278|83258362|FG000|Overall Study|Lost to Follow-up|1|||
47009602|NCT01604278|83258363|FG001|Overall Study|Lost to Follow-up|0|||
47009603|NCT01604278|83258362|FG000|Overall Study|Administrative problems|2|||
47009604|NCT01604278|83258363|FG001|Overall Study|Administrative problems|1|||
47009605|NCT01604278|83258362|FG000|Overall Study|Withdrawal by Subject|3|||
47009606|NCT01604278|83258363|FG001|Overall Study|Withdrawal by Subject|3|||
47009607|NCT01604278|83258362|FG000|Overall Study|Adverse Event|3|||
47009608|NCT01604278|83258363|FG001|Overall Study|Adverse Event|5|||
47009609|NCT01604278|83258362|FG000|Overall Study|Protocol Deviation|5|||
47009610|NCT01604278|83258363|FG001|Overall Study|Protocol Deviation|3|||
47009611|NCT01687270|83258369|FG000|Overall Study|Lack of Efficacy|11|||
47009612|NCT01687270|83258369|FG000|Overall Study|Lost to Follow-up|1|||
47009613|NCT01589770|83258375|FG000|Overall Study|EGFR <60ml/min|6|||
47009614|NCT01589770|83258376|FG001|Overall Study|EGFR <60ml/min|4|||
47009615|NCT01589770|83258375|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
47009616|NCT01589770|83258376|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
47009617|NCT01588990|83258382|FG000|Phase A|Withdrawal by Subject|5|||
47009618|NCT01588990|83258382|FG000|Phase A|Physician Decision|11|||
47009619|NCT01588990|83258382|FG000|Phase A|Other|14|||
47009620|NCT01588990|83258382|FG000|Phase A|Lost to Follow-up|1|||
47009621|NCT01588990|83258382|FG000|Phase A|Death|5|||
47009622|NCT01588990|83258382|FG000|Phase A|Adverse Event|28|||
47009623|NCT01588990|83258382|FG000|Phase A|Still on therapy at end of study|6|||
47009624|NCT01588990|83258382|FG000|Phase B|Adverse Event|2|||
47009625|NCT01588990|83258382|FG000|Phase B|Still on therapy at end of study|5|||
47009626|NCT01588990|83258382|FG000|Phase B|Withdrawal by Subject|3|||
47009627|NCT01588990|83258382|FG000|Phase B|Physician Decision|4|||
47009628|NCT01588990|83258382|FG000|Phase B|Other|2|||
47009629|NCT02176525|83258398|FG000|Overall Study|Adverse Event|0|||
47009630|NCT02176525|83258399|FG001|Overall Study|Adverse Event|0|||
47009631|NCT02176525|83258400|FG002|Overall Study|Adverse Event|0|||
47009632|NCT02176525|83258401|FG003|Overall Study|Adverse Event|1|||
47009633|NCT02176525|83258402|FG004|Overall Study|Adverse Event|1|||
47009634|NCT02176525|83258403|FG005|Overall Study|Adverse Event|0|||
47009635|NCT02176525|83258404|FG006|Overall Study|Adverse Event|1|||
47009636|NCT02176525|83258405|FG007|Overall Study|Adverse Event|0|||
47009637|NCT02176525|83258398|FG000|Overall Study|not treated|1|||
47009638|NCT02176525|83258399|FG001|Overall Study|not treated|0|||
47009639|NCT02176525|83258400|FG002|Overall Study|not treated|0|||
47009640|NCT02176525|83258401|FG003|Overall Study|not treated|0|||
47009641|NCT02176525|83258402|FG004|Overall Study|not treated|0|||
47009642|NCT02176525|83258403|FG005|Overall Study|not treated|1|||
47009643|NCT02176525|83258404|FG006|Overall Study|not treated|0|||
47009644|NCT02176525|83258405|FG007|Overall Study|not treated|0|||
47009645|NCT02127931|83258431|FG000|Overall Study|Glitch in Game|1|||
47009646|NCT02127307|83258436|FG000|Overall Study|Protocol Violation|36|||
47009647|NCT02127307|83258436|FG000|Overall Study|Lost to Follow-up|2|||
47009648|NCT02127307|83258436|FG000|Overall Study|Death|101|||
47009649|NCT02127307|83258436|FG000|Overall Study|Other than specified above|169|||
47009650|NCT02126839|83258442|FG000|Overall Study|Adverse Event|0|||
47009651|NCT02126839|83258443|FG001|Overall Study|Adverse Event|1|||
47009652|NCT02126839|83258442|FG000|Overall Study|Withdrawal by Subject|1|||
47009653|NCT02126839|83258443|FG001|Overall Study|Withdrawal by Subject|0|||
47009654|NCT02126839|83258442|FG000|Overall Study|Withdrawal by parent/guardian|1|||
47009655|NCT02126839|83258443|FG001|Overall Study|Withdrawal by parent/guardian|0|||
47009656|NCT02126839|83258442|FG000|Overall Study|Protocol Violation|2|||
47009657|NCT02126839|83258443|FG001|Overall Study|Protocol Violation|3|||
47009658|NCT02126839|83258442|FG000|Overall Study|Sponsor request|0|||
47009659|NCT02126839|83258443|FG001|Overall Study|Sponsor request|1|||
47009660|NCT02126839|83258442|FG000|Overall Study|Lost to Follow-up|1|||
46620509|NCT02536300|82769742|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
46620510|NCT02536300|82769740|FG000|Overall Study|Enrolled but Never Treated|0|||
47009661|NCT02126839|83258443|FG001|Overall Study|Lost to Follow-up|4|||
47009662|NCT02126839|83258442|FG000|Overall Study|Other|5|||
47009663|NCT02126839|83258443|FG001|Overall Study|Other|5|||
47009664|NCT02125279|83258449|FG000|Overall Study|Lack of Efficacy|2|||
47009665|NCT02125279|83258449|FG000|Overall Study|Withdrawal by Subject|6|||
47009666|NCT02125279|83258449|FG000|Overall Study|Protocol Violation|1|||
47009667|NCT02125279|83258449|FG000|Overall Study|Lost to Follow-up|4|||
47009668|NCT02124811|83258457|FG000|Overall Study|Early termination|2|||
47009669|NCT02124811|83258458|FG001|Overall Study|Early termination|2|||
47009670|NCT02124811|83258457|FG000|Overall Study|Withdrawal by Subject|1|||
47009671|NCT02124811|83258458|FG001|Overall Study|Withdrawal by Subject|0|||
47009672|NCT02148445|83258466|FG000|Overall Study|Death|1|||
47009673|NCT02148445|83258467|FG001|Overall Study|Death|3|||
47009674|NCT02148211|83258475|FG000|Overall Study|Lost to Follow-up|352|||
47009675|NCT02147587|83258481|FG000|Overall Study|Adverse Event|9|||
47009676|NCT02147587|83258482|FG001|Overall Study|Adverse Event|4|||
47009677|NCT02147587|83258481|FG000|Overall Study|Lack of Efficacy|2|||
47009678|NCT02147587|83258482|FG001|Overall Study|Lack of Efficacy|1|||
47009679|NCT02147353|83258490|FG000|Overall Study|Lost to Follow-up|2|||
47009680|NCT02147353|83258491|FG001|Overall Study|Lost to Follow-up|0|||
47009681|NCT02147353|83258490|FG000|Overall Study|unable to make visits|4|||
47009682|NCT02147353|83258491|FG001|Overall Study|unable to make visits|0|||
47009683|NCT02147353|83258490|FG000|Overall Study|medication noncompliance|3|||
47009684|NCT02147353|83258491|FG001|Overall Study|medication noncompliance|0|||
47009685|NCT02147197|83258500|FG000|Overall Study|Adverse Event|1|||
47009686|NCT02147197|83258501|FG001|Overall Study|Adverse Event|0|||
47009687|NCT02147197|83258502|FG002|Overall Study|Adverse Event|0|||
47009688|NCT02147197|83258500|FG000|Overall Study|Withdrawal of Consent|4|||
47009689|NCT02147197|83258501|FG001|Overall Study|Withdrawal of Consent|3|||
47009690|NCT02147197|83258502|FG002|Overall Study|Withdrawal of Consent|2|||
47009691|NCT02147197|83258500|FG000|Overall Study|Lost to Follow-up|2|||
47009692|NCT02147197|83258501|FG001|Overall Study|Lost to Follow-up|3|||
47009693|NCT02147197|83258502|FG002|Overall Study|Lost to Follow-up|1|||
47009694|NCT02147197|83258500|FG000|Overall Study|Protocol Violation|1|||
47009695|NCT02147197|83258501|FG001|Overall Study|Protocol Violation|0|||
47009696|NCT02147197|83258502|FG002|Overall Study|Protocol Violation|3|||
47009697|NCT02147197|83258500|FG000|Overall Study|Other Miscellaneous Reasons|1|||
47009698|NCT02147197|83258501|FG001|Overall Study|Other Miscellaneous Reasons|0|||
47009699|NCT02147197|83258502|FG002|Overall Study|Other Miscellaneous Reasons|3|||
47009700|NCT02176291|83258512|FG000|Overall Study|Death|1|||
47009701|NCT02176291|83258513|FG001|Overall Study|Death|0|||
47009702|NCT02176291|83258512|FG000|Overall Study|non compliance with protocol|2|||
47009703|NCT02176291|83258513|FG001|Overall Study|non compliance with protocol|0|||
47009704|NCT02176291|83258512|FG000|Overall Study|Withdrawal by Subject|2|||
47009705|NCT02176291|83258513|FG001|Overall Study|Withdrawal by Subject|0|||
47009706|NCT02175745|83258519|FG000|Overall Study|Not Eligible|1|||
47009707|NCT02175277|83258523|FG000|Overall Study|Protocol-specified Criteria|1|||
47009708|NCT02124265|83258527|FG000|Overall Study|Adverse Event|1|||
47009709|NCT02146105|83258531|FG000|Overall Study|Adverse Event|1|||
47009710|NCT02146105|83258531|FG000|Overall Study|Withdrawal by Subject|5|||
47009711|NCT02175199|83258537|FG000|Overall Study|Withdrawal by Subject|1|||
47009712|NCT02175199|83258538|FG001|Overall Study|Withdrawal by Subject|5|||
47009713|NCT02175199|83258537|FG000|Overall Study|Randomized in Error|1|||
47009714|NCT02175199|83258538|FG001|Overall Study|Randomized in Error|0|||
47009715|NCT02175199|83258537|FG000|Overall Study|Sponsor Decision|1|||
47009716|NCT02175199|83258538|FG001|Overall Study|Sponsor Decision|0|||
47009717|NCT02123797|83258547|FG000|Baseline Intervention|Death|9|||
47009718|NCT02123797|83258548|FG001|Baseline Intervention|Death|16|||
47009719|NCT02123797|83258549|FG002|Baseline Intervention|Death|0|||
47009720|NCT02123797|83258550|FG003|Baseline Intervention|Death|0|||
47009721|NCT02123797|83258551|FG004|Baseline Intervention|Death|0|||
47009722|NCT02123797|83258547|FG000|Baseline Intervention|Withdrawal by Subject|2|||
47009723|NCT02123797|83258548|FG001|Baseline Intervention|Withdrawal by Subject|8|||
47009724|NCT02123797|83258549|FG002|Baseline Intervention|Withdrawal by Subject|0|||
47009725|NCT02123797|83258550|FG003|Baseline Intervention|Withdrawal by Subject|0|||
46620511|NCT02536300|82769741|FG001|Overall Study|Enrolled but Never Treated|0|||
46620512|NCT02536300|82769742|FG002|Overall Study|Enrolled but Never Treated|1|||
46709537|NCT01217606|82925578|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
46709538|NCT01217606|82925577|FG000|9-Month Masked Extension|Pregnancy|1|||
47009726|NCT02123797|83258551|FG004|Baseline Intervention|Withdrawal by Subject|0|||
47009727|NCT02123797|83258547|FG000|Baseline Intervention|Relocation|2|||
47009728|NCT02123797|83258548|FG001|Baseline Intervention|Relocation|0|||
47009729|NCT02123797|83258549|FG002|Baseline Intervention|Relocation|0|||
47009730|NCT02123797|83258550|FG003|Baseline Intervention|Relocation|0|||
47009731|NCT02123797|83258551|FG004|Baseline Intervention|Relocation|0|||
47009732|NCT02123797|83258547|FG000|Baseline Intervention|Out of window for initial survey|6|||
47009733|NCT02123797|83258548|FG001|Baseline Intervention|Out of window for initial survey|13|||
47009734|NCT02123797|83258549|FG002|Baseline Intervention|Out of window for initial survey|0|||
47009735|NCT02123797|83258550|FG003|Baseline Intervention|Out of window for initial survey|0|||
47009736|NCT02123797|83258551|FG004|Baseline Intervention|Out of window for initial survey|0|||
47009737|NCT02123797|83258547|FG000|Baseline Intervention|Lost to Follow-up|0|||
47009738|NCT02123797|83258548|FG001|Baseline Intervention|Lost to Follow-up|5|||
47009739|NCT02123797|83258549|FG002|Baseline Intervention|Lost to Follow-up|0|||
47009740|NCT02123797|83258550|FG003|Baseline Intervention|Lost to Follow-up|0|||
47009741|NCT02123797|83258551|FG004|Baseline Intervention|Lost to Follow-up|0|||
47009742|NCT02123797|83258547|FG000|Baseline Intervention|Other Disease|3|||
47009743|NCT02123797|83258548|FG001|Baseline Intervention|Other Disease|0|||
47009744|NCT02123797|83258549|FG002|Baseline Intervention|Other Disease|0|||
47009745|NCT02123797|83258550|FG003|Baseline Intervention|Other Disease|0|||
47009746|NCT02123797|83258551|FG004|Baseline Intervention|Other Disease|0|||
47009747|NCT02123797|83258547|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
47009748|NCT02123797|83258548|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
47009749|NCT02123797|83258549|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
47009750|NCT02123797|83258550|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
47009751|NCT02123797|83258551|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
47009752|NCT02123797|83258547|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
47009753|NCT02123797|83258548|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
47009754|NCT02123797|83258549|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
47009755|NCT02123797|83258550|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
47009756|NCT02123797|83258551|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
47009757|NCT02123797|83258547|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
47009758|NCT02123797|83258548|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
47009759|NCT02123797|83258549|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
47009760|NCT02123797|83258550|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
47009761|NCT02123797|83258551|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
47009762|NCT02123797|83258547|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
47009763|NCT02123797|83258548|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
47009764|NCT02123797|83258549|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
47009765|NCT02123797|83258550|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
46910170|NCT03238963|83139588|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
46910171|NCT03238963|83139589|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
46910172|NCT03238963|83139588|FG000|Overall Study|Withdrawal by Subject|1|||
46910173|NCT03238963|83139589|FG001|Overall Study|Withdrawal by Subject|1|||
46910174|NCT03238963|83139588|FG000|Overall Study|Lost to Follow-up|1|||
46910175|NCT03238963|83139589|FG001|Overall Study|Lost to Follow-up|0|||
46910176|NCT03238963|83139588|FG000|Overall Study|Protocol Violation|1|||
46910177|NCT03238963|83139589|FG001|Overall Study|Protocol Violation|1|||
46910178|NCT03238963|83139588|FG000|Overall Study|Adverse Event|1|||
46910179|NCT03238963|83139589|FG001|Overall Study|Adverse Event|0|||
46910180|NCT03337139|83139597|FG000|Phase I|Withdrawal by Subject|10|||
46910181|NCT03337139|83139598|FG001|Phase I|Withdrawal by Subject|0|||
46910182|NCT03042312|83139606|FG000|Overall Study|Administrative Reason|1|||
46910183|NCT03042312|83139607|FG001|Overall Study|Administrative Reason|1|||
46910184|NCT03042312|83139606|FG000|Overall Study|Adverse Event|0|||
46910185|NCT03042312|83139607|FG001|Overall Study|Adverse Event|1|||
46910186|NCT03042312|83139606|FG000|Overall Study|Lost to Follow-up|1|||
46910187|NCT03042312|83139607|FG001|Overall Study|Lost to Follow-up|3|||
46910188|NCT03042312|83139606|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
46910189|NCT03042312|83139607|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
46910190|NCT03042312|83139606|FG000|Overall Study|Withdrawal by Subject|4|||
46910191|NCT03042312|83139607|FG001|Overall Study|Withdrawal by Subject|5|||
46910192|NCT03360071|83139615|FG000|Overall Study|Lost to Follow-up|1|||
46910193|NCT03360071|83139616|FG001|Overall Study|Lost to Follow-up|0|||
46910194|NCT02949011|83139625|FG000|Overall Study|Adverse Event|6|||
46910195|NCT02949011|83139626|FG001|Overall Study|Adverse Event|7|||
46910196|NCT02949011|83139627|FG002|Overall Study|Adverse Event|3|||
46910197|NCT02949011|83139625|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
46910198|NCT02949011|83139626|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
46910199|NCT02949011|83139627|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
46910200|NCT02949011|83139625|FG000|Overall Study|Protocol Deviation|5|||
46910201|NCT02949011|83139626|FG001|Overall Study|Protocol Deviation|3|||
46910202|NCT02949011|83139627|FG002|Overall Study|Protocol Deviation|3|||
46910203|NCT02949011|83139625|FG000|Overall Study|Lack of Efficacy|0|||
46910204|NCT02949011|83139626|FG001|Overall Study|Lack of Efficacy|2|||
46910205|NCT02949011|83139627|FG002|Overall Study|Lack of Efficacy|0|||
46910206|NCT02949011|83139625|FG000|Overall Study|Withdrawal by Subject|13|||
47009766|NCT02123797|83258551|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
47009767|NCT02123797|83258547|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
47009768|NCT02123797|83258548|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
47009769|NCT02123797|83258549|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
47009770|NCT02123797|83258550|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
47009771|NCT02123797|83258551|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
47009772|NCT02123797|83258547|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
47009773|NCT02123797|83258548|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
47009774|NCT02123797|83258549|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
47009775|NCT02123797|83258550|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
47009776|NCT02123797|83258551|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
47009777|NCT02123797|83258547|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
47009778|NCT02123797|83258548|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
47009779|NCT02123797|83258549|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
47009780|NCT02123797|83258550|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
47009781|NCT02123797|83258551|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
47009782|NCT02123797|83258547|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
47009783|NCT02123797|83258548|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
47009784|NCT02123797|83258549|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
47009785|NCT02123797|83258550|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
47009786|NCT02123797|83258551|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
47009787|NCT02123797|83258547|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
47009788|NCT02123797|83258548|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
47009789|NCT02123797|83258549|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
47009790|NCT02123797|83258550|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
47009791|NCT02123797|83258551|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
47009792|NCT02175121|83258576|FG000|Overall Study|Lack of Efficacy|1|||
47009793|NCT02175121|83258577|FG001|Overall Study|Lack of Efficacy|0|||
47009794|NCT02175121|83258578|FG002|Overall Study|Lack of Efficacy|0|||
47009795|NCT02175121|83258579|FG003|Overall Study|Lack of Efficacy|0|||
47009796|NCT02175121|83258580|FG004|Overall Study|Lack of Efficacy|0|||
47009797|NCT02175121|83258576|FG000|Overall Study|Lost to Follow-up|0|||
47009798|NCT02175121|83258577|FG001|Overall Study|Lost to Follow-up|1|||
47009799|NCT02175121|83258578|FG002|Overall Study|Lost to Follow-up|0|||
47009800|NCT02175121|83258579|FG003|Overall Study|Lost to Follow-up|1|||
47009801|NCT02175121|83258580|FG004|Overall Study|Lost to Follow-up|0|||
47009802|NCT02175121|83258576|FG000|Overall Study|Personal emergency|0|||
47009803|NCT02175121|83258577|FG001|Overall Study|Personal emergency|0|||
47009804|NCT02175121|83258578|FG002|Overall Study|Personal emergency|0|||
47009805|NCT02175121|83258579|FG003|Overall Study|Personal emergency|0|||
47009806|NCT02175121|83258580|FG004|Overall Study|Personal emergency|1|||
47009807|NCT02175121|83258576|FG000|Overall Study|Schedule conflict|0|||
47009808|NCT02175121|83258577|FG001|Overall Study|Schedule conflict|0|||
47009809|NCT02175121|83258578|FG002|Overall Study|Schedule conflict|1|||
47009810|NCT02175121|83258579|FG003|Overall Study|Schedule conflict|0|||
47009811|NCT02175121|83258580|FG004|Overall Study|Schedule conflict|0|||
47009812|NCT02175121|83258576|FG000|Overall Study|Time issues|0|||
47009813|NCT02175121|83258577|FG001|Overall Study|Time issues|0|||
47009814|NCT02175121|83258578|FG002|Overall Study|Time issues|1|||
47009815|NCT02175121|83258579|FG003|Overall Study|Time issues|0|||
47009816|NCT02175121|83258580|FG004|Overall Study|Time issues|0|||
47009817|NCT01568866|83258598|FG000|Overall Study|Disease Progression|208|||
47009818|NCT01568866|83258599|FG001|Overall Study|Disease Progression|183|||
47009819|NCT01568866|83258598|FG000|Overall Study|Adverse Event|94|||
47009820|NCT01568866|83258599|FG001|Overall Study|Adverse Event|96|||
47009821|NCT01568866|83258598|FG000|Overall Study|Patient Request|55|||
47009822|NCT01568866|83258599|FG001|Overall Study|Patient Request|71|||
47009823|NCT01568866|83258598|FG000|Overall Study|Physician Decision|40|||
47009824|NCT01568866|83258599|FG001|Overall Study|Physician Decision|32|||
47009825|NCT01568866|83258598|FG000|Overall Study|Withdrawal by Subject|19|||
47009826|NCT01568866|83258599|FG001|Overall Study|Withdrawal by Subject|11|||
47009827|NCT01568866|83258598|FG000|Overall Study|Death|10|||
47009828|NCT01568866|83258599|FG001|Overall Study|Death|18|||
47009829|NCT01568866|83258598|FG000|Overall Study|Protocol Non-compliance|2|||
47009830|NCT01568866|83258599|FG001|Overall Study|Protocol Non-compliance|4|||
47009831|NCT01568866|83258598|FG000|Overall Study|Lost to Follow-up|1|||
47009832|NCT01568866|83258599|FG001|Overall Study|Lost to Follow-up|0|||
47009833|NCT01568866|83258598|FG000|Overall Study|Randomized but Not Dosed|9|||
47009834|NCT01568866|83258599|FG001|Overall Study|Randomized but Not Dosed|1|||
47009835|NCT01568320|83258605|FG000|Overall Study|Death|20|||
47009836|NCT01568320|83258605|FG000|Overall Study|Lost to Follow-up|9|||
47009837|NCT01568320|83258605|FG000|Overall Study|Withdrawal by Subject|10|||
47009838|NCT01568320|83258605|FG000|Overall Study|Conversion to open repair|1|||
47009839|NCT01568320|83258605|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
47009840|NCT01567852|83258611|FG000|Overall Study|Withdrawal by Subject|3|||
47009841|NCT01567852|83258612|FG001|Overall Study|Withdrawal by Subject|6|||
47009842|NCT01567852|83258611|FG000|Overall Study|ECT discontinued|1|||
47009843|NCT01567852|83258612|FG001|Overall Study|ECT discontinued|1|||
47009844|NCT01588366|83258623|FG000|Overall Study|Adverse Event|0|||
47009845|NCT01588366|83258624|FG001|Overall Study|Adverse Event|1|||
47009846|NCT01588366|83258625|FG002|Overall Study|Adverse Event|0|||
47009847|NCT01588366|83258626|FG003|Overall Study|Adverse Event|1|||
47009848|NCT01588366|83258627|FG004|Overall Study|Adverse Event|0|||
47009849|NCT01588366|83258628|FG005|Overall Study|Adverse Event|2|||
47009850|NCT01686958|83258644|FG000|Overall Study|Withdrawal by Subject|1|||
47009851|NCT01686568|83258651|FG000|Main Study|Withdrawal by Subject|1|||
47009852|NCT01686568|83258652|FG001|Main Study|Withdrawal by Subject|3|||
47009853|NCT01686568|83258651|FG000|Main Study|Noncompliance with protocol|0|||
47009854|NCT01686568|83258652|FG001|Main Study|Noncompliance with protocol|1|||
47009855|NCT01686568|83258651|FG000|Main Study|Liver enzymes above range of exclusion|1|||
47009856|NCT01686568|83258652|FG001|Main Study|Liver enzymes above range of exclusion|0|||
47009857|NCT01686568|83258651|FG000|Sub-Study|Not consented for sub-study|2|||
47009858|NCT01686568|83258652|FG001|Sub-Study|Not consented for sub-study|2|||
47009859|NCT01567462|83258660|FG000|Overall Study|Withdrawal by Subject|4|||
47009860|NCT01567462|83258661|FG001|Overall Study|Withdrawal by Subject|7|||
47009861|NCT01587898|83258671|FG000|Overall Study|Adverse Event|1|||
47009862|NCT01587898|83258672|FG001|Overall Study|Adverse Event|1|||
47009863|NCT01587898|83258673|FG002|Overall Study|Adverse Event|0|||
47009864|NCT01587898|83258674|FG003|Overall Study|Adverse Event|0|||
47009865|NCT01587898|83258671|FG000|Overall Study|Protocol Violation|0|||
47009866|NCT01587898|83258672|FG001|Overall Study|Protocol Violation|2|||
47009867|NCT01587898|83258673|FG002|Overall Study|Protocol Violation|1|||
47009868|NCT01587898|83258674|FG003|Overall Study|Protocol Violation|1|||
47009869|NCT01587898|83258671|FG000|Overall Study|Lost to Follow-up|0|||
47009870|NCT01587898|83258672|FG001|Overall Study|Lost to Follow-up|0|||
47009871|NCT01587898|83258673|FG002|Overall Study|Lost to Follow-up|0|||
47009872|NCT01587898|83258674|FG003|Overall Study|Lost to Follow-up|1|||
47009873|NCT01587898|83258671|FG000|Overall Study|Withdrawal by Subject|2|||
47009874|NCT01587898|83258672|FG001|Overall Study|Withdrawal by Subject|1|||
47009875|NCT01587898|83258673|FG002|Overall Study|Withdrawal by Subject|0|||
47009876|NCT01587898|83258674|FG003|Overall Study|Withdrawal by Subject|0|||
47009877|NCT01587898|83258671|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
47009878|NCT01587898|83258672|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
47009879|NCT01587898|83258673|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
47009880|NCT01587898|83258674|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
47009881|NCT01567306|83258693|FG000|Overall Study|Protocol Violation|2|||
47009882|NCT01567306|83258694|FG001|Overall Study|Protocol Violation|2|||
47009883|NCT01567306|83258695|FG002|Overall Study|Protocol Violation|0|||
47009884|NCT01567306|83258696|FG003|Overall Study|Protocol Violation|3|||
47009885|NCT01567306|83258697|FG004|Overall Study|Protocol Violation|1|||
47009886|NCT01567306|83258698|FG005|Overall Study|Protocol Violation|1|||
47009887|NCT01567306|83258693|FG000|Overall Study|Change site living|1|||
47009888|NCT01567306|83258694|FG001|Overall Study|Change site living|0|||
47009889|NCT01567306|83258695|FG002|Overall Study|Change site living|0|||
47009890|NCT01567306|83258696|FG003|Overall Study|Change site living|0|||
47009891|NCT01567306|83258697|FG004|Overall Study|Change site living|0|||
46910207|NCT02949011|83139626|FG001|Overall Study|Withdrawal by Subject|13|||
46910208|NCT02949011|83139627|FG002|Overall Study|Withdrawal by Subject|21|||
46910209|NCT02949011|83139625|FG000|Overall Study|Lost to Follow-up|7|||
46910210|NCT02949011|83139626|FG001|Overall Study|Lost to Follow-up|5|||
47009892|NCT01567306|83258698|FG005|Overall Study|Change site living|0|||
47009893|NCT01567306|83258693|FG000|Overall Study|Adverse Event|0|||
47009894|NCT01567306|83258694|FG001|Overall Study|Adverse Event|0|||
47009895|NCT01567306|83258695|FG002|Overall Study|Adverse Event|0|||
47009896|NCT01567306|83258696|FG003|Overall Study|Adverse Event|2|||
47009897|NCT01567306|83258697|FG004|Overall Study|Adverse Event|4|||
47009898|NCT01567306|83258698|FG005|Overall Study|Adverse Event|1|||
47009899|NCT01567306|83258693|FG000|Overall Study|Lost to Follow-up|0|||
47009900|NCT01567306|83258694|FG001|Overall Study|Lost to Follow-up|0|||
47009901|NCT01567306|83258695|FG002|Overall Study|Lost to Follow-up|0|||
47009902|NCT01567306|83258696|FG003|Overall Study|Lost to Follow-up|0|||
47009903|NCT01567306|83258697|FG004|Overall Study|Lost to Follow-up|2|||
46910211|NCT02949011|83139627|FG002|Overall Study|Lost to Follow-up|5|||
47009904|NCT01567306|83258698|FG005|Overall Study|Lost to Follow-up|0|||
47009905|NCT01567306|83258693|FG000|Overall Study|Withdrawal by Subject|0|||
47009906|NCT01567306|83258694|FG001|Overall Study|Withdrawal by Subject|0|||
47009907|NCT01567306|83258695|FG002|Overall Study|Withdrawal by Subject|0|||
47009908|NCT01567306|83258696|FG003|Overall Study|Withdrawal by Subject|0|||
47009909|NCT01567306|83258697|FG004|Overall Study|Withdrawal by Subject|0|||
47009910|NCT01567306|83258698|FG005|Overall Study|Withdrawal by Subject|1|||
47009911|NCT01587274|83258715|FG000|Overall Study|Lost to Follow-up|4|||
47009912|NCT01587274|83258716|FG001|Overall Study|Lost to Follow-up|5|||
47009913|NCT01587274|83258717|FG002|Overall Study|Lost to Follow-up|3|||
47009914|NCT01587118|83258725|FG000|Overall Study|Adverse Event|3|||
47009915|NCT01587118|83258725|FG000|Overall Study|Lost to Follow-up|2|||
47009916|NCT01587118|83258725|FG000|Overall Study|Relocation|1|||
47009917|NCT01587118|83258725|FG000|Overall Study|nonresponse|1|||
47009918|NCT01905657|83258732|FG000|Overall Study|Adverse Event|23|||
47009919|NCT01905657|83258733|FG001|Overall Study|Adverse Event|17|||
47009920|NCT01905657|83258734|FG002|Overall Study|Adverse Event|18|||
47009921|NCT01905657|83258732|FG000|Overall Study|Clinical Progression|103|||
47009922|NCT01905657|83258733|FG001|Overall Study|Clinical Progression|78|||
47009923|NCT01905657|83258734|FG002|Overall Study|Clinical Progression|59|||
47009924|NCT01905657|83258732|FG000|Overall Study|Death|40|||
47009925|NCT01905657|83258733|FG001|Overall Study|Death|43|||
47009926|NCT01905657|83258734|FG002|Overall Study|Death|47|||
47009927|NCT01905657|83258732|FG000|Overall Study|Excluded Medication|13|||
47009928|NCT01905657|83258733|FG001|Overall Study|Excluded Medication|16|||
47009929|NCT01905657|83258734|FG002|Overall Study|Excluded Medication|9|||
47009930|NCT01905657|83258732|FG000|Overall Study|Lost to Follow-up|1|||
47009931|NCT01905657|83258733|FG001|Overall Study|Lost to Follow-up|2|||
47009932|NCT01905657|83258734|FG002|Overall Study|Lost to Follow-up|1|||
47009933|NCT01905657|83258732|FG000|Overall Study|Physician Decision|5|||
47009934|NCT01905657|83258733|FG001|Overall Study|Physician Decision|8|||
47009935|NCT01905657|83258734|FG002|Overall Study|Physician Decision|12|||
47009936|NCT01905657|83258732|FG000|Overall Study|Protocol Violation|2|||
47009937|NCT01905657|83258733|FG001|Overall Study|Protocol Violation|1|||
47009938|NCT01905657|83258734|FG002|Overall Study|Protocol Violation|1|||
47009939|NCT01905657|83258732|FG000|Overall Study|Screen Failure|0|||
47009940|NCT01905657|83258733|FG001|Overall Study|Screen Failure|1|||
47009941|NCT01905657|83258734|FG002|Overall Study|Screen Failure|0|||
47009942|NCT01905657|83258732|FG000|Overall Study|Withdrawal by Subject|15|||
47009943|NCT01905657|83258733|FG001|Overall Study|Withdrawal by Subject|21|||
47009944|NCT01905657|83258734|FG002|Overall Study|Withdrawal by Subject|53|||
47009945|NCT01905657|83258732|FG000|Overall Study|Sponsor Decision|1|||
47009946|NCT01905657|83258733|FG001|Overall Study|Sponsor Decision|0|||
47009947|NCT01905657|83258734|FG002|Overall Study|Sponsor Decision|0|||
47009948|NCT02202980|83258759|FG000|Overall Study|Lack of Efficacy|1|||
47009949|NCT02202980|83258760|FG001|Overall Study|Lack of Efficacy|0|||
47009950|NCT02202980|83258761|FG002|Overall Study|Lack of Efficacy|7|||
47009951|NCT02202980|83258762|FG003|Overall Study|Lack of Efficacy|0|||
47009952|NCT02202980|83258763|FG004|Overall Study|Lack of Efficacy|3|||
47009953|NCT02202980|83258764|FG005|Overall Study|Lack of Efficacy|1|||
47009954|NCT02202980|83258765|FG006|Overall Study|Lack of Efficacy|11|||
47009955|NCT02202980|83258766|FG007|Overall Study|Lack of Efficacy|2|||
47009956|NCT02202980|83258767|FG008|Overall Study|Lack of Efficacy|2|||
47009957|NCT02202980|83258768|FG009|Overall Study|Lack of Efficacy|0|||
47009958|NCT02202980|83258769|FG010|Overall Study|Lack of Efficacy|0|||
47009959|NCT02202980|83258770|FG011|Overall Study|Lack of Efficacy|3|||
47009960|NCT02202980|83258771|FG012|Overall Study|Lack of Efficacy|10|||
46620513|NCT02536300|82769740|FG000|Overall Study|Non-compliance With Study Drug|1|||
47009961|NCT02202980|83258772|FG013|Overall Study|Lack of Efficacy|0|||
47009962|NCT02202980|83258759|FG000|Overall Study|Protocol Violation|0|||
47009963|NCT02202980|83258760|FG001|Overall Study|Protocol Violation|0|||
47009964|NCT02202980|83258761|FG002|Overall Study|Protocol Violation|0|||
47009965|NCT02202980|83258762|FG003|Overall Study|Protocol Violation|3|||
47009966|NCT02202980|83258763|FG004|Overall Study|Protocol Violation|3|||
47009967|NCT02202980|83258764|FG005|Overall Study|Protocol Violation|0|||
47009968|NCT02202980|83258765|FG006|Overall Study|Protocol Violation|0|||
47009969|NCT02202980|83258766|FG007|Overall Study|Protocol Violation|0|||
47009970|NCT02202980|83258767|FG008|Overall Study|Protocol Violation|0|||
47009971|NCT02202980|83258768|FG009|Overall Study|Protocol Violation|0|||
47009972|NCT02202980|83258769|FG010|Overall Study|Protocol Violation|0|||
47009973|NCT02202980|83258770|FG011|Overall Study|Protocol Violation|0|||
47009974|NCT02202980|83258771|FG012|Overall Study|Protocol Violation|0|||
47009975|NCT02202980|83258772|FG013|Overall Study|Protocol Violation|0|||
46910212|NCT02949011|83139625|FG000|Overall Study|Death|0|||
47009976|NCT02202980|83258759|FG000|Overall Study|Lost to Follow-up|0|||
47009977|NCT02202980|83258760|FG001|Overall Study|Lost to Follow-up|1|||
47009978|NCT02202980|83258761|FG002|Overall Study|Lost to Follow-up|1|||
47009979|NCT02202980|83258762|FG003|Overall Study|Lost to Follow-up|1|||
47009980|NCT02202980|83258763|FG004|Overall Study|Lost to Follow-up|0|||
47009981|NCT02202980|83258764|FG005|Overall Study|Lost to Follow-up|0|||
47009982|NCT02202980|83258765|FG006|Overall Study|Lost to Follow-up|0|||
47009983|NCT02202980|83258766|FG007|Overall Study|Lost to Follow-up|1|||
47009984|NCT02202980|83258767|FG008|Overall Study|Lost to Follow-up|1|||
47009985|NCT02202980|83258768|FG009|Overall Study|Lost to Follow-up|0|||
47009986|NCT02202980|83258769|FG010|Overall Study|Lost to Follow-up|0|||
47009987|NCT02202980|83258770|FG011|Overall Study|Lost to Follow-up|0|||
47009988|NCT02202980|83258771|FG012|Overall Study|Lost to Follow-up|1|||
47009989|NCT02202980|83258772|FG013|Overall Study|Lost to Follow-up|0|||
47009990|NCT02202980|83258759|FG000|Overall Study|Withdrew Consent|0|||
47009991|NCT02202980|83258760|FG001|Overall Study|Withdrew Consent|1|||
47009992|NCT02202980|83258761|FG002|Overall Study|Withdrew Consent|2|||
47009993|NCT02202980|83258762|FG003|Overall Study|Withdrew Consent|0|||
47009994|NCT02202980|83258763|FG004|Overall Study|Withdrew Consent|0|||
47009995|NCT02202980|83258764|FG005|Overall Study|Withdrew Consent|0|||
47009996|NCT02202980|83258765|FG006|Overall Study|Withdrew Consent|0|||
47009997|NCT02202980|83258766|FG007|Overall Study|Withdrew Consent|0|||
47009998|NCT02202980|83258767|FG008|Overall Study|Withdrew Consent|1|||
47009999|NCT02202980|83258768|FG009|Overall Study|Withdrew Consent|0|||
47010000|NCT02202980|83258769|FG010|Overall Study|Withdrew Consent|0|||
47010001|NCT02202980|83258770|FG011|Overall Study|Withdrew Consent|0|||
47010002|NCT02202980|83258771|FG012|Overall Study|Withdrew Consent|0|||
47010003|NCT02202980|83258772|FG013|Overall Study|Withdrew Consent|0|||
47010004|NCT01952145|83258804|FG000|Overall Study|Protocol Violation|2|||
47010005|NCT01952145|83258805|FG001|Overall Study|Protocol Violation|1|||
47010006|NCT01952145|83258804|FG000|Overall Study|Death|0|||
47010007|NCT01952145|83258805|FG001|Overall Study|Death|1|||
47010008|NCT01952145|83258804|FG000|Overall Study|Adverse Event|9|||
47010009|NCT01952145|83258805|FG001|Overall Study|Adverse Event|0|||
47010010|NCT01952145|83258804|FG000|Overall Study|Withdrawal Criteria|16|||
47010011|NCT01952145|83258805|FG001|Overall Study|Withdrawal Criteria|11|||
47010012|NCT01952145|83258804|FG000|Overall Study|Unclassified|1|||
47010013|NCT01952145|83258805|FG001|Overall Study|Unclassified|1|||
47010014|NCT01923363|83258811|FG000|Overall Study|Protocol Violation|1|||
47010015|NCT01905267|83258817|FG000|Overall Study|Physician Decision|2|||
47010016|NCT01905267|83258818|FG001|Overall Study|Physician Decision|2|||
47010017|NCT01923285|83258826|FG000|Overall Study|Withdrawal by Subject|7|||
47010018|NCT01923285|83258827|FG001|Overall Study|Withdrawal by Subject|6|||
47010019|NCT01904721|83258840|FG000|Overall Study|Other Reasons|0|||
47010020|NCT01904721|83258841|FG001|Overall Study|Other Reasons|0|||
47010021|NCT01904721|83258842|FG002|Overall Study|Other Reasons|1|||
47010022|NCT01904721|83258843|FG003|Overall Study|Other Reasons|1|||
47010023|NCT01904721|83258844|FG004|Overall Study|Other Reasons|2|||
47010024|NCT01904721|83258845|FG005|Overall Study|Other Reasons|2|||
47010025|NCT01904721|83258846|FG006|Overall Study|Other Reasons|2|||
47010026|NCT01904721|83258840|FG000|Overall Study|Personal Reasons|0|||
47010027|NCT01904721|83258841|FG001|Overall Study|Personal Reasons|0|||
47010028|NCT01904721|83258842|FG002|Overall Study|Personal Reasons|0|||
47010029|NCT01904721|83258843|FG003|Overall Study|Personal Reasons|0|||
47010030|NCT01904721|83258844|FG004|Overall Study|Personal Reasons|2|||
47010031|NCT01904721|83258845|FG005|Overall Study|Personal Reasons|3|||
47010032|NCT01904721|83258846|FG006|Overall Study|Personal Reasons|3|||
47010033|NCT01904721|83258840|FG000|Overall Study|Lost to Follow-up|0|||
47010034|NCT01904721|83258841|FG001|Overall Study|Lost to Follow-up|0|||
47010035|NCT01904721|83258842|FG002|Overall Study|Lost to Follow-up|0|||
47010036|NCT01904721|83258843|FG003|Overall Study|Lost to Follow-up|0|||
47010037|NCT01904721|83258844|FG004|Overall Study|Lost to Follow-up|1|||
47010038|NCT01904721|83258845|FG005|Overall Study|Lost to Follow-up|3|||
47010039|NCT01904721|83258846|FG006|Overall Study|Lost to Follow-up|1|||
47010040|NCT01904721|83258840|FG000|Overall Study|Lack of Efficacy|0|||
47010041|NCT01904721|83258841|FG001|Overall Study|Lack of Efficacy|0|||
47010042|NCT01904721|83258842|FG002|Overall Study|Lack of Efficacy|0|||
47010043|NCT01904721|83258843|FG003|Overall Study|Lack of Efficacy|0|||
47010044|NCT01904721|83258844|FG004|Overall Study|Lack of Efficacy|0|||
47010045|NCT01904721|83258845|FG005|Overall Study|Lack of Efficacy|0|||
47010046|NCT01904721|83258846|FG006|Overall Study|Lack of Efficacy|1|||
47010047|NCT01904721|83258840|FG000|Overall Study|Adverse Event|0|||
47010048|NCT01904721|83258841|FG001|Overall Study|Adverse Event|0|||
47010049|NCT01904721|83258842|FG002|Overall Study|Adverse Event|0|||
47010050|NCT01904721|83258843|FG003|Overall Study|Adverse Event|0|||
47010051|NCT01904721|83258844|FG004|Overall Study|Adverse Event|3|||
47010052|NCT01904721|83258845|FG005|Overall Study|Adverse Event|1|||
47010053|NCT01904721|83258846|FG006|Overall Study|Adverse Event|0|||
47010054|NCT01904019|83258858|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
47010055|NCT01904019|83258858|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
47010056|NCT01904019|83258858|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
47010057|NCT01904019|83258858|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
47010058|NCT01904019|83258858|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
47010059|NCT01904019|83258858|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
47010060|NCT01922895|83258864|FG000|Overall Study|Death|0|||
47010061|NCT01922895|83258865|FG001|Overall Study|Death|1|||
47010062|NCT01922895|83258864|FG000|Overall Study|Withdrawal by Subject|1|||
46910213|NCT02949011|83139626|FG001|Overall Study|Death|0|||
46910214|NCT02949011|83139627|FG002|Overall Study|Death|1|||
46910215|NCT02949011|83139625|FG000|Overall Study|Miscellaneous|2|||
46910216|NCT02949011|83139626|FG001|Overall Study|Miscellaneous|4|||
46910217|NCT02949011|83139627|FG002|Overall Study|Miscellaneous|6|||
46910218|NCT03357731|83139639|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
46910219|NCT03357731|83139640|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
46910220|NCT03357731|83139641|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
47010063|NCT01922895|83258865|FG001|Overall Study|Withdrawal by Subject|2|||
47010064|NCT01922895|83258864|FG000|Overall Study|Lost to Follow-up|5|||
47010065|NCT01922895|83258865|FG001|Overall Study|Lost to Follow-up|11|||
47010066|NCT01922739|83258873|FG000|Titration/Adjustment Period|Adverse Event|3|||
47010067|NCT01922739|83258873|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
47010068|NCT01922739|83258873|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
47010069|NCT01922739|83258873|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
47010070|NCT01922739|83258873|FG000|Open-label Treatment Period|Adverse Event|6|||
47010071|NCT01922739|83258873|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
47010072|NCT01922739|83258873|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
47010073|NCT01922739|83258873|FG000|Open-label Treatment Period|Protocol Violation|5|||
47010074|NCT01922739|83258873|FG000|Open-label Treatment Period|Pregnancy|1|||
47010075|NCT01922739|83258873|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
47010076|NCT01922739|83258873|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
47010077|NCT01922739|83258873|FG000|Open-label Treatment Period|Physician Decision|1|||
47010078|NCT01922739|83258873|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
47010079|NCT02236988|83258893|FG000|Overall Study|Lost to Follow-up|0|||
47010080|NCT02236988|83258894|FG001|Overall Study|Lost to Follow-up|0|||
47010081|NCT02236988|83258895|FG002|Overall Study|Lost to Follow-up|0|||
46910221|NCT03357731|83139642|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
46910222|NCT03357731|83139643|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
46910223|NCT03357731|83139644|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
47010082|NCT02236988|83258896|FG003|Overall Study|Lost to Follow-up|1|||
47010083|NCT02236988|83258893|FG000|Overall Study|Unable to Comply with Study Visits|0|||
47010084|NCT02236988|83258894|FG001|Overall Study|Unable to Comply with Study Visits|0|||
47010085|NCT02236988|83258895|FG002|Overall Study|Unable to Comply with Study Visits|0|||
47010086|NCT02236988|83258896|FG003|Overall Study|Unable to Comply with Study Visits|2|||
47010087|NCT02236598|83258949|FG000|Overall Study|Adverse Event|0|||
47010088|NCT02236598|83258950|FG001|Overall Study|Adverse Event|1|||
47010089|NCT02236598|83258949|FG000|Overall Study|Withdrawal by Subject|0|||
47010090|NCT02236598|83258950|FG001|Overall Study|Withdrawal by Subject|1|||
47010091|NCT01922349|83258960|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
47010092|NCT01922349|83258961|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
47010093|NCT01922349|83258962|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
47010094|NCT01922349|83258963|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
47010095|NCT02236520|83259001|FG000|Overall Study|Physician Decision|0|||
47010096|NCT02236520|83259002|FG001|Overall Study|Physician Decision|5|||
47010097|NCT02236520|83259003|FG002|Overall Study|Physician Decision|0|||
47010098|NCT02236520|83259004|FG003|Overall Study|Physician Decision|0|||
47010099|NCT02236520|83259001|FG000|Overall Study|Withdrawal by Subject|1|||
47010100|NCT02236520|83259002|FG001|Overall Study|Withdrawal by Subject|0|||
47010101|NCT02236520|83259003|FG002|Overall Study|Withdrawal by Subject|0|||
47010102|NCT02236520|83259004|FG003|Overall Study|Withdrawal by Subject|1|||
47010103|NCT02236520|83259001|FG000|Overall Study|Pregnancy|1|||
47010104|NCT02236520|83259002|FG001|Overall Study|Pregnancy|0|||
47010105|NCT02236520|83259003|FG002|Overall Study|Pregnancy|0|||
47010106|NCT02236520|83259004|FG003|Overall Study|Pregnancy|0|||
47010107|NCT01922271|83259016|FG000|WASHOUT Period|Withdrawal by Subject|1|||
47010108|NCT01922271|83259017|FG001|WASHOUT Period|Withdrawal by Subject|0|||
47010109|NCT02236130|83259025|FG000|Overall Study|Lost to Follow-up|7|||
47010110|NCT02236130|83259026|FG001|Overall Study|Lost to Follow-up|12|||
47010111|NCT02233946|83259034|FG000|Baseline|Withdrawal by Subject|2|||
47010112|NCT02233946|83259035|FG001|Baseline|Withdrawal by Subject|0|||
47010113|NCT02233946|83259034|FG000|3-months Follow-up|Lost to Follow-up|53|||
47010114|NCT02233946|83259035|FG001|3-months Follow-up|Lost to Follow-up|29|||
47010115|NCT02233946|83259034|FG000|6-months Follow-up|Lost to Follow-up|21|||
47010116|NCT02233946|83259035|FG001|6-months Follow-up|Lost to Follow-up|2|||
47010117|NCT02233946|83259034|FG000|9-month Follow-up|Lost to Follow-up|20|||
47010118|NCT02233946|83259035|FG001|9-month Follow-up|Lost to Follow-up|11|||
47010119|NCT02233946|83259034|FG000|12-month Follow-up|Lost to Follow-up|28|||
47010120|NCT02233946|83259035|FG001|12-month Follow-up|Lost to Follow-up|11|||
47010121|NCT02232698|83259043|FG000|Overall Study|Pregnancy|1|||
47010122|NCT02232698|83259044|FG001|Overall Study|Pregnancy|1|||
47010123|NCT02232698|83259043|FG000|Overall Study|Met exclusion criteria|1|||
47010124|NCT02232698|83259044|FG001|Overall Study|Met exclusion criteria|1|||
47010125|NCT02232698|83259043|FG000|Overall Study|Had device-associated symptoms|7|||
47010126|NCT02232698|83259044|FG001|Overall Study|Had device-associated symptoms|0|||
47010127|NCT02232698|83259043|FG000|Overall Study|Non-compliance with study device|1|||
47010128|NCT02232698|83259044|FG001|Overall Study|Non-compliance with study device|4|||
47010129|NCT02232698|83259043|FG000|Overall Study|Allocated to control group|0|||
47010130|NCT02232698|83259044|FG001|Overall Study|Allocated to control group|3|||
47010131|NCT02232698|83259043|FG000|Overall Study|Withdrawal by Subject|0|||
47010132|NCT02232698|83259044|FG001|Overall Study|Withdrawal by Subject|11|||
47010133|NCT01632878|83259052|FG000|Screening|Physician Decision|268|||
47010134|NCT01632878|83259052|FG000|Treatment|Lost to Follow-up|41|||
47010135|NCT01632878|83259052|FG000|Treatment|Withdrawal by Subject|36|||
47010136|NCT01632878|83259052|FG000|Treatment|Physician Decision|34|||
47010137|NCT01632878|83259052|FG000|Treatment|missing information|4|||
47010138|NCT01632878|83259052|FG000|Treatment|no information on study completion|43|||
47010139|NCT01632800|83259056|FG000|Overall Study|Subject did not fit in apparatus|1|||
47010140|NCT01641809|83259064|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
47010141|NCT01641809|83259065|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
47010142|NCT01641809|83259066|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
47010143|NCT01641809|83259067|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
47010144|NCT01641809|83259064|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
47010145|NCT01641809|83259065|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
47010146|NCT01641809|83259066|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
47010147|NCT01641809|83259067|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
47010148|NCT01641809|83259064|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
47010149|NCT01641809|83259065|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
47010150|NCT01641809|83259066|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
47010151|NCT01641809|83259067|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
47010152|NCT01641809|83259064|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
47010153|NCT01641809|83259065|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
47010154|NCT01641809|83259066|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
47010155|NCT01641809|83259067|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
47010156|NCT01641809|83259064|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
47010157|NCT01641809|83259065|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
47010158|NCT01641809|83259066|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
47010159|NCT01641809|83259067|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
47010160|NCT01641809|83259064|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
47010161|NCT01641809|83259065|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
47010162|NCT01641809|83259066|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
47010163|NCT01641809|83259067|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
47010164|NCT01641809|83259064|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
47010165|NCT01641809|83259065|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
47010166|NCT01641809|83259066|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
47010167|NCT01641809|83259067|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
47010168|NCT01641809|83259064|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
47010169|NCT01641809|83259065|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
47010170|NCT01641809|83259066|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
47010171|NCT01641809|83259067|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
47010172|NCT01641809|83259064|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
47010173|NCT01641809|83259065|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
47010174|NCT01641809|83259066|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
47010175|NCT01641809|83259067|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
47010176|NCT01641809|83259064|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
47010177|NCT01641809|83259065|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
47010178|NCT01641809|83259066|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
47010179|NCT01641809|83259067|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
47010180|NCT01641809|83259064|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
47010181|NCT01641809|83259065|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
47010182|NCT01641809|83259066|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
47010183|NCT01641809|83259067|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
47010184|NCT01641809|83259064|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
47010185|NCT01641809|83259065|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
47010186|NCT01641809|83259066|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
47010187|NCT01641809|83259067|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
47010188|NCT01641809|83259064|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
47010189|NCT01641809|83259065|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
47010190|NCT01641809|83259066|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
47010191|NCT01641809|83259067|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
47010192|NCT01641809|83259064|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
47010193|NCT01641809|83259065|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
47010194|NCT01641809|83259066|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
47010195|NCT01641809|83259067|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
47010196|NCT01641809|83259064|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
47010197|NCT01641809|83259065|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
47010198|NCT01641809|83259066|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
47010199|NCT01641809|83259067|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
47010200|NCT01641809|83259064|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
47010201|NCT01641809|83259065|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
47010202|NCT01641809|83259066|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
47010203|NCT01641809|83259067|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
47010204|NCT01641809|83259064|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
47010205|NCT01641809|83259065|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
47010206|NCT01641809|83259066|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
47010207|NCT01641809|83259067|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
47010208|NCT01641809|83259064|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
47010209|NCT01641809|83259065|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
47010210|NCT01641809|83259066|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
47010211|NCT01641809|83259067|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
47010212|NCT01632566|83259090|FG000|Overall Study|Withdrawal by Subject|0|||
47010213|NCT01632566|83259091|FG001|Overall Study|Withdrawal by Subject|1|||
47010214|NCT01632566|83259092|FG002|Overall Study|Withdrawal by Subject|0|||
47010215|NCT01632566|83259093|FG003|Overall Study|Withdrawal by Subject|0|||
47010216|NCT01632566|83259094|FG004|Overall Study|Withdrawal by Subject|0|||
47010217|NCT01632566|83259090|FG000|Overall Study|Sponsor Decision|0|||
47010218|NCT01632566|83259091|FG001|Overall Study|Sponsor Decision|2|||
47010219|NCT01632566|83259092|FG002|Overall Study|Sponsor Decision|9|||
47010220|NCT01632566|83259093|FG003|Overall Study|Sponsor Decision|2|||
47010221|NCT01632566|83259094|FG004|Overall Study|Sponsor Decision|2|||
47010222|NCT02254304|83259112|FG000|Overall Study|Adverse Event|2|||
47010223|NCT02254304|83259113|FG001|Overall Study|Adverse Event|1|||
47010224|NCT02254304|83259112|FG000|Overall Study|Lost to Follow-up|2|||
47010225|NCT02254304|83259113|FG001|Overall Study|Lost to Follow-up|2|||
47010226|NCT02254304|83259112|FG000|Overall Study|Protocol Violation|1|||
47010227|NCT02254304|83259113|FG001|Overall Study|Protocol Violation|0|||
47010228|NCT02254304|83259112|FG000|Overall Study|Withdrawal by Subject|3|||
47010229|NCT02254304|83259113|FG001|Overall Study|Withdrawal by Subject|0|||
47010230|NCT02254304|83259112|FG000|Overall Study|Injection site pain and Injection fear|1|||
47010231|NCT02254304|83259113|FG001|Overall Study|Injection site pain and Injection fear|0|||
47010232|NCT02254304|83259112|FG000|Overall Study|Personal causes|4|||
47010233|NCT02254304|83259113|FG001|Overall Study|Personal causes|1|||
47010234|NCT02254304|83259112|FG000|Overall Study|Personal decision|1|||
47010235|NCT02254304|83259113|FG001|Overall Study|Personal decision|0|||
47010236|NCT02174731|83259123|FG000|Overall Study|Participant decision|67|||
47010237|NCT02174731|83259124|FG001|Overall Study|Participant decision|64|||
47010238|NCT02174731|83259123|FG000|Overall Study|Incorrect enrolment before randomization|0|||
47010239|NCT02174731|83259124|FG001|Overall Study|Incorrect enrolment before randomization|1|||
47010240|NCT02174731|83259123|FG000|Overall Study|Missing|2|||
47010241|NCT02174731|83259124|FG001|Overall Study|Missing|0|||
47010242|NCT01922037|83259132|FG000|Overall Study|Withdrawal by Subject|2|||
47010243|NCT01922037|83259133|FG001|Overall Study|Withdrawal by Subject|44|||
47010244|NCT01922037|83259132|FG000|Overall Study|Adverse Event|1|||
47010245|NCT01922037|83259133|FG001|Overall Study|Adverse Event|7|||
47010246|NCT01922037|83259132|FG000|Overall Study|Death|0|||
47010247|NCT01922037|83259133|FG001|Overall Study|Death|5|||
47010248|NCT01922037|83259132|FG000|Overall Study|Pregnancy|0|||
47010249|NCT01922037|83259133|FG001|Overall Study|Pregnancy|2|||
47010250|NCT01922037|83259132|FG000|Overall Study|Participant non-compliance|4|||
47010251|NCT01922037|83259133|FG001|Overall Study|Participant non-compliance|46|||
47010252|NCT01922037|83259132|FG000|Overall Study|Investigator/Sponsor decision|1|||
47010253|NCT01922037|83259133|FG001|Overall Study|Investigator/Sponsor decision|4|||
47010254|NCT01922037|83259132|FG000|Overall Study|Other unspecified|2|||
47010255|NCT01922037|83259133|FG001|Overall Study|Other unspecified|66|||
47010256|NCT02282813|83259144|FG000|Overall Study|Withdrawal by Subject|4|||
47010257|NCT02282813|83259145|FG001|Overall Study|Withdrawal by Subject|5|||
47010258|NCT02282813|83259146|FG002|Overall Study|Withdrawal by Subject|0|||
47010259|NCT02282813|83259144|FG000|Overall Study|Adverse Event|3|||
47010260|NCT02282813|83259145|FG001|Overall Study|Adverse Event|10|||
46709539|NCT01217606|82925578|FG001|9-Month Masked Extension|Pregnancy|0|||
47010261|NCT02282813|83259146|FG002|Overall Study|Adverse Event|1|||
47010262|NCT02282813|83259144|FG000|Overall Study|Subject non-compliance|1|||
47010263|NCT02282813|83259145|FG001|Overall Study|Subject non-compliance|4|||
47010264|NCT02282813|83259146|FG002|Overall Study|Subject non-compliance|0|||
47010265|NCT02282813|83259144|FG000|Overall Study|Physician Decision|0|||
47010266|NCT02282813|83259145|FG001|Overall Study|Physician Decision|3|||
47010267|NCT02282813|83259146|FG002|Overall Study|Physician Decision|1|||
47010268|NCT02282813|83259144|FG000|Overall Study|Lost to Follow-up|2|||
47010269|NCT02282813|83259145|FG001|Overall Study|Lost to Follow-up|0|||
47010270|NCT02282813|83259146|FG002|Overall Study|Lost to Follow-up|1|||
47010271|NCT02282813|83259144|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
47010272|NCT02282813|83259145|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
47010273|NCT02282813|83259146|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
47010274|NCT02282813|83259144|FG000|Overall Study|Lack of Efficacy|1|||
47010275|NCT02282813|83259145|FG001|Overall Study|Lack of Efficacy|0|||
47010276|NCT02282813|83259146|FG002|Overall Study|Lack of Efficacy|0|||
47010277|NCT02282813|83259144|FG000|Overall Study|Administrative reasons|0|||
47010278|NCT02282813|83259145|FG001|Overall Study|Administrative reasons|1|||
47010279|NCT02282813|83259146|FG002|Overall Study|Administrative reasons|0|||
47010280|NCT01903863|83259158|FG000|Overall Study|Physician Decision|2|||
47010281|NCT01903863|83259159|FG001|Overall Study|Physician Decision|0|||
47010282|NCT02123251|83259167|FG000|Overall Study|Death|1|||
46709540|NCT01217606|82925577|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
47010283|NCT02123251|83259168|FG001|Overall Study|Death|1|||
47010284|NCT02123251|83259167|FG000|Overall Study|Withdrawal by Subject|0|||
47010285|NCT02123251|83259168|FG001|Overall Study|Withdrawal by Subject|3|||
47010286|NCT02123251|83259167|FG000|Overall Study|Lost Medicaid eligibility|29|||
47010287|NCT02123251|83259168|FG001|Overall Study|Lost Medicaid eligibility|22|||
47010288|NCT02123251|83259167|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
47010289|NCT02123251|83259168|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
47010290|NCT01902303|83259177|FG000|Overall Study|Adverse Event|0|||
47010291|NCT01902303|83259178|FG001|Overall Study|Adverse Event|1|||
47010292|NCT01902303|83259177|FG000|Overall Study|Lost to Follow-up|0|||
47010293|NCT01902303|83259178|FG001|Overall Study|Lost to Follow-up|1|||
47010294|NCT01902303|83259177|FG000|Overall Study|Protocol Violation|2|||
47010295|NCT01902303|83259178|FG001|Overall Study|Protocol Violation|2|||
47010296|NCT01902303|83259177|FG000|Overall Study|subject lost investigational product|0|||
47010297|NCT01902303|83259178|FG001|Overall Study|subject lost investigational product|1|||
47010298|NCT01902303|83259177|FG000|Overall Study|Did not develop a cold sore|21|||
47010299|NCT01902303|83259178|FG001|Overall Study|Did not develop a cold sore|19|||
47010300|NCT02122783|83259188|FG000|Overall Study|Adverse Event|0|||
47010301|NCT02122783|83259189|FG001|Overall Study|Adverse Event|1|||
47010302|NCT01921257|83259198|FG000|Overall Study|Adverse Event|1|||
47010303|NCT01921257|83259198|FG000|Overall Study|Protocol Violation|1|||
47010304|NCT01921257|83259198|FG000|Overall Study|Withdrawal by Subject|1|||
47010305|NCT02121847|83259203|FG000|Overall Study|Administrative Reasons|1|||
47010306|NCT02121847|83259203|FG000|Overall Study|Adverse Event|2|||
47010307|NCT01921179|83259209|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
47010308|NCT01921179|83259210|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
47010309|NCT01921179|83259209|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
47010310|NCT01921179|83259210|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
47010311|NCT01587040|83259221|FG000|Overall Study|Protocol Violation|0|||
47010312|NCT01587040|83259222|FG001|Overall Study|Protocol Violation|0|||
47010313|NCT01587040|83259223|FG002|Overall Study|Protocol Violation|1|||
47010314|NCT01587040|83259224|FG003|Overall Study|Protocol Violation|0|||
47010315|NCT01587040|83259221|FG000|Overall Study|Adverse Event|0|||
47010316|NCT01587040|83259222|FG001|Overall Study|Adverse Event|1|||
47010317|NCT01587040|83259223|FG002|Overall Study|Adverse Event|10|||
47010318|NCT01587040|83259224|FG003|Overall Study|Adverse Event|0|||
47010319|NCT01587040|83259221|FG000|Overall Study|Disease progression|12|||
47010320|NCT01587040|83259222|FG001|Overall Study|Disease progression|1|||
47010321|NCT01587040|83259223|FG002|Overall Study|Disease progression|15|||
47010322|NCT01587040|83259224|FG003|Overall Study|Disease progression|3|||
47010323|NCT01587040|83259221|FG000|Overall Study|Other than specified|5|||
47010324|NCT01587040|83259222|FG001|Overall Study|Other than specified|1|||
47010325|NCT01587040|83259223|FG002|Overall Study|Other than specified|11|||
47010326|NCT01587040|83259224|FG003|Overall Study|Other than specified|1|||
47010327|NCT02144701|83259236|FG000|Overall Study|development of relapse, GVHD or death|9|||
47010328|NCT02144701|83259237|FG001|Overall Study|development of relapse, GVHD or death|3|||
47010329|NCT01921101|83259245|FG000|Overall Study|Death|16|||
47010330|NCT01921101|83259246|FG001|Overall Study|Death|6|||
47010331|NCT01586806|83259255|FG000|Overall Study|Protocol Violation|0|||
47010332|NCT01586806|83259256|FG001|Overall Study|Protocol Violation|1|||
47010333|NCT01586806|83259257|FG002|Overall Study|Protocol Violation|0|||
47010334|NCT01586806|83259255|FG000|Overall Study|Withdrawal by Subject|1|||
47010335|NCT01586806|83259256|FG001|Overall Study|Withdrawal by Subject|0|||
47010336|NCT01586806|83259257|FG002|Overall Study|Withdrawal by Subject|0|||
47010337|NCT01586806|83259255|FG000|Overall Study|Lost to Follow-up|2|||
47010338|NCT01586806|83259256|FG001|Overall Study|Lost to Follow-up|3|||
47010339|NCT01586806|83259257|FG002|Overall Study|Lost to Follow-up|2|||
47010340|NCT02144077|83259267|FG000|Overall Study|Withdrawal by Subject|3|||
47010341|NCT02144077|83259268|FG001|Overall Study|Withdrawal by Subject|3|||
47010342|NCT02144077|83259267|FG000|Overall Study|Adverse Event|2|||
47010343|NCT02144077|83259268|FG001|Overall Study|Adverse Event|3|||
47010344|NCT02144077|83259267|FG000|Overall Study|Lost to Follow-up|2|||
47010345|NCT02144077|83259268|FG001|Overall Study|Lost to Follow-up|2|||
47010346|NCT02144077|83259267|FG000|Overall Study|Protocol Violation|1|||
47010347|NCT02144077|83259268|FG001|Overall Study|Protocol Violation|2|||
47010348|NCT02144077|83259267|FG000|Overall Study|Death|0|||
47010349|NCT02144077|83259268|FG001|Overall Study|Death|1|||
47010350|NCT02144077|83259267|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
47010351|NCT02144077|83259268|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
47010352|NCT02172625|83259276|FG000|Overall Study|Adverse Event|0|||
47010353|NCT02172625|83259277|FG001|Overall Study|Adverse Event|1|||
47010354|NCT02172625|83259276|FG000|Overall Study|Pregnancy|0|||
47010355|NCT02172625|83259277|FG001|Overall Study|Pregnancy|1|||
47010356|NCT02172625|83259276|FG000|Overall Study|car accident|0|||
47010357|NCT02172625|83259277|FG001|Overall Study|car accident|1|||
47010358|NCT02143843|83259287|FG000|Overall Study|Adverse Event|8|||
47010359|NCT02143843|83259287|FG000|Overall Study|Lack of Efficacy|2|||
47010360|NCT02143843|83259287|FG000|Overall Study|Withdrawal by Subject|2|||
47010361|NCT02121535|83259293|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
47010362|NCT02121535|83259294|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
47010363|NCT02121535|83259293|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
47010364|NCT02121535|83259294|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
47010365|NCT01586338|83259301|FG000|Overall Study|Adverse Event|3|||
47010366|NCT01586338|83259301|FG000|Overall Study|Lost to Follow-up|1|||
47010367|NCT01586338|83259301|FG000|Overall Study|Withdrawal by participant|3|||
47010368|NCT01586338|83259301|FG000|Overall Study|Other|1|||
47010369|NCT02143141|83259307|FG000|Overall Study|pain scores at 24 hours not collected|1|||
47010370|NCT02143141|83259308|FG001|Overall Study|pain scores at 24 hours not collected|0|||
47010371|NCT02171065|83259317|FG000|Overall Study|Withdrawal by Subject|1|||
47010372|NCT02171065|83259318|FG001|Overall Study|Withdrawal by Subject|0|||
47010373|NCT02171065|83259319|FG002|Overall Study|Withdrawal by Subject|0|||
47010374|NCT02171065|83259317|FG000|Overall Study|Lost to Follow-up|0|||
47010375|NCT02171065|83259318|FG001|Overall Study|Lost to Follow-up|0|||
47010376|NCT02171065|83259319|FG002|Overall Study|Lost to Follow-up|1|||
47010377|NCT01566604|83259331|FG000|Overall Study|Patient's inability to use the device|1|||
47010378|NCT01566604|83259332|FG001|Overall Study|Patient's inability to use the device|0|||
47010379|NCT01566604|83259331|FG000|Overall Study|Administrative problems|1|||
47010380|NCT01566604|83259332|FG001|Overall Study|Administrative problems|0|||
47010381|NCT01566604|83259331|FG000|Overall Study|Lack of Efficacy|1|||
47010382|NCT01566604|83259332|FG001|Overall Study|Lack of Efficacy|2|||
47010383|NCT01566604|83259331|FG000|Overall Study|Protocol deviation|2|||
47010384|NCT01566604|83259332|FG001|Overall Study|Protocol deviation|0|||
47010385|NCT01566604|83259331|FG000|Overall Study|Abnormal laboratory value|2|||
47010386|NCT01566604|83259332|FG001|Overall Study|Abnormal laboratory value|0|||
47010387|NCT01566604|83259331|FG000|Overall Study|Death|4|||
47010388|NCT01566604|83259332|FG001|Overall Study|Death|1|||
47010389|NCT01566604|83259331|FG000|Overall Study|Adverse Event|4|||
47010390|NCT01566604|83259332|FG001|Overall Study|Adverse Event|2|||
47010391|NCT01566604|83259331|FG000|Overall Study|Withdrawal by Subject|9|||
47010392|NCT01566604|83259332|FG001|Overall Study|Withdrawal by Subject|6|||
47010393|NCT01684930|83259340|FG000|Overall Study|Withdrawal by Subject|3|||
47010394|NCT01684930|83259341|FG001|Overall Study|Withdrawal by Subject|1|||
47010395|NCT01566214|83259349|FG000|Overall Study|Lost to Follow-up|3|||
47010396|NCT01566214|83259350|FG001|Overall Study|Lost to Follow-up|0|||
47010397|NCT02253992|83259359|FG000|Overall Study|Study drug toxicity|1|||
47010398|NCT02253992|83259360|FG001|Overall Study|Study drug toxicity|0|||
47010399|NCT02253992|83259361|FG002|Overall Study|Study drug toxicity|10|||
47010400|NCT02253992|83259359|FG000|Overall Study|Disease progression|4|||
47010401|NCT02253992|83259360|FG001|Overall Study|Disease progression|3|||
47010402|NCT02253992|83259361|FG002|Overall Study|Disease progression|98|||
47010403|NCT02253992|83259359|FG000|Overall Study|Withdrawal by Subject|0|||
47010404|NCT02253992|83259360|FG001|Overall Study|Withdrawal by Subject|0|||
47010405|NCT02253992|83259361|FG002|Overall Study|Withdrawal by Subject|3|||
47010406|NCT02253992|83259359|FG000|Overall Study|Adverse Event|0|||
47010407|NCT02253992|83259360|FG001|Overall Study|Adverse Event|0|||
47010408|NCT02253992|83259361|FG002|Overall Study|Adverse Event|8|||
47010409|NCT02253992|83259359|FG000|Overall Study|Death|0|||
47010410|NCT02253992|83259360|FG001|Overall Study|Death|0|||
47010411|NCT02253992|83259361|FG002|Overall Study|Death|1|||
47010412|NCT02253992|83259359|FG000|Overall Study|Subject discontinued study drug|1|||
47010413|NCT02253992|83259360|FG001|Overall Study|Subject discontinued study drug|0|||
47010414|NCT02253992|83259361|FG002|Overall Study|Subject discontinued study drug|1|||
47010415|NCT02253992|83259359|FG000|Overall Study|Completed treatment as per protocol|0|||
47010416|NCT02253992|83259360|FG001|Overall Study|Completed treatment as per protocol|1|||
47010417|NCT02253992|83259361|FG002|Overall Study|Completed treatment as per protocol|22|||
47010418|NCT02253992|83259359|FG000|Overall Study|Other|0|||
47010419|NCT02253992|83259360|FG001|Overall Study|Other|0|||
47010420|NCT02253992|83259361|FG002|Overall Study|Other|1|||
47010421|NCT02252588|83259385|FG000|Overall Study|Withdrawal by Subject|4|||
47010422|NCT02252588|83259386|FG001|Overall Study|Withdrawal by Subject|0|||
47010423|NCT01585558|83259395|FG000|Overall Study|Withdrawal by Subject|4|||
47010424|NCT01585558|83259396|FG001|Overall Study|Withdrawal by Subject|5|||
47010425|NCT01585558|83259397|FG002|Overall Study|Withdrawal by Subject|8|||
47010426|NCT01585558|83259395|FG000|Overall Study|Lost to Follow-up|2|||
47010427|NCT01585558|83259396|FG001|Overall Study|Lost to Follow-up|0|||
47010428|NCT01585558|83259397|FG002|Overall Study|Lost to Follow-up|3|||
47010429|NCT01585558|83259395|FG000|Overall Study|Adverse Event|3|||
47010430|NCT01585558|83259396|FG001|Overall Study|Adverse Event|4|||
47010431|NCT01585558|83259397|FG002|Overall Study|Adverse Event|1|||
47010432|NCT01585558|83259395|FG000|Overall Study|Protocol Violation|4|||
47010433|NCT01585558|83259396|FG001|Overall Study|Protocol Violation|3|||
47010434|NCT01585558|83259397|FG002|Overall Study|Protocol Violation|2|||
47010435|NCT01585558|83259395|FG000|Overall Study|Lack of Efficacy|0|||
46620514|NCT02536300|82769741|FG001|Overall Study|Non-compliance With Study Drug|0|||
47010436|NCT01585558|83259396|FG001|Overall Study|Lack of Efficacy|0|||
47010437|NCT01585558|83259397|FG002|Overall Study|Lack of Efficacy|1|||
47010438|NCT01565980|83259407|FG000|Overall Study|Death|1|||
47010439|NCT01565980|83259408|FG001|Overall Study|Death|0|||
47010440|NCT01565980|83259407|FG000|Overall Study|Lost to Follow-up|1|||
47010441|NCT01565980|83259408|FG001|Overall Study|Lost to Follow-up|0|||
47010442|NCT01565980|83259407|FG000|Overall Study|health complications|1|||
47010443|NCT01565980|83259408|FG001|Overall Study|health complications|1|||
47010444|NCT01565980|83259407|FG000|Overall Study|stopped medical treatment|1|||
47010445|NCT01565980|83259408|FG001|Overall Study|stopped medical treatment|0|||
47010446|NCT01565980|83259407|FG000|Overall Study|Withdrawal by Subject|0|||
47010447|NCT01565980|83259408|FG001|Overall Study|Withdrawal by Subject|3|||
47010448|NCT01585246|83259423|FG000|Overall Study|Lost to Follow-up|0|||
47010449|NCT01585246|83259424|FG001|Overall Study|Lost to Follow-up|0|||
47010450|NCT01585246|83259425|FG002|Overall Study|Lost to Follow-up|2|||
47010451|NCT01585246|83259426|FG003|Overall Study|Lost to Follow-up|1|||
47010452|NCT01585246|83259427|FG004|Overall Study|Lost to Follow-up|0|||
47010453|NCT01585246|83259423|FG000|Overall Study|Protocol Violation|0|||
47010454|NCT01585246|83259424|FG001|Overall Study|Protocol Violation|0|||
47010455|NCT01585246|83259425|FG002|Overall Study|Protocol Violation|0|||
47010456|NCT01585246|83259426|FG003|Overall Study|Protocol Violation|0|||
47010457|NCT01585246|83259427|FG004|Overall Study|Protocol Violation|1|||
47010458|NCT01585246|83259423|FG000|Overall Study|Withdrawal by Subject|0|||
47010459|NCT01585246|83259424|FG001|Overall Study|Withdrawal by Subject|0|||
47010460|NCT01585246|83259425|FG002|Overall Study|Withdrawal by Subject|1|||
47010461|NCT01585246|83259426|FG003|Overall Study|Withdrawal by Subject|2|||
47010462|NCT01585246|83259427|FG004|Overall Study|Withdrawal by Subject|1|||
47010463|NCT01585246|83259423|FG000|Overall Study|Other|0|||
47010464|NCT01585246|83259424|FG001|Overall Study|Other|1|||
47010465|NCT01585246|83259425|FG002|Overall Study|Other|1|||
47010466|NCT01585246|83259426|FG003|Overall Study|Other|1|||
47010467|NCT01585246|83259427|FG004|Overall Study|Other|0|||
47010468|NCT01585168|83259444|FG000|Overall Study|Lost to Follow-up|3|||
47010469|NCT01585168|83259445|FG001|Overall Study|Lost to Follow-up|1|||
47010470|NCT01585168|83259446|FG002|Overall Study|Lost to Follow-up|1|||
47010471|NCT01585168|83259447|FG003|Overall Study|Lost to Follow-up|1|||
47010472|NCT02232074|83259457|FG000|Overall Study|Withdrawal by Subject|5|||
47010473|NCT02232074|83259458|FG001|Overall Study|Withdrawal by Subject|3|||
47010474|NCT02232074|83259457|FG000|Overall Study|No legal concerns at baseline|36|||
47010475|NCT02232074|83259458|FG001|Overall Study|No legal concerns at baseline|41|||
47010476|NCT02232074|83259457|FG000|Overall Study|deemed ineligible|0|||
47010477|NCT02232074|83259458|FG001|Overall Study|deemed ineligible|1|||
47010478|NCT02142283|83259472|FG000|Overall Study|Death|20|||
47010479|NCT02142283|83259473|FG001|Overall Study|Death|18|||
47010480|NCT02142283|83259472|FG000|Overall Study|Withdrawal by Subject|1|||
47010481|NCT02142283|83259473|FG001|Overall Study|Withdrawal by Subject|3|||
47010482|NCT02231918|83259482|FG000|Overall Study|Withdrawal by Subject|0|||
47010483|NCT02231918|83259483|FG001|Overall Study|Withdrawal by Subject|1|||
47010484|NCT02231918|83259484|FG002|Overall Study|Withdrawal by Subject|0|||
47010485|NCT02231918|83259482|FG000|Overall Study|Adverse Event|0|||
47010486|NCT02231918|83259483|FG001|Overall Study|Adverse Event|0|||
47010487|NCT02231918|83259484|FG002|Overall Study|Adverse Event|1|||
47010488|NCT02199314|83259492|FG000|Overall Study|Withdrawal by Subject|6|||
47010489|NCT02199314|83259492|FG000|Overall Study|Physician Decision|10|||
47010490|NCT02251652|83259496|FG000|Overall Study|Withdrawal by Subject|1|||
47010491|NCT02197520|83259502|FG000|Period 1|Withdrawal by Subject|1|||
47010492|NCT02197520|83259503|FG001|Period 1|Withdrawal by Subject|0|||
47010493|NCT02197520|83259502|FG000|Period 2|Adverse Event|0|||
47010494|NCT02197520|83259503|FG001|Period 2|Adverse Event|2|||
47010495|NCT02197520|83259502|FG000|Period 2|Withdrawal by Subject|1|||
47010496|NCT02197520|83259503|FG001|Period 2|Withdrawal by Subject|0|||
47010497|NCT02230904|83259513|FG000|Overall Study|Safety follow up could not take place|0|||
47010498|NCT02230904|83259514|FG001|Overall Study|Safety follow up could not take place|1|||
47010499|NCT02230670|83259524|FG000|Overall Study|Adverse Event|1|||
47010500|NCT02230670|83259525|FG001|Overall Study|Adverse Event|2|||
47010501|NCT02230670|83259524|FG000|Overall Study|Withdrawal by Subject|2|||
47010502|NCT02230670|83259525|FG001|Overall Study|Withdrawal by Subject|2|||
47010503|NCT02230670|83259524|FG000|Overall Study|Physician Decision|0|||
47010504|NCT02230670|83259525|FG001|Overall Study|Physician Decision|1|||
47010505|NCT02230670|83259524|FG000|Overall Study|Protocol Violation|0|||
47010506|NCT02230670|83259525|FG001|Overall Study|Protocol Violation|1|||
47010507|NCT02230670|83259524|FG000|Overall Study|Progression to Child-Pugh C|1|||
47010508|NCT02230670|83259525|FG001|Overall Study|Progression to Child-Pugh C|2|||
47010509|NCT02197130|83259534|FG000|Overall Study|Adverse Event|13|||
47010510|NCT02197130|83259535|FG001|Overall Study|Adverse Event|4|||
47010511|NCT02197130|83259536|FG002|Overall Study|Adverse Event|23|||
47010512|NCT02197130|83259534|FG000|Overall Study|Death|0|||
47010513|NCT02197130|83259535|FG001|Overall Study|Death|1|||
47010514|NCT02197130|83259536|FG002|Overall Study|Death|0|||
47010515|NCT02197130|83259534|FG000|Overall Study|Lost to Follow-up|2|||
47010516|NCT02197130|83259535|FG001|Overall Study|Lost to Follow-up|0|||
47010517|NCT02197130|83259536|FG002|Overall Study|Lost to Follow-up|1|||
47010518|NCT02197130|83259534|FG000|Overall Study|Does not meet entrance criteria|0|||
47010519|NCT02197130|83259535|FG001|Overall Study|Does not meet entrance criteria|0|||
47010520|NCT02197130|83259536|FG002|Overall Study|Does not meet entrance criteria|1|||
47010521|NCT02197130|83259534|FG000|Overall Study|Withdrawal by Subject|0|||
47010522|NCT02197130|83259535|FG001|Overall Study|Withdrawal by Subject|3|||
47010523|NCT02197130|83259536|FG002|Overall Study|Withdrawal by Subject|4|||
47010524|NCT02197130|83259534|FG000|Overall Study|Other|1|||
47010525|NCT02197130|83259535|FG001|Overall Study|Other|0|||
47010526|NCT02197130|83259536|FG002|Overall Study|Other|3|||
47010527|NCT02196506|83259546|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
47010528|NCT02196506|83259547|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
47010529|NCT02196506|83259548|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
47010530|NCT02196506|83259549|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
47010531|NCT02196506|83259546|FG000|Phase A|Withdrawal by Subject|34|||
47010532|NCT02196506|83259547|FG001|Phase A|Withdrawal by Subject|0|||
47010533|NCT02196506|83259548|FG002|Phase A|Withdrawal by Subject|0|||
47010534|NCT02196506|83259549|FG003|Phase A|Withdrawal by Subject|0|||
47010535|NCT02196506|83259546|FG000|Phase A|Adverse Event|22|||
47010536|NCT02196506|83259547|FG001|Phase A|Adverse Event|0|||
47010537|NCT02196506|83259548|FG002|Phase A|Adverse Event|0|||
47010538|NCT02196506|83259549|FG003|Phase A|Adverse Event|0|||
47010539|NCT02196506|83259546|FG000|Phase A|Lost to Follow-up|9|||
47010540|NCT02196506|83259547|FG001|Phase A|Lost to Follow-up|0|||
47010541|NCT02196506|83259548|FG002|Phase A|Lost to Follow-up|0|||
47010542|NCT02196506|83259549|FG003|Phase A|Lost to Follow-up|0|||
47010543|NCT02196506|83259546|FG000|Phase A|Protocol deviation|12|||
47010544|NCT02196506|83259547|FG001|Phase A|Protocol deviation|0|||
47010545|NCT02196506|83259548|FG002|Phase A|Protocol deviation|0|||
47010546|NCT02196506|83259549|FG003|Phase A|Protocol deviation|0|||
47010547|NCT02196506|83259546|FG000|Phase A|Participant withdrawn by investigator|10|||
47010548|NCT02196506|83259547|FG001|Phase A|Participant withdrawn by investigator|0|||
47010549|NCT02196506|83259548|FG002|Phase A|Participant withdrawn by investigator|0|||
47010550|NCT02196506|83259549|FG003|Phase A|Participant withdrawn by investigator|0|||
47010551|NCT02196506|83259546|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
47010552|NCT02196506|83259547|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
47010553|NCT02196506|83259548|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
47010554|NCT02196506|83259549|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
47010555|NCT02196506|83259546|FG000|Phase B|Lack of Efficacy|0|||
47010556|NCT02196506|83259547|FG001|Phase B|Lack of Efficacy|1|||
47010557|NCT02196506|83259548|FG002|Phase B|Lack of Efficacy|2|||
47010558|NCT02196506|83259549|FG003|Phase B|Lack of Efficacy|0|||
47010559|NCT02196506|83259546|FG000|Phase B|Withdrawal by Participant|0|||
47010560|NCT02196506|83259547|FG001|Phase B|Withdrawal by Participant|8|||
47010561|NCT02196506|83259548|FG002|Phase B|Withdrawal by Participant|1|||
47010562|NCT02196506|83259549|FG003|Phase B|Withdrawal by Participant|0|||
47010563|NCT02196506|83259546|FG000|Phase B|Adverse Event|0|||
47010564|NCT02196506|83259547|FG001|Phase B|Adverse Event|4|||
47010565|NCT02196506|83259548|FG002|Phase B|Adverse Event|1|||
47010566|NCT02196506|83259549|FG003|Phase B|Adverse Event|0|||
47010567|NCT02196506|83259546|FG000|Phase B|Lost to Follow-up|0|||
47010568|NCT02196506|83259547|FG001|Phase B|Lost to Follow-up|2|||
47010569|NCT02196506|83259548|FG002|Phase B|Lost to Follow-up|1|||
47010570|NCT02196506|83259549|FG003|Phase B|Lost to Follow-up|0|||
47010571|NCT02196506|83259546|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
47010572|NCT02196506|83259547|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
47010573|NCT02196506|83259548|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
47010574|NCT02196506|83259549|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
47010575|NCT02196506|83259546|FG000|Phase A+|Withdrawal by Participant|0|||
47010576|NCT02196506|83259547|FG001|Phase A+|Withdrawal by Participant|0|||
47010577|NCT02196506|83259548|FG002|Phase A+|Withdrawal by Participant|0|||
47010578|NCT02196506|83259549|FG003|Phase A+|Withdrawal by Participant|5|||
47010579|NCT02196506|83259546|FG000|Phase A+|Adverse Event|0|||
47010580|NCT02196506|83259547|FG001|Phase A+|Adverse Event|0|||
47010581|NCT02196506|83259548|FG002|Phase A+|Adverse Event|0|||
47010582|NCT02196506|83259549|FG003|Phase A+|Adverse Event|1|||
47010583|NCT02196506|83259546|FG000|Phase A+|Lost to Follow-up|0|||
47010584|NCT02196506|83259547|FG001|Phase A+|Lost to Follow-up|0|||
47010585|NCT02196506|83259548|FG002|Phase A+|Lost to Follow-up|0|||
47010586|NCT02196506|83259549|FG003|Phase A+|Lost to Follow-up|6|||
47010587|NCT02196506|83259546|FG000|Phase A+|Participant withdrawn by investigator|0|||
47010588|NCT02196506|83259547|FG001|Phase A+|Participant withdrawn by investigator|0|||
47010589|NCT02196506|83259548|FG002|Phase A+|Participant withdrawn by investigator|0|||
47010590|NCT02196506|83259549|FG003|Phase A+|Participant withdrawn by investigator|1|||
47010591|NCT02228720|83259555|FG000|Open Label - Day 30|Lost to Follow-up|1|||
47010592|NCT02228564|83259559|FG000|Overall Study|Withdrawal by Subject|10|||
47010593|NCT02228564|83259559|FG000|Overall Study|Death|11|||
47010594|NCT02228564|83259559|FG000|Overall Study|Physician Decision|5|||
47010595|NCT02228564|83259559|FG000|Overall Study|Lost to Follow-up|17|||
47010596|NCT02228564|83259559|FG000|Overall Study|Other|6|||
47010597|NCT01640951|83259571|FG000|Overall Study|Adverse Event|8|||
47010598|NCT01640951|83259572|FG001|Overall Study|Adverse Event|3|||
47010599|NCT01640951|83259573|FG002|Overall Study|Adverse Event|10|||
47010600|NCT01640951|83259574|FG003|Overall Study|Adverse Event|6|||
47010601|NCT01640951|83259575|FG004|Overall Study|Adverse Event|1|||
47010602|NCT01640951|83259576|FG005|Overall Study|Adverse Event|11|||
47010603|NCT01640951|83259577|FG006|Overall Study|Adverse Event|1|||
47010604|NCT01640951|83259578|FG007|Overall Study|Adverse Event|3|||
47010605|NCT01640951|83259571|FG000|Overall Study|Lack of Efficacy|20|||
47010606|NCT01640951|83259572|FG001|Overall Study|Lack of Efficacy|1|||
47010607|NCT01640951|83259573|FG002|Overall Study|Lack of Efficacy|7|||
47010608|NCT01640951|83259574|FG003|Overall Study|Lack of Efficacy|14|||
47010609|NCT01640951|83259575|FG004|Overall Study|Lack of Efficacy|0|||
47010610|NCT01640951|83259576|FG005|Overall Study|Lack of Efficacy|6|||
47010611|NCT01640951|83259577|FG006|Overall Study|Lack of Efficacy|5|||
47010612|NCT01640951|83259578|FG007|Overall Study|Lack of Efficacy|6|||
47010613|NCT01640951|83259571|FG000|Overall Study|Lost to Follow-up|1|||
47010614|NCT01640951|83259572|FG001|Overall Study|Lost to Follow-up|0|||
47010615|NCT01640951|83259573|FG002|Overall Study|Lost to Follow-up|6|||
47010616|NCT01640951|83259574|FG003|Overall Study|Lost to Follow-up|2|||
47010617|NCT01640951|83259575|FG004|Overall Study|Lost to Follow-up|2|||
47010618|NCT01640951|83259576|FG005|Overall Study|Lost to Follow-up|3|||
47010619|NCT01640951|83259577|FG006|Overall Study|Lost to Follow-up|1|||
47010620|NCT01640951|83259578|FG007|Overall Study|Lost to Follow-up|1|||
47010621|NCT01640951|83259571|FG000|Overall Study|Non-compliance with study treatment|0|||
47010622|NCT01640951|83259572|FG001|Overall Study|Non-compliance with study treatment|0|||
47010623|NCT01640951|83259573|FG002|Overall Study|Non-compliance with study treatment|1|||
47010624|NCT01640951|83259574|FG003|Overall Study|Non-compliance with study treatment|1|||
47010625|NCT01640951|83259575|FG004|Overall Study|Non-compliance with study treatment|1|||
47010626|NCT01640951|83259576|FG005|Overall Study|Non-compliance with study treatment|4|||
47010627|NCT01640951|83259577|FG006|Overall Study|Non-compliance with study treatment|1|||
47010628|NCT01640951|83259578|FG007|Overall Study|Non-compliance with study treatment|0|||
47010629|NCT01640951|83259571|FG000|Overall Study|Physician Decision|2|||
47010630|NCT01640951|83259572|FG001|Overall Study|Physician Decision|5|||
47010631|NCT01640951|83259573|FG002|Overall Study|Physician Decision|2|||
46910224|NCT03357731|83139639|FG000|Overall Study|Acute bradycardia and hypotension|0|||
46910225|NCT03357731|83139640|FG001|Overall Study|Acute bradycardia and hypotension|0|||
46910226|NCT03357731|83139641|FG002|Overall Study|Acute bradycardia and hypotension|0|||
46910227|NCT03357731|83139642|FG003|Overall Study|Acute bradycardia and hypotension|1|||
46910228|NCT03357731|83139643|FG004|Overall Study|Acute bradycardia and hypotension|0|||
46910229|NCT03357731|83139644|FG005|Overall Study|Acute bradycardia and hypotension|0|||
46910230|NCT03357731|83139639|FG000|Overall Study|Adverse Event|0|||
46910231|NCT03357731|83139640|FG001|Overall Study|Adverse Event|0|||
46910232|NCT03357731|83139641|FG002|Overall Study|Adverse Event|0|||
46910233|NCT03357731|83139642|FG003|Overall Study|Adverse Event|0|||
46910234|NCT03357731|83139643|FG004|Overall Study|Adverse Event|0|||
46910235|NCT03357731|83139644|FG005|Overall Study|Adverse Event|1|||
46910236|NCT03357731|83139639|FG000|Overall Study|Hypotension|0|||
46910237|NCT03357731|83139640|FG001|Overall Study|Hypotension|0|||
46910238|NCT03357731|83139641|FG002|Overall Study|Hypotension|1|||
46910239|NCT03357731|83139642|FG003|Overall Study|Hypotension|1|||
46910240|NCT03357731|83139643|FG004|Overall Study|Hypotension|0|||
46910241|NCT03357731|83139644|FG005|Overall Study|Hypotension|0|||
46910242|NCT03357731|83139639|FG000|Overall Study|Lost to Follow-up|0|||
46910243|NCT03357731|83139640|FG001|Overall Study|Lost to Follow-up|0|||
46910244|NCT03357731|83139641|FG002|Overall Study|Lost to Follow-up|0|||
47010632|NCT01640951|83259574|FG003|Overall Study|Physician Decision|2|||
47010633|NCT01640951|83259575|FG004|Overall Study|Physician Decision|2|||
47010634|NCT01640951|83259576|FG005|Overall Study|Physician Decision|3|||
47010635|NCT01640951|83259577|FG006|Overall Study|Physician Decision|3|||
47010636|NCT01640951|83259578|FG007|Overall Study|Physician Decision|0|||
47010637|NCT01640951|83259571|FG000|Overall Study|Pregnancy|3|||
47010638|NCT01640951|83259572|FG001|Overall Study|Pregnancy|0|||
46910245|NCT03357731|83139642|FG003|Overall Study|Lost to Follow-up|1|||
46910246|NCT03357731|83139643|FG004|Overall Study|Lost to Follow-up|0|||
46910247|NCT03357731|83139644|FG005|Overall Study|Lost to Follow-up|0|||
46910248|NCT03357341|83139654|FG000|Overall Study|Withdrawal by Subject|3|||
46910249|NCT03357341|83139655|FG001|Overall Study|Withdrawal by Subject|6|||
47010639|NCT01640951|83259573|FG002|Overall Study|Pregnancy|0|||
47010640|NCT01640951|83259574|FG003|Overall Study|Pregnancy|4|||
47010641|NCT01640951|83259575|FG004|Overall Study|Pregnancy|0|||
47010642|NCT01640951|83259576|FG005|Overall Study|Pregnancy|0|||
47010643|NCT01640951|83259577|FG006|Overall Study|Pregnancy|2|||
47010644|NCT01640951|83259578|FG007|Overall Study|Pregnancy|0|||
47010645|NCT01640951|83259571|FG000|Overall Study|Protocol Deviation|0|||
46910250|NCT03357341|83139654|FG000|Overall Study|Lost to Follow-up|4|||
46910251|NCT03357341|83139655|FG001|Overall Study|Lost to Follow-up|5|||
46910252|NCT03357341|83139654|FG000|Overall Study|Death|0|||
46910253|NCT03357341|83139655|FG001|Overall Study|Death|1|||
46910254|NCT03039738|83139664|FG000|Overall Study|Incomplete data sets|54|||
46910255|NCT03039738|83139665|FG001|Overall Study|Incomplete data sets|0|||
46910256|NCT03036852|83139696|FG000|Overall Study|Death|2|||
46910257|NCT03036852|83139696|FG000|Overall Study|Lack of Efficacy|2|||
46910258|NCT03036852|83139696|FG000|Overall Study|Adverse Event|1|||
46910259|NCT03036852|83139696|FG000|Overall Study|Lost to Follow-up|1|||
47010646|NCT01640951|83259572|FG001|Overall Study|Protocol Deviation|1|||
47010647|NCT01640951|83259573|FG002|Overall Study|Protocol Deviation|2|||
47010648|NCT01640951|83259574|FG003|Overall Study|Protocol Deviation|1|||
47010649|NCT01640951|83259575|FG004|Overall Study|Protocol Deviation|0|||
47010650|NCT01640951|83259576|FG005|Overall Study|Protocol Deviation|1|||
47010651|NCT01640951|83259577|FG006|Overall Study|Protocol Deviation|0|||
47010652|NCT01640951|83259578|FG007|Overall Study|Protocol Deviation|0|||
47010653|NCT01640951|83259571|FG000|Overall Study|Subject/Guardian decision|12|||
47010654|NCT01640951|83259572|FG001|Overall Study|Subject/Guardian decision|4|||
47010655|NCT01640951|83259573|FG002|Overall Study|Subject/Guardian decision|13|||
47010656|NCT01640951|83259574|FG003|Overall Study|Subject/Guardian decision|15|||
47010657|NCT01640951|83259575|FG004|Overall Study|Subject/Guardian decision|7|||
47010658|NCT01640951|83259576|FG005|Overall Study|Subject/Guardian decision|19|||
47010659|NCT01640951|83259577|FG006|Overall Study|Subject/Guardian decision|5|||
47010660|NCT01640951|83259578|FG007|Overall Study|Subject/Guardian decision|4|||
47010661|NCT01640951|83259571|FG000|Overall Study|Death|0|||
47010662|NCT01640951|83259572|FG001|Overall Study|Death|1|||
47010663|NCT01640951|83259573|FG002|Overall Study|Death|1|||
47010664|NCT01640951|83259574|FG003|Overall Study|Death|0|||
47010665|NCT01640951|83259575|FG004|Overall Study|Death|0|||
47010666|NCT01640951|83259576|FG005|Overall Study|Death|0|||
47010667|NCT01640951|83259577|FG006|Overall Study|Death|0|||
47010668|NCT01640951|83259578|FG007|Overall Study|Death|2|||
47010669|NCT02228096|83259600|FG000|Overall Study|Study terminated by Sponsor|24|||
47010670|NCT02228096|83259600|FG000|Overall Study|Lack of Efficacy|18|||
47010671|NCT02228096|83259600|FG000|Overall Study|Death|12|||
47010672|NCT02228096|83259600|FG000|Overall Study|Physician Decision|3|||
46910260|NCT02945657|83139707|FG000|Overall Study|Adverse Event|1|||
47010673|NCT02228096|83259600|FG000|Overall Study|Subject/guardian decision|2|||
47010674|NCT02228096|83259600|FG000|Overall Study|New therapy for study indication|1|||
47010675|NCT02228096|83259600|FG000|Overall Study|Enrolled, not infused|11|||
47010676|NCT01640873|83259620|FG000|Overall Study|Protocol Violation|2|||
47010677|NCT01640873|83259621|FG001|Overall Study|Protocol Violation|1|||
47010678|NCT01683994|83259632|FG000|Overall Study|Withdrawal by Subject|1|||
47010679|NCT01683994|83259633|FG001|Overall Study|Withdrawal by Subject|0|||
47010680|NCT01683994|83259634|FG002|Overall Study|Withdrawal by Subject|0|||
47010681|NCT01683994|83259635|FG003|Overall Study|Withdrawal by Subject|1|||
47010682|NCT01683994|83259636|FG004|Overall Study|Withdrawal by Subject|0|||
47010683|NCT01683994|83259632|FG000|Overall Study|Intercurrent illness|0|||
47010684|NCT01683994|83259633|FG001|Overall Study|Intercurrent illness|0|||
47010685|NCT01683994|83259634|FG002|Overall Study|Intercurrent illness|0|||
47010686|NCT01683994|83259635|FG003|Overall Study|Intercurrent illness|2|||
47010687|NCT01683994|83259636|FG004|Overall Study|Intercurrent illness|1|||
47010688|NCT02247440|83259654|FG000|Overall Study|Withdrawal by Subject|1|||
47010689|NCT02247440|83259654|FG000|Overall Study|Lack of Efficacy|3|||
47010690|NCT01683838|83259660|FG000|Overall Study|Adverse Event|12|||
47010691|NCT01683838|83259661|FG001|Overall Study|Adverse Event|2|||
47010692|NCT01683838|83259660|FG000|Overall Study|Protocol Violation|3|||
47010693|NCT01683838|83259661|FG001|Overall Study|Protocol Violation|1|||
47010694|NCT01683838|83259660|FG000|Overall Study|Withdrawal by Subject|6|||
47010695|NCT01683838|83259661|FG001|Overall Study|Withdrawal by Subject|5|||
47010696|NCT01683838|83259660|FG000|Overall Study|Lost to Follow-up|1|||
47010697|NCT01683838|83259661|FG001|Overall Study|Lost to Follow-up|1|||
46910261|NCT02945657|83139707|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
46910262|NCT02948777|83139712|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
46910263|NCT03324581|83139720|FG000|Overall Study|Adverse Event|18|||
46910264|NCT03324581|83139721|FG001|Overall Study|Adverse Event|11|||
47010698|NCT01683838|83259660|FG000|Overall Study|Other|4|||
47010699|NCT01683838|83259661|FG001|Overall Study|Other|3|||
47010700|NCT01683604|83259667|FG000|Overall Study|Adverse Event|2|||
47010701|NCT01683604|83259667|FG000|Overall Study|Lack of Efficacy|1|||
46910265|NCT03324581|83139722|FG002|Overall Study|Adverse Event|7|||
47010702|NCT01683604|83259667|FG000|Overall Study|Other|2|||
47010703|NCT02196038|83259678|FG000|Overall Study|Death|16|||
47010704|NCT02196038|83259679|FG001|Overall Study|Death|21|||
47010705|NCT02196038|83259678|FG000|Overall Study|Withdrawal by Subject|0|||
47010706|NCT02196038|83259679|FG001|Overall Study|Withdrawal by Subject|1|||
47010707|NCT02196038|83259678|FG000|Overall Study|Lost to Follow-up|1|||
47010708|NCT02196038|83259679|FG001|Overall Study|Lost to Follow-up|0|||
47010709|NCT02141659|83259691|FG000|Overall Study|Major Protocol Deviation|0|||
47010710|NCT02141659|83259692|FG001|Overall Study|Major Protocol Deviation|1|||
47010711|NCT02141659|83259693|FG002|Overall Study|Major Protocol Deviation|0|||
47010712|NCT02141659|83259694|FG003|Overall Study|Major Protocol Deviation|0|||
47010713|NCT02141659|83259695|FG004|Overall Study|Major Protocol Deviation|0|||
47010714|NCT02141659|83259696|FG005|Overall Study|Major Protocol Deviation|0|||
47010715|NCT02141659|83259691|FG000|Overall Study|Lack of Efficacy|0|||
47010716|NCT02141659|83259692|FG001|Overall Study|Lack of Efficacy|0|||
47010717|NCT02141659|83259693|FG002|Overall Study|Lack of Efficacy|0|||
47010718|NCT02141659|83259694|FG003|Overall Study|Lack of Efficacy|0|||
47010719|NCT02141659|83259695|FG004|Overall Study|Lack of Efficacy|0|||
47010720|NCT02141659|83259696|FG005|Overall Study|Lack of Efficacy|1|||
47010721|NCT02141659|83259691|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
47010722|NCT02141659|83259692|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
47010723|NCT02141659|83259693|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
47010724|NCT02141659|83259694|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
47010725|NCT02141659|83259695|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
47010726|NCT02141659|83259696|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
47010727|NCT01640249|83259717|FG000|Period 1|Withdrawal by Subject|1|||
47010728|NCT01640249|83259718|FG001|Period 1|Withdrawal by Subject|0|||
47010729|NCT01640249|83259719|FG002|Period 1|Withdrawal by Subject|0|||
47010730|NCT01640249|83259720|FG003|Period 1|Withdrawal by Subject|0|||
47010731|NCT01640249|83259721|FG004|Period 1|Withdrawal by Subject|0|||
47010732|NCT01640249|83259722|FG005|Period 1|Withdrawal by Subject|1|||
47010733|NCT01640249|83259723|FG006|Period 1|Withdrawal by Subject|0|||
47010734|NCT02121301|83259745|FG000|Overall Study|Protocol Violation|1|||
47010735|NCT02121301|83259746|FG001|Overall Study|Protocol Violation|4|||
47010736|NCT02121301|83259747|FG002|Overall Study|Protocol Violation|1|||
47010737|NCT02227862|83259757|FG000|Overall Study|Protocol Violation|7|||
47010738|NCT02227862|83259758|FG001|Overall Study|Protocol Violation|9|||
47010739|NCT02227862|83259757|FG000|Overall Study|Other|0|||
47010740|NCT02227862|83259758|FG001|Overall Study|Other|2|||
47010741|NCT02227862|83259757|FG000|Overall Study|Adverse Event|4|||
47010742|NCT02227862|83259758|FG001|Overall Study|Adverse Event|3|||
47010743|NCT02227862|83259757|FG000|Overall Study|Withdrawal by Subject|7|||
47010744|NCT02227862|83259758|FG001|Overall Study|Withdrawal by Subject|6|||
47010745|NCT02227862|83259757|FG000|Overall Study|Lost to Follow-up|1|||
47010746|NCT02227862|83259758|FG001|Overall Study|Lost to Follow-up|2|||
47010747|NCT02120833|83259766|FG000|Overall Study|Adverse Event|1|||
47010748|NCT02120833|83259767|FG001|Overall Study|Adverse Event|0|||
47010749|NCT02120833|83259766|FG000|Overall Study|Withdrawal by Subject|2|||
47010750|NCT02120833|83259767|FG001|Overall Study|Withdrawal by Subject|0|||
47010751|NCT02120833|83259766|FG000|Overall Study|Lost to Follow-up|1|||
47010752|NCT02120833|83259767|FG001|Overall Study|Lost to Follow-up|1|||
47010753|NCT02170207|83259773|FG000|Overall Study|Case report forms unavailable|5|||
47010754|NCT02227784|83259781|FG000|Double-Blind Phase|Adverse Event|3|||
47010755|NCT02227784|83259782|FG001|Double-Blind Phase|Adverse Event|2|||
47010756|NCT02227784|83259783|FG002|Double-Blind Phase|Adverse Event|1|||
47010757|NCT02227784|83259784|FG003|Double-Blind Phase|Adverse Event|3|||
47010758|NCT02227784|83259785|FG004|Double-Blind Phase|Adverse Event|0|||
47010759|NCT02227784|83259781|FG000|Double-Blind Phase|Physician Decision|1|||
47010760|NCT02227784|83259782|FG001|Double-Blind Phase|Physician Decision|0|||
47010761|NCT02227784|83259783|FG002|Double-Blind Phase|Physician Decision|0|||
47010762|NCT02227784|83259784|FG003|Double-Blind Phase|Physician Decision|1|||
47010763|NCT02227784|83259785|FG004|Double-Blind Phase|Physician Decision|0|||
47010764|NCT02227784|83259781|FG000|Double-Blind Phase|Protocol Violation|0|||
47010765|NCT02227784|83259782|FG001|Double-Blind Phase|Protocol Violation|0|||
47010766|NCT02227784|83259783|FG002|Double-Blind Phase|Protocol Violation|1|||
47010767|NCT02227784|83259784|FG003|Double-Blind Phase|Protocol Violation|1|||
47010768|NCT02227784|83259785|FG004|Double-Blind Phase|Protocol Violation|0|||
47010769|NCT02227784|83259781|FG000|Double-Blind Phase|Sponsor Decision|34|||
47010770|NCT02227784|83259782|FG001|Double-Blind Phase|Sponsor Decision|15|||
47010771|NCT02227784|83259783|FG002|Double-Blind Phase|Sponsor Decision|14|||
47010772|NCT02227784|83259784|FG003|Double-Blind Phase|Sponsor Decision|32|||
47010773|NCT02227784|83259785|FG004|Double-Blind Phase|Sponsor Decision|0|||
47010774|NCT02227784|83259781|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
47010775|NCT02227784|83259782|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
47010776|NCT02227784|83259783|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
47010777|NCT02227784|83259784|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
47010778|NCT02227784|83259785|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
47010779|NCT02227784|83259781|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
47010780|NCT02227784|83259782|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
47010781|NCT02227784|83259783|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
47010782|NCT02227784|83259784|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
47010783|NCT02227784|83259785|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
47010784|NCT02227784|83259781|FG000|Open-Label Extension Phase (OLE)|Death|0|||
47010785|NCT02227784|83259782|FG001|Open-Label Extension Phase (OLE)|Death|0|||
47010786|NCT02227784|83259783|FG002|Open-Label Extension Phase (OLE)|Death|0|||
47010787|NCT02227784|83259784|FG003|Open-Label Extension Phase (OLE)|Death|0|||
47010788|NCT02227784|83259785|FG004|Open-Label Extension Phase (OLE)|Death|1|||
47010789|NCT02227784|83259781|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
47010790|NCT02227784|83259782|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
47010791|NCT02227784|83259783|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
47010792|NCT02227784|83259784|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
47010793|NCT02227784|83259785|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
47010794|NCT02227784|83259781|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
47010795|NCT02227784|83259782|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
47010796|NCT02227784|83259783|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
47010797|NCT02227784|83259784|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
47010798|NCT02227784|83259785|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
47010799|NCT01565668|83259800|FG000|Overall Study|Death|2|||
47010800|NCT01565668|83259801|FG001|Overall Study|Death|1|||
47010801|NCT01565668|83259800|FG000|Overall Study|Lack of Efficacy|4|||
47010802|NCT01565668|83259801|FG001|Overall Study|Lack of Efficacy|2|||
47010803|NCT01565668|83259800|FG000|Overall Study|Participant went on Hospice Care|1|||
47010804|NCT01565668|83259801|FG001|Overall Study|Participant went on Hospice Care|0|||
47010805|NCT01565668|83259800|FG000|Overall Study|Adverse Event|6|||
47010806|NCT01565668|83259801|FG001|Overall Study|Adverse Event|1|||
47010807|NCT01565668|83259800|FG000|Overall Study|Randomized, but never received drug|0|||
47010808|NCT01565668|83259801|FG001|Overall Study|Randomized, but never received drug|2|||
47010809|NCT01565668|83259800|FG000|Overall Study|Progressive disease|13|||
47010810|NCT01565668|83259801|FG001|Overall Study|Progressive disease|14|||
47010811|NCT01565668|83259800|FG000|Overall Study|Withdrawal by Subject|1|||
47010812|NCT01565668|83259801|FG001|Overall Study|Withdrawal by Subject|3|||
47010813|NCT01565668|83259800|FG000|Overall Study|HSCT Transplant|11|||
47010814|NCT01565668|83259801|FG001|Overall Study|HSCT Transplant|15|||
47010815|NCT01683058|83259807|FG000|Overall Study|Lost to Follow-up|9|||
47010816|NCT01683058|83259807|FG000|Overall Study|Adverse Event|6|||
47010817|NCT01683058|83259807|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
47010818|NCT01683058|83259807|FG000|Overall Study|Withdrawal by Subject|7|||
47010819|NCT01683058|83259807|FG000|Overall Study|Lack of Efficacy|2|||
47010820|NCT05374421|83259814|FG000|Overall Study|Withdrawal by Subject|3|||
47010821|NCT05374421|83259815|FG001|Overall Study|Withdrawal by Subject|4|||
47010822|NCT01626859|83259824|FG000|Overall Study|Adverse Event|1|||
47010823|NCT01626859|83259825|FG001|Overall Study|Adverse Event|3|||
47010824|NCT01626859|83259826|FG002|Overall Study|Adverse Event|2|||
47010825|NCT01626859|83259824|FG000|Overall Study|Physician Decision|0|||
47010826|NCT01626859|83259825|FG001|Overall Study|Physician Decision|1|||
47010827|NCT01626859|83259826|FG002|Overall Study|Physician Decision|0|||
47010828|NCT01626859|83259824|FG000|Overall Study|Withdrawal by Subject|1|||
47010829|NCT01626859|83259825|FG001|Overall Study|Withdrawal by Subject|4|||
47010830|NCT01626859|83259826|FG002|Overall Study|Withdrawal by Subject|2|||
47010831|NCT02193776|83259838|FG000|Overall Study|Consent withdrawn|1|||
46709541|NCT01217606|82925578|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
46709542|NCT01128114|82925584|FG000|Overall Study|Treatment Withdrawn|6|||
47010832|NCT02193776|83259839|FG001|Overall Study|Consent withdrawn|0|||
47010833|NCT02193776|83259840|FG002|Overall Study|Consent withdrawn|0|||
47010834|NCT02193776|83259841|FG003|Overall Study|Consent withdrawn|0|||
47010835|NCT02193776|83259838|FG000|Overall Study|Failure to comply with protocol|0|||
47010836|NCT02193776|83259839|FG001|Overall Study|Failure to comply with protocol|1|||
47010837|NCT02193776|83259840|FG002|Overall Study|Failure to comply with protocol|0|||
47010838|NCT02193776|83259841|FG003|Overall Study|Failure to comply with protocol|0|||
47010839|NCT02193776|83259838|FG000|Overall Study|Investigator/Sponsor decision|1|||
47010840|NCT02193776|83259839|FG001|Overall Study|Investigator/Sponsor decision|1|||
47010841|NCT02193776|83259840|FG002|Overall Study|Investigator/Sponsor decision|0|||
47010842|NCT02193776|83259841|FG003|Overall Study|Investigator/Sponsor decision|0|||
47010843|NCT02193776|83259838|FG000|Overall Study|Death|1|||
47010844|NCT02193776|83259839|FG001|Overall Study|Death|0|||
47010845|NCT02193776|83259840|FG002|Overall Study|Death|0|||
47010846|NCT02193776|83259841|FG003|Overall Study|Death|0|||
47010847|NCT02193776|83259838|FG000|Overall Study|Adverse event/Specific toxicity|5|||
47010848|NCT02193776|83259839|FG001|Overall Study|Adverse event/Specific toxicity|5|||
47010849|NCT02193776|83259840|FG002|Overall Study|Adverse event/Specific toxicity|2|||
47010850|NCT02193776|83259841|FG003|Overall Study|Adverse event/Specific toxicity|2|||
47010851|NCT02170064|83259854|FG000|Overall Study|Withdrawal by Subject|5|||
47010852|NCT02170064|83259855|FG001|Overall Study|Withdrawal by Subject|1|||
47010853|NCT02170064|83259856|FG002|Overall Study|Withdrawal by Subject|1|||
47010854|NCT02170064|83259854|FG000|Overall Study|Physician Decision|1|||
47010855|NCT02170064|83259855|FG001|Overall Study|Physician Decision|1|||
47010856|NCT02170064|83259856|FG002|Overall Study|Physician Decision|0|||
47010857|NCT02169830|83259867|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
47010858|NCT02169830|83259868|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
47010859|NCT02169830|83259869|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
47010860|NCT02169830|83259867|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
47010861|NCT02169830|83259868|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
47010862|NCT02169830|83259869|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
47010863|NCT02169830|83259867|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
47010864|NCT02169830|83259868|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
47010865|NCT02169830|83259869|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
47010866|NCT02169830|83259867|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
47010867|NCT02169830|83259868|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
47010868|NCT02169830|83259869|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
47010869|NCT02169830|83259867|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
47010870|NCT02169830|83259868|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
47010871|NCT02169830|83259869|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
47010872|NCT02169674|83259879|FG000|Overall Study|Withdrawal by Subject|2|||
47010873|NCT02169674|83259880|FG001|Overall Study|Withdrawal by Subject|1|||
47010874|NCT02169674|83259879|FG000|Overall Study|Seroprotected|30|||
47010875|NCT02169674|83259880|FG001|Overall Study|Seroprotected|76|||
47010876|NCT02169674|83259879|FG000|Overall Study|Lost to Follow-up|0|||
47010877|NCT02169674|83259880|FG001|Overall Study|Lost to Follow-up|1|||
47010878|NCT02169284|83259888|FG000|Overall Study|Physician Decision|0|||
47010879|NCT02169284|83259889|FG001|Overall Study|Physician Decision|1|||
47010880|NCT02119819|83259903|FG000|Overall Study|Adverse Event|3|||
47010881|NCT02119819|83259904|FG001|Overall Study|Adverse Event|1|||
47010882|NCT02119819|83259905|FG002|Overall Study|Adverse Event|2|||
47010883|NCT02119819|83259906|FG003|Overall Study|Adverse Event|3|||
47010884|NCT02119819|83259907|FG004|Overall Study|Adverse Event|0|||
47010885|NCT02119819|83259908|FG005|Overall Study|Adverse Event|1|||
47010886|NCT02119819|83259903|FG000|Overall Study|Lack of Efficacy|0|||
47010887|NCT02119819|83259904|FG001|Overall Study|Lack of Efficacy|0|||
47010888|NCT02119819|83259905|FG002|Overall Study|Lack of Efficacy|0|||
47010889|NCT02119819|83259906|FG003|Overall Study|Lack of Efficacy|0|||
47010890|NCT02119819|83259907|FG004|Overall Study|Lack of Efficacy|0|||
47010891|NCT02119819|83259908|FG005|Overall Study|Lack of Efficacy|1|||
47010892|NCT02119819|83259903|FG000|Overall Study|Lost to Follow-up|0|||
47010893|NCT02119819|83259904|FG001|Overall Study|Lost to Follow-up|0|||
47010894|NCT02119819|83259905|FG002|Overall Study|Lost to Follow-up|1|||
47010895|NCT02119819|83259906|FG003|Overall Study|Lost to Follow-up|2|||
47010896|NCT02119819|83259907|FG004|Overall Study|Lost to Follow-up|1|||
47010897|NCT02119819|83259908|FG005|Overall Study|Lost to Follow-up|2|||
47010898|NCT02119819|83259903|FG000|Overall Study|Physician Decision|1|||
47010899|NCT02119819|83259904|FG001|Overall Study|Physician Decision|1|||
47010900|NCT02119819|83259905|FG002|Overall Study|Physician Decision|0|||
47010901|NCT02119819|83259906|FG003|Overall Study|Physician Decision|0|||
46709543|NCT01128114|82925584|FG000|Overall Study|Screening Failed|2|||
47010902|NCT02119819|83259907|FG004|Overall Study|Physician Decision|0|||
47010903|NCT02119819|83259908|FG005|Overall Study|Physician Decision|1|||
47010904|NCT02119819|83259903|FG000|Overall Study|Withdrawal by Subject|5|||
47010905|NCT02119819|83259904|FG001|Overall Study|Withdrawal by Subject|3|||
47010906|NCT02119819|83259905|FG002|Overall Study|Withdrawal by Subject|0|||
47010907|NCT02119819|83259906|FG003|Overall Study|Withdrawal by Subject|0|||
47010908|NCT02119819|83259907|FG004|Overall Study|Withdrawal by Subject|6|||
47010909|NCT02119819|83259908|FG005|Overall Study|Withdrawal by Subject|10|||
47010910|NCT02119819|83259903|FG000|Overall Study|Jury Duty|0|||
47010911|NCT02119819|83259904|FG001|Overall Study|Jury Duty|0|||
47010912|NCT02119819|83259905|FG002|Overall Study|Jury Duty|1|||
47010913|NCT02119819|83259906|FG003|Overall Study|Jury Duty|0|||
47010914|NCT02119819|83259907|FG004|Overall Study|Jury Duty|0|||
47010915|NCT02119819|83259908|FG005|Overall Study|Jury Duty|0|||
47010916|NCT02119819|83259903|FG000|Overall Study|Protocol Violation|0|||
47010917|NCT02119819|83259904|FG001|Overall Study|Protocol Violation|0|||
47010918|NCT02119819|83259905|FG002|Overall Study|Protocol Violation|0|||
47010919|NCT02119819|83259906|FG003|Overall Study|Protocol Violation|1|||
47010920|NCT02119819|83259907|FG004|Overall Study|Protocol Violation|0|||
47010921|NCT02119819|83259908|FG005|Overall Study|Protocol Violation|0|||
47010922|NCT02119819|83259903|FG000|Overall Study|Left the city to get a job|0|||
47010923|NCT02119819|83259904|FG001|Overall Study|Left the city to get a job|0|||
47010924|NCT02119819|83259905|FG002|Overall Study|Left the city to get a job|0|||
47010925|NCT02119819|83259906|FG003|Overall Study|Left the city to get a job|1|||
47010926|NCT02119819|83259907|FG004|Overall Study|Left the city to get a job|0|||
47010927|NCT02119819|83259908|FG005|Overall Study|Left the city to get a job|0|||
47010928|NCT02168816|83259924|FG000|Overall Study|Lost to Follow-up|2|||
47010929|NCT02168816|83259925|FG001|Overall Study|Lost to Follow-up|2|||
46910266|NCT03324581|83139720|FG000|Overall Study|Lack of Efficacy|0|||
46910267|NCT03324581|83139721|FG001|Overall Study|Lack of Efficacy|1|||
46910268|NCT03324581|83139722|FG002|Overall Study|Lack of Efficacy|0|||
46910269|NCT03324581|83139720|FG000|Overall Study|Lost to Follow-up|5|||
46910270|NCT03324581|83139721|FG001|Overall Study|Lost to Follow-up|3|||
46910271|NCT03324581|83139722|FG002|Overall Study|Lost to Follow-up|6|||
46910272|NCT03324581|83139720|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
46910273|NCT03324581|83139721|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
46910274|NCT03324581|83139722|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
46910275|NCT03324581|83139720|FG000|Overall Study|Physician Decision|0|||
46910276|NCT03324581|83139721|FG001|Overall Study|Physician Decision|1|||
46910277|NCT03324581|83139722|FG002|Overall Study|Physician Decision|2|||
46910278|NCT03324581|83139720|FG000|Overall Study|Protocol Deviation|8|||
46910279|NCT03324581|83139721|FG001|Overall Study|Protocol Deviation|9|||
46910280|NCT03324581|83139722|FG002|Overall Study|Protocol Deviation|4|||
46910281|NCT03324581|83139720|FG000|Overall Study|Withdrawal by Subject|6|||
46910282|NCT03324581|83139721|FG001|Overall Study|Withdrawal by Subject|8|||
46910283|NCT03324581|83139722|FG002|Overall Study|Withdrawal by Subject|6|||
46910284|NCT03324581|83139720|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
46910285|NCT03324581|83139721|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
46910286|NCT03324581|83139722|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
46910287|NCT02943473|83139730|FG000|Overall Study|enrolled but not dosed|1|||
46910288|NCT02943473|83139730|FG000|Overall Study|screen failure|1|||
46910289|NCT02943473|83139730|FG000|Overall Study|Physician Decision|4|||
46910290|NCT03320369|83139734|FG000|Overall Study|Adverse Event|1|||
46910291|NCT03320369|83139734|FG000|Overall Study|Withdrawal by Subject|2|||
46910292|NCT02650895|83139744|FG000|Overall Study|Withdrawal by Subject|0|||
46910293|NCT02650895|83139745|FG001|Overall Study|Withdrawal by Subject|1|||
46910294|NCT02650895|83139746|FG002|Overall Study|Withdrawal by Subject|0|||
46910295|NCT02650895|83139747|FG003|Overall Study|Withdrawal by Subject|0|||
46910296|NCT02650895|83139748|FG004|Overall Study|Withdrawal by Subject|0|||
46910297|NCT02650895|83139749|FG005|Overall Study|Withdrawal by Subject|0|||
46910298|NCT03320057|83139768|FG000|Overall Study|Lost to Follow-up|4|||
46910299|NCT03320057|83139769|FG001|Overall Study|Lost to Follow-up|17|||
46910300|NCT03320057|83139768|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
46910301|NCT03320057|83139769|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
46910302|NCT03316547|83139777|FG000|Overall Study|Death|3|||
46910303|NCT03316547|83139778|FG001|Overall Study|Death|1|||
46910304|NCT03316547|83139777|FG000|Overall Study|Lost to Follow-up|6|||
46910305|NCT03316547|83139778|FG001|Overall Study|Lost to Follow-up|6|||
46910306|NCT03316547|83139777|FG000|Overall Study|Withdrawal by Subject|3|||
46910307|NCT03316547|83139778|FG001|Overall Study|Withdrawal by Subject|2|||
46910308|NCT03316547|83139777|FG000|Overall Study|Transfer to another hospital|6|||
46910309|NCT03316547|83139778|FG001|Overall Study|Transfer to another hospital|4|||
46910310|NCT03315689|83139801|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
46910311|NCT03315689|83139802|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
46910312|NCT03315689|83139801|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
46910313|NCT03315689|83139802|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
46910314|NCT03315689|83139801|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
46910315|NCT03315689|83139802|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
46910316|NCT03314519|83139812|FG000|Overall Study|Protocol Violation|3|||
46910317|NCT03314519|83139813|FG001|Overall Study|Protocol Violation|2|||
46910318|NCT03313037|83139825|FG000|Overall Study|Protocol Violation|4|||
47010930|NCT01584232|83259933|FG000|Overall Study|Adverse Event|3|||
47010931|NCT01584232|83259934|FG001|Overall Study|Adverse Event|1|||
47010932|NCT01584232|83259933|FG000|Overall Study|Withdrawal by Subject|2|||
47010933|NCT01584232|83259934|FG001|Overall Study|Withdrawal by Subject|1|||
47010934|NCT01584232|83259933|FG000|Overall Study|Physician Decision|2|||
47010935|NCT01584232|83259934|FG001|Overall Study|Physician Decision|1|||
47010936|NCT01584232|83259933|FG000|Overall Study|Lost to Follow-up|1|||
47010937|NCT01584232|83259934|FG001|Overall Study|Lost to Follow-up|0|||
47010938|NCT01639703|83259940|FG000|Overall Study|Withdrawal by Subject|5|||
47010939|NCT01639703|83259940|FG000|Overall Study|Other reason|7|||
47010940|NCT02119663|83259958|FG000|Overall Study|Disease progression|26|||
47010941|NCT02119663|83259959|FG001|Overall Study|Disease progression|27|||
47010942|NCT02119663|83259958|FG000|Overall Study|Adverse Event|5|||
47010943|NCT02119663|83259959|FG001|Overall Study|Adverse Event|5|||
47010944|NCT02119663|83259958|FG000|Overall Study|Death|3|||
47010945|NCT02119663|83259959|FG001|Overall Study|Death|2|||
47010946|NCT02119663|83259958|FG000|Overall Study|Physician Decision|1|||
47010947|NCT02119663|83259959|FG001|Overall Study|Physician Decision|2|||
47010948|NCT02119663|83259958|FG000|Overall Study|Other unspecified|2|||
47010949|NCT02119663|83259959|FG001|Overall Study|Other unspecified|0|||
47010950|NCT02119663|83259958|FG000|Overall Study|Subject decision|0|||
47010951|NCT02119663|83259959|FG001|Overall Study|Subject decision|1|||
47010952|NCT02119663|83259958|FG000|Overall Study|Study Terminated by the Sponsor|3|||
47010953|NCT02119663|83259959|FG001|Overall Study|Study Terminated by the Sponsor|4|||
47010954|NCT01639469|83259967|FG000|Overall Study|Death|4|||
47010955|NCT01639469|83259968|FG001|Overall Study|Death|2|||
47010956|NCT01639469|83259967|FG000|Overall Study|Lost to Follow-up|1|||
47010957|NCT01639469|83259968|FG001|Overall Study|Lost to Follow-up|1|||
47010958|NCT02193074|83259976|FG000|Overall Study|Withdrawal by Subject|1|||
47010959|NCT02193074|83259977|FG001|Overall Study|Withdrawal by Subject|2|||
47010960|NCT02193074|83259976|FG000|Overall Study|Adverse Event|16|||
47010961|NCT02193074|83259977|FG001|Overall Study|Adverse Event|13|||
47010962|NCT02192606|83259985|FG000|Overall Study|surgery type was changed|1|||
47010963|NCT02192606|83259986|FG001|Overall Study|surgery type was changed|1|||
47010964|NCT02192606|83259985|FG000|Overall Study|Physician Decision|1|||
47010965|NCT02192606|83259986|FG001|Overall Study|Physician Decision|2|||
47010966|NCT02192606|83259985|FG000|Overall Study|3D equipment rep unable to join|0|||
47010967|NCT02192606|83259986|FG001|Overall Study|3D equipment rep unable to join|1|||
47010968|NCT01628107|83259992|FG000|Overall Study|Withdrawal by Subject|17|||
47010969|NCT01628107|83259992|FG000|Overall Study|Lost to Follow-up|4|||
47010970|NCT01628107|83259992|FG000|Overall Study|Adverse Event|33|||
47010971|NCT01628107|83259992|FG000|Overall Study|Physician Decision|2|||
47010972|NCT01628107|83259992|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
47010973|NCT01628107|83259992|FG000|Overall Study|Non-compliant with Study Procedures|10|||
47010974|NCT01628107|83259992|FG000|Overall Study|Not Treated|8|||
47010975|NCT01628107|83259992|FG000|Overall Study|Sponsor Decision|11|||
47010976|NCT01628107|83259992|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
47010977|NCT01628107|83259992|FG000|Overall Study|Relocated|8|||
47010978|NCT01628107|83259992|FG000|Overall Study|Kidney Transplant|9|||
47010979|NCT01628107|83259992|FG000|Overall Study|Use of Standard of Care|9|||
47010980|NCT01583530|83260002|FG000|Overall Study|Adverse Event|0|||
46709544|NCT01217060|82925588|FG000|Overall Study|Withdrawal by Subject|1|||
46709545|NCT04816669|82925596|FG000|Part 1|Adverse Event|1|||
46709546|NCT04816669|82925597|FG001|Part 1|Adverse Event|1|||
46709547|NCT04816669|82925598|FG002|Part 1|Adverse Event|0|||
46709548|NCT04816669|82925599|FG003|Part 1|Adverse Event|0|||
46709549|NCT04816669|82925596|FG000|Part 1|Lost to Follow-up|2|||
46709550|NCT04816669|82925597|FG001|Part 1|Lost to Follow-up|2|||
46709551|NCT04816669|82925598|FG002|Part 1|Lost to Follow-up|0|||
46709552|NCT04816669|82925599|FG003|Part 1|Lost to Follow-up|0|||
46709553|NCT04816669|82925596|FG000|Part 1|Protocol Violation|0|||
46709554|NCT04816669|82925597|FG001|Part 1|Protocol Violation|1|||
46709555|NCT04816669|82925598|FG002|Part 1|Protocol Violation|0|||
46709556|NCT04816669|82925599|FG003|Part 1|Protocol Violation|0|||
46709557|NCT04816669|82925596|FG000|Part 1|Withdrawal by Subject|1|||
46709558|NCT04816669|82925597|FG001|Part 1|Withdrawal by Subject|2|||
46709559|NCT04816669|82925598|FG002|Part 1|Withdrawal by Subject|0|||
46709560|NCT04816669|82925599|FG003|Part 1|Withdrawal by Subject|0|||
46709561|NCT04816669|82925596|FG000|Part 2|Other|0|||
46709562|NCT04816669|82925597|FG001|Part 2|Other|0|||
46709563|NCT04816669|82925598|FG002|Part 2|Other|1|||
46709564|NCT04816669|82925599|FG003|Part 2|Other|0|||
46709565|NCT04816669|82925596|FG000|Part 2|Withdrawal by Subject|0|||
46709566|NCT04816669|82925597|FG001|Part 2|Withdrawal by Subject|0|||
46709567|NCT04816669|82925598|FG002|Part 2|Withdrawal by Subject|0|||
46709568|NCT04816669|82925599|FG003|Part 2|Withdrawal by Subject|1|||
46709569|NCT04816669|82925596|FG000|Part 2|Lost to Follow-up|0|||
46709570|NCT04816669|82925597|FG001|Part 2|Lost to Follow-up|0|||
46709571|NCT04816669|82925598|FG002|Part 2|Lost to Follow-up|1|||
46709572|NCT04816669|82925599|FG003|Part 2|Lost to Follow-up|0|||
46709573|NCT01165242|82925616|FG000|Overall Study|Unreachable Subjects|1|||
47010981|NCT01583530|83260003|FG001|Overall Study|Adverse Event|0|||
47010982|NCT01583530|83260004|FG002|Overall Study|Adverse Event|0|||
47010983|NCT01583530|83260005|FG003|Overall Study|Adverse Event|0|||
47010984|NCT01583530|83260006|FG004|Overall Study|Adverse Event|0|||
47010985|NCT01583530|83260007|FG005|Overall Study|Adverse Event|1|||
47010986|NCT01583530|83260002|FG000|Overall Study|Withdrawal by Subject|0|||
47010987|NCT01583530|83260003|FG001|Overall Study|Withdrawal by Subject|3|||
47010988|NCT01583530|83260004|FG002|Overall Study|Withdrawal by Subject|0|||
47010989|NCT01583530|83260005|FG003|Overall Study|Withdrawal by Subject|1|||
47010990|NCT01583530|83260006|FG004|Overall Study|Withdrawal by Subject|1|||
47010991|NCT01583530|83260007|FG005|Overall Study|Withdrawal by Subject|2|||
47010992|NCT01583530|83260002|FG000|Overall Study|Lost to Follow-up|0|||
47010993|NCT01583530|83260003|FG001|Overall Study|Lost to Follow-up|0|||
47010994|NCT01583530|83260004|FG002|Overall Study|Lost to Follow-up|0|||
47010995|NCT01583530|83260005|FG003|Overall Study|Lost to Follow-up|0|||
47010996|NCT01583530|83260006|FG004|Overall Study|Lost to Follow-up|3|||
47010997|NCT01583530|83260007|FG005|Overall Study|Lost to Follow-up|0|||
47010998|NCT01583530|83260002|FG000|Overall Study|Lack of compliance|0|||
47010999|NCT01583530|83260003|FG001|Overall Study|Lack of compliance|0|||
47011000|NCT01583530|83260004|FG002|Overall Study|Lack of compliance|0|||
47011001|NCT01583530|83260005|FG003|Overall Study|Lack of compliance|0|||
47011002|NCT01583530|83260006|FG004|Overall Study|Lack of compliance|1|||
47011003|NCT01583530|83260007|FG005|Overall Study|Lack of compliance|0|||
47011004|NCT01639001|83260026|FG000|Overall Study|Refused further follow-up|9|||
47011005|NCT01639001|83260027|FG001|Overall Study|Refused further follow-up|12|||
47011006|NCT01639001|83260026|FG000|Overall Study|Lost to Follow-up|3|||
47011007|NCT01639001|83260027|FG001|Overall Study|Lost to Follow-up|0|||
47011008|NCT01639001|83260026|FG000|Overall Study|Death|62|||
47011009|NCT01639001|83260027|FG001|Overall Study|Death|61|||
47011010|NCT01639001|83260026|FG000|Overall Study|Randomized but not treated|0|||
47011011|NCT01639001|83260027|FG001|Overall Study|Randomized but not treated|2|||
47011012|NCT01639001|83260026|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
47011013|NCT01639001|83260027|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
47011014|NCT02224664|83260035|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
47011015|NCT02224664|83260036|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
47011016|NCT02224664|83260037|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
47011017|NCT02224664|83260038|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
47011018|NCT02224664|83260039|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
47011019|NCT02224664|83260035|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
47011020|NCT02224664|83260036|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
47011021|NCT02224664|83260037|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
47011022|NCT02224664|83260038|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
47011023|NCT02224664|83260039|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
47011024|NCT02224664|83260035|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
47011025|NCT02224664|83260036|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
47011026|NCT02224664|83260037|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
47011027|NCT02224664|83260038|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
47011028|NCT02224664|83260039|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
47011029|NCT02167256|83260057|FG000|Overall Study|Adverse Event|13|||
47011030|NCT02167256|83260058|FG001|Overall Study|Adverse Event|6|||
47011031|NCT02167256|83260057|FG000|Overall Study|Withdrawal by Subject|4|||
47011032|NCT02167256|83260058|FG001|Overall Study|Withdrawal by Subject|4|||
47011033|NCT02167256|83260057|FG000|Overall Study|non-compliance|3|||
47011034|NCT02167256|83260058|FG001|Overall Study|non-compliance|0|||
47011035|NCT02167256|83260057|FG000|Overall Study|Study partner unable to participate|1|||
47011036|NCT02167256|83260058|FG001|Overall Study|Study partner unable to participate|0|||
47011037|NCT02191046|83260066|FG000|Overall Study|low compliance|5|||
47011038|NCT02191046|83260067|FG001|Overall Study|low compliance|1|||
47011039|NCT02166476|83260075|FG000|Overall Study|Withdrawal by Subject|5|||
47011040|NCT02166476|83260076|FG001|Overall Study|Withdrawal by Subject|7|||
47011041|NCT02166476|83260075|FG000|Overall Study|Adverse Event|3|||
47011042|NCT02166476|83260076|FG001|Overall Study|Adverse Event|3|||
47011043|NCT02166476|83260075|FG000|Overall Study|Lost to Follow-up|5|||
47011044|NCT02166476|83260076|FG001|Overall Study|Lost to Follow-up|10|||
47011045|NCT02166476|83260075|FG000|Overall Study|Physician Decision|1|||
47011046|NCT02166476|83260076|FG001|Overall Study|Physician Decision|0|||
47011047|NCT02166476|83260075|FG000|Overall Study|Unable to Come for Visit|0|||
47011048|NCT02166476|83260076|FG001|Overall Study|Unable to Come for Visit|3|||
47011049|NCT02224274|83260087|FG000|Overall Study|Death|1|||
47011050|NCT02224274|83260088|FG001|Overall Study|Death|0|||
47011051|NCT02189252|83260102|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
47011052|NCT02189252|83260103|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
47011053|NCT02189252|83260104|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
47011054|NCT02189252|83260105|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
47011055|NCT02189252|83260102|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
47011056|NCT02189252|83260103|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
47011057|NCT02189252|83260104|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
47011058|NCT02189252|83260105|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
47011059|NCT01583374|83260119|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
47011060|NCT01583374|83260120|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
47011061|NCT01583374|83260121|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
47011062|NCT01583374|83260122|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
47011063|NCT01583374|83260123|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
47011064|NCT01583374|83260124|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
47011065|NCT01583374|83260125|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
47011066|NCT01583374|83260126|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
47011067|NCT01583374|83260127|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
47011068|NCT01583374|83260119|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
47011069|NCT01583374|83260120|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
47011070|NCT01583374|83260121|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
47011071|NCT01583374|83260122|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
47011072|NCT01583374|83260123|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
47011073|NCT01583374|83260124|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
47011074|NCT01583374|83260125|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
47011075|NCT01583374|83260126|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
47011076|NCT01583374|83260127|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
47011077|NCT01583374|83260119|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
47011078|NCT01583374|83260120|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
47011079|NCT01583374|83260121|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
47011080|NCT01583374|83260122|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
47011081|NCT01583374|83260123|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
47011082|NCT01583374|83260124|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
47011083|NCT01583374|83260125|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
47011084|NCT01583374|83260126|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
47011085|NCT01583374|83260127|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
47011086|NCT01583374|83260119|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
47011087|NCT01583374|83260120|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
47011088|NCT01583374|83260121|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
47011089|NCT01583374|83260122|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
47011090|NCT01583374|83260123|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
47011091|NCT01583374|83260124|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
47011092|NCT01583374|83260125|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
47011093|NCT01583374|83260126|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
47011094|NCT01583374|83260127|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
47011095|NCT01583374|83260119|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
47011096|NCT01583374|83260120|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
47011097|NCT01583374|83260121|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
47011098|NCT01583374|83260122|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
47011099|NCT01583374|83260123|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
47011100|NCT01583374|83260124|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
47011101|NCT01583374|83260125|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
47011102|NCT01583374|83260126|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
47011103|NCT01583374|83260127|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
47011104|NCT01583374|83260119|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011105|NCT01583374|83260120|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011106|NCT01583374|83260121|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
47011107|NCT01583374|83260122|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011108|NCT01583374|83260123|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011109|NCT01583374|83260124|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011110|NCT01583374|83260125|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011111|NCT01583374|83260126|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011112|NCT01583374|83260127|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
47011113|NCT01583374|83260119|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011114|NCT01583374|83260120|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
47011115|NCT01583374|83260121|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011116|NCT01583374|83260122|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011117|NCT01583374|83260123|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011118|NCT01583374|83260124|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011119|NCT01583374|83260125|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011120|NCT01583374|83260126|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011121|NCT01583374|83260127|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
47011122|NCT01583374|83260119|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011123|NCT01583374|83260120|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011124|NCT01583374|83260121|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011125|NCT01583374|83260122|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011126|NCT01583374|83260123|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011127|NCT01583374|83260124|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011128|NCT01583374|83260125|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011129|NCT01583374|83260126|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
47011130|NCT01583374|83260127|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
47011131|NCT01583374|83260119|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
47011132|NCT01583374|83260120|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
47011133|NCT01583374|83260121|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
47011134|NCT01583374|83260122|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
47011135|NCT01583374|83260123|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
47011136|NCT01583374|83260124|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
47011137|NCT01583374|83260125|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
47011138|NCT01583374|83260126|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
47011139|NCT01583374|83260127|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
47011140|NCT01583374|83260119|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
47011141|NCT01583374|83260120|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
47011142|NCT01583374|83260121|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
47011143|NCT01583374|83260122|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
47011144|NCT01583374|83260123|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
47011145|NCT01583374|83260124|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
47011146|NCT01583374|83260125|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
47011147|NCT01583374|83260126|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
47011148|NCT01583374|83260127|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
47011149|NCT01583374|83260119|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
47011150|NCT01583374|83260120|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
47011151|NCT01583374|83260121|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
47011152|NCT01583374|83260122|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
47011153|NCT01583374|83260123|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
47011154|NCT01583374|83260124|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
47011155|NCT01583374|83260125|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
47011156|NCT01583374|83260126|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
47011157|NCT01583374|83260127|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
47011158|NCT01583374|83260119|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
47011159|NCT01583374|83260120|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
47011160|NCT01583374|83260121|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
47011161|NCT01583374|83260122|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
47011162|NCT01583374|83260123|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
47011163|NCT01583374|83260124|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
47011164|NCT01583374|83260125|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
47011165|NCT01583374|83260126|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
47011166|NCT01583374|83260127|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
47011167|NCT01583374|83260119|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
47011168|NCT01583374|83260120|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
47011169|NCT01583374|83260121|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
47011170|NCT01583374|83260122|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
47011171|NCT01583374|83260123|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
47011172|NCT01583374|83260124|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
47011173|NCT01583374|83260125|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
47011174|NCT01583374|83260126|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
47011175|NCT01583374|83260127|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
47011176|NCT01583374|83260119|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
47011177|NCT01583374|83260120|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
46910319|NCT03313037|83139826|FG001|Overall Study|Protocol Violation|1|||
47011178|NCT01583374|83260121|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
47011179|NCT01583374|83260122|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
47011180|NCT01583374|83260123|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
47011181|NCT01583374|83260124|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
47011182|NCT01583374|83260125|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
47011183|NCT01583374|83260126|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
47011184|NCT01583374|83260127|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
47011185|NCT01583374|83260119|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
47011186|NCT01583374|83260120|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
47011187|NCT01583374|83260121|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
47011188|NCT01583374|83260122|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
47011189|NCT01583374|83260123|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
46709574|NCT01165242|82925617|FG001|Overall Study|Unreachable Subjects|0|||
46910320|NCT03313037|83139825|FG000|Overall Study|Other|1|||
46910321|NCT03313037|83139826|FG001|Overall Study|Other|1|||
46910322|NCT03313037|83139825|FG000|Overall Study|Withdrawal by Subject|4|||
46910323|NCT03313037|83139826|FG001|Overall Study|Withdrawal by Subject|3|||
46910324|NCT03313037|83139825|FG000|Overall Study|No longer meets eligibility criteria|1|||
46910325|NCT03313037|83139826|FG001|Overall Study|No longer meets eligibility criteria|7|||
46910326|NCT03313037|83139825|FG000|Overall Study|Lost to Follow-up|9|||
46910327|NCT03313037|83139826|FG001|Overall Study|Lost to Follow-up|8|||
46910328|NCT03313037|83139825|FG000|Overall Study|Randomized but not treated|1|||
46910329|NCT03313037|83139826|FG001|Overall Study|Randomized but not treated|0|||
46910330|NCT02420795|83139835|FG000|Overall Study|Withdrawal by Subject|1|||
46910331|NCT02420795|83139836|FG001|Overall Study|Withdrawal by Subject|0|||
46910332|NCT02420795|83139837|FG002|Overall Study|Withdrawal by Subject|0|||
46910333|NCT02420795|83139835|FG000|Overall Study|Adverse Event|1|||
46910334|NCT02420795|83139836|FG001|Overall Study|Adverse Event|0|||
46910335|NCT02420795|83139837|FG002|Overall Study|Adverse Event|0|||
46910336|NCT02420795|83139835|FG000|Overall Study|Progressive disease|2|||
46910337|NCT02420795|83139836|FG001|Overall Study|Progressive disease|2|||
46910338|NCT02420795|83139837|FG002|Overall Study|Progressive disease|4|||
46910339|NCT02420795|83139835|FG000|Overall Study|Death|0|||
46910340|NCT02420795|83139836|FG001|Overall Study|Death|0|||
46910341|NCT02420795|83139837|FG002|Overall Study|Death|1|||
46910342|NCT03334175|83139849|FG000|Overall Study|Lost to Follow-up|0|||
46910343|NCT03334175|83139850|FG001|Overall Study|Lost to Follow-up|1|||
46910344|NCT02942771|83139861|FG000|Overall Study|Adverse Event|1|||
46910345|NCT02942771|83139862|FG001|Overall Study|Adverse Event|0|||
46910346|NCT02942771|83139863|FG002|Overall Study|Adverse Event|0|||
46910347|NCT02942771|83139864|FG003|Overall Study|Adverse Event|0|||
46910348|NCT02942771|83139865|FG004|Overall Study|Adverse Event|2|||
46910349|NCT02942771|83139861|FG000|Overall Study|Lost to Follow-up|1|||
46910350|NCT02942771|83139862|FG001|Overall Study|Lost to Follow-up|0|||
46910351|NCT02942771|83139863|FG002|Overall Study|Lost to Follow-up|0|||
46910352|NCT02942771|83139864|FG003|Overall Study|Lost to Follow-up|0|||
46910353|NCT02942771|83139865|FG004|Overall Study|Lost to Follow-up|0|||
46910354|NCT02942771|83139861|FG000|Overall Study|Withdrawal by Subject|1|||
46910355|NCT02942771|83139862|FG001|Overall Study|Withdrawal by Subject|0|||
46910356|NCT02942771|83139863|FG002|Overall Study|Withdrawal by Subject|0|||
46910357|NCT02942771|83139864|FG003|Overall Study|Withdrawal by Subject|0|||
46910358|NCT02942771|83139865|FG004|Overall Study|Withdrawal by Subject|2|||
46910359|NCT03036150|83139879|FG000|Overall Study|Withdrawal by Subject|8|||
46910360|NCT03036150|83139880|FG001|Overall Study|Withdrawal by Subject|3|||
46910361|NCT03036150|83139879|FG000|Overall Study|Lost to Follow-up|2|||
46709575|NCT01165242|82925618|FG002|Overall Study|Unreachable Subjects|0|||
46709576|NCT01165242|82925616|FG000|Overall Study|Incarcerated Subjects|0|||
46709577|NCT01165242|82925617|FG001|Overall Study|Incarcerated Subjects|1|||
46709578|NCT01165242|82925618|FG002|Overall Study|Incarcerated Subjects|0|||
46709579|NCT01165242|82925616|FG000|Overall Study|Visit 2 Declined by Subject|0|||
46709580|NCT01165242|82925617|FG001|Overall Study|Visit 2 Declined by Subject|0|||
46709581|NCT01165242|82925618|FG002|Overall Study|Visit 2 Declined by Subject|1|||
46709582|NCT01165242|82925616|FG000|Overall Study|Withdrawal by Subject|0|||
46709583|NCT01165242|82925617|FG001|Overall Study|Withdrawal by Subject|2|||
46910362|NCT03036150|83139880|FG001|Overall Study|Lost to Follow-up|2|||
46910363|NCT03332771|83139890|FG000|Overall Study|Adverse Event|6|||
46910364|NCT03332771|83139891|FG001|Overall Study|Adverse Event|4|||
46910365|NCT03332771|83139892|FG002|Overall Study|Adverse Event|1|||
46910366|NCT03332771|83139893|FG003|Overall Study|Adverse Event|3|||
46910367|NCT03332771|83139890|FG000|Overall Study|Poor Compliance to Protocol|0|||
46910368|NCT03332771|83139891|FG001|Overall Study|Poor Compliance to Protocol|1|||
46910369|NCT03332771|83139892|FG002|Overall Study|Poor Compliance to Protocol|0|||
47011190|NCT01583374|83260124|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
47011191|NCT01583374|83260125|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
47011192|NCT01583374|83260126|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
47011193|NCT01583374|83260127|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
47011194|NCT01583374|83260119|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
47011195|NCT01583374|83260120|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
47011196|NCT01583374|83260121|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
47011197|NCT01583374|83260122|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
47011198|NCT01583374|83260123|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
47011199|NCT01583374|83260124|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
47011200|NCT01583374|83260125|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
47011201|NCT01583374|83260126|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
47011202|NCT01583374|83260127|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
47011203|NCT01583374|83260119|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
47011204|NCT01583374|83260120|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
47011205|NCT01583374|83260121|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
47011206|NCT01583374|83260122|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
47011207|NCT01583374|83260123|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
47011208|NCT01583374|83260124|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
47011209|NCT01583374|83260125|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
47011210|NCT01583374|83260126|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
47011211|NCT01583374|83260127|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
47011212|NCT01583374|83260119|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
47011213|NCT01583374|83260120|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
47011214|NCT01583374|83260121|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
47011215|NCT01583374|83260122|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
47011216|NCT01583374|83260123|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
47011217|NCT01583374|83260124|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
47011218|NCT01583374|83260125|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
47011219|NCT01583374|83260126|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
47011220|NCT01583374|83260127|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
47011221|NCT01583374|83260119|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
47011222|NCT01583374|83260120|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
47011223|NCT01583374|83260121|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
47011224|NCT01583374|83260122|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
47011225|NCT01583374|83260123|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
47011226|NCT01583374|83260124|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
47011227|NCT01583374|83260125|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
47011228|NCT01583374|83260126|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
47011229|NCT01583374|83260127|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
47011230|NCT01583296|83260148|FG000|Overall Study|Withdrawal by Subject|11|||
47011231|NCT01583296|83260149|FG001|Overall Study|Withdrawal by Subject|10|||
47011232|NCT02222714|83260160|FG000|Overall Study|Death|0|||
47011233|NCT02222714|83260161|FG001|Overall Study|Death|2|||
46620515|NCT02536300|82769742|FG002|Overall Study|Non-compliance With Study Drug|0|||
46620516|NCT02536300|82769740|FG000|Overall Study|Protocol Violation|0|||
46620517|NCT02536300|82769741|FG001|Overall Study|Protocol Violation|1|||
47011234|NCT02222714|83260162|FG002|Overall Study|Death|3|||
47011235|NCT02222714|83260163|FG003|Overall Study|Death|4|||
47011236|NCT02222714|83260164|FG004|Overall Study|Death|6|||
46620518|NCT02536300|82769742|FG002|Overall Study|Protocol Violation|0|||
47011237|NCT02222714|83260160|FG000|Overall Study|Withdrawal by Subject|0|||
47011238|NCT02222714|83260161|FG001|Overall Study|Withdrawal by Subject|0|||
47011239|NCT02222714|83260162|FG002|Overall Study|Withdrawal by Subject|1|||
47011240|NCT02222714|83260163|FG003|Overall Study|Withdrawal by Subject|0|||
47011241|NCT02222714|83260164|FG004|Overall Study|Withdrawal by Subject|1|||
47011242|NCT02164916|83260181|FG000|Overall Study|Adverse Event|3|||
47011243|NCT02164916|83260182|FG001|Overall Study|Adverse Event|8|||
47011244|NCT02164916|83260181|FG000|Overall Study|Death|1|||
47011245|NCT02164916|83260182|FG001|Overall Study|Death|1|||
47011246|NCT02164916|83260181|FG000|Overall Study|Refusal unrelated to adverse event|3|||
47011247|NCT02164916|83260182|FG001|Overall Study|Refusal unrelated to adverse event|7|||
47011248|NCT02164916|83260181|FG000|Overall Study|Progression|37|||
47011249|NCT02164916|83260182|FG001|Overall Study|Progression|26|||
47011250|NCT02164916|83260181|FG000|Overall Study|Not protocol specified|5|||
47011251|NCT02164916|83260182|FG001|Overall Study|Not protocol specified|1|||
47011252|NCT02164916|83260181|FG000|Overall Study|Reason under review|1|||
47011253|NCT02164916|83260182|FG001|Overall Study|Reason under review|6|||
47011254|NCT02164916|83260181|FG000|Overall Study|Not eligible|2|||
47011255|NCT02164916|83260182|FG001|Overall Study|Not eligible|5|||
47011256|NCT02222558|83260193|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
47011257|NCT02222558|83260194|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
47011258|NCT02222558|83260195|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
47011259|NCT02222558|83260196|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
47011260|NCT02222558|83260197|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
47011261|NCT02222558|83260198|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
47011262|NCT02222558|83260193|FG000|Period 3|Withdrawal by Subject|0|||
47011263|NCT02222558|83260194|FG001|Period 3|Withdrawal by Subject|0|||
47011264|NCT02222558|83260195|FG002|Period 3|Withdrawal by Subject|0|||
47011265|NCT02222558|83260196|FG003|Period 3|Withdrawal by Subject|0|||
47011266|NCT02222558|83260197|FG004|Period 3|Withdrawal by Subject|0|||
47011267|NCT02222558|83260198|FG005|Period 3|Withdrawal by Subject|1|||
47011268|NCT02188784|83260214|FG000|Overall Study|Death|3|||
47011269|NCT02188784|83260215|FG001|Overall Study|Death|1|||
47011270|NCT02188784|83260214|FG000|Overall Study|Lost to Follow-up|1|||
47011271|NCT02188784|83260215|FG001|Overall Study|Lost to Follow-up|0|||
47011272|NCT02188784|83260214|FG000|Overall Study|Withdrawal by Subject|3|||
47011273|NCT02188784|83260215|FG001|Overall Study|Withdrawal by Subject|9|||
47011274|NCT02188784|83260214|FG000|Overall Study|Physician Decision|2|||
47011275|NCT02188784|83260215|FG001|Overall Study|Physician Decision|3|||
47011276|NCT02222246|83260238|FG000|Overall Study|No Emergency Department Visits|27|||
47011277|NCT02222246|83260239|FG001|Overall Study|No Emergency Department Visits|26|||
47011278|NCT02222246|83260238|FG000|Overall Study|Physician Decision|0|||
47011279|NCT02222246|83260239|FG001|Overall Study|Physician Decision|1|||
47011280|NCT02188160|83260249|FG000|Overall Study|Adverse Event|1|||
47011281|NCT02188160|83260250|FG001|Overall Study|Adverse Event|0|||
47011282|NCT02188160|83260249|FG000|Overall Study|Use of an excluded medication|0|||
47011283|NCT02188160|83260250|FG001|Overall Study|Use of an excluded medication|1|||
47011284|NCT02220998|83260258|FG000|Overall Study|Randomized but Never Treated|1|||
47011285|NCT02220998|83260259|FG001|Overall Study|Randomized but Never Treated|2|||
47011286|NCT02220998|83260258|FG000|Overall Study|Death|2|||
47011287|NCT02220998|83260259|FG001|Overall Study|Death|0|||
47011288|NCT02220998|83260258|FG000|Overall Study|Lack of Efficacy|0|||
47011289|NCT02220998|83260259|FG001|Overall Study|Lack of Efficacy|5|||
47011290|NCT02220998|83260258|FG000|Overall Study|Lost to Follow-up|4|||
47011291|NCT02220998|83260259|FG001|Overall Study|Lost to Follow-up|4|||
47011292|NCT02220920|83260267|FG000|Overall Study|Adverse Event|1|||
47011293|NCT02220920|83260268|FG001|Overall Study|Adverse Event|0|||
47011294|NCT02220920|83260267|FG000|Overall Study|Lack of Efficacy|0|||
47011295|NCT02220920|83260268|FG001|Overall Study|Lack of Efficacy|1|||
47011296|NCT02220920|83260267|FG000|Overall Study|Withdrawal by Subject|1|||
47011297|NCT02220920|83260268|FG001|Overall Study|Withdrawal by Subject|0|||
47011298|NCT02220920|83260267|FG000|Overall Study|Conflict with the stopping criteria|1|||
47011299|NCT02220920|83260268|FG001|Overall Study|Conflict with the stopping criteria|2|||
47011300|NCT03966053|83260274|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
47011301|NCT01634555|83260287|FG000|Overall Study|Adverse Event|3|||
47011302|NCT01634555|83260287|FG000|Overall Study|Physician Decision|1|||
47011303|NCT01634243|83260294|FG000|Overall Study|Adverse Event|5|||
47011304|NCT01634243|83260295|FG001|Overall Study|Adverse Event|5|||
47011305|NCT01634243|83260294|FG000|Overall Study|Lack of Efficacy|1|||
47011306|NCT01634243|83260295|FG001|Overall Study|Lack of Efficacy|0|||
47011307|NCT01542034|83260312|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
47011308|NCT01542034|83260313|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
47011309|NCT01542034|83260312|FG000|Overall Study|Administrative decision|0|||
47011310|NCT01542034|83260313|FG001|Overall Study|Administrative decision|3|||
47011311|NCT01542034|83260312|FG000|Overall Study|Subject Noncompliance|1|||
47011312|NCT01542034|83260313|FG001|Overall Study|Subject Noncompliance|0|||
47011313|NCT01542034|83260312|FG000|Overall Study|Adverse Event|2|||
46620519|NCT01856686|82769752|FG000|Overall Study|Lost to Follow-up|5|||
46620520|NCT01856686|82769753|FG001|Overall Study|Lost to Follow-up|11|||
46709584|NCT01165242|82925618|FG002|Overall Study|Withdrawal by Subject|2|||
46910370|NCT03332771|83139893|FG003|Overall Study|Poor Compliance to Protocol|1|||
46910371|NCT03332771|83139890|FG000|Overall Study|Lost to Follow-up|2|||
46910372|NCT03332771|83139891|FG001|Overall Study|Lost to Follow-up|2|||
46910373|NCT03332771|83139892|FG002|Overall Study|Lost to Follow-up|1|||
46910374|NCT03332771|83139893|FG003|Overall Study|Lost to Follow-up|2|||
46910375|NCT03332771|83139890|FG000|Overall Study|At the Participant's own request|20|||
46910376|NCT03332771|83139891|FG001|Overall Study|At the Participant's own request|26|||
46910377|NCT03332771|83139892|FG002|Overall Study|At the Participant's own request|14|||
46910378|NCT03332771|83139893|FG003|Overall Study|At the Participant's own request|23|||
46910379|NCT03332771|83139890|FG000|Overall Study|Reason Not Specified|6|||
46910380|NCT03332771|83139891|FG001|Overall Study|Reason Not Specified|18|||
46910381|NCT03332771|83139892|FG002|Overall Study|Reason Not Specified|16|||
46910382|NCT03332771|83139893|FG003|Overall Study|Reason Not Specified|19|||
46910383|NCT03310775|83139905|FG000|Overall Study|Lost to Follow-up|2|||
46910384|NCT03310775|83139906|FG001|Overall Study|Lost to Follow-up|3|||
46910385|NCT03310775|83139905|FG000|Overall Study|aggravation of depression|0|||
46910386|NCT03310775|83139906|FG001|Overall Study|aggravation of depression|1|||
46910387|NCT03330119|83139918|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
46910388|NCT03330119|83139919|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
46910389|NCT03040986|83139927|FG000|Overall Study|Hospice|1|||
46910390|NCT03040986|83139928|FG001|Overall Study|Hospice|0|||
46910391|NCT03040986|83139927|FG000|Overall Study|Adverse Event|2|||
46910392|NCT03040986|83139928|FG001|Overall Study|Adverse Event|1|||
46910393|NCT03040986|83139927|FG000|Overall Study|Disease progression on study|3|||
46910394|NCT03040986|83139928|FG001|Overall Study|Disease progression on study|1|||
46910395|NCT03039192|83139938|FG000|Overall Study|Lost to Follow-up|4|||
46910396|NCT03039192|83139939|FG001|Overall Study|Lost to Follow-up|4|||
46910397|NCT03039192|83139938|FG000|Overall Study|Adverse event, serious fatal|0|||
46910398|NCT03039192|83139939|FG001|Overall Study|Adverse event, serious fatal|1|||
46910399|NCT03039192|83139938|FG000|Overall Study|Adverse event, non-fatal|0|||
46910400|NCT03039192|83139939|FG001|Overall Study|Adverse event, non-fatal|2|||
46910401|NCT03039192|83139938|FG000|Overall Study|Withdrawal by Subject|6|||
46910402|NCT03039192|83139939|FG001|Overall Study|Withdrawal by Subject|9|||
46910403|NCT03039192|83139938|FG000|Overall Study|Discontinued from treatment phase|19|||
46910404|NCT03039192|83139939|FG001|Overall Study|Discontinued from treatment phase|12|||
46910405|NCT03039192|83139938|FG000|Overall Study|Other|3|||
46910406|NCT03039192|83139939|FG001|Overall Study|Other|2|||
46910407|NCT03698279|83139951|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46910408|NCT03698279|83139952|FG001|Overall Study|Withdrawal by parent/guardian|1|||
47011314|NCT01542034|83260313|FG001|Overall Study|Adverse Event|2|||
46910409|NCT03698279|83139953|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46910410|NCT03698279|83139954|FG003|Overall Study|Withdrawal by parent/guardian|1|||
46910411|NCT03698279|83139955|FG004|Overall Study|Withdrawal by parent/guardian|0|||
46910412|NCT03698279|83139956|FG005|Overall Study|Withdrawal by parent/guardian|0|||
47011315|NCT01542034|83260312|FG000|Overall Study|Lost to Follow-up|7|||
47011316|NCT01542034|83260313|FG001|Overall Study|Lost to Follow-up|6|||
47011317|NCT01564732|83260321|FG000|Overall Study|Early termination by the study sponsor|6|||
47011318|NCT01564732|83260322|FG001|Overall Study|Early termination by the study sponsor|5|||
47011319|NCT01541644|83260328|FG000|Overall Study|Withdrawal by Subject|3|||
47011320|NCT01582282|83260335|FG000|Overall Study|Adverse Event|1|||
47011321|NCT01582282|83260336|FG001|Overall Study|Adverse Event|1|||
47011322|NCT01582282|83260337|FG002|Overall Study|Adverse Event|0|||
47011323|NCT01582282|83260335|FG000|Overall Study|Lost to Follow-up|1|||
47011324|NCT01582282|83260336|FG001|Overall Study|Lost to Follow-up|0|||
47011325|NCT01582282|83260337|FG002|Overall Study|Lost to Follow-up|0|||
47011326|NCT01582282|83260335|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
47011327|NCT01582282|83260336|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
47011328|NCT01582282|83260337|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
47011329|NCT01599650|83260348|FG000|Overall Study|Administrative issue|1|||
47011330|NCT01599650|83260349|FG001|Overall Study|Administrative issue|0|||
47011331|NCT01599650|83260350|FG002|Overall Study|Administrative issue|1|||
47011332|NCT01599650|83260348|FG000|Overall Study|Physician Decision|2|||
47011333|NCT01599650|83260349|FG001|Overall Study|Physician Decision|0|||
47011334|NCT01599650|83260350|FG002|Overall Study|Physician Decision|7|||
47011335|NCT01599650|83260348|FG000|Overall Study|Protocol Violation|0|||
47011336|NCT01599650|83260349|FG001|Overall Study|Protocol Violation|3|||
47011337|NCT01599650|83260350|FG002|Overall Study|Protocol Violation|0|||
47011338|NCT01599650|83260348|FG000|Overall Study|Death|2|||
47011339|NCT01599650|83260349|FG001|Overall Study|Death|1|||
47011340|NCT01599650|83260350|FG002|Overall Study|Death|2|||
47011341|NCT01599650|83260348|FG000|Overall Study|Lost to Follow-up|3|||
47011342|NCT01599650|83260349|FG001|Overall Study|Lost to Follow-up|3|||
47011343|NCT01599650|83260350|FG002|Overall Study|Lost to Follow-up|3|||
47011344|NCT01599650|83260348|FG000|Overall Study|Withdrawal by Subject|11|||
47011345|NCT01599650|83260349|FG001|Overall Study|Withdrawal by Subject|11|||
47011346|NCT01599650|83260350|FG002|Overall Study|Withdrawal by Subject|10|||
47011347|NCT01599650|83260348|FG000|Overall Study|Adverse Event|3|||
47011348|NCT01599650|83260349|FG001|Overall Study|Adverse Event|8|||
47011349|NCT01599650|83260350|FG002|Overall Study|Adverse Event|4|||
47011350|NCT01541254|83260360|FG000|Overall Study|Withdrawal by Subject|1|||
47011351|NCT01541254|83260360|FG000|Overall Study|excluded - metal allergy|1|||
47011352|NCT01541254|83260360|FG000|Overall Study|enrolled after study closed|1|||
47011353|NCT01541254|83260360|FG000|Overall Study|GI bleed prior to procedure|1|||
47011354|NCT01541254|83260360|FG000|Overall Study|stent not required|1|||
47011355|NCT01541254|83260360|FG000|Overall Study|alternate stent used|1|||
47011356|NCT02163902|83260366|FG000|Overall Study|Subject's Request|3|||
47011357|NCT02163902|83260367|FG001|Overall Study|Subject's Request|4|||
47011358|NCT02163902|83260366|FG000|Overall Study|Lost to Follow-up|6|||
47011359|NCT02163902|83260367|FG001|Overall Study|Lost to Follow-up|7|||
47011360|NCT02163902|83260366|FG000|Overall Study|Administrative Decision|2|||
47011361|NCT02163902|83260367|FG001|Overall Study|Administrative Decision|2|||
47011362|NCT01630616|83260379|FG000|Overall Study|Adverse Event|0|||
47011363|NCT01630616|83260380|FG001|Overall Study|Adverse Event|0|||
47011364|NCT01630616|83260381|FG002|Overall Study|Adverse Event|0|||
47011365|NCT01630616|83260382|FG003|Overall Study|Adverse Event|1|||
47011366|NCT01630616|83260383|FG004|Overall Study|Adverse Event|0|||
47011367|NCT01630616|83260384|FG005|Overall Study|Adverse Event|0|||
47011368|NCT01630616|83260379|FG000|Overall Study|Withdrawal by Subject|0|||
47011369|NCT01630616|83260380|FG001|Overall Study|Withdrawal by Subject|0|||
47011370|NCT01630616|83260381|FG002|Overall Study|Withdrawal by Subject|0|||
47011371|NCT01630616|83260382|FG003|Overall Study|Withdrawal by Subject|2|||
47011372|NCT01630616|83260383|FG004|Overall Study|Withdrawal by Subject|0|||
47011373|NCT01630616|83260384|FG005|Overall Study|Withdrawal by Subject|0|||
47011374|NCT03774875|83260403|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
47011375|NCT03774875|83260404|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
47011376|NCT03774875|83260403|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
47011377|NCT03774875|83260404|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
47011378|NCT03774875|83260403|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
47011379|NCT03774875|83260404|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
47011380|NCT03774875|83260403|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
47011381|NCT03774875|83260404|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
47011382|NCT03774875|83260403|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
47011383|NCT03774875|83260404|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
47011384|NCT03774875|83260403|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
47011385|NCT03774875|83260404|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
47011386|NCT03774875|83260403|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
47011387|NCT03774875|83260404|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
47011388|NCT03774875|83260403|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
47011389|NCT03774875|83260404|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
47011390|NCT03774875|83260403|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
47011391|NCT03774875|83260404|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
47011392|NCT03774875|83260403|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
46620521|NCT01770145|82769759|FG000|Baseline|Adverse Event|20|||
47011393|NCT03774875|83260404|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
47011394|NCT03774875|83260403|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
47011395|NCT03774875|83260404|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
47011396|NCT03774875|83260403|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
47011397|NCT03774875|83260404|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
47011398|NCT03774875|83260403|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
46709585|NCT01165242|82925616|FG000|Overall Study|Extended Holiday|0|||
46709586|NCT01165242|82925617|FG001|Overall Study|Extended Holiday|0|||
46709587|NCT01165242|82925618|FG002|Overall Study|Extended Holiday|1|||
46709588|NCT01165242|82925616|FG000|Overall Study|Lost to Follow-up|9|||
46709589|NCT01165242|82925617|FG001|Overall Study|Lost to Follow-up|7|||
46709590|NCT01165242|82925618|FG002|Overall Study|Lost to Follow-up|10|||
46709591|NCT01170065|82925631|FG000|Overall Study|Adverse Event|17|||
46709592|NCT01170065|82925632|FG001|Overall Study|Adverse Event|50|||
46709593|NCT01170065|82925633|FG002|Overall Study|Adverse Event|10|||
46709594|NCT01170065|82925631|FG000|Overall Study|Lost to Follow-up|1|||
46709595|NCT01170065|82925632|FG001|Overall Study|Lost to Follow-up|4|||
46709596|NCT01170065|82925633|FG002|Overall Study|Lost to Follow-up|1|||
46709597|NCT01170065|82925631|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
46709598|NCT01170065|82925632|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
46709599|NCT01170065|82925633|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
46709600|NCT01170065|82925631|FG000|Overall Study|Reason other than specified|3|||
46709601|NCT01170065|82925632|FG001|Overall Study|Reason other than specified|8|||
46709602|NCT01170065|82925633|FG002|Overall Study|Reason other than specified|3|||
46709603|NCT01170065|82925631|FG000|Overall Study|Ongoing after planned observation time|5|||
46709604|NCT01170065|82925632|FG001|Overall Study|Ongoing after planned observation time|26|||
46709605|NCT01170065|82925633|FG002|Overall Study|Ongoing after planned observation time|10|||
46709606|NCT00966693|82925645|FG000|Overall Study|Adverse Event|0|||
46709607|NCT00966693|82925646|FG001|Overall Study|Adverse Event|0|||
46709608|NCT00966693|82925647|FG002|Overall Study|Adverse Event|1|||
46709609|NCT00966693|82925648|FG003|Overall Study|Adverse Event|2|||
46709610|NCT00966693|82925645|FG000|Overall Study|Death|0|||
46910413|NCT03698279|83139951|FG000|Overall Study|Protocol deviation|1|||
46910414|NCT03698279|83139952|FG001|Overall Study|Protocol deviation|0|||
46910415|NCT03698279|83139953|FG002|Overall Study|Protocol deviation|1|||
46910416|NCT03698279|83139954|FG003|Overall Study|Protocol deviation|0|||
46910417|NCT03698279|83139955|FG004|Overall Study|Protocol deviation|0|||
46910418|NCT03698279|83139956|FG005|Overall Study|Protocol deviation|0|||
46910419|NCT03698279|83139951|FG000|Overall Study|Withdrawal by Subject|0|||
46910420|NCT03698279|83139952|FG001|Overall Study|Withdrawal by Subject|0|||
46910421|NCT03698279|83139953|FG002|Overall Study|Withdrawal by Subject|1|||
46910422|NCT03698279|83139954|FG003|Overall Study|Withdrawal by Subject|0|||
47011399|NCT03774875|83260404|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
47011400|NCT02220764|83260417|FG000|Overall Study|Lost to Follow-up|3|||
47011401|NCT02220764|83260418|FG001|Overall Study|Lost to Follow-up|1|||
47011402|NCT02220764|83260417|FG000|Overall Study|Death|1|||
47011403|NCT02220764|83260418|FG001|Overall Study|Death|0|||
47011404|NCT01563172|83260424|FG000|Overall Study|Adverse Event|5|||
47011405|NCT01563172|83260424|FG000|Overall Study|Lost to Follow-up|2|||
47011406|NCT01563172|83260424|FG000|Overall Study|Other (Protocol deviation)|5|||
47011407|NCT01563172|83260424|FG000|Overall Study|Other (Not specified)|1|||
47011408|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
47011409|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
47011410|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
47011411|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
47011412|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
47011413|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
47011414|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
47011415|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
47011416|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
47011417|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
47011418|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
47011419|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
47011420|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
47011421|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
47011422|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
47011423|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
47011424|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
47011425|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
47011426|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
47011427|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
46709611|NCT00966693|82925646|FG001|Overall Study|Death|0|||
46709612|NCT00966693|82925647|FG002|Overall Study|Death|1|||
46709613|NCT00966693|82925648|FG003|Overall Study|Death|0|||
46709614|NCT00966693|82925645|FG000|Overall Study|Withdrawal by Subject|1|||
46709615|NCT00966693|82925646|FG001|Overall Study|Withdrawal by Subject|0|||
46709616|NCT00966693|82925647|FG002|Overall Study|Withdrawal by Subject|0|||
46709617|NCT00966693|82925648|FG003|Overall Study|Withdrawal by Subject|5|||
46709618|NCT00966693|82925645|FG000|Overall Study|Disease Progression|0|||
46709619|NCT00966693|82925646|FG001|Overall Study|Disease Progression|0|||
47011428|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
47011429|NCT02161718|83260441|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
47011430|NCT02161718|83260442|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
47011431|NCT02161718|83260443|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
47011432|NCT02161718|83260441|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
47011433|NCT02161718|83260442|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
47011434|NCT02161718|83260443|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
47011435|NCT02161718|83260441|FG000|Post- Randomization Period|Lost to Follow-up|0|||
47011436|NCT02161718|83260442|FG001|Post- Randomization Period|Lost to Follow-up|9|||
47011437|NCT02161718|83260443|FG002|Post- Randomization Period|Lost to Follow-up|15|||
47011438|NCT02161718|83260441|FG000|Post- Randomization Period|Adverse Event|0|||
47011439|NCT02161718|83260442|FG001|Post- Randomization Period|Adverse Event|9|||
47011440|NCT02161718|83260443|FG002|Post- Randomization Period|Adverse Event|10|||
47011441|NCT02161718|83260441|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
46709620|NCT00966693|82925647|FG002|Overall Study|Disease Progression|1|||
46709621|NCT00966693|82925648|FG003|Overall Study|Disease Progression|16|||
47011442|NCT02161718|83260442|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
47011443|NCT02161718|83260443|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
47011444|NCT02161718|83260441|FG000|Post- Randomization Period|Physician Decision|0|||
47011445|NCT02161718|83260442|FG001|Post- Randomization Period|Physician Decision|2|||
47011446|NCT02161718|83260443|FG002|Post- Randomization Period|Physician Decision|4|||
47011447|NCT02161718|83260441|FG000|Post- Randomization Period|Protocol Violation|0|||
47011448|NCT02161718|83260442|FG001|Post- Randomization Period|Protocol Violation|2|||
47011449|NCT02161718|83260443|FG002|Post- Randomization Period|Protocol Violation|3|||
47011450|NCT02161718|83260441|FG000|Post- Randomization Period|Lack of Efficacy|0|||
47011451|NCT02161718|83260442|FG001|Post- Randomization Period|Lack of Efficacy|0|||
47011452|NCT02161718|83260443|FG002|Post- Randomization Period|Lack of Efficacy|1|||
47011453|NCT02161718|83260441|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
47011454|NCT02161718|83260442|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
47011455|NCT02161718|83260443|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
47011456|NCT02161718|83260441|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
47011457|NCT02161718|83260442|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
47011458|NCT02161718|83260443|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
47011459|NCT02161718|83260441|FG000|Post- Randomization Period|Relocation|0|||
47011460|NCT02161718|83260442|FG001|Post- Randomization Period|Relocation|3|||
47011461|NCT02161718|83260443|FG002|Post- Randomization Period|Relocation|0|||
47011462|NCT02219048|83260452|FG000|Overall Study|Adverse Event|2|||
47011463|NCT02219048|83260453|FG001|Overall Study|Adverse Event|5|||
47011464|NCT02219048|83260452|FG000|Overall Study|No longer meets eligibility criteria|1|||
47011465|NCT02219048|83260453|FG001|Overall Study|No longer meets eligibility criteria|0|||
47011466|NCT02219048|83260452|FG000|Overall Study|Study terminated by sponsor|16|||
47011467|NCT02219048|83260453|FG001|Overall Study|Study terminated by sponsor|15|||
47011468|NCT02219048|83260452|FG000|Overall Study|Withdrawal by Subject|2|||
47011469|NCT02219048|83260453|FG001|Overall Study|Withdrawal by Subject|0|||
47011470|NCT02219048|83260452|FG000|Overall Study|Other|0|||
47011471|NCT02219048|83260453|FG001|Overall Study|Other|1|||
47011472|NCT02218736|83260461|FG000|Overall Study|Withdrawal by Subject|10|||
47011473|NCT02218736|83260462|FG001|Overall Study|Withdrawal by Subject|9|||
47011474|NCT02218736|83260461|FG000|Overall Study|Protocol Violation|2|||
47011475|NCT02218736|83260462|FG001|Overall Study|Protocol Violation|0|||
47011476|NCT01540474|83260472|FG000|Vaccination Period|Lost to Follow-up|0|||
47011477|NCT01540474|83260473|FG001|Vaccination Period|Lost to Follow-up|1|||
47011478|NCT01540474|83260474|FG002|Vaccination Period|Lost to Follow-up|0|||
47011479|NCT01540474|83260475|FG003|Vaccination Period|Lost to Follow-up|0|||
47011480|NCT01580488|83260486|FG000|Overall Study|Withdrawal by Subject|1|||
47011481|NCT01580020|83260502|FG000|Overall Study|Lack of Efficacy|0|||
47011482|NCT01580020|83260503|FG001|Overall Study|Lack of Efficacy|5|||
47011483|NCT01580020|83260504|FG002|Overall Study|Lack of Efficacy|0|||
47011484|NCT01580020|83260505|FG003|Overall Study|Lack of Efficacy|1|||
47011485|NCT01580020|83260502|FG000|Overall Study|Withdrawal by Subject|0|||
46709622|NCT01215968|82925660|FG000|Overall Study|Adverse Event|0|||
46709623|NCT01215968|82925661|FG001|Overall Study|Adverse Event|2|||
46709624|NCT01215968|82925660|FG000|Overall Study|Protocol Violation|2|||
47011486|NCT01580020|83260503|FG001|Overall Study|Withdrawal by Subject|1|||
47011487|NCT01580020|83260504|FG002|Overall Study|Withdrawal by Subject|1|||
46709625|NCT01215968|82925661|FG001|Overall Study|Protocol Violation|4|||
47011488|NCT01580020|83260505|FG003|Overall Study|Withdrawal by Subject|0|||
46910423|NCT03698279|83139955|FG004|Overall Study|Withdrawal by Subject|0|||
46910424|NCT03698279|83139956|FG005|Overall Study|Withdrawal by Subject|0|||
46910425|NCT03698279|83139951|FG000|Overall Study|Lost to Follow-up|3|||
46910426|NCT03698279|83139952|FG001|Overall Study|Lost to Follow-up|1|||
46910427|NCT03698279|83139953|FG002|Overall Study|Lost to Follow-up|4|||
46910428|NCT03698279|83139954|FG003|Overall Study|Lost to Follow-up|5|||
46910429|NCT03698279|83139955|FG004|Overall Study|Lost to Follow-up|0|||
46910430|NCT03698279|83139956|FG005|Overall Study|Lost to Follow-up|0|||
46910431|NCT01529034|83139975|FG000|Overall Study|Discontinued prior to study treatment|14|||
47011489|NCT01580020|83260502|FG000|Overall Study|Adverse Event|1|||
47011490|NCT01580020|83260503|FG001|Overall Study|Adverse Event|1|||
47011491|NCT01580020|83260504|FG002|Overall Study|Adverse Event|1|||
47011492|NCT01580020|83260505|FG003|Overall Study|Adverse Event|1|||
47011493|NCT01580020|83260502|FG000|Overall Study|Administrative Problems|0|||
47011494|NCT01580020|83260503|FG001|Overall Study|Administrative Problems|0|||
47011495|NCT01580020|83260504|FG002|Overall Study|Administrative Problems|1|||
47011496|NCT01580020|83260505|FG003|Overall Study|Administrative Problems|0|||
47011497|NCT01580020|83260502|FG000|Overall Study|Lost to Follow-up|0|||
47011498|NCT01580020|83260503|FG001|Overall Study|Lost to Follow-up|0|||
47011499|NCT01580020|83260504|FG002|Overall Study|Lost to Follow-up|1|||
47011500|NCT01580020|83260505|FG003|Overall Study|Lost to Follow-up|0|||
47011501|NCT01579474|83260521|FG000|Overall Study|Adverse Event|1|||
47011502|NCT01579474|83260522|FG001|Overall Study|Adverse Event|13|||
47011503|NCT01579474|83260523|FG002|Overall Study|Adverse Event|2|||
47011504|NCT01579474|83260524|FG003|Overall Study|Adverse Event|0|||
47011505|NCT01579474|83260525|FG004|Overall Study|Adverse Event|0|||
47011506|NCT01579474|83260526|FG005|Overall Study|Adverse Event|1|||
47011507|NCT01579474|83260521|FG000|Overall Study|Lack of Efficacy|1|||
47011508|NCT01579474|83260522|FG001|Overall Study|Lack of Efficacy|0|||
47011509|NCT01579474|83260523|FG002|Overall Study|Lack of Efficacy|0|||
47011510|NCT01579474|83260524|FG003|Overall Study|Lack of Efficacy|0|||
47011511|NCT01579474|83260525|FG004|Overall Study|Lack of Efficacy|1|||
47011512|NCT01579474|83260526|FG005|Overall Study|Lack of Efficacy|0|||
47011513|NCT01579474|83260521|FG000|Overall Study|Withdrawal by Subject|1|||
47011514|NCT01579474|83260522|FG001|Overall Study|Withdrawal by Subject|0|||
47011515|NCT01579474|83260523|FG002|Overall Study|Withdrawal by Subject|0|||
47011516|NCT01579474|83260524|FG003|Overall Study|Withdrawal by Subject|0|||
47011517|NCT01579474|83260525|FG004|Overall Study|Withdrawal by Subject|0|||
47011518|NCT01579474|83260526|FG005|Overall Study|Withdrawal by Subject|0|||
47011519|NCT01579318|83260539|FG000|Overall Study|Disease Progression|1|||
47011520|NCT01579006|83260543|FG000|Overall Study|Lack of Efficacy|10|||
47011521|NCT01579006|83260543|FG000|Overall Study|Adverse Event|13|||
47011522|NCT01579006|83260543|FG000|Overall Study|Withdrawal by Subject|5|||
47011523|NCT01579006|83260543|FG000|Overall Study|Non-compliance|3|||
47011524|NCT01579006|83260543|FG000|Overall Study|Due to participant's health fund|1|||
47011525|NCT01579006|83260543|FG000|Overall Study|Scheduled surgery|1|||
47011526|NCT01578850|83260549|FG000|Period 1|Insufficient Clinical Response|1|||
47011527|NCT01578850|83260550|FG001|Period 1|Insufficient Clinical Response|0|||
47011528|NCT01578850|83260551|FG002|Period 1|Insufficient Clinical Response|0|||
47011529|NCT01578850|83260549|FG000|Period 1|Adverse Event|11|||
47011530|NCT01578850|83260550|FG001|Period 1|Adverse Event|0|||
47011531|NCT01578850|83260551|FG002|Period 1|Adverse Event|0|||
47011532|NCT01578850|83260549|FG000|Period 1|Death|1|||
47011533|NCT01578850|83260550|FG001|Period 1|Death|0|||
47011534|NCT01578850|83260551|FG002|Period 1|Death|0|||
47011535|NCT01578850|83260549|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
47011536|NCT01578850|83260550|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
47011537|NCT01578850|83260551|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
47011538|NCT01578850|83260549|FG000|Period 1|Withdrawal by Subject|9|||
47011539|NCT01578850|83260550|FG001|Period 1|Withdrawal by Subject|0|||
47011540|NCT01578850|83260551|FG002|Period 1|Withdrawal by Subject|0|||
46910432|NCT01529034|83139975|FG000|Overall Study|Site closure|62|||
47011541|NCT01578850|83260549|FG000|Period 1|Study Terminated by Sponsor|3|||
47011542|NCT01578850|83260550|FG001|Period 1|Study Terminated by Sponsor|0|||
47011543|NCT01578850|83260551|FG002|Period 1|Study Terminated by Sponsor|0|||
47011544|NCT01578850|83260549|FG000|Period 2|Insufficient Clinical Response|0|||
47011545|NCT01578850|83260550|FG001|Period 2|Insufficient Clinical Response|1|||
47011546|NCT01578850|83260551|FG002|Period 2|Insufficient Clinical Response|0|||
46910433|NCT01529034|83139975|FG000|Overall Study|Study termination|29|||
46910434|NCT01529034|83139975|FG000|Overall Study|Withdrawal by Subject|25|||
46910435|NCT01529034|83139975|FG000|Overall Study|No treated SCs within protocol window|13|||
46910436|NCT01529034|83139975|FG000|Overall Study|Noncompliance|8|||
46910437|NCT01529034|83139975|FG000|Overall Study|Caregiver no longer available|7|||
46910438|NCT01529034|83139975|FG000|Overall Study|Adverse Event|4|||
46910439|NCT01529034|83139975|FG000|Overall Study|Protocol Violation|4|||
47011547|NCT01578850|83260549|FG000|Period 2|Adverse Event|0|||
47011548|NCT01578850|83260550|FG001|Period 2|Adverse Event|3|||
47011549|NCT01578850|83260551|FG002|Period 2|Adverse Event|6|||
47011550|NCT01578850|83260549|FG000|Period 2|Lost to Follow-up|0|||
47011551|NCT01578850|83260550|FG001|Period 2|Lost to Follow-up|1|||
47011552|NCT01578850|83260551|FG002|Period 2|Lost to Follow-up|2|||
47011553|NCT01578850|83260549|FG000|Period 2|Withdrawal by Subject|0|||
47011554|NCT01578850|83260550|FG001|Period 2|Withdrawal by Subject|2|||
47011555|NCT01578850|83260551|FG002|Period 2|Withdrawal by Subject|2|||
47011556|NCT01578850|83260549|FG000|Period 2|Study Terminated by Sponsor|0|||
47011557|NCT01578850|83260550|FG001|Period 2|Study Terminated by Sponsor|5|||
47011558|NCT01578850|83260551|FG002|Period 2|Study Terminated by Sponsor|4|||
47011559|NCT01578850|83260549|FG000|Period 2|Unspecified Reasons|0|||
47011560|NCT01578850|83260550|FG001|Period 2|Unspecified Reasons|1|||
47011561|NCT01578850|83260551|FG002|Period 2|Unspecified Reasons|0|||
47011562|NCT01539538|83260561|FG000|Overall Study|Adverse Event|13|||
47011563|NCT01539538|83260562|FG001|Overall Study|Adverse Event|18|||
47011564|NCT01539538|83260561|FG000|Overall Study|Lack of Efficacy|13|||
47011565|NCT01539538|83260562|FG001|Overall Study|Lack of Efficacy|16|||
47011566|NCT01539538|83260561|FG000|Overall Study|Withdrawal by Subject|2|||
47011567|NCT01539538|83260562|FG001|Overall Study|Withdrawal by Subject|3|||
47011568|NCT01539538|83260561|FG000|Overall Study|PCA no longer required or PCA problem|3|||
47011569|NCT01539538|83260562|FG001|Overall Study|PCA no longer required or PCA problem|7|||
47011570|NCT01562548|83260572|FG000|Overall Study|Lost to Follow-up|0|||
47011571|NCT01562548|83260573|FG001|Overall Study|Lost to Follow-up|0|||
47011572|NCT01562548|83260574|FG002|Overall Study|Lost to Follow-up|1|||
47011573|NCT01562548|83260575|FG003|Overall Study|Lost to Follow-up|0|||
47011574|NCT01562314|83260589|FG000|Overall Study|Adverse Event|10|||
47011575|NCT01562314|83260590|FG001|Overall Study|Adverse Event|5|||
47011576|NCT01562314|83260589|FG000|Overall Study|Met Withdrawal Criteria|3|||
47011577|NCT01562314|83260590|FG001|Overall Study|Met Withdrawal Criteria|2|||
47011578|NCT01562314|83260589|FG000|Overall Study|Withdrawal by Subject|0|||
47011579|NCT01562314|83260590|FG001|Overall Study|Withdrawal by Subject|1|||
47011580|NCT01539226|83260598|FG000|Overall Study|Withdrawal by Subject|24|||
47011581|NCT01539226|83260599|FG001|Overall Study|Withdrawal by Subject|54|||
47011582|NCT01539226|83260598|FG000|Overall Study|Lost to Follow-up|20|||
47011583|NCT01539226|83260599|FG001|Overall Study|Lost to Follow-up|54|||
47011584|NCT01539226|83260598|FG000|Overall Study|Death|1|||
47011585|NCT01539226|83260599|FG001|Overall Study|Death|2|||
47011586|NCT01539226|83260598|FG000|Overall Study|Adverse Event|2|||
47011587|NCT01539226|83260599|FG001|Overall Study|Adverse Event|0|||
47011588|NCT01539226|83260598|FG000|Overall Study|Pregnancy|13|||
47011589|NCT01539226|83260599|FG001|Overall Study|Pregnancy|29|||
47011590|NCT01539226|83260598|FG000|Overall Study|inappropriate enrollment|0|||
47011591|NCT01539226|83260599|FG001|Overall Study|inappropriate enrollment|1|||
47011592|NCT01539226|83260598|FG000|Overall Study|Multiple Reasons|3|||
47011593|NCT01539226|83260599|FG001|Overall Study|Multiple Reasons|1|||
47011594|NCT01539226|83260598|FG000|Overall Study|not HIV seroconversion-related|93|||
47011595|NCT01539226|83260599|FG001|Overall Study|not HIV seroconversion-related|176|||
47011596|NCT01539226|83260598|FG000|Overall Study|HIV seroconversion-related|55|||
47011597|NCT01539226|83260599|FG001|Overall Study|HIV seroconversion-related|80|||
47011598|NCT01539226|83260598|FG000|Overall Study|Non-compliance|6|||
47011599|NCT01539226|83260599|FG001|Overall Study|Non-compliance|8|||
47011600|NCT01577758|83260605|FG000|Dose Escalation Phase|Adverse Event|0|||
47011601|NCT01577758|83260606|FG001|Dose Escalation Phase|Adverse Event|0|||
47011602|NCT01577758|83260607|FG002|Dose Escalation Phase|Adverse Event|0|||
47011603|NCT01577758|83260608|FG003|Dose Escalation Phase|Adverse Event|0|||
47011604|NCT01577758|83260609|FG004|Dose Escalation Phase|Adverse Event|0|||
47011605|NCT01577758|83260610|FG005|Dose Escalation Phase|Adverse Event|2|||
46709626|NCT01215968|82925660|FG000|Overall Study|Not received study drug|0|||
46709627|NCT01215968|82925661|FG001|Overall Study|Not received study drug|1|||
47011606|NCT01577758|83260611|FG006|Dose Escalation Phase|Adverse Event|1|||
47011607|NCT01577758|83260612|FG007|Dose Escalation Phase|Adverse Event|0|||
47011608|NCT01577758|83260605|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
47011609|NCT01577758|83260606|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
47011610|NCT01577758|83260607|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
47011611|NCT01577758|83260608|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
47011612|NCT01577758|83260609|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
46709628|NCT00963807|82925670|FG000|Overall Study|Physician Decision|2|||
47011613|NCT01577758|83260610|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
47011614|NCT01577758|83260611|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
47011615|NCT01577758|83260612|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
47011616|NCT01577758|83260605|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
47011617|NCT01577758|83260606|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
47011618|NCT01577758|83260607|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
47011619|NCT01577758|83260608|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
47011620|NCT01577758|83260609|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
47011621|NCT01577758|83260610|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
47011622|NCT01577758|83260611|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
47011623|NCT01577758|83260612|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
47011624|NCT01577758|83260605|FG000|Dose Escalation Phase|Progression Disease|2|||
47011625|NCT01577758|83260606|FG001|Dose Escalation Phase|Progression Disease|2|||
47011626|NCT01577758|83260607|FG002|Dose Escalation Phase|Progression Disease|1|||
47011627|NCT01577758|83260608|FG003|Dose Escalation Phase|Progression Disease|2|||
47011628|NCT01577758|83260609|FG004|Dose Escalation Phase|Progression Disease|5|||
47011629|NCT01577758|83260610|FG005|Dose Escalation Phase|Progression Disease|0|||
47011630|NCT01577758|83260611|FG006|Dose Escalation Phase|Progression Disease|0|||
47011631|NCT01577758|83260612|FG007|Dose Escalation Phase|Progression Disease|0|||
47011632|NCT01577758|83260605|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
47011633|NCT01577758|83260606|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
47011634|NCT01577758|83260607|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
47011635|NCT01577758|83260608|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
47011636|NCT01577758|83260609|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
47011637|NCT01577758|83260610|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
47011638|NCT01577758|83260611|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
47011639|NCT01577758|83260612|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
47011640|NCT01577758|83260605|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
47011641|NCT01577758|83260606|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
47011642|NCT01577758|83260607|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
47011643|NCT01577758|83260608|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
47011644|NCT01577758|83260609|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
47011645|NCT01577758|83260610|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
47011646|NCT01577758|83260611|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
47011647|NCT01577758|83260612|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
47011648|NCT01577758|83260605|FG000|mCRC Expansion Phase|Progression Disease|0|||
47011649|NCT01577758|83260606|FG001|mCRC Expansion Phase|Progression Disease|0|||
47011650|NCT01577758|83260607|FG002|mCRC Expansion Phase|Progression Disease|0|||
47011651|NCT01577758|83260608|FG003|mCRC Expansion Phase|Progression Disease|0|||
47011652|NCT01577758|83260609|FG004|mCRC Expansion Phase|Progression Disease|0|||
47011653|NCT01577758|83260610|FG005|mCRC Expansion Phase|Progression Disease|0|||
47011654|NCT01577758|83260611|FG006|mCRC Expansion Phase|Progression Disease|0|||
47011655|NCT01577758|83260612|FG007|mCRC Expansion Phase|Progression Disease|19|||
47011656|NCT01537432|83260634|FG000|Overall Study|Lost to Follow-up|3|||
47011657|NCT01537432|83260635|FG001|Overall Study|Lost to Follow-up|1|||
47011658|NCT01537432|83260634|FG000|Overall Study|Withdrawal by Subject|0|||
47011659|NCT01537432|83260635|FG001|Overall Study|Withdrawal by Subject|1|||
47011660|NCT01537432|83260634|FG000|Overall Study|Administrative problems|1|||
47011661|NCT01537432|83260635|FG001|Overall Study|Administrative problems|0|||
47011662|NCT01537432|83260634|FG000|Overall Study|Adverse Event|1|||
47011663|NCT01537432|83260635|FG001|Overall Study|Adverse Event|0|||
47011664|NCT01537432|83260634|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
47011665|NCT01537432|83260635|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
47011666|NCT01537198|83260641|FG000|Overall Study|RSV infection|2|||
47011667|NCT01537198|83260641|FG000|Overall Study|Adverse Event|4|||
47011668|NCT01537198|83260641|FG000|Overall Study|No Further Visits to the Clinic|37|||
47011669|NCT01537198|83260641|FG000|Overall Study|Other|111|||
47011670|NCT01537120|83260645|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
47011671|NCT01537120|83260645|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
47011672|NCT01537042|83260653|FG000|Overall Study|Adverse Event|0|||
47011673|NCT01537042|83260654|FG001|Overall Study|Adverse Event|2|||
47011674|NCT01537042|83260653|FG000|Overall Study|Lack of Efficacy|0|||
47011675|NCT01537042|83260654|FG001|Overall Study|Lack of Efficacy|1|||
47011676|NCT01537042|83260653|FG000|Overall Study|Protocol Violation|0|||
47011677|NCT01537042|83260654|FG001|Overall Study|Protocol Violation|1|||
47011678|NCT01537042|83260653|FG000|Overall Study|Other|0|||
47011679|NCT01537042|83260654|FG001|Overall Study|Other|1|||
47011680|NCT01536574|83260675|FG000|Overall Study|Adverse Event|4|||
47011681|NCT01536574|83260676|FG001|Overall Study|Adverse Event|5|||
47011682|NCT01536574|83260675|FG000|Overall Study|Withdrawal by Subject|1|||
47011683|NCT01536574|83260676|FG001|Overall Study|Withdrawal by Subject|2|||
47011684|NCT01536574|83260675|FG000|Overall Study|Lack of Efficacy|1|||
47011685|NCT01536574|83260676|FG001|Overall Study|Lack of Efficacy|0|||
47011686|NCT01536418|83260684|FG000|Overall Study|Protocol Violation|2|||
47011687|NCT01536418|83260685|FG001|Overall Study|Protocol Violation|3|||
47011688|NCT01536418|83260684|FG000|Overall Study|Physician Decision|1|||
46620522|NCT01770145|82769759|FG000|Baseline|Withdrawal by Subject|1|||
47011689|NCT01536418|83260685|FG001|Overall Study|Physician Decision|3|||
47011690|NCT01536418|83260684|FG000|Overall Study|Study closed/terminated|41|||
47011691|NCT01536418|83260685|FG001|Overall Study|Study closed/terminated|37|||
47011692|NCT01536418|83260684|FG000|Overall Study|Lack of Efficacy|10|||
47011693|NCT01536418|83260685|FG001|Overall Study|Lack of Efficacy|16|||
47011694|NCT01536418|83260684|FG000|Overall Study|Adverse Event|9|||
47011695|NCT01536418|83260685|FG001|Overall Study|Adverse Event|4|||
47011696|NCT01536418|83260684|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
47011697|NCT01536418|83260685|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
47011698|NCT01536418|83260684|FG000|Overall Study|Withdrawal by Subject|5|||
47011699|NCT01536418|83260685|FG001|Overall Study|Withdrawal by Subject|3|||
47011700|NCT01576042|83260694|FG000|Overall Study|Physician Decision|2|||
47011701|NCT01576042|83260695|FG001|Overall Study|Physician Decision|0|||
47011702|NCT01561300|83260701|FG000|Run in on Placebo|Adverse Event|1|||
47011703|NCT01561300|83260702|FG001|Run in on Placebo|Adverse Event|0|||
47011704|NCT01536262|83260712|FG000|Overall Study|Adverse Event|6|||
47011705|NCT01536262|83260713|FG001|Overall Study|Adverse Event|1|||
47011706|NCT01536262|83260714|FG002|Overall Study|Adverse Event|2|||
47011707|NCT01536262|83260712|FG000|Overall Study|Withdrawal by Subject|1|||
47011708|NCT01536262|83260713|FG001|Overall Study|Withdrawal by Subject|1|||
47011709|NCT01536262|83260714|FG002|Overall Study|Withdrawal by Subject|0|||
47011710|NCT01536262|83260712|FG000|Overall Study|Other than stated above|1|||
47011711|NCT01536262|83260713|FG001|Overall Study|Other than stated above|0|||
47011712|NCT01536262|83260714|FG002|Overall Study|Other than stated above|0|||
47011713|NCT01560988|83260723|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
47011714|NCT01560988|83260724|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
47011715|NCT01560988|83260723|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
47011716|NCT01560988|83260724|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
47011717|NCT01560988|83260723|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
47011718|NCT01560988|83260724|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
47011719|NCT01535638|83260735|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
47011720|NCT01535638|83260736|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
47011721|NCT01535638|83260737|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
47011722|NCT01535638|83260738|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
47011723|NCT01535638|83260739|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
47011724|NCT01535638|83260740|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
47011725|NCT01535638|83260735|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
47011726|NCT01535638|83260736|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
47011727|NCT01535638|83260737|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
47011728|NCT01535638|83260738|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
47011729|NCT01535638|83260739|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
47011730|NCT01535638|83260740|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
47011731|NCT01535560|83260751|FG000|Overall Study|Adverse Event|12|||
47011732|NCT01535560|83260752|FG001|Overall Study|Adverse Event|7|||
47011733|NCT01535560|83260751|FG000|Overall Study|Lost to Follow-up|1|||
47011734|NCT01535560|83260752|FG001|Overall Study|Lost to Follow-up|3|||
47011735|NCT01535560|83260751|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
47011736|NCT01535560|83260752|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
47011737|NCT01535560|83260751|FG000|Overall Study|Treatment Failure|21|||
47011738|NCT01535560|83260752|FG001|Overall Study|Treatment Failure|83|||
47011739|NCT01535560|83260751|FG000|Overall Study|Other|0|||
47011740|NCT01535560|83260752|FG001|Overall Study|Other|1|||
47011741|NCT01535560|83260751|FG000|Overall Study|Randomized in Error|0|||
47011742|NCT01535560|83260752|FG001|Overall Study|Randomized in Error|1|||
47011743|NCT01575028|83260760|FG000|Overall Study|Physician Decision|0|||
47011744|NCT01575028|83260761|FG001|Overall Study|Physician Decision|1|||
47011745|NCT01574716|83260786|FG000|Part 1|Death|3|||
47011746|NCT01574716|83260787|FG001|Part 1|Death|1|||
47011747|NCT01574716|83260788|FG002|Part 1|Death|8|||
47011748|NCT01574716|83260789|FG003|Part 1|Death|0|||
47011749|NCT01574716|83260790|FG004|Part 1|Death|0|||
47011750|NCT01574716|83260786|FG000|Part 1|Discontinuation of study by sponsor|0|||
47011751|NCT01574716|83260787|FG001|Part 1|Discontinuation of study by sponsor|0|||
47011752|NCT01574716|83260788|FG002|Part 1|Discontinuation of study by sponsor|1|||
47011753|NCT01574716|83260789|FG003|Part 1|Discontinuation of study by sponsor|0|||
47011754|NCT01574716|83260790|FG004|Part 1|Discontinuation of study by sponsor|0|||
47011755|NCT01574716|83260786|FG000|Part 1|Withdrawal by Subject|0|||
47011756|NCT01574716|83260787|FG001|Part 1|Withdrawal by Subject|2|||
47011757|NCT01574716|83260788|FG002|Part 1|Withdrawal by Subject|0|||
47011758|NCT01574716|83260789|FG003|Part 1|Withdrawal by Subject|0|||
47011759|NCT01574716|83260790|FG004|Part 1|Withdrawal by Subject|0|||
46620523|NCT01770145|82769759|FG000|Baseline|Lost to Follow-up|1|||
46620524|NCT01770145|82769759|FG000|Baseline|Unable to define optimal dose|4|||
47011760|NCT01574716|83260786|FG000|Part 1|Lost to Follow-up|0|||
47011761|NCT01574716|83260787|FG001|Part 1|Lost to Follow-up|1|||
47011762|NCT01574716|83260788|FG002|Part 1|Lost to Follow-up|0|||
47011763|NCT01574716|83260789|FG003|Part 1|Lost to Follow-up|0|||
47011764|NCT01574716|83260790|FG004|Part 1|Lost to Follow-up|0|||
47011765|NCT01574716|83260786|FG000|Part 2|Progressive disease|0|||
47011766|NCT01574716|83260787|FG001|Part 2|Progressive disease|0|||
47011767|NCT01574716|83260788|FG002|Part 2|Progressive disease|0|||
46620525|NCT01770145|82769759|FG000|Treatment|Adverse Event|3|||
47011768|NCT01574716|83260789|FG003|Part 2|Progressive disease|1|||
47011769|NCT01574716|83260790|FG004|Part 2|Progressive disease|0|||
47011770|NCT01574716|83260786|FG000|Part 2|Death|0|||
47011771|NCT01574716|83260787|FG001|Part 2|Death|0|||
47011772|NCT01574716|83260788|FG002|Part 2|Death|0|||
47011773|NCT01574716|83260789|FG003|Part 2|Death|76|||
47011774|NCT01574716|83260790|FG004|Part 2|Death|35|||
47011775|NCT01574716|83260786|FG000|Part 2|Discontinuation of study by sponsor|0|||
47011776|NCT01574716|83260787|FG001|Part 2|Discontinuation of study by sponsor|0|||
47011777|NCT01574716|83260788|FG002|Part 2|Discontinuation of study by sponsor|0|||
47011778|NCT01574716|83260789|FG003|Part 2|Discontinuation of study by sponsor|51|||
47011779|NCT01574716|83260790|FG004|Part 2|Discontinuation of study by sponsor|31|||
47011780|NCT01574716|83260786|FG000|Part 2|Withdrawal by Subject|0|||
47011781|NCT01574716|83260787|FG001|Part 2|Withdrawal by Subject|0|||
47011782|NCT01574716|83260788|FG002|Part 2|Withdrawal by Subject|0|||
47011783|NCT01574716|83260789|FG003|Part 2|Withdrawal by Subject|5|||
47011784|NCT01574716|83260790|FG004|Part 2|Withdrawal by Subject|4|||
47011785|NCT01574716|83260786|FG000|Part 2|Brain metastases|0|||
47011786|NCT01574716|83260787|FG001|Part 2|Brain metastases|0|||
47011787|NCT01574716|83260788|FG002|Part 2|Brain metastases|0|||
47011788|NCT01574716|83260789|FG003|Part 2|Brain metastases|1|||
47011789|NCT01574716|83260790|FG004|Part 2|Brain metastases|0|||
47011790|NCT01574716|83260786|FG000|Part 2|Lost to Follow-up|0|||
47011791|NCT01574716|83260787|FG001|Part 2|Lost to Follow-up|0|||
47011792|NCT01574716|83260788|FG002|Part 2|Lost to Follow-up|0|||
47011793|NCT01574716|83260789|FG003|Part 2|Lost to Follow-up|3|||
47011794|NCT01574716|83260790|FG004|Part 2|Lost to Follow-up|0|||
47011795|NCT02161562|83260801|FG000|Overall Study|Withdrawal by Subject|5|||
47011796|NCT02161562|83260802|FG001|Overall Study|Withdrawal by Subject|8|||
47011797|NCT02161562|83260801|FG000|Overall Study|Protocol Violation|9|||
47011798|NCT02161562|83260802|FG001|Overall Study|Protocol Violation|4|||
47011799|NCT02161562|83260801|FG000|Overall Study|Pregnancy|1|||
47011800|NCT02161562|83260802|FG001|Overall Study|Pregnancy|2|||
47011801|NCT02161562|83260801|FG000|Overall Study|Lost to Follow-up|3|||
47011802|NCT02161562|83260802|FG001|Overall Study|Lost to Follow-up|1|||
47011803|NCT02161562|83260801|FG000|Overall Study|Lack of Efficacy|4|||
47011804|NCT02161562|83260802|FG001|Overall Study|Lack of Efficacy|1|||
47011805|NCT02161562|83260801|FG000|Overall Study|Adverse Event|1|||
47011806|NCT02161562|83260802|FG001|Overall Study|Adverse Event|1|||
47011807|NCT02161562|83260801|FG000|Overall Study|Participant moved back to home country|1|||
47011808|NCT02161562|83260802|FG001|Overall Study|Participant moved back to home country|0|||
47011809|NCT02161562|83260801|FG000|Overall Study|Withdrew due to being out of the country|1|||
47011810|NCT02161562|83260802|FG001|Overall Study|Withdrew due to being out of the country|0|||
47011811|NCT02161562|83260801|FG000|Overall Study|Participant moved out of province|1|||
47011812|NCT02161562|83260802|FG001|Overall Study|Participant moved out of province|0|||
47011813|NCT01559116|83260821|FG000|Overall Study|Adverse Event|10|||
47011814|NCT01559116|83260821|FG000|Overall Study|Lack of Efficacy|1|||
47011815|NCT01559116|83260821|FG000|Overall Study|Lost to Follow-up|1|||
47011816|NCT01559116|83260821|FG000|Overall Study|Protocol Violation|1|||
47011817|NCT01559116|83260821|FG000|Overall Study|Withdrawal by Subject|4|||
47011818|NCT01559116|83260821|FG000|Overall Study|other than stated above|9|||
47011819|NCT01574326|83260840|FG000|Overall Study|Randomized but not treated|0|||
47011820|NCT01574326|83260841|FG001|Overall Study|Randomized but not treated|1|||
47011821|NCT01574326|83260840|FG000|Overall Study|Withdrawal by Participant|2|||
47011822|NCT01574326|83260841|FG001|Overall Study|Withdrawal by Participant|4|||
47011823|NCT01574326|83260840|FG000|Overall Study|Physician Decision|5|||
47011824|NCT01574326|83260841|FG001|Overall Study|Physician Decision|3|||
47011825|NCT01574326|83260840|FG000|Overall Study|Adverse Event|1|||
47011826|NCT01574326|83260841|FG001|Overall Study|Adverse Event|3|||
46709629|NCT00963807|82925670|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
46709630|NCT00963807|82925670|FG000|Overall Study|Disease progression|15|||
47011827|NCT01574326|83260840|FG000|Overall Study|Other: Mainly kidney transplant|8|||
47011828|NCT01574326|83260841|FG001|Overall Study|Other: Mainly kidney transplant|8|||
47011829|NCT01574248|83260854|FG000|Overall Study|Withdrawal by Subject|2|||
47011830|NCT01574248|83260855|FG001|Overall Study|Withdrawal by Subject|0|||
47011831|NCT01574248|83260854|FG000|Overall Study|Missing primary endpoint data|1|||
47011832|NCT01574248|83260855|FG001|Overall Study|Missing primary endpoint data|0|||
47011833|NCT01573624|83260861|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
47011834|NCT01573624|83260862|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
47011835|NCT01573624|83260863|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
47011836|NCT01573624|83260864|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
46709631|NCT01142466|82925678|FG000|Overall Study|Adverse Event|2|||
47011837|NCT01573624|83260865|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
47011838|NCT01573624|83260866|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
47011839|NCT01573624|83260867|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
47011840|NCT01573624|83260861|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
47011841|NCT01573624|83260862|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
47011842|NCT01573624|83260863|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
47011843|NCT01573624|83260864|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
47011844|NCT01573624|83260865|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
47011845|NCT01573624|83260866|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
47011846|NCT01573624|83260867|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
47011847|NCT01573624|83260861|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
47011848|NCT01573624|83260862|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
47011849|NCT01573624|83260863|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
47011850|NCT01573624|83260864|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
47011851|NCT01573624|83260865|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
47011852|NCT01573624|83260866|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
47011853|NCT01573624|83260867|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
47011854|NCT01573624|83260861|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
47011855|NCT01573624|83260862|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47011856|NCT01573624|83260863|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
47011857|NCT01573624|83260864|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47011858|NCT01573624|83260865|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47011859|NCT01573624|83260866|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
47011860|NCT01573624|83260867|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47011861|NCT01573624|83260861|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
47011862|NCT01573624|83260862|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
47011863|NCT01573624|83260863|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
47011864|NCT01573624|83260864|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
47011865|NCT01573624|83260865|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
47011866|NCT01573624|83260866|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
47011867|NCT01573624|83260867|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
47011868|NCT01573624|83260861|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
47011869|NCT01573624|83260862|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
47011870|NCT01573624|83260863|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
47011871|NCT01573624|83260864|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
47011872|NCT01573624|83260865|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
47011873|NCT01573624|83260866|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
47011874|NCT01573624|83260867|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
47011875|NCT01573624|83260861|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
47011876|NCT01573624|83260862|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
47011877|NCT01573624|83260863|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
46910440|NCT01529034|83139975|FG000|Overall Study|Lack of Efficacy|4|||
46910441|NCT01529034|83139975|FG000|Overall Study|Investigator no longer available|2|||
46910442|NCT01529034|83139975|FG000|Overall Study|Study drug not available|2|||
47011878|NCT01573624|83260864|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
47011879|NCT01573624|83260865|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
47011880|NCT01573624|83260866|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
47011881|NCT01573624|83260867|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
47011882|NCT01573624|83260861|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
47011883|NCT01573624|83260862|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47011884|NCT01573624|83260863|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
47011885|NCT01573624|83260864|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
47011886|NCT01573624|83260865|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47011887|NCT01573624|83260866|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47011888|NCT01573624|83260867|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
47011889|NCT01573624|83260861|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
47011890|NCT01573624|83260862|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
47011891|NCT01573624|83260863|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
47011892|NCT01573624|83260864|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
47011893|NCT01573624|83260865|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
47011894|NCT01573624|83260866|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
47011895|NCT01573624|83260867|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
47011896|NCT01573624|83260861|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47011897|NCT01573624|83260862|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47011898|NCT01573624|83260863|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47011899|NCT01573624|83260864|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
47011900|NCT01573624|83260865|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47011901|NCT01573624|83260866|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
47011902|NCT01573624|83260867|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
47011903|NCT01573624|83260861|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
47011904|NCT01573624|83260862|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
47011905|NCT01573624|83260863|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
47011906|NCT01573624|83260864|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
47011907|NCT01573624|83260865|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
47011908|NCT01573624|83260866|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
47011909|NCT01573624|83260867|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
47011910|NCT01573624|83260861|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
47011911|NCT01573624|83260862|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
47011912|NCT01573624|83260863|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
47011913|NCT01573624|83260864|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
47011914|NCT01573624|83260865|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
47011915|NCT01573624|83260866|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
47011916|NCT01573624|83260867|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
47011917|NCT01573624|83260861|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
47011918|NCT01573624|83260862|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
47011919|NCT01573624|83260863|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
47011920|NCT01573624|83260864|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
47011921|NCT01573624|83260865|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
47011922|NCT01573624|83260866|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
47011923|NCT01573624|83260867|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
47011924|NCT01573624|83260861|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
47011925|NCT01573624|83260862|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
47011926|NCT01573624|83260863|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
47011927|NCT01573624|83260864|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
47011928|NCT01573624|83260865|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
47011929|NCT01573624|83260866|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
47011930|NCT01573624|83260867|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
47011931|NCT01573624|83260861|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
47011932|NCT01573624|83260862|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
47011933|NCT01573624|83260863|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
47011934|NCT01573624|83260864|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
47011935|NCT01573624|83260865|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
47011936|NCT01573624|83260866|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
47011937|NCT01573624|83260867|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
47011938|NCT01573624|83260861|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
47011939|NCT01573624|83260862|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
47011940|NCT01573624|83260863|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
47011941|NCT01573624|83260864|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
47011942|NCT01573624|83260865|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
47011943|NCT01573624|83260866|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
47011944|NCT01573624|83260867|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
47011945|NCT01573624|83260861|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
47011946|NCT01573624|83260862|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
47011947|NCT01573624|83260863|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
47011948|NCT01573624|83260864|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
47011949|NCT01573624|83260865|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
47011950|NCT01573624|83260866|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
47011951|NCT01573624|83260867|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
47011952|NCT01573624|83260861|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
47011953|NCT01573624|83260862|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
47011954|NCT01573624|83260863|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
47011955|NCT01573624|83260864|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
47011956|NCT01573624|83260865|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
47011957|NCT01573624|83260866|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
47011958|NCT01573624|83260867|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
47011959|NCT01573624|83260861|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
47011960|NCT01573624|83260862|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
47011961|NCT01573624|83260863|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
47011962|NCT01573624|83260864|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
47011963|NCT01573624|83260865|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
47011964|NCT01573624|83260866|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
47011965|NCT01573624|83260867|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
47011966|NCT01573624|83260861|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
47011967|NCT01573624|83260862|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
47011968|NCT01573624|83260863|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
47011969|NCT01573624|83260864|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
47011970|NCT01573624|83260865|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
47011971|NCT01573624|83260866|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
47011972|NCT01573624|83260867|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
47011973|NCT01573624|83260861|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47011974|NCT01573624|83260862|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47011975|NCT01573624|83260863|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47011976|NCT01573624|83260864|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47011977|NCT01573624|83260865|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
47011978|NCT01573624|83260866|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
47011979|NCT01573624|83260867|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
47011980|NCT01573624|83260861|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
47011981|NCT01573624|83260862|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
47011982|NCT01573624|83260863|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
47011983|NCT01573624|83260864|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
46709632|NCT01142466|82925679|FG001|Overall Study|Adverse Event|1|||
47011984|NCT01573624|83260865|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
47011985|NCT01573624|83260866|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
47011986|NCT01573624|83260867|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
47011987|NCT01573624|83260861|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
47011988|NCT01573624|83260862|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47011989|NCT01573624|83260863|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47011990|NCT01573624|83260864|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47011991|NCT01573624|83260865|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
47011992|NCT01573624|83260866|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
47011993|NCT01573624|83260867|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
47011994|NCT01573624|83260861|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
47011995|NCT01573624|83260862|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
47011996|NCT01573624|83260863|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
47011997|NCT01573624|83260864|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
47011998|NCT01573624|83260865|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
47011999|NCT01573624|83260866|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
47012000|NCT01573624|83260867|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
47012001|NCT01573624|83260861|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
47012002|NCT01573624|83260862|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
47012003|NCT01573624|83260863|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
47012004|NCT01573624|83260864|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
47012005|NCT01573624|83260865|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
47012006|NCT01573624|83260866|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
47012007|NCT01573624|83260867|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
47012008|NCT01573624|83260861|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
47012009|NCT01573624|83260862|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
47012010|NCT01573624|83260863|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
47012011|NCT01573624|83260864|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
47012012|NCT01573624|83260865|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
47012013|NCT01573624|83260866|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
47012014|NCT01573624|83260867|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
47012015|NCT01573624|83260861|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
47012016|NCT01573624|83260862|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
47012017|NCT01573624|83260863|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
47012018|NCT01573624|83260864|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
47012019|NCT01573624|83260865|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
47012020|NCT01573624|83260866|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
47012021|NCT01573624|83260867|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
47012022|NCT01557946|83260891|FG000|Overall Study|Adverse Event|3|||
47012023|NCT01557946|83260892|FG001|Overall Study|Adverse Event|0|||
47012024|NCT01534078|83260897|FG000|Overall Study|Death|1|||
47012025|NCT01534078|83260897|FG000|Overall Study|Withdrawal by Subject|1|||
47012026|NCT02185040|83260906|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
47012027|NCT02185040|83260907|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
47012028|NCT02185040|83260908|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
47012029|NCT02185040|83260909|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
47012030|NCT02185040|83260910|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
47012031|NCT02185040|83260911|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
47012032|NCT02185040|83260912|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
47012033|NCT02185040|83260906|FG000|Part 1 Treatment Phase|Adverse Event|1|||
47012034|NCT02185040|83260907|FG001|Part 1 Treatment Phase|Adverse Event|0|||
47012035|NCT02185040|83260908|FG002|Part 1 Treatment Phase|Adverse Event|0|||
47012036|NCT02185040|83260909|FG003|Part 1 Treatment Phase|Adverse Event|2|||
47012037|NCT02185040|83260910|FG004|Part 1 Treatment Phase|Adverse Event|3|||
47012038|NCT02185040|83260911|FG005|Part 1 Treatment Phase|Adverse Event|0|||
47012039|NCT02185040|83260912|FG006|Part 1 Treatment Phase|Adverse Event|0|||
47012040|NCT02185040|83260906|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
47012041|NCT02185040|83260907|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
47012042|NCT02185040|83260908|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
47012043|NCT02185040|83260909|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
47012044|NCT02185040|83260910|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
47012045|NCT02185040|83260911|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
47012046|NCT02185040|83260912|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
47012047|NCT02185040|83260906|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
47012048|NCT02185040|83260907|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
47012049|NCT02185040|83260908|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
47012050|NCT02185040|83260909|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
47012051|NCT02185040|83260910|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
47012052|NCT02185040|83260911|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
47012053|NCT02185040|83260912|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
47012054|NCT02185040|83260906|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
47012055|NCT02185040|83260907|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
47012056|NCT02185040|83260908|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
47012057|NCT02185040|83260909|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
47012058|NCT02185040|83260910|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
47012059|NCT02185040|83260911|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
47012060|NCT02185040|83260912|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
47012061|NCT02185040|83260906|FG000|Active Treatment Extension Phase|Adverse Event|0|||
47012062|NCT02185040|83260907|FG001|Active Treatment Extension Phase|Adverse Event|0|||
47012063|NCT02185040|83260908|FG002|Active Treatment Extension Phase|Adverse Event|0|||
47012064|NCT02185040|83260909|FG003|Active Treatment Extension Phase|Adverse Event|0|||
47012065|NCT02185040|83260910|FG004|Active Treatment Extension Phase|Adverse Event|0|||
46709633|NCT01142466|82925678|FG000|Overall Study|Withdrawal by Subject|1|||
47012066|NCT02185040|83260911|FG005|Active Treatment Extension Phase|Adverse Event|1|||
46709634|NCT01142466|82925679|FG001|Overall Study|Withdrawal by Subject|1|||
47012067|NCT02185040|83260912|FG006|Active Treatment Extension Phase|Adverse Event|4|||
47012068|NCT02185040|83260906|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
47012069|NCT02185040|83260907|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
47012070|NCT02185040|83260908|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
47012071|NCT02185040|83260909|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
47012072|NCT02185040|83260910|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
47012073|NCT02185040|83260911|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
47012074|NCT02185040|83260912|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
47012075|NCT02185040|83260906|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
47012076|NCT02185040|83260907|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
47012077|NCT02185040|83260908|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
47012078|NCT02185040|83260909|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
47012079|NCT02185040|83260910|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
47012080|NCT02185040|83260911|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
47012081|NCT02185040|83260912|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
47012082|NCT02161406|83260934|FG000|Overall Study|Death|2|||
47012083|NCT02161406|83260935|FG001|Overall Study|Death|1|||
47012084|NCT02161406|83260934|FG000|Overall Study|Lost to Follow-up|2|||
47012085|NCT02161406|83260935|FG001|Overall Study|Lost to Follow-up|1|||
47012086|NCT02161406|83260934|FG000|Overall Study|Withdrawal by Subject|2|||
47012087|NCT02161406|83260935|FG001|Overall Study|Withdrawal by Subject|4|||
47012088|NCT02161406|83260934|FG000|Overall Study|investigator withdrew subject|3|||
47012089|NCT02161406|83260935|FG001|Overall Study|investigator withdrew subject|1|||
47012090|NCT02161406|83260934|FG000|Overall Study|Lack of Efficacy|1|||
47012091|NCT02161406|83260935|FG001|Overall Study|Lack of Efficacy|1|||
47012092|NCT02161406|83260934|FG000|Overall Study|relocation|0|||
47012093|NCT02161406|83260935|FG001|Overall Study|relocation|1|||
47012094|NCT02161016|83260941|FG000|Overall Study|withdrawn by IRB|1|||
47012095|NCT01573000|83260947|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
47012096|NCT01573000|83260948|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
47012097|NCT01573000|83260947|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
47012098|NCT01573000|83260948|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
47012099|NCT01573000|83260947|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
47012100|NCT01573000|83260948|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
47012101|NCT01573000|83260947|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
47012102|NCT01573000|83260948|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
47012103|NCT01573000|83260947|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
47012104|NCT01573000|83260948|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
47012105|NCT01573000|83260947|FG000|Crossover Phase|Lack of Efficacy|0|||
47012106|NCT01573000|83260948|FG001|Crossover Phase|Lack of Efficacy|13|||
47012107|NCT01573000|83260947|FG000|Crossover Phase|Lost to Follow-up|0|||
47012108|NCT01573000|83260948|FG001|Crossover Phase|Lost to Follow-up|2|||
47012109|NCT01573000|83260947|FG000|Crossover Phase|Death|0|||
47012110|NCT01573000|83260948|FG001|Crossover Phase|Death|3|||
47012111|NCT01573000|83260947|FG000|Long-Term Follow-Up|Death|3|||
47012112|NCT01573000|83260948|FG001|Long-Term Follow-Up|Death|0|||
47012113|NCT01573000|83260947|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
47012114|NCT01573000|83260948|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
47012115|NCT01572922|83260958|FG000|Overall Study|Adverse Event|1|||
47012116|NCT01572922|83260958|FG000|Overall Study|Protocol Violation|1|||
47012117|NCT01572922|83260958|FG000|Overall Study|Death|1|||
47012118|NCT01572844|83260967|FG000|Overall Study|Physician Decision|1|||
47012119|NCT01572844|83260968|FG001|Overall Study|Physician Decision|1|||
47012120|NCT01557400|83260977|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
47012121|NCT01557400|83260977|FG000|Overall Study|Adverse Event|3|||
47012122|NCT01557400|83260977|FG000|Overall Study|Lost to Follow-up|5|||
47012123|NCT01557400|83260977|FG000|Overall Study|Withdrawal by Subject|9|||
47012124|NCT01533922|83260981|FG000|Overall Study|Adverse Event|5|||
47012125|NCT01533922|83260982|FG001|Overall Study|Adverse Event|8|||
47012126|NCT01533922|83260983|FG002|Overall Study|Adverse Event|6|||
47012127|NCT01533922|83260984|FG003|Overall Study|Adverse Event|3|||
47012128|NCT01533922|83260985|FG004|Overall Study|Adverse Event|4|||
47012129|NCT01533922|83260981|FG000|Overall Study|Lack of Efficacy|0|||
46620526|NCT01770145|82769759|FG000|Treatment|Withdrawal by Subject|1|||
47012130|NCT01533922|83260982|FG001|Overall Study|Lack of Efficacy|0|||
47012131|NCT01533922|83260983|FG002|Overall Study|Lack of Efficacy|1|||
47012132|NCT01533922|83260984|FG003|Overall Study|Lack of Efficacy|0|||
46620527|NCT01749137|82769765|FG000|Overall Study|Adverse Event|4|||
47012133|NCT01533922|83260985|FG004|Overall Study|Lack of Efficacy|0|||
47012134|NCT01533922|83260981|FG000|Overall Study|Protocol Violation|0|||
47012135|NCT01533922|83260982|FG001|Overall Study|Protocol Violation|3|||
47012136|NCT01533922|83260983|FG002|Overall Study|Protocol Violation|0|||
47012137|NCT01533922|83260984|FG003|Overall Study|Protocol Violation|0|||
46620528|NCT01749137|82769766|FG001|Overall Study|Adverse Event|4|||
47012138|NCT01533922|83260985|FG004|Overall Study|Protocol Violation|1|||
47012139|NCT01533922|83260981|FG000|Overall Study|Withdrawal by Subject|3|||
47012140|NCT01533922|83260982|FG001|Overall Study|Withdrawal by Subject|1|||
47012141|NCT01533922|83260983|FG002|Overall Study|Withdrawal by Subject|2|||
47012142|NCT01533922|83260984|FG003|Overall Study|Withdrawal by Subject|2|||
47012143|NCT01533922|83260985|FG004|Overall Study|Withdrawal by Subject|1|||
47012144|NCT01533922|83260981|FG000|Overall Study|Other reason not defined above|2|||
47012145|NCT01533922|83260982|FG001|Overall Study|Other reason not defined above|0|||
47012146|NCT01533922|83260983|FG002|Overall Study|Other reason not defined above|1|||
47012147|NCT01533922|83260984|FG003|Overall Study|Other reason not defined above|0|||
47012148|NCT01533922|83260985|FG004|Overall Study|Other reason not defined above|0|||
47012149|NCT01533688|83261000|FG000|Overall Study|Withdrawal by Subject|5|||
47012150|NCT01533688|83261001|FG001|Overall Study|Withdrawal by Subject|4|||
47012151|NCT01533688|83261002|FG002|Overall Study|Withdrawal by Subject|3|||
47012152|NCT01533688|83261000|FG000|Overall Study|Medically unstable|1|||
47012153|NCT01533688|83261001|FG001|Overall Study|Medically unstable|3|||
47012154|NCT01533688|83261002|FG002|Overall Study|Medically unstable|3|||
46910443|NCT03036072|83139982|FG000|Overall Study|Death|0|||
46910444|NCT03036072|83139983|FG001|Overall Study|Death|1|||
46910445|NCT03036072|83139982|FG000|Overall Study|Withdrawal by Subject|0|||
46910446|NCT03036072|83139983|FG001|Overall Study|Withdrawal by Subject|1|||
47012155|NCT01533688|83261000|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
47012156|NCT01533688|83261001|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
47012157|NCT01533688|83261002|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
47012158|NCT01532986|83261014|FG000|Overall Study|Death|9|||
47012159|NCT01532986|83261015|FG001|Overall Study|Death|9|||
47012160|NCT01532986|83261014|FG000|Overall Study|Withdrawal by Subject|7|||
47012161|NCT01532986|83261015|FG001|Overall Study|Withdrawal by Subject|10|||
47012162|NCT01532986|83261014|FG000|Overall Study|Physician Decision|7|||
47012163|NCT01532986|83261015|FG001|Overall Study|Physician Decision|5|||
47012164|NCT01532908|83261024|FG000|Overall Study|Not Transplanted|1|||
47012165|NCT01532908|83261025|FG001|Overall Study|Not Transplanted|0|||
47012166|NCT02160782|83261031|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
47012167|NCT02160782|83261032|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
47012168|NCT02160782|83261033|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
47012169|NCT02160782|83261034|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
47012170|NCT02160782|83261035|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
47012171|NCT02160782|83261031|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
47012172|NCT02160782|83261032|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
47012173|NCT02160782|83261033|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
47012174|NCT02160782|83261034|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
47012175|NCT02160782|83261035|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
47012176|NCT02160782|83261031|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
47012177|NCT02160782|83261032|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
47012178|NCT02160782|83261033|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
47012179|NCT02160782|83261034|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
47012180|NCT02160782|83261035|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
47012181|NCT02160782|83261031|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
47012182|NCT02160782|83261032|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
47012183|NCT02160782|83261033|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
47012184|NCT02160782|83261034|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
47012185|NCT02160782|83261035|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
47012186|NCT02160782|83261031|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
47012187|NCT02160782|83261032|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
47012188|NCT02160782|83261033|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
47012189|NCT02160782|83261034|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
47012190|NCT02160782|83261035|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
47012191|NCT02160782|83261031|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
47012192|NCT02160782|83261032|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
47012193|NCT02160782|83261033|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
47012194|NCT02160782|83261034|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
47012195|NCT02160782|83261035|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
47012196|NCT02160782|83261031|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
47012197|NCT02160782|83261032|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
47012198|NCT02160782|83261033|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
46910447|NCT03036072|83139982|FG000|Overall Study|Physician Decision|0|||
46910448|NCT03036072|83139983|FG001|Overall Study|Physician Decision|1|||
47012199|NCT02160782|83261034|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
47012200|NCT02160782|83261035|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
47012201|NCT02160626|83261062|FG000|Overall Study|Adverse Event|1|||
47012202|NCT02160626|83261063|FG001|Overall Study|Adverse Event|0|||
47012203|NCT02160626|83261064|FG002|Overall Study|Adverse Event|0|||
47012204|NCT02160626|83261062|FG000|Overall Study|Schedule not conducive to study visits|0|||
47012205|NCT02160626|83261063|FG001|Overall Study|Schedule not conducive to study visits|0|||
47012206|NCT02160626|83261064|FG002|Overall Study|Schedule not conducive to study visits|1|||
47012207|NCT02160626|83261062|FG000|Overall Study|Withdrawal by Subject|0|||
47012208|NCT02160626|83261063|FG001|Overall Study|Withdrawal by Subject|1|||
47012209|NCT02160626|83261064|FG002|Overall Study|Withdrawal by Subject|0|||
47012210|NCT02160314|83261076|FG000|Overall Study|Adverse Event|0|||
47012211|NCT02160314|83261077|FG001|Overall Study|Adverse Event|6|||
47012212|NCT02160314|83261076|FG000|Overall Study|Protocol Violation|0|||
47012213|NCT02160314|83261077|FG001|Overall Study|Protocol Violation|4|||
47012214|NCT02160314|83261076|FG000|Overall Study|Withdrawal by Subject|1|||
47012215|NCT02160314|83261077|FG001|Overall Study|Withdrawal by Subject|2|||
47012216|NCT02160314|83261076|FG000|Overall Study|Lost to Follow-up|0|||
47012217|NCT02160314|83261077|FG001|Overall Study|Lost to Follow-up|1|||
47012218|NCT02160002|83261085|FG000|Overall Study|Withdrawal by Subject|2|||
47012219|NCT02160002|83261086|FG001|Overall Study|Withdrawal by Subject|1|||
47012220|NCT02218268|83261092|FG000|24 Hour Washout|Physician Decision|11|||
47012221|NCT02218268|83261093|FG001|24 Hour Washout|Physician Decision|9|||
47012222|NCT02217878|83261101|FG000|Overall Study|required morphine due to chest pain|1|||
47012223|NCT02217878|83261102|FG001|Overall Study|required morphine due to chest pain|2|||
47012224|NCT02217878|83261101|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
47012225|NCT02217878|83261102|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
47012226|NCT02217566|83261108|FG000|Overall Study|Lost to Follow-up|2|||
47012227|NCT02217566|83261108|FG000|Overall Study|Death|3|||
47012228|NCT02217566|83261108|FG000|Overall Study|Early study termination|6|||
47012229|NCT02217410|83261115|FG000|Overall Study|Graft Loss|0|||
47012230|NCT02217410|83261116|FG001|Overall Study|Graft Loss|0|||
47012231|NCT02217410|83261117|FG002|Overall Study|Graft Loss|2|||
47012232|NCT02217410|83261115|FG000|Overall Study|Withdrawal by Subject|0|||
47012233|NCT02217410|83261116|FG001|Overall Study|Withdrawal by Subject|0|||
47012234|NCT02217410|83261117|FG002|Overall Study|Withdrawal by Subject|2|||
47012235|NCT02217410|83261115|FG000|Overall Study|Lost to Follow-up|0|||
47012236|NCT02217410|83261116|FG001|Overall Study|Lost to Follow-up|0|||
47012237|NCT02217410|83261117|FG002|Overall Study|Lost to Follow-up|1|||
47012238|NCT02217410|83261115|FG000|Overall Study|Lack of Efficacy|0|||
47012239|NCT02217410|83261116|FG001|Overall Study|Lack of Efficacy|1|||
47012240|NCT02217410|83261117|FG002|Overall Study|Lack of Efficacy|0|||
47012241|NCT02217410|83261115|FG000|Overall Study|Physician Decision|1|||
47012242|NCT02217410|83261116|FG001|Overall Study|Physician Decision|3|||
47012243|NCT02217410|83261117|FG002|Overall Study|Physician Decision|0|||
47012244|NCT02217332|83261130|FG000|Overall Study|Adverse Event|3|||
47012245|NCT02217332|83261130|FG000|Overall Study|Dose interruption >1 month|1|||
47012246|NCT02217332|83261130|FG000|Overall Study|Protocol Violation (eligibility)|1|||
47012247|NCT02217332|83261130|FG000|Overall Study|Withdrawal by Subject|1|||
47012248|NCT02217332|83261130|FG000|Overall Study|Lost to Follow-up|1|||
47012249|NCT02184572|83261136|FG000|Overall Study|Lost to Follow-up|29|||
47012250|NCT02184572|83261137|FG001|Overall Study|Lost to Follow-up|21|||
47012251|NCT02184572|83261136|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
47012252|NCT02184572|83261137|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
47012253|NCT02184572|83261136|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
47012254|NCT02184572|83261137|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
47012255|NCT02184572|83261136|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
47012256|NCT02184572|83261137|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
47012257|NCT02184572|83261136|FG000|Overall Study|Traveling Outside The Country|1|||
47012258|NCT02184572|83261137|FG001|Overall Study|Traveling Outside The Country|0|||
47012259|NCT02184572|83261136|FG000|Overall Study|Withdrawal by Subject|14|||
47012260|NCT02184572|83261137|FG001|Overall Study|Withdrawal by Subject|9|||
47012261|NCT02181842|83261145|FG000|Overall Study|Case Report Forms Uncollected|2|||
47012262|NCT01632020|83261151|FG000|Overall Study|Withdrawal by Subject|1|||
46709635|NCT01215734|82925687|FG000|Overall Study|Death|0|||
47012263|NCT01632020|83261152|FG001|Overall Study|Withdrawal by Subject|0|||
47012264|NCT01632020|83261151|FG000|Overall Study|Adverse Event|1|||
47012265|NCT01632020|83261152|FG001|Overall Study|Adverse Event|0|||
47012266|NCT02181296|83261160|FG000|Overall Study|Lost to Follow-up|7|||
46709636|NCT01215734|82925688|FG001|Overall Study|Death|1|||
46910449|NCT03038880|83139992|FG000|Overall Study|Death|1|||
47012267|NCT02181296|83261161|FG001|Overall Study|Lost to Follow-up|6|||
47012268|NCT02215616|83261171|FG000|Overall Study|Sponsor requested to stop study drug|0|||
47012269|NCT02215616|83261172|FG001|Overall Study|Sponsor requested to stop study drug|0|||
46709637|NCT01169987|82925694|FG000|Overall Study|Withdrawal by Subject|3|||
47012270|NCT02215616|83261173|FG002|Overall Study|Sponsor requested to stop study drug|1|||
47012271|NCT02215616|83261174|FG003|Overall Study|Sponsor requested to stop study drug|4|||
47012272|NCT02215616|83261171|FG000|Overall Study|Death|1|||
47012273|NCT02215616|83261172|FG001|Overall Study|Death|0|||
47012274|NCT02215616|83261173|FG002|Overall Study|Death|0|||
47012275|NCT02215616|83261174|FG003|Overall Study|Death|0|||
47012276|NCT02215616|83261171|FG000|Overall Study|Adverse Event|7|||
47012277|NCT02215616|83261172|FG001|Overall Study|Adverse Event|4|||
47012278|NCT02215616|83261173|FG002|Overall Study|Adverse Event|9|||
47012279|NCT02215616|83261174|FG003|Overall Study|Adverse Event|2|||
47012280|NCT02215616|83261171|FG000|Overall Study|Withdrawal by Subject|1|||
47012281|NCT02215616|83261172|FG001|Overall Study|Withdrawal by Subject|8|||
47012282|NCT02215616|83261173|FG002|Overall Study|Withdrawal by Subject|2|||
47012283|NCT02215616|83261174|FG003|Overall Study|Withdrawal by Subject|5|||
47012284|NCT02215616|83261171|FG000|Overall Study|Non-compliance|0|||
47012285|NCT02215616|83261172|FG001|Overall Study|Non-compliance|2|||
47012286|NCT02215616|83261173|FG002|Overall Study|Non-compliance|1|||
47012287|NCT02215616|83261174|FG003|Overall Study|Non-compliance|0|||
47012288|NCT02215616|83261171|FG000|Overall Study|Protocol Violation|0|||
47012289|NCT02215616|83261172|FG001|Overall Study|Protocol Violation|2|||
47012290|NCT02215616|83261173|FG002|Overall Study|Protocol Violation|0|||
47012291|NCT02215616|83261174|FG003|Overall Study|Protocol Violation|0|||
47012292|NCT02215616|83261171|FG000|Overall Study|Lost to Follow-up|1|||
47012293|NCT02215616|83261172|FG001|Overall Study|Lost to Follow-up|1|||
47012294|NCT02215616|83261173|FG002|Overall Study|Lost to Follow-up|0|||
47012295|NCT02215616|83261174|FG003|Overall Study|Lost to Follow-up|1|||
47012296|NCT02215616|83261171|FG000|Overall Study|Other than specified|1|||
47012297|NCT02215616|83261172|FG001|Overall Study|Other than specified|0|||
47012298|NCT02215616|83261173|FG002|Overall Study|Other than specified|1|||
47012299|NCT02215616|83261174|FG003|Overall Study|Other than specified|1|||
47012300|NCT02213666|83261184|FG000|Overall Study|Withdrawal by Subject|1|||
47012301|NCT02213510|83261190|FG000|Overall Study|Death|0|||
47012302|NCT02213510|83261191|FG001|Overall Study|Death|1|||
47012303|NCT02213510|83261190|FG000|Overall Study|Lost to Follow-up|1|||
47012304|NCT02213510|83261191|FG001|Overall Study|Lost to Follow-up|0|||
47012305|NCT02158442|83261199|FG000|Overall Study|Withdrawal by Subject|1|||
47012306|NCT02158442|83261200|FG001|Overall Study|Withdrawal by Subject|0|||
47012307|NCT02158442|83261199|FG000|Overall Study|Perfusion staff not available|1|||
47012308|NCT02158442|83261200|FG001|Overall Study|Perfusion staff not available|0|||
47012309|NCT02158364|83261206|FG000|Overall Study|Case report forms uncollected|10|||
47012310|NCT02158364|83261206|FG000|Overall Study|Protocol Deviation|50|||
47012311|NCT02180672|83261212|FG000|Overall Study|Lost to Follow-up|5|||
47012312|NCT02180672|83261213|FG001|Overall Study|Lost to Follow-up|7|||
47012313|NCT02213198|83261221|FG000|Baseline|No show for intake|7|||
47012314|NCT02213198|83261222|FG001|Baseline|No show for intake|9|||
47012315|NCT02213198|83261221|FG000|Baseline|Withdrawal by Subject|34|||
47012316|NCT02213198|83261222|FG001|Baseline|Withdrawal by Subject|11|||
47012317|NCT02213198|83261221|FG000|Baseline|transferred out of clinic|7|||
47012318|NCT02213198|83261222|FG001|Baseline|transferred out of clinic|9|||
47012319|NCT02213198|83261221|FG000|Baseline|Lost to Follow-up|40|||
47012320|NCT02213198|83261222|FG001|Baseline|Lost to Follow-up|21|||
47012321|NCT02213198|83261221|FG000|Baseline|incarcerated,violent|0|||
47012322|NCT02213198|83261222|FG001|Baseline|incarcerated,violent|1|||
47012323|NCT02213198|83261221|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
47012324|NCT02213198|83261222|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
47012325|NCT02213198|83261221|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
47012326|NCT02213198|83261222|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
47012327|NCT02213198|83261221|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
47012328|NCT02213198|83261222|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
47012329|NCT02213198|83261221|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
47012330|NCT02213198|83261222|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
47012331|NCT02213198|83261221|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
47012332|NCT02213198|83261222|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
47012333|NCT02213198|83261221|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
47012334|NCT02213198|83261222|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
47012335|NCT02157506|83261233|FG000|Overall Study|Adverse Event|0|||
47012336|NCT02157506|83261234|FG001|Overall Study|Adverse Event|1|||
47012337|NCT02157506|83261235|FG002|Overall Study|Adverse Event|0|||
47012338|NCT02157506|83261236|FG003|Overall Study|Adverse Event|0|||
47012339|NCT02157506|83261237|FG004|Overall Study|Adverse Event|0|||
47012340|NCT02157506|83261233|FG000|Overall Study|Lost to Follow-up|0|||
47012341|NCT02157506|83261234|FG001|Overall Study|Lost to Follow-up|0|||
47012342|NCT02157506|83261235|FG002|Overall Study|Lost to Follow-up|1|||
47012343|NCT02157506|83261236|FG003|Overall Study|Lost to Follow-up|0|||
47012344|NCT02157506|83261237|FG004|Overall Study|Lost to Follow-up|0|||
47012345|NCT01920711|83261251|FG000|Overall Study|Death|347|||
47012346|NCT01920711|83261252|FG001|Overall Study|Death|356|||
47012347|NCT01920711|83261251|FG000|Overall Study|Lost to Follow-up|13|||
47012348|NCT01920711|83261252|FG001|Overall Study|Lost to Follow-up|14|||
47012349|NCT01920711|83261251|FG000|Overall Study|Withdrawal by Subject|4|||
47012350|NCT01920711|83261252|FG001|Overall Study|Withdrawal by Subject|3|||
47012351|NCT02180438|83261259|FG000|Overall Study|Lost to Follow-up|1|||
47012352|NCT02179190|83261263|FG000|Enrollment|Exit Prior to Device Attempt|11|||
47012353|NCT02179190|83261263|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
47012354|NCT02179190|83261263|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
47012355|NCT02179190|83261263|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
47012356|NCT02179190|83261263|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
47012357|NCT02179190|83261263|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
47012358|NCT02157116|83261267|FG000|Overall Study|Withdrawal by Subject|4|||
46620529|NCT01749137|82769765|FG000|Overall Study|Lost to Follow-up|2|||
46620530|NCT01749137|82769766|FG001|Overall Study|Lost to Follow-up|3|||
46910450|NCT03038880|83139993|FG001|Overall Study|Death|2|||
47012359|NCT02157116|83261267|FG000|Overall Study|Physician Decision|3|||
47012360|NCT02157116|83261267|FG000|Overall Study|Failed Screening|2|||
47012361|NCT01920555|83261276|FG000|Overall Study|Physician Decision|1|||
47012362|NCT01920555|83261277|FG001|Overall Study|Physician Decision|2|||
47012363|NCT01920555|83261278|FG002|Overall Study|Physician Decision|1|||
47012364|NCT01920555|83261279|FG003|Overall Study|Physician Decision|2|||
47012365|NCT01920555|83261280|FG004|Overall Study|Physician Decision|0|||
47012366|NCT01920555|83261276|FG000|Overall Study|Lack of Efficacy|2|||
47012367|NCT01920555|83261277|FG001|Overall Study|Lack of Efficacy|0|||
47012368|NCT01920555|83261278|FG002|Overall Study|Lack of Efficacy|0|||
47012369|NCT01920555|83261279|FG003|Overall Study|Lack of Efficacy|0|||
47012370|NCT01920555|83261280|FG004|Overall Study|Lack of Efficacy|0|||
47012371|NCT01920555|83261276|FG000|Overall Study|Travel Difficulties|1|||
47012372|NCT01920555|83261277|FG001|Overall Study|Travel Difficulties|1|||
47012373|NCT01920555|83261278|FG002|Overall Study|Travel Difficulties|0|||
47012374|NCT01920555|83261279|FG003|Overall Study|Travel Difficulties|0|||
47012375|NCT01920555|83261280|FG004|Overall Study|Travel Difficulties|1|||
47012376|NCT01920555|83261276|FG000|Overall Study|Lost to Follow-up|0|||
47012377|NCT01920555|83261277|FG001|Overall Study|Lost to Follow-up|1|||
47012378|NCT01920555|83261278|FG002|Overall Study|Lost to Follow-up|0|||
47012379|NCT01920555|83261279|FG003|Overall Study|Lost to Follow-up|1|||
47012380|NCT01920555|83261280|FG004|Overall Study|Lost to Follow-up|0|||
47012381|NCT02156804|83261292|FG000|Overall Study|Withdrawal by Subject|1|||
47012382|NCT02156492|83261299|FG000|Period 1|No Reason Given|0|||
47012383|NCT02156492|83261300|FG001|Period 1|No Reason Given|1|||
47012384|NCT02156492|83261301|FG002|Period 1|No Reason Given|0|||
47012385|NCT02156492|83261299|FG000|Period 3|Adverse Event|0|||
47012386|NCT02156492|83261300|FG001|Period 3|Adverse Event|1|||
46910451|NCT03038880|83139994|FG002|Overall Study|Death|0|||
46910452|NCT03038880|83139992|FG000|Overall Study|Physician Decision|2|||
46910453|NCT03038880|83139993|FG001|Overall Study|Physician Decision|1|||
46910454|NCT03038880|83139994|FG002|Overall Study|Physician Decision|0|||
46910455|NCT03035916|83140005|FG000|Overall Study|Puncture failed|0|||
46910456|NCT03035916|83140006|FG001|Overall Study|Puncture failed|2|||
46910457|NCT03035916|83140007|FG002|Overall Study|Puncture failed|0|||
46910458|NCT01702571|83140017|FG000|Overall Study|Death|1067|||
46910459|NCT01702571|83140018|FG001|Overall Study|Death|76|||
47012387|NCT02156492|83261301|FG002|Period 3|Adverse Event|0|||
47012388|NCT01920477|83261321|FG000|Overall Study|Adverse Event|0|||
46620531|NCT01749137|82769765|FG000|Overall Study|Physician Decision|1|||
46709638|NCT01169987|82925694|FG000|Overall Study|Lost to Follow-up|24|||
46910460|NCT01702571|83140017|FG000|Overall Study|Lost to Follow-up|144|||
46910461|NCT01702571|83140018|FG001|Overall Study|Lost to Follow-up|10|||
46910462|NCT01702571|83140017|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
46910463|NCT01702571|83140018|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
46910464|NCT01702571|83140017|FG000|Overall Study|Investigator Decision|5|||
47012389|NCT01920477|83261322|FG001|Overall Study|Adverse Event|1|||
47012390|NCT01920477|83261321|FG000|Overall Study|Lack of Efficacy|1|||
47012391|NCT01920477|83261322|FG001|Overall Study|Lack of Efficacy|0|||
47012392|NCT01920477|83261321|FG000|Overall Study|Study closed/terminated|14|||
47012393|NCT01920477|83261322|FG001|Overall Study|Study closed/terminated|15|||
47012394|NCT01920477|83261321|FG000|Overall Study|Withdrawal by Subject|0|||
47012395|NCT01920477|83261322|FG001|Overall Study|Withdrawal by Subject|1|||
47012396|NCT02213042|83261331|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
46620532|NCT01749137|82769766|FG001|Overall Study|Physician Decision|0|||
46910465|NCT01702571|83140018|FG001|Overall Study|Investigator Decision|0|||
46910466|NCT01702571|83140017|FG000|Overall Study|Not Classifiable|1|||
47012397|NCT02213042|83261332|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
47012398|NCT02213042|83261333|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
47012399|NCT02213042|83261331|FG000|Overall Study|Adverse Event|2|||
47012400|NCT02213042|83261332|FG001|Overall Study|Adverse Event|1|||
47012401|NCT02213042|83261333|FG002|Overall Study|Adverse Event|0|||
47012402|NCT02213042|83261331|FG000|Overall Study|Withdrawal by Subject|0|||
47012403|NCT02213042|83261332|FG001|Overall Study|Withdrawal by Subject|1|||
47012404|NCT02213042|83261333|FG002|Overall Study|Withdrawal by Subject|1|||
47012405|NCT02213042|83261331|FG000|Overall Study|Protocol Violation|1|||
47012406|NCT02213042|83261332|FG001|Overall Study|Protocol Violation|0|||
47012407|NCT02213042|83261333|FG002|Overall Study|Protocol Violation|0|||
47012408|NCT02213042|83261331|FG000|Overall Study|Investigator discretion|0|||
47012409|NCT02213042|83261332|FG001|Overall Study|Investigator discretion|0|||
47012410|NCT02213042|83261333|FG002|Overall Study|Investigator discretion|1|||
47012411|NCT02212730|83261345|FG000|Overall Study|Tumor not of the required cell histology|1|||
47012412|NCT02212730|83261346|FG001|Overall Study|Tumor not of the required cell histology|0|||
47012413|NCT02212730|83261345|FG000|Overall Study|Withdrawal by Subject|1|||
47012414|NCT02212730|83261346|FG001|Overall Study|Withdrawal by Subject|0|||
47012415|NCT02212730|83261345|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
47012416|NCT02212730|83261346|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
47012417|NCT02178956|83261356|FG000|Overall Study|Lost to Follow-up|4|||
47012418|NCT02178956|83261357|FG001|Overall Study|Lost to Follow-up|4|||
47012419|NCT02178956|83261356|FG000|Overall Study|Sponsor terminated study|49|||
47012420|NCT02178956|83261357|FG001|Overall Study|Sponsor terminated study|58|||
47012421|NCT02178956|83261356|FG000|Overall Study|Withdrawal by Subject|15|||
47012422|NCT02178956|83261357|FG001|Overall Study|Withdrawal by Subject|11|||
47012423|NCT02178956|83261356|FG000|Overall Study|Various Reasons|3|||
47012424|NCT02178956|83261357|FG001|Overall Study|Various Reasons|5|||
47012425|NCT02211638|83261367|FG000|Overall Study|Case Report Forms Uncollected|291|||
47012426|NCT02211638|83261367|FG000|Overall Study|Protocol Violation|692|||
47012427|NCT02178566|83261373|FG000|Overall Study|patient did not complete due to noncompliance|0|||
47012428|NCT02178566|83261374|FG001|Overall Study|patient did not complete due to noncompliance|1|||
47012429|NCT02211014|83261382|FG000|Overall Study|Adverse Event|0|||
47012430|NCT02211014|83261383|FG001|Overall Study|Adverse Event|2|||
47012431|NCT02211014|83261382|FG000|Overall Study|Physician Decision|1|||
47012432|NCT02211014|83261383|FG001|Overall Study|Physician Decision|2|||
47012433|NCT02211014|83261382|FG000|Overall Study|Started another cancer therapy|1|||
47012434|NCT02211014|83261383|FG001|Overall Study|Started another cancer therapy|0|||
47012435|NCT02211014|83261382|FG000|Overall Study|Withdrawal by Subject|0|||
47012436|NCT02211014|83261383|FG001|Overall Study|Withdrawal by Subject|1|||
47012437|NCT02211014|83261382|FG000|Overall Study|In agreement with patient, no benefit|0|||
47012438|NCT02211014|83261383|FG001|Overall Study|In agreement with patient, no benefit|1|||
47012439|NCT01631864|83261407|FG000|Overall Study|Withdrawal by Subject|0|||
47012440|NCT01631864|83261408|FG001|Overall Study|Withdrawal by Subject|1|||
47012441|NCT01631864|83261407|FG000|Overall Study|Adverse Event|2|||
47012442|NCT01631864|83261408|FG001|Overall Study|Adverse Event|3|||
47012443|NCT02210780|83261416|FG000|Overall Study|Adverse Event|0|||
47012444|NCT02210780|83261417|FG001|Overall Study|Adverse Event|5|||
47012445|NCT02210780|83261416|FG000|Overall Study|Lost to Follow-up|2|||
47012446|NCT02210780|83261417|FG001|Overall Study|Lost to Follow-up|1|||
47012447|NCT02210780|83261416|FG000|Overall Study|Withdrawal by Subject|1|||
47012448|NCT02210780|83261417|FG001|Overall Study|Withdrawal by Subject|1|||
47012449|NCT02210780|83261416|FG000|Overall Study|Physician Decision|1|||
47012450|NCT02210780|83261417|FG001|Overall Study|Physician Decision|0|||
47012451|NCT02210780|83261416|FG000|Overall Study|Protocol Violation|1|||
47012452|NCT02210780|83261417|FG001|Overall Study|Protocol Violation|0|||
47012453|NCT02210780|83261416|FG000|Overall Study|Other than specified above|0|||
47012454|NCT02210780|83261417|FG001|Overall Study|Other than specified above|1|||
47012455|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
47012456|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
47012457|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
47012458|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
47012459|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
47012460|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
47012461|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
47012462|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
47012463|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
47012464|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
47012465|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
46709639|NCT01169987|82925694|FG000|Overall Study|Other|4|||
46709640|NCT01215422|82925708|FG000|Overall Study|Relocation|1|||
47012466|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
47012467|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
46709641|NCT01215422|82925709|FG001|Overall Study|Relocation|0|||
46709642|NCT01215422|82925710|FG002|Overall Study|Relocation|0|||
46709643|NCT01215422|82925711|FG003|Overall Study|Relocation|0|||
46709644|NCT01215422|82925708|FG000|Overall Study|Failed intubations|0|||
47012468|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
47012469|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
47012470|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
47012471|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
47012472|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
47012473|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
47012474|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
47012475|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
47012476|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
47012477|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
47012478|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
47012479|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
47012480|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
47012481|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
47012482|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
47012483|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
47012484|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
47012485|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
47012486|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
47012487|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
47012488|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
47012489|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
47012490|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
47012491|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
47012492|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
47012493|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
47012494|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
47012495|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
47012496|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
47012497|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
47012498|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
47012499|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
47012500|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
47012501|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
47012502|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
47012503|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
47012504|NCT01557244|83261428|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
47012505|NCT01557244|83261429|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
47012506|NCT01557244|83261430|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
47012507|NCT01557244|83261431|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
47012508|NCT01557244|83261432|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
47012509|NCT01557244|83261433|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
46709645|NCT01215422|82925709|FG001|Overall Study|Failed intubations|0|||
46709646|NCT01215422|82925710|FG002|Overall Study|Failed intubations|3|||
46709647|NCT01215422|82925711|FG003|Overall Study|Failed intubations|8|||
46910467|NCT01702571|83140018|FG001|Overall Study|Not Classifiable|0|||
46910468|NCT01702571|83140017|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
46910469|NCT01702571|83140018|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
46910470|NCT01702571|83140017|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
46910471|NCT01702571|83140018|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
46910472|NCT01702571|83140017|FG000|Overall Study|Progressive Disease|3|||
46910473|NCT01702571|83140018|FG001|Overall Study|Progressive Disease|0|||
46910474|NCT01702571|83140017|FG000|Overall Study|Protocol Violation|2|||
46910475|NCT01702571|83140018|FG001|Overall Study|Protocol Violation|0|||
46910476|NCT01702571|83140017|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
46910477|NCT01702571|83140018|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
46910478|NCT01702571|83140017|FG000|Overall Study|Termination By Sponsor|4|||
46910479|NCT01702571|83140018|FG001|Overall Study|Termination By Sponsor|0|||
46910480|NCT01702571|83140017|FG000|Overall Study|Withdrawal by Subject|177|||
46910481|NCT01702571|83140018|FG001|Overall Study|Withdrawal by Subject|29|||
46910482|NCT03231943|83140041|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910483|NCT03231943|83140042|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
47012510|NCT01557244|83261434|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
47012511|NCT01557244|83261428|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
47012512|NCT01557244|83261429|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
47012513|NCT01557244|83261430|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
47012514|NCT01557244|83261431|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
47012515|NCT01557244|83261432|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
47012516|NCT01557244|83261433|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
47012517|NCT01557244|83261434|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
47012518|NCT01557244|83261428|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
47012519|NCT01557244|83261429|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
47012520|NCT01557244|83261430|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
47012521|NCT01557244|83261431|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
47012522|NCT01557244|83261432|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
47012523|NCT01557244|83261433|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
47012524|NCT01557244|83261434|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
47012525|NCT01557244|83261428|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
47012526|NCT01557244|83261429|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
47012527|NCT01557244|83261430|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
47012528|NCT01557244|83261431|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
47012529|NCT01557244|83261432|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
47012530|NCT01557244|83261433|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
47012531|NCT01557244|83261434|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
47012532|NCT01557244|83261428|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
47012533|NCT01557244|83261429|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
47012534|NCT01557244|83261430|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
47012535|NCT01557244|83261431|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
47012536|NCT01557244|83261432|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
47012537|NCT01557244|83261433|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
47012538|NCT01557244|83261434|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
47012539|NCT02177942|83261464|FG000|Overall Study|Adverse Event|1|||
47012540|NCT02177942|83261465|FG001|Overall Study|Adverse Event|0|||
47012541|NCT02177942|83261464|FG000|Overall Study|Lost to Follow-up|1|||
47012542|NCT02177942|83261465|FG001|Overall Study|Lost to Follow-up|1|||
47012543|NCT02177942|83261464|FG000|Overall Study|Protocol Violation|4|||
47012544|NCT02177942|83261465|FG001|Overall Study|Protocol Violation|6|||
47012545|NCT02177942|83261464|FG000|Overall Study|Withdrawal by Subject|71|||
47012546|NCT02177942|83261465|FG001|Overall Study|Withdrawal by Subject|81|||
47012547|NCT02155322|83261475|FG000|Overall Study|Adverse Event|1|||
47012548|NCT02155322|83261475|FG000|Overall Study|Physician Decision|1|||
47012549|NCT02155322|83261475|FG000|Overall Study|Relapse/Recurrence|8|||
47012550|NCT02155322|83261475|FG000|Overall Study|Withdrawal by Subject|4|||
47012551|NCT02210000|83261481|FG000|Overall Study|Study Terminated|11|||
47012552|NCT02210000|83261482|FG001|Overall Study|Study Terminated|12|||
47012553|NCT02210000|83261481|FG000|Overall Study|Withdrawal by Subject|7|||
47012554|NCT02210000|83261482|FG001|Overall Study|Withdrawal by Subject|1|||
47012555|NCT02210000|83261481|FG000|Overall Study|Adverse Event|1|||
47012556|NCT02210000|83261482|FG001|Overall Study|Adverse Event|5|||
47012557|NCT02210000|83261481|FG000|Overall Study|Lost to Follow-up|0|||
47012558|NCT02210000|83261482|FG001|Overall Study|Lost to Follow-up|2|||
47012559|NCT02210000|83261481|FG000|Overall Study|Physician Decision|0|||
47012560|NCT02210000|83261482|FG001|Overall Study|Physician Decision|1|||
47012561|NCT01531894|83261488|FG000|Overall Study|Physician Decision|8|||
47012562|NCT01531894|83261488|FG000|Overall Study|Death|1|||
47012563|NCT02209766|83261496|FG000|Overall Study|Withdrawal by Subject|0|||
47012564|NCT02209766|83261497|FG001|Overall Study|Withdrawal by Subject|0|||
47012565|NCT02209766|83261498|FG002|Overall Study|Withdrawal by Subject|0|||
47012566|NCT02209766|83261499|FG003|Overall Study|Withdrawal by Subject|1|||
47012567|NCT02209766|83261500|FG004|Overall Study|Withdrawal by Subject|0|||
47012568|NCT02209454|83261510|FG000|Second Period|Adverse Event|1|||
47012569|NCT02209454|83261511|FG001|Second Period|Adverse Event|0|||
47012570|NCT01571596|83261520|FG000|Overall Study|Adverse Event|2|||
47012571|NCT01571596|83261521|FG001|Overall Study|Adverse Event|0|||
47012572|NCT01571596|83261522|FG002|Overall Study|Adverse Event|0|||
47012573|NCT01571596|83261520|FG000|Overall Study|Study Terminated by the Sponsor|0|||
47012574|NCT01571596|83261521|FG001|Overall Study|Study Terminated by the Sponsor|1|||
47012575|NCT01571596|83261522|FG002|Overall Study|Study Terminated by the Sponsor|1|||
47012576|NCT01557166|83261534|FG000|Overall Study|Adverse Event|20|||
47012577|NCT01557166|83261535|FG001|Overall Study|Adverse Event|6|||
47012578|NCT01557166|83261534|FG000|Overall Study|Lack of Efficacy|2|||
47012579|NCT01557166|83261535|FG001|Overall Study|Lack of Efficacy|1|||
47012580|NCT01557166|83261534|FG000|Overall Study|Protocol Violation|8|||
47012581|NCT01557166|83261535|FG001|Overall Study|Protocol Violation|5|||
47012582|NCT01557166|83261534|FG000|Overall Study|Withdrawn consent|12|||
47012583|NCT01557166|83261535|FG001|Overall Study|Withdrawn consent|20|||
47012584|NCT01557166|83261534|FG000|Overall Study|Target dose not tolerated|1|||
47012585|NCT01557166|83261535|FG001|Overall Study|Target dose not tolerated|0|||
47012586|NCT01557166|83261534|FG000|Overall Study|Psychiatric disorder|1|||
47012587|NCT01557166|83261535|FG001|Overall Study|Psychiatric disorder|0|||
47012588|NCT01557166|83261534|FG000|Overall Study|Unclassified|2|||
47012589|NCT01557166|83261535|FG001|Overall Study|Unclassified|5|||
47012590|NCT01556932|83261541|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
47012591|NCT01556932|83261542|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
47012592|NCT02177786|83261551|FG000|Overall Study|Withdrew Consent|2|||
47012593|NCT02177786|83261552|FG001|Overall Study|Withdrew Consent|6|||
47012594|NCT02177786|83261553|FG002|Overall Study|Withdrew Consent|9|||
47012595|NCT02177786|83261554|FG003|Overall Study|Withdrew Consent|5|||
47012596|NCT02177786|83261551|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
47012597|NCT02177786|83261552|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
47012598|NCT02177786|83261553|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
47012599|NCT02177786|83261554|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
47012600|NCT02177786|83261551|FG000|Overall Study|Adverse Event|1|||
47012601|NCT02177786|83261552|FG001|Overall Study|Adverse Event|1|||
47012602|NCT02177786|83261553|FG002|Overall Study|Adverse Event|2|||
47012603|NCT02177786|83261554|FG003|Overall Study|Adverse Event|3|||
47012604|NCT02177786|83261551|FG000|Overall Study|Death|1|||
47012605|NCT02177786|83261552|FG001|Overall Study|Death|1|||
47012606|NCT02177786|83261553|FG002|Overall Study|Death|1|||
47012607|NCT02177786|83261554|FG003|Overall Study|Death|1|||
47012608|NCT02177786|83261551|FG000|Overall Study|Lost to Follow-up|0|||
47012609|NCT02177786|83261552|FG001|Overall Study|Lost to Follow-up|0|||
47012610|NCT02177786|83261553|FG002|Overall Study|Lost to Follow-up|2|||
47012611|NCT02177786|83261554|FG003|Overall Study|Lost to Follow-up|2|||
47012612|NCT02177786|83261551|FG000|Overall Study|Non-Compliance with Study Drug|0|||
47012613|NCT02177786|83261552|FG001|Overall Study|Non-Compliance with Study Drug|1|||
47012614|NCT02177786|83261553|FG002|Overall Study|Non-Compliance with Study Drug|0|||
47012615|NCT02177786|83261554|FG003|Overall Study|Non-Compliance with Study Drug|1|||
47012616|NCT02177786|83261551|FG000|Overall Study|Protocol Violation|0|||
47012617|NCT02177786|83261552|FG001|Overall Study|Protocol Violation|0|||
47012618|NCT02177786|83261553|FG002|Overall Study|Protocol Violation|2|||
47012619|NCT02177786|83261554|FG003|Overall Study|Protocol Violation|0|||
47012620|NCT02177786|83261551|FG000|Overall Study|Progressive Disease|0|||
47012621|NCT02177786|83261552|FG001|Overall Study|Progressive Disease|1|||
47012622|NCT02177786|83261553|FG002|Overall Study|Progressive Disease|0|||
47012623|NCT02177786|83261554|FG003|Overall Study|Progressive Disease|0|||
47012624|NCT02177786|83261551|FG000|Overall Study|Missing study completion status|0|||
47012625|NCT02177786|83261552|FG001|Overall Study|Missing study completion status|1|||
47012626|NCT02177786|83261553|FG002|Overall Study|Missing study completion status|0|||
47012627|NCT02177786|83261554|FG003|Overall Study|Missing study completion status|0|||
47012628|NCT01555762|83261564|FG000|Overall Study|No information on Bevacizumab intake|11|||
47012629|NCT01555762|83261564|FG000|Overall Study|Missing start date of infusion|8|||
47012630|NCT01555762|83261564|FG000|Overall Study|75 years old or more ticked No|1|||
47012631|NCT01555762|83261564|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
47012632|NCT01555762|83261564|FG000|Overall Study|Death linked to progression of disease|165|||
47012633|NCT01555762|83261564|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
47012634|NCT01555762|83261564|FG000|Overall Study|Investigator's decision|10|||
47012635|NCT01555762|83261564|FG000|Overall Study|Participant not wishing to continue|5|||
47012636|NCT01555762|83261564|FG000|Overall Study|Missing data|1|||
47012637|NCT01555762|83261564|FG000|Overall Study|Death linked to an adverse event|14|||
47012638|NCT02153918|83261568|FG000|Overall Study|Refused further treatment|1|||
47012639|NCT02176928|83261574|FG000|Overall Study|Lost to Follow-up|2|||
47012640|NCT02176928|83261575|FG001|Overall Study|Lost to Follow-up|4|||
47012641|NCT01628510|83261583|FG000|Overall Study|Withdrawal by Subject|0|||
47012642|NCT01628510|83261584|FG001|Overall Study|Withdrawal by Subject|4|||
47012643|NCT01628510|83261583|FG000|Overall Study|Death|3|||
47012644|NCT01628510|83261584|FG001|Overall Study|Death|1|||
47012645|NCT01571362|83261592|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
47012646|NCT01571362|83261593|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
47012647|NCT01571362|83261594|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
47012648|NCT01571362|83261592|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
47012649|NCT01571362|83261593|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
47012650|NCT01571362|83261594|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
47012651|NCT01571362|83261592|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
46709648|NCT01215422|82925708|FG000|Overall Study|Did not complete all intubations|7|||
47012652|NCT01571362|83261593|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
47012653|NCT01571362|83261594|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
47012654|NCT01571362|83261592|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
47012655|NCT01571362|83261593|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
47012656|NCT01571362|83261594|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
47012657|NCT01571362|83261592|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
47012658|NCT01571362|83261593|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
47012659|NCT01571362|83261594|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
47012660|NCT01571362|83261592|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
47012661|NCT01571362|83261593|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
47012662|NCT01571362|83261594|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
47012663|NCT01571362|83261592|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
47012664|NCT01571362|83261593|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
47012665|NCT01571362|83261594|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
47012666|NCT01571362|83261592|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
47012667|NCT01571362|83261593|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
47012668|NCT01571362|83261594|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
47012669|NCT01571362|83261592|FG000|Double-Blind Treatment Period|Adverse Event|0|||
47012670|NCT01571362|83261593|FG001|Double-Blind Treatment Period|Adverse Event|9|||
47012671|NCT01571362|83261594|FG002|Double-Blind Treatment Period|Adverse Event|14|||
47012672|NCT01571362|83261592|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
47012673|NCT01571362|83261593|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
47012674|NCT01571362|83261594|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
47012675|NCT01571362|83261592|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
47012676|NCT01571362|83261593|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
47012677|NCT01571362|83261594|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
47012678|NCT01571362|83261592|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
47012679|NCT01571362|83261593|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
47012680|NCT01571362|83261594|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
47012681|NCT01571284|83261602|FG000|Overall Study|Participant's decision|84|||
47012682|NCT01571284|83261602|FG000|Overall Study|Lost to Follow-up|3|||
47012683|NCT01571284|83261602|FG000|Overall Study|Enrolled but not treated|2|||
47012684|NCT01571284|83261602|FG000|Overall Study|Other than specified above|80|||
47012685|NCT02137772|83261608|FG000|Overall Study|Adverse Event|6|||
47012686|NCT02137772|83261609|FG001|Overall Study|Adverse Event|3|||
47012687|NCT02137772|83261608|FG000|Overall Study|Death|71|||
47012688|NCT02137772|83261609|FG001|Overall Study|Death|44|||
47012689|NCT02137772|83261608|FG000|Overall Study|Lost to Follow-up|8|||
47012690|NCT02137772|83261609|FG001|Overall Study|Lost to Follow-up|4|||
47012691|NCT02137772|83261608|FG000|Overall Study|Physician Decision|15|||
47012692|NCT02137772|83261609|FG001|Overall Study|Physician Decision|5|||
47012693|NCT02137772|83261608|FG000|Overall Study|Withdrawal by Subject|28|||
47012694|NCT02137772|83261609|FG001|Overall Study|Withdrawal by Subject|17|||
47012695|NCT02137772|83261608|FG000|Overall Study|Non-compliance with study drug|1|||
47012696|NCT02137772|83261609|FG001|Overall Study|Non-compliance with study drug|0|||
47012697|NCT02137772|83261608|FG000|Overall Study|Not treated|3|||
47012698|NCT02137772|83261609|FG001|Overall Study|Not treated|2|||
47012699|NCT01555138|83261617|FG000|Overall Study|Death|0|||
47012700|NCT01555138|83261618|FG001|Overall Study|Death|1|||
47012701|NCT01555138|83261617|FG000|Overall Study|Lost to Follow-up|1|||
47012702|NCT01555138|83261618|FG001|Overall Study|Lost to Follow-up|0|||
47012703|NCT01555138|83261617|FG000|Overall Study|Abnormal Lab reults|1|||
47012704|NCT01555138|83261618|FG001|Overall Study|Abnormal Lab reults|3|||
47012705|NCT01555138|83261617|FG000|Overall Study|Lack of Efficacy|2|||
47012706|NCT01555138|83261618|FG001|Overall Study|Lack of Efficacy|2|||
47012707|NCT01555138|83261617|FG000|Overall Study|Protocol Violation|5|||
47012708|NCT01555138|83261618|FG001|Overall Study|Protocol Violation|3|||
47012709|NCT01555138|83261617|FG000|Overall Study|Administrative problems|8|||
46910484|NCT03231943|83140043|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
47012710|NCT01555138|83261618|FG001|Overall Study|Administrative problems|0|||
46709649|NCT01215422|82925709|FG001|Overall Study|Did not complete all intubations|0|||
47012711|NCT01555138|83261617|FG000|Overall Study|Withdrawal by Subject|16|||
47012712|NCT01555138|83261618|FG001|Overall Study|Withdrawal by Subject|15|||
47012713|NCT01555138|83261617|FG000|Overall Study|Adverse Event|14|||
47012714|NCT01555138|83261618|FG001|Overall Study|Adverse Event|14|||
47012715|NCT02137226|83261626|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
47012716|NCT02137226|83261627|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
47012717|NCT02137226|83261628|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
47012718|NCT02137226|83261629|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
47012719|NCT02137226|83261630|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
47012720|NCT02137226|83261626|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
47012721|NCT02137226|83261627|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
47012722|NCT02137226|83261628|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
47012723|NCT02137226|83261629|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
47012724|NCT02137226|83261630|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
47012725|NCT02137226|83261626|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
47012726|NCT02137226|83261627|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
47012727|NCT02137226|83261628|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
47012728|NCT02137226|83261629|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
47012729|NCT02137226|83261630|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
47012730|NCT02137226|83261626|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
47012731|NCT02137226|83261627|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
47012732|NCT02137226|83261628|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
47012733|NCT02137226|83261629|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
47012734|NCT02137226|83261630|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
47012735|NCT02137226|83261626|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
47012736|NCT02137226|83261627|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
47012737|NCT02137226|83261628|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
47012738|NCT02137226|83261629|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
47012739|NCT02137226|83261630|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
47012740|NCT02137226|83261626|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
47012741|NCT02137226|83261627|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
47012742|NCT02137226|83261628|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
47012743|NCT02137226|83261629|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
47012744|NCT02137226|83261630|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
47012745|NCT02137226|83261626|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
47012746|NCT02137226|83261627|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
47012747|NCT02137226|83261628|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
47012748|NCT02137226|83261629|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
47012749|NCT02137226|83261630|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
47012750|NCT02137226|83261626|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
47012751|NCT02137226|83261627|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
47012752|NCT02137226|83261628|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
47012753|NCT02137226|83261629|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
47012754|NCT02137226|83261630|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
47012755|NCT02137226|83261626|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
47012756|NCT02137226|83261627|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
47012757|NCT02137226|83261628|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
47012758|NCT02137226|83261629|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
47012759|NCT02137226|83261630|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
47012760|NCT02137226|83261626|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
47012761|NCT02137226|83261627|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
47012762|NCT02137226|83261628|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
47012763|NCT02137226|83261629|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
47012764|NCT02137226|83261630|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
47012765|NCT02137226|83261626|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
47012766|NCT02137226|83261627|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
47012767|NCT02137226|83261628|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
47012768|NCT02137226|83261629|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
47012769|NCT02137226|83261630|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
47012770|NCT02137226|83261626|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
47012771|NCT02137226|83261627|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
47012772|NCT02137226|83261628|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
46709650|NCT01215422|82925710|FG002|Overall Study|Did not complete all intubations|0|||
47012773|NCT02137226|83261629|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
47012774|NCT02137226|83261630|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
47012775|NCT01530334|83261638|FG000|Overall Study|Adverse Event|3|||
47012776|NCT01530334|83261638|FG000|Overall Study|unknown reason|1|||
47012777|NCT01530334|83261638|FG000|Overall Study|Progressive disease|47|||
47012778|NCT01570192|83261644|FG000|Overall Study|no qualifying organism|6|||
47012779|NCT01570192|83261645|FG001|Overall Study|no qualifying organism|12|||
47012780|NCT01570192|83261644|FG000|Overall Study|changed to palliative care|1|||
47012781|NCT01570192|83261645|FG001|Overall Study|changed to palliative care|0|||
47012782|NCT01570192|83261644|FG000|Overall Study|Physician Decision|0|||
47012783|NCT01570192|83261645|FG001|Overall Study|Physician Decision|1|||
47012784|NCT02136914|83261658|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
47012785|NCT02136914|83261659|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
47012786|NCT02136914|83261658|FG000|Overall Study|Withdrawal by Subject|3|||
47012787|NCT02136914|83261659|FG001|Overall Study|Withdrawal by Subject|10|||
47012788|NCT02136914|83261658|FG000|Overall Study|Subject Unwilling to Proceed|7|||
47012789|NCT02136914|83261659|FG001|Overall Study|Subject Unwilling to Proceed|2|||
47012790|NCT02136914|83261658|FG000|Overall Study|Lost to Follow-up|1|||
47012791|NCT02136914|83261659|FG001|Overall Study|Lost to Follow-up|1|||
47012792|NCT02136914|83261658|FG000|Overall Study|Did Not Receive Study Drug|2|||
47012793|NCT02136914|83261659|FG001|Overall Study|Did Not Receive Study Drug|0|||
47012794|NCT02136914|83261658|FG000|Overall Study|Lack of Efficacy|1|||
47012795|NCT02136914|83261659|FG001|Overall Study|Lack of Efficacy|0|||
47012796|NCT02136914|83261658|FG000|Overall Study|Death|0|||
47012797|NCT02136914|83261659|FG001|Overall Study|Death|1|||
47012798|NCT01530256|83261665|FG000|Overall Study|Death|2|||
47012799|NCT01554904|83261669|FG000|Overall Study|Withdrawal by Subject|3|||
47012800|NCT01554904|83261669|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
47012801|NCT01529632|83261675|FG000|Overall Study|Administrative problem|2|||
47012802|NCT01529632|83261676|FG001|Overall Study|Administrative problem|1|||
47012803|NCT01529632|83261675|FG000|Overall Study|Protocol Violation|0|||
47012804|NCT01529632|83261676|FG001|Overall Study|Protocol Violation|1|||
47012805|NCT01529632|83261675|FG000|Overall Study|Adverse Event|1|||
47012806|NCT01529632|83261676|FG001|Overall Study|Adverse Event|1|||
47012807|NCT01554514|83261682|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
47012808|NCT01554514|83261682|FG000|Overall Study|Physician Decision|1|||
47012809|NCT01553188|83261690|FG000|Overall Study|Patient choice|1|||
47012810|NCT01553188|83261691|FG001|Overall Study|Patient choice|0|||
47012811|NCT01553188|83261692|FG002|Overall Study|Patient choice|0|||
47012812|NCT01553188|83261693|FG003|Overall Study|Patient choice|0|||
47012813|NCT01553188|83261690|FG000|Overall Study|Intercurrent illness and adverse event|0|||
47012814|NCT01553188|83261691|FG001|Overall Study|Intercurrent illness and adverse event|1|||
47012815|NCT01553188|83261692|FG002|Overall Study|Intercurrent illness and adverse event|2|||
47012816|NCT01553188|83261693|FG003|Overall Study|Intercurrent illness and adverse event|0|||
47012817|NCT02175758|83261712|FG000|Treatment Phase|Lost to Follow-up|0|||
47012818|NCT02175758|83261713|FG001|Treatment Phase|Lost to Follow-up|1|||
47012819|NCT02175758|83261714|FG002|Treatment Phase|Lost to Follow-up|0|||
47012820|NCT02175758|83261715|FG003|Treatment Phase|Lost to Follow-up|0|||
47012821|NCT02175758|83261716|FG004|Treatment Phase|Lost to Follow-up|0|||
47012822|NCT02175758|83261717|FG005|Treatment Phase|Lost to Follow-up|0|||
47012823|NCT02175758|83261712|FG000|Treatment Phase|Adverse Event|0|||
47012824|NCT02175758|83261713|FG001|Treatment Phase|Adverse Event|0|||
47012825|NCT02175758|83261714|FG002|Treatment Phase|Adverse Event|0|||
47012826|NCT02175758|83261715|FG003|Treatment Phase|Adverse Event|0|||
47012827|NCT02175758|83261716|FG004|Treatment Phase|Adverse Event|1|||
47012828|NCT02175758|83261717|FG005|Treatment Phase|Adverse Event|0|||
47012829|NCT01529008|83261759|FG000|Bone Marrow Harvesting|Physician Decision|1|||
47012830|NCT01529008|83261760|FG001|Bone Marrow Harvesting|Physician Decision|1|||
47012831|NCT01529008|83261759|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
47012832|NCT01529008|83261760|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
47012833|NCT01529008|83261759|FG000|Treatment|Adverse Event|6|||
47012834|NCT01529008|83261760|FG001|Treatment|Adverse Event|0|||
47012835|NCT01529008|83261759|FG000|Treatment|Other|3|||
47012836|NCT01529008|83261760|FG001|Treatment|Other|1|||
47012837|NCT01529008|83261759|FG000|Efficacy Analysis|Protocol Violation|2|||
46620533|NCT01749137|82769765|FG000|Overall Study|Withdrawal by Subject|8|||
47012838|NCT01529008|83261760|FG001|Efficacy Analysis|Protocol Violation|0|||
47012839|NCT01529008|83261759|FG000|Efficacy Analysis|Physician Decision|0|||
47012840|NCT01529008|83261760|FG001|Efficacy Analysis|Physician Decision|1|||
47012841|NCT01529008|83261759|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
47012842|NCT01529008|83261760|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
47012843|NCT01599104|83261769|FG000|Overall Study|Withdrawal by Subject|1|||
47012844|NCT01599104|83261770|FG001|Overall Study|Withdrawal by Subject|1|||
47012845|NCT01599104|83261771|FG002|Overall Study|Withdrawal by Subject|2|||
47012846|NCT01599104|83261769|FG000|Overall Study|Technical Problems|1|||
47012847|NCT01599104|83261770|FG001|Overall Study|Technical Problems|0|||
47012848|NCT01599104|83261771|FG002|Overall Study|Technical Problems|0|||
47012849|NCT01599104|83261769|FG000|Overall Study|Physician Decision|3|||
47012850|NCT01599104|83261770|FG001|Overall Study|Physician Decision|2|||
47012851|NCT01599104|83261771|FG002|Overall Study|Physician Decision|2|||
47012852|NCT01599104|83261769|FG000|Overall Study|Non-compliance with study treatment|0|||
47012853|NCT01599104|83261770|FG001|Overall Study|Non-compliance with study treatment|1|||
47012854|NCT01599104|83261771|FG002|Overall Study|Non-compliance with study treatment|0|||
47012855|NCT01599104|83261769|FG000|Overall Study|Lack of Efficacy|4|||
47012856|NCT01599104|83261770|FG001|Overall Study|Lack of Efficacy|4|||
47012857|NCT01599104|83261771|FG002|Overall Study|Lack of Efficacy|10|||
47012858|NCT01599104|83261769|FG000|Overall Study|Adverse Event|7|||
47012859|NCT01599104|83261770|FG001|Overall Study|Adverse Event|6|||
47012860|NCT01599104|83261771|FG002|Overall Study|Adverse Event|12|||
47012861|NCT02136680|83261781|FG000|Overall Study|No Longer Interested|1|||
47012862|NCT02136680|83261782|FG001|Overall Study|No Longer Interested|1|||
47012863|NCT02136680|83261781|FG000|Overall Study|No longer receiving care at clinic|3|||
47012864|NCT02136680|83261782|FG001|Overall Study|No longer receiving care at clinic|5|||
47012865|NCT02136680|83261781|FG000|Overall Study|Moved away|5|||
47012866|NCT02136680|83261782|FG001|Overall Study|Moved away|4|||
47012867|NCT02136680|83261781|FG000|Overall Study|Unable to schedule|17|||
47012868|NCT02136680|83261782|FG001|Overall Study|Unable to schedule|16|||
47012869|NCT02136680|83261781|FG000|Overall Study|Study ended before interview due|6|||
47012870|NCT02136680|83261782|FG001|Overall Study|Study ended before interview due|3|||
47012871|NCT01552954|83261790|FG000|Overall Study|Adverse Event|1|||
47012872|NCT01552954|83261791|FG001|Overall Study|Adverse Event|2|||
47012873|NCT01552954|83261790|FG000|Overall Study|Lost to Follow-up|1|||
47012874|NCT01552954|83261791|FG001|Overall Study|Lost to Follow-up|1|||
47012875|NCT01552954|83261790|FG000|Overall Study|Withdrawal by Subject|1|||
47012876|NCT01552954|83261791|FG001|Overall Study|Withdrawal by Subject|1|||
47012877|NCT01552954|83261790|FG000|Overall Study|Protocol Violation|1|||
47012878|NCT01552954|83261791|FG001|Overall Study|Protocol Violation|2|||
47012879|NCT01552954|83261790|FG000|Overall Study|diagnosed DM|1|||
47012880|NCT01552954|83261791|FG001|Overall Study|diagnosed DM|0|||
47012881|NCT02175368|83261797|FG000|Overall Study|Lost to Follow-up|1|||
47012882|NCT01518244|83261801|FG000|Overall Study|Adverse Event|3|||
47012883|NCT01552408|83261807|FG000|Overall Study|Lost to Follow-up|2|||
47012884|NCT01552408|83261808|FG001|Overall Study|Lost to Follow-up|0|||
47012885|NCT01552408|83261807|FG000|Overall Study|Relocation|0|||
47012886|NCT01552408|83261808|FG001|Overall Study|Relocation|1|||
47012887|NCT01552408|83261807|FG000|Overall Study|Withdrawal by Subject|2|||
47012888|NCT01552408|83261808|FG001|Overall Study|Withdrawal by Subject|1|||
47012889|NCT01528696|83261817|FG000|Overall Study|See detailed description|18|||
47012890|NCT01528696|83261818|FG001|Overall Study|See detailed description|19|||
47012891|NCT02174276|83261828|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
47012892|NCT02174276|83261829|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
47012893|NCT02174276|83261830|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
47012894|NCT02174276|83261831|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
47012895|NCT02174276|83261828|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
47012896|NCT02174276|83261829|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
47012897|NCT02174276|83261830|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
47012898|NCT02174276|83261831|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
47012899|NCT02174276|83261828|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
47012900|NCT02174276|83261829|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
47012901|NCT02174276|83261830|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
47012902|NCT02174276|83261831|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
47012903|NCT02174276|83261828|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
47012904|NCT02174276|83261829|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
47012905|NCT02174276|83261830|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
47012906|NCT02174276|83261831|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
47012907|NCT02174276|83261828|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
47012908|NCT02174276|83261829|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
47012909|NCT02174276|83261830|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
47012910|NCT02174276|83261831|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
47012911|NCT02174276|83261828|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
47012912|NCT02174276|83261829|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
47012913|NCT02174276|83261830|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
46709651|NCT01215422|82925711|FG003|Overall Study|Did not complete all intubations|0|||
47012914|NCT02174276|83261831|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
47012915|NCT01528072|83261841|FG000|Overall Study|Withdrawal by Subject|5|||
47012916|NCT01528072|83261841|FG000|Overall Study|Physician Decision|1|||
47012917|NCT01528072|83261841|FG000|Overall Study|Determined not eligible by AEAC|1|||
47012918|NCT01528072|83261841|FG000|Overall Study|Missed Visit|2|||
47012919|NCT01528072|83261841|FG000|Overall Study|Lost to Follow-up|5|||
47012920|NCT01528072|83261841|FG000|Overall Study|Explanted|2|||
47012921|NCT01528072|83261841|FG000|Overall Study|Site Closure|4|||
47012922|NCT01528072|83261841|FG000|Overall Study|Death|2|||
47012923|NCT01528072|83261841|FG000|Overall Study|Early Termination of Study|52|||
47012924|NCT01527682|83261845|FG000|Overall Study|Protocol Violation|8|||
47012925|NCT01527370|83261849|FG000|Overall Study|Withdrawal by Subject|4|||
47012926|NCT01527370|83261849|FG000|Overall Study|Physician Decision|1|||
47012927|NCT01527370|83261849|FG000|Overall Study|Death|1|||
47012928|NCT01527292|83261855|FG000|Overall Study|Physician Decision|0|||
47012929|NCT01527292|83261856|FG001|Overall Study|Physician Decision|3|||
47012930|NCT01516216|83261864|FG000|Overall Study|Adverse Event|2|||
47012931|NCT01516216|83261865|FG001|Overall Study|Adverse Event|4|||
47012932|NCT01516216|83261864|FG000|Overall Study|Disease Progression|38|||
47012933|NCT01516216|83261865|FG001|Overall Study|Disease Progression|34|||
47012934|NCT01516216|83261864|FG000|Overall Study|Withdrawal by Subject|9|||
47012935|NCT01516216|83261865|FG001|Overall Study|Withdrawal by Subject|11|||
47012936|NCT01516216|83261864|FG000|Overall Study|Potentially Curative Resection|6|||
47012937|NCT01516216|83261865|FG001|Overall Study|Potentially Curative Resection|12|||
47012938|NCT01516216|83261864|FG000|Overall Study|Nonadherence|2|||
47012939|NCT01516216|83261865|FG001|Overall Study|Nonadherence|3|||
47012940|NCT01516216|83261864|FG000|Overall Study|Physician Decision|6|||
47012941|NCT01516216|83261865|FG001|Overall Study|Physician Decision|3|||
47012942|NCT01516216|83261864|FG000|Overall Study|Prolonged Treatment Delay|5|||
47012943|NCT01516216|83261865|FG001|Overall Study|Prolonged Treatment Delay|1|||
47012944|NCT01516216|83261864|FG000|Overall Study|Intercurrent Illness|1|||
47012945|NCT01516216|83261865|FG001|Overall Study|Intercurrent Illness|0|||
47012946|NCT01516216|83261864|FG000|Overall Study|Death|1|||
47012947|NCT01516216|83261865|FG001|Overall Study|Death|1|||
47012948|NCT01950819|83261875|FG000|Overall Study|Graft Loss|35|||
47012949|NCT01950819|83261876|FG001|Overall Study|Graft Loss|30|||
47012950|NCT01950819|83261875|FG000|Overall Study|Death|29|||
47012951|NCT01950819|83261876|FG001|Overall Study|Death|34|||
47012952|NCT01950819|83261875|FG000|Overall Study|Subject / Gardian decision|54|||
47012953|NCT01950819|83261876|FG001|Overall Study|Subject / Gardian decision|51|||
47012954|NCT01950819|83261875|FG000|Overall Study|technical problems|2|||
47012955|NCT01950819|83261876|FG001|Overall Study|technical problems|0|||
47012956|NCT01950819|83261875|FG000|Overall Study|Pregnancy|0|||
47012957|NCT01950819|83261876|FG001|Overall Study|Pregnancy|2|||
47012958|NCT01950819|83261875|FG000|Overall Study|Lost to Follow-up|9|||
47012959|NCT01950819|83261876|FG001|Overall Study|Lost to Follow-up|17|||
47012960|NCT01514422|83261882|FG000|Overall Study|Lost to Follow-up|1|||
47012961|NCT01513330|83261886|FG000|SenSura Mio First,|Adverse Event|2|||
47012962|NCT01513330|83261887|FG001|SenSura Mio First,|Adverse Event|0|||
47012963|NCT01513330|83261886|FG000|SenSura Mio First,|Lack of Efficacy|0|||
47012964|NCT01513330|83261887|FG001|SenSura Mio First,|Lack of Efficacy|1|||
47012965|NCT01513330|83261886|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
47012966|NCT01513330|83261887|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
47012967|NCT01513330|83261886|FG000|SenSura Mio First,|Other|1|||
47012968|NCT01513330|83261887|FG001|SenSura Mio First,|Other|0|||
47012969|NCT01513330|83261886|FG000|Standard Care First,|Lack of Efficacy|2|||
47012970|NCT01513330|83261887|FG001|Standard Care First,|Lack of Efficacy|2|||
47012971|NCT01513330|83261886|FG000|Standard Care First,|Withdrawal by Subject|1|||
47012972|NCT01513330|83261887|FG001|Standard Care First,|Withdrawal by Subject|2|||
47012973|NCT01513330|83261886|FG000|Standard Care First,|Other|1|||
47012974|NCT01513330|83261887|FG001|Standard Care First,|Other|0|||
47012975|NCT01524796|83261893|FG000|Overall Study|Adverse Event|13|||
47012976|NCT01524796|83261893|FG000|Overall Study|Lack of Efficacy|3|||
47012977|NCT01524796|83261893|FG000|Overall Study|Lost to Follow-up|1|||
47012978|NCT01524796|83261893|FG000|Overall Study|The price|1|||
47012979|NCT01524796|83261893|FG000|Overall Study|Withdrawal by Subject|4|||
47012980|NCT01524796|83261893|FG000|Overall Study|Move|1|||
47012981|NCT01524796|83261893|FG000|Overall Study|Deterioration of pains|1|||
47012982|NCT01524796|83261893|FG000|Overall Study|Gall stone surgery|1|||
47012983|NCT01524796|83261893|FG000|Overall Study|Nervous about confidentiality|1|||
47012984|NCT01524796|83261893|FG000|Overall Study|Switch to carbamazapine|1|||
47012985|NCT01524796|83261893|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
47012986|NCT01547728|83261897|FG000|Overall Study|Change in procedure and equipment|1|||
47012987|NCT01547728|83261897|FG000|Overall Study|Drug not ready for subject|1|||
47012988|NCT01547728|83261897|FG000|Overall Study|Screen failure|39|||
47012989|NCT01523392|83261903|FG000|Treatment Period 1|Withdrawal by Subject|2|||
47012990|NCT01523392|83261904|FG001|Treatment Period 1|Withdrawal by Subject|0|||
47012991|NCT01523392|83261903|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
47012992|NCT01523392|83261904|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
47012993|NCT01523392|83261903|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
47012994|NCT01523392|83261904|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
47012995|NCT01512160|83261916|FG000|Overall Study|Lost to Follow-up|1|||
47012996|NCT01512160|83261917|FG001|Overall Study|Lost to Follow-up|0|||
47012997|NCT01512160|83261918|FG002|Overall Study|Lost to Follow-up|0|||
47012998|NCT01512160|83261919|FG003|Overall Study|Lost to Follow-up|0|||
47012999|NCT01512160|83261916|FG000|Overall Study|Withdrawal by Subject|1|||
47013000|NCT01512160|83261917|FG001|Overall Study|Withdrawal by Subject|0|||
47013001|NCT01512160|83261918|FG002|Overall Study|Withdrawal by Subject|0|||
47013002|NCT01512160|83261919|FG003|Overall Study|Withdrawal by Subject|1|||
47013003|NCT01546168|83261932|FG000|Overall Study|Lost to Follow-up|1|||
47013004|NCT01546168|83261933|FG001|Overall Study|Lost to Follow-up|0|||
47013005|NCT01546168|83261932|FG000|Overall Study|Withdrawal by Subject|1|||
47013006|NCT01546168|83261933|FG001|Overall Study|Withdrawal by Subject|0|||
47013007|NCT01546168|83261932|FG000|Overall Study|ineligible after signing consent|2|||
47013008|NCT01546168|83261933|FG001|Overall Study|ineligible after signing consent|0|||
47013009|NCT01901289|83261939|FG000|Overall Study|Death|32|||
47013010|NCT01901289|83261939|FG000|Overall Study|Lost to Follow-up|16|||
47013011|NCT01901289|83261939|FG000|Overall Study|Withdrawal by Subject|35|||
47013012|NCT01901289|83261939|FG000|Overall Study|Other type of endpoint met|2|||
47013013|NCT01950741|83261943|FG000|Overall Study|Lost to Follow-up|1|||
47013014|NCT01950741|83261943|FG000|Overall Study|Death|1|||
47013015|NCT01950741|83261943|FG000|Overall Study|Withdrawal by Subject|1|||
47013016|NCT01950273|83261949|FG000|Overall Study|Protocol Violation|1|||
47013017|NCT01950273|83261950|FG001|Overall Study|Protocol Violation|0|||
47013018|NCT01950273|83261949|FG000|Overall Study|Withdrawal by Subject|2|||
47013019|NCT01950273|83261950|FG001|Overall Study|Withdrawal by Subject|0|||
47013020|NCT01950273|83261949|FG000|Overall Study|Other not defined above|1|||
47013021|NCT01950273|83261950|FG001|Overall Study|Other not defined above|0|||
47013022|NCT01919307|83261956|FG000|Overall Study|Withdrawal by Subject|9|||
47013023|NCT01919229|83261963|FG000|Overall Study|Subject/guardian decision|0|||
47013024|NCT01919229|83261964|FG001|Overall Study|Subject/guardian decision|0|||
47013025|NCT01919229|83261965|FG002|Overall Study|Subject/guardian decision|1|||
47013026|NCT01901055|83261975|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
47013027|NCT01901055|83261976|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
47013028|NCT01901055|83261975|FG000|Randomization But Not Titrated|Physician Decision|0|||
47013029|NCT01901055|83261976|FG001|Randomization But Not Titrated|Physician Decision|1|||
47013030|NCT01901055|83261975|FG000|Started Protocol to Week 6|Physician Decision|2|||
47013031|NCT01901055|83261976|FG001|Started Protocol to Week 6|Physician Decision|1|||
47013032|NCT01901055|83261975|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
47013033|NCT01901055|83261976|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
47013034|NCT01901055|83261975|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
47013035|NCT01901055|83261976|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
47013036|NCT01901055|83261975|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
47013037|NCT01901055|83261976|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
47013038|NCT01901055|83261975|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
47013039|NCT01901055|83261976|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
47013040|NCT01901055|83261975|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
47013041|NCT01901055|83261976|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
47013042|NCT01901055|83261975|FG000|Week 24|Withdrawal by Subject|13|||
47013043|NCT01901055|83261976|FG001|Week 24|Withdrawal by Subject|19|||
47013044|NCT01901055|83261975|FG000|Week 24|Physician Decision|1|||
47013045|NCT01901055|83261976|FG001|Week 24|Physician Decision|0|||
47013046|NCT01901055|83261975|FG000|Week 36|Withdrawal by Subject|0|||
47013047|NCT01901055|83261976|FG001|Week 36|Withdrawal by Subject|5|||
47013048|NCT01511536|83261988|FG000|Phase 1|Other|0|||
47013049|NCT01511536|83261989|FG001|Phase 1|Other|1|||
47013050|NCT01511536|83261990|FG002|Phase 1|Other|0|||
47013051|NCT01511536|83261988|FG000|Phase 2|Other|0|||
47013052|NCT01511536|83261989|FG001|Phase 2|Other|0|||
47013053|NCT01511536|83261990|FG002|Phase 2|Other|9|||
47013054|NCT01890759|83262000|FG000|Overall Study|Protocol Violation|0|||
47013055|NCT01890759|83262001|FG001|Overall Study|Protocol Violation|2|||
47013056|NCT01890759|83262000|FG000|Overall Study|Lost to Follow-up|0|||
47013057|NCT01890759|83262001|FG001|Overall Study|Lost to Follow-up|2|||
47013058|NCT01890759|83262000|FG000|Overall Study|Withdrawal by Subject|2|||
47013059|NCT01890759|83262001|FG001|Overall Study|Withdrawal by Subject|8|||
47013060|NCT01900899|83262009|FG000|Overall Study|Withdrawal by Subject|7|||
47013061|NCT01900899|83262010|FG001|Overall Study|Withdrawal by Subject|1|||
47013062|NCT01900899|83262009|FG000|Overall Study|Migrated from study area|2|||
47013063|NCT01900899|83262010|FG001|Overall Study|Migrated from study area|0|||
47013064|NCT01510912|83262016|FG000|Overall Study|Adverse Event|99|||
46709652|NCT00972153|82925736|FG000|Overall Study|Equipment malfunction during case|0|||
46709653|NCT00972153|82925737|FG001|Overall Study|Equipment malfunction during case|1|||
46709654|NCT00972153|82925738|FG002|Overall Study|Equipment malfunction during case|0|||
47013065|NCT01510912|83262016|FG000|Overall Study|Lack of Efficacy|12|||
47013066|NCT01510912|83262016|FG000|Overall Study|Non-compliance with trial drug|23|||
47013067|NCT01510912|83262016|FG000|Overall Study|Withdrawal by Subject|49|||
47013068|NCT01510912|83262016|FG000|Overall Study|Physician Decision|1|||
47013069|NCT01510912|83262016|FG000|Overall Study|Protocol Violation|27|||
47013070|NCT01510912|83262016|FG000|Overall Study|Lost to Follow-up|26|||
47013071|NCT01510912|83262016|FG000|Overall Study|Other, including joint replacement|5|||
47013072|NCT01510756|83262020|FG000|Overall Study|Death|1|||
47013073|NCT01510756|83262020|FG000|Overall Study|Lack of Efficacy|2|||
47013074|NCT01510756|83262020|FG000|Overall Study|Physician Decision|1|||
47013075|NCT01522456|83262024|FG000|Overall Study|Adverse Event|2|||
47013076|NCT01522456|83262024|FG000|Overall Study|Lost to Follow-up|2|||
47013077|NCT01522456|83262024|FG000|Overall Study|Withdrawal by Subject|2|||
47013078|NCT01522456|83262024|FG000|Overall Study|Pregnancy|1|||
47013079|NCT01522456|83262024|FG000|Overall Study|Tolerability Assessment|1|||
47013080|NCT01545934|83262037|FG000|Overall Study|Withdrawal by Subject|4|||
47013081|NCT01545934|83262038|FG001|Overall Study|Withdrawal by Subject|3|||
47013082|NCT01545934|83262037|FG000|Overall Study|Lost to Follow-up|1|||
47013083|NCT01545934|83262038|FG001|Overall Study|Lost to Follow-up|0|||
47013084|NCT01521364|83262045|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
47013085|NCT01521364|83262045|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
47013086|NCT01545388|83262059|FG000|Overall Study|Adverse Event|2|||
47013087|NCT01545388|83262060|FG001|Overall Study|Adverse Event|4|||
47013088|NCT01545388|83262061|FG002|Overall Study|Adverse Event|1|||
47013089|NCT01545388|83262059|FG000|Overall Study|Lack of Efficacy|3|||
47013090|NCT01545388|83262060|FG001|Overall Study|Lack of Efficacy|2|||
47013091|NCT01545388|83262061|FG002|Overall Study|Lack of Efficacy|5|||
47013092|NCT01545388|83262059|FG000|Overall Study|Participant moved or relocated|1|||
47013093|NCT01545388|83262060|FG001|Overall Study|Participant moved or relocated|0|||
47013094|NCT01545388|83262061|FG002|Overall Study|Participant moved or relocated|0|||
47013095|NCT01545388|83262059|FG000|Overall Study|Withdrawal by Subject|1|||
47013096|NCT01545388|83262060|FG001|Overall Study|Withdrawal by Subject|4|||
47013097|NCT01545388|83262061|FG002|Overall Study|Withdrawal by Subject|2|||
47013098|NCT01545388|83262059|FG000|Overall Study|Other|1|||
47013099|NCT01545388|83262060|FG001|Overall Study|Other|1|||
47013100|NCT01545388|83262061|FG002|Overall Study|Other|0|||
47013101|NCT01545076|83262069|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
47013102|NCT01545076|83262070|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
47013103|NCT01545076|83262071|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
47013104|NCT01545076|83262072|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
47013105|NCT01545076|83262073|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
47013106|NCT01545076|83262069|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
47013107|NCT01545076|83262070|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
47013108|NCT01545076|83262071|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
47013109|NCT01545076|83262072|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
47013110|NCT01545076|83262073|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
47013111|NCT01545076|83262069|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
47013112|NCT01545076|83262070|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
47013113|NCT01545076|83262071|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
47013114|NCT01545076|83262072|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
47013115|NCT01545076|83262073|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
47013116|NCT01545076|83262069|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
47013117|NCT01545076|83262070|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
47013118|NCT01545076|83262071|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
47013119|NCT01545076|83262072|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
47013120|NCT01545076|83262073|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
47013121|NCT01545076|83262069|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
47013122|NCT01545076|83262070|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
47013123|NCT01545076|83262071|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
47013124|NCT01545076|83262072|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
47013125|NCT01545076|83262073|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
47013126|NCT01545076|83262069|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
47013127|NCT01545076|83262070|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
47013128|NCT01545076|83262071|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
47013129|NCT01545076|83262072|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
47013130|NCT01545076|83262073|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
47013131|NCT01545076|83262069|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
47013132|NCT01545076|83262070|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
47013133|NCT01545076|83262071|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
47013134|NCT01545076|83262072|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
47013135|NCT01545076|83262073|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
47013136|NCT01545076|83262069|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
47013137|NCT01545076|83262070|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
47013138|NCT01545076|83262071|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
47013139|NCT01545076|83262072|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
47013140|NCT01545076|83262073|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
47013141|NCT01545076|83262069|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
47013142|NCT01545076|83262070|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
47013143|NCT01545076|83262071|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
47013144|NCT01545076|83262072|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
47013145|NCT01545076|83262073|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
47013146|NCT01544920|83262088|FG000|Overall Study|Adverse Event|0|||
46910485|NCT03231943|83140044|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910486|NCT03231943|83140045|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910487|NCT03231943|83140046|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910488|NCT03231943|83140047|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910489|NCT03231943|83140048|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910490|NCT03231943|83140049|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910491|NCT03231943|83140050|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910492|NCT03231943|83140051|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910493|NCT03231943|83140052|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910494|NCT03231943|83140053|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
46910495|NCT03231943|83140041|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910496|NCT03231943|83140042|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
46910497|NCT03231943|83140043|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910498|NCT03231943|83140044|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910499|NCT03231943|83140045|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910500|NCT03231943|83140046|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910501|NCT03231943|83140047|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910502|NCT03231943|83140048|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910503|NCT03231943|83140049|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910504|NCT03231943|83140050|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910505|NCT03231943|83140051|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910506|NCT03231943|83140052|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910507|NCT03231943|83140053|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
46910508|NCT03231943|83140041|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
46910509|NCT03231943|83140042|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910510|NCT03231943|83140043|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910511|NCT03231943|83140044|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910512|NCT03231943|83140045|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910513|NCT03231943|83140046|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910514|NCT03231943|83140047|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910515|NCT03231943|83140048|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910516|NCT03231943|83140049|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910517|NCT03231943|83140050|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910518|NCT03231943|83140051|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910519|NCT03231943|83140052|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910520|NCT03231943|83140053|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
46910521|NCT03231943|83140041|FG000|Part 2|Adverse Event|0|||
46910522|NCT03231943|83140042|FG001|Part 2|Adverse Event|0|||
46910523|NCT03231943|83140043|FG002|Part 2|Adverse Event|0|||
46910524|NCT03231943|83140044|FG003|Part 2|Adverse Event|0|||
46910525|NCT03231943|83140045|FG004|Part 2|Adverse Event|0|||
46910526|NCT03231943|83140046|FG005|Part 2|Adverse Event|0|||
46910527|NCT03231943|83140047|FG006|Part 2|Adverse Event|0|||
46910528|NCT03231943|83140048|FG007|Part 2|Adverse Event|0|||
46910529|NCT03231943|83140049|FG008|Part 2|Adverse Event|0|||
46910530|NCT03231943|83140050|FG009|Part 2|Adverse Event|0|||
46910531|NCT03231943|83140051|FG010|Part 2|Adverse Event|1|||
46910532|NCT03231943|83140052|FG011|Part 2|Adverse Event|0|||
46910533|NCT03231943|83140053|FG012|Part 2|Adverse Event|0|||
46910534|NCT03231943|83140041|FG000|Part 2|Withdrawal by Subject|0|||
46910535|NCT03231943|83140042|FG001|Part 2|Withdrawal by Subject|0|||
47013147|NCT01544920|83262089|FG001|Overall Study|Adverse Event|3|||
47013148|NCT01544920|83262088|FG000|Overall Study|Death|0|||
46910536|NCT03231943|83140043|FG002|Part 2|Withdrawal by Subject|0|||
46910537|NCT03231943|83140044|FG003|Part 2|Withdrawal by Subject|0|||
47013149|NCT01544920|83262089|FG001|Overall Study|Death|1|||
47013150|NCT01544920|83262088|FG000|Overall Study|Lost to Follow-up|11|||
46910538|NCT03231943|83140045|FG004|Part 2|Withdrawal by Subject|0|||
46910539|NCT03231943|83140046|FG005|Part 2|Withdrawal by Subject|0|||
46910540|NCT03231943|83140047|FG006|Part 2|Withdrawal by Subject|0|||
46910541|NCT03231943|83140048|FG007|Part 2|Withdrawal by Subject|0|||
46910542|NCT03231943|83140049|FG008|Part 2|Withdrawal by Subject|0|||
46910543|NCT03231943|83140050|FG009|Part 2|Withdrawal by Subject|0|||
46910544|NCT03231943|83140051|FG010|Part 2|Withdrawal by Subject|0|||
46910545|NCT03231943|83140052|FG011|Part 2|Withdrawal by Subject|1|||
46910546|NCT03231943|83140053|FG012|Part 2|Withdrawal by Subject|0|||
46910547|NCT01578239|83140085|FG000|Treatment Period|Progressive Disease|19|||
46910548|NCT01578239|83140086|FG001|Treatment Period|Progressive Disease|64|||
46910549|NCT01578239|83140085|FG000|Treatment Period|Physician Decision|17|||
46910550|NCT01578239|83140086|FG001|Treatment Period|Physician Decision|17|||
46910551|NCT01578239|83140085|FG000|Treatment Period|Adverse Event|13|||
46910552|NCT01578239|83140086|FG001|Treatment Period|Adverse Event|10|||
46910553|NCT01578239|83140085|FG000|Treatment Period|Non-compliance|2|||
46910554|NCT01578239|83140086|FG001|Treatment Period|Non-compliance|0|||
46910555|NCT01578239|83140085|FG000|Treatment Period|Withdrawal by Subject|10|||
46910556|NCT01578239|83140086|FG001|Treatment Period|Withdrawal by Subject|9|||
46910557|NCT01578239|83140085|FG000|Treatment Period|Other|6|||
47013151|NCT01544920|83262089|FG001|Overall Study|Lost to Follow-up|12|||
47013152|NCT01544920|83262088|FG000|Overall Study|Protocol Violation|0|||
47013153|NCT01544920|83262089|FG001|Overall Study|Protocol Violation|2|||
47013154|NCT01544920|83262088|FG000|Overall Study|Physician Decision|4|||
47013155|NCT01544920|83262089|FG001|Overall Study|Physician Decision|1|||
47013156|NCT01544920|83262088|FG000|Overall Study|Withdrawal by Subject|4|||
47013157|NCT01544920|83262089|FG001|Overall Study|Withdrawal by Subject|4|||
47013158|NCT01509664|83262099|FG000|Overall Study|Lost to Follow-up|15|||
47013159|NCT01509664|83262100|FG001|Overall Study|Lost to Follow-up|21|||
47013160|NCT01543828|83262108|FG000|Treatment 2|Lost to Follow-up|1|||
47013161|NCT01543828|83262109|FG001|Treatment 2|Lost to Follow-up|0|||
47013162|NCT01520506|83262117|FG000|Overall Study|Missed Visit|4|||
47013163|NCT01520506|83262117|FG000|Overall Study|Lost to Follow-up|1|||
47013164|NCT01520506|83262117|FG000|Overall Study|Withdrawal by Subject|1|||
47013165|NCT01519960|83262124|FG000|Overall Study|Withdrawal from the study|26|||
47013166|NCT01519960|83262125|FG001|Overall Study|Withdrawal from the study|22|||
47013167|NCT01519960|83262126|FG002|Overall Study|Withdrawal from the study|5|||
47013168|NCT01543204|83262142|FG000|Overall Study|Non-compliance|1|||
47013169|NCT01543204|83262142|FG000|Overall Study|Adverse Event|1|||
47013170|NCT01543204|83262142|FG000|Overall Study|Withdrawal by Subject|4|||
47013171|NCT01543204|83262142|FG000|Overall Study|Requirement for Alternative Therapy|1|||
47013172|NCT01543204|83262142|FG000|Overall Study|Lost to Follow-up|1|||
47013173|NCT01488994|83262152|FG000|Overall Study|Withdrawal by Subject|0|||
47013174|NCT01488994|83262153|FG001|Overall Study|Withdrawal by Subject|1|||
47013175|NCT01508650|83262166|FG000|Overall Study|Lost to Follow-up|0|||
47013176|NCT01508650|83262167|FG001|Overall Study|Lost to Follow-up|3|||
47013177|NCT01488448|83262175|FG000|Overall Study|Withdrawal by Subject|3|||
47013178|NCT01488448|83262176|FG001|Overall Study|Withdrawal by Subject|1|||
47013179|NCT01488448|83262175|FG000|Overall Study|Adverse Event|9|||
47013180|NCT01488448|83262176|FG001|Overall Study|Adverse Event|4|||
47013181|NCT01488448|83262175|FG000|Overall Study|Physician Decision|4|||
47013182|NCT01488448|83262176|FG001|Overall Study|Physician Decision|9|||
47013183|NCT01488448|83262175|FG000|Overall Study|Protocol Violation|4|||
47013184|NCT01488448|83262176|FG001|Overall Study|Protocol Violation|3|||
47013185|NCT01518946|83262186|FG000|Open-label Phase|Other|4|||
47013186|NCT01518946|83262187|FG001|Open-label Phase|Other|0|||
47013187|NCT01518946|83262188|FG002|Open-label Phase|Other|0|||
46910558|NCT01578239|83140086|FG001|Treatment Period|Other|1|||
46910559|NCT01578239|83140085|FG000|Long-term Follow-Up Period|Death|69|||
46910560|NCT01578239|83140086|FG001|Long-term Follow-Up Period|Death|64|||
46910561|NCT01578239|83140085|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
47013188|NCT01518946|83262186|FG000|Randomized Phase (First Intervention)|Other|0|||
47013189|NCT01518946|83262187|FG001|Randomized Phase (First Intervention)|Other|1|||
47013190|NCT01518946|83262188|FG002|Randomized Phase (First Intervention)|Other|0|||
47013191|NCT01488370|83262198|FG000|Overall Study|Protocol Violation|0|||
47013192|NCT01488370|83262199|FG001|Overall Study|Protocol Violation|1|||
47013193|NCT01488370|83262200|FG002|Overall Study|Protocol Violation|1|||
47013194|NCT01518322|83262208|FG000|Overall Study|FeNO measurement was missing|13|||
47013195|NCT01507246|83262219|FG000|Overall Study|Required different surgical procedures|2|||
47013196|NCT01507246|83262220|FG001|Overall Study|Required different surgical procedures|1|||
47013197|NCT01507090|83262229|FG000|Overall Study|incomplete dataset|18|||
47013198|NCT01464346|83262243|FG000|Overall Study|Withdrawal by Subject|0|||
47013199|NCT01464346|83262244|FG001|Overall Study|Withdrawal by Subject|0|||
47013200|NCT01464346|83262245|FG002|Overall Study|Withdrawal by Subject|1|||
47013201|NCT01487200|83262272|FG000|Overall Study|Withdrawal by Subject|0|||
47013202|NCT01487200|83262273|FG001|Overall Study|Withdrawal by Subject|1|||
47013203|NCT01487200|83262274|FG002|Overall Study|Withdrawal by Subject|0|||
47013204|NCT01487200|83262275|FG003|Overall Study|Withdrawal by Subject|0|||
47013205|NCT01463878|83262288|FG000|Overall Study|no longer met criteria for tube feed|2|||
47013206|NCT01463878|83262289|FG001|Overall Study|no longer met criteria for tube feed|2|||
47013207|NCT01486966|83262297|FG000|Overall Study|Adverse Event|0|||
47013208|NCT01486966|83262298|FG001|Overall Study|Adverse Event|1|||
47013209|NCT01486966|83262297|FG000|Overall Study|Withdrawal by Subject|0|||
47013210|NCT01486966|83262298|FG001|Overall Study|Withdrawal by Subject|1|||
47013211|NCT01900665|83262306|FG000|Placebo Controlled Period|Death|9|||
47013212|NCT01900665|83262307|FG001|Placebo Controlled Period|Death|16|||
47013213|NCT01900665|83262306|FG000|Placebo Controlled Period|Adverse Event|48|||
47013214|NCT01900665|83262307|FG001|Placebo Controlled Period|Adverse Event|39|||
47013215|NCT01900665|83262306|FG000|Placebo Controlled Period|Protocol Violation|1|||
47013216|NCT01900665|83262307|FG001|Placebo Controlled Period|Protocol Violation|7|||
47013217|NCT01900665|83262306|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
47013218|NCT01900665|83262307|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
47013219|NCT01900665|83262306|FG000|Placebo Controlled Period|Physician Decision|11|||
47013220|NCT01900665|83262307|FG001|Placebo Controlled Period|Physician Decision|7|||
47013221|NCT01900665|83262306|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
47013222|NCT01900665|83262307|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
47013223|NCT01900665|83262306|FG000|Placebo Controlled Period|Caregiver Decision|33|||
47013224|NCT01900665|83262307|FG001|Placebo Controlled Period|Caregiver Decision|41|||
47013225|NCT01900665|83262306|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
47013226|NCT01900665|83262307|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
47013227|NCT01900665|83262306|FG000|Open Label Period|Adverse Event|16|||
47013228|NCT01900665|83262307|FG001|Open Label Period|Adverse Event|20|||
47013229|NCT01900665|83262306|FG000|Open Label Period|Death|5|||
47013230|NCT01900665|83262307|FG001|Open Label Period|Death|6|||
47013231|NCT01900665|83262306|FG000|Open Label Period|Lost to Follow-up|1|||
47013232|NCT01900665|83262307|FG001|Open Label Period|Lost to Follow-up|1|||
47013233|NCT01900665|83262306|FG000|Open Label Period|Parent/Caregiver Decision|33|||
47013234|NCT01900665|83262307|FG001|Open Label Period|Parent/Caregiver Decision|34|||
47013235|NCT01900665|83262306|FG000|Open Label Period|Physician Decision|4|||
47013236|NCT01900665|83262307|FG001|Open Label Period|Physician Decision|4|||
47013237|NCT01900665|83262306|FG000|Open Label Period|Protocol Violation|0|||
47013238|NCT01900665|83262307|FG001|Open Label Period|Protocol Violation|1|||
47013239|NCT01900665|83262306|FG000|Open Label Period|Sponsor Decision|802|||
47013240|NCT01900665|83262307|FG001|Open Label Period|Sponsor Decision|765|||
47013241|NCT01900665|83262306|FG000|Open Label Period|Withdrawal by Subject|20|||
47013242|NCT01900665|83262307|FG001|Open Label Period|Withdrawal by Subject|28|||
47013243|NCT01900431|83262318|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
47013244|NCT01900431|83262319|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
47013245|NCT01900431|83262320|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
47013246|NCT01900431|83262318|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
47013247|NCT01900431|83262319|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
47013248|NCT01900431|83262320|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
47013249|NCT01900431|83262318|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
47013250|NCT01900431|83262319|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
47013251|NCT01900431|83262320|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
47013252|NCT01900431|83262318|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
47013253|NCT01900431|83262319|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
47013254|NCT01900431|83262320|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
47013255|NCT01900431|83262318|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
47013256|NCT01900431|83262319|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
47013257|NCT01900431|83262320|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
47013258|NCT01900431|83262318|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
47013259|NCT01900431|83262319|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
47013260|NCT01900431|83262320|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
47013261|NCT01900431|83262318|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
47013262|NCT01900431|83262319|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
47013263|NCT01900431|83262320|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
47013264|NCT01900431|83262318|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
47013265|NCT01900431|83262319|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
47013266|NCT01900431|83262320|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
47013267|NCT01900431|83262318|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
47013268|NCT01900431|83262319|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
47013269|NCT01900431|83262320|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
47013270|NCT01948791|83262328|FG000|Overall Study|Adverse Event|12|||
47013271|NCT01948791|83262328|FG000|Overall Study|Lack of Efficacy|3|||
47013272|NCT01948791|83262328|FG000|Overall Study|Protocol Violation|2|||
47013273|NCT01948791|83262328|FG000|Overall Study|Withdrawal by Subject|5|||
47013274|NCT01948791|83262328|FG000|Overall Study|Lost to Follow-up|6|||
47013275|NCT01948791|83262328|FG000|Overall Study|Management issues|1|||
47013276|NCT01948791|83262328|FG000|Overall Study|Others|7|||
47013277|NCT01948791|83262328|FG000|Overall Study|Screening failure|35|||
47013278|NCT01899729|83262337|FG000|Overall Study|Adverse Event|1|||
47013279|NCT01899729|83262338|FG001|Overall Study|Adverse Event|0|||
47013280|NCT01899729|83262339|FG002|Overall Study|Adverse Event|0|||
47013281|NCT01899729|83262340|FG003|Overall Study|Adverse Event|0|||
47013282|NCT01899729|83262341|FG004|Overall Study|Adverse Event|1|||
47013283|NCT01899729|83262337|FG000|Overall Study|Withdrawal by Subject|1|||
47013284|NCT01899729|83262338|FG001|Overall Study|Withdrawal by Subject|2|||
47013285|NCT01899729|83262339|FG002|Overall Study|Withdrawal by Subject|0|||
47013286|NCT01899729|83262340|FG003|Overall Study|Withdrawal by Subject|0|||
47013287|NCT01899729|83262341|FG004|Overall Study|Withdrawal by Subject|0|||
47013288|NCT01899729|83262337|FG000|Overall Study|Lack of Efficacy|0|||
47013289|NCT01899729|83262338|FG001|Overall Study|Lack of Efficacy|0|||
47013290|NCT01899729|83262339|FG002|Overall Study|Lack of Efficacy|2|||
47013291|NCT01899729|83262340|FG003|Overall Study|Lack of Efficacy|0|||
47013292|NCT01899729|83262341|FG004|Overall Study|Lack of Efficacy|1|||
47013293|NCT01898091|83262355|FG000|Overall Study|Lost to Follow-up|1|||
47013294|NCT01898091|83262356|FG001|Overall Study|Lost to Follow-up|1|||
47013295|NCT01898091|83262355|FG000|Overall Study|Withdrawal by Subject|1|||
47013296|NCT01898091|83262356|FG001|Overall Study|Withdrawal by Subject|5|||
47013297|NCT01947855|83262365|FG000|Overall Study|Withdrawal by Subject|1|||
47013298|NCT01947855|83262366|FG001|Overall Study|Withdrawal by Subject|0|||
47013299|NCT01947855|83262367|FG002|Overall Study|Withdrawal by Subject|0|||
47013300|NCT01888965|83262375|FG000|Overall Study|Adverse Event|5|||
47013301|NCT01888965|83262375|FG000|Overall Study|Lack of Efficacy|4|||
47013302|NCT01888497|83262379|FG000|Washout Period 1|Withdrawal by Subject|0|||
47013303|NCT01888497|83262380|FG001|Washout Period 1|Withdrawal by Subject|0|||
47013304|NCT01888497|83262381|FG002|Washout Period 1|Withdrawal by Subject|1|||
47013305|NCT01888497|83262382|FG003|Washout Period 1|Withdrawal by Subject|1|||
47013306|NCT01888497|83262379|FG000|Washout Period 2|Adverse Event|0|||
47013307|NCT01888497|83262380|FG001|Washout Period 2|Adverse Event|0|||
47013308|NCT01888497|83262381|FG002|Washout Period 2|Adverse Event|0|||
47013309|NCT01888497|83262382|FG003|Washout Period 2|Adverse Event|1|||
47013310|NCT01888497|83262379|FG000|Washout Period 2|Withdrawal by Subject|0|||
47013311|NCT01888497|83262380|FG001|Washout Period 2|Withdrawal by Subject|0|||
47013312|NCT01888497|83262381|FG002|Washout Period 2|Withdrawal by Subject|0|||
47013313|NCT01888497|83262382|FG003|Washout Period 2|Withdrawal by Subject|1|||
47013314|NCT01505530|83262395|FG000|Overall Study|Progressive Disease|19|||
47013315|NCT01505530|83262396|FG001|Overall Study|Progressive Disease|17|||
47013316|NCT01505530|83262397|FG002|Overall Study|Progressive Disease|18|||
47013317|NCT01505530|83262395|FG000|Overall Study|Adverse Event|1|||
47013318|NCT01505530|83262396|FG001|Overall Study|Adverse Event|1|||
47013319|NCT01505530|83262397|FG002|Overall Study|Adverse Event|0|||
47013320|NCT01505530|83262395|FG000|Overall Study|Withdrawal by Subject|7|||
47013321|NCT01505530|83262396|FG001|Overall Study|Withdrawal by Subject|8|||
47013322|NCT01505530|83262397|FG002|Overall Study|Withdrawal by Subject|6|||
47013323|NCT01505530|83262395|FG000|Overall Study|Physician Decision|6|||
47013324|NCT01505530|83262396|FG001|Overall Study|Physician Decision|2|||
47013325|NCT01505530|83262397|FG002|Overall Study|Physician Decision|5|||
47013326|NCT01505530|83262395|FG000|Overall Study|Sponsor Decision|1|||
47013327|NCT01505530|83262396|FG001|Overall Study|Sponsor Decision|8|||
47013328|NCT01505530|83262397|FG002|Overall Study|Sponsor Decision|7|||
47013329|NCT01505530|83262395|FG000|Overall Study|Death|7|||
47013330|NCT01505530|83262396|FG001|Overall Study|Death|6|||
47013331|NCT01505530|83262397|FG002|Overall Study|Death|5|||
47013332|NCT01505530|83262395|FG000|Overall Study|entry criteria not met|0|||
47013333|NCT01505530|83262396|FG001|Overall Study|entry criteria not met|1|||
47013334|NCT01505530|83262397|FG002|Overall Study|entry criteria not met|0|||
47013335|NCT01485796|83262405|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
47013336|NCT01485796|83262405|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
47013337|NCT01485796|83262405|FG000|Period 2: Epoch 2|Adverse Event|3|||
47013338|NCT01485796|83262405|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
47013339|NCT01485796|83262405|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
47013340|NCT01485796|83262405|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
47013341|NCT01485796|83262405|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
47013342|NCT01485796|83262405|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
47013343|NCT01505374|83262413|FG000|Overall Study|Lost to Follow-up|1|||
47013344|NCT01505374|83262414|FG001|Overall Study|Lost to Follow-up|0|||
47013345|NCT01897233|83262421|FG000|Part B (24 Weeks)|Adverse Event|1|||
47013346|NCT01897233|83262421|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
47013347|NCT01897233|83262421|FG000|Part B (24 Weeks)|Physician Decision|1|||
47013348|NCT01887717|83262431|FG000|Overall Study|Withdrawal by Subject|1|||
47013349|NCT01887717|83262432|FG001|Overall Study|Withdrawal by Subject|7|||
47013350|NCT01887717|83262431|FG000|Overall Study|Physician Decision|0|||
47013351|NCT01887717|83262432|FG001|Overall Study|Physician Decision|2|||
47013352|NCT01887717|83262431|FG000|Overall Study|Administrative reasons|5|||
47013353|NCT01887717|83262432|FG001|Overall Study|Administrative reasons|2|||
47013354|NCT01886781|83262440|FG000|Overall Study|Protocol Violation|5|||
47013355|NCT01886781|83262441|FG001|Overall Study|Protocol Violation|0|||
47013356|NCT01886781|83262440|FG000|Overall Study|Adverse Event|1|||
47013357|NCT01886781|83262441|FG001|Overall Study|Adverse Event|0|||
47013358|NCT01886781|83262440|FG000|Overall Study|Lost to Follow-up|5|||
47013359|NCT01886781|83262441|FG001|Overall Study|Lost to Follow-up|0|||
47013360|NCT01886781|83262440|FG000|Overall Study|Withdrawal by Subject|2|||
47013361|NCT01886781|83262441|FG001|Overall Study|Withdrawal by Subject|1|||
47013362|NCT01886781|83262440|FG000|Overall Study|Worsening of symptoms|1|||
47013363|NCT01886781|83262441|FG001|Overall Study|Worsening of symptoms|1|||
47013364|NCT01463098|83262461|FG000|Part A (11 Days)|Participant Choice|2|||
47013365|NCT01463098|83262462|FG001|Part A (11 Days)|Participant Choice|0|||
47013366|NCT01463098|83262463|FG002|Part A (11 Days)|Participant Choice|0|||
47013367|NCT01463098|83262464|FG003|Part A (11 Days)|Participant Choice|0|||
47013368|NCT01463098|83262465|FG004|Part A (11 Days)|Participant Choice|0|||
47013369|NCT01463098|83262466|FG005|Part A (11 Days)|Participant Choice|0|||
47013370|NCT01463098|83262467|FG006|Part A (11 Days)|Participant Choice|0|||
47013371|NCT01463098|83262468|FG007|Part A (11 Days)|Participant Choice|0|||
47013372|NCT01463098|83262469|FG008|Part A (11 Days)|Participant Choice|1|||
47013373|NCT01463098|83262470|FG009|Part A (11 Days)|Participant Choice|0|||
47013374|NCT01463098|83262471|FG010|Part A (11 Days)|Participant Choice|0|||
47013375|NCT01463098|83262472|FG011|Part A (11 Days)|Participant Choice|0|||
47013376|NCT01463098|83262473|FG012|Part A (11 Days)|Participant Choice|0|||
47013377|NCT01463098|83262474|FG013|Part A (11 Days)|Participant Choice|0|||
47013378|NCT01463098|83262461|FG000|Part A (11 Days)|Lost to Follow-up|0|||
47013379|NCT01463098|83262462|FG001|Part A (11 Days)|Lost to Follow-up|0|||
47013380|NCT01463098|83262463|FG002|Part A (11 Days)|Lost to Follow-up|0|||
47013381|NCT01463098|83262464|FG003|Part A (11 Days)|Lost to Follow-up|0|||
47013382|NCT01463098|83262465|FG004|Part A (11 Days)|Lost to Follow-up|1|||
47013383|NCT01463098|83262466|FG005|Part A (11 Days)|Lost to Follow-up|0|||
47013384|NCT01463098|83262467|FG006|Part A (11 Days)|Lost to Follow-up|0|||
47013385|NCT01463098|83262468|FG007|Part A (11 Days)|Lost to Follow-up|0|||
47013386|NCT01463098|83262469|FG008|Part A (11 Days)|Lost to Follow-up|0|||
47013387|NCT01463098|83262470|FG009|Part A (11 Days)|Lost to Follow-up|0|||
47013388|NCT01463098|83262471|FG010|Part A (11 Days)|Lost to Follow-up|0|||
47013389|NCT01463098|83262472|FG011|Part A (11 Days)|Lost to Follow-up|0|||
47013390|NCT01463098|83262473|FG012|Part A (11 Days)|Lost to Follow-up|0|||
47013391|NCT01463098|83262474|FG013|Part A (11 Days)|Lost to Follow-up|0|||
47013392|NCT01463098|83262461|FG000|Part B (11 Days)|Participant Choice|0|||
47013393|NCT01463098|83262462|FG001|Part B (11 Days)|Participant Choice|0|||
47013394|NCT01463098|83262463|FG002|Part B (11 Days)|Participant Choice|0|||
47013395|NCT01463098|83262464|FG003|Part B (11 Days)|Participant Choice|0|||
47013396|NCT01463098|83262465|FG004|Part B (11 Days)|Participant Choice|0|||
47013397|NCT01463098|83262466|FG005|Part B (11 Days)|Participant Choice|0|||
47013398|NCT01463098|83262467|FG006|Part B (11 Days)|Participant Choice|0|||
47013399|NCT01463098|83262468|FG007|Part B (11 Days)|Participant Choice|0|||
47013400|NCT01463098|83262469|FG008|Part B (11 Days)|Participant Choice|0|||
47013401|NCT01463098|83262470|FG009|Part B (11 Days)|Participant Choice|0|||
47013402|NCT01463098|83262471|FG010|Part B (11 Days)|Participant Choice|0|||
47013403|NCT01463098|83262472|FG011|Part B (11 Days)|Participant Choice|1|||
47013404|NCT01463098|83262473|FG012|Part B (11 Days)|Participant Choice|0|||
47013405|NCT01463098|83262474|FG013|Part B (11 Days)|Participant Choice|0|||
47013406|NCT01462942|83262528|FG000|Overall Study|Adverse Event|7|||
47013407|NCT01462942|83262529|FG001|Overall Study|Adverse Event|12|||
47013408|NCT01462942|83262530|FG002|Overall Study|Adverse Event|10|||
47013409|NCT01462942|83262531|FG003|Overall Study|Adverse Event|11|||
47013410|NCT01462942|83262532|FG004|Overall Study|Adverse Event|11|||
47013411|NCT01462942|83262528|FG000|Overall Study|Other, including COPD exacerbation|3|||
47013412|NCT01462942|83262529|FG001|Overall Study|Other, including COPD exacerbation|5|||
47013413|NCT01462942|83262530|FG002|Overall Study|Other, including COPD exacerbation|2|||
47013414|NCT01462942|83262531|FG003|Overall Study|Other, including COPD exacerbation|8|||
47013415|NCT01462942|83262532|FG004|Overall Study|Other, including COPD exacerbation|5|||
47013416|NCT01462942|83262528|FG000|Overall Study|Withdrawal by Subject|14|||
47013417|NCT01462942|83262529|FG001|Overall Study|Withdrawal by Subject|10|||
47013418|NCT01462942|83262530|FG002|Overall Study|Withdrawal by Subject|14|||
47013419|NCT01462942|83262531|FG003|Overall Study|Withdrawal by Subject|16|||
47013420|NCT01462942|83262532|FG004|Overall Study|Withdrawal by Subject|19|||
47013421|NCT01462942|83262528|FG000|Overall Study|Lack of Efficacy|6|||
47013422|NCT01462942|83262529|FG001|Overall Study|Lack of Efficacy|0|||
47013423|NCT01462942|83262530|FG002|Overall Study|Lack of Efficacy|4|||
47013424|NCT01462942|83262531|FG003|Overall Study|Lack of Efficacy|5|||
47013425|NCT01462942|83262532|FG004|Overall Study|Lack of Efficacy|3|||
47013426|NCT01462942|83262528|FG000|Overall Study|Lost to Follow-up|0|||
47013427|NCT01462942|83262529|FG001|Overall Study|Lost to Follow-up|1|||
47013428|NCT01462942|83262530|FG002|Overall Study|Lost to Follow-up|1|||
47013429|NCT01462942|83262531|FG003|Overall Study|Lost to Follow-up|1|||
47013430|NCT01462942|83262532|FG004|Overall Study|Lost to Follow-up|1|||
47013431|NCT01462942|83262528|FG000|Overall Study|Protocol Violation|4|||
47013432|NCT01462942|83262529|FG001|Overall Study|Protocol Violation|6|||
47013433|NCT01462942|83262530|FG002|Overall Study|Protocol Violation|9|||
47013434|NCT01462942|83262531|FG003|Overall Study|Protocol Violation|9|||
47013435|NCT01462942|83262532|FG004|Overall Study|Protocol Violation|6|||
47013436|NCT01462630|83262544|FG000|Overall Study|Did not initiate therapy|3|||
47013437|NCT01462630|83262544|FG000|Overall Study|Death|1|||
47013438|NCT01462630|83262544|FG000|Overall Study|Protocol Violation|2|||
47013439|NCT01462630|83262544|FG000|Overall Study|Adverse Event|1|||
47013440|NCT01504204|83262550|FG000|Overall Study|Lost to Follow-up|1|||
47013441|NCT01504204|83262551|FG001|Overall Study|Lost to Follow-up|1|||
47013442|NCT01485640|83262557|FG000|Overall Study|Adverse Event|10|||
47013443|NCT01485640|83262557|FG000|Overall Study|Lack of Efficacy|2|||
47013444|NCT01485640|83262557|FG000|Overall Study|Protocol Violation|1|||
47013445|NCT01485640|83262557|FG000|Overall Study|Withdrawal by Subject|14|||
47013446|NCT01485640|83262557|FG000|Overall Study|Terminated by Sponsor|95|||
47013447|NCT02118961|83262563|FG000|Overall Study|Withdrawal by Subject|1|||
47013448|NCT02118961|83262564|FG001|Overall Study|Withdrawal by Subject|0|||
47013449|NCT02140645|83262576|FG000|Overall Study|Not linked|5489|||
47013450|NCT02140645|83262577|FG001|Overall Study|Not linked|61654|||
47013451|NCT02140645|83262578|FG002|Overall Study|Not linked|4236|||
47013452|NCT02140645|83262579|FG003|Overall Study|Not linked|13833|||
47013453|NCT02140645|83262580|FG004|Overall Study|Not linked|3286|||
47013454|NCT02140645|83262581|FG005|Overall Study|Not linked|70896|||
47013455|NCT02140567|83262590|FG000|Overall Study|Problems with recording equipment|6|||
47013456|NCT02140411|83262595|FG000|Overall Study|Adverse Event|1|||
47013457|NCT02139943|83262602|FG000|Overall Study|Adverse Event|0|||
47013458|NCT02139943|83262603|FG001|Overall Study|Adverse Event|1|||
47013459|NCT02139943|83262604|FG002|Overall Study|Adverse Event|2|||
47013460|NCT02139943|83262602|FG000|Overall Study|Lost to Follow-up|3|||
47013461|NCT02139943|83262603|FG001|Overall Study|Lost to Follow-up|2|||
47013462|NCT02139943|83262604|FG002|Overall Study|Lost to Follow-up|2|||
47013463|NCT02139943|83262602|FG000|Overall Study|Withdrawal by Subject|4|||
47013464|NCT02139943|83262603|FG001|Overall Study|Withdrawal by Subject|3|||
47013465|NCT02139943|83262604|FG002|Overall Study|Withdrawal by Subject|0|||
47013466|NCT02139943|83262602|FG000|Overall Study|Other|0|||
47013467|NCT02139943|83262603|FG001|Overall Study|Other|0|||
47013468|NCT02139943|83262604|FG002|Overall Study|Other|1|||
47013469|NCT02139943|83262602|FG000|Overall Study|Participant wishes to discontinue|2|||
47013470|NCT02139943|83262603|FG001|Overall Study|Participant wishes to discontinue|0|||
47013471|NCT02139943|83262604|FG002|Overall Study|Participant wishes to discontinue|0|||
47013472|NCT02139943|83262602|FG000|Overall Study|Participant in Poor Compliance|1|||
47013473|NCT02139943|83262603|FG001|Overall Study|Participant in Poor Compliance|0|||
47013474|NCT02139943|83262604|FG002|Overall Study|Participant in Poor Compliance|1|||
47013475|NCT02139943|83262602|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
47013476|NCT02139943|83262603|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
47013477|NCT02139943|83262604|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
47013478|NCT01485172|83262618|FG000|Overall Study|Adverse Event|2|||
47013479|NCT01485172|83262619|FG001|Overall Study|Adverse Event|1|||
47013480|NCT01485172|83262620|FG002|Overall Study|Adverse Event|2|||
47013481|NCT01485172|83262621|FG003|Overall Study|Adverse Event|2|||
47013482|NCT01485172|83262622|FG004|Overall Study|Adverse Event|1|||
47013483|NCT01485172|83262623|FG005|Overall Study|Adverse Event|2|||
47013484|NCT01485172|83262618|FG000|Overall Study|Lack of Efficacy|2|||
47013485|NCT01485172|83262619|FG001|Overall Study|Lack of Efficacy|0|||
47013486|NCT01485172|83262620|FG002|Overall Study|Lack of Efficacy|0|||
47013487|NCT01485172|83262621|FG003|Overall Study|Lack of Efficacy|0|||
47013488|NCT01485172|83262622|FG004|Overall Study|Lack of Efficacy|0|||
47013489|NCT01485172|83262623|FG005|Overall Study|Lack of Efficacy|0|||
47013490|NCT01485172|83262618|FG000|Overall Study|Protocol Violation|0|||
47013491|NCT01485172|83262619|FG001|Overall Study|Protocol Violation|0|||
47013492|NCT01485172|83262620|FG002|Overall Study|Protocol Violation|4|||
47013493|NCT01485172|83262621|FG003|Overall Study|Protocol Violation|5|||
47013494|NCT01485172|83262622|FG004|Overall Study|Protocol Violation|1|||
47013495|NCT01485172|83262623|FG005|Overall Study|Protocol Violation|0|||
47013496|NCT01485172|83262618|FG000|Overall Study|Protocol defined stopping criteria|1|||
47013497|NCT01485172|83262619|FG001|Overall Study|Protocol defined stopping criteria|0|||
47013498|NCT01485172|83262620|FG002|Overall Study|Protocol defined stopping criteria|0|||
47013499|NCT01485172|83262621|FG003|Overall Study|Protocol defined stopping criteria|0|||
47013500|NCT01485172|83262622|FG004|Overall Study|Protocol defined stopping criteria|1|||
47013501|NCT01485172|83262623|FG005|Overall Study|Protocol defined stopping criteria|0|||
47013502|NCT01485172|83262618|FG000|Overall Study|Lost to Follow-up|0|||
47013503|NCT01485172|83262619|FG001|Overall Study|Lost to Follow-up|0|||
47013504|NCT01485172|83262620|FG002|Overall Study|Lost to Follow-up|1|||
47013505|NCT01485172|83262621|FG003|Overall Study|Lost to Follow-up|0|||
47013506|NCT01485172|83262622|FG004|Overall Study|Lost to Follow-up|0|||
47013507|NCT01485172|83262623|FG005|Overall Study|Lost to Follow-up|1|||
47013508|NCT01485172|83262618|FG000|Overall Study|Physician Decision|0|||
47013509|NCT01485172|83262619|FG001|Overall Study|Physician Decision|0|||
47013510|NCT01485172|83262620|FG002|Overall Study|Physician Decision|0|||
47013511|NCT01485172|83262621|FG003|Overall Study|Physician Decision|0|||
47013512|NCT01485172|83262622|FG004|Overall Study|Physician Decision|1|||
47013513|NCT01485172|83262623|FG005|Overall Study|Physician Decision|0|||
47013514|NCT01485172|83262618|FG000|Overall Study|Withdrawal by Subject|2|||
47013515|NCT01485172|83262619|FG001|Overall Study|Withdrawal by Subject|0|||
47013516|NCT01485172|83262620|FG002|Overall Study|Withdrawal by Subject|0|||
47013517|NCT01485172|83262621|FG003|Overall Study|Withdrawal by Subject|1|||
47013518|NCT01485172|83262622|FG004|Overall Study|Withdrawal by Subject|1|||
47013519|NCT01485172|83262623|FG005|Overall Study|Withdrawal by Subject|1|||
47013520|NCT02105701|83262641|FG000|Overall Study|Lost to Follow-up|1|||
47013521|NCT02105701|83262642|FG001|Overall Study|Lost to Follow-up|0|||
47013522|NCT02105701|83262643|FG002|Overall Study|Lost to Follow-up|2|||
47013523|NCT02105701|83262644|FG003|Overall Study|Lost to Follow-up|1|||
47013524|NCT02105701|83262641|FG000|Overall Study|Protocol Violation|0|||
47013525|NCT02105701|83262642|FG001|Overall Study|Protocol Violation|0|||
47013526|NCT02105701|83262643|FG002|Overall Study|Protocol Violation|1|||
47013527|NCT02105701|83262644|FG003|Overall Study|Protocol Violation|0|||
47013528|NCT02105701|83262641|FG000|Overall Study|Withdrawal by Subject|2|||
47013529|NCT02105701|83262642|FG001|Overall Study|Withdrawal by Subject|1|||
47013530|NCT02105701|83262643|FG002|Overall Study|Withdrawal by Subject|0|||
47013531|NCT02105701|83262644|FG003|Overall Study|Withdrawal by Subject|1|||
47013532|NCT02105701|83262641|FG000|Overall Study|Death|1|||
47013533|NCT02105701|83262642|FG001|Overall Study|Death|0|||
47013534|NCT02105701|83262643|FG002|Overall Study|Death|0|||
47013535|NCT02105701|83262644|FG003|Overall Study|Death|0|||
47013536|NCT01502956|83262656|FG000|Overall Study|Death|0|||
47013537|NCT01502956|83262657|FG001|Overall Study|Death|2|||
47013538|NCT01502956|83262656|FG000|Overall Study|Lost to Follow-up|14|||
47013539|NCT01502956|83262657|FG001|Overall Study|Lost to Follow-up|11|||
47013540|NCT01502956|83262656|FG000|Overall Study|Physician Decision|2|||
47013541|NCT01502956|83262657|FG001|Overall Study|Physician Decision|3|||
47013542|NCT01502956|83262656|FG000|Overall Study|Withdrawal by Subject|8|||
47013543|NCT01502956|83262657|FG001|Overall Study|Withdrawal by Subject|10|||
47013544|NCT01502644|83262666|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
47013545|NCT01502644|83262667|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
47013546|NCT01502644|83262668|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
47013547|NCT01502644|83262669|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
47013548|NCT01502644|83262666|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
47013549|NCT01502644|83262667|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
47013550|NCT01502644|83262668|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
47013551|NCT01502644|83262669|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
47013552|NCT01502644|83262666|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
47013553|NCT01502644|83262667|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
47013554|NCT01502644|83262668|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
47013555|NCT01502644|83262669|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
47013556|NCT01502644|83262666|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
47013557|NCT01502644|83262667|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
47013558|NCT01502644|83262668|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
47013559|NCT01502644|83262669|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
47013560|NCT01502644|83262666|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
47013561|NCT01502644|83262667|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
47013562|NCT01502644|83262668|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
47013563|NCT01502644|83262669|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
47013564|NCT01462318|83262679|FG000|Main Study / TP-DI Study|Other|2|||
47013565|NCT01462318|83262680|FG001|Main Study / TP-DI Study|Other|0|||
47013566|NCT01462318|83262681|FG002|Main Study / TP-DI Study|Other|0|||
47013567|NCT01462318|83262679|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
47013568|NCT01462318|83262680|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
47013569|NCT01462318|83262681|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
47013570|NCT01462318|83262679|FG000|Main Study / TP-DI Study|Adverse Event|4|||
47013571|NCT01462318|83262680|FG001|Main Study / TP-DI Study|Adverse Event|0|||
47013572|NCT01462318|83262681|FG002|Main Study / TP-DI Study|Adverse Event|0|||
47013573|NCT01462318|83262679|FG000|Extension Phase|Lost to Follow-up|0|||
47013574|NCT01462318|83262680|FG001|Extension Phase|Lost to Follow-up|0|||
47013575|NCT01462318|83262681|FG002|Extension Phase|Lost to Follow-up|1|||
47013576|NCT01462318|83262679|FG000|Extension Phase|Other|0|||
47013577|NCT01462318|83262680|FG001|Extension Phase|Other|0|||
47013578|NCT01462318|83262681|FG002|Extension Phase|Other|1|||
47013579|NCT01462318|83262679|FG000|Extension Phase|Disease Progression|0|||
47013580|NCT01462318|83262680|FG001|Extension Phase|Disease Progression|0|||
47013581|NCT01462318|83262681|FG002|Extension Phase|Disease Progression|1|||
47013582|NCT01462318|83262679|FG000|Extension Phase|Withdrawal by Subject|0|||
47013583|NCT01462318|83262680|FG001|Extension Phase|Withdrawal by Subject|0|||
47013584|NCT01462318|83262681|FG002|Extension Phase|Withdrawal by Subject|15|||
47013585|NCT01462318|83262679|FG000|Extension Phase|Investigator Decision|0|||
47013586|NCT01462318|83262680|FG001|Extension Phase|Investigator Decision|0|||
47013587|NCT01462318|83262681|FG002|Extension Phase|Investigator Decision|5|||
47013588|NCT01462318|83262679|FG000|Extension Phase|Adverse Event|0|||
47013589|NCT01462318|83262680|FG001|Extension Phase|Adverse Event|0|||
47013590|NCT01462318|83262681|FG002|Extension Phase|Adverse Event|22|||
47013591|NCT01485094|83262689|FG000|Overall Study|Adverse Event|1|||
47013592|NCT01485094|83262690|FG001|Overall Study|Adverse Event|1|||
47013593|NCT01485094|83262691|FG002|Overall Study|Adverse Event|1|||
47013594|NCT01485094|83262689|FG000|Overall Study|Lost to Follow-up|1|||
47013595|NCT01485094|83262690|FG001|Overall Study|Lost to Follow-up|0|||
47013596|NCT01485094|83262691|FG002|Overall Study|Lost to Follow-up|0|||
47013597|NCT01485094|83262689|FG000|Overall Study|Withdrawal by Subject|1|||
47013598|NCT01485094|83262690|FG001|Overall Study|Withdrawal by Subject|1|||
47013599|NCT01485094|83262691|FG002|Overall Study|Withdrawal by Subject|0|||
47013600|NCT01484938|83262699|FG000|Overall Study|Adverse Event|2|||
47013601|NCT01484938|83262699|FG000|Overall Study|Lost to Follow-up|1|||
47013602|NCT01484938|83262699|FG000|Overall Study|Noncompliance|1|||
47013603|NCT01502410|83262707|FG000|Overall Study|Adverse Event|1|||
47013604|NCT01502410|83262708|FG001|Overall Study|Adverse Event|2|||
47013605|NCT01502410|83262709|FG002|Overall Study|Adverse Event|0|||
47013606|NCT01502410|83262710|FG003|Overall Study|Adverse Event|0|||
47013607|NCT01502410|83262707|FG000|Overall Study|Lack of Efficacy|7|||
47013608|NCT01502410|83262708|FG001|Overall Study|Lack of Efficacy|7|||
47013609|NCT01502410|83262709|FG002|Overall Study|Lack of Efficacy|0|||
47013610|NCT01502410|83262710|FG003|Overall Study|Lack of Efficacy|0|||
47013611|NCT01502410|83262707|FG000|Overall Study|Physician Decision|0|||
47013612|NCT01502410|83262708|FG001|Overall Study|Physician Decision|1|||
47013613|NCT01502410|83262709|FG002|Overall Study|Physician Decision|0|||
47013614|NCT01502410|83262710|FG003|Overall Study|Physician Decision|0|||
47013615|NCT01502410|83262707|FG000|Overall Study|Withdrawal by Subject|2|||
47013616|NCT01502410|83262708|FG001|Overall Study|Withdrawal by Subject|0|||
47013617|NCT01502410|83262709|FG002|Overall Study|Withdrawal by Subject|0|||
47013618|NCT01502410|83262710|FG003|Overall Study|Withdrawal by Subject|0|||
47013619|NCT01462162|83262719|FG000|Overall Study|Adverse Event|5|||
47013620|NCT01462162|83262719|FG000|Overall Study|Lack of Efficacy|4|||
47013621|NCT01462162|83262719|FG000|Overall Study|Abnormal laboratory parameters|1|||
47013622|NCT01462162|83262719|FG000|Overall Study|Other|2|||
47013623|NCT01483924|83262729|FG000|Overall Study|Withdrawal by Subject|2|||
47013624|NCT01483924|83262730|FG001|Overall Study|Withdrawal by Subject|0|||
47013625|NCT01483924|83262731|FG002|Overall Study|Withdrawal by Subject|0|||
47013626|NCT01483924|83262732|FG003|Overall Study|Withdrawal by Subject|1|||
47013627|NCT01483924|83262733|FG004|Overall Study|Withdrawal by Subject|1|||
47013628|NCT01483924|83262729|FG000|Overall Study|Adverse Event|0|||
47013629|NCT01483924|83262730|FG001|Overall Study|Adverse Event|0|||
47013630|NCT01483924|83262731|FG002|Overall Study|Adverse Event|1|||
47013631|NCT01483924|83262732|FG003|Overall Study|Adverse Event|1|||
47013632|NCT01483924|83262733|FG004|Overall Study|Adverse Event|0|||
47013633|NCT01483924|83262729|FG000|Overall Study|Non-compliance|0|||
47013634|NCT01483924|83262730|FG001|Overall Study|Non-compliance|0|||
47013635|NCT01483924|83262731|FG002|Overall Study|Non-compliance|0|||
47013636|NCT01483924|83262732|FG003|Overall Study|Non-compliance|1|||
47013637|NCT01483924|83262733|FG004|Overall Study|Non-compliance|1|||
47013638|NCT01483924|83262729|FG000|Overall Study|Sponsor concern over ECG result|0|||
47013639|NCT01483924|83262730|FG001|Overall Study|Sponsor concern over ECG result|0|||
47013640|NCT01483924|83262731|FG002|Overall Study|Sponsor concern over ECG result|0|||
47013641|NCT01483924|83262732|FG003|Overall Study|Sponsor concern over ECG result|1|||
47013642|NCT01483924|83262733|FG004|Overall Study|Sponsor concern over ECG result|0|||
47013643|NCT01462084|83262754|FG000|Overall Study|Withdrawal by Subject|1|||
47013644|NCT01462084|83262755|FG001|Overall Study|Withdrawal by Subject|0|||
47013645|NCT01462084|83262754|FG000|Overall Study|Protocol Violation|1|||
47013646|NCT01462084|83262755|FG001|Overall Study|Protocol Violation|1|||
47013647|NCT02134028|83262770|FG000|Overall Study|Lack of Efficacy|1|||
47013648|NCT02134028|83262771|FG001|Overall Study|Lack of Efficacy|0|||
47013649|NCT02134028|83262772|FG002|Overall Study|Lack of Efficacy|3|||
47013650|NCT02134028|83262773|FG003|Overall Study|Lack of Efficacy|2|||
47013651|NCT02134028|83262774|FG004|Overall Study|Lack of Efficacy|1|||
47013652|NCT02134028|83262775|FG005|Overall Study|Lack of Efficacy|2|||
47013653|NCT02134028|83262776|FG006|Overall Study|Lack of Efficacy|1|||
47013654|NCT02134028|83262777|FG007|Overall Study|Lack of Efficacy|0|||
47013655|NCT02134028|83262770|FG000|Overall Study|Poor compliance to protocol|1|||
47013656|NCT02134028|83262771|FG001|Overall Study|Poor compliance to protocol|1|||
47013657|NCT02134028|83262772|FG002|Overall Study|Poor compliance to protocol|3|||
47013658|NCT02134028|83262773|FG003|Overall Study|Poor compliance to protocol|7|||
47013659|NCT02134028|83262774|FG004|Overall Study|Poor compliance to protocol|1|||
47013660|NCT02134028|83262775|FG005|Overall Study|Poor compliance to protocol|1|||
47013661|NCT02134028|83262776|FG006|Overall Study|Poor compliance to protocol|0|||
47013662|NCT02134028|83262777|FG007|Overall Study|Poor compliance to protocol|0|||
47013663|NCT02134028|83262770|FG000|Overall Study|Other unspecified|4|||
47013664|NCT02134028|83262771|FG001|Overall Study|Other unspecified|22|||
47013665|NCT02134028|83262772|FG002|Overall Study|Other unspecified|33|||
47013666|NCT02134028|83262773|FG003|Overall Study|Other unspecified|64|||
47013667|NCT02134028|83262774|FG004|Overall Study|Other unspecified|8|||
47013668|NCT02134028|83262775|FG005|Overall Study|Other unspecified|6|||
47013669|NCT02134028|83262776|FG006|Overall Study|Other unspecified|2|||
47013670|NCT02134028|83262777|FG007|Overall Study|Other unspecified|1|||
47013671|NCT02134028|83262770|FG000|Overall Study|Adverse Event|3|||
47013672|NCT02134028|83262771|FG001|Overall Study|Adverse Event|19|||
47013673|NCT02134028|83262772|FG002|Overall Study|Adverse Event|13|||
47013674|NCT02134028|83262773|FG003|Overall Study|Adverse Event|32|||
47013675|NCT02134028|83262774|FG004|Overall Study|Adverse Event|4|||
47013676|NCT02134028|83262775|FG005|Overall Study|Adverse Event|5|||
47013677|NCT02134028|83262776|FG006|Overall Study|Adverse Event|1|||
47013678|NCT02134028|83262777|FG007|Overall Study|Adverse Event|2|||
47013679|NCT02172950|83262799|FG000|Overall Study|Physician Decision|3|||
47013680|NCT02172950|83262800|FG001|Overall Study|Physician Decision|3|||
47013681|NCT02172950|83262799|FG000|Overall Study|Lack of Efficacy|1|||
47013682|NCT02172950|83262800|FG001|Overall Study|Lack of Efficacy|0|||
47013683|NCT02172950|83262799|FG000|Overall Study|Adverse Event|4|||
47013684|NCT02172950|83262800|FG001|Overall Study|Adverse Event|1|||
47013685|NCT02172950|83262799|FG000|Overall Study|Withdrawal by Subject|10|||
47013686|NCT02172950|83262800|FG001|Overall Study|Withdrawal by Subject|0|||
47013687|NCT02172950|83262799|FG000|Overall Study|Protocol Violation|1|||
47013688|NCT02172950|83262800|FG001|Overall Study|Protocol Violation|0|||
47013689|NCT02172950|83262799|FG000|Overall Study|Lost to Follow-up|1|||
47013690|NCT02172950|83262800|FG001|Overall Study|Lost to Follow-up|0|||
47013691|NCT02172950|83262799|FG000|Overall Study|Death|1|||
47013692|NCT02172950|83262800|FG001|Overall Study|Death|0|||
47013693|NCT02172950|83262799|FG000|Overall Study|Patient traveling|1|||
47013694|NCT02172950|83262800|FG001|Overall Study|Patient traveling|0|||
47013695|NCT02172950|83262799|FG000|Overall Study|Patient went to other country|1|||
47013696|NCT02172950|83262800|FG001|Overall Study|Patient went to other country|0|||
47013697|NCT02172950|83262799|FG000|Overall Study|Patient relocated overseas|1|||
47013698|NCT02172950|83262800|FG001|Overall Study|Patient relocated overseas|1|||
47013699|NCT02172950|83262799|FG000|Overall Study|Patient moving|1|||
47013700|NCT02172950|83262800|FG001|Overall Study|Patient moving|0|||
47013701|NCT02151266|83262810|FG000|Overall Study|Lost to Follow-up|1|||
47013702|NCT02151266|83262811|FG001|Overall Study|Lost to Follow-up|4|||
47013703|NCT02151266|83262812|FG002|Overall Study|Lost to Follow-up|1|||
47013704|NCT02151266|83262810|FG000|Overall Study|Did NOT receive intervention|3|||
47013705|NCT02151266|83262811|FG001|Overall Study|Did NOT receive intervention|6|||
47013706|NCT02151266|83262812|FG002|Overall Study|Did NOT receive intervention|2|||
47013707|NCT02151266|83262810|FG000|Overall Study|Not able to exercise|4|||
47013708|NCT02151266|83262811|FG001|Overall Study|Not able to exercise|5|||
47013709|NCT02151266|83262812|FG002|Overall Study|Not able to exercise|4|||
47013710|NCT02151110|83262828|FG000|Overall Study|Withdrawal by Subject|0|||
47013711|NCT02151110|83262829|FG001|Overall Study|Withdrawal by Subject|0|||
47013712|NCT02151110|83262830|FG002|Overall Study|Withdrawal by Subject|0|||
47013713|NCT02151110|83262831|FG003|Overall Study|Withdrawal by Subject|0|||
47013714|NCT02151110|83262832|FG004|Overall Study|Withdrawal by Subject|0|||
47013715|NCT02151110|83262833|FG005|Overall Study|Withdrawal by Subject|0|||
47013716|NCT02151110|83262834|FG006|Overall Study|Withdrawal by Subject|0|||
47013717|NCT02151110|83262835|FG007|Overall Study|Withdrawal by Subject|1|||
47013718|NCT02151110|83262828|FG000|Overall Study|Lost to Follow-up|0|||
47013719|NCT02151110|83262829|FG001|Overall Study|Lost to Follow-up|0|||
47013720|NCT02151110|83262830|FG002|Overall Study|Lost to Follow-up|0|||
47013721|NCT02151110|83262831|FG003|Overall Study|Lost to Follow-up|0|||
47013722|NCT02151110|83262832|FG004|Overall Study|Lost to Follow-up|0|||
47013723|NCT02151110|83262833|FG005|Overall Study|Lost to Follow-up|0|||
47013724|NCT02151110|83262834|FG006|Overall Study|Lost to Follow-up|0|||
47013725|NCT02151110|83262835|FG007|Overall Study|Lost to Follow-up|2|||
47013726|NCT02132312|83262862|FG000|Overall Study|Adverse Event|2|||
47013727|NCT02132312|83262863|FG001|Overall Study|Adverse Event|0|||
47013728|NCT02132312|83262862|FG000|Overall Study|Physician Decision|1|||
47013729|NCT02132312|83262863|FG001|Overall Study|Physician Decision|1|||
47013730|NCT02132312|83262862|FG000|Overall Study|Protocol Violation|0|||
47013731|NCT02132312|83262863|FG001|Overall Study|Protocol Violation|1|||
47013732|NCT02132312|83262862|FG000|Overall Study|Withdrawal by Subject|1|||
47013733|NCT02132312|83262863|FG001|Overall Study|Withdrawal by Subject|0|||
47013734|NCT02132312|83262862|FG000|Overall Study|Lost to Follow-up|2|||
47013735|NCT02132312|83262863|FG001|Overall Study|Lost to Follow-up|1|||
47013736|NCT02131766|83262869|FG000|Overall Study|Withdrawal by Subject|4|||
47013737|NCT02150954|83262878|FG000|Overall Study|Protocol Violation|1|||
47013738|NCT02150954|83262879|FG001|Overall Study|Protocol Violation|0|||
47013739|NCT02131532|83262885|FG000|Overall Study|Withdrawal by Subject|1|||
47013740|NCT02131532|83262885|FG000|Overall Study|Physician Decision|1|||
47013741|NCT02131532|83262885|FG000|Overall Study|Other health conditions|2|||
47013742|NCT02170688|83262899|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
47013743|NCT02170688|83262900|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
47013744|NCT02170688|83262901|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
47013745|NCT02170688|83262902|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
47013746|NCT02170688|83262903|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
47013747|NCT02170688|83262899|FG000|Overall Study|Full dose not received|0|||
47013748|NCT02170688|83262900|FG001|Overall Study|Full dose not received|1|||
47013749|NCT02170688|83262901|FG002|Overall Study|Full dose not received|0|||
47013750|NCT02170688|83262902|FG003|Overall Study|Full dose not received|0|||
47013751|NCT02170688|83262903|FG004|Overall Study|Full dose not received|0|||
47013752|NCT02170688|83262899|FG000|Overall Study|Physician Decision|0|||
47013753|NCT02170688|83262900|FG001|Overall Study|Physician Decision|0|||
47013754|NCT02170688|83262901|FG002|Overall Study|Physician Decision|1|||
47013755|NCT02170688|83262902|FG003|Overall Study|Physician Decision|0|||
47013756|NCT02170688|83262903|FG004|Overall Study|Physician Decision|0|||
47013757|NCT02170298|83262917|FG000|Overall Study|Withdrawal by Subject|0|||
47013758|NCT02170298|83262918|FG001|Overall Study|Withdrawal by Subject|1|||
47013759|NCT02170298|83262917|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
47013760|NCT02170298|83262918|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
47013761|NCT02131064|83262926|FG000|Overall Study|Death|5|||
47013762|NCT02131064|83262927|FG001|Overall Study|Death|6|||
47013763|NCT02131064|83262926|FG000|Overall Study|Lost to Follow-up|4|||
47013764|NCT02131064|83262927|FG001|Overall Study|Lost to Follow-up|8|||
47013765|NCT02131064|83262926|FG000|Overall Study|Withdrawal by Subject|14|||
47013766|NCT02131064|83262927|FG001|Overall Study|Withdrawal by Subject|18|||
47013767|NCT02131064|83262926|FG000|Overall Study|Other|2|||
47013768|NCT02131064|83262927|FG001|Overall Study|Other|2|||
47013769|NCT02130986|83262936|FG000|Overall Study|Withdrawal by Subject|4|||
47013770|NCT02130986|83262937|FG001|Overall Study|Withdrawal by Subject|4|||
47013771|NCT02130986|83262936|FG000|Overall Study|Lost to Follow-up|151|||
47013772|NCT02130986|83262937|FG001|Overall Study|Lost to Follow-up|160|||
47013773|NCT02130284|83262945|FG000|Overall Study|Withdrawal by Subject|3|||
47013774|NCT02130284|83262945|FG000|Overall Study|Subject Withdrew Consent|1|||
47013775|NCT02130284|83262945|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
47013776|NCT02130284|83262945|FG000|Overall Study|Subject was screened as backup for study|3|||
47013777|NCT02130284|83262945|FG000|Overall Study|Screen Failure|1|||
47013778|NCT02147288|83262951|FG000|Overall Study|post-operative hematoma|1|||
47013779|NCT02147288|83262952|FG001|Overall Study|post-operative hematoma|1|||
47013780|NCT02147288|83262953|FG002|Overall Study|post-operative hematoma|0|||
47013781|NCT02147288|83262954|FG003|Overall Study|post-operative hematoma|0|||
47013782|NCT02147288|83262955|FG004|Overall Study|post-operative hematoma|0|||
47013783|NCT02147288|83262956|FG005|Overall Study|post-operative hematoma|0|||
47013784|NCT02147288|83262957|FG006|Overall Study|post-operative hematoma|0|||
47013785|NCT02147288|83262958|FG007|Overall Study|post-operative hematoma|0|||
47013786|NCT02147288|83262959|FG008|Overall Study|post-operative hematoma|0|||
47013787|NCT02147288|83262960|FG009|Overall Study|post-operative hematoma|0|||
46709655|NCT00971997|82925746|FG000|Overall Study|Adverse Event|2|||
46709656|NCT00971997|82925746|FG000|Overall Study|Death|1|||
46709657|NCT00971997|82925746|FG000|Overall Study|Protocol Violation|4|||
46709658|NCT00971997|82925746|FG000|Overall Study|Withdrawal by Subject|5|||
46709659|NCT00971997|82925746|FG000|Overall Study|Physician Decision|7|||
46709660|NCT01127646|82925755|FG000|Overall Study|Entry Criteria Not Met|1|||
46709661|NCT01127646|82925756|FG001|Overall Study|Entry Criteria Not Met|0|||
46709662|NCT01127646|82925755|FG000|Overall Study|Protocol Violation|0|||
46709663|NCT01127646|82925756|FG001|Overall Study|Protocol Violation|1|||
46709664|NCT01215188|82925767|FG000|Overall Study|Lost to Follow-up|22|||
47013788|NCT02147288|83262951|FG000|Overall Study|complications from concurrent hernia rep|0|||
47013789|NCT02147288|83262952|FG001|Overall Study|complications from concurrent hernia rep|1|||
47013790|NCT02147288|83262953|FG002|Overall Study|complications from concurrent hernia rep|0|||
47013791|NCT02147288|83262954|FG003|Overall Study|complications from concurrent hernia rep|0|||
47013792|NCT02147288|83262955|FG004|Overall Study|complications from concurrent hernia rep|0|||
47013793|NCT02147288|83262956|FG005|Overall Study|complications from concurrent hernia rep|0|||
47013794|NCT02147288|83262957|FG006|Overall Study|complications from concurrent hernia rep|0|||
47013795|NCT02147288|83262958|FG007|Overall Study|complications from concurrent hernia rep|0|||
47013796|NCT02147288|83262959|FG008|Overall Study|complications from concurrent hernia rep|0|||
47013797|NCT02147288|83262960|FG009|Overall Study|complications from concurrent hernia rep|0|||
47013798|NCT02147132|83262966|FG000|Overall Study|Lost to Follow-up|1|||
47013799|NCT02147132|83262967|FG001|Overall Study|Lost to Follow-up|0|||
47013800|NCT02147132|83262968|FG002|Overall Study|Lost to Follow-up|0|||
47013801|NCT02147132|83262969|FG003|Overall Study|Lost to Follow-up|0|||
47013802|NCT02146430|83262983|FG000|Overall Study|Protocol Violation|5|||
47013803|NCT02146430|83262984|FG001|Overall Study|Protocol Violation|4|||
47013804|NCT02146430|83262985|FG002|Overall Study|Protocol Violation|8|||
47013805|NCT02146430|83262986|FG003|Overall Study|Protocol Violation|6|||
47013806|NCT02146430|83262983|FG000|Overall Study|Lack of Efficacy|13|||
47013807|NCT02146430|83262984|FG001|Overall Study|Lack of Efficacy|11|||
47013808|NCT02146430|83262985|FG002|Overall Study|Lack of Efficacy|8|||
47013809|NCT02146430|83262986|FG003|Overall Study|Lack of Efficacy|5|||
47013810|NCT02146430|83262983|FG000|Overall Study|Adverse Event|20|||
47013811|NCT02146430|83262984|FG001|Overall Study|Adverse Event|40|||
47013812|NCT02146430|83262985|FG002|Overall Study|Adverse Event|32|||
47013813|NCT02146430|83262986|FG003|Overall Study|Adverse Event|49|||
47013814|NCT02146430|83262983|FG000|Overall Study|Reason missing or not reported|2|||
47013815|NCT02146430|83262984|FG001|Overall Study|Reason missing or not reported|3|||
47013816|NCT02146430|83262985|FG002|Overall Study|Reason missing or not reported|4|||
47013817|NCT02146430|83262986|FG003|Overall Study|Reason missing or not reported|5|||
47013818|NCT02146430|83262983|FG000|Overall Study|Withdrawal by Subject|27|||
47013819|NCT02146430|83262984|FG001|Overall Study|Withdrawal by Subject|29|||
47013820|NCT02146430|83262985|FG002|Overall Study|Withdrawal by Subject|30|||
47013821|NCT02146430|83262986|FG003|Overall Study|Withdrawal by Subject|34|||
47013822|NCT02129192|83263002|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
47013823|NCT02129192|83263003|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
47013824|NCT02105948|83263016|FG000|Overall Study|Adverse Event|10|||
47013825|NCT02105948|83263017|FG001|Overall Study|Adverse Event|7|||
47013826|NCT02105948|83263018|FG002|Overall Study|Adverse Event|11|||
47013827|NCT02105948|83263019|FG003|Overall Study|Adverse Event|11|||
47013828|NCT02105948|83263016|FG000|Overall Study|Lack of Efficacy|0|||
47013829|NCT02105948|83263017|FG001|Overall Study|Lack of Efficacy|1|||
47013830|NCT02105948|83263018|FG002|Overall Study|Lack of Efficacy|3|||
47013831|NCT02105948|83263019|FG003|Overall Study|Lack of Efficacy|2|||
47013832|NCT02105948|83263016|FG000|Overall Study|Lost to Follow-up|0|||
47013833|NCT02105948|83263017|FG001|Overall Study|Lost to Follow-up|0|||
47013834|NCT02105948|83263018|FG002|Overall Study|Lost to Follow-up|2|||
47013835|NCT02105948|83263019|FG003|Overall Study|Lost to Follow-up|1|||
47013836|NCT02105948|83263016|FG000|Overall Study|Physician Decision|2|||
47013837|NCT02105948|83263017|FG001|Overall Study|Physician Decision|2|||
47013838|NCT02105948|83263018|FG002|Overall Study|Physician Decision|2|||
46709665|NCT01215188|82925768|FG001|Overall Study|Lost to Follow-up|22|||
46910562|NCT01578239|83140086|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
47013839|NCT02105948|83263019|FG003|Overall Study|Physician Decision|2|||
47013840|NCT02105948|83263016|FG000|Overall Study|Withdrawal by Subject|15|||
47013841|NCT02105948|83263017|FG001|Overall Study|Withdrawal by Subject|10|||
47013842|NCT02105948|83263018|FG002|Overall Study|Withdrawal by Subject|10|||
47013843|NCT02105948|83263019|FG003|Overall Study|Withdrawal by Subject|11|||
47013844|NCT02128724|83263034|FG000|Overall Study|Death|1|||
46709666|NCT01215188|82925769|FG002|Overall Study|Lost to Follow-up|16|||
46709667|NCT01215188|82925767|FG000|Overall Study|Adverse Event|1|||
47013845|NCT02128724|83263035|FG001|Overall Study|Death|0|||
47013846|NCT02128724|83263036|FG002|Overall Study|Death|0|||
47013847|NCT02128724|83263037|FG003|Overall Study|Death|0|||
47013848|NCT02128724|83263034|FG000|Overall Study|Adverse Event|0|||
47013849|NCT02128724|83263035|FG001|Overall Study|Adverse Event|1|||
47013850|NCT02128724|83263036|FG002|Overall Study|Adverse Event|0|||
47013851|NCT02128724|83263037|FG003|Overall Study|Adverse Event|0|||
47013852|NCT02128724|83263034|FG000|Overall Study|Physician Decision|0|||
47013853|NCT02128724|83263035|FG001|Overall Study|Physician Decision|0|||
47013854|NCT02128724|83263036|FG002|Overall Study|Physician Decision|0|||
47013855|NCT02128724|83263037|FG003|Overall Study|Physician Decision|2|||
47013856|NCT02128724|83263034|FG000|Overall Study|Withdrawal by Subject|0|||
47013857|NCT02128724|83263035|FG001|Overall Study|Withdrawal by Subject|0|||
47013858|NCT02128724|83263036|FG002|Overall Study|Withdrawal by Subject|0|||
47013859|NCT02128724|83263037|FG003|Overall Study|Withdrawal by Subject|1|||
47013860|NCT02128490|83263051|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
47013861|NCT02128490|83263052|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
47013862|NCT02128490|83263053|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
47013863|NCT02128490|83263054|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
47013864|NCT02128490|83263055|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
47013865|NCT02128490|83263051|FG000|Overall Study|Major Protocol Deviation|1|||
47013866|NCT02128490|83263052|FG001|Overall Study|Major Protocol Deviation|2|||
47013867|NCT02128490|83263053|FG002|Overall Study|Major Protocol Deviation|0|||
47013868|NCT02128490|83263054|FG003|Overall Study|Major Protocol Deviation|2|||
47013869|NCT02128490|83263055|FG004|Overall Study|Major Protocol Deviation|2|||
47013870|NCT02128490|83263051|FG000|Overall Study|Lost to Follow-up|0|||
47013871|NCT02128490|83263052|FG001|Overall Study|Lost to Follow-up|0|||
47013872|NCT02128490|83263053|FG002|Overall Study|Lost to Follow-up|1|||
47013873|NCT02128490|83263054|FG003|Overall Study|Lost to Follow-up|1|||
47013874|NCT02128490|83263055|FG004|Overall Study|Lost to Follow-up|1|||
47013875|NCT02128490|83263051|FG000|Overall Study|Voluntary Withdrawal|3|||
47013876|NCT02128490|83263052|FG001|Overall Study|Voluntary Withdrawal|3|||
47013877|NCT02128490|83263053|FG002|Overall Study|Voluntary Withdrawal|1|||
47013878|NCT02128490|83263054|FG003|Overall Study|Voluntary Withdrawal|1|||
47013879|NCT02128490|83263055|FG004|Overall Study|Voluntary Withdrawal|2|||
47013880|NCT02128490|83263051|FG000|Overall Study|Lack of Efficacy|0|||
47013881|NCT02128490|83263052|FG001|Overall Study|Lack of Efficacy|1|||
47013882|NCT02128490|83263053|FG002|Overall Study|Lack of Efficacy|0|||
47013883|NCT02128490|83263054|FG003|Overall Study|Lack of Efficacy|0|||
47013884|NCT02128490|83263055|FG004|Overall Study|Lack of Efficacy|0|||
47013885|NCT02128490|83263051|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
47013886|NCT02128490|83263052|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
47013887|NCT02128490|83263053|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
47013888|NCT02128490|83263054|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
47013889|NCT02128490|83263055|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
47013890|NCT02128490|83263051|FG000|Overall Study|Other Miscellaneous Reasons|0|||
47013891|NCT02128490|83263052|FG001|Overall Study|Other Miscellaneous Reasons|0|||
47013892|NCT02128490|83263053|FG002|Overall Study|Other Miscellaneous Reasons|2|||
47013893|NCT02128490|83263054|FG003|Overall Study|Other Miscellaneous Reasons|1|||
47013894|NCT02128490|83263055|FG004|Overall Study|Other Miscellaneous Reasons|1|||
47013895|NCT02146352|83263067|FG000|Overall Study|Death|1|||
47013896|NCT02146352|83263067|FG000|Overall Study|Patient entered hospice care|1|||
47013897|NCT02146274|83263071|FG000|Overall Study|Protocol Violation|73|||
47013898|NCT02105636|83263080|FG000|Pre-Treatment|Disease Progression|1|||
47013899|NCT02105636|83263081|FG001|Pre-Treatment|Disease Progression|0|||
47013900|NCT02105636|83263080|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
47013901|NCT02105636|83263081|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
47013902|NCT02105636|83263080|FG000|Pre-Treatment|Participant withdrew consent|0|||
47013903|NCT02105636|83263081|FG001|Pre-Treatment|Participant withdrew consent|6|||
47013904|NCT02105636|83263080|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
47013905|NCT02105636|83263081|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
47013906|NCT02105636|83263080|FG000|Treatment|Study Drug Toxicity|14|||
47013907|NCT02105636|83263081|FG001|Treatment|Study Drug Toxicity|10|||
47013908|NCT02105636|83263080|FG000|Treatment|Adverse event unrelated to study drug|19|||
47013909|NCT02105636|83263081|FG001|Treatment|Adverse event unrelated to study drug|3|||
47013910|NCT02105636|83263080|FG000|Treatment|Participant request to discontinue study treatment|8|||
47013911|NCT02105636|83263081|FG001|Treatment|Participant request to discontinue study treatment|6|||
47013912|NCT02105636|83263080|FG000|Treatment|Participant withdrew consent|5|||
47013913|NCT02105636|83263081|FG001|Treatment|Participant withdrew consent|1|||
47013914|NCT02105636|83263080|FG000|Treatment|Lost to Follow-up|1|||
47013915|NCT02105636|83263081|FG001|Treatment|Lost to Follow-up|0|||
47013916|NCT02105636|83263080|FG000|Treatment|Maximum Clinical Benefit|1|||
47013917|NCT02105636|83263081|FG001|Treatment|Maximum Clinical Benefit|3|||
47013918|NCT02105636|83263080|FG000|Treatment|Poor/Non-compliance|0|||
47013919|NCT02105636|83263081|FG001|Treatment|Poor/Non-compliance|1|||
47013920|NCT02105636|83263080|FG000|Treatment|Participant no longer meets study criteria|1|||
47013921|NCT02105636|83263081|FG001|Treatment|Participant no longer meets study criteria|0|||
47013922|NCT02105636|83263080|FG000|Treatment|Other reasons|1|||
47013923|NCT02105636|83263081|FG001|Treatment|Other reasons|0|||
47013924|NCT02105636|83263080|FG000|Treatment|Disease Progression|185|||
47013925|NCT02105636|83263081|FG001|Treatment|Disease Progression|87|||
47013926|NCT01626872|83263090|FG000|Overall Study|Physician Decision|13|||
47013927|NCT01626872|83263091|FG001|Overall Study|Physician Decision|9|||
47013928|NCT01626872|83263092|FG002|Overall Study|Physician Decision|6|||
47013929|NCT01626872|83263090|FG000|Overall Study|Withdrawal by Subject|19|||
47013930|NCT01626872|83263091|FG001|Overall Study|Withdrawal by Subject|27|||
47013931|NCT01626872|83263092|FG002|Overall Study|Withdrawal by Subject|8|||
47013932|NCT01626872|83263090|FG000|Overall Study|Adverse Event (including Death)|20|||
47013933|NCT01626872|83263091|FG001|Overall Study|Adverse Event (including Death)|28|||
47013934|NCT01626872|83263092|FG002|Overall Study|Adverse Event (including Death)|8|||
47013935|NCT01626872|83263090|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
47013936|NCT01626872|83263091|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
47013937|NCT01626872|83263092|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
47013938|NCT01598090|83263103|FG000|Treatment Period|Poor/non-compliance|0|||
47013939|NCT01598090|83263104|FG001|Treatment Period|Poor/non-compliance|2|||
47013940|NCT01598090|83263105|FG002|Treatment Period|Poor/non-compliance|0|||
47013941|NCT01598090|83263103|FG000|Treatment Period|No longer meet study criteria|0|||
47013942|NCT01598090|83263104|FG001|Treatment Period|No longer meet study criteria|1|||
47013943|NCT01598090|83263105|FG002|Treatment Period|No longer meet study criteria|0|||
47013944|NCT01598090|83263103|FG000|Treatment Period|Lack of Efficacy|5|||
47013945|NCT01598090|83263104|FG001|Treatment Period|Lack of Efficacy|14|||
47013946|NCT01598090|83263105|FG002|Treatment Period|Lack of Efficacy|6|||
47013947|NCT01598090|83263103|FG000|Treatment Period|Adverse Event|2|||
47013948|NCT01598090|83263104|FG001|Treatment Period|Adverse Event|33|||
47013949|NCT01598090|83263105|FG002|Treatment Period|Adverse Event|17|||
47013950|NCT01598090|83263103|FG000|Treatment Period|Other reasons|0|||
47013951|NCT01598090|83263104|FG001|Treatment Period|Other reasons|4|||
47013952|NCT01598090|83263105|FG002|Treatment Period|Other reasons|1|||
47013953|NCT01598090|83263103|FG000|Treatment Period|Withdrawal by Subject|3|||
47013954|NCT01598090|83263104|FG001|Treatment Period|Withdrawal by Subject|13|||
47013955|NCT01598090|83263105|FG002|Treatment Period|Withdrawal by Subject|10|||
47013956|NCT01598090|83263103|FG000|Treatment Period|Lost to Follow-up|1|||
47013957|NCT01598090|83263104|FG001|Treatment Period|Lost to Follow-up|5|||
47013958|NCT01598090|83263105|FG002|Treatment Period|Lost to Follow-up|1|||
47013959|NCT01598090|83263103|FG000|Follow-up Period|Death|0|||
47013960|NCT01598090|83263104|FG001|Follow-up Period|Death|1|||
47013961|NCT01598090|83263105|FG002|Follow-up Period|Death|0|||
47013962|NCT01598090|83263103|FG000|Follow-up Period|No longer required per protocol|1|||
47013963|NCT01598090|83263104|FG001|Follow-up Period|No longer required per protocol|3|||
47013964|NCT01598090|83263105|FG002|Follow-up Period|No longer required per protocol|2|||
47013965|NCT01598090|83263103|FG000|Follow-up Period|Not reported|0|||
47013966|NCT01598090|83263104|FG001|Follow-up Period|Not reported|10|||
47013967|NCT01598090|83263105|FG002|Follow-up Period|Not reported|4|||
47013968|NCT01598090|83263103|FG000|Follow-up Period|Withdrawal by Subject|0|||
47013969|NCT01598090|83263104|FG001|Follow-up Period|Withdrawal by Subject|3|||
47013970|NCT01598090|83263105|FG002|Follow-up Period|Withdrawal by Subject|2|||
47013971|NCT01598090|83263103|FG000|Follow-up Period|Other reasons|2|||
47013972|NCT01598090|83263104|FG001|Follow-up Period|Other reasons|8|||
47013973|NCT01598090|83263105|FG002|Follow-up Period|Other reasons|8|||
47013974|NCT01598090|83263103|FG000|Follow-up Period|Lost to Follow-up|2|||
47013975|NCT01598090|83263104|FG001|Follow-up Period|Lost to Follow-up|10|||
47013976|NCT01598090|83263105|FG002|Follow-up Period|Lost to Follow-up|12|||
47013977|NCT02105012|83263116|FG000|Overall Study|Withdrawal by Subject|11|||
47013978|NCT02105012|83263116|FG000|Overall Study|Protocol Specified Criteria|9|||
47013979|NCT02105012|83263116|FG000|Overall Study|Lost to Follow-up|4|||
47013980|NCT02105012|83263116|FG000|Overall Study|Protocol Violation|4|||
47013981|NCT02105012|83263116|FG000|Overall Study|Physician Decision|3|||
47013982|NCT02105012|83263116|FG000|Overall Study|Adverse Event|1|||
47013983|NCT02105012|83263116|FG000|Overall Study|Lack of Efficacy|1|||
47013984|NCT02145182|83263130|FG000|Overall Study|Adverse Event|4|||
47013985|NCT02145182|83263131|FG001|Overall Study|Adverse Event|1|||
47013986|NCT02145182|83263130|FG000|Overall Study|Death|7|||
47013987|NCT02145182|83263131|FG001|Overall Study|Death|7|||
47013988|NCT02145182|83263130|FG000|Overall Study|Lost to Follow-up|2|||
47013989|NCT02145182|83263131|FG001|Overall Study|Lost to Follow-up|2|||
47013990|NCT02145182|83263130|FG000|Overall Study|Pre-transplant Withdrawal|0|||
47013991|NCT02145182|83263131|FG001|Overall Study|Pre-transplant Withdrawal|2|||
47013992|NCT02145182|83263130|FG000|Overall Study|Withdrawal by Subject|5|||
47013993|NCT02145182|83263131|FG001|Overall Study|Withdrawal by Subject|4|||
47013994|NCT02145026|83263137|FG000|Overall Study|Adverse Event|2|||
47013995|NCT02145026|83263137|FG000|Overall Study|Death|4|||
47013996|NCT02145026|83263137|FG000|Overall Study|Withdrawal by Subject|2|||
47013997|NCT02145026|83263137|FG000|Overall Study|Physician Decision|4|||
47013998|NCT02144012|83263143|FG000|Overall Study|Adverse Event|1|||
47013999|NCT02144012|83263144|FG001|Overall Study|Adverse Event|0|||
47014000|NCT02144012|83263143|FG000|Overall Study|Death|1|||
47014001|NCT02144012|83263144|FG001|Overall Study|Death|0|||
47014002|NCT02144012|83263143|FG000|Overall Study|Withdrawal by Subject|11|||
47014003|NCT02144012|83263144|FG001|Overall Study|Withdrawal by Subject|3|||
47014004|NCT02144012|83263143|FG000|Overall Study|Study Terminated by Sponsor|18|||
47014005|NCT02144012|83263144|FG001|Overall Study|Study Terminated by Sponsor|12|||
47014006|NCT02144012|83263143|FG000|Overall Study|Other|3|||
47014007|NCT02144012|83263144|FG001|Overall Study|Other|0|||
47014008|NCT02103062|83263152|FG000|Overall Study|Adverse Event|1|||
47014009|NCT02103062|83263153|FG001|Overall Study|Adverse Event|2|||
47014010|NCT02103062|83263152|FG000|Overall Study|Progressive Disease|17|||
47014011|NCT02103062|83263153|FG001|Overall Study|Progressive Disease|20|||
47014012|NCT02103062|83263152|FG000|Overall Study|Death|0|||
47014013|NCT02103062|83263153|FG001|Overall Study|Death|1|||
47014014|NCT02141984|83263161|FG000|Overall Study|Lack of Efficacy|2|||
47014015|NCT02141672|83263168|FG000|Overall Study|Adverse Event|0|||
47014016|NCT02141672|83263169|FG001|Overall Study|Adverse Event|1|||
47014017|NCT02141672|83263170|FG002|Overall Study|Adverse Event|0|||
47014018|NCT02141672|83263168|FG000|Overall Study|Death|10|||
47014019|NCT02141672|83263169|FG001|Overall Study|Death|2|||
47014020|NCT02141672|83263170|FG002|Overall Study|Death|1|||
47014021|NCT02141672|83263168|FG000|Overall Study|Lack of Efficacy|0|||
47014022|NCT02141672|83263169|FG001|Overall Study|Lack of Efficacy|0|||
47014023|NCT02141672|83263170|FG002|Overall Study|Lack of Efficacy|2|||
47014024|NCT02141672|83263168|FG000|Overall Study|Lost to Follow-up|1|||
47014025|NCT02141672|83263169|FG001|Overall Study|Lost to Follow-up|1|||
47014026|NCT02141672|83263170|FG002|Overall Study|Lost to Follow-up|3|||
47014027|NCT02141672|83263168|FG000|Overall Study|Physician Decision|1|||
47014028|NCT02141672|83263169|FG001|Overall Study|Physician Decision|2|||
47014029|NCT02141672|83263170|FG002|Overall Study|Physician Decision|5|||
47014030|NCT02141672|83263168|FG000|Overall Study|Protocol Violation|0|||
47014031|NCT02141672|83263169|FG001|Overall Study|Protocol Violation|0|||
47014032|NCT02141672|83263170|FG002|Overall Study|Protocol Violation|1|||
47014033|NCT02141672|83263168|FG000|Overall Study|Withdrawal by Subject|3|||
47014034|NCT02141672|83263169|FG001|Overall Study|Withdrawal by Subject|2|||
47014035|NCT02141672|83263170|FG002|Overall Study|Withdrawal by Subject|5|||
47014036|NCT02141672|83263168|FG000|Overall Study|refused to follow-up|1|||
47014037|NCT02141672|83263169|FG001|Overall Study|refused to follow-up|0|||
47014038|NCT02141672|83263170|FG002|Overall Study|refused to follow-up|1|||
47014039|NCT02141516|83263181|FG000|Overall Study|Adverse Event|0|||
47014040|NCT02141516|83263182|FG001|Overall Study|Adverse Event|1|||
47014041|NCT02141516|83263183|FG002|Overall Study|Adverse Event|0|||
47014042|NCT02141516|83263181|FG000|Overall Study|Lost to Follow-up|0|||
47014043|NCT02141516|83263182|FG001|Overall Study|Lost to Follow-up|1|||
47014044|NCT02141516|83263183|FG002|Overall Study|Lost to Follow-up|0|||
47014045|NCT02141516|83263181|FG000|Overall Study|Other|0|||
47014046|NCT02141516|83263182|FG001|Overall Study|Other|3|||
47014047|NCT02141516|83263183|FG002|Overall Study|Other|0|||
47014048|NCT02141360|83263197|FG000|Overall Study|Withdrawal by Subject|6|||
47014049|NCT02141360|83263198|FG001|Overall Study|Withdrawal by Subject|0|||
47014050|NCT02141360|83263199|FG002|Overall Study|Withdrawal by Subject|0|||
47014051|NCT02141360|83263197|FG000|Overall Study|Study Terminated before Visit|1|||
47014052|NCT02141360|83263198|FG001|Overall Study|Study Terminated before Visit|0|||
47014053|NCT02141360|83263199|FG002|Overall Study|Study Terminated before Visit|0|||
47014054|NCT01628198|83263207|FG000|Overall Study|Lost to Follow-up|7|||
47014055|NCT01628198|83263207|FG000|Overall Study|Withdrawal by Subject|10|||
47014056|NCT01628198|83263207|FG000|Overall Study|Screen failure|1|||
47014057|NCT01628120|83263211|FG000|Overall Study|Withdrawal by Subject|7|||
47014058|NCT01628120|83263211|FG000|Overall Study|Adverse Event|12|||
47014059|NCT01628120|83263211|FG000|Overall Study|Lost to Follow-up|1|||
47014060|NCT01628120|83263211|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
47014061|NCT01628120|83263211|FG000|Overall Study|Non-compliant with Study Procedures|1|||
47014062|NCT01628120|83263211|FG000|Overall Study|Not Treated|3|||
47014063|NCT01628120|83263211|FG000|Overall Study|Sponsor Decision|5|||
47014064|NCT01628120|83263211|FG000|Overall Study|Switched Dialysis Method|2|||
47014065|NCT01628120|83263211|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
47014066|NCT01628120|83263211|FG000|Overall Study|Moved or Relocated|5|||
47014067|NCT01628120|83263211|FG000|Overall Study|Kidney Transplant|2|||
47014068|NCT01628120|83263211|FG000|Overall Study|Use of Standard of Care|1|||
47014069|NCT01627340|83263217|FG000|Overall Study|Adverse Event|1|||
47014070|NCT01627340|83263218|FG001|Overall Study|Adverse Event|0|||
47014071|NCT01627340|83263217|FG000|Overall Study|Lost to Follow-up|8|||
47014072|NCT01627340|83263218|FG001|Overall Study|Lost to Follow-up|4|||
47014073|NCT01627340|83263217|FG000|Overall Study|Pregnancy|1|||
47014074|NCT01627340|83263218|FG001|Overall Study|Pregnancy|0|||
47014075|NCT01627340|83263217|FG000|Overall Study|Withdrawal by Subject|2|||
47014076|NCT01627340|83263218|FG001|Overall Study|Withdrawal by Subject|0|||
47014077|NCT02125838|83263228|FG000|Overall Study|Lost to Follow-up|4|||
47014078|NCT02125838|83263229|FG001|Overall Study|Lost to Follow-up|4|||
47014079|NCT02125604|83263235|FG000|Overall Study|Other|4|||
47014080|NCT02125604|83263235|FG000|Overall Study|Investigator Decision|1|||
47014081|NCT02125604|83263235|FG000|Overall Study|Lost to Follow-up|2|||
47014082|NCT02125604|83263235|FG000|Overall Study|Consent Withdrawn|4|||
47014083|NCT02125604|83263235|FG000|Overall Study|Adverse Event|20|||
47014084|NCT02124746|83263242|FG000|Overall Study|Adverse Event|2|||
47014085|NCT02124746|83263243|FG001|Overall Study|Adverse Event|1|||
47014086|NCT02124746|83263244|FG002|Overall Study|Adverse Event|2|||
47014087|NCT02124746|83263242|FG000|Overall Study|Death|2|||
47014088|NCT02124746|83263243|FG001|Overall Study|Death|1|||
47014089|NCT02124746|83263244|FG002|Overall Study|Death|3|||
47014090|NCT02124746|83263242|FG000|Overall Study|Lack of Efficacy|3|||
47014091|NCT02124746|83263243|FG001|Overall Study|Lack of Efficacy|2|||
47014092|NCT02124746|83263244|FG002|Overall Study|Lack of Efficacy|2|||
47014093|NCT02124746|83263242|FG000|Overall Study|Physician Decision|6|||
47014094|NCT02124746|83263243|FG001|Overall Study|Physician Decision|4|||
47014095|NCT02124746|83263244|FG002|Overall Study|Physician Decision|5|||
47014096|NCT02124746|83263242|FG000|Overall Study|Non-Compliance with Study Drug|0|||
47014097|NCT02124746|83263243|FG001|Overall Study|Non-Compliance with Study Drug|1|||
47014098|NCT02124746|83263244|FG002|Overall Study|Non-Compliance with Study Drug|0|||
47014099|NCT02124746|83263242|FG000|Overall Study|Withdrawal by Subject|3|||
47014100|NCT02124746|83263243|FG001|Overall Study|Withdrawal by Subject|3|||
47014101|NCT02124746|83263244|FG002|Overall Study|Withdrawal by Subject|0|||
47014102|NCT02124746|83263242|FG000|Overall Study|Study Terminated by Sponsor|0|||
47014103|NCT02124746|83263243|FG001|Overall Study|Study Terminated by Sponsor|0|||
47014104|NCT02124746|83263244|FG002|Overall Study|Study Terminated by Sponsor|6|||
47014105|NCT02124746|83263242|FG000|Overall Study|Disease Progression|3|||
47014106|NCT02124746|83263243|FG001|Overall Study|Disease Progression|6|||
47014107|NCT02124746|83263244|FG002|Overall Study|Disease Progression|4|||
47014108|NCT02123966|83263252|FG000|Overall Study|Intercurrent Illness|1|||
47014109|NCT02123576|83263258|FG000|Overall Study|Adverse Event|1|||
47014110|NCT02123576|83263259|FG001|Overall Study|Adverse Event|0|||
47014111|NCT01177397|83263277|FG000|Overall Study|Protocol Violation|0|||
47014112|NCT01177397|83263278|FG001|Overall Study|Protocol Violation|0|||
47014113|NCT01177397|83263279|FG002|Overall Study|Protocol Violation|0|||
47014114|NCT01177397|83263280|FG003|Overall Study|Protocol Violation|0|||
47014115|NCT01177397|83263281|FG004|Overall Study|Protocol Violation|0|||
47014116|NCT01177397|83263282|FG005|Overall Study|Protocol Violation|1|||
47014117|NCT01177397|83263283|FG006|Overall Study|Protocol Violation|0|||
47014118|NCT01177397|83263284|FG007|Overall Study|Protocol Violation|0|||
47014119|NCT01177397|83263285|FG008|Overall Study|Protocol Violation|0|||
47014120|NCT01177397|83263286|FG009|Overall Study|Protocol Violation|0|||
47014121|NCT01177397|83263287|FG010|Overall Study|Protocol Violation|0|||
47014122|NCT01177397|83263288|FG011|Overall Study|Protocol Violation|0|||
47014123|NCT01177397|83263277|FG000|Overall Study|Lost to Follow-up|0|||
47014124|NCT01177397|83263278|FG001|Overall Study|Lost to Follow-up|0|||
47014125|NCT01177397|83263279|FG002|Overall Study|Lost to Follow-up|0|||
47014126|NCT01177397|83263280|FG003|Overall Study|Lost to Follow-up|0|||
47014127|NCT01177397|83263281|FG004|Overall Study|Lost to Follow-up|1|||
47014128|NCT01177397|83263282|FG005|Overall Study|Lost to Follow-up|0|||
47014129|NCT01177397|83263283|FG006|Overall Study|Lost to Follow-up|0|||
47014130|NCT01177397|83263284|FG007|Overall Study|Lost to Follow-up|2|||
47014131|NCT01177397|83263285|FG008|Overall Study|Lost to Follow-up|0|||
47014132|NCT01177397|83263286|FG009|Overall Study|Lost to Follow-up|0|||
47014133|NCT01177397|83263287|FG010|Overall Study|Lost to Follow-up|0|||
47014134|NCT01177397|83263288|FG011|Overall Study|Lost to Follow-up|0|||
47014135|NCT01177397|83263277|FG000|Overall Study|Death|0|||
47014136|NCT01177397|83263278|FG001|Overall Study|Death|0|||
47014137|NCT01177397|83263279|FG002|Overall Study|Death|1|||
47014138|NCT01177397|83263280|FG003|Overall Study|Death|1|||
47014139|NCT01177397|83263281|FG004|Overall Study|Death|0|||
47014140|NCT01177397|83263282|FG005|Overall Study|Death|0|||
47014141|NCT01177397|83263283|FG006|Overall Study|Death|0|||
47014142|NCT01177397|83263284|FG007|Overall Study|Death|5|||
47014143|NCT01177397|83263285|FG008|Overall Study|Death|2|||
47014144|NCT01177397|83263286|FG009|Overall Study|Death|1|||
47014145|NCT01177397|83263287|FG010|Overall Study|Death|0|||
47014146|NCT01177397|83263288|FG011|Overall Study|Death|0|||
47014147|NCT01177397|83263277|FG000|Overall Study|Withdrawal by Subject|0|||
47014148|NCT01177397|83263278|FG001|Overall Study|Withdrawal by Subject|0|||
47014149|NCT01177397|83263279|FG002|Overall Study|Withdrawal by Subject|1|||
47014150|NCT01177397|83263280|FG003|Overall Study|Withdrawal by Subject|1|||
47014151|NCT01177397|83263281|FG004|Overall Study|Withdrawal by Subject|1|||
47014152|NCT01177397|83263282|FG005|Overall Study|Withdrawal by Subject|2|||
47014153|NCT01177397|83263283|FG006|Overall Study|Withdrawal by Subject|0|||
47014154|NCT01177397|83263284|FG007|Overall Study|Withdrawal by Subject|5|||
47014155|NCT01177397|83263285|FG008|Overall Study|Withdrawal by Subject|9|||
47014156|NCT01177397|83263286|FG009|Overall Study|Withdrawal by Subject|1|||
47014157|NCT01177397|83263287|FG010|Overall Study|Withdrawal by Subject|1|||
47014158|NCT01177397|83263288|FG011|Overall Study|Withdrawal by Subject|0|||
47014159|NCT01177397|83263277|FG000|Overall Study|Adverse Event|0|||
47014160|NCT01177397|83263278|FG001|Overall Study|Adverse Event|0|||
47014161|NCT01177397|83263279|FG002|Overall Study|Adverse Event|1|||
47014162|NCT01177397|83263280|FG003|Overall Study|Adverse Event|2|||
47014163|NCT01177397|83263281|FG004|Overall Study|Adverse Event|0|||
47014164|NCT01177397|83263282|FG005|Overall Study|Adverse Event|12|||
47014165|NCT01177397|83263283|FG006|Overall Study|Adverse Event|1|||
47014166|NCT01177397|83263284|FG007|Overall Study|Adverse Event|14|||
47014167|NCT01177397|83263285|FG008|Overall Study|Adverse Event|8|||
47014168|NCT01177397|83263286|FG009|Overall Study|Adverse Event|6|||
47014169|NCT01177397|83263287|FG010|Overall Study|Adverse Event|3|||
47014170|NCT01177397|83263288|FG011|Overall Study|Adverse Event|7|||
47014171|NCT01177397|83263277|FG000|Overall Study|Disease progression|1|||
47014172|NCT01177397|83263278|FG001|Overall Study|Disease progression|2|||
47014173|NCT01177397|83263279|FG002|Overall Study|Disease progression|5|||
47014174|NCT01177397|83263280|FG003|Overall Study|Disease progression|5|||
47014175|NCT01177397|83263281|FG004|Overall Study|Disease progression|4|||
47014176|NCT01177397|83263282|FG005|Overall Study|Disease progression|10|||
47014177|NCT01177397|83263283|FG006|Overall Study|Disease progression|10|||
47014178|NCT01177397|83263284|FG007|Overall Study|Disease progression|21|||
47014179|NCT01177397|83263285|FG008|Overall Study|Disease progression|18|||
47014180|NCT01177397|83263286|FG009|Overall Study|Disease progression|12|||
47014181|NCT01177397|83263287|FG010|Overall Study|Disease progression|10|||
47014182|NCT01177397|83263288|FG011|Overall Study|Disease progression|8|||
47014183|NCT01177397|83263277|FG000|Overall Study|Other reasons|0|||
47014184|NCT01177397|83263278|FG001|Overall Study|Other reasons|0|||
47014185|NCT01177397|83263279|FG002|Overall Study|Other reasons|1|||
47014186|NCT01177397|83263280|FG003|Overall Study|Other reasons|0|||
47014187|NCT01177397|83263281|FG004|Overall Study|Other reasons|1|||
47014188|NCT01177397|83263282|FG005|Overall Study|Other reasons|1|||
47014189|NCT01177397|83263283|FG006|Overall Study|Other reasons|2|||
47014190|NCT01177397|83263284|FG007|Overall Study|Other reasons|6|||
47014191|NCT01177397|83263285|FG008|Overall Study|Other reasons|10|||
47014192|NCT01177397|83263286|FG009|Overall Study|Other reasons|8|||
47014193|NCT01177397|83263287|FG010|Overall Study|Other reasons|0|||
47014194|NCT01177397|83263288|FG011|Overall Study|Other reasons|2|||
47014195|NCT00864227|83263329|FG000|Overall Study|Withdrawal by Subject|1|||
47014196|NCT00864227|83263329|FG000|Overall Study|Disease Relapse/Progression|3|||
47014197|NCT02102204|83263333|FG000|Overall Study|Withdrawal by Subject|137|||
47014198|NCT02102204|83263333|FG000|Overall Study|Death|92|||
47014199|NCT02102204|83263333|FG000|Overall Study|Lost to Follow-up|65|||
47014200|NCT02102204|83263333|FG000|Overall Study|Sponsor Decision|5|||
47014201|NCT02102204|83263333|FG000|Overall Study|Ongoing|5|||
47014202|NCT02141204|83263339|FG000|Overall Study|Lost to Follow-up|2|||
47014203|NCT02141204|83263340|FG001|Overall Study|Lost to Follow-up|1|||
47014204|NCT02141204|83263339|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
47014205|NCT02141204|83263340|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
47014206|NCT02141204|83263339|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
47014207|NCT02141204|83263340|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
47014208|NCT02141204|83263339|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
47014209|NCT02141204|83263340|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
47014210|NCT02140970|83263348|FG000|Overall Study|Lost to Follow-up|1|||
47014211|NCT02140970|83263349|FG001|Overall Study|Lost to Follow-up|2|||
47014212|NCT02140970|83263348|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
47014213|NCT02140970|83263349|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
47014214|NCT02140970|83263348|FG000|Overall Study|Did not meet inclusion criteria|0|||
47014215|NCT02140970|83263349|FG001|Overall Study|Did not meet inclusion criteria|1|||
47014216|NCT02101112|83263355|FG000|Overall Study|Adverse Event|0|||
47014217|NCT02101112|83263356|FG001|Overall Study|Adverse Event|0|||
47014218|NCT02101112|83263357|FG002|Overall Study|Adverse Event|1|||
47014219|NCT02101112|83263358|FG003|Overall Study|Adverse Event|0|||
47014220|NCT02101112|83263359|FG004|Overall Study|Adverse Event|0|||
47014221|NCT02101112|83263360|FG005|Overall Study|Adverse Event|0|||
47014222|NCT02101112|83263355|FG000|Overall Study|Withdrawal by Subject|0|||
47014223|NCT02101112|83263356|FG001|Overall Study|Withdrawal by Subject|0|||
47014224|NCT02101112|83263357|FG002|Overall Study|Withdrawal by Subject|0|||
47014225|NCT02101112|83263358|FG003|Overall Study|Withdrawal by Subject|0|||
47014226|NCT02101112|83263359|FG004|Overall Study|Withdrawal by Subject|1|||
47014227|NCT02101112|83263360|FG005|Overall Study|Withdrawal by Subject|0|||
47014228|NCT02139644|83263375|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
47014229|NCT02139644|83263376|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
47014230|NCT02139644|83263377|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
47014231|NCT02139644|83263378|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
47014232|NCT02139644|83263379|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
47014233|NCT02139644|83263380|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
47014234|NCT02139644|83263375|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
47014235|NCT02139644|83263376|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
47014236|NCT02139644|83263377|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
47014237|NCT02139644|83263378|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
47014238|NCT02139644|83263379|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
47014239|NCT02139644|83263380|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
47014240|NCT02139644|83263375|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
47014241|NCT02139644|83263376|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
47014242|NCT02139644|83263377|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
47014243|NCT02139644|83263378|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
47014244|NCT02139644|83263379|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
47014245|NCT02139644|83263380|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
47014246|NCT02139644|83263375|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
47014247|NCT02139644|83263376|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
47014248|NCT02139644|83263377|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
47014249|NCT02139644|83263378|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
47014250|NCT02139644|83263379|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
47014251|NCT02139644|83263380|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
47014252|NCT02139644|83263375|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
47014253|NCT02139644|83263376|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
47014254|NCT02139644|83263377|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
47014255|NCT02139644|83263378|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
47014256|NCT02139644|83263379|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
47014257|NCT02139644|83263380|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
47014258|NCT02139644|83263375|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
47014259|NCT02139644|83263376|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
47014260|NCT02139644|83263377|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
47014261|NCT02139644|83263378|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
47014262|NCT02139644|83263379|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
47014263|NCT02139644|83263380|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
47014264|NCT02139644|83263375|FG000|Run-In Period (Pre-assignment)|Other|6|||
47014265|NCT02139644|83263376|FG001|Run-In Period (Pre-assignment)|Other|0|||
47014266|NCT02139644|83263377|FG002|Run-In Period (Pre-assignment)|Other|0|||
47014267|NCT02139644|83263378|FG003|Run-In Period (Pre-assignment)|Other|0|||
47014268|NCT02139644|83263379|FG004|Run-In Period (Pre-assignment)|Other|0|||
47014269|NCT02139644|83263380|FG005|Run-In Period (Pre-assignment)|Other|0|||
47014270|NCT02139644|83263375|FG000|Treatment Period|Adverse Event|0|||
47014271|NCT02139644|83263376|FG001|Treatment Period|Adverse Event|0|||
47014272|NCT02139644|83263377|FG002|Treatment Period|Adverse Event|3|||
47014273|NCT02139644|83263378|FG003|Treatment Period|Adverse Event|2|||
47014274|NCT02139644|83263379|FG004|Treatment Period|Adverse Event|1|||
47014275|NCT02139644|83263380|FG005|Treatment Period|Adverse Event|6|||
47014276|NCT02139644|83263375|FG000|Treatment Period|Withdrawal by Subject|0|||
47014277|NCT02139644|83263376|FG001|Treatment Period|Withdrawal by Subject|0|||
47014278|NCT02139644|83263377|FG002|Treatment Period|Withdrawal by Subject|2|||
47014279|NCT02139644|83263378|FG003|Treatment Period|Withdrawal by Subject|2|||
47014280|NCT02139644|83263379|FG004|Treatment Period|Withdrawal by Subject|3|||
47014281|NCT02139644|83263380|FG005|Treatment Period|Withdrawal by Subject|2|||
47014282|NCT02139644|83263375|FG000|Treatment Period|Non-compliance|0|||
47014283|NCT02139644|83263376|FG001|Treatment Period|Non-compliance|0|||
47014284|NCT02139644|83263377|FG002|Treatment Period|Non-compliance|0|||
47014285|NCT02139644|83263378|FG003|Treatment Period|Non-compliance|1|||
47014286|NCT02139644|83263379|FG004|Treatment Period|Non-compliance|0|||
47014287|NCT02139644|83263380|FG005|Treatment Period|Non-compliance|0|||
47014288|NCT02139644|83263375|FG000|Treatment Period|Protocol Violation|0|||
47014289|NCT02139644|83263376|FG001|Treatment Period|Protocol Violation|0|||
47014290|NCT02139644|83263377|FG002|Treatment Period|Protocol Violation|0|||
47014291|NCT02139644|83263378|FG003|Treatment Period|Protocol Violation|1|||
47014292|NCT02139644|83263379|FG004|Treatment Period|Protocol Violation|1|||
47014293|NCT02139644|83263380|FG005|Treatment Period|Protocol Violation|1|||
47014294|NCT02139644|83263375|FG000|Treatment Period|Disease progression|0|||
47014295|NCT02139644|83263376|FG001|Treatment Period|Disease progression|0|||
47014296|NCT02139644|83263377|FG002|Treatment Period|Disease progression|0|||
47014297|NCT02139644|83263378|FG003|Treatment Period|Disease progression|1|||
47014298|NCT02139644|83263379|FG004|Treatment Period|Disease progression|1|||
47014299|NCT02139644|83263380|FG005|Treatment Period|Disease progression|2|||
47014300|NCT02139644|83263375|FG000|Treatment Period|Lost to Follow-up|0|||
47014301|NCT02139644|83263376|FG001|Treatment Period|Lost to Follow-up|0|||
47014302|NCT02139644|83263377|FG002|Treatment Period|Lost to Follow-up|1|||
47014303|NCT02139644|83263378|FG003|Treatment Period|Lost to Follow-up|1|||
47014304|NCT02139644|83263379|FG004|Treatment Period|Lost to Follow-up|1|||
47014305|NCT02139644|83263380|FG005|Treatment Period|Lost to Follow-up|1|||
47014306|NCT02139644|83263375|FG000|Treatment Period|Lack of Efficacy|0|||
47014307|NCT02139644|83263376|FG001|Treatment Period|Lack of Efficacy|0|||
47014308|NCT02139644|83263377|FG002|Treatment Period|Lack of Efficacy|1|||
47014309|NCT02139644|83263378|FG003|Treatment Period|Lack of Efficacy|0|||
47014310|NCT02139644|83263379|FG004|Treatment Period|Lack of Efficacy|1|||
47014311|NCT02139644|83263380|FG005|Treatment Period|Lack of Efficacy|4|||
47014312|NCT02139644|83263375|FG000|Treatment Period|Other|0|||
47014313|NCT02139644|83263376|FG001|Treatment Period|Other|3|||
47014314|NCT02139644|83263377|FG002|Treatment Period|Other|1|||
47014315|NCT02139644|83263378|FG003|Treatment Period|Other|1|||
47014316|NCT02139644|83263379|FG004|Treatment Period|Other|0|||
47014317|NCT02139644|83263380|FG005|Treatment Period|Other|1|||
47014318|NCT02100644|83263392|FG000|LTG Escalation Phase|Adverse Event|9|||
47014319|NCT02100644|83263393|FG001|LTG Escalation Phase|Adverse Event|0|||
47014320|NCT02100644|83263394|FG002|LTG Escalation Phase|Adverse Event|0|||
47014321|NCT02100644|83263392|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
47014322|NCT02100644|83263393|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
47014323|NCT02100644|83263394|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
47014324|NCT02100644|83263392|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
47014325|NCT02100644|83263393|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
47014326|NCT02100644|83263394|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
47014327|NCT02074982|83263400|FG000|Overall Study|Adverse Event|15|||
47014328|NCT02074982|83263401|FG001|Overall Study|Adverse Event|7|||
47014329|NCT02074982|83263400|FG000|Overall Study|Lack of Efficacy|6|||
47014330|NCT02074982|83263401|FG001|Overall Study|Lack of Efficacy|1|||
47014331|NCT02074982|83263400|FG000|Overall Study|Lost to Follow-up|9|||
47014332|NCT02074982|83263401|FG001|Overall Study|Lost to Follow-up|10|||
47014333|NCT02074982|83263400|FG000|Overall Study|Non-compliance with study treatment|0|||
47014334|NCT02074982|83263401|FG001|Overall Study|Non-compliance with study treatment|2|||
47014335|NCT02074982|83263400|FG000|Overall Study|Physician Decision|1|||
47014336|NCT02074982|83263401|FG001|Overall Study|Physician Decision|1|||
47014337|NCT02074982|83263400|FG000|Overall Study|Pregnancy|1|||
47014338|NCT02074982|83263401|FG001|Overall Study|Pregnancy|2|||
47014339|NCT02074982|83263400|FG000|Overall Study|Protocol deviation|4|||
47014340|NCT02074982|83263401|FG001|Overall Study|Protocol deviation|3|||
47014341|NCT02074982|83263400|FG000|Overall Study|Technical problems|0|||
47014342|NCT02074982|83263401|FG001|Overall Study|Technical problems|2|||
47014343|NCT02074982|83263400|FG000|Overall Study|Subject/guardian decision|15|||
47014344|NCT02074982|83263401|FG001|Overall Study|Subject/guardian decision|24|||
47014345|NCT02074982|83263400|FG000|Overall Study|Death|0|||
47014346|NCT02074982|83263401|FG001|Overall Study|Death|2|||
47014347|NCT02074514|83263411|FG000|Overall Study|Lack of Efficacy|3|||
47014348|NCT02074514|83263412|FG001|Overall Study|Lack of Efficacy|2|||
47014349|NCT02074514|83263411|FG000|Overall Study|Lost to Follow-up|0|||
47014350|NCT02074514|83263412|FG001|Overall Study|Lost to Follow-up|1|||
47014351|NCT02074514|83263411|FG000|Overall Study|Withdrew Consent|0|||
47014352|NCT02074514|83263412|FG001|Overall Study|Withdrew Consent|1|||
47014353|NCT02099708|83263422|FG000|Overall Study|Data Not Available|30|||
47014354|NCT02099708|83263422|FG000|Overall Study|Lost to Follow-up|141|||
47014355|NCT02099708|83263422|FG000|Overall Study|Other|29|||
47014356|NCT02073656|83263426|FG000|Primary Study|Lost to Follow-up|6|||
47014357|NCT02073656|83263426|FG000|Primary Study|Death|1|||
47014358|NCT02073656|83263426|FG000|Primary Study|Withdrew Consent|1|||
47014359|NCT02242643|83263434|FG000|Overall Study|Protocol Violation|1|||
47014360|NCT02242643|83263435|FG001|Overall Study|Protocol Violation|2|||
47014361|NCT02242643|83263434|FG000|Overall Study|Withdrawal by Subject|15|||
47014362|NCT02242643|83263435|FG001|Overall Study|Withdrawal by Subject|10|||
47014363|NCT02242643|83263434|FG000|Overall Study|Migrated/moved from study area|1|||
47014364|NCT02242643|83263435|FG001|Overall Study|Migrated/moved from study area|3|||
47014365|NCT02242643|83263434|FG000|Overall Study|Lost to Follow-up|54|||
47014366|NCT02242643|83263435|FG001|Overall Study|Lost to Follow-up|61|||
47014367|NCT02242643|83263434|FG000|Overall Study|Child placed in foster care by family|0|||
47014368|NCT02242643|83263435|FG001|Overall Study|Child placed in foster care by family|1|||
47014369|NCT02242643|83263434|FG000|Overall Study|Non-compliance|1|||
47014370|NCT02242643|83263435|FG001|Overall Study|Non-compliance|0|||
47014371|NCT02242643|83263434|FG000|Overall Study|Consent withdrawal by parent|1|||
47014372|NCT02242643|83263435|FG001|Overall Study|Consent withdrawal by parent|0|||
47014373|NCT02242643|83263434|FG000|Overall Study|Protocol requirements not followed|1|||
47014374|NCT02242643|83263435|FG001|Overall Study|Protocol requirements not followed|0|||
47014375|NCT02242643|83263434|FG000|Overall Study|Language barrier|1|||
47014376|NCT02242643|83263435|FG001|Overall Study|Language barrier|0|||
47014377|NCT02242643|83263434|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
47014378|NCT02242643|83263435|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
47014379|NCT02097290|83263443|FG000|Overall Study|Death|6|||
47014380|NCT02097290|83263443|FG000|Overall Study|Total Withdrawals|3|||
47014381|NCT02097290|83263443|FG000|Overall Study|Attempt|8|||
47014382|NCT02072174|83263449|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
47014383|NCT02072174|83263450|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
47014384|NCT02072174|83263449|FG000|Overall Study|Protocol Violation|16|||
47014385|NCT02072174|83263450|FG001|Overall Study|Protocol Violation|23|||
47014386|NCT02072174|83263449|FG000|Overall Study|Physician Decision|0|||
47014387|NCT02072174|83263450|FG001|Overall Study|Physician Decision|1|||
47014388|NCT02072174|83263449|FG000|Overall Study|Non-compliance with protocol requirement|2|||
47014389|NCT02072174|83263450|FG001|Overall Study|Non-compliance with protocol requirement|0|||
47014390|NCT02209181|83263462|FG000|Overall Study|Adverse Event|1|||
47014391|NCT02209181|83263463|FG001|Overall Study|Adverse Event|0|||
47014392|NCT02209181|83263464|FG002|Overall Study|Adverse Event|1|||
47014393|NCT02209181|83263465|FG003|Overall Study|Adverse Event|0|||
47014394|NCT02209181|83263462|FG000|Overall Study|Withdrawal by Subject|0|||
47014395|NCT02209181|83263463|FG001|Overall Study|Withdrawal by Subject|1|||
47014396|NCT02209181|83263464|FG002|Overall Study|Withdrawal by Subject|0|||
47014397|NCT02209181|83263465|FG003|Overall Study|Withdrawal by Subject|0|||
47014398|NCT02208089|83263477|FG000|Overall Study|Withdrawal by Subject|1|||
47014399|NCT02208089|83263478|FG001|Overall Study|Withdrawal by Subject|0|||
47014400|NCT02208089|83263477|FG000|Overall Study|Lost to Follow-up|6|||
47014401|NCT02208089|83263478|FG001|Overall Study|Lost to Follow-up|0|||
47014402|NCT02242487|83263487|FG000|Overall Study|Adverse Event|13|||
47014403|NCT02242487|83263488|FG001|Overall Study|Adverse Event|15|||
47014404|NCT02242487|83263487|FG000|Overall Study|Lack of Efficacy|4|||
47014405|NCT02242487|83263488|FG001|Overall Study|Lack of Efficacy|6|||
47014406|NCT02242487|83263487|FG000|Overall Study|Protocol Violation|2|||
47014407|NCT02242487|83263488|FG001|Overall Study|Protocol Violation|0|||
47014408|NCT02242487|83263487|FG000|Overall Study|Lost to Follow-up|2|||
47014409|NCT02242487|83263488|FG001|Overall Study|Lost to Follow-up|1|||
47014410|NCT02242487|83263487|FG000|Overall Study|Other - Miscellaneous|4|||
47014411|NCT02242487|83263488|FG001|Overall Study|Other - Miscellaneous|6|||
47014412|NCT02242487|83263487|FG000|Overall Study|Withdrawal by Subject|37|||
47014413|NCT02242487|83263488|FG001|Overall Study|Withdrawal by Subject|19|||
47014414|NCT02241785|83263496|FG000|Overall Study|Sponsor Termination|43|||
47014415|NCT02241785|83263496|FG000|Overall Study|Withdrawal by Subject|1|||
47014416|NCT02241785|83263496|FG000|Overall Study|Lost to Follow-up|2|||
47014417|NCT02241785|83263496|FG000|Overall Study|Adverse Event|1|||
47014418|NCT02241551|83263502|FG000|Overall Study|Adverse Event|1|||
47014419|NCT02241551|83263503|FG001|Overall Study|Adverse Event|0|||
47014420|NCT02207621|83263514|FG000|Overall Study|Adverse Event|71|||
47014421|NCT02207621|83263515|FG001|Overall Study|Adverse Event|15|||
47014422|NCT02207621|83263516|FG002|Overall Study|Adverse Event|132|||
47014423|NCT02207621|83263514|FG000|Overall Study|Withdrawal by Subject|9|||
47014424|NCT02207621|83263515|FG001|Overall Study|Withdrawal by Subject|9|||
47014425|NCT02207621|83263516|FG002|Overall Study|Withdrawal by Subject|13|||
47014426|NCT02207621|83263514|FG000|Overall Study|Non-Compliant|3|||
47014427|NCT02207621|83263515|FG001|Overall Study|Non-Compliant|3|||
47014428|NCT02207621|83263516|FG002|Overall Study|Non-Compliant|1|||
47014429|NCT02207621|83263514|FG000|Overall Study|Lost to Follow-up|1|||
47014430|NCT02207621|83263515|FG001|Overall Study|Lost to Follow-up|0|||
47014431|NCT02207621|83263516|FG002|Overall Study|Lost to Follow-up|3|||
47014432|NCT02207621|83263514|FG000|Overall Study|Lack of Efficacy|10|||
47014433|NCT02207621|83263515|FG001|Overall Study|Lack of Efficacy|2|||
47014434|NCT02207621|83263516|FG002|Overall Study|Lack of Efficacy|4|||
47014435|NCT02207621|83263514|FG000|Overall Study|Disallowed Concurrent Medication|2|||
47014436|NCT02207621|83263515|FG001|Overall Study|Disallowed Concurrent Medication|5|||
47014437|NCT02207621|83263516|FG002|Overall Study|Disallowed Concurrent Medication|2|||
47014438|NCT02207621|83263514|FG000|Overall Study|Physician Decision|1|||
47014439|NCT02207621|83263515|FG001|Overall Study|Physician Decision|2|||
47014440|NCT02207621|83263516|FG002|Overall Study|Physician Decision|2|||
47014441|NCT02207621|83263514|FG000|Overall Study|Protocol Violation|4|||
47014442|NCT02207621|83263515|FG001|Overall Study|Protocol Violation|10|||
47014443|NCT02207621|83263516|FG002|Overall Study|Protocol Violation|6|||
47014444|NCT02207621|83263514|FG000|Overall Study|Death|2|||
47014445|NCT02207621|83263515|FG001|Overall Study|Death|0|||
47014446|NCT02207621|83263516|FG002|Overall Study|Death|0|||
47014447|NCT02207621|83263514|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
47014448|NCT02207621|83263515|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
47014449|NCT02207621|83263516|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
47014450|NCT02240693|83263530|FG000|Overall Study|Adverse Event|0|||
47014451|NCT02240693|83263531|FG001|Overall Study|Adverse Event|0|||
47014452|NCT02240693|83263532|FG002|Overall Study|Adverse Event|0|||
47014453|NCT02240693|83263533|FG003|Overall Study|Adverse Event|0|||
47014454|NCT02240693|83263534|FG004|Overall Study|Adverse Event|1|||
47014455|NCT02240693|83263530|FG000|Overall Study|Withdrawal by Subject|0|||
47014456|NCT02240693|83263531|FG001|Overall Study|Withdrawal by Subject|0|||
47014457|NCT02240693|83263532|FG002|Overall Study|Withdrawal by Subject|2|||
47014458|NCT02240693|83263533|FG003|Overall Study|Withdrawal by Subject|1|||
47014459|NCT02240693|83263534|FG004|Overall Study|Withdrawal by Subject|0|||
47014460|NCT02240693|83263530|FG000|Overall Study|Other than specified|0|||
47014461|NCT02240693|83263531|FG001|Overall Study|Other than specified|0|||
47014462|NCT02240693|83263532|FG002|Overall Study|Other than specified|2|||
47014463|NCT02240693|83263533|FG003|Overall Study|Other than specified|0|||
47014464|NCT02240693|83263534|FG004|Overall Study|Other than specified|0|||
47014465|NCT02239679|83263551|FG000|Overall Study|Lost to Follow-up|1|||
47014466|NCT02239679|83263552|FG001|Overall Study|Lost to Follow-up|0|||
47014467|NCT02239679|83263553|FG002|Overall Study|Lost to Follow-up|0|||
47014468|NCT02239679|83263551|FG000|Overall Study|Withdrawal by Subject|2|||
47014469|NCT02239679|83263552|FG001|Overall Study|Withdrawal by Subject|3|||
47014470|NCT02239679|83263553|FG002|Overall Study|Withdrawal by Subject|1|||
47014471|NCT02072096|83263563|FG000|Overall Study|Lack of Efficacy|18|||
47014472|NCT02072096|83263564|FG001|Overall Study|Lack of Efficacy|29|||
47014473|NCT02072096|83263563|FG000|Overall Study|Protocol Violation|7|||
47014474|NCT02072096|83263564|FG001|Overall Study|Protocol Violation|7|||
47014475|NCT02072096|83263563|FG000|Overall Study|Withdrawal by Subject|5|||
47014476|NCT02072096|83263564|FG001|Overall Study|Withdrawal by Subject|7|||
47014477|NCT02072096|83263563|FG000|Overall Study|Adverse Event|5|||
47014478|NCT02072096|83263564|FG001|Overall Study|Adverse Event|2|||
47014479|NCT02072096|83263563|FG000|Overall Study|No Reason Provided|4|||
47014480|NCT02072096|83263564|FG001|Overall Study|No Reason Provided|2|||
47014481|NCT02072096|83263563|FG000|Overall Study|Death|2|||
47014482|NCT02072096|83263564|FG001|Overall Study|Death|0|||
47014483|NCT02072096|83263563|FG000|Overall Study|Physician Decision|0|||
47014484|NCT02072096|83263564|FG001|Overall Study|Physician Decision|1|||
47014485|NCT02072096|83263563|FG000|Overall Study|Study Terminated by Sponsor|43|||
47014486|NCT02072096|83263564|FG001|Overall Study|Study Terminated by Sponsor|30|||
47014487|NCT02072096|83263563|FG000|Overall Study|Lost to Follow-up|1|||
47014488|NCT02072096|83263564|FG001|Overall Study|Lost to Follow-up|0|||
47014489|NCT02071706|83263571|FG000|Overall Study|Adverse Event|1|||
47014490|NCT02071706|83263571|FG000|Overall Study|Withdrawal by Subject|2|||
47014491|NCT01631825|83263575|FG000|Overall Study|Adverse Event|42|||
47014492|NCT01631825|83263575|FG000|Overall Study|Lack of Efficacy|7|||
47014493|NCT01631825|83263575|FG000|Overall Study|Withdrawal by Subject|9|||
47014494|NCT01631825|83263575|FG000|Overall Study|Protocol Violation|4|||
47014495|NCT01631825|83263575|FG000|Overall Study|Discontinuation criteria|1|||
47014496|NCT01631825|83263575|FG000|Overall Study|Physician Decision|2|||
47014497|NCT02071082|83263581|FG000|Overall Study|Enrolled and Never Treated|1|||
47014498|NCT02071082|83263582|FG001|Overall Study|Enrolled and Never Treated|1|||
47014499|NCT02071082|83263581|FG000|Overall Study|Adverse Event|0|||
47014500|NCT02071082|83263582|FG001|Overall Study|Adverse Event|1|||
47014501|NCT02071082|83263581|FG000|Overall Study|Withdrew Consent|0|||
47014502|NCT02071082|83263582|FG001|Overall Study|Withdrew Consent|4|||
47014503|NCT02071082|83263581|FG000|Overall Study|Lost to Follow-up|1|||
47014504|NCT02071082|83263582|FG001|Overall Study|Lost to Follow-up|1|||
47014505|NCT02123108|83263590|FG000|Overall Study|Death|2|||
47014506|NCT02123108|83263591|FG001|Overall Study|Death|3|||
47014507|NCT02121392|83263599|FG000|Prior to Intervention|Protocol Violation|40|||
47014508|NCT02121392|83263600|FG001|Prior to Intervention|Protocol Violation|35|||
47014509|NCT02121392|83263599|FG000|Prior to Intervention|Withdrawal by Subject|8|||
47014510|NCT02121392|83263600|FG001|Prior to Intervention|Withdrawal by Subject|6|||
47014511|NCT02121392|83263599|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
47014512|NCT02121392|83263600|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
47014513|NCT02121392|83263599|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
47014514|NCT02121392|83263600|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
47014515|NCT02097056|83263606|FG000|Overall Study|Protocol Violation|2|||
47014516|NCT02097056|83263606|FG000|Overall Study|Withdrawal by Subject|15|||
47014517|NCT02097056|83263606|FG000|Overall Study|Lost to Follow-up|2|||
47014518|NCT02097056|83263606|FG000|Overall Study|Adverse Event|37|||
47014519|NCT02097056|83263606|FG000|Overall Study|Other|2|||
47014520|NCT02121002|83263613|FG000|Overall Study|Physician Decision|2|||
47014521|NCT02121002|83263614|FG001|Overall Study|Physician Decision|0|||
47014522|NCT02121002|83263615|FG002|Overall Study|Physician Decision|0|||
47014523|NCT02121002|83263613|FG000|Overall Study|Withdrawal by Subject|3|||
47014524|NCT02121002|83263614|FG001|Overall Study|Withdrawal by Subject|1|||
47014525|NCT02121002|83263615|FG002|Overall Study|Withdrawal by Subject|4|||
47014526|NCT02121002|83263613|FG000|Overall Study|Protocol Violation|1|||
47014527|NCT02121002|83263614|FG001|Overall Study|Protocol Violation|2|||
47014528|NCT02121002|83263615|FG002|Overall Study|Protocol Violation|4|||
47014529|NCT02121002|83263613|FG000|Overall Study|Concomitant therapy|0|||
47014530|NCT02121002|83263614|FG001|Overall Study|Concomitant therapy|1|||
47014531|NCT02121002|83263615|FG002|Overall Study|Concomitant therapy|1|||
47014532|NCT02121002|83263613|FG000|Overall Study|Others|1|||
47014533|NCT02121002|83263614|FG001|Overall Study|Others|0|||
47014534|NCT02121002|83263615|FG002|Overall Study|Others|1|||
47014535|NCT02096900|83263625|FG000|Overall Study|Did not receive medication|3|||
47014536|NCT02096900|83263626|FG001|Overall Study|Did not receive medication|1|||
47014537|NCT02096900|83263625|FG000|Overall Study|Surgery cancelled- medication received|1|||
47014538|NCT02096900|83263626|FG001|Overall Study|Surgery cancelled- medication received|1|||
47014539|NCT02120924|83263635|FG000|Overall Study|Lack of Efficacy|1|||
47014540|NCT02120924|83263636|FG001|Overall Study|Lack of Efficacy|2|||
47014541|NCT02120924|83263637|FG002|Overall Study|Lack of Efficacy|3|||
47014542|NCT02120924|83263635|FG000|Overall Study|Adverse Event|0|||
47014543|NCT02120924|83263636|FG001|Overall Study|Adverse Event|1|||
47014544|NCT02120924|83263637|FG002|Overall Study|Adverse Event|3|||
47014545|NCT02120924|83263635|FG000|Overall Study|Withdrawal by Subject|16|||
47014546|NCT02120924|83263636|FG001|Overall Study|Withdrawal by Subject|20|||
47014547|NCT02120924|83263637|FG002|Overall Study|Withdrawal by Subject|8|||
47014548|NCT02120924|83263635|FG000|Overall Study|Lost to Follow-up|14|||
47014549|NCT02120924|83263636|FG001|Overall Study|Lost to Follow-up|14|||
47014550|NCT02120924|83263637|FG002|Overall Study|Lost to Follow-up|11|||
47014551|NCT02120924|83263635|FG000|Overall Study|Pregnancy|2|||
47014552|NCT02120924|83263636|FG001|Overall Study|Pregnancy|0|||
47014553|NCT02120924|83263637|FG002|Overall Study|Pregnancy|0|||
47014554|NCT02120924|83263635|FG000|Overall Study|Protocol Violation|3|||
47014555|NCT02120924|83263636|FG001|Overall Study|Protocol Violation|7|||
47014556|NCT02120924|83263637|FG002|Overall Study|Protocol Violation|2|||
47014557|NCT02120924|83263635|FG000|Overall Study|Physician Decision|0|||
47014558|NCT02120924|83263636|FG001|Overall Study|Physician Decision|1|||
47014559|NCT02120924|83263637|FG002|Overall Study|Physician Decision|1|||
47014560|NCT02120924|83263635|FG000|Overall Study|Death|1|||
47014561|NCT02120924|83263636|FG001|Overall Study|Death|0|||
47014562|NCT02120924|83263637|FG002|Overall Study|Death|0|||
47014563|NCT02120924|83263635|FG000|Overall Study|Compliance with IP|5|||
47014564|NCT02120924|83263636|FG001|Overall Study|Compliance with IP|1|||
47014565|NCT02120924|83263637|FG002|Overall Study|Compliance with IP|1|||
47014566|NCT02096744|83263646|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
47014567|NCT02096744|83263647|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
47014568|NCT02096744|83263646|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
47014569|NCT02096744|83263647|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
47014570|NCT02096744|83263646|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
47014571|NCT02096744|83263647|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
47014572|NCT02120456|83263664|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014573|NCT02120456|83263665|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014574|NCT02120456|83263666|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014575|NCT02120456|83263667|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014576|NCT02120456|83263668|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014577|NCT02120456|83263669|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014578|NCT02120456|83263670|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
47014579|NCT02120456|83263671|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014580|NCT02120456|83263672|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
47014581|NCT02120456|83263664|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014582|NCT02120456|83263665|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014583|NCT02120456|83263666|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014584|NCT02120456|83263667|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014585|NCT02120456|83263668|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014586|NCT02120456|83263669|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014587|NCT02120456|83263670|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
47014588|NCT02120456|83263671|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014589|NCT02120456|83263672|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
47014590|NCT02120456|83263664|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
47014591|NCT02120456|83263665|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
47014592|NCT02120456|83263666|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
47014593|NCT02120456|83263667|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
47014594|NCT02120456|83263668|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
47014595|NCT02120456|83263669|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
46709668|NCT01215188|82925768|FG001|Overall Study|Adverse Event|1|||
47014596|NCT02120456|83263670|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
47014597|NCT02120456|83263671|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
47014598|NCT02120456|83263672|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
47014599|NCT02120300|83263696|FG000|Overall Study|Enrolled but Never Treated|2|||
47014600|NCT02120300|83263697|FG001|Overall Study|Enrolled but Never Treated|0|||
47014601|NCT02120300|83263698|FG002|Overall Study|Enrolled but Never Treated|0|||
47014602|NCT02120300|83263699|FG003|Overall Study|Enrolled but Never Treated|0|||
46709669|NCT01215188|82925769|FG002|Overall Study|Adverse Event|3|||
47014603|NCT02120300|83263696|FG000|Overall Study|Lack of Efficacy|0|||
47014604|NCT02120300|83263697|FG001|Overall Study|Lack of Efficacy|0|||
47014605|NCT02120300|83263698|FG002|Overall Study|Lack of Efficacy|0|||
47014606|NCT02120300|83263699|FG003|Overall Study|Lack of Efficacy|1|||
47014607|NCT02120300|83263696|FG000|Overall Study|Lost to Follow-up|1|||
47014608|NCT02120300|83263697|FG001|Overall Study|Lost to Follow-up|0|||
47014609|NCT02120300|83263698|FG002|Overall Study|Lost to Follow-up|0|||
47014610|NCT02120300|83263699|FG003|Overall Study|Lost to Follow-up|0|||
47014611|NCT02070380|83263715|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
47014612|NCT02070380|83263716|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
47014613|NCT02070380|83263717|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
47014614|NCT02070380|83263718|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
47014615|NCT02070380|83263715|FG000|Second Injection|Image sets missing or technically inadeq|0|||
47014616|NCT02070380|83263716|FG001|Second Injection|Image sets missing or technically inadeq|1|||
47014617|NCT02070380|83263717|FG002|Second Injection|Image sets missing or technically inadeq|0|||
47014618|NCT02070380|83263718|FG003|Second Injection|Image sets missing or technically inadeq|0|||
47014619|NCT02070380|83263715|FG000|Second Injection|Protocol Violation|0|||
47014620|NCT02070380|83263716|FG001|Second Injection|Protocol Violation|1|||
47014621|NCT02070380|83263717|FG002|Second Injection|Protocol Violation|1|||
47014622|NCT02070380|83263718|FG003|Second Injection|Protocol Violation|5|||
47014623|NCT02069366|83263736|FG000|Overall Study|Lost to Follow-up|0|||
47014624|NCT02069366|83263737|FG001|Overall Study|Lost to Follow-up|0|||
47014625|NCT02069366|83263738|FG002|Overall Study|Lost to Follow-up|1|||
47014626|NCT02069366|83263739|FG003|Overall Study|Lost to Follow-up|0|||
47014627|NCT02069366|83263740|FG004|Overall Study|Lost to Follow-up|0|||
47014628|NCT02069366|83263741|FG005|Overall Study|Lost to Follow-up|2|||
47014629|NCT02069366|83263736|FG000|Overall Study|Protocol Violation|0|||
47014630|NCT02069366|83263737|FG001|Overall Study|Protocol Violation|0|||
47014631|NCT02069366|83263738|FG002|Overall Study|Protocol Violation|1|||
47014632|NCT02069366|83263739|FG003|Overall Study|Protocol Violation|0|||
47014633|NCT02069366|83263740|FG004|Overall Study|Protocol Violation|0|||
47014634|NCT02069366|83263741|FG005|Overall Study|Protocol Violation|0|||
47014635|NCT02069366|83263736|FG000|Overall Study|Withdrawal by Subject|1|||
47014636|NCT02069366|83263737|FG001|Overall Study|Withdrawal by Subject|0|||
47014637|NCT02069366|83263738|FG002|Overall Study|Withdrawal by Subject|1|||
47014638|NCT02069366|83263739|FG003|Overall Study|Withdrawal by Subject|2|||
47014639|NCT02069366|83263740|FG004|Overall Study|Withdrawal by Subject|0|||
47014640|NCT02069366|83263741|FG005|Overall Study|Withdrawal by Subject|0|||
47014641|NCT02068508|83263756|FG000|Overall Study|Case report forms uncollected|27|||
47014642|NCT02068508|83263756|FG000|Overall Study|Patient did not visit the study site|1|||
47014643|NCT02068508|83263756|FG000|Overall Study|Protocol Violation|4|||
47014644|NCT02068352|83263763|FG000|Overall Study|Lost to Follow-up|0|||
47014645|NCT02068352|83263764|FG001|Overall Study|Lost to Follow-up|2|||
47014646|NCT02068352|83263765|FG002|Overall Study|Lost to Follow-up|0|||
47014647|NCT02068352|83263763|FG000|Overall Study|Adverse Event|4|||
47014648|NCT02068352|83263764|FG001|Overall Study|Adverse Event|2|||
47014649|NCT02068352|83263765|FG002|Overall Study|Adverse Event|7|||
47014650|NCT02068352|83263763|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
47014651|NCT02068352|83263764|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
47014652|NCT02068352|83263765|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
47014653|NCT02068352|83263763|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
47014654|NCT02068352|83263764|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
47014655|NCT02068352|83263765|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
47014656|NCT02068352|83263763|FG000|Overall Study|Protocol Deviation|0|||
47014657|NCT02068352|83263764|FG001|Overall Study|Protocol Deviation|0|||
47014658|NCT02068352|83263765|FG002|Overall Study|Protocol Deviation|1|||
47014659|NCT02207231|83263776|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
47014660|NCT02207231|83263777|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
47014661|NCT02207231|83263778|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
47014662|NCT02207231|83263779|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
47014663|NCT02207231|83263776|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
47014664|NCT02207231|83263777|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
47014665|NCT02207231|83263778|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
47014666|NCT02207231|83263779|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
47014667|NCT02207231|83263776|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
47014668|NCT02207231|83263777|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
47014669|NCT02207231|83263778|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
47014670|NCT02207231|83263779|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
47014671|NCT02207231|83263776|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
47014672|NCT02207231|83263777|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
47014673|NCT02207231|83263778|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
47014674|NCT02207231|83263779|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
47014675|NCT02207231|83263776|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
46709670|NCT01215188|82925767|FG000|Overall Study|Physician Decision|2|||
46709671|NCT01215188|82925768|FG001|Overall Study|Physician Decision|1|||
47014676|NCT02207231|83263777|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
47014677|NCT02207231|83263778|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
47014678|NCT02207231|83263779|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
47014679|NCT02207231|83263776|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
47014680|NCT02207231|83263777|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
46910563|NCT01578239|83140085|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
46910564|NCT01578239|83140086|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
46910565|NCT01578239|83140085|FG000|Long-term Follow-Up Period|Other|2|||
46910566|NCT01578239|83140086|FG001|Long-term Follow-Up Period|Other|2|||
47014681|NCT02207231|83263778|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
47014682|NCT02207231|83263779|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
47014683|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
47014684|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
47014685|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
47014686|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
47014687|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
47014688|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
47014689|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
47014690|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
47014691|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
47014692|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
47014693|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
47014694|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
47014695|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
47014696|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
47014697|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
47014698|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
47014699|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
47014700|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
47014701|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
47014702|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
47014703|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
47014704|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
47014705|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
47014706|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
47014707|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
47014708|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
47014709|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
47014710|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
47014711|NCT02207231|83263776|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
47014712|NCT02207231|83263777|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
47014713|NCT02207231|83263778|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
47014714|NCT02207231|83263779|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
47014715|NCT02207231|83263776|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
47014716|NCT02207231|83263777|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
47014717|NCT02207231|83263778|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
47014718|NCT02207231|83263779|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
47014719|NCT02207231|83263776|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
47014720|NCT02207231|83263777|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
47014721|NCT02207231|83263778|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
47014722|NCT02207231|83263779|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
47014723|NCT02207231|83263776|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
47014724|NCT02207231|83263777|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
47014725|NCT02207231|83263778|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
47014726|NCT02207231|83263779|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
47014727|NCT02207231|83263776|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
47014728|NCT02207231|83263777|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
47014729|NCT02207231|83263778|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
46910567|NCT03241927|83140092|FG000|Overall Study|study terminated|1|||
47014730|NCT02207231|83263779|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
47014731|NCT02207231|83263776|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
47014732|NCT02207231|83263777|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
47014733|NCT02207231|83263778|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
47014734|NCT02207231|83263779|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
47014735|NCT02207231|83263776|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
47014736|NCT02207231|83263777|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
46910568|NCT03241927|83140093|FG001|Overall Study|study terminated|0|||
47014737|NCT02207231|83263778|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
47014738|NCT02207231|83263779|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
47014739|NCT02207231|83263776|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
47014740|NCT02207231|83263777|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
47014741|NCT02207231|83263778|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
47014742|NCT02207231|83263779|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
47014743|NCT02239601|83263799|FG000|Overall Study|Withdrawal by Subject|3|||
47014744|NCT02239601|83263800|FG001|Overall Study|Withdrawal by Subject|4|||
47014745|NCT02239601|83263799|FG000|Overall Study|Protocol Violation|4|||
47014746|NCT02239601|83263800|FG001|Overall Study|Protocol Violation|2|||
47014747|NCT02236559|83263813|FG000|Overall Study|Met Exclusion|3|||
47014748|NCT02236559|83263814|FG001|Overall Study|Met Exclusion|6|||
47014749|NCT02236559|83263813|FG000|Overall Study|Did not Meet Inclusion|3|||
47014750|NCT02236559|83263814|FG001|Overall Study|Did not Meet Inclusion|3|||
47014751|NCT02236559|83263813|FG000|Overall Study|Subject Did Not Consent|4|||
47014752|NCT02236559|83263814|FG001|Overall Study|Subject Did Not Consent|2|||
47014753|NCT02236559|83263813|FG000|Overall Study|Physician Decision|1|||
47014754|NCT02236559|83263814|FG001|Overall Study|Physician Decision|1|||
47014755|NCT02236559|83263813|FG000|Overall Study|Withdrawal by Subject|1|||
47014756|NCT02236559|83263814|FG001|Overall Study|Withdrawal by Subject|0|||
47014757|NCT02206685|83263822|FG000|Overall Study|Surgery cancelled/changed|2|||
47014758|NCT02206685|83263823|FG001|Overall Study|Surgery cancelled/changed|3|||
47014759|NCT02206685|83263822|FG000|Overall Study|Withdrawal by Subject|1|||
47014760|NCT02206685|83263823|FG001|Overall Study|Withdrawal by Subject|2|||
47014761|NCT02206685|83263822|FG000|Overall Study|Protocol Violation|2|||
47014762|NCT02206685|83263823|FG001|Overall Study|Protocol Violation|2|||
47014763|NCT02206607|83263829|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
47014764|NCT02206607|83263830|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
47014765|NCT02206607|83263831|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
47014766|NCT02206607|83263832|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
47014767|NCT02206607|83263833|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
47014768|NCT02206607|83263829|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
47014769|NCT02206607|83263830|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
47014770|NCT02206607|83263831|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
47014771|NCT02206607|83263832|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
47014772|NCT02206607|83263833|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
47014773|NCT02119676|83263853|FG000|Overall Study|Adverse Event|9|||
47014774|NCT02119676|83263854|FG001|Overall Study|Adverse Event|17|||
47014775|NCT02119676|83263855|FG002|Overall Study|Adverse Event|10|||
47014776|NCT02119676|83263856|FG003|Overall Study|Adverse Event|10|||
47014777|NCT02119676|83263853|FG000|Overall Study|Disease progression|53|||
47014778|NCT02119676|83263854|FG001|Overall Study|Disease progression|55|||
47014779|NCT02119676|83263855|FG002|Overall Study|Disease progression|68|||
47014780|NCT02119676|83263856|FG003|Overall Study|Disease progression|73|||
47014781|NCT02119676|83263853|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
47014782|NCT02119676|83263854|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
47014783|NCT02119676|83263855|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
47014784|NCT02119676|83263856|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
47014785|NCT02119676|83263853|FG000|Overall Study|Physician Decision|4|||
47014786|NCT02119676|83263854|FG001|Overall Study|Physician Decision|2|||
47014787|NCT02119676|83263855|FG002|Overall Study|Physician Decision|3|||
47014788|NCT02119676|83263856|FG003|Overall Study|Physician Decision|2|||
47014789|NCT02119676|83263853|FG000|Overall Study|Death|9|||
47014790|NCT02119676|83263854|FG001|Overall Study|Death|3|||
47014791|NCT02119676|83263855|FG002|Overall Study|Death|2|||
47014792|NCT02119676|83263856|FG003|Overall Study|Death|1|||
47014793|NCT02119676|83263853|FG000|Overall Study|Noncompliance|0|||
47014794|NCT02119676|83263854|FG001|Overall Study|Noncompliance|1|||
47014795|NCT02119676|83263855|FG002|Overall Study|Noncompliance|0|||
47014796|NCT02119676|83263856|FG003|Overall Study|Noncompliance|0|||
47014797|NCT02119676|83263853|FG000|Overall Study|Lost to Follow-up|0|||
47014798|NCT02119676|83263854|FG001|Overall Study|Lost to Follow-up|0|||
47014799|NCT02119676|83263855|FG002|Overall Study|Lost to Follow-up|1|||
47014800|NCT02119676|83263856|FG003|Overall Study|Lost to Follow-up|0|||
47014801|NCT02119676|83263853|FG000|Overall Study|Protocol deviation|0|||
46709672|NCT01215188|82925769|FG002|Overall Study|Physician Decision|0|||
47014802|NCT02119676|83263854|FG001|Overall Study|Protocol deviation|0|||
47014803|NCT02119676|83263855|FG002|Overall Study|Protocol deviation|1|||
46709673|NCT01215188|82925767|FG000|Overall Study|Lack of Efficacy|0|||
46709674|NCT01215188|82925768|FG001|Overall Study|Lack of Efficacy|0|||
47014804|NCT02119676|83263856|FG003|Overall Study|Protocol deviation|0|||
47014805|NCT02119676|83263853|FG000|Overall Study|Other, unspecified|2|||
47014806|NCT02119676|83263854|FG001|Overall Study|Other, unspecified|1|||
47014807|NCT02119676|83263855|FG002|Overall Study|Other, unspecified|3|||
47014808|NCT02119676|83263856|FG003|Overall Study|Other, unspecified|4|||
47014809|NCT02119676|83263853|FG000|Overall Study|Did not receive study med|2|||
47014810|NCT02119676|83263854|FG001|Overall Study|Did not receive study med|2|||
47014811|NCT02119676|83263855|FG002|Overall Study|Did not receive study med|4|||
47014812|NCT02119676|83263856|FG003|Overall Study|Did not receive study med|5|||
47014813|NCT02206061|83263869|FG000|Overall Study|Withdrawal by Subject|4|||
47014814|NCT02206061|83263870|FG001|Overall Study|Withdrawal by Subject|7|||
47014815|NCT02206061|83263871|FG002|Overall Study|Withdrawal by Subject|1|||
47014816|NCT02206061|83263869|FG000|Overall Study|Lost to Follow-up|14|||
47014817|NCT02206061|83263870|FG001|Overall Study|Lost to Follow-up|7|||
47014818|NCT02206061|83263871|FG002|Overall Study|Lost to Follow-up|20|||
47014819|NCT02095106|83263881|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
47014820|NCT02095106|83263882|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
47014821|NCT01631747|83263894|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
47014822|NCT01631747|83263895|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
47014823|NCT01631747|83263894|FG000|Live Birth|Pregnancy Termination|1|||
47014824|NCT01631747|83263895|FG001|Live Birth|Pregnancy Termination|0|||
47014825|NCT01631747|83263894|FG000|Live Birth|MIscarriage|2|||
47014826|NCT01631747|83263895|FG001|Live Birth|MIscarriage|0|||
47014827|NCT01631747|83263894|FG000|Live Birth|Stillbirth|1|||
47014828|NCT01631747|83263895|FG001|Live Birth|Stillbirth|1|||
47014829|NCT01631747|83263894|FG000|One Year Infant Outcomes|Patient Refused|13|||
47014830|NCT01631747|83263895|FG001|One Year Infant Outcomes|Patient Refused|9|||
47014831|NCT02068118|83263904|FG000|18-month Comparative Study Period|Death|90|||
47014832|NCT02068118|83263905|FG001|18-month Comparative Study Period|Death|97|||
47014833|NCT02068118|83263904|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
47014834|NCT02068118|83263905|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
47014835|NCT02068118|83263904|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
47014836|NCT02068118|83263905|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
47014837|NCT02068118|83263904|FG000|18-month Comparative Study Period|Heart transplant|9|||
47014838|NCT02068118|83263905|FG001|18-month Comparative Study Period|Heart transplant|15|||
47014839|NCT02068118|83263904|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
47014840|NCT02068118|83263905|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
47014841|NCT02068118|83263904|FG000|18-month Comparative Study Period|Hemiplegia|0|||
47014842|NCT02068118|83263905|FG001|18-month Comparative Study Period|Hemiplegia|1|||
47014843|NCT02068118|83263904|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
47014844|NCT02068118|83263905|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
47014845|NCT02068118|83263904|FG000|18-month Comparative Study Period|Move|0|||
47014846|NCT02068118|83263905|FG001|18-month Comparative Study Period|Move|1|||
47014847|NCT02068118|83263904|FG000|18-month Comparative Study Period|Hearing loss|0|||
47014848|NCT02068118|83263905|FG001|18-month Comparative Study Period|Hearing loss|1|||
47014849|NCT02068118|83263904|FG000|Extension Period|Death|0|||
47014850|NCT02068118|83263905|FG001|Extension Period|Death|2|||
47014851|NCT02068118|83263904|FG000|Extension Period|Withdrawal by Subject|1|||
47014852|NCT02068118|83263905|FG001|Extension Period|Withdrawal by Subject|0|||
47014853|NCT02068118|83263904|FG000|Extension Period|Heart transplant|1|||
47014854|NCT02068118|83263905|FG001|Extension Period|Heart transplant|0|||
47014855|NCT02068118|83263904|FG000|Extension Period|Wrong device use|0|||
47014856|NCT02068118|83263905|FG001|Extension Period|Wrong device use|1|||
47014857|NCT01623830|83263915|FG000|Overall Study|Withdrawal by Subject|6|||
47014858|NCT01623830|83263916|FG001|Overall Study|Withdrawal by Subject|7|||
47014859|NCT01623830|83263915|FG000|Overall Study|Exclusion from Study|1|||
47014860|NCT01623830|83263916|FG001|Overall Study|Exclusion from Study|2|||
47014861|NCT01634165|83263922|FG000|Period 2|Adverse Event|0|||
47014862|NCT01634165|83263923|FG001|Period 2|Adverse Event|1|||
47014863|NCT01634165|83263924|FG002|Period 2|Adverse Event|0|||
47014864|NCT01634165|83263925|FG003|Period 2|Adverse Event|0|||
47014865|NCT02235311|83263937|FG000|Overall Study|Lost to Follow-up|0|||
47014866|NCT02235311|83263938|FG001|Overall Study|Lost to Follow-up|1|||
47014867|NCT02235311|83263937|FG000|Overall Study|Protocol Violation|0|||
47014868|NCT02235311|83263938|FG001|Overall Study|Protocol Violation|1|||
47014869|NCT02204579|83263944|FG000|Overall Study|Screen failures|2|||
47014870|NCT02235077|83263955|FG000|Overall Study|Death|5|||
47014871|NCT02235077|83263956|FG001|Overall Study|Death|7|||
47014872|NCT02235077|83263955|FG000|Overall Study|Lost to Follow-up|5|||
47014873|NCT02235077|83263956|FG001|Overall Study|Lost to Follow-up|6|||
47014874|NCT02235077|83263955|FG000|Overall Study|Withdrawal by Subject|8|||
47014875|NCT02235077|83263956|FG001|Overall Study|Withdrawal by Subject|5|||
47014876|NCT02235077|83263955|FG000|Overall Study|Physician Decision|0|||
47014877|NCT02235077|83263956|FG001|Overall Study|Physician Decision|1|||
47014878|NCT02234141|83263966|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
47014879|NCT02234141|83263967|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
47014880|NCT02234141|83263968|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
47014881|NCT02234141|83263969|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
47014882|NCT02234141|83263970|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
47014883|NCT02234141|83263971|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
47014884|NCT02234141|83263972|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
47014885|NCT02234141|83263966|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
47014886|NCT02234141|83263967|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
47014887|NCT02234141|83263968|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
47014888|NCT02234141|83263969|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
47014889|NCT02234141|83263970|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
47014890|NCT02234141|83263971|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
47014891|NCT02234141|83263972|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
47014892|NCT02234141|83263966|FG000|Treatment Period (24 Weeks)|Death|1|||
47014893|NCT02234141|83263967|FG001|Treatment Period (24 Weeks)|Death|2|||
47014894|NCT02234141|83263968|FG002|Treatment Period (24 Weeks)|Death|0|||
47014895|NCT02234141|83263969|FG003|Treatment Period (24 Weeks)|Death|1|||
47014896|NCT02234141|83263970|FG004|Treatment Period (24 Weeks)|Death|0|||
47014897|NCT02234141|83263971|FG005|Treatment Period (24 Weeks)|Death|0|||
47014898|NCT02234141|83263972|FG006|Treatment Period (24 Weeks)|Death|0|||
47014899|NCT02234141|83263966|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
47014900|NCT02234141|83263967|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
47014901|NCT02234141|83263968|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
47014902|NCT02234141|83263969|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
47014903|NCT02234141|83263970|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
47014904|NCT02234141|83263971|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
47014905|NCT02234141|83263972|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
47014906|NCT02234141|83263966|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
47014907|NCT02234141|83263967|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
47014908|NCT02234141|83263968|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
47014909|NCT02234141|83263969|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
47014910|NCT02234141|83263970|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
47014911|NCT02234141|83263971|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
47014912|NCT02234141|83263972|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
47014913|NCT02234141|83263966|FG000|Long-Term Treatment Period|Death|0|||
47014914|NCT02234141|83263967|FG001|Long-Term Treatment Period|Death|0|||
47014915|NCT02234141|83263968|FG002|Long-Term Treatment Period|Death|0|||
47014916|NCT02234141|83263969|FG003|Long-Term Treatment Period|Death|0|||
47014917|NCT02234141|83263970|FG004|Long-Term Treatment Period|Death|0|||
47014918|NCT02234141|83263971|FG005|Long-Term Treatment Period|Death|1|||
47014919|NCT02234141|83263972|FG006|Long-Term Treatment Period|Death|0|||
47014920|NCT02234141|83263966|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
47014921|NCT02234141|83263967|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
47014922|NCT02234141|83263968|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
47014923|NCT02234141|83263969|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
47014924|NCT02234141|83263970|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
47014925|NCT02234141|83263971|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
47014926|NCT02234141|83263972|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
47014927|NCT02234141|83263966|FG000|Long-Term Treatment Period|Adverse Event|4|||
47014928|NCT02234141|83263967|FG001|Long-Term Treatment Period|Adverse Event|0|||
47014929|NCT02234141|83263968|FG002|Long-Term Treatment Period|Adverse Event|5|||
47014930|NCT02234141|83263969|FG003|Long-Term Treatment Period|Adverse Event|0|||
47014931|NCT02234141|83263970|FG004|Long-Term Treatment Period|Adverse Event|1|||
47014932|NCT02234141|83263971|FG005|Long-Term Treatment Period|Adverse Event|1|||
47014933|NCT02234141|83263972|FG006|Long-Term Treatment Period|Adverse Event|1|||
47014934|NCT02234141|83263966|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
47014935|NCT02234141|83263967|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
47014936|NCT02234141|83263968|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
47014937|NCT02234141|83263969|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
47014938|NCT02234141|83263970|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
47014939|NCT02234141|83263971|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
47014940|NCT02234141|83263972|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
47014941|NCT02234141|83263966|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
47014942|NCT02234141|83263967|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
47014943|NCT02234141|83263968|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
47014944|NCT02234141|83263969|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
47014945|NCT02234141|83263970|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
47014946|NCT02234141|83263971|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
47014947|NCT02234141|83263972|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
46910569|NCT03329885|83140105|FG000|Overall Study|Sponsor discontinued the study early|0|||
46910570|NCT03329885|83140106|FG001|Overall Study|Sponsor discontinued the study early|0|||
46910571|NCT03329885|83140107|FG002|Overall Study|Sponsor discontinued the study early|0|||
47014948|NCT02234063|83263985|FG000|Overall Study|Lost to Follow-up|235|||
47014949|NCT02234063|83263986|FG001|Overall Study|Lost to Follow-up|42|||
47014950|NCT02234063|83263985|FG000|Overall Study|Withdrawal by Subject|20|||
47014951|NCT02234063|83263986|FG001|Overall Study|Withdrawal by Subject|1|||
47014952|NCT02232893|83263999|FG000|Overall Study|Withdrawal by Subject|4|||
47014953|NCT02232893|83264000|FG001|Overall Study|Withdrawal by Subject|1|||
47014954|NCT02232893|83263999|FG000|Overall Study|Adverse Event|0|||
47014955|NCT02232893|83264000|FG001|Overall Study|Adverse Event|1|||
47014956|NCT02232893|83263999|FG000|Overall Study|Sponsor request early termination|0|||
47014957|NCT02232893|83264000|FG001|Overall Study|Sponsor request early termination|1|||
47014958|NCT02232893|83263999|FG000|Overall Study|Developed exclusion criteria|0|||
47014959|NCT02232893|83264000|FG001|Overall Study|Developed exclusion criteria|1|||
47014960|NCT02232893|83263999|FG000|Overall Study|Other|0|||
47014961|NCT02232893|83264000|FG001|Overall Study|Other|3|||
47014962|NCT02203721|83264008|FG000|Overall Study|Lost to Follow-up|1|||
47014963|NCT02203721|83264009|FG001|Overall Study|Lost to Follow-up|0|||
47014964|NCT02203721|83264008|FG000|Overall Study|Death|0|||
47014965|NCT02203721|83264009|FG001|Overall Study|Death|2|||
47014966|NCT02203721|83264008|FG000|Overall Study|Illness|0|||
47014967|NCT02203721|83264009|FG001|Overall Study|Illness|1|||
47014968|NCT01618695|83264019|FG000|Core Phase|Adverse Event|4|||
47014969|NCT01618695|83264020|FG001|Core Phase|Adverse Event|5|||
47014970|NCT01618695|83264021|FG002|Core Phase|Adverse Event|15|||
47014971|NCT01618695|83264022|FG003|Core Phase|Adverse Event|20|||
47014972|NCT01618695|83264019|FG000|Core Phase|Lost to Follow-up|0|||
47014973|NCT01618695|83264020|FG001|Core Phase|Lost to Follow-up|0|||
47014974|NCT01618695|83264021|FG002|Core Phase|Lost to Follow-up|1|||
47014975|NCT01618695|83264022|FG003|Core Phase|Lost to Follow-up|0|||
47014976|NCT01618695|83264019|FG000|Core Phase|Withdrawal by Subject|16|||
47014977|NCT01618695|83264020|FG001|Core Phase|Withdrawal by Subject|11|||
47014978|NCT01618695|83264021|FG002|Core Phase|Withdrawal by Subject|9|||
47014979|NCT01618695|83264022|FG003|Core Phase|Withdrawal by Subject|13|||
47014980|NCT01618695|83264019|FG000|Core Phase|Pregnancy|2|||
47014981|NCT01618695|83264020|FG001|Core Phase|Pregnancy|0|||
47014982|NCT01618695|83264021|FG002|Core Phase|Pregnancy|0|||
47014983|NCT01618695|83264022|FG003|Core Phase|Pregnancy|0|||
47014984|NCT01618695|83264019|FG000|Core Phase|Lack of Efficacy|1|||
47014985|NCT01618695|83264020|FG001|Core Phase|Lack of Efficacy|2|||
47014986|NCT01618695|83264021|FG002|Core Phase|Lack of Efficacy|1|||
47014987|NCT01618695|83264022|FG003|Core Phase|Lack of Efficacy|1|||
47014988|NCT01618695|83264019|FG000|Core Phase|Other than specified|1|||
47014989|NCT01618695|83264020|FG001|Core Phase|Other than specified|2|||
47014990|NCT01618695|83264021|FG002|Core Phase|Other than specified|2|||
47014991|NCT01618695|83264022|FG003|Core Phase|Other than specified|2|||
47014992|NCT01618695|83264019|FG000|Core Phase|Not treated|1|||
47014993|NCT01618695|83264020|FG001|Core Phase|Not treated|0|||
47014994|NCT01618695|83264021|FG002|Core Phase|Not treated|2|||
47014995|NCT01618695|83264022|FG003|Core Phase|Not treated|0|||
47014996|NCT01618695|83264019|FG000|Extension Phase|Lack of Efficacy|17|||
47014997|NCT01618695|83264020|FG001|Extension Phase|Lack of Efficacy|33|||
47014998|NCT01618695|83264021|FG002|Extension Phase|Lack of Efficacy|26|||
47014999|NCT01618695|83264022|FG003|Extension Phase|Lack of Efficacy|24|||
47015000|NCT01618695|83264019|FG000|Extension Phase|Pregnancy|2|||
47015001|NCT01618695|83264020|FG001|Extension Phase|Pregnancy|0|||
47015002|NCT01618695|83264021|FG002|Extension Phase|Pregnancy|1|||
47015003|NCT01618695|83264022|FG003|Extension Phase|Pregnancy|1|||
47015004|NCT01618695|83264019|FG000|Extension Phase|Withdrawal by Subject|43|||
47015005|NCT01618695|83264020|FG001|Extension Phase|Withdrawal by Subject|48|||
47015006|NCT01618695|83264021|FG002|Extension Phase|Withdrawal by Subject|42|||
47015007|NCT01618695|83264022|FG003|Extension Phase|Withdrawal by Subject|33|||
47015008|NCT01618695|83264019|FG000|Extension Phase|Adverse Event|18|||
47015009|NCT01618695|83264020|FG001|Extension Phase|Adverse Event|16|||
47015010|NCT01618695|83264021|FG002|Extension Phase|Adverse Event|9|||
47015011|NCT01618695|83264022|FG003|Extension Phase|Adverse Event|20|||
47015012|NCT01618695|83264019|FG000|Extension Phase|Lost to Follow-up|2|||
47015013|NCT01618695|83264020|FG001|Extension Phase|Lost to Follow-up|1|||
47015014|NCT01618695|83264021|FG002|Extension Phase|Lost to Follow-up|1|||
47015015|NCT01618695|83264022|FG003|Extension Phase|Lost to Follow-up|1|||
47015016|NCT01618695|83264019|FG000|Extension Phase|Other than specified|13|||
47015017|NCT01618695|83264020|FG001|Extension Phase|Other than specified|18|||
47015018|NCT01618695|83264021|FG002|Extension Phase|Other than specified|13|||
47015019|NCT01618695|83264022|FG003|Extension Phase|Other than specified|18|||
46709675|NCT01215188|82925769|FG002|Overall Study|Lack of Efficacy|1|||
47015020|NCT01896531|83264035|FG000|Overall Study|Death|57|||
47015021|NCT01896531|83264036|FG001|Overall Study|Death|59|||
47015022|NCT01896531|83264035|FG000|Overall Study|Lost to Follow-up|3|||
47015023|NCT01896531|83264036|FG001|Overall Study|Lost to Follow-up|0|||
47015024|NCT01896531|83264035|FG000|Overall Study|Non-compliance|0|||
47015025|NCT01896531|83264036|FG001|Overall Study|Non-compliance|1|||
47015026|NCT01896531|83264035|FG000|Overall Study|Study Ended by Sponsor|7|||
47015027|NCT01896531|83264036|FG001|Overall Study|Study Ended by Sponsor|20|||
47015028|NCT01896531|83264035|FG000|Overall Study|Withdrawal by Subject|3|||
47015029|NCT01896531|83264036|FG001|Overall Study|Withdrawal by Subject|2|||
47015030|NCT01896531|83264035|FG000|Overall Study|Death Prior to Treatment|1|||
47015031|NCT01896531|83264036|FG001|Overall Study|Death Prior to Treatment|0|||
47015032|NCT01618305|83264044|FG000|Overall Study|Death|0|||
47015033|NCT01618305|83264045|FG001|Overall Study|Death|1|||
47015034|NCT01618305|83264044|FG000|Overall Study|Lost to Follow-up|11|||
47015035|NCT01618305|83264045|FG001|Overall Study|Lost to Follow-up|7|||
47015036|NCT01618305|83264044|FG000|Overall Study|Protocol Violation|1|||
47015037|NCT01618305|83264045|FG001|Overall Study|Protocol Violation|0|||
47015038|NCT01618305|83264044|FG000|Overall Study|Withdrawal by Subject|3|||
47015039|NCT01618305|83264045|FG001|Overall Study|Withdrawal by Subject|2|||
47015040|NCT01886313|83264057|FG000|Overall Study|Adverse Event|1|||
47015041|NCT01886313|83264058|FG001|Overall Study|Adverse Event|1|||
47015042|NCT01896297|83264064|FG000|Overall Study|Died in post treatment phase|1|||
47015043|NCT01884675|83264070|FG000|Overall Study|Study closed/terminated|3|||
47015044|NCT01884675|83264071|FG001|Overall Study|Study closed/terminated|2|||
47015045|NCT01884597|83264082|FG000|Overall Study|Adverse Event|0|||
47015046|NCT01884597|83264083|FG001|Overall Study|Adverse Event|0|||
47015047|NCT01884597|83264084|FG002|Overall Study|Adverse Event|1|||
47015048|NCT01884597|83264082|FG000|Overall Study|Lack of Efficacy|1|||
47015049|NCT01884597|83264083|FG001|Overall Study|Lack of Efficacy|0|||
47015050|NCT01884597|83264084|FG002|Overall Study|Lack of Efficacy|0|||
47015051|NCT01884597|83264082|FG000|Overall Study|Death|0|||
47015052|NCT01884597|83264083|FG001|Overall Study|Death|1|||
47015053|NCT01884597|83264084|FG002|Overall Study|Death|0|||
47015054|NCT01895361|83264101|FG000|Overall Study|Adverse Event|1|||
47015055|NCT01895361|83264102|FG001|Overall Study|Adverse Event|1|||
47015056|NCT01895361|83264103|FG002|Overall Study|Adverse Event|3|||
47015057|NCT01895361|83264101|FG000|Overall Study|Death|2|||
47015058|NCT01895361|83264102|FG001|Overall Study|Death|1|||
47015059|NCT01895361|83264103|FG002|Overall Study|Death|2|||
47015060|NCT01895361|83264101|FG000|Overall Study|Lost to Follow-up|4|||
47015061|NCT01895361|83264102|FG001|Overall Study|Lost to Follow-up|4|||
47015062|NCT01895361|83264103|FG002|Overall Study|Lost to Follow-up|6|||
47015063|NCT01895361|83264101|FG000|Overall Study|Non-compliance with study|1|||
47015064|NCT01895361|83264102|FG001|Overall Study|Non-compliance with study|3|||
47015065|NCT01895361|83264103|FG002|Overall Study|Non-compliance with study|1|||
47015066|NCT01895361|83264101|FG000|Overall Study|Physician Decision|2|||
47015067|NCT01895361|83264102|FG001|Overall Study|Physician Decision|2|||
47015068|NCT01895361|83264103|FG002|Overall Study|Physician Decision|2|||
47015069|NCT01895361|83264101|FG000|Overall Study|Withdrawal by Subject|7|||
47015070|NCT01895361|83264102|FG001|Overall Study|Withdrawal by Subject|6|||
47015071|NCT01895361|83264103|FG002|Overall Study|Withdrawal by Subject|6|||
47015072|NCT01895361|83264101|FG000|Overall Study|Lack of Efficacy|0|||
47015073|NCT01895361|83264102|FG001|Overall Study|Lack of Efficacy|1|||
47015074|NCT01895361|83264103|FG002|Overall Study|Lack of Efficacy|0|||
47015075|NCT01895361|83264101|FG000|Overall Study|Reasons different from categories above|7|||
47015076|NCT01895361|83264102|FG001|Overall Study|Reasons different from categories above|3|||
47015077|NCT01895361|83264103|FG002|Overall Study|Reasons different from categories above|4|||
47015078|NCT01883895|83264111|FG000|Overall Study|Lost to Follow-up|2|||
47015079|NCT01864005|83264117|FG000|Overall Study|Protocol Violation|0|||
47015080|NCT01864005|83264118|FG001|Overall Study|Protocol Violation|1|||
47015081|NCT01864005|83264117|FG000|Overall Study|Withdrawal by Subject|0|||
47015082|NCT01864005|83264118|FG001|Overall Study|Withdrawal by Subject|1|||
47015083|NCT01864005|83264117|FG000|Overall Study|Incorrect enrolment|1|||
47015084|NCT01864005|83264118|FG001|Overall Study|Incorrect enrolment|0|||
47015085|NCT01864005|83264117|FG000|Overall Study|Disease need|1|||
47015086|NCT01864005|83264118|FG001|Overall Study|Disease need|1|||
47015087|NCT01864005|83264117|FG000|Overall Study|Need GP IIb/IIIa|1|||
47015088|NCT01864005|83264118|FG001|Overall Study|Need GP IIb/IIIa|3|||
47015089|NCT01863849|83264126|FG000|Overall Study|Lost to Follow-up|1|||
47015090|NCT01863849|83264127|FG001|Overall Study|Lost to Follow-up|0|||
47015091|NCT01863771|83264134|FG000|Induction Phase|Adverse Event|9|||
47015092|NCT01863771|83264135|FG001|Induction Phase|Adverse Event|0|||
47015093|NCT01863771|83264136|FG002|Induction Phase|Adverse Event|0|||
47015094|NCT01863771|83264137|FG003|Induction Phase|Adverse Event|0|||
47015095|NCT01863771|83264134|FG000|Induction Phase|Lack of Efficacy|10|||
47015096|NCT01863771|83264135|FG001|Induction Phase|Lack of Efficacy|0|||
47015097|NCT01863771|83264136|FG002|Induction Phase|Lack of Efficacy|0|||
47015098|NCT01863771|83264137|FG003|Induction Phase|Lack of Efficacy|0|||
47015099|NCT01863771|83264134|FG000|Induction Phase|Withdrawal by Subject|2|||
47015100|NCT01863771|83264135|FG001|Induction Phase|Withdrawal by Subject|0|||
47015101|NCT01863771|83264136|FG002|Induction Phase|Withdrawal by Subject|0|||
47015102|NCT01863771|83264137|FG003|Induction Phase|Withdrawal by Subject|0|||
47015103|NCT01863771|83264134|FG000|Maintenance Phase|Adverse Event|0|||
47015104|NCT01863771|83264135|FG001|Maintenance Phase|Adverse Event|0|||
47015105|NCT01863771|83264136|FG002|Maintenance Phase|Adverse Event|1|||
47015106|NCT01863771|83264137|FG003|Maintenance Phase|Adverse Event|1|||
47015107|NCT01863771|83264134|FG000|Maintenance Phase|Lack of Efficacy|0|||
47015108|NCT01863771|83264135|FG001|Maintenance Phase|Lack of Efficacy|3|||
47015109|NCT01863771|83264136|FG002|Maintenance Phase|Lack of Efficacy|7|||
47015110|NCT01863771|83264137|FG003|Maintenance Phase|Lack of Efficacy|38|||
47015111|NCT01863771|83264134|FG000|Maintenance Phase|Physician Decision|0|||
47015112|NCT01863771|83264135|FG001|Maintenance Phase|Physician Decision|0|||
47015113|NCT01863771|83264136|FG002|Maintenance Phase|Physician Decision|2|||
47015114|NCT01863771|83264137|FG003|Maintenance Phase|Physician Decision|1|||
47015115|NCT01863771|83264134|FG000|Maintenance Phase|Pregnancy|0|||
47015116|NCT01863771|83264135|FG001|Maintenance Phase|Pregnancy|1|||
47015117|NCT01863771|83264136|FG002|Maintenance Phase|Pregnancy|0|||
47015118|NCT01863771|83264137|FG003|Maintenance Phase|Pregnancy|0|||
47015119|NCT01863771|83264134|FG000|Maintenance Phase|Withdrawal by Subject|0|||
47015120|NCT01863771|83264135|FG001|Maintenance Phase|Withdrawal by Subject|1|||
47015121|NCT01863771|83264136|FG002|Maintenance Phase|Withdrawal by Subject|2|||
47015122|NCT01863771|83264137|FG003|Maintenance Phase|Withdrawal by Subject|3|||
47015123|NCT01894581|83264147|FG000|Overall Study|Withdrawal by Subject|2|||
47015124|NCT01894581|83264148|FG001|Overall Study|Withdrawal by Subject|3|||
47015125|NCT01894581|83264147|FG000|Overall Study|Screen Failure|3|||
47015126|NCT01894581|83264148|FG001|Overall Study|Screen Failure|4|||
47015127|NCT01893411|83264157|FG000|Overall Study|Protocol Violation|1|||
47015128|NCT01893411|83264158|FG001|Overall Study|Protocol Violation|0|||
47015129|NCT01893411|83264159|FG002|Overall Study|Protocol Violation|0|||
47015130|NCT01893411|83264157|FG000|Overall Study|Physician Decision|1|||
47015131|NCT01893411|83264158|FG001|Overall Study|Physician Decision|1|||
47015132|NCT01893411|83264159|FG002|Overall Study|Physician Decision|2|||
47015133|NCT01893411|83264157|FG000|Overall Study|Lack of Efficacy|2|||
47015134|NCT01893411|83264158|FG001|Overall Study|Lack of Efficacy|1|||
47015135|NCT01893411|83264159|FG002|Overall Study|Lack of Efficacy|0|||
47015136|NCT01893411|83264157|FG000|Overall Study|Other|3|||
47015137|NCT01893411|83264158|FG001|Overall Study|Other|1|||
47015138|NCT01893411|83264159|FG002|Overall Study|Other|3|||
47015139|NCT01893411|83264157|FG000|Overall Study|Adverse Event|1|||
47015140|NCT01893411|83264158|FG001|Overall Study|Adverse Event|0|||
47015141|NCT01893411|83264159|FG002|Overall Study|Adverse Event|0|||
47015142|NCT01893411|83264157|FG000|Overall Study|Withdrawal by Subject|7|||
47015143|NCT01893411|83264158|FG001|Overall Study|Withdrawal by Subject|4|||
47015144|NCT01893411|83264159|FG002|Overall Study|Withdrawal by Subject|3|||
47015145|NCT01893411|83264157|FG000|Overall Study|Lost to Follow-up|2|||
47015146|NCT01893411|83264158|FG001|Overall Study|Lost to Follow-up|0|||
47015147|NCT01893411|83264159|FG002|Overall Study|Lost to Follow-up|1|||
47015148|NCT02232425|83264169|FG000|Overall Study|Lost to Follow-up|6|||
47015149|NCT02232425|83264170|FG001|Overall Study|Lost to Follow-up|2|||
47015150|NCT02232425|83264169|FG000|Overall Study|Adverse Event|2|||
47015151|NCT02232425|83264170|FG001|Overall Study|Adverse Event|0|||
47015152|NCT02232425|83264169|FG000|Overall Study|Withdrawal by Subject|5|||
47015153|NCT02232425|83264170|FG001|Overall Study|Withdrawal by Subject|6|||
47015154|NCT02232425|83264169|FG000|Overall Study|Lack of Efficacy|1|||
47015155|NCT02232425|83264170|FG001|Overall Study|Lack of Efficacy|0|||
47015156|NCT01631435|83264176|FG000|Overall Study|Adverse Event|2|||
47015157|NCT01631435|83264176|FG000|Overall Study|Withdrawal by Subject|2|||
47015158|NCT01631435|83264176|FG000|Overall Study|incomplete study procedure|5|||
47015159|NCT02230085|83264181|FG000|Overall Study|Physician Decision|1|||
47015160|NCT02230085|83264181|FG000|Overall Study|Withdrawal by Subject|3|||
47015161|NCT02202785|83264188|FG000|Overall Study|Study Terminated by Sponsor|1|||
47015162|NCT02202785|83264189|FG001|Overall Study|Study Terminated by Sponsor|6|||
47015163|NCT02202785|83264190|FG002|Overall Study|Study Terminated by Sponsor|4|||
47015164|NCT02202785|83264188|FG000|Overall Study|Withdrawal by Subject|0|||
47015165|NCT02202785|83264189|FG001|Overall Study|Withdrawal by Subject|1|||
47015166|NCT02202785|83264190|FG002|Overall Study|Withdrawal by Subject|0|||
47015167|NCT02202785|83264188|FG000|Overall Study|Lost to Follow-up|0|||
47015168|NCT02202785|83264189|FG001|Overall Study|Lost to Follow-up|1|||
47015169|NCT02202785|83264190|FG002|Overall Study|Lost to Follow-up|0|||
47015170|NCT02202785|83264188|FG000|Overall Study|Reason not Specified|10|||
47015171|NCT02202785|83264189|FG001|Overall Study|Reason not Specified|7|||
47015172|NCT02202785|83264190|FG002|Overall Study|Reason not Specified|13|||
47015173|NCT01882647|83264200|FG000|Overall Study|Lost to Follow-up|2|||
47015174|NCT01882647|83264201|FG001|Overall Study|Lost to Follow-up|2|||
47015175|NCT01882647|83264200|FG000|Overall Study|Withdrawal by Subject|0|||
47015176|NCT01882647|83264201|FG001|Overall Study|Withdrawal by Subject|4|||
47015177|NCT01882257|83264210|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
47015178|NCT01882257|83264211|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
47015179|NCT01882257|83264212|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
47015180|NCT01882257|83264210|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
47015181|NCT01882257|83264211|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
47015182|NCT01882257|83264212|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
47015183|NCT02202551|83264223|FG000|Overall Study|Adverse Event|8|||
47015184|NCT02202551|83264224|FG001|Overall Study|Adverse Event|19|||
47015185|NCT02202551|83264225|FG002|Overall Study|Adverse Event|5|||
47015186|NCT02202551|83264226|FG003|Overall Study|Adverse Event|9|||
47015187|NCT02202551|83264223|FG000|Overall Study|Death|3|||
47015188|NCT02202551|83264224|FG001|Overall Study|Death|2|||
47015189|NCT02202551|83264225|FG002|Overall Study|Death|1|||
47015190|NCT02202551|83264226|FG003|Overall Study|Death|1|||
47015191|NCT02202551|83264223|FG000|Overall Study|Lost to Follow-up|0|||
47015192|NCT02202551|83264224|FG001|Overall Study|Lost to Follow-up|1|||
47015193|NCT02202551|83264225|FG002|Overall Study|Lost to Follow-up|0|||
47015194|NCT02202551|83264226|FG003|Overall Study|Lost to Follow-up|1|||
47015195|NCT02202551|83264223|FG000|Overall Study|Needed to take excluded medication|0|||
47015196|NCT02202551|83264224|FG001|Overall Study|Needed to take excluded medication|2|||
47015197|NCT02202551|83264225|FG002|Overall Study|Needed to take excluded medication|0|||
47015198|NCT02202551|83264226|FG003|Overall Study|Needed to take excluded medication|1|||
47015199|NCT02202551|83264223|FG000|Overall Study|Subject moved away|0|||
47015200|NCT02202551|83264224|FG001|Overall Study|Subject moved away|1|||
47015201|NCT02202551|83264225|FG002|Overall Study|Subject moved away|0|||
47015202|NCT02202551|83264226|FG003|Overall Study|Subject moved away|0|||
47015203|NCT02202551|83264223|FG000|Overall Study|DBS surgery|3|||
47015204|NCT02202551|83264224|FG001|Overall Study|DBS surgery|0|||
47015205|NCT02202551|83264225|FG002|Overall Study|DBS surgery|0|||
47015206|NCT02202551|83264226|FG003|Overall Study|DBS surgery|0|||
47015207|NCT02202551|83264223|FG000|Overall Study|Dyskinesia upon taper|1|||
47015208|NCT02202551|83264224|FG001|Overall Study|Dyskinesia upon taper|0|||
47015209|NCT02202551|83264225|FG002|Overall Study|Dyskinesia upon taper|0|||
47015210|NCT02202551|83264226|FG003|Overall Study|Dyskinesia upon taper|0|||
47015211|NCT02202551|83264223|FG000|Overall Study|Lack of Efficacy|0|||
47015212|NCT02202551|83264224|FG001|Overall Study|Lack of Efficacy|1|||
47015213|NCT02202551|83264225|FG002|Overall Study|Lack of Efficacy|0|||
47015214|NCT02202551|83264226|FG003|Overall Study|Lack of Efficacy|0|||
47015215|NCT02202551|83264223|FG000|Overall Study|Physician Decision|1|||
47015216|NCT02202551|83264224|FG001|Overall Study|Physician Decision|0|||
47015217|NCT02202551|83264225|FG002|Overall Study|Physician Decision|0|||
47015218|NCT02202551|83264226|FG003|Overall Study|Physician Decision|0|||
47015219|NCT02202551|83264223|FG000|Overall Study|Site closure|3|||
47015220|NCT02202551|83264224|FG001|Overall Study|Site closure|0|||
47015221|NCT02202551|83264225|FG002|Overall Study|Site closure|0|||
47015222|NCT02202551|83264226|FG003|Overall Study|Site closure|1|||
47015223|NCT02202551|83264223|FG000|Overall Study|Unable to complete visits per protocol|1|||
47015224|NCT02202551|83264224|FG001|Overall Study|Unable to complete visits per protocol|0|||
47015225|NCT02202551|83264225|FG002|Overall Study|Unable to complete visits per protocol|0|||
47015226|NCT02202551|83264226|FG003|Overall Study|Unable to complete visits per protocol|0|||
47015227|NCT02202551|83264223|FG000|Overall Study|Worsening Dyskinesia|0|||
47015228|NCT02202551|83264224|FG001|Overall Study|Worsening Dyskinesia|0|||
47015229|NCT02202551|83264225|FG002|Overall Study|Worsening Dyskinesia|0|||
47015230|NCT02202551|83264226|FG003|Overall Study|Worsening Dyskinesia|1|||
47015231|NCT02202551|83264223|FG000|Overall Study|Protocol Violation|0|||
47015232|NCT02202551|83264224|FG001|Overall Study|Protocol Violation|1|||
47015233|NCT02202551|83264225|FG002|Overall Study|Protocol Violation|0|||
47015234|NCT02202551|83264226|FG003|Overall Study|Protocol Violation|0|||
47015235|NCT02202551|83264223|FG000|Overall Study|Sponsor's decision|2|||
47015236|NCT02202551|83264224|FG001|Overall Study|Sponsor's decision|0|||
47015237|NCT02202551|83264225|FG002|Overall Study|Sponsor's decision|0|||
47015238|NCT02202551|83264226|FG003|Overall Study|Sponsor's decision|0|||
47015239|NCT02202551|83264223|FG000|Overall Study|Subject unwilling to proceed|1|||
47015240|NCT02202551|83264224|FG001|Overall Study|Subject unwilling to proceed|5|||
47015241|NCT02202551|83264225|FG002|Overall Study|Subject unwilling to proceed|3|||
47015242|NCT02202551|83264226|FG003|Overall Study|Subject unwilling to proceed|5|||
47015243|NCT02202551|83264223|FG000|Overall Study|Subject consent withdrawn|0|||
47015244|NCT02202551|83264224|FG001|Overall Study|Subject consent withdrawn|3|||
47015245|NCT02202551|83264225|FG002|Overall Study|Subject consent withdrawn|1|||
47015246|NCT02202551|83264226|FG003|Overall Study|Subject consent withdrawn|2|||
47015247|NCT02202551|83264223|FG000|Overall Study|eGFR<50mL/min/m2|2|||
47015248|NCT02202551|83264224|FG001|Overall Study|eGFR<50mL/min/m2|2|||
47015249|NCT02202551|83264225|FG002|Overall Study|eGFR<50mL/min/m2|0|||
47015250|NCT02202551|83264226|FG003|Overall Study|eGFR<50mL/min/m2|1|||
47015251|NCT02202317|83264240|FG000|Overall Study|Lost to Follow-up|1|||
47015252|NCT02118337|83264253|FG000|Overall Study|Other|1|||
47015253|NCT02118337|83264254|FG001|Overall Study|Other|0|||
47015254|NCT02118337|83264255|FG002|Overall Study|Other|0|||
47015255|NCT02118337|83264256|FG003|Overall Study|Other|0|||
47015256|NCT02118337|83264257|FG004|Overall Study|Other|2|||
47015257|NCT02118337|83264258|FG005|Overall Study|Other|3|||
47015258|NCT02118337|83264259|FG006|Overall Study|Other|1|||
47015259|NCT02118337|83264260|FG007|Overall Study|Other|28|||
47015260|NCT02118337|83264261|FG008|Overall Study|Other|15|||
47015261|NCT02118337|83264253|FG000|Overall Study|Lost to Follow-up|0|||
47015262|NCT02118337|83264254|FG001|Overall Study|Lost to Follow-up|0|||
47015263|NCT02118337|83264255|FG002|Overall Study|Lost to Follow-up|0|||
47015264|NCT02118337|83264256|FG003|Overall Study|Lost to Follow-up|0|||
47015265|NCT02118337|83264257|FG004|Overall Study|Lost to Follow-up|0|||
47015266|NCT02118337|83264258|FG005|Overall Study|Lost to Follow-up|0|||
47015267|NCT02118337|83264259|FG006|Overall Study|Lost to Follow-up|0|||
47015268|NCT02118337|83264260|FG007|Overall Study|Lost to Follow-up|1|||
47015269|NCT02118337|83264261|FG008|Overall Study|Lost to Follow-up|0|||
47015270|NCT02118337|83264253|FG000|Overall Study|Withdrawal by Subject|1|||
47015271|NCT02118337|83264254|FG001|Overall Study|Withdrawal by Subject|3|||
47015272|NCT02118337|83264255|FG002|Overall Study|Withdrawal by Subject|2|||
47015273|NCT02118337|83264256|FG003|Overall Study|Withdrawal by Subject|1|||
47015274|NCT02118337|83264257|FG004|Overall Study|Withdrawal by Subject|2|||
47015275|NCT02118337|83264258|FG005|Overall Study|Withdrawal by Subject|2|||
47015276|NCT02118337|83264259|FG006|Overall Study|Withdrawal by Subject|1|||
47015277|NCT02118337|83264260|FG007|Overall Study|Withdrawal by Subject|4|||
47015278|NCT02118337|83264261|FG008|Overall Study|Withdrawal by Subject|2|||
47015279|NCT02118337|83264253|FG000|Overall Study|Death|2|||
47015280|NCT02118337|83264254|FG001|Overall Study|Death|2|||
47015281|NCT02118337|83264255|FG002|Overall Study|Death|1|||
47015282|NCT02118337|83264256|FG003|Overall Study|Death|2|||
47015283|NCT02118337|83264257|FG004|Overall Study|Death|5|||
47015284|NCT02118337|83264258|FG005|Overall Study|Death|1|||
47015285|NCT02118337|83264259|FG006|Overall Study|Death|2|||
47015286|NCT02118337|83264260|FG007|Overall Study|Death|9|||
47015287|NCT02118337|83264261|FG008|Overall Study|Death|4|||
47015288|NCT02117713|83264285|FG000|Week 48|Adverse Event|4|||
47015289|NCT02117713|83264285|FG000|Week 48|Withdrawal by caregiver|2|||
47015290|NCT02117713|83264285|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
47015291|NCT02117713|83264285|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
47015292|NCT02117713|83264285|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
47015293|NCT02117713|83264285|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
47015294|NCT02105467|83264299|FG000|Period 1|Lost to Follow-up|1|||
47015295|NCT02105467|83264300|FG001|Period 1|Lost to Follow-up|0|||
47015296|NCT02105467|83264299|FG000|Period 1|Death|1|||
47015297|NCT02105467|83264300|FG001|Period 1|Death|0|||
47015298|NCT02105467|83264299|FG000|Period 2|Lost to Follow-up|1|||
47015299|NCT02105467|83264300|FG001|Period 2|Lost to Follow-up|0|||
47015300|NCT02105467|83264299|FG000|Period 2|Death|1|||
47015301|NCT02105467|83264300|FG001|Period 2|Death|0|||
47015302|NCT02105467|83264299|FG000|Period 2|Withdrawal by Subject|0|||
47015303|NCT02105467|83264300|FG001|Period 2|Withdrawal by Subject|2|||
47015304|NCT02105467|83264299|FG000|Period 3|Lost to Follow-up|0|||
47015305|NCT02105467|83264300|FG001|Period 3|Lost to Follow-up|1|||
47015306|NCT02202161|83264315|FG000|Overall Study|Adverse Event|1|||
47015307|NCT02202161|83264316|FG001|Overall Study|Adverse Event|1|||
47015308|NCT02202161|83264317|FG002|Overall Study|Adverse Event|0|||
47015309|NCT02202161|83264318|FG003|Overall Study|Adverse Event|0|||
47015310|NCT02202161|83264319|FG004|Overall Study|Adverse Event|0|||
47015311|NCT02202161|83264320|FG005|Overall Study|Adverse Event|1|||
47015312|NCT02202161|83264321|FG006|Overall Study|Adverse Event|0|||
47015313|NCT02202161|83264322|FG007|Overall Study|Adverse Event|0|||
47015314|NCT02202161|83264315|FG000|Overall Study|Did not meet continuation criteria|0|||
47015315|NCT02202161|83264316|FG001|Overall Study|Did not meet continuation criteria|0|||
47015316|NCT02202161|83264317|FG002|Overall Study|Did not meet continuation criteria|0|||
47015317|NCT02202161|83264318|FG003|Overall Study|Did not meet continuation criteria|0|||
47015318|NCT02202161|83264319|FG004|Overall Study|Did not meet continuation criteria|0|||
47015319|NCT02202161|83264320|FG005|Overall Study|Did not meet continuation criteria|0|||
47015320|NCT02202161|83264321|FG006|Overall Study|Did not meet continuation criteria|0|||
47015321|NCT02202161|83264322|FG007|Overall Study|Did not meet continuation criteria|3|||
47015322|NCT02202161|83264315|FG000|Overall Study|Physician Decision|0|||
47015323|NCT02202161|83264316|FG001|Overall Study|Physician Decision|0|||
47015324|NCT02202161|83264317|FG002|Overall Study|Physician Decision|0|||
47015325|NCT02202161|83264318|FG003|Overall Study|Physician Decision|0|||
47015326|NCT02202161|83264319|FG004|Overall Study|Physician Decision|0|||
47015327|NCT02202161|83264320|FG005|Overall Study|Physician Decision|0|||
47015328|NCT02202161|83264321|FG006|Overall Study|Physician Decision|0|||
47015329|NCT02202161|83264322|FG007|Overall Study|Physician Decision|3|||
47015330|NCT02202161|83264315|FG000|Overall Study|Withdrawal by Subject|0|||
47015331|NCT02202161|83264316|FG001|Overall Study|Withdrawal by Subject|0|||
47015332|NCT02202161|83264317|FG002|Overall Study|Withdrawal by Subject|0|||
47015333|NCT02202161|83264318|FG003|Overall Study|Withdrawal by Subject|0|||
47015334|NCT02202161|83264319|FG004|Overall Study|Withdrawal by Subject|1|||
47015335|NCT02202161|83264320|FG005|Overall Study|Withdrawal by Subject|0|||
47015336|NCT02202161|83264321|FG006|Overall Study|Withdrawal by Subject|0|||
47015337|NCT02202161|83264322|FG007|Overall Study|Withdrawal by Subject|0|||
47073111|NCT01045161|83361494|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
47073112|NCT01045161|83361495|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
47073113|NCT01045161|83361496|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
47073114|NCT01045161|83361494|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
47073115|NCT01045161|83361495|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
47073116|NCT01045161|83361496|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
47073117|NCT01045161|83361494|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
47073118|NCT01045161|83361495|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
47073119|NCT01045161|83361496|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
47015338|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Adverse Event|76|||
47015339|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Adverse Event|0|||
47015340|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Adverse Event|0|||
47015341|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Death|3|||
47015342|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Death|0|||
47015343|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Death|0|||
47015344|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
47015345|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
47015346|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
47015347|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Physician Decision|9|||
47015348|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Physician Decision|0|||
47015349|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Physician Decision|0|||
47015350|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
47015351|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
47015352|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
47015353|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Disease progression|45|||
47015354|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Disease progression|0|||
47015355|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Disease progression|0|||
47015356|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
47015357|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
47015358|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
47015359|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
47015360|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
47015361|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
47015362|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
47015363|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
47015364|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
47015365|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
47015366|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
47015367|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
47015368|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
47015369|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
47015370|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
47015371|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
47015372|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
47015373|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
47015374|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
47015375|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
47015376|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
47015377|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
47015378|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
47015379|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
47015380|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
47015381|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
47015382|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
47015383|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Promotor request|1|||
47015384|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Promotor request|0|||
47015385|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Promotor request|0|||
47015386|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
47015387|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
47015388|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
47015389|NCT01461928|83264341|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
47015390|NCT01461928|83264342|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
47015391|NCT01461928|83264343|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
47015392|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Death|3|||
47015393|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Death|0|||
47015394|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Death|0|||
46910572|NCT03329885|83140108|FG003|Overall Study|Sponsor discontinued the study early|0|||
46910573|NCT03329885|83140109|FG004|Overall Study|Sponsor discontinued the study early|0|||
46910574|NCT03329885|83140110|FG005|Overall Study|Sponsor discontinued the study early|0|||
47015395|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
47015396|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
47015397|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
47015398|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
47015399|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
47015400|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
46910575|NCT03329885|83140111|FG006|Overall Study|Sponsor discontinued the study early|1|||
46910576|NCT03329885|83140112|FG007|Overall Study|Sponsor discontinued the study early|1|||
46910577|NCT03329885|83140113|FG008|Overall Study|Sponsor discontinued the study early|0|||
46910578|NCT02941523|83140135|FG000|Monotherapy|Withdrawal by Subject|0|||
46910579|NCT02941523|83140136|FG001|Monotherapy|Withdrawal by Subject|1|||
46910580|NCT02941523|83140135|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
46910581|NCT02941523|83140136|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
46910582|NCT02941523|83140135|FG000|Carboplatin Combination Therapy|Death|1|||
46910583|NCT02941523|83140136|FG001|Carboplatin Combination Therapy|Death|2|||
46910584|NCT02941523|83140135|FG000|Carboplatin Combination Therapy|Disease progression|2|||
46910585|NCT02941523|83140136|FG001|Carboplatin Combination Therapy|Disease progression|0|||
46910586|NCT02941523|83140135|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
46910587|NCT02941523|83140136|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
46910588|NCT02938585|83140154|FG000|Overall Study|Withdrawal by parent or guardian|0|||
46910589|NCT02938585|83140155|FG001|Overall Study|Withdrawal by parent or guardian|1|||
46910590|NCT02938585|83140156|FG002|Overall Study|Withdrawal by parent or guardian|0|||
46910591|NCT02938585|83140157|FG003|Overall Study|Withdrawal by parent or guardian|0|||
46910592|NCT02938585|83140154|FG000|Overall Study|Withdrawal by Subject|0|||
46910593|NCT02938585|83140155|FG001|Overall Study|Withdrawal by Subject|0|||
46910594|NCT02938585|83140156|FG002|Overall Study|Withdrawal by Subject|0|||
46910595|NCT02938585|83140157|FG003|Overall Study|Withdrawal by Subject|5|||
46910596|NCT03229759|83140181|FG000|Overall Study|Screen Failure|30|||
46910597|NCT03228433|83140193|FG000|Overall Study|Lost to Follow-up|1|||
46910598|NCT03228433|83140194|FG001|Overall Study|Lost to Follow-up|0|||
46910599|NCT03228433|83140195|FG002|Overall Study|Lost to Follow-up|0|||
46910600|NCT03228433|83140196|FG003|Overall Study|Lost to Follow-up|0|||
46910601|NCT03228433|83140197|FG004|Overall Study|Lost to Follow-up|0|||
46910602|NCT03228433|83140198|FG005|Overall Study|Lost to Follow-up|0|||
46910603|NCT03228433|83140193|FG000|Overall Study|Positive alcohol test|0|||
46910604|NCT03228433|83140194|FG001|Overall Study|Positive alcohol test|0|||
46910605|NCT03228433|83140195|FG002|Overall Study|Positive alcohol test|0|||
46910606|NCT03228433|83140196|FG003|Overall Study|Positive alcohol test|1|||
46910607|NCT03228433|83140197|FG004|Overall Study|Positive alcohol test|0|||
46910608|NCT03228433|83140198|FG005|Overall Study|Positive alcohol test|0|||
46910609|NCT01496118|83140228|FG000|Overall Study|Disease progression|3|||
46910610|NCT01496118|83140229|FG001|Overall Study|Disease progression|2|||
46910611|NCT01496118|83140230|FG002|Overall Study|Disease progression|3|||
46910612|NCT01496118|83140231|FG003|Overall Study|Disease progression|1|||
46910613|NCT01496118|83140232|FG004|Overall Study|Disease progression|2|||
46910614|NCT01496118|83140233|FG005|Overall Study|Disease progression|2|||
46910615|NCT01496118|83140234|FG006|Overall Study|Disease progression|14|||
46910616|NCT01496118|83140235|FG007|Overall Study|Disease progression|10|||
46910617|NCT01496118|83140228|FG000|Overall Study|Physician Decision|0|||
46910618|NCT01496118|83140229|FG001|Overall Study|Physician Decision|0|||
46910619|NCT01496118|83140230|FG002|Overall Study|Physician Decision|0|||
47015401|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Diseases progression|91|||
47015402|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Diseases progression|0|||
47015403|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Diseases progression|0|||
47015404|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Adverse Event|70|||
47015405|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Adverse Event|0|||
47015406|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Adverse Event|0|||
47015407|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Physician Decision|9|||
47015408|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Physician Decision|0|||
47015409|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Physician Decision|0|||
47015410|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
47015411|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
47015412|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
47015413|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
47015414|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
47015415|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
47015416|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
47015417|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
47015418|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
47015419|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Not compliant|1|||
46910620|NCT01496118|83140231|FG003|Overall Study|Physician Decision|0|||
46910621|NCT01496118|83140232|FG004|Overall Study|Physician Decision|1|||
46910622|NCT01496118|83140233|FG005|Overall Study|Physician Decision|0|||
46910623|NCT01496118|83140234|FG006|Overall Study|Physician Decision|3|||
46910624|NCT01496118|83140235|FG007|Overall Study|Physician Decision|6|||
46709676|NCT01215188|82925767|FG000|Overall Study|Protocol Violation|1|||
46910625|NCT01496118|83140228|FG000|Overall Study|Adverse Event|1|||
46910626|NCT01496118|83140229|FG001|Overall Study|Adverse Event|1|||
46910627|NCT01496118|83140230|FG002|Overall Study|Adverse Event|0|||
46910628|NCT01496118|83140231|FG003|Overall Study|Adverse Event|0|||
46910629|NCT01496118|83140232|FG004|Overall Study|Adverse Event|0|||
46910630|NCT01496118|83140233|FG005|Overall Study|Adverse Event|0|||
46910631|NCT01496118|83140234|FG006|Overall Study|Adverse Event|6|||
46910632|NCT01496118|83140235|FG007|Overall Study|Adverse Event|10|||
46910633|NCT01496118|83140228|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
46910634|NCT01496118|83140229|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
46910635|NCT01496118|83140230|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
46910636|NCT01496118|83140231|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
46910637|NCT01496118|83140232|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
46910638|NCT01496118|83140233|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
46910639|NCT01496118|83140234|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
46910640|NCT01496118|83140235|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
46910641|NCT01496118|83140228|FG000|Overall Study|Death|0|||
46910642|NCT01496118|83140229|FG001|Overall Study|Death|0|||
46910643|NCT01496118|83140230|FG002|Overall Study|Death|0|||
46910644|NCT01496118|83140231|FG003|Overall Study|Death|0|||
46910645|NCT01496118|83140232|FG004|Overall Study|Death|0|||
46910646|NCT01496118|83140233|FG005|Overall Study|Death|0|||
46910647|NCT01496118|83140234|FG006|Overall Study|Death|1|||
46910648|NCT01496118|83140235|FG007|Overall Study|Death|1|||
46910649|NCT01496118|83140228|FG000|Overall Study|Withdrawal by Subject|0|||
46910650|NCT01496118|83140229|FG001|Overall Study|Withdrawal by Subject|0|||
46910651|NCT01496118|83140230|FG002|Overall Study|Withdrawal by Subject|0|||
46910652|NCT01496118|83140231|FG003|Overall Study|Withdrawal by Subject|2|||
46910653|NCT01496118|83140232|FG004|Overall Study|Withdrawal by Subject|0|||
46910654|NCT01496118|83140233|FG005|Overall Study|Withdrawal by Subject|1|||
46910655|NCT01496118|83140234|FG006|Overall Study|Withdrawal by Subject|6|||
46910656|NCT01496118|83140235|FG007|Overall Study|Withdrawal by Subject|3|||
46910657|NCT02936869|83140255|FG000|Overall Study|Lost to Follow-up|1|||
46910658|NCT02936869|83140256|FG001|Overall Study|Lost to Follow-up|3|||
46910659|NCT02936869|83140255|FG000|Overall Study|Death|0|||
47015420|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Not compliant|0|||
47015421|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Not compliant|0|||
47015422|NCT01461928|83264341|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
47015423|NCT01461928|83264342|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
47015424|NCT01461928|83264343|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
47015425|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Adverse Event|0|||
47015426|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Adverse Event|2|||
47015427|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Adverse Event|0|||
47015428|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Death|0|||
47015429|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Death|10|||
47015430|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Death|8|||
47015431|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Physician Decision|0|||
47015432|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Physician Decision|0|||
47015433|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Physician Decision|4|||
47015434|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
47015435|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
47015436|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
47015437|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Moved to another town|0|||
47015438|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Moved to another town|1|||
47015439|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Moved to another town|0|||
47015440|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Disease progression|0|||
47015441|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Disease progression|0|||
47015442|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Disease progression|3|||
47015443|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
47015444|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
47015445|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
47015446|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
47015447|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
47015448|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
46910660|NCT02936869|83140256|FG001|Overall Study|Death|1|||
46910661|NCT02936869|83140255|FG000|Overall Study|Legal Case|0|||
46910662|NCT02936869|83140256|FG001|Overall Study|Legal Case|1|||
46910663|NCT02936869|83140255|FG000|Overall Study|Protocol Violation|1|||
47015449|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
47015450|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
47015451|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
46910664|NCT02936869|83140256|FG001|Overall Study|Protocol Violation|0|||
46910665|NCT03309605|83140271|FG000|Overall Study|Adverse Event|0|||
46910666|NCT03309605|83140272|FG001|Overall Study|Adverse Event|0|||
47015452|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
47015453|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
47015454|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
47015455|NCT01461928|83264341|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
47015456|NCT01461928|83264342|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
47015457|NCT01461928|83264343|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
47015458|NCT03097991|83264356|FG000|Overall Study|Didn't meet study criteria|8|||
47015459|NCT03097991|83264357|FG001|Overall Study|Didn't meet study criteria|0|||
47015460|NCT03097991|83264356|FG000|Overall Study|Withdrawal by Subject|12|||
47015461|NCT03097991|83264357|FG001|Overall Study|Withdrawal by Subject|6|||
47015462|NCT03097991|83264356|FG000|Overall Study|Death of Baby|3|||
47015463|NCT03097991|83264357|FG001|Overall Study|Death of Baby|1|||
47015464|NCT03097991|83264356|FG000|Overall Study|Lost to Follow-up|24|||
47015465|NCT03097991|83264357|FG001|Overall Study|Lost to Follow-up|38|||
47015466|NCT03097991|83264356|FG000|Overall Study|Adverse Event|3|||
47015467|NCT03097991|83264357|FG001|Overall Study|Adverse Event|5|||
47015468|NCT02623205|83264369|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
47015469|NCT02623205|83264370|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
47015470|NCT01500694|83264379|FG000|Overall Study|Adverse Event|4|||
47015471|NCT01500694|83264380|FG001|Overall Study|Adverse Event|3|||
47015472|NCT01500694|83264379|FG000|Overall Study|Protocol Violation|0|||
47015473|NCT01500694|83264380|FG001|Overall Study|Protocol Violation|1|||
47015474|NCT01500694|83264379|FG000|Overall Study|Withdrawal by Subject|23|||
47015475|NCT01500694|83264380|FG001|Overall Study|Withdrawal by Subject|14|||
47015476|NCT01500694|83264379|FG000|Overall Study|Lost to Follow-up|2|||
47015477|NCT01500694|83264380|FG001|Overall Study|Lost to Follow-up|3|||
47015478|NCT01500694|83264379|FG000|Overall Study|Lack of Efficacy|14|||
47015479|NCT01500694|83264380|FG001|Overall Study|Lack of Efficacy|5|||
47015480|NCT01500694|83264379|FG000|Overall Study|Other|9|||
47015481|NCT01500694|83264380|FG001|Overall Study|Other|3|||
47015482|NCT01500382|83264390|FG000|Washout Period|Study site went out of business|0|||
47015483|NCT01500382|83264391|FG001|Washout Period|Study site went out of business|0|||
47015484|NCT01500382|83264392|FG002|Washout Period|Study site went out of business|1|||
47015485|NCT01500382|83264393|FG003|Washout Period|Study site went out of business|0|||
47015486|NCT02137837|83264406|FG000|Overall Study|Adverse Event|0|||
47015487|NCT02137837|83264407|FG001|Overall Study|Adverse Event|2|||
47015488|NCT02137837|83264408|FG002|Overall Study|Adverse Event|1|||
47015489|NCT02137837|83264406|FG000|Overall Study|Refusal unrelated to adverse event|2|||
47015490|NCT02137837|83264407|FG001|Overall Study|Refusal unrelated to adverse event|2|||
47015491|NCT02137837|83264408|FG002|Overall Study|Refusal unrelated to adverse event|1|||
47015492|NCT02137837|83264406|FG000|Overall Study|Progression/relapse|9|||
47015493|NCT02137837|83264407|FG001|Overall Study|Progression/relapse|7|||
47015494|NCT02137837|83264408|FG002|Overall Study|Progression/relapse|7|||
47015495|NCT02137837|83264406|FG000|Overall Study|Not protocol specified|2|||
47015496|NCT02137837|83264407|FG001|Overall Study|Not protocol specified|1|||
47015497|NCT02137837|83264408|FG002|Overall Study|Not protocol specified|3|||
47015498|NCT01483690|83264423|FG000|Overall Study|Adverse Event|1|||
47015499|NCT01483690|83264424|FG001|Overall Study|Adverse Event|2|||
47015500|NCT01483690|83264423|FG000|Overall Study|clinical deterioration|1|||
47015501|NCT01483690|83264424|FG001|Overall Study|clinical deterioration|0|||
47015502|NCT01483690|83264423|FG000|Overall Study|Physician Decision|0|||
47015503|NCT01483690|83264424|FG001|Overall Study|Physician Decision|2|||
47015504|NCT01483690|83264423|FG000|Overall Study|exclusionary procedure|0|||
47015505|NCT01483690|83264424|FG001|Overall Study|exclusionary procedure|1|||
47015506|NCT02104765|83264437|FG000|Overall Study|Lost to Follow-up|0|||
47015507|NCT02104765|83264438|FG001|Overall Study|Lost to Follow-up|0|||
47015508|NCT02104765|83264439|FG002|Overall Study|Lost to Follow-up|1|||
47015509|NCT02104765|83264440|FG003|Overall Study|Lost to Follow-up|0|||
47015510|NCT02104765|83264441|FG004|Overall Study|Lost to Follow-up|0|||
47015511|NCT02104765|83264442|FG005|Overall Study|Lost to Follow-up|0|||
47015512|NCT02104765|83264443|FG006|Overall Study|Lost to Follow-up|0|||
47015513|NCT02104765|83264437|FG000|Overall Study|Withdrawal by Subject|0|||
47015514|NCT02104765|83264438|FG001|Overall Study|Withdrawal by Subject|0|||
47015515|NCT02104765|83264439|FG002|Overall Study|Withdrawal by Subject|0|||
47015516|NCT02104765|83264440|FG003|Overall Study|Withdrawal by Subject|1|||
47015517|NCT02104765|83264441|FG004|Overall Study|Withdrawal by Subject|1|||
47015518|NCT02104765|83264442|FG005|Overall Study|Withdrawal by Subject|0|||
47015519|NCT02104765|83264443|FG006|Overall Study|Withdrawal by Subject|1|||
47015520|NCT01483144|83264468|FG000|Overall Study|Adverse Event|9|||
47015521|NCT01483144|83264469|FG001|Overall Study|Adverse Event|4|||
47015522|NCT01483144|83264470|FG002|Overall Study|Adverse Event|6|||
47015523|NCT01483144|83264468|FG000|Overall Study|Withdrawal by Subject|0|||
47015524|NCT01483144|83264469|FG001|Overall Study|Withdrawal by Subject|2|||
47015525|NCT01483144|83264470|FG002|Overall Study|Withdrawal by Subject|5|||
47015526|NCT01483144|83264468|FG000|Overall Study|Physician Decision|1|||
47015527|NCT01483144|83264469|FG001|Overall Study|Physician Decision|0|||
47015528|NCT01483144|83264470|FG002|Overall Study|Physician Decision|0|||
47015529|NCT01483144|83264468|FG000|Overall Study|Lost to Follow-up|2|||
47015530|NCT01483144|83264469|FG001|Overall Study|Lost to Follow-up|4|||
47015531|NCT01483144|83264470|FG002|Overall Study|Lost to Follow-up|1|||
47015532|NCT01483144|83264468|FG000|Overall Study|Protocol Violation|3|||
47015533|NCT01483144|83264469|FG001|Overall Study|Protocol Violation|3|||
47015534|NCT01483144|83264470|FG002|Overall Study|Protocol Violation|3|||
47015535|NCT01881789|83264484|FG000|Overall Study|Withdrawal by Subject|0|||
47015536|NCT01881789|83264485|FG001|Overall Study|Withdrawal by Subject|2|||
47015537|NCT01881789|83264486|FG002|Overall Study|Withdrawal by Subject|1|||
47015538|NCT01881789|83264487|FG003|Overall Study|Withdrawal by Subject|0|||
47015539|NCT01881789|83264488|FG004|Overall Study|Withdrawal by Subject|1|||
47015540|NCT01881789|83264489|FG005|Overall Study|Withdrawal by Subject|1|||
47015541|NCT01881789|83264484|FG000|Overall Study|Study Terminated by Sponsor|0|||
47015542|NCT01881789|83264485|FG001|Overall Study|Study Terminated by Sponsor|0|||
47015543|NCT01881789|83264486|FG002|Overall Study|Study Terminated by Sponsor|0|||
47015544|NCT01881789|83264487|FG003|Overall Study|Study Terminated by Sponsor|0|||
47015545|NCT01881789|83264488|FG004|Overall Study|Study Terminated by Sponsor|0|||
47015546|NCT01881789|83264489|FG005|Overall Study|Study Terminated by Sponsor|1|||
47015547|NCT01881789|83264484|FG000|Overall Study|Other|3|||
47015548|NCT01881789|83264485|FG001|Overall Study|Other|5|||
47015549|NCT01881789|83264486|FG002|Overall Study|Other|2|||
47015550|NCT01881789|83264487|FG003|Overall Study|Other|3|||
47015551|NCT01881789|83264488|FG004|Overall Study|Other|1|||
47015552|NCT01881789|83264489|FG005|Overall Study|Other|1|||
47015553|NCT02075203|83264507|FG000|Overall Study|Withdrawal by Subject|1|||
47015554|NCT02075203|83264508|FG001|Overall Study|Withdrawal by Subject|0|||
47015555|NCT02075203|83264509|FG002|Overall Study|Withdrawal by Subject|1|||
47015556|NCT02075203|83264507|FG000|Overall Study|Adverse Event|1|||
47015557|NCT02075203|83264508|FG001|Overall Study|Adverse Event|0|||
47015558|NCT02075203|83264509|FG002|Overall Study|Adverse Event|0|||
47015559|NCT02075203|83264507|FG000|Overall Study|participant refused to use contraception|1|||
47015560|NCT02075203|83264508|FG001|Overall Study|participant refused to use contraception|0|||
47015561|NCT02075203|83264509|FG002|Overall Study|participant refused to use contraception|0|||
47015562|NCT01892163|83264519|FG000|Overall Study|Death|1|||
47015563|NCT01892163|83264520|FG001|Overall Study|Death|1|||
47015564|NCT01892163|83264519|FG000|Overall Study|Lost to Follow-up|1|||
47015565|NCT01892163|83264520|FG001|Overall Study|Lost to Follow-up|0|||
47015566|NCT01881009|83264528|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
47015567|NCT01881009|83264529|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
47015568|NCT04843930|83264563|FG000|Randomization|Withdrawal by Subject|6|||
47015569|NCT04843930|83264564|FG001|Randomization|Withdrawal by Subject|6|||
47015570|NCT04843930|83264565|FG002|Randomization|Withdrawal by Subject|0|||
47015571|NCT04843930|83264566|FG003|Randomization|Withdrawal by Subject|0|||
47015572|NCT04843930|83264563|FG000|Week 6 Assessment|Adverse Event|3|||
47015573|NCT04843930|83264564|FG001|Week 6 Assessment|Adverse Event|0|||
47015574|NCT04843930|83264565|FG002|Week 6 Assessment|Adverse Event|0|||
47015575|NCT04843930|83264566|FG003|Week 6 Assessment|Adverse Event|0|||
47015576|NCT04843930|83264563|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
47015577|NCT04843930|83264564|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
47015578|NCT04843930|83264565|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
47015579|NCT04843930|83264566|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
47015580|NCT04843930|83264563|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
47015581|NCT04843930|83264564|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
47015582|NCT04843930|83264565|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
47015583|NCT04843930|83264566|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
47015584|NCT04728815|83264582|FG000|Overall Study|Lost to Follow-up|3|||
47015585|NCT04728815|83264583|FG001|Overall Study|Lost to Follow-up|0|||
47015586|NCT04728815|83264584|FG002|Overall Study|Lost to Follow-up|0|||
47015587|NCT04728815|83264585|FG003|Overall Study|Lost to Follow-up|1|||
47015588|NCT04728815|83264586|FG004|Overall Study|Lost to Follow-up|1|||
47015589|NCT04728815|83264587|FG005|Overall Study|Lost to Follow-up|0|||
47015590|NCT04728815|83264588|FG006|Overall Study|Lost to Follow-up|2|||
47015591|NCT04728815|83264589|FG007|Overall Study|Lost to Follow-up|0|||
47015592|NCT04728815|83264582|FG000|Overall Study|Physician Decision|0|||
47015593|NCT04728815|83264583|FG001|Overall Study|Physician Decision|0|||
47015594|NCT04728815|83264584|FG002|Overall Study|Physician Decision|1|||
47015595|NCT04728815|83264585|FG003|Overall Study|Physician Decision|0|||
47015596|NCT04728815|83264586|FG004|Overall Study|Physician Decision|0|||
47015597|NCT04728815|83264587|FG005|Overall Study|Physician Decision|0|||
47015598|NCT04728815|83264588|FG006|Overall Study|Physician Decision|0|||
47015599|NCT04728815|83264589|FG007|Overall Study|Physician Decision|0|||
47015600|NCT04728815|83264582|FG000|Overall Study|Treatment drop|0|||
47015601|NCT04728815|83264583|FG001|Overall Study|Treatment drop|2|||
47015602|NCT04728815|83264584|FG002|Overall Study|Treatment drop|1|||
47015603|NCT04728815|83264585|FG003|Overall Study|Treatment drop|0|||
47015604|NCT04728815|83264586|FG004|Overall Study|Treatment drop|3|||
47015605|NCT04728815|83264587|FG005|Overall Study|Treatment drop|1|||
47015606|NCT04728815|83264588|FG006|Overall Study|Treatment drop|3|||
47015607|NCT04728815|83264589|FG007|Overall Study|Treatment drop|0|||
47015608|NCT04728815|83264582|FG000|Overall Study|Study drop|0|||
47015609|NCT04728815|83264583|FG001|Overall Study|Study drop|3|||
47015610|NCT04728815|83264584|FG002|Overall Study|Study drop|3|||
47015611|NCT04728815|83264585|FG003|Overall Study|Study drop|0|||
47015612|NCT04728815|83264586|FG004|Overall Study|Study drop|0|||
47015613|NCT04728815|83264587|FG005|Overall Study|Study drop|0|||
47015614|NCT04728815|83264588|FG006|Overall Study|Study drop|7|||
47015615|NCT04728815|83264589|FG007|Overall Study|Study drop|0|||
47015616|NCT04345471|83264616|FG000|Overall Study|Adverse Event|8|||
47015617|NCT04345471|83264617|FG001|Overall Study|Adverse Event|5|||
47015618|NCT04345471|83264618|FG002|Overall Study|Adverse Event|6|||
47015619|NCT04345471|83264616|FG000|Overall Study|Lack of Efficacy|1|||
47015620|NCT04345471|83264617|FG001|Overall Study|Lack of Efficacy|1|||
47015621|NCT04345471|83264618|FG002|Overall Study|Lack of Efficacy|0|||
47015622|NCT04345471|83264616|FG000|Overall Study|Protocol Violation|0|||
47015623|NCT04345471|83264617|FG001|Overall Study|Protocol Violation|1|||
47015624|NCT04345471|83264618|FG002|Overall Study|Protocol Violation|2|||
47015625|NCT04345471|83264616|FG000|Overall Study|Withdrawal by Subject|10|||
47015626|NCT04345471|83264617|FG001|Overall Study|Withdrawal by Subject|5|||
47015627|NCT04345471|83264618|FG002|Overall Study|Withdrawal by Subject|10|||
47015628|NCT04237116|83264637|FG000|Overall Study|Adverse Event|0|||
47015629|NCT04237116|83264638|FG001|Overall Study|Adverse Event|1|||
47015630|NCT04237116|83264637|FG000|Overall Study|Study terminated by Sponsor|4|||
47015631|NCT04237116|83264638|FG001|Overall Study|Study terminated by Sponsor|1|||
47015632|NCT04102098|83264646|FG000|Main Study Period|Ongoing in study|302|||
47015633|NCT04102098|83264647|FG001|Main Study Period|Ongoing in study|291|||
47015634|NCT04102098|83264646|FG000|Main Study Period|Death|20|||
47015635|NCT04102098|83264647|FG001|Main Study Period|Death|27|||
47015636|NCT04102098|83264646|FG000|Main Study Period|Lost to Follow-up|1|||
47015637|NCT04102098|83264647|FG001|Main Study Period|Lost to Follow-up|1|||
47015638|NCT04102098|83264646|FG000|Main Study Period|Physician Decision|0|||
47015639|NCT04102098|83264647|FG001|Main Study Period|Physician Decision|1|||
47015640|NCT04102098|83264646|FG000|Main Study Period|Withdrawal by Subject|11|||
47015641|NCT04102098|83264647|FG001|Main Study Period|Withdrawal by Subject|14|||
47015642|NCT04102098|83264646|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
47015643|NCT04102098|83264647|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
47015644|NCT04102098|83264646|FG000|Crossover: AS Who Crossed Over|Death|11|||
47015645|NCT04102098|83264647|FG001|Crossover: AS Who Crossed Over|Death|0|||
47015646|NCT04102098|83264646|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
47015647|NCT04102098|83264647|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
47015648|NCT03917459|83264657|FG000|Overall Study|Adverse Event|1|||
47015649|NCT03917459|83264658|FG001|Overall Study|Adverse Event|0|||
47015650|NCT03917459|83264657|FG000|Overall Study|Withdrawal by Subject|0|||
47015651|NCT03917459|83264658|FG001|Overall Study|Withdrawal by Subject|1|||
47015652|NCT03718533|83264683|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
47015653|NCT03718533|83264683|FG000|Overall Study|Protocol deviation|1|||
47015654|NCT03718533|83264683|FG000|Overall Study|Disease progression|1|||
47015655|NCT03718533|83264683|FG000|Overall Study|Relapse|1|||
47015656|NCT03718533|83264683|FG000|Overall Study|Physician Decision|2|||
47015657|NCT03718533|83264683|FG000|Overall Study|Physician Decision and Adverse Event|1|||
47015658|NCT03481660|83264703|FG000|Overall Study|Adverse Event|5|||
47015659|NCT03481660|83264704|FG001|Overall Study|Adverse Event|4|||
47015660|NCT03481660|83264703|FG000|Overall Study|Death|13|||
47015661|NCT03481660|83264704|FG001|Overall Study|Death|9|||
47015662|NCT03481660|83264703|FG000|Overall Study|Lost to Follow-up|2|||
47015663|NCT03481660|83264704|FG001|Overall Study|Lost to Follow-up|2|||
47015664|NCT03481660|83264703|FG000|Overall Study|Physician Decision|2|||
47015665|NCT03481660|83264704|FG001|Overall Study|Physician Decision|3|||
47015666|NCT03481660|83264703|FG000|Overall Study|Withdrawal by Subject|14|||
47015667|NCT03481660|83264704|FG001|Overall Study|Withdrawal by Subject|7|||
47015668|NCT03471182|83264714|FG000|Overall Study|Withdrawal by Subject|1|||
47015669|NCT03471182|83264715|FG001|Overall Study|Withdrawal by Subject|1|||
47015670|NCT03471182|83264716|FG002|Overall Study|Withdrawal by Subject|0|||
47015671|NCT03471182|83264714|FG000|Overall Study|Technical failure|2|||
47015672|NCT03471182|83264715|FG001|Overall Study|Technical failure|0|||
47015673|NCT03471182|83264716|FG002|Overall Study|Technical failure|0|||
47015674|NCT03412565|83264727|FG000|Overall Study|Lost to Follow-up|0|||
47015675|NCT03412565|83264728|FG001|Overall Study|Lost to Follow-up|0|||
47015676|NCT03412565|83264729|FG002|Overall Study|Lost to Follow-up|1|||
47015677|NCT03412565|83264730|FG003|Overall Study|Lost to Follow-up|0|||
47015678|NCT03412565|83264727|FG000|Overall Study|Physician Decision|0|||
47015679|NCT03412565|83264728|FG001|Overall Study|Physician Decision|0|||
47015680|NCT03412565|83264729|FG002|Overall Study|Physician Decision|0|||
47015681|NCT03412565|83264730|FG003|Overall Study|Physician Decision|1|||
47015682|NCT03412565|83264727|FG000|Overall Study|Withdrawal by Subject|0|||
47015683|NCT03412565|83264728|FG001|Overall Study|Withdrawal by Subject|4|||
47015684|NCT03412565|83264729|FG002|Overall Study|Withdrawal by Subject|5|||
47015685|NCT03412565|83264730|FG003|Overall Study|Withdrawal by Subject|5|||
47015686|NCT03412565|83264727|FG000|Overall Study|Death|1|||
47015687|NCT03412565|83264728|FG001|Overall Study|Death|3|||
47015688|NCT03412565|83264729|FG002|Overall Study|Death|4|||
47015689|NCT03412565|83264730|FG003|Overall Study|Death|5|||
47015690|NCT03412565|83264727|FG000|Overall Study|Data collection ended|0|||
47015691|NCT03412565|83264728|FG001|Overall Study|Data collection ended|41|||
47015692|NCT03412565|83264729|FG002|Overall Study|Data collection ended|41|||
47015693|NCT03412565|83264730|FG003|Overall Study|Data collection ended|40|||
47015694|NCT03379727|83264743|FG000|Overall Study|Lack of Efficacy|73|||
47015695|NCT03379727|83264743|FG000|Overall Study|Adverse Event|32|||
47015696|NCT03379727|83264743|FG000|Overall Study|Death|18|||
47015697|NCT03379727|83264743|FG000|Overall Study|Patient/guardian decision|17|||
47015698|NCT03379727|83264743|FG000|Overall Study|Physician Decision|104|||
47015699|NCT03379727|83264743|FG000|Overall Study|Protocol Violation|4|||
47015700|NCT03379727|83264743|FG000|Overall Study|Lost to Follow-up|1|||
47015701|NCT03280056|83264752|FG000|Overall Study|Withdrawal by Subject|12|||
47015702|NCT03280056|83264753|FG001|Overall Study|Withdrawal by Subject|14|||
47015703|NCT03280056|83264752|FG000|Overall Study|Death|9|||
47015704|NCT03280056|83264753|FG001|Overall Study|Death|2|||
47015705|NCT03280056|83264752|FG000|Overall Study|Adverse Event|1|||
47015706|NCT03280056|83264753|FG001|Overall Study|Adverse Event|3|||
47015707|NCT03280056|83264752|FG000|Overall Study|Lost to Follow-up|1|||
47015708|NCT03280056|83264753|FG001|Overall Study|Lost to Follow-up|1|||
47015709|NCT03280056|83264752|FG000|Overall Study|Physician Decision|0|||
47015710|NCT03280056|83264753|FG001|Overall Study|Physician Decision|1|||
47015711|NCT03280056|83264752|FG000|Overall Study|Early Discontinuation|1|||
47015712|NCT03280056|83264753|FG001|Overall Study|Early Discontinuation|0|||
47015713|NCT03183388|83264778|FG000|Overall Study|Lost to Follow-up|3|||
47015714|NCT03183388|83264779|FG001|Overall Study|Lost to Follow-up|5|||
47015715|NCT03183388|83264778|FG000|Overall Study|Physician Decision|1|||
47015716|NCT03183388|83264779|FG001|Overall Study|Physician Decision|4|||
47015717|NCT03183388|83264778|FG000|Overall Study|Withdrawal by Subject|4|||
47015718|NCT03183388|83264779|FG001|Overall Study|Withdrawal by Subject|1|||
47015719|NCT03183388|83264778|FG000|Overall Study|Moved|1|||
47015720|NCT03183388|83264779|FG001|Overall Study|Moved|0|||
47015721|NCT03183388|83264778|FG000|Overall Study|Met Exclusion Criteria|2|||
47015722|NCT03183388|83264779|FG001|Overall Study|Met Exclusion Criteria|2|||
47015723|NCT03183388|83264778|FG000|Overall Study|COVID Pandemic Related|2|||
47015724|NCT03183388|83264779|FG001|Overall Study|COVID Pandemic Related|4|||
47015725|NCT02667587|83264826|FG000|Pre-Treatment|Not reported|1|||
47015726|NCT02667587|83264827|FG001|Pre-Treatment|Not reported|0|||
47015727|NCT02667587|83264826|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
47015728|NCT02667587|83264827|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
47015729|NCT02667587|83264826|FG000|Pre-Treatment|Participant withdrew consent|0|||
47015730|NCT02667587|83264827|FG001|Pre-Treatment|Participant withdrew consent|1|||
47015731|NCT02667587|83264826|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
47015732|NCT02667587|83264827|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
47015733|NCT02667587|83264826|FG000|End of Treatment|Other reasons|11|||
47015734|NCT02667587|83264827|FG001|End of Treatment|Other reasons|8|||
47015735|NCT02667587|83264826|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
47015736|NCT02667587|83264827|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
47015737|NCT02667587|83264826|FG000|End of Treatment|Poor/Non-Compliance|0|||
47015738|NCT02667587|83264827|FG001|End of Treatment|Poor/Non-Compliance|1|||
47015739|NCT02667587|83264826|FG000|End of Treatment|Maximum Clinical Benefit|3|||
47015740|NCT02667587|83264827|FG001|End of Treatment|Maximum Clinical Benefit|3|||
47015741|NCT02667587|83264826|FG000|End of Treatment|Participant Withdrew Consent|5|||
47015742|NCT02667587|83264827|FG001|End of Treatment|Participant Withdrew Consent|6|||
47015743|NCT02667587|83264826|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
47015744|NCT02667587|83264827|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
47015745|NCT02667587|83264826|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
47015746|NCT02667587|83264827|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
47015747|NCT02667587|83264826|FG000|End of Treatment|Death|2|||
47015748|NCT02667587|83264827|FG001|End of Treatment|Death|1|||
47015749|NCT02667587|83264826|FG000|End of Treatment|Study Drug Toxicity|74|||
47015750|NCT02667587|83264827|FG001|End of Treatment|Study Drug Toxicity|18|||
47015751|NCT02667587|83264826|FG000|End of Treatment|Disease progression|177|||
47015752|NCT02667587|83264827|FG001|End of Treatment|Disease progression|222|||
47015753|NCT02667587|83264826|FG000|End of Treatment|Lost to Follow-up|1|||
47015754|NCT02667587|83264827|FG001|End of Treatment|Lost to Follow-up|3|||
47015755|NCT02195479|83264848|FG000|Overall Study|Lost to Follow-up|3|||
47015756|NCT02195479|83264849|FG001|Overall Study|Lost to Follow-up|0|||
47015757|NCT02195479|83264848|FG000|Overall Study|Death|48|||
47015758|NCT02195479|83264849|FG001|Overall Study|Death|45|||
47015759|NCT02195479|83264848|FG000|Overall Study|Physician Decision|1|||
47015760|NCT02195479|83264849|FG001|Overall Study|Physician Decision|0|||
47015761|NCT02195479|83264848|FG000|Overall Study|Withdrawal by Subject|11|||
47015762|NCT02195479|83264849|FG001|Overall Study|Withdrawal by Subject|6|||
47015763|NCT02195479|83264848|FG000|Overall Study|Other|2|||
47015764|NCT02195479|83264849|FG001|Overall Study|Other|2|||
47015765|NCT02195479|83264848|FG000|Overall Study|Ongoing|291|||
47015766|NCT02195479|83264849|FG001|Overall Study|Ongoing|297|||
47015767|NCT02181621|83264857|FG000|Overall Study|Adverse Event|1|||
47015768|NCT02181621|83264858|FG001|Overall Study|Adverse Event|0|||
47015769|NCT02181621|83264857|FG000|Overall Study|Previously Enrolled|0|||
47015770|NCT02181621|83264858|FG001|Overall Study|Previously Enrolled|1|||
47015771|NCT02181621|83264857|FG000|Overall Study|Enrollment Hold|1|||
47015772|NCT02181621|83264858|FG001|Overall Study|Enrollment Hold|1|||
47015773|NCT01844986|83264872|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
47015774|NCT01844986|83264873|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
47015775|NCT01844986|83264872|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
47015776|NCT01844986|83264873|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
47015777|NCT01844986|83264872|FG000|Overall Study (Global Cohort)|Death|55|||
47015778|NCT01844986|83264873|FG001|Overall Study (Global Cohort)|Death|26|||
47015779|NCT01844986|83264872|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
47015780|NCT01844986|83264873|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
47015781|NCT01844986|83264872|FG000|Overall Study (China Cohort)|Death|10|||
47015782|NCT01844986|83264873|FG001|Overall Study (China Cohort)|Death|6|||
47015783|NCT01784068|83264883|FG000|NTCS Phase|Adverse Event|5|||
47015784|NCT01784068|83264884|FG001|NTCS Phase|Adverse Event|0|||
47015785|NCT01784068|83264883|FG000|NTCS Phase|Physician Decision|2|||
47015786|NCT01784068|83264884|FG001|NTCS Phase|Physician Decision|0|||
47015787|NCT01784068|83264883|FG000|NTCS Phase|Patient/guardian decision|3|||
47015788|NCT01784068|83264884|FG001|NTCS Phase|Patient/guardian decision|0|||
46620534|NCT01749137|82769766|FG001|Overall Study|Withdrawal by Subject|4|||
47015789|NCT01784068|83264883|FG000|NTCS Phase|Death|2|||
47015790|NCT01784068|83264884|FG001|NTCS Phase|Death|0|||
47015791|NCT01784068|83264883|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
47015792|NCT01784068|83264884|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
47015793|NCT01784068|83264883|FG000|TFR Phase|Physician Decision|0|||
47015794|NCT01784068|83264884|FG001|TFR Phase|Physician Decision|1|||
47015795|NCT01784068|83264883|FG000|TFR Phase|Patient/guardian decision|0|||
47015796|NCT01784068|83264884|FG001|TFR Phase|Patient/guardian decision|3|||
47015797|NCT01784068|83264883|FG000|TFR Phase|Death|0|||
47015798|NCT01784068|83264884|FG001|TFR Phase|Death|1|||
47015799|NCT01784068|83264883|FG000|TFR Phase|Lack of Efficacy|0|||
47015800|NCT01784068|83264884|FG001|TFR Phase|Lack of Efficacy|88|||
47015801|NCT01698905|83264895|FG000|Overall Study|Adverse Event|4|||
47015802|NCT01698905|83264895|FG000|Overall Study|Physician Decision|2|||
47015803|NCT01698905|83264895|FG000|Overall Study|Pregnancy|1|||
47015804|NCT01698905|83264895|FG000|Overall Study|Protocol Violation|1|||
47015805|NCT01698905|83264895|FG000|Overall Study|Subject/guardian decision|2|||
47015806|NCT01698905|83264895|FG000|Overall Study|Death|1|||
47015807|NCT01500226|83264923|FG000|Overall Study|Adverse Event|31|||
47015808|NCT01500226|83264924|FG001|Overall Study|Adverse Event|38|||
47015809|NCT01500226|83264923|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
47015810|NCT01500226|83264924|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
47015811|NCT01500226|83264923|FG000|Overall Study|Withdrawal by Subject|93|||
47015812|NCT01500226|83264924|FG001|Overall Study|Withdrawal by Subject|96|||
47015813|NCT01500226|83264923|FG000|Overall Study|Death|12|||
47015814|NCT01500226|83264924|FG001|Overall Study|Death|4|||
47015815|NCT01500226|83264923|FG000|Overall Study|Disease Progression|16|||
47015816|NCT01500226|83264924|FG001|Overall Study|Disease Progression|14|||
47015817|NCT01500226|83264923|FG000|Overall Study|Protocol Violation|53|||
47015818|NCT01500226|83264924|FG001|Overall Study|Protocol Violation|39|||
47015819|NCT01500226|83264923|FG000|Overall Study|Physician Decision|17|||
47015820|NCT01500226|83264924|FG001|Overall Study|Physician Decision|15|||
47015821|NCT01500226|83264923|FG000|Overall Study|Lack of Efficacy|14|||
47015822|NCT01500226|83264924|FG001|Overall Study|Lack of Efficacy|30|||
47015823|NCT01500226|83264923|FG000|Overall Study|Lost to Follow-up|9|||
47015824|NCT01500226|83264924|FG001|Overall Study|Lost to Follow-up|5|||
47015825|NCT01500226|83264923|FG000|Overall Study|Other Reasons|19|||
47015826|NCT01500226|83264924|FG001|Overall Study|Other Reasons|16|||
47015827|NCT02075047|83264932|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
47015828|NCT02075047|83264933|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
47015829|NCT02075047|83264932|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
47015830|NCT02075047|83264933|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
47015831|NCT02075047|83264932|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
47015832|NCT02075047|83264933|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
47015833|NCT02075047|83264932|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
47015834|NCT02075047|83264933|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
47015835|NCT02075047|83264932|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
47015836|NCT02075047|83264933|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
47015837|NCT02075047|83264932|FG000|Treatment Phase (4 Weeks)|Other|1|||
47015838|NCT02075047|83264933|FG001|Treatment Phase (4 Weeks)|Other|1|||
47015839|NCT02075047|83264932|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
47015840|NCT02075047|83264933|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
47015841|NCT02075047|83264932|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
47015842|NCT02075047|83264933|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
47015843|NCT02075047|83264932|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
47015844|NCT02075047|83264933|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
47015845|NCT02075047|83264932|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
47015846|NCT02075047|83264933|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
47015847|NCT02075047|83264932|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
47015848|NCT02075047|83264933|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
47015849|NCT02075047|83264932|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
47015850|NCT02075047|83264933|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
47015851|NCT02075047|83264932|FG000|Follow up Phase (5 Weeks)|Other|1|||
47015852|NCT02075047|83264933|FG001|Follow up Phase (5 Weeks)|Other|2|||
47015853|NCT02075047|83264932|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
47015854|NCT02075047|83264933|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
47015855|NCT01859949|83264941|FG000|Overall Study|Family Matters|0|||
47015856|NCT01859949|83264942|FG001|Overall Study|Family Matters|1|||
47015857|NCT01859949|83264941|FG000|Overall Study|Physician Decision|2|||
47015858|NCT01859949|83264942|FG001|Overall Study|Physician Decision|4|||
47015859|NCT01859949|83264941|FG000|Overall Study|Withdrawal by Subject|11|||
47015860|NCT01859949|83264942|FG001|Overall Study|Withdrawal by Subject|10|||
47015861|NCT01859949|83264941|FG000|Overall Study|Protocol Violation|1|||
47015862|NCT01859949|83264942|FG001|Overall Study|Protocol Violation|1|||
47015863|NCT01859949|83264941|FG000|Overall Study|Adverse Event|0|||
47015864|NCT01859949|83264942|FG001|Overall Study|Adverse Event|1|||
47015865|NCT01859793|83264950|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
47015866|NCT01859793|83264951|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
47015867|NCT01859793|83264950|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
47015868|NCT01859793|83264951|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
47015869|NCT01859793|83264950|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
47015870|NCT01859793|83264951|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
47015871|NCT01859793|83264950|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
47015872|NCT01859793|83264951|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
47015873|NCT01859715|83264960|FG000|Overall Study|No 2nd VAS|16|||
47015874|NCT01859715|83264961|FG001|Overall Study|No 2nd VAS|8|||
47015875|NCT01859715|83264962|FG002|Overall Study|No 2nd VAS|23|||
47015876|NCT01890915|83264974|FG000|Overall Study|Adverse Event|1|||
47015877|NCT01890915|83264975|FG001|Overall Study|Adverse Event|0|||
47015878|NCT01890915|83264974|FG000|Overall Study|Protocol Violation|2|||
47015879|NCT01890915|83264975|FG001|Overall Study|Protocol Violation|0|||
47015880|NCT01890915|83264974|FG000|Overall Study|Equipment Malfunction|0|||
47015881|NCT01890915|83264975|FG001|Overall Study|Equipment Malfunction|1|||
47015882|NCT01615263|83264983|FG000|Overall Study|Post-randomization exclusion|0|||
47015883|NCT01615263|83264984|FG001|Overall Study|Post-randomization exclusion|2|||
47015884|NCT01859403|83265001|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
47015885|NCT01859403|83265002|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
47015886|NCT01859403|83265001|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
47015887|NCT01859403|83265002|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
47015888|NCT01859403|83265001|FG000|Primary Endpoint Measure|Physician Decision|0|||
47015889|NCT01859403|83265002|FG001|Primary Endpoint Measure|Physician Decision|1|||
47015890|NCT01859403|83265001|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
46709677|NCT01215188|82925768|FG001|Overall Study|Protocol Violation|1|||
46709678|NCT01215188|82925769|FG002|Overall Study|Protocol Violation|1|||
46910667|NCT03309605|83140273|FG002|Overall Study|Adverse Event|0|||
46910668|NCT03309605|83140274|FG003|Overall Study|Adverse Event|1|||
46910669|NCT03309605|83140275|FG004|Overall Study|Adverse Event|0|||
47015891|NCT01859403|83265002|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
47015892|NCT01858701|83265008|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
47015893|NCT01858701|83265009|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
47015894|NCT01858701|83265008|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
47015895|NCT01858701|83265009|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
47015896|NCT01858701|83265008|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
46709679|NCT01215188|82925767|FG000|Overall Study|Withdrawal by Subject|32|||
47015897|NCT01858701|83265009|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
47015898|NCT01858701|83265008|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
47015899|NCT01858701|83265009|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
47015900|NCT01461538|83265018|FG000|Overall Study|Death|15|||
47015901|NCT01461538|83265019|FG001|Overall Study|Death|6|||
47015902|NCT01461538|83265020|FG002|Overall Study|Death|2|||
47015903|NCT01461538|83265018|FG000|Overall Study|Study Stopped by Sponsor|2|||
47015904|NCT01461538|83265019|FG001|Overall Study|Study Stopped by Sponsor|1|||
47015905|NCT01461538|83265020|FG002|Overall Study|Study Stopped by Sponsor|0|||
47015906|NCT01461538|83265018|FG000|Overall Study|Withdrawal by Subject|1|||
47015907|NCT01461538|83265019|FG001|Overall Study|Withdrawal by Subject|1|||
47015908|NCT01461538|83265020|FG002|Overall Study|Withdrawal by Subject|0|||
47015909|NCT02117479|83265032|FG000|Overall Study|Death|13|||
47015910|NCT02117479|83265033|FG001|Overall Study|Death|8|||
47015911|NCT02117479|83265032|FG000|Overall Study|Adverse Event|8|||
47015912|NCT02117479|83265033|FG001|Overall Study|Adverse Event|16|||
47015913|NCT02117479|83265032|FG000|Overall Study|Subject decision|8|||
47015914|NCT02117479|83265033|FG001|Overall Study|Subject decision|9|||
47015915|NCT02117479|83265032|FG000|Overall Study|Disease progression|104|||
47015916|NCT02117479|83265033|FG001|Overall Study|Disease progression|108|||
47015917|NCT02117479|83265032|FG000|Overall Study|Noncompliance with study treatment|1|||
47015918|NCT02117479|83265033|FG001|Overall Study|Noncompliance with study treatment|0|||
47015919|NCT02117479|83265032|FG000|Overall Study|Study terminated by the sponsor|4|||
47015920|NCT02117479|83265033|FG001|Overall Study|Study terminated by the sponsor|6|||
47015921|NCT02117479|83265032|FG000|Overall Study|Physician Decision|7|||
47015922|NCT02117479|83265033|FG001|Overall Study|Physician Decision|2|||
47015923|NCT02117479|83265032|FG000|Overall Study|Other unspecified|11|||
47015924|NCT02117479|83265033|FG001|Overall Study|Other unspecified|7|||
47015925|NCT02229851|83265042|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
47015926|NCT02229851|83265043|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
47015927|NCT02229851|83265044|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
47015928|NCT02229851|83265045|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
47015929|NCT02229851|83265046|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
47015930|NCT02229851|83265047|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
47015931|NCT02229851|83265048|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
47015932|NCT02229851|83265042|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
47015933|NCT02229851|83265043|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
46910670|NCT03309605|83140276|FG005|Overall Study|Adverse Event|0|||
46910671|NCT03309605|83140277|FG006|Overall Study|Adverse Event|2|||
46910672|NCT03309605|83140278|FG007|Overall Study|Adverse Event|1|||
46910673|NCT03309605|83140271|FG000|Overall Study|Withdrawal by Subject|0|||
46910674|NCT03309605|83140272|FG001|Overall Study|Withdrawal by Subject|0|||
46910675|NCT03309605|83140273|FG002|Overall Study|Withdrawal by Subject|0|||
47015934|NCT02229851|83265044|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
47015935|NCT02229851|83265045|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
47015936|NCT02229851|83265046|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
47015937|NCT02229851|83265047|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
47015938|NCT02229851|83265048|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
47015939|NCT02229851|83265042|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
47015940|NCT02229851|83265043|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
47015941|NCT02229851|83265044|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
47015942|NCT02229851|83265045|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
47015943|NCT02229851|83265046|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
47015944|NCT02229851|83265047|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
47015945|NCT02229851|83265048|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
47015946|NCT02229851|83265042|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
47015947|NCT02229851|83265043|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
47015948|NCT02229851|83265044|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
47015949|NCT02229851|83265045|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
47015950|NCT02229851|83265046|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
47015951|NCT02229851|83265047|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
46910676|NCT03309605|83140274|FG003|Overall Study|Withdrawal by Subject|0|||
46910677|NCT03309605|83140275|FG004|Overall Study|Withdrawal by Subject|1|||
47015952|NCT02229851|83265048|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
47015953|NCT02229851|83265042|FG000|Main Phase (Double-blind Phase)|Death|1|||
47015954|NCT02229851|83265043|FG001|Main Phase (Double-blind Phase)|Death|1|||
47015955|NCT02229851|83265044|FG002|Main Phase (Double-blind Phase)|Death|0|||
47015956|NCT02229851|83265045|FG003|Main Phase (Double-blind Phase)|Death|0|||
47015957|NCT02229851|83265046|FG004|Main Phase (Double-blind Phase)|Death|0|||
47015958|NCT02229851|83265047|FG005|Main Phase (Double-blind Phase)|Death|0|||
47015959|NCT02229851|83265048|FG006|Main Phase (Double-blind Phase)|Death|0|||
47015960|NCT02229851|83265042|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
47015961|NCT02229851|83265043|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
47015962|NCT02229851|83265044|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
47015963|NCT02229851|83265045|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
47015964|NCT02229851|83265046|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
47015965|NCT02229851|83265047|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
47015966|NCT02229851|83265048|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
47015967|NCT02229851|83265042|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
47015968|NCT02229851|83265043|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
47015969|NCT02229851|83265044|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
47015970|NCT02229851|83265045|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
47015971|NCT02229851|83265046|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
47015972|NCT02229851|83265047|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
47015973|NCT02229851|83265048|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
47015974|NCT02229851|83265042|FG000|Extension Phase (Open-label Phase)|Death|0|||
47015975|NCT02229851|83265043|FG001|Extension Phase (Open-label Phase)|Death|0|||
47015976|NCT02229851|83265044|FG002|Extension Phase (Open-label Phase)|Death|0|||
47015977|NCT02229851|83265045|FG003|Extension Phase (Open-label Phase)|Death|1|||
47015978|NCT02229851|83265046|FG004|Extension Phase (Open-label Phase)|Death|0|||
47015979|NCT02229851|83265047|FG005|Extension Phase (Open-label Phase)|Death|1|||
47015980|NCT02229851|83265048|FG006|Extension Phase (Open-label Phase)|Death|1|||
47015981|NCT01482910|83265065|FG000|Overall Study|Adverse Event|6|||
47015982|NCT01482910|83265066|FG001|Overall Study|Adverse Event|5|||
47015983|NCT01482910|83265065|FG000|Overall Study|Lost to Follow-up|0|||
47015984|NCT01482910|83265066|FG001|Overall Study|Lost to Follow-up|1|||
47015985|NCT01482910|83265065|FG000|Overall Study|Protocol Violation|1|||
47015986|NCT01482910|83265066|FG001|Overall Study|Protocol Violation|1|||
47015987|NCT01482910|83265065|FG000|Overall Study|Withdrawal by Subject|7|||
47015988|NCT01482910|83265066|FG001|Overall Study|Withdrawal by Subject|2|||
47015989|NCT01482910|83265065|FG000|Overall Study|Death|1|||
47015990|NCT01482910|83265066|FG001|Overall Study|Death|0|||
46620535|NCT01726582|82769772|FG000|Overall Study|Physician Decision|99|||
47015991|NCT01626391|83265076|FG000|Overall Study|Physician Decision|1|||
47015992|NCT01626391|83265077|FG001|Overall Study|Physician Decision|0|||
47015993|NCT01626391|83265076|FG000|Overall Study|Withdrawal by Subject|1|||
47015994|NCT01626391|83265077|FG001|Overall Study|Withdrawal by Subject|0|||
47015995|NCT02103439|83265085|FG000|Overall Study|Adverse Event|0|||
47015996|NCT02103439|83265086|FG001|Overall Study|Adverse Event|2|||
47015997|NCT02103439|83265085|FG000|Overall Study|Withdrawal by Subject|3|||
47015998|NCT02103439|83265086|FG001|Overall Study|Withdrawal by Subject|1|||
47015999|NCT02229539|83265099|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
47016000|NCT02229539|83265100|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
47016001|NCT02229539|83265101|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
47016002|NCT02229539|83265099|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
47016003|NCT02229539|83265100|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
47016004|NCT02229539|83265101|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
47016005|NCT02229539|83265099|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
47016006|NCT02229539|83265100|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
47016007|NCT02229539|83265101|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
47016008|NCT02229539|83265099|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
47016009|NCT02229539|83265100|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
47016010|NCT02229539|83265101|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
47016011|NCT02229539|83265099|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
47016012|NCT02229539|83265100|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
47016013|NCT02229539|83265101|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
47016014|NCT02229539|83265099|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
47016015|NCT02229539|83265100|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
47016016|NCT02229539|83265101|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
47016017|NCT02229539|83265099|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
47016018|NCT02229539|83265100|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
47016019|NCT02229539|83265101|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
47016020|NCT02229539|83265099|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
47016021|NCT02229539|83265100|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
47016022|NCT02229539|83265101|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
47016023|NCT02229539|83265099|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
47016024|NCT02229539|83265100|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
47016025|NCT02229539|83265101|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
47016026|NCT01835223|83265111|FG000|Overall Study|Adverse Event|1|||
47016027|NCT01835223|83265112|FG001|Overall Study|Adverse Event|0|||
47016028|NCT01835223|83265111|FG000|Overall Study|Withdrawal by Subject|2|||
47016029|NCT01835223|83265112|FG001|Overall Study|Withdrawal by Subject|0|||
47016030|NCT01835223|83265111|FG000|Overall Study|Disease progression|2|||
47016031|NCT01835223|83265112|FG001|Overall Study|Disease progression|1|||
47016032|NCT01835223|83265111|FG000|Overall Study|Became Inelligible|4|||
47016033|NCT01835223|83265112|FG001|Overall Study|Became Inelligible|0|||
47016034|NCT01482598|83265122|FG000|Overall Study|Death|7|||
47016035|NCT01482598|83265123|FG001|Overall Study|Death|10|||
47016036|NCT01482598|83265122|FG000|Overall Study|Physician Decision|0|||
47016037|NCT01482598|83265123|FG001|Overall Study|Physician Decision|3|||
47016038|NCT01482598|83265122|FG000|Overall Study|Withdrawal by Subject|4|||
47016039|NCT01482598|83265123|FG001|Overall Study|Withdrawal by Subject|5|||
47016040|NCT01482598|83265122|FG000|Overall Study|Lost to Follow-up|5|||
47016041|NCT01482598|83265123|FG001|Overall Study|Lost to Follow-up|4|||
47016042|NCT01460446|83265131|FG000|Overall Study|Non-compliance|2|||
46910678|NCT03309605|83140276|FG005|Overall Study|Withdrawal by Subject|0|||
46910679|NCT03309605|83140277|FG006|Overall Study|Withdrawal by Subject|1|||
46910680|NCT03309605|83140278|FG007|Overall Study|Withdrawal by Subject|1|||
46910681|NCT02936635|83140294|FG000|Overall Study|Adverse Event|43|||
46910682|NCT02936635|83140295|FG001|Overall Study|Adverse Event|25|||
46910683|NCT02936635|83140294|FG000|Overall Study|Progressive Disease|10|||
46910684|NCT02936635|83140295|FG001|Overall Study|Progressive Disease|18|||
46910685|NCT02936635|83140294|FG000|Overall Study|Sponsor Discretion|10|||
46910686|NCT02936635|83140295|FG001|Overall Study|Sponsor Discretion|16|||
46910687|NCT02936635|83140294|FG000|Overall Study|Death|9|||
46910688|NCT02936635|83140295|FG001|Overall Study|Death|15|||
46910689|NCT02936635|83140294|FG000|Overall Study|Withdrawal by Subject|8|||
46910690|NCT02936635|83140295|FG001|Overall Study|Withdrawal by Subject|15|||
46910691|NCT02936635|83140294|FG000|Overall Study|Physician Decision|2|||
46910692|NCT02936635|83140295|FG001|Overall Study|Physician Decision|9|||
46910693|NCT02936635|83140294|FG000|Overall Study|Lost to Follow-up|1|||
46910694|NCT02936635|83140295|FG001|Overall Study|Lost to Follow-up|2|||
46910695|NCT02936635|83140294|FG000|Overall Study|Protocol Violation|1|||
46910696|NCT02936635|83140295|FG001|Overall Study|Protocol Violation|0|||
46910697|NCT02936635|83140294|FG000|Overall Study|Lack of effect/Entry into other study|31|||
46910698|NCT02936635|83140295|FG001|Overall Study|Lack of effect/Entry into other study|65|||
46910699|NCT03227029|83140304|FG000|Overall Study|Child Wheezed (no treatment)|0|||
46910700|NCT03227029|83140305|FG001|Overall Study|Child Wheezed (no treatment)|1|||
46910701|NCT03227029|83140306|FG002|Overall Study|Child Wheezed (no treatment)|0|||
46910702|NCT03227029|83140304|FG000|Overall Study|No post RSV season visit due to COVID|3|||
47016043|NCT01460446|83265132|FG001|Overall Study|Non-compliance|9|||
47016044|NCT01460446|83265131|FG000|Overall Study|Consent Withdrawn|0|||
47016045|NCT01460446|83265132|FG001|Overall Study|Consent Withdrawn|4|||
47016046|NCT01460446|83265131|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
47016047|NCT01460446|83265132|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
47016048|NCT01460446|83265131|FG000|Overall Study|Surgery/Illness|1|||
47016049|NCT01460446|83265132|FG001|Overall Study|Surgery/Illness|1|||
47016050|NCT01460446|83265131|FG000|Overall Study|Pregnancy|1|||
47016051|NCT01460446|83265132|FG001|Overall Study|Pregnancy|0|||
47016052|NCT01460446|83265131|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
47016053|NCT01460446|83265132|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
47016054|NCT02229383|83265141|FG000|Overall Study|Adverse Event|7|||
47016055|NCT02229383|83265142|FG001|Overall Study|Adverse Event|4|||
47016056|NCT02229383|83265141|FG000|Overall Study|Death|0|||
47016057|NCT02229383|83265142|FG001|Overall Study|Death|1|||
47016058|NCT02229383|83265141|FG000|Overall Study|Lost to Follow-up|5|||
47016059|NCT02229383|83265142|FG001|Overall Study|Lost to Follow-up|3|||
47016060|NCT02229383|83265141|FG000|Overall Study|Withdrawal by Subject|4|||
47016061|NCT02229383|83265142|FG001|Overall Study|Withdrawal by Subject|6|||
47016062|NCT02229383|83265141|FG000|Overall Study|Did not receive treatment|1|||
47016063|NCT02229383|83265142|FG001|Overall Study|Did not receive treatment|0|||
47016064|NCT02229383|83265141|FG000|Overall Study|Other|3|||
47016065|NCT02229383|83265142|FG001|Overall Study|Other|8|||
47016066|NCT01499368|83265151|FG000|Overall Study|Did not meet I/E criteria|8|||
47016067|NCT01499368|83265152|FG001|Overall Study|Did not meet I/E criteria|4|||
46709680|NCT01215188|82925768|FG001|Overall Study|Withdrawal by Subject|34|||
46709681|NCT01215188|82925769|FG002|Overall Study|Withdrawal by Subject|31|||
46709682|NCT01215032|82925777|FG000|Overall Study|Adverse Event|3|||
46709683|NCT01215032|82925777|FG000|Overall Study|Lack of Efficacy|17|||
46709684|NCT00962247|82925783|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
46709685|NCT00962247|82925783|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
46709686|NCT00918580|82925789|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
46709687|NCT00918580|82925789|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
46709688|NCT00918580|82925789|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
46709689|NCT00918580|82925789|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
46709690|NCT00918580|82925789|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
46709691|NCT00918580|82925789|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
46709692|NCT00918580|82925789|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
46709693|NCT00920686|82925799|FG000|Overall Study|Lost to Follow-up|2|||
46709694|NCT00920686|82925800|FG001|Overall Study|Lost to Follow-up|3|||
46709695|NCT00920686|82925801|FG002|Overall Study|Lost to Follow-up|1|||
46709696|NCT00920686|82925799|FG000|Overall Study|Study drug dosing criteria not met|17|||
46709697|NCT00920686|82925800|FG001|Overall Study|Study drug dosing criteria not met|19|||
46709698|NCT00920686|82925801|FG002|Overall Study|Study drug dosing criteria not met|12|||
46709699|NCT01214720|82925815|FG000|Overall Study|Alive and still on treatment|34|||
47016068|NCT01499368|83265153|FG002|Overall Study|Did not meet I/E criteria|4|||
47016069|NCT01499368|83265151|FG000|Overall Study|Prohibited Concomitant medication|1|||
47016070|NCT01499368|83265152|FG001|Overall Study|Prohibited Concomitant medication|1|||
47016071|NCT01499368|83265153|FG002|Overall Study|Prohibited Concomitant medication|0|||
47016072|NCT01499368|83265151|FG000|Overall Study|Withdrawal by Subject|11|||
47016073|NCT01499368|83265152|FG001|Overall Study|Withdrawal by Subject|10|||
47016074|NCT01499368|83265153|FG002|Overall Study|Withdrawal by Subject|8|||
47016075|NCT01499368|83265151|FG000|Overall Study|Lost to Follow-up|3|||
47016076|NCT01499368|83265152|FG001|Overall Study|Lost to Follow-up|2|||
46620536|NCT01726582|82769772|FG000|Overall Study|Death|85|||
46620537|NCT00794339|82769787|FG000|Overall Study|Withdrawal by Subject|3|||
46620538|NCT00794339|82769787|FG000|Overall Study|Ineligible|4|||
46620539|NCT00794339|82769787|FG000|Overall Study|Tx prior to ATSM|3|||
46620540|NCT00794339|82769787|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
46620541|NCT00794339|82769787|FG000|Overall Study|Tx not per protocol|1|||
46620542|NCT00506662|82769814|FG000|Overall Study|Adverse Event|0|||
46620543|NCT00506662|82769815|FG001|Overall Study|Adverse Event|2|||
46620544|NCT00506662|82769814|FG000|Overall Study|Lack of Efficacy|1|||
46620545|NCT00506662|82769815|FG001|Overall Study|Lack of Efficacy|0|||
46620546|NCT00506662|82769814|FG000|Overall Study|Protocol Violation|2|||
46620547|NCT00506662|82769815|FG001|Overall Study|Protocol Violation|4|||
46620548|NCT00506662|82769814|FG000|Overall Study|Trial terminated|10|||
46620549|NCT00506662|82769815|FG001|Overall Study|Trial terminated|16|||
46620550|NCT00506662|82769814|FG000|Overall Study|Not recorded|4|||
46620551|NCT00506662|82769815|FG001|Overall Study|Not recorded|6|||
46620552|NCT00161213|82769821|FG000|Overall Study|Withdrawal by Subject|1|||
46620553|NCT00161213|82769821|FG000|Overall Study|Evaluable for toxicity but not response|1|||
46620554|NCT00006436|82769829|FG000|Overall Study|Refused further treatment|2|||
46620555|NCT00006436|82769829|FG000|Overall Study|Declined to participate (before treatment started)|1|||
46620556|NCT03838484|82770052|FG000|Overall Study|Lost to Follow-up|0|||
46620557|NCT03838484|82770053|FG001|Overall Study|Lost to Follow-up|1|||
47016077|NCT01499368|83265153|FG002|Overall Study|Lost to Follow-up|5|||
47016078|NCT01499368|83265151|FG000|Overall Study|Adverse Event|4|||
47016079|NCT01499368|83265152|FG001|Overall Study|Adverse Event|0|||
47016080|NCT01499368|83265153|FG002|Overall Study|Adverse Event|2|||
47016081|NCT01499368|83265151|FG000|Overall Study|Physician Decision|0|||
47016082|NCT01499368|83265152|FG001|Overall Study|Physician Decision|1|||
47016083|NCT01499368|83265153|FG002|Overall Study|Physician Decision|0|||
47016084|NCT01499368|83265151|FG000|Overall Study|Deviation from visit window|0|||
47016085|NCT01499368|83265152|FG001|Overall Study|Deviation from visit window|0|||
47016086|NCT01499368|83265153|FG002|Overall Study|Deviation from visit window|1|||
47016087|NCT01499368|83265151|FG000|Overall Study|Error of Prescriptions|0|||
47016088|NCT01499368|83265152|FG001|Overall Study|Error of Prescriptions|0|||
47016089|NCT01499368|83265153|FG002|Overall Study|Error of Prescriptions|1|||
47016090|NCT01835145|83265163|FG000|Overall Study|Ineligible prior to treatment|1|||
47016091|NCT01835145|83265164|FG001|Overall Study|Ineligible prior to treatment|0|||
47016092|NCT02229227|83265174|FG000|Overall Study|Adverse Event|14|||
47016093|NCT02229227|83265175|FG001|Overall Study|Adverse Event|9|||
47016094|NCT02229227|83265174|FG000|Overall Study|Lack of Efficacy|3|||
47016095|NCT02229227|83265175|FG001|Overall Study|Lack of Efficacy|3|||
47016096|NCT02229227|83265174|FG000|Overall Study|Protocol Violation|6|||
47016097|NCT02229227|83265175|FG001|Overall Study|Protocol Violation|8|||
47016098|NCT02229227|83265174|FG000|Overall Study|Protocol defined stopping criteria|1|||
47016099|NCT02229227|83265175|FG001|Overall Study|Protocol defined stopping criteria|3|||
47016100|NCT02229227|83265174|FG000|Overall Study|Lost to Follow-up|3|||
47016101|NCT02229227|83265175|FG001|Overall Study|Lost to Follow-up|3|||
47016102|NCT02229227|83265174|FG000|Overall Study|Study terminated by sponsor|11|||
47016103|NCT02229227|83265175|FG001|Overall Study|Study terminated by sponsor|11|||
47016104|NCT02229227|83265174|FG000|Overall Study|Withdrawal by Subject|8|||
47016105|NCT02229227|83265175|FG001|Overall Study|Withdrawal by Subject|12|||
47016106|NCT02229227|83265174|FG000|Overall Study|Other|0|||
47016107|NCT02229227|83265175|FG001|Overall Study|Other|1|||
47016108|NCT02229227|83265174|FG000|Overall Study|Physician Decision|5|||
47016109|NCT02229227|83265175|FG001|Overall Study|Physician Decision|12|||
47016110|NCT01499290|83265183|FG000|Overall Study|Withdrawal by Subject|22|||
47016111|NCT01499290|83265184|FG001|Overall Study|Withdrawal by Subject|15|||
47016112|NCT01499290|83265183|FG000|Overall Study|Not specified in study report|11|||
47016113|NCT01499290|83265184|FG001|Overall Study|Not specified in study report|5|||
47016114|NCT01499290|83265183|FG000|Overall Study|Condition improved/subject recovered|1|||
47016115|NCT01499290|83265184|FG001|Overall Study|Condition improved/subject recovered|0|||
47016116|NCT01499290|83265183|FG000|Overall Study|Lack of Efficacy|7|||
47016117|NCT01499290|83265184|FG001|Overall Study|Lack of Efficacy|8|||
47016118|NCT01499290|83265183|FG000|Overall Study|Adverse Event|14|||
47016119|NCT01499290|83265184|FG001|Overall Study|Adverse Event|7|||
47016120|NCT01833897|83265209|FG000|Overall Study|Lack of Efficacy|1|||
47016121|NCT01481896|83265213|FG000|Overall Study|Lost to Follow-up|12|||
47016122|NCT02226653|83265229|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
47016123|NCT02226653|83265230|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
47016124|NCT02226653|83265229|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
47016125|NCT02226653|83265230|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
47016126|NCT02201771|83265246|FG000|Overall Study|Death|3|||
47016127|NCT02201771|83265247|FG001|Overall Study|Death|2|||
47016128|NCT02201771|83265248|FG002|Overall Study|Death|0|||
47016129|NCT02201771|83265246|FG000|Overall Study|Protocol Violation|10|||
47016130|NCT02201771|83265247|FG001|Overall Study|Protocol Violation|8|||
46709700|NCT01214720|82925816|FG001|Overall Study|Alive and still on treatment|18|||
47016131|NCT02201771|83265248|FG002|Overall Study|Protocol Violation|10|||
47016132|NCT01460368|83265258|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
47016133|NCT01460368|83265259|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
47016134|NCT01460368|83265260|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
47016135|NCT01460368|83265261|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
47016136|NCT01460368|83265262|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
47016137|NCT01460368|83265263|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
47016138|NCT01460368|83265264|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
47016139|NCT01460368|83265258|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
47016140|NCT01460368|83265259|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
47016141|NCT01460368|83265260|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
47016142|NCT01460368|83265261|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
47016143|NCT01460368|83265262|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
47016144|NCT01460368|83265263|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
47016145|NCT01460368|83265264|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
47016146|NCT01460368|83265258|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
47016147|NCT01460368|83265259|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
47016148|NCT01460368|83265260|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
47016149|NCT01460368|83265261|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
47016150|NCT01460368|83265262|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
47016151|NCT01460368|83265263|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
47016152|NCT01460368|83265264|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
47016153|NCT01460368|83265258|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
47016154|NCT01460368|83265259|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
47016155|NCT01460368|83265260|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
47016156|NCT01460368|83265261|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
47016157|NCT01460368|83265262|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
47016158|NCT01460368|83265263|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
47016159|NCT01460368|83265264|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
47016160|NCT01460368|83265258|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
47016161|NCT01460368|83265259|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
47016162|NCT01460368|83265260|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
47016163|NCT01460368|83265261|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
47016164|NCT01460368|83265262|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
47016165|NCT01460368|83265263|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
47016166|NCT01460368|83265264|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
47016167|NCT01460290|83265273|FG000|Overall Study|Adverse Event|3|||
47016168|NCT01460290|83265273|FG000|Overall Study|Elevated liver function|1|||
47016169|NCT02200211|83265282|FG000|Overall Study|Lost to Follow-up|7|||
47016170|NCT02200211|83265283|FG001|Overall Study|Lost to Follow-up|7|||
47016171|NCT02200211|83265284|FG002|Overall Study|Lost to Follow-up|1|||
47016172|NCT02200211|83265285|FG003|Overall Study|Lost to Follow-up|2|||
47016173|NCT02200211|83265282|FG000|Overall Study|Withdrawal by Subject|1|||
47016174|NCT02200211|83265283|FG001|Overall Study|Withdrawal by Subject|0|||
47016175|NCT02200211|83265284|FG002|Overall Study|Withdrawal by Subject|0|||
47016176|NCT02200211|83265285|FG003|Overall Study|Withdrawal by Subject|0|||
47016177|NCT01459666|83265305|FG000|Overall Study|PI left institution|5|||
47016178|NCT01459666|83265306|FG001|Overall Study|PI left institution|4|||
47016179|NCT01858389|83265314|FG000|Overall Study|Death|1|||
47016180|NCT01858389|83265315|FG001|Overall Study|Death|3|||
47016181|NCT01858389|83265314|FG000|Overall Study|Study terminated by sponsor|0|||
47016182|NCT01858389|83265315|FG001|Overall Study|Study terminated by sponsor|2|||
47016183|NCT01858389|83265314|FG000|Overall Study|Withdrawal by Subject|0|||
47016184|NCT01858389|83265315|FG001|Overall Study|Withdrawal by Subject|1|||
47016185|NCT01858389|83265314|FG000|Overall Study|Progressive disease|10|||
47016186|NCT01858389|83265315|FG001|Overall Study|Progressive disease|11|||
47016187|NCT01858389|83265314|FG000|Overall Study|Other|2|||
47016188|NCT01858389|83265315|FG001|Overall Study|Other|4|||
47016189|NCT01858389|83265314|FG000|Overall Study|Adverse Event|3|||
47016190|NCT01858389|83265315|FG001|Overall Study|Adverse Event|1|||
47016191|NCT01858389|83265314|FG000|Overall Study|Did not receive treatment|0|||
47016192|NCT01858389|83265315|FG001|Overall Study|Did not receive treatment|3|||
47016193|NCT02199509|83265323|FG000|Overall Study|Suicidal Ideation|0|||
47016194|NCT02199509|83265324|FG001|Overall Study|Suicidal Ideation|1|||
47016195|NCT02199509|83265323|FG000|Overall Study|Misunderstood titration schedule|1|||
47016196|NCT02199509|83265324|FG001|Overall Study|Misunderstood titration schedule|0|||
47016197|NCT01458574|83265337|FG000|Overall Study|Adverse Event|5|||
47016198|NCT01458574|83265338|FG001|Overall Study|Adverse Event|9|||
47016199|NCT01458574|83265339|FG002|Overall Study|Adverse Event|7|||
47016200|NCT01458574|83265337|FG000|Overall Study|Lack of Efficacy|70|||
47016201|NCT01458574|83265338|FG001|Overall Study|Lack of Efficacy|53|||
47016202|NCT01458574|83265339|FG002|Overall Study|Lack of Efficacy|132|||
47016203|NCT01458574|83265337|FG000|Overall Study|Lost to Follow-up|3|||
47016204|NCT01458574|83265338|FG001|Overall Study|Lost to Follow-up|2|||
47016205|NCT01458574|83265339|FG002|Overall Study|Lost to Follow-up|1|||
47016206|NCT01458574|83265337|FG000|Overall Study|Pregnancy|1|||
47016207|NCT01458574|83265338|FG001|Overall Study|Pregnancy|1|||
47016208|NCT01458574|83265339|FG002|Overall Study|Pregnancy|0|||
47016209|NCT01458574|83265337|FG000|Overall Study|Protocol Violation|0|||
47016210|NCT01458574|83265338|FG001|Overall Study|Protocol Violation|1|||
47016211|NCT01458574|83265339|FG002|Overall Study|Protocol Violation|0|||
47016212|NCT01458574|83265337|FG000|Overall Study|Withdrawal by Subject|6|||
47016213|NCT01458574|83265338|FG001|Overall Study|Withdrawal by Subject|3|||
47016214|NCT01458574|83265339|FG002|Overall Study|Withdrawal by Subject|5|||
47016215|NCT01458574|83265337|FG000|Overall Study|Other|2|||
47016216|NCT01458574|83265338|FG001|Overall Study|Other|1|||
47016217|NCT01458574|83265339|FG002|Overall Study|Other|0|||
47016218|NCT01458574|83265337|FG000|Overall Study|Randomized but not treated|0|||
47016219|NCT01458574|83265338|FG001|Overall Study|Randomized but not treated|1|||
47016220|NCT01458574|83265339|FG002|Overall Study|Randomized but not treated|0|||
47016221|NCT02224703|83265350|FG000|Overall Study|Adverse Event|0|||
47016222|NCT02224703|83265351|FG001|Overall Study|Adverse Event|5|||
47016223|NCT02224703|83265352|FG002|Overall Study|Adverse Event|0|||
47016224|NCT02224703|83265350|FG000|Overall Study|Withdrawn by investigator|1|||
47016225|NCT02224703|83265351|FG001|Overall Study|Withdrawn by investigator|0|||
47016226|NCT02224703|83265352|FG002|Overall Study|Withdrawn by investigator|0|||
47016227|NCT02224703|83265350|FG000|Overall Study|Advised by medical monitor|1|||
47016228|NCT02224703|83265351|FG001|Overall Study|Advised by medical monitor|0|||
47016229|NCT02224703|83265352|FG002|Overall Study|Advised by medical monitor|0|||
47016230|NCT02224703|83265350|FG000|Overall Study|Withdrawn by parent/guardian|0|||
47016231|NCT02224703|83265351|FG001|Overall Study|Withdrawn by parent/guardian|1|||
47016232|NCT02224703|83265352|FG002|Overall Study|Withdrawn by parent/guardian|0|||
47016233|NCT02224703|83265350|FG000|Overall Study|Lack of Efficacy|1|||
47016234|NCT02224703|83265351|FG001|Overall Study|Lack of Efficacy|0|||
47016235|NCT02224703|83265352|FG002|Overall Study|Lack of Efficacy|0|||
47016236|NCT02198963|83265361|FG000|Overall Study|Adverse Event|1|||
47016237|NCT02198963|83265361|FG000|Overall Study|Withdrawal by Subject|6|||
47016238|NCT01458106|83265385|FG000|Overall Study|Withdrawal by Subject|2|||
47016239|NCT01458106|83265386|FG001|Overall Study|Withdrawal by Subject|0|||
47016240|NCT01458106|83265385|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
47016241|NCT01458106|83265386|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
47016242|NCT01458106|83265385|FG000|Overall Study|Withdrawn Per Protocol|0|||
47016243|NCT01458106|83265386|FG001|Overall Study|Withdrawn Per Protocol|1|||
47016244|NCT01457950|83265397|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
47016245|NCT01457950|83265398|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
47016246|NCT01457950|83265399|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
47016247|NCT01457950|83265400|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
47016248|NCT01457950|83265397|FG000|Double-Blind Phase|Protocol Violation|2|||
47016249|NCT01457950|83265398|FG001|Double-Blind Phase|Protocol Violation|1|||
47016250|NCT01457950|83265399|FG002|Double-Blind Phase|Protocol Violation|0|||
47016251|NCT01457950|83265400|FG003|Double-Blind Phase|Protocol Violation|0|||
47016252|NCT01457950|83265397|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
47016253|NCT01457950|83265398|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
47016254|NCT01457950|83265399|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
47016255|NCT01457950|83265400|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
47016256|NCT01457950|83265397|FG000|Open-Label Phase|Adverse Event|0|||
47016257|NCT01457950|83265398|FG001|Open-Label Phase|Adverse Event|0|||
47016258|NCT01457950|83265399|FG002|Open-Label Phase|Adverse Event|0|||
47016259|NCT01457950|83265400|FG003|Open-Label Phase|Adverse Event|1|||
47016260|NCT01457950|83265397|FG000|Open-Label Phase|Protocol Violation|0|||
47016261|NCT01457950|83265398|FG001|Open-Label Phase|Protocol Violation|0|||
47016262|NCT01457950|83265399|FG002|Open-Label Phase|Protocol Violation|0|||
47016263|NCT01457950|83265400|FG003|Open-Label Phase|Protocol Violation|1|||
47016264|NCT01457950|83265397|FG000|Open-Label Phase|Withdrawal by Subject|0|||
47016265|NCT01457950|83265398|FG001|Open-Label Phase|Withdrawal by Subject|0|||
47016266|NCT01457950|83265399|FG002|Open-Label Phase|Withdrawal by Subject|2|||
47016267|NCT01457950|83265400|FG003|Open-Label Phase|Withdrawal by Subject|0|||
47016268|NCT01499134|83265413|FG000|Overall Study|Withdrawal by Subject|0|||
47016269|NCT01499134|83265414|FG001|Overall Study|Withdrawal by Subject|1|||
47016270|NCT02198651|83265420|FG000|Lead-in Period|Withdrew consent|13|||
47016271|NCT02198651|83265421|FG001|Lead-in Period|Withdrew consent|0|||
47016272|NCT02198651|83265422|FG002|Lead-in Period|Withdrew consent|0|||
47016273|NCT02198651|83265423|FG003|Lead-in Period|Withdrew consent|0|||
47016274|NCT02198651|83265424|FG004|Lead-in Period|Withdrew consent|0|||
47016275|NCT02198651|83265420|FG000|Lead-in Period|Adverse Event|2|||
47016276|NCT02198651|83265421|FG001|Lead-in Period|Adverse Event|0|||
47016277|NCT02198651|83265422|FG002|Lead-in Period|Adverse Event|0|||
47016278|NCT02198651|83265423|FG003|Lead-in Period|Adverse Event|0|||
47016279|NCT02198651|83265424|FG004|Lead-in Period|Adverse Event|0|||
46709701|NCT01214720|82925815|FG000|Overall Study|Alive and in follow-up|45|||
47016280|NCT02198651|83265420|FG000|Lead-in Period|Other, not specified|22|||
47016281|NCT02198651|83265421|FG001|Lead-in Period|Other, not specified|0|||
47016282|NCT02198651|83265422|FG002|Lead-in Period|Other, not specified|0|||
47016283|NCT02198651|83265423|FG003|Lead-in Period|Other, not specified|0|||
47016284|NCT02198651|83265424|FG004|Lead-in Period|Other, not specified|0|||
47016285|NCT02198651|83265420|FG000|Double-blind Period|Withdrew consent|0|||
47016286|NCT02198651|83265421|FG001|Double-blind Period|Withdrew consent|4|||
47016287|NCT02198651|83265422|FG002|Double-blind Period|Withdrew consent|0|||
47016288|NCT02198651|83265423|FG003|Double-blind Period|Withdrew consent|0|||
47016289|NCT02198651|83265424|FG004|Double-blind Period|Withdrew consent|0|||
47016290|NCT02198651|83265420|FG000|Double-blind Period|Adverse Event|0|||
47016291|NCT02198651|83265421|FG001|Double-blind Period|Adverse Event|1|||
47016292|NCT02198651|83265422|FG002|Double-blind Period|Adverse Event|0|||
47016293|NCT02198651|83265423|FG003|Double-blind Period|Adverse Event|0|||
47016294|NCT02198651|83265424|FG004|Double-blind Period|Adverse Event|0|||
47016295|NCT02198651|83265420|FG000|Double-blind Period|Other, not specified|0|||
47016296|NCT02198651|83265421|FG001|Double-blind Period|Other, not specified|4|||
47016297|NCT02198651|83265422|FG002|Double-blind Period|Other, not specified|1|||
47016298|NCT02198651|83265423|FG003|Double-blind Period|Other, not specified|0|||
47016299|NCT02198651|83265424|FG004|Double-blind Period|Other, not specified|0|||
47016300|NCT02198651|83265420|FG000|Open-label Rescue Period|Withdrew consent|0|||
47016301|NCT02198651|83265421|FG001|Open-label Rescue Period|Withdrew consent|0|||
47016302|NCT02198651|83265422|FG002|Open-label Rescue Period|Withdrew consent|0|||
47016303|NCT02198651|83265423|FG003|Open-label Rescue Period|Withdrew consent|2|||
47016304|NCT02198651|83265424|FG004|Open-label Rescue Period|Withdrew consent|0|||
47016305|NCT02198651|83265420|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
47016306|NCT02198651|83265421|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
47016307|NCT02198651|83265422|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
47016308|NCT02198651|83265423|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
47016309|NCT02198651|83265424|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
47016310|NCT01498822|83265439|FG000|Overall Study|Protocol Violation|8|||
47016311|NCT01498822|83265440|FG001|Overall Study|Protocol Violation|4|||
47016312|NCT01498822|83265439|FG000|Overall Study|Other Reason|5|||
47016313|NCT01498822|83265440|FG001|Overall Study|Other Reason|2|||
47016314|NCT01498822|83265439|FG000|Overall Study|Lack of Efficacy|7|||
47016315|NCT01498822|83265440|FG001|Overall Study|Lack of Efficacy|2|||
47016316|NCT01498822|83265439|FG000|Overall Study|AE, non-serious non-fatal|8|||
47016317|NCT01498822|83265440|FG001|Overall Study|AE, non-serious non-fatal|17|||
47016318|NCT01498822|83265439|FG000|Overall Study|SAE, non-fatal|2|||
47016319|NCT01498822|83265440|FG001|Overall Study|SAE, non-fatal|2|||
47016320|NCT01498822|83265439|FG000|Overall Study|Adverse Event, serious fatal|1|||
47016321|NCT01498822|83265440|FG001|Overall Study|Adverse Event, serious fatal|1|||
47016322|NCT01498822|83265439|FG000|Overall Study|Withdrawal by Subject|15|||
47016323|NCT01498822|83265440|FG001|Overall Study|Withdrawal by Subject|25|||
47016324|NCT01498822|83265439|FG000|Overall Study|Lost to Follow-up|8|||
47016325|NCT01498822|83265440|FG001|Overall Study|Lost to Follow-up|3|||
47016326|NCT01498120|83265448|FG000|Overall Study|Lost to Follow-up|1|||
47016327|NCT01498120|83265448|FG000|Overall Study|Withdrawal by Subject|5|||
47016328|NCT01498120|83265448|FG000|Overall Study|AE, non-serious non-fatal|3|||
47016329|NCT01498120|83265448|FG000|Overall Study|Other|4|||
47016330|NCT01497262|83265452|FG000|Overall Study|Abnormal Lab Values|4|||
47016331|NCT01497262|83265452|FG000|Overall Study|Abnormal Test Procedure Result|1|||
47016332|NCT01497262|83265452|FG000|Overall Study|Physician Decision|1|||
47016333|NCT01497262|83265452|FG000|Overall Study|Withdrawal by Subject|2|||
47016334|NCT01497262|83265452|FG000|Overall Study|Adverse Event|2|||
47016335|NCT01497262|83265452|FG000|Overall Study|Protocol Violation|1|||
47016336|NCT02224625|83265456|FG000|Irritation|Adverse Event|6|||
47016337|NCT02224625|83265456|FG000|Sensitization|Adverse Event|55|||
47016338|NCT02197247|83265468|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
47016339|NCT02197247|83265468|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
47016340|NCT02197247|83265468|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
47016341|NCT02197247|83265468|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
47016342|NCT02197247|83265468|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
47016343|NCT02197247|83265468|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
47016344|NCT02197247|83265468|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
47016345|NCT02197247|83265468|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
47016346|NCT02224157|83265480|FG000|Overall Study|Severe non-compliance to protocol|2|||
47016347|NCT02224157|83265481|FG001|Overall Study|Severe non-compliance to protocol|2|||
47016348|NCT02224157|83265480|FG000|Overall Study|Other|13|||
47016349|NCT02224157|83265481|FG001|Overall Study|Other|10|||
47016350|NCT02224157|83265480|FG000|Overall Study|Subject decision|58|||
47016351|NCT02224157|83265481|FG001|Overall Study|Subject decision|50|||
47016352|NCT02224157|83265480|FG000|Overall Study|Prematurely closed site|4|||
47016353|NCT02224157|83265481|FG001|Overall Study|Prematurely closed site|2|||
47016354|NCT02224157|83265480|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
47016355|NCT02224157|83265481|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
47016356|NCT02224157|83265480|FG000|Overall Study|Lost to Follow-up|27|||
47016357|NCT02224157|83265481|FG001|Overall Study|Lost to Follow-up|35|||
47016358|NCT02224157|83265480|FG000|Overall Study|Death|1|||
47016359|NCT02224157|83265481|FG001|Overall Study|Death|1|||
47016360|NCT02224157|83265480|FG000|Overall Study|Adverse Event|1|||
47016361|NCT02224157|83265481|FG001|Overall Study|Adverse Event|3|||
47016362|NCT02196701|83265489|FG000|Overall Study|Adverse Event|1|||
47016363|NCT02196701|83265489|FG000|Overall Study|Lost to Follow-up|1|||
47016364|NCT02196701|83265489|FG000|Overall Study|Non-adherence to Protocol|1|||
47016365|NCT01481116|83265499|FG000|Overall Study|Adverse Event|26|||
47016366|NCT01481116|83265500|FG001|Overall Study|Adverse Event|26|||
47016367|NCT01481116|83265501|FG002|Overall Study|Adverse Event|42|||
47016368|NCT01481116|83265499|FG000|Overall Study|Major Protocol Deviation|3|||
47016369|NCT01481116|83265500|FG001|Overall Study|Major Protocol Deviation|7|||
47016370|NCT01481116|83265501|FG002|Overall Study|Major Protocol Deviation|1|||
47016371|NCT01481116|83265499|FG000|Overall Study|Lost to Follow-up|8|||
47016372|NCT01481116|83265500|FG001|Overall Study|Lost to Follow-up|12|||
47016373|NCT01481116|83265501|FG002|Overall Study|Lost to Follow-up|11|||
47016374|NCT01481116|83265499|FG000|Overall Study|Withdrawal by Subject|37|||
47016375|NCT01481116|83265500|FG001|Overall Study|Withdrawal by Subject|33|||
47016376|NCT01481116|83265501|FG002|Overall Study|Withdrawal by Subject|37|||
47016377|NCT01481116|83265499|FG000|Overall Study|Study Termination|730|||
47016378|NCT01481116|83265500|FG001|Overall Study|Study Termination|729|||
47016379|NCT01481116|83265501|FG002|Overall Study|Study Termination|713|||
47016380|NCT01481116|83265499|FG000|Overall Study|Pregnancy|0|||
47016381|NCT01481116|83265500|FG001|Overall Study|Pregnancy|0|||
47016382|NCT01481116|83265501|FG002|Overall Study|Pregnancy|1|||
47016383|NCT01481116|83265499|FG000|Overall Study|Lack of Efficacy|3|||
47016384|NCT01481116|83265500|FG001|Overall Study|Lack of Efficacy|3|||
47016385|NCT01481116|83265501|FG002|Overall Study|Lack of Efficacy|1|||
47016386|NCT01481116|83265499|FG000|Overall Study|Contraindications|1|||
47016387|NCT01481116|83265500|FG001|Overall Study|Contraindications|1|||
47016388|NCT01481116|83265501|FG002|Overall Study|Contraindications|0|||
47016389|NCT01481116|83265499|FG000|Overall Study|Other|1|||
47016390|NCT01481116|83265500|FG001|Overall Study|Other|1|||
47016391|NCT01481116|83265501|FG002|Overall Study|Other|0|||
47016392|NCT01481116|83265499|FG000|Overall Study|Participant Started Taking Glipizide|1|||
47016393|NCT01481116|83265500|FG001|Overall Study|Participant Started Taking Glipizide|0|||
47016394|NCT01481116|83265501|FG002|Overall Study|Participant Started Taking Glipizide|0|||
47016395|NCT01481116|83265499|FG000|Overall Study|Participant Moved Out of Area|2|||
47016396|NCT01481116|83265500|FG001|Overall Study|Participant Moved Out of Area|0|||
47016397|NCT01481116|83265501|FG002|Overall Study|Participant Moved Out of Area|1|||
47016398|NCT01481116|83265499|FG000|Overall Study|Participant Moved Out of Country|1|||
47016399|NCT01481116|83265500|FG001|Overall Study|Participant Moved Out of Country|0|||
47016400|NCT01481116|83265501|FG002|Overall Study|Participant Moved Out of Country|1|||
47016401|NCT01481116|83265499|FG000|Overall Study|Investigator Decision|3|||
47016402|NCT01481116|83265500|FG001|Overall Study|Investigator Decision|2|||
47016403|NCT01481116|83265501|FG002|Overall Study|Investigator Decision|1|||
47016404|NCT01481116|83265499|FG000|Overall Study|Sponsor Decision|0|||
47016405|NCT01481116|83265500|FG001|Overall Study|Sponsor Decision|1|||
47016406|NCT01481116|83265501|FG002|Overall Study|Sponsor Decision|3|||
47016407|NCT01481116|83265499|FG000|Overall Study|Non-Compliant With Study Drug|0|||
47016408|NCT01481116|83265500|FG001|Overall Study|Non-Compliant With Study Drug|1|||
47016409|NCT01481116|83265501|FG002|Overall Study|Non-Compliant With Study Drug|1|||
47016410|NCT01481116|83265499|FG000|Overall Study|Investigator's Discretion|2|||
47016411|NCT01481116|83265500|FG001|Overall Study|Investigator's Discretion|0|||
46620558|NCT03838484|82770054|FG002|Overall Study|Lost to Follow-up|0|||
46620559|NCT03838484|82770055|FG003|Overall Study|Lost to Follow-up|0|||
46620560|NCT01349192|82770287|FG000|Overall Study|Protocol Violation|0|||
47016412|NCT01481116|83265501|FG002|Overall Study|Investigator's Discretion|0|||
47016413|NCT01481116|83265499|FG000|Overall Study|Death|2|||
47016414|NCT01481116|83265500|FG001|Overall Study|Death|1|||
47016415|NCT01481116|83265501|FG002|Overall Study|Death|0|||
47016416|NCT01481116|83265499|FG000|Overall Study|Hypoglycemic Event|4|||
47016417|NCT01481116|83265500|FG001|Overall Study|Hypoglycemic Event|0|||
47016418|NCT01481116|83265501|FG002|Overall Study|Hypoglycemic Event|0|||
47016419|NCT02222207|83265509|FG000|Overall Study|Death|1|||
46620561|NCT01349192|82770288|FG001|Overall Study|Protocol Violation|1|||
47016420|NCT02222207|83265509|FG000|Overall Study|Other reasons|2|||
47016421|NCT02222207|83265509|FG000|Overall Study|Adverse Event|1|||
47016422|NCT01457014|83265513|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
47016423|NCT01457014|83265514|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
47016424|NCT01457014|83265515|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
47016425|NCT01457014|83265516|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
47016426|NCT01457014|83265513|FG000|First Night|Withdrawal by Subject|3|||
47016427|NCT01457014|83265514|FG001|First Night|Withdrawal by Subject|0|||
47016428|NCT01457014|83265515|FG002|First Night|Withdrawal by Subject|0|||
47016429|NCT01457014|83265516|FG003|First Night|Withdrawal by Subject|0|||
47016430|NCT02254421|83265526|FG000|Overall Study|Randomized but Not Treated|1|||
47016431|NCT02254421|83265527|FG001|Overall Study|Randomized but Not Treated|0|||
47016432|NCT02254421|83265526|FG000|Overall Study|Death|0|||
47016433|NCT02254421|83265527|FG001|Overall Study|Death|2|||
47016434|NCT02254421|83265526|FG000|Overall Study|Withdrew Consent|1|||
47016435|NCT02254421|83265527|FG001|Overall Study|Withdrew Consent|1|||
47016436|NCT02252939|83265533|FG000|Overall Study|Lost to Follow-up|3|||
47016437|NCT02196077|83265542|FG000|Overall Study|Adverse Event|4|||
47016438|NCT02196077|83265542|FG000|Overall Study|Lack of Efficacy|1|||
47016439|NCT02196077|83265542|FG000|Overall Study|Withdrawal by Subject|14|||
47016440|NCT02196077|83265542|FG000|Overall Study|Physician Decision|1|||
47016441|NCT02196077|83265542|FG000|Overall Study|Lost to Follow-up|3|||
47016442|NCT02196077|83265542|FG000|Overall Study|Protocol Violation|24|||
47016443|NCT02195687|83265556|FG000|Overall Study|Personal Reasons|1|||
47016444|NCT02195687|83265557|FG001|Overall Study|Personal Reasons|1|||
47016445|NCT02195687|83265556|FG000|Overall Study|Lost to Follow-up|4|||
47016446|NCT02195687|83265557|FG001|Overall Study|Lost to Follow-up|1|||
47016447|NCT02195531|83265566|FG000|Overall Study|Withdrawal by Subject|1|||
47016448|NCT02195531|83265567|FG001|Overall Study|Withdrawal by Subject|1|||
47016449|NCT02195531|83265568|FG002|Overall Study|Withdrawal by Subject|1|||
47016450|NCT02252081|83265578|FG000|Overall Study|Withdrawal by Subject|2|||
47016451|NCT02252081|83265579|FG001|Overall Study|Withdrawal by Subject|1|||
47016452|NCT02252081|83265578|FG000|Overall Study|Adverse Event|4|||
47016453|NCT02252081|83265579|FG001|Overall Study|Adverse Event|1|||
47016454|NCT02252081|83265578|FG000|Overall Study|non compliance & others|0|||
47016455|NCT02252081|83265579|FG001|Overall Study|non compliance & others|2|||
47016456|NCT01623752|83265593|FG000|Phase 1 (78 Weeks)|No Data|249|||
47016457|NCT01623752|83265594|FG001|Phase 1 (78 Weeks)|No Data|66|||
47016458|NCT01623752|83265595|FG002|Phase 1 (78 Weeks)|No Data|2|||
47016459|NCT01623752|83265593|FG000|Phase 1 (78 Weeks)|Other|33|||
47016460|NCT01623752|83265594|FG001|Phase 1 (78 Weeks)|Other|20|||
47016461|NCT01623752|83265595|FG002|Phase 1 (78 Weeks)|Other|0|||
47016462|NCT01623752|83265593|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
47016463|NCT01623752|83265594|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
47016464|NCT01623752|83265595|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
47016465|NCT01623752|83265593|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
47016466|NCT01623752|83265594|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
47016467|NCT01623752|83265595|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
47016468|NCT01623752|83265593|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
47016469|NCT01623752|83265594|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
47016470|NCT01623752|83265595|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
47016471|NCT01623752|83265593|FG000|Phase 2 (78 Weeks)|Other|5|||
47016472|NCT01623752|83265594|FG001|Phase 2 (78 Weeks)|Other|1|||
47016473|NCT01623752|83265595|FG002|Phase 2 (78 Weeks)|Other|0|||
47016474|NCT01623752|83265593|FG000|Phase 2 (78 Weeks)|No Data|43|||
47016475|NCT01623752|83265594|FG001|Phase 2 (78 Weeks)|No Data|11|||
47016476|NCT01623752|83265595|FG002|Phase 2 (78 Weeks)|No Data|0|||
47016477|NCT01623752|83265593|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
47016478|NCT01623752|83265594|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
47016479|NCT01623752|83265595|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
47016480|NCT01623596|83265606|FG000|Overall Study|Abnormal laboratory values|2|||
47016481|NCT01623596|83265607|FG001|Overall Study|Abnormal laboratory values|0|||
47016482|NCT01623596|83265606|FG000|Overall Study|Administrative problems|9|||
47016483|NCT01623596|83265607|FG001|Overall Study|Administrative problems|13|||
46620562|NCT01349192|82770287|FG000|Overall Study|Withdrawal by Subject|0|||
46620563|NCT01349192|82770288|FG001|Overall Study|Withdrawal by Subject|2|||
46620564|NCT01349192|82770287|FG000|Overall Study|Lost to Follow-up|1|||
46620565|NCT01349192|82770288|FG001|Overall Study|Lost to Follow-up|3|||
46709702|NCT01214720|82925816|FG001|Overall Study|Alive and in follow-up|48|||
47016484|NCT01623596|83265606|FG000|Overall Study|Adverse Event|20|||
47016485|NCT01623596|83265607|FG001|Overall Study|Adverse Event|29|||
47016486|NCT01623596|83265606|FG000|Overall Study|Death|0|||
47016487|NCT01623596|83265607|FG001|Overall Study|Death|2|||
47016488|NCT01623596|83265606|FG000|Overall Study|Lost to Follow-up|12|||
47016489|NCT01623596|83265607|FG001|Overall Study|Lost to Follow-up|16|||
47016490|NCT01623596|83265606|FG000|Overall Study|Withdrawal by Subject|13|||
47016491|NCT01623596|83265607|FG001|Overall Study|Withdrawal by Subject|31|||
47016492|NCT01623596|83265606|FG000|Overall Study|Patient no longer requires study drug|1|||
47016493|NCT01623596|83265607|FG001|Overall Study|Patient no longer requires study drug|0|||
47016494|NCT01623596|83265606|FG000|Overall Study|Protocol Violation|0|||
47016495|NCT01623596|83265607|FG001|Overall Study|Protocol Violation|6|||
47016496|NCT01623596|83265606|FG000|Overall Study|Lack of Efficacy|5|||
47016497|NCT01623596|83265607|FG001|Overall Study|Lack of Efficacy|3|||
47016498|NCT02219477|83265618|FG000|Overall Study|Adverse Event|0|||
47016499|NCT02219477|83265619|FG001|Overall Study|Adverse Event|1|||
47016500|NCT02219477|83265620|FG002|Overall Study|Adverse Event|1|||
47016501|NCT02219477|83265618|FG000|Overall Study|Withdrawal by Subject|0|||
47016502|NCT02219477|83265619|FG001|Overall Study|Withdrawal by Subject|1|||
47016503|NCT02219477|83265620|FG002|Overall Study|Withdrawal by Subject|0|||
47016504|NCT02119286|83265632|FG000|Overall Study|Adverse Event|9|||
47016505|NCT02119286|83265633|FG001|Overall Study|Adverse Event|7|||
47016506|NCT02119286|83265634|FG002|Overall Study|Adverse Event|2|||
47016507|NCT02119286|83265632|FG000|Overall Study|Lack of Efficacy|11|||
47016508|NCT02119286|83265633|FG001|Overall Study|Lack of Efficacy|3|||
47016509|NCT02119286|83265634|FG002|Overall Study|Lack of Efficacy|4|||
47016510|NCT02119286|83265632|FG000|Overall Study|Lost to Follow-up|2|||
47016511|NCT02119286|83265633|FG001|Overall Study|Lost to Follow-up|0|||
47016512|NCT02119286|83265634|FG002|Overall Study|Lost to Follow-up|1|||
47016513|NCT02119286|83265632|FG000|Overall Study|Withdrawal by Subject|4|||
47016514|NCT02119286|83265633|FG001|Overall Study|Withdrawal by Subject|1|||
47016515|NCT02119286|83265634|FG002|Overall Study|Withdrawal by Subject|0|||
47016516|NCT02250443|83265642|FG000|Overall Study|Administrative problems|7|||
47016517|NCT02250443|83265642|FG000|Overall Study|Adverse Event|3|||
47016518|NCT02093390|83265648|FG000|Overall Study|Withdrawal by Subject|0|||
47016519|NCT02093390|83265649|FG001|Overall Study|Withdrawal by Subject|1|||
47016520|NCT02194985|83265656|FG000|Overall Study|Adverse Event|1|||
47016521|NCT02194985|83265656|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
47016522|NCT02194985|83265656|FG000|Overall Study|Physician Decision|4|||
47016523|NCT02194985|83265656|FG000|Overall Study|Lost to Follow-up|1|||
47016524|NCT02194985|83265656|FG000|Overall Study|Withdrawal by Subject|2|||
47016525|NCT02219087|83265662|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
47016526|NCT02219087|83265663|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
47016527|NCT02248961|83265671|FG000|Overall Study|Adverse Event|1|||
47016528|NCT02248961|83265672|FG001|Overall Study|Adverse Event|0|||
47016529|NCT02248961|83265671|FG000|Overall Study|Withdrawal by Subject|1|||
47016530|NCT02248961|83265672|FG001|Overall Study|Withdrawal by Subject|2|||
47016531|NCT02248961|83265671|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
47016532|NCT02248961|83265672|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
47016533|NCT02219009|83265680|FG000|Overall Study|Withdrawal by Subject|5|||
47016534|NCT02219009|83265681|FG001|Overall Study|Withdrawal by Subject|1|||
47016535|NCT02219009|83265680|FG000|Overall Study|Adverse Event|2|||
47016536|NCT02219009|83265681|FG001|Overall Study|Adverse Event|4|||
47016537|NCT02219009|83265680|FG000|Overall Study|Lost to Follow-up|2|||
47016538|NCT02219009|83265681|FG001|Overall Study|Lost to Follow-up|2|||
47016539|NCT02219009|83265680|FG000|Overall Study|Protocol deviation|1|||
47016540|NCT02219009|83265681|FG001|Overall Study|Protocol deviation|0|||
47016541|NCT02219009|83265680|FG000|Overall Study|Physician Decision|0|||
47016542|NCT02219009|83265681|FG001|Overall Study|Physician Decision|1|||
47016543|NCT02248649|83265689|FG000|Overall Study|Death|7|||
47016544|NCT02248649|83265690|FG001|Overall Study|Death|11|||
47016545|NCT02248649|83265689|FG000|Overall Study|Lost to Follow-up|14|||
47016546|NCT02248649|83265690|FG001|Overall Study|Lost to Follow-up|10|||
47016547|NCT02218541|83265698|FG000|Overall Study|Lost to Follow-up|2|||
46910703|NCT03227029|83140305|FG001|Overall Study|No post RSV season visit due to COVID|3|||
46910704|NCT03227029|83140306|FG002|Overall Study|No post RSV season visit due to COVID|2|||
46910705|NCT03227029|83140304|FG000|Overall Study|Not able to get to clinic|0|||
46910706|NCT03227029|83140305|FG001|Overall Study|Not able to get to clinic|0|||
46910707|NCT03227029|83140306|FG002|Overall Study|Not able to get to clinic|1|||
46910708|NCT03227029|83140304|FG000|Overall Study|Withdrawal by Subject|1|||
46910709|NCT03227029|83140305|FG001|Overall Study|Withdrawal by Subject|0|||
46910710|NCT03227029|83140306|FG002|Overall Study|Withdrawal by Subject|0|||
46910711|NCT03227029|83140304|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
47016548|NCT02218541|83265699|FG001|Overall Study|Lost to Follow-up|1|||
47016549|NCT02218541|83265698|FG000|Overall Study|Implant Failure|4|||
47016550|NCT02218541|83265699|FG001|Overall Study|Implant Failure|1|||
47016551|NCT02217527|83265708|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
47016552|NCT02217527|83265709|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
46620566|NCT01349192|82770287|FG000|Overall Study|Failure to adhere to Protocol|2|||
46910712|NCT03227029|83140305|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
46910713|NCT03227029|83140306|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
47016553|NCT02217527|83265708|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
46620567|NCT01349192|82770288|FG001|Overall Study|Failure to adhere to Protocol|0|||
46620568|NCT01721876|82770643|FG000|Overall Study|Not treated|1|||
46910714|NCT03329573|83140318|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
47016554|NCT02217527|83265709|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
47016555|NCT01456936|83265719|FG000|Overall Study|Other reason|41|||
47016556|NCT01456936|83265720|FG001|Overall Study|Other reason|30|||
46620569|NCT01721876|82770644|FG001|Overall Study|Not treated|4|||
47016557|NCT01456936|83265721|FG002|Overall Study|Other reason|36|||
47016558|NCT01456936|83265722|FG003|Overall Study|Other reason|33|||
47016559|NCT01456936|83265719|FG000|Overall Study|No longer meets eligibility criteria|4|||
47016560|NCT01456936|83265720|FG001|Overall Study|No longer meets eligibility criteria|8|||
47016561|NCT01456936|83265721|FG002|Overall Study|No longer meets eligibility criteria|6|||
47016562|NCT01456936|83265722|FG003|Overall Study|No longer meets eligibility criteria|5|||
47016563|NCT01456936|83265719|FG000|Overall Study|Protocol Violation|4|||
47016564|NCT01456936|83265720|FG001|Overall Study|Protocol Violation|2|||
47016565|NCT01456936|83265721|FG002|Overall Study|Protocol Violation|5|||
47016566|NCT01456936|83265722|FG003|Overall Study|Protocol Violation|5|||
47016567|NCT01456936|83265719|FG000|Overall Study|Pregnancy|1|||
47016568|NCT01456936|83265720|FG001|Overall Study|Pregnancy|0|||
47016569|NCT01456936|83265721|FG002|Overall Study|Pregnancy|0|||
47016570|NCT01456936|83265722|FG003|Overall Study|Pregnancy|1|||
47016571|NCT01456936|83265719|FG000|Overall Study|Insufficient clinical response|4|||
47016572|NCT01456936|83265720|FG001|Overall Study|Insufficient clinical response|4|||
47016573|NCT01456936|83265721|FG002|Overall Study|Insufficient clinical response|14|||
47016574|NCT01456936|83265722|FG003|Overall Study|Insufficient clinical response|13|||
47016575|NCT01456936|83265719|FG000|Overall Study|No longer willing to participate|195|||
47016576|NCT01456936|83265720|FG001|Overall Study|No longer willing to participate|218|||
47016577|NCT01456936|83265721|FG002|Overall Study|No longer willing to participate|224|||
47016578|NCT01456936|83265722|FG003|Overall Study|No longer willing to participate|248|||
47016579|NCT01456936|83265719|FG000|Overall Study|Lost to Follow-up|135|||
47016580|NCT01456936|83265720|FG001|Overall Study|Lost to Follow-up|126|||
47016581|NCT01456936|83265721|FG002|Overall Study|Lost to Follow-up|144|||
47016582|NCT01456936|83265722|FG003|Overall Study|Lost to Follow-up|127|||
47016583|NCT01456936|83265719|FG000|Overall Study|Medication error|0|||
47016584|NCT01456936|83265720|FG001|Overall Study|Medication error|1|||
47016585|NCT01456936|83265721|FG002|Overall Study|Medication error|0|||
47016586|NCT01456936|83265722|FG003|Overall Study|Medication error|1|||
47016587|NCT01456936|83265719|FG000|Overall Study|Adverse event (study drug)|25|||
47016588|NCT01456936|83265720|FG001|Overall Study|Adverse event (study drug)|21|||
47016589|NCT01456936|83265721|FG002|Overall Study|Adverse event (study drug)|26|||
47016590|NCT01456936|83265722|FG003|Overall Study|Adverse event (study drug)|17|||
47016591|NCT01456936|83265719|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
47016592|NCT01456936|83265720|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
47016593|NCT01456936|83265721|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
47016594|NCT01456936|83265722|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
47016595|NCT01456936|83265719|FG000|Overall Study|Death|0|||
47016596|NCT01456936|83265720|FG001|Overall Study|Death|3|||
47016597|NCT01456936|83265721|FG002|Overall Study|Death|1|||
47016598|NCT01456936|83265722|FG003|Overall Study|Death|3|||
47016599|NCT01456936|83265719|FG000|Overall Study|Randomized but not treated|21|||
47016600|NCT01456936|83265720|FG001|Overall Study|Randomized but not treated|28|||
47016601|NCT01456936|83265721|FG002|Overall Study|Randomized but not treated|16|||
47016602|NCT01456936|83265722|FG003|Overall Study|Randomized but not treated|21|||
47016603|NCT01456780|83265735|FG000|Overall Study|Lost to Follow-up|3|||
47016604|NCT01456780|83265736|FG001|Overall Study|Lost to Follow-up|3|||
47016605|NCT01456780|83265737|FG002|Overall Study|Lost to Follow-up|0|||
47016606|NCT01480258|83265747|FG000|Infant Series|Protocol Violation|2|||
47016607|NCT01480258|83265748|FG001|Infant Series|Protocol Violation|0|||
47016608|NCT01480258|83265747|FG000|Infant Series|Physician Decision|0|||
47016609|NCT01480258|83265748|FG001|Infant Series|Physician Decision|1|||
47016610|NCT01480258|83265747|FG000|Infant Series|Not Vaccinated|3|||
47016611|NCT01480258|83265748|FG001|Infant Series|Not Vaccinated|0|||
47016612|NCT01480258|83265747|FG000|Infant Series|Adverse Event|1|||
47016613|NCT01480258|83265748|FG001|Infant Series|Adverse Event|1|||
47016614|NCT01480258|83265747|FG000|Infant Series|Withdrawal by Subject|1|||
47016615|NCT01480258|83265748|FG001|Infant Series|Withdrawal by Subject|6|||
47016616|NCT01480258|83265747|FG000|Interim Period|Lost to Follow-up|0|||
47016617|NCT01480258|83265748|FG001|Interim Period|Lost to Follow-up|2|||
47016618|NCT01480258|83265747|FG000|Interim Period|Physician Decision|1|||
47016619|NCT01480258|83265748|FG001|Interim Period|Physician Decision|0|||
47016620|NCT01480258|83265747|FG000|Interim Period|Protocol Violation|0|||
47016621|NCT01480258|83265748|FG001|Interim Period|Protocol Violation|1|||
47016622|NCT01480258|83265747|FG000|Interim Period|Withdrawal by Subject|9|||
47016623|NCT01480258|83265748|FG001|Interim Period|Withdrawal by Subject|6|||
47016624|NCT01479868|83265754|FG000|Overall Study|Adverse Event|1|||
47016625|NCT01479868|83265754|FG000|Overall Study|Lost to Follow-up|4|||
47016626|NCT01479868|83265754|FG000|Overall Study|Protocol Violation|1|||
47016627|NCT01479868|83265754|FG000|Overall Study|Withdrawal by Subject|1|||
47016628|NCT01479868|83265754|FG000|Overall Study|Sponsor's Decision|1|||
47016629|NCT01479868|83265754|FG000|Overall Study|Initiation of new HCV Therapy|1|||
47016630|NCT01478620|83265758|FG000|Overall Study|Lost to Follow-up|6|||
47016631|NCT01455220|83265762|FG000|Overall Study|screen fail|30|||
47016632|NCT01454830|83265771|FG000|Overall Study|Withdrawal by Subject|4|||
47016633|NCT01454830|83265772|FG001|Overall Study|Withdrawal by Subject|4|||
47016634|NCT01454830|83265771|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
47016635|NCT01454830|83265772|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
47016636|NCT01454830|83265771|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
47016637|NCT01454830|83265772|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
47016638|NCT01454830|83265771|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
47016639|NCT01454830|83265772|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
47016640|NCT01454830|83265771|FG000|Overall Study|Withdrawal - no polysomnography|3|||
47016641|NCT01454830|83265772|FG001|Overall Study|Withdrawal - no polysomnography|2|||
47016642|NCT01454596|83265790|FG000|Overall Study|Death|0|||
47016643|NCT01454596|83265791|FG001|Overall Study|Death|0|||
47016644|NCT01454596|83265792|FG002|Overall Study|Death|0|||
47016645|NCT01454596|83265793|FG003|Overall Study|Death|0|||
47016646|NCT01454596|83265794|FG004|Overall Study|Death|0|||
47016647|NCT01454596|83265795|FG005|Overall Study|Death|0|||
47016648|NCT01454596|83265796|FG006|Overall Study|Death|0|||
47016649|NCT01454596|83265797|FG007|Overall Study|Death|0|||
47016650|NCT01454596|83265798|FG008|Overall Study|Death|0|||
47016651|NCT01454596|83265799|FG009|Overall Study|Death|1|||
47016652|NCT01454596|83265800|FG010|Overall Study|Death|1|||
47016653|NCT01454596|83265801|FG011|Overall Study|Death|0|||
47016654|NCT02247479|83265830|FG000|Overall Study|Adverse Event|8|||
47016655|NCT02247479|83265831|FG001|Overall Study|Adverse Event|9|||
47016656|NCT02247479|83265832|FG002|Overall Study|Adverse Event|8|||
47016657|NCT02247479|83265830|FG000|Overall Study|Death|5|||
47016658|NCT02247479|83265831|FG001|Overall Study|Death|4|||
47016659|NCT02247479|83265832|FG002|Overall Study|Death|6|||
47016660|NCT02247479|83265830|FG000|Overall Study|Lost to Follow-up|3|||
47016661|NCT02247479|83265831|FG001|Overall Study|Lost to Follow-up|3|||
47016662|NCT02247479|83265832|FG002|Overall Study|Lost to Follow-up|1|||
47016663|NCT02247479|83265830|FG000|Overall Study|Non-compliance|0|||
47016664|NCT02247479|83265831|FG001|Overall Study|Non-compliance|0|||
47016665|NCT02247479|83265832|FG002|Overall Study|Non-compliance|1|||
47016666|NCT02247479|83265830|FG000|Overall Study|Withdrawal by Subject|25|||
47016667|NCT02247479|83265831|FG001|Overall Study|Withdrawal by Subject|29|||
47016668|NCT02247479|83265832|FG002|Overall Study|Withdrawal by Subject|24|||
47016669|NCT02247479|83265830|FG000|Overall Study|Study Terminated by Sponsor|98|||
47016670|NCT02247479|83265831|FG001|Overall Study|Study Terminated by Sponsor|88|||
47016671|NCT02247479|83265832|FG002|Overall Study|Study Terminated by Sponsor|94|||
47016672|NCT02247479|83265830|FG000|Overall Study|Physician Decision|1|||
47016673|NCT02247479|83265831|FG001|Overall Study|Physician Decision|0|||
47016674|NCT02247479|83265832|FG002|Overall Study|Physician Decision|2|||
47016675|NCT02247479|83265830|FG000|Overall Study|Unspecified Reason|2|||
47016676|NCT02247479|83265831|FG001|Overall Study|Unspecified Reason|5|||
47016677|NCT02247479|83265832|FG002|Overall Study|Unspecified Reason|2|||
47016678|NCT01454284|83265842|FG000|Overall Study|Adverse Event|20|||
47016679|NCT01454284|83265843|FG001|Overall Study|Adverse Event|7|||
47016680|NCT01454284|83265842|FG000|Overall Study|Death|0|||
47016681|NCT01454284|83265843|FG001|Overall Study|Death|3|||
47016682|NCT01454284|83265842|FG000|Overall Study|Lost to Follow-up|13|||
47016683|NCT01454284|83265843|FG001|Overall Study|Lost to Follow-up|8|||
47016684|NCT01454284|83265842|FG000|Overall Study|Protocol Violation|9|||
47016685|NCT01454284|83265843|FG001|Overall Study|Protocol Violation|6|||
47016686|NCT01454284|83265842|FG000|Overall Study|Withdrawal by Subject|58|||
47016687|NCT01454284|83265843|FG001|Overall Study|Withdrawal by Subject|36|||
47016688|NCT01454284|83265842|FG000|Overall Study|Physician Decision|16|||
47016689|NCT01454284|83265843|FG001|Overall Study|Physician Decision|11|||
47016690|NCT01454284|83265842|FG000|Overall Study|Sponsor Decision|0|||
47016691|NCT01454284|83265843|FG001|Overall Study|Sponsor Decision|2|||
47016692|NCT02247401|83265852|FG000|Overall Study|Adverse Event|1|||
47016693|NCT02247401|83265853|FG001|Overall Study|Adverse Event|0|||
47016694|NCT02247401|83265854|FG002|Overall Study|Adverse Event|0|||
47016695|NCT02247401|83265852|FG000|Overall Study|Withdrawal by Subject|4|||
47016696|NCT02247401|83265853|FG001|Overall Study|Withdrawal by Subject|1|||
47016697|NCT02247401|83265854|FG002|Overall Study|Withdrawal by Subject|1|||
47016698|NCT02247401|83265852|FG000|Overall Study|Lost to Follow-up|1|||
47016699|NCT02247401|83265853|FG001|Overall Study|Lost to Follow-up|1|||
47016700|NCT02247401|83265854|FG002|Overall Study|Lost to Follow-up|1|||
47016701|NCT02247011|83265865|FG000|Overall Study|Poor quality of radiological results|125|||
47016702|NCT02246777|83265872|FG000|Overall Study|Adverse Event|2|||
47016703|NCT02246777|83265872|FG000|Overall Study|Change of residence|1|||
47016704|NCT01495702|83265883|FG000|Randomized Phase|Randomized But Not Treated|1|||
47016705|NCT01495702|83265884|FG001|Randomized Phase|Randomized But Not Treated|4|||
47016706|NCT01495702|83265883|FG000|Randomized Phase|Adverse Event|2|||
47016707|NCT01495702|83265884|FG001|Randomized Phase|Adverse Event|2|||
46620570|NCT01721876|82770643|FG000|Overall Study|Disease progression / relapse|123|||
47016708|NCT01495702|83265883|FG000|Randomized Phase|Death|1|||
47016709|NCT01495702|83265884|FG001|Randomized Phase|Death|0|||
47016710|NCT01495702|83265883|FG000|Randomized Phase|Lack of Efficacy|2|||
47016711|NCT01495702|83265884|FG001|Randomized Phase|Lack of Efficacy|0|||
47016712|NCT01495702|83265883|FG000|Randomized Phase|Investigators Discretion|2|||
47016713|NCT01495702|83265884|FG001|Randomized Phase|Investigators Discretion|0|||
47016714|NCT01495702|83265883|FG000|Randomized Phase|Withdrew Consent|10|||
47016715|NCT01495702|83265884|FG001|Randomized Phase|Withdrew Consent|18|||
47016716|NCT01495702|83265883|FG000|Randomized Phase|Lost to Follow-up|4|||
47016717|NCT01495702|83265884|FG001|Randomized Phase|Lost to Follow-up|3|||
47016718|NCT01495702|83265883|FG000|Randomized Phase|Participant Noncompliance|1|||
47016719|NCT01495702|83265884|FG001|Randomized Phase|Participant Noncompliance|0|||
47016720|NCT01495702|83265883|FG000|Randomized Phase|Protocol Violation|3|||
47016721|NCT01495702|83265884|FG001|Randomized Phase|Protocol Violation|1|||
47016722|NCT01630889|83265891|FG000|Overall Study|Death|2|||
47016723|NCT01630889|83265891|FG000|Overall Study|Withdrawal by Subject|1|||
47016724|NCT01630889|83265891|FG000|Overall Study|Other than Specified|2|||
47016725|NCT01630889|83265891|FG000|Overall Study|Lost to Follow-up|4|||
47016726|NCT01630889|83265891|FG000|Overall Study|Other|1|||
47016727|NCT01495000|83265897|FG000|Overall Study|Lost to Follow-up|2|||
47016728|NCT01495000|83265898|FG001|Overall Study|Lost to Follow-up|2|||
47016729|NCT01495000|83265897|FG000|Overall Study|Protocol Violation|1|||
47016730|NCT01495000|83265898|FG001|Overall Study|Protocol Violation|0|||
47016731|NCT01495000|83265897|FG000|Overall Study|Withdrawal by Subject|10|||
47016732|NCT01495000|83265898|FG001|Overall Study|Withdrawal by Subject|10|||
47016733|NCT01494922|83265904|FG000|Overall Study|Adverse Event|1|||
47016734|NCT02192099|83265908|FG000|Overall Study|Adverse Event|1|||
47016735|NCT02192099|83265908|FG000|Overall Study|Lost to Follow-up|2|||
47016736|NCT02192099|83265908|FG000|Overall Study|Physician Decision|1|||
47016737|NCT02192099|83265908|FG000|Overall Study|Pregnancy|1|||
47016738|NCT02192099|83265908|FG000|Overall Study|Protocol Violation|8|||
47016739|NCT02192099|83265908|FG000|Overall Study|Study Terminated by Sponsor|32|||
47016740|NCT02192099|83265908|FG000|Overall Study|Withdrawal by Subject|11|||
47016741|NCT02192099|83265908|FG000|Overall Study|Miscellaneous Reasons|5|||
47016742|NCT01494610|83265912|FG000|Period 1|Withdrawal by Subject|1|||
47016743|NCT01494610|83265913|FG001|Period 1|Withdrawal by Subject|1|||
47016744|NCT01494610|83265912|FG000|Period 3|Adverse Event|1|||
47016745|NCT01494610|83265913|FG001|Period 3|Adverse Event|0|||
47016746|NCT01494610|83265912|FG000|Period 3|Withdrawal by Subject|1|||
47016747|NCT01494610|83265913|FG001|Period 3|Withdrawal by Subject|0|||
47016748|NCT01494610|83265912|FG000|Period 4|Protocol Violation|1|||
47016749|NCT01494610|83265913|FG001|Period 4|Protocol Violation|0|||
47016750|NCT02116777|83265932|FG000|Overall Study|Adverse Event|0|||
47016751|NCT02116777|83265933|FG001|Overall Study|Adverse Event|0|||
47016752|NCT02116777|83265934|FG002|Overall Study|Adverse Event|0|||
47016753|NCT02116777|83265935|FG003|Overall Study|Adverse Event|0|||
47016754|NCT02116777|83265936|FG004|Overall Study|Adverse Event|2|||
47016755|NCT02116777|83265937|FG005|Overall Study|Adverse Event|2|||
47016756|NCT02116777|83265938|FG006|Overall Study|Adverse Event|0|||
47016757|NCT02116777|83265932|FG000|Overall Study|Death|0|||
47016758|NCT02116777|83265933|FG001|Overall Study|Death|0|||
47016759|NCT02116777|83265934|FG002|Overall Study|Death|0|||
47016760|NCT02116777|83265935|FG003|Overall Study|Death|1|||
47016761|NCT02116777|83265936|FG004|Overall Study|Death|0|||
47016762|NCT02116777|83265937|FG005|Overall Study|Death|0|||
47016763|NCT02116777|83265938|FG006|Overall Study|Death|0|||
47016764|NCT02116777|83265932|FG000|Overall Study|Lack of Efficacy|3|||
47016765|NCT02116777|83265933|FG001|Overall Study|Lack of Efficacy|3|||
47016766|NCT02116777|83265934|FG002|Overall Study|Lack of Efficacy|3|||
47016767|NCT02116777|83265935|FG003|Overall Study|Lack of Efficacy|8|||
47016768|NCT02116777|83265936|FG004|Overall Study|Lack of Efficacy|4|||
47016769|NCT02116777|83265937|FG005|Overall Study|Lack of Efficacy|1|||
47016770|NCT02116777|83265938|FG006|Overall Study|Lack of Efficacy|9|||
47016771|NCT02116777|83265932|FG000|Overall Study|Physician Decision|0|||
47016772|NCT02116777|83265933|FG001|Overall Study|Physician Decision|0|||
47016773|NCT02116777|83265934|FG002|Overall Study|Physician Decision|0|||
47016774|NCT02116777|83265935|FG003|Overall Study|Physician Decision|2|||
47016775|NCT02116777|83265936|FG004|Overall Study|Physician Decision|0|||
47016776|NCT02116777|83265937|FG005|Overall Study|Physician Decision|0|||
47016777|NCT02116777|83265938|FG006|Overall Study|Physician Decision|0|||
47016778|NCT02116777|83265932|FG000|Overall Study|Protocol Violation|0|||
47016779|NCT02116777|83265933|FG001|Overall Study|Protocol Violation|0|||
47016780|NCT02116777|83265934|FG002|Overall Study|Protocol Violation|0|||
47016781|NCT02116777|83265935|FG003|Overall Study|Protocol Violation|1|||
47016782|NCT02116777|83265936|FG004|Overall Study|Protocol Violation|0|||
47016783|NCT02116777|83265937|FG005|Overall Study|Protocol Violation|0|||
47016784|NCT02116777|83265938|FG006|Overall Study|Protocol Violation|0|||
47016785|NCT02116777|83265932|FG000|Overall Study|Withdrawal by Subject|0|||
47016786|NCT02116777|83265933|FG001|Overall Study|Withdrawal by Subject|0|||
47016787|NCT02116777|83265934|FG002|Overall Study|Withdrawal by Subject|0|||
47016788|NCT02116777|83265935|FG003|Overall Study|Withdrawal by Subject|1|||
47016789|NCT02116777|83265936|FG004|Overall Study|Withdrawal by Subject|0|||
47016790|NCT02116777|83265937|FG005|Overall Study|Withdrawal by Subject|0|||
47016791|NCT02116777|83265938|FG006|Overall Study|Withdrawal by Subject|0|||
47016792|NCT01494532|83265963|FG000|Overall Study|Adverse Event|4|||
47016793|NCT01494532|83265964|FG001|Overall Study|Adverse Event|1|||
47016794|NCT01494532|83265965|FG002|Overall Study|Adverse Event|8|||
47016795|NCT01494532|83265966|FG003|Overall Study|Adverse Event|6|||
47016796|NCT01494532|83265967|FG004|Overall Study|Adverse Event|5|||
47016797|NCT01494532|83265968|FG005|Overall Study|Adverse Event|0|||
47016798|NCT01494532|83265963|FG000|Overall Study|Lack of Efficacy|0|||
47016799|NCT01494532|83265964|FG001|Overall Study|Lack of Efficacy|0|||
47016800|NCT01494532|83265965|FG002|Overall Study|Lack of Efficacy|0|||
47016801|NCT01494532|83265966|FG003|Overall Study|Lack of Efficacy|0|||
47016802|NCT01494532|83265967|FG004|Overall Study|Lack of Efficacy|2|||
47016803|NCT01494532|83265968|FG005|Overall Study|Lack of Efficacy|0|||
47016804|NCT01494532|83265963|FG000|Overall Study|Protocol deviation|2|||
47016805|NCT01494532|83265964|FG001|Overall Study|Protocol deviation|1|||
47016806|NCT01494532|83265965|FG002|Overall Study|Protocol deviation|3|||
47016807|NCT01494532|83265966|FG003|Overall Study|Protocol deviation|2|||
47016808|NCT01494532|83265967|FG004|Overall Study|Protocol deviation|3|||
47016809|NCT01494532|83265968|FG005|Overall Study|Protocol deviation|0|||
47016810|NCT01494532|83265963|FG000|Overall Study|Protocol-defined stopping criteria|0|||
47016811|NCT01494532|83265964|FG001|Overall Study|Protocol-defined stopping criteria|0|||
47016812|NCT01494532|83265965|FG002|Overall Study|Protocol-defined stopping criteria|1|||
47016813|NCT01494532|83265966|FG003|Overall Study|Protocol-defined stopping criteria|0|||
47016814|NCT01494532|83265967|FG004|Overall Study|Protocol-defined stopping criteria|0|||
47016815|NCT01494532|83265968|FG005|Overall Study|Protocol-defined stopping criteria|0|||
47016816|NCT01494532|83265963|FG000|Overall Study|Lost to Follow-up|1|||
47016817|NCT01494532|83265964|FG001|Overall Study|Lost to Follow-up|0|||
47016818|NCT01494532|83265965|FG002|Overall Study|Lost to Follow-up|0|||
47016819|NCT01494532|83265966|FG003|Overall Study|Lost to Follow-up|2|||
47016820|NCT01494532|83265967|FG004|Overall Study|Lost to Follow-up|0|||
47016821|NCT01494532|83265968|FG005|Overall Study|Lost to Follow-up|0|||
47016822|NCT01494532|83265963|FG000|Overall Study|Physician Decision|0|||
47016823|NCT01494532|83265964|FG001|Overall Study|Physician Decision|1|||
47016824|NCT01494532|83265965|FG002|Overall Study|Physician Decision|1|||
47016825|NCT01494532|83265966|FG003|Overall Study|Physician Decision|2|||
47016826|NCT01494532|83265967|FG004|Overall Study|Physician Decision|0|||
47016827|NCT01494532|83265968|FG005|Overall Study|Physician Decision|0|||
47016828|NCT01494532|83265963|FG000|Overall Study|Withdrawal by Subject|3|||
47016829|NCT01494532|83265964|FG001|Overall Study|Withdrawal by Subject|1|||
47016830|NCT01494532|83265965|FG002|Overall Study|Withdrawal by Subject|4|||
47016831|NCT01494532|83265966|FG003|Overall Study|Withdrawal by Subject|3|||
47016832|NCT01494532|83265967|FG004|Overall Study|Withdrawal by Subject|2|||
47016833|NCT01494532|83265968|FG005|Overall Study|Withdrawal by Subject|0|||
47016834|NCT02191397|83265985|FG000|Overall Study|Adverse Event|28|||
47016835|NCT02191397|83265986|FG001|Overall Study|Adverse Event|17|||
47016836|NCT02191397|83265985|FG000|Overall Study|Lack of Efficacy|10|||
47016837|NCT02191397|83265986|FG001|Overall Study|Lack of Efficacy|5|||
47016838|NCT02191397|83265985|FG000|Overall Study|Protocol Violation|0|||
47016839|NCT02191397|83265986|FG001|Overall Study|Protocol Violation|3|||
47016840|NCT02191397|83265985|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
47016841|NCT02191397|83265986|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
47016842|NCT02191397|83265985|FG000|Overall Study|Lost to Follow-up|10|||
47016843|NCT02191397|83265986|FG001|Overall Study|Lost to Follow-up|11|||
47016844|NCT02191397|83265985|FG000|Overall Study|Physician Decision|8|||
47016845|NCT02191397|83265986|FG001|Overall Study|Physician Decision|3|||
47016846|NCT02191397|83265985|FG000|Overall Study|Withdrawal by Subject|22|||
47016847|NCT02191397|83265986|FG001|Overall Study|Withdrawal by Subject|27|||
47016848|NCT01630811|83265992|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
47016849|NCT01630811|83265993|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
47016850|NCT01494298|83266003|FG000|Overall Study|Protocol Violation|2|||
47016851|NCT01494298|83266004|FG001|Overall Study|Protocol Violation|8|||
47016852|NCT02169791|83266012|FG000|Overall Study|Death|6|||
47016853|NCT02169791|83266012|FG000|Overall Study|patient withdrew consent|1|||
47016854|NCT02216591|83266018|FG000|Overall Study|Lost to Follow-up|0|||
47016855|NCT02216591|83266019|FG001|Overall Study|Lost to Follow-up|1|||
47016856|NCT02216357|83266027|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
47016857|NCT02216357|83266028|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
47016858|NCT01492426|83266036|FG000|Treatment|Death|0|||
47016859|NCT01492426|83266037|FG001|Treatment|Death|1|||
47016860|NCT01492426|83266036|FG000|Treatment|Other|1|||
47016861|NCT01492426|83266037|FG001|Treatment|Other|0|||
47016862|NCT01492426|83266036|FG000|Treatment|Adverse Event|25|||
47016863|NCT01492426|83266037|FG001|Treatment|Adverse Event|25|||
47016864|NCT01492426|83266036|FG000|Treatment|Lack of Efficacy|38|||
47016865|NCT01492426|83266037|FG001|Treatment|Lack of Efficacy|5|||
47016866|NCT01492426|83266036|FG000|Treatment|Participant withdrew consent|1|||
47016867|NCT01492426|83266037|FG001|Treatment|Participant withdrew consent|2|||
47016868|NCT01492426|83266036|FG000|Treatment|Poor compliance/noncompliance|1|||
47016869|NCT01492426|83266037|FG001|Treatment|Poor compliance/noncompliance|0|||
47016870|NCT01492426|83266036|FG000|Treatment|Subject requested discontinue study drug|7|||
47016871|NCT01492426|83266037|FG001|Treatment|Subject requested discontinue study drug|3|||
47016872|NCT01492426|83266036|FG000|Treatment|Lost to Follow-up|9|||
47016873|NCT01492426|83266037|FG001|Treatment|Lost to Follow-up|4|||
47016874|NCT01492426|83266036|FG000|Treatment|Participant does not meet study criteria|1|||
47016875|NCT01492426|83266037|FG001|Treatment|Participant does not meet study criteria|0|||
47016876|NCT01492426|83266036|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
47016877|NCT01492426|83266037|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
47016878|NCT01492426|83266036|FG000|Follow-Up|Death|1|||
47016879|NCT01492426|83266037|FG001|Follow-Up|Death|0|||
47016880|NCT01492426|83266036|FG000|Follow-Up|Other|4|||
47016881|NCT01492426|83266037|FG001|Follow-Up|Other|2|||
47016882|NCT01492426|83266036|FG000|Follow-Up|Participant Withdrew Consent|6|||
47016883|NCT01492426|83266037|FG001|Follow-Up|Participant Withdrew Consent|1|||
47016884|NCT01492426|83266036|FG000|Follow-Up|Lost to Follow-up|12|||
47016885|NCT01492426|83266037|FG001|Follow-Up|Lost to Follow-up|6|||
47016886|NCT01453348|83266050|FG000|Overall Study|Death|0|||
47016887|NCT01453348|83266051|FG001|Overall Study|Death|0|||
47016888|NCT01453348|83266052|FG002|Overall Study|Death|1|||
47016889|NCT01453348|83266050|FG000|Overall Study|Withdrawal by Subject|0|||
47016890|NCT01453348|83266051|FG001|Overall Study|Withdrawal by Subject|1|||
47016891|NCT01453348|83266052|FG002|Overall Study|Withdrawal by Subject|0|||
47016892|NCT01453348|83266050|FG000|Overall Study|Protocol Violation|1|||
47016893|NCT01453348|83266051|FG001|Overall Study|Protocol Violation|0|||
47016894|NCT01453348|83266052|FG002|Overall Study|Protocol Violation|0|||
47016895|NCT01453036|83266066|FG000|Overall Study|Lost to Follow-up|26|||
47016896|NCT01453036|83266067|FG001|Overall Study|Lost to Follow-up|115|||
47016897|NCT01453036|83266068|FG002|Overall Study|Lost to Follow-up|31|||
47016898|NCT01475734|83266078|FG000|Overall Study|Withdrawal by Subject|1|||
47016899|NCT01475734|83266079|FG001|Overall Study|Withdrawal by Subject|0|||
47016900|NCT01475734|83266078|FG000|Overall Study|Protocol Violation|1|||
47016901|NCT01475734|83266079|FG001|Overall Study|Protocol Violation|0|||
47016902|NCT01475734|83266078|FG000|Overall Study|Physician Decision|0|||
47016903|NCT01475734|83266079|FG001|Overall Study|Physician Decision|1|||
47016904|NCT01452412|83266087|FG000|Overall Study|Withdrawal by Subject|15|||
47016905|NCT01452412|83266088|FG001|Overall Study|Withdrawal by Subject|11|||
47016906|NCT01452412|83266087|FG000|Overall Study|Adverse Event|4|||
47016907|NCT01452412|83266088|FG001|Overall Study|Adverse Event|3|||
47016908|NCT01452412|83266087|FG000|Overall Study|Lost to Follow-up|5|||
47016909|NCT01452412|83266088|FG001|Overall Study|Lost to Follow-up|3|||
47016910|NCT01452412|83266087|FG000|Overall Study|Death|1|||
47016911|NCT01452412|83266088|FG001|Overall Study|Death|0|||
47016912|NCT01452412|83266087|FG000|Overall Study|Initiated dialysis|1|||
47016913|NCT01452412|83266088|FG001|Overall Study|Initiated dialysis|0|||
47016914|NCT01452412|83266087|FG000|Overall Study|Other|2|||
47016915|NCT01452412|83266088|FG001|Overall Study|Other|0|||
47016916|NCT01474876|83266097|FG000|Overall Study|Adverse Event|11|||
47016917|NCT01474876|83266098|FG001|Overall Study|Adverse Event|5|||
47016918|NCT01474876|83266099|FG002|Overall Study|Adverse Event|0|||
47016919|NCT01474876|83266097|FG000|Overall Study|Serious Adverse Event|2|||
47016920|NCT01474876|83266098|FG001|Overall Study|Serious Adverse Event|3|||
47016921|NCT01474876|83266099|FG002|Overall Study|Serious Adverse Event|0|||
47016922|NCT01474876|83266097|FG000|Overall Study|Lost to Follow-up|5|||
47016923|NCT01474876|83266098|FG001|Overall Study|Lost to Follow-up|4|||
47016924|NCT01474876|83266099|FG002|Overall Study|Lost to Follow-up|0|||
47016925|NCT01474876|83266097|FG000|Overall Study|Investigator's decision|28|||
47016926|NCT01474876|83266098|FG001|Overall Study|Investigator's decision|6|||
47016927|NCT01474876|83266099|FG002|Overall Study|Investigator's decision|0|||
47016928|NCT01474876|83266097|FG000|Overall Study|Patient's request|19|||
47016929|NCT01474876|83266098|FG001|Overall Study|Patient's request|5|||
47016930|NCT01474876|83266099|FG002|Overall Study|Patient's request|0|||
47016931|NCT01474876|83266097|FG000|Overall Study|Investigator's decision and pt request|1|||
47016932|NCT01474876|83266098|FG001|Overall Study|Investigator's decision and pt request|0|||
47016933|NCT01474876|83266099|FG002|Overall Study|Investigator's decision and pt request|0|||
47016934|NCT01491802|83266105|FG000|Overall Study|Adverse Event|1|||
47016935|NCT01491802|83266106|FG001|Overall Study|Adverse Event|1|||
47016936|NCT01491802|83266105|FG000|Overall Study|Withdrawal by Subject|0|||
47016937|NCT01491802|83266106|FG001|Overall Study|Withdrawal by Subject|1|||
47016938|NCT02168777|83266116|FG000|Overall Study|Withdrawal by Subject|1|||
47016939|NCT02168777|83266117|FG001|Overall Study|Withdrawal by Subject|0|||
47016940|NCT02168777|83266118|FG002|Overall Study|Withdrawal by Subject|2|||
47016941|NCT02168777|83266116|FG000|Overall Study|Adverse Event|1|||
47016942|NCT02168777|83266117|FG001|Overall Study|Adverse Event|0|||
47016943|NCT02168777|83266118|FG002|Overall Study|Adverse Event|1|||
47016944|NCT02168777|83266116|FG000|Overall Study|Disease recurrence|0|||
46620571|NCT01721876|82770644|FG001|Overall Study|Disease progression / relapse|156|||
47016945|NCT02168777|83266117|FG001|Overall Study|Disease recurrence|0|||
47016946|NCT02168777|83266118|FG002|Overall Study|Disease recurrence|1|||
47016947|NCT02168777|83266116|FG000|Overall Study|Radiological disease progression|0|||
47016948|NCT02168777|83266117|FG001|Overall Study|Radiological disease progression|5|||
47016949|NCT02168777|83266118|FG002|Overall Study|Radiological disease progression|5|||
47016950|NCT02168777|83266116|FG000|Overall Study|Clinical disease progression|0|||
47016951|NCT02168777|83266117|FG001|Overall Study|Clinical disease progression|1|||
47016952|NCT02168777|83266118|FG002|Overall Study|Clinical disease progression|2|||
47016953|NCT02168777|83266116|FG000|Overall Study|Other reason|0|||
47016954|NCT02168777|83266117|FG001|Overall Study|Other reason|1|||
47016955|NCT02168777|83266118|FG002|Overall Study|Other reason|0|||
47016956|NCT01491178|83266129|FG000|Overall Study|Adverse Event|1016|||
47016957|NCT01491178|83266129|FG000|Overall Study|Improvement of NVAF|210|||
47016958|NCT01491178|83266129|FG000|Overall Study|To conduct invasive treatment|59|||
47016959|NCT01491178|83266129|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
47016960|NCT01491178|83266129|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
47016961|NCT01491178|83266129|FG000|Overall Study|To take a contraindication|20|||
47016962|NCT01491178|83266129|FG000|Overall Study|Other than specified above|657|||
47016963|NCT02189837|83266137|FG000|Overall Study|Withdrawal by Subject|2|||
47016964|NCT02189837|83266138|FG001|Overall Study|Withdrawal by Subject|1|||
47016965|NCT02189837|83266139|FG002|Overall Study|Withdrawal by Subject|3|||
47016966|NCT02189837|83266140|FG003|Overall Study|Withdrawal by Subject|1|||
47016967|NCT02189837|83266137|FG000|Overall Study|Sponsor Decision|0|||
47016968|NCT02189837|83266138|FG001|Overall Study|Sponsor Decision|0|||
47016969|NCT02189837|83266139|FG002|Overall Study|Sponsor Decision|0|||
47016970|NCT02189837|83266140|FG003|Overall Study|Sponsor Decision|1|||
47016971|NCT02216123|83266152|FG000|Overall Study|Lost to Follow-up|4|||
47016972|NCT02216123|83266153|FG001|Overall Study|Lost to Follow-up|2|||
47016973|NCT02216123|83266152|FG000|Overall Study|Withdrawal by Subject|2|||
47016974|NCT02216123|83266153|FG001|Overall Study|Withdrawal by Subject|0|||
47016975|NCT02189759|83266167|FG000|Overall Study|Lost to Follow-up|0|||
47016976|NCT02189759|83266168|FG001|Overall Study|Lost to Follow-up|0|||
47016977|NCT02189759|83266169|FG002|Overall Study|Lost to Follow-up|2|||
47016978|NCT02189759|83266170|FG003|Overall Study|Lost to Follow-up|5|||
47016979|NCT01490866|83266182|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
47016980|NCT01490866|83266182|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
47016981|NCT01490866|83266182|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
47016982|NCT01490866|83266182|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
47016983|NCT01490866|83266182|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
47016984|NCT01490866|83266182|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
47016985|NCT01490866|83266182|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
47016986|NCT01490866|83266182|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
47016987|NCT01490866|83266182|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
47016988|NCT01490866|83266182|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
47016989|NCT01490866|83266182|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
47016990|NCT02215967|83266193|FG000|Overall Study|Patient became ineligible for treatment|0|||
47016991|NCT02215967|83266194|FG001|Overall Study|Patient became ineligible for treatment|0|||
47016992|NCT02215967|83266195|FG002|Overall Study|Patient became ineligible for treatment|0|||
47016993|NCT02215967|83266196|FG003|Overall Study|Patient became ineligible for treatment|3|||
47016994|NCT02215967|83266193|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
47016995|NCT02215967|83266194|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
47016996|NCT02215967|83266195|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
47016997|NCT02215967|83266196|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
47016998|NCT02168387|83266208|FG000|Overall Study|Planned exubation|6|||
47016999|NCT02168387|83266209|FG001|Overall Study|Planned exubation|3|||
47017000|NCT02168387|83266208|FG000|Overall Study|Death|1|||
47017001|NCT02168387|83266209|FG001|Overall Study|Death|0|||
47017002|NCT02188589|83266215|FG000|Overall Study|Withdrawal by Subject|5|||
47017003|NCT02167451|83266220|FG000|Overall Study|Withdrawal by Subject|1|||
47017004|NCT02167139|83266226|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
47017005|NCT02167139|83266227|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
47017006|NCT02167139|83266228|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
47017007|NCT02167139|83266229|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
46910715|NCT03329573|83140319|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
46910716|NCT03329573|83140320|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
47017008|NCT02167139|83266226|FG000|Randomised, Double-blind|Adverse Event|2|||
47017009|NCT02167139|83266227|FG001|Randomised, Double-blind|Adverse Event|9|||
47017010|NCT02167139|83266228|FG002|Randomised, Double-blind|Adverse Event|0|||
47017011|NCT02167139|83266229|FG003|Randomised, Double-blind|Adverse Event|0|||
47017012|NCT02167139|83266226|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
47017013|NCT02167139|83266227|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
46910717|NCT03329573|83140321|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
46910718|NCT03329573|83140318|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
47017014|NCT02167139|83266228|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
47017015|NCT02167139|83266229|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
47017016|NCT02167139|83266226|FG000|Randomised, Double-blind|Other|3|||
47017017|NCT02167139|83266227|FG001|Randomised, Double-blind|Other|0|||
47017018|NCT02167139|83266228|FG002|Randomised, Double-blind|Other|0|||
47017019|NCT02167139|83266229|FG003|Randomised, Double-blind|Other|0|||
47017020|NCT02167139|83266226|FG000|Transition-extension|Adverse Event|2|||
47017021|NCT02167139|83266227|FG001|Transition-extension|Adverse Event|0|||
47017022|NCT02167139|83266228|FG002|Transition-extension|Adverse Event|2|||
47017023|NCT02167139|83266229|FG003|Transition-extension|Adverse Event|3|||
47017024|NCT02167139|83266226|FG000|Transition-extension|Withdrawal by Subject|2|||
47017025|NCT02167139|83266227|FG001|Transition-extension|Withdrawal by Subject|0|||
47017026|NCT02167139|83266228|FG002|Transition-extension|Withdrawal by Subject|4|||
47017027|NCT02167139|83266229|FG003|Transition-extension|Withdrawal by Subject|1|||
47017028|NCT02167139|83266226|FG000|Transition-extension|Lack of Efficacy|0|||
47017029|NCT02167139|83266227|FG001|Transition-extension|Lack of Efficacy|0|||
47017030|NCT02167139|83266228|FG002|Transition-extension|Lack of Efficacy|1|||
47017031|NCT02167139|83266229|FG003|Transition-extension|Lack of Efficacy|1|||
47017032|NCT02167139|83266226|FG000|Transition-extension|Other|1|||
47017033|NCT02167139|83266227|FG001|Transition-extension|Other|0|||
47017034|NCT02167139|83266228|FG002|Transition-extension|Other|1|||
47017035|NCT02167139|83266229|FG003|Transition-extension|Other|0|||
47017036|NCT02167139|83266226|FG000|Transition-extension|Lost to Follow-up|1|||
47017037|NCT02167139|83266227|FG001|Transition-extension|Lost to Follow-up|0|||
47017038|NCT02167139|83266228|FG002|Transition-extension|Lost to Follow-up|0|||
47017039|NCT02167139|83266229|FG003|Transition-extension|Lost to Follow-up|0|||
47017040|NCT02116621|83266245|FG000|Baseline|Withdrawal by Subject|0|||
47017041|NCT02116621|83266246|FG001|Baseline|Withdrawal by Subject|4|||
47017042|NCT02116621|83266245|FG000|Three Month Follow-up|Death|1|||
47017043|NCT02116621|83266246|FG001|Three Month Follow-up|Death|1|||
47017044|NCT02116621|83266245|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
47017045|NCT02116621|83266246|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
47017046|NCT02116621|83266245|FG000|Three Month Follow-up|Lost to Follow-up|0|||
47017047|NCT02116621|83266246|FG001|Three Month Follow-up|Lost to Follow-up|1|||
47017048|NCT02116621|83266245|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
47017049|NCT02116621|83266246|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
47017050|NCT02116621|83266245|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
47017051|NCT02116621|83266246|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
47017052|NCT02116621|83266245|FG000|Six Month Follow-up|Lost to Follow-up|2|||
47017053|NCT02116621|83266246|FG001|Six Month Follow-up|Lost to Follow-up|1|||
47017054|NCT02116621|83266245|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
47017055|NCT02116621|83266246|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
47017056|NCT02116621|83266245|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
47017057|NCT02116621|83266246|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
47017058|NCT02116621|83266245|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
47017059|NCT02116621|83266246|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
47017060|NCT02116621|83266245|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
47017061|NCT02116621|83266246|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
47017062|NCT02116621|83266245|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
47017063|NCT02116621|83266246|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
47017064|NCT02116309|83266254|FG000|Overall Study|Lost to Follow-up|0|||
47017065|NCT02116309|83266255|FG001|Overall Study|Lost to Follow-up|1|||
47017066|NCT02115607|83266261|FG000|Overall Study|Withdrawal by Subject|1|||
47017067|NCT01490632|83266270|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
47017068|NCT01490632|83266271|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
47017069|NCT01490632|83266272|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
47017070|NCT01490632|83266273|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
47017071|NCT01490632|83266274|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
46910719|NCT03329573|83140319|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
46910720|NCT03329573|83140320|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
47017072|NCT01490632|83266275|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
47017073|NCT01490632|83266276|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
47017074|NCT01490632|83266277|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
47017075|NCT01490632|83266278|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
47017076|NCT01490632|83266279|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
47017077|NCT01490632|83266280|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
47017078|NCT01490632|83266281|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
47017079|NCT01490632|83266282|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
47017080|NCT01490632|83266283|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
47017081|NCT01490632|83266284|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
47017082|NCT01490632|83266285|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
47017083|NCT01490632|83266286|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
47017084|NCT01490632|83266287|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
47017085|NCT01490632|83266288|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
47017086|NCT01490632|83266289|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
47017087|NCT01490632|83266270|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
47017088|NCT01490632|83266271|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
47017089|NCT01490632|83266272|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
47017090|NCT01490632|83266273|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
47017091|NCT01490632|83266274|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017092|NCT01490632|83266275|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017093|NCT01490632|83266276|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017094|NCT01490632|83266277|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017095|NCT01490632|83266278|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017096|NCT01490632|83266279|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017097|NCT01490632|83266280|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017098|NCT01490632|83266281|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017099|NCT01490632|83266282|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017100|NCT01490632|83266283|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017101|NCT01490632|83266284|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017102|NCT01490632|83266285|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017103|NCT01490632|83266286|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017104|NCT01490632|83266287|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017105|NCT01490632|83266288|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017106|NCT01490632|83266289|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
47017107|NCT01490632|83266270|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017108|NCT01490632|83266271|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017109|NCT01490632|83266272|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
47017110|NCT01490632|83266273|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
47017111|NCT01490632|83266274|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
47017112|NCT01490632|83266275|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017113|NCT01490632|83266276|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017114|NCT01490632|83266277|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017115|NCT01490632|83266278|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017116|NCT01490632|83266279|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017117|NCT01490632|83266280|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017118|NCT01490632|83266281|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017119|NCT01490632|83266282|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017120|NCT01490632|83266283|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017121|NCT01490632|83266284|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017122|NCT01490632|83266285|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017123|NCT01490632|83266286|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017124|NCT01490632|83266287|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017125|NCT01490632|83266288|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017126|NCT01490632|83266289|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
47017127|NCT01490632|83266270|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
47017128|NCT01490632|83266271|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
47017129|NCT01490632|83266272|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
47017130|NCT01490632|83266273|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
47017131|NCT01490632|83266274|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
47017132|NCT01490632|83266275|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
47017133|NCT01490632|83266276|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
47017134|NCT01490632|83266277|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
47017135|NCT01490632|83266278|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
47017136|NCT01490632|83266279|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
47017137|NCT01490632|83266280|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
47017138|NCT01490632|83266281|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
47017139|NCT01490632|83266282|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
47017140|NCT01490632|83266283|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
47017141|NCT01490632|83266284|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
47017142|NCT01490632|83266285|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
47017143|NCT01490632|83266286|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
47017144|NCT01490632|83266287|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
47017145|NCT01490632|83266288|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
47017146|NCT01490632|83266289|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
47017147|NCT01490632|83266270|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
47017148|NCT01490632|83266271|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017149|NCT01490632|83266272|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017150|NCT01490632|83266273|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017151|NCT01490632|83266274|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017152|NCT01490632|83266275|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017153|NCT01490632|83266276|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017154|NCT01490632|83266277|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017155|NCT01490632|83266278|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017156|NCT01490632|83266279|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017157|NCT01490632|83266280|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017158|NCT01490632|83266281|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017159|NCT01490632|83266282|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017160|NCT01490632|83266283|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017161|NCT01490632|83266284|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017162|NCT01490632|83266285|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017163|NCT01490632|83266286|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017164|NCT01490632|83266287|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017165|NCT01490632|83266288|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017166|NCT01490632|83266289|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
47017167|NCT01490632|83266270|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
47017168|NCT01490632|83266271|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
47017169|NCT01490632|83266272|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017170|NCT01490632|83266273|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
47017171|NCT01490632|83266274|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
47017172|NCT01490632|83266275|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017173|NCT01490632|83266276|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017174|NCT01490632|83266277|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017175|NCT01490632|83266278|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017176|NCT01490632|83266279|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017177|NCT01490632|83266280|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017178|NCT01490632|83266281|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017179|NCT01490632|83266282|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017180|NCT01490632|83266283|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017181|NCT01490632|83266284|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017182|NCT01490632|83266285|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017183|NCT01490632|83266286|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017184|NCT01490632|83266287|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017185|NCT01490632|83266288|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017186|NCT01490632|83266289|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
47017187|NCT01490632|83266270|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017188|NCT01490632|83266271|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017189|NCT01490632|83266272|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017190|NCT01490632|83266273|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017191|NCT01490632|83266274|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
47017192|NCT01490632|83266275|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017193|NCT01490632|83266276|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017194|NCT01490632|83266277|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017195|NCT01490632|83266278|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017196|NCT01490632|83266279|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017197|NCT01490632|83266280|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017198|NCT01490632|83266281|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017199|NCT01490632|83266282|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017200|NCT01490632|83266283|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017201|NCT01490632|83266284|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017202|NCT01490632|83266285|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017203|NCT01490632|83266286|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017204|NCT01490632|83266287|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017205|NCT01490632|83266288|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017206|NCT01490632|83266289|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
47017207|NCT01490632|83266270|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017208|NCT01490632|83266271|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017209|NCT01490632|83266272|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017210|NCT01490632|83266273|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017211|NCT01490632|83266274|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017212|NCT01490632|83266275|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
47017213|NCT01490632|83266276|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
47017214|NCT01490632|83266277|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017215|NCT01490632|83266278|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017216|NCT01490632|83266279|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
47017217|NCT01490632|83266280|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
47017218|NCT01490632|83266281|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
47017219|NCT01490632|83266282|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017220|NCT01490632|83266283|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017221|NCT01490632|83266284|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017222|NCT01490632|83266285|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017223|NCT01490632|83266286|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017224|NCT01490632|83266287|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017225|NCT01490632|83266288|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017226|NCT01490632|83266289|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
47017227|NCT01490632|83266270|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017228|NCT01490632|83266271|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017229|NCT01490632|83266272|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017230|NCT01490632|83266273|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017231|NCT01490632|83266274|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017232|NCT01490632|83266275|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017233|NCT01490632|83266276|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
47017234|NCT01490632|83266277|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017235|NCT01490632|83266278|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
47017236|NCT01490632|83266279|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
47017237|NCT01490632|83266280|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
47017238|NCT01490632|83266281|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017239|NCT01490632|83266282|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017240|NCT01490632|83266283|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017241|NCT01490632|83266284|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017242|NCT01490632|83266285|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017243|NCT01490632|83266286|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017244|NCT01490632|83266287|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017245|NCT01490632|83266288|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017246|NCT01490632|83266289|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
47017247|NCT01490632|83266270|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017248|NCT01490632|83266271|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017249|NCT01490632|83266272|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017250|NCT01490632|83266273|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017251|NCT01490632|83266274|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017252|NCT01490632|83266275|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017253|NCT01490632|83266276|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
47017254|NCT01490632|83266277|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017255|NCT01490632|83266278|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017256|NCT01490632|83266279|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
47017257|NCT01490632|83266280|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017258|NCT01490632|83266281|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017259|NCT01490632|83266282|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017260|NCT01490632|83266283|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017261|NCT01490632|83266284|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017262|NCT01490632|83266285|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017263|NCT01490632|83266286|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017264|NCT01490632|83266287|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017265|NCT01490632|83266288|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
47017266|NCT01490632|83266289|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
46910721|NCT03329573|83140321|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46620572|NCT01721876|82770643|FG000|Overall Study|Death|6|||
47017267|NCT01490632|83266270|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017268|NCT01490632|83266271|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017269|NCT01490632|83266272|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017270|NCT01490632|83266273|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017271|NCT01490632|83266274|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017272|NCT01490632|83266275|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017273|NCT01490632|83266276|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
47017274|NCT01490632|83266277|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017275|NCT01490632|83266278|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017276|NCT01490632|83266279|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017277|NCT01490632|83266280|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017278|NCT01490632|83266281|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017279|NCT01490632|83266282|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017280|NCT01490632|83266283|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017281|NCT01490632|83266284|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017282|NCT01490632|83266285|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017283|NCT01490632|83266286|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017284|NCT01490632|83266287|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017285|NCT01490632|83266288|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017286|NCT01490632|83266289|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
47017287|NCT01490632|83266270|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017288|NCT01490632|83266271|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017289|NCT01490632|83266272|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017290|NCT01490632|83266273|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017291|NCT01490632|83266274|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017292|NCT01490632|83266275|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
47017293|NCT01490632|83266276|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017294|NCT01490632|83266277|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017295|NCT01490632|83266278|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017296|NCT01490632|83266279|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017297|NCT01490632|83266280|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017298|NCT01490632|83266281|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017299|NCT01490632|83266282|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017300|NCT01490632|83266283|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017301|NCT01490632|83266284|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017302|NCT01490632|83266285|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017303|NCT01490632|83266286|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017304|NCT01490632|83266287|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017305|NCT01490632|83266288|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017306|NCT01490632|83266289|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
47017307|NCT01490632|83266270|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017308|NCT01490632|83266271|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017309|NCT01490632|83266272|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017310|NCT01490632|83266273|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017311|NCT01490632|83266274|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017312|NCT01490632|83266275|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017313|NCT01490632|83266276|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
47017314|NCT01490632|83266277|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017315|NCT01490632|83266278|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
47017316|NCT01490632|83266279|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017317|NCT01490632|83266280|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
47017318|NCT01490632|83266281|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
47017319|NCT01490632|83266282|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017320|NCT01490632|83266283|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017321|NCT01490632|83266284|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017322|NCT01490632|83266285|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017323|NCT01490632|83266286|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017324|NCT01490632|83266287|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017325|NCT01490632|83266288|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017326|NCT01490632|83266289|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
47017327|NCT01490632|83266270|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017328|NCT01490632|83266271|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017329|NCT01490632|83266272|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017330|NCT01490632|83266273|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
46620573|NCT01721876|82770644|FG001|Overall Study|Death|13|||
47017331|NCT01490632|83266274|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017332|NCT01490632|83266275|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
47017333|NCT01490632|83266276|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
47017334|NCT01490632|83266277|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
47017335|NCT01490632|83266278|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
47017336|NCT01490632|83266279|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
47017337|NCT01490632|83266280|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
47017338|NCT01490632|83266281|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
47017339|NCT01490632|83266282|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017340|NCT01490632|83266283|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017341|NCT01490632|83266284|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017342|NCT01490632|83266285|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017343|NCT01490632|83266286|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017344|NCT01490632|83266287|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017345|NCT01490632|83266288|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017346|NCT01490632|83266289|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
47017347|NCT01490632|83266270|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017348|NCT01490632|83266271|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017349|NCT01490632|83266272|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017350|NCT01490632|83266273|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017351|NCT01490632|83266274|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017352|NCT01490632|83266275|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017353|NCT01490632|83266276|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017354|NCT01490632|83266277|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017355|NCT01490632|83266278|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017356|NCT01490632|83266279|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017357|NCT01490632|83266280|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017358|NCT01490632|83266281|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017359|NCT01490632|83266282|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017360|NCT01490632|83266283|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017361|NCT01490632|83266284|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
47017362|NCT01490632|83266285|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
47017363|NCT01490632|83266286|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017364|NCT01490632|83266287|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017365|NCT01490632|83266288|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017366|NCT01490632|83266289|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
47017367|NCT01490632|83266270|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017368|NCT01490632|83266271|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017369|NCT01490632|83266272|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017370|NCT01490632|83266273|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017371|NCT01490632|83266274|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017372|NCT01490632|83266275|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017373|NCT01490632|83266276|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017374|NCT01490632|83266277|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017375|NCT01490632|83266278|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017376|NCT01490632|83266279|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017377|NCT01490632|83266280|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017378|NCT01490632|83266281|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017379|NCT01490632|83266282|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017380|NCT01490632|83266283|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
47017381|NCT01490632|83266284|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017382|NCT01490632|83266285|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017383|NCT01490632|83266286|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017384|NCT01490632|83266287|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017385|NCT01490632|83266288|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017386|NCT01490632|83266289|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
47017387|NCT01490632|83266270|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017388|NCT01490632|83266271|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017389|NCT01490632|83266272|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017390|NCT01490632|83266273|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017391|NCT01490632|83266274|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017392|NCT01490632|83266275|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017393|NCT01490632|83266276|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017394|NCT01490632|83266277|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017395|NCT01490632|83266278|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017396|NCT01490632|83266279|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017397|NCT01490632|83266280|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017398|NCT01490632|83266281|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017399|NCT01490632|83266282|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017400|NCT01490632|83266283|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017401|NCT01490632|83266284|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
47017402|NCT01490632|83266285|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
47017403|NCT01490632|83266286|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017404|NCT01490632|83266287|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017405|NCT01490632|83266288|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017406|NCT01490632|83266289|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
47017407|NCT01490632|83266270|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017408|NCT01490632|83266271|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017409|NCT01490632|83266272|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017410|NCT01490632|83266273|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017411|NCT01490632|83266274|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017412|NCT01490632|83266275|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017413|NCT01490632|83266276|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017414|NCT01490632|83266277|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017415|NCT01490632|83266278|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017416|NCT01490632|83266279|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017417|NCT01490632|83266280|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017418|NCT01490632|83266281|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017419|NCT01490632|83266282|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
47017420|NCT01490632|83266283|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
47017421|NCT01490632|83266284|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
47017422|NCT01490632|83266285|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
47017423|NCT01490632|83266286|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017424|NCT01490632|83266287|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017425|NCT01490632|83266288|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017426|NCT01490632|83266289|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
47017427|NCT01490632|83266270|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
47017428|NCT01490632|83266271|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
47017429|NCT01490632|83266272|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
47017430|NCT01490632|83266273|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
47017431|NCT01490632|83266274|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
47017432|NCT01490632|83266275|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
47017433|NCT01490632|83266276|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
47017434|NCT01490632|83266277|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
47017435|NCT01490632|83266278|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
47017436|NCT01490632|83266279|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
47017437|NCT01490632|83266280|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
47017438|NCT01490632|83266281|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
47017439|NCT01490632|83266282|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
47017440|NCT01490632|83266283|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
47017441|NCT01490632|83266284|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
47017442|NCT01490632|83266285|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
47017443|NCT01490632|83266286|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
47017444|NCT01490632|83266287|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
47017445|NCT01490632|83266288|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
47017446|NCT01490632|83266289|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
47017447|NCT01490632|83266270|FG000|Part D: Re-Treatment Period|Death|0|||
47017448|NCT01490632|83266271|FG001|Part D: Re-Treatment Period|Death|0|||
47017449|NCT01490632|83266272|FG002|Part D: Re-Treatment Period|Death|0|||
47017450|NCT01490632|83266273|FG003|Part D: Re-Treatment Period|Death|0|||
47017451|NCT01490632|83266274|FG004|Part D: Re-Treatment Period|Death|0|||
47017452|NCT01490632|83266275|FG005|Part D: Re-Treatment Period|Death|0|||
47017453|NCT01490632|83266276|FG006|Part D: Re-Treatment Period|Death|0|||
47017454|NCT01490632|83266277|FG007|Part D: Re-Treatment Period|Death|0|||
47017455|NCT01490632|83266278|FG008|Part D: Re-Treatment Period|Death|0|||
47017456|NCT01490632|83266279|FG009|Part D: Re-Treatment Period|Death|0|||
47017457|NCT01490632|83266280|FG010|Part D: Re-Treatment Period|Death|0|||
47017458|NCT01490632|83266281|FG011|Part D: Re-Treatment Period|Death|0|||
47017459|NCT01490632|83266282|FG012|Part D: Re-Treatment Period|Death|0|||
47017460|NCT01490632|83266283|FG013|Part D: Re-Treatment Period|Death|0|||
46620574|NCT01721876|82770643|FG000|Overall Study|Adverse Event|41|||
47017461|NCT01490632|83266284|FG014|Part D: Re-Treatment Period|Death|0|||
47017462|NCT01490632|83266285|FG015|Part D: Re-Treatment Period|Death|0|||
47017463|NCT01490632|83266286|FG016|Part D: Re-Treatment Period|Death|0|||
47017464|NCT01490632|83266287|FG017|Part D: Re-Treatment Period|Death|0|||
47017465|NCT01490632|83266288|FG018|Part D: Re-Treatment Period|Death|1|||
47017466|NCT01490632|83266289|FG019|Part D: Re-Treatment Period|Death|0|||
47017467|NCT01490632|83266270|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017468|NCT01490632|83266271|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017469|NCT01490632|83266272|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017470|NCT01490632|83266273|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017471|NCT01490632|83266274|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017472|NCT01490632|83266275|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017473|NCT01490632|83266276|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017474|NCT01490632|83266277|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017475|NCT01490632|83266278|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017476|NCT01490632|83266279|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017477|NCT01490632|83266280|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017478|NCT01490632|83266281|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017479|NCT01490632|83266282|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017480|NCT01490632|83266283|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017481|NCT01490632|83266284|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017482|NCT01490632|83266285|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017483|NCT01490632|83266286|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
47017484|NCT01490632|83266287|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
47017485|NCT01490632|83266288|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
47017486|NCT01490632|83266289|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
47017487|NCT01490632|83266270|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017488|NCT01490632|83266271|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017489|NCT01490632|83266272|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017490|NCT01490632|83266273|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017491|NCT01490632|83266274|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017492|NCT01490632|83266275|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017493|NCT01490632|83266276|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017494|NCT01490632|83266277|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017495|NCT01490632|83266278|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017496|NCT01490632|83266279|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017497|NCT01490632|83266280|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017498|NCT01490632|83266281|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017499|NCT01490632|83266282|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017500|NCT01490632|83266283|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017501|NCT01490632|83266284|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017502|NCT01490632|83266285|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017503|NCT01490632|83266286|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017504|NCT01490632|83266287|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017505|NCT01490632|83266288|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
47017506|NCT01490632|83266289|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
47017507|NCT01490632|83266270|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
47017508|NCT01490632|83266271|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
47017509|NCT01490632|83266272|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
47017510|NCT01490632|83266273|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
47017511|NCT01490632|83266274|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
47017512|NCT01490632|83266275|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
47017513|NCT01490632|83266276|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
47017514|NCT01490632|83266277|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
47017515|NCT01490632|83266278|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
47017516|NCT01490632|83266279|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
47017517|NCT01490632|83266280|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
47017518|NCT01490632|83266281|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
47017519|NCT01490632|83266282|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
47017520|NCT01490632|83266283|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
47017521|NCT01490632|83266284|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
47017522|NCT01490632|83266285|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
47017523|NCT01490632|83266286|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
46620575|NCT01721876|82770644|FG001|Overall Study|Adverse Event|165|||
47017524|NCT01490632|83266287|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
47017525|NCT01490632|83266288|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
47017526|NCT01490632|83266289|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
47017527|NCT01490632|83266270|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
47017528|NCT01490632|83266271|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
47017529|NCT01490632|83266272|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
47017530|NCT01490632|83266273|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
47017531|NCT01490632|83266274|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
47017532|NCT01490632|83266275|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
47017533|NCT01490632|83266276|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
47017534|NCT01490632|83266277|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
47017535|NCT01490632|83266278|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
47017536|NCT01490632|83266279|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
47017537|NCT01490632|83266280|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
47017538|NCT01490632|83266281|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
47017539|NCT01490632|83266282|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
47017540|NCT01490632|83266283|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
47017541|NCT01490632|83266284|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
47017542|NCT01490632|83266285|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
47017543|NCT01490632|83266286|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
47017544|NCT01490632|83266287|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
47017545|NCT01490632|83266288|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
47017546|NCT01490632|83266289|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
47017547|NCT01490632|83266270|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017548|NCT01490632|83266271|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017549|NCT01490632|83266272|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017550|NCT01490632|83266273|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017551|NCT01490632|83266274|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017552|NCT01490632|83266275|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017553|NCT01490632|83266276|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017554|NCT01490632|83266277|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017555|NCT01490632|83266278|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017556|NCT01490632|83266279|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017557|NCT01490632|83266280|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017558|NCT01490632|83266281|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017559|NCT01490632|83266282|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017560|NCT01490632|83266283|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017561|NCT01490632|83266284|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017562|NCT01490632|83266285|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017563|NCT01490632|83266286|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
47017564|NCT01490632|83266287|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
47017565|NCT01490632|83266288|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
47017566|NCT01490632|83266289|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
47017567|NCT02073643|83266332|FG000|Overall Study|Lost to Follow-up|24|||
47017568|NCT01451554|83266338|FG000|Overall Study|Withdrawal by Subject|14|||
47017569|NCT01451554|83266339|FG001|Overall Study|Withdrawal by Subject|9|||
47017570|NCT01474486|83266345|FG000|Overall Study|Death|2|||
46910722|NCT03329573|83140318|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
46910723|NCT03329573|83140319|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
46910724|NCT03329573|83140320|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
46910725|NCT03329573|83140321|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
46910726|NCT03329573|83140318|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
46910727|NCT03329573|83140319|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
46910728|NCT03329573|83140320|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
46910729|NCT03329573|83140321|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
46910730|NCT03308825|83140352|FG000|Overall Study|Lost to Follow-up|2|||
46910731|NCT03308825|83140353|FG001|Overall Study|Lost to Follow-up|2|||
46910732|NCT03308825|83140354|FG002|Overall Study|Lost to Follow-up|1|||
46910733|NCT03308825|83140355|FG003|Overall Study|Lost to Follow-up|0|||
46910734|NCT03308825|83140352|FG000|Overall Study|Protocol Violation|0|||
46910735|NCT03308825|83140353|FG001|Overall Study|Protocol Violation|2|||
46910736|NCT03308825|83140354|FG002|Overall Study|Protocol Violation|0|||
46910737|NCT03308825|83140355|FG003|Overall Study|Protocol Violation|0|||
46910738|NCT03328325|83140369|FG000|Overall Study|Lost to Follow-up|4|||
47017571|NCT01474486|83266345|FG000|Overall Study|Withdrawal by Subject|4|||
47017572|NCT01474486|83266345|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
47017573|NCT01451398|83266355|FG000|Overall Study|Adverse Event|7|||
47017574|NCT01451398|83266356|FG001|Overall Study|Adverse Event|9|||
46709703|NCT01214720|82925815|FG000|Overall Study|Lost to Follow-up|6|||
46910739|NCT03328325|83140369|FG000|Overall Study|Physician Decision|1|||
46910740|NCT03328325|83140369|FG000|Overall Study|Withdrawal by Subject|3|||
47017575|NCT01451398|83266355|FG000|Overall Study|Protocol Violation|1|||
47017576|NCT01451398|83266356|FG001|Overall Study|Protocol Violation|2|||
47017577|NCT01451398|83266355|FG000|Overall Study|Physician Decision|1|||
47017578|NCT01451398|83266356|FG001|Overall Study|Physician Decision|1|||
47017579|NCT01451398|83266355|FG000|Overall Study|Withdrawal by Subject|10|||
47017580|NCT01451398|83266356|FG001|Overall Study|Withdrawal by Subject|14|||
47017581|NCT01451398|83266355|FG000|Overall Study|Lost to Follow-up|6|||
47017582|NCT01451398|83266356|FG001|Overall Study|Lost to Follow-up|4|||
47017583|NCT01451398|83266355|FG000|Overall Study|Non-compliance with study drug|1|||
47017584|NCT01451398|83266356|FG001|Overall Study|Non-compliance with study drug|3|||
47017585|NCT01451398|83266355|FG000|Overall Study|Non-compliance with protocol|1|||
47017586|NCT01451398|83266356|FG001|Overall Study|Non-compliance with protocol|1|||
47017587|NCT01451398|83266355|FG000|Overall Study|Moved out of country|0|||
47017588|NCT01451398|83266356|FG001|Overall Study|Moved out of country|1|||
47017589|NCT01451398|83266355|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
47017590|NCT01451398|83266356|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
47017591|NCT01451398|83266355|FG000|Overall Study|Lack of Efficacy|0|||
47017592|NCT01451398|83266356|FG001|Overall Study|Lack of Efficacy|1|||
46910741|NCT03328325|83140369|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
47017593|NCT02073565|83266364|FG000|Cohort A|Withdrawal by Subject|1|||
47017594|NCT02073565|83266365|FG001|Cohort A|Withdrawal by Subject|0|||
47017595|NCT02073565|83266364|FG000|Cohort B|Withdrawal by Subject|1|||
47017596|NCT02073565|83266365|FG001|Cohort B|Withdrawal by Subject|2|||
47017597|NCT02073565|83266364|FG000|Cohort C|Withdrawal by Subject|0|||
47017598|NCT02073565|83266365|FG001|Cohort C|Withdrawal by Subject|2|||
47017599|NCT02073565|83266364|FG000|Cohort C|Lost to Follow-up|0|||
47017600|NCT02073565|83266365|FG001|Cohort C|Lost to Follow-up|2|||
47017601|NCT02072941|83266373|FG000|Overall Study|Withdrawal by Subject|29|||
47017602|NCT02072941|83266374|FG001|Overall Study|Withdrawal by Subject|21|||
47017603|NCT02072941|83266373|FG000|Overall Study|Lost to Follow-up|4|||
47017604|NCT02072941|83266374|FG001|Overall Study|Lost to Follow-up|4|||
47017605|NCT02072941|83266373|FG000|Overall Study|Death|3|||
47017606|NCT02072941|83266374|FG001|Overall Study|Death|2|||
47017607|NCT02072941|83266373|FG000|Overall Study|Removed by Study Staff|2|||
47017608|NCT02072941|83266374|FG001|Overall Study|Removed by Study Staff|2|||
47017609|NCT02100631|83266383|FG000|Overall Study|Withdrawal by Subject|1|||
47017610|NCT02100631|83266384|FG001|Overall Study|Withdrawal by Subject|0|||
47017611|NCT02100631|83266385|FG002|Overall Study|Withdrawal by Subject|0|||
47017612|NCT02100631|83266383|FG000|Overall Study|Lost to Follow-up|3|||
47017613|NCT02100631|83266384|FG001|Overall Study|Lost to Follow-up|4|||
47017614|NCT02100631|83266385|FG002|Overall Study|Lost to Follow-up|0|||
47017615|NCT02100631|83266383|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
47017616|NCT02100631|83266384|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
47017617|NCT02100631|83266385|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
47017618|NCT01451164|83266397|FG000|Overall Study|Adverse Event|19|||
47017619|NCT01451164|83266398|FG001|Overall Study|Adverse Event|12|||
47017620|NCT01451164|83266399|FG002|Overall Study|Adverse Event|18|||
47017621|NCT01451164|83266400|FG003|Overall Study|Adverse Event|21|||
47017622|NCT01451164|83266397|FG000|Overall Study|Withdrawal Criteria|1|||
47017623|NCT01451164|83266398|FG001|Overall Study|Withdrawal Criteria|1|||
47017624|NCT01451164|83266399|FG002|Overall Study|Withdrawal Criteria|1|||
47017625|NCT01451164|83266400|FG003|Overall Study|Withdrawal Criteria|1|||
47017626|NCT01451164|83266397|FG000|Overall Study|Physician Decision|2|||
47017627|NCT01451164|83266398|FG001|Overall Study|Physician Decision|0|||
47017628|NCT01451164|83266399|FG002|Overall Study|Physician Decision|1|||
47017629|NCT01451164|83266400|FG003|Overall Study|Physician Decision|0|||
47017630|NCT01451164|83266397|FG000|Overall Study|Withdrawal by Subject|14|||
47017631|NCT01451164|83266398|FG001|Overall Study|Withdrawal by Subject|11|||
47017632|NCT01451164|83266399|FG002|Overall Study|Withdrawal by Subject|16|||
47017633|NCT01451164|83266400|FG003|Overall Study|Withdrawal by Subject|17|||
47017634|NCT01451164|83266397|FG000|Overall Study|Protocol Violation|0|||
46910742|NCT03305081|83140379|FG000|Overall Study|Lost to Follow-up|10|||
47017635|NCT01451164|83266398|FG001|Overall Study|Protocol Violation|1|||
46910743|NCT03305081|83140380|FG001|Overall Study|Lost to Follow-up|15|||
47017636|NCT01451164|83266399|FG002|Overall Study|Protocol Violation|0|||
47017637|NCT01451164|83266400|FG003|Overall Study|Protocol Violation|0|||
47017638|NCT01451164|83266397|FG000|Overall Study|Lack of Efficacy|7|||
47017639|NCT01451164|83266398|FG001|Overall Study|Lack of Efficacy|9|||
47017640|NCT01451164|83266399|FG002|Overall Study|Lack of Efficacy|9|||
47017641|NCT01451164|83266400|FG003|Overall Study|Lack of Efficacy|7|||
47017642|NCT02071849|83266410|FG000|6-month Primary Endpoint|Did not receive device|4|||
47017643|NCT02071849|83266410|FG000|6-month Primary Endpoint|Adverse Event|1|||
47017644|NCT02071849|83266410|FG000|2-year Extended Follow-up|Adverse Event|1|||
47017645|NCT02071771|83266414|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
46910744|NCT03325673|83140398|FG000|Overall Study|Adverse Event|4|||
47017646|NCT02071771|83266415|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
47017647|NCT02071771|83266414|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
47017648|NCT02071771|83266415|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
47017649|NCT02071225|83266421|FG000|Overall Study|Withdrawal of Consent|2|||
47017650|NCT02071225|83266421|FG000|Overall Study|Protocol Deviation|1|||
47017651|NCT02071225|83266421|FG000|Overall Study|Lost to Follow-up|2|||
47017652|NCT02071225|83266421|FG000|Overall Study|Death|25|||
47017653|NCT01450696|83266427|FG000|Overall Study|Never Treated|1|||
47017654|NCT01450696|83266428|FG001|Overall Study|Never Treated|1|||
47017655|NCT01450696|83266427|FG000|Overall Study|Death|77|||
47017656|NCT01450696|83266428|FG001|Overall Study|Death|84|||
47017657|NCT01450696|83266427|FG000|Overall Study|Lost to Follow-up|3|||
47017658|NCT01450696|83266428|FG001|Overall Study|Lost to Follow-up|3|||
47017659|NCT01450696|83266427|FG000|Overall Study|Non-Compliance|1|||
47017660|NCT01450696|83266428|FG001|Overall Study|Non-Compliance|0|||
47017661|NCT01450696|83266427|FG000|Overall Study|Withdrawal by Subject|13|||
47017662|NCT01450696|83266428|FG001|Overall Study|Withdrawal by Subject|2|||
47017663|NCT01450696|83266427|FG000|Overall Study|Study Terminated by Sponsor|53|||
47017664|NCT01450696|83266428|FG001|Overall Study|Study Terminated by Sponsor|58|||
47017665|NCT02070991|83266436|FG000|Overall Study|Death|2|||
47017666|NCT02070991|83266437|FG001|Overall Study|Death|0|||
47017667|NCT02070991|83266436|FG000|Overall Study|Withdrawal by Subject|1|||
47017668|NCT02070991|83266437|FG001|Overall Study|Withdrawal by Subject|0|||
47017669|NCT02114515|83266445|FG000|Overall Study|Lost to Follow-up|52|||
47017670|NCT02114515|83266446|FG001|Overall Study|Lost to Follow-up|55|||
47017671|NCT02114515|83266445|FG000|Overall Study|Death|12|||
47017672|NCT02114515|83266446|FG001|Overall Study|Death|12|||
47017673|NCT02114515|83266445|FG000|Overall Study|Withdrawal by Subject|4|||
47017674|NCT02114515|83266446|FG001|Overall Study|Withdrawal by Subject|22|||
47017675|NCT02114515|83266445|FG000|Overall Study|Other|65|||
47017676|NCT02114515|83266446|FG001|Overall Study|Other|61|||
47017677|NCT01490086|83266457|FG000|Overall Study|Consent withdrawn|4|||
47017678|NCT01490086|83266458|FG001|Overall Study|Consent withdrawn|4|||
47017679|NCT01490086|83266459|FG002|Overall Study|Consent withdrawn|3|||
47017680|NCT01490086|83266460|FG003|Overall Study|Consent withdrawn|0|||
47017681|NCT01490086|83266461|FG004|Overall Study|Consent withdrawn|1|||
47017682|NCT01490086|83266457|FG000|Overall Study|Non-compliance|0|||
47017683|NCT01490086|83266458|FG001|Overall Study|Non-compliance|1|||
47017684|NCT01490086|83266459|FG002|Overall Study|Non-compliance|0|||
47017685|NCT01490086|83266460|FG003|Overall Study|Non-compliance|0|||
47017686|NCT01490086|83266461|FG004|Overall Study|Non-compliance|0|||
47017687|NCT01490086|83266457|FG000|Overall Study|Abnormal laboratory findings|1|||
47017688|NCT01490086|83266458|FG001|Overall Study|Abnormal laboratory findings|0|||
47017689|NCT01490086|83266459|FG002|Overall Study|Abnormal laboratory findings|0|||
47017690|NCT01490086|83266460|FG003|Overall Study|Abnormal laboratory findings|0|||
47017691|NCT01490086|83266461|FG004|Overall Study|Abnormal laboratory findings|0|||
47017692|NCT01490086|83266457|FG000|Overall Study|Lost to Follow-up|0|||
47017693|NCT01490086|83266458|FG001|Overall Study|Lost to Follow-up|0|||
47017694|NCT01490086|83266459|FG002|Overall Study|Lost to Follow-up|0|||
47017695|NCT01490086|83266460|FG003|Overall Study|Lost to Follow-up|0|||
47017696|NCT01490086|83266461|FG004|Overall Study|Lost to Follow-up|1|||
47017697|NCT01490086|83266457|FG000|Overall Study|Physician Decision|3|||
47017698|NCT01490086|83266458|FG001|Overall Study|Physician Decision|4|||
47017699|NCT01490086|83266459|FG002|Overall Study|Physician Decision|2|||
47017700|NCT01490086|83266460|FG003|Overall Study|Physician Decision|3|||
47017701|NCT01490086|83266461|FG004|Overall Study|Physician Decision|1|||
47017702|NCT01490086|83266457|FG000|Overall Study|Adverse Event|0|||
47017703|NCT01490086|83266458|FG001|Overall Study|Adverse Event|0|||
47017704|NCT01490086|83266459|FG002|Overall Study|Adverse Event|1|||
47017705|NCT01490086|83266460|FG003|Overall Study|Adverse Event|2|||
47017706|NCT01490086|83266461|FG004|Overall Study|Adverse Event|0|||
47017707|NCT01490086|83266457|FG000|Overall Study|Lack of Efficacy|0|||
47017708|NCT01490086|83266458|FG001|Overall Study|Lack of Efficacy|3|||
47017709|NCT01490086|83266459|FG002|Overall Study|Lack of Efficacy|1|||
47017710|NCT01490086|83266460|FG003|Overall Study|Lack of Efficacy|0|||
47017711|NCT01490086|83266461|FG004|Overall Study|Lack of Efficacy|8|||
47017712|NCT01490086|83266457|FG000|Overall Study|Worsening of symptoms|0|||
47017713|NCT01490086|83266458|FG001|Overall Study|Worsening of symptoms|1|||
47017714|NCT01490086|83266459|FG002|Overall Study|Worsening of symptoms|0|||
47017715|NCT01490086|83266460|FG003|Overall Study|Worsening of symptoms|1|||
47017716|NCT01490086|83266461|FG004|Overall Study|Worsening of symptoms|0|||
47017717|NCT01490086|83266457|FG000|Overall Study|Subject uncontrollable and abusive|0|||
47017718|NCT01490086|83266458|FG001|Overall Study|Subject uncontrollable and abusive|1|||
47017719|NCT01490086|83266459|FG002|Overall Study|Subject uncontrollable and abusive|0|||
47017720|NCT01490086|83266460|FG003|Overall Study|Subject uncontrollable and abusive|0|||
47017721|NCT01490086|83266461|FG004|Overall Study|Subject uncontrollable and abusive|0|||
47017722|NCT01490086|83266457|FG000|Overall Study|Subject left hospital|0|||
47017723|NCT01490086|83266458|FG001|Overall Study|Subject left hospital|1|||
47017724|NCT01490086|83266459|FG002|Overall Study|Subject left hospital|0|||
47017725|NCT01490086|83266460|FG003|Overall Study|Subject left hospital|1|||
47017726|NCT01490086|83266461|FG004|Overall Study|Subject left hospital|0|||
47017727|NCT02114203|83266476|FG000|Overall Study|Adverse Event|0|||
47017728|NCT02114203|83266477|FG001|Overall Study|Adverse Event|1|||
47017729|NCT02114203|83266478|FG002|Overall Study|Adverse Event|0|||
47017730|NCT02114203|83266476|FG000|Overall Study|Withdrawal by Subject|0|||
47017731|NCT02114203|83266477|FG001|Overall Study|Withdrawal by Subject|1|||
47017732|NCT02114203|83266478|FG002|Overall Study|Withdrawal by Subject|0|||
47017733|NCT02113579|83266488|FG000|Overall Study|Adverse Event|1|||
47017734|NCT02113579|83266489|FG001|Overall Study|Adverse Event|0|||
47017735|NCT02113579|83266488|FG000|Overall Study|Withdrawal by Subject|3|||
47017736|NCT02113579|83266489|FG001|Overall Study|Withdrawal by Subject|2|||
47017737|NCT02113579|83266488|FG000|Overall Study|Lost to Follow-up|6|||
47017738|NCT02113579|83266489|FG001|Overall Study|Lost to Follow-up|2|||
47017739|NCT01474018|83266497|FG000|Overall Study|Lost to Follow-up|0|||
47017740|NCT01474018|83266498|FG001|Overall Study|Lost to Follow-up|1|||
47017741|NCT01474018|83266497|FG000|Overall Study|Withdrawal by Subject|0|||
47017742|NCT01474018|83266498|FG001|Overall Study|Withdrawal by Subject|2|||
47017743|NCT02100475|83266506|FG000|Overall Study|Unclassified|1|||
47017744|NCT02100475|83266507|FG001|Overall Study|Unclassified|2|||
47017745|NCT02100475|83266506|FG000|Overall Study|Withdrawal criteria|1|||
47017746|NCT02100475|83266507|FG001|Overall Study|Withdrawal criteria|0|||
47017747|NCT02113189|83266516|FG000|Overall Study|Lost to follow up|2|||
47017748|NCT02113189|83266517|FG001|Overall Study|Lost to follow up|1|||
47017749|NCT02113189|83266518|FG002|Overall Study|Lost to follow up|3|||
47017750|NCT01440946|83266531|FG000|Overall Study|Lost to Follow-up|1|||
47017751|NCT01440946|83266532|FG001|Overall Study|Lost to Follow-up|1|||
47017752|NCT01440946|83266531|FG000|Overall Study|Physician Decision|1|||
47017753|NCT01440946|83266532|FG001|Overall Study|Physician Decision|0|||
47017754|NCT01450540|83266541|FG000|Overall Study|Withdrawal by Subject|19|||
47017755|NCT01450540|83266542|FG001|Overall Study|Withdrawal by Subject|13|||
47017756|NCT01450540|83266541|FG000|Overall Study|protocol deviation|3|||
47017757|NCT01450540|83266542|FG001|Overall Study|protocol deviation|23|||
47017758|NCT02070757|83266552|FG000|Overall Study|Adverse Event|107|||
47017759|NCT02070757|83266553|FG001|Overall Study|Adverse Event|99|||
47017760|NCT02070757|83266552|FG000|Overall Study|Lost to Follow-up|7|||
47017761|NCT02070757|83266553|FG001|Overall Study|Lost to Follow-up|4|||
47017762|NCT02070757|83266552|FG000|Overall Study|Protocol Violation|0|||
47017763|NCT02070757|83266553|FG001|Overall Study|Protocol Violation|4|||
47017764|NCT02070757|83266552|FG000|Overall Study|Withdrawal by Subject|1|||
47017765|NCT02070757|83266553|FG001|Overall Study|Withdrawal by Subject|3|||
47017766|NCT02070757|83266552|FG000|Overall Study|Investigator Decision|0|||
47017767|NCT02070757|83266553|FG001|Overall Study|Investigator Decision|2|||
47017768|NCT02070757|83266552|FG000|Overall Study|Discharged from Study Hospital|2|||
47017769|NCT02070757|83266553|FG001|Overall Study|Discharged from Study Hospital|2|||
47017770|NCT02100319|83266559|FG000|Overall Study|Case Report Forms Uncollected|11|||
47017771|NCT02100319|83266559|FG000|Overall Study|Protocol Deviation|5|||
47017772|NCT01625845|83266565|FG000|Overall Study|Adverse Event|1|||
47017773|NCT01625845|83266566|FG001|Overall Study|Adverse Event|2|||
47017774|NCT01625845|83266565|FG000|Overall Study|Lost to Follow-up|2|||
47017775|NCT01625845|83266566|FG001|Overall Study|Lost to Follow-up|1|||
47017776|NCT01625845|83266565|FG000|Overall Study|Withdrawal by Subject|2|||
47017777|NCT01625845|83266566|FG001|Overall Study|Withdrawal by Subject|0|||
47017778|NCT01473940|83266576|FG000|Induction Therapy|Death|0|||
47017779|NCT01473940|83266577|FG001|Induction Therapy|Death|0|||
47017780|NCT01473940|83266578|FG002|Induction Therapy|Death|1|||
47017781|NCT01473940|83266579|FG003|Induction Therapy|Death|1|||
47017782|NCT01473940|83266576|FG000|Induction Therapy|Progressive Disease|0|||
47017783|NCT01473940|83266577|FG001|Induction Therapy|Progressive Disease|1|||
47017784|NCT01473940|83266578|FG002|Induction Therapy|Progressive Disease|1|||
47017785|NCT01473940|83266579|FG003|Induction Therapy|Progressive Disease|0|||
47017786|NCT01473940|83266576|FG000|Maintenance Therapy|Progressive Disease|1|||
47017787|NCT01473940|83266577|FG001|Maintenance Therapy|Progressive Disease|2|||
47017788|NCT01473940|83266578|FG002|Maintenance Therapy|Progressive Disease|1|||
47017789|NCT01473940|83266579|FG003|Maintenance Therapy|Progressive Disease|4|||
47017790|NCT01832727|83266601|FG000|Overall Study|Adverse Event|4|||
47017791|NCT01832727|83266602|FG001|Overall Study|Adverse Event|6|||
47017792|NCT01832727|83266603|FG002|Overall Study|Adverse Event|1|||
47017793|NCT01832727|83266604|FG003|Overall Study|Adverse Event|0|||
47017794|NCT01832727|83266605|FG004|Overall Study|Adverse Event|1|||
47017795|NCT01832727|83266606|FG005|Overall Study|Adverse Event|1|||
47017796|NCT01832727|83266607|FG006|Overall Study|Adverse Event|2|||
47017797|NCT01832727|83266608|FG007|Overall Study|Adverse Event|1|||
47017798|NCT01832727|83266609|FG008|Overall Study|Adverse Event|9|||
47017799|NCT01832727|83266601|FG000|Overall Study|Disease progression|3|||
47017800|NCT01832727|83266602|FG001|Overall Study|Disease progression|0|||
47017801|NCT01832727|83266603|FG002|Overall Study|Disease progression|2|||
47017802|NCT01832727|83266604|FG003|Overall Study|Disease progression|1|||
47017803|NCT01832727|83266605|FG004|Overall Study|Disease progression|3|||
47017804|NCT01832727|83266606|FG005|Overall Study|Disease progression|3|||
47017805|NCT01832727|83266607|FG006|Overall Study|Disease progression|6|||
47017806|NCT01832727|83266608|FG007|Overall Study|Disease progression|2|||
47017807|NCT01832727|83266609|FG008|Overall Study|Disease progression|7|||
47017808|NCT01832727|83266601|FG000|Overall Study|Lost to Follow-up|0|||
47017809|NCT01832727|83266602|FG001|Overall Study|Lost to Follow-up|0|||
47017810|NCT01832727|83266603|FG002|Overall Study|Lost to Follow-up|0|||
47017811|NCT01832727|83266604|FG003|Overall Study|Lost to Follow-up|1|||
47017812|NCT01832727|83266605|FG004|Overall Study|Lost to Follow-up|0|||
47017813|NCT01832727|83266606|FG005|Overall Study|Lost to Follow-up|0|||
47017814|NCT01832727|83266607|FG006|Overall Study|Lost to Follow-up|0|||
47017815|NCT01832727|83266608|FG007|Overall Study|Lost to Follow-up|0|||
47017816|NCT01832727|83266609|FG008|Overall Study|Lost to Follow-up|0|||
47017817|NCT01832727|83266601|FG000|Overall Study|Physician Decision|1|||
47017818|NCT01832727|83266602|FG001|Overall Study|Physician Decision|0|||
47017819|NCT01832727|83266603|FG002|Overall Study|Physician Decision|0|||
47017820|NCT01832727|83266604|FG003|Overall Study|Physician Decision|1|||
47017821|NCT01832727|83266605|FG004|Overall Study|Physician Decision|0|||
47017822|NCT01832727|83266606|FG005|Overall Study|Physician Decision|1|||
47017823|NCT01832727|83266607|FG006|Overall Study|Physician Decision|0|||
47017824|NCT01832727|83266608|FG007|Overall Study|Physician Decision|0|||
47017825|NCT01832727|83266609|FG008|Overall Study|Physician Decision|0|||
47017826|NCT01832727|83266601|FG000|Overall Study|Withdrawal by Subject|1|||
47017827|NCT01832727|83266602|FG001|Overall Study|Withdrawal by Subject|1|||
47017828|NCT01832727|83266603|FG002|Overall Study|Withdrawal by Subject|0|||
47017829|NCT01832727|83266604|FG003|Overall Study|Withdrawal by Subject|1|||
47017830|NCT01832727|83266605|FG004|Overall Study|Withdrawal by Subject|0|||
47017831|NCT01832727|83266606|FG005|Overall Study|Withdrawal by Subject|1|||
47017832|NCT01832727|83266607|FG006|Overall Study|Withdrawal by Subject|0|||
47017833|NCT01832727|83266608|FG007|Overall Study|Withdrawal by Subject|2|||
47017834|NCT01832727|83266609|FG008|Overall Study|Withdrawal by Subject|1|||
47017835|NCT01832727|83266601|FG000|Overall Study|Study terminated by sponsor|0|||
47017836|NCT01832727|83266602|FG001|Overall Study|Study terminated by sponsor|0|||
47017837|NCT01832727|83266603|FG002|Overall Study|Study terminated by sponsor|0|||
47017838|NCT01832727|83266604|FG003|Overall Study|Study terminated by sponsor|0|||
47017839|NCT01832727|83266605|FG004|Overall Study|Study terminated by sponsor|0|||
47017840|NCT01832727|83266606|FG005|Overall Study|Study terminated by sponsor|0|||
47017841|NCT01832727|83266607|FG006|Overall Study|Study terminated by sponsor|0|||
47017842|NCT01832727|83266608|FG007|Overall Study|Study terminated by sponsor|1|||
47017843|NCT01832727|83266609|FG008|Overall Study|Study terminated by sponsor|1|||
47017844|NCT01473394|83266640|FG000|Overall Study|Adverse Event|13|||
47017845|NCT01473394|83266641|FG001|Overall Study|Adverse Event|16|||
47017846|NCT01473394|83266640|FG000|Overall Study|Insufficient Therapeutic Response|4|||
47017847|NCT01473394|83266641|FG001|Overall Study|Insufficient Therapeutic Response|1|||
47017848|NCT01473394|83266640|FG000|Overall Study|Protocol Violation|7|||
47017849|NCT01473394|83266641|FG001|Overall Study|Protocol Violation|5|||
47017850|NCT01473394|83266640|FG000|Overall Study|Withdrew Consent|12|||
47017851|NCT01473394|83266641|FG001|Overall Study|Withdrew Consent|10|||
47017852|NCT01473394|83266640|FG000|Overall Study|Lost to Follow-up|9|||
47017853|NCT01473394|83266641|FG001|Overall Study|Lost to Follow-up|11|||
47017854|NCT01449682|83266649|FG000|Overall Study|Death|0|||
47017855|NCT01449682|83266650|FG001|Overall Study|Death|1|||
47017856|NCT01449682|83266649|FG000|Overall Study|Adverse Event|1|||
47017857|NCT01449682|83266650|FG001|Overall Study|Adverse Event|0|||
47017858|NCT01449526|83266658|FG000|Overall Study|Lost to Follow-up|1|||
47017859|NCT01449526|83266659|FG001|Overall Study|Lost to Follow-up|2|||
47017860|NCT01449526|83266658|FG000|Overall Study|Withdrawal by Subject|1|||
47017861|NCT01449526|83266659|FG001|Overall Study|Withdrawal by Subject|1|||
46910745|NCT03325673|83140399|FG001|Overall Study|Adverse Event|0|||
46910746|NCT03223909|83140408|FG000|Overall Study|Protocol Violation|48|||
46910747|NCT03223909|83140409|FG001|Overall Study|Protocol Violation|45|||
46910748|NCT03223909|83140410|FG002|Overall Study|Protocol Violation|16|||
46910749|NCT03733925|83140418|FG000|Overall Study|Lost to Follow-up|1|||
46910750|NCT03733925|83140418|FG000|Overall Study|Withdrawal by Subject|2|||
46910751|NCT03733925|83140418|FG000|Overall Study|Adverse Event|2|||
46910752|NCT03733925|83140418|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46910753|NCT03649711|83140425|FG000|Overall Study|Adverse Event|0|||
46910754|NCT03649711|83140426|FG001|Overall Study|Adverse Event|1|||
46910755|NCT03649711|83140427|FG002|Overall Study|Adverse Event|0|||
46910756|NCT03649711|83140425|FG000|Overall Study|Kidney Transplant|1|||
47017862|NCT01449526|83266658|FG000|Overall Study|Symptoms/complaints|0|||
46910757|NCT03649711|83140426|FG001|Overall Study|Kidney Transplant|0|||
47017863|NCT01449526|83266659|FG001|Overall Study|Symptoms/complaints|1|||
47017864|NCT01449526|83266658|FG000|Overall Study|Lack of Motivation|0|||
47017865|NCT01449526|83266659|FG001|Overall Study|Lack of Motivation|1|||
47017866|NCT01449526|83266658|FG000|Overall Study|Cannot maintain visits|0|||
47017867|NCT01449526|83266659|FG001|Overall Study|Cannot maintain visits|1|||
46910758|NCT03649711|83140427|FG002|Overall Study|Kidney Transplant|0|||
47017868|NCT01440322|83266667|FG000|Overall Study|Discomfort|2|||
47017869|NCT01440322|83266668|FG001|Overall Study|Discomfort|0|||
47017870|NCT01440322|83266667|FG000|Overall Study|Biomicroscopy|1|||
47017871|NCT01440322|83266668|FG001|Overall Study|Biomicroscopy|0|||
47017872|NCT01440322|83266667|FG000|Overall Study|Symptoms and Problems|1|||
47017873|NCT01440322|83266668|FG001|Overall Study|Symptoms and Problems|0|||
47017874|NCT01440322|83266667|FG000|Overall Study|Unacceptable Subjective Vision|1|||
47017875|NCT01440322|83266668|FG001|Overall Study|Unacceptable Subjective Vision|0|||
47017876|NCT01440322|83266667|FG000|Overall Study|Other Product Related|1|||
47017877|NCT01440322|83266668|FG001|Overall Study|Other Product Related|0|||
47017878|NCT01440322|83266667|FG000|Overall Study|Unrelated Medical Problem|0|||
47017879|NCT01440322|83266668|FG001|Overall Study|Unrelated Medical Problem|1|||
47017880|NCT01440322|83266667|FG000|Overall Study|Other Non-Product Related|1|||
47017881|NCT01440322|83266668|FG001|Overall Study|Other Non-Product Related|0|||
47017882|NCT01832493|83266674|FG000|Overall Study|Physician Decision|2|||
47017883|NCT01832493|83266674|FG000|Overall Study|Protocol Violation|4|||
47017884|NCT01832493|83266674|FG000|Overall Study|Unable to place LV lead|2|||
47017885|NCT01831791|83266678|FG000|Overall Study|Withdrawal by Subject|10|||
47017886|NCT01857531|83266682|FG000|Overall Study|Withdrawal by Subject|4|||
47017887|NCT02166047|83266698|FG000|Overall Study|Withdrawal by Participant|0|||
47017888|NCT02166047|83266699|FG001|Overall Study|Withdrawal by Participant|1|||
47017889|NCT02166047|83266700|FG002|Overall Study|Withdrawal by Participant|2|||
47017890|NCT02166047|83266701|FG003|Overall Study|Withdrawal by Participant|0|||
47017891|NCT02166047|83266702|FG004|Overall Study|Withdrawal by Participant|0|||
47017892|NCT02166047|83266703|FG005|Overall Study|Withdrawal by Participant|0|||
47017893|NCT02166047|83266704|FG006|Overall Study|Withdrawal by Participant|1|||
47017894|NCT02166047|83266705|FG007|Overall Study|Withdrawal by Participant|0|||
47017895|NCT02166047|83266706|FG008|Overall Study|Withdrawal by Participant|0|||
47017896|NCT02166047|83266707|FG009|Overall Study|Withdrawal by Participant|0|||
47017897|NCT02166047|83266708|FG010|Overall Study|Withdrawal by Participant|0|||
47017898|NCT02166047|83266709|FG011|Overall Study|Withdrawal by Participant|0|||
47017899|NCT02166047|83266698|FG000|Overall Study|Adverse Event|0|||
47017900|NCT02166047|83266699|FG001|Overall Study|Adverse Event|0|||
47017901|NCT02166047|83266700|FG002|Overall Study|Adverse Event|0|||
47017902|NCT02166047|83266701|FG003|Overall Study|Adverse Event|0|||
47017903|NCT02166047|83266702|FG004|Overall Study|Adverse Event|1|||
47017904|NCT02166047|83266703|FG005|Overall Study|Adverse Event|0|||
47017905|NCT02166047|83266704|FG006|Overall Study|Adverse Event|1|||
47017906|NCT02166047|83266705|FG007|Overall Study|Adverse Event|0|||
47017907|NCT02166047|83266706|FG008|Overall Study|Adverse Event|0|||
47017908|NCT02166047|83266707|FG009|Overall Study|Adverse Event|0|||
47017909|NCT02166047|83266708|FG010|Overall Study|Adverse Event|2|||
47017910|NCT02166047|83266709|FG011|Overall Study|Adverse Event|0|||
47017911|NCT01493284|83266735|FG000|Overall Study|Death|29|||
47017912|NCT01493284|83266735|FG000|Overall Study|Withdrawal by Subject|32|||
47017913|NCT02165735|83266741|FG000|Overall Study|Lost to Follow-up|12|||
47017914|NCT02165735|83266742|FG001|Overall Study|Lost to Follow-up|10|||
47017915|NCT02165735|83266741|FG000|Overall Study|Withdrawal by Subject|3|||
47017916|NCT02165735|83266742|FG001|Overall Study|Withdrawal by Subject|0|||
47017917|NCT02165735|83266741|FG000|Overall Study|Participant indicated lack of time|1|||
47017918|NCT02165735|83266742|FG001|Overall Study|Participant indicated lack of time|3|||
47017919|NCT02165735|83266741|FG000|Overall Study|Protocol Violation|0|||
47017920|NCT02165735|83266742|FG001|Overall Study|Protocol Violation|1|||
47017921|NCT02069899|83266751|FG000|Overall Study|Adverse Event|6|||
47017922|NCT02069899|83266752|FG001|Overall Study|Adverse Event|0|||
47017923|NCT02069899|83266753|FG002|Overall Study|Adverse Event|1|||
47017924|NCT02069899|83266751|FG000|Overall Study|Withdrawal by Participant|2|||
46910759|NCT03303521|83140437|FG000|Overall Study|Withdrawal by Subject|2|||
46910760|NCT03303521|83140438|FG001|Overall Study|Withdrawal by Subject|0|||
47017925|NCT02069899|83266752|FG001|Overall Study|Withdrawal by Participant|0|||
47017926|NCT02069899|83266753|FG002|Overall Study|Withdrawal by Participant|0|||
47017927|NCT02069899|83266751|FG000|Overall Study|Lost to Follow-up|1|||
47017928|NCT02069899|83266752|FG001|Overall Study|Lost to Follow-up|0|||
47017929|NCT02069899|83266753|FG002|Overall Study|Lost to Follow-up|1|||
47017930|NCT02069899|83266751|FG000|Overall Study|Other|4|||
46620576|NCT01721876|82770643|FG000|Overall Study|Protocol Violation|2|||
46910761|NCT03303521|83140437|FG000|Overall Study|Death|1|||
46910762|NCT03303521|83140438|FG001|Overall Study|Death|0|||
46910763|NCT03303521|83140437|FG000|Overall Study|Kidney transplantation|0|||
46910764|NCT03303521|83140438|FG001|Overall Study|Kidney transplantation|1|||
47017931|NCT02069899|83266752|FG001|Overall Study|Other|0|||
47017932|NCT02069899|83266753|FG002|Overall Study|Other|0|||
47017933|NCT02069899|83266751|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
47017934|NCT02069899|83266752|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
47017935|NCT02069899|83266753|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
47017936|NCT02069899|83266751|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
47017937|NCT02069899|83266752|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
47017938|NCT02069899|83266753|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
47017939|NCT01831089|83266768|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
47017940|NCT01831089|83266769|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
47017941|NCT01831089|83266770|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
47017942|NCT01831089|83266771|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
47017943|NCT01831089|83266772|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
47017944|NCT01831089|83266773|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
47017945|NCT01831089|83266768|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
47017946|NCT01831089|83266769|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
47017947|NCT01831089|83266770|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
47017948|NCT01831089|83266771|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
47017949|NCT01831089|83266772|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
47017950|NCT01831089|83266773|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
47017951|NCT01831089|83266768|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
47017952|NCT01831089|83266769|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
47017953|NCT01831089|83266770|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
47017954|NCT01831089|83266771|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
47017955|NCT01831089|83266772|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
47017956|NCT01831089|83266773|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
47017957|NCT01831089|83266768|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
47017958|NCT01831089|83266769|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
47017959|NCT01831089|83266770|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
47017960|NCT01831089|83266771|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
47017961|NCT01831089|83266772|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
47017962|NCT01831089|83266773|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
47017963|NCT01831089|83266768|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
47017964|NCT01831089|83266769|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
47017965|NCT01831089|83266770|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
46620577|NCT01721876|82770644|FG001|Overall Study|Protocol Violation|1|||
46910765|NCT03303521|83140437|FG000|Overall Study|Investigational product discontinuation|0|||
46910766|NCT03303521|83140438|FG001|Overall Study|Investigational product discontinuation|1|||
46910767|NCT03303521|83140437|FG000|Overall Study|Transferred to non-study dialysis center|1|||
46910768|NCT03303521|83140438|FG001|Overall Study|Transferred to non-study dialysis center|0|||
46910769|NCT03303521|83140437|FG000|Overall Study|Non-comliance to study protocol|0|||
46910770|NCT03303521|83140438|FG001|Overall Study|Non-comliance to study protocol|1|||
46910771|NCT03303521|83140437|FG000|Overall Study|Adverse Event|1|||
46910772|NCT03303521|83140438|FG001|Overall Study|Adverse Event|0|||
46910773|NCT03214081|83140444|FG000|Overall Study|Case Report Forms Uncollected|9|||
46910774|NCT03214081|83140444|FG000|Overall Study|Protocol Deviation|54|||
46910775|NCT02888171|83140450|FG000|Overall Study|Lost to Follow-up|2|||
46910776|NCT02888171|83140451|FG001|Overall Study|Lost to Follow-up|1|||
46910777|NCT02888171|83140450|FG000|Overall Study|Withdrawal by Subject|3|||
46910778|NCT02888171|83140451|FG001|Overall Study|Withdrawal by Subject|2|||
46620578|NCT01721876|82770643|FG000|Overall Study|Withdrawal by Subject|15|||
46910779|NCT02888171|83140450|FG000|Overall Study|Adverse Event|0|||
46910780|NCT02888171|83140451|FG001|Overall Study|Adverse Event|1|||
47017966|NCT01831089|83266771|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
47017967|NCT01831089|83266772|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
47017968|NCT01831089|83266773|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
47017969|NCT01831089|83266768|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
47017970|NCT01831089|83266769|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
47017971|NCT01831089|83266770|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
47017972|NCT01831089|83266771|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
47017973|NCT01831089|83266772|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
47017974|NCT01831089|83266773|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
47017975|NCT01831089|83266768|FG000|Cohort III: Dose Level 3|Global end of study|0|||
47017976|NCT01831089|83266769|FG001|Cohort III: Dose Level 3|Global end of study|0|||
47017977|NCT01831089|83266770|FG002|Cohort III: Dose Level 3|Global end of study|1|||
47017978|NCT01831089|83266771|FG003|Cohort III: Dose Level 3|Global end of study|0|||
47017979|NCT01831089|83266772|FG004|Cohort III: Dose Level 3|Global end of study|0|||
47017980|NCT01831089|83266773|FG005|Cohort III: Dose Level 3|Global end of study|0|||
47017981|NCT01831089|83266768|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
47017982|NCT01831089|83266769|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
47017983|NCT01831089|83266770|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
47017984|NCT01831089|83266771|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
47017985|NCT01831089|83266772|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
47017986|NCT01831089|83266773|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
47017987|NCT01831089|83266768|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
46910781|NCT02932891|83140457|FG000|Overall Study|Lost to Follow-up|2|||
46910782|NCT02932891|83140457|FG000|Overall Study|HPA Suppress|2|||
46910783|NCT03302975|83140461|FG000|Overall Study|Lost to Follow-up|4|||
46910784|NCT03212521|83140465|FG000|Overall Study|Adverse Event|1|||
46910785|NCT03212521|83140465|FG000|Overall Study|Lost to Follow-up|4|||
46910786|NCT03212521|83140465|FG000|Overall Study|Withdrawal by Subject|1|||
46910787|NCT03212521|83140465|FG000|Overall Study|Other|1|||
46910788|NCT03212365|83140471|FG000|Overall Study|Discharged prior to Xa level|12|||
46910789|NCT03212365|83140472|FG001|Overall Study|Discharged prior to Xa level|8|||
46910790|NCT03212365|83140471|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
46910791|NCT03212365|83140472|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
46910792|NCT03212365|83140471|FG000|Overall Study|Refused study medication|3|||
46910793|NCT03212365|83140472|FG001|Overall Study|Refused study medication|0|||
46910794|NCT03212365|83140471|FG000|Overall Study|Initiated heparin infusion on floor|1|||
46910795|NCT03212365|83140472|FG001|Overall Study|Initiated heparin infusion on floor|1|||
46910796|NCT03212365|83140471|FG000|Overall Study|Unexpected return to OR|1|||
46910797|NCT03212365|83140472|FG001|Overall Study|Unexpected return to OR|1|||
46910798|NCT03212365|83140471|FG000|Overall Study|Medication distribution error|1|||
46910799|NCT03212365|83140472|FG001|Overall Study|Medication distribution error|0|||
46910800|NCT03212365|83140471|FG000|Overall Study|Required epidural placement|1|||
46910801|NCT03212365|83140472|FG001|Overall Study|Required epidural placement|0|||
46910802|NCT03212365|83140471|FG000|Overall Study|Withdrawal by Subject|0|||
46910803|NCT03212365|83140472|FG001|Overall Study|Withdrawal by Subject|1|||
46910804|NCT03212365|83140471|FG000|Overall Study|developed acute renal failure|0|||
46910805|NCT03212365|83140472|FG001|Overall Study|developed acute renal failure|1|||
46910806|NCT03273257|83140480|FG000|Overall Study|Death|0|||
46910807|NCT03273257|83140481|FG001|Overall Study|Death|1|||
46910808|NCT03273257|83140480|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
46910809|NCT03273257|83140481|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
46910810|NCT03273257|83140480|FG000|Overall Study|Study terminated|3|||
46910811|NCT03273257|83140481|FG001|Overall Study|Study terminated|2|||
46910812|NCT04316741|83140489|FG000|Baseline Enrollment|Lost to Follow-up|1|||
46910813|NCT04316741|83140490|FG001|Baseline Enrollment|Lost to Follow-up|1|||
46910814|NCT04316741|83140489|FG000|Immediate Post-Test|Lost to Follow-up|5|||
46910815|NCT04316741|83140490|FG001|Immediate Post-Test|Lost to Follow-up|1|||
46910816|NCT04316741|83140489|FG000|1-month Post-test|Lost to Follow-up|7|||
46910817|NCT04316741|83140490|FG001|1-month Post-test|Lost to Follow-up|2|||
46910818|NCT04316741|83140489|FG000|3-month Follow-up|Lost to Follow-up|10|||
46910819|NCT04316741|83140490|FG001|3-month Follow-up|Lost to Follow-up|2|||
46910820|NCT03271307|83140500|FG000|Overall Study|Lost to Follow-up|0|||
46910821|NCT03271307|83140501|FG001|Overall Study|Lost to Follow-up|0|||
46910822|NCT03271307|83140502|FG002|Overall Study|Lost to Follow-up|0|||
46910823|NCT03271307|83140503|FG003|Overall Study|Lost to Follow-up|28|||
46910824|NCT03271307|83140504|FG004|Overall Study|Lost to Follow-up|91|||
46910825|NCT03271151|83140521|FG000|Overall Study|Lost to Follow-up|1|||
47017988|NCT01831089|83266769|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
46709704|NCT01214720|82925816|FG001|Overall Study|Lost to Follow-up|2|||
46910826|NCT03271151|83140522|FG001|Overall Study|Lost to Follow-up|3|||
46910827|NCT03271151|83140521|FG000|Overall Study|Withdrawal by Subject|1|||
46910828|NCT03271151|83140522|FG001|Overall Study|Withdrawal by Subject|0|||
46910829|NCT03245723|83140530|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
47017989|NCT01831089|83266770|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
47017990|NCT01831089|83266771|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
47017991|NCT01831089|83266772|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
47017992|NCT01831089|83266773|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
47017993|NCT01831089|83266768|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
47017994|NCT01831089|83266769|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
47017995|NCT01831089|83266770|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
47017996|NCT01831089|83266771|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
47017997|NCT01831089|83266772|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
47017998|NCT01831089|83266773|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
47017999|NCT01831089|83266768|FG000|Cohort V: Dose Level 5|Death|0|||
47018000|NCT01831089|83266769|FG001|Cohort V: Dose Level 5|Death|0|||
47018001|NCT01831089|83266770|FG002|Cohort V: Dose Level 5|Death|0|||
47018002|NCT01831089|83266771|FG003|Cohort V: Dose Level 5|Death|0|||
47018003|NCT01831089|83266772|FG004|Cohort V: Dose Level 5|Death|1|||
47018004|NCT01831089|83266773|FG005|Cohort V: Dose Level 5|Death|0|||
47018005|NCT01831089|83266768|FG000|Cohort V: Dose Level 5|Global end of study|0|||
47018006|NCT01831089|83266769|FG001|Cohort V: Dose Level 5|Global end of study|0|||
47018007|NCT01831089|83266770|FG002|Cohort V: Dose Level 5|Global end of study|0|||
47018008|NCT01831089|83266771|FG003|Cohort V: Dose Level 5|Global end of study|0|||
47018009|NCT01831089|83266772|FG004|Cohort V: Dose Level 5|Global end of study|2|||
47018010|NCT01831089|83266773|FG005|Cohort V: Dose Level 5|Global end of study|0|||
47018011|NCT01831089|83266768|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
47018012|NCT01831089|83266769|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
47018013|NCT01831089|83266770|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
47018014|NCT01831089|83266771|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
47018015|NCT01831089|83266772|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
47018016|NCT01831089|83266773|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
47018017|NCT01831089|83266768|FG000|Cohort B: Arm B|Progressive disease|0|||
47018018|NCT01831089|83266769|FG001|Cohort B: Arm B|Progressive disease|0|||
47018019|NCT01831089|83266770|FG002|Cohort B: Arm B|Progressive disease|0|||
47018020|NCT01831089|83266771|FG003|Cohort B: Arm B|Progressive disease|0|||
47018021|NCT01831089|83266772|FG004|Cohort B: Arm B|Progressive disease|0|||
47018022|NCT01831089|83266773|FG005|Cohort B: Arm B|Progressive disease|8|||
47018023|NCT01831089|83266768|FG000|Cohort B: Arm B|Physician Decision|0|||
47018024|NCT01831089|83266769|FG001|Cohort B: Arm B|Physician Decision|0|||
47018025|NCT01831089|83266770|FG002|Cohort B: Arm B|Physician Decision|0|||
47018026|NCT01831089|83266771|FG003|Cohort B: Arm B|Physician Decision|0|||
47018027|NCT01831089|83266772|FG004|Cohort B: Arm B|Physician Decision|0|||
47018028|NCT01831089|83266773|FG005|Cohort B: Arm B|Physician Decision|2|||
47018029|NCT01831089|83266768|FG000|Cohort B: Arm B|Never treated|0|||
47018030|NCT01831089|83266769|FG001|Cohort B: Arm B|Never treated|0|||
47018031|NCT01831089|83266770|FG002|Cohort B: Arm B|Never treated|0|||
47018032|NCT01831089|83266771|FG003|Cohort B: Arm B|Never treated|0|||
47018033|NCT01831089|83266772|FG004|Cohort B: Arm B|Never treated|0|||
47018034|NCT01831089|83266773|FG005|Cohort B: Arm B|Never treated|2|||
47018035|NCT01831089|83266768|FG000|Cohort B: Arm B|Adverse Event|0|||
46910830|NCT03245723|83140531|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
46910831|NCT03245723|83140530|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
46910832|NCT03245723|83140531|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
46910833|NCT03245723|83140530|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
46910834|NCT03245723|83140531|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
46910835|NCT03245723|83140530|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
46910836|NCT03245723|83140531|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
46910837|NCT03301649|83140540|FG000|Overall Study|Need alternate therapy due to live lice|17|||
46910838|NCT03301649|83140541|FG001|Overall Study|Need alternate therapy due to live lice|25|||
46910839|NCT03301649|83140542|FG002|Overall Study|Need alternate therapy due to live lice|81|||
46910840|NCT03301649|83140540|FG000|Overall Study|Lost to Follow-up|11|||
46910841|NCT03301649|83140541|FG001|Overall Study|Lost to Follow-up|11|||
46910842|NCT03301649|83140542|FG002|Overall Study|Lost to Follow-up|3|||
46910843|NCT03301649|83140540|FG000|Overall Study|Protocol Violation|0|||
46910844|NCT03301649|83140541|FG001|Overall Study|Protocol Violation|1|||
46910845|NCT03301649|83140542|FG002|Overall Study|Protocol Violation|1|||
46910846|NCT03301649|83140540|FG000|Overall Study|Withdrawal by Subject|10|||
46910847|NCT03301649|83140541|FG001|Overall Study|Withdrawal by Subject|4|||
47018036|NCT01831089|83266769|FG001|Cohort B: Arm B|Adverse Event|0|||
47018037|NCT01831089|83266770|FG002|Cohort B: Arm B|Adverse Event|0|||
47018038|NCT01831089|83266771|FG003|Cohort B: Arm B|Adverse Event|0|||
47018039|NCT01831089|83266772|FG004|Cohort B: Arm B|Adverse Event|0|||
47018040|NCT01831089|83266773|FG005|Cohort B: Arm B|Adverse Event|1|||
47018041|NCT01831089|83266768|FG000|Cohort B: Arm B|Global end of study|0|||
47018042|NCT01831089|83266769|FG001|Cohort B: Arm B|Global end of study|0|||
47018043|NCT01831089|83266770|FG002|Cohort B: Arm B|Global end of study|0|||
47018044|NCT01831089|83266771|FG003|Cohort B: Arm B|Global end of study|0|||
47018045|NCT01831089|83266772|FG004|Cohort B: Arm B|Global end of study|0|||
47018046|NCT01831089|83266773|FG005|Cohort B: Arm B|Global end of study|1|||
47018047|NCT02112877|83266790|FG000|Overall Study|Withdrawal by Subject|1|||
47018048|NCT02112877|83266791|FG001|Overall Study|Withdrawal by Subject|7|||
47018049|NCT02112877|83266790|FG000|Overall Study|Visit Missed|1|||
47018050|NCT02112877|83266791|FG001|Overall Study|Visit Missed|6|||
47018051|NCT02098369|83266802|FG000|Overall Study|Withdrawal by Subject|1|||
47018052|NCT02098369|83266803|FG001|Overall Study|Withdrawal by Subject|5|||
47018053|NCT02098369|83266804|FG002|Overall Study|Withdrawal by Subject|0|||
47018054|NCT02098369|83266802|FG000|Overall Study|Lost to Follow-up|5|||
47018055|NCT02098369|83266803|FG001|Overall Study|Lost to Follow-up|1|||
47018056|NCT02098369|83266804|FG002|Overall Study|Lost to Follow-up|3|||
47018057|NCT02098369|83266802|FG000|Overall Study|Death|1|||
47018058|NCT02098369|83266803|FG001|Overall Study|Death|1|||
47018059|NCT02098369|83266804|FG002|Overall Study|Death|1|||
47018060|NCT02098369|83266802|FG000|Overall Study|Other|0|||
47018061|NCT02098369|83266803|FG001|Overall Study|Other|2|||
47018062|NCT02098369|83266804|FG002|Overall Study|Other|1|||
47018063|NCT02111785|83266816|FG000|Overall Study|Death|0|||
47018064|NCT02111785|83266817|FG001|Overall Study|Death|1|||
47018065|NCT02111785|83266818|FG002|Overall Study|Death|0|||
47018066|NCT02111785|83266819|FG003|Overall Study|Death|0|||
47018067|NCT02068885|83266836|FG000|Overall Study|Withdrew|3|||
47018068|NCT02068885|83266837|FG001|Overall Study|Withdrew|5|||
47018069|NCT02068885|83266838|FG002|Overall Study|Withdrew|8|||
47018070|NCT02068495|83266847|FG000|Overall Study|Case Report Forms Uncollected|60|||
47018071|NCT02068495|83266847|FG000|Overall Study|Protocol Deviation|49|||
47018072|NCT02097823|83266853|FG000|Overall Study|Withdrawal by Subject|1|||
47018073|NCT02097823|83266854|FG001|Overall Study|Withdrawal by Subject|1|||
47018074|NCT01830855|83266865|FG000|Overall Study|Other|7|||
47018075|NCT01830855|83266866|FG001|Overall Study|Other|1|||
47018076|NCT01830855|83266867|FG002|Overall Study|Other|4|||
47018077|NCT01830855|83266868|FG003|Overall Study|Other|4|||
47018078|NCT01830855|83266865|FG000|Overall Study|Medication error without associated AE|1|||
47018079|NCT01830855|83266866|FG001|Overall Study|Medication error without associated AE|0|||
47018080|NCT01830855|83266867|FG002|Overall Study|Medication error without associated AE|0|||
47018081|NCT01830855|83266868|FG003|Overall Study|Medication error without associated AE|1|||
47018082|NCT01830855|83266865|FG000|Overall Study|Pregnancy|3|||
47018083|NCT01830855|83266866|FG001|Overall Study|Pregnancy|1|||
47018084|NCT01830855|83266867|FG002|Overall Study|Pregnancy|2|||
47018085|NCT01830855|83266868|FG003|Overall Study|Pregnancy|1|||
47018086|NCT01830855|83266865|FG000|Overall Study|No longer meets eligibility criteria|11|||
47018087|NCT01830855|83266866|FG001|Overall Study|No longer meets eligibility criteria|2|||
47018088|NCT01830855|83266867|FG002|Overall Study|No longer meets eligibility criteria|3|||
47018089|NCT01830855|83266868|FG003|Overall Study|No longer meets eligibility criteria|5|||
47018090|NCT01830855|83266865|FG000|Overall Study|Adverse Event|11|||
47018091|NCT01830855|83266866|FG001|Overall Study|Adverse Event|5|||
47018092|NCT01830855|83266867|FG002|Overall Study|Adverse Event|6|||
47018093|NCT01830855|83266868|FG003|Overall Study|Adverse Event|3|||
47018094|NCT01830855|83266865|FG000|Overall Study|Protocol deviation|10|||
47018095|NCT01830855|83266866|FG001|Overall Study|Protocol deviation|5|||
47018096|NCT01830855|83266867|FG002|Overall Study|Protocol deviation|6|||
47018097|NCT01830855|83266868|FG003|Overall Study|Protocol deviation|6|||
47018098|NCT01830855|83266865|FG000|Overall Study|Withdrawal by Subject|33|||
47018099|NCT01830855|83266866|FG001|Overall Study|Withdrawal by Subject|14|||
47018100|NCT01830855|83266867|FG002|Overall Study|Withdrawal by Subject|10|||
47018101|NCT01830855|83266868|FG003|Overall Study|Withdrawal by Subject|12|||
47018102|NCT01830855|83266865|FG000|Overall Study|No longer willing to participate|32|||
47018103|NCT01830855|83266866|FG001|Overall Study|No longer willing to participate|13|||
47018104|NCT01830855|83266867|FG002|Overall Study|No longer willing to participate|12|||
47018105|NCT01830855|83266868|FG003|Overall Study|No longer willing to participate|17|||
47018106|NCT01830855|83266865|FG000|Overall Study|Lost to Follow-up|47|||
47018107|NCT01830855|83266866|FG001|Overall Study|Lost to Follow-up|20|||
47018108|NCT01830855|83266867|FG002|Overall Study|Lost to Follow-up|23|||
47018109|NCT01830855|83266868|FG003|Overall Study|Lost to Follow-up|33|||
47018110|NCT01857063|83266885|FG000|Period 1 (7 Days)|Adverse Event|0|||
47018111|NCT01857063|83266886|FG001|Period 1 (7 Days)|Adverse Event|1|||
47018112|NCT01857063|83266885|FG000|Period 1 (7 Days)|Physician Decision|1|||
47018113|NCT01857063|83266886|FG001|Period 1 (7 Days)|Physician Decision|0|||
47018114|NCT01857063|83266885|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
47018115|NCT01857063|83266886|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
47018116|NCT01857063|83266885|FG000|Period 2 (7 Days)|Adverse Event|2|||
47018117|NCT01857063|83266886|FG001|Period 2 (7 Days)|Adverse Event|1|||
47018118|NCT01857063|83266885|FG000|Period 2 (7 Days)|Physician Decision|1|||
47018119|NCT01857063|83266886|FG001|Period 2 (7 Days)|Physician Decision|1|||
47018120|NCT01857063|83266885|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
47018121|NCT01857063|83266886|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
47018122|NCT01856907|83266895|FG000|Overall Study|Pregnancy|0|||
47018123|NCT01856907|83266896|FG001|Overall Study|Pregnancy|1|||
47018124|NCT01856907|83266897|FG002|Overall Study|Pregnancy|0|||
47018125|NCT01856907|83266895|FG000|Overall Study|Pregnancy|0|||
47018126|NCT01856907|83266896|FG001|Overall Study|Pregnancy|1|||
47018127|NCT01856907|83266897|FG002|Overall Study|Pregnancy|0|||
47018128|NCT01856907|83266895|FG000|Overall Study|Withdrawal by Subject|0|||
47018129|NCT01856907|83266896|FG001|Overall Study|Withdrawal by Subject|1|||
47018130|NCT01856907|83266897|FG002|Overall Study|Withdrawal by Subject|0|||
47018131|NCT02212457|83266914|FG000|Overall Study|Adverse Event|1|||
47018132|NCT02212457|83266915|FG001|Overall Study|Adverse Event|2|||
47018133|NCT02212457|83266916|FG002|Overall Study|Adverse Event|2|||
47018134|NCT02212457|83266917|FG003|Overall Study|Adverse Event|2|||
47018135|NCT02212457|83266918|FG004|Overall Study|Adverse Event|0|||
47018136|NCT02212457|83266919|FG005|Overall Study|Adverse Event|1|||
47018137|NCT02212457|83266914|FG000|Overall Study|Withdrawal by Subject|8|||
47018138|NCT02212457|83266915|FG001|Overall Study|Withdrawal by Subject|10|||
47018139|NCT02212457|83266916|FG002|Overall Study|Withdrawal by Subject|8|||
47018140|NCT02212457|83266917|FG003|Overall Study|Withdrawal by Subject|6|||
47018141|NCT02212457|83266918|FG004|Overall Study|Withdrawal by Subject|5|||
47018142|NCT02212457|83266919|FG005|Overall Study|Withdrawal by Subject|4|||
47018143|NCT02212457|83266914|FG000|Overall Study|Lost to Follow-up|6|||
47018144|NCT02212457|83266915|FG001|Overall Study|Lost to Follow-up|7|||
47018145|NCT02212457|83266916|FG002|Overall Study|Lost to Follow-up|4|||
47018146|NCT02212457|83266917|FG003|Overall Study|Lost to Follow-up|1|||
47018147|NCT02212457|83266918|FG004|Overall Study|Lost to Follow-up|8|||
47018148|NCT02212457|83266919|FG005|Overall Study|Lost to Follow-up|4|||
47018149|NCT02212457|83266914|FG000|Overall Study|Protocol Violation|2|||
47018150|NCT02212457|83266915|FG001|Overall Study|Protocol Violation|1|||
47018151|NCT02212457|83266916|FG002|Overall Study|Protocol Violation|0|||
47018152|NCT02212457|83266917|FG003|Overall Study|Protocol Violation|1|||
47018153|NCT02212457|83266918|FG004|Overall Study|Protocol Violation|2|||
47018154|NCT02212457|83266919|FG005|Overall Study|Protocol Violation|3|||
47018155|NCT02212457|83266914|FG000|Overall Study|Other|2|||
47018156|NCT02212457|83266915|FG001|Overall Study|Other|1|||
47018157|NCT02212457|83266916|FG002|Overall Study|Other|2|||
47018158|NCT02212457|83266917|FG003|Overall Study|Other|1|||
47018159|NCT02212457|83266918|FG004|Overall Study|Other|0|||
47018160|NCT02212457|83266919|FG005|Overall Study|Other|1|||
47018161|NCT02097745|83266940|FG000|Overall Study|Adverse Event|25|||
47018162|NCT02097745|83266940|FG000|Overall Study|Death|16|||
47018163|NCT02097745|83266940|FG000|Overall Study|Failure to Return|14|||
47018164|NCT02097745|83266940|FG000|Overall Study|Administrative/Other|27|||
47018165|NCT02097745|83266940|FG000|Overall Study|Reason Not Specified|96|||
47018166|NCT02111083|83266949|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
47018167|NCT02111083|83266950|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
47018168|NCT01629563|83266958|FG000|Overall Study|Adverse Event|16|||
47018169|NCT01629563|83266959|FG001|Overall Study|Adverse Event|16|||
47018170|NCT01629563|83266958|FG000|Overall Study|Death|2|||
47018171|NCT01629563|83266959|FG001|Overall Study|Death|0|||
47018172|NCT01629563|83266958|FG000|Overall Study|Lack of Efficacy|2|||
47018173|NCT01629563|83266959|FG001|Overall Study|Lack of Efficacy|3|||
47018174|NCT01629563|83266958|FG000|Overall Study|Lost to Follow-up|1|||
47018175|NCT01629563|83266959|FG001|Overall Study|Lost to Follow-up|0|||
47018176|NCT01629563|83266958|FG000|Overall Study|Pregnancy|1|||
47018177|NCT01629563|83266959|FG001|Overall Study|Pregnancy|2|||
47018178|NCT01629563|83266958|FG000|Overall Study|Protocol Violation|0|||
47018179|NCT01629563|83266959|FG001|Overall Study|Protocol Violation|1|||
47018180|NCT01629563|83266958|FG000|Overall Study|Withdrawal by Subject|27|||
47018181|NCT01629563|83266959|FG001|Overall Study|Withdrawal by Subject|20|||
47018182|NCT01629563|83266958|FG000|Overall Study|surgery|0|||
47018183|NCT01629563|83266959|FG001|Overall Study|surgery|3|||
47018184|NCT01629563|83266958|FG000|Overall Study|Lack of return of menses|12|||
47018185|NCT01629563|83266959|FG001|Overall Study|Lack of return of menses|7|||
47018186|NCT01629563|83266958|FG000|Overall Study|Protocol Violation|0|||
47018187|NCT01629563|83266959|FG001|Overall Study|Protocol Violation|1|||
47018188|NCT02097277|83266970|FG000|Overall Study|Subject no longer meets study criteria|0|||
47018189|NCT02097277|83266971|FG001|Overall Study|Subject no longer meets study criteria|1|||
47018190|NCT02097277|83266972|FG002|Overall Study|Subject no longer meets study criteria|0|||
47018191|NCT02097277|83266973|FG003|Overall Study|Subject no longer meets study criteria|1|||
47018192|NCT02097277|83266974|FG004|Overall Study|Subject no longer meets study criteria|0|||
47018193|NCT02097277|83266970|FG000|Overall Study|Subject request to discontinue treatment|0|||
47018194|NCT02097277|83266971|FG001|Overall Study|Subject request to discontinue treatment|0|||
47018195|NCT02097277|83266972|FG002|Overall Study|Subject request to discontinue treatment|0|||
47018196|NCT02097277|83266973|FG003|Overall Study|Subject request to discontinue treatment|0|||
47018197|NCT02097277|83266974|FG004|Overall Study|Subject request to discontinue treatment|1|||
47018198|NCT02097277|83266970|FG000|Overall Study|Lost to Follow-up|0|||
47018199|NCT02097277|83266971|FG001|Overall Study|Lost to Follow-up|1|||
47018200|NCT02097277|83266972|FG002|Overall Study|Lost to Follow-up|1|||
47018201|NCT02097277|83266973|FG003|Overall Study|Lost to Follow-up|0|||
47018202|NCT02097277|83266974|FG004|Overall Study|Lost to Follow-up|0|||
47018203|NCT02097277|83266970|FG000|Overall Study|Withdrawal by Subject|2|||
47018204|NCT02097277|83266971|FG001|Overall Study|Withdrawal by Subject|1|||
47018205|NCT02097277|83266972|FG002|Overall Study|Withdrawal by Subject|0|||
47018206|NCT02097277|83266973|FG003|Overall Study|Withdrawal by Subject|1|||
47018207|NCT02097277|83266974|FG004|Overall Study|Withdrawal by Subject|0|||
47018208|NCT02097277|83266970|FG000|Overall Study|Adverse Event|0|||
47018209|NCT02097277|83266971|FG001|Overall Study|Adverse Event|0|||
47018210|NCT02097277|83266972|FG002|Overall Study|Adverse Event|1|||
47018211|NCT02097277|83266973|FG003|Overall Study|Adverse Event|2|||
47018212|NCT02097277|83266974|FG004|Overall Study|Adverse Event|0|||
47018213|NCT02212379|83266990|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
47018214|NCT02212379|83266990|FG000|From Baseline to Week 48|Adverse Event|7|||
47018215|NCT02212379|83266990|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
47018216|NCT02212379|83266990|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
47018217|NCT02212379|83266990|FG000|From Week 48 to Week 96|Adverse Event|1|||
47018218|NCT02212379|83266990|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
47018219|NCT02110693|83266997|FG000|Overall Study|Withdrawal by Subject|6|||
47018220|NCT02110693|83266998|FG001|Overall Study|Withdrawal by Subject|7|||
47018221|NCT02110693|83266997|FG000|Overall Study|skipped assessment|15|||
47018222|NCT02110693|83266998|FG001|Overall Study|skipped assessment|18|||
47018223|NCT02110693|83266997|FG000|Overall Study|technical difficulties|6|||
47018224|NCT02110693|83266998|FG001|Overall Study|technical difficulties|4|||
47018225|NCT02110693|83266997|FG000|Overall Study|Other|1|||
47018226|NCT02110693|83266998|FG001|Overall Study|Other|0|||
47018227|NCT02212301|83267018|FG000|Period 1|Lost to Follow-up|0|||
47018228|NCT02212301|83267019|FG001|Period 1|Lost to Follow-up|1|||
47018229|NCT02211209|83267028|FG000|Overall Study|Investigator judgment|0|||
47018230|NCT02211209|83267029|FG001|Overall Study|Investigator judgment|1|||
47018231|NCT02211209|83267028|FG000|Overall Study|Voluntary withdrawal|1|||
47018232|NCT02211209|83267029|FG001|Overall Study|Voluntary withdrawal|4|||
47018233|NCT02211209|83267028|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
47018234|NCT02211209|83267029|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
47018235|NCT02211209|83267028|FG000|Overall Study|Reason Not Specified|1|||
47018236|NCT02211209|83267029|FG001|Overall Study|Reason Not Specified|0|||
47018237|NCT02187809|83267035|FG000|Overall Study|The study was terminated|3|||
47018238|NCT02187029|83267043|FG000|Overall Study|Adverse Event|0|||
47018239|NCT02187029|83267044|FG001|Overall Study|Adverse Event|1|||
47018240|NCT02187029|83267045|FG002|Overall Study|Adverse Event|1|||
47018241|NCT02187029|83267046|FG003|Overall Study|Adverse Event|0|||
47018242|NCT02187029|83267043|FG000|Overall Study|Study Terminated by Sponsor|0|||
47018243|NCT02187029|83267044|FG001|Overall Study|Study Terminated by Sponsor|0|||
47018244|NCT02187029|83267045|FG002|Overall Study|Study Terminated by Sponsor|10|||
47018245|NCT02187029|83267046|FG003|Overall Study|Study Terminated by Sponsor|3|||
47018246|NCT02187029|83267043|FG000|Overall Study|Withdrawal by Subject|1|||
47018247|NCT02187029|83267044|FG001|Overall Study|Withdrawal by Subject|0|||
46910848|NCT03301649|83140542|FG002|Overall Study|Withdrawal by Subject|0|||
46709705|NCT01142232|82925827|FG000|Overall Study|Adverse Event|1|||
46709706|NCT01142232|82925828|FG001|Overall Study|Adverse Event|2|||
46910849|NCT03301649|83140540|FG000|Overall Study|Other than specified|5|||
46910850|NCT03301649|83140541|FG001|Overall Study|Other than specified|3|||
46910851|NCT03301649|83140542|FG002|Overall Study|Other than specified|0|||
47018248|NCT02187029|83267045|FG002|Overall Study|Withdrawal by Subject|0|||
47018249|NCT02187029|83267046|FG003|Overall Study|Withdrawal by Subject|0|||
47018250|NCT02162771|83267058|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
47018251|NCT02162771|83267059|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
47018252|NCT02162771|83267058|FG000|Core Study Period (Part 2)|Adverse Event|4|||
47018253|NCT02162771|83267059|FG001|Core Study Period (Part 2)|Adverse Event|1|||
46709707|NCT01142232|82925829|FG002|Overall Study|Adverse Event|1|||
46709708|NCT01142232|82925830|FG003|Overall Study|Adverse Event|0|||
46709709|NCT01142232|82925831|FG004|Overall Study|Adverse Event|4|||
46709710|NCT01142232|82925827|FG000|Overall Study|Death|0|||
46709711|NCT01142232|82925828|FG001|Overall Study|Death|0|||
46709712|NCT01142232|82925829|FG002|Overall Study|Death|0|||
46709713|NCT01142232|82925830|FG003|Overall Study|Death|0|||
46709714|NCT01142232|82925831|FG004|Overall Study|Death|1|||
46709715|NCT01142232|82925827|FG000|Overall Study|Disease Progression|2|||
46709716|NCT01142232|82925828|FG001|Overall Study|Disease Progression|0|||
46709717|NCT01142232|82925829|FG002|Overall Study|Disease Progression|1|||
46910852|NCT03222973|83140552|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
47018254|NCT02162771|83267058|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
47018255|NCT02162771|83267059|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
47018256|NCT02162771|83267058|FG000|Core Study Period (Part 2)|Physician Decision|0|||
47018257|NCT02162771|83267059|FG001|Core Study Period (Part 2)|Physician Decision|2|||
47018258|NCT02162771|83267058|FG000|Core Study Period (Part 2)|Death|1|||
47018259|NCT02162771|83267059|FG001|Core Study Period (Part 2)|Death|0|||
47018260|NCT02162771|83267058|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
47018261|NCT02162771|83267059|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
47018262|NCT02162771|83267058|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
47018263|NCT02162771|83267059|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
47018264|NCT02162771|83267058|FG000|Maintenance Study Period (Part 2)|Death|2|||
47018265|NCT02162771|83267059|FG001|Maintenance Study Period (Part 2)|Death|1|||
47018266|NCT02162771|83267058|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
47018267|NCT02162771|83267059|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
47018268|NCT02162771|83267058|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
47018269|NCT02162771|83267059|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
46910853|NCT03222973|83140553|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
46910854|NCT03222973|83140554|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
46910855|NCT03222973|83140555|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
46910856|NCT03222973|83140552|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
46910857|NCT03222973|83140553|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
46910858|NCT03222973|83140554|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
46910859|NCT03222973|83140555|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
46910860|NCT03222973|83140552|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
46910861|NCT03222973|83140553|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
46910862|NCT03222973|83140554|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
46910863|NCT03222973|83140555|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
46910864|NCT03222973|83140552|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
46910865|NCT03222973|83140553|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
46910866|NCT03222973|83140554|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
46910867|NCT03222973|83140555|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
46910868|NCT03222973|83140552|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
46910869|NCT03222973|83140553|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
46910870|NCT03222973|83140554|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
46910871|NCT03222973|83140555|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
46910872|NCT03222973|83140552|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
46910873|NCT03222973|83140553|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
46910874|NCT03222973|83140554|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
46910875|NCT03222973|83140555|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
46910876|NCT03222973|83140552|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
46910877|NCT03222973|83140553|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
46910878|NCT03222973|83140554|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
46910879|NCT03222973|83140555|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
46910880|NCT03222973|83140552|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
46910881|NCT03222973|83140553|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
46910882|NCT03222973|83140554|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
46910883|NCT03222973|83140555|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
46910884|NCT03222973|83140552|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
46910885|NCT03222973|83140553|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
46910886|NCT03222973|83140554|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
46910887|NCT03222973|83140555|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
46910888|NCT03222973|83140552|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
46709718|NCT01142232|82925830|FG003|Overall Study|Disease Progression|2|||
46709719|NCT01142232|82925831|FG004|Overall Study|Disease Progression|12|||
46910889|NCT03222973|83140553|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
46910890|NCT03222973|83140554|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
47018270|NCT02162771|83267058|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
47018271|NCT02162771|83267059|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
47018272|NCT02161757|83267068|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
46910891|NCT03222973|83140555|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
46910892|NCT03222973|83140552|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
46910893|NCT03222973|83140553|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
46910894|NCT03222973|83140554|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
46910895|NCT03222973|83140555|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
46910896|NCT03222973|83140552|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
46910897|NCT03222973|83140553|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
46910898|NCT03222973|83140554|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
46910899|NCT03222973|83140555|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
46910900|NCT01144416|83140567|FG000|Intervention Period|Adverse Event|5|||
46910901|NCT01144416|83140568|FG001|Intervention Period|Adverse Event|6|||
46910902|NCT01144416|83140567|FG000|Intervention Period|Insufficient ovarian response|11|||
46910903|NCT01144416|83140568|FG001|Intervention Period|Insufficient ovarian response|17|||
46910904|NCT01144416|83140567|FG000|Intervention Period|Risk of OHSS|0|||
46910905|NCT01144416|83140568|FG001|Intervention Period|Risk of OHSS|1|||
46910906|NCT01144416|83140567|FG000|Intervention Period|Too high ovarian response|4|||
47018273|NCT02161757|83267069|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
47018274|NCT02161757|83267070|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
47018275|NCT02161757|83267068|FG000|Treatment Through Study Completion|Adverse Event|1|||
47018276|NCT02161757|83267069|FG001|Treatment Through Study Completion|Adverse Event|1|||
47018277|NCT02161757|83267070|FG002|Treatment Through Study Completion|Adverse Event|0|||
47018278|NCT02161757|83267068|FG000|Treatment Through Study Completion|Protocol Violation|0|||
47018279|NCT02161757|83267069|FG001|Treatment Through Study Completion|Protocol Violation|1|||
47018280|NCT02161757|83267070|FG002|Treatment Through Study Completion|Protocol Violation|2|||
47018281|NCT02161757|83267068|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
47018282|NCT02161757|83267069|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
47018283|NCT02161757|83267070|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
47018284|NCT02161757|83267068|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
47018285|NCT02161757|83267069|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
47018286|NCT02161757|83267070|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
46910907|NCT01144416|83140568|FG001|Intervention Period|Too high ovarian response|2|||
46910908|NCT01144416|83140567|FG000|Intervention Period|No/too few/bad oocytes|7|||
46910909|NCT01144416|83140568|FG001|Intervention Period|No/too few/bad oocytes|5|||
46910910|NCT01144416|83140567|FG000|Intervention Period|No or abnormal fertilization|25|||
46910911|NCT01144416|83140568|FG001|Intervention Period|No or abnormal fertilization|10|||
46910912|NCT01144416|83140567|FG000|Intervention Period|No/too few/bad quality embryos|3|||
46910913|NCT01144416|83140568|FG001|Intervention Period|No/too few/bad quality embryos|3|||
46910914|NCT01144416|83140567|FG000|Intervention Period|Other|7|||
46910915|NCT01144416|83140568|FG001|Intervention Period|Other|5|||
46910916|NCT00335777|83140578|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
46910917|NCT00335777|83140578|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
46910918|NCT00335777|83140578|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
46910919|NCT00335777|83140578|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
46910920|NCT00335777|83140578|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
46910921|NCT01140048|83140583|FG000|Overall Study|Physician Decision|1|||
46910922|NCT01140048|83140583|FG000|Overall Study|Withdrawal by Subject|13|||
46910923|NCT01140048|83140583|FG000|Overall Study|Lost to Follow-up|31|||
46910924|NCT00972738|83140594|FG000|Overall Study|Adverse Event|7|||
46910925|NCT00972738|83140595|FG001|Overall Study|Adverse Event|1|||
46910926|NCT00972738|83140596|FG002|Overall Study|Adverse Event|8|||
46910927|NCT00972738|83140594|FG000|Overall Study|Protocol Violation|2|||
46910928|NCT00972738|83140595|FG001|Overall Study|Protocol Violation|1|||
46910929|NCT00972738|83140596|FG002|Overall Study|Protocol Violation|3|||
46910930|NCT00972738|83140594|FG000|Overall Study|Lost to Follow-up|1|||
46910931|NCT00972738|83140595|FG001|Overall Study|Lost to Follow-up|0|||
46910932|NCT00972738|83140596|FG002|Overall Study|Lost to Follow-up|1|||
46910933|NCT00972738|83140594|FG000|Overall Study|Lack of Efficacy|5|||
46910934|NCT00972738|83140595|FG001|Overall Study|Lack of Efficacy|1|||
47018287|NCT02161757|83267068|FG000|Treatment Through Study Completion|Other|20|||
47018288|NCT02161757|83267069|FG001|Treatment Through Study Completion|Other|19|||
47018289|NCT02161757|83267070|FG002|Treatment Through Study Completion|Other|12|||
47018290|NCT02161757|83267068|FG000|Treatment Through Study Completion|Death|2|||
47018291|NCT02161757|83267069|FG001|Treatment Through Study Completion|Death|1|||
47018292|NCT02161757|83267070|FG002|Treatment Through Study Completion|Death|1|||
47018293|NCT02160977|83267080|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
47018294|NCT02160977|83267081|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
47018295|NCT02160977|83267080|FG000|Three Months After Surgery|Lost to Follow-up|0|||
47018296|NCT02160977|83267081|FG001|Three Months After Surgery|Lost to Follow-up|2|||
47018297|NCT02160977|83267080|FG000|Six Months After Surgery|Lost to Follow-up|2|||
47018298|NCT02160977|83267081|FG001|Six Months After Surgery|Lost to Follow-up|1|||
47018299|NCT02160899|83267093|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
47018300|NCT02160899|83267094|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
47018301|NCT02160899|83267095|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
47018302|NCT02160899|83267096|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
47018303|NCT02160899|83267097|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
47018304|NCT02160899|83267098|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
47018305|NCT02160041|83267112|FG000|Overall Study|Adverse Event|11|||
47018306|NCT02160041|83267112|FG000|Overall Study|Death|2|||
47018307|NCT02160041|83267112|FG000|Overall Study|disease progression|57|||
47018308|NCT02160041|83267112|FG000|Overall Study|Protocol Violation|1|||
47018309|NCT02160041|83267112|FG000|Overall Study|non-compliance with study|1|||
47018310|NCT02160041|83267112|FG000|Overall Study|Physician Decision|3|||
47018311|NCT02160041|83267112|FG000|Overall Study|Withdrawal by Subject|8|||
47018312|NCT02160041|83267112|FG000|Overall Study|study terminated by by sponsor|1|||
47018313|NCT02186873|83267118|FG000|Overall Study|Adverse Event|1|||
47018314|NCT02186873|83267119|FG001|Overall Study|Adverse Event|3|||
47018315|NCT02186873|83267118|FG000|Overall Study|Lack of Efficacy|0|||
47018316|NCT02186873|83267119|FG001|Overall Study|Lack of Efficacy|1|||
47018317|NCT02186873|83267118|FG000|Overall Study|Lost to Follow-up|1|||
47018318|NCT02186873|83267119|FG001|Overall Study|Lost to Follow-up|2|||
47018319|NCT02186873|83267118|FG000|Overall Study|Withdrawal by Subject|7|||
46620579|NCT01721876|82770644|FG001|Overall Study|Withdrawal by Subject|38|||
46620580|NCT01721876|82770643|FG000|Overall Study|Reason not listed|34|||
46620581|NCT01721876|82770644|FG001|Overall Study|Reason not listed|63|||
46910935|NCT00972738|83140596|FG002|Overall Study|Lack of Efficacy|11|||
46910936|NCT00972738|83140594|FG000|Overall Study|Withdrawal by Subject|5|||
46910937|NCT00972738|83140595|FG001|Overall Study|Withdrawal by Subject|1|||
47018320|NCT02186873|83267119|FG001|Overall Study|Withdrawal by Subject|2|||
47018321|NCT02096263|83267129|FG000|Overall Study|Adverse Event|1|||
47018322|NCT02096263|83267130|FG001|Overall Study|Adverse Event|0|||
46620582|NCT01721876|82770643|FG000|Overall Study|Sponsor terminated trial|0|||
46910938|NCT00972738|83140596|FG002|Overall Study|Withdrawal by Subject|4|||
46910939|NCT00972738|83140594|FG000|Overall Study|Moved|0|||
47018323|NCT02096263|83267131|FG002|Overall Study|Adverse Event|1|||
47018324|NCT02096263|83267129|FG000|Overall Study|Lost to Follow-up|14|||
47018325|NCT02096263|83267130|FG001|Overall Study|Lost to Follow-up|18|||
47018326|NCT02096263|83267131|FG002|Overall Study|Lost to Follow-up|15|||
47018327|NCT02096263|83267129|FG000|Overall Study|Other|7|||
47018328|NCT02096263|83267130|FG001|Overall Study|Other|9|||
47018329|NCT02096263|83267131|FG002|Overall Study|Other|6|||
47018330|NCT02096263|83267129|FG000|Overall Study|Sponsor study termination|0|||
47018331|NCT02096263|83267130|FG001|Overall Study|Sponsor study termination|0|||
47018332|NCT02096263|83267131|FG002|Overall Study|Sponsor study termination|1|||
47018333|NCT02096263|83267129|FG000|Overall Study|Protocol Violation|7|||
47018334|NCT02096263|83267130|FG001|Overall Study|Protocol Violation|2|||
47018335|NCT02096263|83267131|FG002|Overall Study|Protocol Violation|8|||
47018336|NCT02096263|83267129|FG000|Overall Study|Withdrawal by Subject|5|||
47018337|NCT02096263|83267130|FG001|Overall Study|Withdrawal by Subject|7|||
47018338|NCT02096263|83267131|FG002|Overall Study|Withdrawal by Subject|8|||
47018339|NCT01830543|83267142|FG000|Overall Study|Subject Decision|19|||
47018340|NCT01830543|83267143|FG001|Overall Study|Subject Decision|21|||
47018341|NCT01830543|83267144|FG002|Overall Study|Subject Decision|57|||
47018342|NCT01830543|83267142|FG000|Overall Study|Adverse Event|91|||
47018343|NCT01830543|83267143|FG001|Overall Study|Adverse Event|77|||
47018344|NCT01830543|83267144|FG002|Overall Study|Adverse Event|76|||
47018345|NCT01830543|83267142|FG000|Overall Study|Death|20|||
47018346|NCT01830543|83267143|FG001|Overall Study|Death|22|||
47018347|NCT01830543|83267144|FG002|Overall Study|Death|22|||
47018348|NCT01830543|83267142|FG000|Overall Study|Protocol Violation|3|||
47018349|NCT01830543|83267143|FG001|Overall Study|Protocol Violation|7|||
46709720|NCT01142232|82925827|FG000|Overall Study|Withdrawal by Subject|0|||
46709721|NCT01142232|82925828|FG001|Overall Study|Withdrawal by Subject|0|||
46910940|NCT00972738|83140595|FG001|Overall Study|Moved|0|||
46910941|NCT00972738|83140596|FG002|Overall Study|Moved|1|||
46910942|NCT00972738|83140594|FG000|Overall Study|Other|1|||
46910943|NCT00972738|83140595|FG001|Overall Study|Other|2|||
46910944|NCT00972738|83140596|FG002|Overall Study|Other|1|||
46910945|NCT03243305|83140604|FG000|Overall Study|Lost to Follow-up|250|||
46910946|NCT03243305|83140604|FG000|Overall Study|Withdrawal by Subject|170|||
46910947|NCT03243305|83140604|FG000|Overall Study|Pregnancy|104|||
46910948|NCT03243305|83140604|FG000|Overall Study|Non-Compliance with Study Drug|38|||
46910949|NCT03243305|83140604|FG000|Overall Study|Adverse Event|23|||
46910950|NCT03243305|83140604|FG000|Overall Study|No sexually active|26|||
46910951|NCT03243305|83140604|FG000|Overall Study|Physician Decision|22|||
46910952|NCT03243305|83140604|FG000|Overall Study|Protocol Violation|22|||
46910953|NCT03243305|83140604|FG000|Overall Study|Study method no longer primary method|12|||
46910954|NCT03243305|83140604|FG000|Overall Study|Study Terminated by Sponsor|1|||
46910955|NCT03243305|83140604|FG000|Overall Study|Early terminations|267|||
46910956|NCT03222583|83140610|FG000|Overall Study|Withdrawal by Subject|3|||
46910957|NCT03222583|83140611|FG001|Overall Study|Withdrawal by Subject|3|||
46910958|NCT03222583|83140610|FG000|Overall Study|Lost to Follow-up|1|||
46910959|NCT03222583|83140611|FG001|Overall Study|Lost to Follow-up|0|||
46910960|NCT03222583|83140610|FG000|Overall Study|Other|1|||
46910961|NCT03222583|83140611|FG001|Overall Study|Other|3|||
46910962|NCT03295721|83140620|FG000|Overall Study|Adverse Event|1|||
46910963|NCT03295721|83140621|FG001|Overall Study|Adverse Event|0|||
46910964|NCT03295721|83140622|FG002|Overall Study|Adverse Event|0|||
46910965|NCT03295721|83140620|FG000|Overall Study|Lost to Follow-up|1|||
46910966|NCT03295721|83140621|FG001|Overall Study|Lost to Follow-up|1|||
46910967|NCT03295721|83140622|FG002|Overall Study|Lost to Follow-up|1|||
46910968|NCT03295721|83140620|FG000|Overall Study|Withdrawal by Subject|1|||
46910969|NCT03295721|83140621|FG001|Overall Study|Withdrawal by Subject|0|||
46910970|NCT03295721|83140622|FG002|Overall Study|Withdrawal by Subject|1|||
46910971|NCT03295721|83140620|FG000|Overall Study|Death|0|||
46910972|NCT03295721|83140621|FG001|Overall Study|Death|0|||
46910973|NCT03295721|83140622|FG002|Overall Study|Death|1|||
47018350|NCT01830543|83267144|FG002|Overall Study|Protocol Violation|7|||
46709722|NCT01142232|82925829|FG002|Overall Study|Withdrawal by Subject|0|||
46709723|NCT01142232|82925830|FG003|Overall Study|Withdrawal by Subject|1|||
47018351|NCT01830543|83267142|FG000|Overall Study|Physician Decision|11|||
46709724|NCT01142232|82925831|FG004|Overall Study|Withdrawal by Subject|3|||
46709725|NCT01142232|82925827|FG000|Overall Study|Physician Decision|0|||
46709726|NCT01142232|82925828|FG001|Overall Study|Physician Decision|1|||
46910974|NCT00803790|83140633|FG000|Period 1|Adverse Event|0|||
46910975|NCT00803790|83140634|FG001|Period 1|Adverse Event|1|||
46910976|NCT00803790|83140635|FG002|Period 1|Adverse Event|0|||
46910977|NCT00803790|83140636|FG003|Period 1|Adverse Event|0|||
46910978|NCT00803790|83140633|FG000|Period 1|Lost to Follow-up|1|||
46910979|NCT00803790|83140634|FG001|Period 1|Lost to Follow-up|2|||
47018352|NCT01830543|83267143|FG001|Overall Study|Physician Decision|5|||
47018353|NCT01830543|83267144|FG002|Overall Study|Physician Decision|12|||
47018354|NCT01830543|83267142|FG000|Overall Study|Withdrawal by consent|3|||
46910980|NCT00803790|83140635|FG002|Period 1|Lost to Follow-up|0|||
46910981|NCT00803790|83140636|FG003|Period 1|Lost to Follow-up|0|||
47018355|NCT01830543|83267143|FG001|Overall Study|Withdrawal by consent|3|||
46910982|NCT00803790|83140633|FG000|Period 1|Withdrawal by Subject|8|||
47018356|NCT01830543|83267144|FG002|Overall Study|Withdrawal by consent|3|||
46910983|NCT00803790|83140634|FG001|Period 1|Withdrawal by Subject|6|||
46910984|NCT00803790|83140635|FG002|Period 1|Withdrawal by Subject|0|||
46910985|NCT00803790|83140636|FG003|Period 1|Withdrawal by Subject|0|||
46910986|NCT00803790|83140633|FG000|Period 1|positive drug screen or personal reasons|0|||
46910987|NCT00803790|83140634|FG001|Period 1|positive drug screen or personal reasons|3|||
46910988|NCT00803790|83140635|FG002|Period 1|positive drug screen or personal reasons|0|||
46910989|NCT00803790|83140636|FG003|Period 1|positive drug screen or personal reasons|4|||
46910990|NCT00803790|83140633|FG000|Period 1|Protocol Violation|0|||
46910991|NCT00803790|83140634|FG001|Period 1|Protocol Violation|0|||
46910992|NCT00803790|83140635|FG002|Period 1|Protocol Violation|1|||
46910993|NCT00803790|83140636|FG003|Period 1|Protocol Violation|0|||
46910994|NCT00803790|83140633|FG000|Period 2|Adverse Event|0|||
46910995|NCT00803790|83140634|FG001|Period 2|Adverse Event|0|||
46910996|NCT00803790|83140635|FG002|Period 2|Adverse Event|1|||
46910997|NCT00803790|83140636|FG003|Period 2|Adverse Event|1|||
46910998|NCT00803790|83140633|FG000|Period 2|Withdrawal by Subject|1|||
46910999|NCT00803790|83140634|FG001|Period 2|Withdrawal by Subject|0|||
46911000|NCT00803790|83140635|FG002|Period 2|Withdrawal by Subject|0|||
46911001|NCT00803790|83140636|FG003|Period 2|Withdrawal by Subject|0|||
46911002|NCT00803790|83140633|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
46911003|NCT00803790|83140634|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
46911004|NCT00803790|83140635|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
46911005|NCT00803790|83140636|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
46911006|NCT00250458|83140684|FG000|Overall Study|Lost to Follow-up|4|||
46911007|NCT00250458|83140685|FG001|Overall Study|Lost to Follow-up|2|||
46911008|NCT00250458|83140684|FG000|Overall Study|Protocol Violation|0|||
46911009|NCT00250458|83140685|FG001|Overall Study|Protocol Violation|1|||
46911010|NCT00250458|83140684|FG000|Overall Study|Withdrawal by Subject|4|||
46911011|NCT00250458|83140685|FG001|Overall Study|Withdrawal by Subject|2|||
46911012|NCT00250458|83140684|FG000|Overall Study|Lack of Migraine Attack|20|||
46911013|NCT00250458|83140685|FG001|Overall Study|Lack of Migraine Attack|9|||
46911014|NCT00250458|83140684|FG000|Overall Study|Qualifying migraine but did not treat|3|||
46911015|NCT00250458|83140685|FG001|Overall Study|Qualifying migraine but did not treat|3|||
46911016|NCT00250458|83140684|FG000|Overall Study|Other|1|||
46911017|NCT00250458|83140685|FG001|Overall Study|Other|0|||
46911018|NCT01667133|83140703|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
46911019|NCT01667133|83140704|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
46911020|NCT01667133|83140705|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
46911021|NCT01667133|83140706|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
46911022|NCT01667133|83140707|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
46911023|NCT01667133|83140708|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
46911024|NCT01667133|83140709|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
46911025|NCT01667133|83140710|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
46911026|NCT01667133|83140711|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
46911027|NCT01667133|83140712|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
46911028|NCT01667133|83140713|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
46911029|NCT01667133|83140714|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
46911030|NCT01667133|83140703|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911031|NCT01667133|83140704|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911032|NCT01667133|83140705|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
46911033|NCT01667133|83140706|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911034|NCT01667133|83140707|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911035|NCT01667133|83140708|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911036|NCT01667133|83140709|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911037|NCT01667133|83140710|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911038|NCT01667133|83140711|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
47018357|NCT01830543|83267142|FG000|Overall Study|Other|12|||
47018358|NCT01830543|83267143|FG001|Overall Study|Other|17|||
47018359|NCT01830543|83267144|FG002|Overall Study|Other|37|||
47018360|NCT02109445|83267152|FG000|Overall Study|Symptomatic deterioration|2|||
47018361|NCT02109445|83267152|FG000|Overall Study|Adverse Event|1|||
47018362|NCT02109133|83267158|FG000|Overall Study|Lost to Follow-up|1|||
47018363|NCT02109133|83267159|FG001|Overall Study|Lost to Follow-up|0|||
47018364|NCT01623271|83267167|FG000|Overall Study|Withdrawal by Subject|2|||
47018365|NCT01856673|83267174|FG000|Overall Study|Withdrawal by Subject|44|||
47018366|NCT01856673|83267175|FG001|Overall Study|Withdrawal by Subject|50|||
46911039|NCT01667133|83140712|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911040|NCT01667133|83140713|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911041|NCT01667133|83140714|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
46911042|NCT01667133|83140703|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
46911043|NCT01667133|83140704|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
46911044|NCT01667133|83140705|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
47018367|NCT01856673|83267176|FG002|Overall Study|Withdrawal by Subject|33|||
46911045|NCT01667133|83140706|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
46911046|NCT01667133|83140707|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
47018368|NCT01856673|83267174|FG000|Overall Study|Lost to Follow-up|31|||
47018369|NCT01856673|83267175|FG001|Overall Study|Lost to Follow-up|34|||
47018370|NCT01856673|83267176|FG002|Overall Study|Lost to Follow-up|0|||
47018371|NCT01856673|83267174|FG000|Overall Study|Unknown reasons|9|||
47018372|NCT01856673|83267175|FG001|Overall Study|Unknown reasons|0|||
47018373|NCT01856673|83267176|FG002|Overall Study|Unknown reasons|0|||
47018374|NCT01856673|83267174|FG000|Overall Study|Psychologist decision|1|||
47018375|NCT01856673|83267175|FG001|Overall Study|Psychologist decision|0|||
47018376|NCT01856673|83267176|FG002|Overall Study|Psychologist decision|0|||
47018377|NCT01856673|83267174|FG000|Overall Study|Paperwork errors|8|||
47018378|NCT01856673|83267175|FG001|Overall Study|Paperwork errors|0|||
47018379|NCT01856673|83267176|FG002|Overall Study|Paperwork errors|0|||
47018380|NCT01856673|83267174|FG000|Overall Study|Death|1|||
47018381|NCT01856673|83267175|FG001|Overall Study|Death|1|||
47018382|NCT01856673|83267176|FG002|Overall Study|Death|0|||
47018383|NCT01856673|83267174|FG000|Overall Study|Protocol Violation|1|||
47018384|NCT01856673|83267175|FG001|Overall Study|Protocol Violation|0|||
47018385|NCT01856673|83267176|FG002|Overall Study|Protocol Violation|1|||
47018386|NCT02095951|83267186|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
47018387|NCT02095951|83267187|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
47018388|NCT02095873|83267199|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
47018389|NCT02095873|83267200|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
47018390|NCT02095873|83267199|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
47018391|NCT02095873|83267200|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
47018392|NCT02095873|83267199|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
47018393|NCT02095873|83267200|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
47018394|NCT02094937|83267208|FG000|8 Weeks in Period 1|Adverse Event|9|||
47018395|NCT02094937|83267209|FG001|8 Weeks in Period 1|Adverse Event|0|||
47018396|NCT02094937|83267210|FG002|8 Weeks in Period 1|Adverse Event|0|||
47018397|NCT02094937|83267211|FG003|8 Weeks in Period 1|Adverse Event|0|||
47018398|NCT02094937|83267208|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
47018399|NCT02094937|83267209|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
47018400|NCT02094937|83267210|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
47018401|NCT02094937|83267211|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
47018402|NCT02094937|83267208|FG000|8 Weeks in Period 1|Protocol Violation|2|||
47018403|NCT02094937|83267209|FG001|8 Weeks in Period 1|Protocol Violation|0|||
47018404|NCT02094937|83267210|FG002|8 Weeks in Period 1|Protocol Violation|0|||
47018405|NCT02094937|83267211|FG003|8 Weeks in Period 1|Protocol Violation|0|||
47018406|NCT02094937|83267208|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
47018407|NCT02094937|83267209|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
47018408|NCT02094937|83267210|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
47018409|NCT02094937|83267211|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
47018410|NCT02094937|83267208|FG000|8 Weeks in Period 1|Physician Decision|1|||
47018411|NCT02094937|83267209|FG001|8 Weeks in Period 1|Physician Decision|0|||
47018412|NCT02094937|83267210|FG002|8 Weeks in Period 1|Physician Decision|0|||
47018413|NCT02094937|83267211|FG003|8 Weeks in Period 1|Physician Decision|0|||
47018414|NCT02094937|83267208|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
47018415|NCT02094937|83267209|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
47018416|NCT02094937|83267210|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
46911047|NCT01667133|83140708|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
46911048|NCT01667133|83140709|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
46911049|NCT01667133|83140710|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
46911050|NCT01667133|83140711|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
46911051|NCT01667133|83140712|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
46911052|NCT01667133|83140713|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
46911053|NCT01667133|83140714|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
46911054|NCT01667133|83140703|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
47018417|NCT02094937|83267211|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
47018418|NCT02094937|83267208|FG000|12 Weeks in Period 2|Adverse Event|0|||
47018419|NCT02094937|83267209|FG001|12 Weeks in Period 2|Adverse Event|2|||
46911055|NCT01667133|83140704|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
47018420|NCT02094937|83267210|FG002|12 Weeks in Period 2|Adverse Event|4|||
47018421|NCT02094937|83267211|FG003|12 Weeks in Period 2|Adverse Event|1|||
47018422|NCT02094937|83267208|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
47018423|NCT02094937|83267209|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
47018424|NCT02094937|83267210|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
47018425|NCT02094937|83267211|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
47018426|NCT02094937|83267208|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
47018427|NCT02094937|83267209|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
47018428|NCT02094937|83267210|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
47018429|NCT02094937|83267211|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
47018430|NCT02094937|83267208|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
47018431|NCT02094937|83267209|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
47018432|NCT02094937|83267210|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
47018433|NCT02094937|83267211|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
47018434|NCT02094937|83267208|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
47018435|NCT02094937|83267209|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
47018436|NCT02094937|83267210|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
47018437|NCT02094937|83267211|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
47018438|NCT02093923|83267225|FG000|Overall Study|Lost to Follow-up|0|||
47018439|NCT02093923|83267226|FG001|Overall Study|Lost to Follow-up|0|||
47018440|NCT02093923|83267227|FG002|Overall Study|Lost to Follow-up|0|||
47018441|NCT02093923|83267228|FG003|Overall Study|Lost to Follow-up|1|||
47018442|NCT02093923|83267229|FG004|Overall Study|Lost to Follow-up|0|||
47018443|NCT02093923|83267225|FG000|Overall Study|Screen failure after randomization|0|||
47018444|NCT02093923|83267226|FG001|Overall Study|Screen failure after randomization|0|||
47018445|NCT02093923|83267227|FG002|Overall Study|Screen failure after randomization|0|||
47018446|NCT02093923|83267228|FG003|Overall Study|Screen failure after randomization|1|||
47018447|NCT02093923|83267229|FG004|Overall Study|Screen failure after randomization|0|||
47018448|NCT02186561|83267245|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
47018449|NCT02186561|83267245|FG000|Enrollment|Enrollment Cap Reached|5|||
47018450|NCT02186561|83267245|FG000|Enrollment|Insurance Denial|2|||
47018451|NCT02186561|83267245|FG000|Enrollment|Withdrawal by Subject|2|||
47018452|NCT02186561|83267245|FG000|Enrollment|Investigator Withdrew Consent|1|||
47018453|NCT02186561|83267245|FG000|30-Day Post Index Procedure Visit|Death|1|||
47018454|NCT02186561|83267245|FG000|1- Year Post Index Procedure Visit|Death|1|||
47018455|NCT02186561|83267245|FG000|1- Year Post Index Procedure Visit|Missed|1|||
47018456|NCT02066467|83267251|FG000|Overall Study|Did not undergo implant procedure|24|||
47018457|NCT02066467|83267251|FG000|Overall Study|Attempted to implant withoput success|43|||
47018458|NCT02066467|83267251|FG000|Overall Study|Consent ineligible|1|||
47018459|NCT02066467|83267251|FG000|Overall Study|Death|54|||
47018460|NCT02066467|83267251|FG000|Overall Study|Lost to Follow-up|51|||
47018461|NCT02066467|83267251|FG000|Overall Study|Adverse Event|20|||
47018462|NCT02066467|83267251|FG000|Overall Study|Withdrawal by Subject|16|||
47018463|NCT02066467|83267251|FG000|Overall Study|Physician Decision|2|||
47018464|NCT02066467|83267251|FG000|Overall Study|Not defined|4|||
47018465|NCT02186171|83267257|FG000|Overall Study|Withdrawal by Subject|1|||
47018466|NCT02186171|83267258|FG001|Overall Study|Withdrawal by Subject|9|||
47018467|NCT02186171|83267257|FG000|Overall Study|Lost to Follow-up|2|||
47018468|NCT02186171|83267258|FG001|Overall Study|Lost to Follow-up|2|||
47018469|NCT02186171|83267257|FG000|Overall Study|Death|1|||
47018470|NCT02186171|83267258|FG001|Overall Study|Death|2|||
47018471|NCT02186171|83267257|FG000|Overall Study|Protocol-specified Criteria|0|||
47018472|NCT02186171|83267258|FG001|Overall Study|Protocol-specified Criteria|2|||
47018473|NCT02186015|83267266|FG000|Overall Study|Physician Decision|1|||
47018474|NCT02186015|83267267|FG001|Overall Study|Physician Decision|0|||
47018475|NCT02066389|83267280|FG000|Overall Study|Adverse Event|1|||
47018476|NCT02066389|83267281|FG001|Overall Study|Adverse Event|1|||
47018477|NCT02066389|83267282|FG002|Overall Study|Adverse Event|1|||
47018478|NCT02066389|83267283|FG003|Overall Study|Adverse Event|1|||
47018479|NCT02066389|83267284|FG004|Overall Study|Adverse Event|5|||
47018480|NCT02066389|83267285|FG005|Overall Study|Adverse Event|1|||
47018481|NCT02066389|83267280|FG000|Overall Study|Withdrawal by Subject|4|||
47018482|NCT02066389|83267281|FG001|Overall Study|Withdrawal by Subject|0|||
47018483|NCT02066389|83267282|FG002|Overall Study|Withdrawal by Subject|5|||
47018484|NCT02066389|83267283|FG003|Overall Study|Withdrawal by Subject|1|||
47018485|NCT02066389|83267284|FG004|Overall Study|Withdrawal by Subject|1|||
46911056|NCT01667133|83140705|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911057|NCT01667133|83140706|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
47018486|NCT02066389|83267285|FG005|Overall Study|Withdrawal by Subject|2|||
47018487|NCT02066389|83267280|FG000|Overall Study|Lost to Follow-up|0|||
47018488|NCT02066389|83267281|FG001|Overall Study|Lost to Follow-up|0|||
47018489|NCT02066389|83267282|FG002|Overall Study|Lost to Follow-up|0|||
47018490|NCT02066389|83267283|FG003|Overall Study|Lost to Follow-up|1|||
47018491|NCT02066389|83267284|FG004|Overall Study|Lost to Follow-up|1|||
47018492|NCT02066389|83267285|FG005|Overall Study|Lost to Follow-up|1|||
47018493|NCT02066389|83267280|FG000|Overall Study|Randomized in Error|0|||
47018494|NCT02066389|83267281|FG001|Overall Study|Randomized in Error|0|||
47018495|NCT02066389|83267282|FG002|Overall Study|Randomized in Error|0|||
47018496|NCT02066389|83267283|FG003|Overall Study|Randomized in Error|0|||
47018497|NCT02066389|83267284|FG004|Overall Study|Randomized in Error|0|||
46620583|NCT01721876|82770644|FG001|Overall Study|Sponsor terminated trial|4|||
47018498|NCT02066389|83267285|FG005|Overall Study|Randomized in Error|1|||
47018499|NCT02106403|83267299|FG000|Follow-Up Visit 3|Other Reason|0|||
47018500|NCT02106403|83267300|FG001|Follow-Up Visit 3|Other Reason|0|||
47018501|NCT02106403|83267301|FG002|Follow-Up Visit 3|Other Reason|0|||
47018502|NCT02106403|83267302|FG003|Follow-Up Visit 3|Other Reason|0|||
47018503|NCT02106403|83267303|FG004|Follow-Up Visit 3|Other Reason|0|||
47018504|NCT02106403|83267304|FG005|Follow-Up Visit 3|Other Reason|1|||
47018505|NCT02133131|83267321|FG000|Overall Study|Adverse Event|0|||
47018506|NCT02133131|83267322|FG001|Overall Study|Adverse Event|0|||
47018507|NCT02133131|83267323|FG002|Overall Study|Adverse Event|0|||
47018508|NCT02133131|83267324|FG003|Overall Study|Adverse Event|1|||
47018509|NCT02133131|83267325|FG004|Overall Study|Adverse Event|0|||
47018510|NCT02133131|83267326|FG005|Overall Study|Adverse Event|0|||
47018511|NCT02133131|83267327|FG006|Overall Study|Adverse Event|0|||
47018512|NCT02133131|83267321|FG000|Overall Study|Lost to Follow-up|1|||
47018513|NCT02133131|83267322|FG001|Overall Study|Lost to Follow-up|0|||
47018514|NCT02133131|83267323|FG002|Overall Study|Lost to Follow-up|0|||
47018515|NCT02133131|83267324|FG003|Overall Study|Lost to Follow-up|1|||
47018516|NCT02133131|83267325|FG004|Overall Study|Lost to Follow-up|0|||
47018517|NCT02133131|83267326|FG005|Overall Study|Lost to Follow-up|0|||
47018518|NCT02133131|83267327|FG006|Overall Study|Lost to Follow-up|0|||
47018519|NCT02133131|83267321|FG000|Overall Study|Status not recorded|4|||
47018520|NCT02133131|83267322|FG001|Overall Study|Status not recorded|5|||
47018521|NCT02133131|83267323|FG002|Overall Study|Status not recorded|1|||
47018522|NCT02133131|83267324|FG003|Overall Study|Status not recorded|4|||
47018523|NCT02133131|83267325|FG004|Overall Study|Status not recorded|0|||
47018524|NCT02133131|83267326|FG005|Overall Study|Status not recorded|0|||
47018525|NCT02133131|83267327|FG006|Overall Study|Status not recorded|0|||
47018526|NCT02133131|83267321|FG000|Overall Study|Ongoing in study|0|||
47018527|NCT02133131|83267322|FG001|Overall Study|Ongoing in study|0|||
47018528|NCT02133131|83267323|FG002|Overall Study|Ongoing in study|0|||
47018529|NCT02133131|83267324|FG003|Overall Study|Ongoing in study|0|||
47018530|NCT02133131|83267325|FG004|Overall Study|Ongoing in study|15|||
47018531|NCT02133131|83267326|FG005|Overall Study|Ongoing in study|14|||
47018532|NCT02133131|83267327|FG006|Overall Study|Ongoing in study|11|||
47018533|NCT02133131|83267321|FG000|Overall Study|Protocol Violation|0|||
47018534|NCT02133131|83267322|FG001|Overall Study|Protocol Violation|0|||
47018535|NCT02133131|83267323|FG002|Overall Study|Protocol Violation|0|||
47018536|NCT02133131|83267324|FG003|Overall Study|Protocol Violation|0|||
47018537|NCT02133131|83267325|FG004|Overall Study|Protocol Violation|0|||
47018538|NCT02133131|83267326|FG005|Overall Study|Protocol Violation|0|||
47018539|NCT02133131|83267327|FG006|Overall Study|Protocol Violation|1|||
47018540|NCT02106325|83267345|FG000|Phase 1|Lost to Follow-up|2|||
47018541|NCT02106325|83267346|FG001|Phase 1|Lost to Follow-up|2|||
47018542|NCT02106325|83267345|FG000|Phase 2|Lost to Follow-up|2|||
47018543|NCT02106325|83267346|FG001|Phase 2|Lost to Follow-up|3|||
47018544|NCT02106325|83267345|FG000|Phase 3|Lost to Follow-up|2|||
47018545|NCT02106325|83267346|FG001|Phase 3|Lost to Follow-up|1|||
47018546|NCT01625689|83267354|FG000|Overall Study|Migration|2|||
47018547|NCT01625689|83267355|FG001|Overall Study|Migration|1|||
47018548|NCT02184611|83267363|FG000|Overall Study|Lack of Efficacy|11|||
47018549|NCT02184611|83267364|FG001|Overall Study|Lack of Efficacy|15|||
47018550|NCT02184611|83267363|FG000|Overall Study|Withdrawal by Subject|5|||
47018551|NCT02184611|83267364|FG001|Overall Study|Withdrawal by Subject|6|||
47018552|NCT02184611|83267363|FG000|Overall Study|Adverse Event|4|||
47018553|NCT02184611|83267364|FG001|Overall Study|Adverse Event|5|||
47018554|NCT02184611|83267363|FG000|Overall Study|Protocol Violation|1|||
47018555|NCT02184611|83267364|FG001|Overall Study|Protocol Violation|1|||
47018556|NCT02184611|83267363|FG000|Overall Study|Protocol defined stopping criteria|0|||
47018557|NCT02184611|83267364|FG001|Overall Study|Protocol defined stopping criteria|1|||
47018558|NCT02066311|83267370|FG000|Overall Study|Adverse Event|4|||
47018559|NCT02066311|83267370|FG000|Overall Study|Withdrawal by Subject|1|||
47018560|NCT02184455|83267374|FG000|Overall Study|Lost to Follow-up|1|||
47018561|NCT02184143|83267380|FG000|Overall Study|Withdrawal by Subject|4|||
47018562|NCT02184143|83267381|FG001|Overall Study|Withdrawal by Subject|4|||
47018563|NCT02184143|83267380|FG000|Overall Study|Lost to Follow-up|5|||
47018564|NCT02184143|83267381|FG001|Overall Study|Lost to Follow-up|3|||
46911058|NCT01667133|83140707|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
47018565|NCT02184143|83267380|FG000|Overall Study|Death|1|||
47018566|NCT02184143|83267381|FG001|Overall Study|Death|0|||
47018567|NCT01625611|83267391|FG000|Overall Study|No adlib drinks Lab 1|3|||
47018568|NCT01625611|83267392|FG001|Overall Study|No adlib drinks Lab 1|0|||
47018569|NCT01625611|83267391|FG000|Overall Study|Technical issues with PET|1|||
47018570|NCT01625611|83267392|FG001|Overall Study|Technical issues with PET|0|||
47018571|NCT01625611|83267391|FG000|Overall Study|Unable to complete study procedures|1|||
47018572|NCT01625611|83267392|FG001|Overall Study|Unable to complete study procedures|0|||
47018573|NCT01625611|83267391|FG000|Overall Study|Withdrawal by Subject|3|||
47018574|NCT01625611|83267392|FG001|Overall Study|Withdrawal by Subject|0|||
47018575|NCT02159807|83267402|FG000|Overall Study|Adverse Event|0|||
47018576|NCT02159807|83267403|FG001|Overall Study|Adverse Event|0|||
47018577|NCT02159807|83267404|FG002|Overall Study|Adverse Event|1|||
47018578|NCT02159807|83267402|FG000|Overall Study|No CSF|1|||
47018579|NCT02159807|83267403|FG001|Overall Study|No CSF|1|||
47018580|NCT02159807|83267404|FG002|Overall Study|No CSF|1|||
46911059|NCT01667133|83140708|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911060|NCT01667133|83140709|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911061|NCT01667133|83140710|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911062|NCT01667133|83140711|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911063|NCT01667133|83140712|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911064|NCT01667133|83140713|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911065|NCT01667133|83140714|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
46911066|NCT01667133|83140703|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
47018581|NCT02159807|83267402|FG000|Overall Study|elevated blood pressure|0|||
47018582|NCT02159807|83267403|FG001|Overall Study|elevated blood pressure|0|||
47018583|NCT02159807|83267404|FG002|Overall Study|elevated blood pressure|1|||
47018584|NCT02066233|83267414|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
47018585|NCT02066233|83267415|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
47018586|NCT02159729|83267423|FG000|Overall Study|Adverse Event|0|||
47018587|NCT02159729|83267424|FG001|Overall Study|Adverse Event|1|||
47018588|NCT02159729|83267423|FG000|Overall Study|Subject's Request|13|||
47018589|NCT02159729|83267424|FG001|Overall Study|Subject's Request|10|||
47018590|NCT02159729|83267423|FG000|Overall Study|Lost to Follow-up|24|||
47018591|NCT02159729|83267424|FG001|Overall Study|Lost to Follow-up|9|||
47018592|NCT02159729|83267423|FG000|Overall Study|Non compliance|2|||
47018593|NCT02159729|83267424|FG001|Overall Study|Non compliance|0|||
47018594|NCT02159729|83267423|FG000|Overall Study|Other Unspecified|3|||
47018595|NCT02159729|83267424|FG001|Overall Study|Other Unspecified|1|||
47018596|NCT02159183|83267432|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
47018597|NCT02159183|83267433|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
47018598|NCT02159183|83267432|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
47018599|NCT02159183|83267433|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
47018600|NCT02159183|83267432|FG000|Analysis After the 36 Months Follow-up|Death|0|||
47018601|NCT02159183|83267433|FG001|Analysis After the 36 Months Follow-up|Death|1|||
47018602|NCT02159183|83267432|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
47018603|NCT02159183|83267433|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
47018604|NCT02159183|83267432|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
47018605|NCT02159183|83267433|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
47018606|NCT02183675|83267445|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
47018607|NCT02183675|83267446|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
47018608|NCT02183675|83267447|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
47018609|NCT02183675|83267448|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
47018610|NCT02183675|83267449|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
47018611|NCT02183675|83267450|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
47018612|NCT02183519|83267462|FG000|Overall Study|computer error|3|||
47018613|NCT02183519|83267463|FG001|Overall Study|computer error|0|||
46911067|NCT01667133|83140704|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
47018614|NCT02183519|83267462|FG000|Overall Study|Did not respond to cough inducter|0|||
47018615|NCT02183519|83267463|FG001|Overall Study|Did not respond to cough inducter|3|||
47018616|NCT02132195|83267472|FG000|Initial Assignment|Relapsed|14|||
47018617|NCT02132195|83267473|FG001|Initial Assignment|Relapsed|0|||
47018618|NCT02132195|83267474|FG002|Initial Assignment|Relapsed|0|||
47018619|NCT02132195|83267472|FG000|Rescue Therapy|Relapsed|0|||
47018620|NCT02132195|83267473|FG001|Rescue Therapy|Relapsed|0|||
47018621|NCT02132195|83267474|FG002|Rescue Therapy|Relapsed|7|||
47018622|NCT02132195|83267472|FG000|Rescue Therapy|Physician Decision|0|||
47018623|NCT02132195|83267473|FG001|Rescue Therapy|Physician Decision|0|||
47018624|NCT02132195|83267474|FG002|Rescue Therapy|Physician Decision|1|||
47018625|NCT02132195|83267472|FG000|Rescue Therapy|Withdrawal by Subject|0|||
47018626|NCT02132195|83267473|FG001|Rescue Therapy|Withdrawal by Subject|0|||
47018627|NCT02132195|83267474|FG002|Rescue Therapy|Withdrawal by Subject|1|||
47018628|NCT02132195|83267472|FG000|Rescue Therapy|Adverse Event|0|||
47018629|NCT02132195|83267473|FG001|Rescue Therapy|Adverse Event|0|||
47018630|NCT02132195|83267474|FG002|Rescue Therapy|Adverse Event|2|||
47018631|NCT02182973|83267484|FG000|Overall Study|Withdrawal by Subject|3|||
47018632|NCT02182973|83267485|FG001|Overall Study|Withdrawal by Subject|0|||
47018633|NCT02182895|83267494|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
47018634|NCT02182895|83267495|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
47018635|NCT01625377|83267503|FG000|Overall Study|Death|1|||
47018636|NCT01625377|83267504|FG001|Overall Study|Death|1|||
47018637|NCT01625377|83267503|FG000|Overall Study|Administrative Problem|1|||
47018638|NCT01625377|83267504|FG001|Overall Study|Administrative Problem|1|||
47018639|NCT01625377|83267503|FG000|Overall Study|Protocol Violation|0|||
47018640|NCT01625377|83267504|FG001|Overall Study|Protocol Violation|3|||
47018641|NCT01625377|83267503|FG000|Overall Study|Adverse Event|3|||
47018642|NCT01625377|83267504|FG001|Overall Study|Adverse Event|16|||
47018643|NCT01625377|83267503|FG000|Overall Study|Graft loss|1|||
47018644|NCT01625377|83267504|FG001|Overall Study|Graft loss|0|||
47018645|NCT01625377|83267503|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
47018646|NCT01625377|83267504|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
47018647|NCT01625377|83267503|FG000|Overall Study|Abnormal laboratory values|1|||
47018648|NCT01625377|83267504|FG001|Overall Study|Abnormal laboratory values|0|||
47018649|NCT02158949|83267512|FG000|Overall Study|Withdrawal by Subject|1|||
47018650|NCT02158949|83267513|FG001|Overall Study|Withdrawal by Subject|0|||
47018651|NCT02158949|83267512|FG000|Overall Study|Lost to Follow-up|5|||
47018652|NCT02158949|83267513|FG001|Overall Study|Lost to Follow-up|11|||
47018653|NCT02132117|83267521|FG000|Overall Study|Adverse Event|6|||
47018654|NCT02132117|83267522|FG001|Overall Study|Adverse Event|1|||
47018655|NCT02132117|83267521|FG000|Overall Study|Lost to Follow-up|2|||
47018656|NCT02132117|83267522|FG001|Overall Study|Lost to Follow-up|2|||
47018657|NCT02132117|83267521|FG000|Overall Study|Personal Reasons|1|||
47018658|NCT02132117|83267522|FG001|Overall Study|Personal Reasons|2|||
47018659|NCT02132117|83267521|FG000|Overall Study|Other Miscellaneous Reasons|2|||
47018660|NCT02132117|83267522|FG001|Overall Study|Other Miscellaneous Reasons|0|||
47018661|NCT02093689|83267531|FG000|Overall Study|Physician Decision|4|||
47018662|NCT02093689|83267532|FG001|Overall Study|Physician Decision|0|||
47018663|NCT02093689|83267533|FG002|Overall Study|Physician Decision|0|||
47018664|NCT02047045|83267541|FG000|Baseline|Withdrawal by Subject|3|||
47018665|NCT02047045|83267542|FG001|Baseline|Withdrawal by Subject|2|||
47018666|NCT02047045|83267541|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
47018667|NCT02047045|83267542|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
47018668|NCT02047045|83267541|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
47018669|NCT02047045|83267542|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
47018670|NCT02047045|83267541|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
47018671|NCT02047045|83267542|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
47018672|NCT02047045|83267541|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
47018673|NCT02047045|83267542|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
47018674|NCT02047045|83267541|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
47018675|NCT02047045|83267542|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
47018676|NCT02047045|83267541|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
47018677|NCT02047045|83267542|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
47018678|NCT02047045|83267541|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
47018679|NCT02047045|83267542|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
47018680|NCT02047045|83267541|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
47018681|NCT02047045|83267542|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
47018682|NCT02131259|83267548|FG000|Overall Study|Progressive disease|751|||
47018683|NCT02131259|83267548|FG000|Overall Study|Adverse Event|341|||
47018684|NCT02131259|83267548|FG000|Overall Study|Lost to Follow-up|7|||
46709727|NCT01142232|82925829|FG002|Overall Study|Physician Decision|0|||
47018685|NCT02131259|83267548|FG000|Overall Study|Relocation|32|||
47018686|NCT02131259|83267548|FG000|Overall Study|Other|63|||
47018687|NCT02131259|83267548|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
47018688|NCT02131259|83267548|FG000|Overall Study|Progressive disease/relocation|1|||
47018689|NCT02131259|83267548|FG000|Overall Study|Progressive disease/other|2|||
47018690|NCT02131259|83267548|FG000|Overall Study|AE/lost to follow-up|1|||
47018691|NCT02131259|83267548|FG000|Overall Study|AE/other|1|||
47018692|NCT02131259|83267548|FG000|Overall Study|Progressive disease/AE/other|1|||
47018693|NCT02131259|83267548|FG000|Overall Study|Missing|3|||
47018694|NCT01856595|83267561|FG000|Overall Study|Withdrawal by Subject|0|||
47018695|NCT01856595|83267562|FG001|Overall Study|Withdrawal by Subject|1|||
47018696|NCT01856595|83267563|FG002|Overall Study|Withdrawal by Subject|0|||
47018697|NCT01856595|83267564|FG003|Overall Study|Withdrawal by Subject|0|||
47018698|NCT01856595|83267565|FG004|Overall Study|Withdrawal by Subject|0|||
47018699|NCT01856595|83267566|FG005|Overall Study|Withdrawal by Subject|0|||
47018700|NCT01856595|83267567|FG006|Overall Study|Withdrawal by Subject|1|||
47018701|NCT01856595|83267568|FG007|Overall Study|Withdrawal by Subject|0|||
47018702|NCT01856595|83267569|FG008|Overall Study|Withdrawal by Subject|0|||
47018703|NCT02158247|83267606|FG000|Overall Study|Invisible vocal cords|5|||
47018704|NCT01829295|83267628|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
47018705|NCT01829295|83267629|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
47018706|NCT01829295|83267630|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
47018707|NCT01829295|83267631|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
47018708|NCT01829295|83267628|FG000|6-12 Months|Adverse Event|0|||
47018709|NCT01829295|83267629|FG001|6-12 Months|Adverse Event|0|||
47018710|NCT01829295|83267630|FG002|6-12 Months|Adverse Event|3|||
47018711|NCT01829295|83267631|FG003|6-12 Months|Adverse Event|2|||
47018712|NCT01829295|83267628|FG000|6-12 Months|Lost to Follow-up|2|||
47018713|NCT01829295|83267629|FG001|6-12 Months|Lost to Follow-up|0|||
47018714|NCT01829295|83267630|FG002|6-12 Months|Lost to Follow-up|0|||
47018715|NCT01829295|83267631|FG003|6-12 Months|Lost to Follow-up|0|||
47018716|NCT01829295|83267628|FG000|6-12 Months|Withdrawal by Subject|2|||
47018717|NCT01829295|83267629|FG001|6-12 Months|Withdrawal by Subject|2|||
47018718|NCT01829295|83267630|FG002|6-12 Months|Withdrawal by Subject|0|||
47018719|NCT01829295|83267631|FG003|6-12 Months|Withdrawal by Subject|0|||
47018720|NCT02157935|83267643|FG000|Overall Study|Withdrawal by Subject|25|||
47018721|NCT02157935|83267644|FG001|Overall Study|Withdrawal by Subject|39|||
47018722|NCT02157935|83267643|FG000|Overall Study|Screen failure|1|||
47018723|NCT02157935|83267644|FG001|Overall Study|Screen failure|2|||
47018724|NCT02157935|83267643|FG000|Overall Study|Protocol Violation|1|||
47018725|NCT02157935|83267644|FG001|Overall Study|Protocol Violation|0|||
47018726|NCT02157935|83267643|FG000|Overall Study|Progressive disease|0|||
47018727|NCT02157935|83267644|FG001|Overall Study|Progressive disease|2|||
47018728|NCT02157935|83267643|FG000|Overall Study|Other|5|||
47018729|NCT02157935|83267644|FG001|Overall Study|Other|12|||
47018730|NCT02157935|83267643|FG000|Overall Study|Lack of Efficacy|0|||
47018731|NCT02157935|83267644|FG001|Overall Study|Lack of Efficacy|1|||
47018732|NCT02157935|83267643|FG000|Overall Study|Death|4|||
47018733|NCT02157935|83267644|FG001|Overall Study|Death|4|||
47018734|NCT02157935|83267643|FG000|Overall Study|Adverse Event|3|||
47018735|NCT02157935|83267644|FG001|Overall Study|Adverse Event|5|||
47018736|NCT02157779|83267652|FG000|Overall Study|Logistical|9|||
47018737|NCT02157779|83267653|FG001|Overall Study|Logistical|3|||
47018738|NCT02157779|83267652|FG000|Overall Study|Stopped attending, reason unknown|11|||
47018739|NCT02157779|83267653|FG001|Overall Study|Stopped attending, reason unknown|7|||
47018740|NCT02157779|83267652|FG000|Overall Study|No response to outreach after Baseline|1|||
47018741|NCT02157779|83267653|FG001|Overall Study|No response to outreach after Baseline|1|||
47018742|NCT02157779|83267652|FG000|Overall Study|Moved|1|||
47018743|NCT02157779|83267653|FG001|Overall Study|Moved|0|||
47018744|NCT02157779|83267652|FG000|Overall Study|Medical|1|||
47018745|NCT02157779|83267653|FG001|Overall Study|Medical|0|||
47018746|NCT02157779|83267652|FG000|Overall Study|Legal issue|1|||
47018747|NCT02157779|83267653|FG001|Overall Study|Legal issue|0|||
47018748|NCT02093221|83267667|FG000|Overall Study|Adverse Event|1|||
47018749|NCT02093221|83267668|FG001|Overall Study|Adverse Event|0|||
47018750|NCT02093221|83267669|FG002|Overall Study|Adverse Event|0|||
47018751|NCT02093221|83267670|FG003|Overall Study|Adverse Event|0|||
47018752|NCT02093221|83267671|FG004|Overall Study|Adverse Event|0|||
47018753|NCT02093221|83267667|FG000|Overall Study|Withdrawal by Subject|1|||
47018754|NCT02093221|83267668|FG001|Overall Study|Withdrawal by Subject|1|||
47018755|NCT02093221|83267669|FG002|Overall Study|Withdrawal by Subject|4|||
47018756|NCT02093221|83267670|FG003|Overall Study|Withdrawal by Subject|1|||
47018757|NCT02093221|83267671|FG004|Overall Study|Withdrawal by Subject|1|||
47018758|NCT02093221|83267667|FG000|Overall Study|Lost to Follow-up|2|||
47018759|NCT02093221|83267668|FG001|Overall Study|Lost to Follow-up|0|||
47018760|NCT02093221|83267669|FG002|Overall Study|Lost to Follow-up|1|||
47018761|NCT02093221|83267670|FG003|Overall Study|Lost to Follow-up|1|||
47018762|NCT02093221|83267671|FG004|Overall Study|Lost to Follow-up|0|||
47018763|NCT02093221|83267667|FG000|Overall Study|Death|0|||
47018764|NCT02093221|83267668|FG001|Overall Study|Death|1|||
47018765|NCT02093221|83267669|FG002|Overall Study|Death|0|||
47018766|NCT02093221|83267670|FG003|Overall Study|Death|0|||
46709728|NCT01142232|82925830|FG003|Overall Study|Physician Decision|2|||
47018767|NCT02093221|83267671|FG004|Overall Study|Death|0|||
47018768|NCT02093221|83267667|FG000|Overall Study|Protocol Violation|0|||
47018769|NCT02093221|83267668|FG001|Overall Study|Protocol Violation|1|||
47018770|NCT02093221|83267669|FG002|Overall Study|Protocol Violation|0|||
47018771|NCT02093221|83267670|FG003|Overall Study|Protocol Violation|0|||
47018772|NCT02093221|83267671|FG004|Overall Study|Protocol Violation|0|||
47018773|NCT02093221|83267667|FG000|Overall Study|Study termination|6|||
47018774|NCT02093221|83267668|FG001|Overall Study|Study termination|5|||
47018775|NCT02093221|83267669|FG002|Overall Study|Study termination|4|||
47018776|NCT02093221|83267670|FG003|Overall Study|Study termination|6|||
47018777|NCT02093221|83267671|FG004|Overall Study|Study termination|7|||
47018778|NCT02092909|83267687|FG000|Overall Study|Adverse Event|0|||
47018779|NCT02092909|83267688|FG001|Overall Study|Adverse Event|0|||
47018780|NCT02092909|83267689|FG002|Overall Study|Adverse Event|4|||
47018781|NCT02092909|83267690|FG003|Overall Study|Adverse Event|2|||
47018782|NCT02092909|83267687|FG000|Overall Study|Lack of Efficacy|0|||
47018783|NCT02092909|83267688|FG001|Overall Study|Lack of Efficacy|2|||
47018784|NCT02092909|83267689|FG002|Overall Study|Lack of Efficacy|1|||
47018785|NCT02092909|83267690|FG003|Overall Study|Lack of Efficacy|0|||
47018786|NCT02092909|83267687|FG000|Overall Study|Withdrawal by Subject|0|||
47018787|NCT02092909|83267688|FG001|Overall Study|Withdrawal by Subject|0|||
47018788|NCT02092909|83267689|FG002|Overall Study|Withdrawal by Subject|2|||
47018789|NCT02092909|83267690|FG003|Overall Study|Withdrawal by Subject|1|||
47018790|NCT02092909|83267687|FG000|Overall Study|Study terminated by Sponsor|0|||
47018791|NCT02092909|83267688|FG001|Overall Study|Study terminated by Sponsor|0|||
47018792|NCT02092909|83267689|FG002|Overall Study|Study terminated by Sponsor|0|||
47018793|NCT02092909|83267690|FG003|Overall Study|Study terminated by Sponsor|2|||
47018794|NCT02092909|83267687|FG000|Overall Study|Miscellaneous|1|||
47018795|NCT02092909|83267688|FG001|Overall Study|Miscellaneous|1|||
47018796|NCT02092909|83267689|FG002|Overall Study|Miscellaneous|2|||
47018797|NCT02092909|83267690|FG003|Overall Study|Miscellaneous|1|||
47018798|NCT01623115|83267702|FG000|Overall Study|Randomized but not treated|0|||
47018799|NCT01623115|83267703|FG001|Overall Study|Randomized but not treated|1|||
47018800|NCT01623115|83267702|FG000|Overall Study|Physician Decision|1|||
47018801|NCT01623115|83267703|FG001|Overall Study|Physician Decision|0|||
47018802|NCT01623115|83267702|FG000|Overall Study|Participants moved|1|||
47018803|NCT01623115|83267703|FG001|Overall Study|Participants moved|5|||
47018804|NCT01623115|83267702|FG000|Overall Study|Adverse Event|10|||
47018805|NCT01623115|83267703|FG001|Overall Study|Adverse Event|13|||
47018806|NCT01623115|83267702|FG000|Overall Study|Poor compliance to protocol|4|||
47018807|NCT01623115|83267703|FG001|Overall Study|Poor compliance to protocol|10|||
47018808|NCT01623115|83267702|FG000|Overall Study|Consent withdrawn by participant|2|||
47018809|NCT01623115|83267703|FG001|Overall Study|Consent withdrawn by participant|6|||
47018810|NCT01623115|83267702|FG000|Overall Study|Related to study drug administration|0|||
47018811|NCT01623115|83267703|FG001|Overall Study|Related to study drug administration|2|||
47018812|NCT01623115|83267702|FG000|Overall Study|Last visit outside protocol visit window|14|||
47018813|NCT01623115|83267703|FG001|Overall Study|Last visit outside protocol visit window|26|||
47018814|NCT01623115|83267702|FG000|Overall Study|Site closure|1|||
47018815|NCT01623115|83267703|FG001|Overall Study|Site closure|7|||
47018816|NCT01623115|83267702|FG000|Overall Study|Death|0|||
47018817|NCT01623115|83267703|FG001|Overall Study|Death|4|||
47018818|NCT01623115|83267702|FG000|Overall Study|Other than specified above|0|||
47018819|NCT01623115|83267703|FG001|Overall Study|Other than specified above|3|||
47018820|NCT02092285|83267709|FG000|Induction Phase|Adverse Event|7|||
47018821|NCT02092285|83267709|FG000|Induction Phase|Physician Decision|4|||
47018822|NCT02092285|83267709|FG000|Induction Phase|Pregnancy|1|||
47018823|NCT02092285|83267709|FG000|Induction Phase|Relapse/Recurrence|7|||
47018824|NCT02092285|83267709|FG000|Induction Phase|Withdrawal by Subject|2|||
47018825|NCT02092285|83267709|FG000|Induction Phase|Lack of Efficacy|14|||
47018826|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
47018827|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
47018828|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
47018829|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
47018830|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
47018831|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
47018832|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
47018833|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
47018834|NCT02092285|83267709|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
47018835|NCT02091739|83267716|FG000|MP: 16 Weeks|Adverse Event|1|||
47018836|NCT02091739|83267717|FG001|MP: 16 Weeks|Adverse Event|1|||
47018837|NCT02091739|83267718|FG002|MP: 16 Weeks|Adverse Event|1|||
47018838|NCT02091739|83267719|FG003|MP: 16 Weeks|Adverse Event|0|||
47018839|NCT02091739|83267720|FG004|MP: 16 Weeks|Adverse Event|0|||
47018840|NCT02091739|83267716|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
47018841|NCT02091739|83267717|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
47018842|NCT02091739|83267718|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
47018843|NCT02091739|83267719|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
47018844|NCT02091739|83267720|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
47018845|NCT02091739|83267716|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
47018846|NCT02091739|83267717|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
47018847|NCT02091739|83267718|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
46709729|NCT01142232|82925831|FG004|Overall Study|Physician Decision|10|||
47018848|NCT02091739|83267719|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
47018849|NCT02091739|83267720|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
47018850|NCT02091739|83267716|FG000|EP: 48 Weeks|Other|0|||
47018851|NCT02091739|83267717|FG001|EP: 48 Weeks|Other|0|||
47018852|NCT02091739|83267718|FG002|EP: 48 Weeks|Other|0|||
47018853|NCT02091739|83267719|FG003|EP: 48 Weeks|Other|1|||
47018854|NCT02091739|83267720|FG004|EP: 48 Weeks|Other|0|||
47018855|NCT02091739|83267716|FG000|EP: 48 Weeks|Death|0|||
47018856|NCT02091739|83267717|FG001|EP: 48 Weeks|Death|0|||
47018857|NCT02091739|83267718|FG002|EP: 48 Weeks|Death|0|||
47018858|NCT02091739|83267719|FG003|EP: 48 Weeks|Death|3|||
47018859|NCT02091739|83267720|FG004|EP: 48 Weeks|Death|2|||
47018860|NCT02091739|83267716|FG000|EP: 48 Weeks|Adverse Event|0|||
47018861|NCT02091739|83267717|FG001|EP: 48 Weeks|Adverse Event|0|||
47018862|NCT02091739|83267718|FG002|EP: 48 Weeks|Adverse Event|0|||
47018863|NCT02091739|83267719|FG003|EP: 48 Weeks|Adverse Event|2|||
47018864|NCT02091739|83267720|FG004|EP: 48 Weeks|Adverse Event|6|||
47018865|NCT02091739|83267716|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
47018866|NCT02091739|83267717|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
47018867|NCT02091739|83267718|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
47018868|NCT02091739|83267719|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
47018869|NCT02091739|83267720|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
47018870|NCT02045875|83267732|FG000|Overall Study|Lost to Follow-up|3|||
47018871|NCT02045875|83267733|FG001|Overall Study|Lost to Follow-up|0|||
47018872|NCT02045875|83267732|FG000|Overall Study|Withdrawal by Subject|4|||
47018873|NCT02045875|83267733|FG001|Overall Study|Withdrawal by Subject|3|||
47018874|NCT01597635|83267742|FG000|Part A|Adverse Event|3|||
47018875|NCT01597635|83267743|FG001|Part A|Adverse Event|0|||
47018876|NCT01597635|83267744|FG002|Part A|Adverse Event|0|||
47018877|NCT01597635|83267742|FG000|Part B|Adverse Event|0|||
47018878|NCT01597635|83267743|FG001|Part B|Adverse Event|0|||
47018879|NCT01597635|83267744|FG002|Part B|Adverse Event|1|||
47018880|NCT01597635|83267742|FG000|Part B|Protocol Violation|0|||
47018881|NCT01597635|83267743|FG001|Part B|Protocol Violation|1|||
47018882|NCT01597635|83267744|FG002|Part B|Protocol Violation|0|||
47018883|NCT01597635|83267742|FG000|Part B|Protocol-defined stopping criteria|0|||
47018884|NCT01597635|83267743|FG001|Part B|Protocol-defined stopping criteria|4|||
47018885|NCT01597635|83267744|FG002|Part B|Protocol-defined stopping criteria|3|||
47018886|NCT01597635|83267742|FG000|Part B|Withdrawal by Subject|0|||
47018887|NCT01597635|83267743|FG001|Part B|Withdrawal by Subject|1|||
47018888|NCT01597635|83267744|FG002|Part B|Withdrawal by Subject|0|||
47018889|NCT01828281|83267755|FG000|Overall Study|Withdrawal by Subject|1|||
47018890|NCT01828281|83267756|FG001|Overall Study|Withdrawal by Subject|0|||
47018891|NCT01827267|83267765|FG000|Overall Study|Did not receive study drug|1|||
47018892|NCT01827267|83267766|FG001|Overall Study|Did not receive study drug|1|||
47018893|NCT01827267|83267765|FG000|Overall Study|Physician Decision|1|||
47018894|NCT01827267|83267766|FG001|Overall Study|Physician Decision|0|||
47018895|NCT01827267|83267765|FG000|Overall Study|Disease Progression|1|||
47018896|NCT01827267|83267766|FG001|Overall Study|Disease Progression|1|||
47018897|NCT01827267|83267765|FG000|Overall Study|Sponsor Discontinued Study|2|||
47018898|NCT01827267|83267766|FG001|Overall Study|Sponsor Discontinued Study|8|||
47018899|NCT01827267|83267765|FG000|Overall Study|Still on study|0|||
47018900|NCT01827267|83267766|FG001|Overall Study|Still on study|2|||
47018901|NCT01855425|83267773|FG000|Overall Study|Physician Decision|20|||
47018902|NCT01854879|83267777|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
47018903|NCT01854879|83267777|FG000|Overall Study|screen fail|3|||
47018904|NCT01854879|83267777|FG000|Overall Study|incomplete data set|1|||
47018905|NCT01827111|83267781|FG000|Overall Study|Disease Progression|1|||
47018906|NCT02045095|83267785|FG000|Overall Study|Other|0|||
47018907|NCT02045095|83267786|FG001|Overall Study|Other|0|||
47018908|NCT02045095|83267787|FG002|Overall Study|Other|1|||
47018909|NCT02045095|83267788|FG003|Overall Study|Other|0|||
47018910|NCT02045095|83267789|FG004|Overall Study|Other|0|||
47018911|NCT02045095|83267790|FG005|Overall Study|Other|2|||
47018912|NCT02045095|83267791|FG006|Overall Study|Other|0|||
47018913|NCT02045095|83267785|FG000|Overall Study|Progressive Disease|3|||
47018914|NCT02045095|83267786|FG001|Overall Study|Progressive Disease|3|||
47018915|NCT02045095|83267787|FG002|Overall Study|Progressive Disease|2|||
47018916|NCT02045095|83267788|FG003|Overall Study|Progressive Disease|4|||
47018917|NCT02045095|83267789|FG004|Overall Study|Progressive Disease|2|||
47018918|NCT02045095|83267790|FG005|Overall Study|Progressive Disease|4|||
46709730|NCT01142232|82925827|FG000|Overall Study|Alternative Therapy|0|||
47018919|NCT02045095|83267791|FG006|Overall Study|Progressive Disease|1|||
47018920|NCT02045095|83267785|FG000|Overall Study|Withdrawal by Subject|0|||
47018921|NCT02045095|83267786|FG001|Overall Study|Withdrawal by Subject|0|||
47018922|NCT02045095|83267787|FG002|Overall Study|Withdrawal by Subject|0|||
47018923|NCT02045095|83267788|FG003|Overall Study|Withdrawal by Subject|0|||
47018924|NCT02045095|83267789|FG004|Overall Study|Withdrawal by Subject|3|||
47018925|NCT02045095|83267790|FG005|Overall Study|Withdrawal by Subject|0|||
47018926|NCT02045095|83267791|FG006|Overall Study|Withdrawal by Subject|0|||
47018927|NCT02045095|83267785|FG000|Overall Study|Adverse Event|0|||
47018928|NCT02045095|83267786|FG001|Overall Study|Adverse Event|1|||
47018929|NCT02045095|83267787|FG002|Overall Study|Adverse Event|1|||
47018930|NCT02045095|83267788|FG003|Overall Study|Adverse Event|0|||
47018931|NCT02045095|83267789|FG004|Overall Study|Adverse Event|0|||
47018932|NCT02045095|83267790|FG005|Overall Study|Adverse Event|2|||
47018933|NCT02045095|83267791|FG006|Overall Study|Adverse Event|0|||
47018934|NCT02181803|83267816|FG000|Overall Study|Withdrawal by Subject|0|||
47018935|NCT02181803|83267817|FG001|Overall Study|Withdrawal by Subject|2|||
47018936|NCT02181803|83267818|FG002|Overall Study|Withdrawal by Subject|0|||
47018937|NCT02181803|83267819|FG003|Overall Study|Withdrawal by Subject|0|||
47018938|NCT02181803|83267820|FG004|Overall Study|Withdrawal by Subject|0|||
47018939|NCT02181803|83267821|FG005|Overall Study|Withdrawal by Subject|0|||
47018940|NCT02181803|83267822|FG006|Overall Study|Withdrawal by Subject|0|||
47018941|NCT02181803|83267823|FG007|Overall Study|Withdrawal by Subject|0|||
47018942|NCT02181803|83267824|FG008|Overall Study|Withdrawal by Subject|0|||
47018943|NCT02181803|83267816|FG000|Overall Study|Physician Decision|0|||
47018944|NCT02181803|83267817|FG001|Overall Study|Physician Decision|0|||
47018945|NCT02181803|83267818|FG002|Overall Study|Physician Decision|0|||
47018946|NCT02181803|83267819|FG003|Overall Study|Physician Decision|1|||
47018947|NCT02181803|83267820|FG004|Overall Study|Physician Decision|0|||
47018948|NCT02181803|83267821|FG005|Overall Study|Physician Decision|0|||
47018949|NCT02181803|83267822|FG006|Overall Study|Physician Decision|0|||
47018950|NCT02181803|83267823|FG007|Overall Study|Physician Decision|1|||
47018951|NCT02181803|83267824|FG008|Overall Study|Physician Decision|0|||
47018952|NCT02181803|83267816|FG000|Overall Study|Adverse Event|0|||
47018953|NCT02181803|83267817|FG001|Overall Study|Adverse Event|2|||
47018954|NCT02181803|83267818|FG002|Overall Study|Adverse Event|0|||
47018955|NCT02181803|83267819|FG003|Overall Study|Adverse Event|1|||
47018956|NCT02181803|83267820|FG004|Overall Study|Adverse Event|0|||
47018957|NCT02181803|83267821|FG005|Overall Study|Adverse Event|0|||
47018958|NCT02181803|83267822|FG006|Overall Study|Adverse Event|1|||
47018959|NCT02181803|83267823|FG007|Overall Study|Adverse Event|0|||
47018960|NCT02181803|83267824|FG008|Overall Study|Adverse Event|0|||
47018961|NCT01826487|83267871|FG000|Overall Study|Adverse Event|1|||
47018962|NCT01826487|83267872|FG001|Overall Study|Adverse Event|1|||
47018963|NCT01826487|83267871|FG000|Overall Study|Lost to Follow-up|1|||
47018964|NCT01826487|83267872|FG001|Overall Study|Lost to Follow-up|0|||
47018965|NCT01826487|83267871|FG000|Overall Study|Withdrawal by Subject|1|||
47018966|NCT01826487|83267872|FG001|Overall Study|Withdrawal by Subject|3|||
47018967|NCT01826487|83267871|FG000|Overall Study|Protocol Violation|1|||
47018968|NCT01826487|83267872|FG001|Overall Study|Protocol Violation|1|||
47018969|NCT02064439|83267882|FG000|Overall Study|Adverse Event|51|||
47018970|NCT02064439|83267883|FG001|Overall Study|Adverse Event|47|||
47018971|NCT02064439|83267884|FG002|Overall Study|Adverse Event|46|||
47018972|NCT02064439|83267882|FG000|Overall Study|Death|0|||
47018973|NCT02064439|83267883|FG001|Overall Study|Death|2|||
47018974|NCT02064439|83267884|FG002|Overall Study|Death|3|||
47018975|NCT02064439|83267882|FG000|Overall Study|Withdrawal by Subject|29|||
47018976|NCT02064439|83267883|FG001|Overall Study|Withdrawal by Subject|18|||
47018977|NCT02064439|83267884|FG002|Overall Study|Withdrawal by Subject|26|||
47018978|NCT02064439|83267882|FG000|Overall Study|Protocol Violation|3|||
47018979|NCT02064439|83267883|FG001|Overall Study|Protocol Violation|5|||
47018980|NCT02064439|83267884|FG002|Overall Study|Protocol Violation|3|||
47018981|NCT02064439|83267882|FG000|Overall Study|Lost to Follow-up|1|||
47018982|NCT02064439|83267883|FG001|Overall Study|Lost to Follow-up|3|||
47018983|NCT02064439|83267884|FG002|Overall Study|Lost to Follow-up|4|||
47018984|NCT02064439|83267882|FG000|Overall Study|Non-compliance with study medication|21|||
47018985|NCT02064439|83267883|FG001|Overall Study|Non-compliance with study medication|19|||
47018986|NCT02064439|83267884|FG002|Overall Study|Non-compliance with study medication|23|||
46911068|NCT01667133|83140705|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
46911069|NCT01667133|83140706|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
46911070|NCT01667133|83140707|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
46911071|NCT01667133|83140708|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
46911072|NCT01667133|83140709|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
46911073|NCT01667133|83140710|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
46911074|NCT01667133|83140711|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
46911075|NCT01667133|83140712|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
46911076|NCT01667133|83140713|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
47018987|NCT02064439|83267882|FG000|Overall Study|Physician Decision|0|||
47018988|NCT02064439|83267883|FG001|Overall Study|Physician Decision|1|||
47018989|NCT02064439|83267884|FG002|Overall Study|Physician Decision|1|||
47018990|NCT02064439|83267882|FG000|Overall Study|Logistical difficulties|6|||
47018991|NCT02064439|83267883|FG001|Overall Study|Logistical difficulties|5|||
47018992|NCT02064439|83267884|FG002|Overall Study|Logistical difficulties|2|||
47018993|NCT02064439|83267882|FG000|Overall Study|Efficacy outcome reached|18|||
47018994|NCT02064439|83267883|FG001|Overall Study|Efficacy outcome reached|16|||
47018995|NCT02064439|83267884|FG002|Overall Study|Efficacy outcome reached|57|||
46911077|NCT01667133|83140714|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
46911078|NCT01667133|83140703|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
47018996|NCT02064439|83267882|FG000|Overall Study|Safety outcome reached|12|||
47018997|NCT02064439|83267883|FG001|Overall Study|Safety outcome reached|20|||
47018998|NCT02064439|83267884|FG002|Overall Study|Safety outcome reached|10|||
47018999|NCT02064439|83267882|FG000|Overall Study|Other|2|||
47019000|NCT02064439|83267883|FG001|Overall Study|Other|2|||
47019001|NCT02064439|83267884|FG002|Overall Study|Other|7|||
47019002|NCT02130557|83267894|FG000|Overall Study|Withdrawal by Subject|12|||
47019003|NCT02130557|83267895|FG001|Overall Study|Withdrawal by Subject|12|||
47019004|NCT02130557|83267894|FG000|Overall Study|Investigator Request|0|||
47019005|NCT02130557|83267895|FG001|Overall Study|Investigator Request|2|||
47019006|NCT02130557|83267894|FG000|Overall Study|Deceased|14|||
47019007|NCT02130557|83267895|FG001|Overall Study|Deceased|14|||
47019008|NCT02130557|83267894|FG000|Overall Study|Lost to Follow-up|6|||
47019009|NCT02130557|83267895|FG001|Overall Study|Lost to Follow-up|7|||
47019010|NCT02130557|83267894|FG000|Overall Study|Other|2|||
47019011|NCT02130557|83267895|FG001|Overall Study|Other|1|||
47019012|NCT02130557|83267894|FG000|Overall Study|Missing|2|||
47019013|NCT02130557|83267895|FG001|Overall Study|Missing|1|||
47019014|NCT01854645|83267906|FG000|Overall Study|Protocol-Specified Criteria|13|||
47019015|NCT01854645|83267907|FG001|Overall Study|Protocol-Specified Criteria|10|||
47019016|NCT01854645|83267908|FG002|Overall Study|Protocol-Specified Criteria|8|||
47019017|NCT01854645|83267909|FG003|Overall Study|Protocol-Specified Criteria|5|||
47019018|NCT01854645|83267910|FG004|Overall Study|Protocol-Specified Criteria|7|||
47019019|NCT01854645|83267906|FG000|Overall Study|Administrative Reasons / Missing|0|||
47019020|NCT01854645|83267907|FG001|Overall Study|Administrative Reasons / Missing|0|||
47019021|NCT01854645|83267908|FG002|Overall Study|Administrative Reasons / Missing|0|||
47019022|NCT01854645|83267909|FG003|Overall Study|Administrative Reasons / Missing|1|||
47019023|NCT01854645|83267910|FG004|Overall Study|Administrative Reasons / Missing|1|||
47019024|NCT01854645|83267906|FG000|Overall Study|Protocol Violation|3|||
47019025|NCT01854645|83267907|FG001|Overall Study|Protocol Violation|0|||
47019026|NCT01854645|83267908|FG002|Overall Study|Protocol Violation|5|||
47019027|NCT01854645|83267909|FG003|Overall Study|Protocol Violation|4|||
47019028|NCT01854645|83267910|FG004|Overall Study|Protocol Violation|1|||
47019029|NCT01854645|83267906|FG000|Overall Study|Lost to Follow-up|10|||
47019030|NCT01854645|83267907|FG001|Overall Study|Lost to Follow-up|7|||
47019031|NCT01854645|83267908|FG002|Overall Study|Lost to Follow-up|8|||
47019032|NCT01854645|83267909|FG003|Overall Study|Lost to Follow-up|5|||
47019033|NCT01854645|83267910|FG004|Overall Study|Lost to Follow-up|0|||
47019034|NCT01854645|83267906|FG000|Overall Study|Physician Decision|1|||
47019035|NCT01854645|83267907|FG001|Overall Study|Physician Decision|5|||
47019036|NCT01854645|83267908|FG002|Overall Study|Physician Decision|3|||
47019037|NCT01854645|83267909|FG003|Overall Study|Physician Decision|3|||
47019038|NCT01854645|83267910|FG004|Overall Study|Physician Decision|7|||
47019039|NCT01854645|83267906|FG000|Overall Study|Withdrawal by Subject|31|||
47019040|NCT01854645|83267907|FG001|Overall Study|Withdrawal by Subject|41|||
47019041|NCT01854645|83267908|FG002|Overall Study|Withdrawal by Subject|30|||
47019042|NCT01854645|83267909|FG003|Overall Study|Withdrawal by Subject|21|||
47019043|NCT01854645|83267910|FG004|Overall Study|Withdrawal by Subject|24|||
47019044|NCT01854645|83267906|FG000|Overall Study|Lack of Efficacy|7|||
47019045|NCT01854645|83267907|FG001|Overall Study|Lack of Efficacy|12|||
47019046|NCT01854645|83267908|FG002|Overall Study|Lack of Efficacy|9|||
47019047|NCT01854645|83267909|FG003|Overall Study|Lack of Efficacy|3|||
47019048|NCT01854645|83267910|FG004|Overall Study|Lack of Efficacy|9|||
47019049|NCT01854645|83267906|FG000|Overall Study|Adverse Event|33|||
47019050|NCT01854645|83267907|FG001|Overall Study|Adverse Event|31|||
47019051|NCT01854645|83267908|FG002|Overall Study|Adverse Event|19|||
47019052|NCT01854645|83267909|FG003|Overall Study|Adverse Event|20|||
47019053|NCT01854645|83267910|FG004|Overall Study|Adverse Event|11|||
47019054|NCT01825941|83267924|FG000|Overall Study|Lost to Follow-up|4|||
47019055|NCT01825941|83267925|FG001|Overall Study|Lost to Follow-up|1|||
47019056|NCT02064205|83267931|FG000|Overall Study|Withdrawal by Subject|1|||
47019057|NCT02090959|83267947|FG000|Overall Study|Withdrawal by Subject|10|||
47019058|NCT02090959|83267947|FG000|Overall Study|Adverse Event|1|||
47019059|NCT02090959|83267947|FG000|Overall Study|Investigator decision|2|||
47019060|NCT02090959|83267947|FG000|Overall Study|Study termination|6|||
47019061|NCT02090959|83267947|FG000|Overall Study|Enrolled but not treated|1|||
47019062|NCT02090959|83267947|FG000|Overall Study|Transfer for compassionate use medicine|4|||
47019063|NCT02090959|83267947|FG000|Overall Study|Move to medical need program|3|||
47019064|NCT02090959|83267947|FG000|Overall Study|Entered in to other study|34|||
46709731|NCT01142232|82925828|FG001|Overall Study|Alternative Therapy|1|||
47019065|NCT02090959|83267947|FG000|Overall Study|Switched to commercial supply|88|||
47019066|NCT02090959|83267947|FG000|Overall Study|Other than specified|2|||
47019067|NCT02044159|83267953|FG000|Overall Study|Consent declined (deferred consent)|2|||
47019068|NCT02044159|83267954|FG001|Overall Study|Consent declined (deferred consent)|4|||
47019069|NCT02044159|83267953|FG000|Overall Study|No longer eligible, drug not given|1|||
47019070|NCT02044159|83267954|FG001|Overall Study|No longer eligible, drug not given|0|||
47019071|NCT02044159|83267953|FG000|Overall Study|Nurse declined to give study drug|1|||
47019072|NCT02044159|83267954|FG001|Overall Study|Nurse declined to give study drug|0|||
47019073|NCT02090725|83267963|FG000|Overall Study|Withdrawal by Subject|1|||
47019074|NCT02090725|83267963|FG000|Overall Study|participants moved from area|3|||
47019075|NCT02180165|83267971|FG000|Overall Study|Not Treated|0|||
47019076|NCT02180165|83267972|FG001|Overall Study|Not Treated|0|||
47019077|NCT02180165|83267973|FG002|Overall Study|Not Treated|1|||
47019078|NCT02180165|83267974|FG003|Overall Study|Not Treated|0|||
47019079|NCT02180165|83267971|FG000|Overall Study|Adverse Event|7|||
47019080|NCT02180165|83267972|FG001|Overall Study|Adverse Event|0|||
47019081|NCT02180165|83267973|FG002|Overall Study|Adverse Event|18|||
47019082|NCT02180165|83267974|FG003|Overall Study|Adverse Event|3|||
47019083|NCT02180165|83267971|FG000|Overall Study|Lack of Efficacy|0|||
47019084|NCT02180165|83267972|FG001|Overall Study|Lack of Efficacy|1|||
47019085|NCT02180165|83267973|FG002|Overall Study|Lack of Efficacy|3|||
47019086|NCT02180165|83267974|FG003|Overall Study|Lack of Efficacy|2|||
47019087|NCT02180165|83267971|FG000|Overall Study|Physician Decision|1|||
47019088|NCT02180165|83267972|FG001|Overall Study|Physician Decision|0|||
47019089|NCT02180165|83267973|FG002|Overall Study|Physician Decision|5|||
47019090|NCT02180165|83267974|FG003|Overall Study|Physician Decision|0|||
47019091|NCT02180165|83267971|FG000|Overall Study|Withdrawal by Subject|3|||
47019092|NCT02180165|83267972|FG001|Overall Study|Withdrawal by Subject|0|||
47019093|NCT02180165|83267973|FG002|Overall Study|Withdrawal by Subject|2|||
47019094|NCT02180165|83267974|FG003|Overall Study|Withdrawal by Subject|1|||
47019095|NCT02155985|83267989|FG000|Overall Study|Withdrawal by Subject|0|||
47019096|NCT02155985|83267990|FG001|Overall Study|Withdrawal by Subject|0|||
47019097|NCT02155985|83267991|FG002|Overall Study|Withdrawal by Subject|1|||
47019098|NCT02155985|83267989|FG000|Overall Study|Lost to Follow-up|1|||
47019099|NCT02155985|83267990|FG001|Overall Study|Lost to Follow-up|0|||
47019100|NCT02155985|83267991|FG002|Overall Study|Lost to Follow-up|0|||
47019101|NCT02155829|83268001|FG000|Overall Study|Adverse Event|1|||
47019102|NCT02155829|83268002|FG001|Overall Study|Adverse Event|0|||
47019103|NCT02155829|83268001|FG000|Overall Study|Withdrawal by Subject|3|||
47019104|NCT02155829|83268002|FG001|Overall Study|Withdrawal by Subject|3|||
47019105|NCT02155829|83268001|FG000|Overall Study|Protocol Violation|2|||
47019106|NCT02155829|83268002|FG001|Overall Study|Protocol Violation|0|||
47019107|NCT02129777|83268014|FG000|Double-Blind Period|Adverse Event|0|||
47019108|NCT02129777|83268015|FG001|Double-Blind Period|Adverse Event|0|||
47019109|NCT02129777|83268016|FG002|Double-Blind Period|Adverse Event|0|||
47019110|NCT02129777|83268017|FG003|Double-Blind Period|Adverse Event|0|||
47019111|NCT02129777|83268018|FG004|Double-Blind Period|Adverse Event|1|||
47019112|NCT02129777|83268019|FG005|Double-Blind Period|Adverse Event|0|||
47019113|NCT02129777|83268020|FG006|Double-Blind Period|Adverse Event|0|||
47019114|NCT02129777|83268014|FG000|Double-Blind Period|Lost to Follow-up|1|||
47019115|NCT02129777|83268015|FG001|Double-Blind Period|Lost to Follow-up|1|||
47019116|NCT02129777|83268016|FG002|Double-Blind Period|Lost to Follow-up|1|||
47019117|NCT02129777|83268017|FG003|Double-Blind Period|Lost to Follow-up|2|||
47019118|NCT02129777|83268018|FG004|Double-Blind Period|Lost to Follow-up|0|||
47019119|NCT02129777|83268019|FG005|Double-Blind Period|Lost to Follow-up|0|||
47019120|NCT02129777|83268020|FG006|Double-Blind Period|Lost to Follow-up|0|||
47019121|NCT02129777|83268014|FG000|Double-Blind Period|Withdrawal by Subject|2|||
47019122|NCT02129777|83268015|FG001|Double-Blind Period|Withdrawal by Subject|4|||
47019123|NCT02129777|83268016|FG002|Double-Blind Period|Withdrawal by Subject|3|||
47019124|NCT02129777|83268017|FG003|Double-Blind Period|Withdrawal by Subject|2|||
47019125|NCT02129777|83268018|FG004|Double-Blind Period|Withdrawal by Subject|3|||
47019126|NCT02129777|83268019|FG005|Double-Blind Period|Withdrawal by Subject|0|||
47019127|NCT02129777|83268020|FG006|Double-Blind Period|Withdrawal by Subject|0|||
47019128|NCT02129777|83268014|FG000|Double-Blind Period|Pregnancy|0|||
47019129|NCT02129777|83268015|FG001|Double-Blind Period|Pregnancy|0|||
47019130|NCT02129777|83268016|FG002|Double-Blind Period|Pregnancy|0|||
46620584|NCT02265510|82770875|FG000|Overall Study|Withdrawal by Subject|1|||
46620585|NCT02265510|82770876|FG001|Overall Study|Withdrawal by Subject|1|||
47019131|NCT02129777|83268017|FG003|Double-Blind Period|Pregnancy|0|||
47019132|NCT02129777|83268018|FG004|Double-Blind Period|Pregnancy|1|||
47019133|NCT02129777|83268019|FG005|Double-Blind Period|Pregnancy|0|||
47019134|NCT02129777|83268020|FG006|Double-Blind Period|Pregnancy|0|||
47019135|NCT02129777|83268014|FG000|Double-Blind Period|Lack of Efficacy|3|||
47019136|NCT02129777|83268015|FG001|Double-Blind Period|Lack of Efficacy|1|||
47019137|NCT02129777|83268016|FG002|Double-Blind Period|Lack of Efficacy|0|||
47019138|NCT02129777|83268017|FG003|Double-Blind Period|Lack of Efficacy|3|||
47019139|NCT02129777|83268018|FG004|Double-Blind Period|Lack of Efficacy|2|||
47019140|NCT02129777|83268019|FG005|Double-Blind Period|Lack of Efficacy|0|||
47019141|NCT02129777|83268020|FG006|Double-Blind Period|Lack of Efficacy|0|||
47019142|NCT02129777|83268014|FG000|Double-Blind Period|Other|1|||
47019143|NCT02129777|83268015|FG001|Double-Blind Period|Other|2|||
47019144|NCT02129777|83268016|FG002|Double-Blind Period|Other|0|||
47019145|NCT02129777|83268017|FG003|Double-Blind Period|Other|0|||
47019146|NCT02129777|83268018|FG004|Double-Blind Period|Other|0|||
47019147|NCT02129777|83268019|FG005|Double-Blind Period|Other|0|||
47019148|NCT02129777|83268020|FG006|Double-Blind Period|Other|0|||
47019149|NCT02129777|83268014|FG000|Open-Label Period|Lack of Efficacy|0|||
47019150|NCT02129777|83268015|FG001|Open-Label Period|Lack of Efficacy|0|||
47019151|NCT02129777|83268016|FG002|Open-Label Period|Lack of Efficacy|0|||
47019152|NCT02129777|83268017|FG003|Open-Label Period|Lack of Efficacy|0|||
47019153|NCT02129777|83268018|FG004|Open-Label Period|Lack of Efficacy|0|||
47019154|NCT02129777|83268019|FG005|Open-Label Period|Lack of Efficacy|0|||
47019155|NCT02129777|83268020|FG006|Open-Label Period|Lack of Efficacy|5|||
47019156|NCT02129777|83268014|FG000|Open-Label Period|Lost to Follow-up|0|||
47019157|NCT02129777|83268015|FG001|Open-Label Period|Lost to Follow-up|0|||
47019158|NCT02129777|83268016|FG002|Open-Label Period|Lost to Follow-up|0|||
47019159|NCT02129777|83268017|FG003|Open-Label Period|Lost to Follow-up|0|||
47019160|NCT02129777|83268018|FG004|Open-Label Period|Lost to Follow-up|0|||
47019161|NCT02129777|83268019|FG005|Open-Label Period|Lost to Follow-up|1|||
47019162|NCT02129777|83268020|FG006|Open-Label Period|Lost to Follow-up|1|||
47019163|NCT02129777|83268014|FG000|Open-Label Period|Withdrawal by Subject|0|||
47019164|NCT02129777|83268015|FG001|Open-Label Period|Withdrawal by Subject|0|||
47019165|NCT02129777|83268016|FG002|Open-Label Period|Withdrawal by Subject|0|||
47019166|NCT02129777|83268017|FG003|Open-Label Period|Withdrawal by Subject|0|||
47019167|NCT02129777|83268018|FG004|Open-Label Period|Withdrawal by Subject|0|||
47019168|NCT02129777|83268019|FG005|Open-Label Period|Withdrawal by Subject|1|||
47019169|NCT02129777|83268020|FG006|Open-Label Period|Withdrawal by Subject|3|||
46911079|NCT01667133|83140704|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911080|NCT01667133|83140705|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911081|NCT01667133|83140706|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911082|NCT01667133|83140707|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911083|NCT01667133|83140708|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911084|NCT01667133|83140709|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911085|NCT01667133|83140710|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911086|NCT01667133|83140711|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911087|NCT01667133|83140712|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
46911088|NCT01667133|83140713|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911089|NCT01667133|83140714|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
46911090|NCT01667133|83140703|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
46911091|NCT01667133|83140704|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
46911092|NCT01667133|83140705|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
46911093|NCT01667133|83140706|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
47019170|NCT02129777|83268014|FG000|Open-Label Period|Study Termination|0|||
47019171|NCT02129777|83268015|FG001|Open-Label Period|Study Termination|0|||
47019172|NCT02129777|83268016|FG002|Open-Label Period|Study Termination|0|||
47019173|NCT02129777|83268017|FG003|Open-Label Period|Study Termination|0|||
47019174|NCT02129777|83268018|FG004|Open-Label Period|Study Termination|0|||
47019175|NCT02129777|83268019|FG005|Open-Label Period|Study Termination|10|||
47019176|NCT02129777|83268020|FG006|Open-Label Period|Study Termination|39|||
47019177|NCT02178995|83268041|FG000|Double Blind|Adverse Event|0|||
47019178|NCT02178995|83268042|FG001|Double Blind|Adverse Event|0|||
47019179|NCT02178995|83268043|FG002|Double Blind|Adverse Event|0|||
47019180|NCT02178995|83268044|FG003|Double Blind|Adverse Event|0|||
47019181|NCT02178995|83268045|FG004|Double Blind|Adverse Event|0|||
47019182|NCT02178995|83268046|FG005|Double Blind|Adverse Event|1|||
47019183|NCT02178995|83268047|FG006|Double Blind|Adverse Event|0|||
47019184|NCT02178995|83268048|FG007|Double Blind|Adverse Event|1|||
47019185|NCT02178995|83268049|FG008|Double Blind|Adverse Event|1|||
47019186|NCT02178995|83268041|FG000|Double Blind|Lost to Follow-up|0|||
47019187|NCT02178995|83268042|FG001|Double Blind|Lost to Follow-up|1|||
47019188|NCT02178995|83268043|FG002|Double Blind|Lost to Follow-up|0|||
47019189|NCT02178995|83268044|FG003|Double Blind|Lost to Follow-up|0|||
47019190|NCT02178995|83268045|FG004|Double Blind|Lost to Follow-up|0|||
47019191|NCT02178995|83268046|FG005|Double Blind|Lost to Follow-up|0|||
47019192|NCT02178995|83268047|FG006|Double Blind|Lost to Follow-up|0|||
47019193|NCT02178995|83268048|FG007|Double Blind|Lost to Follow-up|1|||
47019194|NCT02178995|83268049|FG008|Double Blind|Lost to Follow-up|0|||
47019195|NCT02178995|83268041|FG000|Open Label|Adverse Event|2|||
47019196|NCT02178995|83268042|FG001|Open Label|Adverse Event|0|||
47019197|NCT02178995|83268043|FG002|Open Label|Adverse Event|0|||
47019198|NCT02178995|83268044|FG003|Open Label|Adverse Event|0|||
47019199|NCT02178995|83268045|FG004|Open Label|Adverse Event|0|||
47019200|NCT02178995|83268046|FG005|Open Label|Adverse Event|0|||
47019201|NCT02178995|83268047|FG006|Open Label|Adverse Event|0|||
47019202|NCT02178995|83268048|FG007|Open Label|Adverse Event|0|||
47019203|NCT02178995|83268049|FG008|Open Label|Adverse Event|0|||
47019204|NCT02128997|83268075|FG000|Overall Study|Lost to Follow-up|6|||
47019205|NCT02128997|83268076|FG001|Overall Study|Lost to Follow-up|11|||
47019206|NCT02155283|83268082|FG000|Overall Study|Lost to Follow-up|3|||
47019207|NCT02155283|83268082|FG000|Overall Study|Withdrawal by Subject|1|||
47019208|NCT02155283|83268082|FG000|Overall Study|Protocol Violation|3|||
47019209|NCT02154581|83268088|FG000|Overall Study|Lost to Follow-up|7|||
47019210|NCT02154581|83268089|FG001|Overall Study|Lost to Follow-up|8|||
47019211|NCT02154425|83268097|FG000|Screening Period|Adverse Event|1|||
47019212|NCT02154347|83268107|FG000|Double-blind Period|Adverse Event|1|||
47019213|NCT02154347|83268108|FG001|Double-blind Period|Adverse Event|2|||
47019214|NCT02154347|83268107|FG000|Double-blind Period|Lack of Efficacy|1|||
47019215|NCT02154347|83268108|FG001|Double-blind Period|Lack of Efficacy|0|||
47019216|NCT02154347|83268107|FG000|Double-blind Period|Physician Decision|0|||
47019217|NCT02154347|83268108|FG001|Double-blind Period|Physician Decision|1|||
47019218|NCT02154347|83268107|FG000|Double-blind Period|Withdrawal by Subject|1|||
47019219|NCT02154347|83268108|FG001|Double-blind Period|Withdrawal by Subject|1|||
47019220|NCT02154347|83268107|FG000|Open-label Period|Adverse Event|3|||
47019221|NCT02154347|83268108|FG001|Open-label Period|Adverse Event|4|||
47019222|NCT02154347|83268107|FG000|Open-label Period|Lack of Efficacy|4|||
47019223|NCT02154347|83268108|FG001|Open-label Period|Lack of Efficacy|19|||
47019224|NCT02154347|83268107|FG000|Open-label Period|Protocol Violation|0|||
47019225|NCT02154347|83268108|FG001|Open-label Period|Protocol Violation|1|||
47019226|NCT02154347|83268107|FG000|Open-label Period|Withdrawal by Subject|0|||
47019227|NCT02154347|83268108|FG001|Open-label Period|Withdrawal by Subject|1|||
47019228|NCT01627067|83268115|FG000|Overall Study|Screen Failure|1|||
47019229|NCT02178059|83268121|FG000|Washout|Physician Decision|1|||
47019230|NCT02178059|83268122|FG001|Washout|Physician Decision|0|||
47019231|NCT01626989|83268128|FG000|Screening Period|Screen Failure|15|||
47019232|NCT01626989|83268129|FG001|Screening Period|Screen Failure|0|||
47019233|NCT01626989|83268130|FG002|Screening Period|Screen Failure|0|||
47019234|NCT01626989|83268128|FG000|Screening Period|Withdrawal by Subject|2|||
47019235|NCT01626989|83268129|FG001|Screening Period|Withdrawal by Subject|0|||
47019236|NCT01626989|83268130|FG002|Screening Period|Withdrawal by Subject|0|||
47019237|NCT02128217|83268141|FG000|Overall Study|Lost to Follow-up|0|||
47019238|NCT02128217|83268142|FG001|Overall Study|Lost to Follow-up|1|||
47019239|NCT01629953|83268155|FG000|Overall Study|Death|3|||
47019240|NCT01629953|83268156|FG001|Overall Study|Death|1|||
47019241|NCT01629953|83268155|FG000|Overall Study|Lost to Follow-up|10|||
47019242|NCT01629953|83268156|FG001|Overall Study|Lost to Follow-up|14|||
47019243|NCT02127281|83268164|FG000|Overall Study|Lost to Follow-up|1|||
47019244|NCT02127281|83268165|FG001|Overall Study|Lost to Follow-up|0|||
47019245|NCT01628549|83268175|FG000|Overall Study|Adverse Event|1|||
47019246|NCT01628549|83268176|FG001|Overall Study|Adverse Event|1|||
47019247|NCT01628549|83268177|FG002|Overall Study|Adverse Event|0|||
47019248|NCT01628549|83268178|FG003|Overall Study|Adverse Event|4|||
47019249|NCT01628549|83268175|FG000|Overall Study|Lost to Follow-up|3|||
47019250|NCT01628549|83268176|FG001|Overall Study|Lost to Follow-up|4|||
47019251|NCT01628549|83268177|FG002|Overall Study|Lost to Follow-up|3|||
47019252|NCT01628549|83268178|FG003|Overall Study|Lost to Follow-up|3|||
47019253|NCT01628549|83268175|FG000|Overall Study|Withdrawal by Subject|3|||
47019254|NCT01628549|83268176|FG001|Overall Study|Withdrawal by Subject|4|||
47019255|NCT01628549|83268177|FG002|Overall Study|Withdrawal by Subject|4|||
47019256|NCT01628549|83268178|FG003|Overall Study|Withdrawal by Subject|1|||
47019257|NCT01628549|83268175|FG000|Overall Study|Protocol Violation|2|||
47019258|NCT01628549|83268176|FG001|Overall Study|Protocol Violation|1|||
47019259|NCT01628549|83268177|FG002|Overall Study|Protocol Violation|1|||
47019260|NCT01628549|83268178|FG003|Overall Study|Protocol Violation|0|||
47019261|NCT01628549|83268175|FG000|Overall Study|withdrawn for noncompliance|0|||
47019262|NCT01628549|83268176|FG001|Overall Study|withdrawn for noncompliance|2|||
47019263|NCT01628549|83268177|FG002|Overall Study|withdrawn for noncompliance|1|||
47019264|NCT01628549|83268178|FG003|Overall Study|withdrawn for noncompliance|0|||
47019265|NCT01628549|83268175|FG000|Overall Study|abnormal laboratory test results|0|||
47019266|NCT01628549|83268176|FG001|Overall Study|abnormal laboratory test results|0|||
47019267|NCT01628549|83268177|FG002|Overall Study|abnormal laboratory test results|1|||
47019268|NCT01628549|83268178|FG003|Overall Study|abnormal laboratory test results|0|||
47019269|NCT01628549|83268175|FG000|Overall Study|positive pregnancy test|0|||
47019270|NCT01628549|83268176|FG001|Overall Study|positive pregnancy test|0|||
47019271|NCT01628549|83268177|FG002|Overall Study|positive pregnancy test|0|||
47019272|NCT01628549|83268178|FG003|Overall Study|positive pregnancy test|1|||
47019273|NCT02127125|83268197|FG000|Overall Study|Lost to Follow-up|0|||
47019274|NCT02127125|83268198|FG001|Overall Study|Lost to Follow-up|0|||
47019275|NCT02127125|83268199|FG002|Overall Study|Lost to Follow-up|0|||
47019276|NCT02127125|83268200|FG003|Overall Study|Lost to Follow-up|0|||
47019277|NCT02127125|83268201|FG004|Overall Study|Lost to Follow-up|2|||
47019278|NCT02127125|83268202|FG005|Overall Study|Lost to Follow-up|1|||
47019279|NCT02127125|83268203|FG006|Overall Study|Lost to Follow-up|0|||
47019280|NCT02127125|83268204|FG007|Overall Study|Lost to Follow-up|0|||
47019281|NCT02127125|83268205|FG008|Overall Study|Lost to Follow-up|0|||
47019282|NCT02127125|83268197|FG000|Overall Study|Withdrawal by Subject|0|||
47019283|NCT02127125|83268198|FG001|Overall Study|Withdrawal by Subject|0|||
47019284|NCT02127125|83268199|FG002|Overall Study|Withdrawal by Subject|0|||
47019285|NCT02127125|83268200|FG003|Overall Study|Withdrawal by Subject|1|||
47019286|NCT02127125|83268201|FG004|Overall Study|Withdrawal by Subject|0|||
47019287|NCT02127125|83268202|FG005|Overall Study|Withdrawal by Subject|0|||
47019288|NCT02127125|83268203|FG006|Overall Study|Withdrawal by Subject|0|||
47019289|NCT02127125|83268204|FG007|Overall Study|Withdrawal by Subject|0|||
47019290|NCT02127125|83268205|FG008|Overall Study|Withdrawal by Subject|0|||
47019291|NCT02127125|83268197|FG000|Overall Study|Physician Decision|0|||
47019292|NCT02127125|83268198|FG001|Overall Study|Physician Decision|0|||
47019293|NCT02127125|83268199|FG002|Overall Study|Physician Decision|1|||
47019294|NCT02127125|83268200|FG003|Overall Study|Physician Decision|0|||
47019295|NCT02127125|83268201|FG004|Overall Study|Physician Decision|1|||
47019296|NCT02127125|83268202|FG005|Overall Study|Physician Decision|2|||
47019297|NCT02127125|83268203|FG006|Overall Study|Physician Decision|0|||
47019298|NCT02127125|83268204|FG007|Overall Study|Physician Decision|0|||
47019299|NCT02127125|83268205|FG008|Overall Study|Physician Decision|0|||
47019300|NCT02090413|83268228|FG000|Overall Study|Adverse Event|11|||
47019301|NCT02090413|83268229|FG001|Overall Study|Adverse Event|15|||
47019302|NCT02090413|83268230|FG002|Overall Study|Adverse Event|20|||
47019303|NCT02090413|83268228|FG000|Overall Study|Flushing event|2|||
47019304|NCT02090413|83268229|FG001|Overall Study|Flushing event|0|||
47019305|NCT02090413|83268230|FG002|Overall Study|Flushing event|1|||
47019306|NCT02090413|83268228|FG000|Overall Study|Withdrawal by Subject|2|||
47019307|NCT02090413|83268229|FG001|Overall Study|Withdrawal by Subject|2|||
47019308|NCT02090413|83268230|FG002|Overall Study|Withdrawal by Subject|2|||
47019309|NCT02090413|83268228|FG000|Overall Study|Investigator Decision|1|||
47019310|NCT02090413|83268229|FG001|Overall Study|Investigator Decision|1|||
47019311|NCT02090413|83268230|FG002|Overall Study|Investigator Decision|0|||
47019312|NCT02090413|83268228|FG000|Overall Study|Other|2|||
47019313|NCT02090413|83268229|FG001|Overall Study|Other|1|||
47019314|NCT02090413|83268230|FG002|Overall Study|Other|0|||
47019315|NCT02090413|83268228|FG000|Overall Study|Lost to Follow-up|1|||
47019316|NCT02090413|83268229|FG001|Overall Study|Lost to Follow-up|1|||
47019317|NCT02090413|83268230|FG002|Overall Study|Lost to Follow-up|0|||
47019318|NCT02063737|83268241|FG000|Overall Study|Lost to Follow-up|11|||
47019319|NCT02063737|83268242|FG001|Overall Study|Lost to Follow-up|4|||
47019320|NCT02125877|83268250|FG000|Overall Study|Physician Decision|1|||
47019321|NCT02125877|83268251|FG001|Overall Study|Physician Decision|0|||
47019322|NCT02125877|83268250|FG000|Overall Study|Death|0|||
47019323|NCT02125877|83268251|FG001|Overall Study|Death|1|||
47019324|NCT02125877|83268250|FG000|Overall Study|Administrative problems|0|||
47019325|NCT02125877|83268251|FG001|Overall Study|Administrative problems|1|||
47019326|NCT02125877|83268250|FG000|Overall Study|Participant/guardian decision|0|||
47019327|NCT02125877|83268251|FG001|Overall Study|Participant/guardian decision|2|||
47019328|NCT02125877|83268250|FG000|Overall Study|Withdrawal by Subject|2|||
47019329|NCT02125877|83268251|FG001|Overall Study|Withdrawal by Subject|1|||
47019330|NCT02125877|83268250|FG000|Overall Study|Protocol deviation|4|||
47019331|NCT02125877|83268251|FG001|Overall Study|Protocol deviation|1|||
47019332|NCT02125877|83268250|FG000|Overall Study|Adverse Event|6|||
47019333|NCT02125877|83268251|FG001|Overall Study|Adverse Event|4|||
47019334|NCT01598987|83268257|FG000|Baseline to Month 12|Administrative problems|2|||
47019335|NCT01598987|83268257|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
47019336|NCT01598987|83268257|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
47019337|NCT01598987|83268257|FG000|Baseline to 24 Month|Administrative problems|2|||
47019338|NCT01598987|83268257|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
47019339|NCT02063659|83268271|FG000|Double-Blind Treatment Period|Adverse Event|1|||
47019340|NCT02063659|83268272|FG001|Double-Blind Treatment Period|Adverse Event|2|||
47019341|NCT02063659|83268273|FG002|Double-Blind Treatment Period|Adverse Event|0|||
47019342|NCT02063659|83268274|FG003|Double-Blind Treatment Period|Adverse Event|0|||
47019343|NCT02063659|83268271|FG000|Double-Blind Treatment Period|Physician Decision|1|||
47019344|NCT02063659|83268272|FG001|Double-Blind Treatment Period|Physician Decision|0|||
47019345|NCT02063659|83268273|FG002|Double-Blind Treatment Period|Physician Decision|0|||
47019346|NCT02063659|83268274|FG003|Double-Blind Treatment Period|Physician Decision|0|||
47019347|NCT02063659|83268271|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
47019348|NCT02063659|83268272|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
47019349|NCT02063659|83268273|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
47019350|NCT02063659|83268274|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
47019351|NCT02063659|83268271|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
47019352|NCT02063659|83268272|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
47019353|NCT02063659|83268273|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
47019354|NCT02063659|83268274|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
47019355|NCT02063659|83268271|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
47019356|NCT02063659|83268272|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
47019357|NCT02063659|83268273|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
47019358|NCT02063659|83268274|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
47019359|NCT02063659|83268271|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
47019360|NCT02063659|83268272|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
47019361|NCT02063659|83268273|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
47019362|NCT02063659|83268274|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
47019363|NCT02063659|83268271|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
47019364|NCT02063659|83268272|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
47019365|NCT02063659|83268273|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
47019366|NCT02063659|83268274|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
47019367|NCT02063659|83268271|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
47019368|NCT02063659|83268272|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
47019369|NCT02063659|83268273|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
47019370|NCT02063659|83268274|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
47019371|NCT02062879|83268290|FG000|Overall Study|Withdrawal by Subject|4|||
47019372|NCT02062879|83268291|FG001|Overall Study|Withdrawal by Subject|1|||
47019373|NCT02062645|83268297|FG000|Overall Study|Adverse Event|2|||
47019374|NCT02062645|83268297|FG000|Overall Study|Protocol Violation|8|||
47019375|NCT02062645|83268297|FG000|Overall Study|Lost to Follow-up|5|||
47019376|NCT02088697|83268303|FG000|Period I|Physician Decision|1|||
47019377|NCT02088697|83268304|FG001|Period I|Physician Decision|4|||
47019378|NCT02088697|83268303|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
47019379|NCT02088697|83268304|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
47019380|NCT01825785|83268317|FG000|Overall Study|Adverse Event|0|||
47019381|NCT01825785|83268318|FG001|Overall Study|Adverse Event|0|||
47019382|NCT01825785|83268319|FG002|Overall Study|Adverse Event|0|||
47019383|NCT01825785|83268320|FG003|Overall Study|Adverse Event|0|||
47019384|NCT01825785|83268321|FG004|Overall Study|Adverse Event|1|||
47019385|NCT01825785|83268322|FG005|Overall Study|Adverse Event|0|||
47019386|NCT01825785|83268323|FG006|Overall Study|Adverse Event|0|||
47019387|NCT01825785|83268317|FG000|Overall Study|Withdrawal by Subject|0|||
47019388|NCT01825785|83268318|FG001|Overall Study|Withdrawal by Subject|0|||
47019389|NCT01825785|83268319|FG002|Overall Study|Withdrawal by Subject|0|||
47019390|NCT01825785|83268320|FG003|Overall Study|Withdrawal by Subject|0|||
47019391|NCT01825785|83268321|FG004|Overall Study|Withdrawal by Subject|1|||
47019392|NCT01825785|83268322|FG005|Overall Study|Withdrawal by Subject|1|||
47019393|NCT01825785|83268323|FG006|Overall Study|Withdrawal by Subject|0|||
47019394|NCT02043301|83268348|FG000|Overall Study|Discontinued|0|||
47019395|NCT02043301|83268349|FG001|Overall Study|Discontinued|1|||
47019396|NCT02043301|83268350|FG002|Overall Study|Discontinued|0|||
47019397|NCT01598753|83268362|FG000|Overall Study|Adverse Event|1|||
47019398|NCT01598753|83268363|FG001|Overall Study|Adverse Event|9|||
47019399|NCT01598753|83268364|FG002|Overall Study|Adverse Event|1|||
47019400|NCT01598753|83268365|FG003|Overall Study|Adverse Event|7|||
47019401|NCT01598753|83268362|FG000|Overall Study|Lost to Follow-up|4|||
47019402|NCT01598753|83268363|FG001|Overall Study|Lost to Follow-up|3|||
47019403|NCT01598753|83268364|FG002|Overall Study|Lost to Follow-up|7|||
47019404|NCT01598753|83268365|FG003|Overall Study|Lost to Follow-up|5|||
47019405|NCT01598753|83268362|FG000|Overall Study|Physician Decision|0|||
46709732|NCT01142232|82925829|FG002|Overall Study|Alternative Therapy|1|||
46709733|NCT01142232|82925830|FG003|Overall Study|Alternative Therapy|0|||
47019406|NCT01598753|83268363|FG001|Overall Study|Physician Decision|1|||
47019407|NCT01598753|83268364|FG002|Overall Study|Physician Decision|0|||
47019408|NCT01598753|83268365|FG003|Overall Study|Physician Decision|2|||
47019409|NCT01598753|83268362|FG000|Overall Study|Withdrawal by Subject|7|||
47019410|NCT01598753|83268363|FG001|Overall Study|Withdrawal by Subject|2|||
47019411|NCT01598753|83268364|FG002|Overall Study|Withdrawal by Subject|0|||
47019412|NCT01598753|83268365|FG003|Overall Study|Withdrawal by Subject|1|||
47019413|NCT02177123|83268375|FG000|Overall Study|Lost to Follow-up|6|||
47019414|NCT02177123|83268375|FG000|Overall Study|Withdrawal by Subject|4|||
47019415|NCT02177123|83268375|FG000|Overall Study|Adverse Event|4|||
47019416|NCT02177123|83268375|FG000|Overall Study|Physician Decision|3|||
47019417|NCT02177123|83268375|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
47019418|NCT02177123|83268375|FG000|Overall Study|Excluded for medical reasons|2|||
47019419|NCT02177123|83268375|FG000|Overall Study|Death|1|||
46709734|NCT01142232|82925831|FG004|Overall Study|Alternative Therapy|1|||
46709735|NCT01142232|82925827|FG000|Overall Study|Off Trt for other complicating disease|0|||
47019420|NCT02177123|83268375|FG000|Overall Study|Other|1|||
47019421|NCT02177123|83268375|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
47019422|NCT01824693|83268385|FG000|Overall Study|Death|0|||
47019423|NCT01824693|83268386|FG001|Overall Study|Death|1|||
47019424|NCT01824693|83268387|FG002|Overall Study|Death|0|||
47019425|NCT01824693|83268385|FG000|Overall Study|Physician Decision|1|||
47019426|NCT01824693|83268386|FG001|Overall Study|Physician Decision|1|||
47019427|NCT01824693|83268387|FG002|Overall Study|Physician Decision|1|||
47019428|NCT01824693|83268385|FG000|Overall Study|Withdrawal by Subject|0|||
47019429|NCT01824693|83268386|FG001|Overall Study|Withdrawal by Subject|0|||
47019430|NCT01824693|83268387|FG002|Overall Study|Withdrawal by Subject|1|||
47019431|NCT01824693|83268385|FG000|Overall Study|Progressive Disease|0|||
47019432|NCT01824693|83268386|FG001|Overall Study|Progressive Disease|5|||
47019433|NCT01824693|83268387|FG002|Overall Study|Progressive Disease|0|||
47019434|NCT01824693|83268385|FG000|Overall Study|Ineligible|0|||
47019435|NCT01824693|83268386|FG001|Overall Study|Ineligible|0|||
47019436|NCT01824693|83268387|FG002|Overall Study|Ineligible|3|||
47019437|NCT01824693|83268385|FG000|Overall Study|No Transplant Planned|0|||
47019438|NCT01824693|83268386|FG001|Overall Study|No Transplant Planned|0|||
47019439|NCT01824693|83268387|FG002|Overall Study|No Transplant Planned|10|||
47019440|NCT02176655|83268394|FG000|Overall Study|Subjects did not treat|6|||
47019441|NCT02125331|83268401|FG000|Overall Study|Protocol Violation|1|||
47019442|NCT02125331|83268402|FG001|Overall Study|Protocol Violation|0|||
47019443|NCT02125331|83268401|FG000|Overall Study|technical problem|2|||
47019444|NCT02125331|83268402|FG001|Overall Study|technical problem|0|||
47019445|NCT02125331|83268401|FG000|Overall Study|screen failure|2|||
47019446|NCT02125331|83268402|FG001|Overall Study|screen failure|0|||
47019447|NCT01622569|83268412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
47019448|NCT01622569|83268413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
47019449|NCT01622569|83268414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
47019450|NCT01622569|83268415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
47019451|NCT01622569|83268412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
47019452|NCT01622569|83268413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
47019453|NCT01622569|83268414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
47019454|NCT01622569|83268415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
47019455|NCT01622569|83268412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
47019456|NCT01622569|83268413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
47019457|NCT01622569|83268414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
47019458|NCT01622569|83268415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
47019459|NCT01622569|83268412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
47019460|NCT01622569|83268413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
47019461|NCT01622569|83268414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
47019462|NCT01622569|83268415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
47019463|NCT01622569|83268412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
47019464|NCT01622569|83268413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
47019465|NCT01622569|83268414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
47019466|NCT01622569|83268415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
47019467|NCT01622569|83268412|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
47019468|NCT01622569|83268413|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
47019469|NCT01622569|83268414|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
47019470|NCT01622569|83268415|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
47019471|NCT01622569|83268412|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
47019472|NCT01622569|83268413|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
47019473|NCT01622569|83268414|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
47019474|NCT01622569|83268415|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
47019475|NCT01622569|83268412|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
47019476|NCT01622569|83268413|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
47019477|NCT01622569|83268414|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
47019478|NCT01622569|83268415|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
47019479|NCT01824303|83268437|FG000|Randomized Study|Withdrawal by Subject|1|||
47019480|NCT01824303|83268438|FG001|Randomized Study|Withdrawal by Subject|1|||
46709736|NCT01142232|82925828|FG001|Overall Study|Off Trt for other complicating disease|0|||
47019481|NCT01824303|83268437|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
47019482|NCT01824303|83268438|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
47019483|NCT01853397|83268450|FG000|Overall Study|Withdrawal by Subject|0|||
47019484|NCT01853397|83268451|FG001|Overall Study|Withdrawal by Subject|0|||
47019485|NCT01853397|83268452|FG002|Overall Study|Withdrawal by Subject|0|||
47019486|NCT01853397|83268453|FG003|Overall Study|Withdrawal by Subject|1|||
47019487|NCT01853397|83268450|FG000|Overall Study|Subject Noncompliance|0|||
47019488|NCT01853397|83268451|FG001|Overall Study|Subject Noncompliance|0|||
47019489|NCT01853397|83268452|FG002|Overall Study|Subject Noncompliance|0|||
47019490|NCT01853397|83268453|FG003|Overall Study|Subject Noncompliance|1|||
47019491|NCT02088073|83268468|FG000|Acute Phase|Withdrawal by Subject|5|||
47019492|NCT02088073|83268469|FG001|Acute Phase|Withdrawal by Subject|0|||
47019493|NCT02088073|83268470|FG002|Acute Phase|Withdrawal by Subject|0|||
47019494|NCT02088073|83268471|FG003|Acute Phase|Withdrawal by Subject|0|||
47019495|NCT02088073|83268472|FG004|Acute Phase|Withdrawal by Subject|0|||
47019496|NCT02088073|83268468|FG000|Acute Phase|Hyperkalemia|2|||
47019497|NCT02088073|83268469|FG001|Acute Phase|Hyperkalemia|0|||
47019498|NCT02088073|83268470|FG002|Acute Phase|Hyperkalemia|0|||
47019499|NCT02088073|83268471|FG003|Acute Phase|Hyperkalemia|0|||
47019500|NCT02088073|83268472|FG004|Acute Phase|Hyperkalemia|0|||
47019501|NCT02088073|83268468|FG000|Maintanance Phase|Withdrawal by Subject|0|||
47019502|NCT02088073|83268469|FG001|Maintanance Phase|Withdrawal by Subject|2|||
47019503|NCT02088073|83268470|FG002|Maintanance Phase|Withdrawal by Subject|0|||
47019504|NCT02088073|83268471|FG003|Maintanance Phase|Withdrawal by Subject|0|||
47019505|NCT02088073|83268472|FG004|Maintanance Phase|Withdrawal by Subject|0|||
47019506|NCT02088073|83268468|FG000|Maintanance Phase|Adverse Event|0|||
47019507|NCT02088073|83268469|FG001|Maintanance Phase|Adverse Event|0|||
47019508|NCT02088073|83268470|FG002|Maintanance Phase|Adverse Event|3|||
47019509|NCT02088073|83268471|FG003|Maintanance Phase|Adverse Event|0|||
47019510|NCT02088073|83268472|FG004|Maintanance Phase|Adverse Event|1|||
47019511|NCT02088073|83268468|FG000|Maintanance Phase|Physician Decision|0|||
47019512|NCT02088073|83268469|FG001|Maintanance Phase|Physician Decision|0|||
47019513|NCT02088073|83268470|FG002|Maintanance Phase|Physician Decision|0|||
47019514|NCT02088073|83268471|FG003|Maintanance Phase|Physician Decision|0|||
47019515|NCT02088073|83268472|FG004|Maintanance Phase|Physician Decision|1|||
47019516|NCT02088073|83268468|FG000|Maintanance Phase|Sponsor's decision|0|||
47019517|NCT02088073|83268469|FG001|Maintanance Phase|Sponsor's decision|2|||
47019518|NCT02088073|83268470|FG002|Maintanance Phase|Sponsor's decision|0|||
47019519|NCT02088073|83268471|FG003|Maintanance Phase|Sponsor's decision|2|||
47019520|NCT02088073|83268472|FG004|Maintanance Phase|Sponsor's decision|1|||
47019521|NCT02088073|83268468|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
47019522|NCT02088073|83268469|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
47019523|NCT02088073|83268470|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
46911094|NCT01667133|83140707|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
46911095|NCT01667133|83140708|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
46911096|NCT01667133|83140709|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
46911097|NCT01667133|83140710|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
46911098|NCT01667133|83140711|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
46911099|NCT01667133|83140712|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
46911100|NCT01667133|83140713|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
46911101|NCT01667133|83140714|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
46911102|NCT01667133|83140703|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911103|NCT01667133|83140704|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911104|NCT01667133|83140705|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911105|NCT01667133|83140706|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911106|NCT01667133|83140707|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911107|NCT01667133|83140708|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911108|NCT01667133|83140709|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911109|NCT01667133|83140710|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911110|NCT01667133|83140711|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911111|NCT01667133|83140712|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
46911112|NCT01667133|83140713|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911113|NCT01667133|83140714|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
46911114|NCT01667133|83140703|FG000|Phase 2: Dose-expansion|Death|0|||
46911115|NCT01667133|83140704|FG001|Phase 2: Dose-expansion|Death|0|||
46911116|NCT01667133|83140705|FG002|Phase 2: Dose-expansion|Death|0|||
46911117|NCT01667133|83140706|FG003|Phase 2: Dose-expansion|Death|0|||
46911118|NCT01667133|83140707|FG004|Phase 2: Dose-expansion|Death|0|||
46911119|NCT01667133|83140708|FG005|Phase 2: Dose-expansion|Death|0|||
46911120|NCT01667133|83140709|FG006|Phase 2: Dose-expansion|Death|0|||
46911121|NCT01667133|83140710|FG007|Phase 2: Dose-expansion|Death|0|||
46911122|NCT01667133|83140711|FG008|Phase 2: Dose-expansion|Death|0|||
46911123|NCT01667133|83140712|FG009|Phase 2: Dose-expansion|Death|1|||
47019524|NCT02088073|83268471|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
47019525|NCT02088073|83268472|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
47019526|NCT02088073|83268468|FG000|Maintanance Phase|Miscellaneous|0|||
46911124|NCT01667133|83140713|FG010|Phase 2: Dose-expansion|Death|0|||
46911125|NCT01667133|83140714|FG011|Phase 2: Dose-expansion|Death|0|||
46911126|NCT01667133|83140703|FG000|Phase 2: Dose-expansion|Other|0|||
47019527|NCT02088073|83268469|FG001|Maintanance Phase|Miscellaneous|2|||
47019528|NCT02088073|83268470|FG002|Maintanance Phase|Miscellaneous|1|||
47019529|NCT02088073|83268471|FG003|Maintanance Phase|Miscellaneous|2|||
47019530|NCT02088073|83268472|FG004|Maintanance Phase|Miscellaneous|1|||
47019531|NCT02088073|83268468|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
47019532|NCT02088073|83268469|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
47019533|NCT02088073|83268470|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
47019534|NCT02088073|83268471|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
47019535|NCT02088073|83268472|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
47019536|NCT02088073|83268468|FG000|Maintanance Phase|Subject compliance|0|||
47019537|NCT02088073|83268469|FG001|Maintanance Phase|Subject compliance|1|||
47019538|NCT02088073|83268470|FG002|Maintanance Phase|Subject compliance|0|||
47019539|NCT02088073|83268471|FG003|Maintanance Phase|Subject compliance|0|||
47019540|NCT02088073|83268472|FG004|Maintanance Phase|Subject compliance|0|||
47019541|NCT01823991|83268487|FG000|Overall Study|Withdrawal by Subject|8|||
47019542|NCT01823991|83268488|FG001|Overall Study|Withdrawal by Subject|5|||
47019543|NCT02087059|83268498|FG000|Overall Study|Disease Progression|1|||
47019544|NCT02087059|83268498|FG000|Overall Study|Adverse Event|5|||
47019545|NCT02087059|83268498|FG000|Overall Study|Lost to Follow-up|1|||
47019546|NCT02152163|83268504|FG000|Overall Study|Physician Decision|12|||
47019547|NCT02152163|83268505|FG001|Overall Study|Physician Decision|13|||
47019548|NCT02152007|83268511|FG000|Overall Study|Withdrawal by Subject|1|||
47019549|NCT02151851|83268518|FG000|Overall Study|Lack of Efficacy|67|||
47019550|NCT02151851|83268519|FG001|Overall Study|Lack of Efficacy|94|||
47019551|NCT02151851|83268518|FG000|Overall Study|Protocol Violation|0|||
47019552|NCT02151851|83268519|FG001|Overall Study|Protocol Violation|1|||
47019553|NCT02151851|83268518|FG000|Overall Study|Withdrawal by Subject|2|||
47019554|NCT02151851|83268519|FG001|Overall Study|Withdrawal by Subject|5|||
47019555|NCT02151851|83268518|FG000|Overall Study|Medical impairment|1|||
47019556|NCT02151851|83268519|FG001|Overall Study|Medical impairment|0|||
47019557|NCT02151851|83268518|FG000|Overall Study|Low compliance to study visits|0|||
47019558|NCT02151851|83268519|FG001|Overall Study|Low compliance to study visits|1|||
47019559|NCT02151851|83268518|FG000|Overall Study|Subject entered into study in error|0|||
47019560|NCT02151851|83268519|FG001|Overall Study|Subject entered into study in error|1|||
47019561|NCT02151851|83268518|FG000|Overall Study|Adverse Event|6|||
47019562|NCT02151851|83268519|FG001|Overall Study|Adverse Event|28|||
47019563|NCT02176421|83268525|FG000|Overall Study|Lost to Follow-up|4|||
47019564|NCT02176421|83268525|FG000|Overall Study|Adverse Event|1|||
47019565|NCT02042443|83268531|FG000|Overall Study|Adverse Event|2|||
47019566|NCT02042443|83268532|FG001|Overall Study|Adverse Event|1|||
47019567|NCT02042443|83268531|FG000|Overall Study|Withdrawal by Subject|0|||
47019568|NCT02042443|83268532|FG001|Overall Study|Withdrawal by Subject|1|||
47019569|NCT02042443|83268531|FG000|Overall Study|Progression|21|||
47019570|NCT02042443|83268532|FG001|Overall Study|Progression|17|||
47019571|NCT02042443|83268531|FG000|Overall Study|not protocol specified|1|||
47019572|NCT02042443|83268532|FG001|Overall Study|not protocol specified|1|||
46911127|NCT01667133|83140704|FG001|Phase 2: Dose-expansion|Other|0|||
46911128|NCT01667133|83140705|FG002|Phase 2: Dose-expansion|Other|0|||
46911129|NCT01667133|83140706|FG003|Phase 2: Dose-expansion|Other|0|||
46911130|NCT01667133|83140707|FG004|Phase 2: Dose-expansion|Other|0|||
46911131|NCT01667133|83140708|FG005|Phase 2: Dose-expansion|Other|0|||
46911132|NCT01667133|83140709|FG006|Phase 2: Dose-expansion|Other|0|||
46911133|NCT01667133|83140710|FG007|Phase 2: Dose-expansion|Other|0|||
46911134|NCT01667133|83140711|FG008|Phase 2: Dose-expansion|Other|0|||
46911135|NCT01667133|83140712|FG009|Phase 2: Dose-expansion|Other|0|||
46911136|NCT01667133|83140713|FG010|Phase 2: Dose-expansion|Other|0|||
46911137|NCT01667133|83140714|FG011|Phase 2: Dose-expansion|Other|1|||
46911138|NCT01181778|83140775|FG000|Overall Study|Physician Decision|48|||
46911139|NCT00092118|83140783|FG000|Overall Study|Adverse Event|35|||
46911140|NCT00092118|83140784|FG001|Overall Study|Adverse Event|32|||
46911141|NCT00092118|83140783|FG000|Overall Study|Lack of Efficacy|12|||
46911142|NCT00092118|83140784|FG001|Overall Study|Lack of Efficacy|14|||
46911143|NCT00092118|83140783|FG000|Overall Study|Lost to Follow-up|4|||
46911144|NCT00092118|83140784|FG001|Overall Study|Lost to Follow-up|3|||
46911145|NCT00092118|83140783|FG000|Overall Study|Protocol Violation|23|||
46911146|NCT00092118|83140784|FG001|Overall Study|Protocol Violation|25|||
46911147|NCT00092118|83140783|FG000|Overall Study|Withdrawal by Subject|4|||
46911148|NCT00092118|83140784|FG001|Overall Study|Withdrawal by Subject|10|||
46911149|NCT00092118|83140783|FG000|Overall Study|Other|6|||
46911150|NCT00092118|83140784|FG001|Overall Study|Other|5|||
46911151|NCT03261947|83140795|FG000|Overall Study|Death|10|||
46911152|NCT03261947|83140796|FG001|Overall Study|Death|13|||
46911153|NCT03261947|83140797|FG002|Overall Study|Death|17|||
46911154|NCT03261947|83140798|FG003|Overall Study|Death|12|||
46911155|NCT03261947|83140799|FG004|Overall Study|Death|8|||
46911156|NCT03261947|83140795|FG000|Overall Study|Lost to Follow-up|0|||
46911157|NCT03261947|83140796|FG001|Overall Study|Lost to Follow-up|0|||
46911158|NCT03261947|83140797|FG002|Overall Study|Lost to Follow-up|2|||
46911159|NCT03261947|83140798|FG003|Overall Study|Lost to Follow-up|1|||
46911160|NCT03261947|83140799|FG004|Overall Study|Lost to Follow-up|0|||
46911161|NCT03261947|83140795|FG000|Overall Study|Withdrawal by Subject|0|||
46911162|NCT03261947|83140796|FG001|Overall Study|Withdrawal by Subject|0|||
46911163|NCT03261947|83140797|FG002|Overall Study|Withdrawal by Subject|3|||
46911164|NCT03261947|83140798|FG003|Overall Study|Withdrawal by Subject|0|||
46911165|NCT03261947|83140799|FG004|Overall Study|Withdrawal by Subject|1|||
46911166|NCT03261947|83140795|FG000|Overall Study|Site Terminated by Sponsor|0|||
46911167|NCT03261947|83140796|FG001|Overall Study|Site Terminated by Sponsor|0|||
46911168|NCT03261947|83140797|FG002|Overall Study|Site Terminated by Sponsor|4|||
47019573|NCT02042443|83268531|FG000|Overall Study|Not eligible/not analyzable|3|||
47019574|NCT02042443|83268532|FG001|Overall Study|Not eligible/not analyzable|6|||
47019575|NCT02118896|83268549|FG000|Overall Study|Death|4|||
47019576|NCT02118896|83268550|FG001|Overall Study|Death|0|||
47019577|NCT02118896|83268551|FG002|Overall Study|Death|4|||
46911169|NCT03261947|83140798|FG003|Overall Study|Site Terminated by Sponsor|7|||
46911170|NCT03261947|83140799|FG004|Overall Study|Site Terminated by Sponsor|5|||
46911171|NCT03261947|83140795|FG000|Overall Study|Reason not Specified|2|||
46911172|NCT03261947|83140796|FG001|Overall Study|Reason not Specified|0|||
46911173|NCT03261947|83140797|FG002|Overall Study|Reason not Specified|4|||
46911174|NCT03261947|83140798|FG003|Overall Study|Reason not Specified|1|||
46911175|NCT03261947|83140799|FG004|Overall Study|Reason not Specified|3|||
46911176|NCT03098979|83140830|FG000|Overall Study|Adverse Event|1|||
46911177|NCT03098979|83140831|FG001|Overall Study|Adverse Event|0|||
46911178|NCT03098979|83140832|FG002|Overall Study|Adverse Event|1|||
47019578|NCT02118896|83268552|FG003|Overall Study|Death|6|||
47019579|NCT02118896|83268553|FG004|Overall Study|Death|3|||
47019580|NCT02118896|83268554|FG005|Overall Study|Death|1|||
47019581|NCT02118896|83268555|FG006|Overall Study|Death|0|||
47019582|NCT02118896|83268556|FG007|Overall Study|Death|0|||
47019583|NCT02118896|83268557|FG008|Overall Study|Death|0|||
47019584|NCT02118896|83268558|FG009|Overall Study|Death|0|||
47019585|NCT02118896|83268549|FG000|Overall Study|Adverse Event|5|||
47019586|NCT02118896|83268550|FG001|Overall Study|Adverse Event|4|||
47019587|NCT02118896|83268551|FG002|Overall Study|Adverse Event|4|||
47019588|NCT02118896|83268552|FG003|Overall Study|Adverse Event|5|||
47019589|NCT02118896|83268553|FG004|Overall Study|Adverse Event|5|||
47019590|NCT02118896|83268554|FG005|Overall Study|Adverse Event|9|||
47019591|NCT02118896|83268555|FG006|Overall Study|Adverse Event|1|||
47019592|NCT02118896|83268556|FG007|Overall Study|Adverse Event|1|||
47019593|NCT02118896|83268557|FG008|Overall Study|Adverse Event|4|||
47019594|NCT02118896|83268558|FG009|Overall Study|Adverse Event|0|||
47019595|NCT02118896|83268549|FG000|Overall Study|Consent withdrawn|2|||
47019596|NCT02118896|83268550|FG001|Overall Study|Consent withdrawn|0|||
47019597|NCT02118896|83268551|FG002|Overall Study|Consent withdrawn|3|||
47019598|NCT02118896|83268552|FG003|Overall Study|Consent withdrawn|4|||
47019599|NCT02118896|83268553|FG004|Overall Study|Consent withdrawn|1|||
47019600|NCT02118896|83268554|FG005|Overall Study|Consent withdrawn|4|||
47019601|NCT02118896|83268555|FG006|Overall Study|Consent withdrawn|0|||
47019602|NCT02118896|83268556|FG007|Overall Study|Consent withdrawn|0|||
47019603|NCT02118896|83268557|FG008|Overall Study|Consent withdrawn|0|||
47019604|NCT02118896|83268558|FG009|Overall Study|Consent withdrawn|0|||
47019605|NCT02118896|83268549|FG000|Overall Study|Non-compliance|2|||
47019606|NCT02118896|83268550|FG001|Overall Study|Non-compliance|1|||
47019607|NCT02118896|83268551|FG002|Overall Study|Non-compliance|1|||
47019608|NCT02118896|83268552|FG003|Overall Study|Non-compliance|5|||
47019609|NCT02118896|83268553|FG004|Overall Study|Non-compliance|0|||
47019610|NCT02118896|83268554|FG005|Overall Study|Non-compliance|1|||
47019611|NCT02118896|83268555|FG006|Overall Study|Non-compliance|0|||
47019612|NCT02118896|83268556|FG007|Overall Study|Non-compliance|1|||
47019613|NCT02118896|83268557|FG008|Overall Study|Non-compliance|0|||
47019614|NCT02118896|83268558|FG009|Overall Study|Non-compliance|0|||
47019615|NCT02118896|83268549|FG000|Overall Study|Pregnancy|1|||
47019616|NCT02118896|83268550|FG001|Overall Study|Pregnancy|1|||
47019617|NCT02118896|83268551|FG002|Overall Study|Pregnancy|0|||
47019618|NCT02118896|83268552|FG003|Overall Study|Pregnancy|0|||
47019619|NCT02118896|83268553|FG004|Overall Study|Pregnancy|1|||
47019620|NCT02118896|83268554|FG005|Overall Study|Pregnancy|3|||
47019621|NCT02118896|83268555|FG006|Overall Study|Pregnancy|1|||
47019622|NCT02118896|83268556|FG007|Overall Study|Pregnancy|0|||
47019623|NCT02118896|83268557|FG008|Overall Study|Pregnancy|0|||
47019624|NCT02118896|83268558|FG009|Overall Study|Pregnancy|0|||
47019625|NCT02118896|83268549|FG000|Overall Study|Lost to Follow-up|1|||
47019626|NCT02118896|83268550|FG001|Overall Study|Lost to Follow-up|2|||
47019627|NCT02118896|83268551|FG002|Overall Study|Lost to Follow-up|1|||
47019628|NCT02118896|83268552|FG003|Overall Study|Lost to Follow-up|0|||
47019629|NCT02118896|83268553|FG004|Overall Study|Lost to Follow-up|2|||
47019630|NCT02118896|83268554|FG005|Overall Study|Lost to Follow-up|1|||
47019631|NCT02118896|83268555|FG006|Overall Study|Lost to Follow-up|0|||
47019632|NCT02118896|83268556|FG007|Overall Study|Lost to Follow-up|0|||
47019633|NCT02118896|83268557|FG008|Overall Study|Lost to Follow-up|0|||
47019634|NCT02118896|83268558|FG009|Overall Study|Lost to Follow-up|0|||
47019635|NCT02118896|83268549|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
47019636|NCT02118896|83268550|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
47019637|NCT02118896|83268551|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
47019638|NCT02118896|83268552|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
47019639|NCT02118896|83268553|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
47019640|NCT02118896|83268554|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
47019641|NCT02118896|83268555|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
47019642|NCT02118896|83268556|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
47019643|NCT02118896|83268557|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
47019644|NCT02118896|83268558|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
47019645|NCT02118896|83268549|FG000|Overall Study|Prohibited medication|0|||
47019646|NCT02118896|83268550|FG001|Overall Study|Prohibited medication|0|||
47019647|NCT02118896|83268551|FG002|Overall Study|Prohibited medication|0|||
47019648|NCT02118896|83268552|FG003|Overall Study|Prohibited medication|0|||
47019649|NCT02118896|83268553|FG004|Overall Study|Prohibited medication|1|||
47019650|NCT02118896|83268554|FG005|Overall Study|Prohibited medication|3|||
47019651|NCT02118896|83268555|FG006|Overall Study|Prohibited medication|0|||
47019652|NCT02118896|83268556|FG007|Overall Study|Prohibited medication|0|||
46709737|NCT01142232|82925829|FG002|Overall Study|Off Trt for other complicating disease|0|||
46911179|NCT03098979|83140833|FG003|Overall Study|Adverse Event|4|||
46911180|NCT03098979|83140834|FG004|Overall Study|Adverse Event|6|||
46911181|NCT03098979|83140835|FG005|Overall Study|Adverse Event|1|||
46911182|NCT03098979|83140830|FG000|Overall Study|Withdrawal by Subject|2|||
46911183|NCT03098979|83140831|FG001|Overall Study|Withdrawal by Subject|1|||
46911184|NCT03098979|83140832|FG002|Overall Study|Withdrawal by Subject|1|||
46911185|NCT03098979|83140833|FG003|Overall Study|Withdrawal by Subject|1|||
46911186|NCT03098979|83140834|FG004|Overall Study|Withdrawal by Subject|2|||
46911187|NCT03098979|83140835|FG005|Overall Study|Withdrawal by Subject|1|||
46911188|NCT03098979|83140830|FG000|Overall Study|Death|1|||
46911189|NCT03098979|83140831|FG001|Overall Study|Death|0|||
46911190|NCT03098979|83140832|FG002|Overall Study|Death|2|||
46911191|NCT03098979|83140833|FG003|Overall Study|Death|0|||
46911192|NCT03098979|83140834|FG004|Overall Study|Death|1|||
46911193|NCT03098979|83140835|FG005|Overall Study|Death|0|||
46911194|NCT03098979|83140830|FG000|Overall Study|Physician Decision|2|||
46911195|NCT03098979|83140831|FG001|Overall Study|Physician Decision|1|||
46911196|NCT03098979|83140832|FG002|Overall Study|Physician Decision|0|||
46911197|NCT03098979|83140833|FG003|Overall Study|Physician Decision|0|||
46911198|NCT03098979|83140834|FG004|Overall Study|Physician Decision|0|||
46911199|NCT03098979|83140835|FG005|Overall Study|Physician Decision|0|||
46911200|NCT03098979|83140830|FG000|Overall Study|Non-compliance|0|||
46911201|NCT03098979|83140831|FG001|Overall Study|Non-compliance|0|||
46911202|NCT03098979|83140832|FG002|Overall Study|Non-compliance|0|||
46911203|NCT03098979|83140833|FG003|Overall Study|Non-compliance|0|||
46911204|NCT03098979|83140834|FG004|Overall Study|Non-compliance|0|||
46911205|NCT03098979|83140835|FG005|Overall Study|Non-compliance|1|||
46911206|NCT03098979|83140830|FG000|Overall Study|Protocol Violation|0|||
46911207|NCT03098979|83140831|FG001|Overall Study|Protocol Violation|0|||
46911208|NCT03098979|83140832|FG002|Overall Study|Protocol Violation|0|||
46911209|NCT03098979|83140833|FG003|Overall Study|Protocol Violation|0|||
46911210|NCT03098979|83140834|FG004|Overall Study|Protocol Violation|0|||
46911211|NCT03098979|83140835|FG005|Overall Study|Protocol Violation|1|||
46911212|NCT03261167|83140851|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
46911213|NCT03261167|83140852|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
46911214|NCT03261167|83140851|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
46911215|NCT03261167|83140852|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
46911216|NCT03261167|83140851|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
46911217|NCT03261167|83140852|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
46911218|NCT03261167|83140851|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
46911219|NCT03261167|83140852|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
46911220|NCT03261167|83140851|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
46911221|NCT03261167|83140852|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
46911222|NCT03294941|83140866|FG000|Overall Study|Withdrawal by Subject|0|||
46911223|NCT03294941|83140867|FG001|Overall Study|Withdrawal by Subject|2|||
46911224|NCT03098433|83140874|FG000|Overall Study|Withdrawal by Subject|10|||
46911225|NCT03294317|83140879|FG000|Overall Study|Physician Decision|1|||
46911226|NCT03294317|83140879|FG000|Overall Study|Withdrawal by Subject|6|||
46911227|NCT03294317|83140879|FG000|Overall Study|Lost to Follow-up|1|||
46911228|NCT03294317|83140879|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
46911229|NCT03294317|83140879|FG000|Overall Study|Failed HB lead implant|8|||
46911230|NCT03294317|83140879|FG000|Overall Study|Received CRT instead|1|||
46911231|NCT03294317|83140879|FG000|Overall Study|Exited after lead revision|2|||
46911232|NCT03292913|83140885|FG000|Overall Study|Death|9|||
46911233|NCT03292913|83140886|FG001|Overall Study|Death|3|||
46911234|NCT03292913|83140885|FG000|Overall Study|Lost to Follow-up|49|||
46911235|NCT03292913|83140886|FG001|Overall Study|Lost to Follow-up|49|||
46911236|NCT03292913|83140885|FG000|Overall Study|Withdrawal by Subject|2|||
46911237|NCT03292913|83140886|FG001|Overall Study|Withdrawal by Subject|0|||
46911238|NCT03292913|83140885|FG000|Overall Study|Clinic closed due to COVID|22|||
46911239|NCT03292913|83140886|FG001|Overall Study|Clinic closed due to COVID|36|||
46911240|NCT03291587|83140898|FG000|Overall Study|Lost to Follow-up|62|||
46911241|NCT03291587|83140899|FG001|Overall Study|Lost to Follow-up|43|||
46911242|NCT03291587|83140898|FG000|Overall Study|Refused to Answer|5|||
46911243|NCT03291587|83140899|FG001|Overall Study|Refused to Answer|2|||
46911244|NCT03291587|83140898|FG000|Overall Study|Death|2|||
46911245|NCT03291587|83140899|FG001|Overall Study|Death|4|||
46709738|NCT01142232|82925830|FG003|Overall Study|Off Trt for other complicating disease|0|||
46911246|NCT03291587|83140898|FG000|Overall Study|Not interested in participating|8|||
46911247|NCT03291587|83140899|FG001|Overall Study|Not interested in participating|6|||
46911248|NCT03291587|83140898|FG000|Overall Study|Too busy to participate|4|||
46911249|NCT03291587|83140899|FG001|Overall Study|Too busy to participate|2|||
46911250|NCT03210961|83140930|FG000|Overall Study|Adverse Event|0|||
46911251|NCT03210961|83140931|FG001|Overall Study|Adverse Event|0|||
46911252|NCT03210961|83140932|FG002|Overall Study|Adverse Event|0|||
47019653|NCT02118896|83268557|FG008|Overall Study|Prohibited medication|0|||
47019654|NCT02118896|83268558|FG009|Overall Study|Prohibited medication|0|||
47019655|NCT02118896|83268549|FG000|Overall Study|Miscellaneous|1|||
47019656|NCT02118896|83268550|FG001|Overall Study|Miscellaneous|2|||
47019657|NCT02118896|83268551|FG002|Overall Study|Miscellaneous|0|||
47019658|NCT02118896|83268552|FG003|Overall Study|Miscellaneous|2|||
47019659|NCT02118896|83268553|FG004|Overall Study|Miscellaneous|0|||
47019660|NCT02118896|83268554|FG005|Overall Study|Miscellaneous|4|||
47019661|NCT02118896|83268555|FG006|Overall Study|Miscellaneous|0|||
47019662|NCT02118896|83268556|FG007|Overall Study|Miscellaneous|0|||
47019663|NCT02118896|83268557|FG008|Overall Study|Miscellaneous|0|||
47019664|NCT02118896|83268558|FG009|Overall Study|Miscellaneous|0|||
47019665|NCT02124707|83268581|FG000|Overall Study|Adverse Event|5|||
47019666|NCT02124707|83268581|FG000|Overall Study|Physician Decision|1|||
47019667|NCT02124707|83268581|FG000|Overall Study|Death|1|||
47019668|NCT02067728|83268588|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
47019669|NCT02067728|83268589|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
47019670|NCT02067728|83268588|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
47019671|NCT02067728|83268589|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
47019672|NCT02067728|83268588|FG000|6 Month Measurements|Unable to attend|114|||
47019673|NCT02067728|83268589|FG001|6 Month Measurements|Unable to attend|97|||
47019674|NCT02118428|83268597|FG000|Overall Study|Physician Decision|0|||
47019675|NCT02118428|83268598|FG001|Overall Study|Physician Decision|1|||
47019676|NCT02118428|83268599|FG002|Overall Study|Physician Decision|0|||
47019677|NCT02118428|83268597|FG000|Overall Study|Withdrawal by Subject|2|||
47019678|NCT02118428|83268598|FG001|Overall Study|Withdrawal by Subject|2|||
47019679|NCT02118428|83268599|FG002|Overall Study|Withdrawal by Subject|0|||
47019680|NCT02118428|83268597|FG000|Overall Study|Death|7|||
47019681|NCT02118428|83268598|FG001|Overall Study|Death|5|||
47019682|NCT02118428|83268599|FG002|Overall Study|Death|0|||
47019683|NCT02118428|83268597|FG000|Overall Study|Lost to Follow-up|3|||
47019684|NCT02118428|83268598|FG001|Overall Study|Lost to Follow-up|1|||
47019685|NCT02118428|83268599|FG002|Overall Study|Lost to Follow-up|0|||
47019686|NCT02118428|83268597|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
47019687|NCT02118428|83268598|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
47019688|NCT02118428|83268599|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
47019689|NCT02067104|83268607|FG000|Overall Study|Study termination due to low accrual|4|||
47019690|NCT02067104|83268608|FG001|Overall Study|Study termination due to low accrual|5|||
47019691|NCT02092220|83268614|FG000|Period 1|Unrelated Illness|0|||
47019692|NCT02092220|83268615|FG001|Period 1|Unrelated Illness|2|||
47019693|NCT02092220|83268614|FG000|Period 2|Severe Hypoglycaemia|1|||
47019694|NCT02092220|83268615|FG001|Period 2|Severe Hypoglycaemia|0|||
47019695|NCT02092220|83268614|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
47019696|NCT02092220|83268615|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
47019697|NCT02066402|83268625|FG000|Overall Study|Adverse Event|1|||
47019698|NCT02066402|83268626|FG001|Overall Study|Adverse Event|2|||
47019699|NCT02066402|83268625|FG000|Overall Study|Lost to Follow-up|11|||
47019700|NCT02066402|83268626|FG001|Overall Study|Lost to Follow-up|8|||
46911253|NCT03210961|83140933|FG003|Overall Study|Adverse Event|0|||
46911254|NCT03210961|83140934|FG004|Overall Study|Adverse Event|0|||
46911255|NCT03210961|83140935|FG005|Overall Study|Adverse Event|0|||
46911256|NCT03210961|83140936|FG006|Overall Study|Adverse Event|0|||
46911257|NCT03210961|83140937|FG007|Overall Study|Adverse Event|0|||
46911258|NCT03210961|83140938|FG008|Overall Study|Adverse Event|0|||
46911259|NCT03210961|83140939|FG009|Overall Study|Adverse Event|0|||
46911260|NCT03210961|83140940|FG010|Overall Study|Adverse Event|0|||
46911261|NCT03210961|83140941|FG011|Overall Study|Adverse Event|0|||
46911262|NCT03210961|83140942|FG012|Overall Study|Adverse Event|0|||
46911263|NCT03210961|83140943|FG013|Overall Study|Adverse Event|1|||
46911264|NCT03210961|83140944|FG014|Overall Study|Adverse Event|0|||
46911265|NCT03210961|83140930|FG000|Overall Study|Lost to Follow-up|0|||
46911266|NCT03210961|83140931|FG001|Overall Study|Lost to Follow-up|0|||
47019701|NCT02066402|83268625|FG000|Overall Study|Withdrawal by Subject|14|||
47019702|NCT02066402|83268626|FG001|Overall Study|Withdrawal by Subject|11|||
47019703|NCT02066402|83268625|FG000|Overall Study|Progressive disease-clinical progression|0|||
47019704|NCT02066402|83268626|FG001|Overall Study|Progressive disease-clinical progression|1|||
47019705|NCT02066402|83268625|FG000|Overall Study|Protocol driven decision point|0|||
47019706|NCT02066402|83268626|FG001|Overall Study|Protocol driven decision point|1|||
47019707|NCT02060383|83268637|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
47019708|NCT02060383|83268638|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
47019709|NCT02060383|83268639|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
46911267|NCT03210961|83140932|FG002|Overall Study|Lost to Follow-up|0|||
46911268|NCT03210961|83140933|FG003|Overall Study|Lost to Follow-up|0|||
46911269|NCT03210961|83140934|FG004|Overall Study|Lost to Follow-up|0|||
46911270|NCT03210961|83140935|FG005|Overall Study|Lost to Follow-up|0|||
46911271|NCT03210961|83140936|FG006|Overall Study|Lost to Follow-up|0|||
46911272|NCT03210961|83140937|FG007|Overall Study|Lost to Follow-up|0|||
47019710|NCT02060383|83268640|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
47019711|NCT02060383|83268641|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
47019712|NCT02060383|83268637|FG000|Core Phase|Adverse Event|2|||
47019713|NCT02060383|83268638|FG001|Core Phase|Adverse Event|0|||
47019714|NCT02060383|83268639|FG002|Core Phase|Adverse Event|0|||
47019715|NCT02060383|83268640|FG003|Core Phase|Adverse Event|2|||
47019716|NCT02060383|83268641|FG004|Core Phase|Adverse Event|6|||
47019717|NCT02060383|83268637|FG000|Core Phase|Administrative problems|0|||
47019718|NCT02060383|83268638|FG001|Core Phase|Administrative problems|1|||
47019719|NCT02060383|83268639|FG002|Core Phase|Administrative problems|0|||
47019720|NCT02060383|83268640|FG003|Core Phase|Administrative problems|0|||
47019721|NCT02060383|83268641|FG004|Core Phase|Administrative problems|0|||
47019722|NCT02060383|83268637|FG000|Core Phase|Protocol Violation|0|||
47019723|NCT02060383|83268638|FG001|Core Phase|Protocol Violation|0|||
47019724|NCT02060383|83268639|FG002|Core Phase|Protocol Violation|0|||
47019725|NCT02060383|83268640|FG003|Core Phase|Protocol Violation|1|||
47019726|NCT02060383|83268641|FG004|Core Phase|Protocol Violation|0|||
47019727|NCT02060383|83268637|FG000|Core Phase|Withdrawal by Subject|0|||
47019728|NCT02060383|83268638|FG001|Core Phase|Withdrawal by Subject|0|||
47019729|NCT02060383|83268639|FG002|Core Phase|Withdrawal by Subject|0|||
47019730|NCT02060383|83268640|FG003|Core Phase|Withdrawal by Subject|4|||
47019731|NCT02060383|83268641|FG004|Core Phase|Withdrawal by Subject|2|||
47019732|NCT02060383|83268637|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
47019733|NCT02060383|83268638|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
47019734|NCT02060383|83268639|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
47019735|NCT02060383|83268640|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
47019736|NCT02060383|83268641|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
47019737|NCT02060383|83268637|FG000|Extension Phase|Adverse Event|1|||
47019738|NCT02060383|83268638|FG001|Extension Phase|Adverse Event|1|||
47019739|NCT02060383|83268639|FG002|Extension Phase|Adverse Event|2|||
47019740|NCT02060383|83268640|FG003|Extension Phase|Adverse Event|0|||
47019741|NCT02060383|83268641|FG004|Extension Phase|Adverse Event|1|||
47019742|NCT02060383|83268637|FG000|Extension Phase|Withdrawal by Subject|0|||
47019743|NCT02060383|83268638|FG001|Extension Phase|Withdrawal by Subject|1|||
47019744|NCT02060383|83268639|FG002|Extension Phase|Withdrawal by Subject|0|||
47019745|NCT02060383|83268640|FG003|Extension Phase|Withdrawal by Subject|0|||
46911273|NCT03210961|83140938|FG008|Overall Study|Lost to Follow-up|0|||
46911274|NCT03210961|83140939|FG009|Overall Study|Lost to Follow-up|0|||
46911275|NCT03210961|83140940|FG010|Overall Study|Lost to Follow-up|0|||
46911276|NCT03210961|83140941|FG011|Overall Study|Lost to Follow-up|0|||
46911277|NCT03210961|83140942|FG012|Overall Study|Lost to Follow-up|0|||
46911278|NCT03210961|83140943|FG013|Overall Study|Lost to Follow-up|0|||
46911279|NCT03210961|83140944|FG014|Overall Study|Lost to Follow-up|1|||
46911280|NCT03210961|83140930|FG000|Overall Study|Withdrawal by Subject|0|||
46911281|NCT03210961|83140931|FG001|Overall Study|Withdrawal by Subject|0|||
46911282|NCT03210961|83140932|FG002|Overall Study|Withdrawal by Subject|0|||
46911283|NCT03210961|83140933|FG003|Overall Study|Withdrawal by Subject|0|||
46911284|NCT03210961|83140934|FG004|Overall Study|Withdrawal by Subject|0|||
46911285|NCT03210961|83140935|FG005|Overall Study|Withdrawal by Subject|0|||
46911286|NCT03210961|83140936|FG006|Overall Study|Withdrawal by Subject|0|||
46911287|NCT03210961|83140937|FG007|Overall Study|Withdrawal by Subject|0|||
46911288|NCT03210961|83140938|FG008|Overall Study|Withdrawal by Subject|0|||
46911289|NCT03210961|83140939|FG009|Overall Study|Withdrawal by Subject|0|||
46911290|NCT03210961|83140940|FG010|Overall Study|Withdrawal by Subject|0|||
46911291|NCT03210961|83140941|FG011|Overall Study|Withdrawal by Subject|0|||
46911292|NCT03210961|83140942|FG012|Overall Study|Withdrawal by Subject|0|||
46911293|NCT03210961|83140943|FG013|Overall Study|Withdrawal by Subject|0|||
46911294|NCT03210961|83140944|FG014|Overall Study|Withdrawal by Subject|1|||
46911295|NCT03210961|83140930|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911296|NCT03210961|83140931|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911297|NCT03210961|83140932|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911298|NCT03210961|83140933|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911299|NCT03210961|83140934|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911300|NCT03210961|83140935|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911301|NCT03210961|83140936|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911302|NCT03210961|83140937|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911303|NCT03210961|83140938|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911304|NCT03210961|83140939|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911305|NCT03210961|83140940|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
47019746|NCT02060383|83268641|FG004|Extension Phase|Withdrawal by Subject|2|||
47019747|NCT02060383|83268637|FG000|Extension Phase|Administrative problems|1|||
47019748|NCT02060383|83268638|FG001|Extension Phase|Administrative problems|0|||
47019749|NCT02060383|83268639|FG002|Extension Phase|Administrative problems|0|||
47019750|NCT02060383|83268640|FG003|Extension Phase|Administrative problems|0|||
47019751|NCT02060383|83268641|FG004|Extension Phase|Administrative problems|0|||
47019752|NCT02060383|83268637|FG000|Extension Phase|Death|0|||
47019753|NCT02060383|83268638|FG001|Extension Phase|Death|0|||
47019754|NCT02060383|83268639|FG002|Extension Phase|Death|1|||
47019755|NCT02060383|83268640|FG003|Extension Phase|Death|0|||
47019756|NCT02060383|83268641|FG004|Extension Phase|Death|1|||
47019757|NCT02060383|83268637|FG000|Extension Phase|Protocol Violation|0|||
47019758|NCT02060383|83268638|FG001|Extension Phase|Protocol Violation|0|||
47019759|NCT02060383|83268639|FG002|Extension Phase|Protocol Violation|0|||
47019760|NCT02060383|83268640|FG003|Extension Phase|Protocol Violation|0|||
47019761|NCT02060383|83268641|FG004|Extension Phase|Protocol Violation|1|||
47019762|NCT02086591|83268653|FG000|Overall Study|Adverse Event|1|||
47019763|NCT02086591|83268653|FG000|Overall Study|Withdrawal by Subject|1|||
47019764|NCT02086591|83268653|FG000|Overall Study|protocol terminated|3|||
47019765|NCT02065622|83268659|FG000|Induction Study|Adverse Event|13|||
47019766|NCT02065622|83268660|FG001|Induction Study|Adverse Event|19|||
47019767|NCT02065622|83268661|FG002|Induction Study|Adverse Event|0|||
47019768|NCT02065622|83268662|FG003|Induction Study|Adverse Event|0|||
47019769|NCT02065622|83268663|FG004|Induction Study|Adverse Event|0|||
47019770|NCT02065622|83268659|FG000|Induction Study|Withdrawal by Subject|3|||
47019771|NCT02065622|83268660|FG001|Induction Study|Withdrawal by Subject|5|||
47019772|NCT02065622|83268661|FG002|Induction Study|Withdrawal by Subject|0|||
47019773|NCT02065622|83268662|FG003|Induction Study|Withdrawal by Subject|0|||
47019774|NCT02065622|83268663|FG004|Induction Study|Withdrawal by Subject|0|||
47019775|NCT02065622|83268659|FG000|Induction Study|Lost to Follow-up|1|||
47019776|NCT02065622|83268660|FG001|Induction Study|Lost to Follow-up|0|||
47019777|NCT02065622|83268661|FG002|Induction Study|Lost to Follow-up|0|||
47019778|NCT02065622|83268662|FG003|Induction Study|Lost to Follow-up|0|||
47019779|NCT02065622|83268663|FG004|Induction Study|Lost to Follow-up|0|||
47019780|NCT02065622|83268659|FG000|Induction Study|Lack of Efficacy|22|||
47019781|NCT02065622|83268660|FG001|Induction Study|Lack of Efficacy|27|||
47019782|NCT02065622|83268661|FG002|Induction Study|Lack of Efficacy|0|||
47019783|NCT02065622|83268662|FG003|Induction Study|Lack of Efficacy|0|||
47019784|NCT02065622|83268663|FG004|Induction Study|Lack of Efficacy|0|||
47019785|NCT02065622|83268659|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
47019786|NCT02065622|83268660|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
47019787|NCT02065622|83268661|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
47019788|NCT02065622|83268662|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
47019789|NCT02065622|83268663|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
47019790|NCT02065622|83268659|FG000|Induction Study|Subject Noncompliance|1|||
47019791|NCT02065622|83268660|FG001|Induction Study|Subject Noncompliance|1|||
47019792|NCT02065622|83268661|FG002|Induction Study|Subject Noncompliance|0|||
47019793|NCT02065622|83268662|FG003|Induction Study|Subject Noncompliance|0|||
47019794|NCT02065622|83268663|FG004|Induction Study|Subject Noncompliance|0|||
47019795|NCT02065622|83268659|FG000|Induction Study|Other, Not Specified|3|||
47019796|NCT02065622|83268660|FG001|Induction Study|Other, Not Specified|2|||
47019797|NCT02065622|83268661|FG002|Induction Study|Other, Not Specified|0|||
47019798|NCT02065622|83268662|FG003|Induction Study|Other, Not Specified|0|||
47019799|NCT02065622|83268663|FG004|Induction Study|Other, Not Specified|0|||
47019800|NCT02065622|83268659|FG000|Maintenance Study|Adverse Event|0|||
47019801|NCT02065622|83268660|FG001|Maintenance Study|Adverse Event|0|||
47019802|NCT02065622|83268661|FG002|Maintenance Study|Adverse Event|25|||
47019803|NCT02065622|83268662|FG003|Maintenance Study|Adverse Event|22|||
47019804|NCT02065622|83268663|FG004|Maintenance Study|Adverse Event|11|||
47019805|NCT02065622|83268659|FG000|Maintenance Study|Withdrawal by Subject|0|||
47019806|NCT02065622|83268660|FG001|Maintenance Study|Withdrawal by Subject|0|||
47019807|NCT02065622|83268661|FG002|Maintenance Study|Withdrawal by Subject|11|||
47019808|NCT02065622|83268662|FG003|Maintenance Study|Withdrawal by Subject|5|||
47019809|NCT02065622|83268663|FG004|Maintenance Study|Withdrawal by Subject|7|||
47019810|NCT02065622|83268659|FG000|Maintenance Study|Lost to Follow-up|0|||
47019811|NCT02065622|83268660|FG001|Maintenance Study|Lost to Follow-up|0|||
47019812|NCT02065622|83268661|FG002|Maintenance Study|Lost to Follow-up|4|||
47019813|NCT02065622|83268662|FG003|Maintenance Study|Lost to Follow-up|1|||
47019814|NCT02065622|83268663|FG004|Maintenance Study|Lost to Follow-up|1|||
47019815|NCT02065622|83268659|FG000|Maintenance Study|Lack of Efficacy|0|||
47019816|NCT02065622|83268660|FG001|Maintenance Study|Lack of Efficacy|0|||
47019817|NCT02065622|83268661|FG002|Maintenance Study|Lack of Efficacy|70|||
47019818|NCT02065622|83268662|FG003|Maintenance Study|Lack of Efficacy|55|||
47019819|NCT02065622|83268663|FG004|Maintenance Study|Lack of Efficacy|19|||
47019820|NCT02065622|83268659|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
47019821|NCT02065622|83268660|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
47019822|NCT02065622|83268661|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
47019823|NCT02065622|83268662|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
46709739|NCT01142232|82925831|FG004|Overall Study|Off Trt for other complicating disease|1|||
47019824|NCT02065622|83268663|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
47019825|NCT02065622|83268659|FG000|Maintenance Study|Subject Non-Compliance|0|||
47019826|NCT02065622|83268660|FG001|Maintenance Study|Subject Non-Compliance|0|||
47019827|NCT02065622|83268661|FG002|Maintenance Study|Subject Non-Compliance|1|||
47019828|NCT02065622|83268662|FG003|Maintenance Study|Subject Non-Compliance|3|||
47019829|NCT02065622|83268663|FG004|Maintenance Study|Subject Non-Compliance|2|||
47019830|NCT02065622|83268659|FG000|Maintenance Study|Other, Not Specified|0|||
47019831|NCT02065622|83268660|FG001|Maintenance Study|Other, Not Specified|0|||
47019832|NCT02065622|83268661|FG002|Maintenance Study|Other, Not Specified|6|||
47019833|NCT02065622|83268662|FG003|Maintenance Study|Other, Not Specified|14|||
47019834|NCT02065622|83268663|FG004|Maintenance Study|Other, Not Specified|2|||
47019835|NCT02065622|83268659|FG000|Maintenance Study|Unknown Reason|0|||
47019836|NCT02065622|83268660|FG001|Maintenance Study|Unknown Reason|0|||
47019837|NCT02065622|83268661|FG002|Maintenance Study|Unknown Reason|0|||
47019838|NCT02065622|83268662|FG003|Maintenance Study|Unknown Reason|1|||
47019839|NCT02065622|83268663|FG004|Maintenance Study|Unknown Reason|0|||
47019840|NCT02117648|83268678|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
47019841|NCT02117648|83268678|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
47019842|NCT02117648|83268678|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
47019843|NCT02117648|83268678|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
47019844|NCT02117648|83268678|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
47019845|NCT02117648|83268678|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
47019846|NCT02117648|83268678|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
47019847|NCT02117648|83268678|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
47019848|NCT02117648|83268678|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
47019849|NCT02117648|83268678|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
47019850|NCT02117648|83268678|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
47019851|NCT02124161|83268688|FG000|Overall Study|Other unspecified|0|||
47019852|NCT02124161|83268689|FG001|Overall Study|Other unspecified|1|||
47019853|NCT02124161|83268688|FG000|Overall Study|Death|1|||
47019854|NCT02124161|83268689|FG001|Overall Study|Death|0|||
47019855|NCT02124161|83268688|FG000|Overall Study|Protocol Violation|2|||
47019856|NCT02124161|83268689|FG001|Overall Study|Protocol Violation|1|||
47019857|NCT02124161|83268688|FG000|Overall Study|Withdrawal by Subject|1|||
47019858|NCT02124161|83268689|FG001|Overall Study|Withdrawal by Subject|2|||
47019859|NCT02124161|83268688|FG000|Overall Study|Adverse Event|2|||
47019860|NCT02124161|83268689|FG001|Overall Study|Adverse Event|0|||
47019861|NCT02124161|83268688|FG000|Overall Study|Does not meet entrance criteria|2|||
47019862|NCT02124161|83268689|FG001|Overall Study|Does not meet entrance criteria|3|||
47019863|NCT02124161|83268688|FG000|Overall Study|No longer meets eligibility criteria|5|||
47019864|NCT02124161|83268689|FG001|Overall Study|No longer meets eligibility criteria|4|||
47019865|NCT02124161|83268688|FG000|Overall Study|Lost to Follow-up|3|||
47019866|NCT02124161|83268689|FG001|Overall Study|Lost to Follow-up|4|||
47019867|NCT02175641|83268704|FG000|Overall Study|Death|3|||
47019868|NCT02175641|83268705|FG001|Overall Study|Death|4|||
47019869|NCT02175641|83268704|FG000|Overall Study|Lost to Follow-up|4|||
47019870|NCT02175641|83268705|FG001|Overall Study|Lost to Follow-up|4|||
47019871|NCT02175641|83268704|FG000|Overall Study|Withdrawal by Subject|7|||
47019872|NCT02175641|83268705|FG001|Overall Study|Withdrawal by Subject|4|||
47019873|NCT02175641|83268704|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
47019874|NCT02175641|83268705|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
47019875|NCT02175641|83268704|FG000|Overall Study|Developed Contraindicated Condition|8|||
47019876|NCT02175641|83268705|FG001|Overall Study|Developed Contraindicated Condition|0|||
47019877|NCT02117570|83268714|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
47019878|NCT02117570|83268715|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
47019879|NCT02117570|83268716|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
47019880|NCT02117570|83268714|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
47019881|NCT02117570|83268715|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
47019882|NCT02117570|83268716|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
47019883|NCT02117570|83268714|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
47019884|NCT02117570|83268715|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
47019885|NCT02117570|83268716|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
47019886|NCT02117570|83268714|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
47019887|NCT02117570|83268715|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
47019888|NCT02117570|83268716|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
47019889|NCT02117570|83268714|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
47019890|NCT02117570|83268715|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
47019891|NCT02117570|83268716|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
47019892|NCT02117570|83268714|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
47019893|NCT02117570|83268715|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
47019894|NCT02117570|83268716|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
46620586|NCT02265510|82770877|FG002|Overall Study|Withdrawal by Subject|2|||
46620587|NCT02265510|82770878|FG003|Overall Study|Withdrawal by Subject|1|||
46620588|NCT02265510|82770879|FG004|Overall Study|Withdrawal by Subject|0|||
46620589|NCT02265510|82770880|FG005|Overall Study|Withdrawal by Subject|2|||
47019895|NCT02117570|83268714|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
47019896|NCT02117570|83268715|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
47019897|NCT02117570|83268716|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
47019898|NCT02123459|83268727|FG000|Washout Period (1 Day)|Adverse Event|1|||
47019899|NCT02123459|83268728|FG001|Washout Period (1 Day)|Adverse Event|0|||
47019900|NCT01853475|83268737|FG000|Overall Study|Withdrawal by Subject|0|||
47019901|NCT01853475|83268738|FG001|Overall Study|Withdrawal by Subject|1|||
47019902|NCT01853475|83268739|FG002|Overall Study|Withdrawal by Subject|0|||
47019903|NCT02151773|83268747|FG000|Overall Study|Protocol Deviation|64|||
47019904|NCT02151461|83268755|FG000|Overall Study|Adverse Event|5|||
47019905|NCT02151461|83268756|FG001|Overall Study|Adverse Event|1|||
47019906|NCT02151461|83268757|FG002|Overall Study|Adverse Event|0|||
47019907|NCT02151461|83268758|FG003|Overall Study|Adverse Event|2|||
47019908|NCT02151461|83268755|FG000|Overall Study|Lost to Follow-up|0|||
47019909|NCT02151461|83268756|FG001|Overall Study|Lost to Follow-up|0|||
47019910|NCT02151461|83268757|FG002|Overall Study|Lost to Follow-up|1|||
47019911|NCT02151461|83268758|FG003|Overall Study|Lost to Follow-up|1|||
47019912|NCT02151461|83268755|FG000|Overall Study|Withdrawal by Subject|1|||
47019913|NCT02151461|83268756|FG001|Overall Study|Withdrawal by Subject|0|||
47019914|NCT02151461|83268757|FG002|Overall Study|Withdrawal by Subject|1|||
47019915|NCT02151461|83268758|FG003|Overall Study|Withdrawal by Subject|1|||
47019916|NCT02151461|83268755|FG000|Overall Study|Treatment discontinuation|0|||
47019917|NCT02151461|83268756|FG001|Overall Study|Treatment discontinuation|0|||
47019918|NCT02151461|83268757|FG002|Overall Study|Treatment discontinuation|1|||
47019919|NCT02151461|83268758|FG003|Overall Study|Treatment discontinuation|0|||
47019920|NCT02117414|83268770|FG000|Overall Study|Death|5|||
47019921|NCT02117414|83268771|FG001|Overall Study|Death|2|||
47019922|NCT02117414|83268770|FG000|Overall Study|Withdrawal by Subject|10|||
47019923|NCT02117414|83268771|FG001|Overall Study|Withdrawal by Subject|4|||
47019924|NCT02091986|83268782|FG000|Overall Study|7 rand in error 1 patient decision|2|||
47019925|NCT02091986|83268783|FG001|Overall Study|7 rand in error 1 patient decision|3|||
47019926|NCT02091986|83268784|FG002|Overall Study|7 rand in error 1 patient decision|3|||
47019927|NCT02091986|83268782|FG000|Overall Study|Lost to Follow-up|1|||
47019928|NCT02091986|83268783|FG001|Overall Study|Lost to Follow-up|0|||
47019929|NCT02091986|83268784|FG002|Overall Study|Lost to Follow-up|0|||
47019930|NCT02091986|83268782|FG000|Overall Study|Withdrawal by Subject|4|||
47019931|NCT02091986|83268783|FG001|Overall Study|Withdrawal by Subject|8|||
47019932|NCT02091986|83268784|FG002|Overall Study|Withdrawal by Subject|3|||
47019933|NCT02091986|83268782|FG000|Overall Study|Adverse Event|0|||
47019934|NCT02091986|83268783|FG001|Overall Study|Adverse Event|0|||
47019935|NCT02091986|83268784|FG002|Overall Study|Adverse Event|2|||
47019936|NCT02091752|83268792|FG000|Overall Study|Study terminated by Sponsor|2|||
47019937|NCT02091752|83268792|FG000|Overall Study|Adverse Event|1|||
47019938|NCT02117024|83268798|FG000|Overall Study|Progressive Disease|26|||
47019939|NCT02117024|83268799|FG001|Overall Study|Progressive Disease|9|||
47019940|NCT02117024|83268798|FG000|Overall Study|Significant Clinical Progression|7|||
47019941|NCT02117024|83268799|FG001|Overall Study|Significant Clinical Progression|4|||
47019942|NCT02117024|83268798|FG000|Overall Study|Death|5|||
47019943|NCT02117024|83268799|FG001|Overall Study|Death|0|||
47019944|NCT02117024|83268798|FG000|Overall Study|Withdrawal by Subject|3|||
47019945|NCT02117024|83268799|FG001|Overall Study|Withdrawal by Subject|1|||
47019946|NCT02117024|83268798|FG000|Overall Study|Protocol Violation|1|||
47019947|NCT02117024|83268799|FG001|Overall Study|Protocol Violation|0|||
47019948|NCT02117024|83268798|FG000|Overall Study|Adverse Event|1|||
47019949|NCT02117024|83268799|FG001|Overall Study|Adverse Event|2|||
47019950|NCT02117024|83268798|FG000|Overall Study|Randomized in Error|1|||
47019951|NCT02117024|83268799|FG001|Overall Study|Randomized in Error|0|||
47019952|NCT02117024|83268798|FG000|Overall Study|Patient returned to primary oncologist|0|||
47019953|NCT02117024|83268799|FG001|Overall Study|Patient returned to primary oncologist|1|||
47019954|NCT02117024|83268798|FG000|Overall Study|Patient took treatment break|0|||
47019955|NCT02117024|83268799|FG001|Overall Study|Patient took treatment break|1|||
47019956|NCT02117024|83268798|FG000|Overall Study|Physician Decision|0|||
47019957|NCT02117024|83268799|FG001|Overall Study|Physician Decision|2|||
46709740|NCT01142232|82925827|FG000|Overall Study|Noncompliance|0|||
46709741|NCT01142232|82925828|FG001|Overall Study|Noncompliance|0|||
46709742|NCT01142232|82925829|FG002|Overall Study|Noncompliance|0|||
46709743|NCT01142232|82925830|FG003|Overall Study|Noncompliance|0|||
47019958|NCT02091440|83268805|FG000|Overall Study|Death|2|||
47019959|NCT02064920|83268811|FG000|Overall Study|Adverse Event|0|||
46709744|NCT01142232|82925831|FG004|Overall Study|Noncompliance|2|||
47019960|NCT02064920|83268812|FG001|Overall Study|Adverse Event|4|||
47019961|NCT02064920|83268811|FG000|Overall Study|Physician Decision|0|||
47019962|NCT02064920|83268812|FG001|Overall Study|Physician Decision|1|||
47019963|NCT02064920|83268811|FG000|Overall Study|Technical Problems|0|||
47019964|NCT02064920|83268812|FG001|Overall Study|Technical Problems|1|||
47019965|NCT02064920|83268811|FG000|Overall Study|Withdrawal by Subject|1|||
47019966|NCT02064920|83268812|FG001|Overall Study|Withdrawal by Subject|3|||
47019967|NCT02151149|83268820|FG000|Treatment Period|Death|2|||
47019968|NCT02151149|83268821|FG001|Treatment Period|Death|3|||
47019969|NCT02151149|83268820|FG000|Treatment Period|Adverse Event|17|||
47019970|NCT02151149|83268821|FG001|Treatment Period|Adverse Event|14|||
47019971|NCT02151149|83268820|FG000|Treatment Period|Progressive Disease|25|||
47019972|NCT02151149|83268821|FG001|Treatment Period|Progressive Disease|24|||
47019973|NCT02151149|83268820|FG000|Treatment Period|Symptomatic Deterioration|2|||
47019974|NCT02151149|83268821|FG001|Treatment Period|Symptomatic Deterioration|10|||
47019975|NCT02151149|83268820|FG000|Treatment Period|Withdrawal by Subject|13|||
47019976|NCT02151149|83268821|FG001|Treatment Period|Withdrawal by Subject|11|||
47019977|NCT02151149|83268820|FG000|Treatment Period|Miscellaneous|8|||
47019978|NCT02151149|83268821|FG001|Treatment Period|Miscellaneous|7|||
47019979|NCT02151149|83268820|FG000|Treatment Period|Participants randomized but not treated|3|||
47019980|NCT02151149|83268821|FG001|Treatment Period|Participants randomized but not treated|2|||
47019981|NCT02151149|83268820|FG000|Follow-Up Period|Lost to Follow-up|2|||
47019982|NCT02151149|83268821|FG001|Follow-Up Period|Lost to Follow-up|3|||
47019983|NCT02151149|83268820|FG000|Follow-Up Period|Death|37|||
47019984|NCT02151149|83268821|FG001|Follow-Up Period|Death|34|||
47019985|NCT02150213|83268827|FG000|Overall Study|Lost to Follow-up|1|||
47019986|NCT02150213|83268827|FG000|Overall Study|Withdrawal by Subject|1|||
47019987|NCT02091362|83268833|FG000|Period 1|Protocol Violation|1|||
47019988|NCT02091362|83268834|FG001|Period 1|Protocol Violation|0|||
47019989|NCT02091362|83268833|FG000|Period 1|Withdrawal by Subject|2|||
47019990|NCT02091362|83268834|FG001|Period 1|Withdrawal by Subject|3|||
47019991|NCT02091362|83268833|FG000|Period 1|Lost to Follow-up|0|||
47019992|NCT02091362|83268834|FG001|Period 1|Lost to Follow-up|1|||
47019993|NCT02091362|83268833|FG000|Period 1|Adverse Event|2|||
47019994|NCT02091362|83268834|FG001|Period 1|Adverse Event|0|||
47019995|NCT02091362|83268833|FG000|Wash-out|Lost to Follow-up|1|||
47019996|NCT02091362|83268834|FG001|Wash-out|Lost to Follow-up|1|||
47019997|NCT02091362|83268833|FG000|Wash-out|Withdrawal by Subject|0|||
47019998|NCT02091362|83268834|FG001|Wash-out|Withdrawal by Subject|2|||
47019999|NCT02091362|83268833|FG000|Period 2|Adverse Event|1|||
47020000|NCT02091362|83268834|FG001|Period 2|Adverse Event|0|||
47020001|NCT02091362|83268833|FG000|Period 2|Lost to Follow-up|0|||
47020002|NCT02091362|83268834|FG001|Period 2|Lost to Follow-up|1|||
47020003|NCT02091362|83268833|FG000|Period 2|Withdrawal by Subject|1|||
47020004|NCT02091362|83268834|FG001|Period 2|Withdrawal by Subject|1|||
47020005|NCT02150057|83268846|FG000|Overall Study|Lost to Follow-up|6|||
47020006|NCT02150057|83268847|FG001|Overall Study|Lost to Follow-up|4|||
47020007|NCT02064296|83268856|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
47020008|NCT02064296|83268857|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
47020009|NCT02064296|83268858|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
47020010|NCT02064296|83268856|FG000|Intervention|Withdrawal by Subject|0|||
47020011|NCT02064296|83268857|FG001|Intervention|Withdrawal by Subject|1|||
47020012|NCT02064296|83268858|FG002|Intervention|Withdrawal by Subject|2|||
47020013|NCT02063984|83268870|FG000|Overall Study|Lost to Follow-up|6|||
47020014|NCT02063984|83268871|FG001|Overall Study|Lost to Follow-up|5|||
47020015|NCT02091284|83268883|FG000|Overall Study|Withdrawal by Subject|2|||
47020016|NCT02091284|83268884|FG001|Overall Study|Withdrawal by Subject|1|||
47020017|NCT02091284|83268883|FG000|Overall Study|unreliable data|1|||
47020018|NCT02091284|83268884|FG001|Overall Study|unreliable data|0|||
47020019|NCT02115386|83268892|FG000|Overall Study|Protocol Violation|1|||
47020020|NCT02115386|83268892|FG000|Overall Study|Administrative - trial was terminated|6|||
47020021|NCT02091206|83268900|FG000|Treatment Period|Adverse Event|0|||
47020022|NCT02091206|83268901|FG001|Treatment Period|Adverse Event|1|||
47020023|NCT02091206|83268902|FG002|Treatment Period|Adverse Event|0|||
47020024|NCT02091206|83268903|FG003|Treatment Period|Adverse Event|0|||
47020025|NCT02091206|83268900|FG000|Treatment Period|Met withdrawal criteria|0|||
47020026|NCT02091206|83268901|FG001|Treatment Period|Met withdrawal criteria|0|||
47020027|NCT02091206|83268902|FG002|Treatment Period|Met withdrawal criteria|1|||
47020028|NCT02091206|83268903|FG003|Treatment Period|Met withdrawal criteria|0|||
47020029|NCT02091206|83268900|FG000|Taper Period|Participant refused study drug|1|||
47020030|NCT02091206|83268901|FG001|Taper Period|Participant refused study drug|0|||
47020031|NCT02091206|83268902|FG002|Taper Period|Participant refused study drug|0|||
47020032|NCT02091206|83268903|FG003|Taper Period|Participant refused study drug|1|||
47020033|NCT02091206|83268900|FG000|Taper Period|Lost to Follow-up|0|||
47020034|NCT02091206|83268901|FG001|Taper Period|Lost to Follow-up|0|||
47020035|NCT02091206|83268902|FG002|Taper Period|Lost to Follow-up|0|||
47020036|NCT02091206|83268903|FG003|Taper Period|Lost to Follow-up|1|||
47020037|NCT02090426|83268915|FG000|Overall Study|Lost to Follow-up|12|||
46709745|NCT01140906|82925847|FG000|Overall Study|Adverse Event|7|||
47020038|NCT02090426|83268916|FG001|Overall Study|Lost to Follow-up|6|||
47020039|NCT02063828|83268925|FG000|Overall Study|Withdrawal by Subject|4|||
47020040|NCT02063828|83268926|FG001|Overall Study|Withdrawal by Subject|6|||
47020041|NCT02063828|83268927|FG002|Overall Study|Withdrawal by Subject|3|||
47020042|NCT02063828|83268925|FG000|Overall Study|Death|0|||
47020043|NCT02063828|83268926|FG001|Overall Study|Death|0|||
47020044|NCT02063828|83268927|FG002|Overall Study|Death|1|||
47020045|NCT02063672|83268937|FG000|Overall Study|Ongoing Follow-up|27|||
47020046|NCT02063672|83268938|FG001|Overall Study|Ongoing Follow-up|14|||
47020047|NCT02063672|83268937|FG000|Overall Study|Death|5|||
47020048|NCT02063672|83268938|FG001|Overall Study|Death|3|||
47020049|NCT02063672|83268937|FG000|Overall Study|Lost to Follow-up|1|||
47020050|NCT02063672|83268938|FG001|Overall Study|Lost to Follow-up|3|||
47020051|NCT02063672|83268937|FG000|Overall Study|Withdrawal by Subject|2|||
47020052|NCT02063672|83268938|FG001|Overall Study|Withdrawal by Subject|2|||
47020053|NCT02062658|83268944|FG000|Overall Study|Withdrawal by Subject|1|||
47020054|NCT02062658|83268944|FG000|Overall Study|Lack of Efficacy|1|||
47020055|NCT02115308|83268950|FG000|Overall Study|Safety Screening|2|||
47020056|NCT02115308|83268951|FG001|Overall Study|Safety Screening|2|||
47020057|NCT02114684|83268963|FG000|Overall Study|Death|6|||
47020058|NCT02114684|83268964|FG001|Overall Study|Death|4|||
47020059|NCT02114684|83268963|FG000|Overall Study|Lost to Follow-up|1|||
47020060|NCT02114684|83268964|FG001|Overall Study|Lost to Follow-up|2|||
47020061|NCT02114684|83268963|FG000|Overall Study|Withdrawal by Subject|1|||
47020062|NCT02114684|83268964|FG001|Overall Study|Withdrawal by Subject|2|||
47020063|NCT02114684|83268963|FG000|Overall Study|Relocation|3|||
47020064|NCT02114684|83268964|FG001|Overall Study|Relocation|1|||
47020065|NCT02114684|83268963|FG000|Overall Study|Rifampicin resistant on culture|0|||
47020066|NCT02114684|83268964|FG001|Overall Study|Rifampicin resistant on culture|1|||
47020067|NCT02114684|83268963|FG000|Overall Study|Patient Incarcerated|1|||
47020068|NCT02114684|83268964|FG001|Overall Study|Patient Incarcerated|0|||
47020069|NCT02090114|83268978|FG000|Overall Study|Withdrawal by Subject|3|||
47020070|NCT02090114|83268979|FG001|Overall Study|Withdrawal by Subject|6|||
47020071|NCT02090114|83268980|FG002|Overall Study|Withdrawal by Subject|2|||
47020072|NCT02090114|83268981|FG003|Overall Study|Withdrawal by Subject|1|||
47020073|NCT02090114|83268978|FG000|Overall Study|Physician Decision|5|||
47020074|NCT02090114|83268979|FG001|Overall Study|Physician Decision|0|||
47020075|NCT02090114|83268980|FG002|Overall Study|Physician Decision|1|||
47020076|NCT02090114|83268981|FG003|Overall Study|Physician Decision|1|||
47020077|NCT02090114|83268978|FG000|Overall Study|Adverse Event|1|||
47020078|NCT02090114|83268979|FG001|Overall Study|Adverse Event|2|||
47020079|NCT02090114|83268980|FG002|Overall Study|Adverse Event|2|||
47020080|NCT02090114|83268981|FG003|Overall Study|Adverse Event|0|||
47020081|NCT02090114|83268978|FG000|Overall Study|Progressive Disease|20|||
47020082|NCT02090114|83268979|FG001|Overall Study|Progressive Disease|21|||
47020083|NCT02090114|83268980|FG002|Overall Study|Progressive Disease|23|||
47020084|NCT02090114|83268981|FG003|Overall Study|Progressive Disease|6|||
47020085|NCT02090114|83268978|FG000|Overall Study|Death|1|||
47020086|NCT02090114|83268979|FG001|Overall Study|Death|0|||
47020087|NCT02090114|83268980|FG002|Overall Study|Death|1|||
47020088|NCT02090114|83268981|FG003|Overall Study|Death|0|||
47020089|NCT01623050|83268991|FG000|Overall Study|Lost to Follow-up|9|||
47020090|NCT02089334|83268999|FG000|Overall Study|Withdrawal by Subject|0|||
47020091|NCT02089334|83269000|FG001|Overall Study|Withdrawal by Subject|0|||
47020092|NCT02089334|83269001|FG002|Overall Study|Withdrawal by Subject|0|||
47020093|NCT02089334|83269002|FG003|Overall Study|Withdrawal by Subject|2|||
47020094|NCT02089334|83268999|FG000|Overall Study|Adverse Event|0|||
47020095|NCT02089334|83269000|FG001|Overall Study|Adverse Event|0|||
47020096|NCT02089334|83269001|FG002|Overall Study|Adverse Event|0|||
47020097|NCT02089334|83269002|FG003|Overall Study|Adverse Event|2|||
47020098|NCT02089334|83268999|FG000|Overall Study|Progressive disease|0|||
47020099|NCT02089334|83269000|FG001|Overall Study|Progressive disease|0|||
47020100|NCT02089334|83269001|FG002|Overall Study|Progressive disease|0|||
47020101|NCT02089334|83269002|FG003|Overall Study|Progressive disease|2|||
47020102|NCT02089334|83268999|FG000|Overall Study|Physician Decision|0|||
47020103|NCT02089334|83269000|FG001|Overall Study|Physician Decision|0|||
47020104|NCT02089334|83269001|FG002|Overall Study|Physician Decision|1|||
47020105|NCT02089334|83269002|FG003|Overall Study|Physician Decision|1|||
47020106|NCT02114606|83269015|FG000|Overall Study|Unable to swallow Cytosponge|6|||
47020107|NCT02113436|83269021|FG000|Period 1: 8 Weeks|Adverse Event|1|||
47020108|NCT02113436|83269022|FG001|Period 1: 8 Weeks|Adverse Event|0|||
47020109|NCT02113436|83269023|FG002|Period 1: 8 Weeks|Adverse Event|0|||
47020110|NCT02113436|83269024|FG003|Period 1: 8 Weeks|Adverse Event|0|||
47020111|NCT02113436|83269021|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
47020112|NCT02113436|83269022|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
47020113|NCT02113436|83269023|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
47020114|NCT02113436|83269024|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
47020115|NCT02113436|83269021|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
47020116|NCT02113436|83269022|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
47020117|NCT02113436|83269023|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
47020118|NCT02113436|83269024|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
47020119|NCT02113436|83269021|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
47020120|NCT02113436|83269022|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
47020121|NCT02113436|83269023|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
47020122|NCT02113436|83269024|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
47020123|NCT02113436|83269021|FG000|Period 2: 16 Weeks|Adverse Event|0|||
47020124|NCT02113436|83269022|FG001|Period 2: 16 Weeks|Adverse Event|0|||
47020125|NCT02113436|83269023|FG002|Period 2: 16 Weeks|Adverse Event|4|||
47020126|NCT02113436|83269024|FG003|Period 2: 16 Weeks|Adverse Event|5|||
47020127|NCT02113436|83269021|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
47020128|NCT02113436|83269022|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
47020129|NCT02113436|83269023|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
47020130|NCT02113436|83269024|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
47020131|NCT02113436|83269021|FG000|Period 2: 16 Weeks|Physician Decision|0|||
47020132|NCT02113436|83269022|FG001|Period 2: 16 Weeks|Physician Decision|0|||
47020133|NCT02113436|83269023|FG002|Period 2: 16 Weeks|Physician Decision|2|||
47020134|NCT02113436|83269024|FG003|Period 2: 16 Weeks|Physician Decision|0|||
47020135|NCT02113436|83269021|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
47020136|NCT02113436|83269022|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
47020137|NCT02113436|83269023|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
47020138|NCT02113436|83269024|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
47020139|NCT02113124|83269035|FG000|Overall Study|Unable to retrieve blood sample|1|||
47020140|NCT02113124|83269036|FG001|Overall Study|Unable to retrieve blood sample|1|||
47020141|NCT02087774|83269044|FG000|Overall Study|Were absent day of data collection|8|||
47020142|NCT02087774|83269045|FG001|Overall Study|Were absent day of data collection|20|||
47020143|NCT02111564|83269053|FG000|Overall Study|Death|109|||
47020144|NCT02111564|83269054|FG001|Overall Study|Death|120|||
47020145|NCT02111564|83269053|FG000|Overall Study|Lost to Follow-up|2|||
47020146|NCT02111564|83269054|FG001|Overall Study|Lost to Follow-up|3|||
47020147|NCT02111564|83269053|FG000|Overall Study|Withdrawal by Subject|20|||
47020148|NCT02111564|83269054|FG001|Overall Study|Withdrawal by Subject|20|||
47020149|NCT02087150|83269063|FG000|Overall Study|Death|0|||
47020150|NCT02087150|83269064|FG001|Overall Study|Death|1|||
47020151|NCT02087150|83269065|FG002|Overall Study|Death|0|||
47020152|NCT02087150|83269063|FG000|Overall Study|Lost to Follow-up|6|||
47020153|NCT02087150|83269064|FG001|Overall Study|Lost to Follow-up|13|||
47020154|NCT02087150|83269065|FG002|Overall Study|Lost to Follow-up|7|||
47020155|NCT02087150|83269063|FG000|Overall Study|Withdrawal by Subject|2|||
47020156|NCT02087150|83269064|FG001|Overall Study|Withdrawal by Subject|5|||
47020157|NCT02087150|83269065|FG002|Overall Study|Withdrawal by Subject|3|||
47020158|NCT02087150|83269063|FG000|Overall Study|Physician Decision|0|||
47020159|NCT02087150|83269064|FG001|Overall Study|Physician Decision|1|||
47020160|NCT02087150|83269065|FG002|Overall Study|Physician Decision|0|||
47020161|NCT02087150|83269063|FG000|Overall Study|Procedure not done|1|||
47020162|NCT02087150|83269064|FG001|Overall Study|Procedure not done|13|||
47020163|NCT02087150|83269065|FG002|Overall Study|Procedure not done|0|||
47020164|NCT02087150|83269063|FG000|Overall Study|F/U not completed w/in study window|0|||
47020165|NCT02087150|83269064|FG001|Overall Study|F/U not completed w/in study window|0|||
47020166|NCT02087150|83269065|FG002|Overall Study|F/U not completed w/in study window|1|||
47020167|NCT02087150|83269063|FG000|Overall Study|Other|1|||
47020168|NCT02087150|83269064|FG001|Overall Study|Other|0|||
47020169|NCT02087150|83269065|FG002|Overall Study|Other|0|||
47020170|NCT02087150|83269063|FG000|Overall Study|Pt moved out of town|0|||
47020171|NCT02087150|83269064|FG001|Overall Study|Pt moved out of town|1|||
47020172|NCT02087150|83269065|FG002|Overall Study|Pt moved out of town|0|||
47020173|NCT02111174|83269076|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
47020174|NCT02111174|83269077|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
47020175|NCT02111174|83269076|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
47020176|NCT02111174|83269077|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
47020177|NCT02111174|83269076|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
47020178|NCT02111174|83269077|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
47020179|NCT02111174|83269076|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
47020180|NCT02111174|83269077|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
47020181|NCT02111096|83269086|FG000|Overall Study|Adverse Event|4|||
47020182|NCT02111096|83269087|FG001|Overall Study|Adverse Event|1|||
46709746|NCT01140906|82925848|FG001|Overall Study|Adverse Event|10|||
46709747|NCT01140906|82925849|FG002|Overall Study|Adverse Event|17|||
47020183|NCT02111096|83269088|FG002|Overall Study|Adverse Event|2|||
47020184|NCT02111096|83269086|FG000|Overall Study|Non-Compliance with Study Drug|1|||
47020185|NCT02111096|83269087|FG001|Overall Study|Non-Compliance with Study Drug|1|||
47020186|NCT02111096|83269088|FG002|Overall Study|Non-Compliance with Study Drug|0|||
47020187|NCT02111096|83269086|FG000|Overall Study|Lost to Follow Up|1|||
47020188|NCT02111096|83269087|FG001|Overall Study|Lost to Follow Up|1|||
47020189|NCT02111096|83269088|FG002|Overall Study|Lost to Follow Up|1|||
47020190|NCT02111096|83269086|FG000|Overall Study|Physician Decision|0|||
47020191|NCT02111096|83269087|FG001|Overall Study|Physician Decision|1|||
47020192|NCT02111096|83269088|FG002|Overall Study|Physician Decision|0|||
47020193|NCT02111096|83269086|FG000|Overall Study|Protocol Violation|1|||
47020194|NCT02111096|83269087|FG001|Overall Study|Protocol Violation|0|||
47020195|NCT02111096|83269088|FG002|Overall Study|Protocol Violation|1|||
47020196|NCT02111096|83269086|FG000|Overall Study|Terminated by Sponsor|53|||
47020197|NCT02111096|83269087|FG001|Overall Study|Terminated by Sponsor|35|||
47020198|NCT02111096|83269088|FG002|Overall Study|Terminated by Sponsor|54|||
47020199|NCT02111096|83269086|FG000|Overall Study|Withdrawal by Subject|4|||
47020200|NCT02111096|83269087|FG001|Overall Study|Withdrawal by Subject|2|||
47020201|NCT02111096|83269088|FG002|Overall Study|Withdrawal by Subject|8|||
47020202|NCT02110706|83269101|FG000|Overall Study|Adverse Event|2|||
47020203|NCT02110706|83269102|FG001|Overall Study|Adverse Event|3|||
47020204|NCT02110706|83269101|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
47020205|NCT02110706|83269102|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
47020206|NCT02110238|83269112|FG000|12 Week Pivotal Phase|Adverse Event|3|||
47020207|NCT02110238|83269113|FG001|12 Week Pivotal Phase|Adverse Event|0|||
47020208|NCT02110238|83269112|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
47020209|NCT02110238|83269113|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
47020210|NCT02110238|83269112|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
47020211|NCT02110238|83269113|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
47020212|NCT02110238|83269112|FG000|12 Week Pivotal Phase|Physician Decision|0|||
47020213|NCT02110238|83269113|FG001|12 Week Pivotal Phase|Physician Decision|2|||
47020214|NCT02110238|83269112|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
47020215|NCT02110238|83269113|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
47020216|NCT02110238|83269112|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
47020217|NCT02110238|83269113|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
47020218|NCT02110238|83269112|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
47020219|NCT02110238|83269113|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
47020220|NCT02110238|83269112|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
47020221|NCT02110238|83269113|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
47020222|NCT02110238|83269112|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
47020223|NCT02110238|83269113|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
47020224|NCT02110238|83269112|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
47020225|NCT02110238|83269113|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
47020226|NCT02110238|83269112|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
47020227|NCT02110238|83269113|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
47020228|NCT02108912|83269121|FG000|Overall Study|Lost to Follow-up|1|||
47020229|NCT02108912|83269122|FG001|Overall Study|Lost to Follow-up|1|||
47020230|NCT02108912|83269121|FG000|Overall Study|lack of transportation|1|||
47020231|NCT02108912|83269122|FG001|Overall Study|lack of transportation|0|||
47020232|NCT02108912|83269121|FG000|Overall Study|high blood pressure|1|||
47020233|NCT02108912|83269122|FG001|Overall Study|high blood pressure|0|||
47020234|NCT02108600|83269130|FG000|Overall Study|Withdrawal by Subject|2|||
47020235|NCT02108600|83269131|FG001|Overall Study|Withdrawal by Subject|0|||
47020236|NCT02108600|83269130|FG000|Overall Study|Lost to Follow-up|1|||
47020237|NCT02108600|83269131|FG001|Overall Study|Lost to Follow-up|1|||
47020238|NCT02107898|83269139|FG000|Overall Study|Adverse Event|4|||
47020239|NCT02107898|83269140|FG001|Overall Study|Adverse Event|7|||
47020240|NCT02107898|83269139|FG000|Overall Study|Poor compliance to protocol|0|||
47020241|NCT02107898|83269140|FG001|Overall Study|Poor compliance to protocol|1|||
47020242|NCT02107898|83269139|FG000|Overall Study|Participant moved|0|||
47020243|NCT02107898|83269140|FG001|Overall Study|Participant moved|2|||
47020244|NCT02107898|83269139|FG000|Overall Study|Consent withdrawn by participant|2|||
47020245|NCT02107898|83269140|FG001|Overall Study|Consent withdrawn by participant|1|||
47020246|NCT02107898|83269139|FG000|Overall Study|Randomized but not treated|0|||
47020247|NCT02107898|83269140|FG001|Overall Study|Randomized but not treated|1|||
47020248|NCT02059148|83269146|FG000|Treatment 1|Protocol Violation|0|||
47020249|NCT02059148|83269147|FG001|Treatment 1|Protocol Violation|0|||
47020250|NCT02059148|83269148|FG002|Treatment 1|Protocol Violation|0|||
47020251|NCT02059148|83269149|FG003|Treatment 1|Protocol Violation|0|||
47020252|NCT02059148|83269150|FG004|Treatment 1|Protocol Violation|0|||
47020253|NCT02059148|83269151|FG005|Treatment 1|Protocol Violation|1|||
47020254|NCT02058992|83269162|FG000|Overall Study|Lost to Follow-up|4|||
47020255|NCT02058992|83269162|FG000|Overall Study|Protocol Violation|92|||
47020256|NCT02058992|83269162|FG000|Overall Study|CRF Uncollected|20|||
47020257|NCT02058836|83269168|FG000|Overall Study|Withdrawal by Subject|1|||
47020258|NCT02058836|83269169|FG001|Overall Study|Withdrawal by Subject|1|||
47020259|NCT02107274|83269177|FG000|Treatment vs. Placebo|Adverse Event|3|||
47020260|NCT02107274|83269178|FG001|Treatment vs. Placebo|Adverse Event|0|||
47020261|NCT02107274|83269177|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
47020262|NCT02107274|83269178|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
47020263|NCT02107274|83269177|FG000|Control Phase|Lost to Follow-up|1|||
47020264|NCT02107274|83269178|FG001|Control Phase|Lost to Follow-up|1|||
47020265|NCT02107274|83269177|FG000|Control Phase|Death|2|||
47020266|NCT02107274|83269178|FG001|Control Phase|Death|0|||
47020267|NCT02107274|83269177|FG000|Control Phase|Adverse Event|0|||
47020268|NCT02107274|83269178|FG001|Control Phase|Adverse Event|1|||
47020269|NCT02174627|83269186|FG000|Overall Study|Missing|0|||
47020270|NCT02174627|83269187|FG001|Overall Study|Missing|1|||
47020271|NCT02174627|83269186|FG000|Overall Study|Incorrect enrolment before randomization|0|||
47020272|NCT02174627|83269187|FG001|Overall Study|Incorrect enrolment before randomization|1|||
47020273|NCT02174627|83269186|FG000|Overall Study|Participant decision|84|||
47020274|NCT02174627|83269187|FG001|Overall Study|Participant decision|128|||
47020275|NCT02173769|83269193|FG000|Overall Study|Protocol Violation|4|||
47020276|NCT02121509|83269200|FG000|Washout Period (35 Days)|Adverse Event|1|||
47020277|NCT02121509|83269201|FG001|Washout Period (35 Days)|Adverse Event|1|||
47020278|NCT02121509|83269202|FG002|Washout Period (35 Days)|Adverse Event|0|||
47020279|NCT02121509|83269203|FG003|Washout Period (35 Days)|Adverse Event|0|||
47020280|NCT02121509|83269200|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
47020281|NCT02121509|83269201|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
47020282|NCT02121509|83269202|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
47020283|NCT02121509|83269203|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
47020284|NCT02121509|83269200|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
47020285|NCT02121509|83269201|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
47020286|NCT02121509|83269202|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
47020287|NCT02121509|83269203|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
47020288|NCT02149199|83269216|FG000|Overall Study|Study specific withdrawal criteria|4|||
47020289|NCT02149199|83269217|FG001|Overall Study|Study specific withdrawal criteria|21|||
47020290|NCT02149199|83269218|FG002|Overall Study|Study specific withdrawal criteria|6|||
47020291|NCT02149199|83269216|FG000|Overall Study|Other|20|||
47020292|NCT02149199|83269217|FG001|Overall Study|Other|25|||
47020293|NCT02149199|83269218|FG002|Overall Study|Other|20|||
47020294|NCT02149199|83269216|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
47020295|NCT02149199|83269217|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
47020296|NCT02149199|83269218|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
47020297|NCT02149199|83269216|FG000|Overall Study|Withdrawal by Subject|75|||
47020298|NCT02149199|83269217|FG001|Overall Study|Withdrawal by Subject|93|||
47020299|NCT02149199|83269218|FG002|Overall Study|Withdrawal by Subject|77|||
47020300|NCT02149199|83269216|FG000|Overall Study|Protocol Violation|16|||
47020301|NCT02149199|83269217|FG001|Overall Study|Protocol Violation|13|||
47020302|NCT02149199|83269218|FG002|Overall Study|Protocol Violation|15|||
47020303|NCT02149199|83269216|FG000|Overall Study|Lost to Follow-up|3|||
47020304|NCT02149199|83269217|FG001|Overall Study|Lost to Follow-up|12|||
47020305|NCT02149199|83269218|FG002|Overall Study|Lost to Follow-up|11|||
47020306|NCT02149199|83269216|FG000|Overall Study|Death|0|||
47020307|NCT02149199|83269217|FG001|Overall Study|Death|0|||
47020308|NCT02149199|83269218|FG002|Overall Study|Death|1|||
47020309|NCT02149199|83269216|FG000|Overall Study|Adverse Event|6|||
47020310|NCT02149199|83269217|FG001|Overall Study|Adverse Event|15|||
47020311|NCT02149199|83269218|FG002|Overall Study|Adverse Event|9|||
47020312|NCT02120417|83269228|FG000|Overall Study|Death|5|||
47020313|NCT02120417|83269229|FG001|Overall Study|Death|1|||
47020314|NCT02120417|83269228|FG000|Overall Study|Adverse Event|3|||
47020315|NCT02120417|83269229|FG001|Overall Study|Adverse Event|9|||
47020316|NCT02120417|83269228|FG000|Overall Study|Participant decision|4|||
47020317|NCT02120417|83269229|FG001|Overall Study|Participant decision|4|||
47020318|NCT02120417|83269228|FG000|Overall Study|Disease progression|41|||
47020319|NCT02120417|83269229|FG001|Overall Study|Disease progression|45|||
47020320|NCT02120417|83269228|FG000|Overall Study|Noncompliance with study treatment|0|||
47020321|NCT02120417|83269229|FG001|Overall Study|Noncompliance with study treatment|2|||
47020322|NCT02120417|83269228|FG000|Overall Study|Physician Decision|2|||
47020323|NCT02120417|83269229|FG001|Overall Study|Physician Decision|3|||
47020324|NCT02120417|83269228|FG000|Overall Study|Other unspecified|5|||
47020325|NCT02120417|83269229|FG001|Overall Study|Other unspecified|4|||
46709748|NCT01140906|82925850|FG003|Overall Study|Adverse Event|7|||
46709749|NCT01140906|82925847|FG000|Overall Study|Lack of Efficacy|6|||
47020326|NCT02148263|83269237|FG000|Overall Study|Withdrawal by Subject|3|||
47020327|NCT02148263|83269238|FG001|Overall Study|Withdrawal by Subject|2|||
47020328|NCT02147561|83269244|FG000|Overall Study|Lost to Follow-up|3|||
47020329|NCT02147561|83269244|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
47020330|NCT02058368|83269250|FG000|Overall Study|Adverse Event|15|||
47020331|NCT02058368|83269251|FG001|Overall Study|Adverse Event|20|||
47020332|NCT02058368|83269250|FG000|Overall Study|Lack of Efficacy|0|||
47020333|NCT02058368|83269251|FG001|Overall Study|Lack of Efficacy|1|||
47020334|NCT02058368|83269250|FG000|Overall Study|Protocol Violation|0|||
47020335|NCT02058368|83269251|FG001|Overall Study|Protocol Violation|4|||
47020336|NCT02058368|83269250|FG000|Overall Study|Lost to Follow-up|2|||
47020337|NCT02058368|83269251|FG001|Overall Study|Lost to Follow-up|0|||
47020338|NCT02058368|83269250|FG000|Overall Study|Physician Decision|2|||
47020339|NCT02058368|83269251|FG001|Overall Study|Physician Decision|3|||
47020340|NCT02058368|83269250|FG000|Overall Study|Withdrawal by Subject|22|||
47020341|NCT02058368|83269251|FG001|Overall Study|Withdrawal by Subject|26|||
47020342|NCT02107196|83269259|FG000|12-week Treatment Period|Adverse Event|6|||
47020343|NCT02107196|83269260|FG001|12-week Treatment Period|Adverse Event|3|||
47020344|NCT02107196|83269259|FG000|12-week Treatment Period|Lack of Efficacy|2|||
47020345|NCT02107196|83269260|FG001|12-week Treatment Period|Lack of Efficacy|1|||
47020346|NCT02107196|83269259|FG000|12-week Treatment Period|Lost to Follow-up|3|||
47020347|NCT02107196|83269260|FG001|12-week Treatment Period|Lost to Follow-up|6|||
47020348|NCT02107196|83269259|FG000|12-week Treatment Period|Physician Decision|0|||
47020349|NCT02107196|83269260|FG001|12-week Treatment Period|Physician Decision|1|||
47020350|NCT02107196|83269259|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
47020351|NCT02107196|83269260|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
47020352|NCT02107196|83269259|FG000|12-week Treatment Period|Protocol Violation|7|||
47020353|NCT02107196|83269260|FG001|12-week Treatment Period|Protocol Violation|8|||
47020354|NCT02107196|83269259|FG000|12-week Treatment Period|Reason Missing|11|||
47020355|NCT02107196|83269260|FG001|12-week Treatment Period|Reason Missing|8|||
47020356|NCT02107196|83269259|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
47020357|NCT02107196|83269260|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
47020358|NCT02107196|83269259|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
47020359|NCT02107196|83269260|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
47020360|NCT02107196|83269259|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
47020361|NCT02107196|83269260|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
47020362|NCT02107196|83269259|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
47020363|NCT02107196|83269260|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
47020364|NCT02058290|83269268|FG000|Overall Study|Protocol Violation|2|||
47020365|NCT02058290|83269269|FG001|Overall Study|Protocol Violation|1|||
47020366|NCT02058290|83269268|FG000|Overall Study|Physician Decision|1|||
47020367|NCT02058290|83269269|FG001|Overall Study|Physician Decision|0|||
47020368|NCT02058290|83269268|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
47020369|NCT02058290|83269269|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
47020370|NCT02058290|83269268|FG000|Overall Study|Withdrawal by Subject|0|||
47020371|NCT02058290|83269269|FG001|Overall Study|Withdrawal by Subject|1|||
47020372|NCT02082158|83269281|FG000|Overall Study|Withdrawal by Subject|0|||
47020373|NCT02082158|83269282|FG001|Overall Study|Withdrawal by Subject|0|||
47020374|NCT02082158|83269283|FG002|Overall Study|Withdrawal by Subject|0|||
47020375|NCT02082158|83269284|FG003|Overall Study|Withdrawal by Subject|0|||
47020376|NCT02082158|83269285|FG004|Overall Study|Withdrawal by Subject|1|||
47020377|NCT02082158|83269286|FG005|Overall Study|Withdrawal by Subject|0|||
47020378|NCT02082158|83269281|FG000|Overall Study|Failed Fit-testing|8|||
47020379|NCT02082158|83269282|FG001|Overall Study|Failed Fit-testing|8|||
47020380|NCT02082158|83269283|FG002|Overall Study|Failed Fit-testing|14|||
47020381|NCT02082158|83269284|FG003|Overall Study|Failed Fit-testing|4|||
47020382|NCT02082158|83269285|FG004|Overall Study|Failed Fit-testing|3|||
47020383|NCT02082158|83269286|FG005|Overall Study|Failed Fit-testing|7|||
47020384|NCT02106884|83269308|FG000|Overall Study|Change of diagnosis/exclusion|0|||
47020385|NCT02106884|83269309|FG001|Overall Study|Change of diagnosis/exclusion|1|||
47020386|NCT02081846|83269320|FG000|Overall Study|Withdrawal by Subject|1|||
47020387|NCT02081846|83269321|FG001|Overall Study|Withdrawal by Subject|0|||
47020388|NCT02081846|83269320|FG000|Overall Study|invalid consent|1|||
47020389|NCT02081846|83269321|FG001|Overall Study|invalid consent|0|||
47020390|NCT02081690|83269327|FG000|Overall Study|Death|3|||
47020391|NCT02081690|83269327|FG000|Overall Study|Physician Decision|3|||
47020392|NCT02081690|83269327|FG000|Overall Study|Withdrawal by Subject|1|||
47020393|NCT02057666|83269333|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
47020394|NCT02057666|83269334|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
47020395|NCT02057666|83269333|FG000|Double Blind Treatment Period|Poor tolerability|7|||
47020396|NCT02057666|83269334|FG001|Double Blind Treatment Period|Poor tolerability|2|||
47020397|NCT02057666|83269333|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
47020398|NCT02057666|83269334|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
47020399|NCT02057666|83269333|FG000|Double Blind Treatment Period|Physician Decision|1|||
47020400|NCT02057666|83269334|FG001|Double Blind Treatment Period|Physician Decision|0|||
47020401|NCT02057666|83269333|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
47020402|NCT02057666|83269334|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
47020403|NCT02057666|83269333|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
47020404|NCT02057666|83269334|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
47020405|NCT02057666|83269333|FG000|Double Blind Treatment Period|Sponsor's request|70|||
47020406|NCT02057666|83269334|FG001|Double Blind Treatment Period|Sponsor's request|34|||
47020407|NCT02057666|83269333|FG000|Open-Label Treatment Period|Poor tolerability|0|||
47020408|NCT02057666|83269334|FG001|Open-Label Treatment Period|Poor tolerability|1|||
47020409|NCT02057666|83269333|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
47020410|NCT02057666|83269334|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
47020411|NCT02057666|83269333|FG000|Open-Label Treatment Period|Sponsor's request|0|||
47020412|NCT02057666|83269334|FG001|Open-Label Treatment Period|Sponsor's request|4|||
47020413|NCT01625000|83269345|FG000|Overall Study|Physician Decision|15|||
47020414|NCT01625000|83269346|FG001|Overall Study|Physician Decision|7|||
47020415|NCT01625000|83269347|FG002|Overall Study|Physician Decision|7|||
47020416|NCT01625000|83269348|FG003|Overall Study|Physician Decision|2|||
47020417|NCT01625000|83269349|FG004|Overall Study|Physician Decision|15|||
47020418|NCT01625000|83269345|FG000|Overall Study|Protocol Violation|3|||
47020419|NCT01625000|83269346|FG001|Overall Study|Protocol Violation|10|||
47020420|NCT01625000|83269347|FG002|Overall Study|Protocol Violation|4|||
46911306|NCT03210961|83140941|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911307|NCT03210961|83140942|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911308|NCT03210961|83140943|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
46911309|NCT03210961|83140944|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
46911310|NCT03210961|83140930|FG000|Overall Study|Other|0|||
46911311|NCT03210961|83140931|FG001|Overall Study|Other|0|||
46911312|NCT03210961|83140932|FG002|Overall Study|Other|0|||
46911313|NCT03210961|83140933|FG003|Overall Study|Other|1|||
46911314|NCT03210961|83140934|FG004|Overall Study|Other|0|||
46911315|NCT03210961|83140935|FG005|Overall Study|Other|0|||
46911316|NCT03210961|83140936|FG006|Overall Study|Other|1|||
46911317|NCT03210961|83140937|FG007|Overall Study|Other|0|||
46911318|NCT03210961|83140938|FG008|Overall Study|Other|0|||
46911319|NCT03210961|83140939|FG009|Overall Study|Other|0|||
46911320|NCT03210961|83140940|FG010|Overall Study|Other|1|||
46911321|NCT03210961|83140941|FG011|Overall Study|Other|0|||
46911322|NCT03210961|83140942|FG012|Overall Study|Other|2|||
46911323|NCT03210961|83140943|FG013|Overall Study|Other|2|||
46911324|NCT03210961|83140944|FG014|Overall Study|Other|0|||
46911325|NCT03242759|83140997|FG000|Overall Study|Adverse Event|5|||
46911326|NCT03242759|83140998|FG001|Overall Study|Adverse Event|1|||
46911327|NCT03242759|83140997|FG000|Overall Study|Withdrawal by Subject|4|||
46911328|NCT03242759|83140998|FG001|Overall Study|Withdrawal by Subject|3|||
46911329|NCT03242759|83140997|FG000|Overall Study|Lost to Follow-up|3|||
46911330|NCT03242759|83140998|FG001|Overall Study|Lost to Follow-up|1|||
46911331|NCT03242759|83140997|FG000|Overall Study|Administrative problems|1|||
46911332|NCT03242759|83140998|FG001|Overall Study|Administrative problems|1|||
46911333|NCT03242759|83140997|FG000|Overall Study|Death|22|||
46911334|NCT03242759|83140998|FG001|Overall Study|Death|0|||
46911335|NCT03242759|83140997|FG000|Overall Study|Change visit schedule|0|||
46911336|NCT03242759|83140998|FG001|Overall Study|Change visit schedule|1|||
47020421|NCT01625000|83269348|FG003|Overall Study|Protocol Violation|1|||
47020422|NCT01625000|83269349|FG004|Overall Study|Protocol Violation|2|||
46911337|NCT03097029|83141004|FG000|Overall Study|Withdrawal by Subject|1|||
46911338|NCT03257813|83141010|FG000|Overall Study|Protocol Violation|6|||
46911339|NCT03257813|83141011|FG001|Overall Study|Protocol Violation|3|||
46911340|NCT03210259|83141022|FG000|12-Week Run-in Period|Adverse Event|1|||
46911341|NCT03210259|83141023|FG001|12-Week Run-in Period|Adverse Event|0|||
46911342|NCT03210259|83141024|FG002|12-Week Run-in Period|Adverse Event|0|||
46911343|NCT03210259|83141022|FG000|12-Week Run-in Period|Death|1|||
47020423|NCT01625000|83269345|FG000|Overall Study|Withdrawal by Subject|19|||
47020424|NCT01625000|83269346|FG001|Overall Study|Withdrawal by Subject|16|||
47020425|NCT01625000|83269347|FG002|Overall Study|Withdrawal by Subject|11|||
47020426|NCT01625000|83269348|FG003|Overall Study|Withdrawal by Subject|9|||
47020427|NCT01625000|83269349|FG004|Overall Study|Withdrawal by Subject|17|||
47020428|NCT01625000|83269345|FG000|Overall Study|Adverse Event (including Death)|15|||
47020429|NCT01625000|83269346|FG001|Overall Study|Adverse Event (including Death)|19|||
47020430|NCT01625000|83269347|FG002|Overall Study|Adverse Event (including Death)|11|||
47020431|NCT01625000|83269348|FG003|Overall Study|Adverse Event (including Death)|7|||
47020432|NCT01625000|83269349|FG004|Overall Study|Adverse Event (including Death)|21|||
46620590|NCT02265510|82770881|FG006|Overall Study|Withdrawal by Subject|0|||
46620591|NCT02265510|82770882|FG007|Overall Study|Withdrawal by Subject|2|||
46911344|NCT03210259|83141023|FG001|12-Week Run-in Period|Death|0|||
46911345|NCT03210259|83141024|FG002|12-Week Run-in Period|Death|0|||
47020433|NCT02081534|83269368|FG000|Overall Study|Adverse Event|5|||
47020434|NCT02081534|83269369|FG001|Overall Study|Adverse Event|4|||
47020435|NCT02081534|83269370|FG002|Overall Study|Adverse Event|3|||
47020436|NCT02081534|83269371|FG003|Overall Study|Adverse Event|10|||
47020437|NCT02081534|83269372|FG004|Overall Study|Adverse Event|2|||
47020438|NCT02081534|83269373|FG005|Overall Study|Adverse Event|8|||
47020439|NCT02081534|83269374|FG006|Overall Study|Adverse Event|2|||
47020440|NCT02081534|83269368|FG000|Overall Study|Withdrawal by Subject|0|||
47020441|NCT02081534|83269369|FG001|Overall Study|Withdrawal by Subject|1|||
47020442|NCT02081534|83269370|FG002|Overall Study|Withdrawal by Subject|1|||
47020443|NCT02081534|83269371|FG003|Overall Study|Withdrawal by Subject|1|||
47020444|NCT02081534|83269372|FG004|Overall Study|Withdrawal by Subject|1|||
47020445|NCT02081534|83269373|FG005|Overall Study|Withdrawal by Subject|0|||
47020446|NCT02081534|83269374|FG006|Overall Study|Withdrawal by Subject|1|||
47020447|NCT02081534|83269368|FG000|Overall Study|Protocol Violation|0|||
47020448|NCT02081534|83269369|FG001|Overall Study|Protocol Violation|3|||
47020449|NCT02081534|83269370|FG002|Overall Study|Protocol Violation|0|||
47020450|NCT02081534|83269371|FG003|Overall Study|Protocol Violation|0|||
47020451|NCT02081534|83269372|FG004|Overall Study|Protocol Violation|0|||
47020452|NCT02081534|83269373|FG005|Overall Study|Protocol Violation|0|||
47020453|NCT02081534|83269374|FG006|Overall Study|Protocol Violation|1|||
47020454|NCT02081534|83269368|FG000|Overall Study|Lost to Follow-up|0|||
47020455|NCT02081534|83269369|FG001|Overall Study|Lost to Follow-up|0|||
47020456|NCT02081534|83269370|FG002|Overall Study|Lost to Follow-up|0|||
47020457|NCT02081534|83269371|FG003|Overall Study|Lost to Follow-up|2|||
47020458|NCT02081534|83269372|FG004|Overall Study|Lost to Follow-up|1|||
47020459|NCT02081534|83269373|FG005|Overall Study|Lost to Follow-up|1|||
47020460|NCT02081534|83269374|FG006|Overall Study|Lost to Follow-up|0|||
47020461|NCT02057198|83269393|FG000|Overall Study|Death|0|||
47020462|NCT02057198|83269394|FG001|Overall Study|Death|0|||
47020463|NCT02057198|83269395|FG002|Overall Study|Death|1|||
47020464|NCT02057198|83269393|FG000|Overall Study|Discharged early; lost to followup|0|||
47020465|NCT02057198|83269394|FG001|Overall Study|Discharged early; lost to followup|1|||
47020466|NCT02057198|83269395|FG002|Overall Study|Discharged early; lost to followup|0|||
47020467|NCT02056652|83269405|FG000|Overall Study|Withdrawal by Subject|1|||
47020468|NCT02056652|83269406|FG001|Overall Study|Withdrawal by Subject|0|||
47020469|NCT02056652|83269405|FG000|Overall Study|Lost to Follow-up|0|||
47020470|NCT02056652|83269406|FG001|Overall Study|Lost to Follow-up|3|||
47020471|NCT02056340|83269414|FG000|Overall Study|Lost to Follow-up|5|||
47020472|NCT02056340|83269415|FG001|Overall Study|Lost to Follow-up|5|||
47020473|NCT02056340|83269414|FG000|Overall Study|Withdrawal by Subject|2|||
47020474|NCT02056340|83269415|FG001|Overall Study|Withdrawal by Subject|6|||
47020475|NCT02046122|83269421|FG000|Overall Study|Physician Decision|8|||
47020476|NCT02046122|83269421|FG000|Overall Study|Withdrawal by Subject|1|||
47020477|NCT02080832|83269428|FG000|Overall Study|Excluded from analysis by MRI|9|||
47020478|NCT02080832|83269429|FG001|Overall Study|Excluded from analysis by MRI|10|||
47020479|NCT02080832|83269430|FG002|Overall Study|Excluded from analysis by MRI|14|||
47020480|NCT02080832|83269428|FG000|Overall Study|Lost to Follow-up|0|||
47020481|NCT02080832|83269429|FG001|Overall Study|Lost to Follow-up|2|||
47020482|NCT02080832|83269430|FG002|Overall Study|Lost to Follow-up|2|||
47020483|NCT02080364|83269444|FG000|Baseline Period|Protocol Violation|2|||
47020484|NCT02080364|83269445|FG001|Baseline Period|Protocol Violation|1|||
47020485|NCT02080364|83269446|FG002|Baseline Period|Protocol Violation|0|||
47020486|NCT02080364|83269447|FG003|Baseline Period|Protocol Violation|0|||
47020487|NCT02080364|83269444|FG000|Baseline Period|Other|0|||
47020488|NCT02080364|83269445|FG001|Baseline Period|Other|1|||
47020489|NCT02080364|83269446|FG002|Baseline Period|Other|1|||
47020490|NCT02080364|83269447|FG003|Baseline Period|Other|0|||
47020491|NCT02080364|83269444|FG000|Treatment Period|Adverse Event|10|||
47020492|NCT02080364|83269445|FG001|Treatment Period|Adverse Event|15|||
47020493|NCT02080364|83269446|FG002|Treatment Period|Adverse Event|11|||
47020494|NCT02080364|83269447|FG003|Treatment Period|Adverse Event|14|||
47020495|NCT02080364|83269444|FG000|Treatment Period|Lost to Follow-up|2|||
47020496|NCT02080364|83269445|FG001|Treatment Period|Lost to Follow-up|3|||
46709750|NCT01140906|82925848|FG001|Overall Study|Lack of Efficacy|8|||
47020497|NCT02080364|83269446|FG002|Treatment Period|Lost to Follow-up|5|||
47020498|NCT02080364|83269447|FG003|Treatment Period|Lost to Follow-up|0|||
47020499|NCT02080364|83269444|FG000|Treatment Period|Protocol Violation|5|||
47020500|NCT02080364|83269445|FG001|Treatment Period|Protocol Violation|3|||
47020501|NCT02080364|83269446|FG002|Treatment Period|Protocol Violation|5|||
47020502|NCT02080364|83269447|FG003|Treatment Period|Protocol Violation|1|||
47020503|NCT02080364|83269444|FG000|Treatment Period|Withdrawal by Subject|16|||
47020504|NCT02080364|83269445|FG001|Treatment Period|Withdrawal by Subject|16|||
47020505|NCT02080364|83269446|FG002|Treatment Period|Withdrawal by Subject|15|||
47020506|NCT02080364|83269447|FG003|Treatment Period|Withdrawal by Subject|10|||
47020507|NCT02080364|83269444|FG000|Treatment Period|Study Terminated by Sponsor|0|||
47020508|NCT02080364|83269445|FG001|Treatment Period|Study Terminated by Sponsor|0|||
47020509|NCT02080364|83269446|FG002|Treatment Period|Study Terminated by Sponsor|180|||
47020510|NCT02080364|83269447|FG003|Treatment Period|Study Terminated by Sponsor|183|||
47020511|NCT02080364|83269444|FG000|Treatment Period|Other|14|||
47020512|NCT02080364|83269445|FG001|Treatment Period|Other|12|||
47020513|NCT02080364|83269446|FG002|Treatment Period|Other|21|||
47020514|NCT02080364|83269447|FG003|Treatment Period|Other|16|||
47020515|NCT02079038|83269459|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
47020516|NCT02079038|83269460|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
47020517|NCT02079038|83269459|FG000|Modified Intent to Treat Population|Death|1|||
47020518|NCT02079038|83269460|FG001|Modified Intent to Treat Population|Death|0|||
47020519|NCT02079038|83269459|FG000|Completed 6 Months|Lost to Follow-up|2|||
47020520|NCT02079038|83269460|FG001|Completed 6 Months|Lost to Follow-up|1|||
47020521|NCT02045732|83269468|FG000|Overall Study|At the discretion of the investigator|1|||
47020522|NCT02045732|83269469|FG001|Overall Study|At the discretion of the investigator|1|||
47020523|NCT02044874|83269478|FG000|Overall Study|Adverse Event|5|||
47020524|NCT02044874|83269479|FG001|Overall Study|Adverse Event|6|||
47020525|NCT02044874|83269480|FG002|Overall Study|Adverse Event|6|||
47020526|NCT02044874|83269478|FG000|Overall Study|Withdrawal by Subject|8|||
47020527|NCT02044874|83269479|FG001|Overall Study|Withdrawal by Subject|16|||
47020528|NCT02044874|83269480|FG002|Overall Study|Withdrawal by Subject|23|||
47020529|NCT02044874|83269478|FG000|Overall Study|Physician Decision|0|||
47020530|NCT02044874|83269479|FG001|Overall Study|Physician Decision|2|||
47020531|NCT02044874|83269480|FG002|Overall Study|Physician Decision|1|||
47020532|NCT02044874|83269478|FG000|Overall Study|Lost to Follow-up|10|||
47020533|NCT02044874|83269479|FG001|Overall Study|Lost to Follow-up|27|||
47020534|NCT02044874|83269480|FG002|Overall Study|Lost to Follow-up|21|||
47020535|NCT02044874|83269478|FG000|Overall Study|Sponsor Decision|0|||
47020536|NCT02044874|83269479|FG001|Overall Study|Sponsor Decision|1|||
47020537|NCT02044874|83269480|FG002|Overall Study|Sponsor Decision|1|||
47020538|NCT02044874|83269478|FG000|Overall Study|Other|7|||
47020539|NCT02044874|83269479|FG001|Overall Study|Other|3|||
47020540|NCT02044874|83269480|FG002|Overall Study|Other|8|||
47020541|NCT02078960|83269493|FG000|Treatment Period|Other|0|||
47020542|NCT02078960|83269494|FG001|Treatment Period|Other|0|||
47020543|NCT02078960|83269495|FG002|Treatment Period|Other|1|||
47020544|NCT02078960|83269493|FG000|Treatment Period|Lack of Efficacy|0|||
47020545|NCT02078960|83269494|FG001|Treatment Period|Lack of Efficacy|1|||
47020546|NCT02078960|83269495|FG002|Treatment Period|Lack of Efficacy|0|||
47020547|NCT02078960|83269493|FG000|Treatment Period|Disease progression - accelerated phase|0|||
47020548|NCT02078960|83269494|FG001|Treatment Period|Disease progression - accelerated phase|1|||
47020549|NCT02078960|83269495|FG002|Treatment Period|Disease progression - accelerated phase|0|||
47020550|NCT02078960|83269493|FG000|Treatment Period|Disease progression - blast phase|1|||
47020551|NCT02078960|83269494|FG001|Treatment Period|Disease progression - blast phase|0|||
47020552|NCT02078960|83269495|FG002|Treatment Period|Disease progression - blast phase|0|||
47020553|NCT02078960|83269493|FG000|Treatment Period|Withdrawal by Subject|0|||
47020554|NCT02078960|83269494|FG001|Treatment Period|Withdrawal by Subject|1|||
47020555|NCT02078960|83269495|FG002|Treatment Period|Withdrawal by Subject|1|||
47020556|NCT02078960|83269493|FG000|Treatment Period|Adverse Event|1|||
47020557|NCT02078960|83269494|FG001|Treatment Period|Adverse Event|0|||
47020558|NCT02078960|83269495|FG002|Treatment Period|Adverse Event|0|||
47020559|NCT02078960|83269493|FG000|Treatment Period|Death|0|||
47020560|NCT02078960|83269494|FG001|Treatment Period|Death|0|||
47020561|NCT02078960|83269495|FG002|Treatment Period|Death|1|||
47020562|NCT02078960|83269493|FG000|Follow-up Period|Death|2|||
47020563|NCT02078960|83269494|FG001|Follow-up Period|Death|0|||
47020564|NCT02078960|83269495|FG002|Follow-up Period|Death|0|||
47020565|NCT02078960|83269493|FG000|Follow-up Period|Lost to Follow-up|0|||
47020566|NCT02078960|83269494|FG001|Follow-up Period|Lost to Follow-up|1|||
47020567|NCT02078960|83269495|FG002|Follow-up Period|Lost to Follow-up|0|||
47020568|NCT02078102|83269507|FG000|Overall Study|Adverse Event|1|||
47020569|NCT02078102|83269508|FG001|Overall Study|Adverse Event|0|||
47020570|NCT02078102|83269507|FG000|Overall Study|Withdrawal by Subject|1|||
47020571|NCT02078102|83269508|FG001|Overall Study|Withdrawal by Subject|0|||
47020572|NCT02078102|83269507|FG000|Overall Study|Physician Decision|0|||
47020573|NCT02078102|83269508|FG001|Overall Study|Physician Decision|1|||
47020574|NCT02054702|83269517|FG000|Overall Study|Lost to Follow-up|3|||
47020575|NCT02054702|83269518|FG001|Overall Study|Lost to Follow-up|5|||
47020576|NCT02054702|83269517|FG000|Overall Study|Adverse Event|3|||
47020577|NCT02054702|83269518|FG001|Overall Study|Adverse Event|1|||
47020578|NCT02054702|83269517|FG000|Overall Study|Met Withdrawal Criteria|4|||
47020579|NCT02054702|83269518|FG001|Overall Study|Met Withdrawal Criteria|1|||
47020580|NCT02054702|83269517|FG000|Overall Study|Physician Decision|0|||
47020581|NCT02054702|83269518|FG001|Overall Study|Physician Decision|1|||
47020582|NCT02054702|83269517|FG000|Overall Study|Withdrawal by Subject|14|||
47020583|NCT02054702|83269518|FG001|Overall Study|Withdrawal by Subject|4|||
47020584|NCT02044094|83269524|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
47020585|NCT02044094|83269524|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
47020586|NCT02044094|83269524|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
47020587|NCT02044094|83269524|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
47020588|NCT02044094|83269524|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
47020589|NCT02044094|83269524|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
47020590|NCT02044094|83269524|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
47020591|NCT02044094|83269524|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
47020592|NCT02043938|83269539|FG000|Overall Study|Withdrawal by Subject|7|||
47020593|NCT02043938|83269539|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
47020594|NCT02043938|83269539|FG000|Overall Study|No show by subject|1|||
47020595|NCT02043938|83269539|FG000|Overall Study|Investigator decision|1|||
47020596|NCT02053610|83269548|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
47020597|NCT02053610|83269549|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
47020598|NCT02053610|83269548|FG000|Overall Study|Withdrew Consent|2|||
47020599|NCT02053610|83269549|FG001|Overall Study|Withdrew Consent|9|||
47020600|NCT02053610|83269548|FG000|Overall Study|Death|5|||
47020601|NCT02053610|83269549|FG001|Overall Study|Death|5|||
47020602|NCT02053610|83269548|FG000|Overall Study|Administrative/Other|1|||
47020603|NCT02053610|83269549|FG001|Overall Study|Administrative/Other|1|||
47020604|NCT02053610|83269548|FG000|Overall Study|Disease Progression|2|||
47020605|NCT02053610|83269549|FG001|Overall Study|Disease Progression|3|||
47020606|NCT02053610|83269548|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
47020607|NCT02053610|83269549|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
47020608|NCT02053610|83269548|FG000|Overall Study|Did not Receive Treatment|4|||
47020609|NCT02053610|83269549|FG001|Overall Study|Did not Receive Treatment|2|||
47020610|NCT02053610|83269548|FG000|Overall Study|Insufficient Therapeutic Response|1|||
47020611|NCT02053610|83269549|FG001|Overall Study|Insufficient Therapeutic Response|1|||
47020612|NCT02053610|83269548|FG000|Overall Study|Violation of Selection Criteria|1|||
47020613|NCT02053610|83269549|FG001|Overall Study|Violation of Selection Criteria|0|||
47020614|NCT02075606|83269555|FG000|Overall Study|Adverse Event|5|||
47020615|NCT02075606|83269555|FG000|Overall Study|Withdrawal by Subject|1|||
47020616|NCT02075606|83269555|FG000|Overall Study|Death|1|||
47020617|NCT02075606|83269555|FG000|Overall Study|Investigator's decision|1|||
47020618|NCT02075606|83269555|FG000|Overall Study|Symptom management|1|||
47020619|NCT02075606|83269555|FG000|Overall Study|Increasing Symptoms|1|||
47020620|NCT02043782|83269564|FG000|Period 1|Adverse Event|0|||
47020621|NCT02043782|83269565|FG001|Period 1|Adverse Event|0|||
47020622|NCT02043782|83269566|FG002|Period 1|Adverse Event|1|||
47020623|NCT02043782|83269567|FG003|Period 1|Adverse Event|0|||
47020624|NCT02043782|83269568|FG004|Period 1|Adverse Event|0|||
47020625|NCT02043782|83269569|FG005|Period 1|Adverse Event|0|||
47020626|NCT02052596|83269579|FG000|Active Phase|Adverse Event|3|||
47020627|NCT02052596|83269580|FG001|Active Phase|Adverse Event|2|||
47020628|NCT02052596|83269579|FG000|Active Phase|Lost to Follow-up|8|||
47020629|NCT02052596|83269580|FG001|Active Phase|Lost to Follow-up|11|||
47020630|NCT02052596|83269579|FG000|Active Phase|Protocol Violation|1|||
47020631|NCT02052596|83269580|FG001|Active Phase|Protocol Violation|2|||
47020632|NCT02052596|83269579|FG000|Active Phase|Withdrawal by Subject|3|||
47020633|NCT02052596|83269580|FG001|Active Phase|Withdrawal by Subject|4|||
47020634|NCT02052596|83269579|FG000|Active Phase|Enrolled in error|1|||
47020635|NCT02052596|83269580|FG001|Active Phase|Enrolled in error|0|||
47020636|NCT02052596|83269579|FG000|Active Phase|Lost due to Crohn's disease|0|||
47020637|NCT02052596|83269580|FG001|Active Phase|Lost due to Crohn's disease|1|||
47020638|NCT02052596|83269579|FG000|Safety Phase|Adverse Event|6|||
47020639|NCT02052596|83269580|FG001|Safety Phase|Adverse Event|3|||
47020640|NCT02052596|83269579|FG000|Safety Phase|Lost to Follow-up|11|||
47020641|NCT02052596|83269580|FG001|Safety Phase|Lost to Follow-up|18|||
47020642|NCT02052596|83269579|FG000|Safety Phase|Protocol Violation|1|||
47020643|NCT02052596|83269580|FG001|Safety Phase|Protocol Violation|2|||
47020644|NCT02052596|83269579|FG000|Safety Phase|Withdrawal by Subject|8|||
47020645|NCT02052596|83269580|FG001|Safety Phase|Withdrawal by Subject|11|||
47020646|NCT02052596|83269579|FG000|Safety Phase|Enrolled in error|1|||
47020647|NCT02052596|83269580|FG001|Safety Phase|Enrolled in error|0|||
47020648|NCT02052596|83269579|FG000|Safety Phase|Lost due to Crohn's disease|0|||
47020649|NCT02052596|83269580|FG001|Safety Phase|Lost due to Crohn's disease|1|||
47020650|NCT02052440|83269588|FG000|Overall Study|Withdrawal by Subject|0|||
47020651|NCT02052440|83269589|FG001|Overall Study|Withdrawal by Subject|1|||
47020652|NCT02049944|83269595|FG000|Overall Study|Protocol Violation|2|||
47020653|NCT02043548|83269601|FG000|Overall Study|Lack of Efficacy|1|||
47020654|NCT02043548|83269602|FG001|Overall Study|Lack of Efficacy|0|||
47020655|NCT02043548|83269601|FG000|Overall Study|Adverse Event|0|||
47020656|NCT02043548|83269602|FG001|Overall Study|Adverse Event|1|||
47020657|NCT01622348|83269611|FG000|Overall Study|Withdrawal by Subject|1|||
47020658|NCT01622348|83269612|FG001|Overall Study|Withdrawal by Subject|0|||
47020659|NCT01622348|83269613|FG002|Overall Study|Withdrawal by Subject|1|||
47020660|NCT01621880|83269623|FG000|Overall Study|Adverse Event|5|||
47020661|NCT01621880|83269624|FG001|Overall Study|Adverse Event|1|||
47020662|NCT01621880|83269623|FG000|Overall Study|Withdrawal by Subject|5|||
47020663|NCT01621880|83269624|FG001|Overall Study|Withdrawal by Subject|4|||
47020664|NCT01621802|83269637|FG000|Overall Study|Protocol Violation|0|||
47020665|NCT01621802|83269638|FG001|Overall Study|Protocol Violation|0|||
47020666|NCT01621802|83269639|FG002|Overall Study|Protocol Violation|0|||
47020667|NCT01621802|83269640|FG003|Overall Study|Protocol Violation|0|||
47020668|NCT01621802|83269641|FG004|Overall Study|Protocol Violation|0|||
47020669|NCT01621802|83269642|FG005|Overall Study|Protocol Violation|1|||
47020670|NCT01621802|83269637|FG000|Overall Study|Withdrawal by Subject|8|||
47020671|NCT01621802|83269638|FG001|Overall Study|Withdrawal by Subject|4|||
47020672|NCT01621802|83269639|FG002|Overall Study|Withdrawal by Subject|4|||
47020673|NCT01621802|83269640|FG003|Overall Study|Withdrawal by Subject|2|||
47020674|NCT01621802|83269641|FG004|Overall Study|Withdrawal by Subject|2|||
47020675|NCT01621802|83269642|FG005|Overall Study|Withdrawal by Subject|0|||
47020676|NCT01621802|83269637|FG000|Overall Study|Migrated/moved from study area|0|||
47020677|NCT01621802|83269638|FG001|Overall Study|Migrated/moved from study area|0|||
47020678|NCT01621802|83269639|FG002|Overall Study|Migrated/moved from study area|2|||
47020679|NCT01621802|83269640|FG003|Overall Study|Migrated/moved from study area|0|||
47020680|NCT01621802|83269641|FG004|Overall Study|Migrated/moved from study area|1|||
47020681|NCT01621802|83269642|FG005|Overall Study|Migrated/moved from study area|0|||
47020682|NCT01621802|83269637|FG000|Overall Study|Others|3|||
47020683|NCT01621802|83269638|FG001|Overall Study|Others|3|||
47020684|NCT01621802|83269639|FG002|Overall Study|Others|3|||
47020685|NCT01621802|83269640|FG003|Overall Study|Others|2|||
47020686|NCT01621802|83269641|FG004|Overall Study|Others|1|||
47020687|NCT01621802|83269642|FG005|Overall Study|Others|0|||
47020688|NCT01621802|83269637|FG000|Overall Study|Lost to Follow-up|36|||
47020689|NCT01621802|83269638|FG001|Overall Study|Lost to Follow-up|16|||
47020690|NCT01621802|83269639|FG002|Overall Study|Lost to Follow-up|24|||
47020691|NCT01621802|83269640|FG003|Overall Study|Lost to Follow-up|7|||
47020692|NCT01621802|83269641|FG004|Overall Study|Lost to Follow-up|31|||
47020693|NCT01621802|83269642|FG005|Overall Study|Lost to Follow-up|11|||
47020694|NCT02059291|83269668|FG000|Epoch 2|Lack of Efficacy|0|||
47020695|NCT02059291|83269669|FG001|Epoch 2|Lack of Efficacy|0|||
47020696|NCT02059291|83269670|FG002|Epoch 2|Lack of Efficacy|0|||
46620592|NCT02265510|82770883|FG008|Overall Study|Withdrawal by Subject|0|||
46709751|NCT01140906|82925849|FG002|Overall Study|Lack of Efficacy|2|||
46911346|NCT03210259|83141022|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
47020697|NCT02059291|83269671|FG003|Epoch 2|Lack of Efficacy|1|||
47020698|NCT02059291|83269672|FG004|Epoch 2|Lack of Efficacy|0|||
47020699|NCT02059291|83269673|FG005|Epoch 2|Lack of Efficacy|1|||
47020700|NCT02059291|83269674|FG006|Epoch 2|Lack of Efficacy|0|||
47020701|NCT02059291|83269675|FG007|Epoch 2|Lack of Efficacy|0|||
47020702|NCT02059291|83269676|FG008|Epoch 2|Lack of Efficacy|0|||
47020703|NCT02059291|83269677|FG009|Epoch 2|Lack of Efficacy|0|||
47020704|NCT02059291|83269678|FG010|Epoch 2|Lack of Efficacy|0|||
47020705|NCT02059291|83269679|FG011|Epoch 2|Lack of Efficacy|0|||
47020706|NCT02059291|83269680|FG012|Epoch 2|Lack of Efficacy|0|||
47020707|NCT02059291|83269681|FG013|Epoch 2|Lack of Efficacy|0|||
47020708|NCT02059291|83269682|FG014|Epoch 2|Lack of Efficacy|0|||
47020709|NCT02059291|83269683|FG015|Epoch 2|Lack of Efficacy|0|||
47020710|NCT02059291|83269684|FG016|Epoch 2|Lack of Efficacy|0|||
47020711|NCT02059291|83269685|FG017|Epoch 2|Lack of Efficacy|0|||
47020712|NCT02059291|83269686|FG018|Epoch 2|Lack of Efficacy|0|||
47020713|NCT02059291|83269687|FG019|Epoch 2|Lack of Efficacy|0|||
47020714|NCT02059291|83269688|FG020|Epoch 2|Lack of Efficacy|0|||
47020715|NCT02059291|83269689|FG021|Epoch 2|Lack of Efficacy|0|||
47020716|NCT02059291|83269690|FG022|Epoch 2|Lack of Efficacy|0|||
47020717|NCT02059291|83269691|FG023|Epoch 2|Lack of Efficacy|0|||
47020718|NCT02059291|83269692|FG024|Epoch 2|Lack of Efficacy|0|||
47020719|NCT02059291|83269668|FG000|Epoch 2|Adverse Event|0|||
46911347|NCT03210259|83141023|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
47020720|NCT02059291|83269669|FG001|Epoch 2|Adverse Event|0|||
47020721|NCT02059291|83269670|FG002|Epoch 2|Adverse Event|1|||
47020722|NCT02059291|83269671|FG003|Epoch 2|Adverse Event|1|||
47020723|NCT02059291|83269672|FG004|Epoch 2|Adverse Event|0|||
47020724|NCT02059291|83269673|FG005|Epoch 2|Adverse Event|0|||
47020725|NCT02059291|83269674|FG006|Epoch 2|Adverse Event|0|||
47020726|NCT02059291|83269675|FG007|Epoch 2|Adverse Event|1|||
47020727|NCT02059291|83269676|FG008|Epoch 2|Adverse Event|1|||
47020728|NCT02059291|83269677|FG009|Epoch 2|Adverse Event|0|||
47020729|NCT02059291|83269678|FG010|Epoch 2|Adverse Event|0|||
47020730|NCT02059291|83269679|FG011|Epoch 2|Adverse Event|0|||
47020731|NCT02059291|83269680|FG012|Epoch 2|Adverse Event|0|||
47020732|NCT02059291|83269681|FG013|Epoch 2|Adverse Event|0|||
47020733|NCT02059291|83269682|FG014|Epoch 2|Adverse Event|0|||
47020734|NCT02059291|83269683|FG015|Epoch 2|Adverse Event|0|||
47020735|NCT02059291|83269684|FG016|Epoch 2|Adverse Event|0|||
47020736|NCT02059291|83269685|FG017|Epoch 2|Adverse Event|0|||
47020737|NCT02059291|83269686|FG018|Epoch 2|Adverse Event|0|||
47020738|NCT02059291|83269687|FG019|Epoch 2|Adverse Event|0|||
47020739|NCT02059291|83269688|FG020|Epoch 2|Adverse Event|0|||
47020740|NCT02059291|83269689|FG021|Epoch 2|Adverse Event|0|||
47020741|NCT02059291|83269690|FG022|Epoch 2|Adverse Event|0|||
47020742|NCT02059291|83269691|FG023|Epoch 2|Adverse Event|0|||
47020743|NCT02059291|83269692|FG024|Epoch 2|Adverse Event|0|||
47020744|NCT02059291|83269668|FG000|Epoch 2|Withdrawal by Subject|0|||
47020745|NCT02059291|83269669|FG001|Epoch 2|Withdrawal by Subject|1|||
47020746|NCT02059291|83269670|FG002|Epoch 2|Withdrawal by Subject|0|||
47020747|NCT02059291|83269671|FG003|Epoch 2|Withdrawal by Subject|0|||
47020748|NCT02059291|83269672|FG004|Epoch 2|Withdrawal by Subject|0|||
47020749|NCT02059291|83269673|FG005|Epoch 2|Withdrawal by Subject|1|||
47020750|NCT02059291|83269674|FG006|Epoch 2|Withdrawal by Subject|0|||
47020751|NCT02059291|83269675|FG007|Epoch 2|Withdrawal by Subject|0|||
47020752|NCT02059291|83269676|FG008|Epoch 2|Withdrawal by Subject|1|||
47020753|NCT02059291|83269677|FG009|Epoch 2|Withdrawal by Subject|0|||
47020754|NCT02059291|83269678|FG010|Epoch 2|Withdrawal by Subject|0|||
47020755|NCT02059291|83269679|FG011|Epoch 2|Withdrawal by Subject|0|||
47020756|NCT02059291|83269680|FG012|Epoch 2|Withdrawal by Subject|0|||
47020757|NCT02059291|83269681|FG013|Epoch 2|Withdrawal by Subject|0|||
47020758|NCT02059291|83269682|FG014|Epoch 2|Withdrawal by Subject|0|||
47020759|NCT02059291|83269683|FG015|Epoch 2|Withdrawal by Subject|0|||
47020760|NCT02059291|83269684|FG016|Epoch 2|Withdrawal by Subject|0|||
47020761|NCT02059291|83269685|FG017|Epoch 2|Withdrawal by Subject|0|||
47020762|NCT02059291|83269686|FG018|Epoch 2|Withdrawal by Subject|0|||
47020763|NCT02059291|83269687|FG019|Epoch 2|Withdrawal by Subject|0|||
47020764|NCT02059291|83269688|FG020|Epoch 2|Withdrawal by Subject|0|||
47020765|NCT02059291|83269689|FG021|Epoch 2|Withdrawal by Subject|0|||
47020766|NCT02059291|83269690|FG022|Epoch 2|Withdrawal by Subject|0|||
47020767|NCT02059291|83269691|FG023|Epoch 2|Withdrawal by Subject|0|||
47020768|NCT02059291|83269692|FG024|Epoch 2|Withdrawal by Subject|0|||
47020769|NCT02059291|83269668|FG000|Epoch 3|Physician Decision|0|||
47020770|NCT02059291|83269669|FG001|Epoch 3|Physician Decision|0|||
47020771|NCT02059291|83269670|FG002|Epoch 3|Physician Decision|0|||
47020772|NCT02059291|83269671|FG003|Epoch 3|Physician Decision|0|||
47020773|NCT02059291|83269672|FG004|Epoch 3|Physician Decision|0|||
47020774|NCT02059291|83269673|FG005|Epoch 3|Physician Decision|0|||
47020775|NCT02059291|83269674|FG006|Epoch 3|Physician Decision|0|||
47020776|NCT02059291|83269675|FG007|Epoch 3|Physician Decision|0|||
47020777|NCT02059291|83269676|FG008|Epoch 3|Physician Decision|0|||
47020778|NCT02059291|83269677|FG009|Epoch 3|Physician Decision|0|||
47020779|NCT02059291|83269678|FG010|Epoch 3|Physician Decision|0|||
47020780|NCT02059291|83269679|FG011|Epoch 3|Physician Decision|0|||
47020781|NCT02059291|83269680|FG012|Epoch 3|Physician Decision|0|||
47020782|NCT02059291|83269681|FG013|Epoch 3|Physician Decision|1|||
47020783|NCT02059291|83269682|FG014|Epoch 3|Physician Decision|0|||
47020784|NCT02059291|83269683|FG015|Epoch 3|Physician Decision|1|||
47020785|NCT02059291|83269684|FG016|Epoch 3|Physician Decision|0|||
47020786|NCT02059291|83269685|FG017|Epoch 3|Physician Decision|0|||
47020787|NCT02059291|83269686|FG018|Epoch 3|Physician Decision|0|||
47020788|NCT02059291|83269687|FG019|Epoch 3|Physician Decision|0|||
47020789|NCT02059291|83269688|FG020|Epoch 3|Physician Decision|0|||
47020790|NCT02059291|83269689|FG021|Epoch 3|Physician Decision|0|||
47020791|NCT02059291|83269690|FG022|Epoch 3|Physician Decision|0|||
47020792|NCT02059291|83269691|FG023|Epoch 3|Physician Decision|0|||
47020793|NCT02059291|83269692|FG024|Epoch 3|Physician Decision|0|||
47020794|NCT02059291|83269668|FG000|Epoch 3|Adverse Event|0|||
47020795|NCT02059291|83269669|FG001|Epoch 3|Adverse Event|0|||
47020796|NCT02059291|83269670|FG002|Epoch 3|Adverse Event|0|||
47020797|NCT02059291|83269671|FG003|Epoch 3|Adverse Event|0|||
47020798|NCT02059291|83269672|FG004|Epoch 3|Adverse Event|0|||
47020799|NCT02059291|83269673|FG005|Epoch 3|Adverse Event|0|||
47020800|NCT02059291|83269674|FG006|Epoch 3|Adverse Event|0|||
47020801|NCT02059291|83269675|FG007|Epoch 3|Adverse Event|0|||
47020802|NCT02059291|83269676|FG008|Epoch 3|Adverse Event|0|||
47020803|NCT02059291|83269677|FG009|Epoch 3|Adverse Event|0|||
47020804|NCT02059291|83269678|FG010|Epoch 3|Adverse Event|0|||
47020805|NCT02059291|83269679|FG011|Epoch 3|Adverse Event|0|||
47020806|NCT02059291|83269680|FG012|Epoch 3|Adverse Event|0|||
47020807|NCT02059291|83269681|FG013|Epoch 3|Adverse Event|0|||
47020808|NCT02059291|83269682|FG014|Epoch 3|Adverse Event|0|||
47020809|NCT02059291|83269683|FG015|Epoch 3|Adverse Event|1|||
47020810|NCT02059291|83269684|FG016|Epoch 3|Adverse Event|0|||
47020811|NCT02059291|83269685|FG017|Epoch 3|Adverse Event|0|||
47020812|NCT02059291|83269686|FG018|Epoch 3|Adverse Event|0|||
47020813|NCT02059291|83269687|FG019|Epoch 3|Adverse Event|0|||
47020814|NCT02059291|83269688|FG020|Epoch 3|Adverse Event|0|||
47020815|NCT02059291|83269689|FG021|Epoch 3|Adverse Event|0|||
47020816|NCT02059291|83269690|FG022|Epoch 3|Adverse Event|0|||
47020817|NCT02059291|83269691|FG023|Epoch 3|Adverse Event|0|||
47020818|NCT02059291|83269692|FG024|Epoch 3|Adverse Event|0|||
47020819|NCT02059291|83269668|FG000|Epoch 3|Lack of Efficacy|0|||
47020820|NCT02059291|83269669|FG001|Epoch 3|Lack of Efficacy|0|||
47020821|NCT02059291|83269670|FG002|Epoch 3|Lack of Efficacy|0|||
47020822|NCT02059291|83269671|FG003|Epoch 3|Lack of Efficacy|0|||
47020823|NCT02059291|83269672|FG004|Epoch 3|Lack of Efficacy|0|||
47020824|NCT02059291|83269673|FG005|Epoch 3|Lack of Efficacy|0|||
47020825|NCT02059291|83269674|FG006|Epoch 3|Lack of Efficacy|0|||
47020826|NCT02059291|83269675|FG007|Epoch 3|Lack of Efficacy|0|||
47020827|NCT02059291|83269676|FG008|Epoch 3|Lack of Efficacy|0|||
47020828|NCT02059291|83269677|FG009|Epoch 3|Lack of Efficacy|0|||
47020829|NCT02059291|83269678|FG010|Epoch 3|Lack of Efficacy|0|||
47020830|NCT02059291|83269679|FG011|Epoch 3|Lack of Efficacy|0|||
47020831|NCT02059291|83269680|FG012|Epoch 3|Lack of Efficacy|0|||
47020832|NCT02059291|83269681|FG013|Epoch 3|Lack of Efficacy|0|||
47020833|NCT02059291|83269682|FG014|Epoch 3|Lack of Efficacy|0|||
47020834|NCT02059291|83269683|FG015|Epoch 3|Lack of Efficacy|3|||
47020835|NCT02059291|83269684|FG016|Epoch 3|Lack of Efficacy|0|||
47020836|NCT02059291|83269685|FG017|Epoch 3|Lack of Efficacy|0|||
47020837|NCT02059291|83269686|FG018|Epoch 3|Lack of Efficacy|0|||
47020838|NCT02059291|83269687|FG019|Epoch 3|Lack of Efficacy|0|||
47020839|NCT02059291|83269688|FG020|Epoch 3|Lack of Efficacy|0|||
47020840|NCT02059291|83269689|FG021|Epoch 3|Lack of Efficacy|0|||
47020841|NCT02059291|83269690|FG022|Epoch 3|Lack of Efficacy|0|||
47020842|NCT02059291|83269691|FG023|Epoch 3|Lack of Efficacy|0|||
47020843|NCT02059291|83269692|FG024|Epoch 3|Lack of Efficacy|0|||
47020844|NCT02059291|83269668|FG000|Epoch 3|Withdrawal by Subject|0|||
47020845|NCT02059291|83269669|FG001|Epoch 3|Withdrawal by Subject|0|||
47020846|NCT02059291|83269670|FG002|Epoch 3|Withdrawal by Subject|0|||
47020847|NCT02059291|83269671|FG003|Epoch 3|Withdrawal by Subject|0|||
47020848|NCT02059291|83269672|FG004|Epoch 3|Withdrawal by Subject|0|||
47020849|NCT02059291|83269673|FG005|Epoch 3|Withdrawal by Subject|0|||
47020850|NCT02059291|83269674|FG006|Epoch 3|Withdrawal by Subject|0|||
47020851|NCT02059291|83269675|FG007|Epoch 3|Withdrawal by Subject|0|||
47020852|NCT02059291|83269676|FG008|Epoch 3|Withdrawal by Subject|0|||
47020853|NCT02059291|83269677|FG009|Epoch 3|Withdrawal by Subject|0|||
47020854|NCT02059291|83269678|FG010|Epoch 3|Withdrawal by Subject|0|||
47020855|NCT02059291|83269679|FG011|Epoch 3|Withdrawal by Subject|0|||
47020856|NCT02059291|83269680|FG012|Epoch 3|Withdrawal by Subject|0|||
47020857|NCT02059291|83269681|FG013|Epoch 3|Withdrawal by Subject|0|||
47020858|NCT02059291|83269682|FG014|Epoch 3|Withdrawal by Subject|0|||
47020859|NCT02059291|83269683|FG015|Epoch 3|Withdrawal by Subject|1|||
47020860|NCT02059291|83269684|FG016|Epoch 3|Withdrawal by Subject|0|||
47020861|NCT02059291|83269685|FG017|Epoch 3|Withdrawal by Subject|0|||
47020862|NCT02059291|83269686|FG018|Epoch 3|Withdrawal by Subject|0|||
47020863|NCT02059291|83269687|FG019|Epoch 3|Withdrawal by Subject|0|||
47020864|NCT02059291|83269688|FG020|Epoch 3|Withdrawal by Subject|0|||
47020865|NCT02059291|83269689|FG021|Epoch 3|Withdrawal by Subject|0|||
47020866|NCT02059291|83269690|FG022|Epoch 3|Withdrawal by Subject|0|||
47020867|NCT02059291|83269691|FG023|Epoch 3|Withdrawal by Subject|0|||
47020868|NCT02059291|83269692|FG024|Epoch 3|Withdrawal by Subject|0|||
47020869|NCT02059291|83269668|FG000|Epoch 4|Adverse Event|0|||
47020870|NCT02059291|83269669|FG001|Epoch 4|Adverse Event|0|||
47020871|NCT02059291|83269670|FG002|Epoch 4|Adverse Event|0|||
47020872|NCT02059291|83269671|FG003|Epoch 4|Adverse Event|0|||
47020873|NCT02059291|83269672|FG004|Epoch 4|Adverse Event|0|||
47020874|NCT02059291|83269673|FG005|Epoch 4|Adverse Event|0|||
47020875|NCT02059291|83269674|FG006|Epoch 4|Adverse Event|0|||
47020876|NCT02059291|83269675|FG007|Epoch 4|Adverse Event|0|||
47020877|NCT02059291|83269676|FG008|Epoch 4|Adverse Event|0|||
47020878|NCT02059291|83269677|FG009|Epoch 4|Adverse Event|0|||
47020879|NCT02059291|83269678|FG010|Epoch 4|Adverse Event|0|||
47020880|NCT02059291|83269679|FG011|Epoch 4|Adverse Event|0|||
47020881|NCT02059291|83269680|FG012|Epoch 4|Adverse Event|0|||
47020882|NCT02059291|83269681|FG013|Epoch 4|Adverse Event|0|||
47020883|NCT02059291|83269682|FG014|Epoch 4|Adverse Event|0|||
47020884|NCT02059291|83269683|FG015|Epoch 4|Adverse Event|0|||
47020885|NCT02059291|83269684|FG016|Epoch 4|Adverse Event|1|||
47020886|NCT02059291|83269685|FG017|Epoch 4|Adverse Event|0|||
47020887|NCT02059291|83269686|FG018|Epoch 4|Adverse Event|0|||
47020888|NCT02059291|83269687|FG019|Epoch 4|Adverse Event|0|||
47020889|NCT02059291|83269688|FG020|Epoch 4|Adverse Event|0|||
47020890|NCT02059291|83269689|FG021|Epoch 4|Adverse Event|0|||
47020891|NCT02059291|83269690|FG022|Epoch 4|Adverse Event|1|||
47020892|NCT02059291|83269691|FG023|Epoch 4|Adverse Event|0|||
47020893|NCT02059291|83269692|FG024|Epoch 4|Adverse Event|0|||
47020894|NCT02059291|83269668|FG000|Epoch 4|Pregnancy|0|||
47020895|NCT02059291|83269669|FG001|Epoch 4|Pregnancy|0|||
47020896|NCT02059291|83269670|FG002|Epoch 4|Pregnancy|0|||
47020897|NCT02059291|83269671|FG003|Epoch 4|Pregnancy|0|||
47020898|NCT02059291|83269672|FG004|Epoch 4|Pregnancy|0|||
47020899|NCT02059291|83269673|FG005|Epoch 4|Pregnancy|0|||
47020900|NCT02059291|83269674|FG006|Epoch 4|Pregnancy|0|||
47020901|NCT02059291|83269675|FG007|Epoch 4|Pregnancy|0|||
47020902|NCT02059291|83269676|FG008|Epoch 4|Pregnancy|0|||
47020903|NCT02059291|83269677|FG009|Epoch 4|Pregnancy|0|||
47020904|NCT02059291|83269678|FG010|Epoch 4|Pregnancy|0|||
47020905|NCT02059291|83269679|FG011|Epoch 4|Pregnancy|0|||
47020906|NCT02059291|83269680|FG012|Epoch 4|Pregnancy|0|||
47020907|NCT02059291|83269681|FG013|Epoch 4|Pregnancy|0|||
47020908|NCT02059291|83269682|FG014|Epoch 4|Pregnancy|0|||
47020909|NCT02059291|83269683|FG015|Epoch 4|Pregnancy|0|||
47020910|NCT02059291|83269684|FG016|Epoch 4|Pregnancy|1|||
47020911|NCT02059291|83269685|FG017|Epoch 4|Pregnancy|0|||
47020912|NCT02059291|83269686|FG018|Epoch 4|Pregnancy|0|||
47020913|NCT02059291|83269687|FG019|Epoch 4|Pregnancy|0|||
47020914|NCT02059291|83269688|FG020|Epoch 4|Pregnancy|0|||
47020915|NCT02059291|83269689|FG021|Epoch 4|Pregnancy|0|||
47020916|NCT02059291|83269690|FG022|Epoch 4|Pregnancy|0|||
47020917|NCT02059291|83269691|FG023|Epoch 4|Pregnancy|0|||
47020918|NCT02059291|83269692|FG024|Epoch 4|Pregnancy|0|||
47020919|NCT02059291|83269668|FG000|Epoch 4|Withdrawal by Subject|0|||
47020920|NCT02059291|83269669|FG001|Epoch 4|Withdrawal by Subject|0|||
47020921|NCT02059291|83269670|FG002|Epoch 4|Withdrawal by Subject|0|||
47020922|NCT02059291|83269671|FG003|Epoch 4|Withdrawal by Subject|0|||
47020923|NCT02059291|83269672|FG004|Epoch 4|Withdrawal by Subject|0|||
47020924|NCT02059291|83269673|FG005|Epoch 4|Withdrawal by Subject|0|||
47020925|NCT02059291|83269674|FG006|Epoch 4|Withdrawal by Subject|0|||
47020926|NCT02059291|83269675|FG007|Epoch 4|Withdrawal by Subject|0|||
47020927|NCT02059291|83269676|FG008|Epoch 4|Withdrawal by Subject|0|||
47020928|NCT02059291|83269677|FG009|Epoch 4|Withdrawal by Subject|0|||
47020929|NCT02059291|83269678|FG010|Epoch 4|Withdrawal by Subject|0|||
47020930|NCT02059291|83269679|FG011|Epoch 4|Withdrawal by Subject|0|||
47020931|NCT02059291|83269680|FG012|Epoch 4|Withdrawal by Subject|0|||
47020932|NCT02059291|83269681|FG013|Epoch 4|Withdrawal by Subject|0|||
47020933|NCT02059291|83269682|FG014|Epoch 4|Withdrawal by Subject|0|||
47020934|NCT02059291|83269683|FG015|Epoch 4|Withdrawal by Subject|0|||
47020935|NCT02059291|83269684|FG016|Epoch 4|Withdrawal by Subject|0|||
47020936|NCT02059291|83269685|FG017|Epoch 4|Withdrawal by Subject|0|||
47020937|NCT02059291|83269686|FG018|Epoch 4|Withdrawal by Subject|0|||
47020938|NCT02059291|83269687|FG019|Epoch 4|Withdrawal by Subject|0|||
47020939|NCT02059291|83269688|FG020|Epoch 4|Withdrawal by Subject|1|||
47020940|NCT02059291|83269689|FG021|Epoch 4|Withdrawal by Subject|0|||
47020941|NCT02059291|83269690|FG022|Epoch 4|Withdrawal by Subject|0|||
47020942|NCT02059291|83269691|FG023|Epoch 4|Withdrawal by Subject|0|||
47020943|NCT02059291|83269692|FG024|Epoch 4|Withdrawal by Subject|0|||
47020944|NCT02059291|83269668|FG000|Epoch 4|Lack of Efficacy|0|||
47020945|NCT02059291|83269669|FG001|Epoch 4|Lack of Efficacy|0|||
47020946|NCT02059291|83269670|FG002|Epoch 4|Lack of Efficacy|0|||
47020947|NCT02059291|83269671|FG003|Epoch 4|Lack of Efficacy|0|||
47020948|NCT02059291|83269672|FG004|Epoch 4|Lack of Efficacy|0|||
47020949|NCT02059291|83269673|FG005|Epoch 4|Lack of Efficacy|0|||
47020950|NCT02059291|83269674|FG006|Epoch 4|Lack of Efficacy|0|||
47020951|NCT02059291|83269675|FG007|Epoch 4|Lack of Efficacy|0|||
47020952|NCT02059291|83269676|FG008|Epoch 4|Lack of Efficacy|0|||
47020953|NCT02059291|83269677|FG009|Epoch 4|Lack of Efficacy|0|||
47020954|NCT02059291|83269678|FG010|Epoch 4|Lack of Efficacy|0|||
47020955|NCT02059291|83269679|FG011|Epoch 4|Lack of Efficacy|0|||
47020956|NCT02059291|83269680|FG012|Epoch 4|Lack of Efficacy|0|||
47020957|NCT02059291|83269681|FG013|Epoch 4|Lack of Efficacy|0|||
47020958|NCT02059291|83269682|FG014|Epoch 4|Lack of Efficacy|0|||
47020959|NCT02059291|83269683|FG015|Epoch 4|Lack of Efficacy|0|||
47020960|NCT02059291|83269684|FG016|Epoch 4|Lack of Efficacy|0|||
47020961|NCT02059291|83269685|FG017|Epoch 4|Lack of Efficacy|0|||
47020962|NCT02059291|83269686|FG018|Epoch 4|Lack of Efficacy|0|||
47020963|NCT02059291|83269687|FG019|Epoch 4|Lack of Efficacy|0|||
47020964|NCT02059291|83269688|FG020|Epoch 4|Lack of Efficacy|0|||
47020965|NCT02059291|83269689|FG021|Epoch 4|Lack of Efficacy|0|||
47020966|NCT02059291|83269690|FG022|Epoch 4|Lack of Efficacy|0|||
47020967|NCT02059291|83269691|FG023|Epoch 4|Lack of Efficacy|1|||
47020968|NCT02059291|83269692|FG024|Epoch 4|Lack of Efficacy|0|||
47020969|NCT02042924|83269720|FG000|Overall Study|Early Death|1|||
47020970|NCT02041520|83269726|FG000|Overall Study|Adverse Event|2|||
47020971|NCT02041520|83269727|FG001|Overall Study|Adverse Event|1|||
47020972|NCT02041520|83269726|FG000|Overall Study|Withdrawal by Subject|3|||
47020973|NCT02041520|83269727|FG001|Overall Study|Withdrawal by Subject|4|||
47020974|NCT02041520|83269726|FG000|Overall Study|Protocol Violation|1|||
47020975|NCT02041520|83269727|FG001|Overall Study|Protocol Violation|0|||
47020976|NCT02041520|83269726|FG000|Overall Study|Lost to Follow-up|0|||
47020977|NCT02041520|83269727|FG001|Overall Study|Lost to Follow-up|1|||
47020978|NCT02041520|83269726|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
47020979|NCT02041520|83269727|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
47020980|NCT02041429|83269739|FG000|Overall Study|Progressive Disease|2|||
47020981|NCT02041429|83269740|FG001|Overall Study|Progressive Disease|2|||
47020982|NCT02041429|83269741|FG002|Overall Study|Progressive Disease|3|||
47020983|NCT02041429|83269742|FG003|Overall Study|Progressive Disease|2|||
47020984|NCT02041429|83269739|FG000|Overall Study|Toxicity|0|||
47020985|NCT02041429|83269740|FG001|Overall Study|Toxicity|1|||
47020986|NCT02041429|83269741|FG002|Overall Study|Toxicity|4|||
47020987|NCT02041429|83269742|FG003|Overall Study|Toxicity|2|||
47020988|NCT02041429|83269739|FG000|Overall Study|Withdrawal by Subject|0|||
47020989|NCT02041429|83269740|FG001|Overall Study|Withdrawal by Subject|1|||
47020990|NCT02041429|83269741|FG002|Overall Study|Withdrawal by Subject|0|||
47020991|NCT02041429|83269742|FG003|Overall Study|Withdrawal by Subject|0|||
47020992|NCT02041429|83269739|FG000|Overall Study|On Maintenance Therapy|1|||
47020993|NCT02041429|83269740|FG001|Overall Study|On Maintenance Therapy|0|||
47020994|NCT02041429|83269741|FG002|Overall Study|On Maintenance Therapy|0|||
47020995|NCT02041429|83269742|FG003|Overall Study|On Maintenance Therapy|2|||
47020996|NCT02083783|83269759|FG000|Overall Study|Withdrawal by Subject|1|||
47020997|NCT02083783|83269760|FG001|Overall Study|Withdrawal by Subject|0|||
47020998|NCT02083081|83269770|FG000|Overall Study|Lost to Follow-up|31|||
47020999|NCT02083081|83269771|FG001|Overall Study|Lost to Follow-up|9|||
47021000|NCT02040805|83269779|FG000|Overall Study|Lost to Follow-up|14|||
47021001|NCT02040805|83269780|FG001|Overall Study|Lost to Follow-up|9|||
47021002|NCT02040805|83269779|FG000|Overall Study|Withdrawal by Subject|28|||
47021003|NCT02040805|83269780|FG001|Overall Study|Withdrawal by Subject|41|||
47021004|NCT02040259|83269786|FG000|Overall Study|Death|280|||
47021005|NCT02040259|83269786|FG000|Overall Study|Lost to Follow-up|76|||
47021006|NCT02040259|83269786|FG000|Overall Study|Assessment not completed|3|||
47021007|NCT02040259|83269786|FG000|Overall Study|Withdrawal by Subject|4|||
47021008|NCT02059135|83269794|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
47021009|NCT02059135|83269795|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
47021010|NCT02059135|83269794|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
47021011|NCT02059135|83269795|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
47021012|NCT02059135|83269794|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
47021013|NCT02059135|83269795|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
47021014|NCT02059135|83269794|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
47021015|NCT02059135|83269795|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
47021016|NCT02059135|83269794|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
47021017|NCT02059135|83269795|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
47021018|NCT02059135|83269794|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
47021019|NCT02059135|83269795|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
47021020|NCT02059135|83269794|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
47021021|NCT02059135|83269795|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
47021022|NCT02059135|83269794|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
47021023|NCT02059135|83269795|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
47021024|NCT02081677|83269807|FG000|Overall Study|Adverse Event|0|||
47021025|NCT02081677|83269808|FG001|Overall Study|Adverse Event|0|||
47021026|NCT02081677|83269809|FG002|Overall Study|Adverse Event|1|||
47021027|NCT02081677|83269810|FG003|Overall Study|Adverse Event|0|||
47021028|NCT02081677|83269807|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
47021029|NCT02081677|83269808|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
47021030|NCT02081677|83269809|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
47021031|NCT02081677|83269810|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
47021032|NCT02081677|83269807|FG000|Overall Study|Not comfortable with lens care system|1|||
47021033|NCT02081677|83269808|FG001|Overall Study|Not comfortable with lens care system|0|||
47021034|NCT02081677|83269809|FG002|Overall Study|Not comfortable with lens care system|0|||
47021035|NCT02081677|83269810|FG003|Overall Study|Not comfortable with lens care system|0|||
47021036|NCT02081677|83269807|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
47021037|NCT02081677|83269808|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
47021038|NCT02081677|83269809|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
47021039|NCT02081677|83269810|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
47021040|NCT02038933|83269822|FG000|Overall Study|Disease progression|104|||
47021041|NCT02038933|83269822|FG000|Overall Study|Study drug toxicity|6|||
47021042|NCT02038933|83269822|FG000|Overall Study|Adverse event unrelated to study drug|6|||
47021043|NCT02038933|83269822|FG000|Overall Study|Participant request to discontinue treatment|2|||
47021044|NCT02038933|83269822|FG000|Overall Study|Lost to Follow-up|1|||
47021045|NCT02038933|83269822|FG000|Overall Study|Other reasons|2|||
47021046|NCT02081599|83269829|FG000|Period 1：Double-blind Period|Adverse Event|3|||
47021047|NCT02081599|83269830|FG001|Period 1：Double-blind Period|Adverse Event|0|||
47021048|NCT02081599|83269829|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
47021049|NCT02081599|83269830|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
47021050|NCT02081599|83269829|FG000|Period 1：Double-blind Period|Physician Decision|1|||
47021051|NCT02081599|83269830|FG001|Period 1：Double-blind Period|Physician Decision|0|||
46911348|NCT03210259|83141024|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
47021052|NCT02081599|83269829|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
47021053|NCT02081599|83269830|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
47021054|NCT02081599|83269829|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
47021055|NCT02081599|83269830|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
47021056|NCT02081599|83269829|FG000|Period 1：Double-blind Period|stopping criteria|1|||
47021057|NCT02081599|83269830|FG001|Period 1：Double-blind Period|stopping criteria|0|||
47021058|NCT02081599|83269829|FG000|Period 2：Open-label Period|Adverse Event|1|||
47021059|NCT02081599|83269830|FG001|Period 2：Open-label Period|Adverse Event|0|||
47021060|NCT02081599|83269829|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
47021061|NCT02081599|83269830|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
47021062|NCT02081599|83269829|FG000|Period 2：Open-label Period|Physician Decision|1|||
47021063|NCT02081599|83269830|FG001|Period 2：Open-label Period|Physician Decision|0|||
47021064|NCT02081599|83269829|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
47021065|NCT02081599|83269830|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
47021066|NCT02038543|83269842|FG000|Overall Study|Screen Failure|0|||
47021067|NCT02038543|83269843|FG001|Overall Study|Screen Failure|0|||
47021068|NCT02038543|83269844|FG002|Overall Study|Screen Failure|0|||
47021069|NCT02038543|83269845|FG003|Overall Study|Screen Failure|1|||
46911349|NCT03210259|83141022|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
46911350|NCT03210259|83141023|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
46911351|NCT03210259|83141024|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
46911352|NCT03210259|83141022|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
46911353|NCT03210259|83141023|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
46911354|NCT03210259|83141024|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
47021070|NCT02038543|83269842|FG000|Overall Study|Withdrawal by Subject|0|||
47021071|NCT02038543|83269843|FG001|Overall Study|Withdrawal by Subject|0|||
47021072|NCT02038543|83269844|FG002|Overall Study|Withdrawal by Subject|0|||
47021073|NCT02038543|83269845|FG003|Overall Study|Withdrawal by Subject|1|||
47021074|NCT02038153|83269855|FG000|Overall Study|Withdrawal by Subject|1|||
47021075|NCT02058589|83269861|FG000|Overall Study|Serious Adverse Event|1|||
47021076|NCT02058589|83269862|FG001|Overall Study|Serious Adverse Event|1|||
47021077|NCT02058589|83269861|FG000|Overall Study|Non-Serious Adverse Event|1|||
47021078|NCT02058589|83269862|FG001|Overall Study|Non-Serious Adverse Event|0|||
47021079|NCT02058589|83269861|FG000|Overall Study|Withdrawal by Subject|0|||
47021080|NCT02058589|83269862|FG001|Overall Study|Withdrawal by Subject|1|||
47021081|NCT02079805|83269872|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
47021082|NCT02079805|83269873|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
47021083|NCT02079805|83269872|FG000|Overall Study|Voluntary Withdrawal|0|||
47021084|NCT02079805|83269873|FG001|Overall Study|Voluntary Withdrawal|1|||
47021085|NCT02037295|83269883|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
47021086|NCT02037295|83269884|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
47021087|NCT02037295|83269885|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
47021088|NCT02037295|83269886|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
47021089|NCT02079649|83269902|FG000|Overall Study|Lost to Follow-up|0|||
47021090|NCT02079649|83269903|FG001|Overall Study|Lost to Follow-up|0|||
47021091|NCT02079649|83269904|FG002|Overall Study|Lost to Follow-up|0|||
47021092|NCT02079649|83269905|FG003|Overall Study|Lost to Follow-up|1|||
47021093|NCT02079649|83269902|FG000|Overall Study|Withdrawal by Subject|0|||
47021094|NCT02079649|83269903|FG001|Overall Study|Withdrawal by Subject|0|||
47021095|NCT02079649|83269904|FG002|Overall Study|Withdrawal by Subject|0|||
47021096|NCT02079649|83269905|FG003|Overall Study|Withdrawal by Subject|1|||
47021097|NCT02079649|83269902|FG000|Overall Study|Randomization error (prior to treatment)|1|||
47021098|NCT02079649|83269903|FG001|Overall Study|Randomization error (prior to treatment)|0|||
47021099|NCT02079649|83269904|FG002|Overall Study|Randomization error (prior to treatment)|1|||
47021100|NCT02079649|83269905|FG003|Overall Study|Randomization error (prior to treatment)|0|||
47021101|NCT02036515|83269919|FG000|Overall Study|Adverse Event|1|||
47021102|NCT02036515|83269920|FG001|Overall Study|Adverse Event|1|||
47021103|NCT02036515|83269921|FG002|Overall Study|Adverse Event|2|||
47021104|NCT02036515|83269919|FG000|Overall Study|Lost to Follow-up|0|||
47021105|NCT02036515|83269920|FG001|Overall Study|Lost to Follow-up|2|||
47021106|NCT02036515|83269921|FG002|Overall Study|Lost to Follow-up|0|||
47021107|NCT02036515|83269919|FG000|Overall Study|Non-compliance with study drug|0|||
47021108|NCT02036515|83269920|FG001|Overall Study|Non-compliance with study drug|0|||
47021109|NCT02036515|83269921|FG002|Overall Study|Non-compliance with study drug|2|||
47021110|NCT02036515|83269919|FG000|Overall Study|Screen failure|0|||
47021111|NCT02036515|83269920|FG001|Overall Study|Screen failure|2|||
47021112|NCT02036515|83269921|FG002|Overall Study|Screen failure|0|||
47021113|NCT02036515|83269919|FG000|Overall Study|Withdrawal by Subject|4|||
47021114|NCT02036515|83269920|FG001|Overall Study|Withdrawal by Subject|7|||
47021115|NCT02036515|83269921|FG002|Overall Study|Withdrawal by Subject|9|||
47021116|NCT02036515|83269919|FG000|Overall Study|Hyperglycemia|0|||
47021117|NCT02036515|83269920|FG001|Overall Study|Hyperglycemia|0|||
47021118|NCT02036515|83269921|FG002|Overall Study|Hyperglycemia|1|||
47021119|NCT02078713|83269933|FG000|Overall Study|Lost to Follow-up|49|||
47021120|NCT02078713|83269934|FG001|Overall Study|Lost to Follow-up|55|||
47021121|NCT02078713|83269935|FG002|Overall Study|Lost to Follow-up|0|||
47021122|NCT02078713|83269936|FG003|Overall Study|Lost to Follow-up|0|||
47021123|NCT02078713|83269933|FG000|Overall Study|Pregnant at baseline|3|||
47021124|NCT02078713|83269934|FG001|Overall Study|Pregnant at baseline|5|||
47021125|NCT02078713|83269935|FG002|Overall Study|Pregnant at baseline|0|||
47021126|NCT02078713|83269936|FG003|Overall Study|Pregnant at baseline|0|||
47021127|NCT02078713|83269933|FG000|Overall Study|Enrolled twice|0|||
47021128|NCT02078713|83269934|FG001|Overall Study|Enrolled twice|1|||
47021129|NCT02078713|83269935|FG002|Overall Study|Enrolled twice|0|||
47021130|NCT02078713|83269936|FG003|Overall Study|Enrolled twice|0|||
47021131|NCT02035267|83269952|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
47021132|NCT02035267|83269953|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
47021133|NCT02035267|83269954|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
47021134|NCT02035267|83269955|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
47021135|NCT02035267|83269952|FG000|Overall Study|Adverse Event|0|||
47021136|NCT02035267|83269953|FG001|Overall Study|Adverse Event|0|||
47021137|NCT02035267|83269954|FG002|Overall Study|Adverse Event|1|||
47021138|NCT02035267|83269955|FG003|Overall Study|Adverse Event|0|||
47021139|NCT02035267|83269952|FG000|Overall Study|Lost to Follow-up|0|||
47021140|NCT02035267|83269953|FG001|Overall Study|Lost to Follow-up|0|||
47021141|NCT02035267|83269954|FG002|Overall Study|Lost to Follow-up|0|||
47021142|NCT02035267|83269955|FG003|Overall Study|Lost to Follow-up|1|||
47021143|NCT02035267|83269952|FG000|Overall Study|Other unspecified|0|||
47021144|NCT02035267|83269953|FG001|Overall Study|Other unspecified|1|||
47021145|NCT02035267|83269954|FG002|Overall Study|Other unspecified|0|||
47021146|NCT02035267|83269955|FG003|Overall Study|Other unspecified|0|||
47021147|NCT04373460|83269989|FG000|Overall Study|Did not receive tranfusion|18|||
47021148|NCT04373460|83269990|FG001|Overall Study|Did not receive tranfusion|26|||
47021149|NCT04159805|83270003|FG000|Overall Study|Withdrawal by Subject|0|||
47021150|NCT04159805|83270004|FG001|Overall Study|Withdrawal by Subject|2|||
47021151|NCT04159805|83270005|FG002|Overall Study|Withdrawal by Subject|2|||
47021152|NCT03901456|83270016|FG000|Overall Study|Withdrawal by Subject|0|||
47021153|NCT03901456|83270017|FG001|Overall Study|Withdrawal by Subject|0|||
47021154|NCT03901456|83270018|FG002|Overall Study|Withdrawal by Subject|1|||
47021155|NCT03901456|83270016|FG000|Overall Study|Lost to Follow-up|0|||
47021156|NCT03901456|83270017|FG001|Overall Study|Lost to Follow-up|1|||
47021157|NCT03901456|83270018|FG002|Overall Study|Lost to Follow-up|0|||
47021158|NCT03226249|83270069|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
47021159|NCT03226249|83270069|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
47021160|NCT03226249|83270069|FG000|Survival Follow-up|Patients still in follow-up.|30|||
47021161|NCT02849548|83270075|FG000|Overall Study|Lost to Follow-up|1|||
47021162|NCT02849548|83270076|FG001|Overall Study|Lost to Follow-up|2|||
47021163|NCT02849548|83270075|FG000|Overall Study|Protocol Violation|1|||
47021164|NCT02849548|83270076|FG001|Overall Study|Protocol Violation|0|||
47021165|NCT02321514|83270091|FG000|Overall Study|Death|15|||
47021166|NCT02321514|83270091|FG000|Overall Study|Missed Visit|7|||
47021167|NCT02321514|83270091|FG000|Overall Study|Study Exit|3|||
47021168|NCT02266134|83270099|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
47021169|NCT02266134|83270100|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
47021170|NCT02266134|83270101|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
47021171|NCT02266134|83270102|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
47021172|NCT02266134|83270099|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
47021173|NCT02266134|83270100|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
47021174|NCT02266134|83270101|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
47021175|NCT02266134|83270102|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
47021176|NCT02266134|83270099|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
47021177|NCT02266134|83270100|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
47021178|NCT02266134|83270101|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
47021179|NCT02266134|83270102|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
47021180|NCT02266134|83270099|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
47021181|NCT02266134|83270100|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
47021182|NCT02266134|83270101|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
47021183|NCT02266134|83270102|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
47021184|NCT02266134|83270099|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
47021185|NCT02266134|83270100|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
47021186|NCT02266134|83270101|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
47021187|NCT02266134|83270102|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
47021188|NCT02266134|83270099|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
47021189|NCT02266134|83270100|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
47021190|NCT02266134|83270101|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
47021191|NCT02266134|83270102|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
47021192|NCT01847274|83270130|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
47021193|NCT01847274|83270131|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
47021194|NCT01847274|83270132|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
47021195|NCT01847274|83270133|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
47021196|NCT01847274|83270134|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
47021197|NCT01847274|83270135|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
47021198|NCT01847274|83270136|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
47021199|NCT01847274|83270137|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
47021200|NCT01847274|83270138|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
47021201|NCT01847274|83270139|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
47021202|NCT01847274|83270140|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
47021203|NCT01847274|83270130|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
47021204|NCT01847274|83270131|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
47021205|NCT01847274|83270132|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
47021206|NCT01847274|83270133|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
47021207|NCT01847274|83270134|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
47021208|NCT01847274|83270135|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
47021209|NCT01847274|83270136|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
47021210|NCT01847274|83270137|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
47021211|NCT01847274|83270138|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
47021212|NCT01847274|83270139|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
47021213|NCT01847274|83270140|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
47021214|NCT01847274|83270130|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
47021215|NCT01847274|83270131|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
47021216|NCT01847274|83270132|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
47021217|NCT01847274|83270133|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
47021218|NCT01847274|83270134|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
47021219|NCT01847274|83270135|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
47021220|NCT01847274|83270136|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
47021221|NCT01847274|83270137|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
47021222|NCT01847274|83270138|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
47021223|NCT01847274|83270139|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
47021224|NCT01847274|83270140|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
47021225|NCT01847274|83270130|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021226|NCT01847274|83270131|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021227|NCT01847274|83270132|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021228|NCT01847274|83270133|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
47021229|NCT01847274|83270134|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021230|NCT01847274|83270135|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021231|NCT01847274|83270136|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021232|NCT01847274|83270137|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021233|NCT01847274|83270138|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021234|NCT01847274|83270139|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021235|NCT01847274|83270140|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
47021236|NCT01847274|83270130|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
47021237|NCT01847274|83270131|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
47021238|NCT01847274|83270132|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
47021239|NCT01847274|83270133|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
47021240|NCT01847274|83270134|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
47021241|NCT01847274|83270135|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
47021242|NCT01847274|83270136|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
47021243|NCT01847274|83270137|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
47021244|NCT01847274|83270138|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
47021245|NCT01847274|83270139|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
47021246|NCT01847274|83270140|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
47021247|NCT01847274|83270130|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
47021248|NCT01847274|83270131|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
47021249|NCT01847274|83270132|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
47021250|NCT01847274|83270133|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
47021251|NCT01847274|83270134|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
46709752|NCT01140906|82925850|FG003|Overall Study|Lack of Efficacy|1|||
46911355|NCT03210259|83141022|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
46911356|NCT03210259|83141023|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
47021252|NCT01847274|83270135|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
47021253|NCT01847274|83270136|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
47021254|NCT01847274|83270137|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
47021255|NCT01847274|83270138|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
47021256|NCT01847274|83270139|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
47021257|NCT01847274|83270140|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
47021258|NCT01847274|83270130|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
47021259|NCT01847274|83270131|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
47021260|NCT01847274|83270132|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
47021261|NCT01847274|83270133|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
47021262|NCT01847274|83270134|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
47021263|NCT01847274|83270135|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
47021264|NCT01847274|83270136|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
47021265|NCT01847274|83270137|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
47021266|NCT01847274|83270138|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
47021267|NCT01847274|83270139|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
47021268|NCT01847274|83270140|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
47021269|NCT01847274|83270130|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021270|NCT01847274|83270131|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021271|NCT01847274|83270132|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021272|NCT01847274|83270133|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021273|NCT01847274|83270134|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021274|NCT01847274|83270135|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
47021275|NCT01847274|83270136|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021276|NCT01847274|83270137|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021277|NCT01847274|83270138|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021278|NCT01847274|83270139|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021279|NCT01847274|83270140|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
47021280|NCT01847274|83270130|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021281|NCT01847274|83270131|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021282|NCT01847274|83270132|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021283|NCT01847274|83270133|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021284|NCT01847274|83270134|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
47021285|NCT01847274|83270135|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021286|NCT01847274|83270136|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021287|NCT01847274|83270137|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021288|NCT01847274|83270138|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021289|NCT01847274|83270139|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021290|NCT01847274|83270140|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
47021291|NCT01847274|83270130|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021292|NCT01847274|83270131|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021293|NCT01847274|83270132|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021294|NCT01847274|83270133|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021295|NCT01847274|83270134|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021296|NCT01847274|83270135|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021297|NCT01847274|83270136|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
47021298|NCT01847274|83270137|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021299|NCT01847274|83270138|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021300|NCT01847274|83270139|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021301|NCT01847274|83270140|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
47021302|NCT01847274|83270130|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021303|NCT01847274|83270131|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021304|NCT01847274|83270132|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021305|NCT01847274|83270133|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021306|NCT01847274|83270134|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021307|NCT01847274|83270135|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
46620593|NCT02265510|82770884|FG009|Overall Study|Withdrawal by Subject|0|||
47021308|NCT01847274|83270136|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
47021309|NCT01847274|83270137|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021310|NCT01847274|83270138|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021311|NCT01847274|83270139|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021312|NCT01847274|83270140|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
47021313|NCT01847274|83270130|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021314|NCT01847274|83270131|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021315|NCT01847274|83270132|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021316|NCT01847274|83270133|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021317|NCT01847274|83270134|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021318|NCT01847274|83270135|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021319|NCT01847274|83270136|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
47021320|NCT01847274|83270137|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021321|NCT01847274|83270138|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021322|NCT01847274|83270139|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021323|NCT01847274|83270140|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
47021324|NCT01847274|83270130|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
47021325|NCT01847274|83270131|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
47021326|NCT01847274|83270132|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
47021327|NCT01847274|83270133|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
47021328|NCT01847274|83270134|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
47021329|NCT01847274|83270135|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
47021330|NCT01847274|83270136|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
47021331|NCT01847274|83270137|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
47021332|NCT01847274|83270138|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
47021333|NCT01847274|83270139|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
47021334|NCT01847274|83270140|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
47021335|NCT01847274|83270130|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021336|NCT01847274|83270131|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021337|NCT01847274|83270132|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021338|NCT01847274|83270133|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021339|NCT01847274|83270134|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021340|NCT01847274|83270135|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021341|NCT01847274|83270136|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021342|NCT01847274|83270137|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
47021343|NCT01847274|83270138|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021344|NCT01847274|83270139|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
47021345|NCT01847274|83270140|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
47021346|NCT01847274|83270130|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021347|NCT01847274|83270131|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021348|NCT01847274|83270132|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021349|NCT01847274|83270133|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021350|NCT01847274|83270134|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021351|NCT01847274|83270135|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021352|NCT01847274|83270136|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021353|NCT01847274|83270137|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
47021354|NCT01847274|83270138|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
47021355|NCT01847274|83270139|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
47021356|NCT01847274|83270140|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
47021357|NCT01847274|83270130|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021358|NCT01847274|83270131|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021359|NCT01847274|83270132|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021360|NCT01847274|83270133|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021361|NCT01847274|83270134|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021362|NCT01847274|83270135|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021363|NCT01847274|83270136|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021364|NCT01847274|83270137|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
46620594|NCT02265510|82770885|FG010|Overall Study|Withdrawal by Subject|0|||
46620595|NCT02265510|82770886|FG011|Overall Study|Withdrawal by Subject|0|||
47021365|NCT01847274|83270138|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021366|NCT01847274|83270139|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
47021367|NCT01847274|83270140|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
47021368|NCT01560819|83270179|FG000|Overall Study|Physician Decision|1|||
47021369|NCT01560819|83270180|FG001|Overall Study|Physician Decision|0|||
47021370|NCT01425528|83270186|FG000|Overall Study|Withdrawal by Subject|1|||
47021371|NCT01425528|83270187|FG001|Overall Study|Withdrawal by Subject|1|||
47021372|NCT00442104|83270193|FG000|Overall Study|Adverse Event|5|||
47021373|NCT00442104|83270193|FG000|Overall Study|Death|2|||
47021374|NCT00442104|83270193|FG000|Overall Study|Lost to Follow-up|3|||
47021375|NCT00442104|83270193|FG000|Overall Study|Withdrawal by Subject|5|||
47021376|NCT00442104|83270193|FG000|Overall Study|Insufficient Clinical Response|10|||
47021377|NCT00442104|83270193|FG000|Overall Study|Other|21|||
47021378|NCT00442104|83270193|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
47021379|NCT00441896|83270207|FG000|Overall Study|Withdrawal by Subject|0|||
47021380|NCT00441896|83270208|FG001|Overall Study|Withdrawal by Subject|0|||
47021381|NCT00441896|83270209|FG002|Overall Study|Withdrawal by Subject|0|||
47021382|NCT00441896|83270210|FG003|Overall Study|Withdrawal by Subject|1|||
47021383|NCT00441896|83270211|FG004|Overall Study|Withdrawal by Subject|0|||
47021384|NCT00441896|83270212|FG005|Overall Study|Withdrawal by Subject|0|||
47021385|NCT00441896|83270213|FG006|Overall Study|Withdrawal by Subject|0|||
47021386|NCT00441896|83270214|FG007|Overall Study|Withdrawal by Subject|0|||
47021387|NCT00441896|83270215|FG008|Overall Study|Withdrawal by Subject|0|||
47021388|NCT00441896|83270216|FG009|Overall Study|Withdrawal by Subject|0|||
47021389|NCT00441896|83270207|FG000|Overall Study|Other|0|||
47021390|NCT00441896|83270208|FG001|Overall Study|Other|0|||
47021391|NCT00441896|83270209|FG002|Overall Study|Other|0|||
47021392|NCT00441896|83270210|FG003|Overall Study|Other|0|||
47021393|NCT00441896|83270211|FG004|Overall Study|Other|1|||
47021394|NCT00441896|83270212|FG005|Overall Study|Other|0|||
47021395|NCT00441896|83270213|FG006|Overall Study|Other|0|||
47021396|NCT00441896|83270214|FG007|Overall Study|Other|0|||
47021397|NCT00441896|83270215|FG008|Overall Study|Other|0|||
47021398|NCT00441896|83270216|FG009|Overall Study|Other|0|||
47021399|NCT02034877|83270244|FG000|Overall Study|Lost to Follow-up|0|||
47021400|NCT02034877|83270245|FG001|Overall Study|Lost to Follow-up|3|||
47021401|NCT02034877|83270244|FG000|Overall Study|No Longer Willing to Participate|0|||
47021402|NCT02034877|83270245|FG001|Overall Study|No Longer Willing to Participate|3|||
47021403|NCT02034799|83270253|FG000|Overall Study|Withdrawal by Subject|0|||
47021404|NCT02034799|83270254|FG001|Overall Study|Withdrawal by Subject|2|||
47021405|NCT02034799|83270253|FG000|Overall Study|Lost to Follow-up|0|||
47021406|NCT02034799|83270254|FG001|Overall Study|Lost to Follow-up|1|||
47021407|NCT02034799|83270253|FG000|Overall Study|Death|2|||
47021408|NCT02034799|83270254|FG001|Overall Study|Death|1|||
47021409|NCT02057575|83270264|FG000|Overall Study|Adverse Event|0|||
47021410|NCT02057575|83270265|FG001|Overall Study|Adverse Event|2|||
47021411|NCT02057575|83270266|FG002|Overall Study|Adverse Event|0|||
47021412|NCT02057575|83270267|FG003|Overall Study|Adverse Event|1|||
47021413|NCT02057575|83270264|FG000|Overall Study|Withdrawal by Subject|1|||
47021414|NCT02057575|83270265|FG001|Overall Study|Withdrawal by Subject|0|||
47021415|NCT02057575|83270266|FG002|Overall Study|Withdrawal by Subject|0|||
47021416|NCT02057575|83270267|FG003|Overall Study|Withdrawal by Subject|0|||
47021417|NCT02057575|83270264|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
47021418|NCT02057575|83270265|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
47021419|NCT02057575|83270266|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
47021420|NCT02057575|83270267|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
47021421|NCT02057575|83270264|FG000|Overall Study|Protocol Violation|0|||
47021422|NCT02057575|83270265|FG001|Overall Study|Protocol Violation|1|||
47021423|NCT02057575|83270266|FG002|Overall Study|Protocol Violation|0|||
47021424|NCT02057575|83270267|FG003|Overall Study|Protocol Violation|0|||
47021425|NCT02077465|83270279|FG000|Overall Study|Withdrew Consent|0|||
47021426|NCT02077465|83270280|FG001|Overall Study|Withdrew Consent|1|||
47021427|NCT02077465|83270279|FG000|Overall Study|Lost to Follow-up|1|||
47021428|NCT02077465|83270280|FG001|Overall Study|Lost to Follow-up|0|||
47021429|NCT02034565|83270286|FG000|Overall Study|Adverse Event|1|||
47021430|NCT02034565|83270287|FG001|Overall Study|Adverse Event|0|||
47021431|NCT02075515|83270298|FG000|Overall Study|Serious Adverse Event|1|||
47021432|NCT02075515|83270299|FG001|Overall Study|Serious Adverse Event|1|||
47021433|NCT02075515|83270300|FG002|Overall Study|Serious Adverse Event|1|||
47021434|NCT02075515|83270298|FG000|Overall Study|Non-Serious Adverse Event|0|||
47021435|NCT02075515|83270299|FG001|Overall Study|Non-Serious Adverse Event|1|||
47021436|NCT02075515|83270300|FG002|Overall Study|Non-Serious Adverse Event|0|||
47021437|NCT02075515|83270298|FG000|Overall Study|Withdrawal by Subject|2|||
47021438|NCT02075515|83270299|FG001|Overall Study|Withdrawal by Subject|0|||
47021439|NCT02075515|83270300|FG002|Overall Study|Withdrawal by Subject|1|||
47021440|NCT02075515|83270298|FG000|Overall Study|Lost to Follow-up|1|||
47021441|NCT02075515|83270299|FG001|Overall Study|Lost to Follow-up|3|||
47021442|NCT02075515|83270300|FG002|Overall Study|Lost to Follow-up|6|||
47021443|NCT02034409|83270311|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
47021444|NCT02034409|83270312|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
47021445|NCT02034409|83270311|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
47021446|NCT02034409|83270312|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
47021447|NCT02034409|83270311|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
47021448|NCT02034409|83270312|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
47021449|NCT02034409|83270311|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
46709753|NCT01140906|82925847|FG000|Overall Study|Non-compliance|0|||
46709754|NCT01140906|82925848|FG001|Overall Study|Non-compliance|1|||
46709755|NCT01140906|82925849|FG002|Overall Study|Non-compliance|0|||
46709756|NCT01140906|82925850|FG003|Overall Study|Non-compliance|1|||
46911357|NCT03210259|83141024|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
46709757|NCT01140906|82925847|FG000|Overall Study|Protocol Violation|5|||
46709758|NCT01140906|82925848|FG001|Overall Study|Protocol Violation|3|||
46709759|NCT01140906|82925849|FG002|Overall Study|Protocol Violation|2|||
46709760|NCT01140906|82925850|FG003|Overall Study|Protocol Violation|1|||
46709761|NCT01140906|82925847|FG000|Overall Study|Withdrawal of consent|6|||
46709762|NCT01140906|82925848|FG001|Overall Study|Withdrawal of consent|6|||
46709763|NCT01140906|82925849|FG002|Overall Study|Withdrawal of consent|2|||
46709764|NCT01140906|82925850|FG003|Overall Study|Withdrawal of consent|2|||
46709765|NCT01140906|82925847|FG000|Overall Study|Lost to Follow-up|1|||
46911358|NCT03210259|83141022|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
46911359|NCT03210259|83141023|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
46911360|NCT03210259|83141024|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
46911361|NCT03210259|83141022|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
46911362|NCT03210259|83141023|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
47021450|NCT02034409|83270312|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
47021451|NCT02034409|83270311|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
47021452|NCT02034409|83270312|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
47021453|NCT02034409|83270311|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
47021454|NCT02034409|83270312|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
47021455|NCT02021318|83270320|FG000|Overall Study|Adverse Event|2|||
47021456|NCT02021318|83270321|FG001|Overall Study|Adverse Event|1|||
47021457|NCT02021318|83270320|FG000|Overall Study|Death|33|||
47021458|NCT02021318|83270321|FG001|Overall Study|Death|34|||
47021459|NCT02021318|83270320|FG000|Overall Study|Lost to Follow-up|3|||
47021460|NCT02021318|83270321|FG001|Overall Study|Lost to Follow-up|3|||
47021461|NCT02021318|83270320|FG000|Overall Study|Progressive Disease|0|||
47021462|NCT02021318|83270321|FG001|Overall Study|Progressive Disease|1|||
47021463|NCT02021318|83270320|FG000|Overall Study|Withdrawal by Subject|30|||
47021464|NCT02021318|83270321|FG001|Overall Study|Withdrawal by Subject|18|||
47021465|NCT02021318|83270320|FG000|Overall Study|Physician Decision|3|||
47021466|NCT02021318|83270321|FG001|Overall Study|Physician Decision|3|||
47021467|NCT02021318|83270320|FG000|Overall Study|Miscellaneous|2|||
47021468|NCT02021318|83270321|FG001|Overall Study|Miscellaneous|3|||
47021469|NCT02041286|83270328|FG000|Overall Study|Adverse Event|1|||
47021470|NCT02020616|83270341|FG000|Overall Study|Adverse Event|0|||
47021471|NCT02020616|83270342|FG001|Overall Study|Adverse Event|0|||
47021472|NCT02020616|83270343|FG002|Overall Study|Adverse Event|0|||
47021473|NCT02020616|83270344|FG003|Overall Study|Adverse Event|0|||
47021474|NCT02020616|83270345|FG004|Overall Study|Adverse Event|0|||
47021475|NCT02020616|83270346|FG005|Overall Study|Adverse Event|1|||
47021476|NCT02020616|83270347|FG006|Overall Study|Adverse Event|1|||
47021477|NCT02020616|83270341|FG000|Overall Study|Physician Decision|0|||
47021478|NCT02020616|83270342|FG001|Overall Study|Physician Decision|0|||
46911363|NCT03210259|83141024|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
46911364|NCT03210259|83141022|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
46911365|NCT03210259|83141023|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
46911366|NCT03210259|83141024|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
46911367|NCT03210259|83141022|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
47021479|NCT02020616|83270343|FG002|Overall Study|Physician Decision|0|||
47021480|NCT02020616|83270344|FG003|Overall Study|Physician Decision|0|||
47021481|NCT02020616|83270345|FG004|Overall Study|Physician Decision|0|||
47021482|NCT02020616|83270346|FG005|Overall Study|Physician Decision|1|||
46620596|NCT02265510|82770887|FG012|Overall Study|Withdrawal by Subject|1|||
46620597|NCT02265510|82770888|FG013|Overall Study|Withdrawal by Subject|0|||
46620598|NCT02265510|82770875|FG000|Overall Study|Disease Progression|0|||
46620599|NCT02265510|82770876|FG001|Overall Study|Disease Progression|1|||
46620600|NCT02265510|82770877|FG002|Overall Study|Disease Progression|2|||
47021483|NCT02020616|83270347|FG006|Overall Study|Physician Decision|2|||
47021484|NCT02020616|83270341|FG000|Overall Study|Withdrawal by Subject|0|||
47021485|NCT02020616|83270342|FG001|Overall Study|Withdrawal by Subject|0|||
47021486|NCT02020616|83270343|FG002|Overall Study|Withdrawal by Subject|1|||
47021487|NCT02020616|83270344|FG003|Overall Study|Withdrawal by Subject|0|||
47021488|NCT02020616|83270345|FG004|Overall Study|Withdrawal by Subject|0|||
47021489|NCT02020616|83270346|FG005|Overall Study|Withdrawal by Subject|1|||
47021490|NCT02020616|83270347|FG006|Overall Study|Withdrawal by Subject|1|||
47021491|NCT02020616|83270341|FG000|Overall Study|Lost to Follow-up|0|||
47021492|NCT02020616|83270342|FG001|Overall Study|Lost to Follow-up|1|||
47021493|NCT02020616|83270343|FG002|Overall Study|Lost to Follow-up|0|||
47021494|NCT02020616|83270344|FG003|Overall Study|Lost to Follow-up|1|||
47021495|NCT02020616|83270345|FG004|Overall Study|Lost to Follow-up|1|||
47021496|NCT02020616|83270346|FG005|Overall Study|Lost to Follow-up|1|||
47021497|NCT02020616|83270347|FG006|Overall Study|Lost to Follow-up|0|||
47021498|NCT02020616|83270341|FG000|Overall Study|Early Termination Criteria Met|0|||
47021499|NCT02020616|83270342|FG001|Overall Study|Early Termination Criteria Met|0|||
47021500|NCT02020616|83270343|FG002|Overall Study|Early Termination Criteria Met|1|||
47021501|NCT02020616|83270344|FG003|Overall Study|Early Termination Criteria Met|0|||
47021502|NCT02020616|83270345|FG004|Overall Study|Early Termination Criteria Met|0|||
47021503|NCT02020616|83270346|FG005|Overall Study|Early Termination Criteria Met|1|||
47021504|NCT02020616|83270347|FG006|Overall Study|Early Termination Criteria Met|0|||
47021505|NCT02020616|83270341|FG000|Overall Study|Randomized in Error|0|||
47021506|NCT02020616|83270342|FG001|Overall Study|Randomized in Error|0|||
47021507|NCT02020616|83270343|FG002|Overall Study|Randomized in Error|0|||
47021508|NCT02020616|83270344|FG003|Overall Study|Randomized in Error|1|||
47021509|NCT02020616|83270345|FG004|Overall Study|Randomized in Error|0|||
47021510|NCT02020616|83270346|FG005|Overall Study|Randomized in Error|0|||
47021511|NCT02020616|83270347|FG006|Overall Study|Randomized in Error|0|||
47021512|NCT02020616|83270341|FG000|Overall Study|Lack of Efficacy|0|||
47021513|NCT02020616|83270342|FG001|Overall Study|Lack of Efficacy|0|||
47021514|NCT02020616|83270343|FG002|Overall Study|Lack of Efficacy|0|||
47021515|NCT02020616|83270344|FG003|Overall Study|Lack of Efficacy|0|||
47021516|NCT02020616|83270345|FG004|Overall Study|Lack of Efficacy|1|||
47021517|NCT02020616|83270346|FG005|Overall Study|Lack of Efficacy|0|||
47021518|NCT02020616|83270347|FG006|Overall Study|Lack of Efficacy|0|||
47021519|NCT02048072|83270377|FG000|Overall Study|Adverse Event|3|||
47021520|NCT02048072|83270377|FG000|Overall Study|Lost to Follow-up|1|||
47021521|NCT02047604|83270387|FG000|Overall Study|Withdrawal by Subject|0|||
47021522|NCT02047604|83270388|FG001|Overall Study|Withdrawal by Subject|0|||
47021523|NCT02047604|83270389|FG002|Overall Study|Withdrawal by Subject|0|||
47021524|NCT02047604|83270390|FG003|Overall Study|Withdrawal by Subject|0|||
47021525|NCT02047604|83270391|FG004|Overall Study|Withdrawal by Subject|1|||
47021526|NCT02047604|83270392|FG005|Overall Study|Withdrawal by Subject|1|||
47021527|NCT01622660|83270406|FG000|Overall Study|Adverse Event|1|||
47021528|NCT02019602|83270412|FG000|Screening Period|Ineligibility|4|||
47021529|NCT02019602|83270413|FG001|Screening Period|Ineligibility|0|||
47021530|NCT02019602|83270412|FG000|Screening Period|Adverse Event|1|||
47021531|NCT02019602|83270413|FG001|Screening Period|Adverse Event|0|||
47021532|NCT01994876|83270420|FG000|Test Period 1|Withdrawal by Subject|0|||
47021533|NCT01994876|83270421|FG001|Test Period 1|Withdrawal by Subject|1|||
47021534|NCT01994876|83270420|FG000|Test Period 1|Adverse Event|0|||
47021535|NCT01994876|83270421|FG001|Test Period 1|Adverse Event|1|||
47021536|NCT01994876|83270420|FG000|Test Period 2|Adverse Event|1|||
47021537|NCT01994876|83270421|FG001|Test Period 2|Adverse Event|0|||
47021538|NCT01994876|83270420|FG000|Test Period 2|Protocol Violation|0|||
47021539|NCT01994876|83270421|FG001|Test Period 2|Protocol Violation|1|||
47021540|NCT02040428|83270431|FG000|Overall Study|Death|4|||
47021541|NCT02040428|83270432|FG001|Overall Study|Death|3|||
47021542|NCT02040428|83270431|FG000|Overall Study|Withdrawal by Subject|1|||
47021543|NCT02040428|83270432|FG001|Overall Study|Withdrawal by Subject|1|||
47021544|NCT02018822|83270440|FG000|Overall Study|filling replaced by crown|0|||
47021545|NCT02018822|83270441|FG001|Overall Study|filling replaced by crown|1|||
47021546|NCT02018822|83270442|FG002|Overall Study|filling replaced by crown|0|||
47021547|NCT02018822|83270440|FG000|Overall Study|Physician Decision|0|||
47021548|NCT02018822|83270441|FG001|Overall Study|Physician Decision|1|||
47021549|NCT02018822|83270442|FG002|Overall Study|Physician Decision|1|||
47021550|NCT02018822|83270440|FG000|Overall Study|Lost to Follow-up|6|||
47021551|NCT02018822|83270441|FG001|Overall Study|Lost to Follow-up|6|||
47021552|NCT02018822|83270442|FG002|Overall Study|Lost to Follow-up|5|||
47021553|NCT02055157|83270457|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
47021554|NCT02055157|83270458|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
47021555|NCT02055157|83270459|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
47021556|NCT02055157|83270460|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
47021557|NCT02055157|83270457|FG000|Initial 6 Months|Adverse Event|0|||
47021558|NCT02055157|83270458|FG001|Initial 6 Months|Adverse Event|0|||
47021559|NCT02055157|83270459|FG002|Initial 6 Months|Adverse Event|0|||
47021560|NCT02055157|83270460|FG003|Initial 6 Months|Adverse Event|1|||
47021561|NCT02055157|83270457|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
47021562|NCT02055157|83270458|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
47021563|NCT02055157|83270459|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
47021564|NCT02055157|83270460|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
47021565|NCT02055157|83270457|FG000|18-month Extension|Investigator decision|0|||
47021566|NCT02055157|83270458|FG001|18-month Extension|Investigator decision|1|||
47021567|NCT02055157|83270459|FG002|18-month Extension|Investigator decision|0|||
47021568|NCT02055157|83270460|FG003|18-month Extension|Investigator decision|0|||
47021569|NCT02055157|83270457|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
47021570|NCT02055157|83270458|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
47021571|NCT02055157|83270459|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
47021572|NCT02055157|83270460|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
47021573|NCT02022007|83270484|FG000|Overall Study|Withdrawal by Subject|1|||
47021574|NCT02022007|83270485|FG001|Overall Study|Withdrawal by Subject|1|||
47021575|NCT02022007|83270486|FG002|Overall Study|Withdrawal by Subject|1|||
47021576|NCT02022007|83270484|FG000|Overall Study|Noncompliant|0|||
47021577|NCT02022007|83270485|FG001|Overall Study|Noncompliant|0|||
47021578|NCT02022007|83270486|FG002|Overall Study|Noncompliant|1|||
47021579|NCT02031679|83270496|FG000|Overall Study|Protocol Violation|0|||
47021580|NCT02031679|83270497|FG001|Overall Study|Protocol Violation|1|||
47021581|NCT02031679|83270496|FG000|Overall Study|Lack of Efficacy|0|||
47021582|NCT02031679|83270497|FG001|Overall Study|Lack of Efficacy|1|||
47021583|NCT02053753|83270505|FG000|Overall Study|Withdrawal by Subject|2|||
47021584|NCT02053753|83270506|FG001|Overall Study|Withdrawal by Subject|4|||
47021585|NCT02053753|83270505|FG000|Overall Study|Decision by Sponsor|1|||
47021586|NCT02053753|83270506|FG001|Overall Study|Decision by Sponsor|1|||
47021587|NCT02053753|83270505|FG000|Overall Study|Lost to Follow-up|4|||
47021588|NCT02053753|83270506|FG001|Overall Study|Lost to Follow-up|3|||
47021589|NCT02019979|83270512|FG000|Overall Study|study terminated|14|||
47021590|NCT02019667|83270516|FG000|First Intervention (6 Months)|Adverse Event|0|||
47021591|NCT02019667|83270517|FG001|First Intervention (6 Months)|Adverse Event|1|||
47021592|NCT02019667|83270516|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
47021593|NCT02019667|83270517|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
47021594|NCT02019667|83270516|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
47021595|NCT02019667|83270517|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
47021596|NCT02030821|83270529|FG000|Overall Study|Physician Decision|2|||
47021597|NCT02030821|83270530|FG001|Overall Study|Physician Decision|2|||
47021598|NCT02030821|83270531|FG002|Overall Study|Physician Decision|5|||
47021599|NCT02030821|83270532|FG003|Overall Study|Physician Decision|2|||
47021600|NCT02052739|83270544|FG000|Overall Study|Withdrew due to Adverse Event|3|||
47021601|NCT02052739|83270545|FG001|Overall Study|Withdrew due to Adverse Event|0|||
47021602|NCT02052739|83270544|FG000|Overall Study|Participant Died|2|||
47021603|NCT02052739|83270545|FG001|Overall Study|Participant Died|1|||
47021604|NCT02019277|83270553|FG000|Overall Study|Withdrawal by Subject|3|||
47021605|NCT02019277|83270553|FG000|Overall Study|Death|7|||
47021606|NCT02019277|83270553|FG000|Overall Study|Did no Cooperate|1|||
47021607|NCT02019277|83270553|FG000|Overall Study|Adverse Event|1|||
47021608|NCT02030119|83270561|FG000|Overall Study|Withdrawal by Subject|3|||
47021609|NCT02030119|83270562|FG001|Overall Study|Withdrawal by Subject|1|||
47021610|NCT02030119|83270563|FG002|Overall Study|Withdrawal by Subject|5|||
47021611|NCT02030119|83270564|FG003|Overall Study|Withdrawal by Subject|3|||
47021612|NCT02030119|83270561|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
47021613|NCT02030119|83270562|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
47021614|NCT02030119|83270563|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
47021615|NCT02030119|83270564|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
47021616|NCT01823835|83270589|FG000|Overall Study|Adverse Event|0|||
47021617|NCT01823835|83270590|FG001|Overall Study|Adverse Event|0|||
47021618|NCT01823835|83270591|FG002|Overall Study|Adverse Event|0|||
47021619|NCT01823835|83270592|FG003|Overall Study|Adverse Event|0|||
47021620|NCT01823835|83270593|FG004|Overall Study|Adverse Event|1|||
47021621|NCT01823835|83270594|FG005|Overall Study|Adverse Event|0|||
47021622|NCT01823835|83270595|FG006|Overall Study|Adverse Event|1|||
47021623|NCT01823835|83270596|FG007|Overall Study|Adverse Event|0|||
47021624|NCT01823835|83270597|FG008|Overall Study|Adverse Event|0|||
47021625|NCT01823835|83270598|FG009|Overall Study|Adverse Event|0|||
47021626|NCT01823835|83270599|FG010|Overall Study|Adverse Event|1|||
47021627|NCT01823835|83270600|FG011|Overall Study|Adverse Event|2|||
47021628|NCT01823835|83270601|FG012|Overall Study|Adverse Event|0|||
47021629|NCT01823835|83270602|FG013|Overall Study|Adverse Event|0|||
47021630|NCT01823835|83270603|FG014|Overall Study|Adverse Event|0|||
47021631|NCT01823835|83270589|FG000|Overall Study|Physician Decision|0|||
47021632|NCT01823835|83270590|FG001|Overall Study|Physician Decision|0|||
47021633|NCT01823835|83270591|FG002|Overall Study|Physician Decision|0|||
47021634|NCT01823835|83270592|FG003|Overall Study|Physician Decision|0|||
47021635|NCT01823835|83270593|FG004|Overall Study|Physician Decision|0|||
47021636|NCT01823835|83270594|FG005|Overall Study|Physician Decision|0|||
47021637|NCT01823835|83270595|FG006|Overall Study|Physician Decision|0|||
47021638|NCT01823835|83270596|FG007|Overall Study|Physician Decision|0|||
47021639|NCT01823835|83270597|FG008|Overall Study|Physician Decision|0|||
47021640|NCT01823835|83270598|FG009|Overall Study|Physician Decision|0|||
47021641|NCT01823835|83270599|FG010|Overall Study|Physician Decision|0|||
47021642|NCT01823835|83270600|FG011|Overall Study|Physician Decision|2|||
47021643|NCT01823835|83270601|FG012|Overall Study|Physician Decision|0|||
47021644|NCT01823835|83270602|FG013|Overall Study|Physician Decision|0|||
47021645|NCT01823835|83270603|FG014|Overall Study|Physician Decision|0|||
47021646|NCT01823835|83270589|FG000|Overall Study|Progressive Disease|3|||
47021647|NCT01823835|83270590|FG001|Overall Study|Progressive Disease|4|||
47021648|NCT01823835|83270591|FG002|Overall Study|Progressive Disease|3|||
47021649|NCT01823835|83270592|FG003|Overall Study|Progressive Disease|6|||
47021650|NCT01823835|83270593|FG004|Overall Study|Progressive Disease|4|||
47021651|NCT01823835|83270594|FG005|Overall Study|Progressive Disease|6|||
47021652|NCT01823835|83270595|FG006|Overall Study|Progressive Disease|5|||
47021653|NCT01823835|83270596|FG007|Overall Study|Progressive Disease|3|||
47021654|NCT01823835|83270597|FG008|Overall Study|Progressive Disease|3|||
47021655|NCT01823835|83270598|FG009|Overall Study|Progressive Disease|18|||
47021656|NCT01823835|83270599|FG010|Overall Study|Progressive Disease|8|||
47021657|NCT01823835|83270600|FG011|Overall Study|Progressive Disease|46|||
47021658|NCT01823835|83270601|FG012|Overall Study|Progressive Disease|18|||
47021659|NCT01823835|83270602|FG013|Overall Study|Progressive Disease|4|||
47021660|NCT01823835|83270603|FG014|Overall Study|Progressive Disease|6|||
47021661|NCT01823835|83270589|FG000|Overall Study|Study Termination|0|||
47021662|NCT01823835|83270590|FG001|Overall Study|Study Termination|0|||
47021663|NCT01823835|83270591|FG002|Overall Study|Study Termination|0|||
47021664|NCT01823835|83270592|FG003|Overall Study|Study Termination|0|||
47021665|NCT01823835|83270593|FG004|Overall Study|Study Termination|1|||
47021666|NCT01823835|83270594|FG005|Overall Study|Study Termination|0|||
47021667|NCT01823835|83270595|FG006|Overall Study|Study Termination|0|||
47021668|NCT01823835|83270596|FG007|Overall Study|Study Termination|0|||
47021669|NCT01823835|83270597|FG008|Overall Study|Study Termination|0|||
47021670|NCT01823835|83270598|FG009|Overall Study|Study Termination|0|||
47021671|NCT01823835|83270599|FG010|Overall Study|Study Termination|0|||
47021672|NCT01823835|83270600|FG011|Overall Study|Study Termination|1|||
47021673|NCT01823835|83270601|FG012|Overall Study|Study Termination|0|||
47021674|NCT01823835|83270602|FG013|Overall Study|Study Termination|0|||
47021675|NCT01823835|83270603|FG014|Overall Study|Study Termination|0|||
47021676|NCT01823835|83270589|FG000|Overall Study|Withdrawal by Subject|0|||
47021677|NCT01823835|83270590|FG001|Overall Study|Withdrawal by Subject|0|||
47021678|NCT01823835|83270591|FG002|Overall Study|Withdrawal by Subject|1|||
47021679|NCT01823835|83270592|FG003|Overall Study|Withdrawal by Subject|0|||
47021680|NCT01823835|83270593|FG004|Overall Study|Withdrawal by Subject|0|||
47021681|NCT01823835|83270594|FG005|Overall Study|Withdrawal by Subject|0|||
47021682|NCT01823835|83270595|FG006|Overall Study|Withdrawal by Subject|0|||
47021683|NCT01823835|83270596|FG007|Overall Study|Withdrawal by Subject|0|||
47021684|NCT01823835|83270597|FG008|Overall Study|Withdrawal by Subject|0|||
47021685|NCT01823835|83270598|FG009|Overall Study|Withdrawal by Subject|1|||
47021686|NCT01823835|83270599|FG010|Overall Study|Withdrawal by Subject|1|||
47021687|NCT01823835|83270600|FG011|Overall Study|Withdrawal by Subject|2|||
47021688|NCT01823835|83270601|FG012|Overall Study|Withdrawal by Subject|1|||
47021689|NCT01823835|83270602|FG013|Overall Study|Withdrawal by Subject|0|||
47021690|NCT01823835|83270603|FG014|Overall Study|Withdrawal by Subject|0|||
47021691|NCT01823679|83270643|FG000|Overall Study|Death|1|||
47021692|NCT01823289|83270648|FG000|Overall Study|Lost to Follow-up|5|||
47021693|NCT01823289|83270648|FG000|Overall Study|Adverse Event|5|||
47021694|NCT01823289|83270648|FG000|Overall Study|Lack of Efficacy|1|||
47021695|NCT01823289|83270648|FG000|Overall Study|Physician Decision|9|||
47021696|NCT01823289|83270648|FG000|Overall Study|Administered contraindicated medicine|1|||
46620601|NCT02265510|82770878|FG003|Overall Study|Disease Progression|1|||
47021697|NCT01823289|83270648|FG000|Overall Study|Transaminase increased more than 3 times|1|||
47021698|NCT01823289|83270648|FG000|Overall Study|Drug affected efficacy and safety|1|||
47021699|NCT01823289|83270648|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
47021700|NCT01822899|83270654|FG000|Overall Study|Adverse Event|6|||
47021701|NCT01822899|83270655|FG001|Overall Study|Adverse Event|5|||
47021702|NCT01822899|83270654|FG000|Overall Study|Lack of Efficacy|6|||
47021703|NCT01822899|83270655|FG001|Overall Study|Lack of Efficacy|3|||
47021704|NCT01822899|83270654|FG000|Overall Study|Protocol Violation|6|||
47021705|NCT01822899|83270655|FG001|Overall Study|Protocol Violation|3|||
47021706|NCT01822899|83270654|FG000|Overall Study|Lost to Follow-up|1|||
47021707|NCT01822899|83270655|FG001|Overall Study|Lost to Follow-up|0|||
47021708|NCT01822899|83270654|FG000|Overall Study|Withdrawal by Subject|5|||
47021709|NCT01822899|83270655|FG001|Overall Study|Withdrawal by Subject|7|||
47021710|NCT01822821|83270663|FG000|Overall Study|Eligible surgery cancelled|1|||
47021711|NCT01822821|83270664|FG001|Overall Study|Eligible surgery cancelled|1|||
47021712|NCT01822821|83270663|FG000|Overall Study|Other reasons|1|||
47021713|NCT01822821|83270664|FG001|Overall Study|Other reasons|0|||
47021714|NCT01822665|83270670|FG000|Overall Study|Adverse Event|3|||
47021715|NCT01822665|83270670|FG000|Overall Study|Other Reason|5|||
47021716|NCT02173301|83270692|FG000|Overall Study|Adverse Event|7|||
47021717|NCT02173301|83270693|FG001|Overall Study|Adverse Event|8|||
47021718|NCT02173301|83270694|FG002|Overall Study|Adverse Event|13|||
47021719|NCT02173301|83270695|FG003|Overall Study|Adverse Event|5|||
47021720|NCT02173301|83270692|FG000|Overall Study|Withdrawal by Subject|8|||
47021721|NCT02173301|83270693|FG001|Overall Study|Withdrawal by Subject|10|||
47021722|NCT02173301|83270694|FG002|Overall Study|Withdrawal by Subject|4|||
47021723|NCT02173301|83270695|FG003|Overall Study|Withdrawal by Subject|8|||
47021724|NCT02173301|83270692|FG000|Overall Study|Lost to Follow-up|4|||
47021725|NCT02173301|83270693|FG001|Overall Study|Lost to Follow-up|4|||
47021726|NCT02173301|83270694|FG002|Overall Study|Lost to Follow-up|2|||
47021727|NCT02173301|83270695|FG003|Overall Study|Lost to Follow-up|2|||
47021728|NCT02173301|83270692|FG000|Overall Study|Protocol Violation|0|||
47021729|NCT02173301|83270693|FG001|Overall Study|Protocol Violation|1|||
47021730|NCT02173301|83270694|FG002|Overall Study|Protocol Violation|0|||
47021731|NCT02173301|83270695|FG003|Overall Study|Protocol Violation|0|||
47021732|NCT02173301|83270692|FG000|Overall Study|Physician Decision|0|||
47021733|NCT02173301|83270693|FG001|Overall Study|Physician Decision|0|||
47021734|NCT02173301|83270694|FG002|Overall Study|Physician Decision|1|||
47021735|NCT02173301|83270695|FG003|Overall Study|Physician Decision|0|||
47021736|NCT02173301|83270692|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
47021737|NCT02173301|83270693|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
47021738|NCT02173301|83270694|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
47021739|NCT02173301|83270695|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
47021740|NCT01822587|83270708|FG000|Overall Study|Lost to Follow-up|7|||
47021741|NCT01822587|83270709|FG001|Overall Study|Lost to Follow-up|9|||
47021742|NCT01822587|83270710|FG002|Overall Study|Lost to Follow-up|12|||
47021743|NCT01822587|83270708|FG000|Overall Study|Physician Decision|9|||
47021744|NCT01822587|83270709|FG001|Overall Study|Physician Decision|6|||
47021745|NCT01822587|83270710|FG002|Overall Study|Physician Decision|6|||
47021746|NCT01822353|83270721|FG000|Overall Study|Adverse Event|1|||
47021747|NCT01822353|83270722|FG001|Overall Study|Adverse Event|3|||
47021748|NCT01822353|83270723|FG002|Overall Study|Adverse Event|1|||
47021749|NCT01822353|83270721|FG000|Overall Study|Pregnancy|0|||
47021750|NCT01822353|83270722|FG001|Overall Study|Pregnancy|1|||
47021751|NCT01822353|83270723|FG002|Overall Study|Pregnancy|0|||
47021752|NCT01822353|83270721|FG000|Overall Study|Withdrawal by Subject|3|||
47021753|NCT01822353|83270722|FG001|Overall Study|Withdrawal by Subject|1|||
47021754|NCT01822353|83270723|FG002|Overall Study|Withdrawal by Subject|0|||
47021755|NCT01821963|83270734|FG000|Overall Study|Adverse Event|1|||
47021756|NCT01821807|83270740|FG000|Overall Study|Lost to Follow-up|3|||
47021757|NCT01821807|83270741|FG001|Overall Study|Lost to Follow-up|1|||
47021758|NCT01821729|83270747|FG000|Overall Study|Withdrawal by Subject|1|||
47021759|NCT01820637|83270751|FG000|Overall Study|Death|2|||
47021760|NCT01820637|83270751|FG000|Overall Study|Withdrawal by Subject|1|||
47021761|NCT02172911|83270757|FG000|Overall Study|Serious Adverse Event|0|||
47021762|NCT02172911|83270758|FG001|Overall Study|Serious Adverse Event|1|||
47021763|NCT02172911|83270757|FG000|Overall Study|Progression of Disease|0|||
47021764|NCT02172911|83270758|FG001|Overall Study|Progression of Disease|1|||
47021765|NCT02172911|83270757|FG000|Overall Study|Loss of insurance coverage|1|||
47021766|NCT02172911|83270758|FG001|Overall Study|Loss of insurance coverage|0|||
47021767|NCT02120027|83270766|FG000|Overall Study|Adverse Event|4|||
47021768|NCT02120027|83270767|FG001|Overall Study|Adverse Event|5|||
47021769|NCT02120027|83270766|FG000|Overall Study|Lack of Efficacy|3|||
47021770|NCT02120027|83270767|FG001|Overall Study|Lack of Efficacy|5|||
47021771|NCT02120027|83270766|FG000|Overall Study|Lost to Follow-up|5|||
47021772|NCT02120027|83270767|FG001|Overall Study|Lost to Follow-up|13|||
47021773|NCT02120027|83270766|FG000|Overall Study|Other|4|||
47021774|NCT02120027|83270767|FG001|Overall Study|Other|0|||
47021775|NCT02120027|83270766|FG000|Overall Study|Physician Decision|4|||
47021776|NCT02120027|83270767|FG001|Overall Study|Physician Decision|3|||
47021777|NCT02120027|83270766|FG000|Overall Study|Protocol Violation|18|||
47021778|NCT02120027|83270767|FG001|Overall Study|Protocol Violation|21|||
47021779|NCT02120027|83270766|FG000|Overall Study|Study terminated by Sponsor|45|||
47021780|NCT02120027|83270767|FG001|Overall Study|Study terminated by Sponsor|47|||
47021781|NCT02120027|83270766|FG000|Overall Study|Withdrawal by Subject|33|||
47021782|NCT02120027|83270767|FG001|Overall Study|Withdrawal by Subject|25|||
47021783|NCT01850823|83270776|FG000|Overall Study|Early Visit Window|0|||
47021784|NCT01850823|83270777|FG001|Overall Study|Early Visit Window|1|||
47021785|NCT01850823|83270778|FG002|Overall Study|Early Visit Window|4|||
47021786|NCT01850823|83270776|FG000|Overall Study|Enrolled in Error|0|||
47021787|NCT01850823|83270777|FG001|Overall Study|Enrolled in Error|1|||
47021788|NCT01850823|83270778|FG002|Overall Study|Enrolled in Error|2|||
47021789|NCT01850823|83270776|FG000|Overall Study|Lack of Efficacy|1|||
47021790|NCT01850823|83270777|FG001|Overall Study|Lack of Efficacy|0|||
47021791|NCT01850823|83270778|FG002|Overall Study|Lack of Efficacy|0|||
47021792|NCT01850823|83270776|FG000|Overall Study|Lost to Follow-up|0|||
47021793|NCT01850823|83270777|FG001|Overall Study|Lost to Follow-up|0|||
47021794|NCT01850823|83270778|FG002|Overall Study|Lost to Follow-up|1|||
46620602|NCT02265510|82770879|FG004|Overall Study|Disease Progression|1|||
47021795|NCT01850823|83270776|FG000|Overall Study|Restricted Medication|0|||
47021796|NCT01850823|83270777|FG001|Overall Study|Restricted Medication|0|||
47021797|NCT01850823|83270778|FG002|Overall Study|Restricted Medication|2|||
47021798|NCT01850823|83270776|FG000|Overall Study|Significant worstening of SAR|0|||
47021799|NCT01850823|83270777|FG001|Overall Study|Significant worstening of SAR|1|||
47021800|NCT01850823|83270778|FG002|Overall Study|Significant worstening of SAR|0|||
47021801|NCT01850823|83270776|FG000|Overall Study|Withdrawal by Subject|2|||
47021802|NCT01850823|83270777|FG001|Overall Study|Withdrawal by Subject|0|||
47021803|NCT01850823|83270778|FG002|Overall Study|Withdrawal by Subject|1|||
47021804|NCT01820559|83270791|FG000|Overall Study|Adverse Event|4|||
47021805|NCT01820559|83270792|FG001|Overall Study|Adverse Event|6|||
47021806|NCT01820559|83270793|FG002|Overall Study|Adverse Event|13|||
47021807|NCT01820559|83270791|FG000|Overall Study|Withdrawal by Subject|1|||
47021808|NCT01820559|83270792|FG001|Overall Study|Withdrawal by Subject|2|||
47021809|NCT01820559|83270793|FG002|Overall Study|Withdrawal by Subject|5|||
47021810|NCT01820559|83270791|FG000|Overall Study|Protocol Violation|2|||
47021811|NCT01820559|83270792|FG001|Overall Study|Protocol Violation|1|||
47021812|NCT01820559|83270793|FG002|Overall Study|Protocol Violation|3|||
47021813|NCT01820559|83270791|FG000|Overall Study|Subject's non-compliance|1|||
47021814|NCT01820559|83270792|FG001|Overall Study|Subject's non-compliance|0|||
47021815|NCT01820559|83270793|FG002|Overall Study|Subject's non-compliance|2|||
47021816|NCT01820559|83270791|FG000|Overall Study|Lost to Follow-up|3|||
47021817|NCT01820559|83270792|FG001|Overall Study|Lost to Follow-up|2|||
47021818|NCT01820559|83270793|FG002|Overall Study|Lost to Follow-up|2|||
47021819|NCT01820559|83270791|FG000|Overall Study|At sponsor request|0|||
47021820|NCT01820559|83270792|FG001|Overall Study|At sponsor request|0|||
47021821|NCT01820559|83270793|FG002|Overall Study|At sponsor request|1|||
47021822|NCT01820559|83270791|FG000|Overall Study|Lack of Efficacy|3|||
47021823|NCT01820559|83270792|FG001|Overall Study|Lack of Efficacy|2|||
47021824|NCT01820559|83270793|FG002|Overall Study|Lack of Efficacy|3|||
47021825|NCT01818765|83270801|FG000|Overall Study|Death|2|||
47021826|NCT01850589|83270808|FG000|Overall Study|Withdrawal by Subject|8|||
47021827|NCT01850589|83270809|FG001|Overall Study|Withdrawal by Subject|0|||
47021828|NCT01818531|83270817|FG000|Overall Study|Withdrawn for case delay after block|1|||
47021829|NCT01818531|83270818|FG001|Overall Study|Withdrawn for case delay after block|0|||
47021830|NCT01818531|83270817|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
47021831|NCT01818531|83270818|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
47021832|NCT01818531|83270817|FG000|Overall Study|Withdrawn for failure to place block|0|||
47021833|NCT01818531|83270818|FG001|Overall Study|Withdrawn for failure to place block|1|||
47021834|NCT02171429|83270827|FG000|Overall Study|Other|0|||
47021835|NCT02171429|83270828|FG001|Overall Study|Other|1|||
47021836|NCT02171429|83270829|FG002|Overall Study|Other|1|||
47021837|NCT02171429|83270827|FG000|Overall Study|Non-Compliance|0|||
47021838|NCT02171429|83270828|FG001|Overall Study|Non-Compliance|0|||
47021839|NCT02171429|83270829|FG002|Overall Study|Non-Compliance|1|||
47021840|NCT02171429|83270827|FG000|Overall Study|Physician Decision|0|||
47021841|NCT02171429|83270828|FG001|Overall Study|Physician Decision|0|||
47021842|NCT02171429|83270829|FG002|Overall Study|Physician Decision|1|||
47021843|NCT02171429|83270827|FG000|Overall Study|Withdrawal by Subject|1|||
47021844|NCT02171429|83270828|FG001|Overall Study|Withdrawal by Subject|1|||
47021845|NCT02171429|83270829|FG002|Overall Study|Withdrawal by Subject|1|||
47021846|NCT02171429|83270827|FG000|Overall Study|Lost to Follow-up|0|||
47021847|NCT02171429|83270828|FG001|Overall Study|Lost to Follow-up|1|||
47021848|NCT02171429|83270829|FG002|Overall Study|Lost to Follow-up|0|||
47021849|NCT02171429|83270827|FG000|Overall Study|Death|0|||
47021850|NCT02171429|83270828|FG001|Overall Study|Death|0|||
47021851|NCT02171429|83270829|FG002|Overall Study|Death|1|||
47021852|NCT01818297|83270842|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
47021853|NCT01818297|83270843|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
47021854|NCT01818297|83270842|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
47021855|NCT01818297|83270843|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
47021856|NCT01818297|83270842|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
47021857|NCT01818297|83270843|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
47021858|NCT01818141|83270851|FG000|Overall Study|Withdrawal by Subject|2|||
47021859|NCT01818141|83270852|FG001|Overall Study|Withdrawal by Subject|0|||
47021860|NCT01818141|83270851|FG000|Overall Study|No baseline C.diff colonies|1|||
47021861|NCT01818141|83270852|FG001|Overall Study|No baseline C.diff colonies|1|||
47021862|NCT01818141|83270851|FG000|Overall Study|Lost to Follow-up|0|||
47021863|NCT01818141|83270852|FG001|Overall Study|Lost to Follow-up|2|||
47021864|NCT01849497|83270860|FG000|Overall Study|Withdrawal by Subject|1|||
47021865|NCT01849497|83270861|FG001|Overall Study|Withdrawal by Subject|2|||
47021866|NCT01849497|83270860|FG000|Overall Study|Sponsor Decision|0|||
47021867|NCT01849497|83270861|FG001|Overall Study|Sponsor Decision|1|||
47021868|NCT01849497|83270860|FG000|Overall Study|Lost to Follow-up|0|||
47021869|NCT01849497|83270861|FG001|Overall Study|Lost to Follow-up|1|||
47021870|NCT02147093|83270869|FG000|Period 1|Lost to Follow-up|0|||
47021871|NCT02147093|83270870|FG001|Period 1|Lost to Follow-up|1|||
47021872|NCT02147093|83270869|FG000|Period 2|Protocol Violation|2|||
47021873|NCT02147093|83270870|FG001|Period 2|Protocol Violation|0|||
47021874|NCT02119325|83270876|FG000|Washout Period 1|Adverse Event|0|||
47021875|NCT02119325|83270877|FG001|Washout Period 1|Adverse Event|1|||
47021876|NCT01816893|83270887|FG000|Washout Period|Withdrawal by Subject|2|||
47021877|NCT01816893|83270888|FG001|Washout Period|Withdrawal by Subject|0|||
47021878|NCT01848483|83270896|FG000|Overall Study|Death|2|||
47021879|NCT01848483|83270897|FG001|Overall Study|Death|1|||
47021880|NCT01848483|83270896|FG000|Overall Study|Lost to Follow-up|6|||
47021881|NCT01848483|83270897|FG001|Overall Study|Lost to Follow-up|8|||
47021882|NCT01848483|83270896|FG000|Overall Study|Withdrawal by Subject|1|||
47021883|NCT01848483|83270897|FG001|Overall Study|Withdrawal by Subject|0|||
47021884|NCT01848483|83270896|FG000|Overall Study|Incarceration|2|||
47021885|NCT01848483|83270897|FG001|Overall Study|Incarceration|2|||
47021886|NCT01610271|83270906|FG000|Overall Study|Surgery not complete|0|||
47021887|NCT01610271|83270907|FG001|Overall Study|Surgery not complete|1|||
47021888|NCT01610271|83270906|FG000|Overall Study|Prosthesis not implanted|2|||
47021889|NCT01610271|83270907|FG001|Overall Study|Prosthesis not implanted|3|||
47021890|NCT02170727|83270917|FG000|Overall Study|Lost to Follow-up|1|||
47021891|NCT02170727|83270918|FG001|Overall Study|Lost to Follow-up|0|||
47021892|NCT02170727|83270917|FG000|Overall Study|Withdrawal by Subject|2|||
47021893|NCT02170727|83270918|FG001|Overall Study|Withdrawal by Subject|0|||
47021894|NCT01847313|83270929|FG000|Overall Study|Death|0|||
47021895|NCT01847313|83270930|FG001|Overall Study|Death|1|||
47021896|NCT01847313|83270929|FG000|Overall Study|Withdrawal by Subject|0|||
47021897|NCT01847313|83270930|FG001|Overall Study|Withdrawal by Subject|1|||
47021898|NCT02144285|83270946|FG000|Overall Study|Withdrawal by Subject|0|||
47021899|NCT02144285|83270947|FG001|Overall Study|Withdrawal by Subject|0|||
47021900|NCT02144285|83270948|FG002|Overall Study|Withdrawal by Subject|0|||
47021901|NCT02144285|83270949|FG003|Overall Study|Withdrawal by Subject|0|||
47021902|NCT02144285|83270950|FG004|Overall Study|Withdrawal by Subject|1|||
47021903|NCT02144285|83270951|FG005|Overall Study|Withdrawal by Subject|0|||
47021904|NCT02144285|83270952|FG006|Overall Study|Withdrawal by Subject|0|||
47021905|NCT02144285|83270953|FG007|Overall Study|Withdrawal by Subject|0|||
47021906|NCT02144285|83270954|FG008|Overall Study|Withdrawal by Subject|0|||
47021907|NCT02144285|83270955|FG009|Overall Study|Withdrawal by Subject|0|||
47021908|NCT02117687|83270993|FG000|Overall Study|Lost to Follow-up|0|||
47021909|NCT02117687|83270994|FG001|Overall Study|Lost to Follow-up|1|||
47021910|NCT02117687|83270993|FG000|Overall Study|Adverse Event|0|||
47021911|NCT02117687|83270994|FG001|Overall Study|Adverse Event|2|||
47021912|NCT02117687|83270993|FG000|Overall Study|Other Reasons|1|||
47021913|NCT02117687|83270994|FG001|Overall Study|Other Reasons|1|||
47021914|NCT02143583|83271003|FG000|Overall Study|Withdrawal by Subject|1|||
47021915|NCT02143583|83271004|FG001|Overall Study|Withdrawal by Subject|0|||
47021916|NCT02143583|83271005|FG002|Overall Study|Withdrawal by Subject|1|||
47021917|NCT02143583|83271003|FG000|Overall Study|husband illness|0|||
46911368|NCT03210259|83141023|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
46911369|NCT03210259|83141024|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
47021918|NCT02143583|83271004|FG001|Overall Study|husband illness|0|||
47021919|NCT02143583|83271005|FG002|Overall Study|husband illness|1|||
47021920|NCT02105987|83271015|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
47021921|NCT02105987|83271016|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
47021922|NCT02105987|83271017|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
47021923|NCT02105987|83271018|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
47021924|NCT02105987|83271019|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
47021925|NCT02105987|83271020|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
47021926|NCT02105987|83271015|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
47021927|NCT02105987|83271016|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
47021928|NCT02105987|83271017|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
47021929|NCT02105987|83271018|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
47021930|NCT02105987|83271019|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
47021931|NCT02105987|83271020|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
47021932|NCT02105987|83271015|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
47021933|NCT02105987|83271016|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
47021934|NCT02105987|83271017|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021935|NCT02105987|83271018|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021936|NCT02105987|83271019|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021937|NCT02105987|83271020|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021938|NCT02105987|83271015|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
47021939|NCT02105987|83271016|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
47021940|NCT02105987|83271017|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
46709766|NCT01140906|82925848|FG001|Overall Study|Lost to Follow-up|1|||
46709767|NCT01140906|82925849|FG002|Overall Study|Lost to Follow-up|0|||
46709768|NCT01140906|82925850|FG003|Overall Study|Lost to Follow-up|2|||
46709769|NCT01140906|82925847|FG000|Overall Study|Administrative or other reason|0|||
46709770|NCT01140906|82925848|FG001|Overall Study|Administrative or other reason|5|||
47021941|NCT02105987|83271018|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
47021942|NCT02105987|83271019|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
47021943|NCT02105987|83271020|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
47021944|NCT02105987|83271015|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
47021945|NCT02105987|83271016|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
47021946|NCT02105987|83271017|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
47021947|NCT02105987|83271018|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
47021948|NCT02105987|83271019|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
47021949|NCT02105987|83271020|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
47021950|NCT02105987|83271015|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
47021951|NCT02105987|83271016|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
47021952|NCT02105987|83271017|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
47021953|NCT02105987|83271018|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
47021954|NCT02105987|83271019|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
47021955|NCT02105987|83271020|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
47021956|NCT02105987|83271015|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
47021957|NCT02105987|83271016|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
47021958|NCT02105987|83271017|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
47021959|NCT02105987|83271018|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
47021960|NCT02105987|83271019|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
47021961|NCT02105987|83271020|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
47021962|NCT02105987|83271015|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
47021963|NCT02105987|83271016|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
47021964|NCT02105987|83271017|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
47021965|NCT02105987|83271018|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
47021966|NCT02105987|83271019|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
47021967|NCT02105987|83271020|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
47021968|NCT02105987|83271015|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021969|NCT02105987|83271016|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021970|NCT02105987|83271017|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
47021971|NCT02105987|83271018|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
47021972|NCT02105987|83271019|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021973|NCT02105987|83271020|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
47021974|NCT02105987|83271015|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
47021975|NCT02105987|83271016|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
47021976|NCT02105987|83271017|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
47021977|NCT02105987|83271018|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
47021978|NCT02105987|83271019|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
47021979|NCT02105987|83271020|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
47021980|NCT02105987|83271015|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
47021981|NCT02105987|83271016|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
47021982|NCT02105987|83271017|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
46620603|NCT02265510|82770880|FG005|Overall Study|Disease Progression|0|||
46620604|NCT02265510|82770881|FG006|Overall Study|Disease Progression|0|||
46620605|NCT02265510|82770882|FG007|Overall Study|Disease Progression|0|||
46620606|NCT02265510|82770883|FG008|Overall Study|Disease Progression|0|||
46620607|NCT02265510|82770884|FG009|Overall Study|Disease Progression|0|||
46620608|NCT02265510|82770885|FG010|Overall Study|Disease Progression|0|||
46620609|NCT02265510|82770886|FG011|Overall Study|Disease Progression|0|||
46620610|NCT02265510|82770887|FG012|Overall Study|Disease Progression|0|||
46620611|NCT02265510|82770888|FG013|Overall Study|Disease Progression|0|||
46620612|NCT02265510|82770875|FG000|Overall Study|Death|2|||
46620613|NCT02265510|82770876|FG001|Overall Study|Death|0|||
46620614|NCT02265510|82770877|FG002|Overall Study|Death|2|||
46620615|NCT02265510|82770878|FG003|Overall Study|Death|2|||
46620616|NCT02265510|82770879|FG004|Overall Study|Death|1|||
46620617|NCT02265510|82770880|FG005|Overall Study|Death|3|||
46620618|NCT02265510|82770881|FG006|Overall Study|Death|2|||
47021983|NCT02105987|83271018|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
47021984|NCT02105987|83271019|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
47021985|NCT02105987|83271020|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
47021986|NCT02105987|83271015|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
47021987|NCT02105987|83271016|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
47021988|NCT02105987|83271017|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
47021989|NCT02105987|83271018|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
46709771|NCT01140906|82925849|FG002|Overall Study|Administrative or other reason|3|||
46709772|NCT01140906|82925850|FG003|Overall Study|Administrative or other reason|2|||
46709773|NCT00962091|82925867|FG000|Overall Study|Withdrawal by Subject|1|||
46709774|NCT00962091|82925868|FG001|Overall Study|Withdrawal by Subject|2|||
46709775|NCT00962091|82925869|FG002|Overall Study|Withdrawal by Subject|1|||
46709776|NCT00962091|82925870|FG003|Overall Study|Withdrawal by Subject|1|||
46709777|NCT00962091|82925871|FG004|Overall Study|Withdrawal by Subject|0|||
46709778|NCT00962091|82925872|FG005|Overall Study|Withdrawal by Subject|1|||
46709779|NCT00962091|82925873|FG006|Overall Study|Withdrawal by Subject|0|||
46709780|NCT00962091|82925867|FG000|Overall Study|Adverse Event|0|||
46709781|NCT00962091|82925868|FG001|Overall Study|Adverse Event|0|||
46709782|NCT00962091|82925869|FG002|Overall Study|Adverse Event|0|||
46709783|NCT00962091|82925870|FG003|Overall Study|Adverse Event|0|||
46709784|NCT00962091|82925871|FG004|Overall Study|Adverse Event|0|||
46709785|NCT00962091|82925872|FG005|Overall Study|Adverse Event|0|||
46709786|NCT00962091|82925873|FG006|Overall Study|Adverse Event|1|||
46709787|NCT01163916|82925900|FG000|Overall Study|Withdrawal by Subject|2|||
46709788|NCT01163916|82925901|FG001|Overall Study|Withdrawal by Subject|0|||
46709789|NCT01163916|82925902|FG002|Overall Study|Withdrawal by Subject|2|||
46709790|NCT01163916|82925900|FG000|Overall Study|Adverse Event|2|||
46709791|NCT01163916|82925901|FG001|Overall Study|Adverse Event|0|||
46709792|NCT01163916|82925902|FG002|Overall Study|Adverse Event|1|||
46709793|NCT01163916|82925900|FG000|Overall Study|Lack of Efficacy|2|||
46709794|NCT01163916|82925901|FG001|Overall Study|Lack of Efficacy|0|||
46709795|NCT01163916|82925902|FG002|Overall Study|Lack of Efficacy|1|||
46709796|NCT01163916|82925900|FG000|Overall Study|Other|24|||
46709797|NCT01163916|82925901|FG001|Overall Study|Other|4|||
46709798|NCT01163916|82925902|FG002|Overall Study|Other|16|||
46709799|NCT01122576|82925918|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
46709800|NCT01122576|82925919|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
46709801|NCT01122576|82925920|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
46709802|NCT01122576|82925918|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
46709803|NCT01122576|82925919|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
46709804|NCT01122576|82925920|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
46709805|NCT01122576|82925918|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
46709806|NCT01122576|82925919|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
46709807|NCT01122576|82925920|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
46709808|NCT00965523|82925931|FG000|Study 221|Progressive Disease|4|||
46709809|NCT00965523|82925931|FG000|Study 221|Physician Decision|3|||
46709810|NCT00965523|82925931|FG000|Study 224|Progressive Disease|5|||
46709811|NCT00965523|82925931|FG000|Study 224|Physician Decision|1|||
46709812|NCT01122264|82925938|FG000|Overall Study|Adverse Event|6|||
46709813|NCT01122264|82925939|FG001|Overall Study|Adverse Event|5|||
46709814|NCT01122264|82925940|FG002|Overall Study|Adverse Event|7|||
46709815|NCT01122264|82925938|FG000|Overall Study|Death|1|||
46709816|NCT01122264|82925939|FG001|Overall Study|Death|0|||
46709817|NCT01122264|82925940|FG002|Overall Study|Death|0|||
46709818|NCT01122264|82925938|FG000|Overall Study|Lost to Follow-up|5|||
46709819|NCT01122264|82925939|FG001|Overall Study|Lost to Follow-up|9|||
46709820|NCT01122264|82925940|FG002|Overall Study|Lost to Follow-up|13|||
46709821|NCT01122264|82925938|FG000|Overall Study|Entry Criteria Not Met|1|||
46709822|NCT01122264|82925939|FG001|Overall Study|Entry Criteria Not Met|0|||
46709823|NCT01122264|82925940|FG002|Overall Study|Entry Criteria Not Met|0|||
46709824|NCT01122264|82925938|FG000|Overall Study|Protocol Violation|7|||
46709825|NCT01122264|82925939|FG001|Overall Study|Protocol Violation|7|||
46709826|NCT01122264|82925940|FG002|Overall Study|Protocol Violation|9|||
46709827|NCT01122264|82925938|FG000|Overall Study|Withdrawal by Subject|6|||
46709828|NCT01122264|82925939|FG001|Overall Study|Withdrawal by Subject|6|||
46709829|NCT01122264|82925940|FG002|Overall Study|Withdrawal by Subject|16|||
46709830|NCT01122264|82925938|FG000|Overall Study|Physician Decision|3|||
46709831|NCT01122264|82925939|FG001|Overall Study|Physician Decision|1|||
47021990|NCT02105987|83271019|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
47021991|NCT02105987|83271020|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
46709832|NCT01122264|82925940|FG002|Overall Study|Physician Decision|1|||
46709833|NCT01122264|82925938|FG000|Overall Study|Lack of Efficacy|3|||
46709834|NCT01122264|82925939|FG001|Overall Study|Lack of Efficacy|1|||
46709835|NCT01122264|82925940|FG002|Overall Study|Lack of Efficacy|1|||
46709836|NCT00920218|82925956|FG000|Overall Study|Serious Adverse Event|2|||
46709837|NCT00920218|82925957|FG001|Overall Study|Serious Adverse Event|0|||
46709838|NCT00920218|82925958|FG002|Overall Study|Serious Adverse Event|2|||
46709839|NCT00920218|82925959|FG003|Overall Study|Serious Adverse Event|1|||
46709840|NCT00920218|82925956|FG000|Overall Study|Withdrawal by Subject|0|||
46709841|NCT00920218|82925957|FG001|Overall Study|Withdrawal by Subject|3|||
46709842|NCT00920218|82925958|FG002|Overall Study|Withdrawal by Subject|2|||
46709843|NCT00920218|82925959|FG003|Overall Study|Withdrawal by Subject|0|||
46709844|NCT00920218|82925956|FG000|Overall Study|Migrated/moved from study area|0|||
46709845|NCT00920218|82925957|FG001|Overall Study|Migrated/moved from study area|0|||
46709846|NCT00920218|82925958|FG002|Overall Study|Migrated/moved from study area|1|||
47021992|NCT02105987|83271015|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
47021993|NCT02105987|83271016|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
47021994|NCT02105987|83271017|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
47021995|NCT02105987|83271018|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
47021996|NCT02105987|83271019|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
47021997|NCT02105987|83271020|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
47021998|NCT02105987|83271015|FG000|Continuation Phase|Protocol Violation|0|||
47021999|NCT02105987|83271016|FG001|Continuation Phase|Protocol Violation|0|||
47022000|NCT02105987|83271017|FG002|Continuation Phase|Protocol Violation|0|||
47022001|NCT02105987|83271018|FG003|Continuation Phase|Protocol Violation|0|||
47022002|NCT02105987|83271019|FG004|Continuation Phase|Protocol Violation|1|||
47022003|NCT02105987|83271020|FG005|Continuation Phase|Protocol Violation|0|||
47022004|NCT02141633|83271028|FG000|Overall Study|Physician Decision|1|||
47022005|NCT02141633|83271029|FG001|Overall Study|Physician Decision|0|||
47022006|NCT01846611|83271037|FG000|Overall Study|Lost to Follow-up|4|||
47022007|NCT01846611|83271038|FG001|Overall Study|Lost to Follow-up|6|||
47022008|NCT01846611|83271037|FG000|Overall Study|Withdrawal by Subject|15|||
47022009|NCT01846611|83271038|FG001|Overall Study|Withdrawal by Subject|19|||
47022010|NCT01846611|83271037|FG000|Overall Study|Other|19|||
47022011|NCT01846611|83271038|FG001|Overall Study|Other|18|||
47022012|NCT02141399|83271044|FG000|Overall Study|Adverse Event|158|||
47022013|NCT02141399|83271044|FG000|Overall Study|Lack of Efficacy|62|||
47022014|NCT02141399|83271044|FG000|Overall Study|Lost to Follow-up|151|||
47022015|NCT02141399|83271044|FG000|Overall Study|Non-compliance with study drug|18|||
47022016|NCT02141399|83271044|FG000|Overall Study|Other|45|||
47022017|NCT02141399|83271044|FG000|Overall Study|Physician Decision|17|||
47022018|NCT02141399|83271044|FG000|Overall Study|Pregnancy|3|||
47022019|NCT02141399|83271044|FG000|Overall Study|Protocol Violation|38|||
47022020|NCT02141399|83271044|FG000|Overall Study|Withdrawal by Subject|238|||
47022021|NCT02141399|83271044|FG000|Overall Study|Failure to meet eligibility criteria|14|||
47022022|NCT01846299|83271050|FG000|Overall Study|Physician Decision|4|||
47022023|NCT01846299|83271051|FG001|Overall Study|Physician Decision|2|||
47022024|NCT01846299|83271050|FG000|Overall Study|Protocol deviation|1|||
47022025|NCT01846299|83271051|FG001|Overall Study|Protocol deviation|0|||
47022026|NCT01846299|83271050|FG000|Overall Study|Death|1|||
47022027|NCT01846299|83271051|FG001|Overall Study|Death|2|||
47022028|NCT01846299|83271050|FG000|Overall Study|Lost to Follow-up|3|||
47022029|NCT01846299|83271051|FG001|Overall Study|Lost to Follow-up|0|||
47022030|NCT01846299|83271050|FG000|Overall Study|Withdrawal by Subject|1|||
47022031|NCT01846299|83271051|FG001|Overall Study|Withdrawal by Subject|6|||
47022032|NCT01846299|83271050|FG000|Overall Study|Adverse Event|2|||
47022033|NCT01846299|83271051|FG001|Overall Study|Adverse Event|0|||
47022034|NCT01628393|83271062|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
47022035|NCT01628393|83271063|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
47022036|NCT01628393|83271064|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
47022037|NCT01628393|83271065|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
47022038|NCT01628393|83271066|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
47022039|NCT01628393|83271062|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
47022040|NCT01628393|83271063|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
47022041|NCT01628393|83271064|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
47022042|NCT01628393|83271065|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
47022043|NCT01628393|83271066|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
47022044|NCT01628393|83271062|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
47022045|NCT01628393|83271063|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
47022046|NCT01628393|83271064|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
47022047|NCT01628393|83271065|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
47022048|NCT01628393|83271066|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
47022049|NCT01628393|83271062|FG000|Blinded Active Extension Period|Adverse Event|0|||
47022050|NCT01628393|83271063|FG001|Blinded Active Extension Period|Adverse Event|1|||
47022051|NCT01628393|83271064|FG002|Blinded Active Extension Period|Adverse Event|0|||
47022052|NCT01628393|83271065|FG003|Blinded Active Extension Period|Adverse Event|2|||
47022053|NCT01628393|83271066|FG004|Blinded Active Extension Period|Adverse Event|2|||
47022054|NCT01628393|83271062|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
46709847|NCT00920218|82925959|FG003|Overall Study|Migrated/moved from study area|0|||
46709848|NCT00920218|82925956|FG000|Overall Study|Lost to Follow-up|0|||
47022055|NCT01628393|83271063|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
47022056|NCT01628393|83271064|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
47022057|NCT01628393|83271065|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
47022058|NCT01628393|83271066|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
47022059|NCT01628393|83271062|FG000|Blinded Active Extension Period|Physician Decision|0|||
47022060|NCT01628393|83271063|FG001|Blinded Active Extension Period|Physician Decision|3|||
47022061|NCT01628393|83271064|FG002|Blinded Active Extension Period|Physician Decision|0|||
47022062|NCT01628393|83271065|FG003|Blinded Active Extension Period|Physician Decision|1|||
47022063|NCT01628393|83271066|FG004|Blinded Active Extension Period|Physician Decision|0|||
47022064|NCT01628393|83271062|FG000|Blinded Active Extension Period|Protocol Violation|0|||
47022065|NCT01628393|83271063|FG001|Blinded Active Extension Period|Protocol Violation|0|||
47022066|NCT01628393|83271064|FG002|Blinded Active Extension Period|Protocol Violation|2|||
47022067|NCT01628393|83271065|FG003|Blinded Active Extension Period|Protocol Violation|1|||
47022068|NCT01628393|83271066|FG004|Blinded Active Extension Period|Protocol Violation|0|||
47022069|NCT01628393|83271062|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
47022070|NCT01628393|83271063|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
47022071|NCT01628393|83271064|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
47022072|NCT01628393|83271065|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
47022073|NCT01628393|83271066|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
47022074|NCT01846221|83271082|FG000|Overall Study|Catheter Failure|2|||
47022075|NCT01846221|83271083|FG001|Overall Study|Catheter Failure|0|||
47022076|NCT01846221|83271082|FG000|Overall Study|Age Exclusion|1|||
47022077|NCT01846221|83271083|FG001|Overall Study|Age Exclusion|0|||
47022078|NCT01815099|83271089|FG000|Overall Study|Lack of Efficacy|1|||
47022079|NCT01815099|83271089|FG000|Overall Study|unable to attend study visits|1|||
47022080|NCT01845831|83271096|FG000|Inpatient Phase|Withdrawal by Subject|1|||
47022081|NCT01845831|83271097|FG001|Inpatient Phase|Withdrawal by Subject|1|||
47022082|NCT01845831|83271098|FG002|Inpatient Phase|Withdrawal by Subject|0|||
47022083|NCT01845831|83271099|FG003|Inpatient Phase|Withdrawal by Subject|0|||
47022084|NCT01845831|83271100|FG004|Inpatient Phase|Withdrawal by Subject|0|||
47022085|NCT01627691|83271111|FG000|Overall Study|Death|11|||
47022086|NCT01627691|83271111|FG000|Overall Study|Lost to Follow-up|3|||
47022087|NCT01627691|83271111|FG000|Overall Study|Withdrawal by Subject|1|||
47022088|NCT01627691|83271111|FG000|Overall Study|Missed the visit|3|||
47022089|NCT01844895|83271115|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
47022090|NCT01844895|83271115|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
47022091|NCT01844895|83271115|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
47022092|NCT01844895|83271115|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
47022093|NCT01844895|83271115|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
47022094|NCT01844895|83271115|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
47022095|NCT01844895|83271115|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
47022096|NCT02116361|83271132|FG000|Overall Study|Pregnancy|0|||
47022097|NCT02116361|83271133|FG001|Overall Study|Pregnancy|0|||
47022098|NCT02116361|83271134|FG002|Overall Study|Pregnancy|0|||
47022099|NCT02116361|83271135|FG003|Overall Study|Pregnancy|1|||
47022100|NCT02116361|83271132|FG000|Overall Study|Protocol Violation|1|||
47022101|NCT02116361|83271133|FG001|Overall Study|Protocol Violation|0|||
47022102|NCT02116361|83271134|FG002|Overall Study|Protocol Violation|0|||
47022103|NCT02116361|83271135|FG003|Overall Study|Protocol Violation|2|||
47022104|NCT02116361|83271132|FG000|Overall Study|Physician Decision|2|||
47022105|NCT02116361|83271133|FG001|Overall Study|Physician Decision|3|||
46911370|NCT03210259|83141022|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
46911371|NCT03210259|83141023|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
46911372|NCT03210259|83141024|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
46911373|NCT03257657|83141033|FG000|Overall Study|Lost to Follow-up|0|||
46911374|NCT03257657|83141034|FG001|Overall Study|Lost to Follow-up|3|||
46911375|NCT03257657|83141033|FG000|Overall Study|Withdrawn|0|||
46911376|NCT03257657|83141034|FG001|Overall Study|Withdrawn|1|||
46911377|NCT03257657|83141033|FG000|Overall Study|Noted not eligible right after enrolled|0|||
46911378|NCT03257657|83141034|FG001|Overall Study|Noted not eligible right after enrolled|1|||
46911379|NCT02496611|83141043|FG000|Overall Study|Lost to Follow-up|2|||
47022106|NCT02116361|83271134|FG002|Overall Study|Physician Decision|0|||
47022107|NCT02116361|83271135|FG003|Overall Study|Physician Decision|0|||
46911380|NCT02496611|83141044|FG001|Overall Study|Lost to Follow-up|1|||
46911381|NCT02496611|83141043|FG000|Overall Study|Withdrawal by Subject|5|||
47022108|NCT02116361|83271132|FG000|Overall Study|Adverse Event|1|||
47022109|NCT02116361|83271133|FG001|Overall Study|Adverse Event|0|||
47022110|NCT02116361|83271134|FG002|Overall Study|Adverse Event|0|||
47022111|NCT02116361|83271135|FG003|Overall Study|Adverse Event|3|||
47022112|NCT02116361|83271132|FG000|Overall Study|Other Reasons|3|||
47022113|NCT02116361|83271133|FG001|Overall Study|Other Reasons|3|||
47022114|NCT02116361|83271134|FG002|Overall Study|Other Reasons|3|||
47022115|NCT02116361|83271135|FG003|Overall Study|Other Reasons|3|||
47022116|NCT02116361|83271132|FG000|Overall Study|Lack of Efficacy|5|||
47022117|NCT02116361|83271133|FG001|Overall Study|Lack of Efficacy|7|||
47022118|NCT02116361|83271134|FG002|Overall Study|Lack of Efficacy|4|||
47022119|NCT02116361|83271135|FG003|Overall Study|Lack of Efficacy|3|||
47022120|NCT02116361|83271132|FG000|Overall Study|Lost to Follow-up|4|||
47022121|NCT02116361|83271133|FG001|Overall Study|Lost to Follow-up|5|||
47022122|NCT02116361|83271134|FG002|Overall Study|Lost to Follow-up|7|||
47022123|NCT02116361|83271135|FG003|Overall Study|Lost to Follow-up|5|||
47022124|NCT02116361|83271132|FG000|Overall Study|Personal Reasons|6|||
47022125|NCT02116361|83271133|FG001|Overall Study|Personal Reasons|6|||
47022126|NCT02116361|83271134|FG002|Overall Study|Personal Reasons|4|||
47022127|NCT02116361|83271135|FG003|Overall Study|Personal Reasons|9|||
47022128|NCT02116361|83271132|FG000|Overall Study|Investigator Decision - Relapse|9|||
47022129|NCT02116361|83271133|FG001|Overall Study|Investigator Decision - Relapse|7|||
47022130|NCT02116361|83271134|FG002|Overall Study|Investigator Decision - Relapse|8|||
47022131|NCT02116361|83271135|FG003|Overall Study|Investigator Decision - Relapse|5|||
47022132|NCT02140775|83271147|FG000|Overall Study|Withdrawal by Subject|30|||
47022133|NCT02140775|83271148|FG001|Overall Study|Withdrawal by Subject|7|||
47022134|NCT01844817|83271158|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
47022135|NCT01844817|83271159|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
47022136|NCT01844817|83271158|FG000|Treatment|Progressive Disease|27|||
47022137|NCT01844817|83271159|FG001|Treatment|Progressive Disease|36|||
47022138|NCT01844817|83271158|FG000|Treatment|Adverse Event|17|||
47022139|NCT01844817|83271159|FG001|Treatment|Adverse Event|9|||
47022140|NCT01844817|83271158|FG000|Treatment|Withdrawal by Subject|10|||
47022141|NCT01844817|83271159|FG001|Treatment|Withdrawal by Subject|6|||
47022142|NCT01844817|83271158|FG000|Treatment|Death|10|||
47022143|NCT01844817|83271159|FG001|Treatment|Death|8|||
47022144|NCT01844817|83271158|FG000|Treatment|Lost to Follow-up|0|||
47022145|NCT01844817|83271159|FG001|Treatment|Lost to Follow-up|1|||
47022146|NCT01844817|83271158|FG000|Treatment|Other|0|||
47022147|NCT01844817|83271159|FG001|Treatment|Other|3|||
47022148|NCT04594239|83271170|FG000|Overall Study|Withdrawal by Subject|3|||
47022149|NCT04594239|83271171|FG001|Overall Study|Withdrawal by Subject|4|||
47022150|NCT04594239|83271172|FG002|Overall Study|Withdrawal by Subject|2|||
47022151|NCT04594239|83271173|FG003|Overall Study|Withdrawal by Subject|4|||
47022152|NCT04594239|83271170|FG000|Overall Study|Lost to Follow-up|8|||
47022153|NCT04594239|83271171|FG001|Overall Study|Lost to Follow-up|5|||
47022154|NCT04594239|83271172|FG002|Overall Study|Lost to Follow-up|4|||
47022155|NCT04594239|83271173|FG003|Overall Study|Lost to Follow-up|6|||
47022156|NCT04594239|83271170|FG000|Overall Study|Subject relocated|0|||
47022157|NCT04594239|83271171|FG001|Overall Study|Subject relocated|0|||
47022158|NCT04594239|83271172|FG002|Overall Study|Subject relocated|0|||
47022159|NCT04594239|83271173|FG003|Overall Study|Subject relocated|1|||
47022160|NCT01814553|83271191|FG000|Overall Study|PD per clinical progression|6|||
47022161|NCT01814553|83271192|FG001|Overall Study|PD per clinical progression|8|||
47022162|NCT01814553|83271191|FG000|Overall Study|Other Adverse Event|4|||
47022163|NCT01814553|83271192|FG001|Overall Study|Other Adverse Event|5|||
47022164|NCT01814553|83271191|FG000|Overall Study|Withdrawal by Subject|1|||
47022165|NCT01814553|83271192|FG001|Overall Study|Withdrawal by Subject|1|||
47022166|NCT01814553|83271191|FG000|Overall Study|Other than stated|7|||
47022167|NCT01814553|83271192|FG001|Overall Study|Other than stated|8|||
47022168|NCT02116205|83271202|FG000|Overall Study|Withdrawal by Subject|2|||
47022169|NCT02116205|83271203|FG001|Overall Study|Withdrawal by Subject|4|||
47022170|NCT02116205|83271204|FG002|Overall Study|Withdrawal by Subject|1|||
47022171|NCT02116205|83271205|FG003|Overall Study|Withdrawal by Subject|3|||
47022172|NCT02116205|83271202|FG000|Overall Study|Lost to Follow-up|0|||
47022173|NCT02116205|83271203|FG001|Overall Study|Lost to Follow-up|2|||
47022174|NCT02116205|83271204|FG002|Overall Study|Lost to Follow-up|1|||
47022175|NCT02116205|83271205|FG003|Overall Study|Lost to Follow-up|2|||
47022176|NCT02116205|83271202|FG000|Overall Study|Physician Decision|0|||
47022177|NCT02116205|83271203|FG001|Overall Study|Physician Decision|1|||
47022178|NCT02116205|83271204|FG002|Overall Study|Physician Decision|1|||
47022179|NCT02116205|83271205|FG003|Overall Study|Physician Decision|1|||
47022180|NCT02116205|83271202|FG000|Overall Study|Exclusion criteria|0|||
47022181|NCT02116205|83271203|FG001|Overall Study|Exclusion criteria|0|||
47022182|NCT02116205|83271204|FG002|Overall Study|Exclusion criteria|1|||
47022183|NCT02116205|83271205|FG003|Overall Study|Exclusion criteria|0|||
47022184|NCT01844583|83271217|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
47022185|NCT01844583|83271218|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
47022186|NCT02115815|83271236|FG000|Overall Study|Withdrawal by Subject|2|||
47022187|NCT02115815|83271237|FG001|Overall Study|Withdrawal by Subject|0|||
47022188|NCT02115815|83271238|FG002|Overall Study|Withdrawal by Subject|0|||
47022189|NCT02115815|83271239|FG003|Overall Study|Withdrawal by Subject|0|||
47022190|NCT02115815|83271240|FG004|Overall Study|Withdrawal by Subject|0|||
47022191|NCT02115815|83271241|FG005|Overall Study|Withdrawal by Subject|0|||
47022192|NCT02115815|83271242|FG006|Overall Study|Withdrawal by Subject|0|||
47022193|NCT02115815|83271236|FG000|Overall Study|Not enough drug to dose participant|0|||
47022194|NCT02115815|83271237|FG001|Overall Study|Not enough drug to dose participant|0|||
47022195|NCT02115815|83271238|FG002|Overall Study|Not enough drug to dose participant|0|||
47022196|NCT02115815|83271239|FG003|Overall Study|Not enough drug to dose participant|0|||
47022197|NCT02115815|83271240|FG004|Overall Study|Not enough drug to dose participant|0|||
47022198|NCT02115815|83271241|FG005|Overall Study|Not enough drug to dose participant|1|||
47022199|NCT02115815|83271242|FG006|Overall Study|Not enough drug to dose participant|0|||
47022200|NCT02115815|83271236|FG000|Overall Study|Missed appointment, randomized in error|0|||
47022201|NCT02115815|83271237|FG001|Overall Study|Missed appointment, randomized in error|0|||
47022202|NCT02115815|83271238|FG002|Overall Study|Missed appointment, randomized in error|0|||
47022203|NCT02115815|83271239|FG003|Overall Study|Missed appointment, randomized in error|0|||
47022204|NCT02115815|83271240|FG004|Overall Study|Missed appointment, randomized in error|0|||
47022205|NCT02115815|83271241|FG005|Overall Study|Missed appointment, randomized in error|1|||
47022206|NCT02115815|83271242|FG006|Overall Study|Missed appointment, randomized in error|0|||
47022207|NCT02115269|83271258|FG000|Overall Study|Lost to Follow-up|43|||
47022208|NCT02115269|83271258|FG000|Overall Study|Did not complete patient diary|3|||
47022209|NCT02115269|83271258|FG000|Overall Study|Moved to another city|7|||
47022210|NCT02115269|83271258|FG000|Overall Study|Withdrawal by Subject|2|||
47022211|NCT02115269|83271258|FG000|Overall Study|Didn't take study drug|2|||
47022212|NCT02115113|83271273|FG000|Participants in Run-in Period|Death|0|||
47022213|NCT02115113|83271274|FG001|Participants in Run-in Period|Death|0|||
47022214|NCT02115113|83271275|FG002|Participants in Run-in Period|Death|1|||
47022215|NCT02115113|83271273|FG000|Participants in Run-in Period|Administrative problems|0|||
47022216|NCT02115113|83271274|FG001|Participants in Run-in Period|Administrative problems|0|||
47022217|NCT02115113|83271275|FG002|Participants in Run-in Period|Administrative problems|1|||
47022218|NCT02115113|83271273|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
47022219|NCT02115113|83271274|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
47022220|NCT02115113|83271275|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
47022221|NCT02115113|83271273|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
47022222|NCT02115113|83271274|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
47022223|NCT02115113|83271275|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
47022224|NCT02115113|83271273|FG000|Participants Randomized|Lost to Follow-up|1|||
47022225|NCT02115113|83271274|FG001|Participants Randomized|Lost to Follow-up|0|||
47022226|NCT02115113|83271275|FG002|Participants Randomized|Lost to Follow-up|0|||
47022227|NCT02115113|83271273|FG000|Participants Randomized|Death|1|||
47022228|NCT02115113|83271274|FG001|Participants Randomized|Death|0|||
47022229|NCT02115113|83271275|FG002|Participants Randomized|Death|0|||
47022230|NCT02114879|83271286|FG000|Overall Study|Withdrawal by Subject|9|||
47022231|NCT02114879|83271287|FG001|Overall Study|Withdrawal by Subject|5|||
47022232|NCT02114879|83271286|FG000|Overall Study|Death|6|||
47022233|NCT02114879|83271287|FG001|Overall Study|Death|11|||
47022234|NCT02114879|83271286|FG000|Overall Study|Lost to Follow-up|4|||
47022235|NCT02114879|83271287|FG001|Overall Study|Lost to Follow-up|6|||
47022236|NCT02114879|83271286|FG000|Overall Study|Physician Decision|0|||
46911382|NCT02496611|83141044|FG001|Overall Study|Withdrawal by Subject|2|||
46911383|NCT03237481|83141054|FG000|Overall Study|Lost to Follow-up|1|||
46911384|NCT03237481|83141055|FG001|Overall Study|Lost to Follow-up|0|||
46911385|NCT03237481|83141056|FG002|Overall Study|Lost to Follow-up|0|||
46911386|NCT03237481|83141054|FG000|Overall Study|Protocol Violation|1|||
46911387|NCT03237481|83141055|FG001|Overall Study|Protocol Violation|0|||
46911388|NCT03237481|83141056|FG002|Overall Study|Protocol Violation|0|||
46911389|NCT03237481|83141054|FG000|Overall Study|Withdrawal by Subject|3|||
47022237|NCT02114879|83271287|FG001|Overall Study|Physician Decision|2|||
47022238|NCT02114177|83271295|FG000|Overall Study|Lost to Follow-up|1|||
47022239|NCT02114177|83271296|FG001|Overall Study|Lost to Follow-up|2|||
47022240|NCT02114177|83271295|FG000|Overall Study|Withdrawal by Subject|6|||
47022241|NCT02114177|83271296|FG001|Overall Study|Withdrawal by Subject|1|||
47022242|NCT02114177|83271295|FG000|Overall Study|Other|2|||
47022243|NCT02114177|83271296|FG001|Overall Study|Other|1|||
47022244|NCT02138825|83271304|FG000|Main Study Treatment|Adverse Event|11|||
47022245|NCT02138825|83271305|FG001|Main Study Treatment|Adverse Event|3|||
47022246|NCT02138825|83271304|FG000|Main Study Treatment|Death|1|||
47022247|NCT02138825|83271305|FG001|Main Study Treatment|Death|2|||
47022248|NCT02138825|83271304|FG000|Main Study Treatment|Protocol Violation|2|||
47022249|NCT02138825|83271305|FG001|Main Study Treatment|Protocol Violation|2|||
47022250|NCT02138825|83271304|FG000|Main Study Treatment|Sponsor decision|12|||
47022251|NCT02138825|83271305|FG001|Main Study Treatment|Sponsor decision|18|||
47022252|NCT02138825|83271304|FG000|Main Study Treatment|Study terminated by sponsor|10|||
47022253|NCT02138825|83271305|FG001|Main Study Treatment|Study terminated by sponsor|9|||
46911390|NCT03237481|83141055|FG001|Overall Study|Withdrawal by Subject|2|||
46911391|NCT03237481|83141056|FG002|Overall Study|Withdrawal by Subject|1|||
47022254|NCT02138825|83271304|FG000|Main Study Treatment|Withdrawal by Subject|3|||
47022255|NCT02138825|83271305|FG001|Main Study Treatment|Withdrawal by Subject|1|||
47022256|NCT02138825|83271304|FG000|Main Study Treatment|Medical decision|1|||
47022257|NCT02138825|83271305|FG001|Main Study Treatment|Medical decision|0|||
47022258|NCT02138825|83271304|FG000|Long-term Extension|Study termination by sponsor|32|||
47022259|NCT02138825|83271305|FG001|Long-term Extension|Study termination by sponsor|38|||
47022260|NCT02138825|83271304|FG000|Safety Follow-up|Adverse Event|4|||
47022261|NCT02138825|83271305|FG001|Safety Follow-up|Adverse Event|3|||
47022262|NCT02138825|83271304|FG000|Safety Follow-up|Death|11|||
47022263|NCT02138825|83271305|FG001|Safety Follow-up|Death|5|||
47022264|NCT02138825|83271304|FG000|Safety Follow-up|Withdrawal by Subject|5|||
47022265|NCT02138825|83271305|FG001|Safety Follow-up|Withdrawal by Subject|3|||
47022266|NCT02138825|83271304|FG000|Safety Follow-up|clinic worsening|1|||
47022267|NCT02138825|83271305|FG001|Safety Follow-up|clinic worsening|0|||
47022268|NCT02138825|83271304|FG000|Safety Follow-up|withdrawal by PI|1|||
47022269|NCT02138825|83271305|FG001|Safety Follow-up|withdrawal by PI|0|||
47022270|NCT02138825|83271304|FG000|Safety Follow-up|logistical difficulties|0|||
47022271|NCT02138825|83271305|FG001|Safety Follow-up|logistical difficulties|1|||
47022272|NCT02138825|83271304|FG000|Safety Follow-up|progressive disease|0|||
47022273|NCT02138825|83271305|FG001|Safety Follow-up|progressive disease|2|||
47022274|NCT02138825|83271304|FG000|Safety Follow-up|too unwell to attend the visit|0|||
47022275|NCT02138825|83271305|FG001|Safety Follow-up|too unwell to attend the visit|1|||
47022276|NCT02138825|83271304|FG000|Safety Follow-up|treatment unblinded|0|||
47022277|NCT02138825|83271305|FG001|Safety Follow-up|treatment unblinded|1|||
47022278|NCT02138825|83271304|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
47022279|NCT02138825|83271305|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
47022280|NCT02138747|83271320|FG000|Treatment Period 1|Adverse Event|10|||
47022281|NCT02138747|83271321|FG001|Treatment Period 1|Adverse Event|14|||
47022282|NCT02138747|83271322|FG002|Treatment Period 1|Adverse Event|2|||
47022283|NCT02138747|83271323|FG003|Treatment Period 1|Adverse Event|1|||
47022284|NCT02138747|83271320|FG000|Treatment Period 1|Lost to Follow-up|0|||
47022285|NCT02138747|83271321|FG001|Treatment Period 1|Lost to Follow-up|1|||
47022286|NCT02138747|83271322|FG002|Treatment Period 1|Lost to Follow-up|1|||
47022287|NCT02138747|83271323|FG003|Treatment Period 1|Lost to Follow-up|0|||
47022288|NCT02138747|83271320|FG000|Treatment Period 1|Protocol Violation|0|||
47022289|NCT02138747|83271321|FG001|Treatment Period 1|Protocol Violation|2|||
47022290|NCT02138747|83271322|FG002|Treatment Period 1|Protocol Violation|0|||
47022291|NCT02138747|83271323|FG003|Treatment Period 1|Protocol Violation|0|||
47022292|NCT02138747|83271320|FG000|Treatment Period 1|Withdrawal by Subject|8|||
47022293|NCT02138747|83271321|FG001|Treatment Period 1|Withdrawal by Subject|4|||
47022294|NCT02138747|83271322|FG002|Treatment Period 1|Withdrawal by Subject|1|||
47022295|NCT02138747|83271323|FG003|Treatment Period 1|Withdrawal by Subject|3|||
47022296|NCT02138747|83271320|FG000|Treatment Period 1|Other - Miscellaneous|2|||
47022297|NCT02138747|83271321|FG001|Treatment Period 1|Other - Miscellaneous|4|||
47022298|NCT02138747|83271322|FG002|Treatment Period 1|Other - Miscellaneous|0|||
47022299|NCT02138747|83271323|FG003|Treatment Period 1|Other - Miscellaneous|0|||
47022300|NCT02138747|83271320|FG000|Treatment Period 2|Adverse Event|6|||
47022301|NCT02138747|83271321|FG001|Treatment Period 2|Adverse Event|3|||
46911392|NCT03222349|83141064|FG000|Overall Study|Treatment B not done|5|||
47022302|NCT02138747|83271322|FG002|Treatment Period 2|Adverse Event|1|||
47022303|NCT02138747|83271323|FG003|Treatment Period 2|Adverse Event|1|||
47022304|NCT02138747|83271320|FG000|Treatment Period 2|Lost to Follow-up|2|||
47022305|NCT02138747|83271321|FG001|Treatment Period 2|Lost to Follow-up|0|||
47022306|NCT02138747|83271322|FG002|Treatment Period 2|Lost to Follow-up|0|||
47022307|NCT02138747|83271323|FG003|Treatment Period 2|Lost to Follow-up|0|||
47022308|NCT02138747|83271320|FG000|Treatment Period 2|Protocol Violation|1|||
47022309|NCT02138747|83271321|FG001|Treatment Period 2|Protocol Violation|0|||
47022310|NCT02138747|83271322|FG002|Treatment Period 2|Protocol Violation|0|||
47022311|NCT02138747|83271323|FG003|Treatment Period 2|Protocol Violation|0|||
47022312|NCT02138747|83271320|FG000|Treatment Period 2|Withdrawal by Subject|5|||
47022313|NCT02138747|83271321|FG001|Treatment Period 2|Withdrawal by Subject|4|||
47022314|NCT02138747|83271322|FG002|Treatment Period 2|Withdrawal by Subject|1|||
47022315|NCT02138747|83271323|FG003|Treatment Period 2|Withdrawal by Subject|2|||
47022316|NCT02138747|83271320|FG000|Treatment Period 2|Other - Miscellaneous|3|||
47022317|NCT02138747|83271321|FG001|Treatment Period 2|Other - Miscellaneous|0|||
47022318|NCT02138747|83271322|FG002|Treatment Period 2|Other - Miscellaneous|0|||
47022319|NCT02138747|83271323|FG003|Treatment Period 2|Other - Miscellaneous|0|||
47022320|NCT02105285|83271336|FG000|Overall Study|Adverse Event|1|||
47022321|NCT02105285|83271337|FG001|Overall Study|Adverse Event|1|||
47022322|NCT02105285|83271338|FG002|Overall Study|Adverse Event|0|||
47022323|NCT02105285|83271336|FG000|Overall Study|Protocol Violation|0|||
47022324|NCT02105285|83271337|FG001|Overall Study|Protocol Violation|1|||
47022325|NCT02105285|83271338|FG002|Overall Study|Protocol Violation|0|||
47022326|NCT02105285|83271336|FG000|Overall Study|Withdrawal by Subject|1|||
47022327|NCT02105285|83271337|FG001|Overall Study|Withdrawal by Subject|0|||
47022328|NCT02105285|83271338|FG002|Overall Study|Withdrawal by Subject|0|||
47022329|NCT02104895|83271347|FG000|Overall Study|Withdrawal by Subject|0|||
47022330|NCT02104895|83271348|FG001|Overall Study|Withdrawal by Subject|14|||
47022331|NCT01621490|83271363|FG000|Overall Study|Participant completed treatment|4|||
47022332|NCT01621490|83271364|FG001|Overall Study|Participant completed treatment|4|||
47022333|NCT01621490|83271365|FG002|Overall Study|Participant completed treatment|1|||
47022334|NCT01621490|83271366|FG003|Overall Study|Participant completed treatment|0|||
47022335|NCT01621490|83271367|FG004|Overall Study|Participant completed treatment|0|||
47022336|NCT01621490|83271368|FG005|Overall Study|Participant completed treatment|0|||
47022337|NCT01621490|83271369|FG006|Overall Study|Participant completed treatment|0|||
47022338|NCT01621490|83271370|FG007|Overall Study|Participant completed treatment|1|||
47022339|NCT01621490|83271371|FG008|Overall Study|Participant completed treatment|0|||
47022340|NCT01621490|83271363|FG000|Overall Study|Patient could not travel|1|||
47022341|NCT01621490|83271364|FG001|Overall Study|Patient could not travel|0|||
47022342|NCT01621490|83271365|FG002|Overall Study|Patient could not travel|0|||
47022343|NCT01621490|83271366|FG003|Overall Study|Patient could not travel|0|||
47022344|NCT01621490|83271367|FG004|Overall Study|Patient could not travel|0|||
47022345|NCT01621490|83271368|FG005|Overall Study|Patient could not travel|0|||
47022346|NCT01621490|83271369|FG006|Overall Study|Patient could not travel|0|||
47022347|NCT01621490|83271370|FG007|Overall Study|Patient could not travel|0|||
47022348|NCT01621490|83271371|FG008|Overall Study|Patient could not travel|0|||
47022349|NCT01621490|83271363|FG000|Overall Study|Subject no longer meets study criteria|0|||
47022350|NCT01621490|83271364|FG001|Overall Study|Subject no longer meets study criteria|0|||
47022351|NCT01621490|83271365|FG002|Overall Study|Subject no longer meets study criteria|0|||
47022352|NCT01621490|83271366|FG003|Overall Study|Subject no longer meets study criteria|0|||
47022353|NCT01621490|83271367|FG004|Overall Study|Subject no longer meets study criteria|1|||
47022354|NCT01621490|83271368|FG005|Overall Study|Subject no longer meets study criteria|0|||
47022355|NCT01621490|83271369|FG006|Overall Study|Subject no longer meets study criteria|0|||
47022356|NCT01621490|83271370|FG007|Overall Study|Subject no longer meets study criteria|0|||
47022357|NCT01621490|83271371|FG008|Overall Study|Subject no longer meets study criteria|0|||
47022358|NCT01621490|83271363|FG000|Overall Study|Maximum clinical benefit|3|||
47022359|NCT01621490|83271364|FG001|Overall Study|Maximum clinical benefit|2|||
47022360|NCT01621490|83271365|FG002|Overall Study|Maximum clinical benefit|0|||
47022361|NCT01621490|83271366|FG003|Overall Study|Maximum clinical benefit|0|||
47022362|NCT01621490|83271367|FG004|Overall Study|Maximum clinical benefit|0|||
47022363|NCT01621490|83271368|FG005|Overall Study|Maximum clinical benefit|0|||
47022364|NCT01621490|83271369|FG006|Overall Study|Maximum clinical benefit|1|||
47022365|NCT01621490|83271370|FG007|Overall Study|Maximum clinical benefit|2|||
47022366|NCT01621490|83271371|FG008|Overall Study|Maximum clinical benefit|0|||
47022367|NCT01621490|83271363|FG000|Overall Study|Withdrawal by Subject|1|||
47022368|NCT01621490|83271364|FG001|Overall Study|Withdrawal by Subject|0|||
47022369|NCT01621490|83271365|FG002|Overall Study|Withdrawal by Subject|0|||
47022370|NCT01621490|83271366|FG003|Overall Study|Withdrawal by Subject|0|||
47022371|NCT01621490|83271367|FG004|Overall Study|Withdrawal by Subject|0|||
47022372|NCT01621490|83271368|FG005|Overall Study|Withdrawal by Subject|3|||
47022373|NCT01621490|83271369|FG006|Overall Study|Withdrawal by Subject|0|||
47022374|NCT01621490|83271370|FG007|Overall Study|Withdrawal by Subject|0|||
47022375|NCT01621490|83271371|FG008|Overall Study|Withdrawal by Subject|0|||
47022376|NCT01621490|83271363|FG000|Overall Study|Subject request to discontinue study|1|||
47022377|NCT01621490|83271364|FG001|Overall Study|Subject request to discontinue study|3|||
47022378|NCT01621490|83271365|FG002|Overall Study|Subject request to discontinue study|1|||
47022379|NCT01621490|83271366|FG003|Overall Study|Subject request to discontinue study|1|||
47022380|NCT01621490|83271367|FG004|Overall Study|Subject request to discontinue study|0|||
47022381|NCT01621490|83271368|FG005|Overall Study|Subject request to discontinue study|2|||
47022382|NCT01621490|83271369|FG006|Overall Study|Subject request to discontinue study|1|||
47022383|NCT01621490|83271370|FG007|Overall Study|Subject request to discontinue study|0|||
47022384|NCT01621490|83271371|FG008|Overall Study|Subject request to discontinue study|1|||
47022385|NCT01621490|83271363|FG000|Overall Study|Adverse event unrelated to study drug|2|||
47022386|NCT01621490|83271364|FG001|Overall Study|Adverse event unrelated to study drug|1|||
47022387|NCT01621490|83271365|FG002|Overall Study|Adverse event unrelated to study drug|0|||
47022388|NCT01621490|83271366|FG003|Overall Study|Adverse event unrelated to study drug|0|||
47022389|NCT01621490|83271367|FG004|Overall Study|Adverse event unrelated to study drug|0|||
47022390|NCT01621490|83271368|FG005|Overall Study|Adverse event unrelated to study drug|0|||
47022391|NCT01621490|83271369|FG006|Overall Study|Adverse event unrelated to study drug|0|||
47022392|NCT01621490|83271370|FG007|Overall Study|Adverse event unrelated to study drug|2|||
47022393|NCT01621490|83271371|FG008|Overall Study|Adverse event unrelated to study drug|1|||
47022394|NCT01621490|83271363|FG000|Overall Study|Disease progression|27|||
47022395|NCT01621490|83271364|FG001|Overall Study|Disease progression|28|||
47022396|NCT01621490|83271365|FG002|Overall Study|Disease progression|1|||
47022397|NCT01621490|83271366|FG003|Overall Study|Disease progression|5|||
47022398|NCT01621490|83271367|FG004|Overall Study|Disease progression|3|||
47022399|NCT01621490|83271368|FG005|Overall Study|Disease progression|8|||
47022400|NCT01621490|83271369|FG006|Overall Study|Disease progression|7|||
47022401|NCT01621490|83271370|FG007|Overall Study|Disease progression|0|||
47022402|NCT01621490|83271371|FG008|Overall Study|Disease progression|4|||
47022403|NCT01621490|83271363|FG000|Overall Study|Study drug toxicity|1|||
47022404|NCT01621490|83271364|FG001|Overall Study|Study drug toxicity|4|||
47022405|NCT01621490|83271365|FG002|Overall Study|Study drug toxicity|5|||
47022406|NCT01621490|83271366|FG003|Overall Study|Study drug toxicity|3|||
47022407|NCT01621490|83271367|FG004|Overall Study|Study drug toxicity|1|||
47022408|NCT01621490|83271368|FG005|Overall Study|Study drug toxicity|10|||
47022409|NCT01621490|83271369|FG006|Overall Study|Study drug toxicity|1|||
47022410|NCT01621490|83271370|FG007|Overall Study|Study drug toxicity|4|||
47022411|NCT01621490|83271371|FG008|Overall Study|Study drug toxicity|1|||
47022412|NCT01621490|83271363|FG000|Overall Study|Death|0|||
47022413|NCT01621490|83271364|FG001|Overall Study|Death|0|||
47022414|NCT01621490|83271365|FG002|Overall Study|Death|0|||
47022415|NCT01621490|83271366|FG003|Overall Study|Death|0|||
47022416|NCT01621490|83271367|FG004|Overall Study|Death|0|||
47022417|NCT01621490|83271368|FG005|Overall Study|Death|0|||
47022418|NCT01621490|83271369|FG006|Overall Study|Death|0|||
47022419|NCT01621490|83271370|FG007|Overall Study|Death|1|||
47022420|NCT01621490|83271371|FG008|Overall Study|Death|0|||
47022421|NCT01621490|83271363|FG000|Overall Study|Grade 4 Lipase elevation|1|||
47022422|NCT01621490|83271364|FG001|Overall Study|Grade 4 Lipase elevation|0|||
47022423|NCT01621490|83271365|FG002|Overall Study|Grade 4 Lipase elevation|0|||
46911393|NCT03222349|83141065|FG001|Overall Study|Treatment B not done|0|||
46911394|NCT03222349|83141064|FG000|Overall Study|Lost to Follow-up|1|||
46911395|NCT03222349|83141065|FG001|Overall Study|Lost to Follow-up|2|||
46911396|NCT03222349|83141064|FG000|Overall Study|Withdrawal by Subject|1|||
46911397|NCT03222349|83141065|FG001|Overall Study|Withdrawal by Subject|0|||
46911398|NCT03222349|83141064|FG000|Overall Study|Treatment A not done|0|||
46911399|NCT03222349|83141065|FG001|Overall Study|Treatment A not done|5|||
46911400|NCT03222349|83141064|FG000|Overall Study|Study terminated by sponsor|1|||
46911401|NCT03222349|83141065|FG001|Overall Study|Study terminated by sponsor|0|||
46911402|NCT02927925|83141078|FG000|Overall Study|Death|16|||
46911403|NCT02927925|83141078|FG000|Overall Study|Physician Decision|1|||
47022424|NCT01621490|83271366|FG003|Overall Study|Grade 4 Lipase elevation|0|||
47022425|NCT01621490|83271367|FG004|Overall Study|Grade 4 Lipase elevation|0|||
47022426|NCT01621490|83271368|FG005|Overall Study|Grade 4 Lipase elevation|0|||
46620619|NCT02265510|82770882|FG007|Overall Study|Death|1|||
46709849|NCT00920218|82925957|FG001|Overall Study|Lost to Follow-up|1|||
46709850|NCT00920218|82925958|FG002|Overall Study|Lost to Follow-up|0|||
46709851|NCT00920218|82925959|FG003|Overall Study|Lost to Follow-up|3|||
47022427|NCT01621490|83271369|FG006|Overall Study|Grade 4 Lipase elevation|0|||
47022428|NCT01621490|83271370|FG007|Overall Study|Grade 4 Lipase elevation|0|||
46620620|NCT02265510|82770883|FG008|Overall Study|Death|3|||
46911404|NCT02927925|83141078|FG000|Overall Study|Withdrawal by Subject|11|||
46911405|NCT02927925|83141078|FG000|Overall Study|Other|3|||
46911406|NCT02927925|83141078|FG000|Overall Study|Disease progression at clinical cutoff|1|||
47022429|NCT01621490|83271371|FG008|Overall Study|Grade 4 Lipase elevation|0|||
47022430|NCT01621490|83271363|FG000|Overall Study|BMS informed of patient status|0|||
47022431|NCT01621490|83271364|FG001|Overall Study|BMS informed of patient status|0|||
47022432|NCT01621490|83271365|FG002|Overall Study|BMS informed of patient status|1|||
47022433|NCT01621490|83271366|FG003|Overall Study|BMS informed of patient status|0|||
47022434|NCT01621490|83271367|FG004|Overall Study|BMS informed of patient status|0|||
47022435|NCT01621490|83271368|FG005|Overall Study|BMS informed of patient status|0|||
47022436|NCT01621490|83271369|FG006|Overall Study|BMS informed of patient status|0|||
47022437|NCT01621490|83271370|FG007|Overall Study|BMS informed of patient status|0|||
47022438|NCT01621490|83271371|FG008|Overall Study|BMS informed of patient status|0|||
47022439|NCT01621490|83271363|FG000|Overall Study|Investigator decision|0|||
47022440|NCT01621490|83271364|FG001|Overall Study|Investigator decision|0|||
47022441|NCT01621490|83271365|FG002|Overall Study|Investigator decision|1|||
47022442|NCT01621490|83271366|FG003|Overall Study|Investigator decision|0|||
47022443|NCT01621490|83271367|FG004|Overall Study|Investigator decision|1|||
47022444|NCT01621490|83271368|FG005|Overall Study|Investigator decision|0|||
47022445|NCT01621490|83271369|FG006|Overall Study|Investigator decision|1|||
47022446|NCT01621490|83271370|FG007|Overall Study|Investigator decision|0|||
47022447|NCT01621490|83271371|FG008|Overall Study|Investigator decision|0|||
47022448|NCT01621490|83271363|FG000|Overall Study|Documented disease progression|0|||
47022449|NCT01621490|83271364|FG001|Overall Study|Documented disease progression|0|||
47022450|NCT01621490|83271365|FG002|Overall Study|Documented disease progression|1|||
47022451|NCT01621490|83271366|FG003|Overall Study|Documented disease progression|0|||
47022452|NCT01621490|83271367|FG004|Overall Study|Documented disease progression|0|||
47022453|NCT01621490|83271368|FG005|Overall Study|Documented disease progression|0|||
47022454|NCT01621490|83271369|FG006|Overall Study|Documented disease progression|0|||
47022455|NCT01621490|83271370|FG007|Overall Study|Documented disease progression|0|||
47022456|NCT01621490|83271371|FG008|Overall Study|Documented disease progression|0|||
47022457|NCT01621490|83271363|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
47022458|NCT01621490|83271364|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
47022459|NCT01621490|83271365|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
47022460|NCT01621490|83271366|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
47022461|NCT01621490|83271367|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
47022462|NCT01621490|83271368|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
47022463|NCT01621490|83271369|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
47022464|NCT01621490|83271370|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
47022465|NCT01621490|83271371|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
47022466|NCT01621490|83271363|FG000|Overall Study|Clinical deterioration|0|||
47022467|NCT01621490|83271364|FG001|Overall Study|Clinical deterioration|1|||
47022468|NCT01621490|83271365|FG002|Overall Study|Clinical deterioration|0|||
47022469|NCT01621490|83271366|FG003|Overall Study|Clinical deterioration|0|||
47022470|NCT01621490|83271367|FG004|Overall Study|Clinical deterioration|0|||
47022471|NCT01621490|83271368|FG005|Overall Study|Clinical deterioration|0|||
47022472|NCT01621490|83271369|FG006|Overall Study|Clinical deterioration|0|||
47022473|NCT01621490|83271370|FG007|Overall Study|Clinical deterioration|0|||
47022474|NCT01621490|83271371|FG008|Overall Study|Clinical deterioration|0|||
47022475|NCT01621490|83271363|FG000|Overall Study|Complete response|0|||
47022476|NCT01621490|83271364|FG001|Overall Study|Complete response|0|||
47022477|NCT01621490|83271365|FG002|Overall Study|Complete response|0|||
47022478|NCT01621490|83271366|FG003|Overall Study|Complete response|0|||
47022479|NCT01621490|83271367|FG004|Overall Study|Complete response|0|||
47022480|NCT01621490|83271368|FG005|Overall Study|Complete response|0|||
47022481|NCT01621490|83271369|FG006|Overall Study|Complete response|0|||
47022482|NCT01621490|83271370|FG007|Overall Study|Complete response|0|||
47022483|NCT01621490|83271371|FG008|Overall Study|Complete response|1|||
47022484|NCT01621490|83271363|FG000|Overall Study|Patient delayed due to toxicity|0|||
47022485|NCT01621490|83271364|FG001|Overall Study|Patient delayed due to toxicity|0|||
47022486|NCT01621490|83271365|FG002|Overall Study|Patient delayed due to toxicity|0|||
47022487|NCT01621490|83271366|FG003|Overall Study|Patient delayed due to toxicity|0|||
47022488|NCT01621490|83271367|FG004|Overall Study|Patient delayed due to toxicity|0|||
47022489|NCT01621490|83271368|FG005|Overall Study|Patient delayed due to toxicity|1|||
47022490|NCT01621490|83271369|FG006|Overall Study|Patient delayed due to toxicity|0|||
47022491|NCT01621490|83271370|FG007|Overall Study|Patient delayed due to toxicity|0|||
47022492|NCT01621490|83271371|FG008|Overall Study|Patient delayed due to toxicity|0|||
47022493|NCT02018887|83271492|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
47022494|NCT02018887|83271493|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022495|NCT02018887|83271494|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022496|NCT02018887|83271495|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022497|NCT02018887|83271496|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022498|NCT02018887|83271497|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022499|NCT02018887|83271498|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022500|NCT02018887|83271499|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022501|NCT02018887|83271500|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022502|NCT02018887|83271501|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022503|NCT02018887|83271502|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
47022504|NCT02018887|83271492|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022505|NCT02018887|83271493|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022506|NCT02018887|83271494|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022507|NCT02018887|83271495|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022508|NCT02018887|83271496|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
47022509|NCT02018887|83271497|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022510|NCT02018887|83271498|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
47022511|NCT02018887|83271499|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
47022512|NCT02018887|83271500|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022513|NCT02018887|83271501|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022514|NCT02018887|83271502|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
47022515|NCT02018887|83271492|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
47022516|NCT02018887|83271493|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
47022517|NCT02018887|83271494|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
47022518|NCT02018887|83271495|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
47022519|NCT02018887|83271496|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
47022520|NCT02018887|83271497|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
47022521|NCT02018887|83271498|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
47022522|NCT02018887|83271499|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
47022523|NCT02018887|83271500|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
47022524|NCT02018887|83271501|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
47022525|NCT02018887|83271502|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
47022526|NCT02018887|83271492|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
47022527|NCT02018887|83271493|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
47022528|NCT02018887|83271494|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
47022529|NCT02018887|83271495|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
47022530|NCT02018887|83271496|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
47022531|NCT02018887|83271497|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
47022532|NCT02018887|83271498|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
47022533|NCT02018887|83271499|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
47022534|NCT02018887|83271500|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
47022535|NCT02018887|83271501|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
47022536|NCT02018887|83271502|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
47022537|NCT02030041|83271571|FG000|Overall Study|Withdrawal by Subject|2|||
47022538|NCT02030041|83271572|FG001|Overall Study|Withdrawal by Subject|2|||
47022539|NCT02030041|83271573|FG002|Overall Study|Withdrawal by Subject|1|||
47022540|NCT01994720|83271583|FG000|Overall Study|Withdrawal by Subject|46|||
47022541|NCT01994720|83271584|FG001|Overall Study|Withdrawal by Subject|56|||
47022542|NCT01814007|83271590|FG000|Overall Study|Withdrawal by Subject|1|||
47022543|NCT01844115|83271597|FG000|Overall Study|Adverse Event|4|||
47022544|NCT01844115|83271598|FG001|Overall Study|Adverse Event|22|||
47022545|NCT01844115|83271597|FG000|Overall Study|Lack of Efficacy|1|||
47022546|NCT01844115|83271598|FG001|Overall Study|Lack of Efficacy|4|||
47022547|NCT01844115|83271597|FG000|Overall Study|Protocol Violation|12|||
47022548|NCT01844115|83271598|FG001|Overall Study|Protocol Violation|10|||
47022549|NCT01844115|83271597|FG000|Overall Study|Withdrawal by Subject|11|||
47022550|NCT01844115|83271598|FG001|Overall Study|Withdrawal by Subject|11|||
47022551|NCT01844115|83271597|FG000|Overall Study|Lost to Follow-up|11|||
47022552|NCT01844115|83271598|FG001|Overall Study|Lost to Follow-up|10|||
47022553|NCT01844115|83271597|FG000|Overall Study|Pregnancy|0|||
47022554|NCT01844115|83271598|FG001|Overall Study|Pregnancy|1|||
47022555|NCT02018042|83271604|FG000|Overall Study|Withdrawal by Subject|1|||
47022556|NCT01813305|83271610|FG000|Overall Study|Withdrawal by Subject|12|||
47022557|NCT01813305|83271611|FG001|Overall Study|Withdrawal by Subject|5|||
47022558|NCT01813305|83271610|FG000|Overall Study|Safety Concern|4|||
47022559|NCT01813305|83271611|FG001|Overall Study|Safety Concern|0|||
47022560|NCT01813305|83271610|FG000|Overall Study|Ulcer became worse|4|||
47022561|NCT01813305|83271611|FG001|Overall Study|Ulcer became worse|0|||
47022562|NCT01813305|83271610|FG000|Overall Study|Physician Decision|4|||
47022563|NCT01813305|83271611|FG001|Overall Study|Physician Decision|0|||
47022564|NCT01813305|83271610|FG000|Overall Study|Lost to Follow-up|3|||
47022565|NCT01813305|83271611|FG001|Overall Study|Lost to Follow-up|1|||
47022566|NCT01813305|83271610|FG000|Overall Study|Protocol Violation|1|||
47022567|NCT01813305|83271611|FG001|Overall Study|Protocol Violation|0|||
47022568|NCT01813305|83271610|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
47022569|NCT01813305|83271611|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
47022570|NCT01993940|83271621|FG000|Overall Study|Adverse Event|16|||
47022571|NCT01993940|83271622|FG001|Overall Study|Adverse Event|11|||
47022572|NCT01993940|83271621|FG000|Overall Study|Withdrawal by Subject|15|||
47022573|NCT01993940|83271622|FG001|Overall Study|Withdrawal by Subject|19|||
47022574|NCT01993940|83271621|FG000|Overall Study|Lost to Follow-up|2|||
47022575|NCT01993940|83271622|FG001|Overall Study|Lost to Follow-up|5|||
47022576|NCT01993940|83271621|FG000|Overall Study|Protocol Violation|5|||
47022577|NCT01993940|83271622|FG001|Overall Study|Protocol Violation|8|||
47022578|NCT01993940|83271621|FG000|Overall Study|Death|1|||
47022579|NCT01993940|83271622|FG001|Overall Study|Death|0|||
47022580|NCT01993940|83271621|FG000|Overall Study|Other - Miscellaneous|1|||
47022581|NCT01993940|83271622|FG001|Overall Study|Other - Miscellaneous|1|||
47022582|NCT01843803|83271630|FG000|Overall Study|not a Veteran, did not see provider|1|||
47022583|NCT01843803|83271631|FG001|Overall Study|not a Veteran, did not see provider|3|||
47022584|NCT02017171|83271639|FG000|Overall Study|Death|10|||
47022585|NCT02017171|83271640|FG001|Overall Study|Death|4|||
47022586|NCT02017171|83271639|FG000|Overall Study|Withdrawal by Subject|23|||
47022587|NCT02017171|83271640|FG001|Overall Study|Withdrawal by Subject|17|||
47022588|NCT02017171|83271639|FG000|Overall Study|Lost to Follow-up|21|||
47022589|NCT02017171|83271640|FG001|Overall Study|Lost to Follow-up|20|||
47022590|NCT02017171|83271639|FG000|Overall Study|ESKD|6|||
47022591|NCT02017171|83271640|FG001|Overall Study|ESKD|2|||
47022592|NCT02017171|83271639|FG000|Overall Study|Miscellaneous|2|||
47022593|NCT02017171|83271640|FG001|Overall Study|Miscellaneous|3|||
47022594|NCT02029417|83271647|FG000|Overall Study|Death|1|||
47022595|NCT02029417|83271647|FG000|Overall Study|Adverse Event|1|||
47022596|NCT02016716|83271654|FG000|Overall Study|Withdrawal by Subject|5|||
47022597|NCT02016716|83271655|FG001|Overall Study|Withdrawal by Subject|5|||
47022598|NCT02016716|83271656|FG002|Overall Study|Withdrawal by Subject|5|||
47022599|NCT02016716|83271654|FG000|Overall Study|Protocol-specified Criteria|0|||
47022600|NCT02016716|83271655|FG001|Overall Study|Protocol-specified Criteria|1|||
47022601|NCT02016716|83271656|FG002|Overall Study|Protocol-specified Criteria|0|||
47022602|NCT02016716|83271654|FG000|Overall Study|Lost to Follow-up|1|||
47022603|NCT02016716|83271655|FG001|Overall Study|Lost to Follow-up|2|||
47022604|NCT02016716|83271656|FG002|Overall Study|Lost to Follow-up|1|||
47022605|NCT02050321|83271665|FG000|Overall Study|Withdrawal by Subject|1|||
47022606|NCT02050321|83271665|FG000|Overall Study|Adverse Event|1|||
47022607|NCT02039414|83271671|FG000|Overall Study|Delivered|1|||
47022608|NCT02039414|83271672|FG001|Overall Study|Delivered|1|||
47022609|NCT02039414|83271671|FG000|Overall Study|Lost to Follow-up|2|||
47022610|NCT02039414|83271672|FG001|Overall Study|Lost to Follow-up|0|||
47022611|NCT02039414|83271671|FG000|Overall Study|Protocol Violation|3|||
47022612|NCT02039414|83271672|FG001|Overall Study|Protocol Violation|1|||
47022613|NCT02017015|83271678|FG000|Overall Study|Adverse Event|9|||
47022614|NCT02017015|83271678|FG000|Overall Study|Withdrawal by Subject|21|||
47022615|NCT02017015|83271678|FG000|Overall Study|Death|4|||
47022616|NCT02017015|83271678|FG000|Overall Study|Progressive Disease|31|||
47022617|NCT02017015|83271678|FG000|Overall Study|Non-compliance with study drug|2|||
47022618|NCT02017015|83271678|FG000|Overall Study|Physician Decision|2|||
47022619|NCT02016625|83271685|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
47022620|NCT02016625|83271686|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
47022621|NCT02016625|83271685|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
47022622|NCT02016625|83271686|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
47022623|NCT02016625|83271685|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
47022624|NCT02016625|83271686|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
47022625|NCT02016482|83271704|FG000|Period A|Adverse Event|3|||
47022626|NCT02016482|83271705|FG001|Period A|Adverse Event|5|||
47022627|NCT02016482|83271704|FG000|Period A|Withdrawal by Subject|3|||
47022628|NCT02016482|83271705|FG001|Period A|Withdrawal by Subject|4|||
47022629|NCT02016482|83271704|FG000|Period A|Lost to Follow-up|3|||
47022630|NCT02016482|83271705|FG001|Period A|Lost to Follow-up|3|||
47022631|NCT02016482|83271704|FG000|Period A|Lack of Efficacy|2|||
47022632|NCT02016482|83271705|FG001|Period A|Lack of Efficacy|1|||
47022633|NCT02016482|83271704|FG000|Period A|Other|3|||
47022634|NCT02016482|83271705|FG001|Period A|Other|0|||
47022635|NCT02016482|83271704|FG000|Period A|Protocol Violation|0|||
47022636|NCT02016482|83271705|FG001|Period A|Protocol Violation|1|||
47022637|NCT02016482|83271704|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
47022638|NCT02016482|83271705|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
47022639|NCT02016482|83271704|FG000|Period B|Withdrawal by Subject|1|||
47022640|NCT02016482|83271705|FG001|Period B|Withdrawal by Subject|1|||
47022641|NCT02016482|83271704|FG000|Period B|Lost to Follow-up|2|||
47022642|NCT02016482|83271705|FG001|Period B|Lost to Follow-up|0|||
47022643|NCT02016482|83271704|FG000|Period B|Lack of Efficacy|6|||
47022644|NCT02016482|83271705|FG001|Period B|Lack of Efficacy|4|||
47022645|NCT02016482|83271704|FG000|Period B|Other|4|||
47022646|NCT02016482|83271705|FG001|Period B|Other|0|||
47022647|NCT02016482|83271704|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
47022648|NCT02016482|83271705|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
47022649|NCT02028871|83271715|FG000|Overall Study|Positive urine drug screen|1|||
46620621|NCT02265510|82770884|FG009|Overall Study|Death|3|||
47022650|NCT02028871|83271716|FG001|Overall Study|Positive urine drug screen|1|||
47022651|NCT02028871|83271715|FG000|Overall Study|Withdrawal by Subject|1|||
47022652|NCT02028871|83271716|FG001|Overall Study|Withdrawal by Subject|2|||
47022653|NCT02028871|83271715|FG000|Overall Study|IV placement difficulty|1|||
47022654|NCT02028871|83271716|FG001|Overall Study|IV placement difficulty|0|||
47022655|NCT02028871|83271715|FG000|Overall Study|Current Illness|1|||
47022656|NCT02028871|83271716|FG001|Overall Study|Current Illness|0|||
47022657|NCT02028715|83271727|FG000|Overall Study|Adverse Event|2|||
47022658|NCT02028715|83271728|FG001|Overall Study|Adverse Event|2|||
47022659|NCT02028715|83271727|FG000|Overall Study|Physician Decision|1|||
47022660|NCT02028715|83271728|FG001|Overall Study|Physician Decision|0|||
47022661|NCT02028715|83271727|FG000|Overall Study|Did not complete satisfaction surveys|2|||
47022662|NCT02028715|83271728|FG001|Overall Study|Did not complete satisfaction surveys|2|||
47022663|NCT02016170|83271737|FG000|Overall Study|Adverse Event|1|||
47022664|NCT02016170|83271738|FG001|Overall Study|Adverse Event|1|||
47022665|NCT02016170|83271739|FG002|Overall Study|Adverse Event|0|||
47022666|NCT02016170|83271737|FG000|Overall Study|Protocol Violation|1|||
47022667|NCT02016170|83271738|FG001|Overall Study|Protocol Violation|0|||
47022668|NCT02016170|83271739|FG002|Overall Study|Protocol Violation|0|||
47022669|NCT02028169|83271746|FG000|Overall Study|Lost to Follow-up|21|||
47022670|NCT02028169|83271746|FG000|Overall Study|Lack of Efficacy|2|||
47022671|NCT02028169|83271746|FG000|Overall Study|Withdrawal by Subject|2|||
47022672|NCT02028169|83271746|FG000|Overall Study|Adverse Event|1|||
47022673|NCT02028169|83271746|FG000|Overall Study|Cessation of Drug|1|||
47022674|NCT02028169|83271746|FG000|Overall Study|Concomitant Medication Usage|1|||
47022675|NCT02015546|83271753|FG000|Overall Study|Withdrawal by Subject|1|||
47022676|NCT02015546|83271754|FG001|Overall Study|Withdrawal by Subject|1|||
47022677|NCT02015546|83271755|FG002|Overall Study|Withdrawal by Subject|1|||
47022678|NCT02015546|83271753|FG000|Overall Study|Screem Failure|2|||
47022679|NCT02015546|83271754|FG001|Overall Study|Screem Failure|1|||
47022680|NCT02015546|83271755|FG002|Overall Study|Screem Failure|3|||
47022681|NCT02027701|83271763|FG000|Overall Study|Adverse Event|3|||
47022682|NCT02027701|83271763|FG000|Overall Study|Lack of Efficacy|8|||
47022683|NCT02027701|83271763|FG000|Overall Study|Physician Decision|2|||
47022684|NCT02027701|83271763|FG000|Overall Study|Withdrawal by Subject|3|||
47022685|NCT02038790|83271769|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
46911407|NCT03208933|83141082|FG000|Overall Study|Death|3|||
46911408|NCT03208933|83141082|FG000|Overall Study|Withdrawal by Subject|3|||
46911409|NCT03208933|83141082|FG000|Overall Study|Adverse Event|1|||
46911410|NCT03208933|83141082|FG000|Overall Study|Lost to Follow-up|2|||
46911411|NCT03208933|83141082|FG000|Overall Study|Physician Decision|3|||
46911412|NCT03208933|83141082|FG000|Overall Study|Protocol Violation|1|||
46911413|NCT03207763|83141088|FG000|Overall Study|Lost to Follow-up|1|||
46911414|NCT03207763|83141089|FG001|Overall Study|Lost to Follow-up|0|||
46911415|NCT04766034|83141108|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
46911416|NCT04766034|83141109|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
46911417|NCT04766034|83141110|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
46911418|NCT04766034|83141111|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
46911419|NCT04766034|83141112|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
46911420|NCT04766034|83141108|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
46911421|NCT04766034|83141109|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
46911422|NCT04766034|83141110|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
46911423|NCT04766034|83141111|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
46911424|NCT04766034|83141112|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
46911425|NCT04766034|83141108|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
46911426|NCT04766034|83141109|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
46911427|NCT04766034|83141110|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
46911428|NCT04766034|83141111|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
46911429|NCT04766034|83141112|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
46911430|NCT04766034|83141108|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
46911431|NCT04766034|83141109|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
47022686|NCT02038790|83271770|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
47022687|NCT02027623|83271779|FG000|Overall Study|Lost to Follow-up|3|||
47022688|NCT02027623|83271780|FG001|Overall Study|Lost to Follow-up|3|||
47022689|NCT02027623|83271779|FG000|Overall Study|Withdrawal by Subject|6|||
47022690|NCT02027623|83271780|FG001|Overall Study|Withdrawal by Subject|9|||
47022691|NCT02015221|83271789|FG000|Overall Study|Withdrawal by Subject|8|||
47022692|NCT02015221|83271790|FG001|Overall Study|Withdrawal by Subject|6|||
47022693|NCT02015221|83271789|FG000|Overall Study|Lost to Follow-up|1|||
46620622|NCT02265510|82770885|FG010|Overall Study|Death|4|||
46620623|NCT02265510|82770886|FG011|Overall Study|Death|12|||
47022694|NCT02015221|83271790|FG001|Overall Study|Lost to Follow-up|0|||
47022695|NCT02027311|83271798|FG000|Overall Study|Protocol Violation|3|||
47022696|NCT02027311|83271799|FG001|Overall Study|Protocol Violation|2|||
47022697|NCT02047903|83271807|FG000|Overall Study|Adverse Event|14|||
47022698|NCT02047903|83271807|FG000|Overall Study|Serious adverse event|10|||
47022699|NCT02047903|83271807|FG000|Overall Study|Withdrawal by Subject|16|||
47022700|NCT02047903|83271807|FG000|Overall Study|Lost to Follow-up|4|||
47022701|NCT02047903|83271807|FG000|Overall Study|Reason not listed|6|||
47022702|NCT02047903|83271807|FG000|Overall Study|Not Treated|9|||
47022703|NCT02015065|83271814|FG000|Overall Study|Death on study|1|||
47022704|NCT02015065|83271815|FG001|Overall Study|Death on study|2|||
47022705|NCT02015065|83271816|FG002|Overall Study|Death on study|1|||
47022706|NCT02026141|83271826|FG000|Overall Study|Protocol Violation|0|||
47022707|NCT02026141|83271827|FG001|Overall Study|Protocol Violation|1|||
47022708|NCT02026063|83271835|FG000|Overall Study|Physician Decision|0|||
47022709|NCT02026063|83271836|FG001|Overall Study|Physician Decision|10|||
47022710|NCT02026063|83271835|FG000|Overall Study|Noncompliance with Study Drug|1|||
47022711|NCT02026063|83271836|FG001|Overall Study|Noncompliance with Study Drug|1|||
47022712|NCT02026063|83271835|FG000|Overall Study|Withdrawal of Consent|1|||
47022713|NCT02026063|83271836|FG001|Overall Study|Withdrawal of Consent|6|||
47022714|NCT02026063|83271835|FG000|Overall Study|Adverse Event|5|||
47022715|NCT02026063|83271836|FG001|Overall Study|Adverse Event|20|||
47022716|NCT02026063|83271835|FG000|Overall Study|Lack of Efficacy|0|||
47022717|NCT02026063|83271836|FG001|Overall Study|Lack of Efficacy|4|||
47022718|NCT02026063|83271835|FG000|Overall Study|Lost to Follow-up|0|||
47022719|NCT02026063|83271836|FG001|Overall Study|Lost to Follow-up|1|||
47022720|NCT02026063|83271835|FG000|Overall Study|Reason not Specified|2|||
47022721|NCT02026063|83271836|FG001|Overall Study|Reason not Specified|7|||
47022722|NCT02025907|83271845|FG000|Overall Study|Lack of Efficacy|1|||
47022723|NCT02025907|83271846|FG001|Overall Study|Lack of Efficacy|0|||
47022724|NCT02025907|83271845|FG000|Overall Study|Withdrawal by Subject|15|||
47022725|NCT02025907|83271846|FG001|Overall Study|Withdrawal by Subject|8|||
47022726|NCT02025907|83271845|FG000|Overall Study|Protocol Violation|2|||
47022727|NCT02025907|83271846|FG001|Overall Study|Protocol Violation|0|||
47022728|NCT02025907|83271845|FG000|Overall Study|Physician Decision|2|||
47022729|NCT02025907|83271846|FG001|Overall Study|Physician Decision|0|||
47022730|NCT02025907|83271845|FG000|Overall Study|Lost to Follow-up|2|||
47022731|NCT02025907|83271846|FG001|Overall Study|Lost to Follow-up|2|||
47022732|NCT02025907|83271845|FG000|Overall Study|Adverse Event|3|||
47022733|NCT02025907|83271846|FG001|Overall Study|Adverse Event|1|||
47022734|NCT02025907|83271845|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
47022735|NCT02025907|83271846|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
47022736|NCT01813071|83271861|FG000|Overall Study|Protocol Violation|0|||
47022737|NCT01813071|83271862|FG001|Overall Study|Protocol Violation|0|||
47022738|NCT01813071|83271863|FG002|Overall Study|Protocol Violation|0|||
47022739|NCT01813071|83271864|FG003|Overall Study|Protocol Violation|0|||
47022740|NCT01813071|83271865|FG004|Overall Study|Protocol Violation|1|||
47022741|NCT01813071|83271866|FG005|Overall Study|Protocol Violation|4|||
47022742|NCT01813071|83271867|FG006|Overall Study|Protocol Violation|2|||
47022743|NCT01813071|83271868|FG007|Overall Study|Protocol Violation|4|||
47022744|NCT01813071|83271869|FG008|Overall Study|Protocol Violation|2|||
47022745|NCT01813071|83271861|FG000|Overall Study|Withdrawal by Subject|0|||
47022746|NCT01813071|83271862|FG001|Overall Study|Withdrawal by Subject|0|||
46709852|NCT00920218|82925956|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
47022747|NCT01813071|83271863|FG002|Overall Study|Withdrawal by Subject|0|||
47022748|NCT01813071|83271864|FG003|Overall Study|Withdrawal by Subject|0|||
47022749|NCT01813071|83271865|FG004|Overall Study|Withdrawal by Subject|0|||
46709853|NCT00920218|82925957|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
47022750|NCT01813071|83271866|FG005|Overall Study|Withdrawal by Subject|1|||
47022751|NCT01813071|83271867|FG006|Overall Study|Withdrawal by Subject|0|||
47022752|NCT01813071|83271868|FG007|Overall Study|Withdrawal by Subject|0|||
47022753|NCT01813071|83271869|FG008|Overall Study|Withdrawal by Subject|0|||
47022754|NCT01813071|83271861|FG000|Overall Study|Adverse Event|0|||
47022755|NCT01813071|83271862|FG001|Overall Study|Adverse Event|0|||
47022756|NCT01813071|83271863|FG002|Overall Study|Adverse Event|0|||
47022757|NCT01813071|83271864|FG003|Overall Study|Adverse Event|0|||
47022758|NCT01813071|83271865|FG004|Overall Study|Adverse Event|0|||
47022759|NCT01813071|83271866|FG005|Overall Study|Adverse Event|1|||
47022760|NCT01813071|83271867|FG006|Overall Study|Adverse Event|0|||
47022761|NCT01813071|83271868|FG007|Overall Study|Adverse Event|0|||
47022762|NCT01813071|83271869|FG008|Overall Study|Adverse Event|0|||
47022763|NCT01813071|83271861|FG000|Overall Study|Physician Decision|0|||
47022764|NCT01813071|83271862|FG001|Overall Study|Physician Decision|0|||
47022765|NCT01813071|83271863|FG002|Overall Study|Physician Decision|0|||
47022766|NCT01813071|83271864|FG003|Overall Study|Physician Decision|0|||
47022767|NCT01813071|83271865|FG004|Overall Study|Physician Decision|0|||
47022768|NCT01813071|83271866|FG005|Overall Study|Physician Decision|0|||
47022769|NCT01813071|83271867|FG006|Overall Study|Physician Decision|1|||
47022770|NCT01813071|83271868|FG007|Overall Study|Physician Decision|0|||
47022771|NCT01813071|83271869|FG008|Overall Study|Physician Decision|0|||
47022772|NCT01813071|83271861|FG000|Overall Study|Met inc/exc criteria|0|||
47022773|NCT01813071|83271862|FG001|Overall Study|Met inc/exc criteria|0|||
47022774|NCT01813071|83271863|FG002|Overall Study|Met inc/exc criteria|0|||
47022775|NCT01813071|83271864|FG003|Overall Study|Met inc/exc criteria|0|||
47022776|NCT01813071|83271865|FG004|Overall Study|Met inc/exc criteria|0|||
47022777|NCT01813071|83271866|FG005|Overall Study|Met inc/exc criteria|1|||
47022778|NCT01813071|83271867|FG006|Overall Study|Met inc/exc criteria|0|||
47022779|NCT01813071|83271868|FG007|Overall Study|Met inc/exc criteria|1|||
47022780|NCT01813071|83271869|FG008|Overall Study|Met inc/exc criteria|1|||
47022781|NCT02025751|83271905|FG000|Overall Study|Lost to Follow-up|1|||
47022782|NCT02025751|83271906|FG001|Overall Study|Lost to Follow-up|0|||
47022783|NCT02025751|83271905|FG000|Overall Study|Adverse Event|0|||
47022784|NCT02025751|83271906|FG001|Overall Study|Adverse Event|1|||
47022785|NCT02025751|83271905|FG000|Overall Study|Physician Decision|0|||
47022786|NCT02025751|83271906|FG001|Overall Study|Physician Decision|1|||
46620624|NCT02265510|82770887|FG012|Overall Study|Death|7|||
46620625|NCT02265510|82770888|FG013|Overall Study|Death|6|||
46620626|NCT02265510|82770875|FG000|Overall Study|Lost to Follow-up|0|||
46620627|NCT02265510|82770876|FG001|Overall Study|Lost to Follow-up|0|||
46620628|NCT02265510|82770877|FG002|Overall Study|Lost to Follow-up|0|||
46620629|NCT02265510|82770878|FG003|Overall Study|Lost to Follow-up|0|||
46620630|NCT02265510|82770879|FG004|Overall Study|Lost to Follow-up|1|||
46620631|NCT02265510|82770880|FG005|Overall Study|Lost to Follow-up|0|||
46620632|NCT02265510|82770881|FG006|Overall Study|Lost to Follow-up|0|||
46620633|NCT02265510|82770882|FG007|Overall Study|Lost to Follow-up|0|||
46620634|NCT02265510|82770883|FG008|Overall Study|Lost to Follow-up|0|||
46620635|NCT02265510|82770884|FG009|Overall Study|Lost to Follow-up|2|||
46620636|NCT02265510|82770885|FG010|Overall Study|Lost to Follow-up|0|||
46620637|NCT02265510|82770886|FG011|Overall Study|Lost to Follow-up|0|||
46620638|NCT02265510|82770887|FG012|Overall Study|Lost to Follow-up|0|||
46620639|NCT02265510|82770888|FG013|Overall Study|Lost to Follow-up|2|||
46620640|NCT02265510|82770875|FG000|Overall Study|Other|0|||
46620641|NCT02265510|82770876|FG001|Overall Study|Other|1|||
46620642|NCT02265510|82770877|FG002|Overall Study|Other|0|||
46620643|NCT02265510|82770878|FG003|Overall Study|Other|0|||
46620644|NCT02265510|82770879|FG004|Overall Study|Other|0|||
46620645|NCT02265510|82770880|FG005|Overall Study|Other|0|||
46620646|NCT02265510|82770881|FG006|Overall Study|Other|0|||
46620647|NCT02265510|82770882|FG007|Overall Study|Other|0|||
46620648|NCT02265510|82770883|FG008|Overall Study|Other|0|||
46620649|NCT02265510|82770884|FG009|Overall Study|Other|0|||
46620650|NCT02265510|82770885|FG010|Overall Study|Other|0|||
46620651|NCT02265510|82770886|FG011|Overall Study|Other|0|||
46620652|NCT02265510|82770887|FG012|Overall Study|Other|0|||
46620653|NCT02265510|82770888|FG013|Overall Study|Other|0|||
46620654|NCT02265510|82770875|FG000|Overall Study|Study Terminated by Sponsor|0|||
46620655|NCT02265510|82770876|FG001|Overall Study|Study Terminated by Sponsor|0|||
46620656|NCT02265510|82770877|FG002|Overall Study|Study Terminated by Sponsor|0|||
46620657|NCT02265510|82770878|FG003|Overall Study|Study Terminated by Sponsor|0|||
46620658|NCT02265510|82770879|FG004|Overall Study|Study Terminated by Sponsor|0|||
46620659|NCT02265510|82770880|FG005|Overall Study|Study Terminated by Sponsor|1|||
46620660|NCT02265510|82770881|FG006|Overall Study|Study Terminated by Sponsor|1|||
46620661|NCT02265510|82770882|FG007|Overall Study|Study Terminated by Sponsor|1|||
46620662|NCT02265510|82770883|FG008|Overall Study|Study Terminated by Sponsor|1|||
46620663|NCT02265510|82770884|FG009|Overall Study|Study Terminated by Sponsor|2|||
46620664|NCT02265510|82770885|FG010|Overall Study|Study Terminated by Sponsor|1|||
46620665|NCT02265510|82770886|FG011|Overall Study|Study Terminated by Sponsor|4|||
46620666|NCT02265510|82770887|FG012|Overall Study|Study Terminated by Sponsor|1|||
46620667|NCT02265510|82770888|FG013|Overall Study|Study Terminated by Sponsor|2|||
46620668|NCT01238211|82770989|FG000|Overall Study|Continues active treatment|31|||
46620669|NCT01238211|82770989|FG000|Overall Study|Adverse Event|7|||
46620670|NCT01238211|82770989|FG000|Overall Study|Death|4|||
46620671|NCT01238211|82770989|FG000|Overall Study|Relapse/Progression|2|||
46620672|NCT01238211|82770989|FG000|Overall Study|Withdrawal by Subject|7|||
46620673|NCT01238211|82770989|FG000|Overall Study|Non-protocol treatment|4|||
46620674|NCT01238211|82770989|FG000|Overall Study|Investigator/Patient Decision|3|||
46911432|NCT04766034|83141110|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
46620675|NCT02264574|82771165|FG000|Overall Study|Death|21|||
46620676|NCT02264574|82771166|FG001|Overall Study|Death|21|||
46620677|NCT02264574|82771165|FG000|Overall Study|Withdrawal by Subject|8|||
46620678|NCT02264574|82771166|FG001|Overall Study|Withdrawal by Subject|6|||
46620679|NCT02264574|82771165|FG000|Overall Study|Other, Not Specified|0|||
46620680|NCT02264574|82771166|FG001|Overall Study|Other, Not Specified|3|||
47022787|NCT02025751|83271905|FG000|Overall Study|Withdrawal by Subject|0|||
47022788|NCT02025751|83271906|FG001|Overall Study|Withdrawal by Subject|1|||
47022789|NCT02025205|83271914|FG000|Overall Study|Withdrawal by Subject|1|||
47022790|NCT02025205|83271915|FG001|Overall Study|Withdrawal by Subject|1|||
47022791|NCT02025205|83271914|FG000|Overall Study|Protocol Violation|2|||
47022792|NCT02025205|83271915|FG001|Overall Study|Protocol Violation|1|||
46620681|NCT01641900|82771206|FG000|Overall Study|Withdrawal by Subject|2|||
46620682|NCT01641900|82771207|FG001|Overall Study|Withdrawal by Subject|2|||
46911433|NCT04766034|83141111|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
46911434|NCT04766034|83141112|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
46911435|NCT03237013|83141127|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
46911436|NCT03237013|83141128|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
46911437|NCT03237013|83141129|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
46911438|NCT03236779|83141139|FG000|Overall Study|Lost to Follow-up|13|||
46911439|NCT03236779|83141140|FG001|Overall Study|Lost to Follow-up|21|||
47022793|NCT02025205|83271914|FG000|Overall Study|Death|0|||
47022794|NCT02025205|83271915|FG001|Overall Study|Death|1|||
46911440|NCT03096483|83141148|FG000|Overall Study|Withdrawal by site|1|||
46911441|NCT02932579|83141154|FG000|Overall Study|Withdrawal by Subject|4|||
46911442|NCT02932579|83141155|FG001|Overall Study|Withdrawal by Subject|1|||
46911443|NCT03207451|83141165|FG000|Overall Study|scheduling conflict|1|||
46911444|NCT03207451|83141166|FG001|Overall Study|scheduling conflict|0|||
46911445|NCT03207451|83141167|FG002|Overall Study|scheduling conflict|2|||
46911446|NCT03207451|83141168|FG003|Overall Study|scheduling conflict|2|||
46911447|NCT03207451|83141165|FG000|Overall Study|Adverse Event|0|||
46911448|NCT03207451|83141166|FG001|Overall Study|Adverse Event|0|||
46911449|NCT03207451|83141167|FG002|Overall Study|Adverse Event|0|||
46911450|NCT03207451|83141168|FG003|Overall Study|Adverse Event|1|||
46911451|NCT03350503|83141195|FG000|Overall Study|Adverse Event|5|||
46911452|NCT03350503|83141195|FG000|Overall Study|Withdrawal by Subject|5|||
46911453|NCT03350503|83141195|FG000|Overall Study|Continuation impossible due to move|4|||
46911454|NCT03350503|83141195|FG000|Overall Study|Physician Decision|3|||
47022795|NCT01812837|83271924|FG000|Overall Study|Lost to Follow-up|1|||
47022796|NCT01812837|83271925|FG001|Overall Study|Lost to Follow-up|1|||
47022797|NCT01812837|83271926|FG002|Overall Study|Lost to Follow-up|0|||
47022798|NCT01812837|83271924|FG000|Overall Study|Protocol Violation|1|||
47022799|NCT01812837|83271925|FG001|Overall Study|Protocol Violation|0|||
47022800|NCT01812837|83271926|FG002|Overall Study|Protocol Violation|0|||
47022801|NCT02024971|83271934|FG000|Overall Study|Data Not Available|30|||
47022802|NCT02024971|83271934|FG000|Overall Study|Lost to Follow-up|6|||
47022803|NCT01843023|83271940|FG000|Overall Study|Death|1|||
47022804|NCT01843023|83271941|FG001|Overall Study|Death|0|||
47022805|NCT01843023|83271940|FG000|Overall Study|Lost to Follow-up|24|||
47022806|NCT01843023|83271941|FG001|Overall Study|Lost to Follow-up|29|||
47022807|NCT01843023|83271940|FG000|Overall Study|Withdrawal by Subject|8|||
47022808|NCT01843023|83271941|FG001|Overall Study|Withdrawal by Subject|6|||
47022809|NCT01812759|83271950|FG000|Overall Study|Physician Decision|0|||
47022810|NCT01812759|83271951|FG001|Overall Study|Physician Decision|0|||
47022811|NCT01812759|83271952|FG002|Overall Study|Physician Decision|1|||
47022812|NCT01812057|83271962|FG000|Overall Study|Protocol Violation|1|||
47022813|NCT01812057|83271963|FG001|Overall Study|Protocol Violation|0|||
47022814|NCT01812057|83271962|FG000|Overall Study|Physician Decision|1|||
47022815|NCT01812057|83271963|FG001|Overall Study|Physician Decision|0|||
47022816|NCT01842633|83271976|FG000|Overall Study|Screen Failure|1|||
47022817|NCT01842633|83271977|FG001|Overall Study|Screen Failure|0|||
47022818|NCT01842633|83271978|FG002|Overall Study|Screen Failure|0|||
47022819|NCT01842633|83271976|FG000|Overall Study|Adverse Event|1|||
47022820|NCT01842633|83271977|FG001|Overall Study|Adverse Event|1|||
47022821|NCT01842633|83271978|FG002|Overall Study|Adverse Event|0|||
47022822|NCT01842633|83271976|FG000|Overall Study|Withdrawal by Subject|0|||
47022823|NCT01842633|83271977|FG001|Overall Study|Withdrawal by Subject|1|||
47022824|NCT01842633|83271978|FG002|Overall Study|Withdrawal by Subject|0|||
47022825|NCT01842633|83271976|FG000|Overall Study|Technical issues|1|||
47022826|NCT01842633|83271977|FG001|Overall Study|Technical issues|0|||
47022827|NCT01842633|83271978|FG002|Overall Study|Technical issues|0|||
47022828|NCT01810263|83271990|FG000|Overall Study|Lost to Follow-up|8|||
47022829|NCT01810263|83271991|FG001|Overall Study|Lost to Follow-up|7|||
47022830|NCT01841697|83271999|FG000|Overall Study|Death|0|||
47022831|NCT01841697|83272000|FG001|Overall Study|Death|1|||
47022832|NCT01841697|83271999|FG000|Overall Study|Lost to Follow-up|4|||
47022833|NCT01841697|83272000|FG001|Overall Study|Lost to Follow-up|1|||
47022834|NCT01841697|83271999|FG000|Overall Study|Withdrawal by Subject|16|||
47022835|NCT01841697|83272000|FG001|Overall Study|Withdrawal by Subject|16|||
47022836|NCT01841073|83272008|FG000|Overall Study|Adverse Event|1|||
47022837|NCT01841073|83272009|FG001|Overall Study|Adverse Event|1|||
47022838|NCT01841073|83272008|FG000|Overall Study|Physician Decision|1|||
47022839|NCT01841073|83272009|FG001|Overall Study|Physician Decision|0|||
47022840|NCT01841073|83272008|FG000|Overall Study|Lost to Follow-up|0|||
47022841|NCT01841073|83272009|FG001|Overall Study|Lost to Follow-up|2|||
47022842|NCT01809327|83272022|FG000|Overall Study|Lost to Follow-up|5|||
47022843|NCT01809327|83272023|FG001|Overall Study|Lost to Follow-up|2|||
47022844|NCT01809327|83272024|FG002|Overall Study|Lost to Follow-up|4|||
47022845|NCT01809327|83272025|FG003|Overall Study|Lost to Follow-up|2|||
47022846|NCT01809327|83272026|FG004|Overall Study|Lost to Follow-up|3|||
47022847|NCT01809327|83272022|FG000|Overall Study|Withdrawal by Subject|6|||
47022848|NCT01809327|83272023|FG001|Overall Study|Withdrawal by Subject|4|||
46620683|NCT01640808|82771272|FG000|Overall Study|Unable to continue dynamic CT|14|||
47022849|NCT01809327|83272024|FG002|Overall Study|Withdrawal by Subject|4|||
47022850|NCT01809327|83272025|FG003|Overall Study|Withdrawal by Subject|2|||
47022851|NCT01809327|83272026|FG004|Overall Study|Withdrawal by Subject|5|||
47022852|NCT01809327|83272022|FG000|Overall Study|Adverse Event|4|||
46911455|NCT03288779|83141218|FG000|Overall Study|Withdrawal by Subject|3|||
47022853|NCT01809327|83272023|FG001|Overall Study|Adverse Event|3|||
47022854|NCT01809327|83272024|FG002|Overall Study|Adverse Event|7|||
47022855|NCT01809327|83272025|FG003|Overall Study|Adverse Event|4|||
47022856|NCT01809327|83272026|FG004|Overall Study|Adverse Event|8|||
46620684|NCT01640808|82771273|FG001|Overall Study|Unable to continue dynamic CT|4|||
47022857|NCT01809327|83272022|FG000|Overall Study|Death|1|||
47022858|NCT01809327|83272023|FG001|Overall Study|Death|0|||
47022859|NCT01809327|83272024|FG002|Overall Study|Death|0|||
47022860|NCT01809327|83272025|FG003|Overall Study|Death|0|||
47022861|NCT01809327|83272026|FG004|Overall Study|Death|0|||
47022862|NCT01809327|83272022|FG000|Overall Study|Protocol Violation|0|||
47022863|NCT01809327|83272023|FG001|Overall Study|Protocol Violation|1|||
47022864|NCT01809327|83272024|FG002|Overall Study|Protocol Violation|0|||
47022865|NCT01809327|83272025|FG003|Overall Study|Protocol Violation|0|||
47022866|NCT01809327|83272026|FG004|Overall Study|Protocol Violation|0|||
47022867|NCT01809327|83272022|FG000|Overall Study|Physician Decision|1|||
47022868|NCT01809327|83272023|FG001|Overall Study|Physician Decision|1|||
47022869|NCT01809327|83272024|FG002|Overall Study|Physician Decision|0|||
47022870|NCT01809327|83272025|FG003|Overall Study|Physician Decision|0|||
47022871|NCT01809327|83272026|FG004|Overall Study|Physician Decision|0|||
47022872|NCT01809327|83272022|FG000|Overall Study|Pregnancy|1|||
47022873|NCT01809327|83272023|FG001|Overall Study|Pregnancy|0|||
47022874|NCT01809327|83272024|FG002|Overall Study|Pregnancy|0|||
47022875|NCT01809327|83272025|FG003|Overall Study|Pregnancy|0|||
47022876|NCT01809327|83272026|FG004|Overall Study|Pregnancy|0|||
47022877|NCT01809327|83272022|FG000|Overall Study|Other|14|||
47022878|NCT01809327|83272023|FG001|Overall Study|Other|15|||
47022879|NCT01809327|83272024|FG002|Overall Study|Other|7|||
47022880|NCT01809327|83272025|FG003|Overall Study|Other|4|||
47022881|NCT01809327|83272026|FG004|Overall Study|Other|9|||
47022882|NCT01808313|83272047|FG000|Overall Study|Adverse Event|5|||
47022883|NCT01808313|83272047|FG000|Overall Study|Protocol Violation|2|||
47022884|NCT01808313|83272047|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
47022885|NCT01808313|83272047|FG000|Overall Study|Lost to Follow-up|1|||
47022886|NCT01808313|83272047|FG000|Overall Study|Physician Decision|1|||
47022887|NCT01840605|83272053|FG000|Overall Study|Adverse Event|0|||
47022888|NCT01840605|83272054|FG001|Overall Study|Adverse Event|1|||
47022889|NCT01840605|83272053|FG000|Overall Study|Physician Decision|2|||
47022890|NCT01840605|83272054|FG001|Overall Study|Physician Decision|1|||
47022891|NCT02023879|83272063|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
47022892|NCT02023879|83272064|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
47022893|NCT02023879|83272065|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
47022894|NCT02023879|83272063|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
47022895|NCT02023879|83272064|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
47022896|NCT02023879|83272065|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
47022897|NCT02023879|83272063|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
47022898|NCT02023879|83272064|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
47022899|NCT02023879|83272065|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
47022900|NCT02023879|83272063|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
47022901|NCT02023879|83272064|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
47022902|NCT02023879|83272065|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
47022903|NCT02023879|83272063|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
47022904|NCT02023879|83272064|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
47022905|NCT02023879|83272065|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
47022906|NCT02023879|83272063|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
47022907|NCT02023879|83272064|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
47022908|NCT02023879|83272065|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
47022909|NCT02023879|83272063|FG000|Extension Open Label Treatment|Adverse Event|1|||
47022910|NCT02023879|83272064|FG001|Extension Open Label Treatment|Adverse Event|7|||
47022911|NCT02023879|83272065|FG002|Extension Open Label Treatment|Adverse Event|3|||
47022912|NCT02023879|83272063|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
47022913|NCT02023879|83272064|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
47022914|NCT02023879|83272065|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
47022915|NCT02023879|83272063|FG000|Extension Open Label Treatment|Participant moved|1|||
47022916|NCT02023879|83272064|FG001|Extension Open Label Treatment|Participant moved|2|||
47022917|NCT02023879|83272065|FG002|Extension Open Label Treatment|Participant moved|0|||
47022918|NCT02023879|83272063|FG000|Extension Open Label Treatment|Other than specified above|2|||
47022919|NCT02023879|83272064|FG001|Extension Open Label Treatment|Other than specified above|7|||
47022920|NCT02023879|83272065|FG002|Extension Open Label Treatment|Other than specified above|2|||
47022921|NCT02014441|83272080|FG000|Overall Study|Withdrawal by Subject|12|||
47022922|NCT02013817|83272086|FG000|Overall Study|Adverse Event|12|||
46911456|NCT03206749|83141225|FG000|Overall Study|Withdrawal of consent|5|||
47022923|NCT02013817|83272086|FG000|Overall Study|Withdrawal by Subject|4|||
47022924|NCT02013817|83272086|FG000|Overall Study|Death|2|||
47022925|NCT02013817|83272086|FG000|Overall Study|Other|9|||
47022926|NCT01994863|83272090|FG000|Period 1|Adverse Event|4|||
47022927|NCT01994863|83272091|FG001|Period 1|Adverse Event|0|||
47022928|NCT01994863|83272090|FG000|Period 1|Withdrawal by Subject|1|||
47022929|NCT01994863|83272091|FG001|Period 1|Withdrawal by Subject|0|||
46620685|NCT01640808|82771272|FG000|Overall Study|Withdrawal by Subject|12|||
46620686|NCT01640808|82771273|FG001|Overall Study|Withdrawal by Subject|4|||
47022930|NCT01994863|83272090|FG000|Period 1|Trial stopped by sponsor|1|||
47022931|NCT01994863|83272091|FG001|Period 1|Trial stopped by sponsor|3|||
47022932|NCT01994863|83272090|FG000|Period 1|Lack of Efficacy|1|||
47022933|NCT01994863|83272091|FG001|Period 1|Lack of Efficacy|0|||
47022934|NCT01994863|83272090|FG000|Period 2|Adverse Event|0|||
47022935|NCT01994863|83272091|FG001|Period 2|Adverse Event|1|||
47022936|NCT01994863|83272090|FG000|Period 2|Lack of Efficacy|0|||
47022937|NCT01994863|83272091|FG001|Period 2|Lack of Efficacy|2|||
47022938|NCT01994863|83272090|FG000|Period 2|Withdrawal by Subject|1|||
47022939|NCT01994863|83272091|FG001|Period 2|Withdrawal by Subject|1|||
47022940|NCT02023099|83272100|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
47022941|NCT02023099|83272101|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
47022942|NCT02023099|83272102|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
47022943|NCT02023099|83272100|FG000|Overall Study|Withdrawn Consent|3|||
47022944|NCT02023099|83272101|FG001|Overall Study|Withdrawn Consent|0|||
47022945|NCT02023099|83272102|FG002|Overall Study|Withdrawn Consent|1|||
47022946|NCT02023099|83272100|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
47022947|NCT02023099|83272101|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
47022948|NCT02023099|83272102|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
47022949|NCT02013037|83272110|FG000|Overall Study|Death|6|||
47022950|NCT02013037|83272110|FG000|Overall Study|Withdrawal by Subject|1|||
47022951|NCT02013037|83272110|FG000|Overall Study|Awaiting Transplantation|7|||
47022952|NCT02013037|83272110|FG000|Overall Study|Transplanted without DSA|2|||
47022953|NCT01967719|83272117|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
47022954|NCT01967719|83272118|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
47022955|NCT01967719|83272119|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
47022956|NCT01967719|83272120|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
47022957|NCT01967719|83272117|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
47022958|NCT01967719|83272118|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
47022959|NCT01967719|83272119|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
47022960|NCT01967719|83272120|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
47022961|NCT01967173|83272138|FG000|Overall Study|Lost to Follow-up|5|||
47022962|NCT01967173|83272139|FG001|Overall Study|Lost to Follow-up|3|||
47022963|NCT01967173|83272140|FG002|Overall Study|Lost to Follow-up|2|||
47022964|NCT01967173|83272141|FG003|Overall Study|Lost to Follow-up|4|||
47022965|NCT01967173|83272142|FG004|Overall Study|Lost to Follow-up|8|||
47022966|NCT01967173|83272143|FG005|Overall Study|Lost to Follow-up|12|||
47022967|NCT01967173|83272144|FG006|Overall Study|Lost to Follow-up|6|||
47022968|NCT01967173|83272145|FG007|Overall Study|Lost to Follow-up|8|||
47022969|NCT01967173|83272138|FG000|Overall Study|Physician Decision|2|||
47022970|NCT01967173|83272139|FG001|Overall Study|Physician Decision|0|||
47022971|NCT01967173|83272140|FG002|Overall Study|Physician Decision|2|||
47022972|NCT01967173|83272141|FG003|Overall Study|Physician Decision|1|||
47022973|NCT01967173|83272142|FG004|Overall Study|Physician Decision|1|||
47022974|NCT01967173|83272143|FG005|Overall Study|Physician Decision|1|||
47022975|NCT01967173|83272144|FG006|Overall Study|Physician Decision|1|||
47022976|NCT01967173|83272145|FG007|Overall Study|Physician Decision|0|||
47022977|NCT01967173|83272138|FG000|Overall Study|Lack of Efficacy|2|||
47022978|NCT01967173|83272139|FG001|Overall Study|Lack of Efficacy|0|||
47022979|NCT01967173|83272140|FG002|Overall Study|Lack of Efficacy|2|||
47022980|NCT01967173|83272141|FG003|Overall Study|Lack of Efficacy|2|||
47022981|NCT01967173|83272142|FG004|Overall Study|Lack of Efficacy|0|||
47022982|NCT01967173|83272143|FG005|Overall Study|Lack of Efficacy|1|||
47022983|NCT01967173|83272144|FG006|Overall Study|Lack of Efficacy|0|||
47022984|NCT01967173|83272145|FG007|Overall Study|Lack of Efficacy|2|||
47022985|NCT01967173|83272138|FG000|Overall Study|Pregnancy|0|||
47022986|NCT01967173|83272139|FG001|Overall Study|Pregnancy|0|||
47022987|NCT01967173|83272140|FG002|Overall Study|Pregnancy|0|||
47022988|NCT01967173|83272141|FG003|Overall Study|Pregnancy|0|||
47022989|NCT01967173|83272142|FG004|Overall Study|Pregnancy|0|||
47022990|NCT01967173|83272143|FG005|Overall Study|Pregnancy|0|||
47022991|NCT01967173|83272144|FG006|Overall Study|Pregnancy|1|||
47022992|NCT01967173|83272145|FG007|Overall Study|Pregnancy|1|||
47022993|NCT01967173|83272138|FG000|Overall Study|Adverse Event|0|||
47022994|NCT01967173|83272139|FG001|Overall Study|Adverse Event|0|||
47022995|NCT01967173|83272140|FG002|Overall Study|Adverse Event|0|||
47022996|NCT01967173|83272141|FG003|Overall Study|Adverse Event|0|||
47022997|NCT01967173|83272142|FG004|Overall Study|Adverse Event|0|||
47022998|NCT01967173|83272143|FG005|Overall Study|Adverse Event|0|||
47022999|NCT01967173|83272144|FG006|Overall Study|Adverse Event|0|||
47023000|NCT01967173|83272145|FG007|Overall Study|Adverse Event|1|||
47023001|NCT01967173|83272138|FG000|Overall Study|Withdrawal by Subject|15|||
47023002|NCT01967173|83272139|FG001|Overall Study|Withdrawal by Subject|14|||
47023003|NCT01967173|83272140|FG002|Overall Study|Withdrawal by Subject|10|||
47023004|NCT01967173|83272141|FG003|Overall Study|Withdrawal by Subject|7|||
47023005|NCT01967173|83272142|FG004|Overall Study|Withdrawal by Subject|8|||
47023006|NCT01967173|83272143|FG005|Overall Study|Withdrawal by Subject|9|||
47023007|NCT01967173|83272144|FG006|Overall Study|Withdrawal by Subject|10|||
47023008|NCT01967173|83272145|FG007|Overall Study|Withdrawal by Subject|12|||
47023009|NCT01994629|83272159|FG000|Overall Study|Withdrawal by Subject|1|||
47023010|NCT01994629|83272160|FG001|Overall Study|Withdrawal by Subject|0|||
47023011|NCT01994629|83272159|FG000|Overall Study|Lost to Follow-up|0|||
47023012|NCT01994629|83272160|FG001|Overall Study|Lost to Follow-up|3|||
47023013|NCT01994395|83272168|FG000|Overall Study|Withdrawal by Subject|1|||
47023014|NCT01994395|83272169|FG001|Overall Study|Withdrawal by Subject|2|||
47023015|NCT01992536|83272185|FG000|Overall Study|Administrative Reason|0|||
47023016|NCT01992536|83272186|FG001|Overall Study|Administrative Reason|0|||
47023017|NCT01992536|83272187|FG002|Overall Study|Administrative Reason|0|||
47023018|NCT01992536|83272188|FG003|Overall Study|Administrative Reason|0|||
47023019|NCT01992536|83272189|FG004|Overall Study|Administrative Reason|0|||
47023020|NCT01992536|83272190|FG005|Overall Study|Administrative Reason|0|||
47023021|NCT01992536|83272191|FG006|Overall Study|Administrative Reason|7|||
47023022|NCT01992536|83272192|FG007|Overall Study|Administrative Reason|0|||
47023023|NCT01992536|83272193|FG008|Overall Study|Administrative Reason|0|||
47023024|NCT01992536|83272194|FG009|Overall Study|Administrative Reason|0|||
47023025|NCT01992536|83272185|FG000|Overall Study|Lost to Follow-up|4|||
47023026|NCT01992536|83272186|FG001|Overall Study|Lost to Follow-up|2|||
47023027|NCT01992536|83272187|FG002|Overall Study|Lost to Follow-up|1|||
47023028|NCT01992536|83272188|FG003|Overall Study|Lost to Follow-up|0|||
47023029|NCT01992536|83272189|FG004|Overall Study|Lost to Follow-up|0|||
47023030|NCT01992536|83272190|FG005|Overall Study|Lost to Follow-up|1|||
47023031|NCT01992536|83272191|FG006|Overall Study|Lost to Follow-up|0|||
47023032|NCT01992536|83272192|FG007|Overall Study|Lost to Follow-up|0|||
47023033|NCT01992536|83272193|FG008|Overall Study|Lost to Follow-up|1|||
47023034|NCT01992536|83272194|FG009|Overall Study|Lost to Follow-up|1|||
47023035|NCT01992536|83272185|FG000|Overall Study|Withdrawal by Subject|0|||
47023036|NCT01992536|83272186|FG001|Overall Study|Withdrawal by Subject|1|||
47023037|NCT01992536|83272187|FG002|Overall Study|Withdrawal by Subject|0|||
47023038|NCT01992536|83272188|FG003|Overall Study|Withdrawal by Subject|2|||
46709854|NCT00920218|82925958|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
46709855|NCT00920218|82925959|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
46709856|NCT00920218|82925956|FG000|Overall Study|Other|0|||
46709857|NCT00920218|82925957|FG001|Overall Study|Other|0|||
46709858|NCT00920218|82925958|FG002|Overall Study|Other|1|||
46709859|NCT00920218|82925959|FG003|Overall Study|Other|0|||
46709860|NCT01121562|82925973|FG000|Overall Study|Objective progression or relapse|8|||
46911457|NCT03206749|83141226|FG001|Overall Study|Withdrawal of consent|3|||
47023039|NCT01992536|83272189|FG004|Overall Study|Withdrawal by Subject|0|||
47023040|NCT01992536|83272190|FG005|Overall Study|Withdrawal by Subject|0|||
47023041|NCT01992536|83272191|FG006|Overall Study|Withdrawal by Subject|0|||
47023042|NCT01992536|83272192|FG007|Overall Study|Withdrawal by Subject|0|||
47023043|NCT01992536|83272193|FG008|Overall Study|Withdrawal by Subject|0|||
47023044|NCT01992536|83272194|FG009|Overall Study|Withdrawal by Subject|0|||
47023045|NCT01993927|83272236|FG000|Overall Study|Case Report Forms Uncollected|18|||
47023046|NCT01993927|83272236|FG000|Overall Study|Protocol Violation|11|||
47023047|NCT02015390|83272242|FG000|Overall Study|Lost to Follow-up|1|||
47023048|NCT02015390|83272243|FG001|Overall Study|Lost to Follow-up|0|||
47023049|NCT02015390|83272242|FG000|Overall Study|Adverse Event|0|||
47023050|NCT02015390|83272243|FG001|Overall Study|Adverse Event|3|||
47023051|NCT02015390|83272242|FG000|Overall Study|Physician Decision|0|||
47023052|NCT02015390|83272243|FG001|Overall Study|Physician Decision|1|||
47023053|NCT02012959|83272250|FG000|Treatment Phase A|Adverse Event|2|||
46911458|NCT03206749|83141227|FG002|Overall Study|Withdrawal of consent|6|||
46911459|NCT03206749|83141225|FG000|Overall Study|Lost to Follow-up|0|||
46911460|NCT03206749|83141226|FG001|Overall Study|Lost to Follow-up|0|||
46911461|NCT03206749|83141227|FG002|Overall Study|Lost to Follow-up|1|||
46911462|NCT03255941|83141247|FG000|Overall Study|Not eligible or refused injection|37|||
46911463|NCT03255941|83141248|FG001|Overall Study|Not eligible or refused injection|44|||
46911464|NCT03255941|83141249|FG002|Overall Study|Not eligible or refused injection|5|||
46620687|NCT01640808|82771272|FG000|Overall Study|Lost to Follow-up|4|||
46709861|NCT01121562|82925973|FG000|Overall Study|Withdrawal by Subject|1|||
46709862|NCT01121562|82925973|FG000|Overall Study|Adverse Event|1|||
46911465|NCT03255941|83141250|FG003|Overall Study|Not eligible or refused injection|6|||
46911466|NCT03255941|83141247|FG000|Overall Study|Did not complete exit interview|1|||
47023054|NCT02012959|83272251|FG001|Treatment Phase A|Adverse Event|0|||
47023055|NCT02012959|83272252|FG002|Treatment Phase A|Adverse Event|0|||
47023056|NCT02012959|83272253|FG003|Treatment Phase A|Adverse Event|0|||
47023057|NCT02012959|83272254|FG004|Treatment Phase A|Adverse Event|0|||
47023058|NCT01990742|83272266|FG000|Overall Study|Withdrawal by facility|407|||
47023059|NCT01990742|83272267|FG001|Overall Study|Withdrawal by facility|1083|||
47023060|NCT01990742|83272266|FG000|Overall Study|Facility closed|0|||
47023061|NCT01990742|83272267|FG001|Overall Study|Facility closed|270|||
47023062|NCT02012491|83272275|FG000|Overall Study|Lost to Follow-up|1|||
47023063|NCT02012491|83272276|FG001|Overall Study|Lost to Follow-up|0|||
47023064|NCT02012491|83272275|FG000|Overall Study|Protocol Violation|0|||
47023065|NCT02012491|83272276|FG001|Overall Study|Protocol Violation|1|||
47023066|NCT02012491|83272275|FG000|Overall Study|Withdrawal by Subject|1|||
47023067|NCT02012491|83272276|FG001|Overall Study|Withdrawal by Subject|0|||
47023068|NCT01990664|83272284|FG000|Overall Study|Lost to Follow-up|2|||
47023069|NCT01990664|83272285|FG001|Overall Study|Lost to Follow-up|6|||
47023070|NCT01990664|83272284|FG000|Overall Study|Withdrawal by Subject|2|||
47023071|NCT01990664|83272285|FG001|Overall Study|Withdrawal by Subject|3|||
47023072|NCT01990664|83272284|FG000|Overall Study|Protocol Violation|1|||
46709863|NCT01121562|82925973|FG000|Overall Study|Sponsor Decision|1|||
47023073|NCT01990664|83272285|FG001|Overall Study|Protocol Violation|0|||
47023074|NCT01990664|83272284|FG000|Overall Study|Lens Discomfort|1|||
47023075|NCT01990664|83272285|FG001|Overall Study|Lens Discomfort|1|||
47023076|NCT01990664|83272284|FG000|Overall Study|Lens Handling Difficulties|1|||
47023077|NCT01990664|83272285|FG001|Overall Study|Lens Handling Difficulties|0|||
47023078|NCT01990664|83272284|FG000|Overall Study|Unsatisfactory Visual Response|0|||
47023079|NCT01990664|83272285|FG001|Overall Study|Unsatisfactory Visual Response|1|||
47023080|NCT02038010|83272291|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
47023081|NCT02038010|83272292|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
47023082|NCT02038010|83272293|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
47023083|NCT02038010|83272294|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
47023084|NCT02038010|83272291|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
47023085|NCT02038010|83272292|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
47023086|NCT02038010|83272293|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
47023087|NCT02038010|83272294|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
47023088|NCT02038010|83272291|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
47023089|NCT02038010|83272292|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
47023090|NCT02038010|83272293|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
47023091|NCT02038010|83272294|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
47023092|NCT02038010|83272291|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
47023093|NCT02038010|83272292|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
47023094|NCT02038010|83272293|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
47023095|NCT02038010|83272294|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
47023096|NCT02038010|83272291|FG000|Follow Up|Death|4|||
47023097|NCT02038010|83272292|FG001|Follow Up|Death|3|||
47023098|NCT02038010|83272293|FG002|Follow Up|Death|0|||
47023099|NCT02038010|83272294|FG003|Follow Up|Death|0|||
47023100|NCT02038010|83272291|FG000|Follow Up|Other|3|||
47023101|NCT02038010|83272292|FG001|Follow Up|Other|0|||
47023102|NCT02038010|83272293|FG002|Follow Up|Other|0|||
47023103|NCT02038010|83272294|FG003|Follow Up|Other|0|||
47023104|NCT01989572|83272308|FG000|Overall Study|Lack of Efficacy|35|||
47023105|NCT01989572|83272309|FG001|Overall Study|Lack of Efficacy|48|||
47023106|NCT01989572|83272310|FG002|Overall Study|Lack of Efficacy|48|||
47023107|NCT01989572|83272311|FG003|Overall Study|Lack of Efficacy|43|||
47023108|NCT01989572|83272312|FG004|Overall Study|Lack of Efficacy|71|||
47023109|NCT01989572|83272313|FG005|Overall Study|Lack of Efficacy|79|||
47023110|NCT01989572|83272308|FG000|Overall Study|Adverse Event|2|||
47023111|NCT01989572|83272309|FG001|Overall Study|Adverse Event|1|||
47023112|NCT01989572|83272310|FG002|Overall Study|Adverse Event|3|||
47023113|NCT01989572|83272311|FG003|Overall Study|Adverse Event|0|||
47023114|NCT01989572|83272312|FG004|Overall Study|Adverse Event|3|||
47023115|NCT01989572|83272313|FG005|Overall Study|Adverse Event|0|||
47023116|NCT01989572|83272308|FG000|Overall Study|Death|0|||
47023117|NCT01989572|83272309|FG001|Overall Study|Death|0|||
47023118|NCT01989572|83272310|FG002|Overall Study|Death|0|||
47023119|NCT01989572|83272311|FG003|Overall Study|Death|0|||
47023120|NCT01989572|83272312|FG004|Overall Study|Death|1|||
47023121|NCT01989572|83272313|FG005|Overall Study|Death|0|||
47023122|NCT01989572|83272308|FG000|Overall Study|Withdrawal by Subject|4|||
47023123|NCT01989572|83272309|FG001|Overall Study|Withdrawal by Subject|1|||
47023124|NCT01989572|83272310|FG002|Overall Study|Withdrawal by Subject|5|||
47023125|NCT01989572|83272311|FG003|Overall Study|Withdrawal by Subject|1|||
47023126|NCT01989572|83272312|FG004|Overall Study|Withdrawal by Subject|12|||
47023127|NCT01989572|83272313|FG005|Overall Study|Withdrawal by Subject|4|||
47023128|NCT01989572|83272308|FG000|Overall Study|complicating disease|1|||
47023129|NCT01989572|83272309|FG001|Overall Study|complicating disease|1|||
47023130|NCT01989572|83272310|FG002|Overall Study|complicating disease|2|||
47023131|NCT01989572|83272311|FG003|Overall Study|complicating disease|0|||
47023132|NCT01989572|83272312|FG004|Overall Study|complicating disease|1|||
47023133|NCT01989572|83272313|FG005|Overall Study|complicating disease|0|||
47023134|NCT01989572|83272308|FG000|Overall Study|error|2|||
47023135|NCT01989572|83272309|FG001|Overall Study|error|1|||
47023136|NCT01989572|83272310|FG002|Overall Study|error|1|||
47023137|NCT01989572|83272311|FG003|Overall Study|error|1|||
47023138|NCT01989572|83272312|FG004|Overall Study|error|1|||
47023139|NCT01989572|83272313|FG005|Overall Study|error|1|||
47023140|NCT01989572|83272308|FG000|Overall Study|maximum dose reached|0|||
47023141|NCT01989572|83272309|FG001|Overall Study|maximum dose reached|1|||
47023142|NCT01989572|83272310|FG002|Overall Study|maximum dose reached|0|||
47023143|NCT01989572|83272311|FG003|Overall Study|maximum dose reached|0|||
47023144|NCT01989572|83272312|FG004|Overall Study|maximum dose reached|1|||
47023145|NCT01989572|83272313|FG005|Overall Study|maximum dose reached|0|||
47023146|NCT01989572|83272308|FG000|Overall Study|unknown/not specify|3|||
47023147|NCT01989572|83272309|FG001|Overall Study|unknown/not specify|4|||
47023148|NCT01989572|83272310|FG002|Overall Study|unknown/not specify|1|||
47023149|NCT01989572|83272311|FG003|Overall Study|unknown/not specify|3|||
47023150|NCT01989572|83272312|FG004|Overall Study|unknown/not specify|3|||
47023151|NCT01989572|83272313|FG005|Overall Study|unknown/not specify|5|||
47023152|NCT01989572|83272308|FG000|Overall Study|not start protocol therapy|5|||
47023153|NCT01989572|83272309|FG001|Overall Study|not start protocol therapy|1|||
47023154|NCT01989572|83272310|FG002|Overall Study|not start protocol therapy|2|||
47023155|NCT01989572|83272311|FG003|Overall Study|not start protocol therapy|3|||
47023156|NCT01989572|83272312|FG004|Overall Study|not start protocol therapy|4|||
47023157|NCT01989572|83272313|FG005|Overall Study|not start protocol therapy|18|||
47023158|NCT01989572|83272308|FG000|Overall Study|alternative therapy|3|||
47023159|NCT01989572|83272309|FG001|Overall Study|alternative therapy|0|||
47023160|NCT01989572|83272310|FG002|Overall Study|alternative therapy|0|||
47023161|NCT01989572|83272311|FG003|Overall Study|alternative therapy|0|||
47023162|NCT01989572|83272312|FG004|Overall Study|alternative therapy|1|||
47023163|NCT01989572|83272313|FG005|Overall Study|alternative therapy|3|||
47023164|NCT02036294|83272333|FG000|Overall Study|Death|7|||
47023165|NCT02036294|83272334|FG001|Overall Study|Death|8|||
47023166|NCT02036294|83272333|FG000|Overall Study|Withdrawal by Subject|2|||
47023167|NCT02036294|83272334|FG001|Overall Study|Withdrawal by Subject|3|||
47023168|NCT02035748|83272340|FG000|Overall Study|Adverse Event|5|||
47023169|NCT02035748|83272340|FG000|Overall Study|Death|3|||
47023170|NCT02035748|83272340|FG000|Overall Study|Lost to Follow-up|2|||
47023171|NCT02035748|83272340|FG000|Overall Study|Physician Decision|3|||
47023172|NCT02035748|83272340|FG000|Overall Study|Withdrawal by Subject|6|||
47023173|NCT02035748|83272340|FG000|Overall Study|Progressive Disease|1|||
47023174|NCT02014376|83272348|FG000|Overall Study|Adverse Event|1|||
47023175|NCT02014376|83272349|FG001|Overall Study|Adverse Event|1|||
47023176|NCT02014376|83272350|FG002|Overall Study|Adverse Event|0|||
47023177|NCT02014376|83272348|FG000|Overall Study|Lost to Follow-up|2|||
47023178|NCT02014376|83272349|FG001|Overall Study|Lost to Follow-up|0|||
47023179|NCT02014376|83272350|FG002|Overall Study|Lost to Follow-up|0|||
47023180|NCT02035202|83272361|FG000|Overall Study|Lost to Follow-up|8|||
47023181|NCT02035202|83272362|FG001|Overall Study|Lost to Follow-up|16|||
47023182|NCT02035202|83272363|FG002|Overall Study|Lost to Follow-up|2|||
47023183|NCT01988402|83272373|FG000|Overall Study|Adverse Event|1|||
47023184|NCT01988402|83272374|FG001|Overall Study|Adverse Event|2|||
47023185|NCT01988402|83272373|FG000|Overall Study|Withdrawal by Subject|1|||
47023186|NCT01988402|83272374|FG001|Overall Study|Withdrawal by Subject|0|||
47023187|NCT01988090|83272382|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
47023188|NCT01988090|83272383|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
47023189|NCT01988090|83272382|FG000|Start Treament After Randomization|Protocol Violation|0|||
47023190|NCT01988090|83272383|FG001|Start Treament After Randomization|Protocol Violation|1|||
47023191|NCT01988090|83272382|FG000|Complete Study After Start|Withdrawal by Subject|2|||
47023192|NCT01988090|83272383|FG001|Complete Study After Start|Withdrawal by Subject|0|||
47023193|NCT01988090|83272382|FG000|Complete Study After Start|Protocol Violation|1|||
47023194|NCT01988090|83272383|FG001|Complete Study After Start|Protocol Violation|1|||
47023195|NCT01988012|83272389|FG000|Overall Study|Adverse Event|5|||
47023196|NCT01988012|83272389|FG000|Overall Study|Insufficient Therapeutic Response|3|||
47023197|NCT01988012|83272389|FG000|Overall Study|Patient Withdrawal of Consent|4|||
47023198|NCT01988012|83272389|FG000|Overall Study|Lost to Follow-up|1|||
47023199|NCT01988012|83272389|FG000|Overall Study|Physician Decision|1|||
47023200|NCT01988012|83272389|FG000|Overall Study|Protocol Violation|1|||
47023201|NCT02011945|83272396|FG000|Overall Study|Participant requested to Discontinue|0|||
47023202|NCT02011945|83272397|FG001|Overall Study|Participant requested to Discontinue|1|||
47023203|NCT02011945|83272398|FG002|Overall Study|Participant requested to Discontinue|1|||
46709864|NCT01121562|82925973|FG000|Overall Study|Met study discontinuation criteria|1|||
47023204|NCT02011945|83272396|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
47023205|NCT02011945|83272397|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
47023206|NCT02011945|83272398|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
47023207|NCT02011945|83272396|FG000|Overall Study|Study Drug Toxicity|0|||
47023208|NCT02011945|83272397|FG001|Overall Study|Study Drug Toxicity|0|||
47023209|NCT02011945|83272398|FG002|Overall Study|Study Drug Toxicity|1|||
47023210|NCT02011945|83272396|FG000|Overall Study|Treatment Failure|0|||
47023211|NCT02011945|83272397|FG001|Overall Study|Treatment Failure|7|||
47023212|NCT02011945|83272398|FG002|Overall Study|Treatment Failure|6|||
47023213|NCT02011945|83272396|FG000|Overall Study|No Longer Meets Study Criteria|1|||
47023214|NCT02011945|83272397|FG001|Overall Study|No Longer Meets Study Criteria|0|||
47023215|NCT02011945|83272398|FG002|Overall Study|No Longer Meets Study Criteria|0|||
47023216|NCT02011945|83272396|FG000|Overall Study|Proceeded to stem cell transplant|0|||
47023217|NCT02011945|83272397|FG001|Overall Study|Proceeded to stem cell transplant|0|||
47023218|NCT02011945|83272398|FG002|Overall Study|Proceeded to stem cell transplant|1|||
47023219|NCT02011945|83272396|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
47023220|NCT02011945|83272397|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
47023221|NCT02011945|83272398|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
47023222|NCT02013830|83272406|FG000|Overall Study|Adverse Event|3|||
47023223|NCT02013830|83272406|FG000|Overall Study|Death|1|||
47023224|NCT02013830|83272406|FG000|Overall Study|Insufficient therapeutic response|25|||
47023225|NCT02013830|83272406|FG000|Overall Study|Refused treatment|1|||
47023226|NCT02010775|83272415|FG000|Overall Study|Adverse Event|0|||
47023227|NCT02010775|83272416|FG001|Overall Study|Adverse Event|0|||
47023228|NCT02010775|83272417|FG002|Overall Study|Adverse Event|0|||
47023229|NCT02010775|83272418|FG003|Overall Study|Adverse Event|0|||
47023230|NCT02010775|83272419|FG004|Overall Study|Adverse Event|1|||
47023231|NCT02010775|83272415|FG000|Overall Study|Pregnancy|0|||
47023232|NCT02010775|83272416|FG001|Overall Study|Pregnancy|0|||
47023233|NCT02010775|83272417|FG002|Overall Study|Pregnancy|2|||
47023234|NCT02010775|83272418|FG003|Overall Study|Pregnancy|0|||
47023235|NCT02010775|83272419|FG004|Overall Study|Pregnancy|0|||
47023236|NCT02010775|83272415|FG000|Overall Study|Lost to Follow-up|2|||
47023237|NCT02010775|83272416|FG001|Overall Study|Lost to Follow-up|0|||
47023238|NCT02010775|83272417|FG002|Overall Study|Lost to Follow-up|0|||
47023239|NCT02010775|83272418|FG003|Overall Study|Lost to Follow-up|1|||
47023240|NCT02010775|83272419|FG004|Overall Study|Lost to Follow-up|1|||
47023241|NCT02010775|83272415|FG000|Overall Study|Personal Reasons|3|||
47023242|NCT02010775|83272416|FG001|Overall Study|Personal Reasons|3|||
47023243|NCT02010775|83272417|FG002|Overall Study|Personal Reasons|1|||
47023244|NCT02010775|83272418|FG003|Overall Study|Personal Reasons|2|||
47023245|NCT02010775|83272419|FG004|Overall Study|Personal Reasons|4|||
47023246|NCT01993615|83272433|FG000|Overall Study|Death|1|||
47023247|NCT01993615|83272434|FG001|Overall Study|Death|0|||
47023248|NCT01619059|83272442|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
47023249|NCT01619059|83272443|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
47023250|NCT01619059|83272442|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
47023251|NCT01619059|83272443|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
47023252|NCT01619059|83272442|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
47023253|NCT01619059|83272443|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
47023254|NCT01619059|83272442|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
47023255|NCT01619059|83272443|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
47023256|NCT01619059|83272442|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
47023257|NCT01619059|83272443|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
47023258|NCT01619059|83272442|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
47023259|NCT01619059|83272443|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
47023260|NCT01619059|83272442|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
47023261|NCT01619059|83272443|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
47023262|NCT01619059|83272442|FG000|Long-Term (LT) Treatment Period|Death|1|||
47023263|NCT01619059|83272443|FG001|Long-Term (LT) Treatment Period|Death|0|||
47023264|NCT01619059|83272442|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
47023265|NCT01619059|83272443|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
47023266|NCT01619059|83272442|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
47023267|NCT01619059|83272443|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
47023268|NCT02013206|83272451|FG000|Overall Study|Progressive disease (PD)|14|||
47023269|NCT02013206|83272452|FG001|Overall Study|Progressive disease (PD)|17|||
47023270|NCT02013206|83272451|FG000|Overall Study|Symptomatic deterioration|3|||
47023271|NCT02013206|83272452|FG001|Overall Study|Symptomatic deterioration|1|||
47023272|NCT02013206|83272451|FG000|Overall Study|Adverse Event|1|||
47023273|NCT02013206|83272452|FG001|Overall Study|Adverse Event|0|||
47023274|NCT02013206|83272451|FG000|Overall Study|Patient refusal|2|||
47023275|NCT02013206|83272452|FG001|Overall Study|Patient refusal|0|||
47023276|NCT02013206|83272451|FG000|Overall Study|Patient non-compliance|1|||
47023277|NCT02013206|83272452|FG001|Overall Study|Patient non-compliance|0|||
47023278|NCT02013206|83272451|FG000|Overall Study|Death|1|||
47023279|NCT02013206|83272452|FG001|Overall Study|Death|2|||
47023280|NCT02013206|83272451|FG000|Overall Study|Other reasons off treatment|5|||
47023281|NCT02013206|83272452|FG001|Overall Study|Other reasons off treatment|2|||
47023282|NCT01807923|83272461|FG000|Overall Study|Adverse Event|2|||
46620688|NCT01640808|82771273|FG001|Overall Study|Lost to Follow-up|0|||
47023283|NCT01807923|83272462|FG001|Overall Study|Adverse Event|1|||
47023284|NCT01807923|83272463|FG002|Overall Study|Adverse Event|2|||
47023285|NCT01807923|83272461|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
47023286|NCT01807923|83272462|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
47023287|NCT01807923|83272463|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
47023288|NCT01807923|83272461|FG000|Overall Study|Physician Decision|0|||
47023289|NCT01807923|83272462|FG001|Overall Study|Physician Decision|0|||
47023290|NCT01807923|83272463|FG002|Overall Study|Physician Decision|1|||
47023291|NCT01807923|83272461|FG000|Overall Study|Not Eligible (Genotype)|0|||
47023292|NCT01807923|83272462|FG001|Overall Study|Not Eligible (Genotype)|0|||
47023293|NCT01807923|83272463|FG002|Overall Study|Not Eligible (Genotype)|1|||
47023294|NCT01807923|83272461|FG000|Overall Study|Randomized But Not Treated|3|||
47023295|NCT01807923|83272462|FG001|Overall Study|Randomized But Not Treated|2|||
47023296|NCT01807923|83272463|FG002|Overall Study|Randomized But Not Treated|5|||
47023297|NCT01966003|83272475|FG000|Overall Study|Death|43|||
47023298|NCT01966003|83272476|FG001|Overall Study|Death|36|||
47023299|NCT01966003|83272475|FG000|Overall Study|Protocol Violation|6|||
47023300|NCT01966003|83272476|FG001|Overall Study|Protocol Violation|4|||
47023301|NCT01966003|83272475|FG000|Overall Study|Lost to Follow-up|4|||
47023302|NCT01966003|83272476|FG001|Overall Study|Lost to Follow-up|3|||
47023303|NCT01966003|83272475|FG000|Overall Study|Physician Decision|12|||
47023304|NCT01966003|83272476|FG001|Overall Study|Physician Decision|13|||
47023305|NCT01966003|83272475|FG000|Overall Study|Withdrawal by Subject|29|||
47023306|NCT01966003|83272476|FG001|Overall Study|Withdrawal by Subject|19|||
47023307|NCT01966003|83272475|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
47023308|NCT01966003|83272476|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
47023309|NCT01966003|83272475|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
47023310|NCT01966003|83272476|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
47023311|NCT01966003|83272475|FG000|Overall Study|Other|1|||
47023312|NCT01966003|83272476|FG001|Overall Study|Other|1|||
47023313|NCT01839279|83272485|FG000|Overall Study|Adverse Event|4|||
47023314|NCT01839279|83272486|FG001|Overall Study|Adverse Event|1|||
47023315|NCT01839279|83272487|FG002|Overall Study|Adverse Event|1|||
47023316|NCT01839279|83272485|FG000|Overall Study|Withdrawal by Subject|4|||
47023317|NCT01839279|83272486|FG001|Overall Study|Withdrawal by Subject|1|||
47023318|NCT01839279|83272487|FG002|Overall Study|Withdrawal by Subject|1|||
47023319|NCT01839279|83272485|FG000|Overall Study|Classified as 'Other'|5|||
47023320|NCT01839279|83272486|FG001|Overall Study|Classified as 'Other'|0|||
47023321|NCT01839279|83272487|FG002|Overall Study|Classified as 'Other'|0|||
47023322|NCT01807299|83272506|FG000|Overall Study|Protocol Violation|3|||
47023323|NCT01807299|83272507|FG001|Overall Study|Protocol Violation|1|||
47023324|NCT01807299|83272508|FG002|Overall Study|Protocol Violation|0|||
47023325|NCT01807299|83272509|FG003|Overall Study|Protocol Violation|2|||
47023326|NCT01965535|83272521|FG000|Overall Study|Lack of Efficacy|2|||
47023327|NCT01965535|83272522|FG001|Overall Study|Lack of Efficacy|1|||
47023328|NCT01964755|83272528|FG000|Overall Study|Death|2|||
47023329|NCT01964521|83272532|FG000|Overall Study|Lost to Follow-up|4|||
47023330|NCT01992757|83272537|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
47023331|NCT01991743|83272546|FG000|Overall Study|external cephalic version not performed|0|||
47023332|NCT01991743|83272547|FG001|Overall Study|external cephalic version not performed|0|||
47023333|NCT01991743|83272548|FG002|Overall Study|external cephalic version not performed|1|||
47023334|NCT01991743|83272549|FG003|Overall Study|external cephalic version not performed|0|||
47023335|NCT01991197|83272561|FG000|Overall Study|Lost to Follow-up|1|||
47023336|NCT01991197|83272562|FG001|Overall Study|Lost to Follow-up|1|||
47023337|NCT01991197|83272561|FG000|Overall Study|Physician Decision|0|||
47023338|NCT01991197|83272562|FG001|Overall Study|Physician Decision|2|||
46620689|NCT01640808|82771272|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
46620690|NCT01640808|82771273|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
46620691|NCT01640808|82771272|FG000|Overall Study|Administration of anticancer drugs|2|||
47023339|NCT01991197|83272561|FG000|Overall Study|Withdrawal by Subject|2|||
47023340|NCT01991197|83272562|FG001|Overall Study|Withdrawal by Subject|0|||
47023341|NCT01990573|83272576|FG000|Overall Study|Physician Decision|0|||
47023342|NCT01990573|83272577|FG001|Overall Study|Physician Decision|0|||
47023343|NCT01990573|83272578|FG002|Overall Study|Physician Decision|1|||
47023344|NCT01990495|83272588|FG000|Overall Study|Physician Decision|5|||
47023345|NCT01990495|83272589|FG001|Overall Study|Physician Decision|4|||
46620692|NCT01640808|82771273|FG001|Overall Study|Administration of anticancer drugs|1|||
46620693|NCT01640808|82771272|FG000|Overall Study|Physician Decision|19|||
46620694|NCT01640808|82771273|FG001|Overall Study|Physician Decision|5|||
46620695|NCT01640808|82771272|FG000|Overall Study|Randomized but not treated|4|||
47023346|NCT01990339|83272597|FG000|Overall Study|Data Not Available|49|||
47023347|NCT01990339|83272597|FG000|Overall Study|Voluntary Withdrawal|1402|||
47023348|NCT01990339|83272597|FG000|Overall Study|Lost to Follow-up|861|||
47023349|NCT02007577|83272603|FG000|Overall Study|Adverse Event|1|||
47023350|NCT02007577|83272604|FG001|Overall Study|Adverse Event|0|||
47023351|NCT02007577|83272603|FG000|Overall Study|Withdrawal by Subject|0|||
47023352|NCT02007577|83272604|FG001|Overall Study|Withdrawal by Subject|1|||
47023353|NCT01990261|83272610|FG000|Overall Study|Death Before Treatment Start|2|||
47023354|NCT01990261|83272610|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
47023355|NCT01990261|83272610|FG000|Overall Study|Death From other Causes|1|||
47023356|NCT01990261|83272610|FG000|Overall Study|Disease Progression (PD)|8|||
47023357|NCT01990261|83272610|FG000|Overall Study|PD Before Treatment Start|1|||
47023358|NCT01990261|83272610|FG000|Overall Study|Dossier not Approved|1|||
47023359|NCT01990261|83272610|FG000|Overall Study|Lost to Follow-up|2|||
47023360|NCT01963117|83272614|FG000|Overall Study|Death|1|||
47023361|NCT02007109|83272618|FG000|Overall Study|Diary not returned or excluded|102|||
47023362|NCT02007109|83272618|FG000|Overall Study|Excluded - Age<7yo|9|||
47023363|NCT02006719|83272627|FG000|Overall Study|Withdrawal by Subject|10|||
47023364|NCT02006719|83272628|FG001|Overall Study|Withdrawal by Subject|2|||
47023365|NCT02006719|83272627|FG000|Overall Study|Lost to Follow-up|5|||
47023366|NCT02006719|83272628|FG001|Overall Study|Lost to Follow-up|1|||
47023367|NCT02006719|83272627|FG000|Overall Study|Protocol Violation|2|||
47023368|NCT02006719|83272628|FG001|Overall Study|Protocol Violation|0|||
47023369|NCT02006719|83272627|FG000|Overall Study|Adverse Event|1|||
47023370|NCT02006719|83272628|FG001|Overall Study|Adverse Event|1|||
47023371|NCT02006719|83272627|FG000|Overall Study|Other/Unknown|0|||
47023372|NCT02006719|83272628|FG001|Overall Study|Other/Unknown|1|||
47023373|NCT01962493|83272636|FG000|Overall Study|Adverse Event|1|||
47023374|NCT01962493|83272637|FG001|Overall Study|Adverse Event|2|||
47023375|NCT01962493|83272636|FG000|Overall Study|Protocol Violation|0|||
47023376|NCT01962493|83272637|FG001|Overall Study|Protocol Violation|1|||
47023377|NCT01962493|83272636|FG000|Overall Study|Withdrawal by Subject|4|||
47023378|NCT01962493|83272637|FG001|Overall Study|Withdrawal by Subject|2|||
47023379|NCT01989169|83272645|FG000|Period 2|Adverse Event|0|||
47023380|NCT01989169|83272646|FG001|Period 2|Adverse Event|1|||
47023381|NCT01988779|83272654|FG000|Overall Study|Withdrawal by Subject|2|||
47023382|NCT01988779|83272655|FG001|Overall Study|Withdrawal by Subject|2|||
47023383|NCT01988779|83272654|FG000|Overall Study|Protocol Violation|1|||
47023384|NCT01988779|83272655|FG001|Overall Study|Protocol Violation|0|||
47023385|NCT01988233|83272663|FG000|Overall Study|Lost to Follow-up|64|||
47023386|NCT01988233|83272664|FG001|Overall Study|Lost to Follow-up|51|||
47023387|NCT01987765|83272670|FG000|Overall Study|Protocol Violation|65|||
47023388|NCT01987765|83272670|FG000|Overall Study|Lost to Follow-up|37|||
47023389|NCT01987609|83272674|FG000|Overall Study|Adverse Event|1|||
47023390|NCT02013674|83272690|FG000|Overall Study|Death|0|||
47023391|NCT02013674|83272691|FG001|Overall Study|Death|1|||
47023392|NCT02013674|83272690|FG000|Overall Study|Lost to Follow-up|1|||
47023393|NCT02013674|83272691|FG001|Overall Study|Lost to Follow-up|0|||
47023394|NCT01987232|83272702|FG000|Overall Study|Ongoing in Study|0|||
47023395|NCT01987232|83272703|FG001|Overall Study|Ongoing in Study|0|||
47023396|NCT01987232|83272704|FG002|Overall Study|Ongoing in Study|0|||
47023397|NCT01987232|83272705|FG003|Overall Study|Ongoing in Study|1|||
47023398|NCT01987232|83272706|FG004|Overall Study|Ongoing in Study|0|||
47023399|NCT01986920|83272720|FG000|A- 101 25%|Withdrawal by Subject|1|||
47023400|NCT01986920|83272721|FG001|A- 101 25%|Withdrawal by Subject|0|||
47023401|NCT01986920|83272722|FG002|A- 101 25%|Withdrawal by Subject|0|||
47023402|NCT01986920|83272723|FG003|A- 101 25%|Withdrawal by Subject|0|||
47023403|NCT01986920|83272720|FG000|A-101 32.5%|Withdrawal by Subject|0|||
47023404|NCT01986920|83272721|FG001|A-101 32.5%|Withdrawal by Subject|1|||
47023405|NCT01986920|83272722|FG002|A-101 32.5%|Withdrawal by Subject|0|||
47023406|NCT01986920|83272723|FG003|A-101 32.5%|Withdrawal by Subject|0|||
47023407|NCT01986920|83272720|FG000|A-101 40%|Withdrawal by Subject|0|||
47023408|NCT01986920|83272721|FG001|A-101 40%|Withdrawal by Subject|0|||
47023409|NCT01986920|83272722|FG002|A-101 40%|Withdrawal by Subject|1|||
47023410|NCT01986920|83272723|FG003|A-101 40%|Withdrawal by Subject|0|||
47023411|NCT01986920|83272720|FG000|Placebo|Withdrawal by Subject|0|||
47023412|NCT01986920|83272721|FG001|Placebo|Withdrawal by Subject|0|||
47023413|NCT01986920|83272722|FG002|Placebo|Withdrawal by Subject|0|||
47023414|NCT01986920|83272723|FG003|Placebo|Withdrawal by Subject|1|||
47023415|NCT02010632|83272733|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
47023416|NCT02010632|83272734|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
47023417|NCT01986140|83272742|FG000|Overall Study|Withdrawal by Subject|31|||
47023418|NCT01986140|83272743|FG001|Overall Study|Withdrawal by Subject|25|||
47023419|NCT01986140|83272742|FG000|Overall Study|alternative treatment|1|||
47023420|NCT01986140|83272743|FG001|Overall Study|alternative treatment|1|||
47023421|NCT01986140|83272742|FG000|Overall Study|found not eligible|3|||
47023422|NCT01986140|83272743|FG001|Overall Study|found not eligible|0|||
47023423|NCT01986140|83272742|FG000|Overall Study|Adverse Event|0|||
47023424|NCT01986140|83272743|FG001|Overall Study|Adverse Event|1|||
47023425|NCT01986140|83272742|FG000|Overall Study|progression disease|0|||
47023426|NCT01986140|83272743|FG001|Overall Study|progression disease|1|||
47023427|NCT01986062|83272751|FG000|Overall Study|Lost to Follow-up|1|||
47023428|NCT01986062|83272752|FG001|Overall Study|Lost to Follow-up|0|||
47023429|NCT01986062|83272751|FG000|Overall Study|Withdrawal by Subject|0|||
47023430|NCT01986062|83272752|FG001|Overall Study|Withdrawal by Subject|1|||
47023431|NCT01985360|83272760|FG000|Overall Study|Withdrawal by Subject|4|||
47023432|NCT01985360|83272761|FG001|Overall Study|Withdrawal by Subject|0|||
47023433|NCT01985360|83272760|FG000|Overall Study|Lost to Follow-up|5|||
47023434|NCT01985360|83272761|FG001|Overall Study|Lost to Follow-up|3|||
47023435|NCT02032706|83272767|FG000|Overall Study|Did not qualify|5|||
47023436|NCT02032706|83272767|FG000|Overall Study|Protocol Violation|1|||
47023437|NCT02032238|83272773|FG000|Overall Study|Lost to Follow-up|2|||
47023438|NCT02032238|83272774|FG001|Overall Study|Lost to Follow-up|0|||
47023439|NCT02009930|83272780|FG000|Overall Study|withdrawn|5|||
47023440|NCT01985126|83272793|FG000|Overall Study|Death|15|||
47023441|NCT01985126|83272794|FG001|Overall Study|Death|69|||
47023442|NCT01985126|83272793|FG000|Overall Study|Lost to Follow-up|0|||
47023443|NCT01985126|83272794|FG001|Overall Study|Lost to Follow-up|8|||
47023444|NCT01985126|83272793|FG000|Overall Study|Study Terminated By Sponsor|1|||
47023445|NCT01985126|83272794|FG001|Overall Study|Study Terminated By Sponsor|22|||
47023446|NCT01985126|83272793|FG000|Overall Study|Withdrawal by Subject|2|||
47023447|NCT01985126|83272794|FG001|Overall Study|Withdrawal by Subject|7|||
47023448|NCT01984892|83272800|FG000|Overall Study|Progressive disease|7|||
47023449|NCT01807221|83272810|FG000|Overall Study|Progressive disease|1|||
47023450|NCT01807221|83272811|FG001|Overall Study|Progressive disease|0|||
47023451|NCT01807221|83272812|FG002|Overall Study|Progressive disease|1|||
47023452|NCT01807221|83272813|FG003|Overall Study|Progressive disease|0|||
47023453|NCT01807221|83272814|FG004|Overall Study|Progressive disease|0|||
47023454|NCT01807221|83272815|FG005|Overall Study|Progressive disease|0|||
47023455|NCT01807221|83272810|FG000|Overall Study|Death|7|||
47023456|NCT01807221|83272811|FG001|Overall Study|Death|9|||
47023457|NCT01807221|83272812|FG002|Overall Study|Death|4|||
47023458|NCT01807221|83272813|FG003|Overall Study|Death|2|||
47023459|NCT01807221|83272814|FG004|Overall Study|Death|1|||
47023460|NCT01807221|83272815|FG005|Overall Study|Death|6|||
47023461|NCT01807221|83272810|FG000|Overall Study|Physician Decision|2|||
47023462|NCT01807221|83272811|FG001|Overall Study|Physician Decision|1|||
47023463|NCT01807221|83272812|FG002|Overall Study|Physician Decision|0|||
47023464|NCT01807221|83272813|FG003|Overall Study|Physician Decision|0|||
47023465|NCT01807221|83272814|FG004|Overall Study|Physician Decision|0|||
47023466|NCT01807221|83272815|FG005|Overall Study|Physician Decision|0|||
47023467|NCT01807221|83272810|FG000|Overall Study|Adverse Event|33|||
47023468|NCT01807221|83272811|FG001|Overall Study|Adverse Event|22|||
47023469|NCT01807221|83272812|FG002|Overall Study|Adverse Event|26|||
47023470|NCT01807221|83272813|FG003|Overall Study|Adverse Event|25|||
47023471|NCT01807221|83272814|FG004|Overall Study|Adverse Event|18|||
47023472|NCT01807221|83272815|FG005|Overall Study|Adverse Event|21|||
47023473|NCT01807221|83272810|FG000|Overall Study|Protocol Violation|0|||
47023474|NCT01807221|83272811|FG001|Overall Study|Protocol Violation|2|||
47023475|NCT01807221|83272812|FG002|Overall Study|Protocol Violation|1|||
47023476|NCT01807221|83272813|FG003|Overall Study|Protocol Violation|2|||
47023477|NCT01807221|83272814|FG004|Overall Study|Protocol Violation|0|||
47023478|NCT01807221|83272815|FG005|Overall Study|Protocol Violation|1|||
47023479|NCT01807221|83272810|FG000|Overall Study|Non-compliance|1|||
47023480|NCT01807221|83272811|FG001|Overall Study|Non-compliance|2|||
47023481|NCT01807221|83272812|FG002|Overall Study|Non-compliance|0|||
47023482|NCT01807221|83272813|FG003|Overall Study|Non-compliance|1|||
47023483|NCT01807221|83272814|FG004|Overall Study|Non-compliance|0|||
47023484|NCT01807221|83272815|FG005|Overall Study|Non-compliance|0|||
47023485|NCT01807221|83272810|FG000|Overall Study|Logistical difficulties|0|||
47023486|NCT01807221|83272811|FG001|Overall Study|Logistical difficulties|1|||
47023487|NCT01807221|83272812|FG002|Overall Study|Logistical difficulties|0|||
47023488|NCT01807221|83272813|FG003|Overall Study|Logistical difficulties|0|||
47023489|NCT01807221|83272814|FG004|Overall Study|Logistical difficulties|1|||
47023490|NCT01807221|83272815|FG005|Overall Study|Logistical difficulties|0|||
47023491|NCT01807221|83272810|FG000|Overall Study|Withdrawal by Subject|33|||
47023492|NCT01807221|83272811|FG001|Overall Study|Withdrawal by Subject|15|||
47023493|NCT01807221|83272812|FG002|Overall Study|Withdrawal by Subject|8|||
47023494|NCT01807221|83272813|FG003|Overall Study|Withdrawal by Subject|14|||
47023495|NCT01807221|83272814|FG004|Overall Study|Withdrawal by Subject|16|||
47023496|NCT01807221|83272815|FG005|Overall Study|Withdrawal by Subject|13|||
47023497|NCT01807221|83272810|FG000|Overall Study|Sponsor decision|2|||
47023498|NCT01807221|83272811|FG001|Overall Study|Sponsor decision|0|||
47023499|NCT01807221|83272812|FG002|Overall Study|Sponsor decision|1|||
47023500|NCT01807221|83272813|FG003|Overall Study|Sponsor decision|1|||
47023501|NCT01807221|83272814|FG004|Overall Study|Sponsor decision|0|||
47023502|NCT01807221|83272815|FG005|Overall Study|Sponsor decision|0|||
47023503|NCT01807221|83272810|FG000|Overall Study|Lost to Follow-up|1|||
47023504|NCT01807221|83272811|FG001|Overall Study|Lost to Follow-up|0|||
47023505|NCT01807221|83272812|FG002|Overall Study|Lost to Follow-up|2|||
47023506|NCT01807221|83272813|FG003|Overall Study|Lost to Follow-up|1|||
47023507|NCT01807221|83272814|FG004|Overall Study|Lost to Follow-up|0|||
47023508|NCT01807221|83272815|FG005|Overall Study|Lost to Follow-up|0|||
47023509|NCT01838499|83272831|FG000|Overall Study|Protocol Violation|0|||
47023510|NCT01838499|83272832|FG001|Overall Study|Protocol Violation|1|||
46911467|NCT03255941|83141248|FG001|Overall Study|Did not complete exit interview|2|||
46911468|NCT03255941|83141249|FG002|Overall Study|Did not complete exit interview|0|||
46911469|NCT03255941|83141250|FG003|Overall Study|Did not complete exit interview|0|||
46911470|NCT03255629|83141272|FG000|Overall Study|Adverse Event|1|||
46911471|NCT03255629|83141273|FG001|Overall Study|Adverse Event|0|||
46911472|NCT03255629|83141272|FG000|Overall Study|did not experience hypoglycemia|2|||
46911473|NCT03255629|83141273|FG001|Overall Study|did not experience hypoglycemia|1|||
46911474|NCT03031938|83141282|FG000|Overall Study|Death|1|||
46911475|NCT03031938|83141283|FG001|Overall Study|Death|0|||
46911476|NCT01137773|83141291|FG000|Overall Study|Death|3|||
46911477|NCT01137773|83141292|FG001|Overall Study|Death|3|||
46911478|NCT01137773|83141291|FG000|Overall Study|Lost to Follow-up|6|||
46911479|NCT01137773|83141292|FG001|Overall Study|Lost to Follow-up|0|||
46911480|NCT03094611|83141300|FG000|Overall Study|Lack of Efficacy|1|||
46911481|NCT03094611|83141300|FG000|Overall Study|Stem Cell Transplant|1|||
46911482|NCT04105725|83141324|FG000|Primary Intervention|Lost to Follow-up|0|||
46911483|NCT04105725|83141325|FG001|Primary Intervention|Lost to Follow-up|2|||
46911484|NCT04105725|83141324|FG000|Primary Intervention|Withdrawal by Subject|0|||
46911485|NCT04105725|83141325|FG001|Primary Intervention|Withdrawal by Subject|1|||
46911486|NCT04066023|83141334|FG000|Overall Study|Adverse Event|0|||
46911487|NCT04066023|83141335|FG001|Overall Study|Adverse Event|0|||
46911488|NCT04066023|83141336|FG002|Overall Study|Adverse Event|1|||
46911489|NCT04066023|83141334|FG000|Overall Study|Sponsor decision|3|||
46911490|NCT04066023|83141335|FG001|Overall Study|Sponsor decision|6|||
46911491|NCT04066023|83141336|FG002|Overall Study|Sponsor decision|2|||
46911492|NCT04066023|83141334|FG000|Overall Study|Physician Decision|0|||
46911493|NCT04066023|83141335|FG001|Overall Study|Physician Decision|0|||
46911494|NCT04066023|83141336|FG002|Overall Study|Physician Decision|1|||
46911495|NCT04066023|83141334|FG000|Overall Study|Lost to Follow-up|0|||
46911496|NCT04066023|83141335|FG001|Overall Study|Lost to Follow-up|1|||
46911497|NCT04066023|83141336|FG002|Overall Study|Lost to Follow-up|1|||
46911498|NCT04066023|83141334|FG000|Overall Study|Noncompliance|0|||
46911499|NCT04066023|83141335|FG001|Overall Study|Noncompliance|1|||
46911500|NCT04066023|83141336|FG002|Overall Study|Noncompliance|1|||
46911501|NCT03106987|83141348|FG000|Overall Study|Death|37|||
46911502|NCT03106987|83141349|FG001|Overall Study|Death|22|||
46911503|NCT03106987|83141350|FG002|Overall Study|Death|12|||
46911504|NCT03106987|83141351|FG003|Overall Study|Death|8|||
46911505|NCT03106987|83141348|FG000|Overall Study|Lost to Follow-up|2|||
46911506|NCT03106987|83141349|FG001|Overall Study|Lost to Follow-up|0|||
46911507|NCT03106987|83141350|FG002|Overall Study|Lost to Follow-up|2|||
46911508|NCT03106987|83141351|FG003|Overall Study|Lost to Follow-up|2|||
46911509|NCT03106987|83141348|FG000|Overall Study|Withdrawal by Subject|5|||
46911510|NCT03106987|83141349|FG001|Overall Study|Withdrawal by Subject|1|||
46911511|NCT03106987|83141350|FG002|Overall Study|Withdrawal by Subject|4|||
46911512|NCT03106987|83141351|FG003|Overall Study|Withdrawal by Subject|1|||
46911513|NCT02932267|83141361|FG000|Overall Study|Withdrawal by Subject|3|||
46911514|NCT02932267|83141361|FG000|Overall Study|Lost to Follow-up|4|||
46911515|NCT02932267|83141361|FG000|Overall Study|Pregnancy|1|||
46911516|NCT03217591|83141368|FG000|Overall Study|Adverse Event|1|||
46911517|NCT03217591|83141369|FG001|Overall Study|Adverse Event|2|||
46911518|NCT03217591|83141370|FG002|Overall Study|Adverse Event|6|||
46911519|NCT03217591|83141368|FG000|Overall Study|Withdrawal by Subject|0|||
46911520|NCT03217591|83141369|FG001|Overall Study|Withdrawal by Subject|1|||
46911521|NCT03217591|83141370|FG002|Overall Study|Withdrawal by Subject|3|||
46911522|NCT03217591|83141368|FG000|Overall Study|Lost to Follow-up|1|||
46911523|NCT03217591|83141369|FG001|Overall Study|Lost to Follow-up|0|||
46911524|NCT03217591|83141370|FG002|Overall Study|Lost to Follow-up|0|||
46911525|NCT03217591|83141368|FG000|Overall Study|Protocol Violation|1|||
46911526|NCT03217591|83141369|FG001|Overall Study|Protocol Violation|0|||
46911527|NCT03217591|83141370|FG002|Overall Study|Protocol Violation|1|||
46911528|NCT03031782|83141379|FG000|Treatment Period 1|Lack of Efficacy|3|||
46911529|NCT03031782|83141380|FG001|Treatment Period 1|Lack of Efficacy|0|||
46911530|NCT03031782|83141381|FG002|Treatment Period 1|Lack of Efficacy|0|||
46911531|NCT03031782|83141382|FG003|Treatment Period 1|Lack of Efficacy|0|||
46911532|NCT03031782|83141383|FG004|Treatment Period 1|Lack of Efficacy|0|||
46911533|NCT03031782|83141379|FG000|Treatment Period 2|Physician Decision|0|||
46911534|NCT03031782|83141380|FG001|Treatment Period 2|Physician Decision|1|||
46911535|NCT03031782|83141381|FG002|Treatment Period 2|Physician Decision|0|||
46911536|NCT03031782|83141382|FG003|Treatment Period 2|Physician Decision|0|||
46911537|NCT03031782|83141383|FG004|Treatment Period 2|Physician Decision|3|||
46911538|NCT03031782|83141379|FG000|Treatment Period 2|Lack of Efficacy|0|||
46911539|NCT03031782|83141380|FG001|Treatment Period 2|Lack of Efficacy|1|||
46911540|NCT03031782|83141381|FG002|Treatment Period 2|Lack of Efficacy|0|||
46911541|NCT03031782|83141382|FG003|Treatment Period 2|Lack of Efficacy|0|||
46911542|NCT03031782|83141383|FG004|Treatment Period 2|Lack of Efficacy|1|||
46911543|NCT03031782|83141379|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46911544|NCT03031782|83141380|FG001|Treatment Period 2|Withdrawal by Subject|3|||
47023511|NCT01838499|83272831|FG000|Overall Study|Lost to Follow-up|2|||
47023512|NCT01838499|83272832|FG001|Overall Study|Lost to Follow-up|4|||
47023513|NCT01838499|83272831|FG000|Overall Study|Lack of Efficacy|1|||
47023514|NCT01838499|83272832|FG001|Overall Study|Lack of Efficacy|2|||
47023515|NCT01838499|83272831|FG000|Overall Study|Adverse Event|2|||
47023516|NCT01838499|83272832|FG001|Overall Study|Adverse Event|1|||
47023517|NCT01838499|83272831|FG000|Overall Study|Withdrawal by Subject|19|||
47023518|NCT01838499|83272832|FG001|Overall Study|Withdrawal by Subject|9|||
47023519|NCT01807065|83272840|FG000|Overall Study|Receive no sip-T due to IV access|1|||
47023520|NCT01807065|83272841|FG001|Overall Study|Receive no sip-T due to IV access|1|||
47023521|NCT02031458|83272854|FG000|May 8, 2015 to January 11, 2019|Death|89|||
47023522|NCT02031458|83272855|FG001|May 8, 2015 to January 11, 2019|Death|193|||
47023523|NCT02031458|83272856|FG002|May 8, 2015 to January 11, 2019|Death|198|||
47023524|NCT02031458|83272854|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
47023525|NCT02031458|83272855|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
47023526|NCT02031458|83272856|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
47023527|NCT02031458|83272854|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
47023528|NCT02031458|83272855|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
47023529|NCT02031458|83272856|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
47023530|NCT02031458|83272854|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
47023531|NCT02031458|83272855|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
47023532|NCT02031458|83272856|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
47023533|NCT02031458|83272854|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
47023534|NCT02031458|83272855|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
47023535|NCT02031458|83272856|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
47023536|NCT02031458|83272854|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
47023537|NCT02031458|83272855|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
47023538|NCT02031458|83272856|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
47023539|NCT02031458|83272854|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
47023540|NCT02031458|83272855|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
47023541|NCT02031458|83272856|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
47023542|NCT02031458|83272854|FG000|Baseline to May 8, 2015|Death|36|||
47023543|NCT02031458|83272855|FG001|Baseline to May 8, 2015|Death|87|||
47023544|NCT02031458|83272856|FG002|Baseline to May 8, 2015|Death|100|||
47023545|NCT02031458|83272854|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
47023546|NCT02031458|83272855|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
47023547|NCT02031458|83272856|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
47023548|NCT02031458|83272854|FG000|Baseline to May 8, 2015|Physician Decision|0|||
47023549|NCT02031458|83272855|FG001|Baseline to May 8, 2015|Physician Decision|1|||
47023550|NCT02031458|83272856|FG002|Baseline to May 8, 2015|Physician Decision|0|||
47023551|NCT02031458|83272854|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
47023552|NCT02031458|83272855|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
47023553|NCT02031458|83272856|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
47023554|NCT02031458|83272854|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
47023555|NCT02031458|83272855|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
47023556|NCT02031458|83272856|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
47023557|NCT02031458|83272854|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
47023558|NCT02031458|83272855|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
47023559|NCT02031458|83272856|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
47023560|NCT02031458|83272854|FG000|Baseline to May 8, 2015|On Treatment|43|||
47023561|NCT02031458|83272855|FG001|Baseline to May 8, 2015|On Treatment|81|||
47023562|NCT02031458|83272856|FG002|Baseline to May 8, 2015|On Treatment|73|||
47023563|NCT02031458|83272854|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
47023564|NCT02031458|83272855|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
47023565|NCT02031458|83272856|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
47023566|NCT02009696|83272866|FG000|Overall Study|Withdrawal by Subject|2|||
47023567|NCT01806597|83272873|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
47023568|NCT01806597|83272874|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
47023569|NCT01806597|83272875|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
47023570|NCT01806597|83272876|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
46620696|NCT01640808|82771273|FG001|Overall Study|Randomized but not treated|2|||
46620697|NCT02263326|82771294|FG000|Overall Study|Lost to Follow-up|1|||
46620698|NCT02263326|82771295|FG001|Overall Study|Lost to Follow-up|1|||
47023571|NCT01806597|83272877|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
47023572|NCT01806597|83272878|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
47023573|NCT01806597|83272873|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
47023574|NCT01806597|83272874|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
47023575|NCT01806597|83272875|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
47023576|NCT01806597|83272876|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
47023577|NCT01806597|83272877|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
46620699|NCT02260986|82771401|FG000|Overall Study|Adverse Event|24|||
46620700|NCT02260986|82771402|FG001|Overall Study|Adverse Event|0|||
47023578|NCT01806597|83272878|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
47023579|NCT01806597|83272873|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
47023580|NCT01806597|83272874|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
47023581|NCT01806597|83272875|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
47023582|NCT01806597|83272876|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
47023583|NCT01806597|83272877|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
47023584|NCT01806597|83272878|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
47023585|NCT01806597|83272873|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
47023586|NCT01806597|83272874|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
47023587|NCT01806597|83272875|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
47023588|NCT01806597|83272876|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
47023589|NCT01806597|83272877|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
47023590|NCT01806597|83272878|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
47023591|NCT01806597|83272873|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
47023592|NCT01806597|83272874|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
47023593|NCT01806597|83272875|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
47023594|NCT01806597|83272876|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
47023595|NCT01806597|83272877|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
47023596|NCT01806597|83272878|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
47023597|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
47023598|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
47023599|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
47023600|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
47023601|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
47023602|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
47023603|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
47023604|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
47023605|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
47023606|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
47023607|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
47023608|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
47023609|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
47023610|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
47023611|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
47023612|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
47023613|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
47023614|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
47023615|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
47023616|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
47023617|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
47023618|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
47023619|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
47023620|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
47023621|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
47023622|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
47023623|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
47023624|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
47023625|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
47023626|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
47023627|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
47023628|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
47023629|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
47023630|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
47023631|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
47023632|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
47023633|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
47023634|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
47023635|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
47023636|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
47023637|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
47023638|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
47023639|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
47023640|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
47023641|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
47023642|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
47023643|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
47023644|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
47023645|NCT01806597|83272873|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
47023646|NCT01806597|83272874|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
47023647|NCT01806597|83272875|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
47023648|NCT01806597|83272876|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
47023649|NCT01806597|83272877|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
47023650|NCT01806597|83272878|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
47023651|NCT01806597|83272873|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
47023652|NCT01806597|83272874|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
47023653|NCT01806597|83272875|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
47023654|NCT01806597|83272876|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
47023655|NCT01806597|83272877|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
47023656|NCT01806597|83272878|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
47023657|NCT01806597|83272873|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
47023658|NCT01806597|83272874|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
47023659|NCT01806597|83272875|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
47023660|NCT01806597|83272876|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
47023661|NCT01806597|83272877|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
47023662|NCT01806597|83272878|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
47023663|NCT01806597|83272873|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
47023664|NCT01806597|83272874|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
47023665|NCT01806597|83272875|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
47023666|NCT01806597|83272876|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
47023667|NCT01806597|83272877|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
47023668|NCT01806597|83272878|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
47023669|NCT01806597|83272873|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
47023670|NCT01806597|83272874|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
47023671|NCT01806597|83272875|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
47023672|NCT01806597|83272876|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
47023673|NCT01806597|83272877|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
47023674|NCT01806597|83272878|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
47023675|NCT01806597|83272873|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
47023676|NCT01806597|83272874|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
47023677|NCT01806597|83272875|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
47023678|NCT01806597|83272876|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
47023679|NCT01806597|83272877|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
47023680|NCT01806597|83272878|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
47023681|NCT02031302|83272894|FG000|Overall Study|Death|115|||
47023682|NCT02031302|83272895|FG001|Overall Study|Death|0|||
47023683|NCT02031302|83272894|FG000|Overall Study|Not treated with study valve system|18|||
47023684|NCT02031302|83272895|FG001|Overall Study|Not treated with study valve system|0|||
47023685|NCT02031302|83272894|FG000|Overall Study|Missed Follow Up|27|||
47023686|NCT02031302|83272895|FG001|Overall Study|Missed Follow Up|0|||
47023687|NCT02031302|83272894|FG000|Overall Study|Lost to Follow-up|4|||
47023688|NCT02031302|83272895|FG001|Overall Study|Lost to Follow-up|0|||
47023689|NCT01610037|83272905|FG000|All Patients|Adverse Event|27|||
47023690|NCT01610037|83272906|FG001|All Patients|Adverse Event|22|||
47023691|NCT01610037|83272907|FG002|All Patients|Adverse Event|26|||
47023692|NCT01610037|83272905|FG000|All Patients|Withdrawal by Subject|12|||
47023693|NCT01610037|83272906|FG001|All Patients|Withdrawal by Subject|10|||
47023694|NCT01610037|83272907|FG002|All Patients|Withdrawal by Subject|20|||
47023695|NCT01610037|83272905|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
47023696|NCT01610037|83272906|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
47023697|NCT01610037|83272907|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
47023698|NCT01610037|83272905|FG000|All Patients|Death|4|||
47023699|NCT01610037|83272906|FG001|All Patients|Death|2|||
47023700|NCT01610037|83272907|FG002|All Patients|Death|1|||
47023701|NCT01610037|83272905|FG000|All Patients|Protocol deviation|4|||
47023702|NCT01610037|83272906|FG001|All Patients|Protocol deviation|3|||
47023703|NCT01610037|83272907|FG002|All Patients|Protocol deviation|3|||
47023704|NCT01610037|83272905|FG000|All Patients|Abnormal laboratory value|1|||
47023705|NCT01610037|83272906|FG001|All Patients|Abnormal laboratory value|1|||
47023706|NCT01610037|83272907|FG002|All Patients|Abnormal laboratory value|0|||
47023707|NCT01610037|83272905|FG000|All Patients|Administrative problems|1|||
47023708|NCT01610037|83272906|FG001|All Patients|Administrative problems|4|||
47023709|NCT01610037|83272907|FG002|All Patients|Administrative problems|4|||
47023710|NCT01610037|83272905|FG000|All Patients|Lost to Follow-up|1|||
47023711|NCT01610037|83272906|FG001|All Patients|Lost to Follow-up|0|||
47023712|NCT01610037|83272907|FG002|All Patients|Lost to Follow-up|0|||
47023713|NCT01610037|83272905|FG000|All Patients|Abnormal test procedure result(s)|0|||
47023714|NCT01610037|83272906|FG001|All Patients|Abnormal test procedure result(s)|1|||
47023715|NCT01610037|83272907|FG002|All Patients|Abnormal test procedure result(s)|3|||
47023716|NCT01610037|83272905|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
47023717|NCT01610037|83272906|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
47023718|NCT01610037|83272907|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
47023719|NCT01610037|83272905|FG000|Treatment and Follow up Period|Death|10|||
47023720|NCT01610037|83272906|FG001|Treatment and Follow up Period|Death|5|||
47023721|NCT01610037|83272907|FG002|Treatment and Follow up Period|Death|4|||
47023722|NCT01610037|83272905|FG000|Treatment and Follow up Period|Administrative problems|1|||
47023723|NCT01610037|83272906|FG001|Treatment and Follow up Period|Administrative problems|3|||
47023724|NCT01610037|83272907|FG002|Treatment and Follow up Period|Administrative problems|2|||
47023725|NCT01610037|83272905|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
47023726|NCT01610037|83272906|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
47023727|NCT01610037|83272907|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
47023728|NCT01806051|83272915|FG000|Overall Study|Withdrawal by Subject|6|||
47023729|NCT01837797|83272924|FG000|Period 1|Adverse Event|9|||
47023730|NCT01837797|83272925|FG001|Period 1|Adverse Event|0|||
47023731|NCT01837797|83272926|FG002|Period 1|Adverse Event|0|||
47023732|NCT01837797|83272927|FG003|Period 1|Adverse Event|0|||
47023733|NCT01837797|83272928|FG004|Period 1|Adverse Event|0|||
47023734|NCT01837797|83272924|FG000|Period 1|Withdrawal by Subject|6|||
47023735|NCT01837797|83272925|FG001|Period 1|Withdrawal by Subject|0|||
47023736|NCT01837797|83272926|FG002|Period 1|Withdrawal by Subject|0|||
47023737|NCT01837797|83272927|FG003|Period 1|Withdrawal by Subject|0|||
47023738|NCT01837797|83272928|FG004|Period 1|Withdrawal by Subject|0|||
47023739|NCT01837797|83272924|FG000|Period 1|Administrative reasons|76|||
47023740|NCT01837797|83272925|FG001|Period 1|Administrative reasons|0|||
47023741|NCT01837797|83272926|FG002|Period 1|Administrative reasons|0|||
47023742|NCT01837797|83272927|FG003|Period 1|Administrative reasons|0|||
47023743|NCT01837797|83272928|FG004|Period 1|Administrative reasons|0|||
47023744|NCT01837797|83272924|FG000|Period 1|Withdrawal of consent before treatment|1|||
47023745|NCT01837797|83272925|FG001|Period 1|Withdrawal of consent before treatment|0|||
47023746|NCT01837797|83272926|FG002|Period 1|Withdrawal of consent before treatment|0|||
47023747|NCT01837797|83272927|FG003|Period 1|Withdrawal of consent before treatment|0|||
47023748|NCT01837797|83272928|FG004|Period 1|Withdrawal of consent before treatment|0|||
47023749|NCT01837797|83272924|FG000|Period 1|Other|10|||
47023750|NCT01837797|83272925|FG001|Period 1|Other|0|||
47023751|NCT01837797|83272926|FG002|Period 1|Other|0|||
47023752|NCT01837797|83272927|FG003|Period 1|Other|0|||
47023753|NCT01837797|83272928|FG004|Period 1|Other|0|||
47023754|NCT01837797|83272924|FG000|Period 2|Administrative or other reasons|0|||
47023755|NCT01837797|83272925|FG001|Period 2|Administrative or other reasons|5|||
47023756|NCT01837797|83272926|FG002|Period 2|Administrative or other reasons|2|||
47023757|NCT01837797|83272927|FG003|Period 2|Administrative or other reasons|4|||
47023758|NCT01837797|83272928|FG004|Period 2|Administrative or other reasons|0|||
47023759|NCT01837797|83272924|FG000|Period 2|Adverse Event|0|||
47023760|NCT01837797|83272925|FG001|Period 2|Adverse Event|0|||
47023761|NCT01837797|83272926|FG002|Period 2|Adverse Event|0|||
47023762|NCT01837797|83272927|FG003|Period 2|Adverse Event|1|||
47023763|NCT01837797|83272928|FG004|Period 2|Adverse Event|0|||
47023764|NCT01837797|83272924|FG000|Period 3|Adverse Event|0|||
47023765|NCT01837797|83272925|FG001|Period 3|Adverse Event|0|||
47023766|NCT01837797|83272926|FG002|Period 3|Adverse Event|0|||
47023767|NCT01837797|83272927|FG003|Period 3|Adverse Event|0|||
47023768|NCT01837797|83272928|FG004|Period 3|Adverse Event|1|||
47023769|NCT01837797|83272924|FG000|Period 3|Administrative reasons|0|||
47023770|NCT01837797|83272925|FG001|Period 3|Administrative reasons|0|||
47023771|NCT01837797|83272926|FG002|Period 3|Administrative reasons|0|||
47023772|NCT01837797|83272927|FG003|Period 3|Administrative reasons|0|||
46620701|NCT02260986|82771403|FG002|Overall Study|Adverse Event|11|||
47023773|NCT01837797|83272928|FG004|Period 3|Administrative reasons|20|||
47023774|NCT01837797|83272924|FG000|Period 3|Other|0|||
47023775|NCT01837797|83272925|FG001|Period 3|Other|0|||
47023776|NCT01837797|83272926|FG002|Period 3|Other|0|||
47023777|NCT01837797|83272927|FG003|Period 3|Other|0|||
47023778|NCT01837797|83272928|FG004|Period 3|Other|2|||
47023779|NCT01984424|83272938|FG000|Overall Study|Withdrawal by Subject|3|||
47023780|NCT01984424|83272939|FG001|Overall Study|Withdrawal by Subject|5|||
47023781|NCT01984424|83272938|FG000|Overall Study|Sponsor Decision|0|||
47023782|NCT01984424|83272939|FG001|Overall Study|Sponsor Decision|1|||
47023783|NCT01984424|83272938|FG000|Overall Study|Lost to Follow-up|0|||
47023784|NCT01984424|83272939|FG001|Overall Study|Lost to Follow-up|1|||
47023785|NCT01837719|83272945|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
47023786|NCT01837719|83272945|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
47023787|NCT01984268|83272960|FG000|Overall Study|Study Terminated|15|||
47023788|NCT02031146|83272966|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
47023789|NCT02031146|83272967|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
47023790|NCT02031146|83272968|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
47023791|NCT02031146|83272969|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
47023792|NCT02031146|83272970|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
47023793|NCT02031146|83272971|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
47023794|NCT02031146|83272972|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
47023795|NCT02009384|83272982|FG000|Overall Study|Death|2|||
47023796|NCT01805037|83272986|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
47023797|NCT01805037|83272987|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
47023798|NCT01805037|83272986|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
47023799|NCT01805037|83272987|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
47023800|NCT01805037|83272986|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
47023801|NCT01805037|83272987|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
47023802|NCT01805037|83272986|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
47023803|NCT01805037|83272987|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
47023804|NCT01805037|83272986|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
46709865|NCT01121484|82925979|FG000|Overall Study|Adverse Event|12|||
47023805|NCT01805037|83272987|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
47023806|NCT01805037|83272986|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
46709866|NCT01121484|82925980|FG001|Overall Study|Adverse Event|5|||
46709867|NCT01121484|82925979|FG000|Overall Study|Lack of Efficacy|3|||
46709868|NCT01121484|82925980|FG001|Overall Study|Lack of Efficacy|11|||
46709869|NCT01121484|82925979|FG000|Overall Study|Lost to Follow-up|5|||
47023807|NCT01805037|83272987|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
47023808|NCT01805037|83272986|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
47023809|NCT01805037|83272987|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
47023810|NCT01805037|83272986|FG000|Follow Up (up to 3 Years)|Death|0|||
47023811|NCT01805037|83272987|FG001|Follow Up (up to 3 Years)|Death|2|||
47023812|NCT01805037|83272986|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
47023813|NCT01805037|83272987|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
47023814|NCT01805037|83272986|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
47023815|NCT01805037|83272987|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
47023816|NCT01803711|83272993|FG000|Overall Study|Adverse Event|1|||
47023817|NCT01803711|83272994|FG001|Overall Study|Adverse Event|1|||
47023818|NCT01836549|83273008|FG000|Overall Study|Did not receive study drug|0|||
47023819|NCT01836549|83273009|FG001|Overall Study|Did not receive study drug|0|||
47023820|NCT01836549|83273010|FG002|Overall Study|Did not receive study drug|1|||
47023821|NCT01836549|83273011|FG003|Overall Study|Did not receive study drug|0|||
47023822|NCT01836549|83273012|FG004|Overall Study|Did not receive study drug|0|||
47023823|NCT01836549|83273013|FG005|Overall Study|Did not receive study drug|0|||
47023824|NCT01836549|83273014|FG006|Overall Study|Did not receive study drug|0|||
47023825|NCT01836549|83273008|FG000|Overall Study|Patient declared ineligible|0|||
47023826|NCT01836549|83273009|FG001|Overall Study|Patient declared ineligible|0|||
47023827|NCT01836549|83273010|FG002|Overall Study|Patient declared ineligible|0|||
47023828|NCT01836549|83273011|FG003|Overall Study|Patient declared ineligible|1|||
47023829|NCT01836549|83273012|FG004|Overall Study|Patient declared ineligible|0|||
47023830|NCT01836549|83273013|FG005|Overall Study|Patient declared ineligible|0|||
47023831|NCT01836549|83273014|FG006|Overall Study|Patient declared ineligible|0|||
47023832|NCT01836549|83273008|FG000|Overall Study|Patient inevaluable to start therapy|0|||
47023833|NCT01836549|83273009|FG001|Overall Study|Patient inevaluable to start therapy|0|||
46709870|NCT01121484|82925980|FG001|Overall Study|Lost to Follow-up|9|||
46709871|NCT01121484|82925979|FG000|Overall Study|Physician Decision|0|||
46709872|NCT01121484|82925980|FG001|Overall Study|Physician Decision|3|||
47023834|NCT01836549|83273010|FG002|Overall Study|Patient inevaluable to start therapy|0|||
46911545|NCT03031782|83141381|FG002|Treatment Period 2|Withdrawal by Subject|0|||
47023835|NCT01836549|83273011|FG003|Overall Study|Patient inevaluable to start therapy|0|||
47023836|NCT01836549|83273012|FG004|Overall Study|Patient inevaluable to start therapy|0|||
47023837|NCT01836549|83273013|FG005|Overall Study|Patient inevaluable to start therapy|0|||
47023838|NCT01836549|83273014|FG006|Overall Study|Patient inevaluable to start therapy|1|||
47023839|NCT01836471|83273035|FG000|Overall Study|Pregnancy|1|||
47023840|NCT01836471|83273036|FG001|Overall Study|Pregnancy|0|||
47023841|NCT01836471|83273037|FG002|Overall Study|Pregnancy|0|||
47023842|NCT01836471|83273038|FG003|Overall Study|Pregnancy|0|||
47023843|NCT01836471|83273039|FG004|Overall Study|Pregnancy|0|||
47023844|NCT01836471|83273035|FG000|Overall Study|Withdrawal by Subject|3|||
47023845|NCT01836471|83273036|FG001|Overall Study|Withdrawal by Subject|4|||
47023846|NCT01836471|83273037|FG002|Overall Study|Withdrawal by Subject|1|||
47023847|NCT01836471|83273038|FG003|Overall Study|Withdrawal by Subject|0|||
47023848|NCT01836471|83273039|FG004|Overall Study|Withdrawal by Subject|2|||
47023849|NCT01836471|83273035|FG000|Overall Study|Physician Decision|0|||
47023850|NCT01836471|83273036|FG001|Overall Study|Physician Decision|1|||
47023851|NCT01836471|83273037|FG002|Overall Study|Physician Decision|0|||
47023852|NCT01836471|83273038|FG003|Overall Study|Physician Decision|0|||
47023853|NCT01836471|83273039|FG004|Overall Study|Physician Decision|0|||
47023854|NCT01836471|83273035|FG000|Overall Study|Lost to Follow-up|0|||
47023855|NCT01836471|83273036|FG001|Overall Study|Lost to Follow-up|0|||
47023856|NCT01836471|83273037|FG002|Overall Study|Lost to Follow-up|0|||
47023857|NCT01836471|83273038|FG003|Overall Study|Lost to Follow-up|1|||
47023858|NCT01836471|83273039|FG004|Overall Study|Lost to Follow-up|1|||
47023859|NCT01836471|83273035|FG000|Overall Study|Adverse Event|6|||
47023860|NCT01836471|83273036|FG001|Overall Study|Adverse Event|3|||
47023861|NCT01836471|83273037|FG002|Overall Study|Adverse Event|1|||
47023862|NCT01836471|83273038|FG003|Overall Study|Adverse Event|1|||
47023863|NCT01836471|83273039|FG004|Overall Study|Adverse Event|2|||
47023864|NCT01836471|83273035|FG000|Overall Study|Non compliance with tx|1|||
47023865|NCT01836471|83273036|FG001|Overall Study|Non compliance with tx|1|||
47023866|NCT01836471|83273037|FG002|Overall Study|Non compliance with tx|0|||
47023867|NCT01836471|83273038|FG003|Overall Study|Non compliance with tx|0|||
47023868|NCT01836471|83273039|FG004|Overall Study|Non compliance with tx|0|||
47023869|NCT02030600|83273054|FG000|Treatment Period 1|Adverse Event|5|||
47023870|NCT02030600|83273055|FG001|Treatment Period 1|Adverse Event|7|||
47023871|NCT02030600|83273054|FG000|Treatment Period 1|Lack of Efficacy|0|||
47023872|NCT02030600|83273055|FG001|Treatment Period 1|Lack of Efficacy|1|||
47023873|NCT02030600|83273054|FG000|Treatment Period 1|Lost to Follow-up|11|||
47023874|NCT02030600|83273055|FG001|Treatment Period 1|Lost to Follow-up|3|||
47023875|NCT02030600|83273054|FG000|Treatment Period 1|Protocol Violation|22|||
47023876|NCT02030600|83273055|FG001|Treatment Period 1|Protocol Violation|17|||
47023877|NCT02030600|83273054|FG000|Treatment Period 1|Withdrawal by Subject|13|||
47023878|NCT02030600|83273055|FG001|Treatment Period 1|Withdrawal by Subject|17|||
47023879|NCT02030600|83273054|FG000|Treatment Period 1|Casebook Unsigned|1|||
47023880|NCT02030600|83273055|FG001|Treatment Period 1|Casebook Unsigned|0|||
47023881|NCT02030600|83273054|FG000|Treatment Period 1|Unclassified|1|||
47023882|NCT02030600|83273055|FG001|Treatment Period 1|Unclassified|0|||
47023883|NCT02030600|83273054|FG000|Treatment Period 2|Adverse Event|4|||
46911546|NCT03031782|83141382|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46911547|NCT03031782|83141383|FG004|Treatment Period 2|Withdrawal by Subject|1|||
46911548|NCT03031782|83141379|FG000|Treatment Period 2|Adverse Event|0|||
46911549|NCT03031782|83141380|FG001|Treatment Period 2|Adverse Event|1|||
46911550|NCT03031782|83141381|FG002|Treatment Period 2|Adverse Event|2|||
46911551|NCT03031782|83141382|FG003|Treatment Period 2|Adverse Event|0|||
46911552|NCT03031782|83141383|FG004|Treatment Period 2|Adverse Event|0|||
46911553|NCT03031782|83141379|FG000|Treatment Period 3|Withdrawal by Subject|0|||
46911554|NCT03031782|83141380|FG001|Treatment Period 3|Withdrawal by Subject|0|||
46911555|NCT03031782|83141381|FG002|Treatment Period 3|Withdrawal by Subject|0|||
46911556|NCT03031782|83141382|FG003|Treatment Period 3|Withdrawal by Subject|1|||
46911557|NCT03031782|83141383|FG004|Treatment Period 3|Withdrawal by Subject|0|||
46911558|NCT03216265|83141400|FG000|Overall Study|Adverse Event|2|||
47023884|NCT02030600|83273055|FG001|Treatment Period 2|Adverse Event|4|||
47023885|NCT02030600|83273054|FG000|Treatment Period 2|Lack of Efficacy|2|||
46709873|NCT01121484|82925979|FG000|Overall Study|Protocol Violation|1|||
47023886|NCT02030600|83273055|FG001|Treatment Period 2|Lack of Efficacy|1|||
47023887|NCT02030600|83273054|FG000|Treatment Period 2|Lost to Follow-up|4|||
47023888|NCT02030600|83273055|FG001|Treatment Period 2|Lost to Follow-up|2|||
46911559|NCT03216265|83141401|FG001|Overall Study|Adverse Event|0|||
46911560|NCT03216265|83141402|FG002|Overall Study|Adverse Event|2|||
47023889|NCT02030600|83273054|FG000|Treatment Period 2|Protocol Violation|1|||
47023890|NCT02030600|83273055|FG001|Treatment Period 2|Protocol Violation|2|||
47023891|NCT02030600|83273054|FG000|Treatment Period 2|Withdrawal by Subject|13|||
47023892|NCT02030600|83273055|FG001|Treatment Period 2|Withdrawal by Subject|9|||
47023893|NCT02030600|83273054|FG000|Treatment Period 2|Unclassified|1|||
47023894|NCT02030600|83273055|FG001|Treatment Period 2|Unclassified|0|||
47023895|NCT01802775|83273065|FG000|Overall Study|Death|0|||
47023896|NCT01802775|83273066|FG001|Overall Study|Death|3|||
47023897|NCT01802775|83273065|FG000|Overall Study|Reason not provided|0|||
47023898|NCT01802775|83273066|FG001|Overall Study|Reason not provided|1|||
47023899|NCT01802775|83273065|FG000|Overall Study|Physician Decision|1|||
47023900|NCT01802775|83273066|FG001|Overall Study|Physician Decision|0|||
47023901|NCT01802775|83273065|FG000|Overall Study|Adverse Event|1|||
47023902|NCT01802775|83273066|FG001|Overall Study|Adverse Event|1|||
47023903|NCT01802775|83273065|FG000|Overall Study|Withdrawal by Subject|3|||
47023904|NCT01802775|83273066|FG001|Overall Study|Withdrawal by Subject|5|||
47023905|NCT01802775|83273065|FG000|Overall Study|Lost to Follow-up|1|||
47023906|NCT01802775|83273066|FG001|Overall Study|Lost to Follow-up|2|||
47023907|NCT01802385|83273074|FG000|Overall Study|Death|106|||
47023908|NCT01802385|83273075|FG001|Overall Study|Death|120|||
47023909|NCT01773993|83273081|FG000|Overall Study|No Visit After Treatment|35|||
47023910|NCT01802073|83273087|FG000|Overall Study|Lost to Follow-up|0|||
47023911|NCT01802073|83273088|FG001|Overall Study|Lost to Follow-up|1|||
47023912|NCT01802073|83273087|FG000|Overall Study|Non-compliant|4|||
47023913|NCT01802073|83273088|FG001|Overall Study|Non-compliant|2|||
47023914|NCT01802073|83273087|FG000|Overall Study|Withdrawal by Subject|1|||
47023915|NCT01802073|83273088|FG001|Overall Study|Withdrawal by Subject|1|||
47023916|NCT01802073|83273087|FG000|Overall Study|Physician Decision|0|||
47023917|NCT01802073|83273088|FG001|Overall Study|Physician Decision|7|||
47023918|NCT01607073|83273094|FG000|Overall Study|Adverse Event|1|||
47023919|NCT01773291|83273104|FG000|Overall Study|Protocol Violation|1|||
47023920|NCT01773291|83273105|FG001|Overall Study|Protocol Violation|0|||
47023921|NCT01773291|83273106|FG002|Overall Study|Protocol Violation|0|||
47023922|NCT01773291|83273104|FG000|Overall Study|Withdrawal by Subject|0|||
47023923|NCT01773291|83273105|FG001|Overall Study|Withdrawal by Subject|0|||
47023924|NCT01773291|83273106|FG002|Overall Study|Withdrawal by Subject|1|||
47023925|NCT01801917|83273119|FG000|Period 1 - Randomized|Adverse Event|1|||
47023926|NCT01801917|83273120|FG001|Period 1 - Randomized|Adverse Event|0|||
47023927|NCT01801917|83273121|FG002|Period 1 - Randomized|Adverse Event|1|||
47023928|NCT01801917|83273122|FG003|Period 1 - Randomized|Adverse Event|0|||
47023929|NCT02008916|83273136|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
47023930|NCT02008916|83273137|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
47023931|NCT02008916|83273138|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
47023932|NCT02008916|83273136|FG000|Week 16 - 156|Adverse Event|4|||
47023933|NCT02008916|83273137|FG001|Week 16 - 156|Adverse Event|2|||
47023934|NCT02008916|83273138|FG002|Week 16 - 156|Adverse Event|3|||
47023935|NCT02008916|83273136|FG000|Week 16 - 156|Withdrawal by Subject|7|||
47023936|NCT02008916|83273137|FG001|Week 16 - 156|Withdrawal by Subject|3|||
47023937|NCT02008916|83273138|FG002|Week 16 - 156|Withdrawal by Subject|5|||
47023938|NCT02008916|83273136|FG000|Week 16 - 156|No longer requires treatment|0|||
47023939|NCT02008916|83273137|FG001|Week 16 - 156|No longer requires treatment|1|||
47023940|NCT02008916|83273138|FG002|Week 16 - 156|No longer requires treatment|0|||
47023941|NCT02008916|83273136|FG000|Week 16 - 156|Lost to Follow-up|5|||
47023942|NCT02008916|83273137|FG001|Week 16 - 156|Lost to Follow-up|0|||
47023943|NCT02008916|83273138|FG002|Week 16 - 156|Lost to Follow-up|0|||
47023944|NCT02008916|83273136|FG000|Week 16 - 156|Lack of Efficacy|3|||
47023945|NCT02008916|83273137|FG001|Week 16 - 156|Lack of Efficacy|5|||
47023946|NCT02008916|83273138|FG002|Week 16 - 156|Lack of Efficacy|2|||
47023947|NCT02008916|83273136|FG000|Week 16 - 156|Pregnancy|0|||
47023948|NCT02008916|83273137|FG001|Week 16 - 156|Pregnancy|1|||
47023949|NCT02008916|83273138|FG002|Week 16 - 156|Pregnancy|0|||
46911561|NCT03216265|83141400|FG000|Overall Study|Lost to Follow-up|0|||
46911562|NCT03216265|83141401|FG001|Overall Study|Lost to Follow-up|1|||
46911563|NCT03216265|83141402|FG002|Overall Study|Lost to Follow-up|0|||
46911564|NCT03216265|83141400|FG000|Overall Study|Withdrawal by Subject|0|||
47023950|NCT02008916|83273136|FG000|Week 16 - 156|Physician Decision|0|||
46911565|NCT03216265|83141401|FG001|Overall Study|Withdrawal by Subject|0|||
47023951|NCT02008916|83273137|FG001|Week 16 - 156|Physician Decision|1|||
46911566|NCT03216265|83141402|FG002|Overall Study|Withdrawal by Subject|1|||
46911567|NCT04486950|83141433|FG000|Overall Study|Lost to Follow-up|0|||
46911568|NCT04486950|83141434|FG001|Overall Study|Lost to Follow-up|0|||
46911569|NCT04486950|83141435|FG002|Overall Study|Lost to Follow-up|0|||
47023952|NCT02008916|83273138|FG002|Week 16 - 156|Physician Decision|0|||
47023953|NCT01772823|83273149|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
47023954|NCT01772823|83273150|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
47023955|NCT01772823|83273149|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
47023956|NCT01772823|83273150|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
47023957|NCT01772823|83273149|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
47023958|NCT01772823|83273150|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
47023959|NCT01772823|83273149|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
47023960|NCT01772823|83273150|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
47023961|NCT01772823|83273149|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
47023962|NCT01772823|83273150|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
47023963|NCT01772823|83273149|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
47023964|NCT01772823|83273150|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
47023965|NCT01772823|83273149|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
47023966|NCT01772823|83273150|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
47023967|NCT01772823|83273149|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
47023968|NCT01772823|83273150|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
47023969|NCT01772823|83273149|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
47023970|NCT01772823|83273150|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
47023971|NCT01772823|83273149|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
47023972|NCT01772823|83273150|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
47023973|NCT01772823|83273149|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
47023974|NCT01772823|83273150|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
47023975|NCT01772823|83273149|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
47023976|NCT01772823|83273150|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
47023977|NCT01772823|83273149|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
47023978|NCT01772823|83273150|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
47023979|NCT01772823|83273149|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
47023980|NCT01772823|83273150|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
47023981|NCT01772823|83273149|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
47023982|NCT01772823|83273150|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
47023983|NCT01772823|83273149|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
47023984|NCT01772823|83273150|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
47023985|NCT02029976|83273163|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
47023986|NCT02029976|83273164|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
47023987|NCT02029976|83273163|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
47023988|NCT02029976|83273164|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
47023989|NCT02029976|83273163|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
47023990|NCT02029976|83273164|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
47023991|NCT02029976|83273163|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
47023992|NCT02029976|83273164|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
47023993|NCT01983254|83273172|FG000|Overall Study|Death|6|||
47023994|NCT01983254|83273173|FG001|Overall Study|Death|6|||
47023995|NCT01983254|83273172|FG000|Overall Study|Lost to Follow-up|17|||
47023996|NCT01983254|83273173|FG001|Overall Study|Lost to Follow-up|16|||
47023997|NCT01983254|83273172|FG000|Overall Study|too ill|11|||
47023998|NCT01983254|83273173|FG001|Overall Study|too ill|8|||
47023999|NCT01771809|83273181|FG000|Overall Study|Adverse Event|4|||
47024000|NCT01771809|83273182|FG001|Overall Study|Adverse Event|12|||
47024001|NCT01771809|83273181|FG000|Overall Study|Protocol Violation|0|||
47024002|NCT01771809|83273182|FG001|Overall Study|Protocol Violation|1|||
47024003|NCT01771809|83273181|FG000|Overall Study|Withdrawal by Subject|34|||
47024004|NCT01771809|83273182|FG001|Overall Study|Withdrawal by Subject|42|||
47024005|NCT01771809|83273181|FG000|Overall Study|Lost to Follow-up|1|||
46911570|NCT04486950|83141436|FG003|Overall Study|Lost to Follow-up|0|||
47024006|NCT01771809|83273182|FG001|Overall Study|Lost to Follow-up|3|||
47024007|NCT01771809|83273181|FG000|Overall Study|Other (Insufficient clinical response)|22|||
47024008|NCT01771809|83273182|FG001|Overall Study|Other (Insufficient clinical response)|20|||
46620702|NCT02260986|82771401|FG000|Overall Study|Lack of Efficacy|27|||
47024009|NCT01771809|83273181|FG000|Overall Study|Death|1|||
47024010|NCT01771809|83273182|FG001|Overall Study|Death|0|||
47024011|NCT01771809|83273181|FG000|Overall Study|Other (other)|9|||
47024012|NCT01771809|83273182|FG001|Overall Study|Other (other)|5|||
47024013|NCT01771731|83273190|FG000|Overall Study|Physician Decision|1|||
47024014|NCT01771731|83273191|FG001|Overall Study|Physician Decision|0|||
47024015|NCT01771731|83273190|FG000|Overall Study|Protocol Violation|0|||
47024016|NCT01771731|83273191|FG001|Overall Study|Protocol Violation|1|||
47024017|NCT01771731|83273190|FG000|Overall Study|Adverse event: Pain Crisis|1|||
47024018|NCT01771731|83273191|FG001|Overall Study|Adverse event: Pain Crisis|1|||
47024019|NCT01982942|83273199|FG000|Overall Study|Adverse Event|10|||
47024020|NCT01982942|83273200|FG001|Overall Study|Adverse Event|5|||
47024021|NCT01982942|83273199|FG000|Overall Study|Lost to Follow-up|4|||
47024022|NCT01982942|83273200|FG001|Overall Study|Lost to Follow-up|3|||
47024023|NCT01982942|83273199|FG000|Overall Study|Multiple sclerosis progression|3|||
47024024|NCT01982942|83273200|FG001|Overall Study|Multiple sclerosis progression|2|||
47024025|NCT01982942|83273199|FG000|Overall Study|Wanted to try therapy not permitted|1|||
47024026|NCT01982942|83273200|FG001|Overall Study|Wanted to try therapy not permitted|0|||
47024027|NCT01982942|83273199|FG000|Overall Study|Subject declined future visits|0|||
47024028|NCT01982942|83273200|FG001|Overall Study|Subject declined future visits|1|||
47024029|NCT01982942|83273199|FG000|Overall Study|Left geographical area|2|||
47024030|NCT01982942|83273200|FG001|Overall Study|Left geographical area|0|||
47024031|NCT01982942|83273199|FG000|Overall Study|Too many pills|1|||
47024032|NCT01982942|83273200|FG001|Overall Study|Too many pills|0|||
47024033|NCT01982942|83273199|FG000|Overall Study|MS Relapse|0|||
47024034|NCT01982942|83273200|FG001|Overall Study|MS Relapse|1|||
47024035|NCT01982942|83273199|FG000|Overall Study|Chose to join a stem cell trial|0|||
47024036|NCT01982942|83273200|FG001|Overall Study|Chose to join a stem cell trial|1|||
47024037|NCT01982942|83273199|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
47024038|NCT01982942|83273200|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
47024039|NCT01769469|83273206|FG000|Overall Study|Consent Withdrawn|5|||
47024040|NCT01769469|83273206|FG000|Overall Study|Moved Out Of Area|3|||
47024041|NCT01769469|83273206|FG000|Overall Study|Lost to Follow-up|17|||
47024042|NCT01769469|83273206|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
47024043|NCT01769469|83273206|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
47024044|NCT02008526|83273215|FG000|Overall Study|Death|0|||
47024045|NCT02008526|83273216|FG001|Overall Study|Death|2|||
47024046|NCT02008526|83273217|FG002|Overall Study|Death|1|||
47024047|NCT02008526|83273215|FG000|Overall Study|Withdrawal by Subject|3|||
47024048|NCT02008526|83273216|FG001|Overall Study|Withdrawal by Subject|3|||
47024049|NCT02008526|83273217|FG002|Overall Study|Withdrawal by Subject|2|||
47024050|NCT02008526|83273215|FG000|Overall Study|Lost to Follow-up|5|||
47024051|NCT02008526|83273216|FG001|Overall Study|Lost to Follow-up|9|||
47024052|NCT02008526|83273217|FG002|Overall Study|Lost to Follow-up|6|||
47024053|NCT01769391|83273227|FG000|Overall Study|Death|10|||
47024054|NCT01769391|83273228|FG001|Overall Study|Death|1|||
47024055|NCT01769391|83273227|FG000|Overall Study|Adverse Event|0|||
47024056|NCT01769391|83273228|FG001|Overall Study|Adverse Event|3|||
47024057|NCT01769391|83273227|FG000|Overall Study|Progressive Disease|1|||
47024058|NCT01769391|83273228|FG001|Overall Study|Progressive Disease|2|||
47024059|NCT01769391|83273227|FG000|Overall Study|Withdrawal by Subject|4|||
47024060|NCT01769391|83273228|FG001|Overall Study|Withdrawal by Subject|3|||
47024061|NCT01769391|83273227|FG000|Overall Study|Investigator Decision|2|||
47024062|NCT01769391|83273228|FG001|Overall Study|Investigator Decision|0|||
47024063|NCT01800903|83273240|FG000|Second Test Period|unable to catheterise|1|||
46709874|NCT01121484|82925980|FG001|Overall Study|Protocol Violation|0|||
46709875|NCT01121484|82925979|FG000|Overall Study|Withdrawal by Subject|8|||
47024064|NCT01800903|83273241|FG001|Second Test Period|unable to catheterise|0|||
47024065|NCT01800903|83273242|FG002|Second Test Period|unable to catheterise|0|||
47024066|NCT01800903|83273243|FG003|Second Test Period|unable to catheterise|0|||
47024067|NCT01800903|83273244|FG004|Second Test Period|unable to catheterise|0|||
47024068|NCT01800903|83273245|FG005|Second Test Period|unable to catheterise|0|||
47024069|NCT01767987|83273253|FG000|Overall Study|Physician Decision|4|||
47024070|NCT01767987|83273254|FG001|Overall Study|Physician Decision|1|||
47024071|NCT01800201|83273262|FG000|Overall Study|Withdrawal by Subject|2|||
47024072|NCT01800201|83273263|FG001|Overall Study|Withdrawal by Subject|0|||
47024073|NCT01800201|83273262|FG000|Overall Study|patient privacy concerns|1|||
47024074|NCT01800201|83273263|FG001|Overall Study|patient privacy concerns|1|||
47024075|NCT01800201|83273262|FG000|Overall Study|did not want to use device|0|||
47024076|NCT01800201|83273263|FG001|Overall Study|did not want to use device|1|||
47024077|NCT01800201|83273262|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
46620703|NCT02260986|82771402|FG001|Overall Study|Lack of Efficacy|3|||
46620704|NCT02260986|82771403|FG002|Overall Study|Lack of Efficacy|0|||
47024078|NCT01800201|83273263|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
47024079|NCT01767909|83273272|FG000|Overall Study|Withdrawal by Subject|4|||
47024080|NCT01767909|83273273|FG001|Overall Study|Withdrawal by Subject|7|||
47024081|NCT01767909|83273272|FG000|Overall Study|Adverse Event|3|||
47024082|NCT01767909|83273273|FG001|Overall Study|Adverse Event|1|||
47024083|NCT01767909|83273272|FG000|Overall Study|Withdrawal by Study Partner|3|||
47024084|NCT01767909|83273273|FG001|Overall Study|Withdrawal by Study Partner|1|||
47024085|NCT01767909|83273272|FG000|Overall Study|Non-Compliance|2|||
47024086|NCT01767909|83273273|FG001|Overall Study|Non-Compliance|0|||
47024087|NCT01767909|83273272|FG000|Overall Study|Perceived Lack of Efficacy|1|||
47024088|NCT01767909|83273273|FG001|Overall Study|Perceived Lack of Efficacy|0|||
47024089|NCT01767909|83273272|FG000|Overall Study|Investigator Recommendation|0|||
47024090|NCT01767909|83273273|FG001|Overall Study|Investigator Recommendation|1|||
47024091|NCT01767909|83273272|FG000|Overall Study|Lost to Follow-up|0|||
47024092|NCT01767909|83273273|FG001|Overall Study|Lost to Follow-up|1|||
47024093|NCT01767909|83273272|FG000|Overall Study|LP uncessessful|0|||
47024094|NCT01767909|83273273|FG001|Overall Study|LP uncessessful|1|||
47024095|NCT02029274|83273285|FG000|Overall Study|Adverse Event|1|||
47024096|NCT02029274|83273286|FG001|Overall Study|Adverse Event|0|||
47024097|NCT02029274|83273287|FG002|Overall Study|Adverse Event|2|||
47024098|NCT02029274|83273288|FG003|Overall Study|Adverse Event|2|||
47024099|NCT02008370|83273302|FG000|Overall Study|Lost to Follow-up|7|||
47024100|NCT01981616|83273308|FG000|Overall Study|Adverse Event|0|||
47024101|NCT01981616|83273309|FG001|Overall Study|Adverse Event|1|||
47024102|NCT01981616|83273308|FG000|Overall Study|Protocol Violation|1|||
47024103|NCT01981616|83273309|FG001|Overall Study|Protocol Violation|0|||
47024104|NCT02104817|83273317|FG000|Overall Study|Death|363|||
47024105|NCT02104817|83273318|FG001|Overall Study|Death|330|||
47024106|NCT02104817|83273317|FG000|Overall Study|Lost to Follow-up|3|||
47024107|NCT02104817|83273318|FG001|Overall Study|Lost to Follow-up|2|||
47024108|NCT02104817|83273317|FG000|Overall Study|Protocol Violation|0|||
47024109|NCT02104817|83273318|FG001|Overall Study|Protocol Violation|1|||
47024110|NCT02104817|83273317|FG000|Overall Study|Study terminated by sponsor|5854|||
47024111|NCT02104817|83273318|FG001|Overall Study|Study terminated by sponsor|5901|||
47024112|NCT02104817|83273317|FG000|Overall Study|Withdrawal by Subject|111|||
47024113|NCT02104817|83273318|FG001|Overall Study|Withdrawal by Subject|78|||
47024114|NCT02104817|83273317|FG000|Overall Study|Other reasons|128|||
47024115|NCT02104817|83273318|FG001|Overall Study|Other reasons|135|||
47024116|NCT01962103|83273333|FG000|Phase 1|Adverse Event|4|||
47024117|NCT01962103|83273334|FG001|Phase 1|Adverse Event|0|||
47024118|NCT01962103|83273335|FG002|Phase 1|Adverse Event|2|||
47024119|NCT01962103|83273336|FG003|Phase 1|Adverse Event|1|||
47024120|NCT01962103|83273337|FG004|Phase 1|Adverse Event|2|||
47024121|NCT01962103|83273338|FG005|Phase 1|Adverse Event|2|||
47024122|NCT01962103|83273339|FG006|Phase 1|Adverse Event|0|||
47024123|NCT01962103|83273340|FG007|Phase 1|Adverse Event|0|||
47024124|NCT01962103|83273341|FG008|Phase 1|Adverse Event|0|||
47024125|NCT01962103|83273333|FG000|Phase 1|Progressive Disease|8|||
47024126|NCT01962103|83273334|FG001|Phase 1|Progressive Disease|6|||
47024127|NCT01962103|83273335|FG002|Phase 1|Progressive Disease|8|||
47024128|NCT01962103|83273336|FG003|Phase 1|Progressive Disease|4|||
47024129|NCT01962103|83273337|FG004|Phase 1|Progressive Disease|5|||
47024130|NCT01962103|83273338|FG005|Phase 1|Progressive Disease|4|||
47024131|NCT01962103|83273339|FG006|Phase 1|Progressive Disease|0|||
47024132|NCT01962103|83273340|FG007|Phase 1|Progressive Disease|0|||
47024133|NCT01962103|83273341|FG008|Phase 1|Progressive Disease|0|||
47024134|NCT01962103|83273333|FG000|Phase 1|Withdrawal by Subject|0|||
47024135|NCT01962103|83273334|FG001|Phase 1|Withdrawal by Subject|0|||
47024136|NCT01962103|83273335|FG002|Phase 1|Withdrawal by Subject|0|||
47024137|NCT01962103|83273336|FG003|Phase 1|Withdrawal by Subject|2|||
47024138|NCT01962103|83273337|FG004|Phase 1|Withdrawal by Subject|0|||
47024139|NCT01962103|83273338|FG005|Phase 1|Withdrawal by Subject|0|||
47024140|NCT01962103|83273339|FG006|Phase 1|Withdrawal by Subject|0|||
47024141|NCT01962103|83273340|FG007|Phase 1|Withdrawal by Subject|0|||
47024142|NCT01962103|83273341|FG008|Phase 1|Withdrawal by Subject|0|||
47024143|NCT01962103|83273333|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
47024144|NCT01962103|83273334|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
47024145|NCT01962103|83273335|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
46620705|NCT02260986|82771401|FG000|Overall Study|Protocol Violation|14|||
46709876|NCT01121484|82925980|FG001|Overall Study|Withdrawal by Subject|7|||
47024146|NCT01962103|83273336|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
47024147|NCT01962103|83273337|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
47024148|NCT01962103|83273338|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
47024149|NCT01962103|83273339|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
47024150|NCT01962103|83273340|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
47024151|NCT01962103|83273341|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
47024152|NCT01962103|83273333|FG000|Phase 1|Physician Decision|0|||
47024153|NCT01962103|83273334|FG001|Phase 1|Physician Decision|0|||
47024154|NCT01962103|83273335|FG002|Phase 1|Physician Decision|0|||
47024155|NCT01962103|83273336|FG003|Phase 1|Physician Decision|1|||
47024156|NCT01962103|83273337|FG004|Phase 1|Physician Decision|0|||
47024157|NCT01962103|83273338|FG005|Phase 1|Physician Decision|0|||
47024158|NCT01962103|83273339|FG006|Phase 1|Physician Decision|0|||
47024159|NCT01962103|83273340|FG007|Phase 1|Physician Decision|0|||
47024160|NCT01962103|83273341|FG008|Phase 1|Physician Decision|0|||
47024161|NCT01962103|83273333|FG000|Phase 1|Symptomatic Deterioration|3|||
47024162|NCT01962103|83273334|FG001|Phase 1|Symptomatic Deterioration|2|||
47024163|NCT01962103|83273335|FG002|Phase 1|Symptomatic Deterioration|2|||
47024164|NCT01962103|83273336|FG003|Phase 1|Symptomatic Deterioration|2|||
46911571|NCT04486950|83141437|FG004|Overall Study|Lost to Follow-up|0|||
47024165|NCT01962103|83273337|FG004|Phase 1|Symptomatic Deterioration|1|||
47024166|NCT01962103|83273338|FG005|Phase 1|Symptomatic Deterioration|1|||
47024167|NCT01962103|83273339|FG006|Phase 1|Symptomatic Deterioration|0|||
47024168|NCT01962103|83273340|FG007|Phase 1|Symptomatic Deterioration|0|||
47024169|NCT01962103|83273341|FG008|Phase 1|Symptomatic Deterioration|0|||
47024170|NCT01962103|83273333|FG000|Phase 1|Miscellaneous|1|||
47024171|NCT01962103|83273334|FG001|Phase 1|Miscellaneous|0|||
46911572|NCT04486950|83141438|FG005|Overall Study|Lost to Follow-up|1|||
46911573|NCT04486950|83141439|FG006|Overall Study|Lost to Follow-up|0|||
46911574|NCT04693416|83141461|FG000|Overall Study|Lost to Follow-up|13|||
46911575|NCT04693416|83141462|FG001|Overall Study|Lost to Follow-up|0|||
46911576|NCT00265941|83141470|FG000|Overall Study|Protocol Violation|22|||
46911577|NCT00265941|83141471|FG001|Overall Study|Protocol Violation|25|||
46911578|NCT00265941|83141470|FG000|Overall Study|Lost to Follow-up|1|||
46911579|NCT00265941|83141471|FG001|Overall Study|Lost to Follow-up|1|||
46911580|NCT03882957|83141485|FG000|Overall Study|Did not complete all three arms|1|||
46911581|NCT03201211|83141497|FG000|Overall Study|Adverse Event|1|||
46911582|NCT03201211|83141498|FG001|Overall Study|Adverse Event|0|||
46911583|NCT03201211|83141499|FG002|Overall Study|Adverse Event|0|||
46911584|NCT03201211|83141497|FG000|Overall Study|Protocol Violation|1|||
46911585|NCT03201211|83141498|FG001|Overall Study|Protocol Violation|0|||
46911586|NCT03201211|83141499|FG002|Overall Study|Protocol Violation|0|||
46911587|NCT03201211|83141497|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46911588|NCT03201211|83141498|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46911589|NCT03201211|83141499|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
46911590|NCT03201211|83141497|FG000|Overall Study|OTHER unknown reasons|0|||
46911591|NCT03201211|83141498|FG001|Overall Study|OTHER unknown reasons|1|||
46911592|NCT03201211|83141499|FG002|Overall Study|OTHER unknown reasons|0|||
46911593|NCT04633837|83141509|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
46911594|NCT04633837|83141510|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
46911595|NCT03029832|83141518|FG000|Overall Study|Safety Follow-Up Completed|2|||
46911596|NCT03029832|83141519|FG001|Overall Study|Safety Follow-Up Completed|0|||
46911597|NCT03029832|83141518|FG000|Overall Study|Death due to Disease Progression|1|||
46911598|NCT03029832|83141519|FG001|Overall Study|Death due to Disease Progression|0|||
46911599|NCT03029832|83141518|FG000|Overall Study|Study Terminated By Sponsor|1|||
46911600|NCT03029832|83141519|FG001|Overall Study|Study Terminated By Sponsor|1|||
46911601|NCT03089697|83141527|FG000|Overall Study|Adverse Event|1|||
46911602|NCT03089697|83141528|FG001|Overall Study|Adverse Event|2|||
46911603|NCT03089697|83141527|FG000|Overall Study|Withdrawal by Subject|1|||
46911604|NCT03089697|83141528|FG001|Overall Study|Withdrawal by Subject|0|||
46911605|NCT03199963|83141536|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
46911606|NCT03199963|83141537|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
46911607|NCT03199963|83141536|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
46911608|NCT03199963|83141537|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
46911609|NCT03199963|83141536|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
46911610|NCT03199963|83141537|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
46911611|NCT03199963|83141536|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
46967501|NCT02124772|83210019|FG000|Overall Study|Investigator discretion|0|||
46967502|NCT02124772|83210020|FG001|Overall Study|Investigator discretion|2|||
46967503|NCT02124772|83210021|FG002|Overall Study|Investigator discretion|2|||
46967504|NCT02124772|83210022|FG003|Overall Study|Investigator discretion|1|||
46967505|NCT02124772|83210023|FG004|Overall Study|Investigator discretion|1|||
46967506|NCT02124772|83210024|FG005|Overall Study|Investigator discretion|0|||
46967507|NCT02124772|83210025|FG006|Overall Study|Investigator discretion|1|||
46967508|NCT02124772|83210026|FG007|Overall Study|Investigator discretion|0|||
46967509|NCT02124772|83210027|FG008|Overall Study|Investigator discretion|0|||
46967510|NCT02124772|83210028|FG009|Overall Study|Investigator discretion|1|||
46967511|NCT02124772|83210029|FG010|Overall Study|Investigator discretion|0|||
46967512|NCT02124772|83210030|FG011|Overall Study|Investigator discretion|1|||
46967513|NCT02124772|83210031|FG012|Overall Study|Investigator discretion|0|||
46967514|NCT02124772|83210019|FG000|Overall Study|Progressive disease|0|||
46967515|NCT02124772|83210020|FG001|Overall Study|Progressive disease|0|||
46967516|NCT02124772|83210021|FG002|Overall Study|Progressive disease|0|||
47024172|NCT01962103|83273335|FG002|Phase 1|Miscellaneous|0|||
47024173|NCT01962103|83273336|FG003|Phase 1|Miscellaneous|0|||
47024174|NCT01962103|83273337|FG004|Phase 1|Miscellaneous|0|||
47024175|NCT01962103|83273338|FG005|Phase 1|Miscellaneous|0|||
46967517|NCT02124772|83210022|FG003|Overall Study|Progressive disease|0|||
47024176|NCT01962103|83273339|FG006|Phase 1|Miscellaneous|0|||
47024177|NCT01962103|83273340|FG007|Phase 1|Miscellaneous|0|||
47024178|NCT01962103|83273341|FG008|Phase 1|Miscellaneous|0|||
47024179|NCT01962103|83273333|FG000|Phase 2|Adverse Event|0|||
47024180|NCT01962103|83273334|FG001|Phase 2|Adverse Event|0|||
47024181|NCT01962103|83273335|FG002|Phase 2|Adverse Event|0|||
47024182|NCT01962103|83273336|FG003|Phase 2|Adverse Event|0|||
47024183|NCT01962103|83273337|FG004|Phase 2|Adverse Event|0|||
47024184|NCT01962103|83273338|FG005|Phase 2|Adverse Event|0|||
47024185|NCT01962103|83273339|FG006|Phase 2|Adverse Event|1|||
47024186|NCT01962103|83273340|FG007|Phase 2|Adverse Event|0|||
47024187|NCT01962103|83273341|FG008|Phase 2|Adverse Event|3|||
47024188|NCT01962103|83273333|FG000|Phase 2|Progressive Disease|0|||
47024189|NCT01962103|83273334|FG001|Phase 2|Progressive Disease|0|||
47024190|NCT01962103|83273335|FG002|Phase 2|Progressive Disease|0|||
47024191|NCT01962103|83273336|FG003|Phase 2|Progressive Disease|0|||
47024192|NCT01962103|83273337|FG004|Phase 2|Progressive Disease|0|||
47024193|NCT01962103|83273338|FG005|Phase 2|Progressive Disease|0|||
47024194|NCT01962103|83273339|FG006|Phase 2|Progressive Disease|11|||
47024195|NCT01962103|83273340|FG007|Phase 2|Progressive Disease|12|||
47024196|NCT01962103|83273341|FG008|Phase 2|Progressive Disease|11|||
47024197|NCT01962103|83273333|FG000|Phase 2|Symptomatic Deterioration|0|||
47024198|NCT01962103|83273334|FG001|Phase 2|Symptomatic Deterioration|0|||
47024199|NCT01962103|83273335|FG002|Phase 2|Symptomatic Deterioration|0|||
47024200|NCT01962103|83273336|FG003|Phase 2|Symptomatic Deterioration|0|||
47024201|NCT01962103|83273337|FG004|Phase 2|Symptomatic Deterioration|0|||
47024202|NCT01962103|83273338|FG005|Phase 2|Symptomatic Deterioration|0|||
47024203|NCT01962103|83273339|FG006|Phase 2|Symptomatic Deterioration|2|||
47024204|NCT01962103|83273340|FG007|Phase 2|Symptomatic Deterioration|2|||
47024205|NCT01962103|83273341|FG008|Phase 2|Symptomatic Deterioration|0|||
47024206|NCT01961323|83273361|FG000|Overall Study|Withdrawal by Subject|7|||
47024207|NCT01961323|83273361|FG000|Overall Study|Lost to Follow-up|8|||
47024208|NCT01961323|83273361|FG000|Overall Study|screen failure|34|||
47024209|NCT01960855|83273370|FG000|Overall Study|Subject noncompliant|1|||
47024210|NCT01960855|83273371|FG001|Overall Study|Subject noncompliant|0|||
47024211|NCT01960855|83273372|FG002|Overall Study|Subject noncompliant|0|||
47024212|NCT01960855|83273373|FG003|Overall Study|Subject noncompliant|0|||
47024213|NCT01960855|83273374|FG004|Overall Study|Subject noncompliant|0|||
47024214|NCT01960855|83273370|FG000|Overall Study|Adverse Event|2|||
47024215|NCT01960855|83273371|FG001|Overall Study|Adverse Event|0|||
47024216|NCT01960855|83273372|FG002|Overall Study|Adverse Event|6|||
47024217|NCT01960855|83273373|FG003|Overall Study|Adverse Event|2|||
47024218|NCT01960855|83273374|FG004|Overall Study|Adverse Event|2|||
47024219|NCT01960855|83273370|FG000|Overall Study|Lack of Efficacy|1|||
47024220|NCT01960855|83273371|FG001|Overall Study|Lack of Efficacy|1|||
47024221|NCT01960855|83273372|FG002|Overall Study|Lack of Efficacy|0|||
47024222|NCT01960855|83273373|FG003|Overall Study|Lack of Efficacy|0|||
47024223|NCT01960855|83273374|FG004|Overall Study|Lack of Efficacy|0|||
47024224|NCT01960855|83273370|FG000|Overall Study|Other|2|||
47024225|NCT01960855|83273371|FG001|Overall Study|Other|1|||
47024226|NCT01960855|83273372|FG002|Overall Study|Other|1|||
47024227|NCT01960855|83273373|FG003|Overall Study|Other|1|||
47024228|NCT01960855|83273374|FG004|Overall Study|Other|0|||
47024229|NCT01960855|83273370|FG000|Overall Study|Consent withdrawn by subject|3|||
47024230|NCT01960855|83273371|FG001|Overall Study|Consent withdrawn by subject|1|||
47024231|NCT01960855|83273372|FG002|Overall Study|Consent withdrawn by subject|2|||
46967518|NCT02124772|83210023|FG004|Overall Study|Progressive disease|0|||
46967519|NCT02124772|83210024|FG005|Overall Study|Progressive disease|0|||
46967520|NCT02124772|83210025|FG006|Overall Study|Progressive disease|1|||
46967521|NCT02124772|83210026|FG007|Overall Study|Progressive disease|1|||
46967522|NCT02124772|83210027|FG008|Overall Study|Progressive disease|0|||
46967523|NCT02124772|83210028|FG009|Overall Study|Progressive disease|0|||
46967524|NCT02124772|83210029|FG010|Overall Study|Progressive disease|0|||
46967525|NCT02124772|83210030|FG011|Overall Study|Progressive disease|0|||
46967526|NCT02124772|83210031|FG012|Overall Study|Progressive disease|0|||
46967527|NCT02124772|83210019|FG000|Overall Study|Other|0|||
46967528|NCT02124772|83210020|FG001|Overall Study|Other|7|||
46967529|NCT02124772|83210021|FG002|Overall Study|Other|2|||
46967530|NCT02124772|83210022|FG003|Overall Study|Other|5|||
46967531|NCT02124772|83210023|FG004|Overall Study|Other|4|||
46967532|NCT02124772|83210024|FG005|Overall Study|Other|3|||
46967533|NCT02124772|83210025|FG006|Overall Study|Other|4|||
46967534|NCT02124772|83210026|FG007|Overall Study|Other|1|||
46967535|NCT02124772|83210027|FG008|Overall Study|Other|1|||
46967536|NCT02124772|83210028|FG009|Overall Study|Other|1|||
46967537|NCT02124772|83210029|FG010|Overall Study|Other|1|||
46911612|NCT03199963|83141537|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
46967538|NCT02124772|83210030|FG011|Overall Study|Other|1|||
47024232|NCT01960855|83273373|FG003|Overall Study|Consent withdrawn by subject|1|||
47024233|NCT01960855|83273374|FG004|Overall Study|Consent withdrawn by subject|1|||
47024234|NCT01960855|83273370|FG000|Overall Study|Lost to Follow-up|2|||
47024235|NCT01960855|83273371|FG001|Overall Study|Lost to Follow-up|1|||
47024236|NCT01960855|83273372|FG002|Overall Study|Lost to Follow-up|0|||
47024237|NCT01960855|83273373|FG003|Overall Study|Lost to Follow-up|0|||
47024238|NCT01960855|83273374|FG004|Overall Study|Lost to Follow-up|2|||
47024239|NCT02007434|83273394|FG000|Overall Study|Lost to Follow-up|0|||
47024240|NCT02007434|83273395|FG001|Overall Study|Lost to Follow-up|1|||
47024241|NCT02007434|83273396|FG002|Overall Study|Lost to Follow-up|0|||
47024242|NCT02007434|83273397|FG003|Overall Study|Lost to Follow-up|0|||
47024243|NCT02007434|83273398|FG004|Overall Study|Lost to Follow-up|0|||
47024244|NCT02007434|83273399|FG005|Overall Study|Lost to Follow-up|0|||
47024245|NCT02007434|83273400|FG006|Overall Study|Lost to Follow-up|0|||
47024246|NCT02007434|83273401|FG007|Overall Study|Lost to Follow-up|0|||
47024247|NCT02007434|83273394|FG000|Overall Study|Non-compliance|1|||
47024248|NCT02007434|83273395|FG001|Overall Study|Non-compliance|0|||
47024249|NCT02007434|83273396|FG002|Overall Study|Non-compliance|1|||
47024250|NCT02007434|83273397|FG003|Overall Study|Non-compliance|0|||
47024251|NCT02007434|83273398|FG004|Overall Study|Non-compliance|0|||
46620706|NCT02260986|82771402|FG001|Overall Study|Protocol Violation|5|||
46620707|NCT02260986|82771403|FG002|Overall Study|Protocol Violation|16|||
46709877|NCT01121484|82925979|FG000|Overall Study|Discontinuation of study by sponsor|0|||
46620708|NCT02260986|82771401|FG000|Overall Study|Car accident|0|||
46620709|NCT02260986|82771402|FG001|Overall Study|Car accident|0|||
47024252|NCT02007434|83273399|FG005|Overall Study|Non-compliance|0|||
47024253|NCT02007434|83273400|FG006|Overall Study|Non-compliance|0|||
47024254|NCT02007434|83273401|FG007|Overall Study|Non-compliance|0|||
47024255|NCT01987453|83273423|FG000|Overall Study|Death|0|||
47024256|NCT01987453|83273424|FG001|Overall Study|Death|0|||
47024257|NCT01987453|83273425|FG002|Overall Study|Death|1|||
47024258|NCT01987453|83273423|FG000|Overall Study|Lack of Efficacy|1|||
47024259|NCT01987453|83273424|FG001|Overall Study|Lack of Efficacy|12|||
47024260|NCT01987453|83273425|FG002|Overall Study|Lack of Efficacy|0|||
47024261|NCT02006641|83273440|FG000|Overall Study|Withdrawal before treatment|2|||
47024262|NCT02006641|83273441|FG001|Overall Study|Withdrawal before treatment|5|||
47024263|NCT02006641|83273442|FG002|Overall Study|Withdrawal before treatment|3|||
47024264|NCT02006641|83273440|FG000|Overall Study|Adverse Event|15|||
47024265|NCT02006641|83273441|FG001|Overall Study|Adverse Event|11|||
47024266|NCT02006641|83273442|FG002|Overall Study|Adverse Event|15|||
47024267|NCT02006641|83273440|FG000|Overall Study|Protocol Violation|0|||
47024268|NCT02006641|83273441|FG001|Overall Study|Protocol Violation|2|||
47024269|NCT02006641|83273442|FG002|Overall Study|Protocol Violation|2|||
47024270|NCT02006641|83273440|FG000|Overall Study|Lost to Follow-up|0|||
47024271|NCT02006641|83273441|FG001|Overall Study|Lost to Follow-up|1|||
47024272|NCT02006641|83273442|FG002|Overall Study|Lost to Follow-up|0|||
47024273|NCT02006641|83273440|FG000|Overall Study|Withdrawal by Subject|7|||
47024274|NCT02006641|83273441|FG001|Overall Study|Withdrawal by Subject|12|||
47024275|NCT02006641|83273442|FG002|Overall Study|Withdrawal by Subject|11|||
47024276|NCT02006641|83273440|FG000|Overall Study|Other reason: patient didn't show up|1|||
47024277|NCT02006641|83273441|FG001|Overall Study|Other reason: patient didn't show up|0|||
47024278|NCT02006641|83273442|FG002|Overall Study|Other reason: patient didn't show up|0|||
47024279|NCT02006641|83273440|FG000|Overall Study|Other reason:patient didn't want to come|0|||
47024280|NCT02006641|83273441|FG001|Overall Study|Other reason:patient didn't want to come|0|||
47024281|NCT02006641|83273442|FG002|Overall Study|Other reason:patient didn't want to come|1|||
47024282|NCT02006641|83273440|FG000|Overall Study|Other reason: patient has moved|1|||
47024283|NCT02006641|83273441|FG001|Overall Study|Other reason: patient has moved|0|||
47024284|NCT02006641|83273442|FG002|Overall Study|Other reason: patient has moved|1|||
47024285|NCT02006641|83273440|FG000|Overall Study|Other reason: caregiver in hospital|0|||
47024286|NCT02006641|83273441|FG001|Overall Study|Other reason: caregiver in hospital|1|||
47024287|NCT02006641|83273442|FG002|Overall Study|Other reason: caregiver in hospital|0|||
47024288|NCT02006641|83273440|FG000|Overall Study|Other reason: patient's wife has died|0|||
47024289|NCT02006641|83273441|FG001|Overall Study|Other reason: patient's wife has died|0|||
47024290|NCT02006641|83273442|FG002|Overall Study|Other reason: patient's wife has died|1|||
47024291|NCT02006641|83273440|FG000|Overall Study|Other reason: hospitalisation|0|||
47024292|NCT02006641|83273441|FG001|Overall Study|Other reason: hospitalisation|1|||
47024293|NCT02006641|83273442|FG002|Overall Study|Other reason: hospitalisation|0|||
47024294|NCT02006641|83273440|FG000|Overall Study|Other reason: caregiver impossibility|0|||
47024295|NCT02006641|83273441|FG001|Overall Study|Other reason: caregiver impossibility|0|||
47024296|NCT02006641|83273442|FG002|Overall Study|Other reason: caregiver impossibility|1|||
47024297|NCT02006641|83273440|FG000|Overall Study|Other reason: protocol non-compliance|0|||
47024298|NCT02006641|83273441|FG001|Overall Study|Other reason: protocol non-compliance|0|||
47024299|NCT02006641|83273442|FG002|Overall Study|Other reason: protocol non-compliance|1|||
47024300|NCT01959919|83273450|FG000|Overall Study|Did not meet the eligibility criteria|2|||
47024301|NCT01986985|83273458|FG000|Overall Study|Withdrawal by Subject|4|||
47024302|NCT01986985|83273458|FG000|Overall Study|Scan not completed due to malfunction|3|||
47024303|NCT01986907|83273462|FG000|Overall Study|Adverse Event|11|||
47024304|NCT01986907|83273462|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
47024305|NCT01986907|83273462|FG000|Overall Study|Protocol Violation|4|||
47024306|NCT01986907|83273462|FG000|Overall Study|Withdrawal by Subject|76|||
47024307|NCT01986907|83273462|FG000|Overall Study|Lost to Follow-up|38|||
47024308|NCT01986907|83273462|FG000|Overall Study|Death|9|||
47024309|NCT01959841|83273472|FG000|Overall Study|Adverse Event|1|||
47024310|NCT01959841|83273473|FG001|Overall Study|Adverse Event|3|||
47024311|NCT01959841|83273474|FG002|Overall Study|Adverse Event|2|||
47024312|NCT01959841|83273472|FG000|Overall Study|Lack of Efficacy|5|||
47024313|NCT01959841|83273473|FG001|Overall Study|Lack of Efficacy|0|||
47024314|NCT01959841|83273474|FG002|Overall Study|Lack of Efficacy|0|||
47024315|NCT01959841|83273472|FG000|Overall Study|Lost to Follow-up|1|||
47024316|NCT01959841|83273473|FG001|Overall Study|Lost to Follow-up|1|||
47024317|NCT01959841|83273474|FG002|Overall Study|Lost to Follow-up|0|||
47024318|NCT01959841|83273472|FG000|Overall Study|Physician Decision|0|||
47024319|NCT01959841|83273473|FG001|Overall Study|Physician Decision|2|||
47024320|NCT01959841|83273474|FG002|Overall Study|Physician Decision|3|||
47024321|NCT01959841|83273472|FG000|Overall Study|Protocol Violation|16|||
47024322|NCT01959841|83273473|FG001|Overall Study|Protocol Violation|23|||
47024323|NCT01959841|83273474|FG002|Overall Study|Protocol Violation|16|||
47024324|NCT01959841|83273472|FG000|Overall Study|Withdrawal by Subject|7|||
47024325|NCT01959841|83273473|FG001|Overall Study|Withdrawal by Subject|7|||
47024326|NCT01959841|83273474|FG002|Overall Study|Withdrawal by Subject|5|||
47024327|NCT01959841|83273472|FG000|Overall Study|Clinical laboratory value|2|||
47024328|NCT01959841|83273473|FG001|Overall Study|Clinical laboratory value|6|||
47024329|NCT01959841|83273474|FG002|Overall Study|Clinical laboratory value|6|||
47024330|NCT01959841|83273472|FG000|Overall Study|Platelet count below on day1 or 4|11|||
47024331|NCT01959841|83273473|FG001|Overall Study|Platelet count below on day1 or 4|15|||
47024332|NCT01959841|83273474|FG002|Overall Study|Platelet count below on day1 or 4|11|||
47024333|NCT02005627|83273484|FG000|Overall Study|Lost to Follow-up|1|||
47024334|NCT02005627|83273485|FG001|Overall Study|Lost to Follow-up|2|||
47024335|NCT02005627|83273484|FG000|Overall Study|Withdrawal by Subject|1|||
47024336|NCT02005627|83273485|FG001|Overall Study|Withdrawal by Subject|2|||
47024337|NCT02104583|83273497|FG000|Overall Study|New ICD or CRT-D implanted|2|||
47024338|NCT02104583|83273498|FG001|Overall Study|New ICD or CRT-D implanted|0|||
47024339|NCT02104583|83273499|FG002|Overall Study|New ICD or CRT-D implanted|1|||
47024340|NCT02104583|83273500|FG003|Overall Study|New ICD or CRT-D implanted|0|||
47024341|NCT02104583|83273501|FG004|Overall Study|New ICD or CRT-D implanted|0|||
47024342|NCT02104583|83273497|FG000|Overall Study|Death|2|||
47024343|NCT02104583|83273498|FG001|Overall Study|Death|1|||
47024344|NCT02104583|83273499|FG002|Overall Study|Death|3|||
47024345|NCT02104583|83273500|FG003|Overall Study|Death|3|||
47024346|NCT02104583|83273501|FG004|Overall Study|Death|5|||
47024347|NCT02104583|83273497|FG000|Overall Study|Subject required cardiac ablation|6|||
47024348|NCT02104583|83273498|FG001|Overall Study|Subject required cardiac ablation|4|||
47024349|NCT02104583|83273499|FG002|Overall Study|Subject required cardiac ablation|4|||
47024350|NCT02104583|83273500|FG003|Overall Study|Subject required cardiac ablation|5|||
46620710|NCT02260986|82771403|FG002|Overall Study|Car accident|1|||
46620711|NCT02260986|82771401|FG000|Overall Study|Withdrawal by Subject|17|||
46620712|NCT02260986|82771402|FG001|Overall Study|Withdrawal by Subject|4|||
46620713|NCT02260986|82771403|FG002|Overall Study|Withdrawal by Subject|9|||
46620714|NCT02260986|82771401|FG000|Overall Study|Incorrect randomization|0|||
46620715|NCT02260986|82771402|FG001|Overall Study|Incorrect randomization|1|||
46620716|NCT02260986|82771403|FG002|Overall Study|Incorrect randomization|0|||
46620717|NCT02260986|82771401|FG000|Overall Study|Lack of investigation product supply|2|||
46620718|NCT02260986|82771402|FG001|Overall Study|Lack of investigation product supply|0|||
46620719|NCT02260986|82771403|FG002|Overall Study|Lack of investigation product supply|1|||
46620720|NCT02260986|82771401|FG000|Overall Study|Lost to Follow-up|4|||
46620721|NCT02260986|82771402|FG001|Overall Study|Lost to Follow-up|0|||
46620722|NCT02260986|82771403|FG002|Overall Study|Lost to Follow-up|3|||
46620723|NCT02260986|82771401|FG000|Overall Study|Pregnancy|2|||
46620724|NCT02260986|82771402|FG001|Overall Study|Pregnancy|0|||
46620725|NCT02260986|82771403|FG002|Overall Study|Pregnancy|0|||
46620726|NCT02259582|82771419|FG000|Overall Study|Physician Decision|0|||
46620727|NCT02259582|82771420|FG001|Overall Study|Physician Decision|1|||
46620728|NCT02259582|82771421|FG002|Overall Study|Physician Decision|0|||
46620729|NCT02259582|82771419|FG000|Overall Study|Death|0|||
46620730|NCT02259582|82771420|FG001|Overall Study|Death|0|||
46620731|NCT02259582|82771421|FG002|Overall Study|Death|1|||
46620732|NCT02259582|82771419|FG000|Overall Study|Adverse Event|1|||
46620733|NCT02259582|82771420|FG001|Overall Study|Adverse Event|0|||
46620734|NCT02259582|82771421|FG002|Overall Study|Adverse Event|1|||
46620735|NCT02259582|82771419|FG000|Overall Study|Withdrawal by Subject|0|||
46620736|NCT02259582|82771420|FG001|Overall Study|Withdrawal by Subject|0|||
46620737|NCT02259582|82771421|FG002|Overall Study|Withdrawal by Subject|1|||
46620738|NCT02259582|82771419|FG000|Overall Study|Disease progression|14|||
46709878|NCT01121484|82925980|FG001|Overall Study|Discontinuation of study by sponsor|1|||
46709879|NCT01121484|82925979|FG000|Overall Study|Other|3|||
47024351|NCT02104583|83273501|FG004|Overall Study|Subject required cardiac ablation|4|||
47024352|NCT02104583|83273497|FG000|Overall Study|Subject required prohibited medication|0|||
47024353|NCT02104583|83273498|FG001|Overall Study|Subject required prohibited medication|1|||
47024354|NCT02104583|83273499|FG002|Overall Study|Subject required prohibited medication|1|||
47024355|NCT02104583|83273500|FG003|Overall Study|Subject required prohibited medication|0|||
47024356|NCT02104583|83273501|FG004|Overall Study|Subject required prohibited medication|1|||
47024357|NCT02104583|83273497|FG000|Overall Study|Withdrew Consent|3|||
47024358|NCT02104583|83273498|FG001|Overall Study|Withdrew Consent|2|||
47024359|NCT02104583|83273499|FG002|Overall Study|Withdrew Consent|0|||
47024360|NCT02104583|83273500|FG003|Overall Study|Withdrew Consent|2|||
47024361|NCT02104583|83273501|FG004|Overall Study|Withdrew Consent|1|||
47024362|NCT02104583|83273497|FG000|Overall Study|Investigator's Discretion|1|||
47024363|NCT02104583|83273498|FG001|Overall Study|Investigator's Discretion|0|||
47024364|NCT02104583|83273499|FG002|Overall Study|Investigator's Discretion|0|||
47024365|NCT02104583|83273500|FG003|Overall Study|Investigator's Discretion|0|||
47024366|NCT02104583|83273501|FG004|Overall Study|Investigator's Discretion|0|||
47024367|NCT02104583|83273497|FG000|Overall Study|Protocol Violation|0|||
47024368|NCT02104583|83273498|FG001|Overall Study|Protocol Violation|0|||
47024369|NCT02104583|83273499|FG002|Overall Study|Protocol Violation|1|||
47024370|NCT02104583|83273500|FG003|Overall Study|Protocol Violation|0|||
47024371|NCT02104583|83273501|FG004|Overall Study|Protocol Violation|0|||
47024372|NCT02104583|83273497|FG000|Overall Study|Adverse Event|3|||
47024373|NCT02104583|83273498|FG001|Overall Study|Adverse Event|3|||
47024374|NCT02104583|83273499|FG002|Overall Study|Adverse Event|6|||
47024375|NCT02104583|83273500|FG003|Overall Study|Adverse Event|6|||
47024376|NCT02104583|83273501|FG004|Overall Study|Adverse Event|1|||
47024377|NCT02104583|83273497|FG000|Overall Study|Lost to Follow-up|1|||
47024378|NCT02104583|83273498|FG001|Overall Study|Lost to Follow-up|0|||
47024379|NCT02104583|83273499|FG002|Overall Study|Lost to Follow-up|0|||
47024380|NCT02104583|83273500|FG003|Overall Study|Lost to Follow-up|0|||
47024381|NCT02104583|83273501|FG004|Overall Study|Lost to Follow-up|0|||
47024382|NCT02104583|83273497|FG000|Overall Study|Randomized but Never Treated|0|||
47024383|NCT02104583|83273498|FG001|Overall Study|Randomized but Never Treated|0|||
47024384|NCT02104583|83273499|FG002|Overall Study|Randomized but Never Treated|0|||
46620739|NCT02259582|82771420|FG001|Overall Study|Disease progression|15|||
46709880|NCT01121484|82925980|FG001|Overall Study|Other|3|||
46709881|NCT01121484|82925979|FG000|Overall Study|Randomized, not treated|1|||
46709882|NCT01121484|82925980|FG001|Overall Study|Randomized, not treated|4|||
46709883|NCT01169675|82925991|FG000|Overall Study|Progressive disease|13|||
46709884|NCT01169675|82925992|FG001|Overall Study|Progressive disease|2|||
46709885|NCT01169675|82925993|FG002|Overall Study|Progressive disease|5|||
46709886|NCT01169675|82925994|FG003|Overall Study|Progressive disease|15|||
47024385|NCT02104583|83273500|FG003|Overall Study|Randomized but Never Treated|1|||
47024386|NCT02104583|83273501|FG004|Overall Study|Randomized but Never Treated|0|||
47024387|NCT02073929|83273524|FG000|Overall Study|Lost to Follow-up|2|||
47024388|NCT02073929|83273525|FG001|Overall Study|Lost to Follow-up|1|||
47024389|NCT02073929|83273524|FG000|Overall Study|Adverse Event|2|||
47024390|NCT02073929|83273525|FG001|Overall Study|Adverse Event|1|||
47024391|NCT02073929|83273524|FG000|Overall Study|Withdrawal by Subject|0|||
47024392|NCT02073929|83273525|FG001|Overall Study|Withdrawal by Subject|1|||
47024393|NCT02113007|83273531|FG000|Overall Study|Progressive disease|2|||
47024394|NCT02104505|83273537|FG000|First Intervention (14 Days)|Adverse Event|2|||
47024395|NCT02104505|83273538|FG001|First Intervention (14 Days)|Adverse Event|0|||
46620740|NCT02259582|82771421|FG002|Overall Study|Disease progression|17|||
46709887|NCT01169675|82925995|FG004|Overall Study|Progressive disease|1|||
46709888|NCT01169675|82925991|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
46709889|NCT01169675|82925992|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46709890|NCT01169675|82925993|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46709891|NCT01169675|82925994|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46709892|NCT01169675|82925995|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
46620741|NCT02259582|82771419|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
46620742|NCT02259582|82771420|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
46620743|NCT02259582|82771421|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
46620744|NCT03238651|82771434|FG000|Overall Study|Other|0|||
46620745|NCT03238651|82771435|FG001|Overall Study|Other|0|||
46620746|NCT03238651|82771436|FG002|Overall Study|Other|0|||
46620747|NCT03238651|82771437|FG003|Overall Study|Other|0|||
46709893|NCT01169675|82925991|FG000|Overall Study|Adverse Event|5|||
46709894|NCT01169675|82925992|FG001|Overall Study|Adverse Event|1|||
47024396|NCT02104505|83273537|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
46620748|NCT03238651|82771438|FG004|Overall Study|Other|1|||
46709895|NCT01169675|82925993|FG002|Overall Study|Adverse Event|2|||
46709896|NCT01169675|82925994|FG003|Overall Study|Adverse Event|0|||
47024397|NCT02104505|83273538|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
46911613|NCT03199963|83141536|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
46967539|NCT02124772|83210031|FG012|Overall Study|Other|0|||
46967540|NCT02159482|83210083|FG000|Overall Study|Withdrawal by Subject|2|||
46620749|NCT03238651|82771434|FG000|Overall Study|Progressive Disease|2|||
46620750|NCT03238651|82771435|FG001|Overall Study|Progressive Disease|2|||
46620751|NCT03238651|82771436|FG002|Overall Study|Progressive Disease|2|||
46620752|NCT03238651|82771437|FG003|Overall Study|Progressive Disease|2|||
46620753|NCT03238651|82771438|FG004|Overall Study|Progressive Disease|0|||
46620754|NCT03238651|82771434|FG000|Overall Study|Withdrawal by Subject|0|||
46620755|NCT03238651|82771435|FG001|Overall Study|Withdrawal by Subject|1|||
46620756|NCT03238651|82771436|FG002|Overall Study|Withdrawal by Subject|0|||
46967541|NCT02159482|83210083|FG000|Overall Study|Physician Decision|3|||
46967542|NCT02622321|83210091|FG000|Overall Study|Withdrawal by Subject|2|||
46967543|NCT02622321|83210092|FG001|Overall Study|Withdrawal by Subject|0|||
46967544|NCT02622321|83210093|FG002|Overall Study|Withdrawal by Subject|0|||
46967545|NCT02622321|83210094|FG003|Overall Study|Withdrawal by Subject|0|||
46967546|NCT02622321|83210091|FG000|Overall Study|Death|0|||
46967547|NCT02622321|83210092|FG001|Overall Study|Death|0|||
46967548|NCT02622321|83210093|FG002|Overall Study|Death|1|||
46967549|NCT02622321|83210094|FG003|Overall Study|Death|0|||
46967550|NCT02622321|83210091|FG000|Overall Study|Physician Decision|1|||
46967551|NCT02622321|83210092|FG001|Overall Study|Physician Decision|0|||
46967552|NCT02622321|83210093|FG002|Overall Study|Physician Decision|0|||
46967553|NCT02622321|83210094|FG003|Overall Study|Physician Decision|0|||
47024398|NCT02104505|83273537|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
47024399|NCT02104505|83273538|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
47024400|NCT02104505|83273537|FG000|First Intervention (14 Days)|exclusionary condition|0|||
47024401|NCT02104505|83273538|FG001|First Intervention (14 Days)|exclusionary condition|1|||
47024402|NCT02104505|83273537|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
47024403|NCT02104505|83273538|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
47024404|NCT02104505|83273537|FG000|Second Intervention (14 Days)|Adverse Event|2|||
47024405|NCT02104505|83273538|FG001|Second Intervention (14 Days)|Adverse Event|0|||
47024406|NCT02111993|83273547|FG000|Overall Study|Physician Decision|5|||
47024407|NCT02111993|83273548|FG001|Overall Study|Physician Decision|4|||
47024408|NCT01959607|83273558|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
47024409|NCT01959607|83273559|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
47024410|NCT01959607|83273560|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
47024411|NCT01959607|83273561|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
47024412|NCT02111603|83273570|FG000|Overall Study|Withdrawal by Subject|1|||
47024413|NCT02102399|83273576|FG000|Overall Study|Withdrawal by Subject|6|||
47024414|NCT02102399|83273577|FG001|Overall Study|Withdrawal by Subject|4|||
47024415|NCT02111369|83273588|FG000|Overall Study|Lost to Follow-up|2|||
47024416|NCT02111369|83273588|FG000|Overall Study|Withdrawal by Subject|1|||
47024417|NCT02111213|83273594|FG000|Overall Study|Withdrawal by Subject|3|||
47024418|NCT02111213|83273595|FG001|Overall Study|Withdrawal by Subject|2|||
47024419|NCT02111213|83273594|FG000|Overall Study|Lost to Follow-up|3|||
47024420|NCT02111213|83273595|FG001|Overall Study|Lost to Follow-up|4|||
47024421|NCT02110901|83273603|FG000|Overall Study|Death|6|||
47024422|NCT02110901|83273604|FG001|Overall Study|Death|3|||
47024423|NCT02110901|83273603|FG000|Overall Study|Lost to Follow-up|12|||
47024424|NCT02110901|83273604|FG001|Overall Study|Lost to Follow-up|8|||
47024425|NCT02110901|83273603|FG000|Overall Study|Withdrawal by Subject|7|||
47024426|NCT02110901|83273604|FG001|Overall Study|Withdrawal by Subject|3|||
47024427|NCT02110901|83273603|FG000|Overall Study|received a kidney transplant|5|||
47024428|NCT02110901|83273604|FG001|Overall Study|received a kidney transplant|0|||
47024429|NCT02109107|83273611|FG000|Overall Study|Lost to Follow-up|2|||
47024430|NCT02100839|83273617|FG000|Multiple Ascending Dose|Adverse Event|2|||
47024431|NCT02100839|83273618|FG001|Multiple Ascending Dose|Adverse Event|0|||
47024432|NCT02100839|83273617|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
47024433|NCT02100839|83273618|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
47024434|NCT02069093|83273624|FG000|Overall Study|Disease progression|14|||
46911614|NCT03199963|83141537|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
47024435|NCT02069093|83273624|FG000|Overall Study|New cancer therapy|1|||
47024436|NCT02069093|83273624|FG000|Overall Study|Death|1|||
47024437|NCT02069093|83273624|FG000|Overall Study|Administrative problems|1|||
47024438|NCT02069093|83273624|FG000|Overall Study|Withdrawal by Subject|2|||
47024439|NCT02069093|83273624|FG000|Overall Study|Abnormal laboratory values|1|||
47024440|NCT02069093|83273624|FG000|Overall Study|Adverse Event|10|||
47024441|NCT02109029|83273631|FG000|Part B|Adverse Event|0|||
47024442|NCT02109029|83273632|FG001|Part B|Adverse Event|0|||
47024443|NCT02109029|83273633|FG002|Part B|Adverse Event|0|||
47024444|NCT02109029|83273634|FG003|Part B|Adverse Event|0|||
47024445|NCT02109029|83273635|FG004|Part B|Adverse Event|1|||
47024446|NCT02109029|83273636|FG005|Part B|Adverse Event|1|||
47024447|NCT02069015|83273649|FG000|Overall Study|Lost to Follow-up|39|||
47024448|NCT02069015|83273650|FG001|Overall Study|Lost to Follow-up|32|||
47024449|NCT02069015|83273649|FG000|Overall Study|Withdrawal by Subject|1|||
47024450|NCT02069015|83273650|FG001|Overall Study|Withdrawal by Subject|1|||
47024451|NCT01598129|83273657|FG000|Overall Study|Disease progression|6|||
47024452|NCT01598129|83273657|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
46709897|NCT01169675|82925995|FG004|Overall Study|Adverse Event|0|||
47024453|NCT01598129|83273657|FG000|Overall Study|Withdrawal by Subject|1|||
47024454|NCT02068547|83273664|FG000|Overall Study|Lost to Follow-up|3|||
47024455|NCT02068547|83273665|FG001|Overall Study|Lost to Follow-up|3|||
47024456|NCT02068547|83273664|FG000|Overall Study|Physician Decision|1|||
47024457|NCT02068547|83273665|FG001|Overall Study|Physician Decision|0|||
47024458|NCT02108951|83273671|FG000|Overall Study|Lost to Follow-up|1|||
47024459|NCT02108951|83273671|FG000|Overall Study|Patient's/guardian's decision|1|||
47024460|NCT02108951|83273671|FG000|Overall Study|Study Terminated by Sponsor|14|||
47024461|NCT02107859|83273675|FG000|Overall Study|Withdrawal by Subject|14|||
47024462|NCT02107859|83273675|FG000|Overall Study|Adverse Event|3|||
47024463|NCT02107859|83273675|FG000|Overall Study|Study closure|41|||
47024464|NCT02107859|83273675|FG000|Overall Study|Other than specified|3|||
47024465|NCT02007278|83273681|FG000|Overall Study|Failure to comply with an eligibility|0|||
46967554|NCT02187172|83210120|FG000|Overall Study|Lost to Follow-up|1|||
46967555|NCT02187172|83210121|FG001|Overall Study|Lost to Follow-up|2|||
46967556|NCT02187172|83210120|FG000|Overall Study|Lack of Efficacy|1|||
46967557|NCT02187172|83210121|FG001|Overall Study|Lack of Efficacy|2|||
46967558|NCT02187172|83210120|FG000|Overall Study|Adverse Event|0|||
46967559|NCT02187172|83210121|FG001|Overall Study|Adverse Event|1|||
46967560|NCT02187172|83210120|FG000|Overall Study|Physician Decision|1|||
46967561|NCT02187172|83210121|FG001|Overall Study|Physician Decision|1|||
46967562|NCT02621931|83210132|FG000|Overall Study|Death|0|||
46967563|NCT02621931|83210133|FG001|Overall Study|Death|1|||
46967564|NCT02621931|83210134|FG002|Overall Study|Death|0|||
46967565|NCT02621931|83210132|FG000|Overall Study|Adverse Event|8|||
46967566|NCT02621931|83210133|FG001|Overall Study|Adverse Event|5|||
46967567|NCT02621931|83210134|FG002|Overall Study|Adverse Event|7|||
46967568|NCT02621931|83210132|FG000|Overall Study|Withdrawal by Subject|12|||
46709898|NCT01169675|82925991|FG000|Overall Study|Withdrawal by Subject|1|||
46911615|NCT03199963|83141536|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
46911616|NCT03199963|83141537|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
46911617|NCT03883581|83141549|FG000|Overall Study|Withdrawal by Subject|4|||
46911618|NCT03029208|83141555|FG000|Overall Study|Withdrawal by Subject|2|||
46911619|NCT03029208|83141556|FG001|Overall Study|Withdrawal by Subject|3|||
46911620|NCT03029208|83141555|FG000|Overall Study|Lost to Follow-up|0|||
47024466|NCT02007278|83273682|FG001|Overall Study|Failure to comply with an eligibility|1|||
47024467|NCT02007278|83273681|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
47024468|NCT02007278|83273682|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
47024469|NCT02007278|83273681|FG000|Overall Study|Incorrect medication administration|1|||
47024470|NCT02007278|83273682|FG001|Overall Study|Incorrect medication administration|0|||
47024471|NCT02007278|83273681|FG000|Overall Study|Mis-randomization|1|||
47024472|NCT02007278|83273682|FG001|Overall Study|Mis-randomization|1|||
47024473|NCT02107313|83273688|FG000|Overall Study|One participant did not do the FED cohor|0|||
47024474|NCT02107313|83273689|FG001|Overall Study|One participant did not do the FED cohor|1|||
47024475|NCT02028338|83273697|FG000|Overall Study|Withdrawal by Subject|3|||
47024476|NCT02028338|83273698|FG001|Overall Study|Withdrawal by Subject|1|||
47024477|NCT02028338|83273697|FG000|Overall Study|Unable to contact participant|1|||
47024478|NCT02028338|83273698|FG001|Overall Study|Unable to contact participant|0|||
47024479|NCT01625897|83273706|FG000|Overall Study|Adverse Event|27|||
47024480|NCT01625897|83273707|FG001|Overall Study|Adverse Event|10|||
47024481|NCT01625897|83273706|FG000|Overall Study|Physician Decision|0|||
47024482|NCT01625897|83273707|FG001|Overall Study|Physician Decision|1|||
47024483|NCT01625897|83273706|FG000|Overall Study|Withdrawal by Subject|25|||
47024484|NCT01625897|83273707|FG001|Overall Study|Withdrawal by Subject|3|||
47024485|NCT02106923|83273716|FG000|Overall Study|Protocol Violation|0|||
47024486|NCT02106923|83273717|FG001|Overall Study|Protocol Violation|0|||
47024487|NCT02106923|83273718|FG002|Overall Study|Protocol Violation|0|||
47024488|NCT02106923|83273719|FG003|Overall Study|Protocol Violation|0|||
47024489|NCT02106923|83273720|FG004|Overall Study|Protocol Violation|0|||
47024490|NCT02106923|83273721|FG005|Overall Study|Protocol Violation|1|||
47024491|NCT02006732|83273739|FG000|Overall Study|Adverse Event|10|||
47024492|NCT02006732|83273740|FG001|Overall Study|Adverse Event|7|||
47024493|NCT02006732|83273741|FG002|Overall Study|Adverse Event|4|||
47024494|NCT02006732|83273742|FG003|Overall Study|Adverse Event|2|||
47024495|NCT02006732|83273739|FG000|Overall Study|Lack of Efficacy|6|||
47024496|NCT02006732|83273740|FG001|Overall Study|Lack of Efficacy|3|||
47024497|NCT02006732|83273741|FG002|Overall Study|Lack of Efficacy|1|||
47024498|NCT02006732|83273742|FG003|Overall Study|Lack of Efficacy|1|||
47024499|NCT02006732|83273739|FG000|Overall Study|Protocol Violation|1|||
47024500|NCT02006732|83273740|FG001|Overall Study|Protocol Violation|1|||
46620757|NCT03238651|82771437|FG003|Overall Study|Withdrawal by Subject|1|||
46620758|NCT03238651|82771438|FG004|Overall Study|Withdrawal by Subject|0|||
46620759|NCT03238651|82771434|FG000|Overall Study|Adverse Event|1|||
46911621|NCT03029208|83141556|FG001|Overall Study|Lost to Follow-up|1|||
46911622|NCT03198715|83141576|FG000|Overall Study|Death|0|||
46911623|NCT03198715|83141577|FG001|Overall Study|Death|0|||
46911624|NCT03198715|83141578|FG002|Overall Study|Death|1|||
46911625|NCT03198715|83141579|FG003|Overall Study|Death|0|||
46911626|NCT03198715|83141580|FG004|Overall Study|Death|2|||
46620760|NCT03238651|82771435|FG001|Overall Study|Adverse Event|3|||
46620761|NCT03238651|82771436|FG002|Overall Study|Adverse Event|2|||
46620762|NCT03238651|82771437|FG003|Overall Study|Adverse Event|0|||
46620763|NCT03238651|82771438|FG004|Overall Study|Adverse Event|0|||
46620764|NCT05460871|82771464|FG000|Overall Study|Withdrawal by Subject|1|||
46620765|NCT05460871|82771465|FG001|Overall Study|Withdrawal by Subject|2|||
46620766|NCT05346055|82771471|FG000|Overall Study|Withdrawal by Subject|1|||
46620767|NCT05346055|82771471|FG000|Overall Study|Protocol Violation|1|||
46620768|NCT05346055|82771471|FG000|Overall Study|Therapist decision|1|||
46620769|NCT05211739|82771481|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
46620770|NCT05211739|82771482|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
46620771|NCT05211739|82771481|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
46620772|NCT05211739|82771482|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
46620773|NCT05211739|82771481|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
46620774|NCT05211739|82771482|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
46620775|NCT05211739|82771481|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
46620776|NCT05211739|82771482|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
46620777|NCT05085405|82771510|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
46620778|NCT05085405|82771511|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
46911627|NCT03198715|83141576|FG000|Overall Study|Other|0|||
46911628|NCT03198715|83141577|FG001|Overall Study|Other|1|||
46620779|NCT05085405|82771512|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
46620780|NCT05085405|82771513|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
46620781|NCT05085405|82771514|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
46620782|NCT05085405|82771515|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
46620783|NCT05085405|82771510|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
46620784|NCT05085405|82771511|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
46620785|NCT05085405|82771512|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
46620786|NCT05085405|82771513|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
46620787|NCT05085405|82771514|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
46620788|NCT05085405|82771515|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
46620789|NCT04932941|82771527|FG000|Overall Study|Lost to Follow-up|3|||
46620790|NCT04932941|82771528|FG001|Overall Study|Lost to Follow-up|1|||
46620791|NCT04932941|82771527|FG000|Overall Study|Withdrawal by Subject|7|||
46911629|NCT03198715|83141578|FG002|Overall Study|Other|1|||
46911630|NCT03198715|83141579|FG003|Overall Study|Other|0|||
46911631|NCT03198715|83141580|FG004|Overall Study|Other|0|||
46911632|NCT03088917|83141601|FG000|Overall Study|In care/cured elsewhere|15|||
46911633|NCT03088917|83141601|FG000|Overall Study|Refuse re-evaluation|13|||
46911634|NCT03088917|83141601|FG000|Overall Study|Contact not established|13|||
46911635|NCT03088917|83141601|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
47024501|NCT02006732|83273741|FG002|Overall Study|Protocol Violation|0|||
47024502|NCT02006732|83273742|FG003|Overall Study|Protocol Violation|0|||
47024503|NCT02006732|83273739|FG000|Overall Study|Lost to Follow-up|0|||
47024504|NCT02006732|83273740|FG001|Overall Study|Lost to Follow-up|1|||
47024505|NCT02006732|83273741|FG002|Overall Study|Lost to Follow-up|0|||
47024506|NCT02006732|83273742|FG003|Overall Study|Lost to Follow-up|0|||
47024507|NCT02006732|83273739|FG000|Overall Study|Withdrawal by Subject|3|||
47024508|NCT02006732|83273740|FG001|Overall Study|Withdrawal by Subject|0|||
47024509|NCT02006732|83273741|FG002|Overall Study|Withdrawal by Subject|4|||
47024510|NCT02006732|83273742|FG003|Overall Study|Withdrawal by Subject|1|||
47024511|NCT02098733|83273752|FG000|Overall Study|Data Not Available|5|||
47024512|NCT02098733|83273752|FG000|Overall Study|Lost to Follow-up|5|||
47024513|NCT02028182|83273756|FG000|Overall Study|Protocol Violation|2|||
47024514|NCT02098109|83273763|FG000|Overall Study|Protocol Violation|3|||
47024515|NCT02098109|83273764|FG001|Overall Study|Protocol Violation|0|||
47024516|NCT02097719|83273772|FG000|Overall Study|Subject Withdrew Consent|1|||
47024517|NCT02097719|83273773|FG001|Overall Study|Subject Withdrew Consent|0|||
47024518|NCT02097719|83273772|FG000|Overall Study|Lost to Follow-up|0|||
47024519|NCT02097719|83273773|FG001|Overall Study|Lost to Follow-up|1|||
47024520|NCT02097719|83273772|FG000|Overall Study|Adverse Event|2|||
47024521|NCT02097719|83273773|FG001|Overall Study|Adverse Event|0|||
47024522|NCT01449370|83273804|FG000|Overall Study|Disease Progression|5|||
47024523|NCT01449370|83273805|FG001|Overall Study|Disease Progression|4|||
47024524|NCT01449370|83273806|FG002|Overall Study|Disease Progression|8|||
47024525|NCT01449370|83273807|FG003|Overall Study|Disease Progression|3|||
47024526|NCT01449370|83273808|FG004|Overall Study|Disease Progression|3|||
47024527|NCT01449370|83273809|FG005|Overall Study|Disease Progression|3|||
47024528|NCT01449370|83273810|FG006|Overall Study|Disease Progression|3|||
47024529|NCT01449370|83273811|FG007|Overall Study|Disease Progression|2|||
47024530|NCT01449370|83273812|FG008|Overall Study|Disease Progression|9|||
47024531|NCT01449370|83273813|FG009|Overall Study|Disease Progression|1|||
47024532|NCT01449370|83273814|FG010|Overall Study|Disease Progression|3|||
47024533|NCT01449370|83273815|FG011|Overall Study|Disease Progression|3|||
47024534|NCT01449370|83273816|FG012|Overall Study|Disease Progression|2|||
47024535|NCT01449370|83273817|FG013|Overall Study|Disease Progression|8|||
47024536|NCT01449370|83273818|FG014|Overall Study|Disease Progression|3|||
47024537|NCT01449370|83273819|FG015|Overall Study|Disease Progression|1|||
47024538|NCT01449370|83273820|FG016|Overall Study|Disease Progression|4|||
47024539|NCT01449370|83273821|FG017|Overall Study|Disease Progression|3|||
47024540|NCT01449370|83273822|FG018|Overall Study|Disease Progression|1|||
47024541|NCT01449370|83273823|FG019|Overall Study|Disease Progression|2|||
47024542|NCT01449370|83273824|FG020|Overall Study|Disease Progression|5|||
47024543|NCT01449370|83273825|FG021|Overall Study|Disease Progression|2|||
46620792|NCT04932941|82771528|FG001|Overall Study|Withdrawal by Subject|4|||
47024544|NCT01449370|83273826|FG022|Overall Study|Disease Progression|3|||
47024545|NCT01449370|83273827|FG023|Overall Study|Disease Progression|7|||
47024546|NCT01449370|83273828|FG024|Overall Study|Disease Progression|3|||
47024547|NCT01449370|83273804|FG000|Overall Study|Adverse Event|1|||
47024548|NCT01449370|83273805|FG001|Overall Study|Adverse Event|2|||
47024549|NCT01449370|83273806|FG002|Overall Study|Adverse Event|0|||
47024550|NCT01449370|83273807|FG003|Overall Study|Adverse Event|1|||
46620793|NCT04932941|82771527|FG000|Overall Study|Other|4|||
46620794|NCT04932941|82771528|FG001|Overall Study|Other|2|||
46620795|NCT04662073|82771588|FG000|Overall Study|Withdrawal by Subject|1|||
47024551|NCT01449370|83273808|FG004|Overall Study|Adverse Event|0|||
47024552|NCT01449370|83273809|FG005|Overall Study|Adverse Event|0|||
47024553|NCT01449370|83273810|FG006|Overall Study|Adverse Event|0|||
47024554|NCT01449370|83273811|FG007|Overall Study|Adverse Event|0|||
47024555|NCT01449370|83273812|FG008|Overall Study|Adverse Event|1|||
47024556|NCT01449370|83273813|FG009|Overall Study|Adverse Event|1|||
47024557|NCT01449370|83273814|FG010|Overall Study|Adverse Event|0|||
47024558|NCT01449370|83273815|FG011|Overall Study|Adverse Event|0|||
47024559|NCT01449370|83273816|FG012|Overall Study|Adverse Event|0|||
47024560|NCT01449370|83273817|FG013|Overall Study|Adverse Event|2|||
47024561|NCT01449370|83273818|FG014|Overall Study|Adverse Event|0|||
47024562|NCT01449370|83273819|FG015|Overall Study|Adverse Event|1|||
47024563|NCT01449370|83273820|FG016|Overall Study|Adverse Event|0|||
47024564|NCT01449370|83273821|FG017|Overall Study|Adverse Event|0|||
47024565|NCT01449370|83273822|FG018|Overall Study|Adverse Event|1|||
47024566|NCT01449370|83273823|FG019|Overall Study|Adverse Event|1|||
47024567|NCT01449370|83273824|FG020|Overall Study|Adverse Event|0|||
47024568|NCT01449370|83273825|FG021|Overall Study|Adverse Event|1|||
47024569|NCT01449370|83273826|FG022|Overall Study|Adverse Event|0|||
47024570|NCT01449370|83273827|FG023|Overall Study|Adverse Event|1|||
46620796|NCT04662073|82771589|FG001|Overall Study|Withdrawal by Subject|0|||
46620797|NCT04656418|82771597|FG000|Overall Study|Withdrawal by Subject|1|||
47024571|NCT01449370|83273828|FG024|Overall Study|Adverse Event|3|||
47024572|NCT01449370|83273804|FG000|Overall Study|Participant Decision|0|||
47024573|NCT01449370|83273805|FG001|Overall Study|Participant Decision|0|||
47024574|NCT01449370|83273806|FG002|Overall Study|Participant Decision|0|||
47024575|NCT01449370|83273807|FG003|Overall Study|Participant Decision|0|||
47024576|NCT01449370|83273808|FG004|Overall Study|Participant Decision|0|||
47024577|NCT01449370|83273809|FG005|Overall Study|Participant Decision|0|||
47024578|NCT01449370|83273810|FG006|Overall Study|Participant Decision|0|||
47024579|NCT01449370|83273811|FG007|Overall Study|Participant Decision|1|||
47024580|NCT01449370|83273812|FG008|Overall Study|Participant Decision|1|||
47024581|NCT01449370|83273813|FG009|Overall Study|Participant Decision|0|||
47024582|NCT01449370|83273814|FG010|Overall Study|Participant Decision|0|||
47024583|NCT01449370|83273815|FG011|Overall Study|Participant Decision|0|||
47024584|NCT01449370|83273816|FG012|Overall Study|Participant Decision|1|||
47024585|NCT01449370|83273817|FG013|Overall Study|Participant Decision|1|||
47024586|NCT01449370|83273818|FG014|Overall Study|Participant Decision|0|||
47024587|NCT01449370|83273819|FG015|Overall Study|Participant Decision|1|||
47024588|NCT01449370|83273820|FG016|Overall Study|Participant Decision|3|||
47024589|NCT01449370|83273821|FG017|Overall Study|Participant Decision|0|||
47024590|NCT01449370|83273822|FG018|Overall Study|Participant Decision|1|||
47024591|NCT01449370|83273823|FG019|Overall Study|Participant Decision|0|||
47024592|NCT01449370|83273824|FG020|Overall Study|Participant Decision|0|||
47024593|NCT01449370|83273825|FG021|Overall Study|Participant Decision|1|||
47024594|NCT01449370|83273826|FG022|Overall Study|Participant Decision|0|||
47024595|NCT01449370|83273827|FG023|Overall Study|Participant Decision|0|||
47024596|NCT01449370|83273828|FG024|Overall Study|Participant Decision|1|||
47024597|NCT01449370|83273804|FG000|Overall Study|Lost to Follow-up|0|||
47024598|NCT01449370|83273805|FG001|Overall Study|Lost to Follow-up|0|||
47024599|NCT01449370|83273806|FG002|Overall Study|Lost to Follow-up|0|||
47024600|NCT01449370|83273807|FG003|Overall Study|Lost to Follow-up|0|||
47024601|NCT01449370|83273808|FG004|Overall Study|Lost to Follow-up|0|||
47024602|NCT01449370|83273809|FG005|Overall Study|Lost to Follow-up|0|||
47024603|NCT01449370|83273810|FG006|Overall Study|Lost to Follow-up|0|||
47024604|NCT01449370|83273811|FG007|Overall Study|Lost to Follow-up|0|||
47024605|NCT01449370|83273812|FG008|Overall Study|Lost to Follow-up|0|||
47024606|NCT01449370|83273813|FG009|Overall Study|Lost to Follow-up|0|||
47024607|NCT01449370|83273814|FG010|Overall Study|Lost to Follow-up|0|||
47024608|NCT01449370|83273815|FG011|Overall Study|Lost to Follow-up|0|||
47024609|NCT01449370|83273816|FG012|Overall Study|Lost to Follow-up|0|||
47024610|NCT01449370|83273817|FG013|Overall Study|Lost to Follow-up|0|||
47024611|NCT01449370|83273818|FG014|Overall Study|Lost to Follow-up|0|||
47024612|NCT01449370|83273819|FG015|Overall Study|Lost to Follow-up|0|||
47024613|NCT01449370|83273820|FG016|Overall Study|Lost to Follow-up|0|||
47024614|NCT01449370|83273821|FG017|Overall Study|Lost to Follow-up|0|||
47024615|NCT01449370|83273822|FG018|Overall Study|Lost to Follow-up|0|||
47024616|NCT01449370|83273823|FG019|Overall Study|Lost to Follow-up|0|||
47024617|NCT01449370|83273824|FG020|Overall Study|Lost to Follow-up|1|||
47024618|NCT01449370|83273825|FG021|Overall Study|Lost to Follow-up|0|||
47024619|NCT01449370|83273826|FG022|Overall Study|Lost to Follow-up|0|||
47024620|NCT01449370|83273827|FG023|Overall Study|Lost to Follow-up|0|||
47024621|NCT01449370|83273828|FG024|Overall Study|Lost to Follow-up|0|||
47024622|NCT01449370|83273804|FG000|Overall Study|Other|0|||
47024623|NCT01449370|83273805|FG001|Overall Study|Other|0|||
47024624|NCT01449370|83273806|FG002|Overall Study|Other|0|||
47024625|NCT01449370|83273807|FG003|Overall Study|Other|0|||
47024626|NCT01449370|83273808|FG004|Overall Study|Other|0|||
47024627|NCT01449370|83273809|FG005|Overall Study|Other|0|||
47024628|NCT01449370|83273810|FG006|Overall Study|Other|0|||
47024629|NCT01449370|83273811|FG007|Overall Study|Other|0|||
47024630|NCT01449370|83273812|FG008|Overall Study|Other|1|||
47024631|NCT01449370|83273813|FG009|Overall Study|Other|1|||
47024632|NCT01449370|83273814|FG010|Overall Study|Other|0|||
47024633|NCT01449370|83273815|FG011|Overall Study|Other|0|||
47024634|NCT01449370|83273816|FG012|Overall Study|Other|0|||
47024635|NCT01449370|83273817|FG013|Overall Study|Other|0|||
47024636|NCT01449370|83273818|FG014|Overall Study|Other|0|||
47024637|NCT01449370|83273819|FG015|Overall Study|Other|0|||
47024638|NCT01449370|83273820|FG016|Overall Study|Other|0|||
47024639|NCT01449370|83273821|FG017|Overall Study|Other|0|||
47024640|NCT01449370|83273822|FG018|Overall Study|Other|0|||
47024641|NCT01449370|83273823|FG019|Overall Study|Other|0|||
47024642|NCT01449370|83273824|FG020|Overall Study|Other|0|||
47024643|NCT01449370|83273825|FG021|Overall Study|Other|0|||
47024644|NCT01449370|83273826|FG022|Overall Study|Other|1|||
47024645|NCT01449370|83273827|FG023|Overall Study|Other|1|||
47024646|NCT01449370|83273828|FG024|Overall Study|Other|0|||
47024647|NCT01449370|83273804|FG000|Overall Study|Medication Prohibited by Protocol|0|||
47024648|NCT01449370|83273805|FG001|Overall Study|Medication Prohibited by Protocol|0|||
47024649|NCT01449370|83273806|FG002|Overall Study|Medication Prohibited by Protocol|0|||
47024650|NCT01449370|83273807|FG003|Overall Study|Medication Prohibited by Protocol|0|||
47024651|NCT01449370|83273808|FG004|Overall Study|Medication Prohibited by Protocol|0|||
47024652|NCT01449370|83273809|FG005|Overall Study|Medication Prohibited by Protocol|0|||
47024653|NCT01449370|83273810|FG006|Overall Study|Medication Prohibited by Protocol|0|||
47024654|NCT01449370|83273811|FG007|Overall Study|Medication Prohibited by Protocol|0|||
46911636|NCT03088917|83141601|FG000|Overall Study|Moved outside study region|50|||
46911637|NCT03087513|83141607|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
46911638|NCT02917629|83141622|FG000|Overall Study|Withdrawal by Subject|0|||
46911639|NCT02917629|83141623|FG001|Overall Study|Withdrawal by Subject|1|||
46911640|NCT02927847|83141632|FG000|Overall Study|Lost to Follow-up|1|||
46911641|NCT02927847|83141633|FG001|Overall Study|Lost to Follow-up|0|||
46911642|NCT02927847|83141632|FG000|Overall Study|Withdrawal by Subject|4|||
46911643|NCT02927847|83141633|FG001|Overall Study|Withdrawal by Subject|2|||
46911644|NCT02927847|83141632|FG000|Overall Study|PI withdrawn due to missed visits|1|||
46911645|NCT02927847|83141633|FG001|Overall Study|PI withdrawn due to missed visits|1|||
46911646|NCT02960438|83141643|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
46911647|NCT02960438|83141644|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
46911648|NCT02960438|83141645|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
46911649|NCT02960438|83141646|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
46911650|NCT02960438|83141643|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
46911651|NCT02960438|83141644|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
46911652|NCT02960438|83141645|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
46911653|NCT02960438|83141646|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
46911654|NCT02960438|83141643|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
46911655|NCT02960438|83141644|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
46911656|NCT02960438|83141645|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
46911657|NCT02960438|83141646|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
46911658|NCT02960438|83141643|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
46911659|NCT02960438|83141644|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
46911660|NCT02960438|83141645|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
46911661|NCT02960438|83141646|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
46911662|NCT02960438|83141643|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
46911663|NCT02960438|83141644|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
46911664|NCT02960438|83141645|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
46911665|NCT02960438|83141646|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
46911666|NCT02960438|83141643|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
47024655|NCT01449370|83273812|FG008|Overall Study|Medication Prohibited by Protocol|0|||
47024656|NCT01449370|83273813|FG009|Overall Study|Medication Prohibited by Protocol|0|||
47024657|NCT01449370|83273814|FG010|Overall Study|Medication Prohibited by Protocol|0|||
47024658|NCT01449370|83273815|FG011|Overall Study|Medication Prohibited by Protocol|0|||
47024659|NCT01449370|83273816|FG012|Overall Study|Medication Prohibited by Protocol|0|||
47024660|NCT01449370|83273817|FG013|Overall Study|Medication Prohibited by Protocol|0|||
47024661|NCT01449370|83273818|FG014|Overall Study|Medication Prohibited by Protocol|0|||
47024662|NCT01449370|83273819|FG015|Overall Study|Medication Prohibited by Protocol|0|||
47024663|NCT01449370|83273820|FG016|Overall Study|Medication Prohibited by Protocol|0|||
46709899|NCT01169675|82925992|FG001|Overall Study|Withdrawal by Subject|0|||
47024664|NCT01449370|83273821|FG017|Overall Study|Medication Prohibited by Protocol|0|||
47024665|NCT01449370|83273822|FG018|Overall Study|Medication Prohibited by Protocol|0|||
46620798|NCT04656418|82771598|FG001|Overall Study|Withdrawal by Subject|3|||
46620799|NCT04622306|82771605|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
47024666|NCT01449370|83273823|FG019|Overall Study|Medication Prohibited by Protocol|0|||
47024667|NCT01449370|83273824|FG020|Overall Study|Medication Prohibited by Protocol|0|||
47024668|NCT01449370|83273825|FG021|Overall Study|Medication Prohibited by Protocol|0|||
47024669|NCT01449370|83273826|FG022|Overall Study|Medication Prohibited by Protocol|0|||
47024670|NCT01449370|83273827|FG023|Overall Study|Medication Prohibited by Protocol|1|||
47024671|NCT01449370|83273828|FG024|Overall Study|Medication Prohibited by Protocol|0|||
47024672|NCT01449370|83273804|FG000|Overall Study|Death|0|||
47024673|NCT01449370|83273805|FG001|Overall Study|Death|0|||
47024674|NCT01449370|83273806|FG002|Overall Study|Death|0|||
47024675|NCT01449370|83273807|FG003|Overall Study|Death|0|||
47024676|NCT01449370|83273808|FG004|Overall Study|Death|0|||
47024677|NCT01449370|83273809|FG005|Overall Study|Death|0|||
47024678|NCT01449370|83273810|FG006|Overall Study|Death|0|||
47024679|NCT01449370|83273811|FG007|Overall Study|Death|0|||
47024680|NCT01449370|83273812|FG008|Overall Study|Death|0|||
47024681|NCT01449370|83273813|FG009|Overall Study|Death|0|||
47024682|NCT01449370|83273814|FG010|Overall Study|Death|0|||
47024683|NCT01449370|83273815|FG011|Overall Study|Death|0|||
47024684|NCT01449370|83273816|FG012|Overall Study|Death|0|||
47024685|NCT01449370|83273817|FG013|Overall Study|Death|0|||
47024686|NCT01449370|83273818|FG014|Overall Study|Death|0|||
47024687|NCT01449370|83273819|FG015|Overall Study|Death|0|||
47024688|NCT01449370|83273820|FG016|Overall Study|Death|0|||
47024689|NCT01449370|83273821|FG017|Overall Study|Death|0|||
47024690|NCT01449370|83273822|FG018|Overall Study|Death|0|||
47024691|NCT01449370|83273823|FG019|Overall Study|Death|0|||
47024692|NCT01449370|83273824|FG020|Overall Study|Death|0|||
47024693|NCT01449370|83273825|FG021|Overall Study|Death|0|||
47024694|NCT01449370|83273826|FG022|Overall Study|Death|0|||
47024695|NCT01449370|83273827|FG023|Overall Study|Death|0|||
47024696|NCT01449370|83273828|FG024|Overall Study|Death|1|||
47024697|NCT02067533|83273903|FG000|Overall Study|Lost to Follow-up|4|||
47024698|NCT02067533|83273904|FG001|Overall Study|Lost to Follow-up|2|||
47024699|NCT02066129|83273912|FG000|Overall Study|Lost to Follow-up|13|||
47024700|NCT02066129|83273913|FG001|Overall Study|Lost to Follow-up|12|||
47024701|NCT02066129|83273912|FG000|Overall Study|Withdrawal by Subject|7|||
47024702|NCT02066129|83273913|FG001|Overall Study|Withdrawal by Subject|10|||
47024703|NCT02066129|83273912|FG000|Overall Study|Lack of Efficacy|8|||
47024704|NCT02066129|83273913|FG001|Overall Study|Lack of Efficacy|10|||
47024705|NCT02066129|83273912|FG000|Overall Study|Physician Decision|1|||
47024706|NCT02066129|83273913|FG001|Overall Study|Physician Decision|1|||
47024707|NCT02066051|83273919|FG000|Overall Study|Subject developed active GVHD|1|||
47024708|NCT01980992|83273925|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
47024709|NCT01980992|83273926|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
47024710|NCT01980992|83273925|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
47024711|NCT01980992|83273926|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
47024712|NCT01980992|83273925|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
47024713|NCT01980992|83273926|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
47024714|NCT01980992|83273925|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
47024715|NCT01980992|83273926|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
47024716|NCT01980992|83273925|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
47024717|NCT01980992|83273926|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
47024718|NCT01980992|83273925|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
47024719|NCT01980992|83273926|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
47024720|NCT02065895|83273939|FG000|Overall Study|Protocol Violation|1|||
47024721|NCT02065895|83273940|FG001|Overall Study|Protocol Violation|0|||
47024722|NCT02065895|83273941|FG002|Overall Study|Protocol Violation|0|||
47024723|NCT02065895|83273942|FG003|Overall Study|Protocol Violation|1|||
47024724|NCT02065895|83273943|FG004|Overall Study|Protocol Violation|0|||
47024725|NCT02065895|83273944|FG005|Overall Study|Protocol Violation|0|||
47024726|NCT02065895|83273939|FG000|Overall Study|Scheduling conflicts|0|||
47024727|NCT02065895|83273940|FG001|Overall Study|Scheduling conflicts|1|||
47024728|NCT02065895|83273941|FG002|Overall Study|Scheduling conflicts|0|||
47024729|NCT02065895|83273942|FG003|Overall Study|Scheduling conflicts|0|||
47024730|NCT02065895|83273943|FG004|Overall Study|Scheduling conflicts|0|||
47024731|NCT02065895|83273944|FG005|Overall Study|Scheduling conflicts|0|||
47024732|NCT02106455|83273961|FG000|Overall Study|Case Report Form Uncollected|6|||
47024733|NCT02106455|83273961|FG000|Overall Study|Protocol Deviation|2|||
47024734|NCT02006654|83273967|FG000|Overall Study|Withdrawal before treatment|4|||
47024735|NCT02006654|83273968|FG001|Overall Study|Withdrawal before treatment|2|||
46620800|NCT04622306|82771606|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
46620801|NCT04622306|82771607|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
46620802|NCT04622306|82771608|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
46620803|NCT04622306|82771609|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
46620804|NCT04622306|82771610|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
46620805|NCT04622306|82771605|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
46620806|NCT04622306|82771606|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
46620807|NCT04622306|82771607|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
46620808|NCT04622306|82771608|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
46620809|NCT04622306|82771609|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
46620810|NCT04622306|82771610|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
46620811|NCT04601103|82771622|FG000|Overall Study|Needed crown & cleaning|0|||
46620812|NCT04601103|82771623|FG001|Overall Study|Needed crown & cleaning|0|||
46620813|NCT04601103|82771624|FG002|Overall Study|Needed crown & cleaning|1|||
46620814|NCT04601103|82771622|FG000|Overall Study|study was terminated|18|||
46620815|NCT04601103|82771623|FG001|Overall Study|study was terminated|18|||
46620816|NCT04601103|82771624|FG002|Overall Study|study was terminated|16|||
46620817|NCT04575597|82771638|FG000|Overall Study|Death|0|||
46620818|NCT04575597|82771639|FG001|Overall Study|Death|0|||
46620819|NCT04575597|82771640|FG002|Overall Study|Death|0|||
46620820|NCT04575597|82771641|FG003|Overall Study|Death|1|||
46620821|NCT04575597|82771642|FG004|Overall Study|Death|3|||
47024736|NCT02006654|83273967|FG000|Overall Study|Adverse Event|16|||
47024737|NCT02006654|83273968|FG001|Overall Study|Adverse Event|17|||
47024738|NCT02006654|83273967|FG000|Overall Study|Death|1|||
47024739|NCT02006654|83273968|FG001|Overall Study|Death|0|||
47024740|NCT02006654|83273967|FG000|Overall Study|Withdrawal by Subject|14|||
47024741|NCT02006654|83273968|FG001|Overall Study|Withdrawal by Subject|12|||
46620822|NCT04575597|82771643|FG005|Overall Study|Death|14|||
46620823|NCT04575597|82771638|FG000|Overall Study|Lost to Follow-up|2|||
47024742|NCT02006654|83273967|FG000|Overall Study|Protocol Violation|5|||
47024743|NCT02006654|83273968|FG001|Overall Study|Protocol Violation|8|||
47024744|NCT02006654|83273967|FG000|Overall Study|Lost to Follow-up|1|||
47024745|NCT02006654|83273968|FG001|Overall Study|Lost to Follow-up|0|||
47024746|NCT02006654|83273967|FG000|Overall Study|patient's will|2|||
47024747|NCT02006654|83273968|FG001|Overall Study|patient's will|1|||
47024748|NCT02006654|83273967|FG000|Overall Study|insufficient compliance|1|||
47024749|NCT02006654|83273968|FG001|Overall Study|insufficient compliance|0|||
47024750|NCT02006654|83273967|FG000|Overall Study|worsening cognitive condition|0|||
47024751|NCT02006654|83273968|FG001|Overall Study|worsening cognitive condition|1|||
47024752|NCT02006654|83273967|FG000|Overall Study|faecal incontinence|0|||
47024753|NCT02006654|83273968|FG001|Overall Study|faecal incontinence|1|||
47024754|NCT02006654|83273967|FG000|Overall Study|mood disorder|0|||
47024755|NCT02006654|83273968|FG001|Overall Study|mood disorder|1|||
47024756|NCT02006654|83273967|FG000|Overall Study|disallowed medication|1|||
47024757|NCT02006654|83273968|FG001|Overall Study|disallowed medication|0|||
47024758|NCT02006654|83273967|FG000|Overall Study|moving out of state|0|||
47024759|NCT02006654|83273968|FG001|Overall Study|moving out of state|1|||
47024760|NCT01980056|83273978|FG000|Overall Study|Death|1|||
47024761|NCT01980056|83273979|FG001|Overall Study|Death|1|||
47024762|NCT01980056|83273980|FG002|Overall Study|Death|0|||
47024763|NCT02027558|83273994|FG000|Overall Study|Death|0|||
47024764|NCT02027558|83273995|FG001|Overall Study|Death|1|||
47024765|NCT02027558|83273994|FG000|Overall Study|Withdrawal by Subject|2|||
46620824|NCT04575597|82771639|FG001|Overall Study|Lost to Follow-up|1|||
46620825|NCT04575597|82771640|FG002|Overall Study|Lost to Follow-up|1|||
47024766|NCT02027558|83273995|FG001|Overall Study|Withdrawal by Subject|0|||
47024767|NCT02027558|83273994|FG000|Overall Study|Lost to Follow-up|4|||
47024768|NCT02027558|83273995|FG001|Overall Study|Lost to Follow-up|1|||
46620826|NCT04575597|82771641|FG003|Overall Study|Lost to Follow-up|2|||
47024769|NCT02027558|83273994|FG000|Overall Study|Refused assessment|3|||
47024770|NCT02027558|83273995|FG001|Overall Study|Refused assessment|0|||
47024771|NCT02027402|83274005|FG000|Overall Study|Withdrawal by Subject|4|||
47024772|NCT02027402|83274006|FG001|Overall Study|Withdrawal by Subject|1|||
47024773|NCT01448824|83274022|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
47024774|NCT01448824|83274023|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
47024775|NCT01448824|83274024|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
47024776|NCT01448824|83274025|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
47024777|NCT01448824|83274026|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
47024778|NCT01448824|83274027|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
47024779|NCT01448824|83274028|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
47024780|NCT01448824|83274029|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
47024781|NCT01448824|83274022|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
47024782|NCT01448824|83274023|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
47024783|NCT01448824|83274024|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
47024784|NCT01448824|83274025|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
47024785|NCT01448824|83274026|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
47024786|NCT01448824|83274027|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
47024787|NCT01448824|83274028|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
47024788|NCT01448824|83274029|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
47024789|NCT01448824|83274022|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
47024790|NCT01448824|83274023|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
47024791|NCT01448824|83274024|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
47024792|NCT01448824|83274025|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
47024793|NCT01448824|83274026|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
47024794|NCT01448824|83274027|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
46620827|NCT04575597|82771642|FG004|Overall Study|Lost to Follow-up|10|||
46620828|NCT04575597|82771643|FG005|Overall Study|Lost to Follow-up|8|||
46620829|NCT04575597|82771638|FG000|Overall Study|Withdrawal by Subject|2|||
46620830|NCT04575597|82771639|FG001|Overall Study|Withdrawal by Subject|2|||
46911667|NCT02960438|83141644|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
46911668|NCT02960438|83141645|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
46911669|NCT02960438|83141646|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
46911670|NCT02960438|83141643|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
46911671|NCT02960438|83141644|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
46911672|NCT02960438|83141645|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
46911673|NCT02960438|83141646|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
46911674|NCT02960438|83141643|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
46911675|NCT02960438|83141644|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
46911676|NCT02960438|83141645|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
46911677|NCT02960438|83141646|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
46911678|NCT02960438|83141643|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
46911679|NCT02960438|83141644|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
46911680|NCT02960438|83141645|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
46911681|NCT02960438|83141646|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
46911682|NCT02960438|83141643|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
46911683|NCT02960438|83141644|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
46911684|NCT02960438|83141645|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
46911685|NCT02960438|83141646|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
46911686|NCT02960438|83141643|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
46911687|NCT02960438|83141644|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
46911688|NCT02960438|83141645|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
46911689|NCT02960438|83141646|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
46911690|NCT02960438|83141643|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
46911691|NCT02960438|83141644|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
46911692|NCT02960438|83141645|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
46911693|NCT02960438|83141646|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
46911694|NCT02957942|83141666|FG000|Overall Study|Withdrawal by Subject|0|||
46911695|NCT02957942|83141667|FG001|Overall Study|Withdrawal by Subject|1|||
46911696|NCT02957942|83141666|FG000|Overall Study|Practicing experiment protocol|0|||
46911697|NCT02957942|83141667|FG001|Overall Study|Practicing experiment protocol|6|||
46911698|NCT02959970|83141675|FG000|Overall Study|Adverse Event|1|||
46911699|NCT02959970|83141676|FG001|Overall Study|Adverse Event|0|||
46911700|NCT02959970|83141675|FG000|Overall Study|Withdrawal by Subject|0|||
46620831|NCT04575597|82771640|FG002|Overall Study|Withdrawal by Subject|4|||
46911701|NCT02959970|83141676|FG001|Overall Study|Withdrawal by Subject|2|||
46911702|NCT02959970|83141675|FG000|Overall Study|Lost to Follow-up|1|||
46911703|NCT02959970|83141676|FG001|Overall Study|Lost to Follow-up|5|||
46911704|NCT05300763|83141705|FG000|Overall Study|Adverse Event|0|||
46911705|NCT05300763|83141706|FG001|Overall Study|Adverse Event|1|||
46620832|NCT04575597|82771641|FG003|Overall Study|Withdrawal by Subject|2|||
46620833|NCT04575597|82771642|FG004|Overall Study|Withdrawal by Subject|25|||
46620834|NCT04575597|82771643|FG005|Overall Study|Withdrawal by Subject|28|||
46620835|NCT04575597|82771638|FG000|Overall Study|Not Recorded|0|||
46620836|NCT04575597|82771639|FG001|Overall Study|Not Recorded|0|||
46620837|NCT04575597|82771640|FG002|Overall Study|Not Recorded|0|||
46620838|NCT04575597|82771641|FG003|Overall Study|Not Recorded|0|||
46620839|NCT04575597|82771642|FG004|Overall Study|Not Recorded|0|||
46620840|NCT04575597|82771643|FG005|Overall Study|Not Recorded|2|||
46620841|NCT04575597|82771638|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46620842|NCT04575597|82771639|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46620843|NCT04575597|82771640|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46620844|NCT04575597|82771641|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46620845|NCT04575597|82771642|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
46620846|NCT04575597|82771643|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
46620847|NCT04546724|82771665|FG000|Overall Study|Withdrawal by Subject|145|||
46620848|NCT04546724|82771666|FG001|Overall Study|Withdrawal by Subject|41|||
46620849|NCT04546724|82771665|FG000|Overall Study|Adverse Event|1|||
46620850|NCT04546724|82771666|FG001|Overall Study|Adverse Event|1|||
46620851|NCT04546724|82771665|FG000|Overall Study|Lost to Follow-up|186|||
46620852|NCT04546724|82771666|FG001|Overall Study|Lost to Follow-up|63|||
46620853|NCT04546724|82771665|FG000|Overall Study|Physician Decision|8|||
46620854|NCT04546724|82771666|FG001|Overall Study|Physician Decision|2|||
46620855|NCT04546724|82771665|FG000|Overall Study|Death|2|||
46620856|NCT04546724|82771666|FG001|Overall Study|Death|1|||
46620857|NCT04546724|82771665|FG000|Overall Study|subject has been out of town|1|||
46620858|NCT04546724|82771666|FG001|Overall Study|subject has been out of town|0|||
46620859|NCT04546724|82771665|FG000|Overall Study|subject is incarcerated|2|||
46620860|NCT04546724|82771666|FG001|Overall Study|subject is incarcerated|0|||
46620861|NCT04546724|82771665|FG000|Overall Study|subject is relocating|12|||
46620862|NCT04546724|82771666|FG001|Overall Study|subject is relocating|4|||
46620863|NCT04546724|82771665|FG000|Overall Study|Subject in another study|1|||
46620864|NCT04546724|82771666|FG001|Overall Study|Subject in another study|1|||
46620865|NCT04391842|82771682|FG000|Overall Study|Withdrawal by Subject|2|||
46620866|NCT04327024|82771705|FG000|Overall Study|Death|1|||
46620867|NCT04327024|82771706|FG001|Overall Study|Death|2|||
46620868|NCT04327024|82771707|FG002|Overall Study|Death|1|||
46620869|NCT04327024|82771705|FG000|Overall Study|Non-compliance with study drug|0|||
46620870|NCT04327024|82771706|FG001|Overall Study|Non-compliance with study drug|1|||
46620871|NCT04327024|82771707|FG002|Overall Study|Non-compliance with study drug|0|||
46620872|NCT04327024|82771705|FG000|Overall Study|Withdrawal by Subject|1|||
46620873|NCT04327024|82771706|FG001|Overall Study|Withdrawal by Subject|1|||
46620874|NCT04327024|82771707|FG002|Overall Study|Withdrawal by Subject|2|||
46620875|NCT04322149|82771720|FG000|Overall Study|Adverse Event|1|||
46620876|NCT04322149|82771721|FG001|Overall Study|Adverse Event|1|||
46620877|NCT04322149|82771722|FG002|Overall Study|Adverse Event|0|||
46620878|NCT04322149|82771723|FG003|Overall Study|Adverse Event|0|||
46620879|NCT04322149|82771720|FG000|Overall Study|Withdrawal by Subject|0|||
46620880|NCT04322149|82771721|FG001|Overall Study|Withdrawal by Subject|0|||
46620881|NCT04322149|82771722|FG002|Overall Study|Withdrawal by Subject|0|||
46620882|NCT04322149|82771723|FG003|Overall Study|Withdrawal by Subject|2|||
46620883|NCT04322149|82771720|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
46620884|NCT04322149|82771721|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
46620885|NCT04322149|82771722|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
46620886|NCT04322149|82771723|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
46620887|NCT04294459|82771744|FG000|Overall Study|Adverse Event|0|||
46620888|NCT04294459|82771745|FG001|Overall Study|Adverse Event|1|||
46620889|NCT04226742|82771754|FG000|Overall Study|Lost to Follow-up|16|||
46620890|NCT04226742|82771755|FG001|Overall Study|Lost to Follow-up|13|||
46620891|NCT04226742|82771754|FG000|Overall Study|Withdrawal by Subject|5|||
46620892|NCT04226742|82771755|FG001|Overall Study|Withdrawal by Subject|3|||
46620893|NCT04194528|82771761|FG000|Overall Study|Adverse Event|1|||
46620894|NCT04146012|82771793|FG000|Overall Study|Study Terminated|30|||
46620895|NCT04146012|82771794|FG001|Overall Study|Study Terminated|15|||
46620896|NCT04085458|82771800|FG000|Overall Study|Other|1|||
46620897|NCT04085458|82771800|FG000|Overall Study|Withdrawal by Subject|2|||
46620898|NCT04085458|82771800|FG000|Overall Study|Adverse Event|2|||
46620899|NCT04033159|82771806|FG000|Washout Period|Physician Decision|0|||
46620900|NCT04033159|82771807|FG001|Washout Period|Physician Decision|1|||
46620901|NCT04033159|82771808|FG002|Washout Period|Physician Decision|0|||
46620902|NCT04033159|82771806|FG000|Washout Period|Study terminated by Sponsor|0|||
46620903|NCT04033159|82771807|FG001|Washout Period|Study terminated by Sponsor|7|||
46620904|NCT04033159|82771808|FG002|Washout Period|Study terminated by Sponsor|0|||
46620905|NCT04033159|82771806|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
46620906|NCT04033159|82771807|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
46620907|NCT04033159|82771808|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
46620908|NCT03969888|82771824|FG000|Overall Study|Never Received Study Drug|0|||
46620909|NCT03969888|82771825|FG001|Overall Study|Never Received Study Drug|0|||
46620910|NCT03969888|82771826|FG002|Overall Study|Never Received Study Drug|1|||
46620911|NCT03969888|82771827|FG003|Overall Study|Never Received Study Drug|0|||
46620912|NCT03969888|82771828|FG004|Overall Study|Never Received Study Drug|0|||
46620913|NCT03969888|82771829|FG005|Overall Study|Never Received Study Drug|0|||
46620914|NCT03969888|82771830|FG006|Overall Study|Never Received Study Drug|1|||
46620915|NCT03969888|82771831|FG007|Overall Study|Never Received Study Drug|0|||
46620916|NCT03969888|82771824|FG000|Overall Study|Reason Not Specified|0|||
46620917|NCT03969888|82771825|FG001|Overall Study|Reason Not Specified|0|||
46620918|NCT03969888|82771826|FG002|Overall Study|Reason Not Specified|0|||
46709900|NCT01169675|82925993|FG002|Overall Study|Withdrawal by Subject|0|||
46709901|NCT01169675|82925994|FG003|Overall Study|Withdrawal by Subject|1|||
46709902|NCT01169675|82925995|FG004|Overall Study|Withdrawal by Subject|2|||
46709903|NCT01169675|82925991|FG000|Overall Study|Other Reason Not Defined Above|0|||
46911706|NCT05300763|83141705|FG000|Overall Study|Major Protocol Deviation|1|||
46911707|NCT05300763|83141706|FG001|Overall Study|Major Protocol Deviation|0|||
46911708|NCT05300763|83141705|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
46911709|NCT05300763|83141706|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
46911710|NCT01383135|83141716|FG000|Overall Study|Not Scanned / Imaged|1|||
46911711|NCT01383135|83141717|FG001|Overall Study|Not Scanned / Imaged|0|||
46911712|NCT01383135|83141718|FG002|Overall Study|Not Scanned / Imaged|1|||
46911713|NCT01383135|83141719|FG003|Overall Study|Not Scanned / Imaged|0|||
47024795|NCT01448824|83274028|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
47024796|NCT01448824|83274029|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
47024797|NCT01448824|83274022|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
47024798|NCT01448824|83274023|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
47024799|NCT01448824|83274024|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
47024800|NCT01448824|83274025|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
47024801|NCT01448824|83274026|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
47024802|NCT01448824|83274027|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
47024803|NCT01448824|83274028|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
47024804|NCT01448824|83274029|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
47024805|NCT01448824|83274022|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
47024806|NCT01448824|83274023|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
47024807|NCT01448824|83274024|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
47024808|NCT01448824|83274025|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
47024809|NCT01448824|83274026|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
47024810|NCT01448824|83274027|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
47024811|NCT01448824|83274028|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
47024812|NCT01448824|83274029|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
47024813|NCT01448824|83274022|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
47024814|NCT01448824|83274023|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
47024815|NCT01448824|83274024|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
47024816|NCT01448824|83274025|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
47024817|NCT01448824|83274026|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
47024818|NCT01448824|83274027|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
47024819|NCT01448824|83274028|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
46620919|NCT03969888|82771827|FG003|Overall Study|Reason Not Specified|0|||
47024820|NCT01448824|83274029|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
47024821|NCT01448824|83274022|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
47024822|NCT01448824|83274023|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
47024823|NCT01448824|83274024|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
47024824|NCT01448824|83274025|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
47024825|NCT01448824|83274026|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
47024826|NCT01448824|83274027|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
47024827|NCT01448824|83274028|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
47024828|NCT01448824|83274029|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
47024829|NCT01448824|83274022|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
47024830|NCT01448824|83274023|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
47024831|NCT01448824|83274024|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
47024832|NCT01448824|83274025|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
47024833|NCT01448824|83274026|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
47024834|NCT01448824|83274027|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
47024835|NCT01448824|83274028|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
47024836|NCT01448824|83274029|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
47024837|NCT02005562|83274059|FG000|Overall Study|Death|2|||
47024838|NCT02005562|83274060|FG001|Overall Study|Death|2|||
47024839|NCT02005562|83274059|FG000|Overall Study|Graft loss|7|||
47024840|NCT02005562|83274060|FG001|Overall Study|Graft loss|6|||
47024841|NCT02005562|83274059|FG000|Overall Study|Withdrawal by Subject|2|||
47024842|NCT02005562|83274060|FG001|Overall Study|Withdrawal by Subject|2|||
47024843|NCT02005562|83274059|FG000|Overall Study|No transplant|1|||
47024844|NCT02005562|83274060|FG001|Overall Study|No transplant|4|||
47024845|NCT02005562|83274059|FG000|Overall Study|Physician Decision|0|||
47024846|NCT02005562|83274060|FG001|Overall Study|Physician Decision|1|||
47024847|NCT01448044|83274068|FG000|Treatment Period|Adverse Event|4|||
47024848|NCT01448044|83274069|FG001|Treatment Period|Adverse Event|3|||
47024849|NCT01448044|83274068|FG000|Treatment Period|Lack of Efficacy|5|||
47024850|NCT01448044|83274069|FG001|Treatment Period|Lack of Efficacy|12|||
47024851|NCT01448044|83274068|FG000|Treatment Period|Subject requested discontinue study drug|1|||
47024852|NCT01448044|83274069|FG001|Treatment Period|Subject requested discontinue study drug|0|||
47024853|NCT01448044|83274068|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
47024854|NCT01448044|83274069|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
47024855|NCT01448044|83274068|FG000|Treatment Period|Participant does not meet study criteria|1|||
47024856|NCT01448044|83274069|FG001|Treatment Period|Participant does not meet study criteria|0|||
47024857|NCT01448044|83274068|FG000|Treatment Period|Lost to Follow-up|2|||
47024858|NCT01448044|83274069|FG001|Treatment Period|Lost to Follow-up|1|||
47024859|NCT01448044|83274068|FG000|Treatment Period|Other reason|2|||
47024860|NCT01448044|83274069|FG001|Treatment Period|Other reason|0|||
47024861|NCT01448044|83274068|FG000|Follow Up Period|Withdrawal by Subject|1|||
47024862|NCT01448044|83274069|FG001|Follow Up Period|Withdrawal by Subject|1|||
47024863|NCT01448044|83274068|FG000|Follow Up Period|Lost to Follow-up|6|||
47024864|NCT01448044|83274069|FG001|Follow Up Period|Lost to Follow-up|2|||
47024865|NCT01448044|83274068|FG000|Follow Up Period|Other|5|||
47024866|NCT01448044|83274069|FG001|Follow Up Period|Other|11|||
47024867|NCT02025530|83274077|FG000|Overall Study|No longer met elligibility criteria|5|||
47024868|NCT02025530|83274078|FG001|Overall Study|No longer met elligibility criteria|1|||
47024869|NCT01472380|83274084|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
47024870|NCT01472380|83274084|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
47024871|NCT01978262|83274091|FG000|Overall Study|Withdrawal by Subject|9|||
47024872|NCT01978262|83274091|FG000|Overall Study|Lost to Follow-up|2|||
47024873|NCT01447576|83274096|FG000|Overall Study|Lost to Follow-up|52|||
47024874|NCT01447576|83274096|FG000|Overall Study|Adverse Event|127|||
47024875|NCT01447576|83274096|FG000|Overall Study|Participant met withdrawal criteria|40|||
47024876|NCT01447576|83274096|FG000|Overall Study|Withdrawal by Subject|100|||
47024877|NCT01447576|83274096|FG000|Overall Study|Protocol deviation|83|||
47024878|NCT01447576|83274096|FG000|Overall Study|Lack of Efficacy|68|||
47024879|NCT01447576|83274096|FG000|Overall Study|Physician Decision|6|||
47024880|NCT01447420|83274103|FG000|Overall Study|Adverse Event|2|||
47024881|NCT01447420|83274104|FG001|Overall Study|Adverse Event|4|||
47024882|NCT01447420|83274105|FG002|Overall Study|Adverse Event|2|||
47024883|NCT01447420|83274103|FG000|Overall Study|Protocol Violation|3|||
47024884|NCT01447420|83274104|FG001|Overall Study|Protocol Violation|3|||
47024885|NCT01447420|83274105|FG002|Overall Study|Protocol Violation|0|||
47024886|NCT01447420|83274103|FG000|Overall Study|Withdrawal by Subject|4|||
47024887|NCT01447420|83274104|FG001|Overall Study|Withdrawal by Subject|1|||
47024888|NCT01447420|83274105|FG002|Overall Study|Withdrawal by Subject|0|||
47024889|NCT01447420|83274103|FG000|Overall Study|Lack of Efficacy|1|||
47024890|NCT01447420|83274104|FG001|Overall Study|Lack of Efficacy|19|||
47024891|NCT01447420|83274105|FG002|Overall Study|Lack of Efficacy|8|||
47024892|NCT01446874|83274115|FG000|Overall Study|Not eligible|1|||
47024893|NCT01446874|83274116|FG001|Overall Study|Not eligible|0|||
46620920|NCT03969888|82771828|FG004|Overall Study|Reason Not Specified|0|||
46620921|NCT03969888|82771829|FG005|Overall Study|Reason Not Specified|0|||
46620922|NCT03969888|82771830|FG006|Overall Study|Reason Not Specified|0|||
46620923|NCT03969888|82771831|FG007|Overall Study|Reason Not Specified|1|||
46620924|NCT03942406|82771857|FG000|Overall Study|Lost to Follow-up|4|||
46620925|NCT03942406|82771858|FG001|Overall Study|Lost to Follow-up|5|||
46620926|NCT03942406|82771859|FG002|Overall Study|Lost to Follow-up|3|||
46620927|NCT03942406|82771860|FG003|Overall Study|Lost to Follow-up|7|||
46620928|NCT03942406|82771861|FG004|Overall Study|Lost to Follow-up|1|||
46620929|NCT03942406|82771862|FG005|Overall Study|Lost to Follow-up|0|||
46620930|NCT03942406|82771863|FG006|Overall Study|Lost to Follow-up|0|||
46620931|NCT03942406|82771857|FG000|Overall Study|Withdrawal by Subject|3|||
46620932|NCT03942406|82771858|FG001|Overall Study|Withdrawal by Subject|1|||
46620933|NCT03942406|82771859|FG002|Overall Study|Withdrawal by Subject|1|||
46620934|NCT03942406|82771860|FG003|Overall Study|Withdrawal by Subject|3|||
46620935|NCT03942406|82771861|FG004|Overall Study|Withdrawal by Subject|0|||
46620936|NCT03942406|82771862|FG005|Overall Study|Withdrawal by Subject|0|||
46620937|NCT03942406|82771863|FG006|Overall Study|Withdrawal by Subject|0|||
46620938|NCT03942406|82771857|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
46620939|NCT03942406|82771858|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
46620940|NCT03942406|82771859|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
46620941|NCT03942406|82771860|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
46620942|NCT03942406|82771861|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
46620943|NCT03942406|82771862|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
46620944|NCT03942406|82771863|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
46620945|NCT03909100|82771897|FG000|Overall Study|Protocol Deviation|2|||
46620946|NCT03909100|82771897|FG000|Overall Study|Technical Problems|4|||
46620947|NCT03909100|82771897|FG000|Overall Study|Withdrawal by Subject|4|||
46620948|NCT03909100|82771897|FG000|Overall Study|Lost to Follow-up|1|||
46620949|NCT03909100|82771897|FG000|Overall Study|Reason not Specified|4|||
46620950|NCT03896295|82771919|FG000|Overall Study|Adverse Event|0|||
46620951|NCT03896295|82771920|FG001|Overall Study|Adverse Event|1|||
46620952|NCT03896295|82771919|FG000|Overall Study|COVID-19|7|||
46620953|NCT03896295|82771920|FG001|Overall Study|COVID-19|29|||
46620954|NCT03734666|82771961|FG000|Overall Study|Other|7|||
46620955|NCT03734666|82771962|FG001|Overall Study|Other|4|||
46620956|NCT03734666|82771961|FG000|Overall Study|Lost to Follow-up|12|||
46620957|NCT03734666|82771962|FG001|Overall Study|Lost to Follow-up|12|||
46620958|NCT03635489|82771984|FG000|Overall Study|Death|6|||
46620959|NCT03635489|82771985|FG001|Overall Study|Death|3|||
46620960|NCT03635489|82771984|FG000|Overall Study|Lost to Follow-up|0|||
46620961|NCT03635489|82771985|FG001|Overall Study|Lost to Follow-up|1|||
46620962|NCT03635489|82771984|FG000|Overall Study|Withdrawal by Subject|1|||
46620963|NCT03635489|82771985|FG001|Overall Study|Withdrawal by Subject|2|||
46620964|NCT03633617|82771996|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
46620965|NCT03633617|82771997|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
46620966|NCT03633617|82771998|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620967|NCT03633617|82771999|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620968|NCT03633617|82772000|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620969|NCT03633617|82772001|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620970|NCT03633617|82772002|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620971|NCT03633617|82772003|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620972|NCT03633617|82772004|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620973|NCT03633617|82772005|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620974|NCT03633617|82772006|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
46620975|NCT03633617|82771996|FG000|Part A|Unconfirmed early termination visit|1|||
46620976|NCT03633617|82771997|FG001|Part A|Unconfirmed early termination visit|0|||
46620977|NCT03633617|82771998|FG002|Part A|Unconfirmed early termination visit|0|||
46620978|NCT03633617|82771999|FG003|Part A|Unconfirmed early termination visit|0|||
46620979|NCT03633617|82772000|FG004|Part A|Unconfirmed early termination visit|0|||
46620980|NCT03633617|82772001|FG005|Part A|Unconfirmed early termination visit|0|||
46620981|NCT03633617|82772002|FG006|Part A|Unconfirmed early termination visit|0|||
46620982|NCT03633617|82772003|FG007|Part A|Unconfirmed early termination visit|0|||
46620983|NCT03633617|82772004|FG008|Part A|Unconfirmed early termination visit|0|||
46620984|NCT03633617|82772005|FG009|Part A|Unconfirmed early termination visit|0|||
46620985|NCT03633617|82772006|FG010|Part A|Unconfirmed early termination visit|0|||
46620986|NCT03633617|82771996|FG000|Part A|Adverse Event|0|||
46620987|NCT03633617|82771997|FG001|Part A|Adverse Event|1|||
46620988|NCT03633617|82771998|FG002|Part A|Adverse Event|0|||
46620989|NCT03633617|82771999|FG003|Part A|Adverse Event|0|||
46620990|NCT03633617|82772000|FG004|Part A|Adverse Event|0|||
46620991|NCT03633617|82772001|FG005|Part A|Adverse Event|0|||
46620992|NCT03633617|82772002|FG006|Part A|Adverse Event|0|||
46620993|NCT03633617|82772003|FG007|Part A|Adverse Event|0|||
46620994|NCT03633617|82772004|FG008|Part A|Adverse Event|0|||
46620995|NCT03633617|82772005|FG009|Part A|Adverse Event|0|||
46620996|NCT03633617|82772006|FG010|Part A|Adverse Event|0|||
46620997|NCT03633617|82771996|FG000|Part A|Pregnancy|1|||
46620998|NCT03633617|82771997|FG001|Part A|Pregnancy|0|||
46620999|NCT03633617|82771998|FG002|Part A|Pregnancy|0|||
46621000|NCT03633617|82771999|FG003|Part A|Pregnancy|0|||
46621001|NCT03633617|82772000|FG004|Part A|Pregnancy|0|||
46621002|NCT03633617|82772001|FG005|Part A|Pregnancy|0|||
46621003|NCT03633617|82772002|FG006|Part A|Pregnancy|0|||
46621004|NCT03633617|82772003|FG007|Part A|Pregnancy|0|||
46621005|NCT03633617|82772004|FG008|Part A|Pregnancy|0|||
46621006|NCT03633617|82772005|FG009|Part A|Pregnancy|0|||
46621007|NCT03633617|82772006|FG010|Part A|Pregnancy|0|||
46621008|NCT03633617|82771996|FG000|Part A|Withdrawal by Subject|0|||
46621009|NCT03633617|82771997|FG001|Part A|Withdrawal by Subject|1|||
46621010|NCT03633617|82771998|FG002|Part A|Withdrawal by Subject|0|||
46621011|NCT03633617|82771999|FG003|Part A|Withdrawal by Subject|0|||
46621012|NCT03633617|82772000|FG004|Part A|Withdrawal by Subject|0|||
46621013|NCT03633617|82772001|FG005|Part A|Withdrawal by Subject|0|||
46621014|NCT03633617|82772002|FG006|Part A|Withdrawal by Subject|0|||
46621015|NCT03633617|82772003|FG007|Part A|Withdrawal by Subject|0|||
46621016|NCT03633617|82772004|FG008|Part A|Withdrawal by Subject|0|||
46621017|NCT03633617|82772005|FG009|Part A|Withdrawal by Subject|0|||
46621018|NCT03633617|82772006|FG010|Part A|Withdrawal by Subject|0|||
46621019|NCT03633617|82771996|FG000|Part B|Adverse Event|0|||
46621020|NCT03633617|82771997|FG001|Part B|Adverse Event|0|||
46621021|NCT03633617|82771998|FG002|Part B|Adverse Event|2|||
46621022|NCT03633617|82771999|FG003|Part B|Adverse Event|2|||
46621023|NCT03633617|82772000|FG004|Part B|Adverse Event|1|||
46621024|NCT03633617|82772001|FG005|Part B|Adverse Event|0|||
46621025|NCT03633617|82772002|FG006|Part B|Adverse Event|0|||
46621026|NCT03633617|82772003|FG007|Part B|Adverse Event|0|||
46621027|NCT03633617|82772004|FG008|Part B|Adverse Event|0|||
46621028|NCT03633617|82772005|FG009|Part B|Adverse Event|0|||
46621029|NCT03633617|82772006|FG010|Part B|Adverse Event|0|||
46621030|NCT03633617|82771996|FG000|Part B|Withdrawal by Subject|0|||
46621031|NCT03633617|82771997|FG001|Part B|Withdrawal by Subject|0|||
46621032|NCT03633617|82771998|FG002|Part B|Withdrawal by Subject|1|||
46621033|NCT03633617|82771999|FG003|Part B|Withdrawal by Subject|0|||
46621034|NCT03633617|82772000|FG004|Part B|Withdrawal by Subject|2|||
46621035|NCT03633617|82772001|FG005|Part B|Withdrawal by Subject|0|||
46621036|NCT03633617|82772002|FG006|Part B|Withdrawal by Subject|0|||
46621037|NCT03633617|82772003|FG007|Part B|Withdrawal by Subject|0|||
46911714|NCT02925312|83141732|FG000|Overall Study|Lost to Follow-up|25|||
46621038|NCT03633617|82772004|FG008|Part B|Withdrawal by Subject|0|||
46621039|NCT03633617|82772005|FG009|Part B|Withdrawal by Subject|0|||
46621040|NCT03633617|82772006|FG010|Part B|Withdrawal by Subject|0|||
46621041|NCT03633617|82771996|FG000|Part B|Lost to Follow-up|0|||
46621042|NCT03633617|82771997|FG001|Part B|Lost to Follow-up|0|||
46621043|NCT03633617|82771998|FG002|Part B|Lost to Follow-up|0|||
46621044|NCT03633617|82771999|FG003|Part B|Lost to Follow-up|0|||
46621045|NCT03633617|82772000|FG004|Part B|Lost to Follow-up|1|||
46621046|NCT03633617|82772001|FG005|Part B|Lost to Follow-up|0|||
46621047|NCT03633617|82772002|FG006|Part B|Lost to Follow-up|0|||
46621048|NCT03633617|82772003|FG007|Part B|Lost to Follow-up|0|||
46621049|NCT03633617|82772004|FG008|Part B|Lost to Follow-up|0|||
46621050|NCT03633617|82772005|FG009|Part B|Lost to Follow-up|0|||
46621051|NCT03633617|82772006|FG010|Part B|Lost to Follow-up|0|||
46621052|NCT03633617|82771996|FG000|Part B|Physician Decision|0|||
46621053|NCT03633617|82771997|FG001|Part B|Physician Decision|0|||
46621054|NCT03633617|82771998|FG002|Part B|Physician Decision|0|||
46621055|NCT03633617|82771999|FG003|Part B|Physician Decision|0|||
46621056|NCT03633617|82772000|FG004|Part B|Physician Decision|1|||
46621057|NCT03633617|82772001|FG005|Part B|Physician Decision|0|||
46621058|NCT03633617|82772002|FG006|Part B|Physician Decision|0|||
46621059|NCT03633617|82772003|FG007|Part B|Physician Decision|0|||
46621060|NCT03633617|82772004|FG008|Part B|Physician Decision|0|||
46621061|NCT03633617|82772005|FG009|Part B|Physician Decision|0|||
46621062|NCT03633617|82772006|FG010|Part B|Physician Decision|0|||
46621063|NCT03633617|82771996|FG000|Part B|COVID-19 Restrictions|0|||
46621064|NCT03633617|82771997|FG001|Part B|COVID-19 Restrictions|0|||
46621065|NCT03633617|82771998|FG002|Part B|COVID-19 Restrictions|1|||
46621066|NCT03633617|82771999|FG003|Part B|COVID-19 Restrictions|0|||
46621067|NCT03633617|82772000|FG004|Part B|COVID-19 Restrictions|0|||
46621068|NCT03633617|82772001|FG005|Part B|COVID-19 Restrictions|0|||
46621069|NCT03633617|82772002|FG006|Part B|COVID-19 Restrictions|0|||
46621070|NCT03633617|82772003|FG007|Part B|COVID-19 Restrictions|0|||
46621071|NCT03633617|82772004|FG008|Part B|COVID-19 Restrictions|0|||
46621072|NCT03633617|82772005|FG009|Part B|COVID-19 Restrictions|0|||
47024894|NCT01446874|83274117|FG002|Overall Study|Not eligible|0|||
47024895|NCT01446874|83274115|FG000|Overall Study|No surgery/No qualifying surgery|1|||
47024896|NCT01446874|83274116|FG001|Overall Study|No surgery/No qualifying surgery|0|||
47024897|NCT01446874|83274117|FG002|Overall Study|No surgery/No qualifying surgery|12|||
47024898|NCT01446874|83274115|FG000|Overall Study|Non-compliance|0|||
47024899|NCT01446874|83274116|FG001|Overall Study|Non-compliance|4|||
47024900|NCT01446874|83274117|FG002|Overall Study|Non-compliance|0|||
46621073|NCT03633617|82772006|FG010|Part B|COVID-19 Restrictions|0|||
46621074|NCT03633617|82771996|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621075|NCT03633617|82771997|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621076|NCT03633617|82771998|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
46621077|NCT03633617|82771999|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621078|NCT03633617|82772000|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621079|NCT03633617|82772001|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621080|NCT03633617|82772002|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621081|NCT03633617|82772003|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621082|NCT03633617|82772004|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621083|NCT03633617|82772005|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621084|NCT03633617|82772006|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
46621085|NCT03633617|82771996|FG000|Part C (& Follow-up)|Adverse Event|0|||
46621086|NCT03633617|82771997|FG001|Part C (& Follow-up)|Adverse Event|0|||
46621087|NCT03633617|82771998|FG002|Part C (& Follow-up)|Adverse Event|0|||
46621088|NCT03633617|82771999|FG003|Part C (& Follow-up)|Adverse Event|0|||
46621089|NCT03633617|82772000|FG004|Part C (& Follow-up)|Adverse Event|0|||
46621090|NCT03633617|82772001|FG005|Part C (& Follow-up)|Adverse Event|1|||
46621091|NCT03633617|82772002|FG006|Part C (& Follow-up)|Adverse Event|0|||
46621092|NCT03633617|82772003|FG007|Part C (& Follow-up)|Adverse Event|1|||
47024901|NCT01446874|83274115|FG000|Overall Study|Antibiotics for pre-op infection|0|||
47024902|NCT01446874|83274116|FG001|Overall Study|Antibiotics for pre-op infection|0|||
46621093|NCT03633617|82772004|FG008|Part C (& Follow-up)|Adverse Event|0|||
46621094|NCT03633617|82772005|FG009|Part C (& Follow-up)|Adverse Event|0|||
46621095|NCT03633617|82772006|FG010|Part C (& Follow-up)|Adverse Event|0|||
46621096|NCT03633617|82771996|FG000|Part C (& Follow-up)|Pregnancy|0|||
46621097|NCT03633617|82771997|FG001|Part C (& Follow-up)|Pregnancy|0|||
46621098|NCT03633617|82771998|FG002|Part C (& Follow-up)|Pregnancy|0|||
46621099|NCT03633617|82771999|FG003|Part C (& Follow-up)|Pregnancy|0|||
46621100|NCT03633617|82772000|FG004|Part C (& Follow-up)|Pregnancy|0|||
46621101|NCT03633617|82772001|FG005|Part C (& Follow-up)|Pregnancy|0|||
46911715|NCT02925312|83141733|FG001|Overall Study|Lost to Follow-up|0|||
46911716|NCT02925312|83141732|FG000|Overall Study|Adverse Event|2|||
47024903|NCT01446874|83274117|FG002|Overall Study|Antibiotics for pre-op infection|2|||
47024904|NCT01446874|83274115|FG000|Overall Study|Withdrawal by Subject|0|||
46621102|NCT03633617|82772002|FG006|Part C (& Follow-up)|Pregnancy|0|||
46621103|NCT03633617|82772003|FG007|Part C (& Follow-up)|Pregnancy|0|||
46621104|NCT03633617|82772004|FG008|Part C (& Follow-up)|Pregnancy|0|||
46621105|NCT03633617|82772005|FG009|Part C (& Follow-up)|Pregnancy|1|||
46621106|NCT03633617|82772006|FG010|Part C (& Follow-up)|Pregnancy|0|||
46621107|NCT03633617|82771996|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
46621108|NCT03633617|82771997|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
46621109|NCT03633617|82771998|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
46621110|NCT03633617|82771999|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
46621111|NCT03633617|82772000|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
46621112|NCT03633617|82772001|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
46621113|NCT03633617|82772002|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
46621114|NCT03633617|82772003|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
47024905|NCT01446874|83274116|FG001|Overall Study|Withdrawal by Subject|0|||
47024906|NCT01446874|83274117|FG002|Overall Study|Withdrawal by Subject|4|||
47024907|NCT01446796|83274125|FG000|Overall Study|Withdrawal by Subject|1|||
47024908|NCT01446796|83274126|FG001|Overall Study|Withdrawal by Subject|0|||
47024909|NCT01439074|83274136|FG000|Overall Study|Lost to Follow-up|3|||
47024910|NCT01439074|83274137|FG001|Overall Study|Lost to Follow-up|4|||
47024911|NCT01439074|83274136|FG000|Overall Study|Subject shedding|1|||
47024912|NCT01439074|83274137|FG001|Overall Study|Subject shedding|0|||
47024913|NCT01439074|83274136|FG000|Overall Study|Withdrawal by Subject|1|||
47024914|NCT01439074|83274137|FG001|Overall Study|Withdrawal by Subject|5|||
47024915|NCT01439074|83274136|FG000|Overall Study|Other|4|||
47024916|NCT01439074|83274137|FG001|Overall Study|Other|4|||
47024917|NCT01438996|83274146|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
47024918|NCT01438996|83274147|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
47024919|NCT01438996|83274148|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
47024920|NCT01438840|83274158|FG000|Core Study|Adverse Event|0|||
47024921|NCT01438840|83274159|FG001|Core Study|Adverse Event|3|||
46621115|NCT03633617|82772004|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
46621116|NCT03633617|82772005|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
46621117|NCT03633617|82772006|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
46911717|NCT02925312|83141733|FG001|Overall Study|Adverse Event|0|||
47024922|NCT01438840|83274160|FG002|Core Study|Adverse Event|0|||
47024923|NCT01438840|83274158|FG000|Core Study|Lack of Efficacy|15|||
47024924|NCT01438840|83274159|FG001|Core Study|Lack of Efficacy|7|||
47024925|NCT01438840|83274160|FG002|Core Study|Lack of Efficacy|0|||
47024926|NCT01438840|83274158|FG000|Core Study|Withdrawal of consent|1|||
46621118|NCT03633617|82771996|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
46621119|NCT03633617|82771997|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
46621120|NCT03633617|82771998|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
46621121|NCT03633617|82771999|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
46621122|NCT03633617|82772000|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
46709904|NCT01169675|82925992|FG001|Overall Study|Other Reason Not Defined Above|0|||
47024927|NCT01438840|83274159|FG001|Core Study|Withdrawal of consent|0|||
47024928|NCT01438840|83274160|FG002|Core Study|Withdrawal of consent|0|||
47024929|NCT01438840|83274158|FG000|Extension Phase|Adverse Event|0|||
47024930|NCT01438840|83274159|FG001|Extension Phase|Adverse Event|0|||
47024931|NCT01438840|83274160|FG002|Extension Phase|Adverse Event|3|||
47024932|NCT01438840|83274158|FG000|Extension Phase|Lost to Follow-up|0|||
47024933|NCT01438840|83274159|FG001|Extension Phase|Lost to Follow-up|0|||
47024934|NCT01438840|83274160|FG002|Extension Phase|Lost to Follow-up|1|||
47024935|NCT01438840|83274158|FG000|Extension Phase|Withdrawal by Subject|0|||
47024936|NCT01438840|83274159|FG001|Extension Phase|Withdrawal by Subject|0|||
47024937|NCT01438840|83274160|FG002|Extension Phase|Withdrawal by Subject|3|||
47024938|NCT01438840|83274158|FG000|Extension Phase|Lack of Efficacy|0|||
47024939|NCT01438840|83274159|FG001|Extension Phase|Lack of Efficacy|0|||
47024940|NCT01438840|83274160|FG002|Extension Phase|Lack of Efficacy|2|||
47024941|NCT01438840|83274158|FG000|Extension Phase|Other|0|||
47024942|NCT01438840|83274159|FG001|Extension Phase|Other|0|||
47024943|NCT01438840|83274160|FG002|Extension Phase|Other|1|||
46621123|NCT03633617|82772001|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
47024944|NCT01471054|83274169|FG000|Overall Study|Study terminated prematurely|4|||
47024945|NCT01471054|83274170|FG001|Overall Study|Study terminated prematurely|0|||
47024946|NCT01978184|83274188|FG000|Overall Study|Progressive disease|5|||
47024947|NCT01978184|83274189|FG001|Overall Study|Progressive disease|5|||
47024948|NCT01978184|83274188|FG000|Overall Study|Other than PDA|2|||
46911718|NCT03196297|83141748|FG000|Main Period|Withdrawal by Subject|4|||
46621124|NCT03633617|82772002|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
46621125|NCT03633617|82772003|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
46621126|NCT03633617|82772004|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
46621127|NCT03633617|82772005|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
46621128|NCT03633617|82772006|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
46621129|NCT03633617|82771996|FG000|Part C (& Follow-up)|Physician Decision|0|||
46621130|NCT03633617|82771997|FG001|Part C (& Follow-up)|Physician Decision|0|||
46621131|NCT03633617|82771998|FG002|Part C (& Follow-up)|Physician Decision|0|||
46621132|NCT03633617|82771999|FG003|Part C (& Follow-up)|Physician Decision|0|||
46911719|NCT03196297|83141748|FG000|Extension Period|Withdrawal by Subject|1|||
46911720|NCT03196297|83141748|FG000|Extension Period|Lack of Efficacy|2|||
46911721|NCT03192475|83141766|FG000|Overall Study|Death|0|||
46911722|NCT03192475|83141767|FG001|Overall Study|Death|1|||
46911723|NCT03192475|83141766|FG000|Overall Study|Lost to Follow-up|13|||
46911724|NCT03192475|83141767|FG001|Overall Study|Lost to Follow-up|8|||
46911725|NCT03189745|83141776|FG000|Overall Study|Conflict in work schedule of participant|1|||
46911726|NCT03189745|83141777|FG001|Overall Study|Conflict in work schedule of participant|1|||
46911727|NCT03188263|83141785|FG000|Overall Study|Withdrawal by Subject|3|||
46911728|NCT03188263|83141786|FG001|Overall Study|Withdrawal by Subject|0|||
46911729|NCT03188263|83141785|FG000|Overall Study|Physician Decision|1|||
46911730|NCT03188263|83141786|FG001|Overall Study|Physician Decision|0|||
46621133|NCT03633617|82772000|FG004|Part C (& Follow-up)|Physician Decision|0|||
46911731|NCT03188185|83141794|FG000|Stage 1|Adverse Event|4|||
46911732|NCT03188185|83141795|FG001|Stage 1|Adverse Event|12|||
46621134|NCT03633617|82772001|FG005|Part C (& Follow-up)|Physician Decision|0|||
46911733|NCT03188185|83141796|FG002|Stage 1|Adverse Event|0|||
46911734|NCT03188185|83141797|FG003|Stage 1|Adverse Event|0|||
46621135|NCT03633617|82772002|FG006|Part C (& Follow-up)|Physician Decision|0|||
46621136|NCT03633617|82772003|FG007|Part C (& Follow-up)|Physician Decision|1|||
46621137|NCT03633617|82772004|FG008|Part C (& Follow-up)|Physician Decision|0|||
46621138|NCT03633617|82772005|FG009|Part C (& Follow-up)|Physician Decision|0|||
46621139|NCT03633617|82772006|FG010|Part C (& Follow-up)|Physician Decision|1|||
46621140|NCT03633617|82771996|FG000|Part C (& Follow-up)|COVID-19 related|0|||
46621141|NCT03633617|82771997|FG001|Part C (& Follow-up)|COVID-19 related|0|||
46621142|NCT03633617|82771998|FG002|Part C (& Follow-up)|COVID-19 related|0|||
46621143|NCT03633617|82771999|FG003|Part C (& Follow-up)|COVID-19 related|0|||
46621144|NCT03633617|82772000|FG004|Part C (& Follow-up)|COVID-19 related|0|||
46621145|NCT03633617|82772001|FG005|Part C (& Follow-up)|COVID-19 related|1|||
46621146|NCT03633617|82772002|FG006|Part C (& Follow-up)|COVID-19 related|0|||
46621147|NCT03633617|82772003|FG007|Part C (& Follow-up)|COVID-19 related|0|||
46621148|NCT03633617|82772004|FG008|Part C (& Follow-up)|COVID-19 related|0|||
47024949|NCT01978184|83274189|FG001|Overall Study|Other than PDA|2|||
47024950|NCT01978184|83274188|FG000|Overall Study|Physician Decision|0|||
47024951|NCT01978184|83274189|FG001|Overall Study|Physician Decision|3|||
47024952|NCT01978184|83274188|FG000|Overall Study|Noncompliance|1|||
47024953|NCT01978184|83274189|FG001|Overall Study|Noncompliance|2|||
47024954|NCT01978184|83274188|FG000|Overall Study|Death|1|||
47024955|NCT01978184|83274189|FG001|Overall Study|Death|0|||
47024956|NCT01978184|83274188|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
47024957|NCT01978184|83274189|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
47024958|NCT01445548|83274195|FG000|Overall Study|Adverse Event|1|||
47024959|NCT01977794|83274201|FG000|Overall Study|Adverse Event|2|||
47024960|NCT01977794|83274202|FG001|Overall Study|Adverse Event|2|||
47024961|NCT01977794|83274201|FG000|Overall Study|Lost to Follow-up|2|||
47024962|NCT01977794|83274202|FG001|Overall Study|Lost to Follow-up|1|||
47024963|NCT01977794|83274201|FG000|Overall Study|Protocol Violation|1|||
47024964|NCT01977794|83274202|FG001|Overall Study|Protocol Violation|0|||
47024965|NCT01977794|83274201|FG000|Overall Study|Death|1|||
47024966|NCT01977794|83274202|FG001|Overall Study|Death|1|||
47024967|NCT01977794|83274201|FG000|Overall Study|Withdrew consent|2|||
47024968|NCT01977794|83274202|FG001|Overall Study|Withdrew consent|1|||
47024969|NCT01977794|83274201|FG000|Overall Study|Other|0|||
47024970|NCT01977794|83274202|FG001|Overall Study|Other|1|||
47024971|NCT02005484|83274208|FG000|Overall Study|Death|1|||
47024972|NCT02005484|83274208|FG000|Overall Study|Disease progression|1|||
47024973|NCT02005484|83274208|FG000|Overall Study|Changed to a Different Study|1|||
47024974|NCT02005484|83274208|FG000|Overall Study|Sponsor decision|1|||
47024975|NCT02005250|83274214|FG000|Overall Study|Lost to Follow-up|15|||
47024976|NCT02005250|83274215|FG001|Overall Study|Lost to Follow-up|5|||
47024977|NCT02024750|83274223|FG000|Overall Study|Withdrawal by Subject|2|||
47024978|NCT02024750|83274224|FG001|Overall Study|Withdrawal by Subject|1|||
47024979|NCT01597973|83274232|FG000|Overall Study|Found ineligible before study medication started|4|||
47024980|NCT01597973|83274233|FG001|Overall Study|Found ineligible before study medication started|2|||
47024981|NCT01597973|83274232|FG000|Overall Study|Eligible pathogen not confirmed|14|||
47024982|NCT01597973|83274233|FG001|Overall Study|Eligible pathogen not confirmed|15|||
47024983|NCT01597973|83274232|FG000|Overall Study|LAR not authorized to consent|0|||
47024984|NCT01597973|83274233|FG001|Overall Study|LAR not authorized to consent|1|||
47024985|NCT01597973|83274232|FG000|Overall Study|Ineligible due to early seizures|1|||
46621149|NCT03633617|82772005|FG009|Part C (& Follow-up)|COVID-19 related|0|||
47024986|NCT01597973|83274233|FG001|Overall Study|Ineligible due to early seizures|0|||
46621150|NCT03633617|82772006|FG010|Part C (& Follow-up)|COVID-19 related|0|||
46621151|NCT03633617|82771996|FG000|Part C (& Follow-up)|Protocol Violation|0|||
46621152|NCT03633617|82771997|FG001|Part C (& Follow-up)|Protocol Violation|0|||
46621153|NCT03633617|82771998|FG002|Part C (& Follow-up)|Protocol Violation|0|||
46621154|NCT03633617|82771999|FG003|Part C (& Follow-up)|Protocol Violation|0|||
46621155|NCT03633617|82772000|FG004|Part C (& Follow-up)|Protocol Violation|0|||
46621156|NCT03633617|82772001|FG005|Part C (& Follow-up)|Protocol Violation|0|||
46621157|NCT03633617|82772002|FG006|Part C (& Follow-up)|Protocol Violation|0|||
46621158|NCT03633617|82772003|FG007|Part C (& Follow-up)|Protocol Violation|0|||
46621159|NCT03633617|82772004|FG008|Part C (& Follow-up)|Protocol Violation|0|||
46621160|NCT03633617|82772005|FG009|Part C (& Follow-up)|Protocol Violation|3|||
46621161|NCT03633617|82772006|FG010|Part C (& Follow-up)|Protocol Violation|1|||
46621162|NCT03633617|82771996|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
46621163|NCT03633617|82771997|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
46621164|NCT03633617|82771998|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
46621165|NCT03633617|82771999|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
46621166|NCT03633617|82772000|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
46621167|NCT03633617|82772001|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
46621168|NCT03633617|82772002|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
46621169|NCT03633617|82772003|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
46621170|NCT03633617|82772004|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
46621171|NCT03633617|82772005|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
46621172|NCT03633617|82772006|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
46621173|NCT03631784|82772036|FG000|Overall Study|Death|48|||
46621174|NCT03631784|82772037|FG001|Overall Study|Death|28|||
46621175|NCT03631784|82772036|FG000|Overall Study|Lost to Follow-up|1|||
46621176|NCT03631784|82772037|FG001|Overall Study|Lost to Follow-up|0|||
46621177|NCT03631784|82772036|FG000|Overall Study|Withdrawal by Subject|0|||
46621178|NCT03631784|82772037|FG001|Overall Study|Withdrawal by Subject|3|||
46621179|NCT03631784|82772036|FG000|Overall Study|Participants Ongoing|63|||
46621180|NCT03631784|82772037|FG001|Overall Study|Participants Ongoing|71|||
46621181|NCT03617705|82772043|FG000|Overall Study|Withdrawal by Subject|2|||
46621182|NCT03617705|82772043|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
46621183|NCT03617705|82772043|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
46621184|NCT03568318|82772071|FG000|Overall Study|Adverse Event|3|||
46621185|NCT03568318|82772072|FG001|Overall Study|Adverse Event|1|||
47024987|NCT01597973|83274232|FG000|Overall Study|Ineligible due to non-target infection|1|||
47024988|NCT01597973|83274233|FG001|Overall Study|Ineligible due to non-target infection|1|||
47024989|NCT02023268|83274243|FG000|Overall Study|Lack of Efficacy|0|||
47024990|NCT02023268|83274244|FG001|Overall Study|Lack of Efficacy|1|||
47024991|NCT02023268|83274243|FG000|Overall Study|Adverse Event|0|||
47024992|NCT02023268|83274244|FG001|Overall Study|Adverse Event|2|||
47024993|NCT02023268|83274243|FG000|Overall Study|Withdrawal by Subject|0|||
47024994|NCT02023268|83274244|FG001|Overall Study|Withdrawal by Subject|1|||
47024995|NCT02047253|83274250|FG000|Overall Study|Lost to Follow-up|8|||
47024996|NCT02096705|83274256|FG000|Treatment|Adverse Event|6|||
46621186|NCT03568318|82772073|FG002|Overall Study|Adverse Event|1|||
46621187|NCT03568318|82772074|FG003|Overall Study|Adverse Event|0|||
46621188|NCT03568318|82772075|FG004|Overall Study|Adverse Event|1|||
46621189|NCT03568318|82772076|FG005|Overall Study|Adverse Event|0|||
46621190|NCT03568318|82772071|FG000|Overall Study|Withdrawal by Subject|6|||
47024997|NCT02096705|83274257|FG001|Treatment|Adverse Event|3|||
47024998|NCT02096705|83274256|FG000|Treatment|Subject request to discontinue treatment|1|||
47024999|NCT02096705|83274257|FG001|Treatment|Subject request to discontinue treatment|1|||
47025000|NCT02096705|83274256|FG000|Treatment|Withdrawal by Subject|1|||
47025001|NCT02096705|83274257|FG001|Treatment|Withdrawal by Subject|0|||
47025002|NCT02096705|83274256|FG000|Treatment|Other|1|||
47025003|NCT02096705|83274257|FG001|Treatment|Other|1|||
47025004|NCT02096705|83274256|FG000|Follow-up|Withdrawal by Subject|1|||
47025005|NCT02096705|83274257|FG001|Follow-up|Withdrawal by Subject|0|||
47025006|NCT02096705|83274256|FG000|Follow-up|Adverse Event|2|||
47025007|NCT02096705|83274257|FG001|Follow-up|Adverse Event|2|||
47025008|NCT02096705|83274256|FG000|Follow-up|Subjects not reporting status|1|||
47025009|NCT02096705|83274257|FG001|Follow-up|Subjects not reporting status|2|||
46621191|NCT03568318|82772072|FG001|Overall Study|Withdrawal by Subject|5|||
46621192|NCT03568318|82772073|FG002|Overall Study|Withdrawal by Subject|2|||
46621193|NCT03568318|82772074|FG003|Overall Study|Withdrawal by Subject|1|||
47025010|NCT02096471|83274263|FG000|Overall Study|Adverse Event|1|||
47025011|NCT02096471|83274263|FG000|Overall Study|Lack of Efficacy|7|||
47025012|NCT02096471|83274263|FG000|Overall Study|Withdrawal by Subject|3|||
47025013|NCT02096471|83274263|FG000|Overall Study|Non-Compliant|2|||
47025014|NCT02096003|83274269|FG000|Overall Study|Protocol Violation|0|||
46621194|NCT03568318|82772075|FG004|Overall Study|Withdrawal by Subject|0|||
46621195|NCT03568318|82772076|FG005|Overall Study|Withdrawal by Subject|0|||
46621196|NCT03568318|82772071|FG000|Overall Study|Lost to Follow-up|3|||
46621197|NCT03568318|82772072|FG001|Overall Study|Lost to Follow-up|2|||
46621198|NCT03568318|82772073|FG002|Overall Study|Lost to Follow-up|2|||
46621199|NCT03568318|82772074|FG003|Overall Study|Lost to Follow-up|2|||
46621200|NCT03568318|82772075|FG004|Overall Study|Lost to Follow-up|1|||
46621201|NCT03568318|82772076|FG005|Overall Study|Lost to Follow-up|0|||
46621202|NCT03568318|82772071|FG000|Overall Study|Other|3|||
46621203|NCT03568318|82772072|FG001|Overall Study|Other|1|||
46621204|NCT03568318|82772073|FG002|Overall Study|Other|3|||
46621205|NCT03568318|82772074|FG003|Overall Study|Other|0|||
46621206|NCT03568318|82772075|FG004|Overall Study|Other|0|||
46621207|NCT03568318|82772076|FG005|Overall Study|Other|0|||
46621208|NCT03568318|82772071|FG000|Overall Study|Ongoing at Time of Analysis|5|||
46621209|NCT03568318|82772072|FG001|Overall Study|Ongoing at Time of Analysis|3|||
46621210|NCT03568318|82772073|FG002|Overall Study|Ongoing at Time of Analysis|2|||
46621211|NCT03568318|82772074|FG003|Overall Study|Ongoing at Time of Analysis|1|||
46621212|NCT03568318|82772075|FG004|Overall Study|Ongoing at Time of Analysis|0|||
46621213|NCT03568318|82772076|FG005|Overall Study|Ongoing at Time of Analysis|0|||
46621214|NCT03550794|82772092|FG000|Overall Study|No longer met inclusion criteria|1|||
46621215|NCT03550794|82772093|FG001|Overall Study|No longer met inclusion criteria|2|||
46621216|NCT03550794|82772092|FG000|Overall Study|Goals of care changed|1|||
47025015|NCT02096003|83274270|FG001|Overall Study|Protocol Violation|2|||
47025016|NCT02096003|83274269|FG000|Overall Study|additional surgery|2|||
47025017|NCT02096003|83274270|FG001|Overall Study|additional surgery|1|||
47025018|NCT02062385|83274280|FG000|Overall Study|Adverse Event|19|||
47025019|NCT02062385|83274281|FG001|Overall Study|Adverse Event|13|||
47025020|NCT02062385|83274282|FG002|Overall Study|Adverse Event|1|||
47025021|NCT02062385|83274283|FG003|Overall Study|Adverse Event|0|||
47025022|NCT02062385|83274280|FG000|Overall Study|Protocol Violation|1|||
47025023|NCT02062385|83274281|FG001|Overall Study|Protocol Violation|0|||
47025024|NCT02062385|83274282|FG002|Overall Study|Protocol Violation|0|||
47025025|NCT02062385|83274283|FG003|Overall Study|Protocol Violation|0|||
47025026|NCT02062385|83274280|FG000|Overall Study|Incomplete EPI by database lock|2|||
47025027|NCT02062385|83274281|FG001|Overall Study|Incomplete EPI by database lock|0|||
47025028|NCT02062385|83274282|FG002|Overall Study|Incomplete EPI by database lock|0|||
47025029|NCT02062385|83274283|FG003|Overall Study|Incomplete EPI by database lock|0|||
47025030|NCT02062385|83274280|FG000|Overall Study|Moved|10|||
47025031|NCT02062385|83274281|FG001|Overall Study|Moved|11|||
47025032|NCT02062385|83274282|FG002|Overall Study|Moved|1|||
47025033|NCT02062385|83274283|FG003|Overall Study|Moved|0|||
47025034|NCT02062385|83274280|FG000|Overall Study|Withdrawn by parent/guardian|46|||
47025035|NCT02062385|83274281|FG001|Overall Study|Withdrawn by parent/guardian|41|||
46621217|NCT03550794|82772093|FG001|Overall Study|Goals of care changed|0|||
46621218|NCT03550794|82772092|FG000|Overall Study|Withdrawal by Subject|2|||
46621219|NCT03550794|82772093|FG001|Overall Study|Withdrawal by Subject|0|||
46621220|NCT03550794|82772092|FG000|Overall Study|Death|0|||
46621221|NCT03550794|82772093|FG001|Overall Study|Death|1|||
46621222|NCT03427125|82772132|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
46621223|NCT03427125|82772133|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
47025036|NCT02062385|83274282|FG002|Overall Study|Withdrawn by parent/guardian|9|||
47025037|NCT02062385|83274283|FG003|Overall Study|Withdrawn by parent/guardian|8|||
47025038|NCT02062385|83274280|FG000|Overall Study|Death|0|||
47025039|NCT02062385|83274281|FG001|Overall Study|Death|0|||
46621224|NCT03427125|82772134|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
46621225|NCT03341273|82772149|FG000|Overall Study|Lost to Follow-up|7|||
46621226|NCT03341273|82772150|FG001|Overall Study|Lost to Follow-up|7|||
46621227|NCT03341273|82772149|FG000|Overall Study|Withdrawal by Subject|4|||
46621228|NCT03341273|82772150|FG001|Overall Study|Withdrawal by Subject|2|||
46621229|NCT03341273|82772149|FG000|Overall Study|Physician Decision|1|||
46621230|NCT03341273|82772150|FG001|Overall Study|Physician Decision|0|||
46621231|NCT03341273|82772149|FG000|Overall Study|Protocol Violation|0|||
46621232|NCT03341273|82772150|FG001|Overall Study|Protocol Violation|1|||
46621233|NCT03341273|82772149|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
46621234|NCT03341273|82772150|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
46621235|NCT03341273|82772149|FG000|Overall Study|Became ineligible after enrollment|1|||
46621236|NCT03341273|82772150|FG001|Overall Study|Became ineligible after enrollment|0|||
46621237|NCT03341273|82772149|FG000|Overall Study|Not Eligible at Enrollment|0|||
46621238|NCT03341273|82772150|FG001|Overall Study|Not Eligible at Enrollment|1|||
46621239|NCT03341273|82772149|FG000|Overall Study|Participant incarcerated|1|||
46621240|NCT03341273|82772150|FG001|Overall Study|Participant incarcerated|0|||
46621241|NCT03248167|82772158|FG000|Overall Study|Withdrawal by Subject|2|||
46621242|NCT03248167|82772159|FG001|Overall Study|Withdrawal by Subject|2|||
46621243|NCT03248167|82772158|FG000|Overall Study|Physician Decision|0|||
46621244|NCT03248167|82772159|FG001|Overall Study|Physician Decision|1|||
46621245|NCT03248167|82772158|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
46621246|NCT03248167|82772159|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
46621247|NCT03248167|82772158|FG000|Overall Study|Lost to Follow-up|1|||
46621248|NCT03248167|82772159|FG001|Overall Study|Lost to Follow-up|0|||
46621249|NCT03220737|82772173|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
46621250|NCT03220737|82772174|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
46621251|NCT03220737|82772175|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
46621252|NCT03220737|82772176|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
46621253|NCT03220737|82772177|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
46621254|NCT03220737|82772178|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
46621255|NCT03220737|82772179|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
46621256|NCT03220737|82772173|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
46621257|NCT03220737|82772174|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
46621258|NCT03220737|82772175|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
46621259|NCT03220737|82772176|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
46621260|NCT03220737|82772177|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
46621261|NCT03220737|82772178|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
46621262|NCT03220737|82772179|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
46621263|NCT03220737|82772173|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
46621264|NCT03220737|82772174|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
46621265|NCT03220737|82772175|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
46621266|NCT03220737|82772176|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
46709905|NCT01169675|82925993|FG002|Overall Study|Other Reason Not Defined Above|0|||
46709906|NCT01169675|82925994|FG003|Overall Study|Other Reason Not Defined Above|1|||
47025040|NCT02062385|83274282|FG002|Overall Study|Death|0|||
47025041|NCT02062385|83274283|FG003|Overall Study|Death|1|||
47025042|NCT02062385|83274280|FG000|Overall Study|Lost to Follow-up|0|||
47025043|NCT02062385|83274281|FG001|Overall Study|Lost to Follow-up|0|||
47025044|NCT02062385|83274282|FG002|Overall Study|Lost to Follow-up|1|||
47025045|NCT02062385|83274283|FG003|Overall Study|Lost to Follow-up|0|||
47025046|NCT02062151|83274291|FG000|Overall Study|screen failure|1|||
46621267|NCT03220737|82772177|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
46621268|NCT03220737|82772178|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
46621269|NCT03220737|82772179|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
46621270|NCT03220737|82772173|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
46621271|NCT03220737|82772174|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
46621272|NCT03220737|82772175|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
46621273|NCT03220737|82772176|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
46709907|NCT01169675|82925995|FG004|Overall Study|Other Reason Not Defined Above|1|||
47025047|NCT02060903|83274297|FG000|Overall Study|Lost to Follow-up|4|||
47025048|NCT02060903|83274298|FG001|Overall Study|Lost to Follow-up|0|||
47025049|NCT02060903|83274297|FG000|Overall Study|Withdrawal by Subject|0|||
46621274|NCT03220737|82772177|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
46621275|NCT03220737|82772178|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
46621276|NCT03220737|82772179|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
46621277|NCT03220737|82772173|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
46621278|NCT03220737|82772174|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
46621279|NCT03220737|82772175|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
46621280|NCT03220737|82772176|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
46621281|NCT03220737|82772177|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
46621282|NCT03220737|82772178|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
46621283|NCT03220737|82772179|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
46621284|NCT03220737|82772173|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
46621285|NCT03220737|82772174|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
46621286|NCT03220737|82772175|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
46621287|NCT03220737|82772176|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
46621288|NCT03220737|82772177|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
46621289|NCT03220737|82772178|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
46621290|NCT03220737|82772179|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
46621291|NCT03220737|82772173|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
46621292|NCT03220737|82772174|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
46621293|NCT03220737|82772175|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
46621294|NCT03220737|82772176|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
46621295|NCT03220737|82772177|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
46621296|NCT03220737|82772178|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
46621297|NCT03220737|82772179|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
46621298|NCT03220737|82772173|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
46621299|NCT03220737|82772174|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
46621300|NCT03220737|82772175|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
46621301|NCT03220737|82772176|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
46709908|NCT00924664|82926009|FG000|Overall Study|Adverse Event|23|||
46709909|NCT00924664|82926010|FG001|Overall Study|Adverse Event|39|||
46709910|NCT00924664|82926009|FG000|Overall Study|Lack of Efficacy|10|||
46709911|NCT00924664|82926010|FG001|Overall Study|Lack of Efficacy|15|||
46709912|NCT00924664|82926009|FG000|Overall Study|Lost to Follow-up|10|||
46709913|NCT00924664|82926010|FG001|Overall Study|Lost to Follow-up|12|||
46911735|NCT03188185|83141794|FG000|Stage 1|Lack of Efficacy|0|||
47025050|NCT02060903|83274298|FG001|Overall Study|Withdrawal by Subject|7|||
47025051|NCT02095691|83274304|FG000|Overall Study|Physician Decision|1|||
47025052|NCT02095535|83274320|FG000|Recruitment|Protocol Violation|2|||
47025053|NCT02095223|83274326|FG000|Overall Study|Withdrawal by Subject|1|||
47025054|NCT02095223|83274327|FG001|Overall Study|Withdrawal by Subject|0|||
47025055|NCT02095145|83274335|FG000|Overall Study|Withdrawal by Subject|1|||
47025056|NCT02095145|83274336|FG001|Overall Study|Withdrawal by Subject|0|||
46621302|NCT03220737|82772177|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
46621303|NCT03220737|82772178|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
46621304|NCT03220737|82772179|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
46709914|NCT00924664|82926009|FG000|Overall Study|Withdrawal by Subject|47|||
46709915|NCT00924664|82926010|FG001|Overall Study|Withdrawal by Subject|71|||
47025057|NCT02059187|83274346|FG000|Overall Study|Adverse Event|0|||
46621305|NCT03198728|82772203|FG000|Overall Study|Adverse Event|10|||
46621306|NCT03198728|82772204|FG001|Overall Study|Adverse Event|5|||
46621307|NCT03198728|82772203|FG000|Overall Study|Lost to Follow-up|21|||
46621308|NCT03198728|82772204|FG001|Overall Study|Lost to Follow-up|7|||
46621309|NCT03198728|82772203|FG000|Overall Study|Physician Decision|7|||
46621310|NCT03198728|82772204|FG001|Overall Study|Physician Decision|2|||
46621311|NCT03198728|82772203|FG000|Overall Study|Withdrawal by Subject|14|||
46621312|NCT03198728|82772204|FG001|Overall Study|Withdrawal by Subject|10|||
46621313|NCT03144804|82772227|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
46621314|NCT03142334|82772233|FG000|Overall Study|Death|18|||
46621315|NCT03142334|82772234|FG001|Overall Study|Death|33|||
46621316|NCT03142334|82772233|FG000|Overall Study|Withdrawal by Subject|15|||
46621317|NCT03142334|82772234|FG001|Overall Study|Withdrawal by Subject|11|||
46621318|NCT03142334|82772233|FG000|Overall Study|Ongoing on trial follow up|463|||
46621319|NCT03142334|82772234|FG001|Overall Study|Ongoing on trial follow up|454|||
46621320|NCT03126539|82772242|FG000|Overall Study|Lost to Follow-up|1|||
46621321|NCT03126539|82772243|FG001|Overall Study|Lost to Follow-up|1|||
46621322|NCT03126539|82772244|FG002|Overall Study|Lost to Follow-up|1|||
46621323|NCT03126539|82772245|FG003|Overall Study|Lost to Follow-up|0|||
46621324|NCT03126539|82772246|FG004|Overall Study|Lost to Follow-up|0|||
46621325|NCT03123250|82772259|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
46621326|NCT03099096|82772263|FG000|Overall Study|Adverse Event|1|||
46621327|NCT03099096|82772263|FG000|Overall Study|Physician Decision|1|||
46621328|NCT03043664|82772267|FG000|Overall Study|Lost to Follow-up|1|||
46621329|NCT03041467|82772273|FG000|Overall Study|Death|40|||
46621330|NCT03041467|82772274|FG001|Overall Study|Death|36|||
46621331|NCT03041467|82772273|FG000|Overall Study|Withdrawal by Subject|36|||
46621332|NCT03041467|82772274|FG001|Overall Study|Withdrawal by Subject|37|||
46621333|NCT03041467|82772273|FG000|Overall Study|Lost to Follow-up|6|||
46621334|NCT03041467|82772274|FG001|Overall Study|Lost to Follow-up|7|||
46709916|NCT00924664|82926009|FG000|Overall Study|Protocol Violation|2|||
46911736|NCT03188185|83141795|FG001|Stage 1|Lack of Efficacy|2|||
46911737|NCT03188185|83141796|FG002|Stage 1|Lack of Efficacy|0|||
46911738|NCT03188185|83141797|FG003|Stage 1|Lack of Efficacy|0|||
47025058|NCT02059187|83274347|FG001|Overall Study|Adverse Event|3|||
47025059|NCT02059187|83274346|FG000|Overall Study|Death|1|||
47025060|NCT02059187|83274347|FG001|Overall Study|Death|1|||
47025061|NCT02059187|83274346|FG000|Overall Study|Lost to Follow-up|9|||
47025062|NCT02059187|83274347|FG001|Overall Study|Lost to Follow-up|8|||
47025063|NCT02059187|83274346|FG000|Overall Study|Non-compliance with study drug|1|||
47025064|NCT02059187|83274347|FG001|Overall Study|Non-compliance with study drug|0|||
47025065|NCT02059187|83274346|FG000|Overall Study|Physician Decision|1|||
47025066|NCT02059187|83274347|FG001|Overall Study|Physician Decision|2|||
47025067|NCT02059187|83274346|FG000|Overall Study|Protocol Violation|1|||
47025068|NCT02059187|83274347|FG001|Overall Study|Protocol Violation|0|||
47025069|NCT02059187|83274346|FG000|Overall Study|Withdrawal by Subject|12|||
47025070|NCT02059187|83274347|FG001|Overall Study|Withdrawal by Subject|8|||
47025071|NCT02043899|83274353|FG000|Overall Study|Adverse Event|3|||
47025072|NCT02043899|83274353|FG000|Overall Study|Physician Decision|1|||
47025073|NCT02043899|83274353|FG000|Overall Study|Withdrawal by Subject|2|||
46621335|NCT03041467|82772273|FG000|Overall Study|Declined consent for study extension|21|||
46621336|NCT03041467|82772274|FG001|Overall Study|Declined consent for study extension|33|||
46621337|NCT03041467|82772273|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
46621338|NCT03041467|82772274|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
46621339|NCT03041467|82772273|FG000|Overall Study|48 Month visit not completed|9|||
46621340|NCT03041467|82772274|FG001|Overall Study|48 Month visit not completed|4|||
46621341|NCT03019406|82772286|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
46621342|NCT03019406|82772287|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
46621343|NCT03019406|82772288|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
46621344|NCT03019406|82772289|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
46621345|NCT02972593|82772304|FG000|Overall Study|Lost to Follow-up|19|||
46621346|NCT02972593|82772305|FG001|Overall Study|Lost to Follow-up|15|||
46621347|NCT02972593|82772304|FG000|Overall Study|Protocol Violation|1|||
47025074|NCT02043899|83274353|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
47025075|NCT02043899|83274353|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
47025076|NCT02043899|83274353|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
47025077|NCT02043899|83274353|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
47025078|NCT02043899|83274353|FG000|Overall Study|Treatment delayed|1|||
47025079|NCT02043509|83274359|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
47025080|NCT02043509|83274360|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
47025081|NCT02043509|83274359|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
47025082|NCT02043509|83274360|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
47025083|NCT02043509|83274359|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
47025084|NCT02043509|83274360|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
47025085|NCT02043509|83274359|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
47025086|NCT02043509|83274360|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
47025087|NCT02058563|83274368|FG000|Overall Study|Lost to Follow-up|26|||
47025088|NCT02058563|83274369|FG001|Overall Study|Lost to Follow-up|22|||
47025089|NCT02058563|83274368|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
47025090|NCT02058563|83274369|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
47025091|NCT02058563|83274368|FG000|Overall Study|Consent Withdrawal|1|||
47025092|NCT02058563|83274369|FG001|Overall Study|Consent Withdrawal|1|||
47025093|NCT02058563|83274368|FG000|Overall Study|Other (patient incarcerated)|0|||
47025094|NCT02058563|83274369|FG001|Overall Study|Other (patient incarcerated)|1|||
47025095|NCT01622231|83274375|FG000|Overall Study|Physician Decision|1|||
47025096|NCT01622231|83274375|FG000|Overall Study|Withdrawal by Subject|1|||
47025097|NCT02042183|83274381|FG000|Overall Study|Physician Decision|7|||
47025098|NCT02042183|83274382|FG001|Overall Study|Physician Decision|2|||
46911739|NCT03188185|83141794|FG000|Stage 1|Lost to Follow-up|6|||
46911740|NCT03188185|83141795|FG001|Stage 1|Lost to Follow-up|1|||
46911741|NCT03188185|83141796|FG002|Stage 1|Lost to Follow-up|0|||
46911742|NCT03188185|83141797|FG003|Stage 1|Lost to Follow-up|0|||
46911743|NCT03188185|83141794|FG000|Stage 1|Withdrawal by Subject|9|||
46911744|NCT03188185|83141795|FG001|Stage 1|Withdrawal by Subject|0|||
46911745|NCT03188185|83141796|FG002|Stage 1|Withdrawal by Subject|0|||
46911746|NCT03188185|83141797|FG003|Stage 1|Withdrawal by Subject|0|||
46911747|NCT03188185|83141794|FG000|Stage 1|Identified as a professional patient|0|||
46911748|NCT03188185|83141795|FG001|Stage 1|Identified as a professional patient|1|||
46911749|NCT03188185|83141796|FG002|Stage 1|Identified as a professional patient|0|||
46911750|NCT03188185|83141797|FG003|Stage 1|Identified as a professional patient|0|||
46911751|NCT03188185|83141794|FG000|Stage 2|Adverse Event|0|||
46911752|NCT03188185|83141795|FG001|Stage 2|Adverse Event|0|||
46911753|NCT03188185|83141796|FG002|Stage 2|Adverse Event|2|||
46621348|NCT02972593|82772305|FG001|Overall Study|Protocol Violation|0|||
46621349|NCT02949700|82772317|FG000|Phase I|Withdrawal by Subject|1|||
46621350|NCT02949700|82772318|FG001|Phase I|Withdrawal by Subject|1|||
46621351|NCT02949700|82772319|FG002|Phase I|Withdrawal by Subject|0|||
46621352|NCT02949700|82772320|FG003|Phase I|Withdrawal by Subject|0|||
46621353|NCT02949700|82772317|FG000|Phase I|Protocol Violation|1|||
46911754|NCT03188185|83141797|FG003|Stage 2|Adverse Event|4|||
46911755|NCT03188185|83141794|FG000|Stage 2|Lack of Efficacy|0|||
46911756|NCT03188185|83141795|FG001|Stage 2|Lack of Efficacy|0|||
46911757|NCT03188185|83141796|FG002|Stage 2|Lack of Efficacy|3|||
46911758|NCT03188185|83141797|FG003|Stage 2|Lack of Efficacy|0|||
47025099|NCT02042183|83274381|FG000|Overall Study|Lack of Efficacy|4|||
46911759|NCT03188185|83141794|FG000|Stage 2|Lost to Follow-up|0|||
47025100|NCT02042183|83274382|FG001|Overall Study|Lack of Efficacy|3|||
47025101|NCT02042183|83274381|FG000|Overall Study|Non-compliance with Study Drug|2|||
46911760|NCT03188185|83141795|FG001|Stage 2|Lost to Follow-up|0|||
46911761|NCT03188185|83141796|FG002|Stage 2|Lost to Follow-up|1|||
46911762|NCT03188185|83141797|FG003|Stage 2|Lost to Follow-up|0|||
46911763|NCT03188185|83141794|FG000|Stage 2|Physician Decision|0|||
46911764|NCT03188185|83141795|FG001|Stage 2|Physician Decision|0|||
46621354|NCT02949700|82772318|FG001|Phase I|Protocol Violation|0|||
46621355|NCT02949700|82772319|FG002|Phase I|Protocol Violation|0|||
46621356|NCT02949700|82772320|FG003|Phase I|Protocol Violation|0|||
46621357|NCT02949700|82772317|FG000|Phase II|Withdrawal by Subject|0|||
46621358|NCT02949700|82772318|FG001|Phase II|Withdrawal by Subject|0|||
46621359|NCT02949700|82772319|FG002|Phase II|Withdrawal by Subject|0|||
46621360|NCT02949700|82772320|FG003|Phase II|Withdrawal by Subject|2|||
46621361|NCT02949700|82772317|FG000|Phase II|Protocol Violation|0|||
46709917|NCT00924664|82926010|FG001|Overall Study|Protocol Violation|5|||
46709918|NCT00924664|82926009|FG000|Overall Study|Pregnancy|1|||
46911765|NCT03188185|83141796|FG002|Stage 2|Physician Decision|0|||
46911766|NCT03188185|83141797|FG003|Stage 2|Physician Decision|1|||
46911767|NCT03188185|83141794|FG000|Stage 2|Withdrawal by Subject|0|||
46911768|NCT03188185|83141795|FG001|Stage 2|Withdrawal by Subject|0|||
46911769|NCT03188185|83141796|FG002|Stage 2|Withdrawal by Subject|3|||
46911770|NCT03188185|83141797|FG003|Stage 2|Withdrawal by Subject|1|||
46911771|NCT03186781|83141813|FG000|Overall Study|Lost to Follow-up|0|||
46911772|NCT03186781|83141814|FG001|Overall Study|Lost to Follow-up|0|||
46911773|NCT03186781|83141815|FG002|Overall Study|Lost to Follow-up|1|||
46911774|NCT03186781|83141816|FG003|Overall Study|Lost to Follow-up|0|||
46911775|NCT03186781|83141817|FG004|Overall Study|Lost to Follow-up|1|||
46911776|NCT03186781|83141818|FG005|Overall Study|Lost to Follow-up|0|||
46911777|NCT03186781|83141813|FG000|Overall Study|Moved from Area|0|||
46911778|NCT03186781|83141814|FG001|Overall Study|Moved from Area|0|||
46911779|NCT03186781|83141815|FG002|Overall Study|Moved from Area|0|||
46911780|NCT03186781|83141816|FG003|Overall Study|Moved from Area|0|||
46911781|NCT03186781|83141817|FG004|Overall Study|Moved from Area|1|||
46911782|NCT03186781|83141818|FG005|Overall Study|Moved from Area|0|||
46911783|NCT03186781|83141813|FG000|Overall Study|Withdrawal by Subject|0|||
46911784|NCT03186781|83141814|FG001|Overall Study|Withdrawal by Subject|0|||
46911785|NCT03186781|83141815|FG002|Overall Study|Withdrawal by Subject|0|||
46911786|NCT03186781|83141816|FG003|Overall Study|Withdrawal by Subject|0|||
46911787|NCT03186781|83141817|FG004|Overall Study|Withdrawal by Subject|1|||
46911788|NCT03186781|83141818|FG005|Overall Study|Withdrawal by Subject|0|||
46911789|NCT03184987|83141845|FG000|Overall Study|Withdrawal by Subject|0|||
46911790|NCT03184987|83141846|FG001|Overall Study|Withdrawal by Subject|1|||
46911791|NCT03184987|83141847|FG002|Overall Study|Withdrawal by Subject|2|||
46911792|NCT03184987|83141845|FG000|Overall Study|Physician Decision|0|||
46911793|NCT03184987|83141846|FG001|Overall Study|Physician Decision|0|||
46911794|NCT03184987|83141847|FG002|Overall Study|Physician Decision|1|||
46911795|NCT03184987|83141845|FG000|Overall Study|Adverse Event|1|||
47025102|NCT02042183|83274382|FG001|Overall Study|Non-compliance with Study Drug|3|||
46621362|NCT02949700|82772318|FG001|Phase II|Protocol Violation|0|||
46911796|NCT03184987|83141846|FG001|Overall Study|Adverse Event|0|||
46911797|NCT03184987|83141847|FG002|Overall Study|Adverse Event|1|||
46911798|NCT03184519|83141855|FG000|Overall Study|Lost to Follow-up|6|||
47025103|NCT02042183|83274381|FG000|Overall Study|Adverse Event|17|||
47025104|NCT02042183|83274382|FG001|Overall Study|Adverse Event|6|||
47025105|NCT02042183|83274381|FG000|Overall Study|Other|3|||
47025106|NCT02042183|83274382|FG001|Overall Study|Other|3|||
47025107|NCT02042183|83274381|FG000|Overall Study|Withdrawal by Subject|21|||
47025108|NCT02042183|83274382|FG001|Overall Study|Withdrawal by Subject|16|||
47025109|NCT02042183|83274381|FG000|Overall Study|Site Terminated by Sponsor|2|||
47025110|NCT02042183|83274382|FG001|Overall Study|Site Terminated by Sponsor|1|||
47025111|NCT02042183|83274381|FG000|Overall Study|Lost to Follow-up|9|||
46621363|NCT02949700|82772319|FG002|Phase II|Protocol Violation|1|||
46621364|NCT02949700|82772320|FG003|Phase II|Protocol Violation|3|||
46911799|NCT03184519|83141855|FG000|Overall Study|Physician Decision|21|||
46911800|NCT03184441|83141859|FG000|Overall Study|Withdrawal by Subject|1|||
46709919|NCT00924664|82926010|FG001|Overall Study|Pregnancy|1|||
46911801|NCT03026166|83141868|FG000|Overall Study|Death|22|||
47025112|NCT02042183|83274382|FG001|Overall Study|Lost to Follow-up|2|||
46621365|NCT02947087|82772331|FG000|Overall Study|Withdrawal by Subject|3|||
46621366|NCT02947087|82772332|FG001|Overall Study|Withdrawal by Subject|2|||
46621367|NCT02868216|82772340|FG000|Overall Study|Death|0|||
46621368|NCT02868216|82772341|FG001|Overall Study|Death|1|||
46621369|NCT02868216|82772340|FG000|Overall Study|coronary artery bypass|1|||
46621370|NCT02868216|82772341|FG001|Overall Study|coronary artery bypass|0|||
46621371|NCT02868216|82772340|FG000|Overall Study|Withdrawal by Subject|7|||
46621372|NCT02868216|82772341|FG001|Overall Study|Withdrawal by Subject|5|||
46621373|NCT02841995|82772350|FG000|Overall Study|Disease progression|5|||
46621374|NCT02841995|82772351|FG001|Overall Study|Disease progression|11|||
46621375|NCT02841995|82772352|FG002|Overall Study|Disease progression|8|||
46621376|NCT02841995|82772350|FG000|Overall Study|Withdrawal by Subject|2|||
46621377|NCT02841995|82772351|FG001|Overall Study|Withdrawal by Subject|4|||
46621378|NCT02841995|82772352|FG002|Overall Study|Withdrawal by Subject|4|||
46621379|NCT02841995|82772350|FG000|Overall Study|Adverse Event|2|||
46621380|NCT02841995|82772351|FG001|Overall Study|Adverse Event|0|||
46621381|NCT02841995|82772352|FG002|Overall Study|Adverse Event|1|||
46621382|NCT02841995|82772350|FG000|Overall Study|Investigator decision|2|||
46621383|NCT02841995|82772351|FG001|Overall Study|Investigator decision|0|||
46621384|NCT02841995|82772352|FG002|Overall Study|Investigator decision|1|||
46621385|NCT02841995|82772350|FG000|Overall Study|Death|0|||
46621386|NCT02841995|82772351|FG001|Overall Study|Death|0|||
46621387|NCT02841995|82772352|FG002|Overall Study|Death|2|||
46621388|NCT02841995|82772350|FG000|Overall Study|Noncompliance to protocol|1|||
46621389|NCT02841995|82772351|FG001|Overall Study|Noncompliance to protocol|0|||
46621390|NCT02841995|82772352|FG002|Overall Study|Noncompliance to protocol|0|||
46621391|NCT02841995|82772350|FG000|Overall Study|Sponsor decision|1|||
46621392|NCT02841995|82772351|FG001|Overall Study|Sponsor decision|0|||
46911802|NCT03026166|83141869|FG001|Overall Study|Death|7|||
46911803|NCT03026166|83141868|FG000|Overall Study|Physician Decision|2|||
46911804|NCT03026166|83141869|FG001|Overall Study|Physician Decision|0|||
46911805|NCT03026166|83141868|FG000|Overall Study|Withdrawal by Subject|1|||
46911806|NCT03026166|83141869|FG001|Overall Study|Withdrawal by Subject|2|||
46911807|NCT03026166|83141868|FG000|Overall Study|Lost to Follow-up|1|||
46911808|NCT03026166|83141869|FG001|Overall Study|Lost to Follow-up|0|||
46911809|NCT03026166|83141868|FG000|Overall Study|Study Terminated by Sponsor|3|||
46911810|NCT03026166|83141869|FG001|Overall Study|Study Terminated by Sponsor|3|||
46911811|NCT03026166|83141868|FG000|Overall Study|Other|1|||
47025113|NCT01977482|83274396|FG000|Overall Study|Adverse Event|0|||
47025114|NCT01977482|83274397|FG001|Overall Study|Adverse Event|1|||
47025115|NCT01977482|83274398|FG002|Overall Study|Adverse Event|1|||
47025116|NCT01977482|83274399|FG003|Overall Study|Adverse Event|0|||
47025117|NCT01977482|83274400|FG004|Overall Study|Adverse Event|2|||
47025118|NCT01977482|83274401|FG005|Overall Study|Adverse Event|0|||
47025119|NCT01977482|83274396|FG000|Overall Study|Lost to Follow-up|1|||
47025120|NCT01977482|83274397|FG001|Overall Study|Lost to Follow-up|0|||
47025121|NCT01977482|83274398|FG002|Overall Study|Lost to Follow-up|0|||
47025122|NCT01977482|83274399|FG003|Overall Study|Lost to Follow-up|0|||
47025123|NCT01977482|83274400|FG004|Overall Study|Lost to Follow-up|0|||
47025124|NCT01977482|83274401|FG005|Overall Study|Lost to Follow-up|0|||
47025125|NCT01977482|83274396|FG000|Overall Study|Physician Decision|0|||
47025126|NCT01977482|83274397|FG001|Overall Study|Physician Decision|1|||
47025127|NCT01977482|83274398|FG002|Overall Study|Physician Decision|0|||
46911812|NCT03026166|83141869|FG001|Overall Study|Other|0|||
47025128|NCT01977482|83274399|FG003|Overall Study|Physician Decision|0|||
46621393|NCT02841995|82772352|FG002|Overall Study|Sponsor decision|0|||
46621394|NCT02841995|82772350|FG000|Overall Study|Other|4|||
46621395|NCT02841995|82772351|FG001|Overall Study|Other|1|||
46621396|NCT02841995|82772352|FG002|Overall Study|Other|5|||
46621397|NCT02643966|82772360|FG000|First Screening Round|ineligible|1|||
46621398|NCT02643966|82772360|FG000|First Screening Round|excluded from analysis|2|||
46621399|NCT02643966|82772360|FG000|First Screening Round|Lost to Follow-up|56|||
46621400|NCT02643966|82772360|FG000|First Screening Round|Withdrawal by Subject|28|||
46621401|NCT02643966|82772360|FG000|First Screening Round|Death|1|||
46709920|NCT00924664|82926009|FG000|Overall Study|Death|0|||
46911813|NCT03026088|83141875|FG000|Overall Study|Study termination|20|||
47025129|NCT01977482|83274400|FG004|Overall Study|Physician Decision|0|||
47025130|NCT01977482|83274401|FG005|Overall Study|Physician Decision|0|||
47025131|NCT01977482|83274396|FG000|Overall Study|Protocol Violation|0|||
47025132|NCT01977482|83274397|FG001|Overall Study|Protocol Violation|0|||
47025133|NCT01977482|83274398|FG002|Overall Study|Protocol Violation|1|||
47025134|NCT01977482|83274399|FG003|Overall Study|Protocol Violation|0|||
47025135|NCT01977482|83274400|FG004|Overall Study|Protocol Violation|0|||
47025136|NCT01977482|83274401|FG005|Overall Study|Protocol Violation|0|||
47025137|NCT01977482|83274396|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
47025138|NCT01977482|83274397|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
47025139|NCT01977482|83274398|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
47025140|NCT01977482|83274399|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
47025141|NCT01977482|83274400|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
47025142|NCT01977482|83274401|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
47025143|NCT01977482|83274396|FG000|Overall Study|Withdrawal by Subject|2|||
47025144|NCT01977482|83274397|FG001|Overall Study|Withdrawal by Subject|4|||
47025145|NCT01977482|83274398|FG002|Overall Study|Withdrawal by Subject|1|||
47025146|NCT01977482|83274399|FG003|Overall Study|Withdrawal by Subject|3|||
46911814|NCT03024606|83141881|FG000|Overall Study|Withdrawal by Subject|9|||
46911815|NCT03024606|83141882|FG001|Overall Study|Withdrawal by Subject|10|||
47025147|NCT01977482|83274400|FG004|Overall Study|Withdrawal by Subject|1|||
47025148|NCT01977482|83274401|FG005|Overall Study|Withdrawal by Subject|5|||
47025149|NCT02058095|83274422|FG000|Overall Study|Adverse Event|1|||
47025150|NCT02058095|83274423|FG001|Overall Study|Adverse Event|0|||
47025151|NCT02023112|83274431|FG000|Overall Study|Withdrawal by Subject|2|||
47025152|NCT02023112|83274432|FG001|Overall Study|Withdrawal by Subject|1|||
47025153|NCT01977092|83274442|FG000|Overall Study|Death|3|||
47025154|NCT01977092|83274443|FG001|Overall Study|Death|4|||
47025155|NCT01977092|83274442|FG000|Overall Study|Lost to Follow-up|23|||
47025156|NCT01977092|83274443|FG001|Overall Study|Lost to Follow-up|14|||
47025157|NCT01977092|83274442|FG000|Overall Study|Withdrawal by Subject|2|||
47025158|NCT01977092|83274443|FG001|Overall Study|Withdrawal by Subject|1|||
47025159|NCT01977092|83274442|FG000|Overall Study|In prison|3|||
47025160|NCT01977092|83274443|FG001|Overall Study|In prison|11|||
47025161|NCT01976624|83274449|FG000|Overall Study|Participants contraindicated|2|||
47025162|NCT01976624|83274449|FG000|Overall Study|Participants age less than 19 years|12|||
47025163|NCT02041091|83274455|FG000|Treatment|Adverse Event|3|||
47025164|NCT02041091|83274456|FG001|Treatment|Adverse Event|3|||
47025165|NCT02041091|83274455|FG000|Treatment|Withdrawal by Subject|2|||
47025166|NCT02041091|83274456|FG001|Treatment|Withdrawal by Subject|4|||
47025167|NCT02041091|83274455|FG000|Treatment|Physician Decision|1|||
47025168|NCT02041091|83274456|FG001|Treatment|Physician Decision|0|||
47025169|NCT02041091|83274455|FG000|Treatment|Sponsor Decision|15|||
47025170|NCT02041091|83274456|FG001|Treatment|Sponsor Decision|16|||
47025171|NCT02041091|83274455|FG000|Treatment|Lost to Follow-up|1|||
47025172|NCT02041091|83274456|FG001|Treatment|Lost to Follow-up|0|||
47025173|NCT02041091|83274455|FG000|Optional Safety Extension Period|Adverse Event|4|||
47025174|NCT02041091|83274456|FG001|Optional Safety Extension Period|Adverse Event|2|||
47025175|NCT02041091|83274455|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
47025176|NCT02041091|83274456|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
46621402|NCT02643966|82772360|FG000|Between First and Second Screening|Lost to Follow-up|65|||
46621403|NCT02643966|82772360|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
46621404|NCT02643966|82772360|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
46621405|NCT02643966|82772360|FG000|Second Screening Round|Withdrawal by Subject|20|||
47025177|NCT02041091|83274455|FG000|Optional Safety Extension Period|Protocol Violation|2|||
47025178|NCT02041091|83274456|FG001|Optional Safety Extension Period|Protocol Violation|0|||
47025179|NCT02041091|83274455|FG000|Optional Safety Extension Period|Physician Decision|2|||
47025180|NCT02041091|83274456|FG001|Optional Safety Extension Period|Physician Decision|1|||
46621406|NCT02643966|82772360|FG000|Second Screening Round|Lost to Follow-up|57|||
47025181|NCT02041091|83274455|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
47025182|NCT02041091|83274456|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
46621407|NCT02643966|82772360|FG000|Second Screening Round|Physician Decision|2|||
46621408|NCT02643966|82772360|FG000|Second Screening Round|Death|4|||
46621409|NCT02643966|82772360|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
46621410|NCT02643966|82772360|FG000|Between Second and Third Screening|Death|1|||
46621411|NCT02643966|82772360|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
46621412|NCT02643966|82772360|FG000|Third Screening Round|PI excluded|2|||
46621413|NCT02643966|82772360|FG000|Third Screening Round|Lost to Follow-up|241|||
46621414|NCT02554383|82772389|FG000|Overall Study|Ineligible|3|||
46621415|NCT02554383|82772390|FG001|Overall Study|Ineligible|2|||
46621416|NCT02554383|82772389|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
46621417|NCT02554383|82772390|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
46621418|NCT02554383|82772389|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
46621419|NCT02554383|82772390|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
46621420|NCT02554383|82772389|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
46621421|NCT02554383|82772390|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
46621422|NCT02522871|82772398|FG000|Overall Study|Protocol Violation|1|||
46621423|NCT02522871|82772399|FG001|Overall Study|Protocol Violation|4|||
46621424|NCT02522871|82772398|FG000|Overall Study|Treated without randomization|1|||
46621425|NCT02522871|82772399|FG001|Overall Study|Treated without randomization|0|||
46621426|NCT02522871|82772398|FG000|Overall Study|Death|9|||
46621427|NCT02522871|82772399|FG001|Overall Study|Death|9|||
46621428|NCT02522871|82772398|FG000|Overall Study|Died in operating room prior to transplant|0|||
46621429|NCT02522871|82772399|FG001|Overall Study|Died in operating room prior to transplant|1|||
46621430|NCT02519439|82772414|FG000|Overall Study|Study Termination|19|||
46621431|NCT02519439|82772414|FG000|Overall Study|Withdrawal by Subject|1|||
46621432|NCT02519439|82772414|FG000|Overall Study|Adverse Event|1|||
47025183|NCT02041091|83274455|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
47025184|NCT02041091|83274456|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
47025185|NCT02057549|83274470|FG000|Overall Study|Lost to Follow-up|1|||
47025186|NCT02057549|83274471|FG001|Overall Study|Lost to Follow-up|0|||
47025187|NCT02057549|83274470|FG000|Overall Study|Physician Decision|1|||
47025188|NCT02057549|83274471|FG001|Overall Study|Physician Decision|0|||
47025189|NCT02057549|83274470|FG000|Overall Study|Withdrawal by Subject|1|||
47025190|NCT02057549|83274471|FG001|Overall Study|Withdrawal by Subject|0|||
47025191|NCT02057393|83274477|FG000|Overall Study|Withdrawal by Subject|1|||
47025192|NCT02057393|83274477|FG000|Overall Study|Patient did not meet criteria|1|||
47025193|NCT02040779|83274484|FG000|Overall Study|Adverse Event|1|||
47025194|NCT02040779|83274485|FG001|Overall Study|Adverse Event|0|||
47025195|NCT02040779|83274486|FG002|Overall Study|Adverse Event|0|||
47025196|NCT02040779|83274484|FG000|Overall Study|Withdrawal by Subject|4|||
47025197|NCT02040779|83274485|FG001|Overall Study|Withdrawal by Subject|1|||
46621433|NCT02147184|82772424|FG000|Overall Study|Lost to Follow-up|28|||
46621434|NCT02147184|82772425|FG001|Overall Study|Lost to Follow-up|15|||
46621435|NCT02147184|82772424|FG000|Overall Study|Study Burden|11|||
46621436|NCT02147184|82772425|FG001|Overall Study|Study Burden|7|||
46621437|NCT02147184|82772424|FG000|Overall Study|Pregnancy|6|||
46621438|NCT02147184|82772425|FG001|Overall Study|Pregnancy|0|||
46621439|NCT02147184|82772424|FG000|Overall Study|Moved out of state|3|||
47025198|NCT02040779|83274486|FG002|Overall Study|Withdrawal by Subject|3|||
47025199|NCT02040779|83274484|FG000|Overall Study|Non-compliance|0|||
47025200|NCT02040779|83274485|FG001|Overall Study|Non-compliance|1|||
47025201|NCT02040779|83274486|FG002|Overall Study|Non-compliance|0|||
46621440|NCT02147184|82772425|FG001|Overall Study|Moved out of state|3|||
46621441|NCT02147184|82772424|FG000|Overall Study|Physician Decision|0|||
46621442|NCT02147184|82772425|FG001|Overall Study|Physician Decision|2|||
46621443|NCT02147184|82772424|FG000|Overall Study|Other|1|||
46621444|NCT02147184|82772425|FG001|Overall Study|Other|0|||
46621445|NCT02101021|82772436|FG000|Overall Study|Death|4|||
46621446|NCT02101021|82772437|FG001|Overall Study|Death|3|||
46621447|NCT02101021|82772438|FG002|Overall Study|Death|6|||
46621448|NCT02101021|82772439|FG003|Overall Study|Death|0|||
46621449|NCT02101021|82772440|FG004|Overall Study|Death|3|||
46621450|NCT02101021|82772436|FG000|Overall Study|Withdrew Consent from study|1|||
46621451|NCT02101021|82772437|FG001|Overall Study|Withdrew Consent from study|1|||
46621452|NCT02101021|82772438|FG002|Overall Study|Withdrew Consent from study|0|||
46621453|NCT02101021|82772439|FG003|Overall Study|Withdrew Consent from study|2|||
46621454|NCT02101021|82772440|FG004|Overall Study|Withdrew Consent from study|0|||
46621455|NCT02101021|82772436|FG000|Overall Study|Lost to Follow-up|1|||
46621456|NCT02101021|82772437|FG001|Overall Study|Lost to Follow-up|0|||
46621457|NCT02101021|82772438|FG002|Overall Study|Lost to Follow-up|0|||
46621458|NCT02101021|82772439|FG003|Overall Study|Lost to Follow-up|0|||
46621459|NCT02101021|82772440|FG004|Overall Study|Lost to Follow-up|0|||
46911816|NCT03180619|83141891|FG000|Overall Study|Withdrew Consent|5|||
46911817|NCT03180619|83141892|FG001|Overall Study|Withdrew Consent|0|||
46621460|NCT02101021|82772436|FG000|Overall Study|Study Terminated by Sponsor|1|||
46621461|NCT02101021|82772437|FG001|Overall Study|Study Terminated by Sponsor|0|||
46911818|NCT03180619|83141893|FG002|Overall Study|Withdrew Consent|2|||
46621462|NCT02101021|82772438|FG002|Overall Study|Study Terminated by Sponsor|1|||
46621463|NCT02101021|82772439|FG003|Overall Study|Study Terminated by Sponsor|1|||
46621464|NCT02101021|82772440|FG004|Overall Study|Study Terminated by Sponsor|1|||
46621465|NCT02031536|82772465|FG000|Overall Study|ineligible|1|||
46621466|NCT02031536|82772466|FG001|Overall Study|ineligible|0|||
46641223|NCT00831623|82820521|FG000|Overall Study|Not 2 years post-treatment|12|||
46911819|NCT03180619|83141891|FG000|Overall Study|Death|2|||
46621467|NCT02028455|82772480|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
46621468|NCT02028455|82772481|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
46621469|NCT02028455|82772482|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
46621470|NCT02028455|82772483|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
46621471|NCT02028455|82772484|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
46621472|NCT02028455|82772485|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
46621473|NCT02028455|82772486|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
46621474|NCT02028455|82772487|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
46621475|NCT02028455|82772480|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
46621476|NCT02028455|82772481|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
46621477|NCT02028455|82772482|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
46621478|NCT02028455|82772483|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
46621479|NCT02028455|82772484|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
46621480|NCT02028455|82772485|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
46621481|NCT02028455|82772486|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
46621482|NCT02028455|82772487|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
46621483|NCT02028455|82772480|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
46621484|NCT02028455|82772481|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
46621485|NCT02028455|82772482|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
46621486|NCT02028455|82772483|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
46621487|NCT02028455|82772484|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
46621488|NCT02028455|82772485|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
46621489|NCT02028455|82772486|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
46621490|NCT02028455|82772487|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
46621491|NCT02028455|82772480|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
46621492|NCT02028455|82772481|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
46621493|NCT02028455|82772482|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
46621494|NCT02028455|82772483|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
46621495|NCT02028455|82772484|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
46621496|NCT02028455|82772485|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
46621497|NCT02028455|82772486|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
46621498|NCT02028455|82772487|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
46621499|NCT02019641|82772511|FG000|10-Week Follow up|Withdrawal by investigator|2|||
46621500|NCT02019641|82772512|FG001|10-Week Follow up|Withdrawal by investigator|0|||
46621501|NCT02019641|82772513|FG002|10-Week Follow up|Withdrawal by investigator|0|||
46621502|NCT02019641|82772511|FG000|10-Week Follow up|Withdrawal by Subject|1|||
46621503|NCT02019641|82772512|FG001|10-Week Follow up|Withdrawal by Subject|1|||
46621504|NCT02019641|82772513|FG002|10-Week Follow up|Withdrawal by Subject|0|||
46621505|NCT02019641|82772511|FG000|20-Week Follow up|Withdrawal by investigator|0|||
46621506|NCT02019641|82772512|FG001|20-Week Follow up|Withdrawal by investigator|0|||
46621507|NCT02019641|82772513|FG002|20-Week Follow up|Withdrawal by investigator|1|||
46621508|NCT01964430|82772522|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
46621509|NCT01964430|82772523|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
46621510|NCT01964430|82772522|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
46621511|NCT01964430|82772523|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
46621512|NCT01964430|82772522|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
47025202|NCT02040779|83274484|FG000|Overall Study|Protocol Violation|2|||
47025203|NCT02040779|83274485|FG001|Overall Study|Protocol Violation|1|||
47025204|NCT02040779|83274486|FG002|Overall Study|Protocol Violation|0|||
47025205|NCT02040779|83274484|FG000|Overall Study|Lost to Follow-up|1|||
47025206|NCT02040779|83274485|FG001|Overall Study|Lost to Follow-up|2|||
47025207|NCT02040779|83274486|FG002|Overall Study|Lost to Follow-up|1|||
47025208|NCT02040779|83274484|FG000|Overall Study|Lack of Efficacy|4|||
47025209|NCT02040779|83274485|FG001|Overall Study|Lack of Efficacy|2|||
47025210|NCT02040779|83274486|FG002|Overall Study|Lack of Efficacy|0|||
47025211|NCT02056301|83274496|FG000|Overall Study|Protocol Violation|1|||
47025212|NCT02056301|83274497|FG001|Overall Study|Protocol Violation|2|||
47025213|NCT02056301|83274496|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
47025214|NCT02056301|83274497|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
47025215|NCT02056301|83274496|FG000|Overall Study|Withdrawal by Subject|0|||
47025216|NCT02056301|83274497|FG001|Overall Study|Withdrawal by Subject|1|||
47025217|NCT02056301|83274496|FG000|Overall Study|Issues with epidural|0|||
47025218|NCT02056301|83274497|FG001|Overall Study|Issues with epidural|3|||
47025219|NCT01967732|83274505|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
46621513|NCT01964430|82772523|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
46621514|NCT01964430|82772522|FG000|Treatment Period|Adverse Event|71|||
46621515|NCT01964430|82772523|FG001|Treatment Period|Adverse Event|37|||
46621516|NCT01964430|82772522|FG000|Treatment Period|Withdrawal by Subject|36|||
46621517|NCT01964430|82772523|FG001|Treatment Period|Withdrawal by Subject|27|||
46621518|NCT01964430|82772522|FG000|Treatment Period|Death|1|||
46621519|NCT01964430|82772523|FG001|Treatment Period|Death|3|||
46621520|NCT01964430|82772522|FG000|Treatment Period|Protocol Deviation|0|||
46621521|NCT01964430|82772523|FG001|Treatment Period|Protocol Deviation|1|||
46621522|NCT01964430|82772522|FG000|Treatment Period|Physician Decision|5|||
46621523|NCT01964430|82772523|FG001|Treatment Period|Physician Decision|4|||
46621524|NCT01964430|82772522|FG000|Treatment Period|Disease Relapse|28|||
46621525|NCT01964430|82772523|FG001|Treatment Period|Disease Relapse|38|||
46621526|NCT01964430|82772522|FG000|Treatment Period|Other reasons|1|||
46621527|NCT01964430|82772523|FG001|Treatment Period|Other reasons|3|||
46621528|NCT01863043|82772531|FG000|Overall Study|Death|6|||
46621529|NCT01863043|82772532|FG001|Overall Study|Death|1|||
46621530|NCT01863043|82772531|FG000|Overall Study|Withdrawal by Subject|0|||
46621531|NCT01863043|82772532|FG001|Overall Study|Withdrawal by Subject|2|||
46621532|NCT01863043|82772531|FG000|Overall Study|Adverse Event|7|||
46621533|NCT01863043|82772532|FG001|Overall Study|Adverse Event|8|||
46621534|NCT01863043|82772531|FG000|Overall Study|exclusion criteria found after enrollment|0|||
46621535|NCT01863043|82772532|FG001|Overall Study|exclusion criteria found after enrollment|1|||
46621536|NCT01841359|82772538|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
46621537|NCT01841359|82772538|FG000|Overall Study|Concommitant medical issues|2|||
46621538|NCT01841359|82772538|FG000|Overall Study|Adverse Event|3|||
46621539|NCT01841359|82772538|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
46621540|NCT01660451|82772548|FG000|Overall Study|Protocol Violation|0|||
46621541|NCT01660451|82772549|FG001|Overall Study|Protocol Violation|1|||
46621542|NCT01660451|82772550|FG002|Overall Study|Protocol Violation|1|||
46621543|NCT01660451|82772548|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
46621544|NCT01660451|82772549|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
46621545|NCT01660451|82772550|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
46621546|NCT01660451|82772548|FG000|Overall Study|AE with Clinical PD|1|||
46621547|NCT01660451|82772549|FG001|Overall Study|AE with Clinical PD|3|||
46621548|NCT01660451|82772550|FG002|Overall Study|AE with Clinical PD|9|||
46621549|NCT01660451|82772548|FG000|Overall Study|Sponsor Decision|0|||
46621550|NCT01660451|82772549|FG001|Overall Study|Sponsor Decision|0|||
46621551|NCT01660451|82772550|FG002|Overall Study|Sponsor Decision|1|||
46621552|NCT01660451|82772548|FG000|Overall Study|Protocol Deviation|0|||
46621553|NCT01660451|82772549|FG001|Overall Study|Protocol Deviation|0|||
46621554|NCT01660451|82772550|FG002|Overall Study|Protocol Deviation|1|||
46621555|NCT01660451|82772548|FG000|Overall Study|Physician Decision|1|||
46621556|NCT01660451|82772549|FG001|Overall Study|Physician Decision|2|||
46709921|NCT00924664|82926010|FG001|Overall Study|Death|2|||
46709922|NCT00924664|82926009|FG000|Overall Study|Study terminated by sponsor|199|||
46709923|NCT00924664|82926010|FG001|Overall Study|Study terminated by sponsor|330|||
46709924|NCT00924664|82926009|FG000|Overall Study|Other|29|||
46709925|NCT00924664|82926010|FG001|Overall Study|Other|52|||
46709926|NCT00924664|82926009|FG000|Overall Study|Randomized but not Treated|1|||
46621557|NCT01660451|82772550|FG002|Overall Study|Physician Decision|5|||
46621558|NCT01660451|82772548|FG000|Overall Study|Withdrawal by Subject|1|||
46621559|NCT01660451|82772549|FG001|Overall Study|Withdrawal by Subject|0|||
46621560|NCT01660451|82772550|FG002|Overall Study|Withdrawal by Subject|16|||
46621561|NCT01660451|82772548|FG000|Overall Study|Ongoing with treatment|3|||
46621562|NCT01660451|82772549|FG001|Overall Study|Ongoing with treatment|3|||
46621563|NCT01660451|82772550|FG002|Overall Study|Ongoing with treatment|46|||
46621564|NCT01390584|82772569|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
46709927|NCT00924664|82926010|FG001|Overall Study|Randomized but not Treated|0|||
46709928|NCT00600067|82926018|FG000|Overall Study|Adverse Event|0|||
46621565|NCT01390584|82772570|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
46621566|NCT01390584|82772571|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
46621567|NCT01242800|82772582|FG000|Overall Study|Patient refusal|0|||
46621568|NCT01242800|82772583|FG001|Overall Study|Patient refusal|10|||
46621569|NCT01242800|82772582|FG000|Overall Study|Physician Decision|0|||
46621570|NCT01242800|82772583|FG001|Overall Study|Physician Decision|1|||
46621571|NCT01242800|82772582|FG000|Overall Study|Disease progression|0|||
46621572|NCT01242800|82772583|FG001|Overall Study|Disease progression|3|||
46621573|NCT01242800|82772582|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
46621574|NCT01242800|82772583|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
46621575|NCT01242800|82772582|FG000|Overall Study|Reasons not reported|0|||
46621576|NCT01242800|82772583|FG001|Overall Study|Reasons not reported|4|||
46621577|NCT01216683|82772592|FG000|Induction|Never started treatment|0|||
46621578|NCT01216683|82772593|FG001|Induction|Never started treatment|6|||
46621579|NCT01216683|82772594|FG002|Induction|Never started treatment|3|||
46621580|NCT01216683|82772592|FG000|Induction|Lack of Efficacy|4|||
46621581|NCT01216683|82772593|FG001|Induction|Lack of Efficacy|3|||
46621582|NCT01216683|82772594|FG002|Induction|Lack of Efficacy|7|||
46621583|NCT01216683|82772592|FG000|Induction|Adverse Event|0|||
46621584|NCT01216683|82772593|FG001|Induction|Adverse Event|5|||
46621585|NCT01216683|82772594|FG002|Induction|Adverse Event|5|||
46621586|NCT01216683|82772592|FG000|Induction|Death|0|||
47025220|NCT01967732|83274506|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
47025221|NCT01967732|83274507|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
47025222|NCT01967732|83274508|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
47025223|NCT01967732|83274505|FG000|First Intervention (Day 1)|Poor venous access|0|||
47025224|NCT01967732|83274506|FG001|First Intervention (Day 1)|Poor venous access|1|||
47025225|NCT01967732|83274507|FG002|First Intervention (Day 1)|Poor venous access|0|||
47025226|NCT01967732|83274508|FG003|First Intervention (Day 1)|Poor venous access|0|||
47025227|NCT01967576|83274516|FG000|Overall Study|Withdrawal by Subject|3|||
47025228|NCT01967576|83274516|FG000|Overall Study|Progressed/Removed from treatment|1|||
47025229|NCT01967576|83274516|FG000|Overall Study|Study closing at site|1|||
47025230|NCT01967576|83274516|FG000|Overall Study|Adverse Event|1|||
47025231|NCT01967576|83274516|FG000|Overall Study|Refused further treatment|1|||
47025232|NCT02039687|83274524|FG000|Overall Study|Adverse Event|0|||
47025233|NCT02039687|83274525|FG001|Overall Study|Adverse Event|0|||
47025234|NCT02039687|83274526|FG002|Overall Study|Adverse Event|1|||
47025235|NCT02039687|83274527|FG003|Overall Study|Adverse Event|0|||
47025236|NCT02039687|83274524|FG000|Overall Study|Withdrawal by Subject|0|||
46621587|NCT01216683|82772593|FG001|Induction|Death|0|||
46621588|NCT01216683|82772594|FG002|Induction|Death|2|||
46621589|NCT01216683|82772592|FG000|Induction|Withdrawal by Subject|0|||
46621590|NCT01216683|82772593|FG001|Induction|Withdrawal by Subject|4|||
46621591|NCT01216683|82772594|FG002|Induction|Withdrawal by Subject|2|||
46621592|NCT01216683|82772592|FG000|Induction|Other disease|0|||
46621593|NCT01216683|82772593|FG001|Induction|Other disease|1|||
46621594|NCT01216683|82772594|FG002|Induction|Other disease|2|||
46621595|NCT01216683|82772592|FG000|Continuation|Lack of Efficacy|3|||
47025237|NCT02039687|83274525|FG001|Overall Study|Withdrawal by Subject|1|||
46621596|NCT01216683|82772593|FG001|Continuation|Lack of Efficacy|2|||
47025238|NCT02039687|83274526|FG002|Overall Study|Withdrawal by Subject|0|||
47025239|NCT02039687|83274527|FG003|Overall Study|Withdrawal by Subject|0|||
47025240|NCT02039687|83274524|FG000|Overall Study|treatment assignment could not be confir|0|||
47025241|NCT02039687|83274525|FG001|Overall Study|treatment assignment could not be confir|0|||
47025242|NCT02039687|83274526|FG002|Overall Study|treatment assignment could not be confir|2|||
47025243|NCT02039687|83274527|FG003|Overall Study|treatment assignment could not be confir|0|||
47025244|NCT02003534|83274537|FG000|Overall Study|Lost to Follow-up|47|||
47025245|NCT02055365|83274541|FG000|Overall Study|Prematurely Withdrawn|1|||
47025246|NCT02039375|83274552|FG000|Overall Study|Lost to Follow-up|2|||
47025247|NCT02054897|83274559|FG000|Overall Study|Withdrawal by Subject|2|||
47025248|NCT02054897|83274560|FG001|Overall Study|Withdrawal by Subject|0|||
47025249|NCT02054897|83274561|FG002|Overall Study|Withdrawal by Subject|2|||
46621597|NCT01216683|82772594|FG002|Continuation|Lack of Efficacy|7|||
46621598|NCT01216683|82772592|FG000|Continuation|Adverse Event|5|||
47025250|NCT02054897|83274559|FG000|Overall Study|Missing follow-up information|3|||
46621599|NCT01216683|82772593|FG001|Continuation|Adverse Event|3|||
46621600|NCT01216683|82772594|FG002|Continuation|Adverse Event|16|||
46911820|NCT03180619|83141892|FG001|Overall Study|Death|1|||
46911821|NCT03180619|83141893|FG002|Overall Study|Death|2|||
46911822|NCT03180619|83141891|FG000|Overall Study|Adverse Event|2|||
46911823|NCT03180619|83141892|FG001|Overall Study|Adverse Event|0|||
46911824|NCT03180619|83141893|FG002|Overall Study|Adverse Event|1|||
46911825|NCT03180619|83141891|FG000|Overall Study|Investigator's discretion|2|||
46911826|NCT03180619|83141892|FG001|Overall Study|Investigator's discretion|0|||
46911827|NCT03180619|83141893|FG002|Overall Study|Investigator's discretion|1|||
46911828|NCT02915874|83141910|FG000|Overall Study|Lost to Follow-up|5|||
46911829|NCT02915874|83141911|FG001|Overall Study|Lost to Follow-up|4|||
46911830|NCT02915874|83141910|FG000|Overall Study|Withdrawal by Subject|1|||
46911831|NCT02915874|83141911|FG001|Overall Study|Withdrawal by Subject|1|||
46911832|NCT02915874|83141910|FG000|Overall Study|Started New Anxiety Medication|0|||
46911833|NCT02915874|83141911|FG001|Overall Study|Started New Anxiety Medication|1|||
46911834|NCT03022578|83141917|FG000|Overall Study|Adverse Event|1|||
46911835|NCT03022578|83141917|FG000|Overall Study|Lack of Efficacy|2|||
46911836|NCT03022578|83141917|FG000|Overall Study|Withdrawal by Subject|1|||
46911837|NCT03022422|83141927|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
46911838|NCT03022422|83141928|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
46911839|NCT03022422|83141929|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
46911840|NCT03022422|83141930|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
46911841|NCT03022422|83141931|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
46621601|NCT01216683|82772592|FG000|Continuation|Death|1|||
46621602|NCT01216683|82772593|FG001|Continuation|Death|0|||
46621603|NCT01216683|82772594|FG002|Continuation|Death|2|||
46621604|NCT01216683|82772592|FG000|Continuation|Withdrawal by Subject|4|||
46709929|NCT00600067|82926019|FG001|Overall Study|Adverse Event|1|||
46709930|NCT00600067|82926018|FG000|Overall Study|Lost to Follow-up|2|||
46709931|NCT00600067|82926019|FG001|Overall Study|Lost to Follow-up|3|||
46709932|NCT00600067|82926018|FG000|Overall Study|protocol non-compliance|0|||
46621605|NCT01216683|82772593|FG001|Continuation|Withdrawal by Subject|5|||
46621606|NCT01216683|82772594|FG002|Continuation|Withdrawal by Subject|9|||
46621607|NCT01216683|82772592|FG000|Continuation|Other diseases|0|||
46911842|NCT03022422|83141932|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
46911843|NCT03023826|83141948|FG000|Period 1|Withdrawal by Subject|0|||
46911844|NCT03023826|83141949|FG001|Period 1|Withdrawal by Subject|0|||
46911845|NCT03023826|83141950|FG002|Period 1|Withdrawal by Subject|0|||
46911846|NCT03023826|83141951|FG003|Period 1|Withdrawal by Subject|0|||
46709933|NCT00600067|82926019|FG001|Overall Study|protocol non-compliance|3|||
46621608|NCT01216683|82772593|FG001|Continuation|Other diseases|2|||
46621609|NCT01216683|82772594|FG002|Continuation|Other diseases|1|||
46621610|NCT01216683|82772592|FG000|Continuation|Physician Decision|1|||
46709934|NCT00600067|82926018|FG000|Overall Study|Lack of Efficacy|1|||
46709935|NCT00600067|82926019|FG001|Overall Study|Lack of Efficacy|0|||
46709936|NCT00970593|82926033|FG000|Overall Study|Adverse Event|1|||
46709937|NCT00970593|82926034|FG001|Overall Study|Adverse Event|1|||
46709938|NCT00970593|82926035|FG002|Overall Study|Adverse Event|0|||
46709939|NCT00970593|82926036|FG003|Overall Study|Adverse Event|0|||
46709940|NCT00970593|82926037|FG004|Overall Study|Adverse Event|0|||
46709941|NCT00970593|82926038|FG005|Overall Study|Adverse Event|0|||
46709942|NCT00970593|82926039|FG006|Overall Study|Adverse Event|0|||
46709943|NCT00970593|82926033|FG000|Overall Study|Discontinuation of study by sponsor|0|||
46709944|NCT00970593|82926034|FG001|Overall Study|Discontinuation of study by sponsor|0|||
46709945|NCT00970593|82926035|FG002|Overall Study|Discontinuation of study by sponsor|5|||
46709946|NCT00970593|82926036|FG003|Overall Study|Discontinuation of study by sponsor|0|||
46709947|NCT00970593|82926037|FG004|Overall Study|Discontinuation of study by sponsor|0|||
46709948|NCT00970593|82926038|FG005|Overall Study|Discontinuation of study by sponsor|0|||
46709949|NCT00970593|82926039|FG006|Overall Study|Discontinuation of study by sponsor|2|||
46709950|NCT00970593|82926033|FG000|Overall Study|Withdrawal by Subject|0|||
46709951|NCT00970593|82926034|FG001|Overall Study|Withdrawal by Subject|0|||
46911847|NCT03023826|83141952|FG004|Period 1|Withdrawal by Subject|1|||
46911848|NCT03023826|83141953|FG005|Period 1|Withdrawal by Subject|0|||
46911849|NCT03166735|83141966|FG000|Overall Study|Not Treated|1|||
46709952|NCT00970593|82926035|FG002|Overall Study|Withdrawal by Subject|1|||
46911850|NCT03166735|83141967|FG001|Overall Study|Not Treated|0|||
47025251|NCT02054897|83274560|FG001|Overall Study|Missing follow-up information|5|||
47025252|NCT02054897|83274561|FG002|Overall Study|Missing follow-up information|3|||
47025253|NCT02054897|83274559|FG000|Overall Study|Lost to Follow-up|4|||
47025254|NCT02054897|83274560|FG001|Overall Study|Lost to Follow-up|2|||
46709953|NCT00970593|82926036|FG003|Overall Study|Withdrawal by Subject|0|||
46621611|NCT01216683|82772593|FG001|Continuation|Physician Decision|0|||
46621612|NCT01216683|82772594|FG002|Continuation|Physician Decision|1|||
46621613|NCT01216683|82772592|FG000|Continuation|Non-compliance|1|||
46621614|NCT01216683|82772593|FG001|Continuation|Non-compliance|0|||
46621615|NCT01216683|82772594|FG002|Continuation|Non-compliance|1|||
46621616|NCT01216683|82772592|FG000|Continuation|Insurance change|0|||
46621617|NCT01216683|82772593|FG001|Continuation|Insurance change|1|||
46621618|NCT01216683|82772594|FG002|Continuation|Insurance change|0|||
46621619|NCT01216683|82772592|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
47025255|NCT02054897|83274561|FG002|Overall Study|Lost to Follow-up|7|||
46621620|NCT01216683|82772593|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
46621621|NCT01216683|82772594|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
46621622|NCT01216683|82772592|FG000|Continuation|Not reported|0|||
46709954|NCT00970593|82926037|FG004|Overall Study|Withdrawal by Subject|0|||
46709955|NCT00970593|82926038|FG005|Overall Study|Withdrawal by Subject|0|||
46709956|NCT00970593|82926039|FG006|Overall Study|Withdrawal by Subject|0|||
46709957|NCT00962013|82926059|FG000|Overall Study|Did not have surgery|1|||
47025256|NCT02054897|83274559|FG000|Overall Study|Randomized but not exposed|1|||
47025257|NCT02054897|83274560|FG001|Overall Study|Randomized but not exposed|0|||
47025258|NCT02054897|83274561|FG002|Overall Study|Randomized but not exposed|0|||
47025259|NCT01976312|83274571|FG000|Overall Study|Pregnancy|0|||
47025260|NCT01976312|83274572|FG001|Overall Study|Pregnancy|1|||
47025261|NCT01976312|83274571|FG000|Overall Study|Lost to Follow-up|2|||
46911851|NCT03166735|83141968|FG002|Overall Study|Not Treated|0|||
46911852|NCT03166735|83141969|FG003|Overall Study|Not Treated|0|||
47025262|NCT01976312|83274572|FG001|Overall Study|Lost to Follow-up|0|||
47025263|NCT01976312|83274571|FG000|Overall Study|Withdrawal by Subject|7|||
47025264|NCT01976312|83274572|FG001|Overall Study|Withdrawal by Subject|2|||
47025265|NCT01976312|83274571|FG000|Overall Study|Adverse Event|6|||
47025266|NCT01976312|83274572|FG001|Overall Study|Adverse Event|6|||
47025267|NCT01976312|83274571|FG000|Overall Study|Protocol Violation|2|||
47025268|NCT01976312|83274572|FG001|Overall Study|Protocol Violation|0|||
47025269|NCT02039219|83274581|FG000|Treatment|Withdrawal by Subject|1|||
47025270|NCT02039219|83274582|FG001|Treatment|Withdrawal by Subject|0|||
47025271|NCT02039219|83274581|FG000|Treatment|Adverse Event|0|||
47025272|NCT02039219|83274582|FG001|Treatment|Adverse Event|1|||
46621623|NCT01216683|82772593|FG001|Continuation|Not reported|0|||
46621624|NCT01216683|82772594|FG002|Continuation|Not reported|1|||
46911853|NCT03166735|83141970|FG004|Overall Study|Not Treated|0|||
46911854|NCT03166735|83141966|FG000|Overall Study|follow-up not completed as planned|0|||
46911855|NCT03166735|83141967|FG001|Overall Study|follow-up not completed as planned|1|||
46911856|NCT03166735|83141968|FG002|Overall Study|follow-up not completed as planned|1|||
46621625|NCT01216683|82772592|FG000|Continuation|Never started treatment|0|||
46621626|NCT01216683|82772593|FG001|Continuation|Never started treatment|1|||
46621627|NCT01216683|82772594|FG002|Continuation|Never started treatment|5|||
46621628|NCT01145495|82772615|FG000|Overall Study|Adverse Event|6|||
46621629|NCT01145495|82772615|FG000|Overall Study|Withdrawal by Subject|6|||
46621630|NCT01145495|82772615|FG000|Overall Study|Disease progression after respone|2|||
46911857|NCT03166735|83141969|FG003|Overall Study|follow-up not completed as planned|0|||
46911858|NCT03166735|83141970|FG004|Overall Study|follow-up not completed as planned|1|||
46911859|NCT03166735|83141966|FG000|Overall Study|Withdrawal by Subject|0|||
46911860|NCT03166735|83141967|FG001|Overall Study|Withdrawal by Subject|0|||
46911861|NCT03166735|83141968|FG002|Overall Study|Withdrawal by Subject|1|||
46911862|NCT03166735|83141969|FG003|Overall Study|Withdrawal by Subject|1|||
46911863|NCT03166735|83141970|FG004|Overall Study|Withdrawal by Subject|2|||
46911864|NCT03166735|83141966|FG000|Overall Study|Lost to Follow-up|0|||
46911865|NCT03166735|83141967|FG001|Overall Study|Lost to Follow-up|2|||
46621631|NCT01124695|82772621|FG000|Overall Study|Disease progression|77|||
46621632|NCT01124695|82772621|FG000|Overall Study|Adverse Event|11|||
46621633|NCT01124695|82772621|FG000|Overall Study|Death|1|||
46621634|NCT01124695|82772621|FG000|Overall Study|Withdrawal by Subject|7|||
46621635|NCT01124695|82772621|FG000|Overall Study|Physician Decision|3|||
46621636|NCT01124695|82772621|FG000|Overall Study|Alternative therapy|9|||
46621637|NCT01124695|82772621|FG000|Overall Study|No documentation that patient went off treatment|4|||
46621638|NCT01124695|82772621|FG000|Overall Study|Ineligible|9|||
46911866|NCT03166735|83141968|FG002|Overall Study|Lost to Follow-up|1|||
46911867|NCT03166735|83141969|FG003|Overall Study|Lost to Follow-up|0|||
46621639|NCT01124695|82772621|FG000|Overall Study|Ineligible and never start treatment|2|||
46621640|NCT01084083|82772632|FG000|Overall Study|Adverse Event|5|||
46621641|NCT01084083|82772632|FG000|Overall Study|Death|1|||
46621642|NCT01084083|82772632|FG000|Overall Study|Withdrawal by Subject|2|||
46709958|NCT00962013|82926059|FG000|Overall Study|Death|8|||
46911868|NCT03166735|83141970|FG004|Overall Study|Lost to Follow-up|1|||
47025273|NCT02039219|83274581|FG000|Treatment|Physician Decision|1|||
47025274|NCT02039219|83274582|FG001|Treatment|Physician Decision|0|||
47025275|NCT02039219|83274581|FG000|Treatment|Lost to Follow-up|0|||
47025276|NCT02039219|83274582|FG001|Treatment|Lost to Follow-up|1|||
47025277|NCT02039219|83274581|FG000|Treatment|Protocol Violation|1|||
46641224|NCT00079417|82820525|FG000|Overall Study|Physician Decision|2|||
46911869|NCT03165955|83141983|FG000|Treatment|Withdrawal by Subject|3|||
46911870|NCT03165955|83141983|FG000|Treatment|Death|1|||
46911871|NCT03165955|83141983|FG000|Treatment|Adverse Event|1|||
46911872|NCT03165955|83141983|FG000|Treatment|Progressive disease|3|||
46911873|NCT03055494|83141989|FG000|Overall Study|Lost to Follow-up|6|||
46911874|NCT03055494|83141990|FG001|Overall Study|Lost to Follow-up|0|||
46911875|NCT03055494|83141989|FG000|Overall Study|Physician Decision|2|||
46911876|NCT03055494|83141990|FG001|Overall Study|Physician Decision|0|||
46911877|NCT03055494|83141989|FG000|Overall Study|Withdrawal by Subject|1|||
46911878|NCT03055494|83141990|FG001|Overall Study|Withdrawal by Subject|0|||
46911879|NCT03055494|83141989|FG000|Overall Study|Adverse Event|0|||
46911880|NCT03055494|83141990|FG001|Overall Study|Adverse Event|1|||
46911881|NCT03055494|83141989|FG000|Overall Study|Non-compliance with study treatment|1|||
46911882|NCT03055494|83141990|FG001|Overall Study|Non-compliance with study treatment|0|||
46911883|NCT02914548|83142000|FG000|Overall Study|Adverse Event|15|||
46911884|NCT02914548|83142001|FG001|Overall Study|Adverse Event|7|||
46911885|NCT02914548|83142002|FG002|Overall Study|Adverse Event|15|||
46911886|NCT02914548|83142000|FG000|Overall Study|Physician Decision|2|||
46911887|NCT02914548|83142001|FG001|Overall Study|Physician Decision|2|||
46911888|NCT02914548|83142002|FG002|Overall Study|Physician Decision|0|||
46911889|NCT02914548|83142000|FG000|Overall Study|Protocol Violation|1|||
46911890|NCT02914548|83142001|FG001|Overall Study|Protocol Violation|0|||
46911891|NCT02914548|83142002|FG002|Overall Study|Protocol Violation|0|||
46911892|NCT02914548|83142000|FG000|Overall Study|Withdrawal by Subject|3|||
46911893|NCT02914548|83142001|FG001|Overall Study|Withdrawal by Subject|4|||
46911894|NCT02914548|83142002|FG002|Overall Study|Withdrawal by Subject|4|||
46911895|NCT02914548|83142000|FG000|Overall Study|>40% of body surface area|0|||
46911896|NCT02914548|83142001|FG001|Overall Study|>40% of body surface area|1|||
47025278|NCT02039219|83274582|FG001|Treatment|Protocol Violation|0|||
47025279|NCT02039219|83274581|FG000|Treatment|Death|1|||
47025280|NCT02039219|83274582|FG001|Treatment|Death|0|||
47025281|NCT02039219|83274581|FG000|Follow up|Adverse Event|0|||
47025282|NCT02039219|83274582|FG001|Follow up|Adverse Event|1|||
47025283|NCT02053493|83274590|FG000|Overall Study|Withdrawal by Subject|1|||
47025284|NCT02053493|83274591|FG001|Overall Study|Withdrawal by Subject|1|||
47025285|NCT02003144|83274599|FG000|Open Label Maintenance Phase|Other than specified|2|||
47025286|NCT02003144|83274600|FG001|Open Label Maintenance Phase|Other than specified|4|||
47025287|NCT02003144|83274599|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
47025288|NCT02003144|83274600|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
47025289|NCT02003144|83274599|FG000|Open Label Maintenance Phase|Pregnancy|0|||
47025290|NCT02003144|83274600|FG001|Open Label Maintenance Phase|Pregnancy|2|||
47025291|NCT02003144|83274599|FG000|Open Label Maintenance Phase|Physician Decision|1|||
47025292|NCT02003144|83274600|FG001|Open Label Maintenance Phase|Physician Decision|1|||
47025293|NCT02003144|83274599|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
47025294|NCT02003144|83274600|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
47025295|NCT02003144|83274599|FG000|Open Label Maintenance Phase|Adverse Event|2|||
47025296|NCT02003144|83274600|FG001|Open Label Maintenance Phase|Adverse Event|1|||
47025297|NCT02001194|83274611|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
47025298|NCT02001194|83274612|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
47025299|NCT02001194|83274613|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
47025300|NCT02001194|83274614|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
47025301|NCT02001194|83274611|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
47025302|NCT02001194|83274612|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
47025303|NCT02001194|83274613|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
47025304|NCT02001194|83274614|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
47025305|NCT02038907|83274638|FG000|Overall Study|Protocol Violation|0|||
46911897|NCT02914548|83142002|FG002|Overall Study|>40% of body surface area|1|||
46911898|NCT03165721|83142013|FG000|Overall Study|Refused further treatment|3|||
46911899|NCT03165721|83142014|FG001|Overall Study|Refused further treatment|0|||
46911900|NCT03165721|83142015|FG002|Overall Study|Refused further treatment|0|||
46911901|NCT03165721|83142013|FG000|Overall Study|Physician Decision|1|||
46911902|NCT03165721|83142014|FG001|Overall Study|Physician Decision|0|||
46911903|NCT03165721|83142015|FG002|Overall Study|Physician Decision|0|||
46911904|NCT02187198|83142031|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
46911905|NCT02187198|83142032|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
47025306|NCT02038907|83274639|FG001|Overall Study|Protocol Violation|0|||
46911906|NCT02187198|83142031|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
46911907|NCT02187198|83142032|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
46911908|NCT02642029|83142038|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
46911909|NCT02642029|83142039|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
47025307|NCT02038907|83274640|FG002|Overall Study|Protocol Violation|0|||
47025308|NCT02038907|83274641|FG003|Overall Study|Protocol Violation|0|||
47025309|NCT02038907|83274642|FG004|Overall Study|Protocol Violation|0|||
47025310|NCT02038907|83274643|FG005|Overall Study|Protocol Violation|0|||
46911910|NCT02642029|83142040|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
46911911|NCT02642029|83142041|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
46911912|NCT02642029|83142042|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
46621643|NCT01084083|82772632|FG000|Overall Study|Complicating disease|1|||
46621644|NCT01084083|82772632|FG000|Overall Study|Other|2|||
46621645|NCT01084083|82772632|FG000|Overall Study|Never started assigned therapy|1|||
46621646|NCT01079780|82772640|FG000|Overall Study|Disease progression|43|||
46621647|NCT01079780|82772641|FG001|Overall Study|Disease progression|7|||
46621648|NCT01079780|82772642|FG002|Overall Study|Disease progression|31|||
46621649|NCT01079780|82772640|FG000|Overall Study|Adverse Event|13|||
46621650|NCT01079780|82772641|FG001|Overall Study|Adverse Event|5|||
46621651|NCT01079780|82772642|FG002|Overall Study|Adverse Event|7|||
46621652|NCT01079780|82772640|FG000|Overall Study|Death|2|||
46621653|NCT01079780|82772641|FG001|Overall Study|Death|0|||
46621654|NCT01079780|82772642|FG002|Overall Study|Death|2|||
46621655|NCT01079780|82772640|FG000|Overall Study|Withdrawal by Subject|6|||
46621656|NCT01079780|82772641|FG001|Overall Study|Withdrawal by Subject|4|||
46621657|NCT01079780|82772642|FG002|Overall Study|Withdrawal by Subject|4|||
46621658|NCT01079780|82772640|FG000|Overall Study|Alternative therapy|2|||
46621659|NCT01079780|82772641|FG001|Overall Study|Alternative therapy|0|||
46621660|NCT01079780|82772642|FG002|Overall Study|Alternative therapy|2|||
46621661|NCT01079780|82772640|FG000|Overall Study|Physician Decision|1|||
46621662|NCT01079780|82772641|FG001|Overall Study|Physician Decision|0|||
46911913|NCT02642029|83142043|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
46911914|NCT02642029|83142038|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
46911915|NCT02642029|83142039|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
46911916|NCT02642029|83142040|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
46911917|NCT02642029|83142041|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
46911918|NCT02642029|83142042|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
46911919|NCT02642029|83142043|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
46911920|NCT02642029|83142038|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
46911921|NCT02642029|83142039|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
46911922|NCT02642029|83142040|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
46911923|NCT02642029|83142041|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
46911924|NCT02642029|83142042|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
46621663|NCT01079780|82772642|FG002|Overall Study|Physician Decision|1|||
46621664|NCT01079780|82772640|FG000|Overall Study|Error made in lesion measurement|1|||
46621665|NCT01079780|82772641|FG001|Overall Study|Error made in lesion measurement|0|||
46911925|NCT02642029|83142043|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
46911926|NCT02642029|83142038|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
46911927|NCT02642029|83142039|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
46911928|NCT02642029|83142040|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
46911929|NCT02642029|83142041|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
47025311|NCT02038907|83274644|FG006|Overall Study|Protocol Violation|0|||
47025312|NCT02038907|83274645|FG007|Overall Study|Protocol Violation|0|||
47025313|NCT02038907|83274646|FG008|Overall Study|Protocol Violation|0|||
47025314|NCT02038907|83274647|FG009|Overall Study|Protocol Violation|0|||
47025315|NCT02038907|83274648|FG010|Overall Study|Protocol Violation|1|||
47025316|NCT02038907|83274649|FG011|Overall Study|Protocol Violation|0|||
47025317|NCT02038907|83274650|FG012|Overall Study|Protocol Violation|0|||
47025318|NCT02038907|83274651|FG013|Overall Study|Protocol Violation|0|||
47025319|NCT02038907|83274638|FG000|Overall Study|Withdrawal by Subject|0|||
47025320|NCT02038907|83274639|FG001|Overall Study|Withdrawal by Subject|0|||
47025321|NCT02038907|83274640|FG002|Overall Study|Withdrawal by Subject|0|||
47025322|NCT02038907|83274641|FG003|Overall Study|Withdrawal by Subject|0|||
47025323|NCT02038907|83274642|FG004|Overall Study|Withdrawal by Subject|0|||
47025324|NCT02038907|83274643|FG005|Overall Study|Withdrawal by Subject|0|||
47025325|NCT02038907|83274644|FG006|Overall Study|Withdrawal by Subject|0|||
47025326|NCT02038907|83274645|FG007|Overall Study|Withdrawal by Subject|0|||
47025327|NCT02038907|83274646|FG008|Overall Study|Withdrawal by Subject|0|||
47025328|NCT02038907|83274647|FG009|Overall Study|Withdrawal by Subject|0|||
47025329|NCT02038907|83274648|FG010|Overall Study|Withdrawal by Subject|1|||
47025330|NCT02038907|83274649|FG011|Overall Study|Withdrawal by Subject|0|||
47025331|NCT02038907|83274650|FG012|Overall Study|Withdrawal by Subject|0|||
46621666|NCT01079780|82772642|FG002|Overall Study|Error made in lesion measurement|0|||
46621667|NCT01079780|82772640|FG000|Overall Study|Patient had surgery|1|||
46621668|NCT01079780|82772641|FG001|Overall Study|Patient had surgery|0|||
46621669|NCT01079780|82772642|FG002|Overall Study|Patient had surgery|0|||
46621670|NCT01079780|82772640|FG000|Overall Study|Treatment cycle delay|0|||
46911930|NCT02642029|83142042|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
46621671|NCT01079780|82772641|FG001|Overall Study|Treatment cycle delay|0|||
46621672|NCT01079780|82772642|FG002|Overall Study|Treatment cycle delay|1|||
46621673|NCT01079780|82772640|FG000|Overall Study|Never started treatment|1|||
46911931|NCT02642029|83142043|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
46911932|NCT02642029|83142038|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
46911933|NCT02642029|83142039|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
46911934|NCT02642029|83142040|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
46911935|NCT02642029|83142041|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
46911936|NCT02642029|83142042|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
46911937|NCT02642029|83142043|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
46911938|NCT02642029|83142038|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
46911939|NCT02642029|83142039|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
46911940|NCT02642029|83142040|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
46911941|NCT02642029|83142041|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
46911942|NCT02642029|83142042|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
46911943|NCT02642029|83142043|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
46911944|NCT03178669|83142056|FG000|Overall Study|Adverse Event|4|||
46911945|NCT03178669|83142057|FG001|Overall Study|Adverse Event|1|||
46911946|NCT03178669|83142058|FG002|Overall Study|Adverse Event|4|||
46911947|NCT03178669|83142059|FG003|Overall Study|Adverse Event|2|||
46911948|NCT03178669|83142060|FG004|Overall Study|Adverse Event|2|||
46911949|NCT03178669|83142056|FG000|Overall Study|Lack of Efficacy|0|||
46911950|NCT03178669|83142057|FG001|Overall Study|Lack of Efficacy|0|||
46911951|NCT03178669|83142058|FG002|Overall Study|Lack of Efficacy|2|||
46911952|NCT03178669|83142059|FG003|Overall Study|Lack of Efficacy|0|||
46911953|NCT03178669|83142060|FG004|Overall Study|Lack of Efficacy|1|||
46911954|NCT03178669|83142056|FG000|Overall Study|Physician Decision|0|||
46911955|NCT03178669|83142057|FG001|Overall Study|Physician Decision|0|||
46911956|NCT03178669|83142058|FG002|Overall Study|Physician Decision|0|||
46911957|NCT03178669|83142059|FG003|Overall Study|Physician Decision|0|||
47025332|NCT02038907|83274651|FG013|Overall Study|Withdrawal by Subject|0|||
46621674|NCT01079780|82772641|FG001|Overall Study|Never started treatment|0|||
46621675|NCT01079780|82772642|FG002|Overall Study|Never started treatment|2|||
46621676|NCT01013961|82772652|FG000|Overall Study|Adverse Event|2|||
46621677|NCT01013961|82772653|FG001|Overall Study|Adverse Event|2|||
46621678|NCT01013961|82772652|FG000|Overall Study|Withdrawal by Subject|1|||
46621679|NCT01013961|82772653|FG001|Overall Study|Withdrawal by Subject|0|||
46621680|NCT01013961|82772652|FG000|Overall Study|Physician Decision|0|||
47025333|NCT02038829|83274683|FG000|Washout Period 1|Death|0|||
47025334|NCT02038829|83274684|FG001|Washout Period 1|Death|0|||
47025335|NCT02038829|83274685|FG002|Washout Period 1|Death|0|||
47025336|NCT02038829|83274686|FG003|Washout Period 1|Death|0|||
47025337|NCT02038829|83274687|FG004|Washout Period 1|Death|1|||
47025338|NCT02038829|83274688|FG005|Washout Period 1|Death|0|||
47025339|NCT02038829|83274689|FG006|Washout Period 1|Death|0|||
47025340|NCT02038829|83274690|FG007|Washout Period 1|Death|0|||
47025341|NCT02038829|83274691|FG008|Washout Period 1|Death|0|||
47025342|NCT02038829|83274692|FG009|Washout Period 1|Death|0|||
47025343|NCT02038829|83274693|FG010|Washout Period 1|Death|0|||
47025344|NCT02038829|83274694|FG011|Washout Period 1|Death|0|||
47025345|NCT02038829|83274683|FG000|Treatment Period 2|Adverse Event|0|||
47025346|NCT02038829|83274684|FG001|Treatment Period 2|Adverse Event|0|||
46911958|NCT03178669|83142060|FG004|Overall Study|Physician Decision|1|||
46911959|NCT03178669|83142056|FG000|Overall Study|Withdrawal by Subject|1|||
46911960|NCT03178669|83142057|FG001|Overall Study|Withdrawal by Subject|0|||
46911961|NCT03178669|83142058|FG002|Overall Study|Withdrawal by Subject|1|||
47025347|NCT02038829|83274685|FG002|Treatment Period 2|Adverse Event|0|||
47025348|NCT02038829|83274686|FG003|Treatment Period 2|Adverse Event|0|||
47025349|NCT02038829|83274687|FG004|Treatment Period 2|Adverse Event|0|||
46621681|NCT01013961|82772653|FG001|Overall Study|Physician Decision|1|||
46621682|NCT00834093|82772668|FG000|Overall Study|Progressive Disease|3|||
46911962|NCT03178669|83142059|FG003|Overall Study|Withdrawal by Subject|1|||
46911963|NCT03178669|83142060|FG004|Overall Study|Withdrawal by Subject|0|||
47025350|NCT02038829|83274688|FG005|Treatment Period 2|Adverse Event|0|||
47025351|NCT02038829|83274689|FG006|Treatment Period 2|Adverse Event|0|||
47025352|NCT02038829|83274690|FG007|Treatment Period 2|Adverse Event|0|||
47025353|NCT02038829|83274691|FG008|Treatment Period 2|Adverse Event|0|||
47025354|NCT02038829|83274692|FG009|Treatment Period 2|Adverse Event|0|||
47025355|NCT02038829|83274693|FG010|Treatment Period 2|Adverse Event|1|||
47025356|NCT02038829|83274694|FG011|Treatment Period 2|Adverse Event|0|||
47025357|NCT02038829|83274683|FG000|Treatment Period 2|Withdrawal by Subject|1|||
47025358|NCT02038829|83274684|FG001|Treatment Period 2|Withdrawal by Subject|0|||
47025359|NCT02038829|83274685|FG002|Treatment Period 2|Withdrawal by Subject|0|||
47025360|NCT02038829|83274686|FG003|Treatment Period 2|Withdrawal by Subject|0|||
47025361|NCT02038829|83274687|FG004|Treatment Period 2|Withdrawal by Subject|0|||
47025362|NCT02038829|83274688|FG005|Treatment Period 2|Withdrawal by Subject|0|||
47025363|NCT02038829|83274689|FG006|Treatment Period 2|Withdrawal by Subject|0|||
47025364|NCT02038829|83274690|FG007|Treatment Period 2|Withdrawal by Subject|0|||
47025365|NCT02038829|83274691|FG008|Treatment Period 2|Withdrawal by Subject|0|||
47025366|NCT02038829|83274692|FG009|Treatment Period 2|Withdrawal by Subject|0|||
47025367|NCT02038829|83274693|FG010|Treatment Period 2|Withdrawal by Subject|0|||
47025368|NCT02038829|83274694|FG011|Treatment Period 2|Withdrawal by Subject|0|||
47025369|NCT02038829|83274683|FG000|Washout Period 2|Adverse Event|0|||
47025370|NCT02038829|83274684|FG001|Washout Period 2|Adverse Event|0|||
47025371|NCT02038829|83274685|FG002|Washout Period 2|Adverse Event|0|||
47025372|NCT02038829|83274686|FG003|Washout Period 2|Adverse Event|0|||
47025373|NCT02038829|83274687|FG004|Washout Period 2|Adverse Event|0|||
47025374|NCT02038829|83274688|FG005|Washout Period 2|Adverse Event|0|||
47025375|NCT02038829|83274689|FG006|Washout Period 2|Adverse Event|0|||
47025376|NCT02038829|83274690|FG007|Washout Period 2|Adverse Event|0|||
47025377|NCT02038829|83274691|FG008|Washout Period 2|Adverse Event|1|||
47025378|NCT02038829|83274692|FG009|Washout Period 2|Adverse Event|0|||
47025379|NCT02038829|83274693|FG010|Washout Period 2|Adverse Event|0|||
47025380|NCT02038829|83274694|FG011|Washout Period 2|Adverse Event|0|||
47025381|NCT02038829|83274683|FG000|Washout Period 2|Withdrawal by Subject|0|||
47025382|NCT02038829|83274684|FG001|Washout Period 2|Withdrawal by Subject|0|||
47025383|NCT02038829|83274685|FG002|Washout Period 2|Withdrawal by Subject|0|||
47025384|NCT02038829|83274686|FG003|Washout Period 2|Withdrawal by Subject|0|||
47025385|NCT02038829|83274687|FG004|Washout Period 2|Withdrawal by Subject|0|||
47025386|NCT02038829|83274688|FG005|Washout Period 2|Withdrawal by Subject|1|||
47025387|NCT02038829|83274689|FG006|Washout Period 2|Withdrawal by Subject|0|||
47025388|NCT02038829|83274690|FG007|Washout Period 2|Withdrawal by Subject|0|||
47025389|NCT02038829|83274691|FG008|Washout Period 2|Withdrawal by Subject|0|||
47025390|NCT02038829|83274692|FG009|Washout Period 2|Withdrawal by Subject|0|||
47025391|NCT02038829|83274693|FG010|Washout Period 2|Withdrawal by Subject|0|||
47025392|NCT02038829|83274694|FG011|Washout Period 2|Withdrawal by Subject|0|||
46911964|NCT03178669|83142056|FG000|Overall Study|Lost to Follow-up|0|||
46911965|NCT03178669|83142057|FG001|Overall Study|Lost to Follow-up|0|||
46911966|NCT03178669|83142058|FG002|Overall Study|Lost to Follow-up|0|||
46911967|NCT03178669|83142059|FG003|Overall Study|Lost to Follow-up|1|||
46911968|NCT03178669|83142060|FG004|Overall Study|Lost to Follow-up|0|||
46911969|NCT03178201|83142072|FG000|Overall Study|Off study|5|||
46911970|NCT03021642|83142076|FG000|Washout Period (21 Days)|Adverse Event|1|||
46911971|NCT03021642|83142077|FG001|Washout Period (21 Days)|Adverse Event|1|||
46911972|NCT03021564|83142085|FG000|Overall Study|Death|84|||
46911973|NCT03021564|83142086|FG001|Overall Study|Death|466|||
46911974|NCT03021564|83142085|FG000|Overall Study|Lost to Follow-up|0|||
46911975|NCT03021564|83142086|FG001|Overall Study|Lost to Follow-up|2|||
46911976|NCT03023046|83142096|FG000|Overall Study|Withdrawal by Subject|1|||
46911977|NCT03019458|83142104|FG000|Overall Study|Death|0|||
46911978|NCT03019458|83142105|FG001|Overall Study|Death|1|||
46911979|NCT02923830|83142115|FG000|Overall Study|Physician Decision|13|||
46911980|NCT02923830|83142116|FG001|Overall Study|Physician Decision|15|||
46911981|NCT03021018|83142125|FG000|Overall Study|Adverse Event|1|||
46911982|NCT03021018|83142126|FG001|Overall Study|Adverse Event|0|||
46911983|NCT03021018|83142127|FG002|Overall Study|Adverse Event|0|||
46911984|NCT03021018|83142125|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
46911985|NCT03021018|83142126|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
47025393|NCT02038829|83274683|FG000|Treatment Period 4|Adverse Event|0|||
46911986|NCT03021018|83142127|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
46911987|NCT02509507|83142144|FG000|Overall Study|Death|21|||
47025394|NCT02038829|83274684|FG001|Treatment Period 4|Adverse Event|1|||
47025395|NCT02038829|83274685|FG002|Treatment Period 4|Adverse Event|0|||
46911988|NCT02509507|83142145|FG001|Overall Study|Death|3|||
47025396|NCT02038829|83274686|FG003|Treatment Period 4|Adverse Event|0|||
47025397|NCT02038829|83274687|FG004|Treatment Period 4|Adverse Event|0|||
47025398|NCT02038829|83274688|FG005|Treatment Period 4|Adverse Event|0|||
47025399|NCT02038829|83274689|FG006|Treatment Period 4|Adverse Event|0|||
47025400|NCT02038829|83274690|FG007|Treatment Period 4|Adverse Event|0|||
47025401|NCT02038829|83274691|FG008|Treatment Period 4|Adverse Event|0|||
47025402|NCT02038829|83274692|FG009|Treatment Period 4|Adverse Event|0|||
46911989|NCT02509507|83142146|FG002|Overall Study|Death|22|||
46911990|NCT02509507|83142147|FG003|Overall Study|Death|13|||
46911991|NCT02509507|83142148|FG004|Overall Study|Death|6|||
46911992|NCT02509507|83142149|FG005|Overall Study|Death|9|||
46911993|NCT02509507|83142150|FG006|Overall Study|Death|4|||
46911994|NCT02509507|83142151|FG007|Overall Study|Death|3|||
46911995|NCT02509507|83142152|FG008|Overall Study|Death|7|||
46911996|NCT02509507|83142144|FG000|Overall Study|Lost to Follow-up|0|||
46911997|NCT02509507|83142145|FG001|Overall Study|Lost to Follow-up|1|||
46911998|NCT02509507|83142146|FG002|Overall Study|Lost to Follow-up|0|||
46911999|NCT02509507|83142147|FG003|Overall Study|Lost to Follow-up|0|||
46912000|NCT02509507|83142148|FG004|Overall Study|Lost to Follow-up|0|||
46709959|NCT00962013|82926059|FG000|Overall Study|Lost to Follow-up|12|||
46709960|NCT00962013|82926059|FG000|Overall Study|Unable/Unwilling to return|6|||
46709961|NCT00962013|82926059|FG000|Overall Study|Withdrawal by Subject|8|||
46709962|NCT00962013|82926059|FG000|Overall Study|Removal of study device|3|||
46709963|NCT00962013|82926059|FG000|Overall Study|Site Termination|24|||
46709964|NCT00962013|82926059|FG000|Overall Study|No 5 year evaluation|6|||
46709965|NCT00970359|82926063|FG000|Overall Study|Not Treated|4|||
46709966|NCT01121406|82926069|FG000|Overall Study|Progressive disease RECIST|44|||
46709967|NCT01121406|82926070|FG001|Overall Study|Progressive disease RECIST|28|||
46709968|NCT01121406|82926069|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
46709969|NCT01121406|82926070|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
46709970|NCT01121406|82926069|FG000|Overall Study|Other AE|3|||
46709971|NCT01121406|82926070|FG001|Overall Study|Other AE|10|||
46709972|NCT01121406|82926069|FG000|Overall Study|Non-compliant with protocol|0|||
46709973|NCT01121406|82926070|FG001|Overall Study|Non-compliant with protocol|2|||
46709974|NCT01121406|82926069|FG000|Overall Study|Lost to Follow-up|0|||
46709975|NCT01121406|82926070|FG001|Overall Study|Lost to Follow-up|1|||
46709976|NCT01121406|82926069|FG000|Overall Study|Refused continuation of study med.|1|||
46709977|NCT01121406|82926070|FG001|Overall Study|Refused continuation of study med.|2|||
46912001|NCT02509507|83142149|FG005|Overall Study|Lost to Follow-up|1|||
46912002|NCT02509507|83142150|FG006|Overall Study|Lost to Follow-up|0|||
46621683|NCT00834093|82772668|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
46621684|NCT00606294|82772674|FG000|Overall Study|Withdrawal by Subject|36|||
46621685|NCT00606294|82772675|FG001|Overall Study|Withdrawal by Subject|0|||
46621686|NCT00583596|82772681|FG000|Overall Study|Lost to Follow-up|110|||
46621687|NCT00583596|82772681|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
46621688|NCT00583596|82772681|FG000|Overall Study|Death|2|||
46621689|NCT00583596|82772681|FG000|Overall Study|Withdrawal by Subject|6|||
46621690|NCT00583596|82772681|FG000|Overall Study|Lost to Follow-up|94|||
46621691|NCT00583596|82772681|FG000|Overall Study|Data not complete|1|||
46621692|NCT00583596|82772681|FG000|Overall Study|Not consented|15|||
46621693|NCT00583596|82772681|FG000|Overall Study|Outside f-up window|26|||
46621694|NCT00316888|82772692|FG000|Overall Study|Adverse Event|4|||
46621695|NCT00316888|82772693|FG001|Overall Study|Adverse Event|5|||
46621696|NCT00316888|82772692|FG000|Overall Study|Withdrawal by Subject|2|||
46621697|NCT00316888|82772693|FG001|Overall Study|Withdrawal by Subject|2|||
46621698|NCT00316888|82772692|FG000|Overall Study|Not start protocol therapy|0|||
46621699|NCT00316888|82772693|FG001|Overall Study|Not start protocol therapy|1|||
46621700|NCT00274924|82772702|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
46621701|NCT00274924|82772703|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
46621702|NCT00274924|82772704|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
46621703|NCT00274924|82772702|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
46621704|NCT00274924|82772703|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
46621705|NCT00274924|82772704|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
46621706|NCT00274924|82772702|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
46621707|NCT00274924|82772703|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
46621708|NCT00274924|82772704|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
46621709|NCT00274924|82772702|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
46621710|NCT00274924|82772703|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
46621711|NCT00274924|82772704|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
46621712|NCT00274924|82772702|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
46621713|NCT00274924|82772703|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
46621714|NCT00274924|82772704|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
46621715|NCT00274924|82772702|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
46621716|NCT00274924|82772703|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
46621717|NCT00274924|82772704|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
46621718|NCT00274924|82772702|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
46621719|NCT00274924|82772703|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
46641225|NCT00079417|82820525|FG000|Overall Study|Ineligible|7|||
46709978|NCT01121406|82926069|FG000|Overall Study|Reason other than specified above|2|||
46709979|NCT01121406|82926070|FG001|Overall Study|Reason other than specified above|6|||
46709980|NCT01121406|82926069|FG000|Overall Study|Not treated|1|||
46709981|NCT01121406|82926070|FG001|Overall Study|Not treated|0|||
46709982|NCT00960687|82926079|FG000|Washout Period of 7 Days|Adverse Event|3|||
46709983|NCT00960687|82926080|FG001|Washout Period of 7 Days|Adverse Event|2|||
46709984|NCT00960687|82926079|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
46709985|NCT00960687|82926080|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46709986|NCT00920140|82926091|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
46912003|NCT02509507|83142151|FG007|Overall Study|Lost to Follow-up|0|||
46912004|NCT02509507|83142152|FG008|Overall Study|Lost to Follow-up|0|||
46912005|NCT02509507|83142144|FG000|Overall Study|Withdrawal by Subject|2|||
46912006|NCT02509507|83142145|FG001|Overall Study|Withdrawal by Subject|0|||
46912007|NCT02509507|83142146|FG002|Overall Study|Withdrawal by Subject|1|||
46912008|NCT02509507|83142147|FG003|Overall Study|Withdrawal by Subject|4|||
46709987|NCT00920140|82926092|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
46709988|NCT00920140|82926093|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
46709989|NCT00920140|82926094|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
46709990|NCT00920140|82926095|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
46709991|NCT00920140|82926091|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
46709992|NCT00920140|82926092|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
46709993|NCT00920140|82926093|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
46709994|NCT00920140|82926094|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
46709995|NCT00920140|82926095|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
46912009|NCT02509507|83142148|FG004|Overall Study|Withdrawal by Subject|0|||
46912010|NCT02509507|83142149|FG005|Overall Study|Withdrawal by Subject|3|||
46912011|NCT02509507|83142150|FG006|Overall Study|Withdrawal by Subject|3|||
47025403|NCT02038829|83274693|FG010|Treatment Period 4|Adverse Event|0|||
47025404|NCT02038829|83274694|FG011|Treatment Period 4|Adverse Event|0|||
47025405|NCT02038829|83274683|FG000|Washout Period 4|Adverse Event|0|||
47025406|NCT02038829|83274684|FG001|Washout Period 4|Adverse Event|0|||
47025407|NCT02038829|83274685|FG002|Washout Period 4|Adverse Event|0|||
47025408|NCT02038829|83274686|FG003|Washout Period 4|Adverse Event|0|||
47025409|NCT02038829|83274687|FG004|Washout Period 4|Adverse Event|0|||
47025410|NCT02038829|83274688|FG005|Washout Period 4|Adverse Event|0|||
47025411|NCT02038829|83274689|FG006|Washout Period 4|Adverse Event|1|||
47025412|NCT02038829|83274690|FG007|Washout Period 4|Adverse Event|0|||
47025413|NCT02038829|83274691|FG008|Washout Period 4|Adverse Event|0|||
47025414|NCT02038829|83274692|FG009|Washout Period 4|Adverse Event|0|||
47025415|NCT02038829|83274693|FG010|Washout Period 4|Adverse Event|0|||
47025416|NCT02038829|83274694|FG011|Washout Period 4|Adverse Event|0|||
47025417|NCT02038829|83274683|FG000|Treatment Period 6|Adverse Event|0|||
47025418|NCT02038829|83274684|FG001|Treatment Period 6|Adverse Event|0|||
47025419|NCT02038829|83274685|FG002|Treatment Period 6|Adverse Event|1|||
46709996|NCT00920140|82926091|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
46709997|NCT00920140|82926092|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
46709998|NCT00920140|82926093|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
46709999|NCT00920140|82926094|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
46912012|NCT02509507|83142151|FG007|Overall Study|Withdrawal by Subject|0|||
46912013|NCT02509507|83142152|FG008|Overall Study|Withdrawal by Subject|0|||
46912014|NCT02509507|83142144|FG000|Overall Study|Continuing Study|0|||
47025420|NCT02038829|83274686|FG003|Treatment Period 6|Adverse Event|0|||
47025421|NCT02038829|83274687|FG004|Treatment Period 6|Adverse Event|0|||
47025422|NCT02038829|83274688|FG005|Treatment Period 6|Adverse Event|0|||
47025423|NCT02038829|83274689|FG006|Treatment Period 6|Adverse Event|0|||
47025424|NCT02038829|83274690|FG007|Treatment Period 6|Adverse Event|0|||
47025425|NCT02038829|83274691|FG008|Treatment Period 6|Adverse Event|0|||
47025426|NCT02038829|83274692|FG009|Treatment Period 6|Adverse Event|0|||
47025427|NCT02038829|83274693|FG010|Treatment Period 6|Adverse Event|0|||
47025428|NCT02038829|83274694|FG011|Treatment Period 6|Adverse Event|0|||
47025429|NCT02038049|83274711|FG000|Overall Study|Lost to Follow-up|1|||
47025430|NCT02038049|83274712|FG001|Overall Study|Lost to Follow-up|0|||
47025431|NCT02052011|83274724|FG000|Overall Study|Lost to Follow-up|3|||
47025432|NCT02052011|83274725|FG001|Overall Study|Lost to Follow-up|0|||
47025433|NCT02052011|83274724|FG000|Overall Study|Withdrawal by Subject|1|||
47025434|NCT02052011|83274725|FG001|Overall Study|Withdrawal by Subject|2|||
47025435|NCT02036645|83274743|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025436|NCT02036645|83274744|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025437|NCT02036645|83274745|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025438|NCT02036645|83274746|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025439|NCT02036645|83274747|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025440|NCT02036645|83274748|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025441|NCT02036645|83274749|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
47025442|NCT02036645|83274750|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025443|NCT02036645|83274751|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025444|NCT02036645|83274752|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025445|NCT02036645|83274753|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025446|NCT02036645|83274754|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
47025447|NCT02036645|83274743|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025448|NCT02036645|83274744|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025449|NCT02036645|83274745|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025450|NCT02036645|83274746|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
47025451|NCT02036645|83274747|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025452|NCT02036645|83274748|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025453|NCT02036645|83274749|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025454|NCT02036645|83274750|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025455|NCT02036645|83274751|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025456|NCT02036645|83274752|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025457|NCT02036645|83274753|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025458|NCT02036645|83274754|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
47025459|NCT02051933|83274794|FG000|Overall Study|Physician Decision|0|||
47025460|NCT02051933|83274795|FG001|Overall Study|Physician Decision|1|||
47025461|NCT02050373|83274808|FG000|Overall Study|Adverse Event|4|||
47025462|NCT02050373|83274809|FG001|Overall Study|Adverse Event|7|||
47025463|NCT02050373|83274808|FG000|Overall Study|Death|3|||
47025464|NCT02050373|83274809|FG001|Overall Study|Death|3|||
47025465|NCT02049437|83274818|FG000|Period 1|Adverse Event|1|||
46710000|NCT00920140|82926095|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
46710001|NCT00920140|82926091|FG000|Phase 2|Adverse Event|0|||
46710002|NCT00920140|82926092|FG001|Phase 2|Adverse Event|0|||
46710003|NCT00920140|82926093|FG002|Phase 2|Adverse Event|14|||
46710004|NCT00920140|82926094|FG003|Phase 2|Adverse Event|2|||
46710005|NCT00920140|82926095|FG004|Phase 2|Adverse Event|3|||
46710006|NCT00920140|82926091|FG000|Phase 2|Lack of Efficacy|0|||
46710007|NCT00920140|82926092|FG001|Phase 2|Lack of Efficacy|0|||
46710008|NCT00920140|82926093|FG002|Phase 2|Lack of Efficacy|29|||
46710009|NCT00920140|82926094|FG003|Phase 2|Lack of Efficacy|14|||
46710010|NCT00920140|82926095|FG004|Phase 2|Lack of Efficacy|5|||
46710011|NCT00920140|82926091|FG000|Phase 2|Lost to Follow-up|0|||
46710012|NCT00920140|82926092|FG001|Phase 2|Lost to Follow-up|0|||
46710013|NCT00920140|82926093|FG002|Phase 2|Lost to Follow-up|0|||
46710014|NCT00920140|82926094|FG003|Phase 2|Lost to Follow-up|1|||
46710015|NCT00920140|82926095|FG004|Phase 2|Lost to Follow-up|0|||
46710016|NCT00920140|82926091|FG000|Phase 2|Physician Decision|0|||
46710017|NCT00920140|82926092|FG001|Phase 2|Physician Decision|0|||
46710018|NCT00920140|82926093|FG002|Phase 2|Physician Decision|3|||
47025466|NCT02049437|83274819|FG001|Period 1|Adverse Event|1|||
47025467|NCT02049437|83274818|FG000|Period 1|Adverse Event|1|||
47025468|NCT02049437|83274819|FG001|Period 1|Adverse Event|0|||
47025469|NCT02035553|83274827|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
46710019|NCT00920140|82926094|FG003|Phase 2|Physician Decision|3|||
46710020|NCT00920140|82926095|FG004|Phase 2|Physician Decision|2|||
46710021|NCT00920140|82926091|FG000|Phase 2|Withdrawal by Subject|0|||
46710022|NCT00920140|82926092|FG001|Phase 2|Withdrawal by Subject|0|||
46710023|NCT00920140|82926093|FG002|Phase 2|Withdrawal by Subject|4|||
47025470|NCT02035553|83274828|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
47025471|NCT02035553|83274827|FG000|Overall Study|Adverse Event|10|||
47025472|NCT02035553|83274828|FG001|Overall Study|Adverse Event|6|||
47025473|NCT02035553|83274827|FG000|Overall Study|Physician Decision|3|||
46710024|NCT00920140|82926094|FG003|Phase 2|Withdrawal by Subject|2|||
46710025|NCT00920140|82926095|FG004|Phase 2|Withdrawal by Subject|1|||
46710026|NCT01120782|82926108|FG000|Overall Study|Test article shipping error|11|||
46710027|NCT01120626|82926114|FG000|Overall Study|Withdrawal by Subject|1|||
46710028|NCT01120626|82926115|FG001|Overall Study|Withdrawal by Subject|0|||
46710029|NCT00924508|82926121|FG000|Overall Study|Withdrawal by Subject|3|||
46912015|NCT02509507|83142145|FG001|Overall Study|Continuing Study|1|||
46912016|NCT02509507|83142146|FG002|Overall Study|Continuing Study|1|||
47025474|NCT02035553|83274828|FG001|Overall Study|Physician Decision|2|||
47025475|NCT02035553|83274827|FG000|Overall Study|Lack of Efficacy|1|||
47025476|NCT02035553|83274828|FG001|Overall Study|Lack of Efficacy|1|||
47025477|NCT02035553|83274827|FG000|Overall Study|Withdrawal by Subject|4|||
47025478|NCT02035553|83274828|FG001|Overall Study|Withdrawal by Subject|7|||
47025479|NCT02035553|83274827|FG000|Overall Study|Non-compliance with Study Drug|0|||
47025480|NCT02035553|83274828|FG001|Overall Study|Non-compliance with Study Drug|1|||
47025481|NCT02035553|83274827|FG000|Overall Study|Lost to Follow-up|0|||
47025482|NCT02035553|83274828|FG001|Overall Study|Lost to Follow-up|1|||
47025483|NCT02035553|83274827|FG000|Overall Study|Other Reason|0|||
47025484|NCT02035553|83274828|FG001|Overall Study|Other Reason|4|||
47025485|NCT01445080|83274843|FG000|Overall Study|Adverse Event|5|||
47025486|NCT01445080|83274844|FG001|Overall Study|Adverse Event|3|||
47025487|NCT01445080|83274845|FG002|Overall Study|Adverse Event|11|||
47025488|NCT01445080|83274846|FG003|Overall Study|Adverse Event|6|||
47025489|NCT01445080|83274847|FG004|Overall Study|Adverse Event|2|||
47025490|NCT01445080|83274848|FG005|Overall Study|Adverse Event|3|||
46710030|NCT01139658|82926130|FG000|Overall Study|Adverse Event|10|||
46710031|NCT01139658|82926131|FG001|Overall Study|Adverse Event|27|||
46710032|NCT01139658|82926130|FG000|Overall Study|Lack of Efficacy|15|||
46710033|NCT01139658|82926131|FG001|Overall Study|Lack of Efficacy|7|||
46710034|NCT01139658|82926130|FG000|Overall Study|Withdrawal by Subject|2|||
46710035|NCT01139658|82926131|FG001|Overall Study|Withdrawal by Subject|4|||
46710036|NCT01139658|82926130|FG000|Overall Study|No documentation of treatment|1|||
46710037|NCT01139658|82926131|FG001|Overall Study|No documentation of treatment|0|||
46710038|NCT01139658|82926130|FG000|Overall Study|Other|28|||
47025491|NCT01445080|83274849|FG006|Overall Study|Adverse Event|0|||
47025492|NCT01445080|83274850|FG007|Overall Study|Adverse Event|3|||
47025493|NCT01445080|83274851|FG008|Overall Study|Adverse Event|10|||
47025494|NCT01445080|83274843|FG000|Overall Study|Physician Decision|0|||
47025495|NCT01445080|83274844|FG001|Overall Study|Physician Decision|0|||
47025496|NCT01445080|83274845|FG002|Overall Study|Physician Decision|1|||
47025497|NCT01445080|83274846|FG003|Overall Study|Physician Decision|0|||
46710039|NCT01139658|82926131|FG001|Overall Study|Other|75|||
47025498|NCT01445080|83274847|FG004|Overall Study|Physician Decision|0|||
47025499|NCT01445080|83274848|FG005|Overall Study|Physician Decision|3|||
47025500|NCT01445080|83274849|FG006|Overall Study|Physician Decision|2|||
47025501|NCT01445080|83274850|FG007|Overall Study|Physician Decision|2|||
47025502|NCT01445080|83274851|FG008|Overall Study|Physician Decision|0|||
47025503|NCT01445080|83274843|FG000|Overall Study|Withdrawal by Subject|1|||
46621720|NCT00274924|82772704|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
46621721|NCT00274924|82772702|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
46621722|NCT00274924|82772703|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
46621723|NCT00274924|82772704|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
46621724|NCT00274924|82772702|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
46621725|NCT00274924|82772703|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
46621726|NCT00274924|82772704|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
46621727|NCT00274924|82772702|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
46621728|NCT00274924|82772703|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
46621729|NCT00274924|82772704|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
46621730|NCT00274924|82772702|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
46621731|NCT00274924|82772703|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
46621732|NCT00274924|82772704|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
46912017|NCT02509507|83142147|FG003|Overall Study|Continuing Study|5|||
47025504|NCT01445080|83274844|FG001|Overall Study|Withdrawal by Subject|0|||
47025505|NCT01445080|83274845|FG002|Overall Study|Withdrawal by Subject|0|||
47025506|NCT01445080|83274846|FG003|Overall Study|Withdrawal by Subject|1|||
47025507|NCT01445080|83274847|FG004|Overall Study|Withdrawal by Subject|0|||
47025508|NCT01445080|83274848|FG005|Overall Study|Withdrawal by Subject|0|||
47025509|NCT01445080|83274849|FG006|Overall Study|Withdrawal by Subject|0|||
47025510|NCT01445080|83274850|FG007|Overall Study|Withdrawal by Subject|0|||
46710040|NCT01139580|82926139|FG000|Overall Study|Adverse Event|5|||
46710041|NCT01139580|82926140|FG001|Overall Study|Adverse Event|4|||
46710042|NCT01139580|82926139|FG000|Overall Study|Lost to Follow-up|9|||
46710043|NCT01139580|82926140|FG001|Overall Study|Lost to Follow-up|1|||
46710044|NCT01139580|82926139|FG000|Overall Study|Lack of Efficacy|0|||
46710045|NCT01139580|82926140|FG001|Overall Study|Lack of Efficacy|2|||
46710046|NCT01139580|82926139|FG000|Overall Study|Withdrawal by Subject|6|||
46710047|NCT01139580|82926140|FG001|Overall Study|Withdrawal by Subject|9|||
46710048|NCT01139580|82926139|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
46710049|NCT01139580|82926140|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
46710050|NCT01139580|82926139|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
46710051|NCT01139580|82926140|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
46710052|NCT01139580|82926139|FG000|Overall Study|Misrandomized|1|||
46710053|NCT01139580|82926140|FG001|Overall Study|Misrandomized|0|||
46710054|NCT01139580|82926139|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
46710055|NCT01139580|82926140|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
46710056|NCT01139580|82926139|FG000|Overall Study|Participant Randomization in Error|0|||
46710057|NCT01139580|82926140|FG001|Overall Study|Participant Randomization in Error|1|||
46710058|NCT00917644|82926146|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
46710059|NCT00917644|82926147|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
46710060|NCT00917644|82926146|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
46710061|NCT00917644|82926147|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
47025511|NCT01445080|83274851|FG008|Overall Study|Withdrawal by Subject|2|||
47025512|NCT01445080|83274843|FG000|Overall Study|Ineligible/Inevaluable|1|||
47025513|NCT01445080|83274844|FG001|Overall Study|Ineligible/Inevaluable|2|||
47025514|NCT01445080|83274845|FG002|Overall Study|Ineligible/Inevaluable|0|||
47025515|NCT01445080|83274846|FG003|Overall Study|Ineligible/Inevaluable|1|||
47025516|NCT01445080|83274847|FG004|Overall Study|Ineligible/Inevaluable|2|||
47025517|NCT01445080|83274848|FG005|Overall Study|Ineligible/Inevaluable|3|||
47025518|NCT01445080|83274849|FG006|Overall Study|Ineligible/Inevaluable|0|||
47025519|NCT01445080|83274850|FG007|Overall Study|Ineligible/Inevaluable|0|||
47025520|NCT01445080|83274851|FG008|Overall Study|Ineligible/Inevaluable|6|||
47025521|NCT02035475|83274886|FG000|Overall Study|Withdrawal by Subject|4|||
47025522|NCT02035475|83274886|FG000|Overall Study|Physician Decision|1|||
47025523|NCT02035475|83274886|FG000|Overall Study|Equipment Error|1|||
47025524|NCT01444456|83274892|FG000|Overall Study|Withdrawal by Subject|21|||
47025525|NCT01444456|83274892|FG000|Overall Study|Physician Decision|9|||
47025526|NCT01444456|83274892|FG000|Overall Study|Lost to Follow-up|37|||
47025527|NCT01444456|83274892|FG000|Overall Study|Death|73|||
47025528|NCT01444456|83274892|FG000|Overall Study|Ineligibility determined|23|||
47025529|NCT01444456|83274892|FG000|Overall Study|Other|18|||
47025530|NCT01444456|83274892|FG000|Overall Study|Not treated|104|||
47025531|NCT01438294|83274898|FG000|Overall Study|Lost to Follow-up|3|||
47025532|NCT01438294|83274899|FG001|Overall Study|Lost to Follow-up|7|||
46621733|NCT00274924|82772702|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
46710062|NCT00917644|82926146|FG000|Period 2: Second Intervention|family emergency|1|||
46710063|NCT00917644|82926147|FG001|Period 2: Second Intervention|family emergency|0|||
46710064|NCT01137786|82926155|FG000|Overall Study|Lost to Follow-up|0|||
46710065|NCT01137786|82926156|FG001|Overall Study|Lost to Follow-up|2|||
46912018|NCT02509507|83142148|FG004|Overall Study|Continuing Study|4|||
46912019|NCT02509507|83142149|FG005|Overall Study|Continuing Study|5|||
46912020|NCT02509507|83142150|FG006|Overall Study|Continuing Study|3|||
46912021|NCT02509507|83142151|FG007|Overall Study|Continuing Study|2|||
46912022|NCT02509507|83142152|FG008|Overall Study|Continuing Study|3|||
46912023|NCT03176407|83142177|FG000|Overall Study|Protocol Violation|1|||
47025533|NCT02033759|83274907|FG000|Overall Study|Withdrawal by Subject|2|||
46621734|NCT00274924|82772703|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
46912024|NCT03176407|83142177|FG000|Overall Study|human failure|1|||
47025534|NCT02033759|83274908|FG001|Overall Study|Withdrawal by Subject|1|||
47025535|NCT02033759|83274907|FG000|Overall Study|Protocol Violation|1|||
46621735|NCT00274924|82772704|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
46621736|NCT00274924|82772702|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
46621737|NCT00274924|82772703|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
46621738|NCT00274924|82772704|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
46621739|NCT00104884|82772711|FG000|Overall Study|Disease progression|4|||
46621740|NCT00096174|82772715|FG000|Overall Study|Lack of Efficacy|9|||
47025536|NCT02033759|83274908|FG001|Overall Study|Protocol Violation|1|||
47025537|NCT01959529|83274916|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
47025538|NCT01959529|83274917|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
47025539|NCT01959529|83274916|FG000|Overall Study|Lost to Follow-up|4|||
46621741|NCT00096174|82772715|FG000|Overall Study|Adverse Event|15|||
46621742|NCT00096174|82772715|FG000|Overall Study|Death|6|||
46621743|NCT00096174|82772715|FG000|Overall Study|Withdrawal by Subject|15|||
46621744|NCT00096174|82772715|FG000|Overall Study|Not started protocol therapy|3|||
46621745|NCT00096174|82772715|FG000|Overall Study|Ineligible|6|||
46621746|NCT00096174|82772715|FG000|Overall Study|other reason|8|||
46621747|NCT00080938|82772719|FG000|Overall Study|Adverse Event|3|||
46621748|NCT00080938|82772719|FG000|Overall Study|Withdrawal by Subject|6|||
46621749|NCT00080938|82772719|FG000|Overall Study|Death|2|||
46621750|NCT00080938|82772719|FG000|Overall Study|Lack of Efficacy|7|||
46621751|NCT00080938|82772719|FG000|Overall Study|other disease|1|||
46621752|NCT00080938|82772719|FG000|Overall Study|Not started protocol therapy|1|||
46621753|NCT00080938|82772719|FG000|Overall Study|Ineligible|4|||
46621754|NCT00074282|82772723|FG000|Step 1|Adverse Event|32|||
46621755|NCT00074282|82772724|FG001|Step 1|Adverse Event|0|||
46710066|NCT01137786|82926155|FG000|Overall Study|Withdrawal by Subject|1|||
46710067|NCT01137786|82926156|FG001|Overall Study|Withdrawal by Subject|1|||
46710068|NCT00599755|82926164|FG000|Overall Study|Adverse Event|11|||
46710069|NCT00599755|82926164|FG000|Overall Study|Withdrawal by Subject|2|||
46710070|NCT00599755|82926164|FG000|Overall Study|Progression of Disease|3|||
46710071|NCT00599755|82926164|FG000|Overall Study|Other Reason|2|||
46710072|NCT00599755|82926164|FG000|Overall Study|No data available|1|||
46710073|NCT00600613|82926168|FG000|Overall Study|Protocol Deviation|1|||
46710074|NCT01125930|82926174|FG000|Overall Study|Adverse Event|0|||
46621756|NCT00074282|82772725|FG002|Step 1|Adverse Event|0|||
46621757|NCT00074282|82772723|FG000|Step 1|Death|6|||
46621758|NCT00074282|82772724|FG001|Step 1|Death|0|||
46621759|NCT00074282|82772725|FG002|Step 1|Death|0|||
46621760|NCT00074282|82772723|FG000|Step 1|Withdrawal by Subject|7|||
46621761|NCT00074282|82772724|FG001|Step 1|Withdrawal by Subject|0|||
46621762|NCT00074282|82772725|FG002|Step 1|Withdrawal by Subject|0|||
46621763|NCT00074282|82772723|FG000|Step 1|Disease progression|2|||
46710075|NCT01125930|82926175|FG001|Overall Study|Adverse Event|1|||
46710076|NCT01125930|82926174|FG000|Overall Study|Withdrawal by Subject|1|||
46710077|NCT01125930|82926175|FG001|Overall Study|Withdrawal by Subject|6|||
46710078|NCT01125930|82926174|FG000|Overall Study|Protocol Violation|0|||
46710079|NCT01125930|82926175|FG001|Overall Study|Protocol Violation|1|||
46710080|NCT01125930|82926174|FG000|Overall Study|Lost to Follow-up|0|||
46710081|NCT01125930|82926175|FG001|Overall Study|Lost to Follow-up|2|||
46710082|NCT00918346|82926206|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
46710083|NCT00918346|82926207|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
46710084|NCT00913978|82926218|FG000|Overall Study|Surgeon choice|1|||
46710085|NCT00913978|82926219|FG001|Overall Study|Surgeon choice|3|||
46621764|NCT00074282|82772724|FG001|Step 1|Disease progression|0|||
46621765|NCT00074282|82772725|FG002|Step 1|Disease progression|0|||
46621766|NCT00074282|82772723|FG000|Step 1|Alternative therapy|2|||
46621767|NCT00074282|82772724|FG001|Step 1|Alternative therapy|0|||
46621768|NCT00074282|82772725|FG002|Step 1|Alternative therapy|0|||
46621769|NCT00074282|82772723|FG000|Step 1|Other complicating disease|2|||
46621770|NCT00074282|82772724|FG001|Step 1|Other complicating disease|0|||
46621771|NCT00074282|82772725|FG002|Step 1|Other complicating disease|0|||
46621772|NCT00074282|82772723|FG000|Step 1|Physician Decision|1|||
46621773|NCT00074282|82772724|FG001|Step 1|Physician Decision|0|||
46621774|NCT00074282|82772725|FG002|Step 1|Physician Decision|0|||
46621775|NCT00074282|82772723|FG000|Step 1|Ineligible|4|||
46621776|NCT00074282|82772724|FG001|Step 1|Ineligible|0|||
46621777|NCT00074282|82772725|FG002|Step 1|Ineligible|0|||
46621778|NCT00074282|82772723|FG000|Step 1|Never started treatment|2|||
46621779|NCT00074282|82772724|FG001|Step 1|Never started treatment|0|||
46621780|NCT00074282|82772725|FG002|Step 1|Never started treatment|0|||
46621781|NCT00074282|82772723|FG000|Step 2|Adverse Event|0|||
46621782|NCT00074282|82772724|FG001|Step 2|Adverse Event|2|||
46621783|NCT00074282|82772725|FG002|Step 2|Adverse Event|12|||
46621784|NCT00074282|82772723|FG000|Step 2|Disease progression|0|||
46621785|NCT00074282|82772724|FG001|Step 2|Disease progression|0|||
46710086|NCT01137474|82926229|FG000|Overall Study|Adverse Event|3|||
46710087|NCT01137474|82926230|FG001|Overall Study|Adverse Event|5|||
46710088|NCT01137474|82926231|FG002|Overall Study|Adverse Event|1|||
46710089|NCT01137474|82926232|FG003|Overall Study|Adverse Event|3|||
46710090|NCT01137474|82926229|FG000|Overall Study|Withdrawal by Subject|7|||
46710091|NCT01137474|82926230|FG001|Overall Study|Withdrawal by Subject|2|||
46710092|NCT01137474|82926231|FG002|Overall Study|Withdrawal by Subject|6|||
46621786|NCT00074282|82772725|FG002|Step 2|Disease progression|5|||
46621787|NCT00074282|82772723|FG000|Step 2|Death|0|||
46621788|NCT00074282|82772724|FG001|Step 2|Death|0|||
46621789|NCT00074282|82772725|FG002|Step 2|Death|3|||
46621790|NCT00074282|82772723|FG000|Step 2|Withdrawal by Subject|0|||
46621791|NCT00074282|82772724|FG001|Step 2|Withdrawal by Subject|0|||
46621792|NCT00074282|82772725|FG002|Step 2|Withdrawal by Subject|2|||
46621793|NCT00074282|82772723|FG000|Step 2|Physician Decision|0|||
46621794|NCT00074282|82772724|FG001|Step 2|Physician Decision|0|||
46621795|NCT00074282|82772725|FG002|Step 2|Physician Decision|1|||
46621796|NCT00074282|82772723|FG000|Step 2|Ineligible|0|||
46621797|NCT00074282|82772724|FG001|Step 2|Ineligible|0|||
46621798|NCT00074282|82772725|FG002|Step 2|Ineligible|1|||
46621799|NCT00071981|82772737|FG000|Overall Study|Lack of Efficacy|37|||
46621800|NCT00071981|82772738|FG001|Overall Study|Lack of Efficacy|29|||
46621801|NCT00071981|82772739|FG002|Overall Study|Lack of Efficacy|30|||
46621802|NCT00071981|82772740|FG003|Overall Study|Lack of Efficacy|43|||
46621803|NCT00071981|82772737|FG000|Overall Study|Adverse Event|4|||
46621804|NCT00071981|82772738|FG001|Overall Study|Adverse Event|4|||
46710093|NCT01137474|82926232|FG003|Overall Study|Withdrawal by Subject|9|||
46710094|NCT01137474|82926229|FG000|Overall Study|No longer met study criteria|6|||
46710095|NCT01137474|82926230|FG001|Overall Study|No longer met study criteria|1|||
46710096|NCT01137474|82926231|FG002|Overall Study|No longer met study criteria|0|||
46710097|NCT01137474|82926232|FG003|Overall Study|No longer met study criteria|5|||
46621805|NCT00071981|82772739|FG002|Overall Study|Adverse Event|3|||
46621806|NCT00071981|82772740|FG003|Overall Study|Adverse Event|1|||
46621807|NCT00071981|82772737|FG000|Overall Study|Death|0|||
46621808|NCT00071981|82772738|FG001|Overall Study|Death|0|||
46621809|NCT00071981|82772739|FG002|Overall Study|Death|1|||
46621810|NCT00071981|82772740|FG003|Overall Study|Death|1|||
46621811|NCT00071981|82772737|FG000|Overall Study|Withdrawal by Subject|3|||
46621812|NCT00071981|82772738|FG001|Overall Study|Withdrawal by Subject|1|||
46621813|NCT00071981|82772739|FG002|Overall Study|Withdrawal by Subject|0|||
46621814|NCT00071981|82772740|FG003|Overall Study|Withdrawal by Subject|0|||
46621815|NCT00071981|82772737|FG000|Overall Study|No protocol therapy|2|||
46621816|NCT00071981|82772738|FG001|Overall Study|No protocol therapy|5|||
46621817|NCT00071981|82772739|FG002|Overall Study|No protocol therapy|1|||
46621818|NCT00071981|82772740|FG003|Overall Study|No protocol therapy|0|||
46621819|NCT00071981|82772737|FG000|Overall Study|others (not specified in the study)|0|||
46621820|NCT00071981|82772738|FG001|Overall Study|others (not specified in the study)|2|||
46621821|NCT00071981|82772739|FG002|Overall Study|others (not specified in the study)|2|||
46621822|NCT00071981|82772740|FG003|Overall Study|others (not specified in the study)|0|||
46621823|NCT00070291|82772750|FG000|Step 1|Withdrawal by Subject|1|||
46621824|NCT00070291|82772750|FG000|Step 1|Adverse Event|1|||
46621825|NCT00070291|82772750|FG000|Step 2|Adverse Event|1|||
46621826|NCT00064350|82772757|FG000|Induction Treatment|Disease Progression|5|||
46621827|NCT00064350|82772758|FG001|Induction Treatment|Disease Progression|1|||
46621828|NCT00064350|82772759|FG002|Induction Treatment|Disease Progression|110|||
46621829|NCT00064350|82772757|FG000|Induction Treatment|Adverse Event|0|||
46621830|NCT00064350|82772758|FG001|Induction Treatment|Adverse Event|2|||
46621831|NCT00064350|82772759|FG002|Induction Treatment|Adverse Event|49|||
46621832|NCT00064350|82772757|FG000|Induction Treatment|Death|0|||
46621833|NCT00064350|82772758|FG001|Induction Treatment|Death|0|||
46621834|NCT00064350|82772759|FG002|Induction Treatment|Death|9|||
46621835|NCT00064350|82772757|FG000|Induction Treatment|Withdrawal by Subject|0|||
46621836|NCT00064350|82772758|FG001|Induction Treatment|Withdrawal by Subject|0|||
46621837|NCT00064350|82772759|FG002|Induction Treatment|Withdrawal by Subject|21|||
46621838|NCT00064350|82772757|FG000|Induction Treatment|Ineligible or never started treatment|3|||
46621839|NCT00064350|82772758|FG001|Induction Treatment|Ineligible or never started treatment|6|||
46621840|NCT00064350|82772759|FG002|Induction Treatment|Ineligible or never started treatment|34|||
46621841|NCT00064350|82772757|FG000|Induction Treatment|Other|0|||
46621842|NCT00064350|82772758|FG001|Induction Treatment|Other|0|||
46621843|NCT00064350|82772759|FG002|Induction Treatment|Other|13|||
46621844|NCT00064350|82772757|FG000|Randomization|Adverse Event|8|||
46621845|NCT00064350|82772758|FG001|Randomization|Adverse Event|3|||
46621846|NCT00064350|82772759|FG002|Randomization|Adverse Event|0|||
46621847|NCT00064350|82772757|FG000|Randomization|Death|3|||
46621848|NCT00064350|82772758|FG001|Randomization|Death|0|||
46621849|NCT00064350|82772759|FG002|Randomization|Death|0|||
46621850|NCT00064350|82772757|FG000|Randomization|Withdrawal by Subject|1|||
46621851|NCT00064350|82772758|FG001|Randomization|Withdrawal by Subject|0|||
46621852|NCT00064350|82772759|FG002|Randomization|Withdrawal by Subject|0|||
46621853|NCT00064350|82772757|FG000|Randomization|Ineligible or never started treatment|9|||
46621854|NCT00064350|82772758|FG001|Randomization|Ineligible or never started treatment|15|||
46621855|NCT00064350|82772759|FG002|Randomization|Ineligible or never started treatment|0|||
46621856|NCT00064350|82772757|FG000|Randomization|Other|5|||
46621857|NCT00064350|82772758|FG001|Randomization|Other|0|||
46710098|NCT01137474|82926229|FG000|Overall Study|Lost to Follow-up|5|||
46710099|NCT01137474|82926230|FG001|Overall Study|Lost to Follow-up|1|||
46710100|NCT01137474|82926231|FG002|Overall Study|Lost to Follow-up|0|||
46710101|NCT01137474|82926232|FG003|Overall Study|Lost to Follow-up|2|||
46621858|NCT00064350|82772759|FG002|Randomization|Other|0|||
46621859|NCT00064350|82772757|FG000|Cross-Over|Adverse Event|0|||
46621860|NCT00064350|82772758|FG001|Cross-Over|Adverse Event|1|||
46621861|NCT00064350|82772759|FG002|Cross-Over|Adverse Event|0|||
46621862|NCT00064350|82772757|FG000|Cross-Over|Death|1|||
46621863|NCT00064350|82772758|FG001|Cross-Over|Death|3|||
46621864|NCT00064350|82772759|FG002|Cross-Over|Death|0|||
46621865|NCT00064350|82772757|FG000|Cross-Over|Withdrawal by Subject|2|||
46621866|NCT00064350|82772758|FG001|Cross-Over|Withdrawal by Subject|2|||
46621867|NCT00064350|82772759|FG002|Cross-Over|Withdrawal by Subject|0|||
46621868|NCT00064350|82772757|FG000|Cross-Over|Ineligible or never started treatment|3|||
46621869|NCT00064350|82772758|FG001|Cross-Over|Ineligible or never started treatment|6|||
46621870|NCT00064350|82772759|FG002|Cross-Over|Ineligible or never started treatment|0|||
46621871|NCT00064350|82772757|FG000|Cross-Over|Other|0|||
46621872|NCT00064350|82772758|FG001|Cross-Over|Other|2|||
46621873|NCT00064350|82772759|FG002|Cross-Over|Other|0|||
46621874|NCT00063986|82772768|FG000|Overall Study|Withdrawal by Subject|1|||
46621875|NCT00063986|82772768|FG000|Overall Study|Ineligible|1|||
46621876|NCT00063986|82772768|FG000|Overall Study|Intra-operatively ineligible|4|||
46621877|NCT00057954|82772776|FG000|Overall Study|Death|1|||
46621878|NCT00057954|82772776|FG000|Overall Study|Disease progression|1|||
46621879|NCT00049530|82772780|FG000|Overall Study|Lack of Efficacy|25|||
46621880|NCT00049530|82772780|FG000|Overall Study|Adverse Event|2|||
46621881|NCT00049530|82772780|FG000|Overall Study|Death|1|||
46621882|NCT00049530|82772780|FG000|Overall Study|symptomatic deterioration|1|||
46621883|NCT00049530|82772780|FG000|Overall Study|ineligible|3|||
46621884|NCT00045305|82772784|FG000|Overall Study|Lack of Efficacy|6|||
46621885|NCT00045305|82772784|FG000|Overall Study|Adverse Event|3|||
46621886|NCT00045305|82772784|FG000|Overall Study|Death|3|||
46621887|NCT00045305|82772784|FG000|Overall Study|site error|2|||
46621888|NCT00033657|82772790|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
46621889|NCT00033657|82772791|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
46621890|NCT00033657|82772790|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
46621891|NCT00033657|82772791|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
46621892|NCT00033657|82772790|FG000|Neoadjuvant Chemotherapy|Death|1|||
46621893|NCT00033657|82772791|FG001|Neoadjuvant Chemotherapy|Death|1|||
46621894|NCT00033657|82772790|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
46621895|NCT00033657|82772791|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
46621896|NCT00033657|82772790|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
46621897|NCT00033657|82772791|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
46621898|NCT00033657|82772790|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
46621899|NCT00033657|82772791|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
46621900|NCT00033657|82772790|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
46621901|NCT00033657|82772791|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
46621902|NCT00033657|82772790|FG000|Surgical Resection|not complete resection|0|||
46621903|NCT00033657|82772791|FG001|Surgical Resection|not complete resection|3|||
46621904|NCT00033657|82772790|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
46621905|NCT00033657|82772791|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
46621906|NCT00033657|82772790|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
46621907|NCT00033657|82772791|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
46621908|NCT00033657|82772790|FG000|Adjuvant Chemotherapy|Death|2|||
46621909|NCT00033657|82772791|FG001|Adjuvant Chemotherapy|Death|1|||
46621910|NCT00033657|82772790|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
46621911|NCT00033657|82772791|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
46621912|NCT00033657|82772790|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
46621913|NCT00033657|82772791|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
46621914|NCT00033657|82772790|FG000|Adjuvant Chemotherapy|Other|0|||
46621915|NCT00033657|82772791|FG001|Adjuvant Chemotherapy|Other|2|||
46621916|NCT00003389|82772801|FG000|Overall Study|Disease progression|6|||
46621917|NCT00003389|82772802|FG001|Overall Study|Disease progression|1|||
46621918|NCT00003389|82772801|FG000|Overall Study|Adverse Event|13|||
46621919|NCT00003389|82772802|FG001|Overall Study|Adverse Event|2|||
46621920|NCT00003389|82772801|FG000|Overall Study|Death|0|||
46912025|NCT03176407|83142177|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
46912026|NCT03175549|83142185|FG000|Overall Study|Lost to Follow-up|2|||
46912027|NCT03175549|83142186|FG001|Overall Study|Lost to Follow-up|2|||
46912028|NCT03175549|83142185|FG000|Overall Study|Medication non-compliance|2|||
46621921|NCT00003389|82772802|FG001|Overall Study|Death|3|||
46621922|NCT00003389|82772801|FG000|Overall Study|Withdrawal by Subject|12|||
46621923|NCT00003389|82772802|FG001|Overall Study|Withdrawal by Subject|5|||
46621924|NCT00003389|82772801|FG000|Overall Study|Alternative therapy|2|||
46621925|NCT00003389|82772802|FG001|Overall Study|Alternative therapy|1|||
46912029|NCT03175549|83142186|FG001|Overall Study|Medication non-compliance|2|||
46621926|NCT00003389|82772801|FG000|Overall Study|Complicating disease|1|||
46621927|NCT00003389|82772802|FG001|Overall Study|Complicating disease|0|||
46621928|NCT00003389|82772801|FG000|Overall Study|Off-treatment reason missing|31|||
46621929|NCT00003389|82772802|FG001|Overall Study|Off-treatment reason missing|21|||
46621930|NCT00003389|82772801|FG000|Overall Study|Ineligible|33|||
46621931|NCT00003389|82772802|FG001|Overall Study|Ineligible|27|||
46621932|NCT00003138|82772810|FG000|Step 1|Reasons off treatment not documented|60|||
46621933|NCT00003138|82772811|FG001|Step 1|Reasons off treatment not documented|57|||
46621934|NCT00003138|82772810|FG000|Step 1|Never started treatment|1|||
46621935|NCT00003138|82772811|FG001|Step 1|Never started treatment|0|||
46621936|NCT00003138|82772810|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
46621937|NCT00003138|82772811|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
46621938|NCT00003138|82772810|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
46621939|NCT00003138|82772811|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
46621940|NCT00003138|82772810|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
47025540|NCT01959529|83274917|FG001|Overall Study|Lost to Follow-up|1|||
47025541|NCT01959529|83274916|FG000|Overall Study|Other|70|||
47025542|NCT01959529|83274917|FG001|Overall Study|Other|68|||
47025543|NCT01959529|83274916|FG000|Overall Study|Hypoglycaemia|1|||
47025544|NCT01959529|83274917|FG001|Overall Study|Hypoglycaemia|1|||
47025545|NCT01959529|83274916|FG000|Overall Study|Lack of glycaemic control|1|||
47025546|NCT01959529|83274917|FG001|Overall Study|Lack of glycaemic control|1|||
47025547|NCT02033369|83274925|FG000|Overall Study|Physician Decision|1|||
47025548|NCT02033369|83274926|FG001|Overall Study|Physician Decision|2|||
47025549|NCT02033369|83274925|FG000|Overall Study|Not a good demographic match|0|||
47025550|NCT02033369|83274926|FG001|Overall Study|Not a good demographic match|2|||
47025551|NCT02033369|83274925|FG000|Overall Study|Withdrawal by Subject|1|||
47025552|NCT02033369|83274926|FG001|Overall Study|Withdrawal by Subject|1|||
47025553|NCT02033369|83274925|FG000|Overall Study|Lost to Follow-up|1|||
47025554|NCT02033369|83274926|FG001|Overall Study|Lost to Follow-up|0|||
47025555|NCT02033369|83274925|FG000|Overall Study|Protocol Violation|2|||
47025556|NCT02033369|83274926|FG001|Overall Study|Protocol Violation|0|||
46621941|NCT00003138|82772811|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
46621942|NCT00003138|82772810|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
46621943|NCT00003138|82772811|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
46621944|NCT00002525|82772822|FG000|Overall Study|Adverse Event|36|||
46621945|NCT00002525|82772823|FG001|Overall Study|Adverse Event|0|||
46621946|NCT00002525|82772822|FG000|Overall Study|Death|5|||
46621947|NCT00002525|82772823|FG001|Overall Study|Death|0|||
46621948|NCT00002525|82772822|FG000|Overall Study|Withdrawal by Subject|11|||
46621949|NCT00002525|82772823|FG001|Overall Study|Withdrawal by Subject|0|||
46621950|NCT00002525|82772822|FG000|Overall Study|Start non-protocol therapy|1|||
46621951|NCT00002525|82772823|FG001|Overall Study|Start non-protocol therapy|0|||
46621952|NCT00002525|82772822|FG000|Overall Study|Other complicating disease|1|||
46621953|NCT00002525|82772823|FG001|Overall Study|Other complicating disease|0|||
46621954|NCT00002525|82772822|FG000|Overall Study|Duke's A, B1, D disease|92|||
46621955|NCT00002525|82772823|FG001|Overall Study|Duke's A, B1, D disease|0|||
46621956|NCT00002525|82772822|FG000|Overall Study|Error|6|||
46621957|NCT00002525|82772823|FG001|Overall Study|Error|0|||
46621958|NCT00002525|82772822|FG000|Overall Study|Other|26|||
46621959|NCT00002525|82772823|FG001|Overall Study|Other|0|||
46710102|NCT01137474|82926229|FG000|Overall Study|Lack of Efficacy|0|||
46912030|NCT03174925|83142194|FG000|Overall Study|Elastographic images not retrievable|2|||
46912031|NCT03174925|83142194|FG000|Overall Study|Elastography image not interpretable|1|||
46912032|NCT02924688|83142204|FG000|Overall Study|Adverse Event|9|||
46912033|NCT02924688|83142205|FG001|Overall Study|Adverse Event|3|||
46912034|NCT02924688|83142206|FG002|Overall Study|Adverse Event|2|||
46912035|NCT02924688|83142207|FG003|Overall Study|Adverse Event|2|||
46912036|NCT02924688|83142208|FG004|Overall Study|Adverse Event|3|||
46912037|NCT02924688|83142209|FG005|Overall Study|Adverse Event|2|||
46912038|NCT02924688|83142204|FG000|Overall Study|Lack of Efficacy|2|||
46912039|NCT02924688|83142205|FG001|Overall Study|Lack of Efficacy|3|||
46912040|NCT02924688|83142206|FG002|Overall Study|Lack of Efficacy|4|||
46912041|NCT02924688|83142207|FG003|Overall Study|Lack of Efficacy|2|||
47025557|NCT02032901|83274932|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
47025558|NCT02032901|83274933|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
47025559|NCT02032901|83274932|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
47025560|NCT02032901|83274933|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
47025561|NCT02020967|83274943|FG000|Overall Study|Withdrawal by Subject|51|||
47025562|NCT01986829|83274949|FG000|Overall Study|Death|1|||
46621960|NCT00002525|82772822|FG000|Overall Study|Never start protocol therapy|8|||
46621961|NCT00002525|82772823|FG001|Overall Study|Never start protocol therapy|0|||
46621962|NCT02259348|82772831|FG000|Overall Study|Donors|6|||
46621963|NCT02259348|82772831|FG000|Overall Study|Death|4|||
46912042|NCT02924688|83142208|FG004|Overall Study|Lack of Efficacy|1|||
46912043|NCT02924688|83142209|FG005|Overall Study|Lack of Efficacy|1|||
46621964|NCT02259114|82773088|FG000|Overall Study|Progressive Disease|14|||
46621965|NCT02259114|82773089|FG001|Overall Study|Progressive Disease|2|||
46621966|NCT02259114|82773090|FG002|Overall Study|Progressive Disease|10|||
46621967|NCT02259114|82773091|FG003|Overall Study|Progressive Disease|2|||
46621968|NCT02259114|82773092|FG004|Overall Study|Progressive Disease|5|||
46621969|NCT02259114|82773088|FG000|Overall Study|Adverse Event|2|||
46621970|NCT02259114|82773089|FG001|Overall Study|Adverse Event|1|||
46621971|NCT02259114|82773090|FG002|Overall Study|Adverse Event|0|||
46621972|NCT02259114|82773091|FG003|Overall Study|Adverse Event|0|||
46621973|NCT02259114|82773092|FG004|Overall Study|Adverse Event|1|||
46621974|NCT02259114|82773088|FG000|Overall Study|Death|3|||
46621975|NCT02259114|82773089|FG001|Overall Study|Death|0|||
46621976|NCT02259114|82773090|FG002|Overall Study|Death|1|||
46621977|NCT02259114|82773091|FG003|Overall Study|Death|0|||
46621978|NCT02259114|82773092|FG004|Overall Study|Death|0|||
46621979|NCT02259114|82773088|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
46621980|NCT02259114|82773089|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
46621981|NCT02259114|82773090|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
46621982|NCT02259114|82773091|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
46621983|NCT02259114|82773092|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
46621984|NCT02259114|82773088|FG000|Overall Study|Withdrawal by Subject|0|||
46621985|NCT02259114|82773089|FG001|Overall Study|Withdrawal by Subject|0|||
46621986|NCT02259114|82773090|FG002|Overall Study|Withdrawal by Subject|1|||
46621987|NCT02259114|82773091|FG003|Overall Study|Withdrawal by Subject|1|||
46621988|NCT02259114|82773092|FG004|Overall Study|Withdrawal by Subject|0|||
46621989|NCT02259114|82773088|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
46621990|NCT02259114|82773089|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
46621991|NCT02259114|82773090|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
46621992|NCT02259114|82773091|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
46621993|NCT02259114|82773092|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
46621994|NCT02259114|82773088|FG000|Overall Study|Not Treated|1|||
46621995|NCT02259114|82773089|FG001|Overall Study|Not Treated|0|||
46621996|NCT02259114|82773090|FG002|Overall Study|Not Treated|0|||
46621997|NCT02259114|82773091|FG003|Overall Study|Not Treated|0|||
46621998|NCT02259114|82773092|FG004|Overall Study|Not Treated|0|||
46621999|NCT02258334|82773147|FG000|Overall Study|Adverse Event|1|||
46622000|NCT02258334|82773148|FG001|Overall Study|Adverse Event|0|||
46622001|NCT02258334|82773149|FG002|Overall Study|Adverse Event|0|||
46622002|NCT02258334|82773150|FG003|Overall Study|Adverse Event|0|||
46622003|NCT04960202|82773187|FG000|Overall Study|Other|12|||
46622004|NCT04960202|82773188|FG001|Overall Study|Other|10|||
46622005|NCT04960202|82773187|FG000|Overall Study|Withdrawal by Subject|43|||
46622006|NCT04960202|82773188|FG001|Overall Study|Withdrawal by Subject|45|||
46622007|NCT04960202|82773187|FG000|Overall Study|Lost to Follow-up|20|||
46622008|NCT04960202|82773188|FG001|Overall Study|Lost to Follow-up|17|||
46622009|NCT04960202|82773187|FG000|Overall Study|Death|0|||
46622010|NCT04960202|82773188|FG001|Overall Study|Death|15|||
46622011|NCT02257632|82773258|FG000|Overall Study|Withdrawal by Subject|0|||
46622012|NCT02257632|82773259|FG001|Overall Study|Withdrawal by Subject|1|||
46622013|NCT02257632|82773258|FG000|Overall Study|Adverse Event|1|||
46622014|NCT02257632|82773259|FG001|Overall Study|Adverse Event|2|||
46622015|NCT01642914|82773293|FG000|Overall Study|Adverse Event|11|||
46622016|NCT01642914|82773294|FG001|Overall Study|Adverse Event|7|||
46622017|NCT01642914|82773295|FG002|Overall Study|Adverse Event|15|||
46622018|NCT01642914|82773293|FG000|Overall Study|Lack of Efficacy|9|||
46622019|NCT01642914|82773294|FG001|Overall Study|Lack of Efficacy|4|||
46622020|NCT01642914|82773295|FG002|Overall Study|Lack of Efficacy|2|||
46622021|NCT01642914|82773293|FG000|Overall Study|Protocol Violation|15|||
46622022|NCT01642914|82773294|FG001|Overall Study|Protocol Violation|13|||
46622023|NCT01642914|82773295|FG002|Overall Study|Protocol Violation|6|||
46622024|NCT01642914|82773293|FG000|Overall Study|Withdrawal by Subject|5|||
46622025|NCT01642914|82773294|FG001|Overall Study|Withdrawal by Subject|5|||
46622026|NCT01642914|82773295|FG002|Overall Study|Withdrawal by Subject|10|||
46622027|NCT01642914|82773293|FG000|Overall Study|Lost to Follow-up|5|||
46710103|NCT01137474|82926230|FG001|Overall Study|Lack of Efficacy|0|||
46710104|NCT01137474|82926231|FG002|Overall Study|Lack of Efficacy|0|||
46622028|NCT01642914|82773294|FG001|Overall Study|Lost to Follow-up|3|||
46622029|NCT01642914|82773295|FG002|Overall Study|Lost to Follow-up|7|||
46622030|NCT01642914|82773293|FG000|Overall Study|Other Reason|1|||
46622031|NCT01642914|82773294|FG001|Overall Study|Other Reason|0|||
46622032|NCT01642914|82773295|FG002|Overall Study|Other Reason|0|||
46622033|NCT01642602|82773354|FG000|Overall Study|Adverse Event|2|||
46622034|NCT02256540|82773420|FG000|Overall Study|Withdrawal by Subject|0|||
46622035|NCT02256540|82773421|FG001|Overall Study|Withdrawal by Subject|1|||
46622036|NCT02256540|82773422|FG002|Overall Study|Withdrawal by Subject|1|||
46622037|NCT02256540|82773420|FG000|Overall Study|Back pain preventing exercise|0|||
46622038|NCT02256540|82773421|FG001|Overall Study|Back pain preventing exercise|0|||
46622039|NCT02256540|82773422|FG002|Overall Study|Back pain preventing exercise|1|||
46622040|NCT01640184|82773446|FG000|Overall Study|Death|1|||
46622041|NCT01640184|82773447|FG001|Overall Study|Death|0|||
46622042|NCT01640184|82773448|FG002|Overall Study|Death|0|||
46622043|NCT01640184|82773446|FG000|Overall Study|Lost to Follow-up|4|||
46622044|NCT01640184|82773447|FG001|Overall Study|Lost to Follow-up|1|||
46622045|NCT01640184|82773448|FG002|Overall Study|Lost to Follow-up|0|||
46622046|NCT01640184|82773446|FG000|Overall Study|Physician Decision|3|||
46622047|NCT01640184|82773447|FG001|Overall Study|Physician Decision|0|||
46622048|NCT01640184|82773448|FG002|Overall Study|Physician Decision|0|||
46622049|NCT01640184|82773446|FG000|Overall Study|Withdrawal by Subject|0|||
46622050|NCT01640184|82773447|FG001|Overall Study|Withdrawal by Subject|1|||
46622051|NCT01640184|82773448|FG002|Overall Study|Withdrawal by Subject|1|||
46622052|NCT01640184|82773446|FG000|Overall Study|Protocol Violation|0|||
46622053|NCT01640184|82773447|FG001|Overall Study|Protocol Violation|0|||
46622054|NCT01640184|82773448|FG002|Overall Study|Protocol Violation|1|||
46622055|NCT02256384|82773468|FG000|Overall Study|Withdrawal by Subject|12|||
46622056|NCT02256384|82773468|FG000|Overall Study|Equipment not capturing data|2|||
46622057|NCT02255760|82773511|FG000|Overall Study|Lost to Follow-up|0|||
46622058|NCT02255760|82773512|FG001|Overall Study|Lost to Follow-up|1|||
46622059|NCT02255760|82773513|FG002|Overall Study|Lost to Follow-up|0|||
46622060|NCT02255760|82773514|FG003|Overall Study|Lost to Follow-up|0|||
46622061|NCT02255760|82773515|FG004|Overall Study|Lost to Follow-up|0|||
46622062|NCT01641822|82773611|FG000|Run-in Phase|Noncompliance with study drug|1|||
46622063|NCT01641822|82773612|FG001|Run-in Phase|Noncompliance with study drug|0|||
46622064|NCT01641822|82773613|FG002|Run-in Phase|Noncompliance with study drug|0|||
46622065|NCT01641822|82773611|FG000|Run-in Phase|Adverse Event|3|||
46622066|NCT01641822|82773612|FG001|Run-in Phase|Adverse Event|0|||
46622067|NCT01641822|82773613|FG002|Run-in Phase|Adverse Event|0|||
46622068|NCT01641822|82773611|FG000|Run-in Phase|Withdrew consent|1|||
46622069|NCT01641822|82773612|FG001|Run-in Phase|Withdrew consent|0|||
46622070|NCT01641822|82773613|FG002|Run-in Phase|Withdrew consent|0|||
46710105|NCT01137474|82926232|FG003|Overall Study|Lack of Efficacy|2|||
46710106|NCT01137474|82926229|FG000|Overall Study|Other|3|||
47025563|NCT01986751|83274958|FG000|Overall Study|improperly consented|10|||
47025564|NCT01986751|83274959|FG001|Overall Study|improperly consented|2|||
47025565|NCT02004847|83274971|FG000|Overall Study|Protocol Violation|1|||
47025566|NCT02004847|83274972|FG001|Overall Study|Protocol Violation|1|||
47025567|NCT01438060|83274989|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
47025568|NCT01438060|83274990|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
47025569|NCT01438060|83274989|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
46622071|NCT01641822|82773611|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
46622072|NCT01641822|82773612|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
47025570|NCT01438060|83274990|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
47025571|NCT01438060|83274989|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
47025572|NCT01438060|83274990|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
47025573|NCT01438060|83274989|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
47025574|NCT01438060|83274990|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
47025575|NCT01438060|83274989|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
47025576|NCT01438060|83274990|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
47025577|NCT01438060|83274989|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
46622073|NCT01641822|82773613|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
46622074|NCT01641822|82773611|FG000|Comparative Phase|Noncompliance with study drug|0|||
46622075|NCT01641822|82773612|FG001|Comparative Phase|Noncompliance with study drug|1|||
46622076|NCT01641822|82773613|FG002|Comparative Phase|Noncompliance with study drug|0|||
46622077|NCT01641822|82773611|FG000|Comparative Phase|Investigator's discretion|0|||
46622078|NCT01641822|82773612|FG001|Comparative Phase|Investigator's discretion|0|||
46641226|NCT04627038|82825244|FG000|Overall Study|Adverse Event|36|||
46710107|NCT01137474|82926230|FG001|Overall Study|Other|1|||
46710108|NCT01137474|82926231|FG002|Overall Study|Other|0|||
46622079|NCT01641822|82773613|FG002|Comparative Phase|Investigator's discretion|1|||
46622080|NCT01641822|82773611|FG000|Comparative Phase|Pregnancy|0|||
46622081|NCT01641822|82773612|FG001|Comparative Phase|Pregnancy|0|||
46622082|NCT01641822|82773613|FG002|Comparative Phase|Pregnancy|1|||
46622083|NCT01641822|82773611|FG000|Comparative Phase|Adverse event, serious fatal|0|||
46622084|NCT01641822|82773612|FG001|Comparative Phase|Adverse event, serious fatal|1|||
46622085|NCT01641822|82773613|FG002|Comparative Phase|Adverse event, serious fatal|0|||
46622086|NCT01641822|82773611|FG000|Comparative Phase|Withdrew consent|0|||
46622087|NCT01641822|82773612|FG001|Comparative Phase|Withdrew consent|3|||
46622088|NCT01641822|82773613|FG002|Comparative Phase|Withdrew consent|7|||
46622089|NCT01641822|82773611|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
46622090|NCT01641822|82773612|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
46622091|NCT01641822|82773613|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
46622092|NCT01641198|82773693|FG000|After 12 Months of Function|Lost to Follow-up|3|||
47025578|NCT01438060|83274990|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
46622093|NCT01641198|82773694|FG001|After 12 Months of Function|Lost to Follow-up|2|||
46622094|NCT01641198|82773695|FG002|After 12 Months of Function|Lost to Follow-up|2|||
46622095|NCT01641198|82773693|FG000|After 12 Months of Function|Protocol Violation|1|||
46622096|NCT01641198|82773694|FG001|After 12 Months of Function|Protocol Violation|0|||
46622097|NCT01641198|82773695|FG002|After 12 Months of Function|Protocol Violation|0|||
46622098|NCT01641198|82773693|FG000|After 12 Months of Function|Adverse Event|0|||
46622099|NCT01641198|82773694|FG001|After 12 Months of Function|Adverse Event|1|||
46622100|NCT01641198|82773695|FG002|After 12 Months of Function|Adverse Event|0|||
46622101|NCT01641198|82773693|FG000|After 24 Months of Function|Lost to Follow-up|4|||
46622102|NCT01641198|82773694|FG001|After 24 Months of Function|Lost to Follow-up|9|||
46622103|NCT01641198|82773695|FG002|After 24 Months of Function|Lost to Follow-up|6|||
46622104|NCT01641198|82773693|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
46622105|NCT01641198|82773694|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
46622106|NCT01641198|82773695|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
46622107|NCT01641198|82773693|FG000|At 15-20 Years of Function|Death|1|||
46622108|NCT01641198|82773694|FG001|At 15-20 Years of Function|Death|0|||
46622109|NCT01641198|82773695|FG002|At 15-20 Years of Function|Death|1|||
46622110|NCT01639560|82773780|FG000|Overall Study|Withdrawal by Subject|9|||
46622111|NCT01639560|82773781|FG001|Overall Study|Withdrawal by Subject|14|||
46622112|NCT01639560|82773780|FG000|Overall Study|Lack of Efficacy|1|||
46622113|NCT01639560|82773781|FG001|Overall Study|Lack of Efficacy|2|||
47025579|NCT01438060|83274989|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
47025580|NCT01438060|83274990|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
47025581|NCT01438060|83274989|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
47025582|NCT01438060|83274990|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
47025583|NCT01438060|83274989|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
46622114|NCT01639560|82773780|FG000|Overall Study|Lost to Follow-up|9|||
46622115|NCT01639560|82773781|FG001|Overall Study|Lost to Follow-up|11|||
47025584|NCT01438060|83274990|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
47025585|NCT01438060|83274989|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
47025586|NCT01438060|83274990|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
47025587|NCT01438060|83274989|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
46622116|NCT01639560|82773780|FG000|Overall Study|Adverse Event|0|||
46622117|NCT01639560|82773781|FG001|Overall Study|Adverse Event|2|||
46622118|NCT01601652|82773803|FG000|Overall Study|Death|1|||
46622119|NCT03952130|82773841|FG000|Overall Study|Adverse Event|0|||
46622120|NCT03952130|82773842|FG001|Overall Study|Adverse Event|1|||
46622121|NCT03952130|82773841|FG000|Overall Study|Lost to Follow-up|1|||
46622122|NCT03952130|82773842|FG001|Overall Study|Lost to Follow-up|0|||
46622123|NCT03952130|82773841|FG000|Overall Study|Withdrawal by Subject|1|||
47025588|NCT01438060|83274990|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
47025589|NCT01438060|83274989|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
47025590|NCT01438060|83274990|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
46622124|NCT03952130|82773842|FG001|Overall Study|Withdrawal by Subject|5|||
46622125|NCT03925532|82773874|FG000|Overall Study|Lost to Follow-up|1|||
46622126|NCT01640964|82773890|FG000|Overall Study|Lost to Follow-up|0|||
46622127|NCT01640964|82773891|FG001|Overall Study|Lost to Follow-up|0|||
46622128|NCT01640964|82773892|FG002|Overall Study|Lost to Follow-up|1|||
46622129|NCT01640964|82773890|FG000|Overall Study|Protocol Deviation|1|||
46622130|NCT01640964|82773891|FG001|Overall Study|Protocol Deviation|1|||
46622131|NCT01640964|82773892|FG002|Overall Study|Protocol Deviation|2|||
47025591|NCT01438060|83274989|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
46622132|NCT01638390|82774003|FG000|Overall Study|screening failures|21|||
46622133|NCT01600716|82774034|FG000|Overall Study|Other Reasons|3|||
46622134|NCT01600716|82774035|FG001|Overall Study|Other Reasons|1|||
46622135|NCT01600716|82774034|FG000|Overall Study|Personal Reasons|0|||
46622136|NCT01600716|82774035|FG001|Overall Study|Personal Reasons|2|||
46622137|NCT01600716|82774034|FG000|Overall Study|Lost to Follow-up|0|||
47025592|NCT01438060|83274990|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
47025593|NCT01438060|83274989|FG000|On Study Beyond Week 140|Adverse Event|0|||
47025594|NCT01438060|83274990|FG001|On Study Beyond Week 140|Adverse Event|2|||
47025595|NCT01438060|83274989|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
47025596|NCT01438060|83274990|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
47025597|NCT01438060|83274989|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
47025598|NCT01438060|83274990|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
47025599|NCT01438060|83274989|FG000|On Study Beyond Week 140|Death|0|||
46622138|NCT01600716|82774035|FG001|Overall Study|Lost to Follow-up|2|||
46622139|NCT01600716|82774034|FG000|Overall Study|Pregnancy|1|||
46622140|NCT01600716|82774035|FG001|Overall Study|Pregnancy|0|||
46622141|NCT01600716|82774034|FG000|Overall Study|Lack of Efficacy|2|||
46622142|NCT01600716|82774035|FG001|Overall Study|Lack of Efficacy|1|||
46622143|NCT01600716|82774034|FG000|Overall Study|Adverse Event|1|||
46622144|NCT01600716|82774035|FG001|Overall Study|Adverse Event|1|||
46622145|NCT01600326|82774147|FG000|Overall Study|Lost to Follow-up|1|||
46622146|NCT01600326|82774148|FG001|Overall Study|Lost to Follow-up|1|||
46622147|NCT01637142|82774284|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
46622148|NCT01636986|82774302|FG000|Overall Study|Withdrawal by Subject|0|||
46622149|NCT01636986|82774303|FG001|Overall Study|Withdrawal by Subject|1|||
46622150|NCT01636986|82774302|FG000|Overall Study|Corneal Staining|0|||
46622151|NCT01636986|82774303|FG001|Overall Study|Corneal Staining|1|||
46622152|NCT01601496|82774393|FG000|Overall Study|Physician Decision|1|||
46622153|NCT01601496|82774393|FG000|Overall Study|Withdrawal by Subject|1|||
46622154|NCT01601496|82774393|FG000|Overall Study|Lost to Follow-up|6|||
46622155|NCT01601496|82774393|FG000|Overall Study|Death|4|||
46622156|NCT01601496|82774393|FG000|Overall Study|Other: patient refusal to continue|3|||
46622157|NCT03211832|82774399|FG000|Overall Study|No longer with agency|32|||
46622158|NCT03211832|82774400|FG001|Overall Study|No longer with agency|49|||
46622159|NCT03211832|82774401|FG002|Overall Study|No longer with agency|30|||
46622160|NCT03211832|82774399|FG000|Overall Study|Declined survey|3|||
46622161|NCT03211832|82774400|FG001|Overall Study|Declined survey|3|||
46622162|NCT03211832|82774401|FG002|Overall Study|Declined survey|2|||
46622163|NCT03211832|82774399|FG000|Overall Study|Not available during data collection|1|||
46622164|NCT03211832|82774400|FG001|Overall Study|Not available during data collection|0|||
46622165|NCT03211832|82774401|FG002|Overall Study|Not available during data collection|2|||
47025600|NCT01438060|83274990|FG001|On Study Beyond Week 140|Death|1|||
47025601|NCT01438060|83274989|FG000|On Study Beyond Week 140|Other Reason|0|||
47025602|NCT01438060|83274990|FG001|On Study Beyond Week 140|Other Reason|3|||
47025603|NCT01469182|83275003|FG000|Overall Study|Adverse Event|21|||
47025604|NCT01469182|83275004|FG001|Overall Study|Adverse Event|3|||
47025605|NCT01469182|83275003|FG000|Overall Study|Lost to Follow-up|3|||
47025606|NCT01469182|83275004|FG001|Overall Study|Lost to Follow-up|0|||
47025607|NCT01469182|83275003|FG000|Overall Study|Withdrawal by Subject|4|||
47025608|NCT01469182|83275004|FG001|Overall Study|Withdrawal by Subject|1|||
47025609|NCT01469182|83275003|FG000|Overall Study|Protocol Violation|4|||
47025610|NCT01469182|83275004|FG001|Overall Study|Protocol Violation|2|||
47025611|NCT01469182|83275003|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
46622166|NCT04887948|82774410|FG000|Overall Study|Death|1|||
46622167|NCT04887948|82774411|FG001|Overall Study|Death|0|||
46622168|NCT04887948|82774412|FG002|Overall Study|Death|0|||
46622169|NCT04887948|82774410|FG000|Overall Study|Lost to Follow-up|1|||
46622170|NCT04887948|82774411|FG001|Overall Study|Lost to Follow-up|0|||
46710109|NCT01137474|82926232|FG003|Overall Study|Other|0|||
46710110|NCT01137474|82926229|FG000|Overall Study|Pregnancy|0|||
46710111|NCT01137474|82926230|FG001|Overall Study|Pregnancy|1|||
46710112|NCT01137474|82926231|FG002|Overall Study|Pregnancy|0|||
46710113|NCT01137474|82926232|FG003|Overall Study|Pregnancy|0|||
46710114|NCT01137474|82926229|FG000|Overall Study|Administrative reason by sponsor|0|||
46710115|NCT01137474|82926230|FG001|Overall Study|Administrative reason by sponsor|1|||
46710116|NCT01137474|82926231|FG002|Overall Study|Administrative reason by sponsor|0|||
46710117|NCT01137474|82926232|FG003|Overall Study|Administrative reason by sponsor|0|||
46710118|NCT01168973|82926244|FG000|Overall Study|Progressive Disease|341|||
47025612|NCT01469182|83275004|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
46622171|NCT04887948|82774412|FG002|Overall Study|Lost to Follow-up|3|||
46622172|NCT04887948|82774410|FG000|Overall Study|Physician Decision|0|||
46622173|NCT04887948|82774411|FG001|Overall Study|Physician Decision|4|||
46622174|NCT04887948|82774412|FG002|Overall Study|Physician Decision|1|||
46710119|NCT01168973|82926245|FG001|Overall Study|Progressive Disease|429|||
46710120|NCT01168973|82926244|FG000|Overall Study|Adverse Event|94|||
47025613|NCT01444378|83275010|FG000|Overall Study|Lost to Follow-up|1|||
47025614|NCT01444378|83275010|FG000|Overall Study|Withdrawal by Subject|1|||
47025615|NCT01444378|83275010|FG000|Overall Study|Death|3|||
46622175|NCT04887948|82774410|FG000|Overall Study|Protocol Violation|1|||
46710121|NCT01168973|82926245|FG001|Overall Study|Adverse Event|55|||
46710122|NCT01168973|82926244|FG000|Overall Study|Withdrawal by Subject|90|||
47025616|NCT01444378|83275010|FG000|Overall Study|Administrative Closure Of The Study|2|||
47025617|NCT01444378|83275010|FG000|Overall Study|Missed Visits|10|||
46912044|NCT02924688|83142204|FG000|Overall Study|Protocol Violation|3|||
46912045|NCT02924688|83142205|FG001|Overall Study|Protocol Violation|7|||
46912046|NCT02924688|83142206|FG002|Overall Study|Protocol Violation|5|||
46912047|NCT02924688|83142207|FG003|Overall Study|Protocol Violation|6|||
46912048|NCT02924688|83142208|FG004|Overall Study|Protocol Violation|2|||
46912049|NCT02924688|83142209|FG005|Overall Study|Protocol Violation|2|||
46912050|NCT02924688|83142204|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
46912051|NCT02924688|83142205|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
46912052|NCT02924688|83142206|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
46912053|NCT02924688|83142207|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
46912054|NCT02924688|83142208|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
46912055|NCT02924688|83142209|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
46912056|NCT02924688|83142204|FG000|Overall Study|Lost to Follow-up|2|||
46912057|NCT02924688|83142205|FG001|Overall Study|Lost to Follow-up|4|||
46912058|NCT02924688|83142206|FG002|Overall Study|Lost to Follow-up|2|||
46912059|NCT02924688|83142207|FG003|Overall Study|Lost to Follow-up|4|||
46912060|NCT02924688|83142208|FG004|Overall Study|Lost to Follow-up|2|||
46912061|NCT02924688|83142209|FG005|Overall Study|Lost to Follow-up|4|||
46912062|NCT02924688|83142204|FG000|Overall Study|Physician Decision|2|||
46912063|NCT02924688|83142205|FG001|Overall Study|Physician Decision|1|||
46912064|NCT02924688|83142206|FG002|Overall Study|Physician Decision|0|||
46912065|NCT02924688|83142207|FG003|Overall Study|Physician Decision|1|||
46912066|NCT02924688|83142208|FG004|Overall Study|Physician Decision|1|||
46912067|NCT02924688|83142209|FG005|Overall Study|Physician Decision|1|||
46912068|NCT02924688|83142204|FG000|Overall Study|Withdrawal by Subject|14|||
46912069|NCT02924688|83142205|FG001|Overall Study|Withdrawal by Subject|13|||
46912070|NCT02924688|83142206|FG002|Overall Study|Withdrawal by Subject|9|||
46912071|NCT02924688|83142207|FG003|Overall Study|Withdrawal by Subject|12|||
46912072|NCT02924688|83142208|FG004|Overall Study|Withdrawal by Subject|13|||
46912073|NCT02924688|83142209|FG005|Overall Study|Withdrawal by Subject|14|||
46912074|NCT03011892|83142232|FG000|Double Blind (DB) Period|Adverse Event|0|||
46912075|NCT03011892|83142233|FG001|Double Blind (DB) Period|Adverse Event|1|||
46912076|NCT03011892|83142234|FG002|Double Blind (DB) Period|Adverse Event|1|||
46912077|NCT03011892|83142235|FG003|Double Blind (DB) Period|Adverse Event|0|||
46622176|NCT04887948|82774411|FG001|Overall Study|Protocol Violation|1|||
46622177|NCT04887948|82774412|FG002|Overall Study|Protocol Violation|0|||
46622178|NCT04887948|82774410|FG000|Overall Study|Withdrawal by Subject|0|||
46622179|NCT04887948|82774411|FG001|Overall Study|Withdrawal by Subject|6|||
46710123|NCT01168973|82926245|FG001|Overall Study|Withdrawal by Subject|53|||
46912078|NCT03011892|83142236|FG004|Double Blind (DB) Period|Adverse Event|0|||
46622180|NCT04887948|82774412|FG002|Overall Study|Withdrawal by Subject|1|||
46622181|NCT04887948|82774410|FG000|Overall Study|No longer met eligibility criteria|1|||
46622182|NCT04887948|82774411|FG001|Overall Study|No longer met eligibility criteria|2|||
46622183|NCT04887948|82774412|FG002|Overall Study|No longer met eligibility criteria|1|||
46622184|NCT04887948|82774410|FG000|Overall Study|Other|2|||
46622185|NCT04887948|82774411|FG001|Overall Study|Other|1|||
46622186|NCT04887948|82774412|FG002|Overall Study|Other|1|||
46622187|NCT01638000|82774550|FG000|Overall Study|Randomized but Never Received Drug|7|||
46622188|NCT01638000|82774551|FG001|Overall Study|Randomized but Never Received Drug|10|||
46622189|NCT01638000|82774550|FG000|Overall Study|Adverse Event|14|||
46622190|NCT01638000|82774551|FG001|Overall Study|Adverse Event|16|||
46622191|NCT01638000|82774550|FG000|Overall Study|Lack of Efficacy|5|||
46622192|NCT01638000|82774551|FG001|Overall Study|Lack of Efficacy|6|||
46622193|NCT01638000|82774550|FG000|Overall Study|Protocol Violation|11|||
46622194|NCT01638000|82774551|FG001|Overall Study|Protocol Violation|13|||
46622195|NCT01638000|82774550|FG000|Overall Study|Withdrawal by Subject|21|||
46622196|NCT01638000|82774551|FG001|Overall Study|Withdrawal by Subject|24|||
46622197|NCT01638000|82774550|FG000|Overall Study|Miscellaneous|2|||
46622198|NCT01638000|82774551|FG001|Overall Study|Miscellaneous|2|||
46622199|NCT01637922|82774610|FG000|Overall Study|Adverse Event|0|||
46622200|NCT01637922|82774611|FG001|Overall Study|Adverse Event|1|||
46710124|NCT01168973|82926244|FG000|Overall Study|Death|42|||
46912079|NCT03011892|83142237|FG005|Double Blind (DB) Period|Adverse Event|0|||
46912080|NCT03011892|83142238|FG006|Double Blind (DB) Period|Adverse Event|0|||
46912081|NCT03011892|83142239|FG007|Double Blind (DB) Period|Adverse Event|0|||
46912082|NCT03011892|83142240|FG008|Double Blind (DB) Period|Adverse Event|0|||
46912083|NCT03011892|83142241|FG009|Double Blind (DB) Period|Adverse Event|0|||
46912084|NCT03011892|83142242|FG010|Double Blind (DB) Period|Adverse Event|0|||
46912085|NCT03011892|83142243|FG011|Double Blind (DB) Period|Adverse Event|0|||
46622201|NCT01637922|82774610|FG000|Overall Study|Protocol Violation|0|||
46622202|NCT01637922|82774611|FG001|Overall Study|Protocol Violation|1|||
46622203|NCT01637922|82774610|FG000|Overall Study|Withdrawal by Subject|0|||
46622204|NCT01637922|82774611|FG001|Overall Study|Withdrawal by Subject|3|||
46710125|NCT01168973|82926245|FG001|Overall Study|Death|45|||
46912086|NCT03011892|83142232|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
46912087|NCT03011892|83142233|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
46912088|NCT03011892|83142234|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
47025618|NCT02020889|83275019|FG000|Overall Study|Adverse Event|0|||
47025619|NCT02020889|83275020|FG001|Overall Study|Adverse Event|1|||
47025620|NCT02020889|83275019|FG000|Overall Study|Lack of Efficacy|1|||
47025621|NCT02020889|83275020|FG001|Overall Study|Lack of Efficacy|0|||
47025622|NCT02020889|83275019|FG000|Overall Study|Lost to Follow-up|1|||
47025623|NCT02020889|83275020|FG001|Overall Study|Lost to Follow-up|0|||
47025624|NCT02020889|83275019|FG000|Overall Study|Physician Decision|2|||
47025625|NCT02020889|83275020|FG001|Overall Study|Physician Decision|0|||
47025626|NCT02020889|83275019|FG000|Overall Study|Withdrawal by Subject|3|||
47025627|NCT02020889|83275020|FG001|Overall Study|Withdrawal by Subject|2|||
47025628|NCT01444300|83275028|FG000|Overall Study|Adverse Event|4|||
47025629|NCT01444300|83275029|FG001|Overall Study|Adverse Event|0|||
47025630|NCT01443364|83275036|FG000|Overall Study|Lack of Efficacy|14|||
47025631|NCT01443364|83275036|FG000|Overall Study|Lost to Follow-up|3|||
47025632|NCT01443364|83275036|FG000|Overall Study|Withdrawal by Subject|5|||
47025633|NCT01443364|83275036|FG000|Overall Study|Other Reason|4|||
47025634|NCT01443364|83275036|FG000|Overall Study|SAE, non-fatal|6|||
47025635|NCT01443364|83275036|FG000|Overall Study|AE, non-serious non-fatal|8|||
47025636|NCT01443364|83275036|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
47025637|NCT02020577|83275042|FG000|Overall Study|Progressive disease|3|||
47025638|NCT02020577|83275043|FG001|Overall Study|Progressive disease|38|||
47025639|NCT02020577|83275042|FG000|Overall Study|Other AE or clinical progression|0|||
47025640|NCT02020577|83275043|FG001|Overall Study|Other AE or clinical progression|15|||
47025641|NCT02020577|83275042|FG000|Overall Study|Withdrawal by Subject|0|||
47025642|NCT02020577|83275043|FG001|Overall Study|Withdrawal by Subject|1|||
47025643|NCT02020577|83275042|FG000|Overall Study|Other than stated above|0|||
47025644|NCT02020577|83275043|FG001|Overall Study|Other than stated above|1|||
47025645|NCT02020031|83275053|FG000|Overall Study|Physician Decision|1|||
47025646|NCT02020031|83275054|FG001|Overall Study|Physician Decision|1|||
47025647|NCT04179305|83275064|FG000|Overall Study|Death|1|||
47025648|NCT04179305|83275065|FG001|Overall Study|Death|1|||
47025649|NCT04179305|83275066|FG002|Overall Study|Death|0|||
47025650|NCT04179305|83275067|FG003|Overall Study|Death|0|||
47025651|NCT04179305|83275064|FG000|Overall Study|Lost to Follow-up|1|||
47025652|NCT04179305|83275065|FG001|Overall Study|Lost to Follow-up|1|||
47025653|NCT04179305|83275066|FG002|Overall Study|Lost to Follow-up|0|||
47025654|NCT04179305|83275067|FG003|Overall Study|Lost to Follow-up|0|||
47025655|NCT04179305|83275064|FG000|Overall Study|Withdrawal by Subject|0|||
47025656|NCT04179305|83275065|FG001|Overall Study|Withdrawal by Subject|1|||
47025657|NCT04179305|83275066|FG002|Overall Study|Withdrawal by Subject|0|||
47025658|NCT04179305|83275067|FG003|Overall Study|Withdrawal by Subject|0|||
47025659|NCT04179305|83275064|FG000|Overall Study|Did not have scan|1|||
47025660|NCT04179305|83275065|FG001|Overall Study|Did not have scan|0|||
47025661|NCT04179305|83275066|FG002|Overall Study|Did not have scan|0|||
47025662|NCT04179305|83275067|FG003|Overall Study|Did not have scan|0|||
47025663|NCT04179305|83275064|FG000|Overall Study|In hospice care|3|||
47025664|NCT04179305|83275065|FG001|Overall Study|In hospice care|0|||
47025665|NCT04179305|83275066|FG002|Overall Study|In hospice care|0|||
47025666|NCT04179305|83275067|FG003|Overall Study|In hospice care|0|||
47025667|NCT02019719|83275083|FG000|Overall Study|Adverse Event|1|||
47025668|NCT02019719|83275084|FG001|Overall Study|Adverse Event|0|||
47025669|NCT02019719|83275085|FG002|Overall Study|Adverse Event|0|||
47025670|NCT02019719|83275086|FG003|Overall Study|Adverse Event|1|||
47025671|NCT02019719|83275087|FG004|Overall Study|Adverse Event|1|||
47025672|NCT02019719|83275083|FG000|Overall Study|Protocol Violation|1|||
47025673|NCT02019719|83275084|FG001|Overall Study|Protocol Violation|1|||
47025674|NCT02019719|83275085|FG002|Overall Study|Protocol Violation|0|||
47025675|NCT02019719|83275086|FG003|Overall Study|Protocol Violation|0|||
47025676|NCT02019719|83275087|FG004|Overall Study|Protocol Violation|0|||
47025677|NCT02019719|83275083|FG000|Overall Study|Protocol defined stopping criteria|2|||
47025678|NCT02019719|83275084|FG001|Overall Study|Protocol defined stopping criteria|0|||
47025679|NCT02019719|83275085|FG002|Overall Study|Protocol defined stopping criteria|0|||
47025680|NCT02019719|83275086|FG003|Overall Study|Protocol defined stopping criteria|1|||
47025681|NCT02019719|83275087|FG004|Overall Study|Protocol defined stopping criteria|1|||
47025682|NCT02019719|83275083|FG000|Overall Study|Physician Decision|2|||
47025683|NCT02019719|83275084|FG001|Overall Study|Physician Decision|0|||
47025684|NCT02019719|83275085|FG002|Overall Study|Physician Decision|0|||
47025685|NCT02019719|83275086|FG003|Overall Study|Physician Decision|0|||
47025686|NCT02019719|83275087|FG004|Overall Study|Physician Decision|0|||
47025687|NCT02030405|83275106|FG000|Overall Study|Withdrawal by Subject|1|||
47025688|NCT02030405|83275106|FG000|Overall Study|Lost to Follow-up|1|||
47025689|NCT01975376|83275113|FG000|Overall Study|Adverse Event|5|||
47025690|NCT01975376|83275114|FG001|Overall Study|Adverse Event|5|||
47025691|NCT01975376|83275113|FG000|Overall Study|Death|65|||
47025692|NCT01975376|83275114|FG001|Overall Study|Death|72|||
47025693|NCT01975376|83275113|FG000|Overall Study|Lost to Follow-up|70|||
47025694|NCT01975376|83275114|FG001|Overall Study|Lost to Follow-up|66|||
47025695|NCT01975376|83275113|FG000|Overall Study|Withdrew consent|68|||
47025696|NCT01975376|83275114|FG001|Overall Study|Withdrew consent|62|||
46622205|NCT01637922|82774610|FG000|Overall Study|Lost to Follow-up|2|||
46622206|NCT01637922|82774611|FG001|Overall Study|Lost to Follow-up|0|||
46622207|NCT01638546|82774815|FG000|Overall Study|Adverse Event|1|||
46622208|NCT01638546|82774816|FG001|Overall Study|Adverse Event|3|||
46622209|NCT03172494|82774836|FG000|Overall Study|Adverse Event|5|||
46622210|NCT03172494|82774837|FG001|Overall Study|Adverse Event|1|||
46622211|NCT03172494|82774838|FG002|Overall Study|Adverse Event|15|||
46622212|NCT03172494|82774836|FG000|Overall Study|Protocol Violation|3|||
46622213|NCT03172494|82774837|FG001|Overall Study|Protocol Violation|2|||
46622214|NCT03172494|82774838|FG002|Overall Study|Protocol Violation|1|||
46622215|NCT03172494|82774836|FG000|Overall Study|Lack of Efficacy|0|||
46622216|NCT03172494|82774837|FG001|Overall Study|Lack of Efficacy|0|||
46622217|NCT03172494|82774838|FG002|Overall Study|Lack of Efficacy|4|||
46622218|NCT03172494|82774836|FG000|Overall Study|Pregnancy|0|||
46622219|NCT03172494|82774837|FG001|Overall Study|Pregnancy|1|||
46622220|NCT03172494|82774838|FG002|Overall Study|Pregnancy|0|||
46622221|NCT03172494|82774836|FG000|Overall Study|Withdrawal by Subject|10|||
46622222|NCT03172494|82774837|FG001|Overall Study|Withdrawal by Subject|8|||
46622223|NCT03172494|82774838|FG002|Overall Study|Withdrawal by Subject|8|||
46622224|NCT03172494|82774836|FG000|Overall Study|Severe hypoglycaemic episode|0|||
46622225|NCT03172494|82774837|FG001|Overall Study|Severe hypoglycaemic episode|0|||
46622226|NCT03172494|82774838|FG002|Overall Study|Severe hypoglycaemic episode|1|||
46622227|NCT03172494|82774836|FG000|Overall Study|Non-compliance towards treatment|2|||
46622228|NCT03172494|82774837|FG001|Overall Study|Non-compliance towards treatment|0|||
46622229|NCT03172494|82774838|FG002|Overall Study|Non-compliance towards treatment|0|||
46622230|NCT01636362|82774939|FG000|Overall Study|Physician Decision|6|||
46710126|NCT01168973|82926244|FG000|Overall Study|Physician Decision|37|||
46912089|NCT03011892|83142235|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
46912090|NCT03011892|83142236|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
46912091|NCT03011892|83142237|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
46912092|NCT03011892|83142238|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
46912093|NCT03011892|83142239|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
46912094|NCT03011892|83142240|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
46912095|NCT03011892|83142241|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
47025697|NCT01975376|83275113|FG000|Overall Study|Other|2|||
46622231|NCT01636362|82774939|FG000|Overall Study|Subject healed, not returning|1|||
46622232|NCT01636362|82774939|FG000|Overall Study|Withdrawal by Subject|1|||
46710127|NCT01168973|82926245|FG001|Overall Study|Physician Decision|19|||
46710128|NCT01168973|82926244|FG000|Overall Study|Sponsor Decision|2|||
46710129|NCT01168973|82926245|FG001|Overall Study|Sponsor Decision|1|||
46710130|NCT01168973|82926244|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
46710131|NCT01168973|82926245|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
46710132|NCT03918109|82926255|FG000|Overall Study|Withdrawal by Subject|0|||
46710133|NCT03918109|82926256|FG001|Overall Study|Withdrawal by Subject|0|||
46710134|NCT03918109|82926257|FG002|Overall Study|Withdrawal by Subject|2|||
46710135|NCT03918109|82926258|FG003|Overall Study|Withdrawal by Subject|1|||
46710136|NCT03918109|82926255|FG000|Overall Study|Lost to Follow-up|0|||
46710137|NCT03918109|82926256|FG001|Overall Study|Lost to Follow-up|0|||
46710138|NCT03918109|82926257|FG002|Overall Study|Lost to Follow-up|0|||
46710139|NCT03918109|82926258|FG003|Overall Study|Lost to Follow-up|1|||
46710140|NCT01168427|82926268|FG000|Overall Study|Patient exited prior to implant|1|||
46710141|NCT01124916|82926274|FG000|Overall Study|Lost to Follow-up|3|||
46710142|NCT01124916|82926275|FG001|Overall Study|Lost to Follow-up|2|||
46710143|NCT00916006|82926283|FG000|Overall Study|Adverse Event|1|||
46710144|NCT00916006|82926284|FG001|Overall Study|Adverse Event|1|||
46710145|NCT00916006|82926283|FG000|Overall Study|Withdrawal by Subject|2|||
46710146|NCT00916006|82926284|FG001|Overall Study|Withdrawal by Subject|5|||
46710147|NCT00916006|82926283|FG000|Overall Study|Protocol Violation|0|||
46710148|NCT00916006|82926284|FG001|Overall Study|Protocol Violation|1|||
46710149|NCT01168349|82926301|FG000|Overall Study|Death|157|||
46710150|NCT01168349|82926301|FG000|Overall Study|Lost to Follow-up|34|||
46710151|NCT01168349|82926301|FG000|Overall Study|Withdrawal by Subject|9|||
46710152|NCT01168349|82926301|FG000|Overall Study|Kidney transplantation|3|||
46912096|NCT03011892|83142242|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
46912097|NCT03011892|83142243|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
47025698|NCT01975376|83275114|FG001|Overall Study|Other|4|||
47025699|NCT01975376|83275113|FG000|Overall Study|Randomized, Not Treated|16|||
46710153|NCT01168349|82926301|FG000|Overall Study|Other|22|||
46912098|NCT03011892|83142232|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
46622233|NCT03042468|82775004|FG000|Overall Study|Death|0|||
46622234|NCT03042468|82775005|FG001|Overall Study|Death|1|||
46622235|NCT03042468|82775006|FG002|Overall Study|Death|1|||
46710154|NCT01168349|82926301|FG000|Overall Study|Protocol Violation|76|||
46710155|NCT00915772|82926324|FG000|Overall Study|Adverse Event|12|||
46710156|NCT00915772|82926325|FG001|Overall Study|Adverse Event|13|||
46912099|NCT03011892|83142233|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
46622236|NCT03042468|82775007|FG003|Overall Study|Death|0|||
47025700|NCT01975376|83275114|FG001|Overall Study|Randomized, Not Treated|8|||
46622237|NCT03042468|82775008|FG004|Overall Study|Death|0|||
46622238|NCT03042468|82775009|FG005|Overall Study|Death|0|||
46622239|NCT03042468|82775004|FG000|Overall Study|Withdrawal by Subject|0|||
46622240|NCT03042468|82775005|FG001|Overall Study|Withdrawal by Subject|0|||
46622241|NCT03042468|82775006|FG002|Overall Study|Withdrawal by Subject|0|||
46622242|NCT03042468|82775007|FG003|Overall Study|Withdrawal by Subject|0|||
46622243|NCT03042468|82775008|FG004|Overall Study|Withdrawal by Subject|0|||
46622244|NCT03042468|82775009|FG005|Overall Study|Withdrawal by Subject|1|||
46622245|NCT03042468|82775004|FG000|Overall Study|Lost to Follow-up|0|||
46622246|NCT03042468|82775005|FG001|Overall Study|Lost to Follow-up|0|||
46622247|NCT03042468|82775006|FG002|Overall Study|Lost to Follow-up|0|||
46622248|NCT03042468|82775007|FG003|Overall Study|Lost to Follow-up|0|||
46622249|NCT03042468|82775008|FG004|Overall Study|Lost to Follow-up|1|||
46622250|NCT03042468|82775009|FG005|Overall Study|Lost to Follow-up|1|||
46622251|NCT01634178|82775027|FG000|Treatment Period 1|Adverse Event|0|||
46622252|NCT01634178|82775028|FG001|Treatment Period 1|Adverse Event|1|||
46622253|NCT01634178|82775027|FG000|Treatment Period 2|Adverse Event|1|||
46622254|NCT01634178|82775028|FG001|Treatment Period 2|Adverse Event|0|||
46622255|NCT02412306|82775070|FG000|Overall Study|Lost to Follow-up|0|||
46622256|NCT02412306|82775071|FG001|Overall Study|Lost to Follow-up|1|||
46622257|NCT02412306|82775072|FG002|Overall Study|Lost to Follow-up|0|||
46622258|NCT02412306|82775073|FG003|Overall Study|Lost to Follow-up|0|||
46622259|NCT02412306|82775074|FG004|Overall Study|Lost to Follow-up|0|||
46622260|NCT02412306|82775070|FG000|Overall Study|Withdrawal by Subject|0|||
46622261|NCT02412306|82775071|FG001|Overall Study|Withdrawal by Subject|0|||
46622262|NCT02412306|82775072|FG002|Overall Study|Withdrawal by Subject|1|||
46622263|NCT02412306|82775073|FG003|Overall Study|Withdrawal by Subject|0|||
46622264|NCT02412306|82775074|FG004|Overall Study|Withdrawal by Subject|0|||
46622265|NCT02412306|82775070|FG000|Overall Study|Death|5|||
46622266|NCT02412306|82775071|FG001|Overall Study|Death|7|||
46622267|NCT02412306|82775072|FG002|Overall Study|Death|15|||
46622268|NCT02412306|82775073|FG003|Overall Study|Death|0|||
46622269|NCT02412306|82775074|FG004|Overall Study|Death|2|||
46622270|NCT04285723|82775097|FG000|Overall Study|Subject decision|1|||
46622271|NCT04285723|82775098|FG001|Overall Study|Subject decision|2|||
46622272|NCT04285723|82775097|FG000|Overall Study|Physician Decision|1|||
46622273|NCT04285723|82775098|FG001|Overall Study|Physician Decision|0|||
46622274|NCT04285723|82775097|FG000|Overall Study|No efficiency|1|||
46622275|NCT04285723|82775098|FG001|Overall Study|No efficiency|0|||
46622276|NCT01352221|82775112|FG000|Double-blind Phase|Adverse Event|6|||
46622277|NCT01352221|82775113|FG001|Double-blind Phase|Adverse Event|4|||
46622278|NCT01352221|82775114|FG002|Double-blind Phase|Adverse Event|0|||
46622279|NCT01352221|82775115|FG003|Double-blind Phase|Adverse Event|0|||
46622280|NCT01352221|82775112|FG000|Double-blind Phase|Withdrawal by Subject|3|||
46622281|NCT01352221|82775113|FG001|Double-blind Phase|Withdrawal by Subject|5|||
46622282|NCT01352221|82775114|FG002|Double-blind Phase|Withdrawal by Subject|0|||
46622283|NCT01352221|82775115|FG003|Double-blind Phase|Withdrawal by Subject|0|||
46622284|NCT01352221|82775112|FG000|Double-blind Phase|Lost to Follow-up|0|||
46622285|NCT01352221|82775113|FG001|Double-blind Phase|Lost to Follow-up|1|||
46622286|NCT01352221|82775114|FG002|Double-blind Phase|Lost to Follow-up|0|||
46622287|NCT01352221|82775115|FG003|Double-blind Phase|Lost to Follow-up|0|||
46622288|NCT01352221|82775112|FG000|Double-blind Phase|Protocol Violation|0|||
46622289|NCT01352221|82775113|FG001|Double-blind Phase|Protocol Violation|1|||
46622290|NCT01352221|82775114|FG002|Double-blind Phase|Protocol Violation|0|||
46622291|NCT01352221|82775115|FG003|Double-blind Phase|Protocol Violation|0|||
46622292|NCT01352221|82775112|FG000|Open-label Phase|Physician Decision|0|||
46710157|NCT00915772|82926326|FG002|Overall Study|Adverse Event|11|||
46710158|NCT00915772|82926324|FG000|Overall Study|Protocol Violation|4|||
46710159|NCT00915772|82926325|FG001|Overall Study|Protocol Violation|1|||
46710160|NCT00915772|82926326|FG002|Overall Study|Protocol Violation|2|||
47025701|NCT01443130|83275126|FG000|Overall Study|Lost to Follow-up|44|||
47025702|NCT01443130|83275127|FG001|Overall Study|Lost to Follow-up|42|||
47025703|NCT01443130|83275128|FG002|Overall Study|Lost to Follow-up|50|||
47025704|NCT01443130|83275129|FG003|Overall Study|Lost to Follow-up|23|||
47025705|NCT01443130|83275130|FG004|Overall Study|Lost to Follow-up|25|||
46622293|NCT01352221|82775113|FG001|Open-label Phase|Physician Decision|0|||
46622294|NCT01352221|82775114|FG002|Open-label Phase|Physician Decision|2|||
46622295|NCT01352221|82775115|FG003|Open-label Phase|Physician Decision|1|||
46622296|NCT01352221|82775112|FG000|Open-label Phase|Pregnancy|0|||
46622297|NCT01352221|82775113|FG001|Open-label Phase|Pregnancy|0|||
46622298|NCT01352221|82775114|FG002|Open-label Phase|Pregnancy|1|||
46622299|NCT01352221|82775115|FG003|Open-label Phase|Pregnancy|0|||
46622300|NCT01352221|82775112|FG000|Open-label Phase|Adverse Event|0|||
46622301|NCT01352221|82775113|FG001|Open-label Phase|Adverse Event|0|||
46622302|NCT01352221|82775114|FG002|Open-label Phase|Adverse Event|8|||
46710161|NCT00915772|82926324|FG000|Overall Study|Lost to Follow-up|1|||
46622303|NCT01352221|82775115|FG003|Open-label Phase|Adverse Event|4|||
46641227|NCT04627038|82825245|FG001|Overall Study|Adverse Event|8|||
47025706|NCT01443130|83275131|FG005|Overall Study|Lost to Follow-up|21|||
47025707|NCT01443130|83275126|FG000|Overall Study|Death|0|||
46710162|NCT00915772|82926325|FG001|Overall Study|Lost to Follow-up|2|||
46710163|NCT00915772|82926326|FG002|Overall Study|Lost to Follow-up|2|||
46710164|NCT00915772|82926324|FG000|Overall Study|Lack of Efficacy|9|||
46710165|NCT00915772|82926325|FG001|Overall Study|Lack of Efficacy|15|||
46710166|NCT00915772|82926326|FG002|Overall Study|Lack of Efficacy|3|||
46710167|NCT00915772|82926324|FG000|Overall Study|Refused to continue trial medication|6|||
46710168|NCT00915772|82926325|FG001|Overall Study|Refused to continue trial medication|8|||
46710169|NCT00915772|82926326|FG002|Overall Study|Refused to continue trial medication|4|||
46710170|NCT00915772|82926324|FG000|Overall Study|Any other reason|4|||
46710171|NCT00915772|82926325|FG001|Overall Study|Any other reason|7|||
46710172|NCT00915772|82926326|FG002|Overall Study|Any other reason|7|||
46710173|NCT00912964|82926338|FG000|Overall Study|Eligibility criterion not met|1|||
46710174|NCT00912964|82926339|FG001|Overall Study|Eligibility criterion not met|1|||
46710175|NCT00912964|82926340|FG002|Overall Study|Eligibility criterion not met|0|||
46710176|NCT00912964|82926338|FG000|Overall Study|Adverse Event|15|||
46710177|NCT00912964|82926339|FG001|Overall Study|Adverse Event|18|||
46710178|NCT00912964|82926340|FG002|Overall Study|Adverse Event|12|||
46710179|NCT00912964|82926338|FG000|Overall Study|Lack of Efficacy|11|||
46710180|NCT00912964|82926339|FG001|Overall Study|Lack of Efficacy|4|||
46710181|NCT00912964|82926340|FG002|Overall Study|Lack of Efficacy|3|||
47025708|NCT01443130|83275127|FG001|Overall Study|Death|1|||
47025709|NCT01443130|83275128|FG002|Overall Study|Death|0|||
47025710|NCT01443130|83275129|FG003|Overall Study|Death|7|||
47025711|NCT01443130|83275130|FG004|Overall Study|Death|10|||
47025712|NCT01443130|83275131|FG005|Overall Study|Death|8|||
47025713|NCT01443130|83275126|FG000|Overall Study|Adverse Event|2|||
47025714|NCT01443130|83275127|FG001|Overall Study|Adverse Event|1|||
47025715|NCT01443130|83275128|FG002|Overall Study|Adverse Event|1|||
47025716|NCT01443130|83275129|FG003|Overall Study|Adverse Event|0|||
47025717|NCT01443130|83275130|FG004|Overall Study|Adverse Event|0|||
47025718|NCT01443130|83275131|FG005|Overall Study|Adverse Event|0|||
47025719|NCT01443130|83275126|FG000|Overall Study|Protocol Violation|2|||
47025720|NCT01443130|83275127|FG001|Overall Study|Protocol Violation|1|||
47025721|NCT01443130|83275128|FG002|Overall Study|Protocol Violation|3|||
47025722|NCT01443130|83275129|FG003|Overall Study|Protocol Violation|2|||
47025723|NCT01443130|83275130|FG004|Overall Study|Protocol Violation|2|||
47025724|NCT01443130|83275131|FG005|Overall Study|Protocol Violation|3|||
47025725|NCT01443130|83275126|FG000|Overall Study|Withdrawal by Subject|15|||
47025726|NCT01443130|83275127|FG001|Overall Study|Withdrawal by Subject|14|||
47025727|NCT01443130|83275128|FG002|Overall Study|Withdrawal by Subject|12|||
47025728|NCT01443130|83275129|FG003|Overall Study|Withdrawal by Subject|7|||
47025729|NCT01443130|83275130|FG004|Overall Study|Withdrawal by Subject|7|||
47025730|NCT01443130|83275131|FG005|Overall Study|Withdrawal by Subject|2|||
47025731|NCT01443130|83275126|FG000|Overall Study|Death of Subject's Infant|5|||
47025732|NCT01443130|83275127|FG001|Overall Study|Death of Subject's Infant|10|||
47025733|NCT01443130|83275128|FG002|Overall Study|Death of Subject's Infant|11|||
47025734|NCT01443130|83275129|FG003|Overall Study|Death of Subject's Infant|0|||
46622304|NCT01352221|82775112|FG000|Open-label Phase|Withdrawal by Subject|0|||
46622305|NCT01352221|82775113|FG001|Open-label Phase|Withdrawal by Subject|0|||
46622306|NCT01352221|82775114|FG002|Open-label Phase|Withdrawal by Subject|1|||
46622307|NCT01352221|82775115|FG003|Open-label Phase|Withdrawal by Subject|6|||
46622308|NCT01352221|82775112|FG000|Open-label Phase|Worsening of IBD|0|||
46622309|NCT01352221|82775113|FG001|Open-label Phase|Worsening of IBD|0|||
46622310|NCT01352221|82775114|FG002|Open-label Phase|Worsening of IBD|1|||
46622311|NCT01352221|82775115|FG003|Open-label Phase|Worsening of IBD|0|||
46622312|NCT03518034|82775139|FG000|Overall Study|Not Treated|5|||
46710182|NCT00912964|82926338|FG000|Overall Study|Withdrawal by Subject|20|||
46710183|NCT00912964|82926339|FG001|Overall Study|Withdrawal by Subject|12|||
46710184|NCT00912964|82926340|FG002|Overall Study|Withdrawal by Subject|18|||
46710185|NCT00912964|82926338|FG000|Overall Study|Lost to Follow-up|4|||
46912100|NCT03011892|83142234|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
47025735|NCT01443130|83275130|FG004|Overall Study|Death of Subject's Infant|0|||
47025736|NCT01443130|83275131|FG005|Overall Study|Death of Subject's Infant|0|||
47025737|NCT01436500|83275147|FG000|Overall Study|Death|1|||
47025738|NCT01436500|83275148|FG001|Overall Study|Death|0|||
47025739|NCT01436500|83275149|FG002|Overall Study|Death|0|||
47025740|NCT01436500|83275150|FG003|Overall Study|Death|0|||
46622313|NCT03518034|82775140|FG001|Overall Study|Not Treated|1|||
46622314|NCT03518034|82775139|FG000|Overall Study|Withdrawal by Subject|309|||
46622315|NCT03518034|82775140|FG001|Overall Study|Withdrawal by Subject|351|||
46622316|NCT03518034|82775139|FG000|Overall Study|Lost to Follow-up|446|||
46622317|NCT03518034|82775140|FG001|Overall Study|Lost to Follow-up|458|||
46622318|NCT03518034|82775139|FG000|Overall Study|Adverse Event|138|||
46622319|NCT03518034|82775140|FG001|Overall Study|Adverse Event|130|||
46622320|NCT03518034|82775139|FG000|Overall Study|Lack of Efficacy|11|||
46622321|NCT03518034|82775140|FG001|Overall Study|Lack of Efficacy|23|||
46622322|NCT03518034|82775139|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
46622323|NCT03518034|82775140|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
46622324|NCT03518034|82775139|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
46622325|NCT03518034|82775140|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
46622326|NCT03518034|82775139|FG000|Overall Study|Other, Not Specified|84|||
46622327|NCT03518034|82775140|FG001|Overall Study|Other, Not Specified|53|||
46622328|NCT03518034|82775139|FG000|Overall Study|Reason Missing|2|||
46622329|NCT03518034|82775140|FG001|Overall Study|Reason Missing|3|||
46622330|NCT01634100|82775152|FG000|Overall Study|Withdrawal by Subject|1|||
46622331|NCT01634100|82775153|FG001|Overall Study|Withdrawal by Subject|0|||
46622332|NCT01634100|82775154|FG002|Overall Study|Withdrawal by Subject|1|||
46622333|NCT01634100|82775155|FG003|Overall Study|Withdrawal by Subject|0|||
46622334|NCT01634100|82775156|FG004|Overall Study|Withdrawal by Subject|0|||
46622335|NCT01634100|82775157|FG005|Overall Study|Withdrawal by Subject|0|||
46622336|NCT01633944|82775167|FG000|Open-label Titration Phase|Adverse Event|109|||
46622337|NCT01633944|82775168|FG001|Open-label Titration Phase|Adverse Event|0|||
46622338|NCT01633944|82775169|FG002|Open-label Titration Phase|Adverse Event|0|||
46622339|NCT01633944|82775167|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
46622340|NCT01633944|82775168|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
46710186|NCT00912964|82926339|FG001|Overall Study|Lost to Follow-up|3|||
46710187|NCT00912964|82926340|FG002|Overall Study|Lost to Follow-up|3|||
46710188|NCT00912964|82926338|FG000|Overall Study|Protocol Violation|5|||
46912101|NCT03011892|83142235|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
46912102|NCT03011892|83142236|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
46912103|NCT03011892|83142237|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
46912104|NCT03011892|83142238|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
46912105|NCT03011892|83142239|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
46912106|NCT03011892|83142240|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
46912107|NCT03011892|83142241|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
46912108|NCT03011892|83142242|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
47025741|NCT01436500|83275151|FG004|Overall Study|Death|0|||
47025742|NCT01436500|83275147|FG000|Overall Study|Adverse Event|0|||
47025743|NCT01436500|83275148|FG001|Overall Study|Adverse Event|2|||
47025744|NCT01436500|83275149|FG002|Overall Study|Adverse Event|2|||
47025745|NCT01436500|83275150|FG003|Overall Study|Adverse Event|0|||
47025746|NCT01436500|83275151|FG004|Overall Study|Adverse Event|1|||
47025747|NCT01436500|83275147|FG000|Overall Study|Withdrawal by Subject|0|||
47025748|NCT01436500|83275148|FG001|Overall Study|Withdrawal by Subject|0|||
47025749|NCT01436500|83275149|FG002|Overall Study|Withdrawal by Subject|2|||
47025750|NCT01436500|83275150|FG003|Overall Study|Withdrawal by Subject|0|||
47025751|NCT01436500|83275151|FG004|Overall Study|Withdrawal by Subject|2|||
47025752|NCT01436500|83275147|FG000|Overall Study|Physician Decision|0|||
47025753|NCT01436500|83275148|FG001|Overall Study|Physician Decision|0|||
47025754|NCT01436500|83275149|FG002|Overall Study|Physician Decision|1|||
47025755|NCT01436500|83275150|FG003|Overall Study|Physician Decision|0|||
47025756|NCT01436500|83275151|FG004|Overall Study|Physician Decision|0|||
47025757|NCT01436500|83275147|FG000|Overall Study|liver transplant|1|||
47025758|NCT01436500|83275148|FG001|Overall Study|liver transplant|0|||
47025759|NCT01436500|83275149|FG002|Overall Study|liver transplant|0|||
47025760|NCT01436500|83275150|FG003|Overall Study|liver transplant|0|||
47025761|NCT01436500|83275151|FG004|Overall Study|liver transplant|0|||
47025762|NCT01436500|83275147|FG000|Overall Study|initiation of dialysis|0|||
47025763|NCT01436500|83275148|FG001|Overall Study|initiation of dialysis|0|||
47025764|NCT01436500|83275149|FG002|Overall Study|initiation of dialysis|0|||
47025765|NCT01436500|83275150|FG003|Overall Study|initiation of dialysis|0|||
47025766|NCT01436500|83275151|FG004|Overall Study|initiation of dialysis|1|||
47025767|NCT01436500|83275147|FG000|Overall Study|discontinued study drug|1|||
47025768|NCT01436500|83275148|FG001|Overall Study|discontinued study drug|0|||
47025769|NCT01436500|83275149|FG002|Overall Study|discontinued study drug|0|||
47025770|NCT01436500|83275150|FG003|Overall Study|discontinued study drug|0|||
46622341|NCT01633944|82775169|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
46622342|NCT01633944|82775167|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
47025771|NCT01436500|83275151|FG004|Overall Study|discontinued study drug|0|||
47025772|NCT01436500|83275147|FG000|Overall Study|Other|0|||
47025773|NCT01436500|83275148|FG001|Overall Study|Other|1|||
47025774|NCT01436500|83275149|FG002|Overall Study|Other|0|||
47025775|NCT01436500|83275150|FG003|Overall Study|Other|1|||
47025776|NCT01436500|83275151|FG004|Overall Study|Other|0|||
46710189|NCT00912964|82926339|FG001|Overall Study|Protocol Violation|3|||
46710190|NCT00912964|82926340|FG002|Overall Study|Protocol Violation|8|||
46710191|NCT00912964|82926338|FG000|Overall Study|Taking exclusionary medications|7|||
46710192|NCT00912964|82926339|FG001|Overall Study|Taking exclusionary medications|4|||
46710193|NCT00912964|82926340|FG002|Overall Study|Taking exclusionary medications|8|||
46710194|NCT00912964|82926338|FG000|Overall Study|Medical History|1|||
46710195|NCT00912964|82926339|FG001|Overall Study|Medical History|0|||
46710196|NCT00912964|82926340|FG002|Overall Study|Medical History|0|||
46710197|NCT00912964|82926338|FG000|Overall Study|Non-compliance with study procedures|2|||
46710198|NCT00912964|82926339|FG001|Overall Study|Non-compliance with study procedures|0|||
46912109|NCT03011892|83142243|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
46912110|NCT03011892|83142232|FG000|Double Blind (DB) Period|Other|1|||
46912111|NCT03011892|83142233|FG001|Double Blind (DB) Period|Other|1|||
46622343|NCT01633944|82775168|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
46622344|NCT01633944|82775169|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
46622345|NCT01633944|82775167|FG000|Open-label Titration Phase|Protocol Violation|24|||
46622346|NCT01633944|82775168|FG001|Open-label Titration Phase|Protocol Violation|0|||
46622347|NCT01633944|82775169|FG002|Open-label Titration Phase|Protocol Violation|0|||
46622348|NCT01633944|82775167|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
47025777|NCT01958827|83275164|FG000|Overall Study|Adverse Event|3|||
47025778|NCT01958827|83275164|FG000|Overall Study|Lack of Efficacy|6|||
47025779|NCT01958827|83275164|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
47025780|NCT01620086|83275170|FG000|Overall Study|Withdrawal by Subject|3|||
47025781|NCT01620086|83275171|FG001|Overall Study|Withdrawal by Subject|3|||
47025782|NCT01620086|83275172|FG002|Overall Study|Withdrawal by Subject|0|||
47025783|NCT01620086|83275170|FG000|Overall Study|failed study criteria|1|||
47025784|NCT01620086|83275171|FG001|Overall Study|failed study criteria|4|||
47025785|NCT01620086|83275172|FG002|Overall Study|failed study criteria|0|||
47025786|NCT01620086|83275170|FG000|Overall Study|Physician Decision|1|||
47025787|NCT01620086|83275171|FG001|Overall Study|Physician Decision|0|||
47025788|NCT01620086|83275172|FG002|Overall Study|Physician Decision|0|||
47025789|NCT01436110|83275184|FG000|Overall Study|Lack of Efficacy|23|||
47025790|NCT01436110|83275185|FG001|Overall Study|Lack of Efficacy|14|||
47025791|NCT01436110|83275186|FG002|Overall Study|Lack of Efficacy|9|||
47025792|NCT01436110|83275184|FG000|Overall Study|Withdrawal by Subject|6|||
47025793|NCT01436110|83275185|FG001|Overall Study|Withdrawal by Subject|8|||
46622349|NCT01633944|82775168|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
46912112|NCT03011892|83142234|FG002|Double Blind (DB) Period|Other|1|||
46912113|NCT03011892|83142235|FG003|Double Blind (DB) Period|Other|0|||
47025794|NCT01436110|83275186|FG002|Overall Study|Withdrawal by Subject|4|||
47025795|NCT01436110|83275184|FG000|Overall Study|Adverse Event|2|||
46622350|NCT01633944|82775169|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
46622351|NCT01633944|82775167|FG000|Open-label Titration Phase|Other|68|||
46622352|NCT01633944|82775168|FG001|Open-label Titration Phase|Other|0|||
46622353|NCT01633944|82775169|FG002|Open-label Titration Phase|Other|0|||
46622354|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Adverse Event|0|||
47025796|NCT01436110|83275185|FG001|Overall Study|Adverse Event|1|||
46622355|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Adverse Event|13|||
46622356|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Adverse Event|7|||
46622357|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
46622358|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
46622359|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
46622360|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46622361|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
46622362|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
46622363|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
46622364|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
46622365|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
46622366|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
46622367|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
46622368|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
46622369|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
46710199|NCT00912964|82926340|FG002|Overall Study|Non-compliance with study procedures|0|||
46710200|NCT00912964|82926338|FG000|Overall Study|Violation of exclusion criterion|0|||
46710201|NCT00912964|82926339|FG001|Overall Study|Violation of exclusion criterion|0|||
46710202|NCT00912964|82926340|FG002|Overall Study|Violation of exclusion criterion|2|||
46710203|NCT00912964|82926338|FG000|Overall Study|Randomized but never received study drug|0|||
46710204|NCT00912964|82926339|FG001|Overall Study|Randomized but never received study drug|1|||
46710205|NCT00912964|82926340|FG002|Overall Study|Randomized but never received study drug|0|||
46710206|NCT00913744|82926350|FG000|Overall Study|Adverse Event|2|||
46912114|NCT03011892|83142236|FG004|Double Blind (DB) Period|Other|1|||
47025797|NCT01436110|83275186|FG002|Overall Study|Adverse Event|2|||
47025798|NCT01436110|83275184|FG000|Overall Study|Physician Decision|3|||
46622370|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
46622371|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
46622372|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
46622373|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
46622374|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
46622375|NCT01633944|82775167|FG000|Double-blind Treatment Phase|Other|0|||
46622376|NCT01633944|82775168|FG001|Double-blind Treatment Phase|Other|7|||
46622377|NCT01633944|82775169|FG002|Double-blind Treatment Phase|Other|0|||
46622378|NCT01633788|82775214|FG000|Overall Study|Adverse Event|1|||
46622379|NCT01633788|82775215|FG001|Overall Study|Adverse Event|3|||
46622380|NCT01633788|82775216|FG002|Overall Study|Adverse Event|3|||
46622381|NCT01633788|82775217|FG003|Overall Study|Adverse Event|3|||
46622382|NCT01633788|82775214|FG000|Overall Study|Lost to Follow-up|2|||
46622383|NCT01633788|82775215|FG001|Overall Study|Lost to Follow-up|2|||
46622384|NCT01633788|82775216|FG002|Overall Study|Lost to Follow-up|2|||
46622385|NCT01633788|82775217|FG003|Overall Study|Lost to Follow-up|0|||
46622386|NCT01633788|82775214|FG000|Overall Study|Personal Reasons|3|||
46622387|NCT01633788|82775215|FG001|Overall Study|Personal Reasons|1|||
46622388|NCT01633788|82775216|FG002|Overall Study|Personal Reasons|1|||
46622389|NCT01633788|82775217|FG003|Overall Study|Personal Reasons|3|||
46622390|NCT01633788|82775214|FG000|Overall Study|Protocol Violation|1|||
46622391|NCT01633788|82775215|FG001|Overall Study|Protocol Violation|0|||
46622392|NCT01633788|82775216|FG002|Overall Study|Protocol Violation|1|||
46622393|NCT01633788|82775217|FG003|Overall Study|Protocol Violation|0|||
46622394|NCT01633788|82775214|FG000|Overall Study|Other Reasons|0|||
46622395|NCT01633788|82775215|FG001|Overall Study|Other Reasons|2|||
46622396|NCT01633788|82775216|FG002|Overall Study|Other Reasons|3|||
46622397|NCT01633788|82775217|FG003|Overall Study|Other Reasons|7|||
46622398|NCT02032524|82775233|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
46622399|NCT02032524|82775234|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
46622400|NCT02032524|82775235|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
46622401|NCT02032524|82775236|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
46622402|NCT02032524|82775237|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
46622403|NCT02032524|82775238|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
46622404|NCT02032524|82775233|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
46622405|NCT02032524|82775234|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
46622406|NCT02032524|82775235|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
46622407|NCT02032524|82775236|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
46622408|NCT02032524|82775237|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
46622409|NCT02032524|82775238|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
46622410|NCT02032524|82775233|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
46622411|NCT02032524|82775234|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
46622412|NCT02032524|82775235|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
46622413|NCT02032524|82775236|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
46622414|NCT02032524|82775237|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
46622415|NCT02032524|82775238|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
46622416|NCT02032524|82775233|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
46622417|NCT02032524|82775234|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
46622418|NCT02032524|82775235|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
46622419|NCT02032524|82775236|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
46622420|NCT02032524|82775237|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
46622421|NCT02032524|82775238|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
46622422|NCT02032524|82775233|FG000|Period 2: LTS13769 Study|Other|0|||
46622423|NCT02032524|82775234|FG001|Period 2: LTS13769 Study|Other|0|||
46622424|NCT02032524|82775235|FG002|Period 2: LTS13769 Study|Other|0|||
46622425|NCT02032524|82775236|FG003|Period 2: LTS13769 Study|Other|0|||
46622426|NCT02032524|82775237|FG004|Period 2: LTS13769 Study|Other|0|||
46622427|NCT02032524|82775238|FG005|Period 2: LTS13769 Study|Other|1|||
46622428|NCT04154943|82775254|FG000|Overall Study|Study Ongoing|68|||
46622429|NCT04154943|82775254|FG000|Overall Study|Lost to Follow-up|1|||
46622430|NCT04154943|82775254|FG000|Overall Study|Decision by the Investigator|1|||
46622431|NCT04154943|82775254|FG000|Overall Study|Death|5|||
46710207|NCT00913744|82926351|FG001|Overall Study|Adverse Event|0|||
46912115|NCT03011892|83142237|FG005|Double Blind (DB) Period|Other|0|||
46622432|NCT04154943|82775254|FG000|Overall Study|Withdrawal by Subject|4|||
46622433|NCT03476239|82775275|FG000|Overall Study|Withdrawal by Subject|10|||
46622434|NCT03476239|82775275|FG000|Overall Study|Death|80|||
47025799|NCT01436110|83275185|FG001|Overall Study|Physician Decision|1|||
46622435|NCT03476239|82775275|FG000|Overall Study|Lost to Follow-up|8|||
46622436|NCT02678312|82775284|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
46622437|NCT02678312|82775285|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
46622438|NCT02678312|82775286|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
46622439|NCT02678312|82775287|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
46622440|NCT02678312|82775288|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
46622441|NCT02678312|82775284|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
46622442|NCT02678312|82775285|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
46622443|NCT02678312|82775286|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
46622444|NCT02678312|82775287|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
46622445|NCT02678312|82775288|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
46622446|NCT02678312|82775284|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
46622447|NCT02678312|82775285|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
46622448|NCT02678312|82775286|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
46622449|NCT02678312|82775287|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
46622450|NCT02678312|82775288|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
46622451|NCT02678312|82775284|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
46622452|NCT02678312|82775285|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
46622453|NCT02678312|82775286|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
46622454|NCT02678312|82775287|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
46622455|NCT02678312|82775288|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
46622456|NCT02678312|82775284|FG000|Part 2 Double Blind Epoch|Death|0|||
46622457|NCT02678312|82775285|FG001|Part 2 Double Blind Epoch|Death|0|||
46622458|NCT02678312|82775286|FG002|Part 2 Double Blind Epoch|Death|0|||
46622459|NCT02678312|82775287|FG003|Part 2 Double Blind Epoch|Death|8|||
46622460|NCT02678312|82775288|FG004|Part 2 Double Blind Epoch|Death|12|||
46622461|NCT02678312|82775284|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
46622462|NCT02678312|82775285|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
46622463|NCT02678312|82775286|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
46622464|NCT02678312|82775287|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
46622465|NCT02678312|82775288|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
46622466|NCT02678312|82775284|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
46622467|NCT02678312|82775285|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
46622468|NCT02678312|82775286|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
46622469|NCT02678312|82775287|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
46622470|NCT02678312|82775288|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
46622471|NCT02678312|82775284|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
46622472|NCT02678312|82775285|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
46622473|NCT02678312|82775286|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
46622474|NCT02678312|82775287|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
46622475|NCT02678312|82775288|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
46622476|NCT02256631|82775526|FG000|Overall Study|Lost to Follow-up|1|||
46622477|NCT02256631|82775527|FG001|Overall Study|Lost to Follow-up|1|||
46622478|NCT02256631|82775528|FG002|Overall Study|Lost to Follow-up|0|||
46622479|NCT02256631|82775529|FG003|Overall Study|Lost to Follow-up|2|||
46622480|NCT02256631|82775530|FG004|Overall Study|Lost to Follow-up|0|||
46622481|NCT02256631|82775531|FG005|Overall Study|Lost to Follow-up|4|||
46622482|NCT02256631|82775532|FG006|Overall Study|Lost to Follow-up|1|||
46622483|NCT02256631|82775526|FG000|Overall Study|Withdrawal by Subject|0|||
46622484|NCT02256631|82775527|FG001|Overall Study|Withdrawal by Subject|0|||
46622485|NCT02256631|82775528|FG002|Overall Study|Withdrawal by Subject|0|||
46622486|NCT02256631|82775529|FG003|Overall Study|Withdrawal by Subject|1|||
46622487|NCT02256631|82775530|FG004|Overall Study|Withdrawal by Subject|1|||
46622488|NCT02256631|82775531|FG005|Overall Study|Withdrawal by Subject|0|||
46622489|NCT02256631|82775532|FG006|Overall Study|Withdrawal by Subject|1|||
46622490|NCT02256631|82775526|FG000|Overall Study|Unable to get to clinic|0|||
46622491|NCT02256631|82775527|FG001|Overall Study|Unable to get to clinic|2|||
46622492|NCT02256631|82775528|FG002|Overall Study|Unable to get to clinic|0|||
46912116|NCT03011892|83142238|FG006|Double Blind (DB) Period|Other|0|||
46912117|NCT03011892|83142239|FG007|Double Blind (DB) Period|Other|0|||
46912118|NCT03011892|83142240|FG008|Double Blind (DB) Period|Other|0|||
46912119|NCT03011892|83142241|FG009|Double Blind (DB) Period|Other|0|||
46622493|NCT02256631|82775529|FG003|Overall Study|Unable to get to clinic|1|||
46622494|NCT02256631|82775530|FG004|Overall Study|Unable to get to clinic|0|||
46622495|NCT02256631|82775531|FG005|Overall Study|Unable to get to clinic|1|||
46622496|NCT02256631|82775532|FG006|Overall Study|Unable to get to clinic|2|||
46622497|NCT02279745|82775642|FG000|Overall Study|Adverse Event|7|||
46622498|NCT02279745|82775642|FG000|Overall Study|Death|6|||
46622499|NCT02279745|82775642|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
46622500|NCT02279745|82775642|FG000|Overall Study|Withdrawal by Subject|2|||
46622501|NCT02279745|82775642|FG000|Overall Study|Pregnancy|1|||
46622502|NCT02279745|82775642|FG000|Overall Study|Study Non-compliance|1|||
46622503|NCT02279745|82775642|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
46622504|NCT01761877|82775681|FG000|Overall Study|Adverse Event|7|||
46622505|NCT01761877|82775682|FG001|Overall Study|Adverse Event|0|||
46622506|NCT01761877|82775681|FG000|Overall Study|Withdrawal by Subject|6|||
46622507|NCT01761877|82775682|FG001|Overall Study|Withdrawal by Subject|4|||
46912120|NCT03011892|83142242|FG010|Double Blind (DB) Period|Other|0|||
46912121|NCT03011892|83142243|FG011|Double Blind (DB) Period|Other|0|||
46622508|NCT01761877|82775681|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
46622509|NCT01761877|82775682|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
46622510|NCT01761877|82775681|FG000|Overall Study|Death|0|||
46622511|NCT01761877|82775682|FG001|Overall Study|Death|1|||
46622512|NCT01761877|82775681|FG000|Overall Study|MRI intolerant|1|||
46622513|NCT01761877|82775682|FG001|Overall Study|MRI intolerant|6|||
46622514|NCT00588523|82775762|FG000|Overall Study|Not treated|3|||
46622515|NCT03093259|82775936|FG000|Overall Study|Adverse Event|1|||
46622516|NCT03093259|82775937|FG001|Overall Study|Adverse Event|0|||
46622517|NCT03093259|82775936|FG000|Overall Study|Withdrawal by Subject|1|||
46622518|NCT03093259|82775937|FG001|Overall Study|Withdrawal by Subject|0|||
46622519|NCT02997865|82776229|FG000|Overall Study|Death|2|||
46622520|NCT02997865|82776230|FG001|Overall Study|Death|1|||
46622521|NCT02997865|82776229|FG000|Overall Study|Lost to Follow-up|6|||
46622522|NCT02997865|82776230|FG001|Overall Study|Lost to Follow-up|3|||
46622523|NCT02997865|82776229|FG000|Overall Study|Withdrawal by Subject|5|||
46622524|NCT02997865|82776230|FG001|Overall Study|Withdrawal by Subject|0|||
46622525|NCT02253654|82777559|FG000|Overall Study|Withdrawal by Subject|12|||
46622526|NCT02253654|82777560|FG001|Overall Study|Withdrawal by Subject|4|||
47025800|NCT01436110|83275186|FG002|Overall Study|Physician Decision|1|||
47025801|NCT01436110|83275184|FG000|Overall Study|Lost to Follow-up|1|||
47025802|NCT01436110|83275185|FG001|Overall Study|Lost to Follow-up|1|||
47025803|NCT01436110|83275186|FG002|Overall Study|Lost to Follow-up|3|||
47025804|NCT01436110|83275184|FG000|Overall Study|Protocol Violation|3|||
47025805|NCT01436110|83275185|FG001|Overall Study|Protocol Violation|1|||
47025806|NCT01436110|83275186|FG002|Overall Study|Protocol Violation|1|||
47025807|NCT01436110|83275184|FG000|Overall Study|Did Not Receive Trial Medication|1|||
47025808|NCT01436110|83275185|FG001|Overall Study|Did Not Receive Trial Medication|0|||
47025809|NCT01436110|83275186|FG002|Overall Study|Did Not Receive Trial Medication|3|||
47025810|NCT01619852|83275196|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
47025811|NCT01619852|83275197|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
47025812|NCT01619852|83275196|FG000|3 Month Follow up|Lost to Follow-up|31|||
47025813|NCT01619852|83275197|FG001|3 Month Follow up|Lost to Follow-up|34|||
47025814|NCT02000882|83275204|FG000|Overall Study|Adverse Event|3|||
47025815|NCT02000882|83275204|FG000|Overall Study|Physician Decision|2|||
47025816|NCT02000882|83275204|FG000|Overall Study|Withdrawal by Subject|1|||
47025817|NCT01965938|83275210|FG000|Overall Study|Withdrawal by Subject|1|||
47025818|NCT01965938|83275211|FG001|Overall Study|Withdrawal by Subject|0|||
47025819|NCT01965860|83275222|FG000|Overall Study|Pregnancy|1|||
47025820|NCT01965860|83275223|FG001|Overall Study|Pregnancy|0|||
47025821|NCT01965860|83275224|FG002|Overall Study|Pregnancy|1|||
47025822|NCT01965860|83275222|FG000|Overall Study|Logistics|1|||
47025823|NCT01965860|83275223|FG001|Overall Study|Logistics|0|||
47025824|NCT01965860|83275224|FG002|Overall Study|Logistics|0|||
47025825|NCT01965704|83275245|FG000|Overall Study|Withdrawal by Subject|2|||
47025826|NCT01965704|83275246|FG001|Overall Study|Withdrawal by Subject|2|||
47025827|NCT01965704|83275247|FG002|Overall Study|Withdrawal by Subject|1|||
47025828|NCT01965704|83275248|FG003|Overall Study|Withdrawal by Subject|1|||
47025829|NCT01965704|83275245|FG000|Overall Study|Delivered at home|1|||
47025830|NCT01965704|83275246|FG001|Overall Study|Delivered at home|1|||
47025831|NCT01965704|83275247|FG002|Overall Study|Delivered at home|0|||
47025832|NCT01965704|83275248|FG003|Overall Study|Delivered at home|0|||
47025833|NCT01965704|83275245|FG000|Overall Study|Experienced complications|0|||
47025834|NCT01965704|83275246|FG001|Overall Study|Experienced complications|0|||
47025835|NCT01965704|83275247|FG002|Overall Study|Experienced complications|2|||
47025836|NCT01965704|83275248|FG003|Overall Study|Experienced complications|2|||
47025837|NCT01965704|83275245|FG000|Overall Study|Adverse Event|0|||
47025838|NCT01965704|83275246|FG001|Overall Study|Adverse Event|0|||
46710208|NCT00913744|82926350|FG000|Overall Study|Withdrawal by Subject|2|||
46710209|NCT00913744|82926351|FG001|Overall Study|Withdrawal by Subject|1|||
46710210|NCT00913744|82926350|FG000|Overall Study|Death|1|||
46710211|NCT00913744|82926351|FG001|Overall Study|Death|0|||
46710212|NCT00912808|82926359|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
47025839|NCT01965704|83275247|FG002|Overall Study|Adverse Event|1|||
47025840|NCT01965704|83275248|FG003|Overall Study|Adverse Event|1|||
46622527|NCT02253654|82777559|FG000|Overall Study|Decision by Sponsor|1|||
46622528|NCT02253654|82777560|FG001|Overall Study|Decision by Sponsor|1|||
46622529|NCT02253654|82777559|FG000|Overall Study|Lost to Follow-up|2|||
46622530|NCT02253654|82777560|FG001|Overall Study|Lost to Follow-up|5|||
46710213|NCT00912808|82926360|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
46710214|NCT00912808|82926359|FG000|Washout|Withdrawal by Subject|0|||
46622531|NCT02253654|82777559|FG000|Overall Study|Death|4|||
46622532|NCT02253654|82777560|FG001|Overall Study|Death|7|||
46622533|NCT02253654|82777559|FG000|Overall Study|Did Not Receive Study Treatment|4|||
46622534|NCT02253654|82777560|FG001|Overall Study|Did Not Receive Study Treatment|1|||
46622535|NCT02252406|82777568|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
46622536|NCT02252406|82777569|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
46622537|NCT02252406|82777568|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
46622538|NCT02252406|82777569|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
46622539|NCT02252406|82777568|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
46622540|NCT02252406|82777569|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
47025841|NCT01965704|83275245|FG000|Overall Study|Did not meet inclusion criteria|0|||
47025842|NCT01965704|83275246|FG001|Overall Study|Did not meet inclusion criteria|0|||
47025843|NCT01965704|83275247|FG002|Overall Study|Did not meet inclusion criteria|1|||
47025844|NCT01965704|83275248|FG003|Overall Study|Did not meet inclusion criteria|1|||
47025845|NCT02003365|83275259|FG000|Overall Study|Lost to Follow-up|0|||
47025846|NCT02003365|83275260|FG001|Overall Study|Lost to Follow-up|0|||
47025847|NCT02003365|83275261|FG002|Overall Study|Lost to Follow-up|1|||
47025848|NCT01975220|83275272|FG000|Test Period 1|Not treated|0|||
47025849|NCT01975220|83275273|FG001|Test Period 1|Not treated|1|||
47025850|NCT01975220|83275274|FG002|Test Period 1|Not treated|0|||
47025851|NCT01975220|83275275|FG003|Test Period 1|Not treated|0|||
47025852|NCT01975220|83275276|FG004|Test Period 1|Not treated|0|||
47025853|NCT01975220|83275277|FG005|Test Period 1|Not treated|0|||
47025854|NCT01958437|83275294|FG000|Overall Study|Incidental MRI findings|0|||
47025855|NCT01958437|83275295|FG001|Overall Study|Incidental MRI findings|0|||
47025856|NCT01958437|83275296|FG002|Overall Study|Incidental MRI findings|1|||
47025857|NCT01958437|83275297|FG003|Overall Study|Incidental MRI findings|1|||
47025858|NCT01974752|83275316|FG000|Overall Study|Death|33|||
47025859|NCT01974752|83275317|FG001|Overall Study|Death|11|||
47025860|NCT01974752|83275316|FG000|Overall Study|Lost to Follow-up|2|||
47025861|NCT01974752|83275317|FG001|Overall Study|Lost to Follow-up|0|||
47025862|NCT01974752|83275316|FG000|Overall Study|Withdrawal by Subject|2|||
46710215|NCT00912808|82926360|FG001|Washout|Withdrawal by Subject|1|||
46622541|NCT02252406|82777568|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
46622542|NCT02252406|82777569|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
46622543|NCT02252406|82777568|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
46622544|NCT02252406|82777569|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
46622545|NCT02246478|82777579|FG000|Multiple-dose Phase|Protocol Violation|1|||
46622546|NCT02246478|82777580|FG001|Multiple-dose Phase|Protocol Violation|0|||
46622547|NCT02246478|82777581|FG002|Multiple-dose Phase|Protocol Violation|0|||
46622548|NCT02246478|82777582|FG003|Multiple-dose Phase|Protocol Violation|1|||
46622549|NCT02252016|82777601|FG000|Overall Study|Lost to Follow-up|2|||
46622550|NCT02252016|82777602|FG001|Overall Study|Lost to Follow-up|1|||
46622551|NCT02252016|82777601|FG000|Overall Study|Physician Decision|1|||
46622552|NCT02252016|82777602|FG001|Overall Study|Physician Decision|0|||
46622553|NCT02252016|82777601|FG000|Overall Study|Withdrawal by Subject|0|||
46622554|NCT02252016|82777602|FG001|Overall Study|Withdrawal by Subject|2|||
46710216|NCT00912808|82926359|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
46710217|NCT00912808|82926360|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
46710218|NCT00912808|82926359|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
46622555|NCT02249832|82777608|FG000|Overall Study|Withdrawal by Subject|3|||
46710219|NCT00912808|82926360|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
47025863|NCT01974752|83275317|FG001|Overall Study|Withdrawal by Subject|3|||
47025864|NCT01974752|83275316|FG000|Overall Study|Other Eligibility Criteria|0|||
47025865|NCT01974752|83275317|FG001|Overall Study|Other Eligibility Criteria|1|||
46622556|NCT02249832|82777608|FG000|Overall Study|Lost to Follow-up|10|||
46622557|NCT02248974|82777619|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
46622558|NCT02248974|82777620|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
46622559|NCT02248974|82777619|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
46622560|NCT02248974|82777620|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
46622561|NCT02248974|82777619|FG000|1-Day Follow-Up|Enrolled in another study|1|||
46622562|NCT02248974|82777620|FG001|1-Day Follow-Up|Enrolled in another study|0|||
46622563|NCT02248974|82777619|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
46622564|NCT02248974|82777620|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
46622565|NCT02248974|82777619|FG000|1-Week Follow-Up|Enrolled in another study|1|||
46622566|NCT02248974|82777620|FG001|1-Week Follow-Up|Enrolled in another study|1|||
46622567|NCT02248974|82777619|FG000|1-Week Follow-Up|Transferred to another facility|1|||
46622568|NCT02248974|82777620|FG001|1-Week Follow-Up|Transferred to another facility|0|||
46622569|NCT02248974|82777619|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
46622570|NCT02248974|82777620|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
46622571|NCT02248974|82777619|FG000|1-Week Follow-Up|Death|1|||
46622572|NCT02248974|82777620|FG001|1-Week Follow-Up|Death|1|||
46622573|NCT02248974|82777619|FG000|1-Week Follow-Up|Excluded because of age|0|||
46622574|NCT02248974|82777620|FG001|1-Week Follow-Up|Excluded because of age|1|||
46622575|NCT02248974|82777619|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
46622576|NCT02248974|82777620|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
46622577|NCT02248974|82777619|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
47025866|NCT01999946|83275326|FG000|Overall Study|Participant not released from jail|2|||
47025867|NCT01999946|83275327|FG001|Overall Study|Participant not released from jail|2|||
47025868|NCT01999946|83275328|FG002|Overall Study|Participant not released from jail|0|||
47025869|NCT01999946|83275326|FG000|Overall Study|Not included in primary outcome analysis|0|||
47025870|NCT01999946|83275327|FG001|Overall Study|Not included in primary outcome analysis|0|||
47025871|NCT01999946|83275328|FG002|Overall Study|Not included in primary outcome analysis|79|||
47025872|NCT01958281|83275338|FG000|Overall Study|Lack of Efficacy|5|||
47025873|NCT01958281|83275339|FG001|Overall Study|Lack of Efficacy|2|||
46622578|NCT02248974|82777620|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
46622579|NCT02248974|82777619|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
46622580|NCT02248974|82777620|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
46622581|NCT02248974|82777619|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
46622582|NCT02248974|82777620|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
46622583|NCT02248974|82777619|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
46622584|NCT02248974|82777620|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
46622585|NCT02246166|82777628|FG000|Overall Study|Protocol Violation|1|||
46622586|NCT02246166|82777629|FG001|Overall Study|Protocol Violation|0|||
46622587|NCT02706847|82777638|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
46622588|NCT02706847|82777639|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
46622589|NCT02706847|82777640|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
46622590|NCT02706847|82777641|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
46622591|NCT02706847|82777638|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
46622592|NCT02706847|82777639|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
46622593|NCT02706847|82777640|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
46622594|NCT02706847|82777641|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
46622595|NCT02706847|82777638|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
46622596|NCT02706847|82777639|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
46622597|NCT02706847|82777640|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
46622598|NCT02706847|82777641|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
46622599|NCT02706847|82777638|FG000|Period 1: Day 1 to Week 12|Other|4|||
46622600|NCT02706847|82777639|FG001|Period 1: Day 1 to Week 12|Other|4|||
46622601|NCT02706847|82777640|FG002|Period 1: Day 1 to Week 12|Other|2|||
46622602|NCT02706847|82777641|FG003|Period 1: Day 1 to Week 12|Other|2|||
46622603|NCT02706847|82777638|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
46622604|NCT02706847|82777639|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
46622605|NCT02706847|82777640|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
46622606|NCT02706847|82777641|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
46622607|NCT02706847|82777638|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
47025874|NCT01958281|83275340|FG002|Overall Study|Lack of Efficacy|0|||
47025875|NCT01958281|83275338|FG000|Overall Study|Adverse Event|0|||
46622608|NCT02706847|82777639|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
46622609|NCT02706847|82777640|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
46622610|NCT02706847|82777641|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
46622611|NCT02706847|82777638|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
46622612|NCT02706847|82777639|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
47025876|NCT01958281|83275339|FG001|Overall Study|Adverse Event|2|||
46622613|NCT02706847|82777640|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
46622614|NCT02706847|82777641|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
46622615|NCT02706847|82777638|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
47025877|NCT01958281|83275340|FG002|Overall Study|Adverse Event|0|||
47025878|NCT01958281|83275338|FG000|Overall Study|Withdrew Consent|1|||
46622616|NCT02706847|82777639|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
46622617|NCT02706847|82777640|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
46622618|NCT02706847|82777641|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
47025879|NCT01958281|83275339|FG001|Overall Study|Withdrew Consent|0|||
47025880|NCT01958281|83275340|FG002|Overall Study|Withdrew Consent|0|||
47025881|NCT01958125|83275351|FG000|Overall Study|Missing diary data|2|||
47025882|NCT01958125|83275352|FG001|Overall Study|Missing diary data|6|||
47025883|NCT01958125|83275351|FG000|Overall Study|No headache attacks|0|||
47025884|NCT01958125|83275352|FG001|Overall Study|No headache attacks|2|||
47025885|NCT02002975|83275358|FG000|Overall Study|Case Report Forms Uncollected|135|||
47025886|NCT02002975|83275358|FG000|Overall Study|Protocol Deviation|437|||
47025887|NCT02001181|83275364|FG000|Overall Study|Adverse Event|0|||
47025888|NCT02001181|83275365|FG001|Overall Study|Adverse Event|2|||
46912122|NCT03011892|83142232|FG000|Double Blind (DB) Period|Physician Decision|1|||
46912123|NCT03011892|83142233|FG001|Double Blind (DB) Period|Physician Decision|0|||
46912124|NCT03011892|83142234|FG002|Double Blind (DB) Period|Physician Decision|1|||
47025889|NCT02001181|83275364|FG000|Overall Study|Lost to Follow-up|1|||
46622619|NCT02706847|82777638|FG000|Period 1: Week 12 to Week 24|Other|1|||
46622620|NCT02706847|82777639|FG001|Period 1: Week 12 to Week 24|Other|0|||
46622621|NCT02706847|82777640|FG002|Period 1: Week 12 to Week 24|Other|1|||
46622622|NCT02706847|82777641|FG003|Period 1: Week 12 to Week 24|Other|4|||
46622623|NCT02706847|82777638|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
46622624|NCT02706847|82777639|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
46622625|NCT02706847|82777640|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
46622626|NCT02706847|82777641|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
46622627|NCT02706847|82777638|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
46622628|NCT02706847|82777639|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
46622629|NCT02706847|82777640|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
46622630|NCT02706847|82777641|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
46622631|NCT02706847|82777638|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
46622632|NCT02706847|82777639|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
46622633|NCT02706847|82777640|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
46622634|NCT02706847|82777641|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
46622635|NCT02706847|82777638|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
46622636|NCT02706847|82777639|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
47025890|NCT02001181|83275365|FG001|Overall Study|Lost to Follow-up|0|||
47025891|NCT02001181|83275364|FG000|Overall Study|Withdrawal by Subject|0|||
47025892|NCT02001181|83275365|FG001|Overall Study|Withdrawal by Subject|1|||
46622637|NCT02706847|82777640|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
46622638|NCT02706847|82777641|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
46622639|NCT02706847|82777638|FG000|Period 2: Week 24 to Week 260|Other|8|||
46622640|NCT02706847|82777639|FG001|Period 2: Week 24 to Week 260|Other|5|||
46622641|NCT02706847|82777640|FG002|Period 2: Week 24 to Week 260|Other|15|||
46622642|NCT02706847|82777641|FG003|Period 2: Week 24 to Week 260|Other|15|||
46622643|NCT02245620|82777654|FG000|Overall Study|Physician Decision|1|||
46622644|NCT02245620|82777655|FG001|Overall Study|Physician Decision|1|||
46622645|NCT02244996|82777663|FG000|Overall Study|Lack of Efficacy|2|||
46622646|NCT02244996|82777664|FG001|Overall Study|Lack of Efficacy|6|||
46622647|NCT02243280|82777699|FG000|Treated|Adverse Event|1|||
46622648|NCT02243280|82777700|FG001|Treated|Adverse Event|0|||
47025893|NCT01999465|83275373|FG000|Overall Study|Lost to Follow-up|0|||
47025894|NCT01999465|83275374|FG001|Overall Study|Lost to Follow-up|2|||
47025895|NCT01999465|83275373|FG000|Overall Study|Protocol Violation|0|||
47025896|NCT01999465|83275374|FG001|Overall Study|Protocol Violation|1|||
47025897|NCT01982773|83275382|FG000|Overall Study|Withdrawal by Subject|1|||
47025898|NCT01982773|83275383|FG001|Overall Study|Withdrawal by Subject|3|||
47025899|NCT01982773|83275382|FG000|Overall Study|Lost to Follow-up|7|||
47025900|NCT01982773|83275383|FG001|Overall Study|Lost to Follow-up|1|||
47025901|NCT01974206|83275391|FG000|Overall Study|Did Not Take Study Drug|0|||
47025902|NCT01974206|83275392|FG001|Overall Study|Did Not Take Study Drug|1|||
47025903|NCT01974206|83275391|FG000|Overall Study|Physician Decision|1|||
47025904|NCT01974206|83275392|FG001|Overall Study|Physician Decision|0|||
47025905|NCT01974206|83275391|FG000|Overall Study|Withdrawal by Subject|3|||
47025906|NCT01974206|83275392|FG001|Overall Study|Withdrawal by Subject|0|||
47025907|NCT01974206|83275391|FG000|Overall Study|Lost to Follow-up|1|||
47025908|NCT01974206|83275392|FG001|Overall Study|Lost to Follow-up|0|||
47025909|NCT01974206|83275391|FG000|Overall Study|Death|1|||
47025910|NCT01974206|83275392|FG001|Overall Study|Death|0|||
47025911|NCT01999868|83275401|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
47025912|NCT01999868|83275402|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
47025913|NCT01999868|83275403|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
47025914|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
47025915|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
47025916|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
47025917|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
47025918|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
47025919|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
47025920|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
47025921|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
47025922|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
47025923|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
47025924|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
47025925|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
47025926|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
47025927|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
46912125|NCT03011892|83142235|FG003|Double Blind (DB) Period|Physician Decision|0|||
46912126|NCT03011892|83142236|FG004|Double Blind (DB) Period|Physician Decision|0|||
46912127|NCT03011892|83142237|FG005|Double Blind (DB) Period|Physician Decision|0|||
46912128|NCT03011892|83142238|FG006|Double Blind (DB) Period|Physician Decision|0|||
46622649|NCT02243280|82777701|FG002|Treated|Adverse Event|0|||
46622650|NCT02243280|82777702|FG003|Treated|Adverse Event|0|||
46622651|NCT02243280|82777703|FG004|Treated|Adverse Event|0|||
46622652|NCT02243280|82777704|FG005|Treated|Adverse Event|0|||
46622653|NCT02243280|82777705|FG006|Treated|Adverse Event|0|||
46622654|NCT02243280|82777706|FG007|Treated|Adverse Event|0|||
46622655|NCT02243280|82777707|FG008|Treated|Adverse Event|0|||
46622656|NCT02243280|82777708|FG009|Treated|Adverse Event|0|||
46622657|NCT02243280|82777709|FG010|Treated|Adverse Event|1|||
46622658|NCT02243280|82777699|FG000|Treated|Lost to Follow-up|0|||
46622659|NCT02243280|82777700|FG001|Treated|Lost to Follow-up|0|||
46622660|NCT02243280|82777701|FG002|Treated|Lost to Follow-up|0|||
46622661|NCT02243280|82777702|FG003|Treated|Lost to Follow-up|0|||
46622662|NCT02243280|82777703|FG004|Treated|Lost to Follow-up|0|||
46622663|NCT02243280|82777704|FG005|Treated|Lost to Follow-up|0|||
46622664|NCT02243280|82777705|FG006|Treated|Lost to Follow-up|0|||
46622665|NCT02243280|82777706|FG007|Treated|Lost to Follow-up|0|||
46622666|NCT02243280|82777707|FG008|Treated|Lost to Follow-up|1|||
46622667|NCT02243280|82777708|FG009|Treated|Lost to Follow-up|0|||
46622668|NCT02243280|82777709|FG010|Treated|Lost to Follow-up|2|||
46622669|NCT02248818|82777767|FG000|Screening|Protocol Violation|0|||
46622670|NCT02248818|82777768|FG001|Screening|Protocol Violation|0|||
46622671|NCT02248818|82777769|FG002|Screening|Protocol Violation|0|||
46622672|NCT02248818|82777770|FG003|Screening|Protocol Violation|0|||
47025928|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
47025929|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
47025930|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
47025931|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
46622673|NCT02248818|82777771|FG004|Screening|Protocol Violation|0|||
46622674|NCT02248818|82777772|FG005|Screening|Protocol Violation|0|||
47025932|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
47025933|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
47025934|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
46622675|NCT02248818|82777773|FG006|Screening|Protocol Violation|0|||
46622676|NCT02248818|82777774|FG007|Screening|Protocol Violation|0|||
46622677|NCT02248818|82777775|FG008|Screening|Protocol Violation|7|||
46622678|NCT02248818|82777767|FG000|Screening|Study fully enrolled|0|||
46622679|NCT02248818|82777768|FG001|Screening|Study fully enrolled|0|||
47025935|NCT01999868|83275401|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
46912129|NCT03011892|83142239|FG007|Double Blind (DB) Period|Physician Decision|0|||
46912130|NCT03011892|83142240|FG008|Double Blind (DB) Period|Physician Decision|0|||
46912131|NCT03011892|83142241|FG009|Double Blind (DB) Period|Physician Decision|0|||
46912132|NCT03011892|83142242|FG010|Double Blind (DB) Period|Physician Decision|0|||
46912133|NCT03011892|83142243|FG011|Double Blind (DB) Period|Physician Decision|0|||
46912134|NCT03011892|83142232|FG000|Double Blind (DB) Period|Pregnancy|0|||
46912135|NCT03011892|83142233|FG001|Double Blind (DB) Period|Pregnancy|0|||
46912136|NCT03011892|83142234|FG002|Double Blind (DB) Period|Pregnancy|0|||
46912137|NCT03011892|83142235|FG003|Double Blind (DB) Period|Pregnancy|0|||
46912138|NCT03011892|83142236|FG004|Double Blind (DB) Period|Pregnancy|1|||
46912139|NCT03011892|83142237|FG005|Double Blind (DB) Period|Pregnancy|0|||
46912140|NCT03011892|83142238|FG006|Double Blind (DB) Period|Pregnancy|0|||
47025936|NCT01999868|83275402|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
47025937|NCT01999868|83275403|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
46622680|NCT02248818|82777769|FG002|Screening|Study fully enrolled|0|||
46622681|NCT02248818|82777770|FG003|Screening|Study fully enrolled|0|||
46622682|NCT02248818|82777771|FG004|Screening|Study fully enrolled|0|||
46622683|NCT02248818|82777772|FG005|Screening|Study fully enrolled|0|||
46622684|NCT02248818|82777773|FG006|Screening|Study fully enrolled|0|||
46622685|NCT02248818|82777774|FG007|Screening|Study fully enrolled|0|||
46622686|NCT02248818|82777775|FG008|Screening|Study fully enrolled|14|||
46622687|NCT02248818|82777767|FG000|Screening|Physician Decision|0|||
46622688|NCT02248818|82777768|FG001|Screening|Physician Decision|0|||
46622689|NCT02248818|82777769|FG002|Screening|Physician Decision|0|||
46622690|NCT02248818|82777770|FG003|Screening|Physician Decision|0|||
46622691|NCT02248818|82777771|FG004|Screening|Physician Decision|0|||
46622692|NCT02248818|82777772|FG005|Screening|Physician Decision|0|||
46622693|NCT02248818|82777773|FG006|Screening|Physician Decision|0|||
46622694|NCT02248818|82777774|FG007|Screening|Physician Decision|0|||
46622695|NCT02248818|82777775|FG008|Screening|Physician Decision|73|||
46622696|NCT02248818|82777767|FG000|Screening|Withdrawal by Subject|0|||
46622697|NCT02248818|82777768|FG001|Screening|Withdrawal by Subject|0|||
46622698|NCT02248818|82777769|FG002|Screening|Withdrawal by Subject|0|||
46622699|NCT02248818|82777770|FG003|Screening|Withdrawal by Subject|0|||
46622700|NCT02248818|82777771|FG004|Screening|Withdrawal by Subject|0|||
46622701|NCT02248818|82777772|FG005|Screening|Withdrawal by Subject|0|||
46622702|NCT02248818|82777773|FG006|Screening|Withdrawal by Subject|0|||
46622703|NCT02248818|82777774|FG007|Screening|Withdrawal by Subject|0|||
46622704|NCT02248818|82777775|FG008|Screening|Withdrawal by Subject|6|||
46622705|NCT02248818|82777767|FG000|Screening|Lost to Follow-up|0|||
46622706|NCT02248818|82777768|FG001|Screening|Lost to Follow-up|0|||
46622707|NCT02248818|82777769|FG002|Screening|Lost to Follow-up|0|||
46622708|NCT02248818|82777770|FG003|Screening|Lost to Follow-up|0|||
46622709|NCT02248818|82777771|FG004|Screening|Lost to Follow-up|0|||
46622710|NCT02248818|82777772|FG005|Screening|Lost to Follow-up|0|||
46622711|NCT02248818|82777773|FG006|Screening|Lost to Follow-up|0|||
46622712|NCT02248818|82777774|FG007|Screening|Lost to Follow-up|0|||
46622713|NCT02248818|82777775|FG008|Screening|Lost to Follow-up|7|||
46622714|NCT02248818|82777767|FG000|Randomised Study|Administrative - randomization error|0|||
46622715|NCT02248818|82777768|FG001|Randomised Study|Administrative - randomization error|0|||
46622716|NCT02248818|82777769|FG002|Randomised Study|Administrative - randomization error|0|||
46622717|NCT02248818|82777770|FG003|Randomised Study|Administrative - randomization error|0|||
46622718|NCT02248818|82777771|FG004|Randomised Study|Administrative - randomization error|0|||
46622719|NCT02248818|82777772|FG005|Randomised Study|Administrative - randomization error|8|||
46622720|NCT02248818|82777773|FG006|Randomised Study|Administrative - randomization error|0|||
46622721|NCT02248818|82777774|FG007|Randomised Study|Administrative - randomization error|0|||
46622722|NCT02248818|82777775|FG008|Randomised Study|Administrative - randomization error|0|||
46622723|NCT02247960|82777804|FG000|Patient Consent and Randomization|Physician Decision|2|||
46912141|NCT03011892|83142239|FG007|Double Blind (DB) Period|Pregnancy|0|||
46622724|NCT02247960|82777805|FG001|Patient Consent and Randomization|Physician Decision|2|||
46622725|NCT02247960|82777804|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
46622726|NCT02247960|82777805|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
46622727|NCT02247960|82777804|FG000|Catheter Removed|Lost to Follow-up|7|||
46622728|NCT02247960|82777805|FG001|Catheter Removed|Lost to Follow-up|10|||
46622729|NCT02247804|82777894|FG000|Treatment Period 1|Adverse Event|9|||
46622730|NCT02247804|82777895|FG001|Treatment Period 1|Adverse Event|2|||
46622731|NCT02247804|82777896|FG002|Treatment Period 1|Adverse Event|0|||
46622732|NCT02247804|82777894|FG000|Treatment Period 1|Lack of Efficacy|0|||
46622733|NCT02247804|82777895|FG001|Treatment Period 1|Lack of Efficacy|0|||
46912142|NCT03011892|83142240|FG008|Double Blind (DB) Period|Pregnancy|0|||
46912143|NCT03011892|83142241|FG009|Double Blind (DB) Period|Pregnancy|0|||
46622734|NCT02247804|82777896|FG002|Treatment Period 1|Lack of Efficacy|2|||
46912144|NCT03011892|83142242|FG010|Double Blind (DB) Period|Pregnancy|0|||
46622735|NCT02247804|82777894|FG000|Treatment Period 1|Lost to Follow-up|1|||
46641228|NCT04627038|82825244|FG000|Overall Study|Lost to Follow-up|1|||
46622736|NCT02247804|82777895|FG001|Treatment Period 1|Lost to Follow-up|0|||
46622737|NCT02247804|82777896|FG002|Treatment Period 1|Lost to Follow-up|2|||
46622738|NCT02247804|82777894|FG000|Treatment Period 1|Personal Reasons|7|||
46622739|NCT02247804|82777895|FG001|Treatment Period 1|Personal Reasons|1|||
46622740|NCT02247804|82777896|FG002|Treatment Period 1|Personal Reasons|2|||
46912145|NCT03011892|83142243|FG011|Double Blind (DB) Period|Pregnancy|0|||
46912146|NCT03011892|83142232|FG000|Double Blind (DB) Period|Protocol Violation|1|||
46912147|NCT03011892|83142233|FG001|Double Blind (DB) Period|Protocol Violation|0|||
46912148|NCT03011892|83142234|FG002|Double Blind (DB) Period|Protocol Violation|0|||
46912149|NCT03011892|83142235|FG003|Double Blind (DB) Period|Protocol Violation|0|||
46912150|NCT03011892|83142236|FG004|Double Blind (DB) Period|Protocol Violation|0|||
46912151|NCT03011892|83142237|FG005|Double Blind (DB) Period|Protocol Violation|0|||
46912152|NCT03011892|83142238|FG006|Double Blind (DB) Period|Protocol Violation|0|||
46912153|NCT03011892|83142239|FG007|Double Blind (DB) Period|Protocol Violation|0|||
46912154|NCT03011892|83142240|FG008|Double Blind (DB) Period|Protocol Violation|0|||
46912155|NCT03011892|83142241|FG009|Double Blind (DB) Period|Protocol Violation|0|||
46912156|NCT03011892|83142242|FG010|Double Blind (DB) Period|Protocol Violation|0|||
46912157|NCT03011892|83142243|FG011|Double Blind (DB) Period|Protocol Violation|0|||
46912158|NCT03011892|83142232|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
46912159|NCT03011892|83142233|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
46912160|NCT03011892|83142234|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
46912161|NCT03011892|83142235|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
47025938|NCT01999868|83275401|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
47025939|NCT01999868|83275402|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
47025940|NCT01999868|83275403|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
47025941|NCT01999868|83275401|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
47025942|NCT01999868|83275402|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
47025943|NCT01999868|83275403|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
47025944|NCT01999868|83275401|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
47025945|NCT01999868|83275402|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
47025946|NCT01999868|83275403|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
47025947|NCT01999868|83275401|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
47025948|NCT01999868|83275402|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
47025949|NCT01999868|83275403|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
47025950|NCT01999868|83275401|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
47025951|NCT01999868|83275402|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
47025952|NCT01999868|83275403|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
47025953|NCT01999868|83275401|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
47025954|NCT01999868|83275402|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
46622741|NCT02247804|82777894|FG000|Treatment Period 1|Protocol Deviation|0|||
46912162|NCT03011892|83142236|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
46912163|NCT03011892|83142237|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
46912164|NCT03011892|83142238|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
46641229|NCT04627038|82825245|FG001|Overall Study|Lost to Follow-up|0|||
46912165|NCT03011892|83142239|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
46912166|NCT03011892|83142240|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
47025955|NCT01999868|83275403|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
47025956|NCT01957579|83275415|FG000|Overall Study|Withdrawal of concent|0|||
47025957|NCT01957579|83275416|FG001|Overall Study|Withdrawal of concent|1|||
47025958|NCT01957579|83275417|FG002|Overall Study|Withdrawal of concent|0|||
47025959|NCT01957579|83275418|FG003|Overall Study|Withdrawal of concent|0|||
47025960|NCT01957579|83275415|FG000|Overall Study|Death|0|||
46622742|NCT02247804|82777895|FG001|Treatment Period 1|Protocol Deviation|0|||
46622743|NCT02247804|82777896|FG002|Treatment Period 1|Protocol Deviation|1|||
46622744|NCT02247804|82777894|FG000|Treatment Period 1|Randomized but not Treated|5|||
46622745|NCT02247804|82777895|FG001|Treatment Period 1|Randomized but not Treated|1|||
46622746|NCT02247804|82777896|FG002|Treatment Period 1|Randomized but not Treated|1|||
46622747|NCT02247804|82777894|FG000|Treatment Period 2|Adverse Event|6|||
46622748|NCT02247804|82777895|FG001|Treatment Period 2|Adverse Event|3|||
46622749|NCT02247804|82777896|FG002|Treatment Period 2|Adverse Event|3|||
46622750|NCT02247804|82777894|FG000|Treatment Period 2|Lack of Efficacy|0|||
46622751|NCT02247804|82777895|FG001|Treatment Period 2|Lack of Efficacy|0|||
46622752|NCT02247804|82777896|FG002|Treatment Period 2|Lack of Efficacy|1|||
46622753|NCT02247804|82777894|FG000|Treatment Period 2|Lost to Follow-up|0|||
46622754|NCT02247804|82777895|FG001|Treatment Period 2|Lost to Follow-up|1|||
46622755|NCT02247804|82777896|FG002|Treatment Period 2|Lost to Follow-up|1|||
46622756|NCT02247804|82777894|FG000|Treatment Period 2|Personal Reasons|2|||
46622757|NCT02247804|82777895|FG001|Treatment Period 2|Personal Reasons|1|||
46622758|NCT02247804|82777896|FG002|Treatment Period 2|Personal Reasons|1|||
46622759|NCT02247804|82777894|FG000|Treatment Period 2|Reason not Specified|0|||
46622760|NCT02247804|82777895|FG001|Treatment Period 2|Reason not Specified|0|||
46622761|NCT02247804|82777896|FG002|Treatment Period 2|Reason not Specified|2|||
46622762|NCT02247804|82777894|FG000|Treatment Period 3|Adverse Event|4|||
46622763|NCT02247804|82777895|FG001|Treatment Period 3|Adverse Event|3|||
46622764|NCT02247804|82777896|FG002|Treatment Period 3|Adverse Event|3|||
46622765|NCT02247804|82777894|FG000|Treatment Period 3|Lack of Efficacy|0|||
46622766|NCT02247804|82777895|FG001|Treatment Period 3|Lack of Efficacy|1|||
46622767|NCT02247804|82777896|FG002|Treatment Period 3|Lack of Efficacy|0|||
46622768|NCT02247804|82777894|FG000|Treatment Period 3|Lost to Follow-up|1|||
46622769|NCT02247804|82777895|FG001|Treatment Period 3|Lost to Follow-up|2|||
46622770|NCT02247804|82777896|FG002|Treatment Period 3|Lost to Follow-up|2|||
46622771|NCT02247804|82777894|FG000|Treatment Period 3|Personal Reasons|4|||
46622772|NCT02247804|82777895|FG001|Treatment Period 3|Personal Reasons|3|||
46622773|NCT02247804|82777896|FG002|Treatment Period 3|Personal Reasons|2|||
46622774|NCT02247804|82777894|FG000|Treatment Period 3|Reason not Specified|2|||
46912167|NCT03011892|83142241|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
46912168|NCT03011892|83142242|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
47025961|NCT01957579|83275416|FG001|Overall Study|Death|0|||
47025962|NCT01957579|83275417|FG002|Overall Study|Death|2|||
47025963|NCT01957579|83275418|FG003|Overall Study|Death|0|||
47025964|NCT01999322|83275447|FG000|Overall Study|Adverse Event|1|||
47025965|NCT01999322|83275448|FG001|Overall Study|Adverse Event|0|||
47025966|NCT01996982|83275454|FG000|Overall Study|PI/team left institution|7|||
47025967|NCT01965158|83275460|FG000|Overall Study|Adverse Event|14|||
47025968|NCT01965158|83275461|FG001|Overall Study|Adverse Event|5|||
47025969|NCT01965158|83275460|FG000|Overall Study|Withdrawal by Subject|16|||
47025970|NCT01965158|83275461|FG001|Overall Study|Withdrawal by Subject|24|||
47025971|NCT01965158|83275460|FG000|Overall Study|Lost to Follow-up|7|||
47025972|NCT01965158|83275461|FG001|Overall Study|Lost to Follow-up|5|||
47025973|NCT01965158|83275460|FG000|Overall Study|Protocol Violation|1|||
47025974|NCT01965158|83275461|FG001|Overall Study|Protocol Violation|1|||
47025975|NCT01965158|83275460|FG000|Overall Study|Other - Miscellaneous|3|||
46622775|NCT02247804|82777895|FG001|Treatment Period 3|Reason not Specified|1|||
46622776|NCT02247804|82777896|FG002|Treatment Period 3|Reason not Specified|3|||
46622777|NCT02243202|82777921|FG000|Overall Study|Adverse Event|5|||
46622778|NCT02243202|82777922|FG001|Overall Study|Adverse Event|6|||
46912169|NCT03011892|83142243|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
47025976|NCT01965158|83275461|FG001|Overall Study|Other - Miscellaneous|0|||
47025977|NCT01964924|83275467|FG000|Trametinib Monotherapy|Progression|19|||
46622779|NCT02243202|82777923|FG002|Overall Study|Adverse Event|10|||
46622780|NCT02243202|82777924|FG003|Overall Study|Adverse Event|4|||
46622781|NCT02243202|82777921|FG000|Overall Study|Lost to Follow-up|9|||
46622782|NCT02243202|82777922|FG001|Overall Study|Lost to Follow-up|9|||
46622783|NCT02243202|82777923|FG002|Overall Study|Lost to Follow-up|14|||
46622784|NCT02243202|82777924|FG003|Overall Study|Lost to Follow-up|11|||
46622785|NCT02243202|82777921|FG000|Overall Study|Protocol Violation|3|||
46622786|NCT02243202|82777922|FG001|Overall Study|Protocol Violation|1|||
46622787|NCT02243202|82777923|FG002|Overall Study|Protocol Violation|2|||
46622788|NCT02243202|82777924|FG003|Overall Study|Protocol Violation|1|||
46622789|NCT02243202|82777921|FG000|Overall Study|Withdrawal by Subject|7|||
46622790|NCT02243202|82777922|FG001|Overall Study|Withdrawal by Subject|6|||
46622791|NCT02243202|82777923|FG002|Overall Study|Withdrawal by Subject|4|||
46622792|NCT02243202|82777924|FG003|Overall Study|Withdrawal by Subject|4|||
46622793|NCT02243202|82777921|FG000|Overall Study|Other|1|||
46622794|NCT02243202|82777922|FG001|Overall Study|Other|3|||
46622795|NCT02243202|82777923|FG002|Overall Study|Other|1|||
46622796|NCT02243202|82777924|FG003|Overall Study|Other|2|||
46622797|NCT02243202|82777921|FG000|Overall Study|Randomized but not received treatment|0|||
46622798|NCT02243202|82777922|FG001|Overall Study|Randomized but not received treatment|0|||
47025978|NCT01964924|83275468|FG001|Trametinib Monotherapy|Progression|0|||
47025979|NCT01964378|83275479|FG000|Overall Study|Disc. due to death before first dosing|0|||
47025980|NCT01964378|83275480|FG001|Overall Study|Disc. due to death before first dosing|1|||
47025981|NCT01964378|83275479|FG000|Overall Study|Disc. due to AE before first dosing|1|||
47025982|NCT01964378|83275480|FG001|Overall Study|Disc. due to AE before first dosing|0|||
47025983|NCT01964378|83275479|FG000|Overall Study|Death|3|||
47025984|NCT01964378|83275480|FG001|Overall Study|Death|2|||
47025985|NCT01964378|83275479|FG000|Overall Study|Adverse Event|12|||
47025986|NCT01964378|83275480|FG001|Overall Study|Adverse Event|5|||
47025987|NCT01964378|83275479|FG000|Overall Study|Lack of Efficacy|0|||
47025988|NCT01964378|83275480|FG001|Overall Study|Lack of Efficacy|1|||
47025989|NCT01964378|83275479|FG000|Overall Study|Protocol Violation|0|||
47025990|NCT01964378|83275480|FG001|Overall Study|Protocol Violation|1|||
47025991|NCT01964378|83275479|FG000|Overall Study|Lost to Follow-up|0|||
47025992|NCT01964378|83275480|FG001|Overall Study|Lost to Follow-up|1|||
47025993|NCT01964378|83275479|FG000|Overall Study|Withdrawal by Subject|7|||
47025994|NCT01964378|83275480|FG001|Overall Study|Withdrawal by Subject|5|||
47025995|NCT01964378|83275479|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
47025996|NCT01964378|83275480|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
47025997|NCT01964378|83275479|FG000|Overall Study|Other|1|||
47025998|NCT01964378|83275480|FG001|Overall Study|Other|2|||
47025999|NCT01442038|83275488|FG000|Overall Study|Death|35|||
46622799|NCT02243202|82777923|FG002|Overall Study|Randomized but not received treatment|0|||
46622800|NCT02243202|82777924|FG003|Overall Study|Randomized but not received treatment|1|||
46622801|NCT02243046|82777937|FG000|Overall Study|Lost to Follow-up|1|||
46622802|NCT02243046|82777938|FG001|Overall Study|Lost to Follow-up|1|||
46622803|NCT02243046|82777939|FG002|Overall Study|Lost to Follow-up|4|||
46622804|NCT02207946|82777949|FG000|Overall Study|Lost to Follow-up|1|||
47026000|NCT01442038|83275489|FG001|Overall Study|Death|29|||
47026001|NCT01442038|83275488|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
47026002|NCT01442038|83275489|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
47026003|NCT01442038|83275488|FG000|Overall Study|Participant Withdrew Consent|137|||
47026004|NCT01442038|83275489|FG001|Overall Study|Participant Withdrew Consent|102|||
47026005|NCT01442038|83275488|FG000|Overall Study|Lost to Follow-up|37|||
47026006|NCT01442038|83275489|FG001|Overall Study|Lost to Follow-up|51|||
47026007|NCT01442038|83275488|FG000|Overall Study|Adverse Event|26|||
47026008|NCT01442038|83275489|FG001|Overall Study|Adverse Event|15|||
47026009|NCT01442038|83275488|FG000|Overall Study|Protocol Deviation|9|||
47026010|NCT01442038|83275489|FG001|Overall Study|Protocol Deviation|20|||
47026011|NCT01442038|83275488|FG000|Overall Study|Investigator's Discretion|13|||
47026012|NCT01442038|83275489|FG001|Overall Study|Investigator's Discretion|16|||
47026013|NCT01442038|83275488|FG000|Overall Study|Study Terminated By Sponsor|2|||
47026014|NCT01442038|83275489|FG001|Overall Study|Study Terminated By Sponsor|3|||
46622805|NCT02207946|82777950|FG001|Overall Study|Lost to Follow-up|0|||
46622806|NCT02207946|82777949|FG000|Overall Study|Adverse Event|0|||
46622807|NCT02207946|82777950|FG001|Overall Study|Adverse Event|1|||
46622808|NCT03976076|82777957|FG000|Overall Study|Withdrawal by Subject|2|||
46622809|NCT03551210|82778156|FG000|Overall Study|Adverse Event|5|||
46622810|NCT03551210|82778157|FG001|Overall Study|Adverse Event|6|||
47026015|NCT01998919|83275497|FG000|Overall Study|Death|2|||
47026016|NCT01998919|83275498|FG001|Overall Study|Death|2|||
47026017|NCT01998919|83275497|FG000|Overall Study|Adverse Event|0|||
47026018|NCT01998919|83275498|FG001|Overall Study|Adverse Event|5|||
47026019|NCT01998919|83275497|FG000|Overall Study|Disease progression|31|||
47026020|NCT01998919|83275498|FG001|Overall Study|Disease progression|22|||
46622811|NCT03551210|82778156|FG000|Overall Study|Withdrawal by Subject|1|||
46622812|NCT03551210|82778157|FG001|Overall Study|Withdrawal by Subject|7|||
46622813|NCT03551210|82778156|FG000|Overall Study|Needed in other antibiotic treatment|2|||
46622814|NCT03551210|82778157|FG001|Overall Study|Needed in other antibiotic treatment|5|||
46622815|NCT03551210|82778156|FG000|Overall Study|Lost to Follow-up|1|||
46622816|NCT03551210|82778157|FG001|Overall Study|Lost to Follow-up|1|||
46622817|NCT03551210|82778156|FG000|Overall Study|Absence of visit 4 and 5|1|||
46622818|NCT03551210|82778157|FG001|Overall Study|Absence of visit 4 and 5|0|||
46622819|NCT03551210|82778156|FG000|Overall Study|No drug for dispensing|0|||
46622820|NCT03551210|82778157|FG001|Overall Study|No drug for dispensing|1|||
46622821|NCT02207634|82778294|FG000|Overall Study|Withdrawal by Subject|21|||
46622822|NCT02207634|82778295|FG001|Overall Study|Withdrawal by Subject|31|||
46622823|NCT02207634|82778294|FG000|Overall Study|Lost to Follow-up|1|||
46622824|NCT02207634|82778295|FG001|Overall Study|Lost to Follow-up|0|||
46622825|NCT03452228|82778327|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
46622826|NCT03452228|82778328|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
46622827|NCT03452228|82778329|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
46622828|NCT03452228|82778327|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
46622829|NCT03452228|82778328|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
46622830|NCT03452228|82778329|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
46622831|NCT03452228|82778327|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
47026021|NCT01998919|83275497|FG000|Overall Study|Withdrawal by Subject|2|||
46622832|NCT03452228|82778328|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
46622833|NCT03452228|82778329|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
46622834|NCT03452228|82778327|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
46622835|NCT03452228|82778328|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
46622836|NCT03452228|82778329|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
46622837|NCT02207556|82778392|FG000|Overall Study|Physician Decision|1|||
46622838|NCT02207556|82778393|FG001|Overall Study|Physician Decision|0|||
46622839|NCT02207556|82778392|FG000|Overall Study|Withdrawal by Subject|1|||
46622840|NCT02207556|82778393|FG001|Overall Study|Withdrawal by Subject|0|||
46622841|NCT02207556|82778392|FG000|Overall Study|Death|0|||
46622842|NCT02207556|82778393|FG001|Overall Study|Death|5|||
46622843|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
46622844|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
46622845|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
46622846|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
47026022|NCT01998919|83275498|FG001|Overall Study|Withdrawal by Subject|4|||
47026023|NCT01998919|83275497|FG000|Overall Study|Lost to Follow-up|2|||
47026024|NCT01998919|83275498|FG001|Overall Study|Lost to Follow-up|0|||
47026025|NCT01998919|83275497|FG000|Overall Study|Other|5|||
47026026|NCT01998919|83275498|FG001|Overall Study|Other|2|||
47026027|NCT01957111|83275506|FG000|Overall Study|Withdrawal by Subject|1|||
47026028|NCT01957111|83275507|FG001|Overall Study|Withdrawal by Subject|1|||
47026029|NCT01964300|83275515|FG000|Overall Study|Ineligible after enrollment|0|||
47026030|NCT01964300|83275516|FG001|Overall Study|Ineligible after enrollment|1|||
47026031|NCT01964300|83275515|FG000|Overall Study|Adverse Event|1|||
47026032|NCT01964300|83275516|FG001|Overall Study|Adverse Event|1|||
47026033|NCT01964300|83275515|FG000|Overall Study|Lack of Efficacy|3|||
47026034|NCT01964300|83275516|FG001|Overall Study|Lack of Efficacy|5|||
47026035|NCT01964300|83275515|FG000|Overall Study|Withdrawal by Subject|0|||
47026036|NCT01964300|83275516|FG001|Overall Study|Withdrawal by Subject|1|||
47026037|NCT01964300|83275515|FG000|Overall Study|To receive alternative therapy|1|||
47026038|NCT01964300|83275516|FG001|Overall Study|To receive alternative therapy|2|||
47026039|NCT01964300|83275515|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
47026040|NCT01964300|83275516|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
47026041|NCT01964300|83275515|FG000|Overall Study|Weight criteria not met|0|||
47026042|NCT01964300|83275516|FG001|Overall Study|Weight criteria not met|1|||
47026043|NCT01964222|83275524|FG000|Overall Study|Lost to Follow-up|7|||
47026044|NCT01964222|83275525|FG001|Overall Study|Lost to Follow-up|5|||
47026045|NCT01964222|83275524|FG000|Overall Study|Withdrawal by Subject|6|||
47026046|NCT01964222|83275525|FG001|Overall Study|Withdrawal by Subject|6|||
47026047|NCT01964222|83275524|FG000|Overall Study|Screening Failure|2|||
47026048|NCT01964222|83275525|FG001|Overall Study|Screening Failure|0|||
47026049|NCT01467700|83275535|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
47026050|NCT01467700|83275536|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
47026051|NCT01467700|83275537|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
46912170|NCT03011892|83142232|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
47026052|NCT01467700|83275538|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
47026053|NCT01467700|83275535|FG000|Overall Study|Major Protocol Deviation|3|||
47026054|NCT01467700|83275536|FG001|Overall Study|Major Protocol Deviation|3|||
46622847|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
46622848|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
46622849|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
46622850|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
46622851|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
46622852|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
46622853|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
46622854|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
46622855|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
46622856|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
46622857|NCT03732638|82778408|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
46622858|NCT03732638|82778409|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
46622859|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
46622860|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
46622861|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
46622862|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
46622863|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
46622864|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
46622865|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
47026055|NCT01467700|83275537|FG002|Overall Study|Major Protocol Deviation|2|||
47026056|NCT01467700|83275538|FG003|Overall Study|Major Protocol Deviation|3|||
47026057|NCT01467700|83275535|FG000|Overall Study|Lost to Follow-up|6|||
47026058|NCT01467700|83275536|FG001|Overall Study|Lost to Follow-up|5|||
47026059|NCT01467700|83275537|FG002|Overall Study|Lost to Follow-up|2|||
47026060|NCT01467700|83275538|FG003|Overall Study|Lost to Follow-up|3|||
47026061|NCT01467700|83275535|FG000|Overall Study|Voluntary Withdrawal|5|||
47026062|NCT01467700|83275536|FG001|Overall Study|Voluntary Withdrawal|7|||
47026063|NCT01467700|83275537|FG002|Overall Study|Voluntary Withdrawal|6|||
47026064|NCT01467700|83275538|FG003|Overall Study|Voluntary Withdrawal|2|||
47026065|NCT01467700|83275535|FG000|Overall Study|Study Termination|6|||
47026066|NCT01467700|83275536|FG001|Overall Study|Study Termination|5|||
47026067|NCT01467700|83275537|FG002|Overall Study|Study Termination|10|||
47026068|NCT01467700|83275538|FG003|Overall Study|Study Termination|7|||
47026069|NCT01467700|83275535|FG000|Overall Study|Pregnancy|0|||
47026070|NCT01467700|83275536|FG001|Overall Study|Pregnancy|1|||
47026071|NCT01467700|83275537|FG002|Overall Study|Pregnancy|1|||
47026072|NCT01467700|83275538|FG003|Overall Study|Pregnancy|0|||
47026073|NCT01467700|83275535|FG000|Overall Study|Lack of Efficacy|2|||
47026074|NCT01467700|83275536|FG001|Overall Study|Lack of Efficacy|0|||
47026075|NCT01467700|83275537|FG002|Overall Study|Lack of Efficacy|2|||
47026076|NCT01467700|83275538|FG003|Overall Study|Lack of Efficacy|1|||
47026077|NCT01467700|83275535|FG000|Overall Study|Reason not Specified|1|||
47026078|NCT01467700|83275536|FG001|Overall Study|Reason not Specified|3|||
47026079|NCT01467700|83275537|FG002|Overall Study|Reason not Specified|2|||
47026080|NCT01467700|83275538|FG003|Overall Study|Reason not Specified|8|||
47026081|NCT01972724|83275551|FG000|Double-Blind|Rescue Criteria Met|1|||
47026082|NCT01972724|83275552|FG001|Double-Blind|Rescue Criteria Met|0|||
47026083|NCT01972724|83275553|FG002|Double-Blind|Rescue Criteria Met|0|||
47026084|NCT01972724|83275551|FG000|Double-Blind|Adverse Event|1|||
47026085|NCT01972724|83275552|FG001|Double-Blind|Adverse Event|0|||
47026086|NCT01972724|83275553|FG002|Double-Blind|Adverse Event|0|||
47026087|NCT01972724|83275551|FG000|Double-Blind|Withdrawal of Consent|2|||
47026088|NCT01972724|83275552|FG001|Double-Blind|Withdrawal of Consent|1|||
47026089|NCT01972724|83275553|FG002|Double-Blind|Withdrawal of Consent|0|||
47026090|NCT01972724|83275551|FG000|Double-Blind|Significant Protocol Deviation|5|||
47026091|NCT01972724|83275552|FG001|Double-Blind|Significant Protocol Deviation|8|||
47026092|NCT01972724|83275553|FG002|Double-Blind|Significant Protocol Deviation|0|||
47026093|NCT01972724|83275551|FG000|Open-Label|Withdrew Consent|0|||
47026094|NCT01972724|83275552|FG001|Open-Label|Withdrew Consent|0|||
47026095|NCT01972724|83275553|FG002|Open-Label|Withdrew Consent|3|||
47026096|NCT01972724|83275551|FG000|Open-Label|Significant Protocol Deviation|0|||
47026097|NCT01972724|83275552|FG001|Open-Label|Significant Protocol Deviation|0|||
47026098|NCT01972724|83275553|FG002|Open-Label|Significant Protocol Deviation|2|||
47026099|NCT01441960|83275561|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
47026100|NCT01441960|83275562|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
47026101|NCT01441960|83275561|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
47026102|NCT01441960|83275562|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
46622866|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
46912171|NCT03011892|83142233|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
46912172|NCT03011892|83142234|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
46622867|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
46622868|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
46622869|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
46622870|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
46622871|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
46622872|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
46622873|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
46622874|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
46622875|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
46622876|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
46622877|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
46622878|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
46622879|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
46622880|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
46622881|NCT03732638|82778408|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
46622882|NCT03732638|82778409|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
46622883|NCT03732638|82778408|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
46622884|NCT03732638|82778409|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
46622885|NCT03732638|82778408|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
46622886|NCT03732638|82778409|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
46622887|NCT03732638|82778408|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
46622888|NCT03732638|82778409|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
46622889|NCT03732638|82778408|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
46622890|NCT03732638|82778409|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
46622891|NCT03266588|82778448|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
46622892|NCT03266588|82778449|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
46622893|NCT03266588|82778450|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
46622894|NCT03266588|82778448|FG000|Observational Period|Withdrawal by Subject|44|||
46622895|NCT03266588|82778449|FG001|Observational Period|Withdrawal by Subject|22|||
46622896|NCT03266588|82778450|FG002|Observational Period|Withdrawal by Subject|13|||
46622897|NCT03266588|82778448|FG000|Observational Period|Non-compliance|18|||
46622898|NCT03266588|82778449|FG001|Observational Period|Non-compliance|12|||
46622899|NCT03266588|82778450|FG002|Observational Period|Non-compliance|10|||
46622900|NCT03266588|82778448|FG000|Observational Period|Lost to Follow-up|8|||
46622901|NCT03266588|82778449|FG001|Observational Period|Lost to Follow-up|12|||
46622902|NCT03266588|82778450|FG002|Observational Period|Lost to Follow-up|4|||
46622903|NCT03266588|82778448|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
46622904|NCT03266588|82778449|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
46622905|NCT03266588|82778450|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
46622906|NCT03266588|82778448|FG000|Observational Period|Protocol Deviation|1|||
46622907|NCT03266588|82778449|FG001|Observational Period|Protocol Deviation|0|||
46622908|NCT03266588|82778450|FG002|Observational Period|Protocol Deviation|0|||
46622909|NCT03266588|82778448|FG000|Observational Period|Other Reasons|3|||
46622910|NCT03266588|82778449|FG001|Observational Period|Other Reasons|0|||
46622911|NCT03266588|82778450|FG002|Observational Period|Other Reasons|1|||
46622912|NCT03266588|82778448|FG000|Long-term Treatment Period|Adverse Event|33|||
46622913|NCT03266588|82778449|FG001|Long-term Treatment Period|Adverse Event|17|||
46622914|NCT03266588|82778450|FG002|Long-term Treatment Period|Adverse Event|8|||
46622915|NCT03266588|82778448|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
46622916|NCT03266588|82778449|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
46622917|NCT03266588|82778450|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
46622918|NCT03266588|82778448|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
46622919|NCT03266588|82778449|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
46622920|NCT03266588|82778450|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
46622921|NCT03266588|82778448|FG000|Long-term Treatment Period|Non-Compliance|126|||
46912173|NCT03011892|83142235|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
46912174|NCT03011892|83142236|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
46912175|NCT03011892|83142237|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
46622922|NCT03266588|82778449|FG001|Long-term Treatment Period|Non-Compliance|57|||
46622923|NCT03266588|82778450|FG002|Long-term Treatment Period|Non-Compliance|7|||
46622924|NCT03266588|82778448|FG000|Long-term Treatment Period|Pregnancy|11|||
46622925|NCT03266588|82778449|FG001|Long-term Treatment Period|Pregnancy|5|||
46622926|NCT03266588|82778450|FG002|Long-term Treatment Period|Pregnancy|0|||
46622927|NCT03266588|82778448|FG000|Long-term Treatment Period|Protocol Deviation|17|||
46622928|NCT03266588|82778449|FG001|Long-term Treatment Period|Protocol Deviation|10|||
46622929|NCT03266588|82778450|FG002|Long-term Treatment Period|Protocol Deviation|4|||
46622930|NCT03266588|82778448|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
46622931|NCT03266588|82778449|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
46622932|NCT03266588|82778450|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
46622933|NCT03266588|82778448|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
46622934|NCT03266588|82778449|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
46622935|NCT03266588|82778450|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
46622936|NCT03266588|82778448|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
46622937|NCT03266588|82778449|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
46622938|NCT03266588|82778450|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
46622939|NCT03266588|82778448|FG000|Long-term Treatment Period|Other Reasons|5|||
46622940|NCT03266588|82778449|FG001|Long-term Treatment Period|Other Reasons|0|||
46622941|NCT03266588|82778450|FG002|Long-term Treatment Period|Other Reasons|0|||
46912176|NCT03011892|83142238|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
46912177|NCT03011892|83142239|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
47026103|NCT01441960|83275561|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
47026104|NCT01441960|83275562|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
46622942|NCT03266588|82778448|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
46622943|NCT03266588|82778449|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
46622944|NCT03266588|82778450|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
46622945|NCT03019640|82778520|FG000|Overall Study|Screen Failures|4|||
46622946|NCT03019640|82778520|FG000|Overall Study|Adverse Event|3|||
46622947|NCT03019640|82778520|FG000|Overall Study|Participant Relapsed|1|||
46622948|NCT02240706|82778588|FG000|Overall Study|Lack of Efficacy|2|||
46622949|NCT02240706|82778589|FG001|Overall Study|Lack of Efficacy|2|||
46622950|NCT02240706|82778590|FG002|Overall Study|Lack of Efficacy|2|||
46622951|NCT02240706|82778591|FG003|Overall Study|Lack of Efficacy|2|||
46622952|NCT02240706|82778592|FG004|Overall Study|Lack of Efficacy|5|||
46622953|NCT02240706|82778593|FG005|Overall Study|Lack of Efficacy|0|||
46622954|NCT02240706|82778594|FG006|Overall Study|Lack of Efficacy|0|||
46622955|NCT02240706|82778588|FG000|Overall Study|Adverse Event|1|||
46622956|NCT02240706|82778589|FG001|Overall Study|Adverse Event|0|||
46622957|NCT02240706|82778590|FG002|Overall Study|Adverse Event|1|||
46622958|NCT02240706|82778591|FG003|Overall Study|Adverse Event|0|||
46622959|NCT02240706|82778592|FG004|Overall Study|Adverse Event|2|||
46622960|NCT02240706|82778593|FG005|Overall Study|Adverse Event|0|||
46622961|NCT02240706|82778594|FG006|Overall Study|Adverse Event|0|||
46622962|NCT02240706|82778588|FG000|Overall Study|Progressive disease|0|||
46622963|NCT02240706|82778589|FG001|Overall Study|Progressive disease|0|||
46622964|NCT02240706|82778590|FG002|Overall Study|Progressive disease|0|||
46622965|NCT02240706|82778591|FG003|Overall Study|Progressive disease|0|||
46622966|NCT02240706|82778592|FG004|Overall Study|Progressive disease|1|||
46622967|NCT02240706|82778593|FG005|Overall Study|Progressive disease|0|||
46622968|NCT02240706|82778594|FG006|Overall Study|Progressive disease|0|||
46622969|NCT02240706|82778588|FG000|Overall Study|Dose limiting toxicity|0|||
46622970|NCT02240706|82778589|FG001|Overall Study|Dose limiting toxicity|0|||
46622971|NCT02240706|82778590|FG002|Overall Study|Dose limiting toxicity|0|||
46622972|NCT02240706|82778591|FG003|Overall Study|Dose limiting toxicity|0|||
46622973|NCT02240706|82778592|FG004|Overall Study|Dose limiting toxicity|1|||
46622974|NCT02240706|82778593|FG005|Overall Study|Dose limiting toxicity|0|||
46622975|NCT02240706|82778594|FG006|Overall Study|Dose limiting toxicity|0|||
46622976|NCT02240706|82778588|FG000|Overall Study|Refused to continue taking medication|0|||
46622977|NCT02240706|82778589|FG001|Overall Study|Refused to continue taking medication|1|||
46622978|NCT02240706|82778590|FG002|Overall Study|Refused to continue taking medication|3|||
46622979|NCT02240706|82778591|FG003|Overall Study|Refused to continue taking medication|1|||
46622980|NCT02240706|82778592|FG004|Overall Study|Refused to continue taking medication|2|||
46622981|NCT02240706|82778593|FG005|Overall Study|Refused to continue taking medication|0|||
46622982|NCT02240706|82778594|FG006|Overall Study|Refused to continue taking medication|0|||
46622983|NCT02240706|82778588|FG000|Overall Study|Insurance billing concerns|0|||
46622984|NCT02240706|82778589|FG001|Overall Study|Insurance billing concerns|0|||
46622985|NCT02240706|82778590|FG002|Overall Study|Insurance billing concerns|0|||
46622986|NCT02240706|82778591|FG003|Overall Study|Insurance billing concerns|1|||
46622987|NCT02240706|82778592|FG004|Overall Study|Insurance billing concerns|0|||
47026105|NCT01955707|83275574|FG000|Overall Study|Adverse Event|1|||
47026106|NCT01955707|83275575|FG001|Overall Study|Adverse Event|2|||
47026107|NCT01955707|83275574|FG000|Overall Study|Lost to Follow-up|2|||
46622988|NCT02240706|82778593|FG005|Overall Study|Insurance billing concerns|0|||
46622989|NCT02240706|82778594|FG006|Overall Study|Insurance billing concerns|0|||
46622990|NCT01600092|82778619|FG000|Overall Study|Adverse Event|2|||
46622991|NCT01600092|82778620|FG001|Overall Study|Adverse Event|0|||
46622992|NCT01600092|82778619|FG000|Overall Study|Lost to Follow-up|4|||
46622993|NCT01600092|82778620|FG001|Overall Study|Lost to Follow-up|6|||
46622994|NCT01600092|82778619|FG000|Overall Study|Withdrawal by parent/guardian|8|||
46622995|NCT01600092|82778620|FG001|Overall Study|Withdrawal by parent/guardian|6|||
47026108|NCT01955707|83275575|FG001|Overall Study|Lost to Follow-up|1|||
47026109|NCT01955707|83275574|FG000|Overall Study|Withdrawal by Subject|0|||
47026110|NCT01955707|83275575|FG001|Overall Study|Withdrawal by Subject|3|||
47026111|NCT01955707|83275574|FG000|Overall Study|Death|13|||
47026112|NCT01955707|83275575|FG001|Overall Study|Death|14|||
47026113|NCT01955707|83275574|FG000|Overall Study|Other|4|||
47026114|NCT01955707|83275575|FG001|Overall Study|Other|2|||
47026115|NCT01435798|83275581|FG000|Overall Study|Withdrawal by Subject|1|||
47026116|NCT01972568|83275594|FG000|Overall Study|Other events|3|||
47026117|NCT01972568|83275595|FG001|Overall Study|Other events|0|||
47026118|NCT01972568|83275596|FG002|Overall Study|Other events|0|||
47026119|NCT01972568|83275594|FG000|Overall Study|Lack of Efficacy|0|||
47026120|NCT01972568|83275595|FG001|Overall Study|Lack of Efficacy|1|||
47026121|NCT01972568|83275596|FG002|Overall Study|Lack of Efficacy|2|||
47026122|NCT01972568|83275594|FG000|Overall Study|Protocol Violation|1|||
47026123|NCT01972568|83275595|FG001|Overall Study|Protocol Violation|2|||
47026124|NCT01972568|83275596|FG002|Overall Study|Protocol Violation|2|||
47026125|NCT01972568|83275594|FG000|Overall Study|Withdrawal by Subject|6|||
47026126|NCT01972568|83275595|FG001|Overall Study|Withdrawal by Subject|3|||
47026127|NCT01972568|83275596|FG002|Overall Study|Withdrawal by Subject|7|||
47026128|NCT01972568|83275594|FG000|Overall Study|Lost to Follow-up|1|||
47026129|NCT01972568|83275595|FG001|Overall Study|Lost to Follow-up|0|||
47026130|NCT01972568|83275596|FG002|Overall Study|Lost to Follow-up|0|||
47026131|NCT01972568|83275594|FG000|Overall Study|Adverse Event|5|||
47026132|NCT01972568|83275595|FG001|Overall Study|Adverse Event|6|||
47026133|NCT01972568|83275596|FG002|Overall Study|Adverse Event|5|||
47026134|NCT01955161|83275607|FG000|Overall Study|Withdrawal before treatment|2|||
47026135|NCT01955161|83275608|FG001|Overall Study|Withdrawal before treatment|0|||
47026136|NCT01955161|83275609|FG002|Overall Study|Withdrawal before treatment|1|||
47026137|NCT01955161|83275607|FG000|Overall Study|Adverse Event|10|||
47026138|NCT01955161|83275608|FG001|Overall Study|Adverse Event|14|||
47026139|NCT01955161|83275609|FG002|Overall Study|Adverse Event|15|||
47026140|NCT01955161|83275607|FG000|Overall Study|Death|1|||
47026141|NCT01955161|83275608|FG001|Overall Study|Death|1|||
47026142|NCT01955161|83275609|FG002|Overall Study|Death|3|||
47026143|NCT01955161|83275607|FG000|Overall Study|Withdrawal by Subject|9|||
47026144|NCT01955161|83275608|FG001|Overall Study|Withdrawal by Subject|8|||
47026145|NCT01955161|83275609|FG002|Overall Study|Withdrawal by Subject|12|||
47026146|NCT01955161|83275607|FG000|Overall Study|Protocol Violation|2|||
47026147|NCT01955161|83275608|FG001|Overall Study|Protocol Violation|0|||
47026148|NCT01955161|83275609|FG002|Overall Study|Protocol Violation|0|||
47026149|NCT01955161|83275607|FG000|Overall Study|Other reason: physician decision|0|||
47026150|NCT01955161|83275608|FG001|Overall Study|Other reason: physician decision|1|||
47026151|NCT01955161|83275609|FG002|Overall Study|Other reason: physician decision|1|||
47026152|NCT01955161|83275607|FG000|Overall Study|Other reason: disallowed medication|1|||
47026153|NCT01955161|83275608|FG001|Overall Study|Other reason: disallowed medication|0|||
47026154|NCT01955161|83275609|FG002|Overall Study|Other reason: disallowed medication|1|||
47026155|NCT01955161|83275607|FG000|Overall Study|Other reason: caregiver unavailable|1|||
47026156|NCT01955161|83275608|FG001|Overall Study|Other reason: caregiver unavailable|0|||
47026157|NCT01955161|83275609|FG002|Overall Study|Other reason: caregiver unavailable|0|||
47026158|NCT01955161|83275607|FG000|Overall Study|Other reason: moved to nursing home|0|||
47026159|NCT01955161|83275608|FG001|Overall Study|Other reason: moved to nursing home|1|||
47026160|NCT01955161|83275609|FG002|Overall Study|Other reason: moved to nursing home|0|||
47026161|NCT01955161|83275607|FG000|Overall Study|Other reason: insufficient compliance|0|||
47026162|NCT01955161|83275608|FG001|Overall Study|Other reason: insufficient compliance|0|||
47026163|NCT01955161|83275609|FG002|Overall Study|Other reason: insufficient compliance|1|||
47026164|NCT01955161|83275607|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
47026165|NCT01955161|83275608|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
47026166|NCT01955161|83275609|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
47026167|NCT01955161|83275607|FG000|Overall Study|Other reason: patient's will|0|||
47026168|NCT01955161|83275608|FG001|Overall Study|Other reason: patient's will|0|||
47026169|NCT01955161|83275609|FG002|Overall Study|Other reason: patient's will|1|||
47026170|NCT01441414|83275617|FG000|Overall Study|Participant died|9|||
47026171|NCT01441414|83275617|FG000|Overall Study|Other reasons|3|||
46710220|NCT00960531|82926377|FG000|Overall Study|Lack of Efficacy|1|||
46710221|NCT00960531|82926378|FG001|Overall Study|Lack of Efficacy|0|||
47026172|NCT01441414|83275617|FG000|Overall Study|Study terminated by sponsor|2|||
47026173|NCT01441414|83275617|FG000|Overall Study|Subject refused further follow-up|1|||
47026174|NCT01971554|83275637|FG000|Overall Study|Lost to Follow-up|1|||
46710222|NCT00960531|82926379|FG002|Overall Study|Lack of Efficacy|0|||
47026175|NCT01971554|83275638|FG001|Overall Study|Lost to Follow-up|0|||
47026176|NCT01971554|83275639|FG002|Overall Study|Lost to Follow-up|0|||
47026177|NCT01971554|83275640|FG003|Overall Study|Lost to Follow-up|0|||
47026178|NCT01955083|83275652|FG000|Overall Study|Lost to Follow-up|1|||
47026179|NCT01955083|83275653|FG001|Overall Study|Lost to Follow-up|1|||
47026180|NCT01955005|83275685|FG000|Overall Study|Withdrawal by Subject|3|||
47026181|NCT01955005|83275686|FG001|Overall Study|Withdrawal by Subject|5|||
47026182|NCT01954927|83275694|FG000|Overall Study|Withdrawal by Subject|3|||
47026183|NCT01954927|83275695|FG001|Overall Study|Withdrawal by Subject|1|||
47026184|NCT01954771|83275704|FG000|Overall Study|Missing HbA1c of end-point|1|||
47026185|NCT01954771|83275705|FG001|Overall Study|Missing HbA1c of end-point|1|||
47026186|NCT01954771|83275706|FG002|Overall Study|Missing HbA1c of end-point|0|||
47026187|NCT01954771|83275704|FG000|Overall Study|Missing CGMS of end-point|1|||
47026188|NCT01954771|83275705|FG001|Overall Study|Missing CGMS of end-point|1|||
47026189|NCT01954771|83275706|FG002|Overall Study|Missing CGMS of end-point|0|||
47026190|NCT01954771|83275704|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
47026191|NCT01954771|83275705|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
47026192|NCT01954771|83275706|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
47026193|NCT01997281|83275719|FG000|Overall Study|Withdrawal by Subject|1|||
47026194|NCT01997281|83275720|FG001|Overall Study|Withdrawal by Subject|0|||
47026195|NCT01996033|83275726|FG000|Overall Study|Death|1|||
47026196|NCT01996033|83275726|FG000|Overall Study|Physician Decision|1|||
47026197|NCT01996033|83275726|FG000|Overall Study|Withdrawal by Subject|4|||
47026198|NCT01996033|83275726|FG000|Overall Study|Lost to Follow-up|3|||
47026199|NCT01953913|83275730|FG000|Overall Study|Disease Progression|349|||
47026200|NCT01953913|83275730|FG000|Overall Study|Worsening of underlying cancer|22|||
47026201|NCT01953913|83275730|FG000|Overall Study|Adverse Event|20|||
47026202|NCT01953913|83275730|FG000|Overall Study|Protocol Violation|6|||
47026203|NCT01953913|83275730|FG000|Overall Study|Lost to Follow-up|4|||
47026204|NCT01953913|83275730|FG000|Overall Study|Withdrawal by Subject|32|||
47026205|NCT01953913|83275730|FG000|Overall Study|Other than listed|108|||
47026206|NCT01953913|83275730|FG000|Overall Study|Not Treated|1|||
47026207|NCT01971476|83275737|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
47026208|NCT01971476|83275738|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
47026209|NCT01971476|83275739|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
47026210|NCT01971476|83275737|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
47026211|NCT01971476|83275738|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
47026212|NCT01971476|83275739|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
47026213|NCT01971476|83275737|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
47026214|NCT01971476|83275738|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
47026215|NCT01971476|83275739|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
47026216|NCT01996904|83275758|FG000|Overall Study|Lost to Follow-up|38|||
47026217|NCT01996904|83275759|FG001|Overall Study|Lost to Follow-up|27|||
47026218|NCT01970540|83275768|FG000|Overall Study|Non-treatment-related AE|0|||
47026219|NCT01970540|83275769|FG001|Overall Study|Non-treatment-related AE|0|||
47026220|NCT01970540|83275770|FG002|Overall Study|Non-treatment-related AE|1|||
47026221|NCT01970540|83275768|FG000|Overall Study|Progressive disease|55|||
47026222|NCT01970540|83275769|FG001|Overall Study|Progressive disease|23|||
47026223|NCT01970540|83275770|FG002|Overall Study|Progressive disease|10|||
47026224|NCT01970540|83275768|FG000|Overall Study|Treatment delay over protocol|0|||
47026225|NCT01970540|83275769|FG001|Overall Study|Treatment delay over protocol|0|||
47026226|NCT01970540|83275770|FG002|Overall Study|Treatment delay over protocol|1|||
47026227|NCT01970540|83275768|FG000|Overall Study|Physician Decision|7|||
47026228|NCT01970540|83275769|FG001|Overall Study|Physician Decision|2|||
47026229|NCT01970540|83275770|FG002|Overall Study|Physician Decision|0|||
47026230|NCT01970540|83275768|FG000|Overall Study|Clinical progression|0|||
47026231|NCT01970540|83275769|FG001|Overall Study|Clinical progression|1|||
47026232|NCT01970540|83275770|FG002|Overall Study|Clinical progression|1|||
46710223|NCT00960531|82926380|FG003|Overall Study|Lack of Efficacy|0|||
46710224|NCT00960531|82926381|FG004|Overall Study|Lack of Efficacy|0|||
46710225|NCT00960531|82926382|FG005|Overall Study|Lack of Efficacy|0|||
46912178|NCT03011892|83142240|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
47026233|NCT01970540|83275768|FG000|Overall Study|End of study|2|||
47026234|NCT01970540|83275769|FG001|Overall Study|End of study|0|||
47026235|NCT01970540|83275770|FG002|Overall Study|End of study|2|||
47026236|NCT01970540|83275768|FG000|Overall Study|Adverse Event|0|||
47026237|NCT01970540|83275769|FG001|Overall Study|Adverse Event|2|||
47026238|NCT01970540|83275770|FG002|Overall Study|Adverse Event|1|||
47026239|NCT01970540|83275768|FG000|Overall Study|Treatment-related AE|4|||
47026240|NCT01970540|83275769|FG001|Overall Study|Treatment-related AE|0|||
47026241|NCT01970540|83275770|FG002|Overall Study|Treatment-related AE|2|||
47026242|NCT01970540|83275768|FG000|Overall Study|Withdrawal by Subject|4|||
47026243|NCT01970540|83275769|FG001|Overall Study|Withdrawal by Subject|0|||
46622996|NCT01600092|82778619|FG000|Overall Study|Physician Decision|1|||
46912179|NCT03011892|83142241|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
47026244|NCT01970540|83275770|FG002|Overall Study|Withdrawal by Subject|1|||
47026245|NCT01970540|83275768|FG000|Overall Study|Clinical deterioration|1|||
46622997|NCT01600092|82778620|FG001|Overall Study|Physician Decision|1|||
47026246|NCT01970540|83275769|FG001|Overall Study|Clinical deterioration|0|||
47026247|NCT01970540|83275770|FG002|Overall Study|Clinical deterioration|0|||
47026248|NCT01963676|83275791|FG000|Overall Study|Withdrawal by Subject|1|||
47026249|NCT01963676|83275792|FG001|Overall Study|Withdrawal by Subject|0|||
47026250|NCT01996826|83275800|FG000|Overall Study|Lost to Follow-up|6|||
47026251|NCT01996826|83275801|FG001|Overall Study|Lost to Follow-up|2|||
47026252|NCT01996826|83275800|FG000|Overall Study|Physician Decision|1|||
47026253|NCT01996826|83275801|FG001|Overall Study|Physician Decision|1|||
47026254|NCT01996748|83275809|FG000|Overall Study|Personal reason|1|||
47026255|NCT01996748|83275810|FG001|Overall Study|Personal reason|0|||
47026256|NCT01996748|83275809|FG000|Overall Study|Physician Decision|2|||
47026257|NCT01996748|83275810|FG001|Overall Study|Physician Decision|0|||
47026258|NCT01996748|83275809|FG000|Overall Study|Adverse Event|1|||
47026259|NCT01996748|83275810|FG001|Overall Study|Adverse Event|4|||
47026260|NCT01996748|83275809|FG000|Overall Study|Withdrawal by Subject|0|||
47026261|NCT01996748|83275810|FG001|Overall Study|Withdrawal by Subject|1|||
47026262|NCT01996748|83275809|FG000|Overall Study|Lost to Follow-up|4|||
47026263|NCT01996748|83275810|FG001|Overall Study|Lost to Follow-up|1|||
47026264|NCT01621178|83275821|FG000|Overall Study|Adverse Event|5|||
47026265|NCT01621178|83275822|FG001|Overall Study|Adverse Event|2|||
47026266|NCT01621178|83275823|FG002|Overall Study|Adverse Event|8|||
47026267|NCT01621178|83275821|FG000|Overall Study|Death|6|||
47026268|NCT01621178|83275822|FG001|Overall Study|Death|7|||
47026269|NCT01621178|83275823|FG002|Overall Study|Death|2|||
47026270|NCT01621178|83275821|FG000|Overall Study|Lost to Follow-up|1|||
47026271|NCT01621178|83275822|FG001|Overall Study|Lost to Follow-up|2|||
47026272|NCT01621178|83275823|FG002|Overall Study|Lost to Follow-up|1|||
47026273|NCT01621178|83275821|FG000|Overall Study|Withdrawal by Subject|14|||
47026274|NCT01621178|83275822|FG001|Overall Study|Withdrawal by Subject|17|||
47026275|NCT01621178|83275823|FG002|Overall Study|Withdrawal by Subject|18|||
47026276|NCT01621178|83275821|FG000|Overall Study|Physician Decision|5|||
47026277|NCT01621178|83275822|FG001|Overall Study|Physician Decision|2|||
47026278|NCT01621178|83275823|FG002|Overall Study|Physician Decision|7|||
47026279|NCT01962974|83275835|FG000|Overall Study|Study termination|7|||
46622998|NCT01600092|82778619|FG000|Overall Study|Randomized but not vaccinated|3|||
46622999|NCT01600092|82778620|FG001|Overall Study|Randomized but not vaccinated|3|||
46623000|NCT02240628|82778632|FG000|Overall Study|Physician Decision|6|||
46623001|NCT02240628|82778633|FG001|Overall Study|Physician Decision|5|||
46623002|NCT02207400|82778655|FG000|Overall Study|Adverse Event|1|||
46623003|NCT02207400|82778656|FG001|Overall Study|Adverse Event|1|||
46623004|NCT02207400|82778655|FG000|Overall Study|Lost to Follow-up|6|||
46623005|NCT02207400|82778656|FG001|Overall Study|Lost to Follow-up|7|||
46623006|NCT02207400|82778655|FG000|Overall Study|Protocol Violation|1|||
46623007|NCT02207400|82778656|FG001|Overall Study|Protocol Violation|1|||
46623008|NCT02207400|82778655|FG000|Overall Study|Withdrawal by Subject|8|||
46623009|NCT02207400|82778656|FG001|Overall Study|Withdrawal by Subject|4|||
46623010|NCT02207400|82778655|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
46623011|NCT02207400|82778656|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
46623012|NCT02207244|82779015|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
46623013|NCT02207244|82779016|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
46623014|NCT02207244|82779017|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
46623015|NCT02207244|82779018|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46623016|NCT02207244|82779019|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46623017|NCT02207244|82779020|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46912180|NCT03011892|83142242|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
46912181|NCT03011892|83142243|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
47026280|NCT01996592|83275839|FG000|Overall Study|no response to text/no diary entry|32|||
47026281|NCT01996592|83275839|FG000|Overall Study|change in surgical date|4|||
47026282|NCT01996592|83275839|FG000|Overall Study|Withdrawal by Subject|5|||
47026283|NCT01996592|83275839|FG000|Overall Study|change in mode of delivery|4|||
47026284|NCT01962896|83275848|FG000|Overall Study|Lack of Efficacy|4|||
47026285|NCT01970462|83275855|FG000|Overall Study|Lost to Follow-up|0|||
47026286|NCT01970462|83275856|FG001|Overall Study|Lost to Follow-up|2|||
47026287|NCT01958671|83275865|FG000|Overall Study|Adverse Event|1|||
47026288|NCT01958671|83275866|FG001|Overall Study|Adverse Event|1|||
47026289|NCT01958671|83275867|FG002|Overall Study|Adverse Event|5|||
47026290|NCT01958671|83275865|FG000|Overall Study|Death|1|||
47026291|NCT01958671|83275866|FG001|Overall Study|Death|0|||
47026292|NCT01958671|83275867|FG002|Overall Study|Death|0|||
47026293|NCT01958671|83275865|FG000|Overall Study|Excluded medication|0|||
47026294|NCT01958671|83275866|FG001|Overall Study|Excluded medication|0|||
47026295|NCT01958671|83275867|FG002|Overall Study|Excluded medication|1|||
47026296|NCT01958671|83275865|FG000|Overall Study|Hyperglycemia|0|||
47026297|NCT01958671|83275866|FG001|Overall Study|Hyperglycemia|0|||
47026298|NCT01958671|83275867|FG002|Overall Study|Hyperglycemia|2|||
47026299|NCT01958671|83275865|FG000|Overall Study|Lost to Follow-up|7|||
47026300|NCT01958671|83275866|FG001|Overall Study|Lost to Follow-up|11|||
47026301|NCT01958671|83275867|FG002|Overall Study|Lost to Follow-up|7|||
47026302|NCT01958671|83275865|FG000|Overall Study|Non-compliance with study drug|1|||
47026303|NCT01958671|83275866|FG001|Overall Study|Non-compliance with study drug|1|||
47026304|NCT01958671|83275867|FG002|Overall Study|Non-compliance with study drug|1|||
47026305|NCT01958671|83275865|FG000|Overall Study|Pregnancy|0|||
47026306|NCT01958671|83275866|FG001|Overall Study|Pregnancy|0|||
47026307|NCT01958671|83275867|FG002|Overall Study|Pregnancy|1|||
47026308|NCT01958671|83275865|FG000|Overall Study|Protocol Violation|0|||
47026309|NCT01958671|83275866|FG001|Overall Study|Protocol Violation|1|||
47026310|NCT01958671|83275867|FG002|Overall Study|Protocol Violation|0|||
47026311|NCT01958671|83275865|FG000|Overall Study|Study site terminated by sponsor|1|||
47026312|NCT01958671|83275866|FG001|Overall Study|Study site terminated by sponsor|0|||
47026313|NCT01958671|83275867|FG002|Overall Study|Study site terminated by sponsor|1|||
47026314|NCT01958671|83275865|FG000|Overall Study|Participant moved|0|||
47026315|NCT01958671|83275866|FG001|Overall Study|Participant moved|0|||
47026316|NCT01958671|83275867|FG002|Overall Study|Participant moved|1|||
47026317|NCT01958671|83275865|FG000|Overall Study|Withdrawal by Subject|8|||
47026318|NCT01958671|83275866|FG001|Overall Study|Withdrawal by Subject|10|||
47026319|NCT01958671|83275867|FG002|Overall Study|Withdrawal by Subject|13|||
47026320|NCT01995266|83275879|FG000|Overall Study|Death|1|||
47026321|NCT01995266|83275879|FG000|Overall Study|Lack of Efficacy|6|||
47026322|NCT01995266|83275879|FG000|Overall Study|Adverse Event|2|||
47026323|NCT01969058|83275885|FG000|Overall Study|Withdrawal by Subject|2|||
47026324|NCT01969058|83275886|FG001|Overall Study|Withdrawal by Subject|0|||
47026325|NCT01969058|83275885|FG000|Overall Study|Adverse Event|1|||
47026326|NCT01969058|83275886|FG001|Overall Study|Adverse Event|0|||
47026327|NCT01968980|83275894|FG000|Overall Study|Death|0|||
46623018|NCT02207244|82779021|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46623019|NCT02207244|82779022|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46623020|NCT02207244|82779023|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46623021|NCT02207244|82779024|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46623022|NCT02207244|82779025|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
46623023|NCT02207244|82779015|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
46623024|NCT02207244|82779016|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623025|NCT02207244|82779017|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
46623026|NCT02207244|82779018|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
47026328|NCT01968980|83275895|FG001|Overall Study|Death|1|||
47026329|NCT01968980|83275894|FG000|Overall Study|Adverse Event|1|||
47026330|NCT01968980|83275895|FG001|Overall Study|Adverse Event|3|||
47026331|NCT01968980|83275894|FG000|Overall Study|Does not meet entry criteria|1|||
47026332|NCT01968980|83275895|FG001|Overall Study|Does not meet entry criteria|3|||
47026333|NCT01968980|83275894|FG000|Overall Study|Withdrawal by Subject|13|||
47026334|NCT01968980|83275895|FG001|Overall Study|Withdrawal by Subject|5|||
47026335|NCT01968980|83275894|FG000|Overall Study|Other unspecified|1|||
46912182|NCT03011892|83142232|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
47026336|NCT01968980|83275895|FG001|Overall Study|Other unspecified|2|||
47026337|NCT01961882|83275904|FG000|Overall Study|Adverse Event|3|||
46623027|NCT02207244|82779019|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623028|NCT02207244|82779020|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623029|NCT02207244|82779021|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623030|NCT02207244|82779022|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623031|NCT02207244|82779023|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623032|NCT02207244|82779024|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623033|NCT02207244|82779025|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
46623034|NCT02207244|82779015|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
46623035|NCT02207244|82779016|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
47026338|NCT01961882|83275905|FG001|Overall Study|Adverse Event|2|||
47026339|NCT01961882|83275904|FG000|Overall Study|Physician Decision|1|||
47026340|NCT01961882|83275905|FG001|Overall Study|Physician Decision|0|||
47026341|NCT01961882|83275904|FG000|Overall Study|Withdrawal by Subject|4|||
47026342|NCT01961882|83275905|FG001|Overall Study|Withdrawal by Subject|1|||
47026343|NCT01961882|83275904|FG000|Overall Study|Relapse of AML|39|||
47026344|NCT01961882|83275905|FG001|Overall Study|Relapse of AML|37|||
47026345|NCT01961882|83275904|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
47026346|NCT01961882|83275905|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
47026347|NCT01961882|83275904|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
47026348|NCT01961882|83275905|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
47026349|NCT01968434|83275913|FG000|Overall Study|Lost to Follow-up|3|||
47026350|NCT01968434|83275914|FG001|Overall Study|Lost to Follow-up|6|||
47026351|NCT01946438|83275924|FG000|Overall Study|Adverse Event|0|||
47026352|NCT01946438|83275925|FG001|Overall Study|Adverse Event|0|||
47026353|NCT01946438|83275926|FG002|Overall Study|Adverse Event|0|||
47026354|NCT01946438|83275927|FG003|Overall Study|Adverse Event|1|||
47026355|NCT01946438|83275924|FG000|Overall Study|Serious Adverse event|1|||
47026356|NCT01946438|83275925|FG001|Overall Study|Serious Adverse event|0|||
47026357|NCT01946438|83275926|FG002|Overall Study|Serious Adverse event|0|||
47026358|NCT01946438|83275927|FG003|Overall Study|Serious Adverse event|0|||
47026359|NCT01946438|83275924|FG000|Overall Study|Protocol Violation|0|||
47026360|NCT01946438|83275925|FG001|Overall Study|Protocol Violation|0|||
47026361|NCT01946438|83275926|FG002|Overall Study|Protocol Violation|1|||
47026362|NCT01946438|83275927|FG003|Overall Study|Protocol Violation|0|||
47026363|NCT01946438|83275924|FG000|Overall Study|Withdrawal by Subject|1|||
47026364|NCT01946438|83275925|FG001|Overall Study|Withdrawal by Subject|0|||
47026365|NCT01946438|83275926|FG002|Overall Study|Withdrawal by Subject|0|||
47026366|NCT01946438|83275927|FG003|Overall Study|Withdrawal by Subject|0|||
47026367|NCT01946282|83275946|FG000|Year 1|Did not return FIT kit|4186|||
46710226|NCT00960531|82926383|FG006|Overall Study|Lack of Efficacy|0|||
46710227|NCT00960531|82926384|FG007|Overall Study|Lack of Efficacy|0|||
47026368|NCT01946282|83275947|FG001|Year 1|Did not return FIT kit|608|||
47026369|NCT01946282|83275948|FG002|Year 1|Did not return FIT kit|654|||
47026370|NCT01946282|83275946|FG000|Year 2|Did not return FIT kit|803|||
47026371|NCT01946282|83275947|FG001|Year 2|Did not return FIT kit|131|||
47026372|NCT01946282|83275948|FG002|Year 2|Did not return FIT kit|115|||
47026373|NCT01946282|83275946|FG000|Year 3|Did not return FIT kit|288|||
47026374|NCT01946282|83275947|FG001|Year 3|Did not return FIT kit|43|||
47026375|NCT01946282|83275948|FG002|Year 3|Did not return FIT kit|30|||
47026376|NCT01945580|83275960|FG000|Overall Study|Withdrawal by Subject|13|||
46623036|NCT02207244|82779017|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
46623037|NCT02207244|82779018|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
46623038|NCT02207244|82779019|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
46623039|NCT02207244|82779020|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
46623040|NCT02207244|82779021|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
46623041|NCT02207244|82779022|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
46623042|NCT02207244|82779023|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
46623043|NCT02207244|82779024|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
47026377|NCT01945580|83275961|FG001|Overall Study|Withdrawal by Subject|35|||
47026378|NCT01945580|83275960|FG000|Overall Study|Physician Decision|3|||
47026379|NCT01945580|83275961|FG001|Overall Study|Physician Decision|2|||
47026380|NCT01945580|83275960|FG000|Overall Study|Lost to Follow-up|26|||
47026381|NCT01945580|83275961|FG001|Overall Study|Lost to Follow-up|39|||
47026382|NCT01945580|83275960|FG000|Overall Study|Death|7|||
46623044|NCT02207244|82779025|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
46623045|NCT02207244|82779015|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
47026383|NCT01945580|83275961|FG001|Overall Study|Death|2|||
47026384|NCT01945580|83275960|FG000|Overall Study|Patient moved out of state|0|||
47026385|NCT01945580|83275961|FG001|Overall Study|Patient moved out of state|1|||
47026386|NCT01945580|83275960|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
47026387|NCT01945580|83275961|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
46710228|NCT00960531|82926385|FG008|Overall Study|Lack of Efficacy|0|||
47026388|NCT01945580|83275960|FG000|Overall Study|Family illness - unable to return|0|||
47026389|NCT01945580|83275961|FG001|Overall Study|Family illness - unable to return|1|||
47026390|NCT01945580|83275960|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
47026391|NCT01945580|83275961|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
47026392|NCT01945580|83275960|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
47026393|NCT01945580|83275961|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
47026394|NCT01945580|83275960|FG000|Overall Study|Noncompliance with 36 month visit|1|||
47026395|NCT01945580|83275961|FG001|Overall Study|Noncompliance with 36 month visit|0|||
47026396|NCT01945580|83275960|FG000|Overall Study|The patient moved.|1|||
47026397|NCT01945580|83275961|FG001|Overall Study|The patient moved.|0|||
47026398|NCT01945580|83275960|FG000|Overall Study|No data available|0|||
47026399|NCT01945580|83275961|FG001|Overall Study|No data available|2|||
47026400|NCT01945034|83275974|FG000|Overall Study|Medication Error|0|||
47026401|NCT01945034|83275975|FG001|Overall Study|Medication Error|1|||
47026402|NCT01945034|83275976|FG002|Overall Study|Medication Error|0|||
47026403|NCT01945034|83275974|FG000|Overall Study|Withdrawal by Subject|0|||
47026404|NCT01945034|83275975|FG001|Overall Study|Withdrawal by Subject|3|||
47026405|NCT01945034|83275976|FG002|Overall Study|Withdrawal by Subject|1|||
47026406|NCT01945034|83275974|FG000|Overall Study|Other|0|||
47026407|NCT01945034|83275975|FG001|Overall Study|Other|1|||
47026408|NCT01945034|83275976|FG002|Overall Study|Other|3|||
47026409|NCT01945034|83275974|FG000|Overall Study|Lost to Follow-up|0|||
47026410|NCT01945034|83275975|FG001|Overall Study|Lost to Follow-up|0|||
47026411|NCT01945034|83275976|FG002|Overall Study|Lost to Follow-up|2|||
47026412|NCT01945034|83275974|FG000|Overall Study|Protocol Violation|1|||
47026413|NCT01945034|83275975|FG001|Overall Study|Protocol Violation|0|||
47026414|NCT01945034|83275976|FG002|Overall Study|Protocol Violation|1|||
47026415|NCT01960790|83275984|FG000|Overall Study|Survey forms could not be recovered|3|||
47026416|NCT01960790|83275984|FG000|Overall Study|Treat with Humira outside survey period|3|||
47026417|NCT01960790|83275984|FG000|Overall Study|Transferred to another hospital|4|||
47026418|NCT01960790|83275984|FG000|Overall Study|Unevaluable for safety|1|||
47026419|NCT01618214|83275990|FG000|Overall Study|Adverse Event|3|||
47026420|NCT01618214|83275991|FG001|Overall Study|Adverse Event|1|||
47026421|NCT01618214|83275990|FG000|Overall Study|Lack of Efficacy|1|||
47026422|NCT01618214|83275991|FG001|Overall Study|Lack of Efficacy|1|||
47026423|NCT01618214|83275990|FG000|Overall Study|Protocol Violation|1|||
47026424|NCT01618214|83275991|FG001|Overall Study|Protocol Violation|4|||
47026425|NCT01618214|83275990|FG000|Overall Study|Withdrawal Criteria|1|||
47026426|NCT01618214|83275991|FG001|Overall Study|Withdrawal Criteria|2|||
47026427|NCT01618214|83275990|FG000|Overall Study|Unclassified|4|||
47026428|NCT01618214|83275991|FG001|Overall Study|Unclassified|5|||
47026429|NCT01917968|83275999|FG000|Overall Study|Death|3|||
47026430|NCT01917968|83276000|FG001|Overall Study|Death|2|||
47026431|NCT01917968|83275999|FG000|Overall Study|Lost to Follow-up|21|||
46623046|NCT02207244|82779016|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
46623047|NCT02207244|82779017|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623048|NCT02207244|82779018|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623049|NCT02207244|82779019|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623050|NCT02207244|82779020|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623051|NCT02207244|82779021|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623052|NCT02207244|82779022|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623053|NCT02207244|82779023|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623054|NCT02207244|82779024|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623055|NCT02207244|82779025|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
46623056|NCT02207244|82779015|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
46623057|NCT02207244|82779016|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
46623058|NCT02207244|82779017|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
47026432|NCT01917968|83276000|FG001|Overall Study|Lost to Follow-up|39|||
47026433|NCT01917968|83275999|FG000|Overall Study|Physician Decision|1|||
47026434|NCT01917968|83276000|FG001|Overall Study|Physician Decision|2|||
47026435|NCT01917968|83275999|FG000|Overall Study|Withdrawal by Subject|20|||
47026436|NCT01917968|83276000|FG001|Overall Study|Withdrawal by Subject|35|||
47026437|NCT01917968|83275999|FG000|Overall Study|Subject Relocation|5|||
47026438|NCT01917968|83276000|FG001|Overall Study|Subject Relocation|1|||
47026439|NCT01917968|83275999|FG000|Overall Study|36M Missed Visit|3|||
47026440|NCT01917968|83276000|FG001|Overall Study|36M Missed Visit|2|||
46623059|NCT02207244|82779018|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
47026441|NCT01917968|83275999|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
47026442|NCT01917968|83276000|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
47026443|NCT01917968|83275999|FG000|Overall Study|Change in Family Circumstances|0|||
47026444|NCT01917968|83276000|FG001|Overall Study|Change in Family Circumstances|1|||
47026445|NCT01917968|83275999|FG000|Overall Study|No Data Available|0|||
47026446|NCT01917968|83276000|FG001|Overall Study|No Data Available|2|||
47026447|NCT01917656|83276015|FG000|Overall Study|Adverse Event|11|||
47026448|NCT01917656|83276016|FG001|Overall Study|Adverse Event|0|||
47026449|NCT01917656|83276015|FG000|Overall Study|Withdrawal criteria|8|||
47026450|NCT01917656|83276016|FG001|Overall Study|Withdrawal criteria|14|||
47026451|NCT01917656|83276015|FG000|Overall Study|Unclassified|0|||
47026452|NCT01917656|83276016|FG001|Overall Study|Unclassified|3|||
47026453|NCT01917656|83276015|FG000|Overall Study|Withdrawal by Subject|4|||
47026454|NCT01917656|83276016|FG001|Overall Study|Withdrawal by Subject|3|||
47026455|NCT01917656|83276015|FG000|Overall Study|Lost to Follow-up|3|||
47026456|NCT01917656|83276016|FG001|Overall Study|Lost to Follow-up|4|||
47026457|NCT01944722|83276024|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
47026458|NCT01944722|83276024|FG000|Overall Study|Specimen Shipping Issues|34|||
47026459|NCT01944722|83276024|FG000|Overall Study|Improper Storage/Transport|5|||
47026460|NCT01944722|83276024|FG000|Overall Study|Insufficient Volume for Test|1|||
47026461|NCT01944722|83276024|FG000|Overall Study|Missing Specimens|3|||
47026462|NCT01944722|83276024|FG000|Overall Study|Specimens Mislabeled|2|||
47026463|NCT01944722|83276024|FG000|Overall Study|Withdrawal by Subject|8|||
47026464|NCT01944722|83276024|FG000|Overall Study|NILM Subjects <30 years old|8106|||
47026465|NCT01944722|83276024|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
47026466|NCT01944722|83276024|FG000|Overall Study|>ASCUS Cytology|1122|||
47026467|NCT01917344|83276033|FG000|Overall Study|Withdrawal by Subject|1|||
47026468|NCT02017535|83276041|FG000|Overall Study|Withdrawal by Subject|1|||
47026469|NCT02017535|83276042|FG001|Overall Study|Withdrawal by Subject|0|||
47026470|NCT02017535|83276043|FG002|Overall Study|Withdrawal by Subject|0|||
47026471|NCT02017535|83276044|FG003|Overall Study|Withdrawal by Subject|0|||
47026472|NCT01944098|83276056|FG000|Overall Study|Physician Decision|1|||
47026473|NCT01944098|83276057|FG001|Overall Study|Physician Decision|0|||
47026474|NCT02017223|83276063|FG000|Overall Study|Algorithm problems|2|||
47026475|NCT01944020|83276069|FG000|Overall Study|Withdrawal by Subject|5|||
47026476|NCT01944020|83276070|FG001|Overall Study|Withdrawal by Subject|0|||
47026477|NCT01943552|83276078|FG000|Overall Study|Adverse Event|3|||
47026478|NCT01943552|83276079|FG001|Overall Study|Adverse Event|2|||
47026479|NCT01943552|83276078|FG000|Overall Study|Withdrawal by Subject|6|||
47026480|NCT01943552|83276079|FG001|Overall Study|Withdrawal by Subject|6|||
47026481|NCT01943552|83276078|FG000|Overall Study|Other Reasons|16|||
47026482|NCT01943552|83276079|FG001|Overall Study|Other Reasons|17|||
47026483|NCT01915940|83276087|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
47026484|NCT01915940|83276088|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
47026485|NCT01915940|83276089|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
47026486|NCT01915940|83276087|FG000|Treatment Period|Decision of Participant|0|||
47026487|NCT01915940|83276088|FG001|Treatment Period|Decision of Participant|1|||
47026488|NCT01915940|83276089|FG002|Treatment Period|Decision of Participant|3|||
47026489|NCT01915940|83276087|FG000|Treatment Period|Adverse Event|0|||
47026490|NCT01915940|83276088|FG001|Treatment Period|Adverse Event|9|||
47026491|NCT01915940|83276089|FG002|Treatment Period|Adverse Event|1|||
47026492|NCT01915940|83276087|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
47026493|NCT01915940|83276088|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
47026494|NCT01915940|83276089|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
47026495|NCT01914926|83276097|FG000|Overall Study|Adverse Event|1|||
47026496|NCT01914926|83276098|FG001|Overall Study|Adverse Event|0|||
47026497|NCT01914926|83276097|FG000|Overall Study|uncooperative, agitated and removed|0|||
47026498|NCT01914926|83276098|FG001|Overall Study|uncooperative, agitated and removed|1|||
47026499|NCT02016755|83276104|FG000|Overall Study|Major amputation of index limb|2|||
47026500|NCT02016755|83276104|FG000|Overall Study|Adverse Event|2|||
47026501|NCT02016755|83276104|FG000|Overall Study|Physician Decision|1|||
47026502|NCT02016755|83276104|FG000|Overall Study|Death|2|||
47026503|NCT01942148|83276108|FG000|Overall Study|Adverse Event|4|||
47026504|NCT01942148|83276108|FG000|Overall Study|Lack of Efficacy|2|||
47026505|NCT01942148|83276108|FG000|Overall Study|Physician Decision|11|||
47026506|NCT01942148|83276108|FG000|Overall Study|Protocol Violation|1|||
47026507|NCT01942148|83276108|FG000|Overall Study|Withdrawal by Subject|8|||
47026508|NCT01942148|83276108|FG000|Overall Study|Use of the prohibition medicine|1|||
47026509|NCT02030015|83276112|FG000|Overall Study|Withdrawal by Subject|3|||
47026510|NCT02030015|83276112|FG000|Overall Study|Death|13|||
47026511|NCT02029235|83276118|FG000|Overall Study|Non-compliance with study meds or diary|4|||
47026512|NCT02029235|83276119|FG001|Overall Study|Non-compliance with study meds or diary|1|||
47026513|NCT01617434|83276127|FG000|Overall Study|Adverse Event|12|||
47026514|NCT01617434|83276128|FG001|Overall Study|Adverse Event|3|||
47026515|NCT01617434|83276127|FG000|Overall Study|Protocol Violation|8|||
47026516|NCT01617434|83276128|FG001|Overall Study|Protocol Violation|7|||
47026517|NCT01617434|83276127|FG000|Overall Study|Withdrawal Criteria|12|||
47026518|NCT01617434|83276128|FG001|Overall Study|Withdrawal Criteria|37|||
47026519|NCT01617434|83276127|FG000|Overall Study|Unclassified|3|||
47026520|NCT01617434|83276128|FG001|Overall Study|Unclassified|4|||
47026521|NCT01940354|83276136|FG000|Overall Study|Withdrawal by Subject|4|||
47026522|NCT01940354|83276137|FG001|Overall Study|Withdrawal by Subject|2|||
47026523|NCT01940120|83276143|FG000|Overall Study|Death|40|||
47026524|NCT01940120|83276143|FG000|Overall Study|Withdrawal by Subject|8|||
47026525|NCT01911260|83276152|FG000|Supplementation Period|transference or evasion of school|7|||
47026526|NCT01911260|83276153|FG001|Supplementation Period|transference or evasion of school|9|||
47026527|NCT01911260|83276154|FG002|Supplementation Period|transference or evasion of school|7|||
47026528|NCT01911260|83276155|FG003|Supplementation Period|transference or evasion of school|6|||
47026529|NCT01911260|83276152|FG000|Supplementation Period|Adverse Event|2|||
47026530|NCT01911260|83276153|FG001|Supplementation Period|Adverse Event|0|||
47026531|NCT01911260|83276154|FG002|Supplementation Period|Adverse Event|1|||
47026532|NCT01911260|83276155|FG003|Supplementation Period|Adverse Event|0|||
47026533|NCT01911260|83276152|FG000|Supplementation Period|refused to receive supplement|1|||
47026534|NCT01911260|83276153|FG001|Supplementation Period|refused to receive supplement|0|||
47026535|NCT01911260|83276154|FG002|Supplementation Period|refused to receive supplement|1|||
47026536|NCT01911260|83276155|FG003|Supplementation Period|refused to receive supplement|0|||
47026537|NCT01911260|83276152|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
47026538|NCT01911260|83276153|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
47026539|NCT01911260|83276154|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
47026540|NCT01911260|83276155|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
47026541|NCT01911260|83276152|FG000|Follow-up Period|transference or evasion of school|13|||
47026542|NCT01911260|83276153|FG001|Follow-up Period|transference or evasion of school|20|||
47026543|NCT01911260|83276154|FG002|Follow-up Period|transference or evasion of school|15|||
47026544|NCT01911260|83276155|FG003|Follow-up Period|transference or evasion of school|12|||
47026545|NCT02015819|83276169|FG000|Overall Study|Rickham catheter was misaligned|0|||
47026546|NCT02015819|83276170|FG001|Overall Study|Rickham catheter was misaligned|0|||
47026547|NCT02015819|83276171|FG002|Overall Study|Rickham catheter was misaligned|0|||
47026548|NCT02015819|83276172|FG003|Overall Study|Rickham catheter was misaligned|1|||
47026549|NCT01939496|83276189|FG000|Overall Study|Adverse Event|2|||
47026550|NCT01939496|83276190|FG001|Overall Study|Adverse Event|0|||
47026551|NCT01939496|83276191|FG002|Overall Study|Adverse Event|0|||
47026552|NCT01939496|83276189|FG000|Overall Study|Lost to Follow-up|1|||
47026553|NCT01939496|83276190|FG001|Overall Study|Lost to Follow-up|1|||
47026554|NCT01939496|83276191|FG002|Overall Study|Lost to Follow-up|0|||
47026555|NCT01939496|83276189|FG000|Overall Study|Physician Decision|1|||
47026556|NCT01939496|83276190|FG001|Overall Study|Physician Decision|0|||
47026557|NCT01939496|83276191|FG002|Overall Study|Physician Decision|0|||
47026558|NCT01939496|83276189|FG000|Overall Study|Protocol Violation|3|||
47026559|NCT01939496|83276190|FG001|Overall Study|Protocol Violation|0|||
47026560|NCT01939496|83276191|FG002|Overall Study|Protocol Violation|0|||
47026561|NCT01939496|83276189|FG000|Overall Study|Withdrawal by Subject|0|||
47026562|NCT01939496|83276190|FG001|Overall Study|Withdrawal by Subject|1|||
47026563|NCT01939496|83276191|FG002|Overall Study|Withdrawal by Subject|1|||
47026564|NCT01939496|83276189|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
47026565|NCT01939496|83276190|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
47026566|NCT01939496|83276191|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
47026567|NCT01939496|83276189|FG000|Overall Study|Other|2|||
47026568|NCT01939496|83276190|FG001|Overall Study|Other|0|||
47026569|NCT01939496|83276191|FG002|Overall Study|Other|1|||
47026570|NCT01939028|83276199|FG000|Overall Study|Withdrawal by Subject|5|||
47026571|NCT01939028|83276199|FG000|Overall Study|Physician Decision|7|||
47026572|NCT01938716|83276203|FG000|Overall Study|Physician Decision|2|||
47026573|NCT01938716|83276203|FG000|Overall Study|Withdrawal by Subject|2|||
47026574|NCT01937390|83276207|FG000|Overall Study|Death|2|||
47026575|NCT01937390|83276207|FG000|Overall Study|Lost to Follow-up|7|||
47026576|NCT01937390|83276207|FG000|Overall Study|Withdrawal by Subject|5|||
47026577|NCT01937390|83276207|FG000|Overall Study|Fail to return|21|||
47026578|NCT02028767|83276211|FG000|Treatment Period 2|Non compliant with protocol|1|||
46623060|NCT02207244|82779019|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
46710229|NCT00960531|82926386|FG009|Overall Study|Lack of Efficacy|0|||
47026579|NCT02028767|83276212|FG001|Treatment Period 2|Non compliant with protocol|0|||
47026580|NCT02028767|83276211|FG000|Treatment Period 2|Reason other than those specified above|1|||
47026581|NCT02028767|83276212|FG001|Treatment Period 2|Reason other than those specified above|0|||
47026582|NCT01959932|83276221|FG000|Overall Study|Withdrawal by Subject|1|||
47026583|NCT01959932|83276222|FG001|Overall Study|Withdrawal by Subject|0|||
47026584|NCT01959932|83276223|FG002|Overall Study|Withdrawal by Subject|0|||
47026585|NCT02028065|83276235|FG000|Randomization Through Start Treatment|Not treated|1|||
47026586|NCT02028065|83276236|FG001|Randomization Through Start Treatment|Not treated|3|||
47026587|NCT02028065|83276237|FG002|Randomization Through Start Treatment|Not treated|3|||
47026588|NCT02028065|83276235|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
47026589|NCT02028065|83276236|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
47026590|NCT02028065|83276237|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
47026591|NCT02028065|83276235|FG000|Treatment Through Study Completion|Physician Decision|1|||
47026592|NCT02028065|83276236|FG001|Treatment Through Study Completion|Physician Decision|0|||
47026593|NCT02028065|83276237|FG002|Treatment Through Study Completion|Physician Decision|0|||
47026594|NCT02028065|83276235|FG000|Treatment Through Study Completion|Protocol Violation|1|||
47026595|NCT02028065|83276236|FG001|Treatment Through Study Completion|Protocol Violation|4|||
47026596|NCT02028065|83276237|FG002|Treatment Through Study Completion|Protocol Violation|0|||
47026597|NCT02028065|83276235|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
47026598|NCT02028065|83276236|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
47026599|NCT02028065|83276237|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
47026600|NCT02028065|83276235|FG000|Treatment Through Study Completion|Adverse Event|3|||
47026601|NCT02028065|83276236|FG001|Treatment Through Study Completion|Adverse Event|3|||
47026602|NCT02028065|83276237|FG002|Treatment Through Study Completion|Adverse Event|5|||
47026603|NCT02015195|83276252|FG000|Overall Study|Adverse Event|0|||
47026604|NCT02015195|83276253|FG001|Overall Study|Adverse Event|0|||
47026605|NCT02015195|83276254|FG002|Overall Study|Adverse Event|0|||
47026606|NCT02015195|83276255|FG003|Overall Study|Adverse Event|1|||
47026607|NCT02015195|83276256|FG004|Overall Study|Adverse Event|0|||
47026608|NCT02015195|83276257|FG005|Overall Study|Adverse Event|0|||
47026609|NCT02015195|83276258|FG006|Overall Study|Adverse Event|0|||
47026610|NCT02015039|83276275|FG000|Overall Study|Not eligible|0|||
47026611|NCT02015039|83276276|FG001|Overall Study|Not eligible|1|||
47026612|NCT02025725|83276284|FG000|Overall Study|Adverse Event|5|||
47026613|NCT02025725|83276285|FG001|Overall Study|Adverse Event|0|||
47026614|NCT02025725|83276284|FG000|Overall Study|Lost to Follow-up|2|||
47026615|NCT02025725|83276285|FG001|Overall Study|Lost to Follow-up|0|||
47026616|NCT02025725|83276284|FG000|Overall Study|Protocol Violation|1|||
47026617|NCT02025725|83276285|FG001|Overall Study|Protocol Violation|1|||
47026618|NCT02025725|83276284|FG000|Overall Study|Withdrawal by Subject|3|||
47026619|NCT02025725|83276285|FG001|Overall Study|Withdrawal by Subject|2|||
47026620|NCT02025725|83276284|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
47026621|NCT02025725|83276285|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
47026622|NCT02025179|83276296|FG000|Overall Study|Lost to Follow-up|0|||
47026623|NCT02025179|83276297|FG001|Overall Study|Lost to Follow-up|0|||
47026624|NCT02025179|83276298|FG002|Overall Study|Lost to Follow-up|1|||
47026625|NCT02013791|83276315|FG000|Period 1|Lost to Follow-up|0|||
47026626|NCT02013791|83276316|FG001|Period 1|Lost to Follow-up|0|||
47026627|NCT02013791|83276317|FG002|Period 1|Lost to Follow-up|0|||
47026628|NCT02013791|83276318|FG003|Period 1|Lost to Follow-up|1|||
47026629|NCT02013791|83276319|FG004|Period 1|Lost to Follow-up|0|||
47026630|NCT02013791|83276320|FG005|Period 1|Lost to Follow-up|0|||
47026631|NCT02013791|83276321|FG006|Period 1|Lost to Follow-up|1|||
47026632|NCT02013791|83276322|FG007|Period 1|Lost to Follow-up|1|||
47026633|NCT02013791|83276323|FG008|Period 1|Lost to Follow-up|0|||
47026634|NCT02013791|83276315|FG000|Period 1|Other Miscellaneous Reasons|0|||
47026635|NCT02013791|83276316|FG001|Period 1|Other Miscellaneous Reasons|2|||
47026636|NCT02013791|83276317|FG002|Period 1|Other Miscellaneous Reasons|0|||
47026637|NCT02013791|83276318|FG003|Period 1|Other Miscellaneous Reasons|0|||
47026638|NCT02013791|83276319|FG004|Period 1|Other Miscellaneous Reasons|0|||
47026639|NCT02013791|83276320|FG005|Period 1|Other Miscellaneous Reasons|0|||
47026640|NCT02013791|83276321|FG006|Period 1|Other Miscellaneous Reasons|0|||
47026641|NCT02013791|83276322|FG007|Period 1|Other Miscellaneous Reasons|0|||
47026642|NCT02013791|83276323|FG008|Period 1|Other Miscellaneous Reasons|0|||
47026643|NCT02024867|83276346|FG000|Overall Study|Protocol Violation|3|||
47026644|NCT02024867|83276347|FG001|Overall Study|Protocol Violation|3|||
47026645|NCT02024867|83276346|FG000|Overall Study|Lost to Follow-up|6|||
47026646|NCT02024867|83276347|FG001|Overall Study|Lost to Follow-up|4|||
47026647|NCT01953601|83276356|FG000|Part 1 (Base Study)|Adverse Event|24|||
47026648|NCT01953601|83276357|FG001|Part 1 (Base Study)|Adverse Event|37|||
47026649|NCT01953601|83276358|FG002|Part 1 (Base Study)|Adverse Event|15|||
47026650|NCT01953601|83276356|FG000|Part 1 (Base Study)|Death|2|||
47026651|NCT01953601|83276357|FG001|Part 1 (Base Study)|Death|0|||
47026652|NCT01953601|83276358|FG002|Part 1 (Base Study)|Death|3|||
47026653|NCT01953601|83276356|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
47026654|NCT01953601|83276357|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
47026655|NCT01953601|83276358|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
47026656|NCT01953601|83276356|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
47026657|NCT01953601|83276357|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
47026658|NCT01953601|83276358|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
47026659|NCT01953601|83276356|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
47026660|NCT01953601|83276357|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
47026661|NCT01953601|83276358|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
47026662|NCT01953601|83276356|FG000|Part 1 (Base Study)|Physician Decision|3|||
47026663|NCT01953601|83276357|FG001|Part 1 (Base Study)|Physician Decision|7|||
47026664|NCT01953601|83276358|FG002|Part 1 (Base Study)|Physician Decision|4|||
47026665|NCT01953601|83276356|FG000|Part 1 (Base Study)|Screen failure|1|||
47026666|NCT01953601|83276357|FG001|Part 1 (Base Study)|Screen failure|0|||
47026667|NCT01953601|83276358|FG002|Part 1 (Base Study)|Screen failure|1|||
47026668|NCT01953601|83276356|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
47026669|NCT01953601|83276357|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
47026670|NCT01953601|83276358|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
47026671|NCT01953601|83276356|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
47026672|NCT01953601|83276357|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
47026673|NCT01953601|83276358|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
47026674|NCT01953601|83276356|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
47026675|NCT01953601|83276357|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
47026676|NCT01953601|83276358|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
47026677|NCT01953601|83276356|FG000|Part 1 (Base Study)|Subject moved|2|||
47026678|NCT01953601|83276357|FG001|Part 1 (Base Study)|Subject moved|2|||
47026679|NCT01953601|83276358|FG002|Part 1 (Base Study)|Subject moved|1|||
47026680|NCT01953601|83276356|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
47026681|NCT01953601|83276357|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
46623061|NCT02207244|82779020|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
46623062|NCT02207244|82779021|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
46623063|NCT02207244|82779022|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
46623064|NCT02207244|82779023|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
46623065|NCT02207244|82779024|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
46623066|NCT02207244|82779025|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
46623067|NCT02207244|82779015|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623068|NCT02207244|82779016|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
46623069|NCT02207244|82779017|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
46623070|NCT02207244|82779018|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623071|NCT02207244|82779019|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623072|NCT02207244|82779020|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623073|NCT02207244|82779021|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623074|NCT02207244|82779022|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623075|NCT02207244|82779023|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623076|NCT02207244|82779024|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46623077|NCT02207244|82779025|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
46912183|NCT03011892|83142233|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
47026682|NCT01953601|83276358|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
47026683|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Adverse Event|1|||
47026684|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Adverse Event|1|||
47026685|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Adverse Event|10|||
47026686|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Death|0|||
47026687|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Death|3|||
47026688|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Death|0|||
47026689|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
47026690|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
47026691|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
47026692|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
47026693|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
47026694|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
47026695|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Physician Decision|2|||
47026696|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Physician Decision|0|||
47026697|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Physician Decision|2|||
47026698|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
47026699|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
47026700|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
47026701|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
47026702|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
47026703|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
47026704|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
47026705|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
47026706|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
47026707|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Subject moved|0|||
46912184|NCT03011892|83142234|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
46623078|NCT02207244|82779015|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623079|NCT02207244|82779016|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
46623080|NCT02207244|82779017|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623081|NCT02207244|82779018|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623082|NCT02207244|82779019|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623083|NCT02207244|82779020|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623084|NCT02207244|82779021|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623085|NCT02207244|82779022|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623086|NCT02207244|82779023|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623087|NCT02207244|82779024|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623088|NCT02207244|82779025|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
46623089|NCT02207244|82779015|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
46623090|NCT02207244|82779016|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
46623091|NCT02207244|82779017|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
46623092|NCT02207244|82779018|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
46912185|NCT03011892|83142235|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
46912186|NCT03011892|83142236|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
46912187|NCT03011892|83142237|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
46912188|NCT03011892|83142238|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
47026708|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Subject moved|0|||
46623093|NCT02207244|82779019|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
46623094|NCT02207244|82779020|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
46912189|NCT03011892|83142239|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
46912190|NCT03011892|83142240|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
46623095|NCT02207244|82779021|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
46623096|NCT02207244|82779022|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
47026709|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Subject moved|1|||
47026710|NCT01953601|83276356|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
47026711|NCT01953601|83276357|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
47026712|NCT01953601|83276358|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
47026713|NCT01952665|83276371|FG000|Overall Study|Physician Decision|3|||
47026714|NCT01952665|83276372|FG001|Overall Study|Physician Decision|2|||
47026715|NCT01952665|83276371|FG000|Overall Study|Lost to Follow-up|1|||
47026716|NCT01952665|83276372|FG001|Overall Study|Lost to Follow-up|2|||
47026717|NCT01952665|83276371|FG000|Overall Study|Adverse Event|2|||
47026718|NCT01952665|83276372|FG001|Overall Study|Adverse Event|1|||
47026719|NCT01952665|83276371|FG000|Overall Study|Protocol Violation|0|||
47026720|NCT01952665|83276372|FG001|Overall Study|Protocol Violation|1|||
47026721|NCT01952041|83276383|FG000|Overall Study|Lost to Follow-up|9|||
47026722|NCT01952041|83276384|FG001|Overall Study|Lost to Follow-up|16|||
47026723|NCT01952041|83276383|FG000|Overall Study|Withdrawal by Subject|7|||
47026724|NCT01952041|83276384|FG001|Overall Study|Withdrawal by Subject|5|||
47026725|NCT01952041|83276383|FG000|Overall Study|Death|1|||
47026726|NCT01952041|83276384|FG001|Overall Study|Death|0|||
47026727|NCT01951573|83276390|FG000|Washout Period|Adverse Event|0|||
47026728|NCT01951573|83276391|FG001|Washout Period|Adverse Event|1|||
47026729|NCT02023697|83276400|FG000|Treatment Period|Radiological progression|13|||
47026730|NCT02023697|83276401|FG001|Treatment Period|Radiological progression|17|||
47026731|NCT02023697|83276402|FG002|Treatment Period|Radiological progression|26|||
47026732|NCT02023697|83276400|FG000|Treatment Period|Never Treated|5|||
47026733|NCT02023697|83276401|FG001|Treatment Period|Never Treated|6|||
47026734|NCT02023697|83276402|FG002|Treatment Period|Never Treated|10|||
47026735|NCT02023697|83276400|FG000|Treatment Period|Adverse Event|13|||
47026736|NCT02023697|83276401|FG001|Treatment Period|Adverse Event|25|||
47026737|NCT02023697|83276402|FG002|Treatment Period|Adverse Event|23|||
47026738|NCT02023697|83276400|FG000|Treatment Period|Logistical difficulties|1|||
47026739|NCT02023697|83276401|FG001|Treatment Period|Logistical difficulties|1|||
47026740|NCT02023697|83276402|FG002|Treatment Period|Logistical difficulties|1|||
47026741|NCT02023697|83276400|FG000|Treatment Period|Clinical progression|10|||
47026742|NCT02023697|83276401|FG001|Treatment Period|Clinical progression|8|||
47026743|NCT02023697|83276402|FG002|Treatment Period|Clinical progression|28|||
47026744|NCT02023697|83276400|FG000|Treatment Period|Withdrawal by Subject|4|||
47026745|NCT02023697|83276401|FG001|Treatment Period|Withdrawal by Subject|5|||
47026746|NCT02023697|83276402|FG002|Treatment Period|Withdrawal by Subject|13|||
47026747|NCT02023697|83276400|FG000|Treatment Period|Safety outcome reached|0|||
47026748|NCT02023697|83276401|FG001|Treatment Period|Safety outcome reached|1|||
47026749|NCT02023697|83276402|FG002|Treatment Period|Safety outcome reached|0|||
47026750|NCT02023697|83276400|FG000|Treatment Period|Physician Decision|0|||
47026751|NCT02023697|83276401|FG001|Treatment Period|Physician Decision|0|||
47026752|NCT02023697|83276402|FG002|Treatment Period|Physician Decision|1|||
47026753|NCT02023697|83276400|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
47026754|NCT02023697|83276401|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
47026755|NCT02023697|83276402|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
47026756|NCT02023697|83276400|FG000|Active Follow-up Period|Lost to Follow-up|1|||
47026757|NCT02023697|83276401|FG001|Active Follow-up Period|Lost to Follow-up|1|||
47026758|NCT02023697|83276402|FG002|Active Follow-up Period|Lost to Follow-up|1|||
47026759|NCT02023697|83276400|FG000|Active Follow-up Period|Deterioration of general condition|1|||
47026760|NCT02023697|83276401|FG001|Active Follow-up Period|Deterioration of general condition|1|||
47026761|NCT02023697|83276402|FG002|Active Follow-up Period|Deterioration of general condition|1|||
47026762|NCT02023697|83276400|FG000|Active Follow-up Period|Other unspecified|2|||
47026763|NCT02023697|83276401|FG001|Active Follow-up Period|Other unspecified|0|||
47026764|NCT02023697|83276402|FG002|Active Follow-up Period|Other unspecified|1|||
47026765|NCT02023697|83276400|FG000|Active Follow-up Period|Clinical progression|0|||
47026766|NCT02023697|83276401|FG001|Active Follow-up Period|Clinical progression|2|||
47026767|NCT02023697|83276402|FG002|Active Follow-up Period|Clinical progression|1|||
47026768|NCT02023697|83276400|FG000|Active Follow-up Period|Radiological progression|0|||
47026769|NCT02023697|83276401|FG001|Active Follow-up Period|Radiological progression|0|||
47026770|NCT02023697|83276402|FG002|Active Follow-up Period|Radiological progression|1|||
47026771|NCT02023697|83276400|FG000|Active Follow-up Period|Death|83|||
47026772|NCT02023697|83276401|FG001|Active Follow-up Period|Death|82|||
47026773|NCT02023697|83276402|FG002|Active Follow-up Period|Death|87|||
47026774|NCT02023697|83276400|FG000|Long-term Follow-up Period|Death|9|||
47026775|NCT02023697|83276401|FG001|Long-term Follow-up Period|Death|6|||
47026776|NCT02023697|83276402|FG002|Long-term Follow-up Period|Death|4|||
47026777|NCT02023697|83276400|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
47026778|NCT02023697|83276401|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
47026779|NCT02023697|83276402|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
47026780|NCT02023697|83276400|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
47026781|NCT02023697|83276401|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
47026782|NCT02023697|83276402|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
47026783|NCT02023697|83276400|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
47026784|NCT02023697|83276401|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
47026785|NCT02023697|83276402|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
47026786|NCT02023697|83276400|FG000|Long-term Follow-up Period|Technical problems|0|||
47026787|NCT02023697|83276401|FG001|Long-term Follow-up Period|Technical problems|0|||
47026788|NCT02023697|83276402|FG002|Long-term Follow-up Period|Technical problems|1|||
47026789|NCT02023697|83276400|FG000|Long-term Follow-up Period|Other unspecified|6|||
47026790|NCT02023697|83276401|FG001|Long-term Follow-up Period|Other unspecified|3|||
47026791|NCT02023697|83276402|FG002|Long-term Follow-up Period|Other unspecified|5|||
47026792|NCT01951417|83276417|FG000|Overall Study|Withdrawal by Subject|1|||
47026793|NCT01951417|83276417|FG000|Overall Study|Protocol Violation|2|||
47026794|NCT01951417|83276417|FG000|Overall Study|Lost to Follow-up|6|||
47026795|NCT01951261|83276427|FG000|Overall Study|Death|1|||
47026796|NCT01951261|83276428|FG001|Overall Study|Death|0|||
47026797|NCT01951261|83276427|FG000|Overall Study|Lost to Follow-up|4|||
47026798|NCT01951261|83276428|FG001|Overall Study|Lost to Follow-up|3|||
47026799|NCT01951261|83276427|FG000|Overall Study|Protocol Violation|4|||
47026800|NCT01951261|83276428|FG001|Overall Study|Protocol Violation|3|||
47026801|NCT02023151|83276434|FG000|Overall Study|Lost to Follow-up|4|||
47026802|NCT01979185|83276440|FG000|Period 2|Other|0|||
47026803|NCT01979185|83276441|FG001|Period 2|Other|1|||
47026804|NCT01946425|83276449|FG000|Overall Study|Protocol Violation|1|||
47026805|NCT01946425|83276450|FG001|Overall Study|Protocol Violation|0|||
47026806|NCT01946425|83276449|FG000|Overall Study|Withdrawal by Subject|1|||
47026807|NCT01946425|83276450|FG001|Overall Study|Withdrawal by Subject|0|||
47026808|NCT01946191|83276459|FG000|Allocation|Did not complete orientation|1|||
47026809|NCT01946191|83276460|FG001|Allocation|Did not complete orientation|1|||
47026810|NCT01946191|83276459|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
47026811|NCT01946191|83276460|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
47026812|NCT01946191|83276459|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
47026813|NCT01946191|83276460|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
47026814|NCT01946191|83276459|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
47026815|NCT01946191|83276460|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
47026816|NCT01937312|83276469|FG000|Overall Study|Adverse Event|10|||
47026817|NCT01937312|83276470|FG001|Overall Study|Adverse Event|1|||
47026818|NCT01937312|83276469|FG000|Overall Study|Lack of Efficacy|0|||
47026819|NCT01937312|83276470|FG001|Overall Study|Lack of Efficacy|1|||
47026820|NCT01937312|83276469|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
47026821|NCT01937312|83276470|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
47026822|NCT01935128|83276477|FG000|Overall Study|Death|1|||
47026823|NCT01935128|83276477|FG000|Overall Study|Adverse Event|6|||
47026824|NCT01934972|83276483|FG000|Overall Study|Withdrawal by Subject|9|||
47026825|NCT01934972|83276484|FG001|Overall Study|Withdrawal by Subject|6|||
47026826|NCT01959230|83276492|FG000|Overall Study|Failure to follow study procedures|0|||
47026827|NCT01959230|83276493|FG001|Overall Study|Failure to follow study procedures|1|||
47026828|NCT01959230|83276492|FG000|Overall Study|Administrative reasons|2|||
47026829|NCT01959230|83276493|FG001|Overall Study|Administrative reasons|0|||
47026830|NCT01959230|83276492|FG000|Overall Study|Withdrawal by Subject|2|||
47026831|NCT01959230|83276493|FG001|Overall Study|Withdrawal by Subject|0|||
47026832|NCT01909778|83276499|FG000|Overall Study|failed screening|1|||
47026833|NCT01977937|83276507|FG000|Overall Study|Withdrawal by Subject|2|||
47026834|NCT01977937|83276508|FG001|Overall Study|Withdrawal by Subject|1|||
47026835|NCT01977937|83276507|FG000|Overall Study|Adverse Event|1|||
47026836|NCT01977937|83276508|FG001|Overall Study|Adverse Event|0|||
47026837|NCT01977937|83276507|FG000|Overall Study|Physician Decision|0|||
47026838|NCT01977937|83276508|FG001|Overall Study|Physician Decision|1|||
47026839|NCT02015663|83276516|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
47026840|NCT02015663|83276517|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
47026841|NCT02015663|83276516|FG000|Overall Study|Withdrawal by Subject|1|||
47026842|NCT02015663|83276517|FG001|Overall Study|Withdrawal by Subject|0|||
47026843|NCT02015663|83276516|FG000|Overall Study|Protocol Violation|0|||
47026844|NCT02015663|83276517|FG001|Overall Study|Protocol Violation|1|||
47026845|NCT02015663|83276516|FG000|Overall Study|Adverse Event|3|||
47026846|NCT02015663|83276517|FG001|Overall Study|Adverse Event|0|||
46912191|NCT03011892|83142241|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
46912192|NCT03011892|83142242|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
47026847|NCT02015663|83276516|FG000|Overall Study|Administrative problems|10|||
47026848|NCT02015663|83276517|FG001|Overall Study|Administrative problems|11|||
47026849|NCT01978093|83276526|FG000|Overall Study|Death|1|||
47026850|NCT01978093|83276527|FG001|Overall Study|Death|0|||
47026851|NCT01978093|83276526|FG000|Overall Study|Adverse Event|0|||
47026852|NCT01978093|83276527|FG001|Overall Study|Adverse Event|5|||
47026853|NCT01978093|83276526|FG000|Overall Study|Protocol Violation|8|||
47026854|NCT01978093|83276527|FG001|Overall Study|Protocol Violation|2|||
47026855|NCT01978093|83276526|FG000|Overall Study|Withdrawal by Subject|29|||
47026856|NCT01978093|83276527|FG001|Overall Study|Withdrawal by Subject|25|||
47026857|NCT01978093|83276526|FG000|Overall Study|Lost to Follow-up|11|||
47026858|NCT01978093|83276527|FG001|Overall Study|Lost to Follow-up|15|||
47026859|NCT01978093|83276526|FG000|Overall Study|Migrated/moved from study area|11|||
47026860|NCT01978093|83276527|FG001|Overall Study|Migrated/moved from study area|13|||
47026861|NCT01978093|83276526|FG000|Overall Study|Loss of kaiser coverage|4|||
47026862|NCT01978093|83276527|FG001|Overall Study|Loss of kaiser coverage|10|||
47026863|NCT01978093|83276526|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
47026864|NCT01978093|83276527|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
47026865|NCT01978093|83276526|FG000|Overall Study|Mother lost custody of child|0|||
47026866|NCT01978093|83276527|FG001|Overall Study|Mother lost custody of child|1|||
47026867|NCT01978093|83276526|FG000|Overall Study|Child was in care of grandmother|0|||
47026868|NCT01978093|83276527|FG001|Overall Study|Child was in care of grandmother|1|||
47026869|NCT01978093|83276526|FG000|Overall Study|N/A for vaccine administration|0|||
47026870|NCT01978093|83276527|FG001|Overall Study|N/A for vaccine administration|1|||
47026871|NCT01951105|83276539|FG000|Overall Study|Adverse Event|0|||
47026872|NCT01951105|83276540|FG001|Overall Study|Adverse Event|5|||
47026873|NCT01951105|83276541|FG002|Overall Study|Adverse Event|0|||
47026874|NCT01951105|83276539|FG000|Overall Study|Lost to Follow-up|0|||
47026875|NCT01951105|83276540|FG001|Overall Study|Lost to Follow-up|1|||
47026876|NCT01951105|83276541|FG002|Overall Study|Lost to Follow-up|0|||
47026877|NCT01951105|83276539|FG000|Overall Study|Protocol Violation|1|||
47026878|NCT01951105|83276540|FG001|Overall Study|Protocol Violation|1|||
47026879|NCT01951105|83276541|FG002|Overall Study|Protocol Violation|1|||
47026880|NCT01951105|83276539|FG000|Overall Study|Withdrawal by Subject|0|||
47026881|NCT01951105|83276540|FG001|Overall Study|Withdrawal by Subject|3|||
47026882|NCT01951105|83276541|FG002|Overall Study|Withdrawal by Subject|1|||
47026883|NCT01958918|83276557|FG000|Overall Study|Death|1|||
47026884|NCT01958918|83276558|FG001|Overall Study|Death|3|||
47026885|NCT01958918|83276557|FG000|Overall Study|Lost to Follow-up|4|||
47026886|NCT01958918|83276558|FG001|Overall Study|Lost to Follow-up|7|||
47026887|NCT01958918|83276557|FG000|Overall Study|Withdrawal by Subject|13|||
47026888|NCT01958918|83276558|FG001|Overall Study|Withdrawal by Subject|8|||
47026889|NCT01958918|83276557|FG000|Overall Study|Lack of Efficacy|13|||
47026890|NCT01958918|83276558|FG001|Overall Study|Lack of Efficacy|10|||
47026891|NCT01958918|83276557|FG000|Overall Study|Adverse Event|12|||
47026892|NCT01958918|83276558|FG001|Overall Study|Adverse Event|12|||
47026893|NCT01958918|83276557|FG000|Overall Study|administrative problems|0|||
47026894|NCT01958918|83276558|FG001|Overall Study|administrative problems|2|||
47026895|NCT01945489|83276566|FG000|Cycle 1|Adverse Event|2|||
47026896|NCT01945489|83276567|FG001|Cycle 1|Adverse Event|0|||
47026897|NCT01945489|83276566|FG000|Cycle 1|Lost to Follow-up|4|||
47026898|NCT01945489|83276567|FG001|Cycle 1|Lost to Follow-up|0|||
47026899|NCT01945489|83276566|FG000|Cycle 1|Personal Reasons|4|||
47026900|NCT01945489|83276567|FG001|Cycle 1|Personal Reasons|2|||
47026901|NCT01945489|83276566|FG000|Cycle 1|Protocol Violation|0|||
47026902|NCT01945489|83276567|FG001|Cycle 1|Protocol Violation|1|||
47026903|NCT01945489|83276566|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
47026904|NCT01945489|83276567|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
47026905|NCT01945489|83276566|FG000|Cycle 2|Adverse Event|1|||
47026906|NCT01945489|83276567|FG001|Cycle 2|Adverse Event|0|||
47026907|NCT01945489|83276566|FG000|Cycle 2|Lost to Follow-up|0|||
47026908|NCT01945489|83276567|FG001|Cycle 2|Lost to Follow-up|1|||
47026909|NCT01934894|83276576|FG000|Overall Study|Adverse Event|1|||
47026910|NCT01934894|83276577|FG001|Overall Study|Adverse Event|2|||
47026911|NCT01934894|83276576|FG000|Overall Study|Death|2|||
47026912|NCT01934894|83276577|FG001|Overall Study|Death|0|||
47026913|NCT01934894|83276576|FG000|Overall Study|Withdrawal by Subject|0|||
47026914|NCT01934894|83276577|FG001|Overall Study|Withdrawal by Subject|1|||
47026915|NCT01934894|83276576|FG000|Overall Study|Progressive Disease|3|||
47026916|NCT01934894|83276577|FG001|Overall Study|Progressive Disease|2|||
47026917|NCT01950169|83276589|FG000|Overall Study|Withdrawal by Subject|2|||
47026918|NCT01950169|83276590|FG001|Overall Study|Withdrawal by Subject|8|||
47026919|NCT01950169|83276591|FG002|Overall Study|Withdrawal by Subject|1|||
47026920|NCT01950169|83276589|FG000|Overall Study|Death|1|||
47026921|NCT01950169|83276590|FG001|Overall Study|Death|0|||
47026922|NCT01950169|83276591|FG002|Overall Study|Death|0|||
47026923|NCT01934504|83276604|FG000|Overall Study|Protocol Deviation|0|||
47026924|NCT01934504|83276605|FG001|Overall Study|Protocol Deviation|0|||
47026925|NCT01934504|83276606|FG002|Overall Study|Protocol Deviation|0|||
47026926|NCT01934504|83276607|FG003|Overall Study|Protocol Deviation|2|||
47026927|NCT01934504|83276604|FG000|Overall Study|Study Terminated by Sponsor|1|||
47026928|NCT01934504|83276605|FG001|Overall Study|Study Terminated by Sponsor|0|||
46641230|NCT04627038|82825244|FG000|Overall Study|Physician Decision|0|||
47026929|NCT01934504|83276606|FG002|Overall Study|Study Terminated by Sponsor|5|||
47026930|NCT01934504|83276607|FG003|Overall Study|Study Terminated by Sponsor|5|||
47026931|NCT01950013|83276620|FG000|Overall Study|Withdrawal by Subject|0|||
47026932|NCT01950013|83276621|FG001|Overall Study|Withdrawal by Subject|2|||
47026933|NCT01950013|83276622|FG002|Overall Study|Withdrawal by Subject|0|||
47026934|NCT01949155|83276632|FG000|Overall Study|Lost to Follow-up|1|||
47026935|NCT01949155|83276633|FG001|Overall Study|Lost to Follow-up|0|||
46641231|NCT04627038|82825245|FG001|Overall Study|Physician Decision|1|||
47026936|NCT01949155|83276632|FG000|Overall Study|Protocol Violation|1|||
47026937|NCT01949155|83276633|FG001|Overall Study|Protocol Violation|0|||
47026938|NCT01909466|83276640|FG000|Overall Study|Lost to Follow-up|5|||
47026939|NCT01909466|83276641|FG001|Overall Study|Lost to Follow-up|7|||
47026940|NCT01909466|83276640|FG000|Overall Study|Adverse Event|3|||
47026941|NCT01909466|83276641|FG001|Overall Study|Adverse Event|4|||
47026942|NCT01909466|83276640|FG000|Overall Study|Met Withdrawal Criteria|0|||
47026943|NCT01909466|83276641|FG001|Overall Study|Met Withdrawal Criteria|3|||
47026944|NCT01909466|83276640|FG000|Overall Study|Physician Decision|2|||
47026945|NCT01909466|83276641|FG001|Overall Study|Physician Decision|0|||
47026946|NCT01909466|83276640|FG000|Overall Study|Withdrawal by Subject|11|||
47026947|NCT01909466|83276641|FG001|Overall Study|Withdrawal by Subject|9|||
47026948|NCT01909466|83276640|FG000|Overall Study|Lack of Efficacy|1|||
47026949|NCT01909466|83276641|FG001|Overall Study|Lack of Efficacy|0|||
47026950|NCT01977625|83276645|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
47026951|NCT01977625|83276646|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
47026952|NCT01977625|83276645|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
47026953|NCT01977625|83276646|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
47026954|NCT01944631|83276656|FG000|Overall Study|Adverse Event|1|||
47026955|NCT01944631|83276657|FG001|Overall Study|Adverse Event|0|||
47026956|NCT01944631|83276656|FG000|Overall Study|Lost to Follow-up|3|||
47026957|NCT01944631|83276657|FG001|Overall Study|Lost to Follow-up|1|||
47026958|NCT01944631|83276656|FG000|Overall Study|Withdrawal by Subject|0|||
47026959|NCT01944631|83276657|FG001|Overall Study|Withdrawal by Subject|1|||
47026960|NCT01948063|83276665|FG000|Overall Study|Boston MCI halted research protocol|0|||
47026961|NCT01948063|83276666|FG001|Overall Study|Boston MCI halted research protocol|1|||
47026962|NCT01948063|83276665|FG000|Overall Study|Discovered an enrollment in other study|0|||
47026963|NCT01948063|83276666|FG001|Overall Study|Discovered an enrollment in other study|1|||
47026964|NCT01948063|83276665|FG000|Overall Study|Blood samples were accidentally thawed|1|||
47026965|NCT01948063|83276666|FG001|Overall Study|Blood samples were accidentally thawed|0|||
47026966|NCT01995071|83276684|FG000|Overall Study|Adverse Event|0|||
47026967|NCT01995071|83276685|FG001|Overall Study|Adverse Event|0|||
47026968|NCT01995071|83276686|FG002|Overall Study|Adverse Event|0|||
47026969|NCT01995071|83276687|FG003|Overall Study|Adverse Event|0|||
47026970|NCT01995071|83276688|FG004|Overall Study|Adverse Event|0|||
47026971|NCT01995071|83276689|FG005|Overall Study|Adverse Event|0|||
47026972|NCT01995071|83276690|FG006|Overall Study|Adverse Event|1|||
47026973|NCT01995071|83276691|FG007|Overall Study|Adverse Event|0|||
47026974|NCT01995071|83276692|FG008|Overall Study|Adverse Event|0|||
47026975|NCT01995071|83276693|FG009|Overall Study|Adverse Event|0|||
47026976|NCT01995071|83276694|FG010|Overall Study|Adverse Event|0|||
47026977|NCT01995071|83276695|FG011|Overall Study|Adverse Event|0|||
47026978|NCT01995071|83276684|FG000|Overall Study|Moved|0|||
47026979|NCT01995071|83276685|FG001|Overall Study|Moved|0|||
47026980|NCT01995071|83276686|FG002|Overall Study|Moved|1|||
47026981|NCT01995071|83276687|FG003|Overall Study|Moved|0|||
47026982|NCT01995071|83276688|FG004|Overall Study|Moved|1|||
47026983|NCT01995071|83276689|FG005|Overall Study|Moved|0|||
47026984|NCT01995071|83276690|FG006|Overall Study|Moved|0|||
47026985|NCT01995071|83276691|FG007|Overall Study|Moved|0|||
47026986|NCT01995071|83276692|FG008|Overall Study|Moved|0|||
47026987|NCT01995071|83276693|FG009|Overall Study|Moved|0|||
47026988|NCT01995071|83276694|FG010|Overall Study|Moved|1|||
47026989|NCT01995071|83276695|FG011|Overall Study|Moved|0|||
47026990|NCT01995071|83276684|FG000|Overall Study|Lost to Follow-up|1|||
47026991|NCT01995071|83276685|FG001|Overall Study|Lost to Follow-up|0|||
47026992|NCT01995071|83276686|FG002|Overall Study|Lost to Follow-up|0|||
47026993|NCT01995071|83276687|FG003|Overall Study|Lost to Follow-up|0|||
47026994|NCT01995071|83276688|FG004|Overall Study|Lost to Follow-up|0|||
47026995|NCT01995071|83276689|FG005|Overall Study|Lost to Follow-up|0|||
47026996|NCT01995071|83276690|FG006|Overall Study|Lost to Follow-up|0|||
47026997|NCT01995071|83276691|FG007|Overall Study|Lost to Follow-up|1|||
47026998|NCT01995071|83276692|FG008|Overall Study|Lost to Follow-up|1|||
47026999|NCT01995071|83276693|FG009|Overall Study|Lost to Follow-up|0|||
47027000|NCT01995071|83276694|FG010|Overall Study|Lost to Follow-up|0|||
47027001|NCT01995071|83276695|FG011|Overall Study|Lost to Follow-up|0|||
47027002|NCT01995071|83276684|FG000|Overall Study|Incarcerated|0|||
47027003|NCT01995071|83276685|FG001|Overall Study|Incarcerated|0|||
47027004|NCT01995071|83276686|FG002|Overall Study|Incarcerated|0|||
47027005|NCT01995071|83276687|FG003|Overall Study|Incarcerated|0|||
47027006|NCT01995071|83276688|FG004|Overall Study|Incarcerated|0|||
47027007|NCT01995071|83276689|FG005|Overall Study|Incarcerated|0|||
47027008|NCT01995071|83276690|FG006|Overall Study|Incarcerated|0|||
47027009|NCT01995071|83276691|FG007|Overall Study|Incarcerated|1|||
47027010|NCT01995071|83276692|FG008|Overall Study|Incarcerated|0|||
46710230|NCT00960531|82926377|FG000|Overall Study|Withdrawal by Subject|1|||
47027011|NCT01995071|83276693|FG009|Overall Study|Incarcerated|0|||
47027012|NCT01995071|83276694|FG010|Overall Study|Incarcerated|0|||
47027013|NCT01995071|83276695|FG011|Overall Study|Incarcerated|0|||
47027014|NCT01994837|83276727|FG000|Overall Study|Progressive disease per protocol|23|||
47027015|NCT01994837|83276727|FG000|Overall Study|Adv event related to progressive disease|3|||
47027016|NCT01994837|83276727|FG000|Overall Study|Fatal progressive disease|2|||
47027017|NCT01994837|83276727|FG000|Overall Study|Adverse event not related to progression|1|||
47027018|NCT01994837|83276727|FG000|Overall Study|Chose palliative care|1|||
47027019|NCT01994837|83276727|FG000|Overall Study|Proceeded to transplant|1|||
47027020|NCT01994837|83276727|FG000|Overall Study|Removed from study due to no response|1|||
47027021|NCT02010593|83276733|FG000|Overall Study|Lost to Follow-up|1|||
47027022|NCT02010593|83276734|FG001|Overall Study|Lost to Follow-up|0|||
47027023|NCT02010593|83276733|FG000|Overall Study|Physician Decision|1|||
47027024|NCT02010593|83276734|FG001|Overall Study|Physician Decision|0|||
47027025|NCT02010593|83276733|FG000|Overall Study|Unable to adhere to visit schedule|0|||
47027026|NCT02010593|83276734|FG001|Overall Study|Unable to adhere to visit schedule|2|||
47027027|NCT01994291|83276743|FG000|Overall Study|Adverse Event|4|||
47027028|NCT01994291|83276744|FG001|Overall Study|Adverse Event|1|||
47027029|NCT01994291|83276745|FG002|Overall Study|Adverse Event|3|||
47027030|NCT01994291|83276743|FG000|Overall Study|Lost to Follow-up|1|||
47027031|NCT01994291|83276744|FG001|Overall Study|Lost to Follow-up|1|||
47027032|NCT01994291|83276745|FG002|Overall Study|Lost to Follow-up|0|||
47027033|NCT01994291|83276743|FG000|Overall Study|Does not meet entrance criteria|1|||
47027034|NCT01994291|83276744|FG001|Overall Study|Does not meet entrance criteria|0|||
47027035|NCT01994291|83276745|FG002|Overall Study|Does not meet entrance criteria|0|||
47027036|NCT01994291|83276743|FG000|Overall Study|Medication error without associated AE|1|||
47027037|NCT01994291|83276744|FG001|Overall Study|Medication error without associated AE|0|||
47027038|NCT01994291|83276745|FG002|Overall Study|Medication error without associated AE|1|||
47027039|NCT01994291|83276743|FG000|Overall Study|Protocol Violation|1|||
47027040|NCT01994291|83276744|FG001|Overall Study|Protocol Violation|0|||
47027041|NCT01994291|83276745|FG002|Overall Study|Protocol Violation|0|||
47027042|NCT01994291|83276743|FG000|Overall Study|Withdrawal by Subject|6|||
47027043|NCT01994291|83276744|FG001|Overall Study|Withdrawal by Subject|3|||
47027044|NCT01994291|83276745|FG002|Overall Study|Withdrawal by Subject|5|||
47027045|NCT01994291|83276743|FG000|Overall Study|Other|1|||
47027046|NCT01994291|83276744|FG001|Overall Study|Other|2|||
47027047|NCT01994291|83276745|FG002|Overall Study|Other|0|||
47027048|NCT02094677|83276756|FG000|Overall Study|Screening|3|||
47027049|NCT02094677|83276757|FG001|Overall Study|Screening|1|||
47027050|NCT01993823|83276772|FG000|Overall Study|Requested by the patient|6|||
47027051|NCT01993823|83276773|FG001|Overall Study|Requested by the patient|11|||
47027052|NCT01993823|83276772|FG000|Overall Study|Protocol Violation|0|||
47027053|NCT01993823|83276773|FG001|Overall Study|Protocol Violation|1|||
47027054|NCT01993823|83276772|FG000|Overall Study|Lost to Follow-up|1|||
47027055|NCT01993823|83276773|FG001|Overall Study|Lost to Follow-up|4|||
47027056|NCT01993667|83276781|FG000|Overall Study|Insufficient data to analyze|16|||
47027057|NCT01993667|83276782|FG001|Overall Study|Insufficient data to analyze|16|||
47027058|NCT01993667|83276781|FG000|Overall Study|Insufficient altitude reached|3|||
47027059|NCT01993667|83276782|FG001|Overall Study|Insufficient altitude reached|1|||
47027060|NCT01993667|83276781|FG000|Overall Study|Lost to Follow-up|2|||
47027061|NCT01993667|83276782|FG001|Overall Study|Lost to Follow-up|2|||
47027062|NCT01992107|83276791|FG000|Overall Study|Administrative reasons|2|||
47027063|NCT01992107|83276792|FG001|Overall Study|Administrative reasons|0|||
47027064|NCT01992107|83276793|FG002|Overall Study|Administrative reasons|0|||
47027065|NCT01992107|83276791|FG000|Overall Study|Adverse Event|0|||
47027066|NCT01992107|83276792|FG001|Overall Study|Adverse Event|1|||
47027067|NCT01992107|83276793|FG002|Overall Study|Adverse Event|0|||
47027068|NCT01992107|83276791|FG000|Overall Study|Lost to Follow-up|46|||
47027069|NCT01992107|83276792|FG001|Overall Study|Lost to Follow-up|22|||
47027070|NCT01992107|83276793|FG002|Overall Study|Lost to Follow-up|26|||
47027071|NCT01992107|83276791|FG000|Overall Study|noncompliance and were unavailable|7|||
47027072|NCT01992107|83276792|FG001|Overall Study|noncompliance and were unavailable|3|||
47027073|NCT01992107|83276793|FG002|Overall Study|noncompliance and were unavailable|2|||
47027074|NCT01992107|83276791|FG000|Overall Study|Withdrawal by Subject|13|||
47027075|NCT01992107|83276792|FG001|Overall Study|Withdrawal by Subject|7|||
47027076|NCT01992107|83276793|FG002|Overall Study|Withdrawal by Subject|8|||
47027077|NCT01934192|83276822|FG000|Overall Study|Protocol Violation|0|||
46623097|NCT02207244|82779023|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
47027078|NCT01934192|83276823|FG001|Overall Study|Protocol Violation|0|||
47027079|NCT01934192|83276824|FG002|Overall Study|Protocol Violation|0|||
47027080|NCT01934192|83276825|FG003|Overall Study|Protocol Violation|1|||
47027081|NCT01934192|83276822|FG000|Overall Study|Other: reached stopping criteria|6|||
47027082|NCT01934192|83276823|FG001|Overall Study|Other: reached stopping criteria|5|||
47027083|NCT01934192|83276824|FG002|Overall Study|Other: reached stopping criteria|1|||
47027084|NCT01934192|83276825|FG003|Overall Study|Other: reached stopping criteria|0|||
47027085|NCT01934192|83276822|FG000|Overall Study|Physician Decision|3|||
47027086|NCT01934192|83276823|FG001|Overall Study|Physician Decision|2|||
47027087|NCT01934192|83276824|FG002|Overall Study|Physician Decision|0|||
47027088|NCT01934192|83276825|FG003|Overall Study|Physician Decision|0|||
47027089|NCT01933880|83276848|FG000|Overall Study|Withdrawal by Subject|5|||
46623098|NCT02207244|82779024|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
46623099|NCT02207244|82779025|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
46623100|NCT02207244|82779015|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623101|NCT02207244|82779016|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623102|NCT02207244|82779017|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623103|NCT02207244|82779018|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623104|NCT02207244|82779019|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
47027090|NCT01933880|83276849|FG001|Overall Study|Withdrawal by Subject|0|||
47027091|NCT01933880|83276848|FG000|Overall Study|Lack of Efficacy|1|||
47027092|NCT01933880|83276849|FG001|Overall Study|Lack of Efficacy|0|||
47027093|NCT01933880|83276848|FG000|Overall Study|Concomitant medication Interference|0|||
47027094|NCT01933880|83276849|FG001|Overall Study|Concomitant medication Interference|1|||
47027095|NCT01933880|83276848|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
47027096|NCT01933880|83276849|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
47027097|NCT01933880|83276848|FG000|Overall Study|Other|4|||
47027098|NCT01933880|83276849|FG001|Overall Study|Other|0|||
47027099|NCT01933880|83276848|FG000|Overall Study|Protocol Violation|1|||
47027100|NCT01933880|83276849|FG001|Overall Study|Protocol Violation|0|||
47027101|NCT02008877|83276860|FG000|Overall Study|Inevaluable|0|||
47027102|NCT02008877|83276861|FG001|Overall Study|Inevaluable|1|||
47027103|NCT02008877|83276862|FG002|Overall Study|Inevaluable|0|||
47027104|NCT01933334|83276873|FG000|Overall Study|Adverse Event|5|||
47027105|NCT01933334|83276874|FG001|Overall Study|Adverse Event|1|||
47027106|NCT01933334|83276873|FG000|Overall Study|Withdrawal by Subject|0|||
47027107|NCT01933334|83276874|FG001|Overall Study|Withdrawal by Subject|1|||
47027108|NCT01908140|83276882|FG000|Overall Study|Other or Progressive Disease|5|||
47027109|NCT01908140|83276883|FG001|Overall Study|Other or Progressive Disease|12|||
47027110|NCT01908140|83276882|FG000|Overall Study|Lack of Efficacy|7|||
47027111|NCT01908140|83276883|FG001|Overall Study|Lack of Efficacy|5|||
47027112|NCT01908140|83276882|FG000|Overall Study|Withdrawal by Subject|23|||
47027113|NCT01908140|83276883|FG001|Overall Study|Withdrawal by Subject|24|||
47027114|NCT01908140|83276882|FG000|Overall Study|Lost to Follow-up|1|||
46641232|NCT04627038|82825244|FG000|Overall Study|Protocol Violation|3|||
47027115|NCT01908140|83276883|FG001|Overall Study|Lost to Follow-up|6|||
47027116|NCT01908140|83276882|FG000|Overall Study|Protocol Violation|8|||
47027117|NCT01908140|83276883|FG001|Overall Study|Protocol Violation|9|||
46623105|NCT02207244|82779020|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
46623106|NCT02207244|82779021|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623107|NCT02207244|82779022|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623108|NCT02207244|82779023|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623109|NCT02207244|82779024|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623110|NCT02207244|82779025|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
46623111|NCT02207244|82779015|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623112|NCT02207244|82779016|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623113|NCT02207244|82779017|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623114|NCT02207244|82779018|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
46623115|NCT02207244|82779019|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
46623116|NCT02207244|82779020|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
46623117|NCT02207244|82779021|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623118|NCT02207244|82779022|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623119|NCT02207244|82779023|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623120|NCT02207244|82779024|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623121|NCT02207244|82779025|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
46623122|NCT02207244|82779015|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
46623123|NCT02207244|82779016|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
46623124|NCT02207244|82779017|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
47027118|NCT01908140|83276882|FG000|Overall Study|Adverse Event|22|||
47027119|NCT01908140|83276883|FG001|Overall Study|Adverse Event|23|||
47027120|NCT02008565|83276893|FG000|Overall Study|Protocol Violation|1|||
47027121|NCT02008565|83276894|FG001|Overall Study|Protocol Violation|1|||
47027122|NCT02008565|83276895|FG002|Overall Study|Protocol Violation|2|||
47027123|NCT02008565|83276896|FG003|Overall Study|Protocol Violation|0|||
47027124|NCT01907906|83276910|FG000|Overall Study|Withdrawal by Subject|1|||
47027125|NCT01907906|83276911|FG001|Overall Study|Withdrawal by Subject|0|||
47027126|NCT01907906|83276910|FG000|Overall Study|Physician Decision|3|||
46623125|NCT02207244|82779018|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
46623126|NCT02207244|82779019|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
47027127|NCT01907906|83276911|FG001|Overall Study|Physician Decision|1|||
47027128|NCT01907828|83276921|FG000|Overall Study|Exclusion criteria not met|0|||
47027129|NCT01907828|83276922|FG001|Overall Study|Exclusion criteria not met|1|||
47027130|NCT01907828|83276921|FG000|Overall Study|Withdrawal by Subject|3|||
46912193|NCT03011892|83142243|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
47027131|NCT01907828|83276922|FG001|Overall Study|Withdrawal by Subject|4|||
47027132|NCT01907828|83276921|FG000|Overall Study|Lost to Follow-up|3|||
47027133|NCT01907828|83276922|FG001|Overall Study|Lost to Follow-up|0|||
46623127|NCT02207244|82779020|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
46710231|NCT00960531|82926378|FG001|Overall Study|Withdrawal by Subject|0|||
46710232|NCT00960531|82926379|FG002|Overall Study|Withdrawal by Subject|5|||
46710233|NCT00960531|82926380|FG003|Overall Study|Withdrawal by Subject|2|||
46710234|NCT00960531|82926381|FG004|Overall Study|Withdrawal by Subject|0|||
46710235|NCT00960531|82926382|FG005|Overall Study|Withdrawal by Subject|0|||
46710236|NCT00960531|82926383|FG006|Overall Study|Withdrawal by Subject|2|||
46710237|NCT00960531|82926384|FG007|Overall Study|Withdrawal by Subject|0|||
46710238|NCT00960531|82926385|FG008|Overall Study|Withdrawal by Subject|1|||
46710239|NCT00960531|82926386|FG009|Overall Study|Withdrawal by Subject|0|||
46710240|NCT00960531|82926377|FG000|Overall Study|Caregiver Request|2|||
46710241|NCT00960531|82926378|FG001|Overall Study|Caregiver Request|0|||
46710242|NCT00960531|82926379|FG002|Overall Study|Caregiver Request|6|||
46710243|NCT00960531|82926380|FG003|Overall Study|Caregiver Request|5|||
47027134|NCT01907828|83276921|FG000|Overall Study|Participant refused 24-month follow-up|1|||
47027135|NCT01907828|83276922|FG001|Overall Study|Participant refused 24-month follow-up|0|||
47027136|NCT01907828|83276921|FG000|Overall Study|Participant met exclusion criteria|0|||
46623128|NCT02207244|82779021|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
46623129|NCT02207244|82779022|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
46623130|NCT02207244|82779023|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
46623131|NCT02207244|82779024|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
46623132|NCT02207244|82779025|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
46623133|NCT02207244|82779015|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623134|NCT02207244|82779016|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623135|NCT02207244|82779017|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623136|NCT02207244|82779018|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
46623137|NCT02207244|82779019|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623138|NCT02207244|82779020|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
46623139|NCT02207244|82779021|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623140|NCT02207244|82779022|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623141|NCT02207244|82779023|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623142|NCT02207244|82779024|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623143|NCT02207244|82779025|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
46623144|NCT02207244|82779015|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623145|NCT02207244|82779016|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623146|NCT02207244|82779017|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623147|NCT02207244|82779018|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
46623148|NCT02207244|82779019|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623149|NCT02207244|82779020|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623150|NCT02207244|82779021|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623151|NCT02207244|82779022|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623152|NCT02207244|82779023|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623153|NCT02207244|82779024|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623154|NCT02207244|82779025|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
46623155|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
47027137|NCT01907828|83276922|FG001|Overall Study|Participant met exclusion criteria|1|||
47027138|NCT01907516|83276930|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
47027139|NCT01907516|83276931|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
47027140|NCT01907516|83276930|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
47027141|NCT01907516|83276931|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
47027142|NCT01907516|83276930|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
47027143|NCT01907516|83276931|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
46623156|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
46623157|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
46623158|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
46623159|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
46710244|NCT00960531|82926381|FG004|Overall Study|Caregiver Request|0|||
46710245|NCT00960531|82926382|FG005|Overall Study|Caregiver Request|2|||
46710246|NCT00960531|82926383|FG006|Overall Study|Caregiver Request|3|||
46710247|NCT00960531|82926384|FG007|Overall Study|Caregiver Request|1|||
46623160|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
46623161|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
46623162|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
46623163|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
46623164|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
46623165|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
46623166|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623167|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623168|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623169|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623170|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623171|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623172|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623173|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
46623174|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623175|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623176|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
46623177|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
46623178|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
46623179|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
46623180|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
46623181|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
46623182|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
46623183|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
46623184|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
46623185|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
46623186|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
46623187|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
46623188|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623189|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623190|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623191|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623192|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623193|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623194|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
46623195|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
46623196|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623197|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
46623198|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
46623199|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
46623200|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
46623201|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
46623202|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
46623203|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
46623204|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
46623205|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
46623206|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
46623207|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
46623208|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
46623209|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
46623210|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623211|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623212|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623213|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623214|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623215|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623216|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623217|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
46623218|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
46623219|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46623220|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
46912194|NCT03011892|83142232|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
46623221|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623222|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623223|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623224|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623225|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623226|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623227|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623228|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623229|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
46623230|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623231|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
46623232|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623233|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623234|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623235|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623236|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623237|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623238|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623239|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
47027144|NCT01907516|83276930|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
47027145|NCT01907516|83276931|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
47027146|NCT01931462|83276938|FG000|Overall Study|Withdrawal by Subject|1|||
47027147|NCT01931150|83276944|FG000|Overall Study|Withdrawal by Subject|1|||
47027148|NCT01931150|83276945|FG001|Overall Study|Withdrawal by Subject|2|||
47027149|NCT01930214|83276954|FG000|Overall Study|Death|4|||
47027150|NCT01930214|83276955|FG001|Overall Study|Death|4|||
46623240|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
47027151|NCT01930214|83276956|FG002|Overall Study|Death|11|||
47027152|NCT01930214|83276954|FG000|Overall Study|Lost to Follow-up|12|||
47027153|NCT01930214|83276955|FG001|Overall Study|Lost to Follow-up|13|||
47027154|NCT01930214|83276956|FG002|Overall Study|Lost to Follow-up|12|||
47027155|NCT01930214|83276954|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
47027156|NCT01930214|83276955|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
47027157|NCT01930214|83276956|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
47027158|NCT01930214|83276954|FG000|Overall Study|Physician Decision|2|||
47027159|NCT01930214|83276955|FG001|Overall Study|Physician Decision|0|||
46623241|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623242|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
46623243|NCT02207244|82779015|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46641233|NCT04627038|82825245|FG001|Overall Study|Protocol Violation|1|||
47027160|NCT01930214|83276956|FG002|Overall Study|Physician Decision|0|||
47027161|NCT01958294|83276964|FG000|Overall Study|Clinical Circumstances|2|||
47027162|NCT01906346|83276968|FG000|Overall Study|AEs|1|||
47027163|NCT01958060|83276980|FG000|Overall Study|Not treated|2|||
46623244|NCT02207244|82779016|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46623245|NCT02207244|82779017|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46623246|NCT02207244|82779018|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46623247|NCT02207244|82779019|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46710248|NCT00960531|82926385|FG008|Overall Study|Caregiver Request|3|||
46710249|NCT00960531|82926386|FG009|Overall Study|Caregiver Request|0|||
46710250|NCT00960531|82926377|FG000|Overall Study|Investigator Request|0|||
46912195|NCT03011892|83142233|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
47027164|NCT01958060|83276981|FG001|Overall Study|Not treated|0|||
47027165|NCT01958060|83276982|FG002|Overall Study|Not treated|0|||
47027166|NCT01958060|83276983|FG003|Overall Study|Not treated|0|||
47027167|NCT01958060|83276984|FG004|Overall Study|Not treated|1|||
47027168|NCT01958060|83276985|FG005|Overall Study|Not treated|0|||
47027169|NCT01929980|83277004|FG000|Overall Study|Physician Decision|1|||
47027170|NCT01363076|83277010|FG000|Overall Study|Withdrawal by Subject|0|||
47027171|NCT01363076|83277011|FG001|Overall Study|Withdrawal by Subject|1|||
47027172|NCT01929044|83277019|FG000|Overall Study|Adverse Event|1|||
47027173|NCT01929044|83277020|FG001|Overall Study|Adverse Event|0|||
47027174|NCT01929044|83277019|FG000|Overall Study|Protocol Violation|9|||
47027175|NCT01929044|83277020|FG001|Overall Study|Protocol Violation|14|||
47027176|NCT01929044|83277019|FG000|Overall Study|Not Treated|1|||
47027177|NCT01929044|83277020|FG001|Overall Study|Not Treated|3|||
47027178|NCT01903460|83277030|FG000|Overall Study|Adverse Event|0|||
47027179|NCT01903460|83277031|FG001|Overall Study|Adverse Event|0|||
47027180|NCT01903460|83277032|FG002|Overall Study|Adverse Event|0|||
47027181|NCT01903460|83277033|FG003|Overall Study|Adverse Event|1|||
47027182|NCT01957202|83277042|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027183|NCT01957202|83277043|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
47027184|NCT01957202|83277044|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027185|NCT01957202|83277045|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027186|NCT01957202|83277046|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027187|NCT01957202|83277047|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027188|NCT01957202|83277048|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027189|NCT01957202|83277049|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027190|NCT01957202|83277050|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027191|NCT01957202|83277051|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027192|NCT01957202|83277052|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027193|NCT01957202|83277053|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027194|NCT01957202|83277054|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027195|NCT01957202|83277055|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027196|NCT01957202|83277056|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027197|NCT01957202|83277057|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027198|NCT01957202|83277058|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
47027199|NCT01957202|83277059|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
47027200|NCT01957202|83277042|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027201|NCT01957202|83277043|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027202|NCT01957202|83277044|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027203|NCT01957202|83277045|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027204|NCT01957202|83277046|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027205|NCT01957202|83277047|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027206|NCT01957202|83277048|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027207|NCT01957202|83277049|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027208|NCT01957202|83277050|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027209|NCT01957202|83277051|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027210|NCT01957202|83277052|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027211|NCT01957202|83277053|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027212|NCT01957202|83277054|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027213|NCT01957202|83277055|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027214|NCT01957202|83277056|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027215|NCT01957202|83277057|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027216|NCT01957202|83277058|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
47027217|NCT01957202|83277059|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
47027218|NCT01616654|83277074|FG000|Overall Study|Lack of Efficacy|1|||
47027219|NCT01616654|83277075|FG001|Overall Study|Lack of Efficacy|0|||
47027220|NCT01616654|83277076|FG002|Overall Study|Lack of Efficacy|0|||
47027221|NCT01616654|83277077|FG003|Overall Study|Lack of Efficacy|0|||
47027222|NCT01616654|83277078|FG004|Overall Study|Lack of Efficacy|1|||
47027223|NCT01616654|83277074|FG000|Overall Study|Adverse Event|0|||
47027224|NCT01616654|83277075|FG001|Overall Study|Adverse Event|1|||
47027225|NCT01616654|83277076|FG002|Overall Study|Adverse Event|2|||
47027226|NCT01616654|83277077|FG003|Overall Study|Adverse Event|1|||
47027227|NCT01616654|83277078|FG004|Overall Study|Adverse Event|0|||
47027228|NCT01616654|83277074|FG000|Overall Study|Withdrawal by Subject|2|||
46710251|NCT00960531|82926378|FG001|Overall Study|Investigator Request|0|||
46912196|NCT03011892|83142234|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
47027229|NCT01616654|83277075|FG001|Overall Study|Withdrawal by Subject|2|||
46623248|NCT02207244|82779020|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46623249|NCT02207244|82779021|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
46623250|NCT02207244|82779022|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46623251|NCT02207244|82779023|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46623252|NCT02207244|82779024|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
46623253|NCT02207244|82779025|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
47027230|NCT01616654|83277076|FG002|Overall Study|Withdrawal by Subject|3|||
47027231|NCT01616654|83277077|FG003|Overall Study|Withdrawal by Subject|1|||
47027232|NCT01616654|83277078|FG004|Overall Study|Withdrawal by Subject|5|||
47027233|NCT01616654|83277074|FG000|Overall Study|Protocol Violation|0|||
47027234|NCT01616654|83277075|FG001|Overall Study|Protocol Violation|5|||
47027235|NCT01616654|83277076|FG002|Overall Study|Protocol Violation|2|||
47027236|NCT01616654|83277077|FG003|Overall Study|Protocol Violation|4|||
47027237|NCT01616654|83277078|FG004|Overall Study|Protocol Violation|4|||
47027238|NCT01616654|83277074|FG000|Overall Study|Lost to Follow-up|1|||
47027239|NCT01616654|83277075|FG001|Overall Study|Lost to Follow-up|0|||
47027240|NCT01616654|83277076|FG002|Overall Study|Lost to Follow-up|3|||
47027241|NCT01616654|83277077|FG003|Overall Study|Lost to Follow-up|2|||
47027242|NCT01616654|83277078|FG004|Overall Study|Lost to Follow-up|1|||
47027243|NCT01616654|83277074|FG000|Overall Study|Pregnancy|1|||
47027244|NCT01616654|83277075|FG001|Overall Study|Pregnancy|0|||
47027245|NCT01616654|83277076|FG002|Overall Study|Pregnancy|0|||
47027246|NCT01616654|83277077|FG003|Overall Study|Pregnancy|0|||
46912197|NCT03011892|83142235|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
46912198|NCT03011892|83142236|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
46912199|NCT03011892|83142237|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
46623254|NCT02207244|82779015|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623255|NCT02207244|82779016|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623256|NCT02207244|82779017|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623257|NCT02207244|82779018|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623258|NCT02207244|82779019|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623259|NCT02207244|82779020|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623260|NCT02207244|82779021|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623261|NCT02207244|82779022|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623262|NCT02207244|82779023|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
46623263|NCT02207244|82779024|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
46623264|NCT02207244|82779025|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
46710252|NCT00960531|82926379|FG002|Overall Study|Investigator Request|1|||
46912200|NCT03011892|83142238|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
46912201|NCT03011892|83142239|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
46912202|NCT03011892|83142240|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
46912203|NCT03011892|83142241|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
46912204|NCT03011892|83142242|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
46912205|NCT03011892|83142243|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
46912206|NCT03011892|83142232|FG000|Open Label (OL) Period|Reason not specified|0|||
46912207|NCT03011892|83142233|FG001|Open Label (OL) Period|Reason not specified|0|||
46912208|NCT03011892|83142234|FG002|Open Label (OL) Period|Reason not specified|0|||
46912209|NCT03011892|83142235|FG003|Open Label (OL) Period|Reason not specified|0|||
46912210|NCT03011892|83142236|FG004|Open Label (OL) Period|Reason not specified|0|||
46912211|NCT03011892|83142237|FG005|Open Label (OL) Period|Reason not specified|0|||
46912212|NCT03011892|83142238|FG006|Open Label (OL) Period|Reason not specified|0|||
46912213|NCT03011892|83142239|FG007|Open Label (OL) Period|Reason not specified|1|||
47027247|NCT01616654|83277078|FG004|Overall Study|Pregnancy|1|||
47027248|NCT01902290|83277093|FG000|Overall Study|Withdrawal by Subject|19|||
47027249|NCT01902290|83277094|FG001|Overall Study|Withdrawal by Subject|27|||
47027250|NCT01902290|83277093|FG000|Overall Study|Lost to Follow-up|2|||
47027251|NCT01902290|83277094|FG001|Overall Study|Lost to Follow-up|2|||
47027252|NCT01902290|83277093|FG000|Overall Study|Death|1|||
47027253|NCT01902290|83277094|FG001|Overall Study|Death|0|||
47027254|NCT01902290|83277093|FG000|Overall Study|Sponsor Decision|26|||
47027255|NCT01902290|83277094|FG001|Overall Study|Sponsor Decision|24|||
47027256|NCT01467466|83277105|FG000|Overall Study|Withdrawal by Subject|15|||
47027257|NCT01467466|83277106|FG001|Overall Study|Withdrawal by Subject|18|||
47027258|NCT01467466|83277107|FG002|Overall Study|Withdrawal by Subject|13|||
47027259|NCT01467466|83277108|FG003|Overall Study|Withdrawal by Subject|11|||
47027260|NCT01467466|83277105|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
47027261|NCT01467466|83277106|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
47027262|NCT01467466|83277107|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
47027263|NCT01467466|83277108|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
47027264|NCT01467466|83277105|FG000|Overall Study|Procedure Cancelled|46|||
47027265|NCT01467466|83277106|FG001|Overall Study|Procedure Cancelled|45|||
47027266|NCT01467466|83277107|FG002|Overall Study|Procedure Cancelled|25|||
47027267|NCT01467466|83277108|FG003|Overall Study|Procedure Cancelled|29|||
47027268|NCT01467466|83277105|FG000|Overall Study|No Endpoint Blood Draw|38|||
47027269|NCT01467466|83277106|FG001|Overall Study|No Endpoint Blood Draw|32|||
47027270|NCT01467466|83277107|FG002|Overall Study|No Endpoint Blood Draw|51|||
47027271|NCT01467466|83277108|FG003|Overall Study|No Endpoint Blood Draw|43|||
47027272|NCT01441180|83277121|FG000|Overall Study|Lost to Follow-up|1|||
46912214|NCT03011892|83142240|FG008|Open Label (OL) Period|Reason not specified|0|||
46912215|NCT03011892|83142241|FG009|Open Label (OL) Period|Reason not specified|0|||
46912216|NCT03011892|83142242|FG010|Open Label (OL) Period|Reason not specified|0|||
46912217|NCT03011892|83142243|FG011|Open Label (OL) Period|Reason not specified|0|||
47027273|NCT01441180|83277122|FG001|Overall Study|Lost to Follow-up|1|||
47027274|NCT01441180|83277123|FG002|Overall Study|Lost to Follow-up|1|||
46623265|NCT02207244|82779015|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623266|NCT02207244|82779016|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623267|NCT02207244|82779017|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623268|NCT02207244|82779018|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623269|NCT02207244|82779019|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623270|NCT02207244|82779020|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623271|NCT02207244|82779021|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623272|NCT02207244|82779022|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623273|NCT02207244|82779023|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
46623274|NCT02207244|82779024|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
46623275|NCT02207244|82779025|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
46623276|NCT02207244|82779015|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623277|NCT02207244|82779016|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623278|NCT02207244|82779017|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623279|NCT02207244|82779018|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
47027275|NCT01441180|83277121|FG000|Overall Study|Discontinued|0|||
47027276|NCT01441180|83277122|FG001|Overall Study|Discontinued|0|||
47027277|NCT01441180|83277123|FG002|Overall Study|Discontinued|2|||
47027278|NCT01441102|83277134|FG000|Overall Study|Adverse Event|1|||
47027279|NCT01441102|83277134|FG000|Overall Study|Withdrawal by Subject|2|||
47027280|NCT01467076|83277141|FG000|Overall Study|Lost to Follow-up|1|||
47027281|NCT01467076|83277142|FG001|Overall Study|Lost to Follow-up|0|||
47027282|NCT01467076|83277143|FG002|Overall Study|Lost to Follow-up|0|||
47027283|NCT01466062|83277151|FG000|Overall Study|Adverse Event|1|||
46623280|NCT02207244|82779019|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623281|NCT02207244|82779020|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623282|NCT02207244|82779021|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623283|NCT02207244|82779022|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623284|NCT02207244|82779023|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
46623285|NCT02207244|82779024|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
46623286|NCT02207244|82779025|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
46623287|NCT02207244|82779015|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46623288|NCT02207244|82779016|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46623289|NCT02207244|82779017|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46623290|NCT02207244|82779018|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46912218|NCT03017742|83142270|FG000|Overall Study|Protocol Violation|36|||
47027284|NCT01466062|83277151|FG000|Overall Study|Withdrawal by Subject|1|||
47027285|NCT01435018|83277158|FG000|Overall Study|Death|37|||
47027286|NCT01435018|83277159|FG001|Overall Study|Death|18|||
47027287|NCT01435018|83277160|FG002|Overall Study|Death|25|||
47027288|NCT01435018|83277158|FG000|Overall Study|Site is closing|4|||
46623291|NCT02207244|82779019|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46623292|NCT02207244|82779020|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46623293|NCT02207244|82779021|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
47027289|NCT01435018|83277159|FG001|Overall Study|Site is closing|9|||
47027290|NCT01435018|83277160|FG002|Overall Study|Site is closing|7|||
47027291|NCT01435018|83277158|FG000|Overall Study|Withdrew consent|0|||
47027292|NCT01435018|83277159|FG001|Overall Study|Withdrew consent|3|||
47027293|NCT01435018|83277160|FG002|Overall Study|Withdrew consent|1|||
47027294|NCT01435018|83277158|FG000|Overall Study|Not willing to adhere to requirements|0|||
47027295|NCT01435018|83277159|FG001|Overall Study|Not willing to adhere to requirements|2|||
47027296|NCT01435018|83277160|FG002|Overall Study|Not willing to adhere to requirements|3|||
47027297|NCT01435018|83277158|FG000|Overall Study|Not able to get to clinic|2|||
47027298|NCT01435018|83277159|FG001|Overall Study|Not able to get to clinic|0|||
47027299|NCT01435018|83277160|FG002|Overall Study|Not able to get to clinic|2|||
47027300|NCT01435018|83277158|FG000|Overall Study|Severe debilitation, unable to continue|0|||
46710253|NCT00960531|82926380|FG003|Overall Study|Investigator Request|0|||
46710254|NCT00960531|82926381|FG004|Overall Study|Investigator Request|0|||
46710255|NCT00960531|82926382|FG005|Overall Study|Investigator Request|0|||
47027301|NCT01435018|83277159|FG001|Overall Study|Severe debilitation, unable to continue|0|||
47027302|NCT01435018|83277160|FG002|Overall Study|Severe debilitation, unable to continue|1|||
47027303|NCT01435018|83277158|FG000|Overall Study|Unable to contact participant/parent|1|||
47027304|NCT01435018|83277159|FG001|Overall Study|Unable to contact participant/parent|1|||
47027305|NCT01435018|83277160|FG002|Overall Study|Unable to contact participant/parent|1|||
47027306|NCT01435018|83277158|FG000|Overall Study|Enrollment Violation|0|||
47027307|NCT01435018|83277159|FG001|Overall Study|Enrollment Violation|1|||
47027308|NCT01435018|83277160|FG002|Overall Study|Enrollment Violation|0|||
47027309|NCT01435018|83277158|FG000|Overall Study|Never started chemotherapy|3|||
46710256|NCT00960531|82926383|FG006|Overall Study|Investigator Request|0|||
46623294|NCT02207244|82779022|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46623295|NCT02207244|82779023|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
46623296|NCT02207244|82779024|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
46623297|NCT02207244|82779025|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
46623298|NCT02207244|82779015|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
46623299|NCT02207244|82779016|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
46623300|NCT02207244|82779017|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
46710257|NCT00960531|82926384|FG007|Overall Study|Investigator Request|0|||
47027310|NCT01435018|83277159|FG001|Overall Study|Never started chemotherapy|0|||
47027311|NCT01435018|83277160|FG002|Overall Study|Never started chemotherapy|1|||
47027312|NCT01419184|83277172|FG000|Overall Study|Site data not available|3|||
47027313|NCT01419184|83277173|FG001|Overall Study|Site data not available|2|||
46710258|NCT00960531|82926385|FG008|Overall Study|Investigator Request|0|||
46912219|NCT03017742|83142270|FG000|Overall Study|Withdrawal by Subject|37|||
46912220|NCT03012828|83142280|FG000|Overall Study|Lost to Follow-up|1|||
46912221|NCT03012828|83142281|FG001|Overall Study|Lost to Follow-up|0|||
47027314|NCT01419184|83277172|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
47027315|NCT01419184|83277173|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
47027316|NCT01419184|83277172|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
47027317|NCT01419184|83277173|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
47027318|NCT01419184|83277172|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
47027319|NCT01419184|83277173|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
47027320|NCT01419184|83277172|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
47027321|NCT01419184|83277173|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
47027322|NCT01419184|83277172|FG000|Overall Study|Participant randomized, not treated|1|||
47027323|NCT01419184|83277173|FG001|Overall Study|Participant randomized, not treated|0|||
47027324|NCT01417234|83277179|FG000|Overall Study|Subject non-compliant|3|||
47027325|NCT01417156|83277183|FG000|Overall Study|Adverse Event|12|||
47027326|NCT01417156|83277183|FG000|Overall Study|Protocol Violation|2|||
47027327|NCT01417078|83277187|FG000|Overall Study|Withdrawal by Subject|1|||
47027328|NCT01954394|83277195|FG000|Overall Study|Enrolled but not treated|1|||
47027329|NCT01954394|83277196|FG001|Overall Study|Enrolled but not treated|0|||
47027330|NCT01954394|83277195|FG000|Overall Study|Adverse Event|10|||
47027331|NCT01954394|83277196|FG001|Overall Study|Adverse Event|23|||
47027332|NCT01954394|83277195|FG000|Overall Study|Poor compliance to protocol|7|||
47027333|NCT01954394|83277196|FG001|Overall Study|Poor compliance to protocol|7|||
47027334|NCT01954394|83277195|FG000|Overall Study|Participant Moved|0|||
47027335|NCT01954394|83277196|FG001|Overall Study|Participant Moved|4|||
47027336|NCT01954394|83277195|FG000|Overall Study|Related to Study Drug administration|2|||
47027337|NCT01954394|83277196|FG001|Overall Study|Related to Study Drug administration|2|||
47027338|NCT01954394|83277195|FG000|Overall Study|Other than specified above|10|||
47027339|NCT01954394|83277196|FG001|Overall Study|Other than specified above|21|||
47027340|NCT01464424|83277204|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
47027341|NCT01464424|83277205|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
47027342|NCT01902134|83277217|FG000|Overall Study|Adverse Event|3|||
47027343|NCT01902134|83277218|FG001|Overall Study|Adverse Event|1|||
47027344|NCT01902134|83277219|FG002|Overall Study|Adverse Event|2|||
47027345|NCT01902134|83277220|FG003|Overall Study|Adverse Event|1|||
47027346|NCT01902134|83277221|FG004|Overall Study|Adverse Event|1|||
47027347|NCT01902134|83277222|FG005|Overall Study|Adverse Event|3|||
47027348|NCT01902134|83277217|FG000|Overall Study|Lack of Efficacy|0|||
47027349|NCT01902134|83277218|FG001|Overall Study|Lack of Efficacy|0|||
47027350|NCT01902134|83277219|FG002|Overall Study|Lack of Efficacy|2|||
46912222|NCT03012828|83142282|FG002|Overall Study|Lost to Follow-up|1|||
46912223|NCT03012828|83142283|FG003|Overall Study|Lost to Follow-up|0|||
46912224|NCT03012828|83142284|FG004|Overall Study|Lost to Follow-up|1|||
47027351|NCT01902134|83277220|FG003|Overall Study|Lack of Efficacy|0|||
47027352|NCT01902134|83277221|FG004|Overall Study|Lack of Efficacy|0|||
47027353|NCT01902134|83277222|FG005|Overall Study|Lack of Efficacy|1|||
47027354|NCT01902134|83277217|FG000|Overall Study|Physician Decision|0|||
47027355|NCT01902134|83277218|FG001|Overall Study|Physician Decision|1|||
47027356|NCT01902134|83277219|FG002|Overall Study|Physician Decision|0|||
47027357|NCT01902134|83277220|FG003|Overall Study|Physician Decision|0|||
47027358|NCT01902134|83277221|FG004|Overall Study|Physician Decision|0|||
46623301|NCT02207244|82779018|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
46623302|NCT02207244|82779019|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
46623303|NCT02207244|82779020|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
46623304|NCT02207244|82779021|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
46623305|NCT02207244|82779022|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
46623306|NCT02207244|82779023|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
46623307|NCT02207244|82779024|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
47027359|NCT01902134|83277222|FG005|Overall Study|Physician Decision|0|||
47027360|NCT01902134|83277217|FG000|Overall Study|Protocol Violation|0|||
47027361|NCT01902134|83277218|FG001|Overall Study|Protocol Violation|0|||
47027362|NCT01902134|83277219|FG002|Overall Study|Protocol Violation|0|||
47027363|NCT01902134|83277220|FG003|Overall Study|Protocol Violation|0|||
47027364|NCT01902134|83277221|FG004|Overall Study|Protocol Violation|0|||
47027365|NCT01902134|83277222|FG005|Overall Study|Protocol Violation|1|||
47027366|NCT01902134|83277217|FG000|Overall Study|Withdrawal by Subject|4|||
47027367|NCT01902134|83277218|FG001|Overall Study|Withdrawal by Subject|8|||
47027368|NCT01902134|83277219|FG002|Overall Study|Withdrawal by Subject|9|||
47027369|NCT01902134|83277220|FG003|Overall Study|Withdrawal by Subject|1|||
47027370|NCT01902134|83277221|FG004|Overall Study|Withdrawal by Subject|5|||
47027371|NCT01902134|83277222|FG005|Overall Study|Withdrawal by Subject|4|||
47027372|NCT01902134|83277217|FG000|Overall Study|no compliance|1|||
47027373|NCT01902134|83277218|FG001|Overall Study|no compliance|0|||
47027374|NCT01902134|83277219|FG002|Overall Study|no compliance|0|||
47027375|NCT01902134|83277220|FG003|Overall Study|no compliance|0|||
47027376|NCT01902134|83277221|FG004|Overall Study|no compliance|0|||
47027377|NCT01902134|83277222|FG005|Overall Study|no compliance|0|||
47027378|NCT01902134|83277217|FG000|Overall Study|Other|0|||
47027379|NCT01902134|83277218|FG001|Overall Study|Other|1|||
47027380|NCT01902134|83277219|FG002|Overall Study|Other|2|||
47027381|NCT01902134|83277220|FG003|Overall Study|Other|0|||
47027382|NCT01902134|83277221|FG004|Overall Study|Other|1|||
47027383|NCT01902134|83277222|FG005|Overall Study|Other|0|||
47027384|NCT01954082|83277240|FG000|Overall Study|Study Suspension|42|||
47027385|NCT01954082|83277241|FG001|Overall Study|Study Suspension|36|||
47027386|NCT01954082|83277240|FG000|Overall Study|Adverse Event|10|||
47027387|NCT01954082|83277241|FG001|Overall Study|Adverse Event|4|||
47027388|NCT01954082|83277240|FG000|Overall Study|Intolerance|0|||
47027389|NCT01954082|83277241|FG001|Overall Study|Intolerance|1|||
47027390|NCT01954082|83277240|FG000|Overall Study|Non-compliance|6|||
47027391|NCT01954082|83277241|FG001|Overall Study|Non-compliance|4|||
47027392|NCT01954082|83277240|FG000|Overall Study|Physician Decision|2|||
47027393|NCT01954082|83277241|FG001|Overall Study|Physician Decision|0|||
47027394|NCT01954082|83277240|FG000|Overall Study|Parent Decision|1|||
47027395|NCT01954082|83277241|FG001|Overall Study|Parent Decision|0|||
47027396|NCT01954082|83277240|FG000|Overall Study|Withdrawal by Subject|0|||
46623308|NCT02207244|82779025|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
46623309|NCT02207244|82779015|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
46623310|NCT02207244|82779016|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
47027397|NCT01954082|83277241|FG001|Overall Study|Withdrawal by Subject|1|||
47027398|NCT01954082|83277240|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
47027399|NCT01954082|83277241|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
47027400|NCT01954082|83277240|FG000|Overall Study|Redirection of Care|0|||
47027401|NCT01954082|83277241|FG001|Overall Study|Redirection of Care|2|||
47027402|NCT01954082|83277240|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
47027403|NCT01954082|83277241|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
47027404|NCT01954082|83277240|FG000|Overall Study|Comfort Care|0|||
47027405|NCT01954082|83277241|FG001|Overall Study|Comfort Care|1|||
46623311|NCT02207244|82779017|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
46912225|NCT03012828|83142285|FG005|Overall Study|Lost to Follow-up|0|||
47027406|NCT01954082|83277240|FG000|Overall Study|Infant Moved|0|||
47027407|NCT01954082|83277241|FG001|Overall Study|Infant Moved|1|||
47027408|NCT01954082|83277240|FG000|Overall Study|Randomized not Treated|4|||
47027409|NCT01954082|83277241|FG001|Overall Study|Randomized not Treated|2|||
47027410|NCT01417000|83277249|FG000|Overall Study|Death|59|||
47027411|NCT01417000|83277250|FG001|Overall Study|Death|28|||
47027412|NCT01417000|83277249|FG000|Overall Study|Lost to Follow-up|1|||
47027413|NCT01417000|83277250|FG001|Overall Study|Lost to Follow-up|0|||
47027414|NCT01417000|83277249|FG000|Overall Study|Study Terminated by Sponsor|1|||
47027415|NCT01417000|83277250|FG001|Overall Study|Study Terminated by Sponsor|1|||
47027416|NCT01416610|83277256|FG000|Overall Study|Adverse Event|4|||
46623312|NCT02207244|82779018|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
46623313|NCT02207244|82779019|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
46623314|NCT02207244|82779020|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
46623315|NCT02207244|82779021|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
46623316|NCT02207244|82779022|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
46623317|NCT02207244|82779023|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
46623318|NCT02207244|82779024|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
46623319|NCT02207244|82779025|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
46623320|NCT02207244|82779015|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623321|NCT02207244|82779016|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623322|NCT02207244|82779017|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623323|NCT02207244|82779018|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623324|NCT02207244|82779019|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623325|NCT02207244|82779020|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623326|NCT02207244|82779021|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623327|NCT02207244|82779022|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623328|NCT02207244|82779023|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623329|NCT02207244|82779024|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
46623330|NCT02207244|82779025|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
46623331|NCT02207088|82779078|FG000|Overall Study|Adverse Event|2|||
46623332|NCT02206620|82779093|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
46623333|NCT02206620|82779094|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
46623334|NCT02206620|82779093|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
46623335|NCT02206620|82779094|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
46623336|NCT02239926|82779108|FG000|Overall Study|Withdrawal by Subject|0|||
46623337|NCT02239926|82779109|FG001|Overall Study|Withdrawal by Subject|1|||
46623338|NCT02239692|82779117|FG000|Overall Study|Incomplete colonoscopy|1|||
46623339|NCT02239692|82779118|FG001|Overall Study|Incomplete colonoscopy|2|||
46623340|NCT02239692|82779117|FG000|Overall Study|Adverse Event|0|||
46623341|NCT02239692|82779118|FG001|Overall Study|Adverse Event|1|||
46623342|NCT02239692|82779117|FG000|Overall Study|Physician Decision|0|||
46623343|NCT02239692|82779118|FG001|Overall Study|Physician Decision|1|||
46623344|NCT02239692|82779117|FG000|Overall Study|Lost to Follow-up|1|||
46623345|NCT02239692|82779118|FG001|Overall Study|Lost to Follow-up|4|||
46623346|NCT02239692|82779117|FG000|Overall Study|Withdrawal by Subject|3|||
46623347|NCT02239692|82779118|FG001|Overall Study|Withdrawal by Subject|5|||
46623348|NCT02239692|82779117|FG000|Overall Study|Other reason|1|||
46623349|NCT02239692|82779118|FG001|Overall Study|Other reason|0|||
46623350|NCT02206152|82779146|FG000|Pre-Randomization|Withdrawal by Subject|2|||
46623351|NCT02239536|82779154|FG000|Overall Study|Non-neoplastic polyp|23|||
46623352|NCT02239536|82779155|FG001|Overall Study|Non-neoplastic polyp|17|||
46623353|NCT02239224|82779165|FG000|Overall Study|Administrative|0|||
46623354|NCT02239224|82779166|FG001|Overall Study|Administrative|0|||
46623355|NCT02239224|82779167|FG002|Overall Study|Administrative|3|||
46623356|NCT02239224|82779168|FG003|Overall Study|Administrative|1|||
46623357|NCT01600014|82779178|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
46623358|NCT01600014|82779179|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
46623359|NCT01600014|82779178|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
46623360|NCT01600014|82779179|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
46623361|NCT01600014|82779178|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
46623362|NCT01600014|82779179|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
46623363|NCT01600014|82779178|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
46623364|NCT01600014|82779179|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
46623365|NCT01600014|82779178|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
46710259|NCT00960531|82926386|FG009|Overall Study|Investigator Request|0|||
46912226|NCT03012828|83142280|FG000|Overall Study|Withdrawal by Subject|0|||
46623366|NCT01600014|82779179|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
46623367|NCT01600014|82779178|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
47027417|NCT01416610|83277256|FG000|Overall Study|Adverse Event -Patient decision|3|||
46623368|NCT01600014|82779179|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
47027418|NCT01416610|83277256|FG000|Overall Study|Lack of Efficacy|4|||
46623369|NCT01600014|82779178|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
46623370|NCT01600014|82779179|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
46623371|NCT01600014|82779178|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
46623372|NCT01600014|82779179|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
46623373|NCT01600014|82779178|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
46623374|NCT01600014|82779179|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
46623375|NCT01600014|82779178|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
46623376|NCT01600014|82779179|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
46623377|NCT01600014|82779178|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
46623378|NCT01600014|82779179|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
46623379|NCT01600014|82779178|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
46623380|NCT01600014|82779179|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
46623381|NCT01600014|82779178|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
46623382|NCT01600014|82779179|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
46623383|NCT01600014|82779178|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
46623384|NCT01600014|82779179|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
46623385|NCT01600014|82779178|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
46623386|NCT01600014|82779179|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
46623387|NCT01600014|82779178|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
46623388|NCT01600014|82779179|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
46623389|NCT01600014|82779178|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
46623390|NCT01600014|82779179|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
46623391|NCT02237196|82779201|FG000|Overall Study|Adverse Event|0|||
46623392|NCT02237196|82779202|FG001|Overall Study|Adverse Event|1|||
46623393|NCT02237196|82779203|FG002|Overall Study|Adverse Event|1|||
46623394|NCT02237196|82779204|FG003|Overall Study|Adverse Event|0|||
46623395|NCT02237196|82779201|FG000|Overall Study|Lost to Follow-up|4|||
46623396|NCT02237196|82779202|FG001|Overall Study|Lost to Follow-up|2|||
46623397|NCT02237196|82779203|FG002|Overall Study|Lost to Follow-up|4|||
46623398|NCT02237196|82779204|FG003|Overall Study|Lost to Follow-up|6|||
46623399|NCT02237196|82779201|FG000|Overall Study|Physician Decision|2|||
46623400|NCT02237196|82779202|FG001|Overall Study|Physician Decision|0|||
46623401|NCT02237196|82779203|FG002|Overall Study|Physician Decision|0|||
46623402|NCT02237196|82779204|FG003|Overall Study|Physician Decision|1|||
46623403|NCT02237196|82779201|FG000|Overall Study|Pregnancy|0|||
46623404|NCT02237196|82779202|FG001|Overall Study|Pregnancy|0|||
46623405|NCT02237196|82779203|FG002|Overall Study|Pregnancy|1|||
46623406|NCT02237196|82779204|FG003|Overall Study|Pregnancy|1|||
46623407|NCT02237196|82779201|FG000|Overall Study|Withdrawal by Subject|1|||
46623408|NCT02237196|82779202|FG001|Overall Study|Withdrawal by Subject|1|||
46623409|NCT02237196|82779203|FG002|Overall Study|Withdrawal by Subject|4|||
46623410|NCT02237196|82779204|FG003|Overall Study|Withdrawal by Subject|1|||
46623411|NCT02237196|82779201|FG000|Overall Study|Site Error|1|||
46623412|NCT02237196|82779202|FG001|Overall Study|Site Error|2|||
47027419|NCT01416610|83277256|FG000|Overall Study|No reason given|5|||
46623413|NCT02237196|82779203|FG002|Overall Study|Site Error|0|||
46623414|NCT02237196|82779204|FG003|Overall Study|Site Error|2|||
46623415|NCT02237118|82779220|FG000|Overall Study|Protocol Violation|0|||
46623416|NCT02237118|82779221|FG001|Overall Study|Protocol Violation|1|||
47027420|NCT01416610|83277256|FG000|Overall Study|Withdrawal by Subject|13|||
47027421|NCT01416610|83277256|FG000|Overall Study|Lost to Follow-up|7|||
47027422|NCT01416610|83277256|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
47027423|NCT01416142|83277264|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
47027424|NCT01416142|83277265|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
47027425|NCT01416142|83277266|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
47027426|NCT01415986|83277274|FG000|Overall Study|Lost to Follow-up|1|||
47027427|NCT01415908|83277281|FG000|Overall Study|Withdrawal by Subject|1|||
47027428|NCT01415908|83277282|FG001|Overall Study|Withdrawal by Subject|0|||
47027429|NCT01415518|83277290|FG000|Overall Study|Withdrawal by Subject|2|||
47027430|NCT01415518|83277291|FG001|Overall Study|Withdrawal by Subject|12|||
47027431|NCT01415518|83277290|FG000|Overall Study|Protocol Violation|6|||
47027432|NCT01415518|83277291|FG001|Overall Study|Protocol Violation|8|||
47027433|NCT01415518|83277290|FG000|Overall Study|Lost to Follow-up|3|||
47027434|NCT01415518|83277291|FG001|Overall Study|Lost to Follow-up|5|||
47027435|NCT01415518|83277290|FG000|Overall Study|Adverse Event|3|||
46623417|NCT02237118|82779220|FG000|Overall Study|consent withdrawn|1|||
46623418|NCT02237118|82779221|FG001|Overall Study|consent withdrawn|0|||
46623419|NCT02234622|82779237|FG000|Overall Study|Withdrawal by Subject|16|||
46623420|NCT02234622|82779238|FG001|Overall Study|Withdrawal by Subject|22|||
46623421|NCT02234622|82779237|FG000|Overall Study|Lost to Follow-up|27|||
47027436|NCT01415518|83277291|FG001|Overall Study|Adverse Event|4|||
47027437|NCT01415518|83277290|FG000|Overall Study|Death|1|||
46623422|NCT02234622|82779238|FG001|Overall Study|Lost to Follow-up|14|||
46623423|NCT02203032|82779246|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
46623424|NCT02203032|82779247|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
46623425|NCT02203032|82779248|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
47027438|NCT01415518|83277291|FG001|Overall Study|Death|1|||
47027439|NCT01415518|83277290|FG000|Overall Study|Condition under Investigation Worsened|1|||
47027440|NCT01415518|83277291|FG001|Overall Study|Condition under Investigation Worsened|1|||
47027441|NCT01393600|83277297|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
47027442|NCT01393600|83277298|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
47027443|NCT01393600|83277299|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
47027444|NCT01393600|83277300|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
47027445|NCT01393600|83277297|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
47027446|NCT01393600|83277298|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
47027447|NCT01393600|83277299|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
47027448|NCT01393600|83277300|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
47027449|NCT01393600|83277297|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
46710260|NCT00960531|82926377|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
46710261|NCT00960531|82926378|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
46710262|NCT00960531|82926379|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
46710263|NCT00960531|82926380|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
46710264|NCT00960531|82926381|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
46710265|NCT00960531|82926382|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
46710266|NCT00960531|82926383|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
46710267|NCT00960531|82926384|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
46710268|NCT00960531|82926385|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
46710269|NCT00960531|82926386|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
46710270|NCT00960531|82926377|FG000|Overall Study|Lost to Follow-up|0|||
46710271|NCT00960531|82926378|FG001|Overall Study|Lost to Follow-up|0|||
46710272|NCT00960531|82926379|FG002|Overall Study|Lost to Follow-up|1|||
46710273|NCT00960531|82926380|FG003|Overall Study|Lost to Follow-up|0|||
46710274|NCT00960531|82926381|FG004|Overall Study|Lost to Follow-up|0|||
46710275|NCT00960531|82926382|FG005|Overall Study|Lost to Follow-up|0|||
46710276|NCT00960531|82926383|FG006|Overall Study|Lost to Follow-up|1|||
46710277|NCT00960531|82926384|FG007|Overall Study|Lost to Follow-up|0|||
46710278|NCT00960531|82926385|FG008|Overall Study|Lost to Follow-up|0|||
46710279|NCT00960531|82926386|FG009|Overall Study|Lost to Follow-up|0|||
46710280|NCT00960531|82926377|FG000|Overall Study|Failed to Return|2|||
46710281|NCT00960531|82926378|FG001|Overall Study|Failed to Return|0|||
46710282|NCT00960531|82926379|FG002|Overall Study|Failed to Return|0|||
46710283|NCT00960531|82926380|FG003|Overall Study|Failed to Return|0|||
46710284|NCT00960531|82926381|FG004|Overall Study|Failed to Return|0|||
46710285|NCT00960531|82926382|FG005|Overall Study|Failed to Return|0|||
46710286|NCT00960531|82926383|FG006|Overall Study|Failed to Return|0|||
46710287|NCT00960531|82926384|FG007|Overall Study|Failed to Return|2|||
46623426|NCT02203032|82779249|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
46623427|NCT02203032|82779246|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
46623428|NCT02203032|82779247|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
46623429|NCT02203032|82779248|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
46623430|NCT02203032|82779249|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
46623431|NCT02203032|82779246|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
46623432|NCT02203032|82779247|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
46623433|NCT02203032|82779248|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
46623434|NCT02203032|82779249|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
46623435|NCT02203032|82779246|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
46623436|NCT02203032|82779247|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
46623437|NCT02203032|82779248|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
46623438|NCT02203032|82779249|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
46623439|NCT02203032|82779246|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
46623440|NCT02203032|82779247|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
46623441|NCT02203032|82779248|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
46623442|NCT02203032|82779249|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
46623443|NCT02203032|82779246|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
46623444|NCT02203032|82779247|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
46623445|NCT02203032|82779248|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
46623446|NCT02203032|82779249|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
46623447|NCT02203032|82779246|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
46623448|NCT02203032|82779247|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
46623449|NCT02203032|82779248|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
46623450|NCT02203032|82779249|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
46623451|NCT02203032|82779246|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
46623452|NCT02203032|82779247|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
46623453|NCT02203032|82779248|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
46623454|NCT02203032|82779249|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
46623455|NCT02203032|82779246|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
46623456|NCT02203032|82779247|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
46623457|NCT02203032|82779248|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
46623458|NCT02203032|82779249|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
46623459|NCT02203032|82779246|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
46623460|NCT02203032|82779247|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
46623461|NCT02203032|82779248|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
46623462|NCT02203032|82779249|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
46623463|NCT02203032|82779246|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
46623464|NCT02203032|82779247|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
46623465|NCT02203032|82779248|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
46623466|NCT02203032|82779249|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
46623467|NCT02203032|82779246|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
46623468|NCT02203032|82779247|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
46623469|NCT02203032|82779248|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
46710288|NCT00960531|82926385|FG008|Overall Study|Failed to Return|0|||
46710289|NCT00960531|82926386|FG009|Overall Study|Failed to Return|0|||
46710290|NCT00960531|82926377|FG000|Overall Study|Adverse Event (AE)|2|||
46710291|NCT00960531|82926378|FG001|Overall Study|Adverse Event (AE)|0|||
46710292|NCT00960531|82926379|FG002|Overall Study|Adverse Event (AE)|0|||
46623470|NCT02203032|82779249|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
46623471|NCT02169414|82779261|FG000|Overall Study|Withdrawal by Subject|1|||
46623472|NCT02169414|82779262|FG001|Overall Study|Withdrawal by Subject|0|||
46623473|NCT02169414|82779263|FG002|Overall Study|Withdrawal by Subject|0|||
46623474|NCT02169414|82779264|FG003|Overall Study|Withdrawal by Subject|0|||
46623475|NCT02169414|82779261|FG000|Overall Study|Adverse Event|0|||
46623476|NCT02169414|82779262|FG001|Overall Study|Adverse Event|1|||
46623477|NCT02169414|82779263|FG002|Overall Study|Adverse Event|0|||
46623478|NCT02169414|82779264|FG003|Overall Study|Adverse Event|0|||
46623479|NCT02201940|82779280|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
46623480|NCT02201940|82779281|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
46623481|NCT02201940|82779280|FG000|Overall Study|Lack of Efficacy|2|||
46623482|NCT02201940|82779281|FG001|Overall Study|Lack of Efficacy|113|||
46623483|NCT02201940|82779280|FG000|Overall Study|Lost to Follow-up|5|||
46623484|NCT02201940|82779281|FG001|Overall Study|Lost to Follow-up|0|||
46623485|NCT02201940|82779280|FG000|Overall Study|Withdrew Consent|2|||
46623486|NCT02201940|82779281|FG001|Overall Study|Withdrew Consent|1|||
46623487|NCT02201940|82779280|FG000|Overall Study|Investigator's Discretion|1|||
46623488|NCT02201940|82779281|FG001|Overall Study|Investigator's Discretion|1|||
46623489|NCT02201940|82779280|FG000|Overall Study|Death|1|||
46623490|NCT02201940|82779281|FG001|Overall Study|Death|0|||
46623491|NCT02201940|82779280|FG000|Overall Study|Adverse Event|0|||
46623492|NCT02201940|82779281|FG001|Overall Study|Adverse Event|1|||
46623493|NCT02232984|82779287|FG000|Overall Study|Withdrawal by Subject|5|||
46623494|NCT02232984|82779287|FG000|Overall Study|Death|1|||
46623495|NCT02232984|82779287|FG000|Overall Study|Investigator withdrawal|10|||
46623496|NCT02232984|82779287|FG000|Overall Study|Device implant unsuccessful|53|||
46623497|NCT02232984|82779287|FG000|Overall Study|not disclosed by site|7|||
46623498|NCT02232984|82779287|FG000|Overall Study|Protocol Violation|1|||
46623499|NCT02169336|82779297|FG000|Overall Study|Lack of Efficacy|1|||
46623500|NCT02169336|82779298|FG001|Overall Study|Lack of Efficacy|1|||
46623501|NCT02169336|82779299|FG002|Overall Study|Lack of Efficacy|0|||
46623502|NCT02169336|82779297|FG000|Overall Study|Adverse Event|2|||
46623503|NCT02169336|82779298|FG001|Overall Study|Adverse Event|3|||
46623504|NCT02169336|82779299|FG002|Overall Study|Adverse Event|1|||
46623505|NCT02169336|82779297|FG000|Overall Study|Withdrawal by Subject|1|||
46623506|NCT02169336|82779298|FG001|Overall Study|Withdrawal by Subject|0|||
46623507|NCT02169336|82779299|FG002|Overall Study|Withdrawal by Subject|0|||
46623508|NCT02169336|82779297|FG000|Overall Study|Physician Decision|0|||
46623509|NCT02169336|82779298|FG001|Overall Study|Physician Decision|0|||
46623510|NCT02169336|82779299|FG002|Overall Study|Physician Decision|1|||
46623511|NCT02169336|82779297|FG000|Overall Study|Subject declined to continue dosing|0|||
46623512|NCT02169336|82779298|FG001|Overall Study|Subject declined to continue dosing|0|||
46623513|NCT02169336|82779299|FG002|Overall Study|Subject declined to continue dosing|1|||
46623514|NCT02609828|82779315|FG000|Overall Study|Adverse Event|8|||
46623515|NCT02609828|82779316|FG001|Overall Study|Adverse Event|1|||
46623516|NCT02609828|82779317|FG002|Overall Study|Adverse Event|0|||
46623517|NCT02609828|82779318|FG003|Overall Study|Adverse Event|6|||
46623518|NCT02609828|82779315|FG000|Overall Study|Death|15|||
46623519|NCT02609828|82779316|FG001|Overall Study|Death|1|||
46623520|NCT02609828|82779317|FG002|Overall Study|Death|1|||
46623521|NCT02609828|82779318|FG003|Overall Study|Death|19|||
46623522|NCT02609828|82779315|FG000|Overall Study|Insufficient clinical response|2|||
46623523|NCT02609828|82779316|FG001|Overall Study|Insufficient clinical response|1|||
46623524|NCT02609828|82779317|FG002|Overall Study|Insufficient clinical response|0|||
46623525|NCT02609828|82779318|FG003|Overall Study|Insufficient clinical response|0|||
46623526|NCT02609828|82779315|FG000|Overall Study|Lost to Follow-up|0|||
46623527|NCT02609828|82779316|FG001|Overall Study|Lost to Follow-up|0|||
46623528|NCT02609828|82779317|FG002|Overall Study|Lost to Follow-up|0|||
46623529|NCT02609828|82779318|FG003|Overall Study|Lost to Follow-up|1|||
46623530|NCT02609828|82779315|FG000|Overall Study|Protocol Violation|2|||
46623531|NCT02609828|82779316|FG001|Overall Study|Protocol Violation|0|||
46623532|NCT02609828|82779317|FG002|Overall Study|Protocol Violation|0|||
46623533|NCT02609828|82779318|FG003|Overall Study|Protocol Violation|1|||
46623534|NCT02609828|82779315|FG000|Overall Study|Withdrawal by Subject|12|||
46623535|NCT02609828|82779316|FG001|Overall Study|Withdrawal by Subject|1|||
46623536|NCT02609828|82779317|FG002|Overall Study|Withdrawal by Subject|0|||
46623537|NCT02609828|82779318|FG003|Overall Study|Withdrawal by Subject|10|||
46623538|NCT02609828|82779315|FG000|Overall Study|Other|3|||
46623539|NCT02609828|82779316|FG001|Overall Study|Other|0|||
46623540|NCT02609828|82779317|FG002|Overall Study|Other|0|||
46623541|NCT02609828|82779318|FG003|Overall Study|Other|6|||
46623542|NCT02609828|82779315|FG000|Overall Study|Randomized but not treated|1|||
46710293|NCT00960531|82926380|FG003|Overall Study|Adverse Event (AE)|0|||
46710294|NCT00960531|82926381|FG004|Overall Study|Adverse Event (AE)|0|||
46710295|NCT00960531|82926382|FG005|Overall Study|Adverse Event (AE)|1|||
46710296|NCT00960531|82926383|FG006|Overall Study|Adverse Event (AE)|2|||
46710297|NCT00960531|82926384|FG007|Overall Study|Adverse Event (AE)|0|||
46710298|NCT00960531|82926385|FG008|Overall Study|Adverse Event (AE)|2|||
46710299|NCT00960531|82926386|FG009|Overall Study|Adverse Event (AE)|0|||
46710300|NCT00960531|82926377|FG000|Overall Study|Reason not Specified|2|||
46710301|NCT00960531|82926378|FG001|Overall Study|Reason not Specified|1|||
46710302|NCT00960531|82926379|FG002|Overall Study|Reason not Specified|13|||
46623543|NCT02609828|82779316|FG001|Overall Study|Randomized but not treated|0|||
46623544|NCT02609828|82779317|FG002|Overall Study|Randomized but not treated|0|||
46623545|NCT02609828|82779318|FG003|Overall Study|Randomized but not treated|0|||
46623546|NCT01632306|82779334|FG000|Overall Study|Protocol Violation|1|||
46623547|NCT01632306|82779335|FG001|Overall Study|Protocol Violation|0|||
46623548|NCT01632306|82779336|FG002|Overall Study|Protocol Violation|0|||
46623549|NCT02201784|82779344|FG000|Overall Study|Failure to achieve adequate block|2|||
46623550|NCT02201784|82779345|FG001|Overall Study|Failure to achieve adequate block|0|||
46623551|NCT02201472|82779351|FG000|Overall Study|Lack of Efficacy|2|||
46623552|NCT02168946|82779396|FG000|Overall Study|Adverse Event|8|||
46623553|NCT02168946|82779397|FG001|Overall Study|Adverse Event|5|||
46623554|NCT02168946|82779396|FG000|Overall Study|Lost to Follow-up|3|||
46623555|NCT02168946|82779397|FG001|Overall Study|Lost to Follow-up|0|||
46623556|NCT02168946|82779396|FG000|Overall Study|Subject unable to come back for visits|1|||
46623557|NCT02168946|82779397|FG001|Overall Study|Subject unable to come back for visits|0|||
46623558|NCT02168478|82779418|FG000|Overall Study|Withdrawal by Subject|1|||
46623559|NCT02168478|82779418|FG000|Overall Study|Did Not Consent to Participation|2|||
46710303|NCT00960531|82926380|FG003|Overall Study|Reason not Specified|1|||
46710304|NCT00960531|82926381|FG004|Overall Study|Reason not Specified|2|||
46623560|NCT02168478|82779418|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
46623561|NCT02200614|82780569|FG000|Double Blind Treatment|Adverse Event|86|||
46623562|NCT02200614|82780570|FG001|Double Blind Treatment|Adverse Event|48|||
46623563|NCT02200614|82780569|FG000|Double Blind Treatment|Confirmed metastasis|120|||
46623564|NCT02200614|82780570|FG001|Double Blind Treatment|Confirmed metastasis|140|||
46623565|NCT02200614|82780569|FG000|Double Blind Treatment|Judgment of the investigator|59|||
46623566|NCT02200614|82780570|FG001|Double Blind Treatment|Judgment of the investigator|99|||
46623567|NCT02200614|82780569|FG000|Double Blind Treatment|Metastasis by local reading|1|||
46623568|NCT02200614|82780570|FG001|Double Blind Treatment|Metastasis by local reading|3|||
46623569|NCT02200614|82780569|FG000|Double Blind Treatment|Other reason|6|||
46623570|NCT02200614|82780570|FG001|Double Blind Treatment|Other reason|2|||
46623571|NCT02200614|82780569|FG000|Double Blind Treatment|Personal reason|77|||
46623572|NCT02200614|82780570|FG001|Double Blind Treatment|Personal reason|85|||
46623573|NCT02200614|82780569|FG000|Double Blind Treatment|Protocol deviation|14|||
46623574|NCT02200614|82780570|FG001|Double Blind Treatment|Protocol deviation|7|||
46623575|NCT02200614|82780569|FG000|Double Blind Treatment|Not treated|1|||
46623576|NCT02200614|82780570|FG001|Double Blind Treatment|Not treated|0|||
46623577|NCT02200614|82780569|FG000|Open Label|Adverse Event|41|||
46623578|NCT02200614|82780570|FG001|Open Label|Adverse Event|11|||
46623579|NCT02200614|82780569|FG000|Open Label|Confirmed metastasis|1|||
46623580|NCT02200614|82780570|FG001|Open Label|Confirmed metastasis|0|||
46623581|NCT02200614|82780569|FG000|Open Label|Judgment of the investigator|29|||
47027450|NCT01393600|83277298|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
47027451|NCT01393600|83277299|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
47027452|NCT01393600|83277300|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
47027453|NCT01393600|83277297|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
47027454|NCT01393600|83277298|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
47027455|NCT01393600|83277299|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
47027456|NCT01393600|83277300|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
47027457|NCT01393600|83277297|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
47027458|NCT01393600|83277298|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
47027459|NCT01393600|83277299|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
47027460|NCT01393600|83277300|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
47027461|NCT01393600|83277297|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
47027462|NCT01393600|83277298|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
47027463|NCT01393600|83277299|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
47027464|NCT01393600|83277300|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
47027465|NCT01393600|83277297|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
47027466|NCT01393600|83277298|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
47027467|NCT01393600|83277299|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
47027468|NCT01393600|83277300|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
47027469|NCT01432756|83277316|FG000|Overall Study|Lost to Follow-up|1|||
47027470|NCT01432756|83277317|FG001|Overall Study|Lost to Follow-up|0|||
47027471|NCT01432756|83277318|FG002|Overall Study|Lost to Follow-up|2|||
47027472|NCT01432756|83277319|FG003|Overall Study|Lost to Follow-up|1|||
47027473|NCT01432600|83277330|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
47027474|NCT01432600|83277331|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
47027475|NCT01432600|83277332|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
47027476|NCT01432444|83277342|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
47027477|NCT01432444|83277343|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
47027478|NCT01432444|83277344|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
47027479|NCT01432444|83277342|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
47027480|NCT01432444|83277343|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
47027481|NCT01432444|83277344|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
47027482|NCT01432444|83277342|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
47027483|NCT01432444|83277343|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
46623582|NCT02200614|82780570|FG001|Open Label|Judgment of the investigator|2|||
46623583|NCT02200614|82780569|FG000|Open Label|Metastasis by local reading|138|||
46623584|NCT02200614|82780570|FG001|Open Label|Metastasis by local reading|27|||
46623585|NCT02200614|82780569|FG000|Open Label|Other reason|22|||
46623586|NCT02200614|82780570|FG001|Open Label|Other reason|4|||
46623587|NCT02200614|82780569|FG000|Open Label|Personal reason|60|||
46710305|NCT00960531|82926382|FG005|Overall Study|Reason not Specified|0|||
47027484|NCT01432444|83277344|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
47027485|NCT01432444|83277342|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
47027486|NCT01432444|83277343|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
47027487|NCT01432444|83277344|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
47027488|NCT01432444|83277342|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
47027489|NCT01432444|83277343|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
47027490|NCT01432444|83277344|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
47027491|NCT01432444|83277342|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
46623588|NCT02200614|82780570|FG001|Open Label|Personal reason|8|||
46623589|NCT02200614|82780569|FG000|Open Label|Protocol deviation|3|||
46623590|NCT02200614|82780570|FG001|Open Label|Protocol deviation|2|||
46623591|NCT02200614|82780569|FG000|Open Label|Missing|2|||
46623592|NCT02200614|82780570|FG001|Open Label|Missing|2|||
46623593|NCT02231892|82780581|FG000|Overall Study|Lost to Follow-up|1|||
46623594|NCT02231892|82780582|FG001|Overall Study|Lost to Follow-up|0|||
46623595|NCT02231892|82780583|FG002|Overall Study|Lost to Follow-up|3|||
46623596|NCT02231892|82780581|FG000|Overall Study|Withdrawal by Subject|4|||
46623597|NCT02231892|82780582|FG001|Overall Study|Withdrawal by Subject|3|||
46623598|NCT02231892|82780583|FG002|Overall Study|Withdrawal by Subject|15|||
46623599|NCT02231892|82780581|FG000|Overall Study|Physician Decision|0|||
46623600|NCT02231892|82780582|FG001|Overall Study|Physician Decision|2|||
46623601|NCT02231892|82780583|FG002|Overall Study|Physician Decision|4|||
46623602|NCT02231892|82780581|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
46623603|NCT02231892|82780582|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
46623604|NCT02231892|82780583|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
46623605|NCT02231892|82780581|FG000|Overall Study|Participant motor threshold was >83%|0|||
46623606|NCT02231892|82780582|FG001|Overall Study|Participant motor threshold was >83%|0|||
46623607|NCT02231892|82780583|FG002|Overall Study|Participant motor threshold was >83%|9|||
46623608|NCT02231892|82780581|FG000|Overall Study|Could not find motor threshold|2|||
46623609|NCT02231892|82780582|FG001|Overall Study|Could not find motor threshold|0|||
46623610|NCT02231892|82780583|FG002|Overall Study|Could not find motor threshold|1|||
46623611|NCT02231892|82780581|FG000|Overall Study|Could not find reliable motor hotspot|0|||
46623612|NCT02231892|82780582|FG001|Overall Study|Could not find reliable motor hotspot|0|||
46623613|NCT02231892|82780583|FG002|Overall Study|Could not find reliable motor hotspot|1|||
46623614|NCT02231580|82780599|FG000|Overall Study|Adverse Event|5|||
46623615|NCT02231580|82780600|FG001|Overall Study|Adverse Event|0|||
46623616|NCT02166606|82780608|FG000|Overall Study|Adverse Event|3|||
46623617|NCT02166606|82780608|FG000|Overall Study|Death|31|||
46623618|NCT02166606|82780608|FG000|Overall Study|Protocol Violation|7|||
46623619|NCT02166606|82780608|FG000|Overall Study|Lost to Follow-up|30|||
46623620|NCT02166606|82780608|FG000|Overall Study|Withdrawal by Subject|1|||
46623621|NCT02166606|82780608|FG000|Overall Study|Physician Decision|1|||
46623622|NCT02166606|82780608|FG000|Overall Study|Device upgrade|1|||
47027492|NCT01432444|83277343|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
46623623|NCT02166606|82780608|FG000|Overall Study|Enrolled after End of Enrollment|4|||
46623624|NCT02230956|82780615|FG000|Overall Study|Adverse Event|1|||
46623625|NCT02230956|82780616|FG001|Overall Study|Adverse Event|1|||
46623626|NCT02230956|82780617|FG002|Overall Study|Adverse Event|0|||
46623627|NCT02230956|82780615|FG000|Overall Study|Lack of Efficacy|1|||
46623628|NCT02230956|82780616|FG001|Overall Study|Lack of Efficacy|1|||
46623629|NCT02230956|82780617|FG002|Overall Study|Lack of Efficacy|1|||
46623630|NCT02230956|82780615|FG000|Overall Study|Lost to Follow-up|1|||
46623631|NCT02230956|82780616|FG001|Overall Study|Lost to Follow-up|1|||
46623632|NCT02230956|82780617|FG002|Overall Study|Lost to Follow-up|2|||
46623633|NCT02230956|82780615|FG000|Overall Study|Personal Reasons|2|||
46623634|NCT02230956|82780616|FG001|Overall Study|Personal Reasons|1|||
46623635|NCT02230956|82780617|FG002|Overall Study|Personal Reasons|1|||
46623636|NCT02230956|82780615|FG000|Overall Study|Protocol Violation|0|||
46623637|NCT02230956|82780616|FG001|Overall Study|Protocol Violation|1|||
46623638|NCT02230956|82780617|FG002|Overall Study|Protocol Violation|1|||
46623639|NCT02230956|82780615|FG000|Overall Study|Other Miscellaneous Reason|0|||
46623640|NCT02230956|82780616|FG001|Overall Study|Other Miscellaneous Reason|1|||
46623641|NCT02230956|82780617|FG002|Overall Study|Other Miscellaneous Reason|2|||
46623642|NCT02230410|82780625|FG000|Overall Study|Screen Failure|3|||
46623643|NCT02230332|82780631|FG000|Overall Study|Adverse Event|2|||
46623644|NCT02230332|82780632|FG001|Overall Study|Adverse Event|1|||
46623645|NCT02230332|82780631|FG000|Overall Study|Lost to Follow-up|1|||
46623646|NCT02230332|82780632|FG001|Overall Study|Lost to Follow-up|0|||
46623647|NCT02230332|82780631|FG000|Overall Study|Protocol Violation|1|||
46623648|NCT02230332|82780632|FG001|Overall Study|Protocol Violation|0|||
46623649|NCT02230254|82780638|FG000|Overall Study|Lost to Follow-up|3|||
46623650|NCT02198664|82780644|FG000|Overall Study|Adverse Event|2|||
46623651|NCT02198664|82780645|FG001|Overall Study|Adverse Event|0|||
46623652|NCT02198664|82780644|FG000|Overall Study|Withdrawal by Subject|11|||
46623653|NCT02198664|82780645|FG001|Overall Study|Withdrawal by Subject|8|||
46623654|NCT02198664|82780644|FG000|Overall Study|Failure to tolerate|2|||
46623655|NCT02198664|82780645|FG001|Overall Study|Failure to tolerate|0|||
46912227|NCT03012828|83142281|FG001|Overall Study|Withdrawal by Subject|0|||
46912228|NCT03012828|83142282|FG002|Overall Study|Withdrawal by Subject|1|||
46912229|NCT03012828|83142283|FG003|Overall Study|Withdrawal by Subject|0|||
46912230|NCT03012828|83142284|FG004|Overall Study|Withdrawal by Subject|0|||
46912231|NCT03012828|83142285|FG005|Overall Study|Withdrawal by Subject|1|||
46912232|NCT03012828|83142280|FG000|Overall Study|Non-compliance with protocol|0|||
46912233|NCT03012828|83142281|FG001|Overall Study|Non-compliance with protocol|0|||
46912234|NCT03012828|83142282|FG002|Overall Study|Non-compliance with protocol|0|||
46912235|NCT03012828|83142283|FG003|Overall Study|Non-compliance with protocol|0|||
46912236|NCT03012828|83142284|FG004|Overall Study|Non-compliance with protocol|1|||
46912237|NCT03012828|83142285|FG005|Overall Study|Non-compliance with protocol|0|||
46912238|NCT03012828|83142280|FG000|Overall Study|Delay to last visit would delay DBL|0|||
46912239|NCT03012828|83142281|FG001|Overall Study|Delay to last visit would delay DBL|0|||
46912240|NCT03012828|83142282|FG002|Overall Study|Delay to last visit would delay DBL|0|||
47027493|NCT01432444|83277344|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
47027494|NCT01432444|83277342|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
47027495|NCT01432444|83277343|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
47027496|NCT01432444|83277344|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
47027497|NCT01432444|83277342|FG000|Treatment Phase|Lost to Follow-up|0|||
47027498|NCT01432444|83277343|FG001|Treatment Phase|Lost to Follow-up|33|||
47027499|NCT01432444|83277344|FG002|Treatment Phase|Lost to Follow-up|0|||
47027500|NCT01432444|83277342|FG000|Treatment Phase|Adverse Event|0|||
47027501|NCT01432444|83277343|FG001|Treatment Phase|Adverse Event|37|||
47027502|NCT01432444|83277344|FG002|Treatment Phase|Adverse Event|0|||
46912241|NCT03012828|83142283|FG003|Overall Study|Delay to last visit would delay DBL|0|||
47027503|NCT01432444|83277342|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
46623656|NCT02198664|82780644|FG000|Overall Study|Not stated|1|||
46710306|NCT00960531|82926383|FG006|Overall Study|Reason not Specified|16|||
46912242|NCT03012828|83142284|FG004|Overall Study|Delay to last visit would delay DBL|0|||
46912243|NCT03012828|83142285|FG005|Overall Study|Delay to last visit would delay DBL|1|||
46912244|NCT03010254|83142303|FG000|Overall Study|Adverse Event|0|||
47027504|NCT01432444|83277343|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
47027505|NCT01432444|83277344|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
47027506|NCT01432444|83277342|FG000|Treatment Phase|Physician Decision|0|||
47027507|NCT01432444|83277343|FG001|Treatment Phase|Physician Decision|5|||
47027508|NCT01432444|83277344|FG002|Treatment Phase|Physician Decision|0|||
47027509|NCT01432444|83277342|FG000|Treatment Phase|Withdrawal by Subject|0|||
47027510|NCT01432444|83277343|FG001|Treatment Phase|Withdrawal by Subject|41|||
47027511|NCT01432444|83277344|FG002|Treatment Phase|Withdrawal by Subject|0|||
47027512|NCT01432444|83277342|FG000|Treatment Phase|Protocol Deviation|0|||
47027513|NCT01432444|83277343|FG001|Treatment Phase|Protocol Deviation|3|||
47027514|NCT01432444|83277344|FG002|Treatment Phase|Protocol Deviation|0|||
47027515|NCT01432444|83277342|FG000|Treatment Phase|Lack of Efficacy|0|||
47027516|NCT01432444|83277343|FG001|Treatment Phase|Lack of Efficacy|10|||
47027517|NCT01432444|83277344|FG002|Treatment Phase|Lack of Efficacy|0|||
47027518|NCT01432444|83277342|FG000|Extension Phase|Lost to Follow-up|0|||
47027519|NCT01432444|83277343|FG001|Extension Phase|Lost to Follow-up|0|||
47027520|NCT01432444|83277344|FG002|Extension Phase|Lost to Follow-up|17|||
47027521|NCT01432444|83277342|FG000|Extension Phase|Adverse Event|0|||
47027522|NCT01432444|83277343|FG001|Extension Phase|Adverse Event|0|||
47027523|NCT01432444|83277344|FG002|Extension Phase|Adverse Event|10|||
47027524|NCT01432444|83277342|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
47027525|NCT01432444|83277343|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
47027526|NCT01432444|83277344|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
47027527|NCT01432444|83277342|FG000|Extension Phase|Met Withdrawal Criteria|0|||
47027528|NCT01432444|83277343|FG001|Extension Phase|Met Withdrawal Criteria|0|||
47027529|NCT01432444|83277344|FG002|Extension Phase|Met Withdrawal Criteria|144|||
47027530|NCT01432444|83277342|FG000|Extension Phase|Physician Decision|0|||
47027531|NCT01432444|83277343|FG001|Extension Phase|Physician Decision|0|||
47027532|NCT01432444|83277344|FG002|Extension Phase|Physician Decision|1|||
47027533|NCT01432444|83277342|FG000|Extension Phase|Withdrawal by Subject|0|||
47027534|NCT01432444|83277343|FG001|Extension Phase|Withdrawal by Subject|0|||
47027535|NCT01432444|83277344|FG002|Extension Phase|Withdrawal by Subject|13|||
47027536|NCT01432366|83277349|FG000|Overall Study|Non-Responder|7|||
47027537|NCT01432366|83277349|FG000|Overall Study|Adverse Event|8|||
47027538|NCT01432366|83277349|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
47027539|NCT01432366|83277349|FG000|Overall Study|Pregnancy|1|||
47027540|NCT01432366|83277349|FG000|Overall Study|Lost to Follow-up|13|||
47027541|NCT01432366|83277349|FG000|Overall Study|Lack of Efficacy|1|||
47027542|NCT01432366|83277349|FG000|Overall Study|Site Closed|20|||
47027543|NCT01432366|83277349|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
47027544|NCT01432366|83277349|FG000|Overall Study|Other|14|||
47027545|NCT01415440|83277356|FG000|Overall Study|Lost to Follow-up|0|||
47027546|NCT01415440|83277357|FG001|Overall Study|Lost to Follow-up|1|||
47027547|NCT01415440|83277358|FG002|Overall Study|Lost to Follow-up|2|||
47027548|NCT01415440|83277356|FG000|Overall Study|Physician Decision|3|||
47027549|NCT01415440|83277357|FG001|Overall Study|Physician Decision|0|||
47027550|NCT01415440|83277358|FG002|Overall Study|Physician Decision|0|||
47027551|NCT01415440|83277356|FG000|Overall Study|Withdrawal by Subject|1|||
47027552|NCT01415440|83277357|FG001|Overall Study|Withdrawal by Subject|0|||
46912245|NCT03010254|83142304|FG001|Overall Study|Adverse Event|1|||
46912246|NCT03010254|83142303|FG000|Overall Study|Lost to Follow-up|4|||
46912247|NCT03010254|83142304|FG001|Overall Study|Lost to Follow-up|0|||
46912248|NCT03010254|83142303|FG000|Overall Study|Withdrawal by Subject|1|||
46912249|NCT03010254|83142304|FG001|Overall Study|Withdrawal by Subject|1|||
46912250|NCT03010254|83142303|FG000|Overall Study|Other|2|||
46912251|NCT03010254|83142304|FG001|Overall Study|Other|3|||
47027553|NCT01415440|83277358|FG002|Overall Study|Withdrawal by Subject|0|||
47027554|NCT01932788|83277376|FG000|Overall Study|Protocol Violation|18|||
47027555|NCT01932788|83277377|FG001|Overall Study|Protocol Violation|0|||
47027556|NCT01932788|83277376|FG000|Overall Study|Lost to Follow-up|18|||
47027557|NCT01932788|83277377|FG001|Overall Study|Lost to Follow-up|46|||
47027558|NCT01932788|83277376|FG000|Overall Study|Lack of Efficacy|2|||
47027559|NCT01932788|83277377|FG001|Overall Study|Lack of Efficacy|0|||
46912252|NCT03008460|83142319|FG000|Overall Study|Protocol deviation|0|||
46912253|NCT03008460|83142320|FG001|Overall Study|Protocol deviation|2|||
47027560|NCT01932788|83277376|FG000|Overall Study|Withdrawal by Subject|0|||
47027561|NCT01932788|83277377|FG001|Overall Study|Withdrawal by Subject|5|||
47027562|NCT01414738|83277383|FG000|Overall Study|Death|26|||
47027563|NCT01414738|83277383|FG000|Overall Study|Refused testing|5|||
47027564|NCT01414738|83277383|FG000|Overall Study|Lost to Follow-up|2|||
47027565|NCT01414738|83277383|FG000|Overall Study|Refused, disease progression|8|||
46623657|NCT02198664|82780645|FG001|Overall Study|Not stated|0|||
46623658|NCT02165826|82780656|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
46623659|NCT02165826|82780657|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
46623660|NCT02165826|82780658|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
46623661|NCT02165826|82780656|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
46623662|NCT02165826|82780657|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
46623663|NCT02165826|82780658|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
46623664|NCT02165826|82780656|FG000|Main Treatment Period|Lost to Follow-up|4|||
46623665|NCT02165826|82780657|FG001|Main Treatment Period|Lost to Follow-up|2|||
46623666|NCT02165826|82780658|FG002|Main Treatment Period|Lost to Follow-up|1|||
46623667|NCT02165826|82780656|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
46623668|NCT02165826|82780657|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
46623669|NCT02165826|82780658|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
46623670|NCT02165826|82780656|FG000|Main Treatment Period|Lack of Efficacy|2|||
46623671|NCT02165826|82780657|FG001|Main Treatment Period|Lack of Efficacy|0|||
46623672|NCT02165826|82780658|FG002|Main Treatment Period|Lack of Efficacy|0|||
46623673|NCT02165826|82780656|FG000|Main Treatment Period|Reason Not Specified|8|||
46623674|NCT02165826|82780657|FG001|Main Treatment Period|Reason Not Specified|5|||
46623675|NCT02165826|82780658|FG002|Main Treatment Period|Reason Not Specified|16|||
46623676|NCT02165826|82780656|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
46623677|NCT02165826|82780657|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
46623678|NCT02165826|82780658|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
46623679|NCT02165826|82780656|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
46623680|NCT02165826|82780657|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
46623681|NCT02165826|82780658|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
46623682|NCT02165826|82780656|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
46623683|NCT02165826|82780657|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
46623684|NCT02165826|82780658|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
46623685|NCT02165826|82780656|FG000|Down-Titration Period|Reason Not Specified|1|||
46623686|NCT02165826|82780657|FG001|Down-Titration Period|Reason Not Specified|0|||
46623687|NCT02165826|82780658|FG002|Down-Titration Period|Reason Not Specified|2|||
46623688|NCT02198040|82780695|FG000|Overall Study|Work reasons|0|||
46623689|NCT02198040|82780696|FG001|Overall Study|Work reasons|1|||
46623690|NCT02198040|82780697|FG002|Overall Study|Work reasons|0|||
46623691|NCT02198040|82780695|FG000|Overall Study|Withdrawal by Subject|0|||
46623692|NCT02198040|82780696|FG001|Overall Study|Withdrawal by Subject|0|||
46623693|NCT02198040|82780697|FG002|Overall Study|Withdrawal by Subject|1|||
46623694|NCT02197806|82780711|FG000|Overall Study|Adverse Event|0|||
46623695|NCT02197806|82780712|FG001|Overall Study|Adverse Event|1|||
46623696|NCT02197806|82780713|FG002|Overall Study|Adverse Event|0|||
46623697|NCT02197806|82780714|FG003|Overall Study|Adverse Event|1|||
46623698|NCT02229864|82780761|FG000|Overall Study|Death|2|||
46623699|NCT02229864|82780761|FG000|Overall Study|Lost to Follow-up|1|||
46623700|NCT02229552|82780765|FG000|Baseline|Withdrawal by Subject|6|||
46623701|NCT02229552|82780765|FG000|1-year Follow up|Withdrawal by Subject|7|||
46623702|NCT02229552|82780765|FG000|1-year Follow up|Lost to Follow-up|18|||
46623703|NCT02229552|82780765|FG000|2-Year Follow up|Withdrawal by Subject|9|||
46912254|NCT03008460|83142319|FG000|Overall Study|Study drug not dispensed|0|||
46912255|NCT03008460|83142320|FG001|Overall Study|Study drug not dispensed|1|||
46623704|NCT02229552|82780765|FG000|2-Year Follow up|Lost to Follow-up|17|||
46623705|NCT02229396|82780772|FG000|Overall Study|Adverse Event|6|||
46623706|NCT02229396|82780773|FG001|Overall Study|Adverse Event|12|||
46623707|NCT02229396|82780774|FG002|Overall Study|Adverse Event|12|||
46623708|NCT02229396|82780772|FG000|Overall Study|Death|2|||
46623709|NCT02229396|82780773|FG001|Overall Study|Death|3|||
46623710|NCT02229396|82780774|FG002|Overall Study|Death|1|||
46623711|NCT02229396|82780772|FG000|Overall Study|Lost to Follow-up|14|||
46623712|NCT02229396|82780773|FG001|Overall Study|Lost to Follow-up|14|||
46623713|NCT02229396|82780774|FG002|Overall Study|Lost to Follow-up|21|||
46623714|NCT02229396|82780772|FG000|Overall Study|Protocol Violation|2|||
46623715|NCT02229396|82780773|FG001|Overall Study|Protocol Violation|1|||
46623716|NCT02229396|82780774|FG002|Overall Study|Protocol Violation|0|||
46623717|NCT02229396|82780772|FG000|Overall Study|Patient Incorrectly Randomized|0|||
46623718|NCT02229396|82780773|FG001|Overall Study|Patient Incorrectly Randomized|0|||
46623719|NCT02229396|82780774|FG002|Overall Study|Patient Incorrectly Randomized|1|||
46623720|NCT02229396|82780772|FG000|Overall Study|Other|10|||
46623721|NCT02229396|82780773|FG001|Overall Study|Other|18|||
46623722|NCT02229396|82780774|FG002|Overall Study|Other|15|||
46623723|NCT02229396|82780772|FG000|Overall Study|Withdrawal by Subject|42|||
46623724|NCT02229396|82780773|FG001|Overall Study|Withdrawal by Subject|28|||
46623725|NCT02229396|82780774|FG002|Overall Study|Withdrawal by Subject|41|||
46623726|NCT02229396|82780772|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
46623727|NCT02229396|82780773|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
46623728|NCT02229396|82780774|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
46623729|NCT02229396|82780772|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
46623730|NCT02229396|82780773|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
46623731|NCT02229396|82780774|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
46623732|NCT02197416|82780789|FG000|Overall Study|Other reasons|0|||
46623733|NCT02197416|82780790|FG001|Overall Study|Other reasons|2|||
46623734|NCT02197416|82780791|FG002|Overall Study|Other reasons|5|||
46623735|NCT02197416|82780789|FG000|Overall Study|Withdrawal by Subject|0|||
46623736|NCT02197416|82780790|FG001|Overall Study|Withdrawal by Subject|2|||
46623737|NCT02197416|82780791|FG002|Overall Study|Withdrawal by Subject|1|||
46623738|NCT02197416|82780789|FG000|Overall Study|Protocol Violation|1|||
46623739|NCT02197416|82780790|FG001|Overall Study|Protocol Violation|0|||
46623740|NCT02197416|82780791|FG002|Overall Study|Protocol Violation|1|||
46623741|NCT02197416|82780789|FG000|Overall Study|Adverse Event|0|||
46623742|NCT02197416|82780790|FG001|Overall Study|Adverse Event|0|||
46623743|NCT02197416|82780791|FG002|Overall Study|Adverse Event|1|||
46623744|NCT02165202|82780799|FG000|Oral Phase|Refused further participation|5|||
46623745|NCT02165202|82780800|FG001|Oral Phase|Refused further participation|1|||
46623746|NCT02165202|82780799|FG000|Oral Phase|Study product Related Toxicity|1|||
46623747|NCT02165202|82780800|FG001|Oral Phase|Study product Related Toxicity|0|||
46623748|NCT02165202|82780799|FG000|Oral Phase|Unable to contact Participant|1|||
46623749|NCT02165202|82780800|FG001|Oral Phase|Unable to contact Participant|1|||
46623750|NCT02165202|82780799|FG000|Oral Phase|Clinical reasons|1|||
46623751|NCT02165202|82780800|FG001|Oral Phase|Clinical reasons|0|||
46623752|NCT02165202|82780799|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
46623753|NCT02165202|82780800|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
46623754|NCT02165202|82780799|FG000|Oral Phase|CMC advised termination|1|||
46623755|NCT02165202|82780800|FG001|Oral Phase|CMC advised termination|0|||
46623756|NCT02165202|82780799|FG000|Oral Phase|Relocated, no follow-up planned|1|||
46623757|NCT02165202|82780800|FG001|Oral Phase|Relocated, no follow-up planned|0|||
46623758|NCT02165202|82780799|FG000|Oral Phase|Abnormal EKG|0|||
46623759|NCT02165202|82780800|FG001|Oral Phase|Abnormal EKG|1|||
46623760|NCT02165202|82780799|FG000|Injection Phase|Abnormal Lab Value|5|||
46623761|NCT02165202|82780800|FG001|Injection Phase|Abnormal Lab Value|1|||
46623762|NCT02165202|82780799|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
46623763|NCT02165202|82780800|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
46623764|NCT02165202|82780799|FG000|Injection Phase|Unable to attend within Visit Window|1|||
46623765|NCT02165202|82780800|FG001|Injection Phase|Unable to attend within Visit Window|0|||
46623766|NCT02165202|82780799|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
46623767|NCT02165202|82780800|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
46623768|NCT02165202|82780799|FG000|Injection Phase|End of Study|2|||
46623769|NCT02165202|82780800|FG001|Injection Phase|End of Study|1|||
46623770|NCT02165202|82780799|FG000|Injection Phase|Study Product related Toxicity|1|||
46912256|NCT03008460|83142319|FG000|Overall Study|Adverse Event|0|||
46912257|NCT03008460|83142320|FG001|Overall Study|Adverse Event|1|||
46623771|NCT02165202|82780800|FG001|Injection Phase|Study Product related Toxicity|0|||
46623772|NCT02165202|82780799|FG000|Injection Phase|No longer interested|0|||
46623773|NCT02165202|82780800|FG001|Injection Phase|No longer interested|1|||
46623774|NCT02165202|82780799|FG000|Injection Phase|Participant unwilling to comply|1|||
46623775|NCT02165202|82780800|FG001|Injection Phase|Participant unwilling to comply|0|||
46623776|NCT01628874|82780808|FG000|Overall Study|Physician Decision|1|||
46623777|NCT01628874|82780809|FG001|Overall Study|Physician Decision|1|||
46623778|NCT01628874|82780808|FG000|Overall Study|Age >4 months|4|||
46623779|NCT01628874|82780809|FG001|Overall Study|Age >4 months|2|||
46623780|NCT02196714|82780834|FG000|Overall Study|Protocol Violation|0|||
46623781|NCT02196714|82780835|FG001|Overall Study|Protocol Violation|0|||
46623782|NCT02196714|82780836|FG002|Overall Study|Protocol Violation|1|||
46623783|NCT02196714|82780837|FG003|Overall Study|Protocol Violation|0|||
46623784|NCT02196558|82780861|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
46623785|NCT02196558|82780862|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
46623786|NCT02196558|82780863|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
46623787|NCT02196558|82780861|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
46623788|NCT02196558|82780862|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
46623789|NCT02196558|82780863|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
46623790|NCT02196558|82780861|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
46623791|NCT02196558|82780862|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
46623792|NCT02196558|82780863|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
46623793|NCT02196558|82780861|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
46623794|NCT02196558|82780862|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
46623795|NCT02196558|82780863|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
46623796|NCT02196558|82780861|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
46623797|NCT02196558|82780862|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
46623798|NCT02196558|82780863|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
46623799|NCT02196324|82780884|FG000|Overall Study|Withdrawal by Subject|8|||
46623800|NCT02196324|82780885|FG001|Overall Study|Withdrawal by Subject|4|||
46623801|NCT02196324|82780884|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
46623802|NCT02196324|82780885|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
46623803|NCT02196324|82780884|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
46623804|NCT02196324|82780885|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
46623805|NCT02196324|82780884|FG000|Overall Study|Other|1|||
46623806|NCT02196324|82780885|FG001|Overall Study|Other|0|||
46623807|NCT02195700|82780893|FG000|Overall Study|Protocol Violation|0|||
46912258|NCT03008460|83142319|FG000|Overall Study|Withdrawal by Subject|5|||
47027566|NCT01414738|83277383|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
47027567|NCT01414114|83277387|FG000|Overall Study|Adverse Event|2|||
47027568|NCT01414114|83277387|FG000|Overall Study|Withdrawal by Subject|1|||
47027569|NCT01414114|83277387|FG000|Overall Study|Other|2|||
47027570|NCT01393444|83277393|FG000|Overall Study|Withdrawal by Subject|1|||
47027571|NCT01393444|83277393|FG000|Overall Study|Determined ineligible during screening.|2|||
47027572|NCT01431976|83277397|FG000|Overall Study|Adverse Event|6|||
47027573|NCT01431976|83277397|FG000|Overall Study|Lack of Efficacy|2|||
47027574|NCT01431976|83277397|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
47027575|NCT01431976|83277397|FG000|Overall Study|Physician Decision|1|||
47027576|NCT01431976|83277397|FG000|Overall Study|Withdrawal by Subject|1|||
47027577|NCT01392742|83277401|FG000|Overall Study|Premature study termination|42|||
47027578|NCT01392742|83277401|FG000|Overall Study|Failure to return|35|||
47027579|NCT01392742|83277401|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
47027580|NCT01392742|83277401|FG000|Overall Study|Lost to Follow-up|34|||
47027581|NCT01392742|83277401|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
47027582|NCT01392742|83277401|FG000|Overall Study|ITR and Protocol deviation|1|||
47027583|NCT01392742|83277401|FG000|Overall Study|Adverse event/intercurrent illness|17|||
47027584|NCT01392742|83277401|FG000|Overall Study|Protocol Violation|14|||
47027585|NCT01392742|83277401|FG000|Overall Study|Other|3|||
47027586|NCT01392742|83277401|FG000|Overall Study|Missing information|13|||
47027587|NCT01413958|83277407|FG000|Overall Study|Lost to Follow-up|0|||
47027588|NCT01413958|83277408|FG001|Overall Study|Lost to Follow-up|1|||
47027589|NCT01413178|83277417|FG000|Overall Study|Toxicity|1|||
47027590|NCT01413178|83277418|FG001|Overall Study|Toxicity|0|||
47027591|NCT01413178|83277417|FG000|Overall Study|Ineligible|0|||
46623808|NCT02195700|82780894|FG001|Overall Study|Protocol Violation|2|||
46623809|NCT02195700|82780893|FG000|Overall Study|Noncompliance|1|||
47027592|NCT01413178|83277418|FG001|Overall Study|Ineligible|2|||
47027593|NCT01799889|83277436|FG000|Overall Study|Adverse Event|4|||
47027594|NCT01799889|83277437|FG001|Overall Study|Adverse Event|4|||
46623810|NCT02195700|82780894|FG001|Overall Study|Noncompliance|0|||
46623811|NCT02195700|82780893|FG000|Overall Study|Adverse Event|1|||
46623812|NCT02195700|82780894|FG001|Overall Study|Adverse Event|2|||
46623813|NCT02195700|82780893|FG000|Overall Study|Withdrawal by Subject|3|||
46623814|NCT02195700|82780894|FG001|Overall Study|Withdrawal by Subject|2|||
46623815|NCT02195700|82780893|FG000|Overall Study|Lost to Follow-up|1|||
46623816|NCT02195700|82780894|FG001|Overall Study|Lost to Follow-up|1|||
46623817|NCT02228460|82780909|FG000|Overall Study|Adverse Event|1|||
47027595|NCT01799889|83277438|FG002|Overall Study|Adverse Event|5|||
47027596|NCT01799889|83277439|FG003|Overall Study|Adverse Event|1|||
46623818|NCT02228460|82780909|FG000|Overall Study|Lost to Follow-up|1|||
46623819|NCT02227446|82780925|FG000|Overall Study|not eligible post randomization|18|||
46623820|NCT02227446|82780926|FG001|Overall Study|not eligible post randomization|29|||
46623821|NCT02227446|82780925|FG000|Overall Study|Withdrawal by Subject|4|||
46623822|NCT02227446|82780926|FG001|Overall Study|Withdrawal by Subject|5|||
47027597|NCT01799889|83277440|FG004|Overall Study|Adverse Event|11|||
47027598|NCT01799889|83277441|FG005|Overall Study|Adverse Event|1|||
46623823|NCT02227368|82780934|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
46623824|NCT02227368|82780935|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
46623825|NCT02227368|82780934|FG000|Overall Study|Lost to Follow-up|1|||
46623826|NCT02227368|82780935|FG001|Overall Study|Lost to Follow-up|0|||
46623827|NCT02227368|82780934|FG000|Overall Study|Adverse Event|1|||
46623828|NCT02227368|82780935|FG001|Overall Study|Adverse Event|0|||
46623829|NCT02162862|82780944|FG000|Overall Study|Lost to Follow-up|0|||
46623830|NCT02162862|82780945|FG001|Overall Study|Lost to Follow-up|11|||
46623831|NCT02162862|82780946|FG002|Overall Study|Lost to Follow-up|0|||
46623832|NCT02162862|82780944|FG000|Overall Study|Subject did not feel the med was needed|0|||
46623833|NCT02162862|82780945|FG001|Overall Study|Subject did not feel the med was needed|0|||
46623834|NCT02162862|82780946|FG002|Overall Study|Subject did not feel the med was needed|4|||
46623835|NCT02226198|82780984|FG000|Lead-in Phase|Protocol Violation|1|||
46623836|NCT02226198|82780985|FG001|Lead-in Phase|Protocol Violation|0|||
46623837|NCT02226198|82780986|FG002|Lead-in Phase|Protocol Violation|0|||
46623838|NCT02226198|82780984|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
46623839|NCT02226198|82780985|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
46623840|NCT02226198|82780986|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
46623841|NCT02226120|82781157|FG000|Overall Study|Adverse Event|60|||
46623842|NCT02226120|82781157|FG000|Overall Study|Death|172|||
46623843|NCT02226120|82781157|FG000|Overall Study|Study terminated by sponsor|1|||
46623844|NCT02226120|82781157|FG000|Overall Study|Technical problems|4|||
46623845|NCT02226120|82781157|FG000|Overall Study|Lost to Follow-up|13|||
46623846|NCT02226120|82781157|FG000|Overall Study|Physician Decision|21|||
46623847|NCT02226120|82781157|FG000|Overall Study|Withdrawal by parent/guardian|36|||
46623848|NCT02226120|82781157|FG000|Overall Study|Non-compliance with study drug|10|||
46623849|NCT02226120|82781157|FG000|Overall Study|Protocol deviation|1|||
46623850|NCT02226120|82781157|FG000|Overall Study|missing treatment disposition pages|2|||
46623851|NCT02194998|82781322|FG000|On-HCV Treatment|Did not pick up study medication|0|||
46623852|NCT02194998|82781323|FG001|On-HCV Treatment|Did not pick up study medication|1|||
46623853|NCT02194998|82781324|FG002|On-HCV Treatment|Did not pick up study medication|0|||
46623854|NCT02194998|82781325|FG003|On-HCV Treatment|Did not pick up study medication|0|||
46623855|NCT02194998|82781322|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
46623856|NCT02194998|82781323|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
46623857|NCT02194998|82781324|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
46623858|NCT02194998|82781325|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
46623859|NCT02194062|82781338|FG000|Overall Study|Lost to Follow-up|2|||
46623860|NCT02194062|82781339|FG001|Overall Study|Lost to Follow-up|2|||
46623861|NCT02194062|82781340|FG002|Overall Study|Lost to Follow-up|5|||
46623862|NCT02193828|82781361|FG000|Overall Study|Withdrawal by Subject|0|||
46623863|NCT02193828|82781362|FG001|Overall Study|Withdrawal by Subject|0|||
46623864|NCT02193828|82781363|FG002|Overall Study|Withdrawal by Subject|1|||
46623865|NCT02193828|82781364|FG003|Overall Study|Withdrawal by Subject|1|||
46623866|NCT02192970|82781385|FG000|Overall Study|Lost to Follow-up|6|||
46623867|NCT02192970|82781386|FG001|Overall Study|Lost to Follow-up|0|||
47027599|NCT01799889|83277442|FG006|Overall Study|Adverse Event|5|||
47027600|NCT01799889|83277443|FG007|Overall Study|Adverse Event|2|||
47027601|NCT01799889|83277444|FG008|Overall Study|Adverse Event|3|||
47027602|NCT01799889|83277445|FG009|Overall Study|Adverse Event|1|||
46623868|NCT02192190|82781570|FG000|Overall Study|Adverse Event|1|||
46623869|NCT02192190|82781571|FG001|Overall Study|Adverse Event|1|||
46623870|NCT02192190|82781572|FG002|Overall Study|Adverse Event|0|||
47027603|NCT01799889|83277446|FG010|Overall Study|Adverse Event|1|||
47027604|NCT01799889|83277447|FG011|Overall Study|Adverse Event|0|||
47027605|NCT01799889|83277436|FG000|Overall Study|Death|1|||
47027606|NCT01799889|83277437|FG001|Overall Study|Death|0|||
47027607|NCT01799889|83277438|FG002|Overall Study|Death|5|||
47027608|NCT01799889|83277439|FG003|Overall Study|Death|3|||
46623871|NCT02192190|82781573|FG003|Overall Study|Adverse Event|0|||
46623872|NCT02192190|82781574|FG004|Overall Study|Adverse Event|0|||
46623873|NCT02192190|82781575|FG005|Overall Study|Adverse Event|0|||
46623874|NCT02192190|82781570|FG000|Overall Study|Lost to Follow-up|3|||
46623875|NCT02192190|82781571|FG001|Overall Study|Lost to Follow-up|3|||
46623876|NCT02192190|82781572|FG002|Overall Study|Lost to Follow-up|2|||
46623877|NCT02192190|82781573|FG003|Overall Study|Lost to Follow-up|1|||
46623878|NCT02192190|82781574|FG004|Overall Study|Lost to Follow-up|4|||
46623879|NCT02192190|82781575|FG005|Overall Study|Lost to Follow-up|3|||
47027609|NCT01799889|83277440|FG004|Overall Study|Death|1|||
47027610|NCT01799889|83277441|FG005|Overall Study|Death|0|||
47027611|NCT01799889|83277442|FG006|Overall Study|Death|0|||
47027612|NCT01799889|83277443|FG007|Overall Study|Death|0|||
47027613|NCT01799889|83277444|FG008|Overall Study|Death|1|||
47027614|NCT01799889|83277445|FG009|Overall Study|Death|0|||
47027615|NCT01799889|83277446|FG010|Overall Study|Death|1|||
47027616|NCT01799889|83277447|FG011|Overall Study|Death|0|||
47027617|NCT01799889|83277436|FG000|Overall Study|Lack of Efficacy|1|||
47027618|NCT01799889|83277437|FG001|Overall Study|Lack of Efficacy|1|||
47027619|NCT01799889|83277438|FG002|Overall Study|Lack of Efficacy|0|||
47027620|NCT01799889|83277439|FG003|Overall Study|Lack of Efficacy|1|||
47027621|NCT01799889|83277440|FG004|Overall Study|Lack of Efficacy|2|||
47027622|NCT01799889|83277441|FG005|Overall Study|Lack of Efficacy|2|||
47027623|NCT01799889|83277442|FG006|Overall Study|Lack of Efficacy|0|||
47027624|NCT01799889|83277443|FG007|Overall Study|Lack of Efficacy|0|||
47027625|NCT01799889|83277444|FG008|Overall Study|Lack of Efficacy|2|||
47027626|NCT01799889|83277445|FG009|Overall Study|Lack of Efficacy|0|||
47027627|NCT01799889|83277446|FG010|Overall Study|Lack of Efficacy|1|||
47027628|NCT01799889|83277447|FG011|Overall Study|Lack of Efficacy|0|||
47027629|NCT01799889|83277436|FG000|Overall Study|Lost to Follow-up|0|||
47027630|NCT01799889|83277437|FG001|Overall Study|Lost to Follow-up|1|||
47027631|NCT01799889|83277438|FG002|Overall Study|Lost to Follow-up|0|||
47027632|NCT01799889|83277439|FG003|Overall Study|Lost to Follow-up|0|||
47027633|NCT01799889|83277440|FG004|Overall Study|Lost to Follow-up|0|||
47027634|NCT01799889|83277441|FG005|Overall Study|Lost to Follow-up|0|||
47027635|NCT01799889|83277442|FG006|Overall Study|Lost to Follow-up|0|||
47027636|NCT01799889|83277443|FG007|Overall Study|Lost to Follow-up|0|||
47027637|NCT01799889|83277444|FG008|Overall Study|Lost to Follow-up|0|||
47027638|NCT01799889|83277445|FG009|Overall Study|Lost to Follow-up|0|||
47027639|NCT01799889|83277446|FG010|Overall Study|Lost to Follow-up|0|||
47027640|NCT01799889|83277447|FG011|Overall Study|Lost to Follow-up|0|||
47027641|NCT01799889|83277436|FG000|Overall Study|Physician Decision|3|||
47027642|NCT01799889|83277437|FG001|Overall Study|Physician Decision|2|||
47027643|NCT01799889|83277438|FG002|Overall Study|Physician Decision|4|||
47027644|NCT01799889|83277439|FG003|Overall Study|Physician Decision|4|||
47027645|NCT01799889|83277440|FG004|Overall Study|Physician Decision|5|||
47027646|NCT01799889|83277441|FG005|Overall Study|Physician Decision|5|||
47027647|NCT01799889|83277442|FG006|Overall Study|Physician Decision|5|||
47027648|NCT01799889|83277443|FG007|Overall Study|Physician Decision|2|||
47027649|NCT01799889|83277444|FG008|Overall Study|Physician Decision|6|||
47027650|NCT01799889|83277445|FG009|Overall Study|Physician Decision|0|||
47027651|NCT01799889|83277446|FG010|Overall Study|Physician Decision|0|||
47027652|NCT01799889|83277447|FG011|Overall Study|Physician Decision|1|||
47027653|NCT01799889|83277436|FG000|Overall Study|Progressive Disease|30|||
47027654|NCT01799889|83277437|FG001|Overall Study|Progressive Disease|26|||
47027655|NCT01799889|83277438|FG002|Overall Study|Progressive Disease|25|||
47027656|NCT01799889|83277439|FG003|Overall Study|Progressive Disease|30|||
47027657|NCT01799889|83277440|FG004|Overall Study|Progressive Disease|23|||
47027658|NCT01799889|83277441|FG005|Overall Study|Progressive Disease|9|||
47027659|NCT01799889|83277442|FG006|Overall Study|Progressive Disease|8|||
47027660|NCT01799889|83277443|FG007|Overall Study|Progressive Disease|13|||
47027661|NCT01799889|83277444|FG008|Overall Study|Progressive Disease|18|||
47027662|NCT01799889|83277445|FG009|Overall Study|Progressive Disease|5|||
47027663|NCT01799889|83277446|FG010|Overall Study|Progressive Disease|3|||
47027664|NCT01799889|83277447|FG011|Overall Study|Progressive Disease|1|||
47027665|NCT01799889|83277436|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
47027666|NCT01799889|83277437|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
47027667|NCT01799889|83277438|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
47027668|NCT01799889|83277439|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
47027669|NCT01799889|83277440|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
47027670|NCT01799889|83277441|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
47027671|NCT01799889|83277442|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
47027672|NCT01799889|83277443|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
47027673|NCT01799889|83277444|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
47027674|NCT01799889|83277445|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
47027675|NCT01799889|83277446|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
47027676|NCT01799889|83277447|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
47027677|NCT01799889|83277436|FG000|Overall Study|Study Terminated By Sponsor|1|||
47027678|NCT01799889|83277437|FG001|Overall Study|Study Terminated By Sponsor|0|||
47027679|NCT01799889|83277438|FG002|Overall Study|Study Terminated By Sponsor|0|||
47027680|NCT01799889|83277439|FG003|Overall Study|Study Terminated By Sponsor|0|||
47027681|NCT01799889|83277440|FG004|Overall Study|Study Terminated By Sponsor|2|||
47027682|NCT01799889|83277441|FG005|Overall Study|Study Terminated By Sponsor|1|||
47027683|NCT01799889|83277442|FG006|Overall Study|Study Terminated By Sponsor|0|||
47027684|NCT01799889|83277443|FG007|Overall Study|Study Terminated By Sponsor|2|||
47027685|NCT01799889|83277444|FG008|Overall Study|Study Terminated By Sponsor|1|||
47027686|NCT01799889|83277445|FG009|Overall Study|Study Terminated By Sponsor|1|||
46623880|NCT02192190|82781570|FG000|Overall Study|Physician Decision|2|||
47027687|NCT01799889|83277446|FG010|Overall Study|Study Terminated By Sponsor|0|||
46623881|NCT02192190|82781571|FG001|Overall Study|Physician Decision|0|||
46623882|NCT02192190|82781572|FG002|Overall Study|Physician Decision|0|||
46623883|NCT02192190|82781573|FG003|Overall Study|Physician Decision|0|||
46623884|NCT02192190|82781574|FG004|Overall Study|Physician Decision|0|||
46623885|NCT02192190|82781575|FG005|Overall Study|Physician Decision|0|||
46623886|NCT02192190|82781570|FG000|Overall Study|Terminated by Sponsor|43|||
46623887|NCT02192190|82781571|FG001|Overall Study|Terminated by Sponsor|23|||
46623888|NCT02192190|82781572|FG002|Overall Study|Terminated by Sponsor|20|||
46623889|NCT02192190|82781573|FG003|Overall Study|Terminated by Sponsor|23|||
46623890|NCT02192190|82781574|FG004|Overall Study|Terminated by Sponsor|21|||
47027688|NCT01799889|83277447|FG011|Overall Study|Study Terminated By Sponsor|0|||
47027689|NCT01799889|83277436|FG000|Overall Study|Withdrawal by Subject|1|||
47027690|NCT01799889|83277437|FG001|Overall Study|Withdrawal by Subject|6|||
47027691|NCT01799889|83277438|FG002|Overall Study|Withdrawal by Subject|4|||
47027692|NCT01799889|83277439|FG003|Overall Study|Withdrawal by Subject|0|||
47027693|NCT01799889|83277440|FG004|Overall Study|Withdrawal by Subject|5|||
47027694|NCT01799889|83277441|FG005|Overall Study|Withdrawal by Subject|1|||
47027695|NCT01799889|83277442|FG006|Overall Study|Withdrawal by Subject|3|||
47027696|NCT01799889|83277443|FG007|Overall Study|Withdrawal by Subject|1|||
47027697|NCT01799889|83277444|FG008|Overall Study|Withdrawal by Subject|2|||
47027698|NCT01799889|83277445|FG009|Overall Study|Withdrawal by Subject|1|||
47027699|NCT01799889|83277446|FG010|Overall Study|Withdrawal by Subject|1|||
47027700|NCT01799889|83277447|FG011|Overall Study|Withdrawal by Subject|1|||
47027701|NCT01799889|83277436|FG000|Overall Study|Non-Compliance With Study Drug|0|||
47027702|NCT01799889|83277437|FG001|Overall Study|Non-Compliance With Study Drug|0|||
47027703|NCT01799889|83277438|FG002|Overall Study|Non-Compliance With Study Drug|0|||
47027704|NCT01799889|83277439|FG003|Overall Study|Non-Compliance With Study Drug|0|||
47027705|NCT01799889|83277440|FG004|Overall Study|Non-Compliance With Study Drug|0|||
47027706|NCT01799889|83277441|FG005|Overall Study|Non-Compliance With Study Drug|1|||
47027707|NCT01799889|83277442|FG006|Overall Study|Non-Compliance With Study Drug|0|||
47027708|NCT01799889|83277443|FG007|Overall Study|Non-Compliance With Study Drug|0|||
47027709|NCT01799889|83277444|FG008|Overall Study|Non-Compliance With Study Drug|0|||
47027710|NCT01799889|83277445|FG009|Overall Study|Non-Compliance With Study Drug|0|||
47027711|NCT01799889|83277446|FG010|Overall Study|Non-Compliance With Study Drug|0|||
47027712|NCT01799889|83277447|FG011|Overall Study|Non-Compliance With Study Drug|0|||
47027713|NCT01412944|83277486|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
47027714|NCT01412944|83277487|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
47027715|NCT01412944|83277488|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
47027716|NCT01412944|83277489|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
47027717|NCT01412944|83277490|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
47027718|NCT01412944|83277491|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
47027719|NCT01412944|83277486|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
47027720|NCT01412944|83277487|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
47027721|NCT01412944|83277488|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
47027722|NCT01412944|83277489|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
47027723|NCT01412944|83277490|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
47027724|NCT01412944|83277491|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
47027725|NCT01412944|83277486|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
47027726|NCT01412944|83277487|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
47027727|NCT01412944|83277488|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
47027728|NCT01412944|83277489|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
47027729|NCT01412944|83277490|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
47027730|NCT01412944|83277491|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
47027731|NCT01412944|83277486|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
47027732|NCT01412944|83277487|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
47027733|NCT01412944|83277488|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
47027734|NCT01412944|83277489|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
47027735|NCT01412944|83277490|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
47027736|NCT01412944|83277491|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
47027737|NCT01412944|83277486|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
47027738|NCT01412944|83277487|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
47027739|NCT01412944|83277488|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
47027740|NCT01412944|83277489|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
47027741|NCT01412944|83277490|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
47027742|NCT01412944|83277491|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
46623891|NCT02192190|82781575|FG005|Overall Study|Terminated by Sponsor|23|||
46623892|NCT02192190|82781570|FG000|Overall Study|Withdrawal by Subject|4|||
46623893|NCT02192190|82781571|FG001|Overall Study|Withdrawal by Subject|1|||
46623894|NCT02192190|82781572|FG002|Overall Study|Withdrawal by Subject|2|||
46623895|NCT02192190|82781573|FG003|Overall Study|Withdrawal by Subject|1|||
47027743|NCT01412944|83277486|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
47027744|NCT01412944|83277487|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
47027745|NCT01412944|83277488|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
47027746|NCT01412944|83277489|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
47027747|NCT01412944|83277490|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
47027748|NCT01412944|83277491|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
47027749|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
46623896|NCT02192190|82781574|FG004|Overall Study|Withdrawal by Subject|5|||
46623897|NCT02192190|82781575|FG005|Overall Study|Withdrawal by Subject|3|||
46623898|NCT02192190|82781570|FG000|Overall Study|Could not Keep Visit Schedule|1|||
46623899|NCT02192190|82781571|FG001|Overall Study|Could not Keep Visit Schedule|0|||
46623900|NCT02192190|82781572|FG002|Overall Study|Could not Keep Visit Schedule|0|||
46623901|NCT02192190|82781573|FG003|Overall Study|Could not Keep Visit Schedule|0|||
46623902|NCT02192190|82781574|FG004|Overall Study|Could not Keep Visit Schedule|0|||
46623903|NCT02192190|82781575|FG005|Overall Study|Could not Keep Visit Schedule|0|||
46623904|NCT02192190|82781570|FG000|Overall Study|Positive Drug Screen|0|||
46623905|NCT02192190|82781571|FG001|Overall Study|Positive Drug Screen|0|||
46623906|NCT02192190|82781572|FG002|Overall Study|Positive Drug Screen|0|||
46623907|NCT02192190|82781573|FG003|Overall Study|Positive Drug Screen|1|||
46623908|NCT02192190|82781574|FG004|Overall Study|Positive Drug Screen|0|||
46623909|NCT02192190|82781575|FG005|Overall Study|Positive Drug Screen|0|||
46623910|NCT02192190|82781570|FG000|Overall Study|Inadequate Pain Relief|0|||
46623911|NCT02192190|82781571|FG001|Overall Study|Inadequate Pain Relief|1|||
46623912|NCT02192190|82781572|FG002|Overall Study|Inadequate Pain Relief|1|||
46623913|NCT02192190|82781573|FG003|Overall Study|Inadequate Pain Relief|0|||
46623914|NCT02192190|82781574|FG004|Overall Study|Inadequate Pain Relief|0|||
46623915|NCT02192190|82781575|FG005|Overall Study|Inadequate Pain Relief|0|||
46623916|NCT02224638|82781603|FG000|Overall Study|Adverse Event|1|||
46623917|NCT02224638|82781604|FG001|Overall Study|Adverse Event|1|||
46623918|NCT02224560|82781619|FG000|Overall Study|Protocol Deviation|1|||
46623919|NCT02224560|82781620|FG001|Overall Study|Protocol Deviation|0|||
46623920|NCT02224560|82781621|FG002|Overall Study|Protocol Deviation|0|||
46623921|NCT02224560|82781619|FG000|Overall Study|Withdrawal by Subject|2|||
46623922|NCT02224560|82781620|FG001|Overall Study|Withdrawal by Subject|0|||
46623923|NCT02224560|82781621|FG002|Overall Study|Withdrawal by Subject|1|||
46623924|NCT02224560|82781619|FG000|Overall Study|Met Withdrawal Criteria|1|||
46623925|NCT02224560|82781620|FG001|Overall Study|Met Withdrawal Criteria|0|||
46623926|NCT02224560|82781621|FG002|Overall Study|Met Withdrawal Criteria|0|||
46623927|NCT02224560|82781619|FG000|Overall Study|Adverse Event|4|||
46623928|NCT02224560|82781620|FG001|Overall Study|Adverse Event|1|||
47027750|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
47027751|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
47027752|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
47027753|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
47027754|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
47027755|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Adverse Event|0|||
47027756|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Adverse Event|0|||
47027757|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Adverse Event|0|||
47027758|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Adverse Event|0|||
47027759|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Adverse Event|1|||
47027760|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Adverse Event|0|||
47027761|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
47027762|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
47027763|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
47027764|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
47027765|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
47027766|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
47027767|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027768|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027769|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027770|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027771|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027772|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
47027773|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027774|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027775|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027776|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
46623929|NCT02224560|82781621|FG002|Overall Study|Adverse Event|1|||
46623930|NCT02224560|82781619|FG000|Overall Study|Withdrawn by Investigator|1|||
46623931|NCT02224560|82781620|FG001|Overall Study|Withdrawn by Investigator|1|||
46623932|NCT02224560|82781621|FG002|Overall Study|Withdrawn by Investigator|0|||
46623933|NCT02161458|82781633|FG000|Overall Study|Withdrawal by Subject|0|||
46623934|NCT02161458|82781634|FG001|Overall Study|Withdrawal by Subject|4|||
46623935|NCT02161458|82781635|FG002|Overall Study|Withdrawal by Subject|4|||
47027777|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
47027778|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027779|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
47027780|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
47027781|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
47027782|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
47027783|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
47027784|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
47027785|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
47027786|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
47027787|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
47027788|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
47027789|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
46623936|NCT02161458|82781636|FG003|Overall Study|Withdrawal by Subject|0|||
46623937|NCT02161458|82781633|FG000|Overall Study|Lost to Follow-up|0|||
47027790|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
47027791|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027792|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
47027793|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027794|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027795|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027796|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
47027797|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
46623938|NCT02161458|82781634|FG001|Overall Study|Lost to Follow-up|2|||
46623939|NCT02161458|82781635|FG002|Overall Study|Lost to Follow-up|1|||
46623940|NCT02161458|82781636|FG003|Overall Study|Lost to Follow-up|0|||
46623941|NCT02223858|82781648|FG000|Overall Study|Death|1|||
46623942|NCT02223858|82781649|FG001|Overall Study|Death|1|||
46623943|NCT02223858|82781648|FG000|Overall Study|Lost to Follow-up|6|||
46623944|NCT02223858|82781649|FG001|Overall Study|Lost to Follow-up|11|||
46623945|NCT02223858|82781648|FG000|Overall Study|Withdrawal by Subject|8|||
46623946|NCT02223858|82781649|FG001|Overall Study|Withdrawal by Subject|5|||
46623947|NCT02223858|82781648|FG000|Overall Study|Refused|9|||
46623948|NCT02223858|82781649|FG001|Overall Study|Refused|9|||
46623949|NCT02223390|82781657|FG000|Overall Study|Lost to Follow-up|9|||
46623950|NCT02223390|82781658|FG001|Overall Study|Lost to Follow-up|4|||
46623951|NCT04914000|82783525|FG000|Overall Study|Lost to Follow-up|8|||
46623952|NCT04914000|82783525|FG000|Overall Study|Withdrawal by Subject|1|||
46623953|NCT04530825|82783542|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
46623954|NCT04530825|82783543|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
46623955|NCT04530825|82783544|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
46623956|NCT04530825|82783545|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
46623957|NCT04530825|82783542|FG000|Overall Study|Did not complete follow-up|3|||
46623958|NCT04530825|82783543|FG001|Overall Study|Did not complete follow-up|0|||
46623959|NCT04530825|82783544|FG002|Overall Study|Did not complete follow-up|0|||
46623960|NCT04530825|82783545|FG003|Overall Study|Did not complete follow-up|0|||
46623961|NCT04169373|82783559|FG000|Week 1 to Week 14|Adverse Event|1|||
46623962|NCT04169373|82783560|FG001|Week 1 to Week 14|Adverse Event|0|||
46623963|NCT04169373|82783561|FG002|Week 1 to Week 14|Adverse Event|1|||
46623964|NCT04169373|82783562|FG003|Week 1 to Week 14|Adverse Event|2|||
46623965|NCT04169373|82783559|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
46623966|NCT04169373|82783560|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
46623967|NCT04169373|82783561|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
47027798|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
47027799|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027800|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027801|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027802|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
47027803|NCT01412944|83277486|FG000|Entire: IV + Maintenance|Adverse Event|0|||
47027804|NCT01412944|83277487|FG001|Entire: IV + Maintenance|Adverse Event|1|||
47027805|NCT01412944|83277488|FG002|Entire: IV + Maintenance|Adverse Event|0|||
47027806|NCT01412944|83277489|FG003|Entire: IV + Maintenance|Adverse Event|0|||
47027807|NCT01412944|83277490|FG004|Entire: IV + Maintenance|Adverse Event|0|||
47027808|NCT01412944|83277491|FG005|Entire: IV + Maintenance|Adverse Event|0|||
47027809|NCT01798485|83277509|FG000|Overall Study|Adverse Event|32|||
47027810|NCT01798485|83277510|FG001|Overall Study|Adverse Event|40|||
47027811|NCT01798485|83277509|FG000|Overall Study|Withdrawal by Subject|27|||
47027812|NCT01798485|83277510|FG001|Overall Study|Withdrawal by Subject|31|||
47027813|NCT01798485|83277509|FG000|Overall Study|Lost to Follow-up|0|||
47027814|NCT01798485|83277510|FG001|Overall Study|Lost to Follow-up|3|||
47027815|NCT01798485|83277509|FG000|Overall Study|Physician Decision|14|||
47027816|NCT01798485|83277510|FG001|Overall Study|Physician Decision|10|||
47027817|NCT01798485|83277509|FG000|Overall Study|Objective Disease Progression|152|||
47027818|NCT01798485|83277510|FG001|Overall Study|Objective Disease Progression|106|||
47027819|NCT01798485|83277509|FG000|Overall Study|Death|25|||
47027820|NCT01798485|83277510|FG001|Overall Study|Death|22|||
47027821|NCT01798485|83277509|FG000|Overall Study|Sponsor Decision|61|||
47027822|NCT01798485|83277510|FG001|Overall Study|Sponsor Decision|54|||
46623968|NCT04169373|82783562|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
46623969|NCT04169373|82783559|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
46623970|NCT04169373|82783560|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
46710307|NCT00960531|82926384|FG007|Overall Study|Reason not Specified|0|||
46710308|NCT00960531|82926385|FG008|Overall Study|Reason not Specified|8|||
47027823|NCT01798485|83277509|FG000|Overall Study|Clinical Progression|35|||
47027824|NCT01798485|83277510|FG001|Overall Study|Clinical Progression|24|||
47027825|NCT01767597|83277518|FG000|Overall Study|Incomplete intervention|3|||
47027826|NCT01767597|83277519|FG001|Overall Study|Incomplete intervention|1|||
47027827|NCT01767597|83277518|FG000|Overall Study|Withdrawal by Subject|1|||
47027828|NCT01767597|83277519|FG001|Overall Study|Withdrawal by Subject|0|||
47027829|NCT01767519|83277528|FG000|Overall Study|Other Reasons|4|||
46623971|NCT04169373|82783561|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
46623972|NCT04169373|82783562|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
46623973|NCT04169373|82783559|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
46623974|NCT04169373|82783560|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
46623975|NCT04169373|82783561|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
46710309|NCT00960531|82926386|FG009|Overall Study|Reason not Specified|1|||
47027830|NCT01767519|83277529|FG001|Overall Study|Other Reasons|4|||
47027831|NCT01767519|83277530|FG002|Overall Study|Other Reasons|2|||
47027832|NCT01767519|83277528|FG000|Overall Study|Protocol Violation|0|||
47027833|NCT01767519|83277529|FG001|Overall Study|Protocol Violation|3|||
46623976|NCT04169373|82783562|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
46623977|NCT04169373|82783559|FG000|Week 1 to Week 14|Other|1|||
46623978|NCT04169373|82783560|FG001|Week 1 to Week 14|Other|3|||
46623979|NCT04169373|82783561|FG002|Week 1 to Week 14|Other|3|||
46623980|NCT04169373|82783562|FG003|Week 1 to Week 14|Other|5|||
46623981|NCT04169373|82783559|FG000|Week 14 to Week 52|Adverse Event|1|||
46623982|NCT04169373|82783560|FG001|Week 14 to Week 52|Adverse Event|0|||
46623983|NCT04169373|82783561|FG002|Week 14 to Week 52|Adverse Event|0|||
46623984|NCT04169373|82783562|FG003|Week 14 to Week 52|Adverse Event|1|||
46623985|NCT04169373|82783559|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
46623986|NCT04169373|82783560|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
46623987|NCT04169373|82783561|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
46623988|NCT04169373|82783562|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
46623989|NCT04169373|82783559|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
46623990|NCT04169373|82783560|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
46623991|NCT04169373|82783561|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
46623992|NCT04169373|82783562|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
46623993|NCT04169373|82783559|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
46623994|NCT04169373|82783560|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
46623995|NCT04169373|82783561|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
46623996|NCT04169373|82783562|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
46623997|NCT04169373|82783559|FG000|Week 14 to Week 52|Other|4|||
46623998|NCT04169373|82783560|FG001|Week 14 to Week 52|Other|5|||
46623999|NCT04169373|82783561|FG002|Week 14 to Week 52|Other|4|||
46624000|NCT04169373|82783562|FG003|Week 14 to Week 52|Other|5|||
46624001|NCT04169373|82783559|FG000|Week 14 to Week 52|Ongoing|0|||
46624002|NCT04169373|82783560|FG001|Week 14 to Week 52|Ongoing|1|||
46624003|NCT04169373|82783561|FG002|Week 14 to Week 52|Ongoing|0|||
46624004|NCT04169373|82783562|FG003|Week 14 to Week 52|Ongoing|0|||
46624005|NCT04154930|82783577|FG000|Overall Study|Withdrawal by Subject|15|||
46624006|NCT04154930|82783578|FG001|Overall Study|Withdrawal by Subject|6|||
46624007|NCT04154930|82783577|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
46624008|NCT04154930|82783578|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
46624009|NCT04154930|82783577|FG000|Overall Study|Lost to Follow-up|14|||
46624010|NCT04154930|82783578|FG001|Overall Study|Lost to Follow-up|6|||
46624011|NCT04154930|82783577|FG000|Overall Study|Other|6|||
46624012|NCT04154930|82783578|FG001|Overall Study|Other|0|||
46624013|NCT04124471|82783584|FG000|Overall Study|screen failure|1|||
46624014|NCT04093024|82783590|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
46624015|NCT04093024|82783591|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
46624016|NCT04093024|82783590|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
46624017|NCT04093024|82783591|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
46624018|NCT04093024|82783590|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
46624019|NCT04093024|82783591|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
46912259|NCT03008460|83142320|FG001|Overall Study|Withdrawal by Subject|6|||
46912260|NCT03008460|83142319|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
46912261|NCT03008460|83142320|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
47027834|NCT01767519|83277530|FG002|Overall Study|Protocol Violation|0|||
46624020|NCT04093024|82783590|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
46624021|NCT04093024|82783591|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
46624022|NCT03633929|82783625|FG000|Overall Study|Lost to Follow-up|1|||
46624023|NCT03633929|82783625|FG000|Overall Study|Did not login to software. Did not participate|3|||
46624024|NCT03625687|82783629|FG000|Overall Study|Death|1|||
46624025|NCT02785952|82783652|FG000|Overall Study|Adverse Event|31|||
46912262|NCT03008460|83142319|FG000|Overall Study|End of study visit outside permitted time window|0|||
47027835|NCT01767519|83277528|FG000|Overall Study|Personal Reasons|1|||
47027836|NCT01767519|83277529|FG001|Overall Study|Personal Reasons|0|||
47027837|NCT01767519|83277530|FG002|Overall Study|Personal Reasons|0|||
47027838|NCT01767519|83277528|FG000|Overall Study|Lost to Follow-up|3|||
47027839|NCT01767519|83277529|FG001|Overall Study|Lost to Follow-up|1|||
47027840|NCT01767519|83277530|FG002|Overall Study|Lost to Follow-up|2|||
47027841|NCT01767519|83277528|FG000|Overall Study|Lack of Efficacy|1|||
47027842|NCT01767519|83277529|FG001|Overall Study|Lack of Efficacy|0|||
47027843|NCT01767519|83277530|FG002|Overall Study|Lack of Efficacy|0|||
47027844|NCT01767519|83277528|FG000|Overall Study|Adverse Event|5|||
47027845|NCT01767519|83277529|FG001|Overall Study|Adverse Event|5|||
47027846|NCT01767519|83277530|FG002|Overall Study|Adverse Event|1|||
47027847|NCT01797783|83277540|FG000|Overall Study|Adverse Event|1|||
47027848|NCT01797783|83277541|FG001|Overall Study|Adverse Event|1|||
47027849|NCT01797783|83277540|FG000|Overall Study|Withdrawal by Subject|1|||
46624026|NCT02785952|82783653|FG001|Overall Study|Adverse Event|19|||
46624027|NCT02785952|82783652|FG000|Overall Study|Refusal unrelated to adverse events|10|||
46624028|NCT02785952|82783653|FG001|Overall Study|Refusal unrelated to adverse events|5|||
47027850|NCT01797783|83277541|FG001|Overall Study|Withdrawal by Subject|0|||
46624029|NCT02785952|82783652|FG000|Overall Study|Disease progression/relapse|61|||
46624030|NCT02785952|82783653|FG001|Overall Study|Disease progression/relapse|89|||
46624031|NCT02785952|82783652|FG000|Overall Study|Death|11|||
46624032|NCT02785952|82783653|FG001|Overall Study|Death|7|||
46624033|NCT02785952|82783652|FG000|Overall Study|Other- not protocol specified|6|||
46624034|NCT02785952|82783653|FG001|Overall Study|Other- not protocol specified|4|||
46624035|NCT02785952|82783652|FG000|Overall Study|On protocol treatment|6|||
46624036|NCT02785952|82783653|FG001|Overall Study|On protocol treatment|3|||
46624037|NCT02674685|82783661|FG000|Overall Study|Withdrawal by Subject|4|||
46624038|NCT02654236|82783668|FG000|Overall Study|Withdrawal by Subject|0|||
46624039|NCT02654236|82783669|FG001|Overall Study|Withdrawal by Subject|0|||
46624040|NCT02654236|82783670|FG002|Overall Study|Withdrawal by Subject|2|||
46624041|NCT02372136|82783680|FG000|Overall Study|Death|3|||
46624042|NCT02372136|82783681|FG001|Overall Study|Death|1|||
46624043|NCT02194829|82783691|FG000|Overall Study|Adverse Event|2|||
46624044|NCT02194829|82783692|FG001|Overall Study|Adverse Event|2|||
46624045|NCT02194829|82783691|FG000|Overall Study|Death|0|||
46624046|NCT02194829|82783692|FG001|Overall Study|Death|1|||
46624047|NCT02194829|82783691|FG000|Overall Study|Disease progression|0|||
46624048|NCT02194829|82783692|FG001|Overall Study|Disease progression|1|||
46624049|NCT02194829|82783691|FG000|Overall Study|Withdrawal by Subject|0|||
46624050|NCT02194829|82783692|FG001|Overall Study|Withdrawal by Subject|1|||
46624051|NCT02194829|82783691|FG000|Overall Study|Never started protocol therapy|0|||
46624052|NCT02194829|82783692|FG001|Overall Study|Never started protocol therapy|1|||
46624053|NCT02087046|82783699|FG000|Overall Study|Adverse Event|4|||
46624054|NCT02087046|82783699|FG000|Overall Study|Death|1|||
46624055|NCT02087046|82783699|FG000|Overall Study|Lost to Follow-up|3|||
46624056|NCT02087046|82783699|FG000|Overall Study|Withdrawal by Subject|2|||
46624057|NCT02087046|82783699|FG000|Overall Study|Physician Decision|1|||
46624058|NCT01390038|82783708|FG000|Overall Study|Death|1|||
46624059|NCT01390038|82783708|FG000|Overall Study|Lost to Follow-up|1|||
46624060|NCT01390038|82783708|FG000|Overall Study|Withdrawal by Subject|4|||
46624061|NCT01390038|82783708|FG000|Overall Study|Simpliciti System Removal|2|||
46624062|NCT00621192|82783726|FG000|Overall Study|Withdrawal by Subject|0|||
46624063|NCT00621192|82783727|FG001|Overall Study|Withdrawal by Subject|0|||
46624064|NCT00621192|82783728|FG002|Overall Study|Withdrawal by Subject|2|||
46624065|NCT00621192|82783729|FG003|Overall Study|Withdrawal by Subject|0|||
46624066|NCT00621192|82783726|FG000|Overall Study|Physician Decision|1|||
46624067|NCT00621192|82783727|FG001|Overall Study|Physician Decision|3|||
46624068|NCT00621192|82783728|FG002|Overall Study|Physician Decision|0|||
46624069|NCT00621192|82783729|FG003|Overall Study|Physician Decision|0|||
46624070|NCT00621192|82783726|FG000|Overall Study|Protocol Violation|1|||
46624071|NCT00621192|82783727|FG001|Overall Study|Protocol Violation|0|||
46624072|NCT00621192|82783728|FG002|Overall Study|Protocol Violation|0|||
46624073|NCT00621192|82783729|FG003|Overall Study|Protocol Violation|1|||
46624074|NCT00621192|82783726|FG000|Overall Study|Adverse Event|0|||
46624075|NCT00621192|82783727|FG001|Overall Study|Adverse Event|1|||
46624076|NCT00621192|82783728|FG002|Overall Study|Adverse Event|0|||
46624077|NCT00621192|82783729|FG003|Overall Study|Adverse Event|1|||
46624078|NCT00621192|82783726|FG000|Overall Study|Death|2|||
46624079|NCT00621192|82783727|FG001|Overall Study|Death|5|||
46624080|NCT00621192|82783728|FG002|Overall Study|Death|0|||
46624081|NCT00621192|82783729|FG003|Overall Study|Death|0|||
46624082|NCT00621192|82783726|FG000|Overall Study|Final Assessments not Completed|0|||
46624083|NCT00621192|82783727|FG001|Overall Study|Final Assessments not Completed|0|||
46624084|NCT00621192|82783728|FG002|Overall Study|Final Assessments not Completed|3|||
46624085|NCT00621192|82783729|FG003|Overall Study|Final Assessments not Completed|1|||
46624086|NCT00278200|82783741|FG000|Overall Study|Death|1|||
46624087|NCT00278200|82783742|FG001|Overall Study|Death|3|||
46624088|NCT00278200|82783741|FG000|Overall Study|Physician Decision|0|||
46624089|NCT00278200|82783742|FG001|Overall Study|Physician Decision|1|||
46624090|NCT00255346|82783753|FG000|Overall Study|Adverse Event|1|||
46624091|NCT00255346|82783754|FG001|Overall Study|Adverse Event|0|||
46624092|NCT00255346|82783755|FG002|Overall Study|Adverse Event|0|||
46624093|NCT00255346|82783756|FG003|Overall Study|Adverse Event|0|||
46624094|NCT00255346|82783757|FG004|Overall Study|Adverse Event|0|||
46624095|NCT02222922|82785893|FG000|Overall Study|Death|0|||
46624096|NCT02222922|82785894|FG001|Overall Study|Death|0|||
46624097|NCT02222922|82785895|FG002|Overall Study|Death|0|||
46624098|NCT02222922|82785896|FG003|Overall Study|Death|0|||
46624099|NCT02222922|82785897|FG004|Overall Study|Death|13|||
46624100|NCT02222922|82785898|FG005|Overall Study|Death|0|||
46624101|NCT02222922|82785899|FG006|Overall Study|Death|0|||
46624102|NCT02222922|82785900|FG007|Overall Study|Death|0|||
46624103|NCT02222922|82785901|FG008|Overall Study|Death|2|||
46624104|NCT02222922|82785893|FG000|Overall Study|Lost to Follow-up|0|||
46624105|NCT02222922|82785894|FG001|Overall Study|Lost to Follow-up|0|||
46624106|NCT02222922|82785895|FG002|Overall Study|Lost to Follow-up|1|||
46624107|NCT02222922|82785896|FG003|Overall Study|Lost to Follow-up|0|||
46624108|NCT02222922|82785897|FG004|Overall Study|Lost to Follow-up|9|||
46624109|NCT02222922|82785898|FG005|Overall Study|Lost to Follow-up|1|||
46624110|NCT02222922|82785899|FG006|Overall Study|Lost to Follow-up|0|||
47027851|NCT01766817|83277558|FG000|Overall Study|Drug-related adverse event|1|||
47027852|NCT01766817|83277559|FG001|Overall Study|Drug-related adverse event|2|||
47027853|NCT01766817|83277560|FG002|Overall Study|Drug-related adverse event|1|||
47027854|NCT01766817|83277558|FG000|Overall Study|Drug-unrelated adverse event|3|||
47027855|NCT01766817|83277559|FG001|Overall Study|Drug-unrelated adverse event|3|||
47027856|NCT01766817|83277560|FG002|Overall Study|Drug-unrelated adverse event|3|||
47027857|NCT01766817|83277558|FG000|Overall Study|Death|1|||
47027858|NCT01766817|83277559|FG001|Overall Study|Death|1|||
47027859|NCT01766817|83277560|FG002|Overall Study|Death|0|||
47027860|NCT01766817|83277558|FG000|Overall Study|Unable to take study drug|0|||
47027861|NCT01766817|83277559|FG001|Overall Study|Unable to take study drug|1|||
47027862|NCT01766817|83277560|FG002|Overall Study|Unable to take study drug|0|||
47027863|NCT01766817|83277558|FG000|Overall Study|Withdrawal by Subject|2|||
47027864|NCT01766817|83277559|FG001|Overall Study|Withdrawal by Subject|0|||
47027865|NCT01766817|83277560|FG002|Overall Study|Withdrawal by Subject|3|||
47027866|NCT01766817|83277558|FG000|Overall Study|Subject non-compliance|0|||
47027867|NCT01766817|83277559|FG001|Overall Study|Subject non-compliance|1|||
47027868|NCT01766817|83277560|FG002|Overall Study|Subject non-compliance|2|||
47027869|NCT01766817|83277558|FG000|Overall Study|Physician Decision|3|||
47027870|NCT01766817|83277559|FG001|Overall Study|Physician Decision|3|||
47027871|NCT01766817|83277560|FG002|Overall Study|Physician Decision|4|||
47027872|NCT01766817|83277558|FG000|Overall Study|Other|1|||
47027873|NCT01766817|83277559|FG001|Overall Study|Other|0|||
47027874|NCT01766817|83277560|FG002|Overall Study|Other|0|||
47027875|NCT01797705|83277568|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
47027876|NCT01797705|83277568|FG000|Overall Study|Withdrawal by Subject|1|||
47027877|NCT01797081|83277576|FG000|Overall Study|Adverse Event|1|||
47027878|NCT01797081|83277577|FG001|Overall Study|Adverse Event|0|||
47027879|NCT01797081|83277578|FG002|Overall Study|Adverse Event|1|||
47027880|NCT01797081|83277579|FG003|Overall Study|Adverse Event|0|||
47027881|NCT01797081|83277576|FG000|Overall Study|Pregnancy|1|||
47027882|NCT01797081|83277577|FG001|Overall Study|Pregnancy|0|||
47027883|NCT01797081|83277578|FG002|Overall Study|Pregnancy|0|||
47027884|NCT01797081|83277579|FG003|Overall Study|Pregnancy|0|||
47027885|NCT01797081|83277576|FG000|Overall Study|Personal Reasons|12|||
47027886|NCT01797081|83277577|FG001|Overall Study|Personal Reasons|4|||
47027887|NCT01797081|83277578|FG002|Overall Study|Personal Reasons|4|||
47027888|NCT01797081|83277579|FG003|Overall Study|Personal Reasons|8|||
47027889|NCT01797081|83277576|FG000|Overall Study|Protocol Violation|0|||
47027890|NCT01797081|83277577|FG001|Overall Study|Protocol Violation|0|||
47027891|NCT01797081|83277578|FG002|Overall Study|Protocol Violation|0|||
47027892|NCT01797081|83277579|FG003|Overall Study|Protocol Violation|1|||
47027893|NCT01794117|83277591|FG000|Overall Study|Adverse Event|1|||
47027894|NCT01794117|83277592|FG001|Overall Study|Adverse Event|0|||
47027895|NCT01794117|83277593|FG002|Overall Study|Adverse Event|0|||
47027896|NCT01794117|83277594|FG003|Overall Study|Adverse Event|0|||
47027897|NCT01794117|83277591|FG000|Overall Study|Participant noncompliance|0|||
47027898|NCT01794117|83277592|FG001|Overall Study|Participant noncompliance|1|||
47027899|NCT01794117|83277593|FG002|Overall Study|Participant noncompliance|0|||
47027900|NCT01794117|83277594|FG003|Overall Study|Participant noncompliance|0|||
46624111|NCT02222922|82785900|FG007|Overall Study|Lost to Follow-up|0|||
46624112|NCT02222922|82785901|FG008|Overall Study|Lost to Follow-up|0|||
46624113|NCT02222922|82785893|FG000|Overall Study|Other|0|||
46624114|NCT02222922|82785894|FG001|Overall Study|Other|0|||
46624115|NCT02222922|82785895|FG002|Overall Study|Other|0|||
46624116|NCT02222922|82785896|FG003|Overall Study|Other|2|||
46624117|NCT02222922|82785897|FG004|Overall Study|Other|10|||
46624118|NCT02222922|82785898|FG005|Overall Study|Other|2|||
46624119|NCT02222922|82785899|FG006|Overall Study|Other|2|||
46624120|NCT02222922|82785900|FG007|Overall Study|Other|4|||
46624121|NCT02222922|82785901|FG008|Overall Study|Other|1|||
46624122|NCT02222922|82785893|FG000|Overall Study|Participant refused further follow-up|1|||
46624123|NCT02222922|82785894|FG001|Overall Study|Participant refused further follow-up|0|||
47027901|NCT01794117|83277591|FG000|Overall Study|Refused further treatment|0|||
47027902|NCT01794117|83277592|FG001|Overall Study|Refused further treatment|2|||
47027903|NCT01794117|83277593|FG002|Overall Study|Refused further treatment|0|||
47027904|NCT01794117|83277594|FG003|Overall Study|Refused further treatment|0|||
47027905|NCT01766037|83277607|FG000|Overall Study|Adverse Event|1|||
47027906|NCT01766037|83277608|FG001|Overall Study|Adverse Event|0|||
47027907|NCT01766037|83277607|FG000|Overall Study|Lack of Efficacy|1|||
47027908|NCT01766037|83277608|FG001|Overall Study|Lack of Efficacy|0|||
47027909|NCT01766037|83277607|FG000|Overall Study|Lost to Follow-up|0|||
47027910|NCT01766037|83277608|FG001|Overall Study|Lost to Follow-up|10|||
47027911|NCT01766037|83277607|FG000|Overall Study|Physician Decision|0|||
47027912|NCT01766037|83277608|FG001|Overall Study|Physician Decision|1|||
47027913|NCT01766037|83277607|FG000|Overall Study|Withdrawal by Subject|18|||
47027914|NCT01766037|83277608|FG001|Overall Study|Withdrawal by Subject|16|||
47027915|NCT01766037|83277607|FG000|Overall Study|Moved from area|5|||
46624124|NCT02222922|82785895|FG002|Overall Study|Participant refused further follow-up|0|||
46624125|NCT02222922|82785896|FG003|Overall Study|Participant refused further follow-up|1|||
46624126|NCT02222922|82785897|FG004|Overall Study|Participant refused further follow-up|6|||
46624127|NCT02222922|82785898|FG005|Overall Study|Participant refused further follow-up|0|||
46624128|NCT02222922|82785899|FG006|Overall Study|Participant refused further follow-up|0|||
46624129|NCT02222922|82785900|FG007|Overall Study|Participant refused further follow-up|0|||
46624130|NCT02222922|82785901|FG008|Overall Study|Participant refused further follow-up|3|||
46624131|NCT02161146|82785953|FG000|Overall Study|Adverse Event|1|||
46624132|NCT02161146|82785954|FG001|Overall Study|Adverse Event|1|||
46624133|NCT02161146|82785955|FG002|Overall Study|Adverse Event|0|||
46624134|NCT02161146|82785956|FG003|Overall Study|Adverse Event|1|||
46624135|NCT02161146|82785957|FG004|Overall Study|Adverse Event|0|||
46624136|NCT02161146|82785953|FG000|Overall Study|Lost to Follow-up|0|||
46624137|NCT02161146|82785954|FG001|Overall Study|Lost to Follow-up|1|||
46624138|NCT02161146|82785955|FG002|Overall Study|Lost to Follow-up|0|||
46624139|NCT02161146|82785956|FG003|Overall Study|Lost to Follow-up|0|||
46624140|NCT02161146|82785957|FG004|Overall Study|Lost to Follow-up|0|||
46624141|NCT02161146|82785953|FG000|Overall Study|Personal Reasons|0|||
46624142|NCT02161146|82785954|FG001|Overall Study|Personal Reasons|1|||
46624143|NCT02161146|82785955|FG002|Overall Study|Personal Reasons|0|||
46624144|NCT02161146|82785956|FG003|Overall Study|Personal Reasons|2|||
46624145|NCT02161146|82785957|FG004|Overall Study|Personal Reasons|1|||
46624146|NCT02161146|82785953|FG000|Overall Study|Other Miscellaneous Reasons|0|||
46624147|NCT02161146|82785954|FG001|Overall Study|Other Miscellaneous Reasons|1|||
46624148|NCT02161146|82785955|FG002|Overall Study|Other Miscellaneous Reasons|0|||
46624149|NCT02161146|82785956|FG003|Overall Study|Other Miscellaneous Reasons|0|||
46624150|NCT02161146|82785957|FG004|Overall Study|Other Miscellaneous Reasons|0|||
46624151|NCT02222688|82786188|FG000|Overall Study|Withdrawal by Subject|0|||
46624152|NCT02222688|82786189|FG001|Overall Study|Withdrawal by Subject|0|||
46624153|NCT02222688|82786190|FG002|Overall Study|Withdrawal by Subject|0|||
46624154|NCT02222688|82786191|FG003|Overall Study|Withdrawal by Subject|2|||
46624155|NCT02222688|82786192|FG004|Overall Study|Withdrawal by Subject|1|||
46624156|NCT02222688|82786193|FG005|Overall Study|Withdrawal by Subject|0|||
46624157|NCT02222688|82786194|FG006|Overall Study|Withdrawal by Subject|1|||
46624158|NCT02222688|82786188|FG000|Overall Study|Disease progression|1|||
46624159|NCT02222688|82786189|FG001|Overall Study|Disease progression|0|||
46624160|NCT02222688|82786190|FG002|Overall Study|Disease progression|0|||
46624161|NCT02222688|82786191|FG003|Overall Study|Disease progression|0|||
46624162|NCT02222688|82786192|FG004|Overall Study|Disease progression|0|||
46624163|NCT02222688|82786193|FG005|Overall Study|Disease progression|0|||
46624164|NCT02222688|82786194|FG006|Overall Study|Disease progression|0|||
46624165|NCT02159352|82786246|FG000|Overall Study|Adverse Event|3|||
46624166|NCT02159352|82786247|FG001|Overall Study|Adverse Event|1|||
46624167|NCT02159352|82786246|FG000|Overall Study|Withdrawal by Subject|0|||
46624168|NCT02159352|82786247|FG001|Overall Study|Withdrawal by Subject|1|||
46624169|NCT02187744|82786284|FG000|Study|Participant refused further follow-up|1|||
46624170|NCT02187744|82786285|FG001|Study|Participant refused further follow-up|0|||
46624171|NCT02187744|82786284|FG000|Study|Other|2|||
46624172|NCT02187744|82786285|FG001|Study|Other|1|||
46624173|NCT02187744|82786284|FG000|Study|Lost to Follow-up|0|||
46624174|NCT02187744|82786285|FG001|Study|Lost to Follow-up|2|||
46624175|NCT02187744|82786284|FG000|Study|Related adverse event, not serious|0|||
46624176|NCT02187744|82786285|FG001|Study|Related adverse event, not serious|2|||
46624177|NCT02187744|82786284|FG000|Study|Death|1|||
46710310|NCT00960375|82926414|FG000|Overall Study|Lost to Follow-up|20|||
46710311|NCT00960375|82926415|FG001|Overall Study|Lost to Follow-up|22|||
47027916|NCT01766037|83277608|FG001|Overall Study|Moved from area|0|||
47027917|NCT01766037|83277607|FG000|Overall Study|medical - unrelated|1|||
47027918|NCT01766037|83277608|FG001|Overall Study|medical - unrelated|2|||
47027919|NCT01766037|83277607|FG000|Overall Study|nausea / discomfort|3|||
47027920|NCT01766037|83277608|FG001|Overall Study|nausea / discomfort|0|||
47027921|NCT01765569|83277614|FG000|Period B|Withdrawal by Subject|1|||
47027922|NCT01765569|83277614|FG000|Period C|Death|1|||
47027923|NCT01609257|83277623|FG000|Overall Study|Lost to Follow-up|2|||
46624178|NCT02187744|82786285|FG001|Study|Death|0|||
46624179|NCT02187744|82786284|FG000|Study|Related adverse event, serious non-fatal|0|||
46624180|NCT02187744|82786285|FG001|Study|Related adverse event, serious non-fatal|1|||
46624181|NCT02187744|82786284|FG000|Treatment|Death|1|||
46624182|NCT02187744|82786285|FG001|Treatment|Death|0|||
46624183|NCT02187744|82786284|FG000|Treatment|Related adverse event, serious non-fatal|0|||
46624184|NCT02187744|82786285|FG001|Treatment|Related adverse event, serious non-fatal|1|||
46912263|NCT03008460|83142320|FG001|Overall Study|End of study visit outside permitted time window|1|||
47027924|NCT01609257|83277624|FG001|Overall Study|Lost to Follow-up|1|||
46624185|NCT02187744|82786284|FG000|Treatment|Related adverse event, not serious|0|||
46624186|NCT02187744|82786285|FG001|Treatment|Related adverse event, not serious|2|||
46624187|NCT02187744|82786284|FG000|Treatment|Lost to Follow-up|0|||
46624188|NCT02187744|82786285|FG001|Treatment|Lost to Follow-up|1|||
47027925|NCT01609257|83277623|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
46624189|NCT02187744|82786284|FG000|Treatment|Other|2|||
46624190|NCT02187744|82786285|FG001|Treatment|Other|0|||
46624191|NCT02187744|82786284|FG000|Treatment|Participant refused continued treatment|1|||
46624192|NCT02187744|82786285|FG001|Treatment|Participant refused continued treatment|1|||
46624193|NCT02186652|82786466|FG000|Overall Study|Lost to Follow-up|2|||
46624194|NCT02186652|82786467|FG001|Overall Study|Lost to Follow-up|0|||
46624195|NCT04992546|82786542|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
46624196|NCT04992546|82786542|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
46624197|NCT04992546|82786542|FG000|Open-Label Treatment Period|Adverse Event|3|||
46624198|NCT04992546|82786542|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
46624199|NCT04568031|82786593|FG000|Overall Study|Lost to Follow-up|1|||
46624200|NCT04568031|82786594|FG001|Overall Study|Lost to Follow-up|0|||
46624201|NCT04568031|82786595|FG002|Overall Study|Lost to Follow-up|0|||
46624202|NCT04568031|82786596|FG003|Overall Study|Lost to Follow-up|0|||
46624203|NCT04568031|82786593|FG000|Overall Study|Physician Decision|1|||
46624204|NCT04568031|82786594|FG001|Overall Study|Physician Decision|0|||
46624205|NCT04568031|82786595|FG002|Overall Study|Physician Decision|1|||
46624206|NCT04568031|82786596|FG003|Overall Study|Physician Decision|0|||
46624207|NCT04568031|82786593|FG000|Overall Study|Withdrawal by Subject|1|||
46624208|NCT04568031|82786594|FG001|Overall Study|Withdrawal by Subject|0|||
46624209|NCT04568031|82786595|FG002|Overall Study|Withdrawal by Subject|4|||
46624210|NCT04568031|82786596|FG003|Overall Study|Withdrawal by Subject|1|||
46624211|NCT04550039|82786606|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
46624212|NCT04550039|82786607|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
46624213|NCT04550039|82786606|FG000|Overall Study|patient self-withdrew from study|0|||
46624214|NCT04550039|82786607|FG001|Overall Study|patient self-withdrew from study|1|||
46624215|NCT04517253|82786626|FG000|Overall Study|Adverse Event|1|||
46624216|NCT04517253|82786627|FG001|Overall Study|Adverse Event|0|||
46624217|NCT04517253|82786628|FG002|Overall Study|Adverse Event|0|||
46624218|NCT04517253|82786626|FG000|Overall Study|Death|0|||
46624219|NCT04517253|82786627|FG001|Overall Study|Death|1|||
46624220|NCT04517253|82786628|FG002|Overall Study|Death|0|||
46624221|NCT04453202|82786658|FG000|Overall Study|Adverse Event|0|||
46624222|NCT04453202|82786659|FG001|Overall Study|Adverse Event|0|||
46624223|NCT04453202|82786660|FG002|Overall Study|Adverse Event|0|||
46624224|NCT04453202|82786661|FG003|Overall Study|Adverse Event|0|||
46624225|NCT04453202|82786662|FG004|Overall Study|Adverse Event|0|||
46624226|NCT04453202|82786663|FG005|Overall Study|Adverse Event|0|||
46624227|NCT04453202|82786664|FG006|Overall Study|Adverse Event|1|||
46624228|NCT04453202|82786665|FG007|Overall Study|Adverse Event|0|||
46624229|NCT04453202|82786666|FG008|Overall Study|Adverse Event|0|||
46624230|NCT04453202|82786667|FG009|Overall Study|Adverse Event|0|||
46624231|NCT04453202|82786668|FG010|Overall Study|Adverse Event|0|||
46624232|NCT04453202|82786658|FG000|Overall Study|Death|0|||
46624233|NCT04453202|82786659|FG001|Overall Study|Death|0|||
46624234|NCT04453202|82786660|FG002|Overall Study|Death|0|||
46624235|NCT04453202|82786661|FG003|Overall Study|Death|0|||
46624236|NCT04453202|82786662|FG004|Overall Study|Death|0|||
46624237|NCT04453202|82786663|FG005|Overall Study|Death|0|||
46624238|NCT04453202|82786664|FG006|Overall Study|Death|0|||
46624239|NCT04453202|82786665|FG007|Overall Study|Death|0|||
46624240|NCT04453202|82786666|FG008|Overall Study|Death|0|||
46624241|NCT04453202|82786667|FG009|Overall Study|Death|1|||
46624242|NCT04453202|82786668|FG010|Overall Study|Death|0|||
46624243|NCT04453202|82786658|FG000|Overall Study|Lost to Follow-up|0|||
46624244|NCT04453202|82786659|FG001|Overall Study|Lost to Follow-up|1|||
46624245|NCT04453202|82786660|FG002|Overall Study|Lost to Follow-up|0|||
46624246|NCT04453202|82786661|FG003|Overall Study|Lost to Follow-up|1|||
46624247|NCT04453202|82786662|FG004|Overall Study|Lost to Follow-up|0|||
46624248|NCT04453202|82786663|FG005|Overall Study|Lost to Follow-up|0|||
46624249|NCT04453202|82786664|FG006|Overall Study|Lost to Follow-up|0|||
46624250|NCT04453202|82786665|FG007|Overall Study|Lost to Follow-up|0|||
46624251|NCT04453202|82786666|FG008|Overall Study|Lost to Follow-up|0|||
46624252|NCT04453202|82786667|FG009|Overall Study|Lost to Follow-up|1|||
46624253|NCT04453202|82786668|FG010|Overall Study|Lost to Follow-up|1|||
46624254|NCT04453202|82786658|FG000|Overall Study|Withdrawal by Subject|1|||
46912264|NCT03008460|83142319|FG000|Overall Study|Lost to Follow-up|1|||
46624255|NCT04453202|82786659|FG001|Overall Study|Withdrawal by Subject|2|||
46624256|NCT04453202|82786660|FG002|Overall Study|Withdrawal by Subject|1|||
46624257|NCT04453202|82786661|FG003|Overall Study|Withdrawal by Subject|2|||
46624258|NCT04453202|82786662|FG004|Overall Study|Withdrawal by Subject|1|||
46624259|NCT04453202|82786663|FG005|Overall Study|Withdrawal by Subject|1|||
46624260|NCT04453202|82786664|FG006|Overall Study|Withdrawal by Subject|0|||
46624261|NCT04453202|82786665|FG007|Overall Study|Withdrawal by Subject|0|||
46624262|NCT04453202|82786666|FG008|Overall Study|Withdrawal by Subject|0|||
46624263|NCT04453202|82786667|FG009|Overall Study|Withdrawal by Subject|1|||
46624264|NCT04453202|82786668|FG010|Overall Study|Withdrawal by Subject|0|||
46624265|NCT04453202|82786658|FG000|Overall Study|Adverse Event|0|||
46624266|NCT04453202|82786659|FG001|Overall Study|Adverse Event|0|||
46624267|NCT04453202|82786660|FG002|Overall Study|Adverse Event|0|||
46624268|NCT04453202|82786661|FG003|Overall Study|Adverse Event|0|||
46624269|NCT04453202|82786662|FG004|Overall Study|Adverse Event|0|||
46624270|NCT04453202|82786663|FG005|Overall Study|Adverse Event|1|||
46624271|NCT04453202|82786664|FG006|Overall Study|Adverse Event|0|||
46624272|NCT04453202|82786665|FG007|Overall Study|Adverse Event|0|||
46624273|NCT04453202|82786666|FG008|Overall Study|Adverse Event|0|||
46624274|NCT04453202|82786667|FG009|Overall Study|Adverse Event|0|||
46624275|NCT04453202|82786668|FG010|Overall Study|Adverse Event|0|||
46624276|NCT04416204|82786694|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
46624277|NCT04416204|82786695|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
46624278|NCT04416204|82786696|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
46624279|NCT04416204|82786697|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
46624280|NCT04280081|82786707|FG000|Overall Study|Adverse Event|4|||
46624281|NCT04280081|82786707|FG000|Overall Study|Death|2|||
46624282|NCT04280081|82786707|FG000|Overall Study|Progressive Disease|6|||
46624283|NCT04078035|82786726|FG000|Session 2|Lost to Follow-up|3|||
46624284|NCT04078035|82786727|FG001|Session 2|Lost to Follow-up|1|||
46624285|NCT04078035|82786726|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
46624286|NCT04078035|82786727|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
46624287|NCT04059146|82786735|FG000|Overall Study|Withdrawal by Subject|0|||
46624288|NCT04059146|82786736|FG001|Overall Study|Withdrawal by Subject|1|||
46624289|NCT03761849|82786748|FG000|Overall Study|transferred to OpenLabelExtension|35|||
46624290|NCT03761849|82786749|FG001|Overall Study|transferred to OpenLabelExtension|34|||
46624291|NCT03761849|82786750|FG002|Overall Study|transferred to OpenLabelExtension|36|||
46624292|NCT03761849|82786751|FG003|Overall Study|transferred to OpenLabelExtension|0|||
46624293|NCT03761849|82786752|FG004|Overall Study|transferred to OpenLabelExtension|0|||
46624294|NCT03761849|82786753|FG005|Overall Study|transferred to OpenLabelExtension|0|||
46624295|NCT03761849|82786748|FG000|Overall Study|Adverse Event|1|||
46624296|NCT03761849|82786749|FG001|Overall Study|Adverse Event|0|||
46624297|NCT03761849|82786750|FG002|Overall Study|Adverse Event|0|||
46624298|NCT03761849|82786751|FG003|Overall Study|Adverse Event|0|||
46624299|NCT03761849|82786752|FG004|Overall Study|Adverse Event|2|||
46624300|NCT03761849|82786753|FG005|Overall Study|Adverse Event|3|||
46624301|NCT03761849|82786748|FG000|Overall Study|Withdrawal by Subject|0|||
46624302|NCT03761849|82786749|FG001|Overall Study|Withdrawal by Subject|0|||
46624303|NCT03761849|82786750|FG002|Overall Study|Withdrawal by Subject|0|||
46624304|NCT03761849|82786751|FG003|Overall Study|Withdrawal by Subject|41|||
46624305|NCT03761849|82786752|FG004|Overall Study|Withdrawal by Subject|43|||
46624306|NCT03761849|82786753|FG005|Overall Study|Withdrawal by Subject|35|||
46624307|NCT03761849|82786748|FG000|Overall Study|Lost to Follow-up|0|||
46624308|NCT03761849|82786749|FG001|Overall Study|Lost to Follow-up|1|||
46624309|NCT03761849|82786750|FG002|Overall Study|Lost to Follow-up|0|||
46624310|NCT03761849|82786751|FG003|Overall Study|Lost to Follow-up|2|||
46624311|NCT03761849|82786752|FG004|Overall Study|Lost to Follow-up|4|||
46624312|NCT03761849|82786753|FG005|Overall Study|Lost to Follow-up|5|||
46624313|NCT03761849|82786748|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
46624314|NCT03761849|82786749|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
46624315|NCT03761849|82786750|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
46624316|NCT03761849|82786751|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
46624317|NCT03761849|82786752|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
46624318|NCT03761849|82786753|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
46624319|NCT03761849|82786748|FG000|Overall Study|Physician Decision|0|||
46624320|NCT03761849|82786749|FG001|Overall Study|Physician Decision|0|||
46624321|NCT03761849|82786750|FG002|Overall Study|Physician Decision|0|||
46624322|NCT03761849|82786751|FG003|Overall Study|Physician Decision|1|||
46624323|NCT03761849|82786752|FG004|Overall Study|Physician Decision|4|||
46624324|NCT03761849|82786753|FG005|Overall Study|Physician Decision|4|||
46624325|NCT03761849|82786748|FG000|Overall Study|Death|0|||
46624326|NCT03761849|82786749|FG001|Overall Study|Death|0|||
46624327|NCT03761849|82786750|FG002|Overall Study|Death|0|||
46624328|NCT03761849|82786751|FG003|Overall Study|Death|1|||
46624329|NCT03761849|82786752|FG004|Overall Study|Death|1|||
46624330|NCT03761849|82786753|FG005|Overall Study|Death|3|||
46624331|NCT03761849|82786748|FG000|Overall Study|Protocol Violation|0|||
46624332|NCT03761849|82786749|FG001|Overall Study|Protocol Violation|0|||
46624333|NCT03761849|82786750|FG002|Overall Study|Protocol Violation|0|||
46624334|NCT03761849|82786751|FG003|Overall Study|Protocol Violation|2|||
46624335|NCT03761849|82786752|FG004|Overall Study|Protocol Violation|2|||
46624336|NCT03761849|82786753|FG005|Overall Study|Protocol Violation|1|||
46624337|NCT03761849|82786748|FG000|Overall Study|Participant could not come to site|0|||
47027926|NCT01609257|83277624|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
46624338|NCT03761849|82786749|FG001|Overall Study|Participant could not come to site|0|||
46624339|NCT03761849|82786750|FG002|Overall Study|Participant could not come to site|0|||
46624340|NCT03761849|82786751|FG003|Overall Study|Participant could not come to site|0|||
46624341|NCT03761849|82786752|FG004|Overall Study|Participant could not come to site|1|||
46624342|NCT03761849|82786753|FG005|Overall Study|Participant could not come to site|0|||
46624343|NCT03761849|82786748|FG000|Overall Study|SF- safety Finding|0|||
46624344|NCT03761849|82786749|FG001|Overall Study|SF- safety Finding|0|||
46624345|NCT03761849|82786750|FG002|Overall Study|SF- safety Finding|0|||
46624346|NCT03761849|82786751|FG003|Overall Study|SF- safety Finding|0|||
46624347|NCT03761849|82786752|FG004|Overall Study|SF- safety Finding|0|||
46624348|NCT03761849|82786753|FG005|Overall Study|SF- safety Finding|1|||
46624349|NCT03761849|82786748|FG000|Overall Study|Patient did not attend visit|0|||
46624350|NCT03761849|82786749|FG001|Overall Study|Patient did not attend visit|0|||
46624351|NCT03761849|82786750|FG002|Overall Study|Patient did not attend visit|0|||
46624352|NCT03761849|82786751|FG003|Overall Study|Patient did not attend visit|0|||
46624353|NCT03761849|82786752|FG004|Overall Study|Patient did not attend visit|0|||
46624354|NCT03761849|82786753|FG005|Overall Study|Patient did not attend visit|1|||
46624355|NCT03594747|82786770|FG000|Overall Study|Death|78|||
47027927|NCT01609257|83277623|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
47027928|NCT01609257|83277624|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
47027929|NCT01609023|83277633|FG000|Overall Study|Lack of Efficacy|3|||
47027930|NCT01609023|83277633|FG000|Overall Study|Withdrawal by Subject|4|||
47027931|NCT01609023|83277633|FG000|Overall Study|Lost to Follow-up|8|||
47027932|NCT01609023|83277633|FG000|Overall Study|Toxicity|3|||
47027933|NCT01609023|83277633|FG000|Overall Study|Disease progression|10|||
47027934|NCT01609023|83277633|FG000|Overall Study|Physician Decision|2|||
47027935|NCT01609023|83277633|FG000|Overall Study|Death|2|||
47027936|NCT01609023|83277633|FG000|Overall Study|Personal reasons|1|||
47027937|NCT01765179|83277637|FG000|Overall Study|Adverse Event|3|||
47027938|NCT01765179|83277637|FG000|Overall Study|Lost to Follow-up|5|||
47027939|NCT01765179|83277637|FG000|Overall Study|Non-compliance with study drug|2|||
47027940|NCT01765179|83277637|FG000|Overall Study|Protocol Violation|1|||
47027941|NCT01765179|83277637|FG000|Overall Study|Withdrawal by Subject|8|||
47027942|NCT01765179|83277637|FG000|Overall Study|Hematocrit >54%|3|||
47027943|NCT01765179|83277637|FG000|Overall Study|prohibited med|1|||
47027944|NCT01765179|83277637|FG000|Overall Study|Out of country unable to finish study|1|||
47027945|NCT01765179|83277637|FG000|Overall Study|lack of venous access|1|||
47027946|NCT01765179|83277637|FG000|Overall Study|work conflict|1|||
47027947|NCT01765179|83277637|FG000|Overall Study|Ca elevated 10.6|1|||
47027948|NCT01764945|83277649|FG000|Overall Study|Adverse Event|0|||
47027949|NCT01764945|83277650|FG001|Overall Study|Adverse Event|1|||
47027950|NCT01764945|83277651|FG002|Overall Study|Adverse Event|0|||
47027951|NCT01764945|83277652|FG003|Overall Study|Adverse Event|0|||
47027952|NCT01764945|83277653|FG004|Overall Study|Adverse Event|0|||
47027953|NCT01764945|83277654|FG005|Overall Study|Adverse Event|0|||
47027954|NCT01764945|83277655|FG006|Overall Study|Adverse Event|1|||
47027955|NCT01764945|83277656|FG007|Overall Study|Adverse Event|0|||
47027956|NCT01793883|83277677|FG000|Overall Study|Withdrawal by Subject|3|||
47027957|NCT01793883|83277678|FG001|Overall Study|Withdrawal by Subject|7|||
47027958|NCT01793883|83277679|FG002|Overall Study|Withdrawal by Subject|3|||
47027959|NCT01793883|83277677|FG000|Overall Study|Subject noncompliance|0|||
47027960|NCT01793883|83277678|FG001|Overall Study|Subject noncompliance|1|||
47027961|NCT01793883|83277679|FG002|Overall Study|Subject noncompliance|1|||
47027962|NCT01793883|83277677|FG000|Overall Study|Lost to Follow-up|5|||
47027963|NCT01793883|83277678|FG001|Overall Study|Lost to Follow-up|1|||
47027964|NCT01793883|83277679|FG002|Overall Study|Lost to Follow-up|3|||
47027965|NCT01793883|83277677|FG000|Overall Study|Randomized in error|1|||
47027966|NCT01793883|83277678|FG001|Overall Study|Randomized in error|0|||
47027967|NCT01793883|83277679|FG002|Overall Study|Randomized in error|0|||
47027968|NCT01793883|83277677|FG000|Overall Study|Unable to complete spriometry|1|||
47027969|NCT01793883|83277678|FG001|Overall Study|Unable to complete spriometry|0|||
47027970|NCT01793883|83277679|FG002|Overall Study|Unable to complete spriometry|0|||
47027971|NCT01793883|83277677|FG000|Overall Study|Unable to complete measurements|1|||
47027972|NCT01793883|83277678|FG001|Overall Study|Unable to complete measurements|0|||
47027973|NCT01793883|83277679|FG002|Overall Study|Unable to complete measurements|0|||
47027974|NCT01793883|83277677|FG000|Overall Study|Met exclusion criteria|1|||
47027975|NCT01793883|83277678|FG001|Overall Study|Met exclusion criteria|0|||
47027976|NCT01793883|83277679|FG002|Overall Study|Met exclusion criteria|0|||
47027977|NCT01793883|83277677|FG000|Overall Study|Dosing error|0|||
47027978|NCT01793883|83277678|FG001|Overall Study|Dosing error|1|||
47027979|NCT01793883|83277679|FG002|Overall Study|Dosing error|0|||
47027980|NCT01793883|83277677|FG000|Overall Study|Respiratory distress during spirometry|0|||
47027981|NCT01793883|83277678|FG001|Overall Study|Respiratory distress during spirometry|0|||
47027982|NCT01793883|83277679|FG002|Overall Study|Respiratory distress during spirometry|1|||
47027983|NCT01792635|83277690|FG000|Part B|Adverse Event|0|||
47027984|NCT01792635|83277691|FG001|Part B|Adverse Event|0|||
46624356|NCT03594747|82786771|FG001|Overall Study|Death|86|||
47027985|NCT01792635|83277692|FG002|Part B|Adverse Event|1|||
47027986|NCT01792635|83277690|FG000|Part B|Study terminated|0|||
47027987|NCT01792635|83277691|FG001|Part B|Study terminated|4|||
47027988|NCT01792635|83277692|FG002|Part B|Study terminated|3|||
46624357|NCT03594747|82786772|FG002|Overall Study|Death|87|||
46912265|NCT03008460|83142320|FG001|Overall Study|Lost to Follow-up|3|||
47027989|NCT01953692|83277710|FG000|Overall Study|Adverse Event|5|||
46624358|NCT03594747|82786770|FG000|Overall Study|Withdrawal by Subject|5|||
46624359|NCT03594747|82786771|FG001|Overall Study|Withdrawal by Subject|2|||
46624360|NCT03594747|82786772|FG002|Overall Study|Withdrawal by Subject|11|||
46624361|NCT03594747|82786770|FG000|Overall Study|Lost to Follow-up|4|||
46624362|NCT03594747|82786771|FG001|Overall Study|Lost to Follow-up|1|||
46624363|NCT03594747|82786772|FG002|Overall Study|Lost to Follow-up|1|||
46624364|NCT03594747|82786770|FG000|Overall Study|Physician Decision|0|||
46624365|NCT03594747|82786771|FG001|Overall Study|Physician Decision|1|||
46624366|NCT03594747|82786772|FG002|Overall Study|Physician Decision|0|||
46624367|NCT03594747|82786770|FG000|Overall Study|Sponsor decision|23|||
46624368|NCT03594747|82786771|FG001|Overall Study|Sponsor decision|17|||
46624369|NCT03594747|82786772|FG002|Overall Study|Sponsor decision|16|||
46624370|NCT03594747|82786770|FG000|Overall Study|Did not meet inclusion criteria|0|||
46624371|NCT03594747|82786771|FG001|Overall Study|Did not meet inclusion criteria|0|||
46624372|NCT03594747|82786772|FG002|Overall Study|Did not meet inclusion criteria|1|||
46624373|NCT03594747|82786770|FG000|Overall Study|Transfer to long term extension study|10|||
46624374|NCT03594747|82786771|FG001|Overall Study|Transfer to long term extension study|12|||
46624375|NCT03594747|82786772|FG002|Overall Study|Transfer to long term extension study|5|||
47027990|NCT01953692|83277711|FG001|Overall Study|Adverse Event|2|||
47027991|NCT01953692|83277712|FG002|Overall Study|Adverse Event|4|||
47027992|NCT01953692|83277713|FG003|Overall Study|Adverse Event|2|||
47027993|NCT01953692|83277714|FG004|Overall Study|Adverse Event|1|||
47027994|NCT01953692|83277715|FG005|Overall Study|Adverse Event|2|||
47027995|NCT01953692|83277716|FG006|Overall Study|Adverse Event|0|||
47027996|NCT01953692|83277717|FG007|Overall Study|Adverse Event|0|||
47027997|NCT01953692|83277718|FG008|Overall Study|Adverse Event|0|||
47027998|NCT01953692|83277710|FG000|Overall Study|Clinical Progression|0|||
47027999|NCT01953692|83277711|FG001|Overall Study|Clinical Progression|15|||
47028000|NCT01953692|83277712|FG002|Overall Study|Clinical Progression|7|||
47028001|NCT01953692|83277713|FG003|Overall Study|Clinical Progression|5|||
47028002|NCT01953692|83277714|FG004|Overall Study|Clinical Progression|0|||
47028003|NCT01953692|83277715|FG005|Overall Study|Clinical Progression|7|||
47028004|NCT01953692|83277716|FG006|Overall Study|Clinical Progression|20|||
47028005|NCT01953692|83277717|FG007|Overall Study|Clinical Progression|3|||
47028006|NCT01953692|83277718|FG008|Overall Study|Clinical Progression|3|||
47028007|NCT01953692|83277710|FG000|Overall Study|Death|5|||
47028008|NCT01953692|83277711|FG001|Overall Study|Death|0|||
47028009|NCT01953692|83277712|FG002|Overall Study|Death|2|||
47028010|NCT01953692|83277713|FG003|Overall Study|Death|2|||
47028011|NCT01953692|83277714|FG004|Overall Study|Death|1|||
47028012|NCT01953692|83277715|FG005|Overall Study|Death|3|||
47028013|NCT01953692|83277716|FG006|Overall Study|Death|6|||
47028014|NCT01953692|83277717|FG007|Overall Study|Death|2|||
47028015|NCT01953692|83277718|FG008|Overall Study|Death|1|||
47028016|NCT01953692|83277710|FG000|Overall Study|Excluded Medication|1|||
47028017|NCT01953692|83277711|FG001|Overall Study|Excluded Medication|0|||
47028018|NCT01953692|83277712|FG002|Overall Study|Excluded Medication|0|||
47028019|NCT01953692|83277713|FG003|Overall Study|Excluded Medication|0|||
47028020|NCT01953692|83277714|FG004|Overall Study|Excluded Medication|0|||
47028021|NCT01953692|83277715|FG005|Overall Study|Excluded Medication|0|||
47028022|NCT01953692|83277716|FG006|Overall Study|Excluded Medication|0|||
47028023|NCT01953692|83277717|FG007|Overall Study|Excluded Medication|0|||
47028024|NCT01953692|83277718|FG008|Overall Study|Excluded Medication|0|||
47028025|NCT01953692|83277710|FG000|Overall Study|Lost to Follow-up|1|||
47028026|NCT01953692|83277711|FG001|Overall Study|Lost to Follow-up|0|||
47028027|NCT01953692|83277712|FG002|Overall Study|Lost to Follow-up|3|||
47028028|NCT01953692|83277713|FG003|Overall Study|Lost to Follow-up|1|||
47028029|NCT01953692|83277714|FG004|Overall Study|Lost to Follow-up|0|||
47028030|NCT01953692|83277715|FG005|Overall Study|Lost to Follow-up|1|||
47028031|NCT01953692|83277716|FG006|Overall Study|Lost to Follow-up|0|||
47028032|NCT01953692|83277717|FG007|Overall Study|Lost to Follow-up|0|||
47028033|NCT01953692|83277718|FG008|Overall Study|Lost to Follow-up|0|||
47028034|NCT01953692|83277710|FG000|Overall Study|Physician Decision|11|||
47028035|NCT01953692|83277711|FG001|Overall Study|Physician Decision|4|||
47028036|NCT01953692|83277712|FG002|Overall Study|Physician Decision|2|||
47028037|NCT01953692|83277713|FG003|Overall Study|Physician Decision|2|||
47028038|NCT01953692|83277714|FG004|Overall Study|Physician Decision|1|||
46624376|NCT03403361|82786793|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
47028039|NCT01953692|83277715|FG005|Overall Study|Physician Decision|2|||
47028040|NCT01953692|83277716|FG006|Overall Study|Physician Decision|4|||
47028041|NCT01953692|83277717|FG007|Overall Study|Physician Decision|1|||
47028042|NCT01953692|83277718|FG008|Overall Study|Physician Decision|0|||
46624377|NCT03207867|82786834|FG000|Overall Study|Adverse Event|1|||
46624378|NCT03207867|82786835|FG001|Overall Study|Adverse Event|0|||
46624379|NCT03207867|82786836|FG002|Overall Study|Adverse Event|1|||
46624380|NCT03207867|82786837|FG003|Overall Study|Adverse Event|0|||
46624381|NCT03207867|82786838|FG004|Overall Study|Adverse Event|0|||
46624382|NCT03207867|82786839|FG005|Overall Study|Adverse Event|2|||
46624383|NCT03207867|82786840|FG006|Overall Study|Adverse Event|1|||
46624384|NCT03207867|82786841|FG007|Overall Study|Adverse Event|1|||
46624385|NCT03207867|82786842|FG008|Overall Study|Adverse Event|2|||
46624386|NCT03207867|82786843|FG009|Overall Study|Adverse Event|2|||
46624387|NCT03207867|82786844|FG010|Overall Study|Adverse Event|0|||
46624388|NCT03207867|82786845|FG011|Overall Study|Adverse Event|0|||
46624389|NCT03207867|82786846|FG012|Overall Study|Adverse Event|0|||
46624390|NCT03207867|82786847|FG013|Overall Study|Adverse Event|0|||
46624391|NCT03207867|82786848|FG014|Overall Study|Adverse Event|0|||
46624392|NCT03207867|82786849|FG015|Overall Study|Adverse Event|0|||
46624393|NCT03207867|82786850|FG016|Overall Study|Adverse Event|3|||
46624394|NCT03207867|82786851|FG017|Overall Study|Adverse Event|1|||
46624395|NCT03207867|82786852|FG018|Overall Study|Adverse Event|2|||
46624396|NCT03207867|82786853|FG019|Overall Study|Adverse Event|1|||
46624397|NCT03207867|82786854|FG020|Overall Study|Adverse Event|0|||
46624398|NCT03207867|82786855|FG021|Overall Study|Adverse Event|0|||
46624399|NCT03207867|82786856|FG022|Overall Study|Adverse Event|0|||
46624400|NCT03207867|82786857|FG023|Overall Study|Adverse Event|0|||
46624401|NCT03207867|82786834|FG000|Overall Study|Death|0|||
46624402|NCT03207867|82786835|FG001|Overall Study|Death|0|||
46624403|NCT03207867|82786836|FG002|Overall Study|Death|0|||
46624404|NCT03207867|82786837|FG003|Overall Study|Death|0|||
46624405|NCT03207867|82786838|FG004|Overall Study|Death|0|||
46624406|NCT03207867|82786839|FG005|Overall Study|Death|1|||
46624407|NCT03207867|82786840|FG006|Overall Study|Death|0|||
46624408|NCT03207867|82786841|FG007|Overall Study|Death|3|||
46624409|NCT03207867|82786842|FG008|Overall Study|Death|1|||
46624410|NCT03207867|82786843|FG009|Overall Study|Death|2|||
46624411|NCT03207867|82786844|FG010|Overall Study|Death|0|||
46624412|NCT03207867|82786845|FG011|Overall Study|Death|1|||
46624413|NCT03207867|82786846|FG012|Overall Study|Death|0|||
46624414|NCT03207867|82786847|FG013|Overall Study|Death|1|||
46624415|NCT03207867|82786848|FG014|Overall Study|Death|0|||
46624416|NCT03207867|82786849|FG015|Overall Study|Death|0|||
46624417|NCT03207867|82786850|FG016|Overall Study|Death|0|||
46624418|NCT03207867|82786851|FG017|Overall Study|Death|2|||
46624419|NCT03207867|82786852|FG018|Overall Study|Death|0|||
46624420|NCT03207867|82786853|FG019|Overall Study|Death|1|||
46624421|NCT03207867|82786854|FG020|Overall Study|Death|0|||
46624422|NCT03207867|82786855|FG021|Overall Study|Death|0|||
46624423|NCT03207867|82786856|FG022|Overall Study|Death|0|||
46624424|NCT03207867|82786857|FG023|Overall Study|Death|0|||
46624425|NCT03207867|82786834|FG000|Overall Study|Physician Decision|3|||
46624426|NCT03207867|82786835|FG001|Overall Study|Physician Decision|5|||
46624427|NCT03207867|82786836|FG002|Overall Study|Physician Decision|0|||
46624428|NCT03207867|82786837|FG003|Overall Study|Physician Decision|3|||
46624429|NCT03207867|82786838|FG004|Overall Study|Physician Decision|2|||
46624430|NCT03207867|82786839|FG005|Overall Study|Physician Decision|0|||
46624431|NCT03207867|82786840|FG006|Overall Study|Physician Decision|0|||
46624432|NCT03207867|82786841|FG007|Overall Study|Physician Decision|0|||
46624433|NCT03207867|82786842|FG008|Overall Study|Physician Decision|4|||
46624434|NCT03207867|82786843|FG009|Overall Study|Physician Decision|2|||
46624435|NCT03207867|82786844|FG010|Overall Study|Physician Decision|0|||
46624436|NCT03207867|82786845|FG011|Overall Study|Physician Decision|4|||
46624437|NCT03207867|82786846|FG012|Overall Study|Physician Decision|0|||
46624438|NCT03207867|82786847|FG013|Overall Study|Physician Decision|0|||
46624439|NCT03207867|82786848|FG014|Overall Study|Physician Decision|2|||
46912266|NCT02914236|83142326|FG000|Overall Study|Lost to Follow-up|1|||
46624440|NCT03207867|82786849|FG015|Overall Study|Physician Decision|1|||
46624441|NCT03207867|82786850|FG016|Overall Study|Physician Decision|1|||
46624442|NCT03207867|82786851|FG017|Overall Study|Physician Decision|2|||
46624443|NCT03207867|82786852|FG018|Overall Study|Physician Decision|1|||
46624444|NCT03207867|82786853|FG019|Overall Study|Physician Decision|3|||
46624445|NCT03207867|82786854|FG020|Overall Study|Physician Decision|0|||
46624446|NCT03207867|82786855|FG021|Overall Study|Physician Decision|0|||
46624447|NCT03207867|82786856|FG022|Overall Study|Physician Decision|0|||
46624448|NCT03207867|82786857|FG023|Overall Study|Physician Decision|0|||
46912267|NCT03003390|83142332|FG000|Overall Study|Physician Decision|2|||
46624449|NCT03207867|82786834|FG000|Overall Study|Progressive Disease|7|||
46624450|NCT03207867|82786835|FG001|Overall Study|Progressive Disease|7|||
46624451|NCT03207867|82786836|FG002|Overall Study|Progressive Disease|9|||
46624452|NCT03207867|82786837|FG003|Overall Study|Progressive Disease|10|||
46624453|NCT03207867|82786838|FG004|Overall Study|Progressive Disease|11|||
46624454|NCT03207867|82786839|FG005|Overall Study|Progressive Disease|10|||
46624455|NCT03207867|82786840|FG006|Overall Study|Progressive Disease|9|||
46624456|NCT03207867|82786841|FG007|Overall Study|Progressive Disease|8|||
46624457|NCT03207867|82786842|FG008|Overall Study|Progressive Disease|19|||
46624458|NCT03207867|82786843|FG009|Overall Study|Progressive Disease|23|||
46624459|NCT03207867|82786844|FG010|Overall Study|Progressive Disease|2|||
46624460|NCT03207867|82786845|FG011|Overall Study|Progressive Disease|24|||
46624461|NCT03207867|82786846|FG012|Overall Study|Progressive Disease|3|||
46624462|NCT03207867|82786847|FG013|Overall Study|Progressive Disease|11|||
46624463|NCT03207867|82786848|FG014|Overall Study|Progressive Disease|9|||
46624464|NCT03207867|82786849|FG015|Overall Study|Progressive Disease|5|||
46624465|NCT03207867|82786850|FG016|Overall Study|Progressive Disease|10|||
46624466|NCT03207867|82786851|FG017|Overall Study|Progressive Disease|14|||
46624467|NCT03207867|82786852|FG018|Overall Study|Progressive Disease|13|||
46624468|NCT03207867|82786853|FG019|Overall Study|Progressive Disease|14|||
46624469|NCT03207867|82786854|FG020|Overall Study|Progressive Disease|6|||
46624470|NCT03207867|82786855|FG021|Overall Study|Progressive Disease|3|||
46624471|NCT03207867|82786856|FG022|Overall Study|Progressive Disease|3|||
46624472|NCT03207867|82786857|FG023|Overall Study|Progressive Disease|3|||
46624473|NCT03207867|82786834|FG000|Overall Study|Patient/guardian Decision|0|||
46624474|NCT03207867|82786835|FG001|Overall Study|Patient/guardian Decision|0|||
46624475|NCT03207867|82786836|FG002|Overall Study|Patient/guardian Decision|1|||
46624476|NCT03207867|82786837|FG003|Overall Study|Patient/guardian Decision|1|||
46624477|NCT03207867|82786838|FG004|Overall Study|Patient/guardian Decision|1|||
47028043|NCT01953692|83277710|FG000|Overall Study|Protocol Violation|0|||
47028044|NCT01953692|83277711|FG001|Overall Study|Protocol Violation|2|||
47028045|NCT01953692|83277712|FG002|Overall Study|Protocol Violation|1|||
47028046|NCT01953692|83277713|FG003|Overall Study|Protocol Violation|0|||
47028047|NCT01953692|83277714|FG004|Overall Study|Protocol Violation|0|||
47028048|NCT01953692|83277715|FG005|Overall Study|Protocol Violation|0|||
47028049|NCT01953692|83277716|FG006|Overall Study|Protocol Violation|0|||
47028050|NCT01953692|83277717|FG007|Overall Study|Protocol Violation|1|||
47028051|NCT01953692|83277718|FG008|Overall Study|Protocol Violation|0|||
47028052|NCT01953692|83277710|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
47028053|NCT01953692|83277711|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
46624478|NCT03207867|82786839|FG005|Overall Study|Patient/guardian Decision|2|||
46624479|NCT03207867|82786840|FG006|Overall Study|Patient/guardian Decision|1|||
46624480|NCT03207867|82786841|FG007|Overall Study|Patient/guardian Decision|0|||
46624481|NCT03207867|82786842|FG008|Overall Study|Patient/guardian Decision|1|||
46624482|NCT03207867|82786843|FG009|Overall Study|Patient/guardian Decision|0|||
46624483|NCT03207867|82786844|FG010|Overall Study|Patient/guardian Decision|0|||
46624484|NCT03207867|82786845|FG011|Overall Study|Patient/guardian Decision|1|||
46624485|NCT03207867|82786846|FG012|Overall Study|Patient/guardian Decision|0|||
46624486|NCT03207867|82786847|FG013|Overall Study|Patient/guardian Decision|1|||
46624487|NCT03207867|82786848|FG014|Overall Study|Patient/guardian Decision|2|||
46624488|NCT03207867|82786849|FG015|Overall Study|Patient/guardian Decision|0|||
46624489|NCT03207867|82786850|FG016|Overall Study|Patient/guardian Decision|1|||
46624490|NCT03207867|82786851|FG017|Overall Study|Patient/guardian Decision|3|||
46624491|NCT03207867|82786852|FG018|Overall Study|Patient/guardian Decision|4|||
46624492|NCT03207867|82786853|FG019|Overall Study|Patient/guardian Decision|1|||
46624493|NCT03207867|82786854|FG020|Overall Study|Patient/guardian Decision|0|||
46624494|NCT03207867|82786855|FG021|Overall Study|Patient/guardian Decision|0|||
46624495|NCT03207867|82786856|FG022|Overall Study|Patient/guardian Decision|0|||
46624496|NCT03207867|82786857|FG023|Overall Study|Patient/guardian Decision|0|||
46624497|NCT02955277|82786947|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
46624498|NCT02955277|82786948|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
46624499|NCT02955277|82786947|FG000|Post to Follow-up|Lost to Follow-up|8|||
46624500|NCT02955277|82786948|FG001|Post to Follow-up|Lost to Follow-up|11|||
46624501|NCT02577835|82786981|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
46624502|NCT02455557|82786995|FG000|Overall Study|Withdrawal by Subject|2|||
46624503|NCT02383810|82787007|FG000|Overall Study|Physician Decision|1|||
46624504|NCT02383810|82787008|FG001|Overall Study|Physician Decision|1|||
46624505|NCT02383810|82787009|FG002|Overall Study|Physician Decision|0|||
46624506|NCT02383810|82787010|FG003|Overall Study|Physician Decision|0|||
46624507|NCT02383810|82787011|FG004|Overall Study|Physician Decision|0|||
46624508|NCT02383810|82787012|FG005|Overall Study|Physician Decision|0|||
46710312|NCT00957801|82926434|FG000|Overall Study|Withdrawal by Subject|0|||
46710313|NCT00957801|82926435|FG001|Overall Study|Withdrawal by Subject|0|||
46710314|NCT00957801|82926436|FG002|Overall Study|Withdrawal by Subject|0|||
47028054|NCT01953692|83277712|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
46624509|NCT02383810|82787013|FG006|Overall Study|Physician Decision|0|||
46624510|NCT02383810|82787014|FG007|Overall Study|Physician Decision|0|||
46624511|NCT02383810|82787007|FG000|Overall Study|Withdrawal by Subject|2|||
46624512|NCT02383810|82787008|FG001|Overall Study|Withdrawal by Subject|3|||
46624513|NCT02383810|82787009|FG002|Overall Study|Withdrawal by Subject|3|||
46624514|NCT02383810|82787010|FG003|Overall Study|Withdrawal by Subject|3|||
46624515|NCT02383810|82787011|FG004|Overall Study|Withdrawal by Subject|0|||
46624516|NCT02383810|82787012|FG005|Overall Study|Withdrawal by Subject|0|||
46624517|NCT02383810|82787013|FG006|Overall Study|Withdrawal by Subject|0|||
46710315|NCT00957801|82926437|FG003|Overall Study|Withdrawal by Subject|1|||
46624518|NCT02383810|82787014|FG007|Overall Study|Withdrawal by Subject|0|||
46624519|NCT02383810|82787007|FG000|Overall Study|Adverse Event|0|||
46624520|NCT02383810|82787008|FG001|Overall Study|Adverse Event|2|||
46624521|NCT02383810|82787009|FG002|Overall Study|Adverse Event|4|||
46624522|NCT02383810|82787010|FG003|Overall Study|Adverse Event|5|||
46624523|NCT02383810|82787011|FG004|Overall Study|Adverse Event|0|||
46624524|NCT02383810|82787012|FG005|Overall Study|Adverse Event|1|||
46624525|NCT02383810|82787013|FG006|Overall Study|Adverse Event|1|||
46624526|NCT02383810|82787014|FG007|Overall Study|Adverse Event|0|||
46624527|NCT02383810|82787007|FG000|Overall Study|Lost to Follow-up|0|||
46624528|NCT02383810|82787008|FG001|Overall Study|Lost to Follow-up|1|||
46624529|NCT02383810|82787009|FG002|Overall Study|Lost to Follow-up|0|||
46624530|NCT02383810|82787010|FG003|Overall Study|Lost to Follow-up|1|||
46624531|NCT02383810|82787011|FG004|Overall Study|Lost to Follow-up|0|||
46624532|NCT02383810|82787012|FG005|Overall Study|Lost to Follow-up|0|||
46624533|NCT02383810|82787013|FG006|Overall Study|Lost to Follow-up|0|||
46624534|NCT02383810|82787014|FG007|Overall Study|Lost to Follow-up|0|||
46624535|NCT02383810|82787007|FG000|Overall Study|other|0|||
46624536|NCT02383810|82787008|FG001|Overall Study|other|0|||
46624537|NCT02383810|82787009|FG002|Overall Study|other|0|||
46624538|NCT02383810|82787010|FG003|Overall Study|other|2|||
46624539|NCT02383810|82787011|FG004|Overall Study|other|0|||
46624540|NCT02383810|82787012|FG005|Overall Study|other|0|||
46624541|NCT02383810|82787013|FG006|Overall Study|other|0|||
46624542|NCT02383810|82787014|FG007|Overall Study|other|0|||
46624543|NCT02383810|82787007|FG000|Overall Study|subject did not receive study treatment|0|||
46624544|NCT02383810|82787008|FG001|Overall Study|subject did not receive study treatment|1|||
46624545|NCT02383810|82787009|FG002|Overall Study|subject did not receive study treatment|0|||
46624546|NCT02383810|82787010|FG003|Overall Study|subject did not receive study treatment|0|||
46624547|NCT02383810|82787011|FG004|Overall Study|subject did not receive study treatment|0|||
46624548|NCT02383810|82787012|FG005|Overall Study|subject did not receive study treatment|0|||
46624549|NCT02383810|82787013|FG006|Overall Study|subject did not receive study treatment|0|||
46710316|NCT00957723|82926447|FG000|Overall Study|Death|3|||
46710317|NCT00957723|82926447|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
46710318|NCT00957723|82926447|FG000|Overall Study|Lost to Follow-up|8|||
46710319|NCT00957723|82926447|FG000|Overall Study|Withdrawal by Subject|24|||
46710320|NCT00957723|82926447|FG000|Overall Study|Investigative Site Terminated|61|||
46710321|NCT00957723|82926447|FG000|Overall Study|Intercurrent Illness|2|||
46710322|NCT00957723|82926447|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
46710323|NCT03778021|82926455|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
46624550|NCT02383810|82787014|FG007|Overall Study|subject did not receive study treatment|0|||
46624551|NCT02142803|82787027|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
46624552|NCT02142803|82787028|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
46624553|NCT02142803|82787029|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
46624554|NCT02142803|82787030|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
47028055|NCT01953692|83277713|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
47028056|NCT01953692|83277714|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
47028057|NCT01953692|83277715|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
47028058|NCT01953692|83277716|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
47028059|NCT01953692|83277717|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
47028060|NCT01953692|83277718|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
47028061|NCT01953692|83277710|FG000|Overall Study|Withdrawal by Subject|4|||
47028062|NCT01953692|83277711|FG001|Overall Study|Withdrawal by Subject|2|||
47028063|NCT01953692|83277712|FG002|Overall Study|Withdrawal by Subject|1|||
47028064|NCT01953692|83277713|FG003|Overall Study|Withdrawal by Subject|2|||
46624565|NCT01791855|82787058|FG000|Overall Study|Adverse Event|0|||
46624566|NCT01791855|82787059|FG001|Overall Study|Adverse Event|0|||
46624567|NCT01791855|82787060|FG002|Overall Study|Adverse Event|0|||
46624568|NCT01791855|82787061|FG003|Overall Study|Adverse Event|1|||
46624569|NCT01791855|82787058|FG000|Overall Study|Randomized, not treated|0|||
46624570|NCT01791855|82787059|FG001|Overall Study|Randomized, not treated|1|||
46624571|NCT01791855|82787060|FG002|Overall Study|Randomized, not treated|0|||
46624572|NCT01791855|82787061|FG003|Overall Study|Randomized, not treated|0|||
47028065|NCT01953692|83277714|FG004|Overall Study|Withdrawal by Subject|0|||
47028066|NCT01953692|83277715|FG005|Overall Study|Withdrawal by Subject|3|||
47028067|NCT01953692|83277716|FG006|Overall Study|Withdrawal by Subject|2|||
47028068|NCT01953692|83277717|FG007|Overall Study|Withdrawal by Subject|1|||
47028069|NCT01953692|83277718|FG008|Overall Study|Withdrawal by Subject|1|||
47028070|NCT01791153|83277752|FG000|Part 1: Blinded Period|Adverse Event|7|||
47028071|NCT01791153|83277753|FG001|Part 1: Blinded Period|Adverse Event|3|||
47028072|NCT01791153|83277754|FG002|Part 1: Blinded Period|Adverse Event|2|||
47028073|NCT01791153|83277755|FG003|Part 1: Blinded Period|Adverse Event|0|||
47028074|NCT01791153|83277756|FG004|Part 1: Blinded Period|Adverse Event|0|||
47028075|NCT01791153|83277757|FG005|Part 1: Blinded Period|Adverse Event|0|||
47028076|NCT01791153|83277758|FG006|Part 1: Blinded Period|Adverse Event|0|||
47028077|NCT01791153|83277759|FG007|Part 1: Blinded Period|Adverse Event|0|||
47028078|NCT01791153|83277752|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
46912268|NCT03003390|83142333|FG001|Overall Study|Physician Decision|0|||
46710324|NCT03778021|82926456|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
46912269|NCT03003390|83142332|FG000|Overall Study|Parent refused intervention|2|||
47028079|NCT01791153|83277753|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
47028080|NCT01791153|83277754|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
47028081|NCT01791153|83277755|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
47028082|NCT01791153|83277756|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
47028083|NCT01791153|83277757|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
47028084|NCT01791153|83277758|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
47028085|NCT01791153|83277759|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
47028086|NCT01791153|83277752|FG000|Part 1: Blinded Period|Non-Compliance|1|||
47028087|NCT01791153|83277753|FG001|Part 1: Blinded Period|Non-Compliance|0|||
47028088|NCT01791153|83277754|FG002|Part 1: Blinded Period|Non-Compliance|0|||
47028089|NCT01791153|83277755|FG003|Part 1: Blinded Period|Non-Compliance|0|||
47028090|NCT01791153|83277756|FG004|Part 1: Blinded Period|Non-Compliance|0|||
47028091|NCT01791153|83277757|FG005|Part 1: Blinded Period|Non-Compliance|0|||
47028092|NCT01791153|83277758|FG006|Part 1: Blinded Period|Non-Compliance|0|||
47028093|NCT01791153|83277759|FG007|Part 1: Blinded Period|Non-Compliance|0|||
47028094|NCT01791153|83277752|FG000|Part 1: Blinded Period|Physician Decision|0|||
47028095|NCT01791153|83277753|FG001|Part 1: Blinded Period|Physician Decision|0|||
47028096|NCT01791153|83277754|FG002|Part 1: Blinded Period|Physician Decision|0|||
47028097|NCT01791153|83277755|FG003|Part 1: Blinded Period|Physician Decision|1|||
47028098|NCT01791153|83277756|FG004|Part 1: Blinded Period|Physician Decision|0|||
47028099|NCT01791153|83277757|FG005|Part 1: Blinded Period|Physician Decision|0|||
47028100|NCT01791153|83277758|FG006|Part 1: Blinded Period|Physician Decision|0|||
47028101|NCT01791153|83277759|FG007|Part 1: Blinded Period|Physician Decision|0|||
47028102|NCT01791153|83277752|FG000|Part 1: Blinded Period|Protocol Violation|0|||
47028103|NCT01791153|83277753|FG001|Part 1: Blinded Period|Protocol Violation|0|||
47028104|NCT01791153|83277754|FG002|Part 1: Blinded Period|Protocol Violation|0|||
47028105|NCT01791153|83277755|FG003|Part 1: Blinded Period|Protocol Violation|1|||
47028106|NCT01791153|83277756|FG004|Part 1: Blinded Period|Protocol Violation|0|||
47028107|NCT01791153|83277757|FG005|Part 1: Blinded Period|Protocol Violation|0|||
47028108|NCT01791153|83277758|FG006|Part 1: Blinded Period|Protocol Violation|0|||
47028109|NCT01791153|83277759|FG007|Part 1: Blinded Period|Protocol Violation|0|||
47028110|NCT01791153|83277752|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
47028111|NCT01791153|83277753|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
47028112|NCT01791153|83277754|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
47028113|NCT01791153|83277755|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
47028114|NCT01791153|83277756|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
47028115|NCT01791153|83277757|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
47028116|NCT01791153|83277758|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
47028117|NCT01791153|83277759|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
47028118|NCT01791153|83277752|FG000|Part 2: Open-label Period|Adverse Event|0|||
47028119|NCT01791153|83277753|FG001|Part 2: Open-label Period|Adverse Event|0|||
47028120|NCT01791153|83277754|FG002|Part 2: Open-label Period|Adverse Event|0|||
47028121|NCT01791153|83277755|FG003|Part 2: Open-label Period|Adverse Event|0|||
47028122|NCT01791153|83277756|FG004|Part 2: Open-label Period|Adverse Event|0|||
47028123|NCT01791153|83277757|FG005|Part 2: Open-label Period|Adverse Event|1|||
47028124|NCT01791153|83277758|FG006|Part 2: Open-label Period|Adverse Event|1|||
47028125|NCT01791153|83277759|FG007|Part 2: Open-label Period|Adverse Event|2|||
47028126|NCT01791153|83277752|FG000|Part 2: Open-label Period|Death|0|||
47028127|NCT01791153|83277753|FG001|Part 2: Open-label Period|Death|0|||
47028128|NCT01791153|83277754|FG002|Part 2: Open-label Period|Death|0|||
47028129|NCT01791153|83277755|FG003|Part 2: Open-label Period|Death|0|||
47028130|NCT01791153|83277756|FG004|Part 2: Open-label Period|Death|0|||
47028131|NCT01791153|83277757|FG005|Part 2: Open-label Period|Death|1|||
47028132|NCT01791153|83277758|FG006|Part 2: Open-label Period|Death|1|||
47028133|NCT01791153|83277759|FG007|Part 2: Open-label Period|Death|1|||
46624579|NCT01146574|82787087|FG000|Overall Study|Death|0|||
46912270|NCT03003390|83142333|FG001|Overall Study|Parent refused intervention|0|||
46912271|NCT03003000|83142347|FG000|Overall Study|Adverse Event|1|||
46912272|NCT03003000|83142348|FG001|Overall Study|Adverse Event|2|||
47028134|NCT01791153|83277752|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
47028135|NCT01791153|83277753|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
47028136|NCT01791153|83277754|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
46624580|NCT01146574|82787088|FG001|Overall Study|Death|1|||
46624581|NCT01146574|82787089|FG002|Overall Study|Death|1|||
46624582|NCT01146574|82787090|FG003|Overall Study|Death|0|||
46624583|NCT01146574|82787091|FG004|Overall Study|Death|0|||
46624584|NCT01146574|82787092|FG005|Overall Study|Death|0|||
46624585|NCT01146574|82787093|FG006|Overall Study|Death|0|||
46624586|NCT01146574|82787087|FG000|Overall Study|Other reasons|0|||
46624587|NCT01146574|82787088|FG001|Overall Study|Other reasons|0|||
47028137|NCT01791153|83277755|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
47028138|NCT01791153|83277756|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
47028139|NCT01791153|83277757|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
47028140|NCT01791153|83277758|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
47028141|NCT01791153|83277759|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
47028142|NCT01791153|83277752|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
47028143|NCT01791153|83277753|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
47028144|NCT01791153|83277754|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
47028145|NCT01791153|83277755|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
47028146|NCT01791153|83277756|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
47028147|NCT01791153|83277757|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
47028148|NCT01791153|83277758|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
47028149|NCT01791153|83277759|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
47028150|NCT01791153|83277752|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
47028151|NCT01791153|83277753|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
47028152|NCT01791153|83277754|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
47028153|NCT01791153|83277755|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
47028154|NCT01791153|83277756|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
47028155|NCT01791153|83277757|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
47028156|NCT01791153|83277758|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
47028157|NCT01791153|83277759|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
47028158|NCT01791153|83277752|FG000|Part 2: Open-label Period|Physician Decision|0|||
47028159|NCT01791153|83277753|FG001|Part 2: Open-label Period|Physician Decision|0|||
47028160|NCT01791153|83277754|FG002|Part 2: Open-label Period|Physician Decision|0|||
47028161|NCT01791153|83277755|FG003|Part 2: Open-label Period|Physician Decision|0|||
47028162|NCT01791153|83277756|FG004|Part 2: Open-label Period|Physician Decision|1|||
47028163|NCT01791153|83277757|FG005|Part 2: Open-label Period|Physician Decision|1|||
47028164|NCT01791153|83277758|FG006|Part 2: Open-label Period|Physician Decision|0|||
47028165|NCT01791153|83277759|FG007|Part 2: Open-label Period|Physician Decision|0|||
47028166|NCT01926782|83277780|FG000|Overall Study|Participant moved|2|||
47028167|NCT01926782|83277781|FG001|Overall Study|Participant moved|0|||
47028168|NCT01926782|83277782|FG002|Overall Study|Participant moved|1|||
47028169|NCT01926782|83277783|FG003|Overall Study|Participant moved|1|||
47028170|NCT01926782|83277784|FG004|Overall Study|Participant moved|0|||
47028171|NCT01926782|83277785|FG005|Overall Study|Participant moved|3|||
46624588|NCT01146574|82787089|FG002|Overall Study|Other reasons|3|||
46624589|NCT01146574|82787090|FG003|Overall Study|Other reasons|0|||
46624590|NCT01146574|82787091|FG004|Overall Study|Other reasons|0|||
46624591|NCT01146574|82787092|FG005|Overall Study|Other reasons|0|||
46624592|NCT01146574|82787093|FG006|Overall Study|Other reasons|0|||
46624593|NCT01146574|82787087|FG000|Overall Study|Kidney transplant|0|||
46624594|NCT01146574|82787088|FG001|Overall Study|Kidney transplant|0|||
46624595|NCT01146574|82787089|FG002|Overall Study|Kidney transplant|1|||
46624596|NCT01146574|82787090|FG003|Overall Study|Kidney transplant|1|||
46624597|NCT01146574|82787091|FG004|Overall Study|Kidney transplant|0|||
46624598|NCT01146574|82787092|FG005|Overall Study|Kidney transplant|0|||
46624599|NCT01146574|82787093|FG006|Overall Study|Kidney transplant|0|||
46624600|NCT01146574|82787087|FG000|Overall Study|Withdrew consent|0|||
46624601|NCT01146574|82787088|FG001|Overall Study|Withdrew consent|0|||
46624602|NCT01146574|82787089|FG002|Overall Study|Withdrew consent|1|||
46624603|NCT01146574|82787090|FG003|Overall Study|Withdrew consent|1|||
46624604|NCT01146574|82787091|FG004|Overall Study|Withdrew consent|2|||
47028172|NCT01926782|83277780|FG000|Overall Study|Physician Decision|0|||
47028173|NCT01926782|83277781|FG001|Overall Study|Physician Decision|2|||
47028174|NCT01926782|83277782|FG002|Overall Study|Physician Decision|1|||
47028175|NCT01926782|83277783|FG003|Overall Study|Physician Decision|1|||
47028176|NCT01926782|83277784|FG004|Overall Study|Physician Decision|0|||
46624605|NCT01146574|82787092|FG005|Overall Study|Withdrew consent|1|||
46624606|NCT01146574|82787093|FG006|Overall Study|Withdrew consent|1|||
46624607|NCT01065454|82787119|FG000|Treatment|Adverse Event|7|||
46624608|NCT01065454|82787120|FG001|Treatment|Adverse Event|4|||
46624609|NCT01065454|82787121|FG002|Treatment|Adverse Event|3|||
46624610|NCT01065454|82787122|FG003|Treatment|Adverse Event|6|||
46624611|NCT01065454|82787119|FG000|Treatment|Death|1|||
46624612|NCT01065454|82787120|FG001|Treatment|Death|0|||
46624613|NCT01065454|82787121|FG002|Treatment|Death|0|||
46624614|NCT01065454|82787122|FG003|Treatment|Death|0|||
46624615|NCT01065454|82787119|FG000|Treatment|Non-compliance|1|||
46624616|NCT01065454|82787120|FG001|Treatment|Non-compliance|0|||
46624617|NCT01065454|82787121|FG002|Treatment|Non-compliance|0|||
46624618|NCT01065454|82787122|FG003|Treatment|Non-compliance|1|||
47028177|NCT01926782|83277785|FG005|Overall Study|Physician Decision|0|||
47028178|NCT01926782|83277780|FG000|Overall Study|Other than specified|2|||
47028179|NCT01926782|83277781|FG001|Overall Study|Other than specified|3|||
47028180|NCT01926782|83277782|FG002|Overall Study|Other than specified|5|||
47028181|NCT01926782|83277783|FG003|Overall Study|Other than specified|12|||
47028182|NCT01926782|83277784|FG004|Overall Study|Other than specified|4|||
47028183|NCT01926782|83277785|FG005|Overall Study|Other than specified|11|||
47028184|NCT01926782|83277780|FG000|Overall Study|Adverse Event|13|||
47028185|NCT01926782|83277781|FG001|Overall Study|Adverse Event|4|||
47028186|NCT01926782|83277782|FG002|Overall Study|Adverse Event|17|||
47028187|NCT01926782|83277783|FG003|Overall Study|Adverse Event|4|||
47028188|NCT01926782|83277784|FG004|Overall Study|Adverse Event|3|||
47028189|NCT01926782|83277785|FG005|Overall Study|Adverse Event|14|||
47028190|NCT01926782|83277780|FG000|Overall Study|Poor compliance to protocol|5|||
47028191|NCT01926782|83277781|FG001|Overall Study|Poor compliance to protocol|3|||
47028192|NCT01926782|83277782|FG002|Overall Study|Poor compliance to protocol|8|||
47028193|NCT01926782|83277783|FG003|Overall Study|Poor compliance to protocol|0|||
47028194|NCT01926782|83277784|FG004|Overall Study|Poor compliance to protocol|1|||
47028195|NCT01926782|83277785|FG005|Overall Study|Poor compliance to protocol|6|||
47028196|NCT01926782|83277780|FG000|Overall Study|Randomized and not treated|0|||
47028197|NCT01926782|83277781|FG001|Overall Study|Randomized and not treated|0|||
47028198|NCT01926782|83277782|FG002|Overall Study|Randomized and not treated|0|||
47028199|NCT01926782|83277783|FG003|Overall Study|Randomized and not treated|1|||
47028200|NCT01926782|83277784|FG004|Overall Study|Randomized and not treated|0|||
47028201|NCT01926782|83277785|FG005|Overall Study|Randomized and not treated|0|||
47028202|NCT01926782|83277780|FG000|Overall Study|Withdrawal by Subject|6|||
47028203|NCT01926782|83277781|FG001|Overall Study|Withdrawal by Subject|1|||
47028204|NCT01926782|83277782|FG002|Overall Study|Withdrawal by Subject|8|||
47028205|NCT01926782|83277783|FG003|Overall Study|Withdrawal by Subject|1|||
47028206|NCT01926782|83277784|FG004|Overall Study|Withdrawal by Subject|0|||
47028207|NCT01926782|83277785|FG005|Overall Study|Withdrawal by Subject|5|||
47028208|NCT01926782|83277780|FG000|Overall Study|Related to study drug administration|0|||
47028209|NCT01926782|83277781|FG001|Overall Study|Related to study drug administration|0|||
47028210|NCT01926782|83277782|FG002|Overall Study|Related to study drug administration|0|||
47028211|NCT01926782|83277783|FG003|Overall Study|Related to study drug administration|0|||
47028212|NCT01926782|83277784|FG004|Overall Study|Related to study drug administration|0|||
47028213|NCT01926782|83277785|FG005|Overall Study|Related to study drug administration|2|||
47028214|NCT01926626|83277800|FG000|Overall Study|Withdrawal by Subject|15|||
47028215|NCT01926626|83277800|FG000|Overall Study|Lost to Follow-up|7|||
47028216|NCT01953224|83277806|FG000|Overall Study|Lost to Follow-up|1|||
47028217|NCT01953224|83277807|FG001|Overall Study|Lost to Follow-up|1|||
47028218|NCT01953224|83277806|FG000|Overall Study|Withdrawal by Subject|1|||
47028219|NCT01953224|83277807|FG001|Overall Study|Withdrawal by Subject|2|||
47028220|NCT01900730|83277815|FG000|Overall Study|Withdrawal by Subject|1|||
47028221|NCT01900730|83277816|FG001|Overall Study|Withdrawal by Subject|0|||
47028222|NCT01900730|83277815|FG000|Overall Study|Screen Failure|1|||
47028223|NCT01900730|83277816|FG001|Overall Study|Screen Failure|0|||
47028224|NCT01952834|83277822|FG000|Overall Study|Adverse Event|1|||
47028225|NCT01952054|83277827|FG000|Overall Study|Physician Decision|1|||
47028226|NCT01925768|83277833|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
47028227|NCT01925768|83277834|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
47028228|NCT01925768|83277833|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
47028229|NCT01925768|83277834|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
47028230|NCT01925768|83277833|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
47028231|NCT01925768|83277834|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
47028232|NCT01925768|83277833|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
47028233|NCT01925768|83277834|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
47028234|NCT01925768|83277833|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
46624619|NCT01065454|82787119|FG000|Treatment|Protocol Decision|0|||
46624620|NCT01065454|82787120|FG001|Treatment|Protocol Decision|0|||
47028235|NCT01925768|83277834|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
47028236|NCT01925768|83277833|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
47028237|NCT01925768|83277834|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
46624621|NCT01065454|82787121|FG002|Treatment|Protocol Decision|3|||
46624622|NCT01065454|82787122|FG003|Treatment|Protocol Decision|2|||
47028238|NCT01925768|83277833|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
47028239|NCT01925768|83277834|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
47028240|NCT01925768|83277833|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
47028241|NCT01925768|83277834|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
46624623|NCT01065454|82787119|FG000|Treatment|Protocol Violation|1|||
46624624|NCT01065454|82787120|FG001|Treatment|Protocol Violation|0|||
46624625|NCT01065454|82787121|FG002|Treatment|Protocol Violation|1|||
46624626|NCT01065454|82787122|FG003|Treatment|Protocol Violation|0|||
46624627|NCT01065454|82787119|FG000|Treatment|Withdrawal by Subject|3|||
46710325|NCT00911170|82926465|FG000|Treatment Period|Randomized in error|1|||
47028242|NCT01925768|83277833|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
47028243|NCT01925768|83277834|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
47028244|NCT01925768|83277833|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
47028245|NCT01925768|83277834|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
47028246|NCT01925768|83277833|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
47028247|NCT01925768|83277834|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
47028248|NCT01431274|83277849|FG000|Overall Study|Adverse Event|51|||
47028249|NCT01431274|83277850|FG001|Overall Study|Adverse Event|37|||
47028250|NCT01431274|83277851|FG002|Overall Study|Adverse Event|43|||
47028251|NCT01431274|83277852|FG003|Overall Study|Adverse Event|30|||
47028252|NCT01431274|83277853|FG004|Overall Study|Adverse Event|37|||
47028253|NCT01431274|83277849|FG000|Overall Study|Consent withdrawn not due to AE|29|||
47028254|NCT01431274|83277850|FG001|Overall Study|Consent withdrawn not due to AE|20|||
47028255|NCT01431274|83277851|FG002|Overall Study|Consent withdrawn not due to AE|17|||
47028256|NCT01431274|83277852|FG003|Overall Study|Consent withdrawn not due to AE|20|||
47028257|NCT01431274|83277853|FG004|Overall Study|Consent withdrawn not due to AE|11|||
47028258|NCT01431274|83277849|FG000|Overall Study|Non compliant with protocol|5|||
47028259|NCT01431274|83277850|FG001|Overall Study|Non compliant with protocol|8|||
47028260|NCT01431274|83277851|FG002|Overall Study|Non compliant with protocol|4|||
47028261|NCT01431274|83277852|FG003|Overall Study|Non compliant with protocol|4|||
47028262|NCT01431274|83277853|FG004|Overall Study|Non compliant with protocol|4|||
47028263|NCT01431274|83277849|FG000|Overall Study|Lost to Follow-up|6|||
47028264|NCT01431274|83277850|FG001|Overall Study|Lost to Follow-up|7|||
47028265|NCT01431274|83277851|FG002|Overall Study|Lost to Follow-up|1|||
47028266|NCT01431274|83277852|FG003|Overall Study|Lost to Follow-up|4|||
47028267|NCT01431274|83277853|FG004|Overall Study|Lost to Follow-up|0|||
47028268|NCT01431274|83277849|FG000|Overall Study|Other reason not stated above|6|||
47028269|NCT01431274|83277850|FG001|Overall Study|Other reason not stated above|5|||
47028270|NCT01431274|83277851|FG002|Overall Study|Other reason not stated above|7|||
47028271|NCT01431274|83277852|FG003|Overall Study|Other reason not stated above|2|||
47028272|NCT01431274|83277853|FG004|Overall Study|Other reason not stated above|4|||
47028273|NCT01991795|83277867|FG000|Overall Study|Lost to Follow-up|6|||
47028274|NCT01991795|83277868|FG001|Overall Study|Lost to Follow-up|4|||
47028275|NCT01991795|83277867|FG000|Overall Study|Withdrawal by Subject|117|||
47028276|NCT01991795|83277868|FG001|Overall Study|Withdrawal by Subject|94|||
47028277|NCT01991795|83277867|FG000|Overall Study|Site prematurely closed by sponsor|26|||
47028278|NCT01991795|83277868|FG001|Overall Study|Site prematurely closed by sponsor|25|||
47028279|NCT01411852|83277909|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
47028280|NCT01411852|83277910|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
47028281|NCT01411852|83277909|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
47028282|NCT01411852|83277910|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
47028283|NCT01411852|83277909|FG000|Prehospital Intervention Phase|Found to be under age|0|||
47028284|NCT01411852|83277910|FG001|Prehospital Intervention Phase|Found to be under age|1|||
47028285|NCT01411852|83277909|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
47028286|NCT01411852|83277910|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
47028287|NCT01411852|83277909|FG000|Hospital Intervention Phase|Severe head injury|5|||
47028288|NCT01411852|83277910|FG001|Hospital Intervention Phase|Severe head injury|4|||
47028289|NCT01411852|83277909|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
47028290|NCT01411852|83277910|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
47028291|NCT01411852|83277909|FG000|Hospital Intervention Phase|Miscommunication error|1|||
47028292|NCT01411852|83277910|FG001|Hospital Intervention Phase|Miscommunication error|2|||
47028293|NCT01411852|83277909|FG000|Hospital Intervention Phase|CPR administered|3|||
47028294|NCT01411852|83277910|FG001|Hospital Intervention Phase|CPR administered|1|||
47028295|NCT01411852|83277909|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
47028296|NCT01411852|83277910|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
46710326|NCT00911170|82926466|FG001|Treatment Period|Randomized in error|1|||
47028297|NCT01411852|83277909|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
47028298|NCT01411852|83277910|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
47028299|NCT01411852|83277909|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
47028300|NCT01411852|83277910|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
47028301|NCT01411852|83277909|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
46624628|NCT01065454|82787120|FG001|Treatment|Withdrawal by Subject|1|||
46624629|NCT01065454|82787121|FG002|Treatment|Withdrawal by Subject|2|||
46624630|NCT01065454|82787122|FG003|Treatment|Withdrawal by Subject|3|||
47028302|NCT01411852|83277910|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
46624631|NCT01065454|82787119|FG000|Follow up|Adverse Event|1|||
46624632|NCT01065454|82787120|FG001|Follow up|Adverse Event|0|||
46624633|NCT01065454|82787121|FG002|Follow up|Adverse Event|0|||
46624634|NCT01065454|82787122|FG003|Follow up|Adverse Event|1|||
46624635|NCT01065454|82787119|FG000|Follow up|Death|0|||
46624636|NCT01065454|82787120|FG001|Follow up|Death|1|||
46624637|NCT01065454|82787121|FG002|Follow up|Death|1|||
46624638|NCT01065454|82787122|FG003|Follow up|Death|0|||
46624639|NCT01065454|82787119|FG000|Follow up|Lost to Follow-up|0|||
46624640|NCT01065454|82787120|FG001|Follow up|Lost to Follow-up|0|||
46624641|NCT01065454|82787121|FG002|Follow up|Lost to Follow-up|0|||
46624642|NCT01065454|82787122|FG003|Follow up|Lost to Follow-up|1|||
46624643|NCT01065454|82787119|FG000|Follow up|Progressive disease|0|||
46624644|NCT01065454|82787120|FG001|Follow up|Progressive disease|0|||
46624645|NCT01065454|82787121|FG002|Follow up|Progressive disease|0|||
46624646|NCT01065454|82787122|FG003|Follow up|Progressive disease|1|||
46624647|NCT01065454|82787119|FG000|Follow up|Withdrawal by Subject|1|||
46624648|NCT01065454|82787120|FG001|Follow up|Withdrawal by Subject|1|||
46624649|NCT01065454|82787121|FG002|Follow up|Withdrawal by Subject|1|||
46912273|NCT03003000|83142349|FG002|Overall Study|Adverse Event|3|||
46912274|NCT03003000|83142347|FG000|Overall Study|Lack of Efficacy|1|||
47028303|NCT01411852|83277909|FG000|Hospital Intervention Phase|Other ineligible|2|||
47028304|NCT01411852|83277910|FG001|Hospital Intervention Phase|Other ineligible|2|||
47028305|NCT01411852|83277909|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
47028306|NCT01411852|83277910|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
47028307|NCT01411852|83277909|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
47028308|NCT01411852|83277910|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
47028309|NCT01411852|83277909|FG000|Hospital Intervention Phase|Vascular access failed|1|||
47028310|NCT01411852|83277910|FG001|Hospital Intervention Phase|Vascular access failed|0|||
47028311|NCT01411774|83277920|FG000|Overall Study|Withdrawal by Subject|0|||
47028312|NCT01411774|83277921|FG001|Overall Study|Withdrawal by Subject|3|||
47028313|NCT01411228|83277930|FG000|Overall Study|Lost to Follow-up|0|||
47028314|NCT01411228|83277931|FG001|Overall Study|Lost to Follow-up|0|||
47028315|NCT01411228|83277932|FG002|Overall Study|Lost to Follow-up|1|||
47028316|NCT01411228|83277930|FG000|Overall Study|Withdrawal by Subject|1|||
47028317|NCT01411228|83277931|FG001|Overall Study|Withdrawal by Subject|0|||
47028318|NCT01411228|83277932|FG002|Overall Study|Withdrawal by Subject|0|||
47028319|NCT01410604|83277942|FG000|Overall Study|Adverse Event|2|||
47028320|NCT01410604|83277943|FG001|Overall Study|Adverse Event|1|||
47028321|NCT01410604|83277942|FG000|Overall Study|Lost to Follow-up|1|||
47028322|NCT01410604|83277943|FG001|Overall Study|Lost to Follow-up|0|||
47028323|NCT01410604|83277942|FG000|Overall Study|Physician Decision|0|||
47028324|NCT01410604|83277943|FG001|Overall Study|Physician Decision|1|||
47028325|NCT01991483|83277953|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
47028326|NCT01991483|83277954|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
47028327|NCT01991483|83277955|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
47028328|NCT01991483|83277956|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
47028329|NCT01991483|83277953|FG000|Dose Level 600 mg|Physician Decision|0|||
47028330|NCT01991483|83277954|FG001|Dose Level 600 mg|Physician Decision|0|||
47028331|NCT01991483|83277955|FG002|Dose Level 600 mg|Physician Decision|1|||
47028332|NCT01991483|83277956|FG003|Dose Level 600 mg|Physician Decision|0|||
47028333|NCT01991483|83277953|FG000|Dose Level 1000 mg|Protocol Violation|0|||
47028334|NCT01991483|83277954|FG001|Dose Level 1000 mg|Protocol Violation|0|||
46624650|NCT01065454|82787122|FG003|Follow up|Withdrawal by Subject|0|||
46624651|NCT01065454|82787119|FG000|Follow up|study ongoing|37|||
46624652|NCT01065454|82787120|FG001|Follow up|study ongoing|22|||
46624653|NCT01065454|82787121|FG002|Follow up|study ongoing|15|||
46624654|NCT01065454|82787122|FG003|Follow up|study ongoing|41|||
46912275|NCT03003000|83142348|FG001|Overall Study|Lack of Efficacy|0|||
46912276|NCT03003000|83142349|FG002|Overall Study|Lack of Efficacy|0|||
46912277|NCT03003000|83142347|FG000|Overall Study|Non-compliant with protocol|0|||
46912278|NCT03003000|83142348|FG001|Overall Study|Non-compliant with protocol|1|||
46912279|NCT03003000|83142349|FG002|Overall Study|Non-compliant with protocol|1|||
46912280|NCT03003000|83142347|FG000|Overall Study|Refused to continue medication|2|||
46912281|NCT03003000|83142348|FG001|Overall Study|Refused to continue medication|0|||
46912282|NCT03003000|83142349|FG002|Overall Study|Refused to continue medication|0|||
46912283|NCT03003000|83142347|FG000|Overall Study|Other than listed|1|||
47028335|NCT01991483|83277955|FG002|Dose Level 1000 mg|Protocol Violation|0|||
47028336|NCT01991483|83277956|FG003|Dose Level 1000 mg|Protocol Violation|1|||
47028337|NCT01410448|83277971|FG000|Overall Study|No conversion to everolimus|0|||
47028338|NCT01410448|83277972|FG001|Overall Study|No conversion to everolimus|24|||
47028339|NCT01410448|83277971|FG000|Overall Study|Graft loss|4|||
46710327|NCT00911170|82926465|FG000|Treatment Period|Ineligibility determined|1|||
46710328|NCT00911170|82926466|FG001|Treatment Period|Ineligibility determined|3|||
46912284|NCT03003000|83142348|FG001|Overall Study|Other than listed|1|||
46624655|NCT02185794|82787155|FG000|Overall Study|Enrolled but Never Dosed|1|||
46624656|NCT02185794|82787156|FG001|Overall Study|Enrolled but Never Dosed|6|||
46624657|NCT02185794|82787157|FG002|Overall Study|Enrolled but Never Dosed|3|||
46624658|NCT02185794|82787158|FG003|Overall Study|Enrolled but Never Dosed|1|||
46624659|NCT02185794|82787159|FG004|Overall Study|Enrolled but Never Dosed|1|||
46624660|NCT02185794|82787160|FG005|Overall Study|Enrolled but Never Dosed|0|||
46624661|NCT02185794|82787155|FG000|Overall Study|Investigator's Discretion|1|||
46624662|NCT02185794|82787156|FG001|Overall Study|Investigator's Discretion|0|||
46624663|NCT02185794|82787157|FG002|Overall Study|Investigator's Discretion|1|||
46624664|NCT02185794|82787158|FG003|Overall Study|Investigator's Discretion|2|||
46624665|NCT02185794|82787159|FG004|Overall Study|Investigator's Discretion|2|||
46624666|NCT02185794|82787160|FG005|Overall Study|Investigator's Discretion|15|||
46624667|NCT02185794|82787155|FG000|Overall Study|Withdrew Consent|2|||
46624668|NCT02185794|82787156|FG001|Overall Study|Withdrew Consent|5|||
46624669|NCT02185794|82787157|FG002|Overall Study|Withdrew Consent|10|||
46624670|NCT02185794|82787158|FG003|Overall Study|Withdrew Consent|2|||
46624671|NCT02185794|82787159|FG004|Overall Study|Withdrew Consent|0|||
46624672|NCT02185794|82787160|FG005|Overall Study|Withdrew Consent|0|||
46624673|NCT02185794|82787155|FG000|Overall Study|Lost to Follow-up|1|||
46624674|NCT02185794|82787156|FG001|Overall Study|Lost to Follow-up|2|||
46624675|NCT02185794|82787157|FG002|Overall Study|Lost to Follow-up|2|||
46624676|NCT02185794|82787158|FG003|Overall Study|Lost to Follow-up|3|||
46624677|NCT02185794|82787159|FG004|Overall Study|Lost to Follow-up|0|||
46624678|NCT02185794|82787160|FG005|Overall Study|Lost to Follow-up|1|||
46624679|NCT02221674|82787191|FG000|Overall Study|Lost to Follow-up|1|||
46624680|NCT02221674|82787192|FG001|Overall Study|Lost to Follow-up|0|||
46624681|NCT02221674|82787193|FG002|Overall Study|Lost to Follow-up|0|||
46624682|NCT02221284|82787208|FG000|Overall Study|Case Report Forms Uncollected|56|||
46624683|NCT02221284|82787208|FG000|Overall Study|Protocol Deviation|5|||
46624684|NCT02187042|82787365|FG000|Overall Study|Death|1|||
46624685|NCT02187042|82787366|FG001|Overall Study|Death|1|||
46624686|NCT02187042|82787365|FG000|Overall Study|Toxicity|6|||
46624687|NCT02187042|82787366|FG001|Overall Study|Toxicity|5|||
46624688|NCT02187042|82787365|FG000|Overall Study|Participant choice|1|||
46624689|NCT02187042|82787366|FG001|Overall Study|Participant choice|0|||
46624690|NCT02187042|82787365|FG000|Overall Study|Doctor choice|1|||
46624691|NCT02187042|82787366|FG001|Overall Study|Doctor choice|0|||
46624692|NCT02187042|82787365|FG000|Overall Study|Progressive disease|4|||
46624693|NCT02187042|82787366|FG001|Overall Study|Progressive disease|8|||
46624694|NCT02219334|82787549|FG000|Overall Study|Withdrawal by Subject|1|||
46624695|NCT02219334|82787550|FG001|Overall Study|Withdrawal by Subject|0|||
46624696|NCT02219334|82787549|FG000|Overall Study|Protocol Violation|7|||
46624697|NCT02219334|82787550|FG001|Overall Study|Protocol Violation|3|||
46624698|NCT02159040|82787568|FG000|Overall Study|Death|1|||
46624699|NCT02218008|82787593|FG000|Stage 1 (S1)|Adverse Event|6|||
46624700|NCT02218008|82787594|FG001|Stage 1 (S1)|Adverse Event|5|||
46624701|NCT02218008|82787595|FG002|Stage 1 (S1)|Adverse Event|11|||
46624702|NCT02218008|82787596|FG003|Stage 1 (S1)|Adverse Event|0|||
46624703|NCT02218008|82787597|FG004|Stage 1 (S1)|Adverse Event|0|||
46624704|NCT02218008|82787598|FG005|Stage 1 (S1)|Adverse Event|0|||
46624705|NCT02218008|82787593|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
46624706|NCT02218008|82787594|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
46624707|NCT02218008|82787595|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
46624708|NCT02218008|82787596|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
46624709|NCT02218008|82787597|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
46624710|NCT02218008|82787598|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
46624711|NCT02218008|82787593|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
46624712|NCT02218008|82787594|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
46624713|NCT02218008|82787595|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
46624714|NCT02218008|82787596|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
46624715|NCT02218008|82787597|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
46624716|NCT02218008|82787598|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
46624717|NCT02218008|82787593|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
46624718|NCT02218008|82787594|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
46624719|NCT02218008|82787595|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
47028340|NCT01410448|83277972|FG001|Overall Study|Graft loss|1|||
46624720|NCT02218008|82787596|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
46624721|NCT02218008|82787597|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
46624722|NCT02218008|82787598|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
46624723|NCT02218008|82787593|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
46624724|NCT02218008|82787594|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
46624725|NCT02218008|82787595|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
46624726|NCT02218008|82787596|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
46624727|NCT02218008|82787597|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
46624728|NCT02218008|82787598|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
47028341|NCT01410448|83277971|FG000|Overall Study|Administrative issues|2|||
46624729|NCT02218008|82787593|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
46624730|NCT02218008|82787594|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
46624731|NCT02218008|82787595|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
46624732|NCT02218008|82787596|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
46624733|NCT02218008|82787597|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
46624734|NCT02218008|82787598|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
46624735|NCT02218008|82787593|FG000|Stage 1 (S1)|Pregnancy|0|||
46624736|NCT02218008|82787594|FG001|Stage 1 (S1)|Pregnancy|0|||
46624737|NCT02218008|82787595|FG002|Stage 1 (S1)|Pregnancy|1|||
46624738|NCT02218008|82787596|FG003|Stage 1 (S1)|Pregnancy|0|||
46624739|NCT02218008|82787597|FG004|Stage 1 (S1)|Pregnancy|0|||
46624740|NCT02218008|82787598|FG005|Stage 1 (S1)|Pregnancy|0|||
46624741|NCT02218008|82787593|FG000|Stage 1 (S1)|Protocol Violation|0|||
46624742|NCT02218008|82787594|FG001|Stage 1 (S1)|Protocol Violation|0|||
46624743|NCT02218008|82787595|FG002|Stage 1 (S1)|Protocol Violation|1|||
46624744|NCT02218008|82787596|FG003|Stage 1 (S1)|Protocol Violation|0|||
46624745|NCT02218008|82787597|FG004|Stage 1 (S1)|Protocol Violation|0|||
46624746|NCT02218008|82787598|FG005|Stage 1 (S1)|Protocol Violation|0|||
46624747|NCT02218008|82787593|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
46624748|NCT02218008|82787594|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
46624749|NCT02218008|82787595|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
46624750|NCT02218008|82787596|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
46624751|NCT02218008|82787597|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
46624752|NCT02218008|82787598|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
46624753|NCT02218008|82787593|FG000|Stage 2 (S2)|Adverse Event|0|||
47028342|NCT01410448|83277972|FG001|Overall Study|Administrative issues|1|||
47028343|NCT01410448|83277971|FG000|Overall Study|Lost to Follow-up|1|||
47028344|NCT01410448|83277972|FG001|Overall Study|Lost to Follow-up|0|||
47028345|NCT01410448|83277971|FG000|Overall Study|Withdrawal by Subject|3|||
47028346|NCT01410448|83277972|FG001|Overall Study|Withdrawal by Subject|2|||
47028347|NCT01410448|83277971|FG000|Overall Study|Protocol Violation|0|||
47028348|NCT01410448|83277972|FG001|Overall Study|Protocol Violation|4|||
47028349|NCT01410448|83277971|FG000|Overall Study|Death|2|||
47028350|NCT01410448|83277972|FG001|Overall Study|Death|3|||
47028351|NCT01943851|83277996|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028352|NCT01943851|83277997|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028353|NCT01943851|83277998|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028354|NCT01943851|83277999|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
47028355|NCT01943851|83278000|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028356|NCT01943851|83278001|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028357|NCT01943851|83278002|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
47028358|NCT01943851|83278003|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
47028359|NCT01943851|83278004|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
47028360|NCT01943851|83278005|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028361|NCT01943851|83278006|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028362|NCT01943851|83278007|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028363|NCT01943851|83278008|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028364|NCT01943851|83278009|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028365|NCT01943851|83278010|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028366|NCT01943851|83278011|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028367|NCT01943851|83278012|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028368|NCT01943851|83278013|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
47028369|NCT01943851|83277996|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028370|NCT01943851|83277997|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028371|NCT01943851|83277998|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028372|NCT01943851|83277999|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028373|NCT01943851|83278000|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
47028374|NCT01943851|83278001|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028375|NCT01943851|83278002|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028376|NCT01943851|83278003|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
47028377|NCT01943851|83278004|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028378|NCT01943851|83278005|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028379|NCT01943851|83278006|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028380|NCT01943851|83278007|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028381|NCT01943851|83278008|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
46624754|NCT02218008|82787594|FG001|Stage 2 (S2)|Adverse Event|0|||
46624755|NCT02218008|82787595|FG002|Stage 2 (S2)|Adverse Event|0|||
47028382|NCT01943851|83278009|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028383|NCT01943851|83278010|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028384|NCT01943851|83278011|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028385|NCT01943851|83278012|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028386|NCT01943851|83278013|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
47028387|NCT01943851|83277996|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
46624756|NCT02218008|82787596|FG003|Stage 2 (S2)|Adverse Event|2|||
46710329|NCT00911170|82926465|FG000|Treatment Period|Protocol deviation|1|||
46624757|NCT02218008|82787597|FG004|Stage 2 (S2)|Adverse Event|3|||
46624758|NCT02218008|82787598|FG005|Stage 2 (S2)|Adverse Event|3|||
46624759|NCT02218008|82787593|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
46624760|NCT02218008|82787594|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
46624761|NCT02218008|82787595|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
46624762|NCT02218008|82787596|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
46624763|NCT02218008|82787597|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
46624764|NCT02218008|82787598|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
46624765|NCT02218008|82787593|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
46624766|NCT02218008|82787594|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
46624767|NCT02218008|82787595|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
46912285|NCT03003000|83142349|FG002|Overall Study|Other than listed|1|||
46912286|NCT03002610|83142360|FG000|Overall Study|Withdrawal by Subject|6|||
46912287|NCT03002610|83142361|FG001|Overall Study|Withdrawal by Subject|25|||
46912288|NCT03002610|83142362|FG002|Overall Study|Withdrawal by Subject|13|||
46912289|NCT03005106|83142370|FG000|Overall Study|Lost to Follow-up|16|||
46912290|NCT03005106|83142370|FG000|Overall Study|Adverse Event|1|||
46912291|NCT03005106|83142370|FG000|Overall Study|Physician Decision|1|||
46912292|NCT03005106|83142370|FG000|Overall Study|Death|2|||
46912293|NCT01004861|83142387|FG000|Overall Study|Disease progression|3|||
46912294|NCT01004861|83142388|FG001|Overall Study|Disease progression|4|||
46912295|NCT01004861|83142389|FG002|Overall Study|Disease progression|5|||
46912296|NCT01004861|83142390|FG003|Overall Study|Disease progression|4|||
46912297|NCT01004861|83142391|FG004|Overall Study|Disease progression|4|||
46912298|NCT01004861|83142392|FG005|Overall Study|Disease progression|4|||
46912299|NCT01004861|83142393|FG006|Overall Study|Disease progression|5|||
47028388|NCT01943851|83277997|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028389|NCT01943851|83277998|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028390|NCT01943851|83277999|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028391|NCT01943851|83278000|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028392|NCT01943851|83278001|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028393|NCT01943851|83278002|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028394|NCT01943851|83278003|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028395|NCT01943851|83278004|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028396|NCT01943851|83278005|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028397|NCT01943851|83278006|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028398|NCT01943851|83278007|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028399|NCT01943851|83278008|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028400|NCT01943851|83278009|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
47028401|NCT01943851|83278010|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028402|NCT01943851|83278011|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028403|NCT01943851|83278012|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028404|NCT01943851|83278013|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
47028405|NCT01943851|83277996|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
46624768|NCT02218008|82787596|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
46912300|NCT01004861|83142394|FG007|Overall Study|Disease progression|1|||
47028406|NCT01943851|83277997|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028407|NCT01943851|83277998|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028408|NCT01943851|83277999|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028409|NCT01943851|83278000|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028410|NCT01943851|83278001|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028411|NCT01943851|83278002|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028412|NCT01943851|83278003|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028413|NCT01943851|83278004|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028414|NCT01943851|83278005|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028415|NCT01943851|83278006|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028416|NCT01943851|83278007|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028417|NCT01943851|83278008|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028418|NCT01943851|83278009|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028419|NCT01943851|83278010|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028420|NCT01943851|83278011|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
47028421|NCT01943851|83278012|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028422|NCT01943851|83278013|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
47028423|NCT01943851|83277996|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028424|NCT01943851|83277997|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028425|NCT01943851|83277998|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028426|NCT01943851|83277999|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028427|NCT01943851|83278000|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028428|NCT01943851|83278001|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
46912301|NCT01004861|83142395|FG008|Overall Study|Disease progression|4|||
46912302|NCT01004861|83142396|FG009|Overall Study|Disease progression|7|||
46624769|NCT02218008|82787597|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
46624770|NCT02218008|82787598|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
46710330|NCT00911170|82926466|FG001|Treatment Period|Protocol deviation|2|||
46912303|NCT01004861|83142397|FG010|Overall Study|Disease progression|6|||
46912304|NCT01004861|83142398|FG011|Overall Study|Disease progression|3|||
46912305|NCT01004861|83142399|FG012|Overall Study|Disease progression|8|||
46912306|NCT01004861|83142387|FG000|Overall Study|Physician Decision|0|||
46624771|NCT02218008|82787593|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
46624772|NCT02218008|82787594|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
46624773|NCT02218008|82787595|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
46624774|NCT02218008|82787596|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
46624775|NCT02218008|82787597|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
46624776|NCT02218008|82787598|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
46624777|NCT02218008|82787593|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
46624778|NCT02218008|82787594|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
46624779|NCT02218008|82787595|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
46624780|NCT02218008|82787596|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
46624781|NCT02218008|82787597|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
46624782|NCT02218008|82787598|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
46624783|NCT01632150|82787695|FG000|Overall Study|Disease progression|27|||
46624784|NCT01632150|82787695|FG000|Overall Study|Study drug toxicity|1|||
46624785|NCT01632150|82787695|FG000|Overall Study|Unrelated adverse event|7|||
46624786|NCT01632150|82787695|FG000|Overall Study|Withdrawal by Subject|2|||
46624787|NCT01632150|82787695|FG000|Overall Study|Patient underwent autologous transplant|1|||
46624788|NCT01632150|82787695|FG000|Overall Study|Moved to compassionate program|2|||
46624789|NCT02185014|82787720|FG000|Overall Study|Adverse Event|18|||
46624790|NCT02185014|82787720|FG000|Overall Study|Withdrew Consent|8|||
46624791|NCT02185014|82787720|FG000|Overall Study|Lost to Follow-up|4|||
46624792|NCT02185014|82787720|FG000|Overall Study|Lack of Efficacy|14|||
46624793|NCT02185014|82787720|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
46624794|NCT02185014|82787720|FG000|Overall Study|Subject Noncompliance|1|||
46624795|NCT02185014|82787720|FG000|Overall Study|Other|4|||
46624796|NCT02184156|82787770|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
46624797|NCT02184156|82787771|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
46624798|NCT02184156|82787770|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
46624799|NCT02184156|82787771|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
46624800|NCT02158884|82787794|FG000|Baseline Assessment|Missed performance assessment|3|||
46624801|NCT02158884|82787794|FG000|Baseline Assessment|Missed SMFA|1|||
46624802|NCT02158884|82787794|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
46624803|NCT02158884|82787794|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
46624804|NCT02158884|82787794|FG000|6 Month Assessment|Missed SMFA|20|||
46624805|NCT02158884|82787794|FG000|12 Month Assessment|Missed SMFA|17|||
46624806|NCT02158806|82787837|FG000|Overall Study|Death|2|||
46624807|NCT02158806|82787838|FG001|Overall Study|Death|0|||
46624808|NCT02158806|82787837|FG000|Overall Study|Withdrawal by Subject|2|||
46624809|NCT02158806|82787838|FG001|Overall Study|Withdrawal by Subject|0|||
46624810|NCT02158806|82787837|FG000|Overall Study|Lost to Follow-up|0|||
46624811|NCT02158806|82787838|FG001|Overall Study|Lost to Follow-up|3|||
46624812|NCT02158806|82787837|FG000|Overall Study|Moved out of area|0|||
46624813|NCT02158806|82787838|FG001|Overall Study|Moved out of area|1|||
46624814|NCT02158806|82787837|FG000|Overall Study|Transferred to palliative care|0|||
46624815|NCT02158806|82787838|FG001|Overall Study|Transferred to palliative care|1|||
46624816|NCT02158728|82787869|FG000|Overall Study|no procedure according to CIP done|3|||
46624817|NCT02158728|82787869|FG000|Overall Study|no qualified dataset|24|||
46624818|NCT02157948|82787914|FG000|Overall Study|Withdrawal by Subject|4|||
46624819|NCT02157948|82787915|FG001|Overall Study|Withdrawal by Subject|5|||
46624820|NCT02157948|82787914|FG000|Overall Study|Lost to Follow-up|3|||
46624821|NCT02157948|82787915|FG001|Overall Study|Lost to Follow-up|2|||
46624822|NCT02157948|82787914|FG000|Overall Study|Protocol Specified Criteria|2|||
46624823|NCT02157948|82787915|FG001|Overall Study|Protocol Specified Criteria|1|||
46624824|NCT02157948|82787914|FG000|Overall Study|Decision by Sponsor|0|||
46624825|NCT02157948|82787915|FG001|Overall Study|Decision by Sponsor|1|||
46624826|NCT02182830|82787956|FG000|Overall Study|Not Treated|1|||
46624827|NCT02182830|82787957|FG001|Overall Study|Not Treated|1|||
46624828|NCT02182830|82787956|FG000|Overall Study|Trial stopped, reason missing|3|||
46624829|NCT02182830|82787957|FG001|Overall Study|Trial stopped, reason missing|3|||
46624830|NCT02182830|82787956|FG000|Overall Study|Consent withdrawn|8|||
46624831|NCT02182830|82787957|FG001|Overall Study|Consent withdrawn|8|||
46624832|NCT02182830|82787956|FG000|Overall Study|Lost to Follow-up|3|||
46624833|NCT02182830|82787957|FG001|Overall Study|Lost to Follow-up|3|||
46624834|NCT02182440|82788531|FG000|Overall Study|Adverse Event|0|||
46624835|NCT02182440|82788532|FG001|Overall Study|Adverse Event|1|||
46624836|NCT02182440|82788533|FG002|Overall Study|Adverse Event|0|||
46624837|NCT02182440|82788534|FG003|Overall Study|Adverse Event|0|||
46624838|NCT02182440|82788531|FG000|Overall Study|Death|31|||
46624839|NCT02182440|82788532|FG001|Overall Study|Death|8|||
46624840|NCT02182440|82788533|FG002|Overall Study|Death|5|||
46624841|NCT02182440|82788534|FG003|Overall Study|Death|16|||
46624842|NCT02182440|82788531|FG000|Overall Study|Protocol Violation|0|||
46624843|NCT02182440|82788532|FG001|Overall Study|Protocol Violation|1|||
46624844|NCT02182440|82788533|FG002|Overall Study|Protocol Violation|0|||
46624845|NCT02182440|82788534|FG003|Overall Study|Protocol Violation|0|||
46624846|NCT02182440|82788531|FG000|Overall Study|Physician Decision|1|||
46624847|NCT02182440|82788532|FG001|Overall Study|Physician Decision|0|||
47028429|NCT01943851|83278002|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028430|NCT01943851|83278003|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028431|NCT01943851|83278004|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028432|NCT01943851|83278005|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028433|NCT01943851|83278006|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028434|NCT01943851|83278007|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028435|NCT01943851|83278008|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028436|NCT01943851|83278009|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028437|NCT01943851|83278010|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
47028438|NCT01943851|83278011|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
47028439|NCT01943851|83278012|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
47028440|NCT01943851|83278013|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
47028441|NCT01430104|83278054|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
47028442|NCT01990859|83278061|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
47028443|NCT01990859|83278061|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
47028444|NCT02093897|83278066|FG000|Overall Study|Physician Decision|1|||
47028445|NCT02093897|83278066|FG000|Overall Study|Planned age group closure - no's reached|17|||
47028446|NCT02093897|83278066|FG000|Overall Study|Adverse event, non-fatal|1|||
47028447|NCT01990313|83278077|FG000|Overall Study|Lost to Follow-up|1|||
47028448|NCT01947517|83278083|FG000|Overall Study|Withdrawal by Subject|1|||
47028449|NCT01947517|83278084|FG001|Overall Study|Withdrawal by Subject|1|||
47028450|NCT02006927|83278090|FG000|Overall Study|Adverse Event|2|||
47028451|NCT02006927|83278090|FG000|Overall Study|Withdrawal by Subject|1|||
47028452|NCT01947283|83278101|FG000|Overall Study|Death|1|||
47028453|NCT01947283|83278102|FG001|Overall Study|Death|1|||
47028454|NCT01947283|83278103|FG002|Overall Study|Death|1|||
47028455|NCT01947283|83278104|FG003|Overall Study|Death|0|||
47028456|NCT01947283|83278105|FG004|Overall Study|Death|0|||
47028457|NCT01947283|83278106|FG005|Overall Study|Death|0|||
47028458|NCT01947283|83278107|FG006|Overall Study|Death|0|||
47028459|NCT01947283|83278101|FG000|Overall Study|Lost to Follow-up|4|||
47028460|NCT01947283|83278102|FG001|Overall Study|Lost to Follow-up|6|||
47028461|NCT01947283|83278103|FG002|Overall Study|Lost to Follow-up|5|||
47028462|NCT01947283|83278104|FG003|Overall Study|Lost to Follow-up|5|||
47028463|NCT01947283|83278105|FG004|Overall Study|Lost to Follow-up|0|||
47028464|NCT01947283|83278106|FG005|Overall Study|Lost to Follow-up|2|||
47028465|NCT01947283|83278107|FG006|Overall Study|Lost to Follow-up|5|||
47028466|NCT01947283|83278101|FG000|Overall Study|Withdrawal by Subject|10|||
47028467|NCT01947283|83278102|FG001|Overall Study|Withdrawal by Subject|8|||
47028468|NCT01947283|83278103|FG002|Overall Study|Withdrawal by Subject|4|||
47028469|NCT01947283|83278104|FG003|Overall Study|Withdrawal by Subject|1|||
47028470|NCT01947283|83278105|FG004|Overall Study|Withdrawal by Subject|0|||
47028471|NCT01947283|83278106|FG005|Overall Study|Withdrawal by Subject|0|||
47028472|NCT01947283|83278107|FG006|Overall Study|Withdrawal by Subject|2|||
47028473|NCT01947283|83278101|FG000|Overall Study|No Clinical Recording|12|||
47028474|NCT01947283|83278102|FG001|Overall Study|No Clinical Recording|6|||
47028475|NCT01947283|83278103|FG002|Overall Study|No Clinical Recording|8|||
46710331|NCT00911170|82926465|FG000|Treatment Period|Adverse Event|9|||
46710332|NCT00911170|82926466|FG001|Treatment Period|Adverse Event|10|||
46912307|NCT01004861|83142388|FG001|Overall Study|Physician Decision|2|||
47028476|NCT01947283|83278104|FG003|Overall Study|No Clinical Recording|10|||
47028477|NCT01947283|83278105|FG004|Overall Study|No Clinical Recording|0|||
47028478|NCT01947283|83278106|FG005|Overall Study|No Clinical Recording|0|||
47028479|NCT01947283|83278107|FG006|Overall Study|No Clinical Recording|0|||
47028480|NCT01947283|83278101|FG000|Overall Study|Non-coding Clinical Recording language|0|||
46624848|NCT02182440|82788533|FG002|Overall Study|Physician Decision|0|||
46624849|NCT02182440|82788534|FG003|Overall Study|Physician Decision|0|||
46624850|NCT02182440|82788531|FG000|Overall Study|Withdrawal by Subject|1|||
46624851|NCT02182440|82788532|FG001|Overall Study|Withdrawal by Subject|1|||
46624852|NCT02182440|82788533|FG002|Overall Study|Withdrawal by Subject|3|||
46624853|NCT02182440|82788534|FG003|Overall Study|Withdrawal by Subject|4|||
46624854|NCT02182440|82788531|FG000|Overall Study|different, e.g adm other hospital|12|||
46624855|NCT02182440|82788532|FG001|Overall Study|different, e.g adm other hospital|3|||
46624856|NCT02182440|82788533|FG002|Overall Study|different, e.g adm other hospital|3|||
46624857|NCT02182440|82788534|FG003|Overall Study|different, e.g adm other hospital|10|||
46624858|NCT02181816|82788576|FG000|Overall Study|Case Report Forms Uncollected|38|||
46624859|NCT02181816|82788576|FG000|Overall Study|Protocol Deviation|21|||
46624860|NCT02156466|82788732|FG000|Overall Study|Adverse Event|0|||
46624861|NCT02156466|82788733|FG001|Overall Study|Adverse Event|0|||
46624862|NCT02156466|82788734|FG002|Overall Study|Adverse Event|1|||
46624863|NCT02156466|82788735|FG003|Overall Study|Adverse Event|1|||
46624864|NCT02156466|82788736|FG004|Overall Study|Adverse Event|0|||
46624865|NCT02156466|82788732|FG000|Overall Study|Quantiferon Positivity|0|||
46624866|NCT02156466|82788733|FG001|Overall Study|Quantiferon Positivity|0|||
46624867|NCT02156466|82788734|FG002|Overall Study|Quantiferon Positivity|0|||
46624868|NCT02156466|82788735|FG003|Overall Study|Quantiferon Positivity|1|||
46624869|NCT02156466|82788736|FG004|Overall Study|Quantiferon Positivity|0|||
46624870|NCT02216526|82788775|FG000|Overall Study|Adverse Event|1|||
46624871|NCT02216526|82788776|FG001|Overall Study|Adverse Event|1|||
46624872|NCT02216526|82788777|FG002|Overall Study|Adverse Event|0|||
46624873|NCT02216526|82788775|FG000|Overall Study|Death|0|||
46624874|NCT02216526|82788776|FG001|Overall Study|Death|1|||
46624875|NCT02216526|82788777|FG002|Overall Study|Death|3|||
46624876|NCT02216526|82788775|FG000|Overall Study|Protocol Violation|2|||
46624877|NCT02216526|82788776|FG001|Overall Study|Protocol Violation|0|||
46624878|NCT02216526|82788777|FG002|Overall Study|Protocol Violation|2|||
46624879|NCT02216526|82788775|FG000|Overall Study|Hospitalization|2|||
46624880|NCT02216526|82788776|FG001|Overall Study|Hospitalization|1|||
46624881|NCT02216526|82788777|FG002|Overall Study|Hospitalization|3|||
46624882|NCT02216214|82788817|FG000|Overall Study|Randomized Never Received Study Drug|1|||
46624883|NCT02216214|82788818|FG001|Overall Study|Randomized Never Received Study Drug|0|||
46624884|NCT02216214|82788817|FG000|Overall Study|Adverse Event|10|||
46624885|NCT02216214|82788818|FG001|Overall Study|Adverse Event|8|||
46624886|NCT02216214|82788817|FG000|Overall Study|Lack of Efficacy|2|||
46624887|NCT02216214|82788818|FG001|Overall Study|Lack of Efficacy|2|||
46624888|NCT02216214|82788817|FG000|Overall Study|Lost to Follow-up|3|||
46624889|NCT02216214|82788818|FG001|Overall Study|Lost to Follow-up|2|||
46624890|NCT02216214|82788817|FG000|Overall Study|Protocol Violation|4|||
46624891|NCT02216214|82788818|FG001|Overall Study|Protocol Violation|2|||
46624892|NCT02216214|82788817|FG000|Overall Study|Withdrawal by Subject|22|||
46624893|NCT02216214|82788818|FG001|Overall Study|Withdrawal by Subject|20|||
46624894|NCT02216214|82788817|FG000|Overall Study|Study Terminated By Sponsor|0|||
46624895|NCT02216214|82788818|FG001|Overall Study|Study Terminated By Sponsor|1|||
46624896|NCT02216214|82788817|FG000|Overall Study|Miscellaneous|1|||
46624897|NCT02216214|82788818|FG001|Overall Study|Miscellaneous|1|||
46624898|NCT02214186|82788849|FG000|Overall Study|Lost to Follow-up|1|||
46624899|NCT02214186|82788850|FG001|Overall Study|Lost to Follow-up|1|||
46624900|NCT02214186|82788849|FG000|Overall Study|Protocol Violation|1|||
46624901|NCT02214186|82788850|FG001|Overall Study|Protocol Violation|1|||
46624902|NCT02181504|82788896|FG000|Overall Study|Adverse Event|1|||
46624903|NCT02181504|82788897|FG001|Overall Study|Adverse Event|1|||
46624904|NCT02181504|82788898|FG002|Overall Study|Adverse Event|1|||
46624905|NCT02179398|82788928|FG000|Overall Study|Lack of obligatory data|3|||
46624906|NCT02179398|82788929|FG001|Overall Study|Lack of obligatory data|3|||
46624907|NCT02179398|82788928|FG000|Overall Study|Lost to Follow-up|0|||
47028481|NCT01947283|83278102|FG001|Overall Study|Non-coding Clinical Recording language|0|||
46624908|NCT02179398|82788929|FG001|Overall Study|Lost to Follow-up|1|||
46624909|NCT02156076|82788943|FG000|Treatment Period|no longer meets study criteria|0|||
46624910|NCT02156076|82788944|FG001|Treatment Period|no longer meets study criteria|0|||
46624911|NCT02156076|82788945|FG002|Treatment Period|no longer meets study criteria|1|||
46624912|NCT02156076|82788946|FG003|Treatment Period|no longer meets study criteria|0|||
46624913|NCT02156076|82788943|FG000|Treatment Period|Poor/non-compliance|0|||
46624914|NCT02156076|82788944|FG001|Treatment Period|Poor/non-compliance|1|||
46624915|NCT02156076|82788945|FG002|Treatment Period|Poor/non-compliance|0|||
46624916|NCT02156076|82788946|FG003|Treatment Period|Poor/non-compliance|0|||
46624917|NCT02156076|82788943|FG000|Treatment Period|Lost to Follow-up|0|||
46624918|NCT02156076|82788944|FG001|Treatment Period|Lost to Follow-up|0|||
46624919|NCT02156076|82788945|FG002|Treatment Period|Lost to Follow-up|0|||
46624920|NCT02156076|82788946|FG003|Treatment Period|Lost to Follow-up|1|||
46624921|NCT02156076|82788943|FG000|Treatment Period|Withdrawal by Subject|0|||
46624922|NCT02156076|82788944|FG001|Treatment Period|Withdrawal by Subject|0|||
46624923|NCT02156076|82788945|FG002|Treatment Period|Withdrawal by Subject|1|||
46624924|NCT02156076|82788946|FG003|Treatment Period|Withdrawal by Subject|0|||
46624925|NCT02156076|82788943|FG000|Treatment Period|Subject request to discontinue treatment|0|||
46624926|NCT02156076|82788944|FG001|Treatment Period|Subject request to discontinue treatment|1|||
46624927|NCT02156076|82788945|FG002|Treatment Period|Subject request to discontinue treatment|0|||
46624928|NCT02156076|82788946|FG003|Treatment Period|Subject request to discontinue treatment|0|||
46624929|NCT02156076|82788943|FG000|Treatment Period|Adverse Event|0|||
46624930|NCT02156076|82788944|FG001|Treatment Period|Adverse Event|0|||
46624931|NCT02156076|82788945|FG002|Treatment Period|Adverse Event|0|||
46624932|NCT02156076|82788946|FG003|Treatment Period|Adverse Event|1|||
46624933|NCT02156076|82788943|FG000|Follow-up Period|Withdrawal by Subject|1|||
46624934|NCT02156076|82788944|FG001|Follow-up Period|Withdrawal by Subject|0|||
46624935|NCT02156076|82788945|FG002|Follow-up Period|Withdrawal by Subject|0|||
46624936|NCT02156076|82788946|FG003|Follow-up Period|Withdrawal by Subject|0|||
46624937|NCT02213094|82788958|FG000|Overall Study|Adverse Event|1|||
46624938|NCT02213094|82788959|FG001|Overall Study|Adverse Event|0|||
46624939|NCT02155608|82788967|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
46624940|NCT02155608|82788968|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
46624941|NCT02155608|82788967|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
46624942|NCT02155608|82788968|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
46624943|NCT01629966|82788983|FG000|Overall Study|Pregnancy|0|||
46624944|NCT01629966|82788984|FG001|Overall Study|Pregnancy|1|||
46624945|NCT01629966|82788985|FG002|Overall Study|Pregnancy|0|||
46624946|NCT01629966|82788983|FG000|Overall Study|Lost to Follow-up|10|||
46624947|NCT01629966|82788984|FG001|Overall Study|Lost to Follow-up|13|||
46624948|NCT01629966|82788985|FG002|Overall Study|Lost to Follow-up|9|||
46624949|NCT01629966|82788983|FG000|Overall Study|Withdrawal by Subject|8|||
46624950|NCT01629966|82788984|FG001|Overall Study|Withdrawal by Subject|9|||
46624951|NCT01629966|82788985|FG002|Overall Study|Withdrawal by Subject|16|||
46624952|NCT01629966|82788983|FG000|Overall Study|Protocol Violation|7|||
46624953|NCT01629966|82788984|FG001|Overall Study|Protocol Violation|9|||
46624954|NCT01629966|82788985|FG002|Overall Study|Protocol Violation|7|||
46624955|NCT01629966|82788983|FG000|Overall Study|Lack of Efficacy|5|||
46624956|NCT01629966|82788984|FG001|Overall Study|Lack of Efficacy|2|||
46624957|NCT01629966|82788985|FG002|Overall Study|Lack of Efficacy|4|||
46624958|NCT01629966|82788983|FG000|Overall Study|Adverse Event|11|||
46624959|NCT01629966|82788984|FG001|Overall Study|Adverse Event|18|||
46624960|NCT01629966|82788985|FG002|Overall Study|Adverse Event|30|||
46624961|NCT02177838|82789025|FG000|Overall Study|Withdrawal by Subject|1|||
46624962|NCT02177838|82789025|FG000|Overall Study|Physician Decision|1|||
46624963|NCT02177838|82789025|FG000|Overall Study|Death|1|||
46624964|NCT02177136|82789122|FG000|DB Phase|Withdrawal by Subject|2|||
46624965|NCT02177136|82789123|FG001|DB Phase|Withdrawal by Subject|0|||
46624966|NCT02177136|82789124|FG002|DB Phase|Withdrawal by Subject|0|||
46624967|NCT02177136|82789125|FG003|DB Phase|Withdrawal by Subject|0|||
46624968|NCT02177136|82789122|FG000|DB Phase|Discontinued Due to Pruritus|1|||
46624969|NCT02177136|82789123|FG001|DB Phase|Discontinued Due to Pruritus|3|||
46624970|NCT02177136|82789124|FG002|DB Phase|Discontinued Due to Pruritus|0|||
46624971|NCT02177136|82789125|FG003|DB Phase|Discontinued Due to Pruritus|0|||
46624972|NCT02177136|82789122|FG000|DB Phase|Adverse Event|3|||
46624973|NCT02177136|82789123|FG001|DB Phase|Adverse Event|2|||
46624974|NCT02177136|82789124|FG002|DB Phase|Adverse Event|3|||
46624975|NCT02177136|82789125|FG003|DB Phase|Adverse Event|0|||
47028482|NCT01947283|83278103|FG002|Overall Study|Non-coding Clinical Recording language|0|||
47028483|NCT01947283|83278104|FG003|Overall Study|Non-coding Clinical Recording language|1|||
47028484|NCT01947283|83278105|FG004|Overall Study|Non-coding Clinical Recording language|0|||
47028485|NCT01947283|83278106|FG005|Overall Study|Non-coding Clinical Recording language|0|||
47028486|NCT01947283|83278107|FG006|Overall Study|Non-coding Clinical Recording language|0|||
47028487|NCT01947283|83278101|FG000|Overall Study|Missing Follow-up Assessment|2|||
47028488|NCT01947283|83278102|FG001|Overall Study|Missing Follow-up Assessment|2|||
47028489|NCT01947283|83278103|FG002|Overall Study|Missing Follow-up Assessment|3|||
47028490|NCT01947283|83278104|FG003|Overall Study|Missing Follow-up Assessment|0|||
47028491|NCT01947283|83278105|FG004|Overall Study|Missing Follow-up Assessment|0|||
47028492|NCT01947283|83278106|FG005|Overall Study|Missing Follow-up Assessment|2|||
47028493|NCT01947283|83278107|FG006|Overall Study|Missing Follow-up Assessment|0|||
47028494|NCT01947283|83278101|FG000|Overall Study|No patients were enrolled in study|0|||
46624976|NCT02177136|82789122|FG000|DB Phase|Protocol Violation|0|||
47028495|NCT01947283|83278102|FG001|Overall Study|No patients were enrolled in study|0|||
47028496|NCT01947283|83278103|FG002|Overall Study|No patients were enrolled in study|0|||
46624977|NCT02177136|82789123|FG001|DB Phase|Protocol Violation|0|||
46624978|NCT02177136|82789124|FG002|DB Phase|Protocol Violation|1|||
46624979|NCT02177136|82789125|FG003|DB Phase|Protocol Violation|0|||
46624980|NCT02177136|82789122|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
46624981|NCT02177136|82789123|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
46624982|NCT02177136|82789124|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
46624983|NCT02177136|82789125|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
46624984|NCT02177136|82789122|FG000|LTSE Phase|Withdrawal by Subject|0|||
46624985|NCT02177136|82789123|FG001|LTSE Phase|Withdrawal by Subject|0|||
46624986|NCT02177136|82789124|FG002|LTSE Phase|Withdrawal by Subject|0|||
46624987|NCT02177136|82789125|FG003|LTSE Phase|Withdrawal by Subject|6|||
46624988|NCT02177136|82789122|FG000|LTSE Phase|Adverse Event|0|||
46624989|NCT02177136|82789123|FG001|LTSE Phase|Adverse Event|0|||
46624990|NCT02177136|82789124|FG002|LTSE Phase|Adverse Event|0|||
46624991|NCT02177136|82789125|FG003|LTSE Phase|Adverse Event|10|||
46624992|NCT02177136|82789122|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
46624993|NCT02177136|82789123|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
46624994|NCT02177136|82789124|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
46624995|NCT02177136|82789125|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
46624996|NCT02177136|82789122|FG000|LTSE Phase|Physician Decision|0|||
46624997|NCT02177136|82789123|FG001|LTSE Phase|Physician Decision|0|||
46912308|NCT01004861|83142389|FG002|Overall Study|Physician Decision|1|||
46624998|NCT02177136|82789124|FG002|LTSE Phase|Physician Decision|0|||
46624999|NCT02177136|82789125|FG003|LTSE Phase|Physician Decision|2|||
46625000|NCT02177136|82789122|FG000|LTSE Phase|Lost to Follow-up|0|||
46625001|NCT02177136|82789123|FG001|LTSE Phase|Lost to Follow-up|0|||
46625002|NCT02177136|82789124|FG002|LTSE Phase|Lost to Follow-up|0|||
46625003|NCT02177136|82789125|FG003|LTSE Phase|Lost to Follow-up|1|||
46625004|NCT02177136|82789122|FG000|LTSE Phase|Participant Moved|0|||
46625005|NCT02177136|82789123|FG001|LTSE Phase|Participant Moved|0|||
46625006|NCT02177136|82789124|FG002|LTSE Phase|Participant Moved|0|||
46625007|NCT02177136|82789125|FG003|LTSE Phase|Participant Moved|1|||
46625008|NCT02176356|82789153|FG000|Overall Study|Screen Failure|14|||
46625009|NCT02176356|82789153|FG000|Overall Study|Lost to Follow-up|4|||
46625010|NCT02176356|82789153|FG000|Overall Study|Personal Reasons|3|||
46625011|NCT02176356|82789153|FG000|Overall Study|Other Miscellaneous Reasons|2|||
46625012|NCT02210208|82789163|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
46625013|NCT02210208|82789163|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
46625014|NCT02210208|82789163|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
46625015|NCT02209506|82789183|FG000|Overall Study|Withdrawal by Subject|0|||
46710333|NCT00911170|82926465|FG000|Treatment Period|Withdrawal by Subject|4|||
46912309|NCT01004861|83142390|FG003|Overall Study|Physician Decision|1|||
46912310|NCT01004861|83142391|FG004|Overall Study|Physician Decision|1|||
46625016|NCT02209506|82789184|FG001|Overall Study|Withdrawal by Subject|0|||
46625017|NCT02209506|82789185|FG002|Overall Study|Withdrawal by Subject|0|||
46625018|NCT02209506|82789186|FG003|Overall Study|Withdrawal by Subject|0|||
46625019|NCT02209506|82789187|FG004|Overall Study|Withdrawal by Subject|1|||
46625020|NCT02153736|82789204|FG000|Overall Study|Lost to Follow-up|1|||
46625021|NCT02153736|82789205|FG001|Overall Study|Lost to Follow-up|0|||
46912311|NCT01004861|83142392|FG005|Overall Study|Physician Decision|0|||
46625022|NCT02153736|82789204|FG000|Overall Study|Medical status change made ineligible|1|||
46912312|NCT01004861|83142393|FG006|Overall Study|Physician Decision|0|||
46625023|NCT02153736|82789205|FG001|Overall Study|Medical status change made ineligible|0|||
46625024|NCT02153736|82789204|FG000|Overall Study|Death|0|||
46625025|NCT02153736|82789205|FG001|Overall Study|Death|1|||
46625026|NCT02153736|82789204|FG000|Overall Study|Withdrawal by Subject|0|||
46625027|NCT02153736|82789205|FG001|Overall Study|Withdrawal by Subject|1|||
46625028|NCT02175966|82789213|FG000|Follow-up Period|Lack of Efficacy|10|||
46625029|NCT02175966|82789214|FG001|Follow-up Period|Lack of Efficacy|6|||
46625030|NCT02153346|82789220|FG000|Overall Study|Lost to Follow-up|11|||
46625031|NCT02174562|82789227|FG000|Overall Study|Withdrawal by Subject|7|||
46625032|NCT02174562|82789228|FG001|Overall Study|Withdrawal by Subject|2|||
46625033|NCT02174562|82789227|FG000|Overall Study|Death|2|||
46625034|NCT02174562|82789228|FG001|Overall Study|Death|0|||
46625035|NCT02174562|82789227|FG000|Overall Study|Lost to Follow-up|0|||
46625036|NCT02174562|82789228|FG001|Overall Study|Lost to Follow-up|3|||
46625037|NCT02136576|82789237|FG000|Overall Study|Lost to Follow-up|2|||
46625038|NCT02136576|82789238|FG001|Overall Study|Lost to Follow-up|0|||
46625039|NCT02136576|82789239|FG002|Overall Study|Lost to Follow-up|0|||
46625040|NCT02153112|82789496|FG000|Overall Study|Adverse Event|0|||
46625041|NCT02153112|82789497|FG001|Overall Study|Adverse Event|0|||
46625042|NCT02153112|82789498|FG002|Overall Study|Adverse Event|1|||
46625043|NCT02153112|82789499|FG003|Overall Study|Adverse Event|0|||
46625044|NCT02153112|82789500|FG004|Overall Study|Adverse Event|0|||
46625045|NCT02153112|82789501|FG005|Overall Study|Adverse Event|0|||
46625046|NCT02153112|82789502|FG006|Overall Study|Adverse Event|0|||
46625047|NCT02153112|82789503|FG007|Overall Study|Adverse Event|0|||
46625048|NCT02153112|82789504|FG008|Overall Study|Adverse Event|0|||
46625049|NCT02153112|82789505|FG009|Overall Study|Adverse Event|0|||
46625050|NCT02153112|82789496|FG000|Overall Study|Lost to Follow-up|1|||
46625051|NCT02153112|82789497|FG001|Overall Study|Lost to Follow-up|1|||
46625052|NCT02153112|82789498|FG002|Overall Study|Lost to Follow-up|0|||
46625053|NCT02153112|82789499|FG003|Overall Study|Lost to Follow-up|0|||
46625054|NCT02153112|82789500|FG004|Overall Study|Lost to Follow-up|2|||
46625055|NCT02153112|82789501|FG005|Overall Study|Lost to Follow-up|1|||
46625056|NCT02153112|82789502|FG006|Overall Study|Lost to Follow-up|1|||
46625057|NCT02153112|82789503|FG007|Overall Study|Lost to Follow-up|0|||
46625058|NCT02153112|82789504|FG008|Overall Study|Lost to Follow-up|1|||
46625059|NCT02153112|82789505|FG009|Overall Study|Lost to Follow-up|1|||
46625060|NCT02153112|82789496|FG000|Overall Study|Withdrawal by Subject|3|||
46625061|NCT02153112|82789497|FG001|Overall Study|Withdrawal by Subject|1|||
46625062|NCT02153112|82789498|FG002|Overall Study|Withdrawal by Subject|2|||
46625063|NCT02153112|82789499|FG003|Overall Study|Withdrawal by Subject|2|||
46625064|NCT02153112|82789500|FG004|Overall Study|Withdrawal by Subject|1|||
46625065|NCT02153112|82789501|FG005|Overall Study|Withdrawal by Subject|1|||
46625066|NCT02153112|82789502|FG006|Overall Study|Withdrawal by Subject|7|||
47028497|NCT01947283|83278104|FG003|Overall Study|No patients were enrolled in study|0|||
47028498|NCT01947283|83278105|FG004|Overall Study|No patients were enrolled in study|0|||
46625067|NCT02153112|82789503|FG007|Overall Study|Withdrawal by Subject|2|||
46625068|NCT02153112|82789504|FG008|Overall Study|Withdrawal by Subject|13|||
46625069|NCT02153112|82789505|FG009|Overall Study|Withdrawal by Subject|12|||
46625070|NCT02153112|82789496|FG000|Overall Study|Reason not Specified|0|||
46625071|NCT02153112|82789497|FG001|Overall Study|Reason not Specified|0|||
46625072|NCT02153112|82789498|FG002|Overall Study|Reason not Specified|0|||
46625073|NCT02153112|82789499|FG003|Overall Study|Reason not Specified|0|||
46625074|NCT02153112|82789500|FG004|Overall Study|Reason not Specified|0|||
47028499|NCT01947283|83278106|FG005|Overall Study|No patients were enrolled in study|3|||
47028500|NCT01947283|83278107|FG006|Overall Study|No patients were enrolled in study|1|||
47028501|NCT02006693|83278126|FG000|Overall Study|No Reason Specified|6|||
47028502|NCT02006693|83278127|FG001|Overall Study|No Reason Specified|8|||
47028503|NCT02006693|83278126|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
47028504|NCT02006693|83278127|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
47028505|NCT02006693|83278126|FG000|Overall Study|XEN Implant Explantation|0|||
46625075|NCT02153112|82789501|FG005|Overall Study|Reason not Specified|0|||
46625076|NCT02153112|82789502|FG006|Overall Study|Reason not Specified|0|||
46625077|NCT02153112|82789503|FG007|Overall Study|Reason not Specified|0|||
46625078|NCT02153112|82789504|FG008|Overall Study|Reason not Specified|1|||
46625079|NCT02153112|82789505|FG009|Overall Study|Reason not Specified|1|||
46625080|NCT02133924|82789555|FG000|Overall Study|Death|38|||
46625081|NCT02133924|82789555|FG000|Overall Study|Physician Decision|1|||
46625082|NCT02133924|82789555|FG000|Overall Study|Withdrawal by Subject|3|||
46625083|NCT02173704|82789646|FG000|Overall Study|Adverse Event|1|||
46625084|NCT02173704|82789647|FG001|Overall Study|Adverse Event|0|||
46625085|NCT02173704|82789646|FG000|Overall Study|Lost to Follow-up|1|||
46625086|NCT02173704|82789647|FG001|Overall Study|Lost to Follow-up|0|||
46625087|NCT02173704|82789646|FG000|Overall Study|Other|1|||
46625088|NCT02173704|82789647|FG001|Overall Study|Other|0|||
46625089|NCT02173704|82789646|FG000|Overall Study|Protocol Violation|1|||
46625090|NCT02173704|82789647|FG001|Overall Study|Protocol Violation|0|||
46625091|NCT02173704|82789646|FG000|Overall Study|Withdrawal by Subject|9|||
46625092|NCT02173704|82789647|FG001|Overall Study|Withdrawal by Subject|4|||
46625093|NCT02173548|82789668|FG000|Overall Study|Lost to Follow-up|0|||
46625094|NCT02173548|82789669|FG001|Overall Study|Lost to Follow-up|2|||
46625095|NCT02173548|82789668|FG000|Overall Study|Withdrawal by Subject|1|||
46625096|NCT02173548|82789669|FG001|Overall Study|Withdrawal by Subject|0|||
46625097|NCT02173158|82789685|FG000|Efficacy Phase|Adverse Event|1|||
46625098|NCT02152566|82789707|FG000|Overall Study|Lost to Follow-up|1|||
46625099|NCT02152566|82789707|FG000|Overall Study|Withdrawal by Subject|2|||
46625100|NCT02171130|82789736|FG000|Overall Study|Death|1|||
46625101|NCT02171130|82789736|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
46625102|NCT02171130|82789736|FG000|Overall Study|Discontinued; Site Termination|5|||
46625103|NCT02171130|82789736|FG000|Overall Study|Withdrawal by Subject|3|||
46625104|NCT02171130|82789736|FG000|Overall Study|Physician Decision|1|||
46625105|NCT02171130|82789736|FG000|Overall Study|Lost to Follow-up|1|||
46625106|NCT02171130|82789736|FG000|Overall Study|Met Exclusion Criteria|1|||
46625107|NCT03603314|82795570|FG000|Overall Study|Lost to Follow-up|0|||
46625108|NCT03603314|82795571|FG001|Overall Study|Lost to Follow-up|3|||
46625109|NCT03603314|82795572|FG002|Overall Study|Lost to Follow-up|0|||
46625110|NCT03603314|82795570|FG000|Overall Study|Protocol Violation|0|||
46625111|NCT03603314|82795571|FG001|Overall Study|Protocol Violation|1|||
46625112|NCT03603314|82795572|FG002|Overall Study|Protocol Violation|0|||
46625113|NCT03603314|82795570|FG000|Overall Study|Adverse Event|2|||
46625114|NCT03603314|82795571|FG001|Overall Study|Adverse Event|0|||
46625115|NCT03603314|82795572|FG002|Overall Study|Adverse Event|0|||
46625116|NCT03603314|82795570|FG000|Overall Study|Physician Decision|1|||
46625117|NCT03603314|82795571|FG001|Overall Study|Physician Decision|1|||
46625118|NCT03603314|82795572|FG002|Overall Study|Physician Decision|0|||
46625119|NCT03603314|82795570|FG000|Overall Study|Withdrawal by Subject|4|||
46625120|NCT03603314|82795571|FG001|Overall Study|Withdrawal by Subject|5|||
46625121|NCT03603314|82795572|FG002|Overall Study|Withdrawal by Subject|3|||
46625122|NCT03603314|82795570|FG000|Overall Study|Other|0|||
46625123|NCT03603314|82795571|FG001|Overall Study|Other|1|||
46625124|NCT03603314|82795572|FG002|Overall Study|Other|0|||
46625125|NCT04302350|82795587|FG000|Overall Study|Physician Decision|1|||
46625126|NCT04302350|82795588|FG001|Overall Study|Physician Decision|1|||
46625127|NCT04302350|82795589|FG002|Overall Study|Physician Decision|2|||
46625128|NCT04302350|82795587|FG000|Overall Study|Lack of Efficacy|1|||
46625129|NCT04302350|82795588|FG001|Overall Study|Lack of Efficacy|1|||
46625130|NCT04302350|82795589|FG002|Overall Study|Lack of Efficacy|4|||
46625131|NCT04302350|82795587|FG000|Overall Study|Adverse Event|0|||
46625132|NCT04302350|82795588|FG001|Overall Study|Adverse Event|1|||
46625133|NCT04302350|82795589|FG002|Overall Study|Adverse Event|2|||
46625134|NCT05943990|82795614|FG000|Overall Study|Study Terminated by Sponsor|0|||
46625135|NCT05943990|82795615|FG001|Overall Study|Study Terminated by Sponsor|0|||
46625136|NCT05943990|82795616|FG002|Overall Study|Study Terminated by Sponsor|1|||
46912313|NCT01004861|83142394|FG007|Overall Study|Physician Decision|1|||
46625137|NCT05740371|82795623|FG000|Overall Study|Death|1|||
46625138|NCT05300087|82795646|FG000|Overall Study|Withdrawal by Subject|0|||
46625139|NCT05300087|82795647|FG001|Overall Study|Withdrawal by Subject|1|||
46625140|NCT04819113|82795686|FG000|Overall Study|Withdrawal by parent/guardian|3|||
46625141|NCT04819113|82795686|FG000|Overall Study|Lost to Follow-up|1|||
46625142|NCT04819113|82795686|FG000|Overall Study|Withdrawn before vaccination|2|||
46625143|NCT04803734|82795690|FG000|Overall Study|Withdrawal by Subject|0|||
46625144|NCT04803734|82795691|FG001|Overall Study|Withdrawal by Subject|1|||
46625145|NCT04803734|82795690|FG000|Overall Study|Protocol Violation|0|||
46625146|NCT04803734|82795691|FG001|Overall Study|Protocol Violation|1|||
46625147|NCT04785144|82795707|FG000|Overall Study|Withdrawal by Subject|4|||
46625148|NCT04785144|82795708|FG001|Overall Study|Withdrawal by Subject|1|||
46625149|NCT04785144|82795709|FG002|Overall Study|Withdrawal by Subject|0|||
46625150|NCT04785144|82795710|FG003|Overall Study|Withdrawal by Subject|0|||
46625151|NCT04785144|82795711|FG004|Overall Study|Withdrawal by Subject|0|||
46625152|NCT04785144|82795712|FG005|Overall Study|Withdrawal by Subject|2|||
46625153|NCT04785144|82795713|FG006|Overall Study|Withdrawal by Subject|2|||
46625154|NCT04785144|82795714|FG007|Overall Study|Withdrawal by Subject|0|||
46625155|NCT04785144|82795715|FG008|Overall Study|Withdrawal by Subject|1|||
46625156|NCT04785144|82795716|FG009|Overall Study|Withdrawal by Subject|0|||
46625157|NCT04785144|82795707|FG000|Overall Study|Lost to Follow-up|1|||
46625158|NCT04785144|82795708|FG001|Overall Study|Lost to Follow-up|0|||
46625159|NCT04785144|82795709|FG002|Overall Study|Lost to Follow-up|0|||
46625160|NCT04785144|82795710|FG003|Overall Study|Lost to Follow-up|0|||
46625161|NCT04785144|82795711|FG004|Overall Study|Lost to Follow-up|1|||
46625162|NCT04785144|82795712|FG005|Overall Study|Lost to Follow-up|2|||
46625163|NCT04785144|82795713|FG006|Overall Study|Lost to Follow-up|1|||
46625164|NCT04785144|82795714|FG007|Overall Study|Lost to Follow-up|2|||
46625165|NCT04785144|82795715|FG008|Overall Study|Lost to Follow-up|4|||
46625166|NCT04785144|82795716|FG009|Overall Study|Lost to Follow-up|1|||
46625167|NCT04785144|82795707|FG000|Overall Study|Protocol Violation|0|||
46625168|NCT04785144|82795708|FG001|Overall Study|Protocol Violation|0|||
46625169|NCT04785144|82795709|FG002|Overall Study|Protocol Violation|0|||
46625170|NCT04785144|82795710|FG003|Overall Study|Protocol Violation|0|||
46625171|NCT04785144|82795711|FG004|Overall Study|Protocol Violation|0|||
46625172|NCT04785144|82795712|FG005|Overall Study|Protocol Violation|0|||
46625173|NCT04785144|82795713|FG006|Overall Study|Protocol Violation|1|||
46625174|NCT04785144|82795714|FG007|Overall Study|Protocol Violation|0|||
46625175|NCT04785144|82795715|FG008|Overall Study|Protocol Violation|0|||
46625176|NCT04785144|82795716|FG009|Overall Study|Protocol Violation|0|||
46625177|NCT04785144|82795707|FG000|Overall Study|Physician Decision|0|||
46625178|NCT04785144|82795708|FG001|Overall Study|Physician Decision|0|||
46625179|NCT04785144|82795709|FG002|Overall Study|Physician Decision|0|||
46625180|NCT04785144|82795710|FG003|Overall Study|Physician Decision|0|||
46625181|NCT04785144|82795711|FG004|Overall Study|Physician Decision|0|||
46625182|NCT04785144|82795712|FG005|Overall Study|Physician Decision|0|||
46625183|NCT04785144|82795713|FG006|Overall Study|Physician Decision|0|||
46625184|NCT04785144|82795714|FG007|Overall Study|Physician Decision|0|||
46625185|NCT04785144|82795715|FG008|Overall Study|Physician Decision|0|||
46625186|NCT04785144|82795716|FG009|Overall Study|Physician Decision|1|||
46625187|NCT04785144|82795707|FG000|Overall Study|Unable to continue due to work schedule|0|||
46625188|NCT04785144|82795708|FG001|Overall Study|Unable to continue due to work schedule|0|||
46625189|NCT04785144|82795709|FG002|Overall Study|Unable to continue due to work schedule|0|||
46625190|NCT04785144|82795710|FG003|Overall Study|Unable to continue due to work schedule|0|||
46625191|NCT04785144|82795711|FG004|Overall Study|Unable to continue due to work schedule|0|||
46625192|NCT04785144|82795712|FG005|Overall Study|Unable to continue due to work schedule|0|||
46625193|NCT04785144|82795713|FG006|Overall Study|Unable to continue due to work schedule|0|||
46625194|NCT04785144|82795714|FG007|Overall Study|Unable to continue due to work schedule|0|||
46625195|NCT04785144|82795715|FG008|Overall Study|Unable to continue due to work schedule|0|||
47028506|NCT02006693|83278127|FG001|Overall Study|XEN Implant Explantation|1|||
47028507|NCT02006693|83278126|FG000|Overall Study|Death|2|||
47028508|NCT02006693|83278127|FG001|Overall Study|Death|2|||
47028509|NCT02006693|83278126|FG000|Overall Study|Lost to Follow-up|4|||
47028510|NCT02006693|83278127|FG001|Overall Study|Lost to Follow-up|1|||
47028511|NCT02006693|83278126|FG000|Overall Study|Patient Decision|4|||
46625196|NCT04785144|82795716|FG009|Overall Study|Unable to continue due to work schedule|1|||
46625197|NCT04772898|82795759|FG000|Overall Study|Withdrawal by Subject|0|||
46625198|NCT04772898|82795760|FG001|Overall Study|Withdrawal by Subject|1|||
46625199|NCT04538417|82795778|FG000|Overall Study|Withdrawal by Subject|2|||
46625200|NCT04316585|82795784|FG000|Overall Study|Adverse Event|2|||
46625201|NCT04316585|82795785|FG001|Overall Study|Adverse Event|1|||
46625202|NCT04316585|82795784|FG000|Overall Study|Lost to Follow-up|1|||
46625203|NCT04316585|82795785|FG001|Overall Study|Lost to Follow-up|0|||
46625204|NCT04316585|82795784|FG000|Overall Study|Withdrawal by Subject|2|||
46625205|NCT04316585|82795785|FG001|Overall Study|Withdrawal by Subject|3|||
46625206|NCT04316585|82795784|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
46625207|NCT04316585|82795785|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
47028512|NCT02006693|83278127|FG001|Overall Study|Patient Decision|0|||
47028513|NCT01947127|83278135|FG000|Overall Study|Protocol Violation|18|||
47028514|NCT01947127|83278136|FG001|Overall Study|Protocol Violation|38|||
47028515|NCT01947127|83278135|FG000|Overall Study|Withdrawal by Subject|1|||
46625208|NCT04316585|82795784|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
46625209|NCT04316585|82795785|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
46625210|NCT04283461|82795801|FG000|Overall Study|Enrolled in separate trial|0|||
46625211|NCT04283461|82795802|FG001|Overall Study|Enrolled in separate trial|0|||
46625212|NCT04283461|82795803|FG002|Overall Study|Enrolled in separate trial|8|||
46625213|NCT04283461|82795804|FG003|Overall Study|Enrolled in separate trial|13|||
46625214|NCT04283461|82795805|FG004|Overall Study|Enrolled in separate trial|12|||
46625215|NCT04283461|82795806|FG005|Overall Study|Enrolled in separate trial|0|||
46625216|NCT04283461|82795807|FG006|Overall Study|Enrolled in separate trial|0|||
46625217|NCT04283461|82795808|FG007|Overall Study|Enrolled in separate trial|8|||
46625218|NCT04283461|82795809|FG008|Overall Study|Enrolled in separate trial|0|||
46710334|NCT00911170|82926466|FG001|Treatment Period|Withdrawal by Subject|4|||
47028516|NCT01947127|83278136|FG001|Overall Study|Withdrawal by Subject|1|||
47028517|NCT01947127|83278135|FG000|Overall Study|Data loss|4|||
46625219|NCT04283461|82795810|FG009|Overall Study|Enrolled in separate trial|0|||
46625220|NCT04283461|82795811|FG010|Overall Study|Enrolled in separate trial|0|||
46625221|NCT04283461|82795812|FG011|Overall Study|Enrolled in separate trial|7|||
46625222|NCT04283461|82795813|FG012|Overall Study|Enrolled in separate trial|0|||
46625223|NCT04114656|82795844|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
46625224|NCT04114656|82795845|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
46625225|NCT04114656|82795844|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
46625226|NCT04114656|82795845|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
46710335|NCT00911170|82926465|FG000|Treatment Period|Disease progression|0|||
47028518|NCT01947127|83278136|FG001|Overall Study|Data loss|4|||
47028519|NCT01976845|83278145|FG000|Overall Study|Physician Decision|8|||
47028520|NCT01976845|83278146|FG001|Overall Study|Physician Decision|8|||
47028521|NCT01976845|83278147|FG002|Overall Study|Physician Decision|3|||
47028522|NCT01989689|83278157|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
47028523|NCT01989689|83278158|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
47028524|NCT01989689|83278157|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
47028525|NCT01989689|83278158|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
47028526|NCT01943539|83278166|FG000|Overall Study|Non-compliance with at-home intervention|4|||
47028527|NCT01943539|83278167|FG001|Overall Study|Non-compliance with at-home intervention|0|||
47028528|NCT01942993|83278174|FG000|Overall Study|Lost to Follow-up|1|||
47028529|NCT01942993|83278174|FG000|Overall Study|Physician Decision|1|||
47028530|NCT01989455|83278183|FG000|Overall Study|Adverse Event|0|||
47028531|NCT01989455|83278184|FG001|Overall Study|Adverse Event|1|||
47028532|NCT01989455|83278185|FG002|Overall Study|Adverse Event|0|||
47028533|NCT01989455|83278186|FG003|Overall Study|Adverse Event|0|||
47028534|NCT01989455|83278187|FG004|Overall Study|Adverse Event|0|||
47028535|NCT01989455|83278183|FG000|Overall Study|Withdrawal by Subject|0|||
47028536|NCT01989455|83278184|FG001|Overall Study|Withdrawal by Subject|1|||
47028537|NCT01989455|83278185|FG002|Overall Study|Withdrawal by Subject|0|||
47028538|NCT01989455|83278186|FG003|Overall Study|Withdrawal by Subject|0|||
47028539|NCT01989455|83278187|FG004|Overall Study|Withdrawal by Subject|0|||
47028540|NCT01989455|83278183|FG000|Overall Study|Technical problems with infusion|0|||
47028541|NCT01989455|83278184|FG001|Overall Study|Technical problems with infusion|0|||
47028542|NCT01989455|83278185|FG002|Overall Study|Technical problems with infusion|1|||
47028543|NCT01989455|83278186|FG003|Overall Study|Technical problems with infusion|0|||
47028544|NCT01989455|83278187|FG004|Overall Study|Technical problems with infusion|1|||
47028545|NCT01942837|83278203|FG000|Overall Study|Death|1|||
47028546|NCT01942837|83278203|FG000|Overall Study|Symptomatic or radiographic progression|49|||
47028547|NCT01942837|83278203|FG000|Overall Study|Adverse Event|6|||
47028548|NCT01942837|83278203|FG000|Overall Study|Physician Decision|3|||
47028549|NCT01942837|83278203|FG000|Overall Study|Withdrawal by Subject|2|||
47028550|NCT01942837|83278203|FG000|Overall Study|Intercurrent Illness|1|||
47028551|NCT01942837|83278203|FG000|Overall Study|On treatment|3|||
47028552|NCT01942837|83278203|FG000|Overall Study|Never initiate the treatment|2|||
47028553|NCT01987895|83278210|FG000|Overall Study|Withdrawal by Subject|12|||
47028554|NCT01987895|83278211|FG001|Overall Study|Withdrawal by Subject|7|||
47028555|NCT01987895|83278210|FG000|Overall Study|Physician Decision|8|||
47028556|NCT01987895|83278211|FG001|Overall Study|Physician Decision|10|||
47028557|NCT01987895|83278210|FG000|Overall Study|Death|7|||
47028558|NCT01987895|83278211|FG001|Overall Study|Death|7|||
47028559|NCT01987895|83278210|FG000|Overall Study|Lost to Follow-up|3|||
47028560|NCT01987895|83278211|FG001|Overall Study|Lost to Follow-up|5|||
47028561|NCT01987895|83278210|FG000|Overall Study|randomized before giving IC|0|||
47028562|NCT01987895|83278211|FG001|Overall Study|randomized before giving IC|1|||
47028563|NCT02005445|83278219|FG000|Overall Study|Dual study enrollment|0|||
47028564|NCT02005445|83278220|FG001|Overall Study|Dual study enrollment|1|||
47028565|NCT01618669|83278228|FG000|Overall Study|Lost to Follow-up|1|||
46710336|NCT00911170|82926466|FG001|Treatment Period|Disease progression|2|||
47028566|NCT01618669|83278229|FG001|Overall Study|Lost to Follow-up|1|||
47028567|NCT01618669|83278228|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
46710337|NCT00911170|82926465|FG000|Treatment Period|Physician Decision|5|||
46710338|NCT00911170|82926466|FG001|Treatment Period|Physician Decision|5|||
47028568|NCT01618669|83278229|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
47028569|NCT01618669|83278228|FG000|Overall Study|Adverse Event|16|||
47028570|NCT01618669|83278229|FG001|Overall Study|Adverse Event|7|||
47028571|NCT01618669|83278228|FG000|Overall Study|Protocol Violation|5|||
46625227|NCT04114656|82795844|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
46625228|NCT04114656|82795845|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
46625229|NCT04114656|82795844|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
46625230|NCT04114656|82795845|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
46625231|NCT04114656|82795844|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
46625232|NCT04114656|82795845|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
46625233|NCT04095442|82795933|FG000|Overall Study|Lost to Follow-up|0|||
46625234|NCT04095442|82795934|FG001|Overall Study|Lost to Follow-up|1|||
46625235|NCT04095442|82795933|FG000|Overall Study|Screen failure|1|||
46625236|NCT04095442|82795934|FG001|Overall Study|Screen failure|0|||
46625237|NCT04024462|82795942|FG000|Overall Study|Withdrawal by Subject|6|||
46625238|NCT04024462|82795943|FG001|Overall Study|Withdrawal by Subject|7|||
46625239|NCT04024462|82795942|FG000|Overall Study|Progressive Disease|0|||
46625240|NCT04024462|82795943|FG001|Overall Study|Progressive Disease|1|||
46625241|NCT04024462|82795942|FG000|Overall Study|Adverse Event|0|||
46625242|NCT04024462|82795943|FG001|Overall Study|Adverse Event|1|||
46625243|NCT04024462|82795942|FG000|Overall Study|Death|0|||
46625244|NCT04024462|82795943|FG001|Overall Study|Death|1|||
46625245|NCT04024462|82795942|FG000|Overall Study|Lost to Follow-up|1|||
46625246|NCT04024462|82795943|FG001|Overall Study|Lost to Follow-up|0|||
46625247|NCT04024462|82795942|FG000|Overall Study|Ongoing in the Study|94|||
46625248|NCT04024462|82795943|FG001|Overall Study|Ongoing in the Study|89|||
46625249|NCT03927105|82795949|FG000|Overall Study|Death|1|||
46625250|NCT03927105|82795949|FG000|Overall Study|In observation for potential re-treatment|2|||
46625251|NCT03927105|82795949|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
46625252|NCT03907410|82795956|FG000|Overall Study|Lost to Follow-up|4|||
46625253|NCT03907410|82795957|FG001|Overall Study|Lost to Follow-up|1|||
46625254|NCT03907410|82795958|FG002|Overall Study|Lost to Follow-up|1|||
46625255|NCT03907410|82795956|FG000|Overall Study|Lost to follow-up and research burden|0|||
46625256|NCT03907410|82795957|FG001|Overall Study|Lost to follow-up and research burden|0|||
46625257|NCT03907410|82795958|FG002|Overall Study|Lost to follow-up and research burden|1|||
46625258|NCT03877926|82795979|FG000|Overall Study|Adverse Event|1|||
46625259|NCT03877926|82795980|FG001|Overall Study|Adverse Event|0|||
46625260|NCT03877926|82795981|FG002|Overall Study|Adverse Event|0|||
46625261|NCT03877926|82795982|FG003|Overall Study|Adverse Event|0|||
46625262|NCT03877926|82795979|FG000|Overall Study|Death|2|||
46625263|NCT03877926|82795980|FG001|Overall Study|Death|2|||
46625264|NCT03877926|82795981|FG002|Overall Study|Death|2|||
46625265|NCT03877926|82795982|FG003|Overall Study|Death|0|||
46625266|NCT03877926|82795979|FG000|Overall Study|Lost to Follow-up|41|||
46625267|NCT03877926|82795980|FG001|Overall Study|Lost to Follow-up|52|||
46625268|NCT03877926|82795981|FG002|Overall Study|Lost to Follow-up|45|||
46625269|NCT03877926|82795982|FG003|Overall Study|Lost to Follow-up|17|||
46625270|NCT03877926|82795979|FG000|Overall Study|Physician Decision|2|||
46625271|NCT03877926|82795980|FG001|Overall Study|Physician Decision|0|||
46625272|NCT03877926|82795981|FG002|Overall Study|Physician Decision|2|||
46625273|NCT03877926|82795982|FG003|Overall Study|Physician Decision|0|||
46625274|NCT03877926|82795979|FG000|Overall Study|Withdrawal by Subject|18|||
46625275|NCT03877926|82795980|FG001|Overall Study|Withdrawal by Subject|21|||
46625276|NCT03877926|82795981|FG002|Overall Study|Withdrawal by Subject|12|||
46625277|NCT03877926|82795982|FG003|Overall Study|Withdrawal by Subject|4|||
46625278|NCT03877926|82795979|FG000|Overall Study|Other - Various|4|||
46625279|NCT03877926|82795980|FG001|Overall Study|Other - Various|1|||
46625280|NCT03877926|82795981|FG002|Overall Study|Other - Various|1|||
46625281|NCT03877926|82795982|FG003|Overall Study|Other - Various|0|||
46625282|NCT03877926|82795979|FG000|Overall Study|Not Treated|3|||
46625283|NCT03877926|82795980|FG001|Overall Study|Not Treated|1|||
46625284|NCT03877926|82795981|FG002|Overall Study|Not Treated|1|||
46625285|NCT03877926|82795982|FG003|Overall Study|Not Treated|0|||
46625286|NCT03624946|82796013|FG000|Overall Study|Lost to Follow-up|0|||
46625287|NCT03624946|82796014|FG001|Overall Study|Lost to Follow-up|1|||
46625288|NCT03551626|82796024|FG000|Overall Study|Adverse Event|88|||
46625289|NCT03551626|82796024|FG000|Overall Study|Disease relapse|18|||
46625290|NCT03551626|82796024|FG000|Overall Study|Withdrawal of informed consent|6|||
46625291|NCT03551626|82796024|FG000|Overall Study|Patient decision|5|||
46625292|NCT03551626|82796024|FG000|Overall Study|Physician Decision|4|||
46625293|NCT03551626|82796024|FG000|Overall Study|Lost to Follow-up|3|||
46625294|NCT03551626|82796024|FG000|Overall Study|Pregnancy|1|||
46625295|NCT03551626|82796024|FG000|Overall Study|Protocol deviation|1|||
46625296|NCT03551626|82796024|FG000|Overall Study|Technical problems|1|||
46625297|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
46625298|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
46625299|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
46625300|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
46625301|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
46912314|NCT01004861|83142395|FG008|Overall Study|Physician Decision|0|||
46912315|NCT01004861|83142396|FG009|Overall Study|Physician Decision|0|||
46912316|NCT01004861|83142397|FG010|Overall Study|Physician Decision|0|||
46912317|NCT01004861|83142398|FG011|Overall Study|Physician Decision|0|||
46912318|NCT01004861|83142399|FG012|Overall Study|Physician Decision|3|||
46912319|NCT01004861|83142387|FG000|Overall Study|Adverse Event|0|||
46912320|NCT01004861|83142388|FG001|Overall Study|Adverse Event|0|||
46912321|NCT01004861|83142389|FG002|Overall Study|Adverse Event|0|||
46912322|NCT01004861|83142390|FG003|Overall Study|Adverse Event|1|||
46912323|NCT01004861|83142391|FG004|Overall Study|Adverse Event|0|||
46912324|NCT01004861|83142392|FG005|Overall Study|Adverse Event|2|||
46912325|NCT01004861|83142393|FG006|Overall Study|Adverse Event|1|||
46912326|NCT01004861|83142394|FG007|Overall Study|Adverse Event|1|||
46912327|NCT01004861|83142395|FG008|Overall Study|Adverse Event|13|||
46912328|NCT01004861|83142396|FG009|Overall Study|Adverse Event|1|||
46912329|NCT01004861|83142397|FG010|Overall Study|Adverse Event|1|||
46912330|NCT01004861|83142398|FG011|Overall Study|Adverse Event|0|||
46912331|NCT01004861|83142399|FG012|Overall Study|Adverse Event|2|||
46912332|NCT01004861|83142387|FG000|Overall Study|Protocol Violation|0|||
46912333|NCT01004861|83142388|FG001|Overall Study|Protocol Violation|0|||
46912334|NCT01004861|83142389|FG002|Overall Study|Protocol Violation|0|||
46912335|NCT01004861|83142390|FG003|Overall Study|Protocol Violation|0|||
46912336|NCT01004861|83142391|FG004|Overall Study|Protocol Violation|1|||
46912337|NCT01004861|83142392|FG005|Overall Study|Protocol Violation|0|||
47028572|NCT01618669|83278229|FG001|Overall Study|Protocol Violation|3|||
46625302|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
46625303|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
46625304|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
46625305|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
46625306|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
46625307|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
46625308|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
46625309|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
46625310|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
46625311|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
46625312|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
46625313|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
46625314|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
46625315|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
46625316|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
46625317|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
46625318|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
46625319|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
46625320|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
46625321|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
46625322|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
46625323|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
46625324|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
46625325|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
46912338|NCT01004861|83142393|FG006|Overall Study|Protocol Violation|0|||
46912339|NCT01004861|83142394|FG007|Overall Study|Protocol Violation|0|||
46912340|NCT01004861|83142395|FG008|Overall Study|Protocol Violation|0|||
46912341|NCT01004861|83142396|FG009|Overall Study|Protocol Violation|0|||
46912342|NCT01004861|83142397|FG010|Overall Study|Protocol Violation|0|||
47028573|NCT01618669|83278228|FG000|Overall Study|Withdrawal by Subject|9|||
47028574|NCT01618669|83278229|FG001|Overall Study|Withdrawal by Subject|9|||
47028575|NCT01618669|83278228|FG000|Overall Study|Miscellaneous Reason|0|||
47028576|NCT01618669|83278229|FG001|Overall Study|Miscellaneous Reason|1|||
47028577|NCT01390948|83278250|FG000|Overall Study|End of Study|1|||
47028578|NCT01390948|83278251|FG001|Overall Study|End of Study|0|||
47028579|NCT01390948|83278252|FG002|Overall Study|End of Study|0|||
47028580|NCT01390948|83278250|FG000|Overall Study|Withdrew consent|2|||
47028581|NCT01390948|83278251|FG001|Overall Study|Withdrew consent|2|||
47028582|NCT01390948|83278252|FG002|Overall Study|Withdrew consent|0|||
47028583|NCT01390948|83278250|FG000|Overall Study|Progressive Disease|2|||
46912343|NCT01004861|83142398|FG011|Overall Study|Protocol Violation|0|||
46912344|NCT01004861|83142399|FG012|Overall Study|Protocol Violation|0|||
46912345|NCT01004861|83142387|FG000|Overall Study|Lost to Follow-up|0|||
46912346|NCT01004861|83142388|FG001|Overall Study|Lost to Follow-up|0|||
46912347|NCT01004861|83142389|FG002|Overall Study|Lost to Follow-up|0|||
46912348|NCT01004861|83142390|FG003|Overall Study|Lost to Follow-up|0|||
46912349|NCT01004861|83142391|FG004|Overall Study|Lost to Follow-up|0|||
46912350|NCT01004861|83142392|FG005|Overall Study|Lost to Follow-up|0|||
46912351|NCT01004861|83142393|FG006|Overall Study|Lost to Follow-up|0|||
47028584|NCT01390948|83278251|FG001|Overall Study|Progressive Disease|5|||
47028585|NCT01390948|83278252|FG002|Overall Study|Progressive Disease|0|||
47028586|NCT01390948|83278250|FG000|Overall Study|Death during follow-up|10|||
47028587|NCT01390948|83278251|FG001|Overall Study|Death during follow-up|11|||
47028588|NCT01390948|83278252|FG002|Overall Study|Death during follow-up|1|||
47028589|NCT02005211|83278266|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
47028590|NCT02005211|83278267|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
47028591|NCT02005211|83278268|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
47028592|NCT02005211|83278269|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
47028593|NCT02005211|83278270|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
47028594|NCT02005211|83278271|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
47028595|NCT02005211|83278272|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
47028596|NCT01429792|83278295|FG000|Overall Study|Other Reasons|67|||
47028597|NCT01429792|83278295|FG000|Overall Study|Unknown Disposition|94|||
47028598|NCT01429792|83278295|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
47028599|NCT01429792|83278295|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
47028600|NCT01429792|83278295|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
47028601|NCT01429792|83278295|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
47028602|NCT01429792|83278295|FG000|Overall Study|Withdrawal by Subject|70|||
47028603|NCT01429792|83278295|FG000|Overall Study|Lost to Follow-up|88|||
47028604|NCT01409434|83278299|FG000|Overall Study|Protocol Violation|4|||
47028605|NCT01925612|83278308|FG000|Overall Study|Progressive Disease|1|||
47028606|NCT01925612|83278309|FG001|Overall Study|Progressive Disease|1|||
47028607|NCT01925612|83278310|FG002|Overall Study|Progressive Disease|1|||
47028608|NCT01925612|83278311|FG003|Overall Study|Progressive Disease|0|||
47028609|NCT01925612|83278312|FG004|Overall Study|Progressive Disease|0|||
47028610|NCT01925612|83278308|FG000|Overall Study|Adverse Event|3|||
47028611|NCT01925612|83278309|FG001|Overall Study|Adverse Event|3|||
47028612|NCT01925612|83278310|FG002|Overall Study|Adverse Event|0|||
47028613|NCT01925612|83278311|FG003|Overall Study|Adverse Event|1|||
47028614|NCT01925612|83278312|FG004|Overall Study|Adverse Event|2|||
47028615|NCT02093663|83278324|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
47028616|NCT02093663|83278325|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
47028617|NCT02093663|83278326|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
47028618|NCT02093663|83278327|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
47028619|NCT02093663|83278328|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
47028620|NCT02093663|83278324|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
47028621|NCT02093663|83278325|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
47028622|NCT02093663|83278326|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
47028623|NCT02093663|83278327|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
46625326|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
46625327|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
46625328|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
46625329|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
46625330|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
46625331|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
47028624|NCT02093663|83278328|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
47028625|NCT02093663|83278324|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
47028626|NCT02093663|83278325|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
47028627|NCT02093663|83278326|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
47028628|NCT02093663|83278327|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
47028629|NCT02093663|83278328|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
47028630|NCT02093663|83278324|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
47028631|NCT02093663|83278325|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
47028632|NCT02093663|83278326|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
47028633|NCT02093663|83278327|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
46625332|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
46625333|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
46912352|NCT01004861|83142394|FG007|Overall Study|Lost to Follow-up|1|||
46912353|NCT01004861|83142395|FG008|Overall Study|Lost to Follow-up|3|||
46912354|NCT01004861|83142396|FG009|Overall Study|Lost to Follow-up|0|||
46912355|NCT01004861|83142397|FG010|Overall Study|Lost to Follow-up|0|||
46912356|NCT01004861|83142398|FG011|Overall Study|Lost to Follow-up|1|||
46912357|NCT01004861|83142399|FG012|Overall Study|Lost to Follow-up|0|||
46912358|NCT01004861|83142387|FG000|Overall Study|Non-compliance|0|||
46912359|NCT01004861|83142388|FG001|Overall Study|Non-compliance|0|||
46912360|NCT01004861|83142389|FG002|Overall Study|Non-compliance|0|||
46912361|NCT01004861|83142390|FG003|Overall Study|Non-compliance|0|||
46912362|NCT01004861|83142391|FG004|Overall Study|Non-compliance|0|||
46912363|NCT01004861|83142392|FG005|Overall Study|Non-compliance|0|||
46912364|NCT01004861|83142393|FG006|Overall Study|Non-compliance|0|||
46912365|NCT01004861|83142394|FG007|Overall Study|Non-compliance|0|||
46912366|NCT01004861|83142395|FG008|Overall Study|Non-compliance|5|||
47028634|NCT02093663|83278328|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
47028635|NCT02093663|83278324|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
47028636|NCT02093663|83278325|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
47028637|NCT02093663|83278326|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
47028638|NCT02093663|83278327|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
47028639|NCT02093663|83278328|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
47028640|NCT02093663|83278324|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
47028641|NCT02093663|83278325|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
47028642|NCT02093663|83278326|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
47028643|NCT02093663|83278327|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
47028644|NCT02093663|83278328|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
47028645|NCT02093663|83278324|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
47028646|NCT02093663|83278325|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
47028647|NCT02093663|83278326|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
47028648|NCT02093663|83278327|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
47028649|NCT02093663|83278328|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
47028650|NCT02093663|83278324|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
47028651|NCT02093663|83278325|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
47028652|NCT02093663|83278326|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
47028653|NCT02093663|83278327|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
47028654|NCT02093663|83278328|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
47028655|NCT02093663|83278324|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
47028656|NCT02093663|83278325|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
47028657|NCT02093663|83278326|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
47028658|NCT02093663|83278327|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
47028659|NCT02093663|83278328|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
47028660|NCT01408888|83278345|FG000|First Intervention|Adverse Event|0|||
47028661|NCT01408888|83278346|FG001|First Intervention|Adverse Event|1|||
47028662|NCT01408888|83278345|FG000|First Intervention|Withdrawal by Subject|0|||
47028663|NCT01408888|83278346|FG001|First Intervention|Withdrawal by Subject|2|||
47028664|NCT01408888|83278345|FG000|Second Intervention|Withdrawal by Subject|1|||
47028665|NCT01408888|83278346|FG001|Second Intervention|Withdrawal by Subject|0|||
47028666|NCT01408888|83278345|FG000|Second Intervention|Adverse Event|1|||
47028667|NCT01408888|83278346|FG001|Second Intervention|Adverse Event|0|||
47028668|NCT01918033|83278365|FG000|Overall Study|Adverse Event|1|||
47028669|NCT01918033|83278366|FG001|Overall Study|Adverse Event|0|||
47028670|NCT01918033|83278367|FG002|Overall Study|Adverse Event|2|||
47028671|NCT01918033|83278365|FG000|Overall Study|Lost to Follow-up|0|||
47028672|NCT01918033|83278366|FG001|Overall Study|Lost to Follow-up|1|||
47028673|NCT01918033|83278367|FG002|Overall Study|Lost to Follow-up|0|||
47028674|NCT01918033|83278365|FG000|Overall Study|Protocol Violation|2|||
47028675|NCT01918033|83278366|FG001|Overall Study|Protocol Violation|0|||
47028676|NCT01918033|83278367|FG002|Overall Study|Protocol Violation|1|||
47028677|NCT01918033|83278365|FG000|Overall Study|Withdrawal by Subject|2|||
47028678|NCT01918033|83278366|FG001|Overall Study|Withdrawal by Subject|1|||
47028679|NCT01918033|83278367|FG002|Overall Study|Withdrawal by Subject|0|||
47028680|NCT01408732|83278375|FG000|Overall Study|Withdrawal by Subject|2|||
47028681|NCT01408732|83278376|FG001|Overall Study|Withdrawal by Subject|2|||
47028682|NCT01390402|83278382|FG000|Overall Study|Death|1|||
47028683|NCT01390402|83278382|FG000|Overall Study|Disease Progression|4|||
47028684|NCT01976299|83278388|FG000|Overall Study|Withdrawal by Subject|3|||
47028685|NCT01976299|83278389|FG001|Overall Study|Withdrawal by Subject|1|||
47028686|NCT01976299|83278388|FG000|Overall Study|Death|4|||
47028687|NCT01976299|83278389|FG001|Overall Study|Death|2|||
47028688|NCT01976299|83278388|FG000|Overall Study|Lost to Follow-up|7|||
46625334|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
46710339|NCT00911170|82926465|FG000|Treatment Period|Lost to Follow-up|0|||
46710340|NCT00911170|82926466|FG001|Treatment Period|Lost to Follow-up|1|||
47028689|NCT01976299|83278389|FG001|Overall Study|Lost to Follow-up|1|||
47028690|NCT01976299|83278388|FG000|Overall Study|See clarification above in comments|9|||
47028691|NCT01976299|83278389|FG001|Overall Study|See clarification above in comments|2|||
47028692|NCT01428076|83278397|FG000|Overall Study|Adverse Event|0|||
47028693|NCT01428076|83278398|FG001|Overall Study|Adverse Event|1|||
47028694|NCT01900652|83278408|FG000|Overall Study|Progressive Disease|1|||
47028695|NCT01900652|83278409|FG001|Overall Study|Progressive Disease|0|||
47028696|NCT01900652|83278408|FG000|Overall Study|Consent withdrawn by subject|1|||
47028697|NCT01900652|83278409|FG001|Overall Study|Consent withdrawn by subject|1|||
47028698|NCT01900652|83278408|FG000|Overall Study|Death|3|||
47028699|NCT01900652|83278409|FG001|Overall Study|Death|0|||
47028700|NCT01900652|83278408|FG000|Overall Study|Adverse Event|2|||
47028701|NCT01900652|83278409|FG001|Overall Study|Adverse Event|1|||
47028702|NCT01900652|83278408|FG000|Overall Study|Physician Decision|1|||
47028703|NCT01900652|83278409|FG001|Overall Study|Physician Decision|1|||
47028704|NCT02093351|83278423|FG000|Part A|Adverse Event|0|||
47028705|NCT02093351|83278424|FG001|Part A|Adverse Event|1|||
47028706|NCT02093351|83278425|FG002|Part A|Adverse Event|1|||
47028707|NCT02093351|83278426|FG003|Part A|Adverse Event|0|||
47028708|NCT02093351|83278423|FG000|Part A|Condition under investigation worsened|2|||
47028709|NCT02093351|83278424|FG001|Part A|Condition under investigation worsened|0|||
47028710|NCT02093351|83278425|FG002|Part A|Condition under investigation worsened|2|||
47028711|NCT02093351|83278426|FG003|Part A|Condition under investigation worsened|0|||
47028712|NCT02093351|83278423|FG000|Part A|Death|0|||
47028713|NCT02093351|83278424|FG001|Part A|Death|1|||
47028714|NCT02093351|83278425|FG002|Part A|Death|0|||
47028715|NCT02093351|83278426|FG003|Part A|Death|0|||
47028716|NCT02093351|83278423|FG000|Part B|Patient decision|0|||
47028717|NCT02093351|83278424|FG001|Part B|Patient decision|0|||
47028718|NCT02093351|83278425|FG002|Part B|Patient decision|0|||
47028719|NCT02093351|83278426|FG003|Part B|Patient decision|3|||
47028720|NCT02093351|83278423|FG000|Part B|Disease progression|0|||
47028721|NCT02093351|83278424|FG001|Part B|Disease progression|0|||
47028722|NCT02093351|83278425|FG002|Part B|Disease progression|0|||
47028723|NCT02093351|83278426|FG003|Part B|Disease progression|4|||
47028724|NCT02093351|83278423|FG000|Part B|Complete response|0|||
47028725|NCT02093351|83278424|FG001|Part B|Complete response|0|||
47028726|NCT02093351|83278425|FG002|Part B|Complete response|0|||
47028727|NCT02093351|83278426|FG003|Part B|Complete response|1|||
47028728|NCT02093351|83278423|FG000|Part B|Adverse event + disease progression|0|||
47028729|NCT02093351|83278424|FG001|Part B|Adverse event + disease progression|0|||
47028730|NCT02093351|83278425|FG002|Part B|Adverse event + disease progression|0|||
47028731|NCT02093351|83278426|FG003|Part B|Adverse event + disease progression|1|||
47028732|NCT02093351|83278423|FG000|Part B|Lack of therapeutic response|0|||
47028733|NCT02093351|83278424|FG001|Part B|Lack of therapeutic response|0|||
47028734|NCT02093351|83278425|FG002|Part B|Lack of therapeutic response|0|||
47028735|NCT02093351|83278426|FG003|Part B|Lack of therapeutic response|12|||
47028736|NCT02093351|83278423|FG000|Part B|Condition under investigation worsened|0|||
47028737|NCT02093351|83278424|FG001|Part B|Condition under investigation worsened|0|||
47028738|NCT02093351|83278425|FG002|Part B|Condition under investigation worsened|0|||
47028739|NCT02093351|83278426|FG003|Part B|Condition under investigation worsened|39|||
47028740|NCT02093351|83278423|FG000|Part B|Adverse Event|0|||
47028741|NCT02093351|83278424|FG001|Part B|Adverse Event|0|||
47028742|NCT02093351|83278425|FG002|Part B|Adverse Event|0|||
47028743|NCT02093351|83278426|FG003|Part B|Adverse Event|2|||
47028744|NCT02093351|83278423|FG000|Part B|Death|0|||
47028745|NCT02093351|83278424|FG001|Part B|Death|0|||
47028746|NCT02093351|83278425|FG002|Part B|Death|0|||
47028747|NCT02093351|83278426|FG003|Part B|Death|1|||
47028748|NCT02092961|83278465|FG000|Overall Study|Not reported|1|||
47028749|NCT02092961|83278466|FG001|Overall Study|Not reported|0|||
47028750|NCT02092961|83278467|FG002|Overall Study|Not reported|1|||
47028751|NCT02092961|83278465|FG000|Overall Study|Study stopped|13|||
47028752|NCT02092961|83278466|FG001|Overall Study|Study stopped|9|||
47028753|NCT02092961|83278467|FG002|Overall Study|Study stopped|12|||
47028754|NCT02092961|83278465|FG000|Overall Study|Lack of therapeutic response|2|||
47028755|NCT02092961|83278466|FG001|Overall Study|Lack of therapeutic response|1|||
47028756|NCT02092961|83278467|FG002|Overall Study|Lack of therapeutic response|3|||
47028757|NCT02092961|83278465|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
47028758|NCT02092961|83278466|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
47028759|NCT02092961|83278467|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
46625335|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
46625336|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
46625337|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
46625338|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
46625339|NCT03524092|82796033|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
46625340|NCT03524092|82796034|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
46625341|NCT03524092|82796035|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
46625342|NCT03524092|82796036|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
47028760|NCT02092961|83278465|FG000|Overall Study|Adverse Event|2|||
47028761|NCT02092961|83278466|FG001|Overall Study|Adverse Event|4|||
47028762|NCT02092961|83278467|FG002|Overall Study|Adverse Event|0|||
47028763|NCT01898078|83278478|FG000|Overall Study|Progressive Disease|1|||
47028764|NCT01898078|83278479|FG001|Overall Study|Progressive Disease|5|||
47028765|NCT01898078|83278478|FG000|Overall Study|Adverse Event|2|||
47028766|NCT01898078|83278479|FG001|Overall Study|Adverse Event|1|||
47028767|NCT01898078|83278478|FG000|Overall Study|Withdrawal by Subject|1|||
47028768|NCT01898078|83278479|FG001|Overall Study|Withdrawal by Subject|1|||
47028769|NCT01898078|83278478|FG000|Overall Study|Symptomatic Deterioration|2|||
47028770|NCT01898078|83278479|FG001|Overall Study|Symptomatic Deterioration|0|||
47028771|NCT01898078|83278478|FG000|Overall Study|Reason not Specified|0|||
47028772|NCT01898078|83278479|FG001|Overall Study|Reason not Specified|1|||
47028773|NCT01987817|83278489|FG000|Overall Study|Adverse Event|4|||
46710341|NCT00911170|82926465|FG000|Treatment Period|Death|6|||
46710342|NCT00911170|82926466|FG001|Treatment Period|Death|9|||
46710343|NCT00911170|82926465|FG000|Long Term Follow-Up|Continuing in study|274|||
46710344|NCT00911170|82926466|FG001|Long Term Follow-Up|Continuing in study|269|||
46710345|NCT00911170|82926465|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
46710346|NCT00911170|82926466|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
46912367|NCT01004861|83142396|FG009|Overall Study|Non-compliance|0|||
46625343|NCT03524092|82796037|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
46625344|NCT03524092|82796038|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
46625345|NCT03524092|82796033|FG000|Loss of Response Rescue Period|Adverse Event|0|||
46625346|NCT03524092|82796034|FG001|Loss of Response Rescue Period|Adverse Event|0|||
46625347|NCT03524092|82796035|FG002|Loss of Response Rescue Period|Adverse Event|0|||
46625348|NCT03524092|82796036|FG003|Loss of Response Rescue Period|Adverse Event|2|||
46625349|NCT03524092|82796037|FG004|Loss of Response Rescue Period|Adverse Event|0|||
46625350|NCT03524092|82796038|FG005|Loss of Response Rescue Period|Adverse Event|0|||
46625351|NCT03524092|82796033|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
46625352|NCT03524092|82796034|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
46625353|NCT03524092|82796035|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
46625354|NCT03524092|82796036|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
46625355|NCT03524092|82796037|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
46625356|NCT03524092|82796038|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
46625357|NCT03524092|82796033|FG000|Loss of Response Rescue Period|Pregnancy|0|||
46625358|NCT03524092|82796034|FG001|Loss of Response Rescue Period|Pregnancy|0|||
46625359|NCT03524092|82796035|FG002|Loss of Response Rescue Period|Pregnancy|0|||
46625360|NCT03524092|82796036|FG003|Loss of Response Rescue Period|Pregnancy|1|||
46625361|NCT03524092|82796037|FG004|Loss of Response Rescue Period|Pregnancy|0|||
46625362|NCT03524092|82796038|FG005|Loss of Response Rescue Period|Pregnancy|0|||
46625363|NCT03524092|82796033|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
46625364|NCT03524092|82796034|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
46625365|NCT03524092|82796035|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
46625366|NCT03524092|82796036|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
46625367|NCT03524092|82796037|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
46625368|NCT03524092|82796038|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
46625369|NCT03524092|82796033|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
46625370|NCT03524092|82796034|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
46625371|NCT03524092|82796035|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
46625372|NCT03524092|82796036|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
46625373|NCT03524092|82796037|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
46625374|NCT03524092|82796038|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
46625375|NCT03524092|82796033|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
46625376|NCT03524092|82796034|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
46625377|NCT03524092|82796035|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
46625378|NCT03524092|82796036|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
46625379|NCT03524092|82796037|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
46625380|NCT03524092|82796038|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
46625381|NCT03524092|82796033|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
46625382|NCT03524092|82796034|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
46625383|NCT03524092|82796035|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
46625384|NCT03524092|82796036|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
46625385|NCT03524092|82796037|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
46625386|NCT03524092|82796038|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
46625387|NCT03524092|82796033|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
46625388|NCT03524092|82796034|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
46625389|NCT03524092|82796035|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
46625390|NCT03524092|82796036|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
46625391|NCT03524092|82796037|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
46625392|NCT03524092|82796038|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
46625393|NCT03524092|82796033|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
46625394|NCT03524092|82796034|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
46625395|NCT03524092|82796035|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
46625396|NCT03524092|82796036|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
46625397|NCT03524092|82796037|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
46625398|NCT03524092|82796038|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
46625399|NCT03524092|82796033|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
46625400|NCT03524092|82796034|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
46710347|NCT00911170|82926465|FG000|Long Term Follow-Up|Physician Decision|5|||
46912368|NCT01004861|83142397|FG010|Overall Study|Non-compliance|0|||
46710348|NCT00911170|82926466|FG001|Long Term Follow-Up|Physician Decision|4|||
46710349|NCT00911170|82926465|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
46710350|NCT00911170|82926466|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
46710351|NCT00911170|82926465|FG000|Long Term Follow-Up|Death|116|||
46710352|NCT00911170|82926466|FG001|Long Term Follow-Up|Death|121|||
46710353|NCT01167881|82926474|FG000|Overall Study|Adverse Event|47|||
47028774|NCT01987817|83278490|FG001|Overall Study|Adverse Event|0|||
47028775|NCT01987817|83278489|FG000|Overall Study|Withdrawal by Subject|1|||
47028776|NCT01987817|83278490|FG001|Overall Study|Withdrawal by Subject|1|||
47028777|NCT01987817|83278489|FG000|Overall Study|Physician Decision|1|||
47028778|NCT01987817|83278490|FG001|Overall Study|Physician Decision|0|||
47028779|NCT01940497|83278499|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
46912369|NCT01004861|83142398|FG011|Overall Study|Non-compliance|0|||
46912370|NCT01004861|83142399|FG012|Overall Study|Non-compliance|1|||
46912371|NCT01004861|83142387|FG000|Overall Study|Other|0|||
46912372|NCT01004861|83142388|FG001|Overall Study|Other|0|||
46912373|NCT01004861|83142389|FG002|Overall Study|Other|0|||
46912374|NCT01004861|83142390|FG003|Overall Study|Other|0|||
46912375|NCT01004861|83142391|FG004|Overall Study|Other|0|||
46912376|NCT01004861|83142392|FG005|Overall Study|Other|0|||
46912377|NCT01004861|83142393|FG006|Overall Study|Other|0|||
46912378|NCT01004861|83142394|FG007|Overall Study|Other|0|||
46912379|NCT01004861|83142395|FG008|Overall Study|Other|0|||
46912380|NCT01004861|83142396|FG009|Overall Study|Other|2|||
46912381|NCT01004861|83142397|FG010|Overall Study|Other|1|||
46912382|NCT01004861|83142398|FG011|Overall Study|Other|2|||
46912383|NCT01004861|83142399|FG012|Overall Study|Other|3|||
46912384|NCT01004861|83142387|FG000|Overall Study|Patient decision|0|||
46912385|NCT01004861|83142388|FG001|Overall Study|Patient decision|0|||
46912386|NCT01004861|83142389|FG002|Overall Study|Patient decision|0|||
46912387|NCT01004861|83142390|FG003|Overall Study|Patient decision|0|||
46912388|NCT01004861|83142391|FG004|Overall Study|Patient decision|1|||
46912389|NCT01004861|83142392|FG005|Overall Study|Patient decision|0|||
46912390|NCT01004861|83142393|FG006|Overall Study|Patient decision|1|||
46912391|NCT01004861|83142394|FG007|Overall Study|Patient decision|0|||
46912392|NCT01004861|83142395|FG008|Overall Study|Patient decision|7|||
46912393|NCT01004861|83142396|FG009|Overall Study|Patient decision|1|||
46912394|NCT01004861|83142397|FG010|Overall Study|Patient decision|1|||
47028780|NCT01940497|83278500|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
47028781|NCT01940497|83278499|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
47028782|NCT01940497|83278500|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
47028783|NCT01940497|83278499|FG000|Overall Study|Violation of Entry Criteria|1|||
47028784|NCT01940497|83278500|FG001|Overall Study|Violation of Entry Criteria|1|||
47028785|NCT01940497|83278499|FG000|Overall Study|Refused Treatment|1|||
47028786|NCT01940497|83278500|FG001|Overall Study|Refused Treatment|3|||
47028787|NCT01940497|83278499|FG000|Overall Study|Withdrew Consent|6|||
46912395|NCT01004861|83142398|FG011|Overall Study|Patient decision|2|||
46912396|NCT01004861|83142399|FG012|Overall Study|Patient decision|3|||
46912397|NCT01004861|83142387|FG000|Overall Study|Transitioned to Phase 4 study|0|||
46912398|NCT01004861|83142388|FG001|Overall Study|Transitioned to Phase 4 study|0|||
46912399|NCT01004861|83142389|FG002|Overall Study|Transitioned to Phase 4 study|0|||
46912400|NCT01004861|83142390|FG003|Overall Study|Transitioned to Phase 4 study|0|||
46912401|NCT01004861|83142391|FG004|Overall Study|Transitioned to Phase 4 study|0|||
46912402|NCT01004861|83142392|FG005|Overall Study|Transitioned to Phase 4 study|0|||
47028788|NCT01940497|83278500|FG001|Overall Study|Withdrew Consent|2|||
47028789|NCT01940497|83278499|FG000|Overall Study|Administrative/Other|1|||
47028790|NCT01940497|83278500|FG001|Overall Study|Administrative/Other|1|||
46710354|NCT01167881|82926475|FG001|Overall Study|Adverse Event|51|||
46912403|NCT01004861|83142393|FG006|Overall Study|Transitioned to Phase 4 study|0|||
46912404|NCT01004861|83142394|FG007|Overall Study|Transitioned to Phase 4 study|0|||
46912405|NCT01004861|83142395|FG008|Overall Study|Transitioned to Phase 4 study|2|||
47028791|NCT01924754|83278520|FG000|Overall Study|Lost to Follow-up|1|||
47028792|NCT01924754|83278521|FG001|Overall Study|Lost to Follow-up|2|||
47028793|NCT01924754|83278522|FG002|Overall Study|Lost to Follow-up|1|||
47028794|NCT01924754|83278520|FG000|Overall Study|Pregnancy|0|||
47028795|NCT01924754|83278521|FG001|Overall Study|Pregnancy|1|||
47028796|NCT01924754|83278522|FG002|Overall Study|Pregnancy|2|||
47028797|NCT01924364|83278533|FG000|Overall Study|Physician Decision|3|||
47028798|NCT01987505|83278550|FG000|Overall Study|Other|9|||
47028799|NCT01987505|83278550|FG000|Overall Study|Withdrawal by Subject|2|||
47028800|NCT01987505|83278550|FG000|Overall Study|Other Reason|2|||
47028801|NCT01987505|83278550|FG000|Overall Study|Lost to Follow-up|15|||
47028802|NCT01987505|83278550|FG000|Overall Study|Investigator Decision|2|||
47028803|NCT01987505|83278550|FG000|Overall Study|Death|4|||
46625401|NCT03524092|82796035|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
46625402|NCT03524092|82796036|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
46625403|NCT03524092|82796037|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
47028804|NCT01923896|83278558|FG000|Overall Study|Adverse Event|1|||
47028805|NCT01923896|83278559|FG001|Overall Study|Adverse Event|0|||
47028806|NCT02004353|83278565|FG000|Overall Study|Voluntary participation|1334|||
47028807|NCT01938625|83278571|FG000|Overall Study|Withdrawal by Subject|0|||
47028808|NCT01938625|83278572|FG001|Overall Study|Withdrawal by Subject|1|||
47028809|NCT01938625|83278571|FG000|Overall Study|Adverse Event|0|||
47028810|NCT01938625|83278572|FG001|Overall Study|Adverse Event|1|||
47028811|NCT01975675|83278582|FG000|Overall Study|Death|0|||
47028812|NCT01975675|83278583|FG001|Overall Study|Death|1|||
47028813|NCT01975675|83278584|FG002|Overall Study|Death|0|||
47028814|NCT01975675|83278585|FG003|Overall Study|Death|0|||
47028815|NCT01975285|83278597|FG000|Overall Study|Failed Block and follow up|2|||
47028816|NCT01975285|83278598|FG001|Overall Study|Failed Block and follow up|2|||
47028817|NCT01974895|83278606|FG000|Overall Study|Protocol Violation|1|||
46625404|NCT03524092|82796038|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
46625405|NCT03524092|82796033|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
46625406|NCT03524092|82796034|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
46625407|NCT03524092|82796035|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
46625408|NCT03524092|82796036|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
46625409|NCT03524092|82796037|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
46625410|NCT03524092|82796038|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
46625411|NCT03524092|82796033|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
46625412|NCT03524092|82796034|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
46625413|NCT03524092|82796035|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
46625414|NCT03524092|82796036|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
46625415|NCT03524092|82796037|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
46625416|NCT03524092|82796038|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
46625417|NCT03524092|82796033|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
46625418|NCT03524092|82796034|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
46625419|NCT03524092|82796035|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
46625420|NCT03524092|82796036|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
46625421|NCT03524092|82796037|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
46625422|NCT03524092|82796038|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
46710355|NCT01167881|82926474|FG000|Overall Study|Lack of Efficacy|4|||
46710356|NCT01167881|82926475|FG001|Overall Study|Lack of Efficacy|7|||
46912406|NCT01004861|83142396|FG009|Overall Study|Transitioned to Phase 4 study|0|||
46912407|NCT01004861|83142397|FG010|Overall Study|Transitioned to Phase 4 study|0|||
46912408|NCT01004861|83142398|FG011|Overall Study|Transitioned to Phase 4 study|0|||
46912409|NCT01004861|83142399|FG012|Overall Study|Transitioned to Phase 4 study|0|||
46912410|NCT01004861|83142387|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912411|NCT01004861|83142388|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912412|NCT01004861|83142389|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
47028818|NCT01974895|83278607|FG001|Overall Study|Protocol Violation|0|||
47028819|NCT01974895|83278606|FG000|Overall Study|Lost to Follow-up|4|||
47028820|NCT01974895|83278607|FG001|Overall Study|Lost to Follow-up|6|||
47028821|NCT01974895|83278606|FG000|Overall Study|Withdrawal by Subject|0|||
47028822|NCT01974895|83278607|FG001|Overall Study|Withdrawal by Subject|1|||
47028823|NCT01974895|83278606|FG000|Overall Study|Other (Missed Visit)|1|||
47028824|NCT01974895|83278607|FG001|Overall Study|Other (Missed Visit)|0|||
47028825|NCT01974895|83278606|FG000|Overall Study|Other (Reason unknown)|9|||
47028826|NCT01974895|83278607|FG001|Overall Study|Other (Reason unknown)|8|||
47028827|NCT01974817|83278613|FG000|Overall Study|Death|4|||
47028828|NCT01974817|83278613|FG000|Overall Study|Lost to Follow-up|2|||
47028829|NCT01974817|83278613|FG000|Overall Study|Protocol Violation|2|||
46625423|NCT03524092|82796033|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
46625424|NCT03524092|82796034|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
46625425|NCT03524092|82796035|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
46625426|NCT03524092|82796036|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
46625427|NCT03524092|82796037|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
46625428|NCT03524092|82796038|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
46625429|NCT03524092|82796033|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
46625430|NCT03524092|82796034|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
46625431|NCT03524092|82796035|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
46625432|NCT03524092|82796036|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
46625433|NCT03524092|82796037|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
46625434|NCT03524092|82796038|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
46625435|NCT03415308|82796052|FG000|Overall Study|Lost to Follow-up|0|||
46625436|NCT03415308|82796053|FG001|Overall Study|Lost to Follow-up|0|||
46625437|NCT03415308|82796054|FG002|Overall Study|Lost to Follow-up|1|||
46625438|NCT03415308|82796052|FG000|Overall Study|Scheduling Conflicts|0|||
46625439|NCT03415308|82796053|FG001|Overall Study|Scheduling Conflicts|0|||
46625440|NCT03415308|82796054|FG002|Overall Study|Scheduling Conflicts|7|||
46625441|NCT03100903|82796124|FG000|Overall Study|Withdrawal by Subject|0|||
46625442|NCT03100903|82796125|FG001|Overall Study|Withdrawal by Subject|0|||
46625443|NCT03100903|82796126|FG002|Overall Study|Withdrawal by Subject|1|||
46625444|NCT02970318|82796135|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
46625445|NCT02970318|82796136|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
46625446|NCT02970318|82796137|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
46625447|NCT02970318|82796138|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
46625448|NCT02970318|82796135|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
46625449|NCT02970318|82796136|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
46625450|NCT02970318|82796137|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
46625451|NCT02970318|82796138|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
46625452|NCT02970318|82796135|FG000|Overall for Arm A & Main for Arm B|Death|41|||
46625453|NCT02970318|82796136|FG001|Overall for Arm A & Main for Arm B|Death|33|||
46625454|NCT02970318|82796137|FG002|Overall for Arm A & Main for Arm B|Death|0|||
46625455|NCT02970318|82796138|FG003|Overall for Arm A & Main for Arm B|Death|0|||
46625456|NCT02970318|82796135|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
46625457|NCT02970318|82796136|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
46625458|NCT02970318|82796137|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
46625459|NCT02970318|82796138|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
46625460|NCT02970318|82796135|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
46625461|NCT02970318|82796136|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
46625462|NCT02970318|82796137|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
46625463|NCT02970318|82796138|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
46625464|NCT02970318|82796135|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
46625465|NCT02970318|82796136|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
46625466|NCT02970318|82796137|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
46625467|NCT02970318|82796138|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
46625468|NCT02970318|82796135|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
46625469|NCT02970318|82796136|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
46625470|NCT02970318|82796137|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
46625471|NCT02970318|82796138|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
46625472|NCT02950961|82796146|FG000|Overall Study|Study had to stop due to COVID.|7|||
46625473|NCT02852824|82796157|FG000|Overall Study|Withdrawal by Subject|1|||
46625474|NCT02852824|82796158|FG001|Overall Study|Withdrawal by Subject|0|||
46625475|NCT02852824|82796159|FG002|Overall Study|Withdrawal by Subject|0|||
46625476|NCT02852824|82796160|FG003|Overall Study|Withdrawal by Subject|0|||
46625477|NCT02852824|82796161|FG004|Overall Study|Withdrawal by Subject|0|||
47028830|NCT01915849|83278621|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
47028831|NCT01915849|83278622|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
47028832|NCT01915849|83278623|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
47028833|NCT01915849|83278624|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
47028834|NCT01915849|83278621|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
47028835|NCT01915849|83278622|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
47028836|NCT01915849|83278623|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
47028837|NCT01915849|83278624|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
47028838|NCT01915771|83278634|FG000|Day 1|Withdrawal by Subject|1|||
47028839|NCT01915771|83278634|FG000|Day 15|Withdrawal by Subject|1|||
46625478|NCT02852824|82796162|FG005|Overall Study|Withdrawal by Subject|0|||
46625479|NCT02852824|82796163|FG006|Overall Study|Withdrawal by Subject|0|||
46625480|NCT02852824|82796157|FG000|Overall Study|Adverse Event|0|||
46625481|NCT02852824|82796158|FG001|Overall Study|Adverse Event|0|||
46625482|NCT02852824|82796159|FG002|Overall Study|Adverse Event|0|||
46625483|NCT02852824|82796160|FG003|Overall Study|Adverse Event|0|||
46625484|NCT02852824|82796161|FG004|Overall Study|Adverse Event|2|||
46625485|NCT02852824|82796162|FG005|Overall Study|Adverse Event|0|||
46625486|NCT02852824|82796163|FG006|Overall Study|Adverse Event|0|||
46625487|NCT02782949|82796187|FG000|Overall Study|Protocol Violation|1|||
46625488|NCT02782949|82796188|FG001|Overall Study|Protocol Violation|0|||
46625489|NCT02782949|82796187|FG000|Overall Study|Withdrawal by Subject|0|||
46625490|NCT02782949|82796188|FG001|Overall Study|Withdrawal by Subject|1|||
46625491|NCT02618434|82796197|FG000|Overall Study|Withdrawal by Subject|0|||
46625492|NCT02618434|82796198|FG001|Overall Study|Withdrawal by Subject|2|||
46625493|NCT02618434|82796199|FG002|Overall Study|Withdrawal by Subject|3|||
46625494|NCT02618434|82796197|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
46625495|NCT02618434|82796198|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
46625496|NCT02618434|82796199|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
46625497|NCT02618434|82796197|FG000|Overall Study|Lost to Follow-up|3|||
46625498|NCT02618434|82796198|FG001|Overall Study|Lost to Follow-up|1|||
46625499|NCT02618434|82796199|FG002|Overall Study|Lost to Follow-up|3|||
46625500|NCT02618434|82796197|FG000|Overall Study|Adverse Event|1|||
46625501|NCT02618434|82796198|FG001|Overall Study|Adverse Event|0|||
46625502|NCT02618434|82796199|FG002|Overall Study|Adverse Event|12|||
46625503|NCT02618434|82796197|FG000|Overall Study|Physician Decision|0|||
46625504|NCT02618434|82796198|FG001|Overall Study|Physician Decision|1|||
46625505|NCT02618434|82796199|FG002|Overall Study|Physician Decision|0|||
46625506|NCT02618434|82796197|FG000|Overall Study|Protocol Violation|0|||
46625507|NCT02618434|82796198|FG001|Overall Study|Protocol Violation|0|||
46625508|NCT02618434|82796199|FG002|Overall Study|Protocol Violation|1|||
46625509|NCT02618434|82796197|FG000|Overall Study|Other, Multiple categories|1|||
46625510|NCT02618434|82796198|FG001|Overall Study|Other, Multiple categories|1|||
46625511|NCT02618434|82796199|FG002|Overall Study|Other, Multiple categories|1|||
46625512|NCT02593825|82796209|FG000|Intervention|Lost to Follow-up|10|||
46625513|NCT02593825|82796210|FG001|Intervention|Lost to Follow-up|12|||
46625514|NCT02411448|82796227|FG000|Overall Study|Withdrawal by Subject|1|||
46625515|NCT02411448|82796228|FG001|Overall Study|Withdrawal by Subject|14|||
46625516|NCT02411448|82796229|FG002|Overall Study|Withdrawal by Subject|9|||
46625517|NCT02411448|82796227|FG000|Overall Study|Other|0|||
46625518|NCT02411448|82796228|FG001|Overall Study|Other|2|||
46625519|NCT02411448|82796229|FG002|Overall Study|Other|0|||
46625520|NCT02411448|82796227|FG000|Overall Study|Did not receive study treatment|0|||
46625521|NCT02411448|82796228|FG001|Overall Study|Did not receive study treatment|3|||
46625522|NCT02411448|82796229|FG002|Overall Study|Did not receive study treatment|0|||
46625523|NCT02411448|82796227|FG000|Overall Study|Alive on study treatment|3|||
46625524|NCT02411448|82796228|FG001|Overall Study|Alive on study treatment|64|||
46625525|NCT02411448|82796229|FG002|Overall Study|Alive on study treatment|43|||
46625526|NCT02339155|82796243|FG000|Overall Study|Adverse Event|0|||
46625527|NCT02339155|82796244|FG001|Overall Study|Adverse Event|6|||
46625528|NCT02339155|82796243|FG000|Overall Study|Death|1|||
46625529|NCT02339155|82796244|FG001|Overall Study|Death|1|||
46625530|NCT02339155|82796243|FG000|Overall Study|Lost to Follow-up|8|||
46625531|NCT02339155|82796244|FG001|Overall Study|Lost to Follow-up|9|||
46625532|NCT02339155|82796243|FG000|Overall Study|Physician Decision|2|||
46625533|NCT02339155|82796244|FG001|Overall Study|Physician Decision|1|||
46625534|NCT02339155|82796243|FG000|Overall Study|Withdrawal by Subject|4|||
46625535|NCT02339155|82796244|FG001|Overall Study|Withdrawal by Subject|4|||
46625536|NCT02246621|82796254|FG000|Overall Study|Withdrawal by Subject|28|||
46625537|NCT02246621|82796255|FG001|Overall Study|Withdrawal by Subject|16|||
46625538|NCT02246621|82796254|FG000|Overall Study|Lost to Follow-up|1|||
46912413|NCT01004861|83142390|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912414|NCT01004861|83142391|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912415|NCT01004861|83142392|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46625539|NCT02246621|82796255|FG001|Overall Study|Lost to Follow-up|0|||
46625540|NCT02246621|82796254|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
46625541|NCT02246621|82796255|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
46625542|NCT01770743|82796303|FG000|Overall Study|Adverse Event|1|||
46625543|NCT01770743|82796304|FG001|Overall Study|Adverse Event|0|||
46625544|NCT01770743|82796305|FG002|Overall Study|Adverse Event|0|||
46625545|NCT01770743|82796306|FG003|Overall Study|Adverse Event|0|||
46625546|NCT01770743|82796307|FG004|Overall Study|Adverse Event|0|||
46625547|NCT01770743|82796303|FG000|Overall Study|Withdrawal by Subject|0|||
46625548|NCT01770743|82796304|FG001|Overall Study|Withdrawal by Subject|0|||
46625549|NCT01770743|82796305|FG002|Overall Study|Withdrawal by Subject|1|||
46625550|NCT01770743|82796306|FG003|Overall Study|Withdrawal by Subject|1|||
46625551|NCT01770743|82796307|FG004|Overall Study|Withdrawal by Subject|1|||
46625552|NCT01770743|82796303|FG000|Overall Study|Lost to Follow-up|0|||
46625553|NCT01770743|82796304|FG001|Overall Study|Lost to Follow-up|2|||
46625554|NCT01770743|82796305|FG002|Overall Study|Lost to Follow-up|0|||
46625555|NCT01770743|82796306|FG003|Overall Study|Lost to Follow-up|0|||
46625556|NCT01770743|82796307|FG004|Overall Study|Lost to Follow-up|1|||
46625557|NCT01770743|82796303|FG000|Overall Study|Sponsor Terminated Subject|1|||
46625558|NCT01770743|82796304|FG001|Overall Study|Sponsor Terminated Subject|0|||
46625559|NCT01770743|82796305|FG002|Overall Study|Sponsor Terminated Subject|0|||
46625560|NCT01770743|82796306|FG003|Overall Study|Sponsor Terminated Subject|1|||
46625561|NCT01770743|82796307|FG004|Overall Study|Sponsor Terminated Subject|0|||
46625562|NCT01770743|82796303|FG000|Overall Study|Moving Out of State|0|||
46625563|NCT01770743|82796304|FG001|Overall Study|Moving Out of State|1|||
46625564|NCT01770743|82796305|FG002|Overall Study|Moving Out of State|0|||
46625565|NCT01770743|82796306|FG003|Overall Study|Moving Out of State|0|||
46625566|NCT01770743|82796307|FG004|Overall Study|Moving Out of State|0|||
46625567|NCT01759771|82796321|FG000|Overall Study|Withdrawal by Subject|1|||
46625568|NCT01759771|82796322|FG001|Overall Study|Withdrawal by Subject|1|||
46625569|NCT01753115|82796331|FG000|Overall Study|Lost to Follow-up|3|||
46625570|NCT01753115|82796332|FG001|Overall Study|Lost to Follow-up|6|||
46625571|NCT01753115|82796333|FG002|Overall Study|Lost to Follow-up|8|||
46625572|NCT01753115|82796331|FG000|Overall Study|Withdrawal by Subject|6|||
46625573|NCT01753115|82796332|FG001|Overall Study|Withdrawal by Subject|5|||
46625574|NCT01753115|82796333|FG002|Overall Study|Withdrawal by Subject|6|||
46625575|NCT01753115|82796331|FG000|Overall Study|Subject non-compliant|3|||
46625576|NCT01753115|82796332|FG001|Overall Study|Subject non-compliant|3|||
46625577|NCT01753115|82796333|FG002|Overall Study|Subject non-compliant|0|||
46625578|NCT01753115|82796331|FG000|Overall Study|Used excluded drug|0|||
46625579|NCT01753115|82796332|FG001|Overall Study|Used excluded drug|1|||
46625580|NCT01753115|82796333|FG002|Overall Study|Used excluded drug|0|||
46625581|NCT01736618|82796341|FG000|Overall Study|Death|294|||
46625582|NCT01736618|82796341|FG000|Overall Study|Lost to Follow-up|193|||
46625583|NCT01736618|82796341|FG000|Overall Study|Withdrawal by Subject|54|||
46625584|NCT01736618|82796341|FG000|Overall Study|Subject unable to be followed at study location|223|||
46625585|NCT01736618|82796341|FG000|Overall Study|Physician Decision|33|||
46625586|NCT01736618|82796341|FG000|Overall Study|Transplant or removal of target organ|19|||
46625587|NCT01736618|82796341|FG000|Overall Study|Change in indication or condition|78|||
47028840|NCT01938391|83278642|FG000|6 Month Follow up|Withdrawal by Subject|1|||
47028841|NCT01938391|83278642|FG000|12 Month Follow up|Physician Decision|1|||
47028842|NCT01938391|83278642|FG000|12 Month Follow up|Withdrawal by Subject|1|||
47028843|NCT01915303|83278646|FG000|Core Phase|Adverse Event|7|||
47028844|NCT01915303|83278646|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
47028845|NCT01915303|83278646|FG000|Core Phase|Death|2|||
47028846|NCT01915303|83278646|FG000|Core Phase|Protocol Violation|2|||
47028847|NCT01915303|83278646|FG000|Core Phase|Abnormal lab value|1|||
47028848|NCT01915303|83278646|FG000|Core Phase|Withdrawal by Subject|1|||
47028849|NCT01915303|83278646|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
47028850|NCT01915303|83278646|FG000|Extension Phase|Withdrawal by Subject|4|||
47028851|NCT01915303|83278646|FG000|Extension Phase|Adverse Event|3|||
47028852|NCT01915303|83278646|FG000|Extension Phase|Death|1|||
47028853|NCT01915303|83278646|FG000|Extension Phase|Protocol Violation|1|||
47028854|NCT01987427|83278653|FG000|Overall Study|Adverse Event|4|||
47028855|NCT01987427|83278654|FG001|Overall Study|Adverse Event|2|||
47028856|NCT01987427|83278655|FG002|Overall Study|Adverse Event|8|||
47028857|NCT01987427|83278653|FG000|Overall Study|Lost to Follow-up|6|||
47028858|NCT01987427|83278654|FG001|Overall Study|Lost to Follow-up|6|||
47028859|NCT01987427|83278655|FG002|Overall Study|Lost to Follow-up|9|||
46625588|NCT01736618|82796341|FG000|Overall Study|Study device explant|103|||
46625589|NCT01736618|82796341|FG000|Overall Study|Unable to complete implant|2|||
46625590|NCT01263691|82796351|FG000|Overall Study|Lost to Follow-up|1|||
46625591|NCT01263691|82796352|FG001|Overall Study|Lost to Follow-up|0|||
46625592|NCT01263691|82796353|FG002|Overall Study|Lost to Follow-up|1|||
46625593|NCT01263691|82796354|FG003|Overall Study|Lost to Follow-up|1|||
46625594|NCT01263691|82796355|FG004|Overall Study|Lost to Follow-up|0|||
46625595|NCT01263691|82796356|FG005|Overall Study|Lost to Follow-up|0|||
47028860|NCT01987427|83278653|FG000|Overall Study|Withdrawal by Subject|2|||
47028861|NCT01987427|83278654|FG001|Overall Study|Withdrawal by Subject|1|||
47028862|NCT01987427|83278655|FG002|Overall Study|Withdrawal by Subject|3|||
47028863|NCT01987427|83278653|FG000|Overall Study|Lack of Efficacy|1|||
47028864|NCT01987427|83278654|FG001|Overall Study|Lack of Efficacy|0|||
46625596|NCT01263691|82796351|FG000|Overall Study|Withdrawal by Subject|1|||
46625597|NCT01263691|82796352|FG001|Overall Study|Withdrawal by Subject|0|||
46625598|NCT01263691|82796353|FG002|Overall Study|Withdrawal by Subject|0|||
46625599|NCT01263691|82796354|FG003|Overall Study|Withdrawal by Subject|0|||
46625600|NCT01263691|82796355|FG004|Overall Study|Withdrawal by Subject|0|||
46625601|NCT01263691|82796356|FG005|Overall Study|Withdrawal by Subject|0|||
46625602|NCT01263691|82796351|FG000|Overall Study|Adverse Event|1|||
46625603|NCT01263691|82796352|FG001|Overall Study|Adverse Event|0|||
46625604|NCT01263691|82796353|FG002|Overall Study|Adverse Event|0|||
46625605|NCT01263691|82796354|FG003|Overall Study|Adverse Event|0|||
46625606|NCT01263691|82796355|FG004|Overall Study|Adverse Event|0|||
46625607|NCT01263691|82796356|FG005|Overall Study|Adverse Event|0|||
46625608|NCT01216293|82796394|FG000|Main Study|Adverse Event|1|||
46625609|NCT01216293|82796395|FG001|Main Study|Adverse Event|4|||
46625610|NCT01216293|82796396|FG002|Main Study|Adverse Event|2|||
46625611|NCT01216293|82796394|FG000|Main Study|Major Protocol Deviation|1|||
46625612|NCT01216293|82796395|FG001|Main Study|Major Protocol Deviation|0|||
46625613|NCT01216293|82796396|FG002|Main Study|Major Protocol Deviation|1|||
46625614|NCT01216293|82796394|FG000|Main Study|Lost to Follow-up|3|||
46625615|NCT01216293|82796395|FG001|Main Study|Lost to Follow-up|1|||
46625616|NCT01216293|82796396|FG002|Main Study|Lost to Follow-up|0|||
46625617|NCT01216293|82796394|FG000|Main Study|Voluntary Withdrawal|2|||
46625618|NCT01216293|82796395|FG001|Main Study|Voluntary Withdrawal|2|||
46625619|NCT01216293|82796396|FG002|Main Study|Voluntary Withdrawal|2|||
46625620|NCT01216293|82796394|FG000|Main Study|Other Reason Not Specified|0|||
46625621|NCT01216293|82796395|FG001|Main Study|Other Reason Not Specified|1|||
46625622|NCT01216293|82796396|FG002|Main Study|Other Reason Not Specified|1|||
46625623|NCT01216293|82796394|FG000|Main Study|Randomized, Not Treated|1|||
46625624|NCT01216293|82796395|FG001|Main Study|Randomized, Not Treated|0|||
46625625|NCT01216293|82796396|FG002|Main Study|Randomized, Not Treated|0|||
46625626|NCT01216293|82796394|FG000|Calcium Absorption Substudy|Adverse Event|0|||
46625627|NCT01216293|82796395|FG001|Calcium Absorption Substudy|Adverse Event|2|||
46625628|NCT01216293|82796396|FG002|Calcium Absorption Substudy|Adverse Event|0|||
46625629|NCT01216293|82796394|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
46625630|NCT01216293|82796395|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
46625631|NCT01216293|82796396|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
46625632|NCT01216293|82796394|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
46625633|NCT01216293|82796395|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
46625634|NCT01216293|82796396|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
46625635|NCT00845650|82796422|FG000|Overall Study|Withdrawal by Subject|0|||
46625636|NCT00845650|82796423|FG001|Overall Study|Withdrawal by Subject|0|||
46625637|NCT00845650|82796424|FG002|Overall Study|Withdrawal by Subject|0|||
46625638|NCT00845650|82796425|FG003|Overall Study|Withdrawal by Subject|0|||
46625639|NCT00845650|82796426|FG004|Overall Study|Withdrawal by Subject|2|||
46625640|NCT00845650|82796427|FG005|Overall Study|Withdrawal by Subject|0|||
46625641|NCT00845650|82796422|FG000|Overall Study|Lost to Follow-up|0|||
46625642|NCT00845650|82796423|FG001|Overall Study|Lost to Follow-up|0|||
46625643|NCT00845650|82796424|FG002|Overall Study|Lost to Follow-up|3|||
46625644|NCT00845650|82796425|FG003|Overall Study|Lost to Follow-up|1|||
46625645|NCT00845650|82796426|FG004|Overall Study|Lost to Follow-up|0|||
46625646|NCT00845650|82796427|FG005|Overall Study|Lost to Follow-up|1|||
47028865|NCT01987427|83278655|FG002|Overall Study|Lack of Efficacy|0|||
47028866|NCT01987427|83278653|FG000|Overall Study|Other|1|||
46625647|NCT00845650|82796422|FG000|Overall Study|Sponsor hold on dosing|0|||
46625648|NCT00845650|82796423|FG001|Overall Study|Sponsor hold on dosing|0|||
46625649|NCT00845650|82796424|FG002|Overall Study|Sponsor hold on dosing|0|||
46625650|NCT00845650|82796425|FG003|Overall Study|Sponsor hold on dosing|0|||
46625651|NCT00845650|82796426|FG004|Overall Study|Sponsor hold on dosing|1|||
46625652|NCT00845650|82796427|FG005|Overall Study|Sponsor hold on dosing|1|||
46625653|NCT00845650|82796422|FG000|Overall Study|Unable to access IV line|1|||
46625654|NCT00845650|82796423|FG001|Overall Study|Unable to access IV line|0|||
46625655|NCT00845650|82796424|FG002|Overall Study|Unable to access IV line|0|||
46625656|NCT00845650|82796425|FG003|Overall Study|Unable to access IV line|0|||
46912416|NCT01004861|83142393|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912417|NCT01004861|83142394|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912418|NCT01004861|83142395|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
47028867|NCT01987427|83278654|FG001|Overall Study|Other|1|||
47028868|NCT01987427|83278655|FG002|Overall Study|Other|0|||
46625657|NCT00845650|82796426|FG004|Overall Study|Unable to access IV line|0|||
46625658|NCT00845650|82796427|FG005|Overall Study|Unable to access IV line|0|||
46625659|NCT00309985|82796445|FG000|Overall Study|Disease progression|12|||
46625660|NCT00309985|82796446|FG001|Overall Study|Disease progression|0|||
46625661|NCT00309985|82796445|FG000|Overall Study|Adverse Event|30|||
46625662|NCT00309985|82796446|FG001|Overall Study|Adverse Event|0|||
46625663|NCT00309985|82796445|FG000|Overall Study|Death|2|||
46625664|NCT00309985|82796446|FG001|Overall Study|Death|0|||
46625665|NCT00309985|82796445|FG000|Overall Study|Withdrawal by Subject|5|||
46625666|NCT00309985|82796446|FG001|Overall Study|Withdrawal by Subject|1|||
46625667|NCT00309985|82796445|FG000|Overall Study|Physician Decision|3|||
46625668|NCT00309985|82796446|FG001|Overall Study|Physician Decision|0|||
46625669|NCT00309985|82796445|FG000|Overall Study|Never started treatment|7|||
46625670|NCT00309985|82796446|FG001|Overall Study|Never started treatment|0|||
46625671|NCT00309985|82796445|FG000|Overall Study|Complicating disease|1|||
46625672|NCT00309985|82796446|FG001|Overall Study|Complicating disease|0|||
46625673|NCT00309985|82796445|FG000|Overall Study|Non-compliance|1|||
46625674|NCT00309985|82796446|FG001|Overall Study|Non-compliance|0|||
46625675|NCT00309985|82796445|FG000|Overall Study|Chemotherapy discontinued only|1|||
46625676|NCT00309985|82796446|FG001|Overall Study|Chemotherapy discontinued only|0|||
46625677|NCT02335424|82796486|FG000|Overall Study|Withdrawal by Subject|19|||
46625678|NCT02335424|82796486|FG000|Overall Study|Adverse Event|25|||
46625679|NCT02335424|82796486|FG000|Overall Study|Death|273|||
46625680|NCT02335424|82796486|FG000|Overall Study|Lost to Follow-up|3|||
46625681|NCT02335424|82796486|FG000|Overall Study|Physician Decision|13|||
46625682|NCT02335424|82796486|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
46625683|NCT02335424|82796486|FG000|Overall Study|Protocol Violation|1|||
46625684|NCT02335424|82796486|FG000|Overall Study|Screen failure|1|||
46625685|NCT03805412|82796493|FG000|Overall Study|Lost to Follow-up|0|||
46625686|NCT03805412|82796494|FG001|Overall Study|Lost to Follow-up|1|||
46625687|NCT04791319|82796514|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
46625688|NCT04791319|82796515|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
46625689|NCT04791319|82796516|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
46625690|NCT04791319|82796517|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
46625691|NCT04791319|82796518|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
46625692|NCT04791319|82796519|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
46625693|NCT04791319|82796520|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
46625694|NCT04791319|82796521|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
46625695|NCT04791319|82796522|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
46625696|NCT04791319|82796523|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
46625697|NCT04791319|82796524|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
46625698|NCT04791319|82796514|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
46625699|NCT04791319|82796515|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
46625700|NCT04791319|82796516|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
46625701|NCT04791319|82796517|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
46625702|NCT04791319|82796518|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
46625703|NCT04791319|82796519|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
46625704|NCT04791319|82796520|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
46625705|NCT04791319|82796521|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
46625706|NCT04791319|82796522|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
46625707|NCT04791319|82796523|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
47028869|NCT01937299|83278665|FG000|Overall Study|Adverse Event|13|||
47028870|NCT01937299|83278666|FG001|Overall Study|Adverse Event|0|||
47028871|NCT01937299|83278665|FG000|Overall Study|Lack of Efficacy|0|||
47028872|NCT01937299|83278666|FG001|Overall Study|Lack of Efficacy|4|||
47028873|NCT01937299|83278665|FG000|Overall Study|Withdrawal by Subject|1|||
47028874|NCT01937299|83278666|FG001|Overall Study|Withdrawal by Subject|0|||
47028875|NCT01606761|83278676|FG000|Prior to Week 24|Lost to Follow-up|0|||
47028876|NCT01606761|83278677|FG001|Prior to Week 24|Lost to Follow-up|3|||
47028877|NCT01606761|83278678|FG002|Prior to Week 24|Lost to Follow-up|2|||
47028878|NCT01606761|83278679|FG003|Prior to Week 24|Lost to Follow-up|0|||
47028879|NCT01606761|83278680|FG004|Prior to Week 24|Lost to Follow-up|0|||
47028880|NCT01606761|83278676|FG000|Prior to Week 24|Withdrawal by Subject|12|||
47028881|NCT01606761|83278677|FG001|Prior to Week 24|Withdrawal by Subject|10|||
47028882|NCT01606761|83278678|FG002|Prior to Week 24|Withdrawal by Subject|9|||
47028883|NCT01606761|83278679|FG003|Prior to Week 24|Withdrawal by Subject|0|||
47028884|NCT01606761|83278680|FG004|Prior to Week 24|Withdrawal by Subject|0|||
47028885|NCT01606761|83278676|FG000|Prior to Week 24|Adverse Event|11|||
47028886|NCT01606761|83278677|FG001|Prior to Week 24|Adverse Event|18|||
47028887|NCT01606761|83278678|FG002|Prior to Week 24|Adverse Event|22|||
47028888|NCT01606761|83278679|FG003|Prior to Week 24|Adverse Event|0|||
47028889|NCT01606761|83278680|FG004|Prior to Week 24|Adverse Event|0|||
47028890|NCT01606761|83278676|FG000|Prior to Week 24|Lack of Efficacy|15|||
47028891|NCT01606761|83278677|FG001|Prior to Week 24|Lack of Efficacy|14|||
47028892|NCT01606761|83278678|FG002|Prior to Week 24|Lack of Efficacy|8|||
46625708|NCT04791319|82796524|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
46625709|NCT04791319|82796514|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
47028893|NCT01606761|83278679|FG003|Prior to Week 24|Lack of Efficacy|0|||
47028894|NCT01606761|83278680|FG004|Prior to Week 24|Lack of Efficacy|0|||
47028895|NCT01606761|83278676|FG000|Prior to Week 24|Physician Decision|0|||
47028896|NCT01606761|83278677|FG001|Prior to Week 24|Physician Decision|3|||
46625710|NCT04791319|82796515|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
46625711|NCT04791319|82796516|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
46625712|NCT04791319|82796517|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
46625713|NCT04791319|82796518|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
46625714|NCT04791319|82796519|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
46625715|NCT04791319|82796520|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
46625716|NCT04791319|82796521|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
46625717|NCT04791319|82796522|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
46625718|NCT04791319|82796523|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
46625719|NCT04791319|82796524|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
46625720|NCT04791319|82796514|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
46625721|NCT04791319|82796515|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
46625722|NCT04791319|82796516|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
46625723|NCT04791319|82796517|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
46625724|NCT04791319|82796518|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
46625725|NCT04791319|82796519|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
46625726|NCT04791319|82796520|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
46625727|NCT04791319|82796521|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
46625728|NCT04791319|82796522|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
46625729|NCT04791319|82796523|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
46625730|NCT04791319|82796524|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
46625731|NCT04791319|82796514|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625732|NCT04791319|82796515|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625733|NCT04791319|82796516|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625734|NCT04791319|82796517|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
46625735|NCT04791319|82796518|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625736|NCT04791319|82796519|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625737|NCT04791319|82796520|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625738|NCT04791319|82796521|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625739|NCT04791319|82796522|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625740|NCT04791319|82796523|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625741|NCT04791319|82796524|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
46625742|NCT04791319|82796514|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
46625743|NCT04791319|82796515|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
46625744|NCT04791319|82796516|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
46625745|NCT04791319|82796517|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
46625746|NCT04791319|82796518|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
46625747|NCT04791319|82796519|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
46625748|NCT04791319|82796520|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
46625749|NCT04791319|82796521|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
46625750|NCT04791319|82796522|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
46625751|NCT04791319|82796523|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
46625752|NCT04791319|82796524|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
46625753|NCT04791319|82796514|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625754|NCT04791319|82796515|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625755|NCT04791319|82796516|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625756|NCT04791319|82796517|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625757|NCT04791319|82796518|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625758|NCT04791319|82796519|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625759|NCT04791319|82796520|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625760|NCT04791319|82796521|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625761|NCT04791319|82796522|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46625762|NCT04791319|82796523|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
46625763|NCT04791319|82796524|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
46912419|NCT01004861|83142396|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912420|NCT01004861|83142397|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912421|NCT01004861|83142398|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
47028897|NCT01606761|83278678|FG002|Prior to Week 24|Physician Decision|1|||
47028898|NCT01606761|83278679|FG003|Prior to Week 24|Physician Decision|0|||
47028899|NCT01606761|83278680|FG004|Prior to Week 24|Physician Decision|0|||
47028900|NCT01606761|83278676|FG000|Prior to Week 24|Other|4|||
46625764|NCT04791319|82796514|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
46625765|NCT04791319|82796515|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
46625766|NCT04791319|82796516|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
46625767|NCT04791319|82796517|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
46625768|NCT04791319|82796518|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
46625769|NCT04791319|82796519|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
46625770|NCT04791319|82796520|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
46625771|NCT04791319|82796521|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
46625772|NCT04791319|82796522|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
46625773|NCT04791319|82796523|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
46625774|NCT04791319|82796524|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
46625775|NCT04791319|82796514|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
46625776|NCT04791319|82796515|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
46625777|NCT04791319|82796516|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
46625778|NCT04791319|82796517|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
46625779|NCT04791319|82796518|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
46625780|NCT04791319|82796519|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
46625781|NCT04791319|82796520|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
46625782|NCT04791319|82796521|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
46625783|NCT04791319|82796522|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
47028901|NCT01606761|83278677|FG001|Prior to Week 24|Other|7|||
46625784|NCT04791319|82796523|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
46625785|NCT04791319|82796524|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
46625786|NCT03472495|82796581|FG000|Overall Study|Treatment no longer indicated|1|||
46912422|NCT01004861|83142399|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
46912423|NCT01004861|83142387|FG000|Overall Study|Patient withdrew|0|||
46912424|NCT01004861|83142388|FG001|Overall Study|Patient withdrew|0|||
46912425|NCT01004861|83142389|FG002|Overall Study|Patient withdrew|0|||
46625787|NCT03472495|82796582|FG001|Overall Study|Treatment no longer indicated|2|||
46625788|NCT03472495|82796581|FG000|Overall Study|Physician Decision|0|||
46625789|NCT03472495|82796582|FG001|Overall Study|Physician Decision|2|||
46625790|NCT03234907|82796590|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
46625791|NCT03234907|82796591|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
46625792|NCT03234907|82796592|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
46625793|NCT03234907|82796593|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
46625794|NCT03234907|82796594|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
46710357|NCT01167881|82926474|FG000|Overall Study|Non compliant with protocol|9|||
47028902|NCT01606761|83278678|FG002|Prior to Week 24|Other|5|||
47028903|NCT01606761|83278679|FG003|Prior to Week 24|Other|0|||
47028904|NCT01606761|83278680|FG004|Prior to Week 24|Other|0|||
47028905|NCT01606761|83278676|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
47028906|NCT01606761|83278677|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
47028907|NCT01606761|83278678|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
47028908|NCT01606761|83278679|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
47028909|NCT01606761|83278680|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
47028910|NCT01606761|83278676|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
47028911|NCT01606761|83278677|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
47028912|NCT01606761|83278678|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
46710358|NCT01167881|82926475|FG001|Overall Study|Non compliant with protocol|18|||
46710359|NCT01167881|82926474|FG000|Overall Study|Lost to Follow-up|19|||
46710360|NCT01167881|82926475|FG001|Overall Study|Lost to Follow-up|20|||
46912426|NCT01004861|83142390|FG003|Overall Study|Patient withdrew|0|||
46912427|NCT01004861|83142391|FG004|Overall Study|Patient withdrew|0|||
46912428|NCT01004861|83142392|FG005|Overall Study|Patient withdrew|0|||
46912429|NCT01004861|83142393|FG006|Overall Study|Patient withdrew|0|||
46912430|NCT01004861|83142394|FG007|Overall Study|Patient withdrew|0|||
46912431|NCT01004861|83142395|FG008|Overall Study|Patient withdrew|1|||
46912432|NCT01004861|83142396|FG009|Overall Study|Patient withdrew|0|||
46912433|NCT01004861|83142397|FG010|Overall Study|Patient withdrew|0|||
46912434|NCT01004861|83142398|FG011|Overall Study|Patient withdrew|0|||
46912435|NCT01004861|83142399|FG012|Overall Study|Patient withdrew|0|||
46912436|NCT01004861|83142387|FG000|Overall Study|Surgical resection|0|||
46912437|NCT01004861|83142388|FG001|Overall Study|Surgical resection|0|||
46912438|NCT01004861|83142389|FG002|Overall Study|Surgical resection|0|||
46912439|NCT01004861|83142390|FG003|Overall Study|Surgical resection|0|||
46912440|NCT01004861|83142391|FG004|Overall Study|Surgical resection|0|||
47028913|NCT01606761|83278679|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
47028914|NCT01606761|83278680|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
46625795|NCT03234907|82796595|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
46625796|NCT03234907|82796590|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
46625797|NCT03234907|82796591|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
46912441|NCT01004861|83142392|FG005|Overall Study|Surgical resection|0|||
46912442|NCT01004861|83142393|FG006|Overall Study|Surgical resection|0|||
46912443|NCT01004861|83142394|FG007|Overall Study|Surgical resection|0|||
46912444|NCT01004861|83142395|FG008|Overall Study|Surgical resection|1|||
46912445|NCT01004861|83142396|FG009|Overall Study|Surgical resection|0|||
46912446|NCT01004861|83142397|FG010|Overall Study|Surgical resection|0|||
46912447|NCT01004861|83142398|FG011|Overall Study|Surgical resection|0|||
46912448|NCT01004861|83142399|FG012|Overall Study|Surgical resection|0|||
46912449|NCT01004861|83142387|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912450|NCT01004861|83142388|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912451|NCT01004861|83142389|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912452|NCT01004861|83142390|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912453|NCT01004861|83142391|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912454|NCT01004861|83142392|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912455|NCT01004861|83142393|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912456|NCT01004861|83142394|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912457|NCT01004861|83142395|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
46912458|NCT01004861|83142396|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46625798|NCT03234907|82796592|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
46625799|NCT03234907|82796593|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
46625800|NCT03234907|82796594|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
46625801|NCT03234907|82796595|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
46625802|NCT03234907|82796590|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
46625803|NCT03234907|82796591|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
46625804|NCT03234907|82796592|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
46625805|NCT03234907|82796593|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
46625806|NCT03234907|82796594|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
46625807|NCT03234907|82796595|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
46625808|NCT03234907|82796590|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
46625809|NCT03234907|82796591|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
46625810|NCT03234907|82796592|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
46625811|NCT03234907|82796593|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
46625812|NCT03234907|82796594|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
46625813|NCT03234907|82796595|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
46625814|NCT03234907|82796590|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
46625815|NCT03234907|82796591|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
46625816|NCT03234907|82796592|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
46625817|NCT03234907|82796593|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
46625818|NCT03234907|82796594|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
46625819|NCT03234907|82796595|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
46625820|NCT03234907|82796590|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
46625821|NCT03234907|82796591|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
46625822|NCT03234907|82796592|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
46625823|NCT03234907|82796593|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
46625824|NCT03234907|82796594|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
46625825|NCT03234907|82796595|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
46912459|NCT01004861|83142397|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46625826|NCT03234907|82796590|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
46625827|NCT03234907|82796591|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
46625828|NCT03234907|82796592|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
46625829|NCT03234907|82796593|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
46912460|NCT01004861|83142398|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912461|NCT01004861|83142399|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
46912462|NCT01004861|83142387|FG000|Overall Study|Study termination by Sponsor|0|||
46912463|NCT01004861|83142388|FG001|Overall Study|Study termination by Sponsor|0|||
46912464|NCT01004861|83142389|FG002|Overall Study|Study termination by Sponsor|0|||
46912465|NCT01004861|83142390|FG003|Overall Study|Study termination by Sponsor|0|||
46912466|NCT01004861|83142391|FG004|Overall Study|Study termination by Sponsor|0|||
47028915|NCT01606761|83278676|FG000|Week 24 to Week 52|Adverse Event|0|||
46625830|NCT03234907|82796594|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
46625831|NCT03234907|82796595|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
46912467|NCT01004861|83142392|FG005|Overall Study|Study termination by Sponsor|0|||
46912468|NCT01004861|83142393|FG006|Overall Study|Study termination by Sponsor|0|||
46912469|NCT01004861|83142394|FG007|Overall Study|Study termination by Sponsor|0|||
46912470|NCT01004861|83142395|FG008|Overall Study|Study termination by Sponsor|1|||
46912471|NCT01004861|83142396|FG009|Overall Study|Study termination by Sponsor|0|||
46625832|NCT03818581|82796609|FG000|Overall Study|Adverse Event|1|||
46625833|NCT03818581|82796610|FG001|Overall Study|Adverse Event|0|||
46625834|NCT03818581|82796611|FG002|Overall Study|Adverse Event|0|||
46625835|NCT03818581|82796612|FG003|Overall Study|Adverse Event|0|||
46625836|NCT03818581|82796613|FG004|Overall Study|Adverse Event|0|||
46625837|NCT03818581|82796609|FG000|Overall Study|Covid-19|2|||
46625838|NCT03818581|82796610|FG001|Overall Study|Covid-19|0|||
46625839|NCT03818581|82796611|FG002|Overall Study|Covid-19|0|||
46625840|NCT03818581|82796612|FG003|Overall Study|Covid-19|0|||
46625841|NCT03818581|82796613|FG004|Overall Study|Covid-19|1|||
46625842|NCT03818581|82796609|FG000|Overall Study|Withdrawal by Subject|0|||
46625843|NCT03818581|82796610|FG001|Overall Study|Withdrawal by Subject|0|||
46625844|NCT03818581|82796611|FG002|Overall Study|Withdrawal by Subject|0|||
46625845|NCT03818581|82796612|FG003|Overall Study|Withdrawal by Subject|0|||
46625846|NCT03818581|82796613|FG004|Overall Study|Withdrawal by Subject|1|||
46625847|NCT03818581|82796609|FG000|Overall Study|No longer met study criteria|1|||
46625848|NCT03818581|82796610|FG001|Overall Study|No longer met study criteria|0|||
46625849|NCT03818581|82796611|FG002|Overall Study|No longer met study criteria|0|||
46625850|NCT03818581|82796612|FG003|Overall Study|No longer met study criteria|0|||
46625851|NCT03818581|82796613|FG004|Overall Study|No longer met study criteria|2|||
46625852|NCT03736447|82796627|FG000|Overall Study|Adverse Event|5|||
46625853|NCT03736447|82796628|FG001|Overall Study|Adverse Event|1|||
46625854|NCT03736447|82796627|FG000|Overall Study|Withdrawal by Subject|5|||
46625855|NCT03736447|82796628|FG001|Overall Study|Withdrawal by Subject|1|||
46625856|NCT03736447|82796627|FG000|Overall Study|Lost to Follow-up|1|||
46625857|NCT03736447|82796628|FG001|Overall Study|Lost to Follow-up|0|||
46912472|NCT01004861|83142397|FG010|Overall Study|Study termination by Sponsor|0|||
46912473|NCT01004861|83142398|FG011|Overall Study|Study termination by Sponsor|0|||
46912474|NCT01004861|83142399|FG012|Overall Study|Study termination by Sponsor|0|||
46912475|NCT03254459|83142446|FG000|Overall Study|Adverse Event|7|||
46625858|NCT03736447|82796627|FG000|Overall Study|Physician Decision|1|||
46625859|NCT03736447|82796628|FG001|Overall Study|Physician Decision|0|||
46625860|NCT03736447|82796627|FG000|Overall Study|Continued commitment to study treatment|3|||
46625861|NCT03736447|82796628|FG001|Overall Study|Continued commitment to study treatment|0|||
46625862|NCT03736447|82796627|FG000|Overall Study|Taste aversion to study product|0|||
46625863|NCT03736447|82796628|FG001|Overall Study|Taste aversion to study product|1|||
46625864|NCT02132754|82796677|FG000|Overall Study|Adverse Event|0|||
46625865|NCT02132754|82796678|FG001|Overall Study|Adverse Event|0|||
46625866|NCT02132754|82796679|FG002|Overall Study|Adverse Event|0|||
46625867|NCT02132754|82796680|FG003|Overall Study|Adverse Event|0|||
46625868|NCT02132754|82796681|FG004|Overall Study|Adverse Event|0|||
46625869|NCT02132754|82796682|FG005|Overall Study|Adverse Event|0|||
46625870|NCT02132754|82796683|FG006|Overall Study|Adverse Event|0|||
46625871|NCT02132754|82796684|FG007|Overall Study|Adverse Event|0|||
46710361|NCT01167881|82926474|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
47028916|NCT01606761|83278677|FG001|Week 24 to Week 52|Adverse Event|11|||
47028917|NCT01606761|83278678|FG002|Week 24 to Week 52|Adverse Event|14|||
46710362|NCT01167881|82926475|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
46912476|NCT03254459|83142447|FG001|Overall Study|Adverse Event|20|||
47028918|NCT01606761|83278679|FG003|Week 24 to Week 52|Adverse Event|3|||
47028919|NCT01606761|83278680|FG004|Week 24 to Week 52|Adverse Event|15|||
47028920|NCT01606761|83278676|FG000|Week 24 to Week 52|Death|0|||
47028921|NCT01606761|83278677|FG001|Week 24 to Week 52|Death|0|||
47028922|NCT01606761|83278678|FG002|Week 24 to Week 52|Death|2|||
47028923|NCT01606761|83278679|FG003|Week 24 to Week 52|Death|1|||
47028924|NCT01606761|83278680|FG004|Week 24 to Week 52|Death|0|||
47028925|NCT01606761|83278676|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
47028926|NCT01606761|83278677|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
47028927|NCT01606761|83278678|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
47028928|NCT01606761|83278679|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
47028929|NCT01606761|83278680|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
47028930|NCT01606761|83278676|FG000|Week 24 to Week 52|Physician Decision|0|||
46625872|NCT02132754|82796685|FG008|Overall Study|Adverse Event|0|||
46625873|NCT02132754|82796686|FG009|Overall Study|Adverse Event|0|||
46625874|NCT02132754|82796687|FG010|Overall Study|Adverse Event|0|||
46625875|NCT02132754|82796688|FG011|Overall Study|Adverse Event|0|||
46625876|NCT02132754|82796689|FG012|Overall Study|Adverse Event|0|||
46625877|NCT02132754|82796690|FG013|Overall Study|Adverse Event|0|||
46625878|NCT02132754|82796691|FG014|Overall Study|Adverse Event|0|||
46625879|NCT02132754|82796692|FG015|Overall Study|Adverse Event|0|||
47028931|NCT01606761|83278677|FG001|Week 24 to Week 52|Physician Decision|1|||
47028932|NCT01606761|83278678|FG002|Week 24 to Week 52|Physician Decision|1|||
46625880|NCT02132754|82796693|FG016|Overall Study|Adverse Event|0|||
46625881|NCT02132754|82796694|FG017|Overall Study|Adverse Event|1|||
46625882|NCT02132754|82796695|FG018|Overall Study|Adverse Event|0|||
46625883|NCT02132754|82796696|FG019|Overall Study|Adverse Event|0|||
46625884|NCT02132754|82796697|FG020|Overall Study|Adverse Event|0|||
46625885|NCT02132754|82796698|FG021|Overall Study|Adverse Event|0|||
46625886|NCT02132754|82796699|FG022|Overall Study|Adverse Event|0|||
46625887|NCT02132754|82796700|FG023|Overall Study|Adverse Event|0|||
46625888|NCT02132754|82796701|FG024|Overall Study|Adverse Event|0|||
46625889|NCT02132754|82796702|FG025|Overall Study|Adverse Event|1|||
46625890|NCT02132754|82796703|FG026|Overall Study|Adverse Event|1|||
46625891|NCT02132754|82796704|FG027|Overall Study|Adverse Event|0|||
46625892|NCT02132754|82796705|FG028|Overall Study|Adverse Event|0|||
46625893|NCT02132754|82796706|FG029|Overall Study|Adverse Event|0|||
46625894|NCT02132754|82796707|FG030|Overall Study|Adverse Event|1|||
46625895|NCT02132754|82796708|FG031|Overall Study|Adverse Event|0|||
46625896|NCT02132754|82796709|FG032|Overall Study|Adverse Event|1|||
46625897|NCT02132754|82796710|FG033|Overall Study|Adverse Event|1|||
46625898|NCT02132754|82796677|FG000|Overall Study|Clinical Progression|0|||
46625899|NCT02132754|82796678|FG001|Overall Study|Clinical Progression|0|||
46625900|NCT02132754|82796679|FG002|Overall Study|Clinical Progression|0|||
46625901|NCT02132754|82796680|FG003|Overall Study|Clinical Progression|0|||
46625902|NCT02132754|82796681|FG004|Overall Study|Clinical Progression|0|||
46625903|NCT02132754|82796682|FG005|Overall Study|Clinical Progression|0|||
46625904|NCT02132754|82796683|FG006|Overall Study|Clinical Progression|0|||
46625905|NCT02132754|82796684|FG007|Overall Study|Clinical Progression|0|||
46625906|NCT02132754|82796685|FG008|Overall Study|Clinical Progression|0|||
46625907|NCT02132754|82796686|FG009|Overall Study|Clinical Progression|1|||
46625908|NCT02132754|82796687|FG010|Overall Study|Clinical Progression|0|||
46625909|NCT02132754|82796688|FG011|Overall Study|Clinical Progression|0|||
46625910|NCT02132754|82796689|FG012|Overall Study|Clinical Progression|0|||
46625911|NCT02132754|82796690|FG013|Overall Study|Clinical Progression|0|||
46625912|NCT02132754|82796691|FG014|Overall Study|Clinical Progression|0|||
46625913|NCT02132754|82796692|FG015|Overall Study|Clinical Progression|0|||
46625914|NCT02132754|82796693|FG016|Overall Study|Clinical Progression|1|||
46625915|NCT02132754|82796694|FG017|Overall Study|Clinical Progression|1|||
46625916|NCT02132754|82796695|FG018|Overall Study|Clinical Progression|0|||
46912477|NCT03254459|83142446|FG000|Overall Study|Withdrawal by Subject Consent|3|||
46912478|NCT03254459|83142447|FG001|Overall Study|Withdrawal by Subject Consent|1|||
46912479|NCT03254459|83142446|FG000|Overall Study|Lost to Follow-up|0|||
46912480|NCT03254459|83142447|FG001|Overall Study|Lost to Follow-up|1|||
46912481|NCT03254459|83142446|FG000|Overall Study|Miscellaneous|0|||
46912482|NCT03254459|83142447|FG001|Overall Study|Miscellaneous|1|||
46912483|NCT02736617|83142453|FG000|Treatment|Adverse Event|1|||
46912484|NCT02736617|83142453|FG000|Treatment|Lack of Efficacy|1|||
46912485|NCT02736617|83142453|FG000|Treatment|Withdrawal by Subject|1|||
46912486|NCT02736617|83142453|FG000|Maintenance|Lack of Efficacy|4|||
46912487|NCT02736617|83142453|FG000|Maintenance|Physician Decision|1|||
46912488|NCT03251963|83142460|FG000|Overall Study|inappropriate Xa level timing|6|||
46625917|NCT02132754|82796696|FG019|Overall Study|Clinical Progression|1|||
46625918|NCT02132754|82796697|FG020|Overall Study|Clinical Progression|0|||
46625919|NCT02132754|82796698|FG021|Overall Study|Clinical Progression|0|||
46625920|NCT02132754|82796699|FG022|Overall Study|Clinical Progression|1|||
46625921|NCT02132754|82796700|FG023|Overall Study|Clinical Progression|0|||
46625922|NCT02132754|82796701|FG024|Overall Study|Clinical Progression|1|||
46625923|NCT02132754|82796702|FG025|Overall Study|Clinical Progression|1|||
46625924|NCT02132754|82796703|FG026|Overall Study|Clinical Progression|0|||
46625925|NCT02132754|82796704|FG027|Overall Study|Clinical Progression|1|||
46625926|NCT02132754|82796705|FG028|Overall Study|Clinical Progression|1|||
46625927|NCT02132754|82796706|FG029|Overall Study|Clinical Progression|0|||
46912489|NCT03251963|83142461|FG001|Overall Study|inappropriate Xa level timing|3|||
46912490|NCT03251963|83142460|FG000|Overall Study|no peak Xa level drawn|2|||
46912491|NCT03251963|83142461|FG001|Overall Study|no peak Xa level drawn|0|||
46912492|NCT03251963|83142460|FG000|Overall Study|bled prior to Xa level|1|||
47028933|NCT01606761|83278679|FG003|Week 24 to Week 52|Physician Decision|0|||
47028934|NCT01606761|83278680|FG004|Week 24 to Week 52|Physician Decision|0|||
47028935|NCT01606761|83278676|FG000|Week 24 to Week 52|Other|0|||
47028936|NCT01606761|83278677|FG001|Week 24 to Week 52|Other|1|||
47028937|NCT01606761|83278678|FG002|Week 24 to Week 52|Other|5|||
47028938|NCT01606761|83278679|FG003|Week 24 to Week 52|Other|2|||
47028939|NCT01606761|83278680|FG004|Week 24 to Week 52|Other|2|||
47028940|NCT01606761|83278676|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
47028941|NCT01606761|83278677|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
47028942|NCT01606761|83278678|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
47028943|NCT01606761|83278679|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
47028944|NCT01606761|83278680|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
47028945|NCT01606761|83278676|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
47028946|NCT01606761|83278677|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
47028947|NCT01606761|83278678|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
47028948|NCT01606761|83278679|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
47028949|NCT01606761|83278680|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
47028950|NCT01606761|83278676|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
47028951|NCT01606761|83278677|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
47028952|NCT01606761|83278678|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
47028953|NCT01606761|83278679|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
47028954|NCT01606761|83278680|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
47028955|NCT01606761|83278676|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
47028956|NCT01606761|83278677|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
47028957|NCT01606761|83278678|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
47028958|NCT01606761|83278679|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
47028959|NCT01606761|83278680|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
47028960|NCT01790295|83278695|FG000|Overall Study|Adverse Event|1|||
47028961|NCT01790295|83278695|FG000|Overall Study|Death|4|||
47028962|NCT01790295|83278695|FG000|Overall Study|Lack of Efficacy|2|||
47028963|NCT01790295|83278695|FG000|Overall Study|Study closure|4|||
47028964|NCT01597557|83278702|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
47028965|NCT01597557|83278703|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
47028966|NCT01760733|83278709|FG000|Waiting List|Death|18|||
47028967|NCT01760733|83278709|FG000|Waiting List|Removed from waiting list|41|||
47028968|NCT01760733|83278709|FG000|Waiting List|Not received a transplant yet|13|||
47028969|NCT01760733|83278709|FG000|Transplanted|Not reached 10 years post transplant|184|||
47028970|NCT01760733|83278709|FG000|Transplanted|Death|26|||
47028971|NCT01760733|83278709|FG000|Transplanted|Graft loss|7|||
47028972|NCT01914757|83278717|FG000|Overall Study|Severe non-compliance to protocol|3|||
47028973|NCT01914757|83278718|FG001|Overall Study|Severe non-compliance to protocol|1|||
47028974|NCT01914757|83278719|FG002|Overall Study|Severe non-compliance to protocol|2|||
47028975|NCT01914757|83278717|FG000|Overall Study|Lost to Follow-up|5|||
47028976|NCT01914757|83278718|FG001|Overall Study|Lost to Follow-up|8|||
47028977|NCT01914757|83278719|FG002|Overall Study|Lost to Follow-up|6|||
47028978|NCT01914757|83278717|FG000|Overall Study|Withdrawal by Subject|15|||
47028979|NCT01914757|83278718|FG001|Overall Study|Withdrawal by Subject|27|||
47028980|NCT01914757|83278719|FG002|Overall Study|Withdrawal by Subject|19|||
47028981|NCT01914757|83278717|FG000|Overall Study|Death|2|||
47028982|NCT01914757|83278718|FG001|Overall Study|Death|2|||
47028983|NCT01914757|83278719|FG002|Overall Study|Death|1|||
46625928|NCT02132754|82796707|FG030|Overall Study|Clinical Progression|1|||
46625929|NCT02132754|82796708|FG031|Overall Study|Clinical Progression|0|||
46625930|NCT02132754|82796709|FG032|Overall Study|Clinical Progression|0|||
46625931|NCT02132754|82796710|FG033|Overall Study|Clinical Progression|2|||
46625932|NCT02132754|82796677|FG000|Overall Study|Death|0|||
46625933|NCT02132754|82796678|FG001|Overall Study|Death|0|||
47028984|NCT01914757|83278717|FG000|Overall Study|Adverse Event|4|||
47028985|NCT01914757|83278718|FG001|Overall Study|Adverse Event|3|||
47028986|NCT01914757|83278719|FG002|Overall Study|Adverse Event|4|||
47028987|NCT01914757|83278717|FG000|Overall Study|Study specific withdrawal criteria|0|||
47028988|NCT01914757|83278718|FG001|Overall Study|Study specific withdrawal criteria|1|||
47028989|NCT01914757|83278719|FG002|Overall Study|Study specific withdrawal criteria|0|||
46710363|NCT01167881|82926474|FG000|Overall Study|Not treated|4|||
46912493|NCT03251963|83142461|FG001|Overall Study|bled prior to Xa level|2|||
46912494|NCT03287219|83142469|FG000|Overall Study|Protocol Violation|0|||
47028990|NCT01914757|83278717|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46625934|NCT02132754|82796679|FG002|Overall Study|Death|0|||
46625935|NCT02132754|82796680|FG003|Overall Study|Death|0|||
46912495|NCT03287219|83142470|FG001|Overall Study|Protocol Violation|2|||
46912496|NCT03286751|83142509|FG000|Washout Period 1|Withdrawal by Subject|0|||
46625936|NCT02132754|82796681|FG004|Overall Study|Death|0|||
46625937|NCT02132754|82796682|FG005|Overall Study|Death|0|||
46625938|NCT02132754|82796683|FG006|Overall Study|Death|0|||
46625939|NCT02132754|82796684|FG007|Overall Study|Death|0|||
46625940|NCT02132754|82796685|FG008|Overall Study|Death|0|||
46625941|NCT02132754|82796686|FG009|Overall Study|Death|0|||
46625942|NCT02132754|82796687|FG010|Overall Study|Death|0|||
46625943|NCT02132754|82796688|FG011|Overall Study|Death|0|||
46625944|NCT02132754|82796689|FG012|Overall Study|Death|0|||
47028991|NCT01914757|83278718|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
47028992|NCT01914757|83278719|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
47028993|NCT01914757|83278717|FG000|Overall Study|Other reasons|5|||
47028994|NCT01914757|83278718|FG001|Overall Study|Other reasons|9|||
47028995|NCT01914757|83278719|FG002|Overall Study|Other reasons|4|||
47028996|NCT02003573|83278730|FG000|Overall Study|Progressive disease|2|||
47028997|NCT02003573|83278731|FG001|Overall Study|Progressive disease|0|||
47028998|NCT02003573|83278732|FG002|Overall Study|Progressive disease|1|||
47028999|NCT02003573|83278730|FG000|Overall Study|Other Adverse event|0|||
47029000|NCT02003573|83278731|FG001|Overall Study|Other Adverse event|1|||
47029001|NCT02003573|83278732|FG002|Overall Study|Other Adverse event|1|||
47029002|NCT02003573|83278730|FG000|Overall Study|Refuse to take trial medication|0|||
47029003|NCT02003573|83278731|FG001|Overall Study|Refuse to take trial medication|1|||
47029004|NCT02003573|83278732|FG002|Overall Study|Refuse to take trial medication|1|||
47029005|NCT02003573|83278730|FG000|Overall Study|Other than specified|1|||
47029006|NCT02003573|83278731|FG001|Overall Study|Other than specified|2|||
47029007|NCT02003573|83278732|FG002|Overall Study|Other than specified|3|||
47029008|NCT01914679|83278742|FG000|Overall Study|Lack of Efficacy|1|||
47029009|NCT01914679|83278742|FG000|Overall Study|Sponsor terminated study|4|||
47029010|NCT01789281|83278748|FG000|Overall Study|Disease progression|15|||
47029011|NCT01789281|83278749|FG001|Overall Study|Disease progression|4|||
47029012|NCT01789281|83278748|FG000|Overall Study|Adverse Event|5|||
47029013|NCT01789281|83278749|FG001|Overall Study|Adverse Event|5|||
47029014|NCT01789281|83278748|FG000|Overall Study|Withdrawal by Subject|1|||
47029015|NCT01789281|83278749|FG001|Overall Study|Withdrawal by Subject|0|||
47029016|NCT01789281|83278748|FG000|Overall Study|Lost to Follow-up|1|||
47029017|NCT01789281|83278749|FG001|Overall Study|Lost to Follow-up|0|||
47029018|NCT01789281|83278748|FG000|Overall Study|Administrative problems|0|||
47029019|NCT01789281|83278749|FG001|Overall Study|Administrative problems|1|||
47029020|NCT01923740|83278758|FG000|Overall Study|Lost to Follow-up|4|||
47029021|NCT01923740|83278759|FG001|Overall Study|Lost to Follow-up|9|||
47029022|NCT01923740|83278758|FG000|Overall Study|Withdrawal by Subject|2|||
47029023|NCT01923740|83278759|FG001|Overall Study|Withdrawal by Subject|0|||
47029024|NCT01789203|83278767|FG000|Overall Study|Adverse Event|2|||
47029025|NCT01789203|83278768|FG001|Overall Study|Adverse Event|2|||
47029026|NCT01789203|83278767|FG000|Overall Study|Withdrawal by Subject|1|||
47029027|NCT01789203|83278768|FG001|Overall Study|Withdrawal by Subject|0|||
47029028|NCT01789203|83278767|FG000|Overall Study|Death|1|||
47029029|NCT01789203|83278768|FG001|Overall Study|Death|0|||
46625945|NCT02132754|82796690|FG013|Overall Study|Death|0|||
46625946|NCT02132754|82796691|FG014|Overall Study|Death|0|||
46625947|NCT02132754|82796692|FG015|Overall Study|Death|1|||
46625948|NCT02132754|82796693|FG016|Overall Study|Death|0|||
46912497|NCT03286751|83142510|FG001|Washout Period 1|Withdrawal by Subject|0|||
47029030|NCT01789203|83278767|FG000|Overall Study|Protocol Violation|2|||
46625949|NCT02132754|82796694|FG017|Overall Study|Death|0|||
46625950|NCT02132754|82796695|FG018|Overall Study|Death|0|||
46625951|NCT02132754|82796696|FG019|Overall Study|Death|1|||
46625952|NCT02132754|82796697|FG020|Overall Study|Death|0|||
47029031|NCT01789203|83278768|FG001|Overall Study|Protocol Violation|1|||
47029032|NCT01789203|83278767|FG000|Overall Study|Other|1|||
46625953|NCT02132754|82796698|FG021|Overall Study|Death|1|||
47029033|NCT01789203|83278768|FG001|Overall Study|Other|1|||
47029034|NCT01789203|83278767|FG000|Overall Study|patient non-adherent|2|||
47029035|NCT01789203|83278768|FG001|Overall Study|patient non-adherent|0|||
46625954|NCT02132754|82796699|FG022|Overall Study|Death|0|||
46625955|NCT02132754|82796700|FG023|Overall Study|Death|0|||
46625956|NCT02132754|82796701|FG024|Overall Study|Death|0|||
46625957|NCT02132754|82796702|FG025|Overall Study|Death|0|||
46625958|NCT02132754|82796703|FG026|Overall Study|Death|1|||
46625959|NCT02132754|82796704|FG027|Overall Study|Death|0|||
46625960|NCT02132754|82796705|FG028|Overall Study|Death|0|||
46625961|NCT02132754|82796706|FG029|Overall Study|Death|0|||
46625962|NCT02132754|82796707|FG030|Overall Study|Death|0|||
46625963|NCT02132754|82796708|FG031|Overall Study|Death|0|||
46625964|NCT02132754|82796709|FG032|Overall Study|Death|0|||
46625965|NCT02132754|82796710|FG033|Overall Study|Death|2|||
46625966|NCT02132754|82796677|FG000|Overall Study|Excluded Medication|0|||
46625967|NCT02132754|82796678|FG001|Overall Study|Excluded Medication|0|||
46625968|NCT02132754|82796679|FG002|Overall Study|Excluded Medication|0|||
46625969|NCT02132754|82796680|FG003|Overall Study|Excluded Medication|0|||
46625970|NCT02132754|82796681|FG004|Overall Study|Excluded Medication|0|||
46625971|NCT02132754|82796682|FG005|Overall Study|Excluded Medication|0|||
46625972|NCT02132754|82796683|FG006|Overall Study|Excluded Medication|0|||
46625973|NCT02132754|82796684|FG007|Overall Study|Excluded Medication|0|||
46625974|NCT02132754|82796685|FG008|Overall Study|Excluded Medication|0|||
46625975|NCT02132754|82796686|FG009|Overall Study|Excluded Medication|0|||
46625976|NCT02132754|82796687|FG010|Overall Study|Excluded Medication|0|||
46625977|NCT02132754|82796688|FG011|Overall Study|Excluded Medication|0|||
46625978|NCT02132754|82796689|FG012|Overall Study|Excluded Medication|0|||
46625979|NCT02132754|82796690|FG013|Overall Study|Excluded Medication|0|||
46625980|NCT02132754|82796691|FG014|Overall Study|Excluded Medication|0|||
46625981|NCT02132754|82796692|FG015|Overall Study|Excluded Medication|0|||
46625982|NCT02132754|82796693|FG016|Overall Study|Excluded Medication|0|||
46625983|NCT02132754|82796694|FG017|Overall Study|Excluded Medication|0|||
46625984|NCT02132754|82796695|FG018|Overall Study|Excluded Medication|0|||
46625985|NCT02132754|82796696|FG019|Overall Study|Excluded Medication|0|||
46625986|NCT02132754|82796697|FG020|Overall Study|Excluded Medication|1|||
46625987|NCT02132754|82796698|FG021|Overall Study|Excluded Medication|0|||
46625988|NCT02132754|82796699|FG022|Overall Study|Excluded Medication|0|||
46625989|NCT02132754|82796700|FG023|Overall Study|Excluded Medication|0|||
46625990|NCT02132754|82796701|FG024|Overall Study|Excluded Medication|0|||
46625991|NCT02132754|82796702|FG025|Overall Study|Excluded Medication|0|||
46625992|NCT02132754|82796703|FG026|Overall Study|Excluded Medication|0|||
46625993|NCT02132754|82796704|FG027|Overall Study|Excluded Medication|0|||
46625994|NCT02132754|82796705|FG028|Overall Study|Excluded Medication|0|||
46625995|NCT02132754|82796706|FG029|Overall Study|Excluded Medication|0|||
46625996|NCT02132754|82796707|FG030|Overall Study|Excluded Medication|0|||
46625997|NCT02132754|82796708|FG031|Overall Study|Excluded Medication|0|||
46625998|NCT02132754|82796709|FG032|Overall Study|Excluded Medication|0|||
46625999|NCT02132754|82796710|FG033|Overall Study|Excluded Medication|1|||
46626000|NCT02132754|82796677|FG000|Overall Study|Physician Decision|0|||
46626001|NCT02132754|82796678|FG001|Overall Study|Physician Decision|0|||
46626002|NCT02132754|82796679|FG002|Overall Study|Physician Decision|0|||
46626003|NCT02132754|82796680|FG003|Overall Study|Physician Decision|0|||
46626004|NCT02132754|82796681|FG004|Overall Study|Physician Decision|0|||
46626005|NCT02132754|82796682|FG005|Overall Study|Physician Decision|0|||
46626006|NCT02132754|82796683|FG006|Overall Study|Physician Decision|0|||
46626007|NCT02132754|82796684|FG007|Overall Study|Physician Decision|0|||
46626008|NCT02132754|82796685|FG008|Overall Study|Physician Decision|0|||
46626009|NCT02132754|82796686|FG009|Overall Study|Physician Decision|1|||
46626010|NCT02132754|82796687|FG010|Overall Study|Physician Decision|0|||
46626011|NCT02132754|82796688|FG011|Overall Study|Physician Decision|1|||
46626012|NCT02132754|82796689|FG012|Overall Study|Physician Decision|1|||
46626013|NCT02132754|82796690|FG013|Overall Study|Physician Decision|0|||
46626014|NCT02132754|82796691|FG014|Overall Study|Physician Decision|0|||
46626015|NCT02132754|82796692|FG015|Overall Study|Physician Decision|1|||
46626016|NCT02132754|82796693|FG016|Overall Study|Physician Decision|0|||
46626017|NCT02132754|82796694|FG017|Overall Study|Physician Decision|0|||
46626018|NCT02132754|82796695|FG018|Overall Study|Physician Decision|0|||
46626019|NCT02132754|82796696|FG019|Overall Study|Physician Decision|0|||
46626020|NCT02132754|82796697|FG020|Overall Study|Physician Decision|0|||
46626021|NCT02132754|82796698|FG021|Overall Study|Physician Decision|0|||
46626022|NCT02132754|82796699|FG022|Overall Study|Physician Decision|0|||
46626023|NCT02132754|82796700|FG023|Overall Study|Physician Decision|0|||
46626024|NCT02132754|82796701|FG024|Overall Study|Physician Decision|1|||
46626025|NCT02132754|82796702|FG025|Overall Study|Physician Decision|0|||
46626026|NCT02132754|82796703|FG026|Overall Study|Physician Decision|0|||
46626027|NCT02132754|82796704|FG027|Overall Study|Physician Decision|0|||
46626028|NCT02132754|82796705|FG028|Overall Study|Physician Decision|0|||
46626029|NCT02132754|82796706|FG029|Overall Study|Physician Decision|0|||
46626030|NCT02132754|82796707|FG030|Overall Study|Physician Decision|0|||
46626031|NCT02132754|82796708|FG031|Overall Study|Physician Decision|1|||
46626032|NCT02132754|82796709|FG032|Overall Study|Physician Decision|0|||
46626033|NCT02132754|82796710|FG033|Overall Study|Physician Decision|3|||
46626034|NCT02132754|82796677|FG000|Overall Study|Progressive Disease|1|||
46626035|NCT02132754|82796678|FG001|Overall Study|Progressive Disease|1|||
46626036|NCT02132754|82796679|FG002|Overall Study|Progressive Disease|1|||
46626037|NCT02132754|82796680|FG003|Overall Study|Progressive Disease|1|||
46626038|NCT02132754|82796681|FG004|Overall Study|Progressive Disease|1|||
46626039|NCT02132754|82796682|FG005|Overall Study|Progressive Disease|1|||
46626040|NCT02132754|82796683|FG006|Overall Study|Progressive Disease|1|||
46626041|NCT02132754|82796684|FG007|Overall Study|Progressive Disease|1|||
46626042|NCT02132754|82796685|FG008|Overall Study|Progressive Disease|1|||
46626043|NCT02132754|82796686|FG009|Overall Study|Progressive Disease|3|||
46626044|NCT02132754|82796687|FG010|Overall Study|Progressive Disease|3|||
46626045|NCT02132754|82796688|FG011|Overall Study|Progressive Disease|2|||
47029036|NCT01789047|83278778|FG000|Overall Study|Adverse Event|3|||
47029037|NCT01789047|83278779|FG001|Overall Study|Adverse Event|2|||
47029038|NCT01789047|83278778|FG000|Overall Study|Withdrawal by Subject|1|||
47029039|NCT01789047|83278779|FG001|Overall Study|Withdrawal by Subject|2|||
47029040|NCT01788423|83278788|FG000|Overall Study|See Comments in Completed (above)|0|||
47029041|NCT01788423|83278789|FG001|Overall Study|See Comments in Completed (above)|4|||
47029042|NCT01788423|83278790|FG002|Overall Study|See Comments in Completed (above)|5|||
47029043|NCT01617187|83278802|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
47029044|NCT01617187|83278803|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
47029045|NCT01617187|83278804|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
47029046|NCT01617187|83278805|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
47029047|NCT01617187|83278802|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
47029048|NCT01617187|83278803|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
47029049|NCT01617187|83278804|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
47029050|NCT01617187|83278805|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
47029051|NCT01617187|83278802|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
46626046|NCT02132754|82796689|FG012|Overall Study|Progressive Disease|2|||
46626047|NCT02132754|82796690|FG013|Overall Study|Progressive Disease|3|||
46626048|NCT02132754|82796691|FG014|Overall Study|Progressive Disease|2|||
46626049|NCT02132754|82796692|FG015|Overall Study|Progressive Disease|1|||
46626050|NCT02132754|82796693|FG016|Overall Study|Progressive Disease|2|||
46626051|NCT02132754|82796694|FG017|Overall Study|Progressive Disease|1|||
46626052|NCT02132754|82796695|FG018|Overall Study|Progressive Disease|3|||
46626053|NCT02132754|82796696|FG019|Overall Study|Progressive Disease|1|||
46626054|NCT02132754|82796697|FG020|Overall Study|Progressive Disease|1|||
46626055|NCT02132754|82796698|FG021|Overall Study|Progressive Disease|3|||
46626056|NCT02132754|82796699|FG022|Overall Study|Progressive Disease|2|||
46626057|NCT02132754|82796700|FG023|Overall Study|Progressive Disease|3|||
46626058|NCT02132754|82796701|FG024|Overall Study|Progressive Disease|0|||
46626059|NCT02132754|82796702|FG025|Overall Study|Progressive Disease|1|||
46626060|NCT02132754|82796703|FG026|Overall Study|Progressive Disease|2|||
46626061|NCT02132754|82796704|FG027|Overall Study|Progressive Disease|1|||
46626062|NCT02132754|82796705|FG028|Overall Study|Progressive Disease|2|||
46626063|NCT02132754|82796706|FG029|Overall Study|Progressive Disease|3|||
46626064|NCT02132754|82796707|FG030|Overall Study|Progressive Disease|1|||
46626065|NCT02132754|82796708|FG031|Overall Study|Progressive Disease|1|||
46626066|NCT02132754|82796709|FG032|Overall Study|Progressive Disease|3|||
46626067|NCT02132754|82796710|FG033|Overall Study|Progressive Disease|6|||
46626068|NCT02132754|82796677|FG000|Overall Study|Screen Failure|0|||
46626069|NCT02132754|82796678|FG001|Overall Study|Screen Failure|0|||
46626070|NCT02132754|82796679|FG002|Overall Study|Screen Failure|0|||
46626071|NCT02132754|82796680|FG003|Overall Study|Screen Failure|0|||
46626072|NCT02132754|82796681|FG004|Overall Study|Screen Failure|0|||
46626073|NCT02132754|82796682|FG005|Overall Study|Screen Failure|0|||
47029052|NCT01617187|83278803|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
47029053|NCT01617187|83278804|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
47029054|NCT01617187|83278805|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
47029055|NCT01617187|83278802|FG000|Treatment Through Study Completion|Adverse Event|1|||
46626074|NCT02132754|82796683|FG006|Overall Study|Screen Failure|0|||
46626075|NCT02132754|82796684|FG007|Overall Study|Screen Failure|0|||
46626076|NCT02132754|82796685|FG008|Overall Study|Screen Failure|0|||
46626077|NCT02132754|82796686|FG009|Overall Study|Screen Failure|0|||
46626078|NCT02132754|82796687|FG010|Overall Study|Screen Failure|0|||
46626079|NCT02132754|82796688|FG011|Overall Study|Screen Failure|0|||
46626080|NCT02132754|82796689|FG012|Overall Study|Screen Failure|0|||
46626081|NCT02132754|82796690|FG013|Overall Study|Screen Failure|0|||
46626082|NCT02132754|82796691|FG014|Overall Study|Screen Failure|0|||
46626083|NCT02132754|82796692|FG015|Overall Study|Screen Failure|0|||
46626084|NCT02132754|82796693|FG016|Overall Study|Screen Failure|0|||
46626085|NCT02132754|82796694|FG017|Overall Study|Screen Failure|0|||
46626086|NCT02132754|82796695|FG018|Overall Study|Screen Failure|0|||
46626087|NCT02132754|82796696|FG019|Overall Study|Screen Failure|1|||
46626088|NCT02132754|82796697|FG020|Overall Study|Screen Failure|0|||
46626089|NCT02132754|82796698|FG021|Overall Study|Screen Failure|1|||
46626090|NCT02132754|82796699|FG022|Overall Study|Screen Failure|0|||
46626091|NCT02132754|82796700|FG023|Overall Study|Screen Failure|0|||
46626092|NCT02132754|82796701|FG024|Overall Study|Screen Failure|0|||
46626093|NCT02132754|82796702|FG025|Overall Study|Screen Failure|0|||
46626094|NCT02132754|82796703|FG026|Overall Study|Screen Failure|0|||
46626095|NCT02132754|82796704|FG027|Overall Study|Screen Failure|0|||
46626096|NCT02132754|82796705|FG028|Overall Study|Screen Failure|0|||
46626097|NCT02132754|82796706|FG029|Overall Study|Screen Failure|0|||
46626098|NCT02132754|82796707|FG030|Overall Study|Screen Failure|0|||
46626099|NCT02132754|82796708|FG031|Overall Study|Screen Failure|0|||
46626100|NCT02132754|82796709|FG032|Overall Study|Screen Failure|0|||
46626101|NCT02132754|82796710|FG033|Overall Study|Screen Failure|0|||
46626102|NCT02132754|82796677|FG000|Overall Study|Transferred to Extension Study|0|||
46626103|NCT02132754|82796678|FG001|Overall Study|Transferred to Extension Study|0|||
46626104|NCT02132754|82796679|FG002|Overall Study|Transferred to Extension Study|0|||
46626105|NCT02132754|82796680|FG003|Overall Study|Transferred to Extension Study|0|||
46626106|NCT02132754|82796681|FG004|Overall Study|Transferred to Extension Study|0|||
46626107|NCT02132754|82796682|FG005|Overall Study|Transferred to Extension Study|0|||
46626108|NCT02132754|82796683|FG006|Overall Study|Transferred to Extension Study|0|||
46626109|NCT02132754|82796684|FG007|Overall Study|Transferred to Extension Study|0|||
46626110|NCT02132754|82796685|FG008|Overall Study|Transferred to Extension Study|0|||
46626111|NCT02132754|82796686|FG009|Overall Study|Transferred to Extension Study|0|||
46626112|NCT02132754|82796687|FG010|Overall Study|Transferred to Extension Study|0|||
46626113|NCT02132754|82796688|FG011|Overall Study|Transferred to Extension Study|0|||
46626114|NCT02132754|82796689|FG012|Overall Study|Transferred to Extension Study|0|||
46626115|NCT02132754|82796690|FG013|Overall Study|Transferred to Extension Study|0|||
46626116|NCT02132754|82796691|FG014|Overall Study|Transferred to Extension Study|0|||
46626117|NCT02132754|82796692|FG015|Overall Study|Transferred to Extension Study|0|||
46626118|NCT02132754|82796693|FG016|Overall Study|Transferred to Extension Study|0|||
46626119|NCT02132754|82796694|FG017|Overall Study|Transferred to Extension Study|0|||
46626120|NCT02132754|82796695|FG018|Overall Study|Transferred to Extension Study|0|||
46626121|NCT02132754|82796696|FG019|Overall Study|Transferred to Extension Study|0|||
46626122|NCT02132754|82796697|FG020|Overall Study|Transferred to Extension Study|0|||
46626123|NCT02132754|82796698|FG021|Overall Study|Transferred to Extension Study|0|||
46626124|NCT02132754|82796699|FG022|Overall Study|Transferred to Extension Study|0|||
46626125|NCT02132754|82796700|FG023|Overall Study|Transferred to Extension Study|0|||
46626126|NCT02132754|82796701|FG024|Overall Study|Transferred to Extension Study|0|||
46626127|NCT02132754|82796702|FG025|Overall Study|Transferred to Extension Study|0|||
46626128|NCT02132754|82796703|FG026|Overall Study|Transferred to Extension Study|0|||
46626129|NCT02132754|82796704|FG027|Overall Study|Transferred to Extension Study|0|||
46626130|NCT02132754|82796705|FG028|Overall Study|Transferred to Extension Study|0|||
46626131|NCT02132754|82796706|FG029|Overall Study|Transferred to Extension Study|0|||
46626132|NCT02132754|82796707|FG030|Overall Study|Transferred to Extension Study|0|||
46626133|NCT02132754|82796708|FG031|Overall Study|Transferred to Extension Study|0|||
47029056|NCT01617187|83278803|FG001|Treatment Through Study Completion|Adverse Event|1|||
47029057|NCT01617187|83278804|FG002|Treatment Through Study Completion|Adverse Event|0|||
47029058|NCT01617187|83278805|FG003|Treatment Through Study Completion|Adverse Event|1|||
47029059|NCT01617187|83278802|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
47029060|NCT01617187|83278803|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
47029061|NCT01617187|83278804|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
47029062|NCT01617187|83278805|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
47029063|NCT01617187|83278802|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
47029064|NCT01617187|83278803|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
47029065|NCT01617187|83278804|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
47029066|NCT01617187|83278805|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
46626134|NCT02132754|82796709|FG032|Overall Study|Transferred to Extension Study|0|||
46626135|NCT02132754|82796710|FG033|Overall Study|Transferred to Extension Study|6|||
46626136|NCT02132754|82796677|FG000|Overall Study|Withdrawal by Subject|0|||
46626137|NCT02132754|82796678|FG001|Overall Study|Withdrawal by Subject|0|||
46626138|NCT02132754|82796679|FG002|Overall Study|Withdrawal by Subject|0|||
46626139|NCT02132754|82796680|FG003|Overall Study|Withdrawal by Subject|0|||
46626140|NCT02132754|82796681|FG004|Overall Study|Withdrawal by Subject|0|||
46626141|NCT02132754|82796682|FG005|Overall Study|Withdrawal by Subject|0|||
46626142|NCT02132754|82796683|FG006|Overall Study|Withdrawal by Subject|0|||
47029067|NCT01617187|83278802|FG000|Treatment Through Study Completion|Protocol Violation|1|||
47029068|NCT01617187|83278803|FG001|Treatment Through Study Completion|Protocol Violation|0|||
47029069|NCT01617187|83278804|FG002|Treatment Through Study Completion|Protocol Violation|0|||
46626143|NCT02132754|82796684|FG007|Overall Study|Withdrawal by Subject|0|||
46626144|NCT02132754|82796685|FG008|Overall Study|Withdrawal by Subject|0|||
46626145|NCT02132754|82796686|FG009|Overall Study|Withdrawal by Subject|1|||
46626146|NCT02132754|82796687|FG010|Overall Study|Withdrawal by Subject|0|||
46626147|NCT02132754|82796688|FG011|Overall Study|Withdrawal by Subject|0|||
46626148|NCT02132754|82796689|FG012|Overall Study|Withdrawal by Subject|1|||
46626149|NCT02132754|82796690|FG013|Overall Study|Withdrawal by Subject|0|||
46626150|NCT02132754|82796691|FG014|Overall Study|Withdrawal by Subject|1|||
46626151|NCT02132754|82796692|FG015|Overall Study|Withdrawal by Subject|2|||
46626152|NCT02132754|82796693|FG016|Overall Study|Withdrawal by Subject|1|||
46626153|NCT02132754|82796694|FG017|Overall Study|Withdrawal by Subject|0|||
46626154|NCT02132754|82796695|FG018|Overall Study|Withdrawal by Subject|0|||
46626155|NCT02132754|82796696|FG019|Overall Study|Withdrawal by Subject|0|||
46626156|NCT02132754|82796697|FG020|Overall Study|Withdrawal by Subject|1|||
46626157|NCT02132754|82796698|FG021|Overall Study|Withdrawal by Subject|0|||
46626158|NCT02132754|82796699|FG022|Overall Study|Withdrawal by Subject|0|||
46626159|NCT02132754|82796700|FG023|Overall Study|Withdrawal by Subject|0|||
46626160|NCT02132754|82796701|FG024|Overall Study|Withdrawal by Subject|1|||
46626161|NCT02132754|82796702|FG025|Overall Study|Withdrawal by Subject|0|||
46626162|NCT02132754|82796703|FG026|Overall Study|Withdrawal by Subject|0|||
46626163|NCT02132754|82796704|FG027|Overall Study|Withdrawal by Subject|1|||
46626164|NCT02132754|82796705|FG028|Overall Study|Withdrawal by Subject|0|||
46626165|NCT02132754|82796706|FG029|Overall Study|Withdrawal by Subject|0|||
46626166|NCT02132754|82796707|FG030|Overall Study|Withdrawal by Subject|0|||
46626167|NCT02132754|82796708|FG031|Overall Study|Withdrawal by Subject|1|||
46626168|NCT02132754|82796709|FG032|Overall Study|Withdrawal by Subject|0|||
46626169|NCT02132754|82796710|FG033|Overall Study|Withdrawal by Subject|2|||
46626170|NCT02151786|82796820|FG000|Overall Study|Unavailability of Case Report Form|26|||
46626171|NCT02151786|82796820|FG000|Overall Study|Outside the Contract Period|1|||
46626172|NCT02151786|82796820|FG000|Overall Study|Randomized, not Treated|1|||
46626173|NCT02151786|82796820|FG000|Overall Study|Unavailability of Information|8|||
46626174|NCT02132130|82796828|FG000|Overall Study|Lost to Follow-up|0|||
46626175|NCT02132130|82796829|FG001|Overall Study|Lost to Follow-up|2|||
46626176|NCT02132130|82796830|FG002|Overall Study|Lost to Follow-up|0|||
46626177|NCT02132130|82796831|FG003|Overall Study|Lost to Follow-up|0|||
46626178|NCT02132130|82796828|FG000|Overall Study|Withdrawal by Subject|0|||
46626179|NCT02132130|82796829|FG001|Overall Study|Withdrawal by Subject|0|||
46626180|NCT02132130|82796830|FG002|Overall Study|Withdrawal by Subject|0|||
46626181|NCT02132130|82796831|FG003|Overall Study|Withdrawal by Subject|1|||
46626182|NCT02131662|82796850|FG000|Overall Study|Protocol Violation|1|||
46626183|NCT02131662|82796851|FG001|Overall Study|Protocol Violation|0|||
46626184|NCT02131662|82796852|FG002|Overall Study|Protocol Violation|0|||
46626185|NCT02131662|82796853|FG003|Overall Study|Protocol Violation|0|||
46626186|NCT02131662|82796854|FG004|Overall Study|Protocol Violation|0|||
46626187|NCT02131662|82796850|FG000|Overall Study|Other|2|||
47029070|NCT01617187|83278805|FG003|Treatment Through Study Completion|Protocol Violation|1|||
47029071|NCT01759407|83278817|FG000|Overall Study|Protocol Violation|0|||
47029072|NCT01759407|83278818|FG001|Overall Study|Protocol Violation|2|||
47029073|NCT01787331|83278824|FG000|Overall Study|Physician Decision|1|||
47029074|NCT01787331|83278824|FG000|Overall Study|Withdrawal by Subject|1|||
47029075|NCT01757847|83278830|FG000|Overall Study|Withdrawal by Subject|3|||
47029076|NCT01757847|83278831|FG001|Overall Study|Withdrawal by Subject|4|||
46626188|NCT02131662|82796851|FG001|Overall Study|Other|4|||
46626189|NCT02131662|82796852|FG002|Overall Study|Other|3|||
46626190|NCT02131662|82796853|FG003|Overall Study|Other|3|||
46626191|NCT02131662|82796854|FG004|Overall Study|Other|4|||
46626192|NCT02131662|82796850|FG000|Overall Study|Adverse Event|0|||
46626193|NCT02131662|82796851|FG001|Overall Study|Adverse Event|1|||
46626194|NCT02131662|82796852|FG002|Overall Study|Adverse Event|1|||
46912498|NCT03286751|83142511|FG002|Washout Period 1|Withdrawal by Subject|0|||
46912499|NCT03286751|83142512|FG003|Washout Period 1|Withdrawal by Subject|0|||
46912500|NCT03286751|83142513|FG004|Washout Period 1|Withdrawal by Subject|1|||
46912501|NCT03286751|83142514|FG005|Washout Period 1|Withdrawal by Subject|0|||
46912502|NCT03286751|83142509|FG000|Washout Period 2|Personal Reasons|0|||
46912503|NCT03286751|83142510|FG001|Washout Period 2|Personal Reasons|1|||
46626195|NCT02131662|82796853|FG003|Overall Study|Adverse Event|1|||
46626196|NCT02131662|82796854|FG004|Overall Study|Adverse Event|3|||
46626197|NCT02131662|82796850|FG000|Overall Study|Pregnancy|0|||
46912504|NCT03286751|83142511|FG002|Washout Period 2|Personal Reasons|0|||
46912505|NCT03286751|83142512|FG003|Washout Period 2|Personal Reasons|0|||
46912506|NCT03286751|83142513|FG004|Washout Period 2|Personal Reasons|0|||
46912507|NCT03286751|83142514|FG005|Washout Period 2|Personal Reasons|0|||
46912508|NCT03286751|83142509|FG000|Washout Period 5|Adverse Event|0|||
46912509|NCT03286751|83142510|FG001|Washout Period 5|Adverse Event|0|||
46912510|NCT03286751|83142511|FG002|Washout Period 5|Adverse Event|0|||
46626198|NCT02131662|82796851|FG001|Overall Study|Pregnancy|1|||
46626199|NCT02131662|82796852|FG002|Overall Study|Pregnancy|0|||
46626200|NCT02131662|82796853|FG003|Overall Study|Pregnancy|1|||
46626201|NCT02131662|82796854|FG004|Overall Study|Pregnancy|0|||
46626202|NCT02131662|82796850|FG000|Overall Study|Wish for pregnancy|0|||
46626203|NCT02131662|82796851|FG001|Overall Study|Wish for pregnancy|0|||
46912511|NCT03286751|83142512|FG003|Washout Period 5|Adverse Event|0|||
46912512|NCT03286751|83142513|FG004|Washout Period 5|Adverse Event|1|||
46912513|NCT03286751|83142514|FG005|Washout Period 5|Adverse Event|0|||
46912514|NCT03249935|83142528|FG000|Overall Study|Discharged from facility early|36|||
46912515|NCT03249935|83142528|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
46912516|NCT03249935|83142528|FG000|Overall Study|Protocol Violation|5|||
46912517|NCT03285113|83142534|FG000|Overall Study|Unable to implant leads|2|||
46912518|NCT03000348|83142544|FG000|Overall Study|Adverse Event|1|||
46912519|NCT03000348|83142545|FG001|Overall Study|Adverse Event|1|||
46912520|NCT03000348|83142546|FG002|Overall Study|Adverse Event|1|||
46912521|NCT03000348|83142547|FG003|Overall Study|Adverse Event|1|||
46626204|NCT02131662|82796852|FG002|Overall Study|Wish for pregnancy|0|||
46626205|NCT02131662|82796853|FG003|Overall Study|Wish for pregnancy|0|||
46626206|NCT02131662|82796854|FG004|Overall Study|Wish for pregnancy|1|||
46626207|NCT02131662|82796850|FG000|Overall Study|Lack of Efficacy|1|||
46626208|NCT02131662|82796851|FG001|Overall Study|Lack of Efficacy|0|||
46626209|NCT02131662|82796852|FG002|Overall Study|Lack of Efficacy|0|||
46626210|NCT02131662|82796853|FG003|Overall Study|Lack of Efficacy|0|||
46626211|NCT02131662|82796854|FG004|Overall Study|Lack of Efficacy|1|||
46626212|NCT02131662|82796850|FG000|Overall Study|Withdrawal by Subject|1|||
46626213|NCT02131662|82796851|FG001|Overall Study|Withdrawal by Subject|5|||
46626214|NCT02131662|82796852|FG002|Overall Study|Withdrawal by Subject|1|||
46626215|NCT02131662|82796853|FG003|Overall Study|Withdrawal by Subject|5|||
46626216|NCT02131662|82796854|FG004|Overall Study|Withdrawal by Subject|6|||
46626217|NCT02131662|82796850|FG000|Overall Study|Lost to Follow-up|1|||
46626218|NCT02131662|82796851|FG001|Overall Study|Lost to Follow-up|3|||
46626219|NCT02131662|82796852|FG002|Overall Study|Lost to Follow-up|0|||
46626220|NCT02131662|82796853|FG003|Overall Study|Lost to Follow-up|9|||
46626221|NCT02131662|82796854|FG004|Overall Study|Lost to Follow-up|0|||
46626222|NCT02131662|82796850|FG000|Overall Study|Not treated|2|||
46626223|NCT02131662|82796851|FG001|Overall Study|Not treated|0|||
46626224|NCT02131662|82796852|FG002|Overall Study|Not treated|2|||
46626225|NCT02131662|82796853|FG003|Overall Study|Not treated|2|||
46626226|NCT02131662|82796854|FG004|Overall Study|Not treated|3|||
46626227|NCT02106156|82796873|FG000|Overall Study|Patient Died|19|||
46626228|NCT02106156|82796874|FG001|Overall Study|Patient Died|0|||
46626229|NCT02106156|82796875|FG002|Overall Study|Patient Died|0|||
46626230|NCT02106156|82796873|FG000|Overall Study|Lack of Tolerability|305|||
46626231|NCT02106156|82796874|FG001|Overall Study|Lack of Tolerability|3|||
46626232|NCT02106156|82796875|FG002|Overall Study|Lack of Tolerability|0|||
46626233|NCT02106156|82796873|FG000|Overall Study|Lack of Virological Response|1044|||
46626234|NCT02106156|82796874|FG001|Overall Study|Lack of Virological Response|8|||
46626235|NCT02106156|82796875|FG002|Overall Study|Lack of Virological Response|0|||
46626236|NCT02106156|82796873|FG000|Overall Study|Concomitant Disease|74|||
46626237|NCT02106156|82796874|FG001|Overall Study|Concomitant Disease|2|||
46626238|NCT02106156|82796875|FG002|Overall Study|Concomitant Disease|0|||
46626239|NCT02106156|82796873|FG000|Overall Study|Lack of Compliance|211|||
46626240|NCT02106156|82796874|FG001|Overall Study|Lack of Compliance|7|||
46626241|NCT02106156|82796875|FG002|Overall Study|Lack of Compliance|0|||
46626242|NCT02106156|82796873|FG000|Overall Study|Patients Request|307|||
46626243|NCT02106156|82796874|FG001|Overall Study|Patients Request|9|||
46626244|NCT02106156|82796875|FG002|Overall Study|Patients Request|0|||
46626245|NCT02106156|82796873|FG000|Overall Study|Lost to Follow-up|451|||
46626246|NCT02106156|82796874|FG001|Overall Study|Lost to Follow-up|8|||
46626247|NCT02106156|82796875|FG002|Overall Study|Lost to Follow-up|0|||
46626248|NCT02106156|82796873|FG000|Overall Study|Unplanned Event|82|||
46626249|NCT02106156|82796874|FG001|Overall Study|Unplanned Event|2|||
46626250|NCT02106156|82796875|FG002|Overall Study|Unplanned Event|0|||
46626251|NCT02106156|82796873|FG000|Overall Study|Change of Laboratory Parameter|10|||
46626252|NCT02106156|82796874|FG001|Overall Study|Change of Laboratory Parameter|0|||
46626253|NCT02106156|82796875|FG002|Overall Study|Change of Laboratory Parameter|0|||
46626254|NCT02106156|82796873|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
46710364|NCT01167881|82926475|FG001|Overall Study|Not treated|0|||
46912522|NCT03000348|83142548|FG004|Overall Study|Adverse Event|1|||
46912523|NCT03000348|83142549|FG005|Overall Study|Adverse Event|1|||
46912524|NCT03000348|83142544|FG000|Overall Study|Lost to Follow-up|0|||
46912525|NCT03000348|83142545|FG001|Overall Study|Lost to Follow-up|0|||
46912526|NCT03000348|83142546|FG002|Overall Study|Lost to Follow-up|1|||
46912527|NCT03000348|83142547|FG003|Overall Study|Lost to Follow-up|0|||
46912528|NCT03000348|83142548|FG004|Overall Study|Lost to Follow-up|0|||
46626255|NCT02106156|82796874|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
46626256|NCT02106156|82796875|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
46626257|NCT02106156|82796873|FG000|Overall Study|Relocation/Change of Physician|40|||
46626258|NCT02106156|82796874|FG001|Overall Study|Relocation/Change of Physician|1|||
46626259|NCT02106156|82796875|FG002|Overall Study|Relocation/Change of Physician|0|||
46626260|NCT01598610|82796901|FG000|Overall Study|Adverse Event|1|||
46626261|NCT01625988|82796907|FG000|Overall Study|Lost to Follow-up|5|||
46626262|NCT01625988|82796908|FG001|Overall Study|Lost to Follow-up|6|||
46626263|NCT01625988|82796907|FG000|Overall Study|Withdrawal by Subject|8|||
46626264|NCT01625988|82796908|FG001|Overall Study|Withdrawal by Subject|3|||
46626265|NCT01625988|82796907|FG000|Overall Study|Adverse Event|0|||
46626266|NCT01625988|82796908|FG001|Overall Study|Adverse Event|1|||
46626267|NCT01625988|82796907|FG000|Overall Study|Lack of Efficacy|0|||
46626268|NCT01625988|82796908|FG001|Overall Study|Lack of Efficacy|1|||
46626269|NCT01625988|82796907|FG000|Overall Study|Randomized Inappropriately|1|||
46626270|NCT01625988|82796908|FG001|Overall Study|Randomized Inappropriately|0|||
46626271|NCT01625988|82796907|FG000|Overall Study|Protocol Violation|0|||
46626272|NCT01625988|82796908|FG001|Overall Study|Protocol Violation|2|||
46626273|NCT02131272|82796919|FG000|Overall Study|Withdrawal by parent|0|||
46626274|NCT02131272|82796920|FG001|Overall Study|Withdrawal by parent|1|||
46626275|NCT02131272|82796919|FG000|Overall Study|Withdrawal by Subject|0|||
46626276|NCT02131272|82796920|FG001|Overall Study|Withdrawal by Subject|1|||
46626277|NCT02131272|82796919|FG000|Overall Study|Withdrawal Criteria|1|||
46626278|NCT02131272|82796920|FG001|Overall Study|Withdrawal Criteria|0|||
46626279|NCT02130882|82796928|FG000|Overall Study|Withdrawal by Subject|0|||
46626280|NCT02130882|82796929|FG001|Overall Study|Withdrawal by Subject|1|||
46626281|NCT02130570|82796937|FG000|Overall Study|Death|3|||
46626282|NCT02130570|82796938|FG001|Overall Study|Death|5|||
46626283|NCT02130570|82796937|FG000|Overall Study|Withdrawal by Subject|6|||
46626284|NCT02130570|82796938|FG001|Overall Study|Withdrawal by Subject|3|||
46626285|NCT02130570|82796937|FG000|Overall Study|Part of practice that discontinued study|0|||
46626286|NCT02130570|82796938|FG001|Overall Study|Part of practice that discontinued study|5|||
46626287|NCT02149836|82796945|FG000|Overall Study|Withdrawal by Subject|1|||
46626288|NCT02130024|82796951|FG000|Overall Study|Adverse Event|10|||
46626289|NCT02130024|82796952|FG001|Overall Study|Adverse Event|11|||
46626290|NCT02130024|82796951|FG000|Overall Study|Death|2|||
46626291|NCT02130024|82796952|FG001|Overall Study|Death|2|||
46626292|NCT02130024|82796951|FG000|Overall Study|Lost to Follow-up|1|||
46626293|NCT02130024|82796952|FG001|Overall Study|Lost to Follow-up|1|||
46626294|NCT02130024|82796951|FG000|Overall Study|Physician Decision|1|||
46626295|NCT02130024|82796952|FG001|Overall Study|Physician Decision|3|||
46626296|NCT02130024|82796951|FG000|Overall Study|Protocol Deviation|4|||
46626297|NCT02130024|82796952|FG001|Overall Study|Protocol Deviation|0|||
46626298|NCT02130024|82796951|FG000|Overall Study|Site Administration Problems|1|||
46626299|NCT02130024|82796952|FG001|Overall Study|Site Administration Problems|0|||
46626300|NCT02130024|82796951|FG000|Overall Study|Subject Withdrew Consent|6|||
46626301|NCT02130024|82796952|FG001|Overall Study|Subject Withdrew Consent|14|||
46626302|NCT02105688|82796960|FG000|Part A: Double-Blind|Adverse Event|1|||
46626303|NCT02105688|82796961|FG001|Part A: Double-Blind|Adverse Event|0|||
46626304|NCT02105688|82796960|FG000|Part A: Double-Blind|Death|0|||
46626305|NCT02105688|82796961|FG001|Part A: Double-Blind|Death|1|||
46626306|NCT02105688|82796960|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
46626307|NCT02105688|82796961|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
46626308|NCT02105688|82796960|FG000|Part A: Double-Blind|Physician Decision|0|||
46626309|NCT02105688|82796961|FG001|Part A: Double-Blind|Physician Decision|1|||
46626310|NCT02105688|82796960|FG000|Part A: Double-Blind|Status Unknown|0|||
46626311|NCT02105688|82796961|FG001|Part A: Double-Blind|Status Unknown|2|||
47029077|NCT01787097|83278837|FG000|Overall Study|Withdrawal by Subject|1|||
47029078|NCT01787097|83278838|FG001|Overall Study|Withdrawal by Subject|0|||
47029079|NCT01787097|83278839|FG002|Overall Study|Withdrawal by Subject|0|||
47029080|NCT01787097|83278840|FG003|Overall Study|Withdrawal by Subject|0|||
46626312|NCT02105688|82796960|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
46626313|NCT02105688|82796961|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
46626314|NCT02105688|82796960|FG000|Part B: Observational Follow-up|Death|2|||
46626315|NCT02105688|82796961|FG001|Part B: Observational Follow-up|Death|1|||
46626316|NCT02105688|82796960|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
46626317|NCT02105688|82796961|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
46626318|NCT02105688|82796960|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
46626319|NCT02105688|82796961|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
46626320|NCT02105688|82796960|FG000|Part B: Observational Follow-up|Physician Decision|3|||
46626321|NCT02105688|82796961|FG001|Part B: Observational Follow-up|Physician Decision|1|||
47029081|NCT01757691|83278860|FG000|Overall Study|Administrative problems|2|||
47029082|NCT01757691|83278861|FG001|Overall Study|Administrative problems|0|||
47029083|NCT01786707|83278869|FG000|Overall Study|Lost to Follow-up|1|||
47029084|NCT01786707|83278870|FG001|Overall Study|Lost to Follow-up|1|||
46710365|NCT01167881|82926474|FG000|Overall Study|Other not defined above|31|||
46710366|NCT01167881|82926475|FG001|Overall Study|Other not defined above|55|||
47029085|NCT01786629|83278878|FG000|Overall Study|Lack of Efficacy|0|||
47029086|NCT01786629|83278879|FG001|Overall Study|Lack of Efficacy|4|||
47029087|NCT01786629|83278878|FG000|Overall Study|Adverse Event|0|||
46626322|NCT02105454|82796968|FG000|Overall Study|Withdrawal by Subject|1|||
46626323|NCT01625910|82796974|FG000|Overall Study|Lost to Follow-up|3|||
46626324|NCT01625910|82796975|FG001|Overall Study|Lost to Follow-up|4|||
46626325|NCT02104752|82796985|FG000|Overall Study|Withdrawal by Subject|1|||
46626326|NCT02104752|82796986|FG001|Overall Study|Withdrawal by Subject|0|||
46626327|NCT02104752|82796985|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
46626328|NCT02104752|82796986|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
46626329|NCT02102724|82796994|FG000|Overall Study|Lost to Follow-up|1|||
46626330|NCT02102724|82796995|FG001|Overall Study|Lost to Follow-up|0|||
46626331|NCT02102724|82796994|FG000|Overall Study|surgery for brain aneurysm|1|||
46626332|NCT02102724|82796995|FG001|Overall Study|surgery for brain aneurysm|1|||
46626333|NCT02102490|82797001|FG000|Overall Study|Death|6|||
46626334|NCT02102490|82797001|FG000|Overall Study|Lost to Follow-up|1|||
46626335|NCT02101554|82797008|FG000|Overall Study|Protocol Violation|0|||
46626336|NCT02101554|82797009|FG001|Overall Study|Protocol Violation|1|||
46626337|NCT02101554|82797010|FG002|Overall Study|Protocol Violation|0|||
46626338|NCT02101554|82797008|FG000|Overall Study|Insufficient Clinical Response|0|||
46626339|NCT02101554|82797009|FG001|Overall Study|Insufficient Clinical Response|2|||
46626340|NCT02101554|82797010|FG002|Overall Study|Insufficient Clinical Response|0|||
46626341|NCT02101554|82797008|FG000|Overall Study|Adverse Event|2|||
46626342|NCT02101554|82797009|FG001|Overall Study|Adverse Event|1|||
46626343|NCT02101554|82797010|FG002|Overall Study|Adverse Event|1|||
46626344|NCT02101554|82797008|FG000|Overall Study|Lost to Follow-up|0|||
46626345|NCT02101554|82797009|FG001|Overall Study|Lost to Follow-up|1|||
46626346|NCT02101554|82797010|FG002|Overall Study|Lost to Follow-up|0|||
46626347|NCT02101554|82797008|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
46626348|NCT02101554|82797009|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
46626349|NCT02101554|82797010|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
46626350|NCT02128932|82797021|FG000|Overall Study|Withdrawal by Subject|11|||
46626351|NCT02128932|82797022|FG001|Overall Study|Withdrawal by Subject|7|||
46626352|NCT02128932|82797023|FG002|Overall Study|Withdrawal by Subject|8|||
46626353|NCT02128932|82797021|FG000|Overall Study|Death|2|||
46626354|NCT02128932|82797022|FG001|Overall Study|Death|0|||
46626355|NCT02128932|82797023|FG002|Overall Study|Death|2|||
46626356|NCT02128932|82797021|FG000|Overall Study|Lost to Follow-up|2|||
46626357|NCT02128932|82797022|FG001|Overall Study|Lost to Follow-up|1|||
46626358|NCT02128932|82797023|FG002|Overall Study|Lost to Follow-up|1|||
46626359|NCT02128932|82797021|FG000|Overall Study|No reason for withdrawal|12|||
46626360|NCT02128932|82797022|FG001|Overall Study|No reason for withdrawal|11|||
47029088|NCT01786629|83278879|FG001|Overall Study|Adverse Event|1|||
47029089|NCT01786551|83278885|FG000|Overall Study|Participant withdrew consent|2|||
47029090|NCT01973569|83278892|FG000|Overall Study|Adverse Event|9|||
47029091|NCT01973569|83278893|FG001|Overall Study|Adverse Event|2|||
47029092|NCT01973569|83278894|FG002|Overall Study|Adverse Event|4|||
47029093|NCT01973569|83278892|FG000|Overall Study|Protocol Violation|2|||
47029094|NCT01973569|83278893|FG001|Overall Study|Protocol Violation|1|||
47029095|NCT01973569|83278894|FG002|Overall Study|Protocol Violation|3|||
47029096|NCT01973569|83278892|FG000|Overall Study|Withdrawal by Subject|7|||
47029097|NCT01973569|83278893|FG001|Overall Study|Withdrawal by Subject|5|||
47029098|NCT01973569|83278894|FG002|Overall Study|Withdrawal by Subject|2|||
47029099|NCT01973569|83278892|FG000|Overall Study|Invasive dental treatment|3|||
47029100|NCT01973569|83278893|FG001|Overall Study|Invasive dental treatment|5|||
47029101|NCT01973569|83278894|FG002|Overall Study|Invasive dental treatment|6|||
47029102|NCT01973569|83278892|FG000|Overall Study|Prohibited concomitant d|1|||
47029103|NCT01973569|83278893|FG001|Overall Study|Prohibited concomitant d|5|||
47029104|NCT01973569|83278894|FG002|Overall Study|Prohibited concomitant d|0|||
47029105|NCT01973569|83278892|FG000|Overall Study|Disease progression|0|||
47029106|NCT01973569|83278893|FG001|Overall Study|Disease progression|3|||
47029107|NCT01973569|83278894|FG002|Overall Study|Disease progression|0|||
47029108|NCT01973569|83278892|FG000|Overall Study|Other|1|||
47029109|NCT01973569|83278893|FG001|Overall Study|Other|1|||
47029110|NCT01973569|83278894|FG002|Overall Study|Other|0|||
47029111|NCT01973569|83278892|FG000|Overall Study|Did not receive study drug|6|||
47029112|NCT01973569|83278893|FG001|Overall Study|Did not receive study drug|3|||
47029113|NCT01973569|83278894|FG002|Overall Study|Did not receive study drug|3|||
47029114|NCT01973491|83278902|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
47029115|NCT01973491|83278902|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
47029116|NCT01973491|83278902|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
47029117|NCT01951586|83278908|FG000|Overall Study|Death|61|||
46626361|NCT02128932|82797023|FG002|Overall Study|No reason for withdrawal|7|||
46626362|NCT02128542|82797033|FG000|Overall Study|Lost to Follow-up|3|||
46626363|NCT02128542|82797034|FG001|Overall Study|Lost to Follow-up|0|||
46626364|NCT02128542|82797033|FG000|Overall Study|Withdrew Consent|1|||
46626365|NCT02128542|82797034|FG001|Overall Study|Withdrew Consent|0|||
46626366|NCT02127372|82797044|FG000|Overall Study|Withdrawal by Subject|1|||
46626367|NCT02127372|82797045|FG001|Overall Study|Withdrawal by Subject|0|||
46710367|NCT00960063|82926484|FG000|Overall Study|Adverse Event|1|||
47029118|NCT01951586|83278909|FG001|Overall Study|Death|120|||
47029119|NCT01951586|83278908|FG000|Overall Study|Withdrawal by Subject|8|||
47029120|NCT01951586|83278909|FG001|Overall Study|Withdrawal by Subject|17|||
46626368|NCT02126826|82797059|FG000|Overall Study|Withdrawal by Subject|0|||
46626369|NCT02126826|82797060|FG001|Overall Study|Withdrawal by Subject|0|||
46626370|NCT02126826|82797061|FG002|Overall Study|Withdrawal by Subject|0|||
47029121|NCT01951586|83278908|FG000|Overall Study|Lost to Follow-up|0|||
47029122|NCT01951586|83278909|FG001|Overall Study|Lost to Follow-up|1|||
47029123|NCT01951586|83278908|FG000|Overall Study|Sponsor Decision|9|||
47029124|NCT01951586|83278909|FG001|Overall Study|Sponsor Decision|10|||
47029125|NCT01785849|83278918|FG000|Overall Study|Death|7|||
47029126|NCT01785849|83278919|FG001|Overall Study|Death|9|||
47029127|NCT01785849|83278918|FG000|Overall Study|Protocol Specified Criteria|29|||
47029128|NCT01785849|83278919|FG001|Overall Study|Protocol Specified Criteria|1|||
47029129|NCT01785849|83278918|FG000|Overall Study|Withdrawal by Subject|15|||
47029130|NCT01785849|83278919|FG001|Overall Study|Withdrawal by Subject|12|||
47029131|NCT01785849|83278918|FG000|Overall Study|Sponsor Decision|0|||
47029132|NCT01785849|83278919|FG001|Overall Study|Sponsor Decision|1|||
47029133|NCT01785849|83278918|FG000|Overall Study|Lost to Follow-up|10|||
47029134|NCT01785849|83278919|FG001|Overall Study|Lost to Follow-up|11|||
47029135|NCT01756833|83278927|FG000|Overall Study|Withdrawal by Subject|4|||
47029136|NCT01756833|83278928|FG001|Overall Study|Withdrawal by Subject|3|||
47029137|NCT01617967|83278940|FG000|Overall Study|Protocol Violation|0|||
47029138|NCT01617967|83278941|FG001|Overall Study|Protocol Violation|0|||
47029139|NCT01617967|83278942|FG002|Overall Study|Protocol Violation|0|||
47029140|NCT01617967|83278943|FG003|Overall Study|Protocol Violation|1|||
47029141|NCT01617967|83278944|FG004|Overall Study|Protocol Violation|0|||
47029142|NCT01617967|83278945|FG005|Overall Study|Protocol Violation|0|||
47029143|NCT01617967|83278940|FG000|Overall Study|Withdrawal by Subject|0|||
47029144|NCT01617967|83278941|FG001|Overall Study|Withdrawal by Subject|0|||
47029145|NCT01617967|83278942|FG002|Overall Study|Withdrawal by Subject|0|||
47029146|NCT01617967|83278943|FG003|Overall Study|Withdrawal by Subject|0|||
47029147|NCT01617967|83278944|FG004|Overall Study|Withdrawal by Subject|0|||
47029148|NCT01617967|83278945|FG005|Overall Study|Withdrawal by Subject|1|||
47029149|NCT01617967|83278940|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
47029150|NCT01617967|83278941|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
47029151|NCT01617967|83278942|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
47029152|NCT01617967|83278943|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
47029153|NCT01617967|83278944|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
47029154|NCT01617967|83278945|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
47029155|NCT01785615|83278963|FG000|Dietary Phase|Lost to Follow-up|0|||
47029156|NCT01785615|83278964|FG001|Dietary Phase|Lost to Follow-up|0|||
47029157|NCT01785615|83278965|FG002|Dietary Phase|Lost to Follow-up|0|||
47029158|NCT01785615|83278966|FG003|Dietary Phase|Lost to Follow-up|24|||
47029159|NCT01913041|83278978|FG000|Overall Study|Protocol Violation|35|||
47029160|NCT01913041|83278978|FG000|Overall Study|Withdrawal by Subject|3|||
47029161|NCT01913041|83278978|FG000|Overall Study|Physician Decision|1|||
47029162|NCT01756053|83278982|FG000|Period 1 (10 Days)|Protocol Violation|1|||
46710368|NCT00960063|82926485|FG001|Overall Study|Adverse Event|0|||
46710369|NCT00960063|82926486|FG002|Overall Study|Adverse Event|0|||
46710370|NCT00960063|82926484|FG000|Overall Study|Progression of Disease|0|||
47029163|NCT01756053|83278983|FG001|Period 1 (10 Days)|Protocol Violation|1|||
47029164|NCT01756053|83278982|FG000|Period 2 (10 Days)|Protocol Violation|0|||
47029165|NCT01756053|83278983|FG001|Period 2 (10 Days)|Protocol Violation|2|||
47029166|NCT01785069|83278993|FG000|Overall Study|Implanted with nonstudy device|1|||
47029167|NCT01785069|83278994|FG001|Overall Study|Implanted with nonstudy device|2|||
47029168|NCT01785069|83278995|FG002|Overall Study|Implanted with nonstudy device|1|||
47029169|NCT01785069|83278996|FG003|Overall Study|Implanted with nonstudy device|0|||
47029170|NCT01785069|83278993|FG000|Overall Study|Death|0|||
47029171|NCT01785069|83278994|FG001|Overall Study|Death|0|||
47029172|NCT01785069|83278995|FG002|Overall Study|Death|2|||
47029173|NCT01785069|83278996|FG003|Overall Study|Death|0|||
47029174|NCT01785069|83278993|FG000|Overall Study|Subject choice|2|||
47029175|NCT01785069|83278994|FG001|Overall Study|Subject choice|2|||
47029176|NCT01785069|83278995|FG002|Overall Study|Subject choice|0|||
46626371|NCT02126826|82797062|FG003|Overall Study|Withdrawal by Subject|1|||
46626372|NCT02126826|82797063|FG004|Overall Study|Withdrawal by Subject|0|||
46626373|NCT02126826|82797064|FG005|Overall Study|Withdrawal by Subject|0|||
46626374|NCT02126826|82797065|FG006|Overall Study|Withdrawal by Subject|0|||
47029177|NCT01785069|83278996|FG003|Overall Study|Subject choice|1|||
47029178|NCT01785069|83278993|FG000|Overall Study|Lost to Follow-up|1|||
47029179|NCT01785069|83278994|FG001|Overall Study|Lost to Follow-up|2|||
47029180|NCT01785069|83278995|FG002|Overall Study|Lost to Follow-up|4|||
47029181|NCT01785069|83278996|FG003|Overall Study|Lost to Follow-up|1|||
47029182|NCT01785069|83278993|FG000|Overall Study|Reason not Specified|1|||
47029183|NCT01785069|83278994|FG001|Overall Study|Reason not Specified|2|||
47029184|NCT01785069|83278995|FG002|Overall Study|Reason not Specified|1|||
47029185|NCT01785069|83278996|FG003|Overall Study|Reason not Specified|4|||
47029186|NCT01785069|83278993|FG000|Overall Study|Not evaluable|7|||
47029187|NCT01785069|83278994|FG001|Overall Study|Not evaluable|4|||
47029188|NCT01785069|83278995|FG002|Overall Study|Not evaluable|5|||
47029189|NCT01785069|83278996|FG003|Overall Study|Not evaluable|8|||
47029190|NCT01784523|83279008|FG000|Overall Study|Study closed early|7|||
47029191|NCT01784523|83279009|FG001|Overall Study|Study closed early|4|||
47029192|NCT01784211|83279017|FG000|Part A (Days 1-15)|Adverse Event|1|||
47029193|NCT01784211|83279018|FG001|Part A (Days 1-15)|Adverse Event|1|||
47029194|NCT01784211|83279019|FG002|Part A (Days 1-15)|Adverse Event|0|||
47029195|NCT01784211|83279020|FG003|Part A (Days 1-15)|Adverse Event|0|||
47029196|NCT01784211|83279021|FG004|Part A (Days 1-15)|Adverse Event|0|||
47029197|NCT01784211|83279022|FG005|Part A (Days 1-15)|Adverse Event|0|||
47029198|NCT01784211|83279017|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
47029199|NCT01784211|83279018|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
47029200|NCT01784211|83279019|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
47029201|NCT01784211|83279020|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
47029202|NCT01784211|83279021|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
47029203|NCT01784211|83279022|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
47029204|NCT01783821|83279036|FG000|Overall Study|Screen Failure|1|||
47029205|NCT01783821|83279037|FG001|Overall Study|Screen Failure|1|||
47029206|NCT01783743|83279045|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
47029207|NCT01783743|83279046|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
47029208|NCT01783743|83279045|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
47029209|NCT01783743|83279046|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
47029210|NCT01783743|83279045|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
46626375|NCT02126670|82797090|FG000|Overall Study|Withdrawal by Subject|1|||
46626376|NCT02126670|82797091|FG001|Overall Study|Withdrawal by Subject|0|||
47029211|NCT01783743|83279046|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
47029212|NCT01608321|83279054|FG000|Overall Study|Withdrawal by Subject|1|||
47029213|NCT01608321|83279055|FG001|Overall Study|Withdrawal by Subject|0|||
47029214|NCT01608087|83279064|FG000|Overall Study|Lost to Follow-up|0|||
47029215|NCT01608087|83279065|FG001|Overall Study|Lost to Follow-up|1|||
46626377|NCT02126670|82797092|FG002|Overall Study|Withdrawal by Subject|0|||
46626378|NCT02126670|82797093|FG003|Overall Study|Withdrawal by Subject|1|||
46626379|NCT02125734|82797105|FG000|Period 2|Adverse Event|0|||
46626380|NCT02125734|82797106|FG001|Period 2|Adverse Event|1|||
46626381|NCT02124798|82797112|FG000|Overall Study|Adverse Event|3|||
46626382|NCT02124798|82797112|FG000|Overall Study|Lost to Follow-up|1|||
46626383|NCT02146326|82797120|FG000|Overall Study|Lost to Follow-up|3|||
46626384|NCT02146326|82797121|FG001|Overall Study|Lost to Follow-up|3|||
46626385|NCT02146326|82797122|FG002|Overall Study|Lost to Follow-up|11|||
46626386|NCT02146326|82797123|FG003|Overall Study|Lost to Follow-up|19|||
46626387|NCT02146326|82797120|FG000|Overall Study|Withdrawal by Subject|2|||
47029216|NCT01608087|83279066|FG002|Overall Study|Lost to Follow-up|0|||
47029217|NCT01608087|83279064|FG000|Overall Study|Other Reason|0|||
47029218|NCT01608087|83279065|FG001|Overall Study|Other Reason|1|||
46626388|NCT02146326|82797121|FG001|Overall Study|Withdrawal by Subject|1|||
46626389|NCT02146326|82797122|FG002|Overall Study|Withdrawal by Subject|15|||
46626390|NCT02146326|82797123|FG003|Overall Study|Withdrawal by Subject|11|||
46626391|NCT02146326|82797120|FG000|Overall Study|Separated from mental health center|23|||
46626392|NCT02146326|82797121|FG001|Overall Study|Separated from mental health center|33|||
46626393|NCT02146326|82797122|FG002|Overall Study|Separated from mental health center|0|||
47029219|NCT01608087|83279066|FG002|Overall Study|Other Reason|0|||
47029220|NCT01912963|83279077|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
47029221|NCT01912963|83279078|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
47029222|NCT01912963|83279079|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
47029223|NCT01912963|83279077|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
47029224|NCT01912963|83279078|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
47029225|NCT01912963|83279079|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
47029226|NCT01912963|83279077|FG000|Overall Study|Adverse Event|0|||
47029227|NCT01912963|83279078|FG001|Overall Study|Adverse Event|1|||
47029228|NCT01912963|83279079|FG002|Overall Study|Adverse Event|1|||
47029229|NCT01912963|83279077|FG000|Overall Study|Withdrawal by Subject|0|||
47029230|NCT01912963|83279078|FG001|Overall Study|Withdrawal by Subject|1|||
47029231|NCT01912963|83279079|FG002|Overall Study|Withdrawal by Subject|0|||
47029232|NCT01912963|83279077|FG000|Overall Study|Sought treatment locally|0|||
47029233|NCT01912963|83279078|FG001|Overall Study|Sought treatment locally|1|||
47029234|NCT01912963|83279079|FG002|Overall Study|Sought treatment locally|0|||
47029235|NCT01754727|83279087|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
47029236|NCT01912807|83279093|FG000|Overall Study|Did not meet elegibility criteria|6|||
47029237|NCT01912807|83279094|FG001|Overall Study|Did not meet elegibility criteria|4|||
47029238|NCT01912807|83279093|FG000|Overall Study|Lost to Follow-up|36|||
47029239|NCT01912807|83279094|FG001|Overall Study|Lost to Follow-up|37|||
47029240|NCT01782885|83279102|FG000|Overall Study|Lost to Follow-up|4|||
47029241|NCT01782885|83279103|FG001|Overall Study|Lost to Follow-up|6|||
47029242|NCT01912729|83279111|FG000|Overall Study|Withdrawal by Subject|0|||
47029243|NCT01912729|83279112|FG001|Overall Study|Withdrawal by Subject|1|||
47029244|NCT01754493|83279118|FG000|Overall Study|Adverse Event|1|||
47029245|NCT01754493|83279118|FG000|Overall Study|Lost to Follow-up|3|||
47029246|NCT01754493|83279118|FG000|Overall Study|Withdrawal by Subject|1|||
47029247|NCT01754493|83279118|FG000|Overall Study|Moved out of town|1|||
46626394|NCT02146326|82797123|FG003|Overall Study|Separated from mental health center|0|||
46626395|NCT02146326|82797120|FG000|Overall Study|Incarcerated|0|||
46626396|NCT02146326|82797121|FG001|Overall Study|Incarcerated|0|||
46626397|NCT02146326|82797122|FG002|Overall Study|Incarcerated|3|||
46626398|NCT02146326|82797123|FG003|Overall Study|Incarcerated|8|||
46626399|NCT02146326|82797120|FG000|Overall Study|Death|0|||
46626400|NCT02146326|82797121|FG001|Overall Study|Death|0|||
46626401|NCT02146326|82797122|FG002|Overall Study|Death|4|||
46626402|NCT02146326|82797123|FG003|Overall Study|Death|4|||
46626403|NCT02146326|82797120|FG000|Overall Study|Unable to complete interview|0|||
46626404|NCT02146326|82797121|FG001|Overall Study|Unable to complete interview|0|||
46626405|NCT02146326|82797122|FG002|Overall Study|Unable to complete interview|10|||
46626406|NCT02146326|82797123|FG003|Overall Study|Unable to complete interview|6|||
46626407|NCT02146248|82797139|FG000|Overall Study|Withdrawal by Subject|2|||
46626408|NCT02145468|82797149|FG000|Overall Study|Withdrawal by Subject|5|||
46912529|NCT03000348|83142549|FG005|Overall Study|Lost to Follow-up|0|||
47029248|NCT01754493|83279118|FG000|Overall Study|Scheduling conflict|1|||
47029249|NCT01972789|83279124|FG000|Overall Study|Adverse Event|11|||
46626409|NCT02145468|82797150|FG001|Overall Study|Withdrawal by Subject|8|||
47029250|NCT01972789|83279125|FG001|Overall Study|Adverse Event|4|||
47029251|NCT01972789|83279124|FG000|Overall Study|Subject withdrew consent|14|||
47029252|NCT01972789|83279125|FG001|Overall Study|Subject withdrew consent|12|||
47029253|NCT01972789|83279124|FG000|Overall Study|Lost to Follow-up|4|||
46626410|NCT02124564|82797156|FG000|Treatment Period|Adverse Event|2|||
46626411|NCT02124564|82797156|FG000|Treatment Period|Lack of Efficacy|3|||
46626412|NCT02124564|82797156|FG000|Treatment Period|Withdrawal by Subject|2|||
46626413|NCT02145390|82797161|FG000|Overall Study|Withdrawal by Subject|1|||
46626414|NCT02100696|82797171|FG000|Induction Phase|Adverse Event|0|||
47029254|NCT01972789|83279125|FG001|Overall Study|Lost to Follow-up|7|||
47029255|NCT01972789|83279124|FG000|Overall Study|Death|7|||
47029256|NCT01972789|83279125|FG001|Overall Study|Death|5|||
47029257|NCT01972789|83279124|FG000|Overall Study|Protocol deviation|1|||
47029258|NCT01972789|83279125|FG001|Overall Study|Protocol deviation|0|||
47029259|NCT01972789|83279124|FG000|Overall Study|Physician Decision|3|||
47029260|NCT01972789|83279125|FG001|Overall Study|Physician Decision|2|||
47029261|NCT01934335|83279133|FG000|Overall Study|Withdrawal by Subject|1|||
47029262|NCT01934335|83279134|FG001|Overall Study|Withdrawal by Subject|1|||
47029263|NCT01912339|83279142|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
47029264|NCT01912339|83279143|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
47029265|NCT01912339|83279144|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
47029266|NCT01912339|83279142|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
47029267|NCT01912339|83279143|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
47029268|NCT01912339|83279144|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
47029269|NCT01912339|83279142|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
47029270|NCT01912339|83279143|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
47029271|NCT01912339|83279144|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
47029272|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
47029273|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
47029274|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
47029275|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
47029276|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
47029277|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
47029278|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
47029279|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
47029280|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
47029281|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
47029282|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
47029283|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
47029284|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
47029285|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
47029286|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
47029287|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
47029288|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
47029289|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
47029290|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
47029291|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
46626415|NCT02100696|82797172|FG001|Induction Phase|Adverse Event|0|||
46626416|NCT02100696|82797173|FG002|Induction Phase|Adverse Event|1|||
46626417|NCT02100696|82797174|FG003|Induction Phase|Adverse Event|0|||
46626418|NCT02100696|82797175|FG004|Induction Phase|Adverse Event|0|||
46626419|NCT02100696|82797176|FG005|Induction Phase|Adverse Event|0|||
46626420|NCT02100696|82797171|FG000|Induction Phase|Lost to Follow-up|1|||
46626421|NCT02100696|82797172|FG001|Induction Phase|Lost to Follow-up|0|||
46626422|NCT02100696|82797173|FG002|Induction Phase|Lost to Follow-up|1|||
46626423|NCT02100696|82797174|FG003|Induction Phase|Lost to Follow-up|0|||
46626424|NCT02100696|82797175|FG004|Induction Phase|Lost to Follow-up|0|||
46912530|NCT03000348|83142544|FG000|Overall Study|Withdrawal by Subject|0|||
46912531|NCT03000348|83142545|FG001|Overall Study|Withdrawal by Subject|1|||
46912532|NCT03000348|83142546|FG002|Overall Study|Withdrawal by Subject|0|||
46912533|NCT03000348|83142547|FG003|Overall Study|Withdrawal by Subject|0|||
46912534|NCT03000348|83142548|FG004|Overall Study|Withdrawal by Subject|0|||
46912535|NCT03000348|83142549|FG005|Overall Study|Withdrawal by Subject|0|||
46912536|NCT03000348|83142544|FG000|Overall Study|Consent|0|||
46912537|NCT03000348|83142545|FG001|Overall Study|Consent|0|||
46912538|NCT03000348|83142546|FG002|Overall Study|Consent|0|||
46912539|NCT03000348|83142547|FG003|Overall Study|Consent|0|||
46912540|NCT03000348|83142548|FG004|Overall Study|Consent|1|||
46912541|NCT03000348|83142549|FG005|Overall Study|Consent|0|||
46912542|NCT03000348|83142544|FG000|Overall Study|Failure to expectorate sputum|1|||
46912543|NCT03000348|83142545|FG001|Overall Study|Failure to expectorate sputum|0|||
46912544|NCT03000348|83142546|FG002|Overall Study|Failure to expectorate sputum|1|||
46912545|NCT03000348|83142547|FG003|Overall Study|Failure to expectorate sputum|0|||
46912546|NCT03000348|83142548|FG004|Overall Study|Failure to expectorate sputum|1|||
46912547|NCT03000348|83142549|FG005|Overall Study|Failure to expectorate sputum|0|||
46912548|NCT03000348|83142544|FG000|Overall Study|No gram negative|1|||
46912549|NCT03000348|83142545|FG001|Overall Study|No gram negative|2|||
46912550|NCT03000348|83142546|FG002|Overall Study|No gram negative|1|||
46626425|NCT02100696|82797176|FG005|Induction Phase|Lost to Follow-up|0|||
46626426|NCT02100696|82797171|FG000|Induction Phase|Protocol Violation|0|||
46912551|NCT03000348|83142547|FG003|Overall Study|No gram negative|1|||
46912552|NCT03000348|83142548|FG004|Overall Study|No gram negative|1|||
47029292|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
47029293|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
47029294|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
47029295|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
47029296|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
47029297|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
47029298|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
47029299|NCT01912339|83279142|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
47029300|NCT01912339|83279143|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
47029301|NCT01912339|83279144|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
47029302|NCT01911793|83279152|FG000|Overall Study|Physician Decision|1|||
47029303|NCT01911793|83279153|FG001|Overall Study|Physician Decision|5|||
47029304|NCT01933789|83279168|FG000|Overall Study|Death|0|||
47029305|NCT01933789|83279169|FG001|Overall Study|Death|0|||
47029306|NCT01933789|83279170|FG002|Overall Study|Death|0|||
47029307|NCT01933789|83279171|FG003|Overall Study|Death|0|||
47029308|NCT01933789|83279172|FG004|Overall Study|Death|21|||
47029309|NCT01933789|83279173|FG005|Overall Study|Death|32|||
47029310|NCT01933789|83279174|FG006|Overall Study|Death|0|||
47029311|NCT01933789|83279175|FG007|Overall Study|Death|0|||
47029312|NCT01933789|83279176|FG008|Overall Study|Death|0|||
47029313|NCT01933789|83279168|FG000|Overall Study|Lost to Follow-up|0|||
47029314|NCT01933789|83279169|FG001|Overall Study|Lost to Follow-up|0|||
47029315|NCT01933789|83279170|FG002|Overall Study|Lost to Follow-up|0|||
47029316|NCT01933789|83279171|FG003|Overall Study|Lost to Follow-up|1|||
47029317|NCT01933789|83279172|FG004|Overall Study|Lost to Follow-up|8|||
47029318|NCT01933789|83279173|FG005|Overall Study|Lost to Follow-up|9|||
47029319|NCT01933789|83279174|FG006|Overall Study|Lost to Follow-up|1|||
47029320|NCT01933789|83279175|FG007|Overall Study|Lost to Follow-up|4|||
47029321|NCT01933789|83279176|FG008|Overall Study|Lost to Follow-up|0|||
47029322|NCT01933789|83279168|FG000|Overall Study|Withdrawal by Subject|2|||
47029323|NCT01933789|83279169|FG001|Overall Study|Withdrawal by Subject|1|||
47029324|NCT01933789|83279170|FG002|Overall Study|Withdrawal by Subject|0|||
47029325|NCT01933789|83279171|FG003|Overall Study|Withdrawal by Subject|0|||
47029326|NCT01933789|83279172|FG004|Overall Study|Withdrawal by Subject|17|||
47029327|NCT01933789|83279173|FG005|Overall Study|Withdrawal by Subject|16|||
47029328|NCT01933789|83279174|FG006|Overall Study|Withdrawal by Subject|1|||
47029329|NCT01933789|83279175|FG007|Overall Study|Withdrawal by Subject|4|||
47029330|NCT01933789|83279176|FG008|Overall Study|Withdrawal by Subject|0|||
47029331|NCT01933789|83279168|FG000|Overall Study|Became Ineligible|4|||
47029332|NCT01933789|83279169|FG001|Overall Study|Became Ineligible|0|||
47029333|NCT01933789|83279170|FG002|Overall Study|Became Ineligible|0|||
47029334|NCT01933789|83279171|FG003|Overall Study|Became Ineligible|0|||
46626427|NCT02100696|82797172|FG001|Induction Phase|Protocol Violation|1|||
46626428|NCT02100696|82797173|FG002|Induction Phase|Protocol Violation|1|||
46626429|NCT02100696|82797174|FG003|Induction Phase|Protocol Violation|0|||
46626430|NCT02100696|82797175|FG004|Induction Phase|Protocol Violation|0|||
46626431|NCT02100696|82797176|FG005|Induction Phase|Protocol Violation|0|||
46626432|NCT02100696|82797171|FG000|Induction Phase|Withdrawal by Subject|8|||
46626433|NCT02100696|82797172|FG001|Induction Phase|Withdrawal by Subject|2|||
46626434|NCT02100696|82797173|FG002|Induction Phase|Withdrawal by Subject|13|||
46626435|NCT02100696|82797174|FG003|Induction Phase|Withdrawal by Subject|0|||
46626436|NCT02100696|82797175|FG004|Induction Phase|Withdrawal by Subject|0|||
46626437|NCT02100696|82797176|FG005|Induction Phase|Withdrawal by Subject|0|||
46626438|NCT02100696|82797171|FG000|Induction Phase|Physician Decision|1|||
46626439|NCT02100696|82797172|FG001|Induction Phase|Physician Decision|0|||
46626440|NCT02100696|82797173|FG002|Induction Phase|Physician Decision|2|||
46626441|NCT02100696|82797174|FG003|Induction Phase|Physician Decision|0|||
46626442|NCT02100696|82797175|FG004|Induction Phase|Physician Decision|0|||
47029335|NCT01933789|83279172|FG004|Overall Study|Became Ineligible|13|||
47029336|NCT01933789|83279173|FG005|Overall Study|Became Ineligible|10|||
47029337|NCT01933789|83279174|FG006|Overall Study|Became Ineligible|13|||
47029338|NCT01933789|83279175|FG007|Overall Study|Became Ineligible|6|||
47029339|NCT01933789|83279176|FG008|Overall Study|Became Ineligible|0|||
47029340|NCT01910389|83279198|FG000|Overall Study|Withdrawal by Subject|2|||
47029341|NCT01910389|83279199|FG001|Overall Study|Withdrawal by Subject|0|||
47029342|NCT01910389|83279198|FG000|Overall Study|Study Closed|13|||
47029343|NCT01910389|83279199|FG001|Overall Study|Study Closed|8|||
47029344|NCT01970995|83279208|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
47029345|NCT01970995|83279209|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
47029346|NCT01970995|83279210|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
47029347|NCT01970995|83279208|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
47029348|NCT01970995|83279209|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
46626443|NCT02100696|82797176|FG005|Induction Phase|Physician Decision|0|||
47029349|NCT01970995|83279210|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
46626444|NCT02100696|82797171|FG000|Induction Phase|Multiple Reasons|5|||
47029350|NCT01970527|83279220|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
47029351|NCT01970527|83279221|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
47029352|NCT01970527|83279220|FG000|Treatment|Disease progression|0|||
47029353|NCT01970527|83279221|FG001|Treatment|Disease progression|1|||
47029354|NCT01970527|83279220|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
46912553|NCT03000348|83142549|FG005|Overall Study|No gram negative|1|||
46912554|NCT03000348|83142544|FG000|Overall Study|Patient had no transport|0|||
46912555|NCT03000348|83142545|FG001|Overall Study|Patient had no transport|0|||
46912556|NCT03000348|83142546|FG002|Overall Study|Patient had no transport|0|||
46912557|NCT03000348|83142547|FG003|Overall Study|Patient had no transport|1|||
46912558|NCT03000348|83142548|FG004|Overall Study|Patient had no transport|0|||
47029355|NCT01970527|83279221|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
47029356|NCT01970527|83279220|FG000|Treatment|Death|0|||
47029357|NCT01970527|83279221|FG001|Treatment|Death|1|||
47029358|NCT01970527|83279220|FG000|Follow-up Clinic Visit|Disease progression|1|||
47029359|NCT01970527|83279221|FG001|Follow-up Clinic Visit|Disease progression|1|||
47029360|NCT01970527|83279220|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
47029361|NCT01970527|83279221|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
47029362|NCT01970527|83279220|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
47029363|NCT01970527|83279221|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
47029364|NCT01931995|83279232|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
47029365|NCT01931995|83279233|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
47029366|NCT01931995|83279232|FG000|First Intervention (1 Day)|Physician Decision|1|||
47029367|NCT01931995|83279233|FG001|First Intervention (1 Day)|Physician Decision|1|||
47029368|NCT01931995|83279232|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
47029369|NCT01931995|83279233|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
47029370|NCT01408576|83279242|FG000|Overall Study|Lack of Efficacy|17|||
47029371|NCT01408576|83279243|FG001|Overall Study|Lack of Efficacy|30|||
47029372|NCT01408576|83279244|FG002|Overall Study|Lack of Efficacy|48|||
47029373|NCT01408576|83279242|FG000|Overall Study|Protocol Violation|1|||
47029374|NCT01408576|83279243|FG001|Overall Study|Protocol Violation|2|||
47029375|NCT01408576|83279244|FG002|Overall Study|Protocol Violation|2|||
47029376|NCT01408576|83279242|FG000|Overall Study|Lost to Follow-up|10|||
47029377|NCT01408576|83279243|FG001|Overall Study|Lost to Follow-up|9|||
47029378|NCT01408576|83279244|FG002|Overall Study|Lost to Follow-up|17|||
47029379|NCT01408576|83279242|FG000|Overall Study|Withdrawal by Subject|34|||
47029380|NCT01408576|83279243|FG001|Overall Study|Withdrawal by Subject|60|||
47029381|NCT01408576|83279244|FG002|Overall Study|Withdrawal by Subject|66|||
47029382|NCT01408576|83279242|FG000|Overall Study|Sponsor terminated study|89|||
46626445|NCT02100696|82797172|FG001|Induction Phase|Multiple Reasons|2|||
46626446|NCT02100696|82797173|FG002|Induction Phase|Multiple Reasons|8|||
46912559|NCT03000348|83142549|FG005|Overall Study|Patient had no transport|0|||
47029383|NCT01408576|83279243|FG001|Overall Study|Sponsor terminated study|333|||
47029384|NCT01408576|83279244|FG002|Overall Study|Sponsor terminated study|330|||
47029385|NCT01408576|83279242|FG000|Overall Study|AE, serious fatal|4|||
47029386|NCT01408576|83279243|FG001|Overall Study|AE, serious fatal|4|||
47029387|NCT01408576|83279244|FG002|Overall Study|AE, serious fatal|1|||
47029388|NCT01408576|83279242|FG000|Overall Study|SAE, non-fatal|11|||
47029389|NCT01408576|83279243|FG001|Overall Study|SAE, non-fatal|23|||
47029390|NCT01408576|83279244|FG002|Overall Study|SAE, non-fatal|14|||
47029391|NCT01408576|83279242|FG000|Overall Study|AE, non-serious non-fatal|12|||
47029392|NCT01408576|83279243|FG001|Overall Study|AE, non-serious non-fatal|19|||
47029393|NCT01408576|83279244|FG002|Overall Study|AE, non-serious non-fatal|11|||
47029394|NCT01408576|83279242|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
47029395|NCT01408576|83279243|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
47029396|NCT01408576|83279244|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
47029397|NCT01408576|83279242|FG000|Overall Study|AE, unknown type|0|||
47029398|NCT01408576|83279243|FG001|Overall Study|AE, unknown type|1|||
47029399|NCT01408576|83279244|FG002|Overall Study|AE, unknown type|0|||
47029400|NCT01408576|83279242|FG000|Overall Study|Other|10|||
47029401|NCT01408576|83279243|FG001|Overall Study|Other|16|||
47029402|NCT01408576|83279244|FG002|Overall Study|Other|18|||
47029403|NCT01427920|83279266|FG000|Overall Study|Adverse Event|1|||
47029404|NCT01427920|83279267|FG001|Overall Study|Adverse Event|2|||
46912560|NCT03000348|83142544|FG000|Overall Study|Dosing|0|||
46912561|NCT03000348|83142545|FG001|Overall Study|Dosing|0|||
46912562|NCT03000348|83142546|FG002|Overall Study|Dosing|0|||
46912563|NCT03000348|83142547|FG003|Overall Study|Dosing|0|||
46912564|NCT03000348|83142548|FG004|Overall Study|Dosing|1|||
46912565|NCT03000348|83142549|FG005|Overall Study|Dosing|0|||
46912566|NCT03283709|83142568|FG000|Overall Study|trial terminated|0|||
46912567|NCT03283709|83142569|FG001|Overall Study|trial terminated|1|||
46912568|NCT03247673|83142578|FG000|Overall Study|Withdrawal by Subject|1|||
46912569|NCT03247673|83142579|FG001|Overall Study|Withdrawal by Subject|0|||
46912570|NCT03247673|83142580|FG002|Overall Study|Withdrawal by Subject|3|||
47029405|NCT01427920|83279266|FG000|Overall Study|Lack of Efficacy|1|||
46626447|NCT02100696|82797174|FG003|Induction Phase|Multiple Reasons|0|||
46626448|NCT02100696|82797175|FG004|Induction Phase|Multiple Reasons|0|||
46626449|NCT02100696|82797176|FG005|Induction Phase|Multiple Reasons|0|||
46626450|NCT02100696|82797171|FG000|Maintenance Phase|Adverse Event|0|||
46626451|NCT02100696|82797172|FG001|Maintenance Phase|Adverse Event|0|||
46626452|NCT02100696|82797173|FG002|Maintenance Phase|Adverse Event|0|||
46912571|NCT03247673|83142578|FG000|Overall Study|Lost to Follow-up|0|||
46912572|NCT03247673|83142579|FG001|Overall Study|Lost to Follow-up|0|||
46912573|NCT03247673|83142580|FG002|Overall Study|Lost to Follow-up|1|||
46912574|NCT03247517|83142591|FG000|Overall Study|Adverse Event|0|||
46912575|NCT03247517|83142592|FG001|Overall Study|Adverse Event|4|||
46912576|NCT03247517|83142593|FG002|Overall Study|Adverse Event|2|||
46912577|NCT03247517|83142591|FG000|Overall Study|Lost to Follow-up|2|||
46912578|NCT03247517|83142592|FG001|Overall Study|Lost to Follow-up|6|||
46912579|NCT03247517|83142593|FG002|Overall Study|Lost to Follow-up|4|||
46912580|NCT03247517|83142591|FG000|Overall Study|Consent withdrawn by caregiver|1|||
47029406|NCT01427920|83279267|FG001|Overall Study|Lack of Efficacy|0|||
47029407|NCT01427920|83279266|FG000|Overall Study|Protocol Violation|1|||
47029408|NCT01427920|83279267|FG001|Overall Study|Protocol Violation|3|||
47029409|NCT01427920|83279266|FG000|Overall Study|Withdrawal Criteria|4|||
47029410|NCT01427920|83279267|FG001|Overall Study|Withdrawal Criteria|4|||
47029411|NCT01427920|83279266|FG000|Overall Study|Unclassified|2|||
47029412|NCT01427920|83279267|FG001|Overall Study|Unclassified|8|||
47029413|NCT01427608|83279275|FG000|Overall Study|Death|1|||
47029414|NCT01427608|83279276|FG001|Overall Study|Death|0|||
47029415|NCT01427608|83279275|FG000|Overall Study|Withdrawal by Subject|7|||
47029416|NCT01427608|83279276|FG001|Overall Study|Withdrawal by Subject|3|||
47029417|NCT01427608|83279275|FG000|Overall Study|Relapsed-all cause|13|||
47029418|NCT01427608|83279276|FG001|Overall Study|Relapsed-all cause|34|||
47029419|NCT01427608|83279275|FG000|Overall Study|Events not attributed to study meds|0|||
47029420|NCT01427608|83279276|FG001|Overall Study|Events not attributed to study meds|1|||
47029421|NCT01408030|83279288|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
47029422|NCT01408030|83279289|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
47029423|NCT01408030|83279290|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
47029424|NCT01408030|83279291|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
47029425|NCT01408030|83279288|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
47029426|NCT01408030|83279289|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
47029427|NCT01408030|83279290|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
46912581|NCT03247517|83142592|FG001|Overall Study|Consent withdrawn by caregiver|4|||
46912582|NCT03247517|83142593|FG002|Overall Study|Consent withdrawn by caregiver|7|||
46912583|NCT03247517|83142591|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
46912584|NCT03247517|83142592|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
46912585|NCT03247517|83142593|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
46912586|NCT03247517|83142591|FG000|Overall Study|Protocol Violation|0|||
46912587|NCT03247517|83142592|FG001|Overall Study|Protocol Violation|2|||
46912588|NCT03247517|83142593|FG002|Overall Study|Protocol Violation|0|||
46912589|NCT03247517|83142591|FG000|Overall Study|Multiple reasons|3|||
46912590|NCT03247517|83142592|FG001|Overall Study|Multiple reasons|1|||
46912591|NCT03247517|83142593|FG002|Overall Study|Multiple reasons|0|||
46912592|NCT03283553|83142603|FG000|Patient Participant Flow|Death|5|||
46912593|NCT03283553|83142604|FG001|Patient Participant Flow|Death|10|||
46912594|NCT03283553|83142603|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
46912595|NCT03283553|83142604|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
46912596|NCT03283553|83142603|FG000|Patient Participant Flow|Lost to Follow-up|1|||
46912597|NCT03283553|83142604|FG001|Patient Participant Flow|Lost to Follow-up|1|||
46912598|NCT03283553|83142603|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
46912599|NCT03283553|83142604|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
46912600|NCT03283553|83142603|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
46912601|NCT03283553|83142604|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
46912602|NCT03283553|83142603|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
46912603|NCT03283553|83142604|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
46912604|NCT03283319|83142618|FG000|Overall Study|Lost to Follow-up|5|||
47029428|NCT01408030|83279291|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
47029429|NCT01408030|83279288|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
47029430|NCT01408030|83279289|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
46626453|NCT02100696|82797174|FG003|Maintenance Phase|Adverse Event|0|||
46626454|NCT02100696|82797175|FG004|Maintenance Phase|Adverse Event|0|||
46912605|NCT03283319|83142619|FG001|Overall Study|Lost to Follow-up|4|||
46912606|NCT03283319|83142620|FG002|Overall Study|Lost to Follow-up|5|||
47029431|NCT01408030|83279290|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
47029432|NCT01408030|83279291|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
47029433|NCT01408030|83279288|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
46626455|NCT02100696|82797176|FG005|Maintenance Phase|Adverse Event|2|||
46912607|NCT03283319|83142621|FG003|Overall Study|Lost to Follow-up|5|||
46912608|NCT03283319|83142622|FG004|Overall Study|Lost to Follow-up|4|||
46710371|NCT00960063|82926485|FG001|Overall Study|Progression of Disease|0|||
46710372|NCT00960063|82926486|FG002|Overall Study|Progression of Disease|3|||
46710373|NCT00959907|82926496|FG000|Overall Study|Protocol Violation|0|||
46710374|NCT00959907|82926497|FG001|Overall Study|Protocol Violation|1|||
46710375|NCT00959907|82926496|FG000|Overall Study|Adverse Event|1|||
46710376|NCT00959907|82926497|FG001|Overall Study|Adverse Event|0|||
46710377|NCT00959907|82926496|FG000|Overall Study|Withdrawal by Subject|2|||
46710378|NCT00959907|82926497|FG001|Overall Study|Withdrawal by Subject|0|||
46710379|NCT00912340|82926506|FG000|Overall Study|Adverse Event|2|||
46710380|NCT00912340|82926507|FG001|Overall Study|Adverse Event|4|||
46710381|NCT00912340|82926508|FG002|Overall Study|Adverse Event|0|||
46710382|NCT00912340|82926506|FG000|Overall Study|Protocol revised to remove arm|0|||
46710383|NCT00912340|82926507|FG001|Overall Study|Protocol revised to remove arm|0|||
46710384|NCT00912340|82926508|FG002|Overall Study|Protocol revised to remove arm|4|||
46710385|NCT01167257|82926518|FG000|Overall Study|Lost to Follow-up|2|||
46710386|NCT01167257|82926519|FG001|Overall Study|Lost to Follow-up|2|||
46710387|NCT01167257|82926518|FG000|Overall Study|Withdrew consent|1|||
46710388|NCT01167257|82926519|FG001|Overall Study|Withdrew consent|1|||
46710389|NCT01119846|82926532|FG000|Overall Study|Adverse Event|1|||
46710390|NCT01119846|82926533|FG001|Overall Study|Adverse Event|0|||
46710391|NCT01119846|82926534|FG002|Overall Study|Adverse Event|6|||
46710392|NCT01119846|82926532|FG000|Overall Study|Physician Decision|1|||
46710393|NCT01119846|82926533|FG001|Overall Study|Physician Decision|0|||
46710394|NCT01119846|82926534|FG002|Overall Study|Physician Decision|0|||
46710395|NCT01119846|82926532|FG000|Overall Study|Protocol Violation|0|||
46710396|NCT01119846|82926533|FG001|Overall Study|Protocol Violation|0|||
46710397|NCT01119846|82926534|FG002|Overall Study|Protocol Violation|1|||
46710398|NCT01119846|82926532|FG000|Overall Study|Withdrawal by Subject|0|||
46710399|NCT01119846|82926533|FG001|Overall Study|Withdrawal by Subject|0|||
46710400|NCT01119846|82926534|FG002|Overall Study|Withdrawal by Subject|4|||
46710401|NCT01167179|82926571|FG000|Overall Study|disease recurrence|4|||
46710402|NCT01167179|82926572|FG001|Overall Study|disease recurrence|4|||
46710403|NCT01167179|82926571|FG000|Overall Study|Death|4|||
46710404|NCT01167179|82926572|FG001|Overall Study|Death|10|||
46710405|NCT01167179|82926571|FG000|Overall Study|Withdrawal by Subject|1|||
46710406|NCT01167179|82926572|FG001|Overall Study|Withdrawal by Subject|2|||
46710407|NCT01167179|82926571|FG000|Overall Study|diverse|6|||
46710408|NCT01167179|82926572|FG001|Overall Study|diverse|5|||
46710409|NCT01167023|82926645|FG000|Overall Study|Lost to Follow-up|0|||
46710410|NCT01167023|82926646|FG001|Overall Study|Lost to Follow-up|1|||
46710411|NCT01167023|82926647|FG002|Overall Study|Lost to Follow-up|1|||
46710412|NCT01167023|82926645|FG000|Overall Study|Screen Failure|0|||
46710413|NCT01167023|82926646|FG001|Overall Study|Screen Failure|1|||
46710414|NCT01167023|82926647|FG002|Overall Study|Screen Failure|0|||
46710415|NCT01167023|82926645|FG000|Overall Study|Sponsor Decision|0|||
46710416|NCT01167023|82926646|FG001|Overall Study|Sponsor Decision|1|||
46710417|NCT01167023|82926647|FG002|Overall Study|Sponsor Decision|0|||
46710418|NCT01167023|82926645|FG000|Overall Study|Withdrawal by Subject|0|||
46710419|NCT01167023|82926646|FG001|Overall Study|Withdrawal by Subject|0|||
46710420|NCT01167023|82926647|FG002|Overall Study|Withdrawal by Subject|1|||
46710421|NCT03484117|82926655|FG000|Overall Study|Lost to Follow-up|1|||
46710422|NCT03484117|82926656|FG001|Overall Study|Lost to Follow-up|3|||
46710423|NCT03484117|82926655|FG000|Overall Study|Declined participation in exit assess|1|||
46710424|NCT03484117|82926656|FG001|Overall Study|Declined participation in exit assess|1|||
46710425|NCT01166945|82926664|FG000|Randomized|diagnosed with Group A strep|4|||
46710426|NCT01166945|82926665|FG001|Randomized|diagnosed with Group A strep|4|||
46710427|NCT01166945|82926664|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
46710428|NCT01166945|82926665|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
46710429|NCT01166945|82926664|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
46710430|NCT01166945|82926665|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
46710431|NCT01166945|82926664|FG000|Day 30|Lost to Follow-up|4|||
46710432|NCT01166945|82926665|FG001|Day 30|Lost to Follow-up|3|||
46710433|NCT00910000|82926679|FG000|Overall Study|Adverse Event|0|||
46710434|NCT00910000|82926680|FG001|Overall Study|Adverse Event|3|||
46710435|NCT00910000|82926681|FG002|Overall Study|Adverse Event|2|||
46710436|NCT00910000|82926682|FG003|Overall Study|Adverse Event|2|||
46710437|NCT00910000|82926683|FG004|Overall Study|Adverse Event|0|||
46710438|NCT00910000|82926684|FG005|Overall Study|Adverse Event|1|||
46710439|NCT00910000|82926679|FG000|Overall Study|Withdrawal by Subject|0|||
46710440|NCT00910000|82926680|FG001|Overall Study|Withdrawal by Subject|0|||
46710441|NCT00910000|82926681|FG002|Overall Study|Withdrawal by Subject|1|||
46710442|NCT00910000|82926682|FG003|Overall Study|Withdrawal by Subject|0|||
46710443|NCT00910000|82926683|FG004|Overall Study|Withdrawal by Subject|1|||
46710444|NCT00910000|82926684|FG005|Overall Study|Withdrawal by Subject|0|||
46710445|NCT01119768|82926705|FG000|Treatment Period|Lack of Efficacy|18|||
46710446|NCT01119768|82926706|FG001|Treatment Period|Lack of Efficacy|25|||
46710447|NCT01165307|82926714|FG000|Overall Study|Lost to Follow-up|11|||
46710448|NCT01165307|82926715|FG001|Overall Study|Lost to Follow-up|3|||
46710449|NCT01165307|82926714|FG000|Overall Study|Withdrawal by Subject|2|||
46710450|NCT01165307|82926715|FG001|Overall Study|Withdrawal by Subject|0|||
46710451|NCT01165307|82926714|FG000|Overall Study|Subject not available for contact|1|||
46710452|NCT01165307|82926715|FG001|Overall Study|Subject not available for contact|0|||
46710453|NCT00960999|82926723|FG000|Overall Study|Withdrawal by Subject|1|||
46710454|NCT00960999|82926724|FG001|Overall Study|Withdrawal by Subject|0|||
46710455|NCT00960999|82926723|FG000|Overall Study|Protocol Violation|5|||
46710456|NCT00960999|82926724|FG001|Overall Study|Protocol Violation|2|||
46710457|NCT00960999|82926723|FG000|Overall Study|RT dose constraints not met|2|||
46710458|NCT00960999|82926724|FG001|Overall Study|RT dose constraints not met|0|||
47029434|NCT01408030|83279289|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
47029435|NCT01408030|83279290|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
47029436|NCT01408030|83279291|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
47029437|NCT01408030|83279288|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
47029438|NCT01408030|83279289|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
47029439|NCT01408030|83279290|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
47029440|NCT01408030|83279291|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
47029441|NCT01408030|83279288|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
47029442|NCT01408030|83279289|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
47029443|NCT01408030|83279290|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
47029444|NCT01408030|83279291|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
47029445|NCT01408030|83279288|FG000|Observation Phase (Off Drug)|Other|1|||
47029446|NCT01408030|83279289|FG001|Observation Phase (Off Drug)|Other|1|||
47029447|NCT01408030|83279290|FG002|Observation Phase (Off Drug)|Other|1|||
47029448|NCT01408030|83279291|FG003|Observation Phase (Off Drug)|Other|1|||
47029449|NCT01897532|83279303|FG000|Discontinuation From Treatment|Not Treated|7|||
47029450|NCT01897532|83279304|FG001|Discontinuation From Treatment|Not Treated|5|||
47029451|NCT01897532|83279303|FG000|Discontinuation From Treatment|Other reason than specified|196|||
47029452|NCT01897532|83279304|FG001|Discontinuation From Treatment|Other reason than specified|176|||
47029453|NCT01897532|83279303|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
47029454|NCT01897532|83279304|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
47029455|NCT01897532|83279303|FG000|Discontinuation From Treatment|Non compliance|24|||
47029456|NCT01897532|83279304|FG001|Discontinuation From Treatment|Non compliance|15|||
47029457|NCT01897532|83279303|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
47029458|NCT01897532|83279304|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
47029459|NCT01897532|83279303|FG000|Discontinuation From Trial|Not Treated|7|||
47029460|NCT01897532|83279304|FG001|Discontinuation From Trial|Not Treated|5|||
47029461|NCT01897532|83279303|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
47029462|NCT01897532|83279304|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
47029463|NCT01923428|83279314|FG000|Overall Study|Adverse Event|8|||
47029464|NCT01923428|83279315|FG001|Overall Study|Adverse Event|6|||
47029465|NCT01923428|83279316|FG002|Overall Study|Adverse Event|3|||
47029466|NCT01923428|83279317|FG003|Overall Study|Adverse Event|3|||
47029467|NCT01923428|83279314|FG000|Overall Study|Withdrawal by Subject|5|||
47029468|NCT01923428|83279315|FG001|Overall Study|Withdrawal by Subject|3|||
47029469|NCT01923428|83279316|FG002|Overall Study|Withdrawal by Subject|0|||
47029470|NCT01923428|83279317|FG003|Overall Study|Withdrawal by Subject|4|||
47029471|NCT01923428|83279314|FG000|Overall Study|Lost to Follow-up|2|||
47029472|NCT01923428|83279315|FG001|Overall Study|Lost to Follow-up|1|||
46626456|NCT02100696|82797171|FG000|Maintenance Phase|Lost to Follow-up|0|||
46626457|NCT02100696|82797172|FG001|Maintenance Phase|Lost to Follow-up|0|||
46626458|NCT02100696|82797173|FG002|Maintenance Phase|Lost to Follow-up|0|||
46626459|NCT02100696|82797174|FG003|Maintenance Phase|Lost to Follow-up|0|||
46626460|NCT02100696|82797175|FG004|Maintenance Phase|Lost to Follow-up|1|||
46626461|NCT02100696|82797176|FG005|Maintenance Phase|Lost to Follow-up|0|||
46626462|NCT02100696|82797171|FG000|Maintenance Phase|Protocol Violation|0|||
46626463|NCT02100696|82797172|FG001|Maintenance Phase|Protocol Violation|0|||
46626464|NCT02100696|82797173|FG002|Maintenance Phase|Protocol Violation|0|||
46626465|NCT02100696|82797174|FG003|Maintenance Phase|Protocol Violation|0|||
46626466|NCT02100696|82797175|FG004|Maintenance Phase|Protocol Violation|1|||
46626467|NCT02100696|82797176|FG005|Maintenance Phase|Protocol Violation|0|||
46626468|NCT02100696|82797171|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46626469|NCT02100696|82797172|FG001|Maintenance Phase|Withdrawal by Subject|0|||
46626470|NCT02100696|82797173|FG002|Maintenance Phase|Withdrawal by Subject|0|||
46626471|NCT02100696|82797174|FG003|Maintenance Phase|Withdrawal by Subject|1|||
46626472|NCT02100696|82797175|FG004|Maintenance Phase|Withdrawal by Subject|4|||
46626473|NCT02100696|82797176|FG005|Maintenance Phase|Withdrawal by Subject|2|||
46626474|NCT02100696|82797171|FG000|Maintenance Phase|Physician Decision|0|||
46626475|NCT02100696|82797172|FG001|Maintenance Phase|Physician Decision|0|||
46626476|NCT02100696|82797173|FG002|Maintenance Phase|Physician Decision|0|||
46626477|NCT02100696|82797174|FG003|Maintenance Phase|Physician Decision|0|||
46626478|NCT02100696|82797175|FG004|Maintenance Phase|Physician Decision|1|||
46626479|NCT02100696|82797176|FG005|Maintenance Phase|Physician Decision|0|||
47029473|NCT01923428|83279316|FG002|Overall Study|Lost to Follow-up|5|||
47029474|NCT01923428|83279317|FG003|Overall Study|Lost to Follow-up|0|||
47029475|NCT01923428|83279314|FG000|Overall Study|Protocol Violation|3|||
47029476|NCT01923428|83279315|FG001|Overall Study|Protocol Violation|0|||
47029477|NCT01923428|83279316|FG002|Overall Study|Protocol Violation|2|||
47029478|NCT01923428|83279317|FG003|Overall Study|Protocol Violation|1|||
47029479|NCT01923428|83279314|FG000|Overall Study|Non Compliance to treatment|1|||
47029480|NCT01923428|83279315|FG001|Overall Study|Non Compliance to treatment|2|||
47029481|NCT01923428|83279316|FG002|Overall Study|Non Compliance to treatment|0|||
47029482|NCT01923428|83279317|FG003|Overall Study|Non Compliance to treatment|1|||
47029483|NCT01923428|83279314|FG000|Overall Study|Lack of Efficacy|0|||
47029484|NCT01923428|83279315|FG001|Overall Study|Lack of Efficacy|0|||
47029485|NCT01923428|83279316|FG002|Overall Study|Lack of Efficacy|1|||
47029486|NCT01923428|83279317|FG003|Overall Study|Lack of Efficacy|1|||
47029487|NCT01896986|83279329|FG000|Overall Study|samples lost|14|||
47029488|NCT01896986|83279330|FG001|Overall Study|samples lost|23|||
47029489|NCT01896128|83279338|FG000|Overall Study|Withdrawal by Subject|3|||
47029490|NCT01896128|83279339|FG001|Overall Study|Withdrawal by Subject|3|||
47029491|NCT01949870|83279345|FG000|Overall Study|Lack of Efficacy|2|||
47029492|NCT01949870|83279345|FG000|Overall Study|Adverse Event|1|||
47029493|NCT01949870|83279345|FG000|Overall Study|Study termination|1|||
47029494|NCT01949870|83279345|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
47029495|NCT01949480|83279351|FG000|Overall Study|Physician Decision|5|||
47029496|NCT01949480|83279352|FG001|Overall Study|Physician Decision|8|||
47029497|NCT01949090|83279363|FG000|Overall Study|Serious Adverse Event|0|||
47029498|NCT01949090|83279364|FG001|Overall Study|Serious Adverse Event|1|||
47029499|NCT01949090|83279365|FG002|Overall Study|Serious Adverse Event|2|||
47029500|NCT01949090|83279366|FG003|Overall Study|Serious Adverse Event|0|||
47029501|NCT01949090|83279367|FG004|Overall Study|Serious Adverse Event|1|||
47029502|NCT01949090|83279363|FG000|Overall Study|Withdrawal by Subject|2|||
47029503|NCT01949090|83279364|FG001|Overall Study|Withdrawal by Subject|0|||
47029504|NCT01949090|83279365|FG002|Overall Study|Withdrawal by Subject|0|||
47029505|NCT01949090|83279366|FG003|Overall Study|Withdrawal by Subject|0|||
47029506|NCT01949090|83279367|FG004|Overall Study|Withdrawal by Subject|1|||
47029507|NCT01949090|83279363|FG000|Overall Study|Protocol non-compliance|0|||
47029508|NCT01949090|83279364|FG001|Overall Study|Protocol non-compliance|0|||
47029509|NCT01949090|83279365|FG002|Overall Study|Protocol non-compliance|0|||
47029510|NCT01949090|83279366|FG003|Overall Study|Protocol non-compliance|0|||
47029511|NCT01949090|83279367|FG004|Overall Study|Protocol non-compliance|1|||
46710459|NCT01124838|82926732|FG000|Overall Study|Miscellaneous|4|||
46710460|NCT01124838|82926733|FG001|Overall Study|Miscellaneous|2|||
46710461|NCT01124838|82926732|FG000|Overall Study|Adverse Event|7|||
46710462|NCT01124838|82926733|FG001|Overall Study|Adverse Event|11|||
46710463|NCT01124838|82926732|FG000|Overall Study|Lack of Efficacy|2|||
46710464|NCT01124838|82926733|FG001|Overall Study|Lack of Efficacy|0|||
46710465|NCT01124838|82926732|FG000|Overall Study|Withdrawal by Subject|3|||
46710466|NCT01124838|82926733|FG001|Overall Study|Withdrawal by Subject|2|||
46710467|NCT01124838|82926732|FG000|Overall Study|Lost to Follow-up|2|||
46710468|NCT01124838|82926733|FG001|Overall Study|Lost to Follow-up|0|||
46710469|NCT00959751|82926743|FG000|Overall Study|Lost to Follow-up|2|||
47029512|NCT01949090|83279363|FG000|Overall Study|Lost to Follow-up|2|||
47029513|NCT01949090|83279364|FG001|Overall Study|Lost to Follow-up|1|||
47029514|NCT01949090|83279365|FG002|Overall Study|Lost to Follow-up|0|||
47029515|NCT01949090|83279366|FG003|Overall Study|Lost to Follow-up|1|||
47029516|NCT01949090|83279367|FG004|Overall Study|Lost to Follow-up|1|||
47029517|NCT01948076|83279382|FG000|Overall Study|Withdrawal by Subject|0|||
47029518|NCT01948076|83279383|FG001|Overall Study|Withdrawal by Subject|1|||
47029519|NCT01922258|83279393|FG000|Overall Study|Lost to Follow-up|1|||
47029520|NCT01922258|83279394|FG001|Overall Study|Lost to Follow-up|1|||
47029521|NCT01922258|83279393|FG000|Overall Study|Adverse Event|9|||
47029522|NCT01922258|83279394|FG001|Overall Study|Adverse Event|2|||
47029523|NCT01922258|83279393|FG000|Overall Study|Met Withdrawal Criteria|0|||
46626480|NCT02100696|82797171|FG000|Maintenance Phase|Multiple Reasons|0|||
46626481|NCT02100696|82797172|FG001|Maintenance Phase|Multiple Reasons|0|||
46626482|NCT02100696|82797173|FG002|Maintenance Phase|Multiple Reasons|0|||
46626483|NCT02100696|82797174|FG003|Maintenance Phase|Multiple Reasons|0|||
46626484|NCT02100696|82797175|FG004|Maintenance Phase|Multiple Reasons|2|||
46626485|NCT02100696|82797176|FG005|Maintenance Phase|Multiple Reasons|1|||
46626486|NCT02145156|82797200|FG000|Overall Study|No match to vaccination records|60|||
46626487|NCT02145156|82797201|FG001|Overall Study|No match to vaccination records|52|||
46626488|NCT02145156|82797202|FG002|Overall Study|No match to vaccination records|41|||
46626489|NCT02123472|82797210|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
46626490|NCT02123472|82797211|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
46626491|NCT02145078|82797217|FG000|Overall Study|Death|1|||
46626492|NCT02145078|82797217|FG000|Overall Study|Reason not given|3|||
46626493|NCT02144610|82797223|FG000|Overall Study|Physician Decision|1|||
46626494|NCT02144610|82797224|FG001|Overall Study|Physician Decision|0|||
46710470|NCT00959751|82926744|FG001|Overall Study|Lost to Follow-up|3|||
46710471|NCT00959751|82926743|FG000|Overall Study|Consent Withdrawn|0|||
46710472|NCT00959751|82926744|FG001|Overall Study|Consent Withdrawn|1|||
46710473|NCT00959751|82926743|FG000|Overall Study|Non-compliance to Study Procedures|0|||
46710474|NCT00959751|82926744|FG001|Overall Study|Non-compliance to Study Procedures|1|||
46710475|NCT00959751|82926743|FG000|Overall Study|No migraine headache without aura|7|||
46710476|NCT00959751|82926744|FG001|Overall Study|No migraine headache without aura|7|||
46710477|NCT00910858|82926753|FG000|Pharmacokinetic Phase|Adverse Event|1|||
46710478|NCT00910858|82926754|FG001|Pharmacokinetic Phase|Adverse Event|0|||
46710479|NCT00910858|82926755|FG002|Pharmacokinetic Phase|Adverse Event|0|||
46710480|NCT00910858|82926753|FG000|Monotherapy Phase|Adverse Event|3|||
46710481|NCT00910858|82926754|FG001|Monotherapy Phase|Adverse Event|2|||
46710482|NCT00910858|82926755|FG002|Monotherapy Phase|Adverse Event|0|||
46710483|NCT00910858|82926753|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
46710484|NCT00910858|82926754|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
46710485|NCT00910858|82926755|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
46710486|NCT00910858|82926753|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
46710487|NCT00910858|82926754|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
46710488|NCT00910858|82926755|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
46710489|NCT00910858|82926753|FG000|Monotherapy Phase|Protocol Violation|1|||
46710490|NCT00910858|82926754|FG001|Monotherapy Phase|Protocol Violation|0|||
46710491|NCT00910858|82926755|FG002|Monotherapy Phase|Protocol Violation|0|||
46710492|NCT00910858|82926753|FG000|Monotherapy Phase|Other|3|||
46710493|NCT00910858|82926754|FG001|Monotherapy Phase|Other|4|||
46710494|NCT00910858|82926755|FG002|Monotherapy Phase|Other|2|||
46710495|NCT00910858|82926753|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
46710496|NCT00910858|82926754|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
46710497|NCT00910858|82926755|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
46710498|NCT00910858|82926753|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
46710499|NCT00910858|82926754|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
46710500|NCT00910858|82926755|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
46710501|NCT00910858|82926753|FG000|Combined Treatment Phase|Protocol Violation|1|||
46710502|NCT00910858|82926754|FG001|Combined Treatment Phase|Protocol Violation|0|||
46710503|NCT00910858|82926755|FG002|Combined Treatment Phase|Protocol Violation|0|||
46710504|NCT00910858|82926753|FG000|Combined Treatment Phase|Other|0|||
46710505|NCT00910858|82926754|FG001|Combined Treatment Phase|Other|2|||
46710506|NCT00910858|82926755|FG002|Combined Treatment Phase|Other|1|||
46710507|NCT00598975|82926773|FG000|Overall Study|Adverse Event|1|||
46710508|NCT00598975|82926774|FG001|Overall Study|Adverse Event|1|||
46710509|NCT00598975|82926773|FG000|Overall Study|Brain metastases|1|||
46710510|NCT00598975|82926774|FG001|Overall Study|Brain metastases|0|||
46710511|NCT00598975|82926773|FG000|Overall Study|Withdrawal by Subject|1|||
46710512|NCT00598975|82926774|FG001|Overall Study|Withdrawal by Subject|1|||
46710513|NCT00598975|82926773|FG000|Overall Study|Withdrawal of consent|0|||
46710514|NCT00598975|82926774|FG001|Overall Study|Withdrawal of consent|1|||
46710515|NCT00598975|82926773|FG000|Overall Study|Disease progression|8|||
46710516|NCT00598975|82926774|FG001|Overall Study|Disease progression|3|||
46710517|NCT00598975|82926773|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
46710518|NCT00598975|82926774|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
46710519|NCT00957021|82926782|FG000|Overall Study|Death|5|||
46710520|NCT00957021|82926782|FG000|Overall Study|Lost to Follow-up|8|||
46710521|NCT00957021|82926782|FG000|Overall Study|Withdrawal by Subject|34|||
47029524|NCT01922258|83279394|FG001|Overall Study|Met Withdrawal Criteria|4|||
47029525|NCT01922258|83279393|FG000|Overall Study|Withdrawn by the Investigator|1|||
46912609|NCT03283319|83142623|FG005|Overall Study|Lost to Follow-up|3|||
46912610|NCT03283319|83142618|FG000|Overall Study|Withdrawal by Subject|2|||
46912611|NCT03283319|83142619|FG001|Overall Study|Withdrawal by Subject|2|||
46912612|NCT03283319|83142620|FG002|Overall Study|Withdrawal by Subject|2|||
46912613|NCT03283319|83142621|FG003|Overall Study|Withdrawal by Subject|1|||
46912614|NCT03283319|83142622|FG004|Overall Study|Withdrawal by Subject|0|||
46912615|NCT03283319|83142623|FG005|Overall Study|Withdrawal by Subject|1|||
46912616|NCT03283319|83142618|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
46912617|NCT03283319|83142619|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
46912618|NCT03283319|83142620|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
46912619|NCT03283319|83142621|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
46912620|NCT03283319|83142622|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
46710522|NCT00957021|82926782|FG000|Overall Study|No 2 yr ROM data|35|||
46710523|NCT00957021|82926782|FG000|Overall Study|Revised study component by 2 yr visit|8|||
47029526|NCT01922258|83279394|FG001|Overall Study|Withdrawn by the Investigator|4|||
46710524|NCT00957021|82926782|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
46710525|NCT00957021|82926782|FG000|Overall Study|Surgery Cancelled|9|||
46912621|NCT03283319|83142623|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
46710526|NCT00957021|82926782|FG000|Overall Study|Termination due to language issue|2|||
46710527|NCT01124604|82926789|FG000|Overall Study|Adverse Event|10|||
46710528|NCT01124604|82926790|FG001|Overall Study|Adverse Event|1|||
46710529|NCT01124604|82926789|FG000|Overall Study|Lack of Efficacy|1|||
46710530|NCT01124604|82926790|FG001|Overall Study|Lack of Efficacy|0|||
46710531|NCT01124604|82926789|FG000|Overall Study|Withdrawal by Subject|4|||
46710532|NCT01124604|82926790|FG001|Overall Study|Withdrawal by Subject|0|||
46710533|NCT01124604|82926789|FG000|Overall Study|Disease Progression|0|||
46710534|NCT01124604|82926790|FG001|Overall Study|Disease Progression|1|||
46710535|NCT00909844|82926796|FG000|Overall Study|Adverse Event|1|||
46710536|NCT00909844|82926796|FG000|Overall Study|Withdrawal by Subject|1|||
46710537|NCT00909844|82926796|FG000|Overall Study|Lost to Follow-up|2|||
46710538|NCT01124448|82926803|FG000|Overall Study|Lost to Follow-up|0|||
46710539|NCT01124448|82926804|FG001|Overall Study|Lost to Follow-up|3|||
46710540|NCT01124448|82926803|FG000|Overall Study|Protocol Violation|2|||
46710541|NCT01124448|82926804|FG001|Overall Study|Protocol Violation|0|||
46710542|NCT01124292|82926813|FG000|Overall Study|Lost to Follow-up|2|||
47029527|NCT01922258|83279393|FG000|Overall Study|Withdrawal by participant|5|||
47029528|NCT01922258|83279394|FG001|Overall Study|Withdrawal by participant|5|||
47029529|NCT01406938|83279402|FG000|Induction Period|Subject/guardian decision|6|||
47029530|NCT01406938|83279403|FG001|Induction Period|Subject/guardian decision|8|||
47029531|NCT01406938|83279404|FG002|Induction Period|Subject/guardian decision|0|||
47029532|NCT01406938|83279405|FG003|Induction Period|Subject/guardian decision|0|||
47029533|NCT01406938|83279406|FG004|Induction Period|Subject/guardian decision|0|||
47029534|NCT01406938|83279407|FG005|Induction Period|Subject/guardian decision|0|||
47029535|NCT01406938|83279402|FG000|Induction Period|Protocol deviation|1|||
47029536|NCT01406938|83279403|FG001|Induction Period|Protocol deviation|0|||
47029537|NCT01406938|83279404|FG002|Induction Period|Protocol deviation|0|||
47029538|NCT01406938|83279405|FG003|Induction Period|Protocol deviation|0|||
47029539|NCT01406938|83279406|FG004|Induction Period|Protocol deviation|0|||
47029540|NCT01406938|83279407|FG005|Induction Period|Protocol deviation|0|||
47029541|NCT01406938|83279402|FG000|Induction Period|Adverse Event|8|||
47029542|NCT01406938|83279403|FG001|Induction Period|Adverse Event|9|||
47029543|NCT01406938|83279404|FG002|Induction Period|Adverse Event|0|||
47029544|NCT01406938|83279405|FG003|Induction Period|Adverse Event|0|||
47029545|NCT01406938|83279406|FG004|Induction Period|Adverse Event|0|||
47029546|NCT01406938|83279407|FG005|Induction Period|Adverse Event|0|||
47029547|NCT01406938|83279402|FG000|Induction Period|Lack of Efficacy|1|||
47029548|NCT01406938|83279403|FG001|Induction Period|Lack of Efficacy|0|||
47029549|NCT01406938|83279404|FG002|Induction Period|Lack of Efficacy|0|||
47029550|NCT01406938|83279405|FG003|Induction Period|Lack of Efficacy|0|||
47029551|NCT01406938|83279406|FG004|Induction Period|Lack of Efficacy|0|||
47029552|NCT01406938|83279407|FG005|Induction Period|Lack of Efficacy|0|||
47029553|NCT01406938|83279402|FG000|Induction Period|Lost to Follow-up|2|||
46710543|NCT01124292|82926814|FG001|Overall Study|Lost to Follow-up|4|||
46710544|NCT01124292|82926815|FG002|Overall Study|Lost to Follow-up|3|||
46710545|NCT01124292|82926813|FG000|Overall Study|Physician Decision|0|||
46710546|NCT01124292|82926814|FG001|Overall Study|Physician Decision|3|||
46710547|NCT01124292|82926815|FG002|Overall Study|Physician Decision|2|||
46710548|NCT01124292|82926813|FG000|Overall Study|Withdrawal by Subject|0|||
46710549|NCT01124292|82926814|FG001|Overall Study|Withdrawal by Subject|6|||
46710550|NCT01124292|82926815|FG002|Overall Study|Withdrawal by Subject|2|||
46710551|NCT01124292|82926813|FG000|Overall Study|medical issue unrelated to the study|0|||
46710552|NCT01124292|82926814|FG001|Overall Study|medical issue unrelated to the study|0|||
46710553|NCT01124292|82926815|FG002|Overall Study|medical issue unrelated to the study|2|||
46710554|NCT01124292|82926813|FG000|Overall Study|piercing track closed|0|||
46710555|NCT01124292|82926814|FG001|Overall Study|piercing track closed|2|||
46710556|NCT01124292|82926815|FG002|Overall Study|piercing track closed|1|||
46710557|NCT01136772|82926828|FG000|Overall Study|Adverse Event|15|||
46710558|NCT01136772|82926829|FG001|Overall Study|Adverse Event|14|||
46912622|NCT03282227|83142637|FG000|Overall Study|Exposure Goals Achieved|60|||
46912623|NCT03282227|83142637|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
47029554|NCT01406938|83279403|FG001|Induction Period|Lost to Follow-up|3|||
47029555|NCT01406938|83279404|FG002|Induction Period|Lost to Follow-up|0|||
46710559|NCT01136772|82926828|FG000|Overall Study|Lack of Efficacy|42|||
46710560|NCT01136772|82926829|FG001|Overall Study|Lack of Efficacy|39|||
46710561|NCT01136772|82926828|FG000|Overall Study|Administrative|14|||
47029556|NCT01406938|83279405|FG003|Induction Period|Lost to Follow-up|0|||
46710562|NCT01136772|82926829|FG001|Overall Study|Administrative|12|||
46912624|NCT03282227|83142637|FG000|Overall Study|Adverse Event|15|||
47029557|NCT01406938|83279406|FG004|Induction Period|Lost to Follow-up|0|||
46710563|NCT01136772|82926828|FG000|Overall Study|Withdrawal by Subject|33|||
47029558|NCT01406938|83279407|FG005|Induction Period|Lost to Follow-up|0|||
47029559|NCT01406938|83279402|FG000|Maintenance Period|Adverse Event|0|||
47029560|NCT01406938|83279403|FG001|Maintenance Period|Adverse Event|0|||
46710564|NCT01136772|82926829|FG001|Overall Study|Withdrawal by Subject|36|||
46710565|NCT01136772|82926828|FG000|Overall Study|Did not receive injection|10|||
46710566|NCT01136772|82926829|FG001|Overall Study|Did not receive injection|7|||
46710567|NCT01136772|82926828|FG000|Overall Study|Did not follow up after first injection|2|||
46710568|NCT01136772|82926829|FG001|Overall Study|Did not follow up after first injection|2|||
46710569|NCT00909532|82926837|FG000|Overall Study|Adverse Event|4|||
46710570|NCT00909532|82926838|FG001|Overall Study|Adverse Event|1|||
46710571|NCT00909532|82926837|FG000|Overall Study|Pregnancy|0|||
46710572|NCT00909532|82926838|FG001|Overall Study|Pregnancy|1|||
46710573|NCT00909532|82926837|FG000|Overall Study|Prohibited Medication|2|||
46710574|NCT00909532|82926838|FG001|Overall Study|Prohibited Medication|1|||
46710575|NCT00909532|82926837|FG000|Overall Study|Withdrawal of Consent|1|||
46710576|NCT00909532|82926838|FG001|Overall Study|Withdrawal of Consent|1|||
46710577|NCT00909532|82926837|FG000|Overall Study|Noncompliance with Study Requirements|0|||
46710578|NCT00909532|82926838|FG001|Overall Study|Noncompliance with Study Requirements|2|||
46710579|NCT00909532|82926837|FG000|Overall Study|Physician Decision|1|||
46710580|NCT00909532|82926838|FG001|Overall Study|Physician Decision|0|||
46710581|NCT00909532|82926837|FG000|Overall Study|Wrong Genotype|1|||
46710582|NCT00909532|82926838|FG001|Overall Study|Wrong Genotype|0|||
46710583|NCT00909532|82926837|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
46710584|NCT00909532|82926838|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
46710585|NCT01136382|82926847|FG000|Overall Study|Other|8|||
46710586|NCT01136382|82926848|FG001|Overall Study|Other|3|||
46710587|NCT01136382|82926847|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
46710588|NCT01136382|82926848|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
46710589|NCT01136382|82926847|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
46710590|NCT01136382|82926848|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
46710591|NCT01136382|82926847|FG000|Overall Study|Withdrawal by Subject|4|||
46710592|NCT01136382|82926848|FG001|Overall Study|Withdrawal by Subject|1|||
46710593|NCT00912028|82926857|FG000|Overall Study|Lost to Follow-up|2|||
46710594|NCT00912028|82926858|FG001|Overall Study|Lost to Follow-up|3|||
46710595|NCT00912028|82926859|FG002|Overall Study|Lost to Follow-up|0|||
46710596|NCT00912028|82926860|FG003|Overall Study|Lost to Follow-up|1|||
46710597|NCT00912028|82926861|FG004|Overall Study|Lost to Follow-up|3|||
46710598|NCT00912028|82926857|FG000|Overall Study|Withdrawal by Subject|3|||
46710599|NCT00912028|82926858|FG001|Overall Study|Withdrawal by Subject|0|||
46710600|NCT00912028|82926859|FG002|Overall Study|Withdrawal by Subject|0|||
46710601|NCT00912028|82926860|FG003|Overall Study|Withdrawal by Subject|0|||
46710602|NCT00912028|82926861|FG004|Overall Study|Withdrawal by Subject|0|||
46710603|NCT02731729|82926873|FG000|Overall Study|Death|2|||
46710604|NCT02731729|82926874|FG001|Overall Study|Death|2|||
46710605|NCT02731729|82926873|FG000|Overall Study|Study terminated by Sponsor|6|||
46710606|NCT02731729|82926874|FG001|Overall Study|Study terminated by Sponsor|6|||
46710607|NCT02731729|82926873|FG000|Overall Study|Withdrawal by Subject|1|||
46710608|NCT02731729|82926874|FG001|Overall Study|Withdrawal by Subject|0|||
46710609|NCT01119066|82926884|FG000|Overall Study|Withdrawal by Subject|4|||
46710610|NCT01119066|82926885|FG001|Overall Study|Withdrawal by Subject|6|||
46710611|NCT01119066|82926886|FG002|Overall Study|Withdrawal by Subject|0|||
46710612|NCT01119066|82926887|FG003|Overall Study|Withdrawal by Subject|0|||
46710613|NCT01119066|82926884|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
46710614|NCT01119066|82926885|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
46710615|NCT01119066|82926886|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
46710616|NCT01119066|82926887|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
46710617|NCT01119066|82926884|FG000|Overall Study|Relapse identified before transplant|1|||
46710618|NCT01119066|82926885|FG001|Overall Study|Relapse identified before transplant|0|||
46710619|NCT01119066|82926886|FG002|Overall Study|Relapse identified before transplant|0|||
46710620|NCT01119066|82926887|FG003|Overall Study|Relapse identified before transplant|0|||
46710621|NCT01119066|82926884|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
46710622|NCT01119066|82926885|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
46710623|NCT01119066|82926886|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
47029561|NCT01406938|83279404|FG002|Maintenance Period|Adverse Event|2|||
47029562|NCT01406938|83279405|FG003|Maintenance Period|Adverse Event|8|||
47029563|NCT01406938|83279406|FG004|Maintenance Period|Adverse Event|4|||
46710624|NCT01119066|82926887|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
46710625|NCT01119066|82926884|FG000|Overall Study|Relapse identified before transplant|0|||
46710626|NCT01119066|82926885|FG001|Overall Study|Relapse identified before transplant|4|||
46710627|NCT01119066|82926886|FG002|Overall Study|Relapse identified before transplant|0|||
46710628|NCT01119066|82926887|FG003|Overall Study|Relapse identified before transplant|0|||
46710629|NCT00910624|82926901|FG000|Treatment Phase|Adverse Event|2|||
46710630|NCT00910624|82926902|FG001|Treatment Phase|Adverse Event|6|||
46710631|NCT00910624|82926903|FG002|Treatment Phase|Adverse Event|6|||
46710632|NCT00910624|82926904|FG003|Treatment Phase|Adverse Event|0|||
46710633|NCT00910624|82926901|FG000|Treatment Phase|Treatment Failure|23|||
47029564|NCT01406938|83279407|FG005|Maintenance Period|Adverse Event|2|||
47029565|NCT01406938|83279402|FG000|Maintenance Period|Death|0|||
47029566|NCT01406938|83279403|FG001|Maintenance Period|Death|0|||
47029567|NCT01406938|83279404|FG002|Maintenance Period|Death|0|||
47029568|NCT01406938|83279405|FG003|Maintenance Period|Death|0|||
47029569|NCT01406938|83279406|FG004|Maintenance Period|Death|1|||
47029570|NCT01406938|83279407|FG005|Maintenance Period|Death|0|||
47029571|NCT01406938|83279402|FG000|Maintenance Period|Subject/guardian decision|0|||
47029572|NCT01406938|83279403|FG001|Maintenance Period|Subject/guardian decision|0|||
47029573|NCT01406938|83279404|FG002|Maintenance Period|Subject/guardian decision|11|||
47029574|NCT01406938|83279405|FG003|Maintenance Period|Subject/guardian decision|7|||
47029575|NCT01406938|83279406|FG004|Maintenance Period|Subject/guardian decision|10|||
47029576|NCT01406938|83279407|FG005|Maintenance Period|Subject/guardian decision|7|||
47029577|NCT01406938|83279402|FG000|Maintenance Period|Protocol Violation|0|||
47029578|NCT01406938|83279403|FG001|Maintenance Period|Protocol Violation|0|||
47029579|NCT01406938|83279404|FG002|Maintenance Period|Protocol Violation|2|||
47029580|NCT01406938|83279405|FG003|Maintenance Period|Protocol Violation|2|||
47029581|NCT01406938|83279406|FG004|Maintenance Period|Protocol Violation|2|||
47029582|NCT01406938|83279407|FG005|Maintenance Period|Protocol Violation|2|||
47029583|NCT01406938|83279402|FG000|Maintenance Period|Pregnancy|0|||
47029584|NCT01406938|83279403|FG001|Maintenance Period|Pregnancy|0|||
47029585|NCT01406938|83279404|FG002|Maintenance Period|Pregnancy|0|||
47029586|NCT01406938|83279405|FG003|Maintenance Period|Pregnancy|0|||
47029587|NCT01406938|83279406|FG004|Maintenance Period|Pregnancy|1|||
47029588|NCT01406938|83279407|FG005|Maintenance Period|Pregnancy|0|||
47029589|NCT01406938|83279402|FG000|Maintenance Period|Lost to Follow-up|0|||
47029590|NCT01406938|83279403|FG001|Maintenance Period|Lost to Follow-up|0|||
47029591|NCT01406938|83279404|FG002|Maintenance Period|Lost to Follow-up|0|||
47029592|NCT01406938|83279405|FG003|Maintenance Period|Lost to Follow-up|0|||
47029593|NCT01406938|83279406|FG004|Maintenance Period|Lost to Follow-up|4|||
47029594|NCT01406938|83279407|FG005|Maintenance Period|Lost to Follow-up|0|||
47029595|NCT01406938|83279402|FG000|Maintenance Period|Lack of Efficacy|0|||
47029596|NCT01406938|83279403|FG001|Maintenance Period|Lack of Efficacy|0|||
47029597|NCT01406938|83279404|FG002|Maintenance Period|Lack of Efficacy|2|||
47029598|NCT01406938|83279405|FG003|Maintenance Period|Lack of Efficacy|1|||
47029599|NCT01406938|83279406|FG004|Maintenance Period|Lack of Efficacy|3|||
47029600|NCT01406938|83279407|FG005|Maintenance Period|Lack of Efficacy|5|||
47029601|NCT01406938|83279402|FG000|Follow up|Lack of Efficacy|3|||
47029602|NCT01406938|83279403|FG001|Follow up|Lack of Efficacy|2|||
47029603|NCT01406938|83279404|FG002|Follow up|Lack of Efficacy|1|||
47029604|NCT01406938|83279405|FG003|Follow up|Lack of Efficacy|0|||
47029605|NCT01406938|83279406|FG004|Follow up|Lack of Efficacy|0|||
47029606|NCT01406938|83279407|FG005|Follow up|Lack of Efficacy|0|||
47029607|NCT01406938|83279402|FG000|Follow up|Patient/guardian decision|4|||
47029608|NCT01406938|83279403|FG001|Follow up|Patient/guardian decision|2|||
47029609|NCT01406938|83279404|FG002|Follow up|Patient/guardian decision|4|||
47029610|NCT01406938|83279405|FG003|Follow up|Patient/guardian decision|2|||
47029611|NCT01406938|83279406|FG004|Follow up|Patient/guardian decision|4|||
47029612|NCT01406938|83279407|FG005|Follow up|Patient/guardian decision|1|||
47029613|NCT01406938|83279402|FG000|Follow up|Protocol Violation|0|||
47029614|NCT01406938|83279403|FG001|Follow up|Protocol Violation|0|||
47029615|NCT01406938|83279404|FG002|Follow up|Protocol Violation|1|||
47029616|NCT01406938|83279405|FG003|Follow up|Protocol Violation|0|||
47029617|NCT01406938|83279406|FG004|Follow up|Protocol Violation|0|||
47029618|NCT01406938|83279407|FG005|Follow up|Protocol Violation|0|||
47029619|NCT01406938|83279402|FG000|Follow up|Physician Decision|0|||
47029620|NCT01406938|83279403|FG001|Follow up|Physician Decision|0|||
47029621|NCT01406938|83279404|FG002|Follow up|Physician Decision|2|||
47029622|NCT01406938|83279405|FG003|Follow up|Physician Decision|0|||
47029623|NCT01406938|83279406|FG004|Follow up|Physician Decision|3|||
47029624|NCT01406938|83279407|FG005|Follow up|Physician Decision|1|||
47029625|NCT01406938|83279402|FG000|Follow up|Lost to Follow-up|1|||
47029626|NCT01406938|83279403|FG001|Follow up|Lost to Follow-up|1|||
47029627|NCT01406938|83279404|FG002|Follow up|Lost to Follow-up|0|||
47029628|NCT01406938|83279405|FG003|Follow up|Lost to Follow-up|1|||
47029629|NCT01406938|83279406|FG004|Follow up|Lost to Follow-up|2|||
47029630|NCT01406938|83279407|FG005|Follow up|Lost to Follow-up|1|||
47029631|NCT01405924|83279427|FG000|Overall Study|Protocol Violation|8|||
47029632|NCT01405924|83279427|FG000|Overall Study|Missing/Incomplete Data|2|||
47029633|NCT01426438|83279435|FG000|Overall Study|Lost to Follow-up|1|||
47029634|NCT01426438|83279436|FG001|Overall Study|Lost to Follow-up|3|||
47029635|NCT01426438|83279435|FG000|Overall Study|Off study Treatment|9|||
47029636|NCT01426438|83279436|FG001|Overall Study|Off study Treatment|3|||
47029637|NCT01426438|83279435|FG000|Overall Study|Poor scan quality|3|||
47029638|NCT01426438|83279436|FG001|Overall Study|Poor scan quality|2|||
47029639|NCT01426438|83279435|FG000|Overall Study|Missed Scan|2|||
47029640|NCT01426438|83279436|FG001|Overall Study|Missed Scan|2|||
47029641|NCT01425814|83279442|FG000|Period 1|Stability criteria not fulfilled|0|||
47029642|NCT01425814|83279443|FG001|Period 1|Stability criteria not fulfilled|1|||
47029643|NCT01425814|83279444|FG002|Period 1|Stability criteria not fulfilled|0|||
47029644|NCT01425814|83279445|FG003|Period 1|Stability criteria not fulfilled|0|||
47029645|NCT01425814|83279446|FG004|Period 1|Stability criteria not fulfilled|0|||
47029646|NCT01425814|83279447|FG005|Period 1|Stability criteria not fulfilled|0|||
47029647|NCT01425814|83279442|FG000|Period 2|Stability criteria not fulfilled|0|||
47029648|NCT01425814|83279443|FG001|Period 2|Stability criteria not fulfilled|1|||
47029649|NCT01425814|83279444|FG002|Period 2|Stability criteria not fulfilled|0|||
47029650|NCT01425814|83279445|FG003|Period 2|Stability criteria not fulfilled|0|||
47029651|NCT01425814|83279446|FG004|Period 2|Stability criteria not fulfilled|0|||
47029652|NCT01425814|83279447|FG005|Period 2|Stability criteria not fulfilled|0|||
47029653|NCT01425814|83279442|FG000|Period 3|Adverse Event|0|||
47029654|NCT01425814|83279443|FG001|Period 3|Adverse Event|0|||
47029655|NCT01425814|83279444|FG002|Period 3|Adverse Event|0|||
47029656|NCT01425814|83279445|FG003|Period 3|Adverse Event|0|||
47029657|NCT01425814|83279446|FG004|Period 3|Adverse Event|0|||
47029658|NCT01425814|83279447|FG005|Period 3|Adverse Event|1|||
47029659|NCT01425814|83279442|FG000|Period 4|Adverse Event|1|||
47029660|NCT01425814|83279443|FG001|Period 4|Adverse Event|0|||
47029661|NCT01425814|83279444|FG002|Period 4|Adverse Event|1|||
47029662|NCT01425814|83279445|FG003|Period 4|Adverse Event|0|||
47029663|NCT01425814|83279446|FG004|Period 4|Adverse Event|0|||
46912625|NCT03282227|83142637|FG000|Overall Study|Lost to Follow-up|21|||
46912626|NCT03282227|83142637|FG000|Overall Study|Withdrawal by Subject|20|||
46912627|NCT03282227|83142637|FG000|Overall Study|Lack of Efficacy|12|||
46912628|NCT03282227|83142637|FG000|Overall Study|Sponsor decision|3|||
46912629|NCT03282227|83142637|FG000|Overall Study|Physician Decision|2|||
47029664|NCT01425814|83279447|FG005|Period 4|Adverse Event|0|||
47029665|NCT01425814|83279442|FG000|Period 5|Stability criteria not fulfilled|0|||
46912630|NCT03282227|83142637|FG000|Overall Study|Pregnancy|2|||
46912631|NCT03282227|83142637|FG000|Overall Study|Other|1|||
46626495|NCT02144610|82797223|FG000|Overall Study|Withdrawal by Subject|1|||
46626496|NCT02144610|82797224|FG001|Overall Study|Withdrawal by Subject|5|||
46626497|NCT02144610|82797223|FG000|Overall Study|Death|2|||
46626498|NCT02144610|82797224|FG001|Overall Study|Death|2|||
46626499|NCT02144610|82797223|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
46626500|NCT02144610|82797224|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
46626501|NCT02144610|82797223|FG000|Overall Study|Other|0|||
46710634|NCT00910624|82926902|FG001|Treatment Phase|Treatment Failure|10|||
46710635|NCT00910624|82926903|FG002|Treatment Phase|Treatment Failure|0|||
46710636|NCT00910624|82926904|FG003|Treatment Phase|Treatment Failure|0|||
46710637|NCT00910624|82926901|FG000|Treatment Phase|Lost to Follow-up|0|||
46710638|NCT00910624|82926902|FG001|Treatment Phase|Lost to Follow-up|0|||
46710639|NCT00910624|82926903|FG002|Treatment Phase|Lost to Follow-up|1|||
46710640|NCT00910624|82926904|FG003|Treatment Phase|Lost to Follow-up|0|||
46710641|NCT00910624|82926901|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
46710642|NCT00910624|82926902|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
46710643|NCT00910624|82926903|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
46912632|NCT03240575|83142645|FG000|Overall Study|Adverse Event|0|||
46626502|NCT02144610|82797224|FG001|Overall Study|Other|1|||
46626503|NCT02100228|82797232|FG000|Overall Study|Other|19|||
46912633|NCT03240575|83142646|FG001|Overall Study|Adverse Event|2|||
46912634|NCT03240575|83142647|FG002|Overall Study|Adverse Event|0|||
46912635|NCT03240575|83142648|FG003|Overall Study|Adverse Event|1|||
47029666|NCT01425814|83279443|FG001|Period 5|Stability criteria not fulfilled|0|||
46626504|NCT02100228|82797233|FG001|Overall Study|Other|19|||
46626505|NCT02100228|82797232|FG000|Overall Study|Administrative reason|0|||
46626506|NCT02100228|82797233|FG001|Overall Study|Administrative reason|1|||
46626507|NCT02100228|82797232|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
46626508|NCT02100228|82797233|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
46626509|NCT02100228|82797232|FG000|Overall Study|Non-compliance|0|||
46912636|NCT03240575|83142645|FG000|Overall Study|Withdrawal by Subject|2|||
46912637|NCT03240575|83142646|FG001|Overall Study|Withdrawal by Subject|11|||
46912638|NCT03240575|83142647|FG002|Overall Study|Withdrawal by Subject|0|||
47029667|NCT01425814|83279444|FG002|Period 5|Stability criteria not fulfilled|1|||
47029668|NCT01425814|83279445|FG003|Period 5|Stability criteria not fulfilled|0|||
46626510|NCT02100228|82797233|FG001|Overall Study|Non-compliance|3|||
46710644|NCT00910624|82926904|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
46710645|NCT00910624|82926901|FG000|Treatment Phase|Withdrawal by Subject|2|||
46912639|NCT03240575|83142648|FG003|Overall Study|Withdrawal by Subject|1|||
46912640|NCT03240575|83142645|FG000|Overall Study|Other|0|||
46912641|NCT03240575|83142646|FG001|Overall Study|Other|1|||
46912642|NCT03240575|83142647|FG002|Overall Study|Other|0|||
46626511|NCT02100228|82797232|FG000|Overall Study|Lost to Follow-up|0|||
47029669|NCT01425814|83279446|FG004|Period 5|Stability criteria not fulfilled|0|||
47029670|NCT01425814|83279447|FG005|Period 5|Stability criteria not fulfilled|1|||
47029671|NCT01782495|83279472|FG000|Overall Study|Adverse Event|0|||
47029672|NCT01782495|83279473|FG001|Overall Study|Adverse Event|0|||
47029673|NCT01782495|83279474|FG002|Overall Study|Adverse Event|0|||
47029674|NCT01782495|83279475|FG003|Overall Study|Adverse Event|0|||
47029675|NCT01782495|83279476|FG004|Overall Study|Adverse Event|0|||
47029676|NCT01782495|83279477|FG005|Overall Study|Adverse Event|0|||
47029677|NCT01782495|83279478|FG006|Overall Study|Adverse Event|0|||
47029678|NCT01782495|83279479|FG007|Overall Study|Adverse Event|2|||
47029679|NCT01782495|83279480|FG008|Overall Study|Adverse Event|0|||
47029680|NCT01782495|83279481|FG009|Overall Study|Adverse Event|0|||
47029681|NCT01782495|83279482|FG010|Overall Study|Adverse Event|0|||
47029682|NCT01782495|83279472|FG000|Overall Study|Withdrew Consent|0|||
47029683|NCT01782495|83279473|FG001|Overall Study|Withdrew Consent|1|||
47029684|NCT01782495|83279474|FG002|Overall Study|Withdrew Consent|0|||
47029685|NCT01782495|83279475|FG003|Overall Study|Withdrew Consent|0|||
47029686|NCT01782495|83279476|FG004|Overall Study|Withdrew Consent|0|||
47029687|NCT01782495|83279477|FG005|Overall Study|Withdrew Consent|0|||
47029688|NCT01782495|83279478|FG006|Overall Study|Withdrew Consent|0|||
47029689|NCT01782495|83279479|FG007|Overall Study|Withdrew Consent|1|||
47029690|NCT01782495|83279480|FG008|Overall Study|Withdrew Consent|0|||
47029691|NCT01782495|83279481|FG009|Overall Study|Withdrew Consent|0|||
47029692|NCT01782495|83279482|FG010|Overall Study|Withdrew Consent|0|||
47029693|NCT01922102|83279509|FG000|Overall Study|Withdrawal by Subject|7|||
47029694|NCT01922102|83279510|FG001|Overall Study|Withdrawal by Subject|3|||
47029695|NCT01922102|83279511|FG002|Overall Study|Withdrawal by Subject|7|||
47029696|NCT01922102|83279509|FG000|Overall Study|Physician Decision|0|||
47029697|NCT01922102|83279510|FG001|Overall Study|Physician Decision|2|||
47029698|NCT01922102|83279511|FG002|Overall Study|Physician Decision|1|||
47029699|NCT01922102|83279509|FG000|Overall Study|Adverse Event|1|||
47029700|NCT01922102|83279510|FG001|Overall Study|Adverse Event|2|||
47029701|NCT01922102|83279511|FG002|Overall Study|Adverse Event|0|||
47029702|NCT01922102|83279509|FG000|Overall Study|Lost to Follow-up|1|||
47029703|NCT01922102|83279510|FG001|Overall Study|Lost to Follow-up|0|||
47029704|NCT01922102|83279511|FG002|Overall Study|Lost to Follow-up|0|||
47029705|NCT01922102|83279509|FG000|Overall Study|Administrative problems|0|||
47029706|NCT01922102|83279510|FG001|Overall Study|Administrative problems|2|||
47029707|NCT01922102|83279511|FG002|Overall Study|Administrative problems|0|||
46912643|NCT03240575|83142648|FG003|Overall Study|Other|0|||
47029708|NCT01405768|83279525|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
47029709|NCT01405768|83279526|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
47029710|NCT01913353|83279534|FG000|Overall Study|Adverse Event|2|||
47029711|NCT01913353|83279535|FG001|Overall Study|Adverse Event|0|||
47029712|NCT01913353|83279534|FG000|Overall Study|Physician Decision|0|||
47029713|NCT01913353|83279535|FG001|Overall Study|Physician Decision|2|||
47029714|NCT01913353|83279534|FG000|Overall Study|Withdrawal by Subject|20|||
46912644|NCT03385265|83142660|FG000|Overall Study|Withdrawal by Subject|5|||
46912645|NCT03385265|83142661|FG001|Overall Study|Withdrawal by Subject|2|||
46912646|NCT03385265|83142662|FG002|Overall Study|Withdrawal by Subject|5|||
46912647|NCT03385265|83142663|FG003|Overall Study|Withdrawal by Subject|2|||
46912648|NCT03280121|83142675|FG000|Overall Study|Physician Decision|1|||
46912649|NCT03280121|83142675|FG000|Overall Study|Lost to Follow-up|1|||
46912650|NCT03280121|83142675|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
47029715|NCT01913353|83279535|FG001|Overall Study|Withdrawal by Subject|6|||
47029716|NCT01913353|83279534|FG000|Overall Study|multiple reasons|10|||
47029717|NCT01913353|83279535|FG001|Overall Study|multiple reasons|7|||
47029718|NCT01754259|83279550|FG000|Overall Study|Withdrawal by Subject|2|||
47029719|NCT01754259|83279551|FG001|Overall Study|Withdrawal by Subject|4|||
46912651|NCT03233009|83142679|FG000|Overall Study|Lost to Follow-up|1|||
47029720|NCT01754259|83279550|FG000|Overall Study|Adverse Event|3|||
47029721|NCT01754259|83279551|FG001|Overall Study|Adverse Event|1|||
47029722|NCT01754259|83279550|FG000|Overall Study|Lost to Follow-up|0|||
47029723|NCT01754259|83279551|FG001|Overall Study|Lost to Follow-up|1|||
47029724|NCT01405456|83279559|FG000|Overall Study|Lost to Follow-up|2|||
47029725|NCT01405456|83279560|FG001|Overall Study|Lost to Follow-up|1|||
47029726|NCT01405456|83279559|FG000|Overall Study|Physician Decision|1|||
47029727|NCT01405456|83279560|FG001|Overall Study|Physician Decision|0|||
47029728|NCT01404988|83279569|FG000|Overall Study|Death|2|||
47029729|NCT01404988|83279570|FG001|Overall Study|Death|0|||
47029730|NCT01404988|83279571|FG002|Overall Study|Death|2|||
47029731|NCT01404988|83279569|FG000|Overall Study|Adverse Event|1|||
47029732|NCT01404988|83279570|FG001|Overall Study|Adverse Event|0|||
47029733|NCT01404988|83279571|FG002|Overall Study|Adverse Event|0|||
47029734|NCT01404988|83279569|FG000|Overall Study|Withdrawal by Subject|2|||
47029735|NCT01404988|83279570|FG001|Overall Study|Withdrawal by Subject|2|||
47029736|NCT01404988|83279571|FG002|Overall Study|Withdrawal by Subject|0|||
47029737|NCT01404988|83279569|FG000|Overall Study|Lost to Follow-up|1|||
47029738|NCT01404988|83279570|FG001|Overall Study|Lost to Follow-up|2|||
47029739|NCT01404988|83279571|FG002|Overall Study|Lost to Follow-up|1|||
47029740|NCT01389232|83279582|FG000|Overall Study|Had scaffold removed|15|||
47029741|NCT01389232|83279582|FG000|Overall Study|Personal reasons|2|||
47029742|NCT01389232|83279582|FG000|Overall Study|Adverse Event|1|||
47029743|NCT01389232|83279582|FG000|Overall Study|Death|1|||
47029744|NCT01404208|83279598|FG000|Overall Study|Discontinued|3|||
47029745|NCT01404208|83279599|FG001|Overall Study|Discontinued|0|||
47029746|NCT01617668|83279607|FG000|Overall Study|Adverse Event|7|||
47029747|NCT01617668|83279608|FG001|Overall Study|Adverse Event|0|||
47029748|NCT01617668|83279609|FG002|Overall Study|Adverse Event|12|||
47029749|NCT01617668|83279610|FG003|Overall Study|Adverse Event|5|||
47029750|NCT01617668|83279607|FG000|Overall Study|Physician Decision|1|||
47029751|NCT01617668|83279608|FG001|Overall Study|Physician Decision|2|||
47029752|NCT01617668|83279609|FG002|Overall Study|Physician Decision|3|||
47029753|NCT01617668|83279610|FG003|Overall Study|Physician Decision|0|||
47029754|NCT01617668|83279607|FG000|Overall Study|Progressive Disease|4|||
47029755|NCT01617668|83279608|FG001|Overall Study|Progressive Disease|4|||
46626512|NCT02100228|82797233|FG001|Overall Study|Lost to Follow-up|1|||
46626513|NCT02100228|82797232|FG000|Overall Study|Withdrawal by Subject|27|||
46626514|NCT02100228|82797233|FG001|Overall Study|Withdrawal by Subject|37|||
46626515|NCT02100228|82797232|FG000|Overall Study|Adverse Event|16|||
46626516|NCT02100228|82797233|FG001|Overall Study|Adverse Event|12|||
46626517|NCT02100228|82797232|FG000|Overall Study|Death|1|||
46626518|NCT02100228|82797233|FG001|Overall Study|Death|1|||
46626519|NCT02099838|82797241|FG000|Overall Study|Death|1|||
46626520|NCT02099838|82797242|FG001|Overall Study|Death|0|||
46626521|NCT02099838|82797241|FG000|Overall Study|Lost to Follow-up|3|||
46626522|NCT02099838|82797242|FG001|Overall Study|Lost to Follow-up|1|||
46626523|NCT02099838|82797241|FG000|Overall Study|Withdrawal by Subject|0|||
46626524|NCT02099838|82797242|FG001|Overall Study|Withdrawal by Subject|1|||
46626525|NCT02144220|82797248|FG000|Overall Study|technology incompatibility|9|||
46626526|NCT02144220|82797248|FG000|Overall Study|Lack of Efficacy|4|||
46626527|NCT02144220|82797248|FG000|Overall Study|Physician Decision|3|||
46626528|NCT02144220|82797248|FG000|Overall Study|Withdrawal by Subject|2|||
46626529|NCT02144220|82797248|FG000|Overall Study|Protocol Violation|1|||
46626530|NCT02099682|82797252|FG000|Overall Study|Data Not Available|51|||
46710646|NCT00910624|82926902|FG001|Treatment Phase|Withdrawal by Subject|1|||
46710647|NCT00910624|82926903|FG002|Treatment Phase|Withdrawal by Subject|0|||
47029756|NCT01617668|83279609|FG002|Overall Study|Progressive Disease|6|||
47029757|NCT01617668|83279610|FG003|Overall Study|Progressive Disease|9|||
47029758|NCT01617668|83279607|FG000|Overall Study|Subject/guardian decision|1|||
47029759|NCT01617668|83279608|FG001|Overall Study|Subject/guardian decision|3|||
46626531|NCT02099682|82797252|FG000|Overall Study|Lost to Follow-up|31|||
47029760|NCT01617668|83279609|FG002|Overall Study|Subject/guardian decision|2|||
46626532|NCT02099682|82797252|FG000|Overall Study|Other|29|||
46626533|NCT02142894|82797256|FG000|Overall Study|Protocol Violation|8|||
47029761|NCT01617668|83279610|FG003|Overall Study|Subject/guardian decision|1|||
47029762|NCT01425268|83279626|FG000|Overall Study|Withdrawal by Subject|2|||
47029763|NCT01425268|83279627|FG001|Overall Study|Withdrawal by Subject|0|||
47029764|NCT01425268|83279626|FG000|Overall Study|Sponsor Decision|5|||
46626534|NCT02098746|82797260|FG000|Overall Study|Changes of Investigator|2|||
47029765|NCT01425268|83279627|FG001|Overall Study|Sponsor Decision|0|||
46626535|NCT02098746|82797260|FG000|Overall Study|Other Miscellaneous Reasons|1|||
46626536|NCT02098746|82797260|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
46626537|NCT02098746|82797260|FG000|Overall Study|Data Not Available After Treatment|1|||
46626538|NCT02122770|82797268|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
46626539|NCT02122770|82797269|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
46626540|NCT02122770|82797270|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
46626541|NCT02122770|82797271|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
46626542|NCT02122770|82797272|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
47029766|NCT01425268|83279626|FG000|Overall Study|Physician Decision|1|||
47029767|NCT01425268|83279627|FG001|Overall Study|Physician Decision|0|||
47029768|NCT01425190|83279636|FG000|Overall Study|Full dose not consumed.|1|||
47029769|NCT01425190|83279637|FG001|Overall Study|Full dose not consumed.|0|||
47029770|NCT01425190|83279638|FG002|Overall Study|Full dose not consumed.|0|||
47029771|NCT01388530|83279646|FG000|Overall Study|Lost to Follow-up|5|||
47029772|NCT01895270|83279652|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
47029773|NCT01895270|83279653|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
47029774|NCT01895270|83279652|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
47029775|NCT01895270|83279653|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
47029776|NCT01895270|83279652|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
47029777|NCT01895270|83279653|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
47029778|NCT01895270|83279652|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
47029779|NCT01895270|83279653|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
47029780|NCT01895270|83279652|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
47029781|NCT01895270|83279653|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
47029782|NCT01895270|83279652|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
47029783|NCT01895270|83279653|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
47029784|NCT01895270|83279652|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
47029785|NCT01895270|83279653|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
47029786|NCT01424722|83279659|FG000|Overall Study|Sponsor terminated investigation|2258|||
47029787|NCT01424644|83279665|FG000|Overall Study|Adverse Event|2|||
47029788|NCT01424644|83279666|FG001|Overall Study|Adverse Event|0|||
47029789|NCT01424644|83279665|FG000|Overall Study|Withdrawal by Subject|9|||
47029790|NCT01424644|83279666|FG001|Overall Study|Withdrawal by Subject|12|||
46626543|NCT02122770|82797273|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
46626544|NCT02122770|82797268|FG000|Part A: Drug-drug Interaction 2|Other|0|||
46626545|NCT02122770|82797269|FG001|Part A: Drug-drug Interaction 2|Other|0|||
46626546|NCT02122770|82797270|FG002|Part A: Drug-drug Interaction 2|Other|1|||
46626547|NCT02122770|82797271|FG003|Part A: Drug-drug Interaction 2|Other|0|||
46626548|NCT02122770|82797272|FG004|Part A: Drug-drug Interaction 2|Other|0|||
46626549|NCT02122770|82797273|FG005|Part A: Drug-drug Interaction 2|Other|0|||
46626550|NCT02122770|82797268|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
46626551|NCT02122770|82797269|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
46626552|NCT02122770|82797270|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
46626553|NCT02122770|82797271|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
46626554|NCT02122770|82797272|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
46626555|NCT02122770|82797273|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
46626556|NCT02122770|82797268|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
46626557|NCT02122770|82797269|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
46626558|NCT02122770|82797270|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
46626559|NCT02122770|82797271|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
46626560|NCT02122770|82797272|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
46626561|NCT02122770|82797273|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
46626562|NCT02122770|82797268|FG000|Part B: Standard of Care|Adverse Event|0|||
46626563|NCT02122770|82797269|FG001|Part B: Standard of Care|Adverse Event|0|||
46626564|NCT02122770|82797270|FG002|Part B: Standard of Care|Adverse Event|0|||
46626565|NCT02122770|82797271|FG003|Part B: Standard of Care|Adverse Event|0|||
46626566|NCT02122770|82797272|FG004|Part B: Standard of Care|Adverse Event|4|||
46626567|NCT02122770|82797273|FG005|Part B: Standard of Care|Adverse Event|1|||
46626568|NCT02122770|82797268|FG000|Part B: Standard of Care|Other|0|||
46626569|NCT02122770|82797269|FG001|Part B: Standard of Care|Other|0|||
46626570|NCT02122770|82797270|FG002|Part B: Standard of Care|Other|0|||
46626571|NCT02122770|82797271|FG003|Part B: Standard of Care|Other|0|||
46626572|NCT02122770|82797272|FG004|Part B: Standard of Care|Other|0|||
47029791|NCT01424644|83279665|FG000|Overall Study|Lost to Follow-up|16|||
47029792|NCT01424644|83279666|FG001|Overall Study|Lost to Follow-up|12|||
47029793|NCT01424644|83279665|FG000|Overall Study|Protocol Violation|4|||
47029794|NCT01424644|83279666|FG001|Overall Study|Protocol Violation|3|||
46626573|NCT02122770|82797273|FG005|Part B: Standard of Care|Other|2|||
46626574|NCT02122770|82797268|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
46626575|NCT02122770|82797269|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
46912652|NCT04034225|83142694|FG000|Overall Study|Death|3|||
46626576|NCT02122770|82797270|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
46626577|NCT02122770|82797271|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
46626578|NCT02122770|82797272|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
46626579|NCT02122770|82797273|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
46626580|NCT02122770|82797268|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
46626581|NCT02122770|82797269|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
46626582|NCT02122770|82797270|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
46710648|NCT00910624|82926904|FG003|Treatment Phase|Withdrawal by Subject|0|||
46710649|NCT00910624|82926901|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
46710650|NCT00910624|82926902|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
46710651|NCT00910624|82926903|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
46710652|NCT00910624|82926904|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
46710653|NCT00910624|82926901|FG000|Follow-Up Phase|Adverse Event|0|||
46710654|NCT00910624|82926902|FG001|Follow-Up Phase|Adverse Event|0|||
47029795|NCT01424644|83279665|FG000|Overall Study|Administrative Reason|1|||
47029796|NCT01424644|83279666|FG001|Overall Study|Administrative Reason|0|||
47029797|NCT01424644|83279665|FG000|Overall Study|Unable to Classify|1|||
47029798|NCT01424644|83279666|FG001|Overall Study|Unable to Classify|0|||
47029799|NCT01920854|83279679|FG000|Overall Study|Withdrawal by Subject|1|||
47029800|NCT01920854|83279680|FG001|Overall Study|Withdrawal by Subject|0|||
47029801|NCT01920854|83279681|FG002|Overall Study|Withdrawal by Subject|0|||
47029802|NCT01920854|83279682|FG003|Overall Study|Withdrawal by Subject|0|||
47029803|NCT01920854|83279683|FG004|Overall Study|Withdrawal by Subject|1|||
47029804|NCT01920854|83279684|FG005|Overall Study|Withdrawal by Subject|0|||
47029805|NCT01920854|83279685|FG006|Overall Study|Withdrawal by Subject|1|||
46626583|NCT02122770|82797271|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
46626584|NCT02122770|82797272|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
46626585|NCT02122770|82797273|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
46626586|NCT02122770|82797268|FG000|Part B: Standard of Care|Progressive Disease|0|||
46626587|NCT02122770|82797269|FG001|Part B: Standard of Care|Progressive Disease|0|||
46626588|NCT02122770|82797270|FG002|Part B: Standard of Care|Progressive Disease|0|||
46626589|NCT02122770|82797271|FG003|Part B: Standard of Care|Progressive Disease|0|||
46626590|NCT02122770|82797272|FG004|Part B: Standard of Care|Progressive Disease|10|||
46626591|NCT02122770|82797273|FG005|Part B: Standard of Care|Progressive Disease|8|||
46626592|NCT02122380|82797298|FG000|First Intervention (30 Days)|Adverse Event|1|||
46626593|NCT02122380|82797299|FG001|First Intervention (30 Days)|Adverse Event|0|||
46626594|NCT02122380|82797298|FG000|First Intervention (30 Days)|Physician Decision|0|||
46626595|NCT02122380|82797299|FG001|First Intervention (30 Days)|Physician Decision|1|||
46626596|NCT02122380|82797298|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
46626597|NCT02122380|82797299|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
46626598|NCT02122380|82797298|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
46626599|NCT02122380|82797299|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
46626600|NCT02122380|82797298|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
46626601|NCT02122380|82797299|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
46626602|NCT02122146|82797314|FG000|Part 1: Dose Escalation|Death|0|||
46626603|NCT02122146|82797315|FG001|Part 1: Dose Escalation|Death|1|||
46626604|NCT02122146|82797316|FG002|Part 1: Dose Escalation|Death|1|||
46626605|NCT02122146|82797317|FG003|Part 1: Dose Escalation|Death|0|||
46626606|NCT02122146|82797318|FG004|Part 1: Dose Escalation|Death|0|||
46626607|NCT02122146|82797319|FG005|Part 1: Dose Escalation|Death|0|||
46626608|NCT02122146|82797320|FG006|Part 1: Dose Escalation|Death|0|||
46626609|NCT02122146|82797321|FG007|Part 1: Dose Escalation|Death|0|||
46626610|NCT02122146|82797314|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
46626611|NCT02122146|82797315|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
46626612|NCT02122146|82797316|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
46626613|NCT02122146|82797317|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
46626614|NCT02122146|82797318|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
46626615|NCT02122146|82797319|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
46626616|NCT02122146|82797320|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
46626617|NCT02122146|82797321|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
46626618|NCT02122146|82797314|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46626619|NCT02122146|82797315|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46626620|NCT02122146|82797316|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46626621|NCT02122146|82797317|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
46626622|NCT02122146|82797318|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
47029806|NCT01403194|83279720|FG000|Overall Study|Screen Failure|2|||
47029807|NCT01403194|83279720|FG000|Overall Study|Lost to Follow-up|8|||
47029808|NCT01403116|83279726|FG000|Overall Study|Adverse Event|7|||
46626623|NCT02122146|82797319|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46626624|NCT02122146|82797320|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46626625|NCT02122146|82797321|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46626626|NCT02122146|82797314|FG000|Part 1: Dose Escalation|Other|1|||
46626627|NCT02122146|82797315|FG001|Part 1: Dose Escalation|Other|0|||
46626628|NCT02122146|82797316|FG002|Part 1: Dose Escalation|Other|0|||
46626629|NCT02122146|82797317|FG003|Part 1: Dose Escalation|Other|0|||
46626630|NCT02122146|82797318|FG004|Part 1: Dose Escalation|Other|0|||
47029809|NCT01403116|83279727|FG001|Overall Study|Adverse Event|4|||
47029810|NCT01403116|83279726|FG000|Overall Study|Lost to Follow-up|7|||
47029811|NCT01403116|83279727|FG001|Overall Study|Lost to Follow-up|5|||
47029812|NCT01403116|83279726|FG000|Overall Study|Withdrawal by Subject|12|||
47029813|NCT01403116|83279727|FG001|Overall Study|Withdrawal by Subject|15|||
47029814|NCT01403116|83279726|FG000|Overall Study|Non-compliance of study drug|3|||
47029815|NCT01403116|83279727|FG001|Overall Study|Non-compliance of study drug|0|||
47029816|NCT01403116|83279726|FG000|Overall Study|Protocol Violation|0|||
47029817|NCT01403116|83279727|FG001|Overall Study|Protocol Violation|1|||
47029818|NCT01403116|83279726|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
47029819|NCT01403116|83279727|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
47029820|NCT01403116|83279726|FG000|Overall Study|Hct >54%|2|||
47029821|NCT01403116|83279727|FG001|Overall Study|Hct >54%|0|||
47029822|NCT01403116|83279726|FG000|Overall Study|unable to keep appointments|0|||
47029823|NCT01403116|83279727|FG001|Overall Study|unable to keep appointments|2|||
47029824|NCT01402570|83279733|FG000|Overall Study|Adverse Event|1|||
47029825|NCT01753401|83279740|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
47029826|NCT01753401|83279741|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
47029827|NCT01753401|83279742|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
47029828|NCT01753401|83279743|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
47029829|NCT01753401|83279740|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
47029830|NCT01753401|83279741|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
47029831|NCT01753401|83279742|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
47029832|NCT01753401|83279743|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
47029833|NCT01753401|83279740|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
47029834|NCT01753401|83279741|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
47029835|NCT01753401|83279742|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
47029836|NCT01753401|83279743|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
46626631|NCT02122146|82797319|FG005|Part 1: Dose Escalation|Other|1|||
46626632|NCT02122146|82797320|FG006|Part 1: Dose Escalation|Other|1|||
46626633|NCT02122146|82797321|FG007|Part 1: Dose Escalation|Other|2|||
46626634|NCT02121834|82797347|FG000|Overall Study|Protocol Violation|0|||
46626635|NCT02121834|82797348|FG001|Overall Study|Protocol Violation|1|||
46626636|NCT02121834|82797349|FG002|Overall Study|Protocol Violation|0|||
46626637|NCT02121834|82797350|FG003|Overall Study|Protocol Violation|0|||
46626638|NCT02121834|82797351|FG004|Overall Study|Protocol Violation|0|||
46626639|NCT02121834|82797352|FG005|Overall Study|Protocol Violation|0|||
46626640|NCT02121834|82797353|FG006|Overall Study|Protocol Violation|0|||
46626641|NCT02121834|82797347|FG000|Overall Study|Withdrawal by Subject|0|||
46626642|NCT02121834|82797348|FG001|Overall Study|Withdrawal by Subject|1|||
46626643|NCT02121834|82797349|FG002|Overall Study|Withdrawal by Subject|1|||
46626644|NCT02121834|82797350|FG003|Overall Study|Withdrawal by Subject|0|||
46626645|NCT02121834|82797351|FG004|Overall Study|Withdrawal by Subject|0|||
46626646|NCT02121834|82797352|FG005|Overall Study|Withdrawal by Subject|0|||
46626647|NCT02121834|82797353|FG006|Overall Study|Withdrawal by Subject|0|||
46626648|NCT02121834|82797347|FG000|Overall Study|Lost to Follow-up|0|||
46626649|NCT02121834|82797348|FG001|Overall Study|Lost to Follow-up|0|||
46626650|NCT02121834|82797349|FG002|Overall Study|Lost to Follow-up|1|||
46626651|NCT02121834|82797350|FG003|Overall Study|Lost to Follow-up|0|||
46626652|NCT02121834|82797351|FG004|Overall Study|Lost to Follow-up|0|||
46626653|NCT02121834|82797352|FG005|Overall Study|Lost to Follow-up|0|||
46626654|NCT02121834|82797353|FG006|Overall Study|Lost to Follow-up|0|||
46626655|NCT02121756|82797381|FG000|Overall Study|Adverse Event|3|||
46626656|NCT02121756|82797382|FG001|Overall Study|Adverse Event|0|||
46626657|NCT02121756|82797381|FG000|Overall Study|Protocol Violation|1|||
47029837|NCT01753401|83279740|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
47029838|NCT01753401|83279741|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
47029839|NCT01753401|83279742|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
47029840|NCT01753401|83279743|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
47029841|NCT01753401|83279740|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
47029842|NCT01753401|83279741|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
47029843|NCT01753401|83279742|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
47029844|NCT01753401|83279743|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
47029845|NCT01753401|83279740|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
46626658|NCT02121756|82797382|FG001|Overall Study|Protocol Violation|1|||
46626659|NCT02121756|82797381|FG000|Overall Study|Physician Decision|2|||
46626660|NCT02121756|82797382|FG001|Overall Study|Physician Decision|1|||
46626661|NCT02142504|82797394|FG000|Overall Study|Protocol Violation|2|||
46626662|NCT02142504|82797395|FG001|Overall Study|Protocol Violation|1|||
46626663|NCT02142504|82797396|FG002|Overall Study|Protocol Violation|2|||
46626664|NCT02142504|82797394|FG000|Overall Study|Adverse Event|2|||
46626665|NCT02142504|82797395|FG001|Overall Study|Adverse Event|3|||
46626666|NCT02142504|82797396|FG002|Overall Study|Adverse Event|4|||
46626667|NCT02142504|82797394|FG000|Overall Study|Lost to Follow-up|12|||
46626668|NCT02142504|82797395|FG001|Overall Study|Lost to Follow-up|19|||
46626669|NCT02142504|82797396|FG002|Overall Study|Lost to Follow-up|17|||
46626670|NCT02142504|82797394|FG000|Overall Study|Withdrawal by Subject|7|||
46626671|NCT02142504|82797395|FG001|Overall Study|Withdrawal by Subject|9|||
46626672|NCT02142504|82797396|FG002|Overall Study|Withdrawal by Subject|11|||
46626673|NCT02142504|82797394|FG000|Overall Study|Pregnancy|4|||
46626674|NCT02142504|82797395|FG001|Overall Study|Pregnancy|4|||
46626675|NCT02142504|82797396|FG002|Overall Study|Pregnancy|2|||
46626676|NCT02142504|82797394|FG000|Overall Study|Physician Decision|0|||
46626677|NCT02142504|82797395|FG001|Overall Study|Physician Decision|1|||
46626678|NCT02142504|82797396|FG002|Overall Study|Physician Decision|3|||
46626679|NCT02142504|82797394|FG000|Overall Study|Reason Not Specified|4|||
46626680|NCT02142504|82797395|FG001|Overall Study|Reason Not Specified|5|||
46626681|NCT02142504|82797396|FG002|Overall Study|Reason Not Specified|4|||
46626682|NCT02121522|82797404|FG000|Overall Study|Adverse Event|1|||
46626683|NCT02121210|82797410|FG000|Overall Study|Adverse Event|5|||
46626684|NCT02121210|82797411|FG001|Overall Study|Adverse Event|7|||
46626685|NCT02121210|82797410|FG000|Overall Study|Lack of Efficacy|2|||
46626686|NCT02121210|82797411|FG001|Overall Study|Lack of Efficacy|0|||
46626687|NCT02121210|82797410|FG000|Overall Study|Other than specified above|0|||
46626688|NCT02121210|82797411|FG001|Overall Study|Other than specified above|2|||
46626689|NCT02141490|82797420|FG000|Overall Study|Screening failures|4|||
46626690|NCT02141490|82797421|FG001|Overall Study|Screening failures|0|||
46626691|NCT02141490|82797422|FG002|Overall Study|Screening failures|0|||
46626692|NCT02097108|82797432|FG000|Overall Study|Adverse Event|1|||
46626693|NCT02097108|82797432|FG000|Overall Study|patient was abroad for 6 months|1|||
46626694|NCT02097030|82797438|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
46626695|NCT02097030|82797439|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
46626696|NCT02097030|82797438|FG000|First Intervention (3 Days)|Visual Acuity|0|||
46626697|NCT02097030|82797439|FG001|First Intervention (3 Days)|Visual Acuity|1|||
46626698|NCT02096952|82797449|FG000|Overall Study|Adverse Event|1|||
46626699|NCT02120898|82797456|FG000|Overall Study|Withdrawal by Subject|4|||
46626700|NCT02120898|82797457|FG001|Overall Study|Withdrawal by Subject|2|||
46626701|NCT02120898|82797458|FG002|Overall Study|Withdrawal by Subject|2|||
46626702|NCT02120898|82797456|FG000|Overall Study|Non-compliance with study drug|3|||
46626703|NCT02120898|82797457|FG001|Overall Study|Non-compliance with study drug|0|||
46626704|NCT02120898|82797458|FG002|Overall Study|Non-compliance with study drug|0|||
46626705|NCT02120898|82797456|FG000|Overall Study|Adverse Event|1|||
46626706|NCT02120898|82797457|FG001|Overall Study|Adverse Event|2|||
46626707|NCT02120898|82797458|FG002|Overall Study|Adverse Event|1|||
46626708|NCT02120898|82797456|FG000|Overall Study|Protocol Violation|1|||
46626709|NCT02120898|82797457|FG001|Overall Study|Protocol Violation|2|||
46626710|NCT02120898|82797458|FG002|Overall Study|Protocol Violation|0|||
46626711|NCT02120898|82797456|FG000|Overall Study|Lost to Follow-up|0|||
46626712|NCT02120898|82797457|FG001|Overall Study|Lost to Follow-up|0|||
46626713|NCT02120898|82797458|FG002|Overall Study|Lost to Follow-up|1|||
46626714|NCT02120664|82797471|FG000|Overall Study|Withdrawal by Subject|0|||
46626715|NCT02120664|82797472|FG001|Overall Study|Withdrawal by Subject|0|||
47029846|NCT01753401|83279741|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
47029847|NCT01753401|83279742|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
47029848|NCT01753401|83279743|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
47029849|NCT01753401|83279740|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
47029850|NCT01753401|83279741|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
47029851|NCT01753401|83279742|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
47029852|NCT01753401|83279743|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
47029853|NCT01618916|83279759|FG000|Overall Study|Adverse Event|1|||
47029854|NCT01618916|83279760|FG001|Overall Study|Adverse Event|0|||
47029855|NCT01618916|83279761|FG002|Overall Study|Adverse Event|0|||
46626716|NCT02120664|82797473|FG002|Overall Study|Withdrawal by Subject|0|||
46626717|NCT02120664|82797474|FG003|Overall Study|Withdrawal by Subject|1|||
46626718|NCT02120664|82797475|FG004|Overall Study|Withdrawal by Subject|0|||
47029856|NCT01618916|83279762|FG003|Overall Study|Adverse Event|0|||
47029857|NCT01618916|83279763|FG004|Overall Study|Adverse Event|0|||
46626719|NCT01627860|82797490|FG000|Overall Study|Adverse Event|9|||
46626720|NCT01627860|82797491|FG001|Overall Study|Adverse Event|4|||
46626721|NCT01627860|82797490|FG000|Overall Study|Withdrawal by Subject|2|||
46626722|NCT01627860|82797491|FG001|Overall Study|Withdrawal by Subject|1|||
46626723|NCT01627860|82797490|FG000|Overall Study|Seizure frequency doubled|0|||
46626724|NCT01627860|82797491|FG001|Overall Study|Seizure frequency doubled|1|||
46626725|NCT01627860|82797490|FG000|Overall Study|Protocol Violation|1|||
46626726|NCT01627860|82797491|FG001|Overall Study|Protocol Violation|0|||
46626727|NCT01627782|82797501|FG000|Overall Study|Adverse Event|1|||
46626728|NCT01627782|82797502|FG001|Overall Study|Adverse Event|2|||
46626729|NCT01627782|82797503|FG002|Overall Study|Adverse Event|0|||
46626730|NCT01627782|82797504|FG003|Overall Study|Adverse Event|1|||
46626731|NCT01627782|82797501|FG000|Overall Study|Lack of Efficacy|11|||
47029858|NCT01618916|83279764|FG005|Overall Study|Adverse Event|0|||
47029859|NCT01618916|83279759|FG000|Overall Study|Withdrawal by Subject|0|||
47029860|NCT01618916|83279760|FG001|Overall Study|Withdrawal by Subject|1|||
47029861|NCT01618916|83279761|FG002|Overall Study|Withdrawal by Subject|1|||
47029862|NCT01618916|83279762|FG003|Overall Study|Withdrawal by Subject|0|||
47029863|NCT01618916|83279763|FG004|Overall Study|Withdrawal by Subject|1|||
47029864|NCT01618916|83279764|FG005|Overall Study|Withdrawal by Subject|0|||
47029865|NCT01618916|83279759|FG000|Overall Study|Lost to Follow-up|1|||
47029866|NCT01618916|83279760|FG001|Overall Study|Lost to Follow-up|0|||
47029867|NCT01618916|83279761|FG002|Overall Study|Lost to Follow-up|0|||
47029868|NCT01618916|83279762|FG003|Overall Study|Lost to Follow-up|2|||
47029869|NCT01618916|83279763|FG004|Overall Study|Lost to Follow-up|0|||
47029870|NCT01618916|83279764|FG005|Overall Study|Lost to Follow-up|0|||
47029871|NCT01753323|83279780|FG000|Overall Study|Lack of Efficacy|0|||
47029872|NCT01753323|83279781|FG001|Overall Study|Lack of Efficacy|0|||
47029873|NCT01753323|83279782|FG002|Overall Study|Lack of Efficacy|8|||
47029874|NCT01753323|83279780|FG000|Overall Study|Protocol deviation|1|||
47029875|NCT01753323|83279781|FG001|Overall Study|Protocol deviation|0|||
47029876|NCT01753323|83279782|FG002|Overall Study|Protocol deviation|0|||
47029877|NCT01753323|83279780|FG000|Overall Study|Adverse Event|0|||
47029878|NCT01753323|83279781|FG001|Overall Study|Adverse Event|0|||
47029879|NCT01753323|83279782|FG002|Overall Study|Adverse Event|1|||
47029880|NCT01894568|83279793|FG000|Overall Study|Adverse Event|2|||
47029881|NCT01894568|83279794|FG001|Overall Study|Adverse Event|3|||
47029882|NCT01894568|83279793|FG000|Overall Study|Protocol required discontinuation|2|||
47029883|NCT01894568|83279794|FG001|Overall Study|Protocol required discontinuation|1|||
47029884|NCT01894568|83279793|FG000|Overall Study|Withdrawal by Subject|5|||
47029885|NCT01894568|83279794|FG001|Overall Study|Withdrawal by Subject|5|||
47029886|NCT01894568|83279793|FG000|Overall Study|Physician Decision|1|||
47029887|NCT01894568|83279794|FG001|Overall Study|Physician Decision|0|||
47029888|NCT01894568|83279793|FG000|Overall Study|Lost to Follow-up|0|||
47029889|NCT01894568|83279794|FG001|Overall Study|Lost to Follow-up|1|||
47029890|NCT01618838|83279801|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
47029891|NCT01920152|83279808|FG000|Overall Study|Withdrawal by Subject|1|||
47029892|NCT01920152|83279809|FG001|Overall Study|Withdrawal by Subject|2|||
47029893|NCT01752933|83279817|FG000|Treatment|Disease Progression|3|||
47029894|NCT01752933|83279818|FG001|Treatment|Disease Progression|29|||
47029895|NCT01752933|83279817|FG000|Treatment|Withdrawal by Subject|0|||
47029896|NCT01752933|83279818|FG001|Treatment|Withdrawal by Subject|5|||
47029897|NCT01752933|83279817|FG000|Treatment|Adverse Event|1|||
47029898|NCT01752933|83279818|FG001|Treatment|Adverse Event|4|||
47029899|NCT01752933|83279817|FG000|Treatment|Physician Decision|0|||
47029900|NCT01752933|83279818|FG001|Treatment|Physician Decision|3|||
47029901|NCT01752933|83279817|FG000|Treatment|Death|0|||
47029902|NCT01752933|83279818|FG001|Treatment|Death|2|||
47029903|NCT01752933|83279817|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
47029904|NCT01752933|83279818|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
47029905|NCT01752933|83279817|FG000|Treatment|Patient noncompliant|0|||
47029906|NCT01752933|83279818|FG001|Treatment|Patient noncompliant|1|||
47029907|NCT01752933|83279817|FG000|Treatment|Patient unable to travel to appointments|0|||
47029908|NCT01752933|83279818|FG001|Treatment|Patient unable to travel to appointments|1|||
47029909|NCT01752933|83279817|FG000|Overall Study and Follow-up|Death|4|||
47029910|NCT01752933|83279818|FG001|Overall Study and Follow-up|Death|34|||
47029911|NCT01752933|83279817|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
47029912|NCT01752933|83279818|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
47029913|NCT01752933|83279817|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
47029914|NCT01752933|83279818|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
47029915|NCT01752933|83279817|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
47029916|NCT01752933|83279818|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
47029917|NCT01752855|83279827|FG000|Overall Study|Adverse Event|1|||
47029918|NCT01752855|83279828|FG001|Overall Study|Adverse Event|0|||
47029919|NCT01752855|83279827|FG000|Overall Study|Withdrew Consent|0|||
47029920|NCT01752855|83279828|FG001|Overall Study|Withdrew Consent|2|||
47029921|NCT01752855|83279827|FG000|Overall Study|Lack of Efficacy|0|||
47029922|NCT01752855|83279828|FG001|Overall Study|Lack of Efficacy|2|||
47029923|NCT01402492|83279837|FG000|Overall Study|Withdrawal by Subject|17|||
47029924|NCT01402492|83279838|FG001|Overall Study|Withdrawal by Subject|11|||
47029925|NCT01402492|83279839|FG002|Overall Study|Withdrawal by Subject|11|||
47029926|NCT01402492|83279837|FG000|Overall Study|Adverse Event|2|||
47029927|NCT01402492|83279838|FG001|Overall Study|Adverse Event|3|||
47029928|NCT01402492|83279839|FG002|Overall Study|Adverse Event|4|||
47029929|NCT01402492|83279837|FG000|Overall Study|Physician Decision|0|||
47029930|NCT01402492|83279838|FG001|Overall Study|Physician Decision|3|||
47029931|NCT01402492|83279839|FG002|Overall Study|Physician Decision|0|||
47029932|NCT01402492|83279837|FG000|Overall Study|Incarcerated (N=3)|2|||
47029933|NCT01402492|83279838|FG001|Overall Study|Incarcerated (N=3)|0|||
47029934|NCT01402492|83279839|FG002|Overall Study|Incarcerated (N=3)|1|||
47029935|NCT01402102|83279849|FG000|Overall Study|Protocol Violation|1|||
47029936|NCT01402102|83279850|FG001|Overall Study|Protocol Violation|0|||
47029937|NCT01402102|83279849|FG000|Overall Study|Insufficiency of compliance|1|||
47029938|NCT01402102|83279850|FG001|Overall Study|Insufficiency of compliance|1|||
47029939|NCT01402102|83279849|FG000|Overall Study|Withdrawal by Subject|0|||
47029940|NCT01402102|83279850|FG001|Overall Study|Withdrawal by Subject|2|||
47029941|NCT01423084|83279860|FG000|Overall Study|Adverse Event|0|||
47029942|NCT01423084|83279861|FG001|Overall Study|Adverse Event|1|||
47029943|NCT01423084|83279860|FG000|Overall Study|Withdrawal by Subject|2|||
47029944|NCT01423084|83279861|FG001|Overall Study|Withdrawal by Subject|3|||
47029945|NCT01894256|83279871|FG000|Part A|Adverse Event|0|||
47029946|NCT01894256|83279872|FG001|Part A|Adverse Event|1|||
47029947|NCT01894256|83279873|FG002|Part A|Adverse Event|0|||
47029948|NCT01894256|83279871|FG000|Part B|Death|0|||
47029949|NCT01894256|83279872|FG001|Part B|Death|1|||
47029950|NCT01894256|83279873|FG002|Part B|Death|1|||
47029951|NCT01894256|83279871|FG000|Part B|Withdrawal by Subject|0|||
47029952|NCT01894256|83279872|FG001|Part B|Withdrawal by Subject|1|||
47029953|NCT01894256|83279873|FG002|Part B|Withdrawal by Subject|0|||
47029954|NCT01894256|83279871|FG000|Part B|Lack of Efficacy|15|||
47029955|NCT01894256|83279872|FG001|Part B|Lack of Efficacy|12|||
47029956|NCT01894256|83279873|FG002|Part B|Lack of Efficacy|13|||
47029957|NCT01780935|83279886|FG000|Overall Study|Admin problems due to early termination|321|||
47029958|NCT01780935|83279887|FG001|Overall Study|Admin problems due to early termination|309|||
47029959|NCT01780935|83279886|FG000|Overall Study|Adverse Event|2|||
47029960|NCT01780935|83279887|FG001|Overall Study|Adverse Event|4|||
47029961|NCT01780935|83279886|FG000|Overall Study|Death|1|||
47029962|NCT01780935|83279887|FG001|Overall Study|Death|6|||
47029963|NCT01780935|83279886|FG000|Overall Study|Lost to Follow-up|2|||
47029964|NCT01780935|83279887|FG001|Overall Study|Lost to Follow-up|6|||
47029965|NCT01780935|83279886|FG000|Overall Study|Physician Decision|1|||
47029966|NCT01780935|83279887|FG001|Overall Study|Physician Decision|1|||
47029967|NCT01780935|83279886|FG000|Overall Study|Protocol deviation|0|||
47029968|NCT01780935|83279887|FG001|Overall Study|Protocol deviation|1|||
47029969|NCT01780935|83279886|FG000|Overall Study|Patient withdrew consent|8|||
46626732|NCT01627782|82797502|FG001|Overall Study|Lack of Efficacy|1|||
46626733|NCT01627782|82797503|FG002|Overall Study|Lack of Efficacy|15|||
46626734|NCT01627782|82797504|FG003|Overall Study|Lack of Efficacy|2|||
46626735|NCT01627782|82797501|FG000|Overall Study|Protocol Violation|1|||
46626736|NCT01627782|82797502|FG001|Overall Study|Protocol Violation|0|||
46626737|NCT01627782|82797503|FG002|Overall Study|Protocol Violation|0|||
46626738|NCT01627782|82797504|FG003|Overall Study|Protocol Violation|0|||
46626739|NCT01627782|82797501|FG000|Overall Study|Withdrawal by Subject|2|||
46626740|NCT01627782|82797502|FG001|Overall Study|Withdrawal by Subject|1|||
46626741|NCT01627782|82797503|FG002|Overall Study|Withdrawal by Subject|0|||
46626742|NCT01627782|82797504|FG003|Overall Study|Withdrawal by Subject|0|||
46626743|NCT01627782|82797501|FG000|Overall Study|Other|0|||
46626744|NCT01627782|82797502|FG001|Overall Study|Other|2|||
46626745|NCT01627782|82797503|FG002|Overall Study|Other|0|||
46626746|NCT01627782|82797504|FG003|Overall Study|Other|3|||
46626747|NCT01627782|82797501|FG000|Overall Study|Randomized But Not Treated|1|||
46626748|NCT01627782|82797502|FG001|Overall Study|Randomized But Not Treated|0|||
46626749|NCT01627782|82797503|FG002|Overall Study|Randomized But Not Treated|0|||
46626750|NCT01627782|82797504|FG003|Overall Study|Randomized But Not Treated|0|||
46626751|NCT01598532|82797516|FG000|Overall Study|Lost to Follow-up|3|||
46626752|NCT01598532|82797516|FG000|Overall Study|Did not meet inclusion criteria|8|||
46626753|NCT02119650|82797525|FG000|Overall Study|Adverse Event|3|||
47029970|NCT01780935|83279887|FG001|Overall Study|Patient withdrew consent|9|||
47029971|NCT01894100|83279895|FG000|Overall Study|Lost to Follow-up|0|||
47029972|NCT01894100|83279896|FG001|Overall Study|Lost to Follow-up|1|||
46626754|NCT02119650|82797526|FG001|Overall Study|Adverse Event|4|||
47029973|NCT01894100|83279895|FG000|Overall Study|Withdrawal by Subject|3|||
47029974|NCT01894100|83279896|FG001|Overall Study|Withdrawal by Subject|0|||
47029975|NCT01401478|83279942|FG000|Overall Study|Study drug not available|6|||
47029976|NCT01401478|83279942|FG000|Overall Study|Adverse Event|5|||
47029977|NCT01401478|83279942|FG000|Overall Study|Hyperphosphatemia|5|||
47029978|NCT01401478|83279942|FG000|Overall Study|Lost to Follow-up|5|||
47029979|NCT01401478|83279942|FG000|Overall Study|Kidney transplantation|3|||
47029980|NCT01401478|83279942|FG000|Overall Study|Withdrawal by Subject|3|||
47029981|NCT01401478|83279942|FG000|Overall Study|Blood samples not available|1|||
46626755|NCT02119650|82797525|FG000|Overall Study|Subject decision|2|||
46626756|NCT02119650|82797526|FG001|Overall Study|Subject decision|3|||
46626757|NCT02119650|82797525|FG000|Overall Study|Disease progression|11|||
46626758|NCT02119650|82797526|FG001|Overall Study|Disease progression|14|||
46626759|NCT02119650|82797525|FG000|Overall Study|Death|5|||
46626760|NCT02119650|82797526|FG001|Overall Study|Death|1|||
46626761|NCT02119650|82797525|FG000|Overall Study|Noncompliance with study treatment|1|||
47029982|NCT01401478|83279942|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
47029983|NCT01401478|83279942|FG000|Overall Study|Low intact parathyroid hormone|1|||
47029984|NCT01401478|83279942|FG000|Overall Study|Serious adverse event|1|||
47029985|NCT01422850|83279946|FG000|Overall Study|Physician Decision|3|||
47029986|NCT01422538|83279955|FG000|Overall Study|Lost to Follow-up|0|||
47029987|NCT01422538|83279956|FG001|Overall Study|Lost to Follow-up|1|||
47029988|NCT01422538|83279957|FG002|Overall Study|Lost to Follow-up|1|||
47029989|NCT01422538|83279955|FG000|Overall Study|Missed visit|0|||
47029990|NCT01422538|83279956|FG001|Overall Study|Missed visit|1|||
47029991|NCT01422538|83279957|FG002|Overall Study|Missed visit|1|||
47029992|NCT01422382|83279966|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
47029993|NCT01401322|83279970|FG000|Overall Study|Withdrawal by Subject|1|||
47029994|NCT01401322|83279970|FG000|Overall Study|Physician Decision|1|||
47029995|NCT01387594|83279976|FG000|Overall Study|Withdrawal by Subject|0|||
47029996|NCT01387594|83279977|FG001|Overall Study|Withdrawal by Subject|2|||
47029997|NCT01387594|83279976|FG000|Overall Study|Lost to Follow-up|0|||
47029998|NCT01387594|83279977|FG001|Overall Study|Lost to Follow-up|1|||
47029999|NCT01401010|83279988|FG000|Overall Study|Could not interpret assay results|1|||
47030000|NCT01401010|83279989|FG001|Overall Study|Could not interpret assay results|0|||
47030001|NCT01400932|83280002|FG000|Overall Study|Adverse Event|10|||
47030002|NCT01400932|83280003|FG001|Overall Study|Adverse Event|5|||
47030003|NCT01400932|83280002|FG000|Overall Study|Lack of Efficacy|0|||
47030004|NCT01400932|83280003|FG001|Overall Study|Lack of Efficacy|3|||
47030005|NCT01400932|83280002|FG000|Overall Study|Withdrawal by Subject|2|||
47030006|NCT01400932|83280003|FG001|Overall Study|Withdrawal by Subject|6|||
47030007|NCT01400932|83280002|FG000|Overall Study|Lost to Follow-up|1|||
47030008|NCT01400932|83280003|FG001|Overall Study|Lost to Follow-up|0|||
47030009|NCT01400932|83280002|FG000|Overall Study|Protocol Deviation|0|||
46626762|NCT02119650|82797526|FG001|Overall Study|Noncompliance with study treatment|1|||
46626763|NCT02119650|82797525|FG000|Overall Study|Study terminated by the sponsor|1|||
46626764|NCT02119650|82797526|FG001|Overall Study|Study terminated by the sponsor|0|||
46626765|NCT02119650|82797525|FG000|Overall Study|Physician Decision|0|||
46626766|NCT02119650|82797526|FG001|Overall Study|Physician Decision|2|||
46626767|NCT02119650|82797525|FG000|Overall Study|Multiple reasons for termination|2|||
46626768|NCT02119650|82797526|FG001|Overall Study|Multiple reasons for termination|1|||
46626769|NCT02119416|82797535|FG000|Overall Study|Protocol Violation|1|||
46626770|NCT02119416|82797536|FG001|Overall Study|Protocol Violation|1|||
46626771|NCT02119416|82797537|FG002|Overall Study|Protocol Violation|1|||
46626772|NCT02119416|82797535|FG000|Overall Study|wrong pubertal stage|1|||
46626773|NCT02119416|82797536|FG001|Overall Study|wrong pubertal stage|0|||
46626774|NCT02119416|82797537|FG002|Overall Study|wrong pubertal stage|1|||
46626775|NCT02140164|82797548|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
46626776|NCT02119260|82797559|FG000|Overall Study|Adverse Event|1|||
46626777|NCT02119260|82797560|FG001|Overall Study|Adverse Event|0|||
46626778|NCT02119260|82797561|FG002|Overall Study|Adverse Event|0|||
46626779|NCT02119260|82797562|FG003|Overall Study|Adverse Event|0|||
46626780|NCT02119260|82797563|FG004|Overall Study|Adverse Event|0|||
46626781|NCT02119260|82797564|FG005|Overall Study|Adverse Event|0|||
46626782|NCT02119260|82797565|FG006|Overall Study|Adverse Event|0|||
46626783|NCT02119260|82797559|FG000|Overall Study|Withdrew consent|0|||
46626784|NCT02119260|82797560|FG001|Overall Study|Withdrew consent|1|||
46626785|NCT02119260|82797561|FG002|Overall Study|Withdrew consent|1|||
46626786|NCT02119260|82797562|FG003|Overall Study|Withdrew consent|0|||
46626787|NCT02119260|82797563|FG004|Overall Study|Withdrew consent|0|||
46626788|NCT02119260|82797564|FG005|Overall Study|Withdrew consent|0|||
46626789|NCT02119260|82797565|FG006|Overall Study|Withdrew consent|0|||
46626790|NCT02119104|82797590|FG000|Overall Study|Protocol Violation|16|||
46626791|NCT02119026|82797596|FG000|1st-line Treatment|Adverse Event|9|||
46626792|NCT02119026|82797597|FG001|1st-line Treatment|Adverse Event|14|||
46626793|NCT02119026|82797596|FG000|1st-line Treatment|Physician Decision|3|||
46626794|NCT02119026|82797597|FG001|1st-line Treatment|Physician Decision|8|||
46626795|NCT02119026|82797596|FG000|1st-line Treatment|Withdrawal by Subject|4|||
47030010|NCT01400932|83280003|FG001|Overall Study|Protocol Deviation|1|||
47030011|NCT01400932|83280002|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
47030012|NCT01400932|83280003|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
47030013|NCT01400698|83280013|FG000|Overall Study|Lost to Follow-up|2|||
47030014|NCT01400698|83280014|FG001|Overall Study|Lost to Follow-up|5|||
47030015|NCT01400698|83280015|FG002|Overall Study|Lost to Follow-up|2|||
47030016|NCT01400698|83280016|FG003|Overall Study|Lost to Follow-up|1|||
47030017|NCT01400698|83280017|FG004|Overall Study|Lost to Follow-up|4|||
46626796|NCT02119026|82797597|FG001|1st-line Treatment|Withdrawal by Subject|10|||
46626797|NCT02119026|82797596|FG000|1st-line Treatment|Patient condition or compliance|6|||
46626798|NCT02119026|82797597|FG001|1st-line Treatment|Patient condition or compliance|4|||
46626799|NCT02119026|82797596|FG000|1st-line Treatment|Surgery of metastases|2|||
46626800|NCT02119026|82797597|FG001|1st-line Treatment|Surgery of metastases|1|||
46626801|NCT02119026|82797596|FG000|1st-line Treatment|Death|2|||
47030018|NCT01400698|83280018|FG005|Overall Study|Lost to Follow-up|3|||
47030019|NCT01400698|83280013|FG000|Overall Study|Withdrawal by Subject|8|||
47030020|NCT01400698|83280014|FG001|Overall Study|Withdrawal by Subject|2|||
47030021|NCT01400698|83280015|FG002|Overall Study|Withdrawal by Subject|0|||
47030022|NCT01400698|83280016|FG003|Overall Study|Withdrawal by Subject|4|||
47030023|NCT01400698|83280017|FG004|Overall Study|Withdrawal by Subject|1|||
47030024|NCT01400698|83280018|FG005|Overall Study|Withdrawal by Subject|3|||
47030025|NCT01400698|83280013|FG000|Overall Study|Protocol Violation|0|||
47030026|NCT01400698|83280014|FG001|Overall Study|Protocol Violation|1|||
47030027|NCT01400698|83280015|FG002|Overall Study|Protocol Violation|0|||
47030028|NCT01400698|83280016|FG003|Overall Study|Protocol Violation|0|||
47030029|NCT01400698|83280017|FG004|Overall Study|Protocol Violation|1|||
47030030|NCT01400698|83280018|FG005|Overall Study|Protocol Violation|0|||
47030031|NCT01400698|83280013|FG000|Overall Study|Non-compliance|0|||
47030032|NCT01400698|83280014|FG001|Overall Study|Non-compliance|1|||
47030033|NCT01400698|83280015|FG002|Overall Study|Non-compliance|0|||
47030034|NCT01400698|83280016|FG003|Overall Study|Non-compliance|1|||
47030035|NCT01400698|83280017|FG004|Overall Study|Non-compliance|0|||
47030036|NCT01400698|83280018|FG005|Overall Study|Non-compliance|0|||
47030037|NCT01400698|83280013|FG000|Overall Study|Adverse Event|1|||
47030038|NCT01400698|83280014|FG001|Overall Study|Adverse Event|0|||
47030039|NCT01400698|83280015|FG002|Overall Study|Adverse Event|0|||
47030040|NCT01400698|83280016|FG003|Overall Study|Adverse Event|0|||
47030041|NCT01400698|83280017|FG004|Overall Study|Adverse Event|0|||
47030042|NCT01400698|83280018|FG005|Overall Study|Adverse Event|0|||
47030043|NCT01400698|83280013|FG000|Overall Study|Other|4|||
46710655|NCT00910624|82926903|FG002|Follow-Up Phase|Adverse Event|1|||
46710656|NCT00910624|82926904|FG003|Follow-Up Phase|Adverse Event|0|||
46710657|NCT00910624|82926901|FG000|Follow-Up Phase|Lost to Follow-up|3|||
46710658|NCT00910624|82926902|FG001|Follow-Up Phase|Lost to Follow-up|1|||
46710659|NCT00910624|82926903|FG002|Follow-Up Phase|Lost to Follow-up|2|||
46710660|NCT00910624|82926904|FG003|Follow-Up Phase|Lost to Follow-up|0|||
46710661|NCT00910624|82926901|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
46710662|NCT00910624|82926902|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
46710663|NCT00910624|82926903|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
46710664|NCT00910624|82926904|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
46710665|NCT00910624|82926901|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
46710666|NCT00910624|82926902|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
46710667|NCT00910624|82926903|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
46710668|NCT00910624|82926904|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
47030044|NCT01400698|83280014|FG001|Overall Study|Other|2|||
47030045|NCT01400698|83280015|FG002|Overall Study|Other|0|||
47030046|NCT01400698|83280016|FG003|Overall Study|Other|2|||
46710669|NCT00910624|82926901|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
46710670|NCT00910624|82926902|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
47030047|NCT01400698|83280017|FG004|Overall Study|Other|1|||
46626802|NCT02119026|82797597|FG001|1st-line Treatment|Death|1|||
47030048|NCT01400698|83280018|FG005|Overall Study|Other|0|||
47030049|NCT01890746|83280030|FG000|Overall Study|Death|39|||
47030050|NCT01890746|83280031|FG001|Overall Study|Death|30|||
46710671|NCT00910624|82926903|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
46710672|NCT00910624|82926904|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
47030051|NCT01890746|83280030|FG000|Overall Study|Adverse Event|1|||
47030052|NCT01890746|83280031|FG001|Overall Study|Adverse Event|0|||
47030053|NCT01890746|83280030|FG000|Overall Study|Lost to Follow-up|4|||
47030054|NCT01890746|83280031|FG001|Overall Study|Lost to Follow-up|1|||
47030055|NCT01890746|83280030|FG000|Overall Study|Physician Decision|3|||
47030056|NCT01890746|83280031|FG001|Overall Study|Physician Decision|2|||
47030057|NCT01890746|83280030|FG000|Overall Study|Withdrawal by Subject|5|||
47030058|NCT01890746|83280031|FG001|Overall Study|Withdrawal by Subject|8|||
47030059|NCT01422304|83280039|FG000|Overall Study|Adverse Event|0|||
47030060|NCT01422304|83280040|FG001|Overall Study|Adverse Event|1|||
46710673|NCT00910624|82926901|FG000|Follow-Up Phase|Administrative|0|||
46710674|NCT00910624|82926902|FG001|Follow-Up Phase|Administrative|1|||
46710675|NCT00910624|82926903|FG002|Follow-Up Phase|Administrative|1|||
46710676|NCT00910624|82926904|FG003|Follow-Up Phase|Administrative|0|||
46710677|NCT01123980|82926918|FG000|Overall Study|Adverse Event|1|||
46710678|NCT01123980|82926919|FG001|Overall Study|Adverse Event|1|||
46710679|NCT01123980|82926918|FG000|Overall Study|Lack of Efficacy|1|||
46710680|NCT01123980|82926919|FG001|Overall Study|Lack of Efficacy|0|||
46710681|NCT01123980|82926918|FG000|Overall Study|Physician Decision|0|||
47030061|NCT01422304|83280039|FG000|Overall Study|Lost to Follow-up|14|||
47030062|NCT01422304|83280040|FG001|Overall Study|Lost to Follow-up|20|||
47030063|NCT01422304|83280039|FG000|Overall Study|Never Entered Follow-up|2|||
47030064|NCT01422304|83280040|FG001|Overall Study|Never Entered Follow-up|1|||
47030065|NCT01422304|83280039|FG000|Overall Study|Protocol Violation|1|||
47030066|NCT01422304|83280040|FG001|Overall Study|Protocol Violation|0|||
47030067|NCT01422304|83280039|FG000|Overall Study|Withdrawal by Subject|4|||
47030068|NCT01422304|83280040|FG001|Overall Study|Withdrawal by Subject|2|||
46626803|NCT02119026|82797596|FG000|2nd-line Treatment|Lost to Follow-up|2|||
46626804|NCT02119026|82797597|FG001|2nd-line Treatment|Lost to Follow-up|0|||
47030069|NCT01422304|83280039|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
47030070|NCT01422304|83280040|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
47030071|NCT01422304|83280039|FG000|Overall Study|Not Treated|3|||
47030072|NCT01422304|83280040|FG001|Overall Study|Not Treated|11|||
46626805|NCT02119026|82797596|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
46626806|NCT02119026|82797597|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
46626807|NCT02119026|82797596|FG000|2nd-line Treatment|Adverse Event|4|||
46626808|NCT02119026|82797597|FG001|2nd-line Treatment|Adverse Event|1|||
46626809|NCT02095158|82797603|FG000|Overall Study|Adverse Event|14|||
46626810|NCT02095158|82797603|FG000|Overall Study|Lack of Efficacy|3|||
46626811|NCT02095158|82797603|FG000|Overall Study|Pregnancy|1|||
46626812|NCT02095158|82797603|FG000|Overall Study|Lost to Follow-up|20|||
46626813|NCT02095158|82797603|FG000|Overall Study|Personal Reasons|35|||
46626814|NCT02095158|82797603|FG000|Overall Study|Protocol Violation|1|||
46626815|NCT02095158|82797603|FG000|Overall Study|Other Miscellaneous Reasons|1|||
46626816|NCT02094612|82797609|FG000|Overall Study|Lost to Follow-up|47|||
46626817|NCT02094612|82797610|FG001|Overall Study|Lost to Follow-up|47|||
46626818|NCT02094612|82797609|FG000|Overall Study|Never started ADHD medication|32|||
46626819|NCT02094612|82797610|FG001|Overall Study|Never started ADHD medication|23|||
46626820|NCT02139306|82797618|FG000|Overall Study|Withdrawal by Subject|4|||
46626821|NCT02139306|82797619|FG001|Overall Study|Withdrawal by Subject|6|||
46626822|NCT02139306|82797618|FG000|Overall Study|Adverse Event|3|||
46626823|NCT02139306|82797619|FG001|Overall Study|Adverse Event|4|||
46626824|NCT02139306|82797618|FG000|Overall Study|Physician Decision|0|||
46626825|NCT02139306|82797619|FG001|Overall Study|Physician Decision|1|||
46626826|NCT02139306|82797618|FG000|Overall Study|Other Unspecified|2|||
46626827|NCT02139306|82797619|FG001|Overall Study|Other Unspecified|3|||
46626828|NCT02139306|82797618|FG000|Overall Study|Protocol Violation|4|||
46710682|NCT01123980|82926919|FG001|Overall Study|Physician Decision|1|||
47030073|NCT01387516|83280050|FG000|Overall Study|Lost to Follow-up|4|||
47030074|NCT01387516|83280051|FG001|Overall Study|Lost to Follow-up|4|||
47030075|NCT01387516|83280052|FG002|Overall Study|Lost to Follow-up|2|||
46710683|NCT01123980|82926918|FG000|Overall Study|Lost to Follow-up|0|||
46710684|NCT01123980|82926919|FG001|Overall Study|Lost to Follow-up|6|||
47030076|NCT01387516|83280053|FG003|Overall Study|Lost to Follow-up|3|||
47030077|NCT01387516|83280050|FG000|Overall Study|Withdrawal by Subject|1|||
47030078|NCT01387516|83280051|FG001|Overall Study|Withdrawal by Subject|1|||
47030079|NCT01387516|83280052|FG002|Overall Study|Withdrawal by Subject|2|||
47030080|NCT01387516|83280053|FG003|Overall Study|Withdrawal by Subject|0|||
47030081|NCT01387516|83280050|FG000|Overall Study|Death|0|||
47030082|NCT01387516|83280051|FG001|Overall Study|Death|0|||
46626829|NCT02139306|82797619|FG001|Overall Study|Protocol Violation|0|||
46626830|NCT02094300|82797626|FG000|Overall Study|Death|7|||
46626831|NCT02094300|82797626|FG000|Overall Study|Lost to Follow-up|10|||
46626832|NCT02094300|82797626|FG000|Overall Study|Still be eligible for follow-up|3|||
46626833|NCT02118792|82797632|FG000|Overall Study|Withdrawal by Subject|6|||
46626834|NCT02118792|82797633|FG001|Overall Study|Withdrawal by Subject|3|||
46626835|NCT02118792|82797632|FG000|Overall Study|Lost to Follow-up|4|||
46710685|NCT01123980|82926918|FG000|Overall Study|Protocol Violation|6|||
46626836|NCT02118792|82797633|FG001|Overall Study|Lost to Follow-up|4|||
46626837|NCT02118792|82797632|FG000|Overall Study|Adverse Event|5|||
46626838|NCT02118792|82797633|FG001|Overall Study|Adverse Event|4|||
46626839|NCT02118792|82797632|FG000|Overall Study|Withdrawal by parent/guardian|14|||
46626840|NCT02118792|82797633|FG001|Overall Study|Withdrawal by parent/guardian|20|||
46626841|NCT02118792|82797632|FG000|Overall Study|Other|1|||
46626842|NCT02118792|82797633|FG001|Overall Study|Other|6|||
46626843|NCT02118792|82797632|FG000|Overall Study|Randomised but not treated|1|||
46626844|NCT02118792|82797633|FG001|Overall Study|Randomised but not treated|0|||
46626845|NCT02118714|82797641|FG000|Overall Study|Lost to Follow-up|2|||
46626846|NCT02118714|82797641|FG000|Overall Study|Protocol Violation|1|||
46626847|NCT02138916|82797648|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
46626848|NCT02138916|82797649|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
46626849|NCT02138916|82797650|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
46626850|NCT02138916|82797648|FG000|Overall Study|Death|14|||
46626851|NCT02138916|82797649|FG001|Overall Study|Death|11|||
46626852|NCT02138916|82797650|FG002|Overall Study|Death|12|||
46626853|NCT02138916|82797648|FG000|Overall Study|Withdrawal by Subject|27|||
46626854|NCT02138916|82797649|FG001|Overall Study|Withdrawal by Subject|31|||
46626855|NCT02138916|82797650|FG002|Overall Study|Withdrawal by Subject|32|||
46626856|NCT02138916|82797648|FG000|Overall Study|Study specific withdrawal criteria|0|||
46626857|NCT02138916|82797649|FG001|Overall Study|Study specific withdrawal criteria|0|||
46626858|NCT02138916|82797650|FG002|Overall Study|Study specific withdrawal criteria|1|||
46626859|NCT02138916|82797648|FG000|Overall Study|incorrect enrolment|1|||
46626860|NCT02138916|82797649|FG001|Overall Study|incorrect enrolment|1|||
46626861|NCT02138916|82797650|FG002|Overall Study|incorrect enrolment|0|||
46626862|NCT02138916|82797648|FG000|Overall Study|Severe non-compliance|1|||
46626863|NCT02138916|82797649|FG001|Overall Study|Severe non-compliance|2|||
46626864|NCT02138916|82797650|FG002|Overall Study|Severe non-compliance|1|||
46626865|NCT02138916|82797648|FG000|Overall Study|Lost to Follow-up|4|||
46626866|NCT02138916|82797649|FG001|Overall Study|Lost to Follow-up|2|||
46626867|NCT02138916|82797650|FG002|Overall Study|Lost to Follow-up|3|||
46626868|NCT02138916|82797648|FG000|Overall Study|Adverse Event|4|||
46626869|NCT02138916|82797649|FG001|Overall Study|Adverse Event|4|||
46626870|NCT02138916|82797650|FG002|Overall Study|Adverse Event|3|||
46626871|NCT02118012|82797660|FG000|Overall Study|Adverse Event|0|||
46626872|NCT02118012|82797661|FG001|Overall Study|Adverse Event|1|||
46626873|NCT02118012|82797660|FG000|Overall Study|Physician Decision|0|||
46626874|NCT02118012|82797661|FG001|Overall Study|Physician Decision|1|||
46626875|NCT02093520|82797669|FG000|Overall Study|Not treated|6|||
47030083|NCT01387516|83280052|FG002|Overall Study|Death|0|||
47030084|NCT01387516|83280053|FG003|Overall Study|Death|1|||
47030085|NCT01421134|83280074|FG000|Overall Study|Adverse Event|3|||
47030086|NCT01421134|83280075|FG001|Overall Study|Adverse Event|5|||
47030087|NCT01421134|83280074|FG000|Overall Study|Lack of Efficacy|2|||
47030088|NCT01421134|83280075|FG001|Overall Study|Lack of Efficacy|4|||
46626876|NCT02093520|82797670|FG001|Overall Study|Not treated|22|||
46626877|NCT02138838|82797678|FG000|Overall Study|Study Closure|7|||
46626878|NCT02138838|82797679|FG001|Overall Study|Study Closure|6|||
46626879|NCT02138838|82797678|FG000|Overall Study|Withdrawal by Subject|1|||
46626880|NCT02138838|82797679|FG001|Overall Study|Withdrawal by Subject|5|||
46626881|NCT02138214|82797688|FG000|Overall Study|Withdrawal by Subject|0|||
46626882|NCT02138214|82797689|FG001|Overall Study|Withdrawal by Subject|1|||
46626883|NCT02138214|82797690|FG002|Overall Study|Withdrawal by Subject|0|||
46626884|NCT02138214|82797688|FG000|Overall Study|Lost to Follow-up|0|||
46626885|NCT02138214|82797689|FG001|Overall Study|Lost to Follow-up|2|||
46626886|NCT02138214|82797690|FG002|Overall Study|Lost to Follow-up|4|||
46626887|NCT02138214|82797688|FG000|Overall Study|Screen Failure|0|||
46626888|NCT02138214|82797689|FG001|Overall Study|Screen Failure|1|||
46626889|NCT02138214|82797690|FG002|Overall Study|Screen Failure|0|||
46626890|NCT02092662|82797699|FG000|Overall Study|Lost to Follow-up|13|||
46710686|NCT01123980|82926919|FG001|Overall Study|Protocol Violation|6|||
47030089|NCT01421134|83280074|FG000|Overall Study|Protocol Violation|0|||
47030090|NCT01421134|83280075|FG001|Overall Study|Protocol Violation|3|||
47030091|NCT01421134|83280074|FG000|Overall Study|Withdrawal by Subject|1|||
47030092|NCT01421134|83280075|FG001|Overall Study|Withdrawal by Subject|1|||
46626891|NCT02092662|82797700|FG001|Overall Study|Lost to Follow-up|0|||
46626892|NCT02092350|82797709|FG000|Overall Study|Adverse Event|0|||
46626893|NCT02092350|82797710|FG001|Overall Study|Adverse Event|3|||
46626894|NCT02092350|82797709|FG000|Overall Study|Death|2|||
46626895|NCT02092350|82797710|FG001|Overall Study|Death|5|||
46626896|NCT02092350|82797709|FG000|Overall Study|Lost to Follow-up|3|||
46626897|NCT02092350|82797710|FG001|Overall Study|Lost to Follow-up|1|||
46626898|NCT02092350|82797709|FG000|Overall Study|Protocol Violation|1|||
46626899|NCT02092350|82797710|FG001|Overall Study|Protocol Violation|0|||
46626900|NCT02092350|82797709|FG000|Overall Study|Physician Decision|1|||
46626901|NCT02092350|82797710|FG001|Overall Study|Physician Decision|1|||
46626902|NCT02092350|82797709|FG000|Overall Study|Screen Failure|1|||
46626903|NCT02092350|82797710|FG001|Overall Study|Screen Failure|0|||
46626904|NCT02092350|82797709|FG000|Overall Study|Withdrawal by Subject|2|||
46626905|NCT02092350|82797710|FG001|Overall Study|Withdrawal by Subject|2|||
46626906|NCT02117544|82797718|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
46626907|NCT02117544|82797719|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
46626908|NCT02138136|82797726|FG000|Overall Study|Protocol Violation|4|||
46626909|NCT02138136|82797726|FG000|Overall Study|Physician Decision|7|||
46626910|NCT02138136|82797726|FG000|Overall Study|Lack of Efficacy|35|||
46626911|NCT02138136|82797726|FG000|Overall Study|Pregnancy|2|||
46626912|NCT02138136|82797726|FG000|Overall Study|Adverse Event|18|||
46626913|NCT02138136|82797726|FG000|Overall Study|Withdrawal by Subject|36|||
46626914|NCT02138136|82797726|FG000|Overall Study|Lost to Follow-up|32|||
46626915|NCT02138136|82797726|FG000|Overall Study|Withdrawn by Sponsor|5|||
46626916|NCT01626690|82797733|FG000|Overall Study|Protocol Violation|1|||
46626917|NCT01626690|82797734|FG001|Overall Study|Protocol Violation|0|||
46626918|NCT01626690|82797733|FG000|Overall Study|Adverse Event|1|||
46626919|NCT01626690|82797734|FG001|Overall Study|Adverse Event|0|||
46626920|NCT01626456|82797744|FG000|Overall Study|Withdrawal by Subject|21|||
46626921|NCT01626456|82797745|FG001|Overall Study|Withdrawal by Subject|46|||
46626922|NCT01626456|82797744|FG000|Overall Study|Adverse Event|2|||
46626923|NCT01626456|82797745|FG001|Overall Study|Adverse Event|27|||
46626924|NCT01626456|82797744|FG000|Overall Study|Lost to Follow-up|2|||
46626925|NCT01626456|82797745|FG001|Overall Study|Lost to Follow-up|27|||
46626926|NCT01626456|82797744|FG000|Overall Study|Lack of Efficacy|6|||
46626927|NCT01626456|82797745|FG001|Overall Study|Lack of Efficacy|7|||
46626928|NCT01626456|82797744|FG000|Overall Study|Physician Decision|1|||
46626929|NCT01626456|82797745|FG001|Overall Study|Physician Decision|4|||
46626930|NCT01626456|82797744|FG000|Overall Study|Protocol Violation|1|||
46626931|NCT01626456|82797745|FG001|Overall Study|Protocol Violation|1|||
46626932|NCT01626456|82797744|FG000|Overall Study|Site Closure|2|||
46626933|NCT01626456|82797745|FG001|Overall Study|Site Closure|3|||
46626934|NCT01626456|82797744|FG000|Overall Study|Incarceration|0|||
46626935|NCT01626456|82797745|FG001|Overall Study|Incarceration|2|||
46626936|NCT02116608|82797763|FG000|Overall Study|Lost to Follow-up|0|||
46626937|NCT02116608|82797764|FG001|Overall Study|Lost to Follow-up|0|||
46626938|NCT02116608|82797765|FG002|Overall Study|Lost to Follow-up|1|||
46626939|NCT02116608|82797763|FG000|Overall Study|Physician Decision|0|||
46626940|NCT02116608|82797764|FG001|Overall Study|Physician Decision|1|||
46626941|NCT02116608|82797765|FG002|Overall Study|Physician Decision|0|||
46626942|NCT02116608|82797763|FG000|Overall Study|Death|0|||
46626943|NCT02116608|82797764|FG001|Overall Study|Death|1|||
46626944|NCT02116608|82797765|FG002|Overall Study|Death|0|||
46626945|NCT02092116|82797775|FG000|Overall Study|Withdrawal by Subject|0|||
46626946|NCT02092116|82797776|FG001|Overall Study|Withdrawal by Subject|3|||
46626947|NCT02092116|82797775|FG000|Overall Study|Adverse Event|0|||
46626948|NCT02092116|82797776|FG001|Overall Study|Adverse Event|1|||
46626949|NCT02091726|82797782|FG000|Overall Study|Lost to Follow-up|6|||
46626950|NCT02091414|82797786|FG000|Overall Study|Withdrawal by Subject|2|||
46626951|NCT02091414|82797786|FG000|Overall Study|Death|2|||
46626952|NCT02116530|82797792|FG000|Overall Study|Withdrawal by Subject|1|||
46626953|NCT02116530|82797793|FG001|Overall Study|Withdrawal by Subject|2|||
46626954|NCT02116530|82797792|FG000|Overall Study|Adverse Event|4|||
46626955|NCT02116530|82797793|FG001|Overall Study|Adverse Event|0|||
47030093|NCT01421134|83280074|FG000|Overall Study|Administrative|0|||
47030094|NCT01421134|83280075|FG001|Overall Study|Administrative|1|||
47030095|NCT01421134|83280074|FG000|Overall Study|Lost to Follow-up|1|||
47030096|NCT01421134|83280075|FG001|Overall Study|Lost to Follow-up|1|||
47030097|NCT01894022|83280083|FG000|Overall Study|Death|1|||
47030098|NCT01894022|83280084|FG001|Overall Study|Death|0|||
47030099|NCT01894022|83280083|FG000|Overall Study|Adverse Event, non-fatal|1|||
46626956|NCT02116530|82797792|FG000|Overall Study|Physician Decision|1|||
46626957|NCT02116530|82797793|FG001|Overall Study|Physician Decision|0|||
46710687|NCT01123980|82926918|FG000|Overall Study|Withdrawal by Subject|5|||
46626958|NCT02116530|82797792|FG000|Overall Study|Lost to Follow-up|1|||
46626959|NCT02116530|82797793|FG001|Overall Study|Lost to Follow-up|0|||
46626960|NCT02116530|82797792|FG000|Overall Study|Other Medical Problems|2|||
46710688|NCT01123980|82926919|FG001|Overall Study|Withdrawal by Subject|3|||
47030100|NCT01894022|83280084|FG001|Overall Study|Adverse Event, non-fatal|0|||
47030101|NCT01894022|83280083|FG000|Overall Study|Study Closed/terminated|7|||
46626961|NCT02116530|82797793|FG001|Overall Study|Other Medical Problems|2|||
46626962|NCT02072226|82797801|FG000|Overall Study|Lost to Follow-up|11|||
46626963|NCT02072226|82797802|FG001|Overall Study|Lost to Follow-up|7|||
46626964|NCT02072226|82797801|FG000|Overall Study|Patient Non-compliance|2|||
46626965|NCT02072226|82797802|FG001|Overall Study|Patient Non-compliance|3|||
46626966|NCT02072226|82797801|FG000|Overall Study|Death|1|||
46626967|NCT02072226|82797802|FG001|Overall Study|Death|0|||
46626968|NCT02072226|82797801|FG000|Overall Study|Patient Withdrawal of Consent|1|||
46626969|NCT02072226|82797802|FG001|Overall Study|Patient Withdrawal of Consent|0|||
46626970|NCT02090634|82797810|FG000|Overall Study|Lost to Follow-up|0|||
46626971|NCT02090634|82797811|FG001|Overall Study|Lost to Follow-up|1|||
46626972|NCT02090634|82797810|FG000|Overall Study|Death|0|||
47030102|NCT01894022|83280084|FG001|Overall Study|Study Closed/terminated|10|||
47030103|NCT01615328|83280093|FG000|Overall Study|Lost to Follow-up|3|||
47030104|NCT01615328|83280094|FG001|Overall Study|Lost to Follow-up|5|||
47030105|NCT01890512|83280104|FG000|Overall Study|Physician Decision|1|||
47030106|NCT01890512|83280104|FG000|Overall Study|Withdrawal by Subject|1|||
47030107|NCT01890512|83280104|FG000|Overall Study|Protocol Violation|1|||
47030108|NCT01387282|83280110|FG000|Overall Study|Death|47|||
47030109|NCT01387282|83280111|FG001|Overall Study|Death|16|||
47030110|NCT01387282|83280110|FG000|Overall Study|Other|5|||
47030111|NCT01387282|83280111|FG001|Overall Study|Other|1|||
47030112|NCT01387282|83280110|FG000|Overall Study|Unrelated AE|6|||
47030113|NCT01387282|83280111|FG001|Overall Study|Unrelated AE|4|||
46626973|NCT02090634|82797811|FG001|Overall Study|Death|1|||
46626974|NCT02090634|82797810|FG000|Overall Study|Protocol Violation|3|||
46626975|NCT02090634|82797811|FG001|Overall Study|Protocol Violation|1|||
46626976|NCT02090634|82797810|FG000|Overall Study|Adverse Event|2|||
46626977|NCT02090634|82797811|FG001|Overall Study|Adverse Event|0|||
46626978|NCT02114892|82797819|FG000|Overall Study|Lost to Follow-up|1|||
46626979|NCT02114892|82797820|FG001|Overall Study|Lost to Follow-up|2|||
46626980|NCT02070978|82797829|FG000|Overall Study|Adverse Event|6|||
46626981|NCT02070978|82797830|FG001|Overall Study|Adverse Event|2|||
46626982|NCT02070978|82797831|FG002|Overall Study|Adverse Event|0|||
46626983|NCT02070978|82797829|FG000|Overall Study|Lost to Follow-up|1|||
46626984|NCT02070978|82797830|FG001|Overall Study|Lost to Follow-up|3|||
46626985|NCT02070978|82797831|FG002|Overall Study|Lost to Follow-up|4|||
47030114|NCT01387282|83280110|FG000|Overall Study|Withdrawal by patient|33|||
47030115|NCT01387282|83280111|FG001|Overall Study|Withdrawal by patient|23|||
47030116|NCT01387282|83280110|FG000|Overall Study|Study drug-related AE|2|||
47030117|NCT01387282|83280111|FG001|Overall Study|Study drug-related AE|2|||
47030118|NCT01387282|83280110|FG000|Overall Study|Lost to Follow-up|4|||
47030119|NCT01387282|83280111|FG001|Overall Study|Lost to Follow-up|1|||
47030120|NCT01386970|83280119|FG000|Overall Study|Withdrawal by Subject|0|||
47030121|NCT01386970|83280120|FG001|Overall Study|Withdrawal by Subject|1|||
47030122|NCT01386970|83280119|FG000|Overall Study|Adverse Event|4|||
47030123|NCT01386970|83280120|FG001|Overall Study|Adverse Event|1|||
47030124|NCT01890434|83280128|FG000|Overall Study|Adverse Event|8|||
47030125|NCT01890434|83280128|FG000|Overall Study|PCI at external hospital|1|||
47030126|NCT01890434|83280128|FG000|Overall Study|Assessment discrepancy|1|||
47030127|NCT01890434|83280128|FG000|Overall Study|CRC didn't contact participant for FU|1|||
47030128|NCT01890434|83280128|FG000|Overall Study|Could not get whole set of images|1|||
47030129|NCT01890434|83280128|FG000|Overall Study|Decline to return for GSPECT|1|||
47030130|NCT01890434|83280128|FG000|Overall Study|GSPECT at rest was not done|1|||
47030131|NCT01890434|83280128|FG000|Overall Study|Participant didn't complete MRI|1|||
47030132|NCT01890434|83280128|FG000|Overall Study|Uncontactable by phone|1|||
47030133|NCT01890434|83280128|FG000|Overall Study|Moved out of position|1|||
47030134|NCT01890434|83280128|FG000|Overall Study|Unable to contact|1|||
47030135|NCT01890434|83280128|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
47030136|NCT01385566|83280138|FG000|Overall Study|Lost to Follow-up|1|||
47030137|NCT01385566|83280139|FG001|Overall Study|Lost to Follow-up|0|||
47030138|NCT01385566|83280140|FG002|Overall Study|Lost to Follow-up|0|||
47030139|NCT01385566|83280141|FG003|Overall Study|Lost to Follow-up|0|||
47030140|NCT01385566|83280142|FG004|Overall Study|Lost to Follow-up|0|||
47030141|NCT01385566|83280143|FG005|Overall Study|Lost to Follow-up|0|||
47030142|NCT01385566|83280138|FG000|Overall Study|Withdrawal by Subject|0|||
47030143|NCT01385566|83280139|FG001|Overall Study|Withdrawal by Subject|0|||
47030144|NCT01385566|83280140|FG002|Overall Study|Withdrawal by Subject|0|||
47030145|NCT01385566|83280141|FG003|Overall Study|Withdrawal by Subject|1|||
47030146|NCT01385566|83280142|FG004|Overall Study|Withdrawal by Subject|0|||
47030147|NCT01385566|83280143|FG005|Overall Study|Withdrawal by Subject|0|||
46626986|NCT02070978|82797829|FG000|Overall Study|Withdrawal by Subject|3|||
46626987|NCT02070978|82797830|FG001|Overall Study|Withdrawal by Subject|5|||
46626988|NCT02070978|82797831|FG002|Overall Study|Withdrawal by Subject|3|||
46626989|NCT02070978|82797829|FG000|Overall Study|Protocol Violation|1|||
47030148|NCT01780545|83280161|FG000|Overall Study|Withdrawal by Subject|3|||
46626990|NCT02070978|82797830|FG001|Overall Study|Protocol Violation|0|||
46626991|NCT02070978|82797831|FG002|Overall Study|Protocol Violation|3|||
46626992|NCT02070978|82797829|FG000|Overall Study|Lack of Efficacy|0|||
47030149|NCT01780545|83280162|FG001|Overall Study|Withdrawal by Subject|1|||
46626993|NCT02070978|82797830|FG001|Overall Study|Lack of Efficacy|1|||
46626994|NCT02070978|82797831|FG002|Overall Study|Lack of Efficacy|0|||
47030150|NCT01780545|83280161|FG000|Overall Study|Lost to Follow-up|1|||
47030151|NCT01780545|83280162|FG001|Overall Study|Lost to Follow-up|1|||
46626995|NCT02070978|82797829|FG000|Overall Study|Death|0|||
46626996|NCT02070978|82797830|FG001|Overall Study|Death|0|||
46626997|NCT02070978|82797831|FG002|Overall Study|Death|2|||
46626998|NCT02070978|82797829|FG000|Overall Study|Un-specified|3|||
47030152|NCT01780389|83280171|FG000|Overall Study|Adverse Event|1|||
47030153|NCT01778985|83280178|FG000|Overall Study|Lost to Follow-up|1|||
47030154|NCT01778985|83280179|FG001|Overall Study|Lost to Follow-up|0|||
47030155|NCT01778985|83280178|FG000|Overall Study|Physician Decision|2|||
47030156|NCT01778985|83280179|FG001|Overall Study|Physician Decision|2|||
47030157|NCT01778985|83280178|FG000|Overall Study|Protocol Violation|4|||
47030158|NCT01778985|83280179|FG001|Overall Study|Protocol Violation|1|||
47030159|NCT01778751|83280187|FG000|Overall Study|Lost to Follow-up|1|||
47030160|NCT01778751|83280188|FG001|Overall Study|Lost to Follow-up|0|||
47030161|NCT01778751|83280187|FG000|Overall Study|Withdrawal by Subject|0|||
47030162|NCT01778751|83280188|FG001|Overall Study|Withdrawal by Subject|2|||
47030163|NCT01778751|83280187|FG000|Overall Study|Transfered care|1|||
47030164|NCT01778751|83280188|FG001|Overall Study|Transfered care|0|||
47030165|NCT01865084|83280197|FG000|Double Blind Period (DB)|Adverse Event|2|||
47030166|NCT01865084|83280198|FG001|Double Blind Period (DB)|Adverse Event|2|||
47030167|NCT01865084|83280199|FG002|Double Blind Period (DB)|Adverse Event|1|||
47030168|NCT01865084|83280197|FG000|Double Blind Period (DB)|Protocol Violation|0|||
47030169|NCT01865084|83280198|FG001|Double Blind Period (DB)|Protocol Violation|0|||
47030170|NCT01865084|83280199|FG002|Double Blind Period (DB)|Protocol Violation|1|||
47030171|NCT01865084|83280197|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
47030172|NCT01865084|83280198|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
47030173|NCT01865084|83280199|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
47030174|NCT01865084|83280197|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
47030175|NCT01865084|83280198|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
47030176|NCT01865084|83280199|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
47030177|NCT01865084|83280197|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
46626999|NCT02070978|82797830|FG001|Overall Study|Un-specified|2|||
46627000|NCT02070978|82797831|FG002|Overall Study|Un-specified|2|||
46627001|NCT02070978|82797829|FG000|Overall Study|Terminated by Sponsor|33|||
46627002|NCT02070978|82797830|FG001|Overall Study|Terminated by Sponsor|40|||
46627003|NCT02070978|82797831|FG002|Overall Study|Terminated by Sponsor|39|||
46627004|NCT02114268|82797845|FG000|Overall Study|Lost to Follow-up|4|||
46627005|NCT02114268|82797846|FG001|Overall Study|Lost to Follow-up|1|||
46627006|NCT02114268|82797847|FG002|Overall Study|Lost to Follow-up|1|||
46627007|NCT02114268|82797848|FG003|Overall Study|Lost to Follow-up|0|||
46627008|NCT02114268|82797849|FG004|Overall Study|Lost to Follow-up|0|||
46627009|NCT02114268|82797850|FG005|Overall Study|Lost to Follow-up|2|||
46627010|NCT02114268|82797845|FG000|Overall Study|Withdrawal by Subject|1|||
46627011|NCT02114268|82797846|FG001|Overall Study|Withdrawal by Subject|0|||
46627012|NCT02114268|82797847|FG002|Overall Study|Withdrawal by Subject|0|||
46627013|NCT02114268|82797848|FG003|Overall Study|Withdrawal by Subject|0|||
46627014|NCT02114268|82797849|FG004|Overall Study|Withdrawal by Subject|0|||
46627015|NCT02114268|82797850|FG005|Overall Study|Withdrawal by Subject|1|||
46627016|NCT02114268|82797845|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
46627017|NCT02114268|82797846|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
46627018|NCT02114268|82797847|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
46627019|NCT02114268|82797848|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
46627020|NCT02114268|82797849|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
46627021|NCT02114268|82797850|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
46627022|NCT02089230|82797872|FG000|Overall Study|Death|0|||
46627023|NCT02089230|82797873|FG001|Overall Study|Death|0|||
46627024|NCT02089230|82797874|FG002|Overall Study|Death|2|||
46627025|NCT02089230|82797872|FG000|Overall Study|Seeking Alternative Therapy|0|||
46627026|NCT02089230|82797873|FG001|Overall Study|Seeking Alternative Therapy|0|||
46627027|NCT02089230|82797874|FG002|Overall Study|Seeking Alternative Therapy|4|||
46627028|NCT02070744|82797886|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
46627029|NCT02070744|82797887|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
46627030|NCT02070744|82797888|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
46627031|NCT02070744|82797889|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
46627032|NCT02070744|82797890|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
46627033|NCT02070744|82797886|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
46627034|NCT02070744|82797887|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
46627035|NCT02070744|82797888|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
46627036|NCT02070744|82797889|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
46627037|NCT02070744|82797890|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
46627038|NCT02070744|82797886|FG000|OLE Phase (48 Weeks)|Other|0|||
46627039|NCT02070744|82797887|FG001|OLE Phase (48 Weeks)|Other|0|||
46627040|NCT02070744|82797888|FG002|OLE Phase (48 Weeks)|Other|0|||
47030178|NCT01865084|83280198|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
46627041|NCT02070744|82797889|FG003|OLE Phase (48 Weeks)|Other|0|||
46627042|NCT02070744|82797890|FG004|OLE Phase (48 Weeks)|Other|1|||
46627043|NCT02113956|82797907|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
46627044|NCT02113956|82797908|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
46627045|NCT02113956|82797907|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
46627046|NCT02113956|82797908|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
47030179|NCT01865084|83280199|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
46627047|NCT02113956|82797907|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
46627048|NCT02113956|82797908|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
46627049|NCT02070588|82797917|FG000|Overall Study|Withdrawal by Subject|29|||
46627050|NCT02070588|82797918|FG001|Overall Study|Withdrawal by Subject|1|||
46627051|NCT02070588|82797919|FG002|Overall Study|Withdrawal by Subject|0|||
46627052|NCT02070588|82797917|FG000|Overall Study|Writhdrawal due to early termination|9|||
46627053|NCT02070588|82797918|FG001|Overall Study|Writhdrawal due to early termination|0|||
46627054|NCT02070588|82797919|FG002|Overall Study|Writhdrawal due to early termination|0|||
46627055|NCT02070588|82797917|FG000|Overall Study|Adverse Event|1|||
46627056|NCT02070588|82797918|FG001|Overall Study|Adverse Event|0|||
46627057|NCT02070588|82797919|FG002|Overall Study|Adverse Event|0|||
46627058|NCT02111850|82797938|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627059|NCT02111850|82797939|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627060|NCT02111850|82797940|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627061|NCT02111850|82797941|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627062|NCT02111850|82797942|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
46627063|NCT02111850|82797943|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627064|NCT02111850|82797944|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627065|NCT02111850|82797945|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627066|NCT02111850|82797946|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627067|NCT02111850|82797947|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627068|NCT02111850|82797948|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
46627069|NCT02087904|82797978|FG000|Overall Study|Did Not Receive Study Drug|0|||
46627070|NCT02087904|82797979|FG001|Overall Study|Did Not Receive Study Drug|0|||
46627071|NCT02087904|82797980|FG002|Overall Study|Did Not Receive Study Drug|2|||
46627072|NCT02087904|82797981|FG003|Overall Study|Did Not Receive Study Drug|1|||
47030180|NCT01865084|83280197|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
46627073|NCT02087904|82797978|FG000|Overall Study|Adverse Event|8|||
46627074|NCT02087904|82797979|FG001|Overall Study|Adverse Event|4|||
46627075|NCT02087904|82797980|FG002|Overall Study|Adverse Event|4|||
46627076|NCT02087904|82797981|FG003|Overall Study|Adverse Event|12|||
46627077|NCT02087904|82797978|FG000|Overall Study|Lack of Efficacy|3|||
46627078|NCT02087904|82797979|FG001|Overall Study|Lack of Efficacy|6|||
46627079|NCT02087904|82797980|FG002|Overall Study|Lack of Efficacy|3|||
46627080|NCT02087904|82797981|FG003|Overall Study|Lack of Efficacy|2|||
46627081|NCT02087904|82797978|FG000|Overall Study|Other|6|||
46627082|NCT02087904|82797979|FG001|Overall Study|Other|2|||
46627083|NCT02087904|82797980|FG002|Overall Study|Other|4|||
47030181|NCT01865084|83280198|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
47030182|NCT01865084|83280199|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
47030183|NCT01865084|83280197|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
47030184|NCT01865084|83280198|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
47030185|NCT01865084|83280199|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
47030186|NCT01865084|83280197|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
47030187|NCT01865084|83280198|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
47030188|NCT01865084|83280199|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
47030189|NCT01865084|83280197|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
47030190|NCT01865084|83280198|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
47030191|NCT01865084|83280199|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
47030192|NCT01778127|83280214|FG000|Overall Study|Lost to Follow-up|5|||
47030193|NCT01778127|83280215|FG001|Overall Study|Lost to Follow-up|1|||
47030194|NCT01778127|83280216|FG002|Overall Study|Lost to Follow-up|2|||
47030195|NCT01778127|83280214|FG000|Overall Study|Withdrawal by Subject|3|||
47030196|NCT01778127|83280215|FG001|Overall Study|Withdrawal by Subject|1|||
47030197|NCT01778127|83280216|FG002|Overall Study|Withdrawal by Subject|4|||
47030198|NCT01892540|83280227|FG000|Overall Study|Did not complete PET/MRI|0|||
47030199|NCT01892540|83280228|FG001|Overall Study|Did not complete PET/MRI|0|||
47030200|NCT01892540|83280229|FG002|Overall Study|Did not complete PET/MRI|2|||
47030201|NCT01892540|83280227|FG000|Overall Study|Did not fit in scanner|0|||
47030202|NCT01892540|83280228|FG001|Overall Study|Did not fit in scanner|0|||
47030203|NCT01892540|83280229|FG002|Overall Study|Did not fit in scanner|1|||
46627084|NCT02087904|82797981|FG003|Overall Study|Other|4|||
46627085|NCT02087904|82797978|FG000|Overall Study|Withdrawal by Subject|8|||
46627086|NCT02087904|82797979|FG001|Overall Study|Withdrawal by Subject|3|||
46627087|NCT02087904|82797980|FG002|Overall Study|Withdrawal by Subject|7|||
46627088|NCT02087904|82797981|FG003|Overall Study|Withdrawal by Subject|4|||
46627089|NCT02087904|82797978|FG000|Overall Study|Lost to Follow-up|0|||
47030204|NCT01385098|83280237|FG000|Overall Study|Adverse Event|10|||
47030205|NCT01385098|83280237|FG000|Overall Study|Lost to Follow-up|4|||
46627090|NCT02087904|82797979|FG001|Overall Study|Lost to Follow-up|4|||
47030206|NCT01398514|83280245|FG000|Overall Study|Adverse Event|1|||
47030207|NCT01398514|83280246|FG001|Overall Study|Adverse Event|0|||
47030208|NCT01398514|83280245|FG000|Overall Study|Non-compliance with study procedures|2|||
47030209|NCT01398514|83280246|FG001|Overall Study|Non-compliance with study procedures|0|||
47030210|NCT01398514|83280245|FG000|Overall Study|Physiologic non-responsiveness|1|||
47030211|NCT01398514|83280246|FG001|Overall Study|Physiologic non-responsiveness|3|||
47030212|NCT01398514|83280245|FG000|Overall Study|Failure to show a conditioned response|4|||
47030213|NCT01398514|83280246|FG001|Overall Study|Failure to show a conditioned response|3|||
47030214|NCT01398358|83280257|FG000|Overall Study|Lost to Follow-up|11|||
47030215|NCT01398358|83280258|FG001|Overall Study|Lost to Follow-up|21|||
46627091|NCT02087904|82797980|FG002|Overall Study|Lost to Follow-up|2|||
46627092|NCT02087904|82797981|FG003|Overall Study|Lost to Follow-up|2|||
46627093|NCT02087670|82797993|FG000|Overall Study|Withdrawal by Subject|3|||
46627094|NCT02087670|82797994|FG001|Overall Study|Withdrawal by Subject|2|||
46627095|NCT02086968|82798002|FG000|Overall Study|Adverse Event|1|||
46627096|NCT02086968|82798003|FG001|Overall Study|Adverse Event|5|||
46627097|NCT02086968|82798002|FG000|Overall Study|Lost to Follow-up|2|||
46627098|NCT02086968|82798003|FG001|Overall Study|Lost to Follow-up|3|||
46627099|NCT02086968|82798002|FG000|Overall Study|Study drug received outside protocol|0|||
46627100|NCT02086968|82798003|FG001|Overall Study|Study drug received outside protocol|1|||
46627101|NCT02086968|82798002|FG000|Overall Study|Physician Decision|4|||
46627102|NCT02086968|82798003|FG001|Overall Study|Physician Decision|0|||
46627103|NCT02086968|82798002|FG000|Overall Study|Withdrawal by Subject|1|||
46627104|NCT02086968|82798003|FG001|Overall Study|Withdrawal by Subject|4|||
46627105|NCT02086110|82798011|FG000|Overall Study|Withdrawal by Subject|1|||
46627106|NCT02086110|82798012|FG001|Overall Study|Withdrawal by Subject|1|||
46710689|NCT01123980|82926918|FG000|Overall Study|Unclassified|6|||
46627107|NCT02085252|82798021|FG000|Overall Study|Withdrawal of Consent|1|||
46627108|NCT02085252|82798022|FG001|Overall Study|Withdrawal of Consent|0|||
46627109|NCT02085252|82798021|FG000|Overall Study|Adverse Event|0|||
46627110|NCT02085252|82798022|FG001|Overall Study|Adverse Event|1|||
46627111|NCT02085252|82798021|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
46627112|NCT02085252|82798022|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
46627113|NCT02085252|82798021|FG000|Overall Study|Reason Not Specified|0|||
46627114|NCT02085252|82798022|FG001|Overall Study|Reason Not Specified|1|||
46627115|NCT02085252|82798021|FG000|Overall Study|Reason Unknown|0|||
46627116|NCT02085252|82798022|FG001|Overall Study|Reason Unknown|1|||
46627117|NCT02084238|82798028|FG000|Overall Study|Lost to Follow-up|2|||
46627118|NCT02084082|82798041|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
46627119|NCT02084082|82798042|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
46627120|NCT02084082|82798043|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
46627121|NCT02084082|82798044|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
46627122|NCT02084082|82798041|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
46627123|NCT02084082|82798042|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
46627124|NCT02084082|82798043|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
46627125|NCT02084082|82798044|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
46627126|NCT02083926|82798056|FG000|Overall Study|Withdrawal by Subject|1|||
46627127|NCT02083926|82798057|FG001|Overall Study|Withdrawal by Subject|0|||
46627128|NCT02083380|82798067|FG000|Overall Study|Lack of Efficacy|68|||
46627129|NCT02083380|82798068|FG001|Overall Study|Lack of Efficacy|79|||
46627130|NCT02083380|82798069|FG002|Overall Study|Lack of Efficacy|64|||
46627131|NCT02083380|82798067|FG000|Overall Study|Withdrawal by Subject|9|||
46627132|NCT02083380|82798068|FG001|Overall Study|Withdrawal by Subject|3|||
46627133|NCT02083380|82798069|FG002|Overall Study|Withdrawal by Subject|7|||
46627134|NCT02083380|82798067|FG000|Overall Study|Physician Decision|1|||
46912653|NCT04034225|83142694|FG000|Overall Study|Withdrawal by Subject|2|||
46912654|NCT04034225|83142694|FG000|Overall Study|Study termination by Sponsor|18|||
46912655|NCT04034225|83142694|FG000|Overall Study|Physician Decision|1|||
46912656|NCT04034225|83142694|FG000|Overall Study|Lack of Efficacy|1|||
46912657|NCT02999178|83142702|FG000|Overall Study|Adverse Event|85|||
46912658|NCT02999178|83142703|FG001|Overall Study|Adverse Event|62|||
46912659|NCT02999178|83142702|FG000|Overall Study|Protocol Violation|1|||
47030216|NCT01398358|83280259|FG002|Overall Study|Lost to Follow-up|18|||
46627135|NCT02083380|82798068|FG001|Overall Study|Physician Decision|6|||
46627136|NCT02083380|82798069|FG002|Overall Study|Physician Decision|3|||
46627137|NCT02083380|82798067|FG000|Overall Study|Adverse Event|0|||
46627138|NCT02083380|82798068|FG001|Overall Study|Adverse Event|0|||
46627139|NCT02083380|82798069|FG002|Overall Study|Adverse Event|1|||
46627140|NCT02083380|82798067|FG000|Overall Study|Lost to Follow-up|5|||
47030217|NCT01398358|83280257|FG000|Overall Study|Withdrawal by Subject|3|||
46627141|NCT02083380|82798068|FG001|Overall Study|Lost to Follow-up|3|||
46627142|NCT02083380|82798069|FG002|Overall Study|Lost to Follow-up|3|||
46627143|NCT02083380|82798067|FG000|Overall Study|Other|8|||
46627144|NCT02083380|82798068|FG001|Overall Study|Other|4|||
46627145|NCT02083380|82798069|FG002|Overall Study|Other|6|||
46627146|NCT02109744|82798084|FG000|Overall Study|Death|1|||
46627147|NCT02109744|82798085|FG001|Overall Study|Death|1|||
46912660|NCT02999178|83142703|FG001|Overall Study|Protocol Violation|2|||
46912661|NCT02999178|83142702|FG000|Overall Study|Lost to Follow-up|0|||
46912662|NCT02999178|83142703|FG001|Overall Study|Lost to Follow-up|2|||
46912663|NCT02999178|83142702|FG000|Overall Study|Withdrawal by Subject|21|||
46912664|NCT02999178|83142703|FG001|Overall Study|Withdrawal by Subject|21|||
46912665|NCT02999178|83142702|FG000|Overall Study|Other reason not defined above|7|||
46912666|NCT02999178|83142703|FG001|Overall Study|Other reason not defined above|13|||
46912667|NCT02959190|83142715|FG000|Open Label|Adverse Event|5|||
46912668|NCT02959190|83142716|FG001|Open Label|Adverse Event|7|||
46912669|NCT02959190|83142717|FG002|Open Label|Adverse Event|3|||
46912670|NCT02959190|83142718|FG003|Open Label|Adverse Event|4|||
46912671|NCT02959190|83142715|FG000|Open Label|Pregnancy|0|||
46912672|NCT02959190|83142716|FG001|Open Label|Pregnancy|1|||
46912673|NCT02959190|83142717|FG002|Open Label|Pregnancy|0|||
46912674|NCT02959190|83142718|FG003|Open Label|Pregnancy|0|||
46912675|NCT02959190|83142715|FG000|Open Label|Withdrawal by Subject|2|||
46912676|NCT02959190|83142716|FG001|Open Label|Withdrawal by Subject|8|||
47030218|NCT01398358|83280258|FG001|Overall Study|Withdrawal by Subject|2|||
47030219|NCT01398358|83280259|FG002|Overall Study|Withdrawal by Subject|2|||
47030220|NCT01398358|83280257|FG000|Overall Study|no longer eligible|1|||
47030221|NCT01398358|83280258|FG001|Overall Study|no longer eligible|0|||
47030222|NCT01398358|83280259|FG002|Overall Study|no longer eligible|1|||
47030223|NCT01778049|83280269|FG000|Open Label Treatment Period|Adverse Event|5|||
47030224|NCT01778049|83280270|FG001|Open Label Treatment Period|Adverse Event|15|||
47030225|NCT01778049|83280271|FG002|Open Label Treatment Period|Adverse Event|0|||
47030226|NCT01778049|83280272|FG003|Open Label Treatment Period|Adverse Event|0|||
47030227|NCT01778049|83280273|FG004|Open Label Treatment Period|Adverse Event|0|||
47030228|NCT01778049|83280274|FG005|Open Label Treatment Period|Adverse Event|0|||
47030229|NCT01778049|83280269|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
47030230|NCT01778049|83280270|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
47030231|NCT01778049|83280271|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
47030232|NCT01778049|83280272|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
47030233|NCT01778049|83280273|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
47030234|NCT01778049|83280274|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
47030235|NCT01778049|83280269|FG000|Open Label Treatment Period|Protocol Violation|5|||
47030236|NCT01778049|83280270|FG001|Open Label Treatment Period|Protocol Violation|5|||
47030237|NCT01778049|83280271|FG002|Open Label Treatment Period|Protocol Violation|0|||
46710690|NCT01123980|82926919|FG001|Overall Study|Unclassified|7|||
46912677|NCT02959190|83142717|FG002|Open Label|Withdrawal by Subject|0|||
46912678|NCT02959190|83142718|FG003|Open Label|Withdrawal by Subject|0|||
46912679|NCT02959190|83142715|FG000|Open Label|Physician Decision|0|||
46912680|NCT02959190|83142716|FG001|Open Label|Physician Decision|0|||
46912681|NCT02959190|83142717|FG002|Open Label|Physician Decision|1|||
46912682|NCT02959190|83142718|FG003|Open Label|Physician Decision|0|||
46912683|NCT02959190|83142715|FG000|Open Label|Protocol Violation|0|||
46912684|NCT02959190|83142716|FG001|Open Label|Protocol Violation|0|||
46912685|NCT02959190|83142717|FG002|Open Label|Protocol Violation|0|||
46912686|NCT02959190|83142718|FG003|Open Label|Protocol Violation|2|||
46912687|NCT02959190|83142715|FG000|Post Treatment Follow Up|Adverse Event|1|||
46912688|NCT02959190|83142716|FG001|Post Treatment Follow Up|Adverse Event|1|||
46912689|NCT02959190|83142717|FG002|Post Treatment Follow Up|Adverse Event|0|||
46912690|NCT02959190|83142718|FG003|Post Treatment Follow Up|Adverse Event|0|||
46912691|NCT02959190|83142715|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
46912692|NCT02959190|83142716|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
46912693|NCT02959190|83142717|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
46912694|NCT02959190|83142718|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
46912695|NCT01344356|83142739|FG000|Overall Study|Physician Decision|0|||
46912696|NCT01344356|83142740|FG001|Overall Study|Physician Decision|3|||
46912697|NCT01344356|83142739|FG000|Overall Study|Lost to Follow-up|0|||
46912698|NCT01344356|83142740|FG001|Overall Study|Lost to Follow-up|6|||
46912699|NCT02956460|83142766|FG000|Lens 1|Lost to Follow-up|1|||
46912700|NCT02956460|83142767|FG001|Lens 1|Lost to Follow-up|0|||
46912701|NCT02999100|83142779|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
46912702|NCT02999100|83142780|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
46912703|NCT02999100|83142781|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
47030238|NCT01778049|83280272|FG003|Open Label Treatment Period|Protocol Violation|0|||
47030239|NCT01778049|83280273|FG004|Open Label Treatment Period|Protocol Violation|0|||
47030240|NCT01778049|83280274|FG005|Open Label Treatment Period|Protocol Violation|0|||
47030241|NCT01778049|83280269|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
47030242|NCT01778049|83280270|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
46912704|NCT02999100|83142782|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
46912705|NCT02999100|83142783|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
46912706|NCT02999100|83142784|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
47030243|NCT01778049|83280271|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
47030244|NCT01778049|83280272|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
46912707|NCT02999100|83142779|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
47030245|NCT01778049|83280273|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
47030246|NCT01778049|83280274|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
47030247|NCT01778049|83280269|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
47030248|NCT01778049|83280270|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
47030249|NCT01778049|83280271|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
47030250|NCT01778049|83280272|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
47030251|NCT01778049|83280273|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
47030252|NCT01778049|83280274|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
47030253|NCT01778049|83280269|FG000|Open Label Treatment Period|Not treated|2|||
47030254|NCT01778049|83280270|FG001|Open Label Treatment Period|Not treated|1|||
47030255|NCT01778049|83280271|FG002|Open Label Treatment Period|Not treated|0|||
47030256|NCT01778049|83280272|FG003|Open Label Treatment Period|Not treated|0|||
47030257|NCT01778049|83280273|FG004|Open Label Treatment Period|Not treated|0|||
47030258|NCT01778049|83280274|FG005|Open Label Treatment Period|Not treated|0|||
47030259|NCT01778049|83280269|FG000|Open Label Treatment Period|Other reason not defined above|77|||
47030260|NCT01778049|83280270|FG001|Open Label Treatment Period|Other reason not defined above|94|||
47030261|NCT01778049|83280271|FG002|Open Label Treatment Period|Other reason not defined above|0|||
47030262|NCT01778049|83280272|FG003|Open Label Treatment Period|Other reason not defined above|0|||
47030263|NCT01778049|83280273|FG004|Open Label Treatment Period|Other reason not defined above|0|||
47030264|NCT01778049|83280274|FG005|Open Label Treatment Period|Other reason not defined above|0|||
47030265|NCT01778049|83280269|FG000|Double Blind Treatment Period|Adverse Event|0|||
47030266|NCT01778049|83280270|FG001|Double Blind Treatment Period|Adverse Event|0|||
47030267|NCT01778049|83280271|FG002|Double Blind Treatment Period|Adverse Event|4|||
47030268|NCT01778049|83280272|FG003|Double Blind Treatment Period|Adverse Event|5|||
47030269|NCT01778049|83280273|FG004|Double Blind Treatment Period|Adverse Event|3|||
47030270|NCT01778049|83280274|FG005|Double Blind Treatment Period|Adverse Event|2|||
47030271|NCT01778049|83280269|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
47030272|NCT01778049|83280270|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
46627148|NCT02109744|82798084|FG000|Overall Study|no marrow exam|1|||
46627149|NCT02109744|82798085|FG001|Overall Study|no marrow exam|0|||
46627150|NCT02109432|82798091|FG000|Overall Study|Withdrawal by Subject|1|||
46627151|NCT02109042|82798095|FG000|Overall Study|Sponsor Decision|15|||
46627152|NCT02066922|82798100|FG000|Overall Study|Adverse Event|1|||
46627153|NCT02108262|82798111|FG000|Overall Study|Non-compliance|0|||
46627154|NCT02108262|82798112|FG001|Overall Study|Non-compliance|2|||
46627155|NCT02108262|82798113|FG002|Overall Study|Non-compliance|1|||
46627156|NCT02108262|82798114|FG003|Overall Study|Non-compliance|1|||
46627157|NCT02108262|82798111|FG000|Overall Study|Randomized by error/screen failure|0|||
46627158|NCT02108262|82798112|FG001|Overall Study|Randomized by error/screen failure|0|||
46627159|NCT02108262|82798113|FG002|Overall Study|Randomized by error/screen failure|1|||
47030273|NCT01778049|83280271|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
47030274|NCT01778049|83280272|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
47030275|NCT01778049|83280273|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
47030276|NCT01778049|83280274|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
46627160|NCT02108262|82798114|FG003|Overall Study|Randomized by error/screen failure|0|||
46627161|NCT02108262|82798111|FG000|Overall Study|Distance to center|0|||
46627162|NCT02108262|82798112|FG001|Overall Study|Distance to center|1|||
46627163|NCT02108262|82798113|FG002|Overall Study|Distance to center|1|||
46627164|NCT02108262|82798114|FG003|Overall Study|Distance to center|0|||
47030277|NCT01778049|83280269|FG000|Double Blind Treatment Period|Protocol Violation|0|||
47030278|NCT01778049|83280270|FG001|Double Blind Treatment Period|Protocol Violation|0|||
47030279|NCT01778049|83280271|FG002|Double Blind Treatment Period|Protocol Violation|2|||
47030280|NCT01778049|83280272|FG003|Double Blind Treatment Period|Protocol Violation|0|||
47030281|NCT01778049|83280273|FG004|Double Blind Treatment Period|Protocol Violation|0|||
47030282|NCT01778049|83280274|FG005|Double Blind Treatment Period|Protocol Violation|0|||
47030283|NCT01778049|83280269|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
47030284|NCT01778049|83280270|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
47030285|NCT01778049|83280271|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
46627165|NCT02108262|82798111|FG000|Overall Study|Adverse Event|0|||
46627166|NCT02108262|82798112|FG001|Overall Study|Adverse Event|11|||
46627167|NCT02108262|82798113|FG002|Overall Study|Adverse Event|6|||
47030286|NCT01778049|83280272|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
47030287|NCT01778049|83280273|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
47030288|NCT01778049|83280274|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
46627168|NCT02108262|82798114|FG003|Overall Study|Adverse Event|12|||
46627169|NCT02108262|82798111|FG000|Overall Study|Death|0|||
47030289|NCT01778049|83280269|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
46627170|NCT02108262|82798112|FG001|Overall Study|Death|2|||
46627171|NCT02108262|82798113|FG002|Overall Study|Death|2|||
46627172|NCT02108262|82798114|FG003|Overall Study|Death|1|||
46627173|NCT02108262|82798111|FG000|Overall Study|Lost to Follow-up|0|||
46627174|NCT02108262|82798112|FG001|Overall Study|Lost to Follow-up|0|||
47030290|NCT01778049|83280270|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
47030291|NCT01778049|83280271|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
47030292|NCT01778049|83280272|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
46710691|NCT01118520|82926928|FG000|Overall Study|AAA repair|9|||
46710692|NCT01118520|82926929|FG001|Overall Study|AAA repair|7|||
46912708|NCT02999100|83142780|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
46627175|NCT02108262|82798113|FG002|Overall Study|Lost to Follow-up|1|||
46627176|NCT02108262|82798114|FG003|Overall Study|Lost to Follow-up|0|||
46627177|NCT02108262|82798111|FG000|Overall Study|Physician Decision|0|||
46627178|NCT02108262|82798112|FG001|Overall Study|Physician Decision|0|||
46627179|NCT02108262|82798113|FG002|Overall Study|Physician Decision|2|||
46627180|NCT02108262|82798114|FG003|Overall Study|Physician Decision|0|||
46627181|NCT02108262|82798111|FG000|Overall Study|Withdrawal by Subject|0|||
46627182|NCT02108262|82798112|FG001|Overall Study|Withdrawal by Subject|7|||
46627183|NCT02108262|82798113|FG002|Overall Study|Withdrawal by Subject|3|||
46627184|NCT02108262|82798114|FG003|Overall Study|Withdrawal by Subject|4|||
46710693|NCT01118520|82926930|FG002|Overall Study|AAA repair|9|||
46912709|NCT02999100|83142781|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
46912710|NCT02999100|83142782|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
46912711|NCT02999100|83142783|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
46912712|NCT02999100|83142784|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
46912713|NCT02999100|83142779|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
46912714|NCT02999100|83142780|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
46912715|NCT02999100|83142781|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
46912716|NCT02999100|83142782|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
46912717|NCT02999100|83142783|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
46912718|NCT02999100|83142784|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
46912719|NCT02749370|83142806|FG000|Overall Study|Withdrawal by Subject|11|||
46912720|NCT02749370|83142806|FG000|Overall Study|Lost to Follow-up|3|||
46912721|NCT03607994|83142812|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
46967569|NCT02621931|83210133|FG001|Overall Study|Withdrawal by Subject|10|||
46627185|NCT02108262|82798111|FG000|Overall Study|Due to key hepatic values|0|||
46627186|NCT02108262|82798112|FG001|Overall Study|Due to key hepatic values|1|||
46627187|NCT02108262|82798113|FG002|Overall Study|Due to key hepatic values|0|||
46967570|NCT02621931|83210134|FG002|Overall Study|Withdrawal by Subject|11|||
46967571|NCT02621931|83210132|FG000|Overall Study|Protocol Violation|2|||
46710694|NCT01118520|82926928|FG000|Overall Study|Adverse Event|3|||
46967572|NCT02621931|83210133|FG001|Overall Study|Protocol Violation|2|||
46967573|NCT02621931|83210134|FG002|Overall Study|Protocol Violation|2|||
46967574|NCT02621931|83210132|FG000|Overall Study|Pregnancy|2|||
46967575|NCT02621931|83210133|FG001|Overall Study|Pregnancy|0|||
46967576|NCT02621931|83210134|FG002|Overall Study|Pregnancy|0|||
46967577|NCT02621931|83210132|FG000|Overall Study|Noncompliance to study procedures|0|||
46967578|NCT02621931|83210133|FG001|Overall Study|Noncompliance to study procedures|1|||
46967579|NCT02621931|83210134|FG002|Overall Study|Noncompliance to study procedures|2|||
46967580|NCT02621931|83210132|FG000|Overall Study|Lost to Follow-up|8|||
46967581|NCT02621931|83210133|FG001|Overall Study|Lost to Follow-up|7|||
46967582|NCT02621931|83210134|FG002|Overall Study|Lost to Follow-up|10|||
46967583|NCT02621931|83210132|FG000|Overall Study|Lack of Efficacy|0|||
46967584|NCT02621931|83210133|FG001|Overall Study|Lack of Efficacy|0|||
46967585|NCT02621931|83210134|FG002|Overall Study|Lack of Efficacy|1|||
46967586|NCT02621931|83210132|FG000|Overall Study|Other|1|||
46967587|NCT02621931|83210133|FG001|Overall Study|Other|1|||
46967588|NCT02621931|83210134|FG002|Overall Study|Other|3|||
46967589|NCT02621073|83210146|FG000|Overall Study|Lost to Follow-up|0|||
46967590|NCT02621073|83210147|FG001|Overall Study|Lost to Follow-up|1|||
46967591|NCT02621073|83210146|FG000|Overall Study|Physician Decision|3|||
46967592|NCT02621073|83210147|FG001|Overall Study|Physician Decision|2|||
46967593|NCT02158936|83210155|FG000|Overall Study|Study closed/ terminated|57|||
46967594|NCT02158936|83210156|FG001|Overall Study|Study closed/ terminated|77|||
46967595|NCT02158936|83210155|FG000|Overall Study|Azacitidine tx discontinued|53|||
46967596|NCT02158936|83210156|FG001|Overall Study|Azacitidine tx discontinued|46|||
46967597|NCT02158936|83210155|FG000|Overall Study|Adverse Event|39|||
46967598|NCT02158936|83210156|FG001|Overall Study|Adverse Event|24|||
46967599|NCT02158936|83210155|FG000|Overall Study|Withdrawal by Subject|15|||
46967600|NCT02158936|83210156|FG001|Overall Study|Withdrawal by Subject|16|||
46967601|NCT02158936|83210155|FG000|Overall Study|Physician Decision|15|||
46967602|NCT02158936|83210156|FG001|Overall Study|Physician Decision|13|||
46967603|NCT02158936|83210155|FG000|Overall Study|Lost to Follow-up|0|||
46967604|NCT02158936|83210156|FG001|Overall Study|Lost to Follow-up|1|||
46967605|NCT02158546|83210166|FG000|Overall Study|Physician Decision|0|||
46967606|NCT02158546|83210167|FG001|Overall Study|Physician Decision|1|||
46967607|NCT02158546|83210168|FG002|Overall Study|Physician Decision|0|||
46967608|NCT02158546|83210169|FG003|Overall Study|Physician Decision|0|||
47030293|NCT01778049|83280273|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
47030294|NCT01778049|83280274|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
47030295|NCT01778049|83280269|FG000|Double Blind Treatment Period|Not treated|0|||
47030296|NCT01778049|83280270|FG001|Double Blind Treatment Period|Not treated|0|||
47030297|NCT01778049|83280271|FG002|Double Blind Treatment Period|Not treated|0|||
47030298|NCT01778049|83280272|FG003|Double Blind Treatment Period|Not treated|2|||
47030299|NCT01778049|83280273|FG004|Double Blind Treatment Period|Not treated|2|||
47030300|NCT01778049|83280274|FG005|Double Blind Treatment Period|Not treated|0|||
47030301|NCT01778049|83280269|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
47030302|NCT01778049|83280270|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
47030303|NCT01778049|83280271|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
46627188|NCT02108262|82798114|FG003|Overall Study|Due to key hepatic values|0|||
46627189|NCT02108262|82798111|FG000|Overall Study|Unable to contact patient|0|||
46627190|NCT02108262|82798112|FG001|Overall Study|Unable to contact patient|3|||
46627191|NCT02108262|82798113|FG002|Overall Study|Unable to contact patient|1|||
46627192|NCT02108262|82798114|FG003|Overall Study|Unable to contact patient|2|||
46627193|NCT02108262|82798111|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
46627194|NCT02108262|82798112|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
46627195|NCT02108262|82798113|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
46627196|NCT02108262|82798114|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
46627197|NCT02108262|82798111|FG000|Overall Study|Patient did not want another infusion|0|||
46627198|NCT02108262|82798112|FG001|Overall Study|Patient did not want another infusion|3|||
46627199|NCT02108262|82798113|FG002|Overall Study|Patient did not want another infusion|3|||
46627200|NCT02108262|82798114|FG003|Overall Study|Patient did not want another infusion|2|||
46627201|NCT02108262|82798111|FG000|Overall Study|Vacation|0|||
46627202|NCT02108262|82798112|FG001|Overall Study|Vacation|1|||
46627203|NCT02108262|82798113|FG002|Overall Study|Vacation|0|||
47030304|NCT01778049|83280272|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
47030305|NCT01778049|83280273|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
47030306|NCT01778049|83280274|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
47030307|NCT01777581|83280288|FG000|Overall Study|Lost to Follow-up|1|||
47030308|NCT01777581|83280289|FG001|Overall Study|Lost to Follow-up|1|||
47030309|NCT01777581|83280288|FG000|Overall Study|Adverse Event|2|||
47030310|NCT01777581|83280289|FG001|Overall Study|Adverse Event|0|||
46627204|NCT02108262|82798114|FG003|Overall Study|Vacation|0|||
46627205|NCT02108262|82798111|FG000|Overall Study|Patient decision|0|||
46627206|NCT02108262|82798112|FG001|Overall Study|Patient decision|7|||
46627207|NCT02108262|82798113|FG002|Overall Study|Patient decision|9|||
46627208|NCT02108262|82798114|FG003|Overall Study|Patient decision|14|||
46627209|NCT02108262|82798111|FG000|Overall Study|Missed IV due to pharmacy error|0|||
46627210|NCT02108262|82798112|FG001|Overall Study|Missed IV due to pharmacy error|0|||
46627211|NCT02108262|82798113|FG002|Overall Study|Missed IV due to pharmacy error|1|||
46627212|NCT02108262|82798114|FG003|Overall Study|Missed IV due to pharmacy error|0|||
46627213|NCT02107482|82798123|FG000|Overall Study|inconveinence|2|||
46912722|NCT03607994|83142813|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
46912723|NCT02996682|83142821|FG000|Overall Study|Death|0|||
46627214|NCT02107482|82798123|FG000|Overall Study|Lost to Follow-up|1|||
46627215|NCT02107482|82798123|FG000|Overall Study|Lack of Efficacy|1|||
46627216|NCT02066298|82798133|FG000|Overall Study|Lost to Follow-up|3|||
46627217|NCT02066298|82798134|FG001|Overall Study|Lost to Follow-up|2|||
46627218|NCT02066298|82798135|FG002|Overall Study|Lost to Follow-up|3|||
46627219|NCT02066298|82798136|FG003|Overall Study|Lost to Follow-up|2|||
46912724|NCT02996682|83142822|FG001|Overall Study|Death|3|||
46627220|NCT02066298|82798137|FG004|Overall Study|Lost to Follow-up|3|||
46627221|NCT02066298|82798138|FG005|Overall Study|Lost to Follow-up|4|||
46627222|NCT02066298|82798133|FG000|Overall Study|Withdrawal by Subject|6|||
46967609|NCT02158546|83210166|FG000|Overall Study|Non-compliance|0|||
46967610|NCT02158546|83210167|FG001|Overall Study|Non-compliance|1|||
46967611|NCT02158546|83210168|FG002|Overall Study|Non-compliance|0|||
46967612|NCT02158546|83210169|FG003|Overall Study|Non-compliance|1|||
46967613|NCT02158546|83210166|FG000|Overall Study|Failure to meet eligibility criteria|0|||
46967614|NCT02158546|83210167|FG001|Overall Study|Failure to meet eligibility criteria|1|||
46967615|NCT02158546|83210168|FG002|Overall Study|Failure to meet eligibility criteria|0|||
46967616|NCT02158546|83210169|FG003|Overall Study|Failure to meet eligibility criteria|0|||
46967617|NCT02158546|83210166|FG000|Overall Study|Lack of Efficacy|1|||
46967618|NCT02158546|83210167|FG001|Overall Study|Lack of Efficacy|1|||
46967619|NCT02158546|83210168|FG002|Overall Study|Lack of Efficacy|0|||
46967620|NCT02158546|83210169|FG003|Overall Study|Lack of Efficacy|0|||
46967621|NCT02158546|83210166|FG000|Overall Study|Adverse Event|2|||
46967622|NCT02158546|83210167|FG001|Overall Study|Adverse Event|2|||
46967623|NCT02158546|83210168|FG002|Overall Study|Adverse Event|0|||
47030311|NCT01777581|83280288|FG000|Overall Study|Lack of Efficacy|0|||
47030312|NCT01777581|83280289|FG001|Overall Study|Lack of Efficacy|1|||
47030313|NCT01864148|83280300|FG000|Overall Study|Other|2|||
47030314|NCT01864148|83280301|FG001|Overall Study|Other|1|||
47030315|NCT01864148|83280302|FG002|Overall Study|Other|1|||
47030316|NCT01864148|83280303|FG003|Overall Study|Other|3|||
46710695|NCT01118520|82926929|FG001|Overall Study|Adverse Event|3|||
46710696|NCT01118520|82926930|FG002|Overall Study|Adverse Event|3|||
46710697|NCT01118520|82926928|FG000|Overall Study|Withdrawal by Subject|8|||
46710698|NCT01118520|82926929|FG001|Overall Study|Withdrawal by Subject|13|||
46710699|NCT01118520|82926930|FG002|Overall Study|Withdrawal by Subject|8|||
46710700|NCT01135992|82926938|FG000|Overall Study|Adverse Event|1|||
46710701|NCT01135992|82926938|FG000|Overall Study|Lack of Efficacy|1|||
46710702|NCT01135992|82926938|FG000|Overall Study|Protocol Violation|2|||
46710703|NCT01135992|82926938|FG000|Overall Study|Withdrawal criteria|10|||
46710704|NCT01135992|82926938|FG000|Overall Study|Unclassified|7|||
46710705|NCT00959049|82926948|FG000|Overall Study|Adverse Event|1|||
46710706|NCT00959049|82926949|FG001|Overall Study|Adverse Event|0|||
46710707|NCT00959049|82926950|FG002|Overall Study|Adverse Event|0|||
46710708|NCT00959049|82926951|FG003|Overall Study|Adverse Event|0|||
46710709|NCT00959049|82926952|FG004|Overall Study|Adverse Event|0|||
47030317|NCT01864148|83280304|FG004|Overall Study|Other|1|||
47030318|NCT01864148|83280300|FG000|Overall Study|Death|0|||
47030319|NCT01864148|83280301|FG001|Overall Study|Death|0|||
46710710|NCT00959049|82926953|FG005|Overall Study|Adverse Event|0|||
46710711|NCT00959049|82926948|FG000|Overall Study|Lost to Follow-up|17|||
46710712|NCT00959049|82926949|FG001|Overall Study|Lost to Follow-up|5|||
46710713|NCT00959049|82926950|FG002|Overall Study|Lost to Follow-up|1|||
46710714|NCT00959049|82926951|FG003|Overall Study|Lost to Follow-up|10|||
46710715|NCT00959049|82926952|FG004|Overall Study|Lost to Follow-up|9|||
46710716|NCT00959049|82926953|FG005|Overall Study|Lost to Follow-up|1|||
46710717|NCT00959049|82926948|FG000|Overall Study|Contraindicated medication|0|||
46710718|NCT00959049|82926949|FG001|Overall Study|Contraindicated medication|0|||
46710719|NCT00959049|82926950|FG002|Overall Study|Contraindicated medication|0|||
46710720|NCT00959049|82926951|FG003|Overall Study|Contraindicated medication|1|||
46710721|NCT00959049|82926952|FG004|Overall Study|Contraindicated medication|0|||
46710722|NCT00959049|82926953|FG005|Overall Study|Contraindicated medication|0|||
46710723|NCT00959049|82926948|FG000|Overall Study|Withdrawal by Subject|0|||
46710724|NCT00959049|82926949|FG001|Overall Study|Withdrawal by Subject|2|||
46710725|NCT00959049|82926950|FG002|Overall Study|Withdrawal by Subject|0|||
46710726|NCT00959049|82926951|FG003|Overall Study|Withdrawal by Subject|0|||
46710727|NCT00959049|82926952|FG004|Overall Study|Withdrawal by Subject|0|||
46710728|NCT00959049|82926953|FG005|Overall Study|Withdrawal by Subject|0|||
46710729|NCT00956943|82926980|FG000|Overall Study|Lost to Follow-up|9|||
46710730|NCT00956943|82926981|FG001|Overall Study|Lost to Follow-up|10|||
46710731|NCT00958893|82926987|FG000|Overall Study|Study prematurely terminated|4|||
47030320|NCT01864148|83280302|FG002|Overall Study|Death|0|||
47030321|NCT01864148|83280303|FG003|Overall Study|Death|1|||
47030322|NCT01864148|83280304|FG004|Overall Study|Death|0|||
47030323|NCT01864148|83280300|FG000|Overall Study|Investigator Decision|5|||
47030324|NCT01864148|83280301|FG001|Overall Study|Investigator Decision|0|||
47030325|NCT01864148|83280302|FG002|Overall Study|Investigator Decision|0|||
47030326|NCT01864148|83280303|FG003|Overall Study|Investigator Decision|4|||
47030327|NCT01864148|83280304|FG004|Overall Study|Investigator Decision|6|||
47030328|NCT01864148|83280300|FG000|Overall Study|Withdrawal by Subject|9|||
47030329|NCT01864148|83280301|FG001|Overall Study|Withdrawal by Subject|2|||
46710732|NCT01135914|82926994|FG000|Overall Study|Withdrawal by Subject|1|||
47030330|NCT01864148|83280302|FG002|Overall Study|Withdrawal by Subject|6|||
46710733|NCT01135914|82926995|FG001|Overall Study|Withdrawal by Subject|3|||
46710734|NCT01135914|82926996|FG002|Overall Study|Withdrawal by Subject|6|||
46710735|NCT01135914|82926994|FG000|Overall Study|Lost to Follow-up|1|||
46710736|NCT01135914|82926995|FG001|Overall Study|Lost to Follow-up|0|||
46710737|NCT01135914|82926996|FG002|Overall Study|Lost to Follow-up|1|||
46710738|NCT01135914|82926994|FG000|Overall Study|Protocol Violation|0|||
47030331|NCT01864148|83280303|FG003|Overall Study|Withdrawal by Subject|8|||
47030332|NCT01864148|83280304|FG004|Overall Study|Withdrawal by Subject|8|||
47030333|NCT01864148|83280300|FG000|Overall Study|Lost to Follow-up|0|||
47030334|NCT01864148|83280301|FG001|Overall Study|Lost to Follow-up|0|||
47030335|NCT01864148|83280302|FG002|Overall Study|Lost to Follow-up|0|||
47030336|NCT01864148|83280303|FG003|Overall Study|Lost to Follow-up|2|||
47030337|NCT01864148|83280304|FG004|Overall Study|Lost to Follow-up|1|||
47030338|NCT01864148|83280300|FG000|Overall Study|Adverse Event|4|||
47030339|NCT01864148|83280301|FG001|Overall Study|Adverse Event|2|||
47030340|NCT01864148|83280302|FG002|Overall Study|Adverse Event|4|||
47030341|NCT01864148|83280303|FG003|Overall Study|Adverse Event|7|||
47030342|NCT01864148|83280304|FG004|Overall Study|Adverse Event|7|||
47030343|NCT01864148|83280300|FG000|Overall Study|Not Dosed|0|||
47030344|NCT01864148|83280301|FG001|Overall Study|Not Dosed|0|||
47030345|NCT01864148|83280302|FG002|Overall Study|Not Dosed|0|||
47030346|NCT01864148|83280303|FG003|Overall Study|Not Dosed|1|||
47030347|NCT01864148|83280304|FG004|Overall Study|Not Dosed|0|||
47030348|NCT01751139|83280321|FG000|Overall Study|Other|135|||
47030349|NCT01751139|83280321|FG000|Overall Study|Sponsor study termination|1609|||
47030350|NCT01751139|83280321|FG000|Overall Study|Lost to Follow-up|240|||
47030351|NCT01751139|83280321|FG000|Overall Study|Withdrawal by Subject|251|||
47030352|NCT01751139|83280321|FG000|Overall Study|Adverse Event|1|||
47030353|NCT01751139|83280321|FG000|Overall Study|Death|31|||
46710739|NCT01135914|82926995|FG001|Overall Study|Protocol Violation|0|||
46710740|NCT01135914|82926996|FG002|Overall Study|Protocol Violation|3|||
47030354|NCT01890122|83280329|FG000|Overall Study|Adverse Event|1|||
47030355|NCT01890122|83280330|FG001|Overall Study|Adverse Event|1|||
47030356|NCT01890122|83280331|FG002|Overall Study|Adverse Event|1|||
47030357|NCT01890122|83280332|FG003|Overall Study|Adverse Event|2|||
47030358|NCT01890122|83280329|FG000|Overall Study|Major Protocol Deviation|3|||
47030359|NCT01890122|83280330|FG001|Overall Study|Major Protocol Deviation|1|||
47030360|NCT01890122|83280331|FG002|Overall Study|Major Protocol Deviation|0|||
47030361|NCT01890122|83280332|FG003|Overall Study|Major Protocol Deviation|1|||
47030362|NCT01890122|83280329|FG000|Overall Study|Lost to Follow-up|0|||
47030363|NCT01890122|83280330|FG001|Overall Study|Lost to Follow-up|1|||
47030364|NCT01890122|83280331|FG002|Overall Study|Lost to Follow-up|2|||
47030365|NCT01890122|83280332|FG003|Overall Study|Lost to Follow-up|2|||
47030366|NCT01890122|83280329|FG000|Overall Study|Voluntary Withdrawal|8|||
47030367|NCT01890122|83280330|FG001|Overall Study|Voluntary Withdrawal|8|||
47030368|NCT01890122|83280331|FG002|Overall Study|Voluntary Withdrawal|2|||
47030369|NCT01890122|83280332|FG003|Overall Study|Voluntary Withdrawal|11|||
47030370|NCT01890122|83280329|FG000|Overall Study|Lack of Efficacy|14|||
47030371|NCT01890122|83280330|FG001|Overall Study|Lack of Efficacy|24|||
47030372|NCT01890122|83280331|FG002|Overall Study|Lack of Efficacy|7|||
47030373|NCT01890122|83280332|FG003|Overall Study|Lack of Efficacy|41|||
47030374|NCT01890122|83280329|FG000|Overall Study|Reason not Specified|0|||
47030375|NCT01890122|83280330|FG001|Overall Study|Reason not Specified|1|||
47030376|NCT01890122|83280331|FG002|Overall Study|Reason not Specified|1|||
47030377|NCT01890122|83280332|FG003|Overall Study|Reason not Specified|2|||
47030378|NCT01890122|83280329|FG000|Overall Study|Randomized but not Treated|1|||
47030379|NCT01890122|83280330|FG001|Overall Study|Randomized but not Treated|1|||
47030380|NCT01890122|83280331|FG002|Overall Study|Randomized but not Treated|0|||
47030381|NCT01890122|83280332|FG003|Overall Study|Randomized but not Treated|0|||
47030382|NCT01397890|83280344|FG000|Overall Study|Withdrawal by Subject|7|||
47030383|NCT01397890|83280345|FG001|Overall Study|Withdrawal by Subject|11|||
47030384|NCT01397890|83280344|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
46710741|NCT01135914|82926994|FG000|Overall Study|Lack of Efficacy|2|||
46710742|NCT01135914|82926995|FG001|Overall Study|Lack of Efficacy|1|||
46710743|NCT01135914|82926996|FG002|Overall Study|Lack of Efficacy|10|||
46710744|NCT01135914|82926994|FG000|Overall Study|Adverse Event|0|||
46710745|NCT01135914|82926995|FG001|Overall Study|Adverse Event|1|||
46710746|NCT01135914|82926996|FG002|Overall Study|Adverse Event|2|||
46710747|NCT00907738|82927009|FG000|Overall Study|Adverse Event|2|||
46710748|NCT00907738|82927010|FG001|Overall Study|Adverse Event|0|||
46710749|NCT00907738|82927011|FG002|Overall Study|Adverse Event|1|||
46710750|NCT00907738|82927012|FG003|Overall Study|Adverse Event|0|||
46710751|NCT00907738|82927013|FG004|Overall Study|Adverse Event|0|||
46710752|NCT00907738|82927009|FG000|Overall Study|not specified or withdrew consent|3|||
46710753|NCT00907738|82927010|FG001|Overall Study|not specified or withdrew consent|0|||
46710754|NCT00907738|82927011|FG002|Overall Study|not specified or withdrew consent|0|||
46710755|NCT00907738|82927012|FG003|Overall Study|not specified or withdrew consent|0|||
46967624|NCT02158546|83210169|FG003|Overall Study|Adverse Event|0|||
46967625|NCT02158546|83210166|FG000|Overall Study|Withdrawal by Subject|6|||
46967626|NCT02158546|83210167|FG001|Overall Study|Withdrawal by Subject|2|||
46967627|NCT02158546|83210168|FG002|Overall Study|Withdrawal by Subject|1|||
46967628|NCT02158546|83210169|FG003|Overall Study|Withdrawal by Subject|0|||
46967629|NCT02158546|83210166|FG000|Overall Study|Lost to Follow-up|5|||
46967630|NCT02158546|83210167|FG001|Overall Study|Lost to Follow-up|4|||
46967631|NCT02158546|83210168|FG002|Overall Study|Lost to Follow-up|0|||
46627223|NCT02066298|82798134|FG001|Overall Study|Withdrawal by Subject|6|||
46627224|NCT02066298|82798135|FG002|Overall Study|Withdrawal by Subject|6|||
46627225|NCT02066298|82798136|FG003|Overall Study|Withdrawal by Subject|4|||
46627226|NCT02066298|82798137|FG004|Overall Study|Withdrawal by Subject|5|||
46627227|NCT02066298|82798138|FG005|Overall Study|Withdrawal by Subject|8|||
46627228|NCT02066298|82798133|FG000|Overall Study|Physician Decision|0|||
46627229|NCT02066298|82798134|FG001|Overall Study|Physician Decision|0|||
46627230|NCT02066298|82798135|FG002|Overall Study|Physician Decision|1|||
46627231|NCT02066298|82798136|FG003|Overall Study|Physician Decision|0|||
46627232|NCT02066298|82798137|FG004|Overall Study|Physician Decision|1|||
46627233|NCT02066298|82798138|FG005|Overall Study|Physician Decision|0|||
46627234|NCT02082912|82798152|FG000|Overall Study|Physician Decision|0|||
46627235|NCT02082912|82798153|FG001|Overall Study|Physician Decision|1|||
46627236|NCT02082522|82798161|FG000|Overall Study|Sponsor termination|5|||
46627237|NCT02082522|82798162|FG001|Overall Study|Sponsor termination|3|||
46627238|NCT02082522|82798161|FG000|Overall Study|Withdrawal by Subject|2|||
46627239|NCT02082522|82798162|FG001|Overall Study|Withdrawal by Subject|4|||
46627240|NCT02082522|82798161|FG000|Overall Study|Death|1|||
46627241|NCT02082522|82798162|FG001|Overall Study|Death|0|||
46627242|NCT02082522|82798161|FG000|Overall Study|Lost to Follow-up|1|||
46627243|NCT02082522|82798162|FG001|Overall Study|Lost to Follow-up|0|||
46627244|NCT02082522|82798161|FG000|Overall Study|Physician Decision|3|||
46627245|NCT02082522|82798162|FG001|Overall Study|Physician Decision|1|||
46627246|NCT02082522|82798161|FG000|Overall Study|Disease progression|2|||
46627247|NCT02082522|82798162|FG001|Overall Study|Disease progression|2|||
46627248|NCT02082522|82798161|FG000|Overall Study|Chemotherapy change|1|||
46627249|NCT02082522|82798162|FG001|Overall Study|Chemotherapy change|3|||
46627250|NCT02082210|82798174|FG000|Overall Study|Death|0|||
46627251|NCT02082210|82798175|FG001|Overall Study|Death|0|||
46627252|NCT02082210|82798176|FG002|Overall Study|Death|1|||
46627253|NCT02082210|82798177|FG003|Overall Study|Death|1|||
46627254|NCT02082210|82798178|FG004|Overall Study|Death|1|||
46627255|NCT02082210|82798179|FG005|Overall Study|Death|0|||
46627256|NCT02082210|82798174|FG000|Overall Study|Withdrawal by Subject|0|||
46627257|NCT02082210|82798175|FG001|Overall Study|Withdrawal by Subject|0|||
46627258|NCT02082210|82798176|FG002|Overall Study|Withdrawal by Subject|0|||
46627259|NCT02082210|82798177|FG003|Overall Study|Withdrawal by Subject|1|||
46627260|NCT02082210|82798178|FG004|Overall Study|Withdrawal by Subject|2|||
46627261|NCT02082210|82798179|FG005|Overall Study|Withdrawal by Subject|2|||
46627262|NCT02082210|82798174|FG000|Overall Study|Clinical Progression|0|||
46627263|NCT02082210|82798175|FG001|Overall Study|Clinical Progression|0|||
46627264|NCT02082210|82798176|FG002|Overall Study|Clinical Progression|0|||
46627265|NCT02082210|82798177|FG003|Overall Study|Clinical Progression|1|||
46627266|NCT02082210|82798178|FG004|Overall Study|Clinical Progression|0|||
46627267|NCT02082210|82798179|FG005|Overall Study|Clinical Progression|0|||
46627268|NCT02082210|82798174|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
46627269|NCT02082210|82798175|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
46627270|NCT02082210|82798176|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
46627271|NCT02082210|82798177|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
46627272|NCT02082210|82798178|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
46627273|NCT02082210|82798179|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
46627274|NCT02082210|82798174|FG000|Overall Study|Physician Decision|0|||
46627275|NCT02082210|82798175|FG001|Overall Study|Physician Decision|0|||
46627276|NCT02082210|82798176|FG002|Overall Study|Physician Decision|1|||
46627277|NCT02082210|82798177|FG003|Overall Study|Physician Decision|1|||
46627278|NCT02082210|82798178|FG004|Overall Study|Physician Decision|0|||
46627279|NCT02082210|82798179|FG005|Overall Study|Physician Decision|0|||
46627280|NCT02107092|82798205|FG000|Overall Study|Miscellaneous|3|||
46627281|NCT02107092|82798205|FG000|Overall Study|Subject compliance|3|||
46627282|NCT02107092|82798205|FG000|Overall Study|Hypo-or hyperkalemia|2|||
46627283|NCT02107092|82798205|FG000|Overall Study|Met ECG withdrawal criteria|3|||
46627284|NCT02107092|82798205|FG000|Overall Study|Physician Decision|3|||
46627285|NCT02107092|82798205|FG000|Overall Study|Lost to Follow-up|2|||
46627286|NCT02107092|82798205|FG000|Overall Study|Withdrawal by Subject|9|||
46627287|NCT02107092|82798205|FG000|Overall Study|Adverse Event|7|||
46967632|NCT02158546|83210169|FG003|Overall Study|Lost to Follow-up|1|||
46627288|NCT02107092|82798205|FG000|Overall Study|Expected progression of CKD|12|||
46627289|NCT02107014|82798209|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
46627290|NCT01624974|82798215|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
46627291|NCT01624974|82798216|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
46627292|NCT01624974|82798215|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
46967633|NCT02158546|83210166|FG000|Overall Study|Site Excluded|5|||
46967634|NCT02158546|83210167|FG001|Overall Study|Site Excluded|5|||
46967635|NCT02158546|83210168|FG002|Overall Study|Site Excluded|3|||
46967636|NCT02158546|83210169|FG003|Overall Study|Site Excluded|4|||
46967637|NCT02123446|83210179|FG000|Washout Period (1 Day)|Physician Decision|1|||
46967638|NCT02123446|83210180|FG001|Washout Period (1 Day)|Physician Decision|0|||
46627293|NCT01624974|82798216|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
46627294|NCT01624974|82798215|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
46627295|NCT01624974|82798216|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
46627296|NCT01624974|82798215|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
46627297|NCT01624974|82798216|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
46627298|NCT01624974|82798215|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
46627299|NCT01624974|82798216|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
46627300|NCT01624974|82798215|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
46627301|NCT01624974|82798216|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
46627302|NCT01624974|82798215|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
46627303|NCT01624974|82798216|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
46627304|NCT01624974|82798215|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
46627305|NCT01624974|82798216|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
46627306|NCT01624974|82798215|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
46627307|NCT01624974|82798216|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
46627308|NCT01624974|82798215|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
46627309|NCT01624974|82798216|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
46627310|NCT01624974|82798215|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
46627311|NCT01624974|82798216|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
46627312|NCT01624974|82798215|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
46627313|NCT01624974|82798216|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
46627314|NCT02065518|82798227|FG000|Overall Study|Lost to Follow-up|3|||
46627315|NCT02065518|82798228|FG001|Overall Study|Lost to Follow-up|4|||
46627316|NCT02065518|82798229|FG002|Overall Study|Lost to Follow-up|0|||
46627317|NCT02065518|82798230|FG003|Overall Study|Lost to Follow-up|3|||
46627318|NCT02065518|82798227|FG000|Overall Study|Withdrawal by Subject|3|||
46627319|NCT02065518|82798228|FG001|Overall Study|Withdrawal by Subject|4|||
46627320|NCT02065518|82798229|FG002|Overall Study|Withdrawal by Subject|9|||
46627321|NCT02065518|82798230|FG003|Overall Study|Withdrawal by Subject|2|||
46627322|NCT01624662|82798244|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
46627323|NCT01624662|82798245|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
46627324|NCT01624662|82798246|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
46627325|NCT01624662|82798247|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
46627326|NCT01624662|82798244|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
46627327|NCT01624662|82798245|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
46627328|NCT01624662|82798246|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
46627329|NCT01624662|82798247|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
46627330|NCT01624662|82798244|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
46627331|NCT01624662|82798245|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
46627332|NCT01624662|82798246|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
46627333|NCT01624662|82798247|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
46627334|NCT01624662|82798244|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
46627335|NCT01624662|82798245|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
46627336|NCT01624662|82798246|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
46627337|NCT01624662|82798247|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
46627338|NCT01624662|82798244|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
46627339|NCT01624662|82798245|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
46627340|NCT01624662|82798246|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
46627341|NCT01624662|82798247|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
46627342|NCT01624662|82798244|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
46627343|NCT01624662|82798245|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
46627344|NCT01624662|82798246|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
46627345|NCT01624662|82798247|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
46627346|NCT01624662|82798244|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
46627347|NCT01624662|82798245|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
46627348|NCT01624662|82798246|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
46627349|NCT01624662|82798247|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
46627350|NCT01624506|82798270|FG000|Overall Study|Lost to Follow-up|29|||
46627351|NCT01624506|82798271|FG001|Overall Study|Lost to Follow-up|15|||
46627352|NCT01624506|82798270|FG000|Overall Study|Withdrawal by Subject|9|||
46627353|NCT01624506|82798271|FG001|Overall Study|Withdrawal by Subject|2|||
46627354|NCT01624506|82798270|FG000|Overall Study|Death|1|||
46627355|NCT01624506|82798271|FG001|Overall Study|Death|0|||
46627356|NCT01624506|82798270|FG000|Overall Study|LINX explants|23|||
46627357|NCT01624506|82798271|FG001|Overall Study|LINX explants|0|||
46627358|NCT01624506|82798270|FG000|Overall Study|Adverse Event|3|||
46627359|NCT01624506|82798271|FG001|Overall Study|Adverse Event|0|||
46627360|NCT02106390|82798280|FG000|Overall Study|Withdrawal by Subject|15|||
46627361|NCT02106390|82798281|FG001|Overall Study|Withdrawal by Subject|16|||
46627362|NCT02106390|82798282|FG002|Overall Study|Withdrawal by Subject|15|||
46627363|NCT02106390|82798280|FG000|Overall Study|Lost to Follow-up|25|||
46627364|NCT02106390|82798281|FG001|Overall Study|Lost to Follow-up|20|||
46627365|NCT02106390|82798282|FG002|Overall Study|Lost to Follow-up|13|||
46627366|NCT02106390|82798280|FG000|Overall Study|Other: Administrative Reason|8|||
46627367|NCT02106390|82798281|FG001|Overall Study|Other: Administrative Reason|5|||
46627368|NCT02106390|82798282|FG002|Overall Study|Other: Administrative Reason|12|||
46627369|NCT02106390|82798280|FG000|Overall Study|Other: Unspecified|1|||
46627370|NCT02106390|82798281|FG001|Overall Study|Other: Unspecified|4|||
46627371|NCT02106390|82798282|FG002|Overall Study|Other: Unspecified|2|||
46627372|NCT02106390|82798280|FG000|Overall Study|Adverse Event|0|||
46627373|NCT02106390|82798281|FG001|Overall Study|Adverse Event|2|||
46627374|NCT02106390|82798282|FG002|Overall Study|Adverse Event|1|||
46627375|NCT02106390|82798280|FG000|Overall Study|Protocol Violation|0|||
46627376|NCT02106390|82798281|FG001|Overall Study|Protocol Violation|1|||
46627377|NCT02106390|82798282|FG002|Overall Study|Protocol Violation|0|||
46627378|NCT02064894|82798296|FG000|Overall Study|Withdrawal by Subject|43|||
46627379|NCT02064894|82798297|FG001|Overall Study|Withdrawal by Subject|102|||
46627380|NCT02064894|82798298|FG002|Overall Study|Withdrawal by Subject|115|||
46627381|NCT02081586|82798310|FG000|Overall Study|Lost to Follow-up|0|||
46627382|NCT02081586|82798311|FG001|Overall Study|Lost to Follow-up|1|||
46627383|NCT02081586|82798312|FG002|Overall Study|Lost to Follow-up|0|||
46627384|NCT02081586|82798313|FG003|Overall Study|Lost to Follow-up|1|||
46710756|NCT00907738|82927013|FG004|Overall Study|not specified or withdrew consent|0|||
46710757|NCT00907738|82927009|FG000|Overall Study|Disease progression|8|||
46710758|NCT00907738|82927010|FG001|Overall Study|Disease progression|1|||
47030385|NCT01397890|83280345|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
47030386|NCT01397890|83280344|FG000|Overall Study|Death|2|||
47030387|NCT01397890|83280345|FG001|Overall Study|Death|3|||
47030388|NCT01397890|83280344|FG000|Overall Study|Lost to Follow-up|1|||
47030389|NCT01397890|83280345|FG001|Overall Study|Lost to Follow-up|4|||
47030390|NCT01397890|83280344|FG000|Overall Study|Condition under Investigation Worsened|1|||
47030391|NCT01397890|83280345|FG001|Overall Study|Condition under Investigation Worsened|3|||
47030392|NCT01397890|83280344|FG000|Overall Study|Adverse Event|1|||
47030393|NCT01397890|83280345|FG001|Overall Study|Adverse Event|2|||
47030394|NCT01397890|83280344|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
47030395|NCT01397890|83280345|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
47030396|NCT01397890|83280344|FG000|Overall Study|Others|2|||
47030397|NCT01397890|83280345|FG001|Overall Study|Others|1|||
47030398|NCT01777269|83280353|FG000|Overall Study|Adverse Event|24|||
47030399|NCT01777269|83280354|FG001|Overall Study|Adverse Event|33|||
47030400|NCT01777269|83280353|FG000|Overall Study|Lack of Efficacy|8|||
47030401|NCT01777269|83280354|FG001|Overall Study|Lack of Efficacy|10|||
47030402|NCT01777269|83280353|FG000|Overall Study|Protocol Violation|4|||
47030403|NCT01777269|83280354|FG001|Overall Study|Protocol Violation|4|||
47030404|NCT01777269|83280353|FG000|Overall Study|Participants reached stopping criteria|1|||
47030405|NCT01777269|83280354|FG001|Overall Study|Participants reached stopping criteria|1|||
47030406|NCT01777269|83280353|FG000|Overall Study|Lost to Follow-up|4|||
47030407|NCT01777269|83280354|FG001|Overall Study|Lost to Follow-up|0|||
47030408|NCT01777269|83280353|FG000|Overall Study|Physician Decision|5|||
47030409|NCT01777269|83280354|FG001|Overall Study|Physician Decision|2|||
47030410|NCT01777269|83280353|FG000|Overall Study|Withdrawal by Subject|9|||
47030411|NCT01777269|83280354|FG001|Overall Study|Withdrawal by Subject|9|||
47030412|NCT04016272|83280362|FG000|Overall Study|Withdrawal by Subject|1|||
47030413|NCT04016272|83280363|FG001|Overall Study|Withdrawal by Subject|2|||
47030414|NCT01751061|83280371|FG000|Overall Study|Death|1|||
47030415|NCT01751061|83280372|FG001|Overall Study|Death|0|||
47030416|NCT01751061|83280371|FG000|Overall Study|patient death|5|||
47030417|NCT01751061|83280372|FG001|Overall Study|patient death|0|||
46710759|NCT00907738|82927011|FG002|Overall Study|Disease progression|6|||
46710760|NCT00907738|82927012|FG003|Overall Study|Disease progression|4|||
46710761|NCT00907738|82927013|FG004|Overall Study|Disease progression|2|||
46710762|NCT01123356|82927029|FG000|Overall Study|Adverse Event|2|||
46710763|NCT01123356|82927029|FG000|Overall Study|Lack of Efficacy|4|||
46710764|NCT01123356|82927029|FG000|Overall Study|Withdrawal by Subject|1|||
46710765|NCT00908596|82927038|FG000|Overall Study|Other reasons|46|||
47030418|NCT01751061|83280371|FG000|Overall Study|Lost to Follow-up|40|||
47030419|NCT01751061|83280372|FG001|Overall Study|Lost to Follow-up|25|||
46627385|NCT02081586|82798310|FG000|Overall Study|Head injury not related to study|0|||
46627386|NCT02081586|82798311|FG001|Overall Study|Head injury not related to study|0|||
46627387|NCT02081586|82798312|FG002|Overall Study|Head injury not related to study|1|||
47030420|NCT01751061|83280371|FG000|Overall Study|patient regained decisional capacity|4|||
46710766|NCT00908596|82927039|FG001|Overall Study|Other reasons|6|||
46710767|NCT00908596|82927040|FG002|Overall Study|Other reasons|2|||
47030421|NCT01751061|83280372|FG001|Overall Study|patient regained decisional capacity|8|||
47030422|NCT01751061|83280371|FG000|Overall Study|Withdrawal by Subject|4|||
47030423|NCT01751061|83280372|FG001|Overall Study|Withdrawal by Subject|1|||
46710768|NCT00908596|82927041|FG003|Overall Study|Other reasons|0|||
46710769|NCT00908596|82927038|FG000|Overall Study|Lost to Follow-up|0|||
46710770|NCT00908596|82927039|FG001|Overall Study|Lost to Follow-up|1|||
46710771|NCT00908596|82927040|FG002|Overall Study|Lost to Follow-up|12|||
46710772|NCT00908596|82927041|FG003|Overall Study|Lost to Follow-up|4|||
46710773|NCT00908596|82927038|FG000|Overall Study|Death|0|||
46710774|NCT00908596|82927039|FG001|Overall Study|Death|5|||
46710775|NCT00908596|82927040|FG002|Overall Study|Death|57|||
46710776|NCT00908596|82927041|FG003|Overall Study|Death|32|||
46710777|NCT00908596|82927038|FG000|Overall Study|Protocol Violation|1|||
46710778|NCT00908596|82927039|FG001|Overall Study|Protocol Violation|0|||
46710779|NCT00908596|82927040|FG002|Overall Study|Protocol Violation|0|||
46710780|NCT00908596|82927041|FG003|Overall Study|Protocol Violation|0|||
46710781|NCT00908596|82927038|FG000|Overall Study|Withdrawal by Subject|0|||
46710782|NCT00908596|82927039|FG001|Overall Study|Withdrawal by Subject|1|||
46710783|NCT00908596|82927040|FG002|Overall Study|Withdrawal by Subject|3|||
46710784|NCT00908596|82927041|FG003|Overall Study|Withdrawal by Subject|1|||
46710785|NCT01118052|82927051|FG000|Overall Study|Never treated|2|||
46710786|NCT01123200|82927061|FG000|Overall Study|Withdrawal by Subject|1|||
46710787|NCT00955617|82927065|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
46710788|NCT00955617|82927066|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
46710789|NCT00955617|82927065|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
46710790|NCT00955617|82927066|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
46710791|NCT00955617|82927065|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
46710792|NCT00955617|82927066|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
46627388|NCT02081586|82798313|FG003|Overall Study|Head injury not related to study|0|||
46710793|NCT00955617|82927065|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
46710794|NCT00955617|82927066|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
46710795|NCT00958347|82927072|FG000|Overall Study|Death|43|||
46710796|NCT00958347|82927072|FG000|Overall Study|Withdrawal by Subject|23|||
46710797|NCT00958347|82927072|FG000|Overall Study|Lost to Follow-up|15|||
46710798|NCT00958347|82927072|FG000|Overall Study|revision/removal|10|||
46710799|NCT00958347|82927072|FG000|Overall Study|study termination|135|||
46710800|NCT00958191|82927076|FG000|Overall Study|Death|4|||
46710801|NCT00958191|82927076|FG000|Overall Study|Lost to Follow-up|5|||
46710802|NCT00958191|82927076|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
46710803|NCT00958191|82927076|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
46710804|NCT00958191|82927076|FG000|Overall Study|Revision of study device|4|||
46710805|NCT00958191|82927076|FG000|Overall Study|Site termination|11|||
46710806|NCT00958191|82927076|FG000|Overall Study|No 5 yr x-rays|56|||
46710807|NCT00960843|82927084|FG000|Overall Study|Lost to Follow-up|2|||
46710808|NCT00960843|82927085|FG001|Overall Study|Lost to Follow-up|0|||
46710809|NCT00960843|82927084|FG000|Overall Study|Protocol Violation|0|||
46710810|NCT00960843|82927085|FG001|Overall Study|Protocol Violation|4|||
46710811|NCT00960843|82927084|FG000|Overall Study|Repeated needle dislodgment|0|||
46710812|NCT00960843|82927085|FG001|Overall Study|Repeated needle dislodgment|1|||
46710813|NCT01605253|82927093|FG000|Overall Study|Physician Decision|3|||
46710814|NCT01605253|82927094|FG001|Overall Study|Physician Decision|2|||
46710815|NCT01605253|82927093|FG000|Overall Study|Lost to Follow-up|3|||
46710816|NCT01605253|82927094|FG001|Overall Study|Lost to Follow-up|1|||
46710817|NCT00955305|82927104|FG000|Overall Study|Disease progression|39|||
47030424|NCT01751061|83280371|FG000|Overall Study|Physician Decision|2|||
46627389|NCT02081196|82798325|FG000|Overall Study|Lost to Follow-up|1|||
46627390|NCT02064816|82798333|FG000|Overall Study|Adverse Event|3|||
46627391|NCT02064816|82798334|FG001|Overall Study|Adverse Event|2|||
46627392|NCT02064816|82798333|FG000|Overall Study|Withdrawal by Subject|2|||
46627393|NCT02064816|82798334|FG001|Overall Study|Withdrawal by Subject|1|||
46627394|NCT02064816|82798333|FG000|Overall Study|Lost to Follow-up|2|||
46627395|NCT02064816|82798334|FG001|Overall Study|Lost to Follow-up|1|||
46627396|NCT02064816|82798333|FG000|Overall Study|Therapeutic failure|0|||
46627397|NCT02064816|82798334|FG001|Overall Study|Therapeutic failure|1|||
46627398|NCT02064816|82798333|FG000|Overall Study|Other|1|||
46627399|NCT02064816|82798334|FG001|Overall Study|Other|3|||
46627400|NCT02080260|82798340|FG000|Overall Study|Death|18|||
46710818|NCT00955305|82927105|FG001|Overall Study|Disease progression|41|||
46710819|NCT00955305|82927104|FG000|Overall Study|Adverse Event|22|||
46710820|NCT00955305|82927105|FG001|Overall Study|Adverse Event|22|||
46710821|NCT00955305|82927104|FG000|Overall Study|Death|2|||
46710822|NCT00955305|82927105|FG001|Overall Study|Death|1|||
46710823|NCT00955305|82927104|FG000|Overall Study|Withdrawal by Subject|5|||
46710824|NCT00955305|82927105|FG001|Overall Study|Withdrawal by Subject|4|||
46710825|NCT00955305|82927104|FG000|Overall Study|Alternative therapy|4|||
46710826|NCT00955305|82927105|FG001|Overall Study|Alternative therapy|0|||
46710827|NCT00955305|82927104|FG000|Overall Study|Other complicating disease|2|||
46710828|NCT00955305|82927105|FG001|Overall Study|Other complicating disease|4|||
46710829|NCT00955305|82927104|FG000|Overall Study|Physician Decision|1|||
46710830|NCT00955305|82927105|FG001|Overall Study|Physician Decision|0|||
46710831|NCT00955305|82927104|FG000|Overall Study|Continued presence of residual disease|0|||
46627401|NCT02080260|82798340|FG000|Overall Study|Withdrawal by Subject|1|||
46627402|NCT01624194|82798346|FG000|Overall Study|Lost to Follow-up|1|||
46627403|NCT01624194|82798347|FG001|Overall Study|Lost to Follow-up|0|||
46627404|NCT01624194|82798346|FG000|Overall Study|Withdrawal by Subject|1|||
46627405|NCT01624194|82798347|FG001|Overall Study|Withdrawal by Subject|0|||
46627406|NCT02079636|82798369|FG000|Overall Study|Death|2|||
46627407|NCT02079636|82798370|FG001|Overall Study|Death|1|||
46627408|NCT02079636|82798371|FG002|Overall Study|Death|0|||
46627409|NCT02079636|82798372|FG003|Overall Study|Death|5|||
46627410|NCT02079636|82798373|FG004|Overall Study|Death|1|||
46627411|NCT02079636|82798374|FG005|Overall Study|Death|2|||
46627412|NCT02079636|82798375|FG006|Overall Study|Death|1|||
46627413|NCT02079636|82798376|FG007|Overall Study|Death|0|||
46627414|NCT02079636|82798377|FG008|Overall Study|Death|0|||
46627415|NCT02079636|82798378|FG009|Overall Study|Death|0|||
46710832|NCT00955305|82927105|FG001|Overall Study|Continued presence of residual disease|1|||
46710833|NCT00955305|82927104|FG000|Overall Study|Functional decline|2|||
46710834|NCT00955305|82927105|FG001|Overall Study|Functional decline|0|||
46710835|NCT00955305|82927104|FG000|Overall Study|Maximum response achieved|0|||
46710836|NCT00955305|82927105|FG001|Overall Study|Maximum response achieved|1|||
46710837|NCT00955305|82927104|FG000|Overall Study|Lost to Follow-up|0|||
46710838|NCT00955305|82927105|FG001|Overall Study|Lost to Follow-up|1|||
46710839|NCT00955305|82927104|FG000|Overall Study|No off-treatment reason submitted|1|||
46710840|NCT00955305|82927105|FG001|Overall Study|No off-treatment reason submitted|0|||
46710841|NCT00955305|82927104|FG000|Overall Study|Never started protocol treatment|5|||
46710842|NCT00955305|82927105|FG001|Overall Study|Never started protocol treatment|5|||
46710843|NCT00955305|82927104|FG000|Overall Study|Ineligible|5|||
46710844|NCT00955305|82927105|FG001|Overall Study|Ineligible|7|||
46710845|NCT00598585|82927113|FG000|Overall Study|Lost to Follow-up|1|||
46710846|NCT00598585|82927114|FG001|Overall Study|Lost to Follow-up|0|||
47030425|NCT01751061|83280372|FG001|Overall Study|Physician Decision|0|||
47030426|NCT01777191|83280380|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
47030427|NCT01777191|83280381|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
47030428|NCT01777191|83280380|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
47030429|NCT01777191|83280381|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
47030430|NCT01777191|83280380|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
47030431|NCT01777191|83280381|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
47030432|NCT01777191|83280380|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
47030433|NCT01777191|83280381|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
47030434|NCT01777191|83280380|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
47030435|NCT01777191|83280381|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
47030436|NCT01777191|83280380|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
47030437|NCT01777191|83280381|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
47030438|NCT01777191|83280380|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
47030439|NCT01777191|83280381|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
47030440|NCT01777191|83280380|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
47030441|NCT01777191|83280381|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
47030442|NCT01777191|83280380|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
47030443|NCT01777191|83280381|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
47030444|NCT01777191|83280380|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
47030445|NCT01777191|83280381|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
47030446|NCT01777191|83280380|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
47030447|NCT01777191|83280381|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
47030448|NCT01896050|83280392|FG000|Overall Study|Adverse Event|37|||
47030449|NCT01896050|83280393|FG001|Overall Study|Adverse Event|2|||
47030450|NCT01896050|83280392|FG000|Overall Study|Death|1|||
47030451|NCT01896050|83280393|FG001|Overall Study|Death|0|||
47030452|NCT01775787|83280401|FG000|First 7-10 Days|Adverse Event|0|||
46627416|NCT02079636|82798379|FG010|Overall Study|Death|0|||
46627417|NCT02079636|82798380|FG011|Overall Study|Death|1|||
46627418|NCT02079636|82798381|FG012|Overall Study|Death|1|||
46627419|NCT02079636|82798382|FG013|Overall Study|Death|0|||
46627420|NCT02079636|82798383|FG014|Overall Study|Death|2|||
46627421|NCT02079636|82798369|FG000|Overall Study|Adverse Event|1|||
46627422|NCT02079636|82798370|FG001|Overall Study|Adverse Event|1|||
46710847|NCT00953667|82927120|FG000|Overall Study|Lost to Follow-up|11|||
46710848|NCT00953667|82927120|FG000|Overall Study|Physician Decision|35|||
46710849|NCT00953667|82927120|FG000|Overall Study|Withdrawal by Subject|63|||
46710850|NCT00953667|82927120|FG000|Overall Study|Adverse Event|10|||
46710851|NCT00953667|82927120|FG000|Overall Study|poor venous access,unable to draw blood|4|||
46627423|NCT02079636|82798371|FG002|Overall Study|Adverse Event|0|||
46627424|NCT02079636|82798372|FG003|Overall Study|Adverse Event|1|||
46627425|NCT02079636|82798373|FG004|Overall Study|Adverse Event|1|||
46627426|NCT02079636|82798374|FG005|Overall Study|Adverse Event|2|||
46710852|NCT00883129|82927126|FG000|Overall Study|Adverse Event|7|||
47030453|NCT01775787|83280402|FG001|First 7-10 Days|Adverse Event|1|||
47030454|NCT01775787|83280401|FG000|First 7-10 Days|family emergency|0|||
47030455|NCT01775787|83280402|FG001|First 7-10 Days|family emergency|1|||
47030456|NCT01775787|83280401|FG000|First 7-10 Days|time commitment|0|||
47030457|NCT01775787|83280402|FG001|First 7-10 Days|time commitment|2|||
47030458|NCT01775787|83280401|FG000|First 7-10 Days|concerns with using IV|1|||
47030459|NCT01775787|83280402|FG001|First 7-10 Days|concerns with using IV|2|||
47030460|NCT01775787|83280401|FG000|Second 7-10 Days|time commitment|0|||
47030461|NCT01775787|83280402|FG001|Second 7-10 Days|time commitment|1|||
47030462|NCT01775787|83280401|FG000|Second 7-10 Days|concerns with using IV|0|||
47030463|NCT01775787|83280402|FG001|Second 7-10 Days|concerns with using IV|1|||
47030464|NCT01775553|83280410|FG000|Overall Study|Adverse Event|1|||
47030465|NCT01775553|83280410|FG000|Overall Study|Disease Progression|12|||
47030466|NCT01775475|83280416|FG000|Overall Study|Death|3|||
47030467|NCT01775475|83280417|FG001|Overall Study|Death|3|||
47030468|NCT01774929|83280423|FG000|Overall Study|Adverse Event|3|||
47030469|NCT01888874|83280434|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
47030470|NCT01888874|83280435|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
47030471|NCT01888874|83280436|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
47030472|NCT01888874|83280437|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
47030473|NCT01888874|83280438|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
47030474|NCT01888874|83280439|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
47030475|NCT01888874|83280440|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
47030476|NCT01888874|83280434|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
47030477|NCT01888874|83280435|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
47030478|NCT01888874|83280436|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
47030479|NCT01888874|83280437|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
47030480|NCT01888874|83280438|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
47030481|NCT01888874|83280439|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
47030482|NCT01888874|83280440|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
47030483|NCT01888874|83280434|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
47030484|NCT01888874|83280435|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
47030485|NCT01888874|83280436|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
47030486|NCT01888874|83280437|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
47030487|NCT01888874|83280438|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
47030488|NCT01888874|83280439|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
47030489|NCT01888874|83280440|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
47030490|NCT01888874|83280434|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
47030491|NCT01888874|83280435|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
47030492|NCT01888874|83280436|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
47030493|NCT01888874|83280437|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
47030494|NCT01888874|83280438|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
47030495|NCT01888874|83280439|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
47030496|NCT01888874|83280440|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
47030497|NCT01888874|83280434|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
47030498|NCT01888874|83280435|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
47030499|NCT01888874|83280436|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
47030500|NCT01888874|83280437|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
47030501|NCT01888874|83280438|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
47030502|NCT01888874|83280439|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
47030503|NCT01888874|83280440|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
47030504|NCT01888874|83280434|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
47030505|NCT01888874|83280435|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
47030506|NCT01888874|83280436|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
47030507|NCT01888874|83280437|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
47030508|NCT01888874|83280438|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
47030509|NCT01888874|83280439|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
47030510|NCT01888874|83280440|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
47030511|NCT01888874|83280434|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
47030512|NCT01888874|83280435|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
47030513|NCT01888874|83280436|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
47030514|NCT01888874|83280437|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
47030515|NCT01888874|83280438|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
47030516|NCT01888874|83280439|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
47030517|NCT01888874|83280440|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
47030518|NCT01888874|83280434|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
47030519|NCT01888874|83280435|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
47030520|NCT01888874|83280436|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
47030521|NCT01888874|83280437|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
47030522|NCT01888874|83280438|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
47030523|NCT01888874|83280439|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
47030524|NCT01888874|83280440|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
47030525|NCT01888874|83280434|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
47030526|NCT01888874|83280435|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
47030527|NCT01888874|83280436|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
47030528|NCT01888874|83280437|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
47030529|NCT01888874|83280438|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
47030530|NCT01888874|83280439|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
47030531|NCT01888874|83280440|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
47030532|NCT01888874|83280434|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
47030533|NCT01888874|83280435|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
47030534|NCT01888874|83280436|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
47030535|NCT01888874|83280437|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
47030536|NCT01888874|83280438|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
47030537|NCT01888874|83280439|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
47030538|NCT01888874|83280440|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
46627427|NCT02079636|82798375|FG006|Overall Study|Adverse Event|0|||
46627428|NCT02079636|82798376|FG007|Overall Study|Adverse Event|0|||
46627429|NCT02079636|82798377|FG008|Overall Study|Adverse Event|0|||
46627430|NCT02079636|82798378|FG009|Overall Study|Adverse Event|0|||
46627431|NCT02079636|82798379|FG010|Overall Study|Adverse Event|0|||
46627432|NCT02079636|82798380|FG011|Overall Study|Adverse Event|0|||
46627433|NCT02079636|82798381|FG012|Overall Study|Adverse Event|0|||
46627434|NCT02079636|82798382|FG013|Overall Study|Adverse Event|0|||
46627435|NCT02079636|82798383|FG014|Overall Study|Adverse Event|0|||
46627436|NCT02079636|82798369|FG000|Overall Study|Progressive disease|0|||
46627437|NCT02079636|82798370|FG001|Overall Study|Progressive disease|0|||
46627438|NCT02079636|82798371|FG002|Overall Study|Progressive disease|0|||
46627439|NCT02079636|82798372|FG003|Overall Study|Progressive disease|2|||
46627440|NCT02079636|82798373|FG004|Overall Study|Progressive disease|0|||
47030539|NCT01888874|83280434|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
47030540|NCT01888874|83280435|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
47030541|NCT01888874|83280436|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
47030542|NCT01888874|83280437|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
47030543|NCT01888874|83280438|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
47030544|NCT01888874|83280439|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
47030545|NCT01888874|83280440|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
47030546|NCT01888874|83280434|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
47030547|NCT01888874|83280435|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
47030548|NCT01888874|83280436|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
47030549|NCT01888874|83280437|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
47030550|NCT01888874|83280438|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
47030551|NCT01888874|83280439|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
47030552|NCT01888874|83280440|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
47030553|NCT01888874|83280434|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
47030554|NCT01888874|83280435|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
47030555|NCT01888874|83280436|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
47030556|NCT01888874|83280437|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
47030557|NCT01888874|83280438|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
47030558|NCT01888874|83280439|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
47030559|NCT01888874|83280440|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
47030560|NCT01749735|83280459|FG000|Overall Study|Withdrawal by Subject|1|||
47030561|NCT01749735|83280460|FG001|Overall Study|Withdrawal by Subject|0|||
47030562|NCT01749033|83280469|FG000|Overall Study|Did not receive allocated intervention|3|||
47030563|NCT01749033|83280470|FG001|Overall Study|Did not receive allocated intervention|3|||
46627441|NCT02079636|82798374|FG005|Overall Study|Progressive disease|0|||
46627442|NCT02079636|82798375|FG006|Overall Study|Progressive disease|0|||
46627443|NCT02079636|82798376|FG007|Overall Study|Progressive disease|0|||
46627444|NCT02079636|82798377|FG008|Overall Study|Progressive disease|0|||
46912725|NCT02873702|83142830|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
46912726|NCT02873702|83142831|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
46912727|NCT02873702|83142832|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
46627445|NCT02079636|82798378|FG009|Overall Study|Progressive disease|0|||
46627446|NCT02079636|82798379|FG010|Overall Study|Progressive disease|0|||
46912728|NCT02873702|83142833|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
46627447|NCT02079636|82798380|FG011|Overall Study|Progressive disease|0|||
46627448|NCT02079636|82798381|FG012|Overall Study|Progressive disease|1|||
46627449|NCT02079636|82798382|FG013|Overall Study|Progressive disease|0|||
46627450|NCT02079636|82798383|FG014|Overall Study|Progressive disease|0|||
46627451|NCT02079636|82798369|FG000|Overall Study|Withdrawal by Subject|0|||
46627452|NCT02079636|82798370|FG001|Overall Study|Withdrawal by Subject|0|||
46627453|NCT02079636|82798371|FG002|Overall Study|Withdrawal by Subject|0|||
46627454|NCT02079636|82798372|FG003|Overall Study|Withdrawal by Subject|4|||
46627455|NCT02079636|82798373|FG004|Overall Study|Withdrawal by Subject|0|||
46627456|NCT02079636|82798374|FG005|Overall Study|Withdrawal by Subject|1|||
46627457|NCT02079636|82798375|FG006|Overall Study|Withdrawal by Subject|0|||
46627458|NCT02079636|82798376|FG007|Overall Study|Withdrawal by Subject|0|||
46627459|NCT02079636|82798377|FG008|Overall Study|Withdrawal by Subject|0|||
46627460|NCT02079636|82798378|FG009|Overall Study|Withdrawal by Subject|2|||
46627461|NCT02079636|82798379|FG010|Overall Study|Withdrawal by Subject|1|||
46627462|NCT02079636|82798380|FG011|Overall Study|Withdrawal by Subject|1|||
46627463|NCT02079636|82798381|FG012|Overall Study|Withdrawal by Subject|1|||
46627464|NCT02079636|82798382|FG013|Overall Study|Withdrawal by Subject|0|||
46627465|NCT02079636|82798383|FG014|Overall Study|Withdrawal by Subject|2|||
46627466|NCT02079636|82798369|FG000|Overall Study|Physician Decision|0|||
46627467|NCT02079636|82798370|FG001|Overall Study|Physician Decision|0|||
46627468|NCT02079636|82798371|FG002|Overall Study|Physician Decision|0|||
46627469|NCT02079636|82798372|FG003|Overall Study|Physician Decision|0|||
46627470|NCT02079636|82798373|FG004|Overall Study|Physician Decision|0|||
46627471|NCT02079636|82798374|FG005|Overall Study|Physician Decision|1|||
46627472|NCT02079636|82798375|FG006|Overall Study|Physician Decision|0|||
46627473|NCT02079636|82798376|FG007|Overall Study|Physician Decision|0|||
46627474|NCT02079636|82798377|FG008|Overall Study|Physician Decision|0|||
46627475|NCT02079636|82798378|FG009|Overall Study|Physician Decision|1|||
46627476|NCT02079636|82798379|FG010|Overall Study|Physician Decision|1|||
46627477|NCT02079636|82798380|FG011|Overall Study|Physician Decision|0|||
46627478|NCT02079636|82798381|FG012|Overall Study|Physician Decision|0|||
46627479|NCT02079636|82798382|FG013|Overall Study|Physician Decision|0|||
46627480|NCT02079636|82798383|FG014|Overall Study|Physician Decision|1|||
47030564|NCT01749033|83280471|FG002|Overall Study|Did not receive allocated intervention|0|||
47030565|NCT01749033|83280469|FG000|Overall Study|Lost to Follow-up|0|||
47030566|NCT01749033|83280470|FG001|Overall Study|Lost to Follow-up|2|||
47030567|NCT01749033|83280471|FG002|Overall Study|Lost to Follow-up|1|||
47030568|NCT01774305|83280482|FG000|Overall Study|Physician Decision|1|||
47030569|NCT01774305|83280483|FG001|Overall Study|Physician Decision|0|||
47030570|NCT01737021|83280491|FG000|Overall Study|Lost to Follow-up|5|||
47030571|NCT01737021|83280492|FG001|Overall Study|Lost to Follow-up|3|||
47030572|NCT01397422|83280502|FG000|Overall Study|Adverse Event|0|||
47030573|NCT01397422|83280503|FG001|Overall Study|Adverse Event|3|||
47030574|NCT01397422|83280504|FG002|Overall Study|Adverse Event|3|||
47030575|NCT01397422|83280505|FG003|Overall Study|Adverse Event|8|||
47030576|NCT01397422|83280502|FG000|Overall Study|Withdrawal by Subject|1|||
47030577|NCT01397422|83280503|FG001|Overall Study|Withdrawal by Subject|0|||
47030578|NCT01397422|83280504|FG002|Overall Study|Withdrawal by Subject|0|||
47030579|NCT01397422|83280505|FG003|Overall Study|Withdrawal by Subject|0|||
47030580|NCT01397422|83280502|FG000|Overall Study|Increased bradykinesia related to PD|1|||
46627481|NCT02079636|82798369|FG000|Overall Study|Lost to Follow-up|0|||
46627482|NCT02079636|82798370|FG001|Overall Study|Lost to Follow-up|0|||
46627483|NCT02079636|82798371|FG002|Overall Study|Lost to Follow-up|0|||
46627484|NCT02079636|82798372|FG003|Overall Study|Lost to Follow-up|0|||
46710853|NCT00883129|82927127|FG001|Overall Study|Adverse Event|15|||
46627485|NCT02079636|82798373|FG004|Overall Study|Lost to Follow-up|0|||
46627486|NCT02079636|82798374|FG005|Overall Study|Lost to Follow-up|0|||
46627487|NCT02079636|82798375|FG006|Overall Study|Lost to Follow-up|0|||
46627488|NCT02079636|82798376|FG007|Overall Study|Lost to Follow-up|1|||
46627489|NCT02079636|82798377|FG008|Overall Study|Lost to Follow-up|0|||
46627490|NCT02079636|82798378|FG009|Overall Study|Lost to Follow-up|0|||
46627491|NCT02079636|82798379|FG010|Overall Study|Lost to Follow-up|0|||
46710854|NCT00883129|82927126|FG000|Overall Study|Withdrawal by Subject|8|||
46710855|NCT00883129|82927127|FG001|Overall Study|Withdrawal by Subject|9|||
47030581|NCT01397422|83280503|FG001|Overall Study|Increased bradykinesia related to PD|0|||
47030582|NCT01397422|83280504|FG002|Overall Study|Increased bradykinesia related to PD|0|||
47030583|NCT01397422|83280505|FG003|Overall Study|Increased bradykinesia related to PD|0|||
46627492|NCT02079636|82798380|FG011|Overall Study|Lost to Follow-up|0|||
46627493|NCT02079636|82798381|FG012|Overall Study|Lost to Follow-up|0|||
46627494|NCT02079636|82798382|FG013|Overall Study|Lost to Follow-up|0|||
46627495|NCT02079636|82798383|FG014|Overall Study|Lost to Follow-up|0|||
47030584|NCT01736553|83280519|FG000|Overall Study|Death|12|||
47030585|NCT01736553|83280520|FG001|Overall Study|Death|0|||
47030586|NCT01736553|83280519|FG000|Overall Study|Withdrawal by Subject|5|||
47030587|NCT01736553|83280520|FG001|Overall Study|Withdrawal by Subject|2|||
47030588|NCT01736553|83280519|FG000|Overall Study|Lost to Follow-up|2|||
47030589|NCT01736553|83280520|FG001|Overall Study|Lost to Follow-up|2|||
47030590|NCT01888640|83280547|FG000|Overall Study|Lost to Follow-up|1|||
47030591|NCT01888640|83280548|FG001|Overall Study|Lost to Follow-up|2|||
47030592|NCT01888640|83280549|FG002|Overall Study|Lost to Follow-up|0|||
47030593|NCT01888640|83280547|FG000|Overall Study|Withdrawal by Subject|15|||
47030594|NCT01888640|83280548|FG001|Overall Study|Withdrawal by Subject|11|||
47030595|NCT01888640|83280549|FG002|Overall Study|Withdrawal by Subject|4|||
47030596|NCT01888640|83280547|FG000|Overall Study|Minimum dose not met|10|||
47030597|NCT01888640|83280548|FG001|Overall Study|Minimum dose not met|16|||
47030598|NCT01888640|83280549|FG002|Overall Study|Minimum dose not met|0|||
47030599|NCT01888640|83280547|FG000|Overall Study|Given wrong unit (placebo)|1|||
46627496|NCT02079246|82798447|FG000|OLEX|Withdrawal before treatment|1|||
46627497|NCT02079246|82798448|FG001|OLEX|Withdrawal before treatment|0|||
46627498|NCT02079246|82798447|FG000|OLEX|Death|11|||
46627499|NCT02079246|82798448|FG001|OLEX|Death|0|||
46627500|NCT02079246|82798447|FG000|OLEX|Adverse Event|66|||
46627501|NCT02079246|82798448|FG001|OLEX|Adverse Event|0|||
46627502|NCT02079246|82798447|FG000|OLEX|Withdrawal by Subject|60|||
46627503|NCT02079246|82798448|FG001|OLEX|Withdrawal by Subject|0|||
46627504|NCT02079246|82798447|FG000|OLEX|Lost to Follow-up|6|||
46627505|NCT02079246|82798448|FG001|OLEX|Lost to Follow-up|0|||
46627506|NCT02079246|82798447|FG000|OLEX|Protocol Violation|6|||
46627507|NCT02079246|82798448|FG001|OLEX|Protocol Violation|0|||
46627508|NCT02079246|82798447|FG000|OLEX|Lack of Efficacy|3|||
46627509|NCT02079246|82798448|FG001|OLEX|Lack of Efficacy|0|||
46627510|NCT02079246|82798447|FG000|OLEX|Results of the lead-in studies|58|||
47030600|NCT01888640|83280548|FG001|Overall Study|Given wrong unit (placebo)|0|||
47030601|NCT01888640|83280549|FG002|Overall Study|Given wrong unit (placebo)|0|||
47030602|NCT01888640|83280547|FG000|Overall Study|Excluded for prior TENS|0|||
47030603|NCT01888640|83280548|FG001|Overall Study|Excluded for prior TENS|1|||
47030604|NCT01888640|83280549|FG002|Overall Study|Excluded for prior TENS|0|||
47030605|NCT01888640|83280547|FG000|Overall Study|Researcher Termination of Participant|0|||
47030606|NCT01888640|83280548|FG001|Overall Study|Researcher Termination of Participant|1|||
47030607|NCT01888640|83280549|FG002|Overall Study|Researcher Termination of Participant|1|||
47030608|NCT01736475|83280562|FG000|Overall Study|Adverse Event|4|||
47030609|NCT01736475|83280563|FG001|Overall Study|Adverse Event|0|||
47030610|NCT01736475|83280562|FG000|Overall Study|Withdrawal by Subject|2|||
47030611|NCT01736475|83280563|FG001|Overall Study|Withdrawal by Subject|0|||
47030612|NCT01736475|83280562|FG000|Overall Study|Protocol Violation|4|||
47030613|NCT01736475|83280563|FG001|Overall Study|Protocol Violation|0|||
47030614|NCT01736475|83280562|FG000|Overall Study|Other - Screen failure|1|||
47030615|NCT01736475|83280563|FG001|Overall Study|Other - Screen failure|0|||
47030616|NCT01736475|83280562|FG000|Overall Study|Other - Surgical procedure|1|||
47030617|NCT01736475|83280563|FG001|Overall Study|Other - Surgical procedure|0|||
47030618|NCT01863758|83280580|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
47030619|NCT01863758|83280580|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
47030620|NCT01863680|83280584|FG000|Overall Study|Adverse Event|17|||
47030621|NCT01863680|83280584|FG000|Overall Study|Risk of OHSS|17|||
47030622|NCT01863680|83280584|FG000|Overall Study|Spontaneous pregnancy|2|||
47030623|NCT01863680|83280584|FG000|Overall Study|Withdrawal by Subject|1|||
46912729|NCT02873702|83142830|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
46912730|NCT02873702|83142831|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
46912731|NCT02873702|83142832|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
47030624|NCT01863680|83280584|FG000|Overall Study|Did not undergo IVF/ET|14|||
47030625|NCT01863680|83280584|FG000|Overall Study|Other|6|||
47030626|NCT01747629|83280590|FG000|Overall Study|Adverse Event|1|||
46627511|NCT02079246|82798448|FG001|OLEX|Results of the lead-in studies|0|||
46627512|NCT02079246|82798447|FG000|OLEX|Other: Disallowed medication|8|||
46627513|NCT02079246|82798448|FG001|OLEX|Other: Disallowed medication|0|||
47030627|NCT01747629|83280591|FG001|Overall Study|Adverse Event|2|||
47030628|NCT01747629|83280590|FG000|Overall Study|Withdrawal by Subject|2|||
47030629|NCT01747629|83280591|FG001|Overall Study|Withdrawal by Subject|2|||
47030630|NCT01747629|83280590|FG000|Overall Study|Noncompliance|1|||
47030631|NCT01747629|83280591|FG001|Overall Study|Noncompliance|1|||
47030632|NCT01747629|83280590|FG000|Overall Study|Inclusion criteria not met|1|||
47030633|NCT01747629|83280591|FG001|Overall Study|Inclusion criteria not met|0|||
47030634|NCT01747629|83280590|FG000|Overall Study|Not treated|1|||
47030635|NCT01747629|83280591|FG001|Overall Study|Not treated|0|||
47030636|NCT01747629|83280590|FG000|Overall Study|Other|2|||
46627514|NCT02079246|82798447|FG000|OLEX|Other: Insufficient compliance|2|||
46627515|NCT02079246|82798448|FG001|OLEX|Other: Insufficient compliance|0|||
46627516|NCT02079246|82798447|FG000|OLEX|Other: Caregiver unavailable|3|||
46627517|NCT02079246|82798448|FG001|OLEX|Other: Caregiver unavailable|0|||
47030637|NCT01747629|83280591|FG001|Overall Study|Other|1|||
47030638|NCT01863368|83280599|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
47030639|NCT01863368|83280600|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
47030640|NCT01863368|83280599|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
47030641|NCT01863368|83280600|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
47030642|NCT01863368|83280599|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
47030643|NCT01863368|83280600|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
47030644|NCT01863368|83280599|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
47030645|NCT01863368|83280600|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
47030646|NCT01863368|83280599|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
47030647|NCT01863368|83280600|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
47030648|NCT01863368|83280599|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
46627518|NCT02079246|82798447|FG000|OLEX|Other: Coordinator decision|1|||
46627519|NCT02079246|82798448|FG001|OLEX|Other: Coordinator decision|0|||
46627520|NCT02079246|82798447|FG000|OLEX|Other: Worsening of condition|1|||
46627521|NCT02079246|82798448|FG001|OLEX|Other: Worsening of condition|0|||
46627522|NCT02079246|82798447|FG000|OLEX|Other: Moved to nursing home|1|||
46627523|NCT02079246|82798448|FG001|OLEX|Other: Moved to nursing home|0|||
46627524|NCT02079246|82798447|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
46627525|NCT02079246|82798448|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
46627526|NCT02079246|82798447|FG000|OLEX-MEM|Adverse Event|0|||
46627527|NCT02079246|82798448|FG001|OLEX-MEM|Adverse Event|6|||
46627528|NCT02079246|82798447|FG000|OLEX-MEM|Withdrawal by Subject|0|||
46627529|NCT02079246|82798448|FG001|OLEX-MEM|Withdrawal by Subject|7|||
46627530|NCT02079246|82798447|FG000|OLEX-MEM|Protocol Violation|0|||
46627531|NCT02079246|82798448|FG001|OLEX-MEM|Protocol Violation|2|||
46627532|NCT02079246|82798447|FG000|OLEX-MEM|Lost to Follow-up|0|||
46627533|NCT02079246|82798448|FG001|OLEX-MEM|Lost to Follow-up|1|||
46627534|NCT02079246|82798447|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
46627535|NCT02079246|82798448|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
46627536|NCT02077374|82798459|FG000|Overall Study|Withdrawal by Subject|0|||
46627537|NCT02077374|82798460|FG001|Overall Study|Withdrawal by Subject|1|||
46627538|NCT02077374|82798459|FG000|Overall Study|Protocol Violation|0|||
46627539|NCT02077374|82798460|FG001|Overall Study|Protocol Violation|1|||
46627540|NCT02077140|82798474|FG000|Overall Study|Lost to Follow-up|4|||
46627541|NCT02077140|82798475|FG001|Overall Study|Lost to Follow-up|1|||
46627542|NCT02077140|82798476|FG002|Overall Study|Lost to Follow-up|2|||
46627543|NCT02077140|82798477|FG003|Overall Study|Lost to Follow-up|2|||
46627544|NCT02077140|82798478|FG004|Overall Study|Lost to Follow-up|3|||
46627545|NCT02077140|82798474|FG000|Overall Study|Withdrawal by Subject|0|||
46627546|NCT02077140|82798475|FG001|Overall Study|Withdrawal by Subject|1|||
46627547|NCT02077140|82798476|FG002|Overall Study|Withdrawal by Subject|0|||
46627548|NCT02077140|82798477|FG003|Overall Study|Withdrawal by Subject|2|||
46627549|NCT02077140|82798478|FG004|Overall Study|Withdrawal by Subject|2|||
46627550|NCT02047110|82798497|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
46627551|NCT02047110|82798498|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
46627552|NCT02047110|82798499|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
46627553|NCT02047110|82798500|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
46627554|NCT02047110|82798497|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
46627555|NCT02047110|82798498|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
46627556|NCT02047110|82798499|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
46627557|NCT02047110|82798500|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
46627558|NCT02047110|82798497|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
46627559|NCT02047110|82798498|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
46627560|NCT02047110|82798499|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
46627561|NCT02047110|82798500|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
47030649|NCT01863368|83280600|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
47030650|NCT01886690|83280609|FG000|Overall Study|Protocol Violation|0|||
47030651|NCT01886690|83280610|FG001|Overall Study|Protocol Violation|1|||
47030652|NCT01886690|83280609|FG000|Overall Study|Personal Reasons|0|||
46627562|NCT02047110|82798497|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
46627563|NCT02047110|82798498|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
46627564|NCT02047110|82798499|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
46627565|NCT02047110|82798500|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
46627566|NCT02047110|82798497|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
46627567|NCT02047110|82798498|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
46627568|NCT02047110|82798499|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
46627569|NCT02047110|82798500|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
46627570|NCT02047110|82798497|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
46627571|NCT02047110|82798498|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
46627572|NCT02047110|82798499|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
46627573|NCT02047110|82798500|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
47030653|NCT01886690|83280610|FG001|Overall Study|Personal Reasons|1|||
46627574|NCT02047110|82798497|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
46627575|NCT02047110|82798498|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
46627576|NCT02047110|82798499|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
46627577|NCT02047110|82798500|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
46627578|NCT02047110|82798497|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
46627579|NCT02047110|82798498|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
46627580|NCT02047110|82798499|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
46627581|NCT02047110|82798500|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
46627582|NCT02047110|82798497|FG000|Escape Treatment Period|Adverse Event|1|||
46627583|NCT02047110|82798498|FG001|Escape Treatment Period|Adverse Event|2|||
46627584|NCT02047110|82798499|FG002|Escape Treatment Period|Adverse Event|2|||
46627585|NCT02047110|82798500|FG003|Escape Treatment Period|Adverse Event|0|||
46627586|NCT02047110|82798497|FG000|Escape Treatment Period|Other than specified|1|||
46627587|NCT02047110|82798498|FG001|Escape Treatment Period|Other than specified|2|||
46627588|NCT02047110|82798499|FG002|Escape Treatment Period|Other than specified|0|||
46627589|NCT02047110|82798500|FG003|Escape Treatment Period|Other than specified|1|||
46627590|NCT02047110|82798497|FG000|OLE Treatment Period|Other than specified|0|||
46627591|NCT02047110|82798498|FG001|OLE Treatment Period|Other than specified|0|||
46627592|NCT02047110|82798499|FG002|OLE Treatment Period|Other than specified|1|||
46627593|NCT02047110|82798500|FG003|OLE Treatment Period|Other than specified|0|||
46627594|NCT02046564|82798519|FG000|Overall Study|Adverse Event|6|||
46627595|NCT02046564|82798520|FG001|Overall Study|Adverse Event|3|||
46627596|NCT02046564|82798519|FG000|Overall Study|Physician Decision|0|||
46627597|NCT02046564|82798520|FG001|Overall Study|Physician Decision|1|||
46627598|NCT02046564|82798519|FG000|Overall Study|Protocol Violation|3|||
46627599|NCT02046564|82798520|FG001|Overall Study|Protocol Violation|1|||
46627600|NCT02046564|82798519|FG000|Overall Study|Withdrawal by Subject|4|||
46627601|NCT02046564|82798520|FG001|Overall Study|Withdrawal by Subject|10|||
46627602|NCT02046564|82798519|FG000|Overall Study|Subject met withdrawal criteria|2|||
46627603|NCT02046564|82798520|FG001|Overall Study|Subject met withdrawal criteria|5|||
46627604|NCT02046174|82798526|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
47030654|NCT01886378|83280616|FG000|Overall Study|Adverse Event|1|||
47030655|NCT01886378|83280616|FG000|Overall Study|Withdrawal by Subject|4|||
47030656|NCT01886300|83280620|FG000|Overall Study|Trial terminated by sponsor|16|||
47030657|NCT01885208|83280626|FG000|Overall Study|Unclassified|32|||
47030658|NCT01885208|83280627|FG001|Overall Study|Unclassified|38|||
46627605|NCT02046174|82798527|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
46627606|NCT02045862|82798615|FG000|Overall Study|Death|0|||
46627607|NCT02045862|82798616|FG001|Overall Study|Death|0|||
46627608|NCT02045862|82798617|FG002|Overall Study|Death|1|||
46627609|NCT02045862|82798615|FG000|Overall Study|Miscellaneous|5|||
46627610|NCT02045862|82798616|FG001|Overall Study|Miscellaneous|0|||
46627611|NCT02045862|82798617|FG002|Overall Study|Miscellaneous|8|||
46627612|NCT02045862|82798615|FG000|Overall Study|Withdrawal by Patient|18|||
46627613|NCT02045862|82798616|FG001|Overall Study|Withdrawal by Patient|27|||
46627614|NCT02045862|82798617|FG002|Overall Study|Withdrawal by Patient|57|||
46627615|NCT02045862|82798615|FG000|Overall Study|Protocol Violation|0|||
46627616|NCT02045862|82798616|FG001|Overall Study|Protocol Violation|0|||
46627617|NCT02045862|82798617|FG002|Overall Study|Protocol Violation|6|||
46627618|NCT02045862|82798615|FG000|Overall Study|Lack of Efficacy|8|||
46627619|NCT02045862|82798616|FG001|Overall Study|Lack of Efficacy|4|||
46627620|NCT02045862|82798617|FG002|Overall Study|Lack of Efficacy|13|||
46627621|NCT02045862|82798615|FG000|Overall Study|Randomized but not Received Study Drug|0|||
46627622|NCT02045862|82798616|FG001|Overall Study|Randomized but not Received Study Drug|2|||
46627623|NCT02045862|82798617|FG002|Overall Study|Randomized but not Received Study Drug|8|||
46627624|NCT02045862|82798615|FG000|Overall Study|Adverse Event|7|||
46627625|NCT02045862|82798616|FG001|Overall Study|Adverse Event|5|||
46627626|NCT02045862|82798617|FG002|Overall Study|Adverse Event|27|||
46627627|NCT02045862|82798615|FG000|Overall Study|Lost to Follow-up|1|||
46627628|NCT02045862|82798616|FG001|Overall Study|Lost to Follow-up|2|||
46627629|NCT02045862|82798617|FG002|Overall Study|Lost to Follow-up|6|||
46627630|NCT02075658|82798627|FG000|Overall Study|Physician Decision|2|||
46627631|NCT02075658|82798628|FG001|Overall Study|Physician Decision|2|||
46627632|NCT02063880|82798636|FG000|Overall Study|Death|21|||
46627633|NCT02063880|82798637|FG001|Overall Study|Death|18|||
46627634|NCT02063880|82798636|FG000|Overall Study|Lost to Follow-up|7|||
46627635|NCT02063880|82798637|FG001|Overall Study|Lost to Follow-up|7|||
46627636|NCT02063880|82798636|FG000|Overall Study|Ineligible|0|||
46627637|NCT02063880|82798637|FG001|Overall Study|Ineligible|2|||
46627638|NCT02044848|82798645|FG000|Overall Study|Administrative Problems|2|||
46627639|NCT02044848|82798646|FG001|Overall Study|Administrative Problems|3|||
46627640|NCT02044302|82798654|FG000|Overall Study|study terminated|2|||
46627641|NCT02044302|82798655|FG001|Overall Study|study terminated|0|||
46627642|NCT02062944|82798659|FG000|Overall Study|Lost to Follow-up|1|||
47030659|NCT01859702|83280633|FG000|Overall Study|Protocol deviation|3|||
46627643|NCT02062944|82798659|FG000|Overall Study|New hemotological disorder identified|1|||
46627644|NCT02062944|82798659|FG000|Overall Study|Uncontrolled Hypertension|1|||
46627645|NCT02062944|82798659|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
46627646|NCT02062632|82798664|FG000|Overall Study|No treatment data|1|||
46627647|NCT02062398|82798668|FG000|Overall Study|Implant removal|1|||
46627648|NCT02061540|82798672|FG000|Overall Study|Adverse Event|2|||
46627649|NCT02061540|82798672|FG000|Overall Study|Withdrawal by Subject|2|||
46627650|NCT02043366|82798687|FG000|Overall Study|Lost to Follow-up|2|||
46627651|NCT02043366|82798688|FG001|Overall Study|Lost to Follow-up|2|||
46627652|NCT02043366|82798689|FG002|Overall Study|Lost to Follow-up|2|||
46627653|NCT02043366|82798690|FG003|Overall Study|Lost to Follow-up|2|||
46627654|NCT02043366|82798691|FG004|Overall Study|Lost to Follow-up|2|||
46627655|NCT02043366|82798692|FG005|Overall Study|Lost to Follow-up|2|||
46627656|NCT02060370|82798708|FG000|Overall Study|Physician Decision|1|||
46627657|NCT01622088|82798712|FG000|Overall Study|Adverse Event|20|||
46627658|NCT01622088|82798712|FG000|Overall Study|Lost to Follow-up|1|||
46627659|NCT01622088|82798712|FG000|Overall Study|Withdrawal by Subject|20|||
46627660|NCT01622088|82798712|FG000|Overall Study|Investigator Decision|1|||
46627661|NCT01622088|82798712|FG000|Overall Study|Death|53|||
46627662|NCT01622088|82798712|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
46627663|NCT01621542|82798723|FG000|Overall Study|Adverse Event|0|||
46627664|NCT01621542|82798724|FG001|Overall Study|Adverse Event|0|||
46627665|NCT01621542|82798725|FG002|Overall Study|Adverse Event|1|||
46627666|NCT01621542|82798726|FG003|Overall Study|Adverse Event|3|||
46627667|NCT01621542|82798727|FG004|Overall Study|Adverse Event|0|||
46627668|NCT01621542|82798728|FG005|Overall Study|Adverse Event|0|||
46627669|NCT01621542|82798723|FG000|Overall Study|Death|0|||
46627670|NCT01621542|82798724|FG001|Overall Study|Death|1|||
46627671|NCT01621542|82798725|FG002|Overall Study|Death|0|||
46627672|NCT01621542|82798726|FG003|Overall Study|Death|0|||
46627673|NCT01621542|82798727|FG004|Overall Study|Death|0|||
46627674|NCT01621542|82798728|FG005|Overall Study|Death|0|||
46627675|NCT01621542|82798723|FG000|Overall Study|Physician Decision|1|||
46627676|NCT01621542|82798724|FG001|Overall Study|Physician Decision|0|||
46627677|NCT01621542|82798725|FG002|Overall Study|Physician Decision|1|||
46627678|NCT01621542|82798726|FG003|Overall Study|Physician Decision|13|||
46627679|NCT01621542|82798727|FG004|Overall Study|Physician Decision|3|||
46627680|NCT01621542|82798728|FG005|Overall Study|Physician Decision|1|||
46627681|NCT01621542|82798723|FG000|Overall Study|Withdrawal by Subject|2|||
46627682|NCT01621542|82798724|FG001|Overall Study|Withdrawal by Subject|0|||
46627683|NCT01621542|82798725|FG002|Overall Study|Withdrawal by Subject|1|||
46627684|NCT01621542|82798726|FG003|Overall Study|Withdrawal by Subject|3|||
46627685|NCT01621542|82798727|FG004|Overall Study|Withdrawal by Subject|3|||
46627686|NCT01621542|82798728|FG005|Overall Study|Withdrawal by Subject|3|||
46627687|NCT01621542|82798723|FG000|Overall Study|progression/treatment failure|2|||
46627688|NCT01621542|82798724|FG001|Overall Study|progression/treatment failure|4|||
46627689|NCT01621542|82798725|FG002|Overall Study|progression/treatment failure|3|||
46627690|NCT01621542|82798726|FG003|Overall Study|progression/treatment failure|7|||
46627691|NCT01621542|82798727|FG004|Overall Study|progression/treatment failure|3|||
46627692|NCT01621542|82798728|FG005|Overall Study|progression/treatment failure|5|||
46627693|NCT01621542|82798723|FG000|Overall Study|Protocol Violation|0|||
46627694|NCT01621542|82798724|FG001|Overall Study|Protocol Violation|0|||
46627695|NCT01621542|82798725|FG002|Overall Study|Protocol Violation|0|||
46627696|NCT01621542|82798726|FG003|Overall Study|Protocol Violation|1|||
46627697|NCT01621542|82798727|FG004|Overall Study|Protocol Violation|0|||
46627698|NCT01621542|82798728|FG005|Overall Study|Protocol Violation|0|||
46627699|NCT01621542|82798723|FG000|Overall Study|study stopped by sponsor|0|||
46627700|NCT01621542|82798724|FG001|Overall Study|study stopped by sponsor|0|||
46627701|NCT01621542|82798725|FG002|Overall Study|study stopped by sponsor|0|||
46627702|NCT01621542|82798726|FG003|Overall Study|study stopped by sponsor|1|||
46627703|NCT01621542|82798727|FG004|Overall Study|study stopped by sponsor|0|||
46627704|NCT01621542|82798728|FG005|Overall Study|study stopped by sponsor|0|||
46627705|NCT02021292|82798744|FG000|Overall Study|Physician Decision|0|||
46627706|NCT02021292|82798745|FG001|Overall Study|Physician Decision|1|||
46627707|NCT02021292|82798744|FG000|Overall Study|Lost to Follow-up|0|||
46627708|NCT02021292|82798745|FG001|Overall Study|Lost to Follow-up|1|||
46627709|NCT02021292|82798744|FG000|Overall Study|Death|0|||
46627710|NCT02021292|82798745|FG001|Overall Study|Death|1|||
46627711|NCT02059980|82798755|FG000|Overall Study|Lost to Follow-up|2|||
46627712|NCT02059980|82798756|FG001|Overall Study|Lost to Follow-up|1|||
46627713|NCT02043132|82798764|FG000|Overall Study|Lost to Follow-up|1|||
46627714|NCT02043132|82798765|FG001|Overall Study|Lost to Follow-up|1|||
46627715|NCT02043132|82798764|FG000|Overall Study|screen failures|4|||
46627716|NCT02043132|82798765|FG001|Overall Study|screen failures|8|||
46627717|NCT02059434|82798780|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
46627718|NCT02059434|82798781|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
46627719|NCT02059434|82798782|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
46627720|NCT02059434|82798783|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
46627721|NCT02059434|82798784|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
46627722|NCT02059434|82798785|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
46627723|NCT02059434|82798786|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
46627724|NCT02059434|82798787|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
46627725|NCT02059434|82798788|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
46627726|NCT02059434|82798780|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
46627727|NCT02059434|82798781|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
46627728|NCT02059434|82798782|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
46627729|NCT02059434|82798783|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
46627730|NCT02059434|82798784|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
46627731|NCT02059434|82798785|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
46627732|NCT02059434|82798786|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
46627733|NCT02059434|82798787|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
46627734|NCT02059434|82798788|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
46627735|NCT02059434|82798780|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
46627736|NCT02059434|82798781|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
46627737|NCT02059434|82798782|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
46627738|NCT02059434|82798783|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
46627739|NCT02059434|82798784|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
46627740|NCT02059434|82798785|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
46627741|NCT02059434|82798786|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
46627742|NCT02059434|82798787|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
46627743|NCT02059434|82798788|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
46627744|NCT02059434|82798780|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
46627745|NCT02059434|82798781|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
46627746|NCT02059434|82798782|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
46627747|NCT02059434|82798783|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
46627748|NCT02059434|82798784|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
46627749|NCT02059434|82798785|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
46627750|NCT02059434|82798786|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
46627751|NCT02059434|82798787|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
46627752|NCT02059434|82798788|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
46627753|NCT02059434|82798780|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627754|NCT02059434|82798781|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627755|NCT02059434|82798782|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627756|NCT02059434|82798783|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627757|NCT02059434|82798784|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627758|NCT02059434|82798785|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627759|NCT02059434|82798786|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627760|NCT02059434|82798787|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
46627761|NCT02059434|82798788|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
46627762|NCT02059278|82798818|FG000|Overall Study|Adverse Event|1|||
46627763|NCT02059278|82798819|FG001|Overall Study|Adverse Event|1|||
46627764|NCT02059278|82798818|FG000|Overall Study|Lost to Follow-up|1|||
46627765|NCT02059278|82798819|FG001|Overall Study|Lost to Follow-up|0|||
46627766|NCT02059278|82798818|FG000|Overall Study|Withdrawal by Subject|0|||
47030660|NCT01859702|83280633|FG000|Overall Study|Adverse Event|2|||
47030661|NCT01835132|83280637|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
47030662|NCT01747551|83280643|FG000|Overall Study|Progressive Disease|24|||
47030663|NCT01747551|83280644|FG001|Overall Study|Progressive Disease|17|||
47030664|NCT01747551|83280643|FG000|Overall Study|Death|3|||
47030665|NCT01747551|83280644|FG001|Overall Study|Death|1|||
47030666|NCT01747551|83280643|FG000|Overall Study|Adverse Event|7|||
47030667|NCT01747551|83280644|FG001|Overall Study|Adverse Event|1|||
47030668|NCT01747551|83280643|FG000|Overall Study|Prolonged Treatment Delay|2|||
47030669|NCT01747551|83280644|FG001|Overall Study|Prolonged Treatment Delay|0|||
47030670|NCT01747551|83280643|FG000|Overall Study|Withdrawal by Subject|3|||
47030671|NCT01747551|83280644|FG001|Overall Study|Withdrawal by Subject|1|||
47030672|NCT01747551|83280643|FG000|Overall Study|Physician Decision|2|||
47030673|NCT01747551|83280644|FG001|Overall Study|Physician Decision|1|||
47030674|NCT01747551|83280643|FG000|Overall Study|Other|2|||
46627767|NCT02059278|82798819|FG001|Overall Study|Withdrawal by Subject|3|||
46627768|NCT02059278|82798818|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
47030675|NCT01747551|83280644|FG001|Overall Study|Other|0|||
47030676|NCT01736397|83280652|FG000|Overall Study|Lack of Efficacy|1|||
47030677|NCT01736397|83280653|FG001|Overall Study|Lack of Efficacy|11|||
47030678|NCT01736397|83280652|FG000|Overall Study|Withdrawal by Subject|6|||
47030679|NCT01736397|83280653|FG001|Overall Study|Withdrawal by Subject|5|||
47030680|NCT01736397|83280652|FG000|Overall Study|Lost to Follow-up|0|||
47030681|NCT01736397|83280653|FG001|Overall Study|Lost to Follow-up|1|||
47030682|NCT01736397|83280652|FG000|Overall Study|Adverse Event|6|||
47030683|NCT01736397|83280653|FG001|Overall Study|Adverse Event|3|||
47030684|NCT01736397|83280652|FG000|Overall Study|Not stated|1|||
47030685|NCT01736397|83280653|FG001|Overall Study|Not stated|4|||
47030686|NCT01859390|83280661|FG000|Overall Study|Insufficient Sputum Collected|1|||
47030687|NCT01859390|83280662|FG001|Overall Study|Insufficient Sputum Collected|3|||
47030688|NCT01859390|83280661|FG000|Overall Study|Sample Missing Collection Date|0|||
47030689|NCT01859390|83280662|FG001|Overall Study|Sample Missing Collection Date|1|||
47030690|NCT01859390|83280661|FG000|Overall Study|Tube Cracked|0|||
47030691|NCT01859390|83280662|FG001|Overall Study|Tube Cracked|2|||
47030692|NCT01859390|83280661|FG000|Overall Study|Shipment Error|0|||
47030693|NCT01859390|83280662|FG001|Overall Study|Shipment Error|1|||
47030694|NCT01858766|83280687|FG000|Overall Study|Randomized but Never Treated|0|||
46627769|NCT02059278|82798819|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
46627770|NCT02020512|82798825|FG000|Overall Study|Adverse Event|1|||
47030695|NCT01858766|83280688|FG001|Overall Study|Randomized but Never Treated|0|||
47030696|NCT01858766|83280689|FG002|Overall Study|Randomized but Never Treated|0|||
47030697|NCT01858766|83280690|FG003|Overall Study|Randomized but Never Treated|0|||
47030698|NCT01858766|83280691|FG004|Overall Study|Randomized but Never Treated|0|||
47030699|NCT01858766|83280692|FG005|Overall Study|Randomized but Never Treated|1|||
47030700|NCT01858766|83280693|FG006|Overall Study|Randomized but Never Treated|0|||
47030701|NCT01858766|83280694|FG007|Overall Study|Randomized but Never Treated|0|||
47030702|NCT01858766|83280695|FG008|Overall Study|Randomized but Never Treated|0|||
47030703|NCT01858766|83280696|FG009|Overall Study|Randomized but Never Treated|0|||
47030704|NCT01858766|83280697|FG010|Overall Study|Randomized but Never Treated|0|||
47030705|NCT01858766|83280698|FG011|Overall Study|Randomized but Never Treated|0|||
47030706|NCT01858766|83280699|FG012|Overall Study|Randomized but Never Treated|0|||
47030707|NCT01858766|83280700|FG013|Overall Study|Randomized but Never Treated|0|||
47030708|NCT01858766|83280701|FG014|Overall Study|Randomized but Never Treated|0|||
47030709|NCT01858766|83280702|FG015|Overall Study|Randomized but Never Treated|0|||
47030710|NCT01858766|83280703|FG016|Overall Study|Randomized but Never Treated|0|||
47030711|NCT01858766|83280704|FG017|Overall Study|Randomized but Never Treated|1|||
47030712|NCT01858766|83280705|FG018|Overall Study|Randomized but Never Treated|0|||
47030713|NCT01858766|83280687|FG000|Overall Study|Death|0|||
47030714|NCT01858766|83280688|FG001|Overall Study|Death|0|||
47030715|NCT01858766|83280689|FG002|Overall Study|Death|1|||
47030716|NCT01858766|83280690|FG003|Overall Study|Death|0|||
47030717|NCT01858766|83280691|FG004|Overall Study|Death|0|||
47030718|NCT01858766|83280692|FG005|Overall Study|Death|0|||
47030719|NCT01858766|83280693|FG006|Overall Study|Death|0|||
47030720|NCT01858766|83280694|FG007|Overall Study|Death|0|||
47030721|NCT01858766|83280695|FG008|Overall Study|Death|0|||
47030722|NCT01858766|83280696|FG009|Overall Study|Death|0|||
47030723|NCT01858766|83280697|FG010|Overall Study|Death|0|||
47030724|NCT01858766|83280698|FG011|Overall Study|Death|0|||
47030725|NCT01858766|83280699|FG012|Overall Study|Death|0|||
47030726|NCT01858766|83280700|FG013|Overall Study|Death|0|||
47030727|NCT01858766|83280701|FG014|Overall Study|Death|0|||
47030728|NCT01858766|83280702|FG015|Overall Study|Death|0|||
47030729|NCT01858766|83280703|FG016|Overall Study|Death|0|||
47030730|NCT01858766|83280704|FG017|Overall Study|Death|0|||
47030731|NCT01858766|83280705|FG018|Overall Study|Death|0|||
47030732|NCT01858766|83280687|FG000|Overall Study|Lack of Efficacy|1|||
47030733|NCT01858766|83280688|FG001|Overall Study|Lack of Efficacy|0|||
47030734|NCT01858766|83280689|FG002|Overall Study|Lack of Efficacy|0|||
47030735|NCT01858766|83280690|FG003|Overall Study|Lack of Efficacy|0|||
47030736|NCT01858766|83280691|FG004|Overall Study|Lack of Efficacy|1|||
47030737|NCT01858766|83280692|FG005|Overall Study|Lack of Efficacy|2|||
46627771|NCT02020512|82798825|FG000|Overall Study|Lost to Follow-up|3|||
47030738|NCT01858766|83280693|FG006|Overall Study|Lack of Efficacy|0|||
46627772|NCT02020512|82798825|FG000|Overall Study|Protocol Violation|4|||
46627773|NCT02041962|82798831|FG000|Overall Study|Lost Aetna Coverage|43|||
46627774|NCT02041962|82798832|FG001|Overall Study|Lost Aetna Coverage|40|||
46627775|NCT02041962|82798831|FG000|Overall Study|Death|1|||
47030739|NCT01858766|83280694|FG007|Overall Study|Lack of Efficacy|0|||
47030740|NCT01858766|83280695|FG008|Overall Study|Lack of Efficacy|0|||
47030741|NCT01858766|83280696|FG009|Overall Study|Lack of Efficacy|0|||
47030742|NCT01858766|83280697|FG010|Overall Study|Lack of Efficacy|0|||
47030743|NCT01858766|83280698|FG011|Overall Study|Lack of Efficacy|3|||
47030744|NCT01858766|83280699|FG012|Overall Study|Lack of Efficacy|5|||
47030745|NCT01858766|83280700|FG013|Overall Study|Lack of Efficacy|3|||
47030746|NCT01858766|83280701|FG014|Overall Study|Lack of Efficacy|5|||
47030747|NCT01858766|83280702|FG015|Overall Study|Lack of Efficacy|5|||
47030748|NCT01858766|83280703|FG016|Overall Study|Lack of Efficacy|2|||
47030749|NCT01858766|83280704|FG017|Overall Study|Lack of Efficacy|3|||
47030750|NCT01858766|83280705|FG018|Overall Study|Lack of Efficacy|3|||
47030751|NCT01858766|83280687|FG000|Overall Study|Lost to Follow-up|0|||
47030752|NCT01858766|83280688|FG001|Overall Study|Lost to Follow-up|0|||
47030753|NCT01858766|83280689|FG002|Overall Study|Lost to Follow-up|0|||
47030754|NCT01858766|83280690|FG003|Overall Study|Lost to Follow-up|0|||
46627776|NCT02041962|82798832|FG001|Overall Study|Death|1|||
46627777|NCT02041962|82798831|FG000|Overall Study|Lost to Follow-up|37|||
46627778|NCT02041962|82798832|FG001|Overall Study|Lost to Follow-up|32|||
46627779|NCT02041962|82798831|FG000|Overall Study|Withdrawal by Subject|0|||
46627780|NCT02041962|82798832|FG001|Overall Study|Withdrawal by Subject|11|||
46627781|NCT02041494|82798840|FG000|Overall Study|Death|1|||
46627782|NCT02041494|82798841|FG001|Overall Study|Death|3|||
46627783|NCT02041494|82798840|FG000|Overall Study|Lost to Follow-up|2|||
46627784|NCT02041494|82798841|FG001|Overall Study|Lost to Follow-up|6|||
46627785|NCT02041494|82798840|FG000|Overall Study|study terminated|16|||
46627786|NCT02041494|82798841|FG001|Overall Study|study terminated|11|||
47030755|NCT01858766|83280691|FG004|Overall Study|Lost to Follow-up|0|||
47030756|NCT01858766|83280692|FG005|Overall Study|Lost to Follow-up|1|||
47030757|NCT01858766|83280693|FG006|Overall Study|Lost to Follow-up|0|||
47030758|NCT01858766|83280694|FG007|Overall Study|Lost to Follow-up|2|||
47030759|NCT01858766|83280695|FG008|Overall Study|Lost to Follow-up|0|||
47030760|NCT01858766|83280696|FG009|Overall Study|Lost to Follow-up|0|||
47030761|NCT01858766|83280697|FG010|Overall Study|Lost to Follow-up|0|||
47030762|NCT01858766|83280698|FG011|Overall Study|Lost to Follow-up|1|||
47030763|NCT01858766|83280699|FG012|Overall Study|Lost to Follow-up|0|||
47030764|NCT01858766|83280700|FG013|Overall Study|Lost to Follow-up|0|||
47030765|NCT01858766|83280701|FG014|Overall Study|Lost to Follow-up|3|||
47030766|NCT01858766|83280702|FG015|Overall Study|Lost to Follow-up|1|||
47030767|NCT01858766|83280703|FG016|Overall Study|Lost to Follow-up|1|||
47030768|NCT01858766|83280704|FG017|Overall Study|Lost to Follow-up|0|||
47030769|NCT01858766|83280705|FG018|Overall Study|Lost to Follow-up|1|||
47030770|NCT01858766|83280687|FG000|Overall Study|Withdrew Consent|0|||
47030771|NCT01858766|83280688|FG001|Overall Study|Withdrew Consent|0|||
47030772|NCT01858766|83280689|FG002|Overall Study|Withdrew Consent|0|||
46627787|NCT02041104|82798872|FG000|Overall Study|Lost to Follow-up|1|||
46627788|NCT02041104|82798873|FG001|Overall Study|Lost to Follow-up|4|||
46627789|NCT02041104|82798872|FG000|Overall Study|discomfort during OGTT|0|||
46627790|NCT02041104|82798873|FG001|Overall Study|discomfort during OGTT|3|||
46627791|NCT02019420|82798883|FG000|Overall Study|Did not receive study drug|2|||
46627792|NCT02019420|82798884|FG001|Overall Study|Did not receive study drug|2|||
46627793|NCT02019420|82798883|FG000|Overall Study|Withdrawal by Subject|1|||
46627794|NCT02019420|82798884|FG001|Overall Study|Withdrawal by Subject|3|||
46627795|NCT02019420|82798883|FG000|Overall Study|At request of sponsor or investigator|0|||
46627796|NCT02019420|82798884|FG001|Overall Study|At request of sponsor or investigator|1|||
46627797|NCT02019420|82798883|FG000|Overall Study|Death|104|||
46627798|NCT02019420|82798884|FG001|Overall Study|Death|99|||
46627799|NCT02019420|82798883|FG000|Overall Study|Transferred to other care facility|1|||
46627800|NCT02019420|82798884|FG001|Overall Study|Transferred to other care facility|1|||
46627801|NCT02019264|82798892|FG000|Overall Study|Not treated|6|||
46627802|NCT02019264|82798893|FG001|Overall Study|Not treated|4|||
46627803|NCT02019264|82798892|FG000|Overall Study|Lost to Follow-up|50|||
46627804|NCT02019264|82798893|FG001|Overall Study|Lost to Follow-up|47|||
46627805|NCT02019264|82798892|FG000|Overall Study|Withdrawal by Subject|142|||
46627806|NCT02019264|82798893|FG001|Overall Study|Withdrawal by Subject|117|||
46627807|NCT02019264|82798892|FG000|Overall Study|Administrative reason|36|||
46627808|NCT02019264|82798893|FG001|Overall Study|Administrative reason|28|||
46627809|NCT02019264|82798892|FG000|Overall Study|Missing|14|||
46627810|NCT02019264|82798893|FG001|Overall Study|Missing|11|||
46627811|NCT02019108|82798901|FG000|Overall Study|Lost to Follow-up|5|||
46627812|NCT02019108|82798902|FG001|Overall Study|Lost to Follow-up|7|||
46627813|NCT02018562|82798910|FG000|Overall Study|Withdrawal by Subject|2|||
46627814|NCT02018562|82798911|FG001|Overall Study|Withdrawal by Subject|0|||
46627815|NCT02018562|82798910|FG000|Overall Study|Discharged prior to study completion|1|||
47030773|NCT01858766|83280690|FG003|Overall Study|Withdrew Consent|0|||
46627816|NCT02018562|82798911|FG001|Overall Study|Discharged prior to study completion|0|||
46627817|NCT02058966|82798917|FG000|Open-Label Methamphetamine|Adverse Event|1|||
46912732|NCT02873702|83142833|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
47030774|NCT01858766|83280691|FG004|Overall Study|Withdrew Consent|0|||
46912733|NCT02873702|83142830|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
46627818|NCT02058966|82798917|FG000|First Intervention|Withdrawal by Subject|1|||
47030775|NCT01858766|83280692|FG005|Overall Study|Withdrew Consent|0|||
47030776|NCT01858766|83280693|FG006|Overall Study|Withdrew Consent|0|||
47030777|NCT01858766|83280694|FG007|Overall Study|Withdrew Consent|0|||
47030778|NCT01858766|83280695|FG008|Overall Study|Withdrew Consent|0|||
47030779|NCT01858766|83280696|FG009|Overall Study|Withdrew Consent|0|||
47030780|NCT01858766|83280697|FG010|Overall Study|Withdrew Consent|0|||
46627819|NCT02017860|82798929|FG000|Overall Study|Adverse Event|1|||
46627820|NCT02017860|82798929|FG000|Overall Study|Withdrawal by Subject|1|||
47030781|NCT01858766|83280698|FG011|Overall Study|Withdrew Consent|1|||
46627821|NCT02040870|82798933|FG000|Overall Study|Completed treatment phase|6|||
47030782|NCT01858766|83280699|FG012|Overall Study|Withdrew Consent|0|||
46627822|NCT02040870|82798933|FG000|Overall Study|Adverse Event|7|||
46627823|NCT02040870|82798933|FG000|Overall Study|Progressive disease|58|||
46627824|NCT02040870|82798933|FG000|Overall Study|Physician Decision|6|||
46627825|NCT02040870|82798933|FG000|Overall Study|Subject/guardian decision|10|||
46627826|NCT02040870|82798933|FG000|Overall Study|Lost to Follow-up|3|||
46627827|NCT02040870|82798933|FG000|Overall Study|Death|13|||
46627828|NCT02016690|82798937|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
46627829|NCT02016690|82798937|FG000|Overall Study|Excluded from SAS: Duplication|2|||
46627830|NCT02016690|82798937|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
46627831|NCT02016690|82798937|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
46627832|NCT02016690|82798937|FG000|Overall Study|Did not meet inclusion criteria|13|||
46627833|NCT02016690|82798937|FG000|Overall Study|Hospitalized for RSV at study start|3|||
46627834|NCT02016300|82798943|FG000|Overall Study|Lost to Follow-up|0|||
46627835|NCT02016300|82798944|FG001|Overall Study|Lost to Follow-up|3|||
46627836|NCT02040090|82798952|FG000|Overall Study|Adverse Event|2|||
46627837|NCT02040090|82798953|FG001|Overall Study|Adverse Event|0|||
47030783|NCT01858766|83280700|FG013|Overall Study|Withdrew Consent|0|||
47030784|NCT01858766|83280701|FG014|Overall Study|Withdrew Consent|0|||
47030785|NCT01858766|83280702|FG015|Overall Study|Withdrew Consent|0|||
47030786|NCT01858766|83280703|FG016|Overall Study|Withdrew Consent|0|||
47030787|NCT01858766|83280704|FG017|Overall Study|Withdrew Consent|0|||
47030788|NCT01858766|83280705|FG018|Overall Study|Withdrew Consent|0|||
47030789|NCT01734993|83280738|FG000|Overall Study|Adverse Event|1|||
47030790|NCT01734993|83280738|FG000|Overall Study|Lack of Efficacy|1|||
47030791|NCT01745367|83280745|FG000|Overall Study|Death|1|||
47030792|NCT01745367|83280746|FG001|Overall Study|Death|0|||
47030793|NCT01745367|83280745|FG000|Overall Study|Withdrawal by Subject|1|||
47030794|NCT01745367|83280746|FG001|Overall Study|Withdrawal by Subject|2|||
47030795|NCT01745367|83280745|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
47030796|NCT01745367|83280746|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
46627838|NCT02040090|82798952|FG000|Overall Study|Physician Decision|1|||
46627839|NCT02040090|82798953|FG001|Overall Study|Physician Decision|0|||
46627840|NCT02040090|82798952|FG000|Overall Study|Withdrawal by Subject|0|||
46627841|NCT02040090|82798953|FG001|Overall Study|Withdrawal by Subject|1|||
46627842|NCT02040090|82798952|FG000|Overall Study|Lost to Follow-up|0|||
46627843|NCT02040090|82798953|FG001|Overall Study|Lost to Follow-up|1|||
46627844|NCT02058498|82798959|FG000|Overall Study|Withdrawal by Subject|4|||
46627845|NCT02039778|82798963|FG000|Overall Study|Death|2|||
46627846|NCT02039778|82798963|FG000|Overall Study|Withdrawal by Subject|1|||
46627847|NCT02039778|82798963|FG000|Overall Study|Never started the protocol treatment|1|||
46627848|NCT02015754|82798967|FG000|Overall Study|Disease progression|5|||
46627849|NCT02015754|82798967|FG000|Overall Study|Change in treatment modality|5|||
46627850|NCT02015754|82798967|FG000|Overall Study|Lost to Follow-up|1|||
46627851|NCT02015676|82798974|FG000|Overall Study|Adverse Event|2|||
46627852|NCT02015676|82798975|FG001|Overall Study|Adverse Event|18|||
46627853|NCT02015676|82798976|FG002|Overall Study|Adverse Event|0|||
46627854|NCT02015676|82798974|FG000|Overall Study|Lack of Efficacy|2|||
46627855|NCT02015676|82798975|FG001|Overall Study|Lack of Efficacy|4|||
46627856|NCT02015676|82798976|FG002|Overall Study|Lack of Efficacy|0|||
46627857|NCT02015676|82798974|FG000|Overall Study|Protocol Violation|1|||
46627858|NCT02015676|82798975|FG001|Overall Study|Protocol Violation|0|||
46627859|NCT02015676|82798976|FG002|Overall Study|Protocol Violation|0|||
46627860|NCT02015676|82798974|FG000|Overall Study|Withdrawal by Subject|1|||
46627861|NCT02015676|82798975|FG001|Overall Study|Withdrawal by Subject|7|||
46627862|NCT02015676|82798976|FG002|Overall Study|Withdrawal by Subject|1|||
46627863|NCT02015676|82798974|FG000|Overall Study|Administrative reasons|0|||
46627864|NCT02015676|82798975|FG001|Overall Study|Administrative reasons|3|||
46627865|NCT02015676|82798976|FG002|Overall Study|Administrative reasons|1|||
46627866|NCT02015676|82798974|FG000|Overall Study|Death|0|||
46627867|NCT02015676|82798975|FG001|Overall Study|Death|1|||
46627868|NCT02015676|82798976|FG002|Overall Study|Death|0|||
47030797|NCT01745367|83280745|FG000|Overall Study|Other Reasons Unspecified|0|||
46627869|NCT02015676|82798974|FG000|Overall Study|Disease progression|3|||
46710856|NCT00883129|82927126|FG000|Overall Study|Non-compliance|3|||
47030798|NCT01745367|83280746|FG001|Overall Study|Other Reasons Unspecified|2|||
47030799|NCT01733121|83280754|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
46627870|NCT02015676|82798975|FG001|Overall Study|Disease progression|1|||
46627871|NCT02015676|82798976|FG002|Overall Study|Disease progression|1|||
46627872|NCT02015520|82798984|FG000|Overall Study|Lack of Efficacy|1|||
46627873|NCT02015520|82798985|FG001|Overall Study|Lack of Efficacy|0|||
46627874|NCT02015520|82798986|FG002|Overall Study|Lack of Efficacy|3|||
46627875|NCT02015520|82798987|FG003|Overall Study|Lack of Efficacy|2|||
46627876|NCT02015520|82798984|FG000|Overall Study|Adverse Event|0|||
46627877|NCT02015520|82798985|FG001|Overall Study|Adverse Event|0|||
46627878|NCT02015520|82798986|FG002|Overall Study|Adverse Event|0|||
46627879|NCT02015520|82798987|FG003|Overall Study|Adverse Event|1|||
46627880|NCT02015520|82798984|FG000|Overall Study|Withdrawal by Subject|2|||
47030800|NCT01733121|83280755|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
47030801|NCT01733121|83280754|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
47030802|NCT01733121|83280755|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
47030803|NCT01733121|83280754|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
47030804|NCT01733121|83280755|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
47030805|NCT01733121|83280754|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
47030806|NCT01733121|83280755|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
47030807|NCT01744977|83280765|FG000|Overall Study|Withdrawal by Subject|1|||
47030808|NCT01744977|83280766|FG001|Overall Study|Withdrawal by Subject|2|||
47030809|NCT01744977|83280765|FG000|Overall Study|Death|2|||
47030810|NCT01744977|83280766|FG001|Overall Study|Death|3|||
47030811|NCT01744977|83280765|FG000|Overall Study|Lost to Follow-up|2|||
47030812|NCT01744977|83280766|FG001|Overall Study|Lost to Follow-up|0|||
47030813|NCT01744977|83280765|FG000|Overall Study|No longer meets inclusion|6|||
47030814|NCT01744977|83280766|FG001|Overall Study|No longer meets inclusion|0|||
47030815|NCT01383928|83280775|FG000|Overall Study|Initiation of ASCT|2|||
47030816|NCT01383928|83280776|FG001|Overall Study|Initiation of ASCT|1|||
47030817|NCT01383928|83280777|FG002|Overall Study|Initiation of ASCT|18|||
47030818|NCT01383928|83280775|FG000|Overall Study|Adverse Event|1|||
47030819|NCT01383928|83280776|FG001|Overall Study|Adverse Event|2|||
47030820|NCT01383928|83280777|FG002|Overall Study|Adverse Event|8|||
47030821|NCT01383928|83280775|FG000|Overall Study|Other|1|||
47030822|NCT01383928|83280776|FG001|Overall Study|Other|3|||
47030823|NCT01383928|83280777|FG002|Overall Study|Other|4|||
47030824|NCT01383928|83280775|FG000|Overall Study|Progressive Disease|1|||
47030825|NCT01383928|83280776|FG001|Overall Study|Progressive Disease|1|||
47030826|NCT01383928|83280777|FG002|Overall Study|Progressive Disease|5|||
47030827|NCT01383928|83280775|FG000|Overall Study|Withdrawal by Subject|0|||
47030828|NCT01383928|83280776|FG001|Overall Study|Withdrawal by Subject|0|||
47030829|NCT01383928|83280777|FG002|Overall Study|Withdrawal by Subject|4|||
47030830|NCT01383928|83280775|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
47030831|NCT01383928|83280776|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
47030832|NCT01383928|83280777|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
47030833|NCT01382602|83280789|FG000|Overall Study|Protocol Violation|0|||
47030834|NCT01382602|83280790|FG001|Overall Study|Protocol Violation|3|||
47030835|NCT01382602|83280789|FG000|Overall Study|Withdrawal by Subject|0|||
47030836|NCT01382602|83280790|FG001|Overall Study|Withdrawal by Subject|1|||
47030837|NCT04801420|83280799|FG000|Overall Study|Other|1|||
47030838|NCT04801420|83280800|FG001|Overall Study|Other|2|||
47030839|NCT04801420|83280801|FG002|Overall Study|Other|1|||
46627881|NCT02015520|82798985|FG001|Overall Study|Withdrawal by Subject|2|||
46912734|NCT02873702|83142831|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
46912735|NCT02873702|83142832|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
46912736|NCT02873702|83142833|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
46912737|NCT02873702|83142830|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
46912738|NCT02873702|83142831|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
46912739|NCT02873702|83142832|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
46912740|NCT02873702|83142833|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
46912741|NCT02873702|83142830|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
46912742|NCT02873702|83142831|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
46912743|NCT02873702|83142832|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
46912744|NCT02873702|83142833|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
46912745|NCT02911116|83142845|FG000|Overall Study|Insufficient Therapeutic Response|1|||
46912746|NCT02911116|83142846|FG001|Overall Study|Insufficient Therapeutic Response|0|||
46912747|NCT02911116|83142845|FG000|Overall Study|Lost to Follow-up|0|||
46912748|NCT02911116|83142846|FG001|Overall Study|Lost to Follow-up|1|||
46912749|NCT02998554|83142854|FG000|Overall Study|Adverse Event|8|||
46912750|NCT02998554|83142855|FG001|Overall Study|Adverse Event|3|||
46912751|NCT02998554|83142854|FG000|Overall Study|Protocol deviation|1|||
46912752|NCT02998554|83142855|FG001|Overall Study|Protocol deviation|0|||
46912753|NCT02998554|83142854|FG000|Overall Study|Withdrawal by Subject|2|||
46912754|NCT02998554|83142855|FG001|Overall Study|Withdrawal by Subject|6|||
46912755|NCT02998554|83142854|FG000|Overall Study|Lost to Follow-up|0|||
46912756|NCT02998554|83142855|FG001|Overall Study|Lost to Follow-up|1|||
47030840|NCT04801420|83280799|FG000|Overall Study|Lost to Follow-up|7|||
47030841|NCT04801420|83280800|FG001|Overall Study|Lost to Follow-up|9|||
47030842|NCT04801420|83280801|FG002|Overall Study|Lost to Follow-up|10|||
47030843|NCT04801420|83280799|FG000|Overall Study|Moved from study area|0|||
47030844|NCT04801420|83280800|FG001|Overall Study|Moved from study area|1|||
47030845|NCT04801420|83280801|FG002|Overall Study|Moved from study area|1|||
47030846|NCT04801420|83280799|FG000|Overall Study|Withdrawal by Subject|5|||
47030847|NCT04801420|83280800|FG001|Overall Study|Withdrawal by Subject|1|||
47030848|NCT04801420|83280801|FG002|Overall Study|Withdrawal by Subject|4|||
46627882|NCT02015520|82798986|FG002|Overall Study|Withdrawal by Subject|1|||
47030849|NCT04801420|83280799|FG000|Overall Study|Individual stopping criteria reached|0|||
47030850|NCT04801420|83280800|FG001|Overall Study|Individual stopping criteria reached|1|||
47030851|NCT04801420|83280801|FG002|Overall Study|Individual stopping criteria reached|0|||
47030852|NCT04801420|83280799|FG000|Overall Study|Ongoing in the study|195|||
47030853|NCT04801420|83280800|FG001|Overall Study|Ongoing in the study|195|||
47030854|NCT04801420|83280801|FG002|Overall Study|Ongoing in the study|192|||
47030855|NCT04294472|83280816|FG000|Overall Study|Adverse Event|0|||
47030856|NCT04294472|83280817|FG001|Overall Study|Adverse Event|1|||
47030857|NCT04294472|83280818|FG002|Overall Study|Adverse Event|1|||
47030858|NCT04294472|83280816|FG000|Overall Study|Randomized but not treated|0|||
47030859|NCT04294472|83280817|FG001|Overall Study|Randomized but not treated|1|||
47030860|NCT04294472|83280818|FG002|Overall Study|Randomized but not treated|1|||
47030861|NCT04233918|83280828|FG000|Part C (Extension Period)|Ongoing in study|0|||
47030862|NCT04233918|83280829|FG001|Part C (Extension Period)|Ongoing in study|0|||
47030863|NCT04233918|83280830|FG002|Part C (Extension Period)|Ongoing in study|15|||
47030864|NCT04060251|83280842|FG000|Overall Study|Study terminated due to low enrollment.|7|||
47030865|NCT04060251|83280843|FG001|Overall Study|Study terminated due to low enrollment.|5|||
46627883|NCT02015520|82798987|FG003|Overall Study|Withdrawal by Subject|0|||
47030866|NCT04060251|83280844|FG002|Overall Study|Study terminated due to low enrollment.|7|||
47030867|NCT04060251|83280842|FG000|Overall Study|Adverse Event|1|||
47030868|NCT04060251|83280843|FG001|Overall Study|Adverse Event|1|||
47030869|NCT04060251|83280844|FG002|Overall Study|Adverse Event|0|||
47030870|NCT04048876|83280856|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
47030871|NCT04048876|83280857|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
47030872|NCT04048876|83280858|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
47030873|NCT04048876|83280859|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
47030874|NCT04048876|83280856|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
47030875|NCT04048876|83280857|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
47030876|NCT04048876|83280858|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
47030877|NCT04048876|83280859|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
47030878|NCT04048876|83280856|FG000|Placebo Controlled Phase|Adverse Event|0|||
47030879|NCT04048876|83280857|FG001|Placebo Controlled Phase|Adverse Event|1|||
47030880|NCT04048876|83280858|FG002|Placebo Controlled Phase|Adverse Event|0|||
47030881|NCT04048876|83280859|FG003|Placebo Controlled Phase|Adverse Event|0|||
47030882|NCT04048876|83280856|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
47030883|NCT04048876|83280857|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
47030884|NCT04048876|83280858|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
47030885|NCT04048876|83280859|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
46627884|NCT02015520|82798984|FG000|Overall Study|Death|1|||
46627885|NCT02015520|82798985|FG001|Overall Study|Death|0|||
46627886|NCT02015520|82798986|FG002|Overall Study|Death|0|||
46912757|NCT02998554|83142854|FG000|Overall Study|Lack of Efficacy|0|||
46912758|NCT02998554|83142855|FG001|Overall Study|Lack of Efficacy|1|||
46912759|NCT02996448|83142863|FG000|Overall Study|Study terminated due to adverse effects|3|||
46627887|NCT02015520|82798987|FG003|Overall Study|Death|0|||
46912760|NCT02995980|83142868|FG000|Overall Study|Lost to Follow-up|14|||
46912761|NCT02872142|83142873|FG000|Overall Study|Adverse Event|2|||
46912762|NCT02872142|83142873|FG000|Overall Study|Death|1|||
46912763|NCT02872142|83142873|FG000|Overall Study|Participant Decision|3|||
46912764|NCT02994654|83142877|FG000|Overall Study|Lost to Follow-up|1|||
46912765|NCT02870972|83142887|FG000|Overall Study|Adverse Event|1|||
46912766|NCT02870972|83142888|FG001|Overall Study|Adverse Event|0|||
46912767|NCT02870972|83142889|FG002|Overall Study|Adverse Event|0|||
46912768|NCT02870972|83142890|FG003|Overall Study|Adverse Event|0|||
46912769|NCT02870972|83142891|FG004|Overall Study|Adverse Event|0|||
46912770|NCT03214367|83142911|FG000|Lead-in Period|Withdrawal by Subject|50|||
46912771|NCT03214367|83142912|FG001|Lead-in Period|Withdrawal by Subject|0|||
46912772|NCT03214367|83142913|FG002|Lead-in Period|Withdrawal by Subject|0|||
46912773|NCT03214367|83142914|FG003|Lead-in Period|Withdrawal by Subject|0|||
46912774|NCT03214367|83142915|FG004|Lead-in Period|Withdrawal by Subject|2|||
46912775|NCT03214367|83142916|FG005|Lead-in Period|Withdrawal by Subject|0|||
46912776|NCT03214367|83142917|FG006|Lead-in Period|Withdrawal by Subject|0|||
46912777|NCT03214367|83142918|FG007|Lead-in Period|Withdrawal by Subject|0|||
46912778|NCT03214367|83142911|FG000|Lead-in Period|Adverse Event|3|||
46912779|NCT03214367|83142912|FG001|Lead-in Period|Adverse Event|0|||
47030886|NCT03921424|83280886|FG000|Overall Study|Lost to Follow-up|0|||
47030887|NCT03921424|83280887|FG001|Overall Study|Lost to Follow-up|1|||
46627888|NCT02015520|82798984|FG000|Overall Study|Lost to Follow-up|0|||
46627889|NCT02015520|82798985|FG001|Overall Study|Lost to Follow-up|0|||
46627890|NCT02015520|82798986|FG002|Overall Study|Lost to Follow-up|1|||
46627891|NCT02015520|82798987|FG003|Overall Study|Lost to Follow-up|0|||
46627892|NCT02015520|82798984|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
46912780|NCT03214367|83142913|FG002|Lead-in Period|Adverse Event|0|||
47030888|NCT03921424|83280886|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
47030889|NCT03921424|83280887|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
47030890|NCT03852628|83280910|FG000|Overall Study|Lost to Follow-up|7|||
47030891|NCT03852628|83280911|FG001|Overall Study|Lost to Follow-up|6|||
47030892|NCT03852628|83280910|FG000|Overall Study|Lack of Efficacy|6|||
47030893|NCT03852628|83280911|FG001|Overall Study|Lack of Efficacy|6|||
47030894|NCT03602976|83280917|FG000|Overall Study|Withdrawal by Subject|1|||
47030895|NCT03278106|83280933|FG000|Overall Study|No protocol treatment|1|||
47030896|NCT03214198|83280937|FG000|Overall Study|Case Report Forms Uncollected|18|||
47030897|NCT03214198|83280937|FG000|Overall Study|Protocol Deviation|18|||
47030898|NCT02914639|83280943|FG000|Overall Study|Withdrawal by Subject|0|||
47030899|NCT02914639|83280944|FG001|Overall Study|Withdrawal by Subject|2|||
47030900|NCT02865018|83280951|FG000|Overall Study|Withdrawal by Subject|1|||
47030901|NCT02704208|83280966|FG000|Overall Study|Lost to Follow-up|42|||
47030902|NCT02704208|83280967|FG001|Overall Study|Lost to Follow-up|37|||
47030903|NCT02315898|83280986|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
47030904|NCT02315898|83280987|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
47030905|NCT02315898|83280988|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
47030906|NCT02315898|83280989|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
47030907|NCT02071290|83280998|FG000|Overall Study|Death|1|||
47030908|NCT02071290|83280999|FG001|Overall Study|Death|0|||
47030909|NCT02071290|83280998|FG000|Overall Study|Withdrawal by Subject|0|||
47030910|NCT02071290|83280999|FG001|Overall Study|Withdrawal by Subject|1|||
47030911|NCT02071290|83280998|FG000|Overall Study|Protocol Violation|3|||
47030912|NCT02071290|83280999|FG001|Overall Study|Protocol Violation|5|||
47030913|NCT02071290|83280998|FG000|Overall Study|Physician Decision|0|||
47030914|NCT02071290|83280999|FG001|Overall Study|Physician Decision|1|||
47030915|NCT02066181|83281007|FG000|Overall Study|Withdrawal by Subject|1|||
47030916|NCT02066181|83281008|FG001|Overall Study|Withdrawal by Subject|1|||
47030917|NCT01970865|83281034|FG000|Overall Study|Death|3|||
47030918|NCT01970865|83281035|FG001|Overall Study|Death|1|||
47030919|NCT01970865|83281036|FG002|Overall Study|Death|3|||
47030920|NCT01970865|83281037|FG003|Overall Study|Death|4|||
47030921|NCT01970865|83281038|FG004|Overall Study|Death|6|||
47030922|NCT01970865|83281039|FG005|Overall Study|Death|3|||
47030923|NCT01970865|83281040|FG006|Overall Study|Death|1|||
47030924|NCT01970865|83281041|FG007|Overall Study|Death|3|||
47030925|NCT01970865|83281042|FG008|Overall Study|Death|2|||
47030926|NCT01970865|83281043|FG009|Overall Study|Death|1|||
47030927|NCT01970865|83281044|FG010|Overall Study|Death|1|||
47030928|NCT01970865|83281045|FG011|Overall Study|Death|4|||
47030929|NCT01970865|83281046|FG012|Overall Study|Death|14|||
47030930|NCT01970865|83281047|FG013|Overall Study|Death|19|||
47030931|NCT01970865|83281048|FG014|Overall Study|Death|15|||
47030932|NCT01970865|83281049|FG015|Overall Study|Death|10|||
47030933|NCT01970865|83281050|FG016|Overall Study|Death|1|||
47030934|NCT01970865|83281034|FG000|Overall Study|Lost to Follow-up|0|||
47030935|NCT01970865|83281035|FG001|Overall Study|Lost to Follow-up|0|||
47030936|NCT01970865|83281036|FG002|Overall Study|Lost to Follow-up|0|||
47030937|NCT01970865|83281037|FG003|Overall Study|Lost to Follow-up|1|||
47030938|NCT01970865|83281038|FG004|Overall Study|Lost to Follow-up|1|||
47030939|NCT01970865|83281039|FG005|Overall Study|Lost to Follow-up|0|||
47030940|NCT01970865|83281040|FG006|Overall Study|Lost to Follow-up|0|||
47030941|NCT01970865|83281041|FG007|Overall Study|Lost to Follow-up|0|||
47030942|NCT01970865|83281042|FG008|Overall Study|Lost to Follow-up|0|||
46912781|NCT03214367|83142914|FG003|Lead-in Period|Adverse Event|0|||
47030943|NCT01970865|83281043|FG009|Overall Study|Lost to Follow-up|0|||
47030944|NCT01970865|83281044|FG010|Overall Study|Lost to Follow-up|0|||
47030945|NCT01970865|83281045|FG011|Overall Study|Lost to Follow-up|0|||
47030946|NCT01970865|83281046|FG012|Overall Study|Lost to Follow-up|1|||
47030947|NCT01970865|83281047|FG013|Overall Study|Lost to Follow-up|0|||
47030948|NCT01970865|83281048|FG014|Overall Study|Lost to Follow-up|0|||
47030949|NCT01970865|83281049|FG015|Overall Study|Lost to Follow-up|0|||
47030950|NCT01970865|83281050|FG016|Overall Study|Lost to Follow-up|0|||
47030951|NCT01970865|83281034|FG000|Overall Study|Withdrawal by Subject|0|||
47030952|NCT01970865|83281035|FG001|Overall Study|Withdrawal by Subject|0|||
46627893|NCT02015520|82798985|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
47030953|NCT01970865|83281036|FG002|Overall Study|Withdrawal by Subject|0|||
46912782|NCT03214367|83142915|FG004|Lead-in Period|Adverse Event|0|||
47030954|NCT01970865|83281037|FG003|Overall Study|Withdrawal by Subject|1|||
47030955|NCT01970865|83281038|FG004|Overall Study|Withdrawal by Subject|2|||
47030956|NCT01970865|83281039|FG005|Overall Study|Withdrawal by Subject|0|||
47030957|NCT01970865|83281040|FG006|Overall Study|Withdrawal by Subject|0|||
47030958|NCT01970865|83281041|FG007|Overall Study|Withdrawal by Subject|0|||
47030959|NCT01970865|83281042|FG008|Overall Study|Withdrawal by Subject|0|||
47030960|NCT01970865|83281043|FG009|Overall Study|Withdrawal by Subject|0|||
47030961|NCT01970865|83281044|FG010|Overall Study|Withdrawal by Subject|0|||
47030962|NCT01970865|83281045|FG011|Overall Study|Withdrawal by Subject|1|||
47030963|NCT01970865|83281046|FG012|Overall Study|Withdrawal by Subject|2|||
47030964|NCT01970865|83281047|FG013|Overall Study|Withdrawal by Subject|5|||
47030965|NCT01970865|83281048|FG014|Overall Study|Withdrawal by Subject|2|||
47030966|NCT01970865|83281049|FG015|Overall Study|Withdrawal by Subject|7|||
47030967|NCT01970865|83281050|FG016|Overall Study|Withdrawal by Subject|0|||
47030968|NCT01970865|83281034|FG000|Overall Study|Other|0|||
47030969|NCT01970865|83281035|FG001|Overall Study|Other|0|||
47030970|NCT01970865|83281036|FG002|Overall Study|Other|0|||
47030971|NCT01970865|83281037|FG003|Overall Study|Other|1|||
47030972|NCT01970865|83281038|FG004|Overall Study|Other|0|||
47030973|NCT01970865|83281039|FG005|Overall Study|Other|0|||
47030974|NCT01970865|83281040|FG006|Overall Study|Other|0|||
47030975|NCT01970865|83281041|FG007|Overall Study|Other|0|||
47030976|NCT01970865|83281042|FG008|Overall Study|Other|0|||
47030977|NCT01970865|83281043|FG009|Overall Study|Other|0|||
47030978|NCT01970865|83281044|FG010|Overall Study|Other|0|||
47030979|NCT01970865|83281045|FG011|Overall Study|Other|0|||
47030980|NCT01970865|83281046|FG012|Overall Study|Other|0|||
47030981|NCT01970865|83281047|FG013|Overall Study|Other|1|||
47030982|NCT01970865|83281048|FG014|Overall Study|Other|0|||
47030983|NCT01970865|83281049|FG015|Overall Study|Other|1|||
47030984|NCT01970865|83281050|FG016|Overall Study|Other|0|||
47030985|NCT01970865|83281034|FG000|Overall Study|Study ongoing|0|||
47030986|NCT01970865|83281035|FG001|Overall Study|Study ongoing|2|||
47030987|NCT01970865|83281036|FG002|Overall Study|Study ongoing|0|||
47030988|NCT01970865|83281037|FG003|Overall Study|Study ongoing|6|||
47030989|NCT01970865|83281038|FG004|Overall Study|Study ongoing|8|||
47030990|NCT01970865|83281039|FG005|Overall Study|Study ongoing|0|||
47030991|NCT01970865|83281040|FG006|Overall Study|Study ongoing|2|||
47030992|NCT01970865|83281041|FG007|Overall Study|Study ongoing|0|||
47030993|NCT01970865|83281042|FG008|Overall Study|Study ongoing|1|||
47030994|NCT01970865|83281043|FG009|Overall Study|Study ongoing|3|||
47030995|NCT01970865|83281044|FG010|Overall Study|Study ongoing|29|||
47030996|NCT01970865|83281045|FG011|Overall Study|Study ongoing|22|||
47030997|NCT01970865|83281046|FG012|Overall Study|Study ongoing|43|||
47030998|NCT01970865|83281047|FG013|Overall Study|Study ongoing|41|||
47030999|NCT01970865|83281048|FG014|Overall Study|Study ongoing|29|||
47031000|NCT01970865|83281049|FG015|Overall Study|Study ongoing|29|||
47031001|NCT01970865|83281050|FG016|Overall Study|Study ongoing|2|||
47031002|NCT01711541|83281125|FG000|Overall Study|Cancel prior to treatment|0|||
47031003|NCT01711541|83281126|FG001|Overall Study|Cancel prior to treatment|0|||
47031004|NCT01711541|83281127|FG002|Overall Study|Cancel prior to treatment|0|||
47031005|NCT01711541|83281128|FG003|Overall Study|Cancel prior to treatment|1|||
47031006|NCT01711541|83281129|FG004|Overall Study|Cancel prior to treatment|0|||
47031007|NCT01711541|83281125|FG000|Overall Study|Ineligible|0|||
47031008|NCT01711541|83281126|FG001|Overall Study|Ineligible|1|||
47031009|NCT01711541|83281127|FG002|Overall Study|Ineligible|0|||
47031010|NCT01711541|83281128|FG003|Overall Study|Ineligible|0|||
47031011|NCT01711541|83281129|FG004|Overall Study|Ineligible|0|||
47031012|NCT01382446|83281165|FG000|Overall Study|Withdrawal by Subject|0|||
47031013|NCT01382446|83281166|FG001|Overall Study|Withdrawal by Subject|1|||
47031014|NCT01382446|83281165|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
46627894|NCT02015520|82798986|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
46627895|NCT02015520|82798987|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
46627896|NCT02015520|82798984|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
46912783|NCT03214367|83142916|FG005|Lead-in Period|Adverse Event|0|||
47031015|NCT01382446|83281166|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
47031016|NCT01382212|83281172|FG000|Overall Study|Kidney transplant|1|||
47031017|NCT01382212|83281172|FG000|Overall Study|Withdrew consent|1|||
47031018|NCT01381900|83281179|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
47031019|NCT01381900|83281180|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
47031020|NCT01381900|83281181|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
47031021|NCT01381900|83281179|FG000|Overall Study|Adverse Event|4|||
47031022|NCT01381900|83281180|FG001|Overall Study|Adverse Event|6|||
47031023|NCT01381900|83281181|FG002|Overall Study|Adverse Event|7|||
47031024|NCT01381900|83281179|FG000|Overall Study|Noncompliance with study drug|0|||
47031025|NCT01381900|83281180|FG001|Overall Study|Noncompliance with study drug|0|||
47031026|NCT01381900|83281181|FG002|Overall Study|Noncompliance with study drug|1|||
47031027|NCT01381900|83281179|FG000|Overall Study|Physician Decision|0|||
47031028|NCT01381900|83281180|FG001|Overall Study|Physician Decision|1|||
47031029|NCT01381900|83281181|FG002|Overall Study|Physician Decision|1|||
47031030|NCT01381900|83281179|FG000|Overall Study|Protocol Violation|0|||
47031031|NCT01381900|83281180|FG001|Overall Study|Protocol Violation|1|||
47031032|NCT01381900|83281181|FG002|Overall Study|Protocol Violation|1|||
47031033|NCT01381900|83281179|FG000|Overall Study|Withdrawal by Subject|0|||
47031034|NCT01381900|83281180|FG001|Overall Study|Withdrawal by Subject|0|||
47031035|NCT01381900|83281181|FG002|Overall Study|Withdrawal by Subject|1|||
47031036|NCT01381900|83281179|FG000|Overall Study|Early withdraw|3|||
47031037|NCT01381900|83281180|FG001|Overall Study|Early withdraw|1|||
47031038|NCT01381900|83281181|FG002|Overall Study|Early withdraw|1|||
47031039|NCT01744665|83281189|FG000|Monitoring Phase|Adverse Event|4|||
47031040|NCT01744665|83281189|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
47031041|NCT01744665|83281189|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
47031042|NCT01744665|83281189|FG000|Monitoring Phase|Withdrawal by Subject|5|||
47031043|NCT01744665|83281189|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
47031044|NCT01744665|83281189|FG000|Consolidation Phase|Adverse Event|2|||
47031045|NCT01744665|83281189|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
47031046|NCT01744665|83281189|FG000|Consolidation Phase|Withdrawal by Subject|4|||
47031047|NCT01744665|83281189|FG000|Consolidation Phase|Administrative problems|9|||
47031048|NCT01744665|83281189|FG000|Re-initiation Phase|Administrative problems|10|||
47031049|NCT01744665|83281189|FG000|Re-initiation Phase|Adverse Event|1|||
47031050|NCT01744665|83281189|FG000|Re-initiation Phase|No longer required treatment|1|||
47031051|NCT01744665|83281189|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
47031052|NCT01744197|83281198|FG000|Overall Study|Received 1 patch|2|||
47031053|NCT01744197|83281199|FG001|Overall Study|Received 1 patch|1|||
47031054|NCT01744197|83281198|FG000|Overall Study|No patch received|2|||
47031055|NCT01744197|83281199|FG001|Overall Study|No patch received|2|||
47031056|NCT01732107|83281205|FG000|Overall Study|Adverse Event|2|||
47031057|NCT01732107|83281205|FG000|Overall Study|Disease Progression|8|||
47031058|NCT01732107|83281205|FG000|Overall Study|Physician Decision|1|||
47031059|NCT01732107|83281205|FG000|Overall Study|Withdrawal by Subject|2|||
47031060|NCT01743027|83281213|FG000|Overall Study|Adverse Event|2|||
47031061|NCT01743027|83281214|FG001|Overall Study|Adverse Event|0|||
47031062|NCT01743027|83281215|FG002|Overall Study|Adverse Event|0|||
47031063|NCT01743027|83281216|FG003|Overall Study|Adverse Event|0|||
47031064|NCT01743027|83281213|FG000|Overall Study|Lost to Follow-up|0|||
47031065|NCT01743027|83281214|FG001|Overall Study|Lost to Follow-up|0|||
47031066|NCT01743027|83281215|FG002|Overall Study|Lost to Follow-up|2|||
47031067|NCT01743027|83281216|FG003|Overall Study|Lost to Follow-up|0|||
47031068|NCT01743027|83281213|FG000|Overall Study|Progressive Disease|1|||
47031069|NCT01743027|83281214|FG001|Overall Study|Progressive Disease|4|||
47031070|NCT01743027|83281215|FG002|Overall Study|Progressive Disease|3|||
47031071|NCT01743027|83281216|FG003|Overall Study|Progressive Disease|0|||
47031072|NCT01743027|83281213|FG000|Overall Study|Protocol Violation|1|||
47031073|NCT01743027|83281214|FG001|Overall Study|Protocol Violation|1|||
47031074|NCT01743027|83281215|FG002|Overall Study|Protocol Violation|1|||
47031075|NCT01743027|83281216|FG003|Overall Study|Protocol Violation|0|||
47031076|NCT01743027|83281213|FG000|Overall Study|Withdrawal by Subject|1|||
47031077|NCT01743027|83281214|FG001|Overall Study|Withdrawal by Subject|0|||
47031078|NCT01743027|83281215|FG002|Overall Study|Withdrawal by Subject|3|||
47031079|NCT01743027|83281216|FG003|Overall Study|Withdrawal by Subject|1|||
47031080|NCT01380730|83281234|FG000|Overall Study|Death|0|||
47031081|NCT01380730|83281235|FG001|Overall Study|Death|0|||
47031082|NCT01380730|83281236|FG002|Overall Study|Death|0|||
46627897|NCT02015520|82798985|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
46627898|NCT02015520|82798986|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
46627899|NCT02015520|82798987|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
46627900|NCT02058108|82798999|FG000|Overall Study|Abnormal Laboratory Values|0|||
46627901|NCT02058108|82799000|FG001|Overall Study|Abnormal Laboratory Values|1|||
47031083|NCT01380730|83281237|FG003|Overall Study|Death|0|||
47031084|NCT01380730|83281238|FG004|Overall Study|Death|1|||
47031085|NCT01380730|83281239|FG005|Overall Study|Death|0|||
47031086|NCT01380730|83281240|FG006|Overall Study|Death|0|||
46627902|NCT02058108|82798999|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
46627903|NCT02058108|82799000|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
46627904|NCT02058108|82798999|FG000|Overall Study|No longer requires study drug|0|||
46627905|NCT02058108|82799000|FG001|Overall Study|No longer requires study drug|1|||
47031087|NCT01380730|83281241|FG007|Overall Study|Death|0|||
47031088|NCT01395784|83281259|FG000|Overall Study|Lost to Follow-up|7|||
47031089|NCT01395784|83281259|FG000|Overall Study|Withdrawal by Subject|3|||
47031090|NCT01395784|83281259|FG000|Overall Study|Physician Decision|5|||
47031091|NCT01380184|83281263|FG000|Part 1 (19 Days)|Adverse Event|1|||
47031092|NCT01380184|83281263|FG000|Part 2|Adverse Event|5|||
47031093|NCT01380184|83281263|FG000|Part 2|Disease Progression|8|||
47031094|NCT01380184|83281263|FG000|Part 2|Lost to Follow-up|1|||
47031095|NCT01395394|83281270|FG000|Baseline Study Visit|Protocol Violation|1|||
47031096|NCT01395394|83281271|FG001|Baseline Study Visit|Protocol Violation|0|||
47031097|NCT01395394|83281272|FG002|Baseline Study Visit|Protocol Violation|0|||
47031098|NCT01395316|83281280|FG000|Overall Study|Lost to Follow-up|2|||
47031099|NCT01395316|83281280|FG000|Overall Study|poor MRI quality|1|||
47031100|NCT01742091|83281290|FG000|Overall Study|Adverse Event|0|||
47031101|NCT01742091|83281291|FG001|Overall Study|Adverse Event|0|||
47031102|NCT01742091|83281292|FG002|Overall Study|Adverse Event|0|||
47031103|NCT01742091|83281293|FG003|Overall Study|Adverse Event|0|||
47031104|NCT01742091|83281294|FG004|Overall Study|Adverse Event|1|||
47031105|NCT01742091|83281295|FG005|Overall Study|Adverse Event|0|||
47031106|NCT01742091|83281290|FG000|Overall Study|Physician Decision|0|||
47031107|NCT01742091|83281291|FG001|Overall Study|Physician Decision|0|||
47031108|NCT01742091|83281292|FG002|Overall Study|Physician Decision|0|||
47031109|NCT01742091|83281293|FG003|Overall Study|Physician Decision|0|||
47031110|NCT01742091|83281294|FG004|Overall Study|Physician Decision|0|||
47031111|NCT01742091|83281295|FG005|Overall Study|Physician Decision|1|||
47031112|NCT01742091|83281290|FG000|Overall Study|Withdrawal by Subject|0|||
47031113|NCT01742091|83281291|FG001|Overall Study|Withdrawal by Subject|0|||
47031114|NCT01742091|83281292|FG002|Overall Study|Withdrawal by Subject|0|||
47031115|NCT01742091|83281293|FG003|Overall Study|Withdrawal by Subject|1|||
47031116|NCT01742091|83281294|FG004|Overall Study|Withdrawal by Subject|0|||
47031117|NCT01742091|83281295|FG005|Overall Study|Withdrawal by Subject|0|||
47031118|NCT01742091|83281290|FG000|Overall Study|Lost to Follow-up|0|||
47031119|NCT01742091|83281291|FG001|Overall Study|Lost to Follow-up|0|||
47031120|NCT01742091|83281292|FG002|Overall Study|Lost to Follow-up|0|||
47031121|NCT01742091|83281293|FG003|Overall Study|Lost to Follow-up|0|||
47031122|NCT01742091|83281294|FG004|Overall Study|Lost to Follow-up|0|||
47031123|NCT01742091|83281295|FG005|Overall Study|Lost to Follow-up|1|||
47031124|NCT01731951|83281315|FG000|Overall Study|Documented Disease Progression|1|||
47031125|NCT01731951|83281316|FG001|Overall Study|Documented Disease Progression|0|||
47031126|NCT01731951|83281317|FG002|Overall Study|Documented Disease Progression|0|||
47031127|NCT01731951|83281318|FG003|Overall Study|Documented Disease Progression|0|||
47031128|NCT01731951|83281319|FG004|Overall Study|Documented Disease Progression|0|||
47031129|NCT01731951|83281320|FG005|Overall Study|Documented Disease Progression|0|||
47031130|NCT01731951|83281315|FG000|Overall Study|Lost to Follow-up|2|||
47031131|NCT01731951|83281316|FG001|Overall Study|Lost to Follow-up|0|||
47031132|NCT01731951|83281317|FG002|Overall Study|Lost to Follow-up|0|||
47031133|NCT01731951|83281318|FG003|Overall Study|Lost to Follow-up|1|||
46627906|NCT02058108|82798999|FG000|Overall Study|Withdrawal by Subject|1|||
46627907|NCT02058108|82799000|FG001|Overall Study|Withdrawal by Subject|0|||
46627908|NCT02058108|82798999|FG000|Overall Study|Administrative problems|3|||
46627909|NCT02058108|82799000|FG001|Overall Study|Administrative problems|3|||
47031134|NCT01731951|83281319|FG004|Overall Study|Lost to Follow-up|3|||
47031135|NCT01731951|83281320|FG005|Overall Study|Lost to Follow-up|1|||
47031136|NCT01731951|83281315|FG000|Overall Study|Withdrawal of Consent|1|||
47031137|NCT01731951|83281316|FG001|Overall Study|Withdrawal of Consent|0|||
46627910|NCT02058108|82798999|FG000|Overall Study|Protocol Violation|0|||
46627911|NCT02058108|82799000|FG001|Overall Study|Protocol Violation|1|||
46627912|NCT02057874|82799008|FG000|Overall Study|participant did not return for scan|1|||
46627913|NCT02038920|82799015|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
46627914|NCT02038920|82799016|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
46627915|NCT02038920|82799017|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
46627916|NCT02038920|82799018|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
46627917|NCT02038920|82799019|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
47031138|NCT01731951|83281317|FG002|Overall Study|Withdrawal of Consent|0|||
47031139|NCT01731951|83281318|FG003|Overall Study|Withdrawal of Consent|0|||
47031140|NCT01731951|83281319|FG004|Overall Study|Withdrawal of Consent|0|||
47031141|NCT01731951|83281320|FG005|Overall Study|Withdrawal of Consent|2|||
47031142|NCT01731951|83281315|FG000|Overall Study|Death|13|||
46710857|NCT00883129|82927127|FG001|Overall Study|Non-compliance|6|||
47031143|NCT01731951|83281316|FG001|Overall Study|Death|15|||
47031144|NCT01731951|83281317|FG002|Overall Study|Death|9|||
47031145|NCT01731951|83281318|FG003|Overall Study|Death|8|||
47031146|NCT01731951|83281319|FG004|Overall Study|Death|9|||
47031147|NCT01731951|83281320|FG005|Overall Study|Death|6|||
46627918|NCT02038920|82799020|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
46627919|NCT02038920|82799015|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
46627920|NCT02038920|82799016|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
46627921|NCT02038920|82799017|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
46627922|NCT02038920|82799018|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
46627923|NCT02038920|82799019|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
46627924|NCT02038920|82799020|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
46627925|NCT02038920|82799015|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
46627926|NCT02038920|82799016|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
47031148|NCT01731171|83281340|FG000|Overall Study|Withdrawal by Subject|4|||
47031149|NCT01731171|83281341|FG001|Overall Study|Withdrawal by Subject|1|||
47031150|NCT01731171|83281340|FG000|Overall Study|Lost to Follow-up|3|||
47031151|NCT01731171|83281341|FG001|Overall Study|Lost to Follow-up|2|||
47031152|NCT01731171|83281340|FG000|Overall Study|Moved out of Area|0|||
47031153|NCT01731171|83281341|FG001|Overall Study|Moved out of Area|2|||
47031154|NCT01731171|83281340|FG000|Overall Study|Terminated for Lack of Adherence|0|||
47031155|NCT01731171|83281341|FG001|Overall Study|Terminated for Lack of Adherence|1|||
47031156|NCT01731171|83281340|FG000|Overall Study|Terminated for Safety Reasons|0|||
47031157|NCT01731171|83281341|FG001|Overall Study|Terminated for Safety Reasons|1|||
47031158|NCT01741701|83281349|FG000|Overall Study|Adverse Event|5|||
47031159|NCT01741701|83281350|FG001|Overall Study|Adverse Event|1|||
47031160|NCT01741701|83281349|FG000|Overall Study|Withdrawal by Subject|0|||
47031161|NCT01741701|83281350|FG001|Overall Study|Withdrawal by Subject|1|||
47031162|NCT01741545|83281358|FG000|Treatment Period|Lack of Efficacy|0|||
47031163|NCT01741545|83281359|FG001|Treatment Period|Lack of Efficacy|1|||
47031164|NCT01741545|83281358|FG000|Treatment Period|Adverse event, non-fatal|1|||
47031165|NCT01741545|83281359|FG001|Treatment Period|Adverse event, non-fatal|3|||
47031166|NCT01741545|83281358|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
47031167|NCT01741545|83281359|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
47031168|NCT01741545|83281358|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
47031169|NCT01741545|83281359|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
47031170|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
47031171|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
47031172|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
47031173|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
47031174|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
47031175|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
47031176|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
47031177|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
47031178|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
47031179|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
47031180|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
46627927|NCT02038920|82799017|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
46627928|NCT02038920|82799018|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
46627929|NCT02038920|82799019|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
46627930|NCT02038920|82799020|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
46627931|NCT02038920|82799015|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
46627932|NCT02038920|82799016|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
46627933|NCT02038920|82799017|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
46627934|NCT02038920|82799018|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
46627935|NCT02038920|82799019|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
46627936|NCT02038920|82799020|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
46627937|NCT02038920|82799015|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
46627938|NCT02038920|82799016|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
46627939|NCT02038920|82799017|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
46627940|NCT02038920|82799018|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
46627941|NCT02038920|82799019|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
46627942|NCT02038920|82799020|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
46627943|NCT02038920|82799015|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
46627944|NCT02038920|82799016|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
46627945|NCT02038920|82799017|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
46710858|NCT00883129|82927126|FG000|Overall Study|Lost to Follow-up|1|||
46710859|NCT00883129|82927127|FG001|Overall Study|Lost to Follow-up|2|||
47031181|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
47031182|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
47031183|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
47031184|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
47031185|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
46627946|NCT02038920|82799018|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
46627947|NCT02038920|82799019|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
46627948|NCT02038920|82799020|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
46627949|NCT02038920|82799015|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
46627950|NCT02038920|82799016|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
46627951|NCT02038920|82799017|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
46627952|NCT02038920|82799018|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
46627953|NCT02038920|82799019|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
46627954|NCT02038920|82799020|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
46627955|NCT02038920|82799015|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
46627956|NCT02038920|82799016|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
46627957|NCT02038920|82799017|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
46912784|NCT03214367|83142917|FG006|Lead-in Period|Adverse Event|0|||
46912785|NCT03214367|83142918|FG007|Lead-in Period|Adverse Event|0|||
46912786|NCT03214367|83142911|FG000|Lead-in Period|Lost to Follow-up|12|||
46912787|NCT03214367|83142912|FG001|Lead-in Period|Lost to Follow-up|0|||
46912788|NCT03214367|83142913|FG002|Lead-in Period|Lost to Follow-up|0|||
46912789|NCT03214367|83142914|FG003|Lead-in Period|Lost to Follow-up|0|||
46912790|NCT03214367|83142915|FG004|Lead-in Period|Lost to Follow-up|0|||
46912791|NCT03214367|83142916|FG005|Lead-in Period|Lost to Follow-up|0|||
46912792|NCT03214367|83142917|FG006|Lead-in Period|Lost to Follow-up|0|||
46912793|NCT03214367|83142918|FG007|Lead-in Period|Lost to Follow-up|0|||
46912794|NCT03214367|83142911|FG000|Lead-in Period|Sponsor Decision|11|||
46912795|NCT03214367|83142912|FG001|Lead-in Period|Sponsor Decision|0|||
46912796|NCT03214367|83142913|FG002|Lead-in Period|Sponsor Decision|0|||
46912797|NCT03214367|83142914|FG003|Lead-in Period|Sponsor Decision|0|||
46912798|NCT03214367|83142915|FG004|Lead-in Period|Sponsor Decision|0|||
46912799|NCT03214367|83142916|FG005|Lead-in Period|Sponsor Decision|0|||
46912800|NCT03214367|83142917|FG006|Lead-in Period|Sponsor Decision|0|||
46912801|NCT03214367|83142918|FG007|Lead-in Period|Sponsor Decision|0|||
46912802|NCT03214367|83142911|FG000|Lead-in Period|Physician Decision|12|||
46912803|NCT03214367|83142912|FG001|Lead-in Period|Physician Decision|0|||
46912804|NCT03214367|83142913|FG002|Lead-in Period|Physician Decision|0|||
46912805|NCT03214367|83142914|FG003|Lead-in Period|Physician Decision|0|||
46912806|NCT03214367|83142915|FG004|Lead-in Period|Physician Decision|0|||
46912807|NCT03214367|83142916|FG005|Lead-in Period|Physician Decision|0|||
46912808|NCT03214367|83142917|FG006|Lead-in Period|Physician Decision|0|||
46912809|NCT03214367|83142918|FG007|Lead-in Period|Physician Decision|0|||
46912810|NCT03214367|83142911|FG000|Lead-in Period|Protocol Violation|5|||
46912811|NCT03214367|83142912|FG001|Lead-in Period|Protocol Violation|0|||
46912812|NCT03214367|83142913|FG002|Lead-in Period|Protocol Violation|0|||
46912813|NCT03214367|83142914|FG003|Lead-in Period|Protocol Violation|0|||
46912814|NCT03214367|83142915|FG004|Lead-in Period|Protocol Violation|0|||
46912815|NCT03214367|83142916|FG005|Lead-in Period|Protocol Violation|0|||
46912816|NCT03214367|83142917|FG006|Lead-in Period|Protocol Violation|0|||
46912817|NCT03214367|83142918|FG007|Lead-in Period|Protocol Violation|0|||
46912818|NCT03214367|83142911|FG000|Lead-in Period|Treatment Interruption|1|||
46912819|NCT03214367|83142912|FG001|Lead-in Period|Treatment Interruption|0|||
46912820|NCT03214367|83142913|FG002|Lead-in Period|Treatment Interruption|0|||
46912821|NCT03214367|83142914|FG003|Lead-in Period|Treatment Interruption|0|||
46912822|NCT03214367|83142915|FG004|Lead-in Period|Treatment Interruption|0|||
46912823|NCT03214367|83142916|FG005|Lead-in Period|Treatment Interruption|0|||
46912824|NCT03214367|83142917|FG006|Lead-in Period|Treatment Interruption|0|||
46912825|NCT03214367|83142918|FG007|Lead-in Period|Treatment Interruption|0|||
46912826|NCT03214367|83142911|FG000|Treatment Period|Adverse Event|0|||
46912827|NCT03214367|83142912|FG001|Treatment Period|Adverse Event|1|||
46912828|NCT03214367|83142913|FG002|Treatment Period|Adverse Event|4|||
46912829|NCT03214367|83142914|FG003|Treatment Period|Adverse Event|2|||
46912830|NCT03214367|83142915|FG004|Treatment Period|Adverse Event|0|||
46912831|NCT03214367|83142916|FG005|Treatment Period|Adverse Event|0|||
46912832|NCT03214367|83142917|FG006|Treatment Period|Adverse Event|0|||
46912833|NCT03214367|83142918|FG007|Treatment Period|Adverse Event|0|||
46912834|NCT03214367|83142911|FG000|Treatment Period|Death|0|||
46912835|NCT03214367|83142912|FG001|Treatment Period|Death|1|||
46912836|NCT03214367|83142913|FG002|Treatment Period|Death|1|||
46912837|NCT03214367|83142914|FG003|Treatment Period|Death|1|||
46912838|NCT03214367|83142915|FG004|Treatment Period|Death|0|||
46912839|NCT03214367|83142916|FG005|Treatment Period|Death|0|||
46912840|NCT03214367|83142917|FG006|Treatment Period|Death|0|||
46912841|NCT03214367|83142918|FG007|Treatment Period|Death|0|||
46912842|NCT03214367|83142911|FG000|Treatment Period|Lost to Follow-up|0|||
46912843|NCT03214367|83142912|FG001|Treatment Period|Lost to Follow-up|5|||
46912844|NCT03214367|83142913|FG002|Treatment Period|Lost to Follow-up|3|||
46912845|NCT03214367|83142914|FG003|Treatment Period|Lost to Follow-up|2|||
46912846|NCT03214367|83142915|FG004|Treatment Period|Lost to Follow-up|0|||
46912847|NCT03214367|83142916|FG005|Treatment Period|Lost to Follow-up|2|||
46912848|NCT03214367|83142917|FG006|Treatment Period|Lost to Follow-up|1|||
47031186|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
47031187|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
47031188|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
47031189|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
47031190|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
47031191|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
47031192|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
47031193|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
47031194|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
47031195|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
47031196|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
47031197|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
47031198|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
47031199|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
47031200|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
47031201|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
47031202|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
47031203|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
47031204|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
47031205|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
47031206|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
47031207|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
47031208|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
47031209|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
47031210|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
47031211|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
47031212|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
47031213|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
46627958|NCT02038920|82799018|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
46627959|NCT02038920|82799019|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
46627960|NCT02038920|82799020|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
46627961|NCT02038920|82799015|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
46627962|NCT02038920|82799016|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
46627963|NCT02038920|82799017|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
46627964|NCT02038920|82799018|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
46627965|NCT02038920|82799019|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
46627966|NCT02038920|82799020|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
46627967|NCT02038920|82799015|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
46627968|NCT02038920|82799016|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
46627969|NCT02038920|82799017|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
46627970|NCT02038920|82799018|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
46627971|NCT02038920|82799019|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
46627972|NCT02038920|82799020|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
46627973|NCT02038920|82799015|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
46627974|NCT02038920|82799016|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
46627975|NCT02038920|82799017|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
46627976|NCT02038920|82799018|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
46627977|NCT02038920|82799019|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
46627978|NCT02038920|82799020|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
46627979|NCT02038920|82799015|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
46627980|NCT02038920|82799016|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
46627981|NCT02038920|82799017|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
46627982|NCT02038920|82799018|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
46710860|NCT00883129|82927126|FG000|Overall Study|Death|1|||
46912849|NCT03214367|83142918|FG007|Treatment Period|Lost to Follow-up|0|||
46912850|NCT03214367|83142911|FG000|Treatment Period|Sponsor Decision|0|||
46912851|NCT03214367|83142912|FG001|Treatment Period|Sponsor Decision|3|||
46912852|NCT03214367|83142913|FG002|Treatment Period|Sponsor Decision|0|||
46912853|NCT03214367|83142914|FG003|Treatment Period|Sponsor Decision|0|||
46912854|NCT03214367|83142915|FG004|Treatment Period|Sponsor Decision|0|||
46912855|NCT03214367|83142916|FG005|Treatment Period|Sponsor Decision|0|||
46912856|NCT03214367|83142917|FG006|Treatment Period|Sponsor Decision|0|||
46912857|NCT03214367|83142918|FG007|Treatment Period|Sponsor Decision|0|||
46912858|NCT03214367|83142911|FG000|Treatment Period|Physician Decision|0|||
46627983|NCT02038920|82799019|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
46710861|NCT00883129|82927127|FG001|Overall Study|Death|2|||
46627984|NCT02038920|82799020|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
46627985|NCT02038764|82799042|FG000|Overall Study|Adverse Event|0|||
46627986|NCT02038764|82799043|FG001|Overall Study|Adverse Event|0|||
46627987|NCT02038764|82799044|FG002|Overall Study|Adverse Event|1|||
46627988|NCT02038764|82799045|FG003|Overall Study|Adverse Event|0|||
46710862|NCT00883129|82927126|FG000|Overall Study|Defined Treatment Failure|0|||
46710863|NCT00883129|82927127|FG001|Overall Study|Defined Treatment Failure|2|||
47031214|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
47031215|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
47031216|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
47031217|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
47031218|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
47031219|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
47031220|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
47031221|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
47031222|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
47031223|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
47031224|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
47031225|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
47031226|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
47031227|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
47031228|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
47031229|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
47031230|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
47031231|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
47031232|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
47031233|NCT01884350|83281367|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
47031234|NCT01884350|83281368|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
47031235|NCT01884350|83281369|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
47031236|NCT01614795|83281383|FG000|Overall Study|Adverse Event|0|||
47031237|NCT01614795|83281384|FG001|Overall Study|Adverse Event|0|||
47031238|NCT01614795|83281385|FG002|Overall Study|Adverse Event|1|||
47031239|NCT01614795|83281386|FG003|Overall Study|Adverse Event|1|||
47031240|NCT01614795|83281383|FG000|Overall Study|Lack of Efficacy|10|||
47031241|NCT01614795|83281384|FG001|Overall Study|Lack of Efficacy|10|||
47031242|NCT01614795|83281385|FG002|Overall Study|Lack of Efficacy|9|||
47031243|NCT01614795|83281386|FG003|Overall Study|Lack of Efficacy|8|||
47031244|NCT01614795|83281383|FG000|Overall Study|Physician Decision|1|||
47031245|NCT01614795|83281384|FG001|Overall Study|Physician Decision|0|||
47031246|NCT01614795|83281385|FG002|Overall Study|Physician Decision|1|||
47031247|NCT01614795|83281386|FG003|Overall Study|Physician Decision|1|||
47031248|NCT01614795|83281383|FG000|Overall Study|Withdrawal by Subject|0|||
47031249|NCT01614795|83281384|FG001|Overall Study|Withdrawal by Subject|1|||
47031250|NCT01614795|83281385|FG002|Overall Study|Withdrawal by Subject|0|||
47031251|NCT01614795|83281386|FG003|Overall Study|Withdrawal by Subject|2|||
47031252|NCT01614795|83281383|FG000|Overall Study|Ineligible|0|||
47031253|NCT01614795|83281384|FG001|Overall Study|Ineligible|1|||
47031254|NCT01614795|83281385|FG002|Overall Study|Ineligible|0|||
47031255|NCT01614795|83281386|FG003|Overall Study|Ineligible|0|||
47031256|NCT01834586|83281397|FG000|Overall Study|Adverse Event|1|||
47031257|NCT01614249|83281403|FG000|Overall Study|Lost to Follow-up|11|||
47031258|NCT01614249|83281404|FG001|Overall Study|Lost to Follow-up|23|||
47031259|NCT01597778|83281412|FG000|Overall Study|Death|7|||
47031260|NCT01597778|83281413|FG001|Overall Study|Death|10|||
47031261|NCT01597778|83281412|FG000|Overall Study|Withdrawal by Subject|3|||
47031262|NCT01597778|83281413|FG001|Overall Study|Withdrawal by Subject|4|||
47031263|NCT01597778|83281412|FG000|Overall Study|Adverse Event|1|||
47031264|NCT01597778|83281413|FG001|Overall Study|Adverse Event|1|||
47031265|NCT01597778|83281412|FG000|Overall Study|Protocol Violation|1|||
47031266|NCT01597778|83281413|FG001|Overall Study|Protocol Violation|11|||
47031267|NCT01597778|83281412|FG000|Overall Study|Transplanted off protocol|2|||
47031268|NCT01597778|83281413|FG001|Overall Study|Transplanted off protocol|3|||
46710864|NCT00905632|82927158|FG000|Overall Study|Adverse Event|0|||
46627989|NCT02038764|82799046|FG004|Overall Study|Adverse Event|0|||
46627990|NCT02038764|82799042|FG000|Overall Study|Lost to Follow-up|0|||
47031269|NCT01614093|83281419|FG000|Overall Study|Withdrawal by Subject|1|||
47031270|NCT01834274|83281426|FG000|Overall Study|Study Termination|41|||
47031271|NCT01834274|83281427|FG001|Overall Study|Study Termination|38|||
47031272|NCT01834274|83281426|FG000|Overall Study|Withdrawal by Subject|1|||
47031273|NCT01834274|83281427|FG001|Overall Study|Withdrawal by Subject|1|||
47031274|NCT01834274|83281426|FG000|Overall Study|Lost to Follow-up|3|||
47031275|NCT01834274|83281427|FG001|Overall Study|Lost to Follow-up|1|||
47031276|NCT01834274|83281426|FG000|Overall Study|Other|2|||
47031277|NCT01834274|83281427|FG001|Overall Study|Other|1|||
47031278|NCT01739595|83281436|FG000|Overall Study|Adverse Event|3|||
47031279|NCT01739595|83281437|FG001|Overall Study|Adverse Event|0|||
47031280|NCT01739595|83281438|FG002|Overall Study|Adverse Event|0|||
47031281|NCT01739595|83281436|FG000|Overall Study|Lost to Follow-up|2|||
47031282|NCT01739595|83281437|FG001|Overall Study|Lost to Follow-up|0|||
47031283|NCT01739595|83281438|FG002|Overall Study|Lost to Follow-up|0|||
47031284|NCT01739595|83281436|FG000|Overall Study|Withdrawal by Subject|2|||
47031285|NCT01739595|83281437|FG001|Overall Study|Withdrawal by Subject|1|||
47031286|NCT01739595|83281438|FG002|Overall Study|Withdrawal by Subject|2|||
47031287|NCT01739595|83281436|FG000|Overall Study|Eligibility issue|3|||
47031288|NCT01739595|83281437|FG001|Overall Study|Eligibility issue|0|||
47031289|NCT01739595|83281438|FG002|Overall Study|Eligibility issue|0|||
46627991|NCT02038764|82799043|FG001|Overall Study|Lost to Follow-up|1|||
46627992|NCT02038764|82799044|FG002|Overall Study|Lost to Follow-up|0|||
46627993|NCT02038764|82799045|FG003|Overall Study|Lost to Follow-up|0|||
46627994|NCT02038764|82799046|FG004|Overall Study|Lost to Follow-up|0|||
46627995|NCT02038764|82799042|FG000|Overall Study|Withdrawal by Subject|0|||
46627996|NCT02038764|82799043|FG001|Overall Study|Withdrawal by Subject|0|||
46627997|NCT02038764|82799044|FG002|Overall Study|Withdrawal by Subject|0|||
46627998|NCT02038764|82799045|FG003|Overall Study|Withdrawal by Subject|0|||
46627999|NCT02038764|82799046|FG004|Overall Study|Withdrawal by Subject|1|||
46628000|NCT02038764|82799042|FG000|Overall Study|Other|1|||
46628001|NCT02038764|82799043|FG001|Overall Study|Other|0|||
46628002|NCT02038764|82799044|FG002|Overall Study|Other|1|||
46628003|NCT02038764|82799045|FG003|Overall Study|Other|0|||
46628004|NCT02038764|82799046|FG004|Overall Study|Other|0|||
46628005|NCT02014740|82799064|FG000|Overall Study|Lost to Follow-up|4|||
46628006|NCT02014740|82799065|FG001|Overall Study|Lost to Follow-up|4|||
46628007|NCT02014740|82799064|FG000|Overall Study|Withdrawal by Subject|2|||
46628008|NCT02014740|82799065|FG001|Overall Study|Withdrawal by Subject|1|||
46628009|NCT02014584|82799073|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
46628010|NCT02014584|82799074|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
46628011|NCT02014584|82799075|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
46628012|NCT02014584|82799076|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
46628013|NCT02014584|82799077|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
46628014|NCT02014584|82799078|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
46628015|NCT02014584|82799073|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
46628016|NCT02014584|82799074|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
46628017|NCT02014584|82799075|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
46628018|NCT02014584|82799076|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
46628019|NCT02014584|82799077|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
46628020|NCT02014584|82799078|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
46628021|NCT02014584|82799073|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
46628022|NCT02014584|82799074|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
46628023|NCT02014584|82799075|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
46628024|NCT02014584|82799076|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
46628025|NCT02014584|82799077|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
46628026|NCT02014584|82799078|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
46628027|NCT02014584|82799073|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
46628028|NCT02014584|82799074|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
46628029|NCT02014584|82799075|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
46628030|NCT02014584|82799076|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
46628031|NCT02014584|82799077|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
46628032|NCT02014584|82799078|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
46628033|NCT02014584|82799073|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
46628034|NCT02014584|82799074|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
46628035|NCT02014584|82799075|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
46628036|NCT02014584|82799076|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
46710865|NCT00905632|82927159|FG001|Overall Study|Adverse Event|0|||
47031290|NCT01739595|83281436|FG000|Overall Study|Protocol Violation|1|||
46628037|NCT02014584|82799077|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
46710866|NCT00905632|82927160|FG002|Overall Study|Adverse Event|0|||
46710867|NCT00905632|82927161|FG003|Overall Study|Adverse Event|0|||
47031291|NCT01739595|83281437|FG001|Overall Study|Protocol Violation|0|||
47031292|NCT01739595|83281438|FG002|Overall Study|Protocol Violation|0|||
46628038|NCT02014584|82799078|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
47031293|NCT01739595|83281436|FG000|Overall Study|Lab assessment|1|||
47031294|NCT01739595|83281437|FG001|Overall Study|Lab assessment|0|||
46628039|NCT02014272|82799090|FG000|Intervention Period 1|Withdrawal by Subject|1|||
46628040|NCT02014272|82799091|FG001|Intervention Period 1|Withdrawal by Subject|0|||
46628041|NCT02014272|82799090|FG000|Intervention Period 1|Adverse Event|0|||
46628042|NCT02014272|82799091|FG001|Intervention Period 1|Adverse Event|1|||
46628043|NCT02037984|82799105|FG000|Overall Study|Lack of Efficacy|0|||
46628044|NCT02037984|82799106|FG001|Overall Study|Lack of Efficacy|0|||
46628045|NCT02037984|82799107|FG002|Overall Study|Lack of Efficacy|3|||
46628046|NCT02037984|82799108|FG003|Overall Study|Lack of Efficacy|10|||
46628047|NCT02037984|82799109|FG004|Overall Study|Lack of Efficacy|2|||
46628048|NCT02037984|82799110|FG005|Overall Study|Lack of Efficacy|2|||
47031295|NCT01739595|83281438|FG002|Overall Study|Lab assessment|0|||
47031296|NCT01739595|83281436|FG000|Overall Study|Drug discrepancy|1|||
47031297|NCT01739595|83281437|FG001|Overall Study|Drug discrepancy|0|||
47031298|NCT01739595|83281438|FG002|Overall Study|Drug discrepancy|0|||
47031299|NCT01833494|83281445|FG000|Overall Study|Adverse Event|24|||
47031300|NCT01833494|83281445|FG000|Overall Study|Physician Decision|6|||
47031301|NCT01833494|83281445|FG000|Overall Study|Withdrawal by Subject|6|||
47031302|NCT01833494|83281445|FG000|Overall Study|Decrease in serum phosphorus|4|||
47031303|NCT01833494|83281445|FG000|Overall Study|Decrease in serum calcium|4|||
47031304|NCT01833494|83281445|FG000|Overall Study|Increase in serum ferritin|1|||
47031305|NCT01738971|83281452|FG000|Overall Study|Lost to Follow-up|19|||
47031306|NCT01738971|83281453|FG001|Overall Study|Lost to Follow-up|30|||
47031307|NCT01738971|83281454|FG002|Overall Study|Lost to Follow-up|17|||
46912859|NCT03214367|83142912|FG001|Treatment Period|Physician Decision|1|||
46912860|NCT03214367|83142913|FG002|Treatment Period|Physician Decision|2|||
46912861|NCT03214367|83142914|FG003|Treatment Period|Physician Decision|0|||
46912862|NCT03214367|83142915|FG004|Treatment Period|Physician Decision|0|||
46912863|NCT03214367|83142916|FG005|Treatment Period|Physician Decision|0|||
46912864|NCT03214367|83142917|FG006|Treatment Period|Physician Decision|0|||
46912865|NCT03214367|83142918|FG007|Treatment Period|Physician Decision|0|||
46912866|NCT03214367|83142911|FG000|Treatment Period|Protocol Violation|0|||
46912867|NCT03214367|83142912|FG001|Treatment Period|Protocol Violation|3|||
46912868|NCT03214367|83142913|FG002|Treatment Period|Protocol Violation|0|||
46912869|NCT03214367|83142914|FG003|Treatment Period|Protocol Violation|0|||
46912870|NCT03214367|83142915|FG004|Treatment Period|Protocol Violation|0|||
46912871|NCT03214367|83142916|FG005|Treatment Period|Protocol Violation|0|||
46912872|NCT03214367|83142917|FG006|Treatment Period|Protocol Violation|0|||
46912873|NCT03214367|83142918|FG007|Treatment Period|Protocol Violation|0|||
46628049|NCT02037984|82799111|FG006|Overall Study|Lack of Efficacy|4|||
46628050|NCT02037984|82799112|FG007|Overall Study|Lack of Efficacy|3|||
46628051|NCT02037984|82799105|FG000|Overall Study|Lost to Follow-up|1|||
46628052|NCT02037984|82799106|FG001|Overall Study|Lost to Follow-up|0|||
46628053|NCT02037984|82799107|FG002|Overall Study|Lost to Follow-up|3|||
46628054|NCT02037984|82799108|FG003|Overall Study|Lost to Follow-up|5|||
46628055|NCT02037984|82799109|FG004|Overall Study|Lost to Follow-up|2|||
46628056|NCT02037984|82799110|FG005|Overall Study|Lost to Follow-up|2|||
46628057|NCT02037984|82799111|FG006|Overall Study|Lost to Follow-up|2|||
46628058|NCT02037984|82799112|FG007|Overall Study|Lost to Follow-up|4|||
46628059|NCT02037984|82799105|FG000|Overall Study|Physician Decision|0|||
46628060|NCT02037984|82799106|FG001|Overall Study|Physician Decision|0|||
46628061|NCT02037984|82799107|FG002|Overall Study|Physician Decision|0|||
46628062|NCT02037984|82799108|FG003|Overall Study|Physician Decision|0|||
46628063|NCT02037984|82799109|FG004|Overall Study|Physician Decision|0|||
46628064|NCT02037984|82799110|FG005|Overall Study|Physician Decision|0|||
46628065|NCT02037984|82799111|FG006|Overall Study|Physician Decision|1|||
46628066|NCT02037984|82799112|FG007|Overall Study|Physician Decision|0|||
46628067|NCT02037984|82799105|FG000|Overall Study|Protocol Violation|0|||
46628068|NCT02037984|82799106|FG001|Overall Study|Protocol Violation|0|||
46628069|NCT02037984|82799107|FG002|Overall Study|Protocol Violation|0|||
46912874|NCT03214367|83142911|FG000|Treatment Period|Withdrawal by Subject|0|||
47031308|NCT01738581|83281464|FG000|Overall Study|Lost to Follow-up|1|||
47031309|NCT01738581|83281465|FG001|Overall Study|Lost to Follow-up|0|||
47031310|NCT01738503|83281477|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
47031311|NCT01738503|83281478|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
47031312|NCT01738503|83281479|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
47031313|NCT01738503|83281480|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
47031314|NCT01738503|83281481|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
46628070|NCT02037984|82799108|FG003|Overall Study|Protocol Violation|0|||
46628071|NCT02037984|82799109|FG004|Overall Study|Protocol Violation|0|||
46628072|NCT02037984|82799110|FG005|Overall Study|Protocol Violation|1|||
46628073|NCT02037984|82799111|FG006|Overall Study|Protocol Violation|2|||
46628074|NCT02037984|82799112|FG007|Overall Study|Protocol Violation|0|||
46628075|NCT02037984|82799105|FG000|Overall Study|Technical Problems|0|||
46628076|NCT02037984|82799106|FG001|Overall Study|Technical Problems|0|||
46628077|NCT02037984|82799107|FG002|Overall Study|Technical Problems|3|||
46628078|NCT02037984|82799108|FG003|Overall Study|Technical Problems|3|||
46628079|NCT02037984|82799109|FG004|Overall Study|Technical Problems|2|||
47031315|NCT01738503|83281482|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
46628080|NCT02037984|82799110|FG005|Overall Study|Technical Problems|3|||
46628081|NCT02037984|82799111|FG006|Overall Study|Technical Problems|4|||
46628082|NCT02037984|82799112|FG007|Overall Study|Technical Problems|2|||
46628083|NCT02037984|82799105|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46628084|NCT02037984|82799106|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46628085|NCT02037984|82799107|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
46628086|NCT02037984|82799108|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
46628087|NCT02037984|82799109|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
47031316|NCT01738503|83281483|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
47031317|NCT01738503|83281477|FG000|Treatment Period|Adverse Event|0|||
47031318|NCT01738503|83281478|FG001|Treatment Period|Adverse Event|1|||
47031319|NCT01738503|83281479|FG002|Treatment Period|Adverse Event|0|||
47031320|NCT01738503|83281480|FG003|Treatment Period|Adverse Event|1|||
47031321|NCT01738503|83281481|FG004|Treatment Period|Adverse Event|2|||
47031322|NCT01738503|83281482|FG005|Treatment Period|Adverse Event|2|||
47031323|NCT01738503|83281483|FG006|Treatment Period|Adverse Event|2|||
47031324|NCT01738503|83281477|FG000|Treatment Period|Lost to Follow-up|0|||
47031325|NCT01738503|83281478|FG001|Treatment Period|Lost to Follow-up|0|||
47031326|NCT01738503|83281479|FG002|Treatment Period|Lost to Follow-up|3|||
47031327|NCT01738503|83281480|FG003|Treatment Period|Lost to Follow-up|4|||
47031328|NCT01738503|83281481|FG004|Treatment Period|Lost to Follow-up|1|||
47031329|NCT01738503|83281482|FG005|Treatment Period|Lost to Follow-up|1|||
47031330|NCT01738503|83281483|FG006|Treatment Period|Lost to Follow-up|5|||
47031331|NCT01738503|83281477|FG000|Treatment Period|Withdrawal by Subject|0|||
47031332|NCT01738503|83281478|FG001|Treatment Period|Withdrawal by Subject|1|||
47031333|NCT01738503|83281479|FG002|Treatment Period|Withdrawal by Subject|0|||
47031334|NCT01738503|83281480|FG003|Treatment Period|Withdrawal by Subject|1|||
46628088|NCT02037984|82799110|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
46628089|NCT02037984|82799111|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
46628090|NCT02037984|82799112|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
46628091|NCT02037984|82799105|FG000|Overall Study|Withdrawal by Subject|0|||
46628092|NCT02037984|82799106|FG001|Overall Study|Withdrawal by Subject|0|||
46628093|NCT02037984|82799107|FG002|Overall Study|Withdrawal by Subject|0|||
46628094|NCT02037984|82799108|FG003|Overall Study|Withdrawal by Subject|1|||
46628095|NCT02037984|82799109|FG004|Overall Study|Withdrawal by Subject|1|||
46628096|NCT02037984|82799110|FG005|Overall Study|Withdrawal by Subject|3|||
46628097|NCT02037984|82799111|FG006|Overall Study|Withdrawal by Subject|0|||
46628098|NCT02037984|82799112|FG007|Overall Study|Withdrawal by Subject|1|||
46912875|NCT03214367|83142912|FG001|Treatment Period|Withdrawal by Subject|20|||
47031335|NCT01738503|83281481|FG004|Treatment Period|Withdrawal by Subject|1|||
47031336|NCT01738503|83281482|FG005|Treatment Period|Withdrawal by Subject|1|||
47031337|NCT01738503|83281483|FG006|Treatment Period|Withdrawal by Subject|1|||
47031338|NCT01738503|83281477|FG000|Treatment Period|Protocol Violation|0|||
47031339|NCT01738503|83281478|FG001|Treatment Period|Protocol Violation|3|||
47031340|NCT01738503|83281479|FG002|Treatment Period|Protocol Violation|1|||
47031341|NCT01738503|83281480|FG003|Treatment Period|Protocol Violation|0|||
47031342|NCT01738503|83281481|FG004|Treatment Period|Protocol Violation|4|||
47031343|NCT01738503|83281482|FG005|Treatment Period|Protocol Violation|2|||
47031344|NCT01738503|83281483|FG006|Treatment Period|Protocol Violation|0|||
47031345|NCT01738503|83281477|FG000|Treatment Period|Other|0|||
47031346|NCT01738503|83281478|FG001|Treatment Period|Other|0|||
46628099|NCT02057406|82799143|FG000|Overall Study|Physician Decision|0|||
46628100|NCT02057406|82799144|FG001|Overall Study|Physician Decision|0|||
46628101|NCT02057406|82799145|FG002|Overall Study|Physician Decision|2|||
46628102|NCT02057406|82799143|FG000|Overall Study|Withdrawal by Subject|0|||
46628103|NCT02057406|82799144|FG001|Overall Study|Withdrawal by Subject|2|||
46628104|NCT02057406|82799145|FG002|Overall Study|Withdrawal by Subject|0|||
46628105|NCT02057406|82799143|FG000|Overall Study|Lost to Follow-up|0|||
46628106|NCT02057406|82799144|FG001|Overall Study|Lost to Follow-up|0|||
46628107|NCT02057406|82799145|FG002|Overall Study|Lost to Follow-up|1|||
46628108|NCT02057406|82799143|FG000|Overall Study|Death|1|||
46628109|NCT02057406|82799144|FG001|Overall Study|Death|0|||
46628110|NCT02057406|82799145|FG002|Overall Study|Death|0|||
46628111|NCT02057406|82799143|FG000|Overall Study|Protocol Violation|0|||
46628112|NCT02057406|82799144|FG001|Overall Study|Protocol Violation|1|||
46628113|NCT02057406|82799145|FG002|Overall Study|Protocol Violation|0|||
46628114|NCT02057406|82799143|FG000|Overall Study|Patient transportation issues|0|||
46628115|NCT02057406|82799144|FG001|Overall Study|Patient transportation issues|0|||
47031347|NCT01738503|83281479|FG002|Treatment Period|Other|1|||
47031348|NCT01738503|83281480|FG003|Treatment Period|Other|0|||
47031349|NCT01738503|83281481|FG004|Treatment Period|Other|0|||
47031350|NCT01738503|83281482|FG005|Treatment Period|Other|0|||
47031351|NCT01738503|83281483|FG006|Treatment Period|Other|0|||
46628116|NCT02057406|82799145|FG002|Overall Study|Patient transportation issues|1|||
47031352|NCT01738503|83281477|FG000|PET Imaging Sub-study|Adverse Event|0|||
47031353|NCT01738503|83281478|FG001|PET Imaging Sub-study|Adverse Event|0|||
46628117|NCT02036580|82799156|FG000|Overall Study|Withdrawal by Subject|0|||
46628118|NCT02036580|82799157|FG001|Overall Study|Withdrawal by Subject|1|||
46628119|NCT02036580|82799158|FG002|Overall Study|Withdrawal by Subject|0|||
46628120|NCT02036580|82799156|FG000|Overall Study|Adverse Event|1|||
46628121|NCT02036580|82799157|FG001|Overall Study|Adverse Event|0|||
46628122|NCT02036580|82799158|FG002|Overall Study|Adverse Event|0|||
46628123|NCT02014116|82799175|FG000|Overall Study|Progressive Disease|3|||
47031354|NCT01738503|83281479|FG002|PET Imaging Sub-study|Adverse Event|0|||
47031355|NCT01738503|83281480|FG003|PET Imaging Sub-study|Adverse Event|0|||
47031356|NCT01738503|83281481|FG004|PET Imaging Sub-study|Adverse Event|0|||
47031357|NCT01738503|83281482|FG005|PET Imaging Sub-study|Adverse Event|1|||
47031358|NCT01738503|83281483|FG006|PET Imaging Sub-study|Adverse Event|0|||
47031359|NCT01738503|83281477|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
47031360|NCT01738503|83281478|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
47031361|NCT01738503|83281479|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
47031362|NCT01738503|83281480|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
47031363|NCT01738503|83281481|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
47031364|NCT01738503|83281482|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
47031365|NCT01738503|83281483|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
47031366|NCT01738191|83281507|FG000|Overall Study|Withdrawal by Subject|4|||
47031367|NCT01738191|83281508|FG001|Overall Study|Withdrawal by Subject|1|||
47031368|NCT01737879|83281514|FG000|Overall Study|Death|1|||
47031369|NCT01737879|83281514|FG000|Overall Study|Sponsor decision|40|||
47031370|NCT01879683|83281518|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
47031371|NCT01605825|83281524|FG000|Overall Study|Adverse Event|4|||
47031372|NCT01605825|83281525|FG001|Overall Study|Adverse Event|2|||
47031373|NCT01605825|83281524|FG000|Overall Study|Withdrawal by Subject|0|||
47031374|NCT01605825|83281525|FG001|Overall Study|Withdrawal by Subject|1|||
47031375|NCT01605825|83281524|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
47031376|NCT01605825|83281525|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
47031377|NCT01605825|83281524|FG000|Overall Study|Non-Compliance with Protocol|3|||
47031378|NCT01605825|83281525|FG001|Overall Study|Non-Compliance with Protocol|0|||
47031379|NCT01727505|83281531|FG000|First 24 Hours|Adverse Event|0|||
47031380|NCT01727505|83281532|FG001|First 24 Hours|Adverse Event|1|||
47031381|NCT01727505|83281531|FG000|Second 24 Hours|Missing data|0|||
47031382|NCT01727505|83281532|FG001|Second 24 Hours|Missing data|1|||
47031383|NCT01726803|83281540|FG000|Overall Study|Lost to Follow-up|6|||
47031384|NCT01726803|83281541|FG001|Overall Study|Lost to Follow-up|1|||
47031385|NCT01726803|83281540|FG000|Overall Study|Withdrawal by Subject|1|||
47031386|NCT01726803|83281541|FG001|Overall Study|Withdrawal by Subject|0|||
47031387|NCT01726335|83281547|FG000|Overall Study|Lost to Follow-up|2|||
47031388|NCT01726335|83281547|FG000|Overall Study|Withdrawal by Subject|15|||
47031389|NCT01726335|83281547|FG000|Overall Study|Adverse Event|4|||
47031390|NCT01726335|83281547|FG000|Overall Study|Lost to Follow-up|2|||
47031391|NCT01726335|83281547|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
47031392|NCT01877421|83281583|FG000|Phase 2|Lost to Follow-up|0|||
47031393|NCT01877421|83281584|FG001|Phase 2|Lost to Follow-up|0|||
47031394|NCT01877421|83281585|FG002|Phase 2|Lost to Follow-up|0|||
47031395|NCT01877421|83281586|FG003|Phase 2|Lost to Follow-up|0|||
47031396|NCT01877421|83281587|FG004|Phase 2|Lost to Follow-up|0|||
47031397|NCT01877421|83281588|FG005|Phase 2|Lost to Follow-up|0|||
47031398|NCT01877421|83281589|FG006|Phase 2|Lost to Follow-up|1|||
47031399|NCT01877421|83281590|FG007|Phase 2|Lost to Follow-up|0|||
47031400|NCT01877421|83281591|FG008|Phase 2|Lost to Follow-up|0|||
47031401|NCT01877421|83281592|FG009|Phase 2|Lost to Follow-up|0|||
47031402|NCT01877421|83281593|FG010|Phase 2|Lost to Follow-up|0|||
47031403|NCT01877421|83281594|FG011|Phase 2|Lost to Follow-up|0|||
47031404|NCT01877421|83281595|FG012|Phase 2|Lost to Follow-up|0|||
47031405|NCT01877421|83281596|FG013|Phase 2|Lost to Follow-up|0|||
47031406|NCT01877421|83281597|FG014|Phase 2|Lost to Follow-up|0|||
46628124|NCT02014116|82799176|FG001|Overall Study|Progressive Disease|4|||
46628125|NCT02014116|82799177|FG002|Overall Study|Progressive Disease|2|||
46628126|NCT02014116|82799178|FG003|Overall Study|Progressive Disease|6|||
46628127|NCT02014116|82799179|FG004|Overall Study|Progressive Disease|1|||
46628128|NCT02014116|82799180|FG005|Overall Study|Progressive Disease|13|||
46628129|NCT02014116|82799181|FG006|Overall Study|Progressive Disease|1|||
46628130|NCT02014116|82799182|FG007|Overall Study|Progressive Disease|3|||
47031407|NCT01877421|83281598|FG015|Phase 2|Lost to Follow-up|0|||
47031408|NCT01877421|83281599|FG016|Phase 2|Lost to Follow-up|0|||
46628131|NCT02014116|82799183|FG008|Overall Study|Progressive Disease|7|||
46628132|NCT02014116|82799175|FG000|Overall Study|Adverse Event|0|||
46628133|NCT02014116|82799176|FG001|Overall Study|Adverse Event|0|||
47031409|NCT01877421|83281600|FG017|Phase 2|Lost to Follow-up|0|||
47031410|NCT01877421|83281583|FG000|Phase 2|Withdrawal by Subject|0|||
47031411|NCT01877421|83281584|FG001|Phase 2|Withdrawal by Subject|0|||
47031412|NCT01877421|83281585|FG002|Phase 2|Withdrawal by Subject|0|||
47031413|NCT01877421|83281586|FG003|Phase 2|Withdrawal by Subject|0|||
47031414|NCT01877421|83281587|FG004|Phase 2|Withdrawal by Subject|0|||
46628134|NCT02014116|82799177|FG002|Overall Study|Adverse Event|0|||
47031415|NCT01877421|83281588|FG005|Phase 2|Withdrawal by Subject|0|||
47031416|NCT01877421|83281589|FG006|Phase 2|Withdrawal by Subject|0|||
47031417|NCT01877421|83281590|FG007|Phase 2|Withdrawal by Subject|0|||
47031418|NCT01877421|83281591|FG008|Phase 2|Withdrawal by Subject|1|||
47031419|NCT01877421|83281592|FG009|Phase 2|Withdrawal by Subject|0|||
47031420|NCT01877421|83281593|FG010|Phase 2|Withdrawal by Subject|1|||
47031421|NCT01877421|83281594|FG011|Phase 2|Withdrawal by Subject|0|||
47031422|NCT01877421|83281595|FG012|Phase 2|Withdrawal by Subject|1|||
47031423|NCT01877421|83281596|FG013|Phase 2|Withdrawal by Subject|0|||
47031424|NCT01877421|83281597|FG014|Phase 2|Withdrawal by Subject|0|||
47031425|NCT01877421|83281598|FG015|Phase 2|Withdrawal by Subject|1|||
47031426|NCT01877421|83281599|FG016|Phase 2|Withdrawal by Subject|0|||
47031427|NCT01877421|83281600|FG017|Phase 2|Withdrawal by Subject|0|||
47031428|NCT01877421|83281583|FG000|Phase 2|Protocol Violation|0|||
47031429|NCT01877421|83281584|FG001|Phase 2|Protocol Violation|0|||
47031430|NCT01877421|83281585|FG002|Phase 2|Protocol Violation|0|||
47031431|NCT01877421|83281586|FG003|Phase 2|Protocol Violation|0|||
47031432|NCT01877421|83281587|FG004|Phase 2|Protocol Violation|0|||
47031433|NCT01877421|83281588|FG005|Phase 2|Protocol Violation|0|||
47031434|NCT01877421|83281589|FG006|Phase 2|Protocol Violation|0|||
47031435|NCT01877421|83281590|FG007|Phase 2|Protocol Violation|0|||
47031436|NCT01877421|83281591|FG008|Phase 2|Protocol Violation|0|||
47031437|NCT01877421|83281592|FG009|Phase 2|Protocol Violation|0|||
47031438|NCT01877421|83281593|FG010|Phase 2|Protocol Violation|1|||
47031439|NCT01877421|83281594|FG011|Phase 2|Protocol Violation|0|||
47031440|NCT01877421|83281595|FG012|Phase 2|Protocol Violation|0|||
47031441|NCT01877421|83281596|FG013|Phase 2|Protocol Violation|0|||
47031442|NCT01877421|83281597|FG014|Phase 2|Protocol Violation|0|||
47031443|NCT01877421|83281598|FG015|Phase 2|Protocol Violation|0|||
47031444|NCT01877421|83281599|FG016|Phase 2|Protocol Violation|0|||
47031445|NCT01877421|83281600|FG017|Phase 2|Protocol Violation|0|||
47031446|NCT01726023|83281682|FG000|Overall Study|Death|1|||
47031447|NCT01726023|83281683|FG001|Overall Study|Death|1|||
47031448|NCT01726023|83281682|FG000|Overall Study|Lost to Follow-up|5|||
47031449|NCT01726023|83281683|FG001|Overall Study|Lost to Follow-up|10|||
47031450|NCT01726023|83281682|FG000|Overall Study|Other Eligibility criteria|7|||
47031451|NCT01726023|83281683|FG001|Overall Study|Other Eligibility criteria|7|||
47031452|NCT01726023|83281682|FG000|Overall Study|Withdrawal by Subject|16|||
47031453|NCT01726023|83281683|FG001|Overall Study|Withdrawal by Subject|8|||
47031454|NCT01877265|83281696|FG000|Treatment Period 1|Sponsor Decision|0|||
47031455|NCT01877265|83281697|FG001|Treatment Period 1|Sponsor Decision|0|||
47031456|NCT01877265|83281698|FG002|Treatment Period 1|Sponsor Decision|1|||
47031457|NCT01877265|83281699|FG003|Treatment Period 1|Sponsor Decision|0|||
47031458|NCT01877265|83281700|FG004|Treatment Period 1|Sponsor Decision|0|||
47031459|NCT01877265|83281701|FG005|Treatment Period 1|Sponsor Decision|0|||
47031460|NCT01877265|83281696|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
47031461|NCT01877265|83281697|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
47031462|NCT01877265|83281698|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
47031463|NCT01877265|83281699|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
47031464|NCT01877265|83281700|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
47031465|NCT01877265|83281701|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
46912876|NCT03214367|83142913|FG002|Treatment Period|Withdrawal by Subject|23|||
46912877|NCT03214367|83142914|FG003|Treatment Period|Withdrawal by Subject|14|||
46912878|NCT03214367|83142915|FG004|Treatment Period|Withdrawal by Subject|0|||
46912879|NCT03214367|83142916|FG005|Treatment Period|Withdrawal by Subject|1|||
46912880|NCT03214367|83142917|FG006|Treatment Period|Withdrawal by Subject|1|||
46912881|NCT03214367|83142918|FG007|Treatment Period|Withdrawal by Subject|1|||
46912882|NCT02994108|83142934|FG000|Intervention Messages|Withdrawal by Subject|2|||
46912883|NCT02994108|83142935|FG001|Intervention Messages|Withdrawal by Subject|0|||
46912884|NCT02994108|83142934|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
46912885|NCT02994108|83142935|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
46912886|NCT02994108|83142934|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
46912887|NCT02994108|83142935|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
46912888|NCT02994108|83142934|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
46912889|NCT02994108|83142935|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
47031466|NCT01877265|83281696|FG000|Treatment Period 3|Lost to Follow-up|1|||
47031467|NCT01877265|83281697|FG001|Treatment Period 3|Lost to Follow-up|0|||
47031468|NCT01877265|83281698|FG002|Treatment Period 3|Lost to Follow-up|0|||
47031469|NCT01877265|83281699|FG003|Treatment Period 3|Lost to Follow-up|0|||
47031470|NCT01877265|83281700|FG004|Treatment Period 3|Lost to Follow-up|0|||
47031471|NCT01877265|83281701|FG005|Treatment Period 3|Lost to Follow-up|0|||
47031472|NCT01877187|83281712|FG000|Overall Study|Death|2|||
47031473|NCT01877187|83281712|FG000|Overall Study|Withdrawal by Subject|4|||
47031474|NCT01877187|83281712|FG000|Overall Study|Lost to Follow-up|3|||
47031475|NCT01877187|83281712|FG000|Overall Study|Declining clinical status|11|||
47031476|NCT01877187|83281712|FG000|Overall Study|Liver transplant|2|||
47031477|NCT01858532|83281723|FG000|Overall Study|Adverse Event|58|||
47031478|NCT01858532|83281724|FG001|Overall Study|Adverse Event|50|||
47031479|NCT01858532|83281725|FG002|Overall Study|Adverse Event|23|||
47031480|NCT01858532|83281726|FG003|Overall Study|Adverse Event|28|||
47031481|NCT01858532|83281723|FG000|Overall Study|Withdrew consent|71|||
47031482|NCT01858532|83281724|FG001|Overall Study|Withdrew consent|93|||
47031483|NCT01858532|83281725|FG002|Overall Study|Withdrew consent|46|||
47031484|NCT01858532|83281726|FG003|Overall Study|Withdrew consent|27|||
47031485|NCT01858532|83281723|FG000|Overall Study|Lost to Follow-up|17|||
47031486|NCT01858532|83281724|FG001|Overall Study|Lost to Follow-up|26|||
47031487|NCT01858532|83281725|FG002|Overall Study|Lost to Follow-up|11|||
47031488|NCT01858532|83281726|FG003|Overall Study|Lost to Follow-up|14|||
47031489|NCT01858532|83281723|FG000|Overall Study|Deterioration of medical status|3|||
47031490|NCT01858532|83281724|FG001|Overall Study|Deterioration of medical status|4|||
47031491|NCT01858532|83281725|FG002|Overall Study|Deterioration of medical status|3|||
47031492|NCT01858532|83281726|FG003|Overall Study|Deterioration of medical status|7|||
47031493|NCT01858532|83281723|FG000|Overall Study|Investigator request|3|||
47031494|NCT01858532|83281724|FG001|Overall Study|Investigator request|4|||
47031495|NCT01858532|83281725|FG002|Overall Study|Investigator request|2|||
47031496|NCT01858532|83281726|FG003|Overall Study|Investigator request|6|||
47031497|NCT01858532|83281723|FG000|Overall Study|Other, not specified|29|||
47031498|NCT01858532|83281724|FG001|Overall Study|Other, not specified|15|||
47031499|NCT01858532|83281725|FG002|Overall Study|Other, not specified|13|||
47031500|NCT01858532|83281726|FG003|Overall Study|Other, not specified|11|||
47031501|NCT01883492|83281738|FG000|Overall Study|Lost to Follow-up|3|||
47031502|NCT01883492|83281739|FG001|Overall Study|Lost to Follow-up|4|||
47031503|NCT01883492|83281738|FG000|Overall Study|Surgery on contra-lateral hip|0|||
47031504|NCT01883492|83281739|FG001|Overall Study|Surgery on contra-lateral hip|1|||
47031505|NCT01883492|83281738|FG000|Overall Study|Poor X-ray quality|7|||
47031506|NCT01883492|83281739|FG001|Overall Study|Poor X-ray quality|4|||
47031507|NCT01883492|83281738|FG000|Overall Study|Withdrawal by Subject|1|||
47031508|NCT01883492|83281739|FG001|Overall Study|Withdrawal by Subject|0|||
47031509|NCT01883492|83281738|FG000|Overall Study|inappropriate implant used|1|||
47031510|NCT01883492|83281739|FG001|Overall Study|inappropriate implant used|1|||
47031511|NCT01883492|83281738|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
47031512|NCT01883492|83281739|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
47031513|NCT01832480|83281747|FG000|Overall Study|Lost to Follow-up|33|||
47031514|NCT01832480|83281748|FG001|Overall Study|Lost to Follow-up|30|||
47031515|NCT01832480|83281747|FG000|Overall Study|Withdrawal by Subject|0|||
47031516|NCT01832480|83281748|FG001|Overall Study|Withdrawal by Subject|2|||
47031517|NCT01832480|83281747|FG000|Overall Study|post randomization ineligible|8|||
47031518|NCT01832480|83281748|FG001|Overall Study|post randomization ineligible|10|||
47031519|NCT01858376|83281754|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
47031520|NCT01831856|83281760|FG000|Overall Study|Adverse Event|5|||
47031521|NCT01831856|83281761|FG001|Overall Study|Adverse Event|8|||
47031522|NCT01831856|83281760|FG000|Overall Study|Lack of Efficacy|13|||
46628135|NCT02014116|82799178|FG003|Overall Study|Adverse Event|0|||
46628136|NCT02014116|82799179|FG004|Overall Study|Adverse Event|1|||
46628137|NCT02014116|82799180|FG005|Overall Study|Adverse Event|0|||
46628138|NCT02014116|82799181|FG006|Overall Study|Adverse Event|0|||
46628139|NCT02014116|82799182|FG007|Overall Study|Adverse Event|1|||
46628140|NCT02014116|82799183|FG008|Overall Study|Adverse Event|0|||
46628141|NCT02014116|82799175|FG000|Overall Study|Lost to Follow-up|0|||
47031523|NCT01831856|83281761|FG001|Overall Study|Lack of Efficacy|11|||
47031524|NCT01831856|83281760|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
47031525|NCT01831856|83281761|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
47031526|NCT01831544|83281767|FG000|Overall Study|Death|1|||
46628142|NCT02014116|82799176|FG001|Overall Study|Lost to Follow-up|0|||
46628143|NCT02014116|82799177|FG002|Overall Study|Lost to Follow-up|0|||
47031527|NCT01831544|83281767|FG000|Overall Study|Still on original MVAD device|2|||
47031528|NCT01857206|83281773|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
47031529|NCT01857206|83281774|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
47031530|NCT01857206|83281773|FG000|Overall Study|Lost to Follow-up|9|||
47031531|NCT01857206|83281774|FG001|Overall Study|Lost to Follow-up|6|||
47031532|NCT01857206|83281773|FG000|Overall Study|Unclassified|3|||
47031533|NCT01857206|83281774|FG001|Overall Study|Unclassified|3|||
46628144|NCT02014116|82799178|FG003|Overall Study|Lost to Follow-up|0|||
46628145|NCT02014116|82799179|FG004|Overall Study|Lost to Follow-up|0|||
46628146|NCT02014116|82799180|FG005|Overall Study|Lost to Follow-up|1|||
46628147|NCT02014116|82799181|FG006|Overall Study|Lost to Follow-up|0|||
47031534|NCT01857206|83281773|FG000|Overall Study|Withdrawal by Subject|1|||
46628148|NCT02014116|82799182|FG007|Overall Study|Lost to Follow-up|0|||
46628149|NCT02014116|82799183|FG008|Overall Study|Lost to Follow-up|1|||
46628150|NCT02014116|82799175|FG000|Overall Study|Death|0|||
46628151|NCT02014116|82799176|FG001|Overall Study|Death|0|||
46628152|NCT02014116|82799177|FG002|Overall Study|Death|0|||
46628153|NCT02014116|82799178|FG003|Overall Study|Death|0|||
46628154|NCT02014116|82799179|FG004|Overall Study|Death|0|||
46628155|NCT02014116|82799180|FG005|Overall Study|Death|0|||
46628156|NCT02014116|82799181|FG006|Overall Study|Death|0|||
47031535|NCT01857206|83281774|FG001|Overall Study|Withdrawal by Subject|0|||
47031536|NCT01882088|83281784|FG000|Overall Study|Intolerance of esophageal manometry|1|||
47031537|NCT01882088|83281784|FG000|Overall Study|no possibility to place the catheter|1|||
47031538|NCT01882088|83281784|FG000|Overall Study|Protocol Violation|1|||
47031539|NCT01882088|83281784|FG000|Overall Study|inadequate pH-impedance tracings|2|||
47031540|NCT01881776|83281791|FG000|Overall Study|Lost to Follow-up|1|||
47031541|NCT01881776|83281792|FG001|Overall Study|Lost to Follow-up|2|||
46628157|NCT02014116|82799182|FG007|Overall Study|Death|1|||
46628158|NCT02014116|82799183|FG008|Overall Study|Death|1|||
46628159|NCT02014116|82799175|FG000|Overall Study|Withdrawal by Subject|0|||
46628160|NCT02014116|82799176|FG001|Overall Study|Withdrawal by Subject|0|||
46628161|NCT02014116|82799177|FG002|Overall Study|Withdrawal by Subject|1|||
46628162|NCT02014116|82799178|FG003|Overall Study|Withdrawal by Subject|1|||
46628163|NCT02014116|82799179|FG004|Overall Study|Withdrawal by Subject|0|||
46628164|NCT02014116|82799180|FG005|Overall Study|Withdrawal by Subject|1|||
46628165|NCT02014116|82799181|FG006|Overall Study|Withdrawal by Subject|0|||
46628166|NCT02014116|82799182|FG007|Overall Study|Withdrawal by Subject|0|||
46628167|NCT02014116|82799183|FG008|Overall Study|Withdrawal by Subject|0|||
46628168|NCT02014116|82799175|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
46628169|NCT02014116|82799176|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
46628170|NCT02014116|82799177|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
46628171|NCT02014116|82799178|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
46628172|NCT02014116|82799179|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
46628173|NCT02014116|82799180|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
46628174|NCT02014116|82799181|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
46628175|NCT02014116|82799182|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
46628176|NCT02014116|82799183|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
46628177|NCT02014116|82799175|FG000|Overall Study|Physician Decision|0|||
46628178|NCT02014116|82799176|FG001|Overall Study|Physician Decision|0|||
46628179|NCT02014116|82799177|FG002|Overall Study|Physician Decision|0|||
46628180|NCT02014116|82799178|FG003|Overall Study|Physician Decision|0|||
46628181|NCT02014116|82799179|FG004|Overall Study|Physician Decision|0|||
46628182|NCT02014116|82799180|FG005|Overall Study|Physician Decision|0|||
46628183|NCT02014116|82799181|FG006|Overall Study|Physician Decision|0|||
46628184|NCT02014116|82799182|FG007|Overall Study|Physician Decision|0|||
46628185|NCT02014116|82799183|FG008|Overall Study|Physician Decision|1|||
46628186|NCT02057250|82799210|FG000|AID Assessment Phase|Adverse Event|3|||
46628187|NCT02057250|82799211|FG001|AID Assessment Phase|Adverse Event|2|||
46628188|NCT02057250|82799212|FG002|AID Assessment Phase|Adverse Event|6|||
46628189|NCT02057250|82799213|FG003|AID Assessment Phase|Adverse Event|1|||
46628190|NCT02057250|82799214|FG004|AID Assessment Phase|Adverse Event|0|||
46628191|NCT02057250|82799210|FG000|AID Assessment Phase|Other than specified above|1|||
46628192|NCT02057250|82799211|FG001|AID Assessment Phase|Other than specified above|1|||
46628193|NCT02057250|82799212|FG002|AID Assessment Phase|Other than specified above|1|||
46628194|NCT02057250|82799213|FG003|AID Assessment Phase|Other than specified above|1|||
46628195|NCT02057250|82799214|FG004|AID Assessment Phase|Other than specified above|0|||
46628196|NCT02057250|82799210|FG000|Extension Phase|Adverse Event|0|||
46628197|NCT02057250|82799211|FG001|Extension Phase|Adverse Event|0|||
46628198|NCT02057250|82799212|FG002|Extension Phase|Adverse Event|0|||
46628199|NCT02057250|82799213|FG003|Extension Phase|Adverse Event|0|||
46628200|NCT02057250|82799214|FG004|Extension Phase|Adverse Event|15|||
46628201|NCT02057250|82799210|FG000|Extension Phase|Lack of Efficacy|0|||
46628202|NCT02057250|82799211|FG001|Extension Phase|Lack of Efficacy|0|||
47031542|NCT01881776|83281793|FG002|Overall Study|Lost to Follow-up|1|||
46628203|NCT02057250|82799212|FG002|Extension Phase|Lack of Efficacy|0|||
46628204|NCT02057250|82799213|FG003|Extension Phase|Lack of Efficacy|0|||
46628205|NCT02057250|82799214|FG004|Extension Phase|Lack of Efficacy|10|||
46628206|NCT02057250|82799210|FG000|Extension Phase|Entered in this period but not treated|0|||
46628207|NCT02057250|82799211|FG001|Extension Phase|Entered in this period but not treated|0|||
46628208|NCT02057250|82799212|FG002|Extension Phase|Entered in this period but not treated|0|||
46628209|NCT02057250|82799213|FG003|Extension Phase|Entered in this period but not treated|0|||
46628210|NCT02057250|82799214|FG004|Extension Phase|Entered in this period but not treated|4|||
47031543|NCT01881776|83281791|FG000|Overall Study|Protocol Violation|0|||
46628211|NCT02057250|82799210|FG000|Extension Phase|Other than specified above|0|||
46710868|NCT00905632|82927162|FG004|Overall Study|Adverse Event|0|||
46628212|NCT02057250|82799211|FG001|Extension Phase|Other than specified above|0|||
46628213|NCT02057250|82799212|FG002|Extension Phase|Other than specified above|0|||
46628214|NCT02057250|82799213|FG003|Extension Phase|Other than specified above|0|||
46628215|NCT02057250|82799214|FG004|Extension Phase|Other than specified above|7|||
46628216|NCT02036502|82799234|FG000|Part 1:Dose Determination/Escalation|Death|3|||
46628217|NCT02036502|82799235|FG001|Part 1:Dose Determination/Escalation|Death|2|||
46628218|NCT02036502|82799236|FG002|Part 1:Dose Determination/Escalation|Death|0|||
46628219|NCT02036502|82799237|FG003|Part 1:Dose Determination/Escalation|Death|0|||
47031544|NCT01881776|83281792|FG001|Overall Study|Protocol Violation|2|||
47031545|NCT01881776|83281793|FG002|Overall Study|Protocol Violation|1|||
47031546|NCT01708161|83281807|FG000|Overall Study|Adverse Event|1|||
47031547|NCT01708161|83281808|FG001|Overall Study|Adverse Event|3|||
47031548|NCT01708161|83281809|FG002|Overall Study|Adverse Event|4|||
47031549|NCT01708161|83281810|FG003|Overall Study|Adverse Event|2|||
47031550|NCT01708161|83281811|FG004|Overall Study|Adverse Event|3|||
47031551|NCT01708161|83281812|FG005|Overall Study|Adverse Event|0|||
47031552|NCT01708161|83281807|FG000|Overall Study|Death|0|||
47031553|NCT01708161|83281808|FG001|Overall Study|Death|0|||
47031554|NCT01708161|83281809|FG002|Overall Study|Death|0|||
47031555|NCT01708161|83281810|FG003|Overall Study|Death|1|||
47031556|NCT01708161|83281811|FG004|Overall Study|Death|0|||
47031557|NCT01708161|83281812|FG005|Overall Study|Death|1|||
47031558|NCT01708161|83281807|FG000|Overall Study|Withdrawal by Subject|0|||
47031559|NCT01708161|83281808|FG001|Overall Study|Withdrawal by Subject|1|||
47031560|NCT01708161|83281809|FG002|Overall Study|Withdrawal by Subject|1|||
47031561|NCT01708161|83281810|FG003|Overall Study|Withdrawal by Subject|0|||
47031562|NCT01708161|83281811|FG004|Overall Study|Withdrawal by Subject|0|||
47031563|NCT01708161|83281812|FG005|Overall Study|Withdrawal by Subject|0|||
47031564|NCT01708161|83281807|FG000|Overall Study|Administrative problems|0|||
47031565|NCT01708161|83281808|FG001|Overall Study|Administrative problems|1|||
47031566|NCT01708161|83281809|FG002|Overall Study|Administrative problems|0|||
47031567|NCT01708161|83281810|FG003|Overall Study|Administrative problems|0|||
47031568|NCT01708161|83281811|FG004|Overall Study|Administrative problems|0|||
47031569|NCT01708161|83281812|FG005|Overall Study|Administrative problems|0|||
47031570|NCT01708161|83281807|FG000|Overall Study|Disease progression|3|||
47031571|NCT01708161|83281808|FG001|Overall Study|Disease progression|5|||
47031572|NCT01708161|83281809|FG002|Overall Study|Disease progression|5|||
47031573|NCT01708161|83281810|FG003|Overall Study|Disease progression|13|||
47031574|NCT01708161|83281811|FG004|Overall Study|Disease progression|3|||
47031575|NCT01708161|83281812|FG005|Overall Study|Disease progression|0|||
47031576|NCT01707693|83281828|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
47031577|NCT01707693|83281829|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
47031578|NCT01707693|83281828|FG000|Overall Study Allocation|Protocol Violation|4|||
47031579|NCT01707693|83281829|FG001|Overall Study Allocation|Protocol Violation|3|||
47031580|NCT01707693|83281828|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
47031581|NCT01707693|83281829|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
47031582|NCT01707693|83281828|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
47031583|NCT01707693|83281829|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
47031584|NCT01722669|83281842|FG000|Overall Study|Withdrawal by Subject|0|||
47031585|NCT01722669|83281843|FG001|Overall Study|Withdrawal by Subject|0|||
47031586|NCT01722669|83281844|FG002|Overall Study|Withdrawal by Subject|0|||
47031587|NCT01722669|83281845|FG003|Overall Study|Withdrawal by Subject|0|||
47031588|NCT01722669|83281846|FG004|Overall Study|Withdrawal by Subject|0|||
46628220|NCT02036502|82799238|FG004|Part 1:Dose Determination/Escalation|Death|0|||
47031589|NCT01722669|83281847|FG005|Overall Study|Withdrawal by Subject|2|||
47031590|NCT01707147|83281867|FG000|Overall Study|Administered Trajenta prior to contract|5|||
47031591|NCT01707147|83281867|FG000|Overall Study|Patients who have not taken Trajenta|1|||
47031592|NCT01707147|83281867|FG000|Overall Study|Follow-up failure|17|||
47031593|NCT01707147|83281867|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
47031594|NCT01876251|83281874|FG000|Overall Study|Clinical progression|1|||
47031595|NCT01876251|83281875|FG001|Overall Study|Clinical progression|0|||
47031596|NCT01876251|83281876|FG002|Overall Study|Clinical progression|0|||
47031597|NCT01876251|83281874|FG000|Overall Study|Death|2|||
47031598|NCT01876251|83281875|FG001|Overall Study|Death|0|||
47031599|NCT01876251|83281876|FG002|Overall Study|Death|1|||
47031600|NCT01876251|83281874|FG000|Overall Study|Participant started new treatment|1|||
47031601|NCT01876251|83281875|FG001|Overall Study|Participant started new treatment|0|||
47031602|NCT01876251|83281876|FG002|Overall Study|Participant started new treatment|1|||
46628221|NCT02036502|82799239|FG005|Part 1:Dose Determination/Escalation|Death|0|||
47031603|NCT01876251|83281874|FG000|Overall Study|Participant refused further follow-up|0|||
47031604|NCT01876251|83281875|FG001|Overall Study|Participant refused further follow-up|0|||
47031605|NCT01876251|83281876|FG002|Overall Study|Participant refused further follow-up|1|||
47031606|NCT01876251|83281874|FG000|Overall Study|Study terminated|1|||
47031607|NCT01876251|83281875|FG001|Overall Study|Study terminated|0|||
46628222|NCT02036502|82799240|FG006|Part 1:Dose Determination/Escalation|Death|0|||
46628223|NCT02036502|82799241|FG007|Part 1:Dose Determination/Escalation|Death|0|||
47031608|NCT01876251|83281876|FG002|Overall Study|Study terminated|0|||
47031609|NCT01876251|83281874|FG000|Overall Study|Objective progression or relapse|10|||
47031610|NCT01876251|83281875|FG001|Overall Study|Objective progression or relapse|3|||
47031611|NCT01876251|83281876|FG002|Overall Study|Objective progression or relapse|8|||
47031612|NCT01875471|83281887|FG000|Overall Study|Adverse Event|0|||
47031613|NCT01875471|83281888|FG001|Overall Study|Adverse Event|1|||
47031614|NCT01875471|83281887|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
47031615|NCT01875471|83281888|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
47031616|NCT01875237|83281896|FG000|Overall Study|GVDH before DLI|1|||
47031617|NCT01875237|83281897|FG001|Overall Study|GVDH before DLI|0|||
47031618|NCT01875237|83281896|FG000|Overall Study|DLI cells could not be produced|1|||
47031619|NCT01875237|83281897|FG001|Overall Study|DLI cells could not be produced|0|||
47031620|NCT01874535|83281907|FG000|Overall Study|Lost to Follow-up|10|||
47031621|NCT01874535|83281908|FG001|Overall Study|Lost to Follow-up|9|||
46628224|NCT02036502|82799234|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
46628225|NCT02036502|82799235|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
46628226|NCT02036502|82799236|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
46628227|NCT02036502|82799237|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
46628228|NCT02036502|82799238|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
46628229|NCT02036502|82799239|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
46628230|NCT02036502|82799240|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
46628231|NCT02036502|82799241|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
46628232|NCT02036502|82799234|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
46628233|NCT02036502|82799235|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
46628234|NCT02036502|82799236|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
46628235|NCT02036502|82799237|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
46628236|NCT02036502|82799238|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
46628237|NCT02036502|82799239|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
46628238|NCT02036502|82799240|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
46628239|NCT02036502|82799241|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
46628240|NCT02036502|82799234|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
46628241|NCT02036502|82799235|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
46628242|NCT02036502|82799236|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
46628243|NCT02036502|82799237|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
46628244|NCT02036502|82799238|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
46628245|NCT02036502|82799239|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
46628246|NCT02036502|82799240|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
46628247|NCT02036502|82799241|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
46628248|NCT02036502|82799234|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
46628249|NCT02036502|82799235|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
46628250|NCT02036502|82799236|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
46628251|NCT02036502|82799237|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
46628252|NCT02036502|82799238|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
46628253|NCT02036502|82799239|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
46628254|NCT02036502|82799240|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
46628255|NCT02036502|82799241|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
46628256|NCT02036502|82799234|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
46628257|NCT02036502|82799235|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
46628258|NCT02036502|82799236|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
46628259|NCT02036502|82799237|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
46628260|NCT02036502|82799238|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
47031622|NCT01874535|83281907|FG000|Overall Study|incomplete symptom resolution|45|||
47031623|NCT01874535|83281908|FG001|Overall Study|incomplete symptom resolution|35|||
47031624|NCT01722045|83281914|FG000|Overall Study|Adverse Event|8|||
47031625|NCT01722045|83281914|FG000|Overall Study|Death|3|||
47031626|NCT01722045|83281914|FG000|Overall Study|Withdrawal by Subject|8|||
46628261|NCT02036502|82799239|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
46628262|NCT02036502|82799240|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
46628263|NCT02036502|82799241|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
46628264|NCT02036502|82799234|FG000|Part 2:Dose Confirmation|Death|0|||
46628265|NCT02036502|82799235|FG001|Part 2:Dose Confirmation|Death|0|||
47031627|NCT01722045|83281914|FG000|Overall Study|Lost to Follow-up|4|||
47031628|NCT01722045|83281914|FG000|Overall Study|Protocol Deviation|1|||
47031629|NCT01722045|83281914|FG000|Overall Study|Physician Decision|3|||
46628266|NCT02036502|82799236|FG002|Part 2:Dose Confirmation|Death|1|||
47031630|NCT01722045|83281914|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
47031631|NCT01721109|83281918|FG000|Overall Study|Lack of Efficacy|1|||
47031632|NCT01721109|83281918|FG000|Overall Study|Non- Compliance with Study Drug|3|||
47031633|NCT01721109|83281918|FG000|Overall Study|Withdrew Consent|1|||
47031634|NCT01721109|83281918|FG000|Overall Study|Lost to Follow-up|2|||
47031635|NCT01874145|83281924|FG000|Core Period|Non-compliance|1|||
47031636|NCT01874145|83281925|FG001|Core Period|Non-compliance|0|||
47031637|NCT01874145|83281924|FG000|Core Period|Protocol Violation|1|||
47031638|NCT01874145|83281925|FG001|Core Period|Protocol Violation|1|||
47031639|NCT01874145|83281924|FG000|Core Period|Physician Decision|1|||
47031640|NCT01874145|83281925|FG001|Core Period|Physician Decision|1|||
47031641|NCT01874145|83281924|FG000|Core Period|Adverse Event|0|||
47031642|NCT01874145|83281925|FG001|Core Period|Adverse Event|1|||
47031643|NCT01874145|83281924|FG000|Core Period|Withdrawal by Subject|0|||
47031644|NCT01874145|83281925|FG001|Core Period|Withdrawal by Subject|4|||
47031645|NCT01874145|83281924|FG000|Extension Period|Adverse Event|3|||
47031646|NCT01874145|83281925|FG001|Extension Period|Adverse Event|2|||
47031647|NCT01874145|83281924|FG000|Extension Period|Withdrawal by Subject|2|||
47031648|NCT01874145|83281925|FG001|Extension Period|Withdrawal by Subject|1|||
47031649|NCT01874145|83281924|FG000|Extension Period|Lost to Follow-up|1|||
47031650|NCT01874145|83281925|FG001|Extension Period|Lost to Follow-up|1|||
47031651|NCT01720797|83281937|FG000|Overall Study|Withdrawal by Subject|3|||
47031652|NCT01720797|83281938|FG001|Overall Study|Withdrawal by Subject|0|||
47031653|NCT01831466|83281956|FG000|Overall Study|Protocol Violation|1|||
47031654|NCT01831466|83281957|FG001|Overall Study|Protocol Violation|1|||
47031655|NCT01831466|83281958|FG002|Overall Study|Protocol Violation|2|||
47031656|NCT01831466|83281959|FG003|Overall Study|Protocol Violation|0|||
47031657|NCT01831466|83281960|FG004|Overall Study|Protocol Violation|0|||
47031658|NCT01831466|83281961|FG005|Overall Study|Protocol Violation|1|||
47031659|NCT01831466|83281962|FG006|Overall Study|Protocol Violation|0|||
47031660|NCT01831466|83281963|FG007|Overall Study|Protocol Violation|0|||
47031661|NCT01831466|83281964|FG008|Overall Study|Protocol Violation|0|||
47031662|NCT01831466|83281965|FG009|Overall Study|Protocol Violation|0|||
47031663|NCT01831466|83281966|FG010|Overall Study|Protocol Violation|0|||
46628267|NCT02036502|82799237|FG003|Part 2:Dose Confirmation|Death|0|||
46628268|NCT02036502|82799238|FG004|Part 2:Dose Confirmation|Death|0|||
46628269|NCT02036502|82799239|FG005|Part 2:Dose Confirmation|Death|0|||
46628270|NCT02036502|82799240|FG006|Part 2:Dose Confirmation|Death|0|||
46628271|NCT02036502|82799241|FG007|Part 2:Dose Confirmation|Death|0|||
46628272|NCT02036502|82799234|FG000|Part 2:Dose Confirmation|Not treated|0|||
46628273|NCT02036502|82799235|FG001|Part 2:Dose Confirmation|Not treated|0|||
46628274|NCT02036502|82799236|FG002|Part 2:Dose Confirmation|Not treated|0|||
46628275|NCT02036502|82799237|FG003|Part 2:Dose Confirmation|Not treated|1|||
46628276|NCT02036502|82799238|FG004|Part 2:Dose Confirmation|Not treated|0|||
46628277|NCT02036502|82799239|FG005|Part 2:Dose Confirmation|Not treated|0|||
46628278|NCT02036502|82799240|FG006|Part 2:Dose Confirmation|Not treated|0|||
46628279|NCT02036502|82799241|FG007|Part 2:Dose Confirmation|Not treated|0|||
46628280|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Adverse Event|0|||
46628281|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Adverse Event|0|||
46628282|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Adverse Event|0|||
46628283|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Adverse Event|0|||
46628284|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Adverse Event|0|||
46628285|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Adverse Event|4|||
46628286|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Adverse Event|0|||
46628287|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Adverse Event|2|||
46628288|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Death|0|||
46628289|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Death|0|||
46628290|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Death|0|||
46628291|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Death|0|||
46628292|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Death|0|||
46628293|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Death|24|||
46912890|NCT03231371|83142942|FG000|Overall Study|Withdrawal by Subject|1|||
46912891|NCT03231371|83142942|FG000|Overall Study|chose or were ineligible to have MRI|12|||
46912892|NCT02870348|83142946|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
46912893|NCT03239873|83142952|FG000|Overall Study|Lost to Follow-up|15|||
46912894|NCT03239873|83142953|FG001|Overall Study|Lost to Follow-up|16|||
46912895|NCT03239873|83142952|FG000|Overall Study|Physician Decision|1|||
46912896|NCT03239873|83142953|FG001|Overall Study|Physician Decision|0|||
46912897|NCT03239873|83142952|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
46912898|NCT03239873|83142953|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
46912899|NCT03239873|83142952|FG000|Overall Study|Withdrawal by Subject|2|||
46912900|NCT03239873|83142953|FG001|Overall Study|Withdrawal by Subject|0|||
46912901|NCT03239873|83142952|FG000|Overall Study|Contraindication to study medication|1|||
46912902|NCT03239873|83142953|FG001|Overall Study|Contraindication to study medication|0|||
46912903|NCT03239873|83142952|FG000|Overall Study|Protocol Violation|1|||
46912904|NCT03239873|83142953|FG001|Overall Study|Protocol Violation|0|||
47031664|NCT01831466|83281967|FG011|Overall Study|Protocol Violation|0|||
47031665|NCT01831466|83281956|FG000|Overall Study|Other|2|||
46710869|NCT00905632|82927163|FG005|Overall Study|Adverse Event|1|||
46912905|NCT03213509|83142961|FG000|Overall Study|Did not consent for verbal autopsy|4|||
47031666|NCT01831466|83281957|FG001|Overall Study|Other|3|||
46628294|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Death|0|||
47031667|NCT01831466|83281958|FG002|Overall Study|Other|2|||
47031668|NCT01831466|83281959|FG003|Overall Study|Other|2|||
47031669|NCT01831466|83281960|FG004|Overall Study|Other|2|||
46628295|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Death|3|||
46628296|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
46628297|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
46628298|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
47031670|NCT01831466|83281961|FG005|Overall Study|Other|1|||
47031671|NCT01831466|83281962|FG006|Overall Study|Other|0|||
47031672|NCT01831466|83281963|FG007|Overall Study|Other|0|||
47031673|NCT01831466|83281964|FG008|Overall Study|Other|0|||
47031674|NCT01831466|83281965|FG009|Overall Study|Other|0|||
47031675|NCT01831466|83281966|FG010|Overall Study|Other|0|||
47031676|NCT01831466|83281967|FG011|Overall Study|Other|0|||
47031677|NCT01831466|83281956|FG000|Overall Study|Non-compliance with study treatment|2|||
47031678|NCT01831466|83281957|FG001|Overall Study|Non-compliance with study treatment|1|||
47031679|NCT01831466|83281958|FG002|Overall Study|Non-compliance with study treatment|1|||
47031680|NCT01831466|83281959|FG003|Overall Study|Non-compliance with study treatment|0|||
47031681|NCT01831466|83281960|FG004|Overall Study|Non-compliance with study treatment|0|||
47031682|NCT01831466|83281961|FG005|Overall Study|Non-compliance with study treatment|1|||
47031683|NCT01831466|83281962|FG006|Overall Study|Non-compliance with study treatment|0|||
47031684|NCT01831466|83281963|FG007|Overall Study|Non-compliance with study treatment|0|||
47031685|NCT01831466|83281964|FG008|Overall Study|Non-compliance with study treatment|0|||
47031686|NCT01831466|83281965|FG009|Overall Study|Non-compliance with study treatment|0|||
47031687|NCT01831466|83281966|FG010|Overall Study|Non-compliance with study treatment|0|||
47031688|NCT01831466|83281967|FG011|Overall Study|Non-compliance with study treatment|0|||
47031689|NCT01831466|83281956|FG000|Overall Study|Death|0|||
47031690|NCT01831466|83281957|FG001|Overall Study|Death|1|||
47031691|NCT01831466|83281958|FG002|Overall Study|Death|0|||
47031692|NCT01831466|83281959|FG003|Overall Study|Death|0|||
47031693|NCT01831466|83281960|FG004|Overall Study|Death|0|||
47031694|NCT01831466|83281961|FG005|Overall Study|Death|0|||
47031695|NCT01831466|83281962|FG006|Overall Study|Death|0|||
47031696|NCT01831466|83281963|FG007|Overall Study|Death|0|||
47031697|NCT01831466|83281964|FG008|Overall Study|Death|0|||
47031698|NCT01831466|83281965|FG009|Overall Study|Death|0|||
47031699|NCT01831466|83281966|FG010|Overall Study|Death|0|||
47031700|NCT01831466|83281967|FG011|Overall Study|Death|0|||
47031701|NCT01831466|83281956|FG000|Overall Study|Withdrawal by Subject|6|||
47031702|NCT01831466|83281957|FG001|Overall Study|Withdrawal by Subject|3|||
47031703|NCT01831466|83281958|FG002|Overall Study|Withdrawal by Subject|3|||
47031704|NCT01831466|83281959|FG003|Overall Study|Withdrawal by Subject|3|||
47031705|NCT01831466|83281960|FG004|Overall Study|Withdrawal by Subject|3|||
47031706|NCT01831466|83281961|FG005|Overall Study|Withdrawal by Subject|5|||
47031707|NCT01831466|83281962|FG006|Overall Study|Withdrawal by Subject|0|||
47031708|NCT01831466|83281963|FG007|Overall Study|Withdrawal by Subject|0|||
47031709|NCT01831466|83281964|FG008|Overall Study|Withdrawal by Subject|0|||
47031710|NCT01831466|83281965|FG009|Overall Study|Withdrawal by Subject|1|||
47031711|NCT01831466|83281966|FG010|Overall Study|Withdrawal by Subject|0|||
47031712|NCT01831466|83281967|FG011|Overall Study|Withdrawal by Subject|1|||
47031713|NCT01831466|83281956|FG000|Overall Study|Lost to Follow-up|0|||
47031714|NCT01831466|83281957|FG001|Overall Study|Lost to Follow-up|1|||
47031715|NCT01831466|83281958|FG002|Overall Study|Lost to Follow-up|4|||
47031716|NCT01831466|83281959|FG003|Overall Study|Lost to Follow-up|2|||
47031717|NCT01831466|83281960|FG004|Overall Study|Lost to Follow-up|0|||
47031718|NCT01831466|83281961|FG005|Overall Study|Lost to Follow-up|3|||
47031719|NCT01831466|83281962|FG006|Overall Study|Lost to Follow-up|0|||
47031720|NCT01831466|83281963|FG007|Overall Study|Lost to Follow-up|0|||
47031721|NCT01831466|83281964|FG008|Overall Study|Lost to Follow-up|0|||
47031722|NCT01831466|83281965|FG009|Overall Study|Lost to Follow-up|1|||
47031723|NCT01831466|83281966|FG010|Overall Study|Lost to Follow-up|0|||
47031724|NCT01831466|83281967|FG011|Overall Study|Lost to Follow-up|1|||
47031725|NCT01831466|83281956|FG000|Overall Study|Lack of Efficacy|5|||
47031726|NCT01831466|83281957|FG001|Overall Study|Lack of Efficacy|8|||
47031727|NCT01831466|83281958|FG002|Overall Study|Lack of Efficacy|7|||
46628299|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
46628300|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
47031728|NCT01831466|83281959|FG003|Overall Study|Lack of Efficacy|6|||
47031729|NCT01831466|83281960|FG004|Overall Study|Lack of Efficacy|9|||
47031730|NCT01831466|83281961|FG005|Overall Study|Lack of Efficacy|8|||
46628301|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
46628302|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
47031731|NCT01831466|83281962|FG006|Overall Study|Lack of Efficacy|1|||
47031732|NCT01831466|83281963|FG007|Overall Study|Lack of Efficacy|1|||
47031733|NCT01831466|83281964|FG008|Overall Study|Lack of Efficacy|2|||
47031734|NCT01831466|83281965|FG009|Overall Study|Lack of Efficacy|2|||
47031735|NCT01831466|83281966|FG010|Overall Study|Lack of Efficacy|2|||
47031736|NCT01831466|83281967|FG011|Overall Study|Lack of Efficacy|0|||
47031737|NCT01831466|83281956|FG000|Overall Study|Adverse Event|0|||
47031738|NCT01831466|83281957|FG001|Overall Study|Adverse Event|0|||
47031739|NCT01831466|83281958|FG002|Overall Study|Adverse Event|4|||
47031740|NCT01831466|83281959|FG003|Overall Study|Adverse Event|6|||
47031741|NCT01831466|83281960|FG004|Overall Study|Adverse Event|3|||
47031742|NCT01831466|83281961|FG005|Overall Study|Adverse Event|7|||
47031743|NCT01831466|83281962|FG006|Overall Study|Adverse Event|0|||
47031744|NCT01831466|83281963|FG007|Overall Study|Adverse Event|1|||
47031745|NCT01831466|83281964|FG008|Overall Study|Adverse Event|1|||
47031746|NCT01831466|83281965|FG009|Overall Study|Adverse Event|1|||
47031747|NCT01831466|83281966|FG010|Overall Study|Adverse Event|0|||
47031748|NCT01831466|83281967|FG011|Overall Study|Adverse Event|2|||
47031749|NCT01881620|83281987|FG000|Overall Study|Protocol Violation|4|||
47031750|NCT01830920|83281996|FG000|Overall Study|Adverse Event|1|||
47031751|NCT01830920|83281997|FG001|Overall Study|Adverse Event|0|||
47031752|NCT01830920|83281998|FG002|Overall Study|Adverse Event|1|||
47031753|NCT01830920|83281999|FG003|Overall Study|Adverse Event|0|||
47031754|NCT01830920|83282000|FG004|Overall Study|Adverse Event|0|||
47031755|NCT01830920|83281996|FG000|Overall Study|Withdrawal by Subject|2|||
47031756|NCT01830920|83281997|FG001|Overall Study|Withdrawal by Subject|2|||
47031757|NCT01830920|83281998|FG002|Overall Study|Withdrawal by Subject|1|||
47031758|NCT01830920|83281999|FG003|Overall Study|Withdrawal by Subject|7|||
47031759|NCT01830920|83282000|FG004|Overall Study|Withdrawal by Subject|1|||
47031760|NCT01830920|83281996|FG000|Overall Study|Death|3|||
47031761|NCT01830920|83281997|FG001|Overall Study|Death|3|||
47031762|NCT01830920|83281998|FG002|Overall Study|Death|5|||
47031763|NCT01830920|83281999|FG003|Overall Study|Death|4|||
47031764|NCT01830920|83282000|FG004|Overall Study|Death|4|||
47031765|NCT01830920|83281996|FG000|Overall Study|Other|15|||
47031766|NCT01830920|83281997|FG001|Overall Study|Other|1|||
47031767|NCT01830920|83281998|FG002|Overall Study|Other|1|||
47031768|NCT01830920|83281999|FG003|Overall Study|Other|5|||
47031769|NCT01830920|83282000|FG004|Overall Study|Other|3|||
47031770|NCT01881230|83282015|FG000|Overall Study|Death|2|||
47031771|NCT01881230|83282016|FG001|Overall Study|Death|0|||
47031772|NCT01881230|83282017|FG002|Overall Study|Death|1|||
47031773|NCT01881230|83282015|FG000|Overall Study|Adverse Event|9|||
47031774|NCT01881230|83282016|FG001|Overall Study|Adverse Event|13|||
47031775|NCT01881230|83282017|FG002|Overall Study|Adverse Event|12|||
47031776|NCT01881230|83282015|FG000|Overall Study|Progressive Disease|31|||
47031777|NCT01881230|83282016|FG001|Overall Study|Progressive Disease|35|||
47031778|NCT01881230|83282017|FG002|Overall Study|Progressive Disease|36|||
47031779|NCT01881230|83282015|FG000|Overall Study|Symptomatic Deterioration|3|||
47031780|NCT01881230|83282016|FG001|Overall Study|Symptomatic Deterioration|3|||
47031781|NCT01881230|83282017|FG002|Overall Study|Symptomatic Deterioration|1|||
47031782|NCT01881230|83282015|FG000|Overall Study|Withdrawal by Subject|6|||
47031783|NCT01881230|83282016|FG001|Overall Study|Withdrawal by Subject|4|||
47031784|NCT01881230|83282017|FG002|Overall Study|Withdrawal by Subject|6|||
47031785|NCT01881230|83282015|FG000|Overall Study|Physician Decision|4|||
46710870|NCT00905632|82927164|FG006|Overall Study|Adverse Event|4|||
47031786|NCT01881230|83282016|FG001|Overall Study|Physician Decision|3|||
46710871|NCT00954447|82927189|FG000|Overall Study|Adverse Event|33|||
47031787|NCT01881230|83282017|FG002|Overall Study|Physician Decision|6|||
47031788|NCT01881230|83282015|FG000|Overall Study|Non-Compliance with Study Drug|1|||
47031789|NCT01881230|83282016|FG001|Overall Study|Non-Compliance with Study Drug|2|||
47031790|NCT01881230|83282017|FG002|Overall Study|Non-Compliance with Study Drug|0|||
47031791|NCT01881230|83282015|FG000|Overall Study|Given Commercially Available Drug|0|||
47031792|NCT01881230|83282016|FG001|Overall Study|Given Commercially Available Drug|0|||
47031793|NCT01881230|83282017|FG002|Overall Study|Given Commercially Available Drug|2|||
47031794|NCT01881230|83282015|FG000|Overall Study|Protocol Violation|1|||
47031795|NCT01881230|83282016|FG001|Overall Study|Protocol Violation|1|||
47031796|NCT01881230|83282017|FG002|Overall Study|Protocol Violation|0|||
47031797|NCT01881230|83282015|FG000|Overall Study|Miscellaneous|3|||
47031798|NCT01881230|83282016|FG001|Overall Study|Miscellaneous|3|||
47031799|NCT01881230|83282017|FG002|Overall Study|Miscellaneous|0|||
47031800|NCT01881230|83282015|FG000|Overall Study|Untreated: Other|0|||
47031801|NCT01881230|83282016|FG001|Overall Study|Untreated: Other|0|||
47031802|NCT01881230|83282017|FG002|Overall Study|Untreated: Other|1|||
47031803|NCT01881230|83282015|FG000|Overall Study|Untreated: Death|0|||
47031804|NCT01881230|83282016|FG001|Overall Study|Untreated: Death|0|||
47031805|NCT01881230|83282017|FG002|Overall Study|Untreated: Death|1|||
47031806|NCT01881230|83282015|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
47031807|NCT01881230|83282016|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
47031808|NCT01881230|83282017|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
47031809|NCT01856582|83282025|FG000|Overall Study|Died prior to Boost infusion|1|||
47031810|NCT01829360|83282033|FG000|Overall Study|Protocol Violation|0|||
47031811|NCT01829360|83282034|FG001|Overall Study|Protocol Violation|0|||
47031812|NCT01829360|83282035|FG002|Overall Study|Protocol Violation|1|||
46628303|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
46628304|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Physician Decision|0|||
46628305|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Physician Decision|0|||
46628306|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Physician Decision|0|||
46628307|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Physician Decision|0|||
47031813|NCT01829360|83282036|FG003|Overall Study|Protocol Violation|0|||
47031814|NCT01856114|83282052|FG000|Overall Study|Withdrawal by Subject|1|||
47031815|NCT01856114|83282053|FG001|Overall Study|Withdrawal by Subject|0|||
47031816|NCT01856114|83282052|FG000|Overall Study|Adverse Event|1|||
47031817|NCT01856114|83282053|FG001|Overall Study|Adverse Event|0|||
46628308|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Physician Decision|0|||
46628309|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Physician Decision|1|||
46628310|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Physician Decision|0|||
46628311|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Physician Decision|0|||
46628312|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
46628313|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
46628314|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
46628315|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
46628316|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
47031818|NCT01855958|83282061|FG000|Overall Study|Withdrawal by Subject|1|||
47031819|NCT01855958|83282062|FG001|Overall Study|Withdrawal by Subject|0|||
47031820|NCT01855412|83282073|FG000|Overall Study|Death|77|||
47031821|NCT01855412|83282074|FG001|Overall Study|Death|123|||
47031822|NCT01855412|83282075|FG002|Overall Study|Death|30|||
47031823|NCT01855412|83282073|FG000|Overall Study|Lost to Follow-up|28|||
47031824|NCT01855412|83282074|FG001|Overall Study|Lost to Follow-up|46|||
47031825|NCT01855412|83282075|FG002|Overall Study|Lost to Follow-up|15|||
47031826|NCT01855412|83282073|FG000|Overall Study|Withdrawal by Subject|77|||
47031827|NCT01855412|83282074|FG001|Overall Study|Withdrawal by Subject|123|||
47031828|NCT01855412|83282075|FG002|Overall Study|Withdrawal by Subject|24|||
47031829|NCT01855412|83282073|FG000|Overall Study|Physician Decision|25|||
47031830|NCT01855412|83282074|FG001|Overall Study|Physician Decision|31|||
47031831|NCT01855412|83282075|FG002|Overall Study|Physician Decision|3|||
47031832|NCT01855412|83282073|FG000|Overall Study|Site Closure|4|||
47031833|NCT01855412|83282074|FG001|Overall Study|Site Closure|18|||
47031834|NCT01855412|83282075|FG002|Overall Study|Site Closure|1|||
47031835|NCT01855412|83282073|FG000|Overall Study|Reason not Specified|1|||
47031836|NCT01855412|83282074|FG001|Overall Study|Reason not Specified|2|||
47031837|NCT01855412|83282075|FG002|Overall Study|Reason not Specified|3|||
47031838|NCT01614470|83282091|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
47031839|NCT01614470|83282092|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
47031840|NCT01614470|83282093|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
46628317|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
46628318|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
46628319|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
46628320|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
46628321|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
46628322|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
47031841|NCT01614470|83282091|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
47031842|NCT01614470|83282092|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
47031843|NCT01614470|83282093|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
47031844|NCT01880528|83282104|FG000|Overall Study|Other|1|||
47031845|NCT01880528|83282105|FG001|Overall Study|Other|1|||
47031846|NCT01854944|83282114|FG000|Overall Study|Withdrawal by Subject|0|||
47031847|NCT01854944|83282115|FG001|Overall Study|Withdrawal by Subject|0|||
46628323|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
47031848|NCT01854944|83282116|FG002|Overall Study|Withdrawal by Subject|1|||
47031849|NCT01829048|83282143|FG000|Overall Study|Withdrawal by Subject|0|||
47031850|NCT01829048|83282144|FG001|Overall Study|Withdrawal by Subject|0|||
47031851|NCT01829048|83282145|FG002|Overall Study|Withdrawal by Subject|0|||
46628324|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
46710872|NCT00954447|82927190|FG001|Overall Study|Adverse Event|25|||
46628325|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
47031852|NCT01829048|83282146|FG003|Overall Study|Withdrawal by Subject|2|||
47031853|NCT01829048|83282147|FG004|Overall Study|Withdrawal by Subject|0|||
47031854|NCT01854710|83282160|FG000|Overall Study|Withdrawal by Subject|2|||
46628326|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
47031855|NCT01854710|83282161|FG001|Overall Study|Withdrawal by Subject|1|||
47031856|NCT01854710|83282162|FG002|Overall Study|Withdrawal by Subject|0|||
47031857|NCT01854710|83282163|FG003|Overall Study|Withdrawal by Subject|0|||
47031858|NCT01854710|83282164|FG004|Overall Study|Withdrawal by Subject|0|||
47031859|NCT01854710|83282165|FG005|Overall Study|Withdrawal by Subject|0|||
47031860|NCT01854710|83282160|FG000|Overall Study|CRI procedural error|2|||
47031861|NCT01854710|83282161|FG001|Overall Study|CRI procedural error|2|||
47031862|NCT01854710|83282162|FG002|Overall Study|CRI procedural error|2|||
47031863|NCT01854710|83282163|FG003|Overall Study|CRI procedural error|2|||
47031864|NCT01854710|83282164|FG004|Overall Study|CRI procedural error|2|||
47031865|NCT01854710|83282165|FG005|Overall Study|CRI procedural error|2|||
47031866|NCT01828034|83282179|FG000|Overall Study|Withdrawal by Subject|0|||
47031867|NCT01828034|83282180|FG001|Overall Study|Withdrawal by Subject|0|||
47031868|NCT01828034|83282181|FG002|Overall Study|Withdrawal by Subject|0|||
47031869|NCT01828034|83282182|FG003|Overall Study|Withdrawal by Subject|1|||
47031870|NCT01853696|83282191|FG000|Overall Study|Withdrawal by Subject|1|||
47031871|NCT01853696|83282192|FG001|Overall Study|Withdrawal by Subject|1|||
47031872|NCT01853696|83282191|FG000|Overall Study|Lost to Follow-up|5|||
47031873|NCT01853696|83282192|FG001|Overall Study|Lost to Follow-up|4|||
47031874|NCT01871805|83282204|FG000|Phase I|Death|7|||
47031875|NCT01871805|83282205|FG001|Phase I|Death|4|||
47031876|NCT01871805|83282206|FG002|Phase I|Death|6|||
47031877|NCT01871805|83282207|FG003|Phase I|Death|2|||
47031878|NCT01871805|83282208|FG004|Phase I|Death|9|||
47031879|NCT01871805|83282209|FG005|Phase I|Death|0|||
47031880|NCT01871805|83282204|FG000|Phase I|Alive in Survival Follow-up|0|||
47031881|NCT01871805|83282205|FG001|Phase I|Alive in Survival Follow-up|2|||
47031882|NCT01871805|83282206|FG002|Phase I|Alive in Survival Follow-up|4|||
47031883|NCT01871805|83282207|FG003|Phase I|Alive in Survival Follow-up|5|||
47031884|NCT01871805|83282208|FG004|Phase I|Alive in Survival Follow-up|4|||
47031885|NCT01871805|83282209|FG005|Phase I|Alive in Survival Follow-up|0|||
47031886|NCT01871805|83282204|FG000|Phase I|Lost to Follow-up|0|||
47031887|NCT01871805|83282205|FG001|Phase I|Lost to Follow-up|1|||
47031888|NCT01871805|83282206|FG002|Phase I|Lost to Follow-up|3|||
47031889|NCT01871805|83282207|FG003|Phase I|Lost to Follow-up|0|||
47031890|NCT01871805|83282208|FG004|Phase I|Lost to Follow-up|0|||
47031891|NCT01871805|83282209|FG005|Phase I|Lost to Follow-up|0|||
47031892|NCT01871805|83282204|FG000|Phase II|Death|0|||
47031893|NCT01871805|83282205|FG001|Phase II|Death|0|||
47031894|NCT01871805|83282206|FG002|Phase II|Death|0|||
47031895|NCT01871805|83282207|FG003|Phase II|Death|0|||
47031896|NCT01871805|83282208|FG004|Phase II|Death|0|||
47031897|NCT01871805|83282209|FG005|Phase II|Death|45|||
47031898|NCT01871805|83282204|FG000|Phase II|Alive in Survival Follow-up|0|||
47031899|NCT01871805|83282205|FG001|Phase II|Alive in Survival Follow-up|0|||
47031900|NCT01871805|83282206|FG002|Phase II|Alive in Survival Follow-up|0|||
47031901|NCT01871805|83282207|FG003|Phase II|Alive in Survival Follow-up|0|||
47031902|NCT01871805|83282208|FG004|Phase II|Alive in Survival Follow-up|0|||
47031903|NCT01871805|83282209|FG005|Phase II|Alive in Survival Follow-up|29|||
47031904|NCT01871805|83282204|FG000|Phase II|Lost to Follow-up|0|||
47031905|NCT01871805|83282205|FG001|Phase II|Lost to Follow-up|0|||
47031906|NCT01871805|83282206|FG002|Phase II|Lost to Follow-up|0|||
47031907|NCT01871805|83282207|FG003|Phase II|Lost to Follow-up|0|||
47031908|NCT01871805|83282208|FG004|Phase II|Lost to Follow-up|0|||
46628327|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
46628328|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
46628329|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
46628330|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
47031909|NCT01871805|83282209|FG005|Phase II|Lost to Follow-up|13|||
47031910|NCT01719861|83282240|FG000|Cycle 1|Death|4|||
47031911|NCT01719861|83282240|FG000|Cycle 2|Death|1|||
47031912|NCT01853618|83282250|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
46710873|NCT00954447|82927189|FG000|Overall Study|Lack of Efficacy|17|||
47031913|NCT01853618|83282251|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
47031914|NCT01853618|83282252|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
46710874|NCT00954447|82927190|FG001|Overall Study|Lack of Efficacy|3|||
47031915|NCT01853618|83282253|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
47031916|NCT01853618|83282254|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
47031917|NCT01853618|83282250|FG000|Overall Study|Progressive disease|1|||
47031918|NCT01853618|83282251|FG001|Overall Study|Progressive disease|1|||
47031919|NCT01853618|83282252|FG002|Overall Study|Progressive disease|1|||
47031920|NCT01853618|83282253|FG003|Overall Study|Progressive disease|1|||
47031921|NCT01853618|83282254|FG004|Overall Study|Progressive disease|2|||
47031922|NCT01853618|83282250|FG000|Overall Study|Physician Decision|0|||
47031923|NCT01853618|83282251|FG001|Overall Study|Physician Decision|1|||
47031924|NCT01853618|83282252|FG002|Overall Study|Physician Decision|1|||
47031925|NCT01853618|83282253|FG003|Overall Study|Physician Decision|0|||
47031926|NCT01853618|83282254|FG004|Overall Study|Physician Decision|0|||
47031927|NCT01853618|83282250|FG000|Overall Study|Refused further treatment|0|||
47031928|NCT01853618|83282251|FG001|Overall Study|Refused further treatment|0|||
47031929|NCT01853618|83282252|FG002|Overall Study|Refused further treatment|0|||
47031930|NCT01853618|83282253|FG003|Overall Study|Refused further treatment|0|||
47031931|NCT01853618|83282254|FG004|Overall Study|Refused further treatment|1|||
47031932|NCT01853462|83282269|FG000|Overall Study|Withdrawal by Subject|1|||
47031933|NCT01853462|83282270|FG001|Overall Study|Withdrawal by Subject|1|||
47031934|NCT01719783|83282280|FG000|Dose 2|Physician Decision|1|||
47031935|NCT01719783|83282281|FG001|Dose 2|Physician Decision|0|||
47031936|NCT01853384|83282309|FG000|Randomized|Adverse Event|5|||
47031937|NCT01853384|83282310|FG001|Randomized|Adverse Event|3|||
47031938|NCT01853384|83282309|FG000|Randomized|Death|1|||
47031939|NCT01853384|83282310|FG001|Randomized|Death|2|||
47031940|NCT01853384|83282309|FG000|Randomized|Lost to Follow-up|1|||
47031941|NCT01853384|83282310|FG001|Randomized|Lost to Follow-up|1|||
47031942|NCT01853384|83282309|FG000|Randomized|Withdrawal by Subject|5|||
47031943|NCT01853384|83282310|FG001|Randomized|Withdrawal by Subject|3|||
47031944|NCT01853384|83282309|FG000|Randomized|Sponsor Decision|47|||
47031945|NCT01853384|83282310|FG001|Randomized|Sponsor Decision|34|||
47031946|NCT01853384|83282309|FG000|Randomized|Other|3|||
47031947|NCT01853384|83282310|FG001|Randomized|Other|3|||
47031948|NCT01853384|83282309|FG000|Completed Follow up Visit 1|Early Termination|13|||
47031949|NCT01853384|83282310|FG001|Completed Follow up Visit 1|Early Termination|9|||
47031950|NCT01853384|83282309|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
47031951|NCT01853384|83282310|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
47031952|NCT01853384|83282309|FG000|Completed Follow up Visit 2|Adverse Event|1|||
47031953|NCT01853384|83282310|FG001|Completed Follow up Visit 2|Adverse Event|0|||
47031954|NCT01853384|83282309|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
47031955|NCT01853384|83282310|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
47031956|NCT01853384|83282309|FG000|Completed Follow up Visit 2|Death|1|||
47031957|NCT01853384|83282310|FG001|Completed Follow up Visit 2|Death|0|||
47031958|NCT01853384|83282309|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
47031959|NCT01853384|83282310|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
47031960|NCT01878890|83282320|FG000|Overall Study|Protocol Violation|0|||
47031961|NCT01878890|83282321|FG001|Overall Study|Protocol Violation|1|||
47031962|NCT01878890|83282322|FG002|Overall Study|Protocol Violation|0|||
47031963|NCT01878890|83282323|FG003|Overall Study|Protocol Violation|0|||
47031964|NCT01827332|83282336|FG000|Overall Study|Lost to Follow-up|2|||
47031965|NCT01827332|83282337|FG001|Overall Study|Lost to Follow-up|1|||
47031966|NCT01719003|83282351|FG000|Overall Study|Non compliant with protocol|1|||
47031967|NCT01719003|83282352|FG001|Overall Study|Non compliant with protocol|1|||
47031968|NCT01719003|83282353|FG002|Overall Study|Non compliant with protocol|0|||
47031969|NCT01719003|83282354|FG003|Overall Study|Non compliant with protocol|1|||
47031970|NCT01719003|83282355|FG004|Overall Study|Non compliant with protocol|2|||
47031971|NCT01719003|83282356|FG005|Overall Study|Non compliant with protocol|1|||
47031972|NCT01719003|83282357|FG006|Overall Study|Non compliant with protocol|2|||
47031973|NCT01719003|83282358|FG007|Overall Study|Non compliant with protocol|3|||
47031974|NCT01719003|83282359|FG008|Overall Study|Non compliant with protocol|0|||
47031975|NCT01719003|83282351|FG000|Overall Study|Adverse Event|6|||
47031976|NCT01719003|83282352|FG001|Overall Study|Adverse Event|5|||
47031977|NCT01719003|83282353|FG002|Overall Study|Adverse Event|4|||
47031978|NCT01719003|83282354|FG003|Overall Study|Adverse Event|3|||
47031979|NCT01719003|83282355|FG004|Overall Study|Adverse Event|4|||
47031980|NCT01719003|83282356|FG005|Overall Study|Adverse Event|3|||
47031981|NCT01719003|83282357|FG006|Overall Study|Adverse Event|6|||
47031982|NCT01719003|83282358|FG007|Overall Study|Adverse Event|5|||
47031983|NCT01719003|83282359|FG008|Overall Study|Adverse Event|0|||
47031984|NCT01719003|83282351|FG000|Overall Study|Lost to Follow-up|0|||
47031985|NCT01719003|83282352|FG001|Overall Study|Lost to Follow-up|6|||
47031986|NCT01719003|83282353|FG002|Overall Study|Lost to Follow-up|7|||
47031987|NCT01719003|83282354|FG003|Overall Study|Lost to Follow-up|2|||
47031988|NCT01719003|83282355|FG004|Overall Study|Lost to Follow-up|3|||
47031989|NCT01719003|83282356|FG005|Overall Study|Lost to Follow-up|4|||
47031990|NCT01719003|83282357|FG006|Overall Study|Lost to Follow-up|3|||
47031991|NCT01719003|83282358|FG007|Overall Study|Lost to Follow-up|2|||
47031992|NCT01719003|83282359|FG008|Overall Study|Lost to Follow-up|2|||
47031993|NCT01719003|83282351|FG000|Overall Study|Refusal to continue, not due to AE|2|||
47031994|NCT01719003|83282352|FG001|Overall Study|Refusal to continue, not due to AE|5|||
47031995|NCT01719003|83282353|FG002|Overall Study|Refusal to continue, not due to AE|4|||
47031996|NCT01719003|83282354|FG003|Overall Study|Refusal to continue, not due to AE|4|||
47031997|NCT01719003|83282355|FG004|Overall Study|Refusal to continue, not due to AE|4|||
47031998|NCT01719003|83282356|FG005|Overall Study|Refusal to continue, not due to AE|3|||
47031999|NCT01719003|83282357|FG006|Overall Study|Refusal to continue, not due to AE|8|||
47032000|NCT01719003|83282358|FG007|Overall Study|Refusal to continue, not due to AE|7|||
47032001|NCT01719003|83282359|FG008|Overall Study|Refusal to continue, not due to AE|1|||
47032002|NCT01719003|83282351|FG000|Overall Study|Reason other than those specified|0|||
47032003|NCT01719003|83282352|FG001|Overall Study|Reason other than those specified|0|||
47032004|NCT01719003|83282353|FG002|Overall Study|Reason other than those specified|2|||
47032005|NCT01719003|83282354|FG003|Overall Study|Reason other than those specified|3|||
47032006|NCT01719003|83282355|FG004|Overall Study|Reason other than those specified|4|||
47032007|NCT01719003|83282356|FG005|Overall Study|Reason other than those specified|1|||
47032008|NCT01719003|83282357|FG006|Overall Study|Reason other than those specified|0|||
47032009|NCT01719003|83282358|FG007|Overall Study|Reason other than those specified|3|||
47032010|NCT01719003|83282359|FG008|Overall Study|Reason other than those specified|1|||
47032011|NCT01719003|83282351|FG000|Overall Study|Lack of Efficacy|0|||
47032012|NCT01719003|83282352|FG001|Overall Study|Lack of Efficacy|0|||
47032013|NCT01719003|83282353|FG002|Overall Study|Lack of Efficacy|0|||
47032014|NCT01719003|83282354|FG003|Overall Study|Lack of Efficacy|0|||
47032015|NCT01719003|83282355|FG004|Overall Study|Lack of Efficacy|0|||
46628331|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
46628332|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
46628333|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
46628334|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
46628335|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
46628336|NCT02036502|82799234|FG000|Part 3:Dose Expansion|Not Treated|0|||
46628337|NCT02036502|82799235|FG001|Part 3:Dose Expansion|Not Treated|0|||
46628338|NCT02036502|82799236|FG002|Part 3:Dose Expansion|Not Treated|0|||
46628339|NCT02036502|82799237|FG003|Part 3:Dose Expansion|Not Treated|0|||
46628340|NCT02036502|82799238|FG004|Part 3:Dose Expansion|Not Treated|0|||
46628341|NCT02036502|82799239|FG005|Part 3:Dose Expansion|Not Treated|2|||
46628342|NCT02036502|82799240|FG006|Part 3:Dose Expansion|Not Treated|0|||
46628343|NCT02036502|82799241|FG007|Part 3:Dose Expansion|Not Treated|0|||
46628344|NCT02056626|82799265|FG000|Overall Study|patient did not follow directions|3|||
46628345|NCT02056626|82799266|FG001|Overall Study|patient did not follow directions|1|||
46628346|NCT02056626|82799267|FG002|Overall Study|patient did not follow directions|0|||
46628347|NCT02056626|82799268|FG003|Overall Study|patient did not follow directions|0|||
46628348|NCT02035332|82799278|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
46628349|NCT02056392|82799288|FG000|Overall Study|Lost to Follow-up|0|||
46628350|NCT02056392|82799289|FG001|Overall Study|Lost to Follow-up|1|||
46628351|NCT02056392|82799290|FG002|Overall Study|Lost to Follow-up|2|||
46628352|NCT02056392|82799291|FG003|Overall Study|Lost to Follow-up|0|||
46628353|NCT02056392|82799292|FG004|Overall Study|Lost to Follow-up|0|||
46628354|NCT02056392|82799293|FG005|Overall Study|Lost to Follow-up|0|||
46628355|NCT02056392|82799288|FG000|Overall Study|Protocol Violation|1|||
46628356|NCT02056392|82799289|FG001|Overall Study|Protocol Violation|0|||
46628357|NCT02056392|82799290|FG002|Overall Study|Protocol Violation|1|||
46628358|NCT02056392|82799291|FG003|Overall Study|Protocol Violation|0|||
46628359|NCT02056392|82799292|FG004|Overall Study|Protocol Violation|0|||
46628360|NCT02056392|82799293|FG005|Overall Study|Protocol Violation|0|||
46628361|NCT02056392|82799288|FG000|Overall Study|Withdrawal by Subject|1|||
46628362|NCT02056392|82799289|FG001|Overall Study|Withdrawal by Subject|0|||
46628363|NCT02056392|82799290|FG002|Overall Study|Withdrawal by Subject|0|||
46628364|NCT02056392|82799291|FG003|Overall Study|Withdrawal by Subject|0|||
46628365|NCT02056392|82799292|FG004|Overall Study|Withdrawal by Subject|1|||
46628366|NCT02056392|82799293|FG005|Overall Study|Withdrawal by Subject|0|||
46628367|NCT02034708|82799303|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
46628368|NCT02034708|82799304|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
46628369|NCT02034708|82799303|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
47032016|NCT01719003|83282356|FG005|Overall Study|Lack of Efficacy|0|||
47032017|NCT01719003|83282357|FG006|Overall Study|Lack of Efficacy|1|||
47032018|NCT01719003|83282358|FG007|Overall Study|Lack of Efficacy|0|||
47032019|NCT01719003|83282359|FG008|Overall Study|Lack of Efficacy|0|||
47032020|NCT01853228|83282378|FG000|Phase 1|Lack of Efficacy|8|||
46628370|NCT02034708|82799304|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
46628371|NCT02034708|82799303|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
46628372|NCT02034708|82799304|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
46628373|NCT02034708|82799303|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
46710875|NCT00954447|82927189|FG000|Overall Study|Protocol Violation|5|||
46628374|NCT02034708|82799304|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
46628375|NCT02034552|82799318|FG000|Overall Study|Never treated|3|||
47032021|NCT01853228|83282379|FG001|Phase 1|Lack of Efficacy|0|||
47032022|NCT01853228|83282378|FG000|Phase 1|Other|1|||
47032023|NCT01853228|83282379|FG001|Phase 1|Other|0|||
47032024|NCT01853228|83282378|FG000|Phase 2|Physician Decision|0|||
47032025|NCT01853228|83282379|FG001|Phase 2|Physician Decision|1|||
47032026|NCT01853228|83282378|FG000|Phase 2|Proceed To Transplant|0|||
47032027|NCT01853228|83282379|FG001|Phase 2|Proceed To Transplant|3|||
47032028|NCT01853228|83282378|FG000|Phase 2|Lack of Efficacy|0|||
47032029|NCT01853228|83282379|FG001|Phase 2|Lack of Efficacy|4|||
47032030|NCT01705587|83282386|FG000|Overall Study|Withdrawal by Subject|0|||
47032031|NCT01705587|83282387|FG001|Overall Study|Withdrawal by Subject|1|||
47032032|NCT01718535|83282403|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
47032033|NCT01718535|83282404|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
47032034|NCT01718535|83282405|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
47032035|NCT01718535|83282406|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
47032036|NCT01718535|83282407|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
47032037|NCT01718535|83282408|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
47032038|NCT01718535|83282409|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
47032039|NCT01718535|83282410|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
47032040|NCT01718535|83282411|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
47032041|NCT01718535|83282412|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
47032042|NCT01717989|83282434|FG000|Overall Study|Ineligibility determined|6|||
47032043|NCT01717989|83282434|FG000|Overall Study|Protocol deviation|6|||
47032044|NCT01717989|83282434|FG000|Overall Study|Withdrawal by Subject|11|||
47032045|NCT01717989|83282434|FG000|Overall Study|Physician Decision|2|||
47032046|NCT01717989|83282434|FG000|Overall Study|Lost to Follow-up|11|||
47032047|NCT01717989|83282434|FG000|Overall Study|Death|439|||
47032048|NCT01717989|83282434|FG000|Overall Study|Protocol-specified criteria|551|||
47032049|NCT01717989|83282434|FG000|Overall Study|Other|40|||
47032050|NCT01705509|83282453|FG000|Inclusion CPET|Screen Failure|5|||
47032051|NCT01705509|83282453|FG000|Inclusion CPET|Withdrawal by Subject|2|||
47032052|NCT01705509|83282453|FG000|CPET w/ Ranexa|Screen Failure|2|||
47032053|NCT01853072|83282459|FG000|Overall Study|Adverse event prior to treatment|0|||
47032054|NCT01853072|83282460|FG001|Overall Study|Adverse event prior to treatment|1|||
47032055|NCT01853072|83282459|FG000|Overall Study|Adverse Event|0|||
47032056|NCT01853072|83282460|FG001|Overall Study|Adverse Event|3|||
47032057|NCT01853072|83282459|FG000|Overall Study|Death|1|||
47032058|NCT01853072|83282460|FG001|Overall Study|Death|4|||
47032059|NCT01853072|83282459|FG000|Overall Study|Lost to Follow-up|0|||
47032060|NCT01853072|83282460|FG001|Overall Study|Lost to Follow-up|3|||
47032061|NCT01853072|83282459|FG000|Overall Study|Non-compliance with study drug|0|||
47032062|NCT01853072|83282460|FG001|Overall Study|Non-compliance with study drug|1|||
47032063|NCT01853072|83282459|FG000|Overall Study|Physician Decision|1|||
47032064|NCT01853072|83282460|FG001|Overall Study|Physician Decision|1|||
47032065|NCT01853072|83282459|FG000|Overall Study|Withdrawal by Subject|1|||
47032066|NCT01853072|83282460|FG001|Overall Study|Withdrawal by Subject|2|||
47032067|NCT01853072|83282459|FG000|Overall Study|Reason not specified|9|||
47032068|NCT01853072|83282460|FG001|Overall Study|Reason not specified|6|||
47032069|NCT01877720|83282468|FG000|Overall Study|Adverse Event|1|||
47032070|NCT01877720|83282469|FG001|Overall Study|Adverse Event|0|||
47032071|NCT01870869|83282479|FG000|Overall Study|Implanted with nonstudy device|1|||
47032072|NCT01870869|83282480|FG001|Overall Study|Implanted with nonstudy device|3|||
47032073|NCT01870869|83282481|FG002|Overall Study|Implanted with nonstudy device|14|||
47032074|NCT01870869|83282482|FG003|Overall Study|Implanted with nonstudy device|4|||
47032075|NCT01870869|83282479|FG000|Overall Study|Death|0|||
46628376|NCT02034552|82799319|FG001|Overall Study|Never treated|2|||
46628377|NCT02034552|82799320|FG002|Overall Study|Never treated|0|||
46628378|NCT02034552|82799318|FG000|Overall Study|Radiological progression|3|||
46628379|NCT02034552|82799319|FG001|Overall Study|Radiological progression|5|||
46628380|NCT02034552|82799320|FG002|Overall Study|Radiological progression|4|||
46628381|NCT02034552|82799318|FG000|Overall Study|AE not assoc. with disease progression|1|||
46628382|NCT02034552|82799319|FG001|Overall Study|AE not assoc. with disease progression|4|||
46628383|NCT02034552|82799320|FG002|Overall Study|AE not assoc. with disease progression|2|||
46628384|NCT02034552|82799318|FG000|Overall Study|AE associated with disease progression|0|||
46628385|NCT02034552|82799319|FG001|Overall Study|AE associated with disease progression|1|||
46628386|NCT02034552|82799320|FG002|Overall Study|AE associated with disease progression|0|||
47032076|NCT01870869|83282480|FG001|Overall Study|Death|0|||
47032077|NCT01870869|83282481|FG002|Overall Study|Death|7|||
46628387|NCT02034552|82799318|FG000|Overall Study|Withdrawal by Subject|2|||
46628388|NCT02034552|82799319|FG001|Overall Study|Withdrawal by Subject|1|||
46628389|NCT02034552|82799320|FG002|Overall Study|Withdrawal by Subject|1|||
46628390|NCT02034552|82799318|FG000|Overall Study|Non-compliance with study drug|0|||
46628391|NCT02034552|82799319|FG001|Overall Study|Non-compliance with study drug|0|||
47032078|NCT01870869|83282482|FG003|Overall Study|Death|1|||
47032079|NCT01870869|83282479|FG000|Overall Study|Subject choice|6|||
47032080|NCT01870869|83282480|FG001|Overall Study|Subject choice|2|||
47032081|NCT01870869|83282481|FG002|Overall Study|Subject choice|22|||
47032082|NCT01870869|83282482|FG003|Overall Study|Subject choice|8|||
47032083|NCT01870869|83282479|FG000|Overall Study|Lost to Follow-up|10|||
47032084|NCT01870869|83282480|FG001|Overall Study|Lost to Follow-up|2|||
47032085|NCT01870869|83282481|FG002|Overall Study|Lost to Follow-up|25|||
47032086|NCT01870869|83282482|FG003|Overall Study|Lost to Follow-up|3|||
47032087|NCT01870869|83282479|FG000|Overall Study|Reason not Specified|1|||
47032088|NCT01870869|83282480|FG001|Overall Study|Reason not Specified|2|||
47032089|NCT01870869|83282481|FG002|Overall Study|Reason not Specified|20|||
47032090|NCT01870869|83282482|FG003|Overall Study|Reason not Specified|4|||
47032091|NCT01870869|83282479|FG000|Overall Study|Not evaluable|10|||
47032092|NCT01870869|83282480|FG001|Overall Study|Not evaluable|5|||
47032093|NCT01870869|83282481|FG002|Overall Study|Not evaluable|42|||
47032094|NCT01870869|83282482|FG003|Overall Study|Not evaluable|10|||
47032095|NCT01877408|83282494|FG000|Overall Study|Lost to Follow-up|0|||
47032096|NCT01877408|83282495|FG001|Overall Study|Lost to Follow-up|2|||
47032097|NCT01717287|83282504|FG000|Overall Study|Lost to Follow-up|0|||
47032098|NCT01717287|83282505|FG001|Overall Study|Lost to Follow-up|2|||
46628392|NCT02034552|82799320|FG002|Overall Study|Non-compliance with study drug|1|||
47032099|NCT01717287|83282504|FG000|Overall Study|Protocol Violation|0|||
47032100|NCT01717287|83282505|FG001|Overall Study|Protocol Violation|1|||
47032101|NCT01827254|83282511|FG000|Overall Study|Death|10|||
46628393|NCT02034552|82799318|FG000|Overall Study|Clinical progression|5|||
46628394|NCT02034552|82799319|FG001|Overall Study|Clinical progression|7|||
46628395|NCT02034552|82799320|FG002|Overall Study|Clinical progression|9|||
46628396|NCT02034474|82799330|FG000|Overall Study|Adverse Event|3|||
46628397|NCT02034474|82799331|FG001|Overall Study|Adverse Event|2|||
46628398|NCT02034474|82799330|FG000|Overall Study|Withdrawal by Subject|1|||
46628399|NCT02034474|82799331|FG001|Overall Study|Withdrawal by Subject|2|||
46628400|NCT02011542|82799339|FG000|Overall Study|Physician Decision|1|||
46628401|NCT02011386|82799343|FG000|Overall Study|Non-compliance|2|||
46628402|NCT02011386|82799343|FG000|Overall Study|Lack of Efficacy|3|||
46628403|NCT02010684|82799349|FG000|Overall Study|Lost to Follow-up|8|||
46628404|NCT02010684|82799350|FG001|Overall Study|Lost to Follow-up|18|||
46628405|NCT02010684|82799349|FG000|Overall Study|Withdrawal by Subject|4|||
46912906|NCT03213509|83142962|FG001|Overall Study|Did not consent for verbal autopsy|5|||
46912907|NCT03239483|83142971|FG000|Overall Study|Lost to Follow-up|1|||
46912908|NCT03239483|83142972|FG001|Overall Study|Lost to Follow-up|0|||
46912909|NCT03239483|83142971|FG000|Overall Study|Withdrawal by Subject|1|||
46912910|NCT03239483|83142972|FG001|Overall Study|Withdrawal by Subject|0|||
46912911|NCT02868554|83142981|FG000|Overall Study|Lost to Follow-up|3|||
46912912|NCT02868554|83142982|FG001|Overall Study|Lost to Follow-up|0|||
46912913|NCT02868554|83142983|FG002|Overall Study|Lost to Follow-up|1|||
46912914|NCT01068912|83142994|FG000|Overall Study|Adverse Event|2|||
46912915|NCT01068912|83142995|FG001|Overall Study|Adverse Event|3|||
46912916|NCT01068912|83142996|FG002|Overall Study|Adverse Event|2|||
46912917|NCT01068912|83142994|FG000|Overall Study|Withdrawal by Subject|5|||
46912918|NCT01068912|83142995|FG001|Overall Study|Withdrawal by Subject|6|||
46912919|NCT01068912|83142996|FG002|Overall Study|Withdrawal by Subject|6|||
46912920|NCT01068912|83142994|FG000|Overall Study|Lost to Follow-up|3|||
46912921|NCT01068912|83142995|FG001|Overall Study|Lost to Follow-up|7|||
46912922|NCT01068912|83142996|FG002|Overall Study|Lost to Follow-up|3|||
46912923|NCT01068912|83142994|FG000|Overall Study|Protocol Violation|0|||
46912924|NCT01068912|83142995|FG001|Overall Study|Protocol Violation|2|||
46912925|NCT01068912|83142996|FG002|Overall Study|Protocol Violation|0|||
46912926|NCT01068912|83142994|FG000|Overall Study|aggravation influenza|1|||
46912927|NCT01068912|83142995|FG001|Overall Study|aggravation influenza|1|||
46710876|NCT00954447|82927190|FG001|Overall Study|Protocol Violation|7|||
46912928|NCT01068912|83142996|FG002|Overall Study|aggravation influenza|1|||
46912929|NCT01068912|83142994|FG000|Overall Study|other underlying illness|0|||
46912930|NCT01068912|83142995|FG001|Overall Study|other underlying illness|3|||
46912931|NCT01068912|83142996|FG002|Overall Study|other underlying illness|3|||
46912932|NCT03229109|83143008|FG000|Overall Study|Withdrawal by Subject|0|||
46912933|NCT03229109|83143009|FG001|Overall Study|Withdrawal by Subject|0|||
46912934|NCT03229109|83143010|FG002|Overall Study|Withdrawal by Subject|0|||
46912935|NCT03229109|83143011|FG003|Overall Study|Withdrawal by Subject|1|||
46912936|NCT03212261|83143021|FG000|Overall Study|Became ineligible d/t tech|2|||
46912937|NCT03212261|83143021|FG000|Overall Study|Tech Trouble- No first study visit|1|||
47032102|NCT01827254|83282511|FG000|Overall Study|Case report form not completed|4|||
46628406|NCT02010684|82799350|FG001|Overall Study|Withdrawal by Subject|5|||
46912938|NCT03212261|83143021|FG000|Overall Study|Lost to Follow-up|7|||
46628407|NCT02034162|82799358|FG000|Double-blind|Lost to Follow-up|3|||
46710877|NCT00954447|82927189|FG000|Overall Study|Lost to Follow-up|8|||
46710878|NCT00954447|82927190|FG001|Overall Study|Lost to Follow-up|14|||
46710879|NCT00954447|82927189|FG000|Overall Study|Withdrawal by Subject|26|||
46710880|NCT00954447|82927190|FG001|Overall Study|Withdrawal by Subject|21|||
46710881|NCT00954447|82927189|FG000|Overall Study|Other|21|||
46710882|NCT00954447|82927190|FG001|Overall Study|Other|18|||
46710883|NCT00904150|82927198|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
46912939|NCT03212261|83143021|FG000|Overall Study|Family Emergency|1|||
47032103|NCT01827254|83282511|FG000|Overall Study|Invalidated centre|3|||
47032104|NCT01827254|83282511|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
47032105|NCT01827254|83282511|FG000|Overall Study|Did not complete re-challenge|1|||
47032106|NCT01827254|83282511|FG000|Overall Study|Disease progression|36|||
47032107|NCT01827254|83282511|FG000|Overall Study|Intolerance to treatment|4|||
47032108|NCT01824602|83282523|FG000|Overall Study|Withdrawal by Subject|0|||
47032109|NCT01824602|83282524|FG001|Overall Study|Withdrawal by Subject|0|||
47032110|NCT01824602|83282525|FG002|Overall Study|Withdrawal by Subject|1|||
47032111|NCT01824602|83282526|FG003|Overall Study|Withdrawal by Subject|2|||
47032112|NCT01824602|83282523|FG000|Overall Study|Patient non-compliance|0|||
47032113|NCT01824602|83282524|FG001|Overall Study|Patient non-compliance|0|||
47032114|NCT01824602|83282525|FG002|Overall Study|Patient non-compliance|1|||
47032115|NCT01824602|83282526|FG003|Overall Study|Patient non-compliance|0|||
47032116|NCT01824602|83282523|FG000|Overall Study|Adverse Event|1|||
47032117|NCT01824602|83282524|FG001|Overall Study|Adverse Event|0|||
47032118|NCT01824602|83282525|FG002|Overall Study|Adverse Event|2|||
47032119|NCT01824602|83282526|FG003|Overall Study|Adverse Event|2|||
47032120|NCT01824602|83282523|FG000|Overall Study|Treatment failure|0|||
47032121|NCT01824602|83282524|FG001|Overall Study|Treatment failure|0|||
47032122|NCT01824602|83282525|FG002|Overall Study|Treatment failure|0|||
47032123|NCT01824602|83282526|FG003|Overall Study|Treatment failure|1|||
47032124|NCT01704651|83282538|FG000|Overall Study|Pre-op withdrawal by subject|1|||
47032125|NCT01704651|83282539|FG001|Overall Study|Pre-op withdrawal by subject|1|||
47032126|NCT01704651|83282538|FG000|Overall Study|Pre-op change in treatment plan|1|||
47032127|NCT01704651|83282539|FG001|Overall Study|Pre-op change in treatment plan|4|||
47032128|NCT01704651|83282538|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
47032129|NCT01704651|83282539|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
47032130|NCT01704651|83282538|FG000|Overall Study|Post-op did not have laparotomy|2|||
47032131|NCT01704651|83282539|FG001|Overall Study|Post-op did not have laparotomy|1|||
47032132|NCT01876706|83282545|FG000|Overall Study|BPH Intervention|9|||
47032133|NCT01876706|83282545|FG000|Overall Study|Lost to Follow-up|7|||
47032134|NCT01876706|83282545|FG000|Overall Study|Withdrawals|6|||
47032135|NCT01876706|83282545|FG000|Overall Study|Death|3|||
47032136|NCT01876082|83282551|FG000|Overall Study|Withdrawal by Subject|0|||
47032137|NCT01876082|83282552|FG001|Overall Study|Withdrawal by Subject|2|||
47032138|NCT01876082|83282551|FG000|Overall Study|Protocol Violation|1|||
47032139|NCT01876082|83282552|FG001|Overall Study|Protocol Violation|0|||
47032140|NCT01876082|83282551|FG000|Overall Study|Adverse Event|1|||
47032141|NCT01876082|83282552|FG001|Overall Study|Adverse Event|1|||
47032142|NCT01876082|83282551|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
47032143|NCT01876082|83282552|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
47032144|NCT01704495|83282562|FG000|Subjects Randomized|Other Reason|3|||
47032145|NCT01704495|83282563|FG001|Subjects Randomized|Other Reason|2|||
47032146|NCT01704495|83282564|FG002|Subjects Randomized|Other Reason|3|||
47032147|NCT01704495|83282565|FG003|Subjects Randomized|Other Reason|2|||
47032148|NCT01704495|83282562|FG000|Subjects Randomized|Discontinuation criteria met|4|||
47032149|NCT01704495|83282563|FG001|Subjects Randomized|Discontinuation criteria met|2|||
47032150|NCT01704495|83282564|FG002|Subjects Randomized|Discontinuation criteria met|2|||
47032151|NCT01704495|83282565|FG003|Subjects Randomized|Discontinuation criteria met|0|||
47032152|NCT01704495|83282562|FG000|Subjects Randomized|Adverse Event|8|||
47032153|NCT01704495|83282563|FG001|Subjects Randomized|Adverse Event|2|||
47032154|NCT01704495|83282564|FG002|Subjects Randomized|Adverse Event|0|||
47032155|NCT01704495|83282565|FG003|Subjects Randomized|Adverse Event|7|||
47032156|NCT01704495|83282562|FG000|Subjects Randomized|Withdrawal by Subject|5|||
47032157|NCT01704495|83282563|FG001|Subjects Randomized|Withdrawal by Subject|5|||
47032158|NCT01704495|83282564|FG002|Subjects Randomized|Withdrawal by Subject|5|||
47032159|NCT01704495|83282565|FG003|Subjects Randomized|Withdrawal by Subject|5|||
47032160|NCT01704495|83282562|FG000|Subjects Randomized|Protocol Violation|1|||
47032161|NCT01704495|83282563|FG001|Subjects Randomized|Protocol Violation|1|||
47032162|NCT01704495|83282564|FG002|Subjects Randomized|Protocol Violation|2|||
47032163|NCT01704495|83282565|FG003|Subjects Randomized|Protocol Violation|0|||
47032164|NCT01704495|83282562|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
47032165|NCT01704495|83282563|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
47032166|NCT01704495|83282564|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
47032167|NCT01704495|83282565|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
47032168|NCT01704495|83282562|FG000|Optional Safety Extension|Adverse Event|0|||
47032169|NCT01704495|83282563|FG001|Optional Safety Extension|Adverse Event|4|||
47032170|NCT01704495|83282564|FG002|Optional Safety Extension|Adverse Event|0|||
47032171|NCT01704495|83282565|FG003|Optional Safety Extension|Adverse Event|1|||
47032172|NCT01704495|83282562|FG000|Optional Safety Extension|Other reason|27|||
47032173|NCT01704495|83282563|FG001|Optional Safety Extension|Other reason|29|||
47032174|NCT01704495|83282564|FG002|Optional Safety Extension|Other reason|30|||
47032175|NCT01704495|83282565|FG003|Optional Safety Extension|Other reason|28|||
47032176|NCT01704495|83282562|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
47032177|NCT01704495|83282563|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
47032178|NCT01704495|83282564|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
46912940|NCT03212261|83143021|FG000|Overall Study|Too busy/ No time|5|||
47032179|NCT01704495|83282565|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
47032180|NCT01716663|83282575|FG000|Overall Study|Withdrawn prior to procedure|4|||
47032181|NCT01716663|83282575|FG000|Overall Study|Treated with non-study catheter|2|||
47032182|NCT01716585|83282581|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
47032183|NCT01716585|83282582|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
47032184|NCT01716585|83282581|FG000|Double-blind Treatment|Adverse Event|2|||
47032185|NCT01716585|83282582|FG001|Double-blind Treatment|Adverse Event|1|||
47032186|NCT01716585|83282581|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
47032187|NCT01716585|83282582|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
47032188|NCT01716585|83282581|FG000|Double-blind Treatment|Lost to Follow-up|2|||
47032189|NCT01716585|83282582|FG001|Double-blind Treatment|Lost to Follow-up|0|||
47032190|NCT01716585|83282581|FG000|Double-blind Treatment|Subject Noncompliant|1|||
47032191|NCT01716585|83282582|FG001|Double-blind Treatment|Subject Noncompliant|0|||
47032192|NCT01716585|83282581|FG000|Double-blind Treatment|Other|1|||
47032193|NCT01716585|83282582|FG001|Double-blind Treatment|Other|0|||
47032194|NCT01716585|83282581|FG000|Open-label Treatment|Adverse Event|0|||
47032195|NCT01716585|83282582|FG001|Open-label Treatment|Adverse Event|2|||
47032196|NCT01716585|83282581|FG000|Open-label Treatment|Virologic Failure|0|||
47032197|NCT01716585|83282582|FG001|Open-label Treatment|Virologic Failure|2|||
47032198|NCT01716585|83282581|FG000|Open-label Treatment|Withdrawal by Subject|0|||
47032199|NCT01716585|83282582|FG001|Open-label Treatment|Withdrawal by Subject|3|||
47032200|NCT01852292|83282591|FG000|Overall Study|Untreated - did not receive study drug|3|||
47032201|NCT01852292|83282592|FG001|Overall Study|Untreated - did not receive study drug|1|||
47032202|NCT01852292|83282591|FG000|Overall Study|Death|9|||
47032203|NCT01852292|83282592|FG001|Overall Study|Death|8|||
47032204|NCT01852292|83282591|FG000|Overall Study|Patient/guardian decision|8|||
47032205|NCT01852292|83282592|FG001|Overall Study|Patient/guardian decision|4|||
47032206|NCT01852292|83282591|FG000|Overall Study|Adverse Event|8|||
47032207|NCT01852292|83282592|FG001|Overall Study|Adverse Event|11|||
47032208|NCT01852292|83282591|FG000|Overall Study|Physician Decision|6|||
47032209|NCT01852292|83282592|FG001|Overall Study|Physician Decision|2|||
47032210|NCT01852292|83282591|FG000|Overall Study|Protocol Violation|2|||
47032211|NCT01852292|83282592|FG001|Overall Study|Protocol Violation|0|||
47032212|NCT01852292|83282591|FG000|Overall Study|Non-compliance with study treatment|1|||
47032213|NCT01852292|83282592|FG001|Overall Study|Non-compliance with study treatment|0|||
47032214|NCT01852292|83282591|FG000|Overall Study|Study terminated by Sponsor|0|||
47032215|NCT01852292|83282592|FG001|Overall Study|Study terminated by Sponsor|1|||
47032216|NCT01852292|83282591|FG000|Overall Study|Progressive disease|42|||
47032217|NCT01852292|83282592|FG001|Overall Study|Progressive disease|52|||
47032218|NCT01715805|83282598|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
47032219|NCT01715805|83282599|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
47032220|NCT01715805|83282600|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
47032221|NCT01715805|83282601|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
47032222|NCT01715805|83282598|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
47032223|NCT01715805|83282599|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
47032224|NCT01715805|83282600|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
47032225|NCT01715805|83282601|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
47032226|NCT01715805|83282598|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
47032227|NCT01715805|83282599|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
47032228|NCT01715805|83282600|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
47032229|NCT01715805|83282601|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
47032230|NCT01715805|83282598|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
46628408|NCT02034162|82799359|FG001|Double-blind|Lost to Follow-up|0|||
46628409|NCT02034162|82799360|FG002|Double-blind|Lost to Follow-up|0|||
46628410|NCT02034162|82799358|FG000|Double-blind|Physician Decision|1|||
46628411|NCT02034162|82799359|FG001|Double-blind|Physician Decision|0|||
46628412|NCT02034162|82799360|FG002|Double-blind|Physician Decision|0|||
46628413|NCT02034162|82799358|FG000|Double-blind|Protocol Violation|0|||
46628414|NCT02034162|82799359|FG001|Double-blind|Protocol Violation|1|||
47032231|NCT01715805|83282599|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
47032232|NCT01715805|83282600|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
47032233|NCT01715805|83282601|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
47032234|NCT01715805|83282598|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
47032235|NCT01715805|83282599|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
47032236|NCT01715805|83282600|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
46628415|NCT02034162|82799360|FG002|Double-blind|Protocol Violation|0|||
47032237|NCT01715805|83282601|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
47032238|NCT01715805|83282598|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
47032239|NCT01715805|83282599|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
47032240|NCT01715805|83282600|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
47032241|NCT01715805|83282601|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
46628416|NCT02034162|82799358|FG000|Double-blind|Withdrawal by Subject|5|||
46628417|NCT02034162|82799359|FG001|Double-blind|Withdrawal by Subject|7|||
47032242|NCT01715805|83282598|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
47032243|NCT01715805|83282599|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
47032244|NCT01715805|83282600|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
47032245|NCT01715805|83282601|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
47032246|NCT01715805|83282598|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
47032247|NCT01715805|83282599|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
47032248|NCT01715805|83282600|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
47032249|NCT01715805|83282601|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
47032250|NCT01715805|83282598|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
47032251|NCT01715805|83282599|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
47032252|NCT01715805|83282600|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
47032253|NCT01715805|83282601|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
47032254|NCT01715805|83282598|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
47032255|NCT01715805|83282599|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
47032256|NCT01715805|83282600|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
47032257|NCT01715805|83282601|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
47032258|NCT01715805|83282598|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
47032259|NCT01715805|83282599|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
47032260|NCT01715805|83282600|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
47032261|NCT01715805|83282601|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
47032262|NCT01715805|83282598|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
47032263|NCT01715805|83282599|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
47032264|NCT01715805|83282600|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
47032265|NCT01715805|83282601|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
47032266|NCT01715805|83282598|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
47032267|NCT01715805|83282599|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
47032268|NCT01715805|83282600|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
47032269|NCT01715805|83282601|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
47032270|NCT01715805|83282598|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
46628418|NCT02034162|82799360|FG002|Double-blind|Withdrawal by Subject|0|||
46628419|NCT02034006|82799373|FG000|Overall Study|Withdrawal by Subject|7|||
46628420|NCT02034006|82799373|FG000|Overall Study|Lost to Follow-up|5|||
46628421|NCT02034006|82799373|FG000|Overall Study|Death|1|||
46628422|NCT02034006|82799373|FG000|Overall Study|Pregnancy|1|||
46628423|NCT02054910|82799382|FG000|Overall Study|Lost to Follow-up|4|||
46628424|NCT02054910|82799383|FG001|Overall Study|Lost to Follow-up|1|||
46628425|NCT02033850|82799393|FG000|Overall Study|Death|1|||
46628426|NCT02033850|82799394|FG001|Overall Study|Death|0|||
46628427|NCT02033850|82799393|FG000|Overall Study|unrelated medical reason|1|||
46628428|NCT02033850|82799394|FG001|Overall Study|unrelated medical reason|1|||
46628429|NCT02054130|82799404|FG000|Overall Study|Withdrawal by Subject|4|||
46628430|NCT02054130|82799405|FG001|Overall Study|Withdrawal by Subject|4|||
46628431|NCT02054130|82799406|FG002|Overall Study|Withdrawal by Subject|7|||
46628432|NCT02054130|82799407|FG003|Overall Study|Withdrawal by Subject|10|||
46628433|NCT02054130|82799404|FG000|Overall Study|Death|0|||
46628434|NCT02054130|82799405|FG001|Overall Study|Death|1|||
46628435|NCT02054130|82799406|FG002|Overall Study|Death|0|||
46628436|NCT02054130|82799407|FG003|Overall Study|Death|0|||
46628437|NCT02054130|82799404|FG000|Overall Study|Lost to Follow-up|0|||
46628438|NCT02054130|82799405|FG001|Overall Study|Lost to Follow-up|0|||
46628439|NCT02054130|82799406|FG002|Overall Study|Lost to Follow-up|1|||
46628440|NCT02054130|82799407|FG003|Overall Study|Lost to Follow-up|2|||
46628441|NCT02054130|82799404|FG000|Overall Study|Missed dose|4|||
46628442|NCT02054130|82799405|FG001|Overall Study|Missed dose|6|||
46628443|NCT02054130|82799406|FG002|Overall Study|Missed dose|7|||
46628444|NCT02054130|82799407|FG003|Overall Study|Missed dose|10|||
46628445|NCT02009046|82799422|FG000|Overall Study|Lost to Follow-up|256|||
46628446|NCT02009046|82799423|FG001|Overall Study|Lost to Follow-up|206|||
46628447|NCT02052960|82799439|FG000|Overall Study|Adverse Event|19|||
46628448|NCT02052960|82799440|FG001|Overall Study|Adverse Event|17|||
46628449|NCT02052960|82799439|FG000|Overall Study|Protocol Violation|4|||
46628450|NCT02052960|82799440|FG001|Overall Study|Protocol Violation|3|||
47032271|NCT01715805|83282599|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
47032272|NCT01715805|83282600|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
46628451|NCT02052960|82799439|FG000|Overall Study|Withdrawal by Subject|6|||
46628452|NCT02052960|82799440|FG001|Overall Study|Withdrawal by Subject|11|||
46628453|NCT02052960|82799439|FG000|Overall Study|Other|25|||
46628454|NCT02052960|82799440|FG001|Overall Study|Other|15|||
46628455|NCT02008890|82799452|FG000|Period 1|Withdrawal by Subject|7|||
47032273|NCT01715805|83282601|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
47032274|NCT01852214|83282609|FG000|Period 1|Adverse Event|1|||
47032275|NCT01852214|83282610|FG001|Period 1|Adverse Event|2|||
47032276|NCT01852214|83282609|FG000|Period 1|Withdrawal by Subject|0|||
47032277|NCT01852214|83282610|FG001|Period 1|Withdrawal by Subject|1|||
47032278|NCT01852214|83282609|FG000|Washout Period|Withdrawal by Subject|0|||
46628456|NCT02008890|82799453|FG001|Period 1|Withdrawal by Subject|7|||
46628457|NCT02008890|82799454|FG002|Period 1|Withdrawal by Subject|5|||
46628458|NCT02008890|82799455|FG003|Period 1|Withdrawal by Subject|0|||
46628459|NCT02008890|82799456|FG004|Period 1|Withdrawal by Subject|0|||
46628460|NCT02008890|82799452|FG000|Period 1|Pregnancy|1|||
46628461|NCT02008890|82799453|FG001|Period 1|Pregnancy|0|||
46628462|NCT02008890|82799454|FG002|Period 1|Pregnancy|0|||
46628463|NCT02008890|82799455|FG003|Period 1|Pregnancy|0|||
46628464|NCT02008890|82799456|FG004|Period 1|Pregnancy|0|||
46628465|NCT02008890|82799452|FG000|Period 1|Physician Decision|1|||
46628466|NCT02008890|82799453|FG001|Period 1|Physician Decision|0|||
46628467|NCT02008890|82799454|FG002|Period 1|Physician Decision|1|||
46628468|NCT02008890|82799455|FG003|Period 1|Physician Decision|0|||
46628469|NCT02008890|82799456|FG004|Period 1|Physician Decision|0|||
46628470|NCT02008890|82799452|FG000|Period 1|Adverse Event|6|||
46628471|NCT02008890|82799453|FG001|Period 1|Adverse Event|8|||
46628472|NCT02008890|82799454|FG002|Period 1|Adverse Event|6|||
46628473|NCT02008890|82799455|FG003|Period 1|Adverse Event|0|||
46628474|NCT02008890|82799456|FG004|Period 1|Adverse Event|0|||
46628475|NCT02008890|82799452|FG000|Period 2|Adverse Event|12|||
46628476|NCT02008890|82799453|FG001|Period 2|Adverse Event|7|||
46628477|NCT02008890|82799454|FG002|Period 2|Adverse Event|0|||
46628478|NCT02008890|82799455|FG003|Period 2|Adverse Event|5|||
46628479|NCT02008890|82799456|FG004|Period 2|Adverse Event|5|||
46628480|NCT02008890|82799452|FG000|Period 2|Withdrawal by Subject|11|||
46628481|NCT02008890|82799453|FG001|Period 2|Withdrawal by Subject|8|||
46628482|NCT02008890|82799454|FG002|Period 2|Withdrawal by Subject|0|||
46628483|NCT02008890|82799455|FG003|Period 2|Withdrawal by Subject|7|||
46628484|NCT02008890|82799456|FG004|Period 2|Withdrawal by Subject|2|||
46628485|NCT02008890|82799452|FG000|Period 2|Physician Decision|4|||
46628486|NCT02008890|82799453|FG001|Period 2|Physician Decision|0|||
46628487|NCT02008890|82799454|FG002|Period 2|Physician Decision|0|||
46628488|NCT02008890|82799455|FG003|Period 2|Physician Decision|2|||
46628489|NCT02008890|82799456|FG004|Period 2|Physician Decision|1|||
46628490|NCT02008890|82799452|FG000|Period 2|Lost to Follow-up|0|||
46628491|NCT02008890|82799453|FG001|Period 2|Lost to Follow-up|0|||
46628492|NCT02008890|82799454|FG002|Period 2|Lost to Follow-up|1|||
46628493|NCT02008890|82799455|FG003|Period 2|Lost to Follow-up|0|||
46628494|NCT02008890|82799456|FG004|Period 2|Lost to Follow-up|0|||
46628495|NCT02008890|82799452|FG000|Extension Period|Withdrawal by Subject|3|||
46628496|NCT02008890|82799453|FG001|Extension Period|Withdrawal by Subject|2|||
46628497|NCT02008890|82799454|FG002|Extension Period|Withdrawal by Subject|0|||
46628498|NCT02008890|82799455|FG003|Extension Period|Withdrawal by Subject|4|||
46628499|NCT02008890|82799456|FG004|Extension Period|Withdrawal by Subject|2|||
46628500|NCT02008890|82799452|FG000|Extension Period|Lost to Follow-up|1|||
46628501|NCT02008890|82799453|FG001|Extension Period|Lost to Follow-up|0|||
46628502|NCT02008890|82799454|FG002|Extension Period|Lost to Follow-up|0|||
46628503|NCT02008890|82799455|FG003|Extension Period|Lost to Follow-up|0|||
46628504|NCT02008890|82799456|FG004|Extension Period|Lost to Follow-up|0|||
46628505|NCT02008890|82799452|FG000|Extension Period|Adverse Event|1|||
46628506|NCT02008890|82799453|FG001|Extension Period|Adverse Event|3|||
47032279|NCT01852214|83282610|FG001|Washout Period|Withdrawal by Subject|1|||
47032280|NCT01393990|83282635|FG000|Overall Study|Adverse Event|0|||
47032281|NCT01393990|83282636|FG001|Overall Study|Adverse Event|0|||
47032282|NCT01393990|83282637|FG002|Overall Study|Adverse Event|0|||
47032283|NCT01393990|83282638|FG003|Overall Study|Adverse Event|0|||
47032284|NCT01393990|83282639|FG004|Overall Study|Adverse Event|0|||
47032285|NCT01393990|83282640|FG005|Overall Study|Adverse Event|0|||
47032286|NCT01393990|83282641|FG006|Overall Study|Adverse Event|0|||
47032287|NCT01393990|83282642|FG007|Overall Study|Adverse Event|0|||
46628507|NCT02008890|82799454|FG002|Extension Period|Adverse Event|0|||
46628508|NCT02008890|82799455|FG003|Extension Period|Adverse Event|0|||
46628509|NCT02008890|82799456|FG004|Extension Period|Adverse Event|2|||
46628510|NCT02052414|82799471|FG000|Overall Study|Adverse Event|12|||
46628511|NCT02052414|82799471|FG000|Overall Study|Lack of Efficacy|2|||
46628512|NCT02052414|82799471|FG000|Overall Study|Withdrawal by Subject|3|||
47032288|NCT01393990|83282643|FG008|Overall Study|Adverse Event|0|||
47032289|NCT01393990|83282644|FG009|Overall Study|Adverse Event|0|||
47032290|NCT01393990|83282645|FG010|Overall Study|Adverse Event|0|||
46628513|NCT02007954|82799476|FG000|Overall Study|Received liver transplant|3|||
46628514|NCT02007954|82799476|FG000|Overall Study|Switch in treatment modality|2|||
46628515|NCT02007954|82799476|FG000|Overall Study|Disease progression and unrelated AE|1|||
46628516|NCT02007954|82799476|FG000|Overall Study|Death|1|||
46628517|NCT02049450|82799480|FG000|Overall Study|Adverse Event|2|||
47032291|NCT01393990|83282646|FG011|Overall Study|Adverse Event|0|||
47032292|NCT01393990|83282647|FG012|Overall Study|Adverse Event|0|||
47032293|NCT01393990|83282648|FG013|Overall Study|Adverse Event|0|||
47032294|NCT01393990|83282649|FG014|Overall Study|Adverse Event|1|||
47032295|NCT01393990|83282650|FG015|Overall Study|Adverse Event|1|||
47032296|NCT01393990|83282651|FG016|Overall Study|Adverse Event|0|||
47032297|NCT01393990|83282652|FG017|Overall Study|Adverse Event|0|||
47032298|NCT01393990|83282635|FG000|Overall Study|Progressive Disease|1|||
47032299|NCT01393990|83282636|FG001|Overall Study|Progressive Disease|0|||
47032300|NCT01393990|83282637|FG002|Overall Study|Progressive Disease|0|||
47032301|NCT01393990|83282638|FG003|Overall Study|Progressive Disease|1|||
47032302|NCT01393990|83282639|FG004|Overall Study|Progressive Disease|1|||
47032303|NCT01393990|83282640|FG005|Overall Study|Progressive Disease|1|||
47032304|NCT01393990|83282641|FG006|Overall Study|Progressive Disease|1|||
47032305|NCT01393990|83282642|FG007|Overall Study|Progressive Disease|1|||
47032306|NCT01393990|83282643|FG008|Overall Study|Progressive Disease|3|||
47032307|NCT01393990|83282644|FG009|Overall Study|Progressive Disease|1|||
47032308|NCT01393990|83282645|FG010|Overall Study|Progressive Disease|0|||
47032309|NCT01393990|83282646|FG011|Overall Study|Progressive Disease|0|||
47032310|NCT01393990|83282647|FG012|Overall Study|Progressive Disease|0|||
47032311|NCT01393990|83282648|FG013|Overall Study|Progressive Disease|1|||
47032312|NCT01393990|83282649|FG014|Overall Study|Progressive Disease|6|||
47032313|NCT01393990|83282650|FG015|Overall Study|Progressive Disease|1|||
47032314|NCT01393990|83282651|FG016|Overall Study|Progressive Disease|0|||
47032315|NCT01393990|83282652|FG017|Overall Study|Progressive Disease|0|||
47032316|NCT01393990|83282635|FG000|Overall Study|Death|0|||
47032317|NCT01393990|83282636|FG001|Overall Study|Death|0|||
47032318|NCT01393990|83282637|FG002|Overall Study|Death|0|||
47032319|NCT01393990|83282638|FG003|Overall Study|Death|0|||
47032320|NCT01393990|83282639|FG004|Overall Study|Death|1|||
47032321|NCT01393990|83282640|FG005|Overall Study|Death|0|||
47032322|NCT01393990|83282641|FG006|Overall Study|Death|0|||
47032323|NCT01393990|83282642|FG007|Overall Study|Death|0|||
47032324|NCT01393990|83282643|FG008|Overall Study|Death|0|||
47032325|NCT01393990|83282644|FG009|Overall Study|Death|0|||
47032326|NCT01393990|83282645|FG010|Overall Study|Death|0|||
47032327|NCT01393990|83282646|FG011|Overall Study|Death|0|||
47032328|NCT01393990|83282647|FG012|Overall Study|Death|0|||
47032329|NCT01393990|83282648|FG013|Overall Study|Death|1|||
47032330|NCT01393990|83282649|FG014|Overall Study|Death|1|||
47032331|NCT01393990|83282650|FG015|Overall Study|Death|0|||
47032332|NCT01393990|83282651|FG016|Overall Study|Death|0|||
47032333|NCT01393990|83282652|FG017|Overall Study|Death|0|||
47032334|NCT01393990|83282635|FG000|Overall Study|Withdrawal by Subject|0|||
47032335|NCT01393990|83282636|FG001|Overall Study|Withdrawal by Subject|0|||
47032336|NCT01393990|83282637|FG002|Overall Study|Withdrawal by Subject|0|||
47032337|NCT01393990|83282638|FG003|Overall Study|Withdrawal by Subject|0|||
47032338|NCT01393990|83282639|FG004|Overall Study|Withdrawal by Subject|0|||
47032339|NCT01393990|83282640|FG005|Overall Study|Withdrawal by Subject|0|||
47032340|NCT01393990|83282641|FG006|Overall Study|Withdrawal by Subject|0|||
47032341|NCT01393990|83282642|FG007|Overall Study|Withdrawal by Subject|0|||
47032342|NCT01393990|83282643|FG008|Overall Study|Withdrawal by Subject|0|||
47032343|NCT01393990|83282644|FG009|Overall Study|Withdrawal by Subject|0|||
47032344|NCT01393990|83282645|FG010|Overall Study|Withdrawal by Subject|0|||
47032345|NCT01393990|83282646|FG011|Overall Study|Withdrawal by Subject|0|||
47032346|NCT01393990|83282647|FG012|Overall Study|Withdrawal by Subject|0|||
47032347|NCT01393990|83282648|FG013|Overall Study|Withdrawal by Subject|0|||
47032348|NCT01393990|83282649|FG014|Overall Study|Withdrawal by Subject|1|||
47032349|NCT01393990|83282650|FG015|Overall Study|Withdrawal by Subject|1|||
47032350|NCT01393990|83282651|FG016|Overall Study|Withdrawal by Subject|0|||
47032351|NCT01393990|83282652|FG017|Overall Study|Withdrawal by Subject|0|||
47032352|NCT00210184|83282701|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
47032353|NCT00210106|83282705|FG000|Overall Study|Death|1|||
46628518|NCT02049450|82799480|FG000|Overall Study|Withdrawal by Subject|1|||
46710884|NCT00904150|82927199|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
47032354|NCT00210106|83282705|FG000|Overall Study|Protocol Violation|13|||
47032355|NCT01851590|83282713|FG000|Overall Study|Withdrawal by Subject|0|||
47032356|NCT01851590|83282714|FG001|Overall Study|Withdrawal by Subject|0|||
47032357|NCT01851590|83282715|FG002|Overall Study|Withdrawal by Subject|1|||
47032358|NCT01851590|83282713|FG000|Overall Study|Adverse Event|0|||
47032359|NCT01851590|83282714|FG001|Overall Study|Adverse Event|0|||
47032360|NCT01851590|83282715|FG002|Overall Study|Adverse Event|2|||
47032361|NCT01851590|83282713|FG000|Overall Study|Lack of Efficacy|0|||
47032362|NCT01851590|83282714|FG001|Overall Study|Lack of Efficacy|1|||
47032363|NCT01851590|83282715|FG002|Overall Study|Lack of Efficacy|0|||
47032364|NCT01852058|83282730|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
46628519|NCT02049450|82799480|FG000|Overall Study|Patients/guardian decision|1|||
47032365|NCT01852058|83282731|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032366|NCT01852058|83282732|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032367|NCT01852058|83282733|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032368|NCT01852058|83282734|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032369|NCT01852058|83282735|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032370|NCT01852058|83282736|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032371|NCT01852058|83282737|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032372|NCT01852058|83282738|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032373|NCT01852058|83282739|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032374|NCT01852058|83282740|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
47032375|NCT01852058|83282741|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
46628520|NCT02031432|82799491|FG000|Overall Study|Protocol Violation|1|||
46628521|NCT02031432|82799491|FG000|Overall Study|Lack of Efficacy|5|||
46628522|NCT02031432|82799491|FG000|Overall Study|Cancer Progression|2|||
46628523|NCT02031432|82799491|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
46628524|NCT02031432|82799491|FG000|Overall Study|Adverse Event|8|||
46628525|NCT02031432|82799491|FG000|Overall Study|Withdrawal by Subject|5|||
46628526|NCT02031432|82799491|FG000|Overall Study|Lost to Follow-up|1|||
46628527|NCT02031432|82799491|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
46628528|NCT02031432|82799491|FG000|Overall Study|Death|10|||
46628529|NCT02031276|82799498|FG000|Period 1 Double-blind IV|Adverse Event|6|||
46628530|NCT02031276|82799499|FG001|Period 1 Double-blind IV|Adverse Event|5|||
46628531|NCT02031276|82799500|FG002|Period 1 Double-blind IV|Adverse Event|1|||
46628532|NCT02031276|82799498|FG000|Period 1 Double-blind IV|Other|0|||
46628533|NCT02031276|82799499|FG001|Period 1 Double-blind IV|Other|1|||
46628534|NCT02031276|82799500|FG002|Period 1 Double-blind IV|Other|0|||
46628535|NCT02031276|82799498|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
46628536|NCT02031276|82799499|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
46628537|NCT02031276|82799500|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
46628538|NCT02031276|82799498|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
46628539|NCT02031276|82799499|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
46628540|NCT02031276|82799500|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
46628541|NCT02031276|82799498|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
46628542|NCT02031276|82799499|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
46628543|NCT02031276|82799500|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
46628544|NCT02031276|82799498|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
46628545|NCT02031276|82799499|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
46628546|NCT02031276|82799500|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
46628547|NCT02031276|82799498|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
46628548|NCT02031276|82799499|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
46628549|NCT02031276|82799500|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
46628550|NCT02031276|82799498|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
46628551|NCT02031276|82799499|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
46628552|NCT02031276|82799500|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
46628553|NCT02031276|82799498|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
46628554|NCT02031276|82799499|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
46628555|NCT02031276|82799500|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
46628556|NCT02007720|82799514|FG000|Overall Study|Withdrawal by Subject|9|||
46628557|NCT02007720|82799515|FG001|Overall Study|Withdrawal by Subject|11|||
46628558|NCT02007720|82799514|FG000|Overall Study|study terminated by sponsor|58|||
46628559|NCT02007720|82799515|FG001|Overall Study|study terminated by sponsor|54|||
46628560|NCT02007720|82799514|FG000|Overall Study|technical problem|4|||
46628561|NCT02007720|82799515|FG001|Overall Study|technical problem|2|||
46628562|NCT02007720|82799514|FG000|Overall Study|patient followd less than 165 days|11|||
46628563|NCT02007720|82799515|FG001|Overall Study|patient followd less than 165 days|5|||
46628564|NCT01363440|82799525|FG000|Overall Study|Adverse Event|5|||
46628565|NCT01363440|82799526|FG001|Overall Study|Adverse Event|4|||
46628566|NCT01363440|82799527|FG002|Overall Study|Adverse Event|4|||
46628567|NCT01363440|82799525|FG000|Overall Study|Death|3|||
46710885|NCT00904150|82927198|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
46710886|NCT00904150|82927199|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
46710887|NCT00903760|82927207|FG000|Overall Study|Disease Progression/Death|8|||
47032376|NCT01852058|83282730|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032377|NCT01852058|83282731|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032378|NCT01852058|83282732|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
46628568|NCT01363440|82799526|FG001|Overall Study|Death|7|||
46628569|NCT01363440|82799527|FG002|Overall Study|Death|5|||
46628570|NCT01363440|82799525|FG000|Overall Study|Withdrawal by Subject|9|||
46628571|NCT01363440|82799526|FG001|Overall Study|Withdrawal by Subject|11|||
46628572|NCT01363440|82799527|FG002|Overall Study|Withdrawal by Subject|11|||
46628573|NCT01363440|82799525|FG000|Overall Study|Lost to Follow-up|2|||
46628574|NCT01363440|82799526|FG001|Overall Study|Lost to Follow-up|4|||
46628575|NCT01363440|82799527|FG002|Overall Study|Lost to Follow-up|5|||
46710888|NCT00903760|82927208|FG001|Overall Study|Disease Progression/Death|6|||
46628576|NCT01363440|82799525|FG000|Overall Study|Other|4|||
46628577|NCT01363440|82799526|FG001|Overall Study|Other|5|||
46628578|NCT01363440|82799527|FG002|Overall Study|Other|2|||
46628579|NCT02007252|82799540|FG000|Overall Study|Administrative problems|3|||
46628580|NCT02007252|82799541|FG001|Overall Study|Administrative problems|7|||
46628581|NCT02007252|82799540|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46628582|NCT02007252|82799541|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46628583|NCT02007252|82799540|FG000|Overall Study|Adverse Event|7|||
46628584|NCT02007252|82799541|FG001|Overall Study|Adverse Event|4|||
46628585|NCT02007096|82799549|FG000|Overall Study|medication not available|2|||
46628586|NCT02007096|82799550|FG001|Overall Study|medication not available|0|||
46628587|NCT02007096|82799549|FG000|Overall Study|did not inject saline|0|||
46628588|NCT02007096|82799550|FG001|Overall Study|did not inject saline|3|||
46628589|NCT02007096|82799549|FG000|Overall Study|did not follow postoperative protocol|8|||
46628590|NCT02007096|82799550|FG001|Overall Study|did not follow postoperative protocol|11|||
46628591|NCT02007096|82799549|FG000|Overall Study|converted to open surgery|1|||
46628592|NCT02007096|82799550|FG001|Overall Study|converted to open surgery|1|||
46628593|NCT02007096|82799549|FG000|Overall Study|no mesh placed|0|||
46628594|NCT02007096|82799550|FG001|Overall Study|no mesh placed|1|||
46628595|NCT02006706|82799556|FG000|Overall Study|Lost to Follow-up|1|||
46628596|NCT02049138|82799563|FG000|Overall Study|Adverse Event|46|||
46628597|NCT02049138|82799564|FG001|Overall Study|Adverse Event|25|||
46628598|NCT02049138|82799565|FG002|Overall Study|Adverse Event|1|||
46628599|NCT02049138|82799563|FG000|Overall Study|Withdrawal by Subject|57|||
46628600|NCT02049138|82799564|FG001|Overall Study|Withdrawal by Subject|21|||
46628601|NCT02049138|82799565|FG002|Overall Study|Withdrawal by Subject|5|||
46628602|NCT02049138|82799563|FG000|Overall Study|Lost to Follow-up|18|||
46628603|NCT02049138|82799564|FG001|Overall Study|Lost to Follow-up|5|||
46628604|NCT02049138|82799565|FG002|Overall Study|Lost to Follow-up|1|||
46628605|NCT02049138|82799563|FG000|Overall Study|Lack of Efficacy|10|||
46628606|NCT02049138|82799564|FG001|Overall Study|Lack of Efficacy|26|||
46628607|NCT02049138|82799565|FG002|Overall Study|Lack of Efficacy|1|||
46628608|NCT02049138|82799563|FG000|Overall Study|Non-Compliance|15|||
46628609|NCT02049138|82799564|FG001|Overall Study|Non-Compliance|6|||
46628610|NCT02049138|82799565|FG002|Overall Study|Non-Compliance|0|||
46628611|NCT02049138|82799563|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
46628612|NCT02049138|82799564|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
46628613|NCT02049138|82799565|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
46628614|NCT02049138|82799563|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
46628615|NCT02049138|82799564|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
46628616|NCT02049138|82799565|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
46628617|NCT02049138|82799563|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
46628618|NCT02049138|82799564|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
46628619|NCT02049138|82799565|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
46628620|NCT02049138|82799563|FG000|Overall Study|Other|15|||
46628621|NCT02049138|82799564|FG001|Overall Study|Other|13|||
46628622|NCT02049138|82799565|FG002|Overall Study|Other|0|||
46628623|NCT02049138|82799563|FG000|Overall Study|Missing|0|||
46628624|NCT02049138|82799564|FG001|Overall Study|Missing|1|||
46628625|NCT02049138|82799565|FG002|Overall Study|Missing|0|||
46628626|NCT02048904|82799576|FG000|Overall Study|Withdrawal by Subject|7|||
46628627|NCT02048904|82799576|FG000|Overall Study|Physician Decision|70|||
46628628|NCT02006628|82799582|FG000|Overall Study|Adverse Event|1|||
46628629|NCT02006628|82799583|FG001|Overall Study|Adverse Event|1|||
46628630|NCT02006628|82799582|FG000|Overall Study|Withdrawal by Subject|2|||
46628631|NCT02006628|82799583|FG001|Overall Study|Withdrawal by Subject|1|||
46628632|NCT02048826|82799591|FG000|Overall Study|Withdrawal by Subject|1|||
46628633|NCT02048826|82799592|FG001|Overall Study|Withdrawal by Subject|0|||
46628634|NCT02006472|82799603|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
46628635|NCT02006472|82799604|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
46628636|NCT02006472|82799605|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
46628637|NCT02006472|82799606|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
46628638|NCT02006472|82799607|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
46628639|NCT02006472|82799603|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
46628640|NCT02006472|82799604|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
46710889|NCT00903760|82927207|FG000|Overall Study|Stem Cell Transplant|8|||
46628641|NCT02006472|82799605|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
46628642|NCT02006472|82799606|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
46628643|NCT02006472|82799607|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
46628644|NCT02006472|82799603|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
46628645|NCT02006472|82799604|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
46628646|NCT02006472|82799605|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
46628647|NCT02006472|82799606|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
46628648|NCT02006472|82799607|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
46710890|NCT00903760|82927208|FG001|Overall Study|Stem Cell Transplant|4|||
46710891|NCT00903760|82927207|FG000|Overall Study|Physician Decision|1|||
46628649|NCT02006472|82799603|FG000|Period 1 (Through Week 26)|Other|1|||
46628650|NCT02006472|82799604|FG001|Period 1 (Through Week 26)|Other|5|||
46628651|NCT02006472|82799605|FG002|Period 1 (Through Week 26)|Other|0|||
46628652|NCT02006472|82799606|FG003|Period 1 (Through Week 26)|Other|2|||
46628653|NCT02006472|82799607|FG004|Period 1 (Through Week 26)|Other|3|||
46628654|NCT02006472|82799603|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
46628655|NCT02006472|82799604|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
46628656|NCT02006472|82799605|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
46628657|NCT02006472|82799606|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
46628658|NCT02006472|82799607|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
46628659|NCT02006472|82799603|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
46628660|NCT02006472|82799604|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
46628661|NCT02006472|82799605|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
46628662|NCT02006472|82799606|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
46628663|NCT02006472|82799607|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
46628664|NCT02006472|82799603|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
46628665|NCT02006472|82799604|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
46628666|NCT02006472|82799605|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
46628667|NCT02006472|82799606|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
46628668|NCT02006472|82799607|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
46628669|NCT02006472|82799603|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
46628670|NCT02006472|82799604|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
47032379|NCT01852058|83282733|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032380|NCT01852058|83282734|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
47032381|NCT01852058|83282735|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032382|NCT01852058|83282736|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032383|NCT01852058|83282737|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032384|NCT01852058|83282738|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032385|NCT01852058|83282739|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032386|NCT01852058|83282740|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032387|NCT01852058|83282741|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
47032388|NCT01852058|83282730|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032389|NCT01852058|83282731|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032390|NCT01852058|83282732|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032391|NCT01852058|83282733|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032392|NCT01852058|83282734|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
47032393|NCT01852058|83282735|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
47032394|NCT01852058|83282736|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032395|NCT01852058|83282737|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032396|NCT01852058|83282738|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032397|NCT01852058|83282739|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
47032398|NCT01852058|83282740|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
46628671|NCT02006472|82799605|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
46628672|NCT02006472|82799606|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
46628673|NCT02006472|82799607|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
46628674|NCT02006472|82799603|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
46628675|NCT02006472|82799604|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
46628676|NCT02006472|82799605|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
47032399|NCT01852058|83282741|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
46628677|NCT02006472|82799606|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
46710892|NCT00903760|82927208|FG001|Overall Study|Physician Decision|2|||
47032400|NCT01852058|83282730|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032401|NCT01852058|83282731|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032402|NCT01852058|83282732|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032403|NCT01852058|83282733|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032404|NCT01852058|83282734|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
47032405|NCT01852058|83282735|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032406|NCT01852058|83282736|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
46628678|NCT02006472|82799607|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
46628679|NCT02006472|82799603|FG000|Period 2 (Through Week 52)|Other|0|||
46628680|NCT02006472|82799604|FG001|Period 2 (Through Week 52)|Other|1|||
46628681|NCT02006472|82799605|FG002|Period 2 (Through Week 52)|Other|0|||
46628682|NCT02006472|82799606|FG003|Period 2 (Through Week 52)|Other|1|||
47032407|NCT01852058|83282737|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032408|NCT01852058|83282738|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032409|NCT01852058|83282739|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032410|NCT01852058|83282740|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032411|NCT01852058|83282741|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
47032412|NCT01852058|83282730|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032413|NCT01852058|83282731|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032414|NCT01852058|83282732|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032415|NCT01852058|83282733|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032416|NCT01852058|83282734|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
47032417|NCT01852058|83282735|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
47032418|NCT01852058|83282736|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032419|NCT01852058|83282737|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032420|NCT01852058|83282738|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032421|NCT01852058|83282739|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032422|NCT01852058|83282740|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032423|NCT01852058|83282741|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
47032424|NCT01852058|83282730|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032425|NCT01852058|83282731|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032426|NCT01852058|83282732|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032427|NCT01852058|83282733|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
47032428|NCT01852058|83282734|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032429|NCT01852058|83282735|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032430|NCT01852058|83282736|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032431|NCT01852058|83282737|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032432|NCT01852058|83282738|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032433|NCT01852058|83282739|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032434|NCT01852058|83282740|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032435|NCT01852058|83282741|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
47032436|NCT01852058|83282730|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032437|NCT01852058|83282731|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032438|NCT01852058|83282732|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032439|NCT01852058|83282733|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032440|NCT01852058|83282734|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
47032441|NCT01852058|83282735|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
47032442|NCT01852058|83282736|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032443|NCT01852058|83282737|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032444|NCT01852058|83282738|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032445|NCT01852058|83282739|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032446|NCT01852058|83282740|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032447|NCT01852058|83282741|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
47032448|NCT01852058|83282730|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032449|NCT01852058|83282731|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032450|NCT01852058|83282732|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032451|NCT01852058|83282733|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032452|NCT01852058|83282734|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032453|NCT01852058|83282735|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032454|NCT01852058|83282736|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032455|NCT01852058|83282737|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
47032456|NCT01852058|83282738|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032457|NCT01852058|83282739|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032458|NCT01852058|83282740|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032459|NCT01852058|83282741|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
47032460|NCT01852058|83282730|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032461|NCT01852058|83282731|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032462|NCT01852058|83282732|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032463|NCT01852058|83282733|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032464|NCT01852058|83282734|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032465|NCT01852058|83282735|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032466|NCT01852058|83282736|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032467|NCT01852058|83282737|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032468|NCT01852058|83282738|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
47032469|NCT01852058|83282739|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032470|NCT01852058|83282740|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032471|NCT01852058|83282741|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
47032472|NCT00218296|83282778|FG000|Overall Study|Lost to Follow-up|9|||
47032473|NCT00218296|83282779|FG001|Overall Study|Lost to Follow-up|7|||
47032474|NCT00218296|83282778|FG000|Overall Study|Withdrawal by Subject|36|||
47032475|NCT00218296|83282779|FG001|Overall Study|Withdrawal by Subject|47|||
47032476|NCT00218296|83282778|FG000|Overall Study|Randomized but did not enter treatment|66|||
47032477|NCT00218296|83282779|FG001|Overall Study|Randomized but did not enter treatment|67|||
46628683|NCT02006472|82799607|FG004|Period 2 (Through Week 52)|Other|0|||
47032478|NCT00217672|83282787|FG000|Allocation|Ineligible|2|||
47032479|NCT00217672|83282788|FG001|Allocation|Ineligible|0|||
47032480|NCT00217672|83282787|FG000|Treatment|disease progression|33|||
47032481|NCT00217672|83282788|FG001|Treatment|disease progression|4|||
47032482|NCT00217672|83282787|FG000|Treatment|Adverse Event|18|||
47032483|NCT00217672|83282788|FG001|Treatment|Adverse Event|2|||
47032484|NCT00217672|83282787|FG000|Treatment|reqd treatment not permitted by protocol|6|||
47032485|NCT00217672|83282788|FG001|Treatment|reqd treatment not permitted by protocol|0|||
47032486|NCT00217672|83282787|FG000|Treatment|Physician Decision|6|||
47032487|NCT00217672|83282788|FG001|Treatment|Physician Decision|0|||
47032488|NCT00217672|83282787|FG000|Treatment|insurance issues|1|||
47032489|NCT00217672|83282788|FG001|Treatment|insurance issues|1|||
47032490|NCT00217672|83282787|FG000|Treatment|Death|2|||
47032491|NCT00217672|83282788|FG001|Treatment|Death|0|||
47032492|NCT00217672|83282787|FG000|Treatment|secondary malignancy|1|||
47032493|NCT00217672|83282788|FG001|Treatment|secondary malignancy|0|||
47032494|NCT00217672|83282787|FG000|Follow-up|Withdrawal by Subject|4|||
47032495|NCT00217672|83282788|FG001|Follow-up|Withdrawal by Subject|0|||
47032496|NCT00217672|83282787|FG000|Follow-up|Lost to Follow-up|1|||
47032497|NCT00217672|83282788|FG001|Follow-up|Lost to Follow-up|0|||
47032498|NCT00216736|83282794|FG000|Overall Study|Lost to Follow-up|1|||
47032499|NCT00216736|83282795|FG001|Overall Study|Lost to Follow-up|1|||
47032500|NCT01850030|83282803|FG000|Overall Study|Adverse Event|64|||
47032501|NCT01850030|83282804|FG001|Overall Study|Adverse Event|82|||
47032502|NCT01850030|83282803|FG000|Overall Study|Lack of Efficacy|3|||
47032503|NCT01850030|83282804|FG001|Overall Study|Lack of Efficacy|1|||
47032504|NCT01850030|83282803|FG000|Overall Study|Lost to Follow-up|5|||
47032505|NCT01850030|83282804|FG001|Overall Study|Lost to Follow-up|5|||
47032506|NCT01850030|83282803|FG000|Overall Study|Withdrawal by Subject|3|||
47032507|NCT01850030|83282804|FG001|Overall Study|Withdrawal by Subject|4|||
47032508|NCT01850030|83282803|FG000|Overall Study|Protocol Violation|24|||
47032509|NCT01850030|83282804|FG001|Overall Study|Protocol Violation|28|||
47032510|NCT01850030|83282803|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
47032511|NCT01850030|83282804|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
47032512|NCT00215644|83282812|FG000|Overall Study|Disease Progression|28|||
47032513|NCT00215644|83282813|FG001|Overall Study|Disease Progression|10|||
47032514|NCT00215644|83282812|FG000|Overall Study|Adverse Event|2|||
47032515|NCT00215644|83282813|FG001|Overall Study|Adverse Event|9|||
47032516|NCT00215644|83282812|FG000|Overall Study|Death|1|||
47032517|NCT00215644|83282813|FG001|Overall Study|Death|2|||
47032518|NCT00215644|83282812|FG000|Overall Study|Withdrawal by Subject|1|||
47032519|NCT00215644|83282813|FG001|Overall Study|Withdrawal by Subject|0|||
47032520|NCT00215644|83282812|FG000|Overall Study|Other|3|||
47032521|NCT00215644|83282813|FG001|Overall Study|Other|15|||
47032522|NCT00215644|83282812|FG000|Overall Study|Randomized but Not Treated|1|||
47032523|NCT00215644|83282813|FG001|Overall Study|Randomized but Not Treated|0|||
47032524|NCT01870401|83282821|FG000|Overall Study|Death|48|||
47032525|NCT01870401|83282822|FG001|Overall Study|Death|24|||
47032526|NCT01870401|83282821|FG000|Overall Study|Withdrawal by Subject|39|||
47032527|NCT01870401|83282822|FG001|Overall Study|Withdrawal by Subject|26|||
47032528|NCT01870401|83282821|FG000|Overall Study|Lost to Follow-up|19|||
46628684|NCT02006472|82799603|FG000|Period 2 (Through Week 52)|Not treated|0|||
46710893|NCT00903760|82927207|FG000|Overall Study|Death|0|||
47032529|NCT01870401|83282822|FG001|Overall Study|Lost to Follow-up|14|||
47032530|NCT01870401|83282821|FG000|Overall Study|Other|9|||
47032531|NCT01870401|83282822|FG001|Overall Study|Other|7|||
47032532|NCT01870401|83282821|FG000|Overall Study|On-going in the Study|35|||
47032533|NCT01870401|83282822|FG001|Overall Study|On-going in the Study|25|||
47032534|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
47032535|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
47032536|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
47032537|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
47032538|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
47032539|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
47032540|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
47032541|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
47032542|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
47032543|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
47032544|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
47032545|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
47032546|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
47032547|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
47032548|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
47032549|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
47032550|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
47032551|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
47032552|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
47032553|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
47032554|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Other|3|||
47032555|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Other|0|||
47032556|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Other|2|||
47032557|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Other|2|||
47032558|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Other|7|||
47032559|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032560|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032561|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032562|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
47032563|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032564|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032565|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032566|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032567|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032568|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
47032569|NCT00213148|83282834|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
47032570|NCT00213148|83282835|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
47032571|NCT00213148|83282836|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
47032572|NCT00213148|83282837|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
47032573|NCT00213148|83282838|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
47032574|NCT00213148|83282834|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
47032575|NCT00213148|83282835|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
47032576|NCT00213148|83282836|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
47032577|NCT00213148|83282837|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
47032578|NCT00213148|83282838|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
47032579|NCT00213148|83282834|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
47032580|NCT00213148|83282835|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
47032581|NCT00213148|83282836|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
47032582|NCT00213148|83282837|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
47032583|NCT00213148|83282838|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
47032584|NCT00213148|83282834|FG000|Cycle 2 (1 Month)|Other|2|||
47032585|NCT00213148|83282835|FG001|Cycle 2 (1 Month)|Other|1|||
47032586|NCT00213148|83282836|FG002|Cycle 2 (1 Month)|Other|2|||
47032587|NCT00213148|83282837|FG003|Cycle 2 (1 Month)|Other|8|||
47032588|NCT00213148|83282838|FG004|Cycle 2 (1 Month)|Other|7|||
47032589|NCT00213148|83282834|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032590|NCT00213148|83282835|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
47032591|NCT00213148|83282836|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032592|NCT00213148|83282837|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032593|NCT00213148|83282838|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
47032594|NCT00213148|83282834|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
47032595|NCT00213148|83282835|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032596|NCT00213148|83282836|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032597|NCT00213148|83282837|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032598|NCT00213148|83282838|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
47032599|NCT00213148|83282834|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
47032600|NCT00213148|83282835|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
47032601|NCT00213148|83282836|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
47032602|NCT00213148|83282837|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
47032603|NCT00213148|83282838|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
47032604|NCT00213148|83282834|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
47032605|NCT00213148|83282835|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
47032606|NCT00213148|83282836|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
47032607|NCT00213148|83282837|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
47032608|NCT00213148|83282838|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
47032609|NCT00213148|83282834|FG000|Cycle 3 (1 Month)|Other|0|||
47032610|NCT00213148|83282835|FG001|Cycle 3 (1 Month)|Other|0|||
47032611|NCT00213148|83282836|FG002|Cycle 3 (1 Month)|Other|1|||
47032612|NCT00213148|83282837|FG003|Cycle 3 (1 Month)|Other|1|||
47032613|NCT00213148|83282838|FG004|Cycle 3 (1 Month)|Other|0|||
47032614|NCT01704261|83282860|FG000|Overall Study|Withdrawal by Subject|12|||
47032615|NCT01704261|83282861|FG001|Overall Study|Withdrawal by Subject|15|||
47032616|NCT01704261|83282860|FG000|Overall Study|Lost to Follow-up|1|||
47032617|NCT01704261|83282861|FG001|Overall Study|Lost to Follow-up|0|||
47032618|NCT01715571|83282867|FG000|Overall Study|Lost to Follow-up|8|||
47032619|NCT00212758|83282871|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
47032620|NCT00212758|83282872|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
47032621|NCT00212758|83282871|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
47032622|NCT00212758|83282872|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
47032623|NCT01824290|83282880|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
47032624|NCT01824290|83282881|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
47032625|NCT01824290|83282882|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
47032626|NCT01824290|83282883|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
47032627|NCT01824290|83282880|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
47032628|NCT01824290|83282881|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
47032629|NCT01824290|83282882|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
47032630|NCT01824290|83282883|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
47032631|NCT01824290|83282880|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
47032632|NCT01824290|83282881|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
47032633|NCT01824290|83282882|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
47032634|NCT01824290|83282883|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
47032635|NCT01824290|83282880|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
47032636|NCT01824290|83282881|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
47032637|NCT01824290|83282882|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
47032638|NCT01824290|83282883|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
47032639|NCT01824290|83282880|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
47032640|NCT01824290|83282881|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
47032641|NCT01824290|83282882|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
47032642|NCT01824290|83282883|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
47032643|NCT01824290|83282880|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
47032644|NCT01824290|83282881|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
47032645|NCT01824290|83282882|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
47032646|NCT01824290|83282883|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
47032647|NCT01715415|83282897|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
46628685|NCT02006472|82799604|FG001|Period 2 (Through Week 52)|Not treated|0|||
46628686|NCT02006472|82799605|FG002|Period 2 (Through Week 52)|Not treated|2|||
46628687|NCT02006472|82799606|FG003|Period 2 (Through Week 52)|Not treated|0|||
46628688|NCT02006472|82799607|FG004|Period 2 (Through Week 52)|Not treated|0|||
46628689|NCT02006472|82799603|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
46628690|NCT02006472|82799604|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
46628691|NCT02006472|82799605|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
46628692|NCT02006472|82799606|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
46628693|NCT02006472|82799607|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
46628694|NCT02006472|82799603|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
46628695|NCT02006472|82799604|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
46628696|NCT02006472|82799605|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
46628697|NCT02006472|82799606|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
46628698|NCT02006472|82799607|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
46628699|NCT02005692|82799624|FG000|Overall Study|Protocol Violation|1|||
46628700|NCT02005692|82799624|FG000|Overall Study|Withdrawal by Subject|1|||
46628701|NCT02005692|82799624|FG000|Overall Study|Discharged earlier than anticipated|5|||
46628702|NCT02029638|82799632|FG000|Overall Study|Death|0|||
46628703|NCT02029638|82799633|FG001|Overall Study|Death|0|||
46628704|NCT02029638|82799634|FG002|Overall Study|Death|1|||
46628705|NCT02029638|82799632|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
46628706|NCT02029638|82799633|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
46628707|NCT02029638|82799634|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
46628708|NCT02047734|82799645|FG000|Overall Study|Adverse Event|18|||
46628709|NCT02047734|82799646|FG001|Overall Study|Adverse Event|13|||
46628710|NCT02047734|82799647|FG002|Overall Study|Adverse Event|13|||
46710894|NCT00903760|82927208|FG001|Overall Study|Death|1|||
47032648|NCT01715415|83282898|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
46628711|NCT02047734|82799645|FG000|Overall Study|Lack of Efficacy|4|||
46628712|NCT02047734|82799646|FG001|Overall Study|Lack of Efficacy|5|||
46628713|NCT02047734|82799647|FG002|Overall Study|Lack of Efficacy|1|||
46628714|NCT02047734|82799645|FG000|Overall Study|Protocol Violation|3|||
46628715|NCT02047734|82799646|FG001|Overall Study|Protocol Violation|1|||
46628716|NCT02047734|82799647|FG002|Overall Study|Protocol Violation|1|||
46628717|NCT02047734|82799645|FG000|Overall Study|Lost to Follow-up|1|||
46628718|NCT02047734|82799646|FG001|Overall Study|Lost to Follow-up|4|||
46628719|NCT02047734|82799647|FG002|Overall Study|Lost to Follow-up|0|||
46628720|NCT02047734|82799645|FG000|Overall Study|Death|0|||
46628721|NCT02047734|82799646|FG001|Overall Study|Death|1|||
46628722|NCT02047734|82799647|FG002|Overall Study|Death|0|||
46628723|NCT02047734|82799645|FG000|Overall Study|Withdrawal by Subject|30|||
46628724|NCT02047734|82799646|FG001|Overall Study|Withdrawal by Subject|31|||
46628725|NCT02047734|82799647|FG002|Overall Study|Withdrawal by Subject|19|||
46628726|NCT02047734|82799645|FG000|Overall Study|Physician Decision|7|||
46628727|NCT02047734|82799646|FG001|Overall Study|Physician Decision|6|||
46628728|NCT02047734|82799647|FG002|Overall Study|Physician Decision|5|||
46628729|NCT02047734|82799645|FG000|Overall Study|Miscellaneous|2|||
46628730|NCT02047734|82799646|FG001|Overall Study|Miscellaneous|4|||
46628731|NCT02047734|82799647|FG002|Overall Study|Miscellaneous|6|||
46628732|NCT02047734|82799645|FG000|Overall Study|Did Not Receive Study Drug|2|||
46628733|NCT02047734|82799646|FG001|Overall Study|Did Not Receive Study Drug|4|||
46628734|NCT02047734|82799647|FG002|Overall Study|Did Not Receive Study Drug|1|||
46628735|NCT02053350|82799655|FG000|Overall Study|Withdrawal by Subject|1|||
46628736|NCT02053350|82799655|FG000|Overall Study|Adverse Event|4|||
46628737|NCT01994850|82799659|FG000|Overall Study|Physician Decision|1|||
46628738|NCT01994850|82799659|FG000|Overall Study|Withdrawal by Subject|1|||
46628739|NCT02027844|82799666|FG000|Overall Study|Withdrawal by Subject|3|||
46628740|NCT02027844|82799667|FG001|Overall Study|Withdrawal by Subject|2|||
46628741|NCT02027844|82799668|FG002|Overall Study|Withdrawal by Subject|1|||
46628742|NCT02027844|82799666|FG000|Overall Study|Lost to Follow-up|0|||
46628743|NCT02027844|82799667|FG001|Overall Study|Lost to Follow-up|2|||
46628744|NCT02027844|82799668|FG002|Overall Study|Lost to Follow-up|1|||
46628745|NCT02027844|82799666|FG000|Overall Study|Protocol Violation|0|||
46628746|NCT02027844|82799667|FG001|Overall Study|Protocol Violation|2|||
46628747|NCT02027844|82799668|FG002|Overall Study|Protocol Violation|0|||
46628748|NCT02027844|82799666|FG000|Overall Study|Incomlete data|2|||
46628749|NCT02027844|82799667|FG001|Overall Study|Incomlete data|0|||
46628750|NCT02027844|82799668|FG002|Overall Study|Incomlete data|0|||
46628751|NCT01994382|82799693|FG000|Overall Study|Informed consent withdrawn|0|||
46628752|NCT01994382|82799694|FG001|Overall Study|Informed consent withdrawn|0|||
46628753|NCT01994382|82799695|FG002|Overall Study|Informed consent withdrawn|0|||
46628754|NCT01994382|82799696|FG003|Overall Study|Informed consent withdrawn|0|||
46628755|NCT01994382|82799697|FG004|Overall Study|Informed consent withdrawn|0|||
47032649|NCT01715415|83282897|FG000|Double-blind Treatment|Adverse Event|3|||
47032650|NCT01715415|83282898|FG001|Double-blind Treatment|Adverse Event|0|||
47032651|NCT01715415|83282897|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
47032652|NCT01715415|83282898|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
47032653|NCT01715415|83282897|FG000|Double-blind Treatment|Other|1|||
47032654|NCT01715415|83282898|FG001|Double-blind Treatment|Other|0|||
47032655|NCT01715415|83282897|FG000|Open-label Treatment|Adverse Event|0|||
47032656|NCT01715415|83282898|FG001|Open-label Treatment|Adverse Event|1|||
47032657|NCT01715415|83282897|FG000|Open-label Treatment|Subject Noncompliant|0|||
47032658|NCT01715415|83282898|FG001|Open-label Treatment|Subject Noncompliant|1|||
47032659|NCT00211510|83282907|FG000|Overall Study|Physician Decision|3|||
47032660|NCT00211510|83282908|FG001|Overall Study|Physician Decision|1|||
47032661|NCT00211510|83282907|FG000|Overall Study|Withdrawal by Subject|3|||
47032662|NCT00211510|83282908|FG001|Overall Study|Withdrawal by Subject|1|||
47032663|NCT01869777|83282917|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
47032664|NCT01714947|83282921|FG000|Part B|Progressive Disease|3|||
47032665|NCT01869699|83282927|FG000|Overall Study|Withdrawal by Subject|1|||
46628756|NCT01994382|82799698|FG005|Overall Study|Informed consent withdrawn|0|||
46628757|NCT01994382|82799699|FG006|Overall Study|Informed consent withdrawn|1|||
46628758|NCT01994382|82799700|FG007|Overall Study|Informed consent withdrawn|0|||
46628759|NCT01994382|82799701|FG008|Overall Study|Informed consent withdrawn|0|||
46628760|NCT01994382|82799702|FG009|Overall Study|Informed consent withdrawn|0|||
46628761|NCT01994382|82799703|FG010|Overall Study|Informed consent withdrawn|0|||
46628762|NCT01994382|82799704|FG011|Overall Study|Informed consent withdrawn|0|||
46628763|NCT01994382|82799705|FG012|Overall Study|Informed consent withdrawn|0|||
47032666|NCT01869699|83282928|FG001|Overall Study|Withdrawal by Subject|0|||
47032667|NCT01714635|83282937|FG000|Overall Study|Discontinued|1|||
46628764|NCT01994382|82799706|FG013|Overall Study|Informed consent withdrawn|0|||
46628765|NCT01994382|82799707|FG014|Overall Study|Informed consent withdrawn|0|||
47032668|NCT01714635|83282938|FG001|Overall Study|Discontinued|0|||
47032669|NCT01714635|83282939|FG002|Overall Study|Discontinued|2|||
47032670|NCT01714635|83282937|FG000|Overall Study|Missed 6-month exam|1|||
47032671|NCT01714635|83282938|FG001|Overall Study|Missed 6-month exam|0|||
47032672|NCT01714635|83282939|FG002|Overall Study|Missed 6-month exam|0|||
47032673|NCT01713933|83282947|FG000|Overall Study|Lost to Follow-up|2|||
47032674|NCT01713933|83282947|FG000|Overall Study|Withdrawal by Subject|3|||
47032675|NCT01713933|83282947|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
47032676|NCT01868997|83282953|FG000|Overall Study|Adverse Event|2|||
47032677|NCT01868997|83282954|FG001|Overall Study|Adverse Event|5|||
47032678|NCT01868997|83282953|FG000|Overall Study|Lack of Efficacy|2|||
47032679|NCT01868997|83282954|FG001|Overall Study|Lack of Efficacy|0|||
47032680|NCT01868997|83282953|FG000|Overall Study|Other|3|||
47032681|NCT01868997|83282954|FG001|Overall Study|Other|1|||
47032682|NCT01875848|83282962|FG000|Overall Study|Withdrawal by Subject|2|||
47032683|NCT01875848|83282963|FG001|Overall Study|Withdrawal by Subject|0|||
47032684|NCT04191382|83282972|FG000|Overall Study|Withdrawal by Subject|1|||
47032685|NCT04191382|83282973|FG001|Overall Study|Withdrawal by Subject|0|||
47032686|NCT04191382|83282974|FG002|Overall Study|Withdrawal by Subject|0|||
47032687|NCT01703091|83282984|FG000|Overall Study|Adverse Event|5|||
47032688|NCT01703091|83282985|FG001|Overall Study|Adverse Event|3|||
47032689|NCT01703091|83282984|FG000|Overall Study|Physician Decision|2|||
47032690|NCT01703091|83282985|FG001|Overall Study|Physician Decision|1|||
47032691|NCT01703091|83282984|FG000|Overall Study|Withdrawal by Subject|1|||
47032692|NCT01703091|83282985|FG001|Overall Study|Withdrawal by Subject|0|||
47032693|NCT01703091|83282984|FG000|Overall Study|Sponsor Decision|1|||
47032694|NCT01703091|83282985|FG001|Overall Study|Sponsor Decision|0|||
47032695|NCT01712685|83282991|FG000|Overall Study|pt declined to participate before trmt|1|||
47032696|NCT01867671|83282997|FG000|Overall Study|Adverse Event|5|||
47032697|NCT01867671|83282998|FG001|Overall Study|Adverse Event|3|||
47032698|NCT01867671|83282997|FG000|Overall Study|Anaphylaxis|0|||
47032699|NCT01867671|83282998|FG001|Overall Study|Anaphylaxis|1|||
47032700|NCT01867671|83282997|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
47032701|NCT01867671|83282998|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
47032702|NCT01867671|83282997|FG000|Overall Study|Lost to Follow-up|0|||
47032703|NCT01867671|83282998|FG001|Overall Study|Lost to Follow-up|1|||
47032704|NCT01867671|83282997|FG000|Overall Study|Non-compliance with Study Drug|1|||
47032705|NCT01867671|83282998|FG001|Overall Study|Non-compliance with Study Drug|2|||
47032706|NCT01867671|83282997|FG000|Overall Study|Withdrawal by Subject|21|||
47032707|NCT01867671|83282998|FG001|Overall Study|Withdrawal by Subject|21|||
47032708|NCT01702311|83283006|FG000|Overall Study|Withdrawal by Subject|3|||
47032709|NCT01702311|83283007|FG001|Overall Study|Withdrawal by Subject|2|||
47032710|NCT01702311|83283006|FG000|Overall Study|Discharge less than 24 hours|10|||
47032711|NCT01702311|83283007|FG001|Overall Study|Discharge less than 24 hours|7|||
47032712|NCT01702311|83283006|FG000|Overall Study|Physician Decision|3|||
47032713|NCT01702311|83283007|FG001|Overall Study|Physician Decision|4|||
47032714|NCT01712061|83283023|FG000|Overall Study|Adverse Event|4|||
47032715|NCT01712061|83283024|FG001|Overall Study|Adverse Event|9|||
47032716|NCT01712061|83283025|FG002|Overall Study|Adverse Event|5|||
47032717|NCT01712061|83283023|FG000|Overall Study|Death|0|||
47032718|NCT01712061|83283024|FG001|Overall Study|Death|0|||
47032719|NCT01712061|83283025|FG002|Overall Study|Death|1|||
47032720|NCT01712061|83283023|FG000|Overall Study|Lost to Follow-up|1|||
47032721|NCT01712061|83283024|FG001|Overall Study|Lost to Follow-up|0|||
47032722|NCT01712061|83283025|FG002|Overall Study|Lost to Follow-up|1|||
47032723|NCT01712061|83283023|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
47032724|NCT01712061|83283024|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
47032725|NCT01712061|83283025|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
47032726|NCT01712061|83283023|FG000|Overall Study|Medication Error Without Associated AE|0|||
47032727|NCT01712061|83283024|FG001|Overall Study|Medication Error Without Associated AE|1|||
47032728|NCT01712061|83283025|FG002|Overall Study|Medication Error Without Associated AE|0|||
47032729|NCT01712061|83283023|FG000|Overall Study|Withdrawal by Subject|1|||
47032730|NCT01712061|83283024|FG001|Overall Study|Withdrawal by Subject|7|||
47032731|NCT01712061|83283025|FG002|Overall Study|Withdrawal by Subject|1|||
47032732|NCT01712061|83283023|FG000|Overall Study|Other|0|||
47032733|NCT01712061|83283024|FG001|Overall Study|Other|3|||
47032734|NCT01712061|83283025|FG002|Overall Study|Other|0|||
47032735|NCT03592186|83283036|FG000|Overall Study|Withdrawal by Subject|1|||
47032736|NCT03592186|83283037|FG001|Overall Study|Withdrawal by Subject|0|||
47032737|NCT03592186|83283036|FG000|Overall Study|Lost to Follow-up|16|||
47032738|NCT03592186|83283037|FG001|Overall Study|Lost to Follow-up|11|||
47032739|NCT03598114|83283045|FG000|Overall Study|Staff turnover/left the program|3|||
47032740|NCT03598114|83283046|FG001|Overall Study|Staff turnover/left the program|39|||
47032741|NCT01711983|83283073|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
47032742|NCT01711983|83283073|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
47032743|NCT01711983|83283073|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
47032744|NCT01711983|83283073|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
47032745|NCT01874288|83283087|FG000|Overall Study|Withdrawal by Subject|1|||
47032746|NCT01874288|83283088|FG001|Overall Study|Withdrawal by Subject|0|||
46710895|NCT00903760|82927207|FG000|Overall Study|Lost to Follow-up|1|||
46710896|NCT00903760|82927208|FG001|Overall Study|Lost to Follow-up|0|||
47032747|NCT01874288|83283089|FG002|Overall Study|Withdrawal by Subject|2|||
47032748|NCT01874288|83283090|FG003|Overall Study|Withdrawal by Subject|1|||
47032749|NCT01874288|83283091|FG004|Overall Study|Withdrawal by Subject|1|||
47032750|NCT01874288|83283087|FG000|Overall Study|Physician Decision|0|||
47032751|NCT01874288|83283088|FG001|Overall Study|Physician Decision|0|||
47032752|NCT01874288|83283089|FG002|Overall Study|Physician Decision|0|||
47032753|NCT01874288|83283090|FG003|Overall Study|Physician Decision|1|||
47032754|NCT01874288|83283091|FG004|Overall Study|Physician Decision|0|||
47032755|NCT01874288|83283087|FG000|Overall Study|Progressive disease|2|||
47032756|NCT01874288|83283088|FG001|Overall Study|Progressive disease|0|||
47032757|NCT01874288|83283089|FG002|Overall Study|Progressive disease|3|||
47032758|NCT01874288|83283090|FG003|Overall Study|Progressive disease|5|||
47032759|NCT01874288|83283091|FG004|Overall Study|Progressive disease|1|||
47032760|NCT01874054|83283120|FG000|Overall Study|Withdrawal by Subject|3|||
47032761|NCT01874054|83283120|FG000|Overall Study|Study Termination by Sponsor|42|||
47032762|NCT01874054|83283120|FG000|Overall Study|Lost to Follow-up|5|||
47032763|NCT01874054|83283120|FG000|Overall Study|Death|5|||
47032764|NCT01873742|83283126|FG000|Overall Study|Lost to Follow-up|68|||
47032765|NCT01873742|83283127|FG001|Overall Study|Lost to Follow-up|76|||
47032766|NCT01873586|83283133|FG000|Overall Study|Lost to Follow-up|3|||
47032767|NCT04027348|83283167|FG000|Overall Study|Adverse Event|2|||
47032768|NCT04196686|83283180|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
47032769|NCT04196686|83283181|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
47032770|NCT02708680|83283190|FG000|Overall Study|Withdrawal by Subject|4|||
47032771|NCT02708680|83283191|FG001|Overall Study|Withdrawal by Subject|12|||
47032772|NCT02708680|83283192|FG002|Overall Study|Withdrawal by Subject|12|||
47032773|NCT02708680|83283190|FG000|Overall Study|Death|4|||
47032774|NCT02708680|83283191|FG001|Overall Study|Death|19|||
47032775|NCT02708680|83283192|FG002|Overall Study|Death|21|||
47032776|NCT02708680|83283190|FG000|Overall Study|Lost to Follow-up|0|||
47032777|NCT02708680|83283191|FG001|Overall Study|Lost to Follow-up|3|||
47032778|NCT02708680|83283192|FG002|Overall Study|Lost to Follow-up|3|||
47032779|NCT02708680|83283190|FG000|Overall Study|Study Terminated By Sponsor|0|||
47032780|NCT02708680|83283191|FG001|Overall Study|Study Terminated By Sponsor|5|||
47032781|NCT02708680|83283192|FG002|Overall Study|Study Terminated By Sponsor|4|||
47032782|NCT02708680|83283190|FG000|Overall Study|Other than Specified|0|||
47032783|NCT02708680|83283191|FG001|Overall Study|Other than Specified|0|||
47032784|NCT02708680|83283192|FG002|Overall Study|Other than Specified|1|||
47032785|NCT02708680|83283190|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
47032786|NCT02708680|83283191|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
47032787|NCT02708680|83283192|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
47032788|NCT01611974|83283206|FG000|Overall Study|Death|10|||
47032789|NCT01611974|83283207|FG001|Overall Study|Death|12|||
47032790|NCT01611974|83283208|FG002|Overall Study|Death|10|||
47032791|NCT01611974|83283206|FG000|Overall Study|Lost to Follow-up|0|||
47032792|NCT01611974|83283207|FG001|Overall Study|Lost to Follow-up|1|||
46710897|NCT00903760|82927207|FG000|Overall Study|Withdrawal by Subject|1|||
46710898|NCT00903760|82927208|FG001|Overall Study|Withdrawal by Subject|2|||
46710899|NCT00903760|82927207|FG000|Overall Study|Off treatment for long period|0|||
46710900|NCT00903760|82927208|FG001|Overall Study|Off treatment for long period|1|||
46710901|NCT00883051|82927219|FG000|Overall Study|Lost to Follow-up|0|||
46710902|NCT00883051|82927220|FG001|Overall Study|Lost to Follow-up|0|||
46710903|NCT00883051|82927221|FG002|Overall Study|Lost to Follow-up|0|||
46710904|NCT00883051|82927222|FG003|Overall Study|Lost to Follow-up|0|||
46710905|NCT00883051|82927223|FG004|Overall Study|Lost to Follow-up|1|||
46710906|NCT00883051|82927219|FG000|Overall Study|Did not use study medication|24|||
46710907|NCT00883051|82927220|FG001|Overall Study|Did not use study medication|22|||
46710908|NCT00883051|82927221|FG002|Overall Study|Did not use study medication|29|||
47032793|NCT01611974|83283208|FG002|Overall Study|Lost to Follow-up|0|||
47032794|NCT01611974|83283206|FG000|Overall Study|Physician Decision|5|||
47032795|NCT01611974|83283207|FG001|Overall Study|Physician Decision|1|||
47032796|NCT01611974|83283208|FG002|Overall Study|Physician Decision|2|||
47032797|NCT01611974|83283206|FG000|Overall Study|Withdrawal by Subject|0|||
47032798|NCT01611974|83283207|FG001|Overall Study|Withdrawal by Subject|1|||
47032799|NCT01611974|83283208|FG002|Overall Study|Withdrawal by Subject|4|||
46710909|NCT00883051|82927222|FG003|Overall Study|Did not use study medication|29|||
46710910|NCT00883051|82927223|FG004|Overall Study|Did not use study medication|17|||
46710911|NCT00903682|82927237|FG000|Overall Study|Adverse Event|6|||
47032800|NCT01848938|83283218|FG000|Overall Study|Lost to Follow-up|1|||
47032801|NCT01848938|83283219|FG001|Overall Study|Lost to Follow-up|1|||
47032802|NCT01871870|83283225|FG000|Overall Study|Hardware issues|7|||
47032803|NCT01871870|83283225|FG000|Overall Study|hyperglycemia|2|||
47032804|NCT01871558|83283238|FG000|Overall Study|Other reason|0|||
47032805|NCT01871558|83283239|FG001|Overall Study|Other reason|1|||
47032806|NCT01871558|83283238|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
47032807|NCT01871558|83283239|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
47032808|NCT01871558|83283238|FG000|Overall Study|Withdrawal by Subject|2|||
47032809|NCT01871558|83283239|FG001|Overall Study|Withdrawal by Subject|0|||
47032810|NCT01711359|83283248|FG000|Treatment Period|Withdrawal by Subject|18|||
47032811|NCT01711359|83283249|FG001|Treatment Period|Withdrawal by Subject|7|||
47032812|NCT01711359|83283250|FG002|Treatment Period|Withdrawal by Subject|13|||
47032813|NCT01711359|83283248|FG000|Treatment Period|Lack of Efficacy|13|||
47032814|NCT01711359|83283249|FG001|Treatment Period|Lack of Efficacy|2|||
47032815|NCT01711359|83283250|FG002|Treatment Period|Lack of Efficacy|2|||
47032816|NCT01711359|83283248|FG000|Treatment Period|Adverse Event|8|||
47032817|NCT01711359|83283249|FG001|Treatment Period|Adverse Event|10|||
47032818|NCT01711359|83283250|FG002|Treatment Period|Adverse Event|24|||
47032819|NCT01711359|83283248|FG000|Treatment Period|Physician Decision|4|||
47032820|NCT01711359|83283249|FG001|Treatment Period|Physician Decision|3|||
47032821|NCT01711359|83283250|FG002|Treatment Period|Physician Decision|2|||
47032822|NCT01711359|83283248|FG000|Treatment Period|Death|3|||
47032823|NCT01711359|83283249|FG001|Treatment Period|Death|0|||
47032824|NCT01711359|83283250|FG002|Treatment Period|Death|0|||
47032825|NCT01711359|83283248|FG000|Treatment Period|Entry Criteria Not Met|1|||
47032826|NCT01711359|83283249|FG001|Treatment Period|Entry Criteria Not Met|0|||
47032827|NCT01711359|83283250|FG002|Treatment Period|Entry Criteria Not Met|0|||
47032828|NCT01711359|83283248|FG000|Treatment Period|Sponsor Decision|1|||
47032829|NCT01711359|83283249|FG001|Treatment Period|Sponsor Decision|0|||
47032830|NCT01711359|83283250|FG002|Treatment Period|Sponsor Decision|0|||
47032831|NCT01711359|83283248|FG000|Treatment Period|Lost to Follow-up|1|||
47032832|NCT01711359|83283249|FG001|Treatment Period|Lost to Follow-up|1|||
47032833|NCT01711359|83283250|FG002|Treatment Period|Lost to Follow-up|1|||
47032834|NCT01711359|83283248|FG000|Treatment Period|Randomized, Not Treated|3|||
47032835|NCT01711359|83283249|FG001|Treatment Period|Randomized, Not Treated|1|||
47032836|NCT01711359|83283250|FG002|Treatment Period|Randomized, Not Treated|0|||
47032837|NCT01710657|83283277|FG000|Overall Study|Lost to Follow-up|2|||
47032838|NCT01710657|83283278|FG001|Overall Study|Lost to Follow-up|0|||
47032839|NCT01710657|83283279|FG002|Overall Study|Lost to Follow-up|1|||
47032840|NCT01710657|83283277|FG000|Overall Study|Protocol Violation|2|||
47032841|NCT01710657|83283278|FG001|Overall Study|Protocol Violation|2|||
47032842|NCT01710657|83283279|FG002|Overall Study|Protocol Violation|0|||
47032843|NCT01710657|83283277|FG000|Overall Study|Adverse Event|14|||
47032844|NCT01710657|83283278|FG001|Overall Study|Adverse Event|8|||
47032845|NCT01710657|83283279|FG002|Overall Study|Adverse Event|28|||
47032846|NCT01710657|83283277|FG000|Overall Study|Withdrawal by Subject|0|||
47032847|NCT01710657|83283278|FG001|Overall Study|Withdrawal by Subject|1|||
47032848|NCT01710657|83283279|FG002|Overall Study|Withdrawal by Subject|2|||
47032849|NCT01710657|83283277|FG000|Overall Study|Lack of Efficacy|0|||
47032850|NCT01710657|83283278|FG001|Overall Study|Lack of Efficacy|1|||
47032851|NCT01710657|83283279|FG002|Overall Study|Lack of Efficacy|1|||
47032852|NCT01701063|83283290|FG000|Overall Study|Lost to Follow-up|0|||
47032853|NCT01701063|83283291|FG001|Overall Study|Lost to Follow-up|1|||
47032854|NCT01701063|83283292|FG002|Overall Study|Lost to Follow-up|0|||
47032855|NCT01701063|83283290|FG000|Overall Study|Withdrawal by Subject|0|||
47032856|NCT01701063|83283291|FG001|Overall Study|Withdrawal by Subject|0|||
47032857|NCT01701063|83283292|FG002|Overall Study|Withdrawal by Subject|1|||
47032858|NCT01701063|83283290|FG000|Overall Study|Other|0|||
47032859|NCT01701063|83283291|FG001|Overall Study|Other|0|||
47032860|NCT01701063|83283292|FG002|Overall Study|Other|1|||
47032861|NCT01700985|83283303|FG000|Overall Study|Incarcerated|0|||
47032862|NCT01700985|83283304|FG001|Overall Study|Incarcerated|1|||
47032863|NCT01710501|83283313|FG000|Overall Study|Lost to Follow-up|2|||
47032864|NCT01710501|83283314|FG001|Overall Study|Lost to Follow-up|0|||
47032865|NCT01710501|83283315|FG002|Overall Study|Lost to Follow-up|0|||
46628766|NCT01994382|82799708|FG015|Overall Study|Informed consent withdrawn|0|||
46628767|NCT01994382|82799709|FG016|Overall Study|Informed consent withdrawn|0|||
47032866|NCT01700829|83283325|FG000|Overall Study|Withdrawal by Subject|1|||
47032867|NCT01700829|83283326|FG001|Overall Study|Withdrawal by Subject|1|||
47032868|NCT01710345|83283335|FG000|Overall Study|Adverse Event|0|||
47032869|NCT01710345|83283336|FG001|Overall Study|Adverse Event|2|||
46628768|NCT01994382|82799693|FG000|Overall Study|Progressive disease|3|||
47032870|NCT01710345|83283337|FG002|Overall Study|Adverse Event|0|||
47032871|NCT01710345|83283335|FG000|Overall Study|Lack of Efficacy|2|||
47032872|NCT01710345|83283336|FG001|Overall Study|Lack of Efficacy|3|||
46628769|NCT01994382|82799694|FG001|Overall Study|Progressive disease|4|||
46628770|NCT01994382|82799695|FG002|Overall Study|Progressive disease|4|||
47032873|NCT01710345|83283337|FG002|Overall Study|Lack of Efficacy|1|||
47032874|NCT01710345|83283335|FG000|Overall Study|Drug Dosing Error|1|||
47032875|NCT01710345|83283336|FG001|Overall Study|Drug Dosing Error|0|||
47032876|NCT01710345|83283337|FG002|Overall Study|Drug Dosing Error|0|||
47032877|NCT01710033|83283353|FG000|Stage 2|Adverse Event|0|||
47032878|NCT01710033|83283354|FG001|Stage 2|Adverse Event|0|||
47032879|NCT01710033|83283355|FG002|Stage 2|Adverse Event|0|||
47032880|NCT01710033|83283356|FG003|Stage 2|Adverse Event|0|||
47032881|NCT01710033|83283357|FG004|Stage 2|Adverse Event|1|||
47032882|NCT01822496|83283374|FG000|Overall Study|Protocol Violation|2|||
47032883|NCT01822496|83283375|FG001|Overall Study|Protocol Violation|2|||
47032884|NCT01822496|83283376|FG002|Overall Study|Protocol Violation|0|||
46912941|NCT02993250|83143028|FG000|Overall Study|Lost to Follow-up|0|||
46912942|NCT02993250|83143029|FG001|Overall Study|Lost to Follow-up|1|||
46912943|NCT02989194|83143038|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
46912944|NCT02989194|83143039|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
46912945|NCT02989194|83143040|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
47032885|NCT01822496|83283377|FG003|Overall Study|Protocol Violation|1|||
47032886|NCT01822496|83283374|FG000|Overall Study|Withdrawal by Subject|0|||
47032887|NCT01822496|83283375|FG001|Overall Study|Withdrawal by Subject|0|||
47032888|NCT01822496|83283376|FG002|Overall Study|Withdrawal by Subject|0|||
47032889|NCT01822496|83283377|FG003|Overall Study|Withdrawal by Subject|3|||
47032890|NCT01867047|83283389|FG000|Overall Study|Lost to Follow-up|3|||
47032891|NCT01867047|83283390|FG001|Overall Study|Lost to Follow-up|3|||
47032892|NCT01867047|83283389|FG000|Overall Study|Withdrawal by Subject|2|||
47032893|NCT01867047|83283390|FG001|Overall Study|Withdrawal by Subject|0|||
47032894|NCT01867047|83283389|FG000|Overall Study|Physician Decision|2|||
47032895|NCT01867047|83283390|FG001|Overall Study|Physician Decision|0|||
47032896|NCT01867047|83283389|FG000|Overall Study|surgery not indicated in protocol|1|||
47032897|NCT01867047|83283390|FG001|Overall Study|surgery not indicated in protocol|2|||
47032898|NCT01821560|83283402|FG000|Overall Study|Lost to Follow-up|5|||
47032899|NCT01821560|83283403|FG001|Overall Study|Lost to Follow-up|5|||
47032900|NCT01821560|83283402|FG000|Overall Study|Withdrawal by Subject|1|||
47032901|NCT01821560|83283403|FG001|Overall Study|Withdrawal by Subject|1|||
47032902|NCT01821560|83283402|FG000|Overall Study|Protocol Violation|0|||
47032903|NCT01821560|83283403|FG001|Overall Study|Protocol Violation|1|||
47032904|NCT01871402|83283411|FG000|Overall Study|Lost to Follow-up|1|||
47032905|NCT01871402|83283412|FG001|Overall Study|Lost to Follow-up|0|||
47032906|NCT01871402|83283411|FG000|Overall Study|Withdrawal by Subject|0|||
47032907|NCT01871402|83283412|FG001|Overall Study|Withdrawal by Subject|2|||
47032908|NCT01871402|83283411|FG000|Overall Study|Non-compliance|0|||
47032909|NCT01871402|83283412|FG001|Overall Study|Non-compliance|1|||
47032910|NCT01846442|83283422|FG000|Overall Study|Adverse Event|2|||
47032911|NCT01846442|83283423|FG001|Overall Study|Adverse Event|4|||
47032912|NCT01846442|83283424|FG002|Overall Study|Adverse Event|2|||
47032913|NCT01846442|83283425|FG003|Overall Study|Adverse Event|1|||
47032914|NCT01846442|83283422|FG000|Overall Study|Lost to Follow-up|0|||
46628771|NCT01994382|82799696|FG003|Overall Study|Progressive disease|3|||
46710912|NCT00903682|82927238|FG001|Overall Study|Adverse Event|13|||
46710913|NCT00903682|82927237|FG000|Overall Study|Lost to Follow-up|1|||
46912946|NCT02989194|83143038|FG000|Overall Study|Lost to Follow-up|0|||
46912947|NCT02989194|83143039|FG001|Overall Study|Lost to Follow-up|1|||
46912948|NCT02989194|83143040|FG002|Overall Study|Lost to Follow-up|0|||
46912949|NCT02989194|83143038|FG000|Overall Study|Withdrawal by Subject|0|||
46912950|NCT02989194|83143039|FG001|Overall Study|Withdrawal by Subject|1|||
46912951|NCT02989194|83143040|FG002|Overall Study|Withdrawal by Subject|0|||
46912952|NCT02990910|83143061|FG000|Overall Study|Lack of Efficacy|6|||
46912953|NCT02990910|83143062|FG001|Overall Study|Lack of Efficacy|10|||
46912954|NCT03227861|83143068|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
46912955|NCT03227861|83143068|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
46912956|NCT03227861|83143068|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
47032915|NCT01846442|83283423|FG001|Overall Study|Lost to Follow-up|0|||
47032916|NCT01846442|83283424|FG002|Overall Study|Lost to Follow-up|1|||
47032917|NCT01846442|83283425|FG003|Overall Study|Lost to Follow-up|0|||
47032918|NCT01846442|83283422|FG000|Overall Study|Withdrawal by Subject|3|||
47032919|NCT01846442|83283423|FG001|Overall Study|Withdrawal by Subject|2|||
47032920|NCT01846442|83283424|FG002|Overall Study|Withdrawal by Subject|0|||
47032921|NCT01846442|83283425|FG003|Overall Study|Withdrawal by Subject|1|||
47032922|NCT01846442|83283422|FG000|Overall Study|Left the city/Lost medication|1|||
47032923|NCT01846442|83283423|FG001|Overall Study|Left the city/Lost medication|0|||
47032924|NCT01846442|83283424|FG002|Overall Study|Left the city/Lost medication|1|||
47032925|NCT01846442|83283425|FG003|Overall Study|Left the city/Lost medication|1|||
47032926|NCT01709721|83283438|FG000|Open Label Phase|Withdrawal by Subject|0|||
47032927|NCT01709721|83283439|FG001|Open Label Phase|Withdrawal by Subject|0|||
47032928|NCT01709721|83283440|FG002|Open Label Phase|Withdrawal by Subject|5|||
47032929|NCT01709721|83283438|FG000|Open Label Phase|Adverse Event|0|||
47032930|NCT01709721|83283439|FG001|Open Label Phase|Adverse Event|0|||
47032931|NCT01709721|83283440|FG002|Open Label Phase|Adverse Event|8|||
47032932|NCT01709721|83283438|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
47032933|NCT01709721|83283439|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
47032934|NCT01709721|83283440|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
47032935|NCT01709721|83283438|FG000|Open Label Phase|Investigator Decision|0|||
47032936|NCT01709721|83283439|FG001|Open Label Phase|Investigator Decision|0|||
47032937|NCT01709721|83283440|FG002|Open Label Phase|Investigator Decision|1|||
47032938|NCT01709721|83283438|FG000|Open Label Phase|Sponsor Decision|0|||
47032939|NCT01709721|83283439|FG001|Open Label Phase|Sponsor Decision|0|||
47032940|NCT01709721|83283440|FG002|Open Label Phase|Sponsor Decision|2|||
47032941|NCT01709721|83283438|FG000|Open Label Phase|Protocol Violation|0|||
47032942|NCT01709721|83283439|FG001|Open Label Phase|Protocol Violation|0|||
47032943|NCT01709721|83283440|FG002|Open Label Phase|Protocol Violation|1|||
47032944|NCT01709721|83283438|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
47032945|NCT01709721|83283439|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
47032946|NCT01709721|83283440|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
47032947|NCT01709721|83283438|FG000|Open Label Phase|Inadequate Pain Control|0|||
47032948|NCT01709721|83283439|FG001|Open Label Phase|Inadequate Pain Control|0|||
47032949|NCT01709721|83283440|FG002|Open Label Phase|Inadequate Pain Control|37|||
47032950|NCT01709721|83283438|FG000|Open Label Phase|Other, Specify in text field in database|0|||
47032951|NCT01709721|83283439|FG001|Open Label Phase|Other, Specify in text field in database|0|||
47032952|NCT01709721|83283440|FG002|Open Label Phase|Other, Specify in text field in database|14|||
47032953|NCT01709721|83283438|FG000|Randomized Phase|Adverse Event|0|||
47032954|NCT01709721|83283439|FG001|Randomized Phase|Adverse Event|1|||
47032955|NCT01709721|83283440|FG002|Randomized Phase|Adverse Event|0|||
47032956|NCT01709721|83283438|FG000|Randomized Phase|Lost to Follow-up|1|||
47032957|NCT01709721|83283439|FG001|Randomized Phase|Lost to Follow-up|0|||
47032958|NCT01709721|83283440|FG002|Randomized Phase|Lost to Follow-up|0|||
47032959|NCT01709721|83283438|FG000|Randomized Phase|Inadequate Pain Control|1|||
47032960|NCT01709721|83283439|FG001|Randomized Phase|Inadequate Pain Control|2|||
47032961|NCT01709721|83283440|FG002|Randomized Phase|Inadequate Pain Control|0|||
47032962|NCT01709721|83283438|FG000|Randomized Phase|Other, Specify text field in database|1|||
47032963|NCT01709721|83283439|FG001|Randomized Phase|Other, Specify text field in database|3|||
47032964|NCT01709721|83283440|FG002|Randomized Phase|Other, Specify text field in database|0|||
47032965|NCT01866657|83283450|FG000|Overall Study|Surgery canceled|2|||
47032966|NCT01866657|83283451|FG001|Overall Study|Surgery canceled|0|||
47032967|NCT01700205|83283459|FG000|Overall Study|Withdrawal by Subject|13|||
47032968|NCT01700205|83283460|FG001|Overall Study|Withdrawal by Subject|13|||
47032969|NCT01700205|83283459|FG000|Overall Study|Protocol Violation|2|||
47032970|NCT01700205|83283460|FG001|Overall Study|Protocol Violation|2|||
47032971|NCT01700049|83283466|FG000|Overall Study|Withdrawal by Subject|1|||
47032972|NCT01699815|83283473|FG000|Overall Study|Protocol Violation|4|||
47032973|NCT01699815|83283474|FG001|Overall Study|Protocol Violation|7|||
47032974|NCT01699815|83283473|FG000|Overall Study|record could not be located|1|||
47032975|NCT01699815|83283474|FG001|Overall Study|record could not be located|0|||
47032976|NCT01699815|83283473|FG000|Overall Study|Adverse Event|0|||
47032977|NCT01699815|83283474|FG001|Overall Study|Adverse Event|1|||
47032978|NCT01866423|83283480|FG000|Overall Study|Lack of Efficacy|3|||
47032979|NCT01866423|83283480|FG000|Overall Study|Sponsor Decision|1|||
47032980|NCT01846208|83283487|FG000|Overall Study|Withdrew prior to treatment|1|||
47032981|NCT01846208|83283488|FG001|Overall Study|Withdrew prior to treatment|1|||
47032982|NCT01846208|83283489|FG002|Overall Study|Withdrew prior to treatment|1|||
47032983|NCT01846208|83283487|FG000|Overall Study|Dosing Symptoms|1|||
47032984|NCT01846208|83283488|FG001|Overall Study|Dosing Symptoms|2|||
47032985|NCT01846208|83283489|FG002|Overall Study|Dosing Symptoms|6|||
46912957|NCT03227861|83143068|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
46912958|NCT03227861|83143068|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
47032986|NCT01846208|83283487|FG000|Overall Study|Withdrawal by Subject|5|||
47032987|NCT01846208|83283488|FG001|Overall Study|Withdrawal by Subject|0|||
47032988|NCT01846208|83283489|FG002|Overall Study|Withdrawal by Subject|0|||
47032989|NCT01846208|83283487|FG000|Overall Study|Non-compliance|1|||
47032990|NCT01846208|83283488|FG001|Overall Study|Non-compliance|1|||
47032991|NCT01846208|83283489|FG002|Overall Study|Non-compliance|0|||
47032992|NCT01846208|83283487|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
47032993|NCT01846208|83283488|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
47032994|NCT01846208|83283489|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
47032995|NCT01846208|83283487|FG000|Overall Study|Refused SU OFC|0|||
47032996|NCT01846208|83283488|FG001|Overall Study|Refused SU OFC|0|||
47032997|NCT01846208|83283489|FG002|Overall Study|Refused SU OFC|1|||
47032998|NCT01845974|83283499|FG000|Overall Study|screen failure|1|||
47032999|NCT01845974|83283500|FG001|Overall Study|screen failure|0|||
47033000|NCT01865487|83283512|FG000|Overall Study|Lost to Follow-up|0|||
47033001|NCT01865487|83283513|FG001|Overall Study|Lost to Follow-up|0|||
47033002|NCT01865487|83283514|FG002|Overall Study|Lost to Follow-up|0|||
47033003|NCT01865487|83283515|FG003|Overall Study|Lost to Follow-up|1|||
47033004|NCT01865487|83283516|FG004|Overall Study|Lost to Follow-up|0|||
47033005|NCT01865487|83283517|FG005|Overall Study|Lost to Follow-up|0|||
47033006|NCT01865487|83283518|FG006|Overall Study|Lost to Follow-up|1|||
47033007|NCT01865487|83283519|FG007|Overall Study|Lost to Follow-up|0|||
47033008|NCT01865487|83283520|FG008|Overall Study|Lost to Follow-up|0|||
47033009|NCT01865487|83283521|FG009|Overall Study|Lost to Follow-up|0|||
47033010|NCT01865487|83283512|FG000|Overall Study|Withdrawal by Subject|0|||
47033011|NCT01865487|83283513|FG001|Overall Study|Withdrawal by Subject|0|||
47033012|NCT01865487|83283514|FG002|Overall Study|Withdrawal by Subject|0|||
47033013|NCT01865487|83283515|FG003|Overall Study|Withdrawal by Subject|0|||
47033014|NCT01865487|83283516|FG004|Overall Study|Withdrawal by Subject|1|||
47033015|NCT01865487|83283517|FG005|Overall Study|Withdrawal by Subject|0|||
47033016|NCT01865487|83283518|FG006|Overall Study|Withdrawal by Subject|0|||
47033017|NCT01865487|83283519|FG007|Overall Study|Withdrawal by Subject|0|||
47033018|NCT01865487|83283520|FG008|Overall Study|Withdrawal by Subject|0|||
47033019|NCT01865487|83283521|FG009|Overall Study|Withdrawal by Subject|0|||
47033020|NCT01699503|83283551|FG000|Overall Study|Death|31|||
47033021|NCT01699503|83283552|FG001|Overall Study|Death|40|||
47033022|NCT01699503|83283551|FG000|Overall Study|Withdrawal by Subject|65|||
47033023|NCT01699503|83283552|FG001|Overall Study|Withdrawal by Subject|57|||
47033024|NCT01699503|83283551|FG000|Overall Study|Lost to Follow-up|121|||
46710914|NCT00903682|82927238|FG001|Overall Study|Lost to Follow-up|0|||
46710915|NCT00903682|82927237|FG000|Overall Study|Withdrawal by Subject|5|||
46710916|NCT00903682|82927238|FG001|Overall Study|Withdrawal by Subject|0|||
46710917|NCT00903682|82927237|FG000|Overall Study|Pregnancy|0|||
46710918|NCT00903682|82927238|FG001|Overall Study|Pregnancy|1|||
46710919|NCT00903682|82927237|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
46710920|NCT00903682|82927238|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
46710921|NCT00903682|82927237|FG000|Overall Study|Subject Non-Compliant|1|||
46912959|NCT03227861|83143068|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
46912960|NCT03227861|83143068|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
46912961|NCT03227861|83143068|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
46912962|NCT03227861|83143068|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
47033025|NCT01699503|83283552|FG001|Overall Study|Lost to Follow-up|117|||
47033026|NCT01699503|83283551|FG000|Overall Study|Excluded due to quality|783|||
47033027|NCT01699503|83283552|FG001|Overall Study|Excluded due to quality|791|||
47033028|NCT01709409|83283560|FG000|Overall Study|Protocol Violation|1|||
47033029|NCT01709409|83283561|FG001|Overall Study|Protocol Violation|0|||
47033030|NCT01698879|83283570|FG000|Overall Study|Withdrawal by Subject|1|||
47033031|NCT01698879|83283571|FG001|Overall Study|Withdrawal by Subject|0|||
47033032|NCT01698879|83283572|FG002|Overall Study|Withdrawal by Subject|0|||
47033033|NCT01698801|83283611|FG000|Treatment Phase|Adverse Event|4|||
47033034|NCT01698801|83283611|FG000|Treatment Phase|Protocol Violation|1|||
47033035|NCT01698801|83283611|FG000|Treatment Phase|Other|4|||
47033036|NCT01698801|83283611|FG000|Treatment Phase|Withdrawal by Subject|1|||
47033037|NCT01698801|83283611|FG000|Treatment Phase|Disease progression|1|||
47033038|NCT01698801|83283611|FG000|Follow Up Phase|Withdrawal by Subject|1|||
47033039|NCT01698801|83283611|FG000|Follow Up Phase|Death|4|||
47033040|NCT01682811|83283623|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
47033041|NCT01682811|83283624|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
47033042|NCT01682811|83283625|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
47033043|NCT01682811|83283626|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
47033044|NCT01682811|83283627|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
47033045|NCT01682811|83283628|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
47033046|NCT01682811|83283629|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
46912963|NCT03227861|83143068|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
46912964|NCT01336712|83143074|FG000|Overall Study|Death|2|||
47033047|NCT01682811|83283623|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
47033048|NCT01682811|83283624|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
47033049|NCT01682811|83283625|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
47033050|NCT01682811|83283626|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
47033051|NCT01682811|83283627|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
47033052|NCT01682811|83283628|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
46710922|NCT00903682|82927238|FG001|Overall Study|Subject Non-Compliant|0|||
47033053|NCT01682811|83283629|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
47033054|NCT01682811|83283623|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
46710923|NCT00903682|82927237|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
47033055|NCT01682811|83283624|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
47033056|NCT01682811|83283625|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
47033057|NCT01682811|83283626|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
47033058|NCT01682811|83283627|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
47033059|NCT01682811|83283628|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
47033060|NCT01682811|83283629|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
47033061|NCT01682811|83283623|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
47033062|NCT01682811|83283624|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
47033063|NCT01682811|83283625|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
47033064|NCT01682811|83283626|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
47033065|NCT01682811|83283627|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
47033066|NCT01682811|83283628|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
47033067|NCT01682811|83283629|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
47033068|NCT01682031|83283650|FG000|Overall Study|Withdrawal by Subject|0|||
47033069|NCT01682031|83283651|FG001|Overall Study|Withdrawal by Subject|1|||
47033070|NCT01682031|83283650|FG000|Overall Study|Adverse Event|0|||
46628772|NCT01994382|82799697|FG004|Overall Study|Progressive disease|2|||
46628773|NCT01994382|82799698|FG005|Overall Study|Progressive disease|3|||
46710924|NCT00903682|82927238|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
47033071|NCT01682031|83283651|FG001|Overall Study|Adverse Event|2|||
47033072|NCT01682031|83283650|FG000|Overall Study|MRI results indicate increased nodul|0|||
47033073|NCT01682031|83283651|FG001|Overall Study|MRI results indicate increased nodul|1|||
47033074|NCT01682031|83283650|FG000|Overall Study|Patient could not swallow tablets|1|||
47033075|NCT01682031|83283651|FG001|Overall Study|Patient could not swallow tablets|0|||
47033076|NCT01682031|83283650|FG000|Overall Study|Patient stopped selenium on his own|0|||
47033077|NCT01682031|83283651|FG001|Overall Study|Patient stopped selenium on his own|1|||
47033078|NCT01567527|83283672|FG000|Conversion Phase.|Protocol deviation|3|||
47033079|NCT01567527|83283673|FG001|Conversion Phase.|Protocol deviation|0|||
47033080|NCT01567527|83283674|FG002|Conversion Phase.|Protocol deviation|0|||
47033081|NCT01567527|83283675|FG003|Conversion Phase.|Protocol deviation|0|||
47033082|NCT01567527|83283676|FG004|Conversion Phase.|Protocol deviation|0|||
47033083|NCT01567527|83283672|FG000|Conversion Phase.|Met withdrawal criteria|10|||
47033084|NCT01567527|83283673|FG001|Conversion Phase.|Met withdrawal criteria|0|||
47033085|NCT01567527|83283674|FG002|Conversion Phase.|Met withdrawal criteria|0|||
47033086|NCT01567527|83283675|FG003|Conversion Phase.|Met withdrawal criteria|0|||
47033087|NCT01567527|83283676|FG004|Conversion Phase.|Met withdrawal criteria|0|||
47033088|NCT01567527|83283672|FG000|Conversion Phase.|Withdrawal by Subject|32|||
47033089|NCT01567527|83283673|FG001|Conversion Phase.|Withdrawal by Subject|0|||
47033090|NCT01567527|83283674|FG002|Conversion Phase.|Withdrawal by Subject|0|||
47033091|NCT01567527|83283675|FG003|Conversion Phase.|Withdrawal by Subject|0|||
47033092|NCT01567527|83283676|FG004|Conversion Phase.|Withdrawal by Subject|0|||
47033093|NCT01567527|83283672|FG000|Conversion Phase.|Lost to Follow-up|16|||
47033094|NCT01567527|83283673|FG001|Conversion Phase.|Lost to Follow-up|0|||
47033095|NCT01567527|83283674|FG002|Conversion Phase.|Lost to Follow-up|0|||
47033096|NCT01567527|83283675|FG003|Conversion Phase.|Lost to Follow-up|0|||
47033097|NCT01567527|83283676|FG004|Conversion Phase.|Lost to Follow-up|0|||
47033098|NCT01567527|83283672|FG000|Conversion Phase.|Lack of Efficacy|2|||
47033099|NCT01567527|83283673|FG001|Conversion Phase.|Lack of Efficacy|0|||
47033100|NCT01567527|83283674|FG002|Conversion Phase.|Lack of Efficacy|0|||
47033101|NCT01567527|83283675|FG003|Conversion Phase.|Lack of Efficacy|0|||
47033102|NCT01567527|83283676|FG004|Conversion Phase.|Lack of Efficacy|0|||
46628774|NCT01994382|82799699|FG006|Overall Study|Progressive disease|3|||
46628775|NCT01994382|82799700|FG007|Overall Study|Progressive disease|6|||
46628776|NCT01994382|82799701|FG008|Overall Study|Progressive disease|2|||
46628777|NCT01994382|82799702|FG009|Overall Study|Progressive disease|2|||
46628778|NCT01994382|82799703|FG010|Overall Study|Progressive disease|13|||
46628779|NCT01994382|82799704|FG011|Overall Study|Progressive disease|8|||
46628780|NCT01994382|82799705|FG012|Overall Study|Progressive disease|7|||
46628781|NCT01994382|82799706|FG013|Overall Study|Progressive disease|3|||
46628782|NCT01994382|82799707|FG014|Overall Study|Progressive disease|6|||
46628783|NCT01994382|82799708|FG015|Overall Study|Progressive disease|44|||
46710925|NCT00903682|82927237|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
47033103|NCT01567527|83283672|FG000|Conversion Phase.|Adverse Event|33|||
47033104|NCT01567527|83283673|FG001|Conversion Phase.|Adverse Event|0|||
47033105|NCT01567527|83283674|FG002|Conversion Phase.|Adverse Event|0|||
47033106|NCT01567527|83283675|FG003|Conversion Phase.|Adverse Event|0|||
47033107|NCT01567527|83283676|FG004|Conversion Phase.|Adverse Event|0|||
47033108|NCT01567527|83283672|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
47033109|NCT01567527|83283673|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
47033110|NCT01567527|83283674|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
47033111|NCT01567527|83283675|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
46628784|NCT01994382|82799709|FG016|Overall Study|Progressive disease|28|||
46628785|NCT01994382|82799693|FG000|Overall Study|Physician Decision|0|||
46628786|NCT01994382|82799694|FG001|Overall Study|Physician Decision|1|||
47033112|NCT01567527|83283676|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
46628787|NCT01994382|82799695|FG002|Overall Study|Physician Decision|0|||
47033113|NCT01567527|83283672|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
47033114|NCT01567527|83283673|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
47033115|NCT01567527|83283674|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
47033116|NCT01567527|83283675|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
47033117|NCT01567527|83283676|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
47033118|NCT01567527|83283672|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
47033119|NCT01567527|83283673|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
47033120|NCT01567527|83283674|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
47033121|NCT01567527|83283675|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
47033122|NCT01567527|83283676|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
47033123|NCT01567527|83283672|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
47033124|NCT01567527|83283673|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
47033125|NCT01567527|83283674|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
47033126|NCT01567527|83283675|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
47033127|NCT01567527|83283676|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
47033128|NCT01567527|83283672|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
47033129|NCT01567527|83283673|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
47033130|NCT01567527|83283674|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
47033131|NCT01567527|83283675|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
47033132|NCT01567527|83283676|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
47033133|NCT01567527|83283672|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
47033134|NCT01567527|83283673|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
47033135|NCT01567527|83283674|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
47033136|NCT01567527|83283675|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
47033137|NCT01567527|83283676|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
47033138|NCT01567527|83283672|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
47033139|NCT01567527|83283673|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
47033140|NCT01567527|83283674|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
47033141|NCT01567527|83283675|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
47033142|NCT01567527|83283676|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
47033143|NCT01567527|83283672|FG000|IM Depot Stabilization.|Protocol deviation|0|||
47033144|NCT01567527|83283673|FG001|IM Depot Stabilization.|Protocol deviation|0|||
47033145|NCT01567527|83283674|FG002|IM Depot Stabilization.|Protocol deviation|5|||
47033146|NCT01567527|83283675|FG003|IM Depot Stabilization.|Protocol deviation|0|||
47033147|NCT01567527|83283676|FG004|IM Depot Stabilization.|Protocol deviation|0|||
47033148|NCT01567527|83283672|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
47033149|NCT01567527|83283673|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
47033150|NCT01567527|83283674|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
47033151|NCT01567527|83283675|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
47033152|NCT01567527|83283676|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
47033153|NCT01567527|83283672|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
46710926|NCT00903682|82927238|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
46710927|NCT01117428|82927250|FG000|Overall Study|Lack of Efficacy|1|||
46710928|NCT01117428|82927251|FG001|Overall Study|Lack of Efficacy|0|||
46710929|NCT01117428|82927252|FG002|Overall Study|Lack of Efficacy|0|||
46710930|NCT01117428|82927253|FG003|Overall Study|Lack of Efficacy|0|||
46710931|NCT01117428|82927254|FG004|Overall Study|Lack of Efficacy|0|||
47033154|NCT01567527|83283673|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
47033155|NCT01567527|83283674|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
47033156|NCT01567527|83283675|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
46628788|NCT01994382|82799696|FG003|Overall Study|Physician Decision|0|||
46628789|NCT01994382|82799697|FG004|Overall Study|Physician Decision|0|||
46628790|NCT01994382|82799698|FG005|Overall Study|Physician Decision|0|||
46628791|NCT01994382|82799699|FG006|Overall Study|Physician Decision|0|||
46628792|NCT01994382|82799700|FG007|Overall Study|Physician Decision|0|||
46628793|NCT01994382|82799701|FG008|Overall Study|Physician Decision|0|||
46628794|NCT01994382|82799702|FG009|Overall Study|Physician Decision|0|||
46628795|NCT01994382|82799703|FG010|Overall Study|Physician Decision|3|||
46628796|NCT01994382|82799704|FG011|Overall Study|Physician Decision|1|||
46628797|NCT01994382|82799705|FG012|Overall Study|Physician Decision|1|||
47033157|NCT01567527|83283676|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
46628798|NCT01994382|82799706|FG013|Overall Study|Physician Decision|0|||
46628799|NCT01994382|82799707|FG014|Overall Study|Physician Decision|1|||
46628800|NCT01994382|82799708|FG015|Overall Study|Physician Decision|4|||
46628801|NCT01994382|82799709|FG016|Overall Study|Physician Decision|2|||
46710932|NCT01117428|82927255|FG005|Overall Study|Lack of Efficacy|0|||
46628802|NCT01994382|82799693|FG000|Overall Study|Death|0|||
46710933|NCT01117428|82927250|FG000|Overall Study|Adverse Event|4|||
47033158|NCT01567527|83283672|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
47033159|NCT01567527|83283673|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
47033160|NCT01567527|83283674|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
47033161|NCT01567527|83283675|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
47033162|NCT01567527|83283676|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
47033163|NCT01567527|83283672|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
47033164|NCT01567527|83283673|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
47033165|NCT01567527|83283674|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
47033166|NCT01567527|83283675|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
47033167|NCT01567527|83283676|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
47033168|NCT01567527|83283672|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
47033169|NCT01567527|83283673|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
47033170|NCT01567527|83283674|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
47033171|NCT01567527|83283675|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
47033172|NCT01567527|83283676|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
47033173|NCT01567527|83283672|FG000|IM Depot Stabilization.|Adverse Event|0|||
47033174|NCT01567527|83283673|FG001|IM Depot Stabilization.|Adverse Event|0|||
47033175|NCT01567527|83283674|FG002|IM Depot Stabilization.|Adverse Event|37|||
47033176|NCT01567527|83283675|FG003|IM Depot Stabilization.|Adverse Event|0|||
47033177|NCT01567527|83283676|FG004|IM Depot Stabilization.|Adverse Event|0|||
47033178|NCT01567527|83283672|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
47033179|NCT01567527|83283673|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
47033180|NCT01567527|83283674|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
47033181|NCT01567527|83283675|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
47033182|NCT01567527|83283676|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
47033183|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
46628803|NCT01994382|82799694|FG001|Overall Study|Death|0|||
46628804|NCT01994382|82799695|FG002|Overall Study|Death|0|||
46628805|NCT01994382|82799696|FG003|Overall Study|Death|0|||
46628806|NCT01994382|82799697|FG004|Overall Study|Death|1|||
46628807|NCT01994382|82799698|FG005|Overall Study|Death|0|||
46628808|NCT01994382|82799699|FG006|Overall Study|Death|0|||
46628809|NCT01994382|82799700|FG007|Overall Study|Death|0|||
46628810|NCT01994382|82799701|FG008|Overall Study|Death|1|||
46628811|NCT01994382|82799702|FG009|Overall Study|Death|1|||
46628812|NCT01994382|82799703|FG010|Overall Study|Death|0|||
46628813|NCT01994382|82799704|FG011|Overall Study|Death|0|||
46628814|NCT01994382|82799705|FG012|Overall Study|Death|0|||
46628815|NCT01994382|82799706|FG013|Overall Study|Death|0|||
46628816|NCT01994382|82799707|FG014|Overall Study|Death|0|||
46710934|NCT01117428|82927251|FG001|Overall Study|Adverse Event|0|||
47033184|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
47033185|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
47033186|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
47033187|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
47033188|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
47033189|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
47033190|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
47033191|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
46628817|NCT01994382|82799708|FG015|Overall Study|Death|1|||
46628818|NCT01994382|82799709|FG016|Overall Study|Death|0|||
46628819|NCT01994382|82799693|FG000|Overall Study|Adverse Event|0|||
46628820|NCT01994382|82799694|FG001|Overall Study|Adverse Event|1|||
46710935|NCT01117428|82927252|FG002|Overall Study|Adverse Event|0|||
46710936|NCT01117428|82927253|FG003|Overall Study|Adverse Event|0|||
46628821|NCT01994382|82799695|FG002|Overall Study|Adverse Event|2|||
46628822|NCT01994382|82799696|FG003|Overall Study|Adverse Event|0|||
47033192|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
47033193|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
47033194|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
47033195|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
47033196|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
47033197|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
47033198|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
47033199|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
47033200|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
47033201|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
47033202|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
47033203|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
47033204|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
47033205|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
47033206|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
47033207|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
47033208|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
47033209|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
47033210|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
47033211|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
47033212|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
47033213|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
47033214|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
47033215|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
47033216|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
47033217|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
47033218|NCT01567527|83283672|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
47033219|NCT01567527|83283673|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
47033220|NCT01567527|83283674|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
47033221|NCT01567527|83283675|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
47033222|NCT01567527|83283676|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
47033223|NCT01818752|83283687|FG000|Overall Study|Adverse Event|64|||
47033224|NCT01818752|83283688|FG001|Overall Study|Adverse Event|74|||
47033225|NCT01818752|83283687|FG000|Overall Study|Death|14|||
47033226|NCT01818752|83283688|FG001|Overall Study|Death|18|||
47033227|NCT01818752|83283687|FG000|Overall Study|Non-compliance|16|||
47033228|NCT01818752|83283688|FG001|Overall Study|Non-compliance|20|||
47033229|NCT01818752|83283687|FG000|Overall Study|Withdrawal by Subject|15|||
47033230|NCT01818752|83283688|FG001|Overall Study|Withdrawal by Subject|14|||
47033231|NCT01818752|83283687|FG000|Overall Study|Physician Decision|9|||
47033232|NCT01818752|83283688|FG001|Overall Study|Physician Decision|8|||
47033233|NCT01818752|83283687|FG000|Overall Study|Disease Progression|54|||
47033234|NCT01818752|83283688|FG001|Overall Study|Disease Progression|48|||
47033235|NCT01818752|83283687|FG000|Overall Study|Other|7|||
47033236|NCT01818752|83283688|FG001|Overall Study|Other|8|||
47033237|NCT01818752|83283687|FG000|Overall Study|Continuing Treatment|1|||
47033238|NCT01818752|83283688|FG001|Overall Study|Continuing Treatment|4|||
47033239|NCT01818752|83283687|FG000|Overall Study|Randomized but not Dosed|7|||
47033240|NCT01818752|83283688|FG001|Overall Study|Randomized but not Dosed|4|||
47033241|NCT01845818|83283696|FG000|Overall Study|Withdrawal by Subject|0|||
47033242|NCT01845818|83283697|FG001|Overall Study|Withdrawal by Subject|1|||
47033243|NCT01845818|83283696|FG000|Overall Study|Lost to Follow-up|7|||
47033244|NCT01845818|83283697|FG001|Overall Study|Lost to Follow-up|5|||
47033245|NCT01845818|83283696|FG000|Overall Study|Administrative Reasons|3|||
47033246|NCT01845818|83283697|FG001|Overall Study|Administrative Reasons|1|||
47033247|NCT01845818|83283696|FG000|Overall Study|Serious Adverse Event|1|||
47033248|NCT01845818|83283697|FG001|Overall Study|Serious Adverse Event|1|||
47033249|NCT01845818|83283696|FG000|Overall Study|Other|25|||
47033250|NCT01845818|83283697|FG001|Overall Study|Other|8|||
47033251|NCT01845818|83283696|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
47033252|NCT01845818|83283697|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
47033253|NCT01845818|83283696|FG000|Overall Study|No Follow-Up Data Available|4|||
47033254|NCT01845818|83283697|FG001|Overall Study|No Follow-Up Data Available|1|||
47033255|NCT01362608|83283707|FG000|Overall Study|Protocol Violation|0|||
47033256|NCT01362608|83283708|FG001|Overall Study|Protocol Violation|1|||
46710937|NCT01117428|82927254|FG004|Overall Study|Adverse Event|1|||
47033257|NCT01362608|83283707|FG000|Overall Study|Lost to Follow-up|3|||
47033258|NCT01362608|83283708|FG001|Overall Study|Lost to Follow-up|1|||
47033259|NCT01362608|83283707|FG000|Overall Study|Withdrawal by Subject|1|||
47033260|NCT01362608|83283708|FG001|Overall Study|Withdrawal by Subject|2|||
47033261|NCT01362608|83283707|FG000|Overall Study|Lack of Efficacy|0|||
47033262|NCT01362608|83283708|FG001|Overall Study|Lack of Efficacy|2|||
47033263|NCT01362608|83283707|FG000|Overall Study|Adverse Event|0|||
47033264|NCT01362608|83283708|FG001|Overall Study|Adverse Event|2|||
47033265|NCT01871090|83283716|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
47033266|NCT01871090|83283717|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
47033267|NCT01871090|83283716|FG000|Overall Study|Interrogation not completed correctly|1|||
47033268|NCT01871090|83283717|FG001|Overall Study|Interrogation not completed correctly|0|||
47033269|NCT01871090|83283716|FG000|Overall Study|Subject Non-Compliance|0|||
47033270|NCT01871090|83283717|FG001|Overall Study|Subject Non-Compliance|1|||
47033271|NCT01818596|83283725|FG000|Overall Study|Enrolled but Not Treated|4|||
47033272|NCT01818596|83283726|FG001|Overall Study|Enrolled but Not Treated|0|||
47033273|NCT01818596|83283725|FG000|Overall Study|Adverse Event|7|||
47033274|NCT01818596|83283726|FG001|Overall Study|Adverse Event|0|||
47033275|NCT01818596|83283725|FG000|Overall Study|Death|3|||
47033276|NCT01818596|83283726|FG001|Overall Study|Death|0|||
47033277|NCT01818596|83283725|FG000|Overall Study|Investigator's Discretion|4|||
47033278|NCT01818596|83283726|FG001|Overall Study|Investigator's Discretion|0|||
47033279|NCT01818596|83283725|FG000|Overall Study|Protocol Violation|1|||
47033280|NCT01818596|83283726|FG001|Overall Study|Protocol Violation|0|||
47033281|NCT01818596|83283725|FG000|Overall Study|Withdrew Consent|5|||
47033282|NCT01818596|83283726|FG001|Overall Study|Withdrew Consent|0|||
47033283|NCT01818596|83283725|FG000|Overall Study|Lost to Follow-up|7|||
47033284|NCT01818596|83283726|FG001|Overall Study|Lost to Follow-up|0|||
47033285|NCT04577794|83283739|FG000|Overall Study|Adverse Event|1|||
47033286|NCT04577794|83283740|FG001|Overall Study|Adverse Event|1|||
47033287|NCT01594281|83283757|FG000|Interventional Core Phase|Protocol Deviation|1|||
47033288|NCT01594281|83283758|FG001|Interventional Core Phase|Protocol Deviation|0|||
47033289|NCT01594281|83283759|FG002|Interventional Core Phase|Protocol Deviation|0|||
47033290|NCT01594281|83283757|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
47033291|NCT01594281|83283758|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
47033292|NCT01594281|83283759|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
47033293|NCT01594281|83283757|FG000|Interventional Core Phase|Death|1|||
47033294|NCT01594281|83283758|FG001|Interventional Core Phase|Death|1|||
47033295|NCT01594281|83283759|FG002|Interventional Core Phase|Death|2|||
47033296|NCT01594281|83283757|FG000|Interventional Core Phase|Lost to Follow-up|1|||
47033297|NCT01594281|83283758|FG001|Interventional Core Phase|Lost to Follow-up|4|||
47033298|NCT01594281|83283759|FG002|Interventional Core Phase|Lost to Follow-up|1|||
47033299|NCT01594281|83283757|FG000|Interventional Core Phase|Adverse Event|4|||
47033300|NCT01594281|83283758|FG001|Interventional Core Phase|Adverse Event|4|||
47033301|NCT01594281|83283759|FG002|Interventional Core Phase|Adverse Event|4|||
47033302|NCT01594281|83283757|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
47033303|NCT01594281|83283758|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
46628823|NCT01994382|82799697|FG004|Overall Study|Adverse Event|0|||
46912965|NCT01336712|83143074|FG000|Overall Study|Lack of Efficacy|1|||
46912966|NCT03208127|83143078|FG000|Overall Study|Death|1|||
46912967|NCT02865122|83143085|FG000|Overall Study|Adverse Event|1|||
46912968|NCT02865122|83143086|FG001|Overall Study|Adverse Event|0|||
46912969|NCT02865122|83143087|FG002|Overall Study|Adverse Event|0|||
46912970|NCT02864498|83143098|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
46912971|NCT02864498|83143099|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
46912972|NCT02864498|83143100|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
46912973|NCT02864498|83143098|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
46912974|NCT02864498|83143099|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
46912975|NCT02864498|83143100|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
46912976|NCT02864498|83143098|FG000|Overall Study|Investigator Discretion|0|||
46912977|NCT02864498|83143099|FG001|Overall Study|Investigator Discretion|2|||
46912978|NCT02864498|83143100|FG002|Overall Study|Investigator Discretion|1|||
46912979|NCT02864498|83143098|FG000|Overall Study|Lost to Follow-up|8|||
46912980|NCT02864498|83143099|FG001|Overall Study|Lost to Follow-up|6|||
46912981|NCT02864498|83143100|FG002|Overall Study|Lost to Follow-up|3|||
46912982|NCT02864498|83143098|FG000|Overall Study|Lack of Efficacy|5|||
46912983|NCT02864498|83143099|FG001|Overall Study|Lack of Efficacy|3|||
46912984|NCT02864498|83143100|FG002|Overall Study|Lack of Efficacy|3|||
46912985|NCT02864498|83143098|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
46912986|NCT02864498|83143099|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
47033304|NCT01594281|83283759|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
47033305|NCT01594281|83283757|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
47033306|NCT01594281|83283758|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
47033307|NCT01594281|83283759|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
47033308|NCT01594281|83283757|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
47033309|NCT01594281|83283758|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
47033310|NCT01594281|83283759|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
47033311|NCT01566981|83283772|FG000|Overall Study|Lost to Follow-up|5|||
47033312|NCT01566981|83283773|FG001|Overall Study|Lost to Follow-up|8|||
47033313|NCT01870778|83283783|FG000|Overall Study|Withdrawal by Subject|8|||
47033314|NCT01870778|83283784|FG001|Overall Study|Withdrawal by Subject|7|||
47033315|NCT01870778|83283783|FG000|Overall Study|Lost to Follow-up|0|||
47033316|NCT01870778|83283784|FG001|Overall Study|Lost to Follow-up|2|||
47033317|NCT01818284|83283797|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
47033318|NCT01818284|83283798|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
47033319|NCT01818284|83283797|FG000|Overall Study|Death|0|||
47033320|NCT01818284|83283798|FG001|Overall Study|Death|2|||
47033321|NCT01610492|83283834|FG000|Overall Study|Adverse Event|1|||
47033322|NCT01610492|83283834|FG000|Overall Study|Lack of Efficacy|3|||
47033323|NCT01610492|83283834|FG000|Overall Study|Other: Reached stopping criteria|1|||
47033324|NCT01610492|83283834|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
47033325|NCT01817582|83283841|FG000|Overall Study|Withdrawal by Subject|0|||
47033326|NCT01817582|83283842|FG001|Overall Study|Withdrawal by Subject|1|||
47033327|NCT01817582|83283843|FG002|Overall Study|Withdrawal by Subject|0|||
47033328|NCT01817582|83283841|FG000|Overall Study|Participant revealed masked treatment|1|||
47033329|NCT01817582|83283842|FG001|Overall Study|Participant revealed masked treatment|0|||
47033330|NCT01817582|83283843|FG002|Overall Study|Participant revealed masked treatment|0|||
47033331|NCT01817582|83283841|FG000|Overall Study|Randomized but exclusion criteria met|1|||
47033332|NCT01817582|83283842|FG001|Overall Study|Randomized but exclusion criteria met|0|||
47033333|NCT01817582|83283843|FG002|Overall Study|Randomized but exclusion criteria met|0|||
47033334|NCT01594125|83283856|FG000|Overall Study|Withdrawal by Subject|1|||
47033335|NCT01594125|83283857|FG001|Overall Study|Withdrawal by Subject|0|||
47033336|NCT01594125|83283858|FG002|Overall Study|Withdrawal by Subject|0|||
47033337|NCT01594125|83283859|FG003|Overall Study|Withdrawal by Subject|1|||
47033338|NCT01594125|83283860|FG004|Overall Study|Withdrawal by Subject|0|||
47033339|NCT01594125|83283856|FG000|Overall Study|Progressive Disease|3|||
47033340|NCT01594125|83283857|FG001|Overall Study|Progressive Disease|12|||
47033341|NCT01594125|83283858|FG002|Overall Study|Progressive Disease|3|||
47033342|NCT01594125|83283859|FG003|Overall Study|Progressive Disease|3|||
47033343|NCT01594125|83283860|FG004|Overall Study|Progressive Disease|7|||
47033344|NCT01870076|83283876|FG000|Overall Study|Withdrawal by Subject|1|||
47033345|NCT01870076|83283877|FG001|Overall Study|Withdrawal by Subject|0|||
47033346|NCT01870076|83283878|FG002|Overall Study|Withdrawal by Subject|1|||
47033347|NCT01870076|83283879|FG003|Overall Study|Withdrawal by Subject|0|||
47033348|NCT01592721|83283889|FG000|Long-term Follow-up|Death|1|||
47033349|NCT01613378|83283893|FG000|Overall Study|Lack of Efficacy|13|||
47033350|NCT01613378|83283893|FG000|Overall Study|Adverse Event|11|||
47033351|NCT01613378|83283893|FG000|Overall Study|Withdrawal by Subject|8|||
47033352|NCT01613378|83283893|FG000|Overall Study|Death|2|||
47033353|NCT01613378|83283893|FG000|Overall Study|Lost to Follow-up|1|||
47033354|NCT01613378|83283893|FG000|Overall Study|Other Reason|4|||
47033355|NCT01592409|83283899|FG000|Overall Study|Withdrawal by Subject|0|||
47033356|NCT01592409|83283900|FG001|Overall Study|Withdrawal by Subject|1|||
47033357|NCT01697319|83283919|FG000|Primary Phase|Withdrawal by Subject|1|||
47033358|NCT01697319|83283919|FG000|Extension Phase|Terminated by Sponsor|15|||
47033359|NCT01566435|83283934|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
47033360|NCT01696929|83283942|FG000|Overall Study|Physician Decision|1|||
47033361|NCT01696773|83283952|FG000|Days 15-27, Washout|Adverse Event|1|||
47033362|NCT01696773|83283953|FG001|Days 15-27, Washout|Adverse Event|0|||
47033363|NCT01696695|83283968|FG000|Overall Study|Disease progression|373|||
47033364|NCT01696695|83283968|FG000|Overall Study|Death|29|||
47033365|NCT01696695|83283968|FG000|Overall Study|Adverse Event|74|||
47033366|NCT01696695|83283968|FG000|Overall Study|Withdrawal by Subject|92|||
47033367|NCT01696695|83283968|FG000|Overall Study|Lost to Follow-up|48|||
46628824|NCT01994382|82799698|FG005|Overall Study|Adverse Event|0|||
46628825|NCT01994382|82799699|FG006|Overall Study|Adverse Event|0|||
46628826|NCT01994382|82799700|FG007|Overall Study|Adverse Event|0|||
46628827|NCT01994382|82799701|FG008|Overall Study|Adverse Event|0|||
46628828|NCT01994382|82799702|FG009|Overall Study|Adverse Event|0|||
46628829|NCT01994382|82799703|FG010|Overall Study|Adverse Event|15|||
46710938|NCT01117428|82927255|FG005|Overall Study|Adverse Event|2|||
47033368|NCT01696695|83283968|FG000|Overall Study|Other|74|||
47033369|NCT01696695|83283968|FG000|Overall Study|Major Protocol Violation|192|||
47033370|NCT01565889|83284000|FG000|Part A|Withdrawal by Subject|1|||
47033371|NCT01565889|83284001|FG001|Part A|Withdrawal by Subject|0|||
47033372|NCT01565889|83284002|FG002|Part A|Withdrawal by Subject|0|||
47033373|NCT01565889|83284003|FG003|Part A|Withdrawal by Subject|0|||
47033374|NCT01565889|83284004|FG004|Part A|Withdrawal by Subject|0|||
47033375|NCT01565889|83284005|FG005|Part A|Withdrawal by Subject|0|||
47033376|NCT01565889|83284000|FG000|Part B|Withdrawal by Subject|0|||
47033377|NCT01565889|83284001|FG001|Part B|Withdrawal by Subject|0|||
46628830|NCT01994382|82799704|FG011|Overall Study|Adverse Event|2|||
47033378|NCT01565889|83284002|FG002|Part B|Withdrawal by Subject|0|||
47033379|NCT01565889|83284003|FG003|Part B|Withdrawal by Subject|0|||
47033380|NCT01565889|83284004|FG004|Part B|Withdrawal by Subject|0|||
47033381|NCT01565889|83284005|FG005|Part B|Withdrawal by Subject|1|||
47033382|NCT01565889|83284000|FG000|Part B|Lack of Efficacy|0|||
47033383|NCT01565889|83284001|FG001|Part B|Lack of Efficacy|0|||
47033384|NCT01565889|83284002|FG002|Part B|Lack of Efficacy|0|||
47033385|NCT01565889|83284003|FG003|Part B|Lack of Efficacy|0|||
47033386|NCT01565889|83284004|FG004|Part B|Lack of Efficacy|0|||
47033387|NCT01565889|83284005|FG005|Part B|Lack of Efficacy|2|||
47033388|NCT01565889|83284000|FG000|Part B|Lost to Follow-up|0|||
47033389|NCT01565889|83284001|FG001|Part B|Lost to Follow-up|0|||
47033390|NCT01565889|83284002|FG002|Part B|Lost to Follow-up|0|||
47033391|NCT01565889|83284003|FG003|Part B|Lost to Follow-up|0|||
47033392|NCT01565889|83284004|FG004|Part B|Lost to Follow-up|0|||
47033393|NCT01565889|83284005|FG005|Part B|Lost to Follow-up|1|||
47033394|NCT01696071|83284020|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
47033395|NCT01696071|83284021|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
47033396|NCT01591863|83284032|FG000|Overall Study|Adverse Event|3|||
46628831|NCT01994382|82799705|FG012|Overall Study|Adverse Event|7|||
46628832|NCT01994382|82799706|FG013|Overall Study|Adverse Event|3|||
46628833|NCT01994382|82799707|FG014|Overall Study|Adverse Event|17|||
46628834|NCT01994382|82799708|FG015|Overall Study|Adverse Event|6|||
46628835|NCT01994382|82799709|FG016|Overall Study|Adverse Event|3|||
46628836|NCT01994382|82799693|FG000|Overall Study|Other than specified|0|||
46628837|NCT01994382|82799694|FG001|Overall Study|Other than specified|0|||
46628838|NCT01994382|82799695|FG002|Overall Study|Other than specified|0|||
46628839|NCT01994382|82799696|FG003|Overall Study|Other than specified|0|||
46628840|NCT01994382|82799697|FG004|Overall Study|Other than specified|0|||
46628841|NCT01994382|82799698|FG005|Overall Study|Other than specified|0|||
46628842|NCT01994382|82799699|FG006|Overall Study|Other than specified|0|||
46628843|NCT01994382|82799700|FG007|Overall Study|Other than specified|0|||
46628844|NCT01994382|82799701|FG008|Overall Study|Other than specified|0|||
46628845|NCT01994382|82799702|FG009|Overall Study|Other than specified|0|||
46628846|NCT01994382|82799703|FG010|Overall Study|Other than specified|2|||
46628847|NCT01994382|82799704|FG011|Overall Study|Other than specified|0|||
46628848|NCT01994382|82799705|FG012|Overall Study|Other than specified|2|||
46628849|NCT01994382|82799706|FG013|Overall Study|Other than specified|0|||
46628850|NCT01994382|82799707|FG014|Overall Study|Other than specified|0|||
46628851|NCT01994382|82799708|FG015|Overall Study|Other than specified|4|||
46628852|NCT01994382|82799709|FG016|Overall Study|Other than specified|4|||
46628853|NCT01994382|82799693|FG000|Overall Study|Withdrawal by Subject|0|||
46628854|NCT01994382|82799694|FG001|Overall Study|Withdrawal by Subject|0|||
46628855|NCT01994382|82799695|FG002|Overall Study|Withdrawal by Subject|0|||
46628856|NCT01994382|82799696|FG003|Overall Study|Withdrawal by Subject|0|||
47033397|NCT01591863|83284032|FG000|Overall Study|Withdrawal by Subject|1|||
47033398|NCT01591863|83284032|FG000|Overall Study|recurrence|9|||
47033399|NCT01591863|83284032|FG000|Overall Study|Lack of Efficacy|1|||
47033400|NCT01591785|83284038|FG000|Overall Study|worsening condition|1|||
47033401|NCT01591785|83284039|FG001|Overall Study|worsening condition|2|||
47033402|NCT01591785|83284038|FG000|Overall Study|Protocol Violation|2|||
47033403|NCT01591785|83284039|FG001|Overall Study|Protocol Violation|0|||
47033404|NCT01591785|83284038|FG000|Overall Study|Lost to Follow-up|1|||
47033405|NCT01591785|83284039|FG001|Overall Study|Lost to Follow-up|0|||
47033406|NCT01695993|83284048|FG000|Overall Study|Lost to Follow-up|2|||
47033407|NCT01695993|83284049|FG001|Overall Study|Lost to Follow-up|1|||
47033408|NCT01695993|83284050|FG002|Overall Study|Lost to Follow-up|3|||
47033409|NCT01695993|83284048|FG000|Overall Study|Withdrawal by Subject|2|||
47033410|NCT01695993|83284049|FG001|Overall Study|Withdrawal by Subject|2|||
47033411|NCT01695993|83284050|FG002|Overall Study|Withdrawal by Subject|2|||
47033412|NCT01695993|83284048|FG000|Overall Study|To ill to continue|1|||
47033413|NCT01695993|83284049|FG001|Overall Study|To ill to continue|2|||
47033414|NCT01695993|83284050|FG002|Overall Study|To ill to continue|0|||
47033415|NCT01695993|83284048|FG000|Overall Study|Changed Medical Facility|0|||
47033416|NCT01695993|83284049|FG001|Overall Study|Changed Medical Facility|0|||
47033417|NCT01695993|83284050|FG002|Overall Study|Changed Medical Facility|1|||
47033418|NCT01565343|83284061|FG000|Overall Study|Administrative decision/technical issues|1|||
46628857|NCT01994382|82799697|FG004|Overall Study|Withdrawal by Subject|0|||
46628858|NCT01994382|82799698|FG005|Overall Study|Withdrawal by Subject|0|||
46628859|NCT01994382|82799699|FG006|Overall Study|Withdrawal by Subject|0|||
47033419|NCT01565343|83284062|FG001|Overall Study|Administrative decision/technical issues|0|||
47033420|NCT01565343|83284063|FG002|Overall Study|Administrative decision/technical issues|0|||
47033421|NCT01695135|83284088|FG000|Double-blind Treatment Phase|Progressive disease|50|||
47033422|NCT01695135|83284089|FG001|Double-blind Treatment Phase|Progressive disease|110|||
47033423|NCT01695135|83284090|FG002|Double-blind Treatment Phase|Progressive disease|0|||
47033424|NCT01695135|83284091|FG003|Double-blind Treatment Phase|Progressive disease|0|||
46628860|NCT01994382|82799700|FG007|Overall Study|Withdrawal by Subject|0|||
47033425|NCT01695135|83284088|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
46912987|NCT02864498|83143100|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
46912988|NCT02864498|83143098|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
46912989|NCT02864498|83143099|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
46912990|NCT02864498|83143100|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
46912991|NCT02864498|83143098|FG000|Overall Study|Subject moved out of the country.|0|||
46912992|NCT02864498|83143099|FG001|Overall Study|Subject moved out of the country.|0|||
47033426|NCT01695135|83284089|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
47033427|NCT01695135|83284090|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
47033428|NCT01695135|83284091|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
47033429|NCT01695135|83284088|FG000|Double-blind Treatment Phase|Adverse Event|7|||
47033430|NCT01695135|83284089|FG001|Double-blind Treatment Phase|Adverse Event|7|||
47033431|NCT01695135|83284090|FG002|Double-blind Treatment Phase|Adverse Event|0|||
47033432|NCT01695135|83284091|FG003|Double-blind Treatment Phase|Adverse Event|0|||
47033433|NCT01695135|83284088|FG000|Double-blind Treatment Phase|Other|1|||
47033434|NCT01695135|83284089|FG001|Double-blind Treatment Phase|Other|3|||
47033435|NCT01695135|83284090|FG002|Double-blind Treatment Phase|Other|0|||
47033436|NCT01695135|83284091|FG003|Double-blind Treatment Phase|Other|0|||
47033437|NCT01695135|83284088|FG000|Double-blind Treatment Phase|Physician Decision|6|||
47033438|NCT01695135|83284089|FG001|Double-blind Treatment Phase|Physician Decision|3|||
47033439|NCT01695135|83284090|FG002|Double-blind Treatment Phase|Physician Decision|0|||
47033440|NCT01695135|83284091|FG003|Double-blind Treatment Phase|Physician Decision|0|||
47033441|NCT01695135|83284088|FG000|Double-blind Treatment Phase|Death|1|||
47033442|NCT01695135|83284089|FG001|Double-blind Treatment Phase|Death|1|||
47033443|NCT01695135|83284090|FG002|Double-blind Treatment Phase|Death|0|||
47033444|NCT01695135|83284091|FG003|Double-blind Treatment Phase|Death|0|||
47033445|NCT01695135|83284088|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
47033446|NCT01695135|83284089|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
47033447|NCT01695135|83284090|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
47033448|NCT01695135|83284091|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
47033449|NCT01695135|83284088|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
47033450|NCT01695135|83284089|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
47033451|NCT01695135|83284090|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
47033452|NCT01695135|83284091|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
46912993|NCT02864498|83143100|FG002|Overall Study|Subject moved out of the country.|1|||
46912994|NCT03238781|83143111|FG000|Overall Study|Adverse Event|1|||
46912995|NCT03238781|83143112|FG001|Overall Study|Adverse Event|1|||
46912996|NCT03238781|83143113|FG002|Overall Study|Adverse Event|2|||
46912997|NCT03238781|83143111|FG000|Overall Study|Lost to Follow-up|2|||
46912998|NCT03238781|83143112|FG001|Overall Study|Lost to Follow-up|1|||
46912999|NCT03238781|83143113|FG002|Overall Study|Lost to Follow-up|2|||
46913000|NCT03238781|83143111|FG000|Overall Study|Withdrawal by Subject|23|||
46913001|NCT03238781|83143112|FG001|Overall Study|Withdrawal by Subject|14|||
46913002|NCT03238781|83143113|FG002|Overall Study|Withdrawal by Subject|16|||
46913003|NCT03238781|83143111|FG000|Overall Study|Decision by sponsor|0|||
46913004|NCT03238781|83143112|FG001|Overall Study|Decision by sponsor|1|||
47033453|NCT01695135|83284088|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
47033454|NCT01695135|83284089|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
47033455|NCT01695135|83284090|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
46913005|NCT03238781|83143113|FG002|Overall Study|Decision by sponsor|0|||
46913006|NCT02097121|83143124|FG000|Overall Study|Other, not specified|4|||
46913007|NCT02097121|83143125|FG001|Overall Study|Other, not specified|2|||
46913008|NCT02097121|83143126|FG002|Overall Study|Other, not specified|3|||
46913009|NCT02097121|83143124|FG000|Overall Study|Lack of Efficacy|2|||
46913010|NCT02097121|83143125|FG001|Overall Study|Lack of Efficacy|1|||
46913011|NCT02097121|83143126|FG002|Overall Study|Lack of Efficacy|3|||
46913012|NCT02097121|83143124|FG000|Overall Study|Withdrawal by Subject|0|||
46913013|NCT02097121|83143125|FG001|Overall Study|Withdrawal by Subject|1|||
46913014|NCT02097121|83143126|FG002|Overall Study|Withdrawal by Subject|2|||
46913015|NCT02097121|83143124|FG000|Overall Study|Adverse Event|0|||
47033456|NCT01695135|83284091|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
47033457|NCT01695135|83284088|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
46913016|NCT02097121|83143125|FG001|Overall Study|Adverse Event|1|||
46913017|NCT02097121|83143126|FG002|Overall Study|Adverse Event|0|||
46913018|NCT02097121|83143124|FG000|Overall Study|Lost to Follow-up|1|||
46913019|NCT02097121|83143125|FG001|Overall Study|Lost to Follow-up|1|||
46913020|NCT02097121|83143126|FG002|Overall Study|Lost to Follow-up|2|||
47033458|NCT01695135|83284089|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
46913021|NCT02747420|83143155|FG000|Overall Study|Lost to Follow-up|4|||
46913022|NCT02747420|83143156|FG001|Overall Study|Lost to Follow-up|2|||
46913023|NCT02747420|83143155|FG000|Overall Study|Withdrawal by Subject|3|||
46913024|NCT02747420|83143156|FG001|Overall Study|Withdrawal by Subject|2|||
46913025|NCT03238001|83143162|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
46913026|NCT03238001|83143162|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
46913027|NCT03238001|83143162|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
46913028|NCT03238001|83143162|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
46913029|NCT03238001|83143162|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
46913030|NCT03238001|83143162|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
46913031|NCT03238001|83143162|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
46913032|NCT03238001|83143162|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
46913033|NCT02747108|83143176|FG000|Overall Study|Death|2|||
46913034|NCT02747108|83143177|FG001|Overall Study|Death|2|||
46913035|NCT02747108|83143176|FG000|Overall Study|Withdrawal by Subject|1|||
46913036|NCT02747108|83143177|FG001|Overall Study|Withdrawal by Subject|0|||
46913037|NCT02747108|83143176|FG000|Overall Study|Protocol Violation|2|||
46913038|NCT02747108|83143177|FG001|Overall Study|Protocol Violation|0|||
46913039|NCT03226769|83143205|FG000|Overall Study|Withdrawal by Subject|0|||
46913040|NCT03226769|83143206|FG001|Overall Study|Withdrawal by Subject|1|||
46913041|NCT02864342|83143214|FG000|Overall Study|Eligibility Criteria Deviation|2|||
46913042|NCT02864342|83143215|FG001|Overall Study|Eligibility Criteria Deviation|3|||
46913043|NCT02864342|83143214|FG000|Overall Study|Withdrawal by Subject|4|||
46913044|NCT02864342|83143215|FG001|Overall Study|Withdrawal by Subject|2|||
46913045|NCT02864342|83143214|FG000|Overall Study|Device Technology Issue|6|||
46913046|NCT02864342|83143215|FG001|Overall Study|Device Technology Issue|7|||
46913047|NCT02864342|83143214|FG000|Overall Study|Death|0|||
46913048|NCT02864342|83143215|FG001|Overall Study|Death|1|||
46913049|NCT02864342|83143214|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
46913050|NCT02864342|83143215|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
47033459|NCT01695135|83284090|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
47033460|NCT01695135|83284091|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
47033461|NCT01695135|83284088|FG000|Open Label Extension Treatment Phase|Other|0|||
47033462|NCT01695135|83284089|FG001|Open Label Extension Treatment Phase|Other|0|||
47033463|NCT01695135|83284090|FG002|Open Label Extension Treatment Phase|Other|4|||
47033464|NCT01695135|83284091|FG003|Open Label Extension Treatment Phase|Other|7|||
47033465|NCT01695135|83284088|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
47033466|NCT01695135|83284089|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
47033467|NCT01695135|83284090|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
47033468|NCT01695135|83284091|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
47033469|NCT01695135|83284088|FG000|Open Label Extension Treatment Phase|Death|0|||
47033470|NCT01695135|83284089|FG001|Open Label Extension Treatment Phase|Death|0|||
47033471|NCT01695135|83284090|FG002|Open Label Extension Treatment Phase|Death|2|||
47033472|NCT01695135|83284091|FG003|Open Label Extension Treatment Phase|Death|7|||
47033473|NCT01695135|83284088|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
47033474|NCT01695135|83284089|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
47033475|NCT01695135|83284090|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
47033476|NCT01695135|83284091|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
47033477|NCT01610414|83284101|FG000|Study Start - Month 13|Serious Adverse Event|65|||
47033478|NCT01610414|83284102|FG001|Study Start - Month 13|Serious Adverse Event|67|||
47033479|NCT01610414|83284101|FG000|Study Start - Month 13|Adverse Event|14|||
47033480|NCT01610414|83284102|FG001|Study Start - Month 13|Adverse Event|14|||
47033481|NCT01610414|83284101|FG000|Study Start - Month 13|Protocol Violation|3|||
47033482|NCT01610414|83284102|FG001|Study Start - Month 13|Protocol Violation|1|||
47033483|NCT01610414|83284101|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
47033484|NCT01610414|83284102|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
47033485|NCT01610414|83284101|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
47033486|NCT01610414|83284102|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
47033487|NCT01610414|83284101|FG000|Study Start - Month 13|Lost to Follow-up|4|||
46710939|NCT01117428|82927250|FG000|Overall Study|Death|0|||
46710940|NCT01117428|82927251|FG001|Overall Study|Death|1|||
46710941|NCT01117428|82927252|FG002|Overall Study|Death|2|||
46710942|NCT01117428|82927253|FG003|Overall Study|Death|0|||
46913051|NCT02864342|83143214|FG000|Overall Study|Lost to Follow-up|1|||
46913052|NCT02864342|83143215|FG001|Overall Study|Lost to Follow-up|5|||
46710943|NCT01117428|82927254|FG004|Overall Study|Death|0|||
46913053|NCT02864342|83143214|FG000|Overall Study|Lost Device|1|||
46913054|NCT02864342|83143215|FG001|Overall Study|Lost Device|0|||
46913055|NCT02864342|83143214|FG000|Overall Study|Adverse Event|1|||
46913056|NCT02864342|83143215|FG001|Overall Study|Adverse Event|0|||
46710944|NCT01117428|82927255|FG005|Overall Study|Death|1|||
46913057|NCT03237065|83143224|FG000|Overall Study|Adverse Event|0|||
46710945|NCT01117428|82927250|FG000|Overall Study|Physician Decision|0|||
46710946|NCT01117428|82927251|FG001|Overall Study|Physician Decision|1|||
47033488|NCT01610414|83284102|FG001|Study Start - Month 13|Lost to Follow-up|6|||
47033489|NCT01610414|83284101|FG000|Study Start - Month 13|Suspected HZ episode|1|||
47033490|NCT01610414|83284102|FG001|Study Start - Month 13|Suspected HZ episode|3|||
47033491|NCT01610414|83284101|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
47033492|NCT01610414|83284102|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
47033493|NCT01610414|83284101|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
47033494|NCT01610414|83284102|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
47033495|NCT01610414|83284101|FG000|Month 13 - Month 25|Adverse Event|8|||
47033496|NCT01610414|83284102|FG001|Month 13 - Month 25|Adverse Event|4|||
47033497|NCT01610414|83284101|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
47033498|NCT01610414|83284102|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
47033499|NCT01610414|83284101|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
47033500|NCT01610414|83284102|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
47033501|NCT01610414|83284101|FG000|Month 13 - Month 25|Protocol Violation|0|||
47033502|NCT01610414|83284102|FG001|Month 13 - Month 25|Protocol Violation|2|||
47033503|NCT01610414|83284101|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
47033504|NCT01610414|83284102|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
47033505|NCT01610414|83284101|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
47033506|NCT01610414|83284102|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
47033507|NCT01610414|83284101|FG000|After Month 25|Study end not reached|48|||
47033508|NCT01610414|83284102|FG001|After Month 25|Study end not reached|53|||
47033509|NCT01564407|83284138|FG000|Overall Study|Lost to Follow-up|0|||
47033510|NCT01564407|83284139|FG001|Overall Study|Lost to Follow-up|1|||
47033511|NCT01564407|83284140|FG002|Overall Study|Lost to Follow-up|0|||
47033512|NCT01564407|83284141|FG003|Overall Study|Lost to Follow-up|0|||
47033513|NCT01564407|83284142|FG004|Overall Study|Lost to Follow-up|0|||
47033514|NCT01564407|83284138|FG000|Overall Study|Withdrawal by Subject|0|||
47033515|NCT01564407|83284139|FG001|Overall Study|Withdrawal by Subject|1|||
47033516|NCT01564407|83284140|FG002|Overall Study|Withdrawal by Subject|0|||
47033517|NCT01564407|83284141|FG003|Overall Study|Withdrawal by Subject|0|||
47033518|NCT01564407|83284142|FG004|Overall Study|Withdrawal by Subject|0|||
47033519|NCT01564407|83284138|FG000|Overall Study|funding lost, study ended|0|||
47033520|NCT01564407|83284139|FG001|Overall Study|funding lost, study ended|0|||
47033521|NCT01564407|83284140|FG002|Overall Study|funding lost, study ended|0|||
47033522|NCT01564407|83284141|FG003|Overall Study|funding lost, study ended|1|||
47033523|NCT01564407|83284142|FG004|Overall Study|funding lost, study ended|0|||
47033524|NCT01590771|83284165|FG000|Overall Study|Other Protocol Specified Criteria|5|||
47033525|NCT01590771|83284166|FG001|Overall Study|Other Protocol Specified Criteria|14|||
47033526|NCT01590771|83284165|FG000|Overall Study|Withdrawal by Subject|8|||
47033527|NCT01590771|83284166|FG001|Overall Study|Withdrawal by Subject|15|||
47033528|NCT01590771|83284165|FG000|Overall Study|Protocol Violation|1|||
47033529|NCT01590771|83284166|FG001|Overall Study|Protocol Violation|2|||
47033530|NCT01590771|83284165|FG000|Overall Study|Lost to Follow-up|1|||
47033531|NCT01590771|83284166|FG001|Overall Study|Lost to Follow-up|1|||
47033532|NCT01590771|83284165|FG000|Overall Study|Lack of Efficacy|1|||
47033533|NCT01590771|83284166|FG001|Overall Study|Lack of Efficacy|0|||
47033534|NCT01590771|83284165|FG000|Overall Study|Adverse Event|3|||
47033535|NCT01590771|83284166|FG001|Overall Study|Adverse Event|7|||
47033536|NCT01563237|83284172|FG000|Overall Study|Lost to Follow-up|6|||
47033537|NCT01563237|83284173|FG001|Overall Study|Lost to Follow-up|0|||
47033538|NCT01563237|83284172|FG000|Overall Study|Withdrawal by Subject|1|||
47033539|NCT01563237|83284173|FG001|Overall Study|Withdrawal by Subject|0|||
47033540|NCT01563237|83284172|FG000|Overall Study|Adverse Event|1|||
47033541|NCT01563237|83284173|FG001|Overall Study|Adverse Event|0|||
46628861|NCT01994382|82799701|FG008|Overall Study|Withdrawal by Subject|0|||
46628862|NCT01994382|82799702|FG009|Overall Study|Withdrawal by Subject|0|||
46628863|NCT01994382|82799703|FG010|Overall Study|Withdrawal by Subject|6|||
46628864|NCT01994382|82799704|FG011|Overall Study|Withdrawal by Subject|0|||
46628865|NCT01994382|82799705|FG012|Overall Study|Withdrawal by Subject|2|||
46628866|NCT01994382|82799706|FG013|Overall Study|Withdrawal by Subject|0|||
46628867|NCT01994382|82799707|FG014|Overall Study|Withdrawal by Subject|4|||
46628868|NCT01994382|82799708|FG015|Overall Study|Withdrawal by Subject|3|||
47033542|NCT01563237|83284172|FG000|Overall Study|Medical Reasons|1|||
47033543|NCT01563237|83284173|FG001|Overall Study|Medical Reasons|0|||
47033544|NCT01563237|83284172|FG000|Overall Study|Death|1|||
47033545|NCT01563237|83284173|FG001|Overall Study|Death|0|||
47033546|NCT01694433|83284189|FG000|Overall Study|Adverse Event|7|||
47033547|NCT01694433|83284190|FG001|Overall Study|Adverse Event|0|||
47033548|NCT01694433|83284189|FG000|Overall Study|Physician Decision|1|||
47033549|NCT01694433|83284190|FG001|Overall Study|Physician Decision|0|||
47033550|NCT01694433|83284189|FG000|Overall Study|Withdrawal by Subject|3|||
47033551|NCT01694433|83284190|FG001|Overall Study|Withdrawal by Subject|4|||
47033552|NCT01694121|83284198|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
46710947|NCT01117428|82927252|FG002|Overall Study|Physician Decision|0|||
46628869|NCT01994382|82799709|FG016|Overall Study|Withdrawal by Subject|0|||
46628870|NCT01994382|82799693|FG000|Overall Study|Lost to Follow-up|0|||
46628871|NCT01994382|82799694|FG001|Overall Study|Lost to Follow-up|0|||
46628872|NCT01994382|82799695|FG002|Overall Study|Lost to Follow-up|0|||
46628873|NCT01994382|82799696|FG003|Overall Study|Lost to Follow-up|0|||
46628874|NCT01994382|82799697|FG004|Overall Study|Lost to Follow-up|0|||
46628875|NCT01994382|82799698|FG005|Overall Study|Lost to Follow-up|0|||
46628876|NCT01994382|82799699|FG006|Overall Study|Lost to Follow-up|0|||
46628877|NCT01994382|82799700|FG007|Overall Study|Lost to Follow-up|0|||
46628878|NCT01994382|82799701|FG008|Overall Study|Lost to Follow-up|0|||
46628879|NCT01994382|82799702|FG009|Overall Study|Lost to Follow-up|0|||
46628880|NCT01994382|82799703|FG010|Overall Study|Lost to Follow-up|1|||
46628881|NCT01994382|82799704|FG011|Overall Study|Lost to Follow-up|0|||
46628882|NCT01994382|82799705|FG012|Overall Study|Lost to Follow-up|0|||
46628883|NCT01994382|82799706|FG013|Overall Study|Lost to Follow-up|0|||
46628884|NCT01994382|82799707|FG014|Overall Study|Lost to Follow-up|0|||
46628885|NCT01994382|82799708|FG015|Overall Study|Lost to Follow-up|0|||
46628886|NCT01994382|82799709|FG016|Overall Study|Lost to Follow-up|0|||
46628887|NCT01994382|82799693|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628888|NCT01994382|82799694|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628889|NCT01994382|82799695|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628890|NCT01994382|82799696|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628891|NCT01994382|82799697|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628892|NCT01994382|82799698|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628893|NCT01994382|82799699|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628894|NCT01994382|82799700|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628895|NCT01994382|82799701|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628896|NCT01994382|82799702|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628897|NCT01994382|82799703|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
46628898|NCT01994382|82799704|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628899|NCT01994382|82799705|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
46628900|NCT01994382|82799706|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628901|NCT01994382|82799707|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
46628902|NCT01994382|82799708|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
46628903|NCT01994382|82799709|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
46628904|NCT01994382|82799693|FG000|Overall Study|Protocol violation/noncompliance|0|||
46628905|NCT01994382|82799694|FG001|Overall Study|Protocol violation/noncompliance|0|||
46628906|NCT01994382|82799695|FG002|Overall Study|Protocol violation/noncompliance|0|||
46628907|NCT01994382|82799696|FG003|Overall Study|Protocol violation/noncompliance|0|||
46628908|NCT01994382|82799697|FG004|Overall Study|Protocol violation/noncompliance|0|||
46628909|NCT01994382|82799698|FG005|Overall Study|Protocol violation/noncompliance|0|||
46628910|NCT01994382|82799699|FG006|Overall Study|Protocol violation/noncompliance|0|||
46628911|NCT01994382|82799700|FG007|Overall Study|Protocol violation/noncompliance|0|||
46628912|NCT01994382|82799701|FG008|Overall Study|Protocol violation/noncompliance|0|||
46628913|NCT01994382|82799702|FG009|Overall Study|Protocol violation/noncompliance|0|||
46628914|NCT01994382|82799703|FG010|Overall Study|Protocol violation/noncompliance|0|||
46628915|NCT01994382|82799704|FG011|Overall Study|Protocol violation/noncompliance|1|||
47033553|NCT01694121|83284199|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
47033554|NCT01562613|83284205|FG000|Overall Study|Lost to Follow-up|2|||
47033555|NCT01562613|83284205|FG000|Overall Study|Withdrawal by Subject|2|||
47033556|NCT01693185|83284211|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
47033557|NCT01693185|83284212|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
47033558|NCT01693029|83284252|FG000|Overall Study|Withdrawal by Subject|15|||
47033559|NCT01693029|83284253|FG001|Overall Study|Withdrawal by Subject|22|||
47033560|NCT01693029|83284252|FG000|Overall Study|Kidney transplantation|7|||
46628916|NCT01994382|82799705|FG012|Overall Study|Protocol violation/noncompliance|0|||
46628917|NCT01994382|82799706|FG013|Overall Study|Protocol violation/noncompliance|0|||
46628918|NCT01994382|82799707|FG014|Overall Study|Protocol violation/noncompliance|0|||
46628919|NCT01994382|82799708|FG015|Overall Study|Protocol violation/noncompliance|0|||
47033561|NCT01693029|83284253|FG001|Overall Study|Kidney transplantation|7|||
47033562|NCT01693029|83284252|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
47033563|NCT01693029|83284253|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
46628920|NCT01994382|82799709|FG016|Overall Study|Protocol violation/noncompliance|2|||
46628921|NCT01994382|82799693|FG000|Overall Study|Rolled over to Phase 2a|0|||
46628922|NCT01994382|82799694|FG001|Overall Study|Rolled over to Phase 2a|0|||
46628923|NCT01994382|82799695|FG002|Overall Study|Rolled over to Phase 2a|1|||
46628924|NCT01994382|82799696|FG003|Overall Study|Rolled over to Phase 2a|0|||
46628925|NCT01994382|82799697|FG004|Overall Study|Rolled over to Phase 2a|0|||
46628926|NCT01994382|82799698|FG005|Overall Study|Rolled over to Phase 2a|0|||
46628927|NCT01994382|82799699|FG006|Overall Study|Rolled over to Phase 2a|0|||
46628928|NCT01994382|82799700|FG007|Overall Study|Rolled over to Phase 2a|0|||
46628929|NCT01994382|82799701|FG008|Overall Study|Rolled over to Phase 2a|0|||
46628930|NCT01994382|82799702|FG009|Overall Study|Rolled over to Phase 2a|2|||
46628931|NCT01994382|82799703|FG010|Overall Study|Rolled over to Phase 2a|0|||
46628932|NCT01994382|82799704|FG011|Overall Study|Rolled over to Phase 2a|0|||
46628933|NCT01994382|82799705|FG012|Overall Study|Rolled over to Phase 2a|0|||
46628934|NCT01994382|82799706|FG013|Overall Study|Rolled over to Phase 2a|0|||
46628935|NCT01994382|82799707|FG014|Overall Study|Rolled over to Phase 2a|0|||
46628936|NCT01994382|82799708|FG015|Overall Study|Rolled over to Phase 2a|0|||
46628937|NCT01994382|82799709|FG016|Overall Study|Rolled over to Phase 2a|0|||
46628938|NCT02003898|82799752|FG000|Overall Study|Death|3|||
46628939|NCT02003898|82799752|FG000|Overall Study|Lost to Follow-up|12|||
46628940|NCT02003898|82799752|FG000|Overall Study|Withdrawal by Subject|52|||
46628941|NCT01994226|82799758|FG000|Overall Study|Protocol Violation|13|||
46628942|NCT01994226|82799759|FG001|Overall Study|Protocol Violation|10|||
46628943|NCT01994226|82799758|FG000|Overall Study|Early Cessation of treatment|6|||
46628944|NCT01994226|82799759|FG001|Overall Study|Early Cessation of treatment|11|||
46628945|NCT02002884|82799768|FG000|Main Period (MP)|Other|0|||
46628946|NCT02002884|82799769|FG001|Main Period (MP)|Other|3|||
46628947|NCT02002884|82799770|FG002|Main Period (MP)|Other|3|||
46628948|NCT02002884|82799771|FG003|Main Period (MP)|Other|0|||
46628949|NCT02002884|82799768|FG000|Main Period (MP)|Adverse Event|0|||
46628950|NCT02002884|82799769|FG001|Main Period (MP)|Adverse Event|1|||
46628951|NCT02002884|82799770|FG002|Main Period (MP)|Adverse Event|1|||
46628952|NCT02002884|82799771|FG003|Main Period (MP)|Adverse Event|0|||
46628953|NCT02002884|82799768|FG000|Main Period (MP)|Withdrawal by Subject|6|||
46628954|NCT02002884|82799769|FG001|Main Period (MP)|Withdrawal by Subject|2|||
46628955|NCT02002884|82799770|FG002|Main Period (MP)|Withdrawal by Subject|2|||
46628956|NCT02002884|82799771|FG003|Main Period (MP)|Withdrawal by Subject|0|||
46628957|NCT02002884|82799768|FG000|Main Period (MP)|Lost to Follow-up|0|||
46628958|NCT02002884|82799769|FG001|Main Period (MP)|Lost to Follow-up|0|||
46628959|NCT02002884|82799770|FG002|Main Period (MP)|Lost to Follow-up|2|||
46628960|NCT02002884|82799771|FG003|Main Period (MP)|Lost to Follow-up|0|||
46628961|NCT02002884|82799768|FG000|Open-Label Extension Period (OLEX)|Other|0|||
46628962|NCT02002884|82799769|FG001|Open-Label Extension Period (OLEX)|Other|0|||
46628963|NCT02002884|82799770|FG002|Open-Label Extension Period (OLEX)|Other|0|||
46628964|NCT02002884|82799771|FG003|Open-Label Extension Period (OLEX)|Other|24|||
46628965|NCT02002884|82799768|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
46628966|NCT02002884|82799769|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
46913058|NCT03237065|83143225|FG001|Overall Study|Adverse Event|2|||
46913059|NCT03237065|83143224|FG000|Overall Study|Protocol Violation|0|||
46913060|NCT03237065|83143225|FG001|Overall Study|Protocol Violation|1|||
46913061|NCT03237065|83143224|FG000|Overall Study|Withdrawal by Subject|3|||
46913062|NCT03237065|83143225|FG001|Overall Study|Withdrawal by Subject|0|||
47033564|NCT01693029|83284252|FG000|Overall Study|Protocol Violation|6|||
47033565|NCT01693029|83284253|FG001|Overall Study|Protocol Violation|7|||
47033566|NCT01693029|83284252|FG000|Overall Study|Change in dialysis modality|2|||
47033567|NCT01693029|83284253|FG001|Overall Study|Change in dialysis modality|1|||
47033568|NCT01693029|83284252|FG000|Overall Study|Physician Decision|0|||
47033569|NCT01693029|83284253|FG001|Overall Study|Physician Decision|2|||
47033570|NCT01693029|83284252|FG000|Overall Study|Lost to Follow-up|0|||
47033571|NCT01693029|83284253|FG001|Overall Study|Lost to Follow-up|1|||
47033572|NCT01693029|83284252|FG000|Overall Study|Adverse Event|1|||
47033573|NCT01693029|83284253|FG001|Overall Study|Adverse Event|6|||
47033574|NCT01693029|83284252|FG000|Overall Study|Death|5|||
47033575|NCT01693029|83284253|FG001|Overall Study|Death|8|||
47033576|NCT01693029|83284252|FG000|Overall Study|Non-compliance|2|||
47033577|NCT01693029|83284253|FG001|Overall Study|Non-compliance|1|||
47033578|NCT01589445|83284259|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
47033579|NCT01589445|83284259|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
47033580|NCT01589445|83284259|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
47033581|NCT01589445|83284259|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
47033582|NCT01589445|83284259|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
46628967|NCT02002884|82799770|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
46628968|NCT02002884|82799771|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
46628969|NCT02002884|82799768|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
46628970|NCT02002884|82799769|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
46628971|NCT02002884|82799770|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
46628972|NCT02002884|82799771|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
46628973|NCT02002884|82799768|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
46913063|NCT03237065|83143224|FG000|Overall Study|Lost to Follow-up|1|||
47033583|NCT01589445|83284259|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
47033584|NCT01589445|83284259|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
47033585|NCT01589445|83284259|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
47033586|NCT01589445|83284259|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
47033587|NCT01589445|83284259|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
47033588|NCT01588509|83284269|FG000|Overall Study|Lost to Follow-up|1|||
47033589|NCT01588509|83284270|FG001|Overall Study|Lost to Follow-up|0|||
47033590|NCT01588353|83284279|FG000|Step2|Withdrawal by Subject|0|||
47033591|NCT01588353|83284280|FG001|Step2|Withdrawal by Subject|1|||
47033592|NCT01588353|83284281|FG002|Step2|Withdrawal by Subject|0|||
47033593|NCT01588353|83284279|FG000|Step3|Adverse Event|0|||
46628974|NCT02002884|82799769|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
46628975|NCT02002884|82799770|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
46628976|NCT02002884|82799771|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
46628977|NCT02002884|82799768|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
46628978|NCT02002884|82799769|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
46628979|NCT02002884|82799770|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
46628980|NCT02002884|82799771|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
46628981|NCT02002182|82799783|FG000|Overall Study|Withdraw from study|3|||
46628982|NCT02002182|82799784|FG001|Overall Study|Withdraw from study|1|||
46628983|NCT02002182|82799783|FG000|Overall Study|Health Reasons|1|||
46628984|NCT02002182|82799784|FG001|Overall Study|Health Reasons|0|||
46628985|NCT02002182|82799783|FG000|Overall Study|Death|1|||
46628986|NCT02002182|82799784|FG001|Overall Study|Death|0|||
46628987|NCT01990950|82799790|FG000|Overall Study|Death|3|||
47033594|NCT01588353|83284280|FG001|Step3|Adverse Event|0|||
47033595|NCT01588353|83284281|FG002|Step3|Adverse Event|2|||
47033596|NCT01588197|83284290|FG000|Overall Study|Lack of Efficacy|0|||
47033597|NCT01588197|83284291|FG001|Overall Study|Lack of Efficacy|1|||
46628988|NCT01990950|82799790|FG000|Overall Study|Lost to Follow-up|2|||
46628989|NCT01990950|82799790|FG000|Overall Study|Withdrawal by Subject|6|||
46628990|NCT02001558|82799796|FG000|Overall Study|Lost to Follow-up|8|||
46628991|NCT02001558|82799797|FG001|Overall Study|Lost to Follow-up|14|||
46628992|NCT02023866|82799803|FG000|Overall Study|Non-compliance|2|||
46628993|NCT02023866|82799803|FG000|Overall Study|Adverse Event|3|||
46628994|NCT02023866|82799803|FG000|Overall Study|Withdrawal by Subject|1|||
46628995|NCT02023242|82799809|FG000|Overall Study|Lost to Follow-up|3|||
46628996|NCT02023242|82799810|FG001|Overall Study|Lost to Follow-up|1|||
46628997|NCT02023242|82799809|FG000|Overall Study|Death|0|||
46628998|NCT02023242|82799810|FG001|Overall Study|Death|1|||
46628999|NCT01967940|82799819|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
46629000|NCT01967940|82799820|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
46629001|NCT01967940|82799821|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
46629002|NCT01967940|82799822|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
46629003|NCT01967940|82799819|FG000|Part 2|Adverse Event|0|||
47033598|NCT01588197|83284290|FG000|Overall Study|No MRI|1|||
47033599|NCT01588197|83284291|FG001|Overall Study|No MRI|0|||
47033600|NCT01561989|83284299|FG000|Overall Study|accural target not met.|5|||
47033601|NCT01561989|83284300|FG001|Overall Study|accural target not met.|6|||
47033602|NCT01587885|83284315|FG000|Treatment Period 1|Failure to Return|0|||
47033603|NCT01587885|83284316|FG001|Treatment Period 1|Failure to Return|1|||
47033604|NCT01587885|83284315|FG000|Treatment Period 1|Protocol Violation|0|||
47033605|NCT01587885|83284316|FG001|Treatment Period 1|Protocol Violation|2|||
47033606|NCT01587651|83284326|FG000|Overall Study|Adverse Event|0|||
47033607|NCT01587651|83284327|FG001|Overall Study|Adverse Event|1|||
47033608|NCT01587651|83284328|FG002|Overall Study|Adverse Event|0|||
47033609|NCT01587651|83284326|FG000|Overall Study|Protocol Violation|0|||
47033610|NCT01587651|83284327|FG001|Overall Study|Protocol Violation|1|||
47033611|NCT01587651|83284328|FG002|Overall Study|Protocol Violation|1|||
47033612|NCT01587651|83284326|FG000|Overall Study|Withdrawal by Subject|0|||
47033613|NCT01587651|83284327|FG001|Overall Study|Withdrawal by Subject|1|||
47033614|NCT01587651|83284328|FG002|Overall Study|Withdrawal by Subject|0|||
47033615|NCT01691859|83284350|FG000|Overall Study|Adverse Event|19|||
46629004|NCT01967940|82799820|FG001|Part 2|Adverse Event|0|||
46629005|NCT01967940|82799821|FG002|Part 2|Adverse Event|0|||
46710948|NCT01117428|82927253|FG003|Overall Study|Physician Decision|0|||
47033616|NCT01691859|83284350|FG000|Overall Study|Lack of Efficacy|11|||
47033617|NCT01691859|83284350|FG000|Overall Study|Protocol Violation|4|||
46710949|NCT01117428|82927254|FG004|Overall Study|Physician Decision|0|||
47033618|NCT01691859|83284350|FG000|Overall Study|Product commercially available|221|||
47033619|NCT01691859|83284350|FG000|Overall Study|Study closed/terminated|50|||
47033620|NCT01691859|83284350|FG000|Overall Study|Lost to Follow-up|5|||
47033621|NCT01691859|83284350|FG000|Overall Study|Physician Decision|6|||
47033622|NCT01691859|83284350|FG000|Overall Study|Withdrawal by Subject|31|||
47033623|NCT01691781|83284394|FG000|Overall Study|Withdrawal by Subject|4|||
47033624|NCT01691781|83284395|FG001|Overall Study|Withdrawal by Subject|3|||
46629006|NCT01967940|82799822|FG003|Part 2|Adverse Event|1|||
46629007|NCT01967940|82799819|FG000|Part 2|Unknown Reason|0|||
46629008|NCT01967940|82799820|FG001|Part 2|Unknown Reason|0|||
46629009|NCT01967940|82799821|FG002|Part 2|Unknown Reason|0|||
46629010|NCT01967940|82799822|FG003|Part 2|Unknown Reason|1|||
46629011|NCT01990560|82799832|FG000|Overall Study|Withdrawal by Subject|1|||
46629012|NCT01998984|82799840|FG000|Overall Study|Adverse Event|0|||
46629013|NCT01998984|82799841|FG001|Overall Study|Adverse Event|0|||
46629014|NCT01998984|82799842|FG002|Overall Study|Adverse Event|0|||
46629015|NCT01998984|82799843|FG003|Overall Study|Adverse Event|1|||
46629016|NCT01998984|82799840|FG000|Overall Study|Lost to Follow-up|0|||
46629017|NCT01998984|82799841|FG001|Overall Study|Lost to Follow-up|1|||
46629018|NCT01998984|82799842|FG002|Overall Study|Lost to Follow-up|0|||
46629019|NCT01998984|82799843|FG003|Overall Study|Lost to Follow-up|1|||
46629020|NCT01998984|82799840|FG000|Overall Study|Withdrawal by Subject|0|||
46629021|NCT01998984|82799841|FG001|Overall Study|Withdrawal by Subject|0|||
46629022|NCT01998984|82799842|FG002|Overall Study|Withdrawal by Subject|1|||
46629023|NCT01998984|82799843|FG003|Overall Study|Withdrawal by Subject|0|||
46629024|NCT01998984|82799840|FG000|Overall Study|Other|0|||
46629025|NCT01998984|82799841|FG001|Overall Study|Other|0|||
46629026|NCT01998984|82799842|FG002|Overall Study|Other|0|||
46629027|NCT01998984|82799843|FG003|Overall Study|Other|1|||
46629028|NCT01967706|82799855|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
46629029|NCT01967706|82799856|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
46629030|NCT01967706|82799857|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
46629031|NCT01967706|82799858|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
46629032|NCT01967628|82799869|FG000|Overall Study|Withdrawal by Subject|2|||
46629033|NCT01967628|82799870|FG001|Overall Study|Withdrawal by Subject|0|||
46629034|NCT01967628|82799869|FG000|Overall Study|Unable to complete bronchoscopy|4|||
46629035|NCT01967628|82799870|FG001|Overall Study|Unable to complete bronchoscopy|6|||
46629036|NCT01967628|82799869|FG000|Overall Study|Lost to Follow-up|1|||
46629037|NCT01967628|82799870|FG001|Overall Study|Lost to Follow-up|0|||
46629038|NCT01967628|82799869|FG000|Overall Study|Low protein concentration in sample|20|||
46629039|NCT01967628|82799870|FG001|Overall Study|Low protein concentration in sample|25|||
46629040|NCT01998906|82799879|FG000|Overall Study|Participants ongoing in follow-up|77|||
46629041|NCT01998906|82799880|FG001|Overall Study|Participants ongoing in follow-up|60|||
46629042|NCT01998906|82799881|FG002|Overall Study|Participants ongoing in follow-up|58|||
46629043|NCT01998906|82799879|FG000|Overall Study|Death|21|||
46629044|NCT01998906|82799880|FG001|Overall Study|Death|30|||
46629045|NCT01998906|82799881|FG002|Overall Study|Death|17|||
46629046|NCT01998906|82799879|FG000|Overall Study|Lack of Efficacy|10|||
46629047|NCT01998906|82799880|FG001|Overall Study|Lack of Efficacy|9|||
46913064|NCT03237065|83143225|FG001|Overall Study|Lost to Follow-up|0|||
47033625|NCT01691781|83284394|FG000|Overall Study|Physician Decision|1|||
47033626|NCT01691781|83284395|FG001|Overall Study|Physician Decision|1|||
47033627|NCT01691781|83284394|FG000|Overall Study|Protocol Violation|2|||
47033628|NCT01691781|83284395|FG001|Overall Study|Protocol Violation|2|||
47033629|NCT01691781|83284394|FG000|Overall Study|Adverse Event|0|||
47033630|NCT01691781|83284395|FG001|Overall Study|Adverse Event|1|||
47033631|NCT01561755|83284403|FG000|Overall Study|Lost to Follow-up|0|||
47033632|NCT01561755|83284404|FG001|Overall Study|Lost to Follow-up|1|||
47033633|NCT01585155|83284424|FG000|Overall Study|Adverse Event|1|||
47033634|NCT01585155|83284424|FG000|Overall Study|Lack of Efficacy|2|||
47033635|NCT01585155|83284424|FG000|Overall Study|Worsening ulcerative colitis|2|||
47033636|NCT01560507|83284431|FG000|Overall Study|Lost to Follow-up|3|||
47033637|NCT01560507|83284432|FG001|Overall Study|Lost to Follow-up|1|||
47033638|NCT01560507|83284433|FG002|Overall Study|Lost to Follow-up|2|||
47033639|NCT01560507|83284431|FG000|Overall Study|Withdrawal by Subject|1|||
47033640|NCT01560507|83284432|FG001|Overall Study|Withdrawal by Subject|1|||
47033641|NCT01560507|83284433|FG002|Overall Study|Withdrawal by Subject|0|||
47033642|NCT01584843|83284448|FG000|First Treatment Period|Adverse Event|0|||
47033643|NCT01584843|83284449|FG001|First Treatment Period|Adverse Event|0|||
47033644|NCT01584843|83284450|FG002|First Treatment Period|Adverse Event|1|||
47033645|NCT01584843|83284451|FG003|First Treatment Period|Adverse Event|0|||
47033646|NCT01584843|83284452|FG004|First Treatment Period|Adverse Event|0|||
46913065|NCT03237065|83143224|FG000|Overall Study|Unable to obtain venous access|0|||
47033647|NCT01584843|83284453|FG005|First Treatment Period|Adverse Event|0|||
47033648|NCT01584843|83284448|FG000|First Treatment Period|Protocol Violation|0|||
47033649|NCT01584843|83284449|FG001|First Treatment Period|Protocol Violation|0|||
46629048|NCT01998906|82799881|FG002|Overall Study|Lack of Efficacy|8|||
46629049|NCT01998906|82799879|FG000|Overall Study|Failure to return|0|||
46629050|NCT01998906|82799880|FG001|Overall Study|Failure to return|2|||
46629051|NCT01998906|82799881|FG002|Overall Study|Failure to return|4|||
46629052|NCT01998906|82799879|FG000|Overall Study|Violation of Selection Criteria|0|||
46629053|NCT01998906|82799880|FG001|Overall Study|Violation of Selection Criteria|0|||
46710950|NCT01117428|82927255|FG005|Overall Study|Physician Decision|0|||
47033650|NCT01584843|83284450|FG002|First Treatment Period|Protocol Violation|0|||
47033651|NCT01584843|83284451|FG003|First Treatment Period|Protocol Violation|0|||
47033652|NCT01584843|83284452|FG004|First Treatment Period|Protocol Violation|0|||
46629054|NCT01998906|82799881|FG002|Overall Study|Violation of Selection Criteria|1|||
47033653|NCT01584843|83284453|FG005|First Treatment Period|Protocol Violation|1|||
47033654|NCT01584843|83284448|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
47033655|NCT01584843|83284449|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
47033656|NCT01584843|83284450|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
47033657|NCT01584843|83284451|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
47033658|NCT01584843|83284452|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
47033659|NCT01584843|83284453|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
47033660|NCT01584843|83284448|FG000|Second Treatment Period|Withdrawal by Subject|0|||
46629055|NCT01998906|82799879|FG000|Overall Study|Withdrawal by Subject|1|||
46629056|NCT01998906|82799880|FG001|Overall Study|Withdrawal by Subject|4|||
46629057|NCT01998906|82799881|FG002|Overall Study|Withdrawal by Subject|3|||
46629058|NCT01998906|82799879|FG000|Overall Study|Administrative/Other|2|||
46629059|NCT01998906|82799880|FG001|Overall Study|Administrative/Other|1|||
46629060|NCT01998906|82799881|FG002|Overall Study|Administrative/Other|3|||
46629061|NCT01998906|82799879|FG000|Overall Study|Other|3|||
47033661|NCT01584843|83284449|FG001|Second Treatment Period|Withdrawal by Subject|0|||
47033662|NCT01584843|83284450|FG002|Second Treatment Period|Withdrawal by Subject|0|||
47033663|NCT01584843|83284451|FG003|Second Treatment Period|Withdrawal by Subject|0|||
47033664|NCT01584843|83284452|FG004|Second Treatment Period|Withdrawal by Subject|0|||
47033665|NCT01584843|83284453|FG005|Second Treatment Period|Withdrawal by Subject|1|||
47033666|NCT01560429|83284471|FG000|Overall Study|Protocol Violation|3|||
47033667|NCT01560429|83284472|FG001|Overall Study|Protocol Violation|6|||
47033668|NCT01582971|83284482|FG000|Overall Study|Death|2|||
47033669|NCT01582971|83284483|FG001|Overall Study|Death|1|||
47033670|NCT01582971|83284482|FG000|Overall Study|Lost to Follow-up|18|||
47033671|NCT01582971|83284483|FG001|Overall Study|Lost to Follow-up|21|||
47033672|NCT01582971|83284482|FG000|Overall Study|Withdrawal by Subject|4|||
47033673|NCT01582971|83284483|FG001|Overall Study|Withdrawal by Subject|2|||
47033674|NCT01582971|83284482|FG000|Overall Study|Other|15|||
47033675|NCT01582971|83284483|FG001|Overall Study|Other|13|||
47033676|NCT01690299|83284498|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
47033677|NCT01690299|83284499|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
47033678|NCT01690299|83284500|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
47033679|NCT01690299|83284501|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
47033680|NCT01690299|83284502|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
46629062|NCT01998906|82799880|FG001|Overall Study|Other|8|||
46629063|NCT01998906|82799881|FG002|Overall Study|Other|4|||
46629064|NCT01967550|82799894|FG000|Overall Study|Withdrawal by Subject|1|||
46629065|NCT01967550|82799895|FG001|Overall Study|Withdrawal by Subject|0|||
46629066|NCT01967550|82799894|FG000|Overall Study|Adverse Event|2|||
46629067|NCT01967550|82799895|FG001|Overall Study|Adverse Event|0|||
46629068|NCT01967550|82799894|FG000|Overall Study|Protocol Violation|2|||
46629069|NCT01967550|82799895|FG001|Overall Study|Protocol Violation|1|||
46629070|NCT01967550|82799894|FG000|Overall Study|Non Compliance|0|||
46629071|NCT01967550|82799895|FG001|Overall Study|Non Compliance|1|||
46629072|NCT01989546|82799901|FG000|Overall Study|Clinical Progression|1|||
46629073|NCT01989546|82799901|FG000|Overall Study|Disease progression on study|8|||
46629074|NCT01997892|82799905|FG000|Overall Study|Physician Decision|2|||
47033681|NCT01690299|83284503|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
47033682|NCT01690299|83284498|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
47033683|NCT01690299|83284499|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
47033684|NCT01690299|83284500|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
47033685|NCT01690299|83284501|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
47033686|NCT01690299|83284502|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
47033687|NCT01690299|83284503|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
47033688|NCT01690299|83284498|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
47033689|NCT01690299|83284499|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
47033690|NCT01690299|83284500|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
47033691|NCT01690299|83284501|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
47033692|NCT01690299|83284502|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46629075|NCT01997892|82799905|FG000|Overall Study|Lost to Follow-up|6|||
46629076|NCT01997892|82799905|FG000|Overall Study|Death|14|||
46629077|NCT01997892|82799905|FG000|Overall Study|Renal transplant|8|||
46629078|NCT01997892|82799905|FG000|Overall Study|Other|3|||
46629079|NCT01997892|82799905|FG000|Overall Study|Study completion data not recorded|35|||
46629080|NCT01989468|82799917|FG000|Overall Study|Adverse Event|10|||
47033693|NCT01690299|83284503|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
47033694|NCT01690299|83284498|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
47033695|NCT01690299|83284499|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
46629081|NCT01989468|82799918|FG001|Overall Study|Adverse Event|15|||
46629082|NCT01989468|82799919|FG002|Overall Study|Adverse Event|4|||
46629083|NCT01989468|82799920|FG003|Overall Study|Adverse Event|5|||
46629084|NCT01989468|82799921|FG004|Overall Study|Adverse Event|4|||
47033696|NCT01690299|83284500|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
47033697|NCT01690299|83284501|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
47033698|NCT01690299|83284502|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
47033699|NCT01690299|83284503|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
47033700|NCT01690299|83284498|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
47033701|NCT01690299|83284499|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
47033702|NCT01690299|83284500|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
47033703|NCT01690299|83284501|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
47033704|NCT01690299|83284502|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
47033705|NCT01690299|83284503|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
47033706|NCT01690299|83284498|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
47033707|NCT01690299|83284499|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
47033708|NCT01690299|83284500|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
47033709|NCT01690299|83284501|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
47033710|NCT01690299|83284502|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
47033711|NCT01690299|83284503|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
47033712|NCT01690299|83284498|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
47033713|NCT01690299|83284499|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
47033714|NCT01690299|83284500|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
47033715|NCT01690299|83284501|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
47033716|NCT01690299|83284502|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
47033717|NCT01690299|83284503|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
47033718|NCT01690299|83284498|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
46629085|NCT01989468|82799917|FG000|Overall Study|Lack of Efficacy|11|||
46629086|NCT01989468|82799918|FG001|Overall Study|Lack of Efficacy|11|||
47033719|NCT01690299|83284499|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
47033720|NCT01690299|83284500|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
47033721|NCT01690299|83284501|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
47033722|NCT01690299|83284502|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
47033723|NCT01690299|83284503|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
47033724|NCT01690299|83284498|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
47033725|NCT01690299|83284499|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
47033726|NCT01690299|83284500|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
47033727|NCT01690299|83284501|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
47033728|NCT01690299|83284502|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
47033729|NCT01690299|83284503|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
47033730|NCT01690299|83284498|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
47033731|NCT01690299|83284499|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
47033732|NCT01690299|83284500|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
47033733|NCT01690299|83284501|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
47033734|NCT01690299|83284502|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
47033735|NCT01690299|83284503|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
47033736|NCT01690143|83284532|FG000|Overall Study|Withdrawal by Subject|1|||
47033737|NCT01559259|83284551|FG000|Overall Study|Withdrawal by Subject|0|||
47033738|NCT01559259|83284552|FG001|Overall Study|Withdrawal by Subject|0|||
47033739|NCT01559259|83284553|FG002|Overall Study|Withdrawal by Subject|0|||
47033740|NCT01559259|83284554|FG003|Overall Study|Withdrawal by Subject|1|||
47033741|NCT01559259|83284555|FG004|Overall Study|Withdrawal by Subject|0|||
47033742|NCT01559259|83284551|FG000|Overall Study|Adverse Event|0|||
46629087|NCT01989468|82799919|FG002|Overall Study|Lack of Efficacy|7|||
46629088|NCT01989468|82799920|FG003|Overall Study|Lack of Efficacy|4|||
46629089|NCT01989468|82799921|FG004|Overall Study|Lack of Efficacy|2|||
47033743|NCT01559259|83284552|FG001|Overall Study|Adverse Event|1|||
47033744|NCT01559259|83284553|FG002|Overall Study|Adverse Event|1|||
47033745|NCT01559259|83284554|FG003|Overall Study|Adverse Event|0|||
47033746|NCT01559259|83284555|FG004|Overall Study|Adverse Event|0|||
47033747|NCT01670500|83284579|FG000|Overall Study|Withdrawal by Subject|1|||
47033748|NCT01670500|83284580|FG001|Overall Study|Withdrawal by Subject|0|||
47033749|NCT02400736|83284588|FG000|Overall Study|Lost to Follow-up|6|||
47033750|NCT02400736|83284589|FG001|Overall Study|Lost to Follow-up|6|||
47033751|NCT02400736|83284588|FG000|Overall Study|Withdrawal by Subject|2|||
47033752|NCT02400736|83284589|FG001|Overall Study|Withdrawal by Subject|1|||
47033753|NCT02400736|83284588|FG000|Overall Study|Moved from the area|3|||
47033754|NCT02400736|83284589|FG001|Overall Study|Moved from the area|1|||
47033755|NCT01689519|83284601|FG000|Intent to Treat|Death|157|||
46629090|NCT01989468|82799917|FG000|Overall Study|Lost to Follow-up|5|||
46629091|NCT01989468|82799918|FG001|Overall Study|Lost to Follow-up|2|||
46629092|NCT01989468|82799919|FG002|Overall Study|Lost to Follow-up|0|||
47033756|NCT01689519|83284602|FG001|Intent to Treat|Death|167|||
47033757|NCT01689519|83284601|FG000|Intent to Treat|Lost to Follow-up|4|||
47033758|NCT01689519|83284602|FG001|Intent to Treat|Lost to Follow-up|8|||
47033759|NCT01689519|83284601|FG000|Intent to Treat|Other|2|||
47033760|NCT01689519|83284602|FG001|Intent to Treat|Other|4|||
47033761|NCT01689519|83284601|FG000|Intent to Treat|Physician Decision|4|||
47033762|NCT01689519|83284602|FG001|Intent to Treat|Physician Decision|1|||
47033763|NCT01689519|83284601|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
47033764|NCT01689519|83284602|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
47033765|NCT01689519|83284601|FG000|Intent to Treat|Withdrawal by Subject|21|||
47033766|NCT01689519|83284602|FG001|Intent to Treat|Withdrawal by Subject|20|||
47033767|NCT01689519|83284601|FG000|Safety Population|Death|158|||
46629093|NCT01989468|82799920|FG003|Overall Study|Lost to Follow-up|1|||
46629094|NCT01989468|82799921|FG004|Overall Study|Lost to Follow-up|1|||
46629095|NCT01989468|82799917|FG000|Overall Study|Physician Decision|4|||
46629096|NCT01989468|82799918|FG001|Overall Study|Physician Decision|1|||
46629097|NCT01989468|82799919|FG002|Overall Study|Physician Decision|0|||
46629098|NCT01989468|82799920|FG003|Overall Study|Physician Decision|1|||
46629099|NCT01989468|82799921|FG004|Overall Study|Physician Decision|0|||
46629100|NCT01989468|82799917|FG000|Overall Study|Pregnancy|0|||
46629101|NCT01989468|82799918|FG001|Overall Study|Pregnancy|1|||
46629102|NCT01989468|82799919|FG002|Overall Study|Pregnancy|0|||
46629103|NCT01989468|82799920|FG003|Overall Study|Pregnancy|0|||
46629104|NCT01989468|82799921|FG004|Overall Study|Pregnancy|0|||
46629105|NCT01989468|82799917|FG000|Overall Study|Technical Problems|3|||
46629106|NCT01989468|82799918|FG001|Overall Study|Technical Problems|1|||
46629107|NCT01989468|82799919|FG002|Overall Study|Technical Problems|3|||
46629108|NCT01989468|82799920|FG003|Overall Study|Technical Problems|1|||
46629109|NCT01989468|82799921|FG004|Overall Study|Technical Problems|0|||
46629110|NCT01989468|82799917|FG000|Overall Study|Subject Guardian Decision|11|||
46629111|NCT01989468|82799918|FG001|Overall Study|Subject Guardian Decision|6|||
46629112|NCT01989468|82799919|FG002|Overall Study|Subject Guardian Decision|4|||
46629113|NCT01989468|82799920|FG003|Overall Study|Subject Guardian Decision|4|||
46629114|NCT01989468|82799921|FG004|Overall Study|Subject Guardian Decision|1|||
46629115|NCT01989468|82799917|FG000|Overall Study|Death|3|||
46629116|NCT01989468|82799918|FG001|Overall Study|Death|0|||
46629117|NCT01989468|82799919|FG002|Overall Study|Death|1|||
46629118|NCT01989468|82799920|FG003|Overall Study|Death|0|||
46629119|NCT01989468|82799921|FG004|Overall Study|Death|0|||
46629120|NCT01989156|82799937|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
46629121|NCT01989156|82799938|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
46629122|NCT01989156|82799939|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
46629123|NCT01989156|82799937|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
46629124|NCT01989156|82799938|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
47033768|NCT01689519|83284602|FG001|Safety Population|Death|165|||
47033769|NCT01689519|83284601|FG000|Safety Population|Lost to Follow-up|4|||
47033770|NCT01689519|83284602|FG001|Safety Population|Lost to Follow-up|8|||
47033771|NCT01689519|83284601|FG000|Safety Population|Other|2|||
47033772|NCT01689519|83284602|FG001|Safety Population|Other|4|||
47033773|NCT01689519|83284601|FG000|Safety Population|Physician Decision|4|||
47033774|NCT01689519|83284602|FG001|Safety Population|Physician Decision|1|||
47033775|NCT01689519|83284601|FG000|Safety Population|Study Terminated By Sponsor|60|||
47033776|NCT01689519|83284602|FG001|Safety Population|Study Terminated By Sponsor|47|||
47033777|NCT01689519|83284601|FG000|Safety Population|Withdrawal by Subject|20|||
47033778|NCT01689519|83284602|FG001|Safety Population|Withdrawal by Subject|20|||
47033779|NCT01689363|83284608|FG000|Overall Study|Protocol Violation|0|||
47033780|NCT01689363|83284609|FG001|Overall Study|Protocol Violation|1|||
47033781|NCT01689363|83284610|FG002|Overall Study|Protocol Violation|0|||
46629125|NCT01989156|82799939|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
46629126|NCT01989156|82799937|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
46629127|NCT01989156|82799938|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
46629128|NCT01989156|82799939|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
46629129|NCT01989156|82799937|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
46629130|NCT01989156|82799938|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
46629131|NCT01989156|82799939|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
47033782|NCT01689363|83284611|FG003|Overall Study|Protocol Violation|0|||
47033783|NCT01689363|83284612|FG004|Overall Study|Protocol Violation|0|||
47033784|NCT01689363|83284613|FG005|Overall Study|Protocol Violation|0|||
47033785|NCT01689363|83284614|FG006|Overall Study|Protocol Violation|0|||
46629132|NCT01989156|82799937|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
47033786|NCT01689363|83284615|FG007|Overall Study|Protocol Violation|0|||
47033787|NCT01558635|83284631|FG000|Overall Study|Death|1|||
47033788|NCT01558635|83284631|FG000|Overall Study|Withdrawal by Subject|2|||
47033789|NCT01558635|83284631|FG000|Overall Study|Physician Decision|1|||
46629133|NCT01989156|82799938|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
46629134|NCT01989156|82799939|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
47033790|NCT01558635|83284631|FG000|Overall Study|Subject received other treatment|1|||
47033791|NCT01558635|83284631|FG000|Overall Study|Reveal XT was explanted|1|||
47033792|NCT00089986|83284645|FG000|Overall Study|Adverse Event|6|||
47033793|NCT00089986|83284646|FG001|Overall Study|Adverse Event|9|||
47033794|NCT00089986|83284647|FG002|Overall Study|Adverse Event|6|||
47033795|NCT00089986|83284645|FG000|Overall Study|Lost to Follow-up|3|||
47033796|NCT00089986|83284646|FG001|Overall Study|Lost to Follow-up|1|||
47033797|NCT00089986|83284647|FG002|Overall Study|Lost to Follow-up|1|||
47033798|NCT00089986|83284645|FG000|Overall Study|Protocol Violation|0|||
47033799|NCT00089986|83284646|FG001|Overall Study|Protocol Violation|1|||
47033800|NCT00089986|83284647|FG002|Overall Study|Protocol Violation|0|||
47033801|NCT00089986|83284645|FG000|Overall Study|Patient transferred to another hospital|2|||
47033802|NCT00089986|83284646|FG001|Overall Study|Patient transferred to another hospital|1|||
47033803|NCT00089986|83284647|FG002|Overall Study|Patient transferred to another hospital|0|||
47033804|NCT00089986|83284645|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
47033805|NCT00089986|83284646|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
47033806|NCT00089986|83284647|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
47033807|NCT00089986|83284645|FG000|Overall Study|Hemohlobin stopping rule|0|||
47033808|NCT00089986|83284646|FG001|Overall Study|Hemohlobin stopping rule|1|||
47033809|NCT00089986|83284647|FG002|Overall Study|Hemohlobin stopping rule|0|||
47033810|NCT00089986|83284645|FG000|Overall Study|Investigator decision to withdrew|0|||
47033811|NCT00089986|83284646|FG001|Overall Study|Investigator decision to withdrew|1|||
47033812|NCT00089986|83284647|FG002|Overall Study|Investigator decision to withdrew|0|||
47033813|NCT00089986|83284645|FG000|Overall Study|Enrollment in another study|0|||
47033814|NCT00089986|83284646|FG001|Overall Study|Enrollment in another study|1|||
47033815|NCT00089986|83284647|FG002|Overall Study|Enrollment in another study|0|||
47033816|NCT00089986|83284645|FG000|Overall Study|Family decision|0|||
47033817|NCT00089986|83284646|FG001|Overall Study|Family decision|1|||
47033818|NCT00089986|83284647|FG002|Overall Study|Family decision|0|||
47033819|NCT00089986|83284645|FG000|Overall Study|Do not resuscitate (DNR)|0|||
47033820|NCT00089986|83284646|FG001|Overall Study|Do not resuscitate (DNR)|0|||
47033821|NCT00089986|83284647|FG002|Overall Study|Do not resuscitate (DNR)|1|||
47033822|NCT00089986|83284645|FG000|Overall Study|Withdrawal by Subject|3|||
47033823|NCT00089986|83284646|FG001|Overall Study|Withdrawal by Subject|6|||
47033824|NCT00089986|83284647|FG002|Overall Study|Withdrawal by Subject|2|||
47033825|NCT01689207|83284670|FG000|Overall Study|Adverse Event|0|||
47033826|NCT01689207|83284671|FG001|Overall Study|Adverse Event|1|||
47033827|NCT01689207|83284672|FG002|Overall Study|Adverse Event|0|||
47033828|NCT01689207|83284673|FG003|Overall Study|Adverse Event|0|||
47033829|NCT01689207|83284674|FG004|Overall Study|Adverse Event|2|||
46629135|NCT01989156|82799937|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
46629136|NCT01989156|82799938|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
46913066|NCT03237065|83143225|FG001|Overall Study|Unable to obtain venous access|1|||
46913067|NCT03171415|83143236|FG000|Overall Study|Lost to Follow-up|0|||
46913068|NCT03171415|83143237|FG001|Overall Study|Lost to Follow-up|0|||
46913069|NCT03171415|83143238|FG002|Overall Study|Lost to Follow-up|0|||
46913070|NCT03171415|83143239|FG003|Overall Study|Lost to Follow-up|0|||
47033830|NCT01689207|83284675|FG005|Overall Study|Adverse Event|1|||
47033831|NCT01689207|83284676|FG006|Overall Study|Adverse Event|0|||
47033832|NCT01689207|83284677|FG007|Overall Study|Adverse Event|0|||
47033833|NCT01689207|83284678|FG008|Overall Study|Adverse Event|1|||
47033834|NCT01689207|83284679|FG009|Overall Study|Adverse Event|0|||
47033835|NCT01689207|83284680|FG010|Overall Study|Adverse Event|0|||
47033836|NCT00089284|83284715|FG000|Overall Study|Adverse event before starting treatment|0|||
47033837|NCT00089284|83284716|FG001|Overall Study|Adverse event before starting treatment|0|||
47033838|NCT00089284|83284717|FG002|Overall Study|Adverse event before starting treatment|0|||
47033839|NCT00089284|83284718|FG003|Overall Study|Adverse event before starting treatment|0|||
47033840|NCT00089284|83284719|FG004|Overall Study|Adverse event before starting treatment|0|||
47033841|NCT00089284|83284720|FG005|Overall Study|Adverse event before starting treatment|0|||
47033842|NCT00089284|83284721|FG006|Overall Study|Adverse event before starting treatment|1|||
47033843|NCT01688973|83284745|FG000|Overall Study|Ineligible|2|||
47033844|NCT01688973|83284746|FG001|Overall Study|Ineligible|3|||
47033845|NCT00087646|83284757|FG000|Overall Study|Adverse Event|37|||
47033846|NCT00087646|83284758|FG001|Overall Study|Adverse Event|6|||
47033847|NCT00087646|83284759|FG002|Overall Study|Adverse Event|18|||
47033848|NCT00087646|83284760|FG003|Overall Study|Adverse Event|20|||
46629137|NCT01989156|82799939|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
46629138|NCT01989156|82799937|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
46629139|NCT01989156|82799938|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
47033849|NCT00087646|83284757|FG000|Overall Study|Death|0|||
47033850|NCT00087646|83284758|FG001|Overall Study|Death|1|||
47033851|NCT00087646|83284759|FG002|Overall Study|Death|0|||
46629140|NCT01989156|82799939|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
46913071|NCT03171415|83143240|FG004|Overall Study|Lost to Follow-up|2|||
47033852|NCT00087646|83284760|FG003|Overall Study|Death|0|||
47033853|NCT00087646|83284757|FG000|Overall Study|Withdrawal by Subject|6|||
47033854|NCT00087646|83284758|FG001|Overall Study|Withdrawal by Subject|1|||
47033855|NCT00087646|83284759|FG002|Overall Study|Withdrawal by Subject|2|||
47033856|NCT00087646|83284760|FG003|Overall Study|Withdrawal by Subject|2|||
47033857|NCT00087646|83284757|FG000|Overall Study|Insufficient therapeutic response|64|||
47033858|NCT00087646|83284758|FG001|Overall Study|Insufficient therapeutic response|24|||
47033859|NCT00087646|83284759|FG002|Overall Study|Insufficient therapeutic response|38|||
47033860|NCT00087646|83284760|FG003|Overall Study|Insufficient therapeutic response|51|||
47033861|NCT00087646|83284757|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
47033862|NCT00087646|83284758|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
47033863|NCT00087646|83284759|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
47033864|NCT00087646|83284760|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
47033865|NCT00087646|83284757|FG000|Overall Study|Failure to Return|5|||
47033866|NCT00087646|83284758|FG001|Overall Study|Failure to Return|2|||
47033867|NCT00087646|83284759|FG002|Overall Study|Failure to Return|2|||
47033868|NCT00087646|83284760|FG003|Overall Study|Failure to Return|3|||
47033869|NCT00087646|83284757|FG000|Overall Study|Administrative/Other|6|||
47033870|NCT00087646|83284758|FG001|Overall Study|Administrative/Other|1|||
47033871|NCT00087646|83284759|FG002|Overall Study|Administrative/Other|1|||
47033872|NCT00087646|83284760|FG003|Overall Study|Administrative/Other|2|||
47033873|NCT00087646|83284757|FG000|Overall Study|Other Protocol Violation|3|||
47033874|NCT00087646|83284758|FG001|Overall Study|Other Protocol Violation|1|||
47033875|NCT00087646|83284759|FG002|Overall Study|Other Protocol Violation|0|||
47033876|NCT00087646|83284760|FG003|Overall Study|Other Protocol Violation|0|||
47033877|NCT00087646|83284757|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
47033878|NCT00087646|83284758|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
47033879|NCT00087646|83284759|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
47033880|NCT00087646|83284760|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
47033881|NCT00087568|83284777|FG000|Overall Study|Adverse Event|4|||
47033882|NCT00087568|83284778|FG001|Overall Study|Adverse Event|0|||
47033883|NCT00087568|83284777|FG000|Overall Study|Withdrawal by Subject|1|||
47033884|NCT00087568|83284778|FG001|Overall Study|Withdrawal by Subject|1|||
47033885|NCT00087568|83284777|FG000|Overall Study|Lost to Follow-up|1|||
47033886|NCT00087568|83284778|FG001|Overall Study|Lost to Follow-up|0|||
47033887|NCT00087568|83284777|FG000|Overall Study|Lack of Efficacy|24|||
47033888|NCT00087568|83284778|FG001|Overall Study|Lack of Efficacy|1|||
47033889|NCT00085540|83284786|FG000|Overall Study|Withdrawal by Subject|0|||
47033890|NCT00085540|83284787|FG001|Overall Study|Withdrawal by Subject|1|||
47033891|NCT00085540|83284786|FG000|Overall Study|Protocol Violation|0|||
47033892|NCT00085540|83284787|FG001|Overall Study|Protocol Violation|1|||
47033893|NCT01688739|83284803|FG000|Overall Study|Administrative Decision|1|||
47033894|NCT01688739|83284804|FG001|Overall Study|Administrative Decision|0|||
47033895|NCT01688739|83284805|FG002|Overall Study|Administrative Decision|0|||
47033896|NCT01688739|83284806|FG003|Overall Study|Administrative Decision|0|||
47033897|NCT01688739|83284807|FG004|Overall Study|Administrative Decision|0|||
47033898|NCT01688739|83284808|FG005|Overall Study|Administrative Decision|0|||
47033899|NCT01688739|83284809|FG006|Overall Study|Administrative Decision|0|||
47033900|NCT01688739|83284810|FG007|Overall Study|Administrative Decision|0|||
47033901|NCT01688739|83284811|FG008|Overall Study|Administrative Decision|0|||
47033902|NCT01688739|83284812|FG009|Overall Study|Administrative Decision|0|||
47033903|NCT00084838|83284842|FG000|Overall Study|Death|1|||
46629141|NCT01989156|82799937|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
46629142|NCT01989156|82799938|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
46629143|NCT01989156|82799939|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
46629144|NCT01620762|82799950|FG000|Overall Study|Protocol Violation|1|||
46629145|NCT01620762|82799951|FG001|Overall Study|Protocol Violation|1|||
46629146|NCT01620762|82799952|FG002|Overall Study|Protocol Violation|1|||
46629147|NCT01620762|82799950|FG000|Overall Study|Adverse Event|9|||
47033904|NCT00084838|83284842|FG000|Overall Study|Adverse Event|2|||
47033905|NCT00084838|83284842|FG000|Overall Study|Withdrawal by Subject|1|||
47033906|NCT00084838|83284842|FG000|Overall Study|Progressive Disease|4|||
47033907|NCT00084838|83284842|FG000|Overall Study|Pt Non-Compliance|1|||
47033908|NCT00084838|83284842|FG000|Overall Study|Ineligible|4|||
47033909|NCT01558089|83284848|FG000|Overall Study|Adverse Event|1|||
47033910|NCT01558089|83284848|FG000|Overall Study|Lack of Efficacy|1|||
47033911|NCT01558089|83284848|FG000|Overall Study|Lost to Follow-up|5|||
46629148|NCT01620762|82799951|FG001|Overall Study|Adverse Event|5|||
46629149|NCT01620762|82799952|FG002|Overall Study|Adverse Event|2|||
47033912|NCT01558089|83284848|FG000|Overall Study|Withdrawal by Subject|6|||
47033913|NCT01581021|83284854|FG000|Overall Study|Lost to Follow-up|4|||
47033914|NCT01581021|83284855|FG001|Overall Study|Lost to Follow-up|6|||
47033915|NCT01581021|83284854|FG000|Overall Study|More than 2 hooks in thoracic|3|||
47033916|NCT01581021|83284855|FG001|Overall Study|More than 2 hooks in thoracic|0|||
47033917|NCT01581021|83284854|FG000|Overall Study|Neuromuscular|2|||
47033918|NCT01581021|83284855|FG001|Overall Study|Neuromuscular|1|||
47033919|NCT01581021|83284854|FG000|Overall Study|Not Randomized|1|||
47033920|NCT01581021|83284855|FG001|Overall Study|Not Randomized|2|||
47033921|NCT01581021|83284854|FG000|Overall Study|Lenke 6 Classification|0|||
47033922|NCT01581021|83284855|FG001|Overall Study|Lenke 6 Classification|1|||
47033923|NCT01581021|83284854|FG000|Overall Study|Lack of Efficacy|0|||
47033924|NCT01581021|83284855|FG001|Overall Study|Lack of Efficacy|1|||
47033925|NCT00084682|83284861|FG000|Overall Study|Withdrawal by Subject|1|||
47033926|NCT01556997|83284869|FG000|Overall Study|Adverse Event|10|||
47033927|NCT01556997|83284870|FG001|Overall Study|Adverse Event|12|||
47033928|NCT01556997|83284871|FG002|Overall Study|Adverse Event|12|||
47033929|NCT01556997|83284869|FG000|Overall Study|Lost to Follow-up|6|||
47033930|NCT01556997|83284870|FG001|Overall Study|Lost to Follow-up|6|||
47033931|NCT01556997|83284871|FG002|Overall Study|Lost to Follow-up|4|||
47033932|NCT01556997|83284869|FG000|Overall Study|Physician Decision|1|||
47033933|NCT01556997|83284870|FG001|Overall Study|Physician Decision|1|||
47033934|NCT01556997|83284871|FG002|Overall Study|Physician Decision|1|||
47033935|NCT01556997|83284869|FG000|Overall Study|Withdrawal by Subject|7|||
47033936|NCT01556997|83284870|FG001|Overall Study|Withdrawal by Subject|6|||
47033937|NCT01556997|83284871|FG002|Overall Study|Withdrawal by Subject|8|||
47033938|NCT01556997|83284869|FG000|Overall Study|Other|2|||
47033939|NCT01556997|83284870|FG001|Overall Study|Other|3|||
47033940|NCT01556997|83284871|FG002|Overall Study|Other|7|||
47033941|NCT00082888|83284882|FG000|Overall Study|Ineligible|1|||
47033942|NCT00082888|83284883|FG001|Overall Study|Ineligible|0|||
47033943|NCT00082888|83284884|FG002|Overall Study|Ineligible|0|||
47033944|NCT00082810|83284893|FG000|Overall Study|Adverse Event|3|||
47033945|NCT00082810|83284893|FG000|Overall Study|Progressive disease|24|||
47033946|NCT00082810|83284893|FG000|Overall Study|Withdrawal by Subject|4|||
47033947|NCT01577745|83284904|FG000|Overall Study|Withdrawal by Subject|0|||
47033948|NCT01577745|83284905|FG001|Overall Study|Withdrawal by Subject|1|||
47033949|NCT01577745|83284906|FG002|Overall Study|Withdrawal by Subject|0|||
47033950|NCT01577745|83284907|FG003|Overall Study|Withdrawal by Subject|3|||
47033951|NCT01577745|83284908|FG004|Overall Study|Withdrawal by Subject|2|||
47033952|NCT01577745|83284909|FG005|Overall Study|Withdrawal by Subject|0|||
47033953|NCT01577745|83284904|FG000|Overall Study|Death|3|||
47033954|NCT01577745|83284905|FG001|Overall Study|Death|2|||
47033955|NCT01577745|83284906|FG002|Overall Study|Death|2|||
47033956|NCT01577745|83284907|FG003|Overall Study|Death|1|||
47033957|NCT01577745|83284908|FG004|Overall Study|Death|1|||
47033958|NCT01577745|83284909|FG005|Overall Study|Death|3|||
47033959|NCT01577745|83284904|FG000|Overall Study|Physician Decision|0|||
47033960|NCT01577745|83284905|FG001|Overall Study|Physician Decision|0|||
47033961|NCT01577745|83284906|FG002|Overall Study|Physician Decision|0|||
47033962|NCT01577745|83284907|FG003|Overall Study|Physician Decision|1|||
47033963|NCT01577745|83284908|FG004|Overall Study|Physician Decision|1|||
47033964|NCT01577745|83284909|FG005|Overall Study|Physician Decision|0|||
47033965|NCT01577745|83284904|FG000|Overall Study|Lost to Follow-up|0|||
47033966|NCT01577745|83284905|FG001|Overall Study|Lost to Follow-up|0|||
47033967|NCT01577745|83284906|FG002|Overall Study|Lost to Follow-up|0|||
47033968|NCT01577745|83284907|FG003|Overall Study|Lost to Follow-up|0|||
47033969|NCT01577745|83284908|FG004|Overall Study|Lost to Follow-up|0|||
47033970|NCT01577745|83284909|FG005|Overall Study|Lost to Follow-up|1|||
47033971|NCT01577745|83284904|FG000|Overall Study|Alternative Therapy|0|||
47033972|NCT01577745|83284905|FG001|Overall Study|Alternative Therapy|0|||
47033973|NCT01577745|83284906|FG002|Overall Study|Alternative Therapy|0|||
47033974|NCT01577745|83284907|FG003|Overall Study|Alternative Therapy|1|||
47033975|NCT01577745|83284908|FG004|Overall Study|Alternative Therapy|1|||
47033976|NCT01577745|83284909|FG005|Overall Study|Alternative Therapy|0|||
47033977|NCT01688037|83284931|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
47033978|NCT01688037|83284932|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
47033979|NCT01688037|83284933|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
47033980|NCT01688037|83284931|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
47033981|NCT01688037|83284932|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
46629150|NCT01620762|82799950|FG000|Overall Study|Withdrawal by Subject|23|||
47033982|NCT01688037|83284933|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
47033983|NCT01688037|83284931|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
47033984|NCT01688037|83284932|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
47033985|NCT01688037|83284933|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
47033986|NCT01688037|83284931|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
47033987|NCT01688037|83284932|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
46629151|NCT01620762|82799951|FG001|Overall Study|Withdrawal by Subject|26|||
47033988|NCT01688037|83284933|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
46629152|NCT01620762|82799952|FG002|Overall Study|Withdrawal by Subject|27|||
47033989|NCT01688037|83284931|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
47033990|NCT01688037|83284932|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
47033991|NCT01688037|83284933|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
47033992|NCT01688037|83284931|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
47033993|NCT01688037|83284932|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
47033994|NCT01688037|83284933|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
47033995|NCT01688037|83284931|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
47033996|NCT01688037|83284932|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
47033997|NCT01688037|83284933|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
47033998|NCT01688037|83284931|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
47033999|NCT01688037|83284932|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
47034000|NCT01688037|83284933|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
47034001|NCT01688037|83284931|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
47034002|NCT01688037|83284932|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
47034003|NCT01688037|83284933|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
47034004|NCT01688037|83284931|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
47034005|NCT01688037|83284932|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
47034006|NCT01688037|83284933|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
47034007|NCT01610336|83284956|FG000|Overall Study|Progressive Disease|4|||
47034008|NCT01610336|83284957|FG001|Overall Study|Progressive Disease|6|||
47034009|NCT01610336|83284958|FG002|Overall Study|Progressive Disease|6|||
47034010|NCT01610336|83284959|FG003|Overall Study|Progressive Disease|5|||
47034011|NCT01610336|83284960|FG004|Overall Study|Progressive Disease|3|||
47034012|NCT01610336|83284961|FG005|Overall Study|Progressive Disease|10|||
47034013|NCT01610336|83284962|FG006|Overall Study|Progressive Disease|1|||
47034014|NCT01610336|83284963|FG007|Overall Study|Progressive Disease|6|||
46629153|NCT01620762|82799950|FG000|Overall Study|Lost to Follow-up|11|||
46913072|NCT03829241|83143265|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
46629154|NCT01620762|82799951|FG001|Overall Study|Lost to Follow-up|17|||
46629155|NCT01620762|82799952|FG002|Overall Study|Lost to Follow-up|10|||
46629156|NCT01620762|82799950|FG000|Overall Study|Protocol deviation|1|||
46913073|NCT03829241|83143266|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
46913074|NCT03829241|83143265|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
46913075|NCT03829241|83143266|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
46913076|NCT03829241|83143265|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
46913077|NCT03829241|83143266|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
46913078|NCT03829241|83143265|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
46913079|NCT03829241|83143266|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
46913080|NCT03829241|83143265|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
46913081|NCT03829241|83143266|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
46913082|NCT03829241|83143265|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
46913083|NCT03829241|83143266|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
46913084|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
46913085|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
46913086|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
46913087|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
46913088|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
46913089|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
46913090|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
46913091|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
46913092|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
46913093|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
46913094|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
46913095|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
46913096|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
46913097|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
46913098|NCT03829241|83143265|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
46913099|NCT03829241|83143266|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
46913100|NCT03164551|83143278|FG000|Overall Study|Imaging discontinued prior completion|8|||
46913101|NCT03164551|83143279|FG001|Overall Study|Imaging discontinued prior completion|0|||
46913102|NCT03164551|83143278|FG000|Overall Study|Participant was non-compliant|1|||
46913103|NCT03164551|83143279|FG001|Overall Study|Participant was non-compliant|0|||
47034015|NCT01610336|83284964|FG008|Overall Study|Progressive Disease|6|||
47034016|NCT01610336|83284965|FG009|Overall Study|Progressive Disease|40|||
46629157|NCT01620762|82799951|FG001|Overall Study|Protocol deviation|1|||
46629158|NCT01620762|82799952|FG002|Overall Study|Protocol deviation|6|||
46629159|NCT01620762|82799950|FG000|Overall Study|Subject deterioration|0|||
47034017|NCT01610336|83284966|FG010|Overall Study|Progressive Disease|36|||
46629160|NCT01620762|82799951|FG001|Overall Study|Subject deterioration|1|||
47034018|NCT01610336|83284956|FG000|Overall Study|Adverse Event|0|||
47034019|NCT01610336|83284957|FG001|Overall Study|Adverse Event|0|||
47034020|NCT01610336|83284958|FG002|Overall Study|Adverse Event|0|||
47034021|NCT01610336|83284959|FG003|Overall Study|Adverse Event|1|||
47034022|NCT01610336|83284960|FG004|Overall Study|Adverse Event|1|||
47034023|NCT01610336|83284961|FG005|Overall Study|Adverse Event|1|||
47034024|NCT01610336|83284962|FG006|Overall Study|Adverse Event|0|||
47034025|NCT01610336|83284963|FG007|Overall Study|Adverse Event|0|||
47034026|NCT01610336|83284964|FG008|Overall Study|Adverse Event|2|||
47034027|NCT01610336|83284965|FG009|Overall Study|Adverse Event|8|||
47034028|NCT01610336|83284966|FG010|Overall Study|Adverse Event|6|||
47034029|NCT01610336|83284956|FG000|Overall Study|Subject/Guardian decision|1|||
47034030|NCT01610336|83284957|FG001|Overall Study|Subject/Guardian decision|1|||
47034031|NCT01610336|83284958|FG002|Overall Study|Subject/Guardian decision|0|||
47034032|NCT01610336|83284959|FG003|Overall Study|Subject/Guardian decision|1|||
47034033|NCT01610336|83284960|FG004|Overall Study|Subject/Guardian decision|0|||
47034034|NCT01610336|83284961|FG005|Overall Study|Subject/Guardian decision|0|||
47034035|NCT01610336|83284962|FG006|Overall Study|Subject/Guardian decision|0|||
47034036|NCT01610336|83284963|FG007|Overall Study|Subject/Guardian decision|1|||
47034037|NCT01610336|83284964|FG008|Overall Study|Subject/Guardian decision|0|||
47034038|NCT01610336|83284965|FG009|Overall Study|Subject/Guardian decision|2|||
47034039|NCT01610336|83284966|FG010|Overall Study|Subject/Guardian decision|2|||
47034040|NCT01610336|83284956|FG000|Overall Study|Death|0|||
47034041|NCT01610336|83284957|FG001|Overall Study|Death|0|||
47034042|NCT01610336|83284958|FG002|Overall Study|Death|0|||
47034043|NCT01610336|83284959|FG003|Overall Study|Death|0|||
47034044|NCT01610336|83284960|FG004|Overall Study|Death|0|||
46629161|NCT01620762|82799952|FG002|Overall Study|Subject deterioration|1|||
46629162|NCT01620762|82799950|FG000|Overall Study|Non-specified|3|||
46629163|NCT01620762|82799951|FG001|Overall Study|Non-specified|6|||
46629164|NCT01620762|82799952|FG002|Overall Study|Non-specified|5|||
46629165|NCT01620762|82799950|FG000|Overall Study|Use of prohibted therapies|0|||
46629166|NCT01620762|82799951|FG001|Overall Study|Use of prohibted therapies|1|||
46629167|NCT01620762|82799952|FG002|Overall Study|Use of prohibted therapies|1|||
46629168|NCT01966068|82799962|FG000|Overall Study|Withdrawal by Subject|57|||
46629169|NCT01966068|82799962|FG000|Overall Study|Lost to Follow-up|81|||
46629170|NCT01620528|82799970|FG000|Treatment Period|Did Not Receive Study Drug|0|||
46629171|NCT01620528|82799971|FG001|Treatment Period|Did Not Receive Study Drug|0|||
46629172|NCT01620528|82799972|FG002|Treatment Period|Did Not Receive Study Drug|1|||
46629173|NCT01620528|82799970|FG000|Treatment Period|Withdrawal by Subject|35|||
46629174|NCT01620528|82799971|FG001|Treatment Period|Withdrawal by Subject|21|||
46629175|NCT01620528|82799972|FG002|Treatment Period|Withdrawal by Subject|16|||
46629176|NCT01620528|82799970|FG000|Treatment Period|Adverse Event|17|||
46629177|NCT01620528|82799971|FG001|Treatment Period|Adverse Event|13|||
46629178|NCT01620528|82799972|FG002|Treatment Period|Adverse Event|21|||
46629179|NCT01620528|82799970|FG000|Treatment Period|Lost to Follow-up|16|||
46629180|NCT01620528|82799971|FG001|Treatment Period|Lost to Follow-up|8|||
46629181|NCT01620528|82799972|FG002|Treatment Period|Lost to Follow-up|14|||
46629182|NCT01620528|82799970|FG000|Treatment Period|Other|9|||
46629183|NCT01620528|82799971|FG001|Treatment Period|Other|5|||
46629184|NCT01620528|82799972|FG002|Treatment Period|Other|7|||
46629185|NCT01620528|82799970|FG000|Treatment Period|Subject Noncompliant|11|||
47034045|NCT01610336|83284961|FG005|Overall Study|Death|1|||
47034046|NCT01610336|83284962|FG006|Overall Study|Death|3|||
47034047|NCT01610336|83284963|FG007|Overall Study|Death|0|||
47034048|NCT01610336|83284964|FG008|Overall Study|Death|0|||
47034049|NCT01610336|83284965|FG009|Overall Study|Death|1|||
47034050|NCT01610336|83284966|FG010|Overall Study|Death|2|||
47034051|NCT01610336|83284956|FG000|Overall Study|Non-Compliance with study treatment|0|||
46629186|NCT01620528|82799971|FG001|Treatment Period|Subject Noncompliant|2|||
46710951|NCT01117428|82927250|FG000|Overall Study|Withdrawal by Subject|0|||
46710952|NCT01117428|82927251|FG001|Overall Study|Withdrawal by Subject|0|||
47034052|NCT01610336|83284957|FG001|Overall Study|Non-Compliance with study treatment|0|||
47034053|NCT01610336|83284958|FG002|Overall Study|Non-Compliance with study treatment|0|||
47034054|NCT01610336|83284959|FG003|Overall Study|Non-Compliance with study treatment|0|||
47034055|NCT01610336|83284960|FG004|Overall Study|Non-Compliance with study treatment|0|||
47034056|NCT01610336|83284961|FG005|Overall Study|Non-Compliance with study treatment|0|||
46629187|NCT01620528|82799972|FG002|Treatment Period|Subject Noncompliant|2|||
46629188|NCT01620528|82799970|FG000|Treatment Period|Pregnancy|7|||
46629189|NCT01620528|82799971|FG001|Treatment Period|Pregnancy|2|||
46629190|NCT01620528|82799972|FG002|Treatment Period|Pregnancy|2|||
46629191|NCT01620528|82799970|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
47034057|NCT01610336|83284962|FG006|Overall Study|Non-Compliance with study treatment|0|||
46629192|NCT01620528|82799971|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
47034058|NCT01610336|83284963|FG007|Overall Study|Non-Compliance with study treatment|0|||
46629193|NCT01620528|82799972|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
46629194|NCT01620528|82799970|FG000|Treatment Period|Exclusionary Medication Received|0|||
47034059|NCT01610336|83284964|FG008|Overall Study|Non-Compliance with study treatment|0|||
47034060|NCT01610336|83284965|FG009|Overall Study|Non-Compliance with study treatment|1|||
47034061|NCT01610336|83284966|FG010|Overall Study|Non-Compliance with study treatment|0|||
47034062|NCT01610336|83284956|FG000|Overall Study|Physician Decision|0|||
47034063|NCT01610336|83284957|FG001|Overall Study|Physician Decision|0|||
47034064|NCT01610336|83284958|FG002|Overall Study|Physician Decision|0|||
47034065|NCT01610336|83284959|FG003|Overall Study|Physician Decision|0|||
47034066|NCT01610336|83284960|FG004|Overall Study|Physician Decision|0|||
47034067|NCT01610336|83284961|FG005|Overall Study|Physician Decision|0|||
47034068|NCT01610336|83284962|FG006|Overall Study|Physician Decision|1|||
47034069|NCT01610336|83284963|FG007|Overall Study|Physician Decision|0|||
47034070|NCT01610336|83284964|FG008|Overall Study|Physician Decision|0|||
47034071|NCT01610336|83284965|FG009|Overall Study|Physician Decision|0|||
47034072|NCT01610336|83284966|FG010|Overall Study|Physician Decision|0|||
47034073|NCT01610336|83284956|FG000|Overall Study|Protocol Deviation|0|||
47034074|NCT01610336|83284957|FG001|Overall Study|Protocol Deviation|0|||
47034075|NCT01610336|83284958|FG002|Overall Study|Protocol Deviation|0|||
47034076|NCT01610336|83284959|FG003|Overall Study|Protocol Deviation|0|||
47034077|NCT01610336|83284960|FG004|Overall Study|Protocol Deviation|0|||
47034078|NCT01610336|83284961|FG005|Overall Study|Protocol Deviation|0|||
47034079|NCT01610336|83284962|FG006|Overall Study|Protocol Deviation|0|||
47034080|NCT01610336|83284963|FG007|Overall Study|Protocol Deviation|0|||
47034081|NCT01610336|83284964|FG008|Overall Study|Protocol Deviation|0|||
47034082|NCT01610336|83284965|FG009|Overall Study|Protocol Deviation|1|||
47034083|NCT01610336|83284966|FG010|Overall Study|Protocol Deviation|0|||
47034084|NCT01610336|83284956|FG000|Overall Study|Transfer to another trial|0|||
47034085|NCT01610336|83284957|FG001|Overall Study|Transfer to another trial|0|||
47034086|NCT01610336|83284958|FG002|Overall Study|Transfer to another trial|0|||
47034087|NCT01610336|83284959|FG003|Overall Study|Transfer to another trial|0|||
47034088|NCT01610336|83284960|FG004|Overall Study|Transfer to another trial|0|||
47034089|NCT01610336|83284961|FG005|Overall Study|Transfer to another trial|0|||
47034090|NCT01610336|83284962|FG006|Overall Study|Transfer to another trial|0|||
47034091|NCT01610336|83284963|FG007|Overall Study|Transfer to another trial|0|||
47034092|NCT01610336|83284964|FG008|Overall Study|Transfer to another trial|0|||
47034093|NCT01610336|83284965|FG009|Overall Study|Transfer to another trial|0|||
47034094|NCT01610336|83284966|FG010|Overall Study|Transfer to another trial|1|||
47034095|NCT01613222|83284994|FG000|Overall Study|Physician Decision|1|||
47034096|NCT01613222|83284994|FG000|Overall Study|Unable to place arterial line|1|||
47034097|NCT01613222|83284994|FG000|Overall Study|Reused disposable sensors|10|||
47034098|NCT01612676|83285041|FG000|Overall Study|Adverse Event|2|||
47034099|NCT01612676|83285042|FG001|Overall Study|Adverse Event|3|||
47034100|NCT01612676|83285043|FG002|Overall Study|Adverse Event|1|||
47034101|NCT01612676|83285044|FG003|Overall Study|Adverse Event|3|||
47034102|NCT01612676|83285041|FG000|Overall Study|Protocol Violation|0|||
47034103|NCT01612676|83285042|FG001|Overall Study|Protocol Violation|1|||
47034104|NCT01612676|83285043|FG002|Overall Study|Protocol Violation|0|||
47034105|NCT01612676|83285044|FG003|Overall Study|Protocol Violation|0|||
47034106|NCT01869764|83285058|FG000|Overall Study|Withdrawal by Subject|0|||
47034107|NCT01869764|83285059|FG001|Overall Study|Withdrawal by Subject|2|||
47034108|NCT01842620|83285065|FG000|Period 1|Withdrawal by Subject|1|||
47034109|NCT01842620|83285066|FG001|Period 1|Withdrawal by Subject|0|||
47034110|NCT01931839|83285092|FG000|Overall Study|Death|0|||
47034111|NCT01931839|83285093|FG001|Overall Study|Death|1|||
47034112|NCT01931839|83285094|FG002|Overall Study|Death|2|||
47034113|NCT01931839|83285095|FG003|Overall Study|Death|0|||
46913104|NCT03164551|83143278|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
46913105|NCT03164551|83143279|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
46913106|NCT03164551|83143278|FG000|Overall Study|Other|8|||
46913107|NCT03164551|83143279|FG001|Overall Study|Other|2|||
46913108|NCT02863328|83143287|FG000|Overall Study|Lost to Follow-up|4|||
46913109|NCT02863328|83143288|FG001|Overall Study|Lost to Follow-up|10|||
46913110|NCT02863328|83143287|FG000|Overall Study|Withdrawal by Subject|7|||
46913111|NCT02863328|83143288|FG001|Overall Study|Withdrawal by Subject|12|||
46913112|NCT02863328|83143287|FG000|Overall Study|Died|0|||
46913113|NCT02863328|83143288|FG001|Overall Study|Died|1|||
46913114|NCT03040141|83143297|FG000|Overall Study|Death|1|||
46913115|NCT03040141|83143298|FG001|Overall Study|Death|2|||
46913116|NCT03040141|83143299|FG002|Overall Study|Death|3|||
47034114|NCT01931839|83285096|FG004|Overall Study|Death|0|||
47034115|NCT01931839|83285097|FG005|Overall Study|Death|0|||
47034116|NCT01931839|83285098|FG006|Overall Study|Death|0|||
47034117|NCT01931839|83285092|FG000|Overall Study|Physician Decision|1|||
47034118|NCT01931839|83285093|FG001|Overall Study|Physician Decision|0|||
46913117|NCT03040141|83143297|FG000|Overall Study|Withdrawal by Subject|3|||
46913118|NCT03040141|83143298|FG001|Overall Study|Withdrawal by Subject|1|||
47034119|NCT01931839|83285094|FG002|Overall Study|Physician Decision|1|||
47034120|NCT01931839|83285095|FG003|Overall Study|Physician Decision|0|||
47034121|NCT01931839|83285096|FG004|Overall Study|Physician Decision|0|||
47034122|NCT01931839|83285097|FG005|Overall Study|Physician Decision|0|||
47034123|NCT01931839|83285098|FG006|Overall Study|Physician Decision|1|||
46913119|NCT03040141|83143299|FG002|Overall Study|Withdrawal by Subject|1|||
47034124|NCT01931839|83285092|FG000|Overall Study|Withdrawal of consent|0|||
47034125|NCT01931839|83285093|FG001|Overall Study|Withdrawal of consent|0|||
47034126|NCT01931839|83285094|FG002|Overall Study|Withdrawal of consent|0|||
47034127|NCT01931839|83285095|FG003|Overall Study|Withdrawal of consent|0|||
47034128|NCT01931839|83285096|FG004|Overall Study|Withdrawal of consent|1|||
47034129|NCT01931839|83285097|FG005|Overall Study|Withdrawal of consent|0|||
47034130|NCT01931839|83285098|FG006|Overall Study|Withdrawal of consent|0|||
46629195|NCT01620528|82799971|FG001|Treatment Period|Exclusionary Medication Received|1|||
46629196|NCT01620528|82799972|FG002|Treatment Period|Exclusionary Medication Received|0|||
46629197|NCT01620528|82799970|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
46629198|NCT01620528|82799971|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
46629199|NCT01620528|82799972|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
46629200|NCT01620528|82799970|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
46629201|NCT01620528|82799971|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
46629202|NCT01620528|82799972|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
46629203|NCT01620528|82799970|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
46629204|NCT01620528|82799971|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
46629205|NCT01620528|82799972|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
46629206|NCT01620528|82799970|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
46710953|NCT01117428|82927252|FG002|Overall Study|Withdrawal by Subject|1|||
46710954|NCT01117428|82927253|FG003|Overall Study|Withdrawal by Subject|0|||
46710955|NCT01117428|82927254|FG004|Overall Study|Withdrawal by Subject|0|||
46710956|NCT01117428|82927255|FG005|Overall Study|Withdrawal by Subject|0|||
46710957|NCT01117428|82927250|FG000|Overall Study|Progressive disease|15|||
46710958|NCT01117428|82927251|FG001|Overall Study|Progressive disease|27|||
46710959|NCT01117428|82927252|FG002|Overall Study|Progressive disease|10|||
46710960|NCT01117428|82927253|FG003|Overall Study|Progressive disease|12|||
47034131|NCT01931839|83285092|FG000|Overall Study|Adverse Event|9|||
47034132|NCT01931839|83285093|FG001|Overall Study|Adverse Event|4|||
46629207|NCT01620528|82799971|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
46710961|NCT01117428|82927254|FG004|Overall Study|Progressive disease|16|||
47034133|NCT01931839|83285094|FG002|Overall Study|Adverse Event|1|||
47034134|NCT01931839|83285095|FG003|Overall Study|Adverse Event|3|||
47034135|NCT01931839|83285096|FG004|Overall Study|Adverse Event|0|||
47034136|NCT01931839|83285097|FG005|Overall Study|Adverse Event|0|||
47034137|NCT01931839|83285098|FG006|Overall Study|Adverse Event|1|||
47034138|NCT01931839|83285092|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
47034139|NCT01931839|83285093|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
47034140|NCT01931839|83285094|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
47034141|NCT01931839|83285095|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
47034142|NCT01931839|83285096|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
47034143|NCT01931839|83285097|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
47034144|NCT01931839|83285098|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
47034145|NCT01931839|83285092|FG000|Overall Study|Other non-compliance|15|||
47034146|NCT01931839|83285093|FG001|Overall Study|Other non-compliance|9|||
47034147|NCT01931839|83285094|FG002|Overall Study|Other non-compliance|12|||
47034148|NCT01931839|83285095|FG003|Overall Study|Other non-compliance|3|||
47034149|NCT01931839|83285096|FG004|Overall Study|Other non-compliance|0|||
47034150|NCT01931839|83285097|FG005|Overall Study|Other non-compliance|3|||
47034151|NCT01931839|83285098|FG006|Overall Study|Other non-compliance|0|||
47034152|NCT01931839|83285092|FG000|Overall Study|Lost to Follow-up|1|||
47034153|NCT01931839|83285093|FG001|Overall Study|Lost to Follow-up|2|||
47034154|NCT01931839|83285094|FG002|Overall Study|Lost to Follow-up|4|||
47034155|NCT01931839|83285095|FG003|Overall Study|Lost to Follow-up|5|||
47034156|NCT01931839|83285096|FG004|Overall Study|Lost to Follow-up|0|||
47034157|NCT01931839|83285097|FG005|Overall Study|Lost to Follow-up|0|||
46710962|NCT01117428|82927255|FG005|Overall Study|Progressive disease|17|||
47034158|NCT01931839|83285098|FG006|Overall Study|Lost to Follow-up|0|||
47034159|NCT01931839|83285092|FG000|Overall Study|Other|4|||
47034160|NCT01931839|83285093|FG001|Overall Study|Other|2|||
47034161|NCT01931839|83285094|FG002|Overall Study|Other|6|||
47034162|NCT01931839|83285095|FG003|Overall Study|Other|0|||
47034163|NCT01931839|83285096|FG004|Overall Study|Other|0|||
46710963|NCT00655681|82927273|FG000|Overall Study|Lost to Follow-up|1|||
47034164|NCT01931839|83285097|FG005|Overall Study|Other|0|||
47034165|NCT01931839|83285098|FG006|Overall Study|Other|0|||
47034166|NCT01842308|83285123|FG000|Overall Study|Withdrawal by Subject|0|||
47034167|NCT01842308|83285124|FG001|Overall Study|Withdrawal by Subject|0|||
47034168|NCT01842308|83285125|FG002|Overall Study|Withdrawal by Subject|0|||
47034169|NCT01842308|83285126|FG003|Overall Study|Withdrawal by Subject|0|||
47034170|NCT01842308|83285127|FG004|Overall Study|Withdrawal by Subject|1|||
47034171|NCT01931059|83285142|FG000|Day 1|Pregnancy|0|||
47034172|NCT01931059|83285143|FG001|Day 1|Pregnancy|1|||
47034173|NCT01931059|83285142|FG000|Day3|Lost to Follow-up|1|||
47034174|NCT01931059|83285143|FG001|Day3|Lost to Follow-up|0|||
47034175|NCT01841762|83285155|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
47034176|NCT01841762|83285155|FG000|Treatment Period|Adverse Event|16|||
47034177|NCT01841762|83285155|FG000|Treatment Period|Death|1|||
47034178|NCT01841762|83285155|FG000|Treatment Period|Withdrawal by Subject|7|||
47034179|NCT01841762|83285155|FG000|Treatment Period|Lost to Follow-up|1|||
47034180|NCT01841762|83285155|FG000|Treatment Period|Physician Decision|2|||
47034181|NCT01841762|83285155|FG000|Treatment Period|Other, including non-compliance|5|||
47034182|NCT01841762|83285155|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
47034183|NCT01841762|83285155|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
47034184|NCT01841762|83285155|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
47034185|NCT01841762|83285155|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
47034186|NCT01841060|83285172|FG000|Overall Study|Protocol Violation|10|||
47034187|NCT01814696|83285178|FG000|Overall Study|Withdrawal by Subject|1|||
46629208|NCT01620528|82799972|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
46629209|NCT01620528|82799970|FG000|Post-Treatment Follow-Up Period|Other|6|||
46629210|NCT01620528|82799971|FG001|Post-Treatment Follow-Up Period|Other|4|||
46629211|NCT01620528|82799972|FG002|Post-Treatment Follow-Up Period|Other|2|||
46629212|NCT01965834|82799980|FG000|Overall Study|Lack of Efficacy|4|||
46629213|NCT01965600|82799984|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
46629214|NCT01965600|82799985|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
46629215|NCT01965600|82799986|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
46629216|NCT01965600|82799987|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
46629217|NCT01965600|82799984|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
46629218|NCT01965600|82799985|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
46629219|NCT01965600|82799986|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
46629220|NCT01965600|82799987|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
46629221|NCT01965600|82799984|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
46629222|NCT01965600|82799985|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
46629223|NCT01965600|82799986|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
46629224|NCT01965600|82799987|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
46629225|NCT01965600|82799984|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
46629226|NCT01965600|82799985|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
46629227|NCT01965600|82799986|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
47034188|NCT01814696|83285179|FG001|Overall Study|Withdrawal by Subject|0|||
47034189|NCT01814696|83285178|FG000|Overall Study|Randomized to wrong group|1|||
47034190|NCT01814696|83285179|FG001|Overall Study|Randomized to wrong group|0|||
47034191|NCT01970371|83285188|FG000|Overall Study|Death|8|||
47034192|NCT01970371|83285189|FG001|Overall Study|Death|13|||
47034193|NCT01970371|83285190|FG002|Overall Study|Death|12|||
46629228|NCT01965600|82799987|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
46629229|NCT01965600|82799984|FG000|Second Intervention|Study terminated by Sponsor|0|||
46629230|NCT01965600|82799985|FG001|Second Intervention|Study terminated by Sponsor|0|||
46629231|NCT01965600|82799986|FG002|Second Intervention|Study terminated by Sponsor|2|||
46629232|NCT01965600|82799987|FG003|Second Intervention|Study terminated by Sponsor|2|||
46629233|NCT01996332|82799995|FG000|Overall Study|Adverse Event|117|||
46629234|NCT01996332|82799995|FG000|Overall Study|Lack of Efficacy|1245|||
46629235|NCT01996332|82799995|FG000|Overall Study|Death|264|||
46629236|NCT01996332|82799995|FG000|Overall Study|Protocol Violation|9|||
46629237|NCT01996332|82799995|FG000|Overall Study|Withdrawal by Subject|71|||
46629238|NCT01996332|82799995|FG000|Overall Study|Other|20|||
46629239|NCT01996332|82799995|FG000|Overall Study|Clinical Deterioration|28|||
46629240|NCT01996332|82799995|FG000|Overall Study|Physician Decision|17|||
46629241|NCT01996332|82799995|FG000|Overall Study|Lost to Follow-up|34|||
47034194|NCT01970371|83285188|FG000|Overall Study|Lost to Follow-up|0|||
47034195|NCT01970371|83285189|FG001|Overall Study|Lost to Follow-up|0|||
47034196|NCT01970371|83285190|FG002|Overall Study|Lost to Follow-up|1|||
47034197|NCT01868594|83285211|FG000|Overall Study|Do not meet inclusion criteria|4|||
47034198|NCT01868594|83285212|FG001|Overall Study|Do not meet inclusion criteria|3|||
47034199|NCT01616953|83285222|FG000|Overall Study|Lost to Follow-up|1|||
47034200|NCT01616953|83285223|FG001|Overall Study|Lost to Follow-up|0|||
47034201|NCT01616953|83285222|FG000|Overall Study|lack of bone and soft tissue|1|||
47034202|NCT01616953|83285223|FG001|Overall Study|lack of bone and soft tissue|0|||
46629242|NCT01996254|82800001|FG000|Overall Study|Change in Eligibility|0|||
46629243|NCT01996254|82800002|FG001|Overall Study|Change in Eligibility|2|||
46629244|NCT01996254|82800003|FG002|Overall Study|Change in Eligibility|0|||
46629245|NCT01996254|82800001|FG000|Overall Study|Withdrawal by Subject|0|||
46629246|NCT01996254|82800002|FG001|Overall Study|Withdrawal by Subject|3|||
46629247|NCT01996254|82800003|FG002|Overall Study|Withdrawal by Subject|4|||
46629248|NCT01996254|82800001|FG000|Overall Study|Lost to Follow-up|1|||
46629249|NCT01996254|82800002|FG001|Overall Study|Lost to Follow-up|0|||
46629250|NCT01996254|82800003|FG002|Overall Study|Lost to Follow-up|4|||
46629251|NCT01987986|82800017|FG000|Overall Study|Lost to Follow-up|1|||
46629252|NCT01987986|82800018|FG001|Overall Study|Lost to Follow-up|0|||
46629253|NCT01987986|82800019|FG002|Overall Study|Lost to Follow-up|0|||
46629254|NCT01987986|82800020|FG003|Overall Study|Lost to Follow-up|0|||
46629255|NCT01987986|82800017|FG000|Overall Study|Adverse Event|1|||
46629256|NCT01987986|82800018|FG001|Overall Study|Adverse Event|0|||
46629257|NCT01987986|82800019|FG002|Overall Study|Adverse Event|2|||
47034203|NCT01867658|83285229|FG000|Overall Study|Withdrawal by Subject|6|||
47034204|NCT01867658|83285229|FG000|Overall Study|Death|2|||
46629258|NCT01987986|82800020|FG003|Overall Study|Adverse Event|0|||
46629259|NCT01987908|82800030|FG000|Placebo Lead-in Period|Adverse Event|2|||
46629260|NCT01987908|82800031|FG001|Placebo Lead-in Period|Adverse Event|0|||
46629261|NCT01987908|82800032|FG002|Placebo Lead-in Period|Adverse Event|0|||
46629262|NCT01987908|82800030|FG000|Placebo Lead-in Period|Physician Decision|2|||
46629263|NCT01987908|82800031|FG001|Placebo Lead-in Period|Physician Decision|0|||
46629264|NCT01987908|82800032|FG002|Placebo Lead-in Period|Physician Decision|0|||
46629265|NCT01987908|82800030|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
46629266|NCT01987908|82800031|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
46629267|NCT01987908|82800032|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
46629268|NCT01987908|82800030|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
46629269|NCT01987908|82800031|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
46629270|NCT01987908|82800032|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
46629271|NCT01987908|82800030|FG000|Treatment Period|Adverse Event|0|||
46629272|NCT01987908|82800031|FG001|Treatment Period|Adverse Event|1|||
46629273|NCT01987908|82800032|FG002|Treatment Period|Adverse Event|1|||
46629274|NCT01987908|82800030|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
46629275|NCT01987908|82800031|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
46629276|NCT01987908|82800032|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
46629277|NCT01987908|82800030|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
47034205|NCT01867658|83285229|FG000|Overall Study|Subject could not be contacted|1|||
47034206|NCT01867580|83285235|FG000|Overall Study|Withdrawal by Subject|2|||
47034207|NCT01867580|83285236|FG001|Overall Study|Withdrawal by Subject|3|||
47034208|NCT01867580|83285235|FG000|Overall Study|Physician Decision|17|||
47034209|NCT01867580|83285236|FG001|Overall Study|Physician Decision|12|||
47034210|NCT01867580|83285235|FG000|Overall Study|Lost to Follow-up|3|||
47034211|NCT01867580|83285236|FG001|Overall Study|Lost to Follow-up|5|||
47034212|NCT01867580|83285235|FG000|Overall Study|Sponsor terminated study|1|||
47034213|NCT01867580|83285236|FG001|Overall Study|Sponsor terminated study|0|||
47034214|NCT01867580|83285235|FG000|Overall Study|Missed follow-up assessment|2|||
47034215|NCT01867580|83285236|FG001|Overall Study|Missed follow-up assessment|1|||
47034216|NCT01867580|83285235|FG000|Overall Study|Interruption to therapy|3|||
46629278|NCT01987908|82800031|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
46629279|NCT01987908|82800032|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
46629280|NCT01995552|82800056|FG000|Overall Study|Protocol Violation|1|||
46629281|NCT01995552|82800056|FG000|Overall Study|Lack of Efficacy|15|||
46629282|NCT01995552|82800056|FG000|Overall Study|Death|1|||
47034217|NCT01867580|83285236|FG001|Overall Study|Interruption to therapy|0|||
47034218|NCT01867580|83285235|FG000|Overall Study|Osteomyelitis|0|||
47034219|NCT01867580|83285236|FG001|Overall Study|Osteomyelitis|1|||
47034220|NCT01867580|83285235|FG000|Overall Study|Continuation of therapy|0|||
47034221|NCT01867580|83285236|FG001|Overall Study|Continuation of therapy|1|||
46629283|NCT01987830|82800062|FG000|Overall Study|Never received baseline scan|1|||
46629284|NCT01987596|82800068|FG000|Overall Study|Physician Decision|1|||
46629285|NCT01987596|82800069|FG001|Overall Study|Physician Decision|0|||
46629286|NCT01987596|82800068|FG000|Overall Study|Progressive Disease; missing all period|0|||
46629287|NCT01987596|82800069|FG001|Overall Study|Progressive Disease; missing all period|1|||
46629288|NCT01964976|82800083|FG000|Overall Study|Protocol Violation|31|||
46710964|NCT00655681|82927274|FG001|Overall Study|Lost to Follow-up|1|||
46629289|NCT01964898|82800092|FG000|Overall Study|ineligible post-randomization|1|||
46629290|NCT01964898|82800093|FG001|Overall Study|ineligible post-randomization|1|||
46629291|NCT01964898|82800092|FG000|Overall Study|did not receive the allocated interventi|2|||
47034222|NCT01867580|83285235|FG000|Overall Study|Wound recurrence|0|||
47034223|NCT01867580|83285236|FG001|Overall Study|Wound recurrence|1|||
47034224|NCT01839656|83285250|FG000|Overall Study|Withdrawal by Subject|1|||
46629292|NCT01964898|82800093|FG001|Overall Study|did not receive the allocated interventi|1|||
47034225|NCT01839656|83285251|FG001|Overall Study|Withdrawal by Subject|1|||
47034226|NCT01839656|83285250|FG000|Overall Study|Adverse event, serious fatal|1|||
47034227|NCT01839656|83285251|FG001|Overall Study|Adverse event, serious fatal|4|||
47034228|NCT01839656|83285250|FG000|Overall Study|Early study closure|0|||
47034229|NCT01839656|83285251|FG001|Overall Study|Early study closure|11|||
47034230|NCT01839656|83285250|FG000|Overall Study|Adverse Event|1|||
47034231|NCT01839656|83285251|FG001|Overall Study|Adverse Event|0|||
47034232|NCT01839188|83285257|FG000|Overall Study|Withdrawal by Subject|1|||
47034233|NCT01838876|83285266|FG000|Overall Study|Adverse Event|49|||
47034234|NCT01838876|83285266|FG000|Overall Study|Insufficient Therapeutic Response|10|||
47034235|NCT01838876|83285266|FG000|Overall Study|Protocol Violation|34|||
47034236|NCT01838876|83285266|FG000|Overall Study|Withdrawal of Consent|33|||
47034237|NCT01838876|83285266|FG000|Overall Study|Lost to Follow-up|21|||
47034238|NCT01838876|83285266|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
47034239|NCT01838876|83285266|FG000|Overall Study|Reason not Specified|7|||
47034240|NCT01838876|83285266|FG000|Overall Study|Did not meet eligibility criteria|78|||
47034241|NCT01838642|83285281|FG000|Overall Study|Died on study|1|||
47034242|NCT01611194|83285288|FG000|Overall Study|Lost to Follow-up|0|||
47034243|NCT01611194|83285289|FG001|Overall Study|Lost to Follow-up|1|||
46629293|NCT01964898|82800092|FG000|Overall Study|Lost to Follow-up|3|||
46629294|NCT01964898|82800093|FG001|Overall Study|Lost to Follow-up|5|||
46629295|NCT01964898|82800092|FG000|Overall Study|Withdrawal by Subject|1|||
46629296|NCT01964898|82800093|FG001|Overall Study|Withdrawal by Subject|0|||
46629297|NCT01964352|82800103|FG000|Overall Study|Adverse Event|13|||
46629298|NCT01964352|82800104|FG001|Overall Study|Adverse Event|3|||
46629299|NCT01964352|82800105|FG002|Overall Study|Adverse Event|4|||
46629300|NCT01964352|82800106|FG003|Overall Study|Adverse Event|3|||
46629301|NCT01964352|82800103|FG000|Overall Study|Lack of Efficacy|6|||
46629302|NCT01964352|82800104|FG001|Overall Study|Lack of Efficacy|0|||
46629303|NCT01964352|82800105|FG002|Overall Study|Lack of Efficacy|0|||
46629304|NCT01964352|82800106|FG003|Overall Study|Lack of Efficacy|0|||
46629305|NCT01964352|82800103|FG000|Overall Study|Protocol Violation|2|||
46629306|NCT01964352|82800104|FG001|Overall Study|Protocol Violation|4|||
46629307|NCT01964352|82800105|FG002|Overall Study|Protocol Violation|0|||
46629308|NCT01964352|82800106|FG003|Overall Study|Protocol Violation|2|||
46629309|NCT01964352|82800103|FG000|Overall Study|Lost to Follow-up|1|||
46629310|NCT01964352|82800104|FG001|Overall Study|Lost to Follow-up|0|||
47034244|NCT01611194|83285288|FG000|Overall Study|Withdrawal by Subject|0|||
47034245|NCT01611194|83285289|FG001|Overall Study|Withdrawal by Subject|1|||
47034246|NCT01611194|83285288|FG000|Overall Study|drug use|0|||
47034247|NCT01611194|83285289|FG001|Overall Study|drug use|1|||
47034248|NCT01813058|83285297|FG000|Overall Study|Withdrawal by Subject|5|||
47034249|NCT01813058|83285298|FG001|Overall Study|Withdrawal by Subject|4|||
47034250|NCT01867424|83285306|FG000|Overall Study|Patient noncompliance|2|||
47034251|NCT01867424|83285307|FG001|Overall Study|Patient noncompliance|1|||
47034252|NCT01811732|83285315|FG000|Overall Study|Lost to Follow-up|24|||
47034253|NCT01811732|83285316|FG001|Overall Study|Lost to Follow-up|30|||
47034254|NCT01811732|83285315|FG000|Overall Study|Withdrawal by Subject|16|||
47034255|NCT01811732|83285316|FG001|Overall Study|Withdrawal by Subject|10|||
47034256|NCT01811732|83285315|FG000|Overall Study|Adverse Event|3|||
47034257|NCT01811732|83285316|FG001|Overall Study|Adverse Event|9|||
47034258|NCT01811732|83285315|FG000|Overall Study|Lack of Efficacy|3|||
47034259|NCT01811732|83285316|FG001|Overall Study|Lack of Efficacy|1|||
47034260|NCT01811732|83285315|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
47034261|NCT01811732|83285316|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
47034262|NCT01811732|83285315|FG000|Overall Study|Physician Decision|2|||
47034263|NCT01811732|83285316|FG001|Overall Study|Physician Decision|0|||
47034264|NCT01811732|83285315|FG000|Overall Study|Death|1|||
46629311|NCT01964352|82800105|FG002|Overall Study|Lost to Follow-up|0|||
46629312|NCT01964352|82800106|FG003|Overall Study|Lost to Follow-up|1|||
47034265|NCT01811732|83285316|FG001|Overall Study|Death|1|||
47034266|NCT01811732|83285315|FG000|Overall Study|Insufficient venous access|0|||
47034267|NCT01811732|83285316|FG001|Overall Study|Insufficient venous access|1|||
47034268|NCT01811732|83285315|FG000|Overall Study|Protocol Violation|0|||
47034269|NCT01811732|83285316|FG001|Overall Study|Protocol Violation|1|||
47034270|NCT01811732|83285315|FG000|Overall Study|Subject incarcerated|1|||
47034271|NCT01811732|83285316|FG001|Overall Study|Subject incarcerated|2|||
47034272|NCT01811732|83285315|FG000|Overall Study|Admitted to another facility|1|||
47034273|NCT01811732|83285316|FG001|Overall Study|Admitted to another facility|0|||
46629313|NCT01964352|82800103|FG000|Overall Study|Withdrawal by Subject|4|||
46629314|NCT01964352|82800104|FG001|Overall Study|Withdrawal by Subject|2|||
46629315|NCT01964352|82800105|FG002|Overall Study|Withdrawal by Subject|1|||
47034274|NCT01811732|83285315|FG000|Overall Study|Correct study drug not available on site|1|||
46629316|NCT01964352|82800106|FG003|Overall Study|Withdrawal by Subject|0|||
46629317|NCT01964352|82800103|FG000|Overall Study|Other than stated above|0|||
47034275|NCT01811732|83285316|FG001|Overall Study|Correct study drug not available on site|0|||
46629318|NCT01964352|82800104|FG001|Overall Study|Other than stated above|2|||
47034276|NCT01836458|83285327|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
47034277|NCT01836458|83285328|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
47034278|NCT01836458|83285329|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
47034279|NCT01836458|83285330|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
47034280|NCT01811186|83285342|FG000|Overall Study|Adverse Event|54|||
47034281|NCT01811186|83285343|FG001|Overall Study|Adverse Event|38|||
47034282|NCT01811186|83285342|FG000|Overall Study|Protocol Violation|5|||
47034283|NCT01811186|83285343|FG001|Overall Study|Protocol Violation|6|||
47034284|NCT01811186|83285342|FG000|Overall Study|Withdrawal by Subject|5|||
47034285|NCT01811186|83285343|FG001|Overall Study|Withdrawal by Subject|10|||
47034286|NCT01811186|83285342|FG000|Overall Study|Lack of Efficacy|3|||
47034287|NCT01811186|83285343|FG001|Overall Study|Lack of Efficacy|6|||
47034288|NCT01811186|83285342|FG000|Overall Study|Lost to Follow-up|4|||
47034289|NCT01811186|83285343|FG001|Overall Study|Lost to Follow-up|2|||
47034290|NCT01866098|83285356|FG000|Overall Study|Lost to Follow-up|11|||
47034291|NCT01866098|83285357|FG001|Overall Study|Lost to Follow-up|18|||
47034292|NCT01866098|83285358|FG002|Overall Study|Lost to Follow-up|13|||
47034293|NCT01866098|83285356|FG000|Overall Study|Physician Decision|0|||
47034294|NCT01866098|83285357|FG001|Overall Study|Physician Decision|1|||
47034295|NCT01866098|83285358|FG002|Overall Study|Physician Decision|2|||
47034296|NCT01866098|83285356|FG000|Overall Study|Adverse Event|1|||
47034297|NCT01866098|83285357|FG001|Overall Study|Adverse Event|5|||
47034298|NCT01866098|83285358|FG002|Overall Study|Adverse Event|4|||
47034299|NCT01866098|83285356|FG000|Overall Study|Protocol Violation|1|||
47034300|NCT01866098|83285357|FG001|Overall Study|Protocol Violation|0|||
47034301|NCT01866098|83285358|FG002|Overall Study|Protocol Violation|0|||
47034302|NCT01866098|83285356|FG000|Overall Study|Withdrawal by Subject|1|||
47034303|NCT01866098|83285357|FG001|Overall Study|Withdrawal by Subject|2|||
47034304|NCT01866098|83285358|FG002|Overall Study|Withdrawal by Subject|0|||
46913120|NCT03040141|83143297|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
47034305|NCT01866098|83285356|FG000|Overall Study|Unrelated Hospitalization|2|||
47034306|NCT01866098|83285357|FG001|Overall Study|Unrelated Hospitalization|0|||
47034307|NCT01866098|83285358|FG002|Overall Study|Unrelated Hospitalization|1|||
47034308|NCT01866098|83285356|FG000|Overall Study|Non-compliance|1|||
47034309|NCT01866098|83285357|FG001|Overall Study|Non-compliance|0|||
47034310|NCT01866098|83285358|FG002|Overall Study|Non-compliance|1|||
46913121|NCT03040141|83143298|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
46913122|NCT03040141|83143299|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
46913123|NCT03040141|83143297|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
46913124|NCT03040141|83143298|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
46913125|NCT03040141|83143299|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
46913126|NCT02937701|83143313|FG000|Day 1 to Week 22|Adverse Event|11|||
46913127|NCT02937701|83143314|FG001|Day 1 to Week 22|Adverse Event|14|||
46913128|NCT02937701|83143315|FG002|Day 1 to Week 22|Adverse Event|0|||
46913129|NCT02937701|83143316|FG003|Day 1 to Week 22|Adverse Event|0|||
46913130|NCT02937701|83143317|FG004|Day 1 to Week 22|Adverse Event|0|||
46913131|NCT02937701|83143313|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
46913132|NCT02937701|83143314|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
47034311|NCT01866098|83285356|FG000|Overall Study|Pregnancy|2|||
47034312|NCT01866098|83285357|FG001|Overall Study|Pregnancy|0|||
47034313|NCT01866098|83285358|FG002|Overall Study|Pregnancy|0|||
47034314|NCT01866098|83285356|FG000|Overall Study|Death|0|||
47034315|NCT01866098|83285357|FG001|Overall Study|Death|1|||
47034316|NCT01866098|83285358|FG002|Overall Study|Death|0|||
47034317|NCT01865552|83285372|FG000|Period 1|Adverse Event|1|||
47034318|NCT01865552|83285373|FG001|Period 1|Adverse Event|0|||
47034319|NCT01865552|83285374|FG002|Period 1|Adverse Event|0|||
47034320|NCT01865552|83285375|FG003|Period 1|Adverse Event|1|||
47034321|NCT01865552|83285376|FG004|Period 1|Adverse Event|1|||
47034322|NCT01865552|83285377|FG005|Period 1|Adverse Event|1|||
47034323|NCT01865552|83285372|FG000|Period 1|Pathological lab|0|||
47034324|NCT01865552|83285373|FG001|Period 1|Pathological lab|0|||
47034325|NCT01865552|83285374|FG002|Period 1|Pathological lab|0|||
47034326|NCT01865552|83285375|FG003|Period 1|Pathological lab|0|||
47034327|NCT01865552|83285376|FG004|Period 1|Pathological lab|1|||
47034328|NCT01865552|83285377|FG005|Period 1|Pathological lab|0|||
47034329|NCT01865552|83285372|FG000|Period 1|Other|0|||
47034330|NCT01865552|83285373|FG001|Period 1|Other|0|||
47034331|NCT01865552|83285374|FG002|Period 1|Other|0|||
47034332|NCT01865552|83285375|FG003|Period 1|Other|0|||
47034333|NCT01865552|83285376|FG004|Period 1|Other|1|||
47034334|NCT01865552|83285377|FG005|Period 1|Other|0|||
47034335|NCT01809314|83285391|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
47034336|NCT01809314|83285391|FG000|Overall Study|Adverse Event|6|||
47034337|NCT01809314|83285391|FG000|Overall Study|Insufficient Therapeutic Response|14|||
47034338|NCT01809314|83285391|FG000|Overall Study|Lost to Follow-up|724|||
47034339|NCT01803464|83285399|FG000|Overall Study|Incomplete data|0|||
47034340|NCT01803464|83285400|FG001|Overall Study|Incomplete data|0|||
47034341|NCT01803464|83285401|FG002|Overall Study|Incomplete data|4|||
47034342|NCT01803464|83285402|FG003|Overall Study|Incomplete data|0|||
47034343|NCT01803464|83285399|FG000|Overall Study|Withdrawal by Subject|1|||
47034344|NCT01803464|83285400|FG001|Overall Study|Withdrawal by Subject|0|||
47034345|NCT01803464|83285401|FG002|Overall Study|Withdrawal by Subject|0|||
47034346|NCT01803464|83285402|FG003|Overall Study|Withdrawal by Subject|0|||
47034347|NCT01808690|83285418|FG000|Overall Study|Withdrawal by Subject|1|||
47034348|NCT01808690|83285419|FG001|Overall Study|Withdrawal by Subject|2|||
47034349|NCT01363297|83285430|FG000|Overall Study|Other|0|||
47034350|NCT01363297|83285431|FG001|Overall Study|Other|0|||
47034351|NCT01363297|83285432|FG002|Overall Study|Other|0|||
47034352|NCT01363297|83285433|FG003|Overall Study|Other|0|||
47034353|NCT01363297|83285434|FG004|Overall Study|Other|1|||
47034354|NCT01363297|83285430|FG000|Overall Study|Death|3|||
47034355|NCT01363297|83285431|FG001|Overall Study|Death|6|||
47034356|NCT01363297|83285432|FG002|Overall Study|Death|6|||
47034357|NCT01363297|83285433|FG003|Overall Study|Death|10|||
47034358|NCT01363297|83285434|FG004|Overall Study|Death|30|||
47034359|NCT01908907|83285453|FG000|Overall Study|Physician Decision|1|||
47034360|NCT01908907|83285454|FG001|Overall Study|Physician Decision|0|||
47034361|NCT01908907|83285453|FG000|Overall Study|Protocol Violation|1|||
47034362|NCT01908907|83285454|FG001|Overall Study|Protocol Violation|0|||
47034363|NCT01808612|83285467|FG000|Treatment Period|Adverse Event|8|||
47034364|NCT01808612|83285468|FG001|Treatment Period|Adverse Event|4|||
47034365|NCT01808612|83285469|FG002|Treatment Period|Adverse Event|3|||
47034366|NCT01808612|83285467|FG000|Treatment Period|Lost to Follow-up|2|||
47034367|NCT01808612|83285468|FG001|Treatment Period|Lost to Follow-up|2|||
47034368|NCT01808612|83285469|FG002|Treatment Period|Lost to Follow-up|1|||
47034369|NCT01808612|83285467|FG000|Treatment Period|Protocol Violation|1|||
47034370|NCT01808612|83285468|FG001|Treatment Period|Protocol Violation|0|||
47034371|NCT01808612|83285469|FG002|Treatment Period|Protocol Violation|0|||
47034372|NCT01808612|83285467|FG000|Treatment Period|Withdrawal by Subject|1|||
47034373|NCT01808612|83285468|FG001|Treatment Period|Withdrawal by Subject|0|||
47034374|NCT01808612|83285469|FG002|Treatment Period|Withdrawal by Subject|4|||
47034375|NCT01808612|83285467|FG000|Treatment Period|Physician Decision|1|||
47034376|NCT01808612|83285468|FG001|Treatment Period|Physician Decision|0|||
47034377|NCT01808612|83285469|FG002|Treatment Period|Physician Decision|4|||
47034378|NCT01808612|83285467|FG000|Treatment Period|Sponsor Decision|1|||
47034379|NCT01808612|83285468|FG001|Treatment Period|Sponsor Decision|0|||
47034380|NCT01808612|83285469|FG002|Treatment Period|Sponsor Decision|0|||
47034381|NCT01808612|83285467|FG000|Treatment Period|Lack of Efficacy|1|||
47034382|NCT01808612|83285468|FG001|Treatment Period|Lack of Efficacy|1|||
47034383|NCT01808612|83285469|FG002|Treatment Period|Lack of Efficacy|2|||
47034384|NCT01808612|83285467|FG000|Discontinuation Period|Adverse Event|1|||
47034385|NCT01808612|83285468|FG001|Discontinuation Period|Adverse Event|0|||
47034386|NCT01808612|83285469|FG002|Discontinuation Period|Adverse Event|0|||
47034387|NCT01808612|83285467|FG000|Discontinuation Period|Physician Decision|1|||
47034388|NCT01808612|83285468|FG001|Discontinuation Period|Physician Decision|0|||
47034389|NCT01808612|83285469|FG002|Discontinuation Period|Physician Decision|0|||
47034390|NCT01808612|83285467|FG000|Discontinuation Period|Lost to Follow-up|0|||
47034391|NCT01808612|83285468|FG001|Discontinuation Period|Lost to Follow-up|1|||
47034392|NCT01808612|83285469|FG002|Discontinuation Period|Lost to Follow-up|0|||
47034393|NCT01908829|83285483|FG000|Overall Study|Adverse Event|13|||
47034394|NCT01908829|83285484|FG001|Overall Study|Adverse Event|11|||
47034395|NCT01908829|83285485|FG002|Overall Study|Adverse Event|13|||
47034396|NCT01908829|83285483|FG000|Overall Study|Lost to Follow-up|4|||
47034397|NCT01908829|83285484|FG001|Overall Study|Lost to Follow-up|2|||
47034398|NCT01908829|83285485|FG002|Overall Study|Lost to Follow-up|1|||
47034399|NCT01908829|83285483|FG000|Overall Study|Randomized no double-blind drug received|1|||
47034400|NCT01908829|83285484|FG001|Overall Study|Randomized no double-blind drug received|0|||
47034401|NCT01908829|83285485|FG002|Overall Study|Randomized no double-blind drug received|1|||
47034402|NCT01908829|83285483|FG000|Overall Study|Discontinued (no EoT page)|2|||
47034403|NCT01908829|83285484|FG001|Overall Study|Discontinued (no EoT page)|0|||
47034404|NCT01908829|83285485|FG002|Overall Study|Discontinued (no EoT page)|0|||
47034405|NCT01908829|83285483|FG000|Overall Study|Miscellaneous|0|||
47034406|NCT01908829|83285484|FG001|Overall Study|Miscellaneous|2|||
47034407|NCT01908829|83285485|FG002|Overall Study|Miscellaneous|0|||
47034408|NCT01908829|83285483|FG000|Overall Study|Protocol Violation|2|||
47034409|NCT01908829|83285484|FG001|Overall Study|Protocol Violation|2|||
47034410|NCT01908829|83285485|FG002|Overall Study|Protocol Violation|0|||
47034411|NCT01908829|83285483|FG000|Overall Study|Lack of Efficacy|1|||
47034412|NCT01908829|83285484|FG001|Overall Study|Lack of Efficacy|3|||
47034413|NCT01908829|83285485|FG002|Overall Study|Lack of Efficacy|2|||
47034414|NCT01908829|83285483|FG000|Overall Study|Withdrawal by Subject|26|||
47034415|NCT01908829|83285484|FG001|Overall Study|Withdrawal by Subject|29|||
47034416|NCT01908829|83285485|FG002|Overall Study|Withdrawal by Subject|22|||
47034417|NCT01773122|83285497|FG000|Overall Study|Due to amended age eligibility criteria|3|||
47034418|NCT01773122|83285498|FG001|Overall Study|Due to amended age eligibility criteria|1|||
47034419|NCT01773122|83285499|FG002|Overall Study|Due to amended age eligibility criteria|0|||
47034420|NCT01773122|83285500|FG003|Overall Study|Due to amended age eligibility criteria|1|||
47034421|NCT01808534|83285510|FG000|Overall Study|Disease progression|3|||
47034422|NCT01808534|83285510|FG000|Overall Study|Physician Decision|1|||
47034423|NCT01808222|83285514|FG000|Overall Study|mpMR scan was not performed|1|||
47034424|NCT01772576|83285518|FG000|Overall Study|Death|15|||
47034425|NCT01772576|83285518|FG000|Overall Study|Protocol Violation|1|||
47034426|NCT01772576|83285518|FG000|Overall Study|Lost to Follow-up|3|||
47034427|NCT01772576|83285518|FG000|Overall Study|Study device not used|3|||
47034428|NCT01772576|83285518|FG000|Overall Study|Adverse Event|6|||
47034429|NCT01772576|83285518|FG000|Overall Study|Withdrawal by Subject|6|||
47034430|NCT01802216|83285545|FG000|4 Month Visit|Participant did not show to visit|3|||
47034431|NCT01802216|83285546|FG001|4 Month Visit|Participant did not show to visit|4|||
47034432|NCT01802216|83285545|FG000|8 Month Visit|Participant did not show to visit|3|||
47034433|NCT01802216|83285546|FG001|8 Month Visit|Participant did not show to visit|5|||
47034434|NCT01802216|83285545|FG000|12 Month Visit|Participant did not show to visit|3|||
47034435|NCT01802216|83285546|FG001|12 Month Visit|Participant did not show to visit|4|||
47034436|NCT01808144|83285554|FG000|Overall Study|Death|1|||
47034437|NCT01808144|83285555|FG001|Overall Study|Death|0|||
47034438|NCT01808144|83285554|FG000|Overall Study|Withdrawal by Subject|16|||
47034439|NCT01808144|83285555|FG001|Overall Study|Withdrawal by Subject|23|||
47034440|NCT01808144|83285554|FG000|Overall Study|Lost to Follow-up|6|||
47034441|NCT01808144|83285555|FG001|Overall Study|Lost to Follow-up|3|||
47034442|NCT01808144|83285554|FG000|Overall Study|Protocol Violation|6|||
47034443|NCT01808144|83285555|FG001|Overall Study|Protocol Violation|6|||
47034444|NCT01808144|83285554|FG000|Overall Study|Gout flare|0|||
47034445|NCT01808144|83285555|FG001|Overall Study|Gout flare|1|||
47034446|NCT01808144|83285554|FG000|Overall Study|Adverse Event|11|||
47034447|NCT01808144|83285555|FG001|Overall Study|Adverse Event|15|||
47034448|NCT01801982|83285561|FG000|Overall Study|Lost to Follow-up|1|||
47034449|NCT01808066|83285574|FG000|Overall Study|Withdrawal by Subject|15|||
47034450|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
47034451|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
47034452|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
47034453|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
47034454|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
47034455|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
47034456|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
47034457|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
47034458|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
47034459|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
47034460|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
47034461|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
47034462|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
47034463|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
47034464|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
47034465|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Death|5|||
47034466|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Death|0|||
47034467|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Death|2|||
47034468|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Death|0|||
47034469|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Death|4|||
47034470|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
47034471|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
46629319|NCT01964352|82800105|FG002|Overall Study|Other than stated above|1|||
46629320|NCT01964352|82800106|FG003|Overall Study|Other than stated above|2|||
46629321|NCT01946412|82800116|FG000|Overall Study|Adverse Event|1|||
46629322|NCT01946412|82800116|FG000|Overall Study|Non-Compliance|1|||
46629323|NCT01946412|82800116|FG000|Overall Study|Continued with commercial Kalydeco|2|||
46629324|NCT01946412|82800116|FG000|Overall Study|Difficulty in swallowing|1|||
46629325|NCT01946178|82800122|FG000|Overall Study|Pregnancy|1|||
46913133|NCT02937701|83143315|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
46913134|NCT02937701|83143316|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
47034472|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
47034473|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
47034474|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
47034475|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
47034476|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
47034477|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
47034478|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
47034479|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
47034480|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
47034481|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
47034482|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
47034483|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
47034484|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
47034485|NCT01604343|83285582|FG000|Prior to W52 Administration(Through W52)|Other|15|||
47034486|NCT01604343|83285583|FG001|Prior to W52 Administration(Through W52)|Other|0|||
47034487|NCT01604343|83285584|FG002|Prior to W52 Administration(Through W52)|Other|10|||
47034488|NCT01604343|83285585|FG003|Prior to W52 Administration(Through W52)|Other|0|||
47034489|NCT01604343|83285586|FG004|Prior to W52 Administration(Through W52)|Other|6|||
47034490|NCT01604343|83285582|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
47034491|NCT01604343|83285583|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
47034492|NCT01604343|83285584|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
47034493|NCT01604343|83285585|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
47034494|NCT01604343|83285586|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
47034495|NCT01604343|83285582|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
47034496|NCT01604343|83285583|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
47034497|NCT01604343|83285584|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
47034498|NCT01604343|83285585|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
47034499|NCT01604343|83285586|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
47034500|NCT01604343|83285582|FG000|Week 52 to Week 104|Adverse Event|0|||
46629326|NCT01946178|82800122|FG000|Overall Study|Lost to Follow-up|1|||
46629327|NCT01945944|82800132|FG000|Overall Study|Adverse Event|0|||
46629328|NCT01945944|82800133|FG001|Overall Study|Adverse Event|2|||
46629329|NCT01945944|82800132|FG000|Overall Study|Physician Decision|1|||
46629330|NCT01945944|82800133|FG001|Overall Study|Physician Decision|0|||
46629331|NCT01945944|82800132|FG000|Overall Study|Withdrawal by Subject|0|||
46629332|NCT01945944|82800133|FG001|Overall Study|Withdrawal by Subject|1|||
46629333|NCT01945866|82800143|FG000|Overall Study|Eyes did not complete or were dropped|2|||
46629334|NCT01945866|82800144|FG001|Overall Study|Eyes did not complete or were dropped|0|||
46629335|NCT01986114|82800151|FG000|Overall Study|Adverse Event|59|||
46629336|NCT01986114|82800151|FG000|Overall Study|Lack of Efficacy|23|||
46913135|NCT02937701|83143317|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
46913136|NCT02937701|83143313|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
47034501|NCT01604343|83285583|FG001|Week 52 to Week 104|Adverse Event|12|||
47034502|NCT01604343|83285584|FG002|Week 52 to Week 104|Adverse Event|26|||
46629337|NCT01986114|82800151|FG000|Overall Study|Withdrawal by Subject|58|||
46629338|NCT01986114|82800151|FG000|Overall Study|Noncompliance|3|||
47034503|NCT01604343|83285585|FG003|Week 52 to Week 104|Adverse Event|21|||
47034504|NCT01604343|83285586|FG004|Week 52 to Week 104|Adverse Event|27|||
47034505|NCT01604343|83285582|FG000|Week 52 to Week 104|Death|0|||
47034506|NCT01604343|83285583|FG001|Week 52 to Week 104|Death|4|||
47034507|NCT01604343|83285584|FG002|Week 52 to Week 104|Death|2|||
47034508|NCT01604343|83285585|FG003|Week 52 to Week 104|Death|5|||
47034509|NCT01604343|83285586|FG004|Week 52 to Week 104|Death|0|||
47034510|NCT01604343|83285582|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
47034511|NCT01604343|83285583|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
47034512|NCT01604343|83285584|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
47034513|NCT01604343|83285585|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
47034514|NCT01604343|83285586|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
47034515|NCT01604343|83285582|FG000|Week 52 to Week 104|Physician Decision|0|||
47034516|NCT01604343|83285583|FG001|Week 52 to Week 104|Physician Decision|1|||
47034517|NCT01604343|83285584|FG002|Week 52 to Week 104|Physician Decision|0|||
47034518|NCT01604343|83285585|FG003|Week 52 to Week 104|Physician Decision|0|||
47034519|NCT01604343|83285586|FG004|Week 52 to Week 104|Physician Decision|2|||
47034520|NCT01604343|83285582|FG000|Week 52 to Week 104|Pregnancy|0|||
47034521|NCT01604343|83285583|FG001|Week 52 to Week 104|Pregnancy|0|||
47034522|NCT01604343|83285584|FG002|Week 52 to Week 104|Pregnancy|1|||
47034523|NCT01604343|83285585|FG003|Week 52 to Week 104|Pregnancy|2|||
47034524|NCT01604343|83285586|FG004|Week 52 to Week 104|Pregnancy|1|||
47034525|NCT01604343|83285582|FG000|Week 52 to Week 104|Other|0|||
47034526|NCT01604343|83285583|FG001|Week 52 to Week 104|Other|11|||
47034527|NCT01604343|83285584|FG002|Week 52 to Week 104|Other|11|||
47034528|NCT01604343|83285585|FG003|Week 52 to Week 104|Other|6|||
47034529|NCT01604343|83285586|FG004|Week 52 to Week 104|Other|3|||
47034530|NCT01604343|83285582|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
47034531|NCT01604343|83285583|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
47034532|NCT01604343|83285584|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
47034533|NCT01604343|83285585|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
47034534|NCT01604343|83285586|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
47034535|NCT01604343|83285582|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
47034536|NCT01604343|83285583|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
47034537|NCT01604343|83285584|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
47034538|NCT01604343|83285585|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
47034539|NCT01604343|83285586|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
47034540|NCT01604343|83285582|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
47034541|NCT01604343|83285583|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
47034542|NCT01604343|83285584|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
47034543|NCT01604343|83285585|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
47034544|NCT01604343|83285586|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
47034545|NCT01801436|83285596|FG000|Overall Study|Withdrawal by Subject|3|||
47034546|NCT01801436|83285596|FG000|Overall Study|Adverse Event|2|||
47034547|NCT01801436|83285596|FG000|Overall Study|Progressive disease|4|||
47034548|NCT01771250|83285600|FG000|Period 1|Met exclusion criteria|1|||
47034549|NCT01771250|83285601|FG001|Period 1|Met exclusion criteria|0|||
47034550|NCT01770860|83285607|FG000|Overall Study|Withdrawal by Subject|4|||
47034551|NCT01770860|83285607|FG000|Overall Study|Lost to Follow-up|1|||
46913137|NCT02937701|83143314|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
46913138|NCT02937701|83143315|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
46913139|NCT02937701|83143316|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
46913140|NCT02937701|83143317|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
46913141|NCT02937701|83143313|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
46913142|NCT02937701|83143314|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
46913143|NCT02937701|83143315|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
46913144|NCT02937701|83143316|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
46913145|NCT02937701|83143317|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
46913146|NCT02937701|83143313|FG000|Day 1 to Week 22|Death|1|||
46913147|NCT02937701|83143314|FG001|Day 1 to Week 22|Death|1|||
46913148|NCT02937701|83143315|FG002|Day 1 to Week 22|Death|0|||
46913149|NCT02937701|83143316|FG003|Day 1 to Week 22|Death|0|||
46913150|NCT02937701|83143317|FG004|Day 1 to Week 22|Death|0|||
46913151|NCT02937701|83143313|FG000|Day 1 to Week 22|Protocol Violation|1|||
46913152|NCT02937701|83143314|FG001|Day 1 to Week 22|Protocol Violation|1|||
47034552|NCT01770860|83285607|FG000|Overall Study|Administrative decision made by the PI|1|||
46913153|NCT02937701|83143315|FG002|Day 1 to Week 22|Protocol Violation|0|||
46913154|NCT02937701|83143316|FG003|Day 1 to Week 22|Protocol Violation|0|||
47034553|NCT01603875|83285618|FG000|Overall Study|Preexisting rabies antibody|3|||
47034554|NCT01603875|83285619|FG001|Overall Study|Preexisting rabies antibody|4|||
47034555|NCT01603875|83285620|FG002|Overall Study|Preexisting rabies antibody|3|||
46913155|NCT02937701|83143317|FG004|Day 1 to Week 22|Protocol Violation|0|||
46913156|NCT02937701|83143313|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
46913157|NCT02937701|83143314|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
46913158|NCT02937701|83143315|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
47034556|NCT01603875|83285618|FG000|Overall Study|Lost to Follow-up|4|||
47034557|NCT01603875|83285619|FG001|Overall Study|Lost to Follow-up|3|||
47034558|NCT01603875|83285620|FG002|Overall Study|Lost to Follow-up|6|||
47034559|NCT01603875|83285618|FG000|Overall Study|Protocol Violation|0|||
47034560|NCT01603875|83285619|FG001|Overall Study|Protocol Violation|1|||
47034561|NCT01603875|83285620|FG002|Overall Study|Protocol Violation|0|||
47034562|NCT01770392|83285628|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
47034563|NCT01603641|83285638|FG000|Overall Study|Did not Receive Treatment|3|||
47034564|NCT01603641|83285638|FG000|Overall Study|Adverse Event|1|||
47034565|NCT01603641|83285638|FG000|Overall Study|Lack of Efficacy|1|||
47034566|NCT01603641|83285638|FG000|Overall Study|Lost to Follow-up|6|||
47034567|NCT01603641|83285638|FG000|Overall Study|Personal Reasons|18|||
47034568|NCT01603641|83285638|FG000|Overall Study|Other Miscellaneous Reasons|6|||
47034569|NCT01556763|83285645|FG000|Overall Study|Withdrawal by Subject|0|||
47034570|NCT01556763|83285646|FG001|Overall Study|Withdrawal by Subject|1|||
47034571|NCT01556763|83285647|FG002|Overall Study|Withdrawal by Subject|0|||
47034572|NCT01576575|83285657|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
47034573|NCT01576575|83285657|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
47034574|NCT01576575|83285657|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
47034575|NCT01555983|83285667|FG000|Overall Study|Withdrawal by Subject|1|||
47034576|NCT01555983|83285668|FG001|Overall Study|Withdrawal by Subject|0|||
47034577|NCT01555983|83285669|FG002|Overall Study|Withdrawal by Subject|0|||
47034578|NCT01555983|83285670|FG003|Overall Study|Withdrawal by Subject|0|||
47034579|NCT01555983|83285671|FG004|Overall Study|Withdrawal by Subject|1|||
47034580|NCT01555983|83285672|FG005|Overall Study|Withdrawal by Subject|1|||
47034581|NCT01576341|83285680|FG000|Overall Study|Withdrawal by Subject|24|||
47034582|NCT01576341|83285680|FG000|Overall Study|Adverse Event|10|||
46629339|NCT01986114|82800151|FG000|Overall Study|Protocol Violation|1|||
46629340|NCT01986114|82800151|FG000|Overall Study|Lost to Follow-up|5|||
46629341|NCT01986114|82800151|FG000|Overall Study|Other reason|7|||
46629342|NCT01945710|82800164|FG000|Overall Study|Progressive Disease|5|||
46629343|NCT01945710|82800165|FG001|Overall Study|Progressive Disease|4|||
46629344|NCT01945710|82800166|FG002|Overall Study|Progressive Disease|3|||
46629345|NCT01945710|82800167|FG003|Overall Study|Progressive Disease|2|||
46629346|NCT01945710|82800168|FG004|Overall Study|Progressive Disease|7|||
46629347|NCT01945710|82800169|FG005|Overall Study|Progressive Disease|3|||
46629348|NCT01945710|82800170|FG006|Overall Study|Progressive Disease|19|||
46629349|NCT01945710|82800164|FG000|Overall Study|Adverse Event|0|||
46629350|NCT01945710|82800165|FG001|Overall Study|Adverse Event|1|||
46629351|NCT01945710|82800166|FG002|Overall Study|Adverse Event|0|||
46629352|NCT01945710|82800167|FG003|Overall Study|Adverse Event|0|||
46629353|NCT01945710|82800168|FG004|Overall Study|Adverse Event|0|||
46629354|NCT01945710|82800169|FG005|Overall Study|Adverse Event|0|||
46629355|NCT01945710|82800170|FG006|Overall Study|Adverse Event|0|||
46629356|NCT01945710|82800164|FG000|Overall Study|Other|2|||
46629357|NCT01945710|82800165|FG001|Overall Study|Other|0|||
46629358|NCT01945710|82800166|FG002|Overall Study|Other|3|||
46629359|NCT01945710|82800167|FG003|Overall Study|Other|1|||
46629360|NCT01945710|82800168|FG004|Overall Study|Other|1|||
46629361|NCT01945710|82800169|FG005|Overall Study|Other|0|||
46629362|NCT01945710|82800170|FG006|Overall Study|Other|4|||
46629363|NCT01945710|82800164|FG000|Overall Study|Withdrawal by Subject|0|||
46629364|NCT01945710|82800165|FG001|Overall Study|Withdrawal by Subject|1|||
46629365|NCT01945710|82800166|FG002|Overall Study|Withdrawal by Subject|1|||
46629366|NCT01945710|82800167|FG003|Overall Study|Withdrawal by Subject|0|||
46629367|NCT01945710|82800168|FG004|Overall Study|Withdrawal by Subject|1|||
46629368|NCT01945710|82800169|FG005|Overall Study|Withdrawal by Subject|0|||
46629369|NCT01945710|82800170|FG006|Overall Study|Withdrawal by Subject|0|||
46629370|NCT01945242|82800190|FG000|Overall Study|Physician Decision|3|||
46629371|NCT01945242|82800191|FG001|Overall Study|Physician Decision|3|||
46629372|NCT01945086|82800201|FG000|Overall Study|Withdrawal by Subject|1|||
46629373|NCT01945086|82800202|FG001|Overall Study|Withdrawal by Subject|0|||
46629374|NCT01945086|82800203|FG002|Overall Study|Withdrawal by Subject|1|||
47034583|NCT01576341|83285680|FG000|Overall Study|Death|21|||
47034584|NCT01576341|83285680|FG000|Overall Study|Physician Decision|2|||
47034585|NCT01576341|83285680|FG000|Overall Study|Lost to Follow-up|2|||
47034586|NCT01576341|83285680|FG000|Overall Study|Kidney transplantation|10|||
47034587|NCT01576341|83285680|FG000|Overall Study|Protocol Violation|12|||
47034588|NCT01576341|83285680|FG000|Overall Study|Other|12|||
47034589|NCT01687413|83285698|FG000|Overall Study|Withdrawal by Subject|0|||
47034590|NCT01687413|83285699|FG001|Overall Study|Withdrawal by Subject|2|||
47034591|NCT01687413|83285698|FG000|Overall Study|Not eligible|0|||
47034592|NCT01687413|83285699|FG001|Overall Study|Not eligible|2|||
47034593|NCT01687413|83285698|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
46629375|NCT01945086|82800201|FG000|Overall Study|Adverse Event|0|||
46629376|NCT01945086|82800202|FG001|Overall Study|Adverse Event|0|||
46629377|NCT01945086|82800203|FG002|Overall Study|Adverse Event|1|||
46629378|NCT01963728|82800213|FG000|Overall Study|Study terminated early|0|||
46629379|NCT01963728|82800214|FG001|Overall Study|Study terminated early|1|||
46629380|NCT01963260|82800230|FG000|Overall Study|Withdrawal by Subject|2|||
46629381|NCT01963260|82800231|FG001|Overall Study|Withdrawal by Subject|0|||
46629382|NCT01963260|82800232|FG002|Overall Study|Withdrawal by Subject|0|||
46629383|NCT01963260|82800233|FG003|Overall Study|Withdrawal by Subject|1|||
46629384|NCT01963260|82800234|FG004|Overall Study|Withdrawal by Subject|2|||
46629385|NCT01963260|82800235|FG005|Overall Study|Withdrawal by Subject|0|||
46629386|NCT01963260|82800236|FG006|Overall Study|Withdrawal by Subject|0|||
46629387|NCT01963260|82800237|FG007|Overall Study|Withdrawal by Subject|0|||
46629388|NCT01963260|82800238|FG008|Overall Study|Withdrawal by Subject|0|||
46629389|NCT01963260|82800239|FG009|Overall Study|Withdrawal by Subject|0|||
46803628|NCT03523728|83022938|FG000|Stage 1 (24 Months)|Progressive disease|0|||
46803629|NCT03523728|83022939|FG001|Stage 1 (24 Months)|Progressive disease|0|||
46803630|NCT03523728|83022940|FG002|Stage 1 (24 Months)|Progressive disease|1|||
46803631|NCT03523728|83022941|FG003|Stage 1 (24 Months)|Progressive disease|0|||
46629394|NCT01985334|82800290|FG000|Overall Study|Administrative problems|1|||
46629395|NCT01985334|82800291|FG001|Overall Study|Administrative problems|1|||
46629396|NCT01985334|82800292|FG002|Overall Study|Administrative problems|0|||
46629397|NCT01985334|82800293|FG003|Overall Study|Administrative problems|2|||
46629398|NCT01985334|82800294|FG004|Overall Study|Administrative problems|0|||
46710965|NCT01135524|82927293|FG000|Overall Study|Withdrawal by Subject|14|||
46710966|NCT01135524|82927293|FG000|Overall Study|Adverse Event|20|||
46710967|NCT01135524|82927293|FG000|Overall Study|Lost to Follow-up|3|||
46710968|NCT01135524|82927293|FG000|Overall Study|Administrative|151|||
46710969|NCT01135524|82927293|FG000|Overall Study|Lack of Efficacy|8|||
46710970|NCT00948675|82927299|FG000|Overall Study|Lost to Follow-up|1|||
46710971|NCT00948675|82927300|FG001|Overall Study|Lost to Follow-up|0|||
46710972|NCT00903370|82927308|FG000|Overall Study|Death|13|||
46710973|NCT00903370|82927309|FG001|Overall Study|Death|10|||
46710974|NCT00903370|82927308|FG000|Overall Study|Withdrawal by Subject|9|||
46710975|NCT00903370|82927309|FG001|Overall Study|Withdrawal by Subject|6|||
46710976|NCT00903370|82927308|FG000|Overall Study|Lost to Follow-up|6|||
47034594|NCT01687413|83285699|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
47034595|NCT01555671|83285725|FG000|Overall Study|Physician Decision|20|||
47034596|NCT01555671|83285726|FG001|Overall Study|Physician Decision|25|||
47034597|NCT01801358|83285740|FG000|Overall Study|Adverse Event|0|||
47034598|NCT01801358|83285741|FG001|Overall Study|Adverse Event|2|||
47034599|NCT01801358|83285742|FG002|Overall Study|Adverse Event|1|||
46629399|NCT01985334|82800295|FG005|Overall Study|Administrative problems|1|||
46629400|NCT01985334|82800296|FG006|Overall Study|Administrative problems|1|||
46629401|NCT01985334|82800297|FG007|Overall Study|Administrative problems|3|||
46629402|NCT01985334|82800290|FG000|Overall Study|Death|1|||
46629403|NCT01985334|82800291|FG001|Overall Study|Death|0|||
46629404|NCT01985334|82800292|FG002|Overall Study|Death|0|||
46629405|NCT01985334|82800293|FG003|Overall Study|Death|3|||
46629406|NCT01985334|82800294|FG004|Overall Study|Death|0|||
46629407|NCT01985334|82800295|FG005|Overall Study|Death|0|||
46629408|NCT01985334|82800296|FG006|Overall Study|Death|1|||
46629409|NCT01985334|82800297|FG007|Overall Study|Death|2|||
46629410|NCT01985334|82800290|FG000|Overall Study|Worsening of disease|0|||
46629411|NCT01985334|82800291|FG001|Overall Study|Worsening of disease|0|||
46629412|NCT01985334|82800292|FG002|Overall Study|Worsening of disease|0|||
46629413|NCT01985334|82800293|FG003|Overall Study|Worsening of disease|1|||
46629414|NCT01985334|82800294|FG004|Overall Study|Worsening of disease|0|||
46629415|NCT01985334|82800295|FG005|Overall Study|Worsening of disease|3|||
46629416|NCT01985334|82800296|FG006|Overall Study|Worsening of disease|0|||
46710977|NCT00903370|82927309|FG001|Overall Study|Lost to Follow-up|8|||
46710978|NCT01110408|82927317|FG000|Overall Study|Protocol Violation|1|||
46710979|NCT01110408|82927318|FG001|Overall Study|Protocol Violation|0|||
46710980|NCT00953043|82927326|FG000|Overall Study|Withdrawal by Subject|4|||
46710981|NCT00953043|82927327|FG001|Overall Study|Withdrawal by Subject|0|||
46710982|NCT00953043|82927326|FG000|Overall Study|Physician Decision|0|||
47034600|NCT01801358|83285743|FG003|Overall Study|Adverse Event|0|||
46629417|NCT01985334|82800297|FG007|Overall Study|Worsening of disease|1|||
46629418|NCT01985334|82800290|FG000|Overall Study|Other|2|||
46629419|NCT01985334|82800291|FG001|Overall Study|Other|9|||
46629420|NCT01985334|82800292|FG002|Overall Study|Other|7|||
47034601|NCT01801358|83285744|FG004|Overall Study|Adverse Event|0|||
47034602|NCT01801358|83285745|FG005|Overall Study|Adverse Event|1|||
47034603|NCT01801358|83285740|FG000|Overall Study|Physician Decision|0|||
46629421|NCT01985334|82800293|FG003|Overall Study|Other|17|||
46629422|NCT01985334|82800294|FG004|Overall Study|Other|4|||
46710983|NCT00953043|82927327|FG001|Overall Study|Physician Decision|2|||
46710984|NCT01135134|82927335|FG000|Overall Study|Adverse Event|1|||
46710985|NCT01135134|82927336|FG001|Overall Study|Adverse Event|1|||
46710986|NCT01135134|82927335|FG000|Overall Study|Did not meet protocol eligibility|1|||
46803632|NCT03523728|83022942|FG004|Stage 1 (24 Months)|Progressive disease|0|||
46803633|NCT03523728|83022938|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
46710987|NCT01135134|82927336|FG001|Overall Study|Did not meet protocol eligibility|0|||
46710988|NCT00948441|82927344|FG000|Overall Study|no longer meet inclusion criteria|1|||
46710989|NCT00948441|82927345|FG001|Overall Study|no longer meet inclusion criteria|4|||
46710990|NCT01117350|82927355|FG000|Comparative Period|Not Treated|5|||
46710991|NCT01117350|82927356|FG001|Comparative Period|Not Treated|8|||
46710992|NCT01117350|82927355|FG000|Comparative Period|Adverse Event|6|||
46710993|NCT01117350|82927356|FG001|Comparative Period|Adverse Event|33|||
46710994|NCT01117350|82927355|FG000|Comparative Period|Lost to Follow-up|11|||
46710995|NCT01117350|82927356|FG001|Comparative Period|Lost to Follow-up|7|||
46710996|NCT01117350|82927355|FG000|Comparative Period|Withdrawal by Subject|9|||
46710997|NCT01117350|82927356|FG001|Comparative Period|Withdrawal by Subject|13|||
46710998|NCT01117350|82927355|FG000|Comparative Period|Protocol Violation|8|||
46710999|NCT01117350|82927356|FG001|Comparative Period|Protocol Violation|12|||
46711000|NCT01117350|82927355|FG000|Comparative Period|Lack of Efficacy|1|||
46711001|NCT01117350|82927356|FG001|Comparative Period|Lack of Efficacy|0|||
46711002|NCT01117350|82927355|FG000|Comparative Period|Physician Decision|0|||
46711003|NCT01117350|82927356|FG001|Comparative Period|Physician Decision|1|||
46711004|NCT01117350|82927355|FG000|Comparative Period|Move to another city/country|2|||
46711005|NCT01117350|82927356|FG001|Comparative Period|Move to another city/country|1|||
46711006|NCT01117350|82927355|FG000|Extension Period|Not included in extension, not treated|0|||
46711007|NCT01117350|82927356|FG001|Extension Period|Not included in extension, not treated|50|||
46711008|NCT01117350|82927355|FG000|Extension Period|Adverse Event|0|||
46711009|NCT01117350|82927356|FG001|Extension Period|Adverse Event|2|||
46711010|NCT01117350|82927355|FG000|Extension Period|Protocol Violation|0|||
46711011|NCT01117350|82927356|FG001|Extension Period|Protocol Violation|2|||
46711012|NCT01117350|82927355|FG000|Extension Period|Lost to Follow-up|0|||
46711013|NCT01117350|82927356|FG001|Extension Period|Lost to Follow-up|2|||
46711014|NCT01117350|82927355|FG000|Extension Period|Withdrawal by Subject|0|||
46711015|NCT01117350|82927356|FG001|Extension Period|Withdrawal by Subject|3|||
46711016|NCT01117350|82927355|FG000|Extension Period|Lack of Efficacy|0|||
46711017|NCT01117350|82927356|FG001|Extension Period|Lack of Efficacy|2|||
46711018|NCT01117350|82927355|FG000|Extension Period|Inclusion criteria not respected|0|||
46711019|NCT01117350|82927356|FG001|Extension Period|Inclusion criteria not respected|1|||
46711020|NCT01117350|82927355|FG000|Extension Period|Prohibited medication|0|||
46913159|NCT02937701|83143316|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
47034604|NCT01801358|83285741|FG001|Overall Study|Physician Decision|0|||
47034605|NCT01801358|83285742|FG002|Overall Study|Physician Decision|1|||
47034606|NCT01801358|83285743|FG003|Overall Study|Physician Decision|0|||
47034607|NCT01801358|83285744|FG004|Overall Study|Physician Decision|0|||
47034608|NCT01801358|83285745|FG005|Overall Study|Physician Decision|0|||
47034609|NCT01801358|83285740|FG000|Overall Study|Progressive Disease|6|||
47034610|NCT01801358|83285741|FG001|Overall Study|Progressive Disease|4|||
47034611|NCT01801358|83285742|FG002|Overall Study|Progressive Disease|4|||
47034612|NCT01801358|83285743|FG003|Overall Study|Progressive Disease|5|||
47034613|NCT01801358|83285744|FG004|Overall Study|Progressive Disease|6|||
47034614|NCT01801358|83285745|FG005|Overall Study|Progressive Disease|5|||
47034615|NCT01801358|83285740|FG000|Overall Study|Withdrawal by Subject|0|||
47034616|NCT01801358|83285741|FG001|Overall Study|Withdrawal by Subject|0|||
47034617|NCT01801358|83285742|FG002|Overall Study|Withdrawal by Subject|0|||
47034618|NCT01801358|83285743|FG003|Overall Study|Withdrawal by Subject|1|||
46629423|NCT01985334|82800295|FG005|Overall Study|Other|8|||
46629424|NCT01985334|82800296|FG006|Overall Study|Other|4|||
46629425|NCT01985334|82800297|FG007|Overall Study|Other|7|||
46629426|NCT01985334|82800290|FG000|Overall Study|Protocol deviation|6|||
46629427|NCT01985334|82800291|FG001|Overall Study|Protocol deviation|31|||
46629428|NCT01985334|82800292|FG002|Overall Study|Protocol deviation|25|||
46629429|NCT01985334|82800293|FG003|Overall Study|Protocol deviation|84|||
46629430|NCT01985334|82800294|FG004|Overall Study|Protocol deviation|17|||
46629431|NCT01985334|82800295|FG005|Overall Study|Protocol deviation|47|||
46629432|NCT01985334|82800296|FG006|Overall Study|Protocol deviation|15|||
46629433|NCT01985334|82800297|FG007|Overall Study|Protocol deviation|42|||
46629434|NCT01985334|82800290|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
47034619|NCT01801358|83285744|FG004|Overall Study|Withdrawal by Subject|0|||
46629435|NCT01985334|82800291|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
46629436|NCT01985334|82800292|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
46629437|NCT01985334|82800293|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
46629438|NCT01985334|82800294|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
46629439|NCT01985334|82800295|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
46711021|NCT01117350|82927356|FG001|Extension Period|Prohibited medication|1|||
46711022|NCT00952731|82927367|FG000|Overall Study|Drug supply expired|1|||
46711023|NCT00952731|82927368|FG001|Overall Study|Drug supply expired|0|||
46711024|NCT00947427|82927376|FG000|Overall Study|Withdrawal by Subject|1|||
46711025|NCT00947427|82927377|FG001|Overall Study|Withdrawal by Subject|3|||
46711026|NCT00947427|82927376|FG000|Overall Study|Protocol Violation|0|||
46711027|NCT00947427|82927377|FG001|Overall Study|Protocol Violation|1|||
46913160|NCT02937701|83143317|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
47034620|NCT01801358|83285745|FG005|Overall Study|Withdrawal by Subject|2|||
46711028|NCT01116882|82927385|FG000|30-day|Lost to Follow-up|50|||
46711029|NCT01116882|82927386|FG001|30-day|Lost to Follow-up|21|||
46711030|NCT01116882|82927385|FG000|30-day|Withdrawal by Subject|2|||
46711031|NCT01116882|82927386|FG001|30-day|Withdrawal by Subject|4|||
46711032|NCT01116882|82927385|FG000|30-day|Other Reasons|16|||
46711033|NCT01116882|82927386|FG001|30-day|Other Reasons|6|||
46711034|NCT01116882|82927385|FG000|12-month|Lost to Follow-up|111|||
46711035|NCT01116882|82927386|FG001|12-month|Lost to Follow-up|42|||
46711036|NCT01116882|82927385|FG000|12-month|Other Reasons|151|||
46711037|NCT01116882|82927386|FG001|12-month|Other Reasons|49|||
46711038|NCT01116882|82927385|FG000|12-month|Withdrawal by Subject|5|||
46711039|NCT01116882|82927386|FG001|12-month|Withdrawal by Subject|8|||
46711040|NCT00953745|82927397|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
46711041|NCT00953745|82927398|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
46711042|NCT00953745|82927397|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
46711043|NCT00953745|82927398|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
46711044|NCT00953745|82927397|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
46711045|NCT00953745|82927398|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
46711046|NCT00953745|82927397|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
46711047|NCT00953745|82927398|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
46711048|NCT00953745|82927397|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
46711049|NCT00953745|82927398|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
46711050|NCT00953745|82927397|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
46711051|NCT00953745|82927398|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
46711052|NCT00902746|82927415|FG000|Overall Study|Protocol Violation|7|||
46711053|NCT00902746|82927415|FG000|Overall Study|Withdrawal by Subject|16|||
46711054|NCT00902746|82927415|FG000|Overall Study|Adverse Event|8|||
46711055|NCT00902746|82927415|FG000|Overall Study|Lost to Follow-up|3|||
46711056|NCT00902746|82927415|FG000|Overall Study|Physician Decision|2|||
46711057|NCT00902668|82927428|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
46711058|NCT00947349|82927436|FG000|Triple Treatment Combination Period|Adverse Event|0|||
46711059|NCT00947349|82927437|FG001|Triple Treatment Combination Period|Adverse Event|1|||
46711060|NCT00947349|82927438|FG002|Triple Treatment Combination Period|Adverse Event|0|||
46711061|NCT00947349|82927439|FG003|Triple Treatment Combination Period|Adverse Event|0|||
46711062|NCT00947349|82927436|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
46711063|NCT00947349|82927437|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
46711064|NCT00947349|82927438|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
46711065|NCT00947349|82927439|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
46711066|NCT00947349|82927436|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
46711067|NCT00947349|82927437|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
46711068|NCT00947349|82927438|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
46711069|NCT00947349|82927439|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
46711070|NCT00947349|82927436|FG000|Overall Study Standard of Care|Other|0|||
46711071|NCT00947349|82927437|FG001|Overall Study Standard of Care|Other|0|||
47034621|NCT01807598|83285780|FG000|Overall Study|Withdrawal by Subject|4|||
47034622|NCT01807598|83285780|FG000|Overall Study|Adverse Event|1|||
47034623|NCT01807598|83285780|FG000|Overall Study|Other Physician Decision|1|||
47034624|NCT01801280|83285788|FG000|Period 1|Withdrawal by Subject|0|||
47034625|NCT01801280|83285789|FG001|Period 1|Withdrawal by Subject|1|||
47034626|NCT01801280|83285790|FG002|Period 1|Withdrawal by Subject|0|||
47034627|NCT01801280|83285791|FG003|Period 1|Withdrawal by Subject|0|||
47034628|NCT01801280|83285788|FG000|Period 2|Withdrawal by Subject|1|||
47034629|NCT01801280|83285789|FG001|Period 2|Withdrawal by Subject|0|||
47034630|NCT01801280|83285790|FG002|Period 2|Withdrawal by Subject|0|||
47034631|NCT01801280|83285791|FG003|Period 2|Withdrawal by Subject|0|||
47034632|NCT01801280|83285788|FG000|Period 4|Protocol Violation|0|||
46629440|NCT01985334|82800296|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
46629441|NCT01985334|82800297|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
46629442|NCT01985334|82800290|FG000|Overall Study|Subject withdrawal of consent|3|||
46629443|NCT01985334|82800291|FG001|Overall Study|Subject withdrawal of consent|6|||
46629444|NCT01985334|82800292|FG002|Overall Study|Subject withdrawal of consent|2|||
46629445|NCT01985334|82800293|FG003|Overall Study|Subject withdrawal of consent|28|||
46629446|NCT01985334|82800294|FG004|Overall Study|Subject withdrawal of consent|4|||
46629447|NCT01985334|82800295|FG005|Overall Study|Subject withdrawal of consent|19|||
46629448|NCT01985334|82800296|FG006|Overall Study|Subject withdrawal of consent|0|||
46629449|NCT01985334|82800297|FG007|Overall Study|Subject withdrawal of consent|20|||
46629450|NCT01985334|82800290|FG000|Overall Study|Adverse Event|0|||
46711072|NCT00947349|82927438|FG002|Overall Study Standard of Care|Other|0|||
46711073|NCT00947349|82927439|FG003|Overall Study Standard of Care|Other|1|||
47034633|NCT01801280|83285789|FG001|Period 4|Protocol Violation|0|||
46711074|NCT00947193|82927467|FG000|Overall Study|Lost to Follow-up|1|||
46711075|NCT00947193|82927468|FG001|Overall Study|Lost to Follow-up|0|||
46711076|NCT00947193|82927467|FG000|Overall Study|Withdrawal by Subject|1|||
47034634|NCT01801280|83285790|FG002|Period 4|Protocol Violation|1|||
46711077|NCT00947193|82927468|FG001|Overall Study|Withdrawal by Subject|0|||
46711078|NCT00947193|82927467|FG000|Overall Study|Factor VIII >1%|1|||
46711079|NCT00947193|82927468|FG001|Overall Study|Factor VIII >1%|0|||
46711080|NCT00947115|82927476|FG000|Overall Study|Missed reporting interval|3|||
46711081|NCT00947115|82927477|FG001|Overall Study|Missed reporting interval|4|||
46711082|NCT00947115|82927478|FG002|Overall Study|Missed reporting interval|2|||
46711083|NCT00947115|82927476|FG000|Overall Study|Physician Decision|0|||
46711084|NCT00947115|82927477|FG001|Overall Study|Physician Decision|2|||
46711085|NCT00947115|82927478|FG002|Overall Study|Physician Decision|0|||
46711086|NCT00947115|82927476|FG000|Overall Study|Death|0|||
46711087|NCT00947115|82927477|FG001|Overall Study|Death|1|||
46711088|NCT00947115|82927478|FG002|Overall Study|Death|1|||
46711089|NCT00947115|82927476|FG000|Overall Study|Migrated from study area|2|||
46711090|NCT00947115|82927477|FG001|Overall Study|Migrated from study area|0|||
46711091|NCT00947115|82927478|FG002|Overall Study|Migrated from study area|0|||
46711092|NCT00947115|82927476|FG000|Overall Study|Withdrawal by Subject|1|||
46711093|NCT00947115|82927477|FG001|Overall Study|Withdrawal by Subject|3|||
46711094|NCT00947115|82927478|FG002|Overall Study|Withdrawal by Subject|4|||
46711095|NCT00947115|82927476|FG000|Overall Study|Lost to Follow-up|11|||
46711096|NCT00947115|82927477|FG001|Overall Study|Lost to Follow-up|12|||
46711097|NCT00947115|82927478|FG002|Overall Study|Lost to Follow-up|8|||
46711098|NCT00952419|82927489|FG000|Overall Study|Adverse Event|2|||
46711099|NCT00952419|82927490|FG001|Overall Study|Adverse Event|0|||
46711100|NCT00952419|82927491|FG002|Overall Study|Adverse Event|0|||
46711101|NCT00952419|82927489|FG000|Overall Study|Protocol Violation|3|||
46711102|NCT00952419|82927490|FG001|Overall Study|Protocol Violation|7|||
46711103|NCT00952419|82927491|FG002|Overall Study|Protocol Violation|0|||
46711104|NCT00952419|82927489|FG000|Overall Study|Withdrawal by Subject|1|||
46711105|NCT00952419|82927490|FG001|Overall Study|Withdrawal by Subject|3|||
46711106|NCT00952419|82927491|FG002|Overall Study|Withdrawal by Subject|0|||
46711107|NCT00902278|82927504|FG000|Overall Study|Physician Decision|1|||
46711108|NCT00902278|82927505|FG001|Overall Study|Physician Decision|0|||
46711109|NCT00902278|82927506|FG002|Overall Study|Physician Decision|2|||
46711110|NCT00902278|82927507|FG003|Overall Study|Physician Decision|0|||
46711111|NCT00902278|82927508|FG004|Overall Study|Physician Decision|1|||
47034635|NCT01801280|83285791|FG003|Period 4|Protocol Violation|0|||
47034636|NCT01769456|83285801|FG000|Overall Study|Lost to Follow-up|19|||
47034637|NCT01769456|83285801|FG000|Overall Study|Withdrawal by Subject|3|||
47034638|NCT01769456|83285801|FG000|Overall Study|Did not receive PCC intervention|6|||
47034639|NCT01769456|83285801|FG000|Overall Study|Moved out of the area|3|||
47034640|NCT01769456|83285801|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
47034641|NCT01769456|83285801|FG000|Overall Study|Parental request to youth to withdraw|1|||
47034642|NCT01769378|83285808|FG000|Overall Study|Adverse Event|10|||
47034643|NCT01769378|83285809|FG001|Overall Study|Adverse Event|0|||
47034644|NCT01769378|83285808|FG000|Overall Study|Entry criteria not met|1|||
47034645|NCT01769378|83285809|FG001|Overall Study|Entry criteria not met|0|||
47034646|NCT01769378|83285808|FG000|Overall Study|Protocol Violation|1|||
46629451|NCT01985334|82800291|FG001|Overall Study|Adverse Event|8|||
46629452|NCT01985334|82800292|FG002|Overall Study|Adverse Event|2|||
46629453|NCT01985334|82800293|FG003|Overall Study|Adverse Event|26|||
46629454|NCT01985334|82800294|FG004|Overall Study|Adverse Event|3|||
46629455|NCT01985334|82800295|FG005|Overall Study|Adverse Event|18|||
46629456|NCT01985334|82800296|FG006|Overall Study|Adverse Event|3|||
46629457|NCT01985334|82800297|FG007|Overall Study|Adverse Event|15|||
46629458|NCT01985334|82800290|FG000|Overall Study|Other|4|||
46629459|NCT01985334|82800291|FG001|Overall Study|Other|2|||
46629460|NCT01985334|82800292|FG002|Overall Study|Other|3|||
46629461|NCT01985334|82800293|FG003|Overall Study|Other|10|||
46629462|NCT01985334|82800294|FG004|Overall Study|Other|1|||
46629463|NCT01985334|82800295|FG005|Overall Study|Other|6|||
46629464|NCT01985334|82800296|FG006|Overall Study|Other|2|||
46629465|NCT01985334|82800297|FG007|Overall Study|Other|2|||
46629466|NCT01985334|82800290|FG000|Overall Study|Medication non-compliance|0|||
46629467|NCT01985334|82800291|FG001|Overall Study|Medication non-compliance|4|||
47034647|NCT01769378|83285809|FG001|Overall Study|Protocol Violation|1|||
47034648|NCT01769378|83285808|FG000|Overall Study|Withdrawal by Subject|10|||
46629468|NCT01985334|82800292|FG002|Overall Study|Medication non-compliance|1|||
46711112|NCT00902278|82927504|FG000|Overall Study|Lost to Follow-up|3|||
47034649|NCT01769378|83285809|FG001|Overall Study|Withdrawal by Subject|3|||
47034650|NCT01769378|83285808|FG000|Overall Study|Sponsor Decision|1|||
46629469|NCT01985334|82800293|FG003|Overall Study|Medication non-compliance|6|||
46629470|NCT01985334|82800294|FG004|Overall Study|Medication non-compliance|2|||
46711113|NCT00902278|82927505|FG001|Overall Study|Lost to Follow-up|2|||
46711114|NCT00902278|82927506|FG002|Overall Study|Lost to Follow-up|3|||
46711115|NCT00902278|82927507|FG003|Overall Study|Lost to Follow-up|0|||
46711116|NCT00902278|82927508|FG004|Overall Study|Lost to Follow-up|1|||
46711117|NCT01998633|82927522|FG000|Overall Study|Death|1|||
46711118|NCT00952341|82927532|FG000|Cycle 1|Adverse Event|4|||
46629471|NCT01985334|82800295|FG005|Overall Study|Medication non-compliance|3|||
46711119|NCT00952341|82927533|FG001|Cycle 1|Adverse Event|1|||
46711120|NCT00952341|82927532|FG000|Cycle 1|Withdrawal by Subject|3|||
46711121|NCT00952341|82927533|FG001|Cycle 1|Withdrawal by Subject|8|||
46711122|NCT00952341|82927532|FG000|Cycle 1|Protocol Violation|2|||
46711123|NCT00952341|82927533|FG001|Cycle 1|Protocol Violation|1|||
46711124|NCT00952341|82927532|FG000|Cycle 1|Lost to Follow-up|11|||
46711125|NCT00952341|82927533|FG001|Cycle 1|Lost to Follow-up|2|||
46711126|NCT00952341|82927532|FG000|Cycle 1|Physician Decision|0|||
46711127|NCT00952341|82927533|FG001|Cycle 1|Physician Decision|1|||
46711128|NCT00952341|82927532|FG000|Cycle 2|Withdrawal by Subject|1|||
46711129|NCT00952341|82927533|FG001|Cycle 2|Withdrawal by Subject|1|||
46711130|NCT00952341|82927532|FG000|Cycle 2|Protocol Violation|1|||
47034651|NCT01769378|83285809|FG001|Overall Study|Sponsor Decision|0|||
47034652|NCT01769378|83285808|FG000|Overall Study|Lost to Follow-up|2|||
47034653|NCT01769378|83285809|FG001|Overall Study|Lost to Follow-up|0|||
47034654|NCT01807520|83285818|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
47034655|NCT01807520|83285819|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
47034656|NCT01807520|83285820|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
47034657|NCT01807520|83285821|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
47034658|NCT01807520|83285822|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
47034659|NCT01807520|83285823|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
47034660|NCT01807520|83285824|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
47034661|NCT01807520|83285818|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
47034662|NCT01807520|83285819|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
47034663|NCT01807520|83285820|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
47034664|NCT01807520|83285821|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
47034665|NCT01807520|83285822|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
47034666|NCT01807520|83285823|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
47034667|NCT01807520|83285824|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
47034668|NCT01807520|83285818|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
47034669|NCT01807520|83285819|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
47034670|NCT01807520|83285820|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
47034671|NCT01807520|83285821|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
47034672|NCT01807520|83285822|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
47034673|NCT01807520|83285823|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
47034674|NCT01807520|83285824|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
47034675|NCT01807520|83285818|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
47034676|NCT01807520|83285819|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
47034677|NCT01807520|83285820|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
47034678|NCT01807520|83285821|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
47034679|NCT01807520|83285822|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
47034680|NCT01807520|83285823|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
47034681|NCT01807520|83285824|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
47034682|NCT01807520|83285818|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
47034683|NCT01807520|83285819|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
47034684|NCT01807520|83285820|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
47034685|NCT01807520|83285821|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
47034686|NCT01807520|83285822|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
47034687|NCT01807520|83285823|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
47034688|NCT01807520|83285824|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
47034689|NCT01807520|83285818|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
47034690|NCT01807520|83285819|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
47034691|NCT01807520|83285820|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
47034692|NCT01807520|83285821|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
47034693|NCT01807520|83285822|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
47034694|NCT01807520|83285823|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
47034695|NCT01807520|83285824|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
47034696|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
47034697|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
47034698|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
47034699|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
47034700|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
47034701|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
46711131|NCT00952341|82927533|FG001|Cycle 2|Protocol Violation|0|||
46711132|NCT00952341|82927532|FG000|Cycle 2|Lost to Follow-up|6|||
46711133|NCT00952341|82927533|FG001|Cycle 2|Lost to Follow-up|9|||
46711134|NCT00952341|82927532|FG000|Cycle 2|Physician Decision|1|||
46711135|NCT00952341|82927533|FG001|Cycle 2|Physician Decision|1|||
46711136|NCT00952341|82927532|FG000|Cycle 2|Progressive Disease|0|||
46711137|NCT00952341|82927533|FG001|Cycle 2|Progressive Disease|1|||
46711138|NCT01214642|82927551|FG000|Overall Study|Progressive Disease|3|||
47034702|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
47034703|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
47034704|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
47034705|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
47034706|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
47034707|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
47034708|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
47034709|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
47034710|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
47034711|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
47034712|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
47034713|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
47034714|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
47034715|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
47034716|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
47034717|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
47034718|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
47034719|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
47034720|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
47034721|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
47034722|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
47034723|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
47034724|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
47034725|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
47034726|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
47034727|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
47034728|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
47034729|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
47034730|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
47034731|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
47034732|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
47034733|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
47034734|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
47034735|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
47034736|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
47034737|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
47034738|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
47034739|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
47034740|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
47034741|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
47034742|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
47034743|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
47034744|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
47034745|NCT01807520|83285818|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
47034746|NCT01807520|83285819|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
47034747|NCT01807520|83285820|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
47034748|NCT01807520|83285821|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
47034749|NCT01807520|83285822|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
47034750|NCT01807520|83285823|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
47034751|NCT01807520|83285824|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
46629472|NCT01985334|82800296|FG006|Overall Study|Medication non-compliance|1|||
46629473|NCT01985334|82800297|FG007|Overall Study|Medication non-compliance|3|||
46629474|NCT01985334|82800290|FG000|Overall Study|Use of prohibited treatment|1|||
46629475|NCT01985334|82800291|FG001|Overall Study|Use of prohibited treatment|4|||
46629476|NCT01985334|82800292|FG002|Overall Study|Use of prohibited treatment|1|||
46629477|NCT01985334|82800293|FG003|Overall Study|Use of prohibited treatment|2|||
46629478|NCT01985334|82800294|FG004|Overall Study|Use of prohibited treatment|1|||
46629479|NCT01985334|82800295|FG005|Overall Study|Use of prohibited treatment|6|||
46629480|NCT01985334|82800296|FG006|Overall Study|Use of prohibited treatment|2|||
46629481|NCT01985334|82800297|FG007|Overall Study|Use of prohibited treatment|0|||
46629482|NCT01985334|82800290|FG000|Overall Study|Investigator decision|0|||
46629483|NCT01985334|82800291|FG001|Overall Study|Investigator decision|3|||
46629484|NCT01985334|82800292|FG002|Overall Study|Investigator decision|0|||
46629485|NCT01985334|82800293|FG003|Overall Study|Investigator decision|7|||
46711139|NCT01214642|82927552|FG001|Overall Study|Progressive Disease|2|||
46629486|NCT01985334|82800294|FG004|Overall Study|Investigator decision|1|||
46629487|NCT01985334|82800295|FG005|Overall Study|Investigator decision|1|||
47034752|NCT01807520|83285818|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
47034753|NCT01807520|83285819|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
47034754|NCT01807520|83285820|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
47034755|NCT01807520|83285821|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
47034756|NCT01807520|83285822|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
47034757|NCT01807520|83285823|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
47034758|NCT01807520|83285824|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
47034759|NCT01807520|83285818|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
47034760|NCT01807520|83285819|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
47034761|NCT01807520|83285820|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
47034762|NCT01807520|83285821|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
47034763|NCT01807520|83285822|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
47034764|NCT01807520|83285823|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
47034765|NCT01807520|83285824|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
47034766|NCT01807520|83285818|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
47034767|NCT01807520|83285819|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
47034768|NCT01807520|83285820|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
47034769|NCT01807520|83285821|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
47034770|NCT01807520|83285822|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
47034771|NCT01807520|83285823|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
47034772|NCT01807520|83285824|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
47034773|NCT01806896|83285837|FG000|Overall Study|Adverse Event|2|||
47034774|NCT01806896|83285838|FG001|Overall Study|Adverse Event|0|||
47034775|NCT01806896|83285837|FG000|Overall Study|Other|1|||
47034776|NCT01806896|83285838|FG001|Overall Study|Other|0|||
47034777|NCT01768676|83285846|FG000|Overall Study|Adverse Event|3|||
47034778|NCT01768676|83285847|FG001|Overall Study|Adverse Event|3|||
47034779|NCT01768676|83285846|FG000|Overall Study|Lost to Follow-up|13|||
47034780|NCT01768676|83285847|FG001|Overall Study|Lost to Follow-up|16|||
47034781|NCT01768676|83285846|FG000|Overall Study|Protocol Violation|1|||
47034782|NCT01768676|83285847|FG001|Overall Study|Protocol Violation|1|||
47034783|NCT01768676|83285846|FG000|Overall Study|Physician Decision|4|||
47034784|NCT01768676|83285847|FG001|Overall Study|Physician Decision|1|||
47034785|NCT01768676|83285846|FG000|Overall Study|Withdrawal by Subject|3|||
47034786|NCT01768676|83285847|FG001|Overall Study|Withdrawal by Subject|10|||
47034787|NCT01555125|83285856|FG000|Induction Period|Lost to Follow-up|0|||
47034788|NCT01555125|83285857|FG001|Induction Period|Lost to Follow-up|2|||
47034789|NCT01555125|83285858|FG002|Induction Period|Lost to Follow-up|0|||
47034790|NCT01555125|83285859|FG003|Induction Period|Lost to Follow-up|0|||
47034791|NCT01555125|83285860|FG004|Induction Period|Lost to Follow-up|0|||
47034792|NCT01555125|83285856|FG000|Induction Period|Adverse Event|0|||
47034793|NCT01555125|83285857|FG001|Induction Period|Adverse Event|1|||
47034794|NCT01555125|83285858|FG002|Induction Period|Adverse Event|0|||
47034795|NCT01555125|83285859|FG003|Induction Period|Adverse Event|0|||
47034796|NCT01555125|83285860|FG004|Induction Period|Adverse Event|1|||
47034797|NCT01555125|83285856|FG000|Induction Period|Subject / guardian decision|0|||
47034798|NCT01555125|83285857|FG001|Induction Period|Subject / guardian decision|0|||
47034799|NCT01555125|83285858|FG002|Induction Period|Subject / guardian decision|0|||
47034800|NCT01555125|83285859|FG003|Induction Period|Subject / guardian decision|0|||
47034801|NCT01555125|83285860|FG004|Induction Period|Subject / guardian decision|2|||
47034802|NCT01555125|83285856|FG000|Induction Period|Death|1|||
47034803|NCT01555125|83285857|FG001|Induction Period|Death|0|||
47034804|NCT01555125|83285858|FG002|Induction Period|Death|0|||
47034805|NCT01555125|83285859|FG003|Induction Period|Death|0|||
47034806|NCT01555125|83285860|FG004|Induction Period|Death|0|||
47034807|NCT01555125|83285856|FG000|Maintenance Period|Adverse Event|1|||
47034808|NCT01555125|83285857|FG001|Maintenance Period|Adverse Event|1|||
47034809|NCT01555125|83285858|FG002|Maintenance Period|Adverse Event|0|||
47034810|NCT01555125|83285859|FG003|Maintenance Period|Adverse Event|0|||
47034811|NCT01555125|83285860|FG004|Maintenance Period|Adverse Event|0|||
47034812|NCT01555125|83285856|FG000|Maintenance Period|Subject / guardian decision|1|||
47034813|NCT01555125|83285857|FG001|Maintenance Period|Subject / guardian decision|2|||
47034814|NCT01555125|83285858|FG002|Maintenance Period|Subject / guardian decision|0|||
47034815|NCT01555125|83285859|FG003|Maintenance Period|Subject / guardian decision|0|||
47034816|NCT01555125|83285860|FG004|Maintenance Period|Subject / guardian decision|0|||
47034817|NCT01555125|83285856|FG000|Maintenance Period|Lost to Follow-up|2|||
47034818|NCT01555125|83285857|FG001|Maintenance Period|Lost to Follow-up|0|||
47034819|NCT01555125|83285858|FG002|Maintenance Period|Lost to Follow-up|0|||
47034820|NCT01555125|83285859|FG003|Maintenance Period|Lost to Follow-up|1|||
47034821|NCT01555125|83285860|FG004|Maintenance Period|Lost to Follow-up|0|||
47034822|NCT01555125|83285856|FG000|Maintenance Period|Lack of Efficacy|6|||
47034823|NCT01555125|83285857|FG001|Maintenance Period|Lack of Efficacy|1|||
47034824|NCT01555125|83285858|FG002|Maintenance Period|Lack of Efficacy|3|||
47034825|NCT01555125|83285859|FG003|Maintenance Period|Lack of Efficacy|0|||
47034826|NCT01555125|83285860|FG004|Maintenance Period|Lack of Efficacy|0|||
47034827|NCT01555125|83285856|FG000|Maintenance Period|Physician Decision|0|||
47034828|NCT01555125|83285857|FG001|Maintenance Period|Physician Decision|0|||
47034829|NCT01555125|83285858|FG002|Maintenance Period|Physician Decision|1|||
47034830|NCT01555125|83285859|FG003|Maintenance Period|Physician Decision|0|||
47034831|NCT01555125|83285860|FG004|Maintenance Period|Physician Decision|0|||
47034832|NCT01555125|83285856|FG000|Maintenance Period|Death|0|||
46913161|NCT02937701|83143313|FG000|Day 1 to Week 22|Physician Decision|2|||
46913162|NCT02937701|83143314|FG001|Day 1 to Week 22|Physician Decision|0|||
46913163|NCT02937701|83143315|FG002|Day 1 to Week 22|Physician Decision|0|||
46913164|NCT02937701|83143316|FG003|Day 1 to Week 22|Physician Decision|0|||
46913165|NCT02937701|83143317|FG004|Day 1 to Week 22|Physician Decision|0|||
46913166|NCT02937701|83143313|FG000|Day 1 to Week 22|Other|1|||
46913167|NCT02937701|83143314|FG001|Day 1 to Week 22|Other|0|||
46913168|NCT02937701|83143315|FG002|Day 1 to Week 22|Other|0|||
47034833|NCT01555125|83285857|FG001|Maintenance Period|Death|0|||
47034834|NCT01555125|83285858|FG002|Maintenance Period|Death|0|||
47034835|NCT01555125|83285859|FG003|Maintenance Period|Death|1|||
47034836|NCT01555125|83285860|FG004|Maintenance Period|Death|0|||
47034837|NCT01555125|83285856|FG000|Extension|Adverse Event|1|||
47034838|NCT01555125|83285857|FG001|Extension|Adverse Event|2|||
47034839|NCT01555125|83285858|FG002|Extension|Adverse Event|1|||
47034840|NCT01555125|83285859|FG003|Extension|Adverse Event|1|||
47034841|NCT01555125|83285860|FG004|Extension|Adverse Event|0|||
47034842|NCT01555125|83285856|FG000|Extension|Protocol deviation|1|||
47034843|NCT01555125|83285857|FG001|Extension|Protocol deviation|0|||
47034844|NCT01555125|83285858|FG002|Extension|Protocol deviation|0|||
47034845|NCT01555125|83285859|FG003|Extension|Protocol deviation|0|||
47034846|NCT01555125|83285860|FG004|Extension|Protocol deviation|0|||
47034847|NCT01555125|83285856|FG000|Extension|Lack of Efficacy|7|||
47034848|NCT01555125|83285857|FG001|Extension|Lack of Efficacy|6|||
47034849|NCT01555125|83285858|FG002|Extension|Lack of Efficacy|3|||
47034850|NCT01555125|83285859|FG003|Extension|Lack of Efficacy|0|||
47034851|NCT01555125|83285860|FG004|Extension|Lack of Efficacy|0|||
47034852|NCT01555125|83285856|FG000|Extension|Lost to Follow-up|2|||
47034853|NCT01555125|83285857|FG001|Extension|Lost to Follow-up|1|||
47034854|NCT01555125|83285858|FG002|Extension|Lost to Follow-up|2|||
47034855|NCT01555125|83285859|FG003|Extension|Lost to Follow-up|0|||
47034856|NCT01555125|83285860|FG004|Extension|Lost to Follow-up|0|||
47034857|NCT01555125|83285856|FG000|Extension|Study terminated by sponsor|32|||
47034858|NCT01555125|83285857|FG001|Extension|Study terminated by sponsor|33|||
47034859|NCT01555125|83285858|FG002|Extension|Study terminated by sponsor|16|||
47034860|NCT01555125|83285859|FG003|Extension|Study terminated by sponsor|20|||
47034861|NCT01555125|83285860|FG004|Extension|Study terminated by sponsor|0|||
47034862|NCT01555125|83285856|FG000|Extension|Subject/guardian decision|1|||
47034863|NCT01555125|83285857|FG001|Extension|Subject/guardian decision|9|||
47034864|NCT01555125|83285858|FG002|Extension|Subject/guardian decision|1|||
47034865|NCT01555125|83285859|FG003|Extension|Subject/guardian decision|0|||
47034866|NCT01555125|83285860|FG004|Extension|Subject/guardian decision|0|||
47034867|NCT01555125|83285856|FG000|Extension|Technical Problems|1|||
47034868|NCT01555125|83285857|FG001|Extension|Technical Problems|0|||
47034869|NCT01555125|83285858|FG002|Extension|Technical Problems|0|||
47034870|NCT01555125|83285859|FG003|Extension|Technical Problems|1|||
47034871|NCT01555125|83285860|FG004|Extension|Technical Problems|0|||
47034872|NCT01555125|83285856|FG000|Follow-Up Period|Lost to Follow-up|1|||
47034873|NCT01555125|83285857|FG001|Follow-Up Period|Lost to Follow-up|0|||
47034874|NCT01555125|83285858|FG002|Follow-Up Period|Lost to Follow-up|0|||
47034875|NCT01555125|83285859|FG003|Follow-Up Period|Lost to Follow-up|0|||
47034876|NCT01555125|83285860|FG004|Follow-Up Period|Lost to Follow-up|0|||
46629488|NCT01985334|82800296|FG006|Overall Study|Investigator decision|0|||
46629489|NCT01985334|82800297|FG007|Overall Study|Investigator decision|4|||
46629490|NCT01985334|82800290|FG000|Overall Study|Lost to Follow-up|0|||
47034877|NCT01555125|83285856|FG000|Follow-Up Period|Subject / guardian decision|3|||
47034878|NCT01555125|83285857|FG001|Follow-Up Period|Subject / guardian decision|1|||
47034879|NCT01555125|83285858|FG002|Follow-Up Period|Subject / guardian decision|1|||
47034880|NCT01555125|83285859|FG003|Follow-Up Period|Subject / guardian decision|1|||
46913169|NCT02937701|83143316|FG003|Day 1 to Week 22|Other|0|||
47034881|NCT01555125|83285860|FG004|Follow-Up Period|Subject / guardian decision|0|||
47034882|NCT01768286|83285879|FG000|Overall Study|Randomized But Not Treated|0|||
47034883|NCT01768286|83285880|FG001|Overall Study|Randomized But Not Treated|0|||
47034884|NCT01768286|83285881|FG002|Overall Study|Randomized But Not Treated|1|||
47034885|NCT01768286|83285882|FG003|Overall Study|Randomized But Not Treated|0|||
47034886|NCT01768286|83285879|FG000|Overall Study|Lack of Efficacy|7|||
47034887|NCT01768286|83285880|FG001|Overall Study|Lack of Efficacy|4|||
47034888|NCT01768286|83285881|FG002|Overall Study|Lack of Efficacy|0|||
46913170|NCT02937701|83143317|FG004|Day 1 to Week 22|Other|0|||
47034889|NCT01768286|83285882|FG003|Overall Study|Lack of Efficacy|1|||
46913171|NCT02937701|83143313|FG000|Week 22 to Week 50|Adverse Event|0|||
47034890|NCT01768286|83285879|FG000|Overall Study|Withdrew Consent|0|||
46711140|NCT01214642|82927553|FG002|Overall Study|Progressive Disease|3|||
46711141|NCT01214642|82927554|FG003|Overall Study|Progressive Disease|5|||
46711142|NCT01214642|82927555|FG004|Overall Study|Progressive Disease|5|||
46711143|NCT01214642|82927556|FG005|Overall Study|Progressive Disease|3|||
46711144|NCT01214642|82927557|FG006|Overall Study|Progressive Disease|5|||
46711145|NCT01214642|82927558|FG007|Overall Study|Progressive Disease|3|||
46711146|NCT01214642|82927559|FG008|Overall Study|Progressive Disease|10|||
46711147|NCT01214642|82927560|FG009|Overall Study|Progressive Disease|2|||
46711148|NCT01214642|82927561|FG010|Overall Study|Progressive Disease|1|||
46711149|NCT01214642|82927562|FG011|Overall Study|Progressive Disease|4|||
47034891|NCT01768286|83285880|FG001|Overall Study|Withdrew Consent|0|||
47034892|NCT01768286|83285881|FG002|Overall Study|Withdrew Consent|1|||
47034893|NCT01768286|83285882|FG003|Overall Study|Withdrew Consent|0|||
47034894|NCT01800968|83285894|FG000|Overall Study|Death|23|||
47034895|NCT01800968|83285895|FG001|Overall Study|Death|16|||
47034896|NCT01800968|83285894|FG000|Overall Study|Lost to Follow-up|5|||
47034897|NCT01800968|83285895|FG001|Overall Study|Lost to Follow-up|7|||
47034898|NCT01800968|83285894|FG000|Overall Study|Withdrawal by Subject|7|||
47034899|NCT01800968|83285895|FG001|Overall Study|Withdrawal by Subject|9|||
47034900|NCT01800968|83285894|FG000|Overall Study|Physician Decision|1|||
47034901|NCT01800968|83285895|FG001|Overall Study|Physician Decision|0|||
47034902|NCT01799720|83285904|FG000|Overall Study|Withdrawal by Subject|3|||
47034903|NCT01799720|83285905|FG001|Overall Study|Withdrawal by Subject|0|||
47034904|NCT01799720|83285906|FG002|Overall Study|Withdrawal by Subject|0|||
47034905|NCT01799720|83285904|FG000|Overall Study|Protocol Violation|0|||
47034906|NCT01799720|83285905|FG001|Overall Study|Protocol Violation|1|||
47034907|NCT01799720|83285906|FG002|Overall Study|Protocol Violation|0|||
47034908|NCT01799720|83285904|FG000|Overall Study|Pregnancy|0|||
47034909|NCT01799720|83285905|FG001|Overall Study|Pregnancy|0|||
47034910|NCT01799720|83285906|FG002|Overall Study|Pregnancy|1|||
47034911|NCT01687257|83285916|FG000|Overall Study|Efficacy Failure|6|||
47034912|NCT01687257|83285917|FG001|Overall Study|Efficacy Failure|0|||
47034913|NCT01687257|83285918|FG002|Overall Study|Efficacy Failure|5|||
47034914|NCT01687257|83285916|FG000|Overall Study|Subject Withdrew Consent|1|||
47034915|NCT01687257|83285917|FG001|Overall Study|Subject Withdrew Consent|1|||
47034916|NCT01687257|83285918|FG002|Overall Study|Subject Withdrew Consent|1|||
47034917|NCT01687257|83285916|FG000|Overall Study|Adverse Event|1|||
47034918|NCT01687257|83285917|FG001|Overall Study|Adverse Event|0|||
47034919|NCT01687257|83285918|FG002|Overall Study|Adverse Event|0|||
46711150|NCT01214642|82927551|FG000|Overall Study|Adverse Event|0|||
46711151|NCT01214642|82927552|FG001|Overall Study|Adverse Event|1|||
46711152|NCT01214642|82927553|FG002|Overall Study|Adverse Event|0|||
46711153|NCT01214642|82927554|FG003|Overall Study|Adverse Event|0|||
46711154|NCT01214642|82927555|FG004|Overall Study|Adverse Event|0|||
46711155|NCT01214642|82927556|FG005|Overall Study|Adverse Event|0|||
46711156|NCT01214642|82927557|FG006|Overall Study|Adverse Event|1|||
46711157|NCT01214642|82927558|FG007|Overall Study|Adverse Event|0|||
46711158|NCT01214642|82927559|FG008|Overall Study|Adverse Event|0|||
46711159|NCT01214642|82927560|FG009|Overall Study|Adverse Event|1|||
46711160|NCT01214642|82927561|FG010|Overall Study|Adverse Event|1|||
46711161|NCT01214642|82927562|FG011|Overall Study|Adverse Event|0|||
46629491|NCT01985334|82800291|FG001|Overall Study|Lost to Follow-up|2|||
46629492|NCT01985334|82800292|FG002|Overall Study|Lost to Follow-up|0|||
46629493|NCT01985334|82800293|FG003|Overall Study|Lost to Follow-up|3|||
46629494|NCT01985334|82800294|FG004|Overall Study|Lost to Follow-up|1|||
46629495|NCT01985334|82800295|FG005|Overall Study|Lost to Follow-up|4|||
46629496|NCT01985334|82800296|FG006|Overall Study|Lost to Follow-up|0|||
46629497|NCT01985334|82800297|FG007|Overall Study|Lost to Follow-up|3|||
46629498|NCT01944774|82800332|FG000|Overall Study|Withdrawal by Subject|2|||
46629499|NCT01944774|82800333|FG001|Overall Study|Withdrawal by Subject|3|||
46629500|NCT01944774|82800334|FG002|Overall Study|Withdrawal by Subject|3|||
46629501|NCT01944774|82800332|FG000|Overall Study|Adverse Event|3|||
46629502|NCT01944774|82800333|FG001|Overall Study|Adverse Event|2|||
46629503|NCT01944774|82800334|FG002|Overall Study|Adverse Event|3|||
46629504|NCT01944774|82800332|FG000|Overall Study|Lack of Efficacy|1|||
46711162|NCT01214642|82927551|FG000|Overall Study|Death|0|||
46711163|NCT01214642|82927552|FG001|Overall Study|Death|0|||
46711164|NCT01214642|82927553|FG002|Overall Study|Death|1|||
46711165|NCT01214642|82927554|FG003|Overall Study|Death|0|||
46711166|NCT01214642|82927555|FG004|Overall Study|Death|0|||
46711167|NCT01214642|82927556|FG005|Overall Study|Death|0|||
47034920|NCT01687257|83285916|FG000|Overall Study|Investigator's Discretion|0|||
46629505|NCT01944774|82800333|FG001|Overall Study|Lack of Efficacy|2|||
46711168|NCT01214642|82927557|FG006|Overall Study|Death|0|||
46711169|NCT01214642|82927558|FG007|Overall Study|Death|0|||
46711170|NCT01214642|82927559|FG008|Overall Study|Death|0|||
47034921|NCT01687257|83285917|FG001|Overall Study|Investigator's Discretion|3|||
46711171|NCT01214642|82927560|FG009|Overall Study|Death|0|||
46711172|NCT01214642|82927561|FG010|Overall Study|Death|1|||
47034922|NCT01687257|83285918|FG002|Overall Study|Investigator's Discretion|0|||
46711173|NCT01214642|82927562|FG011|Overall Study|Death|0|||
46711174|NCT01214642|82927551|FG000|Overall Study|Withdrawal by Subject|0|||
46711175|NCT01214642|82927552|FG001|Overall Study|Withdrawal by Subject|0|||
46711176|NCT01214642|82927553|FG002|Overall Study|Withdrawal by Subject|1|||
46711177|NCT01214642|82927554|FG003|Overall Study|Withdrawal by Subject|0|||
46711178|NCT01214642|82927555|FG004|Overall Study|Withdrawal by Subject|0|||
46711179|NCT01214642|82927556|FG005|Overall Study|Withdrawal by Subject|0|||
46711180|NCT01214642|82927557|FG006|Overall Study|Withdrawal by Subject|0|||
46711181|NCT01214642|82927558|FG007|Overall Study|Withdrawal by Subject|0|||
46711182|NCT01214642|82927559|FG008|Overall Study|Withdrawal by Subject|3|||
46711183|NCT01214642|82927560|FG009|Overall Study|Withdrawal by Subject|1|||
46711184|NCT01214642|82927561|FG010|Overall Study|Withdrawal by Subject|1|||
46711185|NCT01214642|82927562|FG011|Overall Study|Withdrawal by Subject|0|||
46711186|NCT01214642|82927551|FG000|Overall Study|Physician Decision|0|||
46711187|NCT01214642|82927552|FG001|Overall Study|Physician Decision|0|||
46711188|NCT01214642|82927553|FG002|Overall Study|Physician Decision|1|||
46711189|NCT01214642|82927554|FG003|Overall Study|Physician Decision|1|||
46711190|NCT01214642|82927555|FG004|Overall Study|Physician Decision|1|||
46711191|NCT01214642|82927556|FG005|Overall Study|Physician Decision|0|||
46711192|NCT01214642|82927557|FG006|Overall Study|Physician Decision|0|||
46711193|NCT01214642|82927558|FG007|Overall Study|Physician Decision|0|||
46711194|NCT01214642|82927559|FG008|Overall Study|Physician Decision|0|||
46711195|NCT01214642|82927560|FG009|Overall Study|Physician Decision|0|||
46711196|NCT01214642|82927561|FG010|Overall Study|Physician Decision|0|||
46711197|NCT01214642|82927562|FG011|Overall Study|Physician Decision|2|||
46711198|NCT01214252|82927605|FG000|Overall Study|Not eligible per protocol|82|||
46913172|NCT02937701|83143314|FG001|Week 22 to Week 50|Adverse Event|0|||
46913173|NCT02937701|83143315|FG002|Week 22 to Week 50|Adverse Event|10|||
46913174|NCT02937701|83143316|FG003|Week 22 to Week 50|Adverse Event|3|||
46913175|NCT02937701|83143317|FG004|Week 22 to Week 50|Adverse Event|3|||
46913176|NCT02937701|83143313|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
46913177|NCT02937701|83143314|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
46711199|NCT01214174|82927613|FG000|Overall Study|Withdrawal by Subject|0|||
46629506|NCT01944774|82800334|FG002|Overall Study|Lack of Efficacy|2|||
46629507|NCT01944774|82800332|FG000|Overall Study|Lost to Follow-up|0|||
46629508|NCT01944774|82800333|FG001|Overall Study|Lost to Follow-up|1|||
46629509|NCT01944774|82800334|FG002|Overall Study|Lost to Follow-up|0|||
46629510|NCT01944462|82800345|FG000|PPPP Educational Program|Lost to Follow-up|60|||
46629511|NCT01943292|82800353|FG000|Overall Study|Withdrawal by Subject|1|||
46629512|NCT01943292|82800354|FG001|Overall Study|Withdrawal by Subject|0|||
46629513|NCT01943292|82800355|FG002|Overall Study|Withdrawal by Subject|0|||
46629514|NCT01961544|82800363|FG000|Overall Study|Protocol Violation|1|||
46629515|NCT01961544|82800363|FG000|Overall Study|Withdrawal by Subject|7|||
46629516|NCT01961544|82800363|FG000|Overall Study|Adverse Event|1|||
46913178|NCT02937701|83143315|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
46913179|NCT02937701|83143316|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
46629517|NCT01961544|82800363|FG000|Overall Study|Physician Decision|2|||
46629518|NCT01961544|82800363|FG000|Overall Study|Poor Tolerance|1|||
46629519|NCT01961544|82800363|FG000|Overall Study|Aggravation of Steral Pain|1|||
46629520|NCT01942590|82800369|FG000|Overall Study|Withdrawal by Subject|0|||
46629521|NCT01942590|82800370|FG001|Overall Study|Withdrawal by Subject|1|||
46629522|NCT01942590|82800369|FG000|Overall Study|Adverse Event|1|||
46629523|NCT01942590|82800370|FG001|Overall Study|Adverse Event|0|||
46629524|NCT01984242|82800380|FG000|Overall Study|Death|52|||
46629525|NCT01984242|82800381|FG001|Overall Study|Death|50|||
46629526|NCT01984242|82800382|FG002|Overall Study|Death|52|||
46711200|NCT01214174|82927614|FG001|Overall Study|Withdrawal by Subject|0|||
46913180|NCT02937701|83143317|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
46913181|NCT02937701|83143313|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
46913182|NCT02937701|83143314|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
46913183|NCT02937701|83143315|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
46913184|NCT02937701|83143316|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
47034923|NCT01806740|83285932|FG000|Overall Study|Withdrawal by Subject|4|||
46629527|NCT01984242|82800380|FG000|Overall Study|Withdrawal by Subject|5|||
46629528|NCT01984242|82800381|FG001|Overall Study|Withdrawal by Subject|3|||
46629529|NCT01984242|82800382|FG002|Overall Study|Withdrawal by Subject|10|||
46629530|NCT01984242|82800380|FG000|Overall Study|Physician Decision|0|||
46629531|NCT01984242|82800381|FG001|Overall Study|Physician Decision|0|||
46711201|NCT01214174|82927615|FG002|Overall Study|Withdrawal by Subject|1|||
46711202|NCT00901342|82927623|FG000|Overall Study|Adverse Event|1|||
46711203|NCT00901342|82927623|FG000|Overall Study|Death|4|||
46711204|NCT00901342|82927623|FG000|Overall Study|Disease progression|1|||
46913185|NCT02937701|83143317|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
46913186|NCT02937701|83143313|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
46629532|NCT01984242|82800382|FG002|Overall Study|Physician Decision|1|||
46629533|NCT01984242|82800380|FG000|Overall Study|Lost to Follow-up|4|||
46711205|NCT00901342|82927623|FG000|Overall Study|Withdrawal by Subject|9|||
46711206|NCT00901186|82927629|FG000|Overall Study|Lack of Efficacy|0|||
47034924|NCT01806740|83285932|FG000|Overall Study|Physician Decision|1|||
47034925|NCT01806740|83285932|FG000|Overall Study|Patient's refusal of treatment|1|||
47034926|NCT01687101|83285939|FG000|Overall Study|Lost to Follow-up|7|||
47034927|NCT01968967|83285945|FG000|Treatment Period|Other|22|||
47034928|NCT01968967|83285946|FG001|Treatment Period|Other|22|||
47034929|NCT01968967|83285947|FG002|Treatment Period|Other|0|||
47034930|NCT01968967|83285948|FG003|Treatment Period|Other|0|||
46629534|NCT01984242|82800381|FG001|Overall Study|Lost to Follow-up|0|||
46629535|NCT01984242|82800382|FG002|Overall Study|Lost to Follow-up|3|||
46629536|NCT01984242|82800380|FG000|Overall Study|Sponsor Decision|1|||
46629537|NCT01984242|82800381|FG001|Overall Study|Sponsor Decision|0|||
46629538|NCT01984242|82800382|FG002|Overall Study|Sponsor Decision|0|||
46629539|NCT01984242|82800380|FG000|Overall Study|Non-Compliance|1|||
46629540|NCT01984242|82800381|FG001|Overall Study|Non-Compliance|0|||
46629541|NCT01984242|82800382|FG002|Overall Study|Non-Compliance|0|||
46629542|NCT01984242|82800380|FG000|Overall Study|Study terminated by Sponsor|38|||
46629543|NCT01984242|82800381|FG001|Overall Study|Study terminated by Sponsor|50|||
46629544|NCT01984242|82800382|FG002|Overall Study|Study terminated by Sponsor|34|||
46629545|NCT01984242|82800380|FG000|Overall Study|Disease Progression|0|||
46629546|NCT01984242|82800381|FG001|Overall Study|Disease Progression|0|||
46629547|NCT01984242|82800382|FG002|Overall Study|Disease Progression|1|||
46629548|NCT01941498|82800398|FG000|Overall Study|Relocated out of state|1|||
46629549|NCT01960998|82800419|FG000|Overall Study|Lost to Follow-up|3|||
46629550|NCT01960998|82800420|FG001|Overall Study|Lost to Follow-up|7|||
46629551|NCT01960998|82800419|FG000|Overall Study|Death|0|||
46629552|NCT01960998|82800420|FG001|Overall Study|Death|1|||
46629553|NCT01960998|82800419|FG000|Overall Study|Withdrawal by Subject|8|||
46629554|NCT01960998|82800420|FG001|Overall Study|Withdrawal by Subject|2|||
46629555|NCT01960998|82800419|FG000|Overall Study|lost computer access|0|||
46629556|NCT01960998|82800420|FG001|Overall Study|lost computer access|1|||
46629557|NCT01941186|82800430|FG000|Follow-up|Lost to Follow-up|1|||
46629558|NCT01941186|82800431|FG001|Follow-up|Lost to Follow-up|0|||
46629559|NCT01960842|82800450|FG000|Overall Study|Adverse Event|1|||
46629560|NCT01960842|82800450|FG000|Overall Study|Withdrawal by Subject|2|||
46629561|NCT01984164|82800456|FG000|Overall Study|Withdrawal by Subject|4|||
46629562|NCT01984164|82800457|FG001|Overall Study|Withdrawal by Subject|3|||
46629563|NCT01984164|82800456|FG000|Overall Study|Adverse Event|5|||
46629564|NCT01984164|82800457|FG001|Overall Study|Adverse Event|19|||
46629565|NCT01984164|82800456|FG000|Overall Study|Lost to Follow-up|1|||
46629566|NCT01984164|82800457|FG001|Overall Study|Lost to Follow-up|3|||
46629567|NCT01983930|82800465|FG000|Overall Study|Withdrawal by Subject|9|||
46629568|NCT01983930|82800466|FG001|Overall Study|Withdrawal by Subject|8|||
46629569|NCT01983930|82800465|FG000|Overall Study|Adverse Event|0|||
46629570|NCT01983930|82800466|FG001|Overall Study|Adverse Event|1|||
46629571|NCT01983774|82800479|FG000|Overall Study|Lung Transplant|0|||
46629572|NCT01983774|82800480|FG001|Overall Study|Lung Transplant|1|||
46629573|NCT01983774|82800479|FG000|Overall Study|Lost to Follow-up|1|||
46629574|NCT01983774|82800480|FG001|Overall Study|Lost to Follow-up|0|||
46629575|NCT01982682|82800488|FG000|Overall Study|Physician Decision|1|||
46629576|NCT01940484|82800493|FG000|Overall Study|Withdrawal by Subject|3|||
46629577|NCT01940484|82800493|FG000|Overall Study|Underwent transplantation|4|||
46629578|NCT01940484|82800493|FG000|Overall Study|Death|2|||
46629579|NCT01940484|82800493|FG000|Overall Study|Adverse Event|1|||
46629580|NCT01939548|82800500|FG000|Overall Study|Non compliance|0|||
46629581|NCT01939548|82800501|FG001|Overall Study|Non compliance|2|||
46629582|NCT01939548|82800502|FG002|Overall Study|Non compliance|0|||
46629583|NCT01939548|82800500|FG000|Overall Study|Study Terminated by Sponsor|17|||
46629584|NCT01939548|82800501|FG001|Overall Study|Study Terminated by Sponsor|19|||
46629585|NCT01939548|82800502|FG002|Overall Study|Study Terminated by Sponsor|12|||
46629586|NCT01939548|82800500|FG000|Overall Study|Insufficient Clinical Response|1|||
46629587|NCT01939548|82800501|FG001|Overall Study|Insufficient Clinical Response|0|||
46629588|NCT01939548|82800502|FG002|Overall Study|Insufficient Clinical Response|0|||
46629589|NCT01939548|82800500|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
46629590|NCT01939548|82800501|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
46629591|NCT01939548|82800502|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
46629592|NCT01939548|82800500|FG000|Overall Study|Withdrawal by Subject|4|||
46629593|NCT01939548|82800501|FG001|Overall Study|Withdrawal by Subject|4|||
46629594|NCT01939548|82800502|FG002|Overall Study|Withdrawal by Subject|1|||
46629595|NCT01939548|82800500|FG000|Overall Study|Protocol Violation|7|||
46629596|NCT01939548|82800501|FG001|Overall Study|Protocol Violation|6|||
46629597|NCT01939548|82800502|FG002|Overall Study|Protocol Violation|5|||
47034931|NCT01968967|83285949|FG004|Treatment Period|Other|0|||
47034932|NCT01968967|83285945|FG000|Treatment Period|Withdrawal by Subject|71|||
46629598|NCT01939548|82800500|FG000|Overall Study|Lost to Follow-up|5|||
46629599|NCT01939548|82800501|FG001|Overall Study|Lost to Follow-up|5|||
47034933|NCT01968967|83285946|FG001|Treatment Period|Withdrawal by Subject|61|||
47034934|NCT01968967|83285947|FG002|Treatment Period|Withdrawal by Subject|0|||
46629600|NCT01939548|82800502|FG002|Overall Study|Lost to Follow-up|3|||
46629601|NCT01939548|82800500|FG000|Overall Study|Adverse Event|2|||
46711207|NCT00901186|82927630|FG001|Overall Study|Lack of Efficacy|1|||
46711208|NCT00901186|82927629|FG000|Overall Study|Abnormal laboratory values|0|||
46711209|NCT00901186|82927630|FG001|Overall Study|Abnormal laboratory values|1|||
46711210|NCT00901186|82927629|FG000|Overall Study|Lost to Follow-up|2|||
46711211|NCT00901186|82927630|FG001|Overall Study|Lost to Follow-up|0|||
46711212|NCT00901186|82927629|FG000|Overall Study|Adverse Event|2|||
46711213|NCT00901186|82927630|FG001|Overall Study|Adverse Event|4|||
46711214|NCT00901186|82927629|FG000|Overall Study|Administration problems|0|||
46711215|NCT00901186|82927630|FG001|Overall Study|Administration problems|1|||
47034935|NCT01968967|83285948|FG003|Treatment Period|Withdrawal by Subject|0|||
47034936|NCT01968967|83285949|FG004|Treatment Period|Withdrawal by Subject|0|||
47034937|NCT01968967|83285945|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
47034938|NCT01968967|83285946|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
47034939|NCT01968967|83285947|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
47034940|NCT01968967|83285948|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
47034941|NCT01968967|83285949|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
47034942|NCT01968967|83285945|FG000|Treatment Period|Lost to Follow-up|26|||
47034943|NCT01968967|83285946|FG001|Treatment Period|Lost to Follow-up|31|||
47034944|NCT01968967|83285947|FG002|Treatment Period|Lost to Follow-up|0|||
47034945|NCT01968967|83285948|FG003|Treatment Period|Lost to Follow-up|0|||
47034946|NCT01968967|83285949|FG004|Treatment Period|Lost to Follow-up|0|||
47034947|NCT01968967|83285945|FG000|Treatment Period|Protocol Violation|1|||
47034948|NCT01968967|83285946|FG001|Treatment Period|Protocol Violation|2|||
47034949|NCT01968967|83285947|FG002|Treatment Period|Protocol Violation|0|||
47034950|NCT01968967|83285948|FG003|Treatment Period|Protocol Violation|0|||
47034951|NCT01968967|83285949|FG004|Treatment Period|Protocol Violation|0|||
47034952|NCT01968967|83285945|FG000|Treatment Period|Adverse Event|9|||
47034953|NCT01968967|83285946|FG001|Treatment Period|Adverse Event|8|||
46629602|NCT01939548|82800501|FG001|Overall Study|Adverse Event|9|||
46629603|NCT01939548|82800502|FG002|Overall Study|Adverse Event|7|||
46629604|NCT01939548|82800500|FG000|Overall Study|Death|0|||
46629605|NCT01939548|82800501|FG001|Overall Study|Death|0|||
46629606|NCT01939548|82800502|FG002|Overall Study|Death|1|||
46629607|NCT01939548|82800500|FG000|Overall Study|Participant dropped|0|||
46629608|NCT01939548|82800501|FG001|Overall Study|Participant dropped|0|||
46711216|NCT00901186|82927629|FG000|Overall Study|Protocol deviations|5|||
46711217|NCT00901186|82927630|FG001|Overall Study|Protocol deviations|4|||
46711218|NCT01213472|82927636|FG000|Overall Study|Recurrence/Progressive disease|25|||
46711219|NCT01213472|82927636|FG000|Overall Study|Withdrawal by Subject|1|||
46711220|NCT01213472|82927636|FG000|Overall Study|Physician Decision|1|||
46711221|NCT00900796|82927640|FG000|Phase 1|Lacked sufficient information|4|||
46913187|NCT02937701|83143314|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
46913188|NCT02937701|83143315|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
46913189|NCT02937701|83143316|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
46913190|NCT02937701|83143317|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
46913191|NCT02937701|83143313|FG000|Week 22 to Week 50|Physician Decision|0|||
46913192|NCT02937701|83143314|FG001|Week 22 to Week 50|Physician Decision|0|||
46913193|NCT02937701|83143315|FG002|Week 22 to Week 50|Physician Decision|2|||
46913194|NCT02937701|83143316|FG003|Week 22 to Week 50|Physician Decision|0|||
46913195|NCT02937701|83143317|FG004|Week 22 to Week 50|Physician Decision|1|||
46913196|NCT02937701|83143313|FG000|Week 22 to Week 50|Other|0|||
46913197|NCT02937701|83143314|FG001|Week 22 to Week 50|Other|0|||
47034954|NCT01968967|83285947|FG002|Treatment Period|Adverse Event|0|||
46629609|NCT01939548|82800502|FG002|Overall Study|Participant dropped|1|||
46629610|NCT01939548|82800500|FG000|Overall Study|Participant unwilling to continue|0|||
46629611|NCT01939548|82800501|FG001|Overall Study|Participant unwilling to continue|1|||
46629612|NCT01939548|82800502|FG002|Overall Study|Participant unwilling to continue|0|||
46629613|NCT01939548|82800500|FG000|Overall Study|Participant withdrew consent|0|||
46629614|NCT01939548|82800501|FG001|Overall Study|Participant withdrew consent|2|||
46629615|NCT01939548|82800502|FG002|Overall Study|Participant withdrew consent|0|||
46629616|NCT01939548|82800500|FG000|Overall Study|Did not complete follow-up|0|||
46629617|NCT01939548|82800501|FG001|Overall Study|Did not complete follow-up|1|||
46629618|NCT01939548|82800502|FG002|Overall Study|Did not complete follow-up|0|||
46629619|NCT01960296|82800512|FG000|Overall Study|Postponed surgery|1|||
46629620|NCT01960296|82800513|FG001|Overall Study|Postponed surgery|0|||
46711222|NCT00900796|82927640|FG000|Phase 1|Missing information at Week 16|7|||
46711223|NCT00900796|82927640|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
46711224|NCT00900796|82927640|FG000|Phase 2|Lost to Follow-up|5|||
46711225|NCT01213082|82927648|FG000|Overall Study|Lost to Follow-up|6|||
46913198|NCT02937701|83143315|FG002|Week 22 to Week 50|Other|0|||
46913199|NCT02937701|83143316|FG003|Week 22 to Week 50|Other|0|||
46629621|NCT01960296|82800512|FG000|Overall Study|Received different procedure|1|||
47034955|NCT01968967|83285948|FG003|Treatment Period|Adverse Event|0|||
46711226|NCT01213082|82927649|FG001|Overall Study|Lost to Follow-up|7|||
46913200|NCT02937701|83143317|FG004|Week 22 to Week 50|Other|1|||
47034956|NCT01968967|83285949|FG004|Treatment Period|Adverse Event|0|||
46711227|NCT01213082|82927650|FG002|Overall Study|Lost to Follow-up|4|||
47034957|NCT01968967|83285945|FG000|Treatment Period|Death|9|||
47034958|NCT01968967|83285946|FG001|Treatment Period|Death|2|||
47034959|NCT01968967|83285947|FG002|Treatment Period|Death|0|||
47034960|NCT01968967|83285948|FG003|Treatment Period|Death|0|||
47034961|NCT01968967|83285949|FG004|Treatment Period|Death|0|||
47034962|NCT01968967|83285945|FG000|Treatment Period|Randomized Not Treated|6|||
47034963|NCT01968967|83285946|FG001|Treatment Period|Randomized Not Treated|5|||
47034964|NCT01968967|83285947|FG002|Treatment Period|Randomized Not Treated|0|||
47034965|NCT01968967|83285948|FG003|Treatment Period|Randomized Not Treated|0|||
47034966|NCT01968967|83285949|FG004|Treatment Period|Randomized Not Treated|0|||
46629622|NCT01960296|82800513|FG001|Overall Study|Received different procedure|3|||
46629623|NCT01982292|82800521|FG000|Overall Study|Adverse Event|2|||
46629624|NCT01982292|82800522|FG001|Overall Study|Adverse Event|0|||
46629625|NCT01982292|82800521|FG000|Overall Study|Death|1|||
47034967|NCT01968967|83285945|FG000|Extension Period|Withdrew Consent|0|||
47034968|NCT01968967|83285946|FG001|Extension Period|Withdrew Consent|0|||
47034969|NCT01968967|83285947|FG002|Extension Period|Withdrew Consent|2|||
47034970|NCT01968967|83285948|FG003|Extension Period|Withdrew Consent|0|||
47034971|NCT01968967|83285949|FG004|Extension Period|Withdrew Consent|5|||
47034972|NCT01554579|83285965|FG000|Overall Study|Adverse Event|6|||
47034973|NCT01554579|83285966|FG001|Overall Study|Adverse Event|25|||
47034974|NCT01554579|83285965|FG000|Overall Study|Lack of Efficacy|2|||
47034975|NCT01554579|83285966|FG001|Overall Study|Lack of Efficacy|1|||
47034976|NCT01554579|83285965|FG000|Overall Study|Withdrawal by Subject|2|||
47034977|NCT01554579|83285966|FG001|Overall Study|Withdrawal by Subject|1|||
47034978|NCT01806662|83285973|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
47034979|NCT01806662|83285974|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
47034980|NCT01806662|83285973|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
47034981|NCT01806662|83285974|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
47034982|NCT01806662|83285973|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
47034983|NCT01806662|83285974|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
47034984|NCT01806662|83285973|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
47034985|NCT01806662|83285974|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
47034986|NCT01930123|83285982|FG000|Overall Study|Adverse Event|1|||
47034987|NCT01930123|83285983|FG001|Overall Study|Adverse Event|0|||
47034988|NCT01930123|83285982|FG000|Overall Study|Physician Decision|21|||
47034989|NCT01930123|83285983|FG001|Overall Study|Physician Decision|8|||
47034990|NCT01930123|83285982|FG000|Overall Study|Withdrawal by Subject|1|||
47034991|NCT01930123|83285983|FG001|Overall Study|Withdrawal by Subject|0|||
47034992|NCT01930045|83285989|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
47034993|NCT01930045|83285990|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
47034994|NCT01930045|83285991|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
47034995|NCT01930045|83285992|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
47034996|NCT01930045|83285993|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
47034997|NCT01930045|83285994|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
47034998|NCT01930045|83285989|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
47034999|NCT01930045|83285990|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
47035000|NCT01930045|83285991|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
47035001|NCT01930045|83285992|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
47035002|NCT01930045|83285993|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
47035003|NCT01930045|83285994|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
47035004|NCT01929343|83286009|FG000|Overall Study|Physician Decision|0|||
47035005|NCT01929343|83286010|FG001|Overall Study|Physician Decision|2|||
47035006|NCT01929343|83286011|FG002|Overall Study|Physician Decision|0|||
47035007|NCT01929343|83286009|FG000|Overall Study|Withdrawal by Subject|1|||
47035008|NCT01929343|83286010|FG001|Overall Study|Withdrawal by Subject|0|||
47035009|NCT01929343|83286011|FG002|Overall Study|Withdrawal by Subject|0|||
47035010|NCT01968811|83286019|FG000|Overall Study|Protocol Violation|4|||
47035011|NCT01968811|83286019|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
47035012|NCT01806584|83286025|FG000|Overall Study|Adverse Event|2|||
47035013|NCT01806584|83286026|FG001|Overall Study|Adverse Event|1|||
47035014|NCT01806584|83286025|FG000|Overall Study|Death|1|||
47035015|NCT01806584|83286026|FG001|Overall Study|Death|0|||
47035016|NCT01806584|83286025|FG000|Overall Study|Lost to Follow-up|0|||
46629626|NCT01982292|82800522|FG001|Overall Study|Death|0|||
46629627|NCT01982292|82800521|FG000|Overall Study|Lost to Follow-up|2|||
46629628|NCT01982292|82800522|FG001|Overall Study|Lost to Follow-up|0|||
46629629|NCT01982292|82800521|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
47035017|NCT01806584|83286026|FG001|Overall Study|Lost to Follow-up|2|||
47035018|NCT01806584|83286025|FG000|Overall Study|Study terminated by sponsor|9|||
47035019|NCT01806584|83286026|FG001|Overall Study|Study terminated by sponsor|14|||
47035020|NCT01806584|83286025|FG000|Overall Study|Withdrawal by Subject|1|||
47035021|NCT01806584|83286026|FG001|Overall Study|Withdrawal by Subject|1|||
47035022|NCT01806584|83286025|FG000|Overall Study|Other unspecified|1|||
47035023|NCT01806584|83286026|FG001|Overall Study|Other unspecified|0|||
47035024|NCT01798706|83286034|FG000|Overall Study|Adverse Event|15|||
47035025|NCT01798706|83286035|FG001|Overall Study|Adverse Event|10|||
46711228|NCT01213082|82927648|FG000|Overall Study|Physician Decision|0|||
46711229|NCT01213082|82927649|FG001|Overall Study|Physician Decision|0|||
46711230|NCT01213082|82927650|FG002|Overall Study|Physician Decision|1|||
46711231|NCT00885703|82927665|FG000|Overall Study|Death|9|||
46711232|NCT00885703|82927666|FG001|Overall Study|Death|7|||
46711233|NCT00885703|82927667|FG002|Overall Study|Death|8|||
46711234|NCT00885703|82927668|FG003|Overall Study|Death|7|||
46711235|NCT00885703|82927669|FG004|Overall Study|Death|7|||
46711236|NCT00885703|82927670|FG005|Overall Study|Death|8|||
46711237|NCT00885703|82927671|FG006|Overall Study|Death|4|||
46711238|NCT00885703|82927665|FG000|Overall Study|Lost to Follow-up|0|||
46711239|NCT00885703|82927666|FG001|Overall Study|Lost to Follow-up|0|||
46711240|NCT00885703|82927667|FG002|Overall Study|Lost to Follow-up|1|||
46711241|NCT00885703|82927668|FG003|Overall Study|Lost to Follow-up|0|||
46711242|NCT00885703|82927669|FG004|Overall Study|Lost to Follow-up|0|||
46711243|NCT00885703|82927670|FG005|Overall Study|Lost to Follow-up|1|||
46711244|NCT00885703|82927671|FG006|Overall Study|Lost to Follow-up|0|||
46913201|NCT03169153|83143329|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
46913202|NCT03169153|83143330|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
46913203|NCT03169153|83143329|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
47035026|NCT01798706|83286034|FG000|Overall Study|Lack of Efficacy|0|||
47035027|NCT01798706|83286035|FG001|Overall Study|Lack of Efficacy|2|||
47035028|NCT01798706|83286034|FG000|Overall Study|Poor compliance to protocol|1|||
47035029|NCT01798706|83286035|FG001|Overall Study|Poor compliance to protocol|0|||
47035030|NCT01798706|83286034|FG000|Overall Study|Other than specified above|5|||
47035031|NCT01798706|83286035|FG001|Overall Study|Other than specified above|9|||
47035032|NCT01767194|83286043|FG000|Overall Study|Adverse Event|1|||
47035033|NCT01767194|83286044|FG001|Overall Study|Adverse Event|1|||
47035034|NCT01767194|83286043|FG000|Overall Study|Death|0|||
47035035|NCT01767194|83286044|FG001|Overall Study|Death|1|||
47035036|NCT01767194|83286043|FG000|Overall Study|Lack of Efficacy|12|||
47035037|NCT01767194|83286044|FG001|Overall Study|Lack of Efficacy|11|||
47035038|NCT01767194|83286043|FG000|Overall Study|Physician Decision|2|||
47035039|NCT01767194|83286044|FG001|Overall Study|Physician Decision|23|||
47035040|NCT01767194|83286043|FG000|Overall Study|Withdrawal by Subject|0|||
47035041|NCT01767194|83286044|FG001|Overall Study|Withdrawal by Subject|1|||
47035042|NCT01767194|83286043|FG000|Overall Study|Ineligible|1|||
47035043|NCT01767194|83286044|FG001|Overall Study|Ineligible|1|||
47035044|NCT01767194|83286043|FG000|Overall Study|Refusal by patient/parent|2|||
47035045|NCT01767194|83286044|FG001|Overall Study|Refusal by patient/parent|4|||
47035046|NCT01767194|83286043|FG000|Overall Study|Criteria not met on time for next cycle|0|||
47035047|NCT01767194|83286044|FG001|Overall Study|Criteria not met on time for next cycle|1|||
47035048|NCT01575873|83286055|FG000|Overall Study|Withdrawal by Subject|15|||
47035049|NCT01575873|83286056|FG001|Overall Study|Withdrawal by Subject|20|||
47035050|NCT01575873|83286057|FG002|Overall Study|Withdrawal by Subject|34|||
47035051|NCT01575873|83286058|FG003|Overall Study|Withdrawal by Subject|34|||
47035052|NCT01575873|83286055|FG000|Overall Study|Adverse Event|7|||
47035053|NCT01575873|83286056|FG001|Overall Study|Adverse Event|7|||
47035054|NCT01575873|83286057|FG002|Overall Study|Adverse Event|9|||
47035055|NCT01575873|83286058|FG003|Overall Study|Adverse Event|12|||
47035056|NCT01575873|83286055|FG000|Overall Study|Lost to Follow-up|1|||
47035057|NCT01575873|83286056|FG001|Overall Study|Lost to Follow-up|3|||
47035058|NCT01575873|83286057|FG002|Overall Study|Lost to Follow-up|13|||
46629630|NCT01982292|82800522|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
46629631|NCT01982292|82800521|FG000|Overall Study|Protocol Deviation|1|||
46629632|NCT01982292|82800522|FG001|Overall Study|Protocol Deviation|0|||
46629633|NCT01982292|82800521|FG000|Overall Study|Patient/Guardian Decision|3|||
46629634|NCT01982292|82800522|FG001|Overall Study|Patient/Guardian Decision|1|||
46629635|NCT01982292|82800521|FG000|Overall Study|Technical Problems|2|||
46629636|NCT01982292|82800522|FG001|Overall Study|Technical Problems|0|||
46629637|NCT01939314|82800530|FG000|Overall Study|Withdrawal by Subject|3|||
46629638|NCT01939314|82800531|FG001|Overall Study|Withdrawal by Subject|1|||
46629639|NCT01939314|82800530|FG000|Overall Study|Protocol Violation|1|||
46629640|NCT01939314|82800531|FG001|Overall Study|Protocol Violation|0|||
46629641|NCT01939314|82800530|FG000|Overall Study|Pregnancy|0|||
46629642|NCT01939314|82800531|FG001|Overall Study|Pregnancy|1|||
46629643|NCT01939314|82800530|FG000|Overall Study|Lost to Follow-up|5|||
46629644|NCT01939314|82800531|FG001|Overall Study|Lost to Follow-up|6|||
46711245|NCT00885703|82927665|FG000|Overall Study|Withdrawal by Subject|0|||
46711246|NCT00885703|82927666|FG001|Overall Study|Withdrawal by Subject|0|||
46711247|NCT00885703|82927667|FG002|Overall Study|Withdrawal by Subject|0|||
47035059|NCT01575873|83286058|FG003|Overall Study|Lost to Follow-up|5|||
46629645|NCT01939158|82800543|FG000|Overall Study|Adverse Event|1|||
46711248|NCT00885703|82927668|FG003|Overall Study|Withdrawal by Subject|1|||
46711249|NCT00885703|82927669|FG004|Overall Study|Withdrawal by Subject|3|||
46711250|NCT00885703|82927670|FG005|Overall Study|Withdrawal by Subject|1|||
47035060|NCT01575873|83286055|FG000|Overall Study|Death|3|||
47035061|NCT01575873|83286056|FG001|Overall Study|Death|2|||
47035062|NCT01575873|83286057|FG002|Overall Study|Death|8|||
47035063|NCT01575873|83286058|FG003|Overall Study|Death|9|||
47035064|NCT01575873|83286055|FG000|Overall Study|Noncompliance|1|||
47035065|NCT01575873|83286056|FG001|Overall Study|Noncompliance|2|||
47035066|NCT01575873|83286057|FG002|Overall Study|Noncompliance|4|||
47035067|NCT01575873|83286058|FG003|Overall Study|Noncompliance|3|||
47035068|NCT01575873|83286055|FG000|Overall Study|Administrative decision|1|||
47035069|NCT01575873|83286056|FG001|Overall Study|Administrative decision|1|||
47035070|NCT01575873|83286057|FG002|Overall Study|Administrative decision|1|||
47035071|NCT01575873|83286058|FG003|Overall Study|Administrative decision|0|||
47035072|NCT01575873|83286055|FG000|Overall Study|Protocol deviation|0|||
47035073|NCT01575873|83286056|FG001|Overall Study|Protocol deviation|1|||
47035074|NCT01575873|83286057|FG002|Overall Study|Protocol deviation|0|||
47035075|NCT01575873|83286058|FG003|Overall Study|Protocol deviation|1|||
47035076|NCT01575873|83286055|FG000|Overall Study|Requirement for Alternative Therapy|0|||
47035077|NCT01575873|83286056|FG001|Overall Study|Requirement for Alternative Therapy|0|||
47035078|NCT01575873|83286057|FG002|Overall Study|Requirement for Alternative Therapy|1|||
47035079|NCT01575873|83286058|FG003|Overall Study|Requirement for Alternative Therapy|1|||
47035080|NCT01575873|83286055|FG000|Overall Study|Other|0|||
47035081|NCT01575873|83286056|FG001|Overall Study|Other|0|||
47035082|NCT01575873|83286057|FG002|Overall Study|Other|4|||
47035083|NCT01575873|83286058|FG003|Overall Study|Other|2|||
47035084|NCT01575561|83286066|FG000|Overall Study|Adverse Event|9|||
47035085|NCT01575561|83286066|FG000|Overall Study|Lack of Efficacy|8|||
47035086|NCT01575561|83286066|FG000|Overall Study|Lost to Follow-up|6|||
47035087|NCT01575561|83286066|FG000|Overall Study|Protocol Violation|4|||
47035088|NCT01575561|83286066|FG000|Overall Study|Withdrawal by Subject|11|||
47035089|NCT01575561|83286066|FG000|Overall Study|administration|1|||
47035090|NCT01609790|83286073|FG000|Overall Study|Protocol Violation|1|||
47035091|NCT01609790|83286074|FG001|Overall Study|Protocol Violation|7|||
47035092|NCT01609790|83286075|FG002|Overall Study|Protocol Violation|8|||
47035093|NCT01767116|83286085|FG000|Overall Study|Lost to Follow-up|2|||
47035094|NCT01767116|83286086|FG001|Overall Study|Lost to Follow-up|2|||
47035095|NCT01574703|83286096|FG000|Overall Study|Adverse Event|0|||
47035096|NCT01574703|83286097|FG001|Overall Study|Adverse Event|2|||
47035097|NCT01574703|83286098|FG002|Overall Study|Adverse Event|1|||
47035098|NCT01574703|83286099|FG003|Overall Study|Adverse Event|1|||
47035099|NCT01574703|83286096|FG000|Overall Study|Protocol Violation|0|||
47035100|NCT01574703|83286097|FG001|Overall Study|Protocol Violation|0|||
47035101|NCT01574703|83286098|FG002|Overall Study|Protocol Violation|0|||
47035102|NCT01574703|83286099|FG003|Overall Study|Protocol Violation|1|||
47035103|NCT01574703|83286096|FG000|Overall Study|Unspecified Reason|27|||
47035104|NCT01574703|83286097|FG001|Overall Study|Unspecified Reason|15|||
47035105|NCT01574703|83286098|FG002|Overall Study|Unspecified Reason|20|||
47035106|NCT01574703|83286099|FG003|Overall Study|Unspecified Reason|16|||
47035107|NCT01574703|83286096|FG000|Overall Study|Withdrawal by Subject|53|||
47035108|NCT01574703|83286097|FG001|Overall Study|Withdrawal by Subject|52|||
47035109|NCT01574703|83286098|FG002|Overall Study|Withdrawal by Subject|36|||
47035110|NCT01574703|83286099|FG003|Overall Study|Withdrawal by Subject|61|||
47035111|NCT01574703|83286096|FG000|Overall Study|Met Withdrawal Criteria|0|||
47035112|NCT01574703|83286097|FG001|Overall Study|Met Withdrawal Criteria|1|||
47035113|NCT01574703|83286098|FG002|Overall Study|Met Withdrawal Criteria|1|||
47035114|NCT01574703|83286099|FG003|Overall Study|Met Withdrawal Criteria|0|||
47035115|NCT01574703|83286096|FG000|Overall Study|Lost to Follow-up|43|||
47035116|NCT01574703|83286097|FG001|Overall Study|Lost to Follow-up|41|||
47035117|NCT01574703|83286098|FG002|Overall Study|Lost to Follow-up|46|||
47035118|NCT01574703|83286099|FG003|Overall Study|Lost to Follow-up|35|||
47035119|NCT01574703|83286096|FG000|Overall Study|Death|2|||
47035120|NCT01574703|83286097|FG001|Overall Study|Death|1|||
47035121|NCT01574703|83286098|FG002|Overall Study|Death|1|||
47035122|NCT01574703|83286099|FG003|Overall Study|Death|0|||
47035123|NCT01686633|83286112|FG000|Overall Study|Lack of Efficacy|33|||
47035124|NCT01686633|83286113|FG001|Overall Study|Lack of Efficacy|13|||
47035125|NCT01686633|83286114|FG002|Overall Study|Lack of Efficacy|11|||
47035126|NCT01686633|83286112|FG000|Overall Study|Withdrawal by Subject|8|||
47035127|NCT01686633|83286113|FG001|Overall Study|Withdrawal by Subject|8|||
47035128|NCT01686633|83286114|FG002|Overall Study|Withdrawal by Subject|5|||
46913204|NCT03169153|83143330|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
46913205|NCT03169153|83143329|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
47035129|NCT01686633|83286112|FG000|Overall Study|Physician Decision|3|||
47035130|NCT01686633|83286113|FG001|Overall Study|Physician Decision|4|||
47035131|NCT01686633|83286114|FG002|Overall Study|Physician Decision|4|||
47035132|NCT01686633|83286112|FG000|Overall Study|Adverse Event|4|||
47035133|NCT01686633|83286113|FG001|Overall Study|Adverse Event|3|||
47035134|NCT01686633|83286114|FG002|Overall Study|Adverse Event|3|||
47035135|NCT01686633|83286112|FG000|Overall Study|Protocol Violation|2|||
47035136|NCT01686633|83286113|FG001|Overall Study|Protocol Violation|3|||
47035137|NCT01686633|83286114|FG002|Overall Study|Protocol Violation|0|||
47035138|NCT01686633|83286112|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
47035139|NCT01686633|83286113|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
47035140|NCT01686633|83286114|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
46711251|NCT00885703|82927671|FG006|Overall Study|Withdrawal by Subject|1|||
46711252|NCT00885703|82927665|FG000|Overall Study|Ineligible (no CM)|1|||
46711253|NCT00885703|82927666|FG001|Overall Study|Ineligible (no CM)|3|||
46711254|NCT00885703|82927667|FG002|Overall Study|Ineligible (no CM)|2|||
46711255|NCT00885703|82927668|FG003|Overall Study|Ineligible (no CM)|1|||
46711256|NCT00885703|82927669|FG004|Overall Study|Ineligible (no CM)|2|||
46711257|NCT00885703|82927670|FG005|Overall Study|Ineligible (no CM)|3|||
46711258|NCT00885703|82927671|FG006|Overall Study|Ineligible (no CM)|1|||
46711259|NCT00901576|82927697|FG000|Second Intervention|Withdrawal by Subject|0|||
46711260|NCT00901576|82927698|FG001|Second Intervention|Withdrawal by Subject|0|||
46711261|NCT00901576|82927699|FG002|Second Intervention|Withdrawal by Subject|0|||
46711262|NCT00901576|82927700|FG003|Second Intervention|Withdrawal by Subject|1|||
46711263|NCT00901576|82927701|FG004|Second Intervention|Withdrawal by Subject|0|||
46711264|NCT00901576|82927702|FG005|Second Intervention|Withdrawal by Subject|1|||
46711265|NCT00901576|82927697|FG000|Second Intervention|Physician Decision|1|||
46711266|NCT00901576|82927698|FG001|Second Intervention|Physician Decision|0|||
46913206|NCT03169153|83143330|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
46913207|NCT03169153|83143329|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
46913208|NCT03169153|83143330|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
46913209|NCT03168919|83143336|FG000|Overall Study|Withdrawal by Subject|2|||
46913210|NCT03205163|83143346|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
46913211|NCT03205163|83143347|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
46913212|NCT01759537|83143362|FG000|Overall Study|Death|1|||
46913213|NCT01759537|83143363|FG001|Overall Study|Death|1|||
46913214|NCT01759537|83143362|FG000|Overall Study|Pregnancy|1|||
46913215|NCT01759537|83143363|FG001|Overall Study|Pregnancy|1|||
46913216|NCT01759537|83143362|FG000|Overall Study|Lost to Follow-up|9|||
46913217|NCT01759537|83143363|FG001|Overall Study|Lost to Follow-up|9|||
46913218|NCT01759537|83143362|FG000|Overall Study|Accident involving jaw fracture|1|||
46913219|NCT01759537|83143363|FG001|Overall Study|Accident involving jaw fracture|1|||
46913220|NCT01759537|83143362|FG000|Overall Study|Subcrestal implant too coronal|1|||
46913221|NCT01759537|83143363|FG001|Overall Study|Subcrestal implant too coronal|1|||
46913222|NCT03204539|83143371|FG000|Overall Study|Loss of funding|0|||
46913223|NCT03204539|83143372|FG001|Overall Study|Loss of funding|1|||
46913224|NCT03502681|83143389|FG000|Overall Study|Adverse Event|1|||
46913225|NCT03502681|83143390|FG001|Overall Study|Adverse Event|1|||
46913226|NCT03502681|83143389|FG000|Overall Study|Disease Progression|2|||
46913227|NCT03502681|83143390|FG001|Overall Study|Disease Progression|1|||
46913228|NCT02860130|83143397|FG000|Overall Study|Adverse Event|2|||
46913229|NCT02860130|83143398|FG001|Overall Study|Adverse Event|3|||
46913230|NCT02860130|83143397|FG000|Overall Study|Protocol Violation|1|||
46913231|NCT02860130|83143398|FG001|Overall Study|Protocol Violation|1|||
46913232|NCT02860130|83143397|FG000|Overall Study|Withdrawal by Subject|0|||
46913233|NCT02860130|83143398|FG001|Overall Study|Withdrawal by Subject|2|||
46913234|NCT02860130|83143397|FG000|Overall Study|Physician Decision|2|||
46913235|NCT02860130|83143398|FG001|Overall Study|Physician Decision|2|||
46913236|NCT02860130|83143397|FG000|Overall Study|Other|2|||
46913237|NCT02860130|83143398|FG001|Overall Study|Other|1|||
46913238|NCT02986854|83143407|FG000|Overall Study|Withdrawal by Subject|0|||
46913239|NCT02986854|83143408|FG001|Overall Study|Withdrawal by Subject|1|||
46913240|NCT02986854|83143409|FG002|Overall Study|Withdrawal by Subject|1|||
46913241|NCT02986854|83143407|FG000|Overall Study|Lost to Follow-up|3|||
46913242|NCT02986854|83143408|FG001|Overall Study|Lost to Follow-up|11|||
46913243|NCT02986854|83143409|FG002|Overall Study|Lost to Follow-up|2|||
46913244|NCT02887183|83143419|FG000|Overall Study|Adverse Event|44|||
46913245|NCT02887183|83143419|FG000|Overall Study|Death|30|||
46913246|NCT02887183|83143419|FG000|Overall Study|Pregnancy|1|||
46913247|NCT02887183|83143419|FG000|Overall Study|Protocol Violation|6|||
46913248|NCT02887183|83143419|FG000|Overall Study|Technical Problems|2|||
46913249|NCT02887183|83143419|FG000|Overall Study|Lost to Follow-up|13|||
46913250|NCT02887183|83143419|FG000|Overall Study|Physician Decision|10|||
46913251|NCT02887183|83143419|FG000|Overall Study|Withdrawal by Subject|35|||
46711267|NCT00901576|82927699|FG002|Second Intervention|Physician Decision|0|||
46711268|NCT00901576|82927700|FG003|Second Intervention|Physician Decision|0|||
46711269|NCT00901576|82927701|FG004|Second Intervention|Physician Decision|0|||
46711270|NCT00901576|82927702|FG005|Second Intervention|Physician Decision|0|||
46913252|NCT03167359|83143423|FG000|Overall Study|Physician Decision|1|||
46913253|NCT03167359|83143423|FG000|Overall Study|Lost to Follow-up|1|||
46913254|NCT01068600|83143429|FG000|Overall Study|Withdrawal by Subject|5|||
46913255|NCT01068600|83143430|FG001|Overall Study|Withdrawal by Subject|6|||
46913256|NCT01068600|83143429|FG000|Overall Study|Adverse Event|3|||
46913257|NCT01068600|83143430|FG001|Overall Study|Adverse Event|3|||
46913258|NCT01068600|83143429|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46913259|NCT01068600|83143430|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46913260|NCT01068600|83143429|FG000|Overall Study|Lost to Follow-up|1|||
46913261|NCT01068600|83143430|FG001|Overall Study|Lost to Follow-up|2|||
46913262|NCT01068600|83143429|FG000|Overall Study|Protocol deviation|1|||
46913263|NCT01068600|83143430|FG001|Overall Study|Protocol deviation|1|||
47035141|NCT01686633|83286112|FG000|Overall Study|Lost to Follow-up|0|||
47035142|NCT01686633|83286113|FG001|Overall Study|Lost to Follow-up|1|||
47035143|NCT01686633|83286114|FG002|Overall Study|Lost to Follow-up|1|||
47035144|NCT01685697|83286124|FG000|Overall Study|Protocol Violation|3|||
47035145|NCT01685697|83286125|FG001|Overall Study|Protocol Violation|3|||
47035146|NCT02395120|83286136|FG000|Overall Study|Missed follow-up dental exam|57|||
47035147|NCT02395120|83286137|FG001|Overall Study|Missed follow-up dental exam|62|||
47035148|NCT02395120|83286138|FG002|Overall Study|Missed follow-up dental exam|6|||
47035149|NCT02395120|83286139|FG003|Overall Study|Missed follow-up dental exam|6|||
47035150|NCT02395120|83286140|FG004|Overall Study|Missed follow-up dental exam|51|||
47035151|NCT01685229|83286154|FG000|Overall Study|Subjects missing Study Exit form|3|||
47035152|NCT01685229|83286155|FG001|Overall Study|Subjects missing Study Exit form|1|||
47035153|NCT01685229|83286154|FG000|Overall Study|Lost to Follow-up|16|||
47035154|NCT01685229|83286155|FG001|Overall Study|Lost to Follow-up|10|||
47035155|NCT01685229|83286154|FG000|Overall Study|Withdrawal by Subject|6|||
47035156|NCT01685229|83286155|FG001|Overall Study|Withdrawal by Subject|5|||
47035157|NCT01685229|83286154|FG000|Overall Study|Death|1|||
47035158|NCT01685229|83286155|FG001|Overall Study|Death|0|||
47035159|NCT01551693|83286166|FG000|Overall Study|Disease Progression|1|||
47035160|NCT01551693|83286167|FG001|Overall Study|Disease Progression|0|||
47035161|NCT01551693|83286166|FG000|Overall Study|Adverse Event|0|||
47035162|NCT01551693|83286167|FG001|Overall Study|Adverse Event|1|||
47035163|NCT01551693|83286166|FG000|Overall Study|Withdrawal by Subject|0|||
47035164|NCT01551693|83286167|FG001|Overall Study|Withdrawal by Subject|1|||
47035165|NCT01574157|83286175|FG000|Overall Study|Withdrawal by Subject|4|||
47035166|NCT01574157|83286176|FG001|Overall Study|Withdrawal by Subject|5|||
47035167|NCT01574157|83286175|FG000|Overall Study|Lost to Follow-up|0|||
47035168|NCT01574157|83286176|FG001|Overall Study|Lost to Follow-up|3|||
47035169|NCT01574079|83286188|FG000|Overall Study|Physician Decision|0|||
47035170|NCT01574079|83286189|FG001|Overall Study|Physician Decision|2|||
47035171|NCT01574079|83286188|FG000|Overall Study|Lost to Follow-up|1|||
47035172|NCT01574079|83286189|FG001|Overall Study|Lost to Follow-up|0|||
47035173|NCT01573767|83286199|FG000|Overall Study|Adverse Event|0|||
47035174|NCT01573767|83286200|FG001|Overall Study|Adverse Event|1|||
47035175|NCT01573767|83286201|FG002|Overall Study|Adverse Event|0|||
47035176|NCT01573767|83286202|FG003|Overall Study|Adverse Event|1|||
47035177|NCT01573767|83286199|FG000|Overall Study|Lack of Efficacy|18|||
47035178|NCT01573767|83286200|FG001|Overall Study|Lack of Efficacy|15|||
47035179|NCT01573767|83286201|FG002|Overall Study|Lack of Efficacy|12|||
47035180|NCT01573767|83286202|FG003|Overall Study|Lack of Efficacy|17|||
47035181|NCT01573767|83286199|FG000|Overall Study|Protocol Violation|3|||
47035182|NCT01573767|83286200|FG001|Overall Study|Protocol Violation|1|||
47035183|NCT01573767|83286201|FG002|Overall Study|Protocol Violation|1|||
46711271|NCT00882583|82927712|FG000|Overall Study|Physician Decision|1|||
46711272|NCT00882583|82927713|FG001|Overall Study|Physician Decision|0|||
46711273|NCT00882583|82927712|FG000|Overall Study|Adverse Event|0|||
46913264|NCT01068600|83143429|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46913265|NCT01068600|83143430|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
46913266|NCT01068600|83143429|FG000|Overall Study|Administrative problems|0|||
46913267|NCT01068600|83143430|FG001|Overall Study|Administrative problems|1|||
46913268|NCT01067976|83143436|FG000|Overall Study|Study drug never administered|20|||
46913269|NCT01067976|83143436|FG000|Overall Study|Study prematurely discontinued|2|||
46913270|NCT02858492|83143458|FG000|Overall Study|Withdrawal by Subject|0|||
46913271|NCT02858492|83143459|FG001|Overall Study|Withdrawal by Subject|1|||
46913272|NCT02858492|83143460|FG002|Overall Study|Withdrawal by Subject|0|||
46913273|NCT02858492|83143461|FG003|Overall Study|Withdrawal by Subject|1|||
46913274|NCT02858492|83143458|FG000|Overall Study|Adverse Event|0|||
46913275|NCT02858492|83143459|FG001|Overall Study|Adverse Event|0|||
46913276|NCT02858492|83143460|FG002|Overall Study|Adverse Event|0|||
46913277|NCT02858492|83143461|FG003|Overall Study|Adverse Event|3|||
46913278|NCT02858492|83143458|FG000|Overall Study|Lack of Efficacy|0|||
46913279|NCT02858492|83143459|FG001|Overall Study|Lack of Efficacy|0|||
46913280|NCT02858492|83143460|FG002|Overall Study|Lack of Efficacy|0|||
46913281|NCT02858492|83143461|FG003|Overall Study|Lack of Efficacy|1|||
47035184|NCT01573767|83286202|FG003|Overall Study|Protocol Violation|3|||
47035185|NCT01573767|83286199|FG000|Overall Study|Lost to Follow-up|0|||
47035186|NCT01573767|83286200|FG001|Overall Study|Lost to Follow-up|1|||
46711274|NCT00882583|82927713|FG001|Overall Study|Adverse Event|1|||
46711275|NCT00900562|82927721|FG000|Overall Study|Progressive disease|9|||
46711276|NCT00900562|82927722|FG001|Overall Study|Progressive disease|5|||
46711277|NCT00900562|82927721|FG000|Overall Study|Toxicity|1|||
46913282|NCT02858492|83143458|FG000|Overall Study|Protocol defined stopping criteria|0|||
46913283|NCT02858492|83143459|FG001|Overall Study|Protocol defined stopping criteria|0|||
47035187|NCT01573767|83286201|FG002|Overall Study|Lost to Follow-up|1|||
47035188|NCT01573767|83286202|FG003|Overall Study|Lost to Follow-up|1|||
47035189|NCT01573767|83286199|FG000|Overall Study|Physician Decision|1|||
46711278|NCT00900562|82927722|FG001|Overall Study|Toxicity|0|||
46711279|NCT00900562|82927721|FG000|Overall Study|Death|1|||
46711280|NCT00900562|82927722|FG001|Overall Study|Death|1|||
46711281|NCT00900562|82927721|FG000|Overall Study|Withdrawal by Subject|0|||
46711282|NCT00900562|82927722|FG001|Overall Study|Withdrawal by Subject|1|||
46711283|NCT00900562|82927721|FG000|Overall Study|Unrelated adverse event|1|||
46711284|NCT00900562|82927722|FG001|Overall Study|Unrelated adverse event|0|||
46711285|NCT00599521|82927731|FG000|Overall Study|Lack of Efficacy|4|||
46711286|NCT00599521|82927732|FG001|Overall Study|Lack of Efficacy|8|||
46711287|NCT00599521|82927731|FG000|Overall Study|Adverse Event|4|||
46711288|NCT00599521|82927732|FG001|Overall Study|Adverse Event|1|||
46913284|NCT02858492|83143460|FG002|Overall Study|Protocol defined stopping criteria|0|||
46913285|NCT02858492|83143461|FG003|Overall Study|Protocol defined stopping criteria|1|||
46913286|NCT01067508|83143475|FG000|Overall Study|Physician Decision|0|||
46913287|NCT01067508|83143476|FG001|Overall Study|Physician Decision|1|||
46913288|NCT01067508|83143475|FG000|Overall Study|Withdrawal by Subject|0|||
46913289|NCT01067508|83143476|FG001|Overall Study|Withdrawal by Subject|1|||
46913290|NCT01067352|83143485|FG000|Overall Study|Withdrawal by Subject|1|||
46913291|NCT01067352|83143486|FG001|Overall Study|Withdrawal by Subject|2|||
46913292|NCT01067352|83143487|FG002|Overall Study|Withdrawal by Subject|1|||
47035190|NCT01573767|83286200|FG001|Overall Study|Physician Decision|2|||
47035191|NCT01573767|83286201|FG002|Overall Study|Physician Decision|0|||
47035192|NCT01573767|83286202|FG003|Overall Study|Physician Decision|2|||
47035193|NCT01573767|83286199|FG000|Overall Study|Withdrawal by Subject|0|||
47035194|NCT01573767|83286200|FG001|Overall Study|Withdrawal by Subject|1|||
47035195|NCT01573767|83286201|FG002|Overall Study|Withdrawal by Subject|0|||
47035196|NCT01573767|83286202|FG003|Overall Study|Withdrawal by Subject|0|||
47035197|NCT01551303|83286214|FG000|Overall Study|failed awareness check on vision test|4|||
47035198|NCT01551303|83286215|FG001|Overall Study|failed awareness check on vision test|7|||
47035199|NCT00638404|83286223|FG000|Overall Study|Physician Decision|8|||
47035200|NCT00638404|83286224|FG001|Overall Study|Physician Decision|0|||
47035201|NCT01550757|83286238|FG000|Overall Study|Lost to Follow-up|21|||
47035202|NCT01550757|83286239|FG001|Overall Study|Lost to Follow-up|14|||
47035203|NCT01550757|83286240|FG002|Overall Study|Lost to Follow-up|42|||
47035204|NCT01550757|83286241|FG003|Overall Study|Lost to Follow-up|53|||
47035205|NCT01550757|83286238|FG000|Overall Study|Withdrawal by Subject|2|||
47035206|NCT01550757|83286239|FG001|Overall Study|Withdrawal by Subject|0|||
47035207|NCT01550757|83286240|FG002|Overall Study|Withdrawal by Subject|3|||
47035208|NCT01550757|83286241|FG003|Overall Study|Withdrawal by Subject|1|||
47035209|NCT01685073|83286253|FG000|Overall Study|Lost to Follow-up|6|||
47035210|NCT01685073|83286254|FG001|Overall Study|Lost to Follow-up|8|||
47035211|NCT01685073|83286253|FG000|Overall Study|Withdrawal by Subject|24|||
47035212|NCT01685073|83286254|FG001|Overall Study|Withdrawal by Subject|24|||
47035213|NCT01572909|83286262|FG000|Overall Study|Adverse Event|7|||
47035214|NCT01572909|83286263|FG001|Overall Study|Adverse Event|2|||
47035215|NCT01572909|83286262|FG000|Overall Study|Death|3|||
47035216|NCT01572909|83286263|FG001|Overall Study|Death|1|||
47035217|NCT01572909|83286262|FG000|Overall Study|Lost to Follow-up|8|||
47035218|NCT01572909|83286263|FG001|Overall Study|Lost to Follow-up|7|||
47035219|NCT01572909|83286262|FG000|Overall Study|Physician Decision|1|||
47035220|NCT01572909|83286263|FG001|Overall Study|Physician Decision|1|||
47035221|NCT01572909|83286262|FG000|Overall Study|Technical Issues|1|||
47035222|NCT01572909|83286263|FG001|Overall Study|Technical Issues|0|||
47035223|NCT01572909|83286262|FG000|Overall Study|Withdrawal by Subject|12|||
46711289|NCT00599521|82927731|FG000|Overall Study|Withdrawal by Subject|28|||
46711290|NCT00599521|82927732|FG001|Overall Study|Withdrawal by Subject|34|||
46711291|NCT00599521|82927731|FG000|Overall Study|Protocol Violation|1|||
46711292|NCT00599521|82927732|FG001|Overall Study|Protocol Violation|1|||
46711293|NCT00599521|82927731|FG000|Overall Study|Lost to Follow-up|23|||
46711294|NCT00599521|82927732|FG001|Overall Study|Lost to Follow-up|23|||
46711295|NCT00599521|82927731|FG000|Overall Study|Pregnancy|0|||
46711296|NCT00599521|82927732|FG001|Overall Study|Pregnancy|2|||
46711297|NCT00882115|82927738|FG000|Overall Study|Withdrawal by Subject|3|||
46711298|NCT00882115|82927738|FG000|Overall Study|did not respond to DEP challe|6|||
46711299|NCT00881959|82927744|FG000|Overall Study|Lost to Follow-up|2|||
46711300|NCT00881959|82927745|FG001|Overall Study|Lost to Follow-up|4|||
46711301|NCT00884377|82927753|FG000|Overall Study|Withdrawal by Subject|1|||
46711302|NCT00884377|82927754|FG001|Overall Study|Withdrawal by Subject|0|||
46711303|NCT00884377|82927753|FG000|Overall Study|Could not confirm diagnosis|1|||
46913293|NCT01067352|83143485|FG000|Overall Study|Physician Decision|0|||
46913294|NCT01067352|83143486|FG001|Overall Study|Physician Decision|1|||
47035224|NCT01572909|83286263|FG001|Overall Study|Withdrawal by Subject|11|||
47035225|NCT01572909|83286262|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
47035226|NCT01572909|83286263|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
47035227|NCT01572675|83286273|FG000|Overall Study|End of prescribed treatment|140|||
47035228|NCT01572675|83286274|FG001|Overall Study|End of prescribed treatment|118|||
47035229|NCT01572675|83286273|FG000|Overall Study|Recovery|16|||
47035230|NCT01572675|83286274|FG001|Overall Study|Recovery|23|||
47035231|NCT01572675|83286273|FG000|Overall Study|Lack of Efficacy|31|||
47035232|NCT01572675|83286274|FG001|Overall Study|Lack of Efficacy|31|||
47035233|NCT01572675|83286273|FG000|Overall Study|Intolerance|6|||
47035234|NCT01572675|83286274|FG001|Overall Study|Intolerance|5|||
47035235|NCT01572675|83286273|FG000|Overall Study|Improved symptoms|8|||
47035236|NCT01572675|83286274|FG001|Overall Study|Improved symptoms|2|||
47035237|NCT01572675|83286273|FG000|Overall Study|Surgical intervention|3|||
47035238|NCT01572675|83286274|FG001|Overall Study|Surgical intervention|6|||
47035239|NCT01572675|83286273|FG000|Overall Study|Withdrawal by Subject|5|||
47035240|NCT01572675|83286274|FG001|Overall Study|Withdrawal by Subject|1|||
47035241|NCT01572675|83286273|FG000|Overall Study|Physician Decision|2|||
47035242|NCT01572675|83286274|FG001|Overall Study|Physician Decision|2|||
47035243|NCT01572675|83286273|FG000|Overall Study|Death unrelated to coxibs|1|||
47035244|NCT01572675|83286274|FG001|Overall Study|Death unrelated to coxibs|1|||
47035245|NCT01572675|83286273|FG000|Overall Study|Other disease detected|1|||
47035246|NCT01572675|83286274|FG001|Overall Study|Other disease detected|1|||
47035247|NCT01572675|83286273|FG000|Overall Study|Unknown reason|1|||
47035248|NCT01572675|83286274|FG001|Overall Study|Unknown reason|1|||
47035249|NCT01572675|83286273|FG000|Overall Study|Rheumatologist new evaluation|0|||
47035250|NCT01572675|83286274|FG001|Overall Study|Rheumatologist new evaluation|1|||
47035251|NCT01572675|83286273|FG000|Overall Study|Missing data|1|||
47035252|NCT01572675|83286274|FG001|Overall Study|Missing data|4|||
47035253|NCT01572675|83286273|FG000|Overall Study|Lost to Follow-up|22|||
47035254|NCT01572675|83286274|FG001|Overall Study|Lost to Follow-up|27|||
47035255|NCT05065983|83286293|FG000|Overall Study|Lost to Follow-up|2|||
47035256|NCT04797650|83286300|FG000|Overall Study|Reason Not Specified|5|||
47035257|NCT04797650|83286301|FG001|Overall Study|Reason Not Specified|12|||
47035258|NCT04797650|83286302|FG002|Overall Study|Reason Not Specified|5|||
47035259|NCT04797650|83286300|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
47035260|NCT04797650|83286301|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
47035261|NCT04797650|83286302|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
47035262|NCT04797650|83286300|FG000|Overall Study|Lack of Efficacy|1|||
47035263|NCT04797650|83286301|FG001|Overall Study|Lack of Efficacy|0|||
47035264|NCT04797650|83286302|FG002|Overall Study|Lack of Efficacy|1|||
47035265|NCT04797650|83286300|FG000|Overall Study|Non-compliance with Study Drug|0|||
47035266|NCT04797650|83286301|FG001|Overall Study|Non-compliance with Study Drug|0|||
47035267|NCT04797650|83286302|FG002|Overall Study|Non-compliance with Study Drug|2|||
47035268|NCT04797650|83286300|FG000|Overall Study|Lost to Follow-up|4|||
47035269|NCT04797650|83286301|FG001|Overall Study|Lost to Follow-up|6|||
47035270|NCT04797650|83286302|FG002|Overall Study|Lost to Follow-up|1|||
47035271|NCT04705597|83286314|FG000|Overall Study|Death|16|||
47035272|NCT04705597|83286315|FG001|Overall Study|Death|9|||
47035273|NCT04705597|83286314|FG000|Overall Study|Lost to Follow-up|1|||
47035274|NCT04705597|83286315|FG001|Overall Study|Lost to Follow-up|0|||
47035275|NCT04705597|83286314|FG000|Overall Study|Withdrawal by Subject|1|||
47035276|NCT04705597|83286315|FG001|Overall Study|Withdrawal by Subject|2|||
47035277|NCT04534114|83286325|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
47035278|NCT04534114|83286326|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
47035279|NCT04534114|83286327|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
47035280|NCT04534114|83286328|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
47035281|NCT04534114|83286325|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
46711304|NCT00884377|82927754|FG001|Overall Study|Could not confirm diagnosis|0|||
46711305|NCT00884377|82927753|FG000|Overall Study|Physician Decision|0|||
47035282|NCT04534114|83286326|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
47035283|NCT04534114|83286327|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
47035284|NCT04534114|83286328|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
47035285|NCT04534114|83286325|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
47035286|NCT04534114|83286326|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
46629646|NCT01939158|82800544|FG001|Overall Study|Adverse Event|0|||
46629647|NCT01939158|82800545|FG002|Overall Study|Adverse Event|0|||
46629648|NCT01939158|82800546|FG003|Overall Study|Adverse Event|0|||
46629649|NCT01939158|82800543|FG000|Overall Study|Withdrawal by Subject|22|||
46629650|NCT01939158|82800544|FG001|Overall Study|Withdrawal by Subject|25|||
46629651|NCT01939158|82800545|FG002|Overall Study|Withdrawal by Subject|15|||
46629652|NCT01939158|82800546|FG003|Overall Study|Withdrawal by Subject|17|||
46629653|NCT01939158|82800543|FG000|Overall Study|Migrated/moved from study area|5|||
46629654|NCT01939158|82800544|FG001|Overall Study|Migrated/moved from study area|7|||
46629655|NCT01939158|82800545|FG002|Overall Study|Migrated/moved from study area|3|||
46629656|NCT01939158|82800546|FG003|Overall Study|Migrated/moved from study area|6|||
47035287|NCT04534114|83286327|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
47035288|NCT04534114|83286328|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
47035289|NCT04534114|83286325|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
47035290|NCT04534114|83286326|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
47035291|NCT04534114|83286327|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
47035292|NCT04534114|83286328|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
47035293|NCT04534114|83286325|FG000|Main Treatment Period|Physician Decision|0|||
47035294|NCT04534114|83286326|FG001|Main Treatment Period|Physician Decision|0|||
47035295|NCT04534114|83286327|FG002|Main Treatment Period|Physician Decision|0|||
47035296|NCT04534114|83286328|FG003|Main Treatment Period|Physician Decision|1|||
47035297|NCT04534114|83286325|FG000|Main Treatment Period|Death|1|||
47035298|NCT04534114|83286326|FG001|Main Treatment Period|Death|0|||
47035299|NCT04534114|83286327|FG002|Main Treatment Period|Death|0|||
47035300|NCT04534114|83286328|FG003|Main Treatment Period|Death|1|||
47035301|NCT04534114|83286325|FG000|Main Treatment Period|Other reason|1|||
47035302|NCT04534114|83286326|FG001|Main Treatment Period|Other reason|1|||
47035303|NCT04534114|83286327|FG002|Main Treatment Period|Other reason|0|||
47035304|NCT04534114|83286328|FG003|Main Treatment Period|Other reason|0|||
47035305|NCT04534114|83286325|FG000|Main Treatment Period|Participant decision|1|||
47035306|NCT04534114|83286326|FG001|Main Treatment Period|Participant decision|3|||
47035307|NCT04534114|83286327|FG002|Main Treatment Period|Participant decision|3|||
47035308|NCT04534114|83286328|FG003|Main Treatment Period|Participant decision|1|||
47035309|NCT04534114|83286325|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
47035310|NCT04534114|83286326|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
47035311|NCT04534114|83286327|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
47035312|NCT04534114|83286328|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
47035313|NCT04534114|83286325|FG000|Main Treatment Period|Adverse Event|4|||
47035314|NCT04534114|83286326|FG001|Main Treatment Period|Adverse Event|2|||
47035315|NCT04534114|83286327|FG002|Main Treatment Period|Adverse Event|1|||
47035316|NCT04534114|83286328|FG003|Main Treatment Period|Adverse Event|2|||
47035317|NCT04534114|83286325|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
47035318|NCT04534114|83286326|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
47035319|NCT04534114|83286327|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
47035320|NCT04534114|83286328|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
47035321|NCT04534114|83286325|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
47035322|NCT04534114|83286326|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
47035323|NCT04534114|83286327|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
47035324|NCT04534114|83286328|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
47035325|NCT04534114|83286325|FG000|Extension Treatment Period|Other reason|0|||
47035326|NCT04534114|83286326|FG001|Extension Treatment Period|Other reason|1|||
47035327|NCT04534114|83286327|FG002|Extension Treatment Period|Other reason|0|||
47035328|NCT04534114|83286328|FG003|Extension Treatment Period|Other reason|0|||
47035329|NCT04534114|83286325|FG000|Extension Treatment Period|Death|0|||
47035330|NCT04534114|83286326|FG001|Extension Treatment Period|Death|0|||
47035331|NCT04534114|83286327|FG002|Extension Treatment Period|Death|1|||
47035332|NCT04534114|83286328|FG003|Extension Treatment Period|Death|2|||
47035333|NCT04534114|83286325|FG000|Extension Treatment Period|Adverse Event|0|||
47035334|NCT04534114|83286326|FG001|Extension Treatment Period|Adverse Event|1|||
47035335|NCT04534114|83286327|FG002|Extension Treatment Period|Adverse Event|0|||
47035336|NCT04534114|83286328|FG003|Extension Treatment Period|Adverse Event|1|||
47035337|NCT04534114|83286325|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
47035338|NCT04534114|83286326|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
47035339|NCT04534114|83286327|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
47035340|NCT04534114|83286328|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
47035341|NCT04474366|83286349|FG000|Overall Study|Lost to Follow-up|2|||
47035342|NCT04474366|83286350|FG001|Overall Study|Lost to Follow-up|5|||
47035343|NCT04422431|83286356|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
47035344|NCT04422431|83286356|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
47035345|NCT04422431|83286356|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
47035346|NCT04422431|83286356|FG000|Extension Period (48 Weeks)|ongoing in the Extension Period|25|||
47035347|NCT04115488|83286367|FG000|Overall Study|Adverse Event|8|||
47035348|NCT04115488|83286368|FG001|Overall Study|Adverse Event|4|||
47035349|NCT04115488|83286367|FG000|Overall Study|Withdrawal by Subject|3|||
47035350|NCT04115488|83286368|FG001|Overall Study|Withdrawal by Subject|6|||
47035351|NCT04115488|83286367|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
47035352|NCT04115488|83286368|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
47035353|NCT04115488|83286367|FG000|Overall Study|Patient 's location change|1|||
47035354|NCT04115488|83286368|FG001|Overall Study|Patient 's location change|0|||
47035355|NCT04115488|83286367|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
46711306|NCT00884377|82927754|FG001|Overall Study|Physician Decision|1|||
46711307|NCT00884221|82927768|FG000|Overall Study|Withdrawal by Subject|0|||
46629657|NCT01939158|82800543|FG000|Overall Study|Lost to Follow-up|18|||
46629658|NCT01939158|82800544|FG001|Overall Study|Lost to Follow-up|17|||
47035356|NCT04115488|83286368|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
47035357|NCT04080752|83286392|FG000|Overall Study|Adverse Event|2|||
47035358|NCT04080752|83286393|FG001|Overall Study|Adverse Event|3|||
47035359|NCT04080752|83286392|FG000|Overall Study|Lack of Efficacy|1|||
47035360|NCT04080752|83286393|FG001|Overall Study|Lack of Efficacy|0|||
47035361|NCT04080752|83286392|FG000|Overall Study|Lost to Follow-up|1|||
47035362|NCT04080752|83286393|FG001|Overall Study|Lost to Follow-up|0|||
47035363|NCT04080752|83286392|FG000|Overall Study|Pregnancy|0|||
47035364|NCT04080752|83286393|FG001|Overall Study|Pregnancy|1|||
47035365|NCT04080752|83286392|FG000|Overall Study|Withdrawal by Subject|7|||
47035366|NCT04080752|83286393|FG001|Overall Study|Withdrawal by Subject|0|||
47035367|NCT04080752|83286392|FG000|Overall Study|Non-Compliance with Study Drug|0|||
47035368|NCT04080752|83286393|FG001|Overall Study|Non-Compliance with Study Drug|1|||
47035369|NCT04080752|83286392|FG000|Overall Study|Other|2|||
47035370|NCT04080752|83286393|FG001|Overall Study|Other|1|||
47035371|NCT03968419|83286403|FG000|Treatment Period|Adverse Event|0|||
47035372|NCT03968419|83286404|FG001|Treatment Period|Adverse Event|0|||
47035373|NCT03968419|83286405|FG002|Treatment Period|Adverse Event|1|||
47035374|NCT03968419|83286403|FG000|Safety Follow-up Period|Death|3|||
47035375|NCT03968419|83286404|FG001|Safety Follow-up Period|Death|2|||
47035376|NCT03968419|83286405|FG002|Safety Follow-up Period|Death|1|||
47035377|NCT03968419|83286403|FG000|Safety Follow-up Period|Subject Decision|2|||
47035378|NCT03968419|83286404|FG001|Safety Follow-up Period|Subject Decision|1|||
47035379|NCT03968419|83286405|FG002|Safety Follow-up Period|Subject Decision|0|||
47035380|NCT03784846|83286419|FG000|Pre-COVID Study|Lost to Follow-up|3|||
47035381|NCT03784846|83286420|FG001|Pre-COVID Study|Lost to Follow-up|3|||
47035382|NCT03784846|83286421|FG002|Pre-COVID Study|Lost to Follow-up|2|||
47035383|NCT03784846|83286419|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
47035384|NCT03784846|83286420|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
46711308|NCT00884221|82927769|FG001|Overall Study|Withdrawal by Subject|3|||
47035385|NCT03784846|83286421|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
46629659|NCT01939158|82800545|FG002|Overall Study|Lost to Follow-up|17|||
46629660|NCT01939158|82800546|FG003|Overall Study|Lost to Follow-up|17|||
46629661|NCT01939158|82800543|FG000|Overall Study|Death|0|||
46711309|NCT00884221|82927768|FG000|Overall Study|Adverse Event|6|||
46711310|NCT00884221|82927769|FG001|Overall Study|Adverse Event|3|||
46711311|NCT00884221|82927768|FG000|Overall Study|Protocol Violation|16|||
46711312|NCT00884221|82927769|FG001|Overall Study|Protocol Violation|13|||
46711313|NCT00884221|82927768|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
46711314|NCT00884221|82927769|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
46711315|NCT00899548|82927790|FG000|Overall Study|Physician Decision|3|||
46711316|NCT00899392|82927800|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
46711317|NCT00899392|82927801|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
46711318|NCT00690898|82927807|FG000|SCREENING|Screen failure|18|||
46711319|NCT00690898|82927807|FG000|TREATMENT|Adverse Event|3|||
46711320|NCT00690898|82927807|FG000|TREATMENT|Lack of Efficacy|18|||
46711321|NCT00690898|82927807|FG000|TREATMENT|Withdrawal by Subject|4|||
46711322|NCT00690898|82927807|FG000|TREATMENT|Other (not otherwise specified)|1|||
46711323|NCT00895414|82927811|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
46711324|NCT00895414|82927812|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
46711325|NCT00895414|82927811|FG000|First Intervention (14 Days)|Physician Decision|0|||
46711326|NCT00895414|82927812|FG001|First Intervention (14 Days)|Physician Decision|1|||
46711327|NCT01212770|82927821|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
46711328|NCT01212770|82927822|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
46711329|NCT01212770|82927823|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
46711330|NCT01212770|82927824|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46711331|NCT01212770|82927825|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46629662|NCT01939158|82800544|FG001|Overall Study|Death|0|||
46629663|NCT01939158|82800545|FG002|Overall Study|Death|1|||
46629664|NCT01939158|82800546|FG003|Overall Study|Death|1|||
46711332|NCT01212770|82927826|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46711333|NCT01212770|82927827|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
47035386|NCT03784846|83286419|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
46629665|NCT01939158|82800543|FG000|Overall Study|No longer meets eligibility criteria|0|||
46629666|NCT01939158|82800544|FG001|Overall Study|No longer meets eligibility criteria|0|||
46629667|NCT01939158|82800545|FG002|Overall Study|No longer meets eligibility criteria|1|||
46711334|NCT01212770|82927828|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46711335|NCT01212770|82927829|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
47035387|NCT03784846|83286420|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
47035388|NCT03784846|83286421|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
47035389|NCT03784846|83286419|FG000|Post-COVID Study|Lost to Follow-up|3|||
46711336|NCT01212770|82927821|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
46711337|NCT01212770|82927822|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
46711338|NCT01212770|82927823|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
47035390|NCT03784846|83286420|FG001|Post-COVID Study|Lost to Follow-up|5|||
47035391|NCT03784846|83286421|FG002|Post-COVID Study|Lost to Follow-up|1|||
46629668|NCT01939158|82800546|FG003|Overall Study|No longer meets eligibility criteria|0|||
46711339|NCT01212770|82927824|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46711340|NCT01212770|82927825|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46711341|NCT01212770|82927826|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46711342|NCT01212770|82927827|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46711343|NCT01212770|82927828|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46711344|NCT01212770|82927829|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46711345|NCT01212770|82927821|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
46711346|NCT01212770|82927822|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
46711347|NCT01212770|82927823|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
47035392|NCT03784846|83286419|FG000|Post-COVID Study|Withdrawal by Subject|1|||
47035393|NCT03784846|83286420|FG001|Post-COVID Study|Withdrawal by Subject|2|||
47035394|NCT03784846|83286421|FG002|Post-COVID Study|Withdrawal by Subject|0|||
47035395|NCT03756350|83286429|FG000|Overall Study|Lost to Follow-up|1|||
47035396|NCT03648996|83286451|FG000|Overall Study|Withdrawal by Subject|0|||
47035397|NCT03648996|83286452|FG001|Overall Study|Withdrawal by Subject|2|||
47035398|NCT03648996|83286453|FG002|Overall Study|Withdrawal by Subject|2|||
47035399|NCT03648996|83286451|FG000|Overall Study|Physician Decision|2|||
47035400|NCT03648996|83286452|FG001|Overall Study|Physician Decision|0|||
47035401|NCT03648996|83286453|FG002|Overall Study|Physician Decision|0|||
47035402|NCT03483961|83286478|FG000|Overall Study|Lost to Follow-up|7|||
47035403|NCT03483961|83286479|FG001|Overall Study|Lost to Follow-up|6|||
47035404|NCT03483961|83286480|FG002|Overall Study|Lost to Follow-up|6|||
47035405|NCT03483961|83286481|FG003|Overall Study|Lost to Follow-up|6|||
47035406|NCT03483961|83286482|FG004|Overall Study|Lost to Follow-up|6|||
47035407|NCT03483961|83286483|FG005|Overall Study|Lost to Follow-up|4|||
47035408|NCT03483961|83286484|FG006|Overall Study|Lost to Follow-up|4|||
47035409|NCT03483961|83286485|FG007|Overall Study|Lost to Follow-up|11|||
47035410|NCT03483961|83286486|FG008|Overall Study|Lost to Follow-up|1|||
47035411|NCT03483961|83286487|FG009|Overall Study|Lost to Follow-up|0|||
47035412|NCT03483961|83286478|FG000|Overall Study|Withdrawal by Subject|3|||
47035413|NCT03483961|83286479|FG001|Overall Study|Withdrawal by Subject|4|||
47035414|NCT03483961|83286480|FG002|Overall Study|Withdrawal by Subject|5|||
46711348|NCT01212770|82927824|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46711349|NCT01212770|82927825|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46711350|NCT01212770|82927826|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46711351|NCT01212770|82927827|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46711352|NCT01212770|82927828|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46711353|NCT01212770|82927829|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46711354|NCT01212770|82927821|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
46711355|NCT01212770|82927822|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46711356|NCT01212770|82927823|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
46711357|NCT01212770|82927824|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46711358|NCT01212770|82927825|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46711359|NCT01212770|82927826|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46711360|NCT01212770|82927827|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46711361|NCT01212770|82927828|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46711362|NCT01212770|82927829|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46711363|NCT01212770|82927821|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46913295|NCT01067352|83143487|FG002|Overall Study|Physician Decision|0|||
46913296|NCT02986074|83143495|FG000|First Trial Period|Adverse Event|1|||
46629669|NCT01939158|82800543|FG000|Overall Study|Other|1|||
47035415|NCT03483961|83286481|FG003|Overall Study|Withdrawal by Subject|3|||
46629670|NCT01939158|82800544|FG001|Overall Study|Other|3|||
46629671|NCT01939158|82800545|FG002|Overall Study|Other|4|||
46629672|NCT01939158|82800546|FG003|Overall Study|Other|3|||
46629673|NCT01939002|82800562|FG000|Overall Study|Adverse Event|13|||
46629674|NCT01939002|82800563|FG001|Overall Study|Adverse Event|13|||
46629675|NCT01939002|82800562|FG000|Overall Study|Withdrawal by Subject|5|||
46629676|NCT01939002|82800563|FG001|Overall Study|Withdrawal by Subject|3|||
46711364|NCT01212770|82927822|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
47035416|NCT03483961|83286482|FG004|Overall Study|Withdrawal by Subject|4|||
47035417|NCT03483961|83286483|FG005|Overall Study|Withdrawal by Subject|2|||
47035418|NCT03483961|83286484|FG006|Overall Study|Withdrawal by Subject|1|||
46629677|NCT01939002|82800562|FG000|Overall Study|Other|1|||
46629678|NCT01939002|82800563|FG001|Overall Study|Other|2|||
46629679|NCT01938846|82800577|FG000|Overall Study|Progressive disease|26|||
46913297|NCT02986074|83143496|FG001|First Trial Period|Adverse Event|0|||
46913298|NCT02986074|83143497|FG002|First Trial Period|Adverse Event|0|||
46913299|NCT02986074|83143498|FG003|First Trial Period|Adverse Event|0|||
46913300|NCT02986074|83143495|FG000|Follow up Period|system explant|0|||
46913301|NCT02986074|83143496|FG001|Follow up Period|system explant|0|||
46913302|NCT02986074|83143497|FG002|Follow up Period|system explant|1|||
46913303|NCT02986074|83143498|FG003|Follow up Period|system explant|2|||
46913304|NCT02986074|83143495|FG000|Follow up Period|Physician Decision|0|||
46913305|NCT02986074|83143496|FG001|Follow up Period|Physician Decision|0|||
46913306|NCT02986074|83143497|FG002|Follow up Period|Physician Decision|0|||
46913307|NCT02986074|83143498|FG003|Follow up Period|Physician Decision|1|||
46913308|NCT02920242|83143506|FG000|Overall Study|Withdrawal by Subject|1|||
46629680|NCT01938846|82800578|FG001|Overall Study|Progressive disease|18|||
46629681|NCT01938846|82800579|FG002|Overall Study|Progressive disease|16|||
46629682|NCT01938846|82800577|FG000|Overall Study|Adverse Event|8|||
46629683|NCT01938846|82800578|FG001|Overall Study|Adverse Event|4|||
46629684|NCT01938846|82800579|FG002|Overall Study|Adverse Event|3|||
46629685|NCT01938846|82800577|FG000|Overall Study|Withdrawal by Subject|2|||
46629686|NCT01938846|82800578|FG001|Overall Study|Withdrawal by Subject|2|||
46629687|NCT01938846|82800579|FG002|Overall Study|Withdrawal by Subject|1|||
46629688|NCT01938846|82800577|FG000|Overall Study|Other than listed|5|||
46629689|NCT01938846|82800578|FG001|Overall Study|Other than listed|1|||
46629690|NCT01938846|82800579|FG002|Overall Study|Other than listed|4|||
46629691|NCT01960140|82800620|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
46629692|NCT01981356|82800630|FG000|Overall Study|Lost to Follow-up|4|||
46913309|NCT02920242|83143507|FG001|Overall Study|Withdrawal by Subject|0|||
46913310|NCT02920242|83143508|FG002|Overall Study|Withdrawal by Subject|1|||
46913311|NCT02920242|83143506|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
46913312|NCT02920242|83143507|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
46913313|NCT02920242|83143508|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
46913314|NCT02985996|83143521|FG000|Overall Study|Withdrawal by Subject|0|||
46913315|NCT02985996|83143522|FG001|Overall Study|Withdrawal by Subject|0|||
46913316|NCT02985996|83143523|FG002|Overall Study|Withdrawal by Subject|1|||
46913317|NCT02985996|83143524|FG003|Overall Study|Withdrawal by Subject|0|||
46913318|NCT02985996|83143525|FG004|Overall Study|Withdrawal by Subject|0|||
46913319|NCT02985996|83143521|FG000|Overall Study|Protocol Violation|0|||
46913320|NCT02985996|83143522|FG001|Overall Study|Protocol Violation|1|||
46913321|NCT02985996|83143523|FG002|Overall Study|Protocol Violation|0|||
46913322|NCT02985996|83143524|FG003|Overall Study|Protocol Violation|0|||
46913323|NCT02985996|83143525|FG004|Overall Study|Protocol Violation|0|||
46913324|NCT03225833|83143547|FG000|Overall Study|Adverse Event|0|||
46913325|NCT03225833|83143548|FG001|Overall Study|Adverse Event|1|||
46913326|NCT03225833|83143549|FG002|Overall Study|Adverse Event|2|||
46913327|NCT03225833|83143550|FG003|Overall Study|Adverse Event|0|||
46913328|NCT03225833|83143551|FG004|Overall Study|Adverse Event|0|||
46913329|NCT03225833|83143552|FG005|Overall Study|Adverse Event|2|||
46913330|NCT03225833|83143547|FG000|Overall Study|Withdrawal by Subject|1|||
46913331|NCT03225833|83143548|FG001|Overall Study|Withdrawal by Subject|0|||
46913332|NCT03225833|83143549|FG002|Overall Study|Withdrawal by Subject|0|||
46913333|NCT03225833|83143550|FG003|Overall Study|Withdrawal by Subject|0|||
46913334|NCT03225833|83143551|FG004|Overall Study|Withdrawal by Subject|1|||
46913335|NCT03225833|83143552|FG005|Overall Study|Withdrawal by Subject|0|||
46913336|NCT03225833|83143547|FG000|Overall Study|Termination of Study by Sponsor|4|||
46913337|NCT03225833|83143548|FG001|Overall Study|Termination of Study by Sponsor|0|||
46913338|NCT03225833|83143549|FG002|Overall Study|Termination of Study by Sponsor|0|||
46913339|NCT03225833|83143550|FG003|Overall Study|Termination of Study by Sponsor|0|||
46913340|NCT03225833|83143551|FG004|Overall Study|Termination of Study by Sponsor|0|||
46913341|NCT03225833|83143552|FG005|Overall Study|Termination of Study by Sponsor|7|||
46913342|NCT03225833|83143547|FG000|Overall Study|Sponsor Decision|0|||
46913343|NCT03225833|83143548|FG001|Overall Study|Sponsor Decision|0|||
46913344|NCT03225833|83143549|FG002|Overall Study|Sponsor Decision|0|||
46629693|NCT01981356|82800631|FG001|Overall Study|Lost to Follow-up|1|||
46629694|NCT01981356|82800630|FG000|Overall Study|Withdrawal by Subject|1|||
46629695|NCT01981356|82800631|FG001|Overall Study|Withdrawal by Subject|1|||
46913345|NCT03225833|83143550|FG003|Overall Study|Sponsor Decision|0|||
46913346|NCT03225833|83143551|FG004|Overall Study|Sponsor Decision|0|||
46913347|NCT03225833|83143552|FG005|Overall Study|Sponsor Decision|1|||
46913348|NCT03203447|83143573|FG000|Overall Study|Withdrawal by Subject|2|||
46913349|NCT03203447|83143574|FG001|Overall Study|Withdrawal by Subject|1|||
46913350|NCT03203447|83143573|FG000|Overall Study|Lost to Follow-up|1|||
46913351|NCT03203447|83143574|FG001|Overall Study|Lost to Follow-up|10|||
46913352|NCT03203447|83143573|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
46913353|NCT03203447|83143574|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
46629696|NCT01981356|82800630|FG000|Overall Study|Protocol Violation|2|||
46913354|NCT02858726|83143584|FG000|Overall Study|Adverse Event|4|||
46913355|NCT02858726|83143585|FG001|Overall Study|Adverse Event|4|||
46913356|NCT02858726|83143586|FG002|Overall Study|Adverse Event|9|||
46913357|NCT02858726|83143587|FG003|Overall Study|Adverse Event|1|||
46913358|NCT02858726|83143584|FG000|Overall Study|Physician Decision|0|||
46913359|NCT02858726|83143585|FG001|Overall Study|Physician Decision|0|||
46913360|NCT02858726|83143586|FG002|Overall Study|Physician Decision|1|||
46913361|NCT02858726|83143587|FG003|Overall Study|Physician Decision|0|||
46913362|NCT02858726|83143584|FG000|Overall Study|Protocol Violation|0|||
46913363|NCT02858726|83143585|FG001|Overall Study|Protocol Violation|0|||
46913364|NCT02858726|83143586|FG002|Overall Study|Protocol Violation|0|||
46913365|NCT02858726|83143587|FG003|Overall Study|Protocol Violation|1|||
46913366|NCT02858726|83143584|FG000|Overall Study|Study Terminated by Sponsor|0|||
46913367|NCT02858726|83143585|FG001|Overall Study|Study Terminated by Sponsor|0|||
46913368|NCT02858726|83143586|FG002|Overall Study|Study Terminated by Sponsor|0|||
46913369|NCT02858726|83143587|FG003|Overall Study|Study Terminated by Sponsor|1|||
46913370|NCT02858726|83143584|FG000|Overall Study|Withdrawal by Subject|1|||
46913371|NCT02858726|83143585|FG001|Overall Study|Withdrawal by Subject|2|||
46913372|NCT02858726|83143586|FG002|Overall Study|Withdrawal by Subject|1|||
46913373|NCT02858726|83143587|FG003|Overall Study|Withdrawal by Subject|0|||
46913374|NCT02858726|83143584|FG000|Overall Study|Noncompliance|0|||
46913375|NCT02858726|83143585|FG001|Overall Study|Noncompliance|1|||
47035419|NCT03483961|83286485|FG007|Overall Study|Withdrawal by Subject|2|||
47035420|NCT03483961|83286486|FG008|Overall Study|Withdrawal by Subject|1|||
47035421|NCT03483961|83286487|FG009|Overall Study|Withdrawal by Subject|0|||
47035422|NCT03483961|83286478|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
47035423|NCT03483961|83286479|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035424|NCT03483961|83286480|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035425|NCT03483961|83286481|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035426|NCT03483961|83286482|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035427|NCT03483961|83286483|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035428|NCT03483961|83286484|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035429|NCT03483961|83286485|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035430|NCT03483961|83286486|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035431|NCT03483961|83286487|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
47035432|NCT03483961|83286478|FG000|Overall Study|Adverse Event|0|||
47035433|NCT03483961|83286479|FG001|Overall Study|Adverse Event|0|||
47035434|NCT03483961|83286480|FG002|Overall Study|Adverse Event|1|||
47035435|NCT03483961|83286481|FG003|Overall Study|Adverse Event|0|||
47035436|NCT03483961|83286482|FG004|Overall Study|Adverse Event|0|||
46629697|NCT01981356|82800631|FG001|Overall Study|Protocol Violation|0|||
46629698|NCT01981122|82800640|FG000|Overall Study|Withdrawal by Subject|0|||
46629699|NCT01981122|82800641|FG001|Overall Study|Withdrawal by Subject|2|||
46711365|NCT01212770|82927823|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
46711366|NCT01212770|82927824|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46711367|NCT01212770|82927825|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46711368|NCT01212770|82927826|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46711369|NCT01212770|82927827|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46711370|NCT01212770|82927828|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46711371|NCT01212770|82927829|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46711372|NCT01212770|82927821|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
46711373|NCT01212770|82927822|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
46711374|NCT01212770|82927823|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
46711375|NCT01212770|82927824|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
46711376|NCT01212770|82927825|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
46629700|NCT01981122|82800640|FG000|Overall Study|Protocol Violation|0|||
46629701|NCT01981122|82800641|FG001|Overall Study|Protocol Violation|1|||
46629702|NCT01981122|82800640|FG000|Overall Study|Lost to Follow-up|0|||
46629703|NCT01981122|82800641|FG001|Overall Study|Lost to Follow-up|1|||
46629704|NCT01981122|82800640|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
46629705|NCT01981122|82800641|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
46629706|NCT01981122|82800640|FG000|Overall Study|Death|14|||
46629707|NCT01981122|82800641|FG001|Overall Study|Death|15|||
46629708|NCT01980888|82800649|FG000|Overall Study|Study Terminated by Sponsor|116|||
46629709|NCT01980888|82800650|FG001|Overall Study|Study Terminated by Sponsor|122|||
46913376|NCT02858726|83143586|FG002|Overall Study|Noncompliance|0|||
46913377|NCT02858726|83143587|FG003|Overall Study|Noncompliance|0|||
46913378|NCT03203291|83143601|FG000|Overall Study|Withdrawal by Subject|1|||
46629710|NCT01980888|82800649|FG000|Overall Study|Withdrew Consent|17|||
46913379|NCT01068678|83143607|FG000|Overall Study|Lack of Efficacy|3|||
46913380|NCT01068678|83143608|FG001|Overall Study|Lack of Efficacy|2|||
46913381|NCT01068678|83143607|FG000|Overall Study|Protocol Violation|5|||
47035437|NCT03483961|83286483|FG005|Overall Study|Adverse Event|0|||
47035438|NCT03483961|83286484|FG006|Overall Study|Adverse Event|0|||
47035439|NCT03483961|83286485|FG007|Overall Study|Adverse Event|0|||
47035440|NCT03483961|83286486|FG008|Overall Study|Adverse Event|0|||
47035441|NCT03483961|83286487|FG009|Overall Study|Adverse Event|0|||
47035442|NCT03459807|83286510|FG000|Overall Study|Withdrawal due to transplant|0|||
47035443|NCT03459807|83286511|FG001|Overall Study|Withdrawal due to transplant|1|||
47035444|NCT03439293|83286524|FG000|Overall Study|Ongoing on Treatment|15|||
47035445|NCT03439293|83286524|FG000|Overall Study|Ongoing off Treatment|19|||
47035446|NCT03439293|83286524|FG000|Overall Study|Death|18|||
47035447|NCT03439293|83286524|FG000|Overall Study|Withdrawal by Subject|7|||
47035448|NCT03439293|83286524|FG000|Overall Study|Lost to Follow-up|2|||
47035449|NCT03423979|83286529|FG000|Overall Study|Death|1|||
47035450|NCT03239210|83286535|FG000|Overall Study|Lost to Follow-up|2|||
47035451|NCT03239210|83286536|FG001|Overall Study|Lost to Follow-up|2|||
47035452|NCT03239210|83286535|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
47035453|NCT03239210|83286536|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
47035454|NCT03239210|83286535|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
47035455|NCT03239210|83286536|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
47035456|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
47035457|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
47035458|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
47035459|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
46913382|NCT01068678|83143608|FG001|Overall Study|Protocol Violation|1|||
46913383|NCT01068678|83143607|FG000|Overall Study|Withdrawal criteria|12|||
46913384|NCT01068678|83143608|FG001|Overall Study|Withdrawal criteria|6|||
46913385|NCT01068678|83143607|FG000|Overall Study|Unclassified|18|||
46913386|NCT01068678|83143608|FG001|Overall Study|Unclassified|15|||
46913387|NCT03202511|83143614|FG000|Overall Study|Withdrawal by Subject|1|||
46913388|NCT03202511|83143615|FG001|Overall Study|Withdrawal by Subject|0|||
46913389|NCT02919696|83143636|FG000|Overall Study|Adverse Event|1|||
46913390|NCT02919696|83143637|FG001|Overall Study|Adverse Event|2|||
47035460|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
47035461|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
47035462|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
47035463|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
47035464|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
47035465|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
47035466|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
47035467|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
47035468|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
47035469|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
47035470|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
47035471|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
47035472|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
47035473|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
47035474|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
47035475|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
47035476|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
47035477|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
47035478|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
47035479|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
47035480|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
47035481|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
47035482|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
47035483|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
47035484|NCT03227224|83286546|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
47035485|NCT03227224|83286547|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
47035486|NCT03227224|83286548|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
47035487|NCT03227224|83286549|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
46629711|NCT01980888|82800650|FG001|Overall Study|Withdrew Consent|6|||
46913391|NCT02919696|83143636|FG000|Overall Study|Withdrawal by Subject|2|||
46913392|NCT02919696|83143637|FG001|Overall Study|Withdrawal by Subject|1|||
46629712|NCT01980888|82800649|FG000|Overall Study|Investigator's Discretion|8|||
46629713|NCT01980888|82800650|FG001|Overall Study|Investigator's Discretion|3|||
46913393|NCT02919696|83143636|FG000|Overall Study|Sponsor Decision|1|||
46913394|NCT02919696|83143637|FG001|Overall Study|Sponsor Decision|1|||
46913395|NCT02919696|83143636|FG000|Overall Study|Never Treated|0|||
46913396|NCT02919696|83143637|FG001|Overall Study|Never Treated|1|||
46913397|NCT02935673|83143652|FG000|Overall Study|Adverse Event|0|||
46913398|NCT02935673|83143653|FG001|Overall Study|Adverse Event|1|||
46913399|NCT02935673|83143654|FG002|Overall Study|Adverse Event|0|||
46913400|NCT02935673|83143652|FG000|Overall Study|Withdrawal by Subject|1|||
46913401|NCT02935673|83143653|FG001|Overall Study|Withdrawal by Subject|2|||
46913402|NCT02935673|83143654|FG002|Overall Study|Withdrawal by Subject|0|||
46913403|NCT03201809|83143666|FG000|Overall Study|Lost to Follow-up|2|||
47035488|NCT03227224|83286546|FG000|Follow-up Phase (2 Weeks)|Other|4|||
47035489|NCT03227224|83286547|FG001|Follow-up Phase (2 Weeks)|Other|4|||
47035490|NCT03227224|83286548|FG002|Follow-up Phase (2 Weeks)|Other|6|||
47035491|NCT03227224|83286549|FG003|Follow-up Phase (2 Weeks)|Other|3|||
47035492|NCT03086343|83286568|FG000|Overall Study|Adverse Event|7|||
47035493|NCT03086343|83286569|FG001|Overall Study|Adverse Event|7|||
47035494|NCT03086343|83286568|FG000|Overall Study|Withdrawal by Subject|10|||
47035495|NCT03086343|83286569|FG001|Overall Study|Withdrawal by Subject|6|||
47035496|NCT03086343|83286568|FG000|Overall Study|Lost to Follow-up|3|||
47035497|NCT03086343|83286569|FG001|Overall Study|Lost to Follow-up|1|||
47035498|NCT03086343|83286568|FG000|Overall Study|Lack of Efficacy|4|||
47035499|NCT03086343|83286569|FG001|Overall Study|Lack of Efficacy|6|||
47035500|NCT03086343|83286568|FG000|Overall Study|Other, not specified|8|||
47035501|NCT03086343|83286569|FG001|Overall Study|Other, not specified|4|||
47035502|NCT03086343|83286568|FG000|Overall Study|Missing|0|||
47035503|NCT03086343|83286569|FG001|Overall Study|Missing|1|||
46629714|NCT01980888|82800649|FG000|Overall Study|Non-Compliance with Study Drug|3|||
46629715|NCT01980888|82800650|FG001|Overall Study|Non-Compliance with Study Drug|2|||
46711377|NCT01212770|82927826|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
46711378|NCT01212770|82927827|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
46711379|NCT01212770|82927828|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
46711380|NCT01212770|82927829|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
46711381|NCT01212770|82927821|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
46711382|NCT01212770|82927822|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
46711383|NCT01212770|82927823|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
46711384|NCT01212770|82927824|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
46711385|NCT01212770|82927825|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
46711386|NCT01212770|82927826|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
46711387|NCT01212770|82927827|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
46711388|NCT01212770|82927828|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
46711389|NCT01212770|82927829|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
46711390|NCT01212770|82927821|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
46711391|NCT01212770|82927822|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
46711392|NCT01212770|82927823|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
46711393|NCT01212770|82927824|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
46711394|NCT01212770|82927825|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
46711395|NCT01212770|82927826|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
46711396|NCT01212770|82927827|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
46629716|NCT01937364|82800667|FG000|Overall Study|Adverse Event|2|||
46629717|NCT01937364|82800668|FG001|Overall Study|Adverse Event|1|||
46629718|NCT01979952|82800676|FG000|Overall Study|Adverse Event|4|||
46629719|NCT01979952|82800677|FG001|Overall Study|Adverse Event|5|||
46629720|NCT01979952|82800676|FG000|Overall Study|Protocol Violation|1|||
46629721|NCT01979952|82800677|FG001|Overall Study|Protocol Violation|0|||
46629722|NCT01979952|82800676|FG000|Overall Study|Withdrawal by Subject|2|||
46629723|NCT01979952|82800677|FG001|Overall Study|Withdrawal by Subject|1|||
46629724|NCT01979952|82800676|FG000|Overall Study|Other than specified above|1|||
46629725|NCT01979952|82800677|FG001|Overall Study|Other than specified above|0|||
46629726|NCT01999218|82800686|FG000|Overall Study|Hyperglycemia|18|||
46629727|NCT01999218|82800687|FG001|Overall Study|Hyperglycemia|17|||
46711397|NCT01212770|82927828|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
46711398|NCT01212770|82927829|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
46913404|NCT03201809|83143667|FG001|Overall Study|Lost to Follow-up|0|||
46913405|NCT02985450|83143678|FG000|Overall Study|Lost to Follow-up|7|||
46913406|NCT02908464|83143687|FG000|Overall Study|Withdrawal by Subject|2|||
47035504|NCT02788045|83286613|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
47035505|NCT02788045|83286614|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
47035506|NCT02788045|83286615|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
47035507|NCT02788045|83286613|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
47035508|NCT02788045|83286614|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
47035509|NCT02788045|83286615|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
47035510|NCT02788045|83286613|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
47035511|NCT02788045|83286614|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
46629728|NCT01999218|82800688|FG002|Overall Study|Hyperglycemia|17|||
46629729|NCT01999218|82800686|FG000|Overall Study|Lack of Efficacy|1|||
46629730|NCT01999218|82800687|FG001|Overall Study|Lack of Efficacy|0|||
46629731|NCT01999218|82800688|FG002|Overall Study|Lack of Efficacy|1|||
47035512|NCT02788045|83286615|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
47035513|NCT02788045|83286613|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
47035514|NCT02788045|83286614|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
47035515|NCT02788045|83286615|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
47035516|NCT02788045|83286613|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
47035517|NCT02788045|83286614|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
47035518|NCT02788045|83286615|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
47035519|NCT02788045|83286613|FG000|Main Study (Up to Week 72)|Other|3|||
47035520|NCT02788045|83286614|FG001|Main Study (Up to Week 72)|Other|0|||
47035521|NCT02788045|83286615|FG002|Main Study (Up to Week 72)|Other|0|||
47035522|NCT02788045|83286613|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
47035523|NCT02788045|83286614|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
47035524|NCT02788045|83286615|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
47035525|NCT02788045|83286613|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
47035526|NCT02788045|83286614|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
47035527|NCT02788045|83286615|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
47035528|NCT02788045|83286613|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
47035529|NCT02788045|83286614|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
47035530|NCT02788045|83286615|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
47035531|NCT02315703|83286649|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
47035532|NCT02315703|83286650|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
47035533|NCT02315703|83286651|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
47035534|NCT02315703|83286652|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
47035535|NCT02315703|83286653|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
47035536|NCT02315703|83286654|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
47035537|NCT02315703|83286655|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
47035538|NCT02315703|83286656|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
47035539|NCT02315703|83286649|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
47035540|NCT02315703|83286650|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
47035541|NCT02315703|83286651|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
47035542|NCT02315703|83286652|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
47035543|NCT02315703|83286653|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
47035544|NCT02315703|83286654|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
47035545|NCT02315703|83286655|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
47035546|NCT02315703|83286656|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
47035547|NCT02315703|83286649|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
47035548|NCT02315703|83286650|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
47035549|NCT02315703|83286651|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
47035550|NCT02315703|83286652|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
47035551|NCT02315703|83286653|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
47035552|NCT02315703|83286654|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
47035553|NCT02315703|83286655|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
47035554|NCT02315703|83286656|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
47035555|NCT02315703|83286649|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
47035556|NCT02315703|83286650|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
47035557|NCT02315703|83286651|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
47035558|NCT02315703|83286652|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
47035559|NCT02315703|83286653|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
47035560|NCT02315703|83286654|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
47035561|NCT02315703|83286655|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
47035562|NCT02315703|83286656|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
47035563|NCT02315703|83286649|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
47035564|NCT02315703|83286650|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
47035565|NCT02315703|83286651|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
47035566|NCT02315703|83286652|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
47035567|NCT02315703|83286653|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
47035568|NCT02315703|83286654|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
47035569|NCT02315703|83286655|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
47035570|NCT02315703|83286656|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
47035571|NCT02315703|83286649|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
47035572|NCT02315703|83286650|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
46629732|NCT01999218|82800686|FG000|Overall Study|Lost to Follow-up|22|||
46629733|NCT01999218|82800687|FG001|Overall Study|Lost to Follow-up|17|||
46629734|NCT01999218|82800688|FG002|Overall Study|Lost to Follow-up|18|||
47035573|NCT02315703|83286651|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
46629735|NCT01999218|82800686|FG000|Overall Study|Non-Compliance With Study Drug|6|||
47035574|NCT02315703|83286652|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
47035575|NCT02315703|83286653|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
47035576|NCT02315703|83286654|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
47035577|NCT02315703|83286655|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
47035578|NCT02315703|83286656|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
47035579|NCT02315703|83286649|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
47035580|NCT02315703|83286650|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
47035581|NCT02315703|83286651|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
47035582|NCT02315703|83286652|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
47035583|NCT02315703|83286653|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
46913407|NCT02908464|83143688|FG001|Overall Study|Withdrawal by Subject|1|||
46913408|NCT02908464|83143687|FG000|Overall Study|Found ineligible after randomization|0|||
46913409|NCT02908464|83143688|FG001|Overall Study|Found ineligible after randomization|2|||
46913410|NCT02907216|83143697|FG000|Overall Study|No benefit to be obtained by continuing|0|||
46913411|NCT02907216|83143698|FG001|Overall Study|No benefit to be obtained by continuing|1|||
46913412|NCT02907216|83143697|FG000|Overall Study|Withdrawal by Subject|1|||
46913413|NCT02907216|83143698|FG001|Overall Study|Withdrawal by Subject|0|||
46913414|NCT02984982|83143706|FG000|Overall Study|Adverse Event|2|||
46913415|NCT02984982|83143707|FG001|Overall Study|Adverse Event|5|||
46913416|NCT02984982|83143706|FG000|Overall Study|Poor Compliance to Protocol|4|||
46913417|NCT02984982|83143707|FG001|Overall Study|Poor Compliance to Protocol|4|||
46913418|NCT02984982|83143706|FG000|Overall Study|Withdrawal by Subject|2|||
46913419|NCT02984982|83143707|FG001|Overall Study|Withdrawal by Subject|0|||
46913420|NCT02984982|83143706|FG000|Overall Study|Randomized but not treated|0|||
46913421|NCT02984982|83143707|FG001|Overall Study|Randomized but not treated|1|||
46913422|NCT02981472|83143716|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
46913423|NCT02981472|83143717|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
46913424|NCT02981472|83143716|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
46913425|NCT02981472|83143717|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46913426|NCT02981472|83143716|FG000|Treatment Period|Adverse Event|6|||
46913427|NCT02981472|83143717|FG001|Treatment Period|Adverse Event|1|||
46913428|NCT02981472|83143716|FG000|Treatment Period|Participant withdrew consent|1|||
46913429|NCT02981472|83143717|FG001|Treatment Period|Participant withdrew consent|0|||
46913430|NCT02981472|83143716|FG000|Treatment Period|Lost to Follow-up|0|||
46913431|NCT02981472|83143717|FG001|Treatment Period|Lost to Follow-up|1|||
46913432|NCT02982720|83143729|FG000|Overall Study|Adverse Event|3|||
47035584|NCT02315703|83286654|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
47035585|NCT02315703|83286655|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
47035586|NCT02315703|83286656|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
47035587|NCT02315703|83286649|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
47035588|NCT02315703|83286650|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
47035589|NCT02315703|83286651|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
47035590|NCT02315703|83286652|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
47035591|NCT02315703|83286653|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
47035592|NCT02315703|83286654|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
47035593|NCT02315703|83286655|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
47035594|NCT02315703|83286656|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
47035595|NCT02315703|83286649|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
47035596|NCT02315703|83286650|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
47035597|NCT02315703|83286651|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
47035598|NCT02315703|83286652|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
47035599|NCT02315703|83286653|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
47035600|NCT02315703|83286654|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
47035601|NCT02315703|83286655|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
47035602|NCT02315703|83286656|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
47035603|NCT02049359|83286676|FG000|Overall Study|Lost to Follow-up|26|||
47035604|NCT02049359|83286677|FG001|Overall Study|Lost to Follow-up|19|||
47035605|NCT01466686|83286707|FG000|Overall Study|Withdrawal by Subject|1|||
47035606|NCT01550289|83286713|FG000|Overall Study|Protocol Violation|1|||
47035607|NCT01550289|83286714|FG001|Overall Study|Protocol Violation|0|||
47035608|NCT01550289|83286713|FG000|Overall Study|Lost to Follow-up|1|||
47035609|NCT01550289|83286714|FG001|Overall Study|Lost to Follow-up|1|||
46913433|NCT02982720|83143729|FG000|Overall Study|Death|1|||
46913434|NCT00849667|83143736|FG000|Overall Study|Withdrawal by Subject|16|||
47035610|NCT01550289|83286713|FG000|Overall Study|Withdrawal by Subject|11|||
47035611|NCT01550289|83286714|FG001|Overall Study|Withdrawal by Subject|3|||
47035612|NCT01968031|83286725|FG000|Overall Study|Adverse Event|13|||
46913435|NCT00849667|83143737|FG001|Overall Study|Withdrawal by Subject|33|||
46913436|NCT00849667|83143738|FG002|Overall Study|Withdrawal by Subject|35|||
46913437|NCT00849667|83143736|FG000|Overall Study|Lost to Follow-up|8|||
46913438|NCT00849667|83143737|FG001|Overall Study|Lost to Follow-up|8|||
47035613|NCT01968031|83286726|FG001|Overall Study|Adverse Event|10|||
47035614|NCT01968031|83286727|FG002|Overall Study|Adverse Event|22|||
47035615|NCT01968031|83286725|FG000|Overall Study|Withdrawal by Subject|3|||
47035616|NCT01968031|83286726|FG001|Overall Study|Withdrawal by Subject|7|||
47035617|NCT01968031|83286727|FG002|Overall Study|Withdrawal by Subject|3|||
47035618|NCT01968031|83286725|FG000|Overall Study|Did not meet entry criteria|1|||
47035619|NCT01968031|83286726|FG001|Overall Study|Did not meet entry criteria|1|||
47035620|NCT01968031|83286727|FG002|Overall Study|Did not meet entry criteria|1|||
47035621|NCT01968031|83286725|FG000|Overall Study|Noncompliance|0|||
47035622|NCT01968031|83286726|FG001|Overall Study|Noncompliance|0|||
47035623|NCT01968031|83286727|FG002|Overall Study|Noncompliance|2|||
47035624|NCT01968031|83286725|FG000|Overall Study|Failed inclusion criteria|0|||
47035625|NCT01968031|83286726|FG001|Overall Study|Failed inclusion criteria|2|||
47035626|NCT01968031|83286727|FG002|Overall Study|Failed inclusion criteria|0|||
47035627|NCT01968031|83286725|FG000|Overall Study|Death|0|||
47035628|NCT01968031|83286726|FG001|Overall Study|Death|0|||
47035629|NCT01968031|83286727|FG002|Overall Study|Death|1|||
47035630|NCT01968031|83286725|FG000|Overall Study|Prohibited concomitant medication|1|||
47035631|NCT01968031|83286726|FG001|Overall Study|Prohibited concomitant medication|0|||
47035632|NCT01968031|83286727|FG002|Overall Study|Prohibited concomitant medication|0|||
47035633|NCT01684215|83286739|FG000|Phase 1, Part 1|Adverse Event|1|||
47035634|NCT01684215|83286740|FG001|Phase 1, Part 1|Adverse Event|0|||
47035635|NCT01684215|83286741|FG002|Phase 1, Part 1|Adverse Event|0|||
47035636|NCT01684215|83286742|FG003|Phase 1, Part 1|Adverse Event|0|||
47035637|NCT01684215|83286739|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
47035638|NCT01684215|83286740|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
47035639|NCT01684215|83286741|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
47035640|NCT01684215|83286742|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
46913439|NCT00849667|83143738|FG002|Overall Study|Lost to Follow-up|8|||
46913440|NCT00849667|83143736|FG000|Overall Study|Adverse Event|1|||
46913441|NCT00849667|83143737|FG001|Overall Study|Adverse Event|2|||
46913442|NCT00849667|83143738|FG002|Overall Study|Adverse Event|0|||
46913443|NCT00849667|83143736|FG000|Overall Study|Other|18|||
46913444|NCT00849667|83143737|FG001|Overall Study|Other|19|||
46913445|NCT00849667|83143738|FG002|Overall Study|Other|18|||
46913446|NCT00849667|83143736|FG000|Overall Study|Progressive disease|119|||
47035641|NCT01684215|83286739|FG000|Phase 1, Part 2|Adverse Event|0|||
47035642|NCT01684215|83286740|FG001|Phase 1, Part 2|Adverse Event|0|||
47035643|NCT01684215|83286741|FG002|Phase 1, Part 2|Adverse Event|1|||
47035644|NCT01684215|83286742|FG003|Phase 1, Part 2|Adverse Event|0|||
47035645|NCT01684215|83286739|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
47035646|NCT01684215|83286740|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
47035647|NCT01684215|83286741|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
47035648|NCT01684215|83286742|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
47035649|NCT01684215|83286739|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
47035650|NCT01684215|83286740|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
47035651|NCT01684215|83286741|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
47035652|NCT01684215|83286742|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
47035653|NCT01684215|83286739|FG000|Phase 2|Death|0|||
47035654|NCT01684215|83286740|FG001|Phase 2|Death|0|||
47035655|NCT01684215|83286741|FG002|Phase 2|Death|0|||
47035656|NCT01684215|83286742|FG003|Phase 2|Death|8|||
47035657|NCT01684215|83286739|FG000|Phase 2|Study terminated by sponsor|0|||
47035658|NCT01684215|83286740|FG001|Phase 2|Study terminated by sponsor|0|||
47035659|NCT01684215|83286741|FG002|Phase 2|Study terminated by sponsor|0|||
47035660|NCT01684215|83286742|FG003|Phase 2|Study terminated by sponsor|30|||
47035661|NCT01684215|83286739|FG000|Phase 2|Enrolled but not treated|0|||
47035662|NCT01684215|83286740|FG001|Phase 2|Enrolled but not treated|0|||
47035663|NCT01684215|83286741|FG002|Phase 2|Enrolled but not treated|0|||
47035664|NCT01684215|83286742|FG003|Phase 2|Enrolled but not treated|1|||
47035665|NCT01684215|83286739|FG000|Phase 2|Lost to Follow-up|0|||
47035666|NCT01684215|83286740|FG001|Phase 2|Lost to Follow-up|0|||
47035667|NCT01684215|83286741|FG002|Phase 2|Lost to Follow-up|0|||
46913447|NCT00849667|83143737|FG001|Overall Study|Progressive disease|100|||
46913448|NCT00849667|83143738|FG002|Overall Study|Progressive disease|112|||
46629736|NCT01999218|82800687|FG001|Overall Study|Non-Compliance With Study Drug|4|||
46629737|NCT01999218|82800688|FG002|Overall Study|Non-Compliance With Study Drug|1|||
46629738|NCT01999218|82800686|FG000|Overall Study|Physician Decision|1|||
46913449|NCT00849667|83143736|FG000|Overall Study|Sponsor decision|208|||
46913450|NCT00849667|83143737|FG001|Overall Study|Sponsor decision|204|||
46913451|NCT00849667|83143738|FG002|Overall Study|Sponsor decision|190|||
47035668|NCT01684215|83286742|FG003|Phase 2|Lost to Follow-up|4|||
46629739|NCT01999218|82800687|FG001|Overall Study|Physician Decision|4|||
46913452|NCT00849667|83143736|FG000|Overall Study|Investigator discretion|0|||
46913453|NCT00849667|83143737|FG001|Overall Study|Investigator discretion|0|||
46913454|NCT00849667|83143738|FG002|Overall Study|Investigator discretion|1|||
47035669|NCT01549275|83286757|FG000|Overall Study|Lost to Follow-up|1|||
47035670|NCT01549275|83286758|FG001|Overall Study|Lost to Follow-up|0|||
47035671|NCT01908205|83286770|FG000|Overall Study|Lost to Follow-up|2|||
47035672|NCT01908205|83286771|FG001|Overall Study|Lost to Follow-up|0|||
47035673|NCT01908205|83286770|FG000|Overall Study|Withdrawal by Subject|3|||
47035674|NCT01908205|83286771|FG001|Overall Study|Withdrawal by Subject|1|||
47035675|NCT01549041|83286792|FG000|Overall Study|Lack of Efficacy|2|||
47035676|NCT01549041|83286793|FG001|Overall Study|Lack of Efficacy|4|||
47035677|NCT01549041|83286792|FG000|Overall Study|Adverse Event|0|||
47035678|NCT01549041|83286793|FG001|Overall Study|Adverse Event|4|||
47035679|NCT01907815|83286801|FG000|Overall Study|Withdrawal by Subject|1|||
46913455|NCT03201419|83143757|FG000|Overall Study|Adverse Event|3|||
46913456|NCT03201419|83143758|FG001|Overall Study|Adverse Event|1|||
47035680|NCT01907815|83286802|FG001|Overall Study|Withdrawal by Subject|0|||
46913457|NCT03201419|83143759|FG002|Overall Study|Adverse Event|0|||
46913458|NCT03201419|83143760|FG003|Overall Study|Adverse Event|0|||
46913459|NCT03201419|83143761|FG004|Overall Study|Adverse Event|1|||
46913460|NCT03201419|83143762|FG005|Overall Study|Adverse Event|1|||
46913461|NCT03201419|83143763|FG006|Overall Study|Adverse Event|5|||
46913462|NCT03201419|83143764|FG007|Overall Study|Adverse Event|0|||
46913463|NCT03201419|83143765|FG008|Overall Study|Adverse Event|0|||
46913464|NCT03201419|83143757|FG000|Overall Study|Lost to Follow-up|1|||
46913465|NCT03201419|83143758|FG001|Overall Study|Lost to Follow-up|0|||
46913466|NCT03201419|83143759|FG002|Overall Study|Lost to Follow-up|0|||
47035681|NCT01548573|83286810|FG000|Overall Study|Death|3|||
47035682|NCT01548573|83286810|FG000|Overall Study|Withdrawal by Subject|2|||
47035683|NCT01907737|83286815|FG000|Overall Study|Withdrawal by Subject|1|||
47035684|NCT01570491|83286827|FG000|Overall Study|Lost to Follow-up|3|||
47035685|NCT01570491|83286828|FG001|Overall Study|Lost to Follow-up|1|||
47035686|NCT01570491|83286827|FG000|Overall Study|treatment: not given or discontinued|2|||
47035687|NCT01570491|83286828|FG001|Overall Study|treatment: not given or discontinued|0|||
47035688|NCT01929109|83286839|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
47035689|NCT01929109|83286840|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
47035690|NCT01929109|83286841|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
46629740|NCT01999218|82800688|FG002|Overall Study|Physician Decision|6|||
46913467|NCT03201419|83143760|FG003|Overall Study|Lost to Follow-up|0|||
46913468|NCT03201419|83143761|FG004|Overall Study|Lost to Follow-up|0|||
46913469|NCT03201419|83143762|FG005|Overall Study|Lost to Follow-up|0|||
46913470|NCT03201419|83143763|FG006|Overall Study|Lost to Follow-up|0|||
46913471|NCT03201419|83143764|FG007|Overall Study|Lost to Follow-up|0|||
46913472|NCT03201419|83143765|FG008|Overall Study|Lost to Follow-up|0|||
46913473|NCT03201419|83143757|FG000|Overall Study|Protocol Deviation|0|||
46913474|NCT03201419|83143758|FG001|Overall Study|Protocol Deviation|0|||
46913475|NCT03201419|83143759|FG002|Overall Study|Protocol Deviation|0|||
46913476|NCT03201419|83143760|FG003|Overall Study|Protocol Deviation|0|||
46913477|NCT03201419|83143761|FG004|Overall Study|Protocol Deviation|0|||
46913478|NCT03201419|83143762|FG005|Overall Study|Protocol Deviation|0|||
46913479|NCT03201419|83143763|FG006|Overall Study|Protocol Deviation|1|||
46913480|NCT03201419|83143764|FG007|Overall Study|Protocol Deviation|0|||
46913481|NCT03201419|83143765|FG008|Overall Study|Protocol Deviation|0|||
46913482|NCT03201419|83143757|FG000|Overall Study|Withdrawal by Subject|4|||
46913483|NCT03201419|83143758|FG001|Overall Study|Withdrawal by Subject|2|||
46913484|NCT03201419|83143759|FG002|Overall Study|Withdrawal by Subject|1|||
46913485|NCT03201419|83143760|FG003|Overall Study|Withdrawal by Subject|0|||
46913486|NCT03201419|83143761|FG004|Overall Study|Withdrawal by Subject|0|||
46913487|NCT03201419|83143762|FG005|Overall Study|Withdrawal by Subject|0|||
46913488|NCT03201419|83143763|FG006|Overall Study|Withdrawal by Subject|0|||
46913489|NCT03201419|83143764|FG007|Overall Study|Withdrawal by Subject|1|||
46913490|NCT03201419|83143765|FG008|Overall Study|Withdrawal by Subject|2|||
46913491|NCT03201419|83143757|FG000|Overall Study|Other|0|||
46913492|NCT03201419|83143758|FG001|Overall Study|Other|0|||
46913493|NCT03201419|83143759|FG002|Overall Study|Other|1|||
46913494|NCT03201419|83143760|FG003|Overall Study|Other|0|||
47035691|NCT01929109|83286842|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
46629741|NCT01999218|82800686|FG000|Overall Study|Protocol Violation|4|||
46711399|NCT01212770|82927821|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
46913495|NCT03201419|83143761|FG004|Overall Study|Other|0|||
46913496|NCT03201419|83143762|FG005|Overall Study|Other|0|||
46913497|NCT03201419|83143763|FG006|Overall Study|Other|0|||
46913498|NCT03201419|83143764|FG007|Overall Study|Other|0|||
47035692|NCT01929109|83286843|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
47035693|NCT01518153|83286858|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
47035694|NCT01518153|83286859|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
46913499|NCT03201419|83143765|FG008|Overall Study|Other|0|||
46913500|NCT02924389|83143801|FG000|Overall Study|Lost to Follow-up|1|||
46913501|NCT02924389|83143802|FG001|Overall Study|Lost to Follow-up|0|||
46913502|NCT02924389|83143801|FG000|Overall Study|Physician Decision|2|||
46913503|NCT02924389|83143802|FG001|Overall Study|Physician Decision|0|||
46913504|NCT02924389|83143801|FG000|Overall Study|Withdrawal by Subject|3|||
46913505|NCT02924389|83143802|FG001|Overall Study|Withdrawal by Subject|0|||
46913506|NCT02924389|83143801|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
46913507|NCT02924389|83143802|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
46913508|NCT03235349|83143809|FG000|Overall Study|Adverse Event|1|||
46913509|NCT03235349|83143809|FG000|Overall Study|Other|1|||
46913510|NCT03235115|83143813|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
46913511|NCT03235115|83143814|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
46913512|NCT03235115|83143815|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
46913513|NCT03235115|83143816|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
46913514|NCT03235115|83143817|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
46913515|NCT03235115|83143818|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
46913516|NCT02923531|83143826|FG000|Overall Study|Adverse Event|4|||
46913517|NCT02923531|83143826|FG000|Overall Study|Clinical Deterioration|1|||
46913518|NCT02923531|83143826|FG000|Overall Study|Disease Progression|3|||
46913519|NCT02923531|83143826|FG000|Overall Study|Study Termination|1|||
46913520|NCT02934503|83143831|FG000|Overall Study|progression of disease|3|||
46913521|NCT02934503|83143831|FG000|Overall Study|Withdrawal by Subject|1|||
46913522|NCT02937545|83143837|FG000|Overall Study|Withdrawal by Subject|1|||
46913523|NCT02937545|83143838|FG001|Overall Study|Withdrawal by Subject|2|||
46913524|NCT02937545|83143839|FG002|Overall Study|Withdrawal by Subject|6|||
46913525|NCT02937545|83143840|FG003|Overall Study|Withdrawal by Subject|7|||
46913526|NCT02937545|83143837|FG000|Overall Study|Lost to Follow-up|1|||
46913527|NCT02937545|83143838|FG001|Overall Study|Lost to Follow-up|0|||
46913528|NCT02937545|83143839|FG002|Overall Study|Lost to Follow-up|0|||
46913529|NCT02937545|83143840|FG003|Overall Study|Lost to Follow-up|0|||
46913530|NCT03199391|83143851|FG000|Overall Study|Death|1|||
46913531|NCT03199391|83143851|FG000|Overall Study|Lost to Follow-up|3|||
46913532|NCT03199391|83143851|FG000|Overall Study|Adverse Event|2|||
46913533|NCT03199391|83143851|FG000|Overall Study|Withdrawal by Subject|10|||
47035695|NCT01518153|83286860|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
47035696|NCT01518153|83286858|FG000|Stem Cell Transplant|Death|2|||
47035697|NCT01518153|83286859|FG001|Stem Cell Transplant|Death|0|||
47035698|NCT01518153|83286860|FG002|Stem Cell Transplant|Death|0|||
47035699|NCT01518153|83286858|FG000|Stem Cell Transplant|Secondary graft failure|1|||
47035700|NCT01518153|83286859|FG001|Stem Cell Transplant|Secondary graft failure|0|||
47035701|NCT01518153|83286860|FG002|Stem Cell Transplant|Secondary graft failure|0|||
47035702|NCT01518153|83286858|FG000|Stem Cell Transplant|Adverse Event|1|||
47035703|NCT01518153|83286859|FG001|Stem Cell Transplant|Adverse Event|0|||
47035704|NCT01518153|83286860|FG002|Stem Cell Transplant|Adverse Event|0|||
47035705|NCT01518153|83286858|FG000|Donor Lymphocyte Infusion|Death|0|||
47035706|NCT01518153|83286859|FG001|Donor Lymphocyte Infusion|Death|2|||
47035707|NCT01518153|83286860|FG002|Donor Lymphocyte Infusion|Death|1|||
47035708|NCT01906489|83286870|FG000|Overall Study|Adverse Event|10|||
47035709|NCT01906489|83286871|FG001|Overall Study|Adverse Event|3|||
47035710|NCT01906489|83286870|FG000|Overall Study|Worsening of CKD|6|||
47035711|NCT01906489|83286871|FG001|Overall Study|Worsening of CKD|4|||
47035712|NCT01906489|83286870|FG000|Overall Study|Withdrawal by Subject|5|||
47035713|NCT01906489|83286871|FG001|Overall Study|Withdrawal by Subject|0|||
47035714|NCT01906489|83286870|FG000|Overall Study|Worsening of Anemia|1|||
46629742|NCT01999218|82800687|FG001|Overall Study|Protocol Violation|5|||
46629743|NCT01999218|82800688|FG002|Overall Study|Protocol Violation|4|||
46629744|NCT01999218|82800686|FG000|Overall Study|Screen failure|0|||
46629745|NCT01999218|82800687|FG001|Overall Study|Screen failure|1|||
46629746|NCT01999218|82800688|FG002|Overall Study|Screen failure|0|||
46629747|NCT01999218|82800686|FG000|Overall Study|Study Terminated By Sponsor|7|||
46711400|NCT01212770|82927822|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
46711401|NCT01212770|82927823|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
46711402|NCT01212770|82927824|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
46913534|NCT03198767|83143862|FG000|Overall Study|Protocol Violation|0|||
46913535|NCT03198767|83143863|FG001|Overall Study|Protocol Violation|0|||
46913536|NCT03198767|83143864|FG002|Overall Study|Protocol Violation|0|||
46913537|NCT03198767|83143865|FG003|Overall Study|Protocol Violation|6|||
46913538|NCT03198767|83143866|FG004|Overall Study|Protocol Violation|0|||
46913539|NCT03198767|83143867|FG005|Overall Study|Protocol Violation|0|||
47035715|NCT01906489|83286871|FG001|Overall Study|Worsening of Anemia|0|||
47035716|NCT01906489|83286870|FG000|Overall Study|Protocol Violation|0|||
47035717|NCT01906489|83286871|FG001|Overall Study|Protocol Violation|1|||
46629748|NCT01999218|82800687|FG001|Overall Study|Study Terminated By Sponsor|5|||
46629749|NCT01999218|82800688|FG002|Overall Study|Study Terminated By Sponsor|12|||
47035718|NCT01906489|83286870|FG000|Overall Study|Non- Compliance|1|||
47035719|NCT01906489|83286871|FG001|Overall Study|Non- Compliance|0|||
47035720|NCT01906489|83286870|FG000|Overall Study|Sponsor Decision|1|||
47035721|NCT01906489|83286871|FG001|Overall Study|Sponsor Decision|0|||
47035722|NCT01906489|83286870|FG000|Overall Study|Lost to Follow-up|1|||
47035723|NCT01906489|83286871|FG001|Overall Study|Lost to Follow-up|1|||
47035724|NCT01906489|83286870|FG000|Overall Study|Other|1|||
47035725|NCT01906489|83286871|FG001|Overall Study|Other|0|||
47035726|NCT01517373|83286882|FG000|Run-in Period|Death|1|||
47035727|NCT01517373|83286883|FG001|Run-in Period|Death|0|||
47035728|NCT01517373|83286884|FG002|Run-in Period|Death|0|||
47035729|NCT01517373|83286885|FG003|Run-in Period|Death|0|||
47035730|NCT01517373|83286886|FG004|Run-in Period|Death|0|||
47035731|NCT01517373|83286887|FG005|Run-in Period|Death|0|||
47035732|NCT01517373|83286882|FG000|Run-in Period|Adverse Event|5|||
47035733|NCT01517373|83286883|FG001|Run-in Period|Adverse Event|0|||
47035734|NCT01517373|83286884|FG002|Run-in Period|Adverse Event|0|||
47035735|NCT01517373|83286885|FG003|Run-in Period|Adverse Event|0|||
47035736|NCT01517373|83286886|FG004|Run-in Period|Adverse Event|0|||
47035737|NCT01517373|83286887|FG005|Run-in Period|Adverse Event|0|||
47035738|NCT01517373|83286882|FG000|Run-in Period|Did not meet eligibility criteria|34|||
47035739|NCT01517373|83286883|FG001|Run-in Period|Did not meet eligibility criteria|0|||
47035740|NCT01517373|83286884|FG002|Run-in Period|Did not meet eligibility criteria|0|||
47035741|NCT01517373|83286885|FG003|Run-in Period|Did not meet eligibility criteria|0|||
47035742|NCT01517373|83286886|FG004|Run-in Period|Did not meet eligibility criteria|0|||
47035743|NCT01517373|83286887|FG005|Run-in Period|Did not meet eligibility criteria|0|||
47035744|NCT01517373|83286882|FG000|Run-in Period|Lost to Follow-up|1|||
47035745|NCT01517373|83286883|FG001|Run-in Period|Lost to Follow-up|0|||
47035746|NCT01517373|83286884|FG002|Run-in Period|Lost to Follow-up|0|||
47035747|NCT01517373|83286885|FG003|Run-in Period|Lost to Follow-up|0|||
47035748|NCT01517373|83286886|FG004|Run-in Period|Lost to Follow-up|0|||
47035749|NCT01517373|83286887|FG005|Run-in Period|Lost to Follow-up|0|||
46913540|NCT03198767|83143868|FG006|Overall Study|Protocol Violation|0|||
46913541|NCT03162055|83143885|FG000|Overall Study|Adverse Event|6|||
46913542|NCT03162055|83143886|FG001|Overall Study|Adverse Event|5|||
46913543|NCT03162055|83143885|FG000|Overall Study|Death|3|||
46913544|NCT03162055|83143886|FG001|Overall Study|Death|3|||
46913545|NCT03162055|83143885|FG000|Overall Study|Lost to Follow-up|0|||
46913546|NCT03162055|83143886|FG001|Overall Study|Lost to Follow-up|1|||
46913547|NCT03162055|83143885|FG000|Overall Study|Study-specific withdrawal criteria|22|||
46913548|NCT03162055|83143886|FG001|Overall Study|Study-specific withdrawal criteria|14|||
46913549|NCT03162055|83143885|FG000|Overall Study|Withdrawal by Subject|17|||
46913550|NCT03162055|83143886|FG001|Overall Study|Withdrawal by Subject|2|||
46913551|NCT03162055|83143885|FG000|Overall Study|Did not receive treatment|2|||
46913552|NCT03162055|83143886|FG001|Overall Study|Did not receive treatment|0|||
46913553|NCT03162055|83143885|FG000|Overall Study|Incorrect randomization|4|||
46913554|NCT03162055|83143886|FG001|Overall Study|Incorrect randomization|3|||
46913555|NCT03162055|83143885|FG000|Overall Study|Other|8|||
46913556|NCT03162055|83143886|FG001|Overall Study|Other|15|||
46913557|NCT02927145|83143899|FG000|Initial Recruitment|Withdrawal by Subject|0|||
46913558|NCT02927145|83143900|FG001|Initial Recruitment|Withdrawal by Subject|1|||
46913559|NCT02927145|83143901|FG002|Initial Recruitment|Withdrawal by Subject|1|||
46913560|NCT02927145|83143902|FG003|Initial Recruitment|Withdrawal by Subject|4|||
46913561|NCT02927145|83143903|FG004|Initial Recruitment|Withdrawal by Subject|1|||
46913562|NCT02927145|83143904|FG005|Initial Recruitment|Withdrawal by Subject|1|||
46913563|NCT02927145|83143905|FG006|Initial Recruitment|Withdrawal by Subject|0|||
46913564|NCT02927145|83143906|FG007|Initial Recruitment|Withdrawal by Subject|0|||
46913565|NCT02927145|83143907|FG008|Initial Recruitment|Withdrawal by Subject|2|||
46913566|NCT02927145|83143899|FG000|Initial Recruitment|Adverse Event|0|||
46913567|NCT02927145|83143900|FG001|Initial Recruitment|Adverse Event|0|||
46913568|NCT02927145|83143901|FG002|Initial Recruitment|Adverse Event|0|||
46913569|NCT02927145|83143902|FG003|Initial Recruitment|Adverse Event|0|||
46913570|NCT02927145|83143903|FG004|Initial Recruitment|Adverse Event|2|||
46913571|NCT02927145|83143904|FG005|Initial Recruitment|Adverse Event|0|||
47035750|NCT01517373|83286882|FG000|Run-in Period|Withdrawal by Subject|12|||
46913572|NCT02927145|83143905|FG006|Initial Recruitment|Adverse Event|0|||
46913573|NCT02927145|83143906|FG007|Initial Recruitment|Adverse Event|0|||
46913574|NCT02927145|83143907|FG008|Initial Recruitment|Adverse Event|0|||
46629750|NCT01999218|82800686|FG000|Overall Study|Participant moves|2|||
46913575|NCT02927145|83143899|FG000|Invitation for Additional Challenge|Pregnancy|0|||
46913576|NCT02927145|83143900|FG001|Invitation for Additional Challenge|Pregnancy|0|||
47035751|NCT01517373|83286883|FG001|Run-in Period|Withdrawal by Subject|0|||
47035752|NCT01517373|83286884|FG002|Run-in Period|Withdrawal by Subject|0|||
47035753|NCT01517373|83286885|FG003|Run-in Period|Withdrawal by Subject|0|||
47035754|NCT01517373|83286886|FG004|Run-in Period|Withdrawal by Subject|0|||
47035755|NCT01517373|83286887|FG005|Run-in Period|Withdrawal by Subject|0|||
47035756|NCT01517373|83286882|FG000|Run-in Period|Sponsor Decision|3|||
47035757|NCT01517373|83286883|FG001|Run-in Period|Sponsor Decision|0|||
47035758|NCT01517373|83286884|FG002|Run-in Period|Sponsor Decision|0|||
46913577|NCT02927145|83143901|FG002|Invitation for Additional Challenge|Pregnancy|0|||
46913578|NCT02927145|83143902|FG003|Invitation for Additional Challenge|Pregnancy|0|||
46913579|NCT02927145|83143903|FG004|Invitation for Additional Challenge|Pregnancy|0|||
46913580|NCT02927145|83143904|FG005|Invitation for Additional Challenge|Pregnancy|0|||
46913581|NCT02927145|83143905|FG006|Invitation for Additional Challenge|Pregnancy|1|||
46913582|NCT02927145|83143906|FG007|Invitation for Additional Challenge|Pregnancy|0|||
46913583|NCT02927145|83143907|FG008|Invitation for Additional Challenge|Pregnancy|0|||
46913584|NCT03688919|83143930|FG000|Overall Study|Lost to Follow-up|2|||
46913585|NCT03688919|83143931|FG001|Overall Study|Lost to Follow-up|1|||
46913586|NCT03688919|83143930|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
46913587|NCT03688919|83143931|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
46913588|NCT02888119|83143954|FG000|Overall Study|Lost to Follow-up|5|||
46913589|NCT02888119|83143955|FG001|Overall Study|Lost to Follow-up|4|||
46913590|NCT02888119|83143956|FG002|Overall Study|Lost to Follow-up|0|||
46913591|NCT03197129|83143965|FG000|Overall Study|did not answer the VPT: shyness|4|||
46913592|NCT03197129|83143966|FG001|Overall Study|did not answer the VPT: shyness|5|||
46913593|NCT03196973|83143975|FG000|Overall Study|Adverse Event|1|||
46913594|NCT03196973|83143976|FG001|Overall Study|Adverse Event|1|||
46913595|NCT03196973|83143977|FG002|Overall Study|Adverse Event|2|||
46913596|NCT03196973|83143975|FG000|Overall Study|Lack of Efficacy|2|||
46913597|NCT03196973|83143976|FG001|Overall Study|Lack of Efficacy|6|||
46913598|NCT03196973|83143977|FG002|Overall Study|Lack of Efficacy|1|||
46913599|NCT03196973|83143975|FG000|Overall Study|Lost to Follow-up|4|||
46913600|NCT03196973|83143976|FG001|Overall Study|Lost to Follow-up|3|||
46913601|NCT03196973|83143977|FG002|Overall Study|Lost to Follow-up|2|||
46913602|NCT03196973|83143975|FG000|Overall Study|Consent withdrawn|2|||
46913603|NCT03196973|83143976|FG001|Overall Study|Consent withdrawn|1|||
46913604|NCT03196973|83143977|FG002|Overall Study|Consent withdrawn|0|||
46913605|NCT03196973|83143975|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
46913606|NCT03196973|83143976|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
46913607|NCT03196973|83143977|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
46913608|NCT03196505|83143987|FG000|Overall Study|Physician Decision|26|||
46913609|NCT03196505|83143988|FG001|Overall Study|Physician Decision|26|||
46913610|NCT03196349|83143997|FG000|Overall Study|Did not receive study drug|0|||
46913611|NCT03196349|83143998|FG001|Overall Study|Did not receive study drug|1|||
46913612|NCT03196349|83143999|FG002|Overall Study|Did not receive study drug|2|||
46913613|NCT03196349|83143997|FG000|Overall Study|No data entered|2|||
46913614|NCT03196349|83143998|FG001|Overall Study|No data entered|4|||
46913615|NCT03196349|83143999|FG002|Overall Study|No data entered|0|||
46913616|NCT03196349|83143997|FG000|Overall Study|Study Terminated early|15|||
46913617|NCT03196349|83143998|FG001|Overall Study|Study Terminated early|9|||
46913618|NCT03196349|83143999|FG002|Overall Study|Study Terminated early|11|||
46913619|NCT02886715|83144010|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46913620|NCT02886715|83144011|FG001|Overall Study|Non-Compliance With Study Drug|2|||
46913621|NCT02886715|83144012|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46913622|NCT02886715|83144010|FG000|Overall Study|Adverse Event|4|||
46913623|NCT02886715|83144011|FG001|Overall Study|Adverse Event|2|||
46913624|NCT02886715|83144012|FG002|Overall Study|Adverse Event|0|||
46913625|NCT02886715|83144010|FG000|Overall Study|Lack of Efficacy|0|||
46913626|NCT02886715|83144011|FG001|Overall Study|Lack of Efficacy|2|||
46913627|NCT02886715|83144012|FG002|Overall Study|Lack of Efficacy|1|||
46913628|NCT02886715|83144010|FG000|Overall Study|Lost to Follow-up|29|||
46913629|NCT02886715|83144011|FG001|Overall Study|Lost to Follow-up|26|||
46913630|NCT02886715|83144012|FG002|Overall Study|Lost to Follow-up|10|||
46913631|NCT02886715|83144010|FG000|Overall Study|Pregnancy|1|||
46913632|NCT02886715|83144011|FG001|Overall Study|Pregnancy|1|||
46913633|NCT02886715|83144012|FG002|Overall Study|Pregnancy|1|||
46629751|NCT01999218|82800687|FG001|Overall Study|Participant moves|5|||
46629752|NCT01999218|82800688|FG002|Overall Study|Participant moves|3|||
46629753|NCT01999218|82800686|FG000|Overall Study|Withdrawal by Subject|28|||
46629754|NCT01999218|82800687|FG001|Overall Study|Withdrawal by Subject|29|||
46629755|NCT01999218|82800688|FG002|Overall Study|Withdrawal by Subject|34|||
46629756|NCT01999218|82800686|FG000|Overall Study|Creatinine/eGFR|0|||
46913634|NCT02886715|83144010|FG000|Overall Study|Protocol Violation|3|||
46711403|NCT01212770|82927825|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
46913635|NCT02886715|83144011|FG001|Overall Study|Protocol Violation|2|||
46913636|NCT02886715|83144012|FG002|Overall Study|Protocol Violation|1|||
46629757|NCT01999218|82800687|FG001|Overall Study|Creatinine/eGFR|0|||
46629758|NCT01999218|82800688|FG002|Overall Study|Creatinine/eGFR|1|||
46913637|NCT02886715|83144010|FG000|Overall Study|Withdrawal by Subject|20|||
46913638|NCT02886715|83144011|FG001|Overall Study|Withdrawal by Subject|18|||
46913639|NCT02886715|83144012|FG002|Overall Study|Withdrawal by Subject|5|||
46913640|NCT02886715|83144010|FG000|Overall Study|missing|7|||
46913641|NCT02886715|83144011|FG001|Overall Study|missing|2|||
46913642|NCT02886715|83144012|FG002|Overall Study|missing|2|||
46913643|NCT03085797|83144022|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
46913644|NCT03085797|83144023|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
46913645|NCT03085797|83144022|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
46913646|NCT03085797|83144023|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
46913647|NCT03085797|83144022|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
46913648|NCT03085797|83144023|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
46913649|NCT03157531|83144031|FG000|Overall Study|Death|2|||
46913650|NCT03157531|83144031|FG000|Overall Study|Lost to Follow-up|4|||
46913651|NCT03159091|83144037|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
46913652|NCT03159091|83144038|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
46913653|NCT03159091|83144037|FG000|Overall Study|Patient has taken no dose of study drug|0|||
46913654|NCT03159091|83144038|FG001|Overall Study|Patient has taken no dose of study drug|1|||
46913655|NCT03196193|83144046|FG000|Overall Study|Adverse Event|1|||
46913656|NCT03196193|83144047|FG001|Overall Study|Adverse Event|0|||
46913657|NCT03196193|83144046|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
46913658|NCT03196193|83144047|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
46913659|NCT03621761|83144056|FG000|Overall Study|Lost to Follow-up|1|||
46913660|NCT03621761|83144057|FG001|Overall Study|Lost to Follow-up|1|||
46913661|NCT03621761|83144058|FG002|Overall Study|Lost to Follow-up|2|||
46913662|NCT03621761|83144056|FG000|Overall Study|Withdrawal by Subject|2|||
46913663|NCT03621761|83144057|FG001|Overall Study|Withdrawal by Subject|1|||
46913664|NCT03621761|83144058|FG002|Overall Study|Withdrawal by Subject|1|||
46913665|NCT03621761|83144056|FG000|Overall Study|Became Ineligible|0|||
46913666|NCT03621761|83144057|FG001|Overall Study|Became Ineligible|2|||
46913667|NCT03621761|83144058|FG002|Overall Study|Became Ineligible|0|||
46913668|NCT03221387|83144066|FG000|Overall Study|Lost to Follow-up|1|||
46913669|NCT03221387|83144066|FG000|Overall Study|Lung transplant|1|||
46913670|NCT03318861|83144075|FG000|Overall Study|Death|2|||
46913671|NCT03318861|83144076|FG001|Overall Study|Death|3|||
46913672|NCT03318861|83144077|FG002|Overall Study|Death|3|||
46913673|NCT03318861|83144078|FG003|Overall Study|Death|2|||
46913674|NCT03318861|83144079|FG004|Overall Study|Death|2|||
46913675|NCT03318861|83144075|FG000|Overall Study|Enrolled But Never Treated|0|||
46913676|NCT03318861|83144076|FG001|Overall Study|Enrolled But Never Treated|1|||
46913677|NCT03318861|83144077|FG002|Overall Study|Enrolled But Never Treated|0|||
46913678|NCT03318861|83144078|FG003|Overall Study|Enrolled But Never Treated|1|||
46913679|NCT03318861|83144079|FG004|Overall Study|Enrolled But Never Treated|1|||
46913680|NCT03318861|83144075|FG000|Overall Study|Informed Consent Withdraw|0|||
46913681|NCT03318861|83144076|FG001|Overall Study|Informed Consent Withdraw|0|||
46913682|NCT03318861|83144077|FG002|Overall Study|Informed Consent Withdraw|0|||
46913683|NCT03318861|83144078|FG003|Overall Study|Informed Consent Withdraw|1|||
46913684|NCT03318861|83144079|FG004|Overall Study|Informed Consent Withdraw|0|||
46913685|NCT03318861|83144075|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
46913686|NCT03318861|83144076|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
47035759|NCT01517373|83286885|FG003|Run-in Period|Sponsor Decision|0|||
47035760|NCT01517373|83286886|FG004|Run-in Period|Sponsor Decision|0|||
47035761|NCT01517373|83286887|FG005|Run-in Period|Sponsor Decision|0|||
47035762|NCT01517373|83286882|FG000|Run-in Period|Other|1|||
47035763|NCT01517373|83286883|FG001|Run-in Period|Other|0|||
47035764|NCT01517373|83286884|FG002|Run-in Period|Other|0|||
47035765|NCT01517373|83286885|FG003|Run-in Period|Other|0|||
47035766|NCT01517373|83286886|FG004|Run-in Period|Other|0|||
47035767|NCT01517373|83286887|FG005|Run-in Period|Other|0|||
47035768|NCT01517373|83286882|FG000|Treatment Period|Adverse Event|0|||
47035769|NCT01517373|83286883|FG001|Treatment Period|Adverse Event|0|||
47035770|NCT01517373|83286884|FG002|Treatment Period|Adverse Event|0|||
47035771|NCT01517373|83286885|FG003|Treatment Period|Adverse Event|0|||
47035772|NCT01517373|83286886|FG004|Treatment Period|Adverse Event|0|||
46629759|NCT01999218|82800686|FG000|Overall Study|Death|7|||
46629760|NCT01999218|82800687|FG001|Overall Study|Death|1|||
46629761|NCT01999218|82800688|FG002|Overall Study|Death|2|||
46629762|NCT01999218|82800686|FG000|Overall Study|Excluded Medication|1|||
46629763|NCT01999218|82800687|FG001|Overall Study|Excluded Medication|1|||
46711404|NCT01212770|82927826|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
46913687|NCT03318861|83144077|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
47035773|NCT01517373|83286887|FG005|Treatment Period|Adverse Event|2|||
47035774|NCT01517373|83286882|FG000|Treatment Period|Lost to Follow-up|0|||
47035775|NCT01517373|83286883|FG001|Treatment Period|Lost to Follow-up|0|||
46629764|NCT01999218|82800688|FG002|Overall Study|Excluded Medication|2|||
46629765|NCT01999218|82800686|FG000|Overall Study|Adverse Event|9|||
46913688|NCT03318861|83144078|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
46913689|NCT03318861|83144079|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
46913690|NCT03084315|83144094|FG000|Overall Study|Lost to Follow-up|8|||
46913691|NCT03084315|83144095|FG001|Overall Study|Lost to Follow-up|7|||
46913692|NCT03084315|83144094|FG000|Overall Study|Withdrawal by Subject|2|||
47035776|NCT01517373|83286884|FG002|Treatment Period|Lost to Follow-up|1|||
47035777|NCT01517373|83286885|FG003|Treatment Period|Lost to Follow-up|1|||
47035778|NCT01517373|83286886|FG004|Treatment Period|Lost to Follow-up|0|||
47035779|NCT01517373|83286887|FG005|Treatment Period|Lost to Follow-up|0|||
47035780|NCT01517373|83286882|FG000|Treatment Period|Withdrawal by Subject|0|||
47035781|NCT01517373|83286883|FG001|Treatment Period|Withdrawal by Subject|3|||
47035782|NCT01517373|83286884|FG002|Treatment Period|Withdrawal by Subject|2|||
47035783|NCT01517373|83286885|FG003|Treatment Period|Withdrawal by Subject|2|||
47035784|NCT01517373|83286886|FG004|Treatment Period|Withdrawal by Subject|2|||
47035785|NCT01517373|83286887|FG005|Treatment Period|Withdrawal by Subject|3|||
47035786|NCT01517373|83286882|FG000|Treatment Period|Other|0|||
47035787|NCT01517373|83286883|FG001|Treatment Period|Other|0|||
47035788|NCT01517373|83286884|FG002|Treatment Period|Other|0|||
47035789|NCT01517373|83286885|FG003|Treatment Period|Other|0|||
47035790|NCT01517373|83286886|FG004|Treatment Period|Other|1|||
47035791|NCT01517373|83286887|FG005|Treatment Period|Other|0|||
47035792|NCT01517373|83286882|FG000|Treatment Period|Protocol Violation|0|||
47035793|NCT01517373|83286883|FG001|Treatment Period|Protocol Violation|0|||
47035794|NCT01517373|83286884|FG002|Treatment Period|Protocol Violation|0|||
47035795|NCT01517373|83286885|FG003|Treatment Period|Protocol Violation|0|||
47035796|NCT01517373|83286886|FG004|Treatment Period|Protocol Violation|1|||
47035797|NCT01517373|83286887|FG005|Treatment Period|Protocol Violation|0|||
46629766|NCT01999218|82800687|FG001|Overall Study|Adverse Event|7|||
46629767|NCT01999218|82800688|FG002|Overall Study|Adverse Event|7|||
46629768|NCT01999218|82800686|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
46711405|NCT01212770|82927827|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
46711406|NCT01212770|82927828|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
46711407|NCT01212770|82927829|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
46711408|NCT01212770|82927821|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711409|NCT01212770|82927822|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711410|NCT01212770|82927823|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
46711411|NCT01212770|82927824|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711412|NCT01212770|82927825|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711413|NCT01212770|82927826|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711414|NCT01212770|82927827|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711415|NCT01212770|82927828|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711416|NCT01212770|82927829|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
46711417|NCT01212770|82927821|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
46711418|NCT01212770|82927822|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
46629769|NCT01999218|82800687|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
46629770|NCT01999218|82800688|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
46629771|NCT01937130|82800700|FG000|Overall Study|Withdrawal by Subject|0|||
46629772|NCT01937130|82800701|FG001|Overall Study|Withdrawal by Subject|0|||
46629773|NCT01937130|82800702|FG002|Overall Study|Withdrawal by Subject|0|||
46629774|NCT01937130|82800703|FG003|Overall Study|Withdrawal by Subject|1|||
46629775|NCT01937130|82800700|FG000|Overall Study|Adverse Event|0|||
46629776|NCT01937130|82800701|FG001|Overall Study|Adverse Event|1|||
46629777|NCT01937130|82800702|FG002|Overall Study|Adverse Event|0|||
46629778|NCT01937130|82800703|FG003|Overall Study|Adverse Event|1|||
46629779|NCT01937130|82800700|FG000|Overall Study|Death|1|||
46629780|NCT01937130|82800701|FG001|Overall Study|Death|1|||
46629781|NCT01937130|82800702|FG002|Overall Study|Death|1|||
46629782|NCT01937130|82800703|FG003|Overall Study|Death|0|||
46629783|NCT01937130|82800700|FG000|Overall Study|Lost to Follow-up|2|||
46629784|NCT01937130|82800701|FG001|Overall Study|Lost to Follow-up|0|||
46629785|NCT01937130|82800702|FG002|Overall Study|Lost to Follow-up|2|||
46629786|NCT01937130|82800703|FG003|Overall Study|Lost to Follow-up|0|||
46629787|NCT01937130|82800700|FG000|Overall Study|Physician Decision|0|||
46629788|NCT01937130|82800701|FG001|Overall Study|Physician Decision|1|||
46629789|NCT01937130|82800702|FG002|Overall Study|Physician Decision|0|||
46629790|NCT01937130|82800703|FG003|Overall Study|Physician Decision|0|||
46629791|NCT01937130|82800700|FG000|Overall Study|Patients unable to swallow|0|||
46629792|NCT01937130|82800701|FG001|Overall Study|Patients unable to swallow|1|||
46629793|NCT01937130|82800702|FG002|Overall Study|Patients unable to swallow|0|||
46629794|NCT01937130|82800703|FG003|Overall Study|Patients unable to swallow|0|||
47035798|NCT01517373|83286882|FG000|Treatment Period|Lack of Efficacy|0|||
46629795|NCT01937130|82800700|FG000|Overall Study|Patient lost to FU due to death|2|||
46711419|NCT01212770|82927823|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
46711420|NCT01212770|82927824|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
47035799|NCT01517373|83286883|FG001|Treatment Period|Lack of Efficacy|1|||
47035800|NCT01517373|83286884|FG002|Treatment Period|Lack of Efficacy|1|||
47035801|NCT01517373|83286885|FG003|Treatment Period|Lack of Efficacy|3|||
46629796|NCT01937130|82800701|FG001|Overall Study|Patient lost to FU due to death|0|||
46629797|NCT01937130|82800702|FG002|Overall Study|Patient lost to FU due to death|0|||
46629798|NCT01937130|82800703|FG003|Overall Study|Patient lost to FU due to death|0|||
46629799|NCT01936974|82800715|FG000|Overall Study|Physician Decision|2|||
46629800|NCT01936974|82800716|FG001|Overall Study|Physician Decision|5|||
47035802|NCT01517373|83286886|FG004|Treatment Period|Lack of Efficacy|2|||
47035803|NCT01517373|83286887|FG005|Treatment Period|Lack of Efficacy|0|||
47035804|NCT01517373|83286882|FG000|Treatment Period|Medication error without AEs|0|||
47035805|NCT01517373|83286883|FG001|Treatment Period|Medication error without AEs|0|||
47035806|NCT01517373|83286884|FG002|Treatment Period|Medication error without AEs|2|||
47035807|NCT01517373|83286885|FG003|Treatment Period|Medication error without AEs|1|||
47035808|NCT01517373|83286886|FG004|Treatment Period|Medication error without AEs|0|||
47035809|NCT01517373|83286887|FG005|Treatment Period|Medication error without AEs|2|||
47035810|NCT01517295|83286902|FG000|Overall Study|Physician Decision|1|||
47035811|NCT01517295|83286903|FG001|Overall Study|Physician Decision|0|||
47035812|NCT01541865|83286909|FG000|Overall Study|Lost to Follow-up|11|||
47035813|NCT01541865|83286909|FG000|Overall Study|Withdrawal by Subject|9|||
47035814|NCT01541865|83286909|FG000|Overall Study|Adverse Event|1|||
47035815|NCT01541865|83286909|FG000|Overall Study|Protocol Violation|1|||
47035816|NCT01541397|83286915|FG000|Overall Study|Study ended prior to data collection|4|||
47035817|NCT01541397|83286916|FG001|Overall Study|Study ended prior to data collection|2|||
47035818|NCT01548417|83286924|FG000|Overall Study|Withdrawal by Subject|0|||
47035819|NCT01548417|83286925|FG001|Overall Study|Withdrawal by Subject|2|||
47035820|NCT01546857|83286933|FG000|Overall Study|Withdrawal by Subject|2|||
47035821|NCT01546857|83286934|FG001|Overall Study|Withdrawal by Subject|3|||
47035822|NCT01540851|83286943|FG000|Overall Study|Lost to Follow-up|14|||
47035823|NCT01540851|83286944|FG001|Overall Study|Lost to Follow-up|15|||
47035824|NCT01540851|83286943|FG000|Overall Study|Withdrawal by Subject|7|||
47035825|NCT01540851|83286944|FG001|Overall Study|Withdrawal by Subject|3|||
47035826|NCT01516749|83286952|FG000|Active Therapy|Lost to Follow-up|1|||
47035827|NCT01516749|83286952|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
47035828|NCT01516437|83286960|FG000|Overall Study|Reason not specified|0|||
47035829|NCT01516437|83286961|FG001|Overall Study|Reason not specified|0|||
47035830|NCT01516437|83286962|FG002|Overall Study|Reason not specified|1|||
47035831|NCT01516437|83286963|FG003|Overall Study|Reason not specified|1|||
47035832|NCT01515423|83286977|FG000|Open Label Phase|Adverse Event|57|||
47035833|NCT01515423|83286978|FG001|Open Label Phase|Adverse Event|0|||
47035834|NCT01515423|83286979|FG002|Open Label Phase|Adverse Event|0|||
47035835|NCT01515423|83286977|FG000|Open Label Phase|Death|2|||
47035836|NCT01515423|83286978|FG001|Open Label Phase|Death|0|||
47035837|NCT01515423|83286979|FG002|Open Label Phase|Death|0|||
47035838|NCT01515423|83286977|FG000|Open Label Phase|Lack of Efficacy|117|||
47035839|NCT01515423|83286978|FG001|Open Label Phase|Lack of Efficacy|0|||
47035840|NCT01515423|83286979|FG002|Open Label Phase|Lack of Efficacy|0|||
47035841|NCT01515423|83286977|FG000|Open Label Phase|Lost to Follow-up|21|||
47035842|NCT01515423|83286978|FG001|Open Label Phase|Lost to Follow-up|0|||
47035843|NCT01515423|83286979|FG002|Open Label Phase|Lost to Follow-up|0|||
47035844|NCT01515423|83286977|FG000|Open Label Phase|Withdrawal by Subject|118|||
47035845|NCT01515423|83286978|FG001|Open Label Phase|Withdrawal by Subject|0|||
47035846|NCT01515423|83286979|FG002|Open Label Phase|Withdrawal by Subject|0|||
47035847|NCT01515423|83286977|FG000|Open Label Phase|excluded from DB Phase|70|||
47035848|NCT01515423|83286978|FG001|Open Label Phase|excluded from DB Phase|0|||
47035849|NCT01515423|83286979|FG002|Open Label Phase|excluded from DB Phase|0|||
47035850|NCT01515423|83286977|FG000|Open Label Phase|Other|28|||
47035851|NCT01515423|83286978|FG001|Open Label Phase|Other|0|||
47035852|NCT01515423|83286979|FG002|Open Label Phase|Other|0|||
46629801|NCT01959516|82800722|FG000|Epoch 1|Adverse Event|4|||
46629802|NCT01959516|82800723|FG001|Epoch 1|Adverse Event|1|||
46629803|NCT01959516|82800722|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
46629804|NCT01959516|82800723|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
46629805|NCT01959516|82800722|FG000|Epoch 1|Subject withdrew consent|3|||
46629806|NCT01959516|82800723|FG001|Epoch 1|Subject withdrew consent|2|||
46629807|NCT01959516|82800722|FG000|Epoch 1|Administrative problems|1|||
46629808|NCT01959516|82800723|FG001|Epoch 1|Administrative problems|0|||
47035853|NCT01515423|83286977|FG000|DOUBLE BLIND|Adverse Event|0|||
47035854|NCT01515423|83286978|FG001|DOUBLE BLIND|Adverse Event|15|||
47035855|NCT01515423|83286979|FG002|DOUBLE BLIND|Adverse Event|13|||
47035856|NCT01515423|83286977|FG000|DOUBLE BLIND|Death|0|||
47035857|NCT01515423|83286978|FG001|DOUBLE BLIND|Death|1|||
47035858|NCT01515423|83286979|FG002|DOUBLE BLIND|Death|2|||
47035859|NCT01515423|83286977|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
47035860|NCT01515423|83286978|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
47035861|NCT01515423|83286979|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
47035862|NCT01515423|83286977|FG000|DOUBLE BLIND|Pregnancy|0|||
47035863|NCT01515423|83286978|FG001|DOUBLE BLIND|Pregnancy|2|||
47035864|NCT01515423|83286979|FG002|DOUBLE BLIND|Pregnancy|0|||
47035865|NCT01515423|83286977|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
46629809|NCT01959516|82800722|FG000|Epoch 1|Use of prohibited treatment|1|||
46629810|NCT01959516|82800723|FG001|Epoch 1|Use of prohibited treatment|0|||
46629811|NCT01959516|82800722|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
47035866|NCT01515423|83286978|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
47035867|NCT01515423|83286979|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
47035868|NCT01515423|83286977|FG000|DOUBLE BLIND|Other|0|||
47035869|NCT01515423|83286978|FG001|DOUBLE BLIND|Other|6|||
47035870|NCT01515423|83286979|FG002|DOUBLE BLIND|Other|12|||
47035871|NCT01515423|83286977|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
47035872|NCT01515423|83286978|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
47035873|NCT01515423|83286979|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
47035874|NCT00637156|83286988|FG000|Overall Study|Withdrawal by Subject|0|||
47035875|NCT00637156|83286989|FG001|Overall Study|Withdrawal by Subject|7|||
47035876|NCT00637156|83286988|FG000|Overall Study|Death|0|||
47035877|NCT00637156|83286989|FG001|Overall Study|Death|1|||
47035878|NCT00637156|83286988|FG000|Overall Study|Lost to Follow-up|10|||
47035879|NCT00637156|83286989|FG001|Overall Study|Lost to Follow-up|16|||
47035880|NCT00637000|83286997|FG000|Overall Study|Withdrawal by Subject|4|||
47035881|NCT00637000|83286998|FG001|Overall Study|Withdrawal by Subject|3|||
47035882|NCT01515189|83287006|FG000|Induction|Disease Progression|109|||
47035883|NCT01515189|83287007|FG001|Induction|Disease Progression|155|||
47035884|NCT01515189|83287006|FG000|Induction|Study drug toxicity|86|||
47035885|NCT01515189|83287007|FG001|Induction|Study drug toxicity|36|||
47035886|NCT01515189|83287006|FG000|Induction|Death|24|||
47035887|NCT01515189|83287007|FG001|Induction|Death|17|||
47035888|NCT01515189|83287006|FG000|Induction|Adverse Event|14|||
47035889|NCT01515189|83287007|FG001|Induction|Adverse Event|9|||
47035890|NCT01515189|83287006|FG000|Induction|Withdrawal by Subject|3|||
47035891|NCT01515189|83287007|FG001|Induction|Withdrawal by Subject|9|||
47035892|NCT01515189|83287006|FG000|Induction|No longer meets study criteria|0|||
47035893|NCT01515189|83287007|FG001|Induction|No longer meets study criteria|2|||
47035894|NCT01515189|83287006|FG000|Induction|Lost to Follow-up|1|||
47035895|NCT01515189|83287007|FG001|Induction|Lost to Follow-up|0|||
47035896|NCT01515189|83287006|FG000|Induction|Other|0|||
47035897|NCT01515189|83287007|FG001|Induction|Other|4|||
47035898|NCT01515189|83287006|FG000|First Re-Induction Phase|Disease progression|6|||
47035899|NCT01515189|83287007|FG001|First Re-Induction Phase|Disease progression|14|||
47035900|NCT01515189|83287006|FG000|First Re-Induction Phase|Study drug toxicity|5|||
47035901|NCT01515189|83287007|FG001|First Re-Induction Phase|Study drug toxicity|0|||
47035902|NCT01515189|83287006|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
47035903|NCT01515189|83287007|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
47035904|NCT01515189|83287006|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
47035905|NCT01515189|83287007|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
47035906|NCT01515189|83287006|FG000|First Re-Induction Phase|Other|1|||
47035907|NCT01515189|83287007|FG001|First Re-Induction Phase|Other|0|||
47035908|NCT01546623|83287015|FG000|Overall Study|Adverse Event|2|||
47035909|NCT01546623|83287016|FG001|Overall Study|Adverse Event|3|||
47035910|NCT01546623|83287015|FG000|Overall Study|Major Protocol Deviation|1|||
46629812|NCT01959516|82800723|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
46629813|NCT01959516|82800722|FG000|Epoch 1|Protocol deviation|0|||
46629814|NCT01959516|82800723|FG001|Epoch 1|Protocol deviation|1|||
46629815|NCT01959516|82800722|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
46629816|NCT01959516|82800723|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
46629817|NCT01959516|82800722|FG000|Epoch 2|Subject withdrew consent|1|||
46629818|NCT01959516|82800723|FG001|Epoch 2|Subject withdrew consent|0|||
46629819|NCT01959516|82800722|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
46629820|NCT01959516|82800723|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
46629821|NCT01979016|82800731|FG000|Overall Study|Withdrawal by Subject|2|||
46629822|NCT01979016|82800732|FG001|Overall Study|Withdrawal by Subject|0|||
46629823|NCT01979016|82800731|FG000|Overall Study|Adverse Event|0|||
46629824|NCT01979016|82800732|FG001|Overall Study|Adverse Event|1|||
46629825|NCT01935336|82800742|FG000|Overall Study|Adverse Event|1|||
46711421|NCT01212770|82927825|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
47035911|NCT01546623|83287016|FG001|Overall Study|Major Protocol Deviation|1|||
47035912|NCT01546623|83287015|FG000|Overall Study|High Prostate specific antigen|2|||
47035913|NCT01546623|83287016|FG001|Overall Study|High Prostate specific antigen|1|||
47035914|NCT01546623|83287015|FG000|Overall Study|Did Not Receive Study Drug|1|||
47035915|NCT01546623|83287016|FG001|Overall Study|Did Not Receive Study Drug|1|||
47035916|NCT01546155|83287022|FG000|Overall Study|could not tolerate long scan duration|3|||
47035917|NCT00636610|83287028|FG000|Overall Study|Adverse Event|4|||
47035918|NCT00636610|83287029|FG001|Overall Study|Adverse Event|4|||
46711422|NCT01212770|82927826|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
47035919|NCT00636610|83287028|FG000|Overall Study|Death|6|||
47035920|NCT00636610|83287029|FG001|Overall Study|Death|3|||
47035921|NCT00636610|83287028|FG000|Overall Study|Physician decision to withdraw patient|15|||
46629826|NCT01935336|82800743|FG001|Overall Study|Adverse Event|0|||
46629827|NCT01935336|82800744|FG002|Overall Study|Adverse Event|0|||
46629828|NCT01935336|82800745|FG003|Overall Study|Adverse Event|0|||
46629829|NCT01935336|82800742|FG000|Overall Study|Progressive disease|5|||
46629830|NCT01935336|82800743|FG001|Overall Study|Progressive disease|3|||
47035922|NCT00636610|83287029|FG001|Overall Study|Physician decision to withdraw patient|9|||
47035923|NCT00636610|83287028|FG000|Overall Study|Subject decision to withdraw|15|||
47035924|NCT00636610|83287029|FG001|Overall Study|Subject decision to withdraw|11|||
46711423|NCT01212770|82927827|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
46711424|NCT01212770|82927828|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
46711425|NCT01212770|82927829|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
46711426|NCT01212770|82927821|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
46711427|NCT01212770|82927822|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
46711428|NCT01212770|82927823|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
46711429|NCT01212770|82927824|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
46711430|NCT01212770|82927825|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
46711431|NCT01212770|82927826|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
46711432|NCT01212770|82927827|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
46711433|NCT01212770|82927828|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
46711434|NCT01212770|82927829|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
46711435|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46711436|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
47035925|NCT00636610|83287028|FG000|Overall Study|Disease progression - radiographic|41|||
47035926|NCT00636610|83287029|FG001|Overall Study|Disease progression - radiographic|51|||
47035927|NCT00636610|83287028|FG000|Overall Study|Disease progression - clinical|8|||
47035928|NCT00636610|83287029|FG001|Overall Study|Disease progression - clinical|3|||
47035929|NCT00636610|83287028|FG000|Overall Study|Reason for discontinuation not available|3|||
47035930|NCT00636610|83287029|FG001|Overall Study|Reason for discontinuation not available|2|||
47035931|NCT00635050|83287037|FG000|Overall Study|Withdrawal by Subject|1|||
46711437|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
46711438|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46711439|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46711440|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46711441|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46711442|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46711443|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
46711444|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46711445|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
46711446|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
46711447|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46711448|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46711449|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46711450|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46711451|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
46711452|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
46711453|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46711454|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
46711455|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46711456|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46711457|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46711458|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46711459|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46629831|NCT01935336|82800744|FG002|Overall Study|Progressive disease|47|||
46629832|NCT01935336|82800745|FG003|Overall Study|Progressive disease|66|||
46629833|NCT01978236|82800761|FG000|Overall Study|Discontinued due to study close|2|||
46629834|NCT01977846|82800767|FG000|Total Study - Prospective|Death|0|||
46711460|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46711461|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
46711462|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46711463|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
46711464|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
46711465|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46711466|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
47035932|NCT00634504|83287046|FG000|Overall Study|Protocol Violation|1|||
47035933|NCT00634504|83287047|FG001|Overall Study|Protocol Violation|0|||
46629835|NCT01977846|82800768|FG001|Total Study - Prospective|Death|1|||
46629836|NCT01977846|82800767|FG000|Total Study - Prospective|Lost to Follow-up|0|||
46629837|NCT01977846|82800768|FG001|Total Study - Prospective|Lost to Follow-up|8|||
46629838|NCT01977846|82800767|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
46629839|NCT01977846|82800768|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
47035934|NCT00634114|83287056|FG000|Overall Study|Adverse Event|6|||
47035935|NCT00634114|83287057|FG001|Overall Study|Adverse Event|8|||
47035936|NCT00634114|83287058|FG002|Overall Study|Adverse Event|3|||
47035937|NCT00634114|83287056|FG000|Overall Study|Withdrawal by Subject|9|||
47035938|NCT00634114|83287057|FG001|Overall Study|Withdrawal by Subject|6|||
47035939|NCT00634114|83287058|FG002|Overall Study|Withdrawal by Subject|11|||
46629840|NCT01977846|82800767|FG000|Total Study - Prospective|Not available at time of visit|0|||
46913693|NCT03084315|83144095|FG001|Overall Study|Withdrawal by Subject|2|||
46913694|NCT03187301|83144101|FG000|Titration Period|Adverse Event|0|||
46913695|NCT03187301|83144102|FG001|Titration Period|Adverse Event|0|||
46913696|NCT03187301|83144103|FG002|Titration Period|Adverse Event|0|||
46913697|NCT03187301|83144104|FG003|Titration Period|Adverse Event|0|||
46913698|NCT03187301|83144105|FG004|Titration Period|Adverse Event|0|||
46913699|NCT03187301|83144106|FG005|Titration Period|Adverse Event|0|||
47035940|NCT00634114|83287056|FG000|Overall Study|Lost to Follow-up|0|||
47035941|NCT00634114|83287057|FG001|Overall Study|Lost to Follow-up|0|||
47035942|NCT00634114|83287058|FG002|Overall Study|Lost to Follow-up|1|||
47035943|NCT00634114|83287056|FG000|Overall Study|Protocol Violation|3|||
47035944|NCT00634114|83287057|FG001|Overall Study|Protocol Violation|3|||
47035945|NCT00634114|83287058|FG002|Overall Study|Protocol Violation|1|||
47035946|NCT00634114|83287056|FG000|Overall Study|Pregnancy|1|||
47035947|NCT00634114|83287057|FG001|Overall Study|Pregnancy|0|||
47035948|NCT00634114|83287058|FG002|Overall Study|Pregnancy|0|||
47035949|NCT00634114|83287056|FG000|Overall Study|Incorrect enrolment|0|||
47035950|NCT00634114|83287057|FG001|Overall Study|Incorrect enrolment|1|||
47035951|NCT00634114|83287058|FG002|Overall Study|Incorrect enrolment|0|||
47035952|NCT00634114|83287056|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
47035953|NCT00634114|83287057|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
47035954|NCT00634114|83287058|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
47035955|NCT00634114|83287056|FG000|Overall Study|Difficult to continue|3|||
47035956|NCT00634114|83287057|FG001|Overall Study|Difficult to continue|1|||
47035957|NCT00634114|83287058|FG002|Overall Study|Difficult to continue|1|||
47035958|NCT00634114|83287056|FG000|Overall Study|Other reason|1|||
47035959|NCT00634114|83287057|FG001|Overall Study|Other reason|1|||
47035960|NCT00634114|83287058|FG002|Overall Study|Other reason|1|||
47035961|NCT00634036|83287068|FG000|Overall Study|Lost to Follow-up|1|||
47035962|NCT00634036|83287069|FG001|Overall Study|Lost to Follow-up|1|||
47035963|NCT00634036|83287068|FG000|Overall Study|Withdrawal by Subject|1|||
47035964|NCT00634036|83287069|FG001|Overall Study|Withdrawal by Subject|1|||
47035965|NCT01545375|83287077|FG000|Overall Study|Adverse Event|2|||
47035966|NCT01545375|83287078|FG001|Overall Study|Adverse Event|1|||
47035967|NCT01545375|83287077|FG000|Overall Study|Lost to Follow-up|34|||
47035968|NCT01545375|83287078|FG001|Overall Study|Lost to Follow-up|31|||
47035969|NCT01545375|83287077|FG000|Overall Study|Protocol Violation|3|||
47035970|NCT01545375|83287078|FG001|Overall Study|Protocol Violation|3|||
47035971|NCT01545375|83287077|FG000|Overall Study|Withdrawal by Subject|58|||
47035972|NCT01545375|83287078|FG001|Overall Study|Withdrawal by Subject|55|||
47035973|NCT01539837|83287087|FG000|Overall Study|reduce neutrophil level|0|||
47035974|NCT01539837|83287088|FG001|Overall Study|reduce neutrophil level|1|||
47035975|NCT01539837|83287089|FG002|Overall Study|reduce neutrophil level|1|||
47035976|NCT01539837|83287087|FG000|Overall Study|bad compliance|0|||
47035977|NCT01539837|83287088|FG001|Overall Study|bad compliance|0|||
47035978|NCT01539837|83287089|FG002|Overall Study|bad compliance|1|||
47035979|NCT01539759|83287099|FG000|Overall Study|Lost to Follow-up|6|||
47035980|NCT01539759|83287100|FG001|Overall Study|Lost to Follow-up|8|||
47035981|NCT00633022|83287109|FG000|Overall Study|Adverse Event|1|||
46629841|NCT01977846|82800768|FG001|Total Study - Prospective|Not available at time of visit|5|||
46629842|NCT01977846|82800767|FG000|Total Study - Prospective|No show|0|||
46629843|NCT01977846|82800768|FG001|Total Study - Prospective|No show|1|||
46629844|NCT01977846|82800767|FG000|Total Study - Prospective|Protocol Violation|0|||
46629845|NCT01977846|82800768|FG001|Total Study - Prospective|Protocol Violation|1|||
46629846|NCT01934790|82800775|FG000|Treatment|Adverse Event|3|||
46629847|NCT01934790|82800775|FG000|Treatment|Clinical progression|6|||
46629848|NCT01934790|82800775|FG000|Treatment|Radiological progression|4|||
46629849|NCT01934790|82800775|FG000|Treatment|Withdrawal by Subject|2|||
46629850|NCT01934790|82800775|FG000|Treatment|Study drug never administered|1|||
46629851|NCT01934790|82800775|FG000|Active Follow up|Death|20|||
46629852|NCT01934790|82800775|FG000|Active Follow up|Physician Decision|2|||
46629853|NCT01934790|82800775|FG000|Active Follow up|Progressive disease|1|||
46629854|NCT01934790|82800775|FG000|Active Follow up|Other reason|1|||
46629855|NCT01934556|82800782|FG000|Overall Study|Withdrawal by Subject|0|||
46913700|NCT03187301|83144107|FG006|Titration Period|Adverse Event|5|||
47035982|NCT00633022|83287110|FG001|Overall Study|Adverse Event|0|||
47035983|NCT00633022|83287111|FG002|Overall Study|Adverse Event|5|||
47035984|NCT00633022|83287109|FG000|Overall Study|Physician Decision|0|||
47035985|NCT00633022|83287110|FG001|Overall Study|Physician Decision|1|||
47035986|NCT00633022|83287111|FG002|Overall Study|Physician Decision|0|||
47035987|NCT00630994|83287119|FG000|Overall Study|Adverse Event|1|||
47035988|NCT00630994|83287119|FG000|Overall Study|Disease Progression|1|||
47035989|NCT00630994|83287119|FG000|Overall Study|Lack of Efficacy|1|||
47035990|NCT00630994|83287119|FG000|Overall Study|Other|1|||
47035991|NCT00630838|83287125|FG000|Overall Study|Death|0|||
46913701|NCT03187301|83144101|FG000|Titration Period|Withdrawal by Subject|0|||
46913702|NCT03187301|83144102|FG001|Titration Period|Withdrawal by Subject|0|||
47035992|NCT00630838|83287126|FG001|Overall Study|Death|1|||
47035993|NCT00630838|83287125|FG000|Overall Study|Lost to Follow-up|0|||
47035994|NCT00630838|83287126|FG001|Overall Study|Lost to Follow-up|1|||
47035995|NCT00630058|83287136|FG000|Overall Study|Adverse Event|1|||
47035996|NCT00630058|83287137|FG001|Overall Study|Adverse Event|1|||
47035997|NCT00630058|83287136|FG000|Overall Study|Withdrawal by Subject|0|||
47035998|NCT00630058|83287137|FG001|Overall Study|Withdrawal by Subject|1|||
47035999|NCT00630058|83287136|FG000|Overall Study|stopping criteria|3|||
47036000|NCT00630058|83287137|FG001|Overall Study|stopping criteria|2|||
47036001|NCT01925794|83287143|FG000|180 Days|Death|2|||
46629856|NCT01934556|82800783|FG001|Overall Study|Withdrawal by Subject|1|||
46629857|NCT01934556|82800784|FG002|Overall Study|Withdrawal by Subject|1|||
46629858|NCT01934556|82800782|FG000|Overall Study|Lost to Follow-up|4|||
46629859|NCT01934556|82800783|FG001|Overall Study|Lost to Follow-up|10|||
46629860|NCT01934556|82800784|FG002|Overall Study|Lost to Follow-up|7|||
46711467|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46711468|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46711469|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
46711470|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
46711471|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
46711472|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
46711473|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
46711474|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
46711475|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
46711476|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
46711477|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
46711478|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
46711479|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
46711480|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46711481|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
46711482|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
46711483|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46711484|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46711485|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46711486|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46711487|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46711488|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
46711489|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46711490|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
46711491|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
46711492|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46629861|NCT01934556|82800782|FG000|Overall Study|Death|1|||
46629862|NCT01934556|82800783|FG001|Overall Study|Death|5|||
46629863|NCT01934556|82800784|FG002|Overall Study|Death|2|||
46629864|NCT01977690|82800794|FG000|Overall Study|Withdrawal by Subject|0|||
46629865|NCT01977690|82800795|FG001|Overall Study|Withdrawal by Subject|4|||
46629866|NCT01934010|82800870|FG000|Overall Study|Adverse Event|1|||
46629867|NCT01934010|82800871|FG001|Overall Study|Adverse Event|1|||
46629868|NCT01934010|82800872|FG002|Overall Study|Adverse Event|0|||
46629869|NCT01934010|82800870|FG000|Overall Study|Withdrawal by Subject|15|||
46629870|NCT01934010|82800871|FG001|Overall Study|Withdrawal by Subject|6|||
46629871|NCT01934010|82800872|FG002|Overall Study|Withdrawal by Subject|2|||
46711493|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46711494|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46711495|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46711496|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
46711497|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
46711498|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46711499|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
46711500|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
46711501|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46711502|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46711503|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46711504|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46711505|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
46711506|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
46711507|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46629872|NCT01934010|82800870|FG000|Overall Study|Lost to Follow-up|7|||
46629873|NCT01934010|82800871|FG001|Overall Study|Lost to Follow-up|4|||
46629874|NCT01934010|82800872|FG002|Overall Study|Lost to Follow-up|0|||
46711508|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
46711509|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
47036002|NCT01925794|83287143|FG000|180 Days|Withdrawal by Subject|2|||
47036003|NCT01925794|83287143|FG000|270 Days|Death|2|||
47036004|NCT01925794|83287143|FG000|270 Days|Protocol Violation|3|||
47036005|NCT00989950|83287155|FG000|Randomized Phase|Protocol Violation|1|||
46711510|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46711511|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46711512|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46711513|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46711514|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
46711515|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
46711516|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
47036006|NCT00989950|83287156|FG001|Randomized Phase|Protocol Violation|0|||
47036007|NCT00989950|83287157|FG002|Randomized Phase|Protocol Violation|0|||
47036008|NCT00989950|83287158|FG003|Randomized Phase|Protocol Violation|0|||
46711517|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
46711518|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46711519|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46711520|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46711521|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46711522|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46711523|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46711524|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46711525|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
46711526|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
46711527|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
46711528|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
46711529|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
47036009|NCT00989950|83287155|FG000|Randomized Phase|Adverse Event|0|||
47036010|NCT00989950|83287156|FG001|Randomized Phase|Adverse Event|1|||
47036011|NCT00989950|83287157|FG002|Randomized Phase|Adverse Event|0|||
47036012|NCT00989950|83287158|FG003|Randomized Phase|Adverse Event|0|||
47036013|NCT01905943|83287168|FG000|Overall Study|Withdrawal of consent|90|||
47036014|NCT01905943|83287168|FG000|Overall Study|Lost to Follow-up|16|||
47036015|NCT01905943|83287168|FG000|Overall Study|Investigator discretion|7|||
47036016|NCT01905943|83287168|FG000|Overall Study|Death|186|||
47036017|NCT01905943|83287168|FG000|Overall Study|Adverse Event|3|||
47036018|NCT01905943|83287168|FG000|Overall Study|Other|12|||
47036019|NCT01905553|83287189|FG000|Period 2|Adverse Event|1|||
47036020|NCT01905553|83287190|FG001|Period 2|Adverse Event|0|||
47036021|NCT01929031|83287200|FG000|Overall Study|Adverse Event|3|||
47036022|NCT01929031|83287201|FG001|Overall Study|Adverse Event|1|||
47036023|NCT01929031|83287202|FG002|Overall Study|Adverse Event|1|||
47036024|NCT01929031|83287203|FG003|Overall Study|Adverse Event|0|||
47036025|NCT01929031|83287204|FG004|Overall Study|Adverse Event|0|||
47036026|NCT01929031|83287205|FG005|Overall Study|Adverse Event|0|||
47036027|NCT01929031|83287200|FG000|Overall Study|Protocol Violation|1|||
47036028|NCT01929031|83287201|FG001|Overall Study|Protocol Violation|0|||
47036029|NCT01929031|83287202|FG002|Overall Study|Protocol Violation|0|||
47036030|NCT01929031|83287203|FG003|Overall Study|Protocol Violation|0|||
47036031|NCT01929031|83287204|FG004|Overall Study|Protocol Violation|0|||
47036032|NCT01929031|83287205|FG005|Overall Study|Protocol Violation|1|||
47036033|NCT01929031|83287200|FG000|Overall Study|Reason other than specified above|0|||
47036034|NCT01929031|83287201|FG001|Overall Study|Reason other than specified above|1|||
47036035|NCT01929031|83287202|FG002|Overall Study|Reason other than specified above|0|||
47036036|NCT01929031|83287203|FG003|Overall Study|Reason other than specified above|0|||
47036037|NCT01929031|83287204|FG004|Overall Study|Reason other than specified above|1|||
47036038|NCT01929031|83287205|FG005|Overall Study|Reason other than specified above|0|||
47036039|NCT00989092|83287217|FG000|Overall Study|Physician Decision|9|||
47036040|NCT00989092|83287218|FG001|Overall Study|Physician Decision|6|||
47036041|NCT00989092|83287217|FG000|Overall Study|Adverse Event|20|||
47036042|NCT00989092|83287218|FG001|Overall Study|Adverse Event|1|||
47036043|NCT00989092|83287217|FG000|Overall Study|Chemotherapy initiated|12|||
47036044|NCT00989092|83287218|FG001|Overall Study|Chemotherapy initiated|4|||
46711530|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
46711531|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
46711532|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
46711533|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
47036045|NCT00989092|83287217|FG000|Overall Study|Withdrawal by Subject|17|||
47036046|NCT00989092|83287218|FG001|Overall Study|Withdrawal by Subject|9|||
47036047|NCT00989092|83287217|FG000|Overall Study|Death|14|||
47036048|NCT00989092|83287218|FG001|Overall Study|Death|2|||
47036049|NCT00989092|83287217|FG000|Overall Study|Ineligibility determined|3|||
47036050|NCT00989092|83287218|FG001|Overall Study|Ineligibility determined|3|||
47036051|NCT00989092|83287217|FG000|Overall Study|Lost to Follow-up|6|||
47036052|NCT00989092|83287218|FG001|Overall Study|Lost to Follow-up|2|||
47036053|NCT00989092|83287217|FG000|Overall Study|Other|3|||
46711534|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
47036054|NCT00989092|83287218|FG001|Overall Study|Other|1|||
47036055|NCT00989092|83287217|FG000|Overall Study|Protocol deviation|2|||
47036056|NCT00989092|83287218|FG001|Overall Study|Protocol deviation|0|||
47036057|NCT00989092|83287217|FG000|Overall Study|Erythropoietin therapy initiated|2|||
47036058|NCT00989092|83287218|FG001|Overall Study|Erythropoietin therapy initiated|0|||
47036059|NCT00989092|83287217|FG000|Overall Study|Did not receive study drug|2|||
47036060|NCT00989092|83287218|FG001|Overall Study|Did not receive study drug|0|||
47036061|NCT00988858|83287225|FG000|Overall Study|Adverse Event|7|||
47036062|NCT00988858|83287225|FG000|Overall Study|Death|1|||
47036063|NCT00988858|83287225|FG000|Overall Study|Physician Decision|1|||
47036064|NCT00988858|83287225|FG000|Overall Study|Sponsor Decision|1|||
47036065|NCT00986986|83287231|FG000|Overall Study|Lost to Follow-up|0|||
47036066|NCT00986986|83287232|FG001|Overall Study|Lost to Follow-up|1|||
47036067|NCT01904773|83287239|FG000|Screen|Screen failure|3|||
47036068|NCT01904773|83287240|FG001|Screen|Screen failure|0|||
47036069|NCT01904773|83287241|FG002|Screen|Screen failure|0|||
47036070|NCT01904773|83287242|FG003|Screen|Screen failure|0|||
47036071|NCT01904773|83287243|FG004|Screen|Screen failure|0|||
47036072|NCT01904773|83287244|FG005|Screen|Screen failure|0|||
47036073|NCT01904773|83287245|FG006|Screen|Screen failure|0|||
47036074|NCT01904773|83287246|FG007|Screen|Screen failure|0|||
47036075|NCT01904773|83287247|FG008|Screen|Screen failure|0|||
47036076|NCT01904773|83287239|FG000|Screen|Withdrawal by Subject|1|||
47036077|NCT01904773|83287240|FG001|Screen|Withdrawal by Subject|0|||
47036078|NCT01904773|83287241|FG002|Screen|Withdrawal by Subject|0|||
47036079|NCT01904773|83287242|FG003|Screen|Withdrawal by Subject|0|||
47036080|NCT01904773|83287243|FG004|Screen|Withdrawal by Subject|0|||
47036081|NCT01904773|83287244|FG005|Screen|Withdrawal by Subject|0|||
47036082|NCT01904773|83287245|FG006|Screen|Withdrawal by Subject|0|||
47036083|NCT01904773|83287246|FG007|Screen|Withdrawal by Subject|0|||
47036084|NCT01904773|83287247|FG008|Screen|Withdrawal by Subject|0|||
47036085|NCT01904773|83287239|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
47036086|NCT01904773|83287240|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036087|NCT01904773|83287241|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036088|NCT01904773|83287242|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036089|NCT01904773|83287243|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036090|NCT01904773|83287244|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036091|NCT01904773|83287245|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036092|NCT01904773|83287246|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036093|NCT01904773|83287247|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
47036094|NCT01904773|83287239|FG000|First Intervention|Adverse Event|0|||
47036095|NCT01904773|83287240|FG001|First Intervention|Adverse Event|0|||
47036096|NCT01904773|83287241|FG002|First Intervention|Adverse Event|0|||
47036097|NCT01904773|83287242|FG003|First Intervention|Adverse Event|0|||
47036098|NCT01904773|83287243|FG004|First Intervention|Adverse Event|0|||
47036099|NCT01904773|83287244|FG005|First Intervention|Adverse Event|0|||
47036100|NCT01904773|83287245|FG006|First Intervention|Adverse Event|1|||
47036101|NCT01904773|83287246|FG007|First Intervention|Adverse Event|0|||
47036102|NCT01904773|83287247|FG008|First Intervention|Adverse Event|0|||
47036103|NCT01904773|83287239|FG000|Placebo Washout First Intervention|Condition worsened|0|||
47036104|NCT01904773|83287240|FG001|Placebo Washout First Intervention|Condition worsened|1|||
47036105|NCT01904773|83287241|FG002|Placebo Washout First Intervention|Condition worsened|0|||
47036106|NCT01904773|83287242|FG003|Placebo Washout First Intervention|Condition worsened|0|||
47036107|NCT01904773|83287243|FG004|Placebo Washout First Intervention|Condition worsened|0|||
47036108|NCT01904773|83287244|FG005|Placebo Washout First Intervention|Condition worsened|0|||
47036109|NCT01904773|83287245|FG006|Placebo Washout First Intervention|Condition worsened|0|||
47036110|NCT01904773|83287246|FG007|Placebo Washout First Intervention|Condition worsened|0|||
47036111|NCT01904773|83287247|FG008|Placebo Washout First Intervention|Condition worsened|0|||
47036112|NCT01904773|83287239|FG000|Fifth Intervention|Adverse Event|0|||
47036113|NCT01904773|83287240|FG001|Fifth Intervention|Adverse Event|0|||
47036114|NCT01904773|83287241|FG002|Fifth Intervention|Adverse Event|0|||
47036115|NCT01904773|83287242|FG003|Fifth Intervention|Adverse Event|0|||
47036116|NCT01904773|83287243|FG004|Fifth Intervention|Adverse Event|0|||
47036117|NCT01904773|83287244|FG005|Fifth Intervention|Adverse Event|0|||
47036118|NCT01904773|83287245|FG006|Fifth Intervention|Adverse Event|0|||
47036119|NCT01904773|83287246|FG007|Fifth Intervention|Adverse Event|1|||
47036120|NCT01904773|83287247|FG008|Fifth Intervention|Adverse Event|0|||
47036121|NCT01904773|83287239|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036122|NCT01904773|83287240|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
47036123|NCT01904773|83287241|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036124|NCT01904773|83287242|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036125|NCT01904773|83287243|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036126|NCT01904773|83287244|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036127|NCT01904773|83287245|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036128|NCT01904773|83287246|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036129|NCT01904773|83287247|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
47036130|NCT01928719|83287261|FG000|Overall Study|Lost to Follow-up|26|||
47036131|NCT01928719|83287262|FG001|Overall Study|Lost to Follow-up|11|||
47036132|NCT01928719|83287261|FG000|Overall Study|Withdrawal by Subject|22|||
47036133|NCT01928719|83287262|FG001|Overall Study|Withdrawal by Subject|7|||
47036134|NCT01928719|83287261|FG000|Overall Study|Protocol Violation|3|||
47036135|NCT01928719|83287262|FG001|Overall Study|Protocol Violation|1|||
47036136|NCT01928719|83287261|FG000|Overall Study|Adverse Event|1|||
47036137|NCT01928719|83287262|FG001|Overall Study|Adverse Event|0|||
47036138|NCT00986674|83287273|FG000|Overall Study|Lack of Efficacy|28|||
47036139|NCT00986674|83287274|FG001|Overall Study|Lack of Efficacy|25|||
47036140|NCT00986674|83287275|FG002|Overall Study|Lack of Efficacy|23|||
47036141|NCT00986674|83287273|FG000|Overall Study|Adverse Event|4|||
47036142|NCT00986674|83287274|FG001|Overall Study|Adverse Event|8|||
47036143|NCT00986674|83287275|FG002|Overall Study|Adverse Event|9|||
47036144|NCT00986674|83287273|FG000|Overall Study|Death|5|||
47036145|NCT00986674|83287274|FG001|Overall Study|Death|0|||
47036146|NCT00986674|83287275|FG002|Overall Study|Death|4|||
47036147|NCT00986674|83287273|FG000|Overall Study|Withdrawal by Subject|6|||
47036148|NCT00986674|83287274|FG001|Overall Study|Withdrawal by Subject|2|||
47036149|NCT00986674|83287275|FG002|Overall Study|Withdrawal by Subject|1|||
47036150|NCT00986674|83287273|FG000|Overall Study|alternative therapy|0|||
47036151|NCT00986674|83287274|FG001|Overall Study|alternative therapy|0|||
47036152|NCT00986674|83287275|FG002|Overall Study|alternative therapy|1|||
47036153|NCT00986674|83287273|FG000|Overall Study|not start protocol therapy|4|||
47036154|NCT00986674|83287274|FG001|Overall Study|not start protocol therapy|3|||
47036155|NCT00986674|83287275|FG002|Overall Study|not start protocol therapy|1|||
47036156|NCT00986674|83287273|FG000|Overall Study|unknown/not specify|0|||
47036157|NCT00986674|83287274|FG001|Overall Study|unknown/not specify|7|||
47036158|NCT00986674|83287275|FG002|Overall Study|unknown/not specify|9|||
47036159|NCT00986440|83287285|FG000|Overall Study|Progressive disease|27|||
47036160|NCT00986440|83287286|FG001|Overall Study|Progressive disease|37|||
47036161|NCT00986440|83287285|FG000|Overall Study|Serious adverse event or adverse event|9|||
47036162|NCT00986440|83287286|FG001|Overall Study|Serious adverse event or adverse event|2|||
47036163|NCT00986440|83287285|FG000|Overall Study|Withdrawal by Subject|1|||
47036164|NCT00986440|83287286|FG001|Overall Study|Withdrawal by Subject|2|||
47036165|NCT00986440|83287285|FG000|Overall Study|Screen failure (not dosed)|4|||
47036166|NCT00986440|83287286|FG001|Overall Study|Screen failure (not dosed)|2|||
47036167|NCT01904383|83287292|FG000|Overall Study|CRF not collected|117|||
47036168|NCT01904383|83287292|FG000|Overall Study|Reason not listed|147|||
47036169|NCT01904383|83287292|FG000|Overall Study|Lost to Follow-up|674|||
47036170|NCT01904383|83287292|FG000|Overall Study|Lack of Efficacy|370|||
47036171|NCT01904383|83287292|FG000|Overall Study|Improvement|141|||
47036172|NCT01904383|83287292|FG000|Overall Study|Adverse Event|271|||
47036173|NCT01904383|83287292|FG000|Overall Study|No patient visit after entry|54|||
47036174|NCT01904149|83287302|FG000|Overall Study|Adverse Event|3|||
47036175|NCT01904149|83287303|FG001|Overall Study|Adverse Event|4|||
47036176|NCT01904149|83287304|FG002|Overall Study|Adverse Event|0|||
47036177|NCT01904149|83287305|FG003|Overall Study|Adverse Event|1|||
47036178|NCT01904149|83287306|FG004|Overall Study|Adverse Event|1|||
47036179|NCT01904149|83287307|FG005|Overall Study|Adverse Event|2|||
47036180|NCT01904149|83287302|FG000|Overall Study|Lack of Efficacy|0|||
47036181|NCT01904149|83287303|FG001|Overall Study|Lack of Efficacy|3|||
47036182|NCT01904149|83287304|FG002|Overall Study|Lack of Efficacy|1|||
47036183|NCT01904149|83287305|FG003|Overall Study|Lack of Efficacy|3|||
47036184|NCT01904149|83287306|FG004|Overall Study|Lack of Efficacy|3|||
47036185|NCT01904149|83287307|FG005|Overall Study|Lack of Efficacy|1|||
47036186|NCT01904149|83287302|FG000|Overall Study|Withdrawal by Subject|1|||
47036187|NCT01904149|83287303|FG001|Overall Study|Withdrawal by Subject|3|||
47036188|NCT01904149|83287304|FG002|Overall Study|Withdrawal by Subject|1|||
47036189|NCT01904149|83287305|FG003|Overall Study|Withdrawal by Subject|0|||
46711535|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
46711536|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
47036190|NCT01904149|83287306|FG004|Overall Study|Withdrawal by Subject|1|||
47036191|NCT01904149|83287307|FG005|Overall Study|Withdrawal by Subject|0|||
47036192|NCT01904149|83287302|FG000|Overall Study|Protocol Violation|0|||
46711537|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
47036193|NCT01904149|83287303|FG001|Overall Study|Protocol Violation|1|||
47036194|NCT01904149|83287304|FG002|Overall Study|Protocol Violation|0|||
47036195|NCT01904149|83287305|FG003|Overall Study|Protocol Violation|0|||
47036196|NCT01904149|83287306|FG004|Overall Study|Protocol Violation|0|||
47036197|NCT01904149|83287307|FG005|Overall Study|Protocol Violation|0|||
47036198|NCT01904149|83287302|FG000|Overall Study|non compliance with study drug|1|||
47036199|NCT01904149|83287303|FG001|Overall Study|non compliance with study drug|0|||
47036200|NCT01904149|83287304|FG002|Overall Study|non compliance with study drug|0|||
47036201|NCT01904149|83287305|FG003|Overall Study|non compliance with study drug|0|||
46913703|NCT03187301|83144103|FG002|Titration Period|Withdrawal by Subject|0|||
46913704|NCT03187301|83144104|FG003|Titration Period|Withdrawal by Subject|0|||
46913705|NCT03187301|83144105|FG004|Titration Period|Withdrawal by Subject|0|||
47036202|NCT01904149|83287306|FG004|Overall Study|non compliance with study drug|0|||
47036203|NCT01904149|83287307|FG005|Overall Study|non compliance with study drug|0|||
47036204|NCT00986362|83287325|FG000|Overall Study|Death|2|||
46913706|NCT03187301|83144106|FG005|Titration Period|Withdrawal by Subject|0|||
46913707|NCT03187301|83144107|FG006|Titration Period|Withdrawal by Subject|1|||
46913708|NCT03187301|83144101|FG000|Titration Period|Exclusion Criteria Met|0|||
46913709|NCT03187301|83144102|FG001|Titration Period|Exclusion Criteria Met|0|||
46913710|NCT03187301|83144103|FG002|Titration Period|Exclusion Criteria Met|0|||
46913711|NCT03187301|83144104|FG003|Titration Period|Exclusion Criteria Met|0|||
46913712|NCT03187301|83144105|FG004|Titration Period|Exclusion Criteria Met|0|||
46913713|NCT03187301|83144106|FG005|Titration Period|Exclusion Criteria Met|0|||
46913714|NCT03187301|83144107|FG006|Titration Period|Exclusion Criteria Met|1|||
46913715|NCT03187301|83144101|FG000|Pre-Intervention|Withdrawal by Subject|1|||
46913716|NCT03187301|83144102|FG001|Pre-Intervention|Withdrawal by Subject|0|||
46913717|NCT03187301|83144103|FG002|Pre-Intervention|Withdrawal by Subject|0|||
46913718|NCT03187301|83144104|FG003|Pre-Intervention|Withdrawal by Subject|0|||
46913719|NCT03187301|83144105|FG004|Pre-Intervention|Withdrawal by Subject|0|||
46913720|NCT03187301|83144106|FG005|Pre-Intervention|Withdrawal by Subject|0|||
46913721|NCT03187301|83144107|FG006|Pre-Intervention|Withdrawal by Subject|0|||
46913722|NCT02946047|83144132|FG000|Overall Study|Adverse Event|1|||
46913723|NCT02946047|83144133|FG001|Overall Study|Adverse Event|0|||
46913724|NCT02946047|83144134|FG002|Overall Study|Adverse Event|0|||
46913725|NCT02946047|83144135|FG003|Overall Study|Adverse Event|0|||
46913726|NCT03077919|83144147|FG000|Overall Study|Lost to Follow-up|4|||
46913727|NCT03077919|83144148|FG001|Overall Study|Lost to Follow-up|1|||
46913728|NCT03220217|83144157|FG000|Overall Study|Withdrawal by Subject|0|||
46913729|NCT03220217|83144158|FG001|Overall Study|Withdrawal by Subject|1|||
46913730|NCT03220217|83144159|FG002|Overall Study|Withdrawal by Subject|0|||
46913731|NCT03220217|83144157|FG000|Overall Study|Subject Missed Procedure|0|||
46913732|NCT03220217|83144158|FG001|Overall Study|Subject Missed Procedure|0|||
46913733|NCT03220217|83144159|FG002|Overall Study|Subject Missed Procedure|1|||
46913734|NCT03192137|83144190|FG000|Overall Study|Adverse Event|10|||
46913735|NCT03192137|83144191|FG001|Overall Study|Adverse Event|11|||
46913736|NCT03192137|83144190|FG000|Overall Study|Physician Decision|1|||
46913737|NCT03192137|83144191|FG001|Overall Study|Physician Decision|0|||
46913738|NCT03192137|83144190|FG000|Overall Study|Lack of Efficacy|20|||
46913739|NCT03192137|83144191|FG001|Overall Study|Lack of Efficacy|37|||
46913740|NCT03192137|83144190|FG000|Overall Study|Withdrawal by Subject|3|||
46913741|NCT03192137|83144191|FG001|Overall Study|Withdrawal by Subject|3|||
46913742|NCT03192137|83144190|FG000|Overall Study|Protocol Violation|4|||
46913743|NCT03192137|83144191|FG001|Overall Study|Protocol Violation|3|||
46913744|NCT03192137|83144190|FG000|Overall Study|Surgery Cancelled|4|||
46913745|NCT03192137|83144191|FG001|Overall Study|Surgery Cancelled|1|||
46913746|NCT03192137|83144190|FG000|Overall Study|Other - Various Administrative Reasons|8|||
46913747|NCT03192137|83144191|FG001|Overall Study|Other - Various Administrative Reasons|3|||
46913748|NCT03881059|83144211|FG000|Treatment Period - Part A|Adverse Event|1|||
46913749|NCT03881059|83144212|FG001|Treatment Period - Part A|Adverse Event|3|||
46913750|NCT03881059|83144213|FG002|Treatment Period - Part A|Adverse Event|4|||
46913751|NCT03881059|83144211|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
46913752|NCT03881059|83144212|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
46913753|NCT03881059|83144213|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
46913754|NCT03881059|83144211|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
46913755|NCT03881059|83144212|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
46913756|NCT03881059|83144213|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
46913757|NCT03881059|83144211|FG000|Treatment Period - Part A|Other reasons|2|||
46913758|NCT03881059|83144212|FG001|Treatment Period - Part A|Other reasons|1|||
47036205|NCT00986362|83287326|FG001|Overall Study|Death|0|||
46711538|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46711539|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46711540|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46711541|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
46711542|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
46913759|NCT03881059|83144213|FG002|Treatment Period - Part A|Other reasons|0|||
46913760|NCT03881059|83144211|FG000|Treatment Period - Part B|Adverse Event|0|||
46913761|NCT03881059|83144212|FG001|Treatment Period - Part B|Adverse Event|0|||
46913762|NCT03881059|83144213|FG002|Treatment Period - Part B|Adverse Event|3|||
46913763|NCT03881059|83144211|FG000|Treatment Period - Part B|Death|0|||
47036206|NCT00986362|83287325|FG000|Overall Study|Lost to Follow-up|0|||
46913764|NCT03881059|83144212|FG001|Treatment Period - Part B|Death|1|||
46913765|NCT03881059|83144213|FG002|Treatment Period - Part B|Death|1|||
46913766|NCT03881059|83144211|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
46913767|NCT03881059|83144212|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
46711543|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46711544|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
46711545|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
46711546|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46711547|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
47036207|NCT00986362|83287326|FG001|Overall Study|Lost to Follow-up|1|||
47036208|NCT01890421|83287332|FG000|Overall Study|Adverse Event|1|||
47036209|NCT01890421|83287332|FG000|Overall Study|Other reason|10|||
47036210|NCT00985738|83287338|FG000|Overall Study|Study closed prematurely|8|||
47036211|NCT00985738|83287339|FG001|Overall Study|Study closed prematurely|8|||
47036212|NCT01928485|83287347|FG000|Overall Study|Physician Decision|0|||
47036213|NCT01928485|83287348|FG001|Overall Study|Physician Decision|1|||
47036214|NCT00985504|83287356|FG000|Acute Treatment Period|Adverse Event|3|||
47036215|NCT00985504|83287357|FG001|Acute Treatment Period|Adverse Event|4|||
47036216|NCT00985504|83287356|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
47036217|NCT00985504|83287357|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
47036218|NCT00985504|83287356|FG000|Acute Treatment Period|Protocol Violation|2|||
47036219|NCT00985504|83287357|FG001|Acute Treatment Period|Protocol Violation|0|||
47036220|NCT00985504|83287356|FG000|Acute Treatment Period|Sponsor Decision|0|||
47036221|NCT00985504|83287357|FG001|Acute Treatment Period|Sponsor Decision|1|||
47036222|NCT00985504|83287356|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
47036223|NCT00985504|83287357|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
47036224|NCT00985504|83287356|FG000|Optimization Period|Adverse Event|7|||
47036225|NCT00985504|83287357|FG001|Optimization Period|Adverse Event|9|||
47036226|NCT00985504|83287356|FG000|Optimization Period|Death|0|||
47036227|NCT00985504|83287357|FG001|Optimization Period|Death|1|||
47036228|NCT00985504|83287356|FG000|Optimization Period|Lack of Efficacy|5|||
47036229|NCT00985504|83287357|FG001|Optimization Period|Lack of Efficacy|3|||
47036230|NCT00985504|83287356|FG000|Optimization Period|Lost to Follow-up|0|||
47036231|NCT00985504|83287357|FG001|Optimization Period|Lost to Follow-up|1|||
47036232|NCT00985504|83287356|FG000|Optimization Period|Physician Decision|1|||
47036233|NCT00985504|83287357|FG001|Optimization Period|Physician Decision|0|||
47036234|NCT00985504|83287356|FG000|Optimization Period|Protocol Violation|3|||
47036235|NCT00985504|83287357|FG001|Optimization Period|Protocol Violation|1|||
47036236|NCT00985504|83287356|FG000|Optimization Period|Withdrawal by Subject|10|||
47036237|NCT00985504|83287357|FG001|Optimization Period|Withdrawal by Subject|8|||
47036238|NCT00985426|83287365|FG000|Overall Study|Adverse Event|0|||
47036239|NCT00985426|83287366|FG001|Overall Study|Adverse Event|1|||
47036240|NCT00985426|83287365|FG000|Overall Study|Subject Non-Compliance|3|||
47036241|NCT00985426|83287366|FG001|Overall Study|Subject Non-Compliance|3|||
47036242|NCT00985426|83287365|FG000|Overall Study|Withdrawal by Subject|12|||
47036243|NCT00985426|83287366|FG001|Overall Study|Withdrawal by Subject|16|||
47036244|NCT00985426|83287365|FG000|Overall Study|Lost to Follow-up|8|||
47036245|NCT00985426|83287366|FG001|Overall Study|Lost to Follow-up|10|||
47036246|NCT00985426|83287365|FG000|Overall Study|Death|7|||
47036247|NCT00985426|83287366|FG001|Overall Study|Death|3|||
47036248|NCT00985426|83287365|FG000|Overall Study|Protocol Violation|2|||
47036249|NCT00985426|83287366|FG001|Overall Study|Protocol Violation|0|||
47036250|NCT00985426|83287365|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
47036251|NCT00985426|83287366|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
47036252|NCT00985192|83287372|FG000|Overall Study|Withdrawal by Subject|1|||
47036253|NCT00985192|83287372|FG000|Overall Study|Disease Progression|1|||
47036254|NCT00985192|83287372|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
47036255|NCT00985114|83287378|FG000|Overall Study|Adverse Event|1|||
46711548|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46711549|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46711550|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46711551|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
46711552|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46711553|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
46711554|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
46711555|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46711556|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46711557|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
47036256|NCT00985114|83287379|FG001|Overall Study|Adverse Event|0|||
46711558|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
47036257|NCT00985114|83287378|FG000|Overall Study|Withdrawal by Subject|0|||
46711559|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
47036258|NCT00985114|83287379|FG001|Overall Study|Withdrawal by Subject|2|||
47036259|NCT00984568|83287387|FG000|Overall Study|Withdrawal by Subject|1|||
47036260|NCT00984568|83287388|FG001|Overall Study|Withdrawal by Subject|2|||
47036261|NCT00984568|83287387|FG000|Overall Study|Lack of Efficacy|2|||
46711560|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46711561|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
46711562|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
46711563|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
46711564|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
46711565|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
46711566|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
46711567|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
47036262|NCT00984568|83287388|FG001|Overall Study|Lack of Efficacy|0|||
47036263|NCT00984568|83287387|FG000|Overall Study|Adverse Event|2|||
47036264|NCT00984568|83287388|FG001|Overall Study|Adverse Event|0|||
47036265|NCT00984568|83287387|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
47036266|NCT00984568|83287388|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
47036267|NCT00984568|83287387|FG000|Overall Study|Lost to Follow-up|0|||
47036268|NCT00984568|83287388|FG001|Overall Study|Lost to Follow-up|1|||
47036269|NCT00984568|83287387|FG000|Overall Study|Opportunistic Infection|1|||
47036270|NCT00984568|83287388|FG001|Overall Study|Opportunistic Infection|0|||
47036271|NCT00984568|83287387|FG000|Overall Study|Unknown Reason|1|||
47036272|NCT00984568|83287388|FG001|Overall Study|Unknown Reason|3|||
47036273|NCT00984256|83287396|FG000|Overall Study|Withdrawal by Subject|0|||
46711568|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
46711569|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
46711570|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46711571|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
46711572|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
46711573|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46711574|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46711575|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46711576|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46711577|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46711578|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46711579|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711580|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711581|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
46711582|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711583|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711584|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711585|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711586|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711587|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46711588|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46711589|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
46711590|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46711591|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46711592|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46711593|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46711594|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46711595|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46711596|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
46711597|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
46711598|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
46711599|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
46711600|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
46711601|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
46711602|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
46711603|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
46711604|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
46711605|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
46711606|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46711607|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46711608|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
46711609|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46711610|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46711611|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
47036274|NCT00984256|83287397|FG001|Overall Study|Withdrawal by Subject|1|||
46711612|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
47036275|NCT00984022|83287414|FG000|Overall Study|Lost to Follow-up|10|||
46711613|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46711614|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46711615|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46711616|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46711617|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
46711618|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46711619|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46711620|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46711621|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46711622|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46711623|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
46711624|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
47036276|NCT00984022|83287415|FG001|Overall Study|Lost to Follow-up|14|||
47036277|NCT01890265|83287427|FG000|Overall Study|Other (Unspecified reason)|0|||
46711625|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
47036278|NCT01890265|83287428|FG001|Overall Study|Other (Unspecified reason)|1|||
47036279|NCT01890265|83287429|FG002|Overall Study|Other (Unspecified reason)|0|||
47036280|NCT01890265|83287430|FG003|Overall Study|Other (Unspecified reason)|0|||
47036281|NCT01890265|83287431|FG004|Overall Study|Other (Unspecified reason)|0|||
47036282|NCT01890265|83287432|FG005|Overall Study|Other (Unspecified reason)|0|||
47036283|NCT01890265|83287427|FG000|Overall Study|Progressive disease|6|||
47036284|NCT01890265|83287428|FG001|Overall Study|Progressive disease|6|||
47036285|NCT01890265|83287429|FG002|Overall Study|Progressive disease|0|||
47036286|NCT01890265|83287430|FG003|Overall Study|Progressive disease|0|||
47036287|NCT01890265|83287431|FG004|Overall Study|Progressive disease|0|||
47036288|NCT01890265|83287432|FG005|Overall Study|Progressive disease|0|||
47036289|NCT01890265|83287427|FG000|Overall Study|Adverse Event|2|||
47036290|NCT01890265|83287428|FG001|Overall Study|Adverse Event|1|||
47036291|NCT01890265|83287429|FG002|Overall Study|Adverse Event|0|||
47036292|NCT01890265|83287430|FG003|Overall Study|Adverse Event|0|||
47036293|NCT01890265|83287431|FG004|Overall Study|Adverse Event|0|||
47036294|NCT01890265|83287432|FG005|Overall Study|Adverse Event|0|||
47036295|NCT01890265|83287427|FG000|Overall Study|Death|2|||
47036296|NCT01890265|83287428|FG001|Overall Study|Death|3|||
47036297|NCT01890265|83287429|FG002|Overall Study|Death|1|||
47036298|NCT01890265|83287430|FG003|Overall Study|Death|0|||
47036299|NCT01890265|83287431|FG004|Overall Study|Death|0|||
47036300|NCT01890265|83287432|FG005|Overall Study|Death|0|||
47036301|NCT01890265|83287427|FG000|Overall Study|Withdrawal by Subject|0|||
47036302|NCT01890265|83287428|FG001|Overall Study|Withdrawal by Subject|2|||
47036303|NCT01890265|83287429|FG002|Overall Study|Withdrawal by Subject|3|||
47036304|NCT01890265|83287430|FG003|Overall Study|Withdrawal by Subject|0|||
47036305|NCT01890265|83287431|FG004|Overall Study|Withdrawal by Subject|2|||
47036306|NCT01890265|83287432|FG005|Overall Study|Withdrawal by Subject|0|||
47036307|NCT01928329|83287453|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
47036308|NCT01928329|83287454|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
47036309|NCT01928329|83287453|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
47036310|NCT01928329|83287454|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
47036311|NCT01928329|83287453|FG000|Overall Study|Adverse Event|5|||
47036312|NCT01928329|83287454|FG001|Overall Study|Adverse Event|3|||
47036313|NCT01928329|83287453|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
47036314|NCT01928329|83287454|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
47036315|NCT01928329|83287453|FG000|Overall Study|Withdrawal by Subject|1|||
47036316|NCT01928329|83287454|FG001|Overall Study|Withdrawal by Subject|5|||
47036317|NCT01928329|83287453|FG000|Overall Study|Physician Decision|1|||
47036318|NCT01928329|83287454|FG001|Overall Study|Physician Decision|1|||
46629875|NCT01620138|82800891|FG000|Overall Study|Withdrawal by Subject|3|||
46711626|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
46629876|NCT01620138|82800892|FG001|Overall Study|Withdrawal by Subject|0|||
46629877|NCT01620138|82800891|FG000|Overall Study|Lack of Efficacy|1|||
46629878|NCT01620138|82800892|FG001|Overall Study|Lack of Efficacy|0|||
46629879|NCT01620138|82800891|FG000|Overall Study|Adverse Event|2|||
46629880|NCT01620138|82800892|FG001|Overall Study|Adverse Event|0|||
46629881|NCT01977612|82800900|FG000|Overall Study|Lost to Follow-up|1|||
46629882|NCT01977612|82800901|FG001|Overall Study|Lost to Follow-up|1|||
46711627|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46711628|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46711629|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46711630|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46711631|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46711632|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
47036319|NCT01890109|83287462|FG000|Overall Study|Withdrawal by Subject|0|||
47036320|NCT01890109|83287463|FG001|Overall Study|Withdrawal by Subject|3|||
46711633|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46711634|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
46913768|NCT03881059|83144213|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
46629883|NCT01932996|82800909|FG000|Overall Study|Protocol Violation|2|||
46629884|NCT01932996|82800910|FG001|Overall Study|Protocol Violation|0|||
46629885|NCT01932762|82800920|FG000|Overall Study|Withdrawal by Subject|1|||
46711635|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
46711636|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46711637|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46711638|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46711639|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46711640|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
46711641|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46711642|NCT01212770|82927821|FG000|Long-term Safety Phase (Year 5)|Death|0|||
46711643|NCT01212770|82927822|FG001|Long-term Safety Phase (Year 5)|Death|0|||
46711644|NCT01212770|82927823|FG002|Long-term Safety Phase (Year 5)|Death|0|||
46711645|NCT01212770|82927824|FG003|Long-term Safety Phase (Year 5)|Death|0|||
46711646|NCT01212770|82927825|FG004|Long-term Safety Phase (Year 5)|Death|0|||
46711647|NCT01212770|82927826|FG005|Long-term Safety Phase (Year 5)|Death|0|||
46711648|NCT01212770|82927827|FG006|Long-term Safety Phase (Year 5)|Death|0|||
46711649|NCT01212770|82927828|FG007|Long-term Safety Phase (Year 5)|Death|1|||
46711650|NCT01212770|82927829|FG008|Long-term Safety Phase (Year 5)|Death|0|||
46711651|NCT00598273|82927854|FG000|Overall Study|Adverse Event|4|||
46711652|NCT00598273|82927855|FG001|Overall Study|Adverse Event|5|||
46711653|NCT00598273|82927856|FG002|Overall Study|Adverse Event|2|||
46711654|NCT00598273|82927854|FG000|Overall Study|Death|6|||
46711655|NCT00598273|82927855|FG001|Overall Study|Death|12|||
46711656|NCT00598273|82927856|FG002|Overall Study|Death|8|||
46711657|NCT00598273|82927854|FG000|Overall Study|Lost to Follow-up|8|||
46711658|NCT00598273|82927855|FG001|Overall Study|Lost to Follow-up|3|||
46711659|NCT00598273|82927856|FG002|Overall Study|Lost to Follow-up|5|||
46711660|NCT00598273|82927854|FG000|Overall Study|Physician Decision|0|||
46711661|NCT00598273|82927855|FG001|Overall Study|Physician Decision|0|||
46711662|NCT00598273|82927856|FG002|Overall Study|Physician Decision|1|||
46711663|NCT00598273|82927854|FG000|Overall Study|Withdrawal by Subject|12|||
46711664|NCT00598273|82927855|FG001|Overall Study|Withdrawal by Subject|10|||
46711665|NCT00598273|82927856|FG002|Overall Study|Withdrawal by Subject|10|||
46711666|NCT00598273|82927854|FG000|Overall Study|Noncompliance|3|||
46711667|NCT00598273|82927855|FG001|Overall Study|Noncompliance|2|||
46711668|NCT00598273|82927856|FG002|Overall Study|Noncompliance|3|||
46711669|NCT00598273|82927854|FG000|Overall Study|Relocation|0|||
46711670|NCT00598273|82927855|FG001|Overall Study|Relocation|2|||
46711671|NCT00598273|82927856|FG002|Overall Study|Relocation|4|||
46711672|NCT00598273|82927854|FG000|Overall Study|Renal transplant|1|||
46913769|NCT03881059|83144211|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
46913770|NCT03881059|83144212|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
46913771|NCT03881059|83144213|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
46913772|NCT03881059|83144211|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
46913773|NCT03881059|83144212|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
46913774|NCT03881059|83144213|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
46913775|NCT03881059|83144211|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
46913776|NCT03881059|83144212|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
46913777|NCT03881059|83144213|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
46913778|NCT03881059|83144211|FG000|Treatment Period - Part B|Other reasons|4|||
46913779|NCT03881059|83144212|FG001|Treatment Period - Part B|Other reasons|3|||
46913780|NCT03881059|83144213|FG002|Treatment Period - Part B|Other reasons|3|||
46913781|NCT02861534|83144228|FG000|Overall Study|Death|541|||
46913782|NCT02861534|83144229|FG001|Overall Study|Death|552|||
46913783|NCT02861534|83144228|FG000|Overall Study|Lost to Follow-up|14|||
46913784|NCT02861534|83144229|FG001|Overall Study|Lost to Follow-up|14|||
46913785|NCT02861534|83144228|FG000|Overall Study|Site Terminated by Sponsor|4|||
46913786|NCT02861534|83144229|FG001|Overall Study|Site Terminated by Sponsor|3|||
46913787|NCT02861534|83144228|FG000|Overall Study|Withdrawal by Subject|15|||
46913788|NCT02861534|83144229|FG001|Overall Study|Withdrawal by Subject|18|||
46913789|NCT03083847|83144270|FG000|Main|Physician Decision|0|||
46913790|NCT03083847|83144271|FG001|Main|Physician Decision|0|||
46913791|NCT03083847|83144272|FG002|Main|Physician Decision|0|||
46913792|NCT03083847|83144273|FG003|Main|Physician Decision|0|||
46913793|NCT03083847|83144274|FG004|Main|Physician Decision|0|||
46913794|NCT03083847|83144275|FG005|Main|Physician Decision|1|||
46913795|NCT03083847|83144276|FG006|Main|Physician Decision|0|||
46913796|NCT03083847|83144277|FG007|Main|Physician Decision|0|||
46913797|NCT03083847|83144278|FG008|Main|Physician Decision|0|||
46913798|NCT03083847|83144279|FG009|Main|Physician Decision|0|||
46913799|NCT03083847|83144270|FG000|Main|Pregnancy|0|||
46913800|NCT03083847|83144271|FG001|Main|Pregnancy|0|||
46913801|NCT03083847|83144272|FG002|Main|Pregnancy|0|||
46913802|NCT03083847|83144273|FG003|Main|Pregnancy|0|||
46711673|NCT00598273|82927855|FG001|Overall Study|Renal transplant|0|||
46711674|NCT00598273|82927856|FG002|Overall Study|Renal transplant|1|||
46711675|NCT00598273|82927854|FG000|Overall Study|Site elected to close|1|||
46711676|NCT00598273|82927855|FG001|Overall Study|Site elected to close|0|||
46711677|NCT00598273|82927856|FG002|Overall Study|Site elected to close|0|||
46711678|NCT00598273|82927854|FG000|Overall Study|Started dialysis|6|||
46711679|NCT00598273|82927855|FG001|Overall Study|Started dialysis|4|||
46913803|NCT03083847|83144274|FG004|Main|Pregnancy|0|||
46711680|NCT00598273|82927856|FG002|Overall Study|Started dialysis|5|||
46711681|NCT01211522|82927867|FG000|Overall Study|Withdrawal by Subject|3|||
46711682|NCT01211522|82927868|FG001|Overall Study|Withdrawal by Subject|7|||
46711683|NCT01211522|82927869|FG002|Overall Study|Withdrawal by Subject|5|||
46711684|NCT01211288|82927879|FG000|Overall Study|Lost to Follow-up|1|||
46711685|NCT01211288|82927880|FG001|Overall Study|Lost to Follow-up|1|||
46711686|NCT00883753|82927888|FG000|Overall Study|Adverse Event|37|||
46711687|NCT00883753|82927888|FG000|Overall Study|Death|2|||
46711688|NCT00883753|82927888|FG000|Overall Study|Insufficient therapeutic response|16|||
46711689|NCT00883753|82927888|FG000|Overall Study|Lost to Follow-up|4|||
46711690|NCT00883753|82927888|FG000|Overall Study|Violation of selection criteria at entry|7|||
46711691|NCT00883753|82927888|FG000|Overall Study|Protocol Violation|2|||
46711692|NCT00883753|82927888|FG000|Overall Study|Refused treatment|4|||
46711693|NCT00883753|82927888|FG000|Overall Study|Withdrew consent|10|||
46711694|NCT00883753|82927888|FG000|Overall Study|Investigator's decision|17|||
46711695|NCT00883753|82927888|FG000|Overall Study|Administrative/Other|8|||
46711696|NCT01210664|82927895|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
46711697|NCT01210664|82927896|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
46711698|NCT01210664|82927897|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
46711699|NCT01210664|82927898|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
46711700|NCT01210664|82927895|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
46711701|NCT01210664|82927896|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
46629886|NCT01932762|82800921|FG001|Overall Study|Withdrawal by Subject|2|||
46629887|NCT01932762|82800922|FG002|Overall Study|Withdrawal by Subject|0|||
46629888|NCT01932762|82800923|FG003|Overall Study|Withdrawal by Subject|0|||
46629889|NCT01932762|82800920|FG000|Overall Study|Lost to Follow-up|4|||
46629890|NCT01932762|82800921|FG001|Overall Study|Lost to Follow-up|0|||
46629891|NCT01932762|82800922|FG002|Overall Study|Lost to Follow-up|0|||
46629892|NCT01932762|82800923|FG003|Overall Study|Lost to Follow-up|1|||
46711702|NCT01210664|82927897|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
46711703|NCT01210664|82927898|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
46711704|NCT01210664|82927895|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
46711705|NCT01210664|82927896|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
46711706|NCT01210664|82927897|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
46711707|NCT01210664|82927898|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
46711708|NCT00881569|82927910|FG000|Overall Study|Disease progression|1|||
46711709|NCT00881569|82927911|FG001|Overall Study|Disease progression|1|||
46711710|NCT00881335|82927919|FG000|Overall Study|Lost to Follow-up|3|||
46711711|NCT00881335|82927920|FG001|Overall Study|Lost to Follow-up|2|||
46711712|NCT00879775|82927937|FG000|Overall Study|Lost to Follow-up|2|||
46711713|NCT00879775|82927938|FG001|Overall Study|Lost to Follow-up|1|||
46711714|NCT00894790|82927946|FG000|Overall Study|Protocol Violation|0|||
46711715|NCT00894790|82927947|FG001|Overall Study|Protocol Violation|1|||
46711716|NCT00894790|82927946|FG000|Overall Study|Lost to Follow-up|0|||
46711717|NCT00894790|82927947|FG001|Overall Study|Lost to Follow-up|1|||
46711718|NCT00894790|82927946|FG000|Overall Study|Did not meet entrance criteria|1|||
46711719|NCT00894790|82927947|FG001|Overall Study|Did not meet entrance criteria|0|||
46711720|NCT00879229|82927955|FG000|Overall Study|Study terminated by Sponsor|13|||
46711721|NCT00879229|82927956|FG001|Overall Study|Study terminated by Sponsor|12|||
46711722|NCT00879229|82927955|FG000|Overall Study|Death|4|||
46711723|NCT00879229|82927956|FG001|Overall Study|Death|2|||
46711724|NCT00879229|82927955|FG000|Overall Study|Adverse Event|2|||
46711725|NCT00879229|82927956|FG001|Overall Study|Adverse Event|0|||
46711726|NCT00879229|82927955|FG000|Overall Study|Withdrawal by Subject|1|||
46629893|NCT01932762|82800920|FG000|Overall Study|Physician Decision|1|||
46629894|NCT01932762|82800921|FG001|Overall Study|Physician Decision|0|||
46629895|NCT01932762|82800922|FG002|Overall Study|Physician Decision|0|||
46629896|NCT01932762|82800923|FG003|Overall Study|Physician Decision|0|||
46629897|NCT01618968|82800937|FG000|Overall Study|Adverse Event|1|||
46711727|NCT00879229|82927956|FG001|Overall Study|Withdrawal by Subject|0|||
46629898|NCT01618968|82800938|FG001|Overall Study|Adverse Event|0|||
46629899|NCT01618968|82800939|FG002|Overall Study|Adverse Event|0|||
46629900|NCT01618968|82800940|FG003|Overall Study|Adverse Event|0|||
46629901|NCT01618968|82800937|FG000|Overall Study|Death|0|||
46629902|NCT01618968|82800938|FG001|Overall Study|Death|0|||
46629903|NCT01618968|82800939|FG002|Overall Study|Death|0|||
46629904|NCT01618968|82800940|FG003|Overall Study|Death|1|||
46629905|NCT01932294|82800949|FG000|Overall Study|Death|43|||
46629906|NCT01932294|82800949|FG000|Overall Study|Lost to Follow-up|8|||
46711728|NCT00879229|82927955|FG000|Overall Study|Clinical status did not improve|1|||
46711729|NCT00879229|82927956|FG001|Overall Study|Clinical status did not improve|0|||
46711730|NCT00879229|82927955|FG000|Overall Study|Other|1|||
46711731|NCT00879229|82927956|FG001|Overall Study|Other|0|||
46711732|NCT00878995|82927964|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
46711733|NCT00878995|82927965|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
46711734|NCT00879697|82927973|FG000|Overall Study|Physician Decision|2|||
46711735|NCT00879697|82927974|FG001|Overall Study|Physician Decision|2|||
46711736|NCT00894556|82927983|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
47036321|NCT01890109|83287462|FG000|Overall Study|Lost to Follow-up|1|||
47036322|NCT01890109|83287463|FG001|Overall Study|Lost to Follow-up|2|||
47036323|NCT00982930|83287470|FG000|Overall Study|Adverse Event|1|||
47036324|NCT00982930|83287470|FG000|Overall Study|Withdrawal by Subject|1|||
47036325|NCT00982930|83287470|FG000|Overall Study|Administrative Problems|2|||
47036326|NCT00981682|83287474|FG000|Overall Study|Adverse Event|48|||
47036327|NCT00981682|83287474|FG000|Overall Study|Withdrawal by Subject|52|||
47036328|NCT00981682|83287474|FG000|Overall Study|Lost to Follow-up|14|||
47036329|NCT00981682|83287474|FG000|Overall Study|Lack of Efficacy|13|||
47036330|NCT00981682|83287474|FG000|Overall Study|Protocol Violation|6|||
47036331|NCT00981682|83287474|FG000|Overall Study|administrative|9|||
47036332|NCT01903993|83287480|FG000|Overall Study|Death|118|||
47036333|NCT01903993|83287481|FG001|Overall Study|Death|121|||
47036334|NCT01903993|83287480|FG000|Overall Study|Withdrawal by Subject|15|||
47036335|NCT01903993|83287481|FG001|Overall Study|Withdrawal by Subject|4|||
47036336|NCT01903993|83287480|FG000|Overall Study|Lost to Follow-up|2|||
47036337|NCT01903993|83287481|FG001|Overall Study|Lost to Follow-up|3|||
47036338|NCT01903993|83287480|FG000|Overall Study|Study Terminated by Sponsor|8|||
47036339|NCT01903993|83287481|FG001|Overall Study|Study Terminated by Sponsor|14|||
47036340|NCT01903993|83287480|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
47036341|NCT01903993|83287481|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
47036342|NCT00981292|83287494|FG000|Day 1|Protocol Violation|1|||
47036343|NCT00981292|83287495|FG001|Day 1|Protocol Violation|0|||
47036344|NCT00981292|83287496|FG002|Day 1|Protocol Violation|0|||
47036345|NCT00981292|83287497|FG003|Day 1|Protocol Violation|0|||
47036346|NCT00981292|83287498|FG004|Day 1|Protocol Violation|0|||
47036347|NCT00981292|83287499|FG005|Day 1|Protocol Violation|2|||
47036348|NCT00981292|83287494|FG000|Day 2|Protocol Violation|2|||
47036349|NCT00981292|83287495|FG001|Day 2|Protocol Violation|0|||
47036350|NCT00981292|83287496|FG002|Day 2|Protocol Violation|0|||
47036351|NCT00981292|83287497|FG003|Day 2|Protocol Violation|0|||
47036352|NCT00981292|83287498|FG004|Day 2|Protocol Violation|0|||
47036353|NCT00981292|83287499|FG005|Day 2|Protocol Violation|0|||
47036354|NCT00981292|83287494|FG000|Day 3|Protocol Violation|0|||
47036355|NCT00981292|83287495|FG001|Day 3|Protocol Violation|0|||
47036356|NCT00981292|83287496|FG002|Day 3|Protocol Violation|0|||
47036357|NCT00981292|83287497|FG003|Day 3|Protocol Violation|0|||
47036358|NCT00981292|83287498|FG004|Day 3|Protocol Violation|0|||
47036359|NCT00981292|83287499|FG005|Day 3|Protocol Violation|1|||
47036360|NCT00980044|83287514|FG000|Overall Study|Withdrawal by Subject|5|||
47036361|NCT00980044|83287515|FG001|Overall Study|Withdrawal by Subject|7|||
47036362|NCT00980044|83287516|FG002|Overall Study|Withdrawal by Subject|3|||
47036363|NCT00980044|83287514|FG000|Overall Study|Protocol Violation|0|||
47036364|NCT00980044|83287515|FG001|Overall Study|Protocol Violation|0|||
47036365|NCT00980044|83287516|FG002|Overall Study|Protocol Violation|2|||
47036366|NCT01903837|83287531|FG000|Part A|Withdrawal by Subject|4|||
47036367|NCT01903837|83287532|FG001|Part A|Withdrawal by Subject|9|||
47036368|NCT01903837|83287533|FG002|Part A|Withdrawal by Subject|8|||
47036369|NCT01903837|83287534|FG003|Part A|Withdrawal by Subject|5|||
47036370|NCT01903837|83287531|FG000|Part A|Adverse Event|3|||
47036371|NCT01903837|83287532|FG001|Part A|Adverse Event|6|||
47036372|NCT01903837|83287533|FG002|Part A|Adverse Event|9|||
47036373|NCT01903837|83287534|FG003|Part A|Adverse Event|6|||
46629907|NCT01932294|82800949|FG000|Overall Study|VAD Implantation|20|||
46629908|NCT01932294|82800949|FG000|Overall Study|Heart Transplantation|16|||
46629909|NCT01932294|82800949|FG000|Overall Study|Transferred to other hospitals|12|||
46629910|NCT01931670|82800957|FG000|Treatment Period|Exclusionary Medication Received|1|||
46629911|NCT01931670|82800958|FG001|Treatment Period|Exclusionary Medication Received|1|||
46629912|NCT01931670|82800959|FG002|Treatment Period|Exclusionary Medication Received|1|||
46711737|NCT00894556|82927984|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
46711738|NCT00894556|82927985|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
47036374|NCT01903837|83287531|FG000|Part A|Lost to Follow-up|9|||
47036375|NCT01903837|83287532|FG001|Part A|Lost to Follow-up|7|||
47036376|NCT01903837|83287533|FG002|Part A|Lost to Follow-up|7|||
47036377|NCT01903837|83287534|FG003|Part A|Lost to Follow-up|2|||
47036378|NCT01903837|83287531|FG000|Part A|Non-compliance with study drug|1|||
47036379|NCT01903837|83287532|FG001|Part A|Non-compliance with study drug|4|||
47036380|NCT01903837|83287533|FG002|Part A|Non-compliance with study drug|4|||
46629913|NCT01931670|82800957|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
46629914|NCT01931670|82800958|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
47036381|NCT01903837|83287534|FG003|Part A|Non-compliance with study drug|0|||
47036382|NCT01903837|83287531|FG000|Part A|Physician Decision|1|||
47036383|NCT01903837|83287532|FG001|Part A|Physician Decision|1|||
47036384|NCT01903837|83287533|FG002|Part A|Physician Decision|0|||
47036385|NCT01903837|83287534|FG003|Part A|Physician Decision|0|||
47036386|NCT01903837|83287531|FG000|Part A|Protocol Violation|1|||
47036387|NCT01903837|83287532|FG001|Part A|Protocol Violation|1|||
47036388|NCT01903837|83287533|FG002|Part A|Protocol Violation|0|||
47036389|NCT01903837|83287534|FG003|Part A|Protocol Violation|0|||
47036390|NCT01903837|83287531|FG000|Part B|Lost to Follow-up|0|||
47036391|NCT01903837|83287532|FG001|Part B|Lost to Follow-up|3|||
47036392|NCT01903837|83287533|FG002|Part B|Lost to Follow-up|3|||
47036393|NCT01903837|83287534|FG003|Part B|Lost to Follow-up|4|||
47036394|NCT01903837|83287531|FG000|Part B|Withdrawal by Subject|1|||
47036395|NCT01903837|83287532|FG001|Part B|Withdrawal by Subject|2|||
46629915|NCT01931670|82800959|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
46629916|NCT01931670|82800957|FG000|Treatment Period|Subject Noncompliant|4|||
46711739|NCT00894556|82927986|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
46711740|NCT00894556|82927983|FG000|Treatment Phase|Lost to Follow-up|2|||
46711741|NCT00894556|82927984|FG001|Treatment Phase|Lost to Follow-up|3|||
46711742|NCT00894556|82927985|FG002|Treatment Phase|Lost to Follow-up|1|||
46711743|NCT00894556|82927986|FG003|Treatment Phase|Lost to Follow-up|0|||
46711744|NCT00894556|82927983|FG000|Treatment Phase|Lack of Qualifying Event|2|||
46711745|NCT00894556|82927984|FG001|Treatment Phase|Lack of Qualifying Event|1|||
46711746|NCT00894556|82927985|FG002|Treatment Phase|Lack of Qualifying Event|0|||
46711747|NCT00894556|82927986|FG003|Treatment Phase|Lack of Qualifying Event|0|||
46711748|NCT01210352|82928002|FG000|Overall Study|Adverse Event|0|||
46711749|NCT01210352|82928003|FG001|Overall Study|Adverse Event|0|||
46711750|NCT01210352|82928004|FG002|Overall Study|Adverse Event|0|||
46711751|NCT01210352|82928005|FG003|Overall Study|Adverse Event|0|||
46711752|NCT01210352|82928006|FG004|Overall Study|Adverse Event|0|||
46711753|NCT01210352|82928007|FG005|Overall Study|Adverse Event|0|||
46711754|NCT01210352|82928008|FG006|Overall Study|Adverse Event|0|||
46711755|NCT01210352|82928009|FG007|Overall Study|Adverse Event|2|||
46711756|NCT01210352|82928010|FG008|Overall Study|Adverse Event|1|||
46711757|NCT01210352|82928002|FG000|Overall Study|Lack of Efficacy|0|||
46711758|NCT01210352|82928003|FG001|Overall Study|Lack of Efficacy|0|||
46711759|NCT01210352|82928004|FG002|Overall Study|Lack of Efficacy|0|||
46711760|NCT01210352|82928005|FG003|Overall Study|Lack of Efficacy|0|||
46711761|NCT01210352|82928006|FG004|Overall Study|Lack of Efficacy|0|||
46711762|NCT01210352|82928007|FG005|Overall Study|Lack of Efficacy|0|||
46711763|NCT01210352|82928008|FG006|Overall Study|Lack of Efficacy|1|||
46711764|NCT01210352|82928009|FG007|Overall Study|Lack of Efficacy|0|||
46711765|NCT01210352|82928010|FG008|Overall Study|Lack of Efficacy|0|||
46711766|NCT01210352|82928002|FG000|Overall Study|Physician Decision|0|||
46711767|NCT01210352|82928003|FG001|Overall Study|Physician Decision|0|||
46711768|NCT01210352|82928004|FG002|Overall Study|Physician Decision|0|||
46711769|NCT01210352|82928005|FG003|Overall Study|Physician Decision|0|||
46711770|NCT01210352|82928006|FG004|Overall Study|Physician Decision|0|||
46711771|NCT01210352|82928007|FG005|Overall Study|Physician Decision|0|||
46711772|NCT01210352|82928008|FG006|Overall Study|Physician Decision|0|||
46711773|NCT01210352|82928009|FG007|Overall Study|Physician Decision|1|||
46711774|NCT01210352|82928010|FG008|Overall Study|Physician Decision|2|||
46711775|NCT01210352|82928002|FG000|Overall Study|Withdrawal by Subject|0|||
46711776|NCT01210352|82928003|FG001|Overall Study|Withdrawal by Subject|0|||
46711777|NCT01210352|82928004|FG002|Overall Study|Withdrawal by Subject|1|||
46711778|NCT01210352|82928005|FG003|Overall Study|Withdrawal by Subject|0|||
46711779|NCT01210352|82928006|FG004|Overall Study|Withdrawal by Subject|0|||
46711780|NCT01210352|82928007|FG005|Overall Study|Withdrawal by Subject|0|||
46711781|NCT01210352|82928008|FG006|Overall Study|Withdrawal by Subject|1|||
46711782|NCT01210352|82928009|FG007|Overall Study|Withdrawal by Subject|0|||
46629917|NCT01931670|82800958|FG001|Treatment Period|Subject Noncompliant|9|||
46629918|NCT01931670|82800959|FG002|Treatment Period|Subject Noncompliant|5|||
46629919|NCT01931670|82800957|FG000|Treatment Period|Adverse Event|19|||
46629920|NCT01931670|82800958|FG001|Treatment Period|Adverse Event|8|||
46629921|NCT01931670|82800959|FG002|Treatment Period|Adverse Event|21|||
46629922|NCT01931670|82800957|FG000|Treatment Period|Lack of Efficacy|11|||
46629923|NCT01931670|82800958|FG001|Treatment Period|Lack of Efficacy|2|||
46629924|NCT01931670|82800959|FG002|Treatment Period|Lack of Efficacy|2|||
46629925|NCT01931670|82800957|FG000|Treatment Period|Pregnancy|7|||
46711783|NCT01210352|82928010|FG008|Overall Study|Withdrawal by Subject|1|||
47036396|NCT01903837|83287533|FG002|Part B|Withdrawal by Subject|0|||
46629926|NCT01931670|82800958|FG001|Treatment Period|Pregnancy|2|||
46629927|NCT01931670|82800959|FG002|Treatment Period|Pregnancy|0|||
46711784|NCT01210352|82928002|FG000|Overall Study|Patient Discharged Early|0|||
46711785|NCT01210352|82928003|FG001|Overall Study|Patient Discharged Early|0|||
46711786|NCT01210352|82928004|FG002|Overall Study|Patient Discharged Early|1|||
46711787|NCT01210352|82928005|FG003|Overall Study|Patient Discharged Early|0|||
46711788|NCT01210352|82928006|FG004|Overall Study|Patient Discharged Early|0|||
46711789|NCT01210352|82928007|FG005|Overall Study|Patient Discharged Early|0|||
46711790|NCT01210352|82928008|FG006|Overall Study|Patient Discharged Early|0|||
46711791|NCT01210352|82928009|FG007|Overall Study|Patient Discharged Early|0|||
46711792|NCT01210352|82928010|FG008|Overall Study|Patient Discharged Early|0|||
46711793|NCT01210118|82928117|FG000|Overall Study|Lost to Follow-up|1|||
46711794|NCT01210118|82928118|FG001|Overall Study|Lost to Follow-up|1|||
46711795|NCT01210118|82928117|FG000|Overall Study|Protocol Violation|1|||
47036397|NCT01903837|83287534|FG003|Part B|Withdrawal by Subject|3|||
46711796|NCT01210118|82928118|FG001|Overall Study|Protocol Violation|1|||
46711797|NCT01210118|82928117|FG000|Overall Study|Spontaneous abortion|1|||
46711798|NCT01210118|82928118|FG001|Overall Study|Spontaneous abortion|3|||
46711799|NCT01208870|82928129|FG000|Overall Study|Lost to Follow-up|2|||
46711800|NCT01208870|82928130|FG001|Overall Study|Lost to Follow-up|8|||
46711801|NCT00880555|82928141|FG000|Overall Study|Physician Decision|0|||
46711802|NCT00880555|82928142|FG001|Overall Study|Physician Decision|8|||
46711803|NCT00880555|82928143|FG002|Overall Study|Physician Decision|0|||
46711804|NCT00880555|82928144|FG003|Overall Study|Physician Decision|2|||
46711805|NCT00880555|82928145|FG004|Overall Study|Physician Decision|1|||
46711806|NCT00880555|82928146|FG005|Overall Study|Physician Decision|0|||
46711807|NCT00880555|82928141|FG000|Overall Study|Withdrawal by Subject|1|||
46711808|NCT00880555|82928142|FG001|Overall Study|Withdrawal by Subject|1|||
46711809|NCT00880555|82928143|FG002|Overall Study|Withdrawal by Subject|0|||
47036398|NCT01903837|83287531|FG000|Part B|Adverse Event|3|||
47036399|NCT01903837|83287532|FG001|Part B|Adverse Event|0|||
47036400|NCT01903837|83287533|FG002|Part B|Adverse Event|2|||
47036401|NCT01903837|83287534|FG003|Part B|Adverse Event|0|||
47036402|NCT01903837|83287531|FG000|Part B|Non-compliance with study drug|2|||
47036403|NCT01903837|83287532|FG001|Part B|Non-compliance with study drug|0|||
47036404|NCT01903837|83287533|FG002|Part B|Non-compliance with study drug|0|||
47036405|NCT01903837|83287534|FG003|Part B|Non-compliance with study drug|1|||
47036406|NCT01903837|83287531|FG000|Part B|Incarceration|2|||
47036407|NCT01903837|83287532|FG001|Part B|Incarceration|0|||
47036408|NCT01903837|83287533|FG002|Part B|Incarceration|0|||
47036409|NCT01903837|83287534|FG003|Part B|Incarceration|1|||
47036410|NCT01903837|83287531|FG000|Part B|Physician Decision|1|||
47036411|NCT01903837|83287532|FG001|Part B|Physician Decision|0|||
47036412|NCT01903837|83287533|FG002|Part B|Physician Decision|0|||
47036413|NCT01903837|83287534|FG003|Part B|Physician Decision|2|||
47036414|NCT01903837|83287531|FG000|Part B|Lack of Efficacy|0|||
47036415|NCT01903837|83287532|FG001|Part B|Lack of Efficacy|1|||
47036416|NCT01903837|83287533|FG002|Part B|Lack of Efficacy|0|||
47036417|NCT01903837|83287534|FG003|Part B|Lack of Efficacy|0|||
47036418|NCT01903525|83287567|FG000|Overall Study|Lost to Follow-up|5|||
47036419|NCT01903525|83287568|FG001|Overall Study|Lost to Follow-up|9|||
47036420|NCT01903525|83287567|FG000|Overall Study|Adverse Event|0|||
47036421|NCT01903525|83287568|FG001|Overall Study|Adverse Event|1|||
47036422|NCT00981526|83287576|FG000|Overall Study|Withdrawal by Subject|0|||
47036423|NCT00981526|83287577|FG001|Overall Study|Withdrawal by Subject|2|||
47036424|NCT00981526|83287576|FG000|Overall Study|Physician Decision|4|||
47036425|NCT00981526|83287577|FG001|Overall Study|Physician Decision|4|||
47036426|NCT01927861|83287587|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
47036427|NCT01927861|83287588|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
46629928|NCT01931670|82800957|FG000|Treatment Period|Other|8|||
46629929|NCT01931670|82800958|FG001|Treatment Period|Other|7|||
46629930|NCT01931670|82800959|FG002|Treatment Period|Other|2|||
46629931|NCT01931670|82800957|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
46629932|NCT01931670|82800958|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
46629933|NCT01931670|82800959|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
46629934|NCT01931670|82800957|FG000|Treatment Period|Lost to Follow-up|19|||
46629935|NCT01931670|82800958|FG001|Treatment Period|Lost to Follow-up|5|||
46629936|NCT01931670|82800959|FG002|Treatment Period|Lost to Follow-up|7|||
46629937|NCT01931670|82800957|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
46629938|NCT01931670|82800958|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
46629939|NCT01931670|82800959|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
46629940|NCT01931670|82800957|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
46629941|NCT01931670|82800958|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
46629942|NCT01931670|82800959|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
46629943|NCT01931670|82800957|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
47036428|NCT01927861|83287587|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
47036429|NCT01927861|83287588|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
47036430|NCT01927627|83287594|FG000|Overall Study|Adverse Event|3|||
46629944|NCT01931670|82800958|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
47036431|NCT01927627|83287594|FG000|Overall Study|Lack of Efficacy|1|||
47036432|NCT01927627|83287594|FG000|Overall Study|Financial Concerns|1|||
47036433|NCT01889251|83287600|FG000|Overall Study|Adverse Event|1|||
47036434|NCT01889251|83287601|FG001|Overall Study|Adverse Event|0|||
47036435|NCT01616563|83287607|FG000|Overall Study|Lost to Follow-up|40|||
46629945|NCT01931670|82800959|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
46711810|NCT00880555|82928144|FG003|Overall Study|Withdrawal by Subject|0|||
46711811|NCT00880555|82928145|FG004|Overall Study|Withdrawal by Subject|0|||
46711812|NCT00880555|82928146|FG005|Overall Study|Withdrawal by Subject|0|||
46711813|NCT00880555|82928141|FG000|Overall Study|Lack of resources (hired rater)|9|||
46711814|NCT00880555|82928142|FG001|Overall Study|Lack of resources (hired rater)|7|||
47036436|NCT01616173|83287615|FG000|Overall Study|Lost to Follow-up|0|||
47036437|NCT01616173|83287616|FG001|Overall Study|Lost to Follow-up|2|||
47036438|NCT01616173|83287617|FG002|Overall Study|Lost to Follow-up|0|||
47036439|NCT01544595|83287631|FG000|Status at Week 68|Adverse Event|3|||
47036440|NCT01544595|83287632|FG001|Status at Week 68|Adverse Event|2|||
47036441|NCT01544595|83287633|FG002|Status at Week 68|Adverse Event|1|||
47036442|NCT01544595|83287634|FG003|Status at Week 68|Adverse Event|0|||
47036443|NCT01544595|83287635|FG004|Status at Week 68|Adverse Event|0|||
47036444|NCT01544595|83287636|FG005|Status at Week 68|Adverse Event|0|||
47036445|NCT01544595|83287631|FG000|Status at Week 68|Lack of Efficacy|1|||
47036446|NCT01544595|83287632|FG001|Status at Week 68|Lack of Efficacy|0|||
47036447|NCT01544595|83287633|FG002|Status at Week 68|Lack of Efficacy|0|||
47036448|NCT01544595|83287634|FG003|Status at Week 68|Lack of Efficacy|0|||
47036449|NCT01544595|83287635|FG004|Status at Week 68|Lack of Efficacy|0|||
47036450|NCT01544595|83287636|FG005|Status at Week 68|Lack of Efficacy|0|||
47036451|NCT01544595|83287631|FG000|Status at Week 68|Lost to Follow-up|1|||
47036452|NCT01544595|83287632|FG001|Status at Week 68|Lost to Follow-up|1|||
47036453|NCT01544595|83287633|FG002|Status at Week 68|Lost to Follow-up|0|||
47036454|NCT01544595|83287634|FG003|Status at Week 68|Lost to Follow-up|0|||
47036455|NCT01544595|83287635|FG004|Status at Week 68|Lost to Follow-up|0|||
47036456|NCT01544595|83287636|FG005|Status at Week 68|Lost to Follow-up|0|||
47036457|NCT01544595|83287631|FG000|Status at Week 68|Non-compliance with study treatment|1|||
47036458|NCT01544595|83287632|FG001|Status at Week 68|Non-compliance with study treatment|0|||
47036459|NCT01544595|83287633|FG002|Status at Week 68|Non-compliance with study treatment|0|||
47036460|NCT01544595|83287634|FG003|Status at Week 68|Non-compliance with study treatment|1|||
47036461|NCT01544595|83287635|FG004|Status at Week 68|Non-compliance with study treatment|0|||
47036462|NCT01544595|83287636|FG005|Status at Week 68|Non-compliance with study treatment|0|||
47036463|NCT01544595|83287631|FG000|Status at Week 68|Protocol Violation|2|||
47036464|NCT01544595|83287632|FG001|Status at Week 68|Protocol Violation|0|||
47036465|NCT01544595|83287633|FG002|Status at Week 68|Protocol Violation|1|||
47036466|NCT01544595|83287634|FG003|Status at Week 68|Protocol Violation|1|||
47036467|NCT01544595|83287635|FG004|Status at Week 68|Protocol Violation|0|||
47036468|NCT01544595|83287636|FG005|Status at Week 68|Protocol Violation|0|||
47036469|NCT01544595|83287631|FG000|Status at Week 68|Technical problems|1|||
47036470|NCT01544595|83287632|FG001|Status at Week 68|Technical problems|0|||
47036471|NCT01544595|83287633|FG002|Status at Week 68|Technical problems|0|||
47036472|NCT01544595|83287634|FG003|Status at Week 68|Technical problems|1|||
47036473|NCT01544595|83287635|FG004|Status at Week 68|Technical problems|0|||
47036474|NCT01544595|83287636|FG005|Status at Week 68|Technical problems|0|||
47036475|NCT01544595|83287631|FG000|Status at Week 68|Withdrawal by Subject|0|||
47036476|NCT01544595|83287632|FG001|Status at Week 68|Withdrawal by Subject|1|||
47036477|NCT01544595|83287633|FG002|Status at Week 68|Withdrawal by Subject|1|||
47036478|NCT01544595|83287634|FG003|Status at Week 68|Withdrawal by Subject|2|||
47036479|NCT01544595|83287635|FG004|Status at Week 68|Withdrawal by Subject|0|||
47036480|NCT01544595|83287636|FG005|Status at Week 68|Withdrawal by Subject|0|||
47036481|NCT01544595|83287631|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
47036482|NCT01544595|83287632|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
47036483|NCT01544595|83287633|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
47036484|NCT01544595|83287634|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
47036485|NCT01544595|83287635|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
47036486|NCT01544595|83287636|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
47036487|NCT01544595|83287631|FG000|Status at Week 156|Withdrawal by Subject|9|||
47036488|NCT01544595|83287632|FG001|Status at Week 156|Withdrawal by Subject|10|||
47036489|NCT01544595|83287633|FG002|Status at Week 156|Withdrawal by Subject|4|||
47036490|NCT01544595|83287634|FG003|Status at Week 156|Withdrawal by Subject|9|||
47036491|NCT01544595|83287635|FG004|Status at Week 156|Withdrawal by Subject|20|||
47036492|NCT01544595|83287636|FG005|Status at Week 156|Withdrawal by Subject|6|||
47036493|NCT01544595|83287631|FG000|Status at Week 156|Adverse Event|9|||
47036494|NCT01544595|83287632|FG001|Status at Week 156|Adverse Event|11|||
47036495|NCT01544595|83287633|FG002|Status at Week 156|Adverse Event|1|||
47036496|NCT01544595|83287634|FG003|Status at Week 156|Adverse Event|3|||
47036497|NCT01544595|83287635|FG004|Status at Week 156|Adverse Event|4|||
47036498|NCT01544595|83287636|FG005|Status at Week 156|Adverse Event|2|||
47036499|NCT01544595|83287631|FG000|Status at Week 156|Lost to Follow-up|4|||
47036500|NCT01544595|83287632|FG001|Status at Week 156|Lost to Follow-up|4|||
47036501|NCT01544595|83287633|FG002|Status at Week 156|Lost to Follow-up|0|||
47036502|NCT01544595|83287634|FG003|Status at Week 156|Lost to Follow-up|1|||
46711815|NCT00880555|82928143|FG002|Overall Study|Lack of resources (hired rater)|5|||
47036503|NCT01544595|83287635|FG004|Status at Week 156|Lost to Follow-up|4|||
46711816|NCT00880555|82928144|FG003|Overall Study|Lack of resources (hired rater)|0|||
47036504|NCT01544595|83287636|FG005|Status at Week 156|Lost to Follow-up|1|||
47036505|NCT01544595|83287631|FG000|Status at Week 156|Non-compliance with study treatement|0|||
47036506|NCT01544595|83287632|FG001|Status at Week 156|Non-compliance with study treatement|1|||
47036507|NCT01544595|83287633|FG002|Status at Week 156|Non-compliance with study treatement|0|||
46711817|NCT00880555|82928145|FG004|Overall Study|Lack of resources (hired rater)|0|||
46711818|NCT00880555|82928146|FG005|Overall Study|Lack of resources (hired rater)|0|||
47036508|NCT01544595|83287634|FG003|Status at Week 156|Non-compliance with study treatement|1|||
47036509|NCT01544595|83287635|FG004|Status at Week 156|Non-compliance with study treatement|0|||
47036510|NCT01544595|83287636|FG005|Status at Week 156|Non-compliance with study treatement|1|||
47036511|NCT01544595|83287631|FG000|Status at Week 156|Physician Decision|0|||
47036512|NCT01544595|83287632|FG001|Status at Week 156|Physician Decision|3|||
47036513|NCT01544595|83287633|FG002|Status at Week 156|Physician Decision|1|||
47036514|NCT01544595|83287634|FG003|Status at Week 156|Physician Decision|0|||
47036515|NCT01544595|83287635|FG004|Status at Week 156|Physician Decision|0|||
47036516|NCT01544595|83287636|FG005|Status at Week 156|Physician Decision|0|||
47036517|NCT01544595|83287631|FG000|Status at Week 156|Pregnancy|2|||
47036518|NCT01544595|83287632|FG001|Status at Week 156|Pregnancy|3|||
47036519|NCT01544595|83287633|FG002|Status at Week 156|Pregnancy|0|||
47036520|NCT01544595|83287634|FG003|Status at Week 156|Pregnancy|0|||
47036521|NCT01544595|83287635|FG004|Status at Week 156|Pregnancy|0|||
47036522|NCT01544595|83287636|FG005|Status at Week 156|Pregnancy|0|||
47036523|NCT01544595|83287631|FG000|Status at Week 156|Protocol Violation|3|||
47036524|NCT01544595|83287632|FG001|Status at Week 156|Protocol Violation|1|||
47036525|NCT01544595|83287633|FG002|Status at Week 156|Protocol Violation|2|||
47036526|NCT01544595|83287634|FG003|Status at Week 156|Protocol Violation|2|||
47036527|NCT01544595|83287635|FG004|Status at Week 156|Protocol Violation|0|||
47036528|NCT01544595|83287636|FG005|Status at Week 156|Protocol Violation|0|||
47036529|NCT01544595|83287631|FG000|Status at Week 156|Technical problems|3|||
47036530|NCT01544595|83287632|FG001|Status at Week 156|Technical problems|1|||
47036531|NCT01544595|83287633|FG002|Status at Week 156|Technical problems|0|||
47036532|NCT01544595|83287634|FG003|Status at Week 156|Technical problems|1|||
47036533|NCT01544595|83287635|FG004|Status at Week 156|Technical problems|0|||
47036534|NCT01544595|83287636|FG005|Status at Week 156|Technical problems|0|||
47036535|NCT01544595|83287631|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
47036536|NCT01544595|83287632|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
47036537|NCT01544595|83287633|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
47036538|NCT01544595|83287634|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
47036539|NCT01544595|83287635|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
47036540|NCT01544595|83287636|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
47036541|NCT01544595|83287631|FG000|Status at Week 156|Lack of Efficacy|1|||
47036542|NCT01544595|83287632|FG001|Status at Week 156|Lack of Efficacy|0|||
47036543|NCT01544595|83287633|FG002|Status at Week 156|Lack of Efficacy|1|||
47036544|NCT01544595|83287634|FG003|Status at Week 156|Lack of Efficacy|4|||
47036545|NCT01544595|83287635|FG004|Status at Week 156|Lack of Efficacy|10|||
47036546|NCT01544595|83287636|FG005|Status at Week 156|Lack of Efficacy|5|||
47036547|NCT01539525|83287657|FG000|Overall Study|Lost to Follow-up|19|||
47036548|NCT01539525|83287658|FG001|Overall Study|Lost to Follow-up|12|||
47036549|NCT01539525|83287659|FG002|Overall Study|Lost to Follow-up|11|||
47036550|NCT01539525|83287657|FG000|Overall Study|Withdrawal by Subject|0|||
47036551|NCT01539525|83287658|FG001|Overall Study|Withdrawal by Subject|3|||
47036552|NCT01539525|83287659|FG002|Overall Study|Withdrawal by Subject|2|||
47036553|NCT01539525|83287657|FG000|Overall Study|Protocol Violation|1|||
47036554|NCT01539525|83287658|FG001|Overall Study|Protocol Violation|1|||
47036555|NCT01539525|83287659|FG002|Overall Study|Protocol Violation|4|||
46711819|NCT00880555|82928141|FG000|Overall Study|Death|0|||
46711820|NCT00880555|82928142|FG001|Overall Study|Death|0|||
46711821|NCT00880555|82928143|FG002|Overall Study|Death|0|||
46711822|NCT00880555|82928144|FG003|Overall Study|Death|0|||
46711823|NCT00880555|82928145|FG004|Overall Study|Death|0|||
47036556|NCT01513551|83287673|FG000|Overall Study|Death|0|||
47036557|NCT01513551|83287674|FG001|Overall Study|Death|1|||
46711824|NCT00880555|82928146|FG005|Overall Study|Death|1|||
46711825|NCT00880555|82928141|FG000|Overall Study|Lost to Follow-up|0|||
46711826|NCT00880555|82928142|FG001|Overall Study|Lost to Follow-up|1|||
47036558|NCT01513551|83287675|FG002|Overall Study|Death|0|||
47036559|NCT01513551|83287673|FG000|Overall Study|Lost to Follow-up|3|||
47036560|NCT01513551|83287674|FG001|Overall Study|Lost to Follow-up|5|||
47036561|NCT01513551|83287675|FG002|Overall Study|Lost to Follow-up|2|||
47036562|NCT01513551|83287673|FG000|Overall Study|Withdrawal by Subject|1|||
47036563|NCT01513551|83287674|FG001|Overall Study|Withdrawal by Subject|0|||
46711827|NCT00880555|82928143|FG002|Overall Study|Lost to Follow-up|0|||
47036564|NCT01513551|83287675|FG002|Overall Study|Withdrawal by Subject|2|||
47036565|NCT01513551|83287673|FG000|Overall Study|Randomized but not vaccinated|0|||
47036566|NCT01513551|83287674|FG001|Overall Study|Randomized but not vaccinated|0|||
47036567|NCT01513551|83287675|FG002|Overall Study|Randomized but not vaccinated|1|||
47036568|NCT01513473|83287685|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
47036569|NCT01513473|83287686|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
47036570|NCT01513473|83287685|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
46711828|NCT00880555|82928144|FG003|Overall Study|Lost to Follow-up|0|||
46711829|NCT00880555|82928145|FG004|Overall Study|Lost to Follow-up|0|||
46711830|NCT00880555|82928146|FG005|Overall Study|Lost to Follow-up|0|||
46711831|NCT01208402|82928159|FG000|Overall Study|Withdrawal by Subject|1|||
46913804|NCT03083847|83144275|FG005|Main|Pregnancy|0|||
46711832|NCT01208402|82928160|FG001|Overall Study|Withdrawal by Subject|0|||
46711833|NCT01208324|82928170|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
47036571|NCT01513473|83287686|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
47036572|NCT01513473|83287685|FG000|Main Trial (26 Weeks)|Unclassified|0|||
47036573|NCT01513473|83287686|FG001|Main Trial (26 Weeks)|Unclassified|2|||
47036574|NCT01513473|83287685|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
47036575|NCT01513473|83287686|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
47036576|NCT01513473|83287685|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
47036577|NCT01513473|83287686|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
47036578|NCT01513317|83287694|FG000|Overall Study|Withdrawal by Subject|15|||
47036579|NCT01513317|83287695|FG001|Overall Study|Withdrawal by Subject|4|||
47036580|NCT01513317|83287694|FG000|Overall Study|Death|1|||
47036581|NCT01513317|83287695|FG001|Overall Study|Death|1|||
47036582|NCT01513317|83287694|FG000|Overall Study|Study terminated by sponsor|18|||
47036583|NCT01513317|83287695|FG001|Overall Study|Study terminated by sponsor|18|||
47036584|NCT01513317|83287694|FG000|Overall Study|Other|0|||
47036585|NCT01513317|83287695|FG001|Overall Study|Other|1|||
47036586|NCT03824392|83287705|FG000|Overall Study|Adverse Event|1|||
47036587|NCT03824392|83287706|FG001|Overall Study|Adverse Event|0|||
47036588|NCT03824392|83287707|FG002|Overall Study|Adverse Event|0|||
47036589|NCT03824392|83287708|FG003|Overall Study|Adverse Event|0|||
47036590|NCT03824392|83287705|FG000|Overall Study|Investigator Decision|0|||
47036591|NCT03824392|83287706|FG001|Overall Study|Investigator Decision|1|||
47036592|NCT03824392|83287707|FG002|Overall Study|Investigator Decision|0|||
47036593|NCT03824392|83287708|FG003|Overall Study|Investigator Decision|0|||
47036594|NCT03824392|83287705|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
47036595|NCT03824392|83287706|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
46629946|NCT01931670|82800957|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
46629947|NCT01931670|82800958|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
46711834|NCT01208324|82928171|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
46629948|NCT01931670|82800959|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
46629949|NCT01931670|82800957|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
46629950|NCT01931670|82800958|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
46629951|NCT01931670|82800959|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
46629952|NCT01931670|82800957|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
46629953|NCT01931670|82800958|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
46629954|NCT01931670|82800959|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
46629955|NCT01977456|82800967|FG000|Overall Study|Death|5|||
46629956|NCT01957644|82800976|FG000|Overall Study|Adverse Event|4|||
46629957|NCT01957644|82800977|FG001|Overall Study|Adverse Event|2|||
46629958|NCT01957644|82800978|FG002|Overall Study|Adverse Event|0|||
46629959|NCT01957644|82800979|FG003|Overall Study|Adverse Event|0|||
46629960|NCT01957644|82800980|FG004|Overall Study|Adverse Event|1|||
46629961|NCT01957644|82800976|FG000|Overall Study|Progressive disease / relapse|0|||
46629962|NCT01957644|82800977|FG001|Overall Study|Progressive disease / relapse|1|||
46629963|NCT01957644|82800978|FG002|Overall Study|Progressive disease / relapse|0|||
46629964|NCT01957644|82800979|FG003|Overall Study|Progressive disease / relapse|1|||
46629965|NCT01957644|82800980|FG004|Overall Study|Progressive disease / relapse|0|||
46629966|NCT01957644|82800976|FG000|Overall Study|Other reason|1|||
46629967|NCT01957644|82800977|FG001|Overall Study|Other reason|2|||
46629968|NCT01957644|82800978|FG002|Overall Study|Other reason|1|||
46629969|NCT01957644|82800979|FG003|Overall Study|Other reason|1|||
46629970|NCT01957644|82800980|FG004|Overall Study|Other reason|0|||
46629971|NCT01957644|82800976|FG000|Overall Study|Withdrawal by Subject|1|||
46629972|NCT01957644|82800977|FG001|Overall Study|Withdrawal by Subject|0|||
46629973|NCT01957644|82800978|FG002|Overall Study|Withdrawal by Subject|0|||
46629974|NCT01957644|82800979|FG003|Overall Study|Withdrawal by Subject|0|||
46629975|NCT01957644|82800980|FG004|Overall Study|Withdrawal by Subject|0|||
46629976|NCT01957644|82800976|FG000|Overall Study|Protocol Violation|0|||
46629977|NCT01957644|82800977|FG001|Overall Study|Protocol Violation|1|||
46629978|NCT01957644|82800978|FG002|Overall Study|Protocol Violation|0|||
46629979|NCT01957644|82800979|FG003|Overall Study|Protocol Violation|0|||
46629980|NCT01957644|82800980|FG004|Overall Study|Protocol Violation|0|||
46629981|NCT01931202|82800997|FG000|Overall Study|Withdrawal by Subject|0|||
46711835|NCT01208324|82928172|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
46711836|NCT01208324|82928173|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
46711837|NCT00880399|82928186|FG000|Overall Study|Adverse Event|4|||
46711838|NCT00880399|82928187|FG001|Overall Study|Adverse Event|6|||
46711839|NCT00880399|82928188|FG002|Overall Study|Adverse Event|5|||
46711840|NCT00880399|82928186|FG000|Overall Study|Lack of Efficacy|1|||
46711841|NCT00880399|82928187|FG001|Overall Study|Lack of Efficacy|4|||
46711842|NCT00880399|82928188|FG002|Overall Study|Lack of Efficacy|2|||
46711843|NCT00880399|82928186|FG000|Overall Study|Protocol Violation|4|||
46711844|NCT00880399|82928187|FG001|Overall Study|Protocol Violation|4|||
46711845|NCT00880399|82928188|FG002|Overall Study|Protocol Violation|6|||
46803634|NCT03523728|83022939|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
46803635|NCT03523728|83022940|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
46711846|NCT00880399|82928186|FG000|Overall Study|Study closed/terminated|3|||
46711847|NCT00880399|82928187|FG001|Overall Study|Study closed/terminated|7|||
46711848|NCT00880399|82928188|FG002|Overall Study|Study closed/terminated|4|||
46711849|NCT00880399|82928186|FG000|Overall Study|Lost to Follow-up|8|||
46711850|NCT00880399|82928187|FG001|Overall Study|Lost to Follow-up|5|||
46711851|NCT00880399|82928188|FG002|Overall Study|Lost to Follow-up|3|||
46711852|NCT00880399|82928186|FG000|Overall Study|Physician Decision|5|||
46711853|NCT00880399|82928187|FG001|Overall Study|Physician Decision|0|||
46711854|NCT00880399|82928188|FG002|Overall Study|Physician Decision|3|||
46711855|NCT00880399|82928186|FG000|Overall Study|Withdrawal by Subject|6|||
46711856|NCT00880399|82928187|FG001|Overall Study|Withdrawal by Subject|3|||
46711857|NCT00880399|82928188|FG002|Overall Study|Withdrawal by Subject|3|||
46711858|NCT01207388|82928196|FG000|Overall Study|Death|67|||
46711859|NCT01207388|82928196|FG000|Overall Study|Withdrawal by Subject|1|||
46711860|NCT01206764|82928208|FG000|Overall Study|Adverse Event|20|||
46711861|NCT01206764|82928208|FG000|Overall Study|Abnormal laboratory value|2|||
46711862|NCT01206764|82928208|FG000|Overall Study|Abnormal test procedure result|1|||
46711863|NCT01206764|82928208|FG000|Overall Study|Patient withdrew consent|5|||
46803636|NCT03523728|83022941|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
46803637|NCT03523728|83022942|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
46803638|NCT03523728|83022938|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
47036596|NCT03824392|83287707|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
47036597|NCT03824392|83287708|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
47036598|NCT01901653|83287731|FG000|Overall Study|Death|2|||
47036599|NCT01901653|83287732|FG001|Overall Study|Death|1|||
47036600|NCT01901653|83287733|FG002|Overall Study|Death|8|||
47036601|NCT01901653|83287734|FG003|Overall Study|Death|3|||
47036602|NCT01901653|83287735|FG004|Overall Study|Death|2|||
46629982|NCT01931202|82800998|FG001|Overall Study|Withdrawal by Subject|0|||
46629983|NCT01931202|82800999|FG002|Overall Study|Withdrawal by Subject|2|||
46629984|NCT01931202|82800997|FG000|Overall Study|Lost to Follow-up|0|||
46629985|NCT01931202|82800998|FG001|Overall Study|Lost to Follow-up|5|||
46629986|NCT01931202|82800999|FG002|Overall Study|Lost to Follow-up|2|||
46629987|NCT01930890|82801014|FG000|Overall Study|Study Termination|14|||
46629988|NCT01930890|82801015|FG001|Overall Study|Study Termination|28|||
46629989|NCT01930890|82801016|FG002|Overall Study|Study Termination|13|||
46629990|NCT01930890|82801017|FG003|Overall Study|Study Termination|25|||
46629991|NCT01930890|82801014|FG000|Overall Study|Death|0|||
46629992|NCT01930890|82801015|FG001|Overall Study|Death|0|||
46629993|NCT01930890|82801016|FG002|Overall Study|Death|0|||
46629994|NCT01930890|82801017|FG003|Overall Study|Death|1|||
46629995|NCT01930890|82801014|FG000|Overall Study|Investigator Decision|0|||
46629996|NCT01930890|82801015|FG001|Overall Study|Investigator Decision|1|||
46629997|NCT01930890|82801016|FG002|Overall Study|Investigator Decision|0|||
46629998|NCT01930890|82801017|FG003|Overall Study|Investigator Decision|0|||
46629999|NCT01930890|82801014|FG000|Overall Study|Consent Withdrawn|0|||
46630000|NCT01930890|82801015|FG001|Overall Study|Consent Withdrawn|3|||
46630001|NCT01930890|82801016|FG002|Overall Study|Consent Withdrawn|0|||
46630002|NCT01930890|82801017|FG003|Overall Study|Consent Withdrawn|1|||
46630003|NCT01930890|82801014|FG000|Overall Study|Adverse Event|0|||
46630004|NCT01930890|82801015|FG001|Overall Study|Adverse Event|1|||
46630005|NCT01930890|82801016|FG002|Overall Study|Adverse Event|0|||
46630006|NCT01930890|82801017|FG003|Overall Study|Adverse Event|0|||
46630007|NCT01930188|82801030|FG000|Overall Study|unclassified|4|||
46630008|NCT01930188|82801031|FG001|Overall Study|unclassified|5|||
46630009|NCT01930188|82801032|FG002|Overall Study|unclassified|3|||
47036603|NCT01901653|83287736|FG005|Overall Study|Death|2|||
47036604|NCT01901653|83287737|FG006|Overall Study|Death|6|||
46630010|NCT01930188|82801030|FG000|Overall Study|Missing follow-up information|2|||
46630011|NCT01930188|82801031|FG001|Overall Study|Missing follow-up information|2|||
46630012|NCT01930188|82801032|FG002|Overall Study|Missing follow-up information|3|||
46630013|NCT01930188|82801030|FG000|Overall Study|Lost to Follow-up|5|||
46630014|NCT01930188|82801031|FG001|Overall Study|Lost to Follow-up|2|||
46630015|NCT01930188|82801032|FG002|Overall Study|Lost to Follow-up|2|||
46630016|NCT01930188|82801030|FG000|Overall Study|Death|2|||
46630017|NCT01930188|82801031|FG001|Overall Study|Death|1|||
46630018|NCT01930188|82801032|FG002|Overall Study|Death|3|||
46711864|NCT01206764|82928208|FG000|Overall Study|Lost to Follow-up|6|||
46711865|NCT01206764|82928208|FG000|Overall Study|Death|11|||
46711866|NCT01206764|82928208|FG000|Overall Study|New cancer therapy|2|||
46711867|NCT01206764|82928208|FG000|Overall Study|Disease progression|88|||
46711868|NCT01206764|82928208|FG000|Overall Study|Protocol deviation|3|||
46711869|NCT00894322|82928215|FG000|Overall Study|Withdrawal by Subject|1|||
46711870|NCT00894322|82928216|FG001|Overall Study|Withdrawal by Subject|0|||
46711871|NCT00894322|82928217|FG002|Overall Study|Withdrawal by Subject|0|||
47036605|NCT01901653|83287738|FG007|Overall Study|Death|9|||
47036606|NCT01901653|83287739|FG008|Overall Study|Death|1|||
47036607|NCT01901653|83287740|FG009|Overall Study|Death|16|||
47036608|NCT01901653|83287741|FG010|Overall Study|Death|2|||
47036609|NCT01901653|83287742|FG011|Overall Study|Death|15|||
47036610|NCT01901653|83287743|FG012|Overall Study|Death|4|||
47036611|NCT01901653|83287731|FG000|Overall Study|Lost to Follow-up|1|||
47036612|NCT01901653|83287732|FG001|Overall Study|Lost to Follow-up|0|||
47036613|NCT01901653|83287733|FG002|Overall Study|Lost to Follow-up|2|||
47036614|NCT01901653|83287734|FG003|Overall Study|Lost to Follow-up|0|||
47036615|NCT01901653|83287735|FG004|Overall Study|Lost to Follow-up|0|||
47036616|NCT01901653|83287736|FG005|Overall Study|Lost to Follow-up|1|||
47036617|NCT01901653|83287737|FG006|Overall Study|Lost to Follow-up|0|||
47036618|NCT01901653|83287738|FG007|Overall Study|Lost to Follow-up|1|||
47036619|NCT01901653|83287739|FG008|Overall Study|Lost to Follow-up|0|||
47036620|NCT01901653|83287740|FG009|Overall Study|Lost to Follow-up|0|||
47036621|NCT01901653|83287741|FG010|Overall Study|Lost to Follow-up|0|||
47036622|NCT01901653|83287742|FG011|Overall Study|Lost to Follow-up|0|||
47036623|NCT01901653|83287743|FG012|Overall Study|Lost to Follow-up|0|||
47036624|NCT01901653|83287731|FG000|Overall Study|Withdrawal by Subject|0|||
47036625|NCT01901653|83287732|FG001|Overall Study|Withdrawal by Subject|0|||
47036626|NCT01901653|83287733|FG002|Overall Study|Withdrawal by Subject|0|||
47036627|NCT01901653|83287734|FG003|Overall Study|Withdrawal by Subject|0|||
47036628|NCT01901653|83287735|FG004|Overall Study|Withdrawal by Subject|0|||
47036629|NCT01901653|83287736|FG005|Overall Study|Withdrawal by Subject|0|||
47036630|NCT01901653|83287737|FG006|Overall Study|Withdrawal by Subject|1|||
47036631|NCT01901653|83287738|FG007|Overall Study|Withdrawal by Subject|0|||
47036632|NCT01901653|83287739|FG008|Overall Study|Withdrawal by Subject|0|||
47036633|NCT01901653|83287740|FG009|Overall Study|Withdrawal by Subject|0|||
47036634|NCT01901653|83287741|FG010|Overall Study|Withdrawal by Subject|0|||
47036635|NCT01901653|83287742|FG011|Overall Study|Withdrawal by Subject|0|||
47036636|NCT01901653|83287743|FG012|Overall Study|Withdrawal by Subject|0|||
47036637|NCT01901653|83287731|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
47036638|NCT01901653|83287732|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
47036639|NCT01901653|83287733|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
47036640|NCT01901653|83287734|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
47036641|NCT01901653|83287735|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
47036642|NCT01901653|83287736|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
47036643|NCT01901653|83287737|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
47036644|NCT01901653|83287738|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
47036645|NCT01901653|83287739|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
47036646|NCT01901653|83287740|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
47036647|NCT01901653|83287741|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
47036648|NCT01901653|83287742|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
47036649|NCT01901653|83287743|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
47036650|NCT01925989|83287771|FG000|Period 1|Sponsor Decision|1|||
47036651|NCT01925989|83287772|FG001|Period 1|Sponsor Decision|1|||
47036652|NCT01925989|83287773|FG002|Period 1|Sponsor Decision|0|||
47036653|NCT01925989|83287771|FG000|Period 1|Withdrawal by Subject|0|||
47036654|NCT01925989|83287772|FG001|Period 1|Withdrawal by Subject|1|||
47036655|NCT01925989|83287773|FG002|Period 1|Withdrawal by Subject|0|||
47036656|NCT01901419|83287787|FG000|Overall Study|Protocol Violation|2|||
47036657|NCT01901419|83287788|FG001|Overall Study|Protocol Violation|6|||
47036658|NCT01901419|83287787|FG000|Overall Study|unavailable researchers|6|||
47036659|NCT01901419|83287788|FG001|Overall Study|unavailable researchers|3|||
47036660|NCT01901341|83287815|FG000|Overall Study|Adverse Event|4|||
47036661|NCT01901341|83287816|FG001|Overall Study|Adverse Event|2|||
46630019|NCT01930188|82801030|FG000|Overall Study|Withdrawal by Subject|9|||
46630020|NCT01930188|82801031|FG001|Overall Study|Withdrawal by Subject|11|||
46630021|NCT01930188|82801032|FG002|Overall Study|Withdrawal by Subject|8|||
46630022|NCT01977222|82801041|FG000|Overall Study|Withdrawal by Subject|1|||
46630023|NCT01957488|82801045|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
46630024|NCT01957488|82801046|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
46630025|NCT01957488|82801047|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
46630026|NCT01957488|82801048|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
46630027|NCT01957488|82801049|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
46630028|NCT01957488|82801050|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
47036662|NCT01901341|83287815|FG000|Overall Study|Lack of Efficacy|0|||
47036663|NCT01901341|83287816|FG001|Overall Study|Lack of Efficacy|2|||
47036664|NCT01901341|83287815|FG000|Overall Study|Lost to Follow-up|0|||
46711872|NCT00596635|82928230|FG000|Overall Study|Lost to Follow-up|0|||
47036665|NCT01901341|83287816|FG001|Overall Study|Lost to Follow-up|1|||
47036666|NCT01901341|83287815|FG000|Overall Study|Protocol Violation|2|||
47036667|NCT01901341|83287816|FG001|Overall Study|Protocol Violation|0|||
46630029|NCT01957488|82801045|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
46711873|NCT00596635|82928231|FG001|Overall Study|Lost to Follow-up|2|||
47036668|NCT01901341|83287815|FG000|Overall Study|Study Terminated by Sponsor|13|||
46711874|NCT00596635|82928232|FG002|Overall Study|Lost to Follow-up|0|||
46711875|NCT00596635|82928230|FG000|Overall Study|Treatment for symptomatic UTI|4|||
46711876|NCT00596635|82928231|FG001|Overall Study|Treatment for symptomatic UTI|6|||
46711877|NCT00596635|82928232|FG002|Overall Study|Treatment for symptomatic UTI|3|||
46711878|NCT00596635|82928230|FG000|Overall Study|Hip fracture|2|||
46711879|NCT00596635|82928231|FG001|Overall Study|Hip fracture|3|||
46711880|NCT00596635|82928232|FG002|Overall Study|Hip fracture|3|||
46711881|NCT00596635|82928230|FG000|Overall Study|Could not provide urine specimen|1|||
46711882|NCT00596635|82928231|FG001|Overall Study|Could not provide urine specimen|2|||
46711883|NCT00596635|82928232|FG002|Overall Study|Could not provide urine specimen|2|||
46711884|NCT00894166|82928248|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
46711885|NCT00894166|82928249|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
46711886|NCT00894166|82928250|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
46711887|NCT00894166|82928251|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
46711888|NCT00894166|82928252|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
46711889|NCT00894166|82928253|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
46711890|NCT00894166|82928254|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
46711891|NCT00894166|82928255|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
46711892|NCT00894166|82928248|FG000|Overall Study|Death|0|||
46711893|NCT00894166|82928249|FG001|Overall Study|Death|0|||
46711894|NCT00894166|82928250|FG002|Overall Study|Death|0|||
46711895|NCT00894166|82928251|FG003|Overall Study|Death|1|||
46711896|NCT00894166|82928252|FG004|Overall Study|Death|0|||
46711897|NCT00894166|82928253|FG005|Overall Study|Death|0|||
46711898|NCT00894166|82928254|FG006|Overall Study|Death|0|||
46711899|NCT00894166|82928255|FG007|Overall Study|Death|0|||
46711900|NCT00880165|82928280|FG000|Overall Study|Withdrawal by Subject|27|||
46711901|NCT00880165|82928281|FG001|Overall Study|Withdrawal by Subject|23|||
46711902|NCT00880165|82928280|FG000|Overall Study|Not diagnosed with OSA|14|||
46711903|NCT00880165|82928281|FG001|Overall Study|Not diagnosed with OSA|8|||
46711904|NCT00880165|82928280|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
46711905|NCT00880165|82928281|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
46711906|NCT00880165|82928280|FG000|Overall Study|Lost to follow|9|||
46711907|NCT00880165|82928281|FG001|Overall Study|Lost to follow|15|||
46711908|NCT04153981|82928287|FG000|Overall Study|Death|1|||
46711909|NCT04153981|82928287|FG000|Overall Study|Withdrawal by Subject|24|||
46711910|NCT04153981|82928287|FG000|Overall Study|Lost to Follow-up|1|||
46711911|NCT04153981|82928287|FG000|Overall Study|Physician Decision|1|||
46711912|NCT04153981|82928287|FG000|Overall Study|Due to Unavailable Glucometer|1|||
46711913|NCT04153981|82928287|FG000|Overall Study|Covid 19|52|||
46711914|NCT04153981|82928287|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
46711915|NCT04153981|82928287|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
47036669|NCT01901341|83287816|FG001|Overall Study|Study Terminated by Sponsor|15|||
47036670|NCT01901341|83287815|FG000|Overall Study|Withdrawal by Subject|1|||
47036671|NCT01901341|83287816|FG001|Overall Study|Withdrawal by Subject|1|||
47036672|NCT01615939|83287825|FG000|Overall Study|Lost to Follow-up|5|||
47036673|NCT01615939|83287826|FG001|Overall Study|Lost to Follow-up|0|||
47036674|NCT01901185|83287832|FG000|Overall Study|Withdrawal by Subject|2|||
47036675|NCT01888003|83287839|FG000|Overall Study|Study Terminated|5|||
46630030|NCT01957488|82801046|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
46630031|NCT01957488|82801047|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
46630032|NCT01957488|82801048|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
46630033|NCT01957488|82801049|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
46630034|NCT01957488|82801050|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
46630035|NCT01957488|82801045|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
46630036|NCT01957488|82801046|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
46630037|NCT01957488|82801047|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
46630038|NCT01957488|82801048|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
46630039|NCT01957488|82801049|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
46630040|NCT01957488|82801050|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
46630041|NCT01957488|82801045|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
46711916|NCT01165229|82928293|FG000|Overall Study|Serious Adverse Event|456|||
46711917|NCT01165229|82928294|FG001|Overall Study|Serious Adverse Event|487|||
46711918|NCT01165229|82928293|FG000|Overall Study|Non-Serious Adverse Event|47|||
46711919|NCT01165229|82928294|FG001|Overall Study|Non-Serious Adverse Event|15|||
46711920|NCT01165229|82928293|FG000|Overall Study|Protocol Violation|6|||
46711921|NCT01165229|82928294|FG001|Overall Study|Protocol Violation|8|||
46711922|NCT01165229|82928293|FG000|Overall Study|Withdrawal by Subject|387|||
46711923|NCT01165229|82928294|FG001|Overall Study|Withdrawal by Subject|396|||
46711924|NCT01165229|82928293|FG000|Overall Study|Migrated/moved from study area|51|||
46711925|NCT01165229|82928294|FG001|Overall Study|Migrated/moved from study area|46|||
46711926|NCT01165229|82928293|FG000|Overall Study|Lost to Follow-up|123|||
46711927|NCT01165229|82928294|FG001|Overall Study|Lost to Follow-up|133|||
47036676|NCT01888003|83287840|FG001|Overall Study|Study Terminated|6|||
47036677|NCT01888003|83287841|FG002|Overall Study|Study Terminated|40|||
47036678|NCT02775214|83287851|FG000|Overall Study|Withdrawal by Subject|2|||
47036679|NCT02775214|83287852|FG001|Overall Study|Withdrawal by Subject|0|||
47036680|NCT01925209|83287907|FG000|Treatment Epoch|Physician Decision|1|||
47036681|NCT01925209|83287908|FG001|Treatment Epoch|Physician Decision|0|||
47036682|NCT01925209|83287909|FG002|Treatment Epoch|Physician Decision|0|||
47036683|NCT01925209|83287910|FG003|Treatment Epoch|Physician Decision|0|||
47036684|NCT01925209|83287907|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
47036685|NCT01925209|83287908|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
47036686|NCT01925209|83287909|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
47036687|NCT01925209|83287910|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
47036688|NCT01925209|83287907|FG000|Treatment Epoch|Death|1|||
47036689|NCT01925209|83287908|FG001|Treatment Epoch|Death|0|||
47036690|NCT01925209|83287909|FG002|Treatment Epoch|Death|0|||
47036691|NCT01925209|83287910|FG003|Treatment Epoch|Death|0|||
47036692|NCT01925209|83287907|FG000|Treatment Epoch|Protocol deviation|0|||
47036693|NCT01925209|83287908|FG001|Treatment Epoch|Protocol deviation|0|||
47036694|NCT01925209|83287909|FG002|Treatment Epoch|Protocol deviation|1|||
47036695|NCT01925209|83287910|FG003|Treatment Epoch|Protocol deviation|1|||
47036696|NCT01925209|83287907|FG000|Treatment Epoch|Withdrawal by Subject|4|||
47036697|NCT01925209|83287908|FG001|Treatment Epoch|Withdrawal by Subject|3|||
46711928|NCT01165229|82928293|FG000|Overall Study|Suspected HZ Episode|2|||
46711929|NCT01165229|82928294|FG001|Overall Study|Suspected HZ Episode|2|||
46711930|NCT01165229|82928293|FG000|Overall Study|No reason from the subject|108|||
46711931|NCT01165229|82928294|FG001|Overall Study|No reason from the subject|102|||
46711932|NCT01165229|82928293|FG000|Overall Study|Unknown completion status|0|||
46711933|NCT01165229|82928294|FG001|Overall Study|Unknown completion status|1|||
46711934|NCT00596011|82928332|FG000|Overall Study|Withdrawal by Subject|2|||
46711935|NCT00596011|82928333|FG001|Overall Study|Withdrawal by Subject|3|||
46711936|NCT00596011|82928332|FG000|Overall Study|Adverse Event|11|||
46711937|NCT00596011|82928333|FG001|Overall Study|Adverse Event|7|||
46711938|NCT01163747|82928341|FG000|Overall Study|Adverse Event|0|||
46711939|NCT01163747|82928342|FG001|Overall Study|Adverse Event|5|||
46711940|NCT01163747|82928341|FG000|Overall Study|Insufficient Therapeutic Response|0|||
46711941|NCT01163747|82928342|FG001|Overall Study|Insufficient Therapeutic Response|1|||
46711942|NCT01163747|82928341|FG000|Overall Study|Protocol Violation|0|||
46711943|NCT01163747|82928342|FG001|Overall Study|Protocol Violation|1|||
46711944|NCT01163747|82928341|FG000|Overall Study|Refused Treatment|6|||
46711945|NCT01163747|82928342|FG001|Overall Study|Refused Treatment|4|||
46711946|NCT01163279|82928350|FG000|Overall Study|Withdrawal by Subject|2|||
46711947|NCT01163279|82928351|FG001|Overall Study|Withdrawal by Subject|0|||
46711948|NCT01162499|82928358|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
46711949|NCT01162499|82928359|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
46711950|NCT01206140|82928369|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
46711951|NCT01206140|82928370|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
46711952|NCT01162421|82928378|FG000|Overall Study|Did not receive study drug|2|||
47036698|NCT01925209|83287909|FG002|Treatment Epoch|Withdrawal by Subject|3|||
47036699|NCT01925209|83287910|FG003|Treatment Epoch|Withdrawal by Subject|2|||
47036700|NCT01925209|83287907|FG000|Treatment Epoch|Adverse Event|3|||
47036701|NCT01925209|83287908|FG001|Treatment Epoch|Adverse Event|5|||
47036702|NCT01925209|83287909|FG002|Treatment Epoch|Adverse Event|3|||
47036703|NCT01925209|83287910|FG003|Treatment Epoch|Adverse Event|1|||
47036704|NCT01925209|83287907|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
47036705|NCT01925209|83287908|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
47036706|NCT01925209|83287909|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
46630042|NCT01957488|82801046|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
46630043|NCT01957488|82801047|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
46630044|NCT01957488|82801048|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
46630045|NCT01957488|82801049|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
46630046|NCT01957488|82801050|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
46630047|NCT01957488|82801045|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
46630048|NCT01957488|82801046|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
46630049|NCT01957488|82801047|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
46630050|NCT01957488|82801048|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
46630051|NCT01957488|82801049|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
46711953|NCT01162421|82928379|FG001|Overall Study|Did not receive study drug|1|||
46711954|NCT01162421|82928378|FG000|Overall Study|Adverse Event|2|||
46711955|NCT01162421|82928379|FG001|Overall Study|Adverse Event|5|||
46711956|NCT01162421|82928378|FG000|Overall Study|Lost to Follow-up|0|||
46711957|NCT01162421|82928379|FG001|Overall Study|Lost to Follow-up|2|||
46711958|NCT01162421|82928378|FG000|Overall Study|Lack of Efficacy|2|||
46711959|NCT01162421|82928379|FG001|Overall Study|Lack of Efficacy|2|||
46711960|NCT01162421|82928378|FG000|Overall Study|Other|2|||
47036707|NCT01925209|83287910|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
47036708|NCT01925209|83287907|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
47036709|NCT01925209|83287908|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
47036710|NCT01925209|83287909|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
47036711|NCT01925209|83287910|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
47036712|NCT01925209|83287907|FG000|Follow-up|Adverse Event|1|||
47036713|NCT01925209|83287908|FG001|Follow-up|Adverse Event|4|||
47036714|NCT01925209|83287909|FG002|Follow-up|Adverse Event|0|||
47036715|NCT01925209|83287910|FG003|Follow-up|Adverse Event|1|||
47036716|NCT01925209|83287907|FG000|Follow-up|Physician Decision|0|||
47036717|NCT01925209|83287908|FG001|Follow-up|Physician Decision|0|||
47036718|NCT01925209|83287909|FG002|Follow-up|Physician Decision|1|||
47036719|NCT01925209|83287910|FG003|Follow-up|Physician Decision|0|||
47036720|NCT01925209|83287907|FG000|Follow-up|Non-compliance with study treatment|0|||
47036721|NCT01925209|83287908|FG001|Follow-up|Non-compliance with study treatment|0|||
47036722|NCT01925209|83287909|FG002|Follow-up|Non-compliance with study treatment|0|||
47036723|NCT01925209|83287910|FG003|Follow-up|Non-compliance with study treatment|1|||
47036724|NCT01925209|83287907|FG000|Follow-up|Withdrawal by Subject|0|||
47036725|NCT01925209|83287908|FG001|Follow-up|Withdrawal by Subject|2|||
47036726|NCT01925209|83287909|FG002|Follow-up|Withdrawal by Subject|0|||
46711961|NCT01162421|82928379|FG001|Overall Study|Other|3|||
46711962|NCT01162343|82928385|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
46711963|NCT01162343|82928385|FG000|Overall Study|Refused psychiatrist assessment|12|||
46711964|NCT01188551|82928393|FG000|Overall Study|Pharmacy issues|1|||
46711965|NCT01188551|82928394|FG001|Overall Study|Pharmacy issues|0|||
46711966|NCT01188551|82928395|FG002|Overall Study|Pharmacy issues|0|||
46711967|NCT01188551|82928396|FG003|Overall Study|Pharmacy issues|0|||
46711968|NCT01161407|82928408|FG000|Overall Study|Protocol Violation|3|||
46711969|NCT01161407|82928409|FG001|Overall Study|Protocol Violation|1|||
46711970|NCT01161173|82928415|FG000|Overall Study|Protocol Violation|13|||
46711971|NCT01161173|82928415|FG000|Overall Study|Lost to Follow-up|7|||
46711972|NCT01161173|82928415|FG000|Overall Study|Progressive Disease|82|||
46711973|NCT01161173|82928415|FG000|Overall Study|Withdrawal of Consent|5|||
46711974|NCT01161173|82928415|FG000|Overall Study|Unacceptable Toxicity|21|||
46711975|NCT01161173|82928415|FG000|Overall Study|Death|194|||
46711976|NCT01161173|82928415|FG000|Overall Study|End of Study|2|||
46711977|NCT01161173|82928415|FG000|Overall Study|Reasons Not Specified|23|||
46711978|NCT01159769|82928419|FG000|Overall Study|Adverse Event|1|||
46711979|NCT01159691|82928423|FG000|Overall Study|Lost to Follow-up|2|||
46711980|NCT01159691|82928423|FG000|Overall Study|Unknown reasons|1|||
46711981|NCT01159691|82928423|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
46711982|NCT01159691|82928423|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
46711983|NCT01159691|82928423|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
46711984|NCT01159691|82928423|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
46711985|NCT01159691|82928423|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
46711986|NCT01159691|82928423|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
47036727|NCT01925209|83287910|FG003|Follow-up|Withdrawal by Subject|2|||
47036728|NCT01614925|83287922|FG000|Overall Study|Withdrawal by Subject|1|||
47036729|NCT01614925|83287923|FG001|Overall Study|Withdrawal by Subject|0|||
47036730|NCT01614925|83287922|FG000|Overall Study|Protocol Violation|3|||
46630052|NCT01957488|82801050|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
46630053|NCT01957488|82801045|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
46630054|NCT01957488|82801046|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
46630055|NCT01957488|82801047|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
46630056|NCT01957488|82801048|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
46630057|NCT01957488|82801049|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
46630058|NCT01957488|82801050|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
46630059|NCT01957488|82801045|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
46630060|NCT01957488|82801046|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
46630061|NCT01957488|82801047|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
46630062|NCT01957488|82801048|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
46630063|NCT01957488|82801049|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
46630064|NCT01957488|82801050|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
47036731|NCT01614925|83287923|FG001|Overall Study|Protocol Violation|2|||
47036732|NCT01886833|83287929|FG000|Overall Study|IgA not available from both periods|204|||
47036733|NCT01898923|83287938|FG000|Overall Study|Lack of Efficacy|5|||
47036734|NCT01898923|83287939|FG001|Overall Study|Lack of Efficacy|6|||
46630065|NCT01957488|82801045|FG000|Test Period 2 (2 Weeks)|Other|1|||
46711987|NCT01157897|82928431|FG000|Overall Study|Lost to Follow-up|2|||
46711988|NCT01157897|82928432|FG001|Overall Study|Lost to Follow-up|0|||
46711989|NCT01157897|82928433|FG002|Overall Study|Lost to Follow-up|0|||
46711990|NCT01157897|82928434|FG003|Overall Study|Lost to Follow-up|1|||
46711991|NCT01157897|82928431|FG000|Overall Study|Relocated|0|||
46711992|NCT01157897|82928432|FG001|Overall Study|Relocated|2|||
46711993|NCT01157897|82928433|FG002|Overall Study|Relocated|0|||
46711994|NCT01157897|82928434|FG003|Overall Study|Relocated|0|||
46711995|NCT01185821|82928449|FG000|Overall Study|Abnormal laboratory value(s)|1|||
47036735|NCT01898923|83287938|FG000|Overall Study|Adverse Event|3|||
47036736|NCT01898923|83287939|FG001|Overall Study|Adverse Event|1|||
47036737|NCT01898923|83287938|FG000|Overall Study|Lost to Follow-up|0|||
47036738|NCT01898923|83287939|FG001|Overall Study|Lost to Follow-up|1|||
47036739|NCT01898923|83287938|FG000|Overall Study|Withdrawal by Subject|4|||
47036740|NCT01898923|83287939|FG001|Overall Study|Withdrawal by Subject|7|||
47036741|NCT01898923|83287938|FG000|Overall Study|Physician Decision|3|||
47036742|NCT01898923|83287939|FG001|Overall Study|Physician Decision|4|||
47036743|NCT01898923|83287938|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
47036744|NCT01898923|83287939|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
47036745|NCT01924429|83287947|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
47036746|NCT01924429|83287948|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
47036747|NCT01898299|83287958|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
47036748|NCT01898299|83287959|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
47036749|NCT01886287|83287965|FG000|Overall Study|Radiographic disease progression|1|||
47036750|NCT01886287|83287965|FG000|Overall Study|Clinical progression due to disease|1|||
47036751|NCT01885195|83287969|FG000|Overall Study|Adverse Event|29|||
47036752|NCT01885195|83287969|FG000|Overall Study|Death|1|||
47036753|NCT01885195|83287969|FG000|Overall Study|Disease Progression|67|||
47036754|NCT01885195|83287969|FG000|Overall Study|Protocol Deviation|2|||
46630066|NCT01957488|82801046|FG001|Test Period 2 (2 Weeks)|Other|0|||
46630067|NCT01957488|82801047|FG002|Test Period 2 (2 Weeks)|Other|0|||
46630068|NCT01957488|82801048|FG003|Test Period 2 (2 Weeks)|Other|0|||
46630069|NCT01957488|82801049|FG004|Test Period 2 (2 Weeks)|Other|0|||
46630070|NCT01957488|82801050|FG005|Test Period 2 (2 Weeks)|Other|0|||
46630071|NCT01957488|82801045|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
46711996|NCT01185821|82928450|FG001|Overall Study|Abnormal laboratory value(s)|2|||
46711997|NCT01185821|82928451|FG002|Overall Study|Abnormal laboratory value(s)|1|||
46711998|NCT01185821|82928452|FG003|Overall Study|Abnormal laboratory value(s)|0|||
46711999|NCT01185821|82928453|FG004|Overall Study|Abnormal laboratory value(s)|0|||
46712000|NCT01185821|82928449|FG000|Overall Study|Protocol Violation|0|||
46712001|NCT01185821|82928450|FG001|Overall Study|Protocol Violation|0|||
46712002|NCT01185821|82928451|FG002|Overall Study|Protocol Violation|0|||
46712003|NCT01185821|82928452|FG003|Overall Study|Protocol Violation|1|||
46712004|NCT01185821|82928453|FG004|Overall Study|Protocol Violation|1|||
46712005|NCT01185821|82928449|FG000|Overall Study|Abnormal test procedure result|0|||
46712006|NCT01185821|82928450|FG001|Overall Study|Abnormal test procedure result|0|||
46712007|NCT01185821|82928451|FG002|Overall Study|Abnormal test procedure result|0|||
46712008|NCT01185821|82928452|FG003|Overall Study|Abnormal test procedure result|0|||
46712009|NCT01185821|82928453|FG004|Overall Study|Abnormal test procedure result|1|||
46712010|NCT01185821|82928449|FG000|Overall Study|Death|0|||
46712011|NCT01185821|82928450|FG001|Overall Study|Death|1|||
46712012|NCT01185821|82928451|FG002|Overall Study|Death|0|||
46712013|NCT01185821|82928452|FG003|Overall Study|Death|0|||
46712014|NCT01185821|82928453|FG004|Overall Study|Death|0|||
46712015|NCT01185821|82928449|FG000|Overall Study|Condition no longer required study drug|0|||
46712016|NCT01185821|82928450|FG001|Overall Study|Condition no longer required study drug|0|||
46712017|NCT01185821|82928451|FG002|Overall Study|Condition no longer required study drug|0|||
46712018|NCT01185821|82928452|FG003|Overall Study|Condition no longer required study drug|0|||
46712019|NCT01185821|82928453|FG004|Overall Study|Condition no longer required study drug|1|||
46712020|NCT01185821|82928449|FG000|Overall Study|Adverse Event|2|||
46630072|NCT01957488|82801046|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
46630073|NCT01957488|82801047|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
46630074|NCT01957488|82801048|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
46712021|NCT01185821|82928450|FG001|Overall Study|Adverse Event|3|||
46712022|NCT01185821|82928451|FG002|Overall Study|Adverse Event|1|||
46712023|NCT01185821|82928452|FG003|Overall Study|Adverse Event|2|||
46712024|NCT01185821|82928453|FG004|Overall Study|Adverse Event|5|||
46712025|NCT01185821|82928449|FG000|Overall Study|Lack of Efficacy|0|||
47036755|NCT01885195|83287969|FG000|Overall Study|Physician Decision|3|||
47036756|NCT01885195|83287969|FG000|Overall Study|Patient/guardian decision|8|||
47036757|NCT01896895|83287976|FG000|Double-blind MP|Physician Decision|0|||
47036758|NCT01896895|83287977|FG001|Double-blind MP|Physician Decision|0|||
46630075|NCT01957488|82801049|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
46712026|NCT01185821|82928450|FG001|Overall Study|Lack of Efficacy|0|||
46712027|NCT01185821|82928451|FG002|Overall Study|Lack of Efficacy|3|||
46712028|NCT01185821|82928452|FG003|Overall Study|Lack of Efficacy|0|||
46712029|NCT01185821|82928453|FG004|Overall Study|Lack of Efficacy|9|||
46712030|NCT01185821|82928449|FG000|Overall Study|Withdrawal by Subject|3|||
46712031|NCT01185821|82928450|FG001|Overall Study|Withdrawal by Subject|2|||
46712032|NCT01185821|82928451|FG002|Overall Study|Withdrawal by Subject|2|||
47036759|NCT01896895|83287978|FG002|Double-blind MP|Physician Decision|1|||
47036760|NCT01896895|83287979|FG003|Double-blind MP|Physician Decision|0|||
47036761|NCT01896895|83287976|FG000|Double-blind MP|Withdrawal by Subject|0|||
47036762|NCT01896895|83287977|FG001|Double-blind MP|Withdrawal by Subject|2|||
47036763|NCT01896895|83287978|FG002|Double-blind MP|Withdrawal by Subject|1|||
47036764|NCT01896895|83287979|FG003|Double-blind MP|Withdrawal by Subject|0|||
47036765|NCT01896895|83287976|FG000|Double-blind MP|Lost to Follow-up|1|||
47036766|NCT01896895|83287977|FG001|Double-blind MP|Lost to Follow-up|0|||
47036767|NCT01896895|83287978|FG002|Double-blind MP|Lost to Follow-up|1|||
47036768|NCT01896895|83287979|FG003|Double-blind MP|Lost to Follow-up|0|||
47036769|NCT01923181|83288015|FG000|Overall Study|Protocol Violation|2|||
47036770|NCT01923181|83288016|FG001|Overall Study|Protocol Violation|2|||
47036771|NCT01923181|83288017|FG002|Overall Study|Protocol Violation|0|||
47036772|NCT01923181|83288018|FG003|Overall Study|Protocol Violation|2|||
47036773|NCT01923181|83288019|FG004|Overall Study|Protocol Violation|2|||
46712033|NCT01185821|82928452|FG003|Overall Study|Withdrawal by Subject|1|||
46712034|NCT01185821|82928453|FG004|Overall Study|Withdrawal by Subject|3|||
46712035|NCT01185821|82928449|FG000|Overall Study|Lost to Follow-up|1|||
46712036|NCT01185821|82928450|FG001|Overall Study|Lost to Follow-up|1|||
46712037|NCT01185821|82928451|FG002|Overall Study|Lost to Follow-up|2|||
46712038|NCT01185821|82928452|FG003|Overall Study|Lost to Follow-up|1|||
46712039|NCT01185821|82928453|FG004|Overall Study|Lost to Follow-up|2|||
46712040|NCT01185821|82928449|FG000|Overall Study|Administrative problems|0|||
46712041|NCT01185821|82928450|FG001|Overall Study|Administrative problems|0|||
46712042|NCT01185821|82928451|FG002|Overall Study|Administrative problems|1|||
46712043|NCT01185821|82928452|FG003|Overall Study|Administrative problems|1|||
46712044|NCT01185821|82928453|FG004|Overall Study|Administrative problems|2|||
46712045|NCT00893464|82928475|FG000|Overall Study|Did not complete therapy/experience PD|0|||
46712046|NCT00893464|82928476|FG001|Overall Study|Did not complete therapy/experience PD|0|||
46712047|NCT00893464|82928477|FG002|Overall Study|Did not complete therapy/experience PD|0|||
46712048|NCT00893464|82928478|FG003|Overall Study|Did not complete therapy/experience PD|0|||
46712049|NCT00893464|82928479|FG004|Overall Study|Did not complete therapy/experience PD|0|||
46712050|NCT00893464|82928480|FG005|Overall Study|Did not complete therapy/experience PD|0|||
46712051|NCT00893464|82928481|FG006|Overall Study|Did not complete therapy/experience PD|2|||
46712052|NCT00893464|82928482|FG007|Overall Study|Did not complete therapy/experience PD|2|||
46712053|NCT00891904|82928505|FG000|Overall Study|Death|1|||
46712054|NCT00891904|82928505|FG000|Overall Study|Adverse Event|1|||
46712055|NCT01157351|82928511|FG000|Overall Study|Adverse Event|5|||
46712056|NCT01157351|82928512|FG001|Overall Study|Adverse Event|4|||
46712057|NCT01157351|82928511|FG000|Overall Study|Death|1|||
46712058|NCT01157351|82928512|FG001|Overall Study|Death|0|||
46712059|NCT01157351|82928511|FG000|Overall Study|Lost to Follow-up|53|||
46712060|NCT01157351|82928512|FG001|Overall Study|Lost to Follow-up|55|||
46712061|NCT01157351|82928511|FG000|Overall Study|Withdrawal by Subject|37|||
46712062|NCT01157351|82928512|FG001|Overall Study|Withdrawal by Subject|27|||
46712063|NCT01157351|82928511|FG000|Overall Study|Physician Decision|5|||
46712064|NCT01157351|82928512|FG001|Overall Study|Physician Decision|4|||
46712065|NCT01157351|82928511|FG000|Overall Study|Protocol Violation|0|||
46712066|NCT01157351|82928512|FG001|Overall Study|Protocol Violation|1|||
46712067|NCT01157351|82928511|FG000|Overall Study|Other|32|||
46712068|NCT01157351|82928512|FG001|Overall Study|Other|36|||
46712069|NCT01157351|82928511|FG000|Overall Study|Noncompliance with Study Drug|0|||
46712070|NCT01157351|82928512|FG001|Overall Study|Noncompliance with Study Drug|3|||
46712071|NCT01157351|82928511|FG000|Overall Study|Randomized but not Treated|4|||
46712072|NCT01157351|82928512|FG001|Overall Study|Randomized but not Treated|2|||
46712073|NCT01157117|82928521|FG000|Overall Study|Dosing Symptoms|0|||
46712074|NCT01157117|82928522|FG001|Overall Study|Dosing Symptoms|4|||
46712075|NCT01157117|82928523|FG002|Overall Study|Dosing Symptoms|0|||
46712076|NCT01157117|82928521|FG000|Overall Study|Withdrawal by Subject|4|||
46712077|NCT01157117|82928522|FG001|Overall Study|Withdrawal by Subject|1|||
46712078|NCT01157117|82928523|FG002|Overall Study|Withdrawal by Subject|1|||
46712079|NCT01157117|82928521|FG000|Overall Study|Lack of Efficacy|1|||
46712080|NCT01157117|82928522|FG001|Overall Study|Lack of Efficacy|1|||
46712081|NCT01157117|82928523|FG002|Overall Study|Lack of Efficacy|0|||
46913805|NCT03083847|83144276|FG006|Main|Pregnancy|0|||
47036774|NCT01923181|83288020|FG005|Overall Study|Protocol Violation|1|||
47036775|NCT01923181|83288021|FG006|Overall Study|Protocol Violation|1|||
46712082|NCT01157117|82928521|FG000|Overall Study|Lost to Follow-up|0|||
46712083|NCT01157117|82928522|FG001|Overall Study|Lost to Follow-up|0|||
46913806|NCT03083847|83144277|FG007|Main|Pregnancy|1|||
46712084|NCT01157117|82928523|FG002|Overall Study|Lost to Follow-up|1|||
46712085|NCT01157117|82928521|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
46712086|NCT01157117|82928522|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
46712087|NCT01157117|82928523|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
46712088|NCT00891202|82928533|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
46712089|NCT00891202|82928534|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
46913807|NCT03083847|83144278|FG008|Main|Pregnancy|0|||
46712090|NCT00891202|82928535|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
47036776|NCT01923181|83288022|FG007|Overall Study|Protocol Violation|2|||
47036777|NCT01923181|83288023|FG008|Overall Study|Protocol Violation|1|||
47036778|NCT01923181|83288015|FG000|Overall Study|Withdrawal by Subject|0|||
47036779|NCT01923181|83288016|FG001|Overall Study|Withdrawal by Subject|1|||
47036780|NCT01923181|83288017|FG002|Overall Study|Withdrawal by Subject|0|||
47036781|NCT01923181|83288018|FG003|Overall Study|Withdrawal by Subject|1|||
47036782|NCT01923181|83288019|FG004|Overall Study|Withdrawal by Subject|4|||
47036783|NCT01923181|83288020|FG005|Overall Study|Withdrawal by Subject|2|||
47036784|NCT01923181|83288021|FG006|Overall Study|Withdrawal by Subject|4|||
47036785|NCT01923181|83288022|FG007|Overall Study|Withdrawal by Subject|3|||
47036786|NCT01923181|83288023|FG008|Overall Study|Withdrawal by Subject|1|||
47036787|NCT01923181|83288015|FG000|Overall Study|Other|1|||
47036788|NCT01923181|83288016|FG001|Overall Study|Other|0|||
47036789|NCT01923181|83288017|FG002|Overall Study|Other|0|||
47036790|NCT01923181|83288018|FG003|Overall Study|Other|1|||
47036791|NCT01923181|83288019|FG004|Overall Study|Other|0|||
47036792|NCT01923181|83288020|FG005|Overall Study|Other|0|||
47036793|NCT01923181|83288021|FG006|Overall Study|Other|0|||
47036794|NCT01923181|83288022|FG007|Overall Study|Other|0|||
47036795|NCT01923181|83288023|FG008|Overall Study|Other|0|||
47036796|NCT01923181|83288015|FG000|Overall Study|Lost to Follow-up|0|||
47036797|NCT01923181|83288016|FG001|Overall Study|Lost to Follow-up|3|||
47036798|NCT01923181|83288017|FG002|Overall Study|Lost to Follow-up|2|||
47036799|NCT01923181|83288018|FG003|Overall Study|Lost to Follow-up|1|||
47036800|NCT01923181|83288019|FG004|Overall Study|Lost to Follow-up|2|||
47036801|NCT01923181|83288020|FG005|Overall Study|Lost to Follow-up|1|||
47036802|NCT01923181|83288021|FG006|Overall Study|Lost to Follow-up|3|||
47036803|NCT01923181|83288022|FG007|Overall Study|Lost to Follow-up|3|||
47036804|NCT01923181|83288023|FG008|Overall Study|Lost to Follow-up|1|||
47036805|NCT01896271|83288046|FG000|Overall Study|Physician Decision|10|||
47036806|NCT01884571|83288050|FG000|Overall Study|Adverse Event|1|||
46630076|NCT01957488|82801050|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
46712091|NCT00891202|82928536|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
46712092|NCT00891202|82928533|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
46712093|NCT00891202|82928534|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
46712094|NCT00891202|82928535|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
46712095|NCT00891202|82928536|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
46712096|NCT00891202|82928533|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
46712097|NCT00891202|82928534|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
46712098|NCT00891202|82928535|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
46712099|NCT00891202|82928536|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
46712100|NCT00891202|82928533|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
46712101|NCT00891202|82928534|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
46712102|NCT00891202|82928535|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
46712103|NCT00891202|82928536|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
46712104|NCT01185509|82928546|FG000|Overall Study|Progression/Relapse|9|||
46712105|NCT01185509|82928547|FG001|Overall Study|Progression/Relapse|15|||
46712106|NCT01185509|82928546|FG000|Overall Study|Physician Decision|2|||
46712107|NCT01185509|82928547|FG001|Overall Study|Physician Decision|2|||
46712108|NCT01185509|82928546|FG000|Overall Study|Withdrawal by Subject|0|||
46712109|NCT01185509|82928547|FG001|Overall Study|Withdrawal by Subject|1|||
46712110|NCT01185509|82928546|FG000|Overall Study|Death|0|||
46630077|NCT01957488|82801045|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
46630078|NCT01957488|82801046|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
46630079|NCT01957488|82801047|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
46630080|NCT01957488|82801048|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
46630081|NCT01957488|82801049|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
46630082|NCT01957488|82801050|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
46630083|NCT01957488|82801045|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
46630084|NCT01957488|82801046|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
46712111|NCT01185509|82928547|FG001|Overall Study|Death|1|||
46712112|NCT01185509|82928546|FG000|Overall Study|Intercurrent Illness|0|||
46712113|NCT01185509|82928547|FG001|Overall Study|Intercurrent Illness|1|||
46712114|NCT00891046|82928559|FG000|Overall Study|Protocol Violation|1|||
46630085|NCT01957488|82801047|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
46630086|NCT01957488|82801048|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
46712115|NCT00891046|82928560|FG001|Overall Study|Protocol Violation|1|||
46712116|NCT00891046|82928561|FG002|Overall Study|Protocol Violation|0|||
46712117|NCT00891046|82928562|FG003|Overall Study|Protocol Violation|0|||
46712118|NCT00891046|82928563|FG004|Overall Study|Protocol Violation|1|||
46712119|NCT00891046|82928559|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
47036807|NCT01884571|83288050|FG000|Overall Study|Death|2|||
47036808|NCT01884571|83288050|FG000|Overall Study|Withdrawal by Subject|2|||
47036809|NCT01884571|83288050|FG000|Overall Study|Disease progression|3|||
47036810|NCT01884337|83288056|FG000|Treatment|Adverse Event|2|||
46712120|NCT00891046|82928560|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46712121|NCT00891046|82928561|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
46712122|NCT00891046|82928562|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
46712123|NCT00891046|82928563|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
46712124|NCT00891046|82928559|FG000|Overall Study|Administrative problems|0|||
46712125|NCT00891046|82928560|FG001|Overall Study|Administrative problems|0|||
46712126|NCT00891046|82928561|FG002|Overall Study|Administrative problems|0|||
46712127|NCT00891046|82928562|FG003|Overall Study|Administrative problems|0|||
46712128|NCT00891046|82928563|FG004|Overall Study|Administrative problems|1|||
46712129|NCT00891046|82928559|FG000|Overall Study|Participant no longer required drug|0|||
46712130|NCT00891046|82928560|FG001|Overall Study|Participant no longer required drug|2|||
46712131|NCT00891046|82928561|FG002|Overall Study|Participant no longer required drug|0|||
46712132|NCT00891046|82928562|FG003|Overall Study|Participant no longer required drug|0|||
46712133|NCT00891046|82928563|FG004|Overall Study|Participant no longer required drug|1|||
46712134|NCT00891046|82928559|FG000|Overall Study|Adverse Event|4|||
46712135|NCT00891046|82928560|FG001|Overall Study|Adverse Event|3|||
46712136|NCT00891046|82928561|FG002|Overall Study|Adverse Event|2|||
46712137|NCT00891046|82928562|FG003|Overall Study|Adverse Event|0|||
46712138|NCT00891046|82928563|FG004|Overall Study|Adverse Event|14|||
46712139|NCT00891046|82928559|FG000|Overall Study|Withdrawal by Subject|2|||
46712140|NCT00891046|82928560|FG001|Overall Study|Withdrawal by Subject|1|||
46712141|NCT00891046|82928561|FG002|Overall Study|Withdrawal by Subject|2|||
46712142|NCT00891046|82928562|FG003|Overall Study|Withdrawal by Subject|1|||
46712143|NCT00891046|82928563|FG004|Overall Study|Withdrawal by Subject|1|||
46712144|NCT00891046|82928559|FG000|Overall Study|Lost to Follow-up|0|||
46712145|NCT00891046|82928560|FG001|Overall Study|Lost to Follow-up|0|||
46712146|NCT00891046|82928561|FG002|Overall Study|Lost to Follow-up|0|||
46712147|NCT00891046|82928562|FG003|Overall Study|Lost to Follow-up|0|||
46712148|NCT00891046|82928563|FG004|Overall Study|Lost to Follow-up|1|||
46712149|NCT00889720|82928590|FG000|Overall Study|Withdrawal by Subject|4|||
46712150|NCT00889720|82928590|FG000|Overall Study|Other|4|||
46712151|NCT00880087|82928596|FG000|Overall Study|Lost to Follow-up|0|||
46712152|NCT00880087|82928597|FG001|Overall Study|Lost to Follow-up|2|||
46712153|NCT00889252|82928605|FG000|Overall Study|Adverse Event|2|||
46712154|NCT00889252|82928606|FG001|Overall Study|Adverse Event|4|||
46712155|NCT00889252|82928605|FG000|Overall Study|Withdrawal by Subject|3|||
46712156|NCT00889252|82928606|FG001|Overall Study|Withdrawal by Subject|0|||
46712157|NCT00889252|82928605|FG000|Overall Study|Protocol Violation|2|||
46712158|NCT00889252|82928606|FG001|Overall Study|Protocol Violation|0|||
46712159|NCT01110330|82928615|FG000|Overall Study|Adverse Event|0|||
46712160|NCT01110330|82928616|FG001|Overall Study|Adverse Event|4|||
46712161|NCT01110330|82928617|FG002|Overall Study|Adverse Event|3|||
46712162|NCT01110330|82928615|FG000|Overall Study|Lack of Efficacy|3|||
46712163|NCT01110330|82928616|FG001|Overall Study|Lack of Efficacy|1|||
46712164|NCT01110330|82928617|FG002|Overall Study|Lack of Efficacy|1|||
46712165|NCT01110330|82928615|FG000|Overall Study|Lost to Follow-up|9|||
46712166|NCT01110330|82928616|FG001|Overall Study|Lost to Follow-up|10|||
46712167|NCT01110330|82928617|FG002|Overall Study|Lost to Follow-up|15|||
46712168|NCT01110330|82928615|FG000|Overall Study|Physician Decision|0|||
46712169|NCT01110330|82928616|FG001|Overall Study|Physician Decision|1|||
46712170|NCT01110330|82928617|FG002|Overall Study|Physician Decision|0|||
46712171|NCT01110330|82928615|FG000|Overall Study|Protocol Violation|2|||
46712172|NCT01110330|82928616|FG001|Overall Study|Protocol Violation|0|||
46712173|NCT01110330|82928617|FG002|Overall Study|Protocol Violation|4|||
46712174|NCT01110330|82928615|FG000|Overall Study|Withdrawal by Subject|0|||
46712175|NCT01110330|82928616|FG001|Overall Study|Withdrawal by Subject|6|||
46712176|NCT01110330|82928617|FG002|Overall Study|Withdrawal by Subject|2|||
46712177|NCT01110330|82928615|FG000|Overall Study|Other|1|||
46712178|NCT01110330|82928616|FG001|Overall Study|Other|1|||
46712179|NCT01110330|82928617|FG002|Overall Study|Other|1|||
46712180|NCT00596947|82928627|FG000|Overall Study|study halted due to low enrollment|5|||
46712181|NCT00596947|82928628|FG001|Overall Study|study halted due to low enrollment|3|||
46712182|NCT00596947|82928627|FG000|Overall Study|Lost to Follow-up|1|||
46712183|NCT00596947|82928628|FG001|Overall Study|Lost to Follow-up|0|||
46712184|NCT00888940|82928636|FG000|Overall Study|Adverse Event|12|||
46712185|NCT00888940|82928637|FG001|Overall Study|Adverse Event|3|||
46712186|NCT00888940|82928636|FG000|Overall Study|Lost to Follow-up|5|||
46712187|NCT00888940|82928637|FG001|Overall Study|Lost to Follow-up|5|||
46712188|NCT00888940|82928636|FG000|Overall Study|Randomized Not Treated|11|||
46712189|NCT00888940|82928637|FG001|Overall Study|Randomized Not Treated|13|||
46712190|NCT00595621|82928645|FG000|Open Label Run in|Adverse Event|1|||
46712191|NCT00595621|82928646|FG001|Open Label Run in|Adverse Event|0|||
46712192|NCT00595621|82928645|FG000|Open Label Run in|Physician Decision|1|||
46712193|NCT00595621|82928646|FG001|Open Label Run in|Physician Decision|0|||
46630087|NCT01957488|82801049|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
46630088|NCT01957488|82801050|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
46630089|NCT01957488|82801045|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
46630090|NCT01957488|82801046|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
46630091|NCT01957488|82801047|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
46630092|NCT01957488|82801048|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
46630093|NCT01957488|82801049|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
46630094|NCT01957488|82801050|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
46630095|NCT01957488|82801045|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
46630096|NCT01957488|82801046|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
46630097|NCT01957488|82801047|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
46712194|NCT00595621|82928645|FG000|Open Label Run in|Withdrawal by Subject|1|||
46712195|NCT00595621|82928646|FG001|Open Label Run in|Withdrawal by Subject|0|||
46712196|NCT00595621|82928645|FG000|Randomization and Study|Adverse Event|2|||
46712197|NCT00595621|82928646|FG001|Randomization and Study|Adverse Event|0|||
46712198|NCT00595621|82928645|FG000|Randomization and Study|Withdrawal by Subject|0|||
46712199|NCT00595621|82928646|FG001|Randomization and Study|Withdrawal by Subject|1|||
46712200|NCT00888238|82928653|FG000|Washout Period After Period 2|Adverse Event|0|||
46712201|NCT00888238|82928654|FG001|Washout Period After Period 2|Adverse Event|0|||
46712202|NCT00888238|82928655|FG002|Washout Period After Period 2|Adverse Event|1|||
46712203|NCT00595465|82928664|FG000|Overall Study|Adverse Event|4|||
46712204|NCT00595465|82928665|FG001|Overall Study|Adverse Event|3|||
47036811|NCT01884337|83288057|FG001|Treatment|Adverse Event|2|||
47036812|NCT01884337|83288056|FG000|Treatment|Subj. request to discont. treatment|2|||
47036813|NCT01884337|83288057|FG001|Treatment|Subj. request to discont. treatment|0|||
47036814|NCT01884337|83288056|FG000|Follow-up Period|Lost to Follow-up|1|||
47036815|NCT01884337|83288057|FG001|Follow-up Period|Lost to Follow-up|1|||
47036816|NCT01922089|83288065|FG000|Overall Study|Adverse Event|18|||
47036817|NCT01922089|83288066|FG001|Overall Study|Adverse Event|13|||
47036818|NCT01922089|83288065|FG000|Overall Study|Protocol Deviation|10|||
47036819|NCT01922089|83288066|FG001|Overall Study|Protocol Deviation|7|||
47036820|NCT01922089|83288065|FG000|Overall Study|Withdrawal by Subject|3|||
47036821|NCT01922089|83288066|FG001|Overall Study|Withdrawal by Subject|4|||
47036822|NCT01922089|83288065|FG000|Overall Study|administrative problems|4|||
47036823|NCT01922089|83288066|FG001|Overall Study|administrative problems|1|||
47036824|NCT01922089|83288065|FG000|Overall Study|Physician Decision|2|||
47036825|NCT01922089|83288066|FG001|Overall Study|Physician Decision|3|||
47036826|NCT01922089|83288065|FG000|Overall Study|Death|2|||
47036827|NCT01922089|83288066|FG001|Overall Study|Death|1|||
47036828|NCT01922089|83288065|FG000|Overall Study|Lost to Follow-up|0|||
47036829|NCT01922089|83288066|FG001|Overall Study|Lost to Follow-up|1|||
47036830|NCT01884025|83288074|FG000|Overall Study|Lost to Follow-up|3|||
47036831|NCT01884025|83288075|FG001|Overall Study|Lost to Follow-up|4|||
47036832|NCT01896193|83288085|FG000|Overall Study|Lack of Efficacy|20|||
46630098|NCT01957488|82801048|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
46630099|NCT01957488|82801049|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
46630100|NCT01957488|82801050|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
46712205|NCT00595465|82928666|FG002|Overall Study|Adverse Event|3|||
46712206|NCT00595465|82928664|FG000|Overall Study|Pregnancy|0|||
46712207|NCT00595465|82928665|FG001|Overall Study|Pregnancy|0|||
46712208|NCT00595465|82928666|FG002|Overall Study|Pregnancy|1|||
46712209|NCT00595465|82928664|FG000|Overall Study|Protocol Violation|2|||
46712210|NCT00595465|82928665|FG001|Overall Study|Protocol Violation|1|||
46712211|NCT00595465|82928666|FG002|Overall Study|Protocol Violation|0|||
46712212|NCT00595465|82928664|FG000|Overall Study|Lost to Follow-up|0|||
47036833|NCT01896193|83288086|FG001|Overall Study|Lack of Efficacy|11|||
47036834|NCT01896193|83288085|FG000|Overall Study|Protocol Violation|0|||
47036835|NCT01896193|83288086|FG001|Overall Study|Protocol Violation|1|||
47036836|NCT01896193|83288085|FG000|Overall Study|Withdrew Consent|1|||
47036837|NCT01896193|83288086|FG001|Overall Study|Withdrew Consent|0|||
47036838|NCT01922011|83288096|FG000|Overall Study|Protocol Violation|0|||
47036839|NCT01922011|83288097|FG001|Overall Study|Protocol Violation|1|||
47036840|NCT01922011|83288096|FG000|Overall Study|Physician Decision|0|||
47036841|NCT01922011|83288097|FG001|Overall Study|Physician Decision|1|||
47036842|NCT01922011|83288096|FG000|Overall Study|Parent/Guardian Decision|3|||
47036843|NCT01922011|83288097|FG001|Overall Study|Parent/Guardian Decision|0|||
47036844|NCT01922011|83288096|FG000|Overall Study|Lost to Follow-up|0|||
47036845|NCT01922011|83288097|FG001|Overall Study|Lost to Follow-up|1|||
47036846|NCT01922011|83288096|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
47036847|NCT01922011|83288097|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
47036848|NCT01922011|83288096|FG000|Overall Study|Not Treated|1|||
47036849|NCT01922011|83288097|FG001|Overall Study|Not Treated|0|||
47036850|NCT01922011|83288096|FG000|Overall Study|Lack of willing home health agency|1|||
47036851|NCT01922011|83288097|FG001|Overall Study|Lack of willing home health agency|0|||
47036852|NCT01922011|83288096|FG000|Overall Study|Randomized in error|1|||
47036853|NCT01922011|83288097|FG001|Overall Study|Randomized in error|0|||
47036854|NCT01883635|83288111|FG000|Overall Study|Withdrawal by Subject|4|||
47036855|NCT01883635|83288112|FG001|Overall Study|Withdrawal by Subject|0|||
47036856|NCT01921387|83288120|FG000|Overall Study|Adverse Event|1|||
47036857|NCT01895335|83288124|FG000|Overall Study|Adverse Event|106|||
47036858|NCT01895335|83288124|FG000|Overall Study|Lack of Efficacy|53|||
47036859|NCT01895335|83288124|FG000|Overall Study|Poor Compliance to Protocol|11|||
47036860|NCT01895335|83288124|FG000|Overall Study|Included But Not treated|1|||
47036861|NCT01895335|83288124|FG000|Overall Study|Other than Specified Above|44|||
47036862|NCT01617655|83288130|FG000|Overall Study|Adverse Event|2|||
47036863|NCT01617655|83288131|FG001|Overall Study|Adverse Event|3|||
47036864|NCT01617655|83288130|FG000|Overall Study|Poor compliance to protocol|1|||
47036865|NCT01617655|83288131|FG001|Overall Study|Poor compliance to protocol|4|||
47036866|NCT01617655|83288130|FG000|Overall Study|Participants moved|0|||
47036867|NCT01617655|83288131|FG001|Overall Study|Participants moved|4|||
47036868|NCT01617655|83288130|FG000|Overall Study|Consent withdrawn by participant|1|||
47036869|NCT01617655|83288131|FG001|Overall Study|Consent withdrawn by participant|1|||
47036870|NCT01617655|83288130|FG000|Overall Study|Last visit outside protocol visit window|1|||
47036871|NCT01617655|83288131|FG001|Overall Study|Last visit outside protocol visit window|10|||
47036872|NCT01617655|83288130|FG000|Overall Study|Site closure|3|||
47036873|NCT01617655|83288131|FG001|Overall Study|Site closure|5|||
47036874|NCT01617655|83288130|FG000|Overall Study|Other than specified above|1|||
47036875|NCT01617655|83288131|FG001|Overall Study|Other than specified above|2|||
47036876|NCT01895101|83288142|FG000|Overall Study|OPCAB procedure|1|||
47036877|NCT01895101|83288143|FG001|Overall Study|OPCAB procedure|1|||
47036878|NCT01895101|83288144|FG002|Overall Study|OPCAB procedure|3|||
47036879|NCT01895101|83288142|FG000|Overall Study|Withdrawal by Subject|0|||
47036880|NCT01895101|83288143|FG001|Overall Study|Withdrawal by Subject|1|||
47036881|NCT01895101|83288144|FG002|Overall Study|Withdrawal by Subject|2|||
47036882|NCT01895101|83288142|FG000|Overall Study|another study, enrolled in other study|0|||
47036883|NCT01895101|83288143|FG001|Overall Study|another study, enrolled in other study|1|||
47036884|NCT01895101|83288144|FG002|Overall Study|another study, enrolled in other study|0|||
47036885|NCT01895101|83288142|FG000|Overall Study|Death|0|||
47036886|NCT01895101|83288143|FG001|Overall Study|Death|1|||
47036887|NCT01895101|83288144|FG002|Overall Study|Death|0|||
47036888|NCT01895101|83288142|FG000|Overall Study|coagulation disorder|0|||
47036889|NCT01895101|83288143|FG001|Overall Study|coagulation disorder|1|||
47036890|NCT01895101|83288144|FG002|Overall Study|coagulation disorder|0|||
47036891|NCT01894477|83288154|FG000|Overall Study|Protocol Violation|0|||
46630101|NCT01976364|82801058|FG000|Main Study (36 Months)|Adverse Event|63|||
46630102|NCT01976364|82801059|FG001|Main Study (36 Months)|Adverse Event|0|||
46630103|NCT01976364|82801060|FG002|Main Study (36 Months)|Adverse Event|0|||
46630104|NCT01976364|82801058|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
46630105|NCT01976364|82801059|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
46630106|NCT01976364|82801060|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
46913808|NCT03083847|83144279|FG009|Main|Pregnancy|0|||
47036892|NCT01894477|83288155|FG001|Overall Study|Protocol Violation|1|||
47036893|NCT01894477|83288154|FG000|Overall Study|protocol changed due SC changed to cord|0|||
47036894|NCT01894477|83288155|FG001|Overall Study|protocol changed due SC changed to cord|1|||
47036895|NCT01894243|83288164|FG000|Overall Study|Adverse Event|0|||
47036896|NCT01894243|83288165|FG001|Overall Study|Adverse Event|1|||
47036897|NCT01894243|83288166|FG002|Overall Study|Adverse Event|2|||
47036898|NCT01894243|83288164|FG000|Overall Study|Death|0|||
47036899|NCT01894243|83288165|FG001|Overall Study|Death|0|||
47036900|NCT01894243|83288166|FG002|Overall Study|Death|3|||
47036901|NCT01894243|83288164|FG000|Overall Study|Lack of Efficacy|3|||
47036902|NCT01894243|83288165|FG001|Overall Study|Lack of Efficacy|3|||
47036903|NCT01894243|83288166|FG002|Overall Study|Lack of Efficacy|1|||
46712213|NCT00595465|82928665|FG001|Overall Study|Lost to Follow-up|0|||
46712214|NCT00595465|82928666|FG002|Overall Study|Lost to Follow-up|2|||
46712215|NCT00595465|82928664|FG000|Overall Study|administrative reason|0|||
47036904|NCT01894243|83288164|FG000|Overall Study|Condition under investigation worsened|8|||
47036905|NCT01894243|83288165|FG001|Overall Study|Condition under investigation worsened|6|||
47036906|NCT01894243|83288166|FG002|Overall Study|Condition under investigation worsened|2|||
47036907|NCT01894243|83288164|FG000|Overall Study|Subject decision|1|||
47036908|NCT01894243|83288165|FG001|Overall Study|Subject decision|0|||
47036909|NCT01894243|83288166|FG002|Overall Study|Subject decision|0|||
47036910|NCT01894243|83288164|FG000|Overall Study|Other|1|||
47036911|NCT01894243|83288165|FG001|Overall Study|Other|0|||
47036912|NCT01894243|83288166|FG002|Overall Study|Other|0|||
47036913|NCT03822832|83288183|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
47036914|NCT03822832|83288184|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
47036915|NCT03822832|83288183|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
47036916|NCT03822832|83288184|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
47036917|NCT03822832|83288183|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
47036918|NCT03822832|83288184|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
47036919|NCT03822832|83288183|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
47036920|NCT03822832|83288184|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
47036921|NCT03822832|83288183|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
47036922|NCT03822832|83288184|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
47036923|NCT03822832|83288183|FG000|Re-allocation|Not re-allocated to open label period|2|||
47036924|NCT03822832|83288184|FG001|Re-allocation|Not re-allocated to open label period|6|||
47036925|NCT03822832|83288183|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
47036926|NCT03822832|83288184|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
47036927|NCT03822832|83288183|FG000|Period 2 - Open Label Period|Adverse Event|0|||
47036928|NCT03822832|83288184|FG001|Period 2 - Open Label Period|Adverse Event|3|||
47036929|NCT01513239|83288194|FG000|Period 1: Main Phase|Adverse Event|1|||
47036930|NCT01513239|83288195|FG001|Period 1: Main Phase|Adverse Event|1|||
47036931|NCT01513239|83288196|FG002|Period 1: Main Phase|Adverse Event|2|||
47036932|NCT01513239|83288197|FG003|Period 1: Main Phase|Adverse Event|0|||
47036933|NCT01513239|83288198|FG004|Period 1: Main Phase|Adverse Event|0|||
47036934|NCT01513239|83288199|FG005|Period 1: Main Phase|Adverse Event|0|||
47036935|NCT01513239|83288194|FG000|Period 1: Main Phase|Death|29|||
47036936|NCT01513239|83288195|FG001|Period 1: Main Phase|Death|22|||
47036937|NCT01513239|83288196|FG002|Period 1: Main Phase|Death|32|||
47036938|NCT01513239|83288197|FG003|Period 1: Main Phase|Death|0|||
47036939|NCT01513239|83288198|FG004|Period 1: Main Phase|Death|0|||
47036940|NCT01513239|83288199|FG005|Period 1: Main Phase|Death|0|||
47036941|NCT01513239|83288194|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
47036942|NCT01513239|83288195|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
47036943|NCT01513239|83288196|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
47036944|NCT01513239|83288197|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
47036945|NCT01513239|83288198|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
47036946|NCT01513239|83288199|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
47036947|NCT01513239|83288194|FG000|Period 1: Main Phase|Physician Decision|4|||
46712216|NCT00595465|82928665|FG001|Overall Study|administrative reason|0|||
46712217|NCT00595465|82928666|FG002|Overall Study|administrative reason|1|||
46712218|NCT01205438|82928677|FG000|Overall Study|Adverse Event|19|||
46712219|NCT01205438|82928678|FG001|Overall Study|Adverse Event|17|||
46712220|NCT01205438|82928679|FG002|Overall Study|Adverse Event|24|||
46712221|NCT01205438|82928677|FG000|Overall Study|Death|1|||
46712222|NCT01205438|82928678|FG001|Overall Study|Death|1|||
46712223|NCT01205438|82928679|FG002|Overall Study|Death|3|||
46712224|NCT01205438|82928677|FG000|Overall Study|Entry Criteria Not Met|16|||
46712225|NCT01205438|82928678|FG001|Overall Study|Entry Criteria Not Met|15|||
46712226|NCT01205438|82928679|FG002|Overall Study|Entry Criteria Not Met|13|||
46712227|NCT01205438|82928677|FG000|Overall Study|Lack of Efficacy|14|||
47036948|NCT01513239|83288195|FG001|Period 1: Main Phase|Physician Decision|4|||
47036949|NCT01513239|83288196|FG002|Period 1: Main Phase|Physician Decision|4|||
47036950|NCT01513239|83288197|FG003|Period 1: Main Phase|Physician Decision|0|||
47036951|NCT01513239|83288198|FG004|Period 1: Main Phase|Physician Decision|0|||
47036952|NCT01513239|83288199|FG005|Period 1: Main Phase|Physician Decision|0|||
47036953|NCT01513239|83288194|FG000|Period 1: Main Phase|Protocol Violation|2|||
47036954|NCT01513239|83288195|FG001|Period 1: Main Phase|Protocol Violation|2|||
47036955|NCT01513239|83288196|FG002|Period 1: Main Phase|Protocol Violation|2|||
47036956|NCT01513239|83288197|FG003|Period 1: Main Phase|Protocol Violation|0|||
46712228|NCT01205438|82928678|FG001|Overall Study|Lack of Efficacy|11|||
46712229|NCT01205438|82928679|FG002|Overall Study|Lack of Efficacy|14|||
46712230|NCT01205438|82928677|FG000|Overall Study|Lost to Follow-up|6|||
46712231|NCT01205438|82928678|FG001|Overall Study|Lost to Follow-up|7|||
46913809|NCT03083847|83144270|FG000|Main|Adverse Event|0|||
46913810|NCT03083847|83144271|FG001|Main|Adverse Event|0|||
47036957|NCT01513239|83288198|FG004|Period 1: Main Phase|Protocol Violation|0|||
47036958|NCT01513239|83288199|FG005|Period 1: Main Phase|Protocol Violation|0|||
47036959|NCT01513239|83288194|FG000|Period 1: Main Phase|Technical Problems|1|||
47036960|NCT01513239|83288195|FG001|Period 1: Main Phase|Technical Problems|2|||
47036961|NCT01513239|83288196|FG002|Period 1: Main Phase|Technical Problems|0|||
47036962|NCT01513239|83288197|FG003|Period 1: Main Phase|Technical Problems|0|||
47036963|NCT01513239|83288198|FG004|Period 1: Main Phase|Technical Problems|0|||
47036964|NCT01513239|83288199|FG005|Period 1: Main Phase|Technical Problems|0|||
46630107|NCT01976364|82801058|FG000|Main Study (36 Months)|Other|13|||
46630108|NCT01976364|82801059|FG001|Main Study (36 Months)|Other|0|||
46630109|NCT01976364|82801060|FG002|Main Study (36 Months)|Other|0|||
46630110|NCT01976364|82801058|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
46630111|NCT01976364|82801059|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
46630112|NCT01976364|82801060|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
46630113|NCT01976364|82801058|FG000|Main Study (36 Months)|Medication error|1|||
46630114|NCT01976364|82801059|FG001|Main Study (36 Months)|Medication error|0|||
46630115|NCT01976364|82801060|FG002|Main Study (36 Months)|Medication error|0|||
46630116|NCT01976364|82801058|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
46630117|NCT01976364|82801059|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
46630118|NCT01976364|82801060|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
46630119|NCT01976364|82801058|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
46630120|NCT01976364|82801059|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
46630121|NCT01976364|82801060|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
46630122|NCT01976364|82801058|FG000|Main Study (36 Months)|Protocol Violation|13|||
46630123|NCT01976364|82801059|FG001|Main Study (36 Months)|Protocol Violation|0|||
46630124|NCT01976364|82801060|FG002|Main Study (36 Months)|Protocol Violation|0|||
46630125|NCT01976364|82801058|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
46630126|NCT01976364|82801059|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
46630127|NCT01976364|82801060|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
46630128|NCT01976364|82801058|FG000|Main Study (36 Months)|Death|5|||
46630129|NCT01976364|82801059|FG001|Main Study (36 Months)|Death|0|||
46630130|NCT01976364|82801060|FG002|Main Study (36 Months)|Death|0|||
46630131|NCT01976364|82801058|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
46630132|NCT01976364|82801059|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
46630133|NCT01976364|82801060|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
46630134|NCT01976364|82801058|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
46630135|NCT01976364|82801059|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
46630136|NCT01976364|82801060|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
46630137|NCT01976364|82801058|FG000|Sub-study (12 Months)|Protocol Violation|0|||
46630138|NCT01976364|82801059|FG001|Sub-study (12 Months)|Protocol Violation|1|||
46630139|NCT01976364|82801060|FG002|Sub-study (12 Months)|Protocol Violation|1|||
46630140|NCT01976364|82801058|FG000|Sub-study (12 Months)|Adverse Event|0|||
46630141|NCT01976364|82801059|FG001|Sub-study (12 Months)|Adverse Event|4|||
46630142|NCT01976364|82801060|FG002|Sub-study (12 Months)|Adverse Event|3|||
46630143|NCT01956240|82801071|FG000|Overall Study|Lost to Follow-up|6|||
46630144|NCT01956240|82801072|FG001|Overall Study|Lost to Follow-up|20|||
46630145|NCT01956240|82801071|FG000|Overall Study|Adverse Event|17|||
46630146|NCT01956240|82801072|FG001|Overall Study|Adverse Event|4|||
46630147|NCT01929876|82801078|FG000|Period 2|Non-Compliance|1|||
46630148|NCT01929408|82801082|FG000|Overall Study|received HCT as initial treatment|8|||
46630149|NCT01929018|82801088|FG000|Overall Study|Lost to Follow-up|1|||
46630150|NCT01929018|82801089|FG001|Overall Study|Lost to Follow-up|0|||
46630151|NCT01929018|82801088|FG000|Overall Study|Hospitalization|0|||
46630152|NCT01929018|82801089|FG001|Overall Study|Hospitalization|1|||
46630153|NCT01928940|82801097|FG000|Overall Study|Adverse Event|0|||
46630154|NCT01928940|82801098|FG001|Overall Study|Adverse Event|1|||
46630155|NCT01928862|82801110|FG000|Overall Study|Lost to Follow-up|1|||
46630156|NCT01928862|82801111|FG001|Overall Study|Lost to Follow-up|0|||
46630157|NCT01928862|82801112|FG002|Overall Study|Lost to Follow-up|0|||
46630158|NCT01928862|82801113|FG003|Overall Study|Lost to Follow-up|0|||
46630159|NCT01928862|82801114|FG004|Overall Study|Lost to Follow-up|1|||
46630160|NCT01954056|82801129|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
46630161|NCT01954056|82801130|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
46630162|NCT01953354|82801138|FG000|Overall Study|Withdrawal by Subject|0|||
46712232|NCT01205438|82928679|FG002|Overall Study|Lost to Follow-up|8|||
46630163|NCT01953354|82801139|FG001|Overall Study|Withdrawal by Subject|1|||
46630164|NCT01953354|82801138|FG000|Overall Study|Decision of Sponsor|0|||
46630165|NCT01953354|82801139|FG001|Overall Study|Decision of Sponsor|1|||
46712233|NCT01205438|82928677|FG000|Overall Study|Withdrawal by Subject|19|||
46913811|NCT03083847|83144272|FG002|Main|Adverse Event|0|||
46712234|NCT01205438|82928678|FG001|Overall Study|Withdrawal by Subject|25|||
46712235|NCT01205438|82928679|FG002|Overall Study|Withdrawal by Subject|19|||
46712236|NCT01205438|82928677|FG000|Overall Study|Physician Decision|0|||
46712237|NCT01205438|82928678|FG001|Overall Study|Physician Decision|3|||
46712238|NCT01205438|82928679|FG002|Overall Study|Physician Decision|2|||
46712239|NCT01205438|82928677|FG000|Overall Study|Protocol Violation|2|||
46712240|NCT01205438|82928678|FG001|Overall Study|Protocol Violation|7|||
46712241|NCT01205438|82928679|FG002|Overall Study|Protocol Violation|4|||
46712242|NCT01205438|82928677|FG000|Overall Study|Sponsor Decision|0|||
46712243|NCT01205438|82928678|FG001|Overall Study|Sponsor Decision|1|||
46712244|NCT01205438|82928679|FG002|Overall Study|Sponsor Decision|1|||
46712245|NCT01104870|82928693|FG000|Overall Study|Adverse Event|1|||
46712246|NCT01104870|82928694|FG001|Overall Study|Adverse Event|1|||
46712247|NCT01104870|82928695|FG002|Overall Study|Adverse Event|0|||
46712248|NCT01104870|82928693|FG000|Overall Study|Death|0|||
46712249|NCT01104870|82928694|FG001|Overall Study|Death|0|||
46712250|NCT01104870|82928695|FG002|Overall Study|Death|1|||
46712251|NCT01104870|82928693|FG000|Overall Study|Withdrawal by Subject|0|||
46712252|NCT01104870|82928694|FG001|Overall Study|Withdrawal by Subject|0|||
46712253|NCT01104870|82928695|FG002|Overall Study|Withdrawal by Subject|1|||
46712254|NCT01104792|82928703|FG000|Overall Study|Adverse Event|77|||
46712255|NCT01104792|82928703|FG000|Overall Study|Insufficient Therapeutic Response|22|||
46712256|NCT01104792|82928703|FG000|Overall Study|Protocol Violation|45|||
46712257|NCT01104792|82928703|FG000|Overall Study|Withdrawal of Consent|179|||
46712258|NCT01104792|82928703|FG000|Overall Study|Lost to Follow-up|43|||
46712259|NCT01104792|82928703|FG000|Overall Study|Reasons Not Specified|27|||
46913812|NCT03083847|83144273|FG003|Main|Adverse Event|0|||
47036965|NCT01513239|83288194|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
47036966|NCT01513239|83288195|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
47036967|NCT01513239|83288196|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
47036968|NCT01513239|83288197|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
47036969|NCT01513239|83288198|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
47036970|NCT01513239|83288199|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
47036971|NCT01513239|83288194|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
47036972|NCT01513239|83288195|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
47036973|NCT01513239|83288196|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
47036974|NCT01513239|83288197|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
47036975|NCT01513239|83288198|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
47036976|NCT01513239|83288199|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
47036977|NCT01513239|83288194|FG000|Period 2: 9 Month Extension Phase|Death|0|||
47036978|NCT01513239|83288195|FG001|Period 2: 9 Month Extension Phase|Death|0|||
47036979|NCT01513239|83288196|FG002|Period 2: 9 Month Extension Phase|Death|0|||
47036980|NCT01513239|83288197|FG003|Period 2: 9 Month Extension Phase|Death|2|||
47036981|NCT01513239|83288198|FG004|Period 2: 9 Month Extension Phase|Death|5|||
47036982|NCT01513239|83288199|FG005|Period 2: 9 Month Extension Phase|Death|2|||
47036983|NCT01513239|83288194|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
47036984|NCT01513239|83288195|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
47036985|NCT01513239|83288196|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
47036986|NCT01513239|83288197|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
47036987|NCT01513239|83288198|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
47036988|NCT01513239|83288199|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
47036989|NCT01513239|83288194|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
47036990|NCT01513239|83288195|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
47036991|NCT01513239|83288196|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
47036992|NCT01513239|83288197|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
46630166|NCT01953354|82801138|FG000|Overall Study|Disease Exacerbation|1|||
46630167|NCT01953354|82801139|FG001|Overall Study|Disease Exacerbation|0|||
46630168|NCT01975272|82801148|FG000|Overall Study|Excluded after protocol amendment|1|||
46630169|NCT01975272|82801149|FG001|Overall Study|Excluded after protocol amendment|1|||
46630170|NCT01975272|82801150|FG002|Overall Study|Excluded after protocol amendment|2|||
46630171|NCT01951638|82801163|FG000|Treatment Period|Protocol Violation|0|||
46630172|NCT01951638|82801164|FG001|Treatment Period|Protocol Violation|0|||
47036993|NCT01513239|83288198|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
46630173|NCT01951638|82801165|FG002|Treatment Period|Protocol Violation|0|||
46630174|NCT01951638|82801166|FG003|Treatment Period|Protocol Violation|2|||
46630175|NCT01951638|82801167|FG004|Treatment Period|Protocol Violation|0|||
46630176|NCT01951638|82801163|FG000|Treatment Period|Protocol-driven decision point|1|||
46712260|NCT01104792|82928703|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
46712261|NCT01205126|82928709|FG000|Titration Phase|Adverse Event|5|||
47036994|NCT01513239|83288199|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
46712262|NCT01205126|82928710|FG001|Titration Phase|Adverse Event|3|||
46712263|NCT01205126|82928709|FG000|Titration Phase|Withdrawal by Subject|5|||
46712264|NCT01205126|82928710|FG001|Titration Phase|Withdrawal by Subject|5|||
46712265|NCT01205126|82928709|FG000|Titration Phase|Lost to Follow-up|2|||
46712266|NCT01205126|82928710|FG001|Titration Phase|Lost to Follow-up|2|||
46712267|NCT01205126|82928709|FG000|Titration Phase|No stable titration dose|1|||
46712268|NCT01205126|82928710|FG001|Titration Phase|No stable titration dose|0|||
46712269|NCT01205126|82928709|FG000|Titration Phase|More than maximum dosage required|2|||
46712270|NCT01205126|82928710|FG001|Titration Phase|More than maximum dosage required|3|||
46712271|NCT01205126|82928709|FG000|Titration Phase|Other|8|||
46712272|NCT01205126|82928710|FG001|Titration Phase|Other|6|||
46712273|NCT01205126|82928709|FG000|Between Titration & Maintenance Phase|Other|0|||
46712274|NCT01205126|82928710|FG001|Between Titration & Maintenance Phase|Other|4|||
47036995|NCT01513239|83288194|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
47036996|NCT01513239|83288195|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
47036997|NCT01513239|83288196|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
47036998|NCT01513239|83288197|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
47036999|NCT01513239|83288198|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
47037000|NCT01513239|83288199|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
47037001|NCT01544127|83288214|FG000|Overall Study|Lost to Follow-up|4|||
47037002|NCT01544127|83288215|FG001|Overall Study|Lost to Follow-up|2|||
47037003|NCT01544127|83288216|FG002|Overall Study|Lost to Follow-up|9|||
47037004|NCT01544127|83288214|FG000|Overall Study|Withdrawal by Subject|2|||
47037005|NCT01544127|83288215|FG001|Overall Study|Withdrawal by Subject|2|||
47037006|NCT01544127|83288216|FG002|Overall Study|Withdrawal by Subject|1|||
47037007|NCT01544127|83288214|FG000|Overall Study|Discharged out of catchment area|1|||
47037008|NCT01544127|83288215|FG001|Overall Study|Discharged out of catchment area|1|||
47037009|NCT01544127|83288216|FG002|Overall Study|Discharged out of catchment area|1|||
47037010|NCT01544127|83288214|FG000|Overall Study|Death|1|||
47037011|NCT01544127|83288215|FG001|Overall Study|Death|0|||
47037012|NCT01544127|83288216|FG002|Overall Study|Death|0|||
47037013|NCT01544127|83288214|FG000|Overall Study|Jail or Prison|1|||
47037014|NCT01544127|83288215|FG001|Overall Study|Jail or Prison|1|||
47037015|NCT01544127|83288216|FG002|Overall Study|Jail or Prison|2|||
47037016|NCT01544127|83288214|FG000|Overall Study|Became Psychotic|1|||
47037017|NCT01544127|83288215|FG001|Overall Study|Became Psychotic|0|||
47037018|NCT01544127|83288216|FG002|Overall Study|Became Psychotic|0|||
47037019|NCT01544127|83288214|FG000|Overall Study|Researcher withdrew|1|||
47037020|NCT01544127|83288215|FG001|Overall Study|Researcher withdrew|0|||
47037021|NCT01544127|83288216|FG002|Overall Study|Researcher withdrew|0|||
47037022|NCT01544127|83288214|FG000|Overall Study|Went active duty|0|||
47037023|NCT01544127|83288215|FG001|Overall Study|Went active duty|0|||
47037024|NCT01544127|83288216|FG002|Overall Study|Went active duty|1|||
47037025|NCT01512693|83288227|FG000|Overall Study|Withdrawal by Subject|0|||
47037026|NCT01512693|83288228|FG001|Overall Study|Withdrawal by Subject|1|||
47037027|NCT01458340|83288237|FG000|Overall Study|Adverse Event|5|||
47037028|NCT01458340|83288238|FG001|Overall Study|Adverse Event|4|||
47037029|NCT01458340|83288239|FG002|Overall Study|Adverse Event|2|||
47037030|NCT01458340|83288237|FG000|Overall Study|Lost to Follow-up|3|||
47037031|NCT01458340|83288238|FG001|Overall Study|Lost to Follow-up|3|||
47037032|NCT01458340|83288239|FG002|Overall Study|Lost to Follow-up|10|||
47037033|NCT01458340|83288237|FG000|Overall Study|Miscellaneous|0|||
47037034|NCT01458340|83288238|FG001|Overall Study|Miscellaneous|1|||
46630177|NCT01951638|82801164|FG001|Treatment Period|Protocol-driven decision point|3|||
46630178|NCT01951638|82801165|FG002|Treatment Period|Protocol-driven decision point|0|||
46630179|NCT01951638|82801166|FG003|Treatment Period|Protocol-driven decision point|0|||
46630180|NCT01951638|82801167|FG004|Treatment Period|Protocol-driven decision point|0|||
46630181|NCT01951638|82801163|FG000|Treatment Period|Logistical difficulties|0|||
46630182|NCT01951638|82801164|FG001|Treatment Period|Logistical difficulties|1|||
46630183|NCT01951638|82801165|FG002|Treatment Period|Logistical difficulties|1|||
46630184|NCT01951638|82801166|FG003|Treatment Period|Logistical difficulties|0|||
46630185|NCT01951638|82801167|FG004|Treatment Period|Logistical difficulties|0|||
46630186|NCT01951638|82801163|FG000|Treatment Period|Withdrawal by Subject|9|||
46630187|NCT01951638|82801164|FG001|Treatment Period|Withdrawal by Subject|6|||
46630188|NCT01951638|82801165|FG002|Treatment Period|Withdrawal by Subject|4|||
46630189|NCT01951638|82801166|FG003|Treatment Period|Withdrawal by Subject|5|||
46630190|NCT01951638|82801167|FG004|Treatment Period|Withdrawal by Subject|4|||
46712275|NCT01205126|82928709|FG000|Maintenance Phase|Adverse Event|3|||
47037035|NCT01458340|83288239|FG002|Overall Study|Miscellaneous|0|||
46630191|NCT01951638|82801163|FG000|Treatment Period|Death|0|||
46630192|NCT01951638|82801164|FG001|Treatment Period|Death|0|||
46630193|NCT01951638|82801165|FG002|Treatment Period|Death|0|||
46630194|NCT01951638|82801166|FG003|Treatment Period|Death|3|||
46630195|NCT01951638|82801167|FG004|Treatment Period|Death|1|||
47037036|NCT01458340|83288237|FG000|Overall Study|Physician Decision|1|||
47037037|NCT01458340|83288238|FG001|Overall Study|Physician Decision|1|||
46630196|NCT01951638|82801163|FG000|Treatment Period|Adverse Event|3|||
46630197|NCT01951638|82801164|FG001|Treatment Period|Adverse Event|4|||
46712276|NCT01205126|82928710|FG001|Maintenance Phase|Adverse Event|7|||
47037038|NCT01458340|83288239|FG002|Overall Study|Physician Decision|2|||
47037039|NCT01458340|83288237|FG000|Overall Study|Protocol Violation|6|||
47037040|NCT01458340|83288238|FG001|Overall Study|Protocol Violation|6|||
47037041|NCT01458340|83288239|FG002|Overall Study|Protocol Violation|5|||
46712277|NCT01205126|82928709|FG000|Maintenance Phase|Death|4|||
46712278|NCT01205126|82928710|FG001|Maintenance Phase|Death|4|||
46712279|NCT01205126|82928709|FG000|Maintenance Phase|More than the maximum dosage required|5|||
46712280|NCT01205126|82928710|FG001|Maintenance Phase|More than the maximum dosage required|5|||
46712281|NCT01205126|82928709|FG000|Maintenance Phase|Prohibited drugs used|1|||
46712282|NCT01205126|82928710|FG001|Maintenance Phase|Prohibited drugs used|0|||
46712283|NCT01205126|82928709|FG000|Maintenance Phase|Other|11|||
46712284|NCT01205126|82928710|FG001|Maintenance Phase|Other|8|||
46712285|NCT01205126|82928709|FG000|Maintenance Phase|Lost to Follow-up|5|||
46712286|NCT01205126|82928710|FG001|Maintenance Phase|Lost to Follow-up|5|||
46712287|NCT01205126|82928709|FG000|Maintenance Phase|Withdrawal by Subject|8|||
46712288|NCT01205126|82928710|FG001|Maintenance Phase|Withdrawal by Subject|11|||
46712289|NCT00946647|82928721|FG000|Phase 1 Part|Adverse Event|2|||
46712290|NCT00946647|82928722|FG001|Phase 1 Part|Adverse Event|5|||
46712291|NCT00946647|82928723|FG002|Phase 1 Part|Adverse Event|3|||
46712292|NCT00946647|82928724|FG003|Phase 1 Part|Adverse Event|0|||
46712293|NCT00946647|82928725|FG004|Phase 1 Part|Adverse Event|0|||
46712294|NCT00946647|82928721|FG000|Phase 1 Part|Disease progression|3|||
46712295|NCT00946647|82928722|FG001|Phase 1 Part|Disease progression|6|||
46712296|NCT00946647|82928723|FG002|Phase 1 Part|Disease progression|1|||
46712297|NCT00946647|82928724|FG003|Phase 1 Part|Disease progression|0|||
46712298|NCT00946647|82928725|FG004|Phase 1 Part|Disease progression|0|||
46913813|NCT03083847|83144274|FG004|Main|Adverse Event|0|||
46913814|NCT03083847|83144275|FG005|Main|Adverse Event|0|||
46913815|NCT03083847|83144276|FG006|Main|Adverse Event|0|||
47037042|NCT01458340|83288237|FG000|Overall Study|Withdrawal by Subject|12|||
47037043|NCT01458340|83288238|FG001|Overall Study|Withdrawal by Subject|6|||
47037044|NCT01458340|83288239|FG002|Overall Study|Withdrawal by Subject|4|||
47037045|NCT01539291|83288285|FG000|Study GS-US-312-0116|Adverse Event|9|||
47037046|NCT01539291|83288286|FG001|Study GS-US-312-0116|Adverse Event|0|||
47037047|NCT01539291|83288287|FG002|Study GS-US-312-0116|Adverse Event|0|||
47037048|NCT01539291|83288288|FG003|Study GS-US-312-0116|Adverse Event|0|||
47037049|NCT01539291|83288285|FG000|Study GS-US-312-0116|Physician Decision|1|||
47037050|NCT01539291|83288286|FG001|Study GS-US-312-0116|Physician Decision|0|||
47037051|NCT01539291|83288287|FG002|Study GS-US-312-0116|Physician Decision|0|||
47037052|NCT01539291|83288288|FG003|Study GS-US-312-0116|Physician Decision|0|||
47037053|NCT01539291|83288285|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
46712299|NCT00946647|82928721|FG000|Phase 1 Part|Withdrawal by Subject|1|||
46712300|NCT00946647|82928722|FG001|Phase 1 Part|Withdrawal by Subject|4|||
46712301|NCT00946647|82928723|FG002|Phase 1 Part|Withdrawal by Subject|3|||
46712302|NCT00946647|82928724|FG003|Phase 1 Part|Withdrawal by Subject|0|||
46712303|NCT00946647|82928725|FG004|Phase 1 Part|Withdrawal by Subject|0|||
46712304|NCT00946647|82928721|FG000|Phase 1 Part|Abnormal values|0|||
46712305|NCT00946647|82928722|FG001|Phase 1 Part|Abnormal values|2|||
46913816|NCT03083847|83144277|FG007|Main|Adverse Event|2|||
46913817|NCT03083847|83144278|FG008|Main|Adverse Event|0|||
46913818|NCT03083847|83144279|FG009|Main|Adverse Event|0|||
46913819|NCT03083847|83144270|FG000|Main|Withdrawal by Subject|0|||
46913820|NCT03083847|83144271|FG001|Main|Withdrawal by Subject|0|||
46913821|NCT03083847|83144272|FG002|Main|Withdrawal by Subject|0|||
46712306|NCT00946647|82928723|FG002|Phase 1 Part|Abnormal values|0|||
46712307|NCT00946647|82928724|FG003|Phase 1 Part|Abnormal values|0|||
46712308|NCT00946647|82928725|FG004|Phase 1 Part|Abnormal values|0|||
46712309|NCT00946647|82928721|FG000|Phase 1 Part|Reason missing|0|||
46712310|NCT00946647|82928722|FG001|Phase 1 Part|Reason missing|1|||
46712311|NCT00946647|82928723|FG002|Phase 1 Part|Reason missing|0|||
46712312|NCT00946647|82928724|FG003|Phase 1 Part|Reason missing|0|||
46712313|NCT00946647|82928725|FG004|Phase 1 Part|Reason missing|0|||
46712314|NCT00946647|82928721|FG000|Phase ll Part|Untreated|0|||
46712315|NCT00946647|82928722|FG001|Phase ll Part|Untreated|0|||
46712316|NCT00946647|82928723|FG002|Phase ll Part|Untreated|0|||
46712317|NCT00946647|82928724|FG003|Phase ll Part|Untreated|0|||
46712318|NCT00946647|82928725|FG004|Phase ll Part|Untreated|2|||
46913822|NCT03083847|83144273|FG003|Main|Withdrawal by Subject|0|||
46913823|NCT03083847|83144274|FG004|Main|Withdrawal by Subject|0|||
46913824|NCT03083847|83144275|FG005|Main|Withdrawal by Subject|0|||
46712319|NCT00946647|82928721|FG000|Phase ll Part|Adverse Event|0|||
46712320|NCT00946647|82928722|FG001|Phase ll Part|Adverse Event|0|||
46913825|NCT03083847|83144276|FG006|Main|Withdrawal by Subject|1|||
46712321|NCT00946647|82928723|FG002|Phase ll Part|Adverse Event|0|||
46712322|NCT00946647|82928724|FG003|Phase ll Part|Adverse Event|10|||
46712323|NCT00946647|82928725|FG004|Phase ll Part|Adverse Event|6|||
46712324|NCT00946647|82928721|FG000|Phase ll Part|Withdrawal by Subject|0|||
46712325|NCT00946647|82928722|FG001|Phase ll Part|Withdrawal by Subject|0|||
46712326|NCT00946647|82928723|FG002|Phase ll Part|Withdrawal by Subject|0|||
46913826|NCT03083847|83144277|FG007|Main|Withdrawal by Subject|1|||
46913827|NCT03083847|83144278|FG008|Main|Withdrawal by Subject|0|||
47037054|NCT01539291|83288286|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
47037055|NCT01539291|83288287|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
47037056|NCT01539291|83288288|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
47037057|NCT01539291|83288285|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
47037058|NCT01539291|83288286|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
47037059|NCT01539291|83288287|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
47037060|NCT01539291|83288288|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
47037061|NCT01539291|83288285|FG000|Study GS-US-312-0116|Other|1|||
47037062|NCT01539291|83288286|FG001|Study GS-US-312-0116|Other|0|||
47037063|NCT01539291|83288287|FG002|Study GS-US-312-0116|Other|0|||
47037064|NCT01539291|83288288|FG003|Study GS-US-312-0116|Other|0|||
47037065|NCT01539291|83288285|FG000|Study GS-US-312-0117|Adverse Event|22|||
47037066|NCT01539291|83288286|FG001|Study GS-US-312-0117|Adverse Event|1|||
47037067|NCT01539291|83288287|FG002|Study GS-US-312-0117|Adverse Event|9|||
47037068|NCT01539291|83288288|FG003|Study GS-US-312-0117|Adverse Event|12|||
47037069|NCT01539291|83288285|FG000|Study GS-US-312-0117|Physician Decision|9|||
47037070|NCT01539291|83288286|FG001|Study GS-US-312-0117|Physician Decision|0|||
47037071|NCT01539291|83288287|FG002|Study GS-US-312-0117|Physician Decision|6|||
47037072|NCT01539291|83288288|FG003|Study GS-US-312-0117|Physician Decision|4|||
47037073|NCT01539291|83288285|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
47037074|NCT01539291|83288286|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
47037075|NCT01539291|83288287|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
47037076|NCT01539291|83288288|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
47037077|NCT01539291|83288285|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
47037078|NCT01539291|83288286|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
47037079|NCT01539291|83288287|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
47037080|NCT01539291|83288288|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
47037081|NCT01539291|83288285|FG000|Study GS-US-312-0117|Other|2|||
47037082|NCT01539291|83288286|FG001|Study GS-US-312-0117|Other|1|||
47037083|NCT01539291|83288287|FG002|Study GS-US-312-0117|Other|1|||
47037084|NCT01539291|83288288|FG003|Study GS-US-312-0117|Other|1|||
47037085|NCT01538199|83288311|FG000|Overall Study|Lost to Follow-up|1|||
47037086|NCT01538199|83288312|FG001|Overall Study|Lost to Follow-up|2|||
47037087|NCT01538199|83288313|FG002|Overall Study|Lost to Follow-up|1|||
47037088|NCT01538199|83288314|FG003|Overall Study|Lost to Follow-up|0|||
47037089|NCT01538199|83288311|FG000|Overall Study|participant did not have time|1|||
47037090|NCT01538199|83288312|FG001|Overall Study|participant did not have time|0|||
47037091|NCT01538199|83288313|FG002|Overall Study|participant did not have time|0|||
47037092|NCT01538199|83288314|FG003|Overall Study|participant did not have time|2|||
47037093|NCT01538199|83288311|FG000|Overall Study|Lack of Efficacy|0|||
47037094|NCT01538199|83288312|FG001|Overall Study|Lack of Efficacy|1|||
47037095|NCT01538199|83288313|FG002|Overall Study|Lack of Efficacy|0|||
46630198|NCT01951638|82801165|FG002|Treatment Period|Adverse Event|8|||
46630199|NCT01951638|82801166|FG003|Treatment Period|Adverse Event|6|||
46630200|NCT01951638|82801167|FG004|Treatment Period|Adverse Event|5|||
46630201|NCT01951638|82801163|FG000|Follow-up Period|Protocol Violation|0|||
46630202|NCT01951638|82801164|FG001|Follow-up Period|Protocol Violation|0|||
46630203|NCT01951638|82801165|FG002|Follow-up Period|Protocol Violation|0|||
46712327|NCT00946647|82928724|FG003|Phase ll Part|Withdrawal by Subject|8|||
46712328|NCT00946647|82928725|FG004|Phase ll Part|Withdrawal by Subject|6|||
46712329|NCT00946647|82928721|FG000|Phase ll Part|Administrative problems|0|||
46712330|NCT00946647|82928722|FG001|Phase ll Part|Administrative problems|0|||
46712331|NCT00946647|82928723|FG002|Phase ll Part|Administrative problems|0|||
46712332|NCT00946647|82928724|FG003|Phase ll Part|Administrative problems|3|||
46712333|NCT00946647|82928725|FG004|Phase ll Part|Administrative problems|8|||
46712334|NCT00946647|82928721|FG000|Phase ll Part|Death|0|||
46630204|NCT01951638|82801166|FG003|Follow-up Period|Protocol Violation|1|||
46630205|NCT01951638|82801167|FG004|Follow-up Period|Protocol Violation|0|||
46630206|NCT01951638|82801163|FG000|Follow-up Period|Logistical difficulties|0|||
46712335|NCT00946647|82928722|FG001|Phase ll Part|Death|0|||
46712336|NCT00946647|82928723|FG002|Phase ll Part|Death|0|||
46712337|NCT00946647|82928724|FG003|Phase ll Part|Death|7|||
46712338|NCT00946647|82928725|FG004|Phase ll Part|Death|4|||
46712339|NCT00946647|82928721|FG000|Phase ll Part|Disease progression|0|||
46712340|NCT00946647|82928722|FG001|Phase ll Part|Disease progression|0|||
47037096|NCT01538199|83288314|FG003|Overall Study|Lack of Efficacy|0|||
47037097|NCT01511445|83288333|FG000|Overall Study|Lost to Follow-up|3|||
46630207|NCT01951638|82801164|FG001|Follow-up Period|Logistical difficulties|2|||
46630208|NCT01951638|82801165|FG002|Follow-up Period|Logistical difficulties|0|||
46712341|NCT00946647|82928723|FG002|Phase ll Part|Disease progression|0|||
46630209|NCT01951638|82801166|FG003|Follow-up Period|Logistical difficulties|0|||
46712342|NCT00946647|82928724|FG003|Phase ll Part|Disease progression|6|||
46712343|NCT00946647|82928725|FG004|Phase ll Part|Disease progression|14|||
47037098|NCT01511445|83288334|FG001|Overall Study|Lost to Follow-up|1|||
47037099|NCT01511445|83288333|FG000|Overall Study|Protocol Violation|1|||
47037100|NCT01511445|83288334|FG001|Overall Study|Protocol Violation|3|||
47037101|NCT01511445|83288333|FG000|Overall Study|Protocol Violation|1|||
47037102|NCT01511445|83288334|FG001|Overall Study|Protocol Violation|0|||
47037103|NCT01543503|83288342|FG000|Overall Study|Lost to Follow-up|32|||
47037104|NCT01543503|83288343|FG001|Overall Study|Lost to Follow-up|36|||
47037105|NCT01543503|83288342|FG000|Overall Study|Adverse Event|9|||
47037106|NCT01543503|83288343|FG001|Overall Study|Adverse Event|13|||
47037107|NCT01543503|83288342|FG000|Overall Study|Lack of Efficacy|4|||
47037108|NCT01543503|83288343|FG001|Overall Study|Lack of Efficacy|16|||
47037109|NCT01543503|83288342|FG000|Overall Study|Participant withdrew informed consent|8|||
47037110|NCT01543503|83288343|FG001|Overall Study|Participant withdrew informed consent|10|||
47037111|NCT01543503|83288342|FG000|Overall Study|Change of jobs|0|||
47037112|NCT01543503|83288343|FG001|Overall Study|Change of jobs|1|||
47037113|NCT01543503|83288342|FG000|Overall Study|Intolerance to the biologic treatment|0|||
47037114|NCT01543503|83288343|FG001|Overall Study|Intolerance to the biologic treatment|1|||
47037115|NCT01543503|83288342|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
47037116|NCT01543503|83288343|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
47037117|NCT01543503|83288342|FG000|Overall Study|Participant did not complete last visit|0|||
47037118|NCT01543503|83288343|FG001|Overall Study|Participant did not complete last visit|2|||
47037119|NCT01543503|83288342|FG000|Overall Study|Refused to continue treatment|7|||
47037120|NCT01543503|83288343|FG001|Overall Study|Refused to continue treatment|0|||
47037121|NCT01543503|83288342|FG000|Overall Study|Incorrect medication received|1|||
47037122|NCT01543503|83288343|FG001|Overall Study|Incorrect medication received|0|||
47037123|NCT01543503|83288342|FG000|Overall Study|Participant moved to another city|2|||
47037124|NCT01543503|83288343|FG001|Overall Study|Participant moved to another city|0|||
47037125|NCT01543503|83288342|FG000|Overall Study|Participant will not return for visits|0|||
47037126|NCT01543503|83288343|FG001|Overall Study|Participant will not return for visits|2|||
47037127|NCT01543503|83288342|FG000|Overall Study|Participant transferred to another city|1|||
47037128|NCT01543503|83288343|FG001|Overall Study|Participant transferred to another city|0|||
47037129|NCT01543503|83288342|FG000|Overall Study|Participant moved to Scotland|1|||
47037130|NCT01543503|83288343|FG001|Overall Study|Participant moved to Scotland|0|||
47037131|NCT01543503|83288342|FG000|Overall Study|Participant decision to stop treatment|1|||
47037132|NCT01543503|83288343|FG001|Overall Study|Participant decision to stop treatment|0|||
47037133|NCT01543503|83288342|FG000|Overall Study|Investigator did not wish to participate|1|||
47037134|NCT01543503|83288343|FG001|Overall Study|Investigator did not wish to participate|1|||
47037135|NCT01543503|83288342|FG000|Overall Study|Participant recruited after closing date|0|||
47037136|NCT01543503|83288343|FG001|Overall Study|Participant recruited after closing date|1|||
47037137|NCT01543503|83288342|FG000|Overall Study|Site stopped participation|5|||
47037138|NCT01543503|83288343|FG001|Overall Study|Site stopped participation|1|||
47037139|NCT01543503|83288342|FG000|Overall Study|Participant did not attend a visit|1|||
47037140|NCT01543503|83288343|FG001|Overall Study|Participant did not attend a visit|0|||
47037141|NCT01543503|83288342|FG000|Overall Study|Moved to other rheumatologic site|0|||
47037142|NCT01543503|83288343|FG001|Overall Study|Moved to other rheumatologic site|1|||
47037143|NCT01543503|83288342|FG000|Overall Study|Participant consented to another study|0|||
47037144|NCT01543503|83288343|FG001|Overall Study|Participant consented to another study|2|||
47037145|NCT01543503|83288342|FG000|Overall Study|Participant went to United States|1|||
47037146|NCT01543503|83288343|FG001|Overall Study|Participant went to United States|0|||
47037147|NCT01543503|83288342|FG000|Overall Study|Screen failure|1|||
47037148|NCT01543503|83288343|FG001|Overall Study|Screen failure|0|||
47037149|NCT01511055|83288349|FG000|Overall Study|Withdrawal by Subject|6|||
47037150|NCT01537887|83288353|FG000|Period 1|Physician Decision|0|||
47037151|NCT01537887|83288354|FG001|Period 1|Physician Decision|0|||
47037152|NCT01537887|83288355|FG002|Period 1|Physician Decision|0|||
47037153|NCT01537887|83288356|FG003|Period 1|Physician Decision|0|||
46630210|NCT01951638|82801167|FG004|Follow-up Period|Logistical difficulties|1|||
46630211|NCT01951638|82801163|FG000|Follow-up Period|Withdrawal by Subject|1|||
46630212|NCT01951638|82801164|FG001|Follow-up Period|Withdrawal by Subject|5|||
46630213|NCT01951638|82801165|FG002|Follow-up Period|Withdrawal by Subject|2|||
46630214|NCT01951638|82801166|FG003|Follow-up Period|Withdrawal by Subject|1|||
46630215|NCT01951638|82801167|FG004|Follow-up Period|Withdrawal by Subject|2|||
47037154|NCT01537887|83288357|FG004|Period 1|Physician Decision|1|||
47037155|NCT01537887|83288358|FG005|Period 1|Physician Decision|1|||
47037156|NCT01537887|83288353|FG000|Period 1|Did not receive treatment|0|||
47037157|NCT01537887|83288354|FG001|Period 1|Did not receive treatment|0|||
47037158|NCT01537887|83288355|FG002|Period 1|Did not receive treatment|1|||
47037159|NCT01537887|83288356|FG003|Period 1|Did not receive treatment|0|||
47037160|NCT01537887|83288357|FG004|Period 1|Did not receive treatment|0|||
47037161|NCT01537887|83288358|FG005|Period 1|Did not receive treatment|0|||
47037162|NCT01537887|83288353|FG000|Period 2|Withdrawal by Subject|0|||
46630216|NCT01951638|82801163|FG000|Follow-up Period|Lost to Follow-up|0|||
46630217|NCT01951638|82801164|FG001|Follow-up Period|Lost to Follow-up|1|||
46630218|NCT01951638|82801165|FG002|Follow-up Period|Lost to Follow-up|0|||
46712344|NCT00946647|82928721|FG000|Phase ll Part|Protocol Violation|0|||
47037163|NCT01537887|83288354|FG001|Period 2|Withdrawal by Subject|1|||
47037164|NCT01537887|83288355|FG002|Period 2|Withdrawal by Subject|0|||
46712345|NCT00946647|82928722|FG001|Phase ll Part|Protocol Violation|0|||
46712346|NCT00946647|82928723|FG002|Phase ll Part|Protocol Violation|0|||
46712347|NCT00946647|82928724|FG003|Phase ll Part|Protocol Violation|4|||
47037165|NCT01537887|83288356|FG003|Period 2|Withdrawal by Subject|0|||
47037166|NCT01537887|83288357|FG004|Period 2|Withdrawal by Subject|0|||
47037167|NCT01537887|83288358|FG005|Period 2|Withdrawal by Subject|0|||
47037168|NCT01537887|83288353|FG000|Period 3|Adverse Event|0|||
47037169|NCT01537887|83288354|FG001|Period 3|Adverse Event|0|||
47037170|NCT01537887|83288355|FG002|Period 3|Adverse Event|1|||
47037171|NCT01537887|83288356|FG003|Period 3|Adverse Event|0|||
47037172|NCT01537887|83288357|FG004|Period 3|Adverse Event|0|||
47037173|NCT01537887|83288358|FG005|Period 3|Adverse Event|0|||
47037174|NCT01537887|83288353|FG000|Period 3|Withdrawal by Subject|0|||
47037175|NCT01537887|83288354|FG001|Period 3|Withdrawal by Subject|1|||
47037176|NCT01537887|83288355|FG002|Period 3|Withdrawal by Subject|0|||
47037177|NCT01537887|83288356|FG003|Period 3|Withdrawal by Subject|0|||
47037178|NCT01537887|83288357|FG004|Period 3|Withdrawal by Subject|0|||
47037179|NCT01537887|83288358|FG005|Period 3|Withdrawal by Subject|0|||
47037180|NCT01489527|83288368|FG000|Overall Study|Pregnancy|9|||
47037181|NCT01489527|83288369|FG001|Overall Study|Pregnancy|14|||
47037182|NCT01489527|83288368|FG000|Overall Study|Participant moved|6|||
47037183|NCT01489527|83288369|FG001|Overall Study|Participant moved|7|||
47037184|NCT01489527|83288368|FG000|Overall Study|Withdrawal by Subject|0|||
47037185|NCT01489527|83288369|FG001|Overall Study|Withdrawal by Subject|4|||
47037186|NCT01489527|83288368|FG000|Overall Study|Lost to Follow-up|5|||
47037187|NCT01489527|83288369|FG001|Overall Study|Lost to Follow-up|1|||
47037188|NCT01489527|83288368|FG000|Overall Study|Procedures|1|||
47037189|NCT01489527|83288369|FG001|Overall Study|Procedures|0|||
47037190|NCT01489527|83288368|FG000|Overall Study|Not compliant|1|||
47037191|NCT01489527|83288369|FG001|Overall Study|Not compliant|0|||
47037192|NCT01487577|83288382|FG000|Overall Study|Became ineligible after signing consent|1|||
47037193|NCT01536951|83288388|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037194|NCT01536951|83288389|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037195|NCT01536951|83288390|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
47037196|NCT01536951|83288391|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037197|NCT01536951|83288392|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037198|NCT01536951|83288393|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037199|NCT01536951|83288394|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037200|NCT01536951|83288395|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037201|NCT01536951|83288396|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
47037202|NCT01536951|83288388|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
47037203|NCT01536951|83288389|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
47037204|NCT01536951|83288390|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
47037205|NCT01536951|83288391|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
47037206|NCT01536951|83288392|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
47037207|NCT01536951|83288393|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
47037208|NCT01536951|83288394|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
47037209|NCT01536951|83288395|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
47037210|NCT01536951|83288396|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
47037211|NCT01536795|83288421|FG000|Overall Study|Lost to Follow-up|0|||
47037212|NCT01536795|83288422|FG001|Overall Study|Lost to Follow-up|2|||
47037213|NCT01536795|83288421|FG000|Overall Study|Lack of Efficacy|1|||
47037214|NCT01536795|83288422|FG001|Overall Study|Lack of Efficacy|0|||
47037215|NCT01536561|83288432|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
46630219|NCT01951638|82801166|FG003|Follow-up Period|Lost to Follow-up|1|||
46630220|NCT01951638|82801167|FG004|Follow-up Period|Lost to Follow-up|0|||
46630221|NCT01951638|82801163|FG000|Follow-up Period|Death|1|||
46630222|NCT01951638|82801164|FG001|Follow-up Period|Death|0|||
46630223|NCT01951638|82801165|FG002|Follow-up Period|Death|1|||
46630224|NCT01951638|82801166|FG003|Follow-up Period|Death|4|||
46630225|NCT01951638|82801167|FG004|Follow-up Period|Death|1|||
46630226|NCT01951638|82801163|FG000|Follow-up Period|Adverse Event|0|||
46630227|NCT01951638|82801164|FG001|Follow-up Period|Adverse Event|1|||
46630228|NCT01951638|82801165|FG002|Follow-up Period|Adverse Event|2|||
46712348|NCT00946647|82928725|FG004|Phase ll Part|Protocol Violation|2|||
46712349|NCT00946647|82928721|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
46712350|NCT00946647|82928722|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
46913828|NCT03083847|83144279|FG009|Main|Withdrawal by Subject|0|||
47037216|NCT01536561|83288432|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
47037217|NCT01536561|83288432|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
47037218|NCT01536561|83288432|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
47037219|NCT01536561|83288432|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
47037220|NCT01536561|83288432|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
46630229|NCT01951638|82801166|FG003|Follow-up Period|Adverse Event|1|||
46913829|NCT03082677|83144307|FG000|Overall Study|Not Treated|2|||
46712351|NCT00946647|82928723|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
46712352|NCT00946647|82928724|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
46712353|NCT00946647|82928725|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
46712354|NCT00946101|82928740|FG000|Overall Study|Lost to Follow-up|2|||
46712355|NCT00946101|82928741|FG001|Overall Study|Lost to Follow-up|1|||
46712356|NCT00946101|82928740|FG000|Overall Study|Withdrawal of consent|2|||
46712357|NCT00946101|82928741|FG001|Overall Study|Withdrawal of consent|0|||
46712358|NCT00946101|82928740|FG000|Overall Study|Physician Decision|0|||
46712359|NCT00946101|82928741|FG001|Overall Study|Physician Decision|1|||
46712360|NCT01109940|82928755|FG000|Overall Study|Administrative problems|2|||
46712361|NCT01109940|82928756|FG001|Overall Study|Administrative problems|0|||
46712362|NCT01109940|82928757|FG002|Overall Study|Administrative problems|0|||
46712363|NCT01109940|82928758|FG003|Overall Study|Administrative problems|0|||
46712364|NCT01109940|82928755|FG000|Overall Study|Serious Adverse Event|2|||
47037221|NCT01536405|83288450|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
47037222|NCT01536405|83288451|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
47037223|NCT01536405|83288450|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
47037224|NCT01536405|83288451|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
47037225|NCT01536405|83288450|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
47037226|NCT01536405|83288451|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
47037227|NCT01536405|83288450|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
47037228|NCT01536405|83288451|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
47037229|NCT01536405|83288450|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
47037230|NCT01536405|83288451|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
47037231|NCT01536405|83288450|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
47037232|NCT01536405|83288451|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
46630230|NCT01951638|82801167|FG004|Follow-up Period|Adverse Event|1|||
46630231|NCT01928472|82801183|FG000|Overall Study|Death|0|||
46630232|NCT01928472|82801184|FG001|Overall Study|Death|0|||
46630233|NCT01928472|82801185|FG002|Overall Study|Death|1|||
46630234|NCT01928472|82801186|FG003|Overall Study|Death|0|||
46630235|NCT01928472|82801183|FG000|Overall Study|Withdrawal by Subject|4|||
46630236|NCT01928472|82801184|FG001|Overall Study|Withdrawal by Subject|4|||
46630237|NCT01928472|82801185|FG002|Overall Study|Withdrawal by Subject|1|||
46630238|NCT01928472|82801186|FG003|Overall Study|Withdrawal by Subject|2|||
46630239|NCT01928472|82801183|FG000|Overall Study|Lost to Follow-up|2|||
46630240|NCT01928472|82801184|FG001|Overall Study|Lost to Follow-up|3|||
46630241|NCT01928472|82801185|FG002|Overall Study|Lost to Follow-up|4|||
46630242|NCT01928472|82801186|FG003|Overall Study|Lost to Follow-up|0|||
46630243|NCT01928472|82801183|FG000|Overall Study|Administrative Reason|2|||
46630244|NCT01928472|82801184|FG001|Overall Study|Administrative Reason|1|||
46630245|NCT01928472|82801185|FG002|Overall Study|Administrative Reason|0|||
46630246|NCT01928472|82801186|FG003|Overall Study|Administrative Reason|0|||
46630247|NCT01928472|82801183|FG000|Overall Study|Unclassified|0|||
46630248|NCT01928472|82801184|FG001|Overall Study|Unclassified|0|||
46630249|NCT01928472|82801185|FG002|Overall Study|Unclassified|1|||
46630250|NCT01928472|82801186|FG003|Overall Study|Unclassified|0|||
46630251|NCT01351415|82803039|FG000|Overall Study|Withdrawal by Subject|15|||
46630252|NCT01351415|82803040|FG001|Overall Study|Withdrawal by Subject|17|||
46630253|NCT01351415|82803039|FG000|Overall Study|Trial termination by the Sponsor|28|||
46630254|NCT01351415|82803040|FG001|Overall Study|Trial termination by the Sponsor|19|||
46630255|NCT01351415|82803039|FG000|Overall Study|Lost to Follow-up|5|||
46630256|NCT01351415|82803040|FG001|Overall Study|Lost to Follow-up|7|||
46630257|NCT01351415|82803039|FG000|Overall Study|Death|190|||
46630258|NCT01351415|82803040|FG001|Overall Study|Death|187|||
46630259|NCT01351415|82803039|FG000|Overall Study|Physician Decision|2|||
46630260|NCT01351415|82803040|FG001|Overall Study|Physician Decision|3|||
46630261|NCT01351415|82803039|FG000|Overall Study|Reason unknown|0|||
46630262|NCT01351415|82803040|FG001|Overall Study|Reason unknown|2|||
46630263|NCT01351415|82803039|FG000|Overall Study|Never Started|5|||
46712365|NCT01109940|82928756|FG001|Overall Study|Serious Adverse Event|1|||
46712366|NCT01109940|82928757|FG002|Overall Study|Serious Adverse Event|0|||
46712367|NCT01109940|82928758|FG003|Overall Study|Serious Adverse Event|0|||
47037233|NCT01536405|83288450|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
47037234|NCT01536405|83288451|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
46630264|NCT01351415|82803040|FG001|Overall Study|Never Started|5|||
46630265|NCT04811339|82803148|FG000|Overall Study|lack of transportation not wanting to return|4|||
46630266|NCT04811339|82803149|FG001|Overall Study|lack of transportation not wanting to return|8|||
46630267|NCT04811339|82803150|FG002|Overall Study|lack of transportation not wanting to return|0|||
46630268|NCT04811339|82803148|FG000|Overall Study|Adverse Event|3|||
46712368|NCT01109940|82928755|FG000|Overall Study|Lost to Follow-up|1|||
47037235|NCT01536405|83288450|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
47037236|NCT01536405|83288451|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
47037237|NCT01536405|83288450|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
47037238|NCT01536405|83288451|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
47037239|NCT01536405|83288450|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
47037240|NCT01536405|83288451|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
47037241|NCT01536405|83288450|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
47037242|NCT01536405|83288451|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
47037243|NCT01536405|83288450|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
47037244|NCT01536405|83288451|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
47037245|NCT01536405|83288450|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
47037246|NCT01536405|83288451|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
47037247|NCT01487265|83288457|FG000|Overall Study|Adverse Event|8|||
47037248|NCT01487265|83288457|FG000|Overall Study|Withdrawal by Subject|5|||
47037249|NCT01487265|83288457|FG000|Overall Study|Disease Progression|21|||
47037250|NCT01487265|83288457|FG000|Overall Study|Death|2|||
47037251|NCT01487265|83288457|FG000|Overall Study|Still on Treatment|1|||
47037252|NCT01485627|83288463|FG000|Overall Study|Patient withdrew|6|||
47037253|NCT01485627|83288464|FG001|Overall Study|Patient withdrew|5|||
47037254|NCT01485627|83288463|FG000|Overall Study|Patient died|3|||
47037255|NCT01485627|83288464|FG001|Overall Study|Patient died|1|||
47037256|NCT01485627|83288463|FG000|Overall Study|Patient lost to followup|0|||
47037257|NCT01485627|83288464|FG001|Overall Study|Patient lost to followup|1|||
47037258|NCT01485627|83288463|FG000|Overall Study|Caregiver withdrew|3|||
47037259|NCT01485627|83288464|FG001|Overall Study|Caregiver withdrew|3|||
47037260|NCT01485627|83288463|FG000|Overall Study|Caregiver lost to follow up|11|||
47037261|NCT01485627|83288464|FG001|Overall Study|Caregiver lost to follow up|12|||
47037262|NCT01485627|83288463|FG000|Overall Study|Caregiver died|1|||
47037263|NCT01485627|83288464|FG001|Overall Study|Caregiver died|0|||
47037264|NCT01485627|83288463|FG000|Overall Study|caregiver was not bereaved|42|||
47037265|NCT01485627|83288464|FG001|Overall Study|caregiver was not bereaved|35|||
47037266|NCT01508325|83288487|FG000|Overall Study|Withdrawal by Subject|8|||
47037267|NCT01508325|83288488|FG001|Overall Study|Withdrawal by Subject|9|||
47037268|NCT01508325|83288487|FG000|Overall Study|Protocol Violation|0|||
47037269|NCT01508325|83288488|FG001|Overall Study|Protocol Violation|3|||
47037270|NCT01508325|83288487|FG000|Overall Study|Physician Decision|2|||
47037271|NCT01508325|83288488|FG001|Overall Study|Physician Decision|1|||
47037272|NCT01508325|83288487|FG000|Overall Study|Adverse Event|1|||
47037273|NCT01508325|83288488|FG001|Overall Study|Adverse Event|0|||
47037274|NCT01508325|83288487|FG000|Overall Study|Lost to Follow-up|5|||
47037275|NCT01508325|83288488|FG001|Overall Study|Lost to Follow-up|6|||
47037276|NCT01508325|83288487|FG000|Overall Study|Other|2|||
47037277|NCT01508325|83288488|FG001|Overall Study|Other|2|||
47037278|NCT01508169|83288496|FG000|Overall Study|Adverse Event|1|||
47037279|NCT01508169|83288497|FG001|Overall Study|Adverse Event|0|||
47037280|NCT01508169|83288496|FG000|Overall Study|Withdrawal by Subject|1|||
47037281|NCT01508169|83288497|FG001|Overall Study|Withdrawal by Subject|0|||
47037282|NCT01508169|83288496|FG000|Overall Study|Lost to Follow-up|1|||
47037283|NCT01508169|83288497|FG001|Overall Study|Lost to Follow-up|2|||
47037284|NCT01536171|83288509|FG000|Overall Study|Withdrawal by Subject|1|||
47037285|NCT01536093|83288516|FG000|Overall Study|Death|1|||
47037286|NCT01536093|83288517|FG001|Overall Study|Death|2|||
47037287|NCT01536093|83288516|FG000|Overall Study|absence of maternal colostrum|2|||
47037288|NCT01536093|83288517|FG001|Overall Study|absence of maternal colostrum|0|||
47037289|NCT01536093|83288516|FG000|Overall Study|Withdrawal by Subject|0|||
47037290|NCT01536093|83288517|FG001|Overall Study|Withdrawal by Subject|1|||
47037291|NCT01536015|83288525|FG000|Overall Study|Adverse Event|1|||
47037292|NCT01536015|83288526|FG001|Overall Study|Adverse Event|4|||
47037293|NCT01536015|83288525|FG000|Overall Study|Lost to Follow-up|0|||
47037294|NCT01536015|83288526|FG001|Overall Study|Lost to Follow-up|1|||
47037295|NCT01536015|83288525|FG000|Overall Study|Inclusion Criterion not met|2|||
47037296|NCT01536015|83288526|FG001|Overall Study|Inclusion Criterion not met|0|||
46913830|NCT02858180|83144322|FG000|Overall Study|Lost to Follow-up|0|||
47037297|NCT01536015|83288525|FG000|Overall Study|Study closure|5|||
47037298|NCT01536015|83288526|FG001|Overall Study|Study closure|5|||
47037299|NCT01484691|83288535|FG000|Overall Study|Withdrawal by Subject|1|||
47037300|NCT01484691|83288536|FG001|Overall Study|Withdrawal by Subject|1|||
47037301|NCT01484691|83288537|FG002|Overall Study|Withdrawal by Subject|1|||
47037302|NCT01484691|83288535|FG000|Overall Study|Physician Decision|0|||
47037303|NCT01484691|83288536|FG001|Overall Study|Physician Decision|2|||
47037304|NCT01484691|83288537|FG002|Overall Study|Physician Decision|1|||
47037305|NCT01535235|83288548|FG000|Overall Study|Adverse Event|1|||
47037306|NCT01535235|83288549|FG001|Overall Study|Adverse Event|0|||
47037307|NCT01483599|83288593|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
47037308|NCT01483599|83288594|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037309|NCT01483599|83288595|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
46712369|NCT01109940|82928756|FG001|Overall Study|Lost to Follow-up|0|||
46712370|NCT01109940|82928757|FG002|Overall Study|Lost to Follow-up|0|||
46712371|NCT01109940|82928758|FG003|Overall Study|Lost to Follow-up|0|||
46712372|NCT01109940|82928755|FG000|Overall Study|Patient withdrew consent|1|||
46712373|NCT01109940|82928756|FG001|Overall Study|Patient withdrew consent|1|||
46712374|NCT01109940|82928757|FG002|Overall Study|Patient withdrew consent|0|||
46712375|NCT01109940|82928758|FG003|Overall Study|Patient withdrew consent|0|||
46712376|NCT01109940|82928755|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46712377|NCT01109940|82928756|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46712378|NCT01109940|82928757|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
46712379|NCT01109940|82928758|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
46712380|NCT00595309|82928768|FG000|Overall Study|Lost to Follow-up|1|||
46712381|NCT00595309|82928768|FG000|Overall Study|planned vaccination against yellow fever|1|||
46712382|NCT00595309|82928768|FG000|Overall Study|acute infection after V0|1|||
46712383|NCT00595309|82928768|FG000|Overall Study|personal reason|1|||
46712384|NCT00595075|82928774|FG000|Overall Study|Withdrawal by Subject|1|||
46712385|NCT00595075|82928775|FG001|Overall Study|Withdrawal by Subject|0|||
46712386|NCT00887224|82928784|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
46712387|NCT00887224|82928785|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
46712388|NCT00887224|82928786|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
46712389|NCT00887224|82928784|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
46712390|NCT00887224|82928785|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
47037310|NCT01483599|83288596|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
47037311|NCT01483599|83288597|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
47037312|NCT01483599|83288598|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
47037313|NCT01483599|83288599|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
47037314|NCT01483599|83288600|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037315|NCT01483599|83288601|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037316|NCT01483599|83288602|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037317|NCT01483599|83288603|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037318|NCT01483599|83288604|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037319|NCT01483599|83288605|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037320|NCT01483599|83288606|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
47037321|NCT01483599|83288593|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037322|NCT01483599|83288594|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
47037323|NCT01483599|83288595|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037324|NCT01483599|83288596|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
47037325|NCT01483599|83288597|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037326|NCT01483599|83288598|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037327|NCT01483599|83288599|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
47037328|NCT01483599|83288600|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037329|NCT01483599|83288601|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037330|NCT01483599|83288602|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037331|NCT01483599|83288603|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037332|NCT01483599|83288604|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037333|NCT01483599|83288605|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037334|NCT01483599|83288606|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
47037335|NCT01483599|83288593|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
47037336|NCT01483599|83288594|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037337|NCT01483599|83288595|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037338|NCT01483599|83288596|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037339|NCT01483599|83288597|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037340|NCT01483599|83288598|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037341|NCT01483599|83288599|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037342|NCT01483599|83288600|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037343|NCT01483599|83288601|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037344|NCT01483599|83288602|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037345|NCT01483599|83288603|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037346|NCT01483599|83288604|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
46712391|NCT00887224|82928786|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
47037347|NCT01483599|83288605|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
47037348|NCT01483599|83288606|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
46712392|NCT00887224|82928784|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
46712393|NCT00887224|82928785|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
46712394|NCT00887224|82928786|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
46712395|NCT00887224|82928784|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
46712396|NCT00887224|82928785|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
47037349|NCT01483599|83288593|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
47037350|NCT01483599|83288594|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
47037351|NCT01483599|83288595|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
47037352|NCT01483599|83288596|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
47037353|NCT01483599|83288597|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
47037354|NCT01483599|83288598|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
47037355|NCT01483599|83288599|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
47037356|NCT01483599|83288600|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
47037357|NCT01483599|83288601|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
47037358|NCT01483599|83288602|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
47037359|NCT01483599|83288603|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
47037360|NCT01483599|83288604|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
47037361|NCT01483599|83288605|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
47037362|NCT01483599|83288606|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
47037363|NCT01483599|83288593|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
47037364|NCT01483599|83288594|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
47037365|NCT01483599|83288595|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
47037366|NCT01483599|83288596|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
47037367|NCT01483599|83288597|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
47037368|NCT01483599|83288598|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
47037369|NCT01483599|83288599|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
47037370|NCT01483599|83288600|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
47037371|NCT01483599|83288601|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
46712397|NCT00887224|82928786|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
46712398|NCT00887224|82928784|FG000|Open-label Response (OLR) Phase|Other|1|||
46712399|NCT00887224|82928785|FG001|Open-label Response (OLR) Phase|Other|0|||
46712400|NCT00887224|82928786|FG002|Open-label Response (OLR) Phase|Other|0|||
46712401|NCT00887224|82928784|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
46712402|NCT00887224|82928785|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
46712403|NCT00887224|82928786|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
46712404|NCT00887224|82928784|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
46712405|NCT00887224|82928785|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
46712406|NCT00887224|82928786|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
46712407|NCT00887224|82928784|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
46712408|NCT00887224|82928785|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
46712409|NCT00887224|82928786|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
46712410|NCT00887224|82928784|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
46712411|NCT00887224|82928785|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
46712412|NCT00887224|82928786|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
46712413|NCT00887224|82928784|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
46712414|NCT00887224|82928785|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
46712415|NCT00887224|82928786|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
46712416|NCT00887224|82928784|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
46712417|NCT00887224|82928785|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
46712418|NCT00887224|82928786|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
46712419|NCT00887224|82928784|FG000|Open-label Stability (OLS) Phase|Other|1|||
46712420|NCT00887224|82928785|FG001|Open-label Stability (OLS) Phase|Other|0|||
46712421|NCT00887224|82928786|FG002|Open-label Stability (OLS) Phase|Other|0|||
46712422|NCT00887224|82928784|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
46712423|NCT00887224|82928785|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
46712424|NCT00887224|82928786|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
46712425|NCT00887224|82928784|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
46712426|NCT00887224|82928785|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
46913831|NCT02858180|83144323|FG001|Overall Study|Lost to Follow-up|2|||
47037372|NCT01483599|83288602|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
47037373|NCT01483599|83288603|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
47037374|NCT01483599|83288604|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
47037375|NCT01483599|83288605|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
47037376|NCT01483599|83288606|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
46913832|NCT03082599|83144331|FG000|Overall Study|Lost to Follow-up|1|||
47037377|NCT01483599|83288593|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037378|NCT01483599|83288594|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037379|NCT01483599|83288595|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
46712427|NCT00887224|82928786|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
46712428|NCT00887224|82928784|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
46913833|NCT03082599|83144332|FG001|Overall Study|Lost to Follow-up|0|||
47037380|NCT01483599|83288596|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037381|NCT01483599|83288597|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037382|NCT01483599|83288598|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037383|NCT01483599|83288599|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037384|NCT01483599|83288600|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
47037385|NCT01483599|83288601|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
47037386|NCT01483599|83288602|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037387|NCT01483599|83288603|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037388|NCT01483599|83288604|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
47037389|NCT01483599|83288605|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
47037390|NCT01483599|83288606|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
47037391|NCT01483599|83288593|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037392|NCT01483599|83288594|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037393|NCT01483599|83288595|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037394|NCT01483599|83288596|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037395|NCT01483599|83288597|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037396|NCT01483599|83288598|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037397|NCT01483599|83288599|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037398|NCT01483599|83288600|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037399|NCT01483599|83288601|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
47037400|NCT01483599|83288602|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037401|NCT01483599|83288603|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037402|NCT01483599|83288604|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
47037403|NCT01483599|83288605|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
47037404|NCT01483599|83288606|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
47037405|NCT01483599|83288593|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037406|NCT01483599|83288594|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037407|NCT01483599|83288595|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037408|NCT01483599|83288596|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037409|NCT01483599|83288597|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037410|NCT01483599|83288598|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037411|NCT01483599|83288599|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037412|NCT01483599|83288600|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037413|NCT01483599|83288601|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
47037414|NCT01483599|83288602|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037415|NCT01483599|83288603|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
47037416|NCT01483599|83288604|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037417|NCT01483599|83288605|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
47037418|NCT01483599|83288606|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
47037419|NCT01483599|83288593|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037420|NCT01483599|83288594|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
46712429|NCT00887224|82928785|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
46712430|NCT00887224|82928786|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
46712431|NCT00887224|82928784|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
46712432|NCT00887224|82928785|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
46712433|NCT00887224|82928786|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
46712434|NCT00887224|82928784|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
46712435|NCT00887224|82928785|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
46712436|NCT00887224|82928786|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
46712437|NCT00887224|82928784|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
46712438|NCT00887224|82928785|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
46712439|NCT00887224|82928786|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
46712440|NCT00887224|82928784|FG000|OL Taper Phase / OL Follow Up|Other|30|||
46712441|NCT00887224|82928785|FG001|OL Taper Phase / OL Follow Up|Other|0|||
46712442|NCT00887224|82928786|FG002|OL Taper Phase / OL Follow Up|Other|0|||
46712443|NCT00887224|82928784|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
46712444|NCT00887224|82928785|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
46712445|NCT00887224|82928786|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
46712446|NCT00887224|82928784|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
46712447|NCT00887224|82928785|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
46712448|NCT00887224|82928786|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
46712449|NCT00887224|82928784|FG000|Double-blind (DB) Phase|Adverse Event|0|||
46712450|NCT00887224|82928785|FG001|Double-blind (DB) Phase|Adverse Event|7|||
46712451|NCT00887224|82928786|FG002|Double-blind (DB) Phase|Adverse Event|2|||
46712452|NCT00887224|82928784|FG000|Double-blind (DB) Phase|Failed to return|0|||
46712453|NCT00887224|82928785|FG001|Double-blind (DB) Phase|Failed to return|2|||
46712454|NCT00887224|82928786|FG002|Double-blind (DB) Phase|Failed to return|2|||
46712455|NCT00887224|82928784|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
46712456|NCT00887224|82928785|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
46712457|NCT00887224|82928786|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
46712458|NCT00887224|82928784|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
46712459|NCT00887224|82928785|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
46712460|NCT00887224|82928786|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
46712461|NCT00887224|82928784|FG000|Double-blind (DB) Phase|Other|0|||
46712462|NCT00887224|82928785|FG001|Double-blind (DB) Phase|Other|2|||
46712463|NCT00887224|82928786|FG002|Double-blind (DB) Phase|Other|0|||
46712464|NCT00887224|82928784|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
46712465|NCT00887224|82928785|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
46712466|NCT00887224|82928786|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
46712467|NCT00887224|82928784|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
46712468|NCT00887224|82928785|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
46712469|NCT00887224|82928786|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
46712470|NCT00887224|82928784|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
46712471|NCT00887224|82928785|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
46712472|NCT00887224|82928786|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
46712473|NCT00887224|82928784|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
46712474|NCT00887224|82928785|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
46712475|NCT00887224|82928786|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
46712476|NCT00887224|82928784|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
46712477|NCT00887224|82928785|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
46712478|NCT00887224|82928786|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
46712479|NCT00887224|82928784|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
46712480|NCT00887224|82928785|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
46712481|NCT00887224|82928786|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
46712482|NCT00887224|82928784|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
46712483|NCT00887224|82928785|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
46712484|NCT00887224|82928786|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
46712485|NCT00887224|82928784|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
46712486|NCT00887224|82928785|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
46712487|NCT00887224|82928786|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
47037421|NCT01483599|83288595|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037422|NCT01483599|83288596|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037423|NCT01483599|83288597|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037424|NCT01483599|83288598|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037425|NCT01483599|83288599|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037426|NCT01483599|83288600|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037427|NCT01483599|83288601|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
47037428|NCT01483599|83288602|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037429|NCT01483599|83288603|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037430|NCT01483599|83288604|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
47037431|NCT01483599|83288605|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
47037432|NCT01483599|83288606|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
46712488|NCT00887224|82928784|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
46712489|NCT00887224|82928785|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
46712490|NCT00887224|82928786|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
46712491|NCT01109316|82928804|FG000|Study Period 1|Adverse Event|0|||
46913834|NCT01346501|83144340|FG000|Overall Study|Initiated Other Biological Agents|3|||
46913835|NCT01346501|83144341|FG001|Overall Study|Initiated Other Biological Agents|1|||
46913836|NCT01346501|83144340|FG000|Overall Study|Other|8|||
46913837|NCT01346501|83144341|FG001|Overall Study|Other|12|||
46913838|NCT03160885|83144351|FG000|Initial Treatment Period|Not dosed|2|||
46913839|NCT03160885|83144352|FG001|Initial Treatment Period|Not dosed|0|||
46913840|NCT03160885|83144353|FG002|Initial Treatment Period|Not dosed|0|||
46913841|NCT03160885|83144354|FG003|Initial Treatment Period|Not dosed|0|||
46913842|NCT03160885|83144355|FG004|Initial Treatment Period|Not dosed|0|||
46913843|NCT03160885|83144356|FG005|Initial Treatment Period|Not dosed|0|||
46913844|NCT03160885|83144357|FG006|Initial Treatment Period|Not dosed|0|||
46913845|NCT03160885|83144351|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
46913846|NCT03160885|83144352|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
46913847|NCT03160885|83144353|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
47037433|NCT01483599|83288593|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
46712492|NCT01109316|82928805|FG001|Study Period 1|Adverse Event|0|||
46712493|NCT01109316|82928806|FG002|Study Period 1|Adverse Event|1|||
46712494|NCT01109316|82928807|FG003|Study Period 1|Adverse Event|0|||
46712495|NCT01109316|82928808|FG004|Study Period 1|Adverse Event|0|||
46913848|NCT03160885|83144354|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46913849|NCT03160885|83144355|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46913850|NCT03160885|83144356|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
47037434|NCT01483599|83288594|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
47037435|NCT01483599|83288595|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
47037436|NCT01483599|83288596|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
47037437|NCT01483599|83288597|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
47037438|NCT01483599|83288598|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
47037439|NCT01483599|83288599|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
47037440|NCT01483599|83288600|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
47037441|NCT01483599|83288601|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
47037442|NCT01483599|83288602|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
47037443|NCT01483599|83288603|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
47037444|NCT01483599|83288604|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
47037445|NCT01483599|83288605|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
47037446|NCT01483599|83288606|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
47037447|NCT01507545|83288682|FG000|Overall Study|Withdrawal by Subject|6|||
47037448|NCT01507545|83288683|FG001|Overall Study|Withdrawal by Subject|2|||
47037449|NCT01507545|83288682|FG000|Overall Study|Lost to Follow-up|1|||
47037450|NCT01507545|83288683|FG001|Overall Study|Lost to Follow-up|0|||
47037451|NCT01507545|83288682|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
47037452|NCT01507545|83288683|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
47037453|NCT01507545|83288682|FG000|Overall Study|Progressive disease|60|||
47037454|NCT01507545|83288683|FG001|Overall Study|Progressive disease|27|||
47037455|NCT01507545|83288682|FG000|Overall Study|Other|6|||
47037456|NCT01507545|83288683|FG001|Overall Study|Other|4|||
47037457|NCT01482819|83288689|FG000|Overall Study|Lost to Follow-up|2|||
47037458|NCT01534533|83288701|FG000|Overall Study|Lost to Follow-up|3|||
47037459|NCT01534533|83288702|FG001|Overall Study|Lost to Follow-up|0|||
47037460|NCT01534533|83288703|FG002|Overall Study|Lost to Follow-up|4|||
47037461|NCT01534533|83288704|FG003|Overall Study|Lost to Follow-up|3|||
47037462|NCT01534533|83288701|FG000|Overall Study|Withdrawal by Subject|5|||
47037463|NCT01534533|83288702|FG001|Overall Study|Withdrawal by Subject|3|||
47037464|NCT01534533|83288703|FG002|Overall Study|Withdrawal by Subject|4|||
47037465|NCT01534533|83288704|FG003|Overall Study|Withdrawal by Subject|1|||
47037466|NCT01506609|83288801|FG000|Overall Study|Adverse Event Related to Progression|0|||
47037467|NCT01506609|83288802|FG001|Overall Study|Adverse Event Related to Progression|0|||
47037468|NCT01506609|83288803|FG002|Overall Study|Adverse Event Related to Progression|0|||
47037469|NCT01506609|83288804|FG003|Overall Study|Adverse Event Related to Progression|3|||
47037470|NCT01506609|83288805|FG004|Overall Study|Adverse Event Related to Progression|7|||
47037471|NCT01506609|83288806|FG005|Overall Study|Adverse Event Related to Progression|3|||
47037472|NCT01506609|83288801|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
47037473|NCT01506609|83288802|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
47037474|NCT01506609|83288803|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
47037475|NCT01506609|83288804|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
47037476|NCT01506609|83288805|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
47037477|NCT01506609|83288806|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
47037478|NCT01506609|83288801|FG000|Overall Study|Withdrawal by Subject|0|||
47037479|NCT01506609|83288802|FG001|Overall Study|Withdrawal by Subject|0|||
47037480|NCT01506609|83288803|FG002|Overall Study|Withdrawal by Subject|0|||
47037481|NCT01506609|83288804|FG003|Overall Study|Withdrawal by Subject|9|||
47037482|NCT01506609|83288805|FG004|Overall Study|Withdrawal by Subject|7|||
47037483|NCT01506609|83288806|FG005|Overall Study|Withdrawal by Subject|7|||
47037484|NCT01506609|83288801|FG000|Overall Study|Lost to Follow-up|0|||
47037485|NCT01506609|83288802|FG001|Overall Study|Lost to Follow-up|0|||
47037486|NCT01506609|83288803|FG002|Overall Study|Lost to Follow-up|0|||
47037487|NCT01506609|83288804|FG003|Overall Study|Lost to Follow-up|1|||
47037488|NCT01506609|83288805|FG004|Overall Study|Lost to Follow-up|2|||
47037489|NCT01506609|83288806|FG005|Overall Study|Lost to Follow-up|0|||
47037490|NCT01506609|83288801|FG000|Overall Study|Sponsor Discontinued Study|0|||
46630269|NCT04811339|82803149|FG001|Overall Study|Adverse Event|0|||
46630270|NCT04811339|82803150|FG002|Overall Study|Adverse Event|0|||
46630271|NCT04811339|82803148|FG000|Overall Study|Lost to Follow-up|1|||
46630272|NCT04811339|82803149|FG001|Overall Study|Lost to Follow-up|0|||
46630273|NCT04811339|82803150|FG002|Overall Study|Lost to Follow-up|0|||
46630274|NCT04811339|82803148|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
46630275|NCT04811339|82803149|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
46630276|NCT04811339|82803150|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
46630277|NCT04811339|82803148|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
46630278|NCT04811339|82803149|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
46630279|NCT04811339|82803150|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
47037491|NCT01506609|83288802|FG001|Overall Study|Sponsor Discontinued Study|0|||
47037492|NCT01506609|83288803|FG002|Overall Study|Sponsor Discontinued Study|0|||
47037493|NCT01506609|83288804|FG003|Overall Study|Sponsor Discontinued Study|2|||
47037494|NCT01506609|83288805|FG004|Overall Study|Sponsor Discontinued Study|2|||
46712496|NCT01109316|82928809|FG005|Study Period 1|Adverse Event|0|||
46712497|NCT01109316|82928804|FG000|Study Period 1|Lost to Follow-up|0|||
46712498|NCT01109316|82928805|FG001|Study Period 1|Lost to Follow-up|0|||
46712499|NCT01109316|82928806|FG002|Study Period 1|Lost to Follow-up|1|||
46712500|NCT01109316|82928807|FG003|Study Period 1|Lost to Follow-up|1|||
46712501|NCT01109316|82928808|FG004|Study Period 1|Lost to Follow-up|0|||
46712502|NCT01109316|82928809|FG005|Study Period 1|Lost to Follow-up|0|||
46712503|NCT01109316|82928804|FG000|Study Period 1|Withdrawal by Subject|0|||
46712504|NCT01109316|82928805|FG001|Study Period 1|Withdrawal by Subject|0|||
46712505|NCT01109316|82928806|FG002|Study Period 1|Withdrawal by Subject|1|||
46712506|NCT01109316|82928807|FG003|Study Period 1|Withdrawal by Subject|0|||
46712507|NCT01109316|82928808|FG004|Study Period 1|Withdrawal by Subject|2|||
46712508|NCT01109316|82928809|FG005|Study Period 1|Withdrawal by Subject|0|||
46712509|NCT01109316|82928804|FG000|Study Period 1|Sponsor Decision|0|||
46712510|NCT01109316|82928805|FG001|Study Period 1|Sponsor Decision|0|||
46712511|NCT01109316|82928806|FG002|Study Period 1|Sponsor Decision|0|||
46712512|NCT01109316|82928807|FG003|Study Period 1|Sponsor Decision|0|||
46712513|NCT01109316|82928808|FG004|Study Period 1|Sponsor Decision|0|||
46712514|NCT01109316|82928809|FG005|Study Period 1|Sponsor Decision|2|||
46712515|NCT01109316|82928804|FG000|Study Period 2|Entry Criteria Not Met|0|||
46712516|NCT01109316|82928805|FG001|Study Period 2|Entry Criteria Not Met|1|||
46712517|NCT01109316|82928806|FG002|Study Period 2|Entry Criteria Not Met|0|||
46712518|NCT01109316|82928807|FG003|Study Period 2|Entry Criteria Not Met|0|||
46712519|NCT01109316|82928808|FG004|Study Period 2|Entry Criteria Not Met|0|||
46712520|NCT01109316|82928809|FG005|Study Period 2|Entry Criteria Not Met|0|||
46712521|NCT01109316|82928804|FG000|Study Period 2|Physician Decision|0|||
46712522|NCT01109316|82928805|FG001|Study Period 2|Physician Decision|0|||
46712523|NCT01109316|82928806|FG002|Study Period 2|Physician Decision|0|||
46712524|NCT01109316|82928807|FG003|Study Period 2|Physician Decision|1|||
46712525|NCT01109316|82928808|FG004|Study Period 2|Physician Decision|0|||
46712526|NCT01109316|82928809|FG005|Study Period 2|Physician Decision|0|||
47037495|NCT01506609|83288806|FG005|Overall Study|Sponsor Discontinued Study|0|||
47037496|NCT01506609|83288801|FG000|Overall Study|Progressive Disease per Protocol|1|||
47037497|NCT01506609|83288802|FG001|Overall Study|Progressive Disease per Protocol|0|||
47037498|NCT01506609|83288803|FG002|Overall Study|Progressive Disease per Protocol|0|||
47037499|NCT01506609|83288804|FG003|Overall Study|Progressive Disease per Protocol|64|||
47037500|NCT01506609|83288805|FG004|Overall Study|Progressive Disease per Protocol|57|||
47037501|NCT01506609|83288806|FG005|Overall Study|Progressive Disease per Protocol|74|||
47037502|NCT01506609|83288801|FG000|Overall Study|Other, Not Specified|0|||
47037503|NCT01506609|83288802|FG001|Overall Study|Other, Not Specified|0|||
47037504|NCT01506609|83288803|FG002|Overall Study|Other, Not Specified|0|||
47037505|NCT01506609|83288804|FG003|Overall Study|Other, Not Specified|10|||
47037506|NCT01506609|83288805|FG004|Overall Study|Other, Not Specified|7|||
47037507|NCT01506609|83288806|FG005|Overall Study|Other, Not Specified|3|||
47037508|NCT01506609|83288801|FG000|Overall Study|Missing / Unknown Reason|1|||
47037509|NCT01506609|83288802|FG001|Overall Study|Missing / Unknown Reason|0|||
47037510|NCT01506609|83288803|FG002|Overall Study|Missing / Unknown Reason|1|||
47037511|NCT01506609|83288804|FG003|Overall Study|Missing / Unknown Reason|4|||
47037512|NCT01506609|83288805|FG004|Overall Study|Missing / Unknown Reason|4|||
47037513|NCT01506609|83288806|FG005|Overall Study|Missing / Unknown Reason|2|||
47037514|NCT01506453|83288830|FG000|Overall Study|Withdrawal prior to treatment|0|||
47037515|NCT01506453|83288831|FG001|Overall Study|Withdrawal prior to treatment|2|||
47037516|NCT01482429|83288839|FG000|Care Usual|Protocol Violation|0|||
47037517|NCT01482429|83288840|FG001|Care Usual|Protocol Violation|172|||
47037518|NCT01482429|83288839|FG000|Care Usual|Lost to Follow-up|0|||
47037519|NCT01482429|83288840|FG001|Care Usual|Lost to Follow-up|1|||
47037520|NCT01482429|83288839|FG000|Protocol|Protocol Violation|275|||
46712527|NCT01109316|82928804|FG000|Study Period 2|Protocol Violation|1|||
46712528|NCT01109316|82928805|FG001|Study Period 2|Protocol Violation|0|||
46712529|NCT01109316|82928806|FG002|Study Period 2|Protocol Violation|0|||
46712530|NCT01109316|82928807|FG003|Study Period 2|Protocol Violation|0|||
46712531|NCT01109316|82928808|FG004|Study Period 2|Protocol Violation|0|||
46712532|NCT01109316|82928809|FG005|Study Period 2|Protocol Violation|0|||
46712533|NCT01109316|82928804|FG000|Study Period 2|Withdrawal by Subject|0|||
46712534|NCT01109316|82928805|FG001|Study Period 2|Withdrawal by Subject|0|||
46712535|NCT01109316|82928806|FG002|Study Period 2|Withdrawal by Subject|1|||
46712536|NCT01109316|82928807|FG003|Study Period 2|Withdrawal by Subject|0|||
46712537|NCT01109316|82928808|FG004|Study Period 2|Withdrawal by Subject|0|||
46712538|NCT01109316|82928809|FG005|Study Period 2|Withdrawal by Subject|1|||
47037521|NCT01482429|83288840|FG001|Protocol|Protocol Violation|0|||
46712539|NCT01109316|82928804|FG000|Study Period 3|Lost to Follow-up|0|||
46712540|NCT01109316|82928805|FG001|Study Period 3|Lost to Follow-up|0|||
47037522|NCT01504971|83288846|FG000|Overall Study|Physician Decision|13|||
47037523|NCT01479777|83288854|FG000|Overall Study|Physician Decision|2|||
47037524|NCT01479621|83288864|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
47037525|NCT01479621|83288865|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
46712541|NCT01109316|82928806|FG002|Study Period 3|Lost to Follow-up|0|||
46712542|NCT01109316|82928807|FG003|Study Period 3|Lost to Follow-up|0|||
46712543|NCT01109316|82928808|FG004|Study Period 3|Lost to Follow-up|1|||
46712544|NCT01109316|82928809|FG005|Study Period 3|Lost to Follow-up|0|||
46712545|NCT01109316|82928804|FG000|Study Period 3|Withdrawal by Subject|1|||
47037526|NCT01479621|83288866|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47037527|NCT01479621|83288867|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47037528|NCT01479621|83288868|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47037529|NCT01479621|83288869|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47037530|NCT01479621|83288870|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47037531|NCT01479621|83288864|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
47037532|NCT01479621|83288865|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47037533|NCT01479621|83288866|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47037534|NCT01479621|83288867|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47037535|NCT01479621|83288868|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47037536|NCT01479621|83288869|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47037537|NCT01479621|83288870|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47037538|NCT01479621|83288864|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
47037539|NCT01479621|83288865|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47037540|NCT01479621|83288866|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47037541|NCT01479621|83288867|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47037542|NCT01479621|83288868|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47037543|NCT01479621|83288869|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47037544|NCT01479621|83288870|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
46712546|NCT01109316|82928805|FG001|Study Period 3|Withdrawal by Subject|0|||
46712547|NCT01109316|82928806|FG002|Study Period 3|Withdrawal by Subject|0|||
46712548|NCT01109316|82928807|FG003|Study Period 3|Withdrawal by Subject|0|||
46712549|NCT01109316|82928808|FG004|Study Period 3|Withdrawal by Subject|1|||
46712550|NCT01109316|82928809|FG005|Study Period 3|Withdrawal by Subject|0|||
46712551|NCT00887068|82928819|FG000|Overall Study|Withdrawal by Subject|2|||
46712552|NCT00887068|82928820|FG001|Overall Study|Withdrawal by Subject|0|||
46712553|NCT00887068|82928819|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
46712554|NCT00887068|82928820|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
46712555|NCT00941031|82928830|FG000|Induction Period|Lack of Efficacy|2|||
46712556|NCT00941031|82928831|FG001|Induction Period|Lack of Efficacy|1|||
46712557|NCT00941031|82928832|FG002|Induction Period|Lack of Efficacy|0|||
46712558|NCT00941031|82928833|FG003|Induction Period|Lack of Efficacy|5|||
46712559|NCT00941031|82928834|FG004|Induction Period|Lack of Efficacy|0|||
46712560|NCT00941031|82928835|FG005|Induction Period|Lack of Efficacy|0|||
46712561|NCT00941031|82928836|FG006|Induction Period|Lack of Efficacy|0|||
46712562|NCT00941031|82928830|FG000|Induction Period|Withdrawal by Subject|1|||
46712563|NCT00941031|82928831|FG001|Induction Period|Withdrawal by Subject|2|||
46712564|NCT00941031|82928832|FG002|Induction Period|Withdrawal by Subject|2|||
46712565|NCT00941031|82928833|FG003|Induction Period|Withdrawal by Subject|2|||
46712566|NCT00941031|82928834|FG004|Induction Period|Withdrawal by Subject|0|||
46712567|NCT00941031|82928835|FG005|Induction Period|Withdrawal by Subject|0|||
46712568|NCT00941031|82928836|FG006|Induction Period|Withdrawal by Subject|0|||
46712569|NCT00941031|82928830|FG000|Induction Period|Adminstative Problems|1|||
46712570|NCT00941031|82928831|FG001|Induction Period|Adminstative Problems|1|||
46712571|NCT00941031|82928832|FG002|Induction Period|Adminstative Problems|1|||
46712572|NCT00941031|82928833|FG003|Induction Period|Adminstative Problems|0|||
46712573|NCT00941031|82928834|FG004|Induction Period|Adminstative Problems|0|||
46630280|NCT04811339|82803148|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
46630281|NCT04811339|82803149|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
46630282|NCT04811339|82803150|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
46630283|NCT04811339|82803148|FG000|Overall Study|Withdrawal by Subject|0|||
46630284|NCT04811339|82803149|FG001|Overall Study|Withdrawal by Subject|3|||
46630285|NCT04811339|82803150|FG002|Overall Study|Withdrawal by Subject|0|||
46630286|NCT04811339|82803148|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
46630287|NCT04811339|82803149|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
46712574|NCT00941031|82928835|FG005|Induction Period|Adminstative Problems|0|||
46712575|NCT00941031|82928836|FG006|Induction Period|Adminstative Problems|0|||
46712576|NCT00941031|82928830|FG000|Induction Period|Adverse Event|1|||
46712577|NCT00941031|82928831|FG001|Induction Period|Adverse Event|0|||
46712578|NCT00941031|82928832|FG002|Induction Period|Adverse Event|3|||
46712579|NCT00941031|82928833|FG003|Induction Period|Adverse Event|2|||
46712580|NCT00941031|82928834|FG004|Induction Period|Adverse Event|0|||
46913851|NCT03160885|83144357|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46712581|NCT00941031|82928835|FG005|Induction Period|Adverse Event|0|||
47037545|NCT01479621|83288864|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
47037546|NCT01479621|83288865|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47037547|NCT01479621|83288866|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47037548|NCT01479621|83288867|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47037549|NCT01479621|83288868|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47037550|NCT01479621|83288869|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47037551|NCT01479621|83288870|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47037552|NCT01479621|83288864|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
47037553|NCT01479621|83288865|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47037554|NCT01479621|83288866|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47037555|NCT01479621|83288867|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47037556|NCT01479621|83288868|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47037557|NCT01479621|83288869|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47037558|NCT01479621|83288870|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47037559|NCT01479621|83288864|FG000|Treatment Period|Adverse Event|0|||
47037560|NCT01479621|83288865|FG001|Treatment Period|Adverse Event|0|||
47037561|NCT01479621|83288866|FG002|Treatment Period|Adverse Event|0|||
47037562|NCT01479621|83288867|FG003|Treatment Period|Adverse Event|0|||
47037563|NCT01479621|83288868|FG004|Treatment Period|Adverse Event|1|||
47037564|NCT01479621|83288869|FG005|Treatment Period|Adverse Event|2|||
46712582|NCT00941031|82928836|FG006|Induction Period|Adverse Event|0|||
46712583|NCT00941031|82928830|FG000|Maintenance Period|Withdrawal by Subject|0|||
46712584|NCT00941031|82928831|FG001|Maintenance Period|Withdrawal by Subject|0|||
46712585|NCT00941031|82928832|FG002|Maintenance Period|Withdrawal by Subject|0|||
46712586|NCT00941031|82928833|FG003|Maintenance Period|Withdrawal by Subject|0|||
46712587|NCT00941031|82928834|FG004|Maintenance Period|Withdrawal by Subject|6|||
46712588|NCT00941031|82928835|FG005|Maintenance Period|Withdrawal by Subject|2|||
46712589|NCT00941031|82928836|FG006|Maintenance Period|Withdrawal by Subject|13|||
46712590|NCT00941031|82928830|FG000|Maintenance Period|Administrative Problems|0|||
46712591|NCT00941031|82928831|FG001|Maintenance Period|Administrative Problems|0|||
46712592|NCT00941031|82928832|FG002|Maintenance Period|Administrative Problems|0|||
46712593|NCT00941031|82928833|FG003|Maintenance Period|Administrative Problems|0|||
46712594|NCT00941031|82928834|FG004|Maintenance Period|Administrative Problems|1|||
46712595|NCT00941031|82928835|FG005|Maintenance Period|Administrative Problems|0|||
46712596|NCT00941031|82928836|FG006|Maintenance Period|Administrative Problems|1|||
46712597|NCT00941031|82928830|FG000|Maintenance Period|Protocol Violation|0|||
46712598|NCT00941031|82928831|FG001|Maintenance Period|Protocol Violation|0|||
46913852|NCT03160885|83144351|FG000|Open-label Treatment|Not dosed|0|||
46913853|NCT03160885|83144352|FG001|Open-label Treatment|Not dosed|0|||
46913854|NCT03160885|83144353|FG002|Open-label Treatment|Not dosed|0|||
46913855|NCT03160885|83144354|FG003|Open-label Treatment|Not dosed|0|||
46712599|NCT00941031|82928832|FG002|Maintenance Period|Protocol Violation|0|||
46712600|NCT00941031|82928833|FG003|Maintenance Period|Protocol Violation|0|||
46712601|NCT00941031|82928834|FG004|Maintenance Period|Protocol Violation|0|||
46712602|NCT00941031|82928835|FG005|Maintenance Period|Protocol Violation|0|||
46712603|NCT00941031|82928836|FG006|Maintenance Period|Protocol Violation|1|||
46712604|NCT00941031|82928830|FG000|Maintenance Period|Adverse Event|0|||
47037565|NCT01479621|83288870|FG006|Treatment Period|Adverse Event|2|||
47037566|NCT01479621|83288864|FG000|Treatment Period|Withdrawal by Subject|0|||
47037567|NCT01479621|83288865|FG001|Treatment Period|Withdrawal by Subject|4|||
47037568|NCT01479621|83288866|FG002|Treatment Period|Withdrawal by Subject|2|||
47037569|NCT01479621|83288867|FG003|Treatment Period|Withdrawal by Subject|2|||
47037570|NCT01479621|83288868|FG004|Treatment Period|Withdrawal by Subject|5|||
47037571|NCT01479621|83288869|FG005|Treatment Period|Withdrawal by Subject|5|||
47037572|NCT01479621|83288870|FG006|Treatment Period|Withdrawal by Subject|1|||
47037573|NCT01479621|83288864|FG000|Treatment Period|Physician Decision|0|||
47037574|NCT01479621|83288865|FG001|Treatment Period|Physician Decision|0|||
47037575|NCT01479621|83288866|FG002|Treatment Period|Physician Decision|0|||
47037576|NCT01479621|83288867|FG003|Treatment Period|Physician Decision|0|||
47037577|NCT01479621|83288868|FG004|Treatment Period|Physician Decision|1|||
47037578|NCT01479621|83288869|FG005|Treatment Period|Physician Decision|1|||
46712605|NCT00941031|82928831|FG001|Maintenance Period|Adverse Event|0|||
46712606|NCT00941031|82928832|FG002|Maintenance Period|Adverse Event|0|||
47037579|NCT01479621|83288870|FG006|Treatment Period|Physician Decision|0|||
46712607|NCT00941031|82928833|FG003|Maintenance Period|Adverse Event|0|||
47037580|NCT01479621|83288864|FG000|Treatment Period|Non-compliance to study drug|0|||
46712608|NCT00941031|82928834|FG004|Maintenance Period|Adverse Event|0|||
47037581|NCT01479621|83288865|FG001|Treatment Period|Non-compliance to study drug|1|||
46712609|NCT00941031|82928835|FG005|Maintenance Period|Adverse Event|2|||
46913856|NCT03160885|83144355|FG004|Open-label Treatment|Not dosed|0|||
47037582|NCT01479621|83288866|FG002|Treatment Period|Non-compliance to study drug|0|||
47037583|NCT01479621|83288867|FG003|Treatment Period|Non-compliance to study drug|0|||
46712610|NCT00941031|82928836|FG006|Maintenance Period|Adverse Event|8|||
46712611|NCT00941031|82928830|FG000|Maintenance Period|Lost to Follow-up|0|||
46712612|NCT00941031|82928831|FG001|Maintenance Period|Lost to Follow-up|0|||
46712613|NCT00941031|82928832|FG002|Maintenance Period|Lost to Follow-up|0|||
46712614|NCT00941031|82928833|FG003|Maintenance Period|Lost to Follow-up|0|||
46712615|NCT00941031|82928834|FG004|Maintenance Period|Lost to Follow-up|2|||
46712616|NCT00941031|82928835|FG005|Maintenance Period|Lost to Follow-up|2|||
46712617|NCT00941031|82928836|FG006|Maintenance Period|Lost to Follow-up|7|||
46712618|NCT00941031|82928830|FG000|Maintenance Period|Lack of Efficacy|0|||
46712619|NCT00941031|82928831|FG001|Maintenance Period|Lack of Efficacy|0|||
46712620|NCT00941031|82928832|FG002|Maintenance Period|Lack of Efficacy|0|||
46712621|NCT00941031|82928833|FG003|Maintenance Period|Lack of Efficacy|0|||
46712622|NCT00941031|82928834|FG004|Maintenance Period|Lack of Efficacy|0|||
46712623|NCT00941031|82928835|FG005|Maintenance Period|Lack of Efficacy|0|||
46712624|NCT00941031|82928836|FG006|Maintenance Period|Lack of Efficacy|13|||
46712625|NCT00886834|82928857|FG000|Overall Study|Protocol Violation|0|||
46712626|NCT00886834|82928858|FG001|Overall Study|Protocol Violation|3|||
46712627|NCT00880009|82928864|FG000|Overall Study|Study terminated by sponsor|14|||
46712628|NCT00880009|82928864|FG000|Overall Study|Withdrawal by Subject|1|||
46712629|NCT00880009|82928864|FG000|Overall Study|Protocol Violation|1|||
46712630|NCT01104636|82928871|FG000|Overall Study|Lack of Efficacy|43|||
46712631|NCT01104636|82928871|FG000|Overall Study|Lost to Follow-up|24|||
46712632|NCT01104636|82928871|FG000|Overall Study|Withdrawal by Subject|4|||
46712633|NCT01104636|82928871|FG000|Overall Study|Other|43|||
46712634|NCT01104636|82928871|FG000|Overall Study|Study terminated by sponsor|1|||
46712635|NCT01104636|82928871|FG000|Overall Study|Pregnancy|2|||
47037584|NCT01479621|83288868|FG004|Treatment Period|Non-compliance to study drug|0|||
47037585|NCT01479621|83288869|FG005|Treatment Period|Non-compliance to study drug|0|||
47037586|NCT01479621|83288870|FG006|Treatment Period|Non-compliance to study drug|1|||
47037587|NCT01479621|83288864|FG000|Treatment Period|Protocol Violation|0|||
47037588|NCT01479621|83288865|FG001|Treatment Period|Protocol Violation|9|||
47037589|NCT01479621|83288866|FG002|Treatment Period|Protocol Violation|6|||
47037590|NCT01479621|83288867|FG003|Treatment Period|Protocol Violation|5|||
47037591|NCT01479621|83288868|FG004|Treatment Period|Protocol Violation|2|||
47037592|NCT01479621|83288869|FG005|Treatment Period|Protocol Violation|10|||
47037593|NCT01479621|83288870|FG006|Treatment Period|Protocol Violation|6|||
47037594|NCT01479621|83288864|FG000|Treatment Period|Pregnancy|0|||
47037595|NCT01479621|83288865|FG001|Treatment Period|Pregnancy|0|||
47037596|NCT01479621|83288866|FG002|Treatment Period|Pregnancy|2|||
47037597|NCT01479621|83288867|FG003|Treatment Period|Pregnancy|0|||
46630288|NCT04811339|82803150|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
46630289|NCT04811339|82803148|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
46630290|NCT04811339|82803149|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
46630291|NCT04811339|82803150|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
46630292|NCT04332107|82803162|FG000|Day 3|Lost to Follow-up|23|||
46630293|NCT04332107|82803163|FG001|Day 3|Lost to Follow-up|14|||
46630294|NCT04332107|82803162|FG000|Day 3|Missing outcome data|3|||
46630295|NCT04332107|82803163|FG001|Day 3|Missing outcome data|6|||
46630296|NCT04332107|82803162|FG000|Day 14|Lost to Follow-up|13|||
46630297|NCT04332107|82803163|FG001|Day 14|Lost to Follow-up|4|||
46630298|NCT04332107|82803162|FG000|Day 14|Missing outcome data|4|||
46630299|NCT04332107|82803163|FG001|Day 14|Missing outcome data|4|||
46630300|NCT04332107|82803162|FG000|Day 21|Lost to Follow-up|10|||
46630301|NCT04332107|82803163|FG001|Day 21|Lost to Follow-up|2|||
46630302|NCT03075839|82803182|FG000|Overall Study|Lost to Follow-up|4|||
46913857|NCT03160885|83144356|FG005|Open-label Treatment|Not dosed|0|||
46913858|NCT03160885|83144357|FG006|Open-label Treatment|Not dosed|2|||
46913859|NCT03160885|83144351|FG000|Open-label Treatment|Discontinued IMP|0|||
46913860|NCT03160885|83144352|FG001|Open-label Treatment|Discontinued IMP|0|||
46630307|NCT01928082|82803196|FG000|Overall Study|Study terminated.|1|||
46630308|NCT01972776|82803206|FG000|Part 1|Withdrawal by Subject|0|||
46630309|NCT01972776|82803207|FG001|Part 1|Withdrawal by Subject|0|||
46630310|NCT01972776|82803208|FG002|Part 1|Withdrawal by Subject|1|||
47037598|NCT01479621|83288868|FG004|Treatment Period|Pregnancy|0|||
46630311|NCT01972776|82803209|FG003|Part 1|Withdrawal by Subject|0|||
46630312|NCT01972776|82803210|FG004|Part 1|Withdrawal by Subject|0|||
46630313|NCT01972776|82803211|FG005|Part 1|Withdrawal by Subject|0|||
46630314|NCT01972776|82803206|FG000|Part 1|Adverse Event|0|||
46630315|NCT01972776|82803207|FG001|Part 1|Adverse Event|0|||
46712636|NCT01104636|82928871|FG000|Overall Study|Adverse Event|40|||
46712637|NCT01104636|82928871|FG000|Overall Study|Ongoing|21|||
46712638|NCT01104558|82928875|FG000|Overall Study|Protocol Violation|6|||
46712639|NCT01104558|82928875|FG000|Overall Study|Missing of primary efficacy assessment|10|||
46712640|NCT01104558|82928875|FG000|Overall Study|Missing of genetic analysis results|1|||
46712641|NCT00886288|82928881|FG000|Overall Study|no respect of the 12 weeks period|657|||
47037599|NCT01479621|83288869|FG005|Treatment Period|Pregnancy|0|||
47037600|NCT01479621|83288870|FG006|Treatment Period|Pregnancy|0|||
47037601|NCT01479621|83288864|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
47037602|NCT01479621|83288865|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
47037603|NCT01479621|83288866|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
47037604|NCT01479621|83288867|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
47037605|NCT01479621|83288868|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
47037606|NCT01479621|83288869|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
47037607|NCT01479621|83288870|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
47037608|NCT01479621|83288864|FG000|Treatment Period|Lost to Follow-up|0|||
46712642|NCT00886288|82928882|FG001|Overall Study|no respect of the 12 weeks period|227|||
46712643|NCT00886288|82928881|FG000|Overall Study|Lost to Follow-up|86|||
46712644|NCT00886288|82928882|FG001|Overall Study|Lost to Follow-up|0|||
46712645|NCT01204658|82928894|FG000|Primary Phase|Adverse Event|0|||
46712646|NCT01204658|82928895|FG001|Primary Phase|Adverse Event|0|||
46712647|NCT01204658|82928896|FG002|Primary Phase|Adverse Event|1|||
46712648|NCT01204658|82928897|FG003|Primary Phase|Adverse Event|0|||
46712649|NCT00951483|82928912|FG000|Overall Study|Physician Decision|4|||
46712650|NCT00951483|82928913|FG001|Overall Study|Physician Decision|0|||
46712651|NCT00951483|82928912|FG000|Overall Study|Withdrawal by Subject|15|||
47037609|NCT01479621|83288865|FG001|Treatment Period|Lost to Follow-up|0|||
47037610|NCT01479621|83288866|FG002|Treatment Period|Lost to Follow-up|1|||
47037611|NCT01479621|83288867|FG003|Treatment Period|Lost to Follow-up|0|||
47037612|NCT01479621|83288868|FG004|Treatment Period|Lost to Follow-up|2|||
47037613|NCT01479621|83288869|FG005|Treatment Period|Lost to Follow-up|2|||
47037614|NCT01479621|83288870|FG006|Treatment Period|Lost to Follow-up|1|||
47037615|NCT01479621|83288864|FG000|Treatment Period|Met stopping criteria|0|||
47037616|NCT01479621|83288865|FG001|Treatment Period|Met stopping criteria|8|||
46712652|NCT00951483|82928913|FG001|Overall Study|Withdrawal by Subject|0|||
46712653|NCT01104246|82928921|FG000|Overall Study|Withdrawal by Subject|1|||
46712654|NCT01104246|82928921|FG000|Overall Study|did not meet inclusion criteria|4|||
46712655|NCT01103778|82928925|FG000|Overall Study|Lost to Follow-up|1|||
46913861|NCT03160885|83144353|FG002|Open-label Treatment|Discontinued IMP|0|||
46913862|NCT03160885|83144354|FG003|Open-label Treatment|Discontinued IMP|0|||
46913863|NCT03160885|83144355|FG004|Open-label Treatment|Discontinued IMP|0|||
46913864|NCT03160885|83144356|FG005|Open-label Treatment|Discontinued IMP|0|||
47037617|NCT01479621|83288866|FG002|Treatment Period|Met stopping criteria|7|||
47037618|NCT01479621|83288867|FG003|Treatment Period|Met stopping criteria|4|||
47037619|NCT01479621|83288868|FG004|Treatment Period|Met stopping criteria|9|||
46630316|NCT01972776|82803208|FG002|Part 1|Adverse Event|1|||
46630317|NCT01972776|82803209|FG003|Part 1|Adverse Event|1|||
46630318|NCT01972776|82803210|FG004|Part 1|Adverse Event|0|||
46630319|NCT01972776|82803211|FG005|Part 1|Adverse Event|0|||
46630320|NCT01972776|82803206|FG000|Part 2|Adverse Event|0|||
46630321|NCT01972776|82803207|FG001|Part 2|Adverse Event|0|||
46630322|NCT01972776|82803208|FG002|Part 2|Adverse Event|0|||
46630323|NCT01972776|82803209|FG003|Part 2|Adverse Event|0|||
46630324|NCT01972776|82803210|FG004|Part 2|Adverse Event|3|||
46630325|NCT01972776|82803211|FG005|Part 2|Adverse Event|0|||
46630326|NCT01972776|82803206|FG000|Part 2|Administrative problems|0|||
46630327|NCT01972776|82803207|FG001|Part 2|Administrative problems|0|||
46630328|NCT01972776|82803208|FG002|Part 2|Administrative problems|0|||
46630329|NCT01972776|82803209|FG003|Part 2|Administrative problems|0|||
46630330|NCT01972776|82803210|FG004|Part 2|Administrative problems|10|||
46630331|NCT01972776|82803211|FG005|Part 2|Administrative problems|7|||
46630332|NCT03763331|82803227|FG000|Overall Study|Lost to Follow-up|1|||
46630333|NCT03763331|82803228|FG001|Overall Study|Lost to Follow-up|0|||
46630334|NCT03763331|82803227|FG000|Overall Study|Withdrawal by Subject|1|||
46630335|NCT03763331|82803228|FG001|Overall Study|Withdrawal by Subject|0|||
46630336|NCT03763331|82803227|FG000|Overall Study|Non-compliance|0|||
46630337|NCT03763331|82803228|FG001|Overall Study|Non-compliance|3|||
46630338|NCT00001259|82803255|FG000|Study 2|Adverse Event|0|||
46630339|NCT00001259|82803256|FG001|Study 2|Adverse Event|0|||
46913865|NCT03160885|83144357|FG006|Open-label Treatment|Discontinued IMP|131|||
46913866|NCT03160885|83144351|FG000|Open-label Treatment|Completed Week 50|0|||
47037620|NCT01479621|83288869|FG005|Treatment Period|Met stopping criteria|20|||
46630340|NCT00001259|82803257|FG002|Study 2|Adverse Event|0|||
46630341|NCT00001259|82803258|FG003|Study 2|Adverse Event|0|||
46630342|NCT00001259|82803259|FG004|Study 2|Adverse Event|2|||
46630343|NCT00001259|82803260|FG005|Study 2|Adverse Event|0|||
46630344|NCT00001259|82803261|FG006|Study 2|Adverse Event|0|||
46630345|NCT01926444|82803275|FG000|Overall Study|Colonoscopy not performed|0|||
46630346|NCT01926444|82803276|FG001|Overall Study|Colonoscopy not performed|0|||
46630347|NCT01926444|82803277|FG002|Overall Study|Colonoscopy not performed|4|||
46712656|NCT01103778|82928925|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
46712657|NCT01103778|82928925|FG000|Overall Study|Screen failure|1|||
46712658|NCT01103466|82928931|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
46913867|NCT03160885|83144352|FG001|Open-label Treatment|Completed Week 50|0|||
46913868|NCT03160885|83144353|FG002|Open-label Treatment|Completed Week 50|0|||
46913869|NCT03160885|83144354|FG003|Open-label Treatment|Completed Week 50|0|||
46712659|NCT01103466|82928932|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
46712660|NCT01103466|82928933|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
46712661|NCT01103466|82928931|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
46712662|NCT01103466|82928932|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
46712663|NCT01103466|82928933|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
46712664|NCT01103466|82928931|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
46712665|NCT01103466|82928932|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
46712666|NCT01103466|82928933|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
46712667|NCT01103466|82928931|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
46712668|NCT01103466|82928932|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
46712669|NCT01103466|82928933|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
46712670|NCT01103466|82928931|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
46712671|NCT01103466|82928932|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
46712672|NCT01103466|82928933|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
46712673|NCT01103466|82928931|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
46712674|NCT01103466|82928932|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
46712675|NCT01103466|82928933|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
46712676|NCT00945945|82928943|FG000|Overall Study|Adverse Event|15|||
46712677|NCT00945945|82928944|FG001|Overall Study|Adverse Event|35|||
46712678|NCT00945945|82928943|FG000|Overall Study|Withdrawal by Subject|7|||
46712679|NCT00945945|82928944|FG001|Overall Study|Withdrawal by Subject|10|||
46712680|NCT00945945|82928943|FG000|Overall Study|Lost to Follow-up|4|||
46913870|NCT03160885|83144355|FG004|Open-label Treatment|Completed Week 50|0|||
46913871|NCT03160885|83144356|FG005|Open-label Treatment|Completed Week 50|0|||
47037621|NCT01479621|83288870|FG006|Treatment Period|Met stopping criteria|6|||
47037622|NCT01479465|83288918|FG000|Overall Study|Disease Progression|9|||
47037623|NCT01479465|83288919|FG001|Overall Study|Disease Progression|61|||
47037624|NCT01479465|83288920|FG002|Overall Study|Disease Progression|65|||
47037625|NCT01479465|83288921|FG003|Overall Study|Disease Progression|70|||
47037626|NCT01479465|83288918|FG000|Overall Study|Study Discontinued by Sponsor|0|||
47037627|NCT01479465|83288919|FG001|Overall Study|Study Discontinued by Sponsor|7|||
47037628|NCT01479465|83288920|FG002|Overall Study|Study Discontinued by Sponsor|5|||
47037629|NCT01479465|83288921|FG003|Overall Study|Study Discontinued by Sponsor|3|||
47037630|NCT01479465|83288918|FG000|Overall Study|Adverse Event|0|||
47037631|NCT01479465|83288919|FG001|Overall Study|Adverse Event|3|||
47037632|NCT01479465|83288920|FG002|Overall Study|Adverse Event|6|||
47037633|NCT01479465|83288921|FG003|Overall Study|Adverse Event|4|||
47037634|NCT01479465|83288918|FG000|Overall Study|Investigator Discretion|1|||
46630348|NCT01926444|82803278|FG003|Overall Study|Colonoscopy not performed|2|||
46630349|NCT05003167|82803288|FG000|Overall Study|Withdrawal by Subject|1|||
46630350|NCT04988035|82803294|FG000|Overall Study|Death|19|||
46630351|NCT04988035|82803295|FG001|Overall Study|Death|13|||
46630352|NCT04988035|82803294|FG000|Overall Study|Lost to Follow-up|12|||
46630353|NCT04988035|82803295|FG001|Overall Study|Lost to Follow-up|6|||
46630354|NCT04988035|82803294|FG000|Overall Study|Protocol Violation|0|||
46630355|NCT04988035|82803295|FG001|Overall Study|Protocol Violation|1|||
46630356|NCT04988035|82803294|FG000|Overall Study|Withdrawal by Subject|2|||
46630357|NCT04988035|82803295|FG001|Overall Study|Withdrawal by Subject|4|||
46630358|NCT04988035|82803294|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
46630359|NCT04988035|82803295|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
46630360|NCT04847674|82803313|FG000|Overall Study|Withdrawal by Subject|0|||
46630361|NCT04847674|82803314|FG001|Overall Study|Withdrawal by Subject|1|||
46630362|NCT04847674|82803315|FG002|Overall Study|Withdrawal by Subject|0|||
46630363|NCT04847674|82803313|FG000|Overall Study|Lost to Follow-up|0|||
46630364|NCT04847674|82803314|FG001|Overall Study|Lost to Follow-up|0|||
46630365|NCT04847674|82803315|FG002|Overall Study|Lost to Follow-up|2|||
46630366|NCT04847674|82803313|FG000|Overall Study|Other than specified|21|||
46630367|NCT04847674|82803314|FG001|Overall Study|Other than specified|20|||
46630368|NCT04847674|82803315|FG002|Overall Study|Other than specified|20|||
46712681|NCT00945945|82928944|FG001|Overall Study|Lost to Follow-up|5|||
46712682|NCT00945945|82928943|FG000|Overall Study|Lack of Efficacy|6|||
46712683|NCT00945945|82928944|FG001|Overall Study|Lack of Efficacy|2|||
46712684|NCT00945945|82928943|FG000|Overall Study|Protocol Violation|4|||
46913872|NCT03160885|83144357|FG006|Open-label Treatment|Completed Week 50|4|||
46630369|NCT04649060|82803327|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
46630370|NCT04649060|82803328|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
46630371|NCT04649060|82803327|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
47037635|NCT01479465|83288919|FG001|Overall Study|Investigator Discretion|4|||
47037636|NCT01479465|83288920|FG002|Overall Study|Investigator Discretion|2|||
47037637|NCT01479465|83288921|FG003|Overall Study|Investigator Discretion|4|||
47037638|NCT01479465|83288918|FG000|Overall Study|Subject Request|1|||
46712685|NCT00945945|82928944|FG001|Overall Study|Protocol Violation|2|||
46712686|NCT00945945|82928943|FG000|Overall Study|Entry Criteria Not Met|0|||
46712687|NCT00945945|82928944|FG001|Overall Study|Entry Criteria Not Met|1|||
46712688|NCT01203956|82928950|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
46712689|NCT01203956|82928951|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
46712690|NCT01103232|82928960|FG000|Overall Study|Withdrawal by Subject|1|||
46712691|NCT01103232|82928961|FG001|Overall Study|Withdrawal by Subject|1|||
46712692|NCT01103232|82928960|FG000|Overall Study|Protocol Violation|0|||
46712693|NCT01103232|82928961|FG001|Overall Study|Protocol Violation|1|||
46712694|NCT01112982|82928967|FG000|Overall Study|Withdrawal by Subject|1|||
46712695|NCT01112982|82928967|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
46712696|NCT01203878|82928977|FG000|Overall Study|Withdrawal by Subject|0|||
46712697|NCT01203878|82928978|FG001|Overall Study|Withdrawal by Subject|0|||
46712698|NCT01203878|82928979|FG002|Overall Study|Withdrawal by Subject|1|||
46712699|NCT01203878|82928977|FG000|Overall Study|Adverse Event|0|||
46712700|NCT01203878|82928978|FG001|Overall Study|Adverse Event|0|||
46712701|NCT01203878|82928979|FG002|Overall Study|Adverse Event|2|||
46712702|NCT01112514|82928986|FG000|Overall Study|Lost to Follow-up|1|||
46712703|NCT01203098|82928993|FG000|Overall Study|Adverse Event|3|||
46712704|NCT01203098|82928994|FG001|Overall Study|Adverse Event|1|||
46712705|NCT01203098|82928995|FG002|Overall Study|Adverse Event|7|||
46712706|NCT01203098|82928993|FG000|Overall Study|Lost to Follow-up|0|||
47037639|NCT01479465|83288919|FG001|Overall Study|Subject Request|3|||
47037640|NCT01479465|83288920|FG002|Overall Study|Subject Request|4|||
47037641|NCT01479465|83288921|FG003|Overall Study|Subject Request|2|||
47037642|NCT01479465|83288918|FG000|Overall Study|Subject Withdrew Consent|0|||
47037643|NCT01479465|83288919|FG001|Overall Study|Subject Withdrew Consent|5|||
47037644|NCT01479465|83288920|FG002|Overall Study|Subject Withdrew Consent|2|||
47037645|NCT01479465|83288921|FG003|Overall Study|Subject Withdrew Consent|1|||
47037646|NCT01479465|83288918|FG000|Overall Study|Protocol Violation|0|||
47037647|NCT01479465|83288919|FG001|Overall Study|Protocol Violation|1|||
47037648|NCT01479465|83288920|FG002|Overall Study|Protocol Violation|1|||
47037649|NCT01479465|83288921|FG003|Overall Study|Protocol Violation|0|||
47037650|NCT01479465|83288918|FG000|Overall Study|Death|0|||
47037651|NCT01479465|83288919|FG001|Overall Study|Death|0|||
47037652|NCT01479465|83288920|FG002|Overall Study|Death|0|||
47037653|NCT01479465|83288921|FG003|Overall Study|Death|1|||
47037654|NCT01479465|83288918|FG000|Overall Study|Lost to Follow-up|0|||
47037655|NCT01479465|83288919|FG001|Overall Study|Lost to Follow-up|0|||
47037656|NCT01479465|83288920|FG002|Overall Study|Lost to Follow-up|1|||
47037657|NCT01479465|83288921|FG003|Overall Study|Lost to Follow-up|0|||
47037658|NCT01503021|83288975|FG000|Overall Study|Adverse Event|7|||
46712707|NCT01203098|82928994|FG001|Overall Study|Lost to Follow-up|0|||
46712708|NCT01203098|82928995|FG002|Overall Study|Lost to Follow-up|1|||
46712709|NCT01203098|82928993|FG000|Overall Study|Physician Decision|2|||
46712710|NCT01203098|82928994|FG001|Overall Study|Physician Decision|2|||
46712711|NCT01203098|82928995|FG002|Overall Study|Physician Decision|0|||
46712712|NCT01203098|82928993|FG000|Overall Study|Withdrawal by Subject|1|||
46712713|NCT01203098|82928994|FG001|Overall Study|Withdrawal by Subject|1|||
46712714|NCT01203098|82928995|FG002|Overall Study|Withdrawal by Subject|3|||
46712715|NCT00945555|82929003|FG000|Overall Study|Referred to another hospital|5|||
46712716|NCT00945555|82929003|FG000|Overall Study|Worsening condition, intensive care unit|1|||
46712717|NCT00945555|82929003|FG000|Overall Study|Withdrawal by Subject|2|||
46712718|NCT00945555|82929003|FG000|Overall Study|Participant continued treatment at home|1|||
46712719|NCT00945555|82929003|FG000|Overall Study|Death|18|||
46712720|NCT00945555|82929003|FG000|Overall Study|Other|1|||
46712721|NCT01108458|82929007|FG000|Overall Study|Withdrawal by Subject|1|||
46712722|NCT01108068|82929013|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
46712723|NCT01108068|82929014|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
46712724|NCT01201850|82929021|FG000|Overall Study|Tumor progression|4|||
46712725|NCT00951171|82929027|FG000|Overall Study|Adverse Event|2|||
46712726|NCT00951171|82929028|FG001|Overall Study|Adverse Event|0|||
46712727|NCT01200992|82929036|FG000|Overall Study|Study terminated early|35|||
46712728|NCT01200992|82929037|FG001|Overall Study|Study terminated early|41|||
46712729|NCT01200992|82929036|FG000|Overall Study|Randomized but not treated|2|||
46712730|NCT01200992|82929037|FG001|Overall Study|Randomized but not treated|0|||
46712731|NCT00878215|82929049|FG000|Overall Study|Determined to be ineligible|0|||
46712732|NCT00878215|82929050|FG001|Overall Study|Determined to be ineligible|10|||
46712733|NCT00878215|82929051|FG002|Overall Study|Determined to be ineligible|0|||
46712734|NCT00878215|82929052|FG003|Overall Study|Determined to be ineligible|0|||
47037659|NCT01503021|83288976|FG001|Overall Study|Adverse Event|6|||
47037660|NCT01503021|83288975|FG000|Overall Study|Death|0|||
47037661|NCT01503021|83288976|FG001|Overall Study|Death|2|||
47037662|NCT01503021|83288975|FG000|Overall Study|Lost to Follow-up|2|||
47037663|NCT01503021|83288976|FG001|Overall Study|Lost to Follow-up|0|||
47037664|NCT01503021|83288975|FG000|Overall Study|Physician Decision|3|||
47037665|NCT01503021|83288976|FG001|Overall Study|Physician Decision|0|||
47037666|NCT01503021|83288975|FG000|Overall Study|Protocol Violation|1|||
46712735|NCT01200758|82929064|FG000|Stage I|Death|0|||
46712736|NCT01200758|82929065|FG001|Stage I|Death|1|||
46712737|NCT01200758|82929066|FG002|Stage I|Death|0|||
46712738|NCT01200758|82929067|FG003|Stage I|Death|0|||
46712739|NCT01200758|82929064|FG000|Stage I|Physician Decision|1|||
46712740|NCT01200758|82929065|FG001|Stage I|Physician Decision|1|||
46712741|NCT01200758|82929066|FG002|Stage I|Physician Decision|0|||
46712742|NCT01200758|82929067|FG003|Stage I|Physician Decision|0|||
46712743|NCT01200758|82929064|FG000|Stage I|Lack of Efficacy|2|||
46712744|NCT01200758|82929065|FG001|Stage I|Lack of Efficacy|1|||
46712745|NCT01200758|82929066|FG002|Stage I|Lack of Efficacy|0|||
46913873|NCT03160885|83144351|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
46913874|NCT03160885|83144352|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
46712746|NCT01200758|82929067|FG003|Stage I|Lack of Efficacy|0|||
46712747|NCT01200758|82929064|FG000|Stage I|Adverse Event|5|||
46712748|NCT01200758|82929065|FG001|Stage I|Adverse Event|5|||
46712749|NCT01200758|82929066|FG002|Stage I|Adverse Event|0|||
46712750|NCT01200758|82929067|FG003|Stage I|Adverse Event|0|||
47037667|NCT01503021|83288976|FG001|Overall Study|Protocol Violation|3|||
46712751|NCT01200758|82929064|FG000|Stage I|Withdrawal by Subject|1|||
46712752|NCT01200758|82929065|FG001|Stage I|Withdrawal by Subject|2|||
46712753|NCT01200758|82929066|FG002|Stage I|Withdrawal by Subject|0|||
46712754|NCT01200758|82929067|FG003|Stage I|Withdrawal by Subject|0|||
46712755|NCT01200758|82929064|FG000|Stage I|Disease Progression|9|||
46712756|NCT01200758|82929065|FG001|Stage I|Disease Progression|7|||
46712757|NCT01200758|82929066|FG002|Stage I|Disease Progression|0|||
46712758|NCT01200758|82929067|FG003|Stage I|Disease Progression|0|||
46712759|NCT01200758|82929064|FG000|Stage 2|Disease Progression|0|||
46712760|NCT01200758|82929065|FG001|Stage 2|Disease Progression|0|||
46712761|NCT01200758|82929066|FG002|Stage 2|Disease Progression|16|||
46712762|NCT01200758|82929067|FG003|Stage 2|Disease Progression|21|||
46712763|NCT01200758|82929064|FG000|Stage 2|Lack of Efficacy|0|||
46712764|NCT01200758|82929065|FG001|Stage 2|Lack of Efficacy|0|||
46712765|NCT01200758|82929066|FG002|Stage 2|Lack of Efficacy|4|||
46712766|NCT01200758|82929067|FG003|Stage 2|Lack of Efficacy|2|||
46712767|NCT01200758|82929064|FG000|Stage 2|Physician Decision|0|||
46712768|NCT01200758|82929065|FG001|Stage 2|Physician Decision|0|||
46712769|NCT01200758|82929066|FG002|Stage 2|Physician Decision|5|||
46712770|NCT01200758|82929067|FG003|Stage 2|Physician Decision|7|||
46712771|NCT01200758|82929064|FG000|Stage 2|Adverse Event|0|||
46712772|NCT01200758|82929065|FG001|Stage 2|Adverse Event|0|||
46712773|NCT01200758|82929066|FG002|Stage 2|Adverse Event|5|||
47037668|NCT01503021|83288975|FG000|Overall Study|Withdrawal by Subject|9|||
47037669|NCT01503021|83288976|FG001|Overall Study|Withdrawal by Subject|8|||
47037670|NCT01503021|83288975|FG000|Overall Study|Moved, received transplant, etc.|5|||
47037671|NCT01503021|83288976|FG001|Overall Study|Moved, received transplant, etc.|7|||
47037672|NCT01531725|83288987|FG000|Overall Study|Protocol Violation|5|||
47037673|NCT01478373|83288991|FG000|Treatment Phase|Protocol Violation|1|||
47037674|NCT01478373|83288991|FG000|Survival Phase|Adverse Event|8|||
47037675|NCT01478373|83288991|FG000|Survival Phase|Protocol Violation|1|||
47037676|NCT01478373|83288991|FG000|Survival Phase|crossover to another study|2|||
47037677|NCT01478373|83288991|FG000|Survival Phase|Progressive Disease|27|||
47037678|NCT01502709|83288997|FG000|Overall Study|Lost to Follow-up|4|||
46630372|NCT04649060|82803328|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
46630373|NCT04649060|82803327|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
46630374|NCT04649060|82803328|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
46630375|NCT04649060|82803327|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
46630376|NCT04649060|82803328|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
46630377|NCT04649060|82803327|FG000|Arm A/Arm B Treatment|Patient Request|1|||
46630378|NCT04649060|82803328|FG001|Arm A/Arm B Treatment|Patient Request|0|||
46630379|NCT04649060|82803327|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
46630380|NCT04649060|82803328|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
46630381|NCT04649060|82803327|FG000|Arm A/Arm B Treatment|Other|1|||
46630382|NCT04649060|82803328|FG001|Arm A/Arm B Treatment|Other|0|||
46712774|NCT01200758|82929067|FG003|Stage 2|Adverse Event|9|||
46712775|NCT01200758|82929064|FG000|Stage 2|Withdrawal by Subject|0|||
46712776|NCT01200758|82929065|FG001|Stage 2|Withdrawal by Subject|0|||
46712777|NCT01200758|82929066|FG002|Stage 2|Withdrawal by Subject|4|||
46712778|NCT01200758|82929067|FG003|Stage 2|Withdrawal by Subject|1|||
46712779|NCT01200758|82929064|FG000|Stage 2|Lost to Follow-up|0|||
46712780|NCT01200758|82929065|FG001|Stage 2|Lost to Follow-up|0|||
46712781|NCT01200758|82929066|FG002|Stage 2|Lost to Follow-up|3|||
47037679|NCT01502709|83288998|FG001|Overall Study|Lost to Follow-up|0|||
46630383|NCT04649060|82803327|FG000|Crossover (Arm B)|Adverse Event|0|||
46712782|NCT01200758|82929067|FG003|Stage 2|Lost to Follow-up|1|||
46712783|NCT01200758|82929064|FG000|Stage 2|Protocol Violation|0|||
46712784|NCT01200758|82929065|FG001|Stage 2|Protocol Violation|0|||
47037680|NCT01477749|83289005|FG000|Overall Study|Physician Decision|4|||
47037681|NCT01502631|83289035|FG000|Overall Study|Adverse Event|5|||
46712785|NCT01200758|82929066|FG002|Stage 2|Protocol Violation|1|||
46712786|NCT01200758|82929067|FG003|Stage 2|Protocol Violation|4|||
46712787|NCT01200758|82929064|FG000|Stage 2|Death|0|||
46712788|NCT01200758|82929065|FG001|Stage 2|Death|0|||
46712789|NCT01200758|82929066|FG002|Stage 2|Death|3|||
46712790|NCT01200758|82929067|FG003|Stage 2|Death|5|||
46712791|NCT00876343|82929082|FG000|Overall Study|Adverse Event|7|||
46712792|NCT00876343|82929083|FG001|Overall Study|Adverse Event|8|||
46712793|NCT00876343|82929084|FG002|Overall Study|Adverse Event|2|||
46712794|NCT00876343|82929082|FG000|Overall Study|Withdrawal by Subject|4|||
46712795|NCT00876343|82929083|FG001|Overall Study|Withdrawal by Subject|4|||
46712796|NCT00876343|82929084|FG002|Overall Study|Withdrawal by Subject|3|||
46712797|NCT00876343|82929082|FG000|Overall Study|Lack of Efficacy|0|||
46712798|NCT00876343|82929083|FG001|Overall Study|Lack of Efficacy|0|||
46712799|NCT00876343|82929084|FG002|Overall Study|Lack of Efficacy|1|||
46712800|NCT00876343|82929082|FG000|Overall Study|Protocol Violation|4|||
46712801|NCT00876343|82929083|FG001|Overall Study|Protocol Violation|1|||
46712802|NCT00876343|82929084|FG002|Overall Study|Protocol Violation|1|||
46712803|NCT00876343|82929082|FG000|Overall Study|Physician Decision|0|||
46913875|NCT03160885|83144353|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
47037682|NCT01502631|83289036|FG001|Overall Study|Adverse Event|8|||
47037683|NCT01502631|83289035|FG000|Overall Study|Lost to Follow-up|2|||
47037684|NCT01502631|83289036|FG001|Overall Study|Lost to Follow-up|2|||
47037685|NCT01502631|83289035|FG000|Overall Study|Participant withdrew consent|2|||
47037686|NCT01502631|83289036|FG001|Overall Study|Participant withdrew consent|4|||
47037687|NCT01502631|83289035|FG000|Overall Study|Participant non-compliant|1|||
47037688|NCT01502631|83289036|FG001|Overall Study|Participant non-compliant|0|||
47037689|NCT01502631|83289035|FG000|Overall Study|Investigator's decision|0|||
47037690|NCT01502631|83289036|FG001|Overall Study|Investigator's decision|1|||
47037691|NCT01502631|83289035|FG000|Overall Study|Other|10|||
47037692|NCT01502631|83289036|FG001|Overall Study|Other|5|||
47037693|NCT01475721|83289092|FG000|Overall Study|Death|3|||
47037694|NCT01475721|83289093|FG001|Overall Study|Death|6|||
46712804|NCT00876343|82929083|FG001|Overall Study|Physician Decision|1|||
46712805|NCT00876343|82929084|FG002|Overall Study|Physician Decision|1|||
46712806|NCT00876343|82929082|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
46712807|NCT00876343|82929083|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
46712808|NCT00876343|82929084|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
46712809|NCT00876343|82929082|FG000|Overall Study|Change of residence or other commitments|2|||
46712810|NCT00876343|82929083|FG001|Overall Study|Change of residence or other commitments|2|||
46712811|NCT00876343|82929084|FG002|Overall Study|Change of residence or other commitments|3|||
46712812|NCT01107912|82929096|FG000|Period 1|Adverse Event|0|||
46712813|NCT01107912|82929097|FG001|Period 1|Adverse Event|0|||
46712814|NCT01107912|82929098|FG002|Period 1|Adverse Event|0|||
46712815|NCT01107912|82929099|FG003|Period 1|Adverse Event|0|||
46712816|NCT01107912|82929100|FG004|Period 1|Adverse Event|2|||
46712817|NCT01107912|82929101|FG005|Period 1|Adverse Event|0|||
46712818|NCT01107912|82929096|FG000|Period 1|Physician Decision|0|||
46712819|NCT01107912|82929097|FG001|Period 1|Physician Decision|0|||
46712820|NCT01107912|82929098|FG002|Period 1|Physician Decision|0|||
46712821|NCT01107912|82929099|FG003|Period 1|Physician Decision|0|||
46712822|NCT01107912|82929100|FG004|Period 1|Physician Decision|1|||
47037695|NCT01475721|83289092|FG000|Overall Study|Withdrawal by Subject|8|||
47037696|NCT01475721|83289093|FG001|Overall Study|Withdrawal by Subject|8|||
47037697|NCT01530087|83289117|FG000|Overall Study|Physician Decision|2|||
47037698|NCT01475487|83289135|FG000|Overall Study|had to leave early for personal reasons|2|||
46712823|NCT01107912|82929101|FG005|Period 1|Physician Decision|0|||
46712824|NCT01107912|82929096|FG000|Period 1|Withdrawal by Subject|1|||
46712825|NCT01107912|82929097|FG001|Period 1|Withdrawal by Subject|0|||
46712826|NCT01107912|82929098|FG002|Period 1|Withdrawal by Subject|0|||
46712827|NCT01107912|82929099|FG003|Period 1|Withdrawal by Subject|0|||
46712828|NCT01107912|82929100|FG004|Period 1|Withdrawal by Subject|0|||
46712829|NCT01107912|82929101|FG005|Period 1|Withdrawal by Subject|0|||
46712830|NCT01107912|82929096|FG000|Period 2|Physician Decision|0|||
46712831|NCT01107912|82929097|FG001|Period 2|Physician Decision|0|||
46712832|NCT01107912|82929098|FG002|Period 2|Physician Decision|1|||
46712833|NCT01107912|82929099|FG003|Period 2|Physician Decision|0|||
46712834|NCT01107912|82929100|FG004|Period 2|Physician Decision|0|||
46712835|NCT01107912|82929101|FG005|Period 2|Physician Decision|0|||
46712836|NCT01107912|82929096|FG000|Period 3|Adverse Event|0|||
47037699|NCT01475487|83289136|FG001|Overall Study|had to leave early for personal reasons|1|||
47037700|NCT01475331|83289144|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
47037701|NCT01475331|83289145|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
46712837|NCT01107912|82929097|FG001|Period 3|Adverse Event|1|||
46712838|NCT01107912|82929098|FG002|Period 3|Adverse Event|1|||
46712839|NCT01107912|82929099|FG003|Period 3|Adverse Event|0|||
47037702|NCT01475331|83289144|FG000|Overall Study|excessive main duct communication|1|||
47037703|NCT01475331|83289145|FG001|Overall Study|excessive main duct communication|1|||
47037704|NCT01475331|83289144|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
47037705|NCT01475331|83289145|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
47037706|NCT01475331|83289144|FG000|Overall Study|Sign of malignancy during the procedure|2|||
47037707|NCT01475331|83289145|FG001|Overall Study|Sign of malignancy during the procedure|0|||
47037708|NCT01475331|83289144|FG000|Overall Study|cyst found to be prohibitively small|0|||
47037709|NCT01475331|83289145|FG001|Overall Study|cyst found to be prohibitively small|1|||
47037710|NCT01500213|83289153|FG000|Overall Study|Adverse Event|35|||
47037711|NCT01500213|83289154|FG001|Overall Study|Adverse Event|35|||
47037712|NCT01500213|83289153|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
47037713|NCT01500213|83289154|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
46712840|NCT01107912|82929100|FG004|Period 3|Adverse Event|0|||
46913876|NCT03160885|83144354|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
46712841|NCT01107912|82929101|FG005|Period 3|Adverse Event|0|||
46712842|NCT01107912|82929096|FG000|Period 3|Withdrawal by Subject|0|||
46913877|NCT03160885|83144355|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
46913878|NCT03160885|83144356|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
46913879|NCT03160885|83144357|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
46913880|NCT03160885|83144351|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
46913881|NCT03160885|83144352|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
47037714|NCT01500213|83289153|FG000|Overall Study|Withdrawal by Subject|28|||
46712843|NCT01107912|82929097|FG001|Period 3|Withdrawal by Subject|0|||
46712844|NCT01107912|82929098|FG002|Period 3|Withdrawal by Subject|0|||
46712845|NCT01107912|82929099|FG003|Period 3|Withdrawal by Subject|1|||
46712846|NCT01107912|82929100|FG004|Period 3|Withdrawal by Subject|0|||
46712847|NCT01107912|82929101|FG005|Period 3|Withdrawal by Subject|0|||
46712848|NCT01200524|82929119|FG000|Overall Study|Withdrawal by Subject|1|||
46712849|NCT01200524|82929120|FG001|Overall Study|Withdrawal by Subject|1|||
46712850|NCT01200524|82929121|FG002|Overall Study|Withdrawal by Subject|3|||
47037715|NCT01500213|83289154|FG001|Overall Study|Withdrawal by Subject|37|||
47037716|NCT01500213|83289153|FG000|Overall Study|Death|7|||
47037717|NCT01500213|83289154|FG001|Overall Study|Death|3|||
47037718|NCT01500213|83289153|FG000|Overall Study|Disease Progression|13|||
47037719|NCT01500213|83289154|FG001|Overall Study|Disease Progression|21|||
47037720|NCT01500213|83289153|FG000|Overall Study|Protocol Violation|19|||
47037721|NCT01500213|83289154|FG001|Overall Study|Protocol Violation|19|||
47037722|NCT01500213|83289153|FG000|Overall Study|Physician Decision|12|||
47037723|NCT01500213|83289154|FG001|Overall Study|Physician Decision|10|||
47037724|NCT01500213|83289153|FG000|Overall Study|Lack of Efficacy|9|||
47037725|NCT01500213|83289154|FG001|Overall Study|Lack of Efficacy|7|||
47037726|NCT01500213|83289153|FG000|Overall Study|Lost to Follow-up|3|||
47037727|NCT01500213|83289154|FG001|Overall Study|Lost to Follow-up|6|||
47037728|NCT01500213|83289153|FG000|Overall Study|Other Reasons|7|||
47037729|NCT01500213|83289154|FG001|Overall Study|Other Reasons|5|||
46630384|NCT04649060|82803328|FG001|Crossover (Arm B)|Adverse Event|1|||
46630385|NCT04649060|82803327|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
46630386|NCT04649060|82803328|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
46630387|NCT04640272|82803335|FG000|Overall Study|Subject moved out of area|1|||
46630388|NCT04511650|82803342|FG000|Overall Study|Lost to Follow-up|1|||
46630389|NCT04511650|82803343|FG001|Overall Study|Lost to Follow-up|0|||
46630390|NCT04511650|82803344|FG002|Overall Study|Lost to Follow-up|0|||
46630391|NCT04511650|82803342|FG000|Overall Study|Withdrawal by Subject|1|||
46630392|NCT04511650|82803343|FG001|Overall Study|Withdrawal by Subject|0|||
46630393|NCT04511650|82803344|FG002|Overall Study|Withdrawal by Subject|0|||
46630394|NCT04511650|82803342|FG000|Overall Study|reason not provided|0|||
46630395|NCT04511650|82803343|FG001|Overall Study|reason not provided|0|||
46712851|NCT01200524|82929119|FG000|Overall Study|Adverse Event|1|||
46712852|NCT01200524|82929120|FG001|Overall Study|Adverse Event|0|||
46630396|NCT04511650|82803344|FG002|Overall Study|reason not provided|1|||
46630397|NCT04511650|82803342|FG000|Overall Study|Death|1|||
46630398|NCT04511650|82803343|FG001|Overall Study|Death|1|||
46712853|NCT01200524|82929121|FG002|Overall Study|Adverse Event|0|||
46712854|NCT01200524|82929119|FG000|Overall Study|Non availability of study nurse|0|||
46630399|NCT04511650|82803344|FG002|Overall Study|Death|1|||
47037730|NCT01475253|83289184|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
47037731|NCT01475253|83289185|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
47037732|NCT01475253|83289186|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
47037733|NCT01475253|83289187|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
47037734|NCT01475253|83289184|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
47037735|NCT01475253|83289185|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
47037736|NCT01475253|83289186|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
47037737|NCT01475253|83289187|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
47037738|NCT01500135|83289245|FG000|Overall Study|Withdrawal of Consent|4|||
47037739|NCT01500135|83289246|FG001|Overall Study|Withdrawal of Consent|0|||
47037740|NCT01500135|83289245|FG000|Overall Study|Lost to Follow-up|6|||
47037741|NCT01500135|83289246|FG001|Overall Study|Lost to Follow-up|4|||
47037742|NCT01500135|83289245|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
47037743|NCT01500135|83289246|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
47037744|NCT01500135|83289245|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
47037745|NCT01500135|83289246|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
47037746|NCT01500135|83289245|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
47037747|NCT01500135|83289246|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
47037748|NCT01500135|83289245|FG000|Overall Study|Participant was a Safety Concern|1|||
47037749|NCT01500135|83289246|FG001|Overall Study|Participant was a Safety Concern|0|||
47037750|NCT01500135|83289245|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
47037751|NCT01500135|83289246|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
47037752|NCT01475097|83289258|FG000|Overall Study|Protocol Violation|1|||
47037753|NCT01475097|83289259|FG001|Overall Study|Protocol Violation|1|||
47037754|NCT01529385|83289267|FG000|Overall Study|Lost to Follow-up|2|||
47037755|NCT01529385|83289268|FG001|Overall Study|Lost to Follow-up|1|||
47037756|NCT01474551|83289274|FG000|Overall Study|Death|1|||
47037757|NCT01500057|83289309|FG000|Overall Study|Lost to Follow-up|6|||
47037758|NCT01500057|83289310|FG001|Overall Study|Lost to Follow-up|4|||
47037759|NCT01499667|83289328|FG000|Overall Study|administrative problems|4|||
47037760|NCT01499667|83289329|FG001|Overall Study|administrative problems|5|||
47037761|NCT01499667|83289330|FG002|Overall Study|administrative problems|5|||
47037762|NCT01499667|83289328|FG000|Overall Study|Protocol Violation|1|||
47037763|NCT01499667|83289329|FG001|Overall Study|Protocol Violation|3|||
47037764|NCT01499667|83289330|FG002|Overall Study|Protocol Violation|2|||
47037765|NCT01499667|83289328|FG000|Overall Study|Adverse Event|0|||
47037766|NCT01499667|83289329|FG001|Overall Study|Adverse Event|2|||
47037767|NCT01499667|83289330|FG002|Overall Study|Adverse Event|2|||
47037768|NCT01499667|83289328|FG000|Overall Study|Withdrawal by Subject|2|||
47037769|NCT01499667|83289329|FG001|Overall Study|Withdrawal by Subject|1|||
47037770|NCT01499667|83289330|FG002|Overall Study|Withdrawal by Subject|1|||
47037771|NCT01499667|83289328|FG000|Overall Study|Lack of Efficacy|2|||
47037772|NCT01499667|83289329|FG001|Overall Study|Lack of Efficacy|0|||
47037773|NCT01499667|83289330|FG002|Overall Study|Lack of Efficacy|0|||
47037774|NCT01499511|83289340|FG000|Overall Study|Death|1|||
47037775|NCT01499511|83289341|FG001|Overall Study|Death|0|||
47037776|NCT01474317|83289361|FG000|Overall Study|Adverse Event|1|||
47037777|NCT01474317|83289361|FG000|Overall Study|Subject ineligible for study|1|||
47037778|NCT01499355|83289457|FG000|Run-In Period|Study Termination|15|||
47037779|NCT01499355|83289458|FG001|Run-In Period|Study Termination|0|||
47037780|NCT01499355|83289459|FG002|Run-In Period|Study Termination|0|||
46630400|NCT04285580|82803363|FG000|Overall Study|Protocol Violation|0|||
46630401|NCT04285580|82803364|FG001|Overall Study|Protocol Violation|1|||
46630402|NCT04200248|82803382|FG000|Overall Study|Personal reasons|0|||
46630403|NCT04200248|82803383|FG001|Overall Study|Personal reasons|0|||
46630404|NCT04200248|82803384|FG002|Overall Study|Personal reasons|1|||
46630405|NCT04200248|82803382|FG000|Overall Study|Discontinued prior to treatment|3|||
46630406|NCT04200248|82803383|FG001|Overall Study|Discontinued prior to treatment|3|||
46630407|NCT04200248|82803384|FG002|Overall Study|Discontinued prior to treatment|2|||
47037781|NCT01499355|83289460|FG003|Run-In Period|Study Termination|0|||
47037782|NCT01499355|83289457|FG000|Run-In Period|Other|3|||
47037783|NCT01499355|83289458|FG001|Run-In Period|Other|0|||
47037784|NCT01499355|83289459|FG002|Run-In Period|Other|0|||
47037785|NCT01499355|83289460|FG003|Run-In Period|Other|0|||
46630408|NCT04137887|82803394|FG000|Overall Study|Death|102|||
46630409|NCT04137887|82803395|FG001|Overall Study|Death|92|||
46630410|NCT04137887|82803394|FG000|Overall Study|Withdrawal by Subject|2|||
46630411|NCT04137887|82803395|FG001|Overall Study|Withdrawal by Subject|3|||
46630412|NCT04137887|82803394|FG000|Overall Study|Randomized but not treated|0|||
47037786|NCT01499355|83289457|FG000|Run-In Period|Death|2|||
47037787|NCT01499355|83289458|FG001|Run-In Period|Death|0|||
47037788|NCT01499355|83289459|FG002|Run-In Period|Death|0|||
47037789|NCT01499355|83289460|FG003|Run-In Period|Death|0|||
47037790|NCT01499355|83289457|FG000|Run-In Period|Investigator Decision|2|||
46630413|NCT04137887|82803395|FG001|Overall Study|Randomized but not treated|1|||
47037791|NCT01499355|83289458|FG001|Run-In Period|Investigator Decision|0|||
47037792|NCT01499355|83289459|FG002|Run-In Period|Investigator Decision|0|||
47037793|NCT01499355|83289460|FG003|Run-In Period|Investigator Decision|0|||
47037794|NCT01499355|83289457|FG000|Run-In Period|Consent Withdrawn|1|||
47037795|NCT01499355|83289458|FG001|Run-In Period|Consent Withdrawn|0|||
47037796|NCT01499355|83289459|FG002|Run-In Period|Consent Withdrawn|0|||
46712855|NCT01200524|82929120|FG001|Overall Study|Non availability of study nurse|0|||
46712856|NCT01200524|82929121|FG002|Overall Study|Non availability of study nurse|1|||
46712857|NCT01100034|82929129|FG000|Overall Study|Lost to Follow-up|11|||
46712858|NCT01100034|82929129|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
46712859|NCT01100034|82929129|FG000|Overall Study|Withdrawal by Subject|4|||
46712860|NCT01100034|82929129|FG000|Overall Study|Sponsor decision|21|||
46712861|NCT01100034|82929129|FG000|Overall Study|Participated in another clinical trial|1|||
46712862|NCT01100034|82929129|FG000|Overall Study|Participants moved to another hospital|4|||
46712863|NCT01100034|82929129|FG000|Overall Study|Site closed due to non-responsiveness|1|||
46712864|NCT00876265|82929133|FG000|Overall Study|Miscellaneous reasons|4|||
46712865|NCT00876265|82929133|FG000|Overall Study|Lost to Follow-up|6|||
46712866|NCT00876265|82929133|FG000|Overall Study|Withdrawal by Subject|2|||
46712867|NCT01107444|82929141|FG000|Overall Study|Withdrawal by Subject|8|||
46712868|NCT01107444|82929142|FG001|Overall Study|Withdrawal by Subject|12|||
46712869|NCT01107444|82929141|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
46712870|NCT01107444|82929142|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
46712871|NCT00876187|82929156|FG000|Overall Study|Adverse Event|14|||
46712872|NCT00876187|82929157|FG001|Overall Study|Adverse Event|12|||
46712873|NCT00876187|82929158|FG002|Overall Study|Adverse Event|19|||
46712874|NCT00876187|82929159|FG003|Overall Study|Adverse Event|29|||
46712875|NCT00876187|82929160|FG004|Overall Study|Adverse Event|10|||
46712876|NCT00876187|82929156|FG000|Overall Study|Lack of Efficacy|59|||
46712877|NCT00876187|82929157|FG001|Overall Study|Lack of Efficacy|34|||
46712878|NCT00876187|82929158|FG002|Overall Study|Lack of Efficacy|45|||
47037797|NCT01499355|83289460|FG003|Run-In Period|Consent Withdrawn|0|||
47037798|NCT01499355|83289457|FG000|Run-In Period|Adverse Event|8|||
47037799|NCT01499355|83289458|FG001|Run-In Period|Adverse Event|0|||
47037800|NCT01499355|83289459|FG002|Run-In Period|Adverse Event|0|||
47037801|NCT01499355|83289460|FG003|Run-In Period|Adverse Event|0|||
47037802|NCT01499355|83289457|FG000|Double-Blind Period|Adverse Event|0|||
47037803|NCT01499355|83289458|FG001|Double-Blind Period|Adverse Event|2|||
47037804|NCT01499355|83289459|FG002|Double-Blind Period|Adverse Event|3|||
47037805|NCT01499355|83289460|FG003|Double-Blind Period|Adverse Event|2|||
47037806|NCT01499355|83289457|FG000|Double-Blind Period|Study Termination|0|||
47037807|NCT01499355|83289458|FG001|Double-Blind Period|Study Termination|18|||
47037808|NCT01499355|83289459|FG002|Double-Blind Period|Study Termination|16|||
47037809|NCT01499355|83289460|FG003|Double-Blind Period|Study Termination|14|||
47037810|NCT01499355|83289457|FG000|Double-Blind Period|Other|0|||
47037811|NCT01499355|83289458|FG001|Double-Blind Period|Other|1|||
47037812|NCT01499355|83289459|FG002|Double-Blind Period|Other|2|||
47037813|NCT01499355|83289460|FG003|Double-Blind Period|Other|2|||
47037814|NCT01499355|83289457|FG000|Double-Blind Period|Death|0|||
46630414|NCT04074590|82803403|FG000|Overall Study|Adverse Event|1|||
46913882|NCT03160885|83144353|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
46913883|NCT03160885|83144354|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
46913884|NCT03160885|83144355|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
46913885|NCT03160885|83144356|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
46913886|NCT03160885|83144357|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
46630415|NCT04074590|82803404|FG001|Overall Study|Adverse Event|0|||
46630416|NCT04074590|82803403|FG000|Overall Study|Physician Decision|1|||
46630417|NCT04074590|82803404|FG001|Overall Study|Physician Decision|0|||
46630418|NCT04074590|82803403|FG000|Overall Study|Withdrawal by Subject|2|||
46630419|NCT04074590|82803404|FG001|Overall Study|Withdrawal by Subject|0|||
46630420|NCT03557008|82803441|FG000|Overall Study|Withdrawal by Subject|2|||
46630421|NCT03557008|82803442|FG001|Overall Study|Withdrawal by Subject|2|||
46630422|NCT03557008|82803441|FG000|Overall Study|Early termination from study|3|||
46630423|NCT03557008|82803442|FG001|Overall Study|Early termination from study|1|||
46630424|NCT02366728|82803451|FG000|Overall Study|Death|0|||
46630425|NCT02366728|82803452|FG001|Overall Study|Death|0|||
46712879|NCT00876187|82929159|FG003|Overall Study|Lack of Efficacy|34|||
46712880|NCT00876187|82929160|FG004|Overall Study|Lack of Efficacy|59|||
46712881|NCT00876187|82929156|FG000|Overall Study|Lost to Follow-up|9|||
46712882|NCT00876187|82929157|FG001|Overall Study|Lost to Follow-up|10|||
46913887|NCT03160885|83144351|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
46630426|NCT02366728|82803453|FG002|Overall Study|Death|1|||
46630427|NCT02366728|82803451|FG000|Overall Study|Adverse Event|1|||
46712883|NCT00876187|82929158|FG002|Overall Study|Lost to Follow-up|8|||
46712884|NCT00876187|82929159|FG003|Overall Study|Lost to Follow-up|8|||
46712885|NCT00876187|82929160|FG004|Overall Study|Lost to Follow-up|11|||
46712886|NCT00876187|82929156|FG000|Overall Study|Protocol Violation|6|||
46913888|NCT03160885|83144352|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
46913889|NCT03160885|83144353|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
46913890|NCT03160885|83144354|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
47037815|NCT01499355|83289458|FG001|Double-Blind Period|Death|1|||
47037816|NCT01499355|83289459|FG002|Double-Blind Period|Death|0|||
47037817|NCT01499355|83289460|FG003|Double-Blind Period|Death|0|||
46712887|NCT00876187|82929157|FG001|Overall Study|Protocol Violation|7|||
46712888|NCT00876187|82929158|FG002|Overall Study|Protocol Violation|7|||
46712889|NCT00876187|82929159|FG003|Overall Study|Protocol Violation|6|||
46712890|NCT00876187|82929160|FG004|Overall Study|Protocol Violation|3|||
46913891|NCT03160885|83144355|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
46913892|NCT03160885|83144356|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
46913893|NCT03160885|83144357|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
46913894|NCT03160885|83144351|FG000|Maintenance Treatment Period|Completed Week 50|0|||
46913895|NCT03160885|83144352|FG001|Maintenance Treatment Period|Completed Week 50|0|||
46913896|NCT03160885|83144353|FG002|Maintenance Treatment Period|Completed Week 50|1|||
46913897|NCT03160885|83144354|FG003|Maintenance Treatment Period|Completed Week 50|0|||
47037818|NCT01499355|83289457|FG000|Double-Blind Period|Investigator Decision|0|||
47037819|NCT01499355|83289458|FG001|Double-Blind Period|Investigator Decision|0|||
47037820|NCT01499355|83289459|FG002|Double-Blind Period|Investigator Decision|3|||
47037821|NCT01499355|83289460|FG003|Double-Blind Period|Investigator Decision|3|||
47037822|NCT01499355|83289457|FG000|Double-Blind Period|Consent Withdrawn|0|||
47037823|NCT01499355|83289458|FG001|Double-Blind Period|Consent Withdrawn|0|||
47037824|NCT01499355|83289459|FG002|Double-Blind Period|Consent Withdrawn|1|||
47037825|NCT01499355|83289460|FG003|Double-Blind Period|Consent Withdrawn|2|||
47037826|NCT01499355|83289457|FG000|Double-Blind Period|Lost to Follow-up|0|||
47037827|NCT01499355|83289458|FG001|Double-Blind Period|Lost to Follow-up|1|||
47037828|NCT01499355|83289459|FG002|Double-Blind Period|Lost to Follow-up|0|||
47037829|NCT01499355|83289460|FG003|Double-Blind Period|Lost to Follow-up|0|||
47037830|NCT01474239|83289481|FG000|Overall Study|Disease Progression|37|||
47037831|NCT01474239|83289482|FG001|Overall Study|Disease Progression|25|||
47037832|NCT01474239|83289481|FG000|Overall Study|Adverse Event|12|||
47037833|NCT01474239|83289482|FG001|Overall Study|Adverse Event|3|||
47037834|NCT01474239|83289481|FG000|Overall Study|Withdrawal by Subject|1|||
47037835|NCT01474239|83289482|FG001|Overall Study|Withdrawal by Subject|2|||
46712891|NCT00876187|82929156|FG000|Overall Study|Withdrawal by Subject|16|||
46913898|NCT03160885|83144355|FG004|Maintenance Treatment Period|Completed Week 50|0|||
46913899|NCT03160885|83144356|FG005|Maintenance Treatment Period|Completed Week 50|0|||
46913900|NCT03160885|83144357|FG006|Maintenance Treatment Period|Completed Week 50|0|||
46913901|NCT03181451|83144377|FG000|Overall Study|Adverse Event|0|||
46913902|NCT03181451|83144378|FG001|Overall Study|Adverse Event|1|||
46913903|NCT03181451|83144379|FG002|Overall Study|Adverse Event|0|||
46913904|NCT03181451|83144377|FG000|Overall Study|Withdrawal by Subject|0|||
46913905|NCT03181451|83144378|FG001|Overall Study|Withdrawal by Subject|1|||
46913906|NCT03181451|83144379|FG002|Overall Study|Withdrawal by Subject|0|||
46913907|NCT00406783|83144391|FG000|Overall Study|Adverse Event|4|||
46913908|NCT00406783|83144392|FG001|Overall Study|Adverse Event|4|||
46913909|NCT00406783|83144391|FG000|Overall Study|Treatment Failure|2|||
46913910|NCT00406783|83144392|FG001|Overall Study|Treatment Failure|3|||
46913911|NCT00406783|83144391|FG000|Overall Study|Lost to Follow-up|3|||
46913912|NCT00406783|83144392|FG001|Overall Study|Lost to Follow-up|0|||
46913913|NCT00406783|83144391|FG000|Overall Study|Withdrawal by Subject|1|||
46913914|NCT00406783|83144392|FG001|Overall Study|Withdrawal by Subject|4|||
46913915|NCT00406783|83144391|FG000|Overall Study|Protocol Violation|4|||
46913916|NCT00406783|83144392|FG001|Overall Study|Protocol Violation|4|||
46913917|NCT03179891|83144398|FG000|First Intervention|Withdrawal by Subject|1|||
46913918|NCT03179891|83144399|FG001|First Intervention|Withdrawal by Subject|1|||
46913919|NCT03179891|83144398|FG000|First Intervention|Unspecified reason|1|||
46913920|NCT03179891|83144399|FG001|First Intervention|Unspecified reason|0|||
46913921|NCT03179891|83144398|FG000|First Intervention|Protocol Violation|0|||
46913922|NCT03179891|83144399|FG001|First Intervention|Protocol Violation|1|||
46913923|NCT02973815|83144410|FG000|Post Intervention|Death|1|||
46913924|NCT02973815|83144411|FG001|Post Intervention|Death|0|||
46913925|NCT02973815|83144410|FG000|Post Intervention|Lost to Follow-up|7|||
46913926|NCT02973815|83144411|FG001|Post Intervention|Lost to Follow-up|24|||
46913927|NCT02973815|83144410|FG000|Follow-up|Lost to Follow-up|2|||
46913928|NCT02973815|83144411|FG001|Follow-up|Lost to Follow-up|0|||
46913929|NCT03160573|83144421|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
46913930|NCT03160573|83144422|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
46913931|NCT03160573|83144423|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
46913932|NCT03160573|83144424|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
47037836|NCT01474239|83289481|FG000|Overall Study|Death|1|||
47037837|NCT01474239|83289482|FG001|Overall Study|Death|1|||
47037838|NCT01474239|83289481|FG000|Overall Study|Clinical Disease Progression|7|||
47037839|NCT01474239|83289482|FG001|Overall Study|Clinical Disease Progression|1|||
47037840|NCT01474239|83289481|FG000|Overall Study|Withdrawal for Economic Reason|1|||
47037841|NCT01474239|83289482|FG001|Overall Study|Withdrawal for Economic Reason|0|||
47037842|NCT01473381|83289492|FG000|Overall Study|Adverse Event|8|||
47037843|NCT01473381|83289493|FG001|Overall Study|Adverse Event|20|||
47037844|NCT01473381|83289494|FG002|Overall Study|Adverse Event|25|||
47037845|NCT01473381|83289495|FG003|Overall Study|Adverse Event|17|||
47037846|NCT01473381|83289492|FG000|Overall Study|Insufficient Therapeutic Response|10|||
47037847|NCT01473381|83289493|FG001|Overall Study|Insufficient Therapeutic Response|1|||
47037848|NCT01473381|83289494|FG002|Overall Study|Insufficient Therapeutic Response|2|||
47037849|NCT01473381|83289495|FG003|Overall Study|Insufficient Therapeutic Response|3|||
47037850|NCT01473381|83289492|FG000|Overall Study|Protocol Violation|17|||
47037851|NCT01473381|83289493|FG001|Overall Study|Protocol Violation|23|||
47037852|NCT01473381|83289494|FG002|Overall Study|Protocol Violation|19|||
47037853|NCT01473381|83289495|FG003|Overall Study|Protocol Violation|17|||
47037854|NCT01473381|83289492|FG000|Overall Study|Withdrawal of Consent|20|||
46712892|NCT00876187|82929157|FG001|Overall Study|Withdrawal by Subject|26|||
46712893|NCT00876187|82929158|FG002|Overall Study|Withdrawal by Subject|32|||
46712894|NCT00876187|82929159|FG003|Overall Study|Withdrawal by Subject|38|||
46712895|NCT00876187|82929160|FG004|Overall Study|Withdrawal by Subject|37|||
46712896|NCT00876187|82929156|FG000|Overall Study|Entered extension study|101|||
47037855|NCT01473381|83289493|FG001|Overall Study|Withdrawal of Consent|21|||
47037856|NCT01473381|83289494|FG002|Overall Study|Withdrawal of Consent|20|||
47037857|NCT01473381|83289495|FG003|Overall Study|Withdrawal of Consent|26|||
47037858|NCT01473381|83289492|FG000|Overall Study|Lost to Follow-up|25|||
46712897|NCT00876187|82929157|FG001|Overall Study|Entered extension study|120|||
46712898|NCT00876187|82929158|FG002|Overall Study|Entered extension study|156|||
46712899|NCT00876187|82929159|FG003|Overall Study|Entered extension study|151|||
46712900|NCT00876187|82929160|FG004|Overall Study|Entered extension study|144|||
46712901|NCT00876187|82929156|FG000|Overall Study|Randomized but not treated|3|||
46712902|NCT00876187|82929157|FG001|Overall Study|Randomized but not treated|1|||
46712903|NCT00876187|82929158|FG002|Overall Study|Randomized but not treated|3|||
46712904|NCT00876187|82929159|FG003|Overall Study|Randomized but not treated|2|||
46712905|NCT00876187|82929160|FG004|Overall Study|Randomized but not treated|3|||
46712906|NCT00876187|82929156|FG000|Overall Study|Other|2|||
46712907|NCT00876187|82929157|FG001|Overall Study|Other|5|||
46712908|NCT00876187|82929158|FG002|Overall Study|Other|9|||
46712909|NCT00876187|82929159|FG003|Overall Study|Other|7|||
46712910|NCT00876187|82929160|FG004|Overall Study|Other|4|||
46712911|NCT01102374|82929177|FG000|Overall Study|Death|9|||
46712912|NCT01102374|82929178|FG001|Overall Study|Death|13|||
46712913|NCT01102374|82929177|FG000|Overall Study|Lost to Follow-up|7|||
46712914|NCT01102374|82929178|FG001|Overall Study|Lost to Follow-up|6|||
46712915|NCT01106976|82929184|FG000|Overall Study|Lost to Follow-up|8|||
46712916|NCT00875485|82929190|FG000|Challenge Dose Epoch|Pregnancy|1|||
46712917|NCT00875485|82929191|FG001|Challenge Dose Epoch|Pregnancy|0|||
46712918|NCT04547140|82929199|FG000|Overall Study|Adverse Event|0|||
46712919|NCT04547140|82929200|FG001|Overall Study|Adverse Event|1|||
46712920|NCT04547140|82929199|FG000|Overall Study|Withdrawal by Subject|0|||
47037859|NCT01473381|83289493|FG001|Overall Study|Lost to Follow-up|28|||
47037860|NCT01473381|83289494|FG002|Overall Study|Lost to Follow-up|35|||
47037861|NCT01473381|83289495|FG003|Overall Study|Lost to Follow-up|23|||
47037862|NCT01473381|83289492|FG000|Overall Study|Other Reasons|0|||
47037863|NCT01473381|83289493|FG001|Overall Study|Other Reasons|0|||
47037864|NCT01473381|83289494|FG002|Overall Study|Other Reasons|1|||
47037865|NCT01473381|83289495|FG003|Overall Study|Other Reasons|3|||
47037866|NCT01499277|83289537|FG000|Overall Study|Adverse Event|3|||
47037867|NCT01499277|83289538|FG001|Overall Study|Adverse Event|6|||
47037868|NCT01499277|83289537|FG000|Overall Study|Death|3|||
47037869|NCT01499277|83289538|FG001|Overall Study|Death|2|||
47037870|NCT01499277|83289537|FG000|Overall Study|Lost to Follow-up|15|||
46712921|NCT04547140|82929200|FG001|Overall Study|Withdrawal by Subject|1|||
46712922|NCT04547140|82929199|FG000|Overall Study|Lost to Follow-up|3|||
46712923|NCT04547140|82929200|FG001|Overall Study|Lost to Follow-up|1|||
46712924|NCT04547140|82929199|FG000|Overall Study|Death|2|||
46712925|NCT04547140|82929200|FG001|Overall Study|Death|1|||
46712926|NCT04547140|82929199|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
46712927|NCT04547140|82929200|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
46712928|NCT04547140|82929199|FG000|Overall Study|Pregnancy|1|||
47037871|NCT01499277|83289538|FG001|Overall Study|Lost to Follow-up|8|||
47037872|NCT01499277|83289537|FG000|Overall Study|Protocol Violation|2|||
47037873|NCT01499277|83289538|FG001|Overall Study|Protocol Violation|3|||
46712929|NCT04547140|82929200|FG001|Overall Study|Pregnancy|0|||
46712930|NCT04547140|82929199|FG000|Overall Study|Reason Not Specified|4|||
46712931|NCT04547140|82929200|FG001|Overall Study|Reason Not Specified|1|||
46712932|NCT01098474|82929212|FG000|Active Phase|Other|0|||
46712933|NCT01098474|82929213|FG001|Active Phase|Other|0|||
46712934|NCT01098474|82929214|FG002|Active Phase|Other|3|||
46712935|NCT01098474|82929215|FG003|Active Phase|Other|0|||
47037874|NCT01499277|83289537|FG000|Overall Study|Withdrawal by Subject|16|||
47037875|NCT01499277|83289538|FG001|Overall Study|Withdrawal by Subject|6|||
47037876|NCT01499277|83289537|FG000|Overall Study|Lack of therapeutic response and other|8|||
46712936|NCT01098474|82929216|FG004|Active Phase|Other|0|||
46712937|NCT01098474|82929217|FG005|Active Phase|Other|0|||
46712938|NCT01098474|82929212|FG000|Active Phase|Withdrawal by Subject|1|||
46712939|NCT01098474|82929213|FG001|Active Phase|Withdrawal by Subject|1|||
46712940|NCT01098474|82929214|FG002|Active Phase|Withdrawal by Subject|2|||
46712941|NCT01098474|82929215|FG003|Active Phase|Withdrawal by Subject|0|||
47037877|NCT01499277|83289538|FG001|Overall Study|Lack of therapeutic response and other|7|||
47037878|NCT01499199|83289563|FG000|Overall Study|Adverse Event|1|||
46712942|NCT01098474|82929216|FG004|Active Phase|Withdrawal by Subject|0|||
46712943|NCT01098474|82929217|FG005|Active Phase|Withdrawal by Subject|0|||
46712944|NCT01098474|82929212|FG000|Active Phase|Lost to Follow-up|1|||
46712945|NCT01098474|82929213|FG001|Active Phase|Lost to Follow-up|0|||
46712946|NCT01098474|82929214|FG002|Active Phase|Lost to Follow-up|0|||
46712947|NCT01098474|82929215|FG003|Active Phase|Lost to Follow-up|0|||
46712948|NCT01098474|82929216|FG004|Active Phase|Lost to Follow-up|0|||
46712949|NCT01098474|82929217|FG005|Active Phase|Lost to Follow-up|0|||
46712950|NCT01098474|82929212|FG000|Follow Up Phase|Travelled out of study area|0|||
46712951|NCT01098474|82929213|FG001|Follow Up Phase|Travelled out of study area|0|||
46712952|NCT01098474|82929214|FG002|Follow Up Phase|Travelled out of study area|0|||
47037879|NCT01499199|83289563|FG000|Overall Study|Lack of Efficacy|1|||
46712953|NCT01098474|82929215|FG003|Follow Up Phase|Travelled out of study area|0|||
46712954|NCT01098474|82929216|FG004|Follow Up Phase|Travelled out of study area|1|||
46712955|NCT01098474|82929217|FG005|Follow Up Phase|Travelled out of study area|0|||
46712956|NCT01098474|82929212|FG000|Follow Up Phase|Other|0|||
46712957|NCT01098474|82929213|FG001|Follow Up Phase|Other|0|||
46712958|NCT01098474|82929214|FG002|Follow Up Phase|Other|0|||
46712959|NCT01098474|82929215|FG003|Follow Up Phase|Other|0|||
46712960|NCT01098474|82929216|FG004|Follow Up Phase|Other|0|||
46712961|NCT01098474|82929217|FG005|Follow Up Phase|Other|4|||
46712962|NCT01098474|82929212|FG000|Follow Up Phase|Withdrawal by Subject|0|||
46712963|NCT01098474|82929213|FG001|Follow Up Phase|Withdrawal by Subject|0|||
46712964|NCT01098474|82929214|FG002|Follow Up Phase|Withdrawal by Subject|0|||
47037880|NCT01499043|83289567|FG000|Overall Study|Progressive disease (radiographic)|2|||
47037881|NCT01499043|83289567|FG000|Overall Study|Progressive disease (clinical)|1|||
47037882|NCT01499043|83289567|FG000|Overall Study|Withdrawal by Subject|2|||
47037883|NCT01499043|83289567|FG000|Overall Study|Adverse Event|1|||
47037884|NCT01498887|83289641|FG000|Overall Study|Administrative problems|1|||
47037885|NCT01498887|83289642|FG001|Overall Study|Administrative problems|0|||
47037886|NCT01498887|83289641|FG000|Overall Study|Lost to Follow-up|1|||
47037887|NCT01498887|83289642|FG001|Overall Study|Lost to Follow-up|1|||
47037888|NCT01498887|83289641|FG000|Overall Study|Withdrawal by Subject|1|||
47037889|NCT01498887|83289642|FG001|Overall Study|Withdrawal by Subject|0|||
47037890|NCT01498887|83289641|FG000|Overall Study|Protocol Violation|1|||
46712965|NCT01098474|82929215|FG003|Follow Up Phase|Withdrawal by Subject|2|||
47037891|NCT01498887|83289642|FG001|Overall Study|Protocol Violation|3|||
47037892|NCT01498887|83289641|FG000|Overall Study|Lack of Efficacy|5|||
47037893|NCT01498887|83289642|FG001|Overall Study|Lack of Efficacy|3|||
46630428|NCT02366728|82803452|FG001|Overall Study|Adverse Event|0|||
46630429|NCT02366728|82803453|FG002|Overall Study|Adverse Event|0|||
46630430|NCT02366728|82803451|FG000|Overall Study|Screen Failure|2|||
46630431|NCT02366728|82803452|FG001|Overall Study|Screen Failure|1|||
46630432|NCT02366728|82803453|FG002|Overall Study|Screen Failure|0|||
46630433|NCT02366728|82803451|FG000|Overall Study|Only yielded 2 vaccines|1|||
46630434|NCT02366728|82803452|FG001|Overall Study|Only yielded 2 vaccines|0|||
46712966|NCT01098474|82929216|FG004|Follow Up Phase|Withdrawal by Subject|0|||
46630435|NCT02366728|82803453|FG002|Overall Study|Only yielded 2 vaccines|0|||
46630436|NCT02355002|82803463|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
46712967|NCT01098474|82929217|FG005|Follow Up Phase|Withdrawal by Subject|1|||
46712968|NCT01098474|82929212|FG000|Follow Up Phase|Lost to Follow-up|0|||
46712969|NCT01098474|82929213|FG001|Follow Up Phase|Lost to Follow-up|0|||
46712970|NCT01098474|82929214|FG002|Follow Up Phase|Lost to Follow-up|0|||
47037894|NCT01498887|83289641|FG000|Overall Study|Abnormal result from test procedure|1|||
47037895|NCT01498887|83289642|FG001|Overall Study|Abnormal result from test procedure|1|||
46712971|NCT01098474|82929215|FG003|Follow Up Phase|Lost to Follow-up|0|||
46712972|NCT01098474|82929216|FG004|Follow Up Phase|Lost to Follow-up|1|||
46712973|NCT01098474|82929217|FG005|Follow Up Phase|Lost to Follow-up|0|||
46712974|NCT00876733|82929245|FG000|Overall Study|Adverse Event|34|||
46712975|NCT00876733|82929246|FG001|Overall Study|Adverse Event|20|||
46712976|NCT00876733|82929247|FG002|Overall Study|Adverse Event|10|||
46712977|NCT00876733|82929248|FG003|Overall Study|Adverse Event|3|||
46712978|NCT00876733|82929245|FG000|Overall Study|Lack of Efficacy|17|||
46712979|NCT00876733|82929246|FG001|Overall Study|Lack of Efficacy|9|||
46712980|NCT00876733|82929247|FG002|Overall Study|Lack of Efficacy|10|||
46712981|NCT00876733|82929248|FG003|Overall Study|Lack of Efficacy|1|||
46712982|NCT00876733|82929245|FG000|Overall Study|Lost to Follow-up|26|||
46712983|NCT00876733|82929246|FG001|Overall Study|Lost to Follow-up|10|||
46712984|NCT00876733|82929247|FG002|Overall Study|Lost to Follow-up|3|||
46712985|NCT00876733|82929248|FG003|Overall Study|Lost to Follow-up|2|||
46712986|NCT00876733|82929245|FG000|Overall Study|Data not available|14|||
46712987|NCT00876733|82929246|FG001|Overall Study|Data not available|3|||
46712988|NCT00876733|82929247|FG002|Overall Study|Data not available|7|||
46712989|NCT00876733|82929248|FG003|Overall Study|Data not available|1|||
46712990|NCT00875017|82929268|FG000|First Intervention|Withdrawal by Subject|1|||
46712991|NCT00875017|82929269|FG001|First Intervention|Withdrawal by Subject|0|||
46712992|NCT00875017|82929270|FG002|First Intervention|Withdrawal by Subject|1|||
46712993|NCT00875017|82929271|FG003|First Intervention|Withdrawal by Subject|0|||
46712994|NCT00875017|82929272|FG004|First Intervention|Withdrawal by Subject|0|||
46712995|NCT00875017|82929273|FG005|First Intervention|Withdrawal by Subject|0|||
46712996|NCT00875017|82929268|FG000|First Intervention|Adverse Event|0|||
46712997|NCT00875017|82929269|FG001|First Intervention|Adverse Event|0|||
46712998|NCT00875017|82929270|FG002|First Intervention|Adverse Event|0|||
46712999|NCT00875017|82929271|FG003|First Intervention|Adverse Event|1|||
46713000|NCT00875017|82929272|FG004|First Intervention|Adverse Event|0|||
46713001|NCT00875017|82929273|FG005|First Intervention|Adverse Event|0|||
47037896|NCT01498887|83289641|FG000|Overall Study|Abnormal laboratory value|2|||
47037897|NCT01498887|83289642|FG001|Overall Study|Abnormal laboratory value|2|||
47037898|NCT01498887|83289641|FG000|Overall Study|Adverse Event|4|||
47037899|NCT01498887|83289642|FG001|Overall Study|Adverse Event|1|||
47037900|NCT01498653|83289651|FG000|Overall Study|Adverse Event|2|||
47037901|NCT01498653|83289652|FG001|Overall Study|Adverse Event|2|||
47037902|NCT01498653|83289651|FG000|Overall Study|Lack of Efficacy|12|||
47037903|NCT01498653|83289652|FG001|Overall Study|Lack of Efficacy|26|||
47037904|NCT01498653|83289651|FG000|Overall Study|Protocol Violation|0|||
47037905|NCT01498653|83289652|FG001|Overall Study|Protocol Violation|4|||
47037906|NCT01498653|83289651|FG000|Overall Study|Lost to Follow-up|1|||
46630437|NCT02355002|82803464|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
46630438|NCT02355002|82803463|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
46630439|NCT02355002|82803464|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
46630440|NCT02355002|82803463|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
46630441|NCT02355002|82803464|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
46630442|NCT02355002|82803463|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
46630443|NCT02355002|82803464|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
46630444|NCT02355002|82803463|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
46630445|NCT02355002|82803464|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
46630446|NCT02355002|82803463|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
46630447|NCT02355002|82803464|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
46630448|NCT02355002|82803463|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
46630449|NCT02355002|82803464|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
46630450|NCT02246920|82803474|FG000|Overall Study|Adverse Event|3|||
46630451|NCT02246920|82803475|FG001|Overall Study|Adverse Event|1|||
46630452|NCT02246920|82803476|FG002|Overall Study|Adverse Event|1|||
46630453|NCT02246920|82803474|FG000|Overall Study|Lost to Follow-up|2|||
46630454|NCT02246920|82803475|FG001|Overall Study|Lost to Follow-up|1|||
46630455|NCT02246920|82803476|FG002|Overall Study|Lost to Follow-up|0|||
46630456|NCT02246920|82803474|FG000|Overall Study|Protocol Violation|2|||
46630457|NCT02246920|82803475|FG001|Overall Study|Protocol Violation|5|||
46630458|NCT02246920|82803476|FG002|Overall Study|Protocol Violation|1|||
46630459|NCT02246920|82803474|FG000|Overall Study|Withdrawal by Subject|0|||
46630460|NCT02246920|82803475|FG001|Overall Study|Withdrawal by Subject|0|||
46630461|NCT02246920|82803476|FG002|Overall Study|Withdrawal by Subject|1|||
46630462|NCT01832402|82803486|FG000|Overall Study|Lost to Follow-up|2|||
46630463|NCT01832402|82803487|FG001|Overall Study|Lost to Follow-up|0|||
46630464|NCT01832402|82803486|FG000|Overall Study|Withdrawal by Subject|3|||
46630465|NCT01832402|82803487|FG001|Overall Study|Withdrawal by Subject|3|||
46630466|NCT01832402|82803486|FG000|Overall Study|Declining Performance status|2|||
46630467|NCT01832402|82803487|FG001|Overall Study|Declining Performance status|1|||
46630468|NCT00667628|82803504|FG000|Overall Study|Lost to Follow-up|1|||
47037907|NCT01498653|83289652|FG001|Overall Study|Lost to Follow-up|0|||
46713002|NCT00875017|82929268|FG000|First Intervention|Problems collecting rectal effluent|1|||
47037908|NCT01498653|83289651|FG000|Overall Study|Physician Decision|2|||
47037909|NCT01498653|83289652|FG001|Overall Study|Physician Decision|0|||
47037910|NCT01498653|83289651|FG000|Overall Study|Withdrawal by Subject|2|||
47037911|NCT01498653|83289652|FG001|Overall Study|Withdrawal by Subject|3|||
46713003|NCT00875017|82929269|FG001|First Intervention|Problems collecting rectal effluent|0|||
47037912|NCT01498575|83289660|FG000|Overall Sample|Withdrawal by Subject|60|||
47037913|NCT01498575|83289661|FG001|Overall Sample|Withdrawal by Subject|14|||
47037914|NCT01498575|83289660|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
47037915|NCT01498575|83289661|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
47037916|NCT01498575|83289660|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
46713004|NCT00875017|82929270|FG002|First Intervention|Problems collecting rectal effluent|0|||
46713005|NCT00875017|82929271|FG003|First Intervention|Problems collecting rectal effluent|0|||
46713006|NCT00875017|82929272|FG004|First Intervention|Problems collecting rectal effluent|0|||
46713007|NCT00875017|82929273|FG005|First Intervention|Problems collecting rectal effluent|0|||
47037917|NCT01498575|83289661|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
46630469|NCT00667628|82803505|FG001|Overall Study|Lost to Follow-up|0|||
46630470|NCT00667628|82803504|FG000|Overall Study|Death|6|||
46630471|NCT00667628|82803505|FG001|Overall Study|Death|6|||
46630472|NCT00667628|82803504|FG000|Overall Study|Investigator Considers in Best Interest|1|||
46630473|NCT00667628|82803505|FG001|Overall Study|Investigator Considers in Best Interest|0|||
47037918|NCT01498185|83289672|FG000|Overall Study|Adverse Event|0|||
47037919|NCT01498185|83289673|FG001|Overall Study|Adverse Event|0|||
47037920|NCT01498185|83289674|FG002|Overall Study|Adverse Event|0|||
47037921|NCT01498185|83289675|FG003|Overall Study|Adverse Event|1|||
46630474|NCT00667628|82803504|FG000|Overall Study|Sponsor Terminated Study|17|||
46630475|NCT00667628|82803505|FG001|Overall Study|Sponsor Terminated Study|21|||
46630476|NCT01597908|82803517|FG000|Randomized Phase|Death|217|||
46630477|NCT01597908|82803518|FG001|Randomized Phase|Death|238|||
46630478|NCT01597908|82803519|FG002|Randomized Phase|Death|0|||
46630479|NCT01597908|82803517|FG000|Randomized Phase|Sponsor Decision|93|||
46630480|NCT01597908|82803518|FG001|Randomized Phase|Sponsor Decision|39|||
46630481|NCT01597908|82803519|FG002|Randomized Phase|Sponsor Decision|0|||
46630482|NCT01597908|82803517|FG000|Randomized Phase|Lost to Follow-up|9|||
46630483|NCT01597908|82803518|FG001|Randomized Phase|Lost to Follow-up|16|||
46630484|NCT01597908|82803519|FG002|Randomized Phase|Lost to Follow-up|0|||
46630485|NCT01597908|82803517|FG000|Randomized Phase|Physician Decision|6|||
46630486|NCT01597908|82803518|FG001|Randomized Phase|Physician Decision|3|||
46630487|NCT01597908|82803519|FG002|Randomized Phase|Physician Decision|0|||
46630488|NCT01597908|82803517|FG000|Randomized Phase|Withdrawal by Subject|26|||
46630489|NCT01597908|82803518|FG001|Randomized Phase|Withdrawal by Subject|22|||
46630490|NCT01597908|82803519|FG002|Randomized Phase|Withdrawal by Subject|0|||
46630491|NCT01597908|82803517|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
46630492|NCT01597908|82803518|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
47037922|NCT01498185|83289676|FG004|Overall Study|Adverse Event|0|||
46713008|NCT00875017|82929268|FG000|First Intervention|Intolerance to nasogastric tube|0|||
46713009|NCT00875017|82929269|FG001|First Intervention|Intolerance to nasogastric tube|0|||
46713010|NCT00875017|82929270|FG002|First Intervention|Intolerance to nasogastric tube|0|||
46713011|NCT00875017|82929271|FG003|First Intervention|Intolerance to nasogastric tube|0|||
46713012|NCT00875017|82929272|FG004|First Intervention|Intolerance to nasogastric tube|1|||
46713013|NCT00875017|82929273|FG005|First Intervention|Intolerance to nasogastric tube|0|||
46713014|NCT00875017|82929268|FG000|Washout|Problem collecting rectal effluent|0|||
46713015|NCT00875017|82929269|FG001|Washout|Problem collecting rectal effluent|0|||
46713016|NCT00875017|82929270|FG002|Washout|Problem collecting rectal effluent|1|||
46713017|NCT00875017|82929271|FG003|Washout|Problem collecting rectal effluent|0|||
46713018|NCT00875017|82929272|FG004|Washout|Problem collecting rectal effluent|0|||
46713019|NCT00875017|82929273|FG005|Washout|Problem collecting rectal effluent|0|||
46713020|NCT00875017|82929268|FG000|Second Intervention|Adverse Event|0|||
46713021|NCT00875017|82929269|FG001|Second Intervention|Adverse Event|0|||
46713022|NCT00875017|82929270|FG002|Second Intervention|Adverse Event|0|||
46713023|NCT00875017|82929271|FG003|Second Intervention|Adverse Event|1|||
46713024|NCT00875017|82929272|FG004|Second Intervention|Adverse Event|0|||
46713025|NCT00875017|82929273|FG005|Second Intervention|Adverse Event|0|||
46713026|NCT00875017|82929268|FG000|Washout|Problems collecting rectal effluent|0|||
46913933|NCT02736227|83144437|FG000|Overall Study|Withdrawal by Subject|0|||
47037923|NCT01498185|83289672|FG000|Overall Study|Withdrawal by Subject|1|||
47037924|NCT01498185|83289673|FG001|Overall Study|Withdrawal by Subject|1|||
47037925|NCT01498185|83289674|FG002|Overall Study|Withdrawal by Subject|0|||
47037926|NCT01498185|83289675|FG003|Overall Study|Withdrawal by Subject|2|||
47037927|NCT01498185|83289676|FG004|Overall Study|Withdrawal by Subject|1|||
47037928|NCT01498185|83289672|FG000|Overall Study|No longer met criteria, etc|0|||
47037929|NCT01498185|83289673|FG001|Overall Study|No longer met criteria, etc|0|||
47037930|NCT01498185|83289674|FG002|Overall Study|No longer met criteria, etc|0|||
46630493|NCT01597908|82803519|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
46630494|NCT01597908|82803517|FG000|Crossover Phase|Death|0|||
46630495|NCT01597908|82803518|FG001|Crossover Phase|Death|0|||
46630496|NCT01597908|82803519|FG002|Crossover Phase|Death|11|||
46630497|NCT01597908|82803517|FG000|Crossover Phase|Withdrawal by Subject|0|||
46630498|NCT01597908|82803518|FG001|Crossover Phase|Withdrawal by Subject|0|||
46630499|NCT01597908|82803519|FG002|Crossover Phase|Withdrawal by Subject|3|||
46630500|NCT01597908|82803517|FG000|Crossover Phase|Sponsor Decision|0|||
46630501|NCT01597908|82803518|FG001|Crossover Phase|Sponsor Decision|0|||
46630502|NCT01597908|82803519|FG002|Crossover Phase|Sponsor Decision|20|||
46630503|NCT01951170|82803528|FG000|Overall Study|Investigator decision|1|||
46630504|NCT01951092|82803532|FG000|Overall Study|Lost to Follow-up|10|||
46630505|NCT01951092|82803532|FG000|Overall Study|Incarceration|1|||
46630506|NCT01951092|82803532|FG000|Overall Study|Transfer of Care|1|||
46630507|NCT01949532|82803538|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
46630508|NCT01949532|82803539|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
46630509|NCT01949142|82803547|FG000|Overall Study|Withdrawal of consent|1|||
46630510|NCT01949142|82803548|FG001|Overall Study|Withdrawal of consent|0|||
46630511|NCT01949142|82803547|FG000|Overall Study|Lost to Follow-up|1|||
46630512|NCT01949142|82803548|FG001|Overall Study|Lost to Follow-up|1|||
46630513|NCT01949142|82803547|FG000|Overall Study|Parent changed their mind|1|||
46630514|NCT01949142|82803548|FG001|Overall Study|Parent changed their mind|0|||
46630515|NCT01948908|82803558|FG000|Overall Study|Protocol Violation|1|||
46630516|NCT01948908|82803559|FG001|Overall Study|Protocol Violation|0|||
46713027|NCT00875017|82929269|FG001|Washout|Problems collecting rectal effluent|1|||
46713028|NCT00875017|82929270|FG002|Washout|Problems collecting rectal effluent|0|||
46713029|NCT00875017|82929271|FG003|Washout|Problems collecting rectal effluent|0|||
46913934|NCT02736227|83144438|FG001|Overall Study|Withdrawal by Subject|0|||
47037931|NCT01498185|83289675|FG003|Overall Study|No longer met criteria, etc|0|||
46630517|NCT01948908|82803560|FG002|Overall Study|Protocol Violation|2|||
46630518|NCT01925274|82803571|FG000|Overall Study|Death|1|||
46713030|NCT00875017|82929272|FG004|Washout|Problems collecting rectal effluent|0|||
46713031|NCT00875017|82929273|FG005|Washout|Problems collecting rectal effluent|0|||
46713032|NCT00875017|82929268|FG000|Third Intervention|Adverse Event|0|||
46713033|NCT00875017|82929269|FG001|Third Intervention|Adverse Event|1|||
46713034|NCT00875017|82929270|FG002|Third Intervention|Adverse Event|1|||
46713035|NCT00875017|82929271|FG003|Third Intervention|Adverse Event|0|||
46713036|NCT00875017|82929272|FG004|Third Intervention|Adverse Event|0|||
46713037|NCT00875017|82929273|FG005|Third Intervention|Adverse Event|0|||
46713038|NCT00875017|82929268|FG000|Washout|Withdrawal by Subject|0|||
46713039|NCT00875017|82929269|FG001|Washout|Withdrawal by Subject|0|||
46713040|NCT00875017|82929270|FG002|Washout|Withdrawal by Subject|0|||
46713041|NCT00875017|82929271|FG003|Washout|Withdrawal by Subject|0|||
46713042|NCT00875017|82929272|FG004|Washout|Withdrawal by Subject|1|||
46713043|NCT00875017|82929273|FG005|Washout|Withdrawal by Subject|0|||
46713044|NCT00875017|82929268|FG000|Fourth Intervention|Inability to comply with fasting|0|||
46713045|NCT00875017|82929269|FG001|Fourth Intervention|Inability to comply with fasting|0|||
46713046|NCT00875017|82929270|FG002|Fourth Intervention|Inability to comply with fasting|0|||
46713047|NCT00875017|82929271|FG003|Fourth Intervention|Inability to comply with fasting|0|||
46713048|NCT00875017|82929272|FG004|Fourth Intervention|Inability to comply with fasting|0|||
47037932|NCT01498185|83289676|FG004|Overall Study|No longer met criteria, etc|2|||
47037933|NCT01528605|83289698|FG000|Overall Study|Lost to Follow-up|1|||
47037934|NCT01528605|83289699|FG001|Overall Study|Lost to Follow-up|0|||
47037935|NCT01528605|83289700|FG002|Overall Study|Lost to Follow-up|1|||
47037936|NCT01528605|83289701|FG003|Overall Study|Lost to Follow-up|1|||
47037937|NCT01528605|83289702|FG004|Overall Study|Lost to Follow-up|0|||
47037938|NCT01528605|83289703|FG005|Overall Study|Lost to Follow-up|0|||
47037939|NCT01528605|83289698|FG000|Overall Study|Death|1|||
47037940|NCT01528605|83289699|FG001|Overall Study|Death|0|||
47037941|NCT01528605|83289700|FG002|Overall Study|Death|0|||
47037942|NCT01528605|83289701|FG003|Overall Study|Death|0|||
47037943|NCT01528605|83289702|FG004|Overall Study|Death|0|||
47037944|NCT01528605|83289703|FG005|Overall Study|Death|0|||
47037945|NCT01528215|83289719|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
47037946|NCT01528215|83289720|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
47037947|NCT01528215|83289719|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
47037948|NCT01528215|83289720|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
47037949|NCT01528215|83289719|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
47037950|NCT01528215|83289720|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
47037951|NCT01528215|83289719|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
47037952|NCT01528215|83289720|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
47037953|NCT01527357|83289728|FG000|Overall Study|Death|8|||
47037954|NCT01527357|83289729|FG001|Overall Study|Death|2|||
47037955|NCT01527357|83289728|FG000|Overall Study|Lost to Follow-up|6|||
46630519|NCT01925274|82803572|FG001|Overall Study|Death|0|||
46630520|NCT01925274|82803573|FG002|Overall Study|Death|0|||
46630521|NCT01925274|82803571|FG000|Overall Study|Lost to Follow-up|0|||
46630522|NCT01925274|82803572|FG001|Overall Study|Lost to Follow-up|1|||
46630523|NCT01925274|82803573|FG002|Overall Study|Lost to Follow-up|0|||
46630524|NCT01925274|82803571|FG000|Overall Study|Withdrawal by Subject|1|||
46630525|NCT01925274|82803572|FG001|Overall Study|Withdrawal by Subject|2|||
46630526|NCT01925274|82803573|FG002|Overall Study|Withdrawal by Subject|0|||
46630527|NCT01925274|82803571|FG000|Overall Study|Study terminated by sponsor|4|||
46630528|NCT01925274|82803572|FG001|Overall Study|Study terminated by sponsor|0|||
46630529|NCT01925274|82803573|FG002|Overall Study|Study terminated by sponsor|0|||
46630530|NCT01925274|82803571|FG000|Overall Study|Protocol amendment|1|||
46630531|NCT01925274|82803572|FG001|Overall Study|Protocol amendment|3|||
46630532|NCT01925274|82803573|FG002|Overall Study|Protocol amendment|6|||
47037956|NCT01527357|83289729|FG001|Overall Study|Lost to Follow-up|4|||
46630533|NCT01948830|82803585|FG000|Overall Study|Physician Decision|1|||
46630534|NCT01948830|82803586|FG001|Overall Study|Physician Decision|3|||
46630535|NCT01948830|82803585|FG000|Overall Study|Protocol deviation|1|||
46630536|NCT01948830|82803586|FG001|Overall Study|Protocol deviation|2|||
46713049|NCT00875017|82929273|FG005|Fourth Intervention|Inability to comply with fasting|1|||
46713050|NCT00875797|82929298|FG000|Overall Study|Protocol Violation|6|||
46713051|NCT00875797|82929299|FG001|Overall Study|Protocol Violation|3|||
46713052|NCT00874939|82929325|FG000|Overall Study|Study terminated|4|||
46713053|NCT00875563|82929335|FG000|Overall Study|Death|4|||
46713054|NCT00875563|82929335|FG000|Overall Study|Withdrawal by Subject|7|||
47037957|NCT01527357|83289728|FG000|Overall Study|Withdrew Consent|1|||
46630537|NCT01948830|82803585|FG000|Overall Study|Lost to Follow-up|5|||
47037958|NCT01527357|83289729|FG001|Overall Study|Withdrew Consent|1|||
46713055|NCT00875563|82929335|FG000|Overall Study|No long-term (3-5 year) consent|6|||
46713056|NCT00875563|82929335|FG000|Overall Study|Still be eligible for follow-up|7|||
46713057|NCT01155869|82929341|FG000|Overall Study|Lost to Follow-up|3|||
46713058|NCT01155869|82929342|FG001|Overall Study|Lost to Follow-up|1|||
46713059|NCT01185353|82929353|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
46713060|NCT01185353|82929354|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
46713061|NCT01185353|82929355|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
46713062|NCT01185353|82929356|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
46713063|NCT01185353|82929357|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
46713064|NCT01185353|82929358|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
46713065|NCT01185353|82929359|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
46713066|NCT01185353|82929360|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
46713067|NCT01185353|82929361|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
46713068|NCT01185353|82929362|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
46713069|NCT01185353|82929353|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
46713070|NCT01185353|82929354|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
46713071|NCT01185353|82929355|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
47037959|NCT01527357|83289728|FG000|Overall Study|Non-compliance|0|||
47037960|NCT01527357|83289729|FG001|Overall Study|Non-compliance|1|||
47037961|NCT01527357|83289728|FG000|Overall Study|No Day 29 Visit|0|||
47037962|NCT01527357|83289729|FG001|Overall Study|No Day 29 Visit|1|||
47037963|NCT01527357|83289728|FG000|Overall Study|Did Not Receive Treatment|2|||
47037964|NCT01527357|83289729|FG001|Overall Study|Did Not Receive Treatment|0|||
47037965|NCT01526889|83289748|FG000|Treatment Period|Adverse Event|2|||
47037966|NCT01526889|83289749|FG001|Treatment Period|Adverse Event|0|||
47037967|NCT01526889|83289748|FG000|Treatment Extension Period|Administrative problems|1|||
47037968|NCT01526889|83289749|FG001|Treatment Extension Period|Administrative problems|0|||
47037969|NCT01472835|83289761|FG000|Overall Study|Lost to Follow-up|2|||
47037970|NCT01472835|83289762|FG001|Overall Study|Lost to Follow-up|0|||
46630538|NCT01948830|82803586|FG001|Overall Study|Lost to Follow-up|4|||
46630539|NCT01948830|82803585|FG000|Overall Study|Withdrawal by Subject|14|||
46630540|NCT01948830|82803586|FG001|Overall Study|Withdrawal by Subject|17|||
46630541|NCT01948830|82803585|FG000|Overall Study|Adverse Event|9|||
46630542|NCT01948830|82803586|FG001|Overall Study|Adverse Event|2|||
46630543|NCT01948830|82803585|FG000|Overall Study|Death|3|||
46630544|NCT01948830|82803586|FG001|Overall Study|Death|4|||
46630545|NCT01972464|82803594|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
46630546|NCT01972464|82803595|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
46630547|NCT01972464|82803594|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
46630548|NCT01972464|82803595|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
46713072|NCT01185353|82929356|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
46713073|NCT01185353|82929357|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
46713074|NCT01185353|82929358|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
47037971|NCT01526733|83289775|FG000|Phase 1|Protocol Violation|1|||
47037972|NCT01526733|83289776|FG001|Phase 1|Protocol Violation|0|||
46630549|NCT01972464|82803594|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
46630550|NCT01972464|82803595|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
46713075|NCT01185353|82929359|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
46713076|NCT01185353|82929360|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
46713077|NCT01185353|82929361|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
46713078|NCT01185353|82929362|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
46630551|NCT01972464|82803594|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
46630552|NCT01972464|82803595|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
46630553|NCT01948050|82803604|FG000|Overall Study|Withdrawal by Subject|0|||
47037973|NCT01526733|83289775|FG000|Phase 1|Withdrawal by Subject|1|||
47037974|NCT01526733|83289776|FG001|Phase 1|Withdrawal by Subject|1|||
47037975|NCT01472757|83289821|FG000|Overall Study|Withdrawal by Subject|1|||
47037976|NCT01472757|83289822|FG001|Overall Study|Withdrawal by Subject|2|||
47037977|NCT01472757|83289823|FG002|Overall Study|Withdrawal by Subject|2|||
47037978|NCT01472757|83289824|FG003|Overall Study|Withdrawal by Subject|0|||
47037979|NCT01472757|83289821|FG000|Overall Study|Asthma exacerbation|4|||
47037980|NCT01472757|83289822|FG001|Overall Study|Asthma exacerbation|1|||
47037981|NCT01472757|83289823|FG002|Overall Study|Asthma exacerbation|2|||
47037982|NCT01472757|83289824|FG003|Overall Study|Asthma exacerbation|1|||
47037983|NCT01472757|83289821|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
47037984|NCT01472757|83289822|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
47037985|NCT01472757|83289823|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
47037986|NCT01472757|83289824|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
47037987|NCT01472757|83289821|FG000|Overall Study|Protocol Violation|3|||
47037988|NCT01472757|83289822|FG001|Overall Study|Protocol Violation|2|||
47037989|NCT01472757|83289823|FG002|Overall Study|Protocol Violation|4|||
47037990|NCT01472757|83289824|FG003|Overall Study|Protocol Violation|4|||
47037991|NCT01472757|83289821|FG000|Overall Study|Other reasons|1|||
47037992|NCT01472757|83289822|FG001|Overall Study|Other reasons|0|||
47037993|NCT01472757|83289823|FG002|Overall Study|Other reasons|2|||
47037994|NCT01472757|83289824|FG003|Overall Study|Other reasons|2|||
47037995|NCT01472289|83289843|FG000|Overall Study|Death|2|||
47037996|NCT01525875|83289862|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
46630554|NCT01948050|82803605|FG001|Overall Study|Withdrawal by Subject|1|||
46713079|NCT01185353|82929353|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
46713080|NCT01185353|82929354|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713081|NCT01185353|82929355|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713082|NCT01185353|82929356|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713083|NCT01185353|82929357|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
46713084|NCT01185353|82929358|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713085|NCT01185353|82929359|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713086|NCT01185353|82929360|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713087|NCT01185353|82929361|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713088|NCT01185353|82929362|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
46713089|NCT01185353|82929353|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
46713090|NCT01185353|82929354|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
47037997|NCT01525875|83289863|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
47037998|NCT01525875|83289862|FG000|Open-label Period|Lost to Follow-up|0|||
47037999|NCT01525875|83289863|FG001|Open-label Period|Lost to Follow-up|2|||
46630555|NCT01947894|82803614|FG000|Overall Study|Other|3|||
46630556|NCT01947894|82803615|FG001|Overall Study|Other|4|||
46630557|NCT01947894|82803616|FG002|Overall Study|Other|3|||
46630558|NCT01947894|82803614|FG000|Overall Study|Withdrawal by Subject|12|||
46630559|NCT01947894|82803615|FG001|Overall Study|Withdrawal by Subject|4|||
46713091|NCT01185353|82929355|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
46713092|NCT01185353|82929356|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
47038000|NCT01525641|83289869|FG000|Overall Study|Case report form not collected|25|||
46630560|NCT01947894|82803616|FG002|Overall Study|Withdrawal by Subject|1|||
46713093|NCT01185353|82929357|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
46713094|NCT01185353|82929358|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
46713095|NCT01185353|82929359|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
46713096|NCT01185353|82929360|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
46713097|NCT01185353|82929361|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
46713098|NCT01185353|82929362|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
46713099|NCT01185353|82929353|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713100|NCT01185353|82929354|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713101|NCT01185353|82929355|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713102|NCT01185353|82929356|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713103|NCT01185353|82929357|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
46713104|NCT01185353|82929358|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713105|NCT01185353|82929359|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713106|NCT01185353|82929360|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713107|NCT01185353|82929361|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713108|NCT01185353|82929362|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
46713109|NCT01185353|82929353|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
46713110|NCT01185353|82929354|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713111|NCT01185353|82929355|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713112|NCT01185353|82929356|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713113|NCT01185353|82929357|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
46713114|NCT01185353|82929358|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713115|NCT01185353|82929359|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713116|NCT01185353|82929360|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713117|NCT01185353|82929361|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713118|NCT01185353|82929362|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
46713119|NCT01185353|82929353|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713120|NCT01185353|82929354|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713121|NCT01185353|82929355|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
47038001|NCT01525641|83289869|FG000|Overall Study|No visit since the first visit|16|||
47038002|NCT01525641|83289869|FG000|Overall Study|Adverse Event|73|||
47038003|NCT01525641|83289869|FG000|Overall Study|Lack of Efficacy|24|||
47038004|NCT01525641|83289869|FG000|Overall Study|Improvement|5|||
47038005|NCT01525641|83289869|FG000|Overall Study|Lost to follow-up (relocation)|1|||
47038006|NCT01525641|83289869|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
47038007|NCT01525641|83289869|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
47038008|NCT01525641|83289869|FG000|Overall Study|Other than stated above|7|||
47038009|NCT01496469|83289884|FG000|Overall Study|Adverse Event|1|||
46713122|NCT01185353|82929356|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713123|NCT01185353|82929357|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713124|NCT01185353|82929358|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
46713125|NCT01185353|82929359|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713126|NCT01185353|82929360|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713127|NCT01185353|82929361|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713128|NCT01185353|82929362|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
46713129|NCT01185353|82929353|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713130|NCT01185353|82929354|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
46713131|NCT01185353|82929355|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713132|NCT01185353|82929356|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
46713133|NCT01185353|82929357|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713134|NCT01185353|82929358|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713135|NCT01185353|82929359|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713136|NCT01185353|82929360|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713137|NCT01185353|82929361|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713138|NCT01185353|82929362|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
46713139|NCT01185353|82929353|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
47038010|NCT01496469|83289885|FG001|Overall Study|Adverse Event|0|||
46713140|NCT01185353|82929354|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
47038011|NCT01496469|83289884|FG000|Overall Study|Protocol Violation|2|||
46713141|NCT01185353|82929355|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
46713142|NCT01185353|82929356|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
46713143|NCT01185353|82929357|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
46713144|NCT01185353|82929358|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
46713145|NCT01185353|82929359|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
46713146|NCT01185353|82929360|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
46713147|NCT01185353|82929361|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
46713148|NCT01185353|82929362|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
46713149|NCT01185353|82929353|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
46713150|NCT01185353|82929354|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
46713151|NCT01185353|82929355|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
46713152|NCT01185353|82929356|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
46713153|NCT01185353|82929357|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
46713154|NCT01185353|82929358|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
46713155|NCT01185353|82929359|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
46713156|NCT01185353|82929360|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
46713157|NCT01185353|82929361|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
46713158|NCT01185353|82929362|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
46713159|NCT01185353|82929353|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713160|NCT01185353|82929354|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713161|NCT01185353|82929355|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713162|NCT01185353|82929356|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713163|NCT01185353|82929357|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
47038012|NCT01496469|83289885|FG001|Overall Study|Protocol Violation|0|||
47038013|NCT01496469|83289884|FG000|Overall Study|Lost to Follow-up|1|||
47038014|NCT01496469|83289885|FG001|Overall Study|Lost to Follow-up|1|||
47038015|NCT01496469|83289884|FG000|Overall Study|Withdrawal by Subject|4|||
47038016|NCT01496469|83289885|FG001|Overall Study|Withdrawal by Subject|4|||
47038017|NCT01496469|83289884|FG000|Overall Study|BP exceeds protocol limits|1|||
47038018|NCT01496469|83289885|FG001|Overall Study|BP exceeds protocol limits|2|||
47038019|NCT01496469|83289884|FG000|Overall Study|Other|1|||
47038020|NCT01496469|83289885|FG001|Overall Study|Other|1|||
47038021|NCT01471353|83289900|FG000|Overall Study|remain on study|3|||
47038022|NCT01525407|83289906|FG000|Overall Study|Change in recipient treatment plan|2|||
47038023|NCT01525407|83289907|FG001|Overall Study|Change in recipient treatment plan|2|||
46713164|NCT01185353|82929358|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713165|NCT01185353|82929359|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
46713166|NCT01185353|82929360|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713167|NCT01185353|82929361|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713168|NCT01185353|82929362|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
46713169|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
46713170|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
46713171|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
46713172|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
46713173|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
46713174|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
46713175|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
46713176|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
46713177|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
46713178|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
46713179|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
46713180|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
46713181|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
46713182|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
46713183|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
46713184|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
46713185|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
46713186|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
46713187|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
46713188|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
46713189|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
46713190|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
46713191|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
47038024|NCT01525407|83289906|FG000|Overall Study|Withdrawal by Subject|0|||
47038025|NCT01525407|83289907|FG001|Overall Study|Withdrawal by Subject|1|||
47038026|NCT01525407|83289906|FG000|Overall Study|Transplant was delayed|0|||
46713192|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
46713193|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
46713194|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
46713195|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
46713196|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
46713197|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
46713198|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
46713199|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713200|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713201|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713202|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713203|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713204|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713205|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713206|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713207|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
46713208|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
46713209|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Death|0|||
46713210|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Death|0|||
46713211|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Death|0|||
46713212|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Death|0|||
46713213|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Death|0|||
46713214|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Death|0|||
46713215|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Death|0|||
46713216|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Death|0|||
46713217|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Death|0|||
46713218|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Death|1|||
46713219|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713220|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713221|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713222|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713223|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713224|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713225|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713226|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713227|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
46713228|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
46713229|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713230|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713231|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713232|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713233|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713234|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713235|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713236|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713237|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
46713238|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
46713239|NCT01185353|82929353|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713240|NCT01185353|82929354|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713241|NCT01185353|82929355|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713242|NCT01185353|82929356|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
47038027|NCT01525407|83289907|FG001|Overall Study|Transplant was delayed|1|||
47038028|NCT01525407|83289906|FG000|Overall Study|Delay in Transplant|1|||
47038029|NCT01525407|83289907|FG001|Overall Study|Delay in Transplant|0|||
47038030|NCT01471197|83289915|FG000|Overall Study|Disease Progression|4|||
47038031|NCT01471197|83289916|FG001|Overall Study|Disease Progression|2|||
47038032|NCT01471197|83289915|FG000|Overall Study|Death|1|||
47038033|NCT01471197|83289916|FG001|Overall Study|Death|0|||
46630561|NCT01947894|82803614|FG000|Overall Study|Death|12|||
46630562|NCT01947894|82803615|FG001|Overall Study|Death|1|||
46630563|NCT01947894|82803616|FG002|Overall Study|Death|0|||
46630564|NCT01947894|82803614|FG000|Overall Study|Physician Decision|2|||
46630565|NCT01947894|82803615|FG001|Overall Study|Physician Decision|0|||
46630566|NCT01947894|82803616|FG002|Overall Study|Physician Decision|0|||
46630567|NCT01947894|82803614|FG000|Overall Study|Adverse Event|5|||
46630568|NCT01947894|82803615|FG001|Overall Study|Adverse Event|1|||
46630569|NCT01947894|82803616|FG002|Overall Study|Adverse Event|0|||
46630570|NCT01947894|82803614|FG000|Overall Study|Switched to other growth hormone brand|53|||
46630571|NCT01947894|82803615|FG001|Overall Study|Switched to other growth hormone brand|8|||
46630572|NCT01947894|82803616|FG002|Overall Study|Switched to other growth hormone brand|23|||
46630573|NCT01947582|82803624|FG000|Overall Study|Withdrawal by Subject|1|||
46630574|NCT01924806|82803630|FG000|Overall Study|Physician Decision|2|||
47038034|NCT01471197|83289915|FG000|Overall Study|Study Drug Toxicity|1|||
47038035|NCT01471197|83289916|FG001|Overall Study|Study Drug Toxicity|0|||
46713243|NCT01185353|82929357|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713244|NCT01185353|82929358|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713245|NCT01185353|82929359|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713246|NCT01185353|82929360|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713247|NCT01185353|82929361|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
46713248|NCT01185353|82929362|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
46713249|NCT01185353|82929353|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713250|NCT01185353|82929354|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713251|NCT01185353|82929355|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713252|NCT01185353|82929356|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713253|NCT01185353|82929357|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713254|NCT01185353|82929358|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713255|NCT01185353|82929359|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713256|NCT01185353|82929360|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
46713257|NCT01185353|82929361|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
46713258|NCT01185353|82929362|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
46713259|NCT01185353|82929353|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
46713260|NCT01185353|82929354|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
46713261|NCT01185353|82929355|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
46713262|NCT01185353|82929356|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
46713263|NCT01185353|82929357|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
46713264|NCT01185353|82929358|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
46713265|NCT01185353|82929359|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
46713266|NCT01185353|82929360|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
46713267|NCT01185353|82929361|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
46713268|NCT01185353|82929362|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
46713269|NCT01185353|82929353|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713270|NCT01185353|82929354|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713271|NCT01185353|82929355|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713272|NCT01185353|82929356|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713273|NCT01185353|82929357|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713274|NCT01185353|82929358|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713275|NCT01185353|82929359|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713276|NCT01185353|82929360|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
46713277|NCT01185353|82929361|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
46713278|NCT01185353|82929362|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
46713279|NCT01098240|82929401|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
46713280|NCT01098240|82929402|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
46713281|NCT01098240|82929403|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
46713282|NCT01098240|82929401|FG000|Open-Label Phase|Protocol Violation|4|||
46713283|NCT01098240|82929402|FG001|Open-Label Phase|Protocol Violation|0|||
47038036|NCT01524783|83289950|FG000|Blinded Period|Adverse Event|64|||
47038037|NCT01524783|83289951|FG001|Blinded Period|Adverse Event|7|||
47038038|NCT01524783|83289952|FG002|Blinded Period|Adverse Event|0|||
47038039|NCT01524783|83289950|FG000|Blinded Period|Disease Progression|89|||
47038040|NCT01524783|83289951|FG001|Blinded Period|Disease Progression|75|||
47038041|NCT01524783|83289952|FG002|Blinded Period|Disease Progression|0|||
47038042|NCT01524783|83289950|FG000|Blinded Period|Withdrawal by Subject|19|||
47038043|NCT01524783|83289951|FG001|Blinded Period|Withdrawal by Subject|6|||
47038044|NCT01524783|83289952|FG002|Blinded Period|Withdrawal by Subject|0|||
46713284|NCT01098240|82929403|FG002|Open-Label Phase|Protocol Violation|0|||
46713285|NCT01098240|82929401|FG000|Open-Label Phase|Lost to Follow-up|13|||
46713286|NCT01098240|82929402|FG001|Open-Label Phase|Lost to Follow-up|0|||
46713287|NCT01098240|82929403|FG002|Open-Label Phase|Lost to Follow-up|0|||
46713288|NCT01098240|82929401|FG000|Open-Label Phase|Other|19|||
46713289|NCT01098240|82929402|FG001|Open-Label Phase|Other|0|||
46713290|NCT01098240|82929403|FG002|Open-Label Phase|Other|0|||
46713291|NCT01098240|82929401|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
46713292|NCT01098240|82929402|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
46713293|NCT01098240|82929403|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
46713294|NCT01098240|82929401|FG000|Open-Label Phase|Pregnancy|1|||
46713295|NCT01098240|82929402|FG001|Open-Label Phase|Pregnancy|0|||
46713296|NCT01098240|82929403|FG002|Open-Label Phase|Pregnancy|0|||
47038045|NCT01524783|83289950|FG000|Blinded Period|Protocol deviation|2|||
47038046|NCT01524783|83289951|FG001|Blinded Period|Protocol deviation|1|||
47038047|NCT01524783|83289952|FG002|Blinded Period|Protocol deviation|0|||
46713297|NCT01098240|82929401|FG000|Open-Label Phase|Withdrawal by Subject|9|||
46713298|NCT01098240|82929402|FG001|Open-Label Phase|Withdrawal by Subject|0|||
46713299|NCT01098240|82929403|FG002|Open-Label Phase|Withdrawal by Subject|0|||
46713300|NCT01098240|82929401|FG000|Open-Label Phase|Adverse Event|12|||
46713301|NCT01098240|82929402|FG001|Open-Label Phase|Adverse Event|0|||
46713302|NCT01098240|82929403|FG002|Open-Label Phase|Adverse Event|0|||
46713303|NCT01098240|82929401|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
46713304|NCT01098240|82929402|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
46713305|NCT01098240|82929403|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
46713306|NCT01098240|82929401|FG000|Double-Blind Phase|Protocol Violation|0|||
46713307|NCT01098240|82929402|FG001|Double-Blind Phase|Protocol Violation|2|||
46713308|NCT01098240|82929403|FG002|Double-Blind Phase|Protocol Violation|4|||
46713309|NCT01098240|82929401|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46713310|NCT01098240|82929402|FG001|Double-Blind Phase|Lost to Follow-up|2|||
46713311|NCT01098240|82929403|FG002|Double-Blind Phase|Lost to Follow-up|0|||
46713312|NCT01098240|82929401|FG000|Double-Blind Phase|Other|0|||
46713313|NCT01098240|82929402|FG001|Double-Blind Phase|Other|2|||
46713314|NCT01098240|82929403|FG002|Double-Blind Phase|Other|2|||
46713315|NCT01098240|82929401|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
46713316|NCT01098240|82929402|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
46713317|NCT01098240|82929403|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
46713318|NCT01098240|82929401|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
46713319|NCT01098240|82929402|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
46713320|NCT01098240|82929403|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
46713321|NCT01098240|82929401|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
46713322|NCT01098240|82929402|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
46713323|NCT01098240|82929403|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
46713324|NCT01098240|82929401|FG000|Double-Blind Phase|Adverse Event|0|||
46713325|NCT01098240|82929402|FG001|Double-Blind Phase|Adverse Event|3|||
46713326|NCT01098240|82929403|FG002|Double-Blind Phase|Adverse Event|3|||
46713327|NCT01098162|82929410|FG000|Overall Study|Adverse Event|37|||
46713328|NCT01098162|82929410|FG000|Overall Study|Lack of Efficacy|4|||
46713329|NCT01098162|82929410|FG000|Overall Study|Wish of Patient|7|||
46713330|NCT01098162|82929410|FG000|Overall Study|Lost to Follow-up|9|||
46713331|NCT01098162|82929410|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
46713332|NCT01098162|82929410|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
46713333|NCT01098162|82929410|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
46713334|NCT01098162|82929410|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
46713335|NCT01098162|82929410|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
46713336|NCT01098162|82929410|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
46713337|NCT01098162|82929410|FG000|Overall Study|Other Reason|1|||
46713338|NCT01098162|82929410|FG000|Overall Study|Reason Unknown|26|||
46713339|NCT01097694|82929416|FG000|Overall Study|Adverse Event|5|||
46713340|NCT01097694|82929417|FG001|Overall Study|Adverse Event|0|||
46713341|NCT01097694|82929416|FG000|Overall Study|Lost to Follow-up|0|||
46713342|NCT01097694|82929417|FG001|Overall Study|Lost to Follow-up|3|||
46713343|NCT01097694|82929416|FG000|Overall Study|Withdrawal by Subject|3|||
46713344|NCT01097694|82929417|FG001|Overall Study|Withdrawal by Subject|1|||
46713345|NCT01102140|82929425|FG000|Overall Study|Lost to Follow-up|1|||
46713346|NCT01102140|82929426|FG001|Overall Study|Lost to Follow-up|0|||
46713347|NCT01102140|82929425|FG000|Overall Study|Investigator terminated study|2|||
47038048|NCT01524783|83289950|FG000|Blinded Period|Death|5|||
47038049|NCT01524783|83289951|FG001|Blinded Period|Death|2|||
47038050|NCT01524783|83289952|FG002|Blinded Period|Death|0|||
47038051|NCT01524783|83289950|FG000|Open-label Period|Disease progression|13|||
47038052|NCT01524783|83289951|FG001|Open-label Period|Disease progression|0|||
47038053|NCT01524783|83289952|FG002|Open-label Period|Disease progression|2|||
47038054|NCT01524783|83289950|FG000|Open-label Period|Administrative problems|5|||
47038055|NCT01524783|83289951|FG001|Open-label Period|Administrative problems|0|||
47038056|NCT01524783|83289952|FG002|Open-label Period|Administrative problems|2|||
47038057|NCT01524783|83289950|FG000|Open-label Period|Adverse Event|5|||
47038058|NCT01524783|83289951|FG001|Open-label Period|Adverse Event|0|||
46713348|NCT01102140|82929426|FG001|Overall Study|Investigator terminated study|2|||
47038059|NCT01524783|83289952|FG002|Open-label Period|Adverse Event|1|||
47038060|NCT01524783|83289950|FG000|Open-label Period|Withdrawal by Subject|2|||
46713349|NCT00874549|82929438|FG000|Overall Study|Adverse Event|0|||
46713350|NCT00874549|82929439|FG001|Overall Study|Adverse Event|0|||
46713351|NCT00874549|82929440|FG002|Overall Study|Adverse Event|1|||
47038061|NCT01524783|83289951|FG001|Open-label Period|Withdrawal by Subject|0|||
47038062|NCT01524783|83289952|FG002|Open-label Period|Withdrawal by Subject|1|||
47038063|NCT01524783|83289950|FG000|Open-label Period|Protocol deviation|1|||
47038064|NCT01524783|83289951|FG001|Open-label Period|Protocol deviation|0|||
46713352|NCT00874549|82929441|FG003|Overall Study|Adverse Event|0|||
46713353|NCT00874549|82929438|FG000|Overall Study|Protocol Violation|1|||
46713354|NCT00874549|82929439|FG001|Overall Study|Protocol Violation|0|||
46713355|NCT00874549|82929440|FG002|Overall Study|Protocol Violation|2|||
47038065|NCT01524783|83289952|FG002|Open-label Period|Protocol deviation|0|||
47038066|NCT01494987|83289966|FG000|Overall Study|Adverse Event|6|||
47038067|NCT01494987|83289967|FG001|Overall Study|Adverse Event|5|||
47038068|NCT01494987|83289966|FG000|Overall Study|Hyperglycemia|6|||
47038069|NCT01494987|83289967|FG001|Overall Study|Hyperglycemia|4|||
47038070|NCT01494987|83289966|FG000|Overall Study|Investigator's Discretion|1|||
47038071|NCT01494987|83289967|FG001|Overall Study|Investigator's Discretion|2|||
47038072|NCT01494987|83289966|FG000|Overall Study|Lost to Follow-up|1|||
47038073|NCT01494987|83289967|FG001|Overall Study|Lost to Follow-up|1|||
47038074|NCT01494987|83289966|FG000|Overall Study|Protocol Violation|3|||
47038075|NCT01494987|83289967|FG001|Overall Study|Protocol Violation|3|||
47038076|NCT01494987|83289966|FG000|Overall Study|Subject Non-Compliance|9|||
47038077|NCT01494987|83289967|FG001|Overall Study|Subject Non-Compliance|10|||
47038078|NCT01494987|83289966|FG000|Overall Study|Subject Withdrew Consent|2|||
47038079|NCT01494987|83289967|FG001|Overall Study|Subject Withdrew Consent|3|||
47038080|NCT01524627|83289975|FG000|Overall Study|Physician Decision|0|||
47038081|NCT01524627|83289976|FG001|Overall Study|Physician Decision|1|||
47038082|NCT01524627|83289975|FG000|Overall Study|Lost to Follow-up|1|||
47038083|NCT01524627|83289976|FG001|Overall Study|Lost to Follow-up|1|||
47038084|NCT01469637|83289984|FG000|First Intervention|Unacceptable behavior|0|||
47038085|NCT01469637|83289985|FG001|First Intervention|Unacceptable behavior|1|||
47038086|NCT01469637|83289984|FG000|Second Intervention|Incarcerated|1|||
47038087|NCT01469637|83289985|FG001|Second Intervention|Incarcerated|0|||
47038088|NCT04842747|83290405|FG000|Overall Study|Withdrawal by Subject|6|||
47038089|NCT04842747|83290406|FG001|Overall Study|Withdrawal by Subject|2|||
47038090|NCT04842747|83290405|FG000|Overall Study|Lost to Follow-up|1|||
47038091|NCT04842747|83290406|FG001|Overall Study|Lost to Follow-up|2|||
47038092|NCT04842747|83290405|FG000|Overall Study|Physician Decision|1|||
47038093|NCT04842747|83290406|FG001|Overall Study|Physician Decision|0|||
47038094|NCT04842747|83290405|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
47038095|NCT04842747|83290406|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
47038096|NCT04810481|83290414|FG000|Overall Study|Disqualified data sets|10|||
47038097|NCT04810481|83290415|FG001|Overall Study|Disqualified data sets|28|||
47038098|NCT04755231|83290434|FG000|Overall Study|Lost to Follow-up|5|||
47038099|NCT04755231|83290434|FG000|Overall Study|Withdrawal by Subject|5|||
46713356|NCT00874549|82929441|FG003|Overall Study|Protocol Violation|1|||
46713357|NCT00874549|82929438|FG000|Overall Study|Lost to Follow-up|0|||
46713358|NCT00874549|82929439|FG001|Overall Study|Lost to Follow-up|0|||
46713359|NCT00874549|82929440|FG002|Overall Study|Lost to Follow-up|1|||
46713360|NCT00874549|82929441|FG003|Overall Study|Lost to Follow-up|0|||
46713361|NCT00874549|82929438|FG000|Overall Study|Withdrawal by Subject|0|||
46713362|NCT00874549|82929439|FG001|Overall Study|Withdrawal by Subject|1|||
46713363|NCT00874549|82929440|FG002|Overall Study|Withdrawal by Subject|0|||
46713364|NCT00874549|82929441|FG003|Overall Study|Withdrawal by Subject|1|||
46713365|NCT01155479|82929456|FG000|Part I|Adverse Event|13|||
46713366|NCT01155479|82929457|FG001|Part I|Adverse Event|8|||
46713367|NCT01155479|82929458|FG002|Part I|Adverse Event|18|||
46713368|NCT01155479|82929459|FG003|Part I|Adverse Event|7|||
46713369|NCT01155479|82929460|FG004|Part I|Adverse Event|6|||
46713370|NCT01155479|82929456|FG000|Part I|Administrative|2|||
46713371|NCT01155479|82929457|FG001|Part I|Administrative|2|||
46713372|NCT01155479|82929458|FG002|Part I|Administrative|2|||
46713373|NCT01155479|82929459|FG003|Part I|Administrative|0|||
46713374|NCT01155479|82929460|FG004|Part I|Administrative|0|||
46713375|NCT01155479|82929456|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
46713376|NCT01155479|82929457|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
46713377|NCT01155479|82929458|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
46713378|NCT01155479|82929459|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
46713379|NCT01155479|82929460|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
46713380|NCT01155479|82929456|FG000|Part I|Withdrawal by Subject|11|||
46713381|NCT01155479|82929457|FG001|Part I|Withdrawal by Subject|13|||
47038100|NCT04664400|83290447|FG000|Overall Study|Withdrawal by Subject|2|||
46713382|NCT01155479|82929458|FG002|Part I|Withdrawal by Subject|8|||
46713383|NCT01155479|82929459|FG003|Part I|Withdrawal by Subject|8|||
46713384|NCT01155479|82929460|FG004|Part I|Withdrawal by Subject|9|||
46713385|NCT01155479|82929456|FG000|Part I|Lost to Follow-up|0|||
46713386|NCT01155479|82929457|FG001|Part I|Lost to Follow-up|0|||
46713387|NCT01155479|82929458|FG002|Part I|Lost to Follow-up|1|||
47038101|NCT04657770|83290452|FG000|Overall Study|Withdrawal by Subject|3|||
47038102|NCT04657770|83290452|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
47038103|NCT04496453|83290456|FG000|Overall Study|Lost to Follow-up|6|||
47038104|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
47038105|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
47038106|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
46713388|NCT01155479|82929459|FG003|Part I|Lost to Follow-up|1|||
46713389|NCT01155479|82929460|FG004|Part I|Lost to Follow-up|0|||
46713390|NCT01155479|82929456|FG000|Part I|Treatment Failure|3|||
46713391|NCT01155479|82929457|FG001|Part I|Treatment Failure|0|||
46713392|NCT01155479|82929458|FG002|Part I|Treatment Failure|3|||
46713393|NCT01155479|82929459|FG003|Part I|Treatment Failure|1|||
46713394|NCT01155479|82929460|FG004|Part I|Treatment Failure|2|||
46713395|NCT01155479|82929456|FG000|Part I|Did Not Receive Treatment|4|||
46713396|NCT01155479|82929457|FG001|Part I|Did Not Receive Treatment|2|||
46713397|NCT01155479|82929458|FG002|Part I|Did Not Receive Treatment|2|||
46713398|NCT01155479|82929459|FG003|Part I|Did Not Receive Treatment|6|||
46713399|NCT01155479|82929460|FG004|Part I|Did Not Receive Treatment|1|||
46713400|NCT01155479|82929456|FG000|Part I|Non-Compliance with Protocol|2|||
46713401|NCT01155479|82929457|FG001|Part I|Non-Compliance with Protocol|1|||
46713402|NCT01155479|82929458|FG002|Part I|Non-Compliance with Protocol|3|||
46713403|NCT01155479|82929459|FG003|Part I|Non-Compliance with Protocol|3|||
46713404|NCT01155479|82929460|FG004|Part I|Non-Compliance with Protocol|2|||
46713405|NCT01155479|82929456|FG000|Part II|Adverse Event|7|||
46713406|NCT01155479|82929457|FG001|Part II|Adverse Event|6|||
46713407|NCT01155479|82929458|FG002|Part II|Adverse Event|8|||
46713408|NCT01155479|82929459|FG003|Part II|Adverse Event|3|||
46713409|NCT01155479|82929460|FG004|Part II|Adverse Event|4|||
46713410|NCT01155479|82929456|FG000|Part II|Administrative|43|||
46713411|NCT01155479|82929457|FG001|Part II|Administrative|49|||
46713412|NCT01155479|82929458|FG002|Part II|Administrative|36|||
46713413|NCT01155479|82929459|FG003|Part II|Administrative|38|||
46713414|NCT01155479|82929460|FG004|Part II|Administrative|46|||
46713415|NCT01155479|82929456|FG000|Part II|Withdrawal by Subject|8|||
46713416|NCT01155479|82929457|FG001|Part II|Withdrawal by Subject|4|||
46713417|NCT01155479|82929458|FG002|Part II|Withdrawal by Subject|12|||
46713418|NCT01155479|82929459|FG003|Part II|Withdrawal by Subject|7|||
47038107|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
47038108|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
47038109|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
46713419|NCT01155479|82929460|FG004|Part II|Withdrawal by Subject|3|||
46713420|NCT01155479|82929456|FG000|Part II|Lost to Follow-up|1|||
46713421|NCT01155479|82929457|FG001|Part II|Lost to Follow-up|0|||
46713422|NCT01155479|82929458|FG002|Part II|Lost to Follow-up|0|||
46713423|NCT01155479|82929459|FG003|Part II|Lost to Follow-up|0|||
46713424|NCT01155479|82929460|FG004|Part II|Lost to Follow-up|1|||
46713425|NCT01155479|82929456|FG000|Part II|Treatment Failure|0|||
46713426|NCT01155479|82929457|FG001|Part II|Treatment Failure|1|||
46713427|NCT01155479|82929458|FG002|Part II|Treatment Failure|2|||
46713428|NCT01155479|82929459|FG003|Part II|Treatment Failure|0|||
46713429|NCT01155479|82929460|FG004|Part II|Treatment Failure|1|||
46713430|NCT01155479|82929456|FG000|Part II|Non-Compliance with Protocol|0|||
46713431|NCT01155479|82929457|FG001|Part II|Non-Compliance with Protocol|1|||
46713432|NCT01155479|82929458|FG002|Part II|Non-Compliance with Protocol|0|||
46713433|NCT01155479|82929459|FG003|Part II|Non-Compliance with Protocol|2|||
46713434|NCT01155479|82929460|FG004|Part II|Non-Compliance with Protocol|0|||
46713435|NCT01155323|82929488|FG000|First Intervention|exclusion criteria|1|||
46713436|NCT01155323|82929489|FG001|First Intervention|exclusion criteria|1|||
46713437|NCT01155323|82929488|FG000|Second Intervention|Lost to Follow-up|1|||
46713438|NCT01155323|82929489|FG001|Second Intervention|Lost to Follow-up|1|||
46713439|NCT01155167|82929497|FG000|Overall Study|Insufficient ultrasound data|2|||
46713440|NCT01155167|82929498|FG001|Overall Study|Insufficient ultrasound data|0|||
46713441|NCT01155167|82929497|FG000|Overall Study|Access site changed to femoral artery|1|||
46713442|NCT01155167|82929498|FG001|Overall Study|Access site changed to femoral artery|0|||
46713443|NCT01106586|82929506|FG000|Overall Study|Adverse Event|9|||
46713444|NCT01106586|82929507|FG001|Overall Study|Adverse Event|15|||
46713445|NCT01106586|82929506|FG000|Overall Study|Death|1|||
46713446|NCT01106586|82929507|FG001|Overall Study|Death|3|||
46713447|NCT01106586|82929506|FG000|Overall Study|Pregnancy|2|||
46713448|NCT01106586|82929507|FG001|Overall Study|Pregnancy|2|||
46713449|NCT01106586|82929506|FG000|Overall Study|Lack of Efficacy|1|||
46713450|NCT01106586|82929507|FG001|Overall Study|Lack of Efficacy|0|||
46713451|NCT01106586|82929506|FG000|Overall Study|Investigator's Discretion|5|||
46713452|NCT01106586|82929507|FG001|Overall Study|Investigator's Discretion|8|||
46713453|NCT01106586|82929506|FG000|Overall Study|Withdrew Consent|18|||
46713454|NCT01106586|82929507|FG001|Overall Study|Withdrew Consent|30|||
46713455|NCT01106586|82929506|FG000|Overall Study|Lost to Follow-up|24|||
46713456|NCT01106586|82929507|FG001|Overall Study|Lost to Follow-up|20|||
46713457|NCT01106586|82929506|FG000|Overall Study|Participant Noncompliance|12|||
46713458|NCT01106586|82929507|FG001|Overall Study|Participant Noncompliance|10|||
46713459|NCT01106586|82929506|FG000|Overall Study|Protocol Violation|1|||
46713460|NCT01106586|82929507|FG001|Overall Study|Protocol Violation|0|||
46713461|NCT01106586|82929506|FG000|Overall Study|Participant Transferred to Another Study|212|||
46713462|NCT01106586|82929507|FG001|Overall Study|Participant Transferred to Another Study|197|||
46713463|NCT01155011|82929515|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
46713464|NCT01155011|82929516|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
46713465|NCT01155011|82929515|FG000|Baseline to 6 Months|investigator decision, moved|4|||
46713466|NCT01155011|82929516|FG001|Baseline to 6 Months|investigator decision, moved|5|||
46713467|NCT01155011|82929515|FG000|Baseline to 6 Months|Death|0|||
47038110|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
47038111|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
47038112|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
47038113|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
47038114|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
47038115|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
47038116|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
47038117|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
47038118|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
46713468|NCT01155011|82929516|FG001|Baseline to 6 Months|Death|1|||
46713469|NCT01155011|82929515|FG000|6 to 12 Months|Withdrawal by Subject|8|||
46713470|NCT01155011|82929516|FG001|6 to 12 Months|Withdrawal by Subject|5|||
46713471|NCT01155011|82929515|FG000|6 to 12 Months|Death|1|||
46713472|NCT01155011|82929516|FG001|6 to 12 Months|Death|5|||
46713473|NCT01106430|82929528|FG000|Overall Study|Adverse Event|8|||
46713474|NCT01106430|82929529|FG001|Overall Study|Adverse Event|10|||
47038119|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
47038120|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
47038121|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
46713475|NCT01106430|82929528|FG000|Overall Study|Lack of Efficacy|2|||
46713476|NCT01106430|82929529|FG001|Overall Study|Lack of Efficacy|13|||
46713477|NCT01106430|82929528|FG000|Overall Study|Lost to Follow-up|5|||
46713478|NCT01106430|82929529|FG001|Overall Study|Lost to Follow-up|1|||
46713479|NCT01106430|82929528|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
46713480|NCT01106430|82929529|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
46713481|NCT01106430|82929528|FG000|Overall Study|Moved Out Of State|0|||
46713482|NCT01106430|82929529|FG001|Overall Study|Moved Out Of State|1|||
46713483|NCT01106430|82929528|FG000|Overall Study|Refused To Take Medication|0|||
46713484|NCT01106430|82929529|FG001|Overall Study|Refused To Take Medication|1|||
46713485|NCT01106430|82929528|FG000|Overall Study|Noncompliance|0|||
46713486|NCT01106430|82929529|FG001|Overall Study|Noncompliance|1|||
46713487|NCT01106430|82929528|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
46713488|NCT01106430|82929529|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
46713489|NCT01106430|82929528|FG000|Overall Study|Previous Use Of Marijuana|1|||
46713490|NCT01106430|82929529|FG001|Overall Study|Previous Use Of Marijuana|0|||
46713491|NCT01106430|82929528|FG000|Overall Study|Protocol Violation|7|||
47038122|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
47038123|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
47038124|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
47038125|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
47038126|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
47038127|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
47038128|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
47038129|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
46713492|NCT01106430|82929529|FG001|Overall Study|Protocol Violation|2|||
46713493|NCT01106430|82929528|FG000|Overall Study|Withdrawal by Subject|8|||
46713494|NCT01106430|82929529|FG001|Overall Study|Withdrawal by Subject|4|||
46713495|NCT01154231|82929535|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
46713496|NCT01154231|82929535|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
46713497|NCT01154153|82929541|FG000|Overall Study|Poor compliance to protocol|2|||
46713498|NCT01154153|82929542|FG001|Overall Study|Poor compliance to protocol|0|||
46713499|NCT01154153|82929541|FG000|Overall Study|Unable to use labs|2|||
46713500|NCT01154153|82929542|FG001|Overall Study|Unable to use labs|3|||
46713501|NCT01154153|82929541|FG000|Overall Study|Withdrew consent|1|||
46713502|NCT01154153|82929542|FG001|Overall Study|Withdrew consent|0|||
46713503|NCT00874237|82929548|FG000|Overall Study|Physician Decision|0|||
46713504|NCT00874237|82929549|FG001|Overall Study|Physician Decision|1|||
46713505|NCT00874237|82929550|FG002|Overall Study|Physician Decision|0|||
46713506|NCT00874237|82929551|FG003|Overall Study|Physician Decision|0|||
46713507|NCT00874237|82929552|FG004|Overall Study|Physician Decision|0|||
46713508|NCT00874237|82929553|FG005|Overall Study|Physician Decision|0|||
46713509|NCT00874237|82929548|FG000|Overall Study|Withdrawal by Subject|0|||
46713510|NCT00874237|82929549|FG001|Overall Study|Withdrawal by Subject|0|||
46713511|NCT00874237|82929550|FG002|Overall Study|Withdrawal by Subject|1|||
46713512|NCT00874237|82929551|FG003|Overall Study|Withdrawal by Subject|0|||
46713513|NCT00874237|82929552|FG004|Overall Study|Withdrawal by Subject|0|||
46713514|NCT00874237|82929553|FG005|Overall Study|Withdrawal by Subject|0|||
46713515|NCT01153841|82929565|FG000|Overall Study|Adverse Event|1|||
46713516|NCT01153841|82929566|FG001|Overall Study|Adverse Event|0|||
46713517|NCT01153841|82929565|FG000|Overall Study|Withdrawal by Subject|1|||
46713518|NCT01153841|82929566|FG001|Overall Study|Withdrawal by Subject|0|||
46713519|NCT01153841|82929565|FG000|Overall Study|Protocol Violation|2|||
46713520|NCT01153841|82929566|FG001|Overall Study|Protocol Violation|0|||
46713521|NCT01153841|82929565|FG000|Overall Study|Lost to Follow-up|2|||
46713522|NCT01153841|82929566|FG001|Overall Study|Lost to Follow-up|0|||
46713523|NCT01153763|82929572|FG000|Overall Study|Study Closed|16|||
46713524|NCT01153763|82929572|FG000|Overall Study|Lost to Follow-up|1|||
46713525|NCT01153763|82929572|FG000|Overall Study|Physician Decision|2|||
46713526|NCT01153763|82929572|FG000|Overall Study|Withdrawal by Subject|2|||
46713527|NCT00871741|82929578|FG000|Overall Study|Premature study termination|9|||
46713528|NCT00871741|82929579|FG001|Overall Study|Premature study termination|7|||
46713529|NCT01152437|82929588|FG000|Overall Study|Other Adverse Event|8|||
46713530|NCT01152437|82929589|FG001|Overall Study|Other Adverse Event|1|||
47038130|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
47038131|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
47038132|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
47038133|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
46630575|NCT01924806|82803631|FG001|Overall Study|Physician Decision|1|||
46630576|NCT01924182|82803639|FG000|Overall Study|Withdrawal by Subject|1|||
46630577|NCT01924182|82803640|FG001|Overall Study|Withdrawal by Subject|0|||
46630578|NCT01972308|82803648|FG000|Overall Study|Withdrawal by Subject|0|||
46630579|NCT01972308|82803649|FG001|Overall Study|Withdrawal by Subject|1|||
46630580|NCT01972308|82803648|FG000|Overall Study|Lost to Follow-up|4|||
46630581|NCT01972308|82803649|FG001|Overall Study|Lost to Follow-up|6|||
46630582|NCT01972308|82803648|FG000|Overall Study|Death|4|||
46630583|NCT01972308|82803649|FG001|Overall Study|Death|1|||
46630584|NCT01946880|82803659|FG000|Overall Study|Lost to Follow-up|1|||
46630585|NCT01946880|82803660|FG001|Overall Study|Lost to Follow-up|0|||
46630586|NCT01946880|82803659|FG000|Overall Study|Physician Decision|1|||
46630587|NCT01946880|82803660|FG001|Overall Study|Physician Decision|1|||
46630588|NCT01946880|82803659|FG000|Overall Study|Withdrawal by Subject|3|||
46630589|NCT01946880|82803660|FG001|Overall Study|Withdrawal by Subject|2|||
46630590|NCT01946880|82803659|FG000|Overall Study|Met Primary Endpoint|1|||
46630591|NCT01946880|82803660|FG001|Overall Study|Met Primary Endpoint|0|||
46630592|NCT01946880|82803659|FG000|Overall Study|Personal and Family Issues|1|||
46630593|NCT01946880|82803660|FG001|Overall Study|Personal and Family Issues|0|||
46630594|NCT01972152|82803666|FG000|First Treatment Visit|Lost to Follow-up|0|||
46630595|NCT01972152|82803667|FG001|First Treatment Visit|Lost to Follow-up|1|||
46630596|NCT01972152|82803668|FG002|First Treatment Visit|Lost to Follow-up|0|||
46630597|NCT01972152|82803669|FG003|First Treatment Visit|Lost to Follow-up|0|||
46630598|NCT01972152|82803670|FG004|First Treatment Visit|Lost to Follow-up|0|||
46713531|NCT01152437|82929590|FG002|Overall Study|Other Adverse Event|7|||
46713532|NCT01152437|82929588|FG000|Overall Study|Not treated|0|||
46713533|NCT01152437|82929589|FG001|Overall Study|Not treated|1|||
46713534|NCT01152437|82929590|FG002|Overall Study|Not treated|2|||
46630599|NCT01972152|82803671|FG005|First Treatment Visit|Lost to Follow-up|0|||
46630600|NCT01972152|82803666|FG000|Second Treatment Visit|Protocol Violation|0|||
46630601|NCT01972152|82803667|FG001|Second Treatment Visit|Protocol Violation|1|||
46713535|NCT01152437|82929588|FG000|Overall Study|Progressive disease|27|||
46713536|NCT01152437|82929589|FG001|Overall Study|Progressive disease|13|||
46713537|NCT01152437|82929590|FG002|Overall Study|Progressive disease|32|||
46713538|NCT01152437|82929588|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
46713539|NCT01152437|82929589|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
46713540|NCT01152437|82929590|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
46713541|NCT01151579|82929602|FG000|Overall Study|Physician Decision|3|||
46713542|NCT01151579|82929603|FG001|Overall Study|Physician Decision|1|||
46713543|NCT01151579|82929602|FG000|Overall Study|Withdrawal by Subject|3|||
46713544|NCT01151579|82929603|FG001|Overall Study|Withdrawal by Subject|2|||
46713545|NCT01151579|82929602|FG000|Overall Study|Not meet inclusion criteria|6|||
46713546|NCT01151579|82929603|FG001|Overall Study|Not meet inclusion criteria|4|||
46713547|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
46713548|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
46713549|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
46713550|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46713551|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46713552|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46713553|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46713554|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46713555|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
46713556|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
46713557|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
46713558|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46713559|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46713560|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46713561|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46713562|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46713563|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
46713564|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
46713565|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
46713566|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46713567|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46713568|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46713569|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46713570|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46713571|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
46713572|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
46713573|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46713574|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46713575|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46713576|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46713577|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46713578|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46713579|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
46713580|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
46713581|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
46713582|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46713583|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46713584|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46713585|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46713586|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46713587|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
46713588|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
46713589|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
46713590|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
46713591|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
46713592|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
46713593|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
46713594|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
46713595|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
46713596|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
46713597|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46713598|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46713599|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46713600|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46713601|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46713602|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46713603|NCT01097616|82929612|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46713604|NCT01097616|82929613|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46713605|NCT01097616|82929614|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
46713606|NCT01097616|82929615|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46713607|NCT01097616|82929616|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46713608|NCT01097616|82929617|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46713609|NCT01097616|82929618|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46713610|NCT01097616|82929619|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46713611|NCT01097616|82929612|FG000|Optional DB EXT Phase|Adverse Event|0|||
46713612|NCT01097616|82929613|FG001|Optional DB EXT Phase|Adverse Event|7|||
46713613|NCT01097616|82929614|FG002|Optional DB EXT Phase|Adverse Event|2|||
46713614|NCT01097616|82929615|FG003|Optional DB EXT Phase|Adverse Event|0|||
46713615|NCT01097616|82929616|FG004|Optional DB EXT Phase|Adverse Event|0|||
46713616|NCT01097616|82929617|FG005|Optional DB EXT Phase|Adverse Event|0|||
46713617|NCT01097616|82929618|FG006|Optional DB EXT Phase|Adverse Event|0|||
46713618|NCT01097616|82929619|FG007|Optional DB EXT Phase|Adverse Event|0|||
46713619|NCT01097616|82929612|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
46713620|NCT01097616|82929613|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
46713621|NCT01097616|82929614|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
46713622|NCT01097616|82929615|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
46713623|NCT01097616|82929616|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
46713624|NCT01097616|82929617|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
46713625|NCT01097616|82929618|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
46713626|NCT01097616|82929619|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
46713627|NCT01097616|82929612|FG000|Optional DB EXT Phase|Protocol Violation|0|||
46713628|NCT01097616|82929613|FG001|Optional DB EXT Phase|Protocol Violation|2|||
46713629|NCT01097616|82929614|FG002|Optional DB EXT Phase|Protocol Violation|3|||
46713630|NCT01097616|82929615|FG003|Optional DB EXT Phase|Protocol Violation|0|||
46713631|NCT01097616|82929616|FG004|Optional DB EXT Phase|Protocol Violation|0|||
46713632|NCT01097616|82929617|FG005|Optional DB EXT Phase|Protocol Violation|0|||
46713633|NCT01097616|82929618|FG006|Optional DB EXT Phase|Protocol Violation|0|||
46713634|NCT01097616|82929619|FG007|Optional DB EXT Phase|Protocol Violation|0|||
46713635|NCT01097616|82929612|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
46713636|NCT01097616|82929613|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
46713637|NCT01097616|82929614|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
46713638|NCT01097616|82929615|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
46713639|NCT01097616|82929616|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
46713640|NCT01097616|82929617|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
46713641|NCT01097616|82929618|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
46713642|NCT01097616|82929619|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
46713643|NCT01097616|82929612|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
46713644|NCT01097616|82929613|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
46713645|NCT01097616|82929614|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
46713646|NCT01097616|82929615|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
46713647|NCT01097616|82929616|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
46713648|NCT01097616|82929617|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
46713649|NCT01097616|82929618|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
46713650|NCT01097616|82929619|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
46713651|NCT01097616|82929612|FG000|Optional DB EXT Phase|Physician Decision|1|||
46713652|NCT01097616|82929613|FG001|Optional DB EXT Phase|Physician Decision|0|||
46713653|NCT01097616|82929614|FG002|Optional DB EXT Phase|Physician Decision|0|||
46713654|NCT01097616|82929615|FG003|Optional DB EXT Phase|Physician Decision|0|||
46713655|NCT01097616|82929616|FG004|Optional DB EXT Phase|Physician Decision|0|||
46713656|NCT01097616|82929617|FG005|Optional DB EXT Phase|Physician Decision|0|||
46713657|NCT01097616|82929618|FG006|Optional DB EXT Phase|Physician Decision|0|||
47038134|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
47038135|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
47038136|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
47038137|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
47038138|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
47038139|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
47038140|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
47038141|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
47038142|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
47038143|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
47038144|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
47038145|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
47038146|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
46713658|NCT01097616|82929619|FG007|Optional DB EXT Phase|Physician Decision|0|||
46713659|NCT01097616|82929612|FG000|DB RO Phase|Adverse Event|0|||
46713660|NCT01097616|82929613|FG001|DB RO Phase|Adverse Event|0|||
46713661|NCT01097616|82929614|FG002|DB RO Phase|Adverse Event|0|||
46713662|NCT01097616|82929615|FG003|DB RO Phase|Adverse Event|0|||
46713663|NCT01097616|82929616|FG004|DB RO Phase|Adverse Event|0|||
46713664|NCT01097616|82929617|FG005|DB RO Phase|Adverse Event|0|||
46713665|NCT01097616|82929618|FG006|DB RO Phase|Adverse Event|1|||
46713666|NCT01097616|82929619|FG007|DB RO Phase|Adverse Event|0|||
46713667|NCT01097616|82929612|FG000|DB RO Phase|Withdrawal by Subject|0|||
46713668|NCT01097616|82929613|FG001|DB RO Phase|Withdrawal by Subject|0|||
46713669|NCT01097616|82929614|FG002|DB RO Phase|Withdrawal by Subject|0|||
46713670|NCT01097616|82929615|FG003|DB RO Phase|Withdrawal by Subject|0|||
46713671|NCT01097616|82929616|FG004|DB RO Phase|Withdrawal by Subject|0|||
46713672|NCT01097616|82929617|FG005|DB RO Phase|Withdrawal by Subject|1|||
46713673|NCT01097616|82929618|FG006|DB RO Phase|Withdrawal by Subject|0|||
46713674|NCT01097616|82929619|FG007|DB RO Phase|Withdrawal by Subject|0|||
46713675|NCT01097616|82929612|FG000|DB RO Phase|Lost to Follow-up|0|||
46713676|NCT01097616|82929613|FG001|DB RO Phase|Lost to Follow-up|0|||
46713677|NCT01097616|82929614|FG002|DB RO Phase|Lost to Follow-up|0|||
46713678|NCT01097616|82929615|FG003|DB RO Phase|Lost to Follow-up|1|||
46713679|NCT01097616|82929616|FG004|DB RO Phase|Lost to Follow-up|1|||
46713680|NCT01097616|82929617|FG005|DB RO Phase|Lost to Follow-up|0|||
46713681|NCT01097616|82929618|FG006|DB RO Phase|Lost to Follow-up|0|||
46713682|NCT01097616|82929619|FG007|DB RO Phase|Lost to Follow-up|1|||
46713683|NCT01097616|82929612|FG000|DB RO Phase|Not Treated in RO|0|||
46713684|NCT01097616|82929613|FG001|DB RO Phase|Not Treated in RO|0|||
46713685|NCT01097616|82929614|FG002|DB RO Phase|Not Treated in RO|0|||
46713686|NCT01097616|82929615|FG003|DB RO Phase|Not Treated in RO|0|||
46713687|NCT01097616|82929616|FG004|DB RO Phase|Not Treated in RO|0|||
46713688|NCT01097616|82929617|FG005|DB RO Phase|Not Treated in RO|1|||
46713689|NCT01097616|82929618|FG006|DB RO Phase|Not Treated in RO|0|||
46713690|NCT01097616|82929619|FG007|DB RO Phase|Not Treated in RO|0|||
46713691|NCT00871429|82929645|FG000|Overall Study|Lost to Follow-up|6|||
46713692|NCT00871429|82929645|FG000|Overall Study|Withdrawal by Subject|17|||
46713693|NCT00871429|82929645|FG000|Overall Study|Questionnaire not completed|1|||
46713694|NCT01151345|82929653|FG000|First Intervention Period|Protocol Violation|0|||
46713695|NCT01151345|82929654|FG001|First Intervention Period|Protocol Violation|1|||
46713696|NCT00593827|82929662|FG000|Overall Study|On Active Treatment/Pending|0|||
46713697|NCT00593827|82929663|FG001|Overall Study|On Active Treatment/Pending|2|||
46713698|NCT01150097|82929672|FG000|Months 24 to 36 Post-transplantation|Death|2|||
46713699|NCT01150097|82929673|FG001|Months 24 to 36 Post-transplantation|Death|0|||
46713700|NCT01150097|82929674|FG002|Months 24 to 36 Post-transplantation|Death|0|||
46713701|NCT01150097|82929672|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
46713702|NCT01150097|82929673|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
46713703|NCT01150097|82929674|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
46713704|NCT01150097|82929672|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
46713705|NCT01150097|82929673|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
46713706|NCT01150097|82929674|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
46913935|NCT02736227|83144439|FG002|Overall Study|Withdrawal by Subject|1|||
46913936|NCT02736227|83144437|FG000|Overall Study|Physician Decision|0|||
46913937|NCT02736227|83144438|FG001|Overall Study|Physician Decision|0|||
46913938|NCT02736227|83144439|FG002|Overall Study|Physician Decision|5|||
47038147|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
47038148|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
47038149|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
47038150|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
47038151|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
47038152|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
47038153|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
47038154|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
47038155|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
47038156|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
47038157|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
47038158|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
47038159|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
47038160|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
47038161|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
47038162|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
47038163|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
47038164|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
47038165|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
46713707|NCT01150097|82929672|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
46713708|NCT01150097|82929673|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
46913939|NCT02736227|83144437|FG000|Overall Study|Non Compliant|0|||
46713709|NCT01150097|82929674|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
46713710|NCT01150097|82929672|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
46913940|NCT02736227|83144438|FG001|Overall Study|Non Compliant|0|||
46713711|NCT01150097|82929673|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
46713712|NCT01150097|82929674|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
46713713|NCT01150097|82929672|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
46713714|NCT01150097|82929673|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
46713715|NCT01150097|82929674|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
46713716|NCT01150097|82929672|FG000|Months 24 to 48 Post-transplantation|Death|2|||
46713717|NCT01150097|82929673|FG001|Months 24 to 48 Post-transplantation|Death|0|||
46713718|NCT01150097|82929674|FG002|Months 24 to 48 Post-transplantation|Death|0|||
46713719|NCT01149863|82929684|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
46713720|NCT01149473|82929690|FG000|First Intervention|Adverse Event|1|||
46713721|NCT01149473|82929691|FG001|First Intervention|Adverse Event|1|||
46713722|NCT01149473|82929690|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
46713723|NCT01149473|82929691|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
46713724|NCT00872989|82929699|FG000|Overall Study|Adverse Event|7|||
46713725|NCT00872989|82929700|FG001|Overall Study|Adverse Event|15|||
46713726|NCT00872989|82929699|FG000|Overall Study|Withdrawal by Subject|8|||
46713727|NCT00872989|82929700|FG001|Overall Study|Withdrawal by Subject|5|||
46713728|NCT00872989|82929699|FG000|Overall Study|Progression/relapse|47|||
46713729|NCT00872989|82929700|FG001|Overall Study|Progression/relapse|35|||
46713730|NCT00872989|82929699|FG000|Overall Study|Not protocol specified|3|||
46713731|NCT00872989|82929700|FG001|Overall Study|Not protocol specified|8|||
46713732|NCT01148771|82929714|FG000|Washout Period|Withdrawal by Subject|0|||
46713733|NCT01148771|82929715|FG001|Washout Period|Withdrawal by Subject|1|||
46713734|NCT01148693|82929727|FG000|Overall Study|Attempts for cannulation were failed|13|||
46713735|NCT01148693|82929728|FG001|Overall Study|Attempts for cannulation were failed|10|||
46713736|NCT00872599|82929734|FG000|Second Washout Period|Adverse Event|1|||
46713737|NCT00872599|82929735|FG001|Second Washout Period|Adverse Event|1|||
46713738|NCT01148537|82929744|FG000|Overall Study|Withdrawal by Subject|1|||
46713739|NCT01148537|82929745|FG001|Overall Study|Withdrawal by Subject|0|||
46713740|NCT01148537|82929746|FG002|Overall Study|Withdrawal by Subject|2|||
46713741|NCT01148537|82929744|FG000|Overall Study|Adverse Event|2|||
46713742|NCT01148537|82929745|FG001|Overall Study|Adverse Event|0|||
46713743|NCT01148537|82929746|FG002|Overall Study|Adverse Event|1|||
46713744|NCT01148459|82929757|FG000|Overall Study|Serious Adverse Event|5|||
46713745|NCT01148459|82929758|FG001|Overall Study|Serious Adverse Event|4|||
46713746|NCT01148459|82929757|FG000|Overall Study|Withdrawal by Subject|1|||
46713747|NCT01148459|82929758|FG001|Overall Study|Withdrawal by Subject|0|||
46713748|NCT01148459|82929757|FG000|Overall Study|Migrated/moved from study area|3|||
46713749|NCT01148459|82929758|FG001|Overall Study|Migrated/moved from study area|6|||
46713750|NCT01148459|82929757|FG000|Overall Study|Lost to Follow-up|2|||
46713751|NCT01148459|82929758|FG001|Overall Study|Lost to Follow-up|0|||
46713752|NCT01148459|82929757|FG000|Overall Study|Refusal|1|||
46713753|NCT01148459|82929758|FG001|Overall Study|Refusal|0|||
46713754|NCT01148459|82929757|FG000|Overall Study|Failure to comply with study procedures|0|||
46713755|NCT01148459|82929758|FG001|Overall Study|Failure to comply with study procedures|1|||
46713756|NCT00872521|82929767|FG000|Completed PAD Induction|Patient choice|0|||
46713757|NCT00872521|82929768|FG001|Completed PAD Induction|Patient choice|1|||
46713758|NCT00872521|82929769|FG002|Completed PAD Induction|Patient choice|0|||
46713759|NCT00872521|82929767|FG000|Completed PAD Induction|Disease progression|0|||
46713760|NCT00872521|82929768|FG001|Completed PAD Induction|Disease progression|2|||
46713761|NCT00872521|82929769|FG002|Completed PAD Induction|Disease progression|0|||
46713762|NCT00872521|82929767|FG000|Completed PAD Induction|Adverse Event|4|||
46713763|NCT00872521|82929768|FG001|Completed PAD Induction|Adverse Event|0|||
46713764|NCT00872521|82929769|FG002|Completed PAD Induction|Adverse Event|0|||
46713765|NCT00872521|82929767|FG000|Completed PAD Induction|Death|1|||
46713766|NCT00872521|82929768|FG001|Completed PAD Induction|Death|1|||
46713767|NCT00872521|82929769|FG002|Completed PAD Induction|Death|0|||
46713768|NCT00872521|82929767|FG000|Primary Endpoint Analysis|Other|1|||
46713769|NCT00872521|82929768|FG001|Primary Endpoint Analysis|Other|2|||
46713770|NCT00872521|82929769|FG002|Primary Endpoint Analysis|Other|0|||
46713771|NCT00872521|82929767|FG000|Primary Endpoint Analysis|Patient choice|0|||
46713772|NCT00872521|82929768|FG001|Primary Endpoint Analysis|Patient choice|1|||
46713773|NCT00872521|82929769|FG002|Primary Endpoint Analysis|Patient choice|0|||
46713774|NCT00872521|82929767|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
46713775|NCT00872521|82929768|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
46713776|NCT00872521|82929769|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
46713777|NCT00872521|82929767|FG000|Primary Endpoint Analysis|Patient response missing|0|||
46713778|NCT00872521|82929768|FG001|Primary Endpoint Analysis|Patient response missing|0|||
46713779|NCT00872521|82929769|FG002|Primary Endpoint Analysis|Patient response missing|1|||
46713780|NCT00872521|82929767|FG000|Completed 3-month Follow up|Other|0|||
46713781|NCT00872521|82929768|FG001|Completed 3-month Follow up|Other|2|||
46713782|NCT00872521|82929769|FG002|Completed 3-month Follow up|Other|0|||
46713783|NCT00872521|82929767|FG000|Completed 3-month Follow up|Physician Decision|0|||
46913941|NCT02736227|83144439|FG002|Overall Study|Non Compliant|2|||
46713784|NCT00872521|82929768|FG001|Completed 3-month Follow up|Physician Decision|1|||
46713785|NCT00872521|82929769|FG002|Completed 3-month Follow up|Physician Decision|0|||
46713786|NCT00872521|82929767|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
46713787|NCT00872521|82929768|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
46713788|NCT00872521|82929769|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
46713789|NCT01148225|82929788|FG000|Overall Study|Other|185|||
46713790|NCT01190891|82929797|FG000|Overall Study|Protocol Violation|1|||
46713791|NCT01190891|82929798|FG001|Overall Study|Protocol Violation|0|||
46713792|NCT01190891|82929797|FG000|Overall Study|Withdrawal by Subject|5|||
46713793|NCT01190891|82929798|FG001|Overall Study|Withdrawal by Subject|0|||
46713794|NCT00871975|82929804|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
46713795|NCT00871975|82929804|FG000|Overall Study|Catheters could not be inserted|1|||
46713796|NCT00871975|82929804|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
46713797|NCT00871975|82929804|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
46713798|NCT01190813|82929810|FG000|Overall Study|Lost to Follow-up|1|||
46713799|NCT01190813|82929811|FG001|Overall Study|Lost to Follow-up|2|||
46713800|NCT01190813|82929810|FG000|Overall Study|Withdrawal by Subject|2|||
46713801|NCT01190813|82929811|FG001|Overall Study|Withdrawal by Subject|1|||
46713802|NCT01190813|82929810|FG000|Overall Study|Refused study treatment after randomized|1|||
46713803|NCT01190813|82929811|FG001|Overall Study|Refused study treatment after randomized|0|||
46713804|NCT01190813|82929810|FG000|Overall Study|Adverse Event|0|||
46713805|NCT01190813|82929811|FG001|Overall Study|Adverse Event|1|||
46713806|NCT00870727|82929833|FG000|Overall Study|Lost to Follow-up|0|||
46713807|NCT00870727|82929834|FG001|Overall Study|Lost to Follow-up|1|||
46713808|NCT00870727|82929833|FG000|Overall Study|Lack of Efficacy|1|||
46713809|NCT00870727|82929834|FG001|Overall Study|Lack of Efficacy|3|||
46713810|NCT00870727|82929833|FG000|Overall Study|Adverse Event|0|||
46713811|NCT00870727|82929834|FG001|Overall Study|Adverse Event|1|||
46713812|NCT01147055|82929840|FG000|First Intervention Period|Lost to Follow-up|1|||
46713813|NCT01147055|82929841|FG001|First Intervention Period|Lost to Follow-up|0|||
46713814|NCT01146665|82929849|FG000|Overall Study|Withdrawal by Subject|10|||
46713815|NCT01146665|82929850|FG001|Overall Study|Withdrawal by Subject|16|||
46713816|NCT01145885|82929865|FG000|Overall Study|Progressive Disease|7|||
46713817|NCT01190267|82929877|FG000|Overall Study|Adverse Event|10|||
46713818|NCT01190267|82929878|FG001|Overall Study|Adverse Event|0|||
46713819|NCT01190267|82929877|FG000|Overall Study|Treatment Failure|8|||
46713820|NCT01190267|82929878|FG001|Overall Study|Treatment Failure|2|||
46713821|NCT01190267|82929877|FG000|Overall Study|Lost to Follow-up|2|||
46713822|NCT01190267|82929878|FG001|Overall Study|Lost to Follow-up|0|||
46713823|NCT01190267|82929877|FG000|Overall Study|Withdrawal by Subject|13|||
46713824|NCT01190267|82929878|FG001|Overall Study|Withdrawal by Subject|1|||
46713825|NCT01190267|82929877|FG000|Overall Study|Protocol Violation|8|||
46713826|NCT01190267|82929878|FG001|Overall Study|Protocol Violation|1|||
46713827|NCT00869089|82929884|FG000|Overall Study|Lost to Follow-up|1|||
46713828|NCT00869089|82929884|FG000|Overall Study|Withdrawal by Subject|1|||
46713829|NCT00869089|82929884|FG000|Overall Study|Screen Fail|1|||
46713830|NCT01190189|82929888|FG000|Overall Study|Lost to Follow-up|4|||
46713831|NCT01190189|82929888|FG000|Overall Study|Withdrawal by Subject|1|||
46713832|NCT01190189|82929888|FG000|Overall Study|Migrated/moved from study area|1|||
46713833|NCT00871117|82929894|FG000|Overall Study|Lost to Follow-up|5|||
47038166|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
47038167|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
47038168|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
46630602|NCT01972152|82803668|FG002|Second Treatment Visit|Protocol Violation|0|||
46630603|NCT01972152|82803669|FG003|Second Treatment Visit|Protocol Violation|0|||
46630604|NCT01972152|82803670|FG004|Second Treatment Visit|Protocol Violation|0|||
46630605|NCT01972152|82803671|FG005|Second Treatment Visit|Protocol Violation|0|||
46630606|NCT01972074|82803685|FG000|Overall Study|Adverse Event|4|||
46630607|NCT01972074|82803686|FG001|Overall Study|Adverse Event|1|||
46630608|NCT01972074|82803687|FG002|Overall Study|Adverse Event|0|||
46630609|NCT01972074|82803685|FG000|Overall Study|Lack of Efficacy|1|||
46630610|NCT01972074|82803686|FG001|Overall Study|Lack of Efficacy|1|||
46630611|NCT01972074|82803687|FG002|Overall Study|Lack of Efficacy|0|||
46630612|NCT01972074|82803685|FG000|Overall Study|Lost to Follow-up|0|||
46630613|NCT01972074|82803686|FG001|Overall Study|Lost to Follow-up|1|||
46630614|NCT01972074|82803687|FG002|Overall Study|Lost to Follow-up|1|||
46630615|NCT01972074|82803685|FG000|Overall Study|Withdrawal by Subject|1|||
46713834|NCT00871117|82929895|FG001|Overall Study|Lost to Follow-up|6|||
46713835|NCT00871117|82929894|FG000|Overall Study|Other|0|||
46713836|NCT00871117|82929895|FG001|Overall Study|Other|4|||
46713837|NCT00870103|82929902|FG000|Overall Study|Physician Decision|2|||
46713838|NCT00870103|82929902|FG000|Overall Study|Lost to Follow-up|2|||
46713839|NCT01145417|82929921|FG000|Overall Study|Death|1|||
46630616|NCT01972074|82803686|FG001|Overall Study|Withdrawal by Subject|1|||
46630617|NCT01972074|82803687|FG002|Overall Study|Withdrawal by Subject|1|||
46630618|NCT01972074|82803685|FG000|Overall Study|Scanner Unavailable|0|||
46713840|NCT01145417|82929922|FG001|Overall Study|Death|0|||
46713841|NCT01145417|82929921|FG000|Overall Study|Lost to Follow-up|2|||
46713842|NCT01145417|82929922|FG001|Overall Study|Lost to Follow-up|1|||
46713843|NCT01145417|82929921|FG000|Overall Study|Withdrawal by Subject|1|||
46713844|NCT01145417|82929922|FG001|Overall Study|Withdrawal by Subject|2|||
46713845|NCT01145417|82929921|FG000|Overall Study|Pregnancy|1|||
46713846|NCT01145417|82929922|FG001|Overall Study|Pregnancy|0|||
46713847|NCT01145417|82929921|FG000|Overall Study|Adverse Event|0|||
46713848|NCT01145417|82929922|FG001|Overall Study|Adverse Event|1|||
46713849|NCT01145417|82929921|FG000|Overall Study|Study terminated by sponsor|35|||
46713850|NCT01145417|82929922|FG001|Overall Study|Study terminated by sponsor|43|||
46713851|NCT01145417|82929921|FG000|Overall Study|Other|1|||
46713852|NCT01145417|82929922|FG001|Overall Study|Other|0|||
46713853|NCT01144715|82929930|FG000|Overall Study|Lost to Follow-up|2|||
46713854|NCT01144715|82929931|FG001|Overall Study|Lost to Follow-up|1|||
46713855|NCT01144715|82929930|FG000|Overall Study|Withdrawal by Subject|2|||
46713856|NCT01144715|82929931|FG001|Overall Study|Withdrawal by Subject|1|||
46713857|NCT01144715|82929930|FG000|Overall Study|Adverse Event|0|||
46713858|NCT01144715|82929931|FG001|Overall Study|Adverse Event|1|||
46713859|NCT01189487|82929937|FG000|Overall Study|Lack of Efficacy|2|||
46713860|NCT01189487|82929937|FG000|Overall Study|Adverse Event|1|||
46713861|NCT01106352|82929946|FG000|Overall Study|Subjects untreated|0|||
46713862|NCT01106352|82929947|FG001|Overall Study|Subjects untreated|0|||
46713863|NCT01106352|82929948|FG002|Overall Study|Subjects untreated|0|||
46713864|NCT01106352|82929949|FG003|Overall Study|Subjects untreated|3|||
46713865|NCT01106352|82929950|FG004|Overall Study|Subjects untreated|4|||
46713866|NCT01106352|82929946|FG000|Overall Study|Sponsor Decision|1|||
46713867|NCT01106352|82929947|FG001|Overall Study|Sponsor Decision|0|||
46713868|NCT01106352|82929948|FG002|Overall Study|Sponsor Decision|0|||
46713869|NCT01106352|82929949|FG003|Overall Study|Sponsor Decision|0|||
46713870|NCT01106352|82929950|FG004|Overall Study|Sponsor Decision|0|||
46713871|NCT01106352|82929946|FG000|Overall Study|Too ill to come in for the visit|0|||
46713872|NCT01106352|82929947|FG001|Overall Study|Too ill to come in for the visit|0|||
46713873|NCT01106352|82929948|FG002|Overall Study|Too ill to come in for the visit|1|||
46713874|NCT01106352|82929949|FG003|Overall Study|Too ill to come in for the visit|0|||
46713875|NCT01106352|82929950|FG004|Overall Study|Too ill to come in for the visit|0|||
46713876|NCT01106352|82929946|FG000|Overall Study|Lost to Follow-up|0|||
46713877|NCT01106352|82929947|FG001|Overall Study|Lost to Follow-up|0|||
46713878|NCT01106352|82929948|FG002|Overall Study|Lost to Follow-up|0|||
46713879|NCT01106352|82929949|FG003|Overall Study|Lost to Follow-up|0|||
46713880|NCT01106352|82929950|FG004|Overall Study|Lost to Follow-up|1|||
46713881|NCT01106352|82929946|FG000|Overall Study|Death|0|||
46713882|NCT01106352|82929947|FG001|Overall Study|Death|0|||
46713883|NCT01106352|82929948|FG002|Overall Study|Death|1|||
46713884|NCT01106352|82929949|FG003|Overall Study|Death|3|||
46713885|NCT01106352|82929950|FG004|Overall Study|Death|1|||
46713886|NCT01106352|82929946|FG000|Overall Study|Disease progression|0|||
46713887|NCT01106352|82929947|FG001|Overall Study|Disease progression|0|||
46713888|NCT01106352|82929948|FG002|Overall Study|Disease progression|0|||
46713889|NCT01106352|82929949|FG003|Overall Study|Disease progression|1|||
46713890|NCT01106352|82929950|FG004|Overall Study|Disease progression|0|||
46713891|NCT01106352|82929946|FG000|Overall Study|Withdrawal by Subject|0|||
46713892|NCT01106352|82929947|FG001|Overall Study|Withdrawal by Subject|0|||
46713893|NCT01106352|82929948|FG002|Overall Study|Withdrawal by Subject|0|||
46713894|NCT01106352|82929949|FG003|Overall Study|Withdrawal by Subject|3|||
46713895|NCT01106352|82929950|FG004|Overall Study|Withdrawal by Subject|2|||
46713896|NCT01106352|82929946|FG000|Overall Study|Went on hospice|0|||
46713897|NCT01106352|82929947|FG001|Overall Study|Went on hospice|0|||
46713898|NCT01106352|82929948|FG002|Overall Study|Went on hospice|0|||
46630619|NCT01972074|82803686|FG001|Overall Study|Scanner Unavailable|0|||
46630620|NCT01972074|82803687|FG002|Overall Study|Scanner Unavailable|1|||
46630621|NCT01970982|82803697|FG000|Overall Study|Withdrawal by Subject|0|||
46630622|NCT01970982|82803698|FG001|Overall Study|Withdrawal by Subject|0|||
46630623|NCT01970982|82803699|FG002|Overall Study|Withdrawal by Subject|2|||
46630624|NCT01946802|82803708|FG000|Overall Study|Death|1|||
46630625|NCT01946802|82803708|FG000|Overall Study|Withdrawal by Subject|2|||
46630626|NCT01946802|82803708|FG000|Overall Study|Combined septic shock|1|||
46713899|NCT01106352|82929949|FG003|Overall Study|Went on hospice|1|||
46713900|NCT01106352|82929950|FG004|Overall Study|Went on hospice|0|||
46713901|NCT01106352|82929946|FG000|Overall Study|Subject entered hospice|0|||
46713902|NCT01106352|82929947|FG001|Overall Study|Subject entered hospice|0|||
46713903|NCT01106352|82929948|FG002|Overall Study|Subject entered hospice|0|||
46713904|NCT01106352|82929949|FG003|Overall Study|Subject entered hospice|1|||
46713905|NCT01106352|82929950|FG004|Overall Study|Subject entered hospice|0|||
46713906|NCT01106352|82929946|FG000|Overall Study|Home hospice since July 2013|0|||
46713907|NCT01106352|82929947|FG001|Overall Study|Home hospice since July 2013|0|||
46713908|NCT01106352|82929948|FG002|Overall Study|Home hospice since July 2013|0|||
46713909|NCT01106352|82929949|FG003|Overall Study|Home hospice since July 2013|1|||
46713910|NCT01106352|82929950|FG004|Overall Study|Home hospice since July 2013|0|||
46713911|NCT01144403|82929966|FG000|Overall Study|Lost to Follow-up|3|||
46713912|NCT01144403|82929966|FG000|Overall Study|Death|1|||
46713913|NCT01144403|82929966|FG000|Overall Study|Adverse Event|1|||
46713914|NCT01143389|82929973|FG000|Overall Study|Lost to Follow-up|26|||
46713915|NCT01143389|82929974|FG001|Overall Study|Lost to Follow-up|25|||
46713916|NCT00868231|82929980|FG000|Treatment Period 1|Adverse Event|0|||
46713917|NCT00868231|82929981|FG001|Treatment Period 1|Adverse Event|0|||
46713918|NCT00868231|82929982|FG002|Treatment Period 1|Adverse Event|0|||
46713919|NCT00868231|82929983|FG003|Treatment Period 1|Adverse Event|0|||
46713920|NCT00868231|82929984|FG004|Treatment Period 1|Adverse Event|1|||
46713921|NCT00868231|82929985|FG005|Treatment Period 1|Adverse Event|0|||
46713922|NCT00868231|82929980|FG000|Treatment Period 2|Adverse Event|1|||
46713923|NCT00868231|82929981|FG001|Treatment Period 2|Adverse Event|0|||
46713924|NCT00868231|82929982|FG002|Treatment Period 2|Adverse Event|0|||
46713925|NCT00868231|82929983|FG003|Treatment Period 2|Adverse Event|0|||
46713926|NCT00868231|82929984|FG004|Treatment Period 2|Adverse Event|0|||
46713927|NCT00868231|82929985|FG005|Treatment Period 2|Adverse Event|0|||
46713928|NCT00868231|82929980|FG000|Treatment Period 3|Adverse Event|0|||
46713929|NCT00868231|82929981|FG001|Treatment Period 3|Adverse Event|0|||
46713930|NCT00868231|82929982|FG002|Treatment Period 3|Adverse Event|1|||
46713931|NCT00868231|82929983|FG003|Treatment Period 3|Adverse Event|0|||
46713932|NCT00868231|82929984|FG004|Treatment Period 3|Adverse Event|0|||
46713933|NCT00868231|82929985|FG005|Treatment Period 3|Adverse Event|0|||
46713934|NCT01143077|82929996|FG000|Overall Study|Lack of Efficacy|0|||
46713935|NCT01143077|82929997|FG001|Overall Study|Lack of Efficacy|2|||
46713936|NCT01143077|82929998|FG002|Overall Study|Lack of Efficacy|1|||
46713937|NCT01143077|82929996|FG000|Overall Study|Adverse Event|5|||
46713938|NCT01143077|82929997|FG001|Overall Study|Adverse Event|6|||
46713939|NCT01143077|82929998|FG002|Overall Study|Adverse Event|5|||
46713940|NCT01143077|82929996|FG000|Overall Study|Lost to Follow-up|2|||
46713941|NCT01143077|82929997|FG001|Overall Study|Lost to Follow-up|3|||
46713942|NCT01143077|82929998|FG002|Overall Study|Lost to Follow-up|4|||
46713943|NCT01143077|82929996|FG000|Overall Study|Protocol Violation|2|||
46713944|NCT01143077|82929997|FG001|Overall Study|Protocol Violation|0|||
46713945|NCT01143077|82929998|FG002|Overall Study|Protocol Violation|0|||
46713946|NCT01143077|82929996|FG000|Overall Study|Withdrawal by Subject|4|||
46713947|NCT01143077|82929997|FG001|Overall Study|Withdrawal by Subject|3|||
46713948|NCT01143077|82929998|FG002|Overall Study|Withdrawal by Subject|3|||
46713949|NCT01143077|82929996|FG000|Overall Study|Non-compliance with study drug|0|||
46713950|NCT01143077|82929997|FG001|Overall Study|Non-compliance with study drug|1|||
46713951|NCT01143077|82929998|FG002|Overall Study|Non-compliance with study drug|1|||
46713952|NCT01143077|82929996|FG000|Overall Study|Administrative|1|||
46713953|NCT01143077|82929997|FG001|Overall Study|Administrative|0|||
46713954|NCT01143077|82929998|FG002|Overall Study|Administrative|0|||
46713955|NCT01143077|82929996|FG000|Overall Study|Principal Investigator Decision|2|||
46713956|NCT01143077|82929997|FG001|Overall Study|Principal Investigator Decision|0|||
46713957|NCT01143077|82929998|FG002|Overall Study|Principal Investigator Decision|1|||
46713958|NCT01096446|82930008|FG000|Overall Study|Death|1|||
46713959|NCT01096446|82930009|FG001|Overall Study|Death|0|||
46713960|NCT01096446|82930008|FG000|Overall Study|Protocol Violation|2|||
46713961|NCT01096446|82930009|FG001|Overall Study|Protocol Violation|0|||
46713962|NCT00864721|82930014|FG000|Overall Study|Patient request|11|||
46713963|NCT00864721|82930014|FG000|Overall Study|Hospitalized|1|||
46713964|NCT00864721|82930014|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
46713965|NCT00864721|82930014|FG000|Overall Study|Adverse Event|21|||
46713966|NCT01095666|82930021|FG000|Overall Study|Lack of Efficacy|0|||
46713967|NCT01095666|82930022|FG001|Overall Study|Lack of Efficacy|0|||
46713968|NCT01095666|82930023|FG002|Overall Study|Lack of Efficacy|1|||
46713969|NCT01095666|82930021|FG000|Overall Study|Adverse Event|2|||
46713970|NCT01095666|82930022|FG001|Overall Study|Adverse Event|1|||
46713971|NCT01095666|82930023|FG002|Overall Study|Adverse Event|3|||
46713972|NCT01095666|82930021|FG000|Overall Study|Lost to Follow-up|2|||
46713973|NCT01095666|82930022|FG001|Overall Study|Lost to Follow-up|2|||
46713974|NCT01095666|82930023|FG002|Overall Study|Lost to Follow-up|0|||
46713975|NCT01095666|82930021|FG000|Overall Study|Withdrawal by Subject|6|||
46713976|NCT01095666|82930022|FG001|Overall Study|Withdrawal by Subject|6|||
46713977|NCT01095666|82930023|FG002|Overall Study|Withdrawal by Subject|1|||
46713978|NCT01095666|82930021|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
46713979|NCT01095666|82930022|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
46713980|NCT01095666|82930023|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
46713981|NCT01100658|82930031|FG000|Overall Study|Withdrawal by Subject|1|||
46713982|NCT01100502|82930037|FG000|Overall Study|Withdrawal by Subject|18|||
46713983|NCT01100502|82930038|FG001|Overall Study|Withdrawal by Subject|25|||
46713984|NCT01100502|82930037|FG000|Overall Study|Lost to Follow-up|13|||
46713985|NCT01100502|82930038|FG001|Overall Study|Lost to Follow-up|28|||
46713986|NCT01100502|82930037|FG000|Overall Study|Site request to end participation in study|0|||
46713987|NCT01100502|82930038|FG001|Overall Study|Site request to end participation in study|1|||
46713988|NCT01100502|82930037|FG000|Overall Study|Death|45|||
46713989|NCT01100502|82930038|FG001|Overall Study|Death|40|||
46713990|NCT01094886|82930044|FG000|Overall Study|Adverse Event|2|||
46713991|NCT01094886|82930044|FG000|Overall Study|Withdrawal by Subject|5|||
46713992|NCT01094808|82930051|FG000|Overall Study|Withdrawal by Subject|1|||
46713993|NCT01094808|82930052|FG001|Overall Study|Withdrawal by Subject|1|||
46713994|NCT01094808|82930053|FG002|Overall Study|Withdrawal by Subject|0|||
46713995|NCT00864253|82930063|FG000|Overall Study|Adverse Event|56|||
46713996|NCT00864253|82930064|FG001|Overall Study|Adverse Event|11|||
46713997|NCT00864253|82930063|FG000|Overall Study|Unrelated Adverse Event|3|||
46713998|NCT00864253|82930064|FG001|Overall Study|Unrelated Adverse Event|1|||
46713999|NCT00864253|82930063|FG000|Overall Study|Physician Decision|11|||
46714000|NCT00864253|82930064|FG001|Overall Study|Physician Decision|15|||
46714001|NCT00864253|82930063|FG000|Overall Study|Protocol Violation|0|||
46714002|NCT00864253|82930064|FG001|Overall Study|Protocol Violation|2|||
46714003|NCT00864253|82930063|FG000|Overall Study|Lost to Follow-up|1|||
46714004|NCT00864253|82930064|FG001|Overall Study|Lost to Follow-up|1|||
46714005|NCT00864253|82930063|FG000|Overall Study|Withdrawal by Subject|18|||
46714006|NCT00864253|82930064|FG001|Overall Study|Withdrawal by Subject|18|||
46714007|NCT00864253|82930063|FG000|Overall Study|Death|1|||
46714008|NCT00864253|82930064|FG001|Overall Study|Death|0|||
46714009|NCT00864253|82930063|FG000|Overall Study|Ongoing|2|||
46714010|NCT00864253|82930064|FG001|Overall Study|Ongoing|3|||
46714011|NCT00864253|82930063|FG000|Overall Study|Untreated|7|||
46714012|NCT00864253|82930064|FG001|Overall Study|Untreated|7|||
46714013|NCT01094730|82930072|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
46714014|NCT01094730|82930073|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
46714015|NCT01094730|82930072|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
46714016|NCT01094730|82930073|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
46714017|NCT01094730|82930072|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
46714018|NCT01094730|82930073|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
46714019|NCT01094730|82930072|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
46714020|NCT01094730|82930073|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
46714021|NCT01094730|82930072|FG000|Period 2 (14 Days)|Protocol Violation|2|||
46714022|NCT01094730|82930073|FG001|Period 2 (14 Days)|Protocol Violation|0|||
46714023|NCT01094730|82930072|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
46714024|NCT01094730|82930073|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
46714025|NCT01094730|82930072|FG000|Period 2 (14 Days)|Adverse Event|0|||
46714026|NCT01094730|82930073|FG001|Period 2 (14 Days)|Adverse Event|1|||
46714027|NCT01094730|82930072|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
46714028|NCT01094730|82930073|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
46714029|NCT00864097|82930088|FG000|Overall Study|Death|0|||
46714030|NCT00864097|82930089|FG001|Overall Study|Death|1|||
46714031|NCT00864097|82930090|FG002|Overall Study|Death|0|||
46714032|NCT00864097|82930091|FG003|Overall Study|Death|0|||
46714033|NCT00864097|82930088|FG000|Overall Study|Adverse Event|6|||
46714034|NCT00864097|82930089|FG001|Overall Study|Adverse Event|8|||
46714035|NCT00864097|82930090|FG002|Overall Study|Adverse Event|11|||
46714036|NCT00864097|82930091|FG003|Overall Study|Adverse Event|9|||
46714037|NCT00864097|82930088|FG000|Overall Study|Lack of Efficacy|9|||
46714038|NCT00864097|82930089|FG001|Overall Study|Lack of Efficacy|3|||
46714039|NCT00864097|82930090|FG002|Overall Study|Lack of Efficacy|7|||
46714040|NCT00864097|82930091|FG003|Overall Study|Lack of Efficacy|2|||
46714041|NCT00864097|82930088|FG000|Overall Study|Lost to Follow-up|0|||
46714042|NCT00864097|82930089|FG001|Overall Study|Lost to Follow-up|1|||
46714043|NCT00864097|82930090|FG002|Overall Study|Lost to Follow-up|0|||
46714044|NCT00864097|82930091|FG003|Overall Study|Lost to Follow-up|1|||
46714045|NCT00864097|82930088|FG000|Overall Study|Withdrawal by Subject|15|||
46714046|NCT00864097|82930089|FG001|Overall Study|Withdrawal by Subject|11|||
46714047|NCT00864097|82930090|FG002|Overall Study|Withdrawal by Subject|11|||
46714048|NCT00864097|82930091|FG003|Overall Study|Withdrawal by Subject|12|||
46714049|NCT00864097|82930088|FG000|Overall Study|Protocol Violation|2|||
46714050|NCT00864097|82930089|FG001|Overall Study|Protocol Violation|1|||
46714051|NCT00864097|82930090|FG002|Overall Study|Protocol Violation|0|||
46714052|NCT00864097|82930091|FG003|Overall Study|Protocol Violation|1|||
46714053|NCT00864097|82930088|FG000|Overall Study|Terminated by sponsor|105|||
46714054|NCT00864097|82930089|FG001|Overall Study|Terminated by sponsor|112|||
46714055|NCT00864097|82930090|FG002|Overall Study|Terminated by sponsor|102|||
46714056|NCT00864097|82930091|FG003|Overall Study|Terminated by sponsor|99|||
46714057|NCT00864097|82930088|FG000|Overall Study|Randomized but not treated|2|||
46714058|NCT00864097|82930089|FG001|Overall Study|Randomized but not treated|0|||
46714059|NCT00864097|82930090|FG002|Overall Study|Randomized but not treated|1|||
46714060|NCT00864097|82930091|FG003|Overall Study|Randomized but not treated|0|||
46714061|NCT00864097|82930088|FG000|Overall Study|Other|0|||
46714062|NCT00864097|82930089|FG001|Overall Study|Other|0|||
46714063|NCT00864097|82930090|FG002|Overall Study|Other|0|||
46714064|NCT00864097|82930091|FG003|Overall Study|Other|1|||
46714065|NCT01183013|82930108|FG000|Overall Study|Adverse Event|6|||
46714066|NCT01183013|82930109|FG001|Overall Study|Adverse Event|8|||
46714067|NCT01183013|82930110|FG002|Overall Study|Adverse Event|5|||
46714068|NCT01183013|82930111|FG003|Overall Study|Adverse Event|5|||
46714069|NCT01183013|82930112|FG004|Overall Study|Adverse Event|10|||
46714070|NCT01183013|82930113|FG005|Overall Study|Adverse Event|10|||
46714071|NCT01183013|82930114|FG006|Overall Study|Adverse Event|6|||
46714072|NCT01183013|82930108|FG000|Overall Study|Lack of Efficacy|3|||
46714073|NCT01183013|82930109|FG001|Overall Study|Lack of Efficacy|2|||
46714074|NCT01183013|82930110|FG002|Overall Study|Lack of Efficacy|1|||
46714075|NCT01183013|82930111|FG003|Overall Study|Lack of Efficacy|2|||
46714076|NCT01183013|82930112|FG004|Overall Study|Lack of Efficacy|1|||
46714077|NCT01183013|82930113|FG005|Overall Study|Lack of Efficacy|2|||
46714078|NCT01183013|82930114|FG006|Overall Study|Lack of Efficacy|0|||
46714079|NCT01183013|82930108|FG000|Overall Study|Protocol Violation|5|||
46714080|NCT01183013|82930109|FG001|Overall Study|Protocol Violation|2|||
46714081|NCT01183013|82930110|FG002|Overall Study|Protocol Violation|4|||
46714082|NCT01183013|82930111|FG003|Overall Study|Protocol Violation|0|||
46714083|NCT01183013|82930112|FG004|Overall Study|Protocol Violation|4|||
46714084|NCT01183013|82930113|FG005|Overall Study|Protocol Violation|3|||
46714085|NCT01183013|82930114|FG006|Overall Study|Protocol Violation|3|||
46714086|NCT01183013|82930108|FG000|Overall Study|Lost to Follow-up|7|||
46714087|NCT01183013|82930109|FG001|Overall Study|Lost to Follow-up|3|||
46714088|NCT01183013|82930110|FG002|Overall Study|Lost to Follow-up|4|||
46714089|NCT01183013|82930111|FG003|Overall Study|Lost to Follow-up|3|||
46714090|NCT01183013|82930112|FG004|Overall Study|Lost to Follow-up|2|||
46714091|NCT01183013|82930113|FG005|Overall Study|Lost to Follow-up|6|||
46714092|NCT01183013|82930114|FG006|Overall Study|Lost to Follow-up|5|||
46714093|NCT01183013|82930108|FG000|Overall Study|Withdrawal by Subject|9|||
46714094|NCT01183013|82930109|FG001|Overall Study|Withdrawal by Subject|13|||
46714095|NCT01183013|82930110|FG002|Overall Study|Withdrawal by Subject|10|||
46714096|NCT01183013|82930111|FG003|Overall Study|Withdrawal by Subject|8|||
46714097|NCT01183013|82930112|FG004|Overall Study|Withdrawal by Subject|7|||
47038169|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
47038170|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
47038171|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
47038172|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
47038173|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
47038174|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
47038175|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
47038176|NCT04440163|83290468|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
47038177|NCT04440163|83290469|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
47038178|NCT04440163|83290470|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
47038179|NCT04440163|83290471|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
47038180|NCT04440163|83290472|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
47038181|NCT04440163|83290473|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
47038182|NCT04440163|83290474|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
47038183|NCT04440163|83290475|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
47038184|NCT04440163|83290468|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
46630627|NCT01946802|82803708|FG000|Overall Study|Protocol Violation|1|||
46630628|NCT01618266|82803712|FG000|Overall Study|Lost to Follow-up|9|||
46630629|NCT01618266|82803712|FG000|Overall Study|Treatment satisfaction|10|||
46630630|NCT01618266|82803712|FG000|Overall Study|Other reasons|11|||
46630631|NCT01618266|82803712|FG000|Overall Study|Lack of Efficacy|23|||
46630632|NCT01618266|82803712|FG000|Overall Study|Protocol Violation|43|||
46630633|NCT01919112|82803719|FG000|Secondary Analysis-day 30|Death|1|||
46630634|NCT01919112|82803720|FG001|Secondary Analysis-day 30|Death|1|||
46630635|NCT01919112|82803721|FG002|Secondary Analysis-day 30|Death|1|||
46630636|NCT01919112|82803719|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
46630637|NCT01919112|82803720|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
46630638|NCT01919112|82803721|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
46630639|NCT01918332|82803733|FG000|Overall Study|Adverse Event|0|||
46714098|NCT01183013|82930113|FG005|Overall Study|Withdrawal by Subject|9|||
46714099|NCT01183013|82930114|FG006|Overall Study|Withdrawal by Subject|10|||
46714100|NCT01183013|82930108|FG000|Overall Study|Reasons other than stated above|15|||
46714101|NCT01183013|82930109|FG001|Overall Study|Reasons other than stated above|11|||
46714102|NCT01183013|82930110|FG002|Overall Study|Reasons other than stated above|17|||
46714103|NCT01183013|82930111|FG003|Overall Study|Reasons other than stated above|12|||
46714104|NCT01183013|82930112|FG004|Overall Study|Reasons other than stated above|12|||
46714105|NCT01183013|82930113|FG005|Overall Study|Reasons other than stated above|15|||
46714106|NCT01183013|82930114|FG006|Overall Study|Reasons other than stated above|13|||
46714107|NCT01141283|82930138|FG000|Overall Study|Adverse Event|56|||
46714108|NCT01141283|82930138|FG000|Overall Study|Lost to Follow-up|4|||
46714109|NCT01141283|82930138|FG000|Overall Study|Withdrawal by Subject|14|||
46714110|NCT01141283|82930138|FG000|Overall Study|Administrative|4|||
46714111|NCT01141283|82930138|FG000|Overall Study|Lack of Efficacy|10|||
46714112|NCT00863707|82930144|FG000|Overall Study|Randomized, but drug not received|4|||
46714113|NCT00863707|82930145|FG001|Overall Study|Randomized, but drug not received|3|||
46714114|NCT01094184|82930153|FG000|Overall Study|Death|35|||
46714115|NCT01094184|82930154|FG001|Overall Study|Death|11|||
46714116|NCT01134731|82930163|FG000|Overall Study|Adverse Event|3|||
46714117|NCT01134731|82930164|FG001|Overall Study|Adverse Event|2|||
46714118|NCT01134731|82930165|FG002|Overall Study|Adverse Event|1|||
46714119|NCT01134731|82930163|FG000|Overall Study|Physician Decision|2|||
46714120|NCT01134731|82930164|FG001|Overall Study|Physician Decision|2|||
46714121|NCT01134731|82930165|FG002|Overall Study|Physician Decision|2|||
46714122|NCT01134731|82930163|FG000|Overall Study|Lack of Efficacy|0|||
46714123|NCT01134731|82930164|FG001|Overall Study|Lack of Efficacy|0|||
46714124|NCT01134731|82930165|FG002|Overall Study|Lack of Efficacy|1|||
46714125|NCT01134731|82930163|FG000|Overall Study|Withdrawal by Subject|3|||
46714126|NCT01134731|82930164|FG001|Overall Study|Withdrawal by Subject|3|||
46714127|NCT01134731|82930165|FG002|Overall Study|Withdrawal by Subject|1|||
46714128|NCT01134731|82930163|FG000|Overall Study|Lost to Follow-up|5|||
46714129|NCT01134731|82930164|FG001|Overall Study|Lost to Follow-up|4|||
46714130|NCT01134731|82930165|FG002|Overall Study|Lost to Follow-up|3|||
46714131|NCT01141205|82930176|FG000|Overall Study|Physician Decision|1|||
46714132|NCT01141205|82930177|FG001|Overall Study|Physician Decision|1|||
46714133|NCT01141205|82930176|FG000|Overall Study|Lost to Follow-up|1|||
46714134|NCT01141205|82930177|FG001|Overall Study|Lost to Follow-up|0|||
46714135|NCT01141205|82930176|FG000|Overall Study|Withdrawal by Subject|1|||
46714136|NCT01141205|82930177|FG001|Overall Study|Withdrawal by Subject|1|||
46714137|NCT01140503|82930187|FG000|Overall Study|Withdrawal by Subject|1|||
46714138|NCT00863317|82930193|FG000|Overall Study|Lost to Follow-up|8|||
46714139|NCT00863317|82930194|FG001|Overall Study|Lost to Follow-up|9|||
46714140|NCT01200368|82930203|FG000|Infant Series|Adverse Event|2|||
46714141|NCT01200368|82930204|FG001|Infant Series|Adverse Event|2|||
46714142|NCT01200368|82930205|FG002|Infant Series|Adverse Event|3|||
46714143|NCT01200368|82930203|FG000|Infant Series|Withdrawal by Subject|0|||
46714144|NCT01200368|82930204|FG001|Infant Series|Withdrawal by Subject|2|||
46714145|NCT01200368|82930205|FG002|Infant Series|Withdrawal by Subject|2|||
46714146|NCT01200368|82930203|FG000|Infant Series|Did not meet entrance criteria|0|||
46714147|NCT01200368|82930204|FG001|Infant Series|Did not meet entrance criteria|1|||
46714148|NCT01200368|82930205|FG002|Infant Series|Did not meet entrance criteria|0|||
46714149|NCT01200368|82930203|FG000|Infant Series|Randomized, not vaccinated|0|||
47038185|NCT04440163|83290469|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
46714150|NCT01200368|82930204|FG001|Infant Series|Randomized, not vaccinated|1|||
46714151|NCT01200368|82930205|FG002|Infant Series|Randomized, not vaccinated|1|||
46714152|NCT01200368|82930203|FG000|Infant Series|Other|1|||
46714153|NCT01200368|82930204|FG001|Infant Series|Other|0|||
46714154|NCT01200368|82930205|FG002|Infant Series|Other|0|||
46714155|NCT01200368|82930203|FG000|After Infant Series|Adverse Event|6|||
46714156|NCT01200368|82930204|FG001|After Infant Series|Adverse Event|6|||
47038186|NCT04440163|83290470|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
47038187|NCT04440163|83290471|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
47038188|NCT04440163|83290472|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
47038189|NCT04440163|83290473|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
47038190|NCT04440163|83290474|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
47038191|NCT04440163|83290475|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
47038192|NCT04440163|83290468|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
46714157|NCT01200368|82930205|FG002|After Infant Series|Adverse Event|3|||
46714158|NCT01200368|82930203|FG000|After Infant Series|Withdrawal by Subject|10|||
46714159|NCT01200368|82930204|FG001|After Infant Series|Withdrawal by Subject|8|||
46714160|NCT01200368|82930205|FG002|After Infant Series|Withdrawal by Subject|4|||
46714161|NCT01200368|82930203|FG000|After Infant Series|Lost to Follow-up|1|||
46714162|NCT01200368|82930204|FG001|After Infant Series|Lost to Follow-up|0|||
46714163|NCT01200368|82930205|FG002|After Infant Series|Lost to Follow-up|0|||
46714164|NCT01200368|82930203|FG000|After Infant Series|Other|1|||
46714165|NCT01200368|82930204|FG001|After Infant Series|Other|2|||
46714166|NCT01200368|82930205|FG002|After Infant Series|Other|2|||
46714167|NCT01200368|82930203|FG000|Toddler Dose|Adverse Event|0|||
46714168|NCT01200368|82930204|FG001|Toddler Dose|Adverse Event|3|||
46714169|NCT01200368|82930205|FG002|Toddler Dose|Adverse Event|1|||
46714170|NCT01079130|82930226|FG000|Overall Study|Adverse Event|1|||
46714171|NCT01079130|82930227|FG001|Overall Study|Adverse Event|1|||
46714172|NCT01079130|82930228|FG002|Overall Study|Adverse Event|0|||
46714173|NCT01079130|82930229|FG003|Overall Study|Adverse Event|1|||
47038193|NCT04440163|83290469|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
47038194|NCT04440163|83290470|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
47038195|NCT04440163|83290471|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
47038196|NCT04440163|83290472|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
47038197|NCT04440163|83290473|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
47038198|NCT04440163|83290474|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
47038199|NCT04440163|83290475|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
47038200|NCT04304508|83290506|FG000|Overall Study|Subject Decision|29|||
47038201|NCT04304508|83290507|FG001|Overall Study|Subject Decision|39|||
47038202|NCT04304508|83290508|FG002|Overall Study|Subject Decision|37|||
47038203|NCT04304508|83290509|FG003|Overall Study|Subject Decision|48|||
47038204|NCT04304508|83290506|FG000|Overall Study|Death|6|||
47038205|NCT04304508|83290507|FG001|Overall Study|Death|1|||
47038206|NCT04304508|83290508|FG002|Overall Study|Death|8|||
47038207|NCT04304508|83290509|FG003|Overall Study|Death|5|||
47038208|NCT04304508|83290506|FG000|Overall Study|Non-compliance With Study Drug|3|||
47038209|NCT04304508|83290507|FG001|Overall Study|Non-compliance With Study Drug|1|||
47038210|NCT04304508|83290508|FG002|Overall Study|Non-compliance With Study Drug|2|||
47038211|NCT04304508|83290509|FG003|Overall Study|Non-compliance With Study Drug|0|||
47038212|NCT04304508|83290506|FG000|Overall Study|Switching To Other Therapy|1|||
47038213|NCT04304508|83290507|FG001|Overall Study|Switching To Other Therapy|1|||
47038214|NCT04304508|83290508|FG002|Overall Study|Switching To Other Therapy|1|||
47038215|NCT04304508|83290509|FG003|Overall Study|Switching To Other Therapy|2|||
47038216|NCT04304508|83290506|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
47038217|NCT04304508|83290507|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
47038218|NCT04304508|83290508|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
47038219|NCT04304508|83290509|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
47038220|NCT04304508|83290506|FG000|Overall Study|Withdrawal by Subject|7|||
47038221|NCT04304508|83290507|FG001|Overall Study|Withdrawal by Subject|5|||
47038222|NCT04304508|83290508|FG002|Overall Study|Withdrawal by Subject|11|||
47038223|NCT04304508|83290509|FG003|Overall Study|Withdrawal by Subject|6|||
47038224|NCT04304508|83290506|FG000|Overall Study|Logistical Difficulties|2|||
47038225|NCT04304508|83290507|FG001|Overall Study|Logistical Difficulties|2|||
47038226|NCT04304508|83290508|FG002|Overall Study|Logistical Difficulties|3|||
47038227|NCT04304508|83290509|FG003|Overall Study|Logistical Difficulties|2|||
47038228|NCT04304508|83290506|FG000|Overall Study|Missing Information|1|||
47038229|NCT04304508|83290507|FG001|Overall Study|Missing Information|2|||
47038230|NCT04304508|83290508|FG002|Overall Study|Missing Information|1|||
47038231|NCT04304508|83290509|FG003|Overall Study|Missing Information|3|||
47038232|NCT04304508|83290506|FG000|Overall Study|Other|7|||
47038233|NCT04304508|83290507|FG001|Overall Study|Other|6|||
47038234|NCT04304508|83290508|FG002|Overall Study|Other|5|||
47038235|NCT04304508|83290509|FG003|Overall Study|Other|4|||
47038236|NCT04304508|83290506|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
47038237|NCT04304508|83290507|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
47038238|NCT04304508|83290508|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
47038239|NCT04304508|83290509|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
47038240|NCT04304508|83290506|FG000|Overall Study|Physician Decision|3|||
47038241|NCT04304508|83290507|FG001|Overall Study|Physician Decision|4|||
47038242|NCT04304508|83290508|FG002|Overall Study|Physician Decision|9|||
47038243|NCT04304508|83290509|FG003|Overall Study|Physician Decision|7|||
47038244|NCT04304508|83290506|FG000|Overall Study|Study drug never administered|10|||
47038245|NCT04304508|83290507|FG001|Overall Study|Study drug never administered|4|||
47038246|NCT04304508|83290508|FG002|Overall Study|Study drug never administered|4|||
47038247|NCT04304508|83290509|FG003|Overall Study|Study drug never administered|4|||
47038248|NCT04304508|83290506|FG000|Overall Study|Adverse Event|49|||
47038249|NCT04304508|83290507|FG001|Overall Study|Adverse Event|50|||
47038250|NCT04304508|83290508|FG002|Overall Study|Adverse Event|51|||
47038251|NCT04304508|83290509|FG003|Overall Study|Adverse Event|56|||
47038252|NCT04304508|83290506|FG000|Overall Study|Lost to Follow-up|1|||
47038253|NCT04304508|83290507|FG001|Overall Study|Lost to Follow-up|5|||
46714174|NCT01079130|82930230|FG004|Overall Study|Adverse Event|5|||
46714175|NCT01079130|82930231|FG005|Overall Study|Adverse Event|1|||
46714176|NCT01079130|82930226|FG000|Overall Study|Administrative problems|1|||
46714177|NCT01079130|82930227|FG001|Overall Study|Administrative problems|3|||
47038254|NCT04304508|83290508|FG002|Overall Study|Lost to Follow-up|2|||
47038255|NCT04304508|83290509|FG003|Overall Study|Lost to Follow-up|3|||
47038256|NCT04206332|83290538|FG000|Part A|Lost to Follow-up|0|||
47038257|NCT04206332|83290539|FG001|Part A|Lost to Follow-up|1|||
47038258|NCT04206332|83290540|FG002|Part A|Lost to Follow-up|0|||
47038259|NCT04206332|83290541|FG003|Part A|Lost to Follow-up|0|||
47038260|NCT04206332|83290542|FG004|Part A|Lost to Follow-up|0|||
47038261|NCT04206332|83290543|FG005|Part A|Lost to Follow-up|0|||
47038262|NCT04206332|83290544|FG006|Part A|Lost to Follow-up|0|||
47038263|NCT04206332|83290545|FG007|Part A|Lost to Follow-up|0|||
46714178|NCT01079130|82930228|FG002|Overall Study|Administrative problems|0|||
46714179|NCT01079130|82930229|FG003|Overall Study|Administrative problems|0|||
46714180|NCT01079130|82930230|FG004|Overall Study|Administrative problems|0|||
46714181|NCT01079130|82930231|FG005|Overall Study|Administrative problems|1|||
46714182|NCT01079130|82930226|FG000|Overall Study|Withdrawal by Subject|0|||
46714183|NCT01079130|82930227|FG001|Overall Study|Withdrawal by Subject|1|||
46714184|NCT01079130|82930228|FG002|Overall Study|Withdrawal by Subject|0|||
46714185|NCT01079130|82930229|FG003|Overall Study|Withdrawal by Subject|0|||
46714186|NCT01079130|82930230|FG004|Overall Study|Withdrawal by Subject|1|||
46714187|NCT01079130|82930231|FG005|Overall Study|Withdrawal by Subject|3|||
46714188|NCT01079130|82930226|FG000|Overall Study|Protocol deviation|0|||
46714189|NCT01079130|82930227|FG001|Overall Study|Protocol deviation|2|||
46714190|NCT01079130|82930228|FG002|Overall Study|Protocol deviation|1|||
46714191|NCT01079130|82930229|FG003|Overall Study|Protocol deviation|2|||
46714192|NCT01079130|82930230|FG004|Overall Study|Protocol deviation|0|||
46714193|NCT01079130|82930231|FG005|Overall Study|Protocol deviation|0|||
46714194|NCT01079130|82930226|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46913942|NCT03176459|83144448|FG000|Overall Study|Lost to Follow-up|5|||
46913943|NCT03176459|83144449|FG001|Overall Study|Lost to Follow-up|7|||
46913944|NCT03155269|83144457|FG000|Overall Study|Withdrawal by Subject|4|||
46913945|NCT03155269|83144458|FG001|Overall Study|Withdrawal by Subject|5|||
46913946|NCT03155269|83144457|FG000|Overall Study|Lost to Follow-up|1|||
46913947|NCT03155269|83144458|FG001|Overall Study|Lost to Follow-up|2|||
46913948|NCT02906670|83144474|FG000|Cohort 1, QW|Radiological Progression|1|||
47038264|NCT04206332|83290546|FG008|Part A|Lost to Follow-up|0|||
47038265|NCT04206332|83290547|FG009|Part A|Lost to Follow-up|0|||
47038266|NCT04206332|83290548|FG010|Part A|Lost to Follow-up|0|||
47038267|NCT04206332|83290549|FG011|Part A|Lost to Follow-up|0|||
47038268|NCT04206332|83290550|FG012|Part A|Lost to Follow-up|0|||
47038269|NCT04206332|83290551|FG013|Part A|Lost to Follow-up|0|||
47038270|NCT04206332|83290552|FG014|Part A|Lost to Follow-up|0|||
47038271|NCT04206332|83290553|FG015|Part A|Lost to Follow-up|0|||
47038272|NCT04206332|83290554|FG016|Part A|Lost to Follow-up|0|||
47038273|NCT04206332|83290538|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038274|NCT04206332|83290539|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038275|NCT04206332|83290540|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038276|NCT04206332|83290541|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038277|NCT04206332|83290542|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038278|NCT04206332|83290543|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
47038279|NCT04206332|83290544|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038280|NCT04206332|83290545|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038281|NCT04206332|83290546|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038282|NCT04206332|83290547|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038283|NCT04206332|83290548|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038284|NCT04206332|83290549|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038285|NCT04206332|83290550|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038286|NCT04206332|83290551|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038287|NCT04206332|83290552|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038288|NCT04206332|83290553|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038289|NCT04206332|83290554|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
47038290|NCT04206332|83290538|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
46630640|NCT01918332|82803734|FG001|Overall Study|Adverse Event|0|||
46714195|NCT01079130|82930227|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46630641|NCT01918332|82803735|FG002|Overall Study|Adverse Event|0|||
46630642|NCT01918332|82803736|FG003|Overall Study|Adverse Event|1|||
46630643|NCT01918332|82803733|FG000|Overall Study|Withdrawal by Subject|2|||
46630644|NCT01918332|82803734|FG001|Overall Study|Withdrawal by Subject|3|||
46630645|NCT01918332|82803735|FG002|Overall Study|Withdrawal by Subject|2|||
46630646|NCT01918332|82803736|FG003|Overall Study|Withdrawal by Subject|3|||
46630647|NCT01918332|82803733|FG000|Overall Study|Protocol Violation|6|||
46714196|NCT01079130|82930228|FG002|Overall Study|Abnormal test procedure result(s)|0|||
46714197|NCT01079130|82930229|FG003|Overall Study|Abnormal test procedure result(s)|0|||
46630648|NCT01918332|82803734|FG001|Overall Study|Protocol Violation|2|||
46630649|NCT01918332|82803735|FG002|Overall Study|Protocol Violation|6|||
46714198|NCT01079130|82930230|FG004|Overall Study|Abnormal test procedure result(s)|1|||
46714199|NCT01079130|82930231|FG005|Overall Study|Abnormal test procedure result(s)|0|||
46714200|NCT01079130|82930226|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46913949|NCT02906670|83144475|FG001|Cohort 1, QW|Radiological Progression|0|||
46714201|NCT01079130|82930227|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46714202|NCT01079130|82930228|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
46714203|NCT01079130|82930229|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
46714204|NCT01079130|82930230|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
46714205|NCT01079130|82930231|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
46714206|NCT01079130|82930226|FG000|Overall Study|Lost to Follow-up|0|||
46714207|NCT01079130|82930227|FG001|Overall Study|Lost to Follow-up|0|||
46714208|NCT01079130|82930228|FG002|Overall Study|Lost to Follow-up|0|||
46714209|NCT01079130|82930229|FG003|Overall Study|Lost to Follow-up|0|||
46714210|NCT01079130|82930230|FG004|Overall Study|Lost to Follow-up|1|||
46714211|NCT01079130|82930231|FG005|Overall Study|Lost to Follow-up|0|||
46714212|NCT01078974|82930245|FG000|Overall Study|Adverse Event|3|||
46714213|NCT00869557|82930251|FG000|Randomized Phase|Lost to Follow-up|2|||
46714214|NCT00869557|82930252|FG001|Randomized Phase|Lost to Follow-up|1|||
46714215|NCT00869557|82930251|FG000|Randomized Phase|Investigator's Discretion|1|||
46714216|NCT00869557|82930252|FG001|Randomized Phase|Investigator's Discretion|0|||
46714217|NCT00869557|82930251|FG000|Randomized Phase|Withdrew Consent|0|||
47038291|NCT04206332|83290539|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
46714218|NCT00869557|82930252|FG001|Randomized Phase|Withdrew Consent|1|||
46714219|NCT00869557|82930251|FG000|Extension Phase|Adverse Event|2|||
46714220|NCT00869557|82930252|FG001|Extension Phase|Adverse Event|2|||
47038292|NCT04206332|83290540|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038293|NCT04206332|83290541|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038294|NCT04206332|83290542|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038295|NCT04206332|83290543|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038296|NCT04206332|83290544|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038297|NCT04206332|83290545|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
47038298|NCT04206332|83290546|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038299|NCT04206332|83290547|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038300|NCT04206332|83290548|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
47038301|NCT04206332|83290549|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038302|NCT04206332|83290550|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038303|NCT04206332|83290551|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038304|NCT04206332|83290552|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038305|NCT04206332|83290553|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038306|NCT04206332|83290554|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038307|NCT04206332|83290538|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038308|NCT04206332|83290539|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038309|NCT04206332|83290540|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038310|NCT04206332|83290541|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038311|NCT04206332|83290542|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038312|NCT04206332|83290543|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038313|NCT04206332|83290544|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038314|NCT04206332|83290545|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038315|NCT04206332|83290546|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038316|NCT04206332|83290547|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038317|NCT04206332|83290548|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038318|NCT04206332|83290549|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
46714221|NCT00869557|82930251|FG000|Extension Phase|Lack of Efficacy|1|||
46714222|NCT00869557|82930252|FG001|Extension Phase|Lack of Efficacy|0|||
46714223|NCT00869557|82930251|FG000|Extension Phase|Lost to Follow-up|3|||
46714224|NCT00869557|82930252|FG001|Extension Phase|Lost to Follow-up|1|||
46714225|NCT00869557|82930251|FG000|Extension Phase|Investigator's Discretion|2|||
46714226|NCT00869557|82930252|FG001|Extension Phase|Investigator's Discretion|0|||
46714227|NCT00869557|82930251|FG000|Extension Phase|Withdrew Consent|2|||
46714228|NCT00869557|82930252|FG001|Extension Phase|Withdrew Consent|0|||
46714229|NCT01200290|82930259|FG000|Treatment Period|Adverse Event|1|||
46714230|NCT01200290|82930259|FG000|Post-Treatment Follow-Up Period|Death|2|||
46714231|NCT01134263|82930268|FG000|Overall Study|Serious adverse event|2|||
46714232|NCT01134263|82930269|FG001|Overall Study|Serious adverse event|1|||
46714233|NCT01134263|82930270|FG002|Overall Study|Serious adverse event|1|||
47038319|NCT04206332|83290550|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038320|NCT04206332|83290551|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038321|NCT04206332|83290552|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038322|NCT04206332|83290553|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
47038323|NCT04206332|83290554|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
47038324|NCT04206332|83290538|FG000|Part C|Withdrawal by Subject|0|||
47038325|NCT04206332|83290539|FG001|Part C|Withdrawal by Subject|0|||
47038326|NCT04206332|83290540|FG002|Part C|Withdrawal by Subject|0|||
47038327|NCT04206332|83290541|FG003|Part C|Withdrawal by Subject|0|||
47038328|NCT04206332|83290542|FG004|Part C|Withdrawal by Subject|0|||
47038329|NCT04206332|83290543|FG005|Part C|Withdrawal by Subject|0|||
47038330|NCT04206332|83290544|FG006|Part C|Withdrawal by Subject|0|||
47038331|NCT04206332|83290545|FG007|Part C|Withdrawal by Subject|0|||
47038332|NCT04206332|83290546|FG008|Part C|Withdrawal by Subject|0|||
47038333|NCT04206332|83290547|FG009|Part C|Withdrawal by Subject|0|||
47038334|NCT04206332|83290548|FG010|Part C|Withdrawal by Subject|0|||
47038335|NCT04206332|83290549|FG011|Part C|Withdrawal by Subject|0|||
47038336|NCT04206332|83290550|FG012|Part C|Withdrawal by Subject|0|||
47038337|NCT04206332|83290551|FG013|Part C|Withdrawal by Subject|0|||
47038338|NCT04206332|83290552|FG014|Part C|Withdrawal by Subject|2|||
47038339|NCT04206332|83290553|FG015|Part C|Withdrawal by Subject|0|||
47038340|NCT04206332|83290554|FG016|Part C|Withdrawal by Subject|0|||
46913950|NCT02906670|83144476|FG002|Cohort 1, QW|Radiological Progression|0|||
46913951|NCT02906670|83144477|FG003|Cohort 1, QW|Radiological Progression|0|||
46913952|NCT02906670|83144478|FG004|Cohort 1, QW|Radiological Progression|0|||
47038341|NCT03790111|83290637|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
47038342|NCT03780543|83290644|FG000|Overall Study|Adverse Event|1|||
47038343|NCT03780543|83290645|FG001|Overall Study|Adverse Event|0|||
47038344|NCT03780543|83290646|FG002|Overall Study|Adverse Event|2|||
47038345|NCT03780543|83290644|FG000|Overall Study|Lost to Follow-up|2|||
47038346|NCT03780543|83290645|FG001|Overall Study|Lost to Follow-up|0|||
47038347|NCT03780543|83290646|FG002|Overall Study|Lost to Follow-up|1|||
47038348|NCT03780543|83290644|FG000|Overall Study|Study terminated by Sponsor|8|||
47038349|NCT03780543|83290645|FG001|Overall Study|Study terminated by Sponsor|7|||
47038350|NCT03780543|83290646|FG002|Overall Study|Study terminated by Sponsor|13|||
47038351|NCT03780543|83290644|FG000|Overall Study|Withdrawal by Subject|1|||
47038352|NCT03780543|83290645|FG001|Overall Study|Withdrawal by Subject|8|||
47038353|NCT03780543|83290646|FG002|Overall Study|Withdrawal by Subject|1|||
47038354|NCT03780543|83290644|FG000|Overall Study|Noncompliance with study drug|1|||
47038355|NCT03780543|83290645|FG001|Overall Study|Noncompliance with study drug|0|||
47038356|NCT03780543|83290646|FG002|Overall Study|Noncompliance with study drug|0|||
47038357|NCT03745820|83290659|FG000|Overall Study|Adverse Event|0|||
47038358|NCT03745820|83290660|FG001|Overall Study|Adverse Event|3|||
47038359|NCT03745820|83290661|FG002|Overall Study|Adverse Event|2|||
47038360|NCT03745820|83290659|FG000|Overall Study|Non-Compliance with Study Drug|4|||
47038361|NCT03745820|83290660|FG001|Overall Study|Non-Compliance with Study Drug|3|||
47038362|NCT03745820|83290661|FG002|Overall Study|Non-Compliance with Study Drug|0|||
47038363|NCT03745820|83290659|FG000|Overall Study|Withdrawal by Subject|4|||
47038364|NCT03745820|83290660|FG001|Overall Study|Withdrawal by Subject|4|||
47038365|NCT03745820|83290661|FG002|Overall Study|Withdrawal by Subject|4|||
47038366|NCT03745820|83290659|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
47038367|NCT03745820|83290660|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
47038368|NCT03745820|83290661|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
47038369|NCT03745820|83290659|FG000|Overall Study|Lost to Follow-up|2|||
47038370|NCT03745820|83290660|FG001|Overall Study|Lost to Follow-up|0|||
47038371|NCT03745820|83290661|FG002|Overall Study|Lost to Follow-up|3|||
46630650|NCT01918332|82803736|FG003|Overall Study|Protocol Violation|3|||
46630651|NCT01918332|82803733|FG000|Overall Study|lipid result by central lab did not meet|0|||
46630652|NCT01918332|82803734|FG001|Overall Study|lipid result by central lab did not meet|0|||
46630653|NCT01918332|82803735|FG002|Overall Study|lipid result by central lab did not meet|1|||
46913953|NCT02906670|83144479|FG005|Cohort 1, QW|Radiological Progression|0|||
46913954|NCT02906670|83144480|FG006|Cohort 1, QW|Radiological Progression|0|||
46913955|NCT02906670|83144481|FG007|Cohort 1, QW|Radiological Progression|0|||
46913956|NCT02906670|83144482|FG008|Cohort 1, QW|Radiological Progression|0|||
46913957|NCT02906670|83144483|FG009|Cohort 1, QW|Radiological Progression|0|||
47038372|NCT03745820|83290659|FG000|Overall Study|Reason not Specified|2|||
47038373|NCT03745820|83290660|FG001|Overall Study|Reason not Specified|4|||
47038374|NCT03745820|83290661|FG002|Overall Study|Reason not Specified|1|||
47038375|NCT03699631|83290669|FG000|Overall Study|Adverse Event|3|||
47038376|NCT03686150|83290679|FG000|Overall Study|Withdrawal by Subject|1|||
47038377|NCT03686150|83290680|FG001|Overall Study|Withdrawal by Subject|1|||
47038378|NCT03686150|83290681|FG002|Overall Study|Withdrawal by Subject|1|||
47038379|NCT03686150|83290682|FG003|Overall Study|Withdrawal by Subject|0|||
47038380|NCT03686150|83290683|FG004|Overall Study|Withdrawal by Subject|1|||
47038381|NCT03686150|83290684|FG005|Overall Study|Withdrawal by Subject|2|||
47038382|NCT03686150|83290679|FG000|Overall Study|Physician Decision|1|||
47038383|NCT03686150|83290680|FG001|Overall Study|Physician Decision|0|||
47038384|NCT03686150|83290681|FG002|Overall Study|Physician Decision|0|||
47038385|NCT03686150|83290682|FG003|Overall Study|Physician Decision|0|||
47038386|NCT03686150|83290683|FG004|Overall Study|Physician Decision|0|||
47038387|NCT03686150|83290684|FG005|Overall Study|Physician Decision|1|||
47038388|NCT03686150|83290679|FG000|Overall Study|Lost to Follow-up|0|||
47038389|NCT03686150|83290680|FG001|Overall Study|Lost to Follow-up|1|||
47038390|NCT03686150|83290681|FG002|Overall Study|Lost to Follow-up|0|||
47038391|NCT03686150|83290682|FG003|Overall Study|Lost to Follow-up|0|||
47038392|NCT03686150|83290683|FG004|Overall Study|Lost to Follow-up|0|||
47038393|NCT03686150|83290684|FG005|Overall Study|Lost to Follow-up|0|||
47038394|NCT03604172|83290697|FG000|Overall Study|Lost to Follow-up|1|||
47038395|NCT03604172|83290698|FG001|Overall Study|Lost to Follow-up|2|||
47038396|NCT03496207|83290707|FG000|Base Study|Adverse Event|0|||
47038397|NCT03496207|83290708|FG001|Base Study|Adverse Event|0|||
47038398|NCT03496207|83290709|FG002|Base Study|Adverse Event|1|||
47038399|NCT03496207|83290710|FG003|Base Study|Adverse Event|1|||
47038400|NCT03496207|83290711|FG004|Base Study|Adverse Event|4|||
47038401|NCT03496207|83290707|FG000|Base Study|Death|0|||
47038402|NCT03496207|83290708|FG001|Base Study|Death|0|||
47038403|NCT03496207|83290709|FG002|Base Study|Death|0|||
47038404|NCT03496207|83290710|FG003|Base Study|Death|0|||
47038405|NCT03496207|83290711|FG004|Base Study|Death|1|||
46714234|NCT01134263|82930271|FG003|Overall Study|Serious adverse event|1|||
46714235|NCT01134263|82930272|FG004|Overall Study|Serious adverse event|1|||
46714236|NCT01134263|82930268|FG000|Overall Study|Other adverse event|1|||
46714237|NCT01134263|82930269|FG001|Overall Study|Other adverse event|2|||
46714238|NCT01134263|82930270|FG002|Overall Study|Other adverse event|5|||
46714239|NCT01134263|82930271|FG003|Overall Study|Other adverse event|3|||
46714240|NCT01134263|82930272|FG004|Overall Study|Other adverse event|0|||
46714241|NCT01134263|82930268|FG000|Overall Study|Protocol Violation|8|||
46714242|NCT01134263|82930269|FG001|Overall Study|Protocol Violation|7|||
46714243|NCT01134263|82930270|FG002|Overall Study|Protocol Violation|2|||
46714244|NCT01134263|82930271|FG003|Overall Study|Protocol Violation|4|||
46714245|NCT01134263|82930272|FG004|Overall Study|Protocol Violation|2|||
46714246|NCT01134263|82930268|FG000|Overall Study|Lost to Follow-up|4|||
46714247|NCT01134263|82930269|FG001|Overall Study|Lost to Follow-up|3|||
46714248|NCT01134263|82930270|FG002|Overall Study|Lost to Follow-up|5|||
46714249|NCT01134263|82930271|FG003|Overall Study|Lost to Follow-up|3|||
46714250|NCT01134263|82930272|FG004|Overall Study|Lost to Follow-up|1|||
46714251|NCT01134263|82930268|FG000|Overall Study|Withdrawal by Subject|8|||
46714252|NCT01134263|82930269|FG001|Overall Study|Withdrawal by Subject|6|||
46714253|NCT01134263|82930270|FG002|Overall Study|Withdrawal by Subject|16|||
46714254|NCT01134263|82930271|FG003|Overall Study|Withdrawal by Subject|7|||
46714255|NCT01134263|82930272|FG004|Overall Study|Withdrawal by Subject|5|||
46714256|NCT01134263|82930268|FG000|Overall Study|Enrolled, but not treated|1|||
46714257|NCT01134263|82930269|FG001|Overall Study|Enrolled, but not treated|1|||
46714258|NCT01134263|82930270|FG002|Overall Study|Enrolled, but not treated|0|||
46714259|NCT01134263|82930271|FG003|Overall Study|Enrolled, but not treated|1|||
46714260|NCT01134263|82930272|FG004|Overall Study|Enrolled, but not treated|0|||
46714261|NCT01199822|82930293|FG000|Overall Study|Investigator discontinued therapy|0|||
46714262|NCT01199822|82930294|FG001|Overall Study|Investigator discontinued therapy|1|||
46714263|NCT01199822|82930295|FG002|Overall Study|Investigator discontinued therapy|0|||
46714264|NCT01096056|82930312|FG000|Overall Study|Lost to Follow-up|0|||
46714265|NCT01096056|82930313|FG001|Overall Study|Lost to Follow-up|1|||
46714266|NCT00866359|82930321|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
47038406|NCT03496207|83290707|FG000|Base Study|Withdrawal by Subject|0|||
47038407|NCT03496207|83290708|FG001|Base Study|Withdrawal by Subject|0|||
46714267|NCT00866359|82930322|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
46714268|NCT00866359|82930323|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
47038408|NCT03496207|83290709|FG002|Base Study|Withdrawal by Subject|1|||
47038409|NCT03496207|83290710|FG003|Base Study|Withdrawal by Subject|0|||
46714269|NCT00866359|82930324|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
46714270|NCT00866359|82930321|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
46714271|NCT00866359|82930322|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
46714272|NCT00866359|82930323|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
46714273|NCT00866359|82930324|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
46714274|NCT00866359|82930321|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
46714275|NCT00866359|82930322|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
46714276|NCT00866359|82930323|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
47038410|NCT03496207|83290711|FG004|Base Study|Withdrawal by Subject|1|||
47038411|NCT03496207|83290707|FG000|Extension Period|Adverse Event|0|||
47038412|NCT03496207|83290708|FG001|Extension Period|Adverse Event|0|||
47038413|NCT03496207|83290709|FG002|Extension Period|Adverse Event|0|||
47038414|NCT03496207|83290710|FG003|Extension Period|Adverse Event|1|||
46714277|NCT00866359|82930324|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
46714278|NCT00866359|82930321|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
46714279|NCT00866359|82930322|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
46714280|NCT00866359|82930323|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
46714281|NCT00866359|82930324|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
46714282|NCT00866359|82930321|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
46714283|NCT00866359|82930322|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
46714284|NCT00866359|82930323|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
46714285|NCT00866359|82930324|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
46714286|NCT00866359|82930321|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
46714287|NCT00866359|82930322|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
46714288|NCT00866359|82930323|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
46714289|NCT00866359|82930324|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
46714290|NCT01199198|82930353|FG000|Overall Study|Adverse Event|3|||
46714291|NCT01199198|82930354|FG001|Overall Study|Adverse Event|0|||
46714292|NCT01199198|82930353|FG000|Overall Study|Lost to Follow-up|1|||
46714293|NCT01199198|82930354|FG001|Overall Study|Lost to Follow-up|5|||
46714294|NCT01199198|82930353|FG000|Overall Study|Withdrawal by Subject|1|||
46714295|NCT01199198|82930354|FG001|Overall Study|Withdrawal by Subject|2|||
46714296|NCT01199198|82930353|FG000|Overall Study|ICU Transfer|1|||
46714297|NCT01199198|82930354|FG001|Overall Study|ICU Transfer|2|||
46714298|NCT01199198|82930353|FG000|Overall Study|Hospice-care transfer|1|||
46714299|NCT01199198|82930354|FG001|Overall Study|Hospice-care transfer|2|||
46714300|NCT01095978|82930360|FG000|Overall Study|Did not take Klacid SR|2|||
46714301|NCT01095978|82930360|FG000|Overall Study|Adverse Event|1|||
46714302|NCT01134107|82930368|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
46714303|NCT01134107|82930369|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
46714304|NCT01134107|82930368|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
46714305|NCT01134107|82930369|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
46714306|NCT01134107|82930368|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
46714307|NCT01134107|82930369|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
46714308|NCT01134107|82930368|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
46714309|NCT01134107|82930369|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
46714310|NCT01134107|82930368|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
46714311|NCT01134107|82930369|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
46714312|NCT01134107|82930368|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
46714313|NCT01134107|82930369|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
46714314|NCT01134107|82930368|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
46714315|NCT01134107|82930369|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
46714316|NCT01199042|82930375|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
46714317|NCT01199042|82930375|FG000|At Home (3 Months)|Lost to Follow-up|1|||
46714318|NCT01198574|82930388|FG000|Overall Study|Resigned from schools|4|||
46714319|NCT01198574|82930389|FG001|Overall Study|Resigned from schools|1|||
46714320|NCT01198574|82930390|FG002|Overall Study|Resigned from schools|1|||
46714321|NCT01198574|82930391|FG003|Overall Study|Resigned from schools|4|||
46714322|NCT01198028|82930401|FG000|Overall Study|Adverse Event|5|||
46714323|NCT01198028|82930401|FG000|Overall Study|Death|3|||
46714324|NCT01198028|82930401|FG000|Overall Study|Physician Decision|2|||
46714325|NCT01197950|82930408|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
46714326|NCT01197950|82930409|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
46714327|NCT01197950|82930410|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
46714328|NCT01092780|82930418|FG000|Washout Period 1|Adverse Event|0|||
46714329|NCT01092780|82930419|FG001|Washout Period 1|Adverse Event|1|||
46714330|NCT01092780|82930420|FG002|Washout Period 1|Adverse Event|0|||
46714331|NCT01092780|82930421|FG003|Washout Period 1|Adverse Event|0|||
46714332|NCT01092780|82930418|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
46714333|NCT01092780|82930419|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
46714334|NCT01092780|82930420|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
46714335|NCT01092780|82930421|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
46913958|NCT02906670|83144474|FG000|Cohort 2, QW|Radiological Progression|0|||
46714336|NCT01092780|82930418|FG000|Washout Period 2|Adverse Event|0|||
46714337|NCT01092780|82930419|FG001|Washout Period 2|Adverse Event|1|||
46714338|NCT01092780|82930420|FG002|Washout Period 2|Adverse Event|1|||
46714339|NCT01092780|82930421|FG003|Washout Period 2|Adverse Event|0|||
46714340|NCT01092546|82930431|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
46714341|NCT01197794|82930442|FG000|Overall Study|Adverse Event|3|||
46714342|NCT01197794|82930443|FG001|Overall Study|Adverse Event|2|||
46714343|NCT01197794|82930444|FG002|Overall Study|Adverse Event|4|||
46714344|NCT01197794|82930445|FG003|Overall Study|Adverse Event|4|||
46714345|NCT01197794|82930446|FG004|Overall Study|Adverse Event|4|||
46714346|NCT01197794|82930447|FG005|Overall Study|Adverse Event|2|||
46714347|NCT01197794|82930448|FG006|Overall Study|Adverse Event|3|||
46714348|NCT01197794|82930442|FG000|Overall Study|Protocol Violation|0|||
46714349|NCT01197794|82930443|FG001|Overall Study|Protocol Violation|0|||
46714350|NCT01197794|82930444|FG002|Overall Study|Protocol Violation|0|||
46714351|NCT01197794|82930445|FG003|Overall Study|Protocol Violation|0|||
46714352|NCT01197794|82930446|FG004|Overall Study|Protocol Violation|2|||
46714353|NCT01197794|82930447|FG005|Overall Study|Protocol Violation|0|||
46714354|NCT01197794|82930448|FG006|Overall Study|Protocol Violation|1|||
46714355|NCT01197794|82930442|FG000|Overall Study|Development of study withdrawal criteria|3|||
46714356|NCT01197794|82930443|FG001|Overall Study|Development of study withdrawal criteria|0|||
46714357|NCT01197794|82930444|FG002|Overall Study|Development of study withdrawal criteria|0|||
46714358|NCT01197794|82930445|FG003|Overall Study|Development of study withdrawal criteria|1|||
46714359|NCT01197794|82930446|FG004|Overall Study|Development of study withdrawal criteria|0|||
46714360|NCT01197794|82930447|FG005|Overall Study|Development of study withdrawal criteria|0|||
46714361|NCT01197794|82930448|FG006|Overall Study|Development of study withdrawal criteria|1|||
46714362|NCT01197794|82930442|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
46714363|NCT01197794|82930443|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
46714364|NCT01197794|82930444|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
46714365|NCT01197794|82930445|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
46714366|NCT01197794|82930446|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
46714367|NCT01197794|82930447|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
46714368|NCT01197794|82930448|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
46714369|NCT01197794|82930442|FG000|Overall Study|Withdrawal by Subject|3|||
46714370|NCT01197794|82930443|FG001|Overall Study|Withdrawal by Subject|3|||
46714371|NCT01197794|82930444|FG002|Overall Study|Withdrawal by Subject|4|||
46714372|NCT01197794|82930445|FG003|Overall Study|Withdrawal by Subject|1|||
46714373|NCT01197794|82930446|FG004|Overall Study|Withdrawal by Subject|1|||
46714374|NCT01197794|82930447|FG005|Overall Study|Withdrawal by Subject|5|||
46714375|NCT01197794|82930448|FG006|Overall Study|Withdrawal by Subject|6|||
46714376|NCT01197794|82930442|FG000|Overall Study|Lost to Follow-up|1|||
46714377|NCT01197794|82930443|FG001|Overall Study|Lost to Follow-up|1|||
46913959|NCT02906670|83144475|FG001|Cohort 2, QW|Radiological Progression|1|||
46913960|NCT02906670|83144476|FG002|Cohort 2, QW|Radiological Progression|0|||
46913961|NCT02906670|83144477|FG003|Cohort 2, QW|Radiological Progression|0|||
47038415|NCT03496207|83290711|FG004|Extension Period|Adverse Event|1|||
47038416|NCT03496207|83290707|FG000|Extension Period|Death|1|||
47038417|NCT03496207|83290708|FG001|Extension Period|Death|0|||
47038418|NCT03496207|83290709|FG002|Extension Period|Death|0|||
47038419|NCT03496207|83290710|FG003|Extension Period|Death|1|||
47038420|NCT03496207|83290711|FG004|Extension Period|Death|2|||
47038421|NCT03496207|83290707|FG000|Extension Period|Withdrawal by Subject|1|||
47038422|NCT03496207|83290708|FG001|Extension Period|Withdrawal by Subject|0|||
47038423|NCT03496207|83290709|FG002|Extension Period|Withdrawal by Subject|0|||
47038424|NCT03496207|83290710|FG003|Extension Period|Withdrawal by Subject|1|||
46913962|NCT02906670|83144478|FG004|Cohort 2, QW|Radiological Progression|0|||
46913963|NCT02906670|83144479|FG005|Cohort 2, QW|Radiological Progression|0|||
46913964|NCT02906670|83144480|FG006|Cohort 2, QW|Radiological Progression|0|||
46913965|NCT02906670|83144481|FG007|Cohort 2, QW|Radiological Progression|0|||
46913966|NCT02906670|83144482|FG008|Cohort 2, QW|Radiological Progression|0|||
46913967|NCT02906670|83144483|FG009|Cohort 2, QW|Radiological Progression|0|||
46913968|NCT02906670|83144474|FG000|Cohort 3, QW|Radiological Progression|0|||
46913969|NCT02906670|83144475|FG001|Cohort 3, QW|Radiological Progression|0|||
46913970|NCT02906670|83144476|FG002|Cohort 3, QW|Radiological Progression|2|||
46913971|NCT02906670|83144477|FG003|Cohort 3, QW|Radiological Progression|0|||
46913972|NCT02906670|83144478|FG004|Cohort 3, QW|Radiological Progression|0|||
46913973|NCT02906670|83144479|FG005|Cohort 3, QW|Radiological Progression|0|||
46913974|NCT02906670|83144480|FG006|Cohort 3, QW|Radiological Progression|0|||
46714378|NCT01197794|82930444|FG002|Overall Study|Lost to Follow-up|0|||
46714379|NCT01197794|82930445|FG003|Overall Study|Lost to Follow-up|1|||
46714380|NCT01197794|82930446|FG004|Overall Study|Lost to Follow-up|0|||
46714381|NCT01197794|82930447|FG005|Overall Study|Lost to Follow-up|1|||
46714382|NCT01197794|82930448|FG006|Overall Study|Lost to Follow-up|0|||
46714383|NCT01197794|82930442|FG000|Overall Study|Other|1|||
46714384|NCT01197794|82930443|FG001|Overall Study|Other|1|||
47038425|NCT03496207|83290711|FG004|Extension Period|Withdrawal by Subject|1|||
47038426|NCT03496207|83290707|FG000|Extension Period|Elevated hemoglobin levels|0|||
47038427|NCT03496207|83290708|FG001|Extension Period|Elevated hemoglobin levels|0|||
47038428|NCT03496207|83290709|FG002|Extension Period|Elevated hemoglobin levels|0|||
46714385|NCT01197794|82930444|FG002|Overall Study|Other|3|||
46714386|NCT01197794|82930445|FG003|Overall Study|Other|0|||
46714387|NCT01197794|82930446|FG004|Overall Study|Other|2|||
46714388|NCT01197794|82930447|FG005|Overall Study|Other|2|||
46714389|NCT01197794|82930448|FG006|Overall Study|Other|4|||
46714390|NCT01078662|82930470|FG000|Overall Study|Death|41|||
46714391|NCT01078662|82930471|FG001|Overall Study|Death|103|||
46913975|NCT02906670|83144481|FG007|Cohort 3, QW|Radiological Progression|0|||
46913976|NCT02906670|83144482|FG008|Cohort 3, QW|Radiological Progression|0|||
47038429|NCT03496207|83290710|FG003|Extension Period|Elevated hemoglobin levels|0|||
47038430|NCT03496207|83290711|FG004|Extension Period|Elevated hemoglobin levels|1|||
47038431|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
47038432|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
47038433|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
46630654|NCT01918332|82803736|FG003|Overall Study|lipid result by central lab did not meet|0|||
46630655|NCT01922934|82803748|FG000|Eligible Patients|Death|0|||
46630656|NCT01922934|82803749|FG001|Eligible Patients|Death|7|||
46630657|NCT01922934|82803748|FG000|Eligible Patients|Physician Decision|17|||
46630658|NCT01922934|82803749|FG001|Eligible Patients|Physician Decision|0|||
46630659|NCT01922934|82803748|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
46630660|NCT01922934|82803749|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
46714392|NCT01078662|82930472|FG002|Overall Study|Death|18|||
46714393|NCT01078662|82930473|FG003|Overall Study|Death|5|||
46714394|NCT01078662|82930474|FG004|Overall Study|Death|8|||
46714395|NCT01078662|82930470|FG000|Overall Study|Patients reached data cut-off|12|||
46714396|NCT01078662|82930471|FG001|Overall Study|Patients reached data cut-off|53|||
46714397|NCT01078662|82930472|FG002|Overall Study|Patients reached data cut-off|2|||
46714398|NCT01078662|82930473|FG003|Overall Study|Patients reached data cut-off|2|||
46714399|NCT01078662|82930474|FG004|Overall Study|Patients reached data cut-off|3|||
46714400|NCT01078662|82930470|FG000|Overall Study|Withdrawal by Subject|4|||
46714401|NCT01078662|82930471|FG001|Overall Study|Withdrawal by Subject|11|||
46714402|NCT01078662|82930472|FG002|Overall Study|Withdrawal by Subject|1|||
46714403|NCT01078662|82930473|FG003|Overall Study|Withdrawal by Subject|0|||
46714404|NCT01078662|82930474|FG004|Overall Study|Withdrawal by Subject|0|||
46714405|NCT01078662|82930470|FG000|Overall Study|Protocol Violation|0|||
46714406|NCT01078662|82930471|FG001|Overall Study|Protocol Violation|1|||
46714407|NCT01078662|82930472|FG002|Overall Study|Protocol Violation|0|||
46714408|NCT01078662|82930473|FG003|Overall Study|Protocol Violation|0|||
46714409|NCT01078662|82930474|FG004|Overall Study|Protocol Violation|0|||
46714410|NCT01078662|82930470|FG000|Overall Study|Lost to Follow-up|1|||
46714411|NCT01078662|82930471|FG001|Overall Study|Lost to Follow-up|0|||
46714412|NCT01078662|82930472|FG002|Overall Study|Lost to Follow-up|0|||
46714413|NCT01078662|82930473|FG003|Overall Study|Lost to Follow-up|0|||
46714414|NCT01078662|82930474|FG004|Overall Study|Lost to Follow-up|0|||
46714415|NCT01091454|82930483|FG000|Overall Study|Ineligible|1|||
46714416|NCT01140347|82930489|FG000|Overall Study|Lost to Follow-up|5|||
46714417|NCT01140347|82930490|FG001|Overall Study|Lost to Follow-up|6|||
46714418|NCT01140347|82930489|FG000|Overall Study|Withdrawal by Subject|13|||
46714419|NCT01140347|82930490|FG001|Overall Study|Withdrawal by Subject|8|||
46714420|NCT01197560|82930498|FG000|Overall Study|Adverse Event|6|||
46714421|NCT01197560|82930499|FG001|Overall Study|Adverse Event|8|||
46714422|NCT01197560|82930498|FG000|Overall Study|Death|3|||
46714423|NCT01197560|82930499|FG001|Overall Study|Death|5|||
46714424|NCT01197560|82930498|FG000|Overall Study|Withdrawal by Subject|1|||
46714425|NCT01197560|82930499|FG001|Overall Study|Withdrawal by Subject|1|||
46714426|NCT01197560|82930498|FG000|Overall Study|Disease progression|40|||
46714427|NCT01197560|82930499|FG001|Overall Study|Disease progression|35|||
46714428|NCT01197560|82930498|FG000|Overall Study|Miscellaneous|4|||
46714429|NCT01197560|82930499|FG001|Overall Study|Miscellaneous|3|||
46714430|NCT01197560|82930498|FG000|Overall Study|Missing|0|||
46714431|NCT01197560|82930499|FG001|Overall Study|Missing|1|||
46714432|NCT01133405|82930516|FG000|Period 1|Withdrawal by Subject|0|||
46913977|NCT02906670|83144483|FG009|Cohort 3, QW|Radiological Progression|0|||
46913978|NCT02906670|83144474|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913979|NCT02906670|83144475|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913980|NCT02906670|83144476|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
46714433|NCT01133405|82930517|FG001|Period 1|Withdrawal by Subject|1|||
46714434|NCT01133405|82930518|FG002|Period 1|Withdrawal by Subject|0|||
46714435|NCT01133405|82930519|FG003|Period 1|Withdrawal by Subject|1|||
46714436|NCT01133405|82930520|FG004|Period 1|Withdrawal by Subject|0|||
46714437|NCT01133405|82930521|FG005|Period 1|Withdrawal by Subject|1|||
46714438|NCT01133405|82930522|FG006|Period 1|Withdrawal by Subject|0|||
46714439|NCT01133405|82930523|FG007|Period 1|Withdrawal by Subject|0|||
46714440|NCT01133405|82930524|FG008|Period 1|Withdrawal by Subject|0|||
46714441|NCT01133405|82930525|FG009|Period 1|Withdrawal by Subject|0|||
46714442|NCT01133405|82930516|FG000|Period 1|Physician Decision|0|||
46714443|NCT01133405|82930517|FG001|Period 1|Physician Decision|0|||
46913981|NCT02906670|83144477|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913982|NCT02906670|83144478|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913983|NCT02906670|83144479|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913984|NCT02906670|83144480|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913985|NCT02906670|83144481|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913986|NCT02906670|83144482|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913987|NCT02906670|83144483|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
46913988|NCT02906670|83144474|FG000|Cohort 4, Q2W|Radiological Progression|0|||
46913989|NCT02906670|83144475|FG001|Cohort 4, Q2W|Radiological Progression|0|||
46714444|NCT01133405|82930518|FG002|Period 1|Physician Decision|0|||
46714445|NCT01133405|82930519|FG003|Period 1|Physician Decision|1|||
46714446|NCT01133405|82930520|FG004|Period 1|Physician Decision|0|||
46714447|NCT01133405|82930521|FG005|Period 1|Physician Decision|0|||
46714448|NCT01133405|82930522|FG006|Period 1|Physician Decision|0|||
46714449|NCT01133405|82930523|FG007|Period 1|Physician Decision|0|||
46714450|NCT01133405|82930524|FG008|Period 1|Physician Decision|0|||
46714451|NCT01133405|82930525|FG009|Period 1|Physician Decision|0|||
46714452|NCT01133405|82930516|FG000|Period 1|Discontinued after randomization|1|||
47038434|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
47038435|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
47038436|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
47038437|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
47038438|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
47038439|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
47038440|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
47038441|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
47038442|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
47038443|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
46714453|NCT01133405|82930517|FG001|Period 1|Discontinued after randomization|0|||
46714454|NCT01133405|82930518|FG002|Period 1|Discontinued after randomization|0|||
46714455|NCT01133405|82930519|FG003|Period 1|Discontinued after randomization|0|||
46714456|NCT01133405|82930520|FG004|Period 1|Discontinued after randomization|0|||
46714457|NCT01133405|82930521|FG005|Period 1|Discontinued after randomization|0|||
46714458|NCT01133405|82930522|FG006|Period 1|Discontinued after randomization|1|||
46714459|NCT01133405|82930523|FG007|Period 1|Discontinued after randomization|0|||
46714460|NCT01133405|82930524|FG008|Period 1|Discontinued after randomization|0|||
46714461|NCT01133405|82930525|FG009|Period 1|Discontinued after randomization|0|||
46714462|NCT01133405|82930516|FG000|Period 1|Received drug only in period 2|0|||
46714463|NCT01133405|82930517|FG001|Period 1|Received drug only in period 2|1|||
46714464|NCT01133405|82930518|FG002|Period 1|Received drug only in period 2|0|||
46714465|NCT01133405|82930519|FG003|Period 1|Received drug only in period 2|2|||
46714466|NCT01133405|82930520|FG004|Period 1|Received drug only in period 2|0|||
46714467|NCT01133405|82930521|FG005|Period 1|Received drug only in period 2|1|||
46714468|NCT01133405|82930522|FG006|Period 1|Received drug only in period 2|0|||
46714469|NCT01133405|82930523|FG007|Period 1|Received drug only in period 2|0|||
46714470|NCT01133405|82930524|FG008|Period 1|Received drug only in period 2|0|||
46714471|NCT01133405|82930525|FG009|Period 1|Received drug only in period 2|0|||
46714472|NCT01133405|82930516|FG000|Period 1|Received drug only in period 3|0|||
46714473|NCT01133405|82930517|FG001|Period 1|Received drug only in period 3|1|||
46714474|NCT01133405|82930518|FG002|Period 1|Received drug only in period 3|1|||
46714475|NCT01133405|82930519|FG003|Period 1|Received drug only in period 3|0|||
46714476|NCT01133405|82930520|FG004|Period 1|Received drug only in period 3|0|||
46714477|NCT01133405|82930521|FG005|Period 1|Received drug only in period 3|0|||
46714478|NCT01133405|82930522|FG006|Period 1|Received drug only in period 3|0|||
46714479|NCT01133405|82930523|FG007|Period 1|Received drug only in period 3|0|||
46714480|NCT01133405|82930524|FG008|Period 1|Received drug only in period 3|0|||
46714481|NCT01133405|82930525|FG009|Period 1|Received drug only in period 3|0|||
47038444|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
47038445|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
47038446|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
46630661|NCT01922934|82803748|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
46630662|NCT01922934|82803749|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
46630663|NCT01922934|82803748|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
46630664|NCT01922934|82803749|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
46630665|NCT01922934|82803748|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
46630666|NCT01922934|82803749|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
46630667|NCT01970592|82803757|FG000|Overall Study|Withdrawal by Subject|4|||
46630668|NCT01970592|82803757|FG000|Overall Study|Physician Decision|1|||
46630669|NCT01970592|82803757|FG000|Overall Study|Adverse Event|1|||
46630670|NCT01920594|82803763|FG000|Overall Study|Adverse Event|4|||
46630671|NCT01920594|82803764|FG001|Overall Study|Adverse Event|2|||
46630672|NCT01920594|82803763|FG000|Overall Study|Lost to Follow-up|1|||
46630673|NCT01920594|82803764|FG001|Overall Study|Lost to Follow-up|0|||
46714482|NCT01133405|82930516|FG000|Period 2|Adverse Event|0|||
46630674|NCT01920594|82803763|FG000|Overall Study|Recovery|2|||
46714483|NCT01133405|82930517|FG001|Period 2|Adverse Event|0|||
46714484|NCT01133405|82930518|FG002|Period 2|Adverse Event|1|||
46714485|NCT01133405|82930519|FG003|Period 2|Adverse Event|0|||
46714486|NCT01133405|82930520|FG004|Period 2|Adverse Event|0|||
46714487|NCT01133405|82930521|FG005|Period 2|Adverse Event|0|||
46714488|NCT01133405|82930522|FG006|Period 2|Adverse Event|0|||
46714489|NCT01133405|82930523|FG007|Period 2|Adverse Event|0|||
46714490|NCT01133405|82930524|FG008|Period 2|Adverse Event|0|||
47038447|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
47038448|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
47038449|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
47038450|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
47038451|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
47038452|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
47038453|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
47038454|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
47038455|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
47038456|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
47038457|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
47038458|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
47038459|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
47038460|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
46714491|NCT01133405|82930525|FG009|Period 2|Adverse Event|0|||
46714492|NCT01133405|82930516|FG000|Period 2|Withdrawal by Subject|0|||
46714493|NCT01133405|82930517|FG001|Period 2|Withdrawal by Subject|0|||
46714494|NCT01133405|82930518|FG002|Period 2|Withdrawal by Subject|0|||
46714495|NCT01133405|82930519|FG003|Period 2|Withdrawal by Subject|1|||
46714496|NCT01133405|82930520|FG004|Period 2|Withdrawal by Subject|0|||
46714497|NCT01133405|82930521|FG005|Period 2|Withdrawal by Subject|1|||
46714498|NCT01133405|82930522|FG006|Period 2|Withdrawal by Subject|0|||
47038461|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
47038462|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
46714499|NCT01133405|82930523|FG007|Period 2|Withdrawal by Subject|0|||
46714500|NCT01133405|82930524|FG008|Period 2|Withdrawal by Subject|0|||
46714501|NCT01133405|82930525|FG009|Period 2|Withdrawal by Subject|0|||
46714502|NCT01133405|82930516|FG000|Period 2|Entry Criteria Not Met|0|||
46714503|NCT01133405|82930517|FG001|Period 2|Entry Criteria Not Met|1|||
46714504|NCT01133405|82930518|FG002|Period 2|Entry Criteria Not Met|0|||
46714505|NCT01133405|82930519|FG003|Period 2|Entry Criteria Not Met|0|||
46714506|NCT01133405|82930520|FG004|Period 2|Entry Criteria Not Met|0|||
46714507|NCT01133405|82930521|FG005|Period 2|Entry Criteria Not Met|0|||
46714508|NCT01133405|82930522|FG006|Period 2|Entry Criteria Not Met|0|||
46714509|NCT01133405|82930523|FG007|Period 2|Entry Criteria Not Met|0|||
46714510|NCT01133405|82930524|FG008|Period 2|Entry Criteria Not Met|0|||
46714511|NCT01133405|82930525|FG009|Period 2|Entry Criteria Not Met|0|||
46714512|NCT01133405|82930516|FG000|Period 2|Physician Decision|0|||
46714513|NCT01133405|82930517|FG001|Period 2|Physician Decision|0|||
46714514|NCT01133405|82930518|FG002|Period 2|Physician Decision|0|||
46714515|NCT01133405|82930519|FG003|Period 2|Physician Decision|0|||
46630675|NCT01920594|82803764|FG001|Overall Study|Recovery|0|||
46630676|NCT01920594|82803763|FG000|Overall Study|Investigator discretion|0|||
46630677|NCT01920594|82803764|FG001|Overall Study|Investigator discretion|1|||
46630678|NCT01917084|82803770|FG000|Overall Study|Withdrawal by Subject|1|||
46630679|NCT01917006|82803781|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
46630680|NCT01917006|82803782|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
46630681|NCT01917006|82803783|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
46630682|NCT01917006|82803784|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
46630683|NCT01917006|82803785|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
46630684|NCT01917006|82803786|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
46630685|NCT01917006|82803787|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
46630686|NCT01917006|82803788|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
46630687|NCT01917006|82803781|FG000|Randomized-treatment Period|Personal Reasons|0|||
46630688|NCT01917006|82803782|FG001|Randomized-treatment Period|Personal Reasons|0|||
46630689|NCT01917006|82803783|FG002|Randomized-treatment Period|Personal Reasons|0|||
46630690|NCT01917006|82803784|FG003|Randomized-treatment Period|Personal Reasons|0|||
46630691|NCT01917006|82803785|FG004|Randomized-treatment Period|Personal Reasons|0|||
46630692|NCT01917006|82803786|FG005|Randomized-treatment Period|Personal Reasons|1|||
46630693|NCT01917006|82803787|FG006|Randomized-treatment Period|Personal Reasons|0|||
46630694|NCT01917006|82803788|FG007|Randomized-treatment Period|Personal Reasons|0|||
46630695|NCT01917006|82803781|FG000|Randomized-treatment Period|Protocol Violation|1|||
46630696|NCT01917006|82803782|FG001|Randomized-treatment Period|Protocol Violation|0|||
46630697|NCT01917006|82803783|FG002|Randomized-treatment Period|Protocol Violation|0|||
46630698|NCT01917006|82803784|FG003|Randomized-treatment Period|Protocol Violation|0|||
46630699|NCT01917006|82803785|FG004|Randomized-treatment Period|Protocol Violation|0|||
46714516|NCT01133405|82930520|FG004|Period 2|Physician Decision|0|||
46714517|NCT01133405|82930521|FG005|Period 2|Physician Decision|1|||
46714518|NCT01133405|82930522|FG006|Period 2|Physician Decision|0|||
46714519|NCT01133405|82930523|FG007|Period 2|Physician Decision|0|||
46714520|NCT01133405|82930524|FG008|Period 2|Physician Decision|0|||
46714521|NCT01133405|82930525|FG009|Period 2|Physician Decision|0|||
46714522|NCT01196078|82930557|FG000|Overall Study|Withdrawal by Subject|3|||
46714523|NCT01196078|82930558|FG001|Overall Study|Withdrawal by Subject|5|||
46714524|NCT01196078|82930557|FG000|Overall Study|Adverse Event|4|||
46714525|NCT01196078|82930558|FG001|Overall Study|Adverse Event|4|||
46714526|NCT01196078|82930557|FG000|Overall Study|Protocol Violation|2|||
46714527|NCT01196078|82930558|FG001|Overall Study|Protocol Violation|1|||
46714528|NCT01196078|82930557|FG000|Overall Study|Lack of Efficacy|17|||
46714529|NCT01196078|82930558|FG001|Overall Study|Lack of Efficacy|23|||
46714530|NCT01196078|82930557|FG000|Overall Study|Lost to Follow-up|1|||
47038463|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
47038464|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
47038465|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
47038466|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
47038467|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
47038468|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
47038469|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
47038470|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
47038471|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
47038472|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
47038473|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
47038474|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
47038475|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
47038476|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
47038477|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
47038478|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
47038479|NCT03444870|83290736|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
47038480|NCT03444870|83290737|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
47038481|NCT03444870|83290738|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
47038482|NCT03444870|83290739|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
47038483|NCT03444870|83290740|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
47038484|NCT03444870|83290741|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
47038485|NCT03444870|83290736|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
47038486|NCT03444870|83290737|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
47038487|NCT03444870|83290738|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
47038488|NCT03444870|83290739|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
47038489|NCT03444870|83290740|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
47038490|NCT03444870|83290741|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
47038491|NCT03444870|83290736|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
47038492|NCT03444870|83290737|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
47038493|NCT03444870|83290738|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
47038494|NCT03444870|83290739|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
47038495|NCT03444870|83290740|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
47038496|NCT03444870|83290741|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
47038497|NCT03444870|83290736|FG000|Open-Label Extension (OLE) Period|Death|0|||
47038498|NCT03444870|83290737|FG001|Open-Label Extension (OLE) Period|Death|0|||
47038499|NCT03444870|83290738|FG002|Open-Label Extension (OLE) Period|Death|0|||
47038500|NCT03444870|83290739|FG003|Open-Label Extension (OLE) Period|Death|0|||
47038501|NCT03444870|83290740|FG004|Open-Label Extension (OLE) Period|Death|1|||
47038502|NCT03444870|83290741|FG005|Open-Label Extension (OLE) Period|Death|0|||
47038503|NCT03112590|83290769|FG000|Overall Study|Adverse Event|0|||
47038504|NCT03112590|83290770|FG001|Overall Study|Adverse Event|1|||
47038505|NCT03112590|83290771|FG002|Overall Study|Adverse Event|0|||
47038506|NCT03060629|83290781|FG000|Overall Study|Death|4|||
47038507|NCT03060629|83290782|FG001|Overall Study|Death|5|||
47038508|NCT03060629|83290781|FG000|Overall Study|Withdrawal by Subject|50|||
47038509|NCT03060629|83290782|FG001|Overall Study|Withdrawal by Subject|35|||
46630700|NCT01917006|82803786|FG005|Randomized-treatment Period|Protocol Violation|0|||
46630701|NCT01917006|82803787|FG006|Randomized-treatment Period|Protocol Violation|0|||
46630702|NCT01917006|82803788|FG007|Randomized-treatment Period|Protocol Violation|0|||
46630703|NCT01917006|82803781|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
46630704|NCT01917006|82803782|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
46630705|NCT01917006|82803783|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
46630706|NCT01917006|82803784|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
46630707|NCT01917006|82803785|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
46630708|NCT01917006|82803786|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
46714531|NCT01196078|82930558|FG001|Overall Study|Lost to Follow-up|0|||
47038510|NCT03060629|83290781|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
47038511|NCT03060629|83290782|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
47038512|NCT03060629|83290781|FG000|Overall Study|Participant Relocate|15|||
46714532|NCT01196078|82930557|FG000|Overall Study|Death|6|||
46913990|NCT02906670|83144476|FG002|Cohort 4, Q2W|Radiological Progression|0|||
46714533|NCT01196078|82930558|FG001|Overall Study|Death|4|||
46714534|NCT01078584|82930564|FG000|Overall Study|Final Status Unknown|1073|||
46714535|NCT01078584|82930564|FG000|Overall Study|Lost to Follow-up|670|||
46714536|NCT01078584|82930564|FG000|Overall Study|Non-serious Adverse Event|577|||
46714537|NCT01078584|82930564|FG000|Overall Study|Withdrawal of Consent|244|||
46714538|NCT01078584|82930564|FG000|Overall Study|Physician Withdrew from Study|90|||
46714539|NCT01078584|82930564|FG000|Overall Study|Non-compliance|67|||
46714540|NCT01078584|82930564|FG000|Overall Study|Blood Pressure Controlled|49|||
46714541|NCT01078584|82930564|FG000|Overall Study|Physician Switched Medication|26|||
46714542|NCT01078584|82930564|FG000|Overall Study|Physician Discontinued Patient|12|||
46714543|NCT01078584|82930564|FG000|Overall Study|Lack of Efficacy|98|||
46714544|NCT01078584|82930564|FG000|Overall Study|Protocol Violation|75|||
46714545|NCT01078584|82930564|FG000|Overall Study|Serious Adverse Event|27|||
46714546|NCT01078584|82930564|FG000|Overall Study|Multiple Reasons|2|||
46714547|NCT01133171|82930584|FG000|Overall Study|Withdrawal by Subject|1|||
46714548|NCT01133171|82930585|FG001|Overall Study|Withdrawal by Subject|2|||
46714549|NCT01133171|82930586|FG002|Overall Study|Withdrawal by Subject|0|||
46714550|NCT01195844|82930594|FG000|Overall Study|Fecal sample not collected|40|||
46714551|NCT01132547|82930610|FG000|Overall Study|Withdrawal by Subject|3|||
46714552|NCT01132547|82930611|FG001|Overall Study|Withdrawal by Subject|1|||
46714553|NCT01132547|82930610|FG000|Overall Study|Death|1|||
46714554|NCT01132547|82930611|FG001|Overall Study|Death|0|||
46714555|NCT01194830|82930619|FG000|Overall Study|Adverse Event|3|||
46714556|NCT01194830|82930620|FG001|Overall Study|Adverse Event|2|||
46714557|NCT01194830|82930619|FG000|Overall Study|Protocol Violation|5|||
46714558|NCT01194830|82930620|FG001|Overall Study|Protocol Violation|4|||
46714559|NCT01194830|82930619|FG000|Overall Study|Lost to Follow-up|9|||
46714560|NCT01194830|82930620|FG001|Overall Study|Lost to Follow-up|7|||
46714561|NCT01194830|82930619|FG000|Overall Study|Withdrawal by Subject|2|||
46714562|NCT01194830|82930620|FG001|Overall Study|Withdrawal by Subject|1|||
46714563|NCT01194830|82930619|FG000|Overall Study|Lack of Efficacy|1|||
46913991|NCT02906670|83144477|FG003|Cohort 4, Q2W|Radiological Progression|0|||
47038513|NCT03060629|83290782|FG001|Overall Study|Participant Relocate|15|||
47038514|NCT03060629|83290781|FG000|Overall Study|Unable to Contact Participant|34|||
47038515|NCT03060629|83290782|FG001|Overall Study|Unable to Contact Participant|23|||
47038516|NCT03060629|83290781|FG000|Overall Study|Investigator Decision|7|||
47038517|NCT03060629|83290782|FG001|Overall Study|Investigator Decision|7|||
47038518|NCT03060629|83290781|FG000|Overall Study|Study Terminated by Sponsor|1100|||
47038519|NCT03060629|83290782|FG001|Overall Study|Study Terminated by Sponsor|1123|||
47038520|NCT03060629|83290781|FG000|Overall Study|Other|4|||
47038521|NCT03060629|83290782|FG001|Overall Study|Other|4|||
47038522|NCT03021486|83290791|FG000|Overall Study|Withdrawal by Subject|1|||
47038523|NCT03021486|83290792|FG001|Overall Study|Withdrawal by Subject|1|||
47038524|NCT03021486|83290793|FG002|Overall Study|Withdrawal by Subject|3|||
47038525|NCT03021486|83290791|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
46913992|NCT02906670|83144478|FG004|Cohort 4, Q2W|Radiological Progression|0|||
46913993|NCT02906670|83144479|FG005|Cohort 4, Q2W|Radiological Progression|1|||
46913994|NCT02906670|83144480|FG006|Cohort 4, Q2W|Radiological Progression|0|||
46913995|NCT02906670|83144481|FG007|Cohort 4, Q2W|Radiological Progression|0|||
46913996|NCT02906670|83144482|FG008|Cohort 4, Q2W|Radiological Progression|0|||
46913997|NCT02906670|83144483|FG009|Cohort 4, Q2W|Radiological Progression|0|||
46913998|NCT02906670|83144474|FG000|Cohort 4, Q2W|Clinical Progression|0|||
46913999|NCT02906670|83144475|FG001|Cohort 4, Q2W|Clinical Progression|0|||
46914000|NCT02906670|83144476|FG002|Cohort 4, Q2W|Clinical Progression|0|||
46914001|NCT02906670|83144477|FG003|Cohort 4, Q2W|Clinical Progression|0|||
46914002|NCT02906670|83144478|FG004|Cohort 4, Q2W|Clinical Progression|0|||
46914003|NCT02906670|83144479|FG005|Cohort 4, Q2W|Clinical Progression|2|||
46914004|NCT02906670|83144480|FG006|Cohort 4, Q2W|Clinical Progression|0|||
46914005|NCT02906670|83144481|FG007|Cohort 4, Q2W|Clinical Progression|0|||
46914006|NCT02906670|83144482|FG008|Cohort 4, Q2W|Clinical Progression|0|||
46914007|NCT02906670|83144483|FG009|Cohort 4, Q2W|Clinical Progression|0|||
46914008|NCT02906670|83144474|FG000|Cohort 5, Q2W|Radiological Progression|0|||
46914009|NCT02906670|83144475|FG001|Cohort 5, Q2W|Radiological Progression|0|||
46914010|NCT02906670|83144476|FG002|Cohort 5, Q2W|Radiological Progression|0|||
46914011|NCT02906670|83144477|FG003|Cohort 5, Q2W|Radiological Progression|0|||
46914012|NCT02906670|83144478|FG004|Cohort 5, Q2W|Radiological Progression|0|||
46914013|NCT02906670|83144479|FG005|Cohort 5, Q2W|Radiological Progression|0|||
46914014|NCT02906670|83144480|FG006|Cohort 5, Q2W|Radiological Progression|4|||
46914015|NCT02906670|83144481|FG007|Cohort 5, Q2W|Radiological Progression|0|||
47038526|NCT03021486|83290792|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
47038527|NCT03021486|83290793|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
46714564|NCT01194830|82930620|FG001|Overall Study|Lack of Efficacy|1|||
46714565|NCT01194830|82930619|FG000|Overall Study|Non-compliance issues|4|||
46714566|NCT01194830|82930620|FG001|Overall Study|Non-compliance issues|4|||
46714567|NCT01194830|82930619|FG000|Overall Study|Other Reason|12|||
46714568|NCT01194830|82930620|FG001|Overall Study|Other Reason|8|||
46714569|NCT01194440|82930626|FG000|Baseline (First Dose)|Reason not specified|4|||
46714570|NCT01194440|82930626|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
46714571|NCT01194440|82930626|FG000|Baseline (First Dose)|Change in therapy|1|||
46714572|NCT01194440|82930626|FG000|Baseline (First Dose)|Adverse Event|1|||
46714573|NCT01194440|82930626|FG000|6-months (2nd Dose)|Change in therapy|4|||
46714574|NCT00951015|82930635|FG000|Randomization Phase 96 Week|Adverse Event|1|||
46714575|NCT00951015|82930636|FG001|Randomization Phase 96 Week|Adverse Event|1|||
46714576|NCT00951015|82930637|FG002|Randomization Phase 96 Week|Adverse Event|2|||
46714577|NCT00951015|82930638|FG003|Randomization Phase 96 Week|Adverse Event|5|||
46714578|NCT00951015|82930639|FG004|Randomization Phase 96 Week|Adverse Event|0|||
46714579|NCT00951015|82930635|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
46714580|NCT00951015|82930636|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
46714581|NCT00951015|82930637|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
46714582|NCT00951015|82930638|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
46714583|NCT00951015|82930639|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
46714584|NCT00951015|82930635|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
46714585|NCT00951015|82930636|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
46714586|NCT00951015|82930637|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
46714587|NCT00951015|82930638|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
46714588|NCT00951015|82930639|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
46714589|NCT00951015|82930635|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
46714590|NCT00951015|82930636|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
46714591|NCT00951015|82930637|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
46714592|NCT00951015|82930638|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
46714593|NCT00951015|82930639|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
46714594|NCT00951015|82930635|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
46714595|NCT00951015|82930636|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
46714596|NCT00951015|82930637|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
46714597|NCT00951015|82930638|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
46714598|NCT00951015|82930639|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
46714599|NCT00951015|82930635|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
46714600|NCT00951015|82930636|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
46714601|NCT00951015|82930637|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
46714602|NCT00951015|82930638|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
46714603|NCT00951015|82930639|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
46714604|NCT00951015|82930635|FG000|Open-label Phase|Adverse Event|0|||
46714605|NCT00951015|82930636|FG001|Open-label Phase|Adverse Event|0|||
46714606|NCT00951015|82930637|FG002|Open-label Phase|Adverse Event|0|||
46714607|NCT00951015|82930638|FG003|Open-label Phase|Adverse Event|0|||
46714608|NCT00951015|82930639|FG004|Open-label Phase|Adverse Event|3|||
46714609|NCT00951015|82930635|FG000|Open-label Phase|Lack of Efficacy|0|||
46714610|NCT00951015|82930636|FG001|Open-label Phase|Lack of Efficacy|0|||
46714611|NCT00951015|82930637|FG002|Open-label Phase|Lack of Efficacy|0|||
46714612|NCT00951015|82930638|FG003|Open-label Phase|Lack of Efficacy|0|||
46714613|NCT00951015|82930639|FG004|Open-label Phase|Lack of Efficacy|1|||
46714614|NCT00951015|82930635|FG000|Open-label Phase|Protocol Violation|0|||
46714615|NCT00951015|82930636|FG001|Open-label Phase|Protocol Violation|0|||
46714616|NCT00951015|82930637|FG002|Open-label Phase|Protocol Violation|0|||
46714617|NCT00951015|82930638|FG003|Open-label Phase|Protocol Violation|0|||
46714618|NCT00951015|82930639|FG004|Open-label Phase|Protocol Violation|12|||
46714619|NCT00951015|82930635|FG000|Open-label Phase|Lost to Follow-up|0|||
46714620|NCT00951015|82930636|FG001|Open-label Phase|Lost to Follow-up|0|||
46714621|NCT00951015|82930637|FG002|Open-label Phase|Lost to Follow-up|0|||
46714622|NCT00951015|82930638|FG003|Open-label Phase|Lost to Follow-up|0|||
46714623|NCT00951015|82930639|FG004|Open-label Phase|Lost to Follow-up|12|||
46714624|NCT00951015|82930635|FG000|Open-label Phase|Withdrawal by Subject|0|||
46714625|NCT00951015|82930636|FG001|Open-label Phase|Withdrawal by Subject|0|||
46714626|NCT00951015|82930637|FG002|Open-label Phase|Withdrawal by Subject|0|||
46714627|NCT00951015|82930638|FG003|Open-label Phase|Withdrawal by Subject|0|||
46714628|NCT00951015|82930639|FG004|Open-label Phase|Withdrawal by Subject|14|||
46714629|NCT00951015|82930635|FG000|Open-label Phase|Physician Decision|0|||
46714630|NCT00951015|82930636|FG001|Open-label Phase|Physician Decision|0|||
47038528|NCT02999789|83290805|FG000|Overall Study|Withdrawal by Subject|0|||
46714631|NCT00951015|82930637|FG002|Open-label Phase|Physician Decision|0|||
46714632|NCT00951015|82930638|FG003|Open-label Phase|Physician Decision|0|||
46714633|NCT00951015|82930639|FG004|Open-label Phase|Physician Decision|8|||
46714634|NCT01139021|82930668|FG000|Overall Study|Adverse Event|0|||
46714635|NCT01139021|82930669|FG001|Overall Study|Adverse Event|0|||
46714636|NCT01139021|82930670|FG002|Overall Study|Adverse Event|0|||
46714637|NCT01139021|82930671|FG003|Overall Study|Adverse Event|0|||
46714638|NCT01139021|82930672|FG004|Overall Study|Adverse Event|1|||
46714639|NCT01139021|82930673|FG005|Overall Study|Adverse Event|0|||
46714640|NCT01139021|82930668|FG000|Overall Study|Lost to Follow-up|0|||
46714641|NCT01139021|82930669|FG001|Overall Study|Lost to Follow-up|0|||
46714642|NCT01139021|82930670|FG002|Overall Study|Lost to Follow-up|0|||
46714643|NCT01139021|82930671|FG003|Overall Study|Lost to Follow-up|0|||
46714644|NCT01139021|82930672|FG004|Overall Study|Lost to Follow-up|2|||
46714645|NCT01139021|82930673|FG005|Overall Study|Lost to Follow-up|0|||
46714646|NCT01139021|82930668|FG000|Overall Study|Protocol Violation|1|||
46714647|NCT01139021|82930669|FG001|Overall Study|Protocol Violation|0|||
46714648|NCT01139021|82930670|FG002|Overall Study|Protocol Violation|0|||
46714649|NCT01139021|82930671|FG003|Overall Study|Protocol Violation|0|||
46714650|NCT01139021|82930672|FG004|Overall Study|Protocol Violation|2|||
46714651|NCT01139021|82930673|FG005|Overall Study|Protocol Violation|0|||
46714652|NCT01139021|82930668|FG000|Overall Study|Withdrawal by Subject|0|||
46914016|NCT02906670|83144482|FG008|Cohort 5, Q2W|Radiological Progression|0|||
46914017|NCT02906670|83144483|FG009|Cohort 5, Q2W|Radiological Progression|0|||
46914018|NCT02906670|83144474|FG000|Cohort 5, Q2W|Clinical Progression|0|||
47038529|NCT02999789|83290806|FG001|Overall Study|Withdrawal by Subject|1|||
47038530|NCT02999789|83290805|FG000|Overall Study|Became ineligible|1|||
47038531|NCT02999789|83290806|FG001|Overall Study|Became ineligible|2|||
47038532|NCT02923115|83290819|FG000|Overall Study|Lost to Follow-up|0|||
47038533|NCT02923115|83290820|FG001|Overall Study|Lost to Follow-up|0|||
47038534|NCT02923115|83290821|FG002|Overall Study|Lost to Follow-up|0|||
47038535|NCT02923115|83290822|FG003|Overall Study|Lost to Follow-up|1|||
47038536|NCT02923115|83290823|FG004|Overall Study|Lost to Follow-up|0|||
47038537|NCT02923115|83290824|FG005|Overall Study|Lost to Follow-up|0|||
47038538|NCT02923115|83290819|FG000|Overall Study|Withdrawal by Subject|0|||
47038539|NCT02923115|83290820|FG001|Overall Study|Withdrawal by Subject|1|||
47038540|NCT02923115|83290821|FG002|Overall Study|Withdrawal by Subject|0|||
47038541|NCT02923115|83290822|FG003|Overall Study|Withdrawal by Subject|0|||
47038542|NCT02923115|83290823|FG004|Overall Study|Withdrawal by Subject|0|||
47038543|NCT02923115|83290824|FG005|Overall Study|Withdrawal by Subject|0|||
47038544|NCT02923115|83290819|FG000|Overall Study|Randomized, but not dosed|0|||
47038545|NCT02923115|83290820|FG001|Overall Study|Randomized, but not dosed|0|||
47038546|NCT02923115|83290821|FG002|Overall Study|Randomized, but not dosed|3|||
47038547|NCT02923115|83290822|FG003|Overall Study|Randomized, but not dosed|1|||
47038548|NCT02923115|83290823|FG004|Overall Study|Randomized, but not dosed|5|||
47038549|NCT02923115|83290824|FG005|Overall Study|Randomized, but not dosed|0|||
46630709|NCT01917006|82803787|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
46630710|NCT01917006|82803788|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
46630711|NCT01917006|82803781|FG000|Open-label Period|Adverse Event|0|||
46630712|NCT01917006|82803782|FG001|Open-label Period|Adverse Event|0|||
46630713|NCT01917006|82803783|FG002|Open-label Period|Adverse Event|0|||
46630714|NCT01917006|82803784|FG003|Open-label Period|Adverse Event|0|||
46630715|NCT01917006|82803785|FG004|Open-label Period|Adverse Event|0|||
46630716|NCT01917006|82803786|FG005|Open-label Period|Adverse Event|0|||
46630717|NCT01917006|82803787|FG006|Open-label Period|Adverse Event|0|||
46630718|NCT01917006|82803788|FG007|Open-label Period|Adverse Event|1|||
46630719|NCT01917006|82803781|FG000|Open-label Period|Lost to Follow-up|0|||
46630720|NCT01917006|82803782|FG001|Open-label Period|Lost to Follow-up|0|||
47038550|NCT02910583|83290840|FG000|Overall Study|Withdrawal by Subject|6|||
47038551|NCT02910583|83290841|FG001|Overall Study|Withdrawal by Subject|7|||
47038552|NCT02910583|83290840|FG000|Overall Study|Other, Not Specified|1|||
47038553|NCT02910583|83290841|FG001|Overall Study|Other, Not Specified|0|||
47038554|NCT02487394|83290877|FG000|Phase 1|Withdrawal by Subject|0|||
46630721|NCT01917006|82803783|FG002|Open-label Period|Lost to Follow-up|0|||
46630722|NCT01917006|82803784|FG003|Open-label Period|Lost to Follow-up|0|||
46630723|NCT01917006|82803785|FG004|Open-label Period|Lost to Follow-up|0|||
46630724|NCT01917006|82803786|FG005|Open-label Period|Lost to Follow-up|0|||
46714653|NCT01139021|82930669|FG001|Overall Study|Withdrawal by Subject|0|||
46714654|NCT01139021|82930670|FG002|Overall Study|Withdrawal by Subject|0|||
46714655|NCT01139021|82930671|FG003|Overall Study|Withdrawal by Subject|1|||
46914019|NCT02906670|83144475|FG001|Cohort 5, Q2W|Clinical Progression|0|||
46914020|NCT02906670|83144476|FG002|Cohort 5, Q2W|Clinical Progression|0|||
47038555|NCT02487394|83290878|FG001|Phase 1|Withdrawal by Subject|1|||
47038556|NCT05005507|83290884|FG000|Overall Study|Premature termination of study|1|||
47038557|NCT04675775|83290888|FG000|Overall Study|Withdrawal by Subject|7|||
47038558|NCT04638816|83290894|FG000|Overall Study|Withdrawal by Subject|0|||
47038559|NCT04638816|83290895|FG001|Overall Study|Withdrawal by Subject|1|||
47038560|NCT04638816|83290894|FG000|Overall Study|Lost to Follow-up|0|||
47038561|NCT04638816|83290895|FG001|Overall Study|Lost to Follow-up|1|||
47038562|NCT03973918|83290923|FG000|Overall Study|Adverse Event|0|||
47038563|NCT03973918|83290924|FG001|Overall Study|Adverse Event|0|||
46714656|NCT01139021|82930672|FG004|Overall Study|Withdrawal by Subject|4|||
47038564|NCT03973918|83290925|FG002|Overall Study|Adverse Event|0|||
47038565|NCT03973918|83290926|FG003|Overall Study|Adverse Event|1|||
47038566|NCT03973918|83290923|FG000|Overall Study|pt still on treatment|0|||
47038567|NCT03973918|83290924|FG001|Overall Study|pt still on treatment|1|||
47038568|NCT03973918|83290925|FG002|Overall Study|pt still on treatment|0|||
47038569|NCT03973918|83290926|FG003|Overall Study|pt still on treatment|0|||
47038570|NCT03934216|83290935|FG000|Overall Study|Other Reasons|5|||
46714657|NCT01139021|82930673|FG005|Overall Study|Withdrawal by Subject|0|||
46714658|NCT01193660|82930691|FG000|Overall Study|Withdrawal by Subject|2|||
46714659|NCT01193660|82930692|FG001|Overall Study|Withdrawal by Subject|3|||
46714660|NCT01193660|82930693|FG002|Overall Study|Withdrawal by Subject|1|||
46714661|NCT01193660|82930691|FG000|Overall Study|Death|1|||
46714662|NCT01193660|82930692|FG001|Overall Study|Death|0|||
46714663|NCT01193660|82930693|FG002|Overall Study|Death|0|||
46714664|NCT01193660|82930691|FG000|Overall Study|Physician Decision|1|||
46714665|NCT01193660|82930692|FG001|Overall Study|Physician Decision|0|||
46714666|NCT01193660|82930693|FG002|Overall Study|Physician Decision|1|||
46714667|NCT01076166|82930701|FG000|Overall Study|Adverse Event|3|||
46714668|NCT01076166|82930701|FG000|Overall Study|Symptoms improved/resolved|6|||
46714669|NCT01193582|82930712|FG000|Vaccination Series|Withdrawal by Subject|11|||
46714670|NCT01193582|82930713|FG001|Vaccination Series|Withdrawal by Subject|13|||
46714671|NCT01193582|82930714|FG002|Vaccination Series|Withdrawal by Subject|8|||
46714672|NCT01193582|82930715|FG003|Vaccination Series|Withdrawal by Subject|3|||
46714673|NCT01193582|82930712|FG000|12 Month Follow-up|Death|0|||
46714674|NCT01193582|82930713|FG001|12 Month Follow-up|Death|0|||
46714675|NCT01193582|82930714|FG002|12 Month Follow-up|Death|1|||
46714676|NCT01193582|82930715|FG003|12 Month Follow-up|Death|0|||
46714677|NCT01193582|82930712|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
46714678|NCT01193582|82930713|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
46714679|NCT01193582|82930714|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
46714680|NCT01193582|82930715|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
46714681|NCT00945477|82930727|FG000|Overall Study|Adverse Event|3|||
46714682|NCT00945477|82930727|FG000|Overall Study|Lack of Efficacy|2|||
46714683|NCT00945477|82930727|FG000|Overall Study|Withdrawal by Subject|1|||
46714684|NCT01076088|82930738|FG000|Overall Study|Adverse Event|1|||
46714685|NCT01076088|82930739|FG001|Overall Study|Adverse Event|6|||
46714686|NCT01076088|82930740|FG002|Overall Study|Adverse Event|3|||
46714687|NCT01076088|82930741|FG003|Overall Study|Adverse Event|2|||
46714688|NCT01076088|82930742|FG004|Overall Study|Adverse Event|3|||
46714689|NCT01076088|82930743|FG005|Overall Study|Adverse Event|3|||
46714690|NCT01076088|82930738|FG000|Overall Study|Lost to Follow-up|1|||
46714691|NCT01076088|82930739|FG001|Overall Study|Lost to Follow-up|1|||
46714692|NCT01076088|82930740|FG002|Overall Study|Lost to Follow-up|0|||
46714693|NCT01076088|82930741|FG003|Overall Study|Lost to Follow-up|1|||
46714694|NCT01076088|82930742|FG004|Overall Study|Lost to Follow-up|1|||
46714695|NCT01076088|82930743|FG005|Overall Study|Lost to Follow-up|2|||
46714696|NCT01076088|82930738|FG000|Overall Study|Non-compliance with study drug|0|||
46714697|NCT01076088|82930739|FG001|Overall Study|Non-compliance with study drug|0|||
47038571|NCT03934216|83290936|FG001|Overall Study|Other Reasons|5|||
47038572|NCT03934216|83290935|FG000|Overall Study|Adverse Event|22|||
47038573|NCT03934216|83290936|FG001|Overall Study|Adverse Event|11|||
47038574|NCT03934216|83290935|FG000|Overall Study|Lack of Efficacy|8|||
47038575|NCT03934216|83290936|FG001|Overall Study|Lack of Efficacy|7|||
47038576|NCT03934216|83290935|FG000|Overall Study|Lost to Follow-up|2|||
47038577|NCT03934216|83290936|FG001|Overall Study|Lost to Follow-up|0|||
47038578|NCT03934216|83290935|FG000|Overall Study|Non-Compliance with Study Drug|1|||
47038579|NCT03934216|83290936|FG001|Overall Study|Non-Compliance with Study Drug|1|||
47038580|NCT03934216|83290935|FG000|Overall Study|Pregnancy|1|||
47038581|NCT03934216|83290936|FG001|Overall Study|Pregnancy|0|||
47038582|NCT03934216|83290935|FG000|Overall Study|Withdrawal by Subject|18|||
46714698|NCT01076088|82930740|FG002|Overall Study|Non-compliance with study drug|0|||
46714699|NCT01076088|82930741|FG003|Overall Study|Non-compliance with study drug|1|||
46714700|NCT01076088|82930742|FG004|Overall Study|Non-compliance with study drug|0|||
46714701|NCT01076088|82930743|FG005|Overall Study|Non-compliance with study drug|0|||
46714702|NCT01076088|82930738|FG000|Overall Study|Physician Decision|1|||
46714703|NCT01076088|82930739|FG001|Overall Study|Physician Decision|3|||
46714704|NCT01076088|82930740|FG002|Overall Study|Physician Decision|0|||
47038583|NCT03934216|83290936|FG001|Overall Study|Withdrawal by Subject|6|||
47038584|NCT03934216|83290935|FG000|Overall Study|Randomized but not treated|1|||
47038585|NCT03934216|83290936|FG001|Overall Study|Randomized but not treated|1|||
47038586|NCT03814187|83290946|FG000|Overall Study|Sponsor's Administrative Decision|0|||
47038587|NCT03814187|83290947|FG001|Overall Study|Sponsor's Administrative Decision|0|||
47038588|NCT03814187|83290948|FG002|Overall Study|Sponsor's Administrative Decision|272|||
47038589|NCT03814187|83290946|FG000|Overall Study|Death|80|||
47038590|NCT03814187|83290947|FG001|Overall Study|Death|81|||
47038591|NCT03814187|83290948|FG002|Overall Study|Death|4|||
47038592|NCT03814187|83290946|FG000|Overall Study|Withdrew Consent|77|||
46714705|NCT01076088|82930741|FG003|Overall Study|Physician Decision|1|||
46714706|NCT01076088|82930742|FG004|Overall Study|Physician Decision|1|||
46714707|NCT01076088|82930743|FG005|Overall Study|Physician Decision|0|||
46714708|NCT01076088|82930738|FG000|Overall Study|Withdrawal by Subject|8|||
46714709|NCT01076088|82930739|FG001|Overall Study|Withdrawal by Subject|8|||
46714710|NCT01076088|82930740|FG002|Overall Study|Withdrawal by Subject|14|||
46714711|NCT01076088|82930741|FG003|Overall Study|Withdrawal by Subject|10|||
46714712|NCT01076088|82930742|FG004|Overall Study|Withdrawal by Subject|11|||
47038593|NCT03814187|83290947|FG001|Overall Study|Withdrew Consent|78|||
46714713|NCT01076088|82930743|FG005|Overall Study|Withdrawal by Subject|17|||
46714714|NCT01076088|82930738|FG000|Overall Study|Other protocol specified criteria|0|||
46714715|NCT01076088|82930739|FG001|Overall Study|Other protocol specified criteria|0|||
46714716|NCT01076088|82930740|FG002|Overall Study|Other protocol specified criteria|0|||
46714717|NCT01076088|82930741|FG003|Overall Study|Other protocol specified criteria|0|||
46714718|NCT01076088|82930742|FG004|Overall Study|Other protocol specified criteria|0|||
46714719|NCT01076088|82930743|FG005|Overall Study|Other protocol specified criteria|1|||
46714720|NCT01193348|82930758|FG000|Screening Period|Screen Failure|5|||
46714721|NCT01193348|82930758|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
46714722|NCT01193348|82930758|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
46714723|NCT01193348|82930758|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
46714724|NCT01193348|82930758|FG000|Extension Treatment Period|Physician Decision|1|||
46714725|NCT01193348|82930758|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
46714726|NCT00945321|82930767|FG000|Period 1|Adverse Event|0|||
46714727|NCT00945321|82930768|FG001|Period 1|Adverse Event|0|||
46714728|NCT00945321|82930769|FG002|Period 1|Adverse Event|0|||
46714729|NCT00945321|82930770|FG003|Period 1|Adverse Event|0|||
46714730|NCT00945321|82930771|FG004|Period 1|Adverse Event|1|||
46714731|NCT00945321|82930772|FG005|Period 1|Adverse Event|0|||
46714732|NCT00945321|82930767|FG000|Period 4|Lost to Follow-up|0|||
46714733|NCT00945321|82930768|FG001|Period 4|Lost to Follow-up|0|||
46714734|NCT00945321|82930769|FG002|Period 4|Lost to Follow-up|0|||
46714735|NCT00945321|82930770|FG003|Period 4|Lost to Follow-up|0|||
46714736|NCT00945321|82930771|FG004|Period 4|Lost to Follow-up|0|||
46714737|NCT00945321|82930772|FG005|Period 4|Lost to Follow-up|1|||
46714738|NCT00945243|82930790|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
47038594|NCT03814187|83290948|FG002|Overall Study|Withdrew Consent|2|||
46630725|NCT01917006|82803787|FG006|Open-label Period|Lost to Follow-up|0|||
46630726|NCT01917006|82803788|FG007|Open-label Period|Lost to Follow-up|1|||
46630727|NCT01916304|82803805|FG000|Overall Study|Screening failure|17|||
46630728|NCT01916226|82803813|FG000|Overall Study|Adverse Event|1|||
46630729|NCT01916226|82803814|FG001|Overall Study|Adverse Event|0|||
46630730|NCT01916226|82803815|FG002|Overall Study|Adverse Event|1|||
46630731|NCT01916226|82803816|FG003|Overall Study|Adverse Event|1|||
46630732|NCT01916226|82803813|FG000|Overall Study|Lack of Efficacy|0|||
46630733|NCT01916226|82803814|FG001|Overall Study|Lack of Efficacy|0|||
46630734|NCT01916226|82803815|FG002|Overall Study|Lack of Efficacy|2|||
46630735|NCT01916226|82803816|FG003|Overall Study|Lack of Efficacy|1|||
46630736|NCT01916226|82803813|FG000|Overall Study|Protocol Violation|0|||
46630737|NCT01916226|82803814|FG001|Overall Study|Protocol Violation|1|||
46630738|NCT01916226|82803815|FG002|Overall Study|Protocol Violation|0|||
46630739|NCT01916226|82803816|FG003|Overall Study|Protocol Violation|1|||
46630740|NCT01916226|82803813|FG000|Overall Study|Physician Decision|0|||
46630741|NCT01916226|82803814|FG001|Overall Study|Physician Decision|0|||
46630742|NCT01916226|82803815|FG002|Overall Study|Physician Decision|0|||
46630743|NCT01916226|82803816|FG003|Overall Study|Physician Decision|1|||
46630744|NCT01969500|82803829|FG000|Overall Study|Death|0|||
46630745|NCT01969500|82803830|FG001|Overall Study|Death|1|||
46630746|NCT01969500|82803829|FG000|Overall Study|extended hospitalization|1|||
46630747|NCT01969500|82803830|FG001|Overall Study|extended hospitalization|1|||
46630748|NCT01915914|82803836|FG000|Acute Phase|Withdrawal by Subject|4|||
46630749|NCT01915914|82803837|FG001|Acute Phase|Withdrawal by Subject|0|||
46630750|NCT01915914|82803838|FG002|Acute Phase|Withdrawal by Subject|0|||
46630751|NCT01915914|82803839|FG003|Acute Phase|Withdrawal by Subject|0|||
46630752|NCT01915914|82803836|FG000|Acute Phase|Lost to Follow-up|4|||
46630753|NCT01915914|82803837|FG001|Acute Phase|Lost to Follow-up|0|||
46630754|NCT01915914|82803838|FG002|Acute Phase|Lost to Follow-up|0|||
46630755|NCT01915914|82803839|FG003|Acute Phase|Lost to Follow-up|0|||
46630756|NCT01915914|82803836|FG000|Acute Phase|Physician Decision|1|||
46630757|NCT01915914|82803837|FG001|Acute Phase|Physician Decision|0|||
46630758|NCT01915914|82803838|FG002|Acute Phase|Physician Decision|0|||
46630759|NCT01915914|82803839|FG003|Acute Phase|Physician Decision|0|||
46630760|NCT01915914|82803836|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
46630761|NCT01915914|82803837|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
46630762|NCT01915914|82803838|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
46630763|NCT01915914|82803839|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
46630764|NCT01915914|82803836|FG000|Acute Phase|"Not Achieved treatment success"|1|||
46714739|NCT01192412|82930796|FG000|Overall Study|Lost to Follow-up|2|||
46714740|NCT01192412|82930797|FG001|Overall Study|Lost to Follow-up|1|||
46714741|NCT01192412|82930796|FG000|Overall Study|Withdrawal by Subject|2|||
46714742|NCT01192412|82930797|FG001|Overall Study|Withdrawal by Subject|1|||
46714743|NCT01192178|82930805|FG000|Overall Study|Withdrawal by Subject|6|||
46630765|NCT01915914|82803837|FG001|Acute Phase|"Not Achieved treatment success"|0|||
46630766|NCT01915914|82803838|FG002|Acute Phase|"Not Achieved treatment success"|0|||
46630767|NCT01915914|82803839|FG003|Acute Phase|"Not Achieved treatment success"|0|||
46630768|NCT01915914|82803836|FG000|Acute Phase|Missing|1|||
46630769|NCT01915914|82803837|FG001|Acute Phase|Missing|0|||
46714744|NCT01192178|82930806|FG001|Overall Study|Withdrawal by Subject|10|||
46714745|NCT01192178|82930805|FG000|Overall Study|Protocol Violation|10|||
46714746|NCT01192178|82930806|FG001|Overall Study|Protocol Violation|3|||
47038595|NCT03814187|83290946|FG000|Overall Study|Lost to Follow-up|47|||
47038596|NCT03814187|83290947|FG001|Overall Study|Lost to Follow-up|52|||
47038597|NCT03814187|83290948|FG002|Overall Study|Lost to Follow-up|1|||
47038598|NCT03814187|83290946|FG000|Overall Study|Adverse Event|22|||
47038599|NCT03814187|83290947|FG001|Overall Study|Adverse Event|23|||
47038600|NCT03814187|83290948|FG002|Overall Study|Adverse Event|0|||
47038601|NCT03814187|83290946|FG000|Overall Study|Physician Decision|7|||
47038602|NCT03814187|83290947|FG001|Overall Study|Physician Decision|4|||
47038603|NCT03814187|83290948|FG002|Overall Study|Physician Decision|2|||
47038604|NCT03814187|83290946|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
47038605|NCT03814187|83290947|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
47038606|NCT03814187|83290948|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
47038607|NCT03814187|83290946|FG000|Overall Study|Other reasons|34|||
47038608|NCT03814187|83290947|FG001|Overall Study|Other reasons|40|||
46630770|NCT01915914|82803838|FG002|Acute Phase|Missing|0|||
46630771|NCT01915914|82803839|FG003|Acute Phase|Missing|0|||
46630772|NCT01915914|82803836|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46630773|NCT01915914|82803837|FG001|Maintenance Phase|Withdrawal by Subject|1|||
46630774|NCT01915914|82803838|FG002|Maintenance Phase|Withdrawal by Subject|1|||
46630775|NCT01915914|82803839|FG003|Maintenance Phase|Withdrawal by Subject|0|||
46630776|NCT01915914|82803836|FG000|Maintenance Phase|Lost to Follow-up|0|||
46630777|NCT01915914|82803837|FG001|Maintenance Phase|Lost to Follow-up|4|||
46630778|NCT01915914|82803838|FG002|Maintenance Phase|Lost to Follow-up|1|||
46630779|NCT01915914|82803839|FG003|Maintenance Phase|Lost to Follow-up|0|||
46630780|NCT01915914|82803836|FG000|Maintenance Phase|Missing|0|||
46630781|NCT01915914|82803837|FG001|Maintenance Phase|Missing|1|||
46630782|NCT01915914|82803838|FG002|Maintenance Phase|Missing|0|||
46630783|NCT01915914|82803839|FG003|Maintenance Phase|Missing|0|||
46630784|NCT01915914|82803836|FG000|Follow-up Phase|Withdrawal by Subject|0|||
46630785|NCT01915914|82803837|FG001|Follow-up Phase|Withdrawal by Subject|0|||
46630786|NCT01915914|82803838|FG002|Follow-up Phase|Withdrawal by Subject|0|||
46630787|NCT01915914|82803839|FG003|Follow-up Phase|Withdrawal by Subject|1|||
46630788|NCT01915914|82803836|FG000|Follow-up Phase|Physician Decision|0|||
46630789|NCT01915914|82803837|FG001|Follow-up Phase|Physician Decision|0|||
46630790|NCT01915914|82803838|FG002|Follow-up Phase|Physician Decision|0|||
46630791|NCT01915914|82803839|FG003|Follow-up Phase|Physician Decision|1|||
46630792|NCT01919970|82803859|FG000|Overall Study|Withdrawal by Subject|3|||
46630793|NCT01919970|82803860|FG001|Overall Study|Withdrawal by Subject|0|||
46630794|NCT01919814|82803866|FG000|Overall Study|Adverse Event|1|||
46630795|NCT01919814|82803867|FG001|Overall Study|Adverse Event|0|||
46630796|NCT01919814|82803866|FG000|Overall Study|Protocol Violation|1|||
46630797|NCT01919814|82803867|FG001|Overall Study|Protocol Violation|0|||
46630798|NCT01919814|82803866|FG000|Overall Study|Withdrawal by Subject|1|||
46630799|NCT01919814|82803867|FG001|Overall Study|Withdrawal by Subject|0|||
46630800|NCT01968954|82803875|FG000|Overall Study|Adverse Event|6|||
46630801|NCT01968954|82803876|FG001|Overall Study|Adverse Event|3|||
46630802|NCT01968954|82803875|FG000|Overall Study|Death|1|||
46630803|NCT01968954|82803876|FG001|Overall Study|Death|2|||
46630804|NCT01968954|82803875|FG000|Overall Study|Lost to Follow-up|6|||
46630805|NCT01968954|82803876|FG001|Overall Study|Lost to Follow-up|4|||
46630806|NCT01968954|82803875|FG000|Overall Study|Withdrawal by Subject|20|||
46630807|NCT01968954|82803876|FG001|Overall Study|Withdrawal by Subject|23|||
46630808|NCT01968954|82803875|FG000|Overall Study|Other|7|||
46630809|NCT01968954|82803876|FG001|Overall Study|Other|8|||
46630810|NCT01968954|82803875|FG000|Overall Study|Protocol Violation|0|||
46630811|NCT01968954|82803876|FG001|Overall Study|Protocol Violation|1|||
46630812|NCT01968954|82803875|FG000|Overall Study|Did not met inclusion criteria|0|||
46630813|NCT01968954|82803876|FG001|Overall Study|Did not met inclusion criteria|2|||
46630814|NCT01919190|82803885|FG000|Overall Study|Intra-op findings, etc.|3|||
46630815|NCT01919190|82803886|FG001|Overall Study|Intra-op findings, etc.|0|||
46630816|NCT01620060|82803893|FG000|Overall Study|Adverse Event|9|||
46630817|NCT01620060|82803893|FG000|Overall Study|Protocol Violation|1|||
46630818|NCT01620060|82803893|FG000|Overall Study|Withdrawal by Subject|1|||
46630819|NCT01620060|82803893|FG000|Overall Study|Did not comply with Study Produre|1|||
46630820|NCT01620060|82803893|FG000|Overall Study|Family emergency|1|||
46630821|NCT01620060|82803893|FG000|Overall Study|Per Sponsor Decision|2|||
46630822|NCT01914666|82803900|FG000|Treatment Period|Lack of Efficacy|0|||
46630823|NCT01914666|82803901|FG001|Treatment Period|Lack of Efficacy|0|||
46630824|NCT01914666|82803902|FG002|Treatment Period|Lack of Efficacy|2|||
46630825|NCT01914666|82803900|FG000|Treatment Period|Adverse Event|10|||
47038609|NCT03814187|83290948|FG002|Overall Study|Other reasons|2|||
47038610|NCT03617770|83290960|FG000|Overall Study|Lost to Follow-up|1|||
47038611|NCT03617770|83290961|FG001|Overall Study|Lost to Follow-up|0|||
46630826|NCT01914666|82803901|FG001|Treatment Period|Adverse Event|4|||
46630827|NCT01914666|82803902|FG002|Treatment Period|Adverse Event|2|||
46714747|NCT01192178|82930805|FG000|Overall Study|Physician Decision|2|||
46714748|NCT01192178|82930806|FG001|Overall Study|Physician Decision|4|||
46714749|NCT01192178|82930805|FG000|Overall Study|Lost to Follow-up|3|||
46714750|NCT01192178|82930806|FG001|Overall Study|Lost to Follow-up|3|||
46714751|NCT01192178|82930805|FG000|Overall Study|Adverse Event|2|||
46714752|NCT01192178|82930806|FG001|Overall Study|Adverse Event|1|||
46714753|NCT01192178|82930805|FG000|Overall Study|Lack of Efficacy|1|||
46714754|NCT01192178|82930806|FG001|Overall Study|Lack of Efficacy|2|||
46714755|NCT01192100|82930814|FG000|Overall Study|Withdrawal by Subject|0|||
46714756|NCT01192100|82930815|FG001|Overall Study|Withdrawal by Subject|0|||
46714757|NCT01192100|82930816|FG002|Overall Study|Withdrawal by Subject|0|||
46714758|NCT01192100|82930817|FG003|Overall Study|Withdrawal by Subject|0|||
46714759|NCT01192100|82930818|FG004|Overall Study|Withdrawal by Subject|1|||
46714760|NCT01192100|82930819|FG005|Overall Study|Withdrawal by Subject|0|||
46714761|NCT01192100|82930814|FG000|Overall Study|Protocol Violation|0|||
46714762|NCT01192100|82930815|FG001|Overall Study|Protocol Violation|0|||
46714763|NCT01192100|82930816|FG002|Overall Study|Protocol Violation|0|||
46714764|NCT01192100|82930817|FG003|Overall Study|Protocol Violation|1|||
46714765|NCT01192100|82930818|FG004|Overall Study|Protocol Violation|0|||
46714766|NCT01192100|82930819|FG005|Overall Study|Protocol Violation|0|||
46714767|NCT00869401|82930832|FG000|Overall Study|Withdrawal by Subject|0|||
46714768|NCT00869401|82930833|FG001|Overall Study|Withdrawal by Subject|0|||
46714769|NCT00869401|82930834|FG002|Overall Study|Withdrawal by Subject|0|||
46714770|NCT00869401|82930835|FG003|Overall Study|Withdrawal by Subject|5|||
46714771|NCT00869401|82930836|FG004|Overall Study|Withdrawal by Subject|3|||
46714772|NCT01076010|82930851|FG000|Overall Study|Death|15|||
46714773|NCT01076010|82930852|FG001|Overall Study|Death|1|||
46714774|NCT01076010|82930853|FG002|Overall Study|Death|0|||
46714775|NCT01076010|82930851|FG000|Overall Study|Adverse Event|7|||
46714776|NCT01076010|82930852|FG001|Overall Study|Adverse Event|2|||
46714777|NCT01076010|82930853|FG002|Overall Study|Adverse Event|0|||
46714778|NCT01076010|82930851|FG000|Overall Study|Progressive disease|90|||
46714779|NCT01076010|82930852|FG001|Overall Study|Progressive disease|30|||
46714780|NCT01076010|82930853|FG002|Overall Study|Progressive disease|1|||
46714781|NCT01076010|82930851|FG000|Overall Study|Lack of Efficacy|4|||
46714782|NCT01076010|82930852|FG001|Overall Study|Lack of Efficacy|0|||
46714783|NCT01076010|82930853|FG002|Overall Study|Lack of Efficacy|0|||
46714784|NCT01076010|82930851|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
46714785|NCT01076010|82930852|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
46714786|NCT01076010|82930853|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
46914021|NCT02906670|83144477|FG003|Cohort 5, Q2W|Clinical Progression|0|||
46914022|NCT02906670|83144478|FG004|Cohort 5, Q2W|Clinical Progression|0|||
46914023|NCT02906670|83144479|FG005|Cohort 5, Q2W|Clinical Progression|0|||
46914024|NCT02906670|83144480|FG006|Cohort 5, Q2W|Clinical Progression|1|||
46914025|NCT02906670|83144481|FG007|Cohort 5, Q2W|Clinical Progression|0|||
46914026|NCT02906670|83144482|FG008|Cohort 5, Q2W|Clinical Progression|0|||
46914027|NCT02906670|83144483|FG009|Cohort 5, Q2W|Clinical Progression|0|||
46914028|NCT02906670|83144474|FG000|Cohort 5, Q2W|Adverse Event|0|||
46914029|NCT02906670|83144475|FG001|Cohort 5, Q2W|Adverse Event|0|||
46914030|NCT02906670|83144476|FG002|Cohort 5, Q2W|Adverse Event|0|||
46914031|NCT02906670|83144477|FG003|Cohort 5, Q2W|Adverse Event|0|||
46914032|NCT02906670|83144478|FG004|Cohort 5, Q2W|Adverse Event|0|||
46914033|NCT02906670|83144479|FG005|Cohort 5, Q2W|Adverse Event|0|||
46914034|NCT02906670|83144480|FG006|Cohort 5, Q2W|Adverse Event|1|||
46914035|NCT02906670|83144481|FG007|Cohort 5, Q2W|Adverse Event|0|||
46914036|NCT02906670|83144482|FG008|Cohort 5, Q2W|Adverse Event|0|||
46914037|NCT02906670|83144483|FG009|Cohort 5, Q2W|Adverse Event|0|||
46914038|NCT02906670|83144474|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
47038612|NCT03606980|83290970|FG000|Overall Study|Lost to Follow-up|3|||
46914039|NCT02906670|83144475|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
46914040|NCT02906670|83144476|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
46914041|NCT02906670|83144477|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
47038613|NCT03606980|83290971|FG001|Overall Study|Lost to Follow-up|2|||
46714787|NCT01076010|82930851|FG000|Overall Study|Significant Surgical Procedure|0|||
46914042|NCT02906670|83144478|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
46914043|NCT02906670|83144479|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
46914044|NCT02906670|83144480|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
46714788|NCT01076010|82930852|FG001|Overall Study|Significant Surgical Procedure|1|||
46714789|NCT01076010|82930853|FG002|Overall Study|Significant Surgical Procedure|0|||
46714790|NCT01076010|82930851|FG000|Overall Study|Protocol Violation|0|||
46914045|NCT02906670|83144481|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
46914046|NCT02906670|83144482|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
46914047|NCT02906670|83144483|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
46714791|NCT01076010|82930852|FG001|Overall Study|Protocol Violation|1|||
46714792|NCT01076010|82930853|FG002|Overall Study|Protocol Violation|0|||
46714793|NCT01076010|82930851|FG000|Overall Study|Noncompliance|1|||
46714794|NCT01076010|82930852|FG001|Overall Study|Noncompliance|1|||
46714795|NCT01076010|82930853|FG002|Overall Study|Noncompliance|0|||
46914048|NCT02906670|83144474|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
46914049|NCT02906670|83144475|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
46914050|NCT02906670|83144476|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
46914051|NCT02906670|83144477|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
46914052|NCT02906670|83144478|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
46914053|NCT02906670|83144479|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
46914054|NCT02906670|83144480|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
46914055|NCT02906670|83144481|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
46914056|NCT02906670|83144482|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
46914057|NCT02906670|83144483|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
46914058|NCT02906670|83144474|FG000|Cohort 5P, Q2W|Adverse Event|0|||
46914059|NCT02906670|83144475|FG001|Cohort 5P, Q2W|Adverse Event|0|||
46914060|NCT02906670|83144476|FG002|Cohort 5P, Q2W|Adverse Event|0|||
46914061|NCT02906670|83144477|FG003|Cohort 5P, Q2W|Adverse Event|0|||
46914062|NCT02906670|83144478|FG004|Cohort 5P, Q2W|Adverse Event|0|||
47038614|NCT03606980|83290972|FG002|Overall Study|Lost to Follow-up|3|||
47038615|NCT03606980|83290970|FG000|Overall Study|Withdrawal by Subject|1|||
46914063|NCT02906670|83144479|FG005|Cohort 5P, Q2W|Adverse Event|0|||
46914064|NCT02906670|83144480|FG006|Cohort 5P, Q2W|Adverse Event|0|||
46914065|NCT02906670|83144481|FG007|Cohort 5P, Q2W|Adverse Event|1|||
46914066|NCT02906670|83144482|FG008|Cohort 5P, Q2W|Adverse Event|0|||
46914067|NCT02906670|83144483|FG009|Cohort 5P, Q2W|Adverse Event|0|||
46914068|NCT02906670|83144474|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
47038616|NCT03606980|83290971|FG001|Overall Study|Withdrawal by Subject|0|||
47038617|NCT03606980|83290972|FG002|Overall Study|Withdrawal by Subject|4|||
47038618|NCT03200574|83290990|FG000|Overall Study|Death|4|||
47038619|NCT03200574|83290990|FG000|Overall Study|Withdrawal by Subject|8|||
47038620|NCT03200574|83290990|FG000|Overall Study|Long-Term need for anticoagulation|1|||
47038621|NCT03200574|83290990|FG000|Overall Study|Relocation|2|||
47038622|NCT03200574|83290990|FG000|Overall Study|Lost to Follow-up|2|||
47038623|NCT03123094|83291008|FG000|Overall Study|Withdrawal by Subject|0|||
47038624|NCT03123094|83291009|FG001|Overall Study|Withdrawal by Subject|2|||
47038625|NCT03123094|83291010|FG002|Overall Study|Withdrawal by Subject|1|||
47038626|NCT03123094|83291011|FG003|Overall Study|Withdrawal by Subject|0|||
47038627|NCT03123094|83291012|FG004|Overall Study|Withdrawal by Subject|1|||
47038628|NCT03051659|83291035|FG000|Treatment Period|Withdrawal by Subject|0|||
47038629|NCT03051659|83291036|FG001|Treatment Period|Withdrawal by Subject|2|||
46630828|NCT01914666|82803900|FG000|Treatment Period|Withdrawal by Subject|3|||
46630829|NCT01914666|82803901|FG001|Treatment Period|Withdrawal by Subject|2|||
46630830|NCT01914666|82803902|FG002|Treatment Period|Withdrawal by Subject|2|||
46630831|NCT01914666|82803900|FG000|Treatment Period|Physician Decision|0|||
46630832|NCT01914666|82803901|FG001|Treatment Period|Physician Decision|0|||
46630833|NCT01914666|82803902|FG002|Treatment Period|Physician Decision|2|||
46630834|NCT01913340|82803910|FG000|Overall Study|Death|2|||
46630835|NCT01913340|82803911|FG001|Overall Study|Death|5|||
46630836|NCT01913340|82803910|FG000|Overall Study|Lost to Follow-up|1|||
46630837|NCT01913340|82803911|FG001|Overall Study|Lost to Follow-up|1|||
46630838|NCT01864200|82803919|FG000|Overall Study|Lost to Follow-up|1|||
46630839|NCT01864200|82803920|FG001|Overall Study|Lost to Follow-up|3|||
46630840|NCT01864200|82803919|FG000|Overall Study|Protocol Violation|1|||
46630841|NCT01864200|82803920|FG001|Overall Study|Protocol Violation|0|||
46630842|NCT01912872|82803930|FG000|Overall Study|Lost to Follow-up|2|||
46630843|NCT01912872|82803931|FG001|Overall Study|Lost to Follow-up|3|||
46630844|NCT01912872|82803932|FG002|Overall Study|Lost to Follow-up|5|||
46630845|NCT01912872|82803933|FG003|Overall Study|Lost to Follow-up|5|||
46630846|NCT01912872|82803930|FG000|Overall Study|Other unspecified|3|||
46630847|NCT01912872|82803931|FG001|Overall Study|Other unspecified|1|||
46630848|NCT01912872|82803932|FG002|Overall Study|Other unspecified|3|||
46630849|NCT01912872|82803933|FG003|Overall Study|Other unspecified|0|||
46630850|NCT01912872|82803930|FG000|Overall Study|Informed consent withdrawn|0|||
46630851|NCT01912872|82803931|FG001|Overall Study|Informed consent withdrawn|0|||
46714796|NCT01076010|82930851|FG000|Overall Study|Withdrawal by Subject|3|||
46714797|NCT01076010|82930852|FG001|Overall Study|Withdrawal by Subject|0|||
46714798|NCT01076010|82930853|FG002|Overall Study|Withdrawal by Subject|1|||
46914069|NCT02906670|83144475|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
46914070|NCT02906670|83144476|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
46914071|NCT02906670|83144477|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
46630852|NCT01912872|82803932|FG002|Overall Study|Informed consent withdrawn|1|||
46630853|NCT01912872|82803933|FG003|Overall Study|Informed consent withdrawn|1|||
46630854|NCT01912872|82803930|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
46630855|NCT01912872|82803931|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
46630856|NCT01912872|82803932|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
46914072|NCT02906670|83144478|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
47038630|NCT03051659|83291035|FG000|Survival Follow-up|Lost to Follow-up|23|||
47038631|NCT03051659|83291036|FG001|Survival Follow-up|Lost to Follow-up|22|||
47038632|NCT03033576|83291044|FG000|Overall Study|Ineligible|1|||
46630857|NCT01912872|82803933|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
47038633|NCT03033576|83291045|FG001|Overall Study|Ineligible|1|||
47038634|NCT03033576|83291044|FG000|Overall Study|Adverse Event|4|||
47038635|NCT03033576|83291045|FG001|Overall Study|Adverse Event|20|||
47038636|NCT03033576|83291044|FG000|Overall Study|Progression/relapse|9|||
47038637|NCT03033576|83291045|FG001|Overall Study|Progression/relapse|36|||
47038638|NCT03033576|83291044|FG000|Overall Study|Death|1|||
47038639|NCT03033576|83291045|FG001|Overall Study|Death|1|||
47038640|NCT03033576|83291044|FG000|Overall Study|Patient refusal|1|||
47038641|NCT03033576|83291045|FG001|Overall Study|Patient refusal|6|||
47038642|NCT03033576|83291044|FG000|Overall Study|Other, unspecified reasons|0|||
47038643|NCT03033576|83291045|FG001|Overall Study|Other, unspecified reasons|4|||
47038644|NCT03033576|83291044|FG000|Overall Study|Currently on protocol therapy|0|||
47038645|NCT03033576|83291045|FG001|Overall Study|Currently on protocol therapy|2|||
47038646|NCT02926833|83291071|FG000|Overall Study|Death|1|||
47038647|NCT02926833|83291072|FG001|Overall Study|Death|1|||
47038648|NCT02926833|83291073|FG002|Overall Study|Death|2|||
47038649|NCT02926833|83291074|FG003|Overall Study|Death|13|||
47038650|NCT02926833|83291071|FG000|Overall Study|Lost to Follow-up|1|||
47038651|NCT02926833|83291072|FG001|Overall Study|Lost to Follow-up|2|||
47038652|NCT02926833|83291073|FG002|Overall Study|Lost to Follow-up|0|||
47038653|NCT02926833|83291074|FG003|Overall Study|Lost to Follow-up|3|||
47038654|NCT02926833|83291071|FG000|Overall Study|Full Consent Withdrawal|0|||
47038655|NCT02926833|83291072|FG001|Overall Study|Full Consent Withdrawal|0|||
47038656|NCT02926833|83291073|FG002|Overall Study|Full Consent Withdrawal|0|||
47038657|NCT02926833|83291074|FG003|Overall Study|Full Consent Withdrawal|2|||
47038658|NCT02926833|83291071|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
47038659|NCT02926833|83291072|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
47038660|NCT02926833|83291073|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
47038661|NCT02926833|83291074|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
47038662|NCT02926833|83291071|FG000|Overall Study|Investigator Decision|0|||
47038663|NCT02926833|83291072|FG001|Overall Study|Investigator Decision|1|||
47038664|NCT02926833|83291073|FG002|Overall Study|Investigator Decision|0|||
47038665|NCT02926833|83291074|FG003|Overall Study|Investigator Decision|0|||
47038666|NCT02926833|83291071|FG000|Overall Study|Adverse Event|0|||
47038667|NCT02926833|83291072|FG001|Overall Study|Adverse Event|0|||
47038668|NCT02926833|83291073|FG002|Overall Study|Adverse Event|1|||
47038669|NCT02926833|83291074|FG003|Overall Study|Adverse Event|0|||
47038670|NCT02926833|83291071|FG000|Overall Study|Partial Withdrawal of Consent|0|||
47038671|NCT02926833|83291072|FG001|Overall Study|Partial Withdrawal of Consent|0|||
47038672|NCT02926833|83291073|FG002|Overall Study|Partial Withdrawal of Consent|0|||
47038673|NCT02926833|83291074|FG003|Overall Study|Partial Withdrawal of Consent|1|||
47038674|NCT02879448|83291087|FG000|Overall Study|No implant attempt|17|||
47038675|NCT02879448|83291088|FG001|Overall Study|No implant attempt|28|||
47038676|NCT02879448|83291087|FG000|Overall Study|Withdrawal by Subject|20|||
47038677|NCT02879448|83291088|FG001|Overall Study|Withdrawal by Subject|46|||
47038678|NCT02879448|83291087|FG000|Overall Study|Death|63|||
46630858|NCT01912872|82803930|FG000|Overall Study|Protocol Violation|0|||
46630859|NCT01912872|82803931|FG001|Overall Study|Protocol Violation|0|||
46630860|NCT01912872|82803932|FG002|Overall Study|Protocol Violation|1|||
46630861|NCT01912872|82803933|FG003|Overall Study|Protocol Violation|0|||
46630862|NCT01912872|82803930|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46630863|NCT01912872|82803931|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46630864|NCT01912872|82803932|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
46714799|NCT01076010|82930851|FG000|Overall Study|Other|5|||
46714800|NCT01076010|82930852|FG001|Overall Study|Other|2|||
47038679|NCT02879448|83291088|FG001|Overall Study|Death|85|||
47038680|NCT02879448|83291087|FG000|Overall Study|Lost to Follow-up|3|||
47038681|NCT02879448|83291088|FG001|Overall Study|Lost to Follow-up|4|||
46714801|NCT01076010|82930853|FG002|Overall Study|Other|0|||
46630865|NCT01912872|82803933|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
46714802|NCT01075152|82930863|FG000|Overall Study|Withdrawal by Subject|1|||
46714803|NCT01075152|82930864|FG001|Overall Study|Withdrawal by Subject|0|||
46714804|NCT01078116|82930872|FG000|Overall Study|Lost to Follow-up|17|||
46714805|NCT01078116|82930872|FG000|Overall Study|Adverse Event|5|||
47038682|NCT02879448|83291087|FG000|Overall Study|Missing visit|34|||
47038683|NCT02879448|83291088|FG001|Overall Study|Missing visit|39|||
47038684|NCT02879448|83291087|FG000|Overall Study|Pending evaluation|1|||
46714806|NCT01078116|82930872|FG000|Overall Study|Withdrawal by Subject|8|||
46714807|NCT01078116|82930872|FG000|Overall Study|Lack of effectiveness|15|||
47038685|NCT02879448|83291088|FG001|Overall Study|Pending evaluation|0|||
46630866|NCT01912872|82803930|FG000|Overall Study|Withdrawal of study medication|0|||
47038686|NCT02808897|83291096|FG000|Overall Study|Lost to Follow-up|9|||
47038687|NCT02808897|83291097|FG001|Overall Study|Lost to Follow-up|11|||
47038688|NCT01812174|83291153|FG000|Overall Study|Death|1|||
47038689|NCT01812174|83291154|FG001|Overall Study|Death|0|||
47038690|NCT01812174|83291153|FG000|Overall Study|Protocol Violation|2|||
47038691|NCT01812174|83291154|FG001|Overall Study|Protocol Violation|0|||
47038692|NCT01286467|83291165|FG000|Overall Study|Death|1|||
47038693|NCT01286467|83291166|FG001|Overall Study|Death|1|||
47038694|NCT01286467|83291167|FG002|Overall Study|Death|1|||
47038695|NCT01286467|83291168|FG003|Overall Study|Death|0|||
47038696|NCT01286467|83291165|FG000|Overall Study|Lost to Follow-up|0|||
47038697|NCT01286467|83291166|FG001|Overall Study|Lost to Follow-up|0|||
47038698|NCT01286467|83291167|FG002|Overall Study|Lost to Follow-up|0|||
46714808|NCT01078116|82930872|FG000|Overall Study|Case report form not completed|3|||
46714809|NCT00950859|82930878|FG000|Overall Study|Adverse Event|3|||
46714810|NCT00950859|82930879|FG001|Overall Study|Adverse Event|3|||
46714811|NCT00950859|82930878|FG000|Overall Study|Insufficient Viral Load Response|12|||
46714812|NCT00950859|82930879|FG001|Overall Study|Insufficient Viral Load Response|3|||
46714813|NCT00950859|82930878|FG000|Overall Study|Protocol Violation|1|||
46714814|NCT00950859|82930879|FG001|Overall Study|Protocol Violation|1|||
46714815|NCT00950859|82930878|FG000|Overall Study|Lost to Follow-up|0|||
46714816|NCT00950859|82930879|FG001|Overall Study|Lost to Follow-up|3|||
46714817|NCT00862849|82930885|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
46714818|NCT00862849|82930886|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
46714819|NCT00862849|82930887|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
46714820|NCT00862849|82930888|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
46714821|NCT00862849|82930889|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
46714822|NCT00862849|82930890|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
46714823|NCT00862849|82930885|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
46714824|NCT00862849|82930886|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
46714825|NCT00862849|82930887|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
46714826|NCT00862849|82930888|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
46714827|NCT00862849|82930889|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
46714828|NCT00862849|82930890|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
46714829|NCT01090050|82930900|FG000|Overall Study|Lost to Follow-up|0|||
46714830|NCT01090050|82930901|FG001|Overall Study|Lost to Follow-up|1|||
46714831|NCT01090050|82930900|FG000|Overall Study|Lack of Efficacy|1|||
46714832|NCT01090050|82930901|FG001|Overall Study|Lack of Efficacy|5|||
46714833|NCT01090050|82930900|FG000|Overall Study|Physician Decision|0|||
46714834|NCT01090050|82930901|FG001|Overall Study|Physician Decision|1|||
46714835|NCT00944229|82930911|FG000|Overall Study|Withdrawal by Subject|11|||
46714836|NCT00944229|82930911|FG000|Overall Study|Physician Decision|14|||
46714837|NCT01077960|82930915|FG000|Overall Study|Adverse Event|6|||
46714838|NCT01077960|82930915|FG000|Overall Study|Protocol Violation|3|||
46714839|NCT01077960|82930915|FG000|Overall Study|Lost to Follow-up|5|||
46714840|NCT01077960|82930915|FG000|Overall Study|Subject decision|1|||
46914073|NCT02906670|83144479|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
46914074|NCT02906670|83144480|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
46914075|NCT02906670|83144481|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
46914076|NCT02906670|83144482|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
47038699|NCT01286467|83291168|FG003|Overall Study|Lost to Follow-up|1|||
47038700|NCT01286467|83291165|FG000|Overall Study|Withdrawal by Subject|0|||
46914077|NCT02906670|83144483|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
46914078|NCT02906670|83144474|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
47038701|NCT01286467|83291166|FG001|Overall Study|Withdrawal by Subject|0|||
47038702|NCT01286467|83291167|FG002|Overall Study|Withdrawal by Subject|1|||
47038703|NCT01286467|83291168|FG003|Overall Study|Withdrawal by Subject|0|||
46714841|NCT01077960|82930915|FG000|Overall Study|Reason unspecified|1|||
46714842|NCT00944697|82930921|FG000|Overall Study|Withdrawal by Subject|1|||
46714843|NCT00944697|82930922|FG001|Overall Study|Withdrawal by Subject|1|||
46714844|NCT00944697|82930921|FG000|Overall Study|Adverse Event|0|||
46714845|NCT00944697|82930922|FG001|Overall Study|Adverse Event|3|||
46714846|NCT00944697|82930921|FG000|Overall Study|Administrative|1|||
46714847|NCT00944697|82930922|FG001|Overall Study|Administrative|1|||
46714848|NCT01077804|82930928|FG000|Overall Study|Unreachable|102|||
46714849|NCT01077804|82930928|FG000|Overall Study|Refused to continue|79|||
46714850|NCT01077804|82930928|FG000|Overall Study|Other|18|||
46714851|NCT01075074|82930952|FG000|Overall Study|Surgeon changed to open incisional case|1|||
46914079|NCT02906670|83144475|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
46914080|NCT02906670|83144476|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
47038704|NCT01286467|83291165|FG000|Overall Study|Physician Decision|0|||
47038705|NCT01286467|83291166|FG001|Overall Study|Physician Decision|0|||
46714852|NCT01075074|82930953|FG001|Overall Study|Surgeon changed to open incisional case|2|||
46714853|NCT01075074|82930954|FG002|Overall Study|Surgeon changed to open incisional case|2|||
47038706|NCT01286467|83291167|FG002|Overall Study|Physician Decision|0|||
46714854|NCT00866281|82930968|FG000|Overall Study|Adverse Event|1|||
46714855|NCT00866281|82930969|FG001|Overall Study|Adverse Event|0|||
46714856|NCT00866281|82930968|FG000|Overall Study|Withdrawal by participants|3|||
46714857|NCT00866281|82930969|FG001|Overall Study|Withdrawal by participants|0|||
46714858|NCT00866281|82930968|FG000|Overall Study|Disease progression|3|||
46714859|NCT00866281|82930969|FG001|Overall Study|Disease progression|11|||
46914081|NCT02906670|83144477|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
47038707|NCT01286467|83291168|FG003|Overall Study|Physician Decision|1|||
47038708|NCT01286467|83291165|FG000|Overall Study|Disease progression|3|||
46914082|NCT02906670|83144478|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
46914083|NCT02906670|83144479|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
46914084|NCT02906670|83144480|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
46914085|NCT02906670|83144481|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
46914086|NCT02906670|83144482|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
46914087|NCT02906670|83144483|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
46914088|NCT02906670|83144474|FG000|Cohort 4P, QW|Radiological Progression|0|||
46914089|NCT02906670|83144475|FG001|Cohort 4P, QW|Radiological Progression|0|||
46914090|NCT02906670|83144476|FG002|Cohort 4P, QW|Radiological Progression|0|||
46914091|NCT02906670|83144477|FG003|Cohort 4P, QW|Radiological Progression|3|||
46914092|NCT02906670|83144478|FG004|Cohort 4P, QW|Radiological Progression|0|||
46914093|NCT02906670|83144479|FG005|Cohort 4P, QW|Radiological Progression|0|||
46914094|NCT02906670|83144480|FG006|Cohort 4P, QW|Radiological Progression|0|||
46914095|NCT02906670|83144481|FG007|Cohort 4P, QW|Radiological Progression|0|||
46914096|NCT02906670|83144482|FG008|Cohort 4P, QW|Radiological Progression|0|||
46914097|NCT02906670|83144483|FG009|Cohort 4P, QW|Radiological Progression|0|||
46914098|NCT02906670|83144474|FG000|Cohort 7P, Q2W|Adverse Event|0|||
47038709|NCT01286467|83291166|FG001|Overall Study|Disease progression|2|||
46630867|NCT01912872|82803931|FG001|Overall Study|Withdrawal of study medication|0|||
46630868|NCT01912872|82803932|FG002|Overall Study|Withdrawal of study medication|0|||
46630869|NCT01912872|82803933|FG003|Overall Study|Withdrawal of study medication|2|||
46630870|NCT01912872|82803930|FG000|Overall Study|Missing|0|||
46630871|NCT01912872|82803931|FG001|Overall Study|Missing|0|||
46630872|NCT01912872|82803932|FG002|Overall Study|Missing|0|||
46630873|NCT01912872|82803933|FG003|Overall Study|Missing|1|||
46630874|NCT01912404|82803946|FG000|Overall Study|Due to personal reasons|1|||
46630875|NCT01912404|82803947|FG001|Overall Study|Due to personal reasons|0|||
46630876|NCT01911780|82803955|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
46630877|NCT01911780|82803956|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
46630878|NCT01911780|82803955|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
46630879|NCT01911780|82803956|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
46630880|NCT01911780|82803955|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
46630881|NCT01911780|82803956|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
46630882|NCT01911780|82803955|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
46630883|NCT01911780|82803956|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
46914099|NCT02906670|83144475|FG001|Cohort 7P, Q2W|Adverse Event|0|||
46914100|NCT02906670|83144476|FG002|Cohort 7P, Q2W|Adverse Event|0|||
46914101|NCT02906670|83144477|FG003|Cohort 7P, Q2W|Adverse Event|0|||
46630884|NCT01911780|82803955|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
46630885|NCT01911780|82803956|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
46630886|NCT01911780|82803955|FG000|Extension Period (52 Weeks)|Personal reason|1|||
46630887|NCT01911780|82803956|FG001|Extension Period (52 Weeks)|Personal reason|1|||
46630888|NCT01911546|82803966|FG000|Overall Study|Lost to Follow-up|1|||
46630889|NCT01911546|82803966|FG000|Overall Study|Everolimus was discontinued|5|||
46630890|NCT01910298|82803972|FG000|Overall Study|Adverse Event|1|||
46630891|NCT01910298|82803973|FG001|Overall Study|Adverse Event|0|||
46630892|NCT01910298|82803972|FG000|Overall Study|Withdrawal by Subject|2|||
46630893|NCT01910298|82803973|FG001|Overall Study|Withdrawal by Subject|7|||
46630894|NCT01910298|82803972|FG000|Overall Study|Protocol Deviation|0|||
46630895|NCT01910298|82803973|FG001|Overall Study|Protocol Deviation|5|||
46914102|NCT02906670|83144478|FG004|Cohort 7P, Q2W|Adverse Event|0|||
46914103|NCT02906670|83144479|FG005|Cohort 7P, Q2W|Adverse Event|0|||
46914104|NCT02906670|83144480|FG006|Cohort 7P, Q2W|Adverse Event|0|||
46914105|NCT02906670|83144481|FG007|Cohort 7P, Q2W|Adverse Event|0|||
46914106|NCT02906670|83144482|FG008|Cohort 7P, Q2W|Adverse Event|0|||
46914107|NCT02906670|83144483|FG009|Cohort 7P, Q2W|Adverse Event|1|||
46914108|NCT02906670|83144474|FG000|Cohort 7P, Q2W|Physician Decision|0|||
46914109|NCT02906670|83144475|FG001|Cohort 7P, Q2W|Physician Decision|0|||
47038710|NCT01286467|83291167|FG002|Overall Study|Disease progression|2|||
47038711|NCT01286467|83291168|FG003|Overall Study|Disease progression|3|||
47038712|NCT01286467|83291165|FG000|Overall Study|Adverse Event|0|||
47038713|NCT01286467|83291166|FG001|Overall Study|Adverse Event|1|||
47038714|NCT01286467|83291167|FG002|Overall Study|Adverse Event|2|||
47038715|NCT01286467|83291168|FG003|Overall Study|Adverse Event|3|||
46630896|NCT01910298|82803972|FG000|Overall Study|Lost to Follow-up|1|||
46630897|NCT01910298|82803973|FG001|Overall Study|Lost to Follow-up|1|||
46630898|NCT01910298|82803972|FG000|Overall Study|Study Terminated by Sponsor|1|||
46914110|NCT02906670|83144476|FG002|Cohort 7P, Q2W|Physician Decision|0|||
46914111|NCT02906670|83144477|FG003|Cohort 7P, Q2W|Physician Decision|0|||
46914112|NCT02906670|83144478|FG004|Cohort 7P, Q2W|Physician Decision|0|||
46914113|NCT02906670|83144479|FG005|Cohort 7P, Q2W|Physician Decision|0|||
46914114|NCT02906670|83144480|FG006|Cohort 7P, Q2W|Physician Decision|0|||
47038716|NCT01286467|83291165|FG000|Overall Study|Study drug stop longer than 14 days|0|||
47038717|NCT01286467|83291166|FG001|Overall Study|Study drug stop longer than 14 days|0|||
46630899|NCT01910298|82803973|FG001|Overall Study|Study Terminated by Sponsor|17|||
46630900|NCT01910298|82803972|FG000|Overall Study|Other Miscellaneous Reasons|0|||
46630901|NCT01910298|82803973|FG001|Overall Study|Other Miscellaneous Reasons|2|||
46714860|NCT00866281|82930968|FG000|Overall Study|New cancer therapy|0|||
46714861|NCT00866281|82930969|FG001|Overall Study|New cancer therapy|4|||
47038718|NCT01286467|83291167|FG002|Overall Study|Study drug stop longer than 14 days|1|||
47038719|NCT01286467|83291168|FG003|Overall Study|Study drug stop longer than 14 days|0|||
47038720|NCT00933400|83291184|FG000|Overall Study|Withdrawal by Subject|21|||
47038721|NCT00933400|83291185|FG001|Overall Study|Withdrawal by Subject|1|||
47038722|NCT00569127|83291196|FG000|Overall Study|Adverse Event|57|||
47038723|NCT00569127|83291197|FG001|Overall Study|Adverse Event|47|||
47038724|NCT00569127|83291196|FG000|Overall Study|Withdrawal by Subject|13|||
47038725|NCT00569127|83291197|FG001|Overall Study|Withdrawal by Subject|27|||
47038726|NCT00569127|83291196|FG000|Overall Study|Progression|99|||
47038727|NCT00569127|83291197|FG001|Overall Study|Progression|100|||
47038728|NCT00569127|83291196|FG000|Overall Study|Death|4|||
47038729|NCT00569127|83291197|FG001|Overall Study|Death|3|||
47038730|NCT00569127|83291196|FG000|Overall Study|Other|20|||
47038731|NCT00569127|83291197|FG001|Overall Study|Other|19|||
47038732|NCT00569127|83291196|FG000|Overall Study|Lost to Follow-up|0|||
47038733|NCT00569127|83291197|FG001|Overall Study|Lost to Follow-up|3|||
47038734|NCT00569127|83291196|FG000|Overall Study|Not Eligible|14|||
47038735|NCT00569127|83291197|FG001|Overall Study|Not Eligible|11|||
47038736|NCT00569127|83291196|FG000|Overall Study|Still on Treatment|7|||
47038737|NCT00569127|83291197|FG001|Overall Study|Still on Treatment|3|||
47038738|NCT02029846|83291218|FG000|Overall Study|n=1 each arm|1|||
47038739|NCT02029846|83291219|FG001|Overall Study|n=1 each arm|1|||
47038740|NCT05889039|83291229|FG000|Overall Study|error in completing survey|0|||
47038741|NCT05889039|83291230|FG001|Overall Study|error in completing survey|2|||
47038742|NCT05889039|83291231|FG002|Overall Study|error in completing survey|0|||
47038743|NCT05889039|83291232|FG003|Overall Study|error in completing survey|0|||
47038744|NCT05889039|83291229|FG000|Overall Study|Lost to Follow-up|4|||
47038745|NCT05889039|83291230|FG001|Overall Study|Lost to Follow-up|0|||
47038746|NCT05889039|83291231|FG002|Overall Study|Lost to Follow-up|0|||
47038747|NCT05889039|83291232|FG003|Overall Study|Lost to Follow-up|0|||
47038748|NCT05790408|83291242|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
47038749|NCT04944992|83291252|FG000|Overall Study|Lost to Follow-up|1|||
47038750|NCT04944992|83291253|FG001|Overall Study|Lost to Follow-up|1|||
47038751|NCT04944992|83291252|FG000|Overall Study|Physician Decision|1|||
46630902|NCT01909674|82803981|FG000|Overall Study|Withdrawal by Subject|5|||
46630903|NCT01909674|82803982|FG001|Overall Study|Withdrawal by Subject|2|||
46630904|NCT01908816|82803992|FG000|Overall Study|Subject's no longer requires study drug|0|||
46630905|NCT01908816|82803993|FG001|Overall Study|Subject's no longer requires study drug|0|||
46630906|NCT01908816|82803994|FG002|Overall Study|Subject's no longer requires study drug|0|||
46630907|NCT01908816|82803995|FG003|Overall Study|Subject's no longer requires study drug|1|||
46714862|NCT01077258|82930978|FG000|Overall Study|Lost to Follow-up|1390|||
46714863|NCT01077258|82930978|FG000|Overall Study|Adverse drug reaction|218|||
47038752|NCT04944992|83291253|FG001|Overall Study|Physician Decision|0|||
47038753|NCT04944992|83291252|FG000|Overall Study|Withdrawal by Subject|6|||
47038754|NCT04944992|83291253|FG001|Overall Study|Withdrawal by Subject|1|||
47038755|NCT04820530|83291259|FG000|Extension Treatment Period|Ongoing at the time of the data cut-off date 2022-11-02|32|||
47038756|NCT04535583|83291280|FG000|Overall Study|Lost to Follow-up|1|||
47038757|NCT04535583|83291280|FG000|Overall Study|Physician Decision|1|||
47038758|NCT04535583|83291280|FG000|Overall Study|Withdrawal by Subject|1|||
47038759|NCT04484935|83291295|FG000|Overall Study|Other|0|||
47038760|NCT04484935|83291296|FG001|Overall Study|Other|1|||
46630908|NCT01908816|82803992|FG000|Overall Study|Protocol deviation|1|||
46630909|NCT01908816|82803993|FG001|Overall Study|Protocol deviation|2|||
47038761|NCT04484935|83291295|FG000|Overall Study|Withdrawal by parent/guardian|0|||
47038762|NCT04484935|83291296|FG001|Overall Study|Withdrawal by parent/guardian|1|||
47038763|NCT04484935|83291295|FG000|Overall Study|Lost to Follow-up|1|||
47038764|NCT04484935|83291296|FG001|Overall Study|Lost to Follow-up|0|||
46914115|NCT02906670|83144481|FG007|Cohort 7P, Q2W|Physician Decision|0|||
46630910|NCT01908816|82803994|FG002|Overall Study|Protocol deviation|1|||
46630911|NCT01908816|82803995|FG003|Overall Study|Protocol deviation|1|||
46630912|NCT01908816|82803992|FG000|Overall Study|Withdrawal by Subject|0|||
46630913|NCT01908816|82803993|FG001|Overall Study|Withdrawal by Subject|4|||
46630914|NCT01908816|82803994|FG002|Overall Study|Withdrawal by Subject|2|||
46630915|NCT01908816|82803995|FG003|Overall Study|Withdrawal by Subject|2|||
46630916|NCT01908816|82803992|FG000|Overall Study|Lost to Follow-up|3|||
46630917|NCT01908816|82803993|FG001|Overall Study|Lost to Follow-up|5|||
46630918|NCT01908816|82803994|FG002|Overall Study|Lost to Follow-up|4|||
46630919|NCT01908816|82803995|FG003|Overall Study|Lost to Follow-up|2|||
46630920|NCT01908816|82803992|FG000|Overall Study|Death|1|||
46630921|NCT01908816|82803993|FG001|Overall Study|Death|0|||
46630922|NCT01908816|82803994|FG002|Overall Study|Death|7|||
46630923|NCT01908816|82803995|FG003|Overall Study|Death|1|||
46630924|NCT01908816|82803992|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46630925|NCT01908816|82803993|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
46630926|NCT01908816|82803994|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
46630927|NCT01908816|82803995|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
46914116|NCT02906670|83144482|FG008|Cohort 7P, Q2W|Physician Decision|0|||
46914117|NCT02906670|83144483|FG009|Cohort 7P, Q2W|Physician Decision|1|||
46914118|NCT02906670|83144474|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46630928|NCT01908816|82803992|FG000|Overall Study|Early termination|87|||
46914119|NCT02906670|83144475|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914120|NCT02906670|83144476|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914121|NCT02906670|83144477|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914122|NCT02906670|83144478|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914123|NCT02906670|83144479|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914124|NCT02906670|83144480|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914125|NCT02906670|83144481|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914126|NCT02906670|83144482|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
46914127|NCT02906670|83144483|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
46914128|NCT02906670|83144474|FG000|Cohort 5P, QW|Radiological Progression|0|||
46914129|NCT02906670|83144475|FG001|Cohort 5P, QW|Radiological Progression|0|||
46914130|NCT02906670|83144476|FG002|Cohort 5P, QW|Radiological Progression|0|||
46914131|NCT02906670|83144477|FG003|Cohort 5P, QW|Radiological Progression|0|||
46914132|NCT02906670|83144478|FG004|Cohort 5P, QW|Radiological Progression|3|||
46914133|NCT02906670|83144479|FG005|Cohort 5P, QW|Radiological Progression|0|||
46914134|NCT02906670|83144480|FG006|Cohort 5P, QW|Radiological Progression|0|||
46914135|NCT02906670|83144481|FG007|Cohort 5P, QW|Radiological Progression|0|||
46914136|NCT02906670|83144482|FG008|Cohort 5P, QW|Radiological Progression|0|||
46914137|NCT02906670|83144483|FG009|Cohort 5P, QW|Radiological Progression|0|||
46914138|NCT02906358|83144535|FG000|Overall Study|Withdrawal by Subject|10|||
46914139|NCT02906358|83144536|FG001|Overall Study|Withdrawal by Subject|7|||
46914140|NCT02906358|83144535|FG000|Overall Study|Lost to Follow-up|12|||
46914141|NCT02906358|83144536|FG001|Overall Study|Lost to Follow-up|15|||
46914142|NCT02186834|83144542|FG000|Dose Escalation|Death|0|||
46914143|NCT02186834|83144543|FG001|Dose Escalation|Death|0|||
46914144|NCT02186834|83144544|FG002|Dose Escalation|Death|0|||
46914145|NCT02186834|83144545|FG003|Dose Escalation|Death|1|||
46914146|NCT02186834|83144546|FG004|Dose Escalation|Death|0|||
46914147|NCT02186834|83144547|FG005|Dose Escalation|Death|0|||
46914148|NCT02186834|83144542|FG000|Treatment at RP2D|Died prior to treatment|0|||
46914149|NCT02186834|83144543|FG001|Treatment at RP2D|Died prior to treatment|0|||
46914150|NCT02186834|83144544|FG002|Treatment at RP2D|Died prior to treatment|0|||
46914151|NCT02186834|83144545|FG003|Treatment at RP2D|Died prior to treatment|0|||
46914152|NCT02186834|83144546|FG004|Treatment at RP2D|Died prior to treatment|0|||
46914153|NCT02186834|83144547|FG005|Treatment at RP2D|Died prior to treatment|1|||
46914154|NCT03144687|83144558|FG000|Overall Study|Death|0|||
46914155|NCT03144687|83144559|FG001|Overall Study|Death|2|||
46914156|NCT03144687|83144558|FG000|Overall Study|Lost to Follow-up|0|||
46914157|NCT03144687|83144559|FG001|Overall Study|Lost to Follow-up|1|||
46914158|NCT03144687|83144558|FG000|Overall Study|Physician Decision|0|||
46914159|NCT03144687|83144559|FG001|Overall Study|Physician Decision|1|||
46914160|NCT03144687|83144558|FG000|Overall Study|Withdrawal by Subject|1|||
46914161|NCT03144687|83144559|FG001|Overall Study|Withdrawal by Subject|3|||
46914162|NCT03144687|83144558|FG000|Overall Study|Not Reported|2|||
46914163|NCT03144687|83144559|FG001|Overall Study|Not Reported|0|||
46630929|NCT01908816|82803993|FG001|Overall Study|Early termination|60|||
46630930|NCT01908816|82803994|FG002|Overall Study|Early termination|43|||
46630931|NCT01908816|82803995|FG003|Overall Study|Early termination|28|||
46630932|NCT01908582|82804008|FG000|Period 2|Physician Decision|1|||
46630933|NCT01908582|82804008|FG000|Period 2|Withdrawal by Subject|1|||
46630934|NCT01908426|82804017|FG000|Overall Study|Adverse Event|98|||
46630935|NCT01908426|82804018|FG001|Overall Study|Adverse Event|11|||
46714864|NCT01077258|82930978|FG000|Overall Study|Lack of Efficacy|663|||
46914164|NCT03080961|83144569|FG000|Overall Study|Withdrawal by Subject|3|||
46914165|NCT02905266|83144593|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
46914166|NCT02905266|83144594|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
46914167|NCT02905266|83144593|FG000|Treatment Phase Part 1|Disease Progression|6|||
46914168|NCT02905266|83144594|FG001|Treatment Phase Part 1|Disease Progression|7|||
46914169|NCT02905266|83144593|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
46914170|NCT02905266|83144594|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
46914171|NCT02905266|83144593|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
46914172|NCT02905266|83144594|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
46914173|NCT02905266|83144593|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
46914174|NCT02905266|83144594|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
46914175|NCT02905266|83144593|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
46914176|NCT02905266|83144594|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
46914177|NCT02905266|83144593|FG000|Transition From Part 1 to Part 2|Death|0|||
46914178|NCT02905266|83144594|FG001|Transition From Part 1 to Part 2|Death|1|||
46914179|NCT02905266|83144593|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
46914180|NCT02905266|83144594|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
46914181|NCT02905266|83144593|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
46914182|NCT02905266|83144594|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
46914183|NCT02905266|83144593|FG000|Maintenance Phase Part 2|Disease Progression|9|||
46914184|NCT02905266|83144594|FG001|Maintenance Phase Part 2|Disease Progression|2|||
46914185|NCT02905266|83144593|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
46914186|NCT02905266|83144594|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
46914187|NCT02905266|83144593|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
46914188|NCT02905266|83144594|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
46914189|NCT02982018|83144602|FG000|Overall Study|Incorrect Lens Dispensed|1|||
46914190|NCT02982018|83144603|FG001|Overall Study|Incorrect Lens Dispensed|0|||
46630936|NCT01908426|82804017|FG000|Overall Study|Clinical Deterioration|72|||
46630937|NCT01908426|82804018|FG001|Overall Study|Clinical Deterioration|38|||
46630938|NCT01908426|82804017|FG000|Overall Study|Lack of Efficacy|3|||
46630939|NCT01908426|82804018|FG001|Overall Study|Lack of Efficacy|0|||
46914191|NCT02982018|83144602|FG000|Overall Study|Protocol Violation|1|||
46914192|NCT02982018|83144603|FG001|Overall Study|Protocol Violation|1|||
46914193|NCT02982018|83144602|FG000|Overall Study|Adverse Event|1|||
46914194|NCT02982018|83144603|FG001|Overall Study|Adverse Event|1|||
46914195|NCT02982018|83144602|FG000|Overall Study|Lens Discomfort|2|||
46914196|NCT02982018|83144603|FG001|Overall Study|Lens Discomfort|0|||
46914197|NCT02982018|83144602|FG000|Overall Study|Withdrawal by Subject|0|||
46914198|NCT02982018|83144603|FG001|Overall Study|Withdrawal by Subject|1|||
46914199|NCT03080493|83144611|FG000|Overall Study|Did not provide NRS pain results|1|||
46914200|NCT03080493|83144612|FG001|Overall Study|Did not provide NRS pain results|0|||
46914201|NCT03080493|83144611|FG000|Overall Study|Adverse Event|0|||
46630940|NCT01908426|82804017|FG000|Overall Study|Lost to Follow-up|0|||
46630941|NCT01908426|82804018|FG001|Overall Study|Lost to Follow-up|1|||
46630942|NCT01908426|82804017|FG000|Overall Study|Physician Decision|3|||
46630943|NCT01908426|82804018|FG001|Overall Study|Physician Decision|3|||
46630944|NCT01908426|82804017|FG000|Overall Study|Withdrawal by Subject|11|||
46630945|NCT01908426|82804018|FG001|Overall Study|Withdrawal by Subject|6|||
46630946|NCT01908426|82804017|FG000|Overall Study|Progressive Disease|206|||
46630947|NCT01908426|82804018|FG001|Overall Study|Progressive Disease|152|||
46630948|NCT01908426|82804017|FG000|Overall Study|Protocol Violation|1|||
46630949|NCT01908426|82804018|FG001|Overall Study|Protocol Violation|0|||
46630950|NCT01908426|82804017|FG000|Overall Study|No Study Treatment Given|3|||
46630951|NCT01908426|82804018|FG001|Overall Study|No Study Treatment Given|0|||
46630952|NCT01907100|82804028|FG000|Overall Study|PD based on modified RECIST criteria|31|||
46630953|NCT01907100|82804029|FG001|Overall Study|PD based on modified RECIST criteria|32|||
46630954|NCT01907100|82804030|FG002|Overall Study|PD based on modified RECIST criteria|95|||
46630955|NCT01907100|82804031|FG003|Overall Study|PD based on modified RECIST criteria|92|||
46630956|NCT01907100|82804028|FG000|Overall Study|Withdrawal by Subject|2|||
46630957|NCT01907100|82804029|FG001|Overall Study|Withdrawal by Subject|5|||
46630958|NCT01907100|82804030|FG002|Overall Study|Withdrawal by Subject|10|||
46914202|NCT03080493|83144612|FG001|Overall Study|Adverse Event|1|||
46914203|NCT03080493|83144611|FG000|Overall Study|Randomization error (parity group)|0|||
47038765|NCT04484935|83291295|FG000|Overall Study|Death|2|||
47038766|NCT04484935|83291296|FG001|Overall Study|Death|1|||
47038767|NCT04262882|83291305|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
46630959|NCT01907100|82804031|FG003|Overall Study|Withdrawal by Subject|13|||
46914204|NCT03080493|83144612|FG001|Overall Study|Randomization error (parity group)|1|||
46914205|NCT01339910|83144620|FG000|Overall Study|Withdrawal by Subject|1|||
46914206|NCT01339910|83144621|FG001|Overall Study|Withdrawal by Subject|0|||
46914207|NCT01339910|83144620|FG000|Overall Study|Physician Decision|1|||
46630960|NCT01907100|82804028|FG000|Overall Study|Protocol Violation|0|||
46630961|NCT01907100|82804029|FG001|Overall Study|Protocol Violation|0|||
46914208|NCT01339910|83144621|FG001|Overall Study|Physician Decision|0|||
46914209|NCT01339910|83144620|FG000|Overall Study|Disease relapse|1|||
46914210|NCT01339910|83144621|FG001|Overall Study|Disease relapse|4|||
46914211|NCT02981082|83144629|FG000|Overall Study|Withdrawal by Subject|2|||
46914212|NCT02981082|83144630|FG001|Overall Study|Withdrawal by Subject|0|||
46914213|NCT02981082|83144629|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
46914214|NCT02981082|83144630|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
46914215|NCT02981082|83144629|FG000|Overall Study|Adverse Event|0|||
46914216|NCT02981082|83144630|FG001|Overall Study|Adverse Event|1|||
46914217|NCT01066104|83144638|FG000|Overall Study|Adverse Event|1|||
46914218|NCT01066104|83144639|FG001|Overall Study|Adverse Event|1|||
46914219|NCT01066104|83144638|FG000|Overall Study|Protocol Violation|1|||
46914220|NCT01066104|83144639|FG001|Overall Study|Protocol Violation|0|||
46914221|NCT02736968|83144650|FG000|Overall Study|Lost to Follow-up|0|||
46914222|NCT02736968|83144651|FG001|Overall Study|Lost to Follow-up|0|||
46914223|NCT02736968|83144652|FG002|Overall Study|Lost to Follow-up|0|||
46914224|NCT02736968|83144653|FG003|Overall Study|Lost to Follow-up|0|||
46914225|NCT02736968|83144654|FG004|Overall Study|Lost to Follow-up|0|||
46914226|NCT02736968|83144655|FG005|Overall Study|Lost to Follow-up|0|||
46914227|NCT02736968|83144656|FG006|Overall Study|Lost to Follow-up|5|||
46714865|NCT01077258|82930978|FG000|Overall Study|Clinical remission|37|||
46714866|NCT01077258|82930978|FG000|Overall Study|Other reasons|260|||
46714867|NCT00943917|82931006|FG000|Stage I|Adverse Event|1|||
46714868|NCT00943917|82931007|FG001|Stage I|Adverse Event|2|||
46714869|NCT00943917|82931008|FG002|Stage I|Adverse Event|2|||
46714870|NCT00943917|82931009|FG003|Stage I|Adverse Event|0|||
46714871|NCT00943917|82931010|FG004|Stage I|Adverse Event|0|||
46714872|NCT00943917|82931011|FG005|Stage I|Adverse Event|0|||
46714873|NCT00943917|82931012|FG006|Stage I|Adverse Event|0|||
46714874|NCT00943917|82931013|FG007|Stage I|Adverse Event|0|||
46714875|NCT00943917|82931014|FG008|Stage I|Adverse Event|0|||
46714876|NCT00943917|82931015|FG009|Stage I|Adverse Event|0|||
46714877|NCT00943917|82931016|FG010|Stage I|Adverse Event|0|||
46714878|NCT00943917|82931017|FG011|Stage I|Adverse Event|0|||
46714879|NCT00943917|82931018|FG012|Stage I|Adverse Event|0|||
46714880|NCT00943917|82931019|FG013|Stage I|Adverse Event|0|||
46714881|NCT00943917|82931020|FG014|Stage I|Adverse Event|0|||
46714882|NCT00943917|82931006|FG000|Stage I|Lost to Follow-up|0|||
46714883|NCT00943917|82931007|FG001|Stage I|Lost to Follow-up|0|||
46714884|NCT00943917|82931008|FG002|Stage I|Lost to Follow-up|1|||
46714885|NCT00943917|82931009|FG003|Stage I|Lost to Follow-up|0|||
46714886|NCT00943917|82931010|FG004|Stage I|Lost to Follow-up|0|||
46714887|NCT00943917|82931011|FG005|Stage I|Lost to Follow-up|0|||
46714888|NCT00943917|82931012|FG006|Stage I|Lost to Follow-up|0|||
46714889|NCT00943917|82931013|FG007|Stage I|Lost to Follow-up|0|||
46714890|NCT00943917|82931014|FG008|Stage I|Lost to Follow-up|0|||
46714891|NCT00943917|82931015|FG009|Stage I|Lost to Follow-up|0|||
46714892|NCT00943917|82931016|FG010|Stage I|Lost to Follow-up|0|||
46714893|NCT00943917|82931017|FG011|Stage I|Lost to Follow-up|0|||
46714894|NCT00943917|82931018|FG012|Stage I|Lost to Follow-up|0|||
46714895|NCT00943917|82931019|FG013|Stage I|Lost to Follow-up|0|||
46714896|NCT00943917|82931020|FG014|Stage I|Lost to Follow-up|0|||
46714897|NCT00943917|82931006|FG000|Stage I|hyperglycemia|0|||
46714898|NCT00943917|82931007|FG001|Stage I|hyperglycemia|0|||
46714899|NCT00943917|82931008|FG002|Stage I|hyperglycemia|1|||
46714900|NCT00943917|82931009|FG003|Stage I|hyperglycemia|0|||
46714901|NCT00943917|82931010|FG004|Stage I|hyperglycemia|0|||
46714902|NCT00943917|82931011|FG005|Stage I|hyperglycemia|0|||
46714903|NCT00943917|82931012|FG006|Stage I|hyperglycemia|0|||
46714904|NCT00943917|82931013|FG007|Stage I|hyperglycemia|0|||
46714905|NCT00943917|82931014|FG008|Stage I|hyperglycemia|0|||
46714906|NCT00943917|82931015|FG009|Stage I|hyperglycemia|0|||
46714907|NCT00943917|82931016|FG010|Stage I|hyperglycemia|0|||
46714908|NCT00943917|82931017|FG011|Stage I|hyperglycemia|0|||
46914228|NCT02736968|83144657|FG007|Overall Study|Lost to Follow-up|2|||
46714909|NCT00943917|82931018|FG012|Stage I|hyperglycemia|0|||
46914229|NCT02736968|83144650|FG000|Overall Study|COVID-19 Pandemic|0|||
46914230|NCT02736968|83144651|FG001|Overall Study|COVID-19 Pandemic|0|||
46914231|NCT02736968|83144652|FG002|Overall Study|COVID-19 Pandemic|0|||
46914232|NCT02736968|83144653|FG003|Overall Study|COVID-19 Pandemic|0|||
46914233|NCT02736968|83144654|FG004|Overall Study|COVID-19 Pandemic|0|||
46714910|NCT00943917|82931019|FG013|Stage I|hyperglycemia|0|||
46714911|NCT00943917|82931020|FG014|Stage I|hyperglycemia|0|||
46714912|NCT00943917|82931006|FG000|Stage I|A1C elevation|1|||
46714913|NCT00943917|82931007|FG001|Stage I|A1C elevation|0|||
46714914|NCT00943917|82931008|FG002|Stage I|A1C elevation|0|||
46714915|NCT00943917|82931009|FG003|Stage I|A1C elevation|0|||
46714916|NCT00943917|82931010|FG004|Stage I|A1C elevation|0|||
46714917|NCT00943917|82931011|FG005|Stage I|A1C elevation|0|||
46714918|NCT00943917|82931012|FG006|Stage I|A1C elevation|0|||
46714919|NCT00943917|82931013|FG007|Stage I|A1C elevation|0|||
46714920|NCT00943917|82931014|FG008|Stage I|A1C elevation|0|||
46714921|NCT00943917|82931015|FG009|Stage I|A1C elevation|0|||
46714922|NCT00943917|82931016|FG010|Stage I|A1C elevation|0|||
46914234|NCT02736968|83144655|FG005|Overall Study|COVID-19 Pandemic|0|||
46914235|NCT02736968|83144656|FG006|Overall Study|COVID-19 Pandemic|2|||
46914236|NCT02736968|83144657|FG007|Overall Study|COVID-19 Pandemic|0|||
46914237|NCT02736968|83144650|FG000|Overall Study|Withdrawal by Subject|0|||
47038768|NCT04262882|83291306|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
47038769|NCT04262882|83291305|FG000|Overall Study|Lost to Follow-up|1|||
46714923|NCT00943917|82931017|FG011|Stage I|A1C elevation|0|||
46714924|NCT00943917|82931018|FG012|Stage I|A1C elevation|0|||
46714925|NCT00943917|82931019|FG013|Stage I|A1C elevation|0|||
46714926|NCT00943917|82931020|FG014|Stage I|A1C elevation|0|||
46714927|NCT00943917|82931006|FG000|Stage I|Withdrawal by Subject|2|||
46714928|NCT00943917|82931007|FG001|Stage I|Withdrawal by Subject|1|||
46714929|NCT00943917|82931008|FG002|Stage I|Withdrawal by Subject|2|||
46714930|NCT00943917|82931009|FG003|Stage I|Withdrawal by Subject|0|||
46714931|NCT00943917|82931010|FG004|Stage I|Withdrawal by Subject|0|||
46714932|NCT00943917|82931011|FG005|Stage I|Withdrawal by Subject|0|||
46714933|NCT00943917|82931012|FG006|Stage I|Withdrawal by Subject|0|||
46714934|NCT00943917|82931013|FG007|Stage I|Withdrawal by Subject|0|||
46714935|NCT00943917|82931014|FG008|Stage I|Withdrawal by Subject|0|||
46714936|NCT00943917|82931015|FG009|Stage I|Withdrawal by Subject|0|||
46714937|NCT00943917|82931016|FG010|Stage I|Withdrawal by Subject|0|||
46714938|NCT00943917|82931017|FG011|Stage I|Withdrawal by Subject|0|||
46714939|NCT00943917|82931018|FG012|Stage I|Withdrawal by Subject|0|||
46714940|NCT00943917|82931019|FG013|Stage I|Withdrawal by Subject|0|||
46714941|NCT00943917|82931020|FG014|Stage I|Withdrawal by Subject|0|||
46714942|NCT00943917|82931006|FG000|Stage II|Adverse Event|0|||
46714943|NCT00943917|82931007|FG001|Stage II|Adverse Event|0|||
46714944|NCT00943917|82931008|FG002|Stage II|Adverse Event|0|||
46714945|NCT00943917|82931009|FG003|Stage II|Adverse Event|0|||
46714946|NCT00943917|82931010|FG004|Stage II|Adverse Event|0|||
46714947|NCT00943917|82931011|FG005|Stage II|Adverse Event|1|||
46714948|NCT00943917|82931012|FG006|Stage II|Adverse Event|3|||
46714949|NCT00943917|82931013|FG007|Stage II|Adverse Event|0|||
46714950|NCT00943917|82931014|FG008|Stage II|Adverse Event|1|||
46714951|NCT00943917|82931015|FG009|Stage II|Adverse Event|0|||
46714952|NCT00943917|82931016|FG010|Stage II|Adverse Event|0|||
46714953|NCT00943917|82931017|FG011|Stage II|Adverse Event|0|||
46714954|NCT00943917|82931018|FG012|Stage II|Adverse Event|0|||
46714955|NCT00943917|82931019|FG013|Stage II|Adverse Event|0|||
46714956|NCT00943917|82931020|FG014|Stage II|Adverse Event|0|||
46714957|NCT00943917|82931006|FG000|Stage II|Withdrawal by Subject|0|||
46714958|NCT00943917|82931007|FG001|Stage II|Withdrawal by Subject|0|||
46714959|NCT00943917|82931008|FG002|Stage II|Withdrawal by Subject|0|||
46714960|NCT00943917|82931009|FG003|Stage II|Withdrawal by Subject|0|||
46714961|NCT00943917|82931010|FG004|Stage II|Withdrawal by Subject|0|||
46714962|NCT00943917|82931011|FG005|Stage II|Withdrawal by Subject|1|||
46714963|NCT00943917|82931012|FG006|Stage II|Withdrawal by Subject|0|||
46714964|NCT00943917|82931013|FG007|Stage II|Withdrawal by Subject|0|||
46714965|NCT00943917|82931014|FG008|Stage II|Withdrawal by Subject|0|||
46714966|NCT00943917|82931015|FG009|Stage II|Withdrawal by Subject|0|||
46714967|NCT00943917|82931016|FG010|Stage II|Withdrawal by Subject|0|||
46714968|NCT00943917|82931017|FG011|Stage II|Withdrawal by Subject|0|||
47038770|NCT04262882|83291306|FG001|Overall Study|Lost to Follow-up|0|||
46630962|NCT01907100|82804030|FG002|Overall Study|Protocol Violation|1|||
46630963|NCT01907100|82804031|FG003|Overall Study|Protocol Violation|1|||
46630964|NCT01907100|82804028|FG000|Overall Study|Lost to Follow-up|0|||
46630965|NCT01907100|82804029|FG001|Overall Study|Lost to Follow-up|0|||
46630966|NCT01907100|82804030|FG002|Overall Study|Lost to Follow-up|0|||
46630967|NCT01907100|82804031|FG003|Overall Study|Lost to Follow-up|1|||
46630968|NCT01907100|82804028|FG000|Overall Study|Not treated|2|||
46630969|NCT01907100|82804029|FG001|Overall Study|Not treated|0|||
46630970|NCT01907100|82804030|FG002|Overall Study|Not treated|1|||
46630971|NCT01907100|82804031|FG003|Overall Study|Not treated|2|||
46630972|NCT01907100|82804028|FG000|Overall Study|Other than reasons specified|1|||
46630973|NCT01907100|82804029|FG001|Overall Study|Other than reasons specified|0|||
46630974|NCT01907100|82804030|FG002|Overall Study|Other than reasons specified|10|||
46630975|NCT01907100|82804031|FG003|Overall Study|Other than reasons specified|6|||
46630976|NCT01907100|82804028|FG000|Overall Study|Adverse event (AE)|6|||
46630977|NCT01907100|82804029|FG001|Overall Study|Adverse event (AE)|3|||
46630978|NCT01907100|82804030|FG002|Overall Study|Adverse event (AE)|22|||
46714969|NCT00943917|82931018|FG012|Stage II|Withdrawal by Subject|0|||
46714970|NCT00943917|82931019|FG013|Stage II|Withdrawal by Subject|0|||
46714971|NCT00943917|82931020|FG014|Stage II|Withdrawal by Subject|0|||
46714972|NCT00943917|82931006|FG000|Stage II|Pregnancy|0|||
46714973|NCT00943917|82931007|FG001|Stage II|Pregnancy|0|||
46714974|NCT00943917|82931008|FG002|Stage II|Pregnancy|0|||
47038771|NCT04135859|83291314|FG000|Overall Study|Withdrawal by Subject|1|||
46714975|NCT00943917|82931009|FG003|Stage II|Pregnancy|0|||
46714976|NCT00943917|82931010|FG004|Stage II|Pregnancy|0|||
46714977|NCT00943917|82931011|FG005|Stage II|Pregnancy|1|||
46714978|NCT00943917|82931012|FG006|Stage II|Pregnancy|0|||
46714979|NCT00943917|82931013|FG007|Stage II|Pregnancy|0|||
46914238|NCT02736968|83144651|FG001|Overall Study|Withdrawal by Subject|0|||
46914239|NCT02736968|83144652|FG002|Overall Study|Withdrawal by Subject|0|||
46914240|NCT02736968|83144653|FG003|Overall Study|Withdrawal by Subject|0|||
46914241|NCT02736968|83144654|FG004|Overall Study|Withdrawal by Subject|0|||
46914242|NCT02736968|83144655|FG005|Overall Study|Withdrawal by Subject|0|||
46914243|NCT02736968|83144656|FG006|Overall Study|Withdrawal by Subject|1|||
46914244|NCT02736968|83144657|FG007|Overall Study|Withdrawal by Subject|0|||
46914245|NCT02980224|83144670|FG000|Overall Study|Adverse Event|4|||
46914246|NCT02980224|83144671|FG001|Overall Study|Adverse Event|1|||
46914247|NCT02980224|83144670|FG000|Overall Study|Withdrawal by Subject|0|||
46714980|NCT00943917|82931014|FG008|Stage II|Pregnancy|0|||
46714981|NCT00943917|82931015|FG009|Stage II|Pregnancy|0|||
46714982|NCT00943917|82931016|FG010|Stage II|Pregnancy|0|||
46714983|NCT00943917|82931017|FG011|Stage II|Pregnancy|0|||
46714984|NCT00943917|82931018|FG012|Stage II|Pregnancy|0|||
46714985|NCT00943917|82931019|FG013|Stage II|Pregnancy|0|||
46714986|NCT00943917|82931020|FG014|Stage II|Pregnancy|0|||
46714987|NCT00943917|82931006|FG000|Stage II Continuation|Adverse Event|0|||
46714988|NCT00943917|82931007|FG001|Stage II Continuation|Adverse Event|0|||
46714989|NCT00943917|82931008|FG002|Stage II Continuation|Adverse Event|0|||
46714990|NCT00943917|82931009|FG003|Stage II Continuation|Adverse Event|0|||
46714991|NCT00943917|82931010|FG004|Stage II Continuation|Adverse Event|0|||
46714992|NCT00943917|82931011|FG005|Stage II Continuation|Adverse Event|0|||
46714993|NCT00943917|82931012|FG006|Stage II Continuation|Adverse Event|0|||
46714994|NCT00943917|82931013|FG007|Stage II Continuation|Adverse Event|0|||
46714995|NCT00943917|82931014|FG008|Stage II Continuation|Adverse Event|0|||
46714996|NCT00943917|82931015|FG009|Stage II Continuation|Adverse Event|0|||
46714997|NCT00943917|82931016|FG010|Stage II Continuation|Adverse Event|0|||
46714998|NCT00943917|82931017|FG011|Stage II Continuation|Adverse Event|1|||
46714999|NCT00943917|82931018|FG012|Stage II Continuation|Adverse Event|2|||
46715000|NCT00943917|82931019|FG013|Stage II Continuation|Adverse Event|1|||
46715001|NCT00943917|82931020|FG014|Stage II Continuation|Adverse Event|1|||
46715002|NCT00943917|82931006|FG000|Stage II Continuation|Withdrawal by Subject|0|||
46715003|NCT00943917|82931007|FG001|Stage II Continuation|Withdrawal by Subject|0|||
46715004|NCT00943917|82931008|FG002|Stage II Continuation|Withdrawal by Subject|0|||
46715005|NCT00943917|82931009|FG003|Stage II Continuation|Withdrawal by Subject|0|||
46715006|NCT00943917|82931010|FG004|Stage II Continuation|Withdrawal by Subject|0|||
46715007|NCT00943917|82931011|FG005|Stage II Continuation|Withdrawal by Subject|0|||
46715008|NCT00943917|82931012|FG006|Stage II Continuation|Withdrawal by Subject|0|||
46715009|NCT00943917|82931013|FG007|Stage II Continuation|Withdrawal by Subject|0|||
46715010|NCT00943917|82931014|FG008|Stage II Continuation|Withdrawal by Subject|0|||
46715011|NCT00943917|82931015|FG009|Stage II Continuation|Withdrawal by Subject|0|||
46715012|NCT00943917|82931016|FG010|Stage II Continuation|Withdrawal by Subject|0|||
46715013|NCT00943917|82931017|FG011|Stage II Continuation|Withdrawal by Subject|0|||
46715014|NCT00943917|82931018|FG012|Stage II Continuation|Withdrawal by Subject|0|||
46715015|NCT00943917|82931019|FG013|Stage II Continuation|Withdrawal by Subject|1|||
46715016|NCT00943917|82931020|FG014|Stage II Continuation|Withdrawal by Subject|3|||
46715017|NCT00943917|82931006|FG000|Stage II Continuation|Protocol Violation|0|||
46715018|NCT00943917|82931007|FG001|Stage II Continuation|Protocol Violation|0|||
46715019|NCT00943917|82931008|FG002|Stage II Continuation|Protocol Violation|0|||
46715020|NCT00943917|82931009|FG003|Stage II Continuation|Protocol Violation|0|||
46715021|NCT00943917|82931010|FG004|Stage II Continuation|Protocol Violation|0|||
46715022|NCT00943917|82931011|FG005|Stage II Continuation|Protocol Violation|0|||
46715023|NCT00943917|82931012|FG006|Stage II Continuation|Protocol Violation|0|||
46715024|NCT00943917|82931013|FG007|Stage II Continuation|Protocol Violation|0|||
46715025|NCT00943917|82931014|FG008|Stage II Continuation|Protocol Violation|0|||
46715026|NCT00943917|82931015|FG009|Stage II Continuation|Protocol Violation|1|||
46715027|NCT00943917|82931016|FG010|Stage II Continuation|Protocol Violation|0|||
46715028|NCT00943917|82931017|FG011|Stage II Continuation|Protocol Violation|1|||
46715029|NCT00943917|82931018|FG012|Stage II Continuation|Protocol Violation|0|||
46715030|NCT00943917|82931019|FG013|Stage II Continuation|Protocol Violation|0|||
46914248|NCT02980224|83144671|FG001|Overall Study|Withdrawal by Subject|2|||
46715031|NCT00943917|82931020|FG014|Stage II Continuation|Protocol Violation|0|||
46914249|NCT02591615|83144681|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
46715032|NCT00943917|82931006|FG000|Stage II Continuation|hypoglycemia|0|||
46715033|NCT00943917|82931007|FG001|Stage II Continuation|hypoglycemia|0|||
46914250|NCT02591615|83144682|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
46914251|NCT02591615|83144683|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
46914252|NCT02591615|83144684|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
46914253|NCT02591615|83144681|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
46715034|NCT00943917|82931008|FG002|Stage II Continuation|hypoglycemia|0|||
46715035|NCT00943917|82931009|FG003|Stage II Continuation|hypoglycemia|0|||
46715036|NCT00943917|82931010|FG004|Stage II Continuation|hypoglycemia|0|||
46715037|NCT00943917|82931011|FG005|Stage II Continuation|hypoglycemia|0|||
46715038|NCT00943917|82931012|FG006|Stage II Continuation|hypoglycemia|0|||
46715039|NCT00943917|82931013|FG007|Stage II Continuation|hypoglycemia|0|||
46715040|NCT00943917|82931014|FG008|Stage II Continuation|hypoglycemia|0|||
46715041|NCT00943917|82931015|FG009|Stage II Continuation|hypoglycemia|0|||
46715042|NCT00943917|82931016|FG010|Stage II Continuation|hypoglycemia|0|||
46715043|NCT00943917|82931017|FG011|Stage II Continuation|hypoglycemia|0|||
46715044|NCT00943917|82931018|FG012|Stage II Continuation|hypoglycemia|1|||
46715045|NCT00943917|82931019|FG013|Stage II Continuation|hypoglycemia|0|||
46715046|NCT00943917|82931020|FG014|Stage II Continuation|hypoglycemia|0|||
46715047|NCT00943917|82931006|FG000|Stage II Continuation|A1C elevation|0|||
46715048|NCT00943917|82931007|FG001|Stage II Continuation|A1C elevation|0|||
46715049|NCT00943917|82931008|FG002|Stage II Continuation|A1C elevation|0|||
46715050|NCT00943917|82931009|FG003|Stage II Continuation|A1C elevation|0|||
46715051|NCT00943917|82931010|FG004|Stage II Continuation|A1C elevation|0|||
46715052|NCT00943917|82931011|FG005|Stage II Continuation|A1C elevation|0|||
46715053|NCT00943917|82931012|FG006|Stage II Continuation|A1C elevation|0|||
46715054|NCT00943917|82931013|FG007|Stage II Continuation|A1C elevation|0|||
46715055|NCT00943917|82931014|FG008|Stage II Continuation|A1C elevation|0|||
46715056|NCT00943917|82931015|FG009|Stage II Continuation|A1C elevation|0|||
46715057|NCT00943917|82931016|FG010|Stage II Continuation|A1C elevation|0|||
46715058|NCT00943917|82931017|FG011|Stage II Continuation|A1C elevation|0|||
46715059|NCT00943917|82931018|FG012|Stage II Continuation|A1C elevation|0|||
46715060|NCT00943917|82931019|FG013|Stage II Continuation|A1C elevation|1|||
46715061|NCT00943917|82931020|FG014|Stage II Continuation|A1C elevation|0|||
47038772|NCT04135859|83291315|FG001|Overall Study|Withdrawal by Subject|0|||
47038773|NCT04135859|83291314|FG000|Overall Study|Withdrawal due to screening failure|1|||
47038774|NCT04135859|83291315|FG001|Overall Study|Withdrawal due to screening failure|2|||
47038775|NCT04135859|83291314|FG000|Overall Study|Did not complete stress test|3|||
47038776|NCT04135859|83291315|FG001|Overall Study|Did not complete stress test|3|||
47038777|NCT04135859|83291314|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
47038778|NCT04135859|83291315|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
47038779|NCT04068610|83291324|FG000|Overall Study|Death|4|||
47038780|NCT04068610|83291325|FG001|Overall Study|Death|8|||
47038781|NCT04068610|83291326|FG002|Overall Study|Death|13|||
47038782|NCT04068610|83291324|FG000|Overall Study|Lost to Follow-up|0|||
47038783|NCT04068610|83291325|FG001|Overall Study|Lost to Follow-up|2|||
47038784|NCT04068610|83291326|FG002|Overall Study|Lost to Follow-up|0|||
47038785|NCT04068610|83291324|FG000|Overall Study|Withdrawal by Subject|0|||
46630979|NCT01907100|82804031|FG003|Overall Study|Adverse event (AE)|23|||
46630980|NCT01907100|82804028|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
46630981|NCT01907100|82804029|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
46715062|NCT01077024|82931055|FG000|Overall Study|Lost to Follow-up|20|||
46715063|NCT01077024|82931056|FG001|Overall Study|Lost to Follow-up|14|||
46715064|NCT01077024|82931055|FG000|Overall Study|Withdrawal by Subject|0|||
46715065|NCT01077024|82931056|FG001|Overall Study|Withdrawal by Subject|2|||
46715066|NCT01077024|82931055|FG000|Overall Study|Incarcerated|7|||
46715067|NCT01077024|82931056|FG001|Overall Study|Incarcerated|8|||
46715068|NCT01077024|82931055|FG000|Overall Study|Other|4|||
46715069|NCT01077024|82931056|FG001|Overall Study|Other|4|||
46715070|NCT01089582|82931062|FG000|Overall Study|Death|2|||
46715071|NCT01089582|82931062|FG000|Overall Study|Adverse Event|15|||
46715072|NCT01089582|82931062|FG000|Overall Study|Lost to Follow-up|8|||
46715073|NCT01089582|82931062|FG000|Overall Study|Other|4|||
46715074|NCT01089582|82931062|FG000|Overall Study|Withdrawal by Subject|1|||
46715075|NCT00862459|82931069|FG000|Overall Study|Lost to Follow-up|1|||
46715076|NCT00862459|82931070|FG001|Overall Study|Lost to Follow-up|2|||
46715077|NCT00862459|82931071|FG002|Overall Study|Lost to Follow-up|2|||
46715078|NCT00862459|82931069|FG000|Overall Study|Protocol Violation|1|||
46715079|NCT00862459|82931070|FG001|Overall Study|Protocol Violation|0|||
46630982|NCT01907100|82804030|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
46630983|NCT01907100|82804031|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
46630984|NCT01889862|82804039|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
47038786|NCT04068610|83291325|FG001|Overall Study|Withdrawal by Subject|4|||
46630985|NCT01889862|82804040|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
46630986|NCT01889862|82804041|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
46630987|NCT01889862|82804042|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
47038787|NCT04068610|83291326|FG002|Overall Study|Withdrawal by Subject|2|||
46715080|NCT00862459|82931071|FG002|Overall Study|Protocol Violation|0|||
46715081|NCT00862459|82931069|FG000|Overall Study|Withdrawal by Subject|1|||
46715082|NCT00862459|82931070|FG001|Overall Study|Withdrawal by Subject|1|||
46715083|NCT00862459|82931071|FG002|Overall Study|Withdrawal by Subject|3|||
46715084|NCT00862459|82931069|FG000|Overall Study|Adverse Event|0|||
46715085|NCT00862459|82931070|FG001|Overall Study|Adverse Event|1|||
46715086|NCT00862459|82931071|FG002|Overall Study|Adverse Event|0|||
46715087|NCT00862459|82931069|FG000|Overall Study|Personal reasons|1|||
46715088|NCT00862459|82931070|FG001|Overall Study|Personal reasons|0|||
47038788|NCT04068610|83291324|FG000|Overall Study|Other|3|||
47038789|NCT04068610|83291325|FG001|Overall Study|Other|12|||
46715089|NCT00862459|82931071|FG002|Overall Study|Personal reasons|0|||
46715090|NCT00862459|82931069|FG000|Overall Study|Operation|1|||
46715091|NCT00862459|82931070|FG001|Overall Study|Operation|1|||
46715092|NCT00862459|82931071|FG002|Overall Study|Operation|0|||
46715093|NCT00862459|82931069|FG000|Overall Study|Intravenous (IV) site problems|1|||
46715094|NCT00862459|82931070|FG001|Overall Study|Intravenous (IV) site problems|0|||
46715095|NCT00862459|82931071|FG002|Overall Study|Intravenous (IV) site problems|1|||
46715096|NCT00862459|82931069|FG000|Overall Study|Unable to hold still for imaging|0|||
46715097|NCT00862459|82931070|FG001|Overall Study|Unable to hold still for imaging|1|||
46715098|NCT00862459|82931071|FG002|Overall Study|Unable to hold still for imaging|0|||
46715099|NCT00862459|82931069|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
46715100|NCT00862459|82931070|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
46715101|NCT00862459|82931071|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
46715102|NCT00862459|82931069|FG000|Overall Study|Administrative problems|0|||
46715103|NCT00862459|82931070|FG001|Overall Study|Administrative problems|1|||
46715104|NCT00862459|82931071|FG002|Overall Study|Administrative problems|0|||
46715105|NCT01074450|82931082|FG000|First Intervention|Emesis in Dosing Interval|0|||
46715106|NCT01074450|82931083|FG001|First Intervention|Emesis in Dosing Interval|2|||
46715107|NCT01074450|82931082|FG000|Second Intervention|Protocol Violation|1|||
47038790|NCT04068610|83291326|FG002|Overall Study|Other|11|||
47038791|NCT03860844|83291337|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
47038792|NCT03860844|83291338|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
47038793|NCT03860844|83291339|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
47038794|NCT03860844|83291337|FG000|Overall Study|Progressive disease|5|||
47038795|NCT03860844|83291338|FG001|Overall Study|Progressive disease|3|||
47038796|NCT03860844|83291339|FG002|Overall Study|Progressive disease|4|||
47038797|NCT03860844|83291337|FG000|Overall Study|Other, Not related to COVID-19|0|||
47038798|NCT03860844|83291338|FG001|Overall Study|Other, Not related to COVID-19|1|||
47038799|NCT03860844|83291339|FG002|Overall Study|Other, Not related to COVID-19|0|||
47038800|NCT03298984|83291353|FG000|Overall Study|Physician Decision|1|||
47038801|NCT03298984|83291354|FG001|Overall Study|Physician Decision|0|||
47038802|NCT03298984|83291355|FG002|Overall Study|Physician Decision|0|||
47038803|NCT03298984|83291356|FG003|Overall Study|Physician Decision|6|||
47038804|NCT03298984|83291353|FG000|Overall Study|Lack of Efficacy|0|||
47038805|NCT03298984|83291354|FG001|Overall Study|Lack of Efficacy|1|||
47038806|NCT03298984|83291355|FG002|Overall Study|Lack of Efficacy|1|||
47038807|NCT03298984|83291356|FG003|Overall Study|Lack of Efficacy|4|||
47038808|NCT03298984|83291353|FG000|Overall Study|Relapsed disease (following remission)|0|||
47038809|NCT03298984|83291354|FG001|Overall Study|Relapsed disease (following remission)|0|||
46715108|NCT01074450|82931083|FG001|Second Intervention|Protocol Violation|0|||
46715109|NCT01074450|82931082|FG000|Second Intervention|Physician Decision|0|||
47038810|NCT03298984|83291355|FG002|Overall Study|Relapsed disease (following remission)|1|||
46715110|NCT01074450|82931083|FG001|Second Intervention|Physician Decision|1|||
46715111|NCT00943761|82931091|FG000|Overall Study|Lost to Follow-up|2|||
47038811|NCT03298984|83291356|FG003|Overall Study|Relapsed disease (following remission)|1|||
47038812|NCT03298984|83291353|FG000|Overall Study|Adverse Event|0|||
47038813|NCT03298984|83291354|FG001|Overall Study|Adverse Event|0|||
47038814|NCT03298984|83291355|FG002|Overall Study|Adverse Event|0|||
47038815|NCT03298984|83291356|FG003|Overall Study|Adverse Event|1|||
47038816|NCT03298984|83291353|FG000|Overall Study|Death|0|||
46630988|NCT01889862|82804043|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
46630989|NCT01889862|82804039|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
46630990|NCT01889862|82804040|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
46630991|NCT01889862|82804041|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
46630992|NCT01889862|82804042|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
46630993|NCT01889862|82804043|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
46630994|NCT01889862|82804039|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
46630995|NCT01889862|82804040|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
46630996|NCT01889862|82804041|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
46630997|NCT01889862|82804042|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
46630998|NCT01889862|82804043|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
46630999|NCT01889862|82804039|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
46631000|NCT01889862|82804040|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
46631001|NCT01889862|82804041|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
46631002|NCT01889862|82804042|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
46631003|NCT01889862|82804043|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
46631004|NCT01889862|82804039|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
46631005|NCT01889862|82804040|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
46631006|NCT01889862|82804041|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
46715112|NCT00943761|82931092|FG001|Overall Study|Lost to Follow-up|0|||
46715113|NCT00943761|82931091|FG000|Overall Study|Withdrawal by Subject|2|||
46715114|NCT00943761|82931092|FG001|Overall Study|Withdrawal by Subject|1|||
46715115|NCT00949533|82931100|FG000|Overall Study|Lost to Follow-up|0|||
46715116|NCT00949533|82931101|FG001|Overall Study|Lost to Follow-up|1|||
47038817|NCT03298984|83291354|FG001|Overall Study|Death|0|||
46715117|NCT00866047|82931107|FG000|Treatment Period|Progressive disease|13|||
46715118|NCT00866047|82931107|FG000|Treatment Period|Adverse Event|16|||
46715119|NCT00866047|82931107|FG000|Treatment Period|Physician Decision|14|||
46715120|NCT00866047|82931107|FG000|Treatment Period|Withdrawal by Subject|5|||
46715121|NCT00866047|82931107|FG000|Follow-up Period|Lost to Follow-up|5|||
46715122|NCT00869323|82931111|FG000|Maintenance Therapy|concurrent illness|1|||
46715123|NCT01192022|82931119|FG000|Overall Study|Withdrawal of Consent|3|||
46715124|NCT01192022|82931120|FG001|Overall Study|Withdrawal of Consent|1|||
46715125|NCT01192022|82931121|FG002|Overall Study|Withdrawal of Consent|0|||
46715126|NCT01192022|82931122|FG003|Overall Study|Withdrawal of Consent|0|||
46914254|NCT02591615|83144682|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
46914255|NCT02591615|83144683|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
46914256|NCT02591615|83144684|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
46914257|NCT02591615|83144681|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
46914258|NCT02591615|83144682|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
46914259|NCT02591615|83144683|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
46914260|NCT02591615|83144684|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
46914261|NCT02591615|83144681|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
46914262|NCT02591615|83144682|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
46914263|NCT02591615|83144683|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
46914264|NCT02591615|83144684|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
46914265|NCT02591615|83144681|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
46914266|NCT02591615|83144682|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
46914267|NCT02591615|83144683|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
46914268|NCT02591615|83144684|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
46914269|NCT02591615|83144681|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
46914270|NCT02591615|83144682|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
46914271|NCT02591615|83144683|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
46914272|NCT02591615|83144684|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
46914273|NCT02591615|83144681|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
47038818|NCT03298984|83291355|FG002|Overall Study|Death|0|||
47038819|NCT03298984|83291356|FG003|Overall Study|Death|2|||
47038820|NCT03298984|83291353|FG000|Overall Study|Insurance Company Decision|0|||
47038821|NCT03298984|83291354|FG001|Overall Study|Insurance Company Decision|0|||
46631007|NCT01889862|82804042|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
46631008|NCT01889862|82804043|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
46914274|NCT02591615|83144682|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
46914275|NCT02591615|83144683|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
46914276|NCT02591615|83144684|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
46914277|NCT02591615|83144681|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
46631009|NCT01889862|82804039|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
46631010|NCT01889862|82804040|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
46631011|NCT01889862|82804041|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
46631012|NCT01889862|82804042|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
46631013|NCT01889862|82804043|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
46631014|NCT01889862|82804039|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
46631015|NCT01889862|82804040|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
46631016|NCT01889862|82804041|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
46914278|NCT02591615|83144682|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
46914279|NCT02591615|83144683|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
46914280|NCT02591615|83144684|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
47038822|NCT03298984|83291355|FG002|Overall Study|Insurance Company Decision|0|||
47038823|NCT03298984|83291356|FG003|Overall Study|Insurance Company Decision|1|||
47038824|NCT03248492|83291372|FG000|Overall Study|Ongoing|23|||
47038825|NCT03248492|83291373|FG001|Overall Study|Ongoing|26|||
47038826|NCT03248492|83291374|FG002|Overall Study|Ongoing|3|||
47038827|NCT03248492|83291375|FG003|Overall Study|Ongoing|85|||
47038828|NCT03248492|83291376|FG004|Overall Study|Ongoing|2|||
46631017|NCT01889862|82804042|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
46715127|NCT01192022|82931123|FG004|Overall Study|Withdrawal of Consent|0|||
46715128|NCT01192022|82931119|FG000|Overall Study|Lost to Follow-up|4|||
46715129|NCT01192022|82931120|FG001|Overall Study|Lost to Follow-up|2|||
46715130|NCT01192022|82931121|FG002|Overall Study|Lost to Follow-up|1|||
46715131|NCT01192022|82931122|FG003|Overall Study|Lost to Follow-up|1|||
46715132|NCT01192022|82931123|FG004|Overall Study|Lost to Follow-up|0|||
46715133|NCT01192022|82931119|FG000|Overall Study|Adverse Event|1|||
46715134|NCT01192022|82931120|FG001|Overall Study|Adverse Event|0|||
46715135|NCT01192022|82931121|FG002|Overall Study|Adverse Event|0|||
46715136|NCT01192022|82931122|FG003|Overall Study|Adverse Event|0|||
46715137|NCT01192022|82931123|FG004|Overall Study|Adverse Event|0|||
46715138|NCT01192022|82931119|FG000|Overall Study|Fatal Adverse Event|4|||
46715139|NCT01192022|82931120|FG001|Overall Study|Fatal Adverse Event|6|||
46715140|NCT01192022|82931121|FG002|Overall Study|Fatal Adverse Event|0|||
46715141|NCT01192022|82931122|FG003|Overall Study|Fatal Adverse Event|0|||
46715142|NCT01192022|82931123|FG004|Overall Study|Fatal Adverse Event|1|||
46715143|NCT01192022|82931119|FG000|Overall Study|Physician withdrew-patient hardship|1|||
46715144|NCT01192022|82931120|FG001|Overall Study|Physician withdrew-patient hardship|0|||
46715145|NCT01192022|82931121|FG002|Overall Study|Physician withdrew-patient hardship|0|||
46715146|NCT01192022|82931122|FG003|Overall Study|Physician withdrew-patient hardship|0|||
46715147|NCT01192022|82931123|FG004|Overall Study|Physician withdrew-patient hardship|0|||
46715148|NCT01192022|82931119|FG000|Overall Study|Patient too sick from chemotherapy|0|||
46715149|NCT01192022|82931120|FG001|Overall Study|Patient too sick from chemotherapy|1|||
46715150|NCT01192022|82931121|FG002|Overall Study|Patient too sick from chemotherapy|0|||
46715151|NCT01192022|82931122|FG003|Overall Study|Patient too sick from chemotherapy|0|||
46715152|NCT01192022|82931123|FG004|Overall Study|Patient too sick from chemotherapy|0|||
46715153|NCT01192022|82931119|FG000|Overall Study|Patient needed surgery|0|||
46715154|NCT01192022|82931120|FG001|Overall Study|Patient needed surgery|1|||
46715155|NCT01192022|82931121|FG002|Overall Study|Patient needed surgery|0|||
46715156|NCT01192022|82931122|FG003|Overall Study|Patient needed surgery|0|||
46715157|NCT01192022|82931123|FG004|Overall Study|Patient needed surgery|0|||
46715158|NCT01192022|82931119|FG000|Overall Study|Parents did not allow all follow up|0|||
46715159|NCT01192022|82931120|FG001|Overall Study|Parents did not allow all follow up|0|||
46715160|NCT01192022|82931121|FG002|Overall Study|Parents did not allow all follow up|0|||
46715161|NCT01192022|82931122|FG003|Overall Study|Parents did not allow all follow up|1|||
46914281|NCT02591615|83144681|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
46914282|NCT02591615|83144682|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
46715162|NCT01192022|82931123|FG004|Overall Study|Parents did not allow all follow up|0|||
46715163|NCT01191944|82931136|FG000|Overall Study|Adverse Event|11|||
46715164|NCT01191944|82931137|FG001|Overall Study|Adverse Event|12|||
46715165|NCT01191944|82931136|FG000|Overall Study|Protocol Violation|1|||
46715166|NCT01191944|82931137|FG001|Overall Study|Protocol Violation|2|||
46715167|NCT01191944|82931136|FG000|Overall Study|Withdrawal by Subject|4|||
46715168|NCT01191944|82931137|FG001|Overall Study|Withdrawal by Subject|2|||
46715169|NCT01191944|82931136|FG000|Overall Study|Other|1|||
46715170|NCT01191944|82931137|FG001|Overall Study|Other|3|||
46715171|NCT01191788|82931145|FG000|Overall Study|Lost to Follow-up|21|||
46715172|NCT01191788|82931146|FG001|Overall Study|Lost to Follow-up|22|||
46715173|NCT00940875|82931155|FG000|Treatment Phase|Adverse Event|9|||
46914283|NCT02591615|83144683|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
46914284|NCT02591615|83144684|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
46914285|NCT02591615|83144681|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
46914286|NCT02591615|83144682|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
46631018|NCT01889862|82804043|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
46631019|NCT01889862|82804039|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
46631020|NCT01889862|82804040|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
46631021|NCT01889862|82804041|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
46631022|NCT01889862|82804042|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
46631023|NCT01889862|82804043|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
46631024|NCT01889862|82804039|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
46631025|NCT01889862|82804040|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
46631026|NCT01889862|82804041|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
46631027|NCT01889862|82804042|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
46715174|NCT00940875|82931156|FG001|Treatment Phase|Adverse Event|3|||
46715175|NCT00940875|82931155|FG000|Treatment Phase|Death|3|||
46715176|NCT00940875|82931156|FG001|Treatment Phase|Death|5|||
46631028|NCT01889862|82804043|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
46715177|NCT00940875|82931155|FG000|Treatment Phase|Lack of Efficacy|1|||
46715178|NCT00940875|82931156|FG001|Treatment Phase|Lack of Efficacy|0|||
46715179|NCT00940875|82931155|FG000|Treatment Phase|Withdrawal by Subject|3|||
46715180|NCT00940875|82931156|FG001|Treatment Phase|Withdrawal by Subject|0|||
46715181|NCT00940875|82931155|FG000|Treatment Phase|Disease progression|9|||
46715182|NCT00940875|82931156|FG001|Treatment Phase|Disease progression|11|||
46715183|NCT00940875|82931155|FG000|Treatment Phase|Physician Decision|1|||
46715184|NCT00940875|82931156|FG001|Treatment Phase|Physician Decision|0|||
46715185|NCT00940875|82931155|FG000|Post-Study Treatment|Death|0|||
46715186|NCT00940875|82931156|FG001|Post-Study Treatment|Death|1|||
46715187|NCT00940875|82931155|FG000|Post-Study Treatment|Disease Progression|0|||
46715188|NCT00940875|82931156|FG001|Post-Study Treatment|Disease Progression|2|||
46715189|NCT00940485|82931165|FG000|Overall Study|HBeAb positive at Baseline|3|||
46715190|NCT00940485|82931166|FG001|Overall Study|HBeAb positive at Baseline|2|||
46715191|NCT00940485|82931165|FG000|Overall Study|Lost to Follow-up|2|||
46715192|NCT00940485|82931166|FG001|Overall Study|Lost to Follow-up|3|||
46715193|NCT00940485|82931165|FG000|Overall Study|Adverse Event|8|||
46715194|NCT00940485|82931166|FG001|Overall Study|Adverse Event|0|||
46715195|NCT00940485|82931165|FG000|Overall Study|Withdrawal by Subject|1|||
46715196|NCT00940485|82931166|FG001|Overall Study|Withdrawal by Subject|1|||
46715197|NCT00940485|82931165|FG000|Overall Study|Others|1|||
46715198|NCT00940485|82931166|FG001|Overall Study|Others|1|||
46715199|NCT00943605|82931174|FG000|Overall Study|Study termination|30|||
46715200|NCT00943605|82931175|FG001|Overall Study|Study termination|30|||
46715201|NCT01132313|82931193|FG000|Overall Study|Lack of Efficacy|1|||
46715202|NCT01132313|82931194|FG001|Overall Study|Lack of Efficacy|0|||
46715203|NCT01132313|82931195|FG002|Overall Study|Lack of Efficacy|0|||
46715204|NCT01132313|82931196|FG003|Overall Study|Lack of Efficacy|0|||
46715205|NCT01132313|82931197|FG004|Overall Study|Lack of Efficacy|0|||
46715206|NCT01132313|82931198|FG005|Overall Study|Lack of Efficacy|0|||
46715207|NCT01132313|82931199|FG006|Overall Study|Lack of Efficacy|0|||
46715208|NCT01132313|82931200|FG007|Overall Study|Lack of Efficacy|3|||
47038829|NCT03248492|83291372|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
47038830|NCT03248492|83291373|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
47038831|NCT03248492|83291374|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
47038832|NCT03248492|83291375|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
47038833|NCT03248492|83291376|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
47038834|NCT03248492|83291372|FG000|Overall Study|Adverse Event|6|||
47038835|NCT03248492|83291373|FG001|Overall Study|Adverse Event|6|||
47038836|NCT03248492|83291374|FG002|Overall Study|Adverse Event|8|||
47038837|NCT03248492|83291375|FG003|Overall Study|Adverse Event|8|||
47038838|NCT03248492|83291376|FG004|Overall Study|Adverse Event|1|||
47038839|NCT03248492|83291372|FG000|Overall Study|Withdrawal by Subject|3|||
47038840|NCT03248492|83291373|FG001|Overall Study|Withdrawal by Subject|3|||
47038841|NCT03248492|83291374|FG002|Overall Study|Withdrawal by Subject|0|||
47038842|NCT03248492|83291375|FG003|Overall Study|Withdrawal by Subject|3|||
47038843|NCT03248492|83291376|FG004|Overall Study|Withdrawal by Subject|1|||
47038844|NCT03248492|83291372|FG000|Overall Study|Physician Decision|1|||
47038845|NCT03248492|83291373|FG001|Overall Study|Physician Decision|0|||
47038846|NCT03248492|83291374|FG002|Overall Study|Physician Decision|1|||
47038847|NCT03248492|83291375|FG003|Overall Study|Physician Decision|2|||
47038848|NCT03248492|83291376|FG004|Overall Study|Physician Decision|0|||
47038849|NCT03248492|83291372|FG000|Overall Study|Death|1|||
47038850|NCT03248492|83291373|FG001|Overall Study|Death|0|||
47038851|NCT03248492|83291374|FG002|Overall Study|Death|0|||
47038852|NCT03248492|83291375|FG003|Overall Study|Death|6|||
47038853|NCT03248492|83291376|FG004|Overall Study|Death|0|||
47038854|NCT03248492|83291372|FG000|Overall Study|Other|0|||
47038855|NCT03248492|83291373|FG001|Overall Study|Other|1|||
47038856|NCT03248492|83291374|FG002|Overall Study|Other|0|||
47038857|NCT03248492|83291375|FG003|Overall Study|Other|4|||
47038858|NCT03248492|83291376|FG004|Overall Study|Other|0|||
47038859|NCT03224468|83291398|FG000|Overall Study|Did not obtain MM card|53|||
47038860|NCT03224468|83291399|FG001|Overall Study|Did not obtain MM card|0|||
47038861|NCT03224468|83291398|FG000|Overall Study|Lost to Follow-up|4|||
47038862|NCT03224468|83291399|FG001|Overall Study|Lost to Follow-up|11|||
47038863|NCT03224468|83291398|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
47038864|NCT03224468|83291399|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
47038865|NCT03149003|83291408|FG000|Overall Study|Randomized but not treated|0|||
47038866|NCT03149003|83291409|FG001|Overall Study|Randomized but not treated|1|||
47038867|NCT03149003|83291410|FG002|Overall Study|Randomized but not treated|18|||
47038868|NCT03093974|83291424|FG000|Overall Study|Withdrawal by Subject|32|||
47038869|NCT03093974|83291425|FG001|Overall Study|Withdrawal by Subject|27|||
46715209|NCT01132313|82931201|FG008|Overall Study|Lack of Efficacy|14|||
46715210|NCT01132313|82931202|FG009|Overall Study|Lack of Efficacy|16|||
46715211|NCT01132313|82931203|FG010|Overall Study|Lack of Efficacy|0|||
47038870|NCT03093974|83291424|FG000|Overall Study|Adverse Event|17|||
47038871|NCT03093974|83291425|FG001|Overall Study|Adverse Event|24|||
47038872|NCT03093974|83291424|FG000|Overall Study|Death|0|||
47038873|NCT03093974|83291425|FG001|Overall Study|Death|1|||
46715212|NCT01132313|82931204|FG011|Overall Study|Lack of Efficacy|0|||
46715213|NCT01132313|82931193|FG000|Overall Study|Not treated|2|||
46715214|NCT01132313|82931194|FG001|Overall Study|Not treated|0|||
46715215|NCT01132313|82931195|FG002|Overall Study|Not treated|0|||
46715216|NCT01132313|82931196|FG003|Overall Study|Not treated|0|||
46715217|NCT01132313|82931197|FG004|Overall Study|Not treated|2|||
47038874|NCT03093974|83291424|FG000|Overall Study|Non-Compliance with Study Drug|1|||
47038875|NCT03093974|83291425|FG001|Overall Study|Non-Compliance with Study Drug|0|||
47038876|NCT03093974|83291424|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
47038877|NCT03093974|83291425|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
47038878|NCT03093974|83291424|FG000|Overall Study|Lost to Follow-up|0|||
47038879|NCT03093974|83291425|FG001|Overall Study|Lost to Follow-up|1|||
46914287|NCT02591615|83144683|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
46914288|NCT02591615|83144684|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
46914289|NCT02591615|83144681|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
46914290|NCT02591615|83144682|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
46914291|NCT02591615|83144683|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
46914292|NCT02591615|83144684|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
46914293|NCT02591615|83144681|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
46914294|NCT02591615|83144682|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
46914295|NCT02591615|83144683|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
46914296|NCT02591615|83144684|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
46914297|NCT02591615|83144681|FG000|Maintenance MK-3475|Adverse Event|0|||
46914298|NCT02591615|83144682|FG001|Maintenance MK-3475|Adverse Event|3|||
46914299|NCT02591615|83144683|FG002|Maintenance MK-3475|Adverse Event|1|||
46914300|NCT02591615|83144684|FG003|Maintenance MK-3475|Adverse Event|2|||
46914301|NCT02591615|83144681|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
46914302|NCT02591615|83144682|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
46914303|NCT02591615|83144683|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
46914304|NCT02591615|83144684|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
46914305|NCT02591615|83144681|FG000|Maintenance MK-3475|Death|0|||
46914306|NCT02591615|83144682|FG001|Maintenance MK-3475|Death|1|||
46914307|NCT02591615|83144683|FG002|Maintenance MK-3475|Death|1|||
46914308|NCT02591615|83144684|FG003|Maintenance MK-3475|Death|0|||
46914309|NCT02591615|83144681|FG000|Maintenance MK-3475|Physician discretion|0|||
46914310|NCT02591615|83144682|FG001|Maintenance MK-3475|Physician discretion|0|||
46914311|NCT02591615|83144683|FG002|Maintenance MK-3475|Physician discretion|1|||
46914312|NCT02591615|83144684|FG003|Maintenance MK-3475|Physician discretion|0|||
46914313|NCT02591615|83144681|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
46914314|NCT02591615|83144682|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
47038880|NCT03093974|83291424|FG000|Overall Study|Other|1|||
47038881|NCT03093974|83291425|FG001|Overall Study|Other|2|||
47038882|NCT03089606|83291431|FG000|Overall Study|Progression after Cycle 1|1|||
46715218|NCT01132313|82931198|FG005|Overall Study|Not treated|1|||
46715219|NCT01132313|82931199|FG006|Overall Study|Not treated|3|||
46715220|NCT01132313|82931200|FG007|Overall Study|Not treated|0|||
46715221|NCT01132313|82931201|FG008|Overall Study|Not treated|0|||
46715222|NCT01132313|82931202|FG009|Overall Study|Not treated|0|||
46715223|NCT01132313|82931203|FG010|Overall Study|Not treated|0|||
46715224|NCT01132313|82931204|FG011|Overall Study|Not treated|0|||
46715225|NCT01132313|82931193|FG000|Overall Study|Adverse Event|0|||
46715226|NCT01132313|82931194|FG001|Overall Study|Adverse Event|0|||
46715227|NCT01132313|82931195|FG002|Overall Study|Adverse Event|4|||
46715228|NCT01132313|82931196|FG003|Overall Study|Adverse Event|10|||
46715229|NCT01132313|82931197|FG004|Overall Study|Adverse Event|19|||
46715230|NCT01132313|82931198|FG005|Overall Study|Adverse Event|6|||
46715231|NCT01132313|82931199|FG006|Overall Study|Adverse Event|5|||
46715232|NCT01132313|82931200|FG007|Overall Study|Adverse Event|3|||
46715233|NCT01132313|82931201|FG008|Overall Study|Adverse Event|7|||
46715234|NCT01132313|82931202|FG009|Overall Study|Adverse Event|2|||
46715235|NCT01132313|82931203|FG010|Overall Study|Adverse Event|0|||
46715236|NCT01132313|82931204|FG011|Overall Study|Adverse Event|0|||
46715237|NCT01132313|82931193|FG000|Overall Study|Protocol Violation|0|||
46715238|NCT01132313|82931194|FG001|Overall Study|Protocol Violation|0|||
46715239|NCT01132313|82931195|FG002|Overall Study|Protocol Violation|0|||
46715240|NCT01132313|82931196|FG003|Overall Study|Protocol Violation|1|||
46715241|NCT01132313|82931197|FG004|Overall Study|Protocol Violation|0|||
46715242|NCT01132313|82931198|FG005|Overall Study|Protocol Violation|0|||
46715243|NCT01132313|82931199|FG006|Overall Study|Protocol Violation|0|||
46715244|NCT01132313|82931200|FG007|Overall Study|Protocol Violation|0|||
46715245|NCT01132313|82931201|FG008|Overall Study|Protocol Violation|0|||
46715246|NCT01132313|82931202|FG009|Overall Study|Protocol Violation|0|||
46715247|NCT01132313|82931203|FG010|Overall Study|Protocol Violation|0|||
46914315|NCT02591615|83144683|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
46914316|NCT02591615|83144684|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
46914317|NCT02591615|83144681|FG000|Maintenance MK-3475|In active treatment|2|||
46914318|NCT02591615|83144682|FG001|Maintenance MK-3475|In active treatment|0|||
47038883|NCT03023332|83291447|FG000|Overall Study|Withdrawal by Subject|10|||
47038884|NCT03023332|83291448|FG001|Overall Study|Withdrawal by Subject|5|||
47038885|NCT03023332|83291449|FG002|Overall Study|Withdrawal by Subject|4|||
47038886|NCT03023332|83291450|FG003|Overall Study|Withdrawal by Subject|7|||
46715248|NCT01132313|82931204|FG011|Overall Study|Protocol Violation|0|||
46715249|NCT01132313|82931193|FG000|Overall Study|Lost to Follow-up|0|||
46715250|NCT01132313|82931194|FG001|Overall Study|Lost to Follow-up|0|||
46715251|NCT01132313|82931195|FG002|Overall Study|Lost to Follow-up|1|||
46715252|NCT01132313|82931196|FG003|Overall Study|Lost to Follow-up|0|||
46715253|NCT01132313|82931197|FG004|Overall Study|Lost to Follow-up|0|||
46715254|NCT01132313|82931198|FG005|Overall Study|Lost to Follow-up|0|||
46715255|NCT01132313|82931199|FG006|Overall Study|Lost to Follow-up|0|||
46715256|NCT01132313|82931200|FG007|Overall Study|Lost to Follow-up|1|||
46715257|NCT01132313|82931201|FG008|Overall Study|Lost to Follow-up|0|||
47038887|NCT03023332|83291447|FG000|Overall Study|Lost to Follow-up|13|||
47038888|NCT03023332|83291448|FG001|Overall Study|Lost to Follow-up|16|||
47038889|NCT03023332|83291449|FG002|Overall Study|Lost to Follow-up|8|||
47038890|NCT03023332|83291450|FG003|Overall Study|Lost to Follow-up|13|||
47038891|NCT03023332|83291447|FG000|Overall Study|Death|1|||
47038892|NCT03023332|83291448|FG001|Overall Study|Death|0|||
47038893|NCT03023332|83291449|FG002|Overall Study|Death|0|||
47038894|NCT03023332|83291450|FG003|Overall Study|Death|0|||
47038895|NCT02993731|83291479|FG000|Overall Study|Study Termination|101|||
47038896|NCT02993731|83291480|FG001|Overall Study|Study Termination|105|||
47038897|NCT02903368|83291498|FG000|Part 1|Adverse Event|3|||
47038898|NCT02903368|83291499|FG001|Part 1|Adverse Event|0|||
47038899|NCT02903368|83291500|FG002|Part 1|Adverse Event|0|||
47038900|NCT02903368|83291501|FG003|Part 1|Adverse Event|0|||
47038901|NCT02903368|83291498|FG000|Part 1|Withdrawal by Subject|1|||
47038902|NCT02903368|83291499|FG001|Part 1|Withdrawal by Subject|0|||
47038903|NCT02903368|83291500|FG002|Part 1|Withdrawal by Subject|0|||
47038904|NCT02903368|83291501|FG003|Part 1|Withdrawal by Subject|0|||
47038905|NCT02903368|83291498|FG000|Part 2|Adverse Event|0|||
47038906|NCT02903368|83291499|FG001|Part 2|Adverse Event|0|||
47038907|NCT02903368|83291500|FG002|Part 2|Adverse Event|5|||
47038908|NCT02903368|83291501|FG003|Part 2|Adverse Event|0|||
47038909|NCT02903368|83291498|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
47038910|NCT02903368|83291499|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
47038911|NCT02903368|83291500|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
47038912|NCT02903368|83291501|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
47038913|NCT02903368|83291498|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
47038914|NCT02903368|83291499|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
47038915|NCT02903368|83291500|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
47038916|NCT02903368|83291501|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
47038917|NCT02903368|83291498|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
47038918|NCT02903368|83291499|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
47038919|NCT02903368|83291500|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
47038920|NCT02903368|83291501|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
47038921|NCT02753127|83291521|FG000|Overall Study|Lost to Follow-up|13|||
47038922|NCT02753127|83291522|FG001|Overall Study|Lost to Follow-up|11|||
47038923|NCT02753127|83291521|FG000|Overall Study|Withdrawal by Subject|37|||
47038924|NCT02753127|83291522|FG001|Overall Study|Withdrawal by Subject|47|||
47038925|NCT02753127|83291521|FG000|Overall Study|Other|3|||
47038926|NCT02753127|83291522|FG001|Overall Study|Other|8|||
47038927|NCT02753127|83291521|FG000|Overall Study|Hospice|0|||
47038928|NCT02753127|83291522|FG001|Overall Study|Hospice|2|||
47038929|NCT02657551|83291536|FG000|Overall Study|Adverse Event|2|||
47038930|NCT02657551|83291536|FG000|Overall Study|Withdrawal by Subject|1|||
47038931|NCT02657551|83291536|FG000|Overall Study|Non-Compliance|1|||
47038932|NCT02657551|83291536|FG000|Overall Study|Progression / Relapse|4|||
47038933|NCT02527434|83291543|FG000|Overall Study|Lost to Follow-up|2|||
47038934|NCT02527434|83291544|FG001|Overall Study|Lost to Follow-up|2|||
47038935|NCT02527434|83291545|FG002|Overall Study|Lost to Follow-up|0|||
47038936|NCT02527434|83291543|FG000|Overall Study|Death|19|||
47038937|NCT02527434|83291544|FG001|Overall Study|Death|6|||
47038938|NCT02527434|83291545|FG002|Overall Study|Death|17|||
47038939|NCT02527434|83291543|FG000|Overall Study|Withdrawal by Subject|5|||
47038940|NCT02527434|83291544|FG001|Overall Study|Withdrawal by Subject|3|||
47038941|NCT02527434|83291545|FG002|Overall Study|Withdrawal by Subject|3|||
47038942|NCT02527434|83291543|FG000|Overall Study|Reason Not Specified|1|||
47038943|NCT02527434|83291544|FG001|Overall Study|Reason Not Specified|0|||
47038944|NCT02527434|83291545|FG002|Overall Study|Reason Not Specified|0|||
47038945|NCT02527434|83291543|FG000|Overall Study|Site closure|1|||
47038946|NCT02527434|83291544|FG001|Overall Study|Site closure|0|||
46715258|NCT01132313|82931202|FG009|Overall Study|Lost to Follow-up|0|||
46715259|NCT01132313|82931203|FG010|Overall Study|Lost to Follow-up|0|||
46715260|NCT01132313|82931204|FG011|Overall Study|Lost to Follow-up|0|||
46715261|NCT01132313|82931193|FG000|Overall Study|Withdrawal by Subject|0|||
46715262|NCT01132313|82931194|FG001|Overall Study|Withdrawal by Subject|0|||
46715263|NCT01132313|82931195|FG002|Overall Study|Withdrawal by Subject|3|||
46803639|NCT03523728|83022939|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
47038947|NCT02527434|83291545|FG002|Overall Study|Site closure|0|||
47038948|NCT02460835|83291563|FG000|Overall Study|Disease progression prior to treatment|3|||
47038949|NCT02460835|83291563|FG000|Overall Study|Unable to complete planning scans|2|||
47038950|NCT02460835|83291563|FG000|Overall Study|Decrease in performance status|1|||
46715264|NCT01132313|82931196|FG003|Overall Study|Withdrawal by Subject|3|||
46715265|NCT01132313|82931197|FG004|Overall Study|Withdrawal by Subject|6|||
46715266|NCT01132313|82931198|FG005|Overall Study|Withdrawal by Subject|0|||
46715267|NCT01132313|82931199|FG006|Overall Study|Withdrawal by Subject|1|||
46715268|NCT01132313|82931200|FG007|Overall Study|Withdrawal by Subject|0|||
46715269|NCT01132313|82931201|FG008|Overall Study|Withdrawal by Subject|0|||
46715270|NCT01132313|82931202|FG009|Overall Study|Withdrawal by Subject|2|||
46715271|NCT01132313|82931203|FG010|Overall Study|Withdrawal by Subject|0|||
46715272|NCT01132313|82931204|FG011|Overall Study|Withdrawal by Subject|0|||
46715273|NCT01132313|82931193|FG000|Overall Study|Lack of antiviral response|0|||
46715274|NCT01132313|82931194|FG001|Overall Study|Lack of antiviral response|0|||
46715275|NCT01132313|82931195|FG002|Overall Study|Lack of antiviral response|12|||
46715276|NCT01132313|82931196|FG003|Overall Study|Lack of antiviral response|18|||
46715277|NCT01132313|82931197|FG004|Overall Study|Lack of antiviral response|18|||
46715278|NCT01132313|82931198|FG005|Overall Study|Lack of antiviral response|18|||
46715279|NCT01132313|82931199|FG006|Overall Study|Lack of antiviral response|21|||
46715280|NCT01132313|82931200|FG007|Overall Study|Lack of antiviral response|0|||
46715281|NCT01132313|82931201|FG008|Overall Study|Lack of antiviral response|0|||
46715282|NCT01132313|82931202|FG009|Overall Study|Lack of antiviral response|0|||
46715283|NCT01132313|82931203|FG010|Overall Study|Lack of antiviral response|1|||
46715284|NCT01132313|82931204|FG011|Overall Study|Lack of antiviral response|0|||
46715285|NCT01132313|82931193|FG000|Overall Study|Other reason not defined above|0|||
46715286|NCT01132313|82931194|FG001|Overall Study|Other reason not defined above|0|||
46631029|NCT01889862|82804039|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
46631030|NCT01889862|82804040|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
46631031|NCT01889862|82804041|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
46631032|NCT01889862|82804042|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
46631033|NCT01889862|82804043|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
46631034|NCT01887912|82804070|FG000|Overall Study|Serious adverse event|400|||
46715287|NCT01132313|82931195|FG002|Overall Study|Other reason not defined above|0|||
46715288|NCT01132313|82931196|FG003|Overall Study|Other reason not defined above|0|||
46715289|NCT01132313|82931197|FG004|Overall Study|Other reason not defined above|0|||
46715290|NCT01132313|82931198|FG005|Overall Study|Other reason not defined above|0|||
46715291|NCT01132313|82931199|FG006|Overall Study|Other reason not defined above|0|||
46715292|NCT01132313|82931200|FG007|Overall Study|Other reason not defined above|1|||
46715293|NCT01132313|82931201|FG008|Overall Study|Other reason not defined above|0|||
46715294|NCT01132313|82931202|FG009|Overall Study|Other reason not defined above|0|||
46715295|NCT01132313|82931203|FG010|Overall Study|Other reason not defined above|0|||
46715296|NCT01132313|82931204|FG011|Overall Study|Other reason not defined above|0|||
46715297|NCT00861757|82931239|FG000|Overall Study|Adverse Event|1|||
46715298|NCT00861757|82931240|FG001|Overall Study|Adverse Event|5|||
46715299|NCT00861757|82931241|FG002|Overall Study|Adverse Event|7|||
46914319|NCT02591615|83144683|FG002|Maintenance MK-3475|In active treatment|0|||
46914320|NCT02591615|83144684|FG003|Maintenance MK-3475|In active treatment|1|||
46914321|NCT03077607|83144699|FG000|Period 1 (15 Days)|Adverse Event|1|||
46914322|NCT03077607|83144700|FG001|Period 1 (15 Days)|Adverse Event|0|||
47038951|NCT02460835|83291563|FG000|Overall Study|Withdrawal by Subject|3|||
47038952|NCT02460835|83291563|FG000|Overall Study|Underwent fractionated RT|10|||
47038953|NCT02460835|83291563|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
47038954|NCT02231749|83291599|FG000|Overall Study|Disease progression|229|||
47038955|NCT02231749|83291600|FG001|Overall Study|Disease progression|297|||
47038956|NCT02231749|83291599|FG000|Overall Study|Study Drug Toxicity|134|||
47038957|NCT02231749|83291600|FG001|Overall Study|Study Drug Toxicity|63|||
46631035|NCT01887912|82804071|FG001|Overall Study|Serious adverse event|198|||
46631036|NCT01887912|82804070|FG000|Overall Study|Other Adverse Event|34|||
46631037|NCT01887912|82804071|FG001|Overall Study|Other Adverse Event|15|||
46631038|NCT01887912|82804070|FG000|Overall Study|Protocol Violation|67|||
46631039|NCT01887912|82804071|FG001|Overall Study|Protocol Violation|37|||
46631040|NCT01887912|82804070|FG000|Overall Study|Lost to Follow-up|163|||
46631041|NCT01887912|82804071|FG001|Overall Study|Lost to Follow-up|74|||
46715300|NCT00861757|82931242|FG003|Overall Study|Adverse Event|2|||
46715301|NCT00861757|82931239|FG000|Overall Study|Entry Criteria Not Met|1|||
46715302|NCT00861757|82931240|FG001|Overall Study|Entry Criteria Not Met|2|||
46715303|NCT00861757|82931241|FG002|Overall Study|Entry Criteria Not Met|1|||
46715304|NCT00861757|82931242|FG003|Overall Study|Entry Criteria Not Met|1|||
46914323|NCT03077607|83144699|FG000|Period 1 (15 Days)|Death|1|||
46631042|NCT01887912|82804070|FG000|Overall Study|Withdrawal by Subject|606|||
46715305|NCT00861757|82931239|FG000|Overall Study|Lack of Efficacy|3|||
47038958|NCT02231749|83291599|FG000|Overall Study|Death|1|||
46631043|NCT01887912|82804071|FG001|Overall Study|Withdrawal by Subject|349|||
46715306|NCT00861757|82931240|FG001|Overall Study|Lack of Efficacy|1|||
46715307|NCT00861757|82931241|FG002|Overall Study|Lack of Efficacy|0|||
46715308|NCT00861757|82931242|FG003|Overall Study|Lack of Efficacy|1|||
46715309|NCT00861757|82931239|FG000|Overall Study|Lost to Follow-up|1|||
46715310|NCT00861757|82931240|FG001|Overall Study|Lost to Follow-up|0|||
46715311|NCT00861757|82931241|FG002|Overall Study|Lost to Follow-up|1|||
46914324|NCT03077607|83144700|FG001|Period 1 (15 Days)|Death|0|||
46914325|NCT03077607|83144699|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
46914326|NCT03077607|83144700|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
46914327|NCT03077607|83144699|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
46914328|NCT03077607|83144700|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
46914329|NCT02977572|83144719|FG000|Overall Study|Exclusion criterion|2|||
46914330|NCT02977572|83144720|FG001|Overall Study|Exclusion criterion|2|||
46914331|NCT02746874|83144732|FG000|Overall Study|Withdrawal by Subject|0|||
46914332|NCT02746874|83144733|FG001|Overall Study|Withdrawal by Subject|1|||
46914333|NCT02746874|83144732|FG000|Overall Study|Surgery Date Changed|0|||
46914334|NCT02746874|83144733|FG001|Overall Study|Surgery Date Changed|2|||
46914335|NCT03217175|83144739|FG000|Overall Study|Physician Decision|4|||
46914336|NCT03217175|83144740|FG001|Overall Study|Physician Decision|1|||
46914337|NCT01062126|83144746|FG000|Overall Study|Death|209|||
46914338|NCT01062126|83144746|FG000|Overall Study|All Withdrawals|324|||
46914339|NCT02522429|83144750|FG000|Overall Study|Lost to Follow-up|8|||
46914340|NCT02522429|83144750|FG000|Overall Study|Adverse Event|2|||
46914341|NCT02522429|83144750|FG000|Overall Study|Death|1|||
46914342|NCT02522429|83144750|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
46914343|NCT02974140|83144754|FG000|Overall Study|Adverse Event|2|||
46914344|NCT02974140|83144754|FG000|Overall Study|Lost to Follow-up|1|||
46914345|NCT02974140|83144754|FG000|Overall Study|Study Terminated by Sponsor|36|||
46914346|NCT02974842|83144761|FG000|Overall Study|Withdrawal by Subject|4|||
46914347|NCT02974842|83144761|FG000|Overall Study|Screen failures|4|||
46914348|NCT03172481|83144767|FG000|Double-blind|Withdrawal by Subject|1|||
46914349|NCT03172481|83144768|FG001|Double-blind|Withdrawal by Subject|0|||
46914350|NCT02855450|83144776|FG000|Overall Study|Adverse Event|1|||
46914351|NCT02855450|83144777|FG001|Overall Study|Adverse Event|0|||
46914352|NCT02855450|83144776|FG000|Overall Study|Lost to Follow-up|4|||
46914353|NCT02855450|83144777|FG001|Overall Study|Lost to Follow-up|0|||
46914354|NCT03172325|83144785|FG000|Overall Study|Adverse Event|2|||
47038959|NCT02231749|83291600|FG001|Overall Study|Death|1|||
46715312|NCT00861757|82931242|FG003|Overall Study|Lost to Follow-up|1|||
46715313|NCT00861757|82931239|FG000|Overall Study|Physician Decision|0|||
46715314|NCT00861757|82931240|FG001|Overall Study|Physician Decision|0|||
46715315|NCT00861757|82931241|FG002|Overall Study|Physician Decision|0|||
46715316|NCT00861757|82931242|FG003|Overall Study|Physician Decision|1|||
46715317|NCT00861757|82931239|FG000|Overall Study|Protocol Violation|2|||
46715318|NCT00861757|82931240|FG001|Overall Study|Protocol Violation|2|||
46715319|NCT00861757|82931241|FG002|Overall Study|Protocol Violation|4|||
46715320|NCT00861757|82931242|FG003|Overall Study|Protocol Violation|1|||
46715321|NCT00861757|82931239|FG000|Overall Study|Withdrawal by Subject|1|||
46715322|NCT00861757|82931240|FG001|Overall Study|Withdrawal by Subject|5|||
46715323|NCT00861757|82931241|FG002|Overall Study|Withdrawal by Subject|5|||
46715324|NCT00861757|82931242|FG003|Overall Study|Withdrawal by Subject|2|||
46715325|NCT01131455|82931259|FG000|Overall Study|Death of PI|6|||
46715326|NCT01131455|82931260|FG001|Overall Study|Death of PI|4|||
46715327|NCT01131455|82931261|FG002|Overall Study|Death of PI|0|||
46715328|NCT01138007|82931272|FG000|Overall Study|Adverse Event|4|||
46715329|NCT01138007|82931273|FG001|Overall Study|Adverse Event|12|||
46715330|NCT01138007|82931274|FG002|Overall Study|Adverse Event|9|||
46715331|NCT01138007|82931272|FG000|Overall Study|Lack of Efficacy|2|||
46715332|NCT01138007|82931273|FG001|Overall Study|Lack of Efficacy|0|||
46914355|NCT03172325|83144786|FG001|Overall Study|Adverse Event|3|||
46914356|NCT03172325|83144785|FG000|Overall Study|Positive PPD|1|||
46914357|NCT03172325|83144786|FG001|Overall Study|Positive PPD|0|||
46914358|NCT03172325|83144785|FG000|Overall Study|Poor Compliance|1|||
46914359|NCT03172325|83144786|FG001|Overall Study|Poor Compliance|1|||
47038960|NCT02231749|83291599|FG000|Overall Study|AE unrelated to Study drug|32|||
47038961|NCT02231749|83291600|FG001|Overall Study|AE unrelated to Study drug|31|||
47038962|NCT02231749|83291599|FG000|Overall Study|Participant's request to discontinue|10|||
47038963|NCT02231749|83291600|FG001|Overall Study|Participant's request to discontinue|21|||
46631044|NCT01887912|82804070|FG000|Overall Study|Other|122|||
46914360|NCT03085017|83144794|FG000|Overall Study|Death|0|||
46914361|NCT03085017|83144795|FG001|Overall Study|Death|3|||
46631045|NCT01887912|82804071|FG001|Overall Study|Other|58|||
46631046|NCT01887678|82804079|FG000|Overall Study|Adverse Event|4|||
46631047|NCT01887678|82804080|FG001|Overall Study|Adverse Event|6|||
46631048|NCT01887678|82804079|FG000|Overall Study|Exceeded rescue medication dosage|4|||
46631049|NCT01887678|82804080|FG001|Overall Study|Exceeded rescue medication dosage|5|||
46631050|NCT01887678|82804079|FG000|Overall Study|Withdrawal of consent|3|||
46631051|NCT01887678|82804080|FG001|Overall Study|Withdrawal of consent|4|||
46631052|NCT01887678|82804079|FG000|Overall Study|Lost to Follow-up|4|||
46631053|NCT01887678|82804080|FG001|Overall Study|Lost to Follow-up|2|||
46631054|NCT01887678|82804079|FG000|Overall Study|Deterioration of clinical condition|0|||
46631055|NCT01887678|82804080|FG001|Overall Study|Deterioration of clinical condition|4|||
46631056|NCT01887678|82804079|FG000|Overall Study|Lack of Efficacy|1|||
46914362|NCT03215771|83144801|FG000|Overall Study|Withdrawal by Subject|2|||
46914363|NCT03215771|83144801|FG000|Overall Study|Physician Decision|1|||
46914364|NCT02745392|83144810|FG000|Overall Study|Lost to Follow-up|0|||
46914365|NCT02745392|83144811|FG001|Overall Study|Lost to Follow-up|1|||
46914366|NCT02745392|83144812|FG002|Overall Study|Lost to Follow-up|0|||
46914367|NCT02745392|83144813|FG003|Overall Study|Lost to Follow-up|0|||
46914368|NCT03076515|83144825|FG000|Overall Study|DMC decision based on interim analysis|25|||
46914369|NCT03076515|83144826|FG001|Overall Study|DMC decision based on interim analysis|29|||
46914370|NCT03170609|83144839|FG000|Overall Study|Death|0|||
46914371|NCT03170609|83144840|FG001|Overall Study|Death|0|||
46914372|NCT03170609|83144841|FG002|Overall Study|Death|1|||
46914373|NCT03170609|83144842|FG003|Overall Study|Death|0|||
46914374|NCT03170609|83144843|FG004|Overall Study|Death|0|||
46914375|NCT03170609|83144844|FG005|Overall Study|Death|0|||
46914376|NCT03170609|83144845|FG006|Overall Study|Death|0|||
46914377|NCT03170609|83144839|FG000|Overall Study|Withdrawal by Subject|1|||
46914378|NCT03170609|83144840|FG001|Overall Study|Withdrawal by Subject|2|||
46914379|NCT03170609|83144841|FG002|Overall Study|Withdrawal by Subject|0|||
46914380|NCT03170609|83144842|FG003|Overall Study|Withdrawal by Subject|0|||
46914381|NCT03170609|83144843|FG004|Overall Study|Withdrawal by Subject|0|||
46914382|NCT03170609|83144844|FG005|Overall Study|Withdrawal by Subject|0|||
46914383|NCT03170609|83144845|FG006|Overall Study|Withdrawal by Subject|1|||
46914384|NCT03170609|83144839|FG000|Overall Study|Lost to Follow-up|1|||
46914385|NCT03170609|83144840|FG001|Overall Study|Lost to Follow-up|0|||
46914386|NCT03170609|83144841|FG002|Overall Study|Lost to Follow-up|5|||
46914387|NCT03170609|83144842|FG003|Overall Study|Lost to Follow-up|2|||
46914388|NCT03170609|83144843|FG004|Overall Study|Lost to Follow-up|1|||
46914389|NCT03170609|83144844|FG005|Overall Study|Lost to Follow-up|1|||
46914390|NCT03170609|83144845|FG006|Overall Study|Lost to Follow-up|0|||
46914391|NCT03170609|83144839|FG000|Overall Study|Other|1|||
46914392|NCT03170609|83144840|FG001|Overall Study|Other|0|||
46914393|NCT03170609|83144841|FG002|Overall Study|Other|0|||
46914394|NCT03170609|83144842|FG003|Overall Study|Other|0|||
46914395|NCT03170609|83144843|FG004|Overall Study|Other|0|||
46914396|NCT03170609|83144844|FG005|Overall Study|Other|1|||
46914397|NCT03170609|83144845|FG006|Overall Study|Other|0|||
46914398|NCT01141712|83144861|FG000|Overall Study|Disease progression|3|||
46914399|NCT03219333|83144871|FG000|Overall Study|Withdrawal by Subject|8|||
46914400|NCT03219333|83144872|FG001|Overall Study|Withdrawal by Subject|3|||
46914401|NCT03219333|83144871|FG000|Overall Study|Lost to Follow-up|1|||
46914402|NCT03219333|83144872|FG001|Overall Study|Lost to Follow-up|0|||
46914403|NCT03219333|83144871|FG000|Overall Study|Death|94|||
46914404|NCT03219333|83144872|FG001|Overall Study|Death|44|||
46914405|NCT03219333|83144871|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
46914406|NCT03219333|83144872|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
46914407|NCT03168867|83144880|FG000|Overall Study|Withdrawal by Subject|1|||
46914408|NCT03168867|83144881|FG001|Overall Study|Withdrawal by Subject|5|||
46914409|NCT01064622|83144890|FG000|Randomized Phase II|Withdrawal by Subject|2|||
47038964|NCT02231749|83291599|FG000|Overall Study|Participant withdrew Consent|8|||
47038965|NCT02231749|83291600|FG001|Overall Study|Participant withdrew Consent|15|||
46631057|NCT01887678|82804080|FG001|Overall Study|Lack of Efficacy|2|||
46631058|NCT01887678|82804079|FG000|Overall Study|Non-compliance|0|||
46631059|NCT01887678|82804080|FG001|Overall Study|Non-compliance|3|||
46631060|NCT01887678|82804079|FG000|Overall Study|Specified|1|||
46631061|NCT01887678|82804080|FG001|Overall Study|Specified|2|||
46631062|NCT01887600|82804088|FG000|Overall Study|Death|39|||
46914410|NCT01064622|83144891|FG001|Randomized Phase II|Withdrawal by Subject|2|||
46631063|NCT01887600|82804089|FG001|Overall Study|Death|16|||
46631064|NCT01887600|82804088|FG000|Overall Study|Lack of Efficacy|3|||
46631065|NCT01887600|82804089|FG001|Overall Study|Lack of Efficacy|26|||
46631066|NCT01887600|82804088|FG000|Overall Study|Lost to Follow-up|5|||
46631067|NCT01887600|82804089|FG001|Overall Study|Lost to Follow-up|1|||
46715333|NCT01138007|82931274|FG002|Overall Study|Lack of Efficacy|6|||
46914411|NCT01064622|83144890|FG000|Randomized Phase II|Protocol Violation|0|||
46914412|NCT01064622|83144891|FG001|Randomized Phase II|Protocol Violation|1|||
46914413|NCT04163718|83144900|FG000|Overall Study|Study terminated|12|||
46914414|NCT01063764|83144904|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
46914415|NCT01063764|83144904|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
46914416|NCT01063764|83144904|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
46914417|NCT01063764|83144904|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
46914418|NCT01063764|83144904|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
46914419|NCT01063764|83144904|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
46914420|NCT01063764|83144904|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
47038966|NCT02231749|83291599|FG000|Overall Study|Lost to Follow-up|1|||
46631068|NCT01887600|82804088|FG000|Overall Study|Physician Decision|7|||
47038967|NCT02231749|83291600|FG001|Overall Study|Lost to Follow-up|2|||
46631069|NCT01887600|82804089|FG001|Overall Study|Physician Decision|8|||
46715334|NCT01138007|82931272|FG000|Overall Study|Protocol Violation|2|||
46715335|NCT01138007|82931273|FG001|Overall Study|Protocol Violation|3|||
46715336|NCT01138007|82931274|FG002|Overall Study|Protocol Violation|2|||
46715337|NCT01138007|82931272|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
46715338|NCT01138007|82931273|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
46715339|NCT01138007|82931274|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
46715340|NCT01138007|82931272|FG000|Overall Study|Lost to Follow-up|3|||
46715341|NCT01138007|82931273|FG001|Overall Study|Lost to Follow-up|3|||
46715342|NCT01138007|82931274|FG002|Overall Study|Lost to Follow-up|5|||
46715343|NCT01138007|82931272|FG000|Overall Study|Physician Decision|0|||
46715344|NCT01138007|82931273|FG001|Overall Study|Physician Decision|5|||
46715345|NCT01138007|82931274|FG002|Overall Study|Physician Decision|3|||
46715346|NCT01138007|82931272|FG000|Overall Study|Withdrawal by Subject|5|||
46715347|NCT01138007|82931273|FG001|Overall Study|Withdrawal by Subject|6|||
46715348|NCT01138007|82931274|FG002|Overall Study|Withdrawal by Subject|15|||
46715349|NCT00865345|82931284|FG000|Overall Study|Withdrawal by Subject|2|||
46715350|NCT01131299|82931288|FG000|Overall Study|Withdrawal by Subject|4|||
46715351|NCT01131299|82931289|FG001|Overall Study|Withdrawal by Subject|7|||
46715352|NCT01130831|82931294|FG000|Overall Study|Withdrawal by Subject|7|||
46715353|NCT01130831|82931294|FG000|Overall Study|Death|4|||
46715354|NCT01130831|82931294|FG000|Overall Study|Information was missing|3|||
46715355|NCT01130597|82931310|FG000|Overall Study|Protocol-specified (High K+)|1|||
46715356|NCT01130597|82931310|FG000|Overall Study|Adverse Event|4|||
46715357|NCT01130597|82931310|FG000|Overall Study|Death|1|||
46715358|NCT01130597|82931310|FG000|Overall Study|Protocol Violation|1|||
46715359|NCT00939003|82931316|FG000|Double-blind Treatment Period|Adverse Event|1|||
46715360|NCT00939003|82931317|FG001|Double-blind Treatment Period|Adverse Event|1|||
46715361|NCT00939003|82931316|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
46715362|NCT00939003|82931317|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
46715363|NCT00939003|82931316|FG000|Double-blind Treatment Period|Pregnancy|0|||
47038968|NCT02231749|83291599|FG000|Overall Study|Maximum Clinical Benefit|5|||
47038969|NCT02231749|83291600|FG001|Overall Study|Maximum Clinical Benefit|8|||
47038970|NCT02231749|83291599|FG000|Overall Study|Poor/Non-Compliance|0|||
47038971|NCT02231749|83291600|FG001|Overall Study|Poor/Non-Compliance|3|||
47038972|NCT02231749|83291599|FG000|Overall Study|Pregnancy|1|||
47038973|NCT02231749|83291600|FG001|Overall Study|Pregnancy|0|||
47038974|NCT02231749|83291599|FG000|Overall Study|other|0|||
46631070|NCT01887600|82804088|FG000|Overall Study|Protocol Deviation|3|||
46715364|NCT00939003|82931317|FG001|Double-blind Treatment Period|Pregnancy|1|||
46715365|NCT00939003|82931316|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
46715366|NCT00939003|82931317|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
46715367|NCT00939003|82931316|FG000|Open-label Treatment Period|Adverse Event|4|||
46715368|NCT00939003|82931317|FG001|Open-label Treatment Period|Adverse Event|8|||
46715369|NCT00939003|82931316|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
46715370|NCT00939003|82931317|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
46715371|NCT00939003|82931316|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
46715372|NCT00939003|82931317|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
46631071|NCT01887600|82804089|FG001|Overall Study|Protocol Deviation|0|||
46631072|NCT01887600|82804088|FG000|Overall Study|Withdrawal by Subject|58|||
46631073|NCT01887600|82804089|FG001|Overall Study|Withdrawal by Subject|52|||
46631074|NCT01887600|82804088|FG000|Overall Study|Adverse Event|21|||
46631075|NCT01887600|82804089|FG001|Overall Study|Adverse Event|9|||
46631076|NCT01887600|82804088|FG000|Overall Study|Non-compliance with study drug|3|||
46631077|NCT01887600|82804089|FG001|Overall Study|Non-compliance with study drug|0|||
46631078|NCT01887600|82804088|FG000|Overall Study|Miscellaneous|6|||
46631079|NCT01887600|82804089|FG001|Overall Study|Miscellaneous|2|||
46631080|NCT01887600|82804088|FG000|Overall Study|Progressive Disease|1|||
46631081|NCT01887600|82804089|FG001|Overall Study|Progressive Disease|0|||
46631082|NCT01887288|82804096|FG000|Overall Study|The study was terminated and the PI has|16|||
46631083|NCT01887210|82804102|FG000|Overall Study|Withdrawal by Subject|1|||
46631084|NCT01887210|82804103|FG001|Overall Study|Withdrawal by Subject|3|||
46631085|NCT01887210|82804102|FG000|Overall Study|Lost to Follow-up|0|||
46631086|NCT01887210|82804103|FG001|Overall Study|Lost to Follow-up|1|||
46631087|NCT01885182|82804134|FG000|Overall Study|Adverse Event|11|||
46715373|NCT00939003|82931316|FG000|Open-label Treatment Period|Pregnancy|1|||
46631088|NCT01885182|82804135|FG001|Overall Study|Adverse Event|13|||
46715374|NCT00939003|82931317|FG001|Open-label Treatment Period|Pregnancy|1|||
46715375|NCT00939003|82931316|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
46715376|NCT00939003|82931317|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
46631089|NCT01885182|82804134|FG000|Overall Study|Withdrawal by Subject|13|||
46631090|NCT01885182|82804135|FG001|Overall Study|Withdrawal by Subject|6|||
46715377|NCT00939003|82931316|FG000|Open-label Treatment Period|Site Closure|3|||
46715378|NCT00939003|82931317|FG001|Open-label Treatment Period|Site Closure|4|||
46715379|NCT01188668|82931326|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
46715380|NCT01188668|82931326|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
46715381|NCT01188668|82931326|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
46715382|NCT01130051|82931333|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
46715383|NCT01130051|82931334|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
46715384|NCT01130051|82931333|FG000|Washout Period of 14 Days|Protocol Violation|1|||
46715385|NCT01130051|82931334|FG001|Washout Period of 14 Days|Protocol Violation|1|||
46715386|NCT00865189|82931342|FG000|Overall Study|Other|1|||
46715387|NCT00865189|82931343|FG001|Overall Study|Other|2|||
46715388|NCT00865189|82931342|FG000|Overall Study|Death|4|||
46715389|NCT00865189|82931343|FG001|Overall Study|Death|11|||
46715390|NCT00865189|82931342|FG000|Overall Study|Lost to Follow-up|6|||
46715391|NCT00865189|82931343|FG001|Overall Study|Lost to Follow-up|6|||
46715392|NCT00865189|82931342|FG000|Overall Study|Withdrawal by Subject|1|||
46715393|NCT00865189|82931343|FG001|Overall Study|Withdrawal by Subject|0|||
46715394|NCT01182194|82931351|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
46715395|NCT01182194|82931352|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
46715396|NCT01181726|82931360|FG000|First Intervention|Adverse Event|1|||
46715397|NCT01181726|82931361|FG001|First Intervention|Adverse Event|0|||
46715398|NCT01137071|82931367|FG000|Overall Study|Disease Progression|11|||
46715399|NCT01137071|82931367|FG000|Overall Study|Withdrawal by Subject|2|||
46715400|NCT01137071|82931367|FG000|Overall Study|Wrongly Included|1|||
46715401|NCT00860743|82931382|FG000|Overall Study|Withdrawal by Subject|3|||
46715402|NCT00860743|82931383|FG001|Overall Study|Withdrawal by Subject|0|||
46715403|NCT01186796|82931391|FG000|Overall Study|Adverse Event|3|||
46715404|NCT01186796|82931392|FG001|Overall Study|Adverse Event|0|||
46715405|NCT01186796|82931391|FG000|Overall Study|Withdrawal by Subject|1|||
46715406|NCT01186796|82931392|FG001|Overall Study|Withdrawal by Subject|1|||
46715407|NCT01186796|82931391|FG000|Overall Study|Protocol Violation|0|||
46715408|NCT01186796|82931392|FG001|Overall Study|Protocol Violation|1|||
46715409|NCT01136915|82931400|FG000|Overall Study|Lost to Follow-up|2|||
46715410|NCT01136915|82931401|FG001|Overall Study|Lost to Follow-up|0|||
46715411|NCT01136915|82931400|FG000|Overall Study|Exclusion criterion met|0|||
46715412|NCT01136915|82931401|FG001|Overall Study|Exclusion criterion met|1|||
46715413|NCT00940017|82931409|FG000|Overall Study|did not meet entrance criteria|3|||
46715414|NCT00940017|82931409|FG000|Overall Study|Adverse Event|1|||
46715415|NCT01129583|82931415|FG000|Overall Study|Death|1|||
46715416|NCT01129583|82931416|FG001|Overall Study|Death|0|||
46715417|NCT01129583|82931415|FG000|Overall Study|Lost to Follow-up|1|||
46715418|NCT01129583|82931416|FG001|Overall Study|Lost to Follow-up|1|||
46715419|NCT01129583|82931415|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
46715420|NCT01129583|82931416|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
46715421|NCT00848497|82931424|FG000|Overall Study|Screen failure|2|||
46715422|NCT00848497|82931425|FG001|Overall Study|Screen failure|0|||
46715423|NCT00848497|82931424|FG000|Overall Study|Withdrawal by Subject|0|||
46715424|NCT00848497|82931425|FG001|Overall Study|Withdrawal by Subject|1|||
46715425|NCT00857623|82931435|FG000|Overall Study|Adverse Event|5|||
47038975|NCT02231749|83291600|FG001|Overall Study|other|8|||
46631091|NCT01885182|82804134|FG000|Overall Study|Lost to Follow-up|2|||
46631092|NCT01885182|82804135|FG001|Overall Study|Lost to Follow-up|2|||
46631093|NCT01885182|82804134|FG000|Overall Study|Lack of Efficacy|8|||
46631094|NCT01885182|82804135|FG001|Overall Study|Lack of Efficacy|1|||
46631095|NCT01885104|82804145|FG000|Overall Study|Withdrawal of Consent|1|||
46631096|NCT01885104|82804146|FG001|Overall Study|Withdrawal of Consent|0|||
46631097|NCT01885104|82804145|FG000|Overall Study|Lost to Follow-up|0|||
46631098|NCT01885104|82804146|FG001|Overall Study|Lost to Follow-up|1|||
46715426|NCT00857623|82931436|FG001|Overall Study|Adverse Event|2|||
46715427|NCT00857623|82931435|FG000|Overall Study|Study-specific discontinuation criteria|5|||
46715428|NCT00857623|82931436|FG001|Overall Study|Study-specific discontinuation criteria|3|||
46715429|NCT00857623|82931435|FG000|Overall Study|Withdrawal by Subject|2|||
46715430|NCT00857623|82931436|FG001|Overall Study|Withdrawal by Subject|1|||
46715431|NCT00857623|82931435|FG000|Overall Study|Lack of Efficacy|1|||
46715432|NCT00857623|82931436|FG001|Overall Study|Lack of Efficacy|1|||
46715433|NCT00857623|82931435|FG000|Overall Study|Severe non-compliance to protocol|1|||
46715434|NCT00857623|82931436|FG001|Overall Study|Severe non-compliance to protocol|1|||
46715435|NCT00857623|82931435|FG000|Overall Study|Intake of prohibited medication|0|||
47038976|NCT02231749|83291599|FG000|Overall Study|No longer meets Study Criteria|1|||
46631099|NCT01885104|82804145|FG000|Overall Study|Physician Decision|1|||
46715436|NCT00857623|82931436|FG001|Overall Study|Intake of prohibited medication|1|||
46715437|NCT00857623|82931435|FG000|Overall Study|Positive for HEP C|0|||
46715438|NCT00857623|82931436|FG001|Overall Study|Positive for HEP C|1|||
46715439|NCT01185782|82931444|FG000|Overall Study|Adverse Event|0|||
46715440|NCT01185782|82931445|FG001|Overall Study|Adverse Event|1|||
46631100|NCT01885104|82804146|FG001|Overall Study|Physician Decision|0|||
46715441|NCT01185782|82931444|FG000|Overall Study|Protocol Violation|1|||
46631101|NCT01881750|82804154|FG000|Overall Study|Changes in concomitant therapies|2|||
46715442|NCT01185782|82931445|FG001|Overall Study|Protocol Violation|0|||
46914421|NCT03075891|83144914|FG000|Overall Study|Withdrawal by Subject|3|||
46715443|NCT01185782|82931444|FG000|Overall Study|Poor Response to Treatment|3|||
46715444|NCT01185782|82931445|FG001|Overall Study|Poor Response to Treatment|1|||
46715445|NCT01185782|82931444|FG000|Overall Study|Other|2|||
46715446|NCT01185782|82931445|FG001|Overall Study|Other|5|||
46631102|NCT01881750|82804155|FG001|Overall Study|Changes in concomitant therapies|3|||
46631103|NCT01881750|82804154|FG000|Overall Study|Lost to Follow-up|0|||
46631104|NCT01881750|82804155|FG001|Overall Study|Lost to Follow-up|1|||
46631105|NCT01906008|82804165|FG000|Overall Study|Lost to Follow-up|2|||
46631106|NCT01906008|82804166|FG001|Overall Study|Lost to Follow-up|0|||
46631107|NCT01906008|82804165|FG000|Overall Study|Oxaliplatin toxicity|2|||
46631108|NCT01906008|82804166|FG001|Overall Study|Oxaliplatin toxicity|0|||
46631109|NCT01906008|82804165|FG000|Overall Study|Protocol Violation|0|||
46631110|NCT01906008|82804166|FG001|Overall Study|Protocol Violation|1|||
46631111|NCT01906008|82804165|FG000|Overall Study|Withdrawal by Subject|1|||
46631112|NCT01906008|82804166|FG001|Overall Study|Withdrawal by Subject|5|||
46631113|NCT01906008|82804165|FG000|Overall Study|Did not start study med|3|||
46631114|NCT01906008|82804166|FG001|Overall Study|Did not start study med|4|||
46631115|NCT01906008|82804165|FG000|Overall Study|Oxaliplatin stops|10|||
46631116|NCT01906008|82804166|FG001|Overall Study|Oxaliplatin stops|8|||
46631117|NCT01906008|82804165|FG000|Overall Study|Hospice|1|||
46631118|NCT01906008|82804166|FG001|Overall Study|Hospice|0|||
46631119|NCT01906008|82804165|FG000|Overall Study|Physician Decision|3|||
46631120|NCT01906008|82804166|FG001|Overall Study|Physician Decision|3|||
46631121|NCT01906008|82804165|FG000|Overall Study|Lack of compliance of study med|5|||
46914422|NCT03075891|83144915|FG001|Overall Study|Withdrawal by Subject|6|||
46914423|NCT03075891|83144914|FG000|Overall Study|Lost to Follow-up|1|||
46914424|NCT03075891|83144915|FG001|Overall Study|Lost to Follow-up|0|||
46914425|NCT03075891|83144914|FG000|Overall Study|Pregnancy|3|||
46914426|NCT03075891|83144915|FG001|Overall Study|Pregnancy|1|||
46914427|NCT03075891|83144914|FG000|Overall Study|visits not performed (no time)|1|||
46914428|NCT03075891|83144915|FG001|Overall Study|visits not performed (no time)|0|||
46914429|NCT03075891|83144914|FG000|Overall Study|Drug abuse relapse issue|0|||
46914430|NCT03075891|83144915|FG001|Overall Study|Drug abuse relapse issue|1|||
46914431|NCT03075891|83144914|FG000|Overall Study|Participant requiring study withdrawal|0|||
46914432|NCT03075891|83144915|FG001|Overall Study|Participant requiring study withdrawal|1|||
46914433|NCT03075891|83144914|FG000|Overall Study|Adverse event, non-fatal|1|||
46914434|NCT03075891|83144915|FG001|Overall Study|Adverse event, non-fatal|4|||
46914435|NCT02013167|83144925|FG000|Overall Study|Withdrawal by Subject|15|||
46914436|NCT02013167|83144926|FG001|Overall Study|Withdrawal by Subject|14|||
46914437|NCT02013167|83144925|FG000|Overall Study|Sponsor Decision|1|||
46914438|NCT02013167|83144926|FG001|Overall Study|Sponsor Decision|3|||
46715447|NCT01185782|82931444|FG000|Overall Study|Randomized but not treated|0|||
47038977|NCT02231749|83291600|FG001|Overall Study|No longer meets Study Criteria|0|||
46715448|NCT01185782|82931445|FG001|Overall Study|Randomized but not treated|4|||
46715449|NCT01129115|82931455|FG000|Overall Study|Adverse Event|1|||
46715450|NCT01129115|82931456|FG001|Overall Study|Adverse Event|2|||
46715451|NCT01129115|82931457|FG002|Overall Study|Adverse Event|3|||
46715452|NCT01129115|82931458|FG003|Overall Study|Adverse Event|3|||
46715453|NCT01129115|82931455|FG000|Overall Study|Withdrawal by Subject|1|||
46715454|NCT01129115|82931456|FG001|Overall Study|Withdrawal by Subject|3|||
47038978|NCT01776307|83291665|FG000|Overall Study|Not dosed|0|||
47038979|NCT01776307|83291666|FG001|Overall Study|Not dosed|0|||
47038980|NCT01776307|83291667|FG002|Overall Study|Not dosed|1|||
47038981|NCT05419908|83291729|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
47038982|NCT05419908|83291730|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
47038983|NCT05419908|83291729|FG000|Overall Study|Serious Adverse Event|0|||
47038984|NCT05419908|83291730|FG001|Overall Study|Serious Adverse Event|2|||
47038985|NCT05419908|83291729|FG000|Overall Study|Withdrawal by Subject|2|||
46631122|NCT01906008|82804166|FG001|Overall Study|Lack of compliance of study med|3|||
46715455|NCT01129115|82931457|FG002|Overall Study|Withdrawal by Subject|1|||
46715456|NCT01129115|82931458|FG003|Overall Study|Withdrawal by Subject|4|||
46715457|NCT01129115|82931455|FG000|Overall Study|Protocol Violation|0|||
46715458|NCT01129115|82931456|FG001|Overall Study|Protocol Violation|2|||
46715459|NCT01129115|82931457|FG002|Overall Study|Protocol Violation|2|||
46715460|NCT01129115|82931458|FG003|Overall Study|Protocol Violation|2|||
46715461|NCT01185704|82931470|FG000|Overall Study|Randomized but not treated|3|||
46631123|NCT01906008|82804165|FG000|Overall Study|Adverse Event|0|||
46631124|NCT01906008|82804166|FG001|Overall Study|Adverse Event|3|||
46631125|NCT01863732|82804176|FG000|Overall Study|Adverse Event|2|||
46715462|NCT01185704|82931471|FG001|Overall Study|Randomized but not treated|3|||
46914439|NCT02013167|83144925|FG000|Overall Study|Lost to Follow-up|0|||
46914440|NCT02013167|83144926|FG001|Overall Study|Lost to Follow-up|1|||
46914441|NCT02013167|83144925|FG000|Overall Study|Death|85|||
46914442|NCT02013167|83144926|FG001|Overall Study|Death|160|||
47038986|NCT05419908|83291730|FG001|Overall Study|Withdrawal by Subject|0|||
46631126|NCT01863732|82804177|FG001|Overall Study|Adverse Event|0|||
46631127|NCT01863732|82804178|FG002|Overall Study|Adverse Event|3|||
46631128|NCT01863732|82804179|FG003|Overall Study|Adverse Event|3|||
46631129|NCT01863732|82804176|FG000|Overall Study|Lack of Efficacy|1|||
46715463|NCT01185704|82931470|FG000|Overall Study|Lack of ovarian response|5|||
47038987|NCT05419908|83291729|FG000|Overall Study|Miscellaneous|1|||
47038988|NCT05419908|83291730|FG001|Overall Study|Miscellaneous|1|||
47073120|NCT01045161|83361494|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
47073121|NCT01045161|83361495|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
46715464|NCT01185704|82931471|FG001|Overall Study|Lack of ovarian response|1|||
46715465|NCT01185704|82931470|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
46715466|NCT01185704|82931471|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
46715467|NCT01185704|82931470|FG000|Overall Study|Ectopic pregnancy|0|||
46715468|NCT01185704|82931471|FG001|Overall Study|Ectopic pregnancy|1|||
46715469|NCT01128959|82931477|FG000|Lead in Period|Adverse Event|3|||
46715470|NCT01128959|82931477|FG000|Treatment Period|Adverse Event|3|||
46715471|NCT01128959|82931477|FG000|Treatment Period|Withdrawal by Subject|1|||
46715472|NCT00859573|82931485|FG000|Overall Study|Withdrawal by Subject|4|||
46715473|NCT00859573|82931486|FG001|Overall Study|Withdrawal by Subject|1|||
46715474|NCT00859573|82931485|FG000|Overall Study|Physician Decision|1|||
46715475|NCT00859573|82931486|FG001|Overall Study|Physician Decision|1|||
46715476|NCT01136291|82931494|FG000|Overall Study|Lost to Follow-up|1|||
46715477|NCT01136291|82931495|FG001|Overall Study|Lost to Follow-up|1|||
46715478|NCT01185548|82931501|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
46715479|NCT01128569|82931514|FG000|Washout Period 1|Adverse Event|0|||
47073122|NCT01045161|83361496|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
47073123|NCT01045161|83361494|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
47073124|NCT01045161|83361495|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
47073125|NCT01045161|83361496|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
47073126|NCT01045161|83361494|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
47073127|NCT01045161|83361495|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
46631130|NCT01863732|82804177|FG001|Overall Study|Lack of Efficacy|0|||
46631131|NCT01863732|82804178|FG002|Overall Study|Lack of Efficacy|2|||
46631132|NCT01863732|82804179|FG003|Overall Study|Lack of Efficacy|1|||
46631133|NCT01863732|82804176|FG000|Overall Study|Lost to Follow-up|2|||
46631134|NCT01863732|82804177|FG001|Overall Study|Lost to Follow-up|2|||
46715480|NCT01128569|82931515|FG001|Washout Period 1|Adverse Event|0|||
46715481|NCT01128569|82931516|FG002|Washout Period 1|Adverse Event|1|||
46715482|NCT01128569|82931517|FG003|Washout Period 1|Adverse Event|0|||
46715483|NCT01128569|82931518|FG004|Washout Period 1|Adverse Event|0|||
46715484|NCT01128569|82931519|FG005|Washout Period 1|Adverse Event|0|||
46715485|NCT01128569|82931514|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46715486|NCT01128569|82931515|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46715487|NCT01128569|82931516|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46715488|NCT01128569|82931517|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46715489|NCT01128569|82931518|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46715490|NCT01128569|82931519|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46715491|NCT01128413|82931529|FG000|Overall Study|Withdrawal by Subject|1|||
46715492|NCT01128413|82931530|FG001|Overall Study|Withdrawal by Subject|0|||
46715493|NCT01128413|82931529|FG000|Overall Study|NICOM Monitor Problems|2|||
46715494|NCT01128413|82931530|FG001|Overall Study|NICOM Monitor Problems|1|||
46715495|NCT01128413|82931529|FG000|Overall Study|Pt made DNR|1|||
46715496|NCT01128413|82931530|FG001|Overall Study|Pt made DNR|0|||
46715497|NCT01185080|82931539|FG000|Overall Study|Adverse Event|1|||
46715498|NCT01185080|82931540|FG001|Overall Study|Adverse Event|1|||
46715499|NCT01185080|82931541|FG002|Overall Study|Adverse Event|0|||
46715500|NCT01185080|82931539|FG000|Overall Study|Personal reasons|0|||
46715501|NCT01185080|82931540|FG001|Overall Study|Personal reasons|0|||
46715502|NCT01185080|82931541|FG002|Overall Study|Personal reasons|1|||
46715503|NCT01128179|82931551|FG000|Overall Study|Death|1|||
47073128|NCT01045161|83361496|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
46631135|NCT01863732|82804178|FG002|Overall Study|Lost to Follow-up|1|||
46631136|NCT01863732|82804179|FG003|Overall Study|Lost to Follow-up|1|||
46631137|NCT01863732|82804176|FG000|Overall Study|Physician Decision|1|||
46631138|NCT01863732|82804177|FG001|Overall Study|Physician Decision|0|||
46631139|NCT01863732|82804178|FG002|Overall Study|Physician Decision|1|||
47073129|NCT01045161|83361494|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
46631140|NCT01863732|82804179|FG003|Overall Study|Physician Decision|0|||
46715504|NCT01128179|82931552|FG001|Overall Study|Death|0|||
46715505|NCT01128179|82931551|FG000|Overall Study|Protocol Violation|1|||
46715506|NCT01128179|82931552|FG001|Overall Study|Protocol Violation|0|||
46914443|NCT01063062|83144935|FG000|Overall Study|Patient withdrew consent|0|||
46631141|NCT01863732|82804176|FG000|Overall Study|Pregnancy|0|||
46631142|NCT01863732|82804177|FG001|Overall Study|Pregnancy|0|||
46631143|NCT01863732|82804178|FG002|Overall Study|Pregnancy|0|||
46631144|NCT01863732|82804179|FG003|Overall Study|Pregnancy|1|||
46715507|NCT01181102|82931560|FG000|Overall Study|Adverse Event|28|||
46715508|NCT01181102|82931561|FG001|Overall Study|Adverse Event|26|||
46715509|NCT01181102|82931560|FG000|Overall Study|Lack of Efficacy|3|||
46715510|NCT01181102|82931561|FG001|Overall Study|Lack of Efficacy|1|||
46715511|NCT01181102|82931560|FG000|Overall Study|Lost to Follow-up|2|||
46715512|NCT01181102|82931561|FG001|Overall Study|Lost to Follow-up|0|||
46715513|NCT01181102|82931560|FG000|Overall Study|Physician Decision|3|||
46715514|NCT01181102|82931561|FG001|Overall Study|Physician Decision|1|||
46715515|NCT01181102|82931560|FG000|Overall Study|Protocol Violation|5|||
46715516|NCT01181102|82931561|FG001|Overall Study|Protocol Violation|6|||
46715517|NCT01181102|82931560|FG000|Overall Study|Withdrawal by Subject|10|||
46715518|NCT01181102|82931561|FG001|Overall Study|Withdrawal by Subject|12|||
46715519|NCT00858637|82931569|FG000|Active Comparison Phase|Adverse Event|14|||
46715520|NCT00858637|82931570|FG001|Active Comparison Phase|Adverse Event|0|||
46715521|NCT00858637|82931571|FG002|Active Comparison Phase|Adverse Event|0|||
46715522|NCT00858637|82931572|FG003|Active Comparison Phase|Adverse Event|9|||
46715523|NCT00858637|82931573|FG004|Active Comparison Phase|Adverse Event|0|||
46715524|NCT00858637|82931574|FG005|Active Comparison Phase|Adverse Event|0|||
46715525|NCT00858637|82931569|FG000|Active Comparison Phase|Death|1|||
46715526|NCT00858637|82931570|FG001|Active Comparison Phase|Death|0|||
46715527|NCT00858637|82931571|FG002|Active Comparison Phase|Death|0|||
46715528|NCT00858637|82931572|FG003|Active Comparison Phase|Death|1|||
46715529|NCT00858637|82931573|FG004|Active Comparison Phase|Death|0|||
46715530|NCT00858637|82931574|FG005|Active Comparison Phase|Death|0|||
46715531|NCT00858637|82931569|FG000|Active Comparison Phase|Physician Decision|1|||
46715532|NCT00858637|82931570|FG001|Active Comparison Phase|Physician Decision|0|||
46715533|NCT00858637|82931571|FG002|Active Comparison Phase|Physician Decision|0|||
46715534|NCT00858637|82931572|FG003|Active Comparison Phase|Physician Decision|1|||
46715535|NCT00858637|82931573|FG004|Active Comparison Phase|Physician Decision|0|||
46715536|NCT00858637|82931574|FG005|Active Comparison Phase|Physician Decision|0|||
46715537|NCT00858637|82931569|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
46715538|NCT00858637|82931570|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
46715539|NCT00858637|82931571|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
46715540|NCT00858637|82931572|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
46715541|NCT00858637|82931573|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
46715542|NCT00858637|82931574|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
46715543|NCT00858637|82931569|FG000|Active Comparison Phase|Other Reasons|1|||
46715544|NCT00858637|82931570|FG001|Active Comparison Phase|Other Reasons|0|||
46715545|NCT00858637|82931571|FG002|Active Comparison Phase|Other Reasons|0|||
46715546|NCT00858637|82931572|FG003|Active Comparison Phase|Other Reasons|1|||
46715547|NCT00858637|82931573|FG004|Active Comparison Phase|Other Reasons|0|||
46715548|NCT00858637|82931574|FG005|Active Comparison Phase|Other Reasons|0|||
46715549|NCT00858637|82931569|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
46715550|NCT00858637|82931570|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
46715551|NCT00858637|82931571|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
46715552|NCT00858637|82931572|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
46715553|NCT00858637|82931573|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
46715554|NCT00858637|82931574|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
46914444|NCT01063062|83144936|FG001|Overall Study|Patient withdrew consent|1|||
46715555|NCT00858637|82931569|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
46715556|NCT00858637|82931570|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
46715557|NCT00858637|82931571|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
46715558|NCT00858637|82931572|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
46715559|NCT00858637|82931573|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
46715560|NCT00858637|82931574|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
46715561|NCT00858403|82931584|FG000|Overall Study|Withdrawal by Subject|1|||
46715562|NCT00858403|82931584|FG000|Overall Study|Death|3|||
46715563|NCT00858403|82931584|FG000|Overall Study|Disease Progression|1|||
46715564|NCT00858247|82931590|FG000|Baseline Assessment|Withdrawal by Subject|1|||
46715565|NCT00858247|82931591|FG001|Baseline Assessment|Withdrawal by Subject|1|||
46914445|NCT01063062|83144935|FG000|Overall Study|Adverse Event|2|||
46914446|NCT01063062|83144936|FG001|Overall Study|Adverse Event|4|||
46914447|NCT01063062|83144935|FG000|Overall Study|Protocol Violation|5|||
46914448|NCT01063062|83144936|FG001|Overall Study|Protocol Violation|4|||
46914449|NCT01063062|83144935|FG000|Overall Study|Investigator's request|1|||
46914450|NCT01063062|83144936|FG001|Overall Study|Investigator's request|0|||
46914451|NCT01063062|83144935|FG000|Overall Study|Lost to Follow-up|0|||
46914452|NCT01063062|83144936|FG001|Overall Study|Lost to Follow-up|2|||
46715566|NCT00858247|82931590|FG000|Baseline Assessment|Poor IV access|1|||
46914453|NCT01063062|83144935|FG000|Overall Study|Miscellaneous reason|0|||
46914454|NCT01063062|83144936|FG001|Overall Study|Miscellaneous reason|1|||
46914455|NCT02973048|83144945|FG000|Overall Study|Epidural catheter insertion failure|1|||
46914456|NCT02973048|83144946|FG001|Overall Study|Epidural catheter insertion failure|0|||
46715567|NCT00858247|82931591|FG001|Baseline Assessment|Poor IV access|0|||
46715568|NCT00858247|82931590|FG000|Baseline Assessment|Protocol Violation|0|||
46715569|NCT00858247|82931591|FG001|Baseline Assessment|Protocol Violation|1|||
46715570|NCT00858247|82931590|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
46715571|NCT00858247|82931591|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
46715572|NCT00838435|82931597|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
46715573|NCT00838435|82931597|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
47038989|NCT05091060|83291736|FG000|Overall Study|Lost to Follow-up|1|||
46715574|NCT00838435|82931597|FG000|Part 2 (7 Years)|Adverse Event|2|||
46715575|NCT00838435|82931597|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
46715576|NCT00838435|82931597|FG000|Part 2 (7 Years)|Physician Decision|1|||
46715577|NCT00838435|82931597|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
46715578|NCT00838435|82931597|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
46715579|NCT00838201|82931606|FG000|Overall Study|Investigator decision, or other reasons|2|||
46715580|NCT00838201|82931607|FG001|Overall Study|Investigator decision, or other reasons|3|||
46715581|NCT00838201|82931606|FG000|Overall Study|Noncompliance|0|||
46715582|NCT00838201|82931607|FG001|Overall Study|Noncompliance|1|||
46715583|NCT00838201|82931606|FG000|Overall Study|Administrative decision|1|||
46715584|NCT00838201|82931607|FG001|Overall Study|Administrative decision|2|||
46715585|NCT00838201|82931606|FG000|Overall Study|Disease progression|3|||
46715586|NCT00838201|82931607|FG001|Overall Study|Disease progression|3|||
46715587|NCT00838201|82931606|FG000|Overall Study|Consent withdrawn|16|||
46715588|NCT00838201|82931607|FG001|Overall Study|Consent withdrawn|19|||
46715589|NCT00838201|82931606|FG000|Overall Study|Lost to Follow-up|4|||
46715590|NCT00838201|82931607|FG001|Overall Study|Lost to Follow-up|3|||
46715591|NCT00838201|82931606|FG000|Overall Study|Adverse Event|5|||
46715592|NCT00838201|82931607|FG001|Overall Study|Adverse Event|9|||
46715593|NCT00838201|82931606|FG000|Overall Study|Death|11|||
46715594|NCT00838201|82931607|FG001|Overall Study|Death|13|||
46715595|NCT00837967|82931613|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
46715596|NCT00837967|82931614|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
46715597|NCT02756806|82931620|FG000|Overall Study|Study terminated early|5|||
46715598|NCT00942357|82931626|FG000|Overall Study|Ineligible|37|||
46715599|NCT00942357|82931627|FG001|Overall Study|Ineligible|40|||
46715600|NCT00939783|82931633|FG000|Overall Study|Death|6|||
46715601|NCT00939783|82931633|FG000|Overall Study|Adverse Event|39|||
46715602|NCT00939783|82931633|FG000|Overall Study|Study Terminated by Sponsor|498|||
46715603|NCT00939783|82931633|FG000|Overall Study|Withdrawal by Subject|78|||
47038990|NCT05056311|83291740|FG000|Overall Study|Lost to Follow-up|14|||
47038991|NCT05056311|83291740|FG000|Overall Study|Withdrawal by Subject|1|||
46715604|NCT00939783|82931633|FG000|Overall Study|Other|16|||
46715605|NCT00939783|82931633|FG000|Overall Study|Lost to Follow-up|8|||
46715606|NCT00939783|82931633|FG000|Overall Study|Protocol Violation|3|||
47038992|NCT05056311|83291740|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
47038993|NCT05020899|83291747|FG000|8 Week Follow-up|Lost to Follow-up|3|||
47038994|NCT05020899|83291748|FG001|8 Week Follow-up|Lost to Follow-up|6|||
47038995|NCT05020899|83291747|FG000|12 Week Follow-up|Lost to Follow-up|1|||
47038996|NCT05020899|83291748|FG001|12 Week Follow-up|Lost to Follow-up|0|||
47038997|NCT05020899|83291747|FG000|12 Week Follow-up|Death|0|||
47038998|NCT05020899|83291748|FG001|12 Week Follow-up|Death|1|||
47038999|NCT04806503|83291778|FG000|Overall Study|Lost to Follow-up|0|||
47039000|NCT04806503|83291779|FG001|Overall Study|Lost to Follow-up|0|||
47039001|NCT04806503|83291780|FG002|Overall Study|Lost to Follow-up|1|||
47039002|NCT04806503|83291781|FG003|Overall Study|Lost to Follow-up|0|||
47039003|NCT04806503|83291782|FG004|Overall Study|Lost to Follow-up|0|||
47039004|NCT04806503|83291778|FG000|Overall Study|Withdrawal by Subject|1|||
47039005|NCT04806503|83291779|FG001|Overall Study|Withdrawal by Subject|0|||
47039006|NCT04806503|83291780|FG002|Overall Study|Withdrawal by Subject|1|||
47039007|NCT04806503|83291781|FG003|Overall Study|Withdrawal by Subject|1|||
47039008|NCT04806503|83291782|FG004|Overall Study|Withdrawal by Subject|1|||
47039009|NCT04806503|83291778|FG000|Overall Study|Adverse Event|1|||
46715607|NCT00939783|82931633|FG000|Overall Study|Enrolled but not treated|1|||
46715608|NCT00939627|82931639|FG000|Overall Study|Disease Progression|16|||
46715609|NCT00939627|82931640|FG001|Overall Study|Disease Progression|12|||
46715610|NCT00939627|82931641|FG002|Overall Study|Disease Progression|0|||
46715611|NCT00939627|82931639|FG000|Overall Study|Adverse Event|6|||
46715612|NCT00939627|82931640|FG001|Overall Study|Adverse Event|7|||
46715613|NCT00939627|82931641|FG002|Overall Study|Adverse Event|0|||
46715614|NCT00939627|82931639|FG000|Overall Study|Death|0|||
47039010|NCT04806503|83291779|FG001|Overall Study|Adverse Event|1|||
47039011|NCT04806503|83291780|FG002|Overall Study|Adverse Event|0|||
47039012|NCT04806503|83291781|FG003|Overall Study|Adverse Event|1|||
47039013|NCT04806503|83291782|FG004|Overall Study|Adverse Event|0|||
47039014|NCT04508751|83291798|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
47039015|NCT04508751|83291799|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
47039016|NCT04508751|83291800|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
47039017|NCT04473482|83291810|FG000|Overall Study|Death|0|||
47039018|NCT04473482|83291811|FG001|Overall Study|Death|3|||
46715615|NCT00939627|82931640|FG001|Overall Study|Death|2|||
46715616|NCT00939627|82931641|FG002|Overall Study|Death|0|||
46715617|NCT00939627|82931639|FG000|Overall Study|Withdrawal by Subject|2|||
46715618|NCT00939627|82931640|FG001|Overall Study|Withdrawal by Subject|4|||
46715619|NCT00939627|82931641|FG002|Overall Study|Withdrawal by Subject|0|||
46715620|NCT00939627|82931639|FG000|Overall Study|Other complicating disease|1|||
46715621|NCT00939627|82931640|FG001|Overall Study|Other complicating disease|1|||
46715622|NCT00939627|82931641|FG002|Overall Study|Other complicating disease|0|||
46715623|NCT00939627|82931639|FG000|Overall Study|Not compliant|2|||
46715624|NCT00939627|82931640|FG001|Overall Study|Not compliant|0|||
46715625|NCT00939627|82931641|FG002|Overall Study|Not compliant|0|||
46715626|NCT00939627|82931639|FG000|Overall Study|No off-tx reason given|0|||
46715627|NCT00939627|82931640|FG001|Overall Study|No off-tx reason given|2|||
46715628|NCT00939627|82931641|FG002|Overall Study|No off-tx reason given|0|||
46715629|NCT00937833|82931649|FG000|Overall Study|Protocol Violation|1|||
46715630|NCT00937833|82931650|FG001|Overall Study|Protocol Violation|2|||
46715631|NCT00937833|82931649|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
46715632|NCT00937833|82931650|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
46715633|NCT00937833|82931649|FG000|Overall Study|Lost to Follow-up|10|||
46715634|NCT00937833|82931650|FG001|Overall Study|Lost to Follow-up|8|||
46715635|NCT00937833|82931649|FG000|Overall Study|Withdrawal by Subject|4|||
46715636|NCT00937833|82931650|FG001|Overall Study|Withdrawal by Subject|6|||
46715637|NCT01135511|82931665|FG000|Overall Study|Adverse Event|0|||
46715638|NCT01135511|82931666|FG001|Overall Study|Adverse Event|1|||
46715639|NCT01135511|82931667|FG002|Overall Study|Adverse Event|2|||
46715640|NCT01135511|82931668|FG003|Overall Study|Adverse Event|0|||
46914457|NCT02973048|83144945|FG000|Overall Study|Withdrawal by Subject|0|||
46914458|NCT02973048|83144946|FG001|Overall Study|Withdrawal by Subject|3|||
46914459|NCT02932943|83144954|FG000|Overall Study|Lost to Follow-up|0|||
46914460|NCT02932943|83144955|FG001|Overall Study|Lost to Follow-up|2|||
46914461|NCT02932943|83144954|FG000|Overall Study|Adverse Event|2|||
46914462|NCT02932943|83144955|FG001|Overall Study|Adverse Event|2|||
46914463|NCT02932943|83144954|FG000|Overall Study|Withdrawal by Subject|3|||
46914464|NCT02932943|83144955|FG001|Overall Study|Withdrawal by Subject|3|||
46914465|NCT02972658|83144980|FG000|Overall Study|Adverse Event|0|||
46715641|NCT01135511|82931669|FG004|Overall Study|Adverse Event|0|||
46914466|NCT02972658|83144981|FG001|Overall Study|Adverse Event|3|||
46914467|NCT02972658|83144982|FG002|Overall Study|Adverse Event|0|||
46914468|NCT02972658|83144983|FG003|Overall Study|Adverse Event|2|||
46715642|NCT01135511|82931670|FG005|Overall Study|Adverse Event|1|||
46715643|NCT01135511|82931671|FG006|Overall Study|Adverse Event|0|||
46715644|NCT01135511|82931672|FG007|Overall Study|Adverse Event|1|||
46715645|NCT01135511|82931673|FG008|Overall Study|Adverse Event|0|||
46715646|NCT01135511|82931665|FG000|Overall Study|Lack of Efficacy|0|||
46715647|NCT01135511|82931666|FG001|Overall Study|Lack of Efficacy|1|||
46715648|NCT01135511|82931667|FG002|Overall Study|Lack of Efficacy|1|||
46715649|NCT01135511|82931668|FG003|Overall Study|Lack of Efficacy|2|||
46715650|NCT01135511|82931669|FG004|Overall Study|Lack of Efficacy|0|||
46715651|NCT01135511|82931670|FG005|Overall Study|Lack of Efficacy|0|||
46715652|NCT01135511|82931671|FG006|Overall Study|Lack of Efficacy|0|||
46715653|NCT01135511|82931672|FG007|Overall Study|Lack of Efficacy|0|||
46715654|NCT01135511|82931673|FG008|Overall Study|Lack of Efficacy|0|||
46914469|NCT02972658|83144980|FG000|Overall Study|Other-determined by Investigator|1|||
46914470|NCT02972658|83144981|FG001|Overall Study|Other-determined by Investigator|1|||
46914471|NCT02972658|83144982|FG002|Overall Study|Other-determined by Investigator|0|||
46914472|NCT02972658|83144983|FG003|Overall Study|Other-determined by Investigator|0|||
46631145|NCT01863732|82804176|FG000|Overall Study|Technical problems|0|||
46631146|NCT01863732|82804177|FG001|Overall Study|Technical problems|1|||
46631147|NCT01863732|82804178|FG002|Overall Study|Technical problems|1|||
46631148|NCT01863732|82804179|FG003|Overall Study|Technical problems|0|||
46631149|NCT01863732|82804176|FG000|Overall Study|Subject/guardian decision|6|||
46631150|NCT01863732|82804177|FG001|Overall Study|Subject/guardian decision|9|||
46631151|NCT01863732|82804178|FG002|Overall Study|Subject/guardian decision|3|||
46631152|NCT01863732|82804179|FG003|Overall Study|Subject/guardian decision|1|||
46631153|NCT01863732|82804176|FG000|Overall Study|Death|1|||
46631154|NCT01863732|82804177|FG001|Overall Study|Death|0|||
46631155|NCT01863732|82804178|FG002|Overall Study|Death|0|||
46631156|NCT01863732|82804179|FG003|Overall Study|Death|1|||
46631157|NCT01905540|82804192|FG000|Period 3|Other|1|||
46631158|NCT01905540|82804193|FG001|Period 3|Other|0|||
46631159|NCT01905540|82804194|FG002|Period 3|Other|1|||
46631160|NCT01905540|82804195|FG003|Period 3|Other|1|||
46715655|NCT01135511|82931665|FG000|Overall Study|Protocol Violation|0|||
46715656|NCT01135511|82931666|FG001|Overall Study|Protocol Violation|0|||
46715657|NCT01135511|82931667|FG002|Overall Study|Protocol Violation|3|||
46715658|NCT01135511|82931668|FG003|Overall Study|Protocol Violation|0|||
46715659|NCT01135511|82931669|FG004|Overall Study|Protocol Violation|0|||
46715660|NCT01135511|82931670|FG005|Overall Study|Protocol Violation|0|||
46715661|NCT01135511|82931671|FG006|Overall Study|Protocol Violation|0|||
46715662|NCT01135511|82931672|FG007|Overall Study|Protocol Violation|0|||
46715663|NCT01135511|82931673|FG008|Overall Study|Protocol Violation|0|||
46631161|NCT01904760|82804207|FG000|Overall Study|Protocol Violation|1|||
46631162|NCT01904760|82804208|FG001|Overall Study|Protocol Violation|0|||
46631163|NCT01904604|82804217|FG000|Overall Study|Withdrew before receiving dosing|0|||
46715664|NCT01135511|82931665|FG000|Overall Study|Pregnancy|0|||
46715665|NCT01135511|82931666|FG001|Overall Study|Pregnancy|0|||
46914473|NCT02972658|83144980|FG000|Overall Study|Death|0|||
46715666|NCT01135511|82931667|FG002|Overall Study|Pregnancy|0|||
46715667|NCT01135511|82931668|FG003|Overall Study|Pregnancy|1|||
46715668|NCT01135511|82931669|FG004|Overall Study|Pregnancy|0|||
46715669|NCT01135511|82931670|FG005|Overall Study|Pregnancy|0|||
46715670|NCT01135511|82931671|FG006|Overall Study|Pregnancy|0|||
46715671|NCT01135511|82931672|FG007|Overall Study|Pregnancy|0|||
46715672|NCT01135511|82931673|FG008|Overall Study|Pregnancy|0|||
47039019|NCT04473482|83291810|FG000|Overall Study|Lost to Follow-up|9|||
47039020|NCT04473482|83291811|FG001|Overall Study|Lost to Follow-up|7|||
47039021|NCT04473482|83291810|FG000|Overall Study|Withdrawal by Subject|2|||
47039022|NCT04473482|83291811|FG001|Overall Study|Withdrawal by Subject|1|||
47039023|NCT03919799|83291821|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
46631164|NCT01904604|82804218|FG001|Overall Study|Withdrew before receiving dosing|1|||
46631165|NCT01904604|82804219|FG002|Overall Study|Withdrew before receiving dosing|0|||
46715673|NCT01135511|82931665|FG000|Overall Study|could not visit the clinic|0|||
46715674|NCT01135511|82931666|FG001|Overall Study|could not visit the clinic|1|||
46715675|NCT01135511|82931667|FG002|Overall Study|could not visit the clinic|2|||
46715676|NCT01135511|82931668|FG003|Overall Study|could not visit the clinic|0|||
46715677|NCT01135511|82931669|FG004|Overall Study|could not visit the clinic|0|||
46715678|NCT01135511|82931670|FG005|Overall Study|could not visit the clinic|0|||
46715679|NCT01135511|82931671|FG006|Overall Study|could not visit the clinic|0|||
46715680|NCT01135511|82931672|FG007|Overall Study|could not visit the clinic|0|||
46715681|NCT01135511|82931673|FG008|Overall Study|could not visit the clinic|0|||
46715682|NCT01135511|82931665|FG000|Overall Study|noncompliance with study drug taken|0|||
46715683|NCT01135511|82931666|FG001|Overall Study|noncompliance with study drug taken|0|||
46715684|NCT01135511|82931667|FG002|Overall Study|noncompliance with study drug taken|0|||
46715685|NCT01135511|82931668|FG003|Overall Study|noncompliance with study drug taken|0|||
46715686|NCT01135511|82931669|FG004|Overall Study|noncompliance with study drug taken|1|||
46715687|NCT01135511|82931670|FG005|Overall Study|noncompliance with study drug taken|0|||
46715688|NCT01135511|82931671|FG006|Overall Study|noncompliance with study drug taken|0|||
46715689|NCT01135511|82931672|FG007|Overall Study|noncompliance with study drug taken|0|||
46715690|NCT01135511|82931673|FG008|Overall Study|noncompliance with study drug taken|0|||
46631166|NCT01904604|82804217|FG000|Overall Study|Non-compliance|1|||
46631167|NCT01904604|82804218|FG001|Overall Study|Non-compliance|0|||
46631168|NCT01904604|82804219|FG002|Overall Study|Non-compliance|0|||
46715691|NCT01135511|82931665|FG000|Overall Study|Withdrawal by Subject|0|||
46715692|NCT01135511|82931666|FG001|Overall Study|Withdrawal by Subject|0|||
46715693|NCT01135511|82931667|FG002|Overall Study|Withdrawal by Subject|0|||
46715694|NCT01135511|82931668|FG003|Overall Study|Withdrawal by Subject|0|||
46715695|NCT01135511|82931669|FG004|Overall Study|Withdrawal by Subject|0|||
46715696|NCT01135511|82931670|FG005|Overall Study|Withdrawal by Subject|0|||
46914474|NCT02972658|83144981|FG001|Overall Study|Death|0|||
46914475|NCT02972658|83144982|FG002|Overall Study|Death|0|||
46914476|NCT02972658|83144983|FG003|Overall Study|Death|1|||
46914477|NCT02972658|83144980|FG000|Overall Study|Lost to Follow-up|0|||
46914478|NCT02972658|83144981|FG001|Overall Study|Lost to Follow-up|1|||
46631169|NCT01904604|82804217|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
46631170|NCT01904604|82804218|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
46631171|NCT01904604|82804219|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
46631172|NCT01904604|82804217|FG000|Overall Study|Patch site reactions|1|||
46631173|NCT01904604|82804218|FG001|Overall Study|Patch site reactions|1|||
46631174|NCT01904604|82804219|FG002|Overall Study|Patch site reactions|0|||
46631175|NCT01904604|82804217|FG000|Overall Study|Increased syncope|0|||
46631176|NCT01904604|82804218|FG001|Overall Study|Increased syncope|1|||
46631177|NCT01904604|82804219|FG002|Overall Study|Increased syncope|0|||
46631178|NCT01904604|82804217|FG000|Overall Study|Unrelated illness|0|||
46631179|NCT01904604|82804218|FG001|Overall Study|Unrelated illness|1|||
46631180|NCT01904604|82804219|FG002|Overall Study|Unrelated illness|0|||
46631181|NCT01904604|82804217|FG000|Overall Study|Passed Week 52 OFC|1|||
46631182|NCT01904604|82804218|FG001|Overall Study|Passed Week 52 OFC|0|||
46631183|NCT01904604|82804219|FG002|Overall Study|Passed Week 52 OFC|0|||
46631184|NCT01904604|82804217|FG000|Overall Study|Withdrawal by Subject|1|||
46631185|NCT01904604|82804218|FG001|Overall Study|Withdrawal by Subject|2|||
46631186|NCT01904604|82804219|FG002|Overall Study|Withdrawal by Subject|0|||
46631187|NCT01904604|82804217|FG000|Overall Study|Participant Relocated|1|||
46715697|NCT01135511|82931671|FG006|Overall Study|Withdrawal by Subject|1|||
47039024|NCT03919799|83291822|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
47039025|NCT03919799|83291823|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
46715698|NCT01135511|82931672|FG007|Overall Study|Withdrawal by Subject|0|||
47039026|NCT03919799|83291824|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
46715699|NCT01135511|82931673|FG008|Overall Study|Withdrawal by Subject|1|||
46715700|NCT01184846|82931702|FG000|Overall Study|Adverse Event|2|||
46715701|NCT01184846|82931702|FG000|Overall Study|Insufficient response|1|||
46715702|NCT01180400|82931710|FG000|Overall Study|Withdrawal by Subject|5|||
46631188|NCT01904604|82804218|FG001|Overall Study|Participant Relocated|1|||
46631189|NCT01904604|82804219|FG002|Overall Study|Participant Relocated|1|||
46631190|NCT01904604|82804217|FG000|Overall Study|Lost to Follow-up|0|||
46715703|NCT01180400|82931711|FG001|Overall Study|Withdrawal by Subject|6|||
46715704|NCT01180400|82931710|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46715705|NCT01180400|82931711|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
46715706|NCT01180400|82931710|FG000|Overall Study|Adverse Event|12|||
46715707|NCT01180400|82931711|FG001|Overall Study|Adverse Event|10|||
46715708|NCT01180400|82931710|FG000|Overall Study|Severe non-compliance to protocol|1|||
46715709|NCT01180400|82931711|FG001|Overall Study|Severe non-compliance to protocol|2|||
46715710|NCT01180400|82931710|FG000|Overall Study|Condition under investigation worsened|2|||
46715711|NCT01180400|82931711|FG001|Overall Study|Condition under investigation worsened|1|||
46715712|NCT01180400|82931710|FG000|Overall Study|Lack of Efficacy|2|||
46715713|NCT01180400|82931711|FG001|Overall Study|Lack of Efficacy|0|||
46715714|NCT01180400|82931710|FG000|Overall Study|Study-specific withdrawal criteria|1|||
46715715|NCT01180400|82931711|FG001|Overall Study|Study-specific withdrawal criteria|2|||
46715716|NCT01180400|82931710|FG000|Overall Study|Lost to Follow-up|2|||
46715717|NCT01180400|82931711|FG001|Overall Study|Lost to Follow-up|3|||
46715718|NCT01180400|82931710|FG000|Overall Study|Other|0|||
46715719|NCT01180400|82931711|FG001|Overall Study|Other|1|||
46715720|NCT01180244|82931719|FG000|Overall Study|Lack of Efficacy|0|||
46715721|NCT01180244|82931720|FG001|Overall Study|Lack of Efficacy|7|||
46715722|NCT01180244|82931719|FG000|Overall Study|Physician Decision|3|||
46715723|NCT01180244|82931720|FG001|Overall Study|Physician Decision|0|||
46715724|NCT01180244|82931719|FG000|Overall Study|Adverse Event|1|||
46715725|NCT01180244|82931720|FG001|Overall Study|Adverse Event|0|||
46715726|NCT01180244|82931719|FG000|Overall Study|Withdrawal by Subject|0|||
46715727|NCT01180244|82931720|FG001|Overall Study|Withdrawal by Subject|1|||
46715728|NCT01180244|82931719|FG000|Overall Study|Protocol Violation|1|||
46715729|NCT01180244|82931720|FG001|Overall Study|Protocol Violation|0|||
46715730|NCT01180244|82931719|FG000|Overall Study|Lost to Follow-up|1|||
46715731|NCT01180244|82931720|FG001|Overall Study|Lost to Follow-up|0|||
46715732|NCT01191086|82931726|FG000|Overall Study|Adverse Event|20|||
46715733|NCT01191086|82931726|FG000|Overall Study|Lack of Efficacy|10|||
46715734|NCT01191086|82931726|FG000|Overall Study|Lost to Follow-up|4|||
46715735|NCT01191086|82931726|FG000|Overall Study|Physician Decision|2|||
46715736|NCT01191086|82931726|FG000|Overall Study|Withdrawal by Subject|24|||
46715737|NCT01191086|82931726|FG000|Overall Study|Discontinuation criterion met|1|||
46715738|NCT01191086|82931726|FG000|Overall Study|Other|1|||
46715739|NCT01088412|82931733|FG000|Overall Study|Adverse Event|38|||
46715740|NCT01088412|82931734|FG001|Overall Study|Adverse Event|0|||
46715741|NCT01088412|82931735|FG002|Overall Study|Adverse Event|0|||
46715742|NCT01088412|82931733|FG000|Overall Study|Death|42|||
46715743|NCT01088412|82931734|FG001|Overall Study|Death|6|||
46715744|NCT01088412|82931735|FG002|Overall Study|Death|0|||
46715745|NCT01088412|82931733|FG000|Overall Study|Other Reason per Case Report Form|2089|||
47039027|NCT03919799|83291825|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
47039028|NCT03919799|83291821|FG000|DB Period (28 Weeks)|Adverse Event|1|||
47039029|NCT03919799|83291822|FG001|DB Period (28 Weeks)|Adverse Event|1|||
47039030|NCT03919799|83291823|FG002|DB Period (28 Weeks)|Adverse Event|1|||
47039031|NCT03919799|83291824|FG003|DB Period (28 Weeks)|Adverse Event|0|||
47039032|NCT03919799|83291825|FG004|DB Period (28 Weeks)|Adverse Event|0|||
47039033|NCT03919799|83291821|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
47039034|NCT03919799|83291822|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
46631191|NCT01904604|82804218|FG001|Overall Study|Lost to Follow-up|0|||
46631192|NCT01904604|82804219|FG002|Overall Study|Lost to Follow-up|1|||
46631193|NCT01904058|82804234|FG000|Overall Study|Adverse Event|2|||
46631194|NCT01904058|82804235|FG001|Overall Study|Adverse Event|0|||
46631195|NCT01904058|82804236|FG002|Overall Study|Adverse Event|0|||
46631196|NCT01904058|82804237|FG003|Overall Study|Adverse Event|0|||
46631197|NCT01904058|82804234|FG000|Overall Study|Withdrawal by Subject|1|||
46631198|NCT01904058|82804235|FG001|Overall Study|Withdrawal by Subject|0|||
46631199|NCT01904058|82804236|FG002|Overall Study|Withdrawal by Subject|1|||
46631200|NCT01904058|82804237|FG003|Overall Study|Withdrawal by Subject|0|||
46631201|NCT01904058|82804234|FG000|Overall Study|Pregnancy|0|||
46631202|NCT01904058|82804235|FG001|Overall Study|Pregnancy|0|||
46631203|NCT01904058|82804236|FG002|Overall Study|Pregnancy|0|||
46631204|NCT01904058|82804237|FG003|Overall Study|Pregnancy|1|||
46631205|NCT01881126|82804255|FG000|Overall Study|Non-compliance|1|||
46631206|NCT01881126|82804256|FG001|Overall Study|Non-compliance|1|||
46631207|NCT01881126|82804255|FG000|Overall Study|Adverse Event|0|||
46715746|NCT01088412|82931734|FG001|Overall Study|Other Reason per Case Report Form|103|||
46715747|NCT01088412|82931735|FG002|Overall Study|Other Reason per Case Report Form|9|||
46715748|NCT01088412|82931733|FG000|Overall Study|Withdrawal by Subject|1761|||
46715749|NCT01088412|82931734|FG001|Overall Study|Withdrawal by Subject|25|||
46914479|NCT02972658|83144982|FG002|Overall Study|Lost to Follow-up|1|||
46631208|NCT01881126|82804256|FG001|Overall Study|Adverse Event|1|||
46631209|NCT01614600|82804262|FG000|Overall Study|Unacceptable fit|1|||
46631210|NCT01614600|82804262|FG000|Overall Study|Discomfort|1|||
46715750|NCT01088412|82931735|FG002|Overall Study|Withdrawal by Subject|1|||
46715751|NCT01088412|82931733|FG000|Overall Study|Received Another GH Product|79|||
46715752|NCT01088412|82931734|FG001|Overall Study|Received Another GH Product|0|||
46715753|NCT01088412|82931735|FG002|Overall Study|Received Another GH Product|0|||
46715754|NCT01088412|82931733|FG000|Overall Study|Participant Moved|601|||
47039035|NCT03919799|83291823|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
47039036|NCT03919799|83291824|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
46715755|NCT01088412|82931734|FG001|Overall Study|Participant Moved|21|||
46715756|NCT01088412|82931735|FG002|Overall Study|Participant Moved|2|||
46715757|NCT01088412|82931733|FG000|Overall Study|Physician Decision|1041|||
46715758|NCT01088412|82931734|FG001|Overall Study|Physician Decision|8|||
46715759|NCT01088412|82931735|FG002|Overall Study|Physician Decision|4|||
46715760|NCT01088412|82931733|FG000|Overall Study|Sponsor Decision|4467|||
46715761|NCT01088412|82931734|FG001|Overall Study|Sponsor Decision|79|||
46715762|NCT01088412|82931735|FG002|Overall Study|Sponsor Decision|23|||
46715763|NCT01088412|82931733|FG000|Overall Study|Third Party Required to Change Brand|487|||
46715764|NCT01088412|82931734|FG001|Overall Study|Third Party Required to Change Brand|0|||
46715765|NCT01088412|82931735|FG002|Overall Study|Third Party Required to Change Brand|0|||
47039037|NCT03919799|83291825|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
47039038|NCT03919799|83291821|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
47039039|NCT03919799|83291822|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
47039040|NCT03919799|83291823|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
47039041|NCT03919799|83291824|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
47039042|NCT03919799|83291825|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
47039043|NCT03919799|83291821|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
47039044|NCT03919799|83291822|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
46715766|NCT01088412|82931733|FG000|Overall Study|Lost to Follow-up|3052|||
47039045|NCT03919799|83291823|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
47039046|NCT03919799|83291824|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
47039047|NCT03919799|83291825|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
47039048|NCT03621735|83291870|FG000|Overall Study|Withdrawal by Subject|13|||
47039049|NCT03621735|83291871|FG001|Overall Study|Withdrawal by Subject|13|||
47039050|NCT03245151|83291927|FG000|Overall Study|Withdrawal by Subject|2|||
47039051|NCT03245151|83291928|FG001|Overall Study|Withdrawal by Subject|0|||
47039052|NCT03245151|83291929|FG002|Overall Study|Withdrawal by Subject|0|||
47039053|NCT03245151|83291930|FG003|Overall Study|Withdrawal by Subject|2|||
47039054|NCT03245151|83291931|FG004|Overall Study|Withdrawal by Subject|1|||
47039055|NCT03245151|83291927|FG000|Overall Study|Death|3|||
47039056|NCT03245151|83291928|FG001|Overall Study|Death|14|||
47039057|NCT03245151|83291929|FG002|Overall Study|Death|9|||
47039058|NCT03245151|83291930|FG003|Overall Study|Death|16|||
47039059|NCT03245151|83291931|FG004|Overall Study|Death|7|||
47039060|NCT03245151|83291927|FG000|Overall Study|Sponsor's decision|0|||
47039061|NCT03245151|83291928|FG001|Overall Study|Sponsor's decision|1|||
47039062|NCT03245151|83291929|FG002|Overall Study|Sponsor's decision|0|||
47039063|NCT03245151|83291930|FG003|Overall Study|Sponsor's decision|0|||
47039064|NCT03245151|83291931|FG004|Overall Study|Sponsor's decision|0|||
47039065|NCT02087865|83291965|FG000|Overall Study|Withdrawal by Subject|6|||
47039066|NCT02087865|83291966|FG001|Overall Study|Withdrawal by Subject|0|||
47039067|NCT02087865|83291967|FG002|Overall Study|Withdrawal by Subject|1|||
47039068|NCT02087865|83291965|FG000|Overall Study|Lost to Follow-up|0|||
47039069|NCT02087865|83291966|FG001|Overall Study|Lost to Follow-up|0|||
47039070|NCT02087865|83291967|FG002|Overall Study|Lost to Follow-up|1|||
47039071|NCT02087865|83291965|FG000|Overall Study|Drug Non-compliance|0|||
47039072|NCT02087865|83291966|FG001|Overall Study|Drug Non-compliance|2|||
47039073|NCT02087865|83291967|FG002|Overall Study|Drug Non-compliance|0|||
47039074|NCT02087865|83291965|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
47039075|NCT02087865|83291966|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
47039076|NCT02087865|83291967|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
47039077|NCT01858740|83291976|FG000|Overall Study|Death|4|||
47039078|NCT01682083|83291993|FG000|Overall Study|Lost to Follow-up|11|||
47039079|NCT01682083|83291994|FG001|Overall Study|Lost to Follow-up|18|||
47039080|NCT01682083|83291993|FG000|Overall Study|Withdrawal by Subject|31|||
47039081|NCT01682083|83291994|FG001|Overall Study|Withdrawal by Subject|40|||
46715767|NCT01088412|82931734|FG001|Overall Study|Lost to Follow-up|130|||
46715768|NCT01088412|82931735|FG002|Overall Study|Lost to Follow-up|11|||
46715769|NCT01088412|82931733|FG000|Overall Study|Study Summary Not Completed|4360|||
46715770|NCT01088412|82931734|FG001|Overall Study|Study Summary Not Completed|64|||
47039082|NCT01682083|83291993|FG000|Overall Study|Death|60|||
47039083|NCT01682083|83291994|FG001|Overall Study|Death|93|||
46715771|NCT01088412|82931735|FG002|Overall Study|Study Summary Not Completed|22|||
46715772|NCT01086384|82931748|FG000|2-week Run-in Period|Adverse Event|1|||
46803640|NCT03523728|83022940|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
47039084|NCT01682083|83291993|FG000|Overall Study|Physician Decision|5|||
47039085|NCT01682083|83291994|FG001|Overall Study|Physician Decision|4|||
47039086|NCT01180790|83292011|FG000|Overall Study|Adverse Event|1|||
46715773|NCT01086384|82931749|FG001|2-week Run-in Period|Adverse Event|0|||
46715774|NCT01086384|82931750|FG002|2-week Run-in Period|Adverse Event|0|||
46715775|NCT01086384|82931748|FG000|2-week Run-in Period|Protocol Violation|1|||
46715776|NCT01086384|82931749|FG001|2-week Run-in Period|Protocol Violation|0|||
46715777|NCT01086384|82931750|FG002|2-week Run-in Period|Protocol Violation|0|||
46715778|NCT01086384|82931748|FG000|2-week Run-in Period|Lost to Follow-up|1|||
46715779|NCT01086384|82931749|FG001|2-week Run-in Period|Lost to Follow-up|0|||
46914480|NCT02972658|83144983|FG003|Overall Study|Lost to Follow-up|2|||
46914481|NCT02972658|83144980|FG000|Overall Study|Progressive Disease|0|||
46914482|NCT02972658|83144981|FG001|Overall Study|Progressive Disease|1|||
46914483|NCT02972658|83144982|FG002|Overall Study|Progressive Disease|0|||
46914484|NCT02972658|83144983|FG003|Overall Study|Progressive Disease|1|||
46914485|NCT02972658|83144980|FG000|Overall Study|Withdrawal by Subject|4|||
46914486|NCT02972658|83144981|FG001|Overall Study|Withdrawal by Subject|4|||
46914487|NCT02972658|83144982|FG002|Overall Study|Withdrawal by Subject|1|||
46914488|NCT02972658|83144983|FG003|Overall Study|Withdrawal by Subject|6|||
46914489|NCT02972658|83144980|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
46914490|NCT02972658|83144981|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
46914491|NCT02972658|83144982|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
46914492|NCT02972658|83144983|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
46914493|NCT02972658|83144980|FG000|Overall Study|Sponsor Decision|70|||
46914494|NCT02972658|83144981|FG001|Overall Study|Sponsor Decision|127|||
46914495|NCT02972658|83144982|FG002|Overall Study|Sponsor Decision|72|||
46914496|NCT02972658|83144983|FG003|Overall Study|Sponsor Decision|119|||
46914497|NCT02853032|83144995|FG000|Overall Study|Adverse Event|4|||
46914498|NCT02853032|83144996|FG001|Overall Study|Adverse Event|0|||
46914499|NCT02853032|83144995|FG000|Overall Study|Withdrawal by Subject|3|||
46914500|NCT02853032|83144996|FG001|Overall Study|Withdrawal by Subject|1|||
46914501|NCT02853032|83144995|FG000|Overall Study|Requested to withdraw from all treatment|2|||
46914502|NCT02853032|83144996|FG001|Overall Study|Requested to withdraw from all treatment|2|||
46914503|NCT02232087|83145004|FG000|Overall Study|Withdrawal by Subject|2|||
46914504|NCT02232087|83145005|FG001|Overall Study|Withdrawal by Subject|0|||
46914505|NCT02232087|83145006|FG002|Overall Study|Withdrawal by Subject|0|||
46914506|NCT02232087|83145007|FG003|Overall Study|Withdrawal by Subject|0|||
46914507|NCT02232087|83145008|FG004|Overall Study|Withdrawal by Subject|0|||
46914508|NCT02232087|83145009|FG005|Overall Study|Withdrawal by Subject|1|||
46914509|NCT02232087|83145004|FG000|Overall Study|poor inhalation technique|0|||
46914510|NCT02232087|83145005|FG001|Overall Study|poor inhalation technique|1|||
46914511|NCT02232087|83145006|FG002|Overall Study|poor inhalation technique|0|||
46914512|NCT02232087|83145007|FG003|Overall Study|poor inhalation technique|0|||
46914513|NCT02232087|83145008|FG004|Overall Study|poor inhalation technique|0|||
46914514|NCT02232087|83145009|FG005|Overall Study|poor inhalation technique|2|||
46631211|NCT01614600|82804262|FG000|Overall Study|Unable to remove lens at the end of day|1|||
46631212|NCT01614600|82804262|FG000|Overall Study|Protocol deviation|1|||
46631213|NCT01880736|82804270|FG000|Overall Study|Adverse Event|0|||
46631214|NCT01880736|82804271|FG001|Overall Study|Adverse Event|0|||
46631215|NCT01880736|82804272|FG002|Overall Study|Adverse Event|0|||
46631216|NCT01880736|82804273|FG003|Overall Study|Adverse Event|1|||
46631217|NCT01880736|82804270|FG000|Overall Study|Withdrawal Criteria|1|||
46631218|NCT01880736|82804271|FG001|Overall Study|Withdrawal Criteria|2|||
46631219|NCT01880736|82804272|FG002|Overall Study|Withdrawal Criteria|1|||
46631220|NCT01880736|82804273|FG003|Overall Study|Withdrawal Criteria|5|||
46631221|NCT01880424|82804285|FG000|Overall Study|Adverse Event|7|||
46631222|NCT01880424|82804286|FG001|Overall Study|Adverse Event|6|||
46631223|NCT01880424|82804285|FG000|Overall Study|Lack of Efficacy|1|||
46631224|NCT01880424|82804286|FG001|Overall Study|Lack of Efficacy|4|||
46631225|NCT01880424|82804285|FG000|Overall Study|Lost to Follow-up|3|||
46631226|NCT01880424|82804286|FG001|Overall Study|Lost to Follow-up|2|||
46631227|NCT01880424|82804285|FG000|Overall Study|Protocol Violation|11|||
46631228|NCT01880424|82804286|FG001|Overall Study|Protocol Violation|13|||
46631229|NCT01880424|82804285|FG000|Overall Study|Withdrawal by Subject|10|||
46631230|NCT01880424|82804286|FG001|Overall Study|Withdrawal by Subject|30|||
46631231|NCT01880424|82804285|FG000|Overall Study|Other|1|||
46631232|NCT01880424|82804286|FG001|Overall Study|Other|0|||
46631233|NCT01862874|82804294|FG000|Overall Study|Randomized not treated|1|||
46631234|NCT01862874|82804295|FG001|Overall Study|Randomized not treated|0|||
46631235|NCT01862874|82804294|FG000|Overall Study|Adverse Event|0|||
46631236|NCT01862874|82804295|FG001|Overall Study|Adverse Event|3|||
46631237|NCT01862874|82804294|FG000|Overall Study|Lost to Follow-up|26|||
46631238|NCT01862874|82804295|FG001|Overall Study|Lost to Follow-up|29|||
46631239|NCT01862874|82804294|FG000|Overall Study|Physician Decision|5|||
46631240|NCT01862874|82804295|FG001|Overall Study|Physician Decision|3|||
46715780|NCT01086384|82931750|FG002|2-week Run-in Period|Lost to Follow-up|0|||
46715781|NCT01086384|82931748|FG000|2-week Run-in Period|Physician Decision|6|||
46715782|NCT01086384|82931749|FG001|2-week Run-in Period|Physician Decision|0|||
46715783|NCT01086384|82931750|FG002|2-week Run-in Period|Physician Decision|0|||
46715784|NCT01086384|82931748|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
46715785|NCT01086384|82931749|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
46715786|NCT01086384|82931750|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
46715787|NCT01086384|82931748|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
46715788|NCT01086384|82931749|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
46715789|NCT01086384|82931750|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
46715790|NCT01086384|82931748|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
46715791|NCT01086384|82931749|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
46715792|NCT01086384|82931750|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
46715793|NCT01086384|82931748|FG000|2-week Run-in Period|Randomized in Error|1|||
46715794|NCT01086384|82931749|FG001|2-week Run-in Period|Randomized in Error|0|||
46715795|NCT01086384|82931750|FG002|2-week Run-in Period|Randomized in Error|0|||
46715796|NCT01086384|82931748|FG000|Treatment Period|Withdrawal by Subject|0|||
46715797|NCT01086384|82931749|FG001|Treatment Period|Withdrawal by Subject|53|||
46715798|NCT01086384|82931750|FG002|Treatment Period|Withdrawal by Subject|55|||
46715799|NCT01086384|82931748|FG000|Treatment Period|Protocol Violation|0|||
46715800|NCT01086384|82931749|FG001|Treatment Period|Protocol Violation|26|||
46715801|NCT01086384|82931750|FG002|Treatment Period|Protocol Violation|17|||
47039087|NCT01180790|83292012|FG001|Overall Study|Adverse Event|1|||
46715802|NCT01086384|82931748|FG000|Treatment Period|Lack of Efficacy|0|||
47039088|NCT01180790|83292013|FG002|Overall Study|Adverse Event|2|||
47039089|NCT01180790|83292014|FG003|Overall Study|Adverse Event|0|||
47039090|NCT01180790|83292015|FG004|Overall Study|Adverse Event|1|||
47039091|NCT01180790|83292016|FG005|Overall Study|Adverse Event|3|||
47039092|NCT01180790|83292017|FG006|Overall Study|Adverse Event|0|||
47039093|NCT01180790|83292011|FG000|Overall Study|Withdrawal by Subject|3|||
47039094|NCT01180790|83292012|FG001|Overall Study|Withdrawal by Subject|0|||
47039095|NCT01180790|83292013|FG002|Overall Study|Withdrawal by Subject|5|||
47039096|NCT01180790|83292014|FG003|Overall Study|Withdrawal by Subject|0|||
47039097|NCT01180790|83292015|FG004|Overall Study|Withdrawal by Subject|2|||
47039098|NCT01180790|83292016|FG005|Overall Study|Withdrawal by Subject|1|||
47039099|NCT01180790|83292017|FG006|Overall Study|Withdrawal by Subject|0|||
47039100|NCT01180790|83292011|FG000|Overall Study|Lost to Follow-up|3|||
47039101|NCT01180790|83292012|FG001|Overall Study|Lost to Follow-up|1|||
47039102|NCT01180790|83292013|FG002|Overall Study|Lost to Follow-up|0|||
47039103|NCT01180790|83292014|FG003|Overall Study|Lost to Follow-up|2|||
47039104|NCT01180790|83292015|FG004|Overall Study|Lost to Follow-up|1|||
47039105|NCT01180790|83292016|FG005|Overall Study|Lost to Follow-up|0|||
47039106|NCT01180790|83292017|FG006|Overall Study|Lost to Follow-up|1|||
47039107|NCT01180790|83292011|FG000|Overall Study|Physician Decision|1|||
47039108|NCT01180790|83292012|FG001|Overall Study|Physician Decision|0|||
47039109|NCT01180790|83292013|FG002|Overall Study|Physician Decision|0|||
47039110|NCT01180790|83292014|FG003|Overall Study|Physician Decision|1|||
47039111|NCT01180790|83292015|FG004|Overall Study|Physician Decision|0|||
47039112|NCT01180790|83292016|FG005|Overall Study|Physician Decision|0|||
47039113|NCT01180790|83292017|FG006|Overall Study|Physician Decision|0|||
47039114|NCT01180790|83292011|FG000|Overall Study|Lack of Efficacy|1|||
47039115|NCT01180790|83292012|FG001|Overall Study|Lack of Efficacy|2|||
47039116|NCT01180790|83292013|FG002|Overall Study|Lack of Efficacy|5|||
46715803|NCT01086384|82931749|FG001|Treatment Period|Lack of Efficacy|22|||
46715804|NCT01086384|82931750|FG002|Treatment Period|Lack of Efficacy|13|||
46715805|NCT01086384|82931748|FG000|Treatment Period|Adverse Event|0|||
46715806|NCT01086384|82931749|FG001|Treatment Period|Adverse Event|19|||
46715807|NCT01086384|82931750|FG002|Treatment Period|Adverse Event|15|||
46715808|NCT01086384|82931748|FG000|Treatment Period|Lost to Follow-up|0|||
46715809|NCT01086384|82931749|FG001|Treatment Period|Lost to Follow-up|11|||
46715810|NCT01086384|82931750|FG002|Treatment Period|Lost to Follow-up|9|||
46715811|NCT01086384|82931748|FG000|Treatment Period|Physician Decision|0|||
46715812|NCT01086384|82931749|FG001|Treatment Period|Physician Decision|9|||
46715813|NCT01086384|82931750|FG002|Treatment Period|Physician Decision|6|||
46715814|NCT01086384|82931748|FG000|Treatment Period|Study Closed/Terminated|0|||
46914515|NCT02232087|83145004|FG000|Overall Study|protocol stop criteria|0|||
46715815|NCT01086384|82931749|FG001|Treatment Period|Study Closed/Terminated|7|||
46715816|NCT01086384|82931750|FG002|Treatment Period|Study Closed/Terminated|8|||
46715817|NCT01086384|82931748|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
46715818|NCT01086384|82931749|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
46914516|NCT02232087|83145005|FG001|Overall Study|protocol stop criteria|1|||
47039117|NCT01180790|83292014|FG003|Overall Study|Lack of Efficacy|6|||
47039118|NCT01180790|83292015|FG004|Overall Study|Lack of Efficacy|1|||
47039119|NCT01180790|83292016|FG005|Overall Study|Lack of Efficacy|3|||
47039120|NCT01180790|83292017|FG006|Overall Study|Lack of Efficacy|0|||
47039121|NCT01180790|83292011|FG000|Overall Study|compliance|0|||
47039122|NCT01180790|83292012|FG001|Overall Study|compliance|1|||
47039123|NCT01180790|83292013|FG002|Overall Study|compliance|0|||
46715819|NCT01086384|82931750|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
46715820|NCT01086384|82931748|FG000|Treatment Period|Received Treatment in Error|0|||
46715821|NCT01086384|82931749|FG001|Treatment Period|Received Treatment in Error|1|||
46715822|NCT01086384|82931750|FG002|Treatment Period|Received Treatment in Error|0|||
46715823|NCT01127633|82931758|FG000|Overall Study|Adverse Event|74|||
46715824|NCT01127633|82931759|FG001|Overall Study|Adverse Event|73|||
46715825|NCT01127633|82931758|FG000|Overall Study|Death|40|||
46715826|NCT01127633|82931759|FG001|Overall Study|Death|43|||
46715827|NCT01127633|82931758|FG000|Overall Study|Lost to Follow-up|4|||
46715828|NCT01127633|82931759|FG001|Overall Study|Lost to Follow-up|0|||
46715829|NCT01127633|82931758|FG000|Overall Study|Parent/Caregiver Decision|246|||
46715830|NCT01127633|82931759|FG001|Overall Study|Parent/Caregiver Decision|228|||
46715831|NCT01127633|82931758|FG000|Overall Study|Physician Decision|60|||
46715832|NCT01127633|82931759|FG001|Overall Study|Physician Decision|45|||
46715833|NCT01127633|82931758|FG000|Overall Study|Withdrawal by Subject|57|||
46715834|NCT01127633|82931759|FG001|Overall Study|Withdrawal by Subject|72|||
46715835|NCT01127633|82931758|FG000|Overall Study|Sponsor Decision|163|||
46715836|NCT01127633|82931759|FG001|Overall Study|Sponsor Decision|195|||
46715837|NCT01127633|82931758|FG000|Overall Study|Protocol Violation|8|||
46715838|NCT01127633|82931759|FG001|Overall Study|Protocol Violation|16|||
46715839|NCT01127633|82931758|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
46715840|NCT01127633|82931759|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
46715841|NCT01127633|82931758|FG000|Overall Study|Not treated|1|||
46715842|NCT01127633|82931759|FG001|Overall Study|Not treated|0|||
46715843|NCT01122173|82931765|FG000|Overall Study|Lost to Follow-up|3|||
46715844|NCT01122173|82931765|FG000|Overall Study|Withdrawal by Subject|3|||
46715845|NCT01122173|82931765|FG000|Overall Study|Left study for other reasons|3|||
46715846|NCT01127165|82931772|FG000|Overall Study|Adverse Event|2|||
46715847|NCT01127165|82931773|FG001|Overall Study|Adverse Event|2|||
46715848|NCT01127165|82931772|FG000|Overall Study|Lack of Efficacy|10|||
46715849|NCT01127165|82931773|FG001|Overall Study|Lack of Efficacy|8|||
46715850|NCT01127165|82931772|FG000|Overall Study|Lost to Follow-up|3|||
46715851|NCT01127165|82931773|FG001|Overall Study|Lost to Follow-up|5|||
46715852|NCT01127165|82931772|FG000|Overall Study|Withdrawal by Subject|1|||
46715853|NCT01127165|82931773|FG001|Overall Study|Withdrawal by Subject|3|||
46715854|NCT01127165|82931772|FG000|Overall Study|Protocol Violation|0|||
46715855|NCT01127165|82931773|FG001|Overall Study|Protocol Violation|1|||
46715856|NCT01126619|82931779|FG000|Overall Study|Not eligible for the study|2|||
46715857|NCT01126619|82931779|FG000|Overall Study|Investigator decision|4|||
46715858|NCT01126619|82931779|FG000|Overall Study|Serious adverse event|1|||
46715859|NCT01126619|82931779|FG000|Overall Study|Withdrawal by Subject|9|||
46715860|NCT01126619|82931779|FG000|Overall Study|Non-compliance|1|||
46715861|NCT00941733|82931787|FG000|Overall Study|Death|24|||
46715862|NCT00941733|82931788|FG001|Overall Study|Death|10|||
46715863|NCT00941733|82931787|FG000|Overall Study|Withdrawal by Subject|14|||
46715864|NCT00941733|82931788|FG001|Overall Study|Withdrawal by Subject|6|||
46715865|NCT00941733|82931787|FG000|Overall Study|Adverse Event|20|||
46715866|NCT00941733|82931788|FG001|Overall Study|Adverse Event|4|||
46715867|NCT00941733|82931787|FG000|Overall Study|Lost to Follow-up|1|||
46715868|NCT00941733|82931788|FG001|Overall Study|Lost to Follow-up|2|||
46715869|NCT00941733|82931787|FG000|Overall Study|Protocol Violation|15|||
46715870|NCT00941733|82931788|FG001|Overall Study|Protocol Violation|6|||
46715871|NCT00941655|82931796|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
46715872|NCT00941655|82931797|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
47039124|NCT01180790|83292014|FG003|Overall Study|compliance|0|||
47039125|NCT01180790|83292015|FG004|Overall Study|compliance|0|||
47039126|NCT01180790|83292016|FG005|Overall Study|compliance|0|||
47039127|NCT01180790|83292017|FG006|Overall Study|compliance|0|||
47039128|NCT01180790|83292011|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
47039129|NCT01180790|83292012|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
47039130|NCT01180790|83292013|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
47039131|NCT01180790|83292014|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
46715873|NCT00941655|82931796|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
46715874|NCT00941655|82931797|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
46715875|NCT00941655|82931796|FG000|Overall Study|progressed while on chemo|0|||
46715876|NCT00941655|82931797|FG001|Overall Study|progressed while on chemo|2|||
46715877|NCT00941655|82931796|FG000|Overall Study|refused further treatment|0|||
46715878|NCT00941655|82931797|FG001|Overall Study|refused further treatment|1|||
46715879|NCT00941655|82931796|FG000|Overall Study|withdrew consent|0|||
46715880|NCT00941655|82931797|FG001|Overall Study|withdrew consent|1|||
46715881|NCT00941655|82931796|FG000|Overall Study|non-compliant|0|||
47039132|NCT01180790|83292015|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
46715882|NCT00941655|82931797|FG001|Overall Study|non-compliant|1|||
46715883|NCT00939393|82931806|FG000|Overall Study|Withdrawal by Subject|1|||
46715884|NCT00939393|82931807|FG001|Overall Study|Withdrawal by Subject|0|||
46715885|NCT00939393|82931806|FG000|Overall Study|Lost to Follow-up|3|||
46715886|NCT00939393|82931807|FG001|Overall Study|Lost to Follow-up|0|||
46715887|NCT00936117|82931824|FG000|Overall Study|Adverse Event|7|||
46715888|NCT00936117|82931824|FG000|Overall Study|Unable to continue oral medication|3|||
46715889|NCT04088500|82931829|FG000|Overall Study|Reason unknown|1|||
46715890|NCT04088500|82931829|FG000|Overall Study|Participant withdrew consent|1|||
46715891|NCT04088500|82931829|FG000|Overall Study|Disease progression|3|||
46715892|NCT01082874|82931837|FG000|Overall Study|Lost to Follow-up|10|||
46715893|NCT01082874|82931838|FG001|Overall Study|Lost to Follow-up|10|||
46715894|NCT01082874|82931839|FG002|Overall Study|Lost to Follow-up|6|||
46715895|NCT01082874|82931840|FG003|Overall Study|Lost to Follow-up|10|||
46715896|NCT01082874|82931837|FG000|Overall Study|Withdrawal by Subject|1|||
46715897|NCT01082874|82931838|FG001|Overall Study|Withdrawal by Subject|2|||
46715898|NCT01082874|82931839|FG002|Overall Study|Withdrawal by Subject|5|||
46715899|NCT01082874|82931840|FG003|Overall Study|Withdrawal by Subject|3|||
46715900|NCT00933543|82931852|FG000|Overall Study|Adverse Event|2|||
46715901|NCT00933543|82931853|FG001|Overall Study|Adverse Event|1|||
46715902|NCT00933543|82931852|FG000|Overall Study|Lost to Follow-up|0|||
46715903|NCT00933543|82931853|FG001|Overall Study|Lost to Follow-up|1|||
46715904|NCT00933543|82931852|FG000|Overall Study|Withdrawal by Subject|0|||
46715905|NCT00933543|82931853|FG001|Overall Study|Withdrawal by Subject|1|||
46715906|NCT00933543|82931852|FG000|Overall Study|Lack of Efficacy|0|||
46715907|NCT00933543|82931853|FG001|Overall Study|Lack of Efficacy|3|||
46715908|NCT00933543|82931852|FG000|Overall Study|Other|1|||
46715909|NCT00933543|82931853|FG001|Overall Study|Other|1|||
46715910|NCT01082328|82931859|FG000|Overall Study|Adverse Event|1|||
46715911|NCT01079988|82931868|FG000|Overall Study|Lost to Follow-up|0|||
46715912|NCT01079988|82931869|FG001|Overall Study|Lost to Follow-up|0|||
46914517|NCT02232087|83145006|FG002|Overall Study|protocol stop criteria|0|||
46914518|NCT02232087|83145007|FG003|Overall Study|protocol stop criteria|1|||
46914519|NCT02232087|83145008|FG004|Overall Study|protocol stop criteria|0|||
46914520|NCT02232087|83145009|FG005|Overall Study|protocol stop criteria|0|||
46914521|NCT02232087|83145004|FG000|Overall Study|Adverse Event|0|||
46914522|NCT02232087|83145005|FG001|Overall Study|Adverse Event|0|||
46914523|NCT02232087|83145006|FG002|Overall Study|Adverse Event|0|||
46914524|NCT02232087|83145007|FG003|Overall Study|Adverse Event|0|||
46914525|NCT02232087|83145008|FG004|Overall Study|Adverse Event|1|||
46914526|NCT02232087|83145009|FG005|Overall Study|Adverse Event|0|||
46914527|NCT03168425|83145030|FG000|Overall Study|Lost to Follow-up|5|||
46715913|NCT01079988|82931870|FG002|Overall Study|Lost to Follow-up|0|||
46715914|NCT01079988|82931871|FG003|Overall Study|Lost to Follow-up|1|||
46914528|NCT03168425|83145031|FG001|Overall Study|Lost to Follow-up|8|||
46914529|NCT03168425|83145030|FG000|Overall Study|unable to confirm post op opioids|2|||
46715915|NCT01079988|82931872|FG004|Overall Study|Lost to Follow-up|0|||
46715916|NCT01079988|82931868|FG000|Overall Study|Lack of Efficacy|1|||
46715917|NCT01079988|82931869|FG001|Overall Study|Lack of Efficacy|0|||
46715918|NCT01079988|82931870|FG002|Overall Study|Lack of Efficacy|0|||
46715919|NCT01079988|82931871|FG003|Overall Study|Lack of Efficacy|0|||
46715920|NCT01079988|82931872|FG004|Overall Study|Lack of Efficacy|0|||
46715921|NCT01079988|82931868|FG000|Overall Study|Other|0|||
46715922|NCT01079988|82931869|FG001|Overall Study|Other|0|||
46715923|NCT01079988|82931870|FG002|Overall Study|Other|0|||
46715924|NCT01079988|82931871|FG003|Overall Study|Other|2|||
46715925|NCT01079988|82931872|FG004|Overall Study|Other|1|||
46715926|NCT01074216|82931884|FG000|Overall Study|Physician Decision|1|||
46715927|NCT01074216|82931884|FG000|Overall Study|Not Treated|12|||
46715928|NCT01079832|82931888|FG000|Overall Study|Withdrawal by Subject|1|||
46631241|NCT01862874|82804294|FG000|Overall Study|Withdrawn by parent/guardian|1|||
46631242|NCT01862874|82804295|FG001|Overall Study|Withdrawn by parent/guardian|1|||
46631243|NCT01862874|82804294|FG000|Overall Study|Withdrawal by Subject|46|||
46631244|NCT01862874|82804295|FG001|Overall Study|Withdrawal by Subject|40|||
46631245|NCT01862874|82804294|FG000|Overall Study|Death|0|||
46631246|NCT01862874|82804295|FG001|Overall Study|Death|1|||
46631247|NCT01879722|82804311|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
46631248|NCT01879722|82804312|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
46631249|NCT01879722|82804313|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
46715929|NCT01072344|82931894|FG000|Overall Study|Relasped-reached end point|7|||
46715930|NCT01072344|82931895|FG001|Overall Study|Relasped-reached end point|12|||
46715931|NCT01072344|82931894|FG000|Overall Study|Protocol Violation|1|||
46715932|NCT01072344|82931895|FG001|Overall Study|Protocol Violation|2|||
46914530|NCT03168425|83145031|FG001|Overall Study|unable to confirm post op opioids|3|||
46631250|NCT01879722|82804314|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
46715933|NCT01072344|82931894|FG000|Overall Study|Lost to Follow-up|3|||
46715934|NCT01072344|82931895|FG001|Overall Study|Lost to Follow-up|4|||
46715935|NCT01071954|82931901|FG000|Overall Study|Noncompliance|4|||
46715936|NCT01071954|82931901|FG000|Overall Study|Adverse Event|1|||
46914531|NCT00004445|83145038|FG000|Overall Study|Physician Decision|2|||
46715937|NCT01071954|82931901|FG000|Overall Study|Withdrawal by Subject|11|||
46715938|NCT01071954|82931901|FG000|Overall Study|Requirement for Alternative Therapy|5|||
46715939|NCT01071954|82931901|FG000|Overall Study|Administrative Decision|5|||
46715940|NCT01071954|82931901|FG000|Overall Study|Protocol Specified Criteria|1|||
46715941|NCT00837811|82931908|FG000|Overall Study|Adverse Event|4|||
46715942|NCT00837811|82931909|FG001|Overall Study|Adverse Event|6|||
46715943|NCT00837811|82931910|FG002|Overall Study|Adverse Event|0|||
46715944|NCT00837811|82931908|FG000|Overall Study|Death|1|||
46715945|NCT00837811|82931909|FG001|Overall Study|Death|1|||
46715946|NCT00837811|82931910|FG002|Overall Study|Death|0|||
47039133|NCT01180790|83292016|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
47039134|NCT01180790|83292017|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
47039135|NCT00679042|83292066|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
47039136|NCT00679042|83292066|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
47039137|NCT00679042|83292066|FG000|5-Year Follow Up|Death|1|||
47039138|NCT00679042|83292066|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
47039139|NCT00679042|83292066|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
47039140|NCT00350272|83292072|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
47039141|NCT00350272|83292073|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
47039142|NCT00350272|83292072|FG000|Blinded 12-Week Treatment|Death|1|||
46715947|NCT00837811|82931908|FG000|Overall Study|Lack of Efficacy|0|||
46715948|NCT00837811|82931909|FG001|Overall Study|Lack of Efficacy|11|||
46715949|NCT00837811|82931910|FG002|Overall Study|Lack of Efficacy|0|||
46715950|NCT00837811|82931908|FG000|Overall Study|Lost to Follow-up|1|||
46715951|NCT00837811|82931909|FG001|Overall Study|Lost to Follow-up|3|||
46715952|NCT00837811|82931910|FG002|Overall Study|Lost to Follow-up|0|||
46715953|NCT00837811|82931908|FG000|Overall Study|Physician Decision|0|||
46715954|NCT00837811|82931909|FG001|Overall Study|Physician Decision|2|||
46715955|NCT00837811|82931910|FG002|Overall Study|Physician Decision|1|||
46715956|NCT00837811|82931908|FG000|Overall Study|Withdrawal by Subject|1|||
47039143|NCT00350272|83292073|FG001|Blinded 12-Week Treatment|Death|0|||
47039144|NCT00350272|83292072|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
47039145|NCT00350272|83292073|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
47039146|NCT00350272|83292072|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
47039147|NCT00350272|83292073|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
47039148|NCT00350272|83292072|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
47039149|NCT00350272|83292073|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
47039150|NCT00350272|83292072|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
47039151|NCT00350272|83292073|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
47039152|NCT00350272|83292072|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
47039153|NCT00350272|83292073|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
47039154|NCT00350272|83292072|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
47039155|NCT00350272|83292073|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
47039156|NCT00350272|83292072|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
47039157|NCT00350272|83292073|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
47039158|NCT00350272|83292072|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
47039159|NCT00350272|83292073|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
47039160|NCT00350272|83292072|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
47039161|NCT00350272|83292073|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
47039162|NCT02028884|83292084|FG000|Double-blind Period|Adverse Event|5|||
46631251|NCT01879722|82804315|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
46631252|NCT01879722|82804316|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
46631253|NCT01879722|82804317|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
46631254|NCT01879722|82804318|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
46631255|NCT01879722|82804319|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
46631256|NCT01879722|82804320|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
46631257|NCT01879722|82804311|FG000|Overall Study|Voluntary Withdrawal|0|||
46631258|NCT01879722|82804312|FG001|Overall Study|Voluntary Withdrawal|0|||
46631259|NCT01879722|82804313|FG002|Overall Study|Voluntary Withdrawal|0|||
46631260|NCT01879722|82804314|FG003|Overall Study|Voluntary Withdrawal|0|||
46631261|NCT01879722|82804315|FG004|Overall Study|Voluntary Withdrawal|0|||
46914532|NCT00004445|83145038|FG000|Overall Study|Withdrawal by Subject|1|||
46631262|NCT01879722|82804316|FG005|Overall Study|Voluntary Withdrawal|0|||
46914533|NCT02972502|83145044|FG000|Overall Study|Lost to Follow-up|3|||
47039163|NCT02028884|83292085|FG001|Double-blind Period|Adverse Event|3|||
47039164|NCT02028884|83292086|FG002|Double-blind Period|Adverse Event|0|||
46631263|NCT01879722|82804317|FG006|Overall Study|Voluntary Withdrawal|0|||
46631264|NCT01879722|82804318|FG007|Overall Study|Voluntary Withdrawal|0|||
46715957|NCT00837811|82931909|FG001|Overall Study|Withdrawal by Subject|9|||
46715958|NCT00837811|82931910|FG002|Overall Study|Withdrawal by Subject|0|||
46715959|NCT00837811|82931908|FG000|Overall Study|Sponsor Decision|0|||
47039165|NCT02028884|83292084|FG000|Double-blind Period|Eligibility Violation|1|||
46715960|NCT00837811|82931909|FG001|Overall Study|Sponsor Decision|2|||
46715961|NCT00837811|82931910|FG002|Overall Study|Sponsor Decision|0|||
46914534|NCT02972502|83145045|FG001|Overall Study|Lost to Follow-up|1|||
46715962|NCT00857389|82931927|FG000|Overall Study|Did not proceed to transplant|2|||
46715963|NCT01071798|82931931|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
46715964|NCT01071798|82931931|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
46715965|NCT01071798|82931931|FG000|Participants Who Received One Cycle|Patient requirement|20|||
46715966|NCT01071798|82931931|FG000|Participants Who Received One Cycle|Death|5|||
46715967|NCT01071798|82931931|FG000|Participants Who Received One Cycle|Change of therapy|6|||
46715968|NCT01071798|82931931|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
46715969|NCT01071798|82931931|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
46715970|NCT01071798|82931931|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
46715971|NCT01071798|82931931|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
46715972|NCT01071798|82931931|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
46715973|NCT00857311|82931949|FG000|Overall Study|Lost to Follow-up|1|||
46715974|NCT00857311|82931950|FG001|Overall Study|Lost to Follow-up|0|||
46715975|NCT00857311|82931951|FG002|Overall Study|Lost to Follow-up|0|||
46715976|NCT00857311|82931952|FG003|Overall Study|Lost to Follow-up|0|||
46715977|NCT00857233|82931958|FG000|Overall Study|Adverse Event|24|||
46715978|NCT00857233|82931958|FG000|Overall Study|Lack of Efficacy|1|||
46715979|NCT00857233|82931958|FG000|Overall Study|Non-compliance|1|||
46715980|NCT00857233|82931958|FG000|Overall Study|Withdrawal of Consent|9|||
46715981|NCT00857233|82931958|FG000|Overall Study|Lost to Follow-up|4|||
46715982|NCT00857233|82931958|FG000|Overall Study|Nursing Home Placement|14|||
46715983|NCT00857233|82931958|FG000|Overall Study|Other Reasons|2|||
46715984|NCT00856999|82931962|FG000|Overall Study|Withdrawal by Subject|5|||
46715985|NCT01071252|82931972|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
46715986|NCT01071252|82931973|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
46715987|NCT01071252|82931974|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
46715988|NCT01071252|82931975|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
46715989|NCT01071252|82931976|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
46715990|NCT01071252|82931972|FG000|Overall Study|Withdrawal by Subject|8|||
46715991|NCT01071252|82931973|FG001|Overall Study|Withdrawal by Subject|2|||
46715992|NCT01071252|82931974|FG002|Overall Study|Withdrawal by Subject|1|||
46715993|NCT01071252|82931975|FG003|Overall Study|Withdrawal by Subject|2|||
46715994|NCT01071252|82931976|FG004|Overall Study|Withdrawal by Subject|3|||
46715995|NCT01071252|82931972|FG000|Overall Study|administrative problems|1|||
46715996|NCT01071252|82931973|FG001|Overall Study|administrative problems|1|||
46715997|NCT01071252|82931974|FG002|Overall Study|administrative problems|0|||
46715998|NCT01071252|82931975|FG003|Overall Study|administrative problems|2|||
46715999|NCT01071252|82931976|FG004|Overall Study|administrative problems|1|||
46716000|NCT01071252|82931972|FG000|Overall Study|Lost to Follow-up|1|||
46716001|NCT01071252|82931973|FG001|Overall Study|Lost to Follow-up|0|||
46716002|NCT01071252|82931974|FG002|Overall Study|Lost to Follow-up|1|||
46716003|NCT01071252|82931975|FG003|Overall Study|Lost to Follow-up|2|||
46716004|NCT01071252|82931976|FG004|Overall Study|Lost to Follow-up|0|||
46716005|NCT01071252|82931972|FG000|Overall Study|Adverse Event|1|||
46716006|NCT01071252|82931973|FG001|Overall Study|Adverse Event|1|||
46716007|NCT01071252|82931974|FG002|Overall Study|Adverse Event|0|||
46716008|NCT01071252|82931975|FG003|Overall Study|Adverse Event|1|||
46716009|NCT01071252|82931976|FG004|Overall Study|Adverse Event|0|||
46716010|NCT01071252|82931972|FG000|Overall Study|Death|0|||
46716011|NCT01071252|82931973|FG001|Overall Study|Death|0|||
46716012|NCT01071252|82931974|FG002|Overall Study|Death|0|||
46716013|NCT01071252|82931975|FG003|Overall Study|Death|0|||
46716014|NCT01071252|82931976|FG004|Overall Study|Death|1|||
46716015|NCT00856843|82931990|FG000|Overall Study|Withdrawal by Subject|1|||
46716016|NCT00856843|82931991|FG001|Overall Study|Withdrawal by Subject|5|||
46716017|NCT00856843|82931990|FG000|Overall Study|Lack of Efficacy|1|||
46716018|NCT00856843|82931991|FG001|Overall Study|Lack of Efficacy|0|||
46716019|NCT00856609|82931999|FG000|Overall Study|Adverse Event|1|||
46716020|NCT00856609|82932000|FG001|Overall Study|Adverse Event|0|||
46716021|NCT01071096|82932006|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
46716022|NCT01071096|82932007|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
46716023|NCT00856375|82932026|FG000|Overall Study|Other|0|||
47039166|NCT02028884|83292085|FG001|Double-blind Period|Eligibility Violation|0|||
46716024|NCT00856375|82932027|FG001|Overall Study|Other|1|||
46716025|NCT00856375|82932026|FG000|Overall Study|Death|32|||
46716026|NCT00856375|82932027|FG001|Overall Study|Death|30|||
46716027|NCT00856375|82932026|FG000|Overall Study|Sponsor Terminated Study|7|||
46716028|NCT00856375|82932027|FG001|Overall Study|Sponsor Terminated Study|7|||
46914535|NCT02972502|83145044|FG000|Overall Study|Withdrawal by Subject|1|||
47039167|NCT02028884|83292086|FG002|Double-blind Period|Eligibility Violation|0|||
46716029|NCT00856375|82932026|FG000|Overall Study|Withdrawal by Subject|2|||
46716030|NCT00856375|82932027|FG001|Overall Study|Withdrawal by Subject|1|||
46716031|NCT00856375|82932026|FG000|Overall Study|Lost to Follow-up|1|||
46716032|NCT00856375|82932027|FG001|Overall Study|Lost to Follow-up|2|||
46716033|NCT01070784|82932035|FG000|Overall Study|Withdrawal by Subject|6|||
46716034|NCT01070784|82932036|FG001|Overall Study|Withdrawal by Subject|9|||
46716035|NCT01070784|82932035|FG000|Overall Study|Adverse Event|14|||
46716036|NCT01070784|82932036|FG001|Overall Study|Adverse Event|9|||
46716037|NCT00837577|82932044|FG000|Double-blind Period|Clinical Adverse Event|1|||
46716038|NCT00837577|82932045|FG001|Double-blind Period|Clinical Adverse Event|0|||
46716039|NCT00837577|82932044|FG000|Double-blind Period|Withdrawal by Subject|1|||
46716040|NCT00837577|82932045|FG001|Double-blind Period|Withdrawal by Subject|0|||
46716041|NCT00837577|82932044|FG000|Open-label Period|Clinical Adverse Event|2|||
46716042|NCT00837577|82932045|FG001|Open-label Period|Clinical Adverse Event|2|||
46716043|NCT00837577|82932044|FG000|Open-label Period|Laboratory Adverse Event|0|||
46716044|NCT00837577|82932045|FG001|Open-label Period|Laboratory Adverse Event|1|||
46716045|NCT00837577|82932044|FG000|Open-label Period|Lack of Efficacy|4|||
46716046|NCT00837577|82932045|FG001|Open-label Period|Lack of Efficacy|3|||
46716047|NCT00837577|82932044|FG000|Open-label Period|Withdrawal by Subject|1|||
46716048|NCT00837577|82932045|FG001|Open-label Period|Withdrawal by Subject|2|||
46716049|NCT00837577|82932044|FG000|Open-label Period|Other Reason|1|||
46716050|NCT00837577|82932045|FG001|Open-label Period|Other Reason|1|||
46716051|NCT01070550|82932058|FG000|Overall Study|Adverse Event|43|||
46716052|NCT01070550|82932059|FG001|Overall Study|Adverse Event|1|||
46716053|NCT01070550|82932060|FG002|Overall Study|Adverse Event|3|||
46716054|NCT01070550|82932061|FG003|Overall Study|Adverse Event|0|||
46716055|NCT01070550|82932062|FG004|Overall Study|Adverse Event|0|||
46716056|NCT01070550|82932063|FG005|Overall Study|Adverse Event|0|||
46716057|NCT01070550|82932058|FG000|Overall Study|Death|20|||
46716058|NCT01070550|82932059|FG001|Overall Study|Death|4|||
46716059|NCT01070550|82932060|FG002|Overall Study|Death|3|||
46716060|NCT01070550|82932061|FG003|Overall Study|Death|0|||
46716061|NCT01070550|82932062|FG004|Overall Study|Death|0|||
46716062|NCT01070550|82932063|FG005|Overall Study|Death|0|||
46716063|NCT01070550|82932058|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
46716064|NCT01070550|82932059|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
46716065|NCT01070550|82932060|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
46716066|NCT01070550|82932061|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
46716067|NCT01070550|82932062|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
46716068|NCT01070550|82932063|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
46716069|NCT01070550|82932058|FG000|Overall Study|Early termination|3|||
46716070|NCT01070550|82932059|FG001|Overall Study|Early termination|0|||
46716071|NCT01070550|82932060|FG002|Overall Study|Early termination|0|||
46716072|NCT01070550|82932061|FG003|Overall Study|Early termination|0|||
46716073|NCT01070550|82932062|FG004|Overall Study|Early termination|0|||
46716074|NCT01070550|82932063|FG005|Overall Study|Early termination|0|||
46716075|NCT01070550|82932058|FG000|Overall Study|Failed to return|450|||
46716076|NCT01070550|82932059|FG001|Overall Study|Failed to return|33|||
46716077|NCT01070550|82932060|FG002|Overall Study|Failed to return|144|||
46716078|NCT01070550|82932061|FG003|Overall Study|Failed to return|40|||
46716079|NCT01070550|82932062|FG004|Overall Study|Failed to return|1|||
46716080|NCT01070550|82932063|FG005|Overall Study|Failed to return|2|||
46716081|NCT01070550|82932058|FG000|Overall Study|Incomplete treatment|2|||
46716082|NCT01070550|82932059|FG001|Overall Study|Incomplete treatment|0|||
46716083|NCT01070550|82932060|FG002|Overall Study|Incomplete treatment|0|||
46716084|NCT01070550|82932061|FG003|Overall Study|Incomplete treatment|0|||
46716085|NCT01070550|82932062|FG004|Overall Study|Incomplete treatment|0|||
46716086|NCT01070550|82932063|FG005|Overall Study|Incomplete treatment|0|||
46716087|NCT01070550|82932058|FG000|Overall Study|Lab test not done|22|||
46716088|NCT01070550|82932059|FG001|Overall Study|Lab test not done|3|||
46716089|NCT01070550|82932060|FG002|Overall Study|Lab test not done|4|||
46716090|NCT01070550|82932061|FG003|Overall Study|Lab test not done|1|||
46716091|NCT01070550|82932062|FG004|Overall Study|Lab test not done|0|||
46716092|NCT01070550|82932063|FG005|Overall Study|Lab test not done|1|||
46716093|NCT01070550|82932058|FG000|Overall Study|Lack of Efficacy|65|||
47039168|NCT02028884|83292084|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
47039169|NCT02028884|83292085|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
47039170|NCT02028884|83292086|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
47039171|NCT02028884|83292084|FG000|Double-blind Period|Withdrawal by Subject|2|||
46716094|NCT01070550|82932059|FG001|Overall Study|Lack of Efficacy|1|||
46716095|NCT01070550|82932060|FG002|Overall Study|Lack of Efficacy|5|||
46716096|NCT01070550|82932061|FG003|Overall Study|Lack of Efficacy|5|||
46716097|NCT01070550|82932062|FG004|Overall Study|Lack of Efficacy|0|||
46716098|NCT01070550|82932063|FG005|Overall Study|Lack of Efficacy|1|||
46716099|NCT01070550|82932058|FG000|Overall Study|Miscellaneous|12|||
46716100|NCT01070550|82932059|FG001|Overall Study|Miscellaneous|2|||
46716101|NCT01070550|82932060|FG002|Overall Study|Miscellaneous|3|||
47039172|NCT02028884|83292085|FG001|Double-blind Period|Withdrawal by Subject|0|||
46716102|NCT01070550|82932061|FG003|Overall Study|Miscellaneous|1|||
46716103|NCT01070550|82932062|FG004|Overall Study|Miscellaneous|0|||
46716104|NCT01070550|82932063|FG005|Overall Study|Miscellaneous|0|||
46716105|NCT01070550|82932058|FG000|Overall Study|New treatment started|3|||
46716106|NCT01070550|82932059|FG001|Overall Study|New treatment started|1|||
47039173|NCT02028884|83292086|FG002|Double-blind Period|Withdrawal by Subject|0|||
47039174|NCT02028884|83292084|FG000|Open-label Extension Period|Adverse Event|3|||
47039175|NCT02028884|83292085|FG001|Open-label Extension Period|Adverse Event|1|||
47039176|NCT02028884|83292086|FG002|Open-label Extension Period|Adverse Event|0|||
46716107|NCT01070550|82932060|FG002|Overall Study|New treatment started|0|||
46716108|NCT01070550|82932061|FG003|Overall Study|New treatment started|2|||
46716109|NCT01070550|82932062|FG004|Overall Study|New treatment started|0|||
46716110|NCT01070550|82932063|FG005|Overall Study|New treatment started|0|||
46716111|NCT01070550|82932058|FG000|Overall Study|Non-responders|493|||
46716112|NCT01070550|82932059|FG001|Overall Study|Non-responders|4|||
46716113|NCT01070550|82932060|FG002|Overall Study|Non-responders|21|||
46716114|NCT01070550|82932061|FG003|Overall Study|Non-responders|20|||
46716115|NCT01070550|82932062|FG004|Overall Study|Non-responders|0|||
46716116|NCT01070550|82932063|FG005|Overall Study|Non-responders|2|||
46716117|NCT01070550|82932058|FG000|Overall Study|Not categorized|33|||
46716118|NCT01070550|82932059|FG001|Overall Study|Not categorized|2|||
46716119|NCT01070550|82932060|FG002|Overall Study|Not categorized|6|||
46716120|NCT01070550|82932061|FG003|Overall Study|Not categorized|1|||
46716121|NCT01070550|82932062|FG004|Overall Study|Not categorized|0|||
46716122|NCT01070550|82932063|FG005|Overall Study|Not categorized|1|||
46716123|NCT01070550|82932058|FG000|Overall Study|Protocol Violation|15|||
46716124|NCT01070550|82932059|FG001|Overall Study|Protocol Violation|1|||
46716125|NCT01070550|82932060|FG002|Overall Study|Protocol Violation|1|||
46716126|NCT01070550|82932061|FG003|Overall Study|Protocol Violation|1|||
46716127|NCT01070550|82932062|FG004|Overall Study|Protocol Violation|0|||
46716128|NCT01070550|82932063|FG005|Overall Study|Protocol Violation|0|||
46716129|NCT01070550|82932058|FG000|Overall Study|Relapse|44|||
46716130|NCT01070550|82932059|FG001|Overall Study|Relapse|5|||
46716131|NCT01070550|82932060|FG002|Overall Study|Relapse|14|||
46716132|NCT01070550|82932061|FG003|Overall Study|Relapse|4|||
46716133|NCT01070550|82932062|FG004|Overall Study|Relapse|0|||
46716134|NCT01070550|82932063|FG005|Overall Study|Relapse|0|||
46716135|NCT01070550|82932058|FG000|Overall Study|Result not available|3|||
46716136|NCT01070550|82932059|FG001|Overall Study|Result not available|1|||
46716137|NCT01070550|82932060|FG002|Overall Study|Result not available|3|||
46716138|NCT01070550|82932061|FG003|Overall Study|Result not available|0|||
46716139|NCT01070550|82932062|FG004|Overall Study|Result not available|0|||
46716140|NCT01070550|82932063|FG005|Overall Study|Result not available|0|||
46716141|NCT01070550|82932058|FG000|Overall Study|Screen failure|1|||
46716142|NCT01070550|82932059|FG001|Overall Study|Screen failure|0|||
46716143|NCT01070550|82932060|FG002|Overall Study|Screen failure|0|||
46716144|NCT01070550|82932061|FG003|Overall Study|Screen failure|0|||
46716145|NCT01070550|82932062|FG004|Overall Study|Screen failure|0|||
46716146|NCT01070550|82932063|FG005|Overall Study|Screen failure|0|||
46716147|NCT01070550|82932058|FG000|Overall Study|Sponsor decision|1|||
46716148|NCT01070550|82932059|FG001|Overall Study|Sponsor decision|0|||
46716149|NCT01070550|82932060|FG002|Overall Study|Sponsor decision|0|||
46716150|NCT01070550|82932061|FG003|Overall Study|Sponsor decision|0|||
46716151|NCT01070550|82932062|FG004|Overall Study|Sponsor decision|0|||
46716152|NCT01070550|82932063|FG005|Overall Study|Sponsor decision|0|||
46716153|NCT01070550|82932058|FG000|Overall Study|Treatment duration shortened|1|||
46716154|NCT01070550|82932059|FG001|Overall Study|Treatment duration shortened|0|||
46716155|NCT01070550|82932060|FG002|Overall Study|Treatment duration shortened|0|||
46716156|NCT01070550|82932061|FG003|Overall Study|Treatment duration shortened|0|||
46716157|NCT01070550|82932062|FG004|Overall Study|Treatment duration shortened|0|||
46716158|NCT01070550|82932063|FG005|Overall Study|Treatment duration shortened|0|||
46716159|NCT01070550|82932058|FG000|Overall Study|Treatment interrupted|7|||
46716160|NCT01070550|82932059|FG001|Overall Study|Treatment interrupted|0|||
46716161|NCT01070550|82932060|FG002|Overall Study|Treatment interrupted|1|||
46716162|NCT01070550|82932061|FG003|Overall Study|Treatment interrupted|1|||
46716163|NCT01070550|82932062|FG004|Overall Study|Treatment interrupted|0|||
46716164|NCT01070550|82932063|FG005|Overall Study|Treatment interrupted|0|||
46716165|NCT01070550|82932058|FG000|Overall Study|Treatment not started|14|||
46716166|NCT01070550|82932059|FG001|Overall Study|Treatment not started|2|||
46716167|NCT01070550|82932060|FG002|Overall Study|Treatment not started|4|||
46716168|NCT01070550|82932061|FG003|Overall Study|Treatment not started|0|||
47039177|NCT02028884|83292084|FG000|Open-label Extension Period|Lack of Efficacy|3|||
47039178|NCT02028884|83292085|FG001|Open-label Extension Period|Lack of Efficacy|0|||
46716169|NCT01070550|82932062|FG004|Overall Study|Treatment not started|0|||
46716170|NCT01070550|82932063|FG005|Overall Study|Treatment not started|0|||
46716171|NCT01070550|82932058|FG000|Overall Study|Treatment restarted|0|||
46716172|NCT01070550|82932059|FG001|Overall Study|Treatment restarted|1|||
46716173|NCT01070550|82932060|FG002|Overall Study|Treatment restarted|0|||
46716174|NCT01070550|82932061|FG003|Overall Study|Treatment restarted|0|||
46716175|NCT01070550|82932062|FG004|Overall Study|Treatment restarted|0|||
46716176|NCT01070550|82932063|FG005|Overall Study|Treatment restarted|0|||
46716177|NCT01070550|82932058|FG000|Overall Study|Treatment stopped|3|||
47039179|NCT02028884|83292086|FG002|Open-label Extension Period|Lack of Efficacy|0|||
46716178|NCT01070550|82932059|FG001|Overall Study|Treatment stopped|0|||
46716179|NCT01070550|82932060|FG002|Overall Study|Treatment stopped|0|||
46716180|NCT01070550|82932061|FG003|Overall Study|Treatment stopped|0|||
46716181|NCT01070550|82932062|FG004|Overall Study|Treatment stopped|0|||
46716182|NCT01070550|82932063|FG005|Overall Study|Treatment stopped|0|||
46716183|NCT01070550|82932058|FG000|Overall Study|Treatment unavailable|1|||
46716184|NCT01070550|82932059|FG001|Overall Study|Treatment unavailable|0|||
46716185|NCT01070550|82932060|FG002|Overall Study|Treatment unavailable|0|||
46716186|NCT01070550|82932061|FG003|Overall Study|Treatment unavailable|0|||
46716187|NCT01070550|82932062|FG004|Overall Study|Treatment unavailable|0|||
46716188|NCT01070550|82932063|FG005|Overall Study|Treatment unavailable|0|||
46716189|NCT01070550|82932058|FG000|Overall Study|Treatment was stopped early|7|||
46716190|NCT01070550|82932059|FG001|Overall Study|Treatment was stopped early|0|||
46716191|NCT01070550|82932060|FG002|Overall Study|Treatment was stopped early|0|||
46716192|NCT01070550|82932061|FG003|Overall Study|Treatment was stopped early|0|||
46716193|NCT01070550|82932062|FG004|Overall Study|Treatment was stopped early|0|||
46716194|NCT01070550|82932063|FG005|Overall Study|Treatment was stopped early|0|||
46716195|NCT01070550|82932058|FG000|Overall Study|Other|5|||
46716196|NCT01070550|82932059|FG001|Overall Study|Other|0|||
46716197|NCT01070550|82932060|FG002|Overall Study|Other|0|||
46716198|NCT01070550|82932061|FG003|Overall Study|Other|1|||
46716199|NCT01070550|82932062|FG004|Overall Study|Other|0|||
46716200|NCT01070550|82932063|FG005|Overall Study|Other|0|||
46716201|NCT01070550|82932058|FG000|Overall Study|Withdrawal by Subject|35|||
46716202|NCT01070550|82932059|FG001|Overall Study|Withdrawal by Subject|0|||
46716203|NCT01070550|82932060|FG002|Overall Study|Withdrawal by Subject|3|||
46716204|NCT01070550|82932061|FG003|Overall Study|Withdrawal by Subject|0|||
46716205|NCT01070550|82932062|FG004|Overall Study|Withdrawal by Subject|0|||
46716206|NCT01070550|82932063|FG005|Overall Study|Withdrawal by Subject|0|||
46716207|NCT00848107|82932078|FG000|Overall Study|Lost to Follow-up|2|||
46716208|NCT00848107|82932078|FG000|Overall Study|Withdrawal by Subject|8|||
46716209|NCT00848107|82932078|FG000|Overall Study|Adverse Event|9|||
46716210|NCT00848107|82932078|FG000|Overall Study|Death|1|||
46716211|NCT00848107|82932078|FG000|Overall Study|Pregnancy|1|||
46716212|NCT00856297|82932087|FG000|Overall Study|Unable to classify|2|||
46716213|NCT00856297|82932088|FG001|Overall Study|Unable to classify|0|||
47039180|NCT02028884|83292084|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
47039181|NCT02028884|83292085|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
47039182|NCT02028884|83292086|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
47039183|NCT02028884|83292084|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
47039184|NCT02028884|83292085|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
47039185|NCT02028884|83292086|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
47039186|NCT02028884|83292084|FG000|Open-label Extension Period|Switched to another treatment option|3|||
47039187|NCT02028884|83292085|FG001|Open-label Extension Period|Switched to another treatment option|0|||
47039188|NCT02028884|83292086|FG002|Open-label Extension Period|Switched to another treatment option|0|||
47039189|NCT01422187|83292139|FG000|Overall Study|Personal reason|1|||
47039190|NCT01422187|83292140|FG001|Overall Study|Personal reason|0|||
47039191|NCT01422187|83292141|FG002|Overall Study|Personal reason|0|||
46631265|NCT01879722|82804319|FG008|Overall Study|Voluntary Withdrawal|1|||
46631266|NCT01879722|82804320|FG009|Overall Study|Voluntary Withdrawal|0|||
46631267|NCT01879410|82804347|FG000|Overall Study|Adverse Event|9|||
46631268|NCT01879410|82804348|FG001|Overall Study|Adverse Event|14|||
46631269|NCT01879410|82804347|FG000|Overall Study|Lack of Efficacy|4|||
46631270|NCT01879410|82804348|FG001|Overall Study|Lack of Efficacy|6|||
46631271|NCT01879410|82804347|FG000|Overall Study|Protocol Violation|1|||
46631272|NCT01879410|82804348|FG001|Overall Study|Protocol Violation|7|||
46631273|NCT01879410|82804347|FG000|Overall Study|Lost to Follow-up|2|||
46631274|NCT01879410|82804348|FG001|Overall Study|Lost to Follow-up|1|||
46631275|NCT01879410|82804347|FG000|Overall Study|Withdrawal by Subject|7|||
46716214|NCT00856297|82932089|FG002|Overall Study|Unable to classify|0|||
46716215|NCT00856297|82932090|FG003|Overall Study|Unable to classify|0|||
46716216|NCT00856297|82932091|FG004|Overall Study|Unable to classify|0|||
46716217|NCT01046136|82932110|FG000|Overall Study|Withdrawal by Subject|0|||
46716218|NCT01046136|82932111|FG001|Overall Study|Withdrawal by Subject|4|||
46716219|NCT01046136|82932110|FG000|Overall Study|Physician Decision|1|||
46716220|NCT01046136|82932111|FG001|Overall Study|Physician Decision|1|||
47039192|NCT01422187|83292139|FG000|Overall Study|Lost to Follow-up|0|||
46631276|NCT01879410|82804348|FG001|Overall Study|Withdrawal by Subject|8|||
46716221|NCT01046136|82932110|FG000|Overall Study|Lost to Follow-up|3|||
46716222|NCT01046136|82932111|FG001|Overall Study|Lost to Follow-up|3|||
46716223|NCT01070394|82932119|FG000|Overall Study|Adverse Event|6|||
46716224|NCT01070394|82932119|FG000|Overall Study|Withdrawal by Subject|1|||
46716225|NCT00836953|82932125|FG000|Overall Study|Withdrawal by Subject|1|||
46716226|NCT00836953|82932125|FG000|Overall Study|Lost to Follow-up|1|||
46716227|NCT01070316|82932129|FG000|Extension Phase|Lack of Efficacy|3|||
46716228|NCT01070316|82932129|FG000|Extension Phase|Withdrawal by Subject|1|||
46716229|NCT01126541|82932136|FG000|Overall Study|Adverse Event|0|||
46716230|NCT01126541|82932137|FG001|Overall Study|Adverse Event|2|||
46716231|NCT01126541|82932138|FG002|Overall Study|Adverse Event|4|||
46716232|NCT01126541|82932136|FG000|Overall Study|Death|0|||
46716233|NCT01126541|82932137|FG001|Overall Study|Death|1|||
46716234|NCT01126541|82932138|FG002|Overall Study|Death|0|||
46716235|NCT01126541|82932136|FG000|Overall Study|Lack of Efficacy|6|||
46716236|NCT01126541|82932137|FG001|Overall Study|Lack of Efficacy|1|||
46716237|NCT01126541|82932138|FG002|Overall Study|Lack of Efficacy|11|||
46716238|NCT01126541|82932136|FG000|Overall Study|Lost to Follow-up|1|||
46716239|NCT01126541|82932137|FG001|Overall Study|Lost to Follow-up|2|||
46716240|NCT01126541|82932138|FG002|Overall Study|Lost to Follow-up|2|||
46716241|NCT01126541|82932136|FG000|Overall Study|Withdrawal by Subject|2|||
46716242|NCT01126541|82932137|FG001|Overall Study|Withdrawal by Subject|5|||
46716243|NCT01126541|82932138|FG002|Overall Study|Withdrawal by Subject|6|||
46716244|NCT01126541|82932136|FG000|Overall Study|Protocol Violation|0|||
46716245|NCT01126541|82932137|FG001|Overall Study|Protocol Violation|0|||
46716246|NCT01126541|82932138|FG002|Overall Study|Protocol Violation|1|||
46716247|NCT01126541|82932136|FG000|Overall Study|Administrative reason or other|1|||
46716248|NCT01126541|82932137|FG001|Overall Study|Administrative reason or other|1|||
46716249|NCT01126541|82932138|FG002|Overall Study|Administrative reason or other|2|||
46716250|NCT00836875|82932150|FG000|Overall Study|Death|3|||
46716251|NCT00836875|82932151|FG001|Overall Study|Death|2|||
46716252|NCT00836875|82932150|FG000|Overall Study|Withdrawal by Subject|0|||
46716253|NCT00836875|82932151|FG001|Overall Study|Withdrawal by Subject|1|||
46716254|NCT01125917|82932157|FG000|Overall Study|Adverse Event|43|||
46716255|NCT01125917|82932157|FG000|Overall Study|Lost to Follow-up|23|||
46716256|NCT01125917|82932157|FG000|Overall Study|Withdrawal by Subject|31|||
46716257|NCT01125917|82932157|FG000|Overall Study|Administrative|223|||
46716258|NCT01125917|82932157|FG000|Overall Study|Lack of Efficacy|19|||
46716259|NCT00847561|82932163|FG000|Overall Study|Withdrawal by Subject|4|||
46716260|NCT00847561|82932164|FG001|Overall Study|Withdrawal by Subject|3|||
46716261|NCT00847561|82932163|FG000|Overall Study|Unable to schedule|9|||
46716262|NCT00847561|82932164|FG001|Overall Study|Unable to schedule|1|||
46716263|NCT01121549|82932170|FG000|Overall Study|Adverse Event|10|||
46716264|NCT01121549|82932170|FG000|Overall Study|Lack of Efficacy|11|||
46716265|NCT01121549|82932170|FG000|Overall Study|Lost to Follow-up|12|||
46716266|NCT01121549|82932170|FG000|Overall Study|Did not meet entrance criteria|9|||
46716267|NCT01121549|82932170|FG000|Overall Study|Study terminated by sponsor|197|||
46716268|NCT01121549|82932170|FG000|Overall Study|Pregnancy|1|||
46716269|NCT01121549|82932170|FG000|Overall Study|Protocol Violation|33|||
46716270|NCT01121549|82932170|FG000|Overall Study|Withdrawal by Subject|16|||
47039193|NCT01422187|83292140|FG001|Overall Study|Lost to Follow-up|1|||
46716271|NCT01121549|82932170|FG000|Overall Study|Other|58|||
46716272|NCT00847405|82932176|FG000|First Intervention|Adverse Event|0|||
46716273|NCT00847405|82932177|FG001|First Intervention|Adverse Event|1|||
46716274|NCT00847405|82932176|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
46716275|NCT00847405|82932177|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
47039194|NCT01422187|83292141|FG002|Overall Study|Lost to Follow-up|0|||
47039195|NCT00472212|83292151|FG000|Overall Study|Lost to Follow-up|6|||
47039196|NCT00472212|83292152|FG001|Overall Study|Lost to Follow-up|4|||
47039197|NCT00139477|83292160|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
47039198|NCT00139477|83292161|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
47039199|NCT00139477|83292160|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
47039200|NCT00139477|83292161|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
47039201|NCT00139477|83292160|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
47039202|NCT00139477|83292161|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
46716276|NCT00836095|82932183|FG000|Overall Study|Physician Decision|0|||
46716277|NCT00836095|82932184|FG001|Overall Study|Physician Decision|3|||
46716278|NCT00835237|82932201|FG000|Overall Study|Lost to Follow-up|4|||
46716279|NCT00835237|82932202|FG001|Overall Study|Lost to Follow-up|0|||
46716280|NCT00835237|82932201|FG000|Overall Study|Withdrawal by Subject|2|||
46716281|NCT00835237|82932202|FG001|Overall Study|Withdrawal by Subject|0|||
46716282|NCT01072500|82932210|FG000|Overall Study|Death|2|||
46716283|NCT01072500|82932211|FG001|Overall Study|Death|2|||
46716284|NCT01072500|82932210|FG000|Overall Study|Lost to Follow-up|5|||
47039203|NCT00139477|83292160|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
47039204|NCT00139477|83292161|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
46716285|NCT01072500|82932211|FG001|Overall Study|Lost to Follow-up|2|||
46716286|NCT01072500|82932210|FG000|Overall Study|Withdrawal by Subject|17|||
47039205|NCT00139477|83292160|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
46716287|NCT01072500|82932211|FG001|Overall Study|Withdrawal by Subject|10|||
46716288|NCT00847015|82932219|FG000|Overall Study|Withdrawal by Subject|1|||
46716289|NCT00847015|82932219|FG000|Overall Study|declined any surgery|1|||
46716290|NCT00847015|82932219|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
46716291|NCT00855595|82932225|FG000|Overall Study|Withdrawal by Subject|1|||
46716292|NCT00855595|82932226|FG001|Overall Study|Withdrawal by Subject|2|||
46716293|NCT00855595|82932225|FG000|Overall Study|Lost to Follow-up|3|||
46716294|NCT00855595|82932226|FG001|Overall Study|Lost to Follow-up|3|||
46716295|NCT00855595|82932225|FG000|Overall Study|Adverse Event|1|||
46914536|NCT02972502|83145045|FG001|Overall Study|Withdrawal by Subject|1|||
46914537|NCT02971800|83145051|FG000|Overall Study|Protocol Violation|1|||
46914538|NCT02971800|83145051|FG000|Overall Study|Withdrawal by Subject|1|||
46914539|NCT02971800|83145051|FG000|Overall Study|Exclusion criteria prior intervention|1|||
46914540|NCT02971800|83145051|FG000|Overall Study|Number evaluable participant already reached|4|||
46914541|NCT03163667|83145057|FG000|Overall Study|Death|15|||
46914542|NCT03163667|83145058|FG001|Overall Study|Death|27|||
46914543|NCT03163667|83145057|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
46914544|NCT03163667|83145058|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
46914545|NCT03167411|83145066|FG000|Overall Study|Adverse Event|0|||
46914546|NCT03167411|83145067|FG001|Overall Study|Adverse Event|1|||
46914547|NCT01952847|83145077|FG000|Overall Study|Ineligible|1|||
46914548|NCT01952847|83145078|FG001|Overall Study|Ineligible|0|||
46914549|NCT01952847|83145079|FG002|Overall Study|Ineligible|0|||
46914550|NCT01952847|83145080|FG003|Overall Study|Ineligible|0|||
46914551|NCT01952847|83145077|FG000|Overall Study|Lack of Insurance Coverage|0|||
46914552|NCT01952847|83145078|FG001|Overall Study|Lack of Insurance Coverage|1|||
46914553|NCT01952847|83145079|FG002|Overall Study|Lack of Insurance Coverage|0|||
46914554|NCT01952847|83145080|FG003|Overall Study|Lack of Insurance Coverage|0|||
46914555|NCT01952847|83145077|FG000|Overall Study|Withdrawal by Subject|1|||
46914556|NCT01952847|83145078|FG001|Overall Study|Withdrawal by Subject|1|||
46914557|NCT01952847|83145079|FG002|Overall Study|Withdrawal by Subject|0|||
46914558|NCT01952847|83145080|FG003|Overall Study|Withdrawal by Subject|1|||
46914559|NCT01560585|83145092|FG000|Overall Study|Physician Decision|3|||
46914560|NCT03075501|83145099|FG000|Overall Study|Scheduling difficulties|15|||
46914561|NCT03075501|83145100|FG001|Overall Study|Scheduling difficulties|9|||
46914562|NCT02317991|83145107|FG000|Overall Study|Adverse Event|12|||
46914563|NCT02317991|83145107|FG000|Overall Study|Death|4|||
46914564|NCT02317991|83145107|FG000|Overall Study|Withdrawal by Subject|8|||
46914565|NCT02317991|83145107|FG000|Overall Study|Progressive Disease|41|||
46914566|NCT03075267|83145114|FG000|Overall Study|Protocol Violation|1|||
46914567|NCT03075267|83145115|FG001|Overall Study|Protocol Violation|0|||
46914568|NCT03075267|83145116|FG002|Overall Study|Protocol Violation|0|||
46914569|NCT03074331|83145124|FG000|Overall Study|Enrolled but Not Treated|1|||
46914570|NCT03074331|83145124|FG000|Overall Study|Lost to Follow-up|5|||
46914571|NCT03074331|83145124|FG000|Overall Study|Withdrew Consent|1|||
46914572|NCT02260193|83145131|FG000|Overall Study|Lack of Efficacy|0|||
46914573|NCT02260193|83145132|FG001|Overall Study|Lack of Efficacy|1|||
46716296|NCT00855595|82932226|FG001|Overall Study|Adverse Event|1|||
46716297|NCT00855595|82932225|FG000|Overall Study|patient moved out of state|1|||
46716298|NCT00855595|82932226|FG001|Overall Study|patient moved out of state|0|||
46716299|NCT00855595|82932225|FG000|Overall Study|patient left country|0|||
46716300|NCT00855595|82932226|FG001|Overall Study|patient left country|1|||
46716301|NCT00855439|82932234|FG000|Overall Study|Withdrawal by Subject|2|||
46716302|NCT00855439|82932235|FG001|Overall Study|Withdrawal by Subject|0|||
46716303|NCT00855439|82932234|FG000|Overall Study|Pregnancy|1|||
46716304|NCT00855439|82932235|FG001|Overall Study|Pregnancy|0|||
46716305|NCT01064856|82932243|FG000|Double-blind (DB) Period|Adverse Event|1|||
46716306|NCT01064856|82932244|FG001|Double-blind (DB) Period|Adverse Event|0|||
46716307|NCT01064856|82932245|FG002|Double-blind (DB) Period|Adverse Event|0|||
46716308|NCT01064856|82932246|FG003|Double-blind (DB) Period|Adverse Event|0|||
46716309|NCT01064856|82932243|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
46716310|NCT01064856|82932244|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
46716311|NCT01064856|82932245|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
46716312|NCT01064856|82932246|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
46914574|NCT02260193|83145133|FG002|Overall Study|Lack of Efficacy|6|||
46914575|NCT02260193|83145131|FG000|Overall Study|Adverse Event|3|||
46914576|NCT02260193|83145132|FG001|Overall Study|Adverse Event|4|||
46716313|NCT01064856|82932243|FG000|Open-label (OL) Period|Adverse Event|0|||
46716314|NCT01064856|82932244|FG001|Open-label (OL) Period|Adverse Event|0|||
46716315|NCT01064856|82932245|FG002|Open-label (OL) Period|Adverse Event|12|||
46716316|NCT01064856|82932246|FG003|Open-label (OL) Period|Adverse Event|6|||
46914577|NCT02260193|83145133|FG002|Overall Study|Adverse Event|1|||
47039206|NCT00139477|83292161|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
47039207|NCT00139477|83292160|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
46716317|NCT01064856|82932243|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
46716318|NCT01064856|82932244|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
46914578|NCT02260193|83145131|FG000|Overall Study|Protocol Violation|0|||
46914579|NCT02260193|83145132|FG001|Overall Study|Protocol Violation|4|||
46914580|NCT02260193|83145133|FG002|Overall Study|Protocol Violation|0|||
46716319|NCT01064856|82932245|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
46914581|NCT02260193|83145131|FG000|Overall Study|Withdrawal by Subject|3|||
46716320|NCT01064856|82932246|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
46716321|NCT01064856|82932243|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
46716322|NCT01064856|82932244|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
46716323|NCT01064856|82932245|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
46716324|NCT01064856|82932246|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
46716325|NCT01064856|82932243|FG000|Open-label (OL) Period|Other|0|||
46716326|NCT01064856|82932244|FG001|Open-label (OL) Period|Other|0|||
46716327|NCT01064856|82932245|FG002|Open-label (OL) Period|Other|7|||
46716328|NCT01064856|82932246|FG003|Open-label (OL) Period|Other|7|||
46716329|NCT00846391|82932256|FG000|Overall Study|Physician Decision|0|||
46716330|NCT00846391|82932257|FG001|Overall Study|Physician Decision|0|||
46716331|NCT00846391|82932258|FG002|Overall Study|Physician Decision|1|||
46716332|NCT00846391|82932256|FG000|Overall Study|Study Terminated by Sponsor|1|||
46716333|NCT00846391|82932257|FG001|Overall Study|Study Terminated by Sponsor|2|||
46716334|NCT00846391|82932258|FG002|Overall Study|Study Terminated by Sponsor|2|||
46716335|NCT01042392|82932268|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
46716336|NCT01042392|82932269|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
46716337|NCT01042392|82932270|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
46716338|NCT01042392|82932271|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
46716339|NCT01042392|82932268|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
46716340|NCT01042392|82932269|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
46716341|NCT01042392|82932270|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
46716342|NCT01042392|82932271|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
46716343|NCT01042392|82932268|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
46716344|NCT01042392|82932269|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
46716345|NCT01042392|82932270|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
46716346|NCT01042392|82932271|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
46716347|NCT01042392|82932268|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
46716348|NCT01042392|82932269|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
46716349|NCT01042392|82932270|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
46716350|NCT01042392|82932271|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
46716351|NCT01042392|82932268|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
46716352|NCT01042392|82932269|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
46716353|NCT01042392|82932270|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
46716354|NCT01042392|82932271|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
46716355|NCT01042392|82932268|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
46716356|NCT01042392|82932269|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
46716357|NCT01042392|82932270|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
46716358|NCT01042392|82932271|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
46716359|NCT01042392|82932268|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
46716360|NCT01042392|82932269|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
46716361|NCT01042392|82932270|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
46716362|NCT01042392|82932271|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
46716363|NCT01042392|82932268|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
46716364|NCT01042392|82932269|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
46716365|NCT01042392|82932270|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
46716366|NCT01042392|82932271|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
46716367|NCT01042392|82932268|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
46716368|NCT01042392|82932269|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
46716369|NCT01042392|82932270|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
46716370|NCT01042392|82932271|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
46716371|NCT01064310|82932285|FG000|Period 1|Adverse Event|7|||
46716372|NCT01064310|82932286|FG001|Period 1|Adverse Event|10|||
46716373|NCT01064310|82932287|FG002|Period 1|Adverse Event|0|||
46716374|NCT01064310|82932285|FG000|Period 1|Physician Decision|1|||
46716375|NCT01064310|82932286|FG001|Period 1|Physician Decision|0|||
46716376|NCT01064310|82932287|FG002|Period 1|Physician Decision|0|||
46716377|NCT01064310|82932285|FG000|Period 1|Withdrawal by Subject|2|||
46716378|NCT01064310|82932286|FG001|Period 1|Withdrawal by Subject|2|||
46716379|NCT01064310|82932287|FG002|Period 1|Withdrawal by Subject|0|||
46716380|NCT01064310|82932285|FG000|Period 1|Lack of Efficacy|3|||
46716381|NCT01064310|82932286|FG001|Period 1|Lack of Efficacy|5|||
46716382|NCT01064310|82932287|FG002|Period 1|Lack of Efficacy|0|||
46716383|NCT01064310|82932285|FG000|Period 1|Entered Open-label Period|1|||
46716384|NCT01064310|82932286|FG001|Period 1|Entered Open-label Period|1|||
46716385|NCT01064310|82932287|FG002|Period 1|Entered Open-label Period|0|||
46914582|NCT02260193|83145132|FG001|Overall Study|Withdrawal by Subject|0|||
46716386|NCT01064310|82932285|FG000|Period 2|Adverse Event|2|||
46716387|NCT01064310|82932286|FG001|Period 2|Adverse Event|1|||
46716388|NCT01064310|82932287|FG002|Period 2|Adverse Event|0|||
46716389|NCT01064310|82932285|FG000|Period 2|Physician Decision|0|||
46716390|NCT01064310|82932286|FG001|Period 2|Physician Decision|1|||
46716391|NCT01064310|82932287|FG002|Period 2|Physician Decision|0|||
46716392|NCT01064310|82932285|FG000|Period 2|Entered Open-label Period|1|||
46716393|NCT01064310|82932286|FG001|Period 2|Entered Open-label Period|0|||
46716394|NCT01064310|82932287|FG002|Period 2|Entered Open-label Period|0|||
46716395|NCT01064310|82932285|FG000|Period 2|Lack of Efficacy|1|||
46716396|NCT01064310|82932286|FG001|Period 2|Lack of Efficacy|4|||
46716397|NCT01064310|82932287|FG002|Period 2|Lack of Efficacy|0|||
46716398|NCT01064310|82932285|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
46716399|NCT01064310|82932286|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
46914583|NCT02260193|83145133|FG002|Overall Study|Withdrawal by Subject|2|||
46914584|NCT02260193|83145131|FG000|Overall Study|Kidney Transplantation|0|||
47039208|NCT00139477|83292161|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
47039209|NCT00139477|83292160|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
46716400|NCT01064310|82932287|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
46716401|NCT01064310|82932285|FG000|Open Label Pazopinib|Adverse Event|0|||
46716402|NCT01064310|82932286|FG001|Open Label Pazopinib|Adverse Event|0|||
46716403|NCT01064310|82932287|FG002|Open Label Pazopinib|Adverse Event|12|||
46716404|NCT01064310|82932285|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
46716405|NCT01064310|82932286|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
46716406|NCT01064310|82932287|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
46716407|NCT01064310|82932285|FG000|Open Label Pazopinib|Physician Decision|0|||
46716408|NCT01064310|82932286|FG001|Open Label Pazopinib|Physician Decision|0|||
46716409|NCT01064310|82932287|FG002|Open Label Pazopinib|Physician Decision|20|||
46716410|NCT01037244|82932300|FG000|Overall Study|Adverse Event|3|||
46716411|NCT01037244|82932301|FG001|Overall Study|Adverse Event|2|||
46716412|NCT01037244|82932302|FG002|Overall Study|Adverse Event|6|||
46716413|NCT01037244|82932303|FG003|Overall Study|Adverse Event|3|||
46716414|NCT01037244|82932300|FG000|Overall Study|Lack of Efficacy|1|||
46716415|NCT01037244|82932301|FG001|Overall Study|Lack of Efficacy|1|||
46716416|NCT01037244|82932302|FG002|Overall Study|Lack of Efficacy|0|||
46716417|NCT01037244|82932303|FG003|Overall Study|Lack of Efficacy|1|||
46716418|NCT01037244|82932300|FG000|Overall Study|Lost to Follow-up|3|||
46716419|NCT01037244|82932301|FG001|Overall Study|Lost to Follow-up|3|||
46716420|NCT01037244|82932302|FG002|Overall Study|Lost to Follow-up|4|||
46716421|NCT01037244|82932303|FG003|Overall Study|Lost to Follow-up|4|||
46716422|NCT01037244|82932300|FG000|Overall Study|Withdrawal by Subject|1|||
46716423|NCT01037244|82932301|FG001|Overall Study|Withdrawal by Subject|5|||
47039210|NCT00139477|83292161|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
47039211|NCT01469013|83292460|FG000|Part A (Treatment Period)|Adverse Event|1|||
47039212|NCT01469013|83292461|FG001|Part A (Treatment Period)|Adverse Event|0|||
47039213|NCT01469013|83292462|FG002|Part A (Treatment Period)|Adverse Event|0|||
47039214|NCT01469013|83292463|FG003|Part A (Treatment Period)|Adverse Event|0|||
47039215|NCT01469013|83292464|FG004|Part A (Treatment Period)|Adverse Event|1|||
46631277|NCT01879410|82804347|FG000|Overall Study|Randomised in Error|1|||
46631278|NCT01879410|82804348|FG001|Overall Study|Randomised in Error|2|||
46631279|NCT01903434|82804354|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
46631280|NCT01903434|82804355|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
46631281|NCT01903434|82804354|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
46631282|NCT01903434|82804355|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
46631283|NCT01903356|82804361|FG000|Overall Study|Lost to Follow-up|7|||
46716424|NCT01037244|82932302|FG002|Overall Study|Withdrawal by Subject|3|||
46716425|NCT01037244|82932303|FG003|Overall Study|Withdrawal by Subject|5|||
46716426|NCT01037244|82932300|FG000|Overall Study|Partner Withdrew Consent|2|||
46716427|NCT01037244|82932301|FG001|Overall Study|Partner Withdrew Consent|1|||
46716428|NCT01037244|82932302|FG002|Overall Study|Partner Withdrew Consent|0|||
46716429|NCT01037244|82932303|FG003|Overall Study|Partner Withdrew Consent|0|||
47039216|NCT01469013|83292465|FG005|Part A (Treatment Period)|Adverse Event|0|||
46716430|NCT01037244|82932300|FG000|Overall Study|Various|3|||
46716431|NCT01037244|82932301|FG001|Overall Study|Various|2|||
46716432|NCT01037244|82932302|FG002|Overall Study|Various|1|||
46716433|NCT01037244|82932303|FG003|Overall Study|Various|1|||
46716434|NCT00833989|82932317|FG000|Overall Study|Physician Decision|0|||
46716435|NCT00833989|82932318|FG001|Overall Study|Physician Decision|0|||
46716436|NCT00833989|82932319|FG002|Overall Study|Physician Decision|0|||
46716437|NCT00833989|82932320|FG003|Overall Study|Physician Decision|1|||
46716438|NCT00833989|82932317|FG000|Overall Study|Withdrawal by Subject|3|||
46716439|NCT00833989|82932318|FG001|Overall Study|Withdrawal by Subject|0|||
46716440|NCT00833989|82932319|FG002|Overall Study|Withdrawal by Subject|1|||
47039217|NCT01469013|83292466|FG006|Part A (Treatment Period)|Adverse Event|0|||
46914585|NCT02260193|83145132|FG001|Overall Study|Kidney Transplantation|0|||
46914586|NCT02260193|83145133|FG002|Overall Study|Kidney Transplantation|1|||
46914587|NCT02849678|83145143|FG000|Overall Study|Protocol Violation|3|||
46914588|NCT02849678|83145144|FG001|Overall Study|Protocol Violation|6|||
46914589|NCT01596257|83145152|FG000|Overall Study|Inadequate Collection|23|||
46914590|NCT01596257|83145153|FG001|Overall Study|Inadequate Collection|19|||
46716441|NCT00833989|82932320|FG003|Overall Study|Withdrawal by Subject|1|||
46716442|NCT01037088|82932333|FG000|Overall Study|Withdrawal by Subject|3|||
46716443|NCT01042236|82932342|FG000|Treatment Period 1|Adverse Event|0|||
46716444|NCT01042236|82932343|FG001|Treatment Period 1|Adverse Event|1|||
46716445|NCT01042236|82932344|FG002|Treatment Period 1|Adverse Event|0|||
46716446|NCT01042236|82932345|FG003|Treatment Period 1|Adverse Event|0|||
46716447|NCT01042236|82932346|FG004|Treatment Period 1|Adverse Event|1|||
46716448|NCT01042236|82932347|FG005|Treatment Period 1|Adverse Event|0|||
46716449|NCT01042236|82932342|FG000|Treatment Period 3|Adverse Event|0|||
46716450|NCT01042236|82932343|FG001|Treatment Period 3|Adverse Event|0|||
46716451|NCT01042236|82932344|FG002|Treatment Period 3|Adverse Event|0|||
46716452|NCT01042236|82932345|FG003|Treatment Period 3|Adverse Event|1|||
46716453|NCT01042236|82932346|FG004|Treatment Period 3|Adverse Event|0|||
46716454|NCT01042236|82932347|FG005|Treatment Period 3|Adverse Event|0|||
46716455|NCT01042236|82932342|FG000|Treatment Period 3|Protocol Violation|0|||
46716456|NCT01042236|82932343|FG001|Treatment Period 3|Protocol Violation|0|||
46716457|NCT01042236|82932344|FG002|Treatment Period 3|Protocol Violation|0|||
46716458|NCT01042236|82932345|FG003|Treatment Period 3|Protocol Violation|1|||
46716459|NCT01042236|82932346|FG004|Treatment Period 3|Protocol Violation|0|||
46716460|NCT01042236|82932347|FG005|Treatment Period 3|Protocol Violation|0|||
46716461|NCT00592501|82932355|FG000|Overall Study|Withdrawal by Subject|1|||
46716462|NCT00592501|82932355|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
46716463|NCT01040832|82932361|FG000|Overall Study|Adverse Event|4|||
46716464|NCT01040832|82932362|FG001|Overall Study|Adverse Event|5|||
46716465|NCT01040832|82932361|FG000|Overall Study|Death|4|||
46716466|NCT01040832|82932362|FG001|Overall Study|Death|6|||
46716467|NCT01040832|82932361|FG000|Overall Study|Withdrawal by Subject|2|||
46716468|NCT01040832|82932362|FG001|Overall Study|Withdrawal by Subject|3|||
46716469|NCT01040832|82932361|FG000|Overall Study|Progressive disease|32|||
46716470|NCT01040832|82932362|FG001|Overall Study|Progressive disease|17|||
46716471|NCT01040832|82932361|FG000|Overall Study|Symptomatic deterioration|2|||
46716472|NCT01040832|82932362|FG001|Overall Study|Symptomatic deterioration|5|||
46716473|NCT01040832|82932361|FG000|Overall Study|Other|2|||
46716474|NCT01040832|82932362|FG001|Overall Study|Other|1|||
46716475|NCT00854581|82932368|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
46716476|NCT00854581|82932368|FG000|Induction (Up to Day 21)|Death|1|||
46716477|NCT00854581|82932368|FG000|Induction (Up to Day 21)|Physician Decision|1|||
46716478|NCT00854581|82932368|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
46716479|NCT00833911|82932377|FG000|Titration|Adverse Event|18|||
46716480|NCT00833911|82932377|FG000|Titration|Withdrawal by Subject|3|||
46716481|NCT00833911|82932377|FG000|Maintenance Phase I|Adverse Event|73|||
46716482|NCT00833911|82932377|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
46716483|NCT00833911|82932377|FG000|Maintenance Phase I|Physician Decision|10|||
46716484|NCT00833911|82932377|FG000|Maintenance Phase I|Lack of Efficacy|4|||
46716485|NCT00833911|82932377|FG000|Maintenance Phase II|Adverse Event|6|||
46716486|NCT00833911|82932377|FG000|Maintenance Phase II|Physician Decision|2|||
46716487|NCT00833911|82932377|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
46716488|NCT00833911|82932377|FG000|Maintenance Phase II|Lack of Efficacy|1|||
46716489|NCT01125293|82932391|FG000|Overall Study|Disease Progression|1|||
46914591|NCT04577781|83145163|FG000|Overall Study|Adverse Event|2|||
46914592|NCT04577781|83145164|FG001|Overall Study|Adverse Event|2|||
46914593|NCT04577781|83145163|FG000|Overall Study|Physician Decision|1|||
46914594|NCT04577781|83145164|FG001|Overall Study|Physician Decision|0|||
46914595|NCT02737826|83145171|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
46914596|NCT02737826|83145172|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
46914597|NCT02737826|83145173|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
46914598|NCT03070431|83145200|FG000|Overall Study|Withdrawal by Subject|2|||
46716490|NCT01125293|82932392|FG001|Overall Study|Disease Progression|3|||
46716491|NCT01125293|82932393|FG002|Overall Study|Disease Progression|4|||
46716492|NCT01125293|82932394|FG003|Overall Study|Disease Progression|3|||
46716493|NCT01125293|82932395|FG004|Overall Study|Disease Progression|5|||
46716494|NCT01125293|82932396|FG005|Overall Study|Disease Progression|12|||
46716495|NCT01125293|82932391|FG000|Overall Study|Adverse Event|1|||
46716496|NCT01125293|82932392|FG001|Overall Study|Adverse Event|0|||
46914599|NCT03070431|83145200|FG000|Overall Study|Lost to Follow-up|2|||
46716497|NCT01125293|82932393|FG002|Overall Study|Adverse Event|0|||
46716498|NCT01125293|82932394|FG003|Overall Study|Adverse Event|0|||
46716499|NCT01125293|82932395|FG004|Overall Study|Adverse Event|2|||
46914600|NCT01071395|83145211|FG000|Overall Study|Withdrawal by Subject|2|||
46914601|NCT01071395|83145212|FG001|Overall Study|Withdrawal by Subject|1|||
46716500|NCT01125293|82932396|FG005|Overall Study|Adverse Event|8|||
46716501|NCT01125293|82932391|FG000|Overall Study|Symptomatic Deterioration|1|||
46716502|NCT01125293|82932392|FG001|Overall Study|Symptomatic Deterioration|0|||
46716503|NCT01125293|82932393|FG002|Overall Study|Symptomatic Deterioration|0|||
46716504|NCT01125293|82932394|FG003|Overall Study|Symptomatic Deterioration|0|||
46716505|NCT01125293|82932395|FG004|Overall Study|Symptomatic Deterioration|0|||
46716506|NCT01125293|82932396|FG005|Overall Study|Symptomatic Deterioration|0|||
46716507|NCT01125293|82932391|FG000|Overall Study|Death|0|||
47039218|NCT01469013|83292467|FG007|Part A (Treatment Period)|Adverse Event|0|||
47039219|NCT01469013|83292468|FG008|Part A (Treatment Period)|Adverse Event|0|||
47039220|NCT01469013|83292469|FG009|Part A (Treatment Period)|Adverse Event|0|||
47039221|NCT01469013|83292470|FG010|Part A (Treatment Period)|Adverse Event|0|||
47039222|NCT01469013|83292471|FG011|Part A (Treatment Period)|Adverse Event|0|||
46716508|NCT01125293|82932392|FG001|Overall Study|Death|0|||
46716509|NCT01125293|82932393|FG002|Overall Study|Death|0|||
46716510|NCT01125293|82932394|FG003|Overall Study|Death|0|||
46716511|NCT01125293|82932395|FG004|Overall Study|Death|1|||
46716512|NCT01125293|82932396|FG005|Overall Study|Death|0|||
46716513|NCT01125293|82932391|FG000|Overall Study|Withdrawal by Subject|0|||
46716514|NCT01125293|82932392|FG001|Overall Study|Withdrawal by Subject|0|||
46716515|NCT01125293|82932393|FG002|Overall Study|Withdrawal by Subject|0|||
46716516|NCT01125293|82932394|FG003|Overall Study|Withdrawal by Subject|0|||
46716517|NCT01125293|82932395|FG004|Overall Study|Withdrawal by Subject|2|||
46716518|NCT01125293|82932396|FG005|Overall Study|Withdrawal by Subject|1|||
46716519|NCT01125293|82932391|FG000|Overall Study|Physician Decision|0|||
46716520|NCT01125293|82932392|FG001|Overall Study|Physician Decision|0|||
46716521|NCT01125293|82932393|FG002|Overall Study|Physician Decision|0|||
46716522|NCT01125293|82932394|FG003|Overall Study|Physician Decision|0|||
46716523|NCT01125293|82932395|FG004|Overall Study|Physician Decision|0|||
46914602|NCT01071395|83145211|FG000|Overall Study|Adverse Event|3|||
46716524|NCT01125293|82932396|FG005|Overall Study|Physician Decision|2|||
46716525|NCT01121393|82932415|FG000|Overall Study|Progressive disease|201|||
46716526|NCT01121393|82932416|FG001|Overall Study|Progressive disease|20|||
46716527|NCT01121393|82932415|FG000|Overall Study|Other Adverse events|24|||
46716528|NCT01121393|82932416|FG001|Overall Study|Other Adverse events|45|||
46716529|NCT01121393|82932415|FG000|Overall Study|Non-compliant with protocol|0|||
46716530|NCT01121393|82932416|FG001|Overall Study|Non-compliant with protocol|3|||
46716531|NCT01121393|82932415|FG000|Overall Study|Lost to Follow-up|1|||
46716532|NCT01121393|82932416|FG001|Overall Study|Lost to Follow-up|0|||
46716533|NCT01121393|82932415|FG000|Overall Study|Refused cont. medication|7|||
46716534|NCT01121393|82932416|FG001|Overall Study|Refused cont. medication|7|||
46716535|NCT01121393|82932415|FG000|Overall Study|Not treated|3|||
46716536|NCT01121393|82932416|FG001|Overall Study|Not treated|9|||
46716537|NCT01121393|82932415|FG000|Overall Study|Other than listed|6|||
46716538|NCT01121393|82932416|FG001|Overall Study|Other than listed|0|||
46716539|NCT00937521|82932463|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
46716540|NCT00937521|82932464|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
46716541|NCT00937521|82932465|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
46716542|NCT00937521|82932466|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
46716543|NCT00937521|82932467|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
46716544|NCT00937521|82932468|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
46716545|NCT00937521|82932469|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
46716546|NCT00937521|82932470|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
46716547|NCT00937521|82932463|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
46716548|NCT00937521|82932464|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
46716549|NCT00937521|82932465|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
46716550|NCT00937521|82932466|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
46716551|NCT00937521|82932467|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
46716552|NCT00937521|82932468|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
46716553|NCT00937521|82932469|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
46716554|NCT00937521|82932470|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
46914603|NCT01071395|83145212|FG001|Overall Study|Adverse Event|1|||
46914604|NCT02970942|83145222|FG000|Overall Study|Death|0|||
46914605|NCT02970942|83145223|FG001|Overall Study|Death|1|||
46914606|NCT02970942|83145224|FG002|Overall Study|Death|0|||
46914607|NCT02970942|83145225|FG003|Overall Study|Death|0|||
46914608|NCT02970942|83145222|FG000|Overall Study|Lost to Follow-up|1|||
46914609|NCT02970942|83145223|FG001|Overall Study|Lost to Follow-up|0|||
46914610|NCT02970942|83145224|FG002|Overall Study|Lost to Follow-up|2|||
46914611|NCT02970942|83145225|FG003|Overall Study|Lost to Follow-up|1|||
46914612|NCT02970942|83145222|FG000|Overall Study|Withdrawal by Subject|3|||
46914613|NCT02970942|83145223|FG001|Overall Study|Withdrawal by Subject|5|||
46914614|NCT02970942|83145224|FG002|Overall Study|Withdrawal by Subject|3|||
46914615|NCT02970942|83145225|FG003|Overall Study|Withdrawal by Subject|2|||
46914616|NCT03073005|83145239|FG000|Overall Study|Death|6|||
47039223|NCT01469013|83292472|FG012|Part A (Treatment Period)|Adverse Event|0|||
46716555|NCT00937521|82932463|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
46716556|NCT00937521|82932464|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
46716557|NCT00937521|82932465|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
46716558|NCT00937521|82932466|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
46716559|NCT00937521|82932467|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
46716560|NCT00937521|82932468|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
46716561|NCT00937521|82932469|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
46716562|NCT00937521|82932470|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
46716563|NCT00937521|82932463|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
46716564|NCT00937521|82932464|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
46716565|NCT00937521|82932465|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
46716566|NCT00937521|82932466|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
46716567|NCT00937521|82932467|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
46716568|NCT00937521|82932468|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
46716569|NCT00937521|82932469|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
46716570|NCT00937521|82932470|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
46716571|NCT00937521|82932463|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
46716572|NCT00937521|82932464|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
46716573|NCT00937521|82932465|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
46716574|NCT00937521|82932466|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
46716575|NCT00937521|82932467|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
46716576|NCT00937521|82932468|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
46716577|NCT00937521|82932469|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
46716578|NCT00937521|82932470|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
46716579|NCT00937521|82932463|FG000|Booster Phase|Adverse Event|0|||
46716580|NCT00937521|82932464|FG001|Booster Phase|Adverse Event|0|||
46716581|NCT00937521|82932465|FG002|Booster Phase|Adverse Event|0|||
46716582|NCT00937521|82932466|FG003|Booster Phase|Adverse Event|0|||
46716583|NCT00937521|82932467|FG004|Booster Phase|Adverse Event|0|||
46716584|NCT00937521|82932468|FG005|Booster Phase|Adverse Event|0|||
46716585|NCT00937521|82932469|FG006|Booster Phase|Adverse Event|1|||
46716586|NCT00937521|82932470|FG007|Booster Phase|Adverse Event|0|||
46716587|NCT00937521|82932463|FG000|Booster Phase|Withdrawal by Subject|1|||
46716588|NCT00937521|82932464|FG001|Booster Phase|Withdrawal by Subject|0|||
46716589|NCT00937521|82932465|FG002|Booster Phase|Withdrawal by Subject|0|||
46716590|NCT00937521|82932466|FG003|Booster Phase|Withdrawal by Subject|1|||
46716591|NCT00937521|82932467|FG004|Booster Phase|Withdrawal by Subject|0|||
46716592|NCT00937521|82932468|FG005|Booster Phase|Withdrawal by Subject|0|||
46716593|NCT00937521|82932469|FG006|Booster Phase|Withdrawal by Subject|0|||
46716594|NCT00937521|82932470|FG007|Booster Phase|Withdrawal by Subject|2|||
46716595|NCT00937521|82932463|FG000|Booster Phase|Lost to Follow-up|2|||
46716596|NCT00937521|82932464|FG001|Booster Phase|Lost to Follow-up|2|||
46716597|NCT00937521|82932465|FG002|Booster Phase|Lost to Follow-up|4|||
46716598|NCT00937521|82932466|FG003|Booster Phase|Lost to Follow-up|2|||
46716599|NCT00937521|82932467|FG004|Booster Phase|Lost to Follow-up|4|||
47039224|NCT01469013|83292460|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039225|NCT01469013|83292461|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039226|NCT01469013|83292462|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
47039227|NCT01469013|83292463|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039228|NCT01469013|83292464|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039229|NCT01469013|83292465|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039230|NCT01469013|83292466|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
46631284|NCT01903356|82804361|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
46631285|NCT01903356|82804361|FG000|Overall Study|Violated the dosage and administration|3|||
46631286|NCT01862796|82804368|FG000|Overall Study|Prohibited medications|0|||
46631287|NCT01862796|82804369|FG001|Overall Study|Prohibited medications|0|||
46631288|NCT01862796|82804370|FG002|Overall Study|Prohibited medications|1|||
46631289|NCT01878084|82804378|FG000|Overall Study|Physician Decision|2|||
46631290|NCT01862640|82804387|FG000|Overall Study|Adverse Event|4|||
46716600|NCT00937521|82932468|FG005|Booster Phase|Lost to Follow-up|4|||
46716601|NCT00937521|82932469|FG006|Booster Phase|Lost to Follow-up|3|||
46716602|NCT00937521|82932470|FG007|Booster Phase|Lost to Follow-up|0|||
46716603|NCT00937521|82932463|FG000|Booster Phase|Administrative Reason|0|||
46716604|NCT00937521|82932464|FG001|Booster Phase|Administrative Reason|0|||
46716605|NCT00937521|82932465|FG002|Booster Phase|Administrative Reason|1|||
46716606|NCT00937521|82932466|FG003|Booster Phase|Administrative Reason|0|||
46631291|NCT01862640|82804388|FG001|Overall Study|Adverse Event|10|||
46716607|NCT00937521|82932467|FG004|Booster Phase|Administrative Reason|1|||
47039231|NCT01469013|83292467|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039232|NCT01469013|83292468|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
46716608|NCT00937521|82932468|FG005|Booster Phase|Administrative Reason|1|||
46914617|NCT03073005|83145240|FG001|Overall Study|Death|0|||
47039233|NCT01469013|83292469|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039234|NCT01469013|83292470|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039235|NCT01469013|83292471|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
47039236|NCT01469013|83292472|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
46914618|NCT03073005|83145241|FG002|Overall Study|Death|7|||
46914619|NCT03073005|83145242|FG003|Overall Study|Death|0|||
47039237|NCT01469013|83292460|FG000|Part B (Extension Period)|Adverse Event|0|||
47039238|NCT01469013|83292461|FG001|Part B (Extension Period)|Adverse Event|0|||
47039239|NCT01469013|83292462|FG002|Part B (Extension Period)|Adverse Event|0|||
47039240|NCT01469013|83292463|FG003|Part B (Extension Period)|Adverse Event|0|||
47039241|NCT01469013|83292464|FG004|Part B (Extension Period)|Adverse Event|0|||
47039242|NCT01469013|83292465|FG005|Part B (Extension Period)|Adverse Event|2|||
47039243|NCT01469013|83292466|FG006|Part B (Extension Period)|Adverse Event|5|||
47039244|NCT01469013|83292467|FG007|Part B (Extension Period)|Adverse Event|5|||
47039245|NCT01469013|83292468|FG008|Part B (Extension Period)|Adverse Event|3|||
47039246|NCT01469013|83292469|FG009|Part B (Extension Period)|Adverse Event|3|||
47039247|NCT01469013|83292470|FG010|Part B (Extension Period)|Adverse Event|1|||
47039248|NCT01469013|83292471|FG011|Part B (Extension Period)|Adverse Event|6|||
47039249|NCT01469013|83292472|FG012|Part B (Extension Period)|Adverse Event|3|||
47039250|NCT01469013|83292460|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
47039251|NCT01469013|83292461|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
47039252|NCT01469013|83292462|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
46914620|NCT03073005|83145239|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
46914621|NCT03073005|83145240|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
46914622|NCT03073005|83145241|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
46914623|NCT03073005|83145242|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
46914624|NCT03073005|83145239|FG000|Overall Study|Lost to Follow-up|2|||
47039253|NCT01469013|83292463|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
47039254|NCT01469013|83292464|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
47039255|NCT01469013|83292465|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
47039256|NCT01469013|83292466|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
47039257|NCT01469013|83292467|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
47039258|NCT01469013|83292468|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
47039259|NCT01469013|83292469|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
47039260|NCT01469013|83292470|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
47039261|NCT01469013|83292471|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
47039262|NCT01469013|83292472|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
47039263|NCT01493427|83292499|FG000|Overall Study|Adverse Event|10|||
47039264|NCT01493427|83292499|FG000|Overall Study|Personal Reasons|4|||
47039265|NCT01493427|83292499|FG000|Overall Study|Lost to Follow-up|2|||
47039266|NCT01493427|83292499|FG000|Overall Study|Inability to Follow Instructions|2|||
47039267|NCT01493427|83292499|FG000|Overall Study|Other|2|||
47039268|NCT01523457|83292505|FG000|Overall Study|Withdrawal by Subject|7|||
47039269|NCT01523457|83292506|FG001|Overall Study|Withdrawal by Subject|2|||
47039270|NCT01523301|83292514|FG000|Overall Study|Adverse Event|25|||
47039271|NCT01523301|83292515|FG001|Overall Study|Adverse Event|16|||
47039272|NCT01523301|83292514|FG000|Overall Study|Lack of Efficacy|0|||
47039273|NCT01523301|83292515|FG001|Overall Study|Lack of Efficacy|2|||
46631292|NCT01862640|82804389|FG002|Overall Study|Adverse Event|6|||
46914625|NCT03073005|83145240|FG001|Overall Study|Lost to Follow-up|2|||
46631293|NCT01862640|82804390|FG003|Overall Study|Adverse Event|8|||
46631294|NCT01862640|82804387|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
46914626|NCT03073005|83145241|FG002|Overall Study|Lost to Follow-up|1|||
46631295|NCT01862640|82804388|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
46631296|NCT01862640|82804389|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
46631297|NCT01862640|82804390|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
46631298|NCT01862640|82804387|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
46631299|NCT01862640|82804388|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
47039274|NCT01523301|83292514|FG000|Overall Study|Protocol Violation|3|||
46716609|NCT00937521|82932469|FG006|Booster Phase|Administrative Reason|0|||
46914627|NCT03073005|83145242|FG003|Overall Study|Lost to Follow-up|2|||
46914628|NCT03073005|83145239|FG000|Overall Study|Withdrawal by Subject|0|||
46914629|NCT03073005|83145240|FG001|Overall Study|Withdrawal by Subject|4|||
46914630|NCT03073005|83145241|FG002|Overall Study|Withdrawal by Subject|4|||
47039275|NCT01523301|83292515|FG001|Overall Study|Protocol Violation|4|||
47039276|NCT01523301|83292514|FG000|Overall Study|Lost to Follow-up|1|||
47039277|NCT01523301|83292515|FG001|Overall Study|Lost to Follow-up|0|||
47039278|NCT01523301|83292514|FG000|Overall Study|Withdrawal by Subject|6|||
47039279|NCT01523301|83292515|FG001|Overall Study|Withdrawal by Subject|8|||
47039280|NCT01523301|83292514|FG000|Overall Study|Other Reason|0|||
47039281|NCT01523301|83292515|FG001|Overall Study|Other Reason|2|||
47039282|NCT01806506|83292523|FG000|Overall Study|Lost to Follow-up|2|||
47039283|NCT01806506|83292524|FG001|Overall Study|Lost to Follow-up|1|||
47039284|NCT01766336|83292532|FG000|Overall Study|Adverse Event|11|||
47039285|NCT01766336|83292533|FG001|Overall Study|Adverse Event|8|||
46914631|NCT03073005|83145242|FG003|Overall Study|Withdrawal by Subject|4|||
46914632|NCT02849171|83145255|FG000|Overall Study|Withdrawal by Subject|1|||
46914633|NCT02849171|83145255|FG000|Overall Study|Not treated|1|||
46914634|NCT02848664|83145268|FG000|Overall Study|Withdrawal by Subject|2|||
46914635|NCT02848664|83145268|FG000|Overall Study|Adverse Event|1|||
46914636|NCT02848664|83145268|FG000|Overall Study|no assistance for device training|1|||
46914637|NCT02969382|83145278|FG000|Overall Study|Adverse Event|8|||
47039286|NCT01766336|83292532|FG000|Overall Study|Death|4|||
47039287|NCT01766336|83292533|FG001|Overall Study|Death|3|||
46631300|NCT01862640|82804389|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
46914638|NCT02969382|83145279|FG001|Overall Study|Adverse Event|10|||
46914639|NCT02969382|83145278|FG000|Overall Study|Lack of Efficacy|4|||
46914640|NCT02969382|83145279|FG001|Overall Study|Lack of Efficacy|5|||
46914641|NCT02969382|83145278|FG000|Overall Study|Death|0|||
46914642|NCT02969382|83145279|FG001|Overall Study|Death|1|||
46914643|NCT02969382|83145278|FG000|Overall Study|PROTOCOL DEVIATION|0|||
46914644|NCT02969382|83145279|FG001|Overall Study|PROTOCOL DEVIATION|1|||
46914645|NCT02969382|83145278|FG000|Overall Study|Withdrawal by Subject|14|||
46914646|NCT02969382|83145279|FG001|Overall Study|Withdrawal by Subject|9|||
46914647|NCT01989104|83145290|FG000|Overall Study|Withdrawal by Subject|3|||
46914648|NCT01989104|83145291|FG001|Overall Study|Withdrawal by Subject|0|||
46914649|NCT01989104|83145292|FG002|Overall Study|Withdrawal by Subject|0|||
46914650|NCT01989104|83145293|FG003|Overall Study|Withdrawal by Subject|0|||
46914651|NCT01989104|83145294|FG004|Overall Study|Withdrawal by Subject|0|||
46914652|NCT02903238|83145306|FG000|Overall Study|Lost to Follow-up|4|||
46914653|NCT02847260|83145311|FG000|Overall Study|Adverse Event|3|||
46914654|NCT02847260|83145311|FG000|Overall Study|Withdrawal by Subject|2|||
46914655|NCT02847260|83145311|FG000|Overall Study|Clinical Deterioration|1|||
46914656|NCT02847260|83145311|FG000|Overall Study|Physician Decision|1|||
46914657|NCT02968563|83145317|FG000|Overall Study|Adverse Event|0|||
46914658|NCT02968563|83145318|FG001|Overall Study|Adverse Event|6|||
46914659|NCT02968563|83145317|FG000|Overall Study|Death|1|||
46914660|NCT02968563|83145318|FG001|Overall Study|Death|1|||
46914661|NCT02968563|83145317|FG000|Overall Study|Lost to Follow-up|0|||
46914662|NCT02968563|83145318|FG001|Overall Study|Lost to Follow-up|1|||
46914663|NCT02904096|83145326|FG000|Overall Study|Adverse Event|1|||
46914664|NCT02904096|83145327|FG001|Overall Study|Adverse Event|0|||
46914665|NCT02904096|83145326|FG000|Overall Study|Withdrawal by Subject|4|||
46914666|NCT02904096|83145327|FG001|Overall Study|Withdrawal by Subject|3|||
46914667|NCT02904096|83145326|FG000|Overall Study|Lost to Follow-up|10|||
46914668|NCT02904096|83145327|FG001|Overall Study|Lost to Follow-up|17|||
46914669|NCT02904096|83145326|FG000|Overall Study|Non-compliant|3|||
46914670|NCT02904096|83145327|FG001|Overall Study|Non-compliant|1|||
46914671|NCT02904096|83145326|FG000|Overall Study|Sponsor instructed|1|||
46914672|NCT02904096|83145327|FG001|Overall Study|Sponsor instructed|0|||
46914673|NCT03161405|83145337|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
46631301|NCT01862640|82804390|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
46631302|NCT01862640|82804387|FG000|Overall Study|Withdrawal by Subject|2|||
46631303|NCT01862640|82804388|FG001|Overall Study|Withdrawal by Subject|4|||
46631304|NCT01862640|82804389|FG002|Overall Study|Withdrawal by Subject|8|||
46631305|NCT01862640|82804390|FG003|Overall Study|Withdrawal by Subject|5|||
46631306|NCT01862640|82804387|FG000|Overall Study|Protocol Deviation|0|||
46631307|NCT01862640|82804388|FG001|Overall Study|Protocol Deviation|0|||
46631308|NCT01862640|82804389|FG002|Overall Study|Protocol Deviation|1|||
47039288|NCT01766336|83292532|FG000|Overall Study|Lost to Follow-up|1|||
47039289|NCT01766336|83292533|FG001|Overall Study|Lost to Follow-up|3|||
46631309|NCT01862640|82804390|FG003|Overall Study|Protocol Deviation|0|||
46631310|NCT01902966|82804399|FG000|Overall Study|Death|1|||
46631311|NCT01902966|82804399|FG000|Overall Study|Physician Decision|1|||
46631312|NCT01902966|82804399|FG000|Overall Study|Withdrawal by Subject|1|||
46914674|NCT01813929|83145346|FG000|Overall Study|Withdrawal by Subject|0|||
46914675|NCT01813929|83145347|FG001|Overall Study|Withdrawal by Subject|1|||
46914676|NCT02901054|83145357|FG000|Overall Study|Physician Decision|1|||
46914677|NCT02901054|83145357|FG000|Overall Study|Withdrawal by Subject|3|||
46914678|NCT03068715|83145363|FG000|Overall Study|No longer met inclusion criteria|1|||
46914679|NCT03068715|83145364|FG001|Overall Study|No longer met inclusion criteria|0|||
46914680|NCT02966340|83145372|FG000|Overall Study|Adverse Event|0|||
46914681|NCT02966340|83145373|FG001|Overall Study|Adverse Event|1|||
46914682|NCT02966340|83145372|FG000|Overall Study|Lost to Follow-up|0|||
46914683|NCT02966340|83145373|FG001|Overall Study|Lost to Follow-up|1|||
47039290|NCT01766336|83292532|FG000|Overall Study|Physician Decision|4|||
47039291|NCT01766336|83292533|FG001|Overall Study|Physician Decision|2|||
46914684|NCT02966340|83145372|FG000|Overall Study|Withdrawal by Subject|1|||
46914685|NCT02966340|83145373|FG001|Overall Study|Withdrawal by Subject|0|||
46914686|NCT02966340|83145372|FG000|Overall Study|data acquisition error|1|||
46914687|NCT02966340|83145373|FG001|Overall Study|data acquisition error|0|||
46914688|NCT02966340|83145372|FG000|Overall Study|startle non-responder|1|||
46914689|NCT02966340|83145373|FG001|Overall Study|startle non-responder|1|||
46914690|NCT03067311|83145381|FG000|Overall Study|Lost to Follow-up|1|||
46914691|NCT03067311|83145382|FG001|Overall Study|Lost to Follow-up|1|||
46914692|NCT03067311|83145381|FG000|Overall Study|Moved away|1|||
46914693|NCT03067311|83145382|FG001|Overall Study|Moved away|1|||
46914694|NCT04380519|83145391|FG000|Overall Study|Withdrawal by Subject|4|||
46914695|NCT04380519|83145392|FG001|Overall Study|Withdrawal by Subject|0|||
47039292|NCT01766336|83292532|FG000|Overall Study|Protocol Violation|0|||
46914696|NCT04380519|83145393|FG002|Overall Study|Withdrawal by Subject|1|||
47039293|NCT01766336|83292533|FG001|Overall Study|Protocol Violation|1|||
47039294|NCT01766336|83292532|FG000|Overall Study|Sponsor Decision|52|||
46914697|NCT04380519|83145391|FG000|Overall Study|Death|14|||
46914698|NCT04380519|83145392|FG001|Overall Study|Death|9|||
46914699|NCT04380519|83145393|FG002|Overall Study|Death|6|||
46914700|NCT04380519|83145391|FG000|Overall Study|Adverse Event|0|||
46914701|NCT04380519|83145392|FG001|Overall Study|Adverse Event|1|||
46914702|NCT04380519|83145393|FG002|Overall Study|Adverse Event|0|||
46914703|NCT04380519|83145391|FG000|Overall Study|relatives' decision|0|||
46914704|NCT04380519|83145392|FG001|Overall Study|relatives' decision|1|||
46914705|NCT04380519|83145393|FG002|Overall Study|relatives' decision|0|||
46914706|NCT02847182|83145403|FG000|Overall Study|Withdrawal by Subject|0|||
46914707|NCT02847182|83145404|FG001|Overall Study|Withdrawal by Subject|1|||
46914708|NCT02846558|83145420|FG000|Overall Study|Adverse Event|1|||
46914709|NCT02846558|83145421|FG001|Overall Study|Adverse Event|0|||
46914710|NCT02846558|83145422|FG002|Overall Study|Adverse Event|0|||
46914711|NCT02846558|83145423|FG003|Overall Study|Adverse Event|0|||
46914712|NCT02846558|83145420|FG000|Overall Study|Withdrawal by Subject|5|||
46914713|NCT02846558|83145421|FG001|Overall Study|Withdrawal by Subject|4|||
46914714|NCT02846558|83145422|FG002|Overall Study|Withdrawal by Subject|2|||
46914715|NCT02846558|83145423|FG003|Overall Study|Withdrawal by Subject|2|||
46914716|NCT02846558|83145420|FG000|Overall Study|Lost to Follow-up|2|||
46914717|NCT02846558|83145421|FG001|Overall Study|Lost to Follow-up|0|||
46914718|NCT02846558|83145422|FG002|Overall Study|Lost to Follow-up|0|||
46914719|NCT02846558|83145423|FG003|Overall Study|Lost to Follow-up|0|||
46914720|NCT04362813|83145442|FG000|Overall Study|Death|12|||
46914721|NCT04362813|83145443|FG001|Overall Study|Death|16|||
46914722|NCT04362813|83145442|FG000|Overall Study|Withdrawal by Subject|3|||
46914723|NCT04362813|83145443|FG001|Overall Study|Withdrawal by Subject|1|||
46914724|NCT04362813|83145442|FG000|Overall Study|Protocol Violation|0|||
46914725|NCT04362813|83145443|FG001|Overall Study|Protocol Violation|3|||
46914726|NCT04362813|83145442|FG000|Overall Study|Lost to Follow-up|1|||
46914727|NCT04362813|83145443|FG001|Overall Study|Lost to Follow-up|1|||
46914728|NCT04362813|83145442|FG000|Overall Study|Enrolled but did not receive treatment|2|||
46914729|NCT04362813|83145443|FG001|Overall Study|Enrolled but did not receive treatment|4|||
46914730|NCT02966028|83145452|FG000|Overall Study|Adverse Event|7|||
47039295|NCT01766336|83292533|FG001|Overall Study|Sponsor Decision|43|||
47039296|NCT01766336|83292532|FG000|Overall Study|Withdrawal by Subject|18|||
47039297|NCT01766336|83292533|FG001|Overall Study|Withdrawal by Subject|15|||
47039298|NCT01797536|83292543|FG000|Overall Study|Adverse Event|0|||
46631313|NCT01862484|82804405|FG000|Overall Study|Lack of Efficacy|1|||
46631314|NCT01862484|82804406|FG001|Overall Study|Lack of Efficacy|1|||
46631315|NCT01862484|82804405|FG000|Overall Study|Lost to Follow-up|1|||
46631316|NCT01862484|82804406|FG001|Overall Study|Lost to Follow-up|2|||
46631317|NCT01862484|82804405|FG000|Overall Study|Protocol Violation|0|||
46631318|NCT01862484|82804406|FG001|Overall Study|Protocol Violation|2|||
46631319|NCT01862484|82804405|FG000|Overall Study|Withdrawal by Subject|0|||
46716610|NCT00937521|82932470|FG007|Booster Phase|Administrative Reason|0|||
46716611|NCT00937521|82932463|FG000|Booster Phase|Protocol Deviation|0|||
47039299|NCT01797536|83292544|FG001|Overall Study|Adverse Event|1|||
47039300|NCT01797536|83292545|FG002|Overall Study|Adverse Event|0|||
47039301|NCT01797536|83292546|FG003|Overall Study|Adverse Event|0|||
46716612|NCT00937521|82932464|FG001|Booster Phase|Protocol Deviation|0|||
46914731|NCT02966028|83145453|FG001|Overall Study|Adverse Event|13|||
46914732|NCT02966028|83145454|FG002|Overall Study|Adverse Event|10|||
46914733|NCT02966028|83145452|FG000|Overall Study|Physician Decision|1|||
46914734|NCT02966028|83145453|FG001|Overall Study|Physician Decision|0|||
46914735|NCT02966028|83145454|FG002|Overall Study|Physician Decision|2|||
46914736|NCT02966028|83145452|FG000|Overall Study|Withdrawal by Subject|7|||
46914737|NCT02966028|83145453|FG001|Overall Study|Withdrawal by Subject|5|||
46914738|NCT02966028|83145454|FG002|Overall Study|Withdrawal by Subject|5|||
46914739|NCT02966028|83145452|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
46914740|NCT02966028|83145453|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
46914741|NCT02966028|83145454|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
47039302|NCT01797302|83292559|FG000|Overall Study|Lost to Follow-up|16|||
46914742|NCT02925741|83145468|FG000|Overall Study|Withdrawal by Subject|11|||
46914743|NCT02925741|83145469|FG001|Overall Study|Withdrawal by Subject|0|||
46914744|NCT02964312|83145478|FG000|Overall Study|Lost to Follow-up|28|||
46914745|NCT02964312|83145478|FG000|Overall Study|Withdrawal by Subject|11|||
46914746|NCT02964312|83145478|FG000|Overall Study|Lack of Efficacy|10|||
46914747|NCT02964312|83145478|FG000|Overall Study|Did not consent to long-term FU|14|||
46914748|NCT02964312|83145478|FG000|Overall Study|Death|1|||
46914749|NCT02899962|83145502|FG000|Open-label Phase|Adverse Event|2|||
46914750|NCT02899962|83145503|FG001|Open-label Phase|Adverse Event|0|||
46716613|NCT00937521|82932465|FG002|Booster Phase|Protocol Deviation|0|||
46716614|NCT00937521|82932466|FG003|Booster Phase|Protocol Deviation|0|||
46716615|NCT00937521|82932467|FG004|Booster Phase|Protocol Deviation|0|||
46716616|NCT00937521|82932468|FG005|Booster Phase|Protocol Deviation|0|||
46716617|NCT00937521|82932469|FG006|Booster Phase|Protocol Deviation|1|||
46716618|NCT00937521|82932470|FG007|Booster Phase|Protocol Deviation|0|||
46716619|NCT00935883|82932505|FG000|Treatment Period|Physician Decision|1|||
46716620|NCT00935883|82932506|FG001|Treatment Period|Physician Decision|0|||
46716621|NCT00935883|82932505|FG000|Treatment Period|Withdrawal by Subject|0|||
46716622|NCT00935883|82932506|FG001|Treatment Period|Withdrawal by Subject|2|||
46716623|NCT00936975|82932512|FG000|Overall Study|Withdrawal by Subject|1|||
46716624|NCT00936975|82932512|FG000|Overall Study|Disease progression|3|||
46716625|NCT00936975|82932512|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
46716626|NCT00936897|82932519|FG000|Overall Study|Withdrawal by Subject|9|||
46716627|NCT00936897|82932520|FG001|Overall Study|Withdrawal by Subject|19|||
46716628|NCT00936897|82932519|FG000|Overall Study|Adverse Event|4|||
46716629|NCT00936897|82932520|FG001|Overall Study|Adverse Event|13|||
46716630|NCT00936897|82932519|FG000|Overall Study|Other|3|||
46716631|NCT00936897|82932520|FG001|Overall Study|Other|9|||
46716632|NCT00936897|82932519|FG000|Overall Study|Lost to Follow-up|1|||
46716633|NCT00936897|82932520|FG001|Overall Study|Lost to Follow-up|10|||
46716634|NCT00936897|82932519|FG000|Overall Study|Administrative Decision|1|||
46716635|NCT00936897|82932520|FG001|Overall Study|Administrative Decision|2|||
46914751|NCT02899962|83145504|FG002|Open-label Phase|Adverse Event|0|||
46914752|NCT02899962|83145502|FG000|Open-label Phase|Lost to Follow-up|9|||
47039303|NCT01797302|83292560|FG001|Overall Study|Lost to Follow-up|23|||
47039304|NCT01797302|83292561|FG002|Overall Study|Lost to Follow-up|22|||
47039305|NCT01797302|83292559|FG000|Overall Study|Withdrawal by Subject|1|||
47039306|NCT01797302|83292560|FG001|Overall Study|Withdrawal by Subject|3|||
47039307|NCT01797302|83292561|FG002|Overall Study|Withdrawal by Subject|4|||
47039308|NCT01805180|83292571|FG000|Lead-in Donor Phase|screen failure|1|||
47039309|NCT01805180|83292572|FG001|Lead-in Donor Phase|screen failure|0|||
46716636|NCT00936897|82932519|FG000|Overall Study|Protocol Violation|1|||
46914753|NCT02899962|83145503|FG001|Open-label Phase|Lost to Follow-up|0|||
46914754|NCT02899962|83145504|FG002|Open-label Phase|Lost to Follow-up|0|||
46914755|NCT02899962|83145502|FG000|Open-label Phase|Other reasons|9|||
46914756|NCT02899962|83145503|FG001|Open-label Phase|Other reasons|0|||
46914757|NCT02899962|83145504|FG002|Open-label Phase|Other reasons|0|||
46914758|NCT02899962|83145502|FG000|Open-label Phase|Withdrawal by Subject|7|||
46914759|NCT02899962|83145503|FG001|Open-label Phase|Withdrawal by Subject|0|||
46914760|NCT02899962|83145504|FG002|Open-label Phase|Withdrawal by Subject|0|||
46914761|NCT02899962|83145502|FG000|Maintenance Phase|Adverse Event|0|||
46914762|NCT02899962|83145503|FG001|Maintenance Phase|Adverse Event|2|||
46914763|NCT02899962|83145504|FG002|Maintenance Phase|Adverse Event|1|||
46914764|NCT02899962|83145502|FG000|Maintenance Phase|Death|0|||
46914765|NCT02899962|83145503|FG001|Maintenance Phase|Death|0|||
46914766|NCT02899962|83145504|FG002|Maintenance Phase|Death|1|||
46914767|NCT02899962|83145502|FG000|Maintenance Phase|Lack of Efficacy|0|||
46914768|NCT02899962|83145503|FG001|Maintenance Phase|Lack of Efficacy|20|||
46914769|NCT02899962|83145504|FG002|Maintenance Phase|Lack of Efficacy|16|||
46914770|NCT02899962|83145502|FG000|Maintenance Phase|Lost to Follow-up|0|||
46914771|NCT02899962|83145503|FG001|Maintenance Phase|Lost to Follow-up|12|||
46914772|NCT02899962|83145504|FG002|Maintenance Phase|Lost to Follow-up|14|||
46716637|NCT00936897|82932520|FG001|Overall Study|Protocol Violation|1|||
46716638|NCT00936897|82932519|FG000|Overall Study|Ineligibility Determined|0|||
46716639|NCT00936897|82932520|FG001|Overall Study|Ineligibility Determined|3|||
46716640|NCT00936897|82932519|FG000|Overall Study|Noncompliance|0|||
46716641|NCT00936897|82932520|FG001|Overall Study|Noncompliance|2|||
46716642|NCT00936897|82932519|FG000|Overall Study|Death|0|||
46914773|NCT02899962|83145502|FG000|Maintenance Phase|Other reasons|0|||
46914774|NCT02899962|83145503|FG001|Maintenance Phase|Other reasons|9|||
46914775|NCT02899962|83145504|FG002|Maintenance Phase|Other reasons|13|||
46914776|NCT02899962|83145502|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
46914777|NCT02899962|83145503|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
46914778|NCT02899962|83145504|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
46914779|NCT02899962|83145502|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
46914780|NCT02899962|83145503|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
46716643|NCT00936897|82932520|FG001|Overall Study|Death|1|||
47039310|NCT01805180|83292573|FG002|Lead-in Donor Phase|screen failure|0|||
46914781|NCT02899962|83145504|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
46914782|NCT02899962|83145502|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46914783|NCT02899962|83145503|FG001|Maintenance Phase|Withdrawal by Subject|30|||
46914784|NCT02899962|83145504|FG002|Maintenance Phase|Withdrawal by Subject|36|||
46914785|NCT02899338|83145513|FG000|Overall Study|Adverse Event|1|||
46914786|NCT02899338|83145514|FG001|Overall Study|Adverse Event|2|||
46914787|NCT02899338|83145513|FG000|Overall Study|Withdrawal by Subject|2|||
46914788|NCT02899338|83145514|FG001|Overall Study|Withdrawal by Subject|0|||
47039311|NCT01804946|83292583|FG000|Overall Study|Protocol Violation|1|||
47039312|NCT01804946|83292584|FG001|Overall Study|Protocol Violation|0|||
47039313|NCT01804946|83292583|FG000|Overall Study|Adverse Event|0|||
47039314|NCT01804946|83292584|FG001|Overall Study|Adverse Event|1|||
47039315|NCT01804946|83292583|FG000|Overall Study|Insufficient data available|0|||
46914789|NCT03066609|83145523|FG000|INDUCTION|Pregnancy|0|||
46914790|NCT03066609|83145524|FG001|INDUCTION|Pregnancy|0|||
46914791|NCT03066609|83145525|FG002|INDUCTION|Pregnancy|1|||
46914792|NCT03066609|83145526|FG003|INDUCTION|Pregnancy|0|||
46914793|NCT03066609|83145523|FG000|INDUCTION|Lack of Efficacy|0|||
46914794|NCT03066609|83145524|FG001|INDUCTION|Lack of Efficacy|0|||
46914795|NCT03066609|83145525|FG002|INDUCTION|Lack of Efficacy|1|||
46914796|NCT03066609|83145526|FG003|INDUCTION|Lack of Efficacy|0|||
46914797|NCT03066609|83145523|FG000|INDUCTION|Adverse Event|2|||
46914798|NCT03066609|83145524|FG001|INDUCTION|Adverse Event|2|||
46914799|NCT03066609|83145525|FG002|INDUCTION|Adverse Event|0|||
46914800|NCT03066609|83145526|FG003|INDUCTION|Adverse Event|0|||
46914801|NCT03066609|83145523|FG000|MAINTENANCE|Adverse Event|0|||
46914802|NCT03066609|83145524|FG001|MAINTENANCE|Adverse Event|0|||
46914803|NCT03066609|83145525|FG002|MAINTENANCE|Adverse Event|0|||
46914804|NCT03066609|83145526|FG003|MAINTENANCE|Adverse Event|1|||
46914805|NCT03066609|83145523|FG000|MAINTENANCE|Withdrawal by Subject|4|||
46914806|NCT03066609|83145524|FG001|MAINTENANCE|Withdrawal by Subject|2|||
46914807|NCT03066609|83145525|FG002|MAINTENANCE|Withdrawal by Subject|1|||
46914808|NCT03066609|83145526|FG003|MAINTENANCE|Withdrawal by Subject|1|||
46914809|NCT03066609|83145523|FG000|MAINTENANCE|Lost to Follow-up|0|||
46914810|NCT03066609|83145524|FG001|MAINTENANCE|Lost to Follow-up|1|||
46914811|NCT03066609|83145525|FG002|MAINTENANCE|Lost to Follow-up|1|||
47039316|NCT01804946|83292584|FG001|Overall Study|Insufficient data available|1|||
47039317|NCT01804946|83292583|FG000|Overall Study|Do not meet inclusion criteria|1|||
47039318|NCT01804946|83292584|FG001|Overall Study|Do not meet inclusion criteria|2|||
47039319|NCT01737398|83292594|FG000|Overall Study|Adverse event or SAE|16|||
47039320|NCT01737398|83292595|FG001|Overall Study|Adverse event or SAE|1|||
47039321|NCT01737398|83292594|FG000|Overall Study|Stopping rule met|2|||
47039322|NCT01737398|83292595|FG001|Overall Study|Stopping rule met|1|||
46631320|NCT01862484|82804406|FG001|Overall Study|Withdrawal by Subject|3|||
46631321|NCT01902888|82804412|FG000|Overall Study|Study Terminated|3|||
46631322|NCT01862328|82804423|FG000|Overall Study|Progressive Disease|3|||
46631323|NCT01862328|82804424|FG001|Overall Study|Progressive Disease|11|||
46631324|NCT01862328|82804425|FG002|Overall Study|Progressive Disease|5|||
46631325|NCT01862328|82804426|FG003|Overall Study|Progressive Disease|6|||
46631326|NCT01862328|82804427|FG004|Overall Study|Progressive Disease|7|||
46631327|NCT01862328|82804428|FG005|Overall Study|Progressive Disease|4|||
46631328|NCT01862328|82804429|FG006|Overall Study|Progressive Disease|3|||
46631329|NCT01862328|82804423|FG000|Overall Study|Adverse Event|0|||
46631330|NCT01862328|82804424|FG001|Overall Study|Adverse Event|4|||
46631331|NCT01862328|82804425|FG002|Overall Study|Adverse Event|0|||
46631332|NCT01862328|82804426|FG003|Overall Study|Adverse Event|1|||
46631333|NCT01862328|82804427|FG004|Overall Study|Adverse Event|0|||
46631334|NCT01862328|82804428|FG005|Overall Study|Adverse Event|2|||
46716644|NCT01120691|82932529|FG000|Overall Study|Adverse Event|59|||
46716645|NCT01120691|82932530|FG001|Overall Study|Adverse Event|67|||
46716646|NCT01120691|82932531|FG002|Overall Study|Adverse Event|47|||
46716647|NCT01120691|82932529|FG000|Overall Study|Subject withdrew consent|33|||
46716648|NCT01120691|82932530|FG001|Overall Study|Subject withdrew consent|50|||
46716649|NCT01120691|82932531|FG002|Overall Study|Subject withdrew consent|44|||
46716650|NCT01120691|82932529|FG000|Overall Study|Death|21|||
46914812|NCT03066609|83145526|FG003|MAINTENANCE|Lost to Follow-up|0|||
46914813|NCT03066609|83145523|FG000|MAINTENANCE|Pregnancy|1|||
46914814|NCT03066609|83145524|FG001|MAINTENANCE|Pregnancy|0|||
46914815|NCT03066609|83145525|FG002|MAINTENANCE|Pregnancy|0|||
46914816|NCT03066609|83145526|FG003|MAINTENANCE|Pregnancy|0|||
46914817|NCT03066609|83145523|FG000|MAINTENANCE|Lack of Efficacy|2|||
46914818|NCT03066609|83145524|FG001|MAINTENANCE|Lack of Efficacy|1|||
46631335|NCT01862328|82804429|FG006|Overall Study|Adverse Event|4|||
46914819|NCT03066609|83145525|FG002|MAINTENANCE|Lack of Efficacy|0|||
46914820|NCT03066609|83145526|FG003|MAINTENANCE|Lack of Efficacy|1|||
47039323|NCT01737398|83292594|FG000|Overall Study|Voluntary withdrawal|2|||
46914821|NCT03066609|83145523|FG000|OVERALL STUDY|Adverse Event|2|||
46631336|NCT01862328|82804423|FG000|Overall Study|Other|0|||
46631337|NCT01862328|82804424|FG001|Overall Study|Other|2|||
46914822|NCT03066609|83145524|FG001|OVERALL STUDY|Adverse Event|2|||
47039324|NCT01737398|83292595|FG001|Overall Study|Voluntary withdrawal|3|||
47039325|NCT01737398|83292594|FG000|Overall Study|Ineligibility|1|||
47039326|NCT01737398|83292595|FG001|Overall Study|Ineligibility|0|||
47039327|NCT01737398|83292594|FG000|Overall Study|Liver transplant|1|||
47039328|NCT01737398|83292595|FG001|Overall Study|Liver transplant|0|||
47039329|NCT01737398|83292594|FG000|Overall Study|Disease progression|2|||
47039330|NCT01737398|83292595|FG001|Overall Study|Disease progression|3|||
47039331|NCT01737398|83292594|FG000|Overall Study|Sponsor's decision|2|||
47039332|NCT01737398|83292595|FG001|Overall Study|Sponsor's decision|0|||
47039333|NCT01795898|83292604|FG000|Overall Study|Adverse Event|27|||
47039334|NCT01795898|83292604|FG000|Overall Study|Lost to Follow-up|20|||
47039335|NCT01795898|83292604|FG000|Overall Study|Withdrawal of consent|6|||
47039336|NCT01795898|83292604|FG000|Overall Study|Diagnosed with metastasis|1|||
47039337|NCT01795898|83292604|FG000|Overall Study|No pain|1|||
46914823|NCT03066609|83145525|FG002|OVERALL STUDY|Adverse Event|0|||
46914824|NCT03066609|83145526|FG003|OVERALL STUDY|Adverse Event|1|||
46914825|NCT03066609|83145523|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
46914826|NCT03066609|83145524|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
46914827|NCT03066609|83145525|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
46914828|NCT03066609|83145526|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
46914829|NCT03066609|83145523|FG000|OVERALL STUDY|Lost to Follow-up|1|||
46914830|NCT03066609|83145524|FG001|OVERALL STUDY|Lost to Follow-up|1|||
46914831|NCT03066609|83145525|FG002|OVERALL STUDY|Lost to Follow-up|1|||
46914832|NCT03066609|83145526|FG003|OVERALL STUDY|Lost to Follow-up|1|||
46914833|NCT03066609|83145523|FG000|OVERALL STUDY|Pregnancy|1|||
46914834|NCT03066609|83145524|FG001|OVERALL STUDY|Pregnancy|0|||
46914835|NCT03066609|83145525|FG002|OVERALL STUDY|Pregnancy|1|||
46914836|NCT03066609|83145526|FG003|OVERALL STUDY|Pregnancy|0|||
46914837|NCT03066609|83145523|FG000|OVERALL STUDY|Lack of Efficacy|2|||
46914838|NCT03066609|83145524|FG001|OVERALL STUDY|Lack of Efficacy|1|||
47039338|NCT01795898|83292604|FG000|Overall Study|Death|1|||
47039339|NCT01795898|83292604|FG000|Overall Study|Withdrew consent & had adverse events|3|||
47039340|NCT01795898|83292604|FG000|Overall Study|Physician Decision|1|||
47039341|NCT01736696|83292615|FG000|Overall Study|Withdrawal by Subject|0|||
47039342|NCT01736696|83292616|FG001|Overall Study|Withdrawal by Subject|0|||
47039343|NCT01736696|83292617|FG002|Overall Study|Withdrawal by Subject|1|||
46716651|NCT01120691|82932530|FG001|Overall Study|Death|22|||
46716652|NCT01120691|82932531|FG002|Overall Study|Death|24|||
46716653|NCT01120691|82932529|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
46716654|NCT01120691|82932530|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
46716655|NCT01120691|82932531|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
46716656|NCT01120691|82932529|FG000|Overall Study|Administrative problems|15|||
46716657|NCT01120691|82932530|FG001|Overall Study|Administrative problems|8|||
46716658|NCT01120691|82932531|FG002|Overall Study|Administrative problems|9|||
46716659|NCT01120691|82932529|FG000|Overall Study|Protocol deviation|13|||
46716660|NCT01120691|82932530|FG001|Overall Study|Protocol deviation|12|||
46716661|NCT01120691|82932531|FG002|Overall Study|Protocol deviation|12|||
46716662|NCT01120691|82932529|FG000|Overall Study|Lost to Follow-up|5|||
46716663|NCT01120691|82932530|FG001|Overall Study|Lost to Follow-up|6|||
46716664|NCT01120691|82932531|FG002|Overall Study|Lost to Follow-up|4|||
46716665|NCT01120691|82932529|FG000|Overall Study|Abnormal test procedure result(s)|3|||
46716666|NCT01120691|82932530|FG001|Overall Study|Abnormal test procedure result(s)|2|||
46716667|NCT01120691|82932531|FG002|Overall Study|Abnormal test procedure result(s)|1|||
46716668|NCT01120691|82932529|FG000|Overall Study|Patient's inability to use the device|3|||
46716669|NCT01120691|82932530|FG001|Overall Study|Patient's inability to use the device|1|||
46716670|NCT01120691|82932531|FG002|Overall Study|Patient's inability to use the device|0|||
46716671|NCT01120691|82932529|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46716672|NCT01120691|82932530|FG001|Overall Study|Abnormal laboratory value(s)|3|||
46716673|NCT01120691|82932531|FG002|Overall Study|Abnormal laboratory value(s)|4|||
46716674|NCT00935493|82932546|FG000|Overall Study|Lost to Follow-up|1|||
46716675|NCT00935493|82932547|FG001|Overall Study|Lost to Follow-up|1|||
46716676|NCT00935493|82932548|FG002|Overall Study|Lost to Follow-up|1|||
46716677|NCT00935493|82932546|FG000|Overall Study|Treatment Discontinued|0|||
46716678|NCT00935493|82932547|FG001|Overall Study|Treatment Discontinued|1|||
46716679|NCT00935493|82932548|FG002|Overall Study|Treatment Discontinued|0|||
46716680|NCT03856996|82932558|FG000|Overall Study|Withdrawal by Subject|1|||
46914839|NCT03066609|83145525|FG002|OVERALL STUDY|Lack of Efficacy|1|||
46716681|NCT03856996|82932559|FG001|Overall Study|Withdrawal by Subject|0|||
46716682|NCT03856996|82932558|FG000|Overall Study|Lost to Follow-up|0|||
46716683|NCT03856996|82932559|FG001|Overall Study|Lost to Follow-up|1|||
47039344|NCT01736696|83292618|FG003|Overall Study|Withdrawal by Subject|0|||
47039345|NCT01736696|83292619|FG004|Overall Study|Withdrawal by Subject|0|||
47039346|NCT01736696|83292620|FG005|Overall Study|Withdrawal by Subject|0|||
47039347|NCT01736696|83292621|FG006|Overall Study|Withdrawal by Subject|0|||
46716684|NCT03856996|82932558|FG000|Overall Study|Adverse Event|1|||
46716685|NCT03856996|82932559|FG001|Overall Study|Adverse Event|1|||
46914840|NCT03066609|83145526|FG003|OVERALL STUDY|Lack of Efficacy|1|||
47039348|NCT01736540|83292645|FG000|Overall Study|Did not complete scan within 45 days|2|||
47039349|NCT01736540|83292645|FG000|Overall Study|Death|1|||
47039350|NCT01736540|83292645|FG000|Overall Study|Abnormal test procedure|1|||
47039351|NCT01736540|83292645|FG000|Overall Study|Withdrawal by Subject|5|||
47039352|NCT01736540|83292645|FG000|Overall Study|Protocol Violation|1|||
47039353|NCT01736540|83292645|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
47039354|NCT01736540|83292645|FG000|Overall Study|No show for MRI appointment|1|||
47039355|NCT01736540|83292645|FG000|Overall Study|Unable to make MRI appointment|3|||
47039356|NCT01794338|83292658|FG000|Overall Study|Death|2|||
47039357|NCT01794338|83292659|FG001|Overall Study|Death|0|||
47039358|NCT01794338|83292658|FG000|Overall Study|Lost to Follow-up|6|||
47039359|NCT01794338|83292659|FG001|Overall Study|Lost to Follow-up|9|||
47039360|NCT01609478|83292668|FG000|Overall Study|Adverse Event|3|||
47039361|NCT01609478|83292669|FG001|Overall Study|Adverse Event|1|||
47039362|NCT01609478|83292670|FG002|Overall Study|Adverse Event|5|||
47039363|NCT01609478|83292668|FG000|Overall Study|Protocol Deviation|0|||
47039364|NCT01609478|83292669|FG001|Overall Study|Protocol Deviation|1|||
47039365|NCT01609478|83292670|FG002|Overall Study|Protocol Deviation|1|||
47039366|NCT01609478|83292668|FG000|Overall Study|Non-Compliance with study treatment|1|||
47039367|NCT01609478|83292669|FG001|Overall Study|Non-Compliance with study treatment|0|||
47039368|NCT01609478|83292670|FG002|Overall Study|Non-Compliance with study treatment|0|||
47039369|NCT01609478|83292668|FG000|Overall Study|Physician Decision|1|||
47039370|NCT01609478|83292669|FG001|Overall Study|Physician Decision|0|||
47039371|NCT01609478|83292670|FG002|Overall Study|Physician Decision|1|||
47039372|NCT01609478|83292668|FG000|Overall Study|Withdrawal by Subject|2|||
47039373|NCT01609478|83292669|FG001|Overall Study|Withdrawal by Subject|0|||
47039374|NCT01609478|83292670|FG002|Overall Study|Withdrawal by Subject|2|||
47039375|NCT01764854|83292682|FG000|Overall Study|Adverse Event|0|||
47039376|NCT01764854|83292683|FG001|Overall Study|Adverse Event|0|||
47039377|NCT01764854|83292684|FG002|Overall Study|Adverse Event|2|||
47039378|NCT01764854|83292685|FG003|Overall Study|Adverse Event|0|||
47039379|NCT01764854|83292682|FG000|Overall Study|Withdrawal by Subject|0|||
47039380|NCT01764854|83292683|FG001|Overall Study|Withdrawal by Subject|0|||
47039381|NCT01764854|83292684|FG002|Overall Study|Withdrawal by Subject|1|||
47039382|NCT01764854|83292685|FG003|Overall Study|Withdrawal by Subject|0|||
47039383|NCT01764854|83292682|FG000|Overall Study|relocation|0|||
47039384|NCT01764854|83292683|FG001|Overall Study|relocation|0|||
47039385|NCT01764854|83292684|FG002|Overall Study|relocation|2|||
47039386|NCT01764854|83292685|FG003|Overall Study|relocation|0|||
47039387|NCT01764854|83292682|FG000|Overall Study|Protocol Violation|0|||
47039388|NCT01764854|83292683|FG001|Overall Study|Protocol Violation|0|||
47039389|NCT01764854|83292684|FG002|Overall Study|Protocol Violation|1|||
47039390|NCT01764854|83292685|FG003|Overall Study|Protocol Violation|2|||
47039391|NCT01764464|83292697|FG000|First Intervention|Withdrawal by Subject|1|||
47039392|NCT01764464|83292698|FG001|First Intervention|Withdrawal by Subject|0|||
47039393|NCT01764464|83292697|FG000|First Intervention|Lost to Follow-up|1|||
47039394|NCT01764464|83292698|FG001|First Intervention|Lost to Follow-up|0|||
47039395|NCT01764464|83292697|FG000|First Intervention|Adverse Event|0|||
47039396|NCT01764464|83292698|FG001|First Intervention|Adverse Event|2|||
47039397|NCT01764464|83292697|FG000|First Intervention|did not receive study drug|0|||
47039398|NCT01764464|83292698|FG001|First Intervention|did not receive study drug|1|||
47039399|NCT01764464|83292697|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
47039400|NCT01764464|83292698|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
47039401|NCT01764386|83292706|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
47039402|NCT01764386|83292707|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
47039403|NCT01764386|83292706|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
47039404|NCT01764386|83292707|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
47039405|NCT01764386|83292706|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
47039406|NCT01764386|83292707|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
47039407|NCT01764386|83292706|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
46716686|NCT03856996|82932558|FG000|Overall Study|Other|1|||
47039408|NCT01764386|83292707|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
47039409|NCT01764386|83292706|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
47039410|NCT01764386|83292707|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
47039411|NCT01764386|83292706|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
47039412|NCT01764386|83292707|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
47039413|NCT01764386|83292706|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
47039414|NCT01764386|83292707|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
47039415|NCT01764386|83292706|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
46716687|NCT03856996|82932559|FG001|Overall Study|Other|0|||
47039416|NCT01764386|83292707|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
47039417|NCT01763918|83292718|FG000|Overall Study|Withdrawal by Subject|2|||
47039418|NCT01763918|83292719|FG001|Overall Study|Withdrawal by Subject|1|||
47039419|NCT01763918|83292720|FG002|Overall Study|Withdrawal by Subject|1|||
46914841|NCT03066609|83145523|FG000|OVERALL STUDY|discontinued follow up|0|||
46914842|NCT03066609|83145524|FG001|OVERALL STUDY|discontinued follow up|2|||
46914843|NCT03066609|83145525|FG002|OVERALL STUDY|discontinued follow up|0|||
46914844|NCT03066609|83145526|FG003|OVERALL STUDY|discontinued follow up|0|||
46914845|NCT02964234|83145543|FG000|Overall Study|Lost to Follow-up|22|||
46914846|NCT02964234|83145544|FG001|Overall Study|Lost to Follow-up|13|||
47039420|NCT01763918|83292721|FG003|Overall Study|Withdrawal by Subject|2|||
47039421|NCT01763918|83292718|FG000|Overall Study|Sponsor Decision|4|||
47039422|NCT01763918|83292719|FG001|Overall Study|Sponsor Decision|0|||
47039423|NCT01763918|83292720|FG002|Overall Study|Sponsor Decision|9|||
47039424|NCT01763918|83292721|FG003|Overall Study|Sponsor Decision|0|||
46716688|NCT00935259|82932565|FG000|Period 1|Administrative (scheduling conflict)|1|||
46716689|NCT00935259|82932566|FG001|Period 1|Administrative (scheduling conflict)|1|||
46716690|NCT01120379|82932583|FG000|One Year Timepoint|Withdrawal by Subject|41|||
46716691|NCT01120379|82932583|FG000|One Year Timepoint|Lost to Follow-up|115|||
46716692|NCT01120379|82932583|FG000|One Year Timepoint|Death|108|||
46716693|NCT01120379|82932583|FG000|One Year Timepoint|Physician Decision|9|||
46716694|NCT01120379|82932583|FG000|One Year Timepoint|Any other reason for early termination|5|||
46716695|NCT01120379|82932583|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
46716696|NCT01120379|82932583|FG000|Two Year Timepoint|Lost to Follow-up|87|||
46716697|NCT01120379|82932583|FG000|Two Year Timepoint|Death|123|||
46716698|NCT01120379|82932583|FG000|Two Year Timepoint|Physician Decision|12|||
46716699|NCT01120379|82932583|FG000|Two Year Timepoint|Any other reason for early termination|4|||
46716700|NCT01120379|82932583|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
46716701|NCT01120379|82932583|FG000|Three Year Timepoint|Lost to Follow-up|43|||
46716702|NCT01120379|82932583|FG000|Three Year Timepoint|Death|120|||
46716703|NCT01120379|82932583|FG000|Three Year Timepoint|Physician Decision|9|||
46716704|NCT01120379|82932583|FG000|Three Year Timepoint|Any other reason for early termination|17|||
47039425|NCT01763684|83292733|FG000|Overall Study|Study terminated early due to low enrollment|126|||
46716705|NCT01120379|82932583|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
46716706|NCT01120379|82932583|FG000|Four Year Timepoint|Lost to Follow-up|10|||
47039426|NCT01763684|83292734|FG001|Overall Study|Study terminated early due to low enrollment|127|||
47039427|NCT01763684|83292733|FG000|Overall Study|Study surgery not performed|7|||
47039428|NCT01763684|83292734|FG001|Overall Study|Study surgery not performed|6|||
47039429|NCT01606748|83292742|FG000|Overall Study|Adverse Event|1|||
47039430|NCT01606748|83292743|FG001|Overall Study|Adverse Event|0|||
47039431|NCT01606748|83292742|FG000|Overall Study|Progressive Disease|1|||
47039432|NCT01606748|83292743|FG001|Overall Study|Progressive Disease|0|||
47039433|NCT01606748|83292742|FG000|Overall Study|Withdrawal by Subject|1|||
47039434|NCT01606748|83292743|FG001|Overall Study|Withdrawal by Subject|0|||
47039435|NCT01597622|83292761|FG000|Overall Study|Adverse Event|7|||
46631338|NCT01862328|82804425|FG002|Overall Study|Other|1|||
46631339|NCT01862328|82804426|FG003|Overall Study|Other|0|||
46631340|NCT01862328|82804427|FG004|Overall Study|Other|4|||
46631341|NCT01862328|82804428|FG005|Overall Study|Other|0|||
46631342|NCT01862328|82804429|FG006|Overall Study|Other|1|||
46631343|NCT01862328|82804423|FG000|Overall Study|Withdrawal by Subject|1|||
46631344|NCT01862328|82804424|FG001|Overall Study|Withdrawal by Subject|1|||
46631345|NCT01862328|82804425|FG002|Overall Study|Withdrawal by Subject|0|||
46631346|NCT01862328|82804426|FG003|Overall Study|Withdrawal by Subject|0|||
46631347|NCT01862328|82804427|FG004|Overall Study|Withdrawal by Subject|1|||
46631348|NCT01862328|82804428|FG005|Overall Study|Withdrawal by Subject|1|||
46631349|NCT01862328|82804429|FG006|Overall Study|Withdrawal by Subject|1|||
46631350|NCT01862328|82804423|FG000|Overall Study|Symptomatic Deterioration|0|||
46631351|NCT01862328|82804424|FG001|Overall Study|Symptomatic Deterioration|0|||
46631352|NCT01862328|82804425|FG002|Overall Study|Symptomatic Deterioration|0|||
46631353|NCT01862328|82804426|FG003|Overall Study|Symptomatic Deterioration|0|||
46631354|NCT01862328|82804427|FG004|Overall Study|Symptomatic Deterioration|0|||
46631355|NCT01862328|82804428|FG005|Overall Study|Symptomatic Deterioration|0|||
46631356|NCT01862328|82804429|FG006|Overall Study|Symptomatic Deterioration|1|||
46631357|NCT01862250|82804451|FG000|Overall Study|Adverse Event|4|||
46631358|NCT01860846|82804455|FG000|Overall Study|Lost to Follow-up|33|||
46716707|NCT01120379|82932583|FG000|Four Year Timepoint|Death|131|||
46716708|NCT01120379|82932583|FG000|Four Year Timepoint|Physician Decision|5|||
46716709|NCT01120379|82932583|FG000|Four Year Timepoint|Any other reason for early termination|217|||
46631359|NCT01901874|82804459|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
46716710|NCT01120067|82932589|FG000|Overall Study|Lost to Follow-up|3|||
47039436|NCT01597622|83292761|FG000|Overall Study|Lack of Efficacy|3|||
46716711|NCT01120067|82932590|FG001|Overall Study|Lost to Follow-up|1|||
46914847|NCT01345188|83145550|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
47039437|NCT01597622|83292761|FG000|Overall Study|Protocol Violation|1|||
47039438|NCT01597622|83292761|FG000|Overall Study|Lost to Follow-up|1|||
47039439|NCT01597622|83292761|FG000|Overall Study|Investigator Discretion|5|||
47039440|NCT01597622|83292761|FG000|Overall Study|Withdrawal by Subject|20|||
47039441|NCT01597622|83292761|FG000|Overall Study|Death|1|||
47039442|NCT01761266|83292767|FG000|Overall Study|Death|415|||
47039443|NCT01761266|83292768|FG001|Overall Study|Death|402|||
47039444|NCT01761266|83292767|FG000|Overall Study|Lost to Follow-up|8|||
47039445|NCT01761266|83292768|FG001|Overall Study|Lost to Follow-up|12|||
47039446|NCT01761266|83292767|FG000|Overall Study|Withdrawal by Subject|14|||
46716712|NCT01120067|82932589|FG000|Overall Study|fail to engage >3 sessions|2|||
46716713|NCT01120067|82932590|FG001|Overall Study|fail to engage >3 sessions|0|||
46716714|NCT01124045|82932598|FG000|Overall Study|Lost to Follow-up|0|||
46716715|NCT01124045|82932599|FG001|Overall Study|Lost to Follow-up|1|||
46716716|NCT01124045|82932598|FG000|Overall Study|Physician Decision|0|||
46914848|NCT01345188|83145550|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
46914849|NCT03852459|83145559|FG000|Overall Study|Adverse Event|2|||
46914850|NCT03852459|83145560|FG001|Overall Study|Adverse Event|2|||
46914851|NCT03852459|83145559|FG000|Overall Study|Withdrawal by Subject|1|||
46914852|NCT03852459|83145560|FG001|Overall Study|Withdrawal by Subject|1|||
46914853|NCT02896296|83145566|FG000|Overall Study|Adverse Event|1|||
46716717|NCT01124045|82932599|FG001|Overall Study|Physician Decision|2|||
46716718|NCT01123889|82932607|FG000|Overall Study|Lost to Follow-up|3|||
46716719|NCT01123889|82932608|FG001|Overall Study|Lost to Follow-up|1|||
46716720|NCT00934947|82932616|FG000|Overall Study|Adverse Event|0|||
46716721|NCT00934947|82932617|FG001|Overall Study|Adverse Event|2|||
46716722|NCT01123655|82932627|FG000|Overall Study|Medication for RA had to be changed|1|||
46716723|NCT01123655|82932628|FG001|Overall Study|Medication for RA had to be changed|0|||
46716724|NCT01123655|82932629|FG002|Overall Study|Medication for RA had to be changed|0|||
46716725|NCT01123655|82932627|FG000|Overall Study|new illness|0|||
46716726|NCT01123655|82932628|FG001|Overall Study|new illness|1|||
46716727|NCT01123655|82932629|FG002|Overall Study|new illness|0|||
46716728|NCT01123655|82932627|FG000|Overall Study|began prohibitive drug|0|||
46716729|NCT01123655|82932628|FG001|Overall Study|began prohibitive drug|0|||
46716730|NCT01123655|82932629|FG002|Overall Study|began prohibitive drug|1|||
46716731|NCT00934791|82932637|FG000|Overall Study|Withdrawal by Subject|1|||
46716732|NCT00934791|82932638|FG001|Overall Study|Withdrawal by Subject|0|||
46716733|NCT01119443|82932646|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
46716734|NCT01119443|82932647|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
46716735|NCT01111019|82932656|FG000|Overall Study|Withdrew Prematurely|2|||
46716736|NCT01111019|82932656|FG000|Overall Study|Other|1|||
46716737|NCT01119287|82932675|FG000|Overall Study|Patient Decision, not related to AE|0|||
46716738|NCT01119287|82932676|FG001|Overall Study|Patient Decision, not related to AE|0|||
46716739|NCT01119287|82932677|FG002|Overall Study|Patient Decision, not related to AE|2|||
46716740|NCT01119287|82932678|FG003|Overall Study|Patient Decision, not related to AE|2|||
46716741|NCT01119287|82932679|FG004|Overall Study|Patient Decision, not related to AE|1|||
46716742|NCT01119287|82932680|FG005|Overall Study|Patient Decision, not related to AE|0|||
46716743|NCT01110707|82932694|FG000|Overall Study|Protocol Violation|0|||
46716744|NCT01110707|82932695|FG001|Overall Study|Protocol Violation|3|||
46716745|NCT01119131|82932705|FG000|Overall Study|Adverse Event|1|||
46716746|NCT01119131|82932706|FG001|Overall Study|Adverse Event|1|||
46716747|NCT01119131|82932707|FG002|Overall Study|Adverse Event|1|||
46716748|NCT01119131|82932705|FG000|Overall Study|Non-Compliance|1|||
46716749|NCT01119131|82932706|FG001|Overall Study|Non-Compliance|0|||
46716750|NCT01119131|82932707|FG002|Overall Study|Non-Compliance|4|||
46716751|NCT01119131|82932705|FG000|Overall Study|Physician Decision|0|||
46716752|NCT01119131|82932706|FG001|Overall Study|Physician Decision|0|||
46716753|NCT01119131|82932707|FG002|Overall Study|Physician Decision|1|||
46716754|NCT01118975|82932717|FG000|Overall Study|Adverse Event|0|||
46914854|NCT02896296|83145566|FG000|Overall Study|Lost to Follow-up|19|||
46914855|NCT02896296|83145566|FG000|Overall Study|Pregnancy|1|||
46914856|NCT02896296|83145566|FG000|Overall Study|Physician Decision|2|||
46914857|NCT02896296|83145566|FG000|Overall Study|Withdrawal by Subject|10|||
46914858|NCT02896296|83145566|FG000|Overall Study|Site closing|7|||
46716755|NCT01118975|82932718|FG001|Overall Study|Adverse Event|1|||
46716756|NCT01110239|82932728|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
46914859|NCT02896296|83145566|FG000|Overall Study|Incarceration|1|||
46914860|NCT02896296|83145566|FG000|Overall Study|Relocation|1|||
46716757|NCT01110239|82932729|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
46716758|NCT01110239|82932730|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
46716759|NCT01110239|82932731|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
46914861|NCT03740919|83145573|FG000|Lead-in Period|Lost to Follow-up|1|||
46914862|NCT03740919|83145574|FG001|Lead-in Period|Lost to Follow-up|0|||
47039447|NCT01761266|83292768|FG001|Overall Study|Withdrawal by Subject|10|||
46716760|NCT01110239|82932728|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
46716761|NCT01110239|82932729|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
47039448|NCT01761266|83292767|FG000|Overall Study|Sponsor Decision|41|||
46716762|NCT01110239|82932730|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
46914863|NCT03740919|83145575|FG002|Lead-in Period|Lost to Follow-up|0|||
46914864|NCT03740919|83145576|FG003|Lead-in Period|Lost to Follow-up|0|||
46914865|NCT03740919|83145573|FG000|Lead-in Period|Physician Decision|2|||
46914866|NCT03740919|83145574|FG001|Lead-in Period|Physician Decision|0|||
46716763|NCT01110239|82932731|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
46716764|NCT01118663|82932744|FG000|Overall Study|Adverse Event|2|||
46716765|NCT01118663|82932745|FG001|Overall Study|Adverse Event|1|||
46716766|NCT01118663|82932744|FG000|Overall Study|Withdrawal by Subject|0|||
46716767|NCT01118663|82932745|FG001|Overall Study|Withdrawal by Subject|1|||
46914867|NCT03740919|83145575|FG002|Lead-in Period|Physician Decision|0|||
46914868|NCT03740919|83145576|FG003|Lead-in Period|Physician Decision|0|||
46914869|NCT03740919|83145573|FG000|Lead-in Period|Protocol Violation|1|||
46914870|NCT03740919|83145574|FG001|Lead-in Period|Protocol Violation|0|||
46914871|NCT03740919|83145575|FG002|Lead-in Period|Protocol Violation|0|||
46914872|NCT03740919|83145576|FG003|Lead-in Period|Protocol Violation|0|||
46914873|NCT03740919|83145573|FG000|Lead-in Period|Withdrawal by Subject|10|||
46914874|NCT03740919|83145574|FG001|Lead-in Period|Withdrawal by Subject|0|||
46914875|NCT03740919|83145575|FG002|Lead-in Period|Withdrawal by Subject|0|||
46914876|NCT03740919|83145576|FG003|Lead-in Period|Withdrawal by Subject|0|||
47039449|NCT01761266|83292768|FG001|Overall Study|Sponsor Decision|52|||
47039450|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
47039451|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
47039452|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
47039453|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
46716768|NCT01118351|82932751|FG000|Overall Study|Adverse Event|3|||
46716769|NCT01118351|82932751|FG000|Overall Study|Withdrawal by Subject|1|||
46716770|NCT01118117|82932772|FG000|Overall Study|Death|8|||
46716771|NCT01118117|82932773|FG001|Overall Study|Death|0|||
46716772|NCT01118117|82932772|FG000|Overall Study|Lost to Follow-up|6|||
46716773|NCT01118117|82932773|FG001|Overall Study|Lost to Follow-up|0|||
46716774|NCT01118117|82932772|FG000|Overall Study|Missed 12 Month Visit|7|||
47039454|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Adverse Event|5|||
47039455|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Adverse Event|3|||
46716775|NCT01118117|82932773|FG001|Overall Study|Missed 12 Month Visit|0|||
46716776|NCT01109849|82932781|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
46716777|NCT01109849|82932782|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
46716778|NCT01109849|82932783|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
46716779|NCT01109849|82932784|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
46716780|NCT01109849|82932785|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
46716781|NCT01109849|82932781|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
46716782|NCT01109849|82932782|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
46716783|NCT01109849|82932783|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
46716784|NCT01109849|82932784|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
46716785|NCT01109849|82932785|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
46716786|NCT01109849|82932781|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
46716787|NCT01109849|82932782|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
46716788|NCT01109849|82932783|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
46716789|NCT01109849|82932784|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
46716790|NCT01109849|82932785|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
46716791|NCT01109849|82932781|FG000|Initial Randomization: ADHD Treatment|move away|2|||
46716792|NCT01109849|82932782|FG001|Initial Randomization: ADHD Treatment|move away|7|||
46716793|NCT01109849|82932783|FG002|Initial Randomization: ADHD Treatment|move away|0|||
46716794|NCT01109849|82932784|FG003|Initial Randomization: ADHD Treatment|move away|0|||
46716795|NCT01109849|82932785|FG004|Initial Randomization: ADHD Treatment|move away|0|||
46716796|NCT01109849|82932781|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
46716797|NCT01109849|82932782|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
46716798|NCT01109849|82932783|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
46716799|NCT01109849|82932784|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
46716800|NCT01109849|82932785|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
46716801|NCT01109849|82932781|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
46716802|NCT01109849|82932782|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
46716803|NCT01109849|82932783|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
47039456|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Adverse Event|4|||
46716804|NCT01109849|82932784|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
46716805|NCT01109849|82932785|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
46914877|NCT03740919|83145573|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
46914878|NCT03740919|83145574|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
46914879|NCT03740919|83145575|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
47039457|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Adverse Event|10|||
47039458|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
46716806|NCT01061736|82932815|FG000|Overall Study|Dose regimen not selected|0|||
46716807|NCT01061736|82932816|FG001|Overall Study|Dose regimen not selected|0|||
46716808|NCT01061736|82932817|FG002|Overall Study|Dose regimen not selected|0|||
46716809|NCT01061736|82932818|FG003|Overall Study|Dose regimen not selected|0|||
46716810|NCT01061736|82932819|FG004|Overall Study|Dose regimen not selected|0|||
46716811|NCT01061736|82932820|FG005|Overall Study|Dose regimen not selected|0|||
46716812|NCT01061736|82932821|FG006|Overall Study|Dose regimen not selected|79|||
46716813|NCT01061736|82932822|FG007|Overall Study|Dose regimen not selected|0|||
46716814|NCT01061736|82932823|FG008|Overall Study|Dose regimen not selected|0|||
46716815|NCT01061736|82932824|FG009|Overall Study|Dose regimen not selected|0|||
46716816|NCT01061736|82932815|FG000|Overall Study|Adverse Event|13|||
46716817|NCT01061736|82932816|FG001|Overall Study|Adverse Event|1|||
46716818|NCT01061736|82932817|FG002|Overall Study|Adverse Event|3|||
46716819|NCT01061736|82932818|FG003|Overall Study|Adverse Event|2|||
46716820|NCT01061736|82932819|FG004|Overall Study|Adverse Event|4|||
46716821|NCT01061736|82932820|FG005|Overall Study|Adverse Event|1|||
46716822|NCT01061736|82932821|FG006|Overall Study|Adverse Event|4|||
46716823|NCT01061736|82932822|FG007|Overall Study|Adverse Event|63|||
46716824|NCT01061736|82932823|FG008|Overall Study|Adverse Event|67|||
46716825|NCT01061736|82932824|FG009|Overall Study|Adverse Event|34|||
46716826|NCT01061736|82932815|FG000|Overall Study|Lack of Efficacy|0|||
46716827|NCT01061736|82932816|FG001|Overall Study|Lack of Efficacy|2|||
46716828|NCT01061736|82932817|FG002|Overall Study|Lack of Efficacy|1|||
47039459|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
47039460|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
47039461|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
46716829|NCT01061736|82932818|FG003|Overall Study|Lack of Efficacy|1|||
46716830|NCT01061736|82932819|FG004|Overall Study|Lack of Efficacy|1|||
46716831|NCT01061736|82932820|FG005|Overall Study|Lack of Efficacy|2|||
46716832|NCT01061736|82932821|FG006|Overall Study|Lack of Efficacy|1|||
46716833|NCT01061736|82932822|FG007|Overall Study|Lack of Efficacy|9|||
46716834|NCT01061736|82932823|FG008|Overall Study|Lack of Efficacy|9|||
46914880|NCT03740919|83145576|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
46914881|NCT03740919|83145573|FG000|Lead-in Period|Study Task Too Burdensome|1|||
46914882|NCT03740919|83145574|FG001|Lead-in Period|Study Task Too Burdensome|0|||
46914883|NCT03740919|83145575|FG002|Lead-in Period|Study Task Too Burdensome|0|||
47039462|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
47039463|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
47039464|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
47039465|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
47039466|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Pregnancy|5|||
47039467|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Pregnancy|0|||
47039468|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Pregnancy|3|||
47039469|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Pregnancy|2|||
47039470|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Non-compliance|1|||
47039471|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Non-compliance|4|||
47039472|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Non-compliance|0|||
47039473|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Non-compliance|3|||
47039474|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Other|0|||
47039475|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Other|3|||
47039476|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Other|3|||
47039477|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Other|1|||
47039478|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
47039479|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
47039480|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
47039481|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
47039482|NCT01760954|83292781|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
46716835|NCT01061736|82932824|FG009|Overall Study|Lack of Efficacy|10|||
46716836|NCT01061736|82932815|FG000|Overall Study|Poor compliance to protocol|0|||
47039483|NCT01760954|83292782|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
46716837|NCT01061736|82932816|FG001|Overall Study|Poor compliance to protocol|0|||
46716838|NCT01061736|82932817|FG002|Overall Study|Poor compliance to protocol|0|||
47039484|NCT01760954|83292783|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
46716839|NCT01061736|82932818|FG003|Overall Study|Poor compliance to protocol|0|||
46716840|NCT01061736|82932819|FG004|Overall Study|Poor compliance to protocol|0|||
46716841|NCT01061736|82932820|FG005|Overall Study|Poor compliance to protocol|0|||
46716842|NCT01061736|82932821|FG006|Overall Study|Poor compliance to protocol|0|||
46716843|NCT01061736|82932822|FG007|Overall Study|Poor compliance to protocol|2|||
46716844|NCT01061736|82932823|FG008|Overall Study|Poor compliance to protocol|5|||
46914884|NCT03740919|83145576|FG003|Lead-in Period|Study Task Too Burdensome|0|||
46914885|NCT03740919|83145573|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
46914886|NCT03740919|83145574|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
46914887|NCT03740919|83145575|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
46914888|NCT03740919|83145576|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
47039485|NCT01760954|83292784|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
47039486|NCT01760954|83292781|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
47039487|NCT01760954|83292782|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
47039488|NCT01760954|83292783|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
46914889|NCT03740919|83145573|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
46914890|NCT03740919|83145574|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
46914891|NCT03740919|83145575|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
46914892|NCT03740919|83145576|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
46914893|NCT03740919|83145573|FG000|Treatment Period|Adverse Event|0|||
46914894|NCT03740919|83145574|FG001|Treatment Period|Adverse Event|0|||
46914895|NCT03740919|83145575|FG002|Treatment Period|Adverse Event|2|||
46914896|NCT03740919|83145576|FG003|Treatment Period|Adverse Event|0|||
46914897|NCT03740919|83145573|FG000|Treatment Period|Protocol Violation|0|||
46914898|NCT03740919|83145574|FG001|Treatment Period|Protocol Violation|1|||
46914899|NCT03740919|83145575|FG002|Treatment Period|Protocol Violation|0|||
46914900|NCT03740919|83145576|FG003|Treatment Period|Protocol Violation|0|||
46914901|NCT03740919|83145573|FG000|Treatment Period|Withdrawal by Subject|0|||
46914902|NCT03740919|83145574|FG001|Treatment Period|Withdrawal by Subject|7|||
46914903|NCT03740919|83145575|FG002|Treatment Period|Withdrawal by Subject|6|||
46914904|NCT03740919|83145576|FG003|Treatment Period|Withdrawal by Subject|2|||
47039489|NCT01760954|83292784|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
47039490|NCT01760954|83292781|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
47039491|NCT01760954|83292782|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
46631360|NCT01901874|82804459|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
46716845|NCT01061736|82932824|FG009|Overall Study|Poor compliance to protocol|9|||
46631361|NCT01901874|82804459|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
46631362|NCT01901874|82804459|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
46716846|NCT01061736|82932815|FG000|Overall Study|Not treated|0|||
46716847|NCT01061736|82932816|FG001|Overall Study|Not treated|0|||
46716848|NCT01061736|82932817|FG002|Overall Study|Not treated|0|||
46716849|NCT01061736|82932818|FG003|Overall Study|Not treated|0|||
46716850|NCT01061736|82932819|FG004|Overall Study|Not treated|1|||
46716851|NCT01061736|82932820|FG005|Overall Study|Not treated|0|||
46716852|NCT01061736|82932821|FG006|Overall Study|Not treated|0|||
46716853|NCT01061736|82932822|FG007|Overall Study|Not treated|2|||
46716854|NCT01061736|82932823|FG008|Overall Study|Not treated|1|||
46716855|NCT01061736|82932824|FG009|Overall Study|Not treated|0|||
46716856|NCT01061736|82932815|FG000|Overall Study|Other than specified above|0|||
46716857|NCT01061736|82932816|FG001|Overall Study|Other than specified above|1|||
46716858|NCT01061736|82932817|FG002|Overall Study|Other than specified above|2|||
46716859|NCT01061736|82932818|FG003|Overall Study|Other than specified above|0|||
46716860|NCT01061736|82932819|FG004|Overall Study|Other than specified above|1|||
46716861|NCT01061736|82932820|FG005|Overall Study|Other than specified above|0|||
46716862|NCT01061736|82932821|FG006|Overall Study|Other than specified above|0|||
46716863|NCT01061736|82932822|FG007|Overall Study|Other than specified above|18|||
46716864|NCT01061736|82932823|FG008|Overall Study|Other than specified above|15|||
46716865|NCT01061736|82932824|FG009|Overall Study|Other than specified above|21|||
46716866|NCT01117337|82932851|FG000|Overall Study|Lost to Follow-up|4|||
46716867|NCT01117337|82932852|FG001|Overall Study|Lost to Follow-up|0|||
47039492|NCT01760954|83292783|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
47039493|NCT01760954|83292784|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
47039494|NCT01760954|83292781|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
46631363|NCT01901874|82804459|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
46631364|NCT01901874|82804459|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
46631365|NCT01860534|82804465|FG000|ROP #1|Needed treatment for ROP|0|||
46631366|NCT01860534|82804466|FG001|ROP #1|Needed treatment for ROP|1|||
46716868|NCT01108523|82932862|FG000|Overall Study|Protocol Violation|4|||
46716869|NCT01035606|82932869|FG000|Overall Study|change in health, job demands,family|3|||
46716870|NCT01035606|82932870|FG001|Overall Study|change in health, job demands,family|3|||
46716871|NCT01035606|82932871|FG002|Overall Study|change in health, job demands,family|4|||
46914905|NCT03740919|83145573|FG000|Treatment Period|Terminated by Sponsor|0|||
46914906|NCT03740919|83145574|FG001|Treatment Period|Terminated by Sponsor|1|||
46914907|NCT03740919|83145575|FG002|Treatment Period|Terminated by Sponsor|0|||
46716872|NCT01117181|82932881|FG000|Overall Study|Lost to Follow-up|1|||
46716873|NCT01117181|82932882|FG001|Overall Study|Lost to Follow-up|0|||
46716874|NCT01117181|82932881|FG000|Overall Study|Withdrawal by Subject|0|||
47039495|NCT01760954|83292782|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
47039496|NCT01760954|83292783|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
47039497|NCT01760954|83292784|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
47039498|NCT01760954|83292781|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
47039499|NCT01760954|83292782|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
47039500|NCT01760954|83292783|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
46716875|NCT01117181|82932882|FG001|Overall Study|Withdrawal by Subject|2|||
46716876|NCT01040130|82932890|FG000|Overall Study|Adverse Event|1|||
46716877|NCT01040130|82932891|FG001|Overall Study|Adverse Event|1|||
46716878|NCT01040130|82932892|FG002|Overall Study|Adverse Event|0|||
46716879|NCT01040130|82932893|FG003|Overall Study|Adverse Event|5|||
46716880|NCT01040130|82932894|FG004|Overall Study|Adverse Event|0|||
46716881|NCT01040130|82932895|FG005|Overall Study|Adverse Event|3|||
46716882|NCT01040130|82932890|FG000|Overall Study|Protocol Violation|0|||
46716883|NCT01040130|82932891|FG001|Overall Study|Protocol Violation|0|||
46716884|NCT01040130|82932892|FG002|Overall Study|Protocol Violation|2|||
46716885|NCT01040130|82932893|FG003|Overall Study|Protocol Violation|0|||
46716886|NCT01040130|82932894|FG004|Overall Study|Protocol Violation|0|||
46716887|NCT01040130|82932895|FG005|Overall Study|Protocol Violation|0|||
46716888|NCT01040130|82932890|FG000|Overall Study|Withdrawal by Subject|0|||
46716889|NCT01040130|82932891|FG001|Overall Study|Withdrawal by Subject|2|||
46914908|NCT03740919|83145576|FG003|Treatment Period|Terminated by Sponsor|0|||
46914909|NCT03740919|83145573|FG000|Treatment Period|Issue with Insulin Pump|0|||
46914910|NCT03740919|83145574|FG001|Treatment Period|Issue with Insulin Pump|1|||
46914911|NCT03740919|83145575|FG002|Treatment Period|Issue with Insulin Pump|0|||
46914912|NCT03740919|83145576|FG003|Treatment Period|Issue with Insulin Pump|0|||
46914913|NCT03740919|83145573|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
46914914|NCT03740919|83145574|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
46914915|NCT03740919|83145575|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
46914916|NCT03740919|83145576|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
46914917|NCT03740919|83145573|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
46914918|NCT03740919|83145574|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
46914919|NCT03740919|83145575|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
46914920|NCT03740919|83145576|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
46914921|NCT03740919|83145573|FG000|Treatment Period|Not Completing Diary|0|||
46914922|NCT03740919|83145574|FG001|Treatment Period|Not Completing Diary|0|||
46914923|NCT03740919|83145575|FG002|Treatment Period|Not Completing Diary|1|||
47039501|NCT01760954|83292784|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
47039502|NCT01760954|83292781|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
47073130|NCT01045161|83361495|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
46631367|NCT01860534|82804465|FG000|ROP #2|discharged prior to ROP #2|1|||
46631368|NCT01860534|82804466|FG001|ROP #2|discharged prior to ROP #2|0|||
46631369|NCT01901328|82804476|FG000|Overall Study|Lost to Follow-up|1|||
46631370|NCT01901328|82804477|FG001|Overall Study|Lost to Follow-up|0|||
46631371|NCT01901328|82804476|FG000|Overall Study|Physician Decision|0|||
46631372|NCT01901328|82804477|FG001|Overall Study|Physician Decision|1|||
46631373|NCT01901328|82804476|FG000|Overall Study|Protocol Violation|1|||
46631374|NCT01901328|82804477|FG001|Overall Study|Protocol Violation|1|||
46631375|NCT01901328|82804476|FG000|Overall Study|Study Terminated by Sponsor|19|||
46631376|NCT01901328|82804477|FG001|Overall Study|Study Terminated by Sponsor|16|||
46631377|NCT01901328|82804476|FG000|Overall Study|Withdrawal by Subject|1|||
46631378|NCT01901328|82804477|FG001|Overall Study|Withdrawal by Subject|2|||
46631379|NCT01901328|82804476|FG000|Overall Study|Lack of Efficacy|0|||
46631380|NCT01901328|82804477|FG001|Overall Study|Lack of Efficacy|1|||
46631381|NCT01859988|82804490|FG000|Overall Study|Withdrawal by Subject|6|||
46631382|NCT01859988|82804491|FG001|Overall Study|Withdrawal by Subject|3|||
46631383|NCT01859988|82804492|FG002|Overall Study|Withdrawal by Subject|4|||
46631384|NCT01859988|82804493|FG003|Overall Study|Withdrawal by Subject|3|||
46631385|NCT01859988|82804494|FG004|Overall Study|Withdrawal by Subject|2|||
46631386|NCT01859988|82804495|FG005|Overall Study|Withdrawal by Subject|2|||
46631387|NCT01859988|82804490|FG000|Overall Study|Lack of Efficacy|1|||
46631388|NCT01859988|82804491|FG001|Overall Study|Lack of Efficacy|1|||
46631389|NCT01859988|82804492|FG002|Overall Study|Lack of Efficacy|5|||
46631390|NCT01859988|82804493|FG003|Overall Study|Lack of Efficacy|0|||
46631391|NCT01859988|82804494|FG004|Overall Study|Lack of Efficacy|7|||
46631392|NCT01859988|82804495|FG005|Overall Study|Lack of Efficacy|9|||
46631393|NCT01859988|82804490|FG000|Overall Study|Physician Decision|1|||
46631394|NCT01859988|82804491|FG001|Overall Study|Physician Decision|3|||
46631395|NCT01859988|82804492|FG002|Overall Study|Physician Decision|1|||
46631396|NCT01859988|82804493|FG003|Overall Study|Physician Decision|3|||
46631397|NCT01859988|82804494|FG004|Overall Study|Physician Decision|4|||
46716890|NCT01040130|82932892|FG002|Overall Study|Withdrawal by Subject|0|||
46716891|NCT01040130|82932893|FG003|Overall Study|Withdrawal by Subject|0|||
46716892|NCT01040130|82932894|FG004|Overall Study|Withdrawal by Subject|0|||
46716893|NCT01040130|82932895|FG005|Overall Study|Withdrawal by Subject|1|||
46716894|NCT01040130|82932890|FG000|Overall Study|Other reasons not listed above|2|||
46716895|NCT01040130|82932891|FG001|Overall Study|Other reasons not listed above|0|||
46716896|NCT01040130|82932892|FG002|Overall Study|Other reasons not listed above|0|||
46716897|NCT01040130|82932893|FG003|Overall Study|Other reasons not listed above|0|||
46716898|NCT01040130|82932894|FG004|Overall Study|Other reasons not listed above|0|||
46716899|NCT01040130|82932895|FG005|Overall Study|Other reasons not listed above|0|||
46716900|NCT00932451|82932905|FG000|Overall Study|Withdrawal by Subject|69|||
46716901|NCT00932451|82932905|FG000|Overall Study|Lost to Follow-up|22|||
46716902|NCT00932451|82932905|FG000|Overall Study|Death|726|||
46716903|NCT00932451|82932905|FG000|Overall Study|Other reasons|5|||
46716904|NCT01108055|82932913|FG000|Overall Study|Ineligible|11|||
46716905|NCT01108055|82932913|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
46716906|NCT01107899|82932920|FG000|Overall Study|Physician Decision|5|||
46716907|NCT01107899|82932921|FG001|Overall Study|Physician Decision|0|||
46716908|NCT01107899|82932922|FG002|Overall Study|Physician Decision|3|||
46716909|NCT01107899|82932920|FG000|Overall Study|Withdrawal by Subject|0|||
46716910|NCT01107899|82932921|FG001|Overall Study|Withdrawal by Subject|0|||
46716911|NCT01107899|82932922|FG002|Overall Study|Withdrawal by Subject|1|||
46716912|NCT01115933|82932933|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
46716913|NCT01107743|82932990|FG000|Overall Study|Protocol Violation|46|||
46716914|NCT01059864|82933039|FG000|Open-Label Run-In Phase|Adverse Event|7|||
46716915|NCT01059864|82933040|FG001|Open-Label Run-In Phase|Adverse Event|0|||
46716916|NCT01059864|82933041|FG002|Open-Label Run-In Phase|Adverse Event|0|||
46716917|NCT01059864|82933039|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
46716918|NCT01059864|82933040|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
46716919|NCT01059864|82933041|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
46716920|NCT01059864|82933039|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
46631398|NCT01859988|82804495|FG005|Overall Study|Physician Decision|1|||
46631399|NCT01859988|82804490|FG000|Overall Study|Adverse Event|2|||
46631400|NCT01859988|82804491|FG001|Overall Study|Adverse Event|1|||
46716921|NCT01059864|82933040|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
46716922|NCT01059864|82933041|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
46716923|NCT01059864|82933039|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
46716924|NCT01059864|82933040|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
46716925|NCT01059864|82933041|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
46716926|NCT01059864|82933039|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
46716927|NCT01059864|82933040|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
46716928|NCT01059864|82933041|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
46716929|NCT01059864|82933039|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
46716930|NCT01059864|82933040|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
46716931|NCT01059864|82933041|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
46716932|NCT01035138|82933051|FG000|Overall Study|Adverse Event|4|||
46716933|NCT01035138|82933052|FG001|Overall Study|Adverse Event|0|||
46716934|NCT01035138|82933053|FG002|Overall Study|Adverse Event|2|||
46716935|NCT01035138|82933051|FG000|Overall Study|Caregiver Decision|2|||
46914924|NCT03740919|83145576|FG003|Treatment Period|Not Completing Diary|0|||
46914925|NCT03740919|83145573|FG000|Treatment Period|Insulin Painful to Participant|0|||
47039503|NCT01760954|83292782|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
47039504|NCT01760954|83292783|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
47039505|NCT01760954|83292784|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
46631401|NCT01859988|82804492|FG002|Overall Study|Adverse Event|3|||
46914926|NCT03740919|83145574|FG001|Treatment Period|Insulin Painful to Participant|0|||
46914927|NCT03740919|83145575|FG002|Treatment Period|Insulin Painful to Participant|1|||
46914928|NCT03740919|83145576|FG003|Treatment Period|Insulin Painful to Participant|0|||
46914929|NCT01335685|83145591|FG000|Overall Study|Study Terminated by Sponsor|2|||
46631402|NCT01859988|82804493|FG003|Overall Study|Adverse Event|1|||
46631403|NCT01859988|82804494|FG004|Overall Study|Adverse Event|2|||
46631404|NCT01859988|82804495|FG005|Overall Study|Adverse Event|2|||
46631405|NCT01859988|82804490|FG000|Overall Study|Lost to Follow-up|1|||
46716936|NCT01035138|82933052|FG001|Overall Study|Caregiver Decision|0|||
46716937|NCT01035138|82933053|FG002|Overall Study|Caregiver Decision|1|||
46716938|NCT01035138|82933051|FG000|Overall Study|Withdrawal by Subject|1|||
46914930|NCT01335685|83145592|FG001|Overall Study|Study Terminated by Sponsor|1|||
47039506|NCT01760954|83292781|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
47039507|NCT01760954|83292782|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
47039508|NCT01760954|83292783|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
46631406|NCT01859988|82804491|FG001|Overall Study|Lost to Follow-up|2|||
46716939|NCT01035138|82933052|FG001|Overall Study|Withdrawal by Subject|0|||
46716940|NCT01035138|82933053|FG002|Overall Study|Withdrawal by Subject|0|||
46716941|NCT01035138|82933051|FG000|Overall Study|Physician Decision|0|||
46716942|NCT01035138|82933052|FG001|Overall Study|Physician Decision|0|||
46716943|NCT01035138|82933053|FG002|Overall Study|Physician Decision|1|||
46716944|NCT01035138|82933051|FG000|Overall Study|Sponsor Decision|66|||
46914931|NCT01335685|83145593|FG002|Overall Study|Study Terminated by Sponsor|1|||
46914932|NCT01335685|83145594|FG003|Overall Study|Study Terminated by Sponsor|10|||
47039509|NCT01760954|83292784|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
47039510|NCT01760876|83292794|FG000|Overall Study|Non-cardiac death (head injury)|1|||
47039511|NCT01760876|83292794|FG000|Overall Study|Carcinoma of prostate|1|||
47039512|NCT01760876|83292794|FG000|Overall Study|Impaired renal function|1|||
47039513|NCT01760876|83292794|FG000|Overall Study|Major depression|1|||
46631407|NCT01859988|82804492|FG002|Overall Study|Lost to Follow-up|3|||
46631408|NCT01859988|82804493|FG003|Overall Study|Lost to Follow-up|0|||
46631409|NCT01859988|82804494|FG004|Overall Study|Lost to Follow-up|3|||
46914933|NCT01335685|83145595|FG004|Overall Study|Study Terminated by Sponsor|0|||
46914934|NCT01335685|83145596|FG005|Overall Study|Study Terminated by Sponsor|4|||
46914935|NCT01335685|83145597|FG006|Overall Study|Study Terminated by Sponsor|2|||
46914936|NCT01335685|83145598|FG007|Overall Study|Study Terminated by Sponsor|3|||
46914937|NCT01335685|83145591|FG000|Overall Study|Withdrawal by Subject|1|||
46914938|NCT01335685|83145592|FG001|Overall Study|Withdrawal by Subject|0|||
46914939|NCT01335685|83145593|FG002|Overall Study|Withdrawal by Subject|0|||
46914940|NCT01335685|83145594|FG003|Overall Study|Withdrawal by Subject|1|||
46914941|NCT01335685|83145595|FG004|Overall Study|Withdrawal by Subject|0|||
46914942|NCT01335685|83145596|FG005|Overall Study|Withdrawal by Subject|0|||
46914943|NCT01335685|83145597|FG006|Overall Study|Withdrawal by Subject|0|||
46914944|NCT01335685|83145598|FG007|Overall Study|Withdrawal by Subject|0|||
46914945|NCT01335685|83145591|FG000|Overall Study|Reason not Specified|0|||
46914946|NCT01335685|83145592|FG001|Overall Study|Reason not Specified|0|||
46914947|NCT01335685|83145593|FG002|Overall Study|Reason not Specified|1|||
46914948|NCT01335685|83145594|FG003|Overall Study|Reason not Specified|0|||
46914949|NCT01335685|83145595|FG004|Overall Study|Reason not Specified|0|||
46914950|NCT01335685|83145596|FG005|Overall Study|Reason not Specified|1|||
46914951|NCT01335685|83145597|FG006|Overall Study|Reason not Specified|0|||
47039514|NCT01760876|83292794|FG000|Overall Study|Very poor baseline OCT quality|2|||
47039515|NCT01759862|83292800|FG000|Overall Study|Physician Decision|3|||
47039516|NCT01759862|83292801|FG001|Overall Study|Physician Decision|1|||
47039517|NCT01759862|83292800|FG000|Overall Study|Adverse Event|0|||
47039518|NCT01759862|83292801|FG001|Overall Study|Adverse Event|1|||
47039519|NCT01606670|83292807|FG000|Overall Study|Adverse Event|6|||
47039520|NCT01606670|83292807|FG000|Overall Study|Lack of Efficacy|2|||
47039521|NCT01606670|83292807|FG000|Overall Study|Lost to Follow-up|3|||
47039522|NCT01606670|83292807|FG000|Overall Study|Withdrawal by Subject|3|||
47039523|NCT01606670|83292807|FG000|Overall Study|Other Reason|2|||
47039524|NCT01793792|83292811|FG000|Overall Study|Death|5|||
47039525|NCT01793792|83292811|FG000|Overall Study|Lost to Follow-up|5|||
47039526|NCT01793792|83292811|FG000|Overall Study|Withdrawal by Subject|1|||
47039527|NCT01793792|83292811|FG000|Overall Study|Device Not Implanted|1|||
47039528|NCT01790984|83292817|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
47039529|NCT01790984|83292818|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
47039530|NCT01790984|83292819|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
47039531|NCT01790984|83292820|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
47039532|NCT01735994|83292845|FG000|Overall Study|Withdrawal by Subject|6|||
47039533|NCT01735994|83292846|FG001|Overall Study|Withdrawal by Subject|4|||
47039534|NCT01735994|83292845|FG000|Overall Study|Injury|2|||
47039535|NCT01735994|83292846|FG001|Overall Study|Injury|0|||
47039536|NCT01735994|83292845|FG000|Overall Study|Kicked off team|5|||
47039537|NCT01735994|83292846|FG001|Overall Study|Kicked off team|0|||
47039538|NCT01735994|83292845|FG000|Overall Study|Lost to Follow-up|50|||
47039539|NCT01735994|83292846|FG001|Overall Study|Lost to Follow-up|62|||
47039540|NCT01790828|83292852|FG000|Overall Study|Other|34|||
47039541|NCT01790594|83292858|FG000|Overall Study|Death|1|||
46631410|NCT01859988|82804495|FG005|Overall Study|Lost to Follow-up|2|||
46631411|NCT01859988|82804490|FG000|Overall Study|Protocol Violation|0|||
46631412|NCT01859988|82804491|FG001|Overall Study|Protocol Violation|0|||
46716945|NCT01035138|82933052|FG001|Overall Study|Sponsor Decision|60|||
46914952|NCT01335685|83145598|FG007|Overall Study|Reason not Specified|0|||
47039542|NCT01790594|83292859|FG001|Overall Study|Death|0|||
47039543|NCT01790594|83292860|FG002|Overall Study|Death|0|||
46631413|NCT01859988|82804492|FG002|Overall Study|Protocol Violation|1|||
46914953|NCT02926209|83145621|FG000|Study Cohort|Poor Bowel Preparation|1|||
46914954|NCT02926209|83145622|FG001|Study Cohort|Poor Bowel Preparation|0|||
46914955|NCT03066999|83145631|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
46716946|NCT01035138|82933053|FG002|Overall Study|Sponsor Decision|42|||
46914956|NCT03066999|83145632|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
46631414|NCT01859988|82804493|FG003|Overall Study|Protocol Violation|0|||
46631415|NCT01859988|82804494|FG004|Overall Study|Protocol Violation|0|||
46914957|NCT02963922|83145646|FG000|Overall Study|Adverse Event|15|||
46914958|NCT02963922|83145647|FG001|Overall Study|Adverse Event|6|||
47039544|NCT01790594|83292858|FG000|Overall Study|Physician Decision|2|||
47039545|NCT01790594|83292859|FG001|Overall Study|Physician Decision|1|||
47039546|NCT01790594|83292860|FG002|Overall Study|Physician Decision|0|||
46716947|NCT01035138|82933051|FG000|Overall Study|Lost to Follow-up|0|||
46914959|NCT02963922|83145646|FG000|Overall Study|Protocol deviation|6|||
46914960|NCT02963922|83145647|FG001|Overall Study|Protocol deviation|6|||
47039547|NCT01790594|83292858|FG000|Overall Study|Withdrawal by Subject|2|||
47039548|NCT01790594|83292859|FG001|Overall Study|Withdrawal by Subject|0|||
47039549|NCT01790594|83292860|FG002|Overall Study|Withdrawal by Subject|0|||
47039550|NCT01790594|83292858|FG000|Overall Study|Transplant was not done|0|||
46716948|NCT01035138|82933052|FG001|Overall Study|Lost to Follow-up|0|||
46716949|NCT01035138|82933053|FG002|Overall Study|Lost to Follow-up|1|||
46716950|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
46716951|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
46716952|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
46716953|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
46716954|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
46716955|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
46716956|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
46716957|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
46716958|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
46716959|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
46716960|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
46716961|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
46716962|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
46716963|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
46716964|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
46716965|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
46716966|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Program Termination|3|||
46716967|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Program Termination|0|||
46716968|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Program Termination|1|||
46716969|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Program Termination|1|||
46716970|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
46716971|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
46716972|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
46716973|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
46716974|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
46716975|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
46716976|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
46716977|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
46716978|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
46716979|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
46716980|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
46716981|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
46914961|NCT02963922|83145646|FG000|Overall Study|Lack of Efficacy|1|||
46914962|NCT02963922|83145647|FG001|Overall Study|Lack of Efficacy|1|||
46716982|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
46716983|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
46716984|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
46716985|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
46716986|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
46716987|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
46716988|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
46716989|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
46716990|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
46716991|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
46716992|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
46716993|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
46716994|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
46716995|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
46716996|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
46716997|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
46716998|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
46914963|NCT02963922|83145646|FG000|Overall Study|Lost to Follow-up|2|||
46914964|NCT02963922|83145647|FG001|Overall Study|Lost to Follow-up|3|||
47039551|NCT01790594|83292859|FG001|Overall Study|Transplant was not done|0|||
47039552|NCT01790594|83292860|FG002|Overall Study|Transplant was not done|3|||
46716999|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
46717000|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
46717001|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
46717002|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
46717003|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
46914965|NCT02963922|83145646|FG000|Overall Study|Other|8|||
46914966|NCT02963922|83145647|FG001|Overall Study|Other|14|||
47039553|NCT01790594|83292858|FG000|Overall Study|Terminated prior to week 76|0|||
46717004|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
46717005|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
46717006|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
46717007|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
46717008|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
46717009|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
46717010|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
46717011|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
46717012|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
46717013|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
46717014|NCT03739840|82933067|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
46717015|NCT03739840|82933068|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
46717016|NCT03739840|82933069|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
46717017|NCT03739840|82933070|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
46717018|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
46717019|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
46717020|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
46717021|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
46717022|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
46914967|NCT02881567|83145653|FG000|Overall Study|Adverse Event|1|||
46914968|NCT02881567|83145653|FG000|Overall Study|Lost to Follow-up|3|||
46914969|NCT02881567|83145653|FG000|Overall Study|Consent withdrawn|1|||
46914970|NCT02881567|83145653|FG000|Overall Study|Investigator decision|1|||
46914971|NCT02881567|83145653|FG000|Overall Study|Study terminated by sponsor|9|||
46914972|NCT02881567|83145653|FG000|Overall Study|Reason not Specified|3|||
46914973|NCT02962674|83145657|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
46914974|NCT02962908|83145667|FG000|Overall Study|Lost to Follow-up|0|||
46914975|NCT02962908|83145668|FG001|Overall Study|Lost to Follow-up|3|||
46914976|NCT02962908|83145669|FG002|Overall Study|Lost to Follow-up|0|||
46914977|NCT02962908|83145670|FG003|Overall Study|Lost to Follow-up|1|||
46914978|NCT02962908|83145667|FG000|Overall Study|Withdrawal by Subject|0|||
46914979|NCT02962908|83145668|FG001|Overall Study|Withdrawal by Subject|3|||
46914980|NCT02962908|83145669|FG002|Overall Study|Withdrawal by Subject|0|||
46914981|NCT02962908|83145670|FG003|Overall Study|Withdrawal by Subject|2|||
46914982|NCT02962908|83145667|FG000|Overall Study|Protocol Violation|0|||
46914983|NCT02962908|83145668|FG001|Overall Study|Protocol Violation|1|||
46914984|NCT02962908|83145669|FG002|Overall Study|Protocol Violation|0|||
46914985|NCT02962908|83145670|FG003|Overall Study|Protocol Violation|0|||
46914986|NCT02962908|83145667|FG000|Overall Study|Physician Decision|0|||
46914987|NCT02962908|83145668|FG001|Overall Study|Physician Decision|1|||
46914988|NCT02962908|83145669|FG002|Overall Study|Physician Decision|0|||
46914989|NCT02962908|83145670|FG003|Overall Study|Physician Decision|0|||
46914990|NCT02962284|83145688|FG000|Overall Study|Death|2|||
46914991|NCT02962284|83145689|FG001|Overall Study|Death|0|||
46914992|NCT02962284|83145688|FG000|Overall Study|Progressive disease|2|||
46914993|NCT02962284|83145689|FG001|Overall Study|Progressive disease|3|||
46914994|NCT02962284|83145688|FG000|Overall Study|Withdrawal by Subject|1|||
46914995|NCT02962284|83145689|FG001|Overall Study|Withdrawal by Subject|0|||
46914996|NCT01344876|83145697|FG000|Overall Study|Adverse Event|0|||
46914997|NCT01344876|83145698|FG001|Overall Study|Adverse Event|0|||
46914998|NCT01344876|83145699|FG002|Overall Study|Adverse Event|0|||
46914999|NCT01344876|83145700|FG003|Overall Study|Adverse Event|0|||
46915000|NCT01344876|83145701|FG004|Overall Study|Adverse Event|1|||
46915001|NCT01344876|83145697|FG000|Overall Study|Withdrawal by Subject|0|||
46915002|NCT01344876|83145698|FG001|Overall Study|Withdrawal by Subject|0|||
46915003|NCT01344876|83145699|FG002|Overall Study|Withdrawal by Subject|1|||
46915004|NCT01344876|83145700|FG003|Overall Study|Withdrawal by Subject|0|||
46915005|NCT01344876|83145701|FG004|Overall Study|Withdrawal by Subject|0|||
46915006|NCT01344876|83145697|FG000|Overall Study|Definite progression of primary disease|1|||
46915007|NCT01344876|83145698|FG001|Overall Study|Definite progression of primary disease|0|||
46915008|NCT01344876|83145699|FG002|Overall Study|Definite progression of primary disease|0|||
46717023|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
46717024|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
46915009|NCT01344876|83145700|FG003|Overall Study|Definite progression of primary disease|3|||
46915010|NCT01344876|83145701|FG004|Overall Study|Definite progression of primary disease|0|||
46915011|NCT02846324|83145718|FG000|Overall Study|Other|1|||
46915012|NCT02846324|83145719|FG001|Overall Study|Other|0|||
46915013|NCT02846324|83145720|FG002|Overall Study|Other|0|||
46915014|NCT02846324|83145721|FG003|Overall Study|Other|0|||
46915015|NCT02846324|83145718|FG000|Overall Study|Withdrawal by Subject|1|||
46915016|NCT02846324|83145719|FG001|Overall Study|Withdrawal by Subject|0|||
46915017|NCT02846324|83145720|FG002|Overall Study|Withdrawal by Subject|4|||
47039554|NCT01790594|83292859|FG001|Overall Study|Terminated prior to week 76|2|||
47039555|NCT01790594|83292860|FG002|Overall Study|Terminated prior to week 76|0|||
47039556|NCT01790516|83292869|FG000|Overall Study|Physician Decision|1|||
47039557|NCT01790516|83292870|FG001|Overall Study|Physician Decision|0|||
47039558|NCT01790438|83292878|FG000|Overall Study|Adverse Event|3|||
47039559|NCT01790438|83292879|FG001|Overall Study|Adverse Event|2|||
47039560|NCT01790438|83292878|FG000|Overall Study|Death|4|||
47039561|NCT01790438|83292879|FG001|Overall Study|Death|0|||
47039562|NCT01790438|83292878|FG000|Overall Study|Lost to Follow-up|5|||
47039563|NCT01790438|83292879|FG001|Overall Study|Lost to Follow-up|2|||
47039564|NCT01790438|83292878|FG000|Overall Study|Withdrawal by Subject|13|||
47039565|NCT01790438|83292879|FG001|Overall Study|Withdrawal by Subject|2|||
47039566|NCT01790438|83292878|FG000|Overall Study|Physician Decision|3|||
47039567|NCT01790438|83292879|FG001|Overall Study|Physician Decision|1|||
47039568|NCT01790438|83292878|FG000|Overall Study|Sponsor Decision|0|||
47039569|NCT01790438|83292879|FG001|Overall Study|Sponsor Decision|3|||
47039570|NCT01790438|83292878|FG000|Overall Study|Protocol Required Discontinuation|7|||
47039571|NCT01790438|83292879|FG001|Overall Study|Protocol Required Discontinuation|1|||
47039572|NCT01735916|83292890|FG000|Overall Study|Subject not eligible to be randomized|11|||
47039573|NCT01735916|83292891|FG001|Overall Study|Subject not eligible to be randomized|0|||
47039574|NCT01735916|83292892|FG002|Overall Study|Subject not eligible to be randomized|0|||
47039575|NCT01735916|83292890|FG000|Overall Study|Early termination of study by sponsor|4|||
47039576|NCT01735916|83292891|FG001|Overall Study|Early termination of study by sponsor|19|||
47039577|NCT01735916|83292892|FG002|Overall Study|Early termination of study by sponsor|7|||
47039578|NCT01735916|83292890|FG000|Overall Study|Withdrawal by Subject|3|||
47039579|NCT01735916|83292891|FG001|Overall Study|Withdrawal by Subject|0|||
47039580|NCT01735916|83292892|FG002|Overall Study|Withdrawal by Subject|0|||
47039581|NCT01790126|83292902|FG000|Overall Study|PSA Progression|12|||
47039582|NCT01790126|83292903|FG001|Overall Study|PSA Progression|16|||
47039583|NCT01790126|83292904|FG002|Overall Study|PSA Progression|16|||
47039584|NCT01790126|83292902|FG000|Overall Study|Other|5|||
47039585|NCT01790126|83292903|FG001|Overall Study|Other|4|||
47039586|NCT01790126|83292904|FG002|Overall Study|Other|8|||
47039587|NCT01790126|83292902|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
47039588|NCT01790126|83292903|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
47039589|NCT01790126|83292904|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
47039590|NCT01790126|83292902|FG000|Overall Study|Withdrawal by Physician|1|||
47039591|NCT01790126|83292903|FG001|Overall Study|Withdrawal by Physician|1|||
47039592|NCT01790126|83292904|FG002|Overall Study|Withdrawal by Physician|2|||
47039593|NCT01790126|83292902|FG000|Overall Study|Withdrawal by Subject|3|||
47039594|NCT01790126|83292903|FG001|Overall Study|Withdrawal by Subject|1|||
47039595|NCT01790126|83292904|FG002|Overall Study|Withdrawal by Subject|2|||
47039596|NCT01790126|83292902|FG000|Overall Study|Lost to Follow-up|1|||
47039597|NCT01790126|83292903|FG001|Overall Study|Lost to Follow-up|0|||
47039598|NCT01790126|83292904|FG002|Overall Study|Lost to Follow-up|1|||
47039599|NCT01790126|83292902|FG000|Overall Study|Adverse Event|0|||
47039600|NCT01790126|83292903|FG001|Overall Study|Adverse Event|2|||
47039601|NCT01790126|83292904|FG002|Overall Study|Adverse Event|0|||
47039602|NCT01790126|83292902|FG000|Overall Study|Death|2|||
47039603|NCT01790126|83292903|FG001|Overall Study|Death|0|||
47039604|NCT01790126|83292904|FG002|Overall Study|Death|0|||
47039605|NCT01790126|83292902|FG000|Overall Study|Radiographic Progression|3|||
47039606|NCT01790126|83292903|FG001|Overall Study|Radiographic Progression|1|||
47039607|NCT01790126|83292904|FG002|Overall Study|Radiographic Progression|0|||
47039608|NCT01734902|83292915|FG000|Overall Study|Other than listed|0|||
47039609|NCT01734902|83292916|FG001|Overall Study|Other than listed|2|||
47039610|NCT01790048|83292924|FG000|Overall Study|Incorrect Age|9|||
47039611|NCT01790048|83292925|FG001|Overall Study|Incorrect Age|14|||
47039612|NCT01790048|83292924|FG000|Overall Study|data entry error|0|||
47039613|NCT01790048|83292925|FG001|Overall Study|data entry error|1|||
47039614|NCT01790048|83292924|FG000|Overall Study|Other|0|||
47039615|NCT01790048|83292925|FG001|Overall Study|Other|2|||
47039616|NCT01790048|83292924|FG000|Overall Study|SAM at Enrollment|2|||
47039617|NCT01790048|83292925|FG001|Overall Study|SAM at Enrollment|0|||
47039618|NCT01790048|83292924|FG000|Overall Study|Measurement error|1|||
47039619|NCT01790048|83292925|FG001|Overall Study|Measurement error|0|||
47039620|NCT01789970|83292935|FG000|Open-label Titration Period|Adverse Event|68|||
47039621|NCT01789970|83292936|FG001|Open-label Titration Period|Adverse Event|0|||
47039622|NCT01789970|83292937|FG002|Open-label Titration Period|Adverse Event|0|||
47039623|NCT01789970|83292935|FG000|Open-label Titration Period|Lack of Efficacy|31|||
47039624|NCT01789970|83292936|FG001|Open-label Titration Period|Lack of Efficacy|0|||
47039625|NCT01789970|83292937|FG002|Open-label Titration Period|Lack of Efficacy|0|||
47039626|NCT01789970|83292935|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
47039627|NCT01789970|83292936|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
47039628|NCT01789970|83292937|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
47039629|NCT01789970|83292935|FG000|Open-label Titration Period|Protocol Violation|18|||
47039630|NCT01789970|83292936|FG001|Open-label Titration Period|Protocol Violation|0|||
46915018|NCT02846324|83145721|FG003|Overall Study|Withdrawal by Subject|0|||
46915019|NCT03161093|83145746|FG000|Overall Study|Protocol Violation|11|||
46915020|NCT03161093|83145747|FG001|Overall Study|Protocol Violation|14|||
46915021|NCT03161093|83145748|FG002|Overall Study|Protocol Violation|6|||
46915022|NCT03161093|83145749|FG003|Overall Study|Protocol Violation|13|||
47039631|NCT01789970|83292937|FG002|Open-label Titration Period|Protocol Violation|0|||
46915023|NCT03161093|83145750|FG004|Overall Study|Protocol Violation|1|||
47039632|NCT01789970|83292935|FG000|Open-label Titration Period|Lost to Follow-up|5|||
47039633|NCT01789970|83292936|FG001|Open-label Titration Period|Lost to Follow-up|0|||
47039634|NCT01789970|83292937|FG002|Open-label Titration Period|Lost to Follow-up|0|||
47039635|NCT01789970|83292935|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
47039636|NCT01789970|83292936|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
47039637|NCT01789970|83292937|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
47039638|NCT01789970|83292935|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
47039639|NCT01789970|83292936|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
47039640|NCT01789970|83292937|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
46631416|NCT01859988|82804495|FG005|Overall Study|Protocol Violation|0|||
46631417|NCT01859988|82804490|FG000|Overall Study|Other than specified above|0|||
46631418|NCT01859988|82804491|FG001|Overall Study|Other than specified above|2|||
46717025|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
46717026|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
46717027|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
46717028|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
46717029|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
46717030|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
46717031|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
46717032|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
46717033|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
46717034|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
46717035|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
46717036|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
46717037|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
46717038|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
46717039|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
46717040|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
46717041|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
46717042|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
46717043|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
46717044|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
46717045|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
46717046|NCT03739840|82933067|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
46717047|NCT03739840|82933068|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
46717048|NCT03739840|82933069|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
46717049|NCT03739840|82933070|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
46717050|NCT01035060|82933094|FG000|Overall Study|Lost to Follow-up|0|||
46717051|NCT01035060|82933095|FG001|Overall Study|Lost to Follow-up|7|||
46717052|NCT01035060|82933094|FG000|Overall Study|Did not quality after 2nd screening|14|||
46717053|NCT01035060|82933095|FG001|Overall Study|Did not quality after 2nd screening|1|||
46717054|NCT01035060|82933094|FG000|Overall Study|Withdrawal by Subject|8|||
46717055|NCT01035060|82933095|FG001|Overall Study|Withdrawal by Subject|6|||
46717056|NCT01035060|82933094|FG000|Overall Study|Physician Decision|2|||
46717057|NCT01035060|82933095|FG001|Overall Study|Physician Decision|0|||
46717058|NCT01039428|82933103|FG000|Overall Study|Protocol Violation|1|||
46717059|NCT01039428|82933104|FG001|Overall Study|Protocol Violation|0|||
46915024|NCT03161093|83145751|FG005|Overall Study|Protocol Violation|0|||
47039641|NCT01789970|83292935|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
47039642|NCT01789970|83292936|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
46631419|NCT01859988|82804492|FG002|Overall Study|Other than specified above|11|||
46631420|NCT01859988|82804493|FG003|Overall Study|Other than specified above|3|||
46631421|NCT01859988|82804494|FG004|Overall Study|Other than specified above|5|||
46631422|NCT01859988|82804495|FG005|Overall Study|Other than specified above|3|||
46631423|NCT01859598|82804509|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
46631424|NCT01876446|82804517|FG000|Overall Study|Death|0|||
46631425|NCT01876446|82804518|FG001|Overall Study|Death|1|||
46717060|NCT01039428|82933103|FG000|Overall Study|Withdrawal by Subject|1|||
46717061|NCT01039428|82933104|FG001|Overall Study|Withdrawal by Subject|0|||
46915025|NCT03161093|83145746|FG000|Overall Study|Adverse Event|5|||
46915026|NCT03161093|83145747|FG001|Overall Study|Adverse Event|21|||
47039643|NCT01789970|83292937|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
47039644|NCT01789970|83292935|FG000|Open-label Titration Period|Pregnancy|2|||
46717062|NCT01034358|82933110|FG000|Overall Study|Withdrawal by Subject|1|||
46717063|NCT01034358|82933110|FG000|Overall Study|Protocol Violation|1|||
46717064|NCT01033734|82933118|FG000|Overall Study|Withdrawal by Subject|1|||
47039645|NCT01789970|83292936|FG001|Open-label Titration Period|Pregnancy|0|||
47039646|NCT01789970|83292937|FG002|Open-label Titration Period|Pregnancy|0|||
46717065|NCT01115855|82933133|FG000|Overall Study|Adverse Event|16|||
46717066|NCT01115855|82933134|FG001|Overall Study|Adverse Event|18|||
46717067|NCT01115855|82933133|FG000|Overall Study|Death|6|||
46717068|NCT01115855|82933134|FG001|Overall Study|Death|5|||
46717069|NCT01115855|82933133|FG000|Overall Study|Lab Abnormality|1|||
46717070|NCT01115855|82933134|FG001|Overall Study|Lab Abnormality|1|||
46717071|NCT01115855|82933133|FG000|Overall Study|Protocol Violation|0|||
46717072|NCT01115855|82933134|FG001|Overall Study|Protocol Violation|1|||
46717073|NCT01115855|82933133|FG000|Overall Study|Withdrawal by Subject|5|||
46717074|NCT01115855|82933134|FG001|Overall Study|Withdrawal by Subject|5|||
46717075|NCT01115855|82933133|FG000|Overall Study|Other|8|||
46717076|NCT01115855|82933134|FG001|Overall Study|Other|6|||
46717077|NCT01115309|82933144|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
46717078|NCT01115309|82933144|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
46717079|NCT01115309|82933144|FG000|Long-term Follow-up|Lost to Follow-up|6|||
46717080|NCT03638128|82933152|FG000|Overall Study|Withdrawal by Subject|1|||
46717081|NCT03638128|82933153|FG001|Overall Study|Withdrawal by Subject|7|||
46717082|NCT03638128|82933154|FG002|Overall Study|Withdrawal by Subject|6|||
46717083|NCT03638128|82933152|FG000|Overall Study|Sponsor Decision|15|||
46717084|NCT03638128|82933153|FG001|Overall Study|Sponsor Decision|12|||
46915027|NCT03161093|83145748|FG002|Overall Study|Adverse Event|16|||
46915028|NCT03161093|83145749|FG003|Overall Study|Adverse Event|35|||
46915029|NCT03161093|83145750|FG004|Overall Study|Adverse Event|2|||
47039647|NCT01789970|83292935|FG000|Open-label Titration Period|Other|76|||
47039648|NCT01789970|83292936|FG001|Open-label Titration Period|Other|0|||
47039649|NCT01789970|83292937|FG002|Open-label Titration Period|Other|0|||
47039650|NCT01789970|83292935|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
47039651|NCT01789970|83292936|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
47039652|NCT01789970|83292937|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
47039653|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
47039654|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
47039655|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
47039656|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
47039657|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
47039658|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
47039659|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
47039660|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
47039661|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
47039662|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
47039663|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
46717085|NCT03638128|82933154|FG002|Overall Study|Sponsor Decision|19|||
46717086|NCT03638128|82933152|FG000|Overall Study|Lost to Follow-up|0|||
46717087|NCT03638128|82933153|FG001|Overall Study|Lost to Follow-up|0|||
46717088|NCT03638128|82933154|FG002|Overall Study|Lost to Follow-up|1|||
46717089|NCT01059630|82933167|FG000|Overall Study|Death|100|||
46717090|NCT01059630|82933168|FG001|Overall Study|Death|84|||
46717091|NCT01059630|82933167|FG000|Overall Study|Lost to Follow-up|4|||
46717092|NCT01059630|82933168|FG001|Overall Study|Lost to Follow-up|1|||
46717093|NCT01059630|82933167|FG000|Overall Study|Physician Decision|2|||
46717094|NCT01059630|82933168|FG001|Overall Study|Physician Decision|4|||
46717095|NCT01059630|82933167|FG000|Overall Study|Withdrawal by Subject|21|||
46717096|NCT01059630|82933168|FG001|Overall Study|Withdrawal by Subject|14|||
46717097|NCT00932373|82933185|FG000|Overall Study|Progressive disease|3|||
46717098|NCT00932373|82933186|FG001|Overall Study|Progressive disease|1|||
46915030|NCT03161093|83145751|FG005|Overall Study|Adverse Event|1|||
46915031|NCT03161093|83145746|FG000|Overall Study|Lack of Efficacy|9|||
46717099|NCT00932373|82933187|FG002|Overall Study|Progressive disease|0|||
46717100|NCT00932373|82933188|FG003|Overall Study|Progressive disease|0|||
46915032|NCT03161093|83145747|FG001|Overall Study|Lack of Efficacy|13|||
46717101|NCT00932373|82933189|FG004|Overall Study|Progressive disease|10|||
46717102|NCT00932373|82933190|FG005|Overall Study|Progressive disease|1|||
46717103|NCT00932373|82933191|FG006|Overall Study|Progressive disease|0|||
46717104|NCT00932373|82933192|FG007|Overall Study|Progressive disease|2|||
46915033|NCT03161093|83145748|FG002|Overall Study|Lack of Efficacy|9|||
47039664|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
46915034|NCT03161093|83145749|FG003|Overall Study|Lack of Efficacy|24|||
47039665|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
47039666|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
47039667|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
47039668|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
47039669|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
47039670|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
47039671|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
46717105|NCT00932373|82933193|FG008|Overall Study|Progressive disease|1|||
46717106|NCT00932373|82933194|FG009|Overall Study|Progressive disease|9|||
46915035|NCT03161093|83145750|FG004|Overall Study|Lack of Efficacy|4|||
46915036|NCT03161093|83145751|FG005|Overall Study|Lack of Efficacy|1|||
46915037|NCT03161093|83145746|FG000|Overall Study|Physician Decision|0|||
46915038|NCT03161093|83145747|FG001|Overall Study|Physician Decision|1|||
46915039|NCT03161093|83145748|FG002|Overall Study|Physician Decision|0|||
46915040|NCT03161093|83145749|FG003|Overall Study|Physician Decision|2|||
46915041|NCT03161093|83145750|FG004|Overall Study|Physician Decision|17|||
46915042|NCT03161093|83145751|FG005|Overall Study|Physician Decision|15|||
46915043|NCT03161093|83145746|FG000|Overall Study|Withdrawal by Subject|24|||
46915044|NCT03161093|83145747|FG001|Overall Study|Withdrawal by Subject|73|||
46915045|NCT03161093|83145748|FG002|Overall Study|Withdrawal by Subject|44|||
46915046|NCT03161093|83145749|FG003|Overall Study|Withdrawal by Subject|97|||
46915047|NCT03161093|83145750|FG004|Overall Study|Withdrawal by Subject|11|||
46915048|NCT03161093|83145751|FG005|Overall Study|Withdrawal by Subject|10|||
46915049|NCT03161093|83145746|FG000|Overall Study|Lost to Follow-up|3|||
46915050|NCT03161093|83145747|FG001|Overall Study|Lost to Follow-up|12|||
46915051|NCT03161093|83145748|FG002|Overall Study|Lost to Follow-up|4|||
46915052|NCT03161093|83145749|FG003|Overall Study|Lost to Follow-up|7|||
46915053|NCT03161093|83145750|FG004|Overall Study|Lost to Follow-up|8|||
47039672|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
47039673|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
46717107|NCT00932373|82933195|FG010|Overall Study|Progressive disease|2|||
46717108|NCT00932373|82933185|FG000|Overall Study|Adverse Event|0|||
46717109|NCT00932373|82933186|FG001|Overall Study|Adverse Event|0|||
46717110|NCT00932373|82933187|FG002|Overall Study|Adverse Event|0|||
46717111|NCT00932373|82933188|FG003|Overall Study|Adverse Event|0|||
46717112|NCT00932373|82933189|FG004|Overall Study|Adverse Event|2|||
46717113|NCT00932373|82933190|FG005|Overall Study|Adverse Event|1|||
46717114|NCT00932373|82933191|FG006|Overall Study|Adverse Event|0|||
46717115|NCT00932373|82933192|FG007|Overall Study|Adverse Event|1|||
46717116|NCT00932373|82933193|FG008|Overall Study|Adverse Event|0|||
46717117|NCT00932373|82933194|FG009|Overall Study|Adverse Event|2|||
46717118|NCT00932373|82933195|FG010|Overall Study|Adverse Event|1|||
46717119|NCT00932373|82933185|FG000|Overall Study|Physician Decision|0|||
46717120|NCT00932373|82933186|FG001|Overall Study|Physician Decision|0|||
46717121|NCT00932373|82933187|FG002|Overall Study|Physician Decision|1|||
46717122|NCT00932373|82933188|FG003|Overall Study|Physician Decision|0|||
46717123|NCT00932373|82933189|FG004|Overall Study|Physician Decision|2|||
46717124|NCT00932373|82933190|FG005|Overall Study|Physician Decision|0|||
46717125|NCT00932373|82933191|FG006|Overall Study|Physician Decision|0|||
46717126|NCT00932373|82933192|FG007|Overall Study|Physician Decision|0|||
46717127|NCT00932373|82933193|FG008|Overall Study|Physician Decision|0|||
46717128|NCT00932373|82933194|FG009|Overall Study|Physician Decision|1|||
46717129|NCT00932373|82933195|FG010|Overall Study|Physician Decision|0|||
46717130|NCT00932373|82933185|FG000|Overall Study|Dose limiting toxicity|0|||
46717131|NCT00932373|82933186|FG001|Overall Study|Dose limiting toxicity|0|||
46717132|NCT00932373|82933187|FG002|Overall Study|Dose limiting toxicity|0|||
46717133|NCT00932373|82933188|FG003|Overall Study|Dose limiting toxicity|0|||
46915054|NCT03161093|83145751|FG005|Overall Study|Lost to Follow-up|13|||
46915055|NCT03161093|83145746|FG000|Overall Study|Death|3|||
46915056|NCT03161093|83145747|FG001|Overall Study|Death|9|||
46915057|NCT03161093|83145748|FG002|Overall Study|Death|7|||
46717134|NCT00932373|82933189|FG004|Overall Study|Dose limiting toxicity|0|||
46915058|NCT03161093|83145749|FG003|Overall Study|Death|9|||
46717135|NCT00932373|82933190|FG005|Overall Study|Dose limiting toxicity|1|||
46915059|NCT03161093|83145750|FG004|Overall Study|Death|0|||
46915060|NCT03161093|83145751|FG005|Overall Study|Death|0|||
46915061|NCT03161093|83145746|FG000|Overall Study|Unknown - Not reported|0|||
46717136|NCT00932373|82933191|FG006|Overall Study|Dose limiting toxicity|0|||
46717137|NCT00932373|82933192|FG007|Overall Study|Dose limiting toxicity|0|||
46717138|NCT00932373|82933193|FG008|Overall Study|Dose limiting toxicity|0|||
46717139|NCT00932373|82933194|FG009|Overall Study|Dose limiting toxicity|0|||
46717140|NCT00932373|82933195|FG010|Overall Study|Dose limiting toxicity|0|||
46915062|NCT03161093|83145747|FG001|Overall Study|Unknown - Not reported|1|||
46915063|NCT03161093|83145748|FG002|Overall Study|Unknown - Not reported|0|||
46915064|NCT03161093|83145749|FG003|Overall Study|Unknown - Not reported|0|||
46915065|NCT03161093|83145750|FG004|Overall Study|Unknown - Not reported|0|||
46915066|NCT03161093|83145751|FG005|Overall Study|Unknown - Not reported|1|||
47039674|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
46915067|NCT02847650|83145772|FG000|Overall Study|Adverse Event|2|||
47039675|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
47039676|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
46717141|NCT00932373|82933185|FG000|Overall Study|Withdrawal by Subject|0|||
46717142|NCT00932373|82933186|FG001|Overall Study|Withdrawal by Subject|0|||
46717143|NCT00932373|82933187|FG002|Overall Study|Withdrawal by Subject|0|||
46717144|NCT00932373|82933188|FG003|Overall Study|Withdrawal by Subject|0|||
46717145|NCT00932373|82933189|FG004|Overall Study|Withdrawal by Subject|0|||
46717146|NCT00932373|82933190|FG005|Overall Study|Withdrawal by Subject|0|||
46717147|NCT00932373|82933191|FG006|Overall Study|Withdrawal by Subject|0|||
46717148|NCT00932373|82933192|FG007|Overall Study|Withdrawal by Subject|0|||
46717149|NCT00932373|82933193|FG008|Overall Study|Withdrawal by Subject|1|||
46717150|NCT00932373|82933194|FG009|Overall Study|Withdrawal by Subject|0|||
46717151|NCT00932373|82933195|FG010|Overall Study|Withdrawal by Subject|0|||
46717152|NCT00932373|82933185|FG000|Overall Study|Clinical progression|0|||
46717153|NCT00932373|82933186|FG001|Overall Study|Clinical progression|0|||
46717154|NCT00932373|82933187|FG002|Overall Study|Clinical progression|0|||
46717155|NCT00932373|82933188|FG003|Overall Study|Clinical progression|0|||
46717156|NCT00932373|82933189|FG004|Overall Study|Clinical progression|0|||
46717157|NCT00932373|82933190|FG005|Overall Study|Clinical progression|0|||
46717158|NCT00932373|82933191|FG006|Overall Study|Clinical progression|1|||
46717159|NCT00932373|82933192|FG007|Overall Study|Clinical progression|0|||
46717160|NCT00932373|82933193|FG008|Overall Study|Clinical progression|0|||
46717161|NCT00932373|82933194|FG009|Overall Study|Clinical progression|0|||
46717162|NCT00932373|82933195|FG010|Overall Study|Clinical progression|0|||
46717163|NCT00932373|82933185|FG000|Overall Study|Lack of Efficacy|0|||
46717164|NCT00932373|82933186|FG001|Overall Study|Lack of Efficacy|0|||
46717165|NCT00932373|82933187|FG002|Overall Study|Lack of Efficacy|0|||
46717166|NCT00932373|82933188|FG003|Overall Study|Lack of Efficacy|0|||
46717167|NCT00932373|82933189|FG004|Overall Study|Lack of Efficacy|0|||
46717168|NCT00932373|82933190|FG005|Overall Study|Lack of Efficacy|0|||
46717169|NCT00932373|82933191|FG006|Overall Study|Lack of Efficacy|0|||
46717170|NCT00932373|82933192|FG007|Overall Study|Lack of Efficacy|0|||
46717171|NCT00932373|82933193|FG008|Overall Study|Lack of Efficacy|0|||
46717172|NCT00932373|82933194|FG009|Overall Study|Lack of Efficacy|1|||
46717173|NCT00932373|82933195|FG010|Overall Study|Lack of Efficacy|0|||
46717174|NCT01055496|82933229|FG000|Overall Study|Withdrawal by Subject|2|||
46717175|NCT01055496|82933230|FG001|Overall Study|Withdrawal by Subject|4|||
46717176|NCT01055496|82933229|FG000|Overall Study|Death|13|||
46717177|NCT01055496|82933230|FG001|Overall Study|Death|23|||
46717178|NCT01055496|82933229|FG000|Overall Study|Lost to Follow-up|0|||
46717179|NCT01055496|82933230|FG001|Overall Study|Lost to Follow-up|2|||
46717180|NCT01055496|82933229|FG000|Overall Study|Other - Unspecified|0|||
47039677|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
47039678|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
47039679|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
47039680|NCT01789970|83292935|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
47039681|NCT01789970|83292936|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
47039682|NCT01789970|83292937|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
46717181|NCT01055496|82933230|FG001|Overall Study|Other - Unspecified|1|||
46717182|NCT01055262|82933257|FG000|Overall Study|Adverse Event|5|||
46717183|NCT01055262|82933257|FG000|Overall Study|Protocol Violation|3|||
46915068|NCT02847650|83145773|FG001|Overall Study|Adverse Event|4|||
46915069|NCT02847650|83145772|FG000|Overall Study|Lost to Follow-up|1|||
46915070|NCT02847650|83145773|FG001|Overall Study|Lost to Follow-up|0|||
46915071|NCT02847650|83145772|FG000|Overall Study|Protocol Violation|0|||
46717184|NCT01055262|82933257|FG000|Overall Study|Uncooperativeness|1|||
46717185|NCT01052844|82933263|FG000|Overall Study|Adverse Event|0|||
46717186|NCT01052844|82933264|FG001|Overall Study|Adverse Event|1|||
46717187|NCT01049412|82933272|FG000|Period I|Withdrawal by Subject|4|||
46915072|NCT02847650|83145773|FG001|Overall Study|Protocol Violation|1|||
46915073|NCT02847650|83145772|FG000|Overall Study|Withdrawal by Subject|1|||
46915074|NCT02847650|83145773|FG001|Overall Study|Withdrawal by Subject|1|||
46915075|NCT02847494|83145781|FG000|Overall Study|Lost to Follow-up|8|||
46915076|NCT02847494|83145782|FG001|Overall Study|Lost to Follow-up|5|||
46717188|NCT01049412|82933273|FG001|Period I|Withdrawal by Subject|6|||
46717189|NCT01049412|82933272|FG000|Period I|Lost to Follow-up|2|||
46717190|NCT01049412|82933273|FG001|Period I|Lost to Follow-up|2|||
46717191|NCT01049412|82933272|FG000|Period I|Physician Decision|0|||
46717192|NCT01049412|82933273|FG001|Period I|Physician Decision|3|||
47039683|NCT01734434|83292955|FG000|Overall Study|Death Infant|3|||
47039684|NCT01734434|83292956|FG001|Overall Study|Death Infant|1|||
47039685|NCT01734434|83292957|FG002|Overall Study|Death Infant|17|||
47039686|NCT01734434|83292958|FG003|Overall Study|Death Infant|5|||
47039687|NCT01734434|83292955|FG000|Overall Study|Lost to Follow-up|2|||
47039688|NCT01734434|83292956|FG001|Overall Study|Lost to Follow-up|9|||
47039689|NCT01734434|83292957|FG002|Overall Study|Lost to Follow-up|67|||
47039690|NCT01734434|83292958|FG003|Overall Study|Lost to Follow-up|11|||
47039691|NCT01734434|83292955|FG000|Overall Study|No Live Birth|1|||
47039692|NCT01734434|83292956|FG001|Overall Study|No Live Birth|2|||
47039693|NCT01734434|83292957|FG002|Overall Study|No Live Birth|32|||
47039694|NCT01734434|83292958|FG003|Overall Study|No Live Birth|6|||
47039695|NCT01734434|83292955|FG000|Overall Study|Withdrawal by Subject|4|||
47039696|NCT01734434|83292956|FG001|Overall Study|Withdrawal by Subject|0|||
47039697|NCT01734434|83292957|FG002|Overall Study|Withdrawal by Subject|8|||
47039698|NCT01734434|83292958|FG003|Overall Study|Withdrawal by Subject|1|||
47039699|NCT01734434|83292955|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
47039700|NCT01734434|83292956|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
47039701|NCT01734434|83292957|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
47039702|NCT01734434|83292958|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
47039703|NCT01734434|83292955|FG000|Overall Study|Subject Not Reachable|0|||
47039704|NCT01734434|83292956|FG001|Overall Study|Subject Not Reachable|0|||
47039705|NCT01734434|83292957|FG002|Overall Study|Subject Not Reachable|1|||
47039706|NCT01734434|83292958|FG003|Overall Study|Subject Not Reachable|0|||
47039707|NCT01734434|83292955|FG000|Overall Study|Treatment Defaulter|0|||
47039708|NCT01734434|83292956|FG001|Overall Study|Treatment Defaulter|0|||
47039709|NCT01734434|83292957|FG002|Overall Study|Treatment Defaulter|1|||
47039710|NCT01734434|83292958|FG003|Overall Study|Treatment Defaulter|0|||
47039711|NCT01734434|83292955|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
47039712|NCT01734434|83292956|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
47039713|NCT01734434|83292957|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
47039714|NCT01734434|83292958|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
47039715|NCT01734434|83292955|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
47039716|NCT01734434|83292956|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
47039717|NCT01734434|83292957|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
47039718|NCT01734434|83292958|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
47039719|NCT01788566|83292976|FG000|Overall Study|Death|4|||
47039720|NCT01788566|83292976|FG000|Overall Study|Adverse Event|1|||
47039721|NCT01788566|83292976|FG000|Overall Study|Clinical Progressive Disease|3|||
47039722|NCT01733732|83292982|FG000|Overall Study|Adverse Event|1|||
47039723|NCT01733732|83292983|FG001|Overall Study|Adverse Event|0|||
47039724|NCT01733732|83292982|FG000|Overall Study|Did not attend all study visits|1|||
47039725|NCT01733732|83292983|FG001|Overall Study|Did not attend all study visits|0|||
47039726|NCT01732874|83293001|FG000|Overall Study|Withdrawal by Subject|5|||
47039727|NCT01732874|83293002|FG001|Overall Study|Withdrawal by Subject|1|||
47039728|NCT01732874|83293001|FG000|Overall Study|Death of Infant|3|||
47039729|NCT01732874|83293002|FG001|Overall Study|Death of Infant|2|||
47039730|NCT01732796|83293011|FG000|Overall Study|Adverse Event|16|||
47039731|NCT01732796|83293012|FG001|Overall Study|Adverse Event|16|||
47039732|NCT01732796|83293013|FG002|Overall Study|Adverse Event|4|||
47039733|NCT01732796|83293011|FG000|Overall Study|Lack of Efficacy|21|||
47039734|NCT01732796|83293012|FG001|Overall Study|Lack of Efficacy|18|||
47039735|NCT01732796|83293013|FG002|Overall Study|Lack of Efficacy|5|||
47039736|NCT01732796|83293011|FG000|Overall Study|Lost to Follow-up|2|||
47039737|NCT01732796|83293012|FG001|Overall Study|Lost to Follow-up|0|||
47039738|NCT01732796|83293013|FG002|Overall Study|Lost to Follow-up|0|||
47039739|NCT01732796|83293011|FG000|Overall Study|Withdrawal by Subject|6|||
47039740|NCT01732796|83293012|FG001|Overall Study|Withdrawal by Subject|8|||
47039741|NCT01732796|83293013|FG002|Overall Study|Withdrawal by Subject|2|||
46631426|NCT01876446|82804517|FG000|Overall Study|Withdrawal by Subject|1|||
47039742|NCT01732796|83293011|FG000|Overall Study|Other reason not defined above|1|||
47039743|NCT01732796|83293012|FG001|Overall Study|Other reason not defined above|0|||
47039744|NCT01732796|83293013|FG002|Overall Study|Other reason not defined above|2|||
47039745|NCT01732640|83293023|FG000|Overall Study|Adverse Event|0|||
47039746|NCT01732640|83293024|FG001|Overall Study|Adverse Event|1|||
47039747|NCT01732640|83293023|FG000|Overall Study|Death|0|||
47039748|NCT01732640|83293024|FG001|Overall Study|Death|1|||
47039749|NCT01732484|83293034|FG000|Overall Study|Death|7|||
47039750|NCT01732484|83293034|FG000|Overall Study|Lost to Follow-up|14|||
47039751|NCT01732484|83293034|FG000|Overall Study|chronical illness|5|||
47039752|NCT01786148|83293042|FG000|Overall Study|Lost to Follow-up|21|||
47039753|NCT01786148|83293043|FG001|Overall Study|Lost to Follow-up|13|||
47039754|NCT01786148|83293042|FG000|Overall Study|Death|0|||
47039755|NCT01786148|83293043|FG001|Overall Study|Death|1|||
47039756|NCT01786148|83293042|FG000|Overall Study|Withdrawal by Subject|0|||
47039757|NCT01786148|83293043|FG001|Overall Study|Withdrawal by Subject|7|||
47039758|NCT01786148|83293042|FG000|Overall Study|Incarceration|1|||
47039759|NCT01786148|83293043|FG001|Overall Study|Incarceration|1|||
46631427|NCT01876446|82804518|FG001|Overall Study|Withdrawal by Subject|2|||
46631428|NCT01876446|82804517|FG000|Overall Study|Physician Decision|1|||
46631429|NCT01876446|82804518|FG001|Overall Study|Physician Decision|3|||
46717193|NCT01049412|82933272|FG000|Period I|Protocol Violation|1|||
46717194|NCT01049412|82933273|FG001|Period I|Protocol Violation|2|||
46717195|NCT01049412|82933272|FG000|Period I|Adverse Event|1|||
46717196|NCT01049412|82933273|FG001|Period I|Adverse Event|0|||
46717197|NCT01049412|82933272|FG000|Period II|Withdrawal by Subject|2|||
46717198|NCT01049412|82933273|FG001|Period II|Withdrawal by Subject|3|||
46717199|NCT01049412|82933272|FG000|Period II|Adverse Event|1|||
46717200|NCT01049412|82933273|FG001|Period II|Adverse Event|0|||
46717201|NCT01049412|82933272|FG000|Period II|Lost to Follow-up|1|||
46717202|NCT01049412|82933273|FG001|Period II|Lost to Follow-up|0|||
46717203|NCT00934089|82933283|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
46717204|NCT00934089|82933284|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
46717205|NCT00934089|82933283|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
46717206|NCT00934089|82933284|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
46717207|NCT01032174|82933292|FG000|Overall Study|Adverse Event|0|||
46717208|NCT01032174|82933293|FG001|Overall Study|Adverse Event|1|||
46717209|NCT00933933|82933304|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
46717210|NCT00933933|82933305|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
46717211|NCT00933933|82933306|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
46717212|NCT00933933|82933304|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
46717213|NCT00933933|82933305|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
46717214|NCT00933933|82933306|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
46717215|NCT01032018|82933324|FG000|Overall Study|Lost to Follow-up|6|||
46717216|NCT01032018|82933325|FG001|Overall Study|Lost to Follow-up|5|||
46717217|NCT01032018|82933324|FG000|Overall Study|Death|0|||
46717218|NCT01032018|82933325|FG001|Overall Study|Death|1|||
46717219|NCT01031706|82933333|FG000|Overall Study|Adverse Event|1|||
46717220|NCT01031706|82933334|FG001|Overall Study|Adverse Event|0|||
46717221|NCT01031706|82933333|FG000|Overall Study|Withdrawal by Subject|1|||
46717222|NCT01031706|82933334|FG001|Overall Study|Withdrawal by Subject|1|||
46717223|NCT00927069|82933342|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
46717224|NCT00927069|82933343|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
46717225|NCT00927069|82933344|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
46717226|NCT00927069|82933345|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
46717227|NCT00927069|82933342|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
46717228|NCT00927069|82933343|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
46717229|NCT00927069|82933344|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
46717230|NCT00927069|82933345|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
46717231|NCT00927069|82933342|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
46717232|NCT00927069|82933343|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
46717233|NCT00927069|82933344|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
46717234|NCT00927069|82933345|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
46717235|NCT00927069|82933342|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
46717236|NCT00927069|82933343|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
46717237|NCT00927069|82933344|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
46717238|NCT00927069|82933345|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
46717239|NCT00927069|82933342|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
46717240|NCT00927069|82933343|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
47039760|NCT01785602|83293055|FG000|Overall Study|Withdrawal by Subject|2|||
47039761|NCT01785602|83293056|FG001|Overall Study|Withdrawal by Subject|0|||
47039762|NCT01785602|83293055|FG000|Overall Study|Lost to Follow-up|1|||
47039763|NCT01785602|83293056|FG001|Overall Study|Lost to Follow-up|1|||
47039764|NCT01785602|83293055|FG000|Overall Study|Adverse Event|3|||
46631430|NCT01900626|82804526|FG000|Overall Study|study was closed due to low enrollment|1|||
46631431|NCT01900626|82804527|FG001|Overall Study|study was closed due to low enrollment|1|||
46631432|NCT01900314|82804537|FG000|Overall Study|Lost to Follow-up|1|||
46631433|NCT01900314|82804538|FG001|Overall Study|Lost to Follow-up|0|||
46631434|NCT01900314|82804537|FG000|Overall Study|Protocol Violation|0|||
46631435|NCT01900314|82804538|FG001|Overall Study|Protocol Violation|1|||
46631436|NCT01900314|82804537|FG000|Overall Study|Withdrawal by Subject|3|||
46631437|NCT01900314|82804538|FG001|Overall Study|Withdrawal by Subject|3|||
46631438|NCT01899768|82804545|FG000|Part A|Adverse Event|2|||
46631439|NCT01899768|82804545|FG000|Part A|Withdrawal by Subject|1|||
46631440|NCT01899768|82804545|FG000|Part B|Adverse Event|1|||
46631441|NCT01899768|82804545|FG000|Part B|Withdrawal by Subject|1|||
46631442|NCT01898598|82804555|FG000|Overall Study|Adverse Event|1|||
47039765|NCT01785602|83293056|FG001|Overall Study|Adverse Event|5|||
47039766|NCT01785602|83293055|FG000|Overall Study|Administrative problems|7|||
46631443|NCT01898598|82804556|FG001|Overall Study|Adverse Event|0|||
46631444|NCT01898598|82804555|FG000|Overall Study|Withdrawal by Subject|3|||
47039767|NCT01785602|83293056|FG001|Overall Study|Administrative problems|3|||
47039768|NCT01785524|83293064|FG000|Overall Study|Withdrawal by Subject|2|||
47039769|NCT01785524|83293065|FG001|Overall Study|Withdrawal by Subject|2|||
47039770|NCT01757288|83293074|FG000|Overall Study|Consent withdrawal|0|||
47039771|NCT01757288|83293075|FG001|Overall Study|Consent withdrawal|4|||
47039772|NCT01757288|83293076|FG002|Overall Study|Consent withdrawal|4|||
47039773|NCT01757288|83293074|FG000|Overall Study|Patient off study, IRB hold.|0|||
47039774|NCT01757288|83293075|FG001|Overall Study|Patient off study, IRB hold.|0|||
47039775|NCT01757288|83293076|FG002|Overall Study|Patient off study, IRB hold.|1|||
47039776|NCT01757288|83293074|FG000|Overall Study|Patient death prior to starting treatment|0|||
47039777|NCT01757288|83293075|FG001|Overall Study|Patient death prior to starting treatment|0|||
47039778|NCT01757288|83293076|FG002|Overall Study|Patient death prior to starting treatment|1|||
47039779|NCT01757288|83293074|FG000|Overall Study|Wrong medication administered|0|||
47039780|NCT01757288|83293075|FG001|Overall Study|Wrong medication administered|1|||
47039781|NCT01757288|83293076|FG002|Overall Study|Wrong medication administered|0|||
47039782|NCT01757288|83293074|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
47039783|NCT01757288|83293075|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
47039784|NCT01757288|83293076|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
47039785|NCT01757288|83293074|FG000|Overall Study|Not meeting protocol constraints|0|||
47039786|NCT01757288|83293075|FG001|Overall Study|Not meeting protocol constraints|1|||
47039787|NCT01757288|83293076|FG002|Overall Study|Not meeting protocol constraints|1|||
47039788|NCT01757288|83293074|FG000|Overall Study|Multiple missed appointments|0|||
47039789|NCT01757288|83293075|FG001|Overall Study|Multiple missed appointments|1|||
47039790|NCT01757288|83293076|FG002|Overall Study|Multiple missed appointments|0|||
47039791|NCT01757288|83293074|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
47039792|NCT01757288|83293075|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
47039793|NCT01757288|83293076|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
47039794|NCT01757288|83293074|FG000|Overall Study|>2 weeks treatment break|0|||
47039795|NCT01757288|83293075|FG001|Overall Study|>2 weeks treatment break|0|||
47039796|NCT01757288|83293076|FG002|Overall Study|>2 weeks treatment break|1|||
47039797|NCT01756898|83293089|FG000|Overall Study|Adverse Event|7|||
47039798|NCT01756898|83293090|FG001|Overall Study|Adverse Event|1|||
47039799|NCT01756898|83293091|FG002|Overall Study|Adverse Event|0|||
47039800|NCT01756898|83293092|FG003|Overall Study|Adverse Event|0|||
47039801|NCT01756898|83293089|FG000|Overall Study|Lack of Efficacy|4|||
47039802|NCT01756898|83293090|FG001|Overall Study|Lack of Efficacy|7|||
47039803|NCT01756898|83293091|FG002|Overall Study|Lack of Efficacy|6|||
47039804|NCT01756898|83293092|FG003|Overall Study|Lack of Efficacy|6|||
47039805|NCT01756898|83293089|FG000|Overall Study|Lost to Follow-up|2|||
47039806|NCT01756898|83293090|FG001|Overall Study|Lost to Follow-up|4|||
47039807|NCT01756898|83293091|FG002|Overall Study|Lost to Follow-up|2|||
47039808|NCT01756898|83293092|FG003|Overall Study|Lost to Follow-up|3|||
47039809|NCT01756898|83293089|FG000|Overall Study|Protocol Violation|1|||
47039810|NCT01756898|83293090|FG001|Overall Study|Protocol Violation|2|||
47039811|NCT01756898|83293091|FG002|Overall Study|Protocol Violation|2|||
47039812|NCT01756898|83293092|FG003|Overall Study|Protocol Violation|1|||
47039813|NCT01756898|83293089|FG000|Overall Study|Withdrew Consent|5|||
47039814|NCT01756898|83293090|FG001|Overall Study|Withdrew Consent|3|||
47039815|NCT01756898|83293091|FG002|Overall Study|Withdrew Consent|5|||
47039816|NCT01756898|83293092|FG003|Overall Study|Withdrew Consent|6|||
47039817|NCT01756898|83293089|FG000|Overall Study|Other|0|||
47039818|NCT01756898|83293090|FG001|Overall Study|Other|2|||
47039819|NCT01756898|83293091|FG002|Overall Study|Other|2|||
47039820|NCT01756898|83293092|FG003|Overall Study|Other|0|||
47039821|NCT01731938|83293109|FG000|Preliminary Part I|Withdrawal by Subject|2|||
47039822|NCT01731938|83293110|FG001|Preliminary Part I|Withdrawal by Subject|2|||
47039823|NCT01731938|83293109|FG000|Preliminary Part I|Physician Decision|1|||
47039824|NCT01731938|83293110|FG001|Preliminary Part I|Physician Decision|0|||
47039825|NCT01731938|83293109|FG000|Preliminary Part I|Lost to Follow-up|0|||
46631445|NCT01898598|82804556|FG001|Overall Study|Withdrawal by Subject|0|||
47039826|NCT01731938|83293110|FG001|Preliminary Part I|Lost to Follow-up|3|||
47039827|NCT01731938|83293109|FG000|Preliminary Part I|Missed Week 6 visit|0|||
47039828|NCT01731938|83293110|FG001|Preliminary Part I|Missed Week 6 visit|3|||
47039829|NCT01731938|83293109|FG000|Primary Part II|Withdrawal by Subject|5|||
46631446|NCT01898598|82804555|FG000|Overall Study|Lost to Follow-up|0|||
47039830|NCT01731938|83293110|FG001|Primary Part II|Withdrawal by Subject|4|||
47039831|NCT01731938|83293109|FG000|Primary Part II|Lost to Follow-up|4|||
47039832|NCT01731938|83293110|FG001|Primary Part II|Lost to Follow-up|5|||
47039833|NCT01731938|83293109|FG000|Primary Part II|Death|2|||
46631447|NCT01898598|82804556|FG001|Overall Study|Lost to Follow-up|1|||
47039834|NCT01731938|83293110|FG001|Primary Part II|Death|1|||
47039835|NCT01731938|83293109|FG000|Primary Part II|Missed Week 6 visit|2|||
47039836|NCT01731938|83293110|FG001|Primary Part II|Missed Week 6 visit|3|||
47039837|NCT01731470|83293117|FG000|Overall Study|Withdrawal by Subject|1|||
47039838|NCT01731470|83293117|FG000|Overall Study|Did not meet study criteria|1|||
46717241|NCT00927069|82933344|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
46717242|NCT00927069|82933345|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
46717243|NCT01031628|82933359|FG000|Overall Study|Study terminated early|0|||
46717244|NCT01031628|82933360|FG001|Overall Study|Study terminated early|1|||
46717245|NCT01031628|82933361|FG002|Overall Study|Study terminated early|3|||
46717246|NCT01031628|82933362|FG003|Overall Study|Study terminated early|0|||
46717247|NCT01031004|82933374|FG000|Overall Study|Protocol Violation|0|||
46717248|NCT01031004|82933375|FG001|Overall Study|Protocol Violation|1|||
46717249|NCT01031004|82933374|FG000|Overall Study|Lost to Follow-up|1|||
46717250|NCT01031004|82933375|FG001|Overall Study|Lost to Follow-up|0|||
46717251|NCT00931515|82933383|FG000|Overall Study|Lost to Follow-up|2|||
46717252|NCT00931515|82933384|FG001|Overall Study|Lost to Follow-up|5|||
46717253|NCT01028352|82933390|FG000|Overall Study|Ineligible due to baseline average pain|5|||
46717254|NCT01028352|82933390|FG000|Overall Study|Withdrawal by Subject|1|||
46717255|NCT00929643|82933407|FG000|Overall Study|Protocol Violation|2|||
46717256|NCT00926367|82933413|FG000|Overall Study|Withdrawal by Subject|0|||
46717257|NCT00926367|82933414|FG001|Overall Study|Withdrawal by Subject|1|||
46717258|NCT00926367|82933413|FG000|Overall Study|Lost to Follow-up|1|||
46717259|NCT00926367|82933414|FG001|Overall Study|Lost to Follow-up|0|||
46717260|NCT00926367|82933413|FG000|Overall Study|Skin Irritation|1|||
46717261|NCT00926367|82933414|FG001|Overall Study|Skin Irritation|2|||
46717262|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
46717263|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
46717264|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
46717265|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
46717266|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
46717267|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
46717268|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
46915077|NCT02554253|83145790|FG000|Overall Study|ineligible after enrollment|1|||
46915078|NCT02554253|83145791|FG001|Overall Study|ineligible after enrollment|0|||
46915079|NCT02554253|83145790|FG000|Overall Study|converted to transcatheter procedure|0|||
46915080|NCT02554253|83145791|FG001|Overall Study|converted to transcatheter procedure|1|||
46915081|NCT02554253|83145790|FG000|Overall Study|received both drugs|0|||
47039839|NCT01756352|83293121|FG000|Overall Study|moved away and lost to followup|1|||
46631448|NCT01898598|82804555|FG000|Overall Study|Other|0|||
46717269|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
46717270|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
46717271|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
46717272|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
46717273|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
46717274|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
46631449|NCT01898598|82804556|FG001|Overall Study|Other|1|||
46631450|NCT01898442|82804565|FG000|Overall Study|Hemolysis/technical problems|1|||
46631451|NCT01898442|82804566|FG001|Overall Study|Hemolysis/technical problems|2|||
46631452|NCT01898442|82804567|FG002|Overall Study|Hemolysis/technical problems|2|||
46631453|NCT01898442|82804565|FG000|Overall Study|Patient vomited pills|0|||
46631454|NCT01898442|82804566|FG001|Overall Study|Patient vomited pills|0|||
46631455|NCT01898442|82804567|FG002|Overall Study|Patient vomited pills|1|||
46631456|NCT01898286|82804575|FG000|Overall Study|Withdrawal by Subject|1|||
46631457|NCT01898286|82804575|FG000|Overall Study|Protocol Violation|1|||
46631458|NCT01898286|82804575|FG000|Overall Study|Lost to Follow-up|1|||
46631459|NCT01898208|82804582|FG000|Overall Study|Positive blood culture|17|||
46631460|NCT01898208|82804583|FG001|Overall Study|Positive blood culture|23|||
46631461|NCT01898208|82804584|FG002|Overall Study|Positive blood culture|15|||
46631462|NCT01898208|82804582|FG000|Overall Study|Death/comfort care within 24 hours|10|||
46631463|NCT01898208|82804583|FG001|Overall Study|Death/comfort care within 24 hours|9|||
46631464|NCT01898208|82804584|FG002|Overall Study|Death/comfort care within 24 hours|8|||
46631465|NCT01898208|82804582|FG000|Overall Study|Negative Gram Stain|6|||
46631466|NCT01898208|82804583|FG001|Overall Study|Negative Gram Stain|9|||
46631467|NCT01898208|82804584|FG002|Overall Study|Negative Gram Stain|6|||
46717275|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
46717276|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
46717277|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
46717278|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
46717279|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
46717280|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
46717281|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
47039840|NCT01756274|83293125|FG000|Overall Study|Protocol Violation|2|||
46915082|NCT02554253|83145791|FG001|Overall Study|received both drugs|1|||
46631468|NCT01898208|82804582|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
46631469|NCT01898208|82804583|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
46631470|NCT01898208|82804584|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
46631471|NCT01898208|82804582|FG000|Overall Study|System/Technical Error|1|||
46631472|NCT01898208|82804583|FG001|Overall Study|System/Technical Error|2|||
46631473|NCT01898208|82804584|FG002|Overall Study|System/Technical Error|3|||
46631474|NCT01898208|82804582|FG000|Overall Study|Lost to Follow-up|3|||
46631475|NCT01898208|82804583|FG001|Overall Study|Lost to Follow-up|1|||
46631476|NCT01898208|82804584|FG002|Overall Study|Lost to Follow-up|1|||
46631477|NCT01898130|82804592|FG000|Treatment|Withdrawal by Subject|2|||
46631478|NCT01898130|82804592|FG000|Treatment|Progressive Disease|4|||
46631479|NCT01898130|82804592|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
46631480|NCT01876368|82804598|FG000|Overall Study|Adverse Event|2|||
46631481|NCT01876368|82804599|FG001|Overall Study|Adverse Event|5|||
46717282|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
46717283|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
46717284|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
47039841|NCT01756274|83293125|FG000|Overall Study|Laboratory error|1|||
46631482|NCT01876368|82804598|FG000|Overall Study|Lack of Efficacy|1|||
46631483|NCT01876368|82804599|FG001|Overall Study|Lack of Efficacy|0|||
46631484|NCT01876368|82804598|FG000|Overall Study|Lost to Follow-up|0|||
46631485|NCT01876368|82804599|FG001|Overall Study|Lost to Follow-up|1|||
46631486|NCT01876368|82804598|FG000|Overall Study|Non-compliance with study treatment|0|||
46631487|NCT01876368|82804599|FG001|Overall Study|Non-compliance with study treatment|1|||
46631488|NCT01876368|82804598|FG000|Overall Study|Physician Decision|0|||
46631489|NCT01876368|82804599|FG001|Overall Study|Physician Decision|2|||
46631490|NCT01876368|82804598|FG000|Overall Study|Protocol deviation|3|||
46631491|NCT01876368|82804599|FG001|Overall Study|Protocol deviation|3|||
46631492|NCT01876368|82804598|FG000|Overall Study|Subject/guardian decision|3|||
47039842|NCT01731002|83293133|FG000|Overall Study|Adverse Event|0|||
47039843|NCT01731002|83293134|FG001|Overall Study|Adverse Event|2|||
46631493|NCT01876368|82804599|FG001|Overall Study|Subject/guardian decision|1|||
46631494|NCT01874340|82804609|FG000|Overall Study|Study terminated by Sponsor|6|||
46631495|NCT01874340|82804610|FG001|Overall Study|Study terminated by Sponsor|8|||
46631496|NCT01874340|82804611|FG002|Overall Study|Study terminated by Sponsor|8|||
46631497|NCT01874340|82804612|FG003|Overall Study|Study terminated by Sponsor|4|||
46631498|NCT01874340|82804609|FG000|Overall Study|Withdrawal by Subject|0|||
46631499|NCT01874340|82804610|FG001|Overall Study|Withdrawal by Subject|0|||
46631500|NCT01874340|82804611|FG002|Overall Study|Withdrawal by Subject|0|||
46631501|NCT01874340|82804612|FG003|Overall Study|Withdrawal by Subject|1|||
46631502|NCT01897896|82804624|FG000|Overall Study|Death|1|||
46631503|NCT01897896|82804625|FG001|Overall Study|Death|0|||
46631504|NCT01897896|82804624|FG000|Overall Study|Adverse Event|11|||
46631505|NCT01897896|82804625|FG001|Overall Study|Adverse Event|1|||
46631506|NCT01897896|82804624|FG000|Overall Study|Lost to Follow-up|1|||
46631507|NCT01897896|82804625|FG001|Overall Study|Lost to Follow-up|0|||
46631508|NCT01897896|82804624|FG000|Overall Study|Non-compliance with study drug dosing|1|||
46631509|NCT01897896|82804625|FG001|Overall Study|Non-compliance with study drug dosing|1|||
46631510|NCT01897896|82804624|FG000|Overall Study|Withdrawal by Subject|7|||
46631511|NCT01897896|82804625|FG001|Overall Study|Withdrawal by Subject|1|||
46631512|NCT01897896|82804624|FG000|Overall Study|Require drug that interfere with study|1|||
46631513|NCT01897896|82804625|FG001|Overall Study|Require drug that interfere with study|4|||
46631514|NCT01897896|82804624|FG000|Overall Study|Protocol Violation|1|||
46631515|NCT01897896|82804625|FG001|Overall Study|Protocol Violation|1|||
46631516|NCT01897896|82804624|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
46631517|NCT01897896|82804625|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
46631518|NCT01897896|82804624|FG000|Overall Study|Caregiver can no longer participate|0|||
46631519|NCT01897896|82804625|FG001|Overall Study|Caregiver can no longer participate|2|||
46631520|NCT01897896|82804624|FG000|Overall Study|Other than specified|2|||
46631521|NCT01897896|82804625|FG001|Overall Study|Other than specified|1|||
46631522|NCT01858194|82804635|FG000|Overall Study|Total Artificial Heart Implant|0|||
46631523|NCT01858194|82804636|FG001|Overall Study|Total Artificial Heart Implant|1|||
46631524|NCT01858194|82804635|FG000|Overall Study|Lost to Follow-up|0|||
46631525|NCT01858194|82804636|FG001|Overall Study|Lost to Follow-up|1|||
47039844|NCT01731002|83293135|FG002|Overall Study|Adverse Event|2|||
46631526|NCT01873950|82804644|FG000|Period 5|Withdrawal by Subject|0|||
46631527|NCT01873950|82804645|FG001|Period 5|Withdrawal by Subject|0|||
46631528|NCT01873950|82804646|FG002|Period 5|Withdrawal by Subject|0|||
46631529|NCT01873950|82804647|FG003|Period 5|Withdrawal by Subject|1|||
46631530|NCT01873950|82804648|FG004|Period 5|Withdrawal by Subject|0|||
46631531|NCT01857102|82804662|FG000|Period 1|No longer meets Eligibility Criteria|0|||
46631532|NCT01857102|82804663|FG001|Period 1|No longer meets Eligibility Criteria|2|||
46631533|NCT01857102|82804662|FG000|Period 1|Lost to Follow-up|0|||
46631534|NCT01857102|82804663|FG001|Period 1|Lost to Follow-up|3|||
46631535|NCT01857102|82804662|FG000|Period 1|Unsatisfactory Lens Fit|1|||
47039845|NCT01731002|83293133|FG000|Overall Study|Non-Compliant|0|||
46631536|NCT01857102|82804663|FG001|Period 1|Unsatisfactory Lens Fit|0|||
46631537|NCT01857102|82804662|FG000|Period 1|Unsatisfactory Visual Response|1|||
47039846|NCT01731002|83293134|FG001|Overall Study|Non-Compliant|1|||
47039847|NCT01731002|83293135|FG002|Overall Study|Non-Compliant|0|||
47039848|NCT01731002|83293133|FG000|Overall Study|Lost to Follow-up|1|||
47039849|NCT01731002|83293134|FG001|Overall Study|Lost to Follow-up|0|||
47039850|NCT01731002|83293135|FG002|Overall Study|Lost to Follow-up|0|||
47039851|NCT01731002|83293133|FG000|Overall Study|Test Agent Discontinuation|0|||
47039852|NCT01731002|83293134|FG001|Overall Study|Test Agent Discontinuation|1|||
47039853|NCT01731002|83293135|FG002|Overall Study|Test Agent Discontinuation|0|||
47039854|NCT01731002|83293133|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
47039855|NCT01731002|83293134|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
47039856|NCT01731002|83293135|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
47039857|NCT01731002|83293133|FG000|Overall Study|Elevated IOP|1|||
47039858|NCT01731002|83293134|FG001|Overall Study|Elevated IOP|0|||
47039859|NCT01731002|83293135|FG002|Overall Study|Elevated IOP|0|||
46631538|NCT01857102|82804663|FG001|Period 1|Unsatisfactory Visual Response|0|||
46717285|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
46717286|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Death|2|||
46717287|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Death|1|||
46717288|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Death|2|||
46717289|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Graft loss|0|||
46717290|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Graft loss|2|||
46717291|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Graft loss|0|||
46717292|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
46717293|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
46717294|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
46717295|NCT01114529|82933425|FG000|Completed Study Medication at Month 24|Missing|2|||
46717296|NCT01114529|82933426|FG001|Completed Study Medication at Month 24|Missing|0|||
46717297|NCT01114529|82933427|FG002|Completed Study Medication at Month 24|Missing|0|||
46717298|NCT01114529|82933425|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
46717299|NCT01114529|82933426|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
46717300|NCT01114529|82933427|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
46717301|NCT01114529|82933425|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
46717302|NCT01114529|82933426|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
46717303|NCT01114529|82933427|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
46717304|NCT01114529|82933425|FG000|Completed Study Phase at Month 24|Death|8|||
46717305|NCT01114529|82933426|FG001|Completed Study Phase at Month 24|Death|5|||
46717306|NCT01114529|82933427|FG002|Completed Study Phase at Month 24|Death|4|||
46717307|NCT01114529|82933425|FG000|Completed Study Phase at Month 24|Other|2|||
46717308|NCT01114529|82933426|FG001|Completed Study Phase at Month 24|Other|0|||
46717309|NCT01114529|82933427|FG002|Completed Study Phase at Month 24|Other|0|||
46717310|NCT01114529|82933425|FG000|Completed Study Phase at Month 24|Missing|2|||
46717311|NCT01114529|82933426|FG001|Completed Study Phase at Month 24|Missing|0|||
46717312|NCT01114529|82933427|FG002|Completed Study Phase at Month 24|Missing|0|||
46717313|NCT00926289|82933439|FG000|Overall Study|Adverse Event|9|||
46717314|NCT00926289|82933440|FG001|Overall Study|Adverse Event|11|||
46717315|NCT00926289|82933439|FG000|Overall Study|Protocol Violation|8|||
46717316|NCT00926289|82933440|FG001|Overall Study|Protocol Violation|12|||
46717317|NCT00926289|82933439|FG000|Overall Study|Lost to Follow-up|3|||
46717318|NCT00926289|82933440|FG001|Overall Study|Lost to Follow-up|6|||
46717319|NCT00926289|82933439|FG000|Overall Study|Withdrawal by Subject|4|||
46717320|NCT00926289|82933440|FG001|Overall Study|Withdrawal by Subject|4|||
46717321|NCT00926289|82933439|FG000|Overall Study|Other|1|||
46717322|NCT00926289|82933440|FG001|Overall Study|Other|3|||
46717323|NCT03208036|82933465|FG000|Baseline Assessment|Withdrawal by Subject|1|||
47039860|NCT01731002|83293133|FG000|Overall Study|Inappropriate use of study medications|0|||
47039861|NCT01731002|83293134|FG001|Overall Study|Inappropriate use of study medications|0|||
47039862|NCT01731002|83293135|FG002|Overall Study|Inappropriate use of study medications|1|||
46631539|NCT01857102|82804662|FG000|Period 1|Physician Decision|1|||
46631540|NCT01857102|82804663|FG001|Period 1|Physician Decision|0|||
46631541|NCT01857102|82804662|FG000|Period 2|Lens Discomfort|1|||
46631542|NCT01857102|82804663|FG001|Period 2|Lens Discomfort|0|||
46631543|NCT01857102|82804662|FG000|Period 2|Unsatisfactory Lens Fit|1|||
46631544|NCT01857102|82804663|FG001|Period 2|Unsatisfactory Lens Fit|0|||
46631545|NCT01872078|82804675|FG000|Overall Study|Adverse Event|0|||
46631546|NCT01872078|82804676|FG001|Overall Study|Adverse Event|0|||
46717324|NCT03208036|82933466|FG001|Baseline Assessment|Withdrawal by Subject|1|||
46717325|NCT03208036|82933465|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
46717326|NCT03208036|82933466|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
46717327|NCT03208036|82933465|FG000|Intervention|Withdrawal by Subject|3|||
46717328|NCT03208036|82933466|FG001|Intervention|Withdrawal by Subject|2|||
46775698|NCT00692913|82994154|FG000|Overall Study|Withdrawal by Subject|15|||
47039863|NCT01783886|83293146|FG000|Overall Study|Lost to Follow-up|0|||
47039864|NCT01783886|83293147|FG001|Overall Study|Lost to Follow-up|3|||
47039865|NCT01783886|83293148|FG002|Overall Study|Lost to Follow-up|0|||
47039866|NCT01783886|83293146|FG000|Overall Study|Protocol deviation|0|||
47039867|NCT01783886|83293147|FG001|Overall Study|Protocol deviation|0|||
47039868|NCT01783886|83293148|FG002|Overall Study|Protocol deviation|2|||
47039869|NCT01783886|83293146|FG000|Overall Study|Withdrawal of consent by participant|1|||
47039870|NCT01783886|83293147|FG001|Overall Study|Withdrawal of consent by participant|3|||
47039871|NCT01783886|83293148|FG002|Overall Study|Withdrawal of consent by participant|4|||
47039872|NCT01783886|83293146|FG000|Overall Study|Adverse Event|4|||
46717329|NCT03208036|82933465|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
46717330|NCT03208036|82933466|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
46717331|NCT00926211|82933472|FG000|Overall Study|Lost to Follow-up|1|||
46717332|NCT01114373|82933477|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
46717333|NCT01114373|82933478|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
46717334|NCT01114373|82933477|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
46717335|NCT01114373|82933478|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
46717336|NCT01114373|82933477|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
46717337|NCT01114373|82933478|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
46717338|NCT01114373|82933477|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
46717339|NCT01114373|82933478|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
46717340|NCT00925899|82933490|FG000|Part 1|Death|1|||
46717341|NCT00925899|82933491|FG001|Part 1|Death|2|||
46717342|NCT00925899|82933490|FG000|Part 1|Withdrawal by Subject|10|||
46717343|NCT00925899|82933491|FG001|Part 1|Withdrawal by Subject|9|||
46717344|NCT01114217|82933500|FG000|Overall Study|Adverse Event|5|||
46717345|NCT01114217|82933501|FG001|Overall Study|Adverse Event|3|||
46717346|NCT01114217|82933500|FG000|Overall Study|Lost to Follow-up|17|||
46717347|NCT01114217|82933501|FG001|Overall Study|Lost to Follow-up|33|||
46717348|NCT01114217|82933500|FG000|Overall Study|Withdrawal by Subject|21|||
46717349|NCT01114217|82933501|FG001|Overall Study|Withdrawal by Subject|28|||
46717350|NCT01114217|82933500|FG000|Overall Study|Other-Clerical Error|3|||
46717351|NCT01114217|82933501|FG001|Overall Study|Other-Clerical Error|0|||
46717352|NCT01114217|82933500|FG000|Overall Study|Other-Early termination|6|||
46717353|NCT01114217|82933501|FG001|Overall Study|Other-Early termination|10|||
46717354|NCT01114217|82933500|FG000|Overall Study|Other-Procedure|1|||
46717355|NCT01114217|82933501|FG001|Overall Study|Other-Procedure|1|||
46717356|NCT01114217|82933500|FG000|Overall Study|Other-Pregnancy|2|||
46717357|NCT01114217|82933501|FG001|Overall Study|Other-Pregnancy|4|||
46717358|NCT01114217|82933500|FG000|Overall Study|Other-Protocol Violation|1|||
46717359|NCT01114217|82933501|FG001|Overall Study|Other-Protocol Violation|3|||
46717360|NCT01114217|82933500|FG000|Overall Study|Other-Lack of Efficacy|1|||
46717361|NCT01114217|82933501|FG001|Overall Study|Other-Lack of Efficacy|0|||
46717362|NCT01114217|82933500|FG000|Overall Study|Other-Non Compliance|2|||
46717363|NCT01114217|82933501|FG001|Overall Study|Other-Non Compliance|0|||
46717364|NCT01114217|82933500|FG000|Overall Study|Other-Physician Decision|1|||
46717365|NCT01114217|82933501|FG001|Overall Study|Other-Physician Decision|1|||
47039873|NCT01783886|83293147|FG001|Overall Study|Adverse Event|5|||
47039874|NCT01783886|83293148|FG002|Overall Study|Adverse Event|4|||
47039875|NCT01609556|83293172|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
47039876|NCT01609556|83293173|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
46631547|NCT01872078|82804677|FG002|Overall Study|Adverse Event|1|||
46631548|NCT01872078|82804678|FG003|Overall Study|Adverse Event|0|||
46631549|NCT01872078|82804675|FG000|Overall Study|Dose administration non-compliance|0|||
46631550|NCT01872078|82804676|FG001|Overall Study|Dose administration non-compliance|0|||
46631551|NCT01872078|82804677|FG002|Overall Study|Dose administration non-compliance|0|||
46631552|NCT01872078|82804678|FG003|Overall Study|Dose administration non-compliance|1|||
46631553|NCT01872078|82804675|FG000|Overall Study|Protocol Violation|0|||
46631554|NCT01872078|82804676|FG001|Overall Study|Protocol Violation|0|||
46631555|NCT01872078|82804677|FG002|Overall Study|Protocol Violation|1|||
46631556|NCT01872078|82804678|FG003|Overall Study|Protocol Violation|0|||
46631557|NCT01872078|82804675|FG000|Overall Study|Withdrawal by Subject|0|||
46631558|NCT01872078|82804676|FG001|Overall Study|Withdrawal by Subject|0|||
46631559|NCT01872078|82804677|FG002|Overall Study|Withdrawal by Subject|1|||
46631560|NCT01872078|82804678|FG003|Overall Study|Withdrawal by Subject|0|||
46631561|NCT01872078|82804675|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
46717366|NCT01114217|82933500|FG000|Overall Study|Other-Sponsor Decision|10|||
46717367|NCT01114217|82933501|FG001|Overall Study|Other-Sponsor Decision|12|||
46717368|NCT01114217|82933500|FG000|Overall Study|Other-Study Termination|0|||
46717369|NCT01114217|82933501|FG001|Overall Study|Other-Study Termination|1|||
47039877|NCT01609556|83293174|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
46631562|NCT01872078|82804676|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
46631563|NCT01872078|82804677|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
46717370|NCT01114217|82933500|FG000|Overall Study|Other-Study Withdrawn|1|||
46717371|NCT01114217|82933501|FG001|Overall Study|Other-Study Withdrawn|1|||
46717372|NCT01114217|82933500|FG000|Overall Study|Other-Site Stopped Communicating|2|||
46717373|NCT01114217|82933501|FG001|Overall Study|Other-Site Stopped Communicating|0|||
46717374|NCT01114217|82933500|FG000|Overall Study|Other-Lost to Follow-up|1|||
46717375|NCT01114217|82933501|FG001|Overall Study|Other-Lost to Follow-up|0|||
46717376|NCT01114217|82933500|FG000|Overall Study|Other-Withdrawal by Subject|1|||
46717377|NCT01114217|82933501|FG001|Overall Study|Other-Withdrawal by Subject|1|||
46717378|NCT01030536|82933510|FG000|Overall Study|Withdrawal by Subject|0|||
46717379|NCT01030536|82933511|FG001|Overall Study|Withdrawal by Subject|0|||
46717380|NCT01030536|82933512|FG002|Overall Study|Withdrawal by Subject|1|||
46717381|NCT01030536|82933513|FG003|Overall Study|Withdrawal by Subject|0|||
46717382|NCT01030536|82933514|FG004|Overall Study|Withdrawal by Subject|0|||
46717383|NCT01030536|82933510|FG000|Overall Study|undefined|1|||
46717384|NCT01030536|82933511|FG001|Overall Study|undefined|0|||
47039878|NCT01609556|83293175|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
47039879|NCT01609556|83293176|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
47039880|NCT01609556|83293177|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
46717385|NCT01030536|82933512|FG002|Overall Study|undefined|1|||
46717386|NCT01030536|82933513|FG003|Overall Study|undefined|1|||
46717387|NCT01030536|82933514|FG004|Overall Study|undefined|0|||
46717388|NCT01030536|82933510|FG000|Overall Study|Adverse Event|0|||
46717389|NCT01030536|82933511|FG001|Overall Study|Adverse Event|3|||
46717390|NCT01030536|82933512|FG002|Overall Study|Adverse Event|1|||
46717391|NCT01030536|82933513|FG003|Overall Study|Adverse Event|0|||
46717392|NCT01030536|82933514|FG004|Overall Study|Adverse Event|1|||
46717393|NCT01030536|82933510|FG000|Overall Study|Progressive disease|6|||
46717394|NCT01030536|82933511|FG001|Overall Study|Progressive disease|2|||
46717395|NCT01030536|82933512|FG002|Overall Study|Progressive disease|3|||
46717396|NCT01030536|82933513|FG003|Overall Study|Progressive disease|2|||
46717397|NCT01030536|82933514|FG004|Overall Study|Progressive disease|0|||
46717398|NCT01030536|82933510|FG000|Overall Study|Death|0|||
46717399|NCT01030536|82933511|FG001|Overall Study|Death|1|||
46717400|NCT01030536|82933512|FG002|Overall Study|Death|0|||
46717401|NCT01030536|82933513|FG003|Overall Study|Death|0|||
46717402|NCT01030536|82933514|FG004|Overall Study|Death|0|||
46717403|NCT01030458|82933532|FG000|Overall Study|Lost to Follow-up|9|||
46717404|NCT01030458|82933533|FG001|Overall Study|Lost to Follow-up|10|||
46717405|NCT01030458|82933532|FG000|Overall Study|Withdrawal by Subject|2|||
46717406|NCT01030458|82933533|FG001|Overall Study|Withdrawal by Subject|3|||
46717407|NCT01030458|82933532|FG000|Overall Study|Logistical reasons|9|||
46717408|NCT01030458|82933533|FG001|Overall Study|Logistical reasons|5|||
46717409|NCT01030458|82933532|FG000|Overall Study|Moved or changed job|6|||
46717410|NCT01030458|82933533|FG001|Overall Study|Moved or changed job|13|||
46717411|NCT01030458|82933532|FG000|Overall Study|Side effect of medication|1|||
46717412|NCT01030458|82933533|FG001|Overall Study|Side effect of medication|1|||
46717413|NCT00930969|82933539|FG000|Overall Study|Death|5|||
46717414|NCT00930969|82933539|FG000|Overall Study|Lost to Follow-up|1|||
46717415|NCT00930969|82933539|FG000|Overall Study|Physician Decision|13|||
46717416|NCT00930969|82933539|FG000|Overall Study|Withdrawal by Subject|19|||
46717417|NCT01114139|82933545|FG000|Overall Study|Adverse Event|3|||
47039881|NCT01609556|83293178|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
46717418|NCT01114139|82933546|FG001|Overall Study|Adverse Event|2|||
46717419|NCT01114139|82933545|FG000|Overall Study|Lost to Follow-up|15|||
47039882|NCT01609556|83293179|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
46717420|NCT01114139|82933546|FG001|Overall Study|Lost to Follow-up|3|||
47039883|NCT01609556|83293180|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
46717421|NCT01114139|82933545|FG000|Overall Study|Withdrawal by Subject|17|||
46717422|NCT01114139|82933546|FG001|Overall Study|Withdrawal by Subject|6|||
46717423|NCT01114139|82933545|FG000|Overall Study|Other-Missed 1 visit|1|||
46717424|NCT01114139|82933546|FG001|Overall Study|Other-Missed 1 visit|0|||
46717425|NCT01114139|82933545|FG000|Overall Study|Other-Protocol Violation|1|||
46717426|NCT01114139|82933546|FG001|Overall Study|Other-Protocol Violation|0|||
47039884|NCT01609556|83293181|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
47039885|NCT01609556|83293182|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
46717427|NCT01114139|82933545|FG000|Overall Study|Other-Out of window for study drug dose|1|||
47039886|NCT01609556|83293183|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
47039887|NCT01609556|83293184|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
47039888|NCT01609556|83293185|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
47039889|NCT01609556|83293186|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
46717428|NCT01114139|82933546|FG001|Overall Study|Other-Out of window for study drug dose|0|||
46717429|NCT01114139|82933545|FG000|Overall Study|Other-Participant falsified records|0|||
46717430|NCT01114139|82933546|FG001|Overall Study|Other-Participant falsified records|1|||
46717431|NCT01114139|82933545|FG000|Overall Study|Other-Participant went on hospice|0|||
46717432|NCT01114139|82933546|FG001|Overall Study|Other-Participant went on hospice|1|||
46717433|NCT01114139|82933545|FG000|Overall Study|Other-Physician changed treatment|1|||
46717434|NCT01114139|82933546|FG001|Overall Study|Other-Physician changed treatment|0|||
46717435|NCT01114139|82933545|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
46717436|NCT01114139|82933546|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
46631564|NCT01872078|82804678|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
46631565|NCT01896726|82804688|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
47039890|NCT01609556|83293187|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
47039891|NCT01609556|83293172|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
47039892|NCT01609556|83293173|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
47039893|NCT01609556|83293174|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
47039894|NCT01609556|83293175|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
47039895|NCT01609556|83293176|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
47039896|NCT01609556|83293177|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
47039897|NCT01609556|83293178|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
47039898|NCT01609556|83293179|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
47039899|NCT01609556|83293180|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
47039900|NCT01609556|83293181|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
47039901|NCT01609556|83293182|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
47039902|NCT01609556|83293183|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
47039903|NCT01609556|83293184|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
47039904|NCT01609556|83293185|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
47039905|NCT01609556|83293186|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
46631566|NCT01896726|82804688|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
46631567|NCT01856790|82804695|FG000|Closed Loop Control|Withdrawal by Subject|2|||
46631568|NCT01856790|82804695|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
46631569|NCT01856322|82804709|FG000|Overall Study|off study due to lack of accrual|0|||
46631570|NCT01856322|82804710|FG001|Overall Study|off study due to lack of accrual|0|||
46631571|NCT01856322|82804711|FG002|Overall Study|off study due to lack of accrual|3|||
46631572|NCT01896102|82804718|FG000|Overall Study|Death|1|||
46631573|NCT01896102|82804718|FG000|Overall Study|Participant to receive allogenic transplant|2|||
46631574|NCT01871532|82804725|FG000|Overall Study|Withdrawal by Subject|1|||
46631575|NCT01871532|82804726|FG001|Overall Study|Withdrawal by Subject|2|||
46631576|NCT01855074|82804732|FG000|Overall Study|Adverse Event|1|||
46631577|NCT01855074|82804732|FG000|Overall Study|Lost to Follow-up|4|||
46631578|NCT01855074|82804732|FG000|Overall Study|Withdrawal by Subject|8|||
46631579|NCT01855074|82804732|FG000|Overall Study|Started but not treated|1|||
46631580|NCT01871142|82804736|FG000|Overall Study|Adverse Event|1|||
46631581|NCT01895322|82804750|FG000|Overall Study|Adverse Event|1|||
46631582|NCT01895322|82804750|FG000|Overall Study|Withdrawal by Subject|2|||
46631583|NCT01895322|82804750|FG000|Overall Study|Protocol Violation|10|||
46631584|NCT01894776|82804755|FG000|Overall Study|Withdrawal by Subject|1|||
46631585|NCT01894620|82804761|FG000|Overall Study|Withdrawal by Subject|0|||
46631586|NCT01894620|82804762|FG001|Overall Study|Withdrawal by Subject|1|||
46631587|NCT01854918|82804772|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
46631588|NCT01854918|82804773|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
46631589|NCT01854918|82804772|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
46631590|NCT01854918|82804773|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
46631591|NCT01854918|82804772|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
46631592|NCT01854918|82804773|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
46631593|NCT01854918|82804772|FG000|SOC-controlled Period (Year 1)|Death|5|||
46631594|NCT01854918|82804773|FG001|SOC-controlled Period (Year 1)|Death|5|||
46631595|NCT01854918|82804772|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
46631596|NCT01854918|82804773|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
46631597|NCT01854918|82804772|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
46631598|NCT01854918|82804773|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
46631599|NCT01854918|82804772|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
46631600|NCT01854918|82804773|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
46631601|NCT01854918|82804772|FG000|All-IP Period (Years 2 and 3)|Death|5|||
46631602|NCT01854918|82804773|FG001|All-IP Period (Years 2 and 3)|Death|16|||
46717437|NCT01027884|82933554|FG000|Overall Study|Adverse Event|2|||
46717438|NCT01027884|82933555|FG001|Overall Study|Adverse Event|1|||
46631603|NCT01894230|82804788|FG000|Overall Study|Lost to Follow-up|2|||
46631604|NCT01894230|82804789|FG001|Overall Study|Lost to Follow-up|2|||
46631605|NCT01894230|82804788|FG000|Overall Study|Withdrawal by Subject|4|||
46631606|NCT01894230|82804789|FG001|Overall Study|Withdrawal by Subject|4|||
46631607|NCT01894230|82804788|FG000|Overall Study|Non-adherent|0|||
46717439|NCT01027884|82933554|FG000|Overall Study|Protocol Violation|1|||
47039906|NCT01609556|83293187|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
47039907|NCT01609556|83293172|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
46631608|NCT01894230|82804789|FG001|Overall Study|Non-adherent|1|||
46631609|NCT01894230|82804788|FG000|Overall Study|Death|1|||
46717440|NCT01027884|82933555|FG001|Overall Study|Protocol Violation|0|||
47039908|NCT01609556|83293173|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
46631610|NCT01894230|82804789|FG001|Overall Study|Death|0|||
46717441|NCT01027884|82933554|FG000|Overall Study|Non-compliance|1|||
46717442|NCT01027884|82933555|FG001|Overall Study|Non-compliance|1|||
46717443|NCT01027884|82933554|FG000|Overall Study|Withdrawal by Subject|0|||
46717444|NCT01027884|82933555|FG001|Overall Study|Withdrawal by Subject|1|||
46631611|NCT01894152|82804795|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
46631612|NCT01854528|82804801|FG000|Overall Study|Adverse Event|0|||
46631613|NCT01854528|82804802|FG001|Overall Study|Adverse Event|4|||
46631614|NCT01854528|82804801|FG000|Overall Study|Withdrawal by Subject|0|||
46631615|NCT01854528|82804802|FG001|Overall Study|Withdrawal by Subject|2|||
46631616|NCT01854528|82804801|FG000|Overall Study|Virologic Failure|0|||
46631617|NCT01854528|82804802|FG001|Overall Study|Virologic Failure|9|||
46631618|NCT01853982|82804810|FG000|Overall Study|Withdrawal by Subject|1|||
46631619|NCT01853982|82804811|FG001|Overall Study|Withdrawal by Subject|0|||
46631620|NCT01853982|82804810|FG000|Overall Study|Death|1|||
46631621|NCT01853982|82804811|FG001|Overall Study|Death|0|||
46631622|NCT01853982|82804810|FG000|Overall Study|Lost to Follow-up|0|||
46631623|NCT01853982|82804811|FG001|Overall Study|Lost to Follow-up|1|||
46631624|NCT01853280|82804819|FG000|Overall Study|Lack of Efficacy|2|||
46631625|NCT01853280|82804820|FG001|Overall Study|Lack of Efficacy|2|||
46631626|NCT01853280|82804819|FG000|Overall Study|Lost to Follow-up|0|||
46631627|NCT01853280|82804820|FG001|Overall Study|Lost to Follow-up|1|||
46631628|NCT01853280|82804819|FG000|Overall Study|Physician Decision|0|||
46631629|NCT01853280|82804820|FG001|Overall Study|Physician Decision|1|||
46631630|NCT01853280|82804819|FG000|Overall Study|Withdrawal by Subject|0|||
46631631|NCT01853280|82804820|FG001|Overall Study|Withdrawal by Subject|1|||
46631632|NCT01853280|82804819|FG000|Overall Study|Ineligible|0|||
46631633|NCT01853280|82804820|FG001|Overall Study|Ineligible|1|||
46631634|NCT01892436|82804830|FG000|Overall Study|Withdrawal by Subject|8|||
46717445|NCT01027884|82933554|FG000|Overall Study|Lost to Follow-up|0|||
46717446|NCT01027884|82933555|FG001|Overall Study|Lost to Follow-up|1|||
46717447|NCT01027884|82933554|FG000|Overall Study|Spinal fixation surgery|0|||
46717448|NCT01027884|82933555|FG001|Overall Study|Spinal fixation surgery|3|||
46717449|NCT03387514|82933563|FG000|Overall Study|Withdrawal by Subject|2|||
46717450|NCT03387514|82933563|FG000|Overall Study|Physician Decision|1|||
46717451|NCT03387514|82933563|FG000|Overall Study|Lost to Follow-up|2|||
46717452|NCT01022580|82933578|FG000|Overall Study|Death|18|||
46717453|NCT01022580|82933579|FG001|Overall Study|Death|22|||
46717454|NCT01107353|82933593|FG000|Overall Study|Positive Drug Screen|1|||
46717455|NCT01107353|82933594|FG001|Overall Study|Positive Drug Screen|0|||
46717456|NCT01107197|82933602|FG000|Overall Study|Death|12|||
46717457|NCT01107197|82933603|FG001|Overall Study|Death|10|||
46631635|NCT01892436|82804831|FG001|Overall Study|Withdrawal by Subject|15|||
46631636|NCT01892436|82804832|FG002|Overall Study|Withdrawal by Subject|4|||
46631637|NCT01892436|82804833|FG003|Overall Study|Withdrawal by Subject|4|||
46631638|NCT01892436|82804830|FG000|Overall Study|Death|1|||
46631639|NCT01892436|82804831|FG001|Overall Study|Death|1|||
46631640|NCT01892436|82804832|FG002|Overall Study|Death|0|||
46631641|NCT01892436|82804833|FG003|Overall Study|Death|0|||
46717458|NCT01107197|82933602|FG000|Overall Study|Lost to Follow-up|5|||
46717459|NCT01107197|82933603|FG001|Overall Study|Lost to Follow-up|8|||
46717460|NCT01107197|82933602|FG000|Overall Study|Withdrawal by Subject|3|||
46717461|NCT01107197|82933603|FG001|Overall Study|Withdrawal by Subject|5|||
46717462|NCT01112579|82933620|FG000|Overall Study|Missed Visit|1|||
46717463|NCT01112579|82933621|FG001|Overall Study|Missed Visit|1|||
46717464|NCT01112579|82933620|FG000|Overall Study|Death|0|||
46717465|NCT01112579|82933621|FG001|Overall Study|Death|2|||
46717466|NCT01112267|82933629|FG000|Overall Study|Adverse Event|24|||
46717467|NCT01112267|82933630|FG001|Overall Study|Adverse Event|6|||
46717468|NCT01112267|82933629|FG000|Overall Study|Withdrawal by Subject|3|||
46717469|NCT01112267|82933630|FG001|Overall Study|Withdrawal by Subject|5|||
46717470|NCT01112267|82933629|FG000|Overall Study|Protocol Violation|5|||
46717471|NCT01112267|82933630|FG001|Overall Study|Protocol Violation|3|||
46717472|NCT01112267|82933629|FG000|Overall Study|Participants not compliant|1|||
46717473|NCT01112267|82933630|FG001|Overall Study|Participants not compliant|2|||
46717474|NCT01112267|82933629|FG000|Overall Study|Participants not receive any study drug|1|||
46631642|NCT01892436|82804830|FG000|Overall Study|Physician Decision|2|||
46631643|NCT01892436|82804831|FG001|Overall Study|Physician Decision|1|||
46717475|NCT01112267|82933630|FG001|Overall Study|Participants not receive any study drug|2|||
46631644|NCT01892436|82804832|FG002|Overall Study|Physician Decision|0|||
46631645|NCT01892436|82804833|FG003|Overall Study|Physician Decision|1|||
46631646|NCT01892436|82804830|FG000|Overall Study|Pregnancy|0|||
46717476|NCT00925587|82933638|FG000|Overall Study|Protocol Specified Criteria|6|||
46717477|NCT00925587|82933639|FG001|Overall Study|Protocol Specified Criteria|6|||
46717478|NCT00925587|82933638|FG000|Overall Study|Physician Decision|4|||
46717479|NCT00925587|82933639|FG001|Overall Study|Physician Decision|1|||
46717480|NCT00925587|82933638|FG000|Overall Study|Protocol Violation|6|||
46717481|NCT00925587|82933639|FG001|Overall Study|Protocol Violation|4|||
46717482|NCT00925587|82933638|FG000|Overall Study|Withdrawal by Subject|9|||
46717483|NCT00925587|82933639|FG001|Overall Study|Withdrawal by Subject|6|||
46631647|NCT01892436|82804831|FG001|Overall Study|Pregnancy|2|||
46631648|NCT01892436|82804832|FG002|Overall Study|Pregnancy|1|||
46717484|NCT00925587|82933638|FG000|Overall Study|Death|5|||
46717485|NCT00925587|82933639|FG001|Overall Study|Death|5|||
46717486|NCT00925587|82933638|FG000|Overall Study|Adverse Event|6|||
46717487|NCT00925587|82933639|FG001|Overall Study|Adverse Event|2|||
46717488|NCT00925587|82933638|FG000|Overall Study|Lost to Follow-up|0|||
46717489|NCT00925587|82933639|FG001|Overall Study|Lost to Follow-up|1|||
46717490|NCT00928707|82933651|FG000|Overall Study|Protocol Violation|1|||
46717491|NCT00928707|82933652|FG001|Overall Study|Protocol Violation|0|||
46717492|NCT00930813|82933660|FG000|Overall Study|Death|4|||
46717493|NCT00930813|82933661|FG001|Overall Study|Death|5|||
46717494|NCT00930813|82933660|FG000|Overall Study|Withdrawal by Subject|2|||
46717495|NCT00930813|82933661|FG001|Overall Study|Withdrawal by Subject|5|||
46717496|NCT00930813|82933660|FG000|Overall Study|Lost to Follow-up|2|||
46717497|NCT00930813|82933661|FG001|Overall Study|Lost to Follow-up|4|||
46717498|NCT00930579|82933669|FG000|Overall Study|Withdrawal by Subject|1|||
46717499|NCT00930579|82933669|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
46717500|NCT00925353|82933673|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
46717501|NCT01106651|82933697|FG000|Overall Study|Adverse Event|17|||
46717502|NCT01106651|82933698|FG001|Overall Study|Adverse Event|9|||
46717503|NCT01106651|82933699|FG002|Overall Study|Adverse Event|23|||
46717504|NCT01106651|82933697|FG000|Overall Study|Lost to Follow-up|8|||
46717505|NCT01106651|82933698|FG001|Overall Study|Lost to Follow-up|2|||
46717506|NCT01106651|82933699|FG002|Overall Study|Lost to Follow-up|6|||
46717507|NCT01106651|82933697|FG000|Overall Study|Physician Decision|4|||
46717508|NCT01106651|82933698|FG001|Overall Study|Physician Decision|3|||
46717509|NCT01106651|82933699|FG002|Overall Study|Physician Decision|1|||
46717510|NCT01106651|82933697|FG000|Overall Study|Protocol Violation|1|||
46717511|NCT01106651|82933698|FG001|Overall Study|Protocol Violation|2|||
46717512|NCT01106651|82933699|FG002|Overall Study|Protocol Violation|1|||
46717513|NCT01106651|82933697|FG000|Overall Study|Withdrawal by Subject|14|||
46717514|NCT01106651|82933698|FG001|Overall Study|Withdrawal by Subject|7|||
46717515|NCT01106651|82933699|FG002|Overall Study|Withdrawal by Subject|4|||
46717516|NCT01106651|82933697|FG000|Overall Study|Noncompliance with study drug|1|||
46717517|NCT01106651|82933698|FG001|Overall Study|Noncompliance with study drug|0|||
46717518|NCT01106651|82933699|FG002|Overall Study|Noncompliance with study drug|2|||
46717519|NCT01106651|82933697|FG000|Overall Study|Other|34|||
46717520|NCT01106651|82933698|FG001|Overall Study|Other|31|||
46717521|NCT01106651|82933699|FG002|Overall Study|Other|21|||
46717522|NCT01106651|82933697|FG000|Overall Study|Death|0|||
46717523|NCT01106651|82933698|FG001|Overall Study|Death|3|||
46717524|NCT01106651|82933699|FG002|Overall Study|Death|0|||
46717525|NCT01027650|82933718|FG000|Overall Study|Personal Reasons|0|||
46717526|NCT01027650|82933719|FG001|Overall Study|Personal Reasons|0|||
46717527|NCT01027650|82933720|FG002|Overall Study|Personal Reasons|0|||
46717528|NCT01027650|82933721|FG003|Overall Study|Personal Reasons|0|||
46717529|NCT01027650|82933722|FG004|Overall Study|Personal Reasons|2|||
46717530|NCT01027650|82933723|FG005|Overall Study|Personal Reasons|1|||
46717531|NCT01027650|82933724|FG006|Overall Study|Personal Reasons|0|||
46717532|NCT01027650|82933725|FG007|Overall Study|Personal Reasons|0|||
46717533|NCT01027650|82933718|FG000|Overall Study|Lost to Follow-up|0|||
46717534|NCT01027650|82933719|FG001|Overall Study|Lost to Follow-up|0|||
46717535|NCT01027650|82933720|FG002|Overall Study|Lost to Follow-up|0|||
46717536|NCT01027650|82933721|FG003|Overall Study|Lost to Follow-up|0|||
46717537|NCT01027650|82933722|FG004|Overall Study|Lost to Follow-up|0|||
46717538|NCT01027650|82933723|FG005|Overall Study|Lost to Follow-up|0|||
46717539|NCT01027650|82933724|FG006|Overall Study|Lost to Follow-up|1|||
46717540|NCT01027650|82933725|FG007|Overall Study|Lost to Follow-up|0|||
46717541|NCT01027650|82933718|FG000|Overall Study|Lack of Efficacy|0|||
46717542|NCT01027650|82933719|FG001|Overall Study|Lack of Efficacy|0|||
46717543|NCT01027650|82933720|FG002|Overall Study|Lack of Efficacy|0|||
46717544|NCT01027650|82933721|FG003|Overall Study|Lack of Efficacy|0|||
46717545|NCT01027650|82933722|FG004|Overall Study|Lack of Efficacy|0|||
46915083|NCT03157583|83145798|FG000|Overall Study|Other (did not meet study criteria)|1|||
46717546|NCT01027650|82933723|FG005|Overall Study|Lack of Efficacy|1|||
46717547|NCT01027650|82933724|FG006|Overall Study|Lack of Efficacy|0|||
46915084|NCT02842736|83145816|FG000|Overall Study|Lost to Follow-up|13|||
46915085|NCT02842736|83145816|FG000|Overall Study|Intervention for menstrual bleeding|17|||
46717548|NCT01027650|82933725|FG007|Overall Study|Lack of Efficacy|0|||
46717549|NCT01106027|82933743|FG000|Overall Study|Lost graft early, discontinued|1|||
46717550|NCT00927927|82933762|FG000|Overall Study|Withdrawal by Subject|0|||
46717551|NCT00927927|82933763|FG001|Overall Study|Withdrawal by Subject|0|||
46717552|NCT00927927|82933764|FG002|Overall Study|Withdrawal by Subject|0|||
46717553|NCT00927927|82933765|FG003|Overall Study|Withdrawal by Subject|0|||
46717554|NCT00927927|82933766|FG004|Overall Study|Withdrawal by Subject|0|||
46717555|NCT00927927|82933767|FG005|Overall Study|Withdrawal by Subject|0|||
46717556|NCT00927927|82933768|FG006|Overall Study|Withdrawal by Subject|0|||
46717557|NCT00927927|82933769|FG007|Overall Study|Withdrawal by Subject|2|||
46717558|NCT00927927|82933770|FG008|Overall Study|Withdrawal by Subject|0|||
46717559|NCT00927927|82933771|FG009|Overall Study|Withdrawal by Subject|0|||
46717560|NCT00927927|82933772|FG010|Overall Study|Withdrawal by Subject|0|||
46717561|NCT00927927|82933773|FG011|Overall Study|Withdrawal by Subject|2|||
46717562|NCT00927927|82933774|FG012|Overall Study|Withdrawal by Subject|0|||
46717563|NCT00927927|82933775|FG013|Overall Study|Withdrawal by Subject|0|||
46717564|NCT00927927|82933776|FG014|Overall Study|Withdrawal by Subject|0|||
46717565|NCT01027416|82933810|FG000|Overall Study|Withdrawal by Subject|0|||
46717566|NCT01027416|82933811|FG001|Overall Study|Withdrawal by Subject|1|||
46717567|NCT01027416|82933810|FG000|Overall Study|Physician Decision|1|||
46717568|NCT01027416|82933811|FG001|Overall Study|Physician Decision|4|||
46717569|NCT00923559|82933819|FG000|Overall Study|Lost to Follow-up|2|||
46717570|NCT00923559|82933820|FG001|Overall Study|Lost to Follow-up|3|||
46717571|NCT01015638|82933830|FG000|Overall Study|Withdrawal by Subject|1|||
46717572|NCT01015638|82933831|FG001|Overall Study|Withdrawal by Subject|0|||
46717573|NCT01022502|82933837|FG000|Overall Study|Adverse Event|1|||
46717574|NCT01022502|82933837|FG000|Overall Study|employment related reasons|1|||
46717575|NCT01022502|82933837|FG000|Overall Study|Withdrawal by Subject|1|||
46717576|NCT01105091|82933845|FG000|Overall Study|Death|2|||
46717577|NCT01105091|82933846|FG001|Overall Study|Death|0|||
46717578|NCT00924729|82933856|FG000|Overall Study|insufficient volume for analysis|1|||
46717579|NCT00924729|82933857|FG001|Overall Study|insufficient volume for analysis|0|||
46717580|NCT00924729|82933856|FG000|Overall Study|Protocol Violation|1|||
46717581|NCT00924729|82933857|FG001|Overall Study|Protocol Violation|0|||
46717582|NCT01099709|82933865|FG000|Period 1|Withdrawal by Subject|0|||
46717583|NCT01099709|82933866|FG001|Period 1|Withdrawal by Subject|1|||
46717584|NCT01099709|82933865|FG000|Period 1|Positive cotinine test|0|||
46717585|NCT01099709|82933866|FG001|Period 1|Positive cotinine test|1|||
46717586|NCT01099709|82933865|FG000|Period 1|Adverse Event|1|||
46717587|NCT01099709|82933866|FG001|Period 1|Adverse Event|0|||
46717588|NCT01099397|82933873|FG000|Overall Study|Lost to Follow-up|4|||
46717589|NCT01099397|82933873|FG000|Overall Study|Protocol Violation|4|||
46717590|NCT01099397|82933873|FG000|Overall Study|Withdrawal by Subject|5|||
46717591|NCT01022424|82933878|FG000|Overall Study|Adverse Event|1|||
46717592|NCT01022424|82933878|FG000|Overall Study|Physician Decision|1|||
46717593|NCT01022424|82933878|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
46717594|NCT01098851|82933888|FG000|Overall Study|Equipment failure|1|||
46717595|NCT01098851|82933889|FG001|Overall Study|Equipment failure|0|||
46717596|NCT01026948|82933895|FG000|Overall Study|Physician Decision|8|||
46717597|NCT01104779|82933903|FG000|Overall Study|Protocol Violation|1|||
46717598|NCT01104779|82933904|FG001|Overall Study|Protocol Violation|2|||
46915086|NCT02842736|83145816|FG000|Overall Study|Withdrawal by Subject|4|||
46631649|NCT01892436|82804833|FG003|Overall Study|Pregnancy|0|||
46631650|NCT01892436|82804830|FG000|Overall Study|Technical problems|2|||
46631651|NCT01892436|82804831|FG001|Overall Study|Technical problems|1|||
46631652|NCT01892436|82804832|FG002|Overall Study|Technical problems|1|||
46631653|NCT01892436|82804833|FG003|Overall Study|Technical problems|1|||
46631654|NCT01892436|82804830|FG000|Overall Study|Lack of Efficacy|1|||
46631655|NCT01892436|82804831|FG001|Overall Study|Lack of Efficacy|2|||
46631656|NCT01892436|82804832|FG002|Overall Study|Lack of Efficacy|2|||
46631657|NCT01892436|82804833|FG003|Overall Study|Lack of Efficacy|2|||
46631658|NCT01892436|82804830|FG000|Overall Study|Lost to Follow-up|1|||
46631659|NCT01892436|82804831|FG001|Overall Study|Lost to Follow-up|1|||
46631660|NCT01892436|82804832|FG002|Overall Study|Lost to Follow-up|1|||
46631661|NCT01892436|82804833|FG003|Overall Study|Lost to Follow-up|3|||
46631662|NCT01892436|82804830|FG000|Overall Study|non-compliance with treatment|1|||
46631663|NCT01892436|82804831|FG001|Overall Study|non-compliance with treatment|0|||
46631664|NCT01892436|82804832|FG002|Overall Study|non-compliance with treatment|0|||
46631665|NCT01892436|82804833|FG003|Overall Study|non-compliance with treatment|0|||
46631666|NCT01892436|82804830|FG000|Overall Study|Adverse Event|7|||
46631667|NCT01892436|82804831|FG001|Overall Study|Adverse Event|6|||
46631668|NCT01892436|82804832|FG002|Overall Study|Adverse Event|2|||
46631669|NCT01892436|82804833|FG003|Overall Study|Adverse Event|3|||
46631670|NCT01853046|82804845|FG000|Overall Study|Withdrawal by Subject|1|||
46631671|NCT01853046|82804846|FG001|Overall Study|Withdrawal by Subject|1|||
46631672|NCT01853046|82804845|FG000|Overall Study|Adverse Event|4|||
46631673|NCT01853046|82804846|FG001|Overall Study|Adverse Event|2|||
46631674|NCT01853046|82804845|FG000|Overall Study|Disease progression|13|||
46631675|NCT01853046|82804846|FG001|Overall Study|Disease progression|3|||
46631676|NCT01891890|82804856|FG000|Overall Study|Lost to Follow-up|0|||
46631677|NCT01891890|82804857|FG001|Overall Study|Lost to Follow-up|0|||
46631678|NCT01891890|82804858|FG002|Overall Study|Lost to Follow-up|1|||
46631679|NCT01891890|82804856|FG000|Overall Study|Study ended before endpoint reached|7|||
46631680|NCT01891890|82804857|FG001|Overall Study|Study ended before endpoint reached|3|||
46631681|NCT01891890|82804858|FG002|Overall Study|Study ended before endpoint reached|6|||
46631682|NCT01852812|82804869|FG000|Overall Study|Adverse Event|0|||
46717599|NCT01104779|82933905|FG002|Overall Study|Protocol Violation|2|||
46717600|NCT01104779|82933903|FG000|Overall Study|Lack of Efficacy|26|||
46631683|NCT01852812|82804870|FG001|Overall Study|Adverse Event|0|||
46717601|NCT01104779|82933904|FG001|Overall Study|Lack of Efficacy|12|||
46717602|NCT01104779|82933905|FG002|Overall Study|Lack of Efficacy|13|||
46717603|NCT01104779|82933903|FG000|Overall Study|Adverse Event|13|||
46717604|NCT01104779|82933904|FG001|Overall Study|Adverse Event|14|||
46717605|NCT01104779|82933905|FG002|Overall Study|Adverse Event|13|||
46717606|NCT01104779|82933903|FG000|Overall Study|Did not meet inc/exc criteria|1|||
46717607|NCT01104779|82933904|FG001|Overall Study|Did not meet inc/exc criteria|1|||
46717608|NCT01104779|82933905|FG002|Overall Study|Did not meet inc/exc criteria|1|||
46717609|NCT01104779|82933903|FG000|Overall Study|Other reasons|0|||
46717610|NCT01104779|82933904|FG001|Overall Study|Other reasons|1|||
46717611|NCT01104779|82933905|FG002|Overall Study|Other reasons|0|||
46717612|NCT01104779|82933903|FG000|Overall Study|Lost to Follow-up|2|||
46717613|NCT01104779|82933904|FG001|Overall Study|Lost to Follow-up|0|||
46717614|NCT01104779|82933905|FG002|Overall Study|Lost to Follow-up|1|||
46717615|NCT01104779|82933903|FG000|Overall Study|Withdrawal by Subject|16|||
46717616|NCT01104779|82933904|FG001|Overall Study|Withdrawal by Subject|25|||
46717617|NCT01104779|82933905|FG002|Overall Study|Withdrawal by Subject|32|||
46717618|NCT00918957|82933915|FG000|Overall Study|Adverse Event|2|||
46717619|NCT00918957|82933916|FG001|Overall Study|Adverse Event|0|||
46717620|NCT00918957|82933915|FG000|Overall Study|Withdrawal by Subject|1|||
46717621|NCT00918957|82933916|FG001|Overall Study|Withdrawal by Subject|0|||
46717622|NCT01022268|82933924|FG000|Overall Study|Withdrawal by Subject|1|||
46717623|NCT01022268|82933925|FG001|Overall Study|Withdrawal by Subject|0|||
46717624|NCT01022268|82933924|FG000|Overall Study|Withdrawal by Subject|1|||
46717625|NCT01022268|82933925|FG001|Overall Study|Withdrawal by Subject|0|||
46717626|NCT01015560|82933931|FG000|Overall Study|Adverse Event|1|||
46717627|NCT01015560|82933931|FG000|Overall Study|Not protocol specified|1|||
46717628|NCT01015560|82933931|FG000|Overall Study|Withdrawal by Subject|1|||
46717629|NCT00918879|82933937|FG000|Overall Study|Withdrawal by Subject|4|||
46717630|NCT00918879|82933938|FG001|Overall Study|Withdrawal by Subject|4|||
46717631|NCT00918879|82933937|FG000|Overall Study|Lost to Follow-up|1|||
46717632|NCT00918879|82933938|FG001|Overall Study|Lost to Follow-up|1|||
46717633|NCT00918879|82933937|FG000|Overall Study|Severe non-compliance to protocol|1|||
46717634|NCT00918879|82933938|FG001|Overall Study|Severe non-compliance to protocol|1|||
46717635|NCT01026792|82933944|FG000|Overall Study|Protocol Violation|1|||
46717636|NCT01026324|82933951|FG000|Follow up/Survival|Withdrawal by Subject|1|||
46717637|NCT01026324|82933952|FG001|Follow up/Survival|Withdrawal by Subject|0|||
46717638|NCT01026324|82933953|FG002|Follow up/Survival|Withdrawal by Subject|0|||
46717639|NCT01098539|82933964|FG000|Overall Study|Adverse Event|26|||
46717640|NCT01098539|82933965|FG001|Overall Study|Adverse Event|26|||
46717641|NCT01098539|82933964|FG000|Overall Study|Protocol Violation|1|||
46717642|NCT01098539|82933965|FG001|Overall Study|Protocol Violation|4|||
46717643|NCT01098539|82933964|FG000|Overall Study|Noncompliance|3|||
46717644|NCT01098539|82933965|FG001|Overall Study|Noncompliance|5|||
46717645|NCT01098539|82933964|FG000|Overall Study|Lost to Follow-up|4|||
46717646|NCT01098539|82933965|FG001|Overall Study|Lost to Follow-up|4|||
46717647|NCT01098539|82933964|FG000|Overall Study|Withdrawal by Subject|12|||
46717648|NCT01098539|82933965|FG001|Overall Study|Withdrawal by Subject|26|||
46631684|NCT01852812|82804871|FG002|Overall Study|Adverse Event|1|||
46631685|NCT01852812|82804869|FG000|Overall Study|Non-compliance With Study Drug|0|||
46631686|NCT01852812|82804870|FG001|Overall Study|Non-compliance With Study Drug|1|||
46631687|NCT01852812|82804871|FG002|Overall Study|Non-compliance With Study Drug|0|||
46631688|NCT01869348|82804881|FG000|Overall Study|Withdrawal by Subject|1|||
46631689|NCT01869348|82804882|FG001|Overall Study|Withdrawal by Subject|1|||
46631690|NCT01869192|82804890|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
46631691|NCT01869192|82804891|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
46631692|NCT01869192|82804890|FG000|Postoperative Chemotherapy|Physician Decision|0|||
46631693|NCT01869192|82804891|FG001|Postoperative Chemotherapy|Physician Decision|2|||
46631694|NCT01868646|82804899|FG000|Overall Study|Do not meet inclusion criteria|3|||
46631695|NCT01868646|82804900|FG001|Overall Study|Do not meet inclusion criteria|5|||
46631696|NCT01852110|82804908|FG000|Overall Study|Adverse Event|12|||
46631697|NCT01852110|82804909|FG001|Overall Study|Adverse Event|5|||
46631698|NCT01852110|82804910|FG002|Overall Study|Adverse Event|0|||
46631699|NCT01852110|82804911|FG003|Overall Study|Adverse Event|0|||
46631700|NCT01852110|82804912|FG004|Overall Study|Adverse Event|0|||
46631701|NCT01852110|82804913|FG005|Overall Study|Adverse Event|0|||
46631702|NCT01852110|82804908|FG000|Overall Study|Lost to Follow-up|1|||
46631703|NCT01852110|82804909|FG001|Overall Study|Lost to Follow-up|3|||
46631704|NCT01852110|82804910|FG002|Overall Study|Lost to Follow-up|0|||
46631705|NCT01852110|82804911|FG003|Overall Study|Lost to Follow-up|0|||
46717649|NCT01098539|82933964|FG000|Overall Study|Physician Decision|5|||
46717650|NCT01098539|82933965|FG001|Overall Study|Physician Decision|3|||
46717651|NCT01098461|82933975|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
46717652|NCT01098461|82933976|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
46915087|NCT02842736|83145816|FG000|Overall Study|Pregnancy|3|||
46717653|NCT01098461|82933977|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
46717654|NCT01098461|82933978|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
46717655|NCT01098461|82933975|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
46717656|NCT01098461|82933976|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
46717657|NCT01098461|82933977|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
46717658|NCT01098461|82933978|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
46717659|NCT01098461|82933975|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
46717660|NCT01098461|82933976|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
46717661|NCT01098461|82933977|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
46717662|NCT01098461|82933978|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
46717663|NCT01098461|82933975|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
46717664|NCT01098461|82933976|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
46717665|NCT01098461|82933977|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
46717666|NCT01098461|82933978|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
46717667|NCT01098461|82933975|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
46717668|NCT01098461|82933976|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
46717669|NCT01098461|82933977|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
46717670|NCT01098461|82933978|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
46717671|NCT01098461|82933975|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
46717672|NCT01098461|82933976|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
46717673|NCT01098461|82933977|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
46717674|NCT01098461|82933978|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
46717675|NCT01098461|82933975|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
46717676|NCT01098461|82933976|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
46717677|NCT01098461|82933977|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
46717678|NCT01098461|82933978|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
46717679|NCT01098305|82933991|FG000|Overall Study|Lost to Follow-up|31|||
46717680|NCT01098305|82933992|FG001|Overall Study|Lost to Follow-up|33|||
46717681|NCT00833833|82934004|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
46717682|NCT00833833|82934005|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
46717683|NCT00833833|82934006|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
46717684|NCT00833833|82934007|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
46717685|NCT00833833|82934008|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
46717686|NCT00833833|82934009|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
46717687|NCT00833833|82934004|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
46717688|NCT00833833|82934005|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
46717689|NCT00833833|82934006|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
46717690|NCT00833833|82934007|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
46717691|NCT00833833|82934008|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
46717692|NCT00833833|82934009|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
46717693|NCT00833833|82934004|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
46717694|NCT00833833|82934005|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
46717695|NCT00833833|82934006|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
46717696|NCT00833833|82934007|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
46717697|NCT00833833|82934008|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
46717698|NCT00833833|82934009|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
46717699|NCT00833833|82934004|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
46717700|NCT00833833|82934005|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
46717701|NCT00833833|82934006|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
46717702|NCT00833833|82934007|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
46717703|NCT00833833|82934008|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
46717704|NCT00833833|82934009|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
46717705|NCT00833833|82934004|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
46717706|NCT00833833|82934005|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
46717707|NCT00833833|82934006|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
47039909|NCT01609556|83293174|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
46717708|NCT00833833|82934007|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
46717709|NCT00833833|82934008|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
47039910|NCT01609556|83293175|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
47039911|NCT01609556|83293176|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
47039912|NCT01609556|83293177|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
47039913|NCT01609556|83293178|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
47039914|NCT01609556|83293179|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
46717710|NCT00833833|82934009|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
46717711|NCT00833833|82934004|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
47039915|NCT01609556|83293180|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
46717712|NCT00833833|82934005|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
46717713|NCT00833833|82934006|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
46717714|NCT00833833|82934007|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
46717715|NCT00833833|82934008|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
46717716|NCT00833833|82934009|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
46717717|NCT00833833|82934004|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
46717718|NCT00833833|82934005|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
46717719|NCT00833833|82934006|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
46717720|NCT00833833|82934007|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
46717721|NCT00833833|82934008|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
46717722|NCT00833833|82934009|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
46717723|NCT00833833|82934004|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
46717724|NCT00833833|82934005|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
46717725|NCT00833833|82934006|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
46717726|NCT00833833|82934007|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
46717727|NCT00833833|82934008|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
46717728|NCT00833833|82934009|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
46717729|NCT00833833|82934004|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
46717730|NCT00833833|82934005|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
46717731|NCT00833833|82934006|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
46717732|NCT00833833|82934007|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
47039916|NCT01609556|83293181|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
47039917|NCT01609556|83293182|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
47039918|NCT01609556|83293183|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
47039919|NCT01609556|83293184|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
47039920|NCT01609556|83293185|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
47039921|NCT01609556|83293186|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
47039922|NCT01609556|83293187|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
47039923|NCT01609556|83293172|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039924|NCT01609556|83293173|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039925|NCT01609556|83293174|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039926|NCT01609556|83293175|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039927|NCT01609556|83293176|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039928|NCT01609556|83293177|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
47039929|NCT01609556|83293178|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039930|NCT01609556|83293179|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039931|NCT01609556|83293180|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039932|NCT01609556|83293181|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039933|NCT01609556|83293182|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039934|NCT01609556|83293183|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
47039935|NCT01609556|83293184|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039936|NCT01609556|83293185|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039937|NCT01609556|83293186|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039938|NCT01609556|83293187|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
47039939|NCT01609556|83293172|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039940|NCT01609556|83293173|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039941|NCT01609556|83293174|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039942|NCT01609556|83293175|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039943|NCT01609556|83293176|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039944|NCT01609556|83293177|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
47039945|NCT01609556|83293178|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039946|NCT01609556|83293179|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039947|NCT01609556|83293180|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039948|NCT01609556|83293181|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039949|NCT01609556|83293182|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039950|NCT01609556|83293183|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
46717733|NCT00833833|82934008|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
46717734|NCT00833833|82934009|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
46717735|NCT00833833|82934004|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
46717736|NCT00833833|82934005|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
46717737|NCT00833833|82934006|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
47039951|NCT01609556|83293184|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
46717738|NCT00833833|82934007|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
46717739|NCT00833833|82934008|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
46717740|NCT00833833|82934009|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
46717741|NCT00833833|82934004|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
46717742|NCT00833833|82934005|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
46717743|NCT00833833|82934006|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
46717744|NCT00833833|82934007|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
46717745|NCT00833833|82934008|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
46717746|NCT00833833|82934009|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
46717747|NCT00833833|82934004|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
46717748|NCT00833833|82934005|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
46717749|NCT00833833|82934006|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
46717750|NCT00833833|82934007|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
46717751|NCT00833833|82934008|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
46717752|NCT00833833|82934009|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
46717753|NCT00833833|82934004|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
46717754|NCT00833833|82934005|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
46717755|NCT00833833|82934006|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
46717756|NCT00833833|82934007|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
46717757|NCT00833833|82934008|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
46717758|NCT00833833|82934009|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
46717759|NCT01098071|82934029|FG000|Overall Study|Surgery (adenoidectomy)|2|||
46717760|NCT01098071|82934029|FG000|Overall Study|Lost to Follow-up|13|||
46717761|NCT01097057|82934033|FG000|Overall Study|Physician Decision|3|||
46717762|NCT01022112|82934042|FG000|Overall Study|Adverse Event|1|||
46717763|NCT01022112|82934043|FG001|Overall Study|Adverse Event|2|||
46717764|NCT01022112|82934044|FG002|Overall Study|Adverse Event|0|||
46717765|NCT01022112|82934045|FG003|Overall Study|Adverse Event|1|||
46717766|NCT01022112|82934046|FG004|Overall Study|Adverse Event|0|||
46717767|NCT01022112|82934042|FG000|Overall Study|Lack of Efficacy|1|||
46717768|NCT01022112|82934043|FG001|Overall Study|Lack of Efficacy|0|||
46717769|NCT01022112|82934044|FG002|Overall Study|Lack of Efficacy|0|||
46717770|NCT01022112|82934045|FG003|Overall Study|Lack of Efficacy|0|||
46717771|NCT01022112|82934046|FG004|Overall Study|Lack of Efficacy|1|||
46717772|NCT01022112|82934042|FG000|Overall Study|Physician Decision|0|||
46717773|NCT01022112|82934043|FG001|Overall Study|Physician Decision|0|||
46717774|NCT01022112|82934044|FG002|Overall Study|Physician Decision|1|||
46717775|NCT01022112|82934045|FG003|Overall Study|Physician Decision|0|||
46717776|NCT01022112|82934046|FG004|Overall Study|Physician Decision|1|||
47039952|NCT01609556|83293185|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039953|NCT01609556|83293186|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039954|NCT01609556|83293187|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
47039955|NCT01609556|83293172|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039956|NCT01609556|83293173|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039957|NCT01609556|83293174|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039958|NCT01609556|83293175|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039959|NCT01609556|83293176|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039960|NCT01609556|83293177|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039961|NCT01609556|83293178|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039962|NCT01609556|83293179|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039963|NCT01609556|83293180|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
47039964|NCT01609556|83293181|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039965|NCT01609556|83293182|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039966|NCT01609556|83293183|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
46631706|NCT01852110|82804912|FG004|Overall Study|Lost to Follow-up|0|||
46631707|NCT01852110|82804913|FG005|Overall Study|Lost to Follow-up|0|||
46631708|NCT01852110|82804908|FG000|Overall Study|Non-compliance with Study Drug|2|||
46631709|NCT01852110|82804909|FG001|Overall Study|Non-compliance with Study Drug|1|||
46631710|NCT01852110|82804910|FG002|Overall Study|Non-compliance with Study Drug|0|||
46631711|NCT01852110|82804911|FG003|Overall Study|Non-compliance with Study Drug|0|||
46631712|NCT01852110|82804912|FG004|Overall Study|Non-compliance with Study Drug|0|||
46631713|NCT01852110|82804913|FG005|Overall Study|Non-compliance with Study Drug|0|||
46631714|NCT01852110|82804908|FG000|Overall Study|Physician Decision|1|||
46717777|NCT01022112|82934042|FG000|Overall Study|Withdrawal by Subject|0|||
46717778|NCT01022112|82934043|FG001|Overall Study|Withdrawal by Subject|1|||
47039967|NCT01609556|83293184|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
46717779|NCT01022112|82934044|FG002|Overall Study|Withdrawal by Subject|2|||
46717780|NCT01022112|82934045|FG003|Overall Study|Withdrawal by Subject|2|||
46717781|NCT01022112|82934046|FG004|Overall Study|Withdrawal by Subject|1|||
46717782|NCT01022112|82934042|FG000|Overall Study|Fasting plasma glucose level increased|1|||
46717783|NCT01022112|82934043|FG001|Overall Study|Fasting plasma glucose level increased|0|||
47039968|NCT01609556|83293185|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039969|NCT01609556|83293186|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039970|NCT01609556|83293187|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
47039971|NCT01609556|83293172|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
47039972|NCT01609556|83293173|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039973|NCT01609556|83293174|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
46717784|NCT01022112|82934044|FG002|Overall Study|Fasting plasma glucose level increased|0|||
46717785|NCT01022112|82934045|FG003|Overall Study|Fasting plasma glucose level increased|0|||
46717786|NCT01022112|82934046|FG004|Overall Study|Fasting plasma glucose level increased|7|||
46717787|NCT01096667|82934063|FG000|Overall Study|Lost to Follow-up|1|||
46717788|NCT01096667|82934064|FG001|Overall Study|Lost to Follow-up|1|||
46717789|NCT01096667|82934065|FG002|Overall Study|Lost to Follow-up|1|||
46717790|NCT01096667|82934066|FG003|Overall Study|Lost to Follow-up|0|||
46717791|NCT01096667|82934067|FG004|Overall Study|Lost to Follow-up|0|||
46717792|NCT01096667|82934063|FG000|Overall Study|Withdrawal by Subject|1|||
46717793|NCT01096667|82934064|FG001|Overall Study|Withdrawal by Subject|0|||
46717794|NCT01096667|82934065|FG002|Overall Study|Withdrawal by Subject|0|||
46717795|NCT01096667|82934066|FG003|Overall Study|Withdrawal by Subject|1|||
46717796|NCT01096667|82934067|FG004|Overall Study|Withdrawal by Subject|0|||
46717797|NCT01096667|82934063|FG000|Overall Study|Reason not available|0|||
46717798|NCT01096667|82934064|FG001|Overall Study|Reason not available|1|||
46717799|NCT01096667|82934065|FG002|Overall Study|Reason not available|1|||
46717800|NCT01096667|82934066|FG003|Overall Study|Reason not available|1|||
46717801|NCT01096667|82934067|FG004|Overall Study|Reason not available|0|||
46717802|NCT01096667|82934063|FG000|Overall Study|Protocol Violation|0|||
46717803|NCT01096667|82934064|FG001|Overall Study|Protocol Violation|0|||
46717804|NCT01096667|82934065|FG002|Overall Study|Protocol Violation|0|||
46717805|NCT01096667|82934066|FG003|Overall Study|Protocol Violation|1|||
46717806|NCT01096667|82934067|FG004|Overall Study|Protocol Violation|0|||
46717807|NCT01096667|82934063|FG000|Overall Study|Not treated|1|||
46717808|NCT01096667|82934064|FG001|Overall Study|Not treated|0|||
46717809|NCT01096667|82934065|FG002|Overall Study|Not treated|0|||
46717810|NCT01096667|82934066|FG003|Overall Study|Not treated|0|||
46717811|NCT01096667|82934067|FG004|Overall Study|Not treated|0|||
46717812|NCT01014624|82934082|FG000|Overall Study|Adverse Event|0|||
46717813|NCT01014624|82934083|FG001|Overall Study|Adverse Event|1|||
46717814|NCT01014624|82934082|FG000|Overall Study|Protocol Violation|1|||
46717815|NCT01014624|82934083|FG001|Overall Study|Protocol Violation|0|||
46717816|NCT01014624|82934082|FG000|Overall Study|Withdrawal by Subject|1|||
46717817|NCT01014624|82934083|FG001|Overall Study|Withdrawal by Subject|0|||
46717818|NCT01021878|82934093|FG000|Overall Study|Lost to Follow-up|4|||
46717819|NCT01021878|82934094|FG001|Overall Study|Lost to Follow-up|3|||
47039974|NCT01609556|83293175|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039975|NCT01609556|83293176|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039976|NCT01609556|83293177|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
47039977|NCT01609556|83293178|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039978|NCT01609556|83293179|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039979|NCT01609556|83293180|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039980|NCT01609556|83293181|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039981|NCT01609556|83293182|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
47039982|NCT01609556|83293183|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
46631715|NCT01852110|82804909|FG001|Overall Study|Physician Decision|0|||
46717820|NCT01021878|82934093|FG000|Overall Study|Death|0|||
46631716|NCT01852110|82804910|FG002|Overall Study|Physician Decision|0|||
46717821|NCT01021878|82934094|FG001|Overall Study|Death|1|||
46631717|NCT01852110|82804911|FG003|Overall Study|Physician Decision|0|||
46631718|NCT01852110|82804912|FG004|Overall Study|Physician Decision|0|||
46631719|NCT01852110|82804913|FG005|Overall Study|Physician Decision|0|||
46631720|NCT01852110|82804908|FG000|Overall Study|Protocol Violation|0|||
46631721|NCT01852110|82804909|FG001|Overall Study|Protocol Violation|1|||
46631722|NCT01852110|82804910|FG002|Overall Study|Protocol Violation|0|||
46717822|NCT01021878|82934093|FG000|Overall Study|Adverse Event|6|||
47039983|NCT01609556|83293184|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
46717823|NCT01021878|82934094|FG001|Overall Study|Adverse Event|5|||
46717824|NCT01021878|82934093|FG000|Overall Study|Transplantation|6|||
46717825|NCT01021878|82934094|FG001|Overall Study|Transplantation|1|||
46717826|NCT00854113|82934114|FG000|Overall Study|Adverse Event|0|||
46717827|NCT00854113|82934115|FG001|Overall Study|Adverse Event|0|||
46717828|NCT00854113|82934116|FG002|Overall Study|Adverse Event|0|||
46717829|NCT00854113|82934117|FG003|Overall Study|Adverse Event|0|||
46717830|NCT00854113|82934118|FG004|Overall Study|Adverse Event|0|||
46717831|NCT00854113|82934119|FG005|Overall Study|Adverse Event|0|||
46717832|NCT00854113|82934120|FG006|Overall Study|Adverse Event|0|||
46717833|NCT00854113|82934121|FG007|Overall Study|Adverse Event|2|||
46717834|NCT00854113|82934122|FG008|Overall Study|Adverse Event|0|||
46717835|NCT00854113|82934123|FG009|Overall Study|Adverse Event|0|||
46717836|NCT00854113|82934124|FG010|Overall Study|Adverse Event|0|||
46717837|NCT00854113|82934114|FG000|Overall Study|Withdrawal by Subject|0|||
46717838|NCT00854113|82934115|FG001|Overall Study|Withdrawal by Subject|0|||
46717839|NCT00854113|82934116|FG002|Overall Study|Withdrawal by Subject|0|||
46717840|NCT00854113|82934117|FG003|Overall Study|Withdrawal by Subject|0|||
46717841|NCT00854113|82934118|FG004|Overall Study|Withdrawal by Subject|0|||
46717842|NCT00854113|82934119|FG005|Overall Study|Withdrawal by Subject|0|||
46717843|NCT00854113|82934120|FG006|Overall Study|Withdrawal by Subject|0|||
46717844|NCT00854113|82934121|FG007|Overall Study|Withdrawal by Subject|1|||
46717845|NCT00854113|82934122|FG008|Overall Study|Withdrawal by Subject|1|||
46717846|NCT00854113|82934123|FG009|Overall Study|Withdrawal by Subject|0|||
46717847|NCT00854113|82934124|FG010|Overall Study|Withdrawal by Subject|0|||
46717848|NCT00845845|82934150|FG000|Overall Study|Lost to Follow-up|0|||
46717849|NCT00845845|82934151|FG001|Overall Study|Lost to Follow-up|4|||
46717850|NCT01104701|82934161|FG000|Overall Study|Withdrawal by Subject|0|||
46717851|NCT01104701|82934162|FG001|Overall Study|Withdrawal by Subject|1|||
46717852|NCT01104701|82934163|FG002|Overall Study|Withdrawal by Subject|2|||
46717853|NCT01104701|82934164|FG003|Overall Study|Withdrawal by Subject|1|||
46717854|NCT01104701|82934161|FG000|Overall Study|Adverse Event|0|||
46717855|NCT01104701|82934162|FG001|Overall Study|Adverse Event|0|||
46717856|NCT01104701|82934163|FG002|Overall Study|Adverse Event|0|||
46717857|NCT01104701|82934164|FG003|Overall Study|Adverse Event|1|||
46717858|NCT01104701|82934161|FG000|Overall Study|Physician Decision|0|||
46717859|NCT01104701|82934162|FG001|Overall Study|Physician Decision|2|||
46717860|NCT01104701|82934163|FG002|Overall Study|Physician Decision|0|||
46717861|NCT01104701|82934164|FG003|Overall Study|Physician Decision|0|||
46717862|NCT00833755|82934178|FG000|Overall Study|Physician Decision|4|||
46717863|NCT00833755|82934179|FG001|Overall Study|Physician Decision|4|||
46717864|NCT00833755|82934180|FG002|Overall Study|Physician Decision|2|||
46717865|NCT00833755|82934181|FG003|Overall Study|Physician Decision|6|||
46717866|NCT00833755|82934178|FG000|Overall Study|Subject had scheduling issues|0|||
46717867|NCT00833755|82934179|FG001|Overall Study|Subject had scheduling issues|1|||
46717868|NCT00833755|82934180|FG002|Overall Study|Subject had scheduling issues|0|||
46717869|NCT00833755|82934181|FG003|Overall Study|Subject had scheduling issues|0|||
46717870|NCT01021332|82934192|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
46717871|NCT01021332|82934192|FG000|Overall Study|Adverse Event|43|||
46717872|NCT01021332|82934192|FG000|Overall Study|Lack of Efficacy|19|||
46717873|NCT01021332|82934192|FG000|Overall Study|Withdrawal of Consent|23|||
46717874|NCT01021332|82934192|FG000|Overall Study|Lost to Follow-up|4|||
46717875|NCT01021332|82934192|FG000|Overall Study|Protocol Violation|9|||
46717876|NCT01021332|82934192|FG000|Overall Study|Miscellaneous|3|||
46631723|NCT01852110|82804911|FG003|Overall Study|Protocol Violation|0|||
46631724|NCT01852110|82804912|FG004|Overall Study|Protocol Violation|0|||
46631725|NCT01852110|82804913|FG005|Overall Study|Protocol Violation|0|||
46631726|NCT01852110|82804908|FG000|Overall Study|Study Terminated by Sponsor|30|||
46631727|NCT01852110|82804909|FG001|Overall Study|Study Terminated by Sponsor|32|||
46631728|NCT01852110|82804910|FG002|Overall Study|Study Terminated by Sponsor|0|||
46631729|NCT01852110|82804911|FG003|Overall Study|Study Terminated by Sponsor|0|||
46631730|NCT01852110|82804912|FG004|Overall Study|Study Terminated by Sponsor|0|||
46631731|NCT01852110|82804913|FG005|Overall Study|Study Terminated by Sponsor|0|||
46631732|NCT01852110|82804908|FG000|Overall Study|Withdrawal by Subject|4|||
46717877|NCT00923091|82934206|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
46717878|NCT00923091|82934207|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
46717879|NCT00923091|82934208|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
46717880|NCT00923091|82934209|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
46717881|NCT00923091|82934210|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
46717882|NCT00923091|82934211|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
46717883|NCT00923091|82934212|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
46717884|NCT00923091|82934213|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
46717885|NCT00923091|82934214|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
46717886|NCT00923091|82934215|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
46717887|NCT00923091|82934216|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
46717888|NCT00923091|82934217|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
46717889|NCT00923091|82934218|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
46717890|NCT00923091|82934206|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
46717891|NCT00923091|82934207|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
46717892|NCT00923091|82934208|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
46717893|NCT00923091|82934209|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
46717894|NCT00923091|82934210|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
46717895|NCT00923091|82934211|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
46717896|NCT00923091|82934212|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
46717897|NCT00923091|82934213|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
46717898|NCT00923091|82934214|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
46717899|NCT00923091|82934215|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
46717900|NCT00923091|82934216|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
46717901|NCT00923091|82934217|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
46717902|NCT00923091|82934218|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
46717903|NCT00923091|82934206|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
46717904|NCT00923091|82934207|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
46717905|NCT00923091|82934208|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
46717906|NCT00923091|82934209|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
47039984|NCT01609556|83293185|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039985|NCT01609556|83293186|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039986|NCT01609556|83293187|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
47039987|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039988|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039989|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
46631733|NCT01852110|82804909|FG001|Overall Study|Withdrawal by Subject|4|||
46631734|NCT01852110|82804910|FG002|Overall Study|Withdrawal by Subject|0|||
46631735|NCT01852110|82804911|FG003|Overall Study|Withdrawal by Subject|0|||
46631736|NCT01852110|82804912|FG004|Overall Study|Withdrawal by Subject|0|||
46631737|NCT01852110|82804913|FG005|Overall Study|Withdrawal by Subject|0|||
46631738|NCT01851720|82804929|FG000|Overall Study|Lost to Follow-up|0|||
46631739|NCT01851720|82804930|FG001|Overall Study|Lost to Follow-up|1|||
46631740|NCT01851330|82804939|FG000|Overall Study|Lack of Efficacy|10|||
46631741|NCT01851330|82804940|FG001|Overall Study|Lack of Efficacy|9|||
46631742|NCT01851330|82804941|FG002|Overall Study|Lack of Efficacy|2|||
46631743|NCT01851330|82804939|FG000|Overall Study|Lost to Follow-up|1|||
46631744|NCT01851330|82804940|FG001|Overall Study|Lost to Follow-up|6|||
46631745|NCT01851330|82804941|FG002|Overall Study|Lost to Follow-up|9|||
46631746|NCT01851330|82804939|FG000|Overall Study|Withdrew Consent|2|||
46631747|NCT01851330|82804940|FG001|Overall Study|Withdrew Consent|1|||
46631748|NCT01851330|82804941|FG002|Overall Study|Withdrew Consent|0|||
46631749|NCT01851330|82804939|FG000|Overall Study|Investigator's Discretion|0|||
46631750|NCT01851330|82804940|FG001|Overall Study|Investigator's Discretion|0|||
46631751|NCT01851330|82804941|FG002|Overall Study|Investigator's Discretion|1|||
46631752|NCT01868022|82804958|FG000|Overall Study|Withdrawal by Subject|0|||
46631753|NCT01868022|82804959|FG001|Overall Study|Withdrawal by Subject|0|||
46631754|NCT01868022|82804960|FG002|Overall Study|Withdrawal by Subject|1|||
46631755|NCT01868022|82804961|FG003|Overall Study|Withdrawal by Subject|1|||
46631756|NCT01868022|82804962|FG004|Overall Study|Withdrawal by Subject|0|||
46631757|NCT01868022|82804963|FG005|Overall Study|Withdrawal by Subject|0|||
46631758|NCT01868022|82804964|FG006|Overall Study|Withdrawal by Subject|0|||
46631759|NCT01868022|82804965|FG007|Overall Study|Withdrawal by Subject|1|||
46631760|NCT01868022|82804966|FG008|Overall Study|Withdrawal by Subject|0|||
46631761|NCT01868022|82804958|FG000|Overall Study|Adverse Event|0|||
46631762|NCT01868022|82804959|FG001|Overall Study|Adverse Event|0|||
46717907|NCT00923091|82934210|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
46717908|NCT00923091|82934211|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
46717909|NCT00923091|82934212|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
47039990|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039991|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039992|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039993|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
46631763|NCT01868022|82804960|FG002|Overall Study|Adverse Event|0|||
46631764|NCT01868022|82804961|FG003|Overall Study|Adverse Event|0|||
46631765|NCT01868022|82804962|FG004|Overall Study|Adverse Event|2|||
46631766|NCT01868022|82804963|FG005|Overall Study|Adverse Event|0|||
46631767|NCT01868022|82804964|FG006|Overall Study|Adverse Event|0|||
46631768|NCT01868022|82804965|FG007|Overall Study|Adverse Event|2|||
46631769|NCT01868022|82804966|FG008|Overall Study|Adverse Event|2|||
46631770|NCT01868022|82804958|FG000|Overall Study|Physician Decision|0|||
46631771|NCT01868022|82804959|FG001|Overall Study|Physician Decision|0|||
47039994|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039995|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039996|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039997|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039998|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
47039999|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
47040000|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
47040001|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
47040002|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
47040003|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040004|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040005|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040006|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040007|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040008|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040009|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040010|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
47040011|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
46717910|NCT00923091|82934213|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
46717911|NCT00923091|82934214|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
46717912|NCT00923091|82934215|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
46717913|NCT00923091|82934216|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
46717914|NCT00923091|82934217|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
46717915|NCT00923091|82934218|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
46717916|NCT00923091|82934206|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717917|NCT00923091|82934207|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717918|NCT00923091|82934208|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717919|NCT00923091|82934209|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717920|NCT00923091|82934210|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717921|NCT00923091|82934211|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
46717922|NCT00923091|82934212|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717923|NCT00923091|82934213|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717924|NCT00923091|82934214|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717925|NCT00923091|82934215|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717926|NCT00923091|82934216|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717927|NCT00923091|82934217|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
47040012|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
46717928|NCT00923091|82934218|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
46717929|NCT00923091|82934206|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717930|NCT00923091|82934207|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
46717931|NCT00923091|82934208|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717932|NCT00923091|82934209|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
46717933|NCT00923091|82934210|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717934|NCT00923091|82934211|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
46717935|NCT00923091|82934212|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717936|NCT00923091|82934213|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717937|NCT00923091|82934214|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717938|NCT00923091|82934215|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
47040013|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
46631772|NCT01868022|82804960|FG002|Overall Study|Physician Decision|0|||
46631773|NCT01868022|82804961|FG003|Overall Study|Physician Decision|0|||
46631774|NCT01868022|82804962|FG004|Overall Study|Physician Decision|0|||
46631775|NCT01868022|82804963|FG005|Overall Study|Physician Decision|1|||
46631776|NCT01868022|82804964|FG006|Overall Study|Physician Decision|0|||
46631777|NCT01868022|82804965|FG007|Overall Study|Physician Decision|2|||
46631778|NCT01868022|82804966|FG008|Overall Study|Physician Decision|0|||
46631779|NCT01868022|82804958|FG000|Overall Study|Study closed/terminated|0|||
46631780|NCT01868022|82804959|FG001|Overall Study|Study closed/terminated|0|||
46631781|NCT01868022|82804960|FG002|Overall Study|Study closed/terminated|0|||
46631782|NCT01868022|82804961|FG003|Overall Study|Study closed/terminated|0|||
46631783|NCT01868022|82804962|FG004|Overall Study|Study closed/terminated|0|||
46631784|NCT01868022|82804963|FG005|Overall Study|Study closed/terminated|0|||
46631785|NCT01868022|82804964|FG006|Overall Study|Study closed/terminated|0|||
46631786|NCT01868022|82804965|FG007|Overall Study|Study closed/terminated|1|||
46631787|NCT01868022|82804966|FG008|Overall Study|Study closed/terminated|0|||
46631788|NCT01868022|82804958|FG000|Overall Study|Ongoing|0|||
46631789|NCT01868022|82804959|FG001|Overall Study|Ongoing|0|||
46631790|NCT01868022|82804960|FG002|Overall Study|Ongoing|0|||
46717939|NCT00923091|82934216|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
47040014|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
46717940|NCT00923091|82934217|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717941|NCT00923091|82934218|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
46717942|NCT00923091|82934206|FG000|Period III (Single-Blind)|Adverse Event|5|||
46717943|NCT00923091|82934207|FG001|Period III (Single-Blind)|Adverse Event|0|||
46717944|NCT00923091|82934208|FG002|Period III (Single-Blind)|Adverse Event|0|||
46717945|NCT00923091|82934209|FG003|Period III (Single-Blind)|Adverse Event|0|||
46717946|NCT00923091|82934210|FG004|Period III (Single-Blind)|Adverse Event|0|||
46717947|NCT00923091|82934211|FG005|Period III (Single-Blind)|Adverse Event|0|||
46717948|NCT00923091|82934212|FG006|Period III (Single-Blind)|Adverse Event|0|||
46717949|NCT00923091|82934213|FG007|Period III (Single-Blind)|Adverse Event|0|||
46717950|NCT00923091|82934214|FG008|Period III (Single-Blind)|Adverse Event|0|||
46717951|NCT00923091|82934215|FG009|Period III (Single-Blind)|Adverse Event|0|||
46717952|NCT00923091|82934216|FG010|Period III (Single-Blind)|Adverse Event|0|||
46717953|NCT00923091|82934217|FG011|Period III (Single-Blind)|Adverse Event|0|||
46717954|NCT00923091|82934218|FG012|Period III (Single-Blind)|Adverse Event|0|||
46717955|NCT00923091|82934206|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
46717956|NCT00923091|82934207|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717957|NCT00923091|82934208|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717958|NCT00923091|82934209|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717959|NCT00923091|82934210|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717960|NCT00923091|82934211|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717961|NCT00923091|82934212|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717962|NCT00923091|82934213|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717963|NCT00923091|82934214|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717964|NCT00923091|82934215|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717965|NCT00923091|82934216|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717966|NCT00923091|82934217|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717967|NCT00923091|82934218|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
46717968|NCT00923091|82934206|FG000|Period III (Single-Blind)|Protocol Violation|3|||
46717969|NCT00923091|82934207|FG001|Period III (Single-Blind)|Protocol Violation|0|||
46717970|NCT00923091|82934208|FG002|Period III (Single-Blind)|Protocol Violation|0|||
46717971|NCT00923091|82934209|FG003|Period III (Single-Blind)|Protocol Violation|0|||
46717972|NCT00923091|82934210|FG004|Period III (Single-Blind)|Protocol Violation|0|||
46717973|NCT00923091|82934211|FG005|Period III (Single-Blind)|Protocol Violation|0|||
46717974|NCT00923091|82934212|FG006|Period III (Single-Blind)|Protocol Violation|0|||
46717975|NCT00923091|82934213|FG007|Period III (Single-Blind)|Protocol Violation|0|||
46717976|NCT00923091|82934214|FG008|Period III (Single-Blind)|Protocol Violation|0|||
46717977|NCT00923091|82934215|FG009|Period III (Single-Blind)|Protocol Violation|0|||
46717978|NCT00923091|82934216|FG010|Period III (Single-Blind)|Protocol Violation|0|||
46717979|NCT00923091|82934217|FG011|Period III (Single-Blind)|Protocol Violation|0|||
46717980|NCT00923091|82934218|FG012|Period III (Single-Blind)|Protocol Violation|0|||
46717981|NCT00923091|82934206|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
46717982|NCT00923091|82934207|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
46717983|NCT00923091|82934208|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
46717984|NCT00923091|82934209|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
46717985|NCT00923091|82934210|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
46717986|NCT00923091|82934211|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
46717987|NCT00923091|82934212|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
46717988|NCT00923091|82934213|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
46717989|NCT00923091|82934214|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
46717990|NCT00923091|82934215|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
46717991|NCT00923091|82934216|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
46717992|NCT00923091|82934217|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
46717993|NCT00923091|82934218|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
46717994|NCT00923091|82934206|FG000|Period IV (Double-Blind)|Adverse Event|2|||
46717995|NCT00923091|82934207|FG001|Period IV (Double-Blind)|Adverse Event|0|||
46717996|NCT00923091|82934208|FG002|Period IV (Double-Blind)|Adverse Event|0|||
46915088|NCT02842736|83145816|FG000|Overall Study|Hysterectomy for fibroids|2|||
46717997|NCT00923091|82934209|FG003|Period IV (Double-Blind)|Adverse Event|0|||
46717998|NCT00923091|82934210|FG004|Period IV (Double-Blind)|Adverse Event|0|||
46717999|NCT00923091|82934211|FG005|Period IV (Double-Blind)|Adverse Event|0|||
46718000|NCT00923091|82934212|FG006|Period IV (Double-Blind)|Adverse Event|0|||
46718001|NCT00923091|82934213|FG007|Period IV (Double-Blind)|Adverse Event|0|||
46718002|NCT00923091|82934214|FG008|Period IV (Double-Blind)|Adverse Event|0|||
46718003|NCT00923091|82934215|FG009|Period IV (Double-Blind)|Adverse Event|0|||
46718004|NCT00923091|82934216|FG010|Period IV (Double-Blind)|Adverse Event|0|||
46718005|NCT00923091|82934217|FG011|Period IV (Double-Blind)|Adverse Event|0|||
46718006|NCT00923091|82934218|FG012|Period IV (Double-Blind)|Adverse Event|0|||
46718007|NCT00923091|82934206|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718008|NCT00923091|82934207|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
46718009|NCT00923091|82934208|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718010|NCT00923091|82934209|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718011|NCT00923091|82934210|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718012|NCT00923091|82934211|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718013|NCT00923091|82934212|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718014|NCT00923091|82934213|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718015|NCT00923091|82934214|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718016|NCT00923091|82934215|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718017|NCT00923091|82934216|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718018|NCT00923091|82934217|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718019|NCT00923091|82934218|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
46718020|NCT00923091|82934206|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
46718021|NCT00923091|82934207|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
46718022|NCT00923091|82934208|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
46718023|NCT00923091|82934209|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
46718024|NCT00923091|82934210|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
46718025|NCT00923091|82934211|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
46718026|NCT00923091|82934212|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
46718027|NCT00923091|82934213|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
47040015|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
47040016|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
46718028|NCT00923091|82934214|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
47040017|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
47040018|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
47040019|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040020|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040021|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040022|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040023|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040024|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040025|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040026|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040027|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040028|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040029|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040030|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
47040031|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
47040032|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
47040033|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
47040034|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
47040035|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040036|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
46718029|NCT00923091|82934215|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
46718030|NCT00923091|82934216|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
46718031|NCT00923091|82934217|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
46718032|NCT00923091|82934218|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
46718033|NCT00923091|82934206|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718034|NCT00923091|82934207|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718035|NCT00923091|82934208|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718036|NCT00923091|82934209|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718037|NCT00923091|82934210|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718038|NCT00923091|82934211|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718039|NCT00923091|82934212|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718040|NCT00923091|82934213|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718041|NCT00923091|82934214|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
46718042|NCT00923091|82934215|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
46915089|NCT02842736|83145816|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
46718043|NCT00923091|82934216|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718044|NCT00923091|82934217|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
46718045|NCT00923091|82934218|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
46718046|NCT00923091|82934206|FG000|Period V (Double -Blind)|Protocol Violation|0|||
46718047|NCT00923091|82934207|FG001|Period V (Double -Blind)|Protocol Violation|0|||
46718048|NCT00923091|82934208|FG002|Period V (Double -Blind)|Protocol Violation|0|||
46915090|NCT02842736|83145816|FG000|Overall Study|IUD: Mirena|1|||
46718049|NCT00923091|82934209|FG003|Period V (Double -Blind)|Protocol Violation|0|||
46718050|NCT00923091|82934210|FG004|Period V (Double -Blind)|Protocol Violation|0|||
46718051|NCT00923091|82934211|FG005|Period V (Double -Blind)|Protocol Violation|0|||
46718052|NCT00923091|82934212|FG006|Period V (Double -Blind)|Protocol Violation|0|||
46718053|NCT00923091|82934213|FG007|Period V (Double -Blind)|Protocol Violation|0|||
46718054|NCT00923091|82934214|FG008|Period V (Double -Blind)|Protocol Violation|0|||
46718055|NCT00923091|82934215|FG009|Period V (Double -Blind)|Protocol Violation|0|||
46718056|NCT00923091|82934216|FG010|Period V (Double -Blind)|Protocol Violation|0|||
46718057|NCT00923091|82934217|FG011|Period V (Double -Blind)|Protocol Violation|0|||
46718058|NCT00923091|82934218|FG012|Period V (Double -Blind)|Protocol Violation|1|||
46718059|NCT00923091|82934206|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
46718060|NCT00923091|82934207|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
46718061|NCT00923091|82934208|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
46718062|NCT00923091|82934209|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
46718063|NCT00923091|82934210|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
46718064|NCT00923091|82934211|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
46718065|NCT00923091|82934212|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
46718066|NCT00923091|82934213|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
46718067|NCT00923091|82934214|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
46718068|NCT00923091|82934215|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
46718069|NCT00923091|82934216|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
46718070|NCT00923091|82934217|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
46718071|NCT00923091|82934218|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
46718072|NCT00923091|82934206|FG000|Period VI (Open-Label)|Adverse Event|17|||
46718073|NCT00923091|82934207|FG001|Period VI (Open-Label)|Adverse Event|0|||
46718074|NCT00923091|82934208|FG002|Period VI (Open-Label)|Adverse Event|4|||
46718075|NCT00923091|82934209|FG003|Period VI (Open-Label)|Adverse Event|1|||
46718076|NCT00923091|82934210|FG004|Period VI (Open-Label)|Adverse Event|1|||
46718077|NCT00923091|82934211|FG005|Period VI (Open-Label)|Adverse Event|0|||
46718078|NCT00923091|82934212|FG006|Period VI (Open-Label)|Adverse Event|0|||
46718079|NCT00923091|82934213|FG007|Period VI (Open-Label)|Adverse Event|0|||
46718080|NCT00923091|82934214|FG008|Period VI (Open-Label)|Adverse Event|0|||
46718081|NCT00923091|82934215|FG009|Period VI (Open-Label)|Adverse Event|0|||
46718082|NCT00923091|82934216|FG010|Period VI (Open-Label)|Adverse Event|0|||
46718083|NCT00923091|82934217|FG011|Period VI (Open-Label)|Adverse Event|0|||
46718084|NCT00923091|82934218|FG012|Period VI (Open-Label)|Adverse Event|0|||
46718085|NCT00923091|82934206|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
46718086|NCT00923091|82934207|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
46718087|NCT00923091|82934208|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
46631791|NCT01868022|82804961|FG003|Overall Study|Ongoing|0|||
46631792|NCT01868022|82804962|FG004|Overall Study|Ongoing|0|||
46631793|NCT01868022|82804963|FG005|Overall Study|Ongoing|0|||
46631794|NCT01868022|82804964|FG006|Overall Study|Ongoing|0|||
46631795|NCT01868022|82804965|FG007|Overall Study|Ongoing|3|||
46631796|NCT01868022|82804966|FG008|Overall Study|Ongoing|0|||
46631797|NCT01850004|82804992|FG000|Overall Study|Poor/Non-compliance|1|||
46631798|NCT01850004|82804992|FG000|Overall Study|Participant Withdrew Consent|9|||
46631799|NCT01850004|82804992|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
46631800|NCT01850004|82804992|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
46631801|NCT01850004|82804992|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
46631802|NCT01850004|82804992|FG000|Overall Study|Other Reasons|2|||
46631803|NCT01850004|82804992|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
46631804|NCT01850004|82804992|FG000|Overall Study|Maximum Clinical Benefit|4|||
46631805|NCT01867710|82805000|FG000|Overall Study|Death|25|||
46631806|NCT01867710|82805001|FG001|Overall Study|Death|15|||
46631807|NCT01867710|82805002|FG002|Overall Study|Death|27|||
46631808|NCT01867710|82805003|FG003|Overall Study|Death|20|||
46718088|NCT00923091|82934209|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
46718089|NCT00923091|82934210|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
46718090|NCT00923091|82934211|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
46718091|NCT00923091|82934212|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
46718092|NCT00923091|82934213|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
46718093|NCT00923091|82934214|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
46718094|NCT00923091|82934215|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
46631809|NCT01867710|82805000|FG000|Overall Study|Lost to Follow-up|3|||
46631810|NCT01867710|82805001|FG001|Overall Study|Lost to Follow-up|4|||
46718095|NCT00923091|82934216|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
46718096|NCT00923091|82934217|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
46718097|NCT00923091|82934218|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
46631811|NCT01867710|82805002|FG002|Overall Study|Lost to Follow-up|3|||
46631812|NCT01867710|82805003|FG003|Overall Study|Lost to Follow-up|2|||
46631813|NCT01867710|82805000|FG000|Overall Study|Withdrawal of consent|2|||
46718098|NCT00923091|82934206|FG000|Period VI (Open-Label)|Protocol Violation|6|||
46718099|NCT00923091|82934207|FG001|Period VI (Open-Label)|Protocol Violation|1|||
46718100|NCT00923091|82934208|FG002|Period VI (Open-Label)|Protocol Violation|3|||
46718101|NCT00923091|82934209|FG003|Period VI (Open-Label)|Protocol Violation|1|||
46718102|NCT00923091|82934210|FG004|Period VI (Open-Label)|Protocol Violation|4|||
46718103|NCT00923091|82934211|FG005|Period VI (Open-Label)|Protocol Violation|0|||
46718104|NCT00923091|82934212|FG006|Period VI (Open-Label)|Protocol Violation|0|||
46718105|NCT00923091|82934213|FG007|Period VI (Open-Label)|Protocol Violation|0|||
46718106|NCT00923091|82934214|FG008|Period VI (Open-Label)|Protocol Violation|0|||
46718107|NCT00923091|82934215|FG009|Period VI (Open-Label)|Protocol Violation|0|||
46718108|NCT00923091|82934216|FG010|Period VI (Open-Label)|Protocol Violation|0|||
46718109|NCT00923091|82934217|FG011|Period VI (Open-Label)|Protocol Violation|0|||
46718110|NCT00923091|82934218|FG012|Period VI (Open-Label)|Protocol Violation|0|||
46718111|NCT00923091|82934206|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
46718112|NCT00923091|82934207|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
46718113|NCT00923091|82934208|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
46718114|NCT00923091|82934209|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
46718115|NCT00923091|82934210|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
46718116|NCT00923091|82934211|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
46718117|NCT00923091|82934212|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
46718118|NCT00923091|82934213|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
46718119|NCT00923091|82934214|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
46718120|NCT00923091|82934215|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
46718121|NCT00923091|82934216|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
46718122|NCT00923091|82934217|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
46718123|NCT00923091|82934218|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
46718124|NCT00923091|82934206|FG000|Period VI (Open-Label)|Other Reason|0|||
46718125|NCT00923091|82934207|FG001|Period VI (Open-Label)|Other Reason|0|||
46718126|NCT00923091|82934208|FG002|Period VI (Open-Label)|Other Reason|0|||
46718127|NCT00923091|82934209|FG003|Period VI (Open-Label)|Other Reason|1|||
46718128|NCT00923091|82934210|FG004|Period VI (Open-Label)|Other Reason|1|||
46718129|NCT00923091|82934211|FG005|Period VI (Open-Label)|Other Reason|0|||
46718130|NCT00923091|82934212|FG006|Period VI (Open-Label)|Other Reason|0|||
46915091|NCT01307033|83145822|FG000|8-week Double-blind Period|Adverse Event|2|||
46915092|NCT01307033|83145823|FG001|8-week Double-blind Period|Adverse Event|0|||
46915093|NCT01307033|83145824|FG002|8-week Double-blind Period|Adverse Event|0|||
46915094|NCT01307033|83145825|FG003|8-week Double-blind Period|Adverse Event|0|||
46915095|NCT01307033|83145822|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
46915096|NCT01307033|83145823|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
46915097|NCT01307033|83145824|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
46915098|NCT01307033|83145825|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
46915099|NCT01307033|83145822|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
46915100|NCT01307033|83145823|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
46915101|NCT01307033|83145824|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
46915102|NCT01307033|83145825|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
46915103|NCT01307033|83145822|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
46915104|NCT01307033|83145823|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
46915105|NCT01307033|83145824|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
46915106|NCT01307033|83145825|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
47040037|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040038|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040039|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040040|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040041|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
46631814|NCT01867710|82805001|FG001|Overall Study|Withdrawal of consent|5|||
46631815|NCT01867710|82805002|FG002|Overall Study|Withdrawal of consent|1|||
46631816|NCT01867710|82805003|FG003|Overall Study|Withdrawal of consent|2|||
46631817|NCT01867710|82805000|FG000|Overall Study|Study Terminated by Sponsor|9|||
46631818|NCT01867710|82805001|FG001|Overall Study|Study Terminated by Sponsor|13|||
46631819|NCT01867710|82805002|FG002|Overall Study|Study Terminated by Sponsor|8|||
46631820|NCT01867710|82805003|FG003|Overall Study|Study Terminated by Sponsor|16|||
46718131|NCT00923091|82934213|FG007|Period VI (Open-Label)|Other Reason|0|||
46718132|NCT00923091|82934214|FG008|Period VI (Open-Label)|Other Reason|0|||
46631821|NCT01867710|82805000|FG000|Overall Study|Biochemical progression|0|||
46631822|NCT01867710|82805001|FG001|Overall Study|Biochemical progression|1|||
46718133|NCT00923091|82934215|FG009|Period VI (Open-Label)|Other Reason|0|||
46718134|NCT00923091|82934216|FG010|Period VI (Open-Label)|Other Reason|0|||
46718135|NCT00923091|82934217|FG011|Period VI (Open-Label)|Other Reason|0|||
46718136|NCT00923091|82934218|FG012|Period VI (Open-Label)|Other Reason|0|||
46718137|NCT00853957|82934245|FG000|Overall Study|Adverse Event|9|||
46718138|NCT00853957|82934246|FG001|Overall Study|Adverse Event|3|||
46718139|NCT00853957|82934245|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46718140|NCT00853957|82934246|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46915107|NCT01307033|83145822|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
46915108|NCT01307033|83145823|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
46915109|NCT01307033|83145824|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
46915110|NCT01307033|83145825|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
46915111|NCT01307033|83145822|FG000|44-week Open-label Extension|Adverse Event|0|||
46915112|NCT01307033|83145823|FG001|44-week Open-label Extension|Adverse Event|0|||
46915113|NCT01307033|83145824|FG002|44-week Open-label Extension|Adverse Event|2|||
46915114|NCT01307033|83145825|FG003|44-week Open-label Extension|Adverse Event|1|||
46915115|NCT01307033|83145822|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
46915116|NCT01307033|83145823|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
46915117|NCT01307033|83145824|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
46915118|NCT01307033|83145825|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
46915119|NCT01307033|83145822|FG000|44-week Open-label Extension|Physician Decision|0|||
46915120|NCT01307033|83145823|FG001|44-week Open-label Extension|Physician Decision|0|||
46915121|NCT01307033|83145824|FG002|44-week Open-label Extension|Physician Decision|1|||
46915122|NCT01307033|83145825|FG003|44-week Open-label Extension|Physician Decision|0|||
46915123|NCT01307033|83145822|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
46915124|NCT01307033|83145823|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
46915125|NCT01307033|83145824|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
46915126|NCT01307033|83145825|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
46915127|NCT01307033|83145822|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
46915128|NCT01307033|83145823|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
46915129|NCT01307033|83145824|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
46915130|NCT01307033|83145825|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
46915131|NCT01307033|83145822|FG000|44-week Open-label Extension|Death|0|||
46718141|NCT00853957|82934245|FG000|Overall Study|Subject withdrew consent|4|||
46718142|NCT00853957|82934246|FG001|Overall Study|Subject withdrew consent|5|||
46718143|NCT00853957|82934245|FG000|Overall Study|Lost to Follow-up|1|||
46718144|NCT00853957|82934246|FG001|Overall Study|Lost to Follow-up|6|||
46718145|NCT00853957|82934245|FG000|Overall Study|Protocol deviation|0|||
46718146|NCT00853957|82934246|FG001|Overall Study|Protocol deviation|3|||
46915132|NCT01307033|83145823|FG001|44-week Open-label Extension|Death|0|||
46915133|NCT01307033|83145824|FG002|44-week Open-label Extension|Death|0|||
46915134|NCT01307033|83145825|FG003|44-week Open-label Extension|Death|1|||
46915135|NCT02844920|83145837|FG000|Overall Study|Lost to Follow-up|2|||
46915136|NCT03158311|83145844|FG000|Overall Study|Subject/Guardian Decision|10|||
46915137|NCT03158311|83145845|FG001|Overall Study|Subject/Guardian Decision|6|||
46915138|NCT03158311|83145846|FG002|Overall Study|Subject/Guardian Decision|11|||
46915139|NCT03158311|83145844|FG000|Overall Study|Adverse Event|5|||
46915140|NCT03158311|83145845|FG001|Overall Study|Adverse Event|3|||
46631823|NCT01867710|82805002|FG002|Overall Study|Biochemical progression|0|||
46631824|NCT01867710|82805003|FG003|Overall Study|Biochemical progression|0|||
46631825|NCT01867710|82805000|FG000|Overall Study|Clinical progression|0|||
46631826|NCT01867710|82805001|FG001|Overall Study|Clinical progression|0|||
46631827|NCT01867710|82805002|FG002|Overall Study|Clinical progression|1|||
46631828|NCT01867710|82805003|FG003|Overall Study|Clinical progression|0|||
46631829|NCT01867710|82805000|FG000|Overall Study|Disease progression|1|||
46631830|NCT01867710|82805001|FG001|Overall Study|Disease progression|0|||
46718147|NCT01021020|82934252|FG000|Period I|Protocol Violation|1|||
46718148|NCT01021020|82934252|FG000|Period I|Withdrawal by Subject|1|||
46718149|NCT01021020|82934252|FG000|14 Day Washout Period A|Physician Decision|1|||
46718150|NCT00833053|82934266|FG000|Overall Study|Adverse Event|4|||
46718151|NCT00833053|82934267|FG001|Overall Study|Adverse Event|0|||
46915141|NCT03158311|83145846|FG002|Overall Study|Adverse Event|3|||
46915142|NCT03158311|83145844|FG000|Overall Study|Techinical Problems|3|||
47040042|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040043|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040044|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040045|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040046|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040047|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
47040048|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040049|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
46631831|NCT01867710|82805002|FG002|Overall Study|Disease progression|0|||
46631832|NCT01867710|82805003|FG003|Overall Study|Disease progression|0|||
46915143|NCT03158311|83145845|FG001|Overall Study|Techinical Problems|1|||
46915144|NCT03158311|83145846|FG002|Overall Study|Techinical Problems|5|||
46631833|NCT01867710|82805000|FG000|Overall Study|Patient decision|0|||
46631834|NCT01867710|82805001|FG001|Overall Study|Patient decision|0|||
46718152|NCT00833053|82934266|FG000|Overall Study|Treatment Failure|3|||
46718153|NCT00833053|82934267|FG001|Overall Study|Treatment Failure|1|||
46718154|NCT00833053|82934266|FG000|Overall Study|Withdrawal by Subject|0|||
46718155|NCT00833053|82934267|FG001|Overall Study|Withdrawal by Subject|1|||
46718156|NCT00833053|82934266|FG000|Overall Study|Protocol Violation|2|||
46718157|NCT00833053|82934267|FG001|Overall Study|Protocol Violation|1|||
46718158|NCT00832975|82934273|FG000|Overall Study|Lost to Follow-up|7|||
46718159|NCT00832975|82934273|FG000|Overall Study|Protocol Violation|6|||
46718160|NCT00832975|82934273|FG000|Overall Study|Death|5|||
46718161|NCT00832975|82934273|FG000|Overall Study|Physician Decision|4|||
46718162|NCT00832975|82934273|FG000|Overall Study|Withdrawal by Subject|3|||
46718163|NCT00832975|82934273|FG000|Overall Study|Other reasons|14|||
46718164|NCT01020786|82934277|FG000|Induction Period|Entry Criteria Not Met|2|||
46718165|NCT01020786|82934277|FG000|Induction Period|Adverse Event|10|||
46718166|NCT01020786|82934277|FG000|Induction Period|Progressive Disease|31|||
46718167|NCT01020786|82934277|FG000|Induction Period|Investigator Decision|3|||
46718168|NCT01020786|82934277|FG000|Induction Period|Withdrawal by Subject|3|||
46718169|NCT01020786|82934277|FG000|Maintenance Period|Adverse Event|8|||
46718170|NCT01020786|82934277|FG000|Maintenance Period|Progressive Disease|43|||
46718171|NCT01020786|82934277|FG000|Maintenance Period|Withdrawal by Subject|8|||
46718172|NCT01020786|82934277|FG000|Maintenance Period|Sponsor Decision|1|||
46718173|NCT00918645|82934282|FG000|Overall Study|Withdrawal by Subject|1|||
46718174|NCT00922935|82934289|FG000|Overall Study|Protocol Violation|0|||
46718175|NCT00922935|82934290|FG001|Overall Study|Protocol Violation|3|||
46718176|NCT00922935|82934291|FG002|Overall Study|Protocol Violation|0|||
46718177|NCT00922935|82934289|FG000|Overall Study|Physician Decision|1|||
46718178|NCT00922935|82934290|FG001|Overall Study|Physician Decision|1|||
46718179|NCT00922935|82934291|FG002|Overall Study|Physician Decision|0|||
46718180|NCT00922935|82934289|FG000|Overall Study|Lost to Follow-up|0|||
46718181|NCT00922935|82934290|FG001|Overall Study|Lost to Follow-up|1|||
46718182|NCT00922935|82934291|FG002|Overall Study|Lost to Follow-up|0|||
46718183|NCT01020474|82934301|FG000|Overall Study|Adverse Event|4|||
46718184|NCT01020474|82934302|FG001|Overall Study|Adverse Event|4|||
46718185|NCT01020474|82934301|FG000|Overall Study|Protocol Violation|0|||
46718186|NCT01020474|82934302|FG001|Overall Study|Protocol Violation|2|||
46718187|NCT01020474|82934301|FG000|Overall Study|Withdrawal by Subject|5|||
46718188|NCT01020474|82934302|FG001|Overall Study|Withdrawal by Subject|7|||
46718189|NCT01020474|82934301|FG000|Overall Study|Other Reasons|1|||
46718190|NCT01020474|82934302|FG001|Overall Study|Other Reasons|1|||
46718191|NCT01020474|82934301|FG000|Overall Study|Insufficient Clinical Response|0|||
46718192|NCT01020474|82934302|FG001|Overall Study|Insufficient Clinical Response|3|||
46718193|NCT00922779|82934308|FG000|Overall Study|Adverse Event|67|||
46718194|NCT00922779|82934308|FG000|Overall Study|Pregnancy|7|||
46718195|NCT00922779|82934308|FG000|Overall Study|Withdrawal by Subject|308|||
46718196|NCT00922779|82934308|FG000|Overall Study|Lost to Follow-up|44|||
46718197|NCT00922779|82934308|FG000|Overall Study|Other|27|||
46718198|NCT00922779|82934308|FG000|Overall Study|Missing|1874|||
46718199|NCT00924651|82934314|FG000|Overall Study|Chemo started too soon|2|||
46718200|NCT00924651|82934315|FG001|Overall Study|Chemo started too soon|3|||
46718201|NCT00924651|82934314|FG000|Overall Study|No Reason|3|||
46718202|NCT00924651|82934315|FG001|Overall Study|No Reason|7|||
46718203|NCT00924651|82934314|FG000|Overall Study|Overwhelmed|6|||
46718204|NCT00924651|82934315|FG001|Overall Study|Overwhelmed|6|||
46718205|NCT00924651|82934314|FG000|Overall Study|Noncompliant|1|||
46718206|NCT00924651|82934315|FG001|Overall Study|Noncompliant|4|||
47040050|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
47040051|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040052|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
46718207|NCT00924651|82934314|FG000|Overall Study|Medical|1|||
47040053|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
46631835|NCT01867710|82805002|FG002|Overall Study|Patient decision|0|||
46631836|NCT01867710|82805003|FG003|Overall Study|Patient decision|1|||
46631837|NCT01867710|82805000|FG000|Overall Study|Patient to follow subsequent treatment|0|||
46631838|NCT01867710|82805001|FG001|Overall Study|Patient to follow subsequent treatment|1|||
46631839|NCT01867710|82805002|FG002|Overall Study|Patient to follow subsequent treatment|0|||
46631840|NCT01867710|82805003|FG003|Overall Study|Patient to follow subsequent treatment|0|||
46631841|NCT01867710|82805000|FG000|Overall Study|Progressive disease|1|||
46631842|NCT01867710|82805001|FG001|Overall Study|Progressive disease|0|||
46631843|NCT01867710|82805002|FG002|Overall Study|Progressive disease|0|||
46631844|NCT01867710|82805003|FG003|Overall Study|Progressive disease|0|||
46631845|NCT01867710|82805000|FG000|Overall Study|Protocol Violation|0|||
46631846|NCT01867710|82805001|FG001|Overall Study|Protocol Violation|0|||
46631847|NCT01867710|82805002|FG002|Overall Study|Protocol Violation|0|||
46631848|NCT01867710|82805003|FG003|Overall Study|Protocol Violation|1|||
46631849|NCT01867710|82805000|FG000|Overall Study|PSA-progression|0|||
46631850|NCT01867710|82805001|FG001|Overall Study|PSA-progression|1|||
46718208|NCT00924651|82934315|FG001|Overall Study|Medical|3|||
46718209|NCT00924651|82934314|FG000|Overall Study|Changed Mind|10|||
46718210|NCT00924651|82934315|FG001|Overall Study|Changed Mind|1|||
46718211|NCT00924651|82934314|FG000|Overall Study|Incomplete Form|2|||
46915145|NCT03158311|83145844|FG000|Overall Study|Physician Decision|2|||
46915146|NCT03158311|83145845|FG001|Overall Study|Physician Decision|3|||
46915147|NCT03158311|83145846|FG002|Overall Study|Physician Decision|7|||
46915148|NCT03158311|83145844|FG000|Overall Study|Lost to Follow-up|1|||
46915149|NCT03158311|83145845|FG001|Overall Study|Lost to Follow-up|1|||
46915150|NCT03158311|83145846|FG002|Overall Study|Lost to Follow-up|1|||
46718212|NCT00924651|82934315|FG001|Overall Study|Incomplete Form|1|||
46718213|NCT00922623|82934321|FG000|Overall Study|Other|4|||
46718214|NCT00922623|82934321|FG000|Overall Study|Lost to Follow-up|1|||
46718215|NCT01025232|82934329|FG000|Overall Study|Study drug no longer available|3|||
46718216|NCT01025232|82934330|FG001|Overall Study|Study drug no longer available|6|||
46718217|NCT01025154|82934336|FG000|Overall Study|Lost to Follow-up|1|||
46718218|NCT01025154|82934336|FG000|Overall Study|Withdrawal by Subject|1|||
46718219|NCT00832819|82934343|FG000|Overall Study|Adverse Event|0|||
46718220|NCT00832819|82934344|FG001|Overall Study|Adverse Event|1|||
46718221|NCT00832819|82934345|FG002|Overall Study|Adverse Event|0|||
46718222|NCT00832819|82934343|FG000|Overall Study|Protocol Violation|0|||
46718223|NCT00832819|82934344|FG001|Overall Study|Protocol Violation|0|||
46718224|NCT00832819|82934345|FG002|Overall Study|Protocol Violation|1|||
46718225|NCT00853723|82934354|FG000|Overall Study|Adverse Event|3|||
46718226|NCT00853723|82934355|FG001|Overall Study|Adverse Event|4|||
46718227|NCT00853723|82934356|FG002|Overall Study|Adverse Event|1|||
46718228|NCT00853723|82934354|FG000|Overall Study|Withdrawal by Subject|2|||
46718229|NCT00853723|82934355|FG001|Overall Study|Withdrawal by Subject|1|||
46718230|NCT00853723|82934356|FG002|Overall Study|Withdrawal by Subject|0|||
46718231|NCT00853723|82934354|FG000|Overall Study|Protocol Violation|1|||
46718232|NCT00853723|82934355|FG001|Overall Study|Protocol Violation|2|||
46718233|NCT00853723|82934356|FG002|Overall Study|Protocol Violation|1|||
46718234|NCT01104545|82934370|FG000|Overall Study|Adverse Event|0|||
46718235|NCT01104545|82934371|FG001|Overall Study|Adverse Event|1|||
46718236|NCT01104545|82934372|FG002|Overall Study|Adverse Event|2|||
46718237|NCT00918255|82934420|FG000|Overall Study|Adverse Event|1|||
46718238|NCT00918255|82934421|FG001|Overall Study|Adverse Event|0|||
46718239|NCT00918255|82934422|FG002|Overall Study|Adverse Event|0|||
46718240|NCT00918255|82934420|FG000|Overall Study|Withdrawal by Subject|1|||
46718241|NCT00918255|82934421|FG001|Overall Study|Withdrawal by Subject|0|||
46718242|NCT00918255|82934422|FG002|Overall Study|Withdrawal by Subject|2|||
46718243|NCT00918255|82934420|FG000|Overall Study|Lack of Efficacy|1|||
46718244|NCT00918255|82934421|FG001|Overall Study|Lack of Efficacy|0|||
46718245|NCT00918255|82934422|FG002|Overall Study|Lack of Efficacy|0|||
46718246|NCT00918255|82934420|FG000|Overall Study|Lost to Follow-up|1|||
46718247|NCT00918255|82934421|FG001|Overall Study|Lost to Follow-up|0|||
46718248|NCT00918255|82934422|FG002|Overall Study|Lost to Follow-up|2|||
46718249|NCT00918255|82934420|FG000|Overall Study|Exceeded allowed number of interventions|0|||
46718250|NCT00918255|82934421|FG001|Overall Study|Exceeded allowed number of interventions|0|||
46718251|NCT00918255|82934422|FG002|Overall Study|Exceeded allowed number of interventions|1|||
46718252|NCT00918255|82934420|FG000|Overall Study|Non-compliance|1|||
46718253|NCT00918255|82934421|FG001|Overall Study|Non-compliance|0|||
46718254|NCT00918255|82934422|FG002|Overall Study|Non-compliance|0|||
46718255|NCT00918255|82934420|FG000|Overall Study|Investigator discretion|1|||
46718256|NCT00918255|82934421|FG001|Overall Study|Investigator discretion|0|||
46718257|NCT00918255|82934422|FG002|Overall Study|Investigator discretion|0|||
46718258|NCT01096589|82934434|FG000|Overall Study|Adverse Event|2|||
46718259|NCT01096589|82934435|FG001|Overall Study|Adverse Event|1|||
46718260|NCT01096589|82934436|FG002|Overall Study|Adverse Event|2|||
46915151|NCT03158311|83145844|FG000|Overall Study|Sponsor decision|1|||
46915152|NCT03158311|83145845|FG001|Overall Study|Sponsor decision|0|||
46631851|NCT01867710|82805002|FG002|Overall Study|PSA-progression|0|||
46631852|NCT01867710|82805003|FG003|Overall Study|PSA-progression|0|||
46631853|NCT01867710|82805000|FG000|Overall Study|Study medication no longer effective|0|||
46631854|NCT01867710|82805001|FG001|Overall Study|Study medication no longer effective|1|||
46631855|NCT01867710|82805002|FG002|Overall Study|Study medication no longer effective|0|||
46631856|NCT01867710|82805003|FG003|Overall Study|Study medication no longer effective|0|||
46631857|NCT01849848|82805013|FG000|Overall Study|Physician Decision|1|||
46631858|NCT01849848|82805013|FG000|Overall Study|Progression of the primary disease|3|||
46631859|NCT01849458|82805017|FG000|Overall Study|Lost to Follow-up|4|||
46631860|NCT01832766|82805021|FG000|Washout|Lost to Follow-up|0|||
46718261|NCT01096589|82934437|FG003|Overall Study|Adverse Event|1|||
46718262|NCT01096589|82934434|FG000|Overall Study|Withdrawal by Subject|2|||
46915153|NCT03158311|83145846|FG002|Overall Study|Sponsor decision|0|||
46718263|NCT01096589|82934435|FG001|Overall Study|Withdrawal by Subject|1|||
46718264|NCT01096589|82934436|FG002|Overall Study|Withdrawal by Subject|1|||
46718265|NCT01096589|82934437|FG003|Overall Study|Withdrawal by Subject|1|||
46718266|NCT01096589|82934434|FG000|Overall Study|Compliance with protocol|0|||
46718267|NCT01096589|82934435|FG001|Overall Study|Compliance with protocol|0|||
46915154|NCT03158311|83145844|FG000|Overall Study|Pregnancy|0|||
46915155|NCT03158311|83145845|FG001|Overall Study|Pregnancy|2|||
46718268|NCT01096589|82934436|FG002|Overall Study|Compliance with protocol|1|||
46718269|NCT01096589|82934437|FG003|Overall Study|Compliance with protocol|0|||
46718270|NCT01096589|82934434|FG000|Overall Study|found treatment exhausting|0|||
46718271|NCT01096589|82934435|FG001|Overall Study|found treatment exhausting|0|||
46631861|NCT01832766|82805022|FG001|Washout|Lost to Follow-up|1|||
46631862|NCT01832532|82805030|FG000|Overall Study|Withdrawal by Subject|5|||
46631863|NCT01832532|82805031|FG001|Overall Study|Withdrawal by Subject|2|||
46631864|NCT01848990|82805040|FG000|Overall Study|Adverse Event|6|||
46718272|NCT01096589|82934436|FG002|Overall Study|found treatment exhausting|0|||
46718273|NCT01096589|82934437|FG003|Overall Study|found treatment exhausting|1|||
46718274|NCT00845065|82934453|FG000|Overall Study|Adverse Event|3|||
46718275|NCT00845065|82934454|FG001|Overall Study|Adverse Event|23|||
46718276|NCT00845065|82934453|FG000|Overall Study|Lack of Efficacy|43|||
46718277|NCT00845065|82934454|FG001|Overall Study|Lack of Efficacy|21|||
46718278|NCT00845065|82934453|FG000|Overall Study|Non-Medical Reasons|1|||
46718279|NCT00845065|82934454|FG001|Overall Study|Non-Medical Reasons|11|||
46718280|NCT00832585|82934460|FG000|Overall Study|Withdrawal by Subject|1|||
46718281|NCT00832585|82934460|FG000|Overall Study|Lost to Follow-up|1|||
46718282|NCT00918567|82934466|FG000|Overall Study|Lack of Efficacy|3|||
46718283|NCT00918567|82934467|FG001|Overall Study|Lack of Efficacy|1|||
46718284|NCT00918567|82934466|FG000|Overall Study|Withdrawal by Subject|1|||
46718285|NCT00918567|82934467|FG001|Overall Study|Withdrawal by Subject|1|||
46718286|NCT00918567|82934466|FG000|Overall Study|Adverse Event|1|||
46718287|NCT00918567|82934467|FG001|Overall Study|Adverse Event|0|||
46718288|NCT01024920|82934475|FG000|Overall Study|Progressive disease|47|||
46718289|NCT01024920|82934476|FG001|Overall Study|Progressive disease|25|||
46718290|NCT01024920|82934475|FG000|Overall Study|Adverse Event|8|||
46718291|NCT01024920|82934476|FG001|Overall Study|Adverse Event|4|||
46718292|NCT01024920|82934475|FG000|Overall Study|Lost to Follow-up|0|||
46718293|NCT01024920|82934476|FG001|Overall Study|Lost to Follow-up|1|||
46718294|NCT01024920|82934475|FG000|Overall Study|Patient refusal to continue|4|||
46718295|NCT01024920|82934476|FG001|Overall Study|Patient refusal to continue|0|||
46718296|NCT01024920|82934475|FG000|Overall Study|Other than listed|5|||
46718297|NCT01024920|82934476|FG001|Overall Study|Other than listed|1|||
46718298|NCT01024920|82934475|FG000|Overall Study|Not treated|3|||
46718299|NCT01024920|82934476|FG001|Overall Study|Not treated|0|||
46718300|NCT01024920|82934475|FG000|Overall Study|Protocol Violation|0|||
46718301|NCT01024920|82934476|FG001|Overall Study|Protocol Violation|1|||
46718302|NCT00832117|82934484|FG000|Overall Study|Death|1|||
46718303|NCT00832117|82934484|FG000|Overall Study|Disease Progression|11|||
46718304|NCT01104311|82934493|FG000|Overall Study|Withdrawal by Subject|6|||
46718305|NCT01104311|82934494|FG001|Overall Study|Withdrawal by Subject|6|||
46718306|NCT01104311|82934493|FG000|Overall Study|Protocol Violation|0|||
46718307|NCT01104311|82934494|FG001|Overall Study|Protocol Violation|1|||
46718308|NCT01104311|82934493|FG000|Overall Study|Physician Decision|2|||
46718309|NCT01104311|82934494|FG001|Overall Study|Physician Decision|2|||
46718310|NCT01104311|82934493|FG000|Overall Study|low compliance|1|||
46718311|NCT01104311|82934494|FG001|Overall Study|low compliance|1|||
46718312|NCT01104311|82934493|FG000|Overall Study|Adverse Event|1|||
46718313|NCT01104311|82934494|FG001|Overall Study|Adverse Event|2|||
46718314|NCT00831493|82934504|FG000|Overall Study|Intractable nausea and vomiting|1|||
46718315|NCT00853567|82934511|FG000|Overall Study|Study prematurely terminated|71|||
46718316|NCT00853489|82934521|FG000|Overall Study|Lost to Follow-up|5|||
46718317|NCT00853489|82934522|FG001|Overall Study|Lost to Follow-up|2|||
46718318|NCT01019694|82934531|FG000|Overall Study|Adverse Event|12|||
46718319|NCT01019694|82934532|FG001|Overall Study|Adverse Event|16|||
46718320|NCT01019694|82934533|FG002|Overall Study|Adverse Event|19|||
46718321|NCT01019694|82934531|FG000|Overall Study|Protocol Violation|2|||
46718322|NCT01019694|82934532|FG001|Overall Study|Protocol Violation|6|||
46915156|NCT03158311|83145846|FG002|Overall Study|Pregnancy|0|||
46915157|NCT03158311|83145844|FG000|Overall Study|Randomized in error|0|||
46915158|NCT03158311|83145845|FG001|Overall Study|Randomized in error|0|||
46631865|NCT01848990|82805041|FG001|Overall Study|Adverse Event|2|||
46631866|NCT01848990|82805042|FG002|Overall Study|Adverse Event|0|||
46631867|NCT01848990|82805040|FG000|Overall Study|Lost to Follow-up|6|||
46631868|NCT01848990|82805041|FG001|Overall Study|Lost to Follow-up|2|||
46631869|NCT01848990|82805042|FG002|Overall Study|Lost to Follow-up|2|||
46631870|NCT01848990|82805040|FG000|Overall Study|Protocol Violation|1|||
46631871|NCT01848990|82805041|FG001|Overall Study|Protocol Violation|1|||
46631872|NCT01848990|82805042|FG002|Overall Study|Protocol Violation|0|||
46631873|NCT01848990|82805040|FG000|Overall Study|Withdrawal by Subject|29|||
46631874|NCT01848990|82805041|FG001|Overall Study|Withdrawal by Subject|10|||
46631875|NCT01848990|82805042|FG002|Overall Study|Withdrawal by Subject|11|||
46631876|NCT01848990|82805040|FG000|Overall Study|Physician Decision|1|||
46718323|NCT01019694|82934533|FG002|Overall Study|Protocol Violation|4|||
46718324|NCT01019694|82934531|FG000|Overall Study|Lost to Follow-up|5|||
46718325|NCT01019694|82934532|FG001|Overall Study|Lost to Follow-up|3|||
46718326|NCT01019694|82934533|FG002|Overall Study|Lost to Follow-up|3|||
46718327|NCT01019694|82934531|FG000|Overall Study|Withdrawal by Subject|4|||
46915159|NCT03158311|83145846|FG002|Overall Study|Randomized in error|1|||
46915160|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
46915161|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
46915162|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
46718328|NCT01019694|82934532|FG001|Overall Study|Withdrawal by Subject|6|||
46718329|NCT01019694|82934533|FG002|Overall Study|Withdrawal by Subject|12|||
46718330|NCT01019694|82934531|FG000|Overall Study|Not treated|0|||
46718331|NCT01019694|82934532|FG001|Overall Study|Not treated|2|||
46718332|NCT01019694|82934533|FG002|Overall Study|Not treated|3|||
46718333|NCT01019694|82934531|FG000|Overall Study|Other reason (not specified)|1|||
46718334|NCT01019694|82934532|FG001|Overall Study|Other reason (not specified)|5|||
46718335|NCT01019694|82934533|FG002|Overall Study|Other reason (not specified)|6|||
46718336|NCT00831415|82934541|FG000|Overall Study|Adverse Event|14|||
46718337|NCT00831415|82934541|FG000|Overall Study|Failed to return|3|||
46718338|NCT00831415|82934541|FG000|Overall Study|Physician Decision|6|||
46718339|NCT00831415|82934541|FG000|Overall Study|Lost to Follow-up|9|||
46718340|NCT00831415|82934541|FG000|Overall Study|Protocol Violation|3|||
46718341|NCT00831415|82934541|FG000|Overall Study|Withdrawal by Subject|35|||
46718342|NCT00831415|82934541|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
46718343|NCT00831415|82934541|FG000|Overall Study|Death|1|||
46718344|NCT01095653|82934548|FG000|Overall Study|Lack of Efficacy|3|||
46718345|NCT01095653|82934549|FG001|Overall Study|Lack of Efficacy|0|||
46718346|NCT01095653|82934550|FG002|Overall Study|Lack of Efficacy|0|||
46718347|NCT01095653|82934548|FG000|Overall Study|Adverse Event|1|||
46718348|NCT01095653|82934549|FG001|Overall Study|Adverse Event|4|||
46718349|NCT01095653|82934550|FG002|Overall Study|Adverse Event|4|||
46718350|NCT01095653|82934548|FG000|Overall Study|Lost to Follow-up|1|||
46718351|NCT01095653|82934549|FG001|Overall Study|Lost to Follow-up|0|||
46718352|NCT01095653|82934550|FG002|Overall Study|Lost to Follow-up|4|||
46718353|NCT01095653|82934548|FG000|Overall Study|Withdrawal by Subject|4|||
46718354|NCT01095653|82934549|FG001|Overall Study|Withdrawal by Subject|5|||
46718355|NCT01095653|82934550|FG002|Overall Study|Withdrawal by Subject|3|||
46718356|NCT01095653|82934548|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
46718357|NCT01095653|82934549|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
46718358|NCT01095653|82934550|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
46718359|NCT00920907|82934560|FG000|Induction Period|Adverse Event|0|||
46718360|NCT00920907|82934561|FG001|Induction Period|Adverse Event|2|||
46718361|NCT00920907|82934560|FG000|Induction Period|Death|1|||
46718362|NCT00920907|82934561|FG001|Induction Period|Death|1|||
46718363|NCT00920907|82934560|FG000|Induction Period|Disease Progression|12|||
46718364|NCT00920907|82934561|FG001|Induction Period|Disease Progression|11|||
46718365|NCT00920907|82934560|FG000|Induction Period|Study Drug Toxicity|8|||
46718366|NCT00920907|82934561|FG001|Induction Period|Study Drug Toxicity|6|||
46718367|NCT00920907|82934560|FG000|Induction Period|No longer meets study criteria|0|||
46718368|NCT00920907|82934561|FG001|Induction Period|No longer meets study criteria|1|||
46718369|NCT00920907|82934560|FG000|Induction Period|Withdrawal by Subject|1|||
46718370|NCT00920907|82934561|FG001|Induction Period|Withdrawal by Subject|1|||
46718371|NCT00920907|82934560|FG000|Maintenance Period|Disease Progression|3|||
46718372|NCT00920907|82934561|FG001|Maintenance Period|Disease Progression|7|||
46718373|NCT00920907|82934560|FG000|Maintenance Period|Administrative (study closure)|7|||
46718374|NCT00920907|82934561|FG001|Maintenance Period|Administrative (study closure)|2|||
46718375|NCT00920907|82934560|FG000|Maintenance Period|Study Drug Toxicity|0|||
46718376|NCT00920907|82934561|FG001|Maintenance Period|Study Drug Toxicity|2|||
46718377|NCT00920907|82934560|FG000|Maintenance Period|Death|1|||
46718378|NCT00920907|82934561|FG001|Maintenance Period|Death|1|||
46718379|NCT00920907|82934560|FG000|Maintenance Period|Withdrawal by Subject|1|||
46718380|NCT00920907|82934561|FG001|Maintenance Period|Withdrawal by Subject|0|||
46718381|NCT00920907|82934560|FG000|Maintenance Period|Adverse Event|0|||
46718382|NCT00920907|82934561|FG001|Maintenance Period|Adverse Event|1|||
46915163|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
46915164|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
46915165|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
46718383|NCT01103141|82934571|FG000|Overall Study|Death|0|||
46718384|NCT01103141|82934572|FG001|Overall Study|Death|1|||
46718385|NCT01103141|82934571|FG000|Overall Study|Lost to Follow-up|2|||
46915166|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
46915167|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
46915168|NCT01336621|83145858|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
46718386|NCT01103141|82934572|FG001|Overall Study|Lost to Follow-up|1|||
46718387|NCT00844831|82934578|FG000|Overall Study|Withdrawal by Subject|4|||
46718388|NCT00844831|82934578|FG000|Overall Study|Adverse Event|1|||
46718389|NCT00844831|82934578|FG000|Overall Study|Physician Decision|1|||
46718390|NCT00920829|82934590|FG000|Allocation|No post randomization data|3|||
46915169|NCT01336621|83145858|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
46718391|NCT00920829|82934591|FG001|Allocation|No post randomization data|1|||
46718392|NCT00920829|82934592|FG002|Allocation|No post randomization data|0|||
46631877|NCT01848990|82805041|FG001|Overall Study|Physician Decision|1|||
46631878|NCT01848990|82805042|FG002|Overall Study|Physician Decision|0|||
46631879|NCT01848990|82805040|FG000|Overall Study|Non Compliance|1|||
46631880|NCT01848990|82805041|FG001|Overall Study|Non Compliance|0|||
46631881|NCT01848990|82805042|FG002|Overall Study|Non Compliance|0|||
46631882|NCT01848990|82805040|FG000|Overall Study|Death|1|||
46631883|NCT01848990|82805041|FG001|Overall Study|Death|0|||
46631884|NCT01848990|82805042|FG002|Overall Study|Death|1|||
46631885|NCT01848990|82805040|FG000|Overall Study|Other|1|||
46631886|NCT01848990|82805041|FG001|Overall Study|Other|4|||
46631887|NCT01848990|82805042|FG002|Overall Study|Other|2|||
46631888|NCT01867086|82805054|FG000|Overall Study|Disease Progression|1|||
46631889|NCT01831596|82805058|FG000|Overall Study|Other|8|||
46631890|NCT01848834|82805067|FG000|Overall Study|Adverse Event|3|||
46631891|NCT01848834|82805068|FG001|Overall Study|Adverse Event|11|||
46631892|NCT01848834|82805069|FG002|Overall Study|Adverse Event|3|||
46631893|NCT01848834|82805070|FG003|Overall Study|Adverse Event|5|||
46631894|NCT01848834|82805071|FG004|Overall Study|Adverse Event|9|||
46631895|NCT01848834|82805067|FG000|Overall Study|Death|2|||
46631896|NCT01848834|82805068|FG001|Overall Study|Death|11|||
46631897|NCT01848834|82805069|FG002|Overall Study|Death|1|||
46631898|NCT01848834|82805070|FG003|Overall Study|Death|8|||
46631899|NCT01848834|82805071|FG004|Overall Study|Death|27|||
46631900|NCT01848834|82805067|FG000|Overall Study|Excluded Medication|5|||
46631901|NCT01848834|82805068|FG001|Overall Study|Excluded Medication|4|||
46631902|NCT01848834|82805069|FG002|Overall Study|Excluded Medication|3|||
46631903|NCT01848834|82805070|FG003|Overall Study|Excluded Medication|6|||
46631904|NCT01848834|82805071|FG004|Overall Study|Excluded Medication|6|||
46631905|NCT01848834|82805067|FG000|Overall Study|Lost to Follow-up|5|||
46631906|NCT01848834|82805068|FG001|Overall Study|Lost to Follow-up|5|||
46631907|NCT01848834|82805069|FG002|Overall Study|Lost to Follow-up|3|||
46631908|NCT01848834|82805070|FG003|Overall Study|Lost to Follow-up|0|||
46631909|NCT01848834|82805071|FG004|Overall Study|Lost to Follow-up|3|||
46631910|NCT01848834|82805067|FG000|Overall Study|Physician Decision|1|||
46631911|NCT01848834|82805068|FG001|Overall Study|Physician Decision|3|||
46631912|NCT01848834|82805069|FG002|Overall Study|Physician Decision|4|||
46631913|NCT01848834|82805070|FG003|Overall Study|Physician Decision|0|||
46631914|NCT01848834|82805071|FG004|Overall Study|Physician Decision|11|||
46631915|NCT01848834|82805067|FG000|Overall Study|Protocol Violation|0|||
46631916|NCT01848834|82805068|FG001|Overall Study|Protocol Violation|0|||
46631917|NCT01848834|82805069|FG002|Overall Study|Protocol Violation|0|||
46631918|NCT01848834|82805070|FG003|Overall Study|Protocol Violation|0|||
46631919|NCT01848834|82805071|FG004|Overall Study|Protocol Violation|1|||
46631920|NCT01848834|82805067|FG000|Overall Study|Sponsor Decision|1|||
46631921|NCT01848834|82805068|FG001|Overall Study|Sponsor Decision|1|||
46631922|NCT01848834|82805069|FG002|Overall Study|Sponsor Decision|0|||
46631923|NCT01848834|82805070|FG003|Overall Study|Sponsor Decision|1|||
46631924|NCT01848834|82805071|FG004|Overall Study|Sponsor Decision|1|||
46631925|NCT01848834|82805067|FG000|Overall Study|Withdrawal by Subject|2|||
46631926|NCT01848834|82805068|FG001|Overall Study|Withdrawal by Subject|13|||
46631927|NCT01848834|82805069|FG002|Overall Study|Withdrawal by Subject|10|||
46631928|NCT01848834|82805070|FG003|Overall Study|Withdrawal by Subject|6|||
46631929|NCT01848834|82805071|FG004|Overall Study|Withdrawal by Subject|36|||
46631930|NCT01867008|82805087|FG000|Overall Study|Withdrawal by Subject|1|||
46631931|NCT01848756|82805091|FG000|Overall Study|Adverse Event|1|||
46631932|NCT01848756|82805091|FG000|Overall Study|Withdrawal by Subject|1|||
46631933|NCT01848756|82805091|FG000|Overall Study|Enrolled in Error|1|||
46718393|NCT00920829|82934593|FG003|Allocation|No post randomization data|2|||
46718394|NCT00920829|82934590|FG000|Available for Analysis|Withdrawal by Subject|6|||
46718395|NCT00920829|82934591|FG001|Available for Analysis|Withdrawal by Subject|6|||
46631934|NCT01830972|82805098|FG000|Part II|Withdrawal by Subject|2|||
46631935|NCT01830972|82805099|FG001|Part II|Withdrawal by Subject|2|||
46631936|NCT01830972|82805098|FG000|Part III|Withdrawal by Subject|1|||
46631937|NCT01830972|82805099|FG001|Part III|Withdrawal by Subject|0|||
46631938|NCT01830972|82805098|FG000|Part III|Noncompliance|1|||
46631939|NCT01830972|82805099|FG001|Part III|Noncompliance|0|||
46631940|NCT01830972|82805098|FG000|Part IV|Withdrawal by Subject|2|||
46631941|NCT01830972|82805099|FG001|Part IV|Withdrawal by Subject|1|||
46631942|NCT01830972|82805098|FG000|Part IV|Non-Compliance|1|||
46631943|NCT01830972|82805099|FG001|Part IV|Non-Compliance|0|||
46631944|NCT01848288|82805115|FG000|Overall Study|Death|1|||
46631945|NCT01848288|82805115|FG000|Overall Study|Protocol Violation|1|||
46631946|NCT01848288|82805115|FG000|Overall Study|Withdrawal by Subject|1|||
46631947|NCT01848210|82805122|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
46631948|NCT01848210|82805123|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
46631949|NCT01848210|82805122|FG000|Overall Study|Lost to Follow-up|24|||
46631950|NCT01848210|82805123|FG001|Overall Study|Lost to Follow-up|12|||
46631951|NCT01848210|82805122|FG000|Overall Study|Protocol Violation|3|||
46718396|NCT00920829|82934592|FG002|Available for Analysis|Withdrawal by Subject|6|||
46718397|NCT00920829|82934593|FG003|Available for Analysis|Withdrawal by Subject|10|||
46718398|NCT00920829|82934590|FG000|Available for Analysis|Required Medical Treatment|0|||
46718399|NCT00920829|82934591|FG001|Available for Analysis|Required Medical Treatment|1|||
46718400|NCT00920829|82934592|FG002|Available for Analysis|Required Medical Treatment|2|||
46718401|NCT00920829|82934593|FG003|Available for Analysis|Required Medical Treatment|0|||
46718402|NCT00920829|82934590|FG000|Available for Analysis|Adverse Event|1|||
46718403|NCT00920829|82934591|FG001|Available for Analysis|Adverse Event|2|||
46718404|NCT00920829|82934592|FG002|Available for Analysis|Adverse Event|1|||
46718405|NCT00920829|82934593|FG003|Available for Analysis|Adverse Event|0|||
46718406|NCT00920829|82934590|FG000|Available for Analysis|Death|1|||
46718407|NCT00920829|82934591|FG001|Available for Analysis|Death|0|||
46718408|NCT00920829|82934592|FG002|Available for Analysis|Death|0|||
46718409|NCT00920829|82934593|FG003|Available for Analysis|Death|0|||
46718410|NCT00920829|82934590|FG000|Available for Analysis|Protocol Violation|0|||
46718411|NCT00920829|82934591|FG001|Available for Analysis|Protocol Violation|0|||
46718412|NCT00920829|82934592|FG002|Available for Analysis|Protocol Violation|1|||
46718413|NCT00920829|82934593|FG003|Available for Analysis|Protocol Violation|0|||
46718414|NCT00920829|82934590|FG000|Available for Analysis|Required more treatment|0|||
46718415|NCT00920829|82934591|FG001|Available for Analysis|Required more treatment|2|||
46718416|NCT00920829|82934592|FG002|Available for Analysis|Required more treatment|0|||
46718417|NCT00920829|82934593|FG003|Available for Analysis|Required more treatment|1|||
46718418|NCT00831181|82934603|FG000|Overall Study|Adverse Event|12|||
46718419|NCT01023672|82934608|FG000|Overall Study|Worsening disease|2|||
46718420|NCT01023672|82934608|FG000|Overall Study|Death|1|||
46718421|NCT01094171|82934612|FG000|Overall Study|Lost to Follow-up|2|||
46718422|NCT01094171|82934612|FG000|Overall Study|Informed consent withdrawal|4|||
46718423|NCT01094171|82934612|FG000|Overall Study|Migration from the study area|3|||
46718424|NCT01094171|82934612|FG000|Overall Study|Other|1|||
46718425|NCT01093625|82934618|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
46718426|NCT01093625|82934619|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
46718427|NCT01093625|82934618|FG000|2-Week Visit|Withdrawal by Subject|1|||
46718428|NCT01093625|82934619|FG001|2-Week Visit|Withdrawal by Subject|0|||
46718429|NCT01093625|82934618|FG000|1-Month Visit|Lost to Follow-up|2|||
46718430|NCT01093625|82934619|FG001|1-Month Visit|Lost to Follow-up|0|||
46718431|NCT01093625|82934618|FG000|3-Month Visit|Lost to Follow-up|2|||
46718432|NCT01093625|82934619|FG001|3-Month Visit|Lost to Follow-up|0|||
46718433|NCT01093625|82934618|FG000|6-Month Visit|Withdrawal by Subject|6|||
46718434|NCT01093625|82934619|FG001|6-Month Visit|Withdrawal by Subject|7|||
46718435|NCT01093625|82934618|FG000|6-Month Visit|Lost to Follow-up|2|||
46915170|NCT01336621|83145858|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
46915171|NCT01336621|83145858|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
46915172|NCT01336621|83145858|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
46915173|NCT01336621|83145858|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
47040054|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040055|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040056|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040057|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040058|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
46915174|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
46915175|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
46915176|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
47040059|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040060|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040061|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040062|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
47040063|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
47040064|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
47040065|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
47040066|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
47040067|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040068|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040069|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040070|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040071|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
46718436|NCT01093625|82934619|FG001|6-Month Visit|Lost to Follow-up|2|||
46718437|NCT01093625|82934618|FG000|1-Year Visit|Lost to Follow-up|5|||
46718438|NCT01093625|82934619|FG001|1-Year Visit|Lost to Follow-up|3|||
46718439|NCT01023516|82934627|FG000|Overall Study|Voluntary discontinuation|7|||
46718440|NCT01023516|82934628|FG001|Overall Study|Voluntary discontinuation|5|||
46718441|NCT01023516|82934627|FG000|Overall Study|Adverse Event|9|||
46718442|NCT01023516|82934628|FG001|Overall Study|Adverse Event|6|||
46718443|NCT01023516|82934627|FG000|Overall Study|Safety reason|0|||
46718444|NCT01023516|82934628|FG001|Overall Study|Safety reason|3|||
46718445|NCT01023516|82934627|FG000|Overall Study|Study-specific criteria|4|||
46718446|NCT01023516|82934628|FG001|Overall Study|Study-specific criteria|2|||
46718447|NCT01023516|82934627|FG000|Overall Study|Incorrect enrolment|4|||
46718448|NCT01023516|82934628|FG001|Overall Study|Incorrect enrolment|2|||
46718449|NCT00844753|82934638|FG000|Overall Study|Lack of Efficacy|1|||
46718450|NCT00844753|82934639|FG001|Overall Study|Lack of Efficacy|0|||
46718451|NCT00844753|82934640|FG002|Overall Study|Lack of Efficacy|2|||
46718452|NCT00844753|82934641|FG003|Overall Study|Lack of Efficacy|2|||
46718453|NCT00844753|82934638|FG000|Overall Study|Adverse Event|3|||
46718454|NCT00844753|82934639|FG001|Overall Study|Adverse Event|2|||
46718455|NCT00844753|82934640|FG002|Overall Study|Adverse Event|5|||
46718456|NCT00844753|82934641|FG003|Overall Study|Adverse Event|5|||
46718457|NCT00844753|82934638|FG000|Overall Study|Lost to Follow-up|1|||
46718458|NCT00844753|82934639|FG001|Overall Study|Lost to Follow-up|1|||
46718459|NCT00844753|82934640|FG002|Overall Study|Lost to Follow-up|0|||
46718460|NCT00844753|82934641|FG003|Overall Study|Lost to Follow-up|1|||
46718461|NCT00844753|82934638|FG000|Overall Study|could not swallow medication|2|||
46718462|NCT00844753|82934639|FG001|Overall Study|could not swallow medication|0|||
46718463|NCT00844753|82934640|FG002|Overall Study|could not swallow medication|0|||
46718464|NCT00844753|82934641|FG003|Overall Study|could not swallow medication|0|||
46718465|NCT00844753|82934638|FG000|Overall Study|Withdrawal by Subject|1|||
46718466|NCT00844753|82934639|FG001|Overall Study|Withdrawal by Subject|0|||
46718467|NCT00844753|82934640|FG002|Overall Study|Withdrawal by Subject|0|||
46718468|NCT00844753|82934641|FG003|Overall Study|Withdrawal by Subject|3|||
46718469|NCT00830947|82934651|FG000|Overall Study|Lost to Follow-up|4|||
46718470|NCT00830947|82934652|FG001|Overall Study|Lost to Follow-up|4|||
46718471|NCT01018992|82934660|FG000|Overall Study|Adverse Event|8|||
46718472|NCT01018992|82934661|FG001|Overall Study|Adverse Event|3|||
46718473|NCT01018992|82934660|FG000|Overall Study|Withdrawal by Subject|3|||
46718474|NCT01018992|82934661|FG001|Overall Study|Withdrawal by Subject|8|||
46718475|NCT01018992|82934660|FG000|Overall Study|Protocol Violation|0|||
46718476|NCT01018992|82934661|FG001|Overall Study|Protocol Violation|4|||
46718477|NCT01018992|82934660|FG000|Overall Study|Lost to Follow-up|5|||
47040072|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040073|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
46718478|NCT01018992|82934661|FG001|Overall Study|Lost to Follow-up|1|||
46718479|NCT00917553|82934669|FG000|Overall Study|Lost to Follow-up|2|||
46718480|NCT00917553|82934670|FG001|Overall Study|Lost to Follow-up|1|||
46718481|NCT01018680|82934678|FG000|Overall Study|Adverse Event|23|||
46718482|NCT01018680|82934679|FG001|Overall Study|Adverse Event|40|||
46718483|NCT01018680|82934678|FG000|Overall Study|Withdrawal by Subject|10|||
47040074|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040075|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040076|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040077|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040078|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040079|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040080|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040081|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
47040082|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
47040083|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040084|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040085|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040086|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
46631952|NCT01848210|82805123|FG001|Overall Study|Protocol Violation|5|||
46631953|NCT01848210|82805122|FG000|Overall Study|Use of Forbidden Drugs|9|||
46631954|NCT01848210|82805123|FG001|Overall Study|Use of Forbidden Drugs|10|||
46631955|NCT01848210|82805122|FG000|Overall Study|Impedition Condition|5|||
46631956|NCT01848210|82805123|FG001|Overall Study|Impedition Condition|9|||
46631957|NCT01848210|82805122|FG000|Overall Study|Adverse Event|7|||
46631958|NCT01848210|82805123|FG001|Overall Study|Adverse Event|9|||
46631959|NCT01848210|82805122|FG000|Overall Study|Discontinuation Criterion|5|||
46718484|NCT01018680|82934679|FG001|Overall Study|Withdrawal by Subject|10|||
47040087|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040088|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040089|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
46631960|NCT01848210|82805123|FG001|Overall Study|Discontinuation Criterion|7|||
46718485|NCT01018680|82934678|FG000|Overall Study|Protocol Violation|5|||
46718486|NCT01018680|82934679|FG001|Overall Study|Protocol Violation|8|||
46718487|NCT01018680|82934678|FG000|Overall Study|Sponsor Decision|6|||
46718488|NCT01018680|82934679|FG001|Overall Study|Sponsor Decision|7|||
46718489|NCT01018680|82934678|FG000|Overall Study|Lack of Efficacy|8|||
46718490|NCT01018680|82934679|FG001|Overall Study|Lack of Efficacy|2|||
46718491|NCT01018680|82934678|FG000|Overall Study|Lost to Follow-up|5|||
46718492|NCT01018680|82934679|FG001|Overall Study|Lost to Follow-up|3|||
46718493|NCT01018680|82934678|FG000|Overall Study|Entry Criteria Not Met|1|||
46718494|NCT01018680|82934679|FG001|Overall Study|Entry Criteria Not Met|4|||
46718495|NCT01018680|82934678|FG000|Overall Study|Physician Decision|3|||
46718496|NCT01018680|82934679|FG001|Overall Study|Physician Decision|1|||
46718497|NCT01012440|82934685|FG000|Overall Study|Withdrawal by Subject|2|||
46718498|NCT00916929|82934691|FG000|Overall Study|Lost to Follow-up|1|||
46718499|NCT00916929|82934692|FG001|Overall Study|Lost to Follow-up|3|||
46718500|NCT00916929|82934691|FG000|Overall Study|Death|5|||
46718501|NCT00916929|82934692|FG001|Overall Study|Death|10|||
46718502|NCT00916929|82934691|FG000|Overall Study|Withdrawal by Subject|1|||
46718503|NCT00916929|82934692|FG001|Overall Study|Withdrawal by Subject|5|||
46718504|NCT00916929|82934691|FG000|Overall Study|Left ventricular epicardial lead|1|||
46718505|NCT00916929|82934692|FG001|Overall Study|Left ventricular epicardial lead|2|||
46718506|NCT00916929|82934691|FG000|Overall Study|Transferred to hospice care|1|||
46718507|NCT00916929|82934692|FG001|Overall Study|Transferred to hospice care|1|||
46718508|NCT00916929|82934691|FG000|Overall Study|System explant|1|||
46718509|NCT00916929|82934692|FG001|Overall Study|System explant|0|||
46718510|NCT00916929|82934691|FG000|Overall Study|Moved to another state|0|||
46718511|NCT00916929|82934692|FG001|Overall Study|Moved to another state|1|||
46718512|NCT00916929|82934691|FG000|Overall Study|Device unable to process impedance data|0|||
46718513|NCT00916929|82934692|FG001|Overall Study|Device unable to process impedance data|7|||
46718514|NCT00844597|82934706|FG000|Overall Study|Adverse Event|0|||
46718515|NCT00844597|82934707|FG001|Overall Study|Adverse Event|0|||
46718516|NCT00844597|82934708|FG002|Overall Study|Adverse Event|0|||
46718517|NCT00844597|82934709|FG003|Overall Study|Adverse Event|1|||
46718518|NCT00844597|82934710|FG004|Overall Study|Adverse Event|0|||
46718519|NCT00844597|82934711|FG005|Overall Study|Adverse Event|0|||
46718520|NCT01017120|82934729|FG000|Overall Study|Adverse Event|9|||
46718521|NCT01017120|82934730|FG001|Overall Study|Adverse Event|0|||
46718522|NCT01017120|82934729|FG000|Overall Study|Lost to Follow-up|13|||
46718523|NCT01017120|82934730|FG001|Overall Study|Lost to Follow-up|11|||
46718524|NCT01017120|82934729|FG000|Overall Study|Lack of Efficacy|1|||
46718525|NCT01017120|82934730|FG001|Overall Study|Lack of Efficacy|0|||
47040090|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040091|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040092|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040093|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040094|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040095|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
47040096|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
47040097|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
47040098|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
47040099|NCT01609556|83293172|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040100|NCT01609556|83293173|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040101|NCT01609556|83293174|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040102|NCT01609556|83293175|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040103|NCT01609556|83293176|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040104|NCT01609556|83293177|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040105|NCT01609556|83293178|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
46631961|NCT01848210|82805122|FG000|Overall Study|Hypesensitivity|1|||
46631962|NCT01848210|82805123|FG001|Overall Study|Hypesensitivity|0|||
46631963|NCT01848210|82805122|FG000|Overall Study|Hepatic Function Alteration|4|||
46631964|NCT01848210|82805123|FG001|Overall Study|Hepatic Function Alteration|0|||
46631965|NCT01848210|82805122|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
46631966|NCT01848210|82805123|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
46631967|NCT01848210|82805122|FG000|Overall Study|Administrative|1|||
46631968|NCT01848210|82805123|FG001|Overall Study|Administrative|0|||
46631969|NCT01830816|82805132|FG000|Overall Study|Progressive Disease|12|||
46631970|NCT01830816|82805133|FG001|Overall Study|Progressive Disease|7|||
46631971|NCT01830816|82805134|FG002|Overall Study|Progressive Disease|7|||
46631972|NCT01830816|82805132|FG000|Overall Study|Adverse Event|3|||
46631973|NCT01830816|82805133|FG001|Overall Study|Adverse Event|4|||
46718526|NCT01017120|82934729|FG000|Overall Study|Withdrawal by Subject|39|||
46718527|NCT01017120|82934730|FG001|Overall Study|Withdrawal by Subject|21|||
46718528|NCT01017120|82934729|FG000|Overall Study|Pregnancy|1|||
46718529|NCT01017120|82934730|FG001|Overall Study|Pregnancy|1|||
46718530|NCT01017120|82934729|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
46718531|NCT01017120|82934730|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
46718532|NCT01017120|82934729|FG000|Overall Study|Relocated Out of Town|0|||
47040106|NCT01609556|83293179|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
46718533|NCT01017120|82934730|FG001|Overall Study|Relocated Out of Town|2|||
46718534|NCT01017120|82934729|FG000|Overall Study|Protocol Violation|1|||
46718535|NCT01017120|82934730|FG001|Overall Study|Protocol Violation|0|||
46718536|NCT01017120|82934729|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
46718537|NCT01017120|82934730|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
46718538|NCT01016964|82934738|FG000|Overall Study|Lost to Follow-up|3|||
46718539|NCT01016964|82934739|FG001|Overall Study|Lost to Follow-up|3|||
46718540|NCT02996110|82934750|FG000|Pre-Treatment|Other Reasons|0|||
46718541|NCT02996110|82934751|FG001|Pre-Treatment|Other Reasons|1|||
46718542|NCT02996110|82934752|FG002|Pre-Treatment|Other Reasons|0|||
46718543|NCT02996110|82934753|FG003|Pre-Treatment|Other Reasons|0|||
46718544|NCT02996110|82934754|FG004|Pre-Treatment|Other Reasons|1|||
46718545|NCT02996110|82934750|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
46718546|NCT02996110|82934751|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
46718547|NCT02996110|82934752|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
46718548|NCT02996110|82934753|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
46718549|NCT02996110|82934754|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
46718550|NCT02996110|82934750|FG000|Track 1|Disease Progression|15|||
46718551|NCT02996110|82934751|FG001|Track 1|Disease Progression|17|||
46718552|NCT02996110|82934752|FG002|Track 1|Disease Progression|0|||
46718553|NCT02996110|82934753|FG003|Track 1|Disease Progression|0|||
46718554|NCT02996110|82934754|FG004|Track 1|Disease Progression|0|||
46718555|NCT02996110|82934750|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
46718556|NCT02996110|82934751|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
46718557|NCT02996110|82934752|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
46718558|NCT02996110|82934753|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
46718559|NCT02996110|82934754|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
46718560|NCT02996110|82934750|FG000|Track 1|Study Drug Toxicity|5|||
46718561|NCT02996110|82934751|FG001|Track 1|Study Drug Toxicity|3|||
46718562|NCT02996110|82934752|FG002|Track 1|Study Drug Toxicity|0|||
46718563|NCT02996110|82934753|FG003|Track 1|Study Drug Toxicity|0|||
46915177|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
46915178|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
47040107|NCT01609556|83293180|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040108|NCT01609556|83293181|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
46631974|NCT01830816|82805134|FG002|Overall Study|Adverse Event|0|||
46631975|NCT01830816|82805132|FG000|Overall Study|Study Terminated by Sponsor|1|||
46631976|NCT01830816|82805133|FG001|Overall Study|Study Terminated by Sponsor|1|||
46631977|NCT01830816|82805134|FG002|Overall Study|Study Terminated by Sponsor|0|||
46631978|NCT01830816|82805132|FG000|Overall Study|Withdrawal by Subject|1|||
46631979|NCT01830816|82805133|FG001|Overall Study|Withdrawal by Subject|1|||
46631980|NCT01830816|82805134|FG002|Overall Study|Withdrawal by Subject|0|||
46631981|NCT01830816|82805132|FG000|Overall Study|Lost to Follow-up|0|||
46631982|NCT01830816|82805133|FG001|Overall Study|Lost to Follow-up|1|||
46631983|NCT01830816|82805134|FG002|Overall Study|Lost to Follow-up|0|||
46631984|NCT01830816|82805132|FG000|Overall Study|Symptomatic Deterioration|1|||
46631985|NCT01830816|82805133|FG001|Overall Study|Symptomatic Deterioration|0|||
46631986|NCT01830816|82805134|FG002|Overall Study|Symptomatic Deterioration|0|||
46631987|NCT01830816|82805132|FG000|Overall Study|Reason not Specified|2|||
46631988|NCT01830816|82805133|FG001|Overall Study|Reason not Specified|0|||
46631989|NCT01830816|82805134|FG002|Overall Study|Reason not Specified|0|||
46631990|NCT01846416|82805148|FG000|Treatment Phase|Death|2|||
46631991|NCT01846416|82805149|FG001|Treatment Phase|Death|9|||
46631992|NCT01846416|82805150|FG002|Treatment Phase|Death|1|||
46631993|NCT01846416|82805148|FG000|Treatment Phase|Withdrawal by Subject|2|||
46631994|NCT01846416|82805149|FG001|Treatment Phase|Withdrawal by Subject|4|||
46631995|NCT01846416|82805150|FG002|Treatment Phase|Withdrawal by Subject|2|||
46631996|NCT01846416|82805148|FG000|Treatment Phase|Other|1|||
46631997|NCT01846416|82805149|FG001|Treatment Phase|Other|5|||
46631998|NCT01846416|82805150|FG002|Treatment Phase|Other|1|||
46631999|NCT01846416|82805148|FG000|Treatment Phase|Physician Decision|1|||
46632000|NCT01846416|82805149|FG001|Treatment Phase|Physician Decision|2|||
46632001|NCT01846416|82805150|FG002|Treatment Phase|Physician Decision|0|||
46632002|NCT01846416|82805148|FG000|Treatment Phase|Adverse Event|3|||
46632003|NCT01846416|82805149|FG001|Treatment Phase|Adverse Event|4|||
46632004|NCT01846416|82805150|FG002|Treatment Phase|Adverse Event|0|||
46632005|NCT01846416|82805148|FG000|Treatment Phase|Non-compliance|0|||
46632006|NCT01846416|82805149|FG001|Treatment Phase|Non-compliance|2|||
46632007|NCT01846416|82805150|FG002|Treatment Phase|Non-compliance|0|||
46718564|NCT02996110|82934754|FG004|Track 1|Study Drug Toxicity|0|||
46718565|NCT02996110|82934750|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
46718566|NCT02996110|82934751|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
46718567|NCT02996110|82934752|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
46915179|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
46915180|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
46718568|NCT02996110|82934753|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
46718569|NCT02996110|82934754|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
46718570|NCT02996110|82934750|FG000|Track 1|Administrative Reason by Sponsor|0|||
46718571|NCT02996110|82934751|FG001|Track 1|Administrative Reason by Sponsor|1|||
46718572|NCT02996110|82934752|FG002|Track 1|Administrative Reason by Sponsor|0|||
46718573|NCT02996110|82934753|FG003|Track 1|Administrative Reason by Sponsor|0|||
46718574|NCT02996110|82934754|FG004|Track 1|Administrative Reason by Sponsor|0|||
46718575|NCT02996110|82934750|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
46718576|NCT02996110|82934751|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
46718577|NCT02996110|82934752|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
46718578|NCT02996110|82934753|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
46718579|NCT02996110|82934754|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
46718580|NCT02996110|82934750|FG000|Track 2|Disease Progression|33|||
46718581|NCT02996110|82934751|FG001|Track 2|Disease Progression|26|||
46718582|NCT02996110|82934752|FG002|Track 2|Disease Progression|19|||
46718583|NCT02996110|82934753|FG003|Track 2|Disease Progression|16|||
46718584|NCT02996110|82934754|FG004|Track 2|Disease Progression|15|||
46718585|NCT02996110|82934750|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
46718586|NCT02996110|82934751|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
46718587|NCT02996110|82934752|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
46718588|NCT02996110|82934753|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
46718589|NCT02996110|82934754|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
46718590|NCT02996110|82934750|FG000|Track 2|Death|0|||
46718591|NCT02996110|82934751|FG001|Track 2|Death|0|||
46718592|NCT02996110|82934752|FG002|Track 2|Death|1|||
46718593|NCT02996110|82934753|FG003|Track 2|Death|0|||
47040109|NCT01609556|83293182|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040110|NCT01609556|83293183|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040111|NCT01609556|83293184|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
47040112|NCT01609556|83293185|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040113|NCT01609556|83293186|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040114|NCT01609556|83293187|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
47040115|NCT01763996|83293561|FG000|Treatment Period 2|Adverse Event|0|||
47040116|NCT01763996|83293562|FG001|Treatment Period 2|Adverse Event|1|||
47040117|NCT01468701|83293994|FG000|Overall Study|Not eligible|91|||
47040118|NCT01468701|83293995|FG001|Overall Study|Not eligible|140|||
47040119|NCT01468701|83293996|FG002|Overall Study|Not eligible|29|||
47040120|NCT01468701|83293997|FG003|Overall Study|Not eligible|12|||
47040121|NCT01468701|83293998|FG004|Overall Study|Not eligible|22|||
47040122|NCT01468701|83293999|FG005|Overall Study|Not eligible|2|||
47040123|NCT01468701|83294000|FG006|Overall Study|Not eligible|39|||
47040124|NCT01468701|83294001|FG007|Overall Study|Not eligible|1|||
47040125|NCT01468701|83294002|FG008|Overall Study|Not eligible|40|||
47040126|NCT01468701|83294003|FG009|Overall Study|Not eligible|126|||
47040127|NCT01468701|83294004|FG010|Overall Study|Not eligible|39|||
47040128|NCT01468701|83294005|FG011|Overall Study|Not eligible|33|||
47040129|NCT01468701|83294006|FG012|Overall Study|Not eligible|1|||
47040130|NCT01468701|83294007|FG013|Overall Study|Not eligible|19|||
47040131|NCT01468701|83294008|FG014|Overall Study|Not eligible|1|||
47040132|NCT01468701|83294009|FG015|Overall Study|Not eligible|32|||
47040133|NCT01468701|83294010|FG016|Overall Study|Not eligible|0|||
47040134|NCT01468701|83293994|FG000|Overall Study|Lost to Follow-up|306|||
47040135|NCT01468701|83293995|FG001|Overall Study|Lost to Follow-up|0|||
47040136|NCT01468701|83293996|FG002|Overall Study|Lost to Follow-up|0|||
47040137|NCT01468701|83293997|FG003|Overall Study|Lost to Follow-up|0|||
47040138|NCT01468701|83293998|FG004|Overall Study|Lost to Follow-up|0|||
47040139|NCT01468701|83293999|FG005|Overall Study|Lost to Follow-up|0|||
47040140|NCT01468701|83294000|FG006|Overall Study|Lost to Follow-up|0|||
47040141|NCT01468701|83294001|FG007|Overall Study|Lost to Follow-up|0|||
47040142|NCT01468701|83294002|FG008|Overall Study|Lost to Follow-up|215|||
47040143|NCT01468701|83294003|FG009|Overall Study|Lost to Follow-up|309|||
47040144|NCT01468701|83294004|FG010|Overall Study|Lost to Follow-up|224|||
47040145|NCT01468701|83294005|FG011|Overall Study|Lost to Follow-up|212|||
47040146|NCT01468701|83294006|FG012|Overall Study|Lost to Follow-up|11|||
47040147|NCT01468701|83294007|FG013|Overall Study|Lost to Follow-up|164|||
47040148|NCT01468701|83294008|FG014|Overall Study|Lost to Follow-up|17|||
47040149|NCT01468701|83294009|FG015|Overall Study|Lost to Follow-up|127|||
47040150|NCT01468701|83294010|FG016|Overall Study|Lost to Follow-up|1|||
46718594|NCT02996110|82934754|FG004|Track 2|Death|1|||
47040151|NCT01468701|83293994|FG000|Overall Study|Withdrawal by Subject|165|||
47040152|NCT01468701|83293995|FG001|Overall Study|Withdrawal by Subject|0|||
47040153|NCT01468701|83293996|FG002|Overall Study|Withdrawal by Subject|0|||
46718595|NCT02996110|82934750|FG000|Track 2|Study Drug Toxicity|4|||
46718596|NCT02996110|82934751|FG001|Track 2|Study Drug Toxicity|1|||
46718597|NCT02996110|82934752|FG002|Track 2|Study Drug Toxicity|4|||
47040154|NCT01468701|83293997|FG003|Overall Study|Withdrawal by Subject|0|||
47040155|NCT01468701|83293998|FG004|Overall Study|Withdrawal by Subject|0|||
47040156|NCT01468701|83293999|FG005|Overall Study|Withdrawal by Subject|0|||
47040157|NCT01468701|83294000|FG006|Overall Study|Withdrawal by Subject|0|||
47040158|NCT01468701|83294001|FG007|Overall Study|Withdrawal by Subject|0|||
47040159|NCT01468701|83294002|FG008|Overall Study|Withdrawal by Subject|83|||
47040160|NCT01468701|83294003|FG009|Overall Study|Withdrawal by Subject|88|||
47040161|NCT01468701|83294004|FG010|Overall Study|Withdrawal by Subject|100|||
47040162|NCT01468701|83294005|FG011|Overall Study|Withdrawal by Subject|114|||
47040163|NCT01468701|83294006|FG012|Overall Study|Withdrawal by Subject|9|||
47040164|NCT01468701|83294007|FG013|Overall Study|Withdrawal by Subject|47|||
47040165|NCT01468701|83294008|FG014|Overall Study|Withdrawal by Subject|6|||
47040166|NCT01468701|83294009|FG015|Overall Study|Withdrawal by Subject|31|||
47040167|NCT01468701|83294010|FG016|Overall Study|Withdrawal by Subject|0|||
47040168|NCT01468701|83293994|FG000|Overall Study|Other reasons than listed|437|||
47040169|NCT01468701|83293995|FG001|Overall Study|Other reasons than listed|0|||
47040170|NCT01468701|83293996|FG002|Overall Study|Other reasons than listed|0|||
47040171|NCT01468701|83293997|FG003|Overall Study|Other reasons than listed|0|||
47040172|NCT01468701|83293998|FG004|Overall Study|Other reasons than listed|0|||
47040173|NCT01468701|83293999|FG005|Overall Study|Other reasons than listed|0|||
47040174|NCT01468701|83294000|FG006|Overall Study|Other reasons than listed|0|||
47040175|NCT01468701|83294001|FG007|Overall Study|Other reasons than listed|0|||
47040176|NCT01468701|83294002|FG008|Overall Study|Other reasons than listed|318|||
47040177|NCT01468701|83294003|FG009|Overall Study|Other reasons than listed|658|||
47040178|NCT01468701|83294004|FG010|Overall Study|Other reasons than listed|433|||
47040179|NCT01468701|83294005|FG011|Overall Study|Other reasons than listed|504|||
47040180|NCT01468701|83294006|FG012|Overall Study|Other reasons than listed|28|||
46718598|NCT02996110|82934753|FG003|Track 2|Study Drug Toxicity|1|||
46718599|NCT02996110|82934754|FG004|Track 2|Study Drug Toxicity|0|||
46718600|NCT02996110|82934750|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
46718601|NCT02996110|82934751|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
46718602|NCT02996110|82934752|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
46718603|NCT02996110|82934753|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
46718604|NCT02996110|82934754|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
46718605|NCT02996110|82934750|FG000|Track 2|Participant Withdrew Consent|1|||
47040181|NCT01468701|83294007|FG013|Overall Study|Other reasons than listed|239|||
47040182|NCT01468701|83294008|FG014|Overall Study|Other reasons than listed|39|||
47040183|NCT01468701|83294009|FG015|Overall Study|Other reasons than listed|172|||
47040184|NCT01468701|83294010|FG016|Overall Study|Other reasons than listed|0|||
47040185|NCT01468701|83293994|FG000|Overall Study|No end of study case report form|0|||
47040186|NCT01468701|83293995|FG001|Overall Study|No end of study case report form|0|||
47040187|NCT01468701|83293996|FG002|Overall Study|No end of study case report form|0|||
47040188|NCT01468701|83293997|FG003|Overall Study|No end of study case report form|0|||
47040189|NCT01468701|83293998|FG004|Overall Study|No end of study case report form|0|||
47040190|NCT01468701|83293999|FG005|Overall Study|No end of study case report form|0|||
47040191|NCT01468701|83294000|FG006|Overall Study|No end of study case report form|0|||
47040192|NCT01468701|83294001|FG007|Overall Study|No end of study case report form|0|||
47040193|NCT01468701|83294002|FG008|Overall Study|No end of study case report form|4|||
47040194|NCT01468701|83294003|FG009|Overall Study|No end of study case report form|1|||
46718606|NCT02996110|82934751|FG001|Track 2|Participant Withdrew Consent|2|||
46718607|NCT02996110|82934752|FG002|Track 2|Participant Withdrew Consent|3|||
46718608|NCT02996110|82934753|FG003|Track 2|Participant Withdrew Consent|1|||
46718609|NCT02996110|82934754|FG004|Track 2|Participant Withdrew Consent|1|||
46718610|NCT02996110|82934750|FG000|Track 2|Other Reasons|0|||
47040195|NCT01468701|83294004|FG010|Overall Study|No end of study case report form|2|||
47040196|NCT01468701|83294005|FG011|Overall Study|No end of study case report form|3|||
47040197|NCT01468701|83294006|FG012|Overall Study|No end of study case report form|0|||
47040198|NCT01468701|83294007|FG013|Overall Study|No end of study case report form|1|||
47040199|NCT01468701|83294008|FG014|Overall Study|No end of study case report form|0|||
47040200|NCT01468701|83294009|FG015|Overall Study|No end of study case report form|0|||
47040201|NCT01468701|83294010|FG016|Overall Study|No end of study case report form|0|||
47040202|NCT01468701|83293994|FG000|Overall Study|Not being followed up|0|||
47040203|NCT01468701|83293995|FG001|Overall Study|Not being followed up|4963|||
47040204|NCT01468701|83293996|FG002|Overall Study|Not being followed up|1755|||
47040205|NCT01468701|83293997|FG003|Overall Study|Not being followed up|703|||
47040206|NCT01468701|83293998|FG004|Overall Study|Not being followed up|1714|||
47040207|NCT01468701|83293999|FG005|Overall Study|Not being followed up|126|||
46632008|NCT01846416|82805148|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
46632009|NCT01846416|82805149|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
46632010|NCT01846416|82805150|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
46632011|NCT01846416|82805148|FG000|Treatment Phase|Progressive Disease|21|||
46632012|NCT01846416|82805149|FG001|Treatment Phase|Progressive Disease|63|||
46632013|NCT01846416|82805150|FG002|Treatment Phase|Progressive Disease|9|||
46632014|NCT01846416|82805148|FG000|Survival Follow-up|Death|21|||
46632015|NCT01846416|82805149|FG001|Survival Follow-up|Death|62|||
46718611|NCT02996110|82934751|FG001|Track 2|Other Reasons|0|||
46718612|NCT02996110|82934752|FG002|Track 2|Other Reasons|1|||
46718613|NCT02996110|82934753|FG003|Track 2|Other Reasons|0|||
46718614|NCT02996110|82934754|FG004|Track 2|Other Reasons|1|||
46718615|NCT00916617|82934772|FG000|Overall Study|Adverse Event|3|||
46718616|NCT00916617|82934773|FG001|Overall Study|Adverse Event|2|||
46718617|NCT00916617|82934774|FG002|Overall Study|Adverse Event|6|||
46718618|NCT00916617|82934775|FG003|Overall Study|Adverse Event|3|||
46718619|NCT00916617|82934772|FG000|Overall Study|Withdrawal by Subject|3|||
46718620|NCT00916617|82934773|FG001|Overall Study|Withdrawal by Subject|2|||
46718621|NCT00916617|82934774|FG002|Overall Study|Withdrawal by Subject|0|||
46718622|NCT00916617|82934775|FG003|Overall Study|Withdrawal by Subject|1|||
46718623|NCT00916617|82934772|FG000|Overall Study|Caregiver Request|3|||
46718624|NCT00916617|82934773|FG001|Overall Study|Caregiver Request|2|||
46718625|NCT00916617|82934774|FG002|Overall Study|Caregiver Request|1|||
46718626|NCT00916617|82934775|FG003|Overall Study|Caregiver Request|0|||
46718627|NCT00916617|82934772|FG000|Overall Study|Physician Decision|1|||
46718628|NCT00916617|82934773|FG001|Overall Study|Physician Decision|1|||
46718629|NCT00916617|82934774|FG002|Overall Study|Physician Decision|0|||
46718630|NCT00916617|82934775|FG003|Overall Study|Physician Decision|0|||
46718631|NCT00916617|82934772|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
46718632|NCT00916617|82934773|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
46718633|NCT00916617|82934774|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
46718634|NCT00916617|82934775|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
46718635|NCT00916617|82934772|FG000|Overall Study|Lost to Follow-up|2|||
46718636|NCT00916617|82934773|FG001|Overall Study|Lost to Follow-up|1|||
46718637|NCT00916617|82934774|FG002|Overall Study|Lost to Follow-up|0|||
46718638|NCT00916617|82934775|FG003|Overall Study|Lost to Follow-up|0|||
46718639|NCT00916617|82934772|FG000|Overall Study|Lack of Efficacy|1|||
46718640|NCT00916617|82934773|FG001|Overall Study|Lack of Efficacy|0|||
46718641|NCT00916617|82934774|FG002|Overall Study|Lack of Efficacy|0|||
46718642|NCT00916617|82934775|FG003|Overall Study|Lack of Efficacy|0|||
46718643|NCT00916617|82934772|FG000|Overall Study|Other|2|||
46718644|NCT00916617|82934773|FG001|Overall Study|Other|0|||
46718645|NCT00916617|82934774|FG002|Overall Study|Other|0|||
46718646|NCT00916617|82934775|FG003|Overall Study|Other|2|||
46718647|NCT01103063|82934787|FG000|Overall Study|Adverse Event|3|||
46718648|NCT01103063|82934788|FG001|Overall Study|Adverse Event|1|||
46718649|NCT01103063|82934787|FG000|Overall Study|Lost to Follow-up|68|||
46718650|NCT01103063|82934788|FG001|Overall Study|Lost to Follow-up|51|||
46718651|NCT01103063|82934787|FG000|Overall Study|Withdrawal by Subject|60|||
46718652|NCT01103063|82934788|FG001|Overall Study|Withdrawal by Subject|15|||
46718653|NCT01103063|82934787|FG000|Overall Study|Other|16|||
46718654|NCT01103063|82934788|FG001|Overall Study|Other|11|||
46718655|NCT01103063|82934787|FG000|Overall Study|Protocol Violation|1|||
46718656|NCT01103063|82934788|FG001|Overall Study|Protocol Violation|0|||
46718657|NCT01103063|82934787|FG000|Overall Study|Study terminated by Sponsor|326|||
46718658|NCT01103063|82934788|FG001|Overall Study|Study terminated by Sponsor|342|||
46718659|NCT01103063|82934787|FG000|Overall Study|Death|3|||
46718660|NCT01103063|82934788|FG001|Overall Study|Death|1|||
46718661|NCT01091675|82934796|FG000|Overall Study|Adverse Event|7|||
46718662|NCT01091675|82934796|FG000|Overall Study|Lack of Efficacy|27|||
46718663|NCT01091519|82934802|FG000|Overall Study|Adverse Event|12|||
46718664|NCT01091519|82934803|FG001|Overall Study|Adverse Event|16|||
46718665|NCT01091519|82934802|FG000|Overall Study|Death|1|||
46718666|NCT01091519|82934803|FG001|Overall Study|Death|0|||
46718667|NCT01091519|82934802|FG000|Overall Study|Lack of Efficacy|16|||
46718668|NCT01091519|82934803|FG001|Overall Study|Lack of Efficacy|19|||
46718669|NCT01091519|82934802|FG000|Overall Study|Lost to Follow-up|14|||
46718670|NCT01091519|82934803|FG001|Overall Study|Lost to Follow-up|24|||
46718671|NCT01091519|82934802|FG000|Overall Study|Withdrawal by Subject|2|||
46718672|NCT01091519|82934803|FG001|Overall Study|Withdrawal by Subject|2|||
46718673|NCT01091519|82934802|FG000|Overall Study|Other|6|||
46718674|NCT01091519|82934803|FG001|Overall Study|Other|8|||
46718675|NCT01091519|82934802|FG000|Overall Study|Randomized not treated|4|||
46718676|NCT01091519|82934803|FG001|Overall Study|Randomized not treated|4|||
46718677|NCT01011738|82934812|FG000|Overall Study|Death|12|||
46718678|NCT01011738|82934813|FG001|Overall Study|Death|3|||
46718679|NCT01011738|82934814|FG002|Overall Study|Death|0|||
46718680|NCT01011738|82934812|FG000|Overall Study|Unknown reasons|312|||
46718681|NCT01011738|82934813|FG001|Overall Study|Unknown reasons|291|||
46718682|NCT01011738|82934814|FG002|Overall Study|Unknown reasons|17|||
46718683|NCT00918333|82934825|FG000|Overall Study|Drug not taken per protocol|1|||
46718684|NCT00918333|82934826|FG001|Overall Study|Drug not taken per protocol|0|||
46718685|NCT00918333|82934825|FG000|Overall Study|Inadequate amount of drugs provided|1|||
46718686|NCT00918333|82934826|FG001|Overall Study|Inadequate amount of drugs provided|4|||
46718687|NCT00918333|82934825|FG000|Overall Study|Ineligible|1|||
46718688|NCT00918333|82934826|FG001|Overall Study|Ineligible|0|||
46718689|NCT00918333|82934825|FG000|Overall Study|Withdrawal by Subject|0|||
46718690|NCT00918333|82934826|FG001|Overall Study|Withdrawal by Subject|1|||
46718691|NCT01091363|82934837|FG000|Overall Study|Withdrawal by Subject|11|||
46718692|NCT01091363|82934838|FG001|Overall Study|Withdrawal by Subject|15|||
46718693|NCT01091363|82934837|FG000|Overall Study|Lost to Follow-up|2|||
46718694|NCT01091363|82934838|FG001|Overall Study|Lost to Follow-up|2|||
46718695|NCT01090973|82934844|FG000|Overall Study|Disease progression|1|||
47040208|NCT01468701|83294000|FG006|Overall Study|Not being followed up|1170|||
47040209|NCT01468701|83294001|FG007|Overall Study|Not being followed up|4|||
47040210|NCT01468701|83294002|FG008|Overall Study|Not being followed up|0|||
47040211|NCT01468701|83294003|FG009|Overall Study|Not being followed up|0|||
47040212|NCT01468701|83294004|FG010|Overall Study|Not being followed up|0|||
47040213|NCT01468701|83294005|FG011|Overall Study|Not being followed up|0|||
47040214|NCT01468701|83294006|FG012|Overall Study|Not being followed up|0|||
47040215|NCT01468701|83294007|FG013|Overall Study|Not being followed up|0|||
47040216|NCT01468701|83294008|FG014|Overall Study|Not being followed up|0|||
47040217|NCT01468701|83294009|FG015|Overall Study|Not being followed up|0|||
47040218|NCT01468701|83294010|FG016|Overall Study|Not being followed up|0|||
47040219|NCT01492101|83294025|FG000|Overall Study|Death|323|||
47040220|NCT01492101|83294026|FG001|Overall Study|Death|322|||
47040221|NCT01492101|83294025|FG000|Overall Study|Withdrawal by Subject|14|||
47040222|NCT01492101|83294026|FG001|Overall Study|Withdrawal by Subject|18|||
47040223|NCT01492101|83294025|FG000|Overall Study|Lost to Follow-up|0|||
47040224|NCT01492101|83294026|FG001|Overall Study|Lost to Follow-up|2|||
47040225|NCT01468311|83294032|FG000|Overall Study|mobilization failure|1|||
47040226|NCT01468311|83294032|FG000|Overall Study|Withdrawal by Subject|1|||
47040227|NCT01730534|83294143|FG000|Overall Study|Withdrawal by Subject|97|||
47040228|NCT01730534|83294144|FG001|Overall Study|Withdrawal by Subject|127|||
47040229|NCT01730534|83294143|FG000|Overall Study|Lost to Follow-up|12|||
47040230|NCT01730534|83294144|FG001|Overall Study|Lost to Follow-up|18|||
47040231|NCT01783730|83294164|FG000|Overall Study|Failed to meet inclusion criteria|6|||
47040232|NCT01730378|83294170|FG000|Overall Study|Lost to Follow-up|1|||
47040233|NCT01730378|83294171|FG001|Overall Study|Lost to Follow-up|0|||
47040234|NCT01783496|83294184|FG000|Overall Study|Lost to Follow-up|0|||
47040235|NCT01783496|83294185|FG001|Overall Study|Lost to Follow-up|0|||
47040236|NCT01783496|83294186|FG002|Overall Study|Lost to Follow-up|0|||
47040237|NCT01783496|83294187|FG003|Overall Study|Lost to Follow-up|2|||
47040238|NCT01783496|83294188|FG004|Overall Study|Lost to Follow-up|0|||
47040239|NCT01783496|83294189|FG005|Overall Study|Lost to Follow-up|1|||
47040240|NCT01783496|83294184|FG000|Overall Study|Withdrawal by Subject|1|||
47040241|NCT01783496|83294185|FG001|Overall Study|Withdrawal by Subject|0|||
47040242|NCT01783496|83294186|FG002|Overall Study|Withdrawal by Subject|0|||
47040243|NCT01783496|83294187|FG003|Overall Study|Withdrawal by Subject|0|||
47040244|NCT01783496|83294188|FG004|Overall Study|Withdrawal by Subject|0|||
47040245|NCT01783496|83294189|FG005|Overall Study|Withdrawal by Subject|0|||
47040246|NCT01729208|83294214|FG000|Baseline|Physician Decision|5|||
47040247|NCT01729208|83294215|FG001|Baseline|Physician Decision|4|||
47040248|NCT01729208|83294214|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
47040249|NCT01729208|83294215|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
47040250|NCT01729208|83294214|FG000|12 Months Follow-up|Lost to Follow-up|3|||
46632016|NCT01846416|82805150|FG002|Survival Follow-up|Death|9|||
46632017|NCT01846416|82805148|FG000|Survival Follow-up|Lost to Follow-up|0|||
46632018|NCT01846416|82805149|FG001|Survival Follow-up|Lost to Follow-up|2|||
46632019|NCT01846416|82805150|FG002|Survival Follow-up|Lost to Follow-up|2|||
46632020|NCT01846416|82805148|FG000|Survival Follow-up|Withdrawal by Subject|2|||
46632021|NCT01846416|82805149|FG001|Survival Follow-up|Withdrawal by Subject|7|||
46632022|NCT01846416|82805150|FG002|Survival Follow-up|Withdrawal by Subject|0|||
46632023|NCT01846416|82805148|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
46632024|NCT01846416|82805149|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
46632025|NCT01846416|82805150|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
46632026|NCT01846416|82805148|FG000|Survival Follow-up|Other|3|||
46632027|NCT01846416|82805149|FG001|Survival Follow-up|Other|1|||
46632028|NCT01846416|82805150|FG002|Survival Follow-up|Other|1|||
46718696|NCT01090739|82934848|FG000|Enrollment|Withdrawal by Subject|24|||
47040251|NCT01729208|83294215|FG001|12 Months Follow-up|Lost to Follow-up|3|||
47040252|NCT01729208|83294214|FG000|24 Months Follow-up|Lost to Follow-up|3|||
47040253|NCT01729208|83294215|FG001|24 Months Follow-up|Lost to Follow-up|0|||
47040254|NCT01729208|83294214|FG000|36 Months Follow-up|Physician Decision|1|||
47040255|NCT01729208|83294215|FG001|36 Months Follow-up|Physician Decision|0|||
47040256|NCT01729208|83294214|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
47040257|NCT01729208|83294215|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
47040258|NCT01609010|83294232|FG000|Overall Study|Stable disease (SD)|22|||
47040259|NCT01609010|83294233|FG001|Overall Study|Stable disease (SD)|16|||
47040260|NCT01609010|83294232|FG000|Overall Study|Progressive disease (PD)|8|||
46632029|NCT01865448|82805161|FG000|Overall Study|Adverse Event|1|||
46632030|NCT01865448|82805162|FG001|Overall Study|Adverse Event|1|||
46632031|NCT01865448|82805161|FG000|Overall Study|Pregnancy|0|||
46718697|NCT01090739|82934848|FG000|Enrollment|Protocol Violation|14|||
47040261|NCT01609010|83294233|FG001|Overall Study|Progressive disease (PD)|10|||
47040262|NCT01609010|83294232|FG000|Overall Study|Adverse Event|3|||
46632032|NCT01865448|82805162|FG001|Overall Study|Pregnancy|1|||
46718698|NCT01090739|82934848|FG000|Enrollment|Lost to Follow-up|5|||
46718699|NCT01090739|82934848|FG000|Enrollment|Physician Decision|5|||
46718700|NCT01090739|82934848|FG000|Enrollment|Sponsor termination of site|4|||
46718701|NCT01090739|82934848|FG000|Enrollment|Study implant limit reached|2|||
46718702|NCT01090739|82934848|FG000|Enrollment|Adverse Event|1|||
46718703|NCT01090739|82934848|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
46718704|NCT01090739|82934848|FG000|12 Month Follow-up|Lost to Follow-up|1|||
46718705|NCT01090739|82934848|FG000|12 Month Follow-up|Physician Decision|1|||
46718706|NCT01090739|82934848|FG000|12 Month Follow-up|Death|1|||
46718707|NCT01090739|82934848|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
46718708|NCT01090739|82934848|FG000|24 Month Follow-up|Lost to Follow-up|1|||
46718709|NCT01090739|82934848|FG000|24 Month Follow-up|Death|1|||
46718710|NCT01090739|82934848|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
46718711|NCT01090739|82934848|FG000|36 Month Follow-up|Visit still pending|17|||
46718712|NCT00916383|82934866|FG000|Overall Study|Adverse Event|1|||
46718713|NCT00916383|82934866|FG000|Overall Study|Death|1|||
46718714|NCT00916383|82934866|FG000|Overall Study|Protocol Violation|1|||
46718715|NCT00916305|82934876|FG000|Overall Study|Lost to Follow-up|21|||
46718716|NCT00916305|82934877|FG001|Overall Study|Lost to Follow-up|27|||
46718717|NCT00916305|82934876|FG000|Overall Study|Withdrawal by Subject|0|||
46718718|NCT00916305|82934877|FG001|Overall Study|Withdrawal by Subject|1|||
46718719|NCT00916149|82934886|FG000|Overall Study|Lost to Follow-up|3|||
46718720|NCT00916149|82934887|FG001|Overall Study|Lost to Follow-up|2|||
46718721|NCT00916149|82934888|FG002|Overall Study|Lost to Follow-up|0|||
46718722|NCT00916149|82934886|FG000|Overall Study|Unable to place scalp EEG leads|1|||
46718723|NCT00916149|82934887|FG001|Overall Study|Unable to place scalp EEG leads|0|||
46718724|NCT00916149|82934888|FG002|Overall Study|Unable to place scalp EEG leads|0|||
46718725|NCT01090427|82934898|FG000|After Controlled Period|Death|0|||
46718726|NCT01090427|82934899|FG001|After Controlled Period|Death|0|||
46718727|NCT01090427|82934900|FG002|After Controlled Period|Death|0|||
46718728|NCT01090427|82934901|FG003|After Controlled Period|Death|0|||
46718729|NCT01090427|82934902|FG004|After Controlled Period|Death|0|||
46718730|NCT01090427|82934903|FG005|After Controlled Period|Death|1|||
46718731|NCT01090427|82934904|FG006|After Controlled Period|Death|0|||
46718732|NCT01090427|82934898|FG000|After Controlled Period|Lack of Efficacy|0|||
47040263|NCT01609010|83294233|FG001|Overall Study|Adverse Event|6|||
46718733|NCT01090427|82934899|FG001|After Controlled Period|Lack of Efficacy|0|||
46718734|NCT01090427|82934900|FG002|After Controlled Period|Lack of Efficacy|0|||
46718735|NCT01090427|82934901|FG003|After Controlled Period|Lack of Efficacy|0|||
46718736|NCT01090427|82934902|FG004|After Controlled Period|Lack of Efficacy|0|||
46718737|NCT01090427|82934903|FG005|After Controlled Period|Lack of Efficacy|3|||
46718738|NCT01090427|82934904|FG006|After Controlled Period|Lack of Efficacy|2|||
46718739|NCT01090427|82934898|FG000|After Controlled Period|Adverse Event|0|||
46718740|NCT01090427|82934899|FG001|After Controlled Period|Adverse Event|0|||
46718741|NCT01090427|82934900|FG002|After Controlled Period|Adverse Event|0|||
46718742|NCT01090427|82934901|FG003|After Controlled Period|Adverse Event|2|||
46718743|NCT01090427|82934902|FG004|After Controlled Period|Adverse Event|0|||
46718744|NCT01090427|82934903|FG005|After Controlled Period|Adverse Event|1|||
46718745|NCT01090427|82934904|FG006|After Controlled Period|Adverse Event|0|||
46718746|NCT01016262|82934928|FG000|Double-blind Phase|Adverse Event|0|||
46718747|NCT01016262|82934929|FG001|Double-blind Phase|Adverse Event|0|||
46718748|NCT01016262|82934930|FG002|Double-blind Phase|Adverse Event|1|||
46718749|NCT01016262|82934931|FG003|Double-blind Phase|Adverse Event|0|||
46718750|NCT01016262|82934932|FG004|Double-blind Phase|Adverse Event|0|||
46718751|NCT01016262|82934933|FG005|Double-blind Phase|Adverse Event|0|||
47040264|NCT01609010|83294232|FG000|Overall Study|Withdrawal by Subject|2|||
46632033|NCT01865448|82805161|FG000|Overall Study|dropout unrelated to study|1|||
46632034|NCT01865448|82805162|FG001|Overall Study|dropout unrelated to study|1|||
46632035|NCT01804140|82805169|FG000|Overall Study|No sampling or biopsy procedures done|114|||
46632036|NCT01846104|82805173|FG000|Overall Study|Withdrawal by Subject|1|||
46632037|NCT01803282|82805189|FG000|Overall Study|Progressive Disease|4|||
46632038|NCT01803282|82805190|FG001|Overall Study|Progressive Disease|3|||
46632039|NCT01803282|82805191|FG002|Overall Study|Progressive Disease|6|||
46632040|NCT01803282|82805192|FG003|Overall Study|Progressive Disease|22|||
46632041|NCT01803282|82805193|FG004|Overall Study|Progressive Disease|5|||
46632042|NCT01803282|82805194|FG005|Overall Study|Progressive Disease|8|||
46718752|NCT01016262|82934928|FG000|Double-blind Phase|Lack of Efficacy|1|||
46718753|NCT01016262|82934929|FG001|Double-blind Phase|Lack of Efficacy|0|||
46718754|NCT01016262|82934930|FG002|Double-blind Phase|Lack of Efficacy|5|||
46718755|NCT01016262|82934931|FG003|Double-blind Phase|Lack of Efficacy|0|||
46632043|NCT01803282|82805195|FG006|Overall Study|Progressive Disease|23|||
46718756|NCT01016262|82934932|FG004|Double-blind Phase|Lack of Efficacy|0|||
46718757|NCT01016262|82934933|FG005|Double-blind Phase|Lack of Efficacy|0|||
46718758|NCT01016262|82934928|FG000|Double-blind Phase|Disease Progression|0|||
46632044|NCT01803282|82805196|FG007|Overall Study|Progressive Disease|24|||
46718759|NCT01016262|82934929|FG001|Double-blind Phase|Disease Progression|1|||
46718760|NCT01016262|82934930|FG002|Double-blind Phase|Disease Progression|2|||
46718761|NCT01016262|82934931|FG003|Double-blind Phase|Disease Progression|0|||
46718762|NCT01016262|82934932|FG004|Double-blind Phase|Disease Progression|0|||
46718763|NCT01016262|82934933|FG005|Double-blind Phase|Disease Progression|0|||
46718764|NCT01016262|82934928|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
46718765|NCT01016262|82934929|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
46718766|NCT01016262|82934930|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
46718767|NCT01016262|82934931|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
47040265|NCT01609010|83294233|FG001|Overall Study|Withdrawal by Subject|2|||
47040266|NCT01609010|83294232|FG000|Overall Study|Other|2|||
47040267|NCT01609010|83294233|FG001|Overall Study|Other|0|||
47040268|NCT01609010|83294232|FG000|Overall Study|Other malignancy|1|||
47040269|NCT01609010|83294233|FG001|Overall Study|Other malignancy|0|||
47040270|NCT01609010|83294232|FG000|Overall Study|Pathology review|2|||
47040271|NCT01609010|83294233|FG001|Overall Study|Pathology review|1|||
47040272|NCT01609010|83294232|FG000|Overall Study|Protocol Violation|1|||
47040273|NCT01609010|83294233|FG001|Overall Study|Protocol Violation|1|||
47040274|NCT01609010|83294232|FG000|Overall Study|New cancer|1|||
47040275|NCT01609010|83294233|FG001|Overall Study|New cancer|0|||
47040276|NCT01609010|83294232|FG000|Overall Study|Lost to Follow-up|1|||
47040277|NCT01609010|83294233|FG001|Overall Study|Lost to Follow-up|1|||
47040278|NCT01608308|83294241|FG000|Overall Study|pretreatment medical and billing reasons|0|||
47040279|NCT01608308|83294242|FG001|Overall Study|pretreatment medical and billing reasons|2|||
47040280|NCT01755416|83294273|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
47040281|NCT01755416|83294274|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
47040282|NCT01755026|83294282|FG000|Overall Study|Adverse Event|1|||
47040283|NCT01755026|83294283|FG001|Overall Study|Adverse Event|0|||
47040284|NCT01755026|83294282|FG000|Overall Study|Withdrawal by Subject|1|||
46632045|NCT01803282|82805197|FG008|Overall Study|Progressive Disease|3|||
46632046|NCT01803282|82805198|FG009|Overall Study|Progressive Disease|29|||
46632047|NCT01803282|82805199|FG010|Overall Study|Progressive Disease|6|||
46632048|NCT01803282|82805200|FG011|Overall Study|Progressive Disease|11|||
46632049|NCT01803282|82805189|FG000|Overall Study|Death|0|||
46632050|NCT01803282|82805190|FG001|Overall Study|Death|0|||
46632051|NCT01803282|82805191|FG002|Overall Study|Death|0|||
46632052|NCT01803282|82805192|FG003|Overall Study|Death|0|||
46632053|NCT01803282|82805193|FG004|Overall Study|Death|2|||
46632054|NCT01803282|82805194|FG005|Overall Study|Death|1|||
46632055|NCT01803282|82805195|FG006|Overall Study|Death|1|||
46632056|NCT01803282|82805196|FG007|Overall Study|Death|5|||
46632057|NCT01803282|82805197|FG008|Overall Study|Death|1|||
46632058|NCT01803282|82805198|FG009|Overall Study|Death|1|||
46632059|NCT01803282|82805199|FG010|Overall Study|Death|0|||
46632060|NCT01803282|82805200|FG011|Overall Study|Death|0|||
46632061|NCT01803282|82805189|FG000|Overall Study|Withdrew Consent|0|||
46632062|NCT01803282|82805190|FG001|Overall Study|Withdrew Consent|0|||
46632063|NCT01803282|82805191|FG002|Overall Study|Withdrew Consent|0|||
46632064|NCT01803282|82805192|FG003|Overall Study|Withdrew Consent|6|||
46632065|NCT01803282|82805193|FG004|Overall Study|Withdrew Consent|1|||
46632066|NCT01803282|82805194|FG005|Overall Study|Withdrew Consent|0|||
46632067|NCT01803282|82805195|FG006|Overall Study|Withdrew Consent|8|||
46632068|NCT01803282|82805196|FG007|Overall Study|Withdrew Consent|3|||
46632069|NCT01803282|82805197|FG008|Overall Study|Withdrew Consent|1|||
46632070|NCT01803282|82805198|FG009|Overall Study|Withdrew Consent|5|||
46632071|NCT01803282|82805199|FG010|Overall Study|Withdrew Consent|0|||
46632072|NCT01803282|82805200|FG011|Overall Study|Withdrew Consent|1|||
46632073|NCT01803282|82805189|FG000|Overall Study|Investigator's Discretion|0|||
46632074|NCT01803282|82805190|FG001|Overall Study|Investigator's Discretion|0|||
46632075|NCT01803282|82805191|FG002|Overall Study|Investigator's Discretion|0|||
46632076|NCT01803282|82805192|FG003|Overall Study|Investigator's Discretion|7|||
46632077|NCT01803282|82805193|FG004|Overall Study|Investigator's Discretion|2|||
46632078|NCT01803282|82805194|FG005|Overall Study|Investigator's Discretion|1|||
46632079|NCT01803282|82805195|FG006|Overall Study|Investigator's Discretion|7|||
46632080|NCT01803282|82805196|FG007|Overall Study|Investigator's Discretion|10|||
46632081|NCT01803282|82805197|FG008|Overall Study|Investigator's Discretion|6|||
46632082|NCT01803282|82805198|FG009|Overall Study|Investigator's Discretion|7|||
46632083|NCT01803282|82805199|FG010|Overall Study|Investigator's Discretion|1|||
46632084|NCT01803282|82805200|FG011|Overall Study|Investigator's Discretion|0|||
46632085|NCT01803282|82805189|FG000|Overall Study|Adverse Event|0|||
46632086|NCT01803282|82805190|FG001|Overall Study|Adverse Event|0|||
46632087|NCT01803282|82805191|FG002|Overall Study|Adverse Event|0|||
46632088|NCT01803282|82805192|FG003|Overall Study|Adverse Event|0|||
46632089|NCT01803282|82805193|FG004|Overall Study|Adverse Event|0|||
46632090|NCT01803282|82805194|FG005|Overall Study|Adverse Event|0|||
46632091|NCT01803282|82805195|FG006|Overall Study|Adverse Event|1|||
46632092|NCT01803282|82805196|FG007|Overall Study|Adverse Event|2|||
46632093|NCT01803282|82805197|FG008|Overall Study|Adverse Event|0|||
46632094|NCT01803282|82805198|FG009|Overall Study|Adverse Event|1|||
46632095|NCT01803282|82805199|FG010|Overall Study|Adverse Event|0|||
46632096|NCT01803282|82805200|FG011|Overall Study|Adverse Event|3|||
46632097|NCT01803282|82805189|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46718768|NCT01016262|82934932|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
46718769|NCT01016262|82934933|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
46718770|NCT01016262|82934928|FG000|Open-Label Phase|Adverse Event|0|||
46718771|NCT01016262|82934929|FG001|Open-Label Phase|Adverse Event|0|||
46718772|NCT01016262|82934930|FG002|Open-Label Phase|Adverse Event|0|||
46718773|NCT01016262|82934931|FG003|Open-Label Phase|Adverse Event|1|||
46718774|NCT01016262|82934932|FG004|Open-Label Phase|Adverse Event|0|||
46718775|NCT01016262|82934933|FG005|Open-Label Phase|Adverse Event|0|||
46718776|NCT01016262|82934928|FG000|Open-Label Phase|Lost to Follow-up|0|||
46718777|NCT01016262|82934929|FG001|Open-Label Phase|Lost to Follow-up|0|||
46718778|NCT01016262|82934930|FG002|Open-Label Phase|Lost to Follow-up|0|||
46718779|NCT01016262|82934931|FG003|Open-Label Phase|Lost to Follow-up|0|||
46718780|NCT01016262|82934932|FG004|Open-Label Phase|Lost to Follow-up|1|||
46718781|NCT01016262|82934933|FG005|Open-Label Phase|Lost to Follow-up|0|||
46718782|NCT01016262|82934928|FG000|Open-Label Phase|Lack of Efficacy|0|||
46718783|NCT01016262|82934929|FG001|Open-Label Phase|Lack of Efficacy|0|||
46718784|NCT01016262|82934930|FG002|Open-Label Phase|Lack of Efficacy|0|||
46718785|NCT01016262|82934931|FG003|Open-Label Phase|Lack of Efficacy|1|||
46718786|NCT01016262|82934932|FG004|Open-Label Phase|Lack of Efficacy|0|||
46718787|NCT01016262|82934933|FG005|Open-Label Phase|Lack of Efficacy|0|||
46718788|NCT01016262|82934928|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
46718789|NCT01016262|82934929|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
46718790|NCT01016262|82934930|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
46718791|NCT01016262|82934931|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
46915181|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
46915182|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
46915183|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
46915184|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
46915185|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
47040285|NCT01755026|83294283|FG001|Overall Study|Withdrawal by Subject|1|||
47040286|NCT01491945|83294298|FG000|Overall Study|Death|30|||
47040287|NCT01491945|83294298|FG000|Overall Study|Withdrwan/LTF|16|||
47040288|NCT01491945|83294298|FG000|Overall Study|Conversion|4|||
46632098|NCT01803282|82805190|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46632099|NCT01803282|82805191|FG002|Overall Study|Non-Compliance with Study Drug|0|||
46632100|NCT01803282|82805192|FG003|Overall Study|Non-Compliance with Study Drug|1|||
46632101|NCT01803282|82805193|FG004|Overall Study|Non-Compliance with Study Drug|0|||
46632102|NCT01803282|82805194|FG005|Overall Study|Non-Compliance with Study Drug|0|||
46632103|NCT01803282|82805195|FG006|Overall Study|Non-Compliance with Study Drug|0|||
46632104|NCT01803282|82805196|FG007|Overall Study|Non-Compliance with Study Drug|0|||
46632105|NCT01803282|82805197|FG008|Overall Study|Non-Compliance with Study Drug|0|||
46632106|NCT01803282|82805198|FG009|Overall Study|Non-Compliance with Study Drug|0|||
46632107|NCT01803282|82805199|FG010|Overall Study|Non-Compliance with Study Drug|0|||
46632108|NCT01803282|82805200|FG011|Overall Study|Non-Compliance with Study Drug|0|||
46632109|NCT01803282|82805189|FG000|Overall Study|Unknown Reason|0|||
46632110|NCT01803282|82805190|FG001|Overall Study|Unknown Reason|0|||
46632111|NCT01803282|82805191|FG002|Overall Study|Unknown Reason|0|||
46632112|NCT01803282|82805192|FG003|Overall Study|Unknown Reason|0|||
46632113|NCT01803282|82805193|FG004|Overall Study|Unknown Reason|0|||
46632114|NCT01803282|82805194|FG005|Overall Study|Unknown Reason|0|||
46632115|NCT01803282|82805195|FG006|Overall Study|Unknown Reason|0|||
46632116|NCT01803282|82805196|FG007|Overall Study|Unknown Reason|1|||
46632117|NCT01803282|82805197|FG008|Overall Study|Unknown Reason|0|||
46632118|NCT01803282|82805198|FG009|Overall Study|Unknown Reason|0|||
46632119|NCT01803282|82805199|FG010|Overall Study|Unknown Reason|0|||
46632120|NCT01803282|82805200|FG011|Overall Study|Unknown Reason|0|||
46632121|NCT01803282|82805189|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
46632122|NCT01803282|82805190|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
46632123|NCT01803282|82805191|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
46632124|NCT01803282|82805192|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
46632125|NCT01803282|82805193|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
46632126|NCT01803282|82805194|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
46632127|NCT01803282|82805195|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
46632128|NCT01803282|82805196|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
46718792|NCT01016262|82934932|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
46718793|NCT01016262|82934933|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
47040289|NCT01491945|83294298|FG000|Overall Study|Missed Visit|1|||
47040290|NCT01728584|83294320|FG000|Overall Study|Adverse Event|1|||
47040291|NCT01728584|83294321|FG001|Overall Study|Adverse Event|0|||
46718794|NCT01009554|82934946|FG000|Overall Study|Adverse Event|1|||
46718795|NCT01009554|82934947|FG001|Overall Study|Adverse Event|1|||
46718796|NCT01009554|82934946|FG000|Overall Study|Withdrawal by Subject|1|||
47040292|NCT01728584|83294322|FG002|Overall Study|Adverse Event|0|||
46632129|NCT01803282|82805197|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
46718797|NCT01009554|82934947|FG001|Overall Study|Withdrawal by Subject|3|||
46718798|NCT01009554|82934946|FG000|Overall Study|Noncompliant with Study Product|0|||
46718799|NCT01009554|82934947|FG001|Overall Study|Noncompliant with Study Product|3|||
46718800|NCT01006590|82934955|FG000|Overall Study|Adverse Event|2|||
46718801|NCT01006590|82934956|FG001|Overall Study|Adverse Event|3|||
46718802|NCT01006590|82934955|FG000|Overall Study|Death|1|||
46718803|NCT01006590|82934956|FG001|Overall Study|Death|1|||
47040293|NCT01728584|83294323|FG003|Overall Study|Adverse Event|0|||
47040294|NCT01728584|83294320|FG000|Overall Study|Physician Decision|4|||
47040295|NCT01728584|83294321|FG001|Overall Study|Physician Decision|0|||
47040296|NCT01728584|83294322|FG002|Overall Study|Physician Decision|1|||
47040297|NCT01728584|83294323|FG003|Overall Study|Physician Decision|0|||
47040298|NCT01728584|83294320|FG000|Overall Study|Withdrawal by Subject|1|||
46632130|NCT01803282|82805198|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
46718804|NCT01006590|82934955|FG000|Overall Study|Lost to Follow-up|1|||
46718805|NCT01006590|82934956|FG001|Overall Study|Lost to Follow-up|1|||
46718806|NCT01006590|82934955|FG000|Overall Study|Protocol Violation|1|||
46718807|NCT01006590|82934956|FG001|Overall Study|Protocol Violation|0|||
46718808|NCT01006590|82934955|FG000|Overall Study|Withdrawal by Subject|4|||
46718809|NCT01006590|82934956|FG001|Overall Study|Withdrawal by Subject|2|||
46718810|NCT01006590|82934955|FG000|Overall Study|Study specific discontinuation criteria|16|||
46718811|NCT01006590|82934956|FG001|Overall Study|Study specific discontinuation criteria|23|||
46718812|NCT01006590|82934955|FG000|Overall Study|Other|3|||
46718813|NCT01006590|82934956|FG001|Overall Study|Other|2|||
46718814|NCT01001832|82934964|FG000|Short-term Period|Adverse Event|2|||
46718815|NCT01001832|82934965|FG001|Short-term Period|Adverse Event|3|||
46718816|NCT01001832|82934964|FG000|Long-term Period|Adverse Event|2|||
46718817|NCT01001832|82934965|FG001|Long-term Period|Adverse Event|1|||
46718818|NCT01001832|82934964|FG000|Long-term Period|Withdrawal by Subject|1|||
46718819|NCT01001832|82934965|FG001|Long-term Period|Withdrawal by Subject|0|||
46632131|NCT01803282|82805199|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
46632132|NCT01803282|82805200|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
46632133|NCT01803282|82805189|FG000|Overall Study|Enrolled but Never Treated|0|||
46632134|NCT01803282|82805190|FG001|Overall Study|Enrolled but Never Treated|0|||
46632135|NCT01803282|82805191|FG002|Overall Study|Enrolled but Never Treated|0|||
46632136|NCT01803282|82805192|FG003|Overall Study|Enrolled but Never Treated|0|||
46632137|NCT01803282|82805193|FG004|Overall Study|Enrolled but Never Treated|1|||
46632138|NCT01803282|82805194|FG005|Overall Study|Enrolled but Never Treated|0|||
46632139|NCT01803282|82805195|FG006|Overall Study|Enrolled but Never Treated|1|||
46632140|NCT01803282|82805196|FG007|Overall Study|Enrolled but Never Treated|1|||
46632141|NCT01803282|82805197|FG008|Overall Study|Enrolled but Never Treated|0|||
46632142|NCT01803282|82805198|FG009|Overall Study|Enrolled but Never Treated|1|||
46632143|NCT01803282|82805199|FG010|Overall Study|Enrolled but Never Treated|0|||
46632144|NCT01803282|82805200|FG011|Overall Study|Enrolled but Never Treated|0|||
46632145|NCT01844778|82805229|FG000|Overall Study|Protocol deviation|0|||
46632146|NCT01844778|82805230|FG001|Overall Study|Protocol deviation|1|||
46632147|NCT01844778|82805231|FG002|Overall Study|Protocol deviation|2|||
46632148|NCT01844778|82805229|FG000|Overall Study|Withdrawal by Subject|2|||
46632149|NCT01844778|82805230|FG001|Overall Study|Withdrawal by Subject|0|||
46632150|NCT01844778|82805231|FG002|Overall Study|Withdrawal by Subject|0|||
46632151|NCT01844778|82805229|FG000|Overall Study|Adverse Event|0|||
46632152|NCT01844778|82805230|FG001|Overall Study|Adverse Event|2|||
46632153|NCT01844778|82805231|FG002|Overall Study|Adverse Event|2|||
46632154|NCT01802580|82805245|FG000|Overall Study|Physician Decision|1|||
46632155|NCT01802580|82805246|FG001|Overall Study|Physician Decision|0|||
46632156|NCT01802580|82805245|FG000|Overall Study|Protocol Violation|2|||
46632157|NCT01802580|82805246|FG001|Overall Study|Protocol Violation|0|||
46632158|NCT01802580|82805245|FG000|Overall Study|Withdrawal by Subject|5|||
46632159|NCT01802580|82805246|FG001|Overall Study|Withdrawal by Subject|6|||
46632160|NCT01802580|82805245|FG000|Overall Study|Other|1|||
46632161|NCT01802580|82805246|FG001|Overall Study|Other|3|||
46632162|NCT01802580|82805245|FG000|Overall Study|Lack of Efficacy|0|||
46632163|NCT01802580|82805246|FG001|Overall Study|Lack of Efficacy|2|||
46632164|NCT01611090|82805254|FG000|Randomized Period|Lost to Follow-up|8|||
46632165|NCT01611090|82805255|FG001|Randomized Period|Lost to Follow-up|3|||
46632166|NCT01611090|82805256|FG002|Randomized Period|Lost to Follow-up|0|||
46632167|NCT01611090|82805254|FG000|Randomized Period|Withdrawal by Subject|22|||
46718820|NCT01001832|82934964|FG000|Long-term Period|Lack of Efficacy|0|||
46632168|NCT01611090|82805255|FG001|Randomized Period|Withdrawal by Subject|26|||
46718821|NCT01001832|82934965|FG001|Long-term Period|Lack of Efficacy|2|||
46632169|NCT01611090|82805256|FG002|Randomized Period|Withdrawal by Subject|0|||
46718822|NCT01001832|82934964|FG000|Long-term Period|Other|1|||
46718823|NCT01001832|82934965|FG001|Long-term Period|Other|2|||
46718824|NCT01001832|82934964|FG000|Follow-up Period|Withdrawal by Subject|1|||
47040299|NCT01728584|83294321|FG001|Overall Study|Withdrawal by Subject|0|||
47040300|NCT01728584|83294322|FG002|Overall Study|Withdrawal by Subject|0|||
47040301|NCT01728584|83294323|FG003|Overall Study|Withdrawal by Subject|0|||
47040302|NCT01728584|83294320|FG000|Overall Study|Screen failure|1|||
47040303|NCT01728584|83294321|FG001|Overall Study|Screen failure|0|||
46718825|NCT01001832|82934965|FG001|Follow-up Period|Withdrawal by Subject|0|||
46718826|NCT01001832|82934964|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
46718827|NCT01001832|82934965|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
46718828|NCT01001832|82934964|FG000|Follow-up Period|Other|2|||
46718829|NCT01001832|82934965|FG001|Follow-up Period|Other|1|||
46718830|NCT01001598|82934974|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
46718831|NCT01001598|82934974|FG000|Overall Study|Adverse Event|1|||
46718832|NCT01006356|82934978|FG000|Overall Study|Adverse Event|6|||
46718833|NCT01006356|82934978|FG000|Overall Study|Physician Decision|1|||
46718834|NCT01006356|82934978|FG000|Overall Study|Paticipants did not cooperate|6|||
46718835|NCT01006356|82934978|FG000|Overall Study|Withdrawal by Subject|1|||
46718836|NCT01006356|82934978|FG000|Overall Study|Choice by participants|2|||
46718837|NCT01006356|82934978|FG000|Overall Study|Protocol Violation|3|||
46718838|NCT01006356|82934978|FG000|Overall Study|Other|23|||
46718839|NCT01089725|82934987|FG000|Overall Study|Adverse Event|1|||
46718840|NCT01089725|82934988|FG001|Overall Study|Adverse Event|1|||
46718841|NCT01089725|82934989|FG002|Overall Study|Adverse Event|0|||
46718842|NCT01089725|82934990|FG003|Overall Study|Adverse Event|0|||
46718843|NCT01089725|82934991|FG004|Overall Study|Adverse Event|2|||
46718844|NCT01089725|82934987|FG000|Overall Study|Lack of Efficacy|4|||
46718845|NCT01089725|82934988|FG001|Overall Study|Lack of Efficacy|3|||
46718846|NCT01089725|82934989|FG002|Overall Study|Lack of Efficacy|1|||
46718847|NCT01089725|82934990|FG003|Overall Study|Lack of Efficacy|0|||
46718848|NCT01089725|82934991|FG004|Overall Study|Lack of Efficacy|4|||
46718849|NCT01089725|82934987|FG000|Overall Study|Lost to Follow-up|2|||
46718850|NCT01089725|82934988|FG001|Overall Study|Lost to Follow-up|2|||
46718851|NCT01089725|82934989|FG002|Overall Study|Lost to Follow-up|0|||
46718852|NCT01089725|82934990|FG003|Overall Study|Lost to Follow-up|3|||
46718853|NCT01089725|82934991|FG004|Overall Study|Lost to Follow-up|0|||
46718854|NCT01089725|82934987|FG000|Overall Study|Protocol Violation|0|||
46718855|NCT01089725|82934988|FG001|Overall Study|Protocol Violation|0|||
46718856|NCT01089725|82934989|FG002|Overall Study|Protocol Violation|1|||
46718857|NCT01089725|82934990|FG003|Overall Study|Protocol Violation|1|||
46718858|NCT01089725|82934991|FG004|Overall Study|Protocol Violation|0|||
46718859|NCT01089725|82934987|FG000|Overall Study|Withdrawal by Subject|5|||
46718860|NCT01089725|82934988|FG001|Overall Study|Withdrawal by Subject|5|||
46718861|NCT01089725|82934989|FG002|Overall Study|Withdrawal by Subject|4|||
46718862|NCT01089725|82934990|FG003|Overall Study|Withdrawal by Subject|5|||
46718863|NCT01089725|82934991|FG004|Overall Study|Withdrawal by Subject|4|||
46718864|NCT01089725|82934987|FG000|Overall Study|Study Terminated by Sponsor|51|||
46718865|NCT01089725|82934988|FG001|Overall Study|Study Terminated by Sponsor|56|||
46718866|NCT01089725|82934989|FG002|Overall Study|Study Terminated by Sponsor|53|||
46718867|NCT01089725|82934990|FG003|Overall Study|Study Terminated by Sponsor|68|||
46718868|NCT01089725|82934991|FG004|Overall Study|Study Terminated by Sponsor|68|||
46718869|NCT01089725|82934987|FG000|Overall Study|Randomized, but not treated|0|||
46718870|NCT01089725|82934988|FG001|Overall Study|Randomized, but not treated|1|||
46718871|NCT01089725|82934989|FG002|Overall Study|Randomized, but not treated|2|||
46718872|NCT01089725|82934990|FG003|Overall Study|Randomized, but not treated|1|||
46718873|NCT01089725|82934991|FG004|Overall Study|Randomized, but not treated|2|||
46718874|NCT01089725|82934987|FG000|Overall Study|Other|3|||
46718875|NCT01089725|82934988|FG001|Overall Study|Other|0|||
46718876|NCT01089725|82934989|FG002|Overall Study|Other|0|||
46718877|NCT01089725|82934990|FG003|Overall Study|Other|1|||
46718878|NCT01089725|82934991|FG004|Overall Study|Other|0|||
46718879|NCT01101191|82935007|FG000|Period 1|Withdrawal by Subject|1|||
46718880|NCT01101191|82935008|FG001|Period 1|Withdrawal by Subject|0|||
46718881|NCT01101191|82935007|FG000|Period 1|Adverse Event|1|||
46718882|NCT01101191|82935008|FG001|Period 1|Adverse Event|2|||
46718883|NCT01178762|82935015|FG000|Overall Study|Lost to Follow-up|15|||
46718884|NCT01178294|82935019|FG000|Overall Study|Adverse Event|4|||
46718885|NCT01178294|82935019|FG000|Overall Study|Lost to Follow-up|2|||
47040304|NCT01728584|83294322|FG002|Overall Study|Screen failure|0|||
46632170|NCT01611090|82805254|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
46632171|NCT01611090|82805255|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
46632172|NCT01611090|82805256|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
46632173|NCT01611090|82805254|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
46632174|NCT01611090|82805255|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
46632175|NCT01611090|82805256|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
46632176|NCT01844700|82805265|FG000|Overall Study|Lack of Efficacy|1|||
46632177|NCT01844700|82805266|FG001|Overall Study|Lack of Efficacy|0|||
46632178|NCT01844700|82805265|FG000|Overall Study|refused medication switch|1|||
46632179|NCT01844700|82805266|FG001|Overall Study|refused medication switch|0|||
46718886|NCT01178294|82935019|FG000|Overall Study|Lack of Efficacy|1|||
46718887|NCT01178294|82935019|FG000|Overall Study|Death|1|||
46718888|NCT01178294|82935019|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
46718889|NCT01178294|82935019|FG000|Overall Study|Subject status is terminal|1|||
46718890|NCT01178294|82935019|FG000|Overall Study|Completion status could not be verified|1|||
46718891|NCT01178138|82935023|FG000|Overall Study|Lost to Follow-up|8|||
46915186|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
46915187|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
46915188|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
46915189|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
46915190|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
46915191|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
46915192|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
46915193|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
46915194|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
46915195|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
46915196|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
46915197|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
46915198|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
46915199|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
46915200|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
46915201|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
46915202|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
46915203|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
46915204|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
46915205|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
46915206|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
46915207|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
46915208|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
46915209|NCT00383435|83145870|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
46915210|NCT00383435|83145871|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
46915211|NCT00383435|83145872|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
46915212|NCT00383435|83145873|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
46915213|NCT00383435|83145874|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
46915214|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
46915215|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
46915216|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
46915217|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
46718892|NCT01178138|82935023|FG000|Overall Study|Withdrawal by Subject|7|||
46718893|NCT01178138|82935023|FG000|Overall Study|Physician Decision|8|||
46718894|NCT01177670|82935032|FG000|Overall Study|Study Terminated|115|||
46718895|NCT01177670|82935032|FG000|Overall Study|Physician Decision|50|||
46718896|NCT01177670|82935032|FG000|Overall Study|Withdrawal by Subject|4|||
46718897|NCT01190228|82935039|FG000|Overall Study|Protocol Violation|4|||
46718898|NCT01190228|82935040|FG001|Overall Study|Protocol Violation|0|||
46718899|NCT01190228|82935041|FG002|Overall Study|Protocol Violation|0|||
46718900|NCT01190228|82935039|FG000|Overall Study|Withdrawal by Subject|1|||
46718901|NCT01190228|82935040|FG001|Overall Study|Withdrawal by Subject|0|||
46718902|NCT01190228|82935041|FG002|Overall Study|Withdrawal by Subject|0|||
46718903|NCT01009086|82935054|FG000|Overall Study|Lack of Efficacy|16|||
46718904|NCT01009086|82935055|FG001|Overall Study|Lack of Efficacy|15|||
46718905|NCT01009086|82935056|FG002|Overall Study|Lack of Efficacy|9|||
46718906|NCT01009086|82935054|FG000|Overall Study|Lost to Follow-up|4|||
46718907|NCT01009086|82935055|FG001|Overall Study|Lost to Follow-up|5|||
46718908|NCT01009086|82935056|FG002|Overall Study|Lost to Follow-up|3|||
46718909|NCT01009086|82935054|FG000|Overall Study|Adverse Event|12|||
46718910|NCT01009086|82935055|FG001|Overall Study|Adverse Event|11|||
46718911|NCT01009086|82935056|FG002|Overall Study|Adverse Event|8|||
46718912|NCT01009086|82935054|FG000|Overall Study|Withdrawal by Subject|9|||
46718913|NCT01009086|82935055|FG001|Overall Study|Withdrawal by Subject|11|||
46718914|NCT01009086|82935056|FG002|Overall Study|Withdrawal by Subject|13|||
46718915|NCT01009086|82935054|FG000|Overall Study|Other|3|||
46915218|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
46915219|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
47040305|NCT01728584|83294323|FG003|Overall Study|Screen failure|0|||
46718916|NCT01009086|82935055|FG001|Overall Study|Other|5|||
46718917|NCT01009086|82935056|FG002|Overall Study|Other|1|||
46718918|NCT01190150|82935071|FG000|First Treatment|Withdrawal by Subject|1|||
46718919|NCT01190150|82935072|FG001|First Treatment|Withdrawal by Subject|0|||
46718920|NCT01190150|82935071|FG000|Washout|Withdrawal by Subject|0|||
46718921|NCT01190150|82935072|FG001|Washout|Withdrawal by Subject|1|||
46718922|NCT01190150|82935071|FG000|Washout|Difficulty in adherence|0|||
46718923|NCT01190150|82935072|FG001|Washout|Difficulty in adherence|1|||
46718924|NCT01001520|82935078|FG000|Medication Period 1|Withdrawal by Subject|2|||
46718925|NCT01001520|82935079|FG001|Medication Period 1|Withdrawal by Subject|2|||
46718926|NCT01001520|82935078|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
46718927|NCT01001520|82935079|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
46718928|NCT01001520|82935078|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
46718929|NCT01001520|82935079|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
46718930|NCT01001520|82935078|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
46718931|NCT01001520|82935079|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
46718932|NCT01001520|82935078|FG000|Washout Period|Withdrawal by Subject|2|||
46718933|NCT01001520|82935079|FG001|Washout Period|Withdrawal by Subject|1|||
46718934|NCT01001520|82935078|FG000|Medication Period 2|Withdrawal by Subject|0|||
46718935|NCT01001520|82935079|FG001|Medication Period 2|Withdrawal by Subject|3|||
46718936|NCT01189604|82935112|FG000|Overall Study|Impossible to visit|0|||
46718937|NCT01189604|82935113|FG001|Overall Study|Impossible to visit|0|||
46718938|NCT01189604|82935114|FG002|Overall Study|Impossible to visit|0|||
46718939|NCT01189604|82935115|FG003|Overall Study|Impossible to visit|0|||
46718940|NCT01189604|82935116|FG004|Overall Study|Impossible to visit|0|||
46718941|NCT01189604|82935117|FG005|Overall Study|Impossible to visit|1|||
46718942|NCT01189604|82935118|FG006|Overall Study|Impossible to visit|0|||
46718943|NCT01189604|82935112|FG000|Overall Study|Adverse Event|0|||
46718944|NCT01189604|82935113|FG001|Overall Study|Adverse Event|1|||
46718945|NCT01189604|82935114|FG002|Overall Study|Adverse Event|0|||
46718946|NCT01189604|82935115|FG003|Overall Study|Adverse Event|0|||
46718947|NCT01189604|82935116|FG004|Overall Study|Adverse Event|2|||
46718948|NCT01189604|82935117|FG005|Overall Study|Adverse Event|0|||
46718949|NCT01189604|82935118|FG006|Overall Study|Adverse Event|1|||
46718950|NCT01189604|82935112|FG000|Overall Study|Withdrawal by Subject|1|||
46718951|NCT01189604|82935113|FG001|Overall Study|Withdrawal by Subject|0|||
46718952|NCT01189604|82935114|FG002|Overall Study|Withdrawal by Subject|0|||
46718953|NCT01189604|82935115|FG003|Overall Study|Withdrawal by Subject|0|||
46718954|NCT01189604|82935116|FG004|Overall Study|Withdrawal by Subject|0|||
46718955|NCT01189604|82935117|FG005|Overall Study|Withdrawal by Subject|0|||
46718956|NCT01189604|82935118|FG006|Overall Study|Withdrawal by Subject|0|||
46718957|NCT01008696|82935136|FG000|Overall Study|Participant's evasion of hospital visit|5|||
46718958|NCT01008696|82935137|FG001|Overall Study|Participant's evasion of hospital visit|4|||
46718959|NCT01008696|82935136|FG000|Overall Study|Withdrawal by Subject|2|||
46718960|NCT01008696|82935137|FG001|Overall Study|Withdrawal by Subject|4|||
46915220|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
46915221|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
46915222|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
46915223|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
46915224|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
46915225|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
46915226|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
46915227|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
46718961|NCT01008696|82935136|FG000|Overall Study|Physician Decision|5|||
46718962|NCT01008696|82935137|FG001|Overall Study|Physician Decision|1|||
46718963|NCT01008696|82935136|FG000|Overall Study|Adverse Event|1|||
46915228|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
46718964|NCT01008696|82935137|FG001|Overall Study|Adverse Event|0|||
46632180|NCT01844700|82805265|FG000|Overall Study|Withdrawal by Subject|1|||
46632181|NCT01844700|82805266|FG001|Overall Study|Withdrawal by Subject|0|||
46632182|NCT01844700|82805265|FG000|Overall Study|stopped taking meds|0|||
46632183|NCT01844700|82805266|FG001|Overall Study|stopped taking meds|1|||
46632184|NCT01844076|82805276|FG000|Overall Study|Adverse Event|1|||
46632185|NCT01844076|82805277|FG001|Overall Study|Adverse Event|0|||
46632186|NCT01844076|82805278|FG002|Overall Study|Adverse Event|0|||
46632187|NCT01844076|82805279|FG003|Overall Study|Adverse Event|0|||
46718965|NCT01008696|82935136|FG000|Overall Study|Participants' non-cooperation|2|||
46718966|NCT01008696|82935137|FG001|Overall Study|Participants' non-cooperation|3|||
46718967|NCT01008696|82935136|FG000|Overall Study|Other|2|||
46718968|NCT01008696|82935137|FG001|Overall Study|Other|3|||
46718969|NCT01008696|82935136|FG000|Overall Study|Other|0|||
46718970|NCT01008696|82935137|FG001|Overall Study|Other|2|||
46915229|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
46915230|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
46632188|NCT01844076|82805276|FG000|Overall Study|Withdrawal by Subject|1|||
46718971|NCT01176968|82935156|FG000|Overall Study|Adverse Event|10|||
46718972|NCT01176968|82935157|FG001|Overall Study|Adverse Event|11|||
46718973|NCT01176968|82935156|FG000|Overall Study|Death|2|||
46718974|NCT01176968|82935157|FG001|Overall Study|Death|3|||
46718975|NCT01176968|82935156|FG000|Overall Study|Lack of Efficacy|0|||
46718976|NCT01176968|82935157|FG001|Overall Study|Lack of Efficacy|1|||
46718977|NCT01176968|82935156|FG000|Overall Study|Lost to Follow-up|16|||
46718978|NCT01176968|82935157|FG001|Overall Study|Lost to Follow-up|14|||
46718979|NCT01176968|82935156|FG000|Overall Study|Withdrawal by Subject|48|||
46718980|NCT01176968|82935157|FG001|Overall Study|Withdrawal by Subject|48|||
46718981|NCT01176968|82935156|FG000|Overall Study|Protocol Violation|2|||
46718982|NCT01176968|82935157|FG001|Overall Study|Protocol Violation|1|||
46718983|NCT01176968|82935156|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
46915231|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
46915232|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
46915233|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
46915234|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
46915235|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
46915236|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
46915237|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
46915238|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
46915239|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
46915240|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
46915241|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
46915242|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
46915243|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
46915244|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
46915245|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
46915246|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
46915247|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
46915248|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
46915249|NCT00383435|83145870|FG000|26-Week Treatment Safety Extension|Administrative|1|||
46915250|NCT00383435|83145871|FG001|26-Week Treatment Safety Extension|Administrative|1|||
46915251|NCT00383435|83145872|FG002|26-Week Treatment Safety Extension|Administrative|0|||
46915252|NCT00383435|83145873|FG003|26-Week Treatment Safety Extension|Administrative|1|||
46915253|NCT00383435|83145874|FG004|26-Week Treatment Safety Extension|Administrative|0|||
46915254|NCT03157037|83145886|FG000|Overall Study|Death|1|||
46915255|NCT00381485|83145908|FG000|Open-Label Run-In Period|Adverse Event|9|||
46915256|NCT00381485|83145909|FG001|Open-Label Run-In Period|Adverse Event|0|||
46632189|NCT01844076|82805277|FG001|Overall Study|Withdrawal by Subject|0|||
46632190|NCT01844076|82805278|FG002|Overall Study|Withdrawal by Subject|0|||
46632191|NCT01844076|82805279|FG003|Overall Study|Withdrawal by Subject|0|||
46632192|NCT01826604|82805291|FG000|Overall Study|Lost to Follow-up|8|||
46632193|NCT01826604|82805292|FG001|Overall Study|Lost to Follow-up|9|||
46632194|NCT01843842|82805300|FG000|Overall Study|Do not meet inclusion criteria|1|||
46632195|NCT01843842|82805301|FG001|Overall Study|Do not meet inclusion criteria|1|||
46632196|NCT01826448|82805309|FG000|Overall Study|Adverse Event|1|||
46632197|NCT01826448|82805310|FG001|Overall Study|Adverse Event|3|||
46632198|NCT01826448|82805309|FG000|Overall Study|Disease progression|2|||
46632199|NCT01826448|82805310|FG001|Overall Study|Disease progression|4|||
46632200|NCT01826448|82805309|FG000|Overall Study|Withdrawal by Subject|1|||
46632201|NCT01826448|82805310|FG001|Overall Study|Withdrawal by Subject|0|||
46632202|NCT01826448|82805309|FG000|Overall Study|Physician Decision|0|||
46632203|NCT01826448|82805310|FG001|Overall Study|Physician Decision|1|||
46632204|NCT01826448|82805309|FG000|Overall Study|2 active cancers|0|||
46632205|NCT01826448|82805310|FG001|Overall Study|2 active cancers|1|||
46632206|NCT01826370|82805316|FG000|Overall Study|Protocol Violation|6|||
46632207|NCT01826370|82805316|FG000|Overall Study|Lost to Follow-up|12|||
46632208|NCT01826370|82805316|FG000|Overall Study|Other reason not defined above|2|||
46632209|NCT01826214|82805322|FG000|Overall Study|Adverse Event|7|||
46632210|NCT01826214|82805323|FG001|Overall Study|Adverse Event|6|||
46632211|NCT01826214|82805322|FG000|Overall Study|Death|3|||
46632212|NCT01826214|82805323|FG001|Overall Study|Death|1|||
46632213|NCT01826214|82805322|FG000|Overall Study|Lost to Follow-up|1|||
46632214|NCT01826214|82805323|FG001|Overall Study|Lost to Follow-up|0|||
46632215|NCT01826214|82805322|FG000|Overall Study|Physician Decision|0|||
46632216|NCT01826214|82805323|FG001|Overall Study|Physician Decision|2|||
46632217|NCT01826214|82805322|FG000|Overall Study|Progressive disease|22|||
46915257|NCT00381485|83145910|FG002|Open-Label Run-In Period|Adverse Event|0|||
46632218|NCT01826214|82805323|FG001|Overall Study|Progressive disease|21|||
46632219|NCT01826214|82805322|FG000|Overall Study|Study terminated by Sponsor|0|||
46632220|NCT01826214|82805323|FG001|Overall Study|Study terminated by Sponsor|1|||
46632221|NCT01826214|82805322|FG000|Overall Study|Subject/guardian decision|2|||
46632222|NCT01826214|82805323|FG001|Overall Study|Subject/guardian decision|3|||
46632223|NCT01843062|82805331|FG000|Overall Study|Protocol Violation|1|||
46632224|NCT01843062|82805332|FG001|Overall Study|Protocol Violation|0|||
46718984|NCT01176968|82935157|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
46632225|NCT01843062|82805331|FG000|Overall Study|New treatment following progression|2|||
46632226|NCT01843062|82805332|FG001|Overall Study|New treatment following progression|0|||
46915258|NCT00381485|83145911|FG003|Open-Label Run-In Period|Adverse Event|0|||
46915259|NCT00381485|83145908|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
46915260|NCT00381485|83145909|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
46915261|NCT00381485|83145910|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
46915262|NCT00381485|83145911|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
46915263|NCT00381485|83145908|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
46915264|NCT00381485|83145909|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
46915265|NCT00381485|83145910|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
46915266|NCT00381485|83145911|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
46915267|NCT00381485|83145908|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
46915268|NCT00381485|83145909|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
46915269|NCT00381485|83145910|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
46915270|NCT00381485|83145911|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
47040306|NCT01728584|83294320|FG000|Overall Study|Other reason (not specified)|1|||
47040307|NCT01728584|83294321|FG001|Overall Study|Other reason (not specified)|0|||
46718985|NCT01176968|82935156|FG000|Overall Study|Study terminated by sponsor|0|||
46718986|NCT01176968|82935157|FG001|Overall Study|Study terminated by sponsor|1|||
46718987|NCT01176968|82935156|FG000|Overall Study|Reason not defined|5|||
46718988|NCT01176968|82935157|FG001|Overall Study|Reason not defined|3|||
46718989|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
46718990|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
46718991|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
46718992|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
46718993|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Pregnancy|0|||
46718994|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Pregnancy|1|||
46718995|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
46718996|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
46718997|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
46718998|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
46718999|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
46719000|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
46719001|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Other|3|||
46719002|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Other|0|||
46719003|NCT01006122|82935168|FG000|First Double-blind Intervention Period|Adverse Event|0|||
46719004|NCT01006122|82935169|FG001|First Double-blind Intervention Period|Adverse Event|4|||
46719005|NCT01006122|82935168|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
46719006|NCT01006122|82935169|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
46719007|NCT01006122|82935168|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
46719008|NCT01006122|82935169|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
46719009|NCT01006122|82935168|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
46719010|NCT01006122|82935169|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
46719011|NCT01006122|82935168|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
46719012|NCT01006122|82935169|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
46719013|NCT01006122|82935168|FG000|Second Double-blind Intervention Period|Death|0|||
46719014|NCT01006122|82935169|FG001|Second Double-blind Intervention Period|Death|1|||
46719015|NCT01005966|82935175|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
46719016|NCT01005966|82935176|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
46719017|NCT01005966|82935177|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
46719018|NCT01005966|82935178|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
46719019|NCT01005966|82935179|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
46719020|NCT01005966|82935175|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
46719021|NCT01005966|82935176|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
46719022|NCT01005966|82935177|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
46719023|NCT01005966|82935178|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
46719024|NCT01005966|82935179|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
46719025|NCT01005966|82935175|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
46719026|NCT01005966|82935176|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
46719027|NCT01005966|82935177|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
46719028|NCT01005966|82935178|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
46719029|NCT01005966|82935179|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
46719030|NCT01005966|82935175|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
46719031|NCT01005966|82935176|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
46719032|NCT01005966|82935177|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
47040308|NCT01728584|83294322|FG002|Overall Study|Other reason (not specified)|0|||
47040309|NCT01728584|83294323|FG003|Overall Study|Other reason (not specified)|1|||
47040310|NCT01522443|83294356|FG000|Overall Study|No longer receiving clinical benefit|36|||
46915271|NCT00381485|83145908|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
46915272|NCT00381485|83145909|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
46915273|NCT00381485|83145910|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
46915274|NCT00381485|83145911|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
46915275|NCT00381485|83145908|FG000|Open-Label Run-In Period|Treatment failure|1|||
46915276|NCT00381485|83145909|FG001|Open-Label Run-In Period|Treatment failure|0|||
46915277|NCT00381485|83145910|FG002|Open-Label Run-In Period|Treatment failure|0|||
46915278|NCT00381485|83145911|FG003|Open-Label Run-In Period|Treatment failure|0|||
46915279|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46915280|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Adverse Event|2|||
46915281|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Adverse Event|2|||
46915282|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Adverse Event|5|||
46915283|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
46915284|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
46915285|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
46915286|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
46915287|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46915288|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
46915289|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
46915290|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
46915291|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
46915292|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
46915293|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
46915294|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
46915295|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
46915296|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
47040311|NCT01522443|83294357|FG001|Overall Study|No longer receiving clinical benefit|28|||
47040312|NCT01522443|83294356|FG000|Overall Study|Adverse Event|10|||
47040313|NCT01522443|83294357|FG001|Overall Study|Adverse Event|15|||
47040314|NCT01522443|83294356|FG000|Overall Study|Withdrawal by Subject|5|||
47040315|NCT01522443|83294357|FG001|Overall Study|Withdrawal by Subject|8|||
47040316|NCT01522443|83294356|FG000|Overall Study|No study treatment given|1|||
47040317|NCT01522443|83294357|FG001|Overall Study|No study treatment given|1|||
47040318|NCT01522443|83294356|FG000|Overall Study|Other|1|||
47040319|NCT01522443|83294357|FG001|Overall Study|Other|3|||
47040320|NCT01468233|83294374|FG000|Treatment Period 1|Adverse Event|5|||
47040321|NCT01468233|83294375|FG001|Treatment Period 1|Adverse Event|3|||
47040322|NCT01468233|83294376|FG002|Treatment Period 1|Adverse Event|0|||
46915297|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
46915298|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
46915299|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
47040323|NCT01468233|83294377|FG003|Treatment Period 1|Adverse Event|0|||
47040324|NCT01468233|83294378|FG004|Treatment Period 1|Adverse Event|0|||
47040325|NCT01468233|83294379|FG005|Treatment Period 1|Adverse Event|0|||
47040326|NCT01468233|83294374|FG000|Treatment Period 1|Withdrawal by Subject|3|||
47040327|NCT01468233|83294375|FG001|Treatment Period 1|Withdrawal by Subject|4|||
47040328|NCT01468233|83294376|FG002|Treatment Period 1|Withdrawal by Subject|0|||
47040329|NCT01468233|83294377|FG003|Treatment Period 1|Withdrawal by Subject|0|||
47040330|NCT01468233|83294378|FG004|Treatment Period 1|Withdrawal by Subject|0|||
47040331|NCT01468233|83294379|FG005|Treatment Period 1|Withdrawal by Subject|0|||
47040332|NCT01468233|83294374|FG000|Treatment Period 1|Lost to Follow-up|3|||
47040333|NCT01468233|83294375|FG001|Treatment Period 1|Lost to Follow-up|0|||
47040334|NCT01468233|83294376|FG002|Treatment Period 1|Lost to Follow-up|0|||
47040335|NCT01468233|83294377|FG003|Treatment Period 1|Lost to Follow-up|0|||
47040336|NCT01468233|83294378|FG004|Treatment Period 1|Lost to Follow-up|0|||
47040337|NCT01468233|83294379|FG005|Treatment Period 1|Lost to Follow-up|0|||
47040338|NCT01468233|83294374|FG000|Treatment Period 1|Other|1|||
47040339|NCT01468233|83294375|FG001|Treatment Period 1|Other|1|||
47040340|NCT01468233|83294376|FG002|Treatment Period 1|Other|0|||
47040341|NCT01468233|83294377|FG003|Treatment Period 1|Other|0|||
47040342|NCT01468233|83294378|FG004|Treatment Period 1|Other|0|||
47040343|NCT01468233|83294379|FG005|Treatment Period 1|Other|0|||
47040344|NCT01468233|83294374|FG000|Treatment Period 2|Adverse Event|0|||
47040345|NCT01468233|83294375|FG001|Treatment Period 2|Adverse Event|0|||
47040346|NCT01468233|83294376|FG002|Treatment Period 2|Adverse Event|3|||
47040347|NCT01468233|83294377|FG003|Treatment Period 2|Adverse Event|0|||
47040348|NCT01468233|83294378|FG004|Treatment Period 2|Adverse Event|2|||
47040349|NCT01468233|83294379|FG005|Treatment Period 2|Adverse Event|1|||
47040350|NCT01468233|83294374|FG000|Treatment Period 2|Lack of Efficacy|0|||
47040351|NCT01468233|83294375|FG001|Treatment Period 2|Lack of Efficacy|0|||
47040352|NCT01468233|83294376|FG002|Treatment Period 2|Lack of Efficacy|9|||
47040353|NCT01468233|83294377|FG003|Treatment Period 2|Lack of Efficacy|2|||
46915300|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
46915301|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
46915302|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
46915303|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
46915304|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
46915305|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
46915306|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
46915307|NCT00381485|83145908|FG000|Double-Blind Treatment Period|Administrative|0|||
46915308|NCT00381485|83145909|FG001|Double-Blind Treatment Period|Administrative|1|||
46915309|NCT00381485|83145910|FG002|Double-Blind Treatment Period|Administrative|0|||
46915310|NCT00381485|83145911|FG003|Double-Blind Treatment Period|Administrative|1|||
46915311|NCT02840474|83145922|FG000|Overall Study|Lost to Follow-up|1|||
46915312|NCT02840474|83145923|FG001|Overall Study|Lost to Follow-up|0|||
46915313|NCT03155945|83145931|FG000|Overall Study|Lost to Follow-up|0|||
46915314|NCT03155945|83145932|FG001|Overall Study|Lost to Follow-up|1|||
46915315|NCT03155945|83145931|FG000|Overall Study|Withdrawal by Subject|0|||
46915316|NCT03155945|83145932|FG001|Overall Study|Withdrawal by Subject|1|||
46915317|NCT03155945|83145931|FG000|Overall Study|Other Reason|0|||
46915318|NCT03155945|83145932|FG001|Overall Study|Other Reason|1|||
46915319|NCT03160703|83145942|FG000|Overall Study|Withdrawal by Subject|0|||
47040354|NCT01468233|83294378|FG004|Treatment Period 2|Lack of Efficacy|0|||
47040355|NCT01468233|83294379|FG005|Treatment Period 2|Lack of Efficacy|1|||
47040356|NCT01468233|83294374|FG000|Treatment Period 2|Withdrawal by Subject|0|||
47040357|NCT01468233|83294375|FG001|Treatment Period 2|Withdrawal by Subject|0|||
47040358|NCT01468233|83294376|FG002|Treatment Period 2|Withdrawal by Subject|9|||
47040359|NCT01468233|83294377|FG003|Treatment Period 2|Withdrawal by Subject|1|||
47040360|NCT01468233|83294378|FG004|Treatment Period 2|Withdrawal by Subject|1|||
47040361|NCT01468233|83294379|FG005|Treatment Period 2|Withdrawal by Subject|1|||
47040362|NCT01468233|83294374|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
47040363|NCT01468233|83294375|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
47040364|NCT01468233|83294376|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
47040365|NCT01468233|83294377|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
47040366|NCT01468233|83294378|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
47040367|NCT01468233|83294379|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
47040368|NCT01468233|83294374|FG000|Treatment Period 2|Lost to Follow-up|0|||
47040369|NCT01468233|83294375|FG001|Treatment Period 2|Lost to Follow-up|0|||
47040370|NCT01468233|83294376|FG002|Treatment Period 2|Lost to Follow-up|3|||
46915320|NCT03160703|83145943|FG001|Overall Study|Withdrawal by Subject|0|||
46915321|NCT03160703|83145944|FG002|Overall Study|Withdrawal by Subject|0|||
46915322|NCT03160703|83145945|FG003|Overall Study|Withdrawal by Subject|1|||
46915323|NCT03159611|83145957|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
47040371|NCT01468233|83294377|FG003|Treatment Period 2|Lost to Follow-up|0|||
47040372|NCT01468233|83294378|FG004|Treatment Period 2|Lost to Follow-up|2|||
47040373|NCT01468233|83294379|FG005|Treatment Period 2|Lost to Follow-up|0|||
47040374|NCT01468233|83294374|FG000|Treatment Period 2|Other|0|||
46915324|NCT03159611|83145958|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
47040375|NCT01468233|83294375|FG001|Treatment Period 2|Other|0|||
47040376|NCT01468233|83294376|FG002|Treatment Period 2|Other|3|||
47040377|NCT01468233|83294377|FG003|Treatment Period 2|Other|0|||
47040378|NCT01468233|83294378|FG004|Treatment Period 2|Other|1|||
47040379|NCT01468233|83294379|FG005|Treatment Period 2|Other|0|||
47040380|NCT01468077|83294399|FG000|Overall Study|Adverse Event|2|||
47040381|NCT01468077|83294400|FG001|Overall Study|Adverse Event|2|||
47040382|NCT01468077|83294399|FG000|Overall Study|Lack of Efficacy|1|||
47040383|NCT01468077|83294400|FG001|Overall Study|Lack of Efficacy|1|||
47040384|NCT01468077|83294399|FG000|Overall Study|Physician Decision|1|||
47040385|NCT01468077|83294400|FG001|Overall Study|Physician Decision|0|||
47040386|NCT01522365|83294408|FG000|Overall Study|Withdrawal by Subject|1|||
47040387|NCT01522365|83294409|FG001|Overall Study|Withdrawal by Subject|1|||
47040388|NCT01522365|83294408|FG000|Overall Study|Lost to Follow-up|1|||
47040389|NCT01522365|83294409|FG001|Overall Study|Lost to Follow-up|1|||
47040390|NCT01783418|83294418|FG000|Overall Study|Withdrawal by Subject|1|||
47040391|NCT01783418|83294419|FG001|Overall Study|Withdrawal by Subject|0|||
47040392|NCT01521897|83294425|FG000|Overall Study|Protocol Violation|18|||
47040393|NCT01521897|83294425|FG000|Overall Study|Lost to Follow-up|5|||
47040394|NCT01782872|83294433|FG000|Overall Study|Protocol Violation|0|||
47040395|NCT01782872|83294434|FG001|Overall Study|Protocol Violation|0|||
47040396|NCT01782872|83294435|FG002|Overall Study|Protocol Violation|0|||
47040397|NCT01782872|83294436|FG003|Overall Study|Protocol Violation|1|||
47040398|NCT01782872|83294433|FG000|Overall Study|Withdrawal by Subject|0|||
47040399|NCT01782872|83294434|FG001|Overall Study|Withdrawal by Subject|1|||
47040400|NCT01782872|83294435|FG002|Overall Study|Withdrawal by Subject|0|||
46632227|NCT01843062|82805331|FG000|Overall Study|Pregnancy|1|||
46632228|NCT01843062|82805332|FG001|Overall Study|Pregnancy|0|||
46915325|NCT03159611|83145957|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
46915326|NCT03159611|83145958|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
46915327|NCT03159611|83145957|FG000|Overall Study|Protocol Violation|7|||
46915328|NCT03159611|83145958|FG001|Overall Study|Protocol Violation|4|||
46915329|NCT03159611|83145957|FG000|Overall Study|Adverse Event|1|||
46915330|NCT03159611|83145958|FG001|Overall Study|Adverse Event|0|||
46915331|NCT03159611|83145957|FG000|Overall Study|Withdrawal by Subject|1|||
46915332|NCT03159611|83145958|FG001|Overall Study|Withdrawal by Subject|1|||
46915333|NCT03159611|83145957|FG000|Overall Study|Non-compliance with protocol requirement|3|||
46915334|NCT03159611|83145958|FG001|Overall Study|Non-compliance with protocol requirement|2|||
46915335|NCT03159611|83145957|FG000|Overall Study|Inability to perform procedures|1|||
46915336|NCT03159611|83145958|FG001|Overall Study|Inability to perform procedures|0|||
46915337|NCT03159455|83145970|FG000|Overall Study|Adverse Event|0|||
46915338|NCT03159455|83145971|FG001|Overall Study|Adverse Event|0|||
46915339|NCT03159455|83145972|FG002|Overall Study|Adverse Event|0|||
46915340|NCT03159455|83145973|FG003|Overall Study|Adverse Event|0|||
46915341|NCT03159455|83145974|FG004|Overall Study|Adverse Event|0|||
46915342|NCT03159455|83145975|FG005|Overall Study|Adverse Event|1|||
46915343|NCT02838134|83145995|FG000|Overall Study|Lost to Follow-up|1|||
46915344|NCT02838134|83145996|FG001|Overall Study|Lost to Follow-up|2|||
46915345|NCT02838134|83145995|FG000|Overall Study|logistic problems|1|||
46915346|NCT02838134|83145996|FG001|Overall Study|logistic problems|1|||
46915347|NCT03150589|83146004|FG000|Overall Study|Withdrawal by Subject|16|||
46915348|NCT03150589|83146005|FG001|Overall Study|Withdrawal by Subject|9|||
46915349|NCT03150589|83146004|FG000|Overall Study|Adverse Event|7|||
46915350|NCT03150589|83146005|FG001|Overall Study|Adverse Event|6|||
46915351|NCT03150589|83146004|FG000|Overall Study|Protocol Violation|4|||
46915352|NCT03150589|83146005|FG001|Overall Study|Protocol Violation|3|||
46915353|NCT03150589|83146004|FG000|Overall Study|Lost to Follow-up|3|||
46915354|NCT03150589|83146005|FG001|Overall Study|Lost to Follow-up|3|||
46915355|NCT03150589|83146004|FG000|Overall Study|Death|2|||
46915356|NCT03150589|83146005|FG001|Overall Study|Death|3|||
46632229|NCT01843062|82805331|FG000|Overall Study|Adverse Event|2|||
46632230|NCT01843062|82805332|FG001|Overall Study|Adverse Event|0|||
46632231|NCT01843062|82805331|FG000|Overall Study|Incorrect randomisation|1|||
46915357|NCT03150589|83146004|FG000|Overall Study|IP non-compliance and other reasons|12|||
46915358|NCT03150589|83146005|FG001|Overall Study|IP non-compliance and other reasons|3|||
46915359|NCT02835092|83146014|FG000|Overall Study|Withdrawal by Subject|3|||
46915360|NCT02835092|83146015|FG001|Overall Study|Withdrawal by Subject|6|||
46915361|NCT02835092|83146016|FG002|Overall Study|Withdrawal by Subject|3|||
46915362|NCT02835092|83146014|FG000|Overall Study|Lost to Follow-up|0|||
46915363|NCT02835092|83146015|FG001|Overall Study|Lost to Follow-up|2|||
46915364|NCT02835092|83146016|FG002|Overall Study|Lost to Follow-up|0|||
47040401|NCT01782872|83294436|FG003|Overall Study|Withdrawal by Subject|0|||
47040402|NCT01490697|83294448|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
47040403|NCT01490697|83294449|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
46632232|NCT01843062|82805332|FG001|Overall Study|Incorrect randomisation|0|||
46915365|NCT03145207|83146024|FG000|Overall Study|volunteer started taking allergy shots|1|||
47040404|NCT01728194|83294457|FG000|Overall Study|Lost to Follow-up|4|||
46915366|NCT03145207|83146024|FG000|Overall Study|baseline blood pressure high|1|||
46915367|NCT02836652|83146041|FG000|Overall Study|Death|3|||
46915368|NCT02836652|83146042|FG001|Overall Study|Death|3|||
46915369|NCT02836652|83146041|FG000|Overall Study|Transplant/Explant|3|||
46915370|NCT02836652|83146042|FG001|Overall Study|Transplant/Explant|4|||
46915371|NCT02836652|83146041|FG000|Overall Study|Withdrawn|9|||
46915372|NCT02836652|83146042|FG001|Overall Study|Withdrawn|9|||
46915373|NCT02836652|83146041|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
46915374|NCT02836652|83146042|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
46915375|NCT02836496|83146050|FG000|Overall Study|Adverse Event|2|||
46915376|NCT02836496|83146051|FG001|Overall Study|Adverse Event|1|||
46915377|NCT02836496|83146050|FG000|Overall Study|Withdrawal by Subject|0|||
46915378|NCT02836496|83146051|FG001|Overall Study|Withdrawal by Subject|1|||
46915379|NCT04213807|83146060|FG000|Overall Study|Physician Decision|0|||
46915380|NCT04213807|83146061|FG001|Overall Study|Physician Decision|0|||
46915381|NCT04213807|83146062|FG002|Overall Study|Physician Decision|1|||
46915382|NCT00577577|83146081|FG000|Overall Study|Adverse Event|3|||
46915383|NCT00577577|83146082|FG001|Overall Study|Adverse Event|2|||
46915384|NCT00577577|83146081|FG000|Overall Study|Lost to Follow-up|1|||
47040405|NCT01728194|83294458|FG001|Overall Study|Lost to Follow-up|3|||
46632233|NCT01843062|82805331|FG000|Overall Study|Withdrawal by Subject|12|||
46632234|NCT01843062|82805332|FG001|Overall Study|Withdrawal by Subject|3|||
46915385|NCT00577577|83146082|FG001|Overall Study|Lost to Follow-up|0|||
46915386|NCT00577577|83146081|FG000|Overall Study|Protocol Violation|0|||
46915387|NCT00577577|83146082|FG001|Overall Study|Protocol Violation|3|||
46915388|NCT00577577|83146081|FG000|Overall Study|Transportation|1|||
46915389|NCT00577577|83146082|FG001|Overall Study|Transportation|0|||
46915390|NCT02833844|83146090|FG000|Double-Blind Period|Withdrawal by Subject|2|||
46915391|NCT02833844|83146091|FG001|Double-Blind Period|Withdrawal by Subject|3|||
46915392|NCT02833844|83146090|FG000|Double-Blind Period|Protocol Violation|0|||
46915393|NCT02833844|83146091|FG001|Double-Blind Period|Protocol Violation|4|||
46915394|NCT02833844|83146090|FG000|Open-Label Period|Death|0|||
46915395|NCT02833844|83146091|FG001|Open-Label Period|Death|2|||
46915396|NCT02833844|83146090|FG000|Open-Label Period|Lost to Follow-up|1|||
46915397|NCT02833844|83146091|FG001|Open-Label Period|Lost to Follow-up|0|||
46915398|NCT02833844|83146090|FG000|Open-Label Period|Withdrawal by Subject|1|||
46915399|NCT02833844|83146091|FG001|Open-Label Period|Withdrawal by Subject|0|||
46915400|NCT01341782|83146101|FG000|Overall Study|Adverse Event|1|||
46915401|NCT01341782|83146102|FG001|Overall Study|Adverse Event|1|||
46915402|NCT01341782|83146101|FG000|Overall Study|Withdrawal by Subject|6|||
46915403|NCT01341782|83146102|FG001|Overall Study|Withdrawal by Subject|5|||
46915404|NCT01341782|83146101|FG000|Overall Study|Missed 3 consecutive doses|0|||
46915405|NCT01341782|83146102|FG001|Overall Study|Missed 3 consecutive doses|4|||
46915406|NCT01341782|83146101|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
46915407|NCT01341782|83146102|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
46915408|NCT01341782|83146101|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
46915409|NCT01341782|83146102|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
46915410|NCT01341782|83146101|FG000|Overall Study|Other|5|||
46915411|NCT01341782|83146102|FG001|Overall Study|Other|0|||
46915412|NCT01341470|83146114|FG000|Overall Study|Sponsor decision|0|||
46915413|NCT01341470|83146115|FG001|Overall Study|Sponsor decision|0|||
46915414|NCT01341470|83146116|FG002|Overall Study|Sponsor decision|1|||
46915415|NCT01341470|83146117|FG003|Overall Study|Sponsor decision|1|||
46915416|NCT01341470|83146118|FG004|Overall Study|Sponsor decision|0|||
46915417|NCT01341470|83146119|FG005|Overall Study|Sponsor decision|1|||
46915418|NCT03143101|83146138|FG000|Overall Study|Withdrawal by Subject|0|||
46915419|NCT03143101|83146139|FG001|Overall Study|Withdrawal by Subject|1|||
46915420|NCT03143101|83146140|FG002|Overall Study|Withdrawal by Subject|0|||
46915421|NCT03143101|83146138|FG000|Overall Study|Lost to Follow-up|2|||
46915422|NCT03143101|83146139|FG001|Overall Study|Lost to Follow-up|2|||
46915423|NCT03143101|83146140|FG002|Overall Study|Lost to Follow-up|0|||
46915424|NCT00871351|83146151|FG000|Overall Study|Withdrawal by Subject|1|||
46915425|NCT00871351|83146152|FG001|Overall Study|Withdrawal by Subject|0|||
46915426|NCT00871351|83146153|FG002|Overall Study|Withdrawal by Subject|0|||
46915427|NCT00871351|83146151|FG000|Overall Study|Adverse Event|3|||
46915428|NCT00871351|83146152|FG001|Overall Study|Adverse Event|1|||
46915429|NCT00871351|83146153|FG002|Overall Study|Adverse Event|0|||
46915430|NCT02745080|83146163|FG000|Overall Study|Adverse Event|13|||
46915431|NCT02745080|83146164|FG001|Overall Study|Adverse Event|21|||
46915432|NCT02745080|83146163|FG000|Overall Study|Lack of Efficacy|11|||
46915433|NCT02745080|83146164|FG001|Overall Study|Lack of Efficacy|23|||
46915434|NCT02745080|83146163|FG000|Overall Study|Lost to Follow-up|3|||
46915435|NCT02745080|83146164|FG001|Overall Study|Lost to Follow-up|3|||
46915436|NCT02745080|83146163|FG000|Overall Study|Physician Decision|3|||
46915437|NCT02745080|83146164|FG001|Overall Study|Physician Decision|0|||
46915438|NCT02745080|83146163|FG000|Overall Study|Protocol Violation|3|||
46915439|NCT02745080|83146164|FG001|Overall Study|Protocol Violation|1|||
46915440|NCT02745080|83146163|FG000|Overall Study|Withdrawal by Subject|22|||
46915441|NCT02745080|83146164|FG001|Overall Study|Withdrawal by Subject|41|||
47040406|NCT01728194|83294457|FG000|Overall Study|Physician Decision|4|||
47040407|NCT01728194|83294458|FG001|Overall Study|Physician Decision|0|||
47040408|NCT01728194|83294457|FG000|Overall Study|Withdrawal by Subject|7|||
46632235|NCT01843062|82805331|FG000|Overall Study|Death|1|||
46719033|NCT01005966|82935178|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
46719034|NCT01005966|82935179|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
46719035|NCT01005966|82935175|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
46719036|NCT01005966|82935176|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
46719037|NCT01005966|82935177|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
46719038|NCT01005966|82935178|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
46719039|NCT01005966|82935179|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
46719040|NCT01005966|82935175|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
46719041|NCT01005966|82935176|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
46719042|NCT01005966|82935177|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
46719043|NCT01005966|82935178|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
46719044|NCT01005966|82935179|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
46719045|NCT01005966|82935175|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
46719046|NCT01005966|82935176|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
46719047|NCT01005966|82935177|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
46719048|NCT01005966|82935178|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
46719049|NCT01005966|82935179|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
46719050|NCT01005966|82935175|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
46719051|NCT01005966|82935176|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
46719052|NCT01005966|82935177|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
46719053|NCT01005966|82935178|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
46719054|NCT01005966|82935179|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
46719055|NCT01005966|82935175|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
46719056|NCT01005966|82935176|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
46719057|NCT01005966|82935177|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
46719058|NCT01005966|82935178|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
46719059|NCT01005966|82935179|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
46719060|NCT01005732|82935205|FG000|Overall Study|Lost to Follow-up|10|||
46719061|NCT01005732|82935205|FG000|Overall Study|Death|1|||
46719062|NCT00603382|82935219|FG000|Overall Study|Adverse Event|0|||
46719063|NCT00603382|82935220|FG001|Overall Study|Adverse Event|1|||
46719064|NCT00603382|82935221|FG002|Overall Study|Adverse Event|1|||
46719065|NCT00603382|82935222|FG003|Overall Study|Adverse Event|2|||
46719066|NCT00603382|82935223|FG004|Overall Study|Adverse Event|1|||
46719067|NCT00603382|82935224|FG005|Overall Study|Adverse Event|2|||
46719068|NCT00603382|82935219|FG000|Overall Study|Lack of Efficacy|14|||
46719069|NCT00603382|82935220|FG001|Overall Study|Lack of Efficacy|9|||
46719070|NCT00603382|82935221|FG002|Overall Study|Lack of Efficacy|3|||
46719071|NCT00603382|82935222|FG003|Overall Study|Lack of Efficacy|6|||
46719072|NCT00603382|82935223|FG004|Overall Study|Lack of Efficacy|6|||
46719073|NCT00603382|82935224|FG005|Overall Study|Lack of Efficacy|11|||
46719074|NCT00603382|82935219|FG000|Overall Study|Protocol Violation|1|||
46719075|NCT00603382|82935220|FG001|Overall Study|Protocol Violation|0|||
46719076|NCT00603382|82935221|FG002|Overall Study|Protocol Violation|1|||
47040409|NCT01728194|83294458|FG001|Overall Study|Withdrawal by Subject|3|||
46632236|NCT01843062|82805332|FG001|Overall Study|Death|2|||
46632237|NCT01843062|82805331|FG000|Overall Study|Lost to Follow-up|2|||
46632238|NCT01843062|82805332|FG001|Overall Study|Lost to Follow-up|4|||
46632239|NCT01842438|82805340|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
46632240|NCT01842438|82805341|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
46632241|NCT01842438|82805340|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
46632242|NCT01842438|82805341|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
46632243|NCT01842438|82805340|FG000|T2: 6month Follow-up|Death|0|||
46632244|NCT01842438|82805341|FG001|T2: 6month Follow-up|Death|1|||
46632245|NCT01799226|82805353|FG000|Overall Study|Withdrawal by Subject|1|||
46632246|NCT01799226|82805354|FG001|Overall Study|Withdrawal by Subject|0|||
46719077|NCT00603382|82935222|FG003|Overall Study|Protocol Violation|2|||
46719078|NCT00603382|82935223|FG004|Overall Study|Protocol Violation|1|||
46719079|NCT00603382|82935224|FG005|Overall Study|Protocol Violation|0|||
46719080|NCT00603382|82935219|FG000|Overall Study|Lost to Follow-up|0|||
46719081|NCT00603382|82935220|FG001|Overall Study|Lost to Follow-up|1|||
46719082|NCT00603382|82935221|FG002|Overall Study|Lost to Follow-up|1|||
46719083|NCT00603382|82935222|FG003|Overall Study|Lost to Follow-up|1|||
47040410|NCT01728194|83294457|FG000|Overall Study|Perceived Medication Side Effects|4|||
46719084|NCT00603382|82935223|FG004|Overall Study|Lost to Follow-up|0|||
46719085|NCT00603382|82935224|FG005|Overall Study|Lost to Follow-up|1|||
46719086|NCT00603382|82935219|FG000|Overall Study|Physician Decision|0|||
46719087|NCT00603382|82935220|FG001|Overall Study|Physician Decision|0|||
47040411|NCT01728194|83294458|FG001|Overall Study|Perceived Medication Side Effects|0|||
46719088|NCT00603382|82935221|FG002|Overall Study|Physician Decision|2|||
46719089|NCT00603382|82935222|FG003|Overall Study|Physician Decision|0|||
46719090|NCT00603382|82935223|FG004|Overall Study|Physician Decision|1|||
46719091|NCT00603382|82935224|FG005|Overall Study|Physician Decision|3|||
46719092|NCT00603382|82935219|FG000|Overall Study|Withdrawal by Subject|3|||
46719093|NCT00603382|82935220|FG001|Overall Study|Withdrawal by Subject|3|||
46719094|NCT00603382|82935221|FG002|Overall Study|Withdrawal by Subject|1|||
46719095|NCT00603382|82935222|FG003|Overall Study|Withdrawal by Subject|1|||
46719096|NCT00603382|82935223|FG004|Overall Study|Withdrawal by Subject|0|||
46719097|NCT00603382|82935224|FG005|Overall Study|Withdrawal by Subject|1|||
46719098|NCT01176266|82935238|FG000|Overall Study|Death|6|||
46719099|NCT01176266|82935238|FG000|Overall Study|Withdrawal by Subject|3|||
46719100|NCT01182428|82935248|FG000|Overall Study|Physician Decision|1|||
46719101|NCT01182428|82935249|FG001|Overall Study|Physician Decision|0|||
46719102|NCT01182428|82935248|FG000|Overall Study|Lost to Follow-up|9|||
46719103|NCT01182428|82935249|FG001|Overall Study|Lost to Follow-up|1|||
46719104|NCT01182428|82935248|FG000|Overall Study|Withdrawal by Subject|1|||
46719105|NCT01182428|82935249|FG001|Overall Study|Withdrawal by Subject|0|||
46719106|NCT00603304|82935257|FG000|Overall Study|Lost to Follow-up|5|||
46719107|NCT00603304|82935258|FG001|Overall Study|Lost to Follow-up|7|||
46719108|NCT00603304|82935257|FG000|Overall Study|Withdrawal by Subject|8|||
46632247|NCT01799226|82805353|FG000|Overall Study|Disqualified at Day 14|1|||
46632248|NCT01799226|82805354|FG001|Overall Study|Disqualified at Day 14|0|||
46719109|NCT00603304|82935258|FG001|Overall Study|Withdrawal by Subject|5|||
46719110|NCT00603304|82935257|FG000|Overall Study|Protocol Violation|1|||
46719111|NCT00603304|82935258|FG001|Overall Study|Protocol Violation|0|||
46719112|NCT00603304|82935257|FG000|Overall Study|Adverse Event|4|||
46719113|NCT00603304|82935258|FG001|Overall Study|Adverse Event|2|||
46719114|NCT00603304|82935257|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
46719115|NCT00603304|82935258|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
46719116|NCT00603304|82935257|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
46719117|NCT00603304|82935258|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
46719118|NCT00603304|82935257|FG000|Overall Study|Exclusionary Medication|2|||
46719119|NCT00603304|82935258|FG001|Overall Study|Exclusionary Medication|3|||
46719120|NCT00603304|82935257|FG000|Overall Study|Non-Compliant|0|||
46719121|NCT00603304|82935258|FG001|Overall Study|Non-Compliant|1|||
46719122|NCT00603304|82935257|FG000|Overall Study|Moved Away|0|||
46719123|NCT00603304|82935258|FG001|Overall Study|Moved Away|2|||
46719124|NCT00603304|82935257|FG000|Overall Study|Other|2|||
46719125|NCT00603304|82935258|FG001|Overall Study|Other|0|||
46719126|NCT00603304|82935257|FG000|Overall Study|Patient Decision|2|||
46719127|NCT00603304|82935258|FG001|Overall Study|Patient Decision|0|||
46719128|NCT01176032|82935268|FG000|Overall Study|Adverse Event|1|||
46719129|NCT01176032|82935269|FG001|Overall Study|Adverse Event|0|||
46719130|NCT01176032|82935268|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46719131|NCT01176032|82935269|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46719132|NCT01176032|82935268|FG000|Overall Study|Protocol Violation|1|||
46719133|NCT01176032|82935269|FG001|Overall Study|Protocol Violation|0|||
46719134|NCT01176032|82935268|FG000|Overall Study|Informed consent withdrawn|3|||
46719135|NCT01176032|82935269|FG001|Overall Study|Informed consent withdrawn|0|||
46719136|NCT01176032|82935268|FG000|Overall Study|Other|1|||
46719137|NCT01176032|82935269|FG001|Overall Study|Other|0|||
46632249|NCT01825200|82805362|FG000|Overall Study|Lost to Follow-up|5|||
46632250|NCT01825200|82805363|FG001|Overall Study|Lost to Follow-up|6|||
46632251|NCT01825200|82805362|FG000|Overall Study|Withdrawal by Subject|0|||
46632252|NCT01825200|82805363|FG001|Overall Study|Withdrawal by Subject|1|||
46632253|NCT01824576|82805369|FG000|Overall Study|Device deficiency|2|||
46632254|NCT01824498|82805379|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
46632255|NCT01824498|82805380|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
46632256|NCT01824498|82805381|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
46632257|NCT01824498|82805382|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
46719138|NCT01008618|82935280|FG000|Period 1 (Titration Period)|Physician Decision|2|||
46719139|NCT01008618|82935281|FG001|Period 1 (Titration Period)|Physician Decision|0|||
46719140|NCT01008618|82935282|FG002|Period 1 (Titration Period)|Physician Decision|0|||
46719141|NCT01008618|82935280|FG000|Period 1 (Titration Period)|Adverse Event|33|||
46719142|NCT01008618|82935281|FG001|Period 1 (Titration Period)|Adverse Event|0|||
46719143|NCT01008618|82935282|FG002|Period 1 (Titration Period)|Adverse Event|0|||
46719144|NCT01008618|82935280|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
46719145|NCT01008618|82935281|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
46719146|NCT01008618|82935282|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
46719147|NCT01008618|82935280|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
46719148|NCT01008618|82935281|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
46719149|NCT01008618|82935282|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
46719150|NCT01008618|82935280|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
46719151|NCT01008618|82935281|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
46719152|NCT01008618|82935282|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
46719153|NCT01008618|82935280|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
46719154|NCT01008618|82935281|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
46719155|NCT01008618|82935282|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
46719156|NCT01008618|82935280|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
46719157|NCT01008618|82935281|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
46719158|NCT01008618|82935282|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
46719159|NCT01008618|82935280|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
46719160|NCT01008618|82935281|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
46719161|NCT01008618|82935282|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
46719162|NCT01008618|82935280|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
46719163|NCT01008618|82935281|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
46719164|NCT01008618|82935282|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
46719165|NCT01008618|82935280|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
46719166|NCT01008618|82935281|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
46719167|NCT01008618|82935282|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
46719168|NCT01008618|82935280|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
46719169|NCT01008618|82935281|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
46719170|NCT01008618|82935282|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
46719171|NCT01008618|82935280|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
46719172|NCT01008618|82935281|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
46719173|NCT01008618|82935282|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
46719174|NCT01001208|82935293|FG000|Overall Study|Adverse Event|10|||
46719175|NCT01001208|82935294|FG001|Overall Study|Adverse Event|5|||
46719176|NCT01001208|82935293|FG000|Overall Study|Lost to Follow-up|5|||
46719177|NCT01001208|82935294|FG001|Overall Study|Lost to Follow-up|9|||
46719178|NCT01001208|82935293|FG000|Overall Study|Physician Decision|1|||
46719179|NCT01001208|82935294|FG001|Overall Study|Physician Decision|0|||
46719180|NCT01001208|82935293|FG000|Overall Study|Withdrawal by Subject|4|||
46719181|NCT01001208|82935294|FG001|Overall Study|Withdrawal by Subject|5|||
46719182|NCT01001208|82935293|FG000|Overall Study|Ineligibility Determined|4|||
46719183|NCT01001208|82935294|FG001|Overall Study|Ineligibility Determined|2|||
46719184|NCT01001208|82935293|FG000|Overall Study|Noncompliance|4|||
46719185|NCT01001208|82935294|FG001|Overall Study|Noncompliance|7|||
46719186|NCT01001208|82935293|FG000|Overall Study|Disease Progression|0|||
46719187|NCT01001208|82935294|FG001|Overall Study|Disease Progression|3|||
46719188|NCT01001208|82935293|FG000|Overall Study|Other|0|||
46719189|NCT01001208|82935294|FG001|Overall Study|Other|2|||
46719190|NCT01000974|82935303|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
46719191|NCT01000974|82935304|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
46719192|NCT01000974|82935305|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
46719193|NCT01000974|82935303|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
46915442|NCT00521599|83146174|FG000|Overall Study|Adverse Event|5|||
46915443|NCT00521599|83146175|FG001|Overall Study|Adverse Event|7|||
46915444|NCT00521599|83146176|FG002|Overall Study|Adverse Event|6|||
46915445|NCT00521599|83146174|FG000|Overall Study|Treatment Failure|8|||
46915446|NCT00521599|83146175|FG001|Overall Study|Treatment Failure|9|||
46915447|NCT00521599|83146176|FG002|Overall Study|Treatment Failure|22|||
46915448|NCT00521599|83146174|FG000|Overall Study|Lost to Follow-up|2|||
46915449|NCT00521599|83146175|FG001|Overall Study|Lost to Follow-up|1|||
46915450|NCT00521599|83146176|FG002|Overall Study|Lost to Follow-up|2|||
46915451|NCT00521599|83146174|FG000|Overall Study|Withdrawal by Subject|3|||
46915452|NCT00521599|83146175|FG001|Overall Study|Withdrawal by Subject|5|||
46915453|NCT00521599|83146176|FG002|Overall Study|Withdrawal by Subject|1|||
46915454|NCT00521599|83146174|FG000|Overall Study|Withdrawal by subject treatment related|3|||
46915455|NCT00521599|83146175|FG001|Overall Study|Withdrawal by subject treatment related|1|||
46632258|NCT01824498|82805383|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
46632259|NCT01824498|82805384|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
46632260|NCT01798134|82805392|FG000|Overall Study|Lost to Follow-up|1|||
46632261|NCT01798134|82805392|FG000|Overall Study|Withdrawal by Subject|3|||
46632262|NCT01798134|82805392|FG000|Overall Study|Death|2|||
46632263|NCT01798134|82805392|FG000|Overall Study|Adverse Event|3|||
46632264|NCT01798134|82805392|FG000|Overall Study|Physician Decision|3|||
46632265|NCT01798134|82805392|FG000|Overall Study|Liver transplant/surgery|4|||
46632266|NCT01798056|82805398|FG000|Overall Study|Serious Adverse Event|13|||
46632267|NCT01798056|82805399|FG001|Overall Study|Serious Adverse Event|12|||
46719194|NCT01000974|82935304|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
46719195|NCT01000974|82935305|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
46719196|NCT01000974|82935303|FG000|Primary Vaccination Phase|Protocol Violation|40|||
46915456|NCT00521599|83146176|FG002|Overall Study|Withdrawal by subject treatment related|2|||
46915457|NCT00521599|83146174|FG000|Overall Study|Protocol Violation|2|||
46719197|NCT01000974|82935304|FG001|Primary Vaccination Phase|Protocol Violation|3|||
46915458|NCT00521599|83146175|FG001|Overall Study|Protocol Violation|4|||
46719198|NCT01000974|82935305|FG002|Primary Vaccination Phase|Protocol Violation|2|||
46719199|NCT01000974|82935303|FG000|Primary Vaccination Phase|Adverse Event|14|||
46719200|NCT01000974|82935304|FG001|Primary Vaccination Phase|Adverse Event|2|||
46719201|NCT01000974|82935305|FG002|Primary Vaccination Phase|Adverse Event|2|||
46719202|NCT01000974|82935303|FG000|Primary Vaccination Phase|Other|4|||
46719203|NCT01000974|82935304|FG001|Primary Vaccination Phase|Other|9|||
46719204|NCT01000974|82935305|FG002|Primary Vaccination Phase|Other|12|||
46719205|NCT01000974|82935303|FG000|Booster Vaccination Phase|Protocol Violation|0|||
46719206|NCT01000974|82935304|FG001|Booster Vaccination Phase|Protocol Violation|0|||
46719207|NCT01000974|82935305|FG002|Booster Vaccination Phase|Protocol Violation|2|||
46719208|NCT01000974|82935303|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
47040412|NCT01728194|83294457|FG000|Overall Study|Family Member Request|1|||
47040413|NCT01728194|83294458|FG001|Overall Study|Family Member Request|0|||
47040414|NCT01782482|83294466|FG000|Overall Study|Adverse Event|2|||
47040415|NCT01782482|83294467|FG001|Overall Study|Adverse Event|1|||
47040416|NCT01782482|83294466|FG000|Overall Study|Lost to Follow-up|2|||
47040417|NCT01782482|83294467|FG001|Overall Study|Lost to Follow-up|3|||
47040418|NCT01782482|83294466|FG000|Overall Study|Physician Decision|1|||
47040419|NCT01782482|83294467|FG001|Overall Study|Physician Decision|0|||
47040420|NCT01782482|83294466|FG000|Overall Study|Protocol Violation|1|||
47040421|NCT01782482|83294467|FG001|Overall Study|Protocol Violation|0|||
47040422|NCT01782482|83294466|FG000|Overall Study|Withdrawal by Subject|2|||
47040423|NCT01782482|83294467|FG001|Overall Study|Withdrawal by Subject|3|||
47040424|NCT01782482|83294466|FG000|Overall Study|Randomized in Error|2|||
47040425|NCT01782482|83294467|FG001|Overall Study|Randomized in Error|2|||
47040426|NCT01782482|83294466|FG000|Overall Study|Habitually wearing toric lens OS|0|||
47040427|NCT01782482|83294467|FG001|Overall Study|Habitually wearing toric lens OS|1|||
47040428|NCT01466673|83294475|FG000|Overall Study|Non-compliance with study treatment|2|||
47040429|NCT01466673|83294476|FG001|Overall Study|Non-compliance with study treatment|0|||
47040430|NCT01466673|83294475|FG000|Overall Study|Lost to Follow-up|3|||
47040431|NCT01466673|83294476|FG001|Overall Study|Lost to Follow-up|5|||
47040432|NCT01466673|83294475|FG000|Overall Study|Adverse Event|2|||
47040433|NCT01466673|83294476|FG001|Overall Study|Adverse Event|1|||
47040434|NCT01753856|83294484|FG000|Overall Study|Adverse Event|1|||
47040435|NCT01753856|83294485|FG001|Overall Study|Adverse Event|0|||
47040436|NCT01753856|83294484|FG000|Overall Study|Withdrawal by Subject|0|||
47040437|NCT01753856|83294485|FG001|Overall Study|Withdrawal by Subject|2|||
47040438|NCT01753856|83294484|FG000|Overall Study|Sponsor Decision|2|||
47040439|NCT01753856|83294485|FG001|Overall Study|Sponsor Decision|0|||
47040440|NCT01464333|83294494|FG000|Overall Study|Adverse Event|34|||
47040441|NCT01464333|83294494|FG000|Overall Study|Lack of Efficacy|72|||
47040442|NCT01464333|83294494|FG000|Overall Study|Withdrawal by Subject|11|||
47040443|NCT01464333|83294494|FG000|Overall Study|Other|4|||
47040444|NCT01464333|83294494|FG000|Overall Study|No Hospital Visit|42|||
47040445|NCT01464255|83294500|FG000|Overall Study|unresolve corneal staining|0|||
47040446|NCT01464255|83294501|FG001|Overall Study|unresolve corneal staining|1|||
47040447|NCT01464021|83294508|FG000|Overall Study|Withdrawal by Subject|13|||
47040448|NCT01464021|83294508|FG000|Overall Study|Lost to Follow-up|1|||
47040449|NCT01464021|83294508|FG000|Overall Study|Lack of Efficacy|1|||
46632268|NCT01798056|82805398|FG000|Overall Study|Withdrawal by Subject|12|||
46632269|NCT01798056|82805399|FG001|Overall Study|Withdrawal by Subject|9|||
46632270|NCT01798056|82805398|FG000|Overall Study|Migrated/moved from study area|1|||
46632271|NCT01798056|82805399|FG001|Overall Study|Migrated/moved from study area|1|||
46632272|NCT01798056|82805398|FG000|Overall Study|Lost to Follow-up|1|||
46632273|NCT01798056|82805399|FG001|Overall Study|Lost to Follow-up|1|||
46632274|NCT01798056|82805398|FG000|Overall Study|Other|0|||
46632275|NCT01798056|82805399|FG001|Overall Study|Other|2|||
46632276|NCT01824342|82805409|FG000|Overall Study|Withdrawal by Subject|0|||
46632277|NCT01824342|82805410|FG001|Overall Study|Withdrawal by Subject|3|||
46632278|NCT01824342|82805409|FG000|Overall Study|Adverse Event|1|||
46632279|NCT01824342|82805410|FG001|Overall Study|Adverse Event|1|||
46719209|NCT01000974|82935304|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
46632280|NCT01824342|82805409|FG000|Overall Study|Disease Progression|1|||
46632281|NCT01824342|82805410|FG001|Overall Study|Disease Progression|1|||
47040450|NCT01464021|83294508|FG000|Overall Study|various|11|||
47040451|NCT01753310|83294514|FG000|Overall Study|Entered into open label extension study|25|||
47040452|NCT01753310|83294515|FG001|Overall Study|Entered into open label extension study|22|||
47040453|NCT01753310|83294514|FG000|Overall Study|Adverse Event|1|||
47040454|NCT01753310|83294515|FG001|Overall Study|Adverse Event|0|||
46719210|NCT01000974|82935305|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
47040455|NCT01753310|83294514|FG000|Overall Study|Lost to Follow-up|2|||
47040456|NCT01753310|83294515|FG001|Overall Study|Lost to Follow-up|0|||
47040457|NCT01753310|83294514|FG000|Overall Study|Subject decision|2|||
47040458|NCT01753310|83294515|FG001|Overall Study|Subject decision|2|||
46632282|NCT01824342|82805409|FG000|Overall Study|Physician Decision|5|||
47040459|NCT01753310|83294514|FG000|Overall Study|Sponsor decision|1|||
47040460|NCT01753310|83294515|FG001|Overall Study|Sponsor decision|0|||
47040461|NCT01753310|83294514|FG000|Overall Study|Withdrawal by Subject|1|||
47040462|NCT01753310|83294515|FG001|Overall Study|Withdrawal by Subject|0|||
47040463|NCT01463631|83294525|FG000|Overall Study|Withdrawal by Subject|0|||
47040464|NCT01463631|83294526|FG001|Overall Study|Withdrawal by Subject|0|||
47040465|NCT01463631|83294527|FG002|Overall Study|Withdrawal by Subject|0|||
47040466|NCT01463631|83294528|FG003|Overall Study|Withdrawal by Subject|1|||
47040467|NCT01463631|83294525|FG000|Overall Study|Death|0|||
47040468|NCT01463631|83294526|FG001|Overall Study|Death|0|||
47040469|NCT01463631|83294527|FG002|Overall Study|Death|1|||
47040470|NCT01463631|83294528|FG003|Overall Study|Death|0|||
47040471|NCT01463631|83294525|FG000|Overall Study|Progressive Disease|0|||
47040472|NCT01463631|83294526|FG001|Overall Study|Progressive Disease|0|||
47040473|NCT01463631|83294527|FG002|Overall Study|Progressive Disease|0|||
47040474|NCT01463631|83294528|FG003|Overall Study|Progressive Disease|5|||
47040475|NCT01521507|83294542|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
47040476|NCT01521507|83294543|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
47040477|NCT01521507|83294542|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
47040478|NCT01521507|83294543|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
47040479|NCT01521507|83294542|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
47040480|NCT01521507|83294543|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
47040481|NCT01521507|83294542|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
47040482|NCT01521507|83294543|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
47040483|NCT01521507|83294542|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
46632283|NCT01824342|82805410|FG001|Overall Study|Physician Decision|0|||
46719211|NCT01000974|82935303|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
46719212|NCT01000974|82935304|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
46719213|NCT01000974|82935305|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
46719214|NCT01000974|82935303|FG000|Booster Vaccination Phase|Other|24|||
46719215|NCT01000974|82935304|FG001|Booster Vaccination Phase|Other|6|||
46719216|NCT01000974|82935305|FG002|Booster Vaccination Phase|Other|4|||
46719217|NCT01004406|82935318|FG000|Overall Study|Withdrawal by Subject|2|||
46719218|NCT01004406|82935319|FG001|Overall Study|Withdrawal by Subject|0|||
46719219|NCT01004406|82935318|FG000|Overall Study|Lost to Follow-up|1|||
46719220|NCT01004406|82935319|FG001|Overall Study|Lost to Follow-up|0|||
46719221|NCT01182350|82935325|FG000|Overall Study|Adverse Event|5|||
46719222|NCT01182350|82935326|FG001|Overall Study|Adverse Event|0|||
46719223|NCT01182350|82935327|FG002|Overall Study|Adverse Event|0|||
46719224|NCT01182350|82935328|FG003|Overall Study|Adverse Event|0|||
46719225|NCT01182350|82935329|FG004|Overall Study|Adverse Event|0|||
46719226|NCT01182350|82935325|FG000|Overall Study|Disease Progression|15|||
46719227|NCT01182350|82935326|FG001|Overall Study|Disease Progression|12|||
46719228|NCT01182350|82935327|FG002|Overall Study|Disease Progression|0|||
46719229|NCT01182350|82935328|FG003|Overall Study|Disease Progression|1|||
46719230|NCT01182350|82935329|FG004|Overall Study|Disease Progression|0|||
46719231|NCT01182350|82935325|FG000|Overall Study|Death|0|||
46719232|NCT01182350|82935326|FG001|Overall Study|Death|1|||
46719233|NCT01182350|82935327|FG002|Overall Study|Death|1|||
46719234|NCT01182350|82935328|FG003|Overall Study|Death|0|||
46719235|NCT01182350|82935329|FG004|Overall Study|Death|0|||
46719236|NCT01182350|82935325|FG000|Overall Study|Withdrawal by Subject|3|||
46719237|NCT01182350|82935326|FG001|Overall Study|Withdrawal by Subject|1|||
46719238|NCT01182350|82935327|FG002|Overall Study|Withdrawal by Subject|0|||
46719239|NCT01182350|82935328|FG003|Overall Study|Withdrawal by Subject|1|||
46719240|NCT01182350|82935329|FG004|Overall Study|Withdrawal by Subject|0|||
46632284|NCT01824342|82805409|FG000|Overall Study|Death|2|||
46632285|NCT01824342|82805410|FG001|Overall Study|Death|0|||
46632286|NCT01841970|82805416|FG000|Overall Study|Withdrawal by Subject|1|||
46632287|NCT01841970|82805416|FG000|Overall Study|Physician Decision|2|||
46632288|NCT01841970|82805416|FG000|Overall Study|Lost to Follow-up|8|||
46632289|NCT01823328|82805425|FG000|Overall Study|Withdrawal by Subject|8|||
46632290|NCT01823328|82805426|FG001|Overall Study|Withdrawal by Subject|6|||
46632291|NCT01840410|82805434|FG000|Overall Study|Physician Decision|1|||
46632292|NCT01840410|82805435|FG001|Overall Study|Physician Decision|2|||
46719241|NCT01182350|82935325|FG000|Overall Study|Alternative Therapy|2|||
46719242|NCT01182350|82935326|FG001|Overall Study|Alternative Therapy|0|||
46632293|NCT01840410|82805434|FG000|Overall Study|Pregnancy|1|||
46632294|NCT01840410|82805435|FG001|Overall Study|Pregnancy|0|||
47040484|NCT01521507|83294543|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
46632295|NCT01840410|82805434|FG000|Overall Study|Protocol deviation|1|||
46719243|NCT01182350|82935327|FG002|Overall Study|Alternative Therapy|1|||
46719244|NCT01182350|82935328|FG003|Overall Study|Alternative Therapy|0|||
46719245|NCT01182350|82935329|FG004|Overall Study|Alternative Therapy|0|||
46719246|NCT01182350|82935325|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
46719247|NCT01182350|82935326|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
46719248|NCT01182350|82935327|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
47040485|NCT01521507|83294542|FG000|Stage 2: Observational Design|Physician Decision|1|||
47040486|NCT01521507|83294543|FG001|Stage 2: Observational Design|Physician Decision|0|||
46915459|NCT00521599|83146176|FG002|Overall Study|Protocol Violation|2|||
46915460|NCT00521599|83146174|FG000|Overall Study|Did not meet protocol eligibility|2|||
46915461|NCT00521599|83146175|FG001|Overall Study|Did not meet protocol eligibility|2|||
46915462|NCT00521599|83146176|FG002|Overall Study|Did not meet protocol eligibility|1|||
46915463|NCT00442897|83146187|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
46915464|NCT00442897|83146188|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
46915465|NCT00442897|83146187|FG000|Base Study (12 Week Follow-up)|Death|0|||
46915466|NCT00442897|83146188|FG001|Base Study (12 Week Follow-up)|Death|1|||
46915467|NCT00442897|83146187|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
46915468|NCT00442897|83146188|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
46915469|NCT00442897|83146187|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
46915470|NCT00442897|83146188|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
46915471|NCT00442897|83146187|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
46915472|NCT00442897|83146188|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
46915473|NCT00442897|83146187|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
46915474|NCT00442897|83146188|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
46915475|NCT00442897|83146187|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
46915476|NCT00442897|83146188|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
46915477|NCT00442897|83146187|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
46915478|NCT00442897|83146188|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
46915479|NCT02834390|83146196|FG000|Induction Phase|Progressive disease|0|||
46915480|NCT02834390|83146197|FG001|Induction Phase|Progressive disease|1|||
46915481|NCT02834390|83146196|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
46915482|NCT02834390|83146197|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
46915483|NCT02834390|83146196|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
46915484|NCT02834390|83146197|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
46915485|NCT02834390|83146196|FG000|Consolidation Phase|Physician Decision|1|||
46915486|NCT02834390|83146197|FG001|Consolidation Phase|Physician Decision|1|||
46915487|NCT03141151|83146205|FG000|Overall Study|Lost to Follow-up|3|||
46915488|NCT03141151|83146206|FG001|Overall Study|Lost to Follow-up|2|||
46915489|NCT03141151|83146205|FG000|Overall Study|Withdrawal by Subject|3|||
46915490|NCT03141151|83146206|FG001|Overall Study|Withdrawal by Subject|2|||
47040487|NCT01521117|83294556|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
47040488|NCT01521117|83294557|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
47040489|NCT01521117|83294556|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
47040490|NCT01521117|83294557|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
47040491|NCT01521117|83294556|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
47040492|NCT01521117|83294557|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
47040493|NCT01466595|83294565|FG000|Overall Study|Withdrawal by Subject|0|||
47040494|NCT01466595|83294566|FG001|Overall Study|Withdrawal by Subject|1|||
47040495|NCT01728116|83294583|FG000|Overall Study|Sponsor Terminated Study|106|||
47040496|NCT01728116|83294584|FG001|Overall Study|Sponsor Terminated Study|35|||
47040497|NCT01728116|83294583|FG000|Overall Study|Withdrawal by Subject|16|||
47040498|NCT01728116|83294584|FG001|Overall Study|Withdrawal by Subject|9|||
47040499|NCT01728116|83294583|FG000|Overall Study|Adverse Event|13|||
47040500|NCT01728116|83294584|FG001|Overall Study|Adverse Event|0|||
47040501|NCT01728116|83294583|FG000|Overall Study|Procedure/device failure|7|||
47040502|NCT01728116|83294584|FG001|Overall Study|Procedure/device failure|0|||
47040503|NCT01728116|83294583|FG000|Overall Study|Lost to Follow-up|9|||
46632296|NCT01840410|82805435|FG001|Overall Study|Protocol deviation|0|||
46719249|NCT01182350|82935328|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
46632297|NCT01840410|82805434|FG000|Overall Study|Lost to Follow-up|1|||
46632298|NCT01840410|82805435|FG001|Overall Study|Lost to Follow-up|0|||
46632299|NCT01840410|82805434|FG000|Overall Study|Withdrawal by Subject|2|||
46719250|NCT01182350|82935329|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
46915491|NCT01358708|83146214|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
46915492|NCT01358708|83146215|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46915493|NCT01358708|83146214|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
46915494|NCT01358708|83146215|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
46915495|NCT01356602|83146228|FG000|Overall Study|Protocol Deviation|0|||
46915496|NCT01356602|83146229|FG001|Overall Study|Protocol Deviation|1|||
47040504|NCT01728116|83294584|FG001|Overall Study|Lost to Follow-up|2|||
47040505|NCT01728116|83294583|FG000|Overall Study|Physician Decision|2|||
46915497|NCT01356602|83146230|FG002|Overall Study|Protocol Deviation|1|||
46915498|NCT01356602|83146228|FG000|Overall Study|Administrative Problems|1|||
46915499|NCT01356602|83146229|FG001|Overall Study|Administrative Problems|4|||
46915500|NCT01356602|83146230|FG002|Overall Study|Administrative Problems|5|||
46915501|NCT01356602|83146228|FG000|Overall Study|Lost to Follow-up|4|||
46915502|NCT01356602|83146229|FG001|Overall Study|Lost to Follow-up|5|||
46915503|NCT01356602|83146230|FG002|Overall Study|Lost to Follow-up|6|||
46915504|NCT01356602|83146228|FG000|Overall Study|Withdrawal by Subject|4|||
46915505|NCT01356602|83146229|FG001|Overall Study|Withdrawal by Subject|3|||
46915506|NCT01356602|83146230|FG002|Overall Study|Withdrawal by Subject|7|||
46915507|NCT01356602|83146228|FG000|Overall Study|Lack of Efficacy|0|||
46915508|NCT01356602|83146229|FG001|Overall Study|Lack of Efficacy|1|||
46915509|NCT01356602|83146230|FG002|Overall Study|Lack of Efficacy|4|||
46915510|NCT01356602|83146228|FG000|Overall Study|Adverse Event|0|||
46915511|NCT01356602|83146229|FG001|Overall Study|Adverse Event|1|||
46915512|NCT01356602|83146230|FG002|Overall Study|Adverse Event|1|||
46915513|NCT02830880|83146238|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
46915514|NCT02830880|83146238|FG000|Overall Study|Death|1|||
46915515|NCT02830880|83146238|FG000|Overall Study|Physician Decision|1|||
46915516|NCT03141307|83146244|FG000|In-Hospital|Withdrawal by Subject|0|||
46915517|NCT03141307|83146245|FG001|In-Hospital|Withdrawal by Subject|2|||
46915518|NCT03141307|83146244|FG000|In-Hospital|Protocol Violation|4|||
46915519|NCT03141307|83146245|FG001|In-Hospital|Protocol Violation|0|||
46915520|NCT03141307|83146244|FG000|Follow-Up|Lost to Follow-up|97|||
46915521|NCT03141307|83146245|FG001|Follow-Up|Lost to Follow-up|54|||
46915522|NCT02825420|83146253|FG000|Overall Study|Death|30|||
46915523|NCT02825420|83146254|FG001|Overall Study|Death|12|||
46915524|NCT02825420|83146253|FG000|Overall Study|Progressive disease|6|||
46915525|NCT02825420|83146254|FG001|Overall Study|Progressive disease|1|||
46915526|NCT02825420|83146253|FG000|Overall Study|Lost to Follow-up|2|||
46915527|NCT02825420|83146254|FG001|Overall Study|Lost to Follow-up|2|||
46915528|NCT02825420|83146253|FG000|Overall Study|Withdrawal by Subject|1|||
46915529|NCT02825420|83146254|FG001|Overall Study|Withdrawal by Subject|1|||
46915530|NCT02825420|83146253|FG000|Overall Study|Protocol amendment not signed|1|||
46915531|NCT02825420|83146254|FG001|Overall Study|Protocol amendment not signed|1|||
46915532|NCT02825420|83146253|FG000|Overall Study|Physician Decision|1|||
46915533|NCT02825420|83146254|FG001|Overall Study|Physician Decision|0|||
46915534|NCT02825420|83146253|FG000|Overall Study|Did not receive PLD|2|||
46915535|NCT02825420|83146254|FG001|Overall Study|Did not receive PLD|0|||
46915536|NCT02829944|83146267|FG000|Overall Study|Physician Decision|0|||
46915537|NCT02829944|83146268|FG001|Overall Study|Physician Decision|1|||
46915538|NCT02829944|83146267|FG000|Overall Study|Screen Failure|2|||
46915539|NCT02829944|83146268|FG001|Overall Study|Screen Failure|2|||
46915540|NCT02829944|83146267|FG000|Overall Study|Inadequate Neuraxial Block|1|||
46915541|NCT02829944|83146268|FG001|Overall Study|Inadequate Neuraxial Block|1|||
46915542|NCT02829944|83146267|FG000|Overall Study|Withdrawal by Subject|2|||
46915543|NCT02829944|83146268|FG001|Overall Study|Withdrawal by Subject|1|||
46915544|NCT02829944|83146267|FG000|Overall Study|Catheter Displacement|1|||
46915545|NCT02829944|83146268|FG001|Overall Study|Catheter Displacement|0|||
46915546|NCT02829944|83146267|FG000|Overall Study|Catheter broke|0|||
46915547|NCT02829944|83146268|FG001|Overall Study|Catheter broke|1|||
46915548|NCT02829944|83146267|FG000|Overall Study|Staff unavailable|0|||
46915549|NCT02829944|83146268|FG001|Overall Study|Staff unavailable|1|||
46915550|NCT02824562|83146276|FG000|Overall Study|Lost to Follow-up|3|||
46915551|NCT02824562|83146277|FG001|Overall Study|Lost to Follow-up|4|||
46915552|NCT02824562|83146276|FG000|Overall Study|Death|0|||
46915553|NCT02824562|83146277|FG001|Overall Study|Death|1|||
46632300|NCT01840410|82805435|FG001|Overall Study|Withdrawal by Subject|1|||
46632301|NCT01840410|82805434|FG000|Overall Study|Adverse Event|1|||
46632302|NCT01840410|82805435|FG001|Overall Study|Adverse Event|1|||
46915554|NCT02744066|83146285|FG000|Overall Study|Withdrawal by parent|0|||
46915555|NCT02744066|83146286|FG001|Overall Study|Withdrawal by parent|1|||
46915556|NCT02744066|83146285|FG000|Overall Study|Discharged from NICU prior to completion|0|||
46915557|NCT02744066|83146286|FG001|Overall Study|Discharged from NICU prior to completion|4|||
46632303|NCT01797432|82805443|FG000|Overall Study|Lost to Follow-up|1|||
46915558|NCT01338818|83146294|FG000|Overall Study|Adverse Event|8|||
46915559|NCT01338818|83146294|FG000|Overall Study|Lack of Efficacy|5|||
46915560|NCT01338818|83146294|FG000|Overall Study|no longer require study drug|1|||
46632304|NCT01797432|82805443|FG000|Overall Study|Adverse Event|1|||
46915561|NCT01338818|83146294|FG000|Overall Study|Withdrawal by Subject|11|||
46915562|NCT01338818|83146294|FG000|Overall Study|Lost to Follow-up|4|||
46915563|NCT01338818|83146294|FG000|Overall Study|Administrative problems|3|||
46915564|NCT01338818|83146294|FG000|Overall Study|Protocol Deviation|4|||
46915565|NCT02823470|83146300|FG000|Overall Study|Adverse Event|1|||
46915566|NCT02823470|83146301|FG001|Overall Study|Adverse Event|0|||
46915567|NCT02823470|83146300|FG000|Overall Study|Study terminated by sponsor|8|||
46915568|NCT02823470|83146301|FG001|Overall Study|Study terminated by sponsor|15|||
46915569|NCT01371656|83146312|FG000|Overall Study|Death|7|||
46915570|NCT01371656|83146313|FG001|Overall Study|Death|4|||
47040506|NCT01728116|83294584|FG001|Overall Study|Physician Decision|0|||
47040507|NCT01728116|83294583|FG000|Overall Study|Subject Non-Compliance|2|||
47040508|NCT01728116|83294584|FG001|Overall Study|Subject Non-Compliance|0|||
47040509|NCT01728116|83294583|FG000|Overall Study|Inter-current finding at procedure|1|||
47040510|NCT01728116|83294584|FG001|Overall Study|Inter-current finding at procedure|0|||
47040511|NCT01728116|83294583|FG000|Overall Study|Incorrectly enrolled in Study|0|||
47040512|NCT01728116|83294584|FG001|Overall Study|Incorrectly enrolled in Study|1|||
47040513|NCT01728116|83294583|FG000|Overall Study|various not noted previously|5|||
47040514|NCT01728116|83294584|FG001|Overall Study|various not noted previously|0|||
47040515|NCT01465659|83294595|FG000|Completed 1 Cycle of Treatment|Death|0|||
47040516|NCT01465659|83294596|FG001|Completed 1 Cycle of Treatment|Death|1|||
47040517|NCT01465659|83294597|FG002|Completed 1 Cycle of Treatment|Death|0|||
47040518|NCT01465659|83294598|FG003|Completed 1 Cycle of Treatment|Death|0|||
47040519|NCT01465659|83294595|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
47040520|NCT01465659|83294596|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
47040521|NCT01465659|83294597|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
47040522|NCT01465659|83294598|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
47040523|NCT01465659|83294595|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
47040524|NCT01465659|83294596|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
47040525|NCT01465659|83294597|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
47040526|NCT01465659|83294598|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
47040527|NCT01465659|83294595|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
47040528|NCT01465659|83294596|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
47040529|NCT01465659|83294597|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
47040530|NCT01465659|83294598|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
47040531|NCT01465659|83294595|FG000|Completed Follow for 1 Year|Death|6|||
47040532|NCT01465659|83294596|FG001|Completed Follow for 1 Year|Death|3|||
47040533|NCT01465659|83294597|FG002|Completed Follow for 1 Year|Death|2|||
47040534|NCT01465659|83294598|FG003|Completed Follow for 1 Year|Death|4|||
47040535|NCT01753076|83294613|FG000|Overall Study|Adverse Event|17|||
47040536|NCT01753076|83294614|FG001|Overall Study|Adverse Event|18|||
47040537|NCT01753076|83294613|FG000|Overall Study|Lack of Efficacy|3|||
47040538|NCT01753076|83294614|FG001|Overall Study|Lack of Efficacy|1|||
47040539|NCT01753076|83294613|FG000|Overall Study|Lost to Follow-up|2|||
47040540|NCT01753076|83294614|FG001|Overall Study|Lost to Follow-up|1|||
47040541|NCT01753076|83294613|FG000|Overall Study|Physician Decision|4|||
47040542|NCT01753076|83294614|FG001|Overall Study|Physician Decision|2|||
47040543|NCT01753076|83294613|FG000|Overall Study|Withdrawal by Subject|14|||
47040544|NCT01753076|83294614|FG001|Overall Study|Withdrawal by Subject|24|||
47040545|NCT01753076|83294613|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
47040546|NCT01753076|83294614|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
47040547|NCT01463007|83294622|FG000|Overall Study|Physician Decision|1|||
47040548|NCT01462929|83294630|FG000|Overall Study|Adverse Event|3|||
46915571|NCT01371656|83146312|FG000|Overall Study|Physician Decision|46|||
46915572|NCT01371656|83146313|FG001|Overall Study|Physician Decision|7|||
46915573|NCT01371656|83146312|FG000|Overall Study|Withdrawal by Subject|7|||
46915574|NCT01371656|83146313|FG001|Overall Study|Withdrawal by Subject|0|||
46915575|NCT01371656|83146312|FG000|Overall Study|Ineligible|4|||
46915576|NCT01371656|83146313|FG001|Overall Study|Ineligible|3|||
46915577|NCT01354106|83146319|FG000|Overall Study|Withdrawal by Subject|2|||
47040549|NCT01462929|83294631|FG001|Overall Study|Adverse Event|3|||
47040550|NCT01462929|83294632|FG002|Overall Study|Adverse Event|4|||
47040551|NCT01462929|83294630|FG000|Overall Study|Withdrawal by Subject|2|||
47040552|NCT01462929|83294631|FG001|Overall Study|Withdrawal by Subject|1|||
47040553|NCT01462929|83294632|FG002|Overall Study|Withdrawal by Subject|0|||
47040554|NCT01462929|83294630|FG000|Overall Study|Lack of Efficacy|0|||
47040555|NCT01462929|83294631|FG001|Overall Study|Lack of Efficacy|0|||
47040556|NCT01462929|83294632|FG002|Overall Study|Lack of Efficacy|1|||
47040557|NCT01462695|83294642|FG000|Overall Study|Adverse Event|1|||
46915578|NCT01354028|83146325|FG000|Overall Study|Physician Decision|0|||
46915579|NCT01354028|83146326|FG001|Overall Study|Physician Decision|2|||
46915580|NCT01354028|83146325|FG000|Overall Study|Discharged before study start|2|||
47040558|NCT01462695|83294643|FG001|Overall Study|Adverse Event|1|||
47040559|NCT01462695|83294642|FG000|Overall Study|Death|2|||
47040560|NCT01462695|83294643|FG001|Overall Study|Death|0|||
47040561|NCT01462695|83294642|FG000|Overall Study|Lack of Efficacy|6|||
47040562|NCT01462695|83294643|FG001|Overall Study|Lack of Efficacy|12|||
47040563|NCT01462695|83294642|FG000|Overall Study|Physician Decision|5|||
46915581|NCT01354028|83146326|FG001|Overall Study|Discharged before study start|2|||
47040564|NCT01462695|83294643|FG001|Overall Study|Physician Decision|0|||
47040565|NCT01462695|83294642|FG000|Overall Study|Withdrawal by Subject|2|||
47040566|NCT01462695|83294643|FG001|Overall Study|Withdrawal by Subject|0|||
47040567|NCT01462695|83294642|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
46915582|NCT01354028|83146325|FG000|Overall Study|No quiet alert state|0|||
47040568|NCT01462695|83294643|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
47040569|NCT01465347|83294649|FG000|Overall Study|Withdrawal by Subject|1|||
47040570|NCT01465347|83294650|FG001|Overall Study|Withdrawal by Subject|1|||
47040571|NCT01465347|83294649|FG000|Overall Study|Physician Decision|0|||
47040572|NCT01465347|83294650|FG001|Overall Study|Physician Decision|1|||
47040573|NCT01465347|83294649|FG000|Overall Study|Admitted to hospice|0|||
47040574|NCT01465347|83294650|FG001|Overall Study|Admitted to hospice|1|||
47040575|NCT01465191|83294662|FG000|Overall Study|Protocol Violation|6|||
47040576|NCT01465191|83294663|FG001|Overall Study|Protocol Violation|3|||
47040577|NCT01465191|83294664|FG002|Overall Study|Protocol Violation|3|||
47040578|NCT01465191|83294662|FG000|Overall Study|Lost to Follow-up|3|||
47040579|NCT01465191|83294663|FG001|Overall Study|Lost to Follow-up|6|||
47040580|NCT01465191|83294664|FG002|Overall Study|Lost to Follow-up|4|||
47040581|NCT01519947|83294679|FG000|Overall Study|Death|0|||
47040582|NCT01519947|83294680|FG001|Overall Study|Death|0|||
47040583|NCT01519947|83294681|FG002|Overall Study|Death|0|||
47040584|NCT01519947|83294682|FG003|Overall Study|Death|1|||
47040585|NCT01519947|83294679|FG000|Overall Study|Protocol Violation|0|||
47040586|NCT01519947|83294680|FG001|Overall Study|Protocol Violation|0|||
47040587|NCT01519947|83294681|FG002|Overall Study|Protocol Violation|2|||
47040588|NCT01519947|83294682|FG003|Overall Study|Protocol Violation|1|||
47040589|NCT01519947|83294679|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
47040590|NCT01519947|83294680|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
47040591|NCT01519947|83294681|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
47040592|NCT01519947|83294682|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
47040593|NCT01519947|83294679|FG000|Overall Study|Development of Anemia|0|||
46632305|NCT01797432|82805443|FG000|Overall Study|Withdrawal by Subject|1|||
46719251|NCT01182350|82935325|FG000|Overall Study|Unevaluable for Biopsy|0|||
46719252|NCT01182350|82935326|FG001|Overall Study|Unevaluable for Biopsy|0|||
47040594|NCT01519947|83294680|FG001|Overall Study|Development of Anemia|1|||
47040595|NCT01519947|83294681|FG002|Overall Study|Development of Anemia|0|||
47040596|NCT01519947|83294682|FG003|Overall Study|Development of Anemia|1|||
47040597|NCT01519947|83294679|FG000|Overall Study|Blood Transfusion|0|||
47040598|NCT01519947|83294680|FG001|Overall Study|Blood Transfusion|1|||
47040599|NCT01519947|83294681|FG002|Overall Study|Blood Transfusion|1|||
47040600|NCT01519947|83294682|FG003|Overall Study|Blood Transfusion|0|||
47040601|NCT01519947|83294679|FG000|Overall Study|Withdrawal by Subject|0|||
47040602|NCT01519947|83294680|FG001|Overall Study|Withdrawal by Subject|1|||
47040603|NCT01519947|83294681|FG002|Overall Study|Withdrawal by Subject|0|||
47040604|NCT01519947|83294682|FG003|Overall Study|Withdrawal by Subject|1|||
47040605|NCT01519947|83294679|FG000|Overall Study|Lost to Follow-up|0|||
47040606|NCT01519947|83294680|FG001|Overall Study|Lost to Follow-up|0|||
46719253|NCT01182350|82935327|FG002|Overall Study|Unevaluable for Biopsy|0|||
46719254|NCT01182350|82935328|FG003|Overall Study|Unevaluable for Biopsy|0|||
46719255|NCT01182350|82935329|FG004|Overall Study|Unevaluable for Biopsy|3|||
46719256|NCT01163474|82935345|FG000|Overall Study|Withdrawal by Subject|1|||
46719257|NCT01163474|82935345|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
46719258|NCT01163474|82935345|FG000|Overall Study|Lost to Follow-up|3|||
46719259|NCT00603538|82935355|FG000|Overall Study|Adverse Event|0|||
46719260|NCT00603538|82935356|FG001|Overall Study|Adverse Event|4|||
46719261|NCT00603538|82935357|FG002|Overall Study|Adverse Event|2|||
46719262|NCT00603538|82935355|FG000|Overall Study|Objective progression or relapse|3|||
47040607|NCT01519947|83294681|FG002|Overall Study|Lost to Follow-up|3|||
46632306|NCT01797432|82805443|FG000|Overall Study|lived too far from study site|1|||
46632307|NCT01797120|82805449|FG000|Overall Study|Disesae progression|37|||
46632308|NCT01797120|82805450|FG001|Overall Study|Disesae progression|49|||
46632309|NCT01797120|82805449|FG000|Overall Study|Adverse Event|13|||
46632310|NCT01797120|82805450|FG001|Overall Study|Adverse Event|5|||
46632311|NCT01797120|82805449|FG000|Overall Study|Withdrawal by Subject|6|||
46632312|NCT01797120|82805450|FG001|Overall Study|Withdrawal by Subject|6|||
46632313|NCT01797120|82805449|FG000|Overall Study|Symptomatic progression|2|||
46632314|NCT01797120|82805450|FG001|Overall Study|Symptomatic progression|1|||
46632315|NCT01797120|82805449|FG000|Overall Study|Non-compliance|1|||
46632316|NCT01797120|82805450|FG001|Overall Study|Non-compliance|0|||
46632317|NCT01797120|82805449|FG000|Overall Study|Physician Decision|3|||
46632318|NCT01797120|82805450|FG001|Overall Study|Physician Decision|0|||
46632319|NCT01797120|82805449|FG000|Overall Study|still on treatment|2|||
46719263|NCT00603538|82935356|FG001|Overall Study|Objective progression or relapse|0|||
47040608|NCT01519947|83294682|FG003|Overall Study|Lost to Follow-up|2|||
47040609|NCT01519947|83294679|FG000|Overall Study|Poor Response|1|||
47040610|NCT01519947|83294680|FG001|Overall Study|Poor Response|0|||
47040611|NCT01519947|83294681|FG002|Overall Study|Poor Response|0|||
47040612|NCT01519947|83294682|FG003|Overall Study|Poor Response|1|||
47040613|NCT01519947|83294679|FG000|Overall Study|Adverse Event|1|||
47040614|NCT01519947|83294680|FG001|Overall Study|Adverse Event|0|||
47040615|NCT01519947|83294681|FG002|Overall Study|Adverse Event|1|||
47040616|NCT01519947|83294682|FG003|Overall Study|Adverse Event|1|||
47040617|NCT01462227|83294694|FG000|Second Assignment|Lost to Follow-up|1|||
47040618|NCT01462227|83294695|FG001|Second Assignment|Lost to Follow-up|0|||
47040619|NCT01462227|83294696|FG002|Second Assignment|Lost to Follow-up|0|||
47040620|NCT01462227|83294697|FG003|Second Assignment|Lost to Follow-up|0|||
47040621|NCT01462227|83294694|FG000|Second Assignment|Protocol Violation|0|||
47040622|NCT01462227|83294695|FG001|Second Assignment|Protocol Violation|1|||
47040623|NCT01462227|83294696|FG002|Second Assignment|Protocol Violation|1|||
47040624|NCT01462227|83294697|FG003|Second Assignment|Protocol Violation|0|||
47040625|NCT01464879|83294705|FG000|Overall Study|Physician Decision|1|||
47040626|NCT01464879|83294705|FG000|Overall Study|Non-compliance|1|||
47040627|NCT01519869|83294715|FG000|Overall Study|Lost to Follow-up|1|||
47040628|NCT01519791|83294721|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
47040629|NCT01519791|83294722|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
47040630|NCT01519791|83294721|FG000|Overall Study|Protocol Violation|6|||
47040631|NCT01519791|83294722|FG001|Overall Study|Protocol Violation|19|||
47040632|NCT01519791|83294721|FG000|Overall Study|Other Reason|87|||
47040633|NCT01519791|83294722|FG001|Overall Study|Other Reason|222|||
47040634|NCT01519791|83294721|FG000|Overall Study|subjects randomized in error|2|||
47040635|NCT01519791|83294722|FG001|Overall Study|subjects randomized in error|0|||
47040636|NCT01519791|83294721|FG000|Overall Study|Lack of Efficacy|16|||
47040637|NCT01519791|83294722|FG001|Overall Study|Lack of Efficacy|20|||
47040638|NCT01519791|83294721|FG000|Overall Study|SAE, non-fatal|6|||
47040639|NCT01519791|83294722|FG001|Overall Study|SAE, non-fatal|22|||
47040640|NCT01519791|83294721|FG000|Overall Study|AE, serious fatal|0|||
47040641|NCT01519791|83294722|FG001|Overall Study|AE, serious fatal|1|||
47040642|NCT01519791|83294721|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
47040643|NCT01519791|83294722|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
47040644|NCT01519791|83294721|FG000|Overall Study|AE, non-serious non-fatal|12|||
47040645|NCT01519791|83294722|FG001|Overall Study|AE, non-serious non-fatal|31|||
47040646|NCT01519791|83294721|FG000|Overall Study|Withdrawal by Subject|15|||
47040647|NCT01519791|83294722|FG001|Overall Study|Withdrawal by Subject|37|||
47040648|NCT01519791|83294721|FG000|Overall Study|Lost to Follow-up|6|||
47040649|NCT01519791|83294722|FG001|Overall Study|Lost to Follow-up|14|||
47040650|NCT01461993|83294733|FG000|Overall Study|Withdrawal by Subject|60|||
47040651|NCT01461993|83294734|FG001|Overall Study|Withdrawal by Subject|53|||
47040652|NCT01461993|83294735|FG002|Overall Study|Withdrawal by Subject|16|||
47040653|NCT01461993|83294733|FG000|Overall Study|Lost to Follow-up|44|||
47040654|NCT01461993|83294734|FG001|Overall Study|Lost to Follow-up|48|||
47040655|NCT01461993|83294735|FG002|Overall Study|Lost to Follow-up|22|||
47040656|NCT01461993|83294733|FG000|Overall Study|Protocol Violation|10|||
47040657|NCT01461993|83294734|FG001|Overall Study|Protocol Violation|9|||
47040658|NCT01461993|83294735|FG002|Overall Study|Protocol Violation|7|||
47040659|NCT01461993|83294733|FG000|Overall Study|Adverse Event|9|||
47040660|NCT01461993|83294734|FG001|Overall Study|Adverse Event|11|||
47040661|NCT01461993|83294735|FG002|Overall Study|Adverse Event|3|||
47040662|NCT01461993|83294733|FG000|Overall Study|No longer met eligibility criteria|13|||
47040663|NCT01461993|83294734|FG001|Overall Study|No longer met eligibility criteria|18|||
47040664|NCT01461993|83294735|FG002|Overall Study|No longer met eligibility criteria|10|||
47040665|NCT01461993|83294733|FG000|Overall Study|Did not meet entrance criteria|2|||
47040666|NCT01461993|83294734|FG001|Overall Study|Did not meet entrance criteria|3|||
47040667|NCT01461993|83294735|FG002|Overall Study|Did not meet entrance criteria|0|||
47040668|NCT01461993|83294733|FG000|Overall Study|Other|13|||
47040669|NCT01461993|83294734|FG001|Overall Study|Other|15|||
47040670|NCT01461993|83294735|FG002|Overall Study|Other|6|||
47040671|NCT01782326|83294746|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
47040672|NCT01782326|83294747|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
47040673|NCT01782326|83294746|FG000|Planned Treatment Epoch|Death|29|||
47040674|NCT01782326|83294747|FG001|Planned Treatment Epoch|Death|30|||
47040675|NCT01782326|83294746|FG000|Planned Treatment Epoch|Physician Decision|18|||
47040676|NCT01782326|83294747|FG001|Planned Treatment Epoch|Physician Decision|16|||
47040677|NCT01782326|83294746|FG000|Planned Treatment Epoch|Protocol deviation|2|||
46719264|NCT00603538|82935357|FG002|Overall Study|Objective progression or relapse|0|||
46719265|NCT01163318|82935368|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
46719266|NCT01163318|82935368|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
46719267|NCT01163318|82935368|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
46719268|NCT01163318|82935368|FG000|Overall Study|Participants Without Case Report Form|7|||
46719269|NCT01163318|82935368|FG000|Overall Study|Multiple Reasons Per Participant|224|||
47040678|NCT01782326|83294747|FG001|Planned Treatment Epoch|Protocol deviation|3|||
47040679|NCT01782326|83294746|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
47040680|NCT01782326|83294747|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
47040681|NCT01782326|83294746|FG000|Planned Treatment Epoch|Technical problems|0|||
47040682|NCT01782326|83294747|FG001|Planned Treatment Epoch|Technical problems|4|||
47040683|NCT01782326|83294746|FG000|Double-blind Treatment|Adverse Event|129|||
47040684|NCT01782326|83294747|FG001|Double-blind Treatment|Adverse Event|145|||
47040685|NCT01782326|83294746|FG000|Double-blind Treatment|Subject/guardian decision|111|||
47040686|NCT01782326|83294747|FG001|Double-blind Treatment|Subject/guardian decision|125|||
47040687|NCT01782326|83294746|FG000|Double-blind Treatment|Lack of Efficacy|17|||
47040688|NCT01782326|83294747|FG001|Double-blind Treatment|Lack of Efficacy|22|||
46719270|NCT01162304|82935372|FG000|Overall Study|Beck scale to high|11|||
46719271|NCT04515394|82935378|FG000|Overall Study|Participant did not receive treatment|1|||
46719272|NCT01175018|82935384|FG000|Overall Study|Adverse Event|3|||
46719273|NCT01175018|82935385|FG001|Overall Study|Adverse Event|1|||
46719274|NCT01174784|82935393|FG000|Overall Study|Screen fails|4|||
46719275|NCT01174550|82935400|FG000|Overall Study|Death|75|||
46719276|NCT01174550|82935401|FG001|Overall Study|Death|74|||
46719277|NCT01174550|82935400|FG000|Overall Study|Lost to Follow-up|652|||
46719278|NCT01174550|82935401|FG001|Overall Study|Lost to Follow-up|510|||
46915583|NCT01354028|83146326|FG001|Overall Study|No quiet alert state|1|||
46915584|NCT01354964|83146340|FG000|Overall Study|Lost to Follow-up|2|||
46915585|NCT01354964|83146341|FG001|Overall Study|Lost to Follow-up|0|||
46915586|NCT01354964|83146340|FG000|Overall Study|IV access issues|1|||
46915587|NCT01354964|83146341|FG001|Overall Study|IV access issues|1|||
46915588|NCT01354964|83146340|FG000|Overall Study|Physician Decision|1|||
46915589|NCT01354964|83146341|FG001|Overall Study|Physician Decision|0|||
46915590|NCT01354496|83146351|FG000|Period 1|Adverse Event|0|||
46915591|NCT01354496|83146352|FG001|Period 1|Adverse Event|0|||
46915592|NCT01354496|83146353|FG002|Period 1|Adverse Event|1|||
46915593|NCT01354496|83146354|FG003|Period 1|Adverse Event|0|||
46915594|NCT01354496|83146355|FG004|Period 1|Adverse Event|0|||
46915595|NCT01354496|83146356|FG005|Period 1|Adverse Event|0|||
46915596|NCT01354496|83146351|FG000|Period 1|Physician Decision|0|||
46915597|NCT01354496|83146352|FG001|Period 1|Physician Decision|0|||
46915598|NCT01354496|83146353|FG002|Period 1|Physician Decision|1|||
46915599|NCT01354496|83146354|FG003|Period 1|Physician Decision|0|||
46915600|NCT01354496|83146355|FG004|Period 1|Physician Decision|0|||
46915601|NCT01354496|83146356|FG005|Period 1|Physician Decision|0|||
46915602|NCT01354496|83146351|FG000|Period 2|Adverse Event|0|||
46915603|NCT01354496|83146352|FG001|Period 2|Adverse Event|0|||
46915604|NCT01354496|83146353|FG002|Period 2|Adverse Event|0|||
46915605|NCT01354496|83146354|FG003|Period 2|Adverse Event|1|||
46915606|NCT01354496|83146355|FG004|Period 2|Adverse Event|0|||
46915607|NCT01354496|83146356|FG005|Period 2|Adverse Event|0|||
46915608|NCT01354496|83146351|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
46915609|NCT01354496|83146352|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
46915610|NCT01354496|83146353|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
46915611|NCT01354496|83146354|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
46915612|NCT01354496|83146355|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
46915613|NCT01354496|83146356|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
46915614|NCT02822222|83146379|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
46915615|NCT02822222|83146380|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
46915616|NCT02821910|83146392|FG000|Overall Study|Withdrawal by Subject|0|||
46915617|NCT02821910|83146393|FG001|Overall Study|Withdrawal by Subject|0|||
46915618|NCT02821910|83146394|FG002|Overall Study|Withdrawal by Subject|1|||
46915619|NCT02821910|83146395|FG003|Overall Study|Withdrawal by Subject|0|||
46915620|NCT02821910|83146396|FG004|Overall Study|Withdrawal by Subject|0|||
46915621|NCT02821910|83146397|FG005|Overall Study|Withdrawal by Subject|1|||
46915622|NCT02821910|83146392|FG000|Overall Study|Other than specified|1|||
46915623|NCT02821910|83146393|FG001|Overall Study|Other than specified|0|||
46915624|NCT02821910|83146394|FG002|Overall Study|Other than specified|1|||
46915625|NCT02821910|83146395|FG003|Overall Study|Other than specified|0|||
46915626|NCT02821910|83146396|FG004|Overall Study|Other than specified|0|||
46915627|NCT02821910|83146397|FG005|Overall Study|Other than specified|0|||
46915628|NCT02817776|83146411|FG000|Overall Study|Excluded|33|||
46915629|NCT02817776|83146411|FG000|Overall Study|Lost to Follow-up|20|||
46915630|NCT02817776|83146411|FG000|Overall Study|Withdrawal by Subject|33|||
46915631|NCT02817776|83146411|FG000|Overall Study|Death|2|||
46915632|NCT03138655|83146423|FG000|Overall Study|Adverse Event|2|||
46915633|NCT03138655|83146424|FG001|Overall Study|Adverse Event|1|||
46915634|NCT03138655|83146425|FG002|Overall Study|Adverse Event|2|||
46915635|NCT03138655|83146426|FG003|Overall Study|Adverse Event|1|||
46915636|NCT03138655|83146427|FG004|Overall Study|Adverse Event|1|||
46915637|NCT03138655|83146428|FG005|Overall Study|Adverse Event|4|||
46915638|NCT03138655|83146429|FG006|Overall Study|Adverse Event|2|||
46915639|NCT03138655|83146430|FG007|Overall Study|Adverse Event|2|||
46915640|NCT03138655|83146423|FG000|Overall Study|Withdrawal by Subject|0|||
46915641|NCT03138655|83146424|FG001|Overall Study|Withdrawal by Subject|1|||
46915642|NCT03138655|83146425|FG002|Overall Study|Withdrawal by Subject|0|||
46915643|NCT03138655|83146426|FG003|Overall Study|Withdrawal by Subject|0|||
46915644|NCT03138655|83146427|FG004|Overall Study|Withdrawal by Subject|0|||
46915645|NCT03138655|83146428|FG005|Overall Study|Withdrawal by Subject|0|||
46915646|NCT03138655|83146429|FG006|Overall Study|Withdrawal by Subject|1|||
46915647|NCT03138655|83146430|FG007|Overall Study|Withdrawal by Subject|0|||
46915648|NCT03138655|83146423|FG000|Overall Study|Reason not Specified|1|||
46719279|NCT01174550|82935400|FG000|Overall Study|Withdrawal by Subject|543|||
46719280|NCT01174550|82935401|FG001|Overall Study|Withdrawal by Subject|289|||
46915649|NCT03138655|83146424|FG001|Overall Study|Reason not Specified|0|||
46915650|NCT03138655|83146425|FG002|Overall Study|Reason not Specified|0|||
47040689|NCT01782326|83294746|FG000|Double-blind Treatment|Physician Decision|13|||
47040690|NCT01782326|83294747|FG001|Double-blind Treatment|Physician Decision|16|||
47040691|NCT01782326|83294746|FG000|Double-blind Treatment|Protocol deviation|8|||
47040692|NCT01782326|83294747|FG001|Double-blind Treatment|Protocol deviation|7|||
47040693|NCT01782326|83294746|FG000|Double-blind Treatment|Technical problems|0|||
47040694|NCT01782326|83294747|FG001|Double-blind Treatment|Technical problems|5|||
47040695|NCT01439373|83294755|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
47040696|NCT01439373|83294756|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
47040697|NCT01439373|83294755|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
47040698|NCT01439373|83294756|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
47040699|NCT01461369|83294769|FG000|Overall Study|Lack of Efficacy|2|||
47040700|NCT01461369|83294770|FG001|Overall Study|Lack of Efficacy|0|||
47040701|NCT01461369|83294771|FG002|Overall Study|Lack of Efficacy|6|||
47040702|NCT01461369|83294769|FG000|Overall Study|Lost to Follow-up|0|||
47040703|NCT01461369|83294770|FG001|Overall Study|Lost to Follow-up|0|||
47040704|NCT01461369|83294771|FG002|Overall Study|Lost to Follow-up|3|||
47040705|NCT01461369|83294769|FG000|Overall Study|Adverse Event|9|||
47040706|NCT01461369|83294770|FG001|Overall Study|Adverse Event|12|||
47040707|NCT01461369|83294771|FG002|Overall Study|Adverse Event|4|||
46915651|NCT03138655|83146426|FG003|Overall Study|Reason not Specified|2|||
46915652|NCT03138655|83146427|FG004|Overall Study|Reason not Specified|1|||
46915653|NCT03138655|83146428|FG005|Overall Study|Reason not Specified|1|||
46915654|NCT03138655|83146429|FG006|Overall Study|Reason not Specified|0|||
46915655|NCT03138655|83146430|FG007|Overall Study|Reason not Specified|0|||
46915656|NCT02820038|83146456|FG000|Overall Study|Lost to Follow-up|7|||
46915657|NCT02820038|83146457|FG001|Overall Study|Lost to Follow-up|11|||
46915658|NCT02820038|83146458|FG002|Overall Study|Lost to Follow-up|2|||
46915659|NCT02820038|83146459|FG003|Overall Study|Lost to Follow-up|9|||
47040708|NCT01461369|83294769|FG000|Overall Study|Protocol Violation|1|||
47040709|NCT01461369|83294770|FG001|Overall Study|Protocol Violation|2|||
47040710|NCT01461369|83294771|FG002|Overall Study|Protocol Violation|2|||
47040711|NCT01461369|83294769|FG000|Overall Study|Withdrawal by Subject|1|||
46632320|NCT01797120|82805450|FG001|Overall Study|still on treatment|4|||
46632321|NCT01797120|82805449|FG000|Overall Study|never start protocol therapy|2|||
46632322|NCT01797120|82805450|FG001|Overall Study|never start protocol therapy|0|||
46632323|NCT01796964|82805458|FG000|Overall Study|Adverse Event|1|||
46632324|NCT01796964|82805459|FG001|Overall Study|Adverse Event|1|||
46915660|NCT02820038|83146456|FG000|Overall Study|Withdrawal by Subject|3|||
46915661|NCT02820038|83146457|FG001|Overall Study|Withdrawal by Subject|14|||
46915662|NCT02820038|83146458|FG002|Overall Study|Withdrawal by Subject|3|||
46915663|NCT02820038|83146459|FG003|Overall Study|Withdrawal by Subject|13|||
46915664|NCT02819804|83146470|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
46915665|NCT02819726|83146477|FG000|Part A (All Participants)|Lost to Follow-up|0|||
46915666|NCT02819726|83146478|FG001|Part A (All Participants)|Lost to Follow-up|1|||
46915667|NCT02819726|83146479|FG002|Part A (All Participants)|Lost to Follow-up|0|||
46915668|NCT02819726|83146480|FG003|Part A (All Participants)|Lost to Follow-up|0|||
46915669|NCT02819726|83146477|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
46915670|NCT02819726|83146478|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
46915671|NCT02819726|83146479|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
46915672|NCT02819726|83146480|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
46915673|NCT02819726|83146477|FG000|Part A (All Participants)|Protocol non-compliance|3|||
46915674|NCT02819726|83146478|FG001|Part A (All Participants)|Protocol non-compliance|4|||
46915675|NCT02819726|83146479|FG002|Part A (All Participants)|Protocol non-compliance|5|||
46915676|NCT02819726|83146480|FG003|Part A (All Participants)|Protocol non-compliance|0|||
46915677|NCT02819726|83146477|FG000|Part B (All Participants)|Lost to Follow-up|1|||
46915678|NCT02819726|83146478|FG001|Part B (All Participants)|Lost to Follow-up|1|||
46915679|NCT02819726|83146479|FG002|Part B (All Participants)|Lost to Follow-up|2|||
46915680|NCT02819726|83146480|FG003|Part B (All Participants)|Lost to Follow-up|2|||
46915681|NCT02819726|83146477|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
46915682|NCT02819726|83146478|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
46915683|NCT02819726|83146479|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
46915684|NCT02819726|83146480|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
46915685|NCT02819726|83146477|FG000|Part B (All Participants)|Protocol non-compliance|0|||
46915686|NCT02819726|83146478|FG001|Part B (All Participants)|Protocol non-compliance|0|||
46915687|NCT02819726|83146479|FG002|Part B (All Participants)|Protocol non-compliance|1|||
46915688|NCT02819726|83146480|FG003|Part B (All Participants)|Protocol non-compliance|0|||
46915689|NCT02816138|83146488|FG000|Overall Study|Adverse Event|1|||
46632325|NCT01796964|82805458|FG000|Overall Study|Death|1|||
47040712|NCT01461369|83294770|FG001|Overall Study|Withdrawal by Subject|3|||
47040713|NCT01461369|83294771|FG002|Overall Study|Withdrawal by Subject|2|||
47040714|NCT01727258|83294782|FG000|Overall Study|Adverse Event|0|||
47040715|NCT01727258|83294783|FG001|Overall Study|Adverse Event|2|||
47040716|NCT01727258|83294784|FG002|Overall Study|Adverse Event|0|||
47040717|NCT01727258|83294782|FG000|Overall Study|Noncompliance with Study Drug|0|||
47040718|NCT01727258|83294783|FG001|Overall Study|Noncompliance with Study Drug|0|||
47040719|NCT01727258|83294784|FG002|Overall Study|Noncompliance with Study Drug|1|||
47040720|NCT01727258|83294782|FG000|Overall Study|Withdrawal by Subject|1|||
47040721|NCT01727258|83294783|FG001|Overall Study|Withdrawal by Subject|1|||
47040722|NCT01727258|83294784|FG002|Overall Study|Withdrawal by Subject|0|||
47040723|NCT01727258|83294782|FG000|Overall Study|Lost to Follow-up|1|||
47040724|NCT01727258|83294783|FG001|Overall Study|Lost to Follow-up|0|||
47040725|NCT01727258|83294784|FG002|Overall Study|Lost to Follow-up|0|||
47040726|NCT01781390|83294795|FG000|Overall Study|Withdrawal of Consent|0|||
47040727|NCT01781390|83294796|FG001|Overall Study|Withdrawal of Consent|3|||
47040728|NCT01781390|83294797|FG002|Overall Study|Withdrawal of Consent|1|||
47040729|NCT01781390|83294795|FG000|Overall Study|Lost to Follow-up|1|||
47040730|NCT01781390|83294796|FG001|Overall Study|Lost to Follow-up|1|||
47040731|NCT01781390|83294797|FG002|Overall Study|Lost to Follow-up|1|||
47040732|NCT01781390|83294795|FG000|Overall Study|Adverse Event|1|||
47040733|NCT01781390|83294796|FG001|Overall Study|Adverse Event|2|||
47040734|NCT01781390|83294797|FG002|Overall Study|Adverse Event|1|||
47040735|NCT01781390|83294795|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
47040736|NCT01781390|83294796|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
47040737|NCT01781390|83294797|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
47040738|NCT01781234|83294807|FG000|Overall Study|Adverse Event|2|||
47040739|NCT01781234|83294808|FG001|Overall Study|Adverse Event|0|||
47040740|NCT01781234|83294807|FG000|Overall Study|Protocol Violation|3|||
47040741|NCT01781234|83294808|FG001|Overall Study|Protocol Violation|0|||
47040742|NCT01781234|83294807|FG000|Overall Study|Withdrawal by Subject|4|||
47040743|NCT01781234|83294808|FG001|Overall Study|Withdrawal by Subject|3|||
47040744|NCT01752842|83294818|FG000|Overall Study|Adverse Event|3|||
47040745|NCT01752842|83294819|FG001|Overall Study|Adverse Event|0|||
47040746|NCT01752842|83294818|FG000|Overall Study|Withdrawal by Subject|0|||
47040747|NCT01752842|83294819|FG001|Overall Study|Withdrawal by Subject|2|||
47040748|NCT01461057|83294827|FG000|Overall Study|Death|10|||
47040749|NCT01461057|83294828|FG001|Overall Study|Death|9|||
47040750|NCT01461057|83294827|FG000|Overall Study|Withdrawal by Subject|2|||
47040751|NCT01461057|83294828|FG001|Overall Study|Withdrawal by Subject|3|||
47040752|NCT01461057|83294827|FG000|Overall Study|Physician Decision|0|||
47040753|NCT01461057|83294828|FG001|Overall Study|Physician Decision|2|||
47040754|NCT01461057|83294827|FG000|Overall Study|Adverse Event|0|||
47040755|NCT01461057|83294828|FG001|Overall Study|Adverse Event|1|||
47040756|NCT01461057|83294827|FG000|Overall Study|Progression of Disease|1|||
47040757|NCT01461057|83294828|FG001|Overall Study|Progression of Disease|0|||
47040758|NCT01461057|83294827|FG000|Overall Study|Study Terminated by Sponsor|2|||
47040759|NCT01461057|83294828|FG001|Overall Study|Study Terminated by Sponsor|0|||
47040760|NCT01460901|83294834|FG000|Overall Study|Withdrawal by Subject|2|||
47040761|NCT01519635|83294843|FG000|Overall Study|Withdrawal by Subject|0|||
47040762|NCT01519635|83294844|FG001|Overall Study|Withdrawal by Subject|1|||
47040763|NCT01519635|83294843|FG000|Overall Study|No possibility to put a catheter|1|||
47040764|NCT01519635|83294844|FG001|Overall Study|No possibility to put a catheter|2|||
47040765|NCT01519323|83294850|FG000|Overall Study|Death|3|||
47040766|NCT01519323|83294851|FG001|Overall Study|Death|2|||
47040767|NCT01519323|83294850|FG000|Overall Study|Study terminated by sponsor|0|||
47040768|NCT01519323|83294851|FG001|Overall Study|Study terminated by sponsor|1|||
47040769|NCT01519245|83294859|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
47040770|NCT01519245|83294860|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
47040771|NCT01519167|83294870|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
47040772|NCT01519167|83294871|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
47040773|NCT01519167|83294870|FG000|Overall Study|Adverse Event|0|||
47040774|NCT01519167|83294871|FG001|Overall Study|Adverse Event|1|||
47040775|NCT01519167|83294870|FG000|Overall Study|Lack of Efficacy|0|||
47040776|NCT01519167|83294871|FG001|Overall Study|Lack of Efficacy|1|||
46632326|NCT01796964|82805459|FG001|Overall Study|Death|0|||
47040777|NCT01519167|83294870|FG000|Overall Study|Medical condition changes&deep sedation|0|||
47040778|NCT01519167|83294871|FG001|Overall Study|Medical condition changes&deep sedation|2|||
47040779|NCT01519167|83294870|FG000|Overall Study|Physician Decision|0|||
47040780|NCT01519167|83294871|FG001|Overall Study|Physician Decision|1|||
47040781|NCT01519089|83295112|FG000|Overall Study|Adverse Event|4|||
47040782|NCT01519089|83295113|FG001|Overall Study|Adverse Event|4|||
47040783|NCT01519089|83295112|FG000|Overall Study|Lack of Efficacy|0|||
47040784|NCT01519089|83295113|FG001|Overall Study|Lack of Efficacy|2|||
47040785|NCT01519089|83295112|FG000|Overall Study|Lost to Follow-up|1|||
47040786|NCT01519089|83295113|FG001|Overall Study|Lost to Follow-up|0|||
47040787|NCT01519089|83295112|FG000|Overall Study|Withdrawal by Subject|0|||
46632327|NCT01796964|82805458|FG000|Overall Study|Protocol Violation|0|||
47040788|NCT01519089|83295113|FG001|Overall Study|Withdrawal by Subject|2|||
46632328|NCT01796964|82805459|FG001|Overall Study|Protocol Violation|1|||
47040789|NCT01519089|83295112|FG000|Overall Study|Other|2|||
47040790|NCT01519089|83295113|FG001|Overall Study|Other|6|||
47040791|NCT01519089|83295112|FG000|Overall Study|Not received study drug|0|||
46915690|NCT02815670|83146492|FG000|Overall Study|Prematurely discontinued of the trial|1|||
46915691|NCT02809976|83146496|FG000|Overall Study|Lost to Follow-up|1|||
47040792|NCT01519089|83295113|FG001|Overall Study|Not received study drug|1|||
47040793|NCT01518699|83295135|FG000|Period 2|Protocol Violation|1|||
47040794|NCT01518699|83295136|FG001|Period 2|Protocol Violation|1|||
47040795|NCT01518699|83295137|FG002|Period 2|Protocol Violation|0|||
47040796|NCT01518699|83295138|FG003|Period 2|Protocol Violation|0|||
47040797|NCT01518699|83295139|FG004|Period 2|Protocol Violation|0|||
47040798|NCT01518699|83295140|FG005|Period 2|Protocol Violation|0|||
47040799|NCT01518699|83295135|FG000|Period 2|Lost to Follow-up|0|||
47040800|NCT01518699|83295136|FG001|Period 2|Lost to Follow-up|1|||
47040801|NCT01518699|83295137|FG002|Period 2|Lost to Follow-up|0|||
47040802|NCT01518699|83295138|FG003|Period 2|Lost to Follow-up|0|||
47040803|NCT01518699|83295139|FG004|Period 2|Lost to Follow-up|0|||
47040804|NCT01518699|83295140|FG005|Period 2|Lost to Follow-up|0|||
47040805|NCT01518699|83295135|FG000|Period 2|Adverse Event|1|||
47040806|NCT01518699|83295136|FG001|Period 2|Adverse Event|0|||
47040807|NCT01518699|83295137|FG002|Period 2|Adverse Event|0|||
46915692|NCT02809976|83146496|FG000|Overall Study|Withdrawal by Subject|1|||
46915693|NCT02880865|83146502|FG000|Overall Study|Adverse Event|1|||
46915694|NCT02880865|83146503|FG001|Overall Study|Adverse Event|0|||
46915695|NCT02880865|83146502|FG000|Overall Study|Withdrawal by Subject|0|||
46915696|NCT02880865|83146503|FG001|Overall Study|Withdrawal by Subject|2|||
46915697|NCT02880865|83146502|FG000|Overall Study|Physician Decision|0|||
46915698|NCT02880865|83146503|FG001|Overall Study|Physician Decision|1|||
46915699|NCT01854385|83146530|FG000|Pre-Treatment|Withdrawal by Subject|4|||
46915700|NCT01854385|83146530|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
46915701|NCT01854385|83146530|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
46915702|NCT01854385|83146530|FG000|Pre-Treatment|Unable to come for study visits|1|||
46915703|NCT01854385|83146530|FG000|Treatment|Lost to Follow-up|1|||
46915704|NCT02809118|83146537|FG000|Overall Study|Withdrawal by Subject|0|||
46915705|NCT02809118|83146538|FG001|Overall Study|Withdrawal by Subject|1|||
46915706|NCT02809118|83146539|FG002|Overall Study|Withdrawal by Subject|1|||
46915707|NCT03604159|83146549|FG000|Overall Study|Lost to Follow-up|6|||
46915708|NCT03604159|83146550|FG001|Overall Study|Lost to Follow-up|7|||
46915709|NCT02808338|83146556|FG000|Screening|Screen Failure|10|||
46915710|NCT02808338|83146556|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
46915711|NCT02808338|83146556|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
46915712|NCT02807948|83146567|FG000|Overall Study|Physician Decision|1|||
46915713|NCT02807948|83146568|FG001|Overall Study|Physician Decision|0|||
46915714|NCT02049710|83146575|FG000|Overall Study|Lost to Follow-up|319|||
46915715|NCT02049710|83146576|FG001|Overall Study|Lost to Follow-up|324|||
46915716|NCT05513625|83146595|FG000|Overall Study|Withdrawal by Subject|1|||
46915717|NCT04816708|83146616|FG000|Overall Study|Lost to Follow-up|10|||
46915718|NCT04816708|83146617|FG001|Overall Study|Lost to Follow-up|4|||
46915719|NCT04669600|83146634|FG000|Overall Study|Withdrawal by Subject|1|||
46915720|NCT04669600|83146634|FG000|Overall Study|Other|6|||
46915721|NCT04120974|83146638|FG000|Overall Study|Death|1|||
46915722|NCT04120974|83146638|FG000|Overall Study|Physician Decision|1|||
46915723|NCT04120974|83146638|FG000|Overall Study|Lost to Follow-up|6|||
46915724|NCT04107805|83146651|FG000|Overall Study|Adverse Event|0|||
46915725|NCT04107805|83146652|FG001|Overall Study|Adverse Event|0|||
46915726|NCT04107805|83146653|FG002|Overall Study|Adverse Event|0|||
46915727|NCT04107805|83146654|FG003|Overall Study|Adverse Event|1|||
46915728|NCT04107805|83146655|FG004|Overall Study|Adverse Event|0|||
46915729|NCT04107805|83146656|FG005|Overall Study|Adverse Event|1|||
46915730|NCT04107805|83146657|FG006|Overall Study|Adverse Event|0|||
46915731|NCT04107805|83146658|FG007|Overall Study|Adverse Event|0|||
46915732|NCT04107805|83146659|FG008|Overall Study|Adverse Event|1|||
46915733|NCT03988751|83146702|FG000|Overall Study|Withdrawal by Subject|1|||
46915734|NCT03988751|83146703|FG001|Overall Study|Withdrawal by Subject|0|||
46915735|NCT03988751|83146702|FG000|Overall Study|Protocol Violation|0|||
46915736|NCT03988751|83146703|FG001|Overall Study|Protocol Violation|1|||
46915737|NCT03802331|83146721|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
46915738|NCT03802331|83146722|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
47040808|NCT01518699|83295138|FG003|Period 2|Adverse Event|0|||
47040809|NCT01518699|83295139|FG004|Period 2|Adverse Event|0|||
47040810|NCT01518699|83295140|FG005|Period 2|Adverse Event|0|||
47040811|NCT01518309|83295148|FG000|Overall Study|Adverse Event|6|||
47040812|NCT01518309|83295148|FG000|Overall Study|Death|6|||
47040813|NCT01518309|83295148|FG000|Overall Study|Lack of Efficacy|7|||
47040814|NCT01518309|83295148|FG000|Overall Study|Withdrawal by Subject|6|||
46915739|NCT03782376|83146730|FG000|Overall Study|Lost to Follow-up|2|||
46915740|NCT03782376|83146731|FG001|Overall Study|Lost to Follow-up|2|||
46915741|NCT03782376|83146730|FG000|Overall Study|Withdrawal by Subject|7|||
46915742|NCT03782376|83146731|FG001|Overall Study|Withdrawal by Subject|11|||
47040815|NCT01518309|83295148|FG000|Overall Study|Physician Decision|3|||
47040816|NCT01518309|83295148|FG000|Overall Study|Sponsor Decision|2|||
47040817|NCT01518309|83295148|FG000|Overall Study|Not in Predefined Categories|9|||
46915743|NCT03782376|83146730|FG000|Overall Study|Death|1|||
46915744|NCT03782376|83146731|FG001|Overall Study|Death|0|||
46915745|NCT03782376|83146730|FG000|Overall Study|Other|16|||
46915746|NCT03782376|83146731|FG001|Overall Study|Other|17|||
46915747|NCT03573544|83146791|FG000|Overall Study|Adverse Event|0|||
46915748|NCT03573544|83146792|FG001|Overall Study|Adverse Event|0|||
46915749|NCT03573544|83146793|FG002|Overall Study|Adverse Event|0|||
46915750|NCT03573544|83146794|FG003|Overall Study|Adverse Event|3|||
46915751|NCT03573544|83146795|FG004|Overall Study|Adverse Event|1|||
46719281|NCT01008150|82935411|FG000|Overall Study|did not receive study drug|1|||
46719282|NCT01008150|82935412|FG001|Overall Study|did not receive study drug|1|||
46719283|NCT01008150|82935413|FG002|Overall Study|did not receive study drug|1|||
46915752|NCT03573544|83146796|FG005|Overall Study|Adverse Event|0|||
46915753|NCT03573544|83146797|FG006|Overall Study|Adverse Event|2|||
46915754|NCT03573544|83146798|FG007|Overall Study|Adverse Event|0|||
46915755|NCT03573544|83146791|FG000|Overall Study|Physician Decision|0|||
46915756|NCT03573544|83146792|FG001|Overall Study|Physician Decision|0|||
46915757|NCT03573544|83146793|FG002|Overall Study|Physician Decision|0|||
46915758|NCT03573544|83146794|FG003|Overall Study|Physician Decision|0|||
46915759|NCT03573544|83146795|FG004|Overall Study|Physician Decision|0|||
46915760|NCT03573544|83146796|FG005|Overall Study|Physician Decision|0|||
46915761|NCT03573544|83146797|FG006|Overall Study|Physician Decision|1|||
46632329|NCT01796964|82805458|FG000|Overall Study|Withdrawal by Subject|1|||
46632330|NCT01796964|82805459|FG001|Overall Study|Withdrawal by Subject|1|||
46632331|NCT01838694|82805468|FG000|Overall Study|Adverse Event|0|||
46632332|NCT01838694|82805469|FG001|Overall Study|Adverse Event|1|||
46632333|NCT01795638|82805480|FG000|Overall Study|Death|0|||
46632334|NCT01795638|82805481|FG001|Overall Study|Death|3|||
46632335|NCT01795638|82805480|FG000|Overall Study|transferred to quaternary hospital|2|||
46632336|NCT01795638|82805481|FG001|Overall Study|transferred to quaternary hospital|3|||
46632337|NCT01795638|82805480|FG000|Overall Study|Protocol Violation|3|||
46632338|NCT01795638|82805481|FG001|Overall Study|Protocol Violation|0|||
46632339|NCT01795638|82805480|FG000|Overall Study|discharged from hospital|7|||
46632340|NCT01795638|82805481|FG001|Overall Study|discharged from hospital|5|||
46632341|NCT01795638|82805480|FG000|Overall Study|Withdrawal by Subject|1|||
46632342|NCT01795638|82805481|FG001|Overall Study|Withdrawal by Subject|0|||
46632343|NCT01794780|82805495|FG000|Overall Study|Adverse Event|0|||
46632344|NCT01794780|82805496|FG001|Overall Study|Adverse Event|1|||
46915762|NCT03573544|83146798|FG007|Overall Study|Physician Decision|0|||
46915763|NCT03573544|83146791|FG000|Overall Study|Withdrawal by Subject|2|||
46915764|NCT03573544|83146792|FG001|Overall Study|Withdrawal by Subject|0|||
46915765|NCT03573544|83146793|FG002|Overall Study|Withdrawal by Subject|0|||
46915766|NCT03573544|83146794|FG003|Overall Study|Withdrawal by Subject|1|||
46915767|NCT03573544|83146795|FG004|Overall Study|Withdrawal by Subject|1|||
46915768|NCT03573544|83146796|FG005|Overall Study|Withdrawal by Subject|1|||
46915769|NCT03573544|83146797|FG006|Overall Study|Withdrawal by Subject|0|||
46915770|NCT03573544|83146798|FG007|Overall Study|Withdrawal by Subject|1|||
46915771|NCT03573544|83146791|FG000|Overall Study|Disease progression|3|||
46915772|NCT03573544|83146792|FG001|Overall Study|Disease progression|3|||
46915773|NCT03573544|83146793|FG002|Overall Study|Disease progression|6|||
46915774|NCT03573544|83146794|FG003|Overall Study|Disease progression|4|||
46915775|NCT03573544|83146795|FG004|Overall Study|Disease progression|5|||
46915776|NCT03573544|83146796|FG005|Overall Study|Disease progression|7|||
46915777|NCT03573544|83146797|FG006|Overall Study|Disease progression|6|||
46632345|NCT01794780|82805497|FG002|Overall Study|Adverse Event|2|||
46632346|NCT01794780|82805498|FG003|Overall Study|Adverse Event|0|||
46632347|NCT01794780|82805499|FG004|Overall Study|Adverse Event|0|||
46632348|NCT01794780|82805500|FG005|Overall Study|Adverse Event|0|||
46632349|NCT01794780|82805501|FG006|Overall Study|Adverse Event|0|||
46632350|NCT01794780|82805502|FG007|Overall Study|Adverse Event|0|||
46632351|NCT01794780|82805495|FG000|Overall Study|Death|0|||
46915778|NCT03573544|83146798|FG007|Overall Study|Disease progression|7|||
46915779|NCT03333915|83146834|FG000|Overall Study|Lost to Follow-up|0|||
46632352|NCT01794780|82805496|FG001|Overall Study|Death|2|||
46632353|NCT01794780|82805497|FG002|Overall Study|Death|14|||
46915780|NCT03333915|83146835|FG001|Overall Study|Lost to Follow-up|0|||
46915781|NCT03333915|83146836|FG002|Overall Study|Lost to Follow-up|1|||
46915782|NCT03333915|83146837|FG003|Overall Study|Lost to Follow-up|0|||
46915783|NCT03333915|83146838|FG004|Overall Study|Lost to Follow-up|0|||
46915784|NCT03333915|83146834|FG000|Overall Study|Disease Progression|0|||
46915785|NCT03333915|83146835|FG001|Overall Study|Disease Progression|1|||
46632354|NCT01794780|82805498|FG003|Overall Study|Death|1|||
46632355|NCT01794780|82805499|FG004|Overall Study|Death|0|||
46632356|NCT01794780|82805500|FG005|Overall Study|Death|9|||
46632357|NCT01794780|82805501|FG006|Overall Study|Death|4|||
46632358|NCT01794780|82805502|FG007|Overall Study|Death|0|||
46915786|NCT03333915|83146836|FG002|Overall Study|Disease Progression|0|||
46632359|NCT01794780|82805495|FG000|Overall Study|Lost to Follow-up|10|||
46632360|NCT01794780|82805496|FG001|Overall Study|Lost to Follow-up|64|||
46915787|NCT03333915|83146837|FG003|Overall Study|Disease Progression|0|||
46915788|NCT03333915|83146838|FG004|Overall Study|Disease Progression|0|||
46632361|NCT01794780|82805497|FG002|Overall Study|Lost to Follow-up|165|||
46632362|NCT01794780|82805498|FG003|Overall Study|Lost to Follow-up|53|||
46632363|NCT01794780|82805499|FG004|Overall Study|Lost to Follow-up|2|||
46632364|NCT01794780|82805500|FG005|Overall Study|Lost to Follow-up|99|||
46632365|NCT01794780|82805501|FG006|Overall Study|Lost to Follow-up|30|||
46632366|NCT01794780|82805502|FG007|Overall Study|Lost to Follow-up|5|||
46632367|NCT01794780|82805495|FG000|Overall Study|Withdrew informed consent|7|||
46632368|NCT01794780|82805496|FG001|Overall Study|Withdrew informed consent|17|||
46632369|NCT01794780|82805497|FG002|Overall Study|Withdrew informed consent|36|||
46632370|NCT01794780|82805498|FG003|Overall Study|Withdrew informed consent|9|||
46632371|NCT01794780|82805499|FG004|Overall Study|Withdrew informed consent|0|||
46632372|NCT01794780|82805500|FG005|Overall Study|Withdrew informed consent|48|||
46632373|NCT01794780|82805501|FG006|Overall Study|Withdrew informed consent|4|||
46915789|NCT03333915|83146834|FG000|Overall Study|Death|0|||
46915790|NCT03333915|83146835|FG001|Overall Study|Death|0|||
46632374|NCT01794780|82805502|FG007|Overall Study|Withdrew informed consent|3|||
46719284|NCT01008150|82935414|FG003|Overall Study|did not receive study drug|0|||
46719285|NCT01007916|82935425|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
46915791|NCT03333915|83146836|FG002|Overall Study|Death|0|||
46915792|NCT03333915|83146837|FG003|Overall Study|Death|37|||
46632375|NCT01794780|82805495|FG000|Overall Study|Other|0|||
46632376|NCT01794780|82805496|FG001|Overall Study|Other|12|||
46632377|NCT01794780|82805497|FG002|Overall Study|Other|25|||
46632378|NCT01794780|82805498|FG003|Overall Study|Other|20|||
46632379|NCT01794780|82805499|FG004|Overall Study|Other|1|||
46632380|NCT01794780|82805500|FG005|Overall Study|Other|24|||
46632381|NCT01794780|82805501|FG006|Overall Study|Other|4|||
46632382|NCT01794780|82805502|FG007|Overall Study|Other|1|||
46632383|NCT01838616|82805529|FG000|Titration Period|Adverse Event|18|||
46632384|NCT01838616|82805530|FG001|Titration Period|Adverse Event|48|||
46632385|NCT01838616|82805529|FG000|Titration Period|Lack of Efficacy|5|||
46632386|NCT01838616|82805530|FG001|Titration Period|Lack of Efficacy|12|||
46632387|NCT01838616|82805529|FG000|Titration Period|Withdrawal by Subject|5|||
46632388|NCT01838616|82805530|FG001|Titration Period|Withdrawal by Subject|5|||
46632389|NCT01838616|82805529|FG000|Titration Period|Technical problems|1|||
46632390|NCT01838616|82805530|FG001|Titration Period|Technical problems|0|||
46632391|NCT01838616|82805529|FG000|Titration Period|Other|1|||
46632392|NCT01838616|82805530|FG001|Titration Period|Other|0|||
46632393|NCT01838616|82805529|FG000|Titration Period|Protocol Violation|0|||
46632394|NCT01838616|82805530|FG001|Titration Period|Protocol Violation|1|||
46632395|NCT01838616|82805529|FG000|Continuation Period|Lack of Efficacy|3|||
46632396|NCT01838616|82805530|FG001|Continuation Period|Lack of Efficacy|5|||
46632397|NCT01838616|82805529|FG000|Continuation Period|Adverse Event|8|||
46632398|NCT01838616|82805530|FG001|Continuation Period|Adverse Event|4|||
46632399|NCT01838616|82805529|FG000|Continuation Period|Protocol Violation|2|||
46632400|NCT01838616|82805530|FG001|Continuation Period|Protocol Violation|0|||
46632401|NCT01838616|82805529|FG000|Continuation Period|Lost to Follow-up|1|||
46632402|NCT01838616|82805530|FG001|Continuation Period|Lost to Follow-up|0|||
46632403|NCT01838616|82805529|FG000|Continuation Period|Withdrawal by Subject|0|||
46632404|NCT01838616|82805530|FG001|Continuation Period|Withdrawal by Subject|4|||
46632405|NCT01838616|82805529|FG000|Continuation Period|Technical problems|0|||
46632406|NCT01838616|82805530|FG001|Continuation Period|Technical problems|1|||
46632407|NCT01838616|82805529|FG000|Pick-up Arm|Lack of Efficacy|4|||
46632408|NCT01838616|82805530|FG001|Pick-up Arm|Lack of Efficacy|0|||
46632409|NCT01838616|82805529|FG000|Pick-up Arm|Adverse Event|9|||
46632410|NCT01838616|82805530|FG001|Pick-up Arm|Adverse Event|0|||
46632411|NCT01838616|82805529|FG000|Pick-up Arm|Withdrawal by Subject|1|||
46632412|NCT01838616|82805530|FG001|Pick-up Arm|Withdrawal by Subject|0|||
46632413|NCT01838616|82805529|FG000|Pick-up Arm|Technical problems|1|||
46632414|NCT01838616|82805530|FG001|Pick-up Arm|Technical problems|0|||
46632415|NCT01611792|82805543|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
46632416|NCT01611792|82805544|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
46632417|NCT01611792|82805543|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
46632418|NCT01611792|82805544|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
46632419|NCT01820364|82805551|FG000|Part I: LGX818|Death|1|||
46632420|NCT01820364|82805552|FG001|Part I: LGX818|Death|0|||
46632421|NCT01820364|82805551|FG000|Part I: LGX818|Administrative Problems|3|||
46632422|NCT01820364|82805552|FG001|Part I: LGX818|Administrative Problems|0|||
46632423|NCT01820364|82805551|FG000|Part I: LGX818|Adverse Event|6|||
46632424|NCT01820364|82805552|FG001|Part I: LGX818|Adverse Event|0|||
46632425|NCT01820364|82805551|FG000|Part I: LGX818|Disease Progression|4|||
46632426|NCT01820364|82805552|FG001|Part I: LGX818|Disease Progression|0|||
46632427|NCT01820364|82805551|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
46915793|NCT03333915|83146838|FG004|Overall Study|Death|18|||
47040818|NCT01419717|83295152|FG000|Overall Study|Protocol-specified Criteria|62|||
47040819|NCT01419717|83295152|FG000|Overall Study|Adverse Event|19|||
46632428|NCT01820364|82805552|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
46632429|NCT01819506|82805560|FG000|Overall Study|Physician Decision|5|||
46915794|NCT03333915|83146834|FG000|Overall Study|Sponsor's Decision|0|||
46719286|NCT01007916|82935426|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
46719287|NCT01007916|82935425|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
46915795|NCT03333915|83146835|FG001|Overall Study|Sponsor's Decision|0|||
46915796|NCT03333915|83146836|FG002|Overall Study|Sponsor's Decision|0|||
46915797|NCT03333915|83146837|FG003|Overall Study|Sponsor's Decision|48|||
46915798|NCT03333915|83146838|FG004|Overall Study|Sponsor's Decision|4|||
46915799|NCT03333915|83146834|FG000|Overall Study|Withdrawal by Subject|0|||
46915800|NCT03333915|83146835|FG001|Overall Study|Withdrawal by Subject|0|||
46915801|NCT03333915|83146836|FG002|Overall Study|Withdrawal by Subject|0|||
46915802|NCT03333915|83146837|FG003|Overall Study|Withdrawal by Subject|5|||
46915803|NCT03333915|83146838|FG004|Overall Study|Withdrawal by Subject|1|||
46915804|NCT02993146|83146871|FG000|Overall Study|Withdrawal by Subject|0|||
46915805|NCT02993146|83146872|FG001|Overall Study|Withdrawal by Subject|0|||
46915806|NCT02993146|83146873|FG002|Overall Study|Withdrawal by Subject|1|||
46915807|NCT02993146|83146874|FG003|Overall Study|Withdrawal by Subject|1|||
46915808|NCT02865928|83146890|FG000|Overall Study|Withdrawal by Subject|1|||
46915809|NCT02865928|83146891|FG001|Overall Study|Withdrawal by Subject|0|||
46915810|NCT02865928|83146890|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
46915811|NCT02865928|83146891|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
46915812|NCT02865928|83146890|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
46915813|NCT02865928|83146891|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
46915814|NCT02734290|83146899|FG000|Overall Study|Adverse Event|1|||
46915815|NCT02734290|83146900|FG001|Overall Study|Adverse Event|0|||
46915816|NCT02734290|83146899|FG000|Overall Study|Death|1|||
46915817|NCT02734290|83146900|FG001|Overall Study|Death|0|||
46915818|NCT02652260|83146908|FG000|Overall Study|Pregnancy|0|||
46915819|NCT02652260|83146909|FG001|Overall Study|Pregnancy|1|||
46915820|NCT02652260|83146908|FG000|Overall Study|Withdrawal by Subject|0|||
46915821|NCT02652260|83146909|FG001|Overall Study|Withdrawal by Subject|1|||
46915822|NCT02535741|83146933|FG000|Overall Study|Adverse Event|3|||
46915823|NCT02535741|83146933|FG000|Overall Study|Withdrawal by Subject|9|||
46915824|NCT02535741|83146933|FG000|Overall Study|Lost to Follow-up|10|||
46915825|NCT02535741|83146933|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
46915826|NCT02535741|83146933|FG000|Overall Study|Missing data|6|||
46915827|NCT02525627|83146940|FG000|Overall Study|Revision|1|||
46915828|NCT02525627|83146941|FG001|Overall Study|Revision|1|||
46915829|NCT02525627|83146940|FG000|Overall Study|Withdrawal by Subject|1|||
46915830|NCT02525627|83146941|FG001|Overall Study|Withdrawal by Subject|2|||
46915831|NCT02525627|83146940|FG000|Overall Study|Death|1|||
46915832|NCT02525627|83146941|FG001|Overall Study|Death|0|||
46915833|NCT02525627|83146940|FG000|Overall Study|Site terminated|11|||
46915834|NCT02525627|83146941|FG001|Overall Study|Site terminated|10|||
46915835|NCT02525588|83146949|FG000|Overall Study|Death|3|||
46915836|NCT02525588|83146950|FG001|Overall Study|Death|1|||
46915837|NCT02525588|83146949|FG000|Overall Study|Lost to Follow-up|2|||
46915838|NCT02525588|83146950|FG001|Overall Study|Lost to Follow-up|0|||
46915839|NCT02525588|83146949|FG000|Overall Study|Withdrawal by Subject|1|||
47040820|NCT01419717|83295152|FG000|Overall Study|Death|17|||
46632430|NCT01819506|82805561|FG001|Overall Study|Physician Decision|2|||
46632431|NCT01819506|82805560|FG000|Overall Study|Withdrawal by Subject|3|||
46632432|NCT01819506|82805561|FG001|Overall Study|Withdrawal by Subject|3|||
46632433|NCT01794000|82805569|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
46632434|NCT01794000|82805570|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
46632435|NCT01794000|82805569|FG000|Double-Blind Phase (DBP)|Death|1|||
46632436|NCT01794000|82805570|FG001|Double-Blind Phase (DBP)|Death|2|||
46632437|NCT01794000|82805569|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
46632438|NCT01794000|82805570|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
46632439|NCT01794000|82805569|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
46632440|NCT01794000|82805570|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
46632441|NCT01794000|82805569|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
46632442|NCT01794000|82805570|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
46632443|NCT01794000|82805569|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
46632444|NCT01794000|82805570|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
46632445|NCT01794000|82805569|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
46632446|NCT01794000|82805570|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
46719288|NCT01007916|82935426|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
46915840|NCT02525588|83146950|FG001|Overall Study|Withdrawal by Subject|1|||
46915841|NCT02525588|83146949|FG000|Overall Study|Adverse Event|0|||
46915842|NCT02525588|83146950|FG001|Overall Study|Adverse Event|1|||
46915843|NCT02525562|83146956|FG000|Overall Study|Death|9|||
46915844|NCT02525562|83146957|FG001|Overall Study|Death|0|||
46915845|NCT02525562|83146958|FG002|Overall Study|Death|0|||
46915846|NCT02525562|83146956|FG000|Overall Study|Lost to Follow-up|19|||
46915847|NCT02525562|83146957|FG001|Overall Study|Lost to Follow-up|0|||
46915848|NCT02525562|83146958|FG002|Overall Study|Lost to Follow-up|0|||
46915849|NCT02525562|83146956|FG000|Overall Study|Withdrawal by Subject|37|||
46915850|NCT02525562|83146957|FG001|Overall Study|Withdrawal by Subject|0|||
46915851|NCT02525562|83146958|FG002|Overall Study|Withdrawal by Subject|0|||
46915852|NCT02525562|83146956|FG000|Overall Study|Revision/Removal of Study Device|4|||
46915853|NCT02525562|83146957|FG001|Overall Study|Revision/Removal of Study Device|0|||
46915854|NCT02525562|83146958|FG002|Overall Study|Revision/Removal of Study Device|0|||
46915855|NCT02525562|83146956|FG000|Overall Study|Study Closed by Sponsor|154|||
46915856|NCT02525562|83146957|FG001|Overall Study|Study Closed by Sponsor|0|||
46915857|NCT02525562|83146958|FG002|Overall Study|Study Closed by Sponsor|0|||
46915858|NCT02524730|83146963|FG000|Overall Study|Lost to Follow-up|5|||
46915859|NCT02524730|83146963|FG000|Overall Study|Withdrawal by Subject|18|||
46915860|NCT02524730|83146963|FG000|Overall Study|Death|10|||
46915861|NCT02524730|83146963|FG000|Overall Study|Adverse Event|8|||
46915862|NCT02524730|83146963|FG000|Overall Study|Protocol Violation|1|||
46915863|NCT02524730|83146963|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
46915864|NCT02522728|83146969|FG000|Overall Study|Withdrawal by Subject|6|||
46915865|NCT02522728|83146970|FG001|Overall Study|Withdrawal by Subject|6|||
46915866|NCT02522728|83146969|FG000|Overall Study|Death|4|||
46915867|NCT02522728|83146970|FG001|Overall Study|Death|3|||
46915868|NCT02522728|83146969|FG000|Overall Study|Adverse Event|2|||
46915869|NCT02522728|83146970|FG001|Overall Study|Adverse Event|1|||
46915870|NCT02522728|83146969|FG000|Overall Study|Did not receive randomized study device|0|||
46915871|NCT02522728|83146970|FG001|Overall Study|Did not receive randomized study device|1|||
46915872|NCT02520531|83146978|FG000|Overall Study|Revision of study device components|2|||
46915873|NCT02520531|83146979|FG001|Overall Study|Revision of study device components|2|||
46915874|NCT02520531|83146978|FG000|Overall Study|Death|1|||
46915875|NCT02520531|83146979|FG001|Overall Study|Death|2|||
46915876|NCT02520531|83146978|FG000|Overall Study|Lost to Follow-up|1|||
46915877|NCT02520531|83146979|FG001|Overall Study|Lost to Follow-up|1|||
46915878|NCT02520531|83146978|FG000|Overall Study|Meet exclusion criterion|0|||
46915879|NCT02520531|83146979|FG001|Overall Study|Meet exclusion criterion|1|||
46915880|NCT02520531|83146978|FG000|Overall Study|Withdrawal by Subject|1|||
46915881|NCT02520531|83146979|FG001|Overall Study|Withdrawal by Subject|0|||
46915882|NCT02520531|83146978|FG000|Overall Study|Not study device|1|||
46915883|NCT02520531|83146979|FG001|Overall Study|Not study device|0|||
46915884|NCT02446236|83146988|FG000|Overall Study|Screen Failure|1|||
46915885|NCT02446236|83146989|FG001|Overall Study|Screen Failure|0|||
46915886|NCT02446236|83146990|FG002|Overall Study|Screen Failure|1|||
46915887|NCT02446236|83146988|FG000|Overall Study|Actively Receiving Therapy|0|||
46915888|NCT02446236|83146989|FG001|Overall Study|Actively Receiving Therapy|0|||
46915889|NCT02446236|83146990|FG002|Overall Study|Actively Receiving Therapy|1|||
46915890|NCT02441803|83146999|FG000|Overall Study|Physician Decision|0|||
46915891|NCT02441803|83147000|FG001|Overall Study|Physician Decision|2|||
46915892|NCT02441803|83147001|FG002|Overall Study|Physician Decision|2|||
46915893|NCT02337829|83147013|FG000|Overall Study|Death|0|||
46915894|NCT02337829|83147014|FG001|Overall Study|Death|1|||
46915895|NCT02337829|83147015|FG002|Overall Study|Death|0|||
46915896|NCT02337829|83147016|FG003|Overall Study|Death|0|||
46915897|NCT02337829|83147013|FG000|Overall Study|Study terminated by sponsor|12|||
46915898|NCT02337829|83147014|FG001|Overall Study|Study terminated by sponsor|10|||
46915899|NCT02337829|83147015|FG002|Overall Study|Study terminated by sponsor|5|||
46915900|NCT02337829|83147016|FG003|Overall Study|Study terminated by sponsor|6|||
46915901|NCT02337829|83147013|FG000|Overall Study|discontinued for other reasons|6|||
46915902|NCT02337829|83147014|FG001|Overall Study|discontinued for other reasons|3|||
46915903|NCT02337829|83147015|FG002|Overall Study|discontinued for other reasons|1|||
46632447|NCT01794000|82805569|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
46632448|NCT01794000|82805570|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
46915904|NCT02337829|83147016|FG003|Overall Study|discontinued for other reasons|4|||
46915905|NCT02120352|83147028|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
46915906|NCT02120352|83147029|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
46915907|NCT02120352|83147030|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
47040821|NCT01419717|83295152|FG000|Overall Study|Withdrawal by Subject|10|||
47040822|NCT01419717|83295152|FG000|Overall Study|Disease Progression|9|||
46632449|NCT01609296|82805577|FG000|Overall Study|Death|253|||
46915908|NCT02120352|83147031|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
47040823|NCT01419717|83295152|FG000|Overall Study|Other|4|||
46915909|NCT02120352|83147028|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
46915910|NCT02120352|83147029|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
46915911|NCT02120352|83147030|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
46915912|NCT02120352|83147031|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
46915913|NCT02120352|83147028|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
46915914|NCT02120352|83147029|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
46632450|NCT01609296|82805577|FG000|Overall Study|Withdrawal by Subject|151|||
46915915|NCT02120352|83147030|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
46915916|NCT02120352|83147031|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
47040824|NCT01419717|83295152|FG000|Overall Study|Lost to Follow-up|2|||
46719289|NCT01007838|82935436|FG000|Overall Study|Withdrawal by Subject|1|||
46719290|NCT01007838|82935437|FG001|Overall Study|Withdrawal by Subject|0|||
46719291|NCT01007838|82935438|FG002|Overall Study|Withdrawal by Subject|0|||
46719292|NCT01007838|82935439|FG003|Overall Study|Withdrawal by Subject|0|||
46719293|NCT01007838|82935436|FG000|Overall Study|Physician Decision|1|||
46719294|NCT01007838|82935437|FG001|Overall Study|Physician Decision|0|||
46719295|NCT01007838|82935438|FG002|Overall Study|Physician Decision|0|||
46719296|NCT01007838|82935439|FG003|Overall Study|Physician Decision|0|||
46719297|NCT01007838|82935436|FG000|Overall Study|Started home haemodialysis|1|||
46719298|NCT01007838|82935437|FG001|Overall Study|Started home haemodialysis|0|||
46719299|NCT01007838|82935438|FG002|Overall Study|Started home haemodialysis|0|||
46719300|NCT01007838|82935439|FG003|Overall Study|Started home haemodialysis|0|||
46719301|NCT01007448|82935451|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
47040825|NCT01419717|83295152|FG000|Overall Study|Administrative Decision|1|||
47040826|NCT01419717|83295152|FG000|Overall Study|Noncompliance|1|||
47040827|NCT01458951|83295159|FG000|Overall Study|Other|1|||
47040828|NCT01458951|83295160|FG001|Overall Study|Other|0|||
47040829|NCT01458951|83295161|FG002|Overall Study|Other|0|||
47040830|NCT01458951|83295159|FG000|Overall Study|Protocol Violation|5|||
47040831|NCT01458951|83295160|FG001|Overall Study|Protocol Violation|1|||
47040832|NCT01458951|83295161|FG002|Overall Study|Protocol Violation|0|||
47040833|NCT01458951|83295159|FG000|Overall Study|Withdrawal by Subject|2|||
47040834|NCT01458951|83295160|FG001|Overall Study|Withdrawal by Subject|0|||
47040835|NCT01458951|83295161|FG002|Overall Study|Withdrawal by Subject|2|||
47040836|NCT01458951|83295159|FG000|Overall Study|Adverse Event|7|||
47040837|NCT01458951|83295160|FG001|Overall Study|Adverse Event|0|||
47040838|NCT01458951|83295161|FG002|Overall Study|Adverse Event|2|||
47040839|NCT01458951|83295159|FG000|Overall Study|Insufficient Clinical Response|17|||
47040840|NCT01458951|83295160|FG001|Overall Study|Insufficient Clinical Response|0|||
47040841|NCT01458951|83295161|FG002|Overall Study|Insufficient Clinical Response|11|||
47040842|NCT01458639|83295168|FG000|Overall Study|Physician Decision|4|||
47040843|NCT01458639|83295168|FG000|Overall Study|Equipment issue|1|||
47040844|NCT01458639|83295168|FG000|Overall Study|Inability to obtain subject blood sample|1|||
47040845|NCT01437423|83295172|FG000|Overall Study|Lost to Follow-up|12|||
47040846|NCT01437423|83295172|FG000|Overall Study|Off label usage|3|||
47040847|NCT01458249|83295203|FG000|Overall Study|Not treated|1|||
47040848|NCT01458249|83295203|FG000|Overall Study|Adverse Event|4|||
47040849|NCT01458249|83295203|FG000|Overall Study|Other|2|||
47040850|NCT01458249|83295203|FG000|Overall Study|Ongoing|1|||
47040851|NCT01458171|83295219|FG000|Overall Study|Adverse Event|1|||
47040852|NCT01457703|83295236|FG000|Overall Study|Screen Failure|5|||
47040853|NCT01457703|83295237|FG001|Overall Study|Screen Failure|7|||
47040854|NCT01457703|83295236|FG000|Overall Study|Withdrawal by Subject|1|||
47040855|NCT01457703|83295237|FG001|Overall Study|Withdrawal by Subject|4|||
47040856|NCT01419015|83295255|FG000|Overall Study|Death|2|||
47040857|NCT01418937|83295276|FG000|Overall Study|Lost to Follow-up|5|||
47040858|NCT01418937|83295276|FG000|Overall Study|Protocol Violation|1|||
47040859|NCT01418937|83295276|FG000|Overall Study|Pregnancy|1|||
46632451|NCT01609296|82805577|FG000|Overall Study|Lost to Follow-up|21|||
46632452|NCT01609296|82805577|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
46632453|NCT01609296|82805577|FG000|Overall Study|missed visit but known to be alive|28|||
46632454|NCT01609218|82805585|FG000|Period 1|Adverse Event|3|||
46632455|NCT01609218|82805586|FG001|Period 1|Adverse Event|5|||
46632456|NCT01609218|82805585|FG000|Period 1|Sponsor Decision|0|||
46632457|NCT01609218|82805586|FG001|Period 1|Sponsor Decision|1|||
46632458|NCT01609218|82805585|FG000|Period 2|Adverse Event|1|||
46632459|NCT01609218|82805586|FG001|Period 2|Adverse Event|0|||
46632460|NCT01609062|82805594|FG000|Extension Phase|Terminated by Sponsor|14|||
46632461|NCT01609062|82805595|FG001|Extension Phase|Terminated by Sponsor|9|||
46632462|NCT01609062|82805594|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
46632463|NCT01609062|82805595|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
46632464|NCT01609062|82805594|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
46632465|NCT01609062|82805595|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
46632466|NCT01819272|82805608|FG000|Overall Study|Adverse Event|1|||
46632467|NCT01819272|82805609|FG001|Overall Study|Adverse Event|0|||
46719302|NCT01007448|82935452|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
47040860|NCT01418937|83295276|FG000|Overall Study|Withdrawal by Subject|1|||
47040861|NCT01417377|83295289|FG000|Overall Study|Lost to Follow-up|12|||
47040862|NCT01417377|83295289|FG000|Overall Study|Enrolled, but not treated|1|||
47040863|NCT01437267|83295336|FG000|Overall Study|Withdrawal by Subject|0|||
46632468|NCT01819272|82805610|FG002|Overall Study|Adverse Event|0|||
46719303|NCT01007448|82935451|FG000|Overall Study|Staph Skin Infection Flare|1|||
46719304|NCT01007448|82935452|FG001|Overall Study|Staph Skin Infection Flare|0|||
47040864|NCT01437267|83295337|FG001|Overall Study|Withdrawal by Subject|0|||
47040865|NCT01437267|83295338|FG002|Overall Study|Withdrawal by Subject|0|||
47040866|NCT01437267|83295339|FG003|Overall Study|Withdrawal by Subject|1|||
46632469|NCT01819272|82805611|FG003|Overall Study|Adverse Event|2|||
46632470|NCT01819272|82805612|FG004|Overall Study|Adverse Event|0|||
46632471|NCT01819272|82805613|FG005|Overall Study|Adverse Event|0|||
46632472|NCT01819272|82805608|FG000|Overall Study|Lost to Follow-up|3|||
46632473|NCT01819272|82805609|FG001|Overall Study|Lost to Follow-up|0|||
46632474|NCT01819272|82805610|FG002|Overall Study|Lost to Follow-up|1|||
46632475|NCT01819272|82805611|FG003|Overall Study|Lost to Follow-up|0|||
46632476|NCT01819272|82805612|FG004|Overall Study|Lost to Follow-up|0|||
46632477|NCT01819272|82805613|FG005|Overall Study|Lost to Follow-up|3|||
46632478|NCT01819272|82805608|FG000|Overall Study|Protocol Violation|0|||
46719305|NCT01007448|82935451|FG000|Overall Study|Participant Leaving the Country|1|||
46719306|NCT01007448|82935452|FG001|Overall Study|Participant Leaving the Country|0|||
46719307|NCT01007448|82935451|FG000|Overall Study|Participant Given Prohibited Medication|1|||
46719308|NCT01007448|82935452|FG001|Overall Study|Participant Given Prohibited Medication|0|||
46915917|NCT02120352|83147028|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
46915918|NCT02120352|83147029|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
46915919|NCT02120352|83147030|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
46915920|NCT02120352|83147031|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
46915921|NCT02120352|83147028|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
46915922|NCT02120352|83147029|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
46915923|NCT02120352|83147030|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
46915924|NCT02120352|83147031|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
46915925|NCT02120352|83147028|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
46915926|NCT02120352|83147029|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
46915927|NCT02120352|83147030|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
46915928|NCT02120352|83147031|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
46915929|NCT02120352|83147028|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
46915930|NCT02120352|83147029|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
46915931|NCT02120352|83147030|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
46915932|NCT02120352|83147031|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
46915933|NCT02120352|83147028|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
46915934|NCT02120352|83147029|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
46915935|NCT02120352|83147030|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
46915936|NCT02120352|83147031|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
46915937|NCT02120352|83147028|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
46915938|NCT02120352|83147029|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
46915939|NCT02120352|83147030|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
46915940|NCT02120352|83147031|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
46915941|NCT02120352|83147028|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
46915942|NCT02120352|83147029|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
46915943|NCT02120352|83147030|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
46915944|NCT02120352|83147031|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
46915945|NCT02120352|83147028|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
46915946|NCT02120352|83147029|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
46915947|NCT02120352|83147030|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
46915948|NCT02120352|83147031|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
46915949|NCT02120352|83147028|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
46915950|NCT02120352|83147029|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
46915951|NCT02120352|83147030|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
46915952|NCT02120352|83147031|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
46915953|NCT02120352|83147028|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
46915954|NCT02120352|83147029|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
46719309|NCT01007448|82935451|FG000|Overall Study|Progressive Disease|1|||
46719310|NCT01007448|82935452|FG001|Overall Study|Progressive Disease|2|||
46719311|NCT01007448|82935451|FG000|Overall Study|Lack of Efficacy|2|||
46719312|NCT01007448|82935452|FG001|Overall Study|Lack of Efficacy|0|||
47040867|NCT01437267|83295340|FG004|Overall Study|Withdrawal by Subject|0|||
47040868|NCT01437267|83295341|FG005|Overall Study|Withdrawal by Subject|0|||
46915955|NCT02120352|83147030|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
46915956|NCT02120352|83147031|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
46719313|NCT01007448|82935451|FG000|Overall Study|Withdrawal by Subject|2|||
46719314|NCT01007448|82935452|FG001|Overall Study|Withdrawal by Subject|3|||
46915957|NCT02120352|83147028|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
46719315|NCT01007448|82935451|FG000|Overall Study|Adverse Event|1|||
46915958|NCT02120352|83147029|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
47040869|NCT01437267|83295336|FG000|Overall Study|Protocol Violation|0|||
46632479|NCT01819272|82805609|FG001|Overall Study|Protocol Violation|0|||
46632480|NCT01819272|82805610|FG002|Overall Study|Protocol Violation|0|||
46719316|NCT01007448|82935452|FG001|Overall Study|Adverse Event|4|||
46719317|NCT03538756|82935458|FG000|Long-Term Follow-up|Adverse Event|0|||
46719318|NCT03538756|82935459|FG001|Long-Term Follow-up|Adverse Event|0|||
46915959|NCT02120352|83147030|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
46915960|NCT02120352|83147031|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
46915961|NCT02040857|83147045|FG000|Overall Study|Adverse Event|14|||
46915962|NCT02040857|83147045|FG000|Overall Study|Physician Decision|5|||
46915963|NCT02040857|83147045|FG000|Overall Study|Withdrawal by Subject|31|||
46915964|NCT02040857|83147045|FG000|Overall Study|patient non-compliance|3|||
46915965|NCT02040857|83147045|FG000|Overall Study|Lost to Follow-up|2|||
46915966|NCT02040857|83147045|FG000|Overall Study|recurrence|4|||
46915967|NCT02040857|83147045|FG000|Overall Study|ineligible|1|||
46632481|NCT01819272|82805611|FG003|Overall Study|Protocol Violation|1|||
46632482|NCT01819272|82805612|FG004|Overall Study|Protocol Violation|2|||
46632483|NCT01819272|82805613|FG005|Overall Study|Protocol Violation|3|||
46632484|NCT01819272|82805608|FG000|Overall Study|Physician Decision|0|||
46632485|NCT01819272|82805609|FG001|Overall Study|Physician Decision|1|||
46632486|NCT01819272|82805610|FG002|Overall Study|Physician Decision|0|||
46632487|NCT01819272|82805611|FG003|Overall Study|Physician Decision|0|||
46632488|NCT01819272|82805612|FG004|Overall Study|Physician Decision|0|||
46632489|NCT01819272|82805613|FG005|Overall Study|Physician Decision|0|||
46632490|NCT01819272|82805608|FG000|Overall Study|Withdrawal of Consent|0|||
46632491|NCT01819272|82805609|FG001|Overall Study|Withdrawal of Consent|1|||
46632492|NCT01819272|82805610|FG002|Overall Study|Withdrawal of Consent|2|||
46632493|NCT01819272|82805611|FG003|Overall Study|Withdrawal of Consent|1|||
46632494|NCT01819272|82805612|FG004|Overall Study|Withdrawal of Consent|0|||
46632495|NCT01819272|82805613|FG005|Overall Study|Withdrawal of Consent|1|||
46719319|NCT03538756|82935460|FG002|Long-Term Follow-up|Adverse Event|6|||
46719320|NCT03538756|82935458|FG000|Long-Term Follow-up|Death|0|||
46719321|NCT03538756|82935459|FG001|Long-Term Follow-up|Death|0|||
46915968|NCT00676715|83147082|FG000|Overall Study|Withdrawal by Subject|7|||
46915969|NCT00676715|83147083|FG001|Overall Study|Withdrawal by Subject|9|||
46915970|NCT00676715|83147084|FG002|Overall Study|Withdrawal by Subject|10|||
46915971|NCT00676715|83147085|FG003|Overall Study|Withdrawal by Subject|10|||
46915972|NCT00676715|83147082|FG000|Overall Study|Other|2|||
46915973|NCT00676715|83147083|FG001|Overall Study|Other|6|||
46915974|NCT00676715|83147084|FG002|Overall Study|Other|4|||
46915975|NCT00676715|83147085|FG003|Overall Study|Other|3|||
46915976|NCT00676715|83147082|FG000|Overall Study|Lost to Follow-up|1|||
46915977|NCT00676715|83147083|FG001|Overall Study|Lost to Follow-up|1|||
46915978|NCT00676715|83147084|FG002|Overall Study|Lost to Follow-up|7|||
46915979|NCT00676715|83147085|FG003|Overall Study|Lost to Follow-up|3|||
46915980|NCT00676715|83147082|FG000|Overall Study|Death|1|||
46915981|NCT00676715|83147083|FG001|Overall Study|Death|1|||
46915982|NCT00676715|83147084|FG002|Overall Study|Death|1|||
46915983|NCT00676715|83147085|FG003|Overall Study|Death|0|||
46915984|NCT00676715|83147082|FG000|Overall Study|Adverse Event|0|||
46915985|NCT00676715|83147083|FG001|Overall Study|Adverse Event|1|||
46915986|NCT00676715|83147084|FG002|Overall Study|Adverse Event|2|||
46915987|NCT00676715|83147085|FG003|Overall Study|Adverse Event|0|||
46915988|NCT00676715|83147082|FG000|Overall Study|Participants Ongoing|29|||
46915989|NCT00676715|83147083|FG001|Overall Study|Participants Ongoing|29|||
46915990|NCT00676715|83147084|FG002|Overall Study|Participants Ongoing|17|||
46915991|NCT00676715|83147085|FG003|Overall Study|Participants Ongoing|24|||
46915992|NCT00436982|83147097|FG000|Overall Study|Withdrawal by Subject|3|||
46915993|NCT00436982|83147098|FG001|Overall Study|Withdrawal by Subject|1|||
46915994|NCT00436982|83147097|FG000|Overall Study|Did not receive allocated intervention|0|||
46915995|NCT00436982|83147098|FG001|Overall Study|Did not receive allocated intervention|1|||
46915996|NCT00436982|83147097|FG000|Overall Study|no RSA data|1|||
46915997|NCT00436982|83147098|FG001|Overall Study|no RSA data|2|||
46915998|NCT00378105|83147110|FG000|Overall Study|Adverse Event|3|||
46915999|NCT00378105|83147111|FG001|Overall Study|Adverse Event|1|||
46916000|NCT00378105|83147110|FG000|Overall Study|Withdrawal by Subject|3|||
46916001|NCT00378105|83147111|FG001|Overall Study|Withdrawal by Subject|3|||
46916002|NCT00378105|83147110|FG000|Overall Study|Death|1|||
46632496|NCT01819272|82805608|FG000|Overall Study|Loss of Glucose Control|2|||
46916003|NCT00378105|83147111|FG001|Overall Study|Death|0|||
46632497|NCT01819272|82805609|FG001|Overall Study|Loss of Glucose Control|1|||
46916004|NCT00378105|83147110|FG000|Overall Study|Going to transplant|7|||
46916005|NCT00378105|83147111|FG001|Overall Study|Going to transplant|8|||
46916006|NCT00378105|83147110|FG000|Overall Study|Progressive disease|3|||
46916007|NCT00378105|83147111|FG001|Overall Study|Progressive disease|3|||
46916008|NCT00378105|83147110|FG000|Overall Study|remain on study|3|||
46916009|NCT00378105|83147111|FG001|Overall Study|remain on study|11|||
46916010|NCT00378105|83147110|FG000|Overall Study|Physician Decision|0|||
46916011|NCT00378105|83147111|FG001|Overall Study|Physician Decision|2|||
46916012|NCT00378105|83147110|FG000|Overall Study|Going non-protocol therapy|0|||
46632498|NCT01819272|82805610|FG002|Overall Study|Loss of Glucose Control|0|||
46632499|NCT01819272|82805611|FG003|Overall Study|Loss of Glucose Control|1|||
46632500|NCT01819272|82805612|FG004|Overall Study|Loss of Glucose Control|2|||
46719322|NCT03538756|82935460|FG002|Long-Term Follow-up|Death|1|||
47040870|NCT01437267|83295337|FG001|Overall Study|Protocol Violation|1|||
47040871|NCT01437267|83295338|FG002|Overall Study|Protocol Violation|0|||
47040872|NCT01437267|83295339|FG003|Overall Study|Protocol Violation|0|||
47040873|NCT01437267|83295340|FG004|Overall Study|Protocol Violation|0|||
47040874|NCT01437267|83295341|FG005|Overall Study|Protocol Violation|0|||
47040875|NCT01437111|83295368|FG000|Overall Study|Adverse Event|2|||
47040876|NCT01437111|83295368|FG000|Overall Study|Withdrawal by Subject|4|||
47040877|NCT01437111|83295368|FG000|Overall Study|Not reported|5|||
47040878|NCT01437111|83295368|FG000|Overall Study|Physician Decision|1|||
47040879|NCT01437111|83295368|FG000|Overall Study|Lost to Follow-up|5|||
47040880|NCT01437111|83295368|FG000|Overall Study|Protocol Violation|1|||
47040881|NCT01436643|83295416|FG000|2-week Pre-treatment|Abnormal test result|0|||
47040882|NCT01436643|83295417|FG001|2-week Pre-treatment|Abnormal test result|0|||
47040883|NCT01436643|83295418|FG002|2-week Pre-treatment|Abnormal test result|0|||
47040884|NCT01436643|83295419|FG003|2-week Pre-treatment|Abnormal test result|1|||
47040885|NCT01436643|83295416|FG000|2-week Pre-treatment|Adverse Event|0|||
47040886|NCT01436643|83295417|FG001|2-week Pre-treatment|Adverse Event|0|||
47040887|NCT01436643|83295418|FG002|2-week Pre-treatment|Adverse Event|0|||
47040888|NCT01436643|83295419|FG003|2-week Pre-treatment|Adverse Event|5|||
47040889|NCT01436643|83295416|FG000|2-week Pre-treatment|Protocol Violation|0|||
47040890|NCT01436643|83295417|FG001|2-week Pre-treatment|Protocol Violation|0|||
47040891|NCT01436643|83295418|FG002|2-week Pre-treatment|Protocol Violation|0|||
47040892|NCT01436643|83295419|FG003|2-week Pre-treatment|Protocol Violation|4|||
47040893|NCT01436643|83295416|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
46632501|NCT01819272|82805613|FG005|Overall Study|Loss of Glucose Control|0|||
46632502|NCT01819194|82805627|FG000|Overall Study|Loss of study articles|2|||
46916013|NCT00378105|83147111|FG001|Overall Study|Going non-protocol therapy|1|||
46916014|NCT00378105|83147110|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
46916015|NCT00378105|83147111|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
46916016|NCT02806232|83147127|FG000|Overall Study|Lost to Follow-up|1|||
46916017|NCT02806232|83147128|FG001|Overall Study|Lost to Follow-up|2|||
46916018|NCT02806232|83147129|FG002|Overall Study|Lost to Follow-up|1|||
46916019|NCT02806232|83147130|FG003|Overall Study|Lost to Follow-up|0|||
46916020|NCT02806232|83147131|FG004|Overall Study|Lost to Follow-up|0|||
46916021|NCT02806232|83147132|FG005|Overall Study|Lost to Follow-up|1|||
46916022|NCT02806232|83147133|FG006|Overall Study|Lost to Follow-up|0|||
46916023|NCT02806232|83147134|FG007|Overall Study|Lost to Follow-up|0|||
46916024|NCT02806232|83147135|FG008|Overall Study|Lost to Follow-up|0|||
46916025|NCT02806232|83147127|FG000|Overall Study|Withdrawal by Subject|0|||
46916026|NCT02806232|83147128|FG001|Overall Study|Withdrawal by Subject|2|||
46916027|NCT02806232|83147129|FG002|Overall Study|Withdrawal by Subject|0|||
46916028|NCT02806232|83147130|FG003|Overall Study|Withdrawal by Subject|0|||
46916029|NCT02806232|83147131|FG004|Overall Study|Withdrawal by Subject|2|||
46916030|NCT02806232|83147132|FG005|Overall Study|Withdrawal by Subject|1|||
46916031|NCT02806232|83147133|FG006|Overall Study|Withdrawal by Subject|0|||
46916032|NCT02806232|83147134|FG007|Overall Study|Withdrawal by Subject|0|||
46916033|NCT02806232|83147135|FG008|Overall Study|Withdrawal by Subject|0|||
46916034|NCT02807402|83147155|FG000|Overall Study|Failure to Return|1|||
46916035|NCT02807402|83147155|FG000|Overall Study|Death|3|||
46916036|NCT02807402|83147155|FG000|Overall Study|Other|2|||
46916037|NCT02960490|83147169|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
46916038|NCT02960490|83147170|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
46916039|NCT02960490|83147171|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916040|NCT02960490|83147172|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916041|NCT02960490|83147173|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916042|NCT02960490|83147174|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916043|NCT02960490|83147175|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916044|NCT02960490|83147176|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916045|NCT02960490|83147177|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916046|NCT02960490|83147178|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
46916047|NCT02960490|83147169|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46916048|NCT02960490|83147170|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
46632503|NCT01611558|82805631|FG000|Induction Phase|Study drug toxicity|15|||
46916049|NCT02960490|83147171|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46916050|NCT02960490|83147172|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46916051|NCT02960490|83147173|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46916052|NCT02960490|83147174|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
47040894|NCT01436643|83295417|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
47040895|NCT01436643|83295418|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
47040896|NCT01436643|83295419|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
47040897|NCT01436643|83295416|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
47040898|NCT01436643|83295417|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
46632504|NCT01611558|82805631|FG000|Induction Phase|Disease progression|18|||
47040899|NCT01436643|83295418|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
47040900|NCT01436643|83295419|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
47040901|NCT01436643|83295416|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
47040902|NCT01436643|83295417|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
47040903|NCT01436643|83295418|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
47040904|NCT01436643|83295419|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
47040905|NCT01454739|83295517|FG000|Overall Study|Protocol Violation|2|||
47040906|NCT01454739|83295518|FG001|Overall Study|Protocol Violation|3|||
47040907|NCT01454739|83295517|FG000|Overall Study|Withdrawal by Subject|2|||
47040908|NCT01454739|83295518|FG001|Overall Study|Withdrawal by Subject|6|||
47040909|NCT01454739|83295517|FG000|Overall Study|Other|3|||
47040910|NCT01454739|83295518|FG001|Overall Study|Other|5|||
47040911|NCT01454739|83295517|FG000|Overall Study|Physician Decision|0|||
46916053|NCT02960490|83147175|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46916054|NCT02960490|83147176|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46916055|NCT02960490|83147177|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46719323|NCT03538756|82935458|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
46719324|NCT03538756|82935459|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
46719325|NCT03538756|82935460|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
46719326|NCT03538756|82935458|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
46719327|NCT03538756|82935459|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
46719328|NCT03538756|82935460|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
46719329|NCT03538756|82935458|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
46719330|NCT03538756|82935459|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
46719331|NCT03538756|82935460|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
46719332|NCT01004250|82935470|FG000|Induction Therapy Period|Adverse Event|10|||
46719333|NCT01004250|82935470|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
47040912|NCT01454739|83295518|FG001|Overall Study|Physician Decision|5|||
46719334|NCT01004250|82935470|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
46719335|NCT01004250|82935470|FG000|Induction Therapy Period|Physician Decision|2|||
46719336|NCT01004250|82935470|FG000|Maintenance Therapy Period|Adverse Event|15|||
46719337|NCT01004250|82935470|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
46916056|NCT02960490|83147178|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
46916057|NCT02960490|83147169|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
47040913|NCT01454739|83295517|FG000|Overall Study|Lost to Follow-up|0|||
47040914|NCT01454739|83295518|FG001|Overall Study|Lost to Follow-up|1|||
47040915|NCT01454739|83295517|FG000|Overall Study|Adverse Event|0|||
47040916|NCT01454739|83295518|FG001|Overall Study|Adverse Event|1|||
47040917|NCT01416441|83295556|FG000|Overall Study|Lost to Follow-up|5|||
47040918|NCT01416441|83295556|FG000|Overall Study|Adverse Event|6|||
47040919|NCT01416441|83295556|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
47040920|NCT01416441|83295556|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
47040921|NCT01416441|83295556|FG000|Overall Study|Investigator Withdrew Subject|2|||
47040922|NCT01416441|83295556|FG000|Overall Study|Subject Withdrew Consent|12|||
47040923|NCT01416441|83295556|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
47040924|NCT01436253|83295565|FG000|Overall Study|Lost to Follow-up|182|||
47040925|NCT01436253|83295565|FG000|Overall Study|Not meeting all eligibility criteria|117|||
47040926|NCT01454583|83296478|FG000|1st Year|Lost to Follow-up|1057|||
47040927|NCT01454583|83296479|FG001|1st Year|Lost to Follow-up|318|||
47040928|NCT01454583|83296480|FG002|1st Year|Lost to Follow-up|180|||
47040929|NCT01454583|83296478|FG000|2nd Year|Lost to Follow-up|3965|||
46632505|NCT01611558|82805631|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
46632506|NCT01611558|82805631|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
46632507|NCT01611558|82805631|FG000|Induction Phase|Death|1|||
46632508|NCT01611558|82805631|FG000|Maintenance Phase|Withdrawal by Subject|1|||
46632509|NCT01611558|82805631|FG000|Maintenance Phase|Elevated Uric acid|1|||
46632510|NCT01818726|82805638|FG000|Overall Study|Administrative reasons|5|||
46632511|NCT01818726|82805639|FG001|Overall Study|Administrative reasons|1|||
46632512|NCT01818726|82805638|FG000|Overall Study|Withdrawal by Subject|0|||
46632513|NCT01818726|82805639|FG001|Overall Study|Withdrawal by Subject|1|||
46632514|NCT01818726|82805638|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
46632515|NCT01818726|82805639|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
47040930|NCT01454583|83296479|FG001|2nd Year|Lost to Follow-up|1049|||
47040931|NCT01454583|83296480|FG002|2nd Year|Lost to Follow-up|737|||
47040932|NCT01454583|83296478|FG000|3rd Year|Lost to Follow-up|1959|||
46632516|NCT01818336|82805645|FG000|Overall Study|Declined retest visit|0|||
47040933|NCT01454583|83296479|FG001|3rd Year|Lost to Follow-up|512|||
47040934|NCT01454583|83296480|FG002|3rd Year|Lost to Follow-up|297|||
46632517|NCT01818336|82805646|FG001|Overall Study|Declined retest visit|11|||
46719338|NCT01004250|82935470|FG000|Maintenance Therapy Period|Protocol Violation|1|||
47040935|NCT01436175|83296503|FG000|Overall Study|Adverse Event|111|||
47040936|NCT01436175|83296503|FG000|Overall Study|Protocol Violation|49|||
47040937|NCT01436175|83296503|FG000|Overall Study|Withdrawal by Subject|108|||
47040938|NCT01436175|83296503|FG000|Overall Study|Lost to Follow-up|89|||
47040939|NCT01436175|83296503|FG000|Overall Study|Lack of Efficacy|24|||
47040940|NCT01436175|83296503|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
47040941|NCT01436175|83296503|FG000|Overall Study|Other|826|||
47040942|NCT01453725|83296531|FG000|Overall Study|Adverse Event|3|||
47040943|NCT01453725|83296532|FG001|Overall Study|Adverse Event|3|||
47040944|NCT01453725|83296531|FG000|Overall Study|Lost to Follow-up|4|||
47040945|NCT01453725|83296532|FG001|Overall Study|Lost to Follow-up|0|||
47040946|NCT01453725|83296531|FG000|Overall Study|Non-compliance With Protocol|1|||
46916058|NCT02960490|83147170|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
46916059|NCT02960490|83147171|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916060|NCT02960490|83147172|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916061|NCT02960490|83147173|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916062|NCT02960490|83147174|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916063|NCT02960490|83147175|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916064|NCT02960490|83147176|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916065|NCT02960490|83147177|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916066|NCT02960490|83147178|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
46916067|NCT02960490|83147169|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
46916068|NCT02960490|83147170|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
46916069|NCT02960490|83147171|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
46916070|NCT02960490|83147172|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
46916071|NCT02960490|83147173|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
46916072|NCT02960490|83147174|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
46916073|NCT02960490|83147175|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
46916074|NCT02960490|83147176|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
46916075|NCT02960490|83147177|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
47040947|NCT01453725|83296532|FG001|Overall Study|Non-compliance With Protocol|2|||
47040948|NCT01453725|83296531|FG000|Overall Study|Protocol Violation|1|||
47040949|NCT01453725|83296532|FG001|Overall Study|Protocol Violation|0|||
47040950|NCT01453725|83296531|FG000|Overall Study|Withdrawal by Subject|2|||
47040951|NCT01453725|83296532|FG001|Overall Study|Withdrawal by Subject|3|||
47040952|NCT01453725|83296531|FG000|Overall Study|Pregnancy Wish|0|||
47040953|NCT01453725|83296532|FG001|Overall Study|Pregnancy Wish|2|||
47040954|NCT01453725|83296531|FG000|Overall Study|Pregnancy|1|||
47040955|NCT01453725|83296532|FG001|Overall Study|Pregnancy|0|||
47040956|NCT01453725|83296531|FG000|Overall Study|Physician Decision|1|||
47040957|NCT01453725|83296532|FG001|Overall Study|Physician Decision|1|||
47040958|NCT01415349|83296571|FG000|Treatment Period 1|Adverse Event|0|||
47040959|NCT01415349|83296572|FG001|Treatment Period 1|Adverse Event|1|||
47040960|NCT01415349|83296571|FG000|Treatment Period 1|Withdrawal by Subject|0|||
47040961|NCT01415349|83296572|FG001|Treatment Period 1|Withdrawal by Subject|1|||
47040962|NCT01453023|83296626|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
47040963|NCT01453023|83296627|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
47040964|NCT01453023|83296626|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
47040965|NCT01453023|83296627|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
47040966|NCT01453023|83296626|FG000|Treatment Period 2|Protocol Violation|0|||
47040967|NCT01453023|83296627|FG001|Treatment Period 2|Protocol Violation|1|||
47040968|NCT01452789|83296635|FG000|Overall Study|Withdrawal by Subject|3|||
47040969|NCT01452789|83296636|FG001|Overall Study|Withdrawal by Subject|2|||
47040970|NCT01451931|83296645|FG000|Overall Study|Lost to Follow-up|17|||
47040971|NCT01451931|83296646|FG001|Overall Study|Lost to Follow-up|36|||
47040972|NCT01451931|83296647|FG002|Overall Study|Lost to Follow-up|21|||
47040973|NCT01451931|83296645|FG000|Overall Study|Withdrawal by Subject|16|||
47040974|NCT01451931|83296646|FG001|Overall Study|Withdrawal by Subject|22|||
47040975|NCT01451931|83296647|FG002|Overall Study|Withdrawal by Subject|22|||
47040976|NCT01414257|83296670|FG000|Overall Study|No Visit After First Day of Treatment|12|||
46632518|NCT01818336|82805645|FG000|Overall Study|Lost to Follow-up|0|||
46632519|NCT01818336|82805646|FG001|Overall Study|Lost to Follow-up|1|||
46916076|NCT02960490|83147178|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
46916077|NCT02960490|83147169|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
47040977|NCT01414257|83296670|FG000|Overall Study|Protocol Violation|10|||
47040978|NCT01434693|83296713|FG000|Overall Study|Adverse Event|1|||
47040979|NCT01434693|83296714|FG001|Overall Study|Adverse Event|0|||
47040980|NCT01434693|83296715|FG002|Overall Study|Adverse Event|0|||
47040981|NCT01434693|83296716|FG003|Overall Study|Adverse Event|0|||
47040982|NCT01434693|83296713|FG000|Overall Study|Withdrawal by Subject|1|||
47040983|NCT01434693|83296714|FG001|Overall Study|Withdrawal by Subject|0|||
47040984|NCT01434693|83296715|FG002|Overall Study|Withdrawal by Subject|1|||
47040985|NCT01434693|83296716|FG003|Overall Study|Withdrawal by Subject|1|||
47040986|NCT01434693|83296713|FG000|Overall Study|Lost to Follow-up|1|||
47040987|NCT01434693|83296714|FG001|Overall Study|Lost to Follow-up|0|||
47040988|NCT01434693|83296715|FG002|Overall Study|Lost to Follow-up|0|||
47040989|NCT01434693|83296716|FG003|Overall Study|Lost to Follow-up|0|||
47040990|NCT01451541|83296733|FG000|Overall Study|Adverse Event|4|||
47040991|NCT01451541|83296734|FG001|Overall Study|Adverse Event|3|||
47040992|NCT01451541|83296735|FG002|Overall Study|Adverse Event|6|||
47040993|NCT01451541|83296733|FG000|Overall Study|Lack of Efficacy|2|||
46719339|NCT01004250|82935470|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
46916078|NCT02960490|83147170|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
46916079|NCT02960490|83147171|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
47040994|NCT01451541|83296734|FG001|Overall Study|Lack of Efficacy|0|||
47040995|NCT01451541|83296735|FG002|Overall Study|Lack of Efficacy|0|||
46632520|NCT01818258|82805654|FG000|Overall Study|Death|3|||
46632521|NCT01818258|82805655|FG001|Overall Study|Death|0|||
46719340|NCT01004250|82935470|FG000|Maintenance Therapy Period|Physician Decision|4|||
46719341|NCT01004250|82935470|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
46719342|NCT01004172|82935478|FG000|Overall Study|Progressive Disease in CNS Only|16|||
46719343|NCT01004172|82935478|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
46719344|NCT01004172|82935478|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
46719345|NCT01004172|82935478|FG000|Overall Study|Adverse Event|1|||
46719346|NCT01004172|82935478|FG000|Overall Study|Physician Decision|1|||
46719347|NCT01004172|82935478|FG000|Overall Study|Symptomatic Deterioration|2|||
46719348|NCT01161524|82935485|FG000|Core Study (23 Weeks)|Adverse Event|3|||
46719349|NCT01161524|82935486|FG001|Core Study (23 Weeks)|Adverse Event|0|||
46719350|NCT01161524|82935487|FG002|Core Study (23 Weeks)|Adverse Event|0|||
46719351|NCT01161524|82935485|FG000|Core Study (23 Weeks)|Other|1|||
46719352|NCT01161524|82935486|FG001|Core Study (23 Weeks)|Other|0|||
46719353|NCT01161524|82935487|FG002|Core Study (23 Weeks)|Other|0|||
46719354|NCT01161524|82935485|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
46719355|NCT01161524|82935486|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
46719356|NCT01161524|82935487|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
46719357|NCT01161524|82935485|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
46719358|NCT01161524|82935486|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
46719359|NCT01161524|82935487|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
46719360|NCT01161524|82935485|FG000|Core Study (23 Weeks)|Subject Choice|3|||
46719361|NCT01161524|82935486|FG001|Core Study (23 Weeks)|Subject Choice|2|||
46719362|NCT01161524|82935487|FG002|Core Study (23 Weeks)|Subject Choice|0|||
46719363|NCT01161524|82935485|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
46719364|NCT01161524|82935486|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
46719365|NCT01161524|82935487|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
46719366|NCT01161524|82935485|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
46719367|NCT01161524|82935486|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
46719368|NCT01161524|82935487|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
46719369|NCT01161524|82935485|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
46719370|NCT01161524|82935486|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
46719371|NCT01161524|82935487|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
46632522|NCT01818258|82805654|FG000|Overall Study|Withdrawal by Subject|0|||
46632523|NCT01818258|82805655|FG001|Overall Study|Withdrawal by Subject|1|||
46632524|NCT01818258|82805654|FG000|Overall Study|Lost to Follow-up|0|||
46632525|NCT01818258|82805655|FG001|Overall Study|Lost to Follow-up|1|||
46632526|NCT01818258|82805654|FG000|Overall Study|Unable to Travel to Clinic|0|||
46632527|NCT01818258|82805655|FG001|Overall Study|Unable to Travel to Clinic|1|||
46719372|NCT01161524|82935485|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
46719373|NCT01161524|82935486|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
46719374|NCT01161524|82935487|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
46719375|NCT01161524|82935485|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
46719376|NCT01161524|82935486|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
46719377|NCT01161524|82935487|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
46719378|NCT01000506|82935500|FG000|Overall Study|Adverse Event|6|||
46719379|NCT01000506|82935501|FG001|Overall Study|Adverse Event|5|||
46719380|NCT01000506|82935502|FG002|Overall Study|Adverse Event|8|||
46719381|NCT01000506|82935503|FG003|Overall Study|Adverse Event|9|||
46632528|NCT01817790|82805664|FG000|Overall Study|Adverse Event|0|||
46632529|NCT01817790|82805665|FG001|Overall Study|Adverse Event|2|||
46719382|NCT01000506|82935500|FG000|Overall Study|Lack of Efficacy|8|||
47040996|NCT01451541|83296733|FG000|Overall Study|Lost to Follow-up|4|||
46719383|NCT01000506|82935501|FG001|Overall Study|Lack of Efficacy|6|||
46719384|NCT01000506|82935502|FG002|Overall Study|Lack of Efficacy|4|||
46719385|NCT01000506|82935503|FG003|Overall Study|Lack of Efficacy|4|||
46719386|NCT01000506|82935500|FG000|Overall Study|Protocol Violation|1|||
47040997|NCT01451541|83296734|FG001|Overall Study|Lost to Follow-up|4|||
47040998|NCT01451541|83296735|FG002|Overall Study|Lost to Follow-up|7|||
46916080|NCT02960490|83147172|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
46916081|NCT02960490|83147173|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
46916082|NCT02960490|83147174|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
46916083|NCT02960490|83147175|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
46916084|NCT02960490|83147176|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
46916085|NCT02960490|83147177|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
46916086|NCT02960490|83147178|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
46916087|NCT02960490|83147169|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916088|NCT02960490|83147170|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916089|NCT02960490|83147171|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
46916090|NCT02960490|83147172|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916091|NCT02960490|83147173|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
46916092|NCT02960490|83147174|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916093|NCT02960490|83147175|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916094|NCT02960490|83147176|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916095|NCT02960490|83147177|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916096|NCT02960490|83147178|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
46916097|NCT02960490|83147169|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
46916098|NCT02960490|83147170|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
46916099|NCT02960490|83147171|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
46916100|NCT02960490|83147172|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
46916101|NCT02960490|83147173|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
46916102|NCT02960490|83147174|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
46916103|NCT02960490|83147175|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
46916104|NCT02960490|83147176|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
46916105|NCT02960490|83147177|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
46916106|NCT02960490|83147178|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
46916107|NCT02960490|83147169|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
46916108|NCT02960490|83147170|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
46916109|NCT02960490|83147171|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
46916110|NCT02960490|83147172|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
46916111|NCT02960490|83147173|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
46916112|NCT02960490|83147174|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
46916113|NCT02960490|83147175|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
46916114|NCT02960490|83147176|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
46916115|NCT02960490|83147177|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
46916116|NCT02960490|83147178|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
46916117|NCT02960490|83147169|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916118|NCT02960490|83147170|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916119|NCT02960490|83147171|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916120|NCT02960490|83147172|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916121|NCT02960490|83147173|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916122|NCT02960490|83147174|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916123|NCT02960490|83147175|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916124|NCT02960490|83147176|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
46916125|NCT02960490|83147177|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916126|NCT02960490|83147178|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
46916127|NCT02960490|83147169|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
46916128|NCT02960490|83147170|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
46916129|NCT02960490|83147171|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
46916130|NCT02960490|83147172|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
46916131|NCT02960490|83147173|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
46916132|NCT02960490|83147174|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
46916133|NCT02960490|83147175|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
46916134|NCT02960490|83147176|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
46916135|NCT02960490|83147177|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
46916136|NCT02960490|83147178|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
47040999|NCT01451541|83296733|FG000|Overall Study|Withdrawal by Subject|15|||
47041000|NCT01451541|83296734|FG001|Overall Study|Withdrawal by Subject|8|||
46632530|NCT01817790|82805664|FG000|Overall Study|Lost to Follow-up|0|||
47041001|NCT01451541|83296735|FG002|Overall Study|Withdrawal by Subject|6|||
47041002|NCT01451541|83296733|FG000|Overall Study|randomization error, noncompliance|11|||
46632531|NCT01817790|82805665|FG001|Overall Study|Lost to Follow-up|1|||
46632532|NCT01817790|82805664|FG000|Overall Study|Protocol Violation|2|||
46916137|NCT02960490|83147169|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
46916138|NCT02960490|83147170|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
47041003|NCT01451541|83296734|FG001|Overall Study|randomization error, noncompliance|10|||
47041004|NCT01451541|83296735|FG002|Overall Study|randomization error, noncompliance|8|||
47041005|NCT01450761|83296863|FG000|Randomization|Subject no longer meets study criteria|1|||
47041006|NCT01450761|83296864|FG001|Randomization|Subject no longer meets study criteria|2|||
47041007|NCT01450761|83296863|FG000|Randomization|Withdrawal by Subject|2|||
47041008|NCT01450761|83296864|FG001|Randomization|Withdrawal by Subject|0|||
47041009|NCT01450761|83296863|FG000|Randomization|Disease progression|0|||
46916139|NCT02960490|83147171|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
46916140|NCT02960490|83147172|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
46916141|NCT02960490|83147173|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
46916142|NCT02960490|83147174|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
46916143|NCT02960490|83147175|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
46916144|NCT02960490|83147176|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
46916145|NCT02960490|83147177|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
47041010|NCT01450761|83296864|FG001|Randomization|Disease progression|2|||
47041011|NCT01450761|83296863|FG000|Randomization|Adverse Event unrelated to study drug|1|||
47041012|NCT01450761|83296864|FG001|Randomization|Adverse Event unrelated to study drug|0|||
47041013|NCT01450761|83296863|FG000|Randomization|Other|0|||
47041014|NCT01450761|83296864|FG001|Randomization|Other|1|||
47041015|NCT01450761|83296863|FG000|Lead-in Chemotherapy|Disease progression|33|||
47041016|NCT01450761|83296864|FG001|Lead-in Chemotherapy|Disease progression|32|||
47041017|NCT01450761|83296863|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
46719387|NCT01000506|82935501|FG001|Overall Study|Protocol Violation|1|||
46719388|NCT01000506|82935502|FG002|Overall Study|Protocol Violation|0|||
46719389|NCT01000506|82935503|FG003|Overall Study|Protocol Violation|0|||
46719390|NCT01000506|82935500|FG000|Overall Study|Lost to Follow-up|1|||
46719391|NCT01000506|82935501|FG001|Overall Study|Lost to Follow-up|1|||
46719392|NCT01000506|82935502|FG002|Overall Study|Lost to Follow-up|4|||
47041018|NCT01450761|83296864|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
46719393|NCT01000506|82935503|FG003|Overall Study|Lost to Follow-up|0|||
46719394|NCT01000506|82935500|FG000|Overall Study|Physician Decision|1|||
46719395|NCT01000506|82935501|FG001|Overall Study|Physician Decision|3|||
46719396|NCT01000506|82935502|FG002|Overall Study|Physician Decision|3|||
46719397|NCT01000506|82935503|FG003|Overall Study|Physician Decision|3|||
46719398|NCT01000506|82935500|FG000|Overall Study|Withdrawal by Subject|11|||
46719399|NCT01000506|82935501|FG001|Overall Study|Withdrawal by Subject|8|||
46719400|NCT01000506|82935502|FG002|Overall Study|Withdrawal by Subject|2|||
46719401|NCT01000506|82935503|FG003|Overall Study|Withdrawal by Subject|7|||
46719402|NCT01174238|82935513|FG000|Overall Study|Lost to Follow-up|2|||
46719403|NCT01174160|82935522|FG000|Overall Study|Adverse Event|1|||
46719404|NCT01174160|82935523|FG001|Overall Study|Adverse Event|0|||
46719405|NCT01174160|82935522|FG000|Overall Study|Lost to Follow-up|1|||
46719406|NCT01174160|82935523|FG001|Overall Study|Lost to Follow-up|0|||
46719407|NCT01174160|82935522|FG000|Overall Study|Physician Decision|1|||
46719408|NCT01174160|82935523|FG001|Overall Study|Physician Decision|0|||
46719409|NCT01174160|82935522|FG000|Overall Study|Protocol Violation|4|||
46719410|NCT01174160|82935523|FG001|Overall Study|Protocol Violation|6|||
46719411|NCT01174160|82935522|FG000|Overall Study|Withdrawal by Subject|1|||
46719412|NCT01174160|82935523|FG001|Overall Study|Withdrawal by Subject|0|||
46719413|NCT01161446|82935531|FG000|Overall Study|Lost to Follow-up|18|||
46719414|NCT01161446|82935532|FG001|Overall Study|Lost to Follow-up|14|||
46719415|NCT01161446|82935531|FG000|Overall Study|Withdrawal by Subject|0|||
46719416|NCT01161446|82935532|FG001|Overall Study|Withdrawal by Subject|1|||
46719417|NCT01174004|82935540|FG000|Overall Study|Adverse Event|2|||
46916146|NCT02960490|83147178|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
47041019|NCT01450761|83296863|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
47041020|NCT01450761|83296864|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
47041021|NCT01450761|83296863|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
47041022|NCT01450761|83296864|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
47041023|NCT01450761|83296863|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
47041024|NCT01450761|83296864|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
47041025|NCT01450761|83296863|FG000|Lead-in Chemotherapy|Death|3|||
47041026|NCT01450761|83296864|FG001|Lead-in Chemotherapy|Death|3|||
47041027|NCT01450761|83296863|FG000|Lead-in Chemotherapy|Other|2|||
47041028|NCT01450761|83296864|FG001|Lead-in Chemotherapy|Other|2|||
47041029|NCT01450761|83296863|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
47041030|NCT01450761|83296864|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
46719418|NCT01174004|82935541|FG001|Overall Study|Adverse Event|10|||
46719419|NCT01174004|82935540|FG000|Overall Study|Withdrawal by Subject|2|||
46719420|NCT01174004|82935541|FG001|Overall Study|Withdrawal by Subject|3|||
46719421|NCT01174004|82935540|FG000|Overall Study|At Discretion of Sponsor|2|||
46719422|NCT01174004|82935541|FG001|Overall Study|At Discretion of Sponsor|2|||
46719423|NCT01174004|82935540|FG000|Overall Study|Protocol Violation|0|||
46719424|NCT01174004|82935541|FG001|Overall Study|Protocol Violation|1|||
46719425|NCT01174004|82935540|FG000|Overall Study|Physician Decision|1|||
47041031|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
47041032|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
47041033|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
47041034|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
47041035|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
47041036|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
47041037|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
46916147|NCT02960490|83147169|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916148|NCT02960490|83147170|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916149|NCT02960490|83147171|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916150|NCT02960490|83147172|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916151|NCT02960490|83147173|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916152|NCT02960490|83147174|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916153|NCT02960490|83147175|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916154|NCT02960490|83147176|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
46916155|NCT02960490|83147177|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916156|NCT02960490|83147178|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
46916157|NCT02804750|83147202|FG000|Period 1|Adverse Event|0|||
46916158|NCT02804750|83147203|FG001|Period 1|Adverse Event|2|||
46916159|NCT02804750|83147202|FG000|Period 1|Withdrawal by Subject|0|||
46916160|NCT02804750|83147203|FG001|Period 1|Withdrawal by Subject|1|||
46916161|NCT02804750|83147202|FG000|Period 2|Adverse Event|1|||
46916162|NCT02804750|83147203|FG001|Period 2|Adverse Event|0|||
46916163|NCT02804750|83147202|FG000|Period 3|Adverse Event|0|||
46916164|NCT02804750|83147203|FG001|Period 3|Adverse Event|2|||
46916165|NCT02804750|83147202|FG000|Period 4|Adverse Event|0|||
46916166|NCT02804750|83147203|FG001|Period 4|Adverse Event|5|||
46916167|NCT02959866|83147211|FG000|Overall Study|Withdrawal by Subject|1|||
46916168|NCT02748512|83147218|FG000|Overall Study|Lost to Follow-up|1|||
46916169|NCT02748512|83147219|FG001|Overall Study|Lost to Follow-up|1|||
46916170|NCT02748356|83147225|FG000|Overall Study|Withdrawal by Subject|1|||
46916171|NCT03439657|83147231|FG000|Overall Study|Adverse Event|2|||
46916172|NCT03439657|83147232|FG001|Overall Study|Adverse Event|3|||
46916173|NCT03439657|83147231|FG000|Overall Study|Lost to Follow-up|1|||
46916174|NCT03439657|83147232|FG001|Overall Study|Lost to Follow-up|0|||
46916175|NCT03439657|83147231|FG000|Overall Study|Protocol Violation|1|||
46916176|NCT03439657|83147232|FG001|Overall Study|Protocol Violation|1|||
46916177|NCT03439657|83147231|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
46916178|NCT03439657|83147232|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
47041038|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
47041039|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
47041040|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
47041041|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Death|5|||
47041042|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Death|6|||
47041043|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
47041044|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
47041045|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
47041046|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
47041047|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
47041048|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
47041049|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
47041050|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
47041051|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
47041052|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
46916179|NCT02803580|83147240|FG000|Overall Study|Death|13|||
46916180|NCT02803580|83147240|FG000|Overall Study|Lost to Follow-up|19|||
46916181|NCT02803580|83147240|FG000|Overall Study|Withdrawal by Subject|3|||
46916182|NCT02803580|83147240|FG000|Overall Study|Inclusion in clinical trial|1|||
46916183|NCT02878213|83147244|FG000|Overall Study|Withdrawal by Subject|2|||
46916184|NCT02878213|83147244|FG000|Overall Study|Adverse Event|1|||
46916185|NCT02802878|83147251|FG000|Overall Study|Withdrawal by Subject|3|||
46916186|NCT02802878|83147252|FG001|Overall Study|Withdrawal by Subject|3|||
46916187|NCT02802878|83147251|FG000|Overall Study|Protocol Violation|1|||
46916188|NCT02802878|83147252|FG001|Overall Study|Protocol Violation|0|||
46916189|NCT02801396|83147258|FG000|Period 1|Withdrawal by Subject|0|||
46916190|NCT02801396|83147259|FG001|Period 1|Withdrawal by Subject|0|||
46916191|NCT02801396|83147260|FG002|Period 1|Withdrawal by Subject|0|||
46916192|NCT02801396|83147261|FG003|Period 1|Withdrawal by Subject|0|||
46916193|NCT02801396|83147262|FG004|Period 1|Withdrawal by Subject|1|||
46916194|NCT02801396|83147263|FG005|Period 1|Withdrawal by Subject|0|||
46916195|NCT02800928|83147271|FG000|Overall Study|Withdrawal by Subject|1|||
46916196|NCT02800928|83147272|FG001|Overall Study|Withdrawal by Subject|1|||
46916197|NCT02800928|83147271|FG000|Overall Study|Protocol Violation|1|||
46916198|NCT02800928|83147272|FG001|Overall Study|Protocol Violation|1|||
46916199|NCT03148691|83147281|FG000|Overall Study|Protocol Violation|1|||
46916200|NCT03148691|83147282|FG001|Overall Study|Protocol Violation|2|||
46916201|NCT03148691|83147283|FG002|Overall Study|Protocol Violation|7|||
46916202|NCT03148691|83147281|FG000|Overall Study|Lost to Follow-up|0|||
46916203|NCT03148691|83147282|FG001|Overall Study|Lost to Follow-up|0|||
46916204|NCT03148691|83147283|FG002|Overall Study|Lost to Follow-up|1|||
46916205|NCT03148691|83147281|FG000|Overall Study|Other|1|||
46916206|NCT03148691|83147282|FG001|Overall Study|Other|0|||
46916207|NCT03148691|83147283|FG002|Overall Study|Other|0|||
46916208|NCT03148691|83147281|FG000|Overall Study|Withdrawal by Subject|1|||
46916209|NCT03148691|83147282|FG001|Overall Study|Withdrawal by Subject|0|||
46916210|NCT03148691|83147283|FG002|Overall Study|Withdrawal by Subject|0|||
46916211|NCT03148067|83147291|FG000|Overall Study|Lost to Follow-up|3|||
46916212|NCT03148067|83147291|FG000|Overall Study|Death|1|||
46916213|NCT03146741|83147305|FG000|Overall Study|Txp with non-HCV+ heart|4|||
46916214|NCT03146741|83147305|FG000|Overall Study|Listeted for MOT|2|||
46916215|NCT03146741|83147305|FG000|Overall Study|Physician Decision|2|||
46916216|NCT03146741|83147305|FG000|Overall Study|Awaiting txp|2|||
46916217|NCT03150719|83147311|FG000|Overall Study|Adverse Event|0|||
46916218|NCT03150719|83147312|FG001|Overall Study|Adverse Event|1|||
46916219|NCT03150719|83147311|FG000|Overall Study|Death|0|||
46916220|NCT03150719|83147312|FG001|Overall Study|Death|1|||
46916221|NCT03150719|83147311|FG000|Overall Study|Other|1|||
46916222|NCT03150719|83147312|FG001|Overall Study|Other|0|||
46916223|NCT04039217|83147318|FG000|Overall Study|Lost to Follow-up|1|||
46916224|NCT00982111|83147328|FG000|Overall Study|Adverse Event|1|||
46916225|NCT00982111|83147329|FG001|Overall Study|Adverse Event|1|||
46916226|NCT00982111|83147328|FG000|Overall Study|Progressive Disease|46|||
46916227|NCT00982111|83147329|FG001|Overall Study|Progressive Disease|39|||
46916228|NCT00982111|83147328|FG000|Overall Study|Lost to Follow-up|9|||
46916229|NCT00982111|83147329|FG001|Overall Study|Lost to Follow-up|6|||
46916230|NCT00982111|83147328|FG000|Overall Study|New Anti-Cancer Therapy|5|||
46916231|NCT00982111|83147329|FG001|Overall Study|New Anti-Cancer Therapy|5|||
46916232|NCT00982111|83147328|FG000|Overall Study|Medical Decision|1|||
46916233|NCT00982111|83147329|FG001|Overall Study|Medical Decision|0|||
46916234|NCT00982111|83147328|FG000|Overall Study|Withdrawal by Subject|17|||
46916235|NCT00982111|83147329|FG001|Overall Study|Withdrawal by Subject|19|||
46916236|NCT00982111|83147328|FG000|Overall Study|Global Study End|0|||
46916237|NCT00982111|83147329|FG001|Overall Study|Global Study End|1|||
46916238|NCT00982111|83147328|FG000|Overall Study|Sponsor's Decision|0|||
46916239|NCT00982111|83147329|FG001|Overall Study|Sponsor's Decision|1|||
46916240|NCT02957682|83147338|FG000|Overall Study|Adverse Event|64|||
46916241|NCT02957682|83147339|FG001|Overall Study|Adverse Event|67|||
46916242|NCT02957682|83147338|FG000|Overall Study|Poor Compliance to Protocol|30|||
46916243|NCT02957682|83147339|FG001|Overall Study|Poor Compliance to Protocol|26|||
46916244|NCT02957682|83147338|FG000|Overall Study|Physician Decision|4|||
46916245|NCT02957682|83147339|FG001|Overall Study|Physician Decision|4|||
46916246|NCT02957682|83147338|FG000|Overall Study|Study Terminated by Sponsor|4|||
46916247|NCT02957682|83147339|FG001|Overall Study|Study Terminated by Sponsor|3|||
46916248|NCT02957682|83147338|FG000|Overall Study|Subject Moved|10|||
46916249|NCT02957682|83147339|FG001|Overall Study|Subject Moved|16|||
46916250|NCT02957682|83147338|FG000|Overall Study|Withdrawal by Subject|64|||
46916251|NCT02957682|83147339|FG001|Overall Study|Withdrawal by Subject|33|||
46916252|NCT02957682|83147338|FG000|Overall Study|Related to IMP Administration|3|||
46916253|NCT02957682|83147339|FG001|Overall Study|Related to IMP Administration|6|||
46916254|NCT02957682|83147338|FG000|Overall Study|Non-disclosed|16|||
46916255|NCT02957682|83147339|FG001|Overall Study|Non-disclosed|12|||
46916256|NCT02957682|83147338|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
46916257|NCT02957682|83147339|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
46916258|NCT03057951|83147347|FG000|Overall Study|Adverse Event|553|||
46632533|NCT01817790|82805665|FG001|Overall Study|Protocol Violation|1|||
46916259|NCT03057951|83147348|FG001|Overall Study|Adverse Event|575|||
46916260|NCT03057951|83147347|FG000|Overall Study|Protocol Violation|30|||
46916261|NCT03057951|83147348|FG001|Overall Study|Protocol Violation|24|||
46916262|NCT03057951|83147347|FG000|Overall Study|Lost to Follow-up|6|||
46916263|NCT03057951|83147348|FG001|Overall Study|Lost to Follow-up|16|||
46916264|NCT03057951|83147347|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
46916265|NCT03057951|83147348|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
46632534|NCT01817790|82805664|FG000|Overall Study|Withdrawal by Subject|1|||
46719426|NCT01174004|82935541|FG001|Overall Study|Physician Decision|0|||
46719427|NCT01173692|82935549|FG000|Overall Study|Adverse Event|1|||
46916266|NCT03057951|83147347|FG000|Overall Study|Study drug stopped, reason missing|6|||
46916267|NCT03057951|83147348|FG001|Overall Study|Study drug stopped, reason missing|1|||
46916268|NCT03057951|83147347|FG000|Overall Study|Medical advice|6|||
46916269|NCT03057951|83147348|FG001|Overall Study|Medical advice|2|||
46916270|NCT03057951|83147347|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
46916271|NCT03057951|83147348|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
46916272|NCT03057951|83147347|FG000|Overall Study|Investigator decision|2|||
46916273|NCT03057951|83147348|FG001|Overall Study|Investigator decision|0|||
46916274|NCT03057951|83147347|FG000|Overall Study|Patient decision|5|||
46916275|NCT03057951|83147348|FG001|Overall Study|Patient decision|2|||
46916276|NCT03057951|83147347|FG000|Overall Study|Not attending study visits|3|||
46916277|NCT03057951|83147348|FG001|Overall Study|Not attending study visits|0|||
46916278|NCT03057951|83147347|FG000|Overall Study|Patient moved away|3|||
46916279|NCT03057951|83147348|FG001|Overall Study|Patient moved away|4|||
47041053|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
47041054|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
46916280|NCT03057951|83147347|FG000|Overall Study|Other reason than stated above|23|||
46916281|NCT03057951|83147348|FG001|Overall Study|Other reason than stated above|29|||
46916282|NCT03057951|83147347|FG000|Overall Study|Not treated|2|||
46916283|NCT03057951|83147348|FG001|Overall Study|Not treated|1|||
46916284|NCT03146663|83147356|FG000|Overall Study|Did not receive study treatment|1|||
46916285|NCT03146663|83147357|FG001|Overall Study|Did not receive study treatment|1|||
46916286|NCT02956278|83147367|FG000|Overall Study|Withdrawal by Subject|6|||
47041055|NCT01450761|83296863|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
47041056|NCT01450761|83296864|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
47041057|NCT01433991|83296914|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
47041058|NCT01433991|83296915|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
47041059|NCT01433991|83296916|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
47041060|NCT01433991|83296917|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
47041061|NCT01433991|83296914|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
47041062|NCT01433991|83296915|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
47041063|NCT01433991|83296916|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
47041064|NCT01433991|83296917|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
47041065|NCT01433991|83296914|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
47041066|NCT01433991|83296915|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
47041067|NCT01433991|83296916|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
47041068|NCT01433991|83296917|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
47041069|NCT01433991|83296914|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
47041070|NCT01433991|83296915|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
46916287|NCT02956278|83147368|FG001|Overall Study|Withdrawal by Subject|2|||
46916288|NCT02956278|83147369|FG002|Overall Study|Withdrawal by Subject|0|||
46916289|NCT02957136|83147379|FG000|Overall Study|Withdrawal by Subject|2|||
46916290|NCT02957136|83147380|FG001|Overall Study|Withdrawal by Subject|1|||
46916291|NCT03150485|83147386|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
46916292|NCT03150485|83147387|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
46916293|NCT03150485|83147388|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
46916294|NCT03150485|83147389|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
46916295|NCT03150485|83147390|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
46916296|NCT03150485|83147391|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
46916297|NCT03134911|83147398|FG000|Overall Study|Screen failure|31|||
46916298|NCT03134911|83147398|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
46916299|NCT03134599|83147417|FG000|Week 1|Lost to Follow-up|0|||
46916300|NCT03134599|83147418|FG001|Week 1|Lost to Follow-up|0|||
46916301|NCT03134599|83147419|FG002|Week 1|Lost to Follow-up|0|||
46916302|NCT03134599|83147420|FG003|Week 1|Lost to Follow-up|0|||
46916303|NCT03134599|83147421|FG004|Week 1|Lost to Follow-up|1|||
46916304|NCT03134599|83147422|FG005|Week 1|Lost to Follow-up|0|||
46916305|NCT03134599|83147417|FG000|Week 2|Lost to Follow-up|1|||
46916306|NCT03134599|83147418|FG001|Week 2|Lost to Follow-up|0|||
46916307|NCT03134599|83147419|FG002|Week 2|Lost to Follow-up|0|||
46916308|NCT03134599|83147420|FG003|Week 2|Lost to Follow-up|1|||
46916309|NCT03134599|83147421|FG004|Week 2|Lost to Follow-up|1|||
46916310|NCT03134599|83147422|FG005|Week 2|Lost to Follow-up|0|||
46916311|NCT03134599|83147417|FG000|Week 3|Lost to Follow-up|0|||
47041071|NCT01433991|83296916|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
46719428|NCT01173692|82935550|FG001|Overall Study|Adverse Event|2|||
47041072|NCT01433991|83296917|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
47041073|NCT01433991|83296914|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
46719429|NCT01173692|82935549|FG000|Overall Study|Withdrawal by Subject|1|||
47041074|NCT01433991|83296915|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
46719430|NCT01173692|82935550|FG001|Overall Study|Withdrawal by Subject|3|||
46916312|NCT03134599|83147418|FG001|Week 3|Lost to Follow-up|0|||
46916313|NCT03134599|83147419|FG002|Week 3|Lost to Follow-up|0|||
46916314|NCT03134599|83147420|FG003|Week 3|Lost to Follow-up|1|||
46916315|NCT03134599|83147421|FG004|Week 3|Lost to Follow-up|0|||
46916316|NCT03134599|83147422|FG005|Week 3|Lost to Follow-up|1|||
46916317|NCT03153137|83147432|FG000|Overall Study|Lost to Follow-up|1|||
46916318|NCT03153137|83147433|FG001|Overall Study|Lost to Follow-up|0|||
46916319|NCT03153137|83147432|FG000|Overall Study|Withdrawal by Subject|2|||
46916320|NCT03153137|83147433|FG001|Overall Study|Withdrawal by Subject|1|||
46916321|NCT03153137|83147432|FG000|Overall Study|Physician Decision|0|||
46632535|NCT01817790|82805665|FG001|Overall Study|Withdrawal by Subject|3|||
47041075|NCT01433991|83296916|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
47041076|NCT01433991|83296917|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
47041077|NCT01433991|83296914|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
46719431|NCT01101035|82935558|FG000|Overall Study|Adverse Event|191|||
46719432|NCT01101035|82935559|FG001|Overall Study|Adverse Event|172|||
46719433|NCT01101035|82935558|FG000|Overall Study|Major Protocol Deviation|52|||
46719434|NCT01101035|82935559|FG001|Overall Study|Major Protocol Deviation|46|||
46719435|NCT01101035|82935558|FG000|Overall Study|Lost to Follow-up|226|||
46719436|NCT01101035|82935559|FG001|Overall Study|Lost to Follow-up|223|||
46719437|NCT01101035|82935558|FG000|Overall Study|Voluntary Withdrawal|595|||
46719438|NCT01101035|82935559|FG001|Overall Study|Voluntary Withdrawal|587|||
46719439|NCT01101035|82935558|FG000|Overall Study|Reason not Specified|333|||
46719440|NCT01101035|82935559|FG001|Overall Study|Reason not Specified|363|||
46719441|NCT01100567|82935567|FG000|Overall Study|Withdrawal by Subject|5|||
46719442|NCT01100567|82935568|FG001|Overall Study|Withdrawal by Subject|8|||
46719443|NCT01100567|82935567|FG000|Overall Study|Early Hospital Discharge|6|||
46719444|NCT01100567|82935568|FG001|Overall Study|Early Hospital Discharge|4|||
46719445|NCT01100567|82935567|FG000|Overall Study|Lost to Follow-up|1|||
46719446|NCT01100567|82935568|FG001|Overall Study|Lost to Follow-up|2|||
46719447|NCT01100567|82935567|FG000|Overall Study|Physician Decision|0|||
46719448|NCT01100567|82935568|FG001|Overall Study|Physician Decision|1|||
46719449|NCT01100567|82935567|FG000|Overall Study|Deemed ineligible after consent|0|||
46719450|NCT01100567|82935568|FG001|Overall Study|Deemed ineligible after consent|1|||
46916322|NCT03153137|83147433|FG001|Overall Study|Physician Decision|3|||
46916323|NCT03136861|83147446|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
46916324|NCT03136861|83147447|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
46916325|NCT03136861|83147448|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
46916326|NCT03136861|83147449|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
46916327|NCT03136861|83147450|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
47041078|NCT01433991|83296915|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
46632536|NCT01817790|82805664|FG000|Overall Study|Other: Could not attend appointment|1|||
46632537|NCT01817790|82805665|FG001|Overall Study|Other: Could not attend appointment|1|||
46632538|NCT01793688|82805673|FG000|Overall Study|Protocol Violation|2|||
46632539|NCT01793142|82805677|FG000|Overall Study|Randomized not treated|7|||
46632540|NCT01792830|82805692|FG000|Overall Study|Withdrawal by Subject|22|||
46632541|NCT01792830|82805693|FG001|Overall Study|Withdrawal by Subject|0|||
46632542|NCT01792830|82805694|FG002|Overall Study|Withdrawal by Subject|0|||
46632543|NCT01792830|82805695|FG003|Overall Study|Withdrawal by Subject|2|||
46632544|NCT01792830|82805696|FG004|Overall Study|Withdrawal by Subject|1|||
46632545|NCT01792830|82805697|FG005|Overall Study|Withdrawal by Subject|1|||
46632546|NCT01792830|82805698|FG006|Overall Study|Withdrawal by Subject|1|||
46632547|NCT01792830|82805699|FG007|Overall Study|Withdrawal by Subject|1|||
46632548|NCT01792830|82805700|FG008|Overall Study|Withdrawal by Subject|7|||
46632549|NCT01792830|82805701|FG009|Overall Study|Withdrawal by Subject|0|||
46632550|NCT01792830|82805702|FG010|Overall Study|Withdrawal by Subject|2|||
46632551|NCT01792830|82805692|FG000|Overall Study|Death|3|||
46632552|NCT01792830|82805693|FG001|Overall Study|Death|0|||
46632553|NCT01792830|82805694|FG002|Overall Study|Death|0|||
46632554|NCT01792830|82805695|FG003|Overall Study|Death|1|||
46632555|NCT01792830|82805696|FG004|Overall Study|Death|0|||
46632556|NCT01792830|82805697|FG005|Overall Study|Death|0|||
46632557|NCT01792830|82805698|FG006|Overall Study|Death|1|||
46632558|NCT01792830|82805699|FG007|Overall Study|Death|0|||
46632559|NCT01792830|82805700|FG008|Overall Study|Death|1|||
46632560|NCT01792830|82805701|FG009|Overall Study|Death|0|||
46632561|NCT01792830|82805702|FG010|Overall Study|Death|1|||
46632562|NCT01792830|82805692|FG000|Overall Study|Adverse Event|0|||
47041079|NCT01433991|83296916|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
46632563|NCT01792830|82805693|FG001|Overall Study|Adverse Event|0|||
46632564|NCT01792830|82805694|FG002|Overall Study|Adverse Event|0|||
46632565|NCT01792830|82805695|FG003|Overall Study|Adverse Event|0|||
46719451|NCT01160822|82935581|FG000|Overall Study|Adverse Event|0|||
46719452|NCT01160822|82935582|FG001|Overall Study|Adverse Event|0|||
46632566|NCT01792830|82805696|FG004|Overall Study|Adverse Event|0|||
46632567|NCT01792830|82805697|FG005|Overall Study|Adverse Event|0|||
46632568|NCT01792830|82805698|FG006|Overall Study|Adverse Event|0|||
46632569|NCT01792830|82805699|FG007|Overall Study|Adverse Event|0|||
46632570|NCT01792830|82805700|FG008|Overall Study|Adverse Event|1|||
46632571|NCT01792830|82805701|FG009|Overall Study|Adverse Event|0|||
46632572|NCT01792830|82805702|FG010|Overall Study|Adverse Event|0|||
46632573|NCT01792518|82805734|FG000|Overall Study|Adverse Event|3|||
46719453|NCT01160822|82935583|FG002|Overall Study|Adverse Event|0|||
46719454|NCT01160822|82935584|FG003|Overall Study|Adverse Event|0|||
46719455|NCT01160822|82935585|FG004|Overall Study|Adverse Event|1|||
46719456|NCT01160822|82935586|FG005|Overall Study|Adverse Event|2|||
46916328|NCT03136861|83147451|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
46916329|NCT03136861|83147452|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
46916330|NCT03136861|83147446|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
46916331|NCT03136861|83147447|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
46916332|NCT03136861|83147448|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
46916333|NCT03136861|83147449|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
46916334|NCT03136861|83147450|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
46916335|NCT03136861|83147451|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
46916336|NCT03136861|83147452|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
46916337|NCT03136861|83147446|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
46916338|NCT03136861|83147447|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
46916339|NCT03136861|83147448|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
46916340|NCT03136861|83147449|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
46916341|NCT03136861|83147450|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
46916342|NCT03136861|83147451|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
46916343|NCT03136861|83147452|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
46916344|NCT03136861|83147446|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
46916345|NCT03136861|83147447|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
46916346|NCT03136861|83147448|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
46916347|NCT03136861|83147449|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
46916348|NCT03136861|83147450|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
46916349|NCT03136861|83147451|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
46916350|NCT03136861|83147452|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
46916351|NCT03136861|83147446|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
46916352|NCT03136861|83147447|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
46916353|NCT03136861|83147448|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
46916354|NCT03136861|83147449|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
46916355|NCT03136861|83147450|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
46916356|NCT03136861|83147451|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
46916357|NCT03136861|83147452|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
46916358|NCT03136861|83147446|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
46916359|NCT03136861|83147447|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
46916360|NCT03136861|83147448|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
46916361|NCT03136861|83147449|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
46916362|NCT03136861|83147450|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
46916363|NCT03136861|83147451|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
46916364|NCT03136861|83147452|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
46916365|NCT03136861|83147446|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
46916366|NCT03136861|83147447|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
46916367|NCT03136861|83147448|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
46916368|NCT03136861|83147449|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
46916369|NCT03136861|83147450|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
46916370|NCT03136861|83147451|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
46916371|NCT03136861|83147452|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
46916372|NCT03136861|83147446|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
46916373|NCT03136861|83147447|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
46916374|NCT03136861|83147448|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
46916375|NCT03136861|83147449|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
46916376|NCT03136861|83147450|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
46916377|NCT03136861|83147451|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
46916378|NCT03136861|83147452|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
46632574|NCT01792518|82805735|FG001|Overall Study|Adverse Event|4|||
46916379|NCT03316950|83147480|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
46916380|NCT03316950|83147481|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
46916381|NCT03316950|83147482|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
46916382|NCT03316950|83147483|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
46916383|NCT03316950|83147480|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
46916384|NCT03316950|83147481|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
46916385|NCT03316950|83147482|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
46916386|NCT03316950|83147483|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
46916387|NCT03316950|83147480|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
46916388|NCT03316950|83147481|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
46916389|NCT03316950|83147482|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
46916390|NCT03316950|83147483|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
46916391|NCT03139279|83147497|FG000|Overall Study|Physician Decision|2|||
46916392|NCT03139279|83147498|FG001|Overall Study|Physician Decision|0|||
46916393|NCT03139279|83147497|FG000|Overall Study|Protocol Violation|5|||
46916394|NCT03139279|83147498|FG001|Overall Study|Protocol Violation|4|||
46916395|NCT03139279|83147497|FG000|Overall Study|Withdrawal by Subject|0|||
46916396|NCT03139279|83147498|FG001|Overall Study|Withdrawal by Subject|2|||
46916397|NCT01370642|83147507|FG000|Overall Study|Adverse Event|2|||
46916398|NCT01370642|83147508|FG001|Overall Study|Adverse Event|1|||
46916399|NCT01370642|83147509|FG002|Overall Study|Adverse Event|1|||
46916400|NCT01370642|83147507|FG000|Overall Study|Detectable HCV RNA|0|||
46916401|NCT01370642|83147508|FG001|Overall Study|Detectable HCV RNA|0|||
46916402|NCT01370642|83147509|FG002|Overall Study|Detectable HCV RNA|22|||
46916403|NCT01370642|83147507|FG000|Overall Study|Lost to Follow-up|0|||
46916404|NCT01370642|83147508|FG001|Overall Study|Lost to Follow-up|0|||
46916405|NCT01370642|83147509|FG002|Overall Study|Lost to Follow-up|1|||
46916406|NCT01370642|83147507|FG000|Overall Study|Physician Decision|4|||
46916407|NCT01370642|83147508|FG001|Overall Study|Physician Decision|1|||
46916408|NCT01370642|83147509|FG002|Overall Study|Physician Decision|2|||
46916409|NCT01370642|83147507|FG000|Overall Study|Withdrawal by Subject|2|||
46916410|NCT01370642|83147508|FG001|Overall Study|Withdrawal by Subject|4|||
46916411|NCT01370642|83147509|FG002|Overall Study|Withdrawal by Subject|3|||
46916412|NCT02873208|83147517|FG000|Overall Study|Withdrawal by Subject|36|||
46916413|NCT02873208|83147517|FG000|Overall Study|Lost to Follow-up|22|||
46916414|NCT02873208|83147517|FG000|Overall Study|Adverse Event|15|||
46916415|NCT02873208|83147517|FG000|Overall Study|Non-compliance with study drug|12|||
46916416|NCT02873208|83147517|FG000|Overall Study|Protocol Violation|8|||
46916417|NCT02873208|83147517|FG000|Overall Study|Pregnancy|2|||
46916418|NCT02873208|83147517|FG000|Overall Study|Incarceration|1|||
46916419|NCT02873208|83147517|FG000|Overall Study|Lack of Efficacy|1|||
46916420|NCT02873208|83147517|FG000|Overall Study|Physician Decision|1|||
46916421|NCT03138967|83147523|FG000|Overall Study|Death|0|||
46916422|NCT03138967|83147524|FG001|Overall Study|Death|1|||
46916423|NCT03138967|83147523|FG000|Overall Study|Physician Decision|1|||
46916424|NCT03138967|83147524|FG001|Overall Study|Physician Decision|3|||
46916425|NCT01547117|83147534|FG000|Overall Study|Physician Decision|0|||
46916426|NCT01547117|83147535|FG001|Overall Study|Physician Decision|1|||
46916427|NCT01547117|83147536|FG002|Overall Study|Physician Decision|1|||
46916428|NCT01547117|83147537|FG003|Overall Study|Physician Decision|3|||
46916429|NCT01547117|83147534|FG000|Overall Study|Withdrawal by Subject|1|||
46916430|NCT01547117|83147535|FG001|Overall Study|Withdrawal by Subject|2|||
46916431|NCT01547117|83147536|FG002|Overall Study|Withdrawal by Subject|1|||
46916432|NCT01547117|83147537|FG003|Overall Study|Withdrawal by Subject|2|||
46916433|NCT03136159|83147565|FG000|Overall Study|chorioamnionitis|2|||
46916434|NCT03136159|83147566|FG001|Overall Study|chorioamnionitis|0|||
46916435|NCT03136159|83147565|FG000|Overall Study|vertical skin incision|1|||
46916436|NCT03136159|83147566|FG001|Overall Study|vertical skin incision|0|||
46916437|NCT03136159|83147565|FG000|Overall Study|additional dressing|1|||
46916438|NCT03136159|83147566|FG001|Overall Study|additional dressing|0|||
46916439|NCT03136159|83147565|FG000|Overall Study|never got dressing placed|1|||
46916440|NCT03136159|83147566|FG001|Overall Study|never got dressing placed|0|||
46916441|NCT01986933|83147577|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
47041080|NCT01433991|83296917|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
47041081|NCT01433991|83296914|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
47041082|NCT01433991|83296915|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
46916442|NCT01986933|83147578|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
47041083|NCT01433991|83296916|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
47041084|NCT01433991|83296917|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
46916443|NCT01986933|83147579|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
46916444|NCT01986933|83147580|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
46916445|NCT01986933|83147581|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
46916446|NCT01986933|83147577|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
46916447|NCT01986933|83147578|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
46916448|NCT01986933|83147579|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
46916449|NCT01986933|83147580|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
46916450|NCT01986933|83147581|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
47041085|NCT01450683|83296933|FG000|Overall Study|Adverse Event|2|||
47041086|NCT01433055|83296939|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
46916451|NCT01986933|83147577|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
46719457|NCT01160822|82935587|FG006|Overall Study|Adverse Event|5|||
46916452|NCT01986933|83147578|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
46916453|NCT01986933|83147579|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
46916454|NCT01986933|83147580|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
46916455|NCT01986933|83147581|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
46916456|NCT01986933|83147577|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
46916457|NCT01986933|83147578|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
46916458|NCT01986933|83147579|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
46916459|NCT01986933|83147580|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
46916460|NCT01986933|83147581|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
46916461|NCT01986933|83147577|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
46916462|NCT01986933|83147578|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
46916463|NCT01986933|83147579|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
46916464|NCT01986933|83147580|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
46916465|NCT01986933|83147581|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
46916466|NCT01986933|83147577|FG000|Active-to-active (Part B)|Adverse Event|0|||
46916467|NCT01986933|83147578|FG001|Active-to-active (Part B)|Adverse Event|2|||
46916468|NCT01986933|83147579|FG002|Active-to-active (Part B)|Adverse Event|0|||
46916469|NCT01986933|83147580|FG003|Active-to-active (Part B)|Adverse Event|1|||
46916470|NCT01986933|83147581|FG004|Active-to-active (Part B)|Adverse Event|3|||
46916471|NCT01986933|83147577|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
46916472|NCT01986933|83147578|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
46916473|NCT01986933|83147579|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
46916474|NCT01986933|83147580|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
46916475|NCT01986933|83147581|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
46916476|NCT01986933|83147577|FG000|Active-to-active (Part B)|Pregnancy|0|||
46916477|NCT01986933|83147578|FG001|Active-to-active (Part B)|Pregnancy|0|||
46916478|NCT01986933|83147579|FG002|Active-to-active (Part B)|Pregnancy|0|||
46916479|NCT01986933|83147580|FG003|Active-to-active (Part B)|Pregnancy|0|||
46916480|NCT01986933|83147581|FG004|Active-to-active (Part B)|Pregnancy|1|||
46916481|NCT01986933|83147577|FG000|Active-to-active (Part B)|Physician Decision|0|||
46916482|NCT01986933|83147578|FG001|Active-to-active (Part B)|Physician Decision|0|||
46916483|NCT01986933|83147579|FG002|Active-to-active (Part B)|Physician Decision|1|||
46916484|NCT01986933|83147580|FG003|Active-to-active (Part B)|Physician Decision|1|||
46916485|NCT01986933|83147581|FG004|Active-to-active (Part B)|Physician Decision|0|||
46916486|NCT01986933|83147577|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
46916487|NCT01986933|83147578|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
46916488|NCT01986933|83147579|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
46916489|NCT01986933|83147580|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
46916490|NCT01986933|83147581|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
46916491|NCT01986933|83147577|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
46916492|NCT01986933|83147578|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
46916493|NCT01986933|83147579|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
46916494|NCT01986933|83147580|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
46916495|NCT01986933|83147581|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
46916496|NCT01986933|83147577|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
46916497|NCT01986933|83147578|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
46916498|NCT01986933|83147579|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
46916499|NCT01986933|83147580|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
46916500|NCT01986933|83147581|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
46916501|NCT01986933|83147577|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
46916502|NCT01986933|83147578|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
46916503|NCT01986933|83147579|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
46916504|NCT01986933|83147580|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
46916505|NCT01986933|83147581|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
46916506|NCT01986933|83147577|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
46916507|NCT01986933|83147578|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
46916508|NCT01986933|83147579|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
46916509|NCT01986933|83147580|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
46916510|NCT01986933|83147581|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
46916511|NCT01986933|83147577|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
46916512|NCT01986933|83147578|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
46916513|NCT01986933|83147579|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
46916514|NCT01986933|83147580|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
46916515|NCT01986933|83147581|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
46719458|NCT01160822|82935581|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46719459|NCT01160822|82935582|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46719460|NCT01160822|82935583|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
46719461|NCT01160822|82935584|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
46719462|NCT01160822|82935585|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
46719463|NCT01160822|82935586|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
46916516|NCT01986933|83147577|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
46719464|NCT01160822|82935587|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
46719465|NCT01160822|82935581|FG000|Overall Study|Withdrawal by Subject|0|||
46916517|NCT01986933|83147578|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
46719466|NCT01160822|82935582|FG001|Overall Study|Withdrawal by Subject|0|||
46719467|NCT01160822|82935583|FG002|Overall Study|Withdrawal by Subject|0|||
46916518|NCT01986933|83147579|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
46916519|NCT01986933|83147580|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
46916520|NCT01986933|83147581|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
46916521|NCT01986933|83147577|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
46916522|NCT01986933|83147578|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
46916523|NCT01986933|83147579|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
46916524|NCT01986933|83147580|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
46916525|NCT01986933|83147581|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
46916526|NCT00394355|83147625|FG000|Overall Study|Adverse Event|10|||
46916527|NCT00394355|83147626|FG001|Overall Study|Adverse Event|6|||
46916528|NCT00394355|83147627|FG002|Overall Study|Adverse Event|7|||
46916529|NCT00394355|83147628|FG003|Overall Study|Adverse Event|8|||
46916530|NCT00394355|83147625|FG000|Overall Study|Did not meet protocol eligibility|1|||
46916531|NCT00394355|83147626|FG001|Overall Study|Did not meet protocol eligibility|5|||
46916532|NCT00394355|83147627|FG002|Overall Study|Did not meet protocol eligibility|4|||
46916533|NCT00394355|83147628|FG003|Overall Study|Did not meet protocol eligibility|2|||
46916534|NCT00394355|83147625|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
46916535|NCT00394355|83147626|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
46916536|NCT00394355|83147627|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
46916537|NCT00394355|83147628|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
46916538|NCT00394355|83147625|FG000|Overall Study|Subject withdrawal - related to drug|1|||
46719468|NCT01160822|82935584|FG003|Overall Study|Withdrawal by Subject|0|||
46719469|NCT01160822|82935585|FG004|Overall Study|Withdrawal by Subject|0|||
46719470|NCT01160822|82935586|FG005|Overall Study|Withdrawal by Subject|0|||
46916539|NCT00394355|83147626|FG001|Overall Study|Subject withdrawal - related to drug|0|||
46916540|NCT00394355|83147627|FG002|Overall Study|Subject withdrawal - related to drug|0|||
46916541|NCT00394355|83147628|FG003|Overall Study|Subject withdrawal - related to drug|0|||
46916542|NCT00394355|83147625|FG000|Overall Study|Lost to Follow-up|7|||
46916543|NCT00394355|83147626|FG001|Overall Study|Lost to Follow-up|5|||
46916544|NCT00394355|83147627|FG002|Overall Study|Lost to Follow-up|4|||
46916545|NCT00394355|83147628|FG003|Overall Study|Lost to Follow-up|3|||
46916546|NCT00394355|83147625|FG000|Overall Study|Noncompliance with protocol|4|||
46916547|NCT00394355|83147626|FG001|Overall Study|Noncompliance with protocol|3|||
46916548|NCT00394355|83147627|FG002|Overall Study|Noncompliance with protocol|10|||
46916549|NCT00394355|83147628|FG003|Overall Study|Noncompliance with protocol|8|||
46916550|NCT00394355|83147625|FG000|Overall Study|Administrative|0|||
46916551|NCT00394355|83147626|FG001|Overall Study|Administrative|1|||
46916552|NCT00394355|83147627|FG002|Overall Study|Administrative|1|||
46916553|NCT00394355|83147628|FG003|Overall Study|Administrative|1|||
46916554|NCT00394355|83147625|FG000|Overall Study|Lack of Efficacy|0|||
46916555|NCT00394355|83147626|FG001|Overall Study|Lack of Efficacy|0|||
46916556|NCT00394355|83147627|FG002|Overall Study|Lack of Efficacy|2|||
46916557|NCT00394355|83147628|FG003|Overall Study|Lack of Efficacy|3|||
46916558|NCT02797808|83147640|FG000|Overall Study|Withdrawal by Subject|1|||
46916559|NCT02797808|83147641|FG001|Overall Study|Withdrawal by Subject|1|||
46916560|NCT02797808|83147640|FG000|Overall Study|Physician Decision|6|||
46916561|NCT02797808|83147641|FG001|Overall Study|Physician Decision|2|||
46916562|NCT02796560|83147649|FG000|Overall Study|Adverse Event|2|||
46916563|NCT02796560|83147650|FG001|Overall Study|Adverse Event|0|||
46916564|NCT02796560|83147649|FG000|Overall Study|Withdrawal by Subject|2|||
46916565|NCT02796560|83147650|FG001|Overall Study|Withdrawal by Subject|2|||
46719471|NCT01160822|82935587|FG006|Overall Study|Withdrawal by Subject|1|||
46916566|NCT00344487|83147656|FG000|Overall Study|immunologic failure|1|||
46916567|NCT02871492|83147665|FG000|Overall Study|Lost to Follow-up|6|||
46916568|NCT02871492|83147666|FG001|Overall Study|Lost to Follow-up|3|||
46916569|NCT02871492|83147667|FG002|Overall Study|Lost to Follow-up|5|||
46916570|NCT02871492|83147665|FG000|Overall Study|Withdrawal by Subject|0|||
46916571|NCT02871492|83147666|FG001|Overall Study|Withdrawal by Subject|0|||
46916572|NCT02871492|83147667|FG002|Overall Study|Withdrawal by Subject|1|||
46916573|NCT03143855|83147677|FG000|Overall Study|Withdrawal by Subject|4|||
46916574|NCT03143855|83147678|FG001|Overall Study|Withdrawal by Subject|3|||
46916575|NCT03143855|83147677|FG000|Overall Study|Protocol Violation|1|||
46916576|NCT03143855|83147678|FG001|Overall Study|Protocol Violation|0|||
46916577|NCT03143855|83147677|FG000|Overall Study|Participant experienced withdrawal|0|||
46916578|NCT03143855|83147678|FG001|Overall Study|Participant experienced withdrawal|1|||
46916579|NCT02878603|83147686|FG000|Overall Study|Lost to Follow-up|4|||
46916580|NCT02878603|83147687|FG001|Overall Study|Lost to Follow-up|1|||
46916581|NCT02878603|83147686|FG000|Overall Study|Withdrawal by Subject|1|||
46916582|NCT02878603|83147687|FG001|Overall Study|Withdrawal by Subject|1|||
46916583|NCT02878603|83147686|FG000|Overall Study|Death|1|||
46916584|NCT02878603|83147687|FG001|Overall Study|Death|0|||
46916585|NCT02878603|83147686|FG000|Overall Study|Physician Decision|0|||
47041087|NCT01433055|83296940|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
47041088|NCT01433055|83296939|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
47041089|NCT01433055|83296940|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
47041090|NCT01450137|83296948|FG000|Up to Week 12|Adverse Event|2|||
47041091|NCT01450137|83296949|FG001|Up to Week 12|Adverse Event|1|||
47041092|NCT01450137|83296948|FG000|Up to Week 12|Withdrawal by Subject|0|||
47041093|NCT01450137|83296949|FG001|Up to Week 12|Withdrawal by Subject|2|||
47041094|NCT01450137|83296948|FG000|Week 12 to Study End|Death|0|||
47041095|NCT01450137|83296949|FG001|Week 12 to Study End|Death|1|||
47041096|NCT01450137|83296948|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
47041097|NCT01450137|83296949|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
47041098|NCT01412229|83296955|FG000|Overall Study|Physician Decision|1|||
47041099|NCT01412151|83296960|FG000|Week 0 - 306 - Treatment Period|Death|1|||
47041100|NCT01412151|83296960|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
47041101|NCT01412151|83296960|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
47041102|NCT01412151|83296960|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
47041103|NCT01432275|83296966|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
47041104|NCT01432275|83296967|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
47041105|NCT01432275|83296966|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
47041106|NCT01432275|83296967|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
47041107|NCT01432275|83296966|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
47041108|NCT01432275|83296967|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
47041109|NCT01432275|83296966|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
47041110|NCT01432275|83296967|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
47041111|NCT01432275|83296966|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
47041112|NCT01432275|83296967|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
47041113|NCT01432275|83296966|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
47041114|NCT01432275|83296967|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
47041115|NCT01432275|83296966|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
47041116|NCT01432275|83296967|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
47041117|NCT01432275|83296966|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
47041118|NCT01432275|83296967|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
47041119|NCT01432275|83296966|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
47041120|NCT01432275|83296967|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
47041121|NCT01411995|83296975|FG000|Overall Study|Failed IUD insertion|0|||
47041122|NCT01411995|83296976|FG001|Overall Study|Failed IUD insertion|1|||
47041123|NCT01411917|83296984|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
47041124|NCT01411917|83296985|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
47041125|NCT01411839|83296993|FG000|Overall Study|Lost to Follow-up|4|||
47041126|NCT01411839|83296994|FG001|Overall Study|Lost to Follow-up|3|||
47041127|NCT01411215|83297002|FG000|Overall Study|Adverse Event|1|||
47041128|NCT01411215|83297003|FG001|Overall Study|Adverse Event|2|||
47041129|NCT01411215|83297002|FG000|Overall Study|Lack of Efficacy|2|||
47041130|NCT01411215|83297003|FG001|Overall Study|Lack of Efficacy|4|||
46916586|NCT02878603|83147687|FG001|Overall Study|Physician Decision|3|||
46916587|NCT01370408|83147693|FG000|Overall Study|treatment failure|9|||
46916588|NCT03294109|83147699|FG000|Overall Study|Withdrawal by Subject|6|||
46916589|NCT03294109|83147700|FG001|Overall Study|Withdrawal by Subject|5|||
47041131|NCT01411215|83297002|FG000|Overall Study|Lost to Follow-up|12|||
47041132|NCT01411215|83297003|FG001|Overall Study|Lost to Follow-up|18|||
47041133|NCT01411215|83297002|FG000|Overall Study|Did not meet entrance criteria|0|||
47041134|NCT01411215|83297003|FG001|Overall Study|Did not meet entrance criteria|1|||
47041135|NCT01411215|83297002|FG000|Overall Study|Study terminated by sponsor|2|||
46916590|NCT03132805|83147719|FG000|Overall Study|Lost to Follow-up|142|||
46916591|NCT03132805|83147720|FG001|Overall Study|Lost to Follow-up|141|||
46916592|NCT03132805|83147721|FG002|Overall Study|Lost to Follow-up|113|||
46916593|NCT02793128|83147729|FG000|Overall Study|Death|4|||
46916594|NCT02793128|83147729|FG000|Overall Study|Withdrawal by Subject|2|||
46916595|NCT02793128|83147729|FG000|Overall Study|Physician Decision|1|||
46916596|NCT02793128|83147729|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
46916597|NCT02793128|83147729|FG000|Overall Study|Patient elected nephroureterectomy|1|||
47041136|NCT01411215|83297003|FG001|Overall Study|Study terminated by sponsor|15|||
47041137|NCT01411215|83297002|FG000|Overall Study|Protocol Violation|3|||
47041138|NCT01411215|83297003|FG001|Overall Study|Protocol Violation|5|||
47041139|NCT01411215|83297002|FG000|Overall Study|Withdrawal by Subject|34|||
46719472|NCT01160822|82935581|FG000|Overall Study|Lost to Follow-up|0|||
46719473|NCT01160822|82935582|FG001|Overall Study|Lost to Follow-up|0|||
46719474|NCT01160822|82935583|FG002|Overall Study|Lost to Follow-up|0|||
46719475|NCT01160822|82935584|FG003|Overall Study|Lost to Follow-up|0|||
46719476|NCT01160822|82935585|FG004|Overall Study|Lost to Follow-up|1|||
46719477|NCT01160822|82935586|FG005|Overall Study|Lost to Follow-up|0|||
46719478|NCT01160822|82935587|FG006|Overall Study|Lost to Follow-up|0|||
46719479|NCT01160822|82935581|FG000|Overall Study|Administrative problems|0|||
46719480|NCT01160822|82935582|FG001|Overall Study|Administrative problems|0|||
46719481|NCT01160822|82935583|FG002|Overall Study|Administrative problems|0|||
46719482|NCT01160822|82935584|FG003|Overall Study|Administrative problems|0|||
46719483|NCT01160822|82935585|FG004|Overall Study|Administrative problems|1|||
46719484|NCT01160822|82935586|FG005|Overall Study|Administrative problems|0|||
46719485|NCT01160822|82935587|FG006|Overall Study|Administrative problems|0|||
46719486|NCT01160822|82935581|FG000|Overall Study|Protocol deviation|0|||
46719487|NCT01160822|82935582|FG001|Overall Study|Protocol deviation|0|||
46719488|NCT01160822|82935583|FG002|Overall Study|Protocol deviation|0|||
46719489|NCT01160822|82935584|FG003|Overall Study|Protocol deviation|0|||
46719490|NCT01160822|82935585|FG004|Overall Study|Protocol deviation|2|||
47041140|NCT01411215|83297003|FG001|Overall Study|Withdrawal by Subject|21|||
46719491|NCT01160822|82935586|FG005|Overall Study|Protocol deviation|0|||
46719492|NCT01160822|82935587|FG006|Overall Study|Protocol deviation|0|||
46719493|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
46719494|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
46719495|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
47041141|NCT01411215|83297002|FG000|Overall Study|Other|12|||
47041142|NCT01411215|83297003|FG001|Overall Study|Other|17|||
47041143|NCT01411215|83297002|FG000|Overall Study|Screen failure|0|||
47041144|NCT01411215|83297003|FG001|Overall Study|Screen failure|1|||
47041145|NCT01449279|83297009|FG000|Overall Study|Lack of Efficacy|5|||
47041146|NCT01449279|83297009|FG000|Overall Study|Toxicity|2|||
47041147|NCT01447719|83297013|FG000|Overall Study|Image acquisition failure|2|||
47041148|NCT01447719|83297013|FG000|Overall Study|Invalid image or not imaged|3|||
47041149|NCT01447719|83297013|FG000|Overall Study|Subject still living at end of study|79|||
47041150|NCT01447719|83297013|FG000|Overall Study|Withdrawal by Subject|2|||
47041151|NCT01447719|83297013|FG000|Overall Study|Family withdrew autopsy consent|7|||
47041152|NCT01431963|83297022|FG000|Overall Study|Adverse Event|18|||
47041153|NCT01431963|83297022|FG000|Overall Study|Lack of Efficacy|7|||
47041154|NCT01431963|83297022|FG000|Overall Study|Protocol Violation|1|||
47041155|NCT01431963|83297022|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
46719496|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
46719497|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Death|13|||
46719498|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Death|12|||
46719499|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Progression|257|||
46719500|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Progression|218|||
47041156|NCT01431963|83297022|FG000|Overall Study|Physician Decision|4|||
46719501|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
46719502|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
46719503|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
46719504|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
46916598|NCT03142451|83147743|FG000|Overall Study|Adverse Event|5|||
47041157|NCT01431963|83297022|FG000|Overall Study|Withdrawal by Subject|3|||
47041158|NCT01447407|83297030|FG000|Overall Study|Withdrawal by Subject|2|||
46719505|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
46719506|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
46719507|NCT01006980|82935606|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
46719508|NCT01006980|82935607|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
46719509|NCT01006980|82935606|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
46719510|NCT01006980|82935607|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
46916599|NCT03142451|83147744|FG001|Overall Study|Adverse Event|2|||
46916600|NCT03142451|83147743|FG000|Overall Study|Lost to Follow-up|25|||
47041159|NCT01447407|83297031|FG001|Overall Study|Withdrawal by Subject|0|||
47041160|NCT01447407|83297032|FG002|Overall Study|Withdrawal by Subject|0|||
47041161|NCT01447407|83297033|FG003|Overall Study|Withdrawal by Subject|1|||
47041162|NCT01447407|83297030|FG000|Overall Study|Physician Decision|0|||
47041163|NCT01447407|83297031|FG001|Overall Study|Physician Decision|0|||
47041164|NCT01447407|83297032|FG002|Overall Study|Physician Decision|1|||
47041165|NCT01447407|83297033|FG003|Overall Study|Physician Decision|1|||
47041166|NCT01446237|83297043|FG000|Overall Study|Adverse Event|1|||
47041167|NCT01446237|83297043|FG000|Overall Study|Lost to Follow-up|2|||
46916601|NCT03142451|83147744|FG001|Overall Study|Lost to Follow-up|8|||
46916602|NCT03142451|83147743|FG000|Overall Study|Participant request|24|||
46916603|NCT03142451|83147744|FG001|Overall Study|Participant request|12|||
46916604|NCT03142451|83147743|FG000|Overall Study|Protocol Violation|3|||
46916605|NCT03142451|83147744|FG001|Overall Study|Protocol Violation|1|||
46916606|NCT03142451|83147743|FG000|Overall Study|Other|1|||
46916607|NCT03142451|83147744|FG001|Overall Study|Other|1|||
46916608|NCT03141905|83147752|FG000|Overall Study|Death|3|||
46916609|NCT03141905|83147753|FG001|Overall Study|Death|2|||
46916610|NCT03141905|83147752|FG000|Overall Study|Withdrawal by Subject|1|||
46916611|NCT03141905|83147753|FG001|Overall Study|Withdrawal by Subject|0|||
46916612|NCT03141905|83147752|FG000|Overall Study|Lost to Follow-up|3|||
47041168|NCT01446237|83297043|FG000|Overall Study|Withdrawal by Subject|7|||
47041169|NCT01446159|83297187|FG000|Overall Study|Withdrawal by Subject|1|||
47041170|NCT01446159|83297188|FG001|Overall Study|Withdrawal by Subject|0|||
47041171|NCT01446159|83297189|FG002|Overall Study|Withdrawal by Subject|14|||
47041172|NCT01446159|83297190|FG003|Overall Study|Withdrawal by Subject|11|||
47041173|NCT01446159|83297187|FG000|Overall Study|Lost to Follow-up|0|||
47041174|NCT01446159|83297188|FG001|Overall Study|Lost to Follow-up|0|||
47041175|NCT01446159|83297189|FG002|Overall Study|Lost to Follow-up|1|||
47041176|NCT01446159|83297190|FG003|Overall Study|Lost to Follow-up|2|||
47041177|NCT01446159|83297187|FG000|Overall Study|Death|2|||
47041178|NCT01446159|83297188|FG001|Overall Study|Death|3|||
47041179|NCT01446159|83297189|FG002|Overall Study|Death|43|||
47041180|NCT01446159|83297190|FG003|Overall Study|Death|36|||
47041181|NCT01446159|83297187|FG000|Overall Study|Other|0|||
47041182|NCT01446159|83297188|FG001|Overall Study|Other|0|||
47041183|NCT01446159|83297189|FG002|Overall Study|Other|13|||
47041184|NCT01446159|83297190|FG003|Overall Study|Other|13|||
47041185|NCT01446003|83297226|FG000|Period 1|Protocol Violation|2|||
47041186|NCT01446003|83297227|FG001|Period 1|Protocol Violation|0|||
47041187|NCT01446003|83297226|FG000|Period 2|Adverse Event|1|||
47041188|NCT01446003|83297227|FG001|Period 2|Adverse Event|0|||
47041189|NCT01430559|83297244|FG000|Overall Study|Adverse Event|7|||
47041190|NCT01430559|83297245|FG001|Overall Study|Adverse Event|3|||
47041191|NCT01430559|83297244|FG000|Overall Study|Entry criteria not met|1|||
47041192|NCT01430559|83297245|FG001|Overall Study|Entry criteria not met|1|||
46916613|NCT03141905|83147753|FG001|Overall Study|Lost to Follow-up|7|||
46916614|NCT03141905|83147752|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
46916615|NCT03141905|83147753|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
46916616|NCT01370018|83147760|FG000|Overall Study|Did not meet criteria for analysis|1|||
46916617|NCT04034355|83147766|FG000|Overall Study|Study terminated by Sponsor|10|||
46916618|NCT04034355|83147767|FG001|Overall Study|Study terminated by Sponsor|17|||
46916619|NCT04034355|83147766|FG000|Overall Study|Withdrawal by Subject|12|||
46916620|NCT04034355|83147767|FG001|Overall Study|Withdrawal by Subject|11|||
46916621|NCT04034355|83147766|FG000|Overall Study|Site terminated by Sponsor|4|||
46916622|NCT04034355|83147767|FG001|Overall Study|Site terminated by Sponsor|5|||
46916623|NCT04034355|83147766|FG000|Overall Study|Adverse Event|2|||
46916624|NCT04034355|83147767|FG001|Overall Study|Adverse Event|0|||
46916625|NCT04034355|83147766|FG000|Overall Study|Death|1|||
46916626|NCT04034355|83147767|FG001|Overall Study|Death|1|||
46916627|NCT04034355|83147766|FG000|Overall Study|Not reported|2|||
46916628|NCT04034355|83147767|FG001|Overall Study|Not reported|0|||
46916629|NCT04034355|83147766|FG000|Overall Study|Lost to Follow-up|1|||
46916630|NCT04034355|83147767|FG001|Overall Study|Lost to Follow-up|0|||
47041193|NCT01430559|83297244|FG000|Overall Study|Lost to Follow-up|1|||
47041194|NCT01430559|83297245|FG001|Overall Study|Lost to Follow-up|0|||
47041195|NCT01430559|83297244|FG000|Overall Study|Medication error|1|||
47041196|NCT01430559|83297245|FG001|Overall Study|Medication error|0|||
47041197|NCT01430559|83297244|FG000|Overall Study|Withdrawal by Subject|3|||
46719511|NCT01006980|82935606|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
46916631|NCT04034355|83147766|FG000|Overall Study|Physician Decision|1|||
46916632|NCT04034355|83147767|FG001|Overall Study|Physician Decision|0|||
46916633|NCT04034355|83147766|FG000|Overall Study|Protocol Violation|0|||
46916634|NCT04034355|83147767|FG001|Overall Study|Protocol Violation|1|||
47041198|NCT01430559|83297245|FG001|Overall Study|Withdrawal by Subject|2|||
47041199|NCT01430559|83297244|FG000|Overall Study|Protocol Violation|1|||
47041200|NCT01430559|83297245|FG001|Overall Study|Protocol Violation|0|||
46916635|NCT04034355|83147766|FG000|Overall Study|Progressive disease|1|||
47041201|NCT01430559|83297244|FG000|Overall Study|Other|3|||
47041202|NCT01430559|83297245|FG001|Overall Study|Other|3|||
47041203|NCT01430559|83297244|FG000|Overall Study|Randomized, Not Treated|3|||
47041204|NCT01430559|83297245|FG001|Overall Study|Randomized, Not Treated|3|||
47041205|NCT01410357|83297258|FG000|Overall Study|Death|2|||
47041206|NCT01410357|83297259|FG001|Overall Study|Death|1|||
47041207|NCT01410357|83297258|FG000|Overall Study|Withdrawal by Subject|1|||
47041208|NCT01410357|83297259|FG001|Overall Study|Withdrawal by Subject|2|||
47041209|NCT01410357|83297258|FG000|Overall Study|Lost to Follow-up|23|||
46916636|NCT04034355|83147767|FG001|Overall Study|Progressive disease|0|||
46916637|NCT01336764|83147784|FG000|Overall Study|Withdrawal by Subject|5|||
47041210|NCT01410357|83297259|FG001|Overall Study|Lost to Follow-up|21|||
47041211|NCT01409811|83297284|FG000|Overall Study|Insurance denial|1|||
47041212|NCT01445847|83297290|FG000|Overall Study|Protocol Violation|13|||
47041213|NCT01445847|83297291|FG001|Overall Study|Protocol Violation|14|||
47041214|NCT01445847|83297290|FG000|Overall Study|Missed Data|1|||
47041215|NCT01445847|83297291|FG001|Overall Study|Missed Data|0|||
47041216|NCT01445769|83297310|FG000|Overall Study|Consent Withdrawn|2|||
47041217|NCT01445769|83297310|FG000|Overall Study|Disease Progression|1|||
47041218|NCT01445769|83297310|FG000|Overall Study|Lost to Follow-up|5|||
47041219|NCT01445613|83297392|FG000|30-day Follow-up|Withdrawal by Subject|6|||
46916638|NCT01336764|83147785|FG001|Overall Study|Withdrawal by Subject|5|||
47041220|NCT01445613|83297392|FG000|30-day Follow-up|Physician Decision|3|||
47041221|NCT01445613|83297392|FG000|30-day Follow-up|Missed visit|23|||
47041222|NCT01445613|83297392|FG000|30-day Follow-up|Death|3|||
46916639|NCT01336608|83147794|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
47041223|NCT01445613|83297392|FG000|1-year Follow-up|Withdrawal by Subject|12|||
47041224|NCT01445613|83297392|FG000|1-year Follow-up|Missed visit|29|||
46916640|NCT01336608|83147795|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
47041225|NCT01445613|83297392|FG000|1-year Follow-up|Lost to Follow-up|2|||
46719512|NCT01006980|82935607|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
46719513|NCT01006980|82935606|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
46719514|NCT01006980|82935607|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
46719515|NCT01006980|82935606|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
46719516|NCT01006980|82935607|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
46719517|NCT01006980|82935606|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
46719518|NCT01006980|82935607|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
46719519|NCT00887926|82935618|FG000|Overall Study|Withdrawal by Subject|0|||
46719520|NCT00887926|82935619|FG001|Overall Study|Withdrawal by Subject|1|||
46719521|NCT00887926|82935620|FG002|Overall Study|Withdrawal by Subject|0|||
46719522|NCT00887926|82935621|FG003|Overall Study|Withdrawal by Subject|0|||
46719523|NCT00998400|82935635|FG000|Overall Study|Lack of interest/motivation|1|||
47041226|NCT01445613|83297392|FG000|1-year Follow-up|Death|30|||
47041227|NCT01445613|83297392|FG000|1-year Follow-up|Physician Decision|2|||
47041228|NCT01445613|83297392|FG000|1-year Follow-up|Received a non-study stent|2|||
47041229|NCT01445535|83297496|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
47041230|NCT01445535|83297497|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
47041231|NCT01445535|83297498|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
46632575|NCT01792518|82805734|FG000|Overall Study|Protocol Violation|0|||
46632576|NCT01792518|82805735|FG001|Overall Study|Protocol Violation|1|||
46632577|NCT01792518|82805734|FG000|Overall Study|Lost to Follow-up|3|||
46632578|NCT01792518|82805735|FG001|Overall Study|Lost to Follow-up|1|||
46632579|NCT01792518|82805734|FG000|Overall Study|Withdrawal by Subject|2|||
46632580|NCT01792518|82805735|FG001|Overall Study|Withdrawal by Subject|0|||
46632581|NCT01792518|82805734|FG000|Overall Study|Other Reason|0|||
46632582|NCT01792518|82805735|FG001|Overall Study|Other Reason|1|||
46632583|NCT01792284|82805741|FG000|Lead-in Period|Adverse Event|15|||
46632584|NCT01792284|82805742|FG001|Lead-in Period|Adverse Event|0|||
46632585|NCT01792284|82805743|FG002|Lead-in Period|Adverse Event|0|||
46632586|NCT01792284|82805741|FG000|Lead-in Period|Lost to Follow-up|2|||
46632587|NCT01792284|82805742|FG001|Lead-in Period|Lost to Follow-up|0|||
46719524|NCT00998400|82935636|FG001|Overall Study|Lack of interest/motivation|2|||
46916641|NCT01336608|83147796|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
47041232|NCT01445535|83297499|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
47041233|NCT01445535|83297496|FG000|Overall Study|Disease progression|1|||
47041234|NCT01445535|83297497|FG001|Overall Study|Disease progression|0|||
46632588|NCT01792284|82805743|FG002|Lead-in Period|Lost to Follow-up|0|||
47041235|NCT01445535|83297498|FG002|Overall Study|Disease progression|1|||
47041236|NCT01445535|83297499|FG003|Overall Study|Disease progression|0|||
47041237|NCT01445535|83297496|FG000|Overall Study|PI discretion|0|||
47041238|NCT01445535|83297497|FG001|Overall Study|PI discretion|0|||
47041239|NCT01445535|83297498|FG002|Overall Study|PI discretion|0|||
46632589|NCT01792284|82805741|FG000|Lead-in Period|Protocol Violation|1|||
46632590|NCT01792284|82805742|FG001|Lead-in Period|Protocol Violation|0|||
46719525|NCT00998400|82935635|FG000|Overall Study|Logistical problems|1|||
47041240|NCT01445535|83297499|FG003|Overall Study|PI discretion|1|||
47041241|NCT01445301|83297513|FG000|Overall Study|Adverse Event|15|||
47041242|NCT01445301|83297514|FG001|Overall Study|Adverse Event|25|||
47041243|NCT01445301|83297515|FG002|Overall Study|Adverse Event|4|||
47041244|NCT01445301|83297513|FG000|Overall Study|Lack of Efficacy|0|||
47041245|NCT01445301|83297514|FG001|Overall Study|Lack of Efficacy|1|||
47041246|NCT01445301|83297515|FG002|Overall Study|Lack of Efficacy|0|||
47041247|NCT01445301|83297513|FG000|Overall Study|Protocol Violation|1|||
47041248|NCT01445301|83297514|FG001|Overall Study|Protocol Violation|0|||
47041249|NCT01445301|83297515|FG002|Overall Study|Protocol Violation|0|||
46916642|NCT01336608|83147797|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
47041250|NCT01445301|83297513|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
46916643|NCT01336608|83147794|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
46916644|NCT01336608|83147795|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46916645|NCT01336608|83147796|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46916646|NCT01336608|83147797|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46916647|NCT01336608|83147794|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
46916648|NCT01336608|83147795|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
46916649|NCT01336608|83147796|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
46916650|NCT01336608|83147797|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
46916651|NCT01336608|83147794|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
46916652|NCT01336608|83147795|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
46916653|NCT01336608|83147796|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
46916654|NCT01336608|83147797|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
46916655|NCT01336608|83147794|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
46916656|NCT01336608|83147795|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46916657|NCT01336608|83147796|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46916658|NCT01336608|83147797|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46916659|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
46916660|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
46916661|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
46916662|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
46916663|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46916664|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
46916665|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46916666|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46916667|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
46916668|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
46916669|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
46916670|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
46916671|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
46916672|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
46916673|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
46916674|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
46916675|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
46916676|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
46916677|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
46916678|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
46916679|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46916680|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
46916681|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
47041251|NCT01445301|83297514|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
47041252|NCT01445301|83297515|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
47041253|NCT01445301|83297513|FG000|Overall Study|Physician Decision|0|||
47041254|NCT01445301|83297514|FG001|Overall Study|Physician Decision|2|||
47041255|NCT01445301|83297515|FG002|Overall Study|Physician Decision|0|||
47041256|NCT01445301|83297513|FG000|Overall Study|Withdrawal by Subject|5|||
47041257|NCT01445301|83297514|FG001|Overall Study|Withdrawal by Subject|6|||
47041258|NCT01445301|83297515|FG002|Overall Study|Withdrawal by Subject|4|||
47041259|NCT01409031|83297525|FG000|Overall Study|transferred to other hosp|1|||
47041260|NCT01409031|83297526|FG001|Overall Study|transferred to other hosp|0|||
47041261|NCT01430403|83297535|FG000|Overall Study|Lost to Follow-up|5|||
47041262|NCT01430403|83297536|FG001|Overall Study|Lost to Follow-up|5|||
47041263|NCT01430403|83297537|FG002|Overall Study|Lost to Follow-up|3|||
47041264|NCT01430403|83297535|FG000|Overall Study|Physician Decision|1|||
47041265|NCT01430403|83297536|FG001|Overall Study|Physician Decision|0|||
47041266|NCT01430403|83297537|FG002|Overall Study|Physician Decision|0|||
47041267|NCT01430403|83297535|FG000|Overall Study|Protocol Violation|2|||
47041268|NCT01430403|83297536|FG001|Overall Study|Protocol Violation|3|||
47041269|NCT01430403|83297537|FG002|Overall Study|Protocol Violation|2|||
47041270|NCT01430403|83297535|FG000|Overall Study|Withdrawal by Subject|9|||
47041271|NCT01430403|83297536|FG001|Overall Study|Withdrawal by Subject|1|||
47041272|NCT01430403|83297537|FG002|Overall Study|Withdrawal by Subject|3|||
47041273|NCT01429623|83297552|FG000|Overall Study|Death|1|||
47041274|NCT01429623|83297553|FG001|Overall Study|Death|0|||
47041275|NCT01429623|83297552|FG000|Overall Study|Adverse Event|7|||
47041276|NCT01429623|83297553|FG001|Overall Study|Adverse Event|14|||
47041277|NCT01429623|83297552|FG000|Overall Study|Withdrawal by Subject|19|||
46632591|NCT01792284|82805743|FG002|Lead-in Period|Protocol Violation|0|||
46632592|NCT01792284|82805741|FG000|Lead-in Period|Withdrawal by Subject|10|||
46632593|NCT01792284|82805742|FG001|Lead-in Period|Withdrawal by Subject|0|||
46719526|NCT00998400|82935636|FG001|Overall Study|Logistical problems|0|||
46916682|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46916683|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
46916684|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
46916685|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
46916686|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
46916687|NCT01336608|83147794|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
46916688|NCT01336608|83147795|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
46916689|NCT01336608|83147796|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
46916690|NCT01336608|83147797|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
46916691|NCT01346371|83147816|FG000|Overall Study|Lost to Follow-up|2|||
46916692|NCT01346371|83147817|FG001|Overall Study|Lost to Follow-up|0|||
46916693|NCT03644849|83147835|FG000|Overall Study|Lost to Follow-up|1|||
46916694|NCT03644849|83147836|FG001|Overall Study|Lost to Follow-up|3|||
46916695|NCT03131479|83147847|FG000|Overall Study|Adverse Event|0|||
46916696|NCT03131479|83147848|FG001|Overall Study|Adverse Event|0|||
46916697|NCT03131479|83147849|FG002|Overall Study|Adverse Event|1|||
46916698|NCT03131479|83147850|FG003|Overall Study|Adverse Event|1|||
46916699|NCT03131479|83147851|FG004|Overall Study|Adverse Event|0|||
46916700|NCT03131479|83147847|FG000|Overall Study|Subject/Guardian Decision|0|||
46916701|NCT03131479|83147848|FG001|Overall Study|Subject/Guardian Decision|0|||
46916702|NCT03131479|83147849|FG002|Overall Study|Subject/Guardian Decision|0|||
46916703|NCT03131479|83147850|FG003|Overall Study|Subject/Guardian Decision|1|||
46916704|NCT03131479|83147851|FG004|Overall Study|Subject/Guardian Decision|0|||
46916705|NCT03602885|83147865|FG000|Overall Study|Lost to Follow-up|3|||
46916706|NCT03602885|83147866|FG001|Overall Study|Lost to Follow-up|0|||
46916707|NCT02880761|83147874|FG000|Overall Study|Death|6|||
46916708|NCT02880761|83147875|FG001|Overall Study|Death|8|||
46916709|NCT02880761|83147874|FG000|Overall Study|Withdrawal by Subject|3|||
46916710|NCT02880761|83147875|FG001|Overall Study|Withdrawal by Subject|6|||
46916711|NCT02880761|83147874|FG000|Overall Study|Protocol Violation|4|||
46916712|NCT02880761|83147875|FG001|Overall Study|Protocol Violation|3|||
46916713|NCT02880761|83147874|FG000|Overall Study|Lost to Follow-up|3|||
46916714|NCT02880761|83147875|FG001|Overall Study|Lost to Follow-up|4|||
46916715|NCT02930941|83147883|FG000|Overall Study|Lost to Follow-up|1|||
46916716|NCT02930941|83147884|FG001|Overall Study|Lost to Follow-up|2|||
46916717|NCT03137537|83147896|FG000|Overall Study|Adverse Event|0|||
46916718|NCT03137537|83147897|FG001|Overall Study|Adverse Event|1|||
46916719|NCT03137459|83147905|FG000|2-month Assessment|Withdrawal by Subject|13|||
46916720|NCT03137459|83147906|FG001|2-month Assessment|Withdrawal by Subject|3|||
46916721|NCT03137459|83147905|FG000|2-month Assessment|Unable to reach|42|||
46916722|NCT03137459|83147906|FG001|2-month Assessment|Unable to reach|32|||
47041278|NCT01429623|83297553|FG001|Overall Study|Withdrawal by Subject|13|||
47041279|NCT01429623|83297552|FG000|Overall Study|Physician Decision|2|||
47041280|NCT01429623|83297553|FG001|Overall Study|Physician Decision|3|||
47041281|NCT01429623|83297552|FG000|Overall Study|Protocol Violation|3|||
47041282|NCT01429623|83297553|FG001|Overall Study|Protocol Violation|2|||
47041283|NCT01429623|83297552|FG000|Overall Study|Assorted|1|||
46916723|NCT03137459|83147905|FG000|2-month Assessment|Refused assessment|7|||
47041284|NCT01429623|83297553|FG001|Overall Study|Assorted|2|||
46916724|NCT03137459|83147906|FG001|2-month Assessment|Refused assessment|5|||
46916725|NCT03137459|83147905|FG000|2-month Assessment|Acutely ill|6|||
46916726|NCT03137459|83147906|FG001|2-month Assessment|Acutely ill|2|||
46916727|NCT03137459|83147905|FG000|4-month Assessment|Death|4|||
46916728|NCT03137459|83147906|FG001|4-month Assessment|Death|2|||
46916729|NCT03137459|83147905|FG000|4-month Assessment|Withdrawal by Subject|4|||
46916730|NCT03137459|83147906|FG001|4-month Assessment|Withdrawal by Subject|2|||
46916731|NCT03137459|83147905|FG000|4-month Assessment|Unable to reach|44|||
46916732|NCT03137459|83147906|FG001|4-month Assessment|Unable to reach|29|||
46916733|NCT03137459|83147905|FG000|4-month Assessment|Refused assessment|24|||
46916734|NCT03137459|83147906|FG001|4-month Assessment|Refused assessment|10|||
46916735|NCT03137459|83147905|FG000|4-month Assessment|Acutely ill|2|||
46916736|NCT03137459|83147906|FG001|4-month Assessment|Acutely ill|3|||
46916737|NCT03137459|83147905|FG000|6-months|Lost to Follow-up|14|||
46916738|NCT03137459|83147906|FG001|6-months|Lost to Follow-up|11|||
47041285|NCT01429623|83297552|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
47041286|NCT01429623|83297553|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
47041287|NCT01429623|83297552|FG000|Overall Study|No post baseline data|4|||
46916739|NCT03137459|83147905|FG000|6-months|Death|0|||
46916740|NCT03137459|83147906|FG001|6-months|Death|2|||
47041288|NCT01429623|83297553|FG001|Overall Study|No post baseline data|4|||
47041289|NCT01408641|83297561|FG000|Overall Study|Physician Decision|1|||
46916741|NCT03137459|83147905|FG000|6-months|Refused assessment|6|||
46916742|NCT03137459|83147906|FG001|6-months|Refused assessment|3|||
46916743|NCT03137459|83147905|FG000|6-months|Acutely ill|1|||
46916744|NCT03137459|83147906|FG001|6-months|Acutely ill|1|||
46916745|NCT03131713|83147915|FG000|Overall Study|Lost to Follow-up|5|||
46916746|NCT03131713|83147916|FG001|Overall Study|Lost to Follow-up|0|||
46916747|NCT02930005|83147924|FG000|Overall Study|Lost to Follow-up|1|||
46916748|NCT02930005|83147925|FG001|Overall Study|Lost to Follow-up|5|||
46916749|NCT03637491|83147935|FG000|Overall Study|Death|9|||
46916750|NCT03637491|83147936|FG001|Overall Study|Death|9|||
46916751|NCT03637491|83147937|FG002|Overall Study|Death|5|||
46916752|NCT03637491|83147938|FG003|Overall Study|Death|3|||
46916753|NCT03637491|83147935|FG000|Overall Study|Lost to Follow-up|0|||
46916754|NCT03637491|83147936|FG001|Overall Study|Lost to Follow-up|1|||
46916755|NCT03637491|83147937|FG002|Overall Study|Lost to Follow-up|0|||
46916756|NCT03637491|83147938|FG003|Overall Study|Lost to Follow-up|1|||
46916757|NCT03637491|83147935|FG000|Overall Study|Study Terminated By Sponsor|0|||
46916758|NCT03637491|83147936|FG001|Overall Study|Study Terminated By Sponsor|2|||
46916759|NCT03637491|83147937|FG002|Overall Study|Study Terminated By Sponsor|1|||
46916760|NCT03637491|83147938|FG003|Overall Study|Study Terminated By Sponsor|0|||
46916761|NCT03637491|83147935|FG000|Overall Study|Withdrawal by Subject|1|||
47041290|NCT01408641|83297562|FG001|Overall Study|Physician Decision|0|||
47041291|NCT01429077|83297570|FG000|Overall Study|Lost to Follow-up|0|||
47041292|NCT01429077|83297571|FG001|Overall Study|Lost to Follow-up|3|||
47041293|NCT01428453|83297579|FG000|Overall Study|Adverse Event|2|||
47041294|NCT01428453|83297580|FG001|Overall Study|Adverse Event|7|||
47041295|NCT01428453|83297579|FG000|Overall Study|Protocol Violation|1|||
47041296|NCT01428453|83297580|FG001|Overall Study|Protocol Violation|0|||
47041297|NCT01428453|83297579|FG000|Overall Study|Lost to Follow-up|0|||
47041298|NCT01428453|83297580|FG001|Overall Study|Lost to Follow-up|1|||
47041299|NCT01428453|83297579|FG000|Overall Study|Withdrawal by Subject|3|||
47041300|NCT01428453|83297580|FG001|Overall Study|Withdrawal by Subject|1|||
47041301|NCT01408563|83297588|FG000|Overall Study|Ineligible after consent/ registration|2|||
47041302|NCT01442493|83297594|FG000|Overall Study|withdrawn from study|3|||
47041303|NCT01442493|83297595|FG001|Overall Study|withdrawn from study|2|||
47041304|NCT01442181|83297603|FG000|Overall Study|patient refused surgery|1|||
47041305|NCT01442181|83297604|FG001|Overall Study|patient refused surgery|0|||
47041306|NCT01442181|83297603|FG000|Overall Study|no insurance for surgery|1|||
47041307|NCT01442181|83297604|FG001|Overall Study|no insurance for surgery|0|||
47041308|NCT01442181|83297603|FG000|Overall Study|low ejection factor|0|||
47041309|NCT01442181|83297604|FG001|Overall Study|low ejection factor|1|||
47041310|NCT01442181|83297603|FG000|Overall Study|Lost to Follow-up|1|||
47041311|NCT01442181|83297604|FG001|Overall Study|Lost to Follow-up|1|||
47041312|NCT01442181|83297603|FG000|Overall Study|patient in an additional study|1|||
46719527|NCT00997386|82935643|FG000|Overall Study|Death|7|||
46916762|NCT03637491|83147936|FG001|Overall Study|Withdrawal by Subject|0|||
47041313|NCT01442181|83297604|FG001|Overall Study|patient in an additional study|0|||
47041314|NCT01442181|83297603|FG000|Overall Study|atrial fibrillation not noted|0|||
46916763|NCT03637491|83147937|FG002|Overall Study|Withdrawal by Subject|1|||
46916764|NCT03637491|83147938|FG003|Overall Study|Withdrawal by Subject|2|||
46916765|NCT03296553|83147971|FG000|Overall Study|Withdrawal by Subject|1|||
46916766|NCT03296553|83147972|FG001|Overall Study|Withdrawal by Subject|1|||
46916767|NCT03296553|83147971|FG000|Overall Study|Death|1|||
46916768|NCT03296553|83147972|FG001|Overall Study|Death|0|||
46916769|NCT03131167|83147991|FG000|Overall Study|Other (Unspecified)|0|||
46916770|NCT03131167|83147992|FG001|Overall Study|Other (Unspecified)|0|||
46916771|NCT03131167|83147993|FG002|Overall Study|Other (Unspecified)|0|||
46916772|NCT03131167|83147994|FG003|Overall Study|Other (Unspecified)|0|||
46916773|NCT03131167|83147995|FG004|Overall Study|Other (Unspecified)|0|||
46916774|NCT03131167|83147996|FG005|Overall Study|Other (Unspecified)|1|||
46719528|NCT00996996|82935647|FG000|Overall Study|Progressive Disease|10|||
46719529|NCT00996996|82935647|FG000|Overall Study|Non-compliance|8|||
46719530|NCT00996996|82935647|FG000|Overall Study|Lost to Follow-up|9|||
46719531|NCT00996996|82935647|FG000|Overall Study|Death|5|||
46719532|NCT00996996|82935647|FG000|Overall Study|Did Not Receive Study Medications|1|||
46719533|NCT00996918|82935656|FG000|Overall Study|Lack of Efficacy|1|||
46719534|NCT00996918|82935657|FG001|Overall Study|Lack of Efficacy|1|||
46719535|NCT00996918|82935658|FG002|Overall Study|Lack of Efficacy|2|||
46719536|NCT00996918|82935659|FG003|Overall Study|Lack of Efficacy|2|||
46719537|NCT00996918|82935660|FG004|Overall Study|Lack of Efficacy|0|||
46719538|NCT00996918|82935656|FG000|Overall Study|Adverse Event|2|||
46719539|NCT00996918|82935657|FG001|Overall Study|Adverse Event|5|||
46719540|NCT00996918|82935658|FG002|Overall Study|Adverse Event|2|||
46719541|NCT00996918|82935659|FG003|Overall Study|Adverse Event|6|||
46719542|NCT00996918|82935660|FG004|Overall Study|Adverse Event|0|||
46719543|NCT00996918|82935656|FG000|Overall Study|Withdrawal by Subject|1|||
46719544|NCT00996918|82935657|FG001|Overall Study|Withdrawal by Subject|4|||
46719545|NCT00996918|82935658|FG002|Overall Study|Withdrawal by Subject|3|||
46719546|NCT00996918|82935659|FG003|Overall Study|Withdrawal by Subject|3|||
46719547|NCT00996918|82935660|FG004|Overall Study|Withdrawal by Subject|2|||
46719548|NCT00996918|82935656|FG000|Overall Study|Physician Decision|1|||
46719549|NCT00996918|82935657|FG001|Overall Study|Physician Decision|0|||
46719550|NCT00996918|82935658|FG002|Overall Study|Physician Decision|0|||
46719551|NCT00996918|82935659|FG003|Overall Study|Physician Decision|0|||
46719552|NCT00996918|82935660|FG004|Overall Study|Physician Decision|0|||
46719553|NCT00996918|82935656|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
46719554|NCT00996918|82935657|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
46719555|NCT00996918|82935658|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
46719556|NCT00996918|82935659|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
46719557|NCT00996918|82935660|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
46719558|NCT00996918|82935656|FG000|Overall Study|Loss of Caregiver|0|||
46719559|NCT00996918|82935657|FG001|Overall Study|Loss of Caregiver|1|||
46719560|NCT00996918|82935658|FG002|Overall Study|Loss of Caregiver|0|||
46719561|NCT00996918|82935659|FG003|Overall Study|Loss of Caregiver|0|||
46719562|NCT00996918|82935660|FG004|Overall Study|Loss of Caregiver|0|||
46719563|NCT00996918|82935656|FG000|Overall Study|Other|3|||
46719564|NCT00996918|82935657|FG001|Overall Study|Other|1|||
46719565|NCT00996918|82935658|FG002|Overall Study|Other|0|||
46719566|NCT00996918|82935659|FG003|Overall Study|Other|0|||
46719567|NCT00996918|82935660|FG004|Overall Study|Other|0|||
46719568|NCT01160744|82935676|FG000|Overall Study|Withdrawal by Subject|11|||
46719569|NCT01160744|82935677|FG001|Overall Study|Withdrawal by Subject|5|||
46719570|NCT01160744|82935678|FG002|Overall Study|Withdrawal by Subject|6|||
46719571|NCT01160744|82935679|FG003|Overall Study|Withdrawal by Subject|4|||
46719572|NCT01160744|82935676|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
46719573|NCT01160744|82935677|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
46719574|NCT01160744|82935678|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
46719575|NCT01160744|82935679|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
46719576|NCT01160354|82935694|FG000|Overall Study|Death|0|||
46719577|NCT01160354|82935695|FG001|Overall Study|Death|1|||
46719578|NCT01160354|82935696|FG002|Overall Study|Death|1|||
46719579|NCT01160198|82935707|FG000|Overall Study|Withdrawal by Subject|2|||
46719580|NCT01160198|82935708|FG001|Overall Study|Withdrawal by Subject|1|||
46719581|NCT01160198|82935709|FG002|Overall Study|Withdrawal by Subject|0|||
46719582|NCT01160198|82935707|FG000|Overall Study|Adverse Event|0|||
46719583|NCT01160198|82935708|FG001|Overall Study|Adverse Event|1|||
46719584|NCT01160198|82935709|FG002|Overall Study|Adverse Event|0|||
46719585|NCT01160198|82935707|FG000|Overall Study|Lost to Follow-up|0|||
46719586|NCT01160198|82935708|FG001|Overall Study|Lost to Follow-up|1|||
46719587|NCT01160198|82935709|FG002|Overall Study|Lost to Follow-up|0|||
46916775|NCT03131167|83147997|FG006|Overall Study|Other (Unspecified)|0|||
46916776|NCT03131167|83147998|FG007|Overall Study|Other (Unspecified)|0|||
46719588|NCT01160198|82935707|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
46719589|NCT01160198|82935708|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
46719590|NCT01160198|82935709|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
46719591|NCT01159574|82935717|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
46719592|NCT01159574|82935717|FG000|Treatment Phase|Adverse Event|3|||
46719593|NCT01159574|82935717|FG000|Treatment Phase|Death|6|||
46719594|NCT01159574|82935717|FG000|Treatment Phase|Physician Decision|2|||
46719595|NCT01159574|82935717|FG000|Treatment Phase|Withdrawal by Subject|7|||
46719596|NCT01159574|82935717|FG000|Treatment Phase|still on treatment|2|||
46719597|NCT01159574|82935717|FG000|Follow Up Phase|Lost to Follow-up|2|||
46719598|NCT01159574|82935717|FG000|Follow Up Phase|still being followed for overall surviva|18|||
46719599|NCT01158950|82935721|FG000|1st Intervention (1 Day)|Physician Decision|1|||
46916777|NCT03131167|83147999|FG008|Overall Study|Other (Unspecified)|0|||
46916778|NCT03131167|83148000|FG009|Overall Study|Other (Unspecified)|0|||
46916779|NCT03131167|83148001|FG010|Overall Study|Other (Unspecified)|0|||
46916780|NCT03131167|83148002|FG011|Overall Study|Other (Unspecified)|0|||
46916781|NCT03131167|83148003|FG012|Overall Study|Other (Unspecified)|0|||
46916782|NCT03060447|83148034|FG000|Overall Study|Withdrawal by Subject|2|||
46916783|NCT03060447|83148035|FG001|Overall Study|Withdrawal by Subject|0|||
46916784|NCT01712789|83148047|FG000|Overall Study|Lack of Efficacy|2|||
46916785|NCT01712789|83148047|FG000|Overall Study|Lost to Follow-up|1|||
46916786|NCT01712789|83148047|FG000|Overall Study|Progressive Disease|504|||
46916787|NCT01712789|83148047|FG000|Overall Study|Death|57|||
46916788|NCT01712789|83148047|FG000|Overall Study|Adverse Event|52|||
46916789|NCT01712789|83148047|FG000|Overall Study|Miscellaneous|31|||
46916790|NCT01712789|83148047|FG000|Overall Study|Withdrawal by Subject|21|||
46916791|NCT01712789|83148047|FG000|Overall Study|Transition to Commercial Treatment|8|||
46916792|NCT01712789|83148047|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
46916793|NCT03074318|83148055|FG000|Overall Study|Adverse Event|0|||
46916794|NCT03074318|83148056|FG001|Overall Study|Adverse Event|1|||
46916795|NCT03074318|83148057|FG002|Overall Study|Adverse Event|1|||
46916796|NCT03074318|83148058|FG003|Overall Study|Adverse Event|1|||
46916797|NCT03074318|83148055|FG000|Overall Study|Death|1|||
46916798|NCT03074318|83148056|FG001|Overall Study|Death|0|||
46916799|NCT03074318|83148057|FG002|Overall Study|Death|0|||
46916800|NCT03074318|83148058|FG003|Overall Study|Death|0|||
46916801|NCT03074318|83148055|FG000|Overall Study|Withdrawal by Subject|1|||
46916802|NCT03074318|83148056|FG001|Overall Study|Withdrawal by Subject|2|||
46916803|NCT03074318|83148057|FG002|Overall Study|Withdrawal by Subject|2|||
46916804|NCT03074318|83148058|FG003|Overall Study|Withdrawal by Subject|4|||
46916805|NCT03074318|83148055|FG000|Overall Study|Trial Closure|2|||
46916806|NCT03074318|83148056|FG001|Overall Study|Trial Closure|2|||
46916807|NCT03074318|83148057|FG002|Overall Study|Trial Closure|3|||
46916808|NCT03074318|83148058|FG003|Overall Study|Trial Closure|11|||
46916809|NCT03135119|83148079|FG000|Overall Study|Lost to Follow-up|2|||
46916810|NCT03135119|83148080|FG001|Overall Study|Lost to Follow-up|0|||
46916811|NCT03135119|83148079|FG000|Overall Study|Physician Decision|1|||
46916812|NCT03135119|83148080|FG001|Overall Study|Physician Decision|1|||
46916813|NCT03135119|83148079|FG000|Overall Study|COVID-19 Shutdown|2|||
46916814|NCT03135119|83148080|FG001|Overall Study|COVID-19 Shutdown|2|||
46916815|NCT01369784|83148086|FG000|Overall Study|Protocol Violation|12|||
46916816|NCT03353675|83148090|FG000|Overall Study|Adverse Event|4|||
46916817|NCT03137069|83148100|FG000|Overall Study|Withdrawal by Subject|1|||
46916818|NCT03137069|83148101|FG001|Overall Study|Withdrawal by Subject|2|||
46916819|NCT03137069|83148102|FG002|Overall Study|Withdrawal by Subject|2|||
46916820|NCT03137069|83148103|FG003|Overall Study|Withdrawal by Subject|2|||
46916821|NCT03137069|83148104|FG004|Overall Study|Withdrawal by Subject|0|||
46916822|NCT03137069|83148105|FG005|Overall Study|Withdrawal by Subject|0|||
46916823|NCT03137069|83148100|FG000|Overall Study|Adverse Event|0|||
46916824|NCT03137069|83148101|FG001|Overall Study|Adverse Event|3|||
46916825|NCT03137069|83148102|FG002|Overall Study|Adverse Event|1|||
46916826|NCT03137069|83148103|FG003|Overall Study|Adverse Event|1|||
46916827|NCT03137069|83148104|FG004|Overall Study|Adverse Event|0|||
46916828|NCT03137069|83148105|FG005|Overall Study|Adverse Event|1|||
46916829|NCT03137069|83148100|FG000|Overall Study|Protocol Violation|0|||
46632594|NCT01792284|82805743|FG002|Lead-in Period|Withdrawal by Subject|0|||
46632595|NCT01792284|82805741|FG000|Lead-in Period|Physician Decision|1|||
46632596|NCT01792284|82805742|FG001|Lead-in Period|Physician Decision|0|||
46632597|NCT01792284|82805743|FG002|Lead-in Period|Physician Decision|0|||
46632598|NCT01792284|82805741|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
46632599|NCT01792284|82805742|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
46719600|NCT01158950|82935722|FG001|1st Intervention (1 Day)|Physician Decision|2|||
46632600|NCT01792284|82805743|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
46632601|NCT01792284|82805741|FG000|Randomization Period 1|Withdrawal by Subject|0|||
46632602|NCT01792284|82805742|FG001|Randomization Period 1|Withdrawal by Subject|1|||
46916830|NCT03137069|83148101|FG001|Overall Study|Protocol Violation|1|||
46916831|NCT03137069|83148102|FG002|Overall Study|Protocol Violation|0|||
46916832|NCT03137069|83148103|FG003|Overall Study|Protocol Violation|1|||
46916833|NCT03137069|83148104|FG004|Overall Study|Protocol Violation|1|||
46916834|NCT03137069|83148105|FG005|Overall Study|Protocol Violation|1|||
46916835|NCT03137069|83148100|FG000|Overall Study|Physician Decision|0|||
46916836|NCT03137069|83148101|FG001|Overall Study|Physician Decision|0|||
46916837|NCT03137069|83148102|FG002|Overall Study|Physician Decision|0|||
46916838|NCT03137069|83148103|FG003|Overall Study|Physician Decision|1|||
46916839|NCT03137069|83148104|FG004|Overall Study|Physician Decision|0|||
46916840|NCT03137069|83148105|FG005|Overall Study|Physician Decision|0|||
46916841|NCT03137069|83148100|FG000|Overall Study|Study Terminated by Sponsor|0|||
46916842|NCT03137069|83148101|FG001|Overall Study|Study Terminated by Sponsor|0|||
46916843|NCT03137069|83148102|FG002|Overall Study|Study Terminated by Sponsor|0|||
46916844|NCT03137069|83148103|FG003|Overall Study|Study Terminated by Sponsor|0|||
46916845|NCT03137069|83148104|FG004|Overall Study|Study Terminated by Sponsor|1|||
46916846|NCT03137069|83148105|FG005|Overall Study|Study Terminated by Sponsor|0|||
46916847|NCT03137069|83148100|FG000|Overall Study|Data Entry Error|0|||
46916848|NCT03137069|83148101|FG001|Overall Study|Data Entry Error|0|||
46916849|NCT03137069|83148102|FG002|Overall Study|Data Entry Error|0|||
46916850|NCT03137069|83148103|FG003|Overall Study|Data Entry Error|1|||
46916851|NCT03137069|83148104|FG004|Overall Study|Data Entry Error|0|||
46916852|NCT03137069|83148105|FG005|Overall Study|Data Entry Error|0|||
46916853|NCT02792504|83148123|FG000|Overall Study|Lost to Follow-up|24|||
46916854|NCT02792504|83148123|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
46916855|NCT03124459|83148133|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
46916856|NCT03124459|83148134|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
46916857|NCT03124459|83148135|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
46916858|NCT03124459|83148136|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
46916859|NCT03124459|83148137|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
46916860|NCT03124459|83148138|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
46916861|NCT03124459|83148133|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
46916862|NCT03124459|83148134|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
46916863|NCT03124459|83148135|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
46916864|NCT03124459|83148136|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
46916865|NCT03124459|83148137|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
46916866|NCT03124459|83148138|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
47041315|NCT01442181|83297604|FG001|Overall Study|atrial fibrillation not noted|1|||
46632603|NCT01792284|82805743|FG002|Randomization Period 1|Withdrawal by Subject|1|||
46719601|NCT01172288|82935729|FG000|Overall Study|Adverse Event|1|||
46719602|NCT01172288|82935730|FG001|Overall Study|Adverse Event|0|||
46719603|NCT01172288|82935729|FG000|Overall Study|Protocol Violation|0|||
46719604|NCT01172288|82935730|FG001|Overall Study|Protocol Violation|1|||
46719605|NCT00996840|82935741|FG000|Overall Study|Adverse Event|0|||
46719606|NCT00996840|82935742|FG001|Overall Study|Adverse Event|1|||
46719607|NCT00996840|82935743|FG002|Overall Study|Adverse Event|0|||
46719608|NCT00996840|82935744|FG003|Overall Study|Adverse Event|0|||
46719609|NCT00996840|82935745|FG004|Overall Study|Adverse Event|0|||
46719610|NCT00996840|82935741|FG000|Overall Study|Physician Decision|0|||
46719611|NCT00996840|82935742|FG001|Overall Study|Physician Decision|0|||
46719612|NCT00996840|82935743|FG002|Overall Study|Physician Decision|1|||
46719613|NCT00996840|82935744|FG003|Overall Study|Physician Decision|1|||
46719614|NCT00996840|82935745|FG004|Overall Study|Physician Decision|2|||
46719615|NCT00996840|82935741|FG000|Overall Study|Withdrawal by Subject|1|||
46719616|NCT00996840|82935742|FG001|Overall Study|Withdrawal by Subject|1|||
46719617|NCT00996840|82935743|FG002|Overall Study|Withdrawal by Subject|0|||
46719618|NCT00996840|82935744|FG003|Overall Study|Withdrawal by Subject|0|||
46719619|NCT00996840|82935745|FG004|Overall Study|Withdrawal by Subject|0|||
46719620|NCT00998946|82935761|FG000|Overall Study|Lost to Follow-up|1|||
46719621|NCT00998946|82935761|FG000|Overall Study|Withdrawal by Subject|1|||
46719622|NCT00998946|82935761|FG000|Overall Study|Death|2|||
46719623|NCT00998946|82935761|FG000|Overall Study|Reason Unspecified|3|||
46719624|NCT00998946|82935761|FG000|Overall Study|Enrolled but not Dosed|2|||
46719625|NCT01158404|82935773|FG000|Overall Study|Withdrawal by Subject|0|||
46719626|NCT01158404|82935774|FG001|Overall Study|Withdrawal by Subject|1|||
46719627|NCT01158404|82935775|FG002|Overall Study|Withdrawal by Subject|0|||
46719628|NCT01158404|82935776|FG003|Overall Study|Withdrawal by Subject|0|||
46719629|NCT01158404|82935777|FG004|Overall Study|Withdrawal by Subject|3|||
46719630|NCT01158404|82935778|FG005|Overall Study|Withdrawal by Subject|1|||
46719631|NCT01158404|82935779|FG006|Overall Study|Withdrawal by Subject|0|||
46719632|NCT01158404|82935780|FG007|Overall Study|Withdrawal by Subject|1|||
46719633|NCT01158404|82935773|FG000|Overall Study|Physician Decision|0|||
46632604|NCT01792284|82805741|FG000|Randomization Period 1|Physician Decision|0|||
46632605|NCT01792284|82805742|FG001|Randomization Period 1|Physician Decision|1|||
46632606|NCT01792284|82805743|FG002|Randomization Period 1|Physician Decision|1|||
46632607|NCT01792284|82805741|FG000|Randomization Period 1|Adverse Event|0|||
46632608|NCT01792284|82805742|FG001|Randomization Period 1|Adverse Event|0|||
46632609|NCT01792284|82805743|FG002|Randomization Period 1|Adverse Event|2|||
46719634|NCT01158404|82935774|FG001|Overall Study|Physician Decision|0|||
46719635|NCT01158404|82935775|FG002|Overall Study|Physician Decision|0|||
46719636|NCT01158404|82935776|FG003|Overall Study|Physician Decision|0|||
46719637|NCT01158404|82935777|FG004|Overall Study|Physician Decision|0|||
46719638|NCT01158404|82935778|FG005|Overall Study|Physician Decision|0|||
46719639|NCT01158404|82935779|FG006|Overall Study|Physician Decision|0|||
46719640|NCT01158404|82935780|FG007|Overall Study|Physician Decision|1|||
46719641|NCT01158404|82935773|FG000|Overall Study|Progressive Disease|0|||
46719642|NCT01158404|82935774|FG001|Overall Study|Progressive Disease|0|||
46719643|NCT01158404|82935775|FG002|Overall Study|Progressive Disease|0|||
46719644|NCT01158404|82935776|FG003|Overall Study|Progressive Disease|0|||
46916867|NCT03124459|83148133|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
46719645|NCT01158404|82935777|FG004|Overall Study|Progressive Disease|0|||
46719646|NCT01158404|82935778|FG005|Overall Study|Progressive Disease|0|||
46719647|NCT01158404|82935779|FG006|Overall Study|Progressive Disease|1|||
46719648|NCT01158404|82935780|FG007|Overall Study|Progressive Disease|0|||
46719649|NCT00998790|82935800|FG000|Overall Study|Withdrawal by Subject|21|||
46719650|NCT01001988|82935804|FG000|Overall Study|Protocol Violation|84|||
46719651|NCT01001988|82935804|FG000|Overall Study|Withdrawal by Subject|18|||
46719652|NCT01001988|82935804|FG000|Overall Study|Lost to Follow-up|15|||
46719653|NCT00996606|82935808|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
46719654|NCT00996606|82935808|FG000|Overall Study|Insufficient Therapeutic Response|2|||
46719655|NCT00996606|82935808|FG000|Overall Study|Protocol Violation|1|||
46719656|NCT00996606|82935808|FG000|Overall Study|Withdrawal by Subject|3|||
46719657|NCT00995436|82935815|FG000|Overall Study|Withdrawal by Subject|2|||
46719658|NCT00995436|82935816|FG001|Overall Study|Withdrawal by Subject|5|||
46719659|NCT00995436|82935817|FG002|Overall Study|Withdrawal by Subject|0|||
46719660|NCT00994890|82935828|FG000|Overall Study|Adverse Event|13|||
46719661|NCT00994890|82935829|FG001|Overall Study|Adverse Event|9|||
46719662|NCT00994890|82935830|FG002|Overall Study|Adverse Event|11|||
46719663|NCT00994890|82935828|FG000|Overall Study|Lack of Efficacy|0|||
46719664|NCT00994890|82935829|FG001|Overall Study|Lack of Efficacy|0|||
46719665|NCT00994890|82935830|FG002|Overall Study|Lack of Efficacy|1|||
46719666|NCT00994890|82935828|FG000|Overall Study|Lost to Follow-up|6|||
46719667|NCT00994890|82935829|FG001|Overall Study|Lost to Follow-up|1|||
46719668|NCT00994890|82935830|FG002|Overall Study|Lost to Follow-up|3|||
46719669|NCT00994890|82935828|FG000|Overall Study|No longer willing to participate|8|||
46719670|NCT00994890|82935829|FG001|Overall Study|No longer willing to participate|5|||
46719671|NCT00994890|82935830|FG002|Overall Study|No longer willing to participate|13|||
46719672|NCT00994890|82935828|FG000|Overall Study|Protocol Violation|2|||
46719673|NCT00994890|82935829|FG001|Overall Study|Protocol Violation|4|||
46719674|NCT00994890|82935830|FG002|Overall Study|Protocol Violation|0|||
46719675|NCT00994890|82935828|FG000|Overall Study|Study terminated by sponsor|199|||
46719676|NCT00994890|82935829|FG001|Overall Study|Study terminated by sponsor|201|||
46719677|NCT00994890|82935830|FG002|Overall Study|Study terminated by sponsor|197|||
46719678|NCT00994890|82935828|FG000|Overall Study|Randomized, but not treated|1|||
46719679|NCT00994890|82935829|FG001|Overall Study|Randomized, but not treated|0|||
46719680|NCT00994890|82935830|FG002|Overall Study|Randomized, but not treated|0|||
46719681|NCT00994890|82935828|FG000|Overall Study|Other|2|||
46719682|NCT00994890|82935829|FG001|Overall Study|Other|2|||
46719683|NCT00994890|82935830|FG002|Overall Study|Other|1|||
46719684|NCT00994422|82935840|FG000|Overall Study|Lost to Follow-up|7|||
46719685|NCT00994422|82935841|FG001|Overall Study|Lost to Follow-up|1|||
46719686|NCT01171976|82935852|FG000|Overall Study|Protocol Violation|0|||
46719687|NCT01171976|82935853|FG001|Overall Study|Protocol Violation|0|||
47041316|NCT01442103|83297611|FG000|Overall Study|Lost to Follow-up|2|||
47041317|NCT01428219|83297615|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
47041318|NCT01428063|83297622|FG000|Overall Study|Lack of Efficacy|8|||
47041319|NCT01428063|83297623|FG001|Overall Study|Lack of Efficacy|4|||
46719688|NCT01171976|82935854|FG002|Overall Study|Protocol Violation|1|||
46719689|NCT01171976|82935852|FG000|Overall Study|Death|2|||
46719690|NCT01171976|82935853|FG001|Overall Study|Death|4|||
46719691|NCT01171976|82935854|FG002|Overall Study|Death|1|||
46719692|NCT01171976|82935852|FG000|Overall Study|Lost to Follow-up|4|||
46719693|NCT01171976|82935853|FG001|Overall Study|Lost to Follow-up|0|||
46719694|NCT01171976|82935854|FG002|Overall Study|Lost to Follow-up|2|||
46719695|NCT01171976|82935852|FG000|Overall Study|Withdrawal by Subject|1|||
46719696|NCT01171976|82935853|FG001|Overall Study|Withdrawal by Subject|5|||
46719697|NCT01171976|82935854|FG002|Overall Study|Withdrawal by Subject|6|||
46719698|NCT01171976|82935852|FG000|Overall Study|Abnormal test result|1|||
46719699|NCT01171976|82935853|FG001|Overall Study|Abnormal test result|0|||
46719700|NCT01171976|82935854|FG002|Overall Study|Abnormal test result|0|||
47041320|NCT01428063|83297624|FG002|Overall Study|Lack of Efficacy|1|||
46719701|NCT01171976|82935852|FG000|Overall Study|Adverse Event|6|||
47041321|NCT01428063|83297622|FG000|Overall Study|Adverse Event|2|||
46719702|NCT01171976|82935853|FG001|Overall Study|Adverse Event|2|||
46719703|NCT01171976|82935854|FG002|Overall Study|Adverse Event|5|||
46719704|NCT00996216|82935862|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
46719705|NCT00996216|82935862|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
46719706|NCT00996216|82935862|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
46719707|NCT00830869|82935879|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
46719708|NCT00830869|82935880|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
46719709|NCT00830869|82935881|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
46719710|NCT00830869|82935882|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
46719711|NCT00830869|82935883|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
46719712|NCT00830869|82935884|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
46719713|NCT00830869|82935885|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
47041322|NCT01428063|83297623|FG001|Overall Study|Adverse Event|3|||
46719714|NCT00830869|82935886|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
46719715|NCT00830869|82935887|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
47041323|NCT01428063|83297624|FG002|Overall Study|Adverse Event|0|||
46916868|NCT03124459|83148134|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
46916869|NCT03124459|83148135|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
46916870|NCT03124459|83148136|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
46916871|NCT03124459|83148137|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
46916872|NCT03124459|83148138|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
46916873|NCT03124459|83148133|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
46916874|NCT03124459|83148134|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
46916875|NCT03124459|83148135|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
46916876|NCT03124459|83148136|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
46916877|NCT03124459|83148137|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
46916878|NCT03124459|83148138|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
46916879|NCT03124459|83148133|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
46916880|NCT03124459|83148134|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
46916881|NCT03124459|83148135|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
46916882|NCT03124459|83148136|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
47041324|NCT01428063|83297622|FG000|Overall Study|Lost to Follow-up|0|||
47041325|NCT01428063|83297623|FG001|Overall Study|Lost to Follow-up|2|||
47041326|NCT01428063|83297624|FG002|Overall Study|Lost to Follow-up|0|||
46632610|NCT01792284|82805741|FG000|Randomization Period 1|Lost to Follow-up|0|||
46632611|NCT01792284|82805742|FG001|Randomization Period 1|Lost to Follow-up|0|||
46632612|NCT01792284|82805743|FG002|Randomization Period 1|Lost to Follow-up|1|||
46632613|NCT01792284|82805741|FG000|Randomization Period 2|Protocol Violation|0|||
46632614|NCT01792284|82805742|FG001|Randomization Period 2|Protocol Violation|1|||
46632615|NCT01792284|82805743|FG002|Randomization Period 2|Protocol Violation|0|||
46632616|NCT01792284|82805741|FG000|Randomization Period 2|Withdrawal by Subject|0|||
46632617|NCT01792284|82805742|FG001|Randomization Period 2|Withdrawal by Subject|2|||
46632618|NCT01792284|82805743|FG002|Randomization Period 2|Withdrawal by Subject|0|||
46632619|NCT01791894|82805751|FG000|Overall Study|Adverse Event|1|||
46632620|NCT01837680|82805758|FG000|Overall Study|Lost to Follow-up|2|||
46632621|NCT01837680|82805759|FG001|Overall Study|Lost to Follow-up|2|||
46632622|NCT01837680|82805758|FG000|Overall Study|lack of insurance|0|||
46719716|NCT00830869|82935888|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
46719717|NCT00830869|82935889|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
46719718|NCT00830869|82935890|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
46719719|NCT00830869|82935879|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
46719720|NCT00830869|82935880|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
46719721|NCT00830869|82935881|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
46719722|NCT00830869|82935882|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
46719723|NCT00830869|82935883|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
46719724|NCT00830869|82935884|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
46719725|NCT00830869|82935885|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
46719726|NCT00830869|82935886|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
46719727|NCT00830869|82935887|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
46719728|NCT00830869|82935888|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
46719729|NCT00830869|82935889|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
46719730|NCT00830869|82935890|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
46719731|NCT00830869|82935879|FG000|Period 1: Part 1|Adverse Event|0|||
46916883|NCT03124459|83148137|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
46916884|NCT03124459|83148138|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
46916885|NCT03124459|83148133|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
46916886|NCT03124459|83148134|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
46916887|NCT03124459|83148135|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
47041327|NCT01428063|83297622|FG000|Overall Study|No longer meets study criteria|0|||
47041328|NCT01428063|83297623|FG001|Overall Study|No longer meets study criteria|1|||
47041329|NCT01428063|83297624|FG002|Overall Study|No longer meets study criteria|0|||
47041330|NCT01441635|83297782|FG000|Overall Study|Adverse Event|4|||
47041331|NCT01441635|83297783|FG001|Overall Study|Adverse Event|3|||
47041332|NCT01441635|83297784|FG002|Overall Study|Adverse Event|1|||
46916888|NCT03124459|83148136|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
47041333|NCT01441635|83297785|FG003|Overall Study|Adverse Event|5|||
46632623|NCT01837680|82805759|FG001|Overall Study|lack of insurance|2|||
46719732|NCT00830869|82935880|FG001|Period 1: Part 1|Adverse Event|0|||
46719733|NCT00830869|82935881|FG002|Period 1: Part 1|Adverse Event|0|||
46916889|NCT03124459|83148137|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
47041334|NCT01441635|83297786|FG004|Overall Study|Adverse Event|1|||
47041335|NCT01441635|83297787|FG005|Overall Study|Adverse Event|2|||
47041336|NCT01441635|83297788|FG006|Overall Study|Adverse Event|2|||
46719734|NCT00830869|82935882|FG003|Period 1: Part 1|Adverse Event|0|||
46719735|NCT00830869|82935883|FG004|Period 1: Part 1|Adverse Event|0|||
46719736|NCT00830869|82935884|FG005|Period 1: Part 1|Adverse Event|1|||
46719737|NCT00830869|82935885|FG006|Period 1: Part 1|Adverse Event|1|||
46719738|NCT00830869|82935886|FG007|Period 1: Part 1|Adverse Event|0|||
47041337|NCT01441635|83297789|FG007|Overall Study|Adverse Event|2|||
47041338|NCT01441635|83297790|FG008|Overall Study|Adverse Event|1|||
47041339|NCT01441635|83297791|FG009|Overall Study|Adverse Event|0|||
47041340|NCT01441635|83297782|FG000|Overall Study|Withdrawal by Subject|1|||
46916890|NCT03124459|83148138|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
46916891|NCT03134183|83148153|FG000|Overall Study|Withdrawal by Subject|1|||
46916892|NCT03134183|83148154|FG001|Overall Study|Withdrawal by Subject|1|||
46916893|NCT03136367|83148163|FG000|T1 Consultation|discontinued mistakenly included|2|||
46916894|NCT03136367|83148164|FG001|T1 Consultation|discontinued mistakenly included|6|||
46916895|NCT03136367|83148165|FG002|T1 Consultation|discontinued mistakenly included|1|||
46916896|NCT03136367|83148163|FG000|T1 Consultation|Discontinued other|0|||
46916897|NCT03136367|83148164|FG001|T1 Consultation|Discontinued other|1|||
46916898|NCT03136367|83148165|FG002|T1 Consultation|Discontinued other|0|||
46916899|NCT03136367|83148163|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
46916900|NCT03136367|83148164|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
46916901|NCT03136367|83148165|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
46916902|NCT03136367|83148163|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
46916903|NCT03136367|83148164|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
46916904|NCT03136367|83148165|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
46916905|NCT03136367|83148163|FG000|T2 Post-consultation|Discontinued other|0|||
46916906|NCT03136367|83148164|FG001|T2 Post-consultation|Discontinued other|2|||
46916907|NCT03136367|83148165|FG002|T2 Post-consultation|Discontinued other|6|||
46916908|NCT03136367|83148163|FG000|T2 Post-consultation|Discontinued transferred care|0|||
46916909|NCT03136367|83148164|FG001|T2 Post-consultation|Discontinued transferred care|0|||
46916910|NCT03136367|83148165|FG002|T2 Post-consultation|Discontinued transferred care|3|||
46916911|NCT03136367|83148163|FG000|T2 Post-consultation|Discontinued lost contact|0|||
46916912|NCT03136367|83148164|FG001|T2 Post-consultation|Discontinued lost contact|1|||
46916913|NCT03136367|83148165|FG002|T2 Post-consultation|Discontinued lost contact|0|||
46916914|NCT03136367|83148163|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
46916915|NCT03136367|83148164|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
46916916|NCT03136367|83148165|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
46916917|NCT03136367|83148163|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
46916918|NCT03136367|83148164|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
46916919|NCT03136367|83148165|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
46916920|NCT03136367|83148163|FG000|T3 1 Week After Surgery|other discontinued|2|||
46916921|NCT03136367|83148164|FG001|T3 1 Week After Surgery|other discontinued|4|||
46916922|NCT03136367|83148165|FG002|T3 1 Week After Surgery|other discontinued|3|||
46916923|NCT03136367|83148163|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
46916924|NCT03136367|83148164|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
46916925|NCT03136367|83148165|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
46916926|NCT03136367|83148163|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
46916927|NCT03136367|83148164|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
46916928|NCT03136367|83148165|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
46916929|NCT03136367|83148163|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
46916930|NCT03136367|83148164|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
46916931|NCT03136367|83148165|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
46916932|NCT03136367|83148163|FG000|T4 12 Weeks After Surgery|Death|0|||
46916933|NCT03136367|83148164|FG001|T4 12 Weeks After Surgery|Death|1|||
46916934|NCT03136367|83148165|FG002|T4 12 Weeks After Surgery|Death|3|||
46916935|NCT03136367|83148163|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
46916936|NCT03136367|83148164|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
46916937|NCT03136367|83148165|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
46916938|NCT03136367|83148163|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
46916939|NCT03136367|83148164|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
47041341|NCT01441635|83297783|FG001|Overall Study|Withdrawal by Subject|1|||
47041342|NCT01441635|83297784|FG002|Overall Study|Withdrawal by Subject|0|||
47041343|NCT01441635|83297785|FG003|Overall Study|Withdrawal by Subject|1|||
47041344|NCT01441635|83297786|FG004|Overall Study|Withdrawal by Subject|0|||
47041345|NCT01441635|83297787|FG005|Overall Study|Withdrawal by Subject|0|||
47041346|NCT01441635|83297788|FG006|Overall Study|Withdrawal by Subject|2|||
47041347|NCT01441635|83297789|FG007|Overall Study|Withdrawal by Subject|0|||
47041348|NCT01441635|83297790|FG008|Overall Study|Withdrawal by Subject|1|||
47041349|NCT01441635|83297791|FG009|Overall Study|Withdrawal by Subject|1|||
47041350|NCT01441635|83297782|FG000|Overall Study|Lost to Follow-up|0|||
47041351|NCT01441635|83297783|FG001|Overall Study|Lost to Follow-up|1|||
46916940|NCT03136367|83148165|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
46916941|NCT03136367|83148163|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
46916942|NCT03136367|83148164|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
46916943|NCT03136367|83148165|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
46916944|NCT03136367|83148163|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
47041352|NCT01441635|83297784|FG002|Overall Study|Lost to Follow-up|1|||
47041353|NCT01441635|83297785|FG003|Overall Study|Lost to Follow-up|1|||
46916945|NCT03136367|83148164|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
46916946|NCT03136367|83148165|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
46916947|NCT03136367|83148163|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
46916948|NCT03136367|83148164|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
46916949|NCT03136367|83148165|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
46916950|NCT03136367|83148163|FG000|T5 1 Year After Surgery|Death|0|||
46916951|NCT03136367|83148164|FG001|T5 1 Year After Surgery|Death|0|||
46916952|NCT03136367|83148165|FG002|T5 1 Year After Surgery|Death|1|||
46916953|NCT03136367|83148163|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
46916954|NCT03136367|83148164|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
46916955|NCT03136367|83148165|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
46916956|NCT03136367|83148163|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
46916957|NCT03136367|83148164|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
46916958|NCT03136367|83148165|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
46916959|NCT03136367|83148163|FG000|T5 1 Year After Surgery|study ended before due|31|||
46916960|NCT03136367|83148164|FG001|T5 1 Year After Surgery|study ended before due|103|||
46916961|NCT03136367|83148165|FG002|T5 1 Year After Surgery|study ended before due|110|||
46916962|NCT03136367|83148163|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
46916963|NCT03136367|83148164|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
46916964|NCT03136367|83148165|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
46916965|NCT03124381|83148178|FG000|Overall Study|Lost to Follow-up|1|||
46916966|NCT03124381|83148179|FG001|Overall Study|Lost to Follow-up|1|||
46916967|NCT03124381|83148178|FG000|Overall Study|Withdrawal by Subject|6|||
46916968|NCT03124381|83148179|FG001|Overall Study|Withdrawal by Subject|3|||
46916969|NCT03124381|83148178|FG000|Overall Study|Protocol Violation|0|||
46916970|NCT03124381|83148179|FG001|Overall Study|Protocol Violation|1|||
46916971|NCT03124381|83148178|FG000|Overall Study|Adverse Event|1|||
46916972|NCT03124381|83148179|FG001|Overall Study|Adverse Event|1|||
46916973|NCT03124381|83148178|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
46916974|NCT03124381|83148179|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
46916975|NCT03133793|83148189|FG000|Overall Study|Withdrawal by Subject|0|||
46916976|NCT03133793|83148190|FG001|Overall Study|Withdrawal by Subject|4|||
46916977|NCT03133793|83148191|FG002|Overall Study|Withdrawal by Subject|2|||
46916978|NCT03133793|83148192|FG003|Overall Study|Withdrawal by Subject|4|||
46916979|NCT03133793|83148189|FG000|Overall Study|Lost to Follow-up|1|||
46916980|NCT03133793|83148190|FG001|Overall Study|Lost to Follow-up|0|||
46916981|NCT03133793|83148191|FG002|Overall Study|Lost to Follow-up|2|||
46916982|NCT03133793|83148192|FG003|Overall Study|Lost to Follow-up|0|||
46916983|NCT03133793|83148189|FG000|Overall Study|Death|0|||
46916984|NCT03133793|83148190|FG001|Overall Study|Death|0|||
46916985|NCT03133793|83148191|FG002|Overall Study|Death|0|||
46916986|NCT03133793|83148192|FG003|Overall Study|Death|1|||
46916987|NCT02747238|83148208|FG000|Overall Study|Lack of Efficacy|0|||
46916988|NCT02747238|83148209|FG001|Overall Study|Lack of Efficacy|1|||
46916989|NCT02747238|83148208|FG000|Overall Study|Data lost|3|||
46916990|NCT02747238|83148209|FG001|Overall Study|Data lost|5|||
46916991|NCT03133481|83148217|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
46916992|NCT03133481|83148218|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
46916993|NCT02864316|83148226|FG000|Overall Study|Progressive Disease|2|||
46916994|NCT02864316|83148227|FG001|Overall Study|Progressive Disease|1|||
46916995|NCT02864316|83148226|FG000|Overall Study|Adverse Event|0|||
46916996|NCT02864316|83148227|FG001|Overall Study|Adverse Event|1|||
46916997|NCT02862600|83148233|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
46916998|NCT02862600|83148233|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
46916999|NCT02862600|83148233|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
46917000|NCT02862600|83148233|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
46917001|NCT02864082|83148241|FG000|Overall Study|Adverse Event|1|||
46917002|NCT02864082|83148242|FG001|Overall Study|Adverse Event|1|||
46917003|NCT02864082|83148241|FG000|Overall Study|Lost to Follow-up|0|||
46917004|NCT02864082|83148242|FG001|Overall Study|Lost to Follow-up|1|||
46917005|NCT02864082|83148241|FG000|Overall Study|Withdrawal by Subject|2|||
46917006|NCT02864082|83148242|FG001|Overall Study|Withdrawal by Subject|2|||
46917007|NCT02792192|83148266|FG000|Overall Study|Death|1|||
46917008|NCT02792192|83148267|FG001|Overall Study|Death|0|||
46917009|NCT02792192|83148268|FG002|Overall Study|Death|0|||
46917010|NCT02792192|83148269|FG003|Overall Study|Death|0|||
46917011|NCT02792192|83148266|FG000|Overall Study|Informed Consent Withdrawn|4|||
46917012|NCT02792192|83148267|FG001|Overall Study|Informed Consent Withdrawn|0|||
46917013|NCT02792192|83148268|FG002|Overall Study|Informed Consent Withdrawn|0|||
46917014|NCT02792192|83148269|FG003|Overall Study|Informed Consent Withdrawn|0|||
46917015|NCT02792192|83148266|FG000|Overall Study|Physician Decision|1|||
46917016|NCT02792192|83148267|FG001|Overall Study|Physician Decision|0|||
46917017|NCT02792192|83148268|FG002|Overall Study|Physician Decision|0|||
46917018|NCT02792192|83148269|FG003|Overall Study|Physician Decision|0|||
46917019|NCT02792192|83148266|FG000|Overall Study|Progressive Disease|0|||
46917020|NCT02792192|83148267|FG001|Overall Study|Progressive Disease|1|||
46917021|NCT02792192|83148268|FG002|Overall Study|Progressive Disease|0|||
46917022|NCT02792192|83148269|FG003|Overall Study|Progressive Disease|0|||
46917023|NCT02792192|83148266|FG000|Overall Study|Study Terminated By Sponsor|6|||
47041354|NCT01441635|83297786|FG004|Overall Study|Lost to Follow-up|1|||
46917024|NCT02792192|83148267|FG001|Overall Study|Study Terminated By Sponsor|10|||
46917025|NCT02792192|83148268|FG002|Overall Study|Study Terminated By Sponsor|0|||
46917026|NCT02792192|83148269|FG003|Overall Study|Study Terminated By Sponsor|0|||
46917027|NCT02964507|83148288|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
46917028|NCT02964507|83148289|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
46917029|NCT02964507|83148290|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
46917030|NCT02964507|83148291|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
46917031|NCT02964507|83148292|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
46917032|NCT02964507|83148293|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
46917033|NCT02964507|83148294|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
46917034|NCT02964507|83148295|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
46917035|NCT02964507|83148288|FG000|Overall Study|Study terminated by Sponsor|9|||
46917036|NCT02964507|83148289|FG001|Overall Study|Study terminated by Sponsor|1|||
46917037|NCT02964507|83148290|FG002|Overall Study|Study terminated by Sponsor|9|||
46917038|NCT02964507|83148291|FG003|Overall Study|Study terminated by Sponsor|3|||
46917039|NCT02964507|83148292|FG004|Overall Study|Study terminated by Sponsor|3|||
46917040|NCT02964507|83148293|FG005|Overall Study|Study terminated by Sponsor|2|||
46917041|NCT02964507|83148294|FG006|Overall Study|Study terminated by Sponsor|0|||
46917042|NCT02964507|83148295|FG007|Overall Study|Study terminated by Sponsor|0|||
46917043|NCT02964507|83148288|FG000|Overall Study|Other|3|||
46917044|NCT02964507|83148289|FG001|Overall Study|Other|0|||
46917045|NCT02964507|83148290|FG002|Overall Study|Other|0|||
46917046|NCT02964507|83148291|FG003|Overall Study|Other|0|||
46917047|NCT02964507|83148292|FG004|Overall Study|Other|1|||
46917048|NCT02964507|83148293|FG005|Overall Study|Other|0|||
46917049|NCT02964507|83148294|FG006|Overall Study|Other|0|||
46917050|NCT02964507|83148295|FG007|Overall Study|Other|0|||
46917051|NCT02964507|83148288|FG000|Overall Study|Death|11|||
46917052|NCT02964507|83148289|FG001|Overall Study|Death|9|||
46917053|NCT02964507|83148290|FG002|Overall Study|Death|12|||
46917054|NCT02964507|83148291|FG003|Overall Study|Death|2|||
46917055|NCT02964507|83148292|FG004|Overall Study|Death|10|||
46917056|NCT02964507|83148293|FG005|Overall Study|Death|5|||
46917057|NCT02964507|83148294|FG006|Overall Study|Death|0|||
46917058|NCT02964507|83148295|FG007|Overall Study|Death|0|||
46917059|NCT02964507|83148288|FG000|Overall Study|Withdrawal by Subject|1|||
46917060|NCT02964507|83148289|FG001|Overall Study|Withdrawal by Subject|0|||
46917061|NCT02964507|83148290|FG002|Overall Study|Withdrawal by Subject|1|||
46917062|NCT02964507|83148291|FG003|Overall Study|Withdrawal by Subject|1|||
46917063|NCT02964507|83148292|FG004|Overall Study|Withdrawal by Subject|0|||
46917064|NCT02964507|83148293|FG005|Overall Study|Withdrawal by Subject|1|||
46917065|NCT02964507|83148294|FG006|Overall Study|Withdrawal by Subject|0|||
47041355|NCT01441635|83297787|FG005|Overall Study|Lost to Follow-up|3|||
47041356|NCT01441635|83297788|FG006|Overall Study|Lost to Follow-up|1|||
47041357|NCT01441635|83297789|FG007|Overall Study|Lost to Follow-up|1|||
47041358|NCT01441635|83297790|FG008|Overall Study|Lost to Follow-up|0|||
47041359|NCT01441635|83297791|FG009|Overall Study|Lost to Follow-up|1|||
47041360|NCT01441635|83297782|FG000|Overall Study|Noncompliance|0|||
46917066|NCT02964507|83148295|FG007|Overall Study|Withdrawal by Subject|0|||
46917067|NCT02964507|83148288|FG000|Overall Study|Physician Decision|2|||
46917068|NCT02964507|83148289|FG001|Overall Study|Physician Decision|0|||
47041361|NCT01441635|83297783|FG001|Overall Study|Noncompliance|1|||
47041362|NCT01441635|83297784|FG002|Overall Study|Noncompliance|0|||
47041363|NCT01441635|83297785|FG003|Overall Study|Noncompliance|0|||
47041364|NCT01441635|83297786|FG004|Overall Study|Noncompliance|0|||
47041365|NCT01441635|83297787|FG005|Overall Study|Noncompliance|0|||
46917069|NCT02964507|83148290|FG002|Overall Study|Physician Decision|3|||
46917070|NCT02964507|83148291|FG003|Overall Study|Physician Decision|0|||
46917071|NCT02964507|83148292|FG004|Overall Study|Physician Decision|1|||
47041366|NCT01441635|83297788|FG006|Overall Study|Noncompliance|1|||
47041367|NCT01441635|83297789|FG007|Overall Study|Noncompliance|0|||
46917072|NCT02964507|83148293|FG005|Overall Study|Physician Decision|0|||
47041368|NCT01441635|83297790|FG008|Overall Study|Noncompliance|0|||
46917073|NCT02964507|83148294|FG006|Overall Study|Physician Decision|0|||
46917074|NCT02964507|83148295|FG007|Overall Study|Physician Decision|0|||
46917075|NCT03170869|83148314|FG000|Overall Study|Protocol Violation|5|||
46917076|NCT03170869|83148314|FG000|Overall Study|Early study termination|3|||
46917077|NCT02440464|83148321|FG000|Overall Study|Withdrawal by Subject|3|||
46917078|NCT02440464|83148322|FG001|Overall Study|Withdrawal by Subject|2|||
46917079|NCT03131453|83148332|FG000|Overall Study|Study terminated by Sponsor|424|||
47041369|NCT01441635|83297791|FG009|Overall Study|Noncompliance|0|||
47041370|NCT01441635|83297782|FG000|Overall Study|Surgery or Invasive Intervention|0|||
47041371|NCT01441635|83297783|FG001|Overall Study|Surgery or Invasive Intervention|0|||
47041372|NCT01441635|83297784|FG002|Overall Study|Surgery or Invasive Intervention|1|||
46917080|NCT03131453|83148333|FG001|Overall Study|Study terminated by Sponsor|222|||
46917081|NCT03131453|83148334|FG002|Overall Study|Study terminated by Sponsor|438|||
46917082|NCT03131453|83148332|FG000|Overall Study|Withdrawal by Subject|18|||
46917083|NCT03131453|83148333|FG001|Overall Study|Withdrawal by Subject|7|||
46917084|NCT03131453|83148334|FG002|Overall Study|Withdrawal by Subject|13|||
46917085|NCT03131453|83148332|FG000|Overall Study|Adverse Event|10|||
46917086|NCT03131453|83148333|FG001|Overall Study|Adverse Event|3|||
46917087|NCT03131453|83148334|FG002|Overall Study|Adverse Event|3|||
46917088|NCT03131453|83148332|FG000|Overall Study|Lost to Follow-up|1|||
46917089|NCT03131453|83148333|FG001|Overall Study|Lost to Follow-up|0|||
46917090|NCT03131453|83148334|FG002|Overall Study|Lost to Follow-up|1|||
46917091|NCT03131453|83148332|FG000|Overall Study|Physician Decision|1|||
46917092|NCT03131453|83148333|FG001|Overall Study|Physician Decision|0|||
46917093|NCT03131453|83148334|FG002|Overall Study|Physician Decision|1|||
46917094|NCT03131453|83148332|FG000|Overall Study|Non-compliance with study treatment|1|||
46917095|NCT03131453|83148333|FG001|Overall Study|Non-compliance with study treatment|0|||
46917096|NCT03131453|83148334|FG002|Overall Study|Non-compliance with study treatment|0|||
46917097|NCT03131453|83148332|FG000|Overall Study|Technical problems|1|||
46917098|NCT03131453|83148333|FG001|Overall Study|Technical problems|0|||
46917099|NCT03131453|83148334|FG002|Overall Study|Technical problems|0|||
46917100|NCT03131453|83148332|FG000|Overall Study|Protocol deviation|0|||
46917101|NCT03131453|83148333|FG001|Overall Study|Protocol deviation|1|||
46917102|NCT03131453|83148334|FG002|Overall Study|Protocol deviation|0|||
46917103|NCT02942277|83148362|FG000|Year 1|Withdrawal by Subject|0|||
46917104|NCT02942277|83148363|FG001|Year 1|Withdrawal by Subject|0|||
46917105|NCT02942277|83148364|FG002|Year 1|Withdrawal by Subject|0|||
46917106|NCT02942277|83148365|FG003|Year 1|Withdrawal by Subject|0|||
46917107|NCT02942277|83148366|FG004|Year 1|Withdrawal by Subject|1|||
46917108|NCT02942277|83148367|FG005|Year 1|Withdrawal by Subject|3|||
46917109|NCT02942277|83148368|FG006|Year 1|Withdrawal by Subject|0|||
46917110|NCT02942277|83148369|FG007|Year 1|Withdrawal by Subject|1|||
46917111|NCT02942277|83148370|FG008|Year 1|Withdrawal by Subject|0|||
46917112|NCT02942277|83148371|FG009|Year 1|Withdrawal by Subject|0|||
46917113|NCT02942277|83148372|FG010|Year 1|Withdrawal by Subject|3|||
46917114|NCT02942277|83148362|FG000|Year 1|Travel|0|||
46917115|NCT02942277|83148363|FG001|Year 1|Travel|1|||
46917116|NCT02942277|83148364|FG002|Year 1|Travel|0|||
46917117|NCT02942277|83148365|FG003|Year 1|Travel|0|||
46917118|NCT02942277|83148366|FG004|Year 1|Travel|4|||
46917119|NCT02942277|83148367|FG005|Year 1|Travel|5|||
46917120|NCT02942277|83148368|FG006|Year 1|Travel|0|||
46917121|NCT02942277|83148369|FG007|Year 1|Travel|0|||
46917122|NCT02942277|83148370|FG008|Year 1|Travel|0|||
46917123|NCT02942277|83148371|FG009|Year 1|Travel|0|||
46917124|NCT02942277|83148372|FG010|Year 1|Travel|8|||
46917125|NCT02942277|83148362|FG000|Year 1|Joined Army|0|||
46917126|NCT02942277|83148363|FG001|Year 1|Joined Army|1|||
46917127|NCT02942277|83148364|FG002|Year 1|Joined Army|0|||
46917128|NCT02942277|83148365|FG003|Year 1|Joined Army|0|||
46917129|NCT02942277|83148366|FG004|Year 1|Joined Army|0|||
46917130|NCT02942277|83148367|FG005|Year 1|Joined Army|0|||
46917131|NCT02942277|83148368|FG006|Year 1|Joined Army|0|||
46917132|NCT02942277|83148369|FG007|Year 1|Joined Army|0|||
46917133|NCT02942277|83148370|FG008|Year 1|Joined Army|0|||
47041373|NCT01441635|83297785|FG003|Overall Study|Surgery or Invasive Intervention|0|||
47041374|NCT01441635|83297786|FG004|Overall Study|Surgery or Invasive Intervention|0|||
47041375|NCT01441635|83297787|FG005|Overall Study|Surgery or Invasive Intervention|0|||
46917134|NCT02942277|83148371|FG009|Year 1|Joined Army|0|||
46917135|NCT02942277|83148372|FG010|Year 1|Joined Army|0|||
47041376|NCT01441635|83297788|FG006|Overall Study|Surgery or Invasive Intervention|0|||
47041377|NCT01441635|83297789|FG007|Overall Study|Surgery or Invasive Intervention|0|||
47041378|NCT01441635|83297790|FG008|Overall Study|Surgery or Invasive Intervention|0|||
46719739|NCT00830869|82935887|FG008|Period 1: Part 1|Adverse Event|0|||
46917136|NCT02942277|83148362|FG000|Year 1|Subject met withdrawal criteria|0|||
46917137|NCT02942277|83148363|FG001|Year 1|Subject met withdrawal criteria|0|||
46917138|NCT02942277|83148364|FG002|Year 1|Subject met withdrawal criteria|0|||
46719740|NCT00830869|82935888|FG009|Period 1: Part 1|Adverse Event|0|||
46719741|NCT00830869|82935889|FG010|Period 1: Part 1|Adverse Event|0|||
46719742|NCT00830869|82935890|FG011|Period 1: Part 1|Adverse Event|0|||
46917139|NCT02942277|83148365|FG003|Year 1|Subject met withdrawal criteria|1|||
46917140|NCT02942277|83148366|FG004|Year 1|Subject met withdrawal criteria|0|||
46917141|NCT02942277|83148367|FG005|Year 1|Subject met withdrawal criteria|0|||
46719743|NCT00830869|82935879|FG000|Period 1: Part 1|Progressive disease|1|||
46719744|NCT00830869|82935880|FG001|Period 1: Part 1|Progressive disease|0|||
46719745|NCT00830869|82935881|FG002|Period 1: Part 1|Progressive disease|1|||
46719746|NCT00830869|82935882|FG003|Period 1: Part 1|Progressive disease|6|||
46719747|NCT00830869|82935883|FG004|Period 1: Part 1|Progressive disease|4|||
46719748|NCT00830869|82935884|FG005|Period 1: Part 1|Progressive disease|4|||
46917142|NCT02942277|83148368|FG006|Year 1|Subject met withdrawal criteria|0|||
46917143|NCT02942277|83148369|FG007|Year 1|Subject met withdrawal criteria|0|||
46917144|NCT02942277|83148370|FG008|Year 1|Subject met withdrawal criteria|0|||
46917145|NCT02942277|83148371|FG009|Year 1|Subject met withdrawal criteria|0|||
46917146|NCT02942277|83148372|FG010|Year 1|Subject met withdrawal criteria|0|||
46917147|NCT02942277|83148362|FG000|Year 1|Lost to Follow-up|0|||
46917148|NCT02942277|83148363|FG001|Year 1|Lost to Follow-up|0|||
46917149|NCT02942277|83148364|FG002|Year 1|Lost to Follow-up|0|||
46917150|NCT02942277|83148365|FG003|Year 1|Lost to Follow-up|0|||
46917151|NCT02942277|83148366|FG004|Year 1|Lost to Follow-up|1|||
46917152|NCT02942277|83148367|FG005|Year 1|Lost to Follow-up|0|||
46917153|NCT02942277|83148368|FG006|Year 1|Lost to Follow-up|0|||
46917154|NCT02942277|83148369|FG007|Year 1|Lost to Follow-up|0|||
46917155|NCT02942277|83148370|FG008|Year 1|Lost to Follow-up|0|||
46917156|NCT02942277|83148371|FG009|Year 1|Lost to Follow-up|0|||
46917157|NCT02942277|83148372|FG010|Year 1|Lost to Follow-up|2|||
46917158|NCT02942277|83148362|FG000|Year 1|Protocol Violation|0|||
46917159|NCT02942277|83148363|FG001|Year 1|Protocol Violation|0|||
46917160|NCT02942277|83148364|FG002|Year 1|Protocol Violation|0|||
46917161|NCT02942277|83148365|FG003|Year 1|Protocol Violation|0|||
46917162|NCT02942277|83148366|FG004|Year 1|Protocol Violation|1|||
46917163|NCT02942277|83148367|FG005|Year 1|Protocol Violation|1|||
46917164|NCT02942277|83148368|FG006|Year 1|Protocol Violation|0|||
46917165|NCT02942277|83148369|FG007|Year 1|Protocol Violation|0|||
46917166|NCT02942277|83148370|FG008|Year 1|Protocol Violation|0|||
46917167|NCT02942277|83148371|FG009|Year 1|Protocol Violation|0|||
46917168|NCT02942277|83148372|FG010|Year 1|Protocol Violation|2|||
46917169|NCT02942277|83148362|FG000|Year 1|Pregnancy|0|||
46917170|NCT02942277|83148363|FG001|Year 1|Pregnancy|0|||
46917171|NCT02942277|83148364|FG002|Year 1|Pregnancy|0|||
46917172|NCT02942277|83148365|FG003|Year 1|Pregnancy|0|||
46917173|NCT02942277|83148366|FG004|Year 1|Pregnancy|0|||
46917174|NCT02942277|83148367|FG005|Year 1|Pregnancy|1|||
46917175|NCT02942277|83148368|FG006|Year 1|Pregnancy|0|||
46917176|NCT02942277|83148369|FG007|Year 1|Pregnancy|0|||
46917177|NCT02942277|83148370|FG008|Year 1|Pregnancy|0|||
46917178|NCT02942277|83148371|FG009|Year 1|Pregnancy|0|||
46917179|NCT02942277|83148372|FG010|Year 1|Pregnancy|0|||
46917180|NCT02942277|83148362|FG000|Year 2|Lost to Follow-up|0|||
46917181|NCT02942277|83148363|FG001|Year 2|Lost to Follow-up|0|||
46917182|NCT02942277|83148364|FG002|Year 2|Lost to Follow-up|0|||
46917183|NCT02942277|83148365|FG003|Year 2|Lost to Follow-up|0|||
46917184|NCT02942277|83148366|FG004|Year 2|Lost to Follow-up|2|||
46917185|NCT02942277|83148367|FG005|Year 2|Lost to Follow-up|1|||
46917186|NCT02942277|83148368|FG006|Year 2|Lost to Follow-up|0|||
46917187|NCT02942277|83148369|FG007|Year 2|Lost to Follow-up|0|||
46917188|NCT02942277|83148370|FG008|Year 2|Lost to Follow-up|0|||
46917189|NCT02942277|83148371|FG009|Year 2|Lost to Follow-up|0|||
46917190|NCT02942277|83148372|FG010|Year 2|Lost to Follow-up|0|||
46917191|NCT02942277|83148362|FG000|Year 2|Did not rescreen|0|||
46719749|NCT00830869|82935885|FG006|Period 1: Part 1|Progressive disease|1|||
46719750|NCT00830869|82935886|FG007|Period 1: Part 1|Progressive disease|0|||
46719751|NCT00830869|82935887|FG008|Period 1: Part 1|Progressive disease|0|||
46719752|NCT00830869|82935888|FG009|Period 1: Part 1|Progressive disease|0|||
46917192|NCT02942277|83148363|FG001|Year 2|Did not rescreen|0|||
46917193|NCT02942277|83148364|FG002|Year 2|Did not rescreen|1|||
46917194|NCT02942277|83148365|FG003|Year 2|Did not rescreen|1|||
46917195|NCT02942277|83148366|FG004|Year 2|Did not rescreen|9|||
46917196|NCT02942277|83148367|FG005|Year 2|Did not rescreen|6|||
46917197|NCT02942277|83148368|FG006|Year 2|Did not rescreen|0|||
46917198|NCT02942277|83148369|FG007|Year 2|Did not rescreen|1|||
46917199|NCT02942277|83148370|FG008|Year 2|Did not rescreen|0|||
46917200|NCT02942277|83148371|FG009|Year 2|Did not rescreen|0|||
46917201|NCT02942277|83148372|FG010|Year 2|Did not rescreen|21|||
46917202|NCT02942277|83148362|FG000|Year 2|Met withdrawal criteria|0|||
46719753|NCT00830869|82935889|FG010|Period 1: Part 1|Progressive disease|0|||
46917203|NCT02942277|83148363|FG001|Year 2|Met withdrawal criteria|0|||
46632624|NCT01837680|82805758|FG000|Overall Study|allergic reaction|6|||
46719754|NCT00830869|82935890|FG011|Period 1: Part 1|Progressive disease|0|||
46917204|NCT02942277|83148364|FG002|Year 2|Met withdrawal criteria|0|||
46917205|NCT02942277|83148365|FG003|Year 2|Met withdrawal criteria|0|||
46917206|NCT02942277|83148366|FG004|Year 2|Met withdrawal criteria|1|||
46917207|NCT02942277|83148367|FG005|Year 2|Met withdrawal criteria|2|||
46917208|NCT02942277|83148368|FG006|Year 2|Met withdrawal criteria|0|||
46917209|NCT02942277|83148369|FG007|Year 2|Met withdrawal criteria|0|||
46917210|NCT02942277|83148370|FG008|Year 2|Met withdrawal criteria|0|||
46917211|NCT02942277|83148371|FG009|Year 2|Met withdrawal criteria|0|||
46917212|NCT02942277|83148372|FG010|Year 2|Met withdrawal criteria|1|||
46917213|NCT02942277|83148362|FG000|Year 2|Travel|0|||
46719755|NCT00830869|82935879|FG000|Period 2: Part 2|Protocol Violation|0|||
46917214|NCT02942277|83148363|FG001|Year 2|Travel|1|||
46917215|NCT02942277|83148364|FG002|Year 2|Travel|0|||
46917216|NCT02942277|83148365|FG003|Year 2|Travel|0|||
46917217|NCT02942277|83148366|FG004|Year 2|Travel|0|||
46917218|NCT02942277|83148367|FG005|Year 2|Travel|1|||
46917219|NCT02942277|83148368|FG006|Year 2|Travel|0|||
46917220|NCT02942277|83148369|FG007|Year 2|Travel|0|||
46917221|NCT02942277|83148370|FG008|Year 2|Travel|0|||
46917222|NCT02942277|83148371|FG009|Year 2|Travel|1|||
46917223|NCT02942277|83148372|FG010|Year 2|Travel|3|||
46917224|NCT02942277|83148362|FG000|Year 2|Non-compliant|0|||
46917225|NCT02942277|83148363|FG001|Year 2|Non-compliant|0|||
46917226|NCT02942277|83148364|FG002|Year 2|Non-compliant|0|||
46917227|NCT02942277|83148365|FG003|Year 2|Non-compliant|0|||
46917228|NCT02942277|83148366|FG004|Year 2|Non-compliant|1|||
46917229|NCT02942277|83148367|FG005|Year 2|Non-compliant|1|||
46917230|NCT02942277|83148368|FG006|Year 2|Non-compliant|0|||
46917231|NCT02942277|83148369|FG007|Year 2|Non-compliant|0|||
46917232|NCT02942277|83148370|FG008|Year 2|Non-compliant|0|||
46917233|NCT02942277|83148371|FG009|Year 2|Non-compliant|0|||
46917234|NCT02942277|83148372|FG010|Year 2|Non-compliant|0|||
46917235|NCT02942277|83148362|FG000|Year 2|Withdrawal by Subject|0|||
46917236|NCT02942277|83148363|FG001|Year 2|Withdrawal by Subject|0|||
46917237|NCT02942277|83148364|FG002|Year 2|Withdrawal by Subject|0|||
46917238|NCT02942277|83148365|FG003|Year 2|Withdrawal by Subject|0|||
46917239|NCT02942277|83148366|FG004|Year 2|Withdrawal by Subject|0|||
46917240|NCT02942277|83148367|FG005|Year 2|Withdrawal by Subject|0|||
46917241|NCT02942277|83148368|FG006|Year 2|Withdrawal by Subject|1|||
46917242|NCT02942277|83148369|FG007|Year 2|Withdrawal by Subject|0|||
46917243|NCT02942277|83148370|FG008|Year 2|Withdrawal by Subject|0|||
46917244|NCT02942277|83148371|FG009|Year 2|Withdrawal by Subject|0|||
46917245|NCT02942277|83148372|FG010|Year 2|Withdrawal by Subject|0|||
46917246|NCT02859324|83148423|FG000|Overall Study|Death|4|||
46917247|NCT02859324|83148424|FG001|Overall Study|Death|6|||
46917248|NCT02859324|83148425|FG002|Overall Study|Death|5|||
46917249|NCT02859324|83148423|FG000|Overall Study|Other reasons|3|||
46917250|NCT02859324|83148424|FG001|Overall Study|Other reasons|3|||
46917251|NCT02859324|83148425|FG002|Overall Study|Other reasons|0|||
46917252|NCT02143063|83148436|FG000|Overall Study|Lost to Follow-up|16|||
46917253|NCT02143063|83148437|FG001|Overall Study|Lost to Follow-up|28|||
46917254|NCT02143063|83148438|FG002|Overall Study|Lost to Follow-up|29|||
46917255|NCT02143063|83148436|FG000|Overall Study|Withdrawal by Subject|0|||
46917256|NCT02143063|83148437|FG001|Overall Study|Withdrawal by Subject|1|||
46917257|NCT02143063|83148438|FG002|Overall Study|Withdrawal by Subject|0|||
46917258|NCT02143063|83148436|FG000|Overall Study|Death|0|||
46917259|NCT02143063|83148437|FG001|Overall Study|Death|1|||
46917260|NCT02143063|83148438|FG002|Overall Study|Death|1|||
46917261|NCT02859246|83148446|FG000|Overall Study|Screen fails|3|||
46917262|NCT02859246|83148446|FG000|Overall Study|Adverse Event|1|||
46917263|NCT02859246|83148446|FG000|Overall Study|Withdrawal by Subject|1|||
46917264|NCT01083433|83148454|FG000|Overall Study|Lost to Follow-up|2|||
46917265|NCT01083433|83148455|FG001|Overall Study|Lost to Follow-up|1|||
46917266|NCT01083433|83148456|FG002|Overall Study|Lost to Follow-up|1|||
46917267|NCT01083433|83148454|FG000|Overall Study|Withdrawal by Subject|0|||
46917268|NCT01083433|83148455|FG001|Overall Study|Withdrawal by Subject|5|||
46917269|NCT01083433|83148456|FG002|Overall Study|Withdrawal by Subject|3|||
46917270|NCT01083433|83148454|FG000|Overall Study|Pregnancy|0|||
46917271|NCT01083433|83148455|FG001|Overall Study|Pregnancy|0|||
46917272|NCT01083433|83148456|FG002|Overall Study|Pregnancy|1|||
46917273|NCT02791490|83148470|FG000|Overall Study|Lost to Follow-up|1|||
46917274|NCT02791490|83148471|FG001|Overall Study|Lost to Follow-up|2|||
46917275|NCT02791490|83148470|FG000|Overall Study|Withdrawal by Subject|2|||
46917276|NCT02791490|83148471|FG001|Overall Study|Withdrawal by Subject|6|||
46917277|NCT02507973|83148486|FG000|Overall Study|Adverse Event|1|||
46917278|NCT02425644|83148494|FG000|Overall Study|Lost to Follow-up|2|||
46917279|NCT02425644|83148495|FG001|Overall Study|Lost to Follow-up|3|||
46917280|NCT02425644|83148494|FG000|Overall Study|Withdrawal by Subject|41|||
46917281|NCT02425644|83148495|FG001|Overall Study|Withdrawal by Subject|36|||
46719756|NCT00830869|82935880|FG001|Period 2: Part 2|Protocol Violation|0|||
46719757|NCT00830869|82935881|FG002|Period 2: Part 2|Protocol Violation|0|||
46719758|NCT00830869|82935882|FG003|Period 2: Part 2|Protocol Violation|0|||
46719759|NCT00830869|82935883|FG004|Period 2: Part 2|Protocol Violation|0|||
46917282|NCT02425644|83148494|FG000|Overall Study|Lack of Efficacy|3|||
46917283|NCT02425644|83148495|FG001|Overall Study|Lack of Efficacy|10|||
46917284|NCT02425644|83148494|FG000|Overall Study|Adverse Event|13|||
46917285|NCT02425644|83148495|FG001|Overall Study|Adverse Event|3|||
46917286|NCT02425644|83148494|FG000|Overall Study|Death|0|||
46917287|NCT02425644|83148495|FG001|Overall Study|Death|2|||
46917288|NCT02425644|83148494|FG000|Overall Study|Other|18|||
46917289|NCT02425644|83148495|FG001|Overall Study|Other|17|||
46917290|NCT02861664|83148507|FG000|Overall Study|Withdrawal of Consent|0|||
46917291|NCT02861664|83148508|FG001|Overall Study|Withdrawal of Consent|1|||
46917292|NCT01307787|83148516|FG000|Overall Study|Withdrawal by Subject|2|||
46917293|NCT01307787|83148517|FG001|Overall Study|Withdrawal by Subject|0|||
46917294|NCT03284853|83148530|FG000|Overall Study|Adverse Event|40|||
46917295|NCT03284853|83148531|FG001|Overall Study|Adverse Event|4|||
46719760|NCT00830869|82935884|FG005|Period 2: Part 2|Protocol Violation|0|||
46917296|NCT03284853|83148530|FG000|Overall Study|Withdrawal by Subject|5|||
46917297|NCT03284853|83148531|FG001|Overall Study|Withdrawal by Subject|1|||
46917298|NCT03284853|83148530|FG000|Overall Study|Lost to Follow-up|1|||
46917299|NCT03284853|83148531|FG001|Overall Study|Lost to Follow-up|0|||
46917300|NCT03284853|83148530|FG000|Overall Study|Lack of Efficacy|1|||
46917301|NCT03284853|83148531|FG001|Overall Study|Lack of Efficacy|0|||
46917302|NCT03284853|83148530|FG000|Overall Study|Disallowed Concurrent Medication|1|||
46917303|NCT03284853|83148531|FG001|Overall Study|Disallowed Concurrent Medication|1|||
47041379|NCT01441635|83297791|FG009|Overall Study|Surgery or Invasive Intervention|0|||
47041380|NCT01441635|83297782|FG000|Overall Study|Received Exclusionary Medication|1|||
46719761|NCT00830869|82935885|FG006|Period 2: Part 2|Protocol Violation|0|||
46719762|NCT00830869|82935886|FG007|Period 2: Part 2|Protocol Violation|1|||
46719763|NCT00830869|82935887|FG008|Period 2: Part 2|Protocol Violation|0|||
46719764|NCT00830869|82935888|FG009|Period 2: Part 2|Protocol Violation|1|||
46719765|NCT00830869|82935889|FG010|Period 2: Part 2|Protocol Violation|0|||
46719766|NCT00830869|82935890|FG011|Period 2: Part 2|Protocol Violation|0|||
46719767|NCT00830869|82935879|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
46719768|NCT00830869|82935880|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
46719769|NCT00830869|82935881|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
46719770|NCT00830869|82935882|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
46719771|NCT00830869|82935883|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
46719772|NCT00830869|82935884|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
46719773|NCT00830869|82935885|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
46719774|NCT00830869|82935886|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
46719775|NCT00830869|82935887|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
46719776|NCT00830869|82935888|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
46719777|NCT00830869|82935889|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
46719778|NCT00830869|82935890|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
46719779|NCT00830869|82935879|FG000|Period 2: Part 2|Adverse Event|0|||
46719780|NCT00830869|82935880|FG001|Period 2: Part 2|Adverse Event|0|||
46719781|NCT00830869|82935881|FG002|Period 2: Part 2|Adverse Event|0|||
46719782|NCT00830869|82935882|FG003|Period 2: Part 2|Adverse Event|0|||
46719783|NCT00830869|82935883|FG004|Period 2: Part 2|Adverse Event|0|||
46719784|NCT00830869|82935884|FG005|Period 2: Part 2|Adverse Event|0|||
46719785|NCT00830869|82935885|FG006|Period 2: Part 2|Adverse Event|0|||
46719786|NCT00830869|82935886|FG007|Period 2: Part 2|Adverse Event|4|||
46719787|NCT00830869|82935887|FG008|Period 2: Part 2|Adverse Event|3|||
46719788|NCT00830869|82935888|FG009|Period 2: Part 2|Adverse Event|2|||
46719789|NCT00830869|82935889|FG010|Period 2: Part 2|Adverse Event|2|||
46719790|NCT00830869|82935890|FG011|Period 2: Part 2|Adverse Event|0|||
46719791|NCT00830869|82935879|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
46719792|NCT00830869|82935880|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
46719793|NCT00830869|82935881|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
46719794|NCT00830869|82935882|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
46719795|NCT00830869|82935883|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
46719796|NCT00830869|82935884|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
46719797|NCT00830869|82935885|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
46719798|NCT00830869|82935886|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
46719799|NCT00830869|82935887|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
46719800|NCT00830869|82935888|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
46719801|NCT00830869|82935889|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
46719802|NCT00830869|82935890|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
46719803|NCT00830869|82935879|FG000|Period 2: Part 2|Progressive disease|0|||
47041381|NCT01441635|83297783|FG001|Overall Study|Received Exclusionary Medication|0|||
47041382|NCT01441635|83297784|FG002|Overall Study|Received Exclusionary Medication|0|||
46632625|NCT01837680|82805759|FG001|Overall Study|allergic reaction|0|||
46632626|NCT01837680|82805758|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
46632627|NCT01837680|82805759|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
46632628|NCT01836276|82805767|FG000|Overall Study|Lost to Follow-up|28|||
46632629|NCT01836276|82805768|FG001|Overall Study|Lost to Follow-up|51|||
46632630|NCT01790568|82805774|FG000|Overall Study|Progression prior to transplant|0|||
46632631|NCT01790568|82805775|FG001|Overall Study|Progression prior to transplant|1|||
46632632|NCT01610076|82805781|FG000|Overall Study|Technical issue with video|0|||
46632633|NCT01610076|82805782|FG001|Overall Study|Technical issue with video|1|||
46632634|NCT01610076|82805781|FG000|Overall Study|Lost to Follow-up|3|||
46719804|NCT00830869|82935880|FG001|Period 2: Part 2|Progressive disease|0|||
46719805|NCT00830869|82935881|FG002|Period 2: Part 2|Progressive disease|0|||
46632635|NCT01610076|82805782|FG001|Overall Study|Lost to Follow-up|4|||
46719806|NCT00830869|82935882|FG003|Period 2: Part 2|Progressive disease|0|||
46719807|NCT00830869|82935883|FG004|Period 2: Part 2|Progressive disease|0|||
46719808|NCT00830869|82935884|FG005|Period 2: Part 2|Progressive disease|0|||
46719809|NCT00830869|82935885|FG006|Period 2: Part 2|Progressive disease|0|||
46719810|NCT00830869|82935886|FG007|Period 2: Part 2|Progressive disease|14|||
46719811|NCT00830869|82935887|FG008|Period 2: Part 2|Progressive disease|11|||
46719812|NCT00830869|82935888|FG009|Period 2: Part 2|Progressive disease|12|||
46719813|NCT00830869|82935889|FG010|Period 2: Part 2|Progressive disease|8|||
46719814|NCT00830869|82935890|FG011|Period 2: Part 2|Progressive disease|15|||
46719815|NCT00830869|82935879|FG000|Period 2: Part 2|Other|0|||
46917304|NCT03284853|83148530|FG000|Overall Study|Protocol Violation|3|||
46917305|NCT03284853|83148531|FG001|Overall Study|Protocol Violation|3|||
46917306|NCT03284853|83148530|FG000|Overall Study|Death|0|||
46917307|NCT03284853|83148531|FG001|Overall Study|Death|1|||
46917308|NCT03284853|83148530|FG000|Overall Study|Other - Reason not reported in CSR|4|||
46917309|NCT03284853|83148531|FG001|Overall Study|Other - Reason not reported in CSR|3|||
46917310|NCT04497415|83148559|FG000|Overall Study|Lost to Follow-up|43|||
46917311|NCT04497415|83148560|FG001|Overall Study|Lost to Follow-up|27|||
46917312|NCT03125941|83148568|FG000|Overall Study|did not receive intervention|1|||
46917313|NCT03125941|83148569|FG001|Overall Study|did not receive intervention|2|||
46917314|NCT02774889|83148577|FG000|Overall Study|Lost to Follow-up|2|||
46917315|NCT02774889|83148578|FG001|Overall Study|Lost to Follow-up|1|||
46917316|NCT03125629|83148586|FG000|Overall Study|Withdrawal by Subject|2|||
46917317|NCT03125629|83148586|FG000|Overall Study|Equipment malfunction|1|||
46917318|NCT03125395|83148598|FG000|Overall Study|Adverse Event|2|||
46917319|NCT03125395|83148598|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
46917320|NCT03125395|83148598|FG000|Overall Study|Physician Decision|2|||
46917321|NCT03125395|83148598|FG000|Overall Study|Commercial drug is available|5|||
46917322|NCT00261807|83148612|FG000|Overall Study|Lost to Follow-up|2|||
46917323|NCT00261807|83148612|FG000|Overall Study|Adverse Event|2|||
46917324|NCT00261807|83148612|FG000|Overall Study|Death|1|||
46917325|NCT00261807|83148612|FG000|Overall Study|Protocol Violation|2|||
46917326|NCT02820753|83148619|FG000|2 Month|Withdrawal by Subject|3|||
46917327|NCT02820753|83148620|FG001|2 Month|Withdrawal by Subject|3|||
46917328|NCT02820753|83148619|FG000|2 Month|Lost to Follow-up|24|||
46917329|NCT02820753|83148620|FG001|2 Month|Lost to Follow-up|26|||
46917330|NCT02820753|83148619|FG000|2 Month|Stopped per NIH Hold|51|||
46917331|NCT02820753|83148620|FG001|2 Month|Stopped per NIH Hold|13|||
46917332|NCT02820753|83148619|FG000|6 Month|Withdrawal by Subject|2|||
46917333|NCT02820753|83148620|FG001|6 Month|Withdrawal by Subject|2|||
46917334|NCT02820753|83148619|FG000|6 Month|Lost to Follow-up|20|||
46917335|NCT02820753|83148620|FG001|6 Month|Lost to Follow-up|27|||
46917336|NCT02820753|83148619|FG000|6 Month|Stopped per NIH Hold|81|||
46917337|NCT02820753|83148620|FG001|6 Month|Stopped per NIH Hold|81|||
46917338|NCT02820753|83148619|FG000|6 Month|Death|0|||
46917339|NCT02820753|83148620|FG001|6 Month|Death|1|||
46917340|NCT02861586|83148634|FG000|Overall Study|Withdrawal by Subject|1|||
46917341|NCT02861586|83148635|FG001|Overall Study|Withdrawal by Subject|2|||
46917342|NCT02861586|83148636|FG002|Overall Study|Withdrawal by Subject|0|||
46917343|NCT02861586|83148637|FG003|Overall Study|Withdrawal by Subject|0|||
46917344|NCT02861586|83148638|FG004|Overall Study|Withdrawal by Subject|0|||
46917345|NCT02861586|83148639|FG005|Overall Study|Withdrawal by Subject|1|||
47041383|NCT01441635|83297785|FG003|Overall Study|Received Exclusionary Medication|0|||
47041384|NCT01441635|83297786|FG004|Overall Study|Received Exclusionary Medication|0|||
47041385|NCT01441635|83297787|FG005|Overall Study|Received Exclusionary Medication|0|||
47041386|NCT01441635|83297788|FG006|Overall Study|Received Exclusionary Medication|0|||
47041387|NCT01441635|83297789|FG007|Overall Study|Received Exclusionary Medication|0|||
47041388|NCT01441635|83297790|FG008|Overall Study|Received Exclusionary Medication|0|||
47041389|NCT01441635|83297791|FG009|Overall Study|Received Exclusionary Medication|0|||
47041390|NCT01441635|83297782|FG000|Overall Study|Other|0|||
47041391|NCT01441635|83297783|FG001|Overall Study|Other|0|||
47041392|NCT01441635|83297784|FG002|Overall Study|Other|0|||
47041393|NCT01441635|83297785|FG003|Overall Study|Other|0|||
47041394|NCT01441635|83297786|FG004|Overall Study|Other|0|||
47041395|NCT01441635|83297787|FG005|Overall Study|Other|0|||
47041396|NCT01441635|83297788|FG006|Overall Study|Other|0|||
47041397|NCT01441635|83297789|FG007|Overall Study|Other|1|||
47041398|NCT01441635|83297790|FG008|Overall Study|Other|0|||
47041399|NCT01441635|83297791|FG009|Overall Study|Other|0|||
47041400|NCT01408485|83297813|FG000|Overall Study|Withdrawal by Subject|21|||
46632636|NCT01836198|82805791|FG000|Part A, Period 2|Protocol Violation|0|||
46632637|NCT01836198|82805792|FG001|Part A, Period 2|Protocol Violation|1|||
46719816|NCT00830869|82935880|FG001|Period 2: Part 2|Other|0|||
46917346|NCT02861586|83148640|FG006|Overall Study|Withdrawal by Subject|1|||
46632638|NCT01836198|82805793|FG002|Part A, Period 2|Protocol Violation|0|||
46632639|NCT01816074|82805813|FG000|Phase 1|Time commitment issues|0|||
46917347|NCT02861586|83148641|FG007|Overall Study|Withdrawal by Subject|0|||
46917348|NCT02861586|83148634|FG000|Overall Study|Lost to Follow-up|3|||
46917349|NCT02861586|83148635|FG001|Overall Study|Lost to Follow-up|1|||
46917350|NCT02861586|83148636|FG002|Overall Study|Lost to Follow-up|1|||
46917351|NCT02861586|83148637|FG003|Overall Study|Lost to Follow-up|0|||
46917352|NCT02861586|83148638|FG004|Overall Study|Lost to Follow-up|0|||
46917353|NCT02861586|83148639|FG005|Overall Study|Lost to Follow-up|3|||
46917354|NCT02861586|83148640|FG006|Overall Study|Lost to Follow-up|0|||
46917355|NCT02861586|83148641|FG007|Overall Study|Lost to Follow-up|0|||
46917356|NCT02861586|83148634|FG000|Overall Study|Adverse Event|0|||
46917357|NCT02861586|83148635|FG001|Overall Study|Adverse Event|0|||
47041401|NCT01427907|83297819|FG000|Overall Study|Withdrawal by Subject|3|||
47041402|NCT01427907|83297820|FG001|Overall Study|Withdrawal by Subject|4|||
47041403|NCT01427751|83297828|FG000|Overall Study|Adverse Event|18|||
47041404|NCT01427751|83297829|FG001|Overall Study|Adverse Event|2|||
47041405|NCT01427751|83297828|FG000|Overall Study|No further treatment benefit expected|5|||
46917358|NCT02861586|83148636|FG002|Overall Study|Adverse Event|0|||
46917359|NCT02861586|83148637|FG003|Overall Study|Adverse Event|0|||
46917360|NCT02861586|83148638|FG004|Overall Study|Adverse Event|0|||
46917361|NCT02861586|83148639|FG005|Overall Study|Adverse Event|1|||
46917362|NCT02861586|83148640|FG006|Overall Study|Adverse Event|0|||
46917363|NCT02861586|83148641|FG007|Overall Study|Adverse Event|0|||
46917364|NCT03124537|83148684|FG000|Overall Study|Lost to Follow-up|3|||
46917365|NCT03124537|83148685|FG001|Overall Study|Lost to Follow-up|5|||
46917366|NCT03124537|83148684|FG000|Overall Study|App Crash, Incomplete Data|7|||
46917367|NCT03124537|83148685|FG001|Overall Study|App Crash, Incomplete Data|8|||
46917368|NCT03118297|83148693|FG000|Overall Study|Lost to Follow-up|0|||
46917369|NCT03118297|83148694|FG001|Overall Study|Lost to Follow-up|2|||
46917370|NCT03117361|83148700|FG000|Overall Study|Progressive disease|5|||
46917371|NCT03117361|83148700|FG000|Overall Study|Death|1|||
46917372|NCT03117361|83148700|FG000|Overall Study|Physician Decision|2|||
46917373|NCT03117361|83148700|FG000|Overall Study|On study treatment at the end of study|1|||
46917374|NCT03117361|83148700|FG000|Overall Study|Treatment-related adverse event|1|||
46917375|NCT01368614|83148704|FG000|Screening Period|Screen Failure|58|||
46917376|NCT01368614|83148705|FG001|Screening Period|Screen Failure|0|||
46917377|NCT01368614|83148706|FG002|Screening Period|Screen Failure|0|||
46917378|NCT01368614|83148707|FG003|Screening Period|Screen Failure|0|||
46917379|NCT01368614|83148704|FG000|Study Period|Withdrawal by Subject|0|||
46917380|NCT01368614|83148705|FG001|Study Period|Withdrawal by Subject|1|||
46917381|NCT01368614|83148706|FG002|Study Period|Withdrawal by Subject|1|||
46917382|NCT01368614|83148707|FG003|Study Period|Withdrawal by Subject|3|||
46917383|NCT01368614|83148704|FG000|Study Period|Lost to Follow-up|0|||
46917384|NCT01368614|83148705|FG001|Study Period|Lost to Follow-up|0|||
46917385|NCT01368614|83148706|FG002|Study Period|Lost to Follow-up|1|||
46917386|NCT01368614|83148707|FG003|Study Period|Lost to Follow-up|0|||
46917387|NCT03053427|83148717|FG000|Overall Study|Adverse Event|4|||
46917388|NCT03053427|83148718|FG001|Overall Study|Adverse Event|4|||
46917389|NCT03053427|83148717|FG000|Overall Study|Lack of Efficacy|1|||
46917390|NCT03053427|83148718|FG001|Overall Study|Lack of Efficacy|3|||
46917391|NCT03053427|83148717|FG000|Overall Study|Lost to Follow-up|2|||
46917392|NCT03053427|83148718|FG001|Overall Study|Lost to Follow-up|2|||
47041406|NCT01427751|83297829|FG001|Overall Study|No further treatment benefit expected|1|||
47041407|NCT01427751|83297828|FG000|Overall Study|Lost to Follow-up|3|||
47041408|NCT01427751|83297829|FG001|Overall Study|Lost to Follow-up|1|||
47041409|NCT01427751|83297828|FG000|Overall Study|Withdrawal of consent|2|||
47041410|NCT01427751|83297829|FG001|Overall Study|Withdrawal of consent|2|||
47041411|NCT01427751|83297828|FG000|Overall Study|Protocol Violation|6|||
47041412|NCT01427751|83297829|FG001|Overall Study|Protocol Violation|4|||
47041413|NCT01427751|83297828|FG000|Overall Study|Death|2|||
47041414|NCT01427751|83297829|FG001|Overall Study|Death|0|||
47041415|NCT01427751|83297828|FG000|Overall Study|Other miscellaneous reasons|6|||
47041416|NCT01427751|83297829|FG001|Overall Study|Other miscellaneous reasons|4|||
47041417|NCT01920061|83297855|FG000|Overall Study|Death|1|||
46719817|NCT00830869|82935881|FG002|Period 2: Part 2|Other|0|||
46719818|NCT00830869|82935882|FG003|Period 2: Part 2|Other|0|||
46719819|NCT00830869|82935883|FG004|Period 2: Part 2|Other|0|||
46719820|NCT00830869|82935884|FG005|Period 2: Part 2|Other|0|||
46719821|NCT00830869|82935885|FG006|Period 2: Part 2|Other|0|||
46719822|NCT00830869|82935886|FG007|Period 2: Part 2|Other|0|||
46719823|NCT00830869|82935887|FG008|Period 2: Part 2|Other|0|||
46719824|NCT00830869|82935888|FG009|Period 2: Part 2|Other|1|||
46719825|NCT00830869|82935889|FG010|Period 2: Part 2|Other|0|||
46719826|NCT00830869|82935890|FG011|Period 2: Part 2|Other|0|||
46719827|NCT00844519|82935919|FG000|Overall Study|Withdrawal by Subject|1|||
46719828|NCT00844519|82935920|FG001|Overall Study|Withdrawal by Subject|1|||
46719829|NCT00844519|82935919|FG000|Overall Study|Adverse Event|1|||
46917393|NCT03053427|83148717|FG000|Overall Study|Worsening of the target disease|0|||
46917394|NCT03053427|83148718|FG001|Overall Study|Worsening of the target disease|1|||
46917395|NCT03053427|83148717|FG000|Overall Study|Protocol Deviation|3|||
46917396|NCT03053427|83148718|FG001|Overall Study|Protocol Deviation|3|||
46917397|NCT03053427|83148717|FG000|Overall Study|Withdrawal by Subject|3|||
46917398|NCT03053427|83148718|FG001|Overall Study|Withdrawal by Subject|2|||
46917399|NCT03053427|83148717|FG000|Overall Study|Miscellaneous|0|||
46917400|NCT03053427|83148718|FG001|Overall Study|Miscellaneous|1|||
46917401|NCT03052959|83148735|FG000|Overall Study|Lost to Follow-up|4|||
46917402|NCT03052959|83148736|FG001|Overall Study|Lost to Follow-up|5|||
47041418|NCT01920061|83297856|FG001|Overall Study|Death|1|||
47041419|NCT01920061|83297857|FG002|Overall Study|Death|0|||
46719830|NCT00844519|82935920|FG001|Overall Study|Adverse Event|0|||
46719831|NCT01171820|82935928|FG000|Overall Study|Death|3|||
46719832|NCT01171820|82935929|FG001|Overall Study|Death|3|||
46719833|NCT01171820|82935928|FG000|Overall Study|Lost to Follow-up|0|||
46917403|NCT03120013|83148743|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46917404|NCT03120013|83148744|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
47041420|NCT01920061|83297858|FG003|Overall Study|Death|1|||
46917405|NCT01845649|83148752|FG000|Overall Study|Adverse Event|7|||
46917406|NCT01845649|83148753|FG001|Overall Study|Adverse Event|10|||
46917407|NCT01845649|83148752|FG000|Overall Study|Lack of Efficacy|1|||
46917408|NCT01845649|83148753|FG001|Overall Study|Lack of Efficacy|1|||
46917409|NCT01845649|83148752|FG000|Overall Study|Lost to Follow-up|2|||
46917410|NCT01845649|83148753|FG001|Overall Study|Lost to Follow-up|2|||
46917411|NCT01845649|83148752|FG000|Overall Study|Withdrew Consent|12|||
46917412|NCT01845649|83148753|FG001|Overall Study|Withdrew Consent|4|||
46917413|NCT01845649|83148752|FG000|Overall Study|Protocol Deviation|7|||
46917414|NCT01845649|83148753|FG001|Overall Study|Protocol Deviation|4|||
46917415|NCT01845649|83148752|FG000|Overall Study|Reason not Specified|2|||
46917416|NCT01845649|83148753|FG001|Overall Study|Reason not Specified|1|||
46917417|NCT01345929|83148761|FG000|Overall Study|Withdrawal by Subject|9|||
46917418|NCT01345929|83148762|FG001|Overall Study|Withdrawal by Subject|8|||
46917419|NCT01345929|83148761|FG000|Overall Study|Lost to Follow-up|9|||
46917420|NCT01345929|83148762|FG001|Overall Study|Lost to Follow-up|9|||
46917421|NCT01345929|83148761|FG000|Overall Study|Adverse Event|0|||
46917422|NCT01345929|83148762|FG001|Overall Study|Adverse Event|1|||
46917423|NCT01345929|83148761|FG000|Overall Study|Didn't meet eligibility criteria|2|||
46917424|NCT01345929|83148762|FG001|Overall Study|Didn't meet eligibility criteria|0|||
46917425|NCT01345929|83148761|FG000|Overall Study|40,000 CFU/ML|1|||
46917426|NCT01345929|83148762|FG001|Overall Study|40,000 CFU/ML|0|||
46917427|NCT01345929|83148761|FG000|Overall Study|Patient withdrawal|0|||
46917428|NCT01345929|83148762|FG001|Overall Study|Patient withdrawal|1|||
46917429|NCT01343901|83148768|FG000|Overall Study|Death|85|||
46917430|NCT01343901|83148768|FG000|Overall Study|Physician Decision|4|||
46917431|NCT01343901|83148768|FG000|Overall Study|Lost to Follow-up|12|||
46917432|NCT01343901|83148768|FG000|Overall Study|Management by another medical team|11|||
46917433|NCT01343901|83148768|FG000|Overall Study|Participant decision|1|||
46917434|NCT03053271|83148772|FG000|Overall Study|Did not meet randomization criteria|3|||
46917435|NCT03053271|83148772|FG000|Overall Study|Withdrawal by Subject|1|||
46917436|NCT01343823|83148780|FG000|Overall Study|Study Terminated|1|||
46917437|NCT01343823|83148781|FG001|Overall Study|Study Terminated|0|||
46917438|NCT01343823|83148782|FG002|Overall Study|Study Terminated|0|||
46917439|NCT01343823|83148783|FG003|Overall Study|Study Terminated|1|||
46917440|NCT01343823|83148780|FG000|Overall Study|Withdrawal by Subject|1|||
46917441|NCT01343823|83148781|FG001|Overall Study|Withdrawal by Subject|0|||
46917442|NCT01343823|83148782|FG002|Overall Study|Withdrawal by Subject|0|||
46917443|NCT01343823|83148783|FG003|Overall Study|Withdrawal by Subject|0|||
46917444|NCT01318083|83148796|FG000|Overall Study|Adverse Event|4|||
46917445|NCT01318083|83148797|FG001|Overall Study|Adverse Event|1|||
46917446|NCT01318083|83148798|FG002|Overall Study|Adverse Event|2|||
46917447|NCT01318083|83148796|FG000|Overall Study|Withdrawal by Subject|1|||
46917448|NCT01318083|83148797|FG001|Overall Study|Withdrawal by Subject|0|||
46917449|NCT01318083|83148798|FG002|Overall Study|Withdrawal by Subject|2|||
46917450|NCT01318083|83148796|FG000|Overall Study|Lack of Efficacy|0|||
46917451|NCT01318083|83148797|FG001|Overall Study|Lack of Efficacy|0|||
46917452|NCT01318083|83148798|FG002|Overall Study|Lack of Efficacy|1|||
46917453|NCT01318083|83148796|FG000|Overall Study|Treatment Complications|1|||
46917454|NCT01318083|83148797|FG001|Overall Study|Treatment Complications|0|||
46917455|NCT01318083|83148798|FG002|Overall Study|Treatment Complications|0|||
46917456|NCT01318083|83148796|FG000|Overall Study|Lack of Study Medication Compliance|0|||
46917457|NCT01318083|83148797|FG001|Overall Study|Lack of Study Medication Compliance|1|||
46917458|NCT01318083|83148798|FG002|Overall Study|Lack of Study Medication Compliance|0|||
46917459|NCT01376323|83148811|FG000|Overall Study|Adverse Event|1|||
46917460|NCT01376323|83148812|FG001|Overall Study|Adverse Event|0|||
46917461|NCT01376323|83148813|FG002|Overall Study|Adverse Event|0|||
46917462|NCT01376323|83148814|FG003|Overall Study|Adverse Event|2|||
46917463|NCT01376323|83148815|FG004|Overall Study|Adverse Event|0|||
46917464|NCT01376323|83148811|FG000|Overall Study|Lost to Follow-up|0|||
46917465|NCT01376323|83148812|FG001|Overall Study|Lost to Follow-up|0|||
46917466|NCT01376323|83148813|FG002|Overall Study|Lost to Follow-up|0|||
46917467|NCT01376323|83148814|FG003|Overall Study|Lost to Follow-up|2|||
46917468|NCT01376323|83148815|FG004|Overall Study|Lost to Follow-up|0|||
46917469|NCT01376323|83148811|FG000|Overall Study|Physician Decision|1|||
46917470|NCT01376323|83148812|FG001|Overall Study|Physician Decision|0|||
46917471|NCT01376323|83148813|FG002|Overall Study|Physician Decision|2|||
46917472|NCT01376323|83148814|FG003|Overall Study|Physician Decision|1|||
46917473|NCT01376323|83148815|FG004|Overall Study|Physician Decision|1|||
46917474|NCT01376323|83148811|FG000|Overall Study|Withdrawal by Subject|0|||
46917475|NCT01376323|83148812|FG001|Overall Study|Withdrawal by Subject|1|||
46917476|NCT01376323|83148813|FG002|Overall Study|Withdrawal by Subject|1|||
46917477|NCT01376323|83148814|FG003|Overall Study|Withdrawal by Subject|0|||
46917478|NCT01376323|83148815|FG004|Overall Study|Withdrawal by Subject|0|||
47041421|NCT01920061|83297859|FG004|Overall Study|Death|1|||
46917479|NCT03725293|83148852|FG000|Overall Study|Physician Decision|9|||
46917480|NCT03725293|83148853|FG001|Overall Study|Physician Decision|6|||
47041422|NCT01920061|83297860|FG005|Overall Study|Death|0|||
47041423|NCT01920061|83297861|FG006|Overall Study|Death|0|||
46917481|NCT03725293|83148852|FG000|Overall Study|alternative vascular access needs|1|||
46917482|NCT03725293|83148853|FG001|Overall Study|alternative vascular access needs|2|||
46917483|NCT03725293|83148852|FG000|Overall Study|venous anatomy screen failures|2|||
46917484|NCT03725293|83148853|FG001|Overall Study|venous anatomy screen failures|1|||
46917485|NCT01368536|83148862|FG000|Overall Study|Adverse Event|5|||
46917486|NCT01368536|83148863|FG001|Overall Study|Adverse Event|6|||
46917487|NCT01368536|83148864|FG002|Overall Study|Adverse Event|8|||
46917488|NCT01368536|83148862|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46917489|NCT01368536|83148863|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46917490|NCT01368536|83148864|FG002|Overall Study|Abnormal laboratory value(s)|2|||
46917491|NCT01368536|83148862|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46917492|NCT01368536|83148863|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46917493|NCT01368536|83148864|FG002|Overall Study|Abnormal test procedure result(s)|1|||
46917494|NCT01368536|83148862|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
46917495|NCT01368536|83148863|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46917496|NCT01368536|83148864|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
46917497|NCT01368536|83148862|FG000|Overall Study|No longer required study medication|0|||
46917498|NCT01368536|83148863|FG001|Overall Study|No longer required study medication|0|||
46917499|NCT01368536|83148864|FG002|Overall Study|No longer required study medication|1|||
46917500|NCT01368536|83148862|FG000|Overall Study|Withdrawal by Subject|2|||
46917501|NCT01368536|83148863|FG001|Overall Study|Withdrawal by Subject|5|||
46917502|NCT01368536|83148864|FG002|Overall Study|Withdrawal by Subject|4|||
46917503|NCT01368536|83148862|FG000|Overall Study|Lost to Follow-up|3|||
46917504|NCT01368536|83148863|FG001|Overall Study|Lost to Follow-up|3|||
46917505|NCT01368536|83148864|FG002|Overall Study|Lost to Follow-up|5|||
46917506|NCT01368536|83148862|FG000|Overall Study|Administrative problems|34|||
46917507|NCT01368536|83148863|FG001|Overall Study|Administrative problems|39|||
46917508|NCT01368536|83148864|FG002|Overall Study|Administrative problems|35|||
46917509|NCT01368536|83148862|FG000|Overall Study|Protocol deviation|0|||
46917510|NCT01368536|83148863|FG001|Overall Study|Protocol deviation|3|||
46917511|NCT01368536|83148864|FG002|Overall Study|Protocol deviation|1|||
46917512|NCT03051165|83148873|FG000|Overall Study|Withdrawal by Subject|1|||
46917513|NCT03051165|83148873|FG000|Overall Study|Early termination of study|12|||
46917514|NCT01319929|83148879|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
46917515|NCT01319929|83148880|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
46917516|NCT01319929|83148879|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
46917517|NCT01319929|83148880|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
46917518|NCT01319929|83148879|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
46917519|NCT01319929|83148880|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
46917520|NCT01319929|83148879|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
46917521|NCT01319929|83148880|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
46917522|NCT01319929|83148879|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
46917523|NCT01319929|83148880|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
46917524|NCT03110185|83148889|FG000|Overall Study|Death|0|||
46917525|NCT03110185|83148890|FG001|Overall Study|Death|1|||
46917526|NCT03110185|83148889|FG000|Overall Study|Withdrawal by Subject|2|||
46917527|NCT03110185|83148890|FG001|Overall Study|Withdrawal by Subject|7|||
46917528|NCT03110185|83148889|FG000|Overall Study|Time Constraints|0|||
46917529|NCT03110185|83148890|FG001|Overall Study|Time Constraints|6|||
46917530|NCT03110185|83148889|FG000|Overall Study|Conflict with care|5|||
46917531|NCT03110185|83148890|FG001|Overall Study|Conflict with care|12|||
46917532|NCT03110185|83148889|FG000|Overall Study|Protocol Violation|1|||
46917533|NCT03110185|83148890|FG001|Overall Study|Protocol Violation|4|||
46917534|NCT03110185|83148889|FG000|Overall Study|MRI Incompatible|2|||
46917535|NCT03110185|83148890|FG001|Overall Study|MRI Incompatible|0|||
46917536|NCT03110185|83148889|FG000|Overall Study|Patient Refusal|0|||
46917537|NCT03110185|83148890|FG001|Overall Study|Patient Refusal|1|||
46917538|NCT02858076|83148901|FG000|Overall Study|Death|6|||
46917539|NCT02858076|83148902|FG001|Overall Study|Death|3|||
47041424|NCT01920061|83297862|FG007|Overall Study|Death|1|||
47041425|NCT01920061|83297863|FG008|Overall Study|Death|0|||
46632640|NCT01816074|82805814|FG001|Phase 1|Time commitment issues|0|||
46917540|NCT02858076|83148901|FG000|Overall Study|Withdrawal by Subject|1|||
47041426|NCT01920061|83297864|FG009|Overall Study|Death|1|||
46719834|NCT01171820|82935929|FG001|Overall Study|Lost to Follow-up|1|||
46917541|NCT02858076|83148902|FG001|Overall Study|Withdrawal by Subject|5|||
46917542|NCT02858076|83148901|FG000|Overall Study|Lost to Follow-up|2|||
46917543|NCT02858076|83148902|FG001|Overall Study|Lost to Follow-up|7|||
46917544|NCT02858076|83148901|FG000|Overall Study|Completed Out of Window|1|||
46917545|NCT02858076|83148902|FG001|Overall Study|Completed Out of Window|3|||
46917546|NCT04594759|83148910|FG000|Overall Study|Lost to Follow-up|3|||
46917547|NCT02856282|83148914|FG000|Overall Study|Withdrawal by Subject|1|||
46917548|NCT03833817|83148920|FG000|Overall Study|Withdrawal by Subject|3|||
47041427|NCT01920061|83297865|FG010|Overall Study|Death|0|||
47041428|NCT01920061|83297866|FG011|Overall Study|Death|1|||
47041429|NCT01920061|83297867|FG012|Overall Study|Death|0|||
47041430|NCT01920061|83297868|FG013|Overall Study|Death|2|||
46917549|NCT03833817|83148921|FG001|Overall Study|Withdrawal by Subject|3|||
46917550|NCT03833817|83148920|FG000|Overall Study|Lost to Follow-up|3|||
46917551|NCT03833817|83148921|FG001|Overall Study|Lost to Follow-up|3|||
46917552|NCT03119701|83148929|FG000|6-day Dosing|Death|4|||
46719835|NCT01171820|82935928|FG000|Overall Study|Withdrawal by Subject|2|||
46719836|NCT01171820|82935929|FG001|Overall Study|Withdrawal by Subject|0|||
46719837|NCT01171820|82935928|FG000|Overall Study|Physician Decision|0|||
46917553|NCT03119701|83148930|FG001|6-day Dosing|Death|1|||
46917554|NCT03119701|83148929|FG000|6-day Dosing|Adverse Event|3|||
46917555|NCT03119701|83148930|FG001|6-day Dosing|Adverse Event|0|||
46917556|NCT03119701|83148929|FG000|6-day Dosing|Physician Decision|0|||
46917557|NCT03119701|83148930|FG001|6-day Dosing|Physician Decision|1|||
46917558|NCT03119701|83148929|FG000|6-day Dosing|Withdrawal by Subject|0|||
46917559|NCT03119701|83148930|FG001|6-day Dosing|Withdrawal by Subject|1|||
46917560|NCT03119701|83148929|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
46917561|NCT03119701|83148930|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
46917562|NCT02679781|83148944|FG000|Overall Study|Lost to Follow-up|1|||
46917563|NCT02679781|83148945|FG001|Overall Study|Lost to Follow-up|2|||
46917564|NCT02679781|83148944|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
46917565|NCT02679781|83148945|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
46917566|NCT03110029|83148962|FG000|Overall Study|Withdrawal by Subject|1|||
46917567|NCT03110029|83148963|FG001|Overall Study|Withdrawal by Subject|1|||
46917568|NCT04207749|83148971|FG000|Overall Study|Lost to Follow-up|0|||
46917569|NCT04207749|83148972|FG001|Overall Study|Lost to Follow-up|2|||
46917570|NCT04207749|83148971|FG000|Overall Study|Protocol Violation|0|||
46719838|NCT01171820|82935929|FG001|Overall Study|Physician Decision|1|||
46719839|NCT01171820|82935928|FG000|Overall Study|1-Year Missed Visit|1|||
46719840|NCT01171820|82935929|FG001|Overall Study|1-Year Missed Visit|1|||
46719841|NCT00994110|82935937|FG000|Overall Study|Withdrawal by Subject|9|||
46719842|NCT00994110|82935938|FG001|Overall Study|Withdrawal by Subject|9|||
46719843|NCT00994110|82935937|FG000|Overall Study|Not Treated|4|||
46719844|NCT00994110|82935938|FG001|Overall Study|Not Treated|8|||
46719845|NCT00994110|82935937|FG000|Overall Study|Adverse Event|1|||
46719846|NCT00994110|82935938|FG001|Overall Study|Adverse Event|0|||
46719847|NCT00994110|82935937|FG000|Overall Study|Patient not resected|41|||
46719848|NCT00994110|82935938|FG001|Overall Study|Patient not resected|52|||
46719849|NCT00994110|82935937|FG000|Overall Study|Pt not eligible|10|||
46719850|NCT00994110|82935938|FG001|Overall Study|Pt not eligible|5|||
46719851|NCT00993954|82935946|FG000|Overall Study|Protocol Violation|21|||
46719852|NCT00993954|82935947|FG001|Overall Study|Protocol Violation|2|||
46719853|NCT01157234|82935955|FG000|Overall Study|Withdrawal by Subject|1|||
46719854|NCT01157234|82935956|FG001|Overall Study|Withdrawal by Subject|0|||
46719855|NCT00991302|82935971|FG000|Overall Study|Death|0|||
46719856|NCT00991302|82935972|FG001|Overall Study|Death|1|||
46719857|NCT00991302|82935971|FG000|Overall Study|Lost to Follow-up|14|||
46719858|NCT00991302|82935972|FG001|Overall Study|Lost to Follow-up|12|||
46719859|NCT00995670|82935981|FG000|Overall Study|Failed arterial cannulation|1|||
46719860|NCT00995670|82935982|FG001|Overall Study|Failed arterial cannulation|0|||
46719861|NCT00995670|82935983|FG002|Overall Study|Failed arterial cannulation|3|||
46719862|NCT00601354|82935993|FG000|Overall Study|Lost to Follow-up|4|||
46719863|NCT00601354|82935994|FG001|Overall Study|Lost to Follow-up|5|||
46719864|NCT00853099|82936003|FG000|Double-blind Period|Adverse Event|7|||
46719865|NCT00853099|82936004|FG001|Double-blind Period|Adverse Event|9|||
46917571|NCT04207749|83148972|FG001|Overall Study|Protocol Violation|1|||
46917572|NCT04207749|83148971|FG000|Overall Study|Withdrawal by Subject|3|||
46917573|NCT04207749|83148972|FG001|Overall Study|Withdrawal by Subject|0|||
46917574|NCT04207749|83148971|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
46917575|NCT04207749|83148972|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
47041431|NCT01920061|83297869|FG014|Overall Study|Death|0|||
47041432|NCT01920061|83297870|FG015|Overall Study|Death|0|||
47041433|NCT01920061|83297871|FG016|Overall Study|Death|0|||
46719866|NCT00853099|82936005|FG002|Double-blind Period|Adverse Event|13|||
46719867|NCT00853099|82936006|FG003|Double-blind Period|Adverse Event|0|||
46719868|NCT00853099|82936003|FG000|Double-blind Period|Withdrawal by Subject|2|||
46719869|NCT00853099|82936004|FG001|Double-blind Period|Withdrawal by Subject|3|||
46719870|NCT00853099|82936005|FG002|Double-blind Period|Withdrawal by Subject|0|||
46719871|NCT00853099|82936006|FG003|Double-blind Period|Withdrawal by Subject|0|||
46719872|NCT00853099|82936003|FG000|Double-blind Period|Lack of Efficacy|14|||
46719873|NCT00853099|82936004|FG001|Double-blind Period|Lack of Efficacy|17|||
46719874|NCT00853099|82936005|FG002|Double-blind Period|Lack of Efficacy|16|||
46719875|NCT00853099|82936006|FG003|Double-blind Period|Lack of Efficacy|0|||
46917576|NCT03043365|83148983|FG000|Weeks 0 to Week 8|Adverse Event|1|||
46917577|NCT03043365|83148984|FG001|Weeks 0 to Week 8|Adverse Event|3|||
46917578|NCT03043365|83148983|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
46917579|NCT03043365|83148984|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
46917580|NCT03043365|83148983|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
47041434|NCT01920061|83297872|FG017|Overall Study|Death|0|||
46917581|NCT03043365|83148984|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
47041435|NCT01920061|83297873|FG018|Overall Study|Death|1|||
46917582|NCT03108157|83148994|FG000|Overall Study|Protocol Violation|15|||
46917583|NCT03108157|83148995|FG001|Overall Study|Protocol Violation|4|||
46917584|NCT04421131|83149002|FG000|Overall Study|Lost to Follow-up|1|||
46917585|NCT04421131|83149002|FG000|Overall Study|Protocol Violation|2|||
46917586|NCT04421131|83149002|FG000|Overall Study|App crashed|5|||
46917587|NCT04167345|83149011|FG000|Overall Study|Other|1|||
46917588|NCT04167345|83149012|FG001|Overall Study|Other|1|||
46917589|NCT04167345|83149013|FG002|Overall Study|Other|0|||
46917590|NCT04167345|83149014|FG003|Overall Study|Other|0|||
46917591|NCT04167345|83149015|FG004|Overall Study|Other|0|||
46917592|NCT02854800|83149034|FG000|Overall Study|Protocol Violation|16|||
46917593|NCT02854800|83149035|FG001|Overall Study|Protocol Violation|11|||
46917594|NCT02854800|83149036|FG002|Overall Study|Protocol Violation|3|||
46917595|NCT02854800|83149034|FG000|Overall Study|Withdrawal by Subject|4|||
46917596|NCT02854800|83149035|FG001|Overall Study|Withdrawal by Subject|2|||
46917597|NCT02854800|83149036|FG002|Overall Study|Withdrawal by Subject|3|||
46917598|NCT02931539|83149049|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
46917599|NCT02931539|83149050|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
46917600|NCT02931539|83149051|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
46917601|NCT02931539|83149049|FG000|Period 1: Treatment Phase|Adverse Event|5|||
46917602|NCT02931539|83149050|FG001|Period 1: Treatment Phase|Adverse Event|1|||
46917603|NCT02931539|83149051|FG002|Period 1: Treatment Phase|Adverse Event|0|||
46917604|NCT02931539|83149049|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
46917605|NCT02931539|83149050|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
46917606|NCT02931539|83149051|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
46917607|NCT02931539|83149049|FG000|Period 1: Treatment Phase|Death|8|||
46917608|NCT02931539|83149050|FG001|Period 1: Treatment Phase|Death|24|||
46917609|NCT02931539|83149051|FG002|Period 1: Treatment Phase|Death|0|||
46917610|NCT02931539|83149049|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
46917611|NCT02931539|83149050|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
46917612|NCT02931539|83149051|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
46917613|NCT02931539|83149049|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
46917614|NCT02931539|83149050|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
46917615|NCT02931539|83149051|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
46917616|NCT02931539|83149049|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
46917617|NCT02931539|83149050|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
46917618|NCT02931539|83149051|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
46917619|NCT02931539|83149049|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
46917620|NCT02931539|83149050|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
46917621|NCT02931539|83149051|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
46917622|NCT04042077|83149068|FG000|Overall Study|Adverse Event|0|||
47041436|NCT01920061|83297874|FG019|Overall Study|Death|0|||
47041437|NCT01920061|83297855|FG000|Overall Study|Lost to Follow-up|0|||
47041438|NCT01920061|83297856|FG001|Overall Study|Lost to Follow-up|2|||
47041439|NCT01920061|83297857|FG002|Overall Study|Lost to Follow-up|0|||
47041440|NCT01920061|83297858|FG003|Overall Study|Lost to Follow-up|0|||
47041441|NCT01920061|83297859|FG004|Overall Study|Lost to Follow-up|0|||
47041442|NCT01920061|83297860|FG005|Overall Study|Lost to Follow-up|0|||
47041443|NCT01920061|83297861|FG006|Overall Study|Lost to Follow-up|1|||
47041444|NCT01920061|83297862|FG007|Overall Study|Lost to Follow-up|0|||
47041445|NCT01920061|83297863|FG008|Overall Study|Lost to Follow-up|0|||
47041446|NCT01920061|83297864|FG009|Overall Study|Lost to Follow-up|0|||
47041447|NCT01920061|83297865|FG010|Overall Study|Lost to Follow-up|3|||
47041448|NCT01920061|83297866|FG011|Overall Study|Lost to Follow-up|0|||
47041449|NCT01920061|83297867|FG012|Overall Study|Lost to Follow-up|0|||
47041450|NCT01920061|83297868|FG013|Overall Study|Lost to Follow-up|0|||
47041451|NCT01920061|83297869|FG014|Overall Study|Lost to Follow-up|0|||
47041452|NCT01920061|83297870|FG015|Overall Study|Lost to Follow-up|0|||
47041453|NCT01920061|83297871|FG016|Overall Study|Lost to Follow-up|0|||
46719876|NCT00853099|82936003|FG000|Double-blind Period|Other|0|||
46917623|NCT04042077|83149069|FG001|Overall Study|Adverse Event|1|||
47041454|NCT01920061|83297872|FG017|Overall Study|Lost to Follow-up|1|||
47041455|NCT01920061|83297873|FG018|Overall Study|Lost to Follow-up|4|||
47041456|NCT01920061|83297874|FG019|Overall Study|Lost to Follow-up|3|||
46632641|NCT01816074|82805815|FG002|Phase 1|Time commitment issues|1|||
46632642|NCT01816074|82805816|FG003|Phase 1|Time commitment issues|0|||
46632643|NCT01816074|82805813|FG000|Phase 2|Time commitment Issues|0|||
46632644|NCT01816074|82805814|FG001|Phase 2|Time commitment Issues|2|||
46632645|NCT01816074|82805815|FG002|Phase 2|Time commitment Issues|0|||
46719877|NCT00853099|82936004|FG001|Double-blind Period|Other|0|||
46917624|NCT04042077|83149068|FG000|Overall Study|Death|2|||
46917625|NCT04042077|83149069|FG001|Overall Study|Death|1|||
46917626|NCT04042077|83149068|FG000|Overall Study|Physician Decision|2|||
46917627|NCT04042077|83149069|FG001|Overall Study|Physician Decision|0|||
47041457|NCT01920061|83297855|FG000|Overall Study|Other|1|||
47041458|NCT01920061|83297856|FG001|Overall Study|Other|1|||
47041459|NCT01920061|83297857|FG002|Overall Study|Other|2|||
46719878|NCT00853099|82936005|FG002|Double-blind Period|Other|1|||
46719879|NCT00853099|82936006|FG003|Double-blind Period|Other|0|||
46719880|NCT00853099|82936003|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
46719881|NCT00853099|82936004|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
46719882|NCT00853099|82936005|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
46719883|NCT00853099|82936006|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
46719884|NCT00853099|82936003|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
46719885|NCT00853099|82936004|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
46719886|NCT00853099|82936005|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
46719887|NCT00853099|82936006|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
46719888|NCT00853099|82936003|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
46719889|NCT00853099|82936004|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
46719890|NCT00853099|82936005|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
46719891|NCT00853099|82936006|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
46719892|NCT00853099|82936003|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
46719893|NCT00853099|82936004|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
46719894|NCT00853099|82936005|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
46719895|NCT00853099|82936006|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
46719896|NCT00853099|82936003|FG000|Double-blind + Open-label Periods|Other|0|||
46719897|NCT00853099|82936004|FG001|Double-blind + Open-label Periods|Other|0|||
46719898|NCT00853099|82936005|FG002|Double-blind + Open-label Periods|Other|0|||
46719899|NCT00853099|82936006|FG003|Double-blind + Open-label Periods|Other|6|||
46719900|NCT00992784|82936019|FG000|Overall Study|Adverse Event|2|||
46719901|NCT00992784|82936020|FG001|Overall Study|Adverse Event|1|||
46719902|NCT00992784|82936021|FG002|Overall Study|Adverse Event|0|||
46719903|NCT00992784|82936019|FG000|Overall Study|Withdrawal by Subject|1|||
46719904|NCT00992784|82936020|FG001|Overall Study|Withdrawal by Subject|1|||
46719905|NCT00992784|82936021|FG002|Overall Study|Withdrawal by Subject|1|||
46719906|NCT00830167|82936031|FG000|Overall Study|Lack of Efficacy|26|||
46719907|NCT00830167|82936032|FG001|Overall Study|Lack of Efficacy|10|||
47041460|NCT01920061|83297858|FG003|Overall Study|Other|1|||
47041461|NCT01920061|83297859|FG004|Overall Study|Other|0|||
47041462|NCT01920061|83297860|FG005|Overall Study|Other|1|||
47041463|NCT01920061|83297861|FG006|Overall Study|Other|0|||
47041464|NCT01920061|83297862|FG007|Overall Study|Other|0|||
47041465|NCT01920061|83297863|FG008|Overall Study|Other|0|||
47041466|NCT01920061|83297864|FG009|Overall Study|Other|1|||
47041467|NCT01920061|83297865|FG010|Overall Study|Other|1|||
47041468|NCT01920061|83297866|FG011|Overall Study|Other|2|||
47041469|NCT01920061|83297867|FG012|Overall Study|Other|1|||
47041470|NCT01920061|83297868|FG013|Overall Study|Other|4|||
47041471|NCT01920061|83297869|FG014|Overall Study|Other|0|||
47041472|NCT01920061|83297870|FG015|Overall Study|Other|1|||
47041473|NCT01920061|83297871|FG016|Overall Study|Other|1|||
47041474|NCT01920061|83297872|FG017|Overall Study|Other|0|||
47041475|NCT01920061|83297873|FG018|Overall Study|Other|1|||
47041476|NCT01920061|83297874|FG019|Overall Study|Other|1|||
47041477|NCT01920061|83297855|FG000|Overall Study|Participant refused further follow-up|0|||
47041478|NCT01920061|83297856|FG001|Overall Study|Participant refused further follow-up|0|||
47041479|NCT01920061|83297857|FG002|Overall Study|Participant refused further follow-up|0|||
47041480|NCT01920061|83297858|FG003|Overall Study|Participant refused further follow-up|0|||
46632646|NCT01816074|82805816|FG003|Phase 2|Time commitment Issues|0|||
46632647|NCT01816074|82805813|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
46632648|NCT01816074|82805814|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
46632649|NCT01816074|82805815|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
46632650|NCT01816074|82805816|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
46632651|NCT01816074|82805813|FG000|Phase 2|Physician Decision|0|||
46632652|NCT01816074|82805814|FG001|Phase 2|Physician Decision|0|||
46632653|NCT01816074|82805815|FG002|Phase 2|Physician Decision|0|||
46632654|NCT01816074|82805816|FG003|Phase 2|Physician Decision|1|||
46719908|NCT00830167|82936031|FG000|Overall Study|Adverse Event|8|||
46719909|NCT00830167|82936032|FG001|Overall Study|Adverse Event|24|||
46719910|NCT00830167|82936031|FG000|Overall Study|Not meeting entrance criteria|2|||
46719911|NCT00830167|82936032|FG001|Overall Study|Not meeting entrance criteria|5|||
46719912|NCT00830167|82936031|FG000|Overall Study|Withdrawal by Subject|2|||
46719913|NCT00830167|82936032|FG001|Overall Study|Withdrawal by Subject|0|||
46719914|NCT00830167|82936031|FG000|Overall Study|Lost to Follow-up|0|||
46719915|NCT00830167|82936032|FG001|Overall Study|Lost to Follow-up|1|||
46719916|NCT00830167|82936031|FG000|Overall Study|Protocol Violation|0|||
46719917|NCT00830167|82936032|FG001|Overall Study|Protocol Violation|1|||
46632655|NCT01816074|82805813|FG000|Phase 2|Withdrawal by Subject|1|||
47041481|NCT01920061|83297859|FG004|Overall Study|Participant refused further follow-up|1|||
47041482|NCT01920061|83297860|FG005|Overall Study|Participant refused further follow-up|1|||
47041483|NCT01920061|83297861|FG006|Overall Study|Participant refused further follow-up|0|||
47041484|NCT01920061|83297862|FG007|Overall Study|Participant refused further follow-up|0|||
46917628|NCT04042077|83149068|FG000|Overall Study|Withdrawal by Subject|3|||
46917629|NCT04042077|83149069|FG001|Overall Study|Withdrawal by Subject|2|||
46917630|NCT04042077|83149068|FG000|Overall Study|Lack of Efficacy|0|||
46719918|NCT00830167|82936031|FG000|Overall Study|Other|2|||
46719919|NCT00830167|82936032|FG001|Overall Study|Other|2|||
46917631|NCT04042077|83149069|FG001|Overall Study|Lack of Efficacy|1|||
46917632|NCT02853318|83149090|FG000|Overall Study|Withdrawal by Subject|1|||
46917633|NCT03113071|83149100|FG000|Overall Study|Withdrawal by Subject|1|||
46917634|NCT03113071|83149101|FG001|Overall Study|Withdrawal by Subject|0|||
46917635|NCT03050307|83149109|FG000|Overall Study|Adverse Event|4|||
46917636|NCT03050307|83149110|FG001|Overall Study|Adverse Event|2|||
46917637|NCT03050307|83149109|FG000|Overall Study|Significant Protocol Deviation|0|||
46917638|NCT03050307|83149110|FG001|Overall Study|Significant Protocol Deviation|1|||
46917639|NCT03050307|83149109|FG000|Overall Study|Lost to Follow-up|0|||
46917640|NCT03050307|83149110|FG001|Overall Study|Lost to Follow-up|1|||
46917641|NCT03050307|83149109|FG000|Overall Study|Voluntary Withdrawal|3|||
46917642|NCT03050307|83149110|FG001|Overall Study|Voluntary Withdrawal|4|||
46917643|NCT03050307|83149109|FG000|Overall Study|Reason not Specified|1|||
46917644|NCT03050307|83149110|FG001|Overall Study|Reason not Specified|1|||
46917645|NCT03118765|83149136|FG000|Overall Study|Withdrawal by Subject|0|||
46917646|NCT03118765|83149137|FG001|Overall Study|Withdrawal by Subject|0|||
46917647|NCT03118765|83149138|FG002|Overall Study|Withdrawal by Subject|1|||
46917648|NCT03118765|83149139|FG003|Overall Study|Withdrawal by Subject|0|||
46917649|NCT03118765|83149140|FG004|Overall Study|Withdrawal by Subject|0|||
46917650|NCT03118765|83149136|FG000|Overall Study|Adverse Event|1|||
46917651|NCT03118765|83149137|FG001|Overall Study|Adverse Event|1|||
46917652|NCT03118765|83149138|FG002|Overall Study|Adverse Event|1|||
46917653|NCT03118765|83149139|FG003|Overall Study|Adverse Event|1|||
46917654|NCT03118765|83149140|FG004|Overall Study|Adverse Event|1|||
46917655|NCT03118765|83149136|FG000|Overall Study|Non compliance with Study Procedures|0|||
46917656|NCT03118765|83149137|FG001|Overall Study|Non compliance with Study Procedures|0|||
46917657|NCT03118765|83149138|FG002|Overall Study|Non compliance with Study Procedures|0|||
46917658|NCT03118765|83149139|FG003|Overall Study|Non compliance with Study Procedures|1|||
46917659|NCT03118765|83149140|FG004|Overall Study|Non compliance with Study Procedures|0|||
46917660|NCT03118765|83149136|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
46917661|NCT03118765|83149137|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
46917662|NCT03118765|83149138|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
46917663|NCT03118765|83149139|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
46917664|NCT03118765|83149140|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
46917665|NCT03118765|83149136|FG000|Overall Study|COPD Exacerbation|1|||
46917666|NCT03118765|83149137|FG001|Overall Study|COPD Exacerbation|0|||
46917667|NCT03118765|83149138|FG002|Overall Study|COPD Exacerbation|0|||
46917668|NCT03118765|83149139|FG003|Overall Study|COPD Exacerbation|1|||
46917669|NCT03118765|83149140|FG004|Overall Study|COPD Exacerbation|0|||
46917670|NCT03118765|83149136|FG000|Overall Study|Lost to Follow-up|1|||
46917671|NCT03118765|83149137|FG001|Overall Study|Lost to Follow-up|0|||
46917672|NCT03118765|83149138|FG002|Overall Study|Lost to Follow-up|1|||
46917673|NCT03118765|83149139|FG003|Overall Study|Lost to Follow-up|0|||
46917674|NCT03118765|83149140|FG004|Overall Study|Lost to Follow-up|0|||
46917675|NCT03118765|83149136|FG000|Overall Study|Sponsor Decision|1|||
46917676|NCT03118765|83149137|FG001|Overall Study|Sponsor Decision|0|||
46917677|NCT03118765|83149138|FG002|Overall Study|Sponsor Decision|1|||
46917678|NCT03118765|83149139|FG003|Overall Study|Sponsor Decision|0|||
46917679|NCT03118765|83149140|FG004|Overall Study|Sponsor Decision|1|||
46917680|NCT05222880|83149159|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
46917681|NCT05222880|83149159|FG000|Overall Study|Withdrew Consent during Study|1|||
46917682|NCT05222880|83149159|FG000|Overall Study|COVID-19 Related|1|||
46719920|NCT00992394|82936040|FG000|Overall Study|Lack of Efficacy|6|||
46917683|NCT04810962|83149176|FG000|Overall Study|Adverse Event|0|||
46917684|NCT04810962|83149177|FG001|Overall Study|Adverse Event|1|||
46917685|NCT04810962|83149176|FG000|Overall Study|Lost to Follow-up|2|||
46917686|NCT04810962|83149177|FG001|Overall Study|Lost to Follow-up|1|||
46917687|NCT04810962|83149176|FG000|Overall Study|Physician Decision|1|||
46917688|NCT04810962|83149177|FG001|Overall Study|Physician Decision|0|||
46917689|NCT04810962|83149176|FG000|Overall Study|Withdrawal by Subject|1|||
46917690|NCT04810962|83149177|FG001|Overall Study|Withdrawal by Subject|3|||
46967639|NCT02123134|83210188|FG000|Overall Study|Withdrawal of consent|3|||
46967640|NCT02123134|83210189|FG001|Overall Study|Withdrawal of consent|2|||
46967641|NCT02123134|83210188|FG000|Overall Study|Administrative decision|0|||
46967642|NCT02123134|83210189|FG001|Overall Study|Administrative decision|1|||
46967643|NCT02185534|83210201|FG000|First Period|Withdrawal by Subject|0|||
46967644|NCT02185534|83210202|FG001|First Period|Withdrawal by Subject|0|||
46967645|NCT02185534|83210203|FG002|First Period|Withdrawal by Subject|0|||
46967646|NCT02185534|83210204|FG003|First Period|Withdrawal by Subject|1|||
46967647|NCT02185534|83210205|FG004|First Period|Withdrawal by Subject|0|||
46967648|NCT02185534|83210206|FG005|First Period|Withdrawal by Subject|0|||
46917691|NCT04810962|83149176|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
46917692|NCT04810962|83149177|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
46917693|NCT04606134|83149210|FG000|Overall Study|Adverse Event|0|||
46917694|NCT04606134|83149211|FG001|Overall Study|Adverse Event|1|||
46917695|NCT04426825|83149217|FG000|Overall Study|Continuing on study|6|||
46917696|NCT04426825|83149217|FG000|Overall Study|Death|17|||
46917697|NCT04399538|83149226|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
46917698|NCT04399538|83149227|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
46917699|NCT04399538|83149228|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
46917700|NCT04399538|83149229|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
46917701|NCT04399538|83149230|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
46917702|NCT04399538|83149226|FG000|Double-Blind Treatment|Adverse Event|0|||
46917703|NCT04399538|83149227|FG001|Double-Blind Treatment|Adverse Event|0|||
46917704|NCT04399538|83149228|FG002|Double-Blind Treatment|Adverse Event|0|||
46917705|NCT04399538|83149229|FG003|Double-Blind Treatment|Adverse Event|0|||
46917706|NCT04399538|83149230|FG004|Double-Blind Treatment|Adverse Event|1|||
46917707|NCT04399538|83149226|FG000|Follow-Up|Adverse Event|0|||
46917708|NCT04399538|83149227|FG001|Follow-Up|Adverse Event|0|||
46917709|NCT04399538|83149228|FG002|Follow-Up|Adverse Event|0|||
46917710|NCT04399538|83149229|FG003|Follow-Up|Adverse Event|0|||
46917711|NCT04399538|83149230|FG004|Follow-Up|Adverse Event|1|||
46917712|NCT04399538|83149226|FG000|Follow-Up|Withdrawal by Subject|0|||
46917713|NCT04399538|83149227|FG001|Follow-Up|Withdrawal by Subject|0|||
46917714|NCT04399538|83149228|FG002|Follow-Up|Withdrawal by Subject|0|||
46917715|NCT04399538|83149229|FG003|Follow-Up|Withdrawal by Subject|2|||
46917716|NCT04399538|83149230|FG004|Follow-Up|Withdrawal by Subject|0|||
46917717|NCT03094832|83149289|FG000|Overall Study|Lost to Follow-up|0|||
46917718|NCT03094832|83149290|FG001|Overall Study|Lost to Follow-up|0|||
46917719|NCT03094832|83149291|FG002|Overall Study|Lost to Follow-up|0|||
46917720|NCT03094832|83149292|FG003|Overall Study|Lost to Follow-up|1|||
46917721|NCT03094832|83149293|FG004|Overall Study|Lost to Follow-up|1|||
46917722|NCT03094832|83149289|FG000|Overall Study|Death|1|||
46917723|NCT03094832|83149290|FG001|Overall Study|Death|0|||
46917724|NCT03094832|83149291|FG002|Overall Study|Death|0|||
46917725|NCT03094832|83149292|FG003|Overall Study|Death|0|||
46917726|NCT03094832|83149293|FG004|Overall Study|Death|0|||
46917727|NCT03094832|83149289|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
46917728|NCT03094832|83149290|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46917729|NCT03094832|83149291|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
46917730|NCT03094832|83149292|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
46917731|NCT03094832|83149293|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
46917732|NCT03094832|83149289|FG000|Overall Study|Other|13|||
46917733|NCT03094832|83149290|FG001|Overall Study|Other|20|||
46917734|NCT03094832|83149291|FG002|Overall Study|Other|1|||
46917735|NCT03094832|83149292|FG003|Overall Study|Other|7|||
46917736|NCT03094832|83149293|FG004|Overall Study|Other|1|||
46917737|NCT03036579|83149307|FG000|2 Years|Lost to Follow-up|1|||
46917738|NCT03036579|83149308|FG001|2 Years|Lost to Follow-up|0|||
46917739|NCT03036579|83149307|FG000|3 Years|Lost to Follow-up|0|||
46917740|NCT03036579|83149308|FG001|3 Years|Lost to Follow-up|1|||
46719921|NCT00992394|82936041|FG001|Overall Study|Lack of Efficacy|3|||
46719922|NCT00992394|82936040|FG000|Overall Study|Adverse Event|4|||
46719923|NCT00992394|82936041|FG001|Overall Study|Adverse Event|5|||
46632656|NCT01816074|82805814|FG001|Phase 2|Withdrawal by Subject|0|||
46632657|NCT01816074|82805815|FG002|Phase 2|Withdrawal by Subject|0|||
46632658|NCT01816074|82805816|FG003|Phase 2|Withdrawal by Subject|0|||
46632659|NCT01815918|82805842|FG000|Overall Study|Patient samples not analyzable|3|||
46632660|NCT01815918|82805843|FG001|Overall Study|Patient samples not analyzable|4|||
46632661|NCT01815918|82805842|FG000|Overall Study|Lack of Efficacy|15|||
46632662|NCT01815918|82805843|FG001|Overall Study|Lack of Efficacy|15|||
46632663|NCT01789476|82805855|FG000|Overall Study|Lack of Efficacy|6|||
46632664|NCT01789476|82805856|FG001|Overall Study|Lack of Efficacy|2|||
46719924|NCT00992394|82936040|FG000|Overall Study|Withdrawal by Subject|8|||
46719925|NCT00992394|82936041|FG001|Overall Study|Withdrawal by Subject|2|||
46917741|NCT02867761|83149316|FG000|Overall Study|Participant withdrawn by investigator|0|||
46917742|NCT02867761|83149317|FG001|Overall Study|Participant withdrawn by investigator|1|||
46917743|NCT02867761|83149316|FG000|Overall Study|Lost to Follow-up|25|||
46917744|NCT02867761|83149317|FG001|Overall Study|Lost to Follow-up|18|||
46917745|NCT02867761|83149316|FG000|Overall Study|Unable to complete protocol|3|||
46632665|NCT01789476|82805855|FG000|Overall Study|Adverse Event|1|||
46719926|NCT00992394|82936040|FG000|Overall Study|Physician Decision|1|||
46719927|NCT00992394|82936041|FG001|Overall Study|Physician Decision|0|||
46917746|NCT02867761|83149317|FG001|Overall Study|Unable to complete protocol|7|||
46917747|NCT02719990|83149332|FG000|Overall Study|Physician Decision|2|||
46917748|NCT02719990|83149332|FG000|Overall Study|Withdrawal by Subject|2|||
46917749|NCT02719990|83149332|FG000|Overall Study|Study Terminated By Sponsor|32|||
46632666|NCT01789476|82805856|FG001|Overall Study|Adverse Event|0|||
46917750|NCT02494583|83149339|FG000|Overall Study|Death|224|||
46917751|NCT02494583|83149340|FG001|Overall Study|Death|214|||
46917752|NCT02494583|83149341|FG002|Overall Study|Death|225|||
46917753|NCT02494583|83149339|FG000|Overall Study|Lost to Follow-up|1|||
46917754|NCT02494583|83149340|FG001|Overall Study|Lost to Follow-up|0|||
46917755|NCT02494583|83149341|FG002|Overall Study|Lost to Follow-up|0|||
46917756|NCT02494583|83149339|FG000|Overall Study|Protocol Violation|1|||
46917757|NCT02494583|83149340|FG001|Overall Study|Protocol Violation|2|||
46917758|NCT02494583|83149341|FG002|Overall Study|Protocol Violation|0|||
46917759|NCT02494583|83149339|FG000|Overall Study|Screen Failure|0|||
46719928|NCT00992394|82936040|FG000|Overall Study|Protocol Violation|2|||
46917760|NCT02494583|83149340|FG001|Overall Study|Screen Failure|1|||
46917761|NCT02494583|83149341|FG002|Overall Study|Screen Failure|0|||
46917762|NCT02494583|83149339|FG000|Overall Study|Transferred to Extension Study|15|||
46917763|NCT02494583|83149340|FG001|Overall Study|Transferred to Extension Study|15|||
46917764|NCT02494583|83149341|FG002|Overall Study|Transferred to Extension Study|6|||
46917765|NCT02494583|83149339|FG000|Overall Study|Did Not Continue on Extension Study|8|||
46917766|NCT02494583|83149340|FG001|Overall Study|Did Not Continue on Extension Study|10|||
46917767|NCT02494583|83149341|FG002|Overall Study|Did Not Continue on Extension Study|4|||
46917768|NCT02494583|83149339|FG000|Overall Study|Withdrawal by Subject|7|||
46917769|NCT02494583|83149340|FG001|Overall Study|Withdrawal by Subject|15|||
46917770|NCT02494583|83149341|FG002|Overall Study|Withdrawal by Subject|15|||
46917771|NCT02322814|83149356|FG000|Overall Study|Death|7|||
46917772|NCT02322814|83149357|FG001|Overall Study|Death|29|||
46719929|NCT00992394|82936041|FG001|Overall Study|Protocol Violation|4|||
46719930|NCT00992394|82936040|FG000|Overall Study|Lost to Follow-up|2|||
46719931|NCT00992394|82936041|FG001|Overall Study|Lost to Follow-up|0|||
46719932|NCT00992394|82936040|FG000|Overall Study|Other event|1|||
46917773|NCT02322814|83149358|FG002|Overall Study|Death|32|||
46917774|NCT02322814|83149359|FG003|Overall Study|Death|23|||
46917775|NCT02322814|83149360|FG004|Overall Study|Death|14|||
46917776|NCT02322814|83149356|FG000|Overall Study|Lost to Follow-up|1|||
46917777|NCT02322814|83149357|FG001|Overall Study|Lost to Follow-up|3|||
46917778|NCT02322814|83149358|FG002|Overall Study|Lost to Follow-up|3|||
46917779|NCT02322814|83149359|FG003|Overall Study|Lost to Follow-up|1|||
46917780|NCT02322814|83149360|FG004|Overall Study|Lost to Follow-up|0|||
46917781|NCT02322814|83149356|FG000|Overall Study|Various Reasons|2|||
46917782|NCT02322814|83149357|FG001|Overall Study|Various Reasons|0|||
46917783|NCT02322814|83149358|FG002|Overall Study|Various Reasons|1|||
46917784|NCT02322814|83149359|FG003|Overall Study|Various Reasons|1|||
46917785|NCT02322814|83149360|FG004|Overall Study|Various Reasons|0|||
46917786|NCT02322814|83149356|FG000|Overall Study|Progressive Disease|0|||
46917787|NCT02322814|83149357|FG001|Overall Study|Progressive Disease|0|||
46917788|NCT02322814|83149358|FG002|Overall Study|Progressive Disease|0|||
46917789|NCT02322814|83149359|FG003|Overall Study|Progressive Disease|1|||
46917790|NCT02322814|83149360|FG004|Overall Study|Progressive Disease|1|||
46917791|NCT02322814|83149356|FG000|Overall Study|Protocol Violation|1|||
46917792|NCT02322814|83149357|FG001|Overall Study|Protocol Violation|0|||
46917793|NCT02322814|83149358|FG002|Overall Study|Protocol Violation|0|||
47041485|NCT01920061|83297863|FG008|Overall Study|Participant refused further follow-up|1|||
47041486|NCT01920061|83297864|FG009|Overall Study|Participant refused further follow-up|0|||
47041487|NCT01920061|83297865|FG010|Overall Study|Participant refused further follow-up|1|||
47041488|NCT01920061|83297866|FG011|Overall Study|Participant refused further follow-up|0|||
47041489|NCT01920061|83297867|FG012|Overall Study|Participant refused further follow-up|1|||
47041490|NCT01920061|83297868|FG013|Overall Study|Participant refused further follow-up|0|||
47041491|NCT01920061|83297869|FG014|Overall Study|Participant refused further follow-up|1|||
47041492|NCT01920061|83297870|FG015|Overall Study|Participant refused further follow-up|2|||
47041493|NCT01920061|83297871|FG016|Overall Study|Participant refused further follow-up|1|||
47041494|NCT01920061|83297872|FG017|Overall Study|Participant refused further follow-up|1|||
46719933|NCT00992394|82936041|FG001|Overall Study|Other event|0|||
46719934|NCT00829933|82936051|FG000|Overall Study|Adverse Event|2|||
46719935|NCT00829933|82936052|FG001|Overall Study|Adverse Event|3|||
46917794|NCT02322814|83149359|FG003|Overall Study|Protocol Violation|0|||
46917795|NCT02322814|83149360|FG004|Overall Study|Protocol Violation|0|||
46917796|NCT02322814|83149356|FG000|Overall Study|Study Terminated by Sponsor|0|||
46917797|NCT02322814|83149357|FG001|Overall Study|Study Terminated by Sponsor|7|||
46917798|NCT02322814|83149358|FG002|Overall Study|Study Terminated by Sponsor|9|||
46917799|NCT02322814|83149359|FG003|Overall Study|Study Terminated by Sponsor|5|||
47041495|NCT01920061|83297873|FG018|Overall Study|Participant refused further follow-up|0|||
46719936|NCT00829933|82936053|FG002|Overall Study|Adverse Event|2|||
46917800|NCT02322814|83149360|FG004|Overall Study|Study Terminated by Sponsor|13|||
46917801|NCT02322814|83149356|FG000|Overall Study|Withdrawal by Subject|5|||
46917802|NCT02322814|83149357|FG001|Overall Study|Withdrawal by Subject|4|||
46917803|NCT02322814|83149358|FG002|Overall Study|Withdrawal by Subject|2|||
46917804|NCT02322814|83149359|FG003|Overall Study|Withdrawal by Subject|1|||
46917805|NCT02322814|83149360|FG004|Overall Study|Withdrawal by Subject|3|||
46917806|NCT01333033|83149382|FG000|Overall Study|Ineligible|0|||
46917807|NCT01333033|83149383|FG001|Overall Study|Ineligible|0|||
46917808|NCT01333033|83149384|FG002|Overall Study|Ineligible|0|||
46917809|NCT01333033|83149385|FG003|Overall Study|Ineligible|0|||
46917810|NCT01333033|83149386|FG004|Overall Study|Ineligible|6|||
46917811|NCT01333033|83149387|FG005|Overall Study|Ineligible|8|||
46917812|NCT01333033|83149382|FG000|Overall Study|Withdrawal by Subject|0|||
46917813|NCT01333033|83149383|FG001|Overall Study|Withdrawal by Subject|0|||
46917814|NCT01333033|83149384|FG002|Overall Study|Withdrawal by Subject|0|||
46917815|NCT01333033|83149385|FG003|Overall Study|Withdrawal by Subject|0|||
46917816|NCT01333033|83149386|FG004|Overall Study|Withdrawal by Subject|4|||
46917817|NCT01333033|83149387|FG005|Overall Study|Withdrawal by Subject|2|||
46917818|NCT01333033|83149382|FG000|Overall Study|PET inevaluable|0|||
47041496|NCT01920061|83297874|FG019|Overall Study|Participant refused further follow-up|0|||
47041497|NCT01426425|83297937|FG000|Overall Study|Exited prior to EP study|22|||
47041498|NCT01426425|83297937|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
47041499|NCT01426425|83297937|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
47041500|NCT01426347|83297950|FG000|Overall Study|Lost to Follow-up|0|||
46719937|NCT00829933|82936054|FG003|Overall Study|Adverse Event|1|||
46719938|NCT00829933|82936051|FG000|Overall Study|Death|0|||
46719939|NCT00829933|82936052|FG001|Overall Study|Death|0|||
46719940|NCT00829933|82936053|FG002|Overall Study|Death|1|||
46719941|NCT00829933|82936054|FG003|Overall Study|Death|1|||
46719942|NCT00829933|82936051|FG000|Overall Study|Lack of Efficacy|0|||
46719943|NCT00829933|82936052|FG001|Overall Study|Lack of Efficacy|1|||
46719944|NCT00829933|82936053|FG002|Overall Study|Lack of Efficacy|0|||
46719945|NCT00829933|82936054|FG003|Overall Study|Lack of Efficacy|0|||
46719946|NCT00829933|82936051|FG000|Overall Study|Physician Decision|5|||
46719947|NCT00829933|82936052|FG001|Overall Study|Physician Decision|7|||
46719948|NCT00829933|82936053|FG002|Overall Study|Physician Decision|8|||
46719949|NCT00829933|82936054|FG003|Overall Study|Physician Decision|1|||
46719950|NCT00829933|82936051|FG000|Overall Study|Pregnancy|0|||
46719951|NCT00829933|82936052|FG001|Overall Study|Pregnancy|0|||
46719952|NCT00829933|82936053|FG002|Overall Study|Pregnancy|0|||
46719953|NCT00829933|82936054|FG003|Overall Study|Pregnancy|2|||
46719954|NCT00829933|82936051|FG000|Overall Study|Protocol Violation|2|||
46917819|NCT01333033|83149383|FG001|Overall Study|PET inevaluable|0|||
46917820|NCT01333033|83149384|FG002|Overall Study|PET inevaluable|0|||
46917821|NCT01333033|83149385|FG003|Overall Study|PET inevaluable|0|||
46917822|NCT01333033|83149386|FG004|Overall Study|PET inevaluable|2|||
47041501|NCT01426347|83297951|FG001|Overall Study|Lost to Follow-up|3|||
47041502|NCT01426347|83297950|FG000|Overall Study|Protocol Violation|2|||
46632667|NCT01789476|82805855|FG000|Overall Study|Unable to get IV access|1|||
46632668|NCT01789476|82805856|FG001|Overall Study|Unable to get IV access|0|||
46632669|NCT01789320|82805862|FG000|Overall Study|Re-enrolled into study|1|||
46632670|NCT01789320|82805862|FG000|Overall Study|Lost to Follow-up|1|||
46632671|NCT01815840|82805868|FG000|Overall Study|Missing|1|||
46632672|NCT01815840|82805869|FG001|Overall Study|Missing|0|||
46632673|NCT01815840|82805868|FG000|Overall Study|Withdrew Consent|31|||
46632674|NCT01815840|82805869|FG001|Overall Study|Withdrew Consent|30|||
46632675|NCT01815840|82805868|FG000|Overall Study|Administrative/Other|1|||
46632676|NCT01815840|82805869|FG001|Overall Study|Administrative/Other|3|||
46632677|NCT01815840|82805868|FG000|Overall Study|Adverse Event|10|||
46632678|NCT01815840|82805869|FG001|Overall Study|Adverse Event|16|||
46632679|NCT01815840|82805868|FG000|Overall Study|Death|2|||
46632680|NCT01815840|82805869|FG001|Overall Study|Death|2|||
46632681|NCT01815840|82805868|FG000|Overall Study|Disease progression|3|||
46632682|NCT01815840|82805869|FG001|Overall Study|Disease progression|2|||
46632683|NCT01815840|82805868|FG000|Overall Study|Investigators Decision|2|||
46632684|NCT01815840|82805869|FG001|Overall Study|Investigators Decision|3|||
46632685|NCT01815840|82805868|FG000|Overall Study|Lost to Follow-up|3|||
46632686|NCT01815840|82805869|FG001|Overall Study|Lost to Follow-up|6|||
46632687|NCT01815840|82805868|FG000|Overall Study|Refused Treatment|5|||
46632688|NCT01815840|82805869|FG001|Overall Study|Refused Treatment|1|||
46632689|NCT01815840|82805868|FG000|Overall Study|Sponsor Termination Treatment|1|||
46632690|NCT01815840|82805869|FG001|Overall Study|Sponsor Termination Treatment|0|||
46632691|NCT01774110|82805875|FG000|Overall Study|Lost to Follow-up|7|||
46719955|NCT00829933|82936052|FG001|Overall Study|Protocol Violation|1|||
46719956|NCT00829933|82936053|FG002|Overall Study|Protocol Violation|0|||
47041503|NCT01426347|83297951|FG001|Overall Study|Protocol Violation|0|||
47041504|NCT01426347|83297950|FG000|Overall Study|Withdrawal by Subject|5|||
47041505|NCT01426347|83297951|FG001|Overall Study|Withdrawal by Subject|0|||
46719957|NCT00829933|82936054|FG003|Overall Study|Protocol Violation|0|||
46917823|NCT01333033|83149387|FG005|Overall Study|PET inevaluable|4|||
46917824|NCT01333033|83149382|FG000|Overall Study|Adverse Event|0|||
47041506|NCT01882465|83297957|FG000|Period 1|Lens Discomfort|0|||
46917825|NCT01333033|83149383|FG001|Overall Study|Adverse Event|0|||
46632692|NCT01788228|82805882|FG000|Overall Study|Migrated/moved from study area|1|||
46917826|NCT01333033|83149384|FG002|Overall Study|Adverse Event|0|||
46719958|NCT00829933|82936051|FG000|Overall Study|withdrew before treatment started|5|||
46917827|NCT01333033|83149385|FG003|Overall Study|Adverse Event|0|||
46917828|NCT01333033|83149386|FG004|Overall Study|Adverse Event|2|||
46917829|NCT01333033|83149387|FG005|Overall Study|Adverse Event|1|||
46917830|NCT01333033|83149382|FG000|Overall Study|Progression|0|||
46917831|NCT01333033|83149383|FG001|Overall Study|Progression|0|||
46917832|NCT01333033|83149384|FG002|Overall Study|Progression|0|||
46917833|NCT01333033|83149385|FG003|Overall Study|Progression|0|||
46917834|NCT01333033|83149386|FG004|Overall Study|Progression|0|||
46917835|NCT01333033|83149387|FG005|Overall Study|Progression|1|||
46917836|NCT01333033|83149382|FG000|Overall Study|MD Decision|0|||
46917837|NCT01333033|83149383|FG001|Overall Study|MD Decision|0|||
46917838|NCT01333033|83149384|FG002|Overall Study|MD Decision|0|||
46917839|NCT01333033|83149385|FG003|Overall Study|MD Decision|0|||
46917840|NCT01333033|83149386|FG004|Overall Study|MD Decision|0|||
46917841|NCT01333033|83149387|FG005|Overall Study|MD Decision|2|||
46917842|NCT01192776|83149409|FG000|Overall Study|Death|8|||
46917843|NCT01192776|83149410|FG001|Overall Study|Death|15|||
46917844|NCT01192776|83149411|FG002|Overall Study|Death|18|||
46917845|NCT01192776|83149412|FG003|Overall Study|Death|15|||
46917846|NCT01192776|83149409|FG000|Overall Study|Lost to Follow-up|3|||
46917847|NCT01192776|83149410|FG001|Overall Study|Lost to Follow-up|6|||
46917848|NCT01192776|83149411|FG002|Overall Study|Lost to Follow-up|3|||
46917849|NCT01192776|83149412|FG003|Overall Study|Lost to Follow-up|5|||
46917850|NCT01367834|83149445|FG000|Overall Study|Withdrawal by Subject|2|||
46917851|NCT01367834|83149446|FG001|Overall Study|Withdrawal by Subject|2|||
46917852|NCT01367834|83149445|FG000|Overall Study|Study was ended.|0|||
46917853|NCT01367834|83149446|FG001|Overall Study|Study was ended.|1|||
46917854|NCT03106753|83149454|FG000|Overall Study|Withdrawal by Subject|0|||
46917855|NCT03106753|83149455|FG001|Overall Study|Withdrawal by Subject|1|||
47041507|NCT01882465|83297958|FG001|Period 1|Lens Discomfort|0|||
47041508|NCT01882465|83297959|FG002|Period 1|Lens Discomfort|0|||
47041509|NCT01882465|83297960|FG003|Period 1|Lens Discomfort|1|||
47041510|NCT01882465|83297961|FG004|Period 1|Lens Discomfort|0|||
47041511|NCT01882465|83297962|FG005|Period 1|Lens Discomfort|0|||
47041512|NCT01882465|83297963|FG006|Period 1|Lens Discomfort|0|||
47041513|NCT01882465|83297957|FG000|Period 1|Withdrawal by Subject|0|||
47041514|NCT01882465|83297958|FG001|Period 1|Withdrawal by Subject|0|||
47041515|NCT01882465|83297959|FG002|Period 1|Withdrawal by Subject|0|||
47041516|NCT01882465|83297960|FG003|Period 1|Withdrawal by Subject|0|||
47041517|NCT01882465|83297961|FG004|Period 1|Withdrawal by Subject|0|||
47041518|NCT01882465|83297962|FG005|Period 1|Withdrawal by Subject|0|||
47041519|NCT01882465|83297963|FG006|Period 1|Withdrawal by Subject|1|||
47041520|NCT01882465|83297957|FG000|Period 2|Protocol Violation|0|||
47041521|NCT01882465|83297958|FG001|Period 2|Protocol Violation|0|||
47041522|NCT01882465|83297959|FG002|Period 2|Protocol Violation|0|||
47041523|NCT01882465|83297960|FG003|Period 2|Protocol Violation|0|||
47041524|NCT01882465|83297961|FG004|Period 2|Protocol Violation|1|||
47041525|NCT01882465|83297962|FG005|Period 2|Protocol Violation|0|||
47041526|NCT01882465|83297963|FG006|Period 2|Protocol Violation|0|||
47041527|NCT01426269|83297971|FG000|Period 1: 12 Weeks|Adverse Event|5|||
46917856|NCT03045081|83149465|FG000|Overall Study|Withdrawal by Subject|6|||
46917857|NCT03045081|83149466|FG001|Overall Study|Withdrawal by Subject|11|||
46917858|NCT03107377|83149474|FG000|Overall Study|Adverse Event|3|||
46917859|NCT03107377|83149475|FG001|Overall Study|Adverse Event|3|||
46917860|NCT03107377|83149474|FG000|Overall Study|Protocol Violation|9|||
46917861|NCT03107377|83149475|FG001|Overall Study|Protocol Violation|12|||
46917862|NCT03107377|83149474|FG000|Overall Study|Physician Decision|3|||
46917863|NCT03107377|83149475|FG001|Overall Study|Physician Decision|6|||
46917864|NCT03107377|83149474|FG000|Overall Study|Pregnancy|7|||
46917865|NCT03107377|83149475|FG001|Overall Study|Pregnancy|7|||
46917866|NCT03107377|83149474|FG000|Overall Study|Withdrawal by Subject|16|||
46917867|NCT03107377|83149475|FG001|Overall Study|Withdrawal by Subject|22|||
46917868|NCT03107377|83149474|FG000|Overall Study|Lost to Follow-up|37|||
46917869|NCT03107377|83149475|FG001|Overall Study|Lost to Follow-up|34|||
46917870|NCT03107377|83149474|FG000|Overall Study|Other reason not specified|16|||
46719959|NCT00829933|82936052|FG001|Overall Study|withdrew before treatment started|1|||
46719960|NCT00829933|82936053|FG002|Overall Study|withdrew before treatment started|2|||
46917871|NCT03107377|83149475|FG001|Overall Study|Other reason not specified|15|||
47041528|NCT01426269|83297972|FG001|Period 1: 12 Weeks|Adverse Event|0|||
47041529|NCT01426269|83297973|FG002|Period 1: 12 Weeks|Adverse Event|0|||
47041530|NCT01426269|83297971|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
47041531|NCT01426269|83297972|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
47041532|NCT01426269|83297973|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
47041533|NCT01426269|83297971|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
47041534|NCT01426269|83297972|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
47041535|NCT01426269|83297973|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
47041536|NCT01426269|83297971|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
46917872|NCT02545283|83149483|FG000|Overall Study|Lost to Follow-up|2|||
46917873|NCT02545283|83149484|FG001|Overall Study|Lost to Follow-up|4|||
46917874|NCT02545283|83149483|FG000|Overall Study|Withdrawal by Subject|5|||
46917875|NCT02545283|83149484|FG001|Overall Study|Withdrawal by Subject|9|||
46917876|NCT02545283|83149483|FG000|Overall Study|Death|109|||
46917877|NCT02545283|83149484|FG001|Overall Study|Death|211|||
46719961|NCT00829933|82936054|FG003|Overall Study|withdrew before treatment started|9|||
46719962|NCT01170962|82936067|FG000|Treatment Period|Lack of Efficacy|96|||
46917878|NCT02545283|83149483|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
46917879|NCT02545283|83149484|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
46917880|NCT02545283|83149483|FG000|Overall Study|Study Terminated By Sponsor|33|||
46917881|NCT02545283|83149484|FG001|Overall Study|Study Terminated By Sponsor|71|||
46917882|NCT03282565|83149495|FG000|Overall Study|COVID-19 Research Shutdown|0|||
46917883|NCT03282565|83149496|FG001|Overall Study|COVID-19 Research Shutdown|2|||
46917884|NCT03282565|83149497|FG002|Overall Study|COVID-19 Research Shutdown|2|||
46917885|NCT02875613|83149505|FG000|Overall Study|Withdrawal by Subject|1|||
46917886|NCT02815267|83149515|FG000|Double-Blind Phase|Adverse Event|0|||
46917887|NCT02815267|83149516|FG001|Double-Blind Phase|Adverse Event|3|||
46917888|NCT02815267|83149515|FG000|Double-Blind Phase|Lost to Follow-up|17|||
46917889|NCT02815267|83149516|FG001|Double-Blind Phase|Lost to Follow-up|9|||
46917890|NCT02815267|83149515|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
46917891|NCT02815267|83149516|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
46917892|NCT02815267|83149515|FG000|Double-Blind Phase|Protocol Violation|3|||
46917893|NCT02815267|83149516|FG001|Double-Blind Phase|Protocol Violation|2|||
46719963|NCT01170962|82936068|FG001|Treatment Period|Lack of Efficacy|91|||
46719964|NCT01170962|82936069|FG002|Treatment Period|Lack of Efficacy|7|||
46719965|NCT01170962|82936067|FG000|Treatment Period|Adverse Event|11|||
46719966|NCT01170962|82936068|FG001|Treatment Period|Adverse Event|12|||
46719967|NCT01170962|82936069|FG002|Treatment Period|Adverse Event|3|||
46719968|NCT01170962|82936067|FG000|Treatment Period|Withdrawal by Subject|2|||
46719969|NCT01170962|82936068|FG001|Treatment Period|Withdrawal by Subject|1|||
46719970|NCT01170962|82936069|FG002|Treatment Period|Withdrawal by Subject|0|||
46719971|NCT01170962|82936067|FG000|Treatment Period|Lost to Follow-up|1|||
46719972|NCT01170962|82936068|FG001|Treatment Period|Lost to Follow-up|1|||
46719973|NCT01170962|82936069|FG002|Treatment Period|Lost to Follow-up|1|||
46719974|NCT01170962|82936067|FG000|Treatment Period|Participant no longer meets criteria|0|||
46719975|NCT01170962|82936068|FG001|Treatment Period|Participant no longer meets criteria|1|||
46719976|NCT01170962|82936069|FG002|Treatment Period|Participant no longer meets criteria|0|||
46719977|NCT01170962|82936067|FG000|Treatment Period|Request to discontinue treatment|7|||
46719978|NCT01170962|82936068|FG001|Treatment Period|Request to discontinue treatment|3|||
46719979|NCT01170962|82936069|FG002|Treatment Period|Request to discontinue treatment|1|||
46719980|NCT01170962|82936067|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
46719981|NCT01170962|82936068|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
46719982|NCT01170962|82936069|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
46719983|NCT01170962|82936067|FG000|Follow up Period|Withdrawal by Subject|14|||
46719984|NCT01170962|82936068|FG001|Follow up Period|Withdrawal by Subject|10|||
46719985|NCT01170962|82936069|FG002|Follow up Period|Withdrawal by Subject|2|||
46917894|NCT02815267|83149515|FG000|Double-Blind Phase|Site withdrawal|1|||
46917895|NCT02815267|83149516|FG001|Double-Blind Phase|Site withdrawal|6|||
46917896|NCT02815267|83149515|FG000|Double-Blind Phase|Received a disallowed medication|1|||
46917897|NCT02815267|83149516|FG001|Double-Blind Phase|Received a disallowed medication|1|||
46917898|NCT02815267|83149515|FG000|Open-Label Phase|Adverse Event|1|||
46632693|NCT01788228|82805883|FG001|Overall Study|Migrated/moved from study area|0|||
46632694|NCT01607346|82805892|FG000|Overall Study|Adverse Event|3|||
46632695|NCT01787838|82805896|FG000|Overall Study|refused|1413|||
46632696|NCT01787760|82805903|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
46632697|NCT01787760|82805904|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
46632698|NCT01787760|82805905|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
46632699|NCT01787760|82805903|FG000|Overall Study|Decompensated on left exotropia|0|||
46632700|NCT01787760|82805904|FG001|Overall Study|Decompensated on left exotropia|0|||
46632701|NCT01787760|82805905|FG002|Overall Study|Decompensated on left exotropia|1|||
46632702|NCT01787760|82805903|FG000|Overall Study|Dryness|0|||
46632703|NCT01787760|82805904|FG001|Overall Study|Dryness|1|||
46632704|NCT01787760|82805905|FG002|Overall Study|Dryness|0|||
46632705|NCT01787760|82805903|FG000|Overall Study|Relocation|1|||
46632706|NCT01787760|82805904|FG001|Overall Study|Relocation|1|||
46632707|NCT01787760|82805905|FG002|Overall Study|Relocation|0|||
46632708|NCT01787760|82805903|FG000|Overall Study|Lens discomfort|3|||
46632709|NCT01787760|82805904|FG001|Overall Study|Lens discomfort|0|||
46632710|NCT01787760|82805905|FG002|Overall Study|Lens discomfort|0|||
46632711|NCT01787760|82805903|FG000|Overall Study|Lens handling difficulty|1|||
46632712|NCT01787760|82805904|FG001|Overall Study|Lens handling difficulty|2|||
46632713|NCT01787760|82805905|FG002|Overall Study|Lens handling difficulty|0|||
46632714|NCT01787760|82805903|FG000|Overall Study|Protocol Violation|6|||
46632715|NCT01787760|82805904|FG001|Overall Study|Protocol Violation|0|||
46632716|NCT01787760|82805905|FG002|Overall Study|Protocol Violation|1|||
46632717|NCT01787760|82805903|FG000|Overall Study|Withdrawal by Subject|5|||
46632718|NCT01787760|82805904|FG001|Overall Study|Withdrawal by Subject|1|||
46632719|NCT01787760|82805905|FG002|Overall Study|Withdrawal by Subject|2|||
46632720|NCT01787760|82805903|FG000|Overall Study|Lost to Follow-up|1|||
46917899|NCT02815267|83149516|FG001|Open-Label Phase|Adverse Event|1|||
46917900|NCT02815267|83149515|FG000|Open-Label Phase|Lost to Follow-up|23|||
46917901|NCT02815267|83149516|FG001|Open-Label Phase|Lost to Follow-up|9|||
46917902|NCT02815267|83149515|FG000|Open-Label Phase|Withdrawal by Subject|24|||
46917903|NCT02815267|83149516|FG001|Open-Label Phase|Withdrawal by Subject|13|||
46917904|NCT02815267|83149515|FG000|Open-Label Phase|Protocol Violation|0|||
46917905|NCT02815267|83149516|FG001|Open-Label Phase|Protocol Violation|1|||
46917906|NCT02815267|83149515|FG000|Open-Label Phase|Administrative|21|||
46917907|NCT02815267|83149516|FG001|Open-Label Phase|Administrative|12|||
46917908|NCT02815267|83149515|FG000|Open-Label Phase|Other|2|||
46917909|NCT02815267|83149516|FG001|Open-Label Phase|Other|5|||
46917910|NCT02930837|83149526|FG000|Overall Study|Adverse Event|6|||
46917911|NCT02930837|83149526|FG000|Overall Study|Lost to Follow-up|5|||
46917912|NCT02930837|83149526|FG000|Overall Study|Withdrawal by Subject|1|||
46917913|NCT01343277|83149532|FG000|Overall Study|Other|3|||
46917914|NCT01343277|83149533|FG001|Overall Study|Other|3|||
46917915|NCT01343277|83149532|FG000|Overall Study|Withdrawal by Subject|18|||
46917916|NCT01343277|83149533|FG001|Overall Study|Withdrawal by Subject|13|||
46917917|NCT01343277|83149532|FG000|Overall Study|Physician Decision|1|||
46917918|NCT01343277|83149533|FG001|Overall Study|Physician Decision|2|||
46917919|NCT01343277|83149532|FG000|Overall Study|Death|10|||
46917920|NCT01343277|83149533|FG001|Overall Study|Death|1|||
46917921|NCT01343277|83149532|FG000|Overall Study|Adverse Event|67|||
46917922|NCT01343277|83149533|FG001|Overall Study|Adverse Event|13|||
46917923|NCT01343277|83149532|FG000|Overall Study|Disease progression|270|||
46917924|NCT01343277|83149533|FG001|Overall Study|Disease progression|138|||
46917925|NCT01343277|83149532|FG000|Overall Study|Randomized not treated|6|||
46917926|NCT01343277|83149533|FG001|Overall Study|Randomized not treated|21|||
46917927|NCT01343277|83149532|FG000|Overall Study|Treatment ongoing|8|||
46917928|NCT01343277|83149533|FG001|Overall Study|Treatment ongoing|2|||
46917929|NCT01343277|83149532|FG000|Overall Study|Subsequent anticancer therapy|1|||
46917930|NCT01343277|83149533|FG001|Overall Study|Subsequent anticancer therapy|0|||
46917931|NCT03135899|83149547|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
46917932|NCT03135899|83149548|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
46917933|NCT03135899|83149549|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
46917934|NCT03135899|83149550|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
47041537|NCT01426269|83297972|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
47041538|NCT01426269|83297973|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
47041539|NCT01426269|83297971|FG000|Period 1: 12 Weeks|Pregnancy|1|||
47041540|NCT01426269|83297972|FG001|Period 1: 12 Weeks|Pregnancy|0|||
46917935|NCT03135899|83149551|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
46917936|NCT03135899|83149552|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
47041541|NCT01426269|83297973|FG002|Period 1: 12 Weeks|Pregnancy|0|||
47041542|NCT01426269|83297971|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
47041543|NCT01426269|83297972|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
46917937|NCT03135899|83149553|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
46917938|NCT03135899|83149554|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
46917939|NCT03135899|83149547|FG000|Overall Study|Withdrawal by Subject|0|||
46917940|NCT03135899|83149548|FG001|Overall Study|Withdrawal by Subject|0|||
46917941|NCT03135899|83149549|FG002|Overall Study|Withdrawal by Subject|0|||
46917942|NCT03135899|83149550|FG003|Overall Study|Withdrawal by Subject|0|||
46917943|NCT03135899|83149551|FG004|Overall Study|Withdrawal by Subject|0|||
46917944|NCT03135899|83149552|FG005|Overall Study|Withdrawal by Subject|2|||
46917945|NCT03135899|83149553|FG006|Overall Study|Withdrawal by Subject|0|||
46917946|NCT03135899|83149554|FG007|Overall Study|Withdrawal by Subject|0|||
46917947|NCT02487979|83149568|FG000|Overall Study|Physician Decision|2|||
46917948|NCT02487979|83149568|FG000|Overall Study|Withdrawal by Subject|2|||
46917949|NCT02487979|83149568|FG000|Overall Study|Progressive Disease|17|||
47041544|NCT01426269|83297973|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
47041545|NCT01426269|83297971|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
47041546|NCT01426269|83297972|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
47041547|NCT01426269|83297973|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
47041548|NCT01426269|83297971|FG000|Period 2: 40 Weeks|Adverse Event|0|||
46917950|NCT03103087|83149579|FG000|Overall Study|Did not receive any study drug|1|||
46917951|NCT03103087|83149580|FG001|Overall Study|Did not receive any study drug|0|||
46917952|NCT03103087|83149581|FG002|Overall Study|Did not receive any study drug|0|||
46917953|NCT03103087|83149579|FG000|Overall Study|Protocol Violation|1|||
46917954|NCT03103087|83149580|FG001|Overall Study|Protocol Violation|2|||
47041549|NCT01426269|83297972|FG001|Period 2: 40 Weeks|Adverse Event|1|||
47041550|NCT01426269|83297973|FG002|Period 2: 40 Weeks|Adverse Event|2|||
46917955|NCT03103087|83149581|FG002|Overall Study|Protocol Violation|1|||
46917956|NCT03103087|83149579|FG000|Overall Study|Lack of Efficacy|2|||
46917957|NCT03103087|83149580|FG001|Overall Study|Lack of Efficacy|1|||
47041551|NCT01426269|83297971|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
47041552|NCT01426269|83297972|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
46917958|NCT03103087|83149581|FG002|Overall Study|Lack of Efficacy|1|||
46917959|NCT03103087|83149579|FG000|Overall Study|Pregnancy|0|||
46917960|NCT03103087|83149580|FG001|Overall Study|Pregnancy|0|||
46917961|NCT03103087|83149581|FG002|Overall Study|Pregnancy|1|||
46917962|NCT03103087|83149579|FG000|Overall Study|Adverse Event|2|||
46917963|NCT03103087|83149580|FG001|Overall Study|Adverse Event|15|||
46917964|NCT03103087|83149581|FG002|Overall Study|Adverse Event|6|||
46917965|NCT03103087|83149579|FG000|Overall Study|Withdrawal by Subject|13|||
46917966|NCT03103087|83149580|FG001|Overall Study|Withdrawal by Subject|6|||
46917967|NCT03103087|83149581|FG002|Overall Study|Withdrawal by Subject|6|||
46917968|NCT03103087|83149579|FG000|Overall Study|Lost to Follow-up|4|||
46917969|NCT03103087|83149580|FG001|Overall Study|Lost to Follow-up|2|||
46917970|NCT03103087|83149581|FG002|Overall Study|Lost to Follow-up|7|||
46917971|NCT03103087|83149579|FG000|Overall Study|Other reason not reported|1|||
46917972|NCT03103087|83149580|FG001|Overall Study|Other reason not reported|3|||
46917973|NCT03103087|83149581|FG002|Overall Study|Other reason not reported|5|||
46917974|NCT03131999|83149593|FG000|Overall Study|Withdrawal by Subject|0|||
46917975|NCT03131999|83149594|FG001|Overall Study|Withdrawal by Subject|1|||
46917976|NCT02263885|83149609|FG000|Overall Study|Withdrawal by Subject|7|||
46917977|NCT02263885|83149609|FG000|Overall Study|Alternative Treatment|3|||
46917978|NCT02000219|83149614|FG000|14-Week Study Period|Physician Decision|1|||
46917979|NCT02000219|83149614|FG000|14-Week Study Period|Adverse Event|1|||
46917980|NCT02000219|83149614|FG000|14-Week Study Period|Underwent transplantation|1|||
46917981|NCT02000219|83149614|FG000|Continuation Period|Withdrawal by Subject|1|||
46917982|NCT02000219|83149614|FG000|Continuation Period|Had liver transplant|2|||
47041553|NCT01426269|83297973|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
47041554|NCT01426269|83297971|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
47041555|NCT01426269|83297972|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
47041556|NCT01426269|83297973|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
47041557|NCT01426269|83297971|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
47041558|NCT01426269|83297972|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
47041559|NCT01426269|83297973|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
47041560|NCT01426269|83297971|FG000|Period 2: 40 Weeks|Site closed|0|||
47041561|NCT01426269|83297972|FG001|Period 2: 40 Weeks|Site closed|6|||
47041562|NCT01426269|83297973|FG002|Period 2: 40 Weeks|Site closed|5|||
47041563|NCT01426269|83297971|FG000|Period 2: 40 Weeks|Relapsed|0|||
47041564|NCT01426269|83297972|FG001|Period 2: 40 Weeks|Relapsed|9|||
47041565|NCT01426269|83297973|FG002|Period 2: 40 Weeks|Relapsed|18|||
47041566|NCT01426113|83297986|FG000|Overall Study|Study Discontinued|1|||
47041567|NCT01426113|83297987|FG001|Overall Study|Study Discontinued|1|||
47041568|NCT01426113|83297986|FG000|Overall Study|Adverse Event|0|||
47041569|NCT01426113|83297987|FG001|Overall Study|Adverse Event|1|||
47041570|NCT01864603|83297995|FG000|Stage 2|DSMB design modification|86056|||
47041571|NCT01864603|83297996|FG001|Stage 2|DSMB design modification|92558|||
47041572|NCT01892293|83298007|FG000|Overall Study|Apheresed but not treated|4|||
47041573|NCT01393899|83298014|FG000|Overall Study|Study terminated by sponsor|1|||
47041574|NCT01393899|83298015|FG001|Overall Study|Study terminated by sponsor|0|||
47041575|NCT01393899|83298016|FG002|Overall Study|Study terminated by sponsor|1|||
47041576|NCT01393899|83298014|FG000|Overall Study|Other|1|||
47041577|NCT01393899|83298015|FG001|Overall Study|Other|0|||
47041578|NCT01393899|83298016|FG002|Overall Study|Other|0|||
47041579|NCT01393899|83298014|FG000|Overall Study|Withdrawal by Subject|2|||
46917983|NCT02000219|83149614|FG000|Continuation Period|Non-compliance with study drug|2|||
47041580|NCT01393899|83298015|FG001|Overall Study|Withdrawal by Subject|2|||
47041581|NCT01393899|83298016|FG002|Overall Study|Withdrawal by Subject|1|||
47041582|NCT01393899|83298014|FG000|Overall Study|Lost to Follow-up|0|||
46917984|NCT03101371|83149620|FG000|Overall Study|Physician Decision|0|||
46917985|NCT03101371|83149621|FG001|Overall Study|Physician Decision|1|||
46917986|NCT03101371|83149620|FG000|Overall Study|Lost to Follow-up|1|||
46917987|NCT03101371|83149621|FG001|Overall Study|Lost to Follow-up|4|||
46917988|NCT03101371|83149620|FG000|Overall Study|Did not meet eligibility criteria|2|||
47041583|NCT01393899|83298015|FG001|Overall Study|Lost to Follow-up|0|||
47041584|NCT01393899|83298016|FG002|Overall Study|Lost to Follow-up|1|||
46917989|NCT03101371|83149621|FG001|Overall Study|Did not meet eligibility criteria|1|||
46917990|NCT02850276|83149627|FG000|Overall Study|screen failure|43|||
47041585|NCT01393899|83298014|FG000|Overall Study|Does not meet entrance criteria|1|||
47041586|NCT01393899|83298015|FG001|Overall Study|Does not meet entrance criteria|0|||
47041587|NCT01393899|83298016|FG002|Overall Study|Does not meet entrance criteria|1|||
47041588|NCT01393899|83298014|FG000|Overall Study|Lack of Efficacy|26|||
47041589|NCT01393899|83298015|FG001|Overall Study|Lack of Efficacy|21|||
47041590|NCT01393899|83298016|FG002|Overall Study|Lack of Efficacy|16|||
46917991|NCT02850276|83149627|FG000|Overall Study|Withdrawal by Subject|14|||
46917992|NCT02850276|83149627|FG000|Overall Study|Physician Decision|2|||
46917993|NCT02850276|83149627|FG000|Overall Study|Lost to Follow-up|2|||
46917994|NCT02783768|83149632|FG000|Overall Study|Lost to Follow-up|1|||
47041591|NCT01393899|83298014|FG000|Overall Study|Adverse Event|1|||
47041592|NCT01393899|83298015|FG001|Overall Study|Adverse Event|5|||
46917995|NCT02783768|83149633|FG001|Overall Study|Lost to Follow-up|0|||
46917996|NCT03131687|83149645|FG000|Overall Study|Adverse Event|0|||
46917997|NCT03131687|83149646|FG001|Overall Study|Adverse Event|1|||
46917998|NCT03131687|83149647|FG002|Overall Study|Adverse Event|0|||
46917999|NCT03131687|83149648|FG003|Overall Study|Adverse Event|1|||
46918000|NCT03131687|83149649|FG004|Overall Study|Adverse Event|2|||
46918001|NCT03131687|83149650|FG005|Overall Study|Adverse Event|2|||
46918002|NCT03131687|83149645|FG000|Overall Study|Death|1|||
46918003|NCT03131687|83149646|FG001|Overall Study|Death|0|||
46918004|NCT03131687|83149647|FG002|Overall Study|Death|0|||
46918005|NCT03131687|83149648|FG003|Overall Study|Death|0|||
46918006|NCT03131687|83149649|FG004|Overall Study|Death|0|||
46918007|NCT03131687|83149650|FG005|Overall Study|Death|0|||
46918008|NCT03131687|83149645|FG000|Overall Study|Withdrawal by Subject|3|||
46918009|NCT03131687|83149646|FG001|Overall Study|Withdrawal by Subject|3|||
46918010|NCT03131687|83149647|FG002|Overall Study|Withdrawal by Subject|3|||
46918011|NCT03131687|83149648|FG003|Overall Study|Withdrawal by Subject|1|||
46918012|NCT03131687|83149649|FG004|Overall Study|Withdrawal by Subject|2|||
46918013|NCT03131687|83149650|FG005|Overall Study|Withdrawal by Subject|1|||
46918014|NCT03131687|83149645|FG000|Overall Study|Lost to Follow-up|1|||
46918015|NCT03131687|83149646|FG001|Overall Study|Lost to Follow-up|4|||
46918016|NCT03131687|83149647|FG002|Overall Study|Lost to Follow-up|0|||
46918017|NCT03131687|83149648|FG003|Overall Study|Lost to Follow-up|1|||
46918018|NCT03131687|83149649|FG004|Overall Study|Lost to Follow-up|4|||
46918019|NCT03131687|83149650|FG005|Overall Study|Lost to Follow-up|2|||
46918020|NCT03131687|83149645|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
46918021|NCT03131687|83149646|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
46918022|NCT03131687|83149647|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
46918023|NCT03131687|83149648|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
46918024|NCT03131687|83149649|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
46918025|NCT03131687|83149650|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
46918026|NCT03131687|83149645|FG000|Overall Study|Principle Investigator Decision|0|||
46918027|NCT03131687|83149646|FG001|Overall Study|Principle Investigator Decision|1|||
46918028|NCT03131687|83149647|FG002|Overall Study|Principle Investigator Decision|0|||
46918029|NCT03131687|83149648|FG003|Overall Study|Principle Investigator Decision|0|||
46918030|NCT03131687|83149649|FG004|Overall Study|Principle Investigator Decision|0|||
46918031|NCT03131687|83149650|FG005|Overall Study|Principle Investigator Decision|0|||
46918032|NCT03131687|83149645|FG000|Overall Study|Inadvertent Enrollment|0|||
46918033|NCT03131687|83149646|FG001|Overall Study|Inadvertent Enrollment|0|||
46918034|NCT03131687|83149647|FG002|Overall Study|Inadvertent Enrollment|0|||
46918035|NCT03131687|83149648|FG003|Overall Study|Inadvertent Enrollment|1|||
46918036|NCT03131687|83149649|FG004|Overall Study|Inadvertent Enrollment|0|||
46918037|NCT03131687|83149650|FG005|Overall Study|Inadvertent Enrollment|0|||
46918038|NCT03101293|83149679|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
46918039|NCT03101293|83149680|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
46918040|NCT02850978|83149686|FG000|Overall Study|Uncollectable CRF|27|||
46918041|NCT02850978|83149686|FG000|Overall Study|No visit since the first visit|35|||
46918042|NCT02850978|83149686|FG000|Overall Study|Adverse Event|81|||
46918043|NCT02850978|83149686|FG000|Overall Study|Lack of Efficacy|40|||
46918044|NCT02850978|83149686|FG000|Overall Study|Improvement in condition|34|||
46918045|NCT02850978|83149686|FG000|Overall Study|Lost to Follow-up|121|||
46918046|NCT02850978|83149686|FG000|Overall Study|Reason not listed|88|||
46918047|NCT03135431|83149692|FG000|Overall Study|Study Surgeon not available|2|||
46918048|NCT03135431|83149693|FG001|Overall Study|Study Surgeon not available|0|||
46918049|NCT04534517|83149715|FG000|Overall Study|Adverse Event|1|||
46918050|NCT04534517|83149715|FG000|Overall Study|Withdrawal by Subject|1|||
46918051|NCT04534517|83149715|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
46918052|NCT04534517|83149715|FG000|Overall Study|COVID-19 Related|1|||
46918053|NCT02831257|83149719|FG000|Overall Study|Lack of Efficacy|3|||
46918054|NCT02831257|83149719|FG000|Overall Study|Adverse Event|2|||
46918055|NCT02831257|83149719|FG000|Overall Study|Physician Decision|1|||
46918056|NCT02831257|83149719|FG000|Overall Study|Withdrawal by Subject|6|||
46918057|NCT03100825|83149723|FG000|Overall Study|Participant/Guardian Decision|7|||
46918058|NCT03100825|83149723|FG000|Overall Study|Physician Decision|1|||
46918059|NCT02250534|83149730|FG000|Overall Study|Lost to Follow-up|18|||
46918060|NCT02250534|83149731|FG001|Overall Study|Lost to Follow-up|28|||
46632721|NCT01787760|82805904|FG001|Overall Study|Lost to Follow-up|0|||
46918061|NCT02250534|83149732|FG002|Overall Study|Lost to Follow-up|33|||
46918062|NCT02250534|83149730|FG000|Overall Study|Personal reasons|7|||
46918063|NCT02250534|83149731|FG001|Overall Study|Personal reasons|8|||
46918064|NCT02250534|83149732|FG002|Overall Study|Personal reasons|14|||
46918065|NCT02250534|83149730|FG000|Overall Study|Adverse Event|6|||
46918066|NCT02250534|83149731|FG001|Overall Study|Adverse Event|3|||
46918067|NCT02250534|83149732|FG002|Overall Study|Adverse Event|8|||
46918068|NCT02250534|83149730|FG000|Overall Study|incarcerated|2|||
46918069|NCT02250534|83149731|FG001|Overall Study|incarcerated|1|||
46918070|NCT02250534|83149732|FG002|Overall Study|incarcerated|2|||
46918071|NCT02250534|83149730|FG000|Overall Study|Withdrawal by Subject|0|||
46918072|NCT02250534|83149731|FG001|Overall Study|Withdrawal by Subject|1|||
46918073|NCT02250534|83149732|FG002|Overall Study|Withdrawal by Subject|2|||
46918074|NCT02250534|83149730|FG000|Overall Study|Death|0|||
46918075|NCT02250534|83149731|FG001|Overall Study|Death|1|||
46918076|NCT02250534|83149732|FG002|Overall Study|Death|1|||
46918077|NCT02250534|83149730|FG000|Overall Study|Physician Decision|1|||
46918078|NCT02250534|83149731|FG001|Overall Study|Physician Decision|3|||
46918079|NCT02250534|83149732|FG002|Overall Study|Physician Decision|1|||
46918080|NCT02250534|83149730|FG000|Overall Study|Protocol Violation|1|||
46918081|NCT02250534|83149731|FG001|Overall Study|Protocol Violation|0|||
46918082|NCT02250534|83149732|FG002|Overall Study|Protocol Violation|1|||
46918083|NCT02250534|83149730|FG000|Overall Study|Reason unknown|1|||
46918084|NCT02250534|83149731|FG001|Overall Study|Reason unknown|0|||
46918085|NCT02250534|83149732|FG002|Overall Study|Reason unknown|0|||
46918086|NCT02848326|83149746|FG000|Treatment Period|Adverse Event|5|||
46918087|NCT02848326|83149747|FG001|Treatment Period|Adverse Event|4|||
46918088|NCT02848326|83149748|FG002|Treatment Period|Adverse Event|11|||
46918089|NCT02848326|83149749|FG003|Treatment Period|Adverse Event|6|||
46918090|NCT02848326|83149750|FG004|Treatment Period|Adverse Event|5|||
46918091|NCT02848326|83149751|FG005|Treatment Period|Adverse Event|7|||
46918092|NCT02848326|83149746|FG000|Treatment Period|Withdrawal of Consent|20|||
46918093|NCT02848326|83149747|FG001|Treatment Period|Withdrawal of Consent|6|||
46918094|NCT02848326|83149748|FG002|Treatment Period|Withdrawal of Consent|9|||
46918095|NCT02848326|83149749|FG003|Treatment Period|Withdrawal of Consent|6|||
46918096|NCT02848326|83149750|FG004|Treatment Period|Withdrawal of Consent|9|||
46719986|NCT01170962|82936067|FG000|Follow up Period|Lost to Follow-up|13|||
46719987|NCT01170962|82936068|FG001|Follow up Period|Lost to Follow-up|8|||
46719988|NCT01170962|82936069|FG002|Follow up Period|Lost to Follow-up|1|||
46719989|NCT01170962|82936067|FG000|Follow up Period|Death|2|||
46719990|NCT01170962|82936068|FG001|Follow up Period|Death|2|||
46719991|NCT01170962|82936069|FG002|Follow up Period|Death|0|||
46719992|NCT01170962|82936067|FG000|Follow up Period|Others|10|||
46719993|NCT01170962|82936068|FG001|Follow up Period|Others|7|||
46719994|NCT01170962|82936069|FG002|Follow up Period|Others|3|||
46719995|NCT00843193|82936088|FG000|Overall Study|Adverse Event|2|||
46719996|NCT00843193|82936089|FG001|Overall Study|Adverse Event|4|||
46719997|NCT00843193|82936088|FG000|Overall Study|Lack of Efficacy|1|||
46719998|NCT00843193|82936089|FG001|Overall Study|Lack of Efficacy|1|||
46719999|NCT00843193|82936088|FG000|Overall Study|Protocol Violation|1|||
46720000|NCT00843193|82936089|FG001|Overall Study|Protocol Violation|2|||
46720001|NCT00843193|82936088|FG000|Overall Study|Lost to Follow-up|1|||
46720002|NCT00843193|82936089|FG001|Overall Study|Lost to Follow-up|0|||
46720003|NCT00843193|82936088|FG000|Overall Study|Physician Decision|0|||
46720004|NCT00843193|82936089|FG001|Overall Study|Physician Decision|1|||
46720005|NCT00843193|82936088|FG000|Overall Study|Withdrawal by Subject|3|||
46720006|NCT00843193|82936089|FG001|Overall Study|Withdrawal by Subject|3|||
46720007|NCT00829621|82936098|FG000|Overall Study|Death|1|||
46720008|NCT00829621|82936099|FG001|Overall Study|Death|0|||
46720009|NCT00829621|82936098|FG000|Overall Study|Lost to Follow-up|3|||
46720010|NCT00829621|82936099|FG001|Overall Study|Lost to Follow-up|4|||
46720011|NCT01157078|82936107|FG000|Overall Study|Withdrawal by Subject|12|||
46720012|NCT01157078|82936108|FG001|Overall Study|Withdrawal by Subject|14|||
46720013|NCT01157078|82936107|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46720014|NCT01157078|82936108|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46720015|NCT01157078|82936107|FG000|Overall Study|Adverse Event|6|||
46720016|NCT01157078|82936108|FG001|Overall Study|Adverse Event|6|||
46720017|NCT01157078|82936107|FG000|Overall Study|Severe non-compliance to protocol|2|||
46720018|NCT01157078|82936108|FG001|Overall Study|Severe non-compliance to protocol|4|||
46720019|NCT01157078|82936107|FG000|Overall Study|Condition under investigation worsened|0|||
46720020|NCT01157078|82936108|FG001|Overall Study|Condition under investigation worsened|1|||
46720021|NCT01157078|82936107|FG000|Overall Study|Lack of Efficacy|2|||
46720022|NCT01157078|82936108|FG001|Overall Study|Lack of Efficacy|0|||
46720023|NCT01157078|82936107|FG000|Overall Study|Study-specific withdrawal criteria|2|||
46720024|NCT01157078|82936108|FG001|Overall Study|Study-specific withdrawal criteria|2|||
46720025|NCT01157078|82936107|FG000|Overall Study|Lost to Follow-up|7|||
46720026|NCT01157078|82936108|FG001|Overall Study|Lost to Follow-up|5|||
46720027|NCT01157078|82936107|FG000|Overall Study|Other|2|||
46720028|NCT01157078|82936108|FG001|Overall Study|Other|4|||
46918097|NCT02848326|83149751|FG005|Treatment Period|Withdrawal of Consent|6|||
46720029|NCT00591721|82936116|FG000|Overall Study|Withdrawal by Subject|10|||
46720030|NCT00591721|82936117|FG001|Overall Study|Withdrawal by Subject|10|||
46720031|NCT00591721|82936116|FG000|Overall Study|Lost to Follow-up|1|||
46720032|NCT00591721|82936117|FG001|Overall Study|Lost to Follow-up|4|||
46918098|NCT02848326|83149746|FG000|Treatment Period|Lost to Follow-up|5|||
46918099|NCT02848326|83149747|FG001|Treatment Period|Lost to Follow-up|1|||
46720033|NCT00591721|82936116|FG000|Overall Study|Intervention not received|10|||
46918100|NCT02848326|83149748|FG002|Treatment Period|Lost to Follow-up|11|||
46918101|NCT02848326|83149749|FG003|Treatment Period|Lost to Follow-up|7|||
46918102|NCT02848326|83149750|FG004|Treatment Period|Lost to Follow-up|2|||
46918103|NCT02848326|83149751|FG005|Treatment Period|Lost to Follow-up|3|||
46918104|NCT02848326|83149746|FG000|Treatment Period|Pregnancy|0|||
46918105|NCT02848326|83149747|FG001|Treatment Period|Pregnancy|0|||
46918106|NCT02848326|83149748|FG002|Treatment Period|Pregnancy|1|||
46918107|NCT02848326|83149749|FG003|Treatment Period|Pregnancy|1|||
46918108|NCT02848326|83149750|FG004|Treatment Period|Pregnancy|0|||
46918109|NCT02848326|83149751|FG005|Treatment Period|Pregnancy|1|||
46918110|NCT02848326|83149746|FG000|Treatment Period|Protocol Violation|4|||
46918111|NCT02848326|83149747|FG001|Treatment Period|Protocol Violation|3|||
46918112|NCT02848326|83149748|FG002|Treatment Period|Protocol Violation|4|||
46918113|NCT02848326|83149749|FG003|Treatment Period|Protocol Violation|2|||
46918114|NCT02848326|83149750|FG004|Treatment Period|Protocol Violation|3|||
46918115|NCT02848326|83149751|FG005|Treatment Period|Protocol Violation|3|||
46918116|NCT02848326|83149746|FG000|Treatment Period|Non-compliance with Study Drug|4|||
46918117|NCT02848326|83149747|FG001|Treatment Period|Non-compliance with Study Drug|0|||
46918118|NCT02848326|83149748|FG002|Treatment Period|Non-compliance with Study Drug|0|||
46918119|NCT02848326|83149749|FG003|Treatment Period|Non-compliance with Study Drug|1|||
46918120|NCT02848326|83149750|FG004|Treatment Period|Non-compliance with Study Drug|0|||
46918121|NCT02848326|83149751|FG005|Treatment Period|Non-compliance with Study Drug|0|||
46918122|NCT02848326|83149746|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
46918123|NCT02848326|83149747|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
46918124|NCT02848326|83149748|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
46918125|NCT02848326|83149749|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
46918126|NCT02848326|83149750|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
46918127|NCT02848326|83149751|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
46918128|NCT02848326|83149746|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
46918129|NCT02848326|83149747|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
46918130|NCT02848326|83149748|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
46918131|NCT02848326|83149749|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
46918132|NCT02848326|83149750|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
46918133|NCT02848326|83149751|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
46918134|NCT03128723|83149765|FG000|Overall Study|Withdrawal by Subject|2|||
46918135|NCT03128411|83149769|FG000|Treatment Phase|Adverse Event|21|||
46918136|NCT03128411|83149769|FG000|Treatment Phase|Physician Decision|1|||
46918137|NCT03128411|83149769|FG000|Treatment Phase|Other|2|||
46918138|NCT03128411|83149769|FG000|Long Term Follow-up Phase|Death|2|||
46918139|NCT02847858|83149775|FG000|Overall Study|Lost to Follow-up|401|||
46918140|NCT02847858|83149776|FG001|Overall Study|Lost to Follow-up|269|||
46918141|NCT03124199|83149787|FG000|Overall Study|Lost to Follow-up|4|||
46918142|NCT04465916|83149793|FG000|Overall Study|Withdrawal by Subject|0|||
46918143|NCT04465916|83149794|FG001|Overall Study|Withdrawal by Subject|1|||
46918144|NCT05090852|83149800|FG000|Overall Study|Physician Decision|5|||
46918145|NCT00075816|83149815|FG000|Overall Study|Did not undergo transplantation|14|||
46918146|NCT00075816|83149816|FG001|Overall Study|Did not undergo transplantation|11|||
46918147|NCT00109772|83149830|FG000|Double-blind Treatment|Adverse Event|14|||
47041593|NCT01393899|83298016|FG002|Overall Study|Adverse Event|3|||
47041594|NCT01393743|83298028|FG000|Core Study|Adverse Event|5|||
47041595|NCT01393743|83298029|FG001|Core Study|Adverse Event|9|||
47041596|NCT01393743|83298030|FG002|Core Study|Adverse Event|0|||
47041597|NCT01393743|83298028|FG000|Core Study|Lost to Follow-up|1|||
47041598|NCT01393743|83298029|FG001|Core Study|Lost to Follow-up|1|||
47041599|NCT01393743|83298030|FG002|Core Study|Lost to Follow-up|0|||
47041600|NCT01393743|83298028|FG000|Core Study|Participant's Choice|2|||
47041601|NCT01393743|83298029|FG001|Core Study|Participant's Choice|3|||
47041602|NCT01393743|83298030|FG002|Core Study|Participant's Choice|0|||
47041603|NCT01393743|83298028|FG000|Core Study|Inadequate therapeutic effect|2|||
47041604|NCT01393743|83298029|FG001|Core Study|Inadequate therapeutic effect|0|||
47041605|NCT01393743|83298030|FG002|Core Study|Inadequate therapeutic effect|0|||
47041606|NCT01393743|83298028|FG000|Extension Phase|Adverse Event|0|||
47041607|NCT01393743|83298029|FG001|Extension Phase|Adverse Event|0|||
47041608|NCT01393743|83298030|FG002|Extension Phase|Adverse Event|12|||
46918148|NCT00109772|83149831|FG001|Double-blind Treatment|Adverse Event|5|||
46918149|NCT00109772|83149830|FG000|Double-blind Treatment|Lack of Efficacy|1|||
46918150|NCT00109772|83149831|FG001|Double-blind Treatment|Lack of Efficacy|0|||
46918151|NCT00109772|83149830|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
46918152|NCT00109772|83149831|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
46918153|NCT00109772|83149830|FG000|Double-blind Treatment|Lost to Follow-up|2|||
46918154|NCT00109772|83149831|FG001|Double-blind Treatment|Lost to Follow-up|3|||
46918155|NCT00109772|83149830|FG000|Double-blind Treatment|Protocol Violation|0|||
46918156|NCT00109772|83149831|FG001|Double-blind Treatment|Protocol Violation|1|||
47041609|NCT01393743|83298028|FG000|Extension Phase|Lost to Follow-up|0|||
47041610|NCT01393743|83298029|FG001|Extension Phase|Lost to Follow-up|0|||
46918157|NCT00109772|83149830|FG000|Double-blind Treatment|Other|0|||
46918158|NCT00109772|83149831|FG001|Double-blind Treatment|Other|4|||
46918159|NCT00109772|83149830|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
47041611|NCT01393743|83298030|FG002|Extension Phase|Lost to Follow-up|2|||
46918160|NCT00109772|83149831|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
46918161|NCT00109772|83149830|FG000|Open-label Extension|Adverse Event|10|||
46918162|NCT00109772|83149831|FG001|Open-label Extension|Adverse Event|19|||
46918163|NCT00109772|83149830|FG000|Open-label Extension|Lack of Efficacy|19|||
46918164|NCT00109772|83149831|FG001|Open-label Extension|Lack of Efficacy|11|||
46918165|NCT00109772|83149830|FG000|Open-label Extension|Withdrawal by Subject|9|||
46918166|NCT00109772|83149831|FG001|Open-label Extension|Withdrawal by Subject|6|||
46918167|NCT00109772|83149830|FG000|Open-label Extension|Lost to Follow-up|1|||
46918168|NCT00109772|83149831|FG001|Open-label Extension|Lost to Follow-up|0|||
46918169|NCT00109772|83149830|FG000|Open-label Extension|Death|0|||
46918170|NCT00109772|83149831|FG001|Open-label Extension|Death|1|||
46918171|NCT00109772|83149830|FG000|Open-label Extension|Protocol Violation|2|||
46918172|NCT00109772|83149831|FG001|Open-label Extension|Protocol Violation|2|||
46918173|NCT00109772|83149830|FG000|Open-label Extension|Other|4|||
46918174|NCT00109772|83149831|FG001|Open-label Extension|Other|10|||
46918175|NCT02783066|83149837|FG000|Overall Study|Withdrawal by Subject|13|||
46918176|NCT01371305|83149848|FG000|Overall Study|Adverse Event|0|||
46918177|NCT01371305|83149849|FG001|Overall Study|Adverse Event|0|||
46918178|NCT01371305|83149850|FG002|Overall Study|Adverse Event|0|||
46918179|NCT01371305|83149851|FG003|Overall Study|Adverse Event|2|||
46918180|NCT01371305|83149852|FG004|Overall Study|Adverse Event|1|||
46918181|NCT01371305|83149853|FG005|Overall Study|Adverse Event|0|||
46918182|NCT01371305|83149848|FG000|Overall Study|Study terminated by sponsor|0|||
46918183|NCT01371305|83149849|FG001|Overall Study|Study terminated by sponsor|0|||
46918184|NCT01371305|83149850|FG002|Overall Study|Study terminated by sponsor|0|||
46918185|NCT01371305|83149851|FG003|Overall Study|Study terminated by sponsor|0|||
46918186|NCT01371305|83149852|FG004|Overall Study|Study terminated by sponsor|3|||
46918187|NCT01371305|83149853|FG005|Overall Study|Study terminated by sponsor|1|||
46918188|NCT01371305|83149848|FG000|Overall Study|Subject request|0|||
46918189|NCT01371305|83149849|FG001|Overall Study|Subject request|0|||
46918190|NCT01371305|83149850|FG002|Overall Study|Subject request|0|||
46918191|NCT01371305|83149851|FG003|Overall Study|Subject request|0|||
46918192|NCT01371305|83149852|FG004|Overall Study|Subject request|0|||
46918193|NCT01371305|83149853|FG005|Overall Study|Subject request|1|||
46918194|NCT00109928|83149868|FG000|Overall Study|Adverse Event|2|||
46918195|NCT00109928|83149868|FG000|Overall Study|Progression|6|||
46918196|NCT00109928|83149868|FG000|Overall Study|Death|2|||
46918197|NCT00109928|83149868|FG000|Overall Study|not protocol specified|2|||
46918198|NCT00109928|83149868|FG000|Overall Study|not eligible|1|||
46918199|NCT00109850|83149873|FG000|Overall Study|Adverse Event|1|||
46918200|NCT00109850|83149873|FG000|Overall Study|Death|2|||
46918201|NCT00109850|83149873|FG000|Overall Study|Ineligible|1|||
46918202|NCT01342926|83149881|FG000|Overall Study|Adverse Event|5|||
46918203|NCT01342926|83149882|FG001|Overall Study|Adverse Event|8|||
46918204|NCT01342926|83149883|FG002|Overall Study|Adverse Event|10|||
46918205|NCT01342926|83149884|FG003|Overall Study|Adverse Event|7|||
46918206|NCT01342926|83149881|FG000|Overall Study|Lost to Follow-up|0|||
46918207|NCT01342926|83149882|FG001|Overall Study|Lost to Follow-up|1|||
47041612|NCT01393743|83298028|FG000|Extension Phase|Participant choice|0|||
47041613|NCT01393743|83298029|FG001|Extension Phase|Participant choice|0|||
47041614|NCT01393743|83298030|FG002|Extension Phase|Participant choice|16|||
47041615|NCT01393743|83298028|FG000|Extension Phase|Inadequate therapeutic effect|0|||
47041616|NCT01393743|83298029|FG001|Extension Phase|Inadequate therapeutic effect|0|||
47041617|NCT01393743|83298030|FG002|Extension Phase|Inadequate therapeutic effect|7|||
47041618|NCT01393743|83298028|FG000|Extension Phase|Withdrawal by Subject|0|||
47041619|NCT01393743|83298029|FG001|Extension Phase|Withdrawal by Subject|0|||
47041620|NCT01393743|83298030|FG002|Extension Phase|Withdrawal by Subject|8|||
47041621|NCT01393743|83298028|FG000|Extension Phase|Pregnancy|0|||
47041622|NCT01393743|83298029|FG001|Extension Phase|Pregnancy|0|||
47041623|NCT01393743|83298030|FG002|Extension Phase|Pregnancy|1|||
47041624|NCT01393743|83298028|FG000|Extension Phase|Other|0|||
47041625|NCT01393743|83298029|FG001|Extension Phase|Other|0|||
46918208|NCT01342926|83149883|FG002|Overall Study|Lost to Follow-up|1|||
46918209|NCT01342926|83149884|FG003|Overall Study|Lost to Follow-up|0|||
46918210|NCT01342926|83149881|FG000|Overall Study|Investigator Discretion|2|||
47041626|NCT01393743|83298030|FG002|Extension Phase|Other|14|||
47041627|NCT01405911|83298049|FG000|Overall Study|Pre-treatment lab AE|0|||
47041628|NCT01405911|83298050|FG001|Overall Study|Pre-treatment lab AE|1|||
47041629|NCT01405911|83298051|FG002|Overall Study|Pre-treatment lab AE|0|||
47041630|NCT01405911|83298049|FG000|Overall Study|Lost to Follow-up|0|||
47041631|NCT01405911|83298050|FG001|Overall Study|Lost to Follow-up|1|||
47041632|NCT01405911|83298051|FG002|Overall Study|Lost to Follow-up|0|||
46918211|NCT01342926|83149882|FG001|Overall Study|Investigator Discretion|2|||
46918212|NCT01342926|83149883|FG002|Overall Study|Investigator Discretion|0|||
46918213|NCT01342926|83149884|FG003|Overall Study|Investigator Discretion|0|||
46918214|NCT01342926|83149881|FG000|Overall Study|Withdrawal by Subject|2|||
47041633|NCT01405911|83298049|FG000|Overall Study|Protocol Violation|1|||
47041634|NCT01405911|83298050|FG001|Overall Study|Protocol Violation|0|||
47041635|NCT01405911|83298051|FG002|Overall Study|Protocol Violation|0|||
46918215|NCT01342926|83149882|FG001|Overall Study|Withdrawal by Subject|4|||
46918216|NCT01342926|83149883|FG002|Overall Study|Withdrawal by Subject|3|||
46918217|NCT01342926|83149884|FG003|Overall Study|Withdrawal by Subject|5|||
46918218|NCT01810016|83149897|FG000|Overall Study|Progressive disease|1|||
46918219|NCT01810016|83149898|FG001|Overall Study|Progressive disease|1|||
46918220|NCT01810016|83149899|FG002|Overall Study|Progressive disease|0|||
46918221|NCT01810016|83149897|FG000|Overall Study|Death|0|||
46918222|NCT01810016|83149898|FG001|Overall Study|Death|0|||
46918223|NCT01810016|83149899|FG002|Overall Study|Death|1|||
46918224|NCT02843178|83149911|FG000|Overall Study|Lost to Follow-up|8|||
46918225|NCT02843178|83149912|FG001|Overall Study|Lost to Follow-up|8|||
46918226|NCT02843178|83149913|FG002|Overall Study|Lost to Follow-up|6|||
46918227|NCT02843178|83149914|FG003|Overall Study|Lost to Follow-up|3|||
46918228|NCT02843178|83149911|FG000|Overall Study|Withdrawal by Subject|0|||
46918229|NCT02843178|83149912|FG001|Overall Study|Withdrawal by Subject|0|||
46918230|NCT02843178|83149913|FG002|Overall Study|Withdrawal by Subject|1|||
46918231|NCT02843178|83149914|FG003|Overall Study|Withdrawal by Subject|1|||
46918232|NCT03123185|83149938|FG000|Overall Study|Withdrawal by Subject|0|||
46918233|NCT03123185|83149939|FG001|Overall Study|Withdrawal by Subject|0|||
46918234|NCT03123185|83149940|FG002|Overall Study|Withdrawal by Subject|0|||
46918235|NCT03123185|83149941|FG003|Overall Study|Withdrawal by Subject|0|||
46918236|NCT03123185|83149942|FG004|Overall Study|Withdrawal by Subject|0|||
46918237|NCT03123185|83149943|FG005|Overall Study|Withdrawal by Subject|0|||
46918238|NCT03123185|83149944|FG006|Overall Study|Withdrawal by Subject|0|||
46918239|NCT03123185|83149945|FG007|Overall Study|Withdrawal by Subject|0|||
46918240|NCT03123185|83149946|FG008|Overall Study|Withdrawal by Subject|0|||
46918241|NCT03123185|83149947|FG009|Overall Study|Withdrawal by Subject|0|||
46918242|NCT03123185|83149948|FG010|Overall Study|Withdrawal by Subject|0|||
46918243|NCT03123185|83149949|FG011|Overall Study|Withdrawal by Subject|0|||
46918244|NCT03123185|83149950|FG012|Overall Study|Withdrawal by Subject|1|||
46918245|NCT03123185|83149951|FG013|Overall Study|Withdrawal by Subject|0|||
46918246|NCT02842866|83150010|FG000|Overall Study|Serious Adverse Event|0|||
46918247|NCT02842866|83150011|FG001|Overall Study|Serious Adverse Event|1|||
46918248|NCT02842866|83150010|FG000|Overall Study|Protocol Violation|4|||
46918249|NCT02842866|83150011|FG001|Overall Study|Protocol Violation|2|||
46918250|NCT02842866|83150010|FG000|Overall Study|Lost to Follow-up|2|||
46918251|NCT02842866|83150011|FG001|Overall Study|Lost to Follow-up|0|||
46918252|NCT02842866|83150010|FG000|Overall Study|Withdrawal by Subject|1|||
46918253|NCT02842866|83150011|FG001|Overall Study|Withdrawal by Subject|0|||
46918254|NCT01316913|83150021|FG000|Overall Study|Adverse Event|17|||
46918255|NCT01316913|83150022|FG001|Overall Study|Adverse Event|20|||
46918256|NCT01316913|83150023|FG002|Overall Study|Adverse Event|15|||
46918257|NCT01316913|83150024|FG003|Overall Study|Adverse Event|11|||
46918258|NCT01316913|83150021|FG000|Overall Study|Lack of Efficacy|22|||
46918259|NCT01316913|83150022|FG001|Overall Study|Lack of Efficacy|12|||
46918260|NCT01316913|83150023|FG002|Overall Study|Lack of Efficacy|9|||
46918261|NCT01316913|83150024|FG003|Overall Study|Lack of Efficacy|13|||
46918262|NCT01316913|83150021|FG000|Overall Study|Protocol Violation|1|||
46918263|NCT01316913|83150022|FG001|Overall Study|Protocol Violation|4|||
46918264|NCT01316913|83150023|FG002|Overall Study|Protocol Violation|4|||
46918265|NCT01316913|83150024|FG003|Overall Study|Protocol Violation|1|||
46918266|NCT01316913|83150021|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
46918267|NCT01316913|83150022|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
46918268|NCT01316913|83150023|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
46918269|NCT01316913|83150024|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
46918270|NCT01316913|83150021|FG000|Overall Study|Lost to Follow-up|0|||
46918271|NCT01316913|83150022|FG001|Overall Study|Lost to Follow-up|1|||
46918272|NCT01316913|83150023|FG002|Overall Study|Lost to Follow-up|0|||
46918273|NCT01316913|83150024|FG003|Overall Study|Lost to Follow-up|2|||
46918274|NCT01316913|83150021|FG000|Overall Study|Withdrawal by Subject|10|||
46918275|NCT01316913|83150022|FG001|Overall Study|Withdrawal by Subject|9|||
46720034|NCT00591721|82936117|FG001|Overall Study|Intervention not received|8|||
46918276|NCT01316913|83150023|FG002|Overall Study|Withdrawal by Subject|10|||
46918277|NCT01316913|83150024|FG003|Overall Study|Withdrawal by Subject|6|||
46918278|NCT02875067|83150035|FG000|Overall Study|Withdrawal by Subject|1|||
46918279|NCT02875067|83150035|FG000|Overall Study|Withdrawal by Termination of Study|5|||
46918280|NCT02781506|83150039|FG000|Overall Study|Adverse Event|5|||
46918281|NCT03132753|83150045|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
46720035|NCT01156844|82936127|FG000|Overall Study|Adverse Event|0|||
46720036|NCT01156844|82936128|FG001|Overall Study|Adverse Event|0|||
46720037|NCT01156844|82936129|FG002|Overall Study|Adverse Event|1|||
46918282|NCT03132753|83150046|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
46918283|NCT03132753|83150045|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
46918284|NCT03132753|83150046|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
46918285|NCT01468454|83150052|FG000|Overall Study|Did not have surgery after PET|9|||
46918286|NCT03067077|83150057|FG000|Overall Study|Did not receive surgery|4|||
46918287|NCT03067077|83150058|FG001|Overall Study|Did not receive surgery|5|||
46918288|NCT03067077|83150057|FG000|Overall Study|Lost to Follow-up|3|||
46918289|NCT03067077|83150058|FG001|Overall Study|Lost to Follow-up|2|||
46918290|NCT03096847|83150067|FG000|Overall Study|Other|2|||
46918291|NCT03096847|83150068|FG001|Overall Study|Other|1|||
46632722|NCT01787760|82805905|FG002|Overall Study|Lost to Follow-up|1|||
46720038|NCT01156844|82936130|FG003|Overall Study|Adverse Event|1|||
46720039|NCT01156844|82936127|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46720040|NCT01156844|82936128|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46720041|NCT01156844|82936129|FG002|Overall Study|Abnormal test procedure result(s)|2|||
46720042|NCT01156844|82936130|FG003|Overall Study|Abnormal test procedure result(s)|2|||
46720043|NCT01156844|82936127|FG000|Overall Study|Withdrawal by Subject|0|||
46720044|NCT01156844|82936128|FG001|Overall Study|Withdrawal by Subject|0|||
46720045|NCT01156844|82936129|FG002|Overall Study|Withdrawal by Subject|2|||
46720046|NCT01156844|82936130|FG003|Overall Study|Withdrawal by Subject|2|||
46720047|NCT01156844|82936127|FG000|Overall Study|Lost to Follow-up|0|||
46720048|NCT01156844|82936128|FG001|Overall Study|Lost to Follow-up|0|||
46720049|NCT01156844|82936129|FG002|Overall Study|Lost to Follow-up|1|||
46720050|NCT01156844|82936130|FG003|Overall Study|Lost to Follow-up|0|||
46720051|NCT01156844|82936127|FG000|Overall Study|Administrative problems|0|||
46720052|NCT01156844|82936128|FG001|Overall Study|Administrative problems|1|||
46720053|NCT01156844|82936129|FG002|Overall Study|Administrative problems|0|||
46720054|NCT01156844|82936130|FG003|Overall Study|Administrative problems|1|||
46720055|NCT01156844|82936127|FG000|Overall Study|Protocol deviation|2|||
46720056|NCT01156844|82936128|FG001|Overall Study|Protocol deviation|0|||
46720057|NCT01156844|82936129|FG002|Overall Study|Protocol deviation|0|||
46720058|NCT01156844|82936130|FG003|Overall Study|Protocol deviation|0|||
46720059|NCT00853021|82936143|FG000|Overall Study|Adverse Event|2|||
46720060|NCT00853021|82936143|FG000|Overall Study|Withdrawal by Subject|2|||
46720061|NCT00853021|82936143|FG000|Overall Study|Death|1|||
46720062|NCT01156532|82936147|FG000|Overall Study|Family Reasons|1|||
46720063|NCT01156532|82936147|FG000|Overall Study|Lost to Follow-up|1|||
46720064|NCT00843115|82936151|FG000|Overall Study|Death|4|||
46720065|NCT00843115|82936151|FG000|Overall Study|Adverse Event|30|||
46720066|NCT00843115|82936151|FG000|Overall Study|Lost to Follow-up|4|||
46720067|NCT00843115|82936151|FG000|Overall Study|Withdrawal by Subject|17|||
46720068|NCT00843115|82936151|FG000|Overall Study|Family wanted meds stopped|1|||
46720069|NCT00843115|82936151|FG000|Overall Study|Family does not want continuation|1|||
46720070|NCT00843115|82936151|FG000|Overall Study|Patient forgot to take meds|1|||
46720071|NCT00843115|82936151|FG000|Overall Study|Does not meet entrance criteria|1|||
46720072|NCT00843115|82936151|FG000|Overall Study|Physician Decision|1|||
46720073|NCT00843115|82936151|FG000|Overall Study|Family discontinued meds|1|||
46720074|NCT00843115|82936151|FG000|Overall Study|patient took for 2 days then stopped|1|||
46720075|NCT00843115|82936151|FG000|Overall Study|patient never took the medication|1|||
46720076|NCT00843115|82936151|FG000|Overall Study|hospitalized due to deterioration|1|||
46720077|NCT00843115|82936151|FG000|Overall Study|week 12 not done|1|||
46720078|NCT00843115|82936151|FG000|Overall Study|Syndrome De Glissement|1|||
46632723|NCT01787760|82805903|FG000|Overall Study|Stroke|1|||
46632724|NCT01787760|82805904|FG001|Overall Study|Stroke|0|||
46632725|NCT01787760|82805905|FG002|Overall Study|Stroke|0|||
46632726|NCT01787760|82805903|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
46632727|NCT01787760|82805904|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
46632728|NCT01787760|82805905|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
46632729|NCT01787760|82805903|FG000|Overall Study|Unsatisfactory physiological response|2|||
46632730|NCT01787760|82805904|FG001|Overall Study|Unsatisfactory physiological response|4|||
46632731|NCT01787760|82805905|FG002|Overall Study|Unsatisfactory physiological response|0|||
46632732|NCT01787760|82805903|FG000|Overall Study|Unsatisfactory visual response|1|||
46632733|NCT01787760|82805904|FG001|Overall Study|Unsatisfactory visual response|1|||
46632734|NCT01787760|82805905|FG002|Overall Study|Unsatisfactory visual response|0|||
46632735|NCT01787760|82805903|FG000|Overall Study|Near vision blur|1|||
46632736|NCT01787760|82805904|FG001|Overall Study|Near vision blur|0|||
46632737|NCT01787760|82805905|FG002|Overall Study|Near vision blur|0|||
46720079|NCT01156376|82936158|FG000|Overall Study|Adverse Event|1|||
46720080|NCT01156376|82936159|FG001|Overall Study|Adverse Event|0|||
46720081|NCT01156376|82936160|FG002|Overall Study|Adverse Event|1|||
46720082|NCT01156376|82936158|FG000|Overall Study|Withdrawal by Subject|0|||
46720083|NCT01156376|82936159|FG001|Overall Study|Withdrawal by Subject|0|||
46720084|NCT01156376|82936160|FG002|Overall Study|Withdrawal by Subject|3|||
46720085|NCT00829387|82936170|FG000|Overall Study|Withdrawal by Subject|2|||
46720086|NCT00829387|82936171|FG001|Overall Study|Withdrawal by Subject|3|||
46720087|NCT00829387|82936170|FG000|Overall Study|Disqualified by PI|1|||
46720088|NCT00829387|82936171|FG001|Overall Study|Disqualified by PI|0|||
46720089|NCT01156142|82936179|FG000|Overall Study|Withdrawal by Subject|8|||
46720090|NCT01156142|82936180|FG001|Overall Study|Withdrawal by Subject|6|||
46632738|NCT01815138|82805916|FG000|Overall Study|Withdrawal by Subject|0|||
46720091|NCT01156142|82936179|FG000|Overall Study|Ineligible|0|||
46918292|NCT03096847|83150069|FG002|Overall Study|Other|2|||
46918293|NCT03096847|83150067|FG000|Overall Study|Lost to Follow-up|1|||
46632739|NCT01815138|82805917|FG001|Overall Study|Withdrawal by Subject|1|||
46632740|NCT01815138|82805916|FG000|Overall Study|Physician Decision|8|||
46720092|NCT01156142|82936180|FG001|Overall Study|Ineligible|1|||
46720093|NCT00842257|82936186|FG000|Overall Study|Adverse Event|1|||
46720094|NCT00852475|82936192|FG000|Overall Study|Lost to Follow-up|3|||
46918294|NCT03096847|83150068|FG001|Overall Study|Lost to Follow-up|0|||
46918295|NCT03096847|83150069|FG002|Overall Study|Lost to Follow-up|1|||
46918296|NCT03096847|83150067|FG000|Overall Study|Death|6|||
46918297|NCT03096847|83150068|FG001|Overall Study|Death|0|||
46918298|NCT03096847|83150069|FG002|Overall Study|Death|2|||
46918299|NCT03096847|83150067|FG000|Overall Study|Protocol Violation|3|||
46918300|NCT03096847|83150068|FG001|Overall Study|Protocol Violation|0|||
46918301|NCT03096847|83150069|FG002|Overall Study|Protocol Violation|6|||
46918302|NCT03096847|83150067|FG000|Overall Study|Physician Decision|12|||
46918303|NCT03096847|83150068|FG001|Overall Study|Physician Decision|2|||
46918304|NCT03096847|83150069|FG002|Overall Study|Physician Decision|8|||
46918305|NCT03096847|83150067|FG000|Overall Study|Withdrawal by Subject|24|||
46918306|NCT03096847|83150068|FG001|Overall Study|Withdrawal by Subject|1|||
46918307|NCT03096847|83150069|FG002|Overall Study|Withdrawal by Subject|12|||
46918308|NCT03096847|83150067|FG000|Overall Study|Adverse Event|72|||
46918309|NCT03096847|83150068|FG001|Overall Study|Adverse Event|6|||
46918310|NCT03096847|83150069|FG002|Overall Study|Adverse Event|28|||
46918311|NCT03096847|83150067|FG000|Overall Study|Progressive disease|97|||
46918312|NCT03096847|83150068|FG001|Overall Study|Progressive disease|10|||
46918313|NCT03096847|83150069|FG002|Overall Study|Progressive disease|78|||
46918314|NCT03096847|83150067|FG000|Overall Study|Non-compliance with study medication|1|||
46918315|NCT03096847|83150068|FG001|Overall Study|Non-compliance with study medication|0|||
46918316|NCT03096847|83150069|FG002|Overall Study|Non-compliance with study medication|0|||
46918317|NCT03096847|83150067|FG000|Overall Study|New therapy for study indication|1|||
46918318|NCT03096847|83150068|FG001|Overall Study|New therapy for study indication|0|||
46918319|NCT03096847|83150069|FG002|Overall Study|New therapy for study indication|1|||
46918320|NCT01365182|83150088|FG000|Overall Study|Withdrawal by Subject|10|||
46918321|NCT01365182|83150089|FG001|Overall Study|Withdrawal by Subject|13|||
46918322|NCT01365182|83150090|FG002|Overall Study|Withdrawal by Subject|12|||
46918323|NCT03128099|83150108|FG000|Overall Study|High dose task was too long|0|||
46918324|NCT03128099|83150109|FG001|Overall Study|High dose task was too long|4|||
46918325|NCT03128099|83150110|FG002|Overall Study|High dose task was too long|0|||
46918326|NCT03128099|83150108|FG000|Overall Study|Participant got a full time job.|1|||
46918327|NCT03128099|83150109|FG001|Overall Study|Participant got a full time job.|0|||
46918328|NCT03128099|83150110|FG002|Overall Study|Participant got a full time job.|0|||
46918329|NCT03128099|83150108|FG000|Overall Study|Became homeless and lost contact|1|||
46918330|NCT03128099|83150109|FG001|Overall Study|Became homeless and lost contact|0|||
46918331|NCT03128099|83150110|FG002|Overall Study|Became homeless and lost contact|0|||
46918332|NCT03128099|83150108|FG000|Overall Study|Did not complete all the assessments|0|||
46918333|NCT03128099|83150109|FG001|Overall Study|Did not complete all the assessments|0|||
46918334|NCT03128099|83150110|FG002|Overall Study|Did not complete all the assessments|1|||
46918335|NCT02886494|83150118|FG000|Overall Study|Adverse Event|1|||
46918336|NCT02886494|83150119|FG001|Overall Study|Adverse Event|0|||
46918337|NCT02886494|83150118|FG000|Overall Study|Withdrawal by Subject|12|||
46918338|NCT02886494|83150119|FG001|Overall Study|Withdrawal by Subject|3|||
46918339|NCT02886494|83150118|FG000|Overall Study|Protocol Violation|4|||
46918340|NCT02886494|83150119|FG001|Overall Study|Protocol Violation|1|||
46918341|NCT00204477|83150130|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
46918342|NCT00204477|83150131|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
46918343|NCT00204477|83150130|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
46918344|NCT00204477|83150131|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
46918345|NCT02846532|83150140|FG000|Overall Study|Lost to Follow-up|0|||
46918346|NCT02846532|83150141|FG001|Overall Study|Lost to Follow-up|1|||
46918347|NCT02846532|83150142|FG002|Overall Study|Lost to Follow-up|1|||
46918348|NCT02846532|83150140|FG000|Overall Study|Withdrawal by Subject|1|||
46918349|NCT02846532|83150141|FG001|Overall Study|Withdrawal by Subject|2|||
46918350|NCT02846532|83150142|FG002|Overall Study|Withdrawal by Subject|0|||
46918351|NCT00842348|83150161|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
46918352|NCT00842348|83150162|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
46918353|NCT00842348|83150161|FG000|Study 729|Disease progression/death|19|||
46918354|NCT00842348|83150162|FG001|Study 729|Disease progression/death|30|||
46918355|NCT00842348|83150161|FG000|Study 729|Adverse Event|1|||
46918356|NCT00842348|83150162|FG001|Study 729|Adverse Event|1|||
46918357|NCT00842348|83150161|FG000|Study 729|Protocol Violation|1|||
46918358|NCT00842348|83150162|FG001|Study 729|Protocol Violation|1|||
46918359|NCT00842348|83150161|FG000|Study 729|Withdrawal by Subject|2|||
46632741|NCT01815138|82805917|FG001|Overall Study|Physician Decision|5|||
46918360|NCT00842348|83150162|FG001|Study 729|Withdrawal by Subject|4|||
46918361|NCT00842348|83150161|FG000|Study 729|Due to Sponsor stopping the study|1|||
46918362|NCT00842348|83150162|FG001|Study 729|Due to Sponsor stopping the study|1|||
46918363|NCT00842348|83150161|FG000|Study 729|Due to non-availability of IP|0|||
46918364|NCT00842348|83150162|FG001|Study 729|Due to non-availability of IP|1|||
46918365|NCT00842348|83150161|FG000|Study 729|Sponsor's decision|1|||
46918366|NCT00842348|83150162|FG001|Study 729|Sponsor's decision|0|||
46918367|NCT00842348|83150161|FG000|Study 729|Surgical resection|1|||
46918368|NCT00842348|83150162|FG001|Study 729|Surgical resection|0|||
46918369|NCT03095599|83150174|FG000|Overall Study|Withdrawal by Subject|1|||
46918370|NCT03095599|83150175|FG001|Overall Study|Withdrawal by Subject|0|||
46918371|NCT03095599|83150174|FG000|Overall Study|Lost to Follow-up|1|||
46918372|NCT03095599|83150175|FG001|Overall Study|Lost to Follow-up|0|||
46918373|NCT03095599|83150174|FG000|Overall Study|Withdrawal prior to vaccination|1|||
46918374|NCT03095599|83150175|FG001|Overall Study|Withdrawal prior to vaccination|0|||
46918375|NCT03095521|83150185|FG000|Overall Study|Withdrawal by Subject|0|||
46918376|NCT03095521|83150186|FG001|Overall Study|Withdrawal by Subject|1|||
46918377|NCT03095521|83150185|FG000|Overall Study|Lost to Follow-up|0|||
46918378|NCT03095521|83150186|FG001|Overall Study|Lost to Follow-up|1|||
46918379|NCT03033875|83150195|FG000|Overall Study|Withdrawal by Subject|5|||
46918380|NCT03033875|83150196|FG001|Overall Study|Withdrawal by Subject|9|||
46918381|NCT03033875|83150197|FG002|Overall Study|Withdrawal by Subject|4|||
46918382|NCT03033875|83150195|FG000|Overall Study|Other|14|||
46918383|NCT03033875|83150196|FG001|Overall Study|Other|15|||
46918384|NCT03033875|83150197|FG002|Overall Study|Other|8|||
46918385|NCT01968785|83150211|FG000|Overall Study|Withdrawal by Subject|1|||
46918386|NCT01968785|83150212|FG001|Overall Study|Withdrawal by Subject|0|||
46918387|NCT03095287|83150218|FG000|Overall Study|Treatment Failure|1|||
46918388|NCT03095287|83150218|FG000|Overall Study|Adverse Event|1|||
46918389|NCT02839746|83150236|FG000|Overall Study|Not met selection criteria|12|||
46918390|NCT00033293|83150242|FG000|Overall Study|Death|0|||
46918391|NCT00033293|83150243|FG001|Overall Study|Death|1|||
46918392|NCT00033293|83150242|FG000|Overall Study|Lack of Efficacy|5|||
46918393|NCT00033293|83150243|FG001|Overall Study|Lack of Efficacy|8|||
46918394|NCT00033293|83150242|FG000|Overall Study|Lost to Follow-up|0|||
46918395|NCT00033293|83150243|FG001|Overall Study|Lost to Follow-up|1|||
46918396|NCT00033293|83150242|FG000|Overall Study|Physician Decision|3|||
46918397|NCT00033293|83150243|FG001|Overall Study|Physician Decision|1|||
46918398|NCT00033293|83150242|FG000|Overall Study|Withdrawal by Subject|1|||
46918399|NCT00033293|83150243|FG001|Overall Study|Withdrawal by Subject|0|||
46918400|NCT00033293|83150242|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
46918401|NCT00033293|83150243|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
47041636|NCT01405911|83298049|FG000|Overall Study|Withdrawal by Subject|3|||
47041637|NCT01405911|83298050|FG001|Overall Study|Withdrawal by Subject|1|||
47041638|NCT01405911|83298051|FG002|Overall Study|Withdrawal by Subject|1|||
47041639|NCT01425801|83298059|FG000|Period 1|Withdrawal by Subject|0|||
46918402|NCT00033293|83150242|FG000|Overall Study|Treatment refused|0|||
46918403|NCT00033293|83150243|FG001|Overall Study|Treatment refused|6|||
46918404|NCT02039674|83150265|FG000|Overall Study|Adverse Event|0|||
46918405|NCT02039674|83150266|FG001|Overall Study|Adverse Event|0|||
47041640|NCT01425801|83298060|FG001|Period 1|Withdrawal by Subject|0|||
47041641|NCT01425801|83298061|FG002|Period 1|Withdrawal by Subject|0|||
46918406|NCT02039674|83150267|FG002|Overall Study|Adverse Event|0|||
46918407|NCT02039674|83150268|FG003|Overall Study|Adverse Event|1|||
46918408|NCT02039674|83150269|FG004|Overall Study|Adverse Event|0|||
46918409|NCT02039674|83150270|FG005|Overall Study|Adverse Event|0|||
46918410|NCT02039674|83150271|FG006|Overall Study|Adverse Event|0|||
46918411|NCT02039674|83150272|FG007|Overall Study|Adverse Event|0|||
46918412|NCT02039674|83150273|FG008|Overall Study|Adverse Event|2|||
47041642|NCT01425801|83298062|FG003|Period 1|Withdrawal by Subject|0|||
47041643|NCT01425801|83298063|FG004|Period 1|Withdrawal by Subject|1|||
47041644|NCT01425801|83298064|FG005|Period 1|Withdrawal by Subject|0|||
47041645|NCT01425801|83298059|FG000|Period 2|Withdrawal by Subject|0|||
47041646|NCT01425801|83298060|FG001|Period 2|Withdrawal by Subject|0|||
46918413|NCT02039674|83150274|FG009|Overall Study|Adverse Event|1|||
46918414|NCT02039674|83150275|FG010|Overall Study|Adverse Event|0|||
46918415|NCT02039674|83150276|FG011|Overall Study|Adverse Event|2|||
46918416|NCT02039674|83150277|FG012|Overall Study|Adverse Event|3|||
47041647|NCT01425801|83298061|FG002|Period 2|Withdrawal by Subject|0|||
47041648|NCT01425801|83298062|FG003|Period 2|Withdrawal by Subject|0|||
47041649|NCT01425801|83298063|FG004|Period 2|Withdrawal by Subject|1|||
47041650|NCT01425801|83298064|FG005|Period 2|Withdrawal by Subject|0|||
46918417|NCT02039674|83150278|FG013|Overall Study|Adverse Event|1|||
46918418|NCT02039674|83150265|FG000|Overall Study|Death|2|||
46918419|NCT02039674|83150266|FG001|Overall Study|Death|0|||
46918420|NCT02039674|83150267|FG002|Overall Study|Death|2|||
47041651|NCT01425801|83298059|FG000|Period 3|Stability criteria not fullfilled|0|||
47041652|NCT01425801|83298060|FG001|Period 3|Stability criteria not fullfilled|0|||
46918421|NCT02039674|83150268|FG003|Overall Study|Death|3|||
46918422|NCT02039674|83150269|FG004|Overall Study|Death|0|||
46918423|NCT02039674|83150270|FG005|Overall Study|Death|0|||
46918424|NCT02039674|83150271|FG006|Overall Study|Death|1|||
46918425|NCT02039674|83150272|FG007|Overall Study|Death|0|||
46918426|NCT02039674|83150273|FG008|Overall Study|Death|2|||
46918427|NCT02039674|83150274|FG009|Overall Study|Death|0|||
46918428|NCT02039674|83150275|FG010|Overall Study|Death|1|||
46918429|NCT02039674|83150276|FG011|Overall Study|Death|3|||
46918430|NCT02039674|83150277|FG012|Overall Study|Death|2|||
46918431|NCT02039674|83150278|FG013|Overall Study|Death|8|||
46918432|NCT02039674|83150265|FG000|Overall Study|Excluded Medication|1|||
46918433|NCT02039674|83150266|FG001|Overall Study|Excluded Medication|1|||
46918434|NCT02039674|83150267|FG002|Overall Study|Excluded Medication|0|||
46918435|NCT02039674|83150268|FG003|Overall Study|Excluded Medication|1|||
46918436|NCT02039674|83150269|FG004|Overall Study|Excluded Medication|0|||
46918437|NCT02039674|83150270|FG005|Overall Study|Excluded Medication|1|||
46918438|NCT02039674|83150271|FG006|Overall Study|Excluded Medication|0|||
46918439|NCT02039674|83150272|FG007|Overall Study|Excluded Medication|0|||
46918440|NCT02039674|83150273|FG008|Overall Study|Excluded Medication|2|||
46918441|NCT02039674|83150274|FG009|Overall Study|Excluded Medication|3|||
46918442|NCT02039674|83150275|FG010|Overall Study|Excluded Medication|5|||
46918443|NCT02039674|83150276|FG011|Overall Study|Excluded Medication|6|||
46918444|NCT02039674|83150277|FG012|Overall Study|Excluded Medication|8|||
46918445|NCT02039674|83150278|FG013|Overall Study|Excluded Medication|3|||
46918446|NCT02039674|83150265|FG000|Overall Study|Lost to Follow-up|0|||
46918447|NCT02039674|83150266|FG001|Overall Study|Lost to Follow-up|0|||
46918448|NCT02039674|83150267|FG002|Overall Study|Lost to Follow-up|0|||
46918449|NCT02039674|83150268|FG003|Overall Study|Lost to Follow-up|0|||
46918450|NCT02039674|83150269|FG004|Overall Study|Lost to Follow-up|1|||
46918451|NCT02039674|83150270|FG005|Overall Study|Lost to Follow-up|1|||
46918452|NCT02039674|83150271|FG006|Overall Study|Lost to Follow-up|0|||
46918453|NCT02039674|83150272|FG007|Overall Study|Lost to Follow-up|0|||
46918454|NCT02039674|83150273|FG008|Overall Study|Lost to Follow-up|0|||
46918455|NCT02039674|83150274|FG009|Overall Study|Lost to Follow-up|0|||
46918456|NCT02039674|83150275|FG010|Overall Study|Lost to Follow-up|0|||
46918457|NCT02039674|83150276|FG011|Overall Study|Lost to Follow-up|2|||
46918458|NCT02039674|83150277|FG012|Overall Study|Lost to Follow-up|2|||
46918459|NCT02039674|83150278|FG013|Overall Study|Lost to Follow-up|1|||
46918460|NCT02039674|83150265|FG000|Overall Study|Physician Decision|0|||
46918461|NCT02039674|83150266|FG001|Overall Study|Physician Decision|0|||
46918462|NCT02039674|83150267|FG002|Overall Study|Physician Decision|0|||
46918463|NCT02039674|83150268|FG003|Overall Study|Physician Decision|0|||
46918464|NCT02039674|83150269|FG004|Overall Study|Physician Decision|0|||
46918465|NCT02039674|83150270|FG005|Overall Study|Physician Decision|0|||
46918466|NCT02039674|83150271|FG006|Overall Study|Physician Decision|0|||
46918467|NCT02039674|83150272|FG007|Overall Study|Physician Decision|0|||
46918468|NCT02039674|83150273|FG008|Overall Study|Physician Decision|0|||
46918469|NCT02039674|83150274|FG009|Overall Study|Physician Decision|0|||
46918470|NCT02039674|83150275|FG010|Overall Study|Physician Decision|0|||
46918471|NCT02039674|83150276|FG011|Overall Study|Physician Decision|1|||
46918472|NCT02039674|83150277|FG012|Overall Study|Physician Decision|1|||
46918473|NCT02039674|83150278|FG013|Overall Study|Physician Decision|0|||
46918474|NCT02039674|83150265|FG000|Overall Study|Progressive Disease|8|||
46918475|NCT02039674|83150266|FG001|Overall Study|Progressive Disease|8|||
46918476|NCT02039674|83150267|FG002|Overall Study|Progressive Disease|6|||
46918477|NCT02039674|83150268|FG003|Overall Study|Progressive Disease|7|||
46918478|NCT02039674|83150269|FG004|Overall Study|Progressive Disease|9|||
46918479|NCT02039674|83150270|FG005|Overall Study|Progressive Disease|10|||
46918480|NCT02039674|83150271|FG006|Overall Study|Progressive Disease|1|||
46918481|NCT02039674|83150272|FG007|Overall Study|Progressive Disease|3|||
46918482|NCT02039674|83150273|FG008|Overall Study|Progressive Disease|6|||
46918483|NCT02039674|83150274|FG009|Overall Study|Progressive Disease|4|||
46918484|NCT02039674|83150275|FG010|Overall Study|Progressive Disease|0|||
46918485|NCT02039674|83150276|FG011|Overall Study|Progressive Disease|34|||
46918486|NCT02039674|83150277|FG012|Overall Study|Progressive Disease|34|||
46918487|NCT02039674|83150278|FG013|Overall Study|Progressive Disease|18|||
46918488|NCT02039674|83150265|FG000|Overall Study|Withdrawal by Subject|1|||
47041653|NCT01425801|83298061|FG002|Period 3|Stability criteria not fullfilled|1|||
46918489|NCT02039674|83150266|FG001|Overall Study|Withdrawal by Subject|2|||
46918490|NCT02039674|83150267|FG002|Overall Study|Withdrawal by Subject|3|||
46918491|NCT02039674|83150268|FG003|Overall Study|Withdrawal by Subject|0|||
46918492|NCT02039674|83150269|FG004|Overall Study|Withdrawal by Subject|1|||
46918493|NCT02039674|83150270|FG005|Overall Study|Withdrawal by Subject|0|||
46918494|NCT02039674|83150271|FG006|Overall Study|Withdrawal by Subject|0|||
46918495|NCT02039674|83150272|FG007|Overall Study|Withdrawal by Subject|0|||
46918496|NCT02039674|83150273|FG008|Overall Study|Withdrawal by Subject|0|||
46918497|NCT02039674|83150274|FG009|Overall Study|Withdrawal by Subject|1|||
46918498|NCT02039674|83150275|FG010|Overall Study|Withdrawal by Subject|1|||
46918499|NCT02039674|83150276|FG011|Overall Study|Withdrawal by Subject|4|||
46918500|NCT02039674|83150277|FG012|Overall Study|Withdrawal by Subject|6|||
46918501|NCT02039674|83150278|FG013|Overall Study|Withdrawal by Subject|2|||
46918502|NCT02039674|83150265|FG000|Overall Study|Clinical Progression|0|||
46918503|NCT02039674|83150266|FG001|Overall Study|Clinical Progression|0|||
46918504|NCT02039674|83150267|FG002|Overall Study|Clinical Progression|0|||
46918505|NCT02039674|83150268|FG003|Overall Study|Clinical Progression|0|||
46918506|NCT02039674|83150269|FG004|Overall Study|Clinical Progression|0|||
46918507|NCT02039674|83150270|FG005|Overall Study|Clinical Progression|0|||
46918508|NCT02039674|83150271|FG006|Overall Study|Clinical Progression|1|||
46918509|NCT02039674|83150272|FG007|Overall Study|Clinical Progression|0|||
46918510|NCT02039674|83150273|FG008|Overall Study|Clinical Progression|0|||
46918511|NCT02039674|83150274|FG009|Overall Study|Clinical Progression|0|||
46918512|NCT02039674|83150275|FG010|Overall Study|Clinical Progression|0|||
46918513|NCT02039674|83150276|FG011|Overall Study|Clinical Progression|0|||
46918514|NCT02039674|83150277|FG012|Overall Study|Clinical Progression|1|||
46918515|NCT02039674|83150278|FG013|Overall Study|Clinical Progression|0|||
46918516|NCT02039674|83150265|FG000|Overall Study|Sponsor Decision|1|||
46918517|NCT02039674|83150266|FG001|Overall Study|Sponsor Decision|1|||
46918518|NCT02039674|83150267|FG002|Overall Study|Sponsor Decision|1|||
46918519|NCT02039674|83150268|FG003|Overall Study|Sponsor Decision|1|||
46918520|NCT02039674|83150269|FG004|Overall Study|Sponsor Decision|1|||
46918521|NCT02039674|83150270|FG005|Overall Study|Sponsor Decision|0|||
46918522|NCT02039674|83150271|FG006|Overall Study|Sponsor Decision|0|||
46918523|NCT02039674|83150272|FG007|Overall Study|Sponsor Decision|0|||
46918524|NCT02039674|83150273|FG008|Overall Study|Sponsor Decision|0|||
46918525|NCT02039674|83150274|FG009|Overall Study|Sponsor Decision|3|||
46918526|NCT02039674|83150275|FG010|Overall Study|Sponsor Decision|0|||
46918527|NCT02039674|83150276|FG011|Overall Study|Sponsor Decision|8|||
46918528|NCT02039674|83150277|FG012|Overall Study|Sponsor Decision|5|||
46918529|NCT02039674|83150278|FG013|Overall Study|Sponsor Decision|0|||
46918530|NCT02039674|83150265|FG000|Overall Study|Other|0|||
46918531|NCT02039674|83150266|FG001|Overall Study|Other|0|||
46918532|NCT02039674|83150267|FG002|Overall Study|Other|0|||
46918533|NCT02039674|83150268|FG003|Overall Study|Other|0|||
46918534|NCT02039674|83150269|FG004|Overall Study|Other|0|||
46918535|NCT02039674|83150270|FG005|Overall Study|Other|0|||
46918536|NCT02039674|83150271|FG006|Overall Study|Other|0|||
46918537|NCT02039674|83150272|FG007|Overall Study|Other|0|||
46918538|NCT02039674|83150273|FG008|Overall Study|Other|0|||
46918539|NCT02039674|83150274|FG009|Overall Study|Other|0|||
46918540|NCT02039674|83150275|FG010|Overall Study|Other|0|||
46720095|NCT00852475|82936193|FG001|Overall Study|Lost to Follow-up|4|||
46720096|NCT01155284|82936203|FG000|Overall Study|Withdrawal by Subject|4|||
46720097|NCT01155284|82936204|FG001|Overall Study|Withdrawal by Subject|3|||
46720098|NCT01155284|82936203|FG000|Overall Study|Lost to Follow-up|1|||
46720099|NCT01155284|82936204|FG001|Overall Study|Lost to Follow-up|2|||
46720100|NCT01155284|82936203|FG000|Overall Study|Physician Decision|1|||
46720101|NCT01155284|82936204|FG001|Overall Study|Physician Decision|0|||
46720102|NCT01155284|82936203|FG000|Overall Study|Adverse Event|1|||
46720103|NCT01155284|82936204|FG001|Overall Study|Adverse Event|0|||
46720104|NCT00852397|82936215|FG000|Overall Study|Adverse Event|4|||
46720105|NCT00852397|82936216|FG001|Overall Study|Adverse Event|6|||
46720106|NCT00852397|82936217|FG002|Overall Study|Adverse Event|4|||
46720107|NCT00852397|82936215|FG000|Overall Study|Death|0|||
46720108|NCT00852397|82936216|FG001|Overall Study|Death|0|||
46720109|NCT00852397|82936217|FG002|Overall Study|Death|1|||
46720110|NCT00852397|82936215|FG000|Overall Study|Withdrawal by Subject|4|||
46720111|NCT00852397|82936216|FG001|Overall Study|Withdrawal by Subject|1|||
46720112|NCT00852397|82936217|FG002|Overall Study|Withdrawal by Subject|2|||
46720113|NCT00852397|82936215|FG000|Overall Study|Study terminated by sponsor|2|||
46720114|NCT00852397|82936216|FG001|Overall Study|Study terminated by sponsor|1|||
46720115|NCT00852397|82936217|FG002|Overall Study|Study terminated by sponsor|6|||
46720116|NCT00852397|82936215|FG000|Overall Study|Difficulty in study site visit|1|||
46918541|NCT02039674|83150276|FG011|Overall Study|Other|0|||
46918542|NCT02039674|83150277|FG012|Overall Study|Other|1|||
46720117|NCT00852397|82936216|FG001|Overall Study|Difficulty in study site visit|0|||
46720118|NCT00852397|82936217|FG002|Overall Study|Difficulty in study site visit|0|||
46720119|NCT00852397|82936215|FG000|Overall Study|Protocol Violation|0|||
46720120|NCT00852397|82936216|FG001|Overall Study|Protocol Violation|0|||
46720121|NCT00852397|82936217|FG002|Overall Study|Protocol Violation|1|||
46720122|NCT00841321|82936227|FG000|Overall Study|Lost to Follow-up|1|||
46720123|NCT00841321|82936228|FG001|Overall Study|Lost to Follow-up|1|||
46918543|NCT02039674|83150278|FG013|Overall Study|Other|0|||
46720124|NCT00841321|82936227|FG000|Overall Study|Adverse Event|0|||
46918544|NCT03126227|83150318|FG000|Overall Study|Adverse Event|43|||
46918545|NCT03126227|83150319|FG001|Overall Study|Adverse Event|4|||
46918546|NCT03126227|83150318|FG000|Overall Study|Death|0|||
46918547|NCT03126227|83150319|FG001|Overall Study|Death|1|||
46918548|NCT03126227|83150318|FG000|Overall Study|Lost to Follow-up|0|||
46720125|NCT00841321|82936228|FG001|Overall Study|Adverse Event|2|||
46720126|NCT00986232|82936240|FG000|Overall Study|Adverse Event|1|||
46918549|NCT03126227|83150319|FG001|Overall Study|Lost to Follow-up|1|||
46918550|NCT03126227|83150318|FG000|Overall Study|Physician Decision|2|||
46918551|NCT03126227|83150319|FG001|Overall Study|Physician Decision|0|||
46918552|NCT03126227|83150318|FG000|Overall Study|Protocol Violation|1|||
46918553|NCT03126227|83150319|FG001|Overall Study|Protocol Violation|0|||
46918554|NCT03126227|83150318|FG000|Overall Study|Withdrawal by Subject|19|||
46918555|NCT03126227|83150319|FG001|Overall Study|Withdrawal by Subject|3|||
46918556|NCT03126227|83150318|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
46918557|NCT03126227|83150319|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
46918558|NCT03126227|83150318|FG000|Overall Study|Lack of dosing compliance|2|||
46918559|NCT03126227|83150319|FG001|Overall Study|Lack of dosing compliance|0|||
46918560|NCT03126227|83150318|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
46918561|NCT03126227|83150319|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
46918562|NCT03126227|83150318|FG000|Overall Study|Scheduling conflict|1|||
46918563|NCT03126227|83150319|FG001|Overall Study|Scheduling conflict|0|||
46918564|NCT03099187|83150327|FG000|Double-blind Treatment|Adverse Event|19|||
46918565|NCT03099187|83150328|FG001|Double-blind Treatment|Adverse Event|1|||
46918566|NCT03099187|83150329|FG002|Double-blind Treatment|Adverse Event|0|||
46918567|NCT03099187|83150330|FG003|Double-blind Treatment|Adverse Event|0|||
46918568|NCT03099187|83150327|FG000|Double-blind Treatment|Death|1|||
46918569|NCT03099187|83150328|FG001|Double-blind Treatment|Death|3|||
46918570|NCT03099187|83150329|FG002|Double-blind Treatment|Death|0|||
46918571|NCT03099187|83150330|FG003|Double-blind Treatment|Death|0|||
46918572|NCT03099187|83150327|FG000|Double-blind Treatment|Lack of Efficacy|1|||
46918573|NCT03099187|83150328|FG001|Double-blind Treatment|Lack of Efficacy|0|||
46918574|NCT03099187|83150329|FG002|Double-blind Treatment|Lack of Efficacy|0|||
46918575|NCT03099187|83150330|FG003|Double-blind Treatment|Lack of Efficacy|0|||
46918576|NCT03099187|83150327|FG000|Double-blind Treatment|Physician Decision|2|||
46918577|NCT03099187|83150328|FG001|Double-blind Treatment|Physician Decision|1|||
46918578|NCT03099187|83150329|FG002|Double-blind Treatment|Physician Decision|0|||
46918579|NCT03099187|83150330|FG003|Double-blind Treatment|Physician Decision|0|||
46918580|NCT03099187|83150327|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
46918581|NCT03099187|83150328|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
46918582|NCT03099187|83150329|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
46918583|NCT03099187|83150330|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
46918584|NCT03099187|83150327|FG000|Double-blind Treatment|Lung transplantation|0|||
46918585|NCT03099187|83150328|FG001|Double-blind Treatment|Lung transplantation|1|||
46918586|NCT03099187|83150329|FG002|Double-blind Treatment|Lung transplantation|0|||
46918587|NCT03099187|83150330|FG003|Double-blind Treatment|Lung transplantation|0|||
46918588|NCT03099187|83150327|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
46918589|NCT03099187|83150328|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
46918590|NCT03099187|83150329|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
46918591|NCT03099187|83150330|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
46918592|NCT03099187|83150327|FG000|Double-blind Treatment|Disease progression|0|||
46918593|NCT03099187|83150328|FG001|Double-blind Treatment|Disease progression|1|||
46918594|NCT03099187|83150329|FG002|Double-blind Treatment|Disease progression|0|||
46918595|NCT03099187|83150330|FG003|Double-blind Treatment|Disease progression|0|||
46918596|NCT03099187|83150327|FG000|Double-blind Treatment|Randomization error|0|||
46918597|NCT03099187|83150328|FG001|Double-blind Treatment|Randomization error|2|||
46918598|NCT03099187|83150329|FG002|Double-blind Treatment|Randomization error|0|||
46918599|NCT03099187|83150330|FG003|Double-blind Treatment|Randomization error|0|||
46918600|NCT03099187|83150327|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
46918601|NCT03099187|83150328|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
46918602|NCT03099187|83150329|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
46918603|NCT03099187|83150330|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
46918604|NCT03099187|83150327|FG000|12-month Safety Follow-up|Adverse Event|0|||
46918605|NCT03099187|83150328|FG001|12-month Safety Follow-up|Adverse Event|0|||
46918606|NCT03099187|83150329|FG002|12-month Safety Follow-up|Adverse Event|5|||
46918607|NCT03099187|83150330|FG003|12-month Safety Follow-up|Adverse Event|12|||
46918608|NCT03099187|83150327|FG000|12-month Safety Follow-up|Death|0|||
46918609|NCT03099187|83150328|FG001|12-month Safety Follow-up|Death|0|||
46918610|NCT03099187|83150329|FG002|12-month Safety Follow-up|Death|7|||
46918611|NCT03099187|83150330|FG003|12-month Safety Follow-up|Death|9|||
46918612|NCT03099187|83150327|FG000|12-month Safety Follow-up|Lung transplantation|0|||
46918613|NCT03099187|83150328|FG001|12-month Safety Follow-up|Lung transplantation|0|||
46918614|NCT03099187|83150329|FG002|12-month Safety Follow-up|Lung transplantation|2|||
46918615|NCT03099187|83150330|FG003|12-month Safety Follow-up|Lung transplantation|1|||
46918616|NCT03099187|83150327|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
46918617|NCT03099187|83150328|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
46918618|NCT03099187|83150329|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
46918619|NCT03099187|83150330|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
46918620|NCT03099187|83150327|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
46918621|NCT03099187|83150328|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
46918622|NCT03099187|83150329|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
47041654|NCT01425801|83298062|FG003|Period 3|Stability criteria not fullfilled|0|||
47041655|NCT01425801|83298063|FG004|Period 3|Stability criteria not fullfilled|0|||
47041656|NCT01425801|83298064|FG005|Period 3|Stability criteria not fullfilled|0|||
47041657|NCT01425801|83298059|FG000|Period 4|Not able to maintain visit schedule|0|||
47041658|NCT01425801|83298060|FG001|Period 4|Not able to maintain visit schedule|0|||
47041659|NCT01425801|83298061|FG002|Period 4|Not able to maintain visit schedule|1|||
46918623|NCT03099187|83150330|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
46918624|NCT03099187|83150327|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
46918625|NCT03099187|83150328|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
46918626|NCT03099187|83150329|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
46918627|NCT03099187|83150330|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
46918628|NCT03099187|83150327|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
46918629|NCT03099187|83150328|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
46918630|NCT03099187|83150329|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
46918631|NCT03099187|83150330|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
46918632|NCT04535453|83150352|FG000|Overall Study|Death|0|||
46918633|NCT04535453|83150353|FG001|Overall Study|Death|1|||
46918634|NCT04535453|83150354|FG002|Overall Study|Death|0|||
46918635|NCT04535453|83150355|FG003|Overall Study|Death|0|||
46918636|NCT04535453|83150356|FG004|Overall Study|Death|0|||
46918637|NCT04535453|83150357|FG005|Overall Study|Death|0|||
46918638|NCT04535453|83150358|FG006|Overall Study|Death|0|||
46918639|NCT04535453|83150359|FG007|Overall Study|Death|0|||
46918640|NCT04535453|83150360|FG008|Overall Study|Death|0|||
46918641|NCT04535453|83150361|FG009|Overall Study|Death|0|||
46918642|NCT04535453|83150362|FG010|Overall Study|Death|0|||
46918643|NCT04535453|83150363|FG011|Overall Study|Death|0|||
46918644|NCT04535453|83150352|FG000|Overall Study|Lost to Follow-up|1|||
46918645|NCT04535453|83150353|FG001|Overall Study|Lost to Follow-up|1|||
46918646|NCT04535453|83150354|FG002|Overall Study|Lost to Follow-up|1|||
46918647|NCT04535453|83150355|FG003|Overall Study|Lost to Follow-up|0|||
46918648|NCT04535453|83150356|FG004|Overall Study|Lost to Follow-up|3|||
46918649|NCT04535453|83150357|FG005|Overall Study|Lost to Follow-up|1|||
46918650|NCT04535453|83150358|FG006|Overall Study|Lost to Follow-up|0|||
46918651|NCT04535453|83150359|FG007|Overall Study|Lost to Follow-up|0|||
46918652|NCT04535453|83150360|FG008|Overall Study|Lost to Follow-up|1|||
46918653|NCT04535453|83150361|FG009|Overall Study|Lost to Follow-up|1|||
46918654|NCT04535453|83150362|FG010|Overall Study|Lost to Follow-up|0|||
46918655|NCT04535453|83150363|FG011|Overall Study|Lost to Follow-up|0|||
46918656|NCT04535453|83150352|FG000|Overall Study|Physician Decision|0|||
46918657|NCT04535453|83150353|FG001|Overall Study|Physician Decision|0|||
46918658|NCT04535453|83150354|FG002|Overall Study|Physician Decision|0|||
46918659|NCT04535453|83150355|FG003|Overall Study|Physician Decision|1|||
46918660|NCT04535453|83150356|FG004|Overall Study|Physician Decision|0|||
46918661|NCT04535453|83150357|FG005|Overall Study|Physician Decision|0|||
46918662|NCT04535453|83150358|FG006|Overall Study|Physician Decision|0|||
46918663|NCT04535453|83150359|FG007|Overall Study|Physician Decision|0|||
46918664|NCT04535453|83150360|FG008|Overall Study|Physician Decision|0|||
46918665|NCT04535453|83150361|FG009|Overall Study|Physician Decision|0|||
46918666|NCT04535453|83150362|FG010|Overall Study|Physician Decision|0|||
46918667|NCT04535453|83150363|FG011|Overall Study|Physician Decision|0|||
46918668|NCT04535453|83150352|FG000|Overall Study|Withdrawal by Subject|3|||
46918669|NCT04535453|83150353|FG001|Overall Study|Withdrawal by Subject|6|||
46918670|NCT04535453|83150354|FG002|Overall Study|Withdrawal by Subject|3|||
46918671|NCT04535453|83150355|FG003|Overall Study|Withdrawal by Subject|3|||
46918672|NCT04535453|83150356|FG004|Overall Study|Withdrawal by Subject|2|||
46918673|NCT04535453|83150357|FG005|Overall Study|Withdrawal by Subject|1|||
46918674|NCT04535453|83150358|FG006|Overall Study|Withdrawal by Subject|1|||
46918675|NCT04535453|83150359|FG007|Overall Study|Withdrawal by Subject|1|||
46918676|NCT04535453|83150360|FG008|Overall Study|Withdrawal by Subject|1|||
46918677|NCT04535453|83150361|FG009|Overall Study|Withdrawal by Subject|1|||
46918678|NCT04535453|83150362|FG010|Overall Study|Withdrawal by Subject|0|||
46918679|NCT04535453|83150363|FG011|Overall Study|Withdrawal by Subject|1|||
46918680|NCT04535453|83150352|FG000|Overall Study|Other|0|||
46918681|NCT04535453|83150353|FG001|Overall Study|Other|0|||
46918682|NCT04535453|83150354|FG002|Overall Study|Other|1|||
46918683|NCT04535453|83150355|FG003|Overall Study|Other|0|||
46918684|NCT04535453|83150356|FG004|Overall Study|Other|1|||
46918685|NCT04535453|83150357|FG005|Overall Study|Other|0|||
47041660|NCT01425801|83298062|FG003|Period 4|Not able to maintain visit schedule|0|||
46720127|NCT00986232|82936241|FG001|Overall Study|Adverse Event|2|||
47041661|NCT01425801|83298063|FG004|Period 4|Not able to maintain visit schedule|0|||
46918686|NCT04535453|83150358|FG006|Overall Study|Other|1|||
46918687|NCT04535453|83150359|FG007|Overall Study|Other|1|||
46918688|NCT04535453|83150360|FG008|Overall Study|Other|1|||
46918689|NCT04535453|83150361|FG009|Overall Study|Other|0|||
46918690|NCT04535453|83150362|FG010|Overall Study|Other|0|||
46918691|NCT04535453|83150363|FG011|Overall Study|Other|0|||
46918692|NCT04463069|83150406|FG000|Overall Study|Withdrawal by Subject|2|||
46918693|NCT04463069|83150407|FG001|Overall Study|Withdrawal by Subject|10|||
46918694|NCT04463069|83150406|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
46918695|NCT04463069|83150407|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
46918696|NCT03521687|83150413|FG000|Overall Study|Adverse Event|4|||
46918697|NCT03521687|83150413|FG000|Overall Study|Physician Decision|1|||
46918698|NCT03125915|83150421|FG000|1 Month Follow up|Lost to Follow-up|3|||
46918699|NCT03125915|83150422|FG001|1 Month Follow up|Lost to Follow-up|3|||
46918700|NCT03125915|83150423|FG002|1 Month Follow up|Lost to Follow-up|2|||
46918701|NCT03125915|83150424|FG003|1 Month Follow up|Lost to Follow-up|3|||
46918702|NCT03125915|83150421|FG000|3 Month Follow-up|Lost to Follow-up|6|||
46918703|NCT03125915|83150422|FG001|3 Month Follow-up|Lost to Follow-up|4|||
46918704|NCT03125915|83150423|FG002|3 Month Follow-up|Lost to Follow-up|4|||
46918705|NCT03125915|83150424|FG003|3 Month Follow-up|Lost to Follow-up|2|||
46918706|NCT03125915|83150421|FG000|6 Month Follow-up|Lost to Follow-up|7|||
46918707|NCT03125915|83150422|FG001|6 Month Follow-up|Lost to Follow-up|3|||
46918708|NCT03125915|83150423|FG002|6 Month Follow-up|Lost to Follow-up|6|||
46918709|NCT03125915|83150424|FG003|6 Month Follow-up|Lost to Follow-up|3|||
46918710|NCT03122171|83150434|FG000|Overall Study|Withdrawal by Subject|1|||
46918711|NCT01427725|83150438|FG000|Overall Study|Lost to Follow-up|17|||
46918712|NCT01427725|83150438|FG000|Overall Study|Protocol Violation|1|||
46918713|NCT01427725|83150438|FG000|Overall Study|Drug not administered|1|||
47041662|NCT01425801|83298064|FG005|Period 4|Not able to maintain visit schedule|0|||
47041663|NCT01425723|83298089|FG000|Overall Study|Lack of Efficacy|0|||
46918714|NCT01427725|83150438|FG000|Overall Study|Failure to visit|7|||
46918715|NCT01427725|83150438|FG000|Overall Study|Adverse Event|46|||
46918716|NCT01427725|83150438|FG000|Overall Study|Failure to visit after administration|40|||
46918717|NCT01427725|83150438|FG000|Overall Study|Patient's rejection|27|||
46918718|NCT01427725|83150438|FG000|Overall Study|Transfer to a different hospital|17|||
46918719|NCT01427725|83150438|FG000|Overall Study|Lack of Efficacy|8|||
46918720|NCT01427725|83150438|FG000|Overall Study|Death|7|||
46918721|NCT01427725|83150438|FG000|Overall Study|Symptom improvement|6|||
46918722|NCT01427725|83150438|FG000|Overall Study|AE and Patient's rejection|5|||
46918723|NCT01427725|83150438|FG000|Overall Study|Physician Decision|5|||
46918724|NCT01427725|83150438|FG000|Overall Study|Exacerbation of underlying disease|5|||
46918725|NCT01427725|83150438|FG000|Overall Study|Oral feeding difficulty|5|||
46918726|NCT01427725|83150438|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
46918727|NCT01427725|83150438|FG000|Overall Study|Forgetting prescription|1|||
46918728|NCT01427725|83150438|FG000|Overall Study|Other|2|||
46918729|NCT02839200|83150449|FG000|Overall Study|Withdrawal by Subject|2|||
46918730|NCT02839200|83150450|FG001|Overall Study|Withdrawal by Subject|0|||
46918731|NCT02839200|83150451|FG002|Overall Study|Withdrawal by Subject|1|||
46918732|NCT02839200|83150452|FG003|Overall Study|Withdrawal by Subject|0|||
46918733|NCT02839200|83150453|FG004|Overall Study|Withdrawal by Subject|0|||
46918734|NCT02839200|83150454|FG005|Overall Study|Withdrawal by Subject|1|||
46918735|NCT02839200|83150449|FG000|Overall Study|Lost to Follow-up|2|||
46918736|NCT02839200|83150450|FG001|Overall Study|Lost to Follow-up|0|||
46918737|NCT02839200|83150451|FG002|Overall Study|Lost to Follow-up|0|||
47041664|NCT01425723|83298090|FG001|Overall Study|Lack of Efficacy|1|||
47041665|NCT01425723|83298089|FG000|Overall Study|Withdrawal by Subject|1|||
47041666|NCT01425723|83298090|FG001|Overall Study|Withdrawal by Subject|4|||
47041667|NCT01425723|83298089|FG000|Overall Study|Lost to Follow-up|0|||
47041668|NCT01425723|83298090|FG001|Overall Study|Lost to Follow-up|3|||
47041669|NCT01425723|83298089|FG000|Overall Study|Physician Decision|2|||
47041670|NCT01425723|83298090|FG001|Overall Study|Physician Decision|0|||
47041671|NCT01425723|83298089|FG000|Overall Study|Other|1|||
47041672|NCT01425723|83298090|FG001|Overall Study|Other|10|||
46918738|NCT02839200|83150452|FG003|Overall Study|Lost to Follow-up|0|||
46918739|NCT02839200|83150453|FG004|Overall Study|Lost to Follow-up|1|||
46918740|NCT02839200|83150454|FG005|Overall Study|Lost to Follow-up|0|||
47041673|NCT01424397|83298121|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041674|NCT01424397|83298122|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041675|NCT01424397|83298123|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
47041676|NCT01424397|83298124|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041677|NCT01424397|83298125|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
46918741|NCT02839200|83150449|FG000|Overall Study|Adverse Event|0|||
46918742|NCT02839200|83150450|FG001|Overall Study|Adverse Event|0|||
46918743|NCT02839200|83150451|FG002|Overall Study|Adverse Event|0|||
46918744|NCT02839200|83150452|FG003|Overall Study|Adverse Event|0|||
46918745|NCT02839200|83150453|FG004|Overall Study|Adverse Event|1|||
46918746|NCT02839200|83150454|FG005|Overall Study|Adverse Event|0|||
46918747|NCT02839200|83150449|FG000|Overall Study|Randomized in error|0|||
46918748|NCT02839200|83150450|FG001|Overall Study|Randomized in error|1|||
46918749|NCT02839200|83150451|FG002|Overall Study|Randomized in error|0|||
46918750|NCT02839200|83150452|FG003|Overall Study|Randomized in error|0|||
46918751|NCT02839200|83150453|FG004|Overall Study|Randomized in error|0|||
46918752|NCT02839200|83150454|FG005|Overall Study|Randomized in error|0|||
46918753|NCT03118739|83150470|FG000|Overall Study|Physician Decision|0|||
46918754|NCT03118739|83150471|FG001|Overall Study|Physician Decision|1|||
46918755|NCT03118739|83150470|FG000|Overall Study|Withdrawal by Subject|5|||
46918756|NCT03118739|83150471|FG001|Overall Study|Withdrawal by Subject|3|||
46918757|NCT03118739|83150470|FG000|Overall Study|Lost to Follow-up|2|||
46918758|NCT03118739|83150471|FG001|Overall Study|Lost to Follow-up|0|||
46918759|NCT03094195|83150480|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
46918760|NCT03094195|83150481|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
46918761|NCT03094195|83150482|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
46918762|NCT03094195|83150483|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46918763|NCT03094195|83150484|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46918764|NCT03094195|83150485|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46918765|NCT03094195|83150486|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46918766|NCT03094195|83150487|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46918767|NCT03094195|83150480|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
46918768|NCT03094195|83150481|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
46918769|NCT03094195|83150482|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
46918770|NCT03094195|83150483|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46918771|NCT03094195|83150484|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46918772|NCT03094195|83150485|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46918773|NCT03094195|83150486|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46918774|NCT03094195|83150487|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46918775|NCT03094195|83150480|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46918776|NCT03094195|83150481|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46918777|NCT03094195|83150482|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
46918778|NCT03094195|83150483|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46918779|NCT03094195|83150484|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46918780|NCT03094195|83150485|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46918781|NCT03094195|83150486|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46918782|NCT03094195|83150487|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46918783|NCT03094195|83150480|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46918784|NCT03094195|83150481|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
46918785|NCT03094195|83150482|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
46918786|NCT03094195|83150483|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46918787|NCT03094195|83150484|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46918788|NCT03094195|83150485|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46918789|NCT03094195|83150486|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46918790|NCT03094195|83150487|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46918791|NCT02835690|83150508|FG000|Overall Study|Death|12|||
46918792|NCT02835690|83150509|FG001|Overall Study|Death|11|||
46918793|NCT02835690|83150510|FG002|Overall Study|Death|13|||
46918794|NCT02835690|83150508|FG000|Overall Study|Transferred to Extension Study|2|||
46918795|NCT02835690|83150509|FG001|Overall Study|Transferred to Extension Study|2|||
46918796|NCT02835690|83150510|FG002|Overall Study|Transferred to Extension Study|1|||
46918797|NCT02835690|83150508|FG000|Overall Study|Did Not Continue on Extension Study|0|||
46918798|NCT02835690|83150509|FG001|Overall Study|Did Not Continue on Extension Study|0|||
46918799|NCT02835690|83150510|FG002|Overall Study|Did Not Continue on Extension Study|1|||
46918800|NCT02835690|83150508|FG000|Overall Study|Not Treated|0|||
46918801|NCT02835690|83150509|FG001|Overall Study|Not Treated|2|||
46918802|NCT02835690|83150510|FG002|Overall Study|Not Treated|0|||
46918803|NCT02837952|83150521|FG000|Overall Study|Adverse Event|0|||
46918804|NCT02837952|83150522|FG001|Overall Study|Adverse Event|1|||
46918805|NCT02837952|83150521|FG000|Overall Study|Withdrawal by Subject|4|||
46720128|NCT00986232|82936242|FG002|Overall Study|Adverse Event|3|||
46918806|NCT02837952|83150522|FG001|Overall Study|Withdrawal by Subject|5|||
46918807|NCT02837952|83150521|FG000|Overall Study|Medication Error|1|||
47041678|NCT01424397|83298126|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
46632742|NCT01606800|82805925|FG000|Overall Study|Adverse Event|3|||
46918808|NCT02837952|83150522|FG001|Overall Study|Medication Error|0|||
46918809|NCT02832167|83150528|FG000|Treatment Period 1|Disease progression|90|||
46632743|NCT01606800|82805926|FG001|Overall Study|Adverse Event|1|||
46632744|NCT01606800|82805925|FG000|Overall Study|Participant withdrew consent|0|||
46632745|NCT01606800|82805926|FG001|Overall Study|Participant withdrew consent|1|||
46918810|NCT02832167|83150528|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
46918811|NCT02832167|83150528|FG000|Treatment Period 1|Death|2|||
46918812|NCT02832167|83150528|FG000|Treatment Period 1|Study Drug Toxicity|6|||
46918813|NCT02832167|83150528|FG000|Treatment Period 1|Participant request to discontinue|9|||
46918814|NCT02832167|83150528|FG000|Treatment Period 1|No longer meet study criteria|1|||
46918815|NCT02832167|83150528|FG000|Treatment Period 1|Participant withdrew consent|3|||
46918816|NCT02832167|83150528|FG000|Treatment Period 1|Other reasons|6|||
46918817|NCT02832167|83150528|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
46918818|NCT02832167|83150528|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
46918819|NCT02832167|83150528|FG000|Transition From Period 1 to Period 2|Death|2|||
46918820|NCT02832167|83150528|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
46918821|NCT02832167|83150528|FG000|Treatment Period 2|Disease progression|69|||
46918822|NCT02832167|83150528|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
46918823|NCT02832167|83150528|FG000|Treatment Period 2|Maximum clinical benefit|1|||
46918824|NCT02832167|83150528|FG000|Treatment Period 2|Study Drug Toxicity|5|||
46918825|NCT02832167|83150528|FG000|Treatment Period 2|Participant request to discontinue|2|||
46918826|NCT02832167|83150528|FG000|Treatment Period 2|Participant withdrew consent|3|||
46918827|NCT02832167|83150528|FG000|Treatment Period 2|Other reasons|3|||
46918828|NCT02674529|83150534|FG000|Overall Study|Lost to Follow-up|1|||
46918829|NCT02674529|83150535|FG001|Overall Study|Lost to Follow-up|2|||
46918830|NCT02674529|83150534|FG000|Overall Study|Withdrawal by Subject|2|||
46918831|NCT02674529|83150535|FG001|Overall Study|Withdrawal by Subject|1|||
46918832|NCT02674529|83150534|FG000|Overall Study|Physician Decision|0|||
46918833|NCT02674529|83150535|FG001|Overall Study|Physician Decision|1|||
46918834|NCT02674529|83150534|FG000|Overall Study|Protocol Violation|0|||
46918835|NCT02674529|83150535|FG001|Overall Study|Protocol Violation|1|||
46918836|NCT02626949|83150546|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
46918837|NCT02626949|83150547|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
46918838|NCT02626949|83150546|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
46918839|NCT02626949|83150547|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
46918840|NCT02626949|83150546|FG000|Enrolled|Lost to Follow-up|7|||
46918841|NCT02626949|83150547|FG001|Enrolled|Lost to Follow-up|6|||
46918842|NCT02626949|83150546|FG000|Enrolled|Withdrawal by Subject|3|||
46918843|NCT02626949|83150547|FG001|Enrolled|Withdrawal by Subject|2|||
46918844|NCT03116399|83150555|FG000|Overall Study|Death|8|||
46918845|NCT03116399|83150556|FG001|Overall Study|Death|3|||
46918846|NCT03116399|83150555|FG000|Overall Study|Lost to Follow-up|7|||
46918847|NCT03116399|83150556|FG001|Overall Study|Lost to Follow-up|11|||
46918848|NCT03116399|83150555|FG000|Overall Study|Investigator Decision|1|||
46918849|NCT03116399|83150556|FG001|Overall Study|Investigator Decision|1|||
46918850|NCT03116399|83150555|FG000|Overall Study|Withdrawal by Subject|24|||
46918851|NCT03116399|83150556|FG001|Overall Study|Withdrawal by Subject|9|||
47041679|NCT01424397|83298127|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041680|NCT01424397|83298128|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041681|NCT01424397|83298129|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041682|NCT01424397|83298130|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041683|NCT01424397|83298131|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041684|NCT01424397|83298132|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
47041685|NCT01392963|83298148|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
46632746|NCT01606800|82805925|FG000|Overall Study|Missing completion status|2|||
46632747|NCT01606800|82805926|FG001|Overall Study|Missing completion status|0|||
46632748|NCT01772550|82805935|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
46720129|NCT00986232|82936243|FG003|Overall Study|Adverse Event|0|||
46720130|NCT00986232|82936240|FG000|Overall Study|Lost to Follow-up|19|||
46632749|NCT01772550|82805936|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
46632750|NCT01772550|82805937|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
46632751|NCT01772550|82805935|FG000|Overall Study|Adverse Event|0|||
46632752|NCT01772550|82805936|FG001|Overall Study|Adverse Event|0|||
46632753|NCT01772550|82805937|FG002|Overall Study|Adverse Event|1|||
46632754|NCT01787292|82805945|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
46632755|NCT01787292|82805946|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
46720131|NCT00986232|82936241|FG001|Overall Study|Lost to Follow-up|12|||
46720132|NCT00986232|82936242|FG002|Overall Study|Lost to Follow-up|12|||
46720133|NCT00986232|82936243|FG003|Overall Study|Lost to Follow-up|7|||
46918852|NCT03097861|83150565|FG000|Overall Study|Adverse Event|3|||
46918853|NCT03097861|83150566|FG001|Overall Study|Adverse Event|8|||
46918854|NCT03097861|83150567|FG002|Overall Study|Adverse Event|4|||
46918855|NCT03097861|83150565|FG000|Overall Study|Investigator Decision|0|||
47041686|NCT01392963|83298149|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
47041687|NCT01392963|83298148|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
47041688|NCT01392963|83298149|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
47041689|NCT01392963|83298148|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
46720134|NCT00986232|82936240|FG000|Overall Study|Protocol Violation|2|||
46918856|NCT03097861|83150566|FG001|Overall Study|Investigator Decision|1|||
46918857|NCT03097861|83150567|FG002|Overall Study|Investigator Decision|0|||
46918858|NCT03097861|83150565|FG000|Overall Study|Lost to Follow-up|0|||
46918859|NCT03097861|83150566|FG001|Overall Study|Lost to Follow-up|7|||
46918860|NCT03097861|83150567|FG002|Overall Study|Lost to Follow-up|1|||
46918861|NCT03097861|83150565|FG000|Overall Study|Withdrawal by Subject|1|||
46918862|NCT03097861|83150566|FG001|Overall Study|Withdrawal by Subject|5|||
46918863|NCT03097861|83150567|FG002|Overall Study|Withdrawal by Subject|3|||
46918864|NCT03097861|83150565|FG000|Overall Study|Reason not provided|3|||
46918865|NCT03097861|83150566|FG001|Overall Study|Reason not provided|1|||
46918866|NCT03097861|83150567|FG002|Overall Study|Reason not provided|1|||
46918867|NCT01816139|83150583|FG000|Overall Study|Adverse Event|6|||
46918868|NCT01816139|83150584|FG001|Overall Study|Adverse Event|8|||
46918869|NCT01816139|83150583|FG000|Overall Study|Lack of Efficacy|1|||
46918870|NCT01816139|83150584|FG001|Overall Study|Lack of Efficacy|2|||
46918871|NCT01816139|83150583|FG000|Overall Study|Lost to Follow-up|5|||
46918872|NCT01816139|83150584|FG001|Overall Study|Lost to Follow-up|3|||
46918873|NCT01816139|83150583|FG000|Overall Study|Withdrew Consent|6|||
46918874|NCT01816139|83150584|FG001|Overall Study|Withdrew Consent|4|||
46918875|NCT01816139|83150583|FG000|Overall Study|Protocol Violation|6|||
46918876|NCT01816139|83150584|FG001|Overall Study|Protocol Violation|3|||
46918877|NCT01816139|83150583|FG000|Overall Study|Reason not Specified|4|||
46918878|NCT01816139|83150584|FG001|Overall Study|Reason not Specified|2|||
46918879|NCT02833350|83150627|FG000|Overall Study|Adverse Event|0|||
46918880|NCT02833350|83150628|FG001|Overall Study|Adverse Event|3|||
46918881|NCT02833350|83150629|FG002|Overall Study|Adverse Event|4|||
46918882|NCT02833350|83150630|FG003|Overall Study|Adverse Event|4|||
46918883|NCT02833350|83150631|FG004|Overall Study|Adverse Event|1|||
46918884|NCT02833350|83150632|FG005|Overall Study|Adverse Event|0|||
46918885|NCT02833350|83150633|FG006|Overall Study|Adverse Event|1|||
46918886|NCT02833350|83150627|FG000|Overall Study|Death|0|||
46918887|NCT02833350|83150628|FG001|Overall Study|Death|0|||
46918888|NCT02833350|83150629|FG002|Overall Study|Death|1|||
46918889|NCT02833350|83150630|FG003|Overall Study|Death|0|||
46918890|NCT02833350|83150631|FG004|Overall Study|Death|0|||
46918891|NCT02833350|83150632|FG005|Overall Study|Death|0|||
46918892|NCT02833350|83150633|FG006|Overall Study|Death|0|||
46918893|NCT02833350|83150627|FG000|Overall Study|Lack of Efficacy|0|||
46918894|NCT02833350|83150628|FG001|Overall Study|Lack of Efficacy|2|||
46918895|NCT02833350|83150629|FG002|Overall Study|Lack of Efficacy|1|||
46918896|NCT02833350|83150630|FG003|Overall Study|Lack of Efficacy|4|||
46918897|NCT02833350|83150631|FG004|Overall Study|Lack of Efficacy|0|||
46918898|NCT02833350|83150632|FG005|Overall Study|Lack of Efficacy|1|||
46918899|NCT02833350|83150633|FG006|Overall Study|Lack of Efficacy|1|||
46918900|NCT02833350|83150627|FG000|Overall Study|Lost to Follow-up|0|||
46918901|NCT02833350|83150628|FG001|Overall Study|Lost to Follow-up|1|||
46918902|NCT02833350|83150629|FG002|Overall Study|Lost to Follow-up|0|||
46918903|NCT02833350|83150630|FG003|Overall Study|Lost to Follow-up|0|||
46918904|NCT02833350|83150631|FG004|Overall Study|Lost to Follow-up|0|||
46918905|NCT02833350|83150632|FG005|Overall Study|Lost to Follow-up|0|||
46918906|NCT02833350|83150633|FG006|Overall Study|Lost to Follow-up|1|||
46918907|NCT02833350|83150627|FG000|Overall Study|Withdrawal by Subject|3|||
46918908|NCT02833350|83150628|FG001|Overall Study|Withdrawal by Subject|3|||
46918909|NCT02833350|83150629|FG002|Overall Study|Withdrawal by Subject|2|||
46918910|NCT02833350|83150630|FG003|Overall Study|Withdrawal by Subject|0|||
46918911|NCT02833350|83150631|FG004|Overall Study|Withdrawal by Subject|2|||
46918912|NCT02833350|83150632|FG005|Overall Study|Withdrawal by Subject|0|||
47041690|NCT01392963|83298149|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
47041691|NCT01392573|83298159|FG000|Overall Study|Adverse Event|1|||
46918913|NCT02833350|83150633|FG006|Overall Study|Withdrawal by Subject|2|||
46918914|NCT01343043|83150656|FG000|Overall Study|Disease progression before treatment|1|||
46918915|NCT01343043|83150657|FG001|Overall Study|Disease progression before treatment|0|||
46918916|NCT01343043|83150658|FG002|Overall Study|Disease progression before treatment|0|||
46918917|NCT01343043|83150659|FG003|Overall Study|Disease progression before treatment|0|||
46918918|NCT01343043|83150656|FG000|Overall Study|Withdrawal by Subject|1|||
46918919|NCT01343043|83150657|FG001|Overall Study|Withdrawal by Subject|0|||
46918920|NCT01343043|83150658|FG002|Overall Study|Withdrawal by Subject|0|||
46918921|NCT01343043|83150659|FG003|Overall Study|Withdrawal by Subject|0|||
46918922|NCT01343043|83150656|FG000|Overall Study|Death|1|||
46918923|NCT01343043|83150657|FG001|Overall Study|Death|1|||
46918924|NCT01343043|83150658|FG002|Overall Study|Death|0|||
46918925|NCT01343043|83150659|FG003|Overall Study|Death|1|||
46918926|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
47041692|NCT01392573|83298160|FG001|Overall Study|Adverse Event|3|||
47041693|NCT01392573|83298159|FG000|Overall Study|Lack of Efficacy|1|||
46918927|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
46918928|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
47041694|NCT01392573|83298160|FG001|Overall Study|Lack of Efficacy|2|||
47041695|NCT01392573|83298159|FG000|Overall Study|Protocol Violation|0|||
46918929|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
46918930|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
46918931|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
46918932|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
46918933|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
46918934|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
46918935|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
46720135|NCT00986232|82936241|FG001|Overall Study|Protocol Violation|3|||
47041696|NCT01392573|83298160|FG001|Overall Study|Protocol Violation|2|||
46720136|NCT00986232|82936242|FG002|Overall Study|Protocol Violation|0|||
46720137|NCT00986232|82936243|FG003|Overall Study|Protocol Violation|1|||
46720138|NCT00986232|82936240|FG000|Overall Study|Withdrawal by Subject|13|||
46720139|NCT00986232|82936241|FG001|Overall Study|Withdrawal by Subject|16|||
46720140|NCT00986232|82936242|FG002|Overall Study|Withdrawal by Subject|12|||
46720141|NCT00986232|82936243|FG003|Overall Study|Withdrawal by Subject|3|||
46720142|NCT00986232|82936240|FG000|Overall Study|Missed one or more bleeds|13|||
46720143|NCT00986232|82936241|FG001|Overall Study|Missed one or more bleeds|10|||
46720144|NCT00986232|82936242|FG002|Overall Study|Missed one or more bleeds|6|||
46720145|NCT00986232|82936243|FG003|Overall Study|Missed one or more bleeds|7|||
46720146|NCT00986232|82936240|FG000|Overall Study|Incomplete safety follow-up|3|||
46720147|NCT00986232|82936241|FG001|Overall Study|Incomplete safety follow-up|7|||
46720148|NCT00986232|82936242|FG002|Overall Study|Incomplete safety follow-up|2|||
46720149|NCT00986232|82936243|FG003|Overall Study|Incomplete safety follow-up|2|||
46720150|NCT00852241|82936259|FG000|Overall Study|Physician Decision|18|||
46720151|NCT01169636|82936268|FG000|Overall Study|Adverse Event|0|||
46720152|NCT01169636|82936269|FG001|Overall Study|Adverse Event|0|||
46720153|NCT01169636|82936270|FG002|Overall Study|Adverse Event|1|||
46720154|NCT01169636|82936271|FG003|Overall Study|Adverse Event|1|||
46720155|NCT01169636|82936272|FG004|Overall Study|Adverse Event|0|||
46720156|NCT01169636|82936268|FG000|Overall Study|Screen failure|0|||
46720157|NCT01169636|82936269|FG001|Overall Study|Screen failure|0|||
46720158|NCT01169636|82936270|FG002|Overall Study|Screen failure|2|||
46720159|NCT01169636|82936271|FG003|Overall Study|Screen failure|0|||
46720160|NCT01169636|82936272|FG004|Overall Study|Screen failure|0|||
46720161|NCT01169636|82936268|FG000|Overall Study|Withdrawal by Subject|0|||
46720162|NCT01169636|82936269|FG001|Overall Study|Withdrawal by Subject|0|||
46720163|NCT01169636|82936270|FG002|Overall Study|Withdrawal by Subject|0|||
46720164|NCT01169636|82936271|FG003|Overall Study|Withdrawal by Subject|0|||
46720165|NCT01169636|82936272|FG004|Overall Study|Withdrawal by Subject|3|||
46918936|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
46918937|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
46918938|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
46918939|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
46918940|NCT03548987|83150674|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
46918941|NCT03548987|83150675|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
46918942|NCT03548987|83150674|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
47041697|NCT01392573|83298159|FG000|Overall Study|Withdrawal Criteria|13|||
47041698|NCT01392573|83298160|FG001|Overall Study|Withdrawal Criteria|15|||
47041699|NCT01392573|83298159|FG000|Overall Study|Site closure|8|||
47041700|NCT01392573|83298160|FG001|Overall Study|Site closure|7|||
47041701|NCT01392573|83298159|FG000|Overall Study|Unclassified|9|||
47041702|NCT01392573|83298160|FG001|Overall Study|Unclassified|6|||
47041703|NCT01392495|83298166|FG000|Overall Study|Death|3|||
47041704|NCT01392495|83298166|FG000|Overall Study|Administrative problems|8|||
47041705|NCT01392495|83298166|FG000|Overall Study|Withdrawal by Subject|2|||
47041706|NCT01392495|83298166|FG000|Overall Study|Adverse Event|3|||
47041707|NCT01405053|83298174|FG000|Overall Study|Adverse Event|3|||
46720166|NCT01169558|82936282|FG000|Overall Study|Disease progression|98|||
46720167|NCT01169558|82936282|FG000|Overall Study|Adverse Event|25|||
46720168|NCT01169558|82936282|FG000|Overall Study|Withdrawal of Consent|8|||
46720169|NCT01169558|82936282|FG000|Overall Study|Medical Decision|7|||
46720170|NCT01169558|82936282|FG000|Overall Study|Stable Disease|4|||
46720171|NCT01169558|82936282|FG000|Overall Study|Lost to Follow-up|4|||
46720172|NCT01169558|82936282|FG000|Overall Study|Need for Surgery|4|||
46720173|NCT01169558|82936282|FG000|Overall Study|Non-compliance|2|||
46720174|NCT01169558|82936282|FG000|Overall Study|Protocol Violation|2|||
46720175|NCT01169558|82936282|FG000|Overall Study|Partial response|2|||
46720176|NCT00840463|82936288|FG000|Overall Study|Adverse Event|1|||
46720177|NCT00840463|82936289|FG001|Overall Study|Adverse Event|0|||
46720178|NCT01168856|82936297|FG000|Overall Study|Lost to Follow-up|4|||
46720179|NCT01168856|82936298|FG001|Overall Study|Lost to Follow-up|34|||
46720180|NCT01168856|82936297|FG000|Overall Study|Withdrawal by Subject|6|||
46720181|NCT01168856|82936298|FG001|Overall Study|Withdrawal by Subject|8|||
46720182|NCT01168856|82936297|FG000|Overall Study|Physician Decision|2|||
47041708|NCT01405053|83298175|FG001|Overall Study|Adverse Event|0|||
46918943|NCT03548987|83150675|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
46918944|NCT03548987|83150674|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
46918945|NCT03548987|83150675|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
46918946|NCT03548987|83150674|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
46918947|NCT03548987|83150675|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
46918948|NCT03548987|83150674|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
46918949|NCT03548987|83150675|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
46918950|NCT03548987|83150674|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
46918951|NCT03548987|83150675|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
46918952|NCT03548987|83150674|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
46918953|NCT03548987|83150675|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
46918954|NCT01358760|83150685|FG000|Overall Study|Adverse Event|3|||
46918955|NCT01358760|83150686|FG001|Overall Study|Adverse Event|4|||
46918956|NCT01358760|83150687|FG002|Overall Study|Adverse Event|3|||
46918957|NCT01358760|83150685|FG000|Overall Study|Lost to Follow-up|1|||
46918958|NCT01358760|83150686|FG001|Overall Study|Lost to Follow-up|1|||
46918959|NCT01358760|83150687|FG002|Overall Study|Lost to Follow-up|3|||
46918960|NCT01358760|83150685|FG000|Overall Study|Withdrawal by Subject|5|||
46918961|NCT01358760|83150686|FG001|Overall Study|Withdrawal by Subject|3|||
46918962|NCT01358760|83150687|FG002|Overall Study|Withdrawal by Subject|2|||
46918963|NCT01358760|83150685|FG000|Overall Study|Physician Decision|1|||
46918964|NCT01358760|83150686|FG001|Overall Study|Physician Decision|0|||
46918965|NCT01358760|83150687|FG002|Overall Study|Physician Decision|1|||
46918966|NCT01358760|83150685|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
46918967|NCT01358760|83150686|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
46918968|NCT01358760|83150687|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
46918969|NCT01341990|83150697|FG000|Overall Study|Adverse Event|0|||
46918970|NCT01341990|83150698|FG001|Overall Study|Adverse Event|1|||
46918971|NCT01341990|83150697|FG000|Overall Study|Torn Study Lens|1|||
46918972|NCT01341990|83150698|FG001|Overall Study|Torn Study Lens|0|||
46918973|NCT01341990|83150697|FG000|Overall Study|Withdrawal by Subject|2|||
46918974|NCT01341990|83150698|FG001|Overall Study|Withdrawal by Subject|0|||
46918975|NCT03048747|83150704|FG000|Overall Study|Adverse Event|2|||
46918976|NCT03048747|83150704|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
46918977|NCT03048747|83150704|FG000|Overall Study|Physician Decision|1|||
46918978|NCT01991067|83150766|FG000|Overall Study|Lost to Follow-up|6|||
46918979|NCT01991067|83150767|FG001|Overall Study|Lost to Follow-up|5|||
46918980|NCT01709331|83150773|FG000|Overall Study|Adverse Event|1|||
46918981|NCT03255083|83150781|FG000|Overall Study|Clinical progression|1|||
46918982|NCT03255083|83150782|FG001|Overall Study|Clinical progression|0|||
46918983|NCT03255083|83150783|FG002|Overall Study|Clinical progression|0|||
46918984|NCT03255083|83150784|FG003|Overall Study|Clinical progression|0|||
46918985|NCT03255083|83150781|FG000|Overall Study|Adverse Event|0|||
46918986|NCT03255083|83150782|FG001|Overall Study|Adverse Event|1|||
46918987|NCT03255083|83150783|FG002|Overall Study|Adverse Event|0|||
46918988|NCT03255083|83150784|FG003|Overall Study|Adverse Event|0|||
46918989|NCT03255083|83150781|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
47041709|NCT01405053|83298174|FG000|Overall Study|Lost to Follow-up|0|||
47041710|NCT01405053|83298175|FG001|Overall Study|Lost to Follow-up|1|||
46918990|NCT03255083|83150782|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
46918991|NCT03255083|83150783|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
46918992|NCT03255083|83150784|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
47041711|NCT01405053|83298174|FG000|Overall Study|Participant choice|2|||
47041712|NCT01405053|83298175|FG001|Overall Study|Participant choice|1|||
47041713|NCT01405053|83298174|FG000|Overall Study|Inadequate therapeutic effect|2|||
47041714|NCT01405053|83298175|FG001|Overall Study|Inadequate therapeutic effect|1|||
47041715|NCT01405053|83298174|FG000|Overall Study|Withdrawal by Subject|3|||
47041716|NCT01405053|83298175|FG001|Overall Study|Withdrawal by Subject|4|||
47041717|NCT01405053|83298174|FG000|Overall Study|Other|0|||
47041718|NCT01405053|83298175|FG001|Overall Study|Other|1|||
46632756|NCT01787292|82805945|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
46632757|NCT01787292|82805946|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
46918993|NCT03255083|83150781|FG000|Overall Study|Withdrawal by Subject|1|||
46918994|NCT03255083|83150782|FG001|Overall Study|Withdrawal by Subject|1|||
47041719|NCT01403805|83298183|FG000|Overall Study|Withdrawal by Subject|0|||
46720183|NCT01168856|82936298|FG001|Overall Study|Physician Decision|1|||
46918995|NCT03255083|83150783|FG002|Overall Study|Withdrawal by Subject|1|||
46918996|NCT03255083|83150784|FG003|Overall Study|Withdrawal by Subject|0|||
46918997|NCT04552587|83150800|FG000|Overall Study|Lost to Follow-up|4|||
46918998|NCT01316055|83150816|FG000|Overall Study|Lost to Follow-up|1|||
47041720|NCT01403805|83298184|FG001|Overall Study|Withdrawal by Subject|4|||
46720184|NCT01168856|82936297|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
46918999|NCT01316055|83150817|FG001|Overall Study|Lost to Follow-up|0|||
46919000|NCT01316055|83150818|FG002|Overall Study|Lost to Follow-up|0|||
47041721|NCT01403805|83298183|FG000|Overall Study|Lost to Follow-up|0|||
47041722|NCT01403805|83298184|FG001|Overall Study|Lost to Follow-up|2|||
47041723|NCT01403805|83298183|FG000|Overall Study|Death|0|||
47041724|NCT01403805|83298184|FG001|Overall Study|Death|1|||
47041725|NCT01423617|83298196|FG000|Overall Study|Lost to Follow-up|0|||
47041726|NCT01423617|83298197|FG001|Overall Study|Lost to Follow-up|1|||
47041727|NCT01392183|83298205|FG000|First Drug Administration|Adverse Event|3|||
47041728|NCT01392183|83298206|FG001|First Drug Administration|Adverse Event|2|||
47041729|NCT01392183|83298205|FG000|First Drug Administration|Death|1|||
47041730|NCT01392183|83298206|FG001|First Drug Administration|Death|0|||
46919001|NCT01340976|83150835|FG000|Overall Study|Physician Decision|2|||
46919002|NCT01340976|83150836|FG001|Overall Study|Physician Decision|0|||
46919003|NCT01340976|83150837|FG002|Overall Study|Physician Decision|1|||
46919004|NCT01340976|83150838|FG003|Overall Study|Physician Decision|1|||
46919005|NCT01340976|83150839|FG004|Overall Study|Physician Decision|1|||
46919006|NCT01340976|83150840|FG005|Overall Study|Physician Decision|0|||
46919007|NCT01340976|83150835|FG000|Overall Study|Death|0|||
46919008|NCT01340976|83150836|FG001|Overall Study|Death|1|||
46919009|NCT01340976|83150837|FG002|Overall Study|Death|0|||
46919010|NCT01340976|83150838|FG003|Overall Study|Death|0|||
46919011|NCT01340976|83150839|FG004|Overall Study|Death|0|||
46919012|NCT01340976|83150840|FG005|Overall Study|Death|0|||
46919013|NCT01340976|83150835|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
46919014|NCT01340976|83150836|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
46919015|NCT01340976|83150837|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
46919016|NCT01340976|83150838|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
46919017|NCT01340976|83150839|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
46919018|NCT01340976|83150840|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
46919019|NCT01340976|83150835|FG000|Overall Study|Withdrawal by Subject|0|||
46919020|NCT01340976|83150836|FG001|Overall Study|Withdrawal by Subject|0|||
46919021|NCT01340976|83150837|FG002|Overall Study|Withdrawal by Subject|0|||
46919022|NCT01340976|83150838|FG003|Overall Study|Withdrawal by Subject|1|||
46919023|NCT01340976|83150839|FG004|Overall Study|Withdrawal by Subject|1|||
46919024|NCT01340976|83150840|FG005|Overall Study|Withdrawal by Subject|0|||
46919025|NCT01340976|83150835|FG000|Overall Study|Other anemia treatment|1|||
46919026|NCT01340976|83150836|FG001|Overall Study|Other anemia treatment|0|||
46919027|NCT01340976|83150837|FG002|Overall Study|Other anemia treatment|2|||
46919028|NCT01340976|83150838|FG003|Overall Study|Other anemia treatment|1|||
46919029|NCT01340976|83150839|FG004|Overall Study|Other anemia treatment|0|||
46919030|NCT01340976|83150840|FG005|Overall Study|Other anemia treatment|1|||
46919031|NCT01340976|83150835|FG000|Overall Study|Adverse Event|0|||
47041731|NCT01392183|83298205|FG000|First Drug Administration|Withdrawal by Subject|10|||
47041732|NCT01392183|83298206|FG001|First Drug Administration|Withdrawal by Subject|17|||
47041733|NCT01402947|83298216|FG000|First Intervention|Adverse Event|0|||
47041734|NCT01402947|83298217|FG001|First Intervention|Adverse Event|1|||
47041735|NCT01402869|83298226|FG000|Overall Study|Required Tooth Extraction|0|||
47041736|NCT01402869|83298227|FG001|Overall Study|Required Tooth Extraction|0|||
47041737|NCT01402869|83298228|FG002|Overall Study|Required Tooth Extraction|1|||
47041738|NCT01391793|83298238|FG000|Overall Study|Ineligible|3|||
47041739|NCT01391793|83298239|FG001|Overall Study|Ineligible|0|||
46919032|NCT01340976|83150836|FG001|Overall Study|Adverse Event|1|||
46919033|NCT01340976|83150837|FG002|Overall Study|Adverse Event|0|||
46919034|NCT01340976|83150838|FG003|Overall Study|Adverse Event|0|||
46919035|NCT01340976|83150839|FG004|Overall Study|Adverse Event|0|||
46919036|NCT01340976|83150840|FG005|Overall Study|Adverse Event|0|||
46919037|NCT01680016|83150862|FG000|Overall Study|Adverse Event|0|||
47041740|NCT01391793|83298238|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
46919038|NCT01680016|83150863|FG001|Overall Study|Adverse Event|0|||
46919039|NCT01680016|83150864|FG002|Overall Study|Adverse Event|1|||
46919040|NCT01680016|83150865|FG003|Overall Study|Adverse Event|4|||
47041741|NCT01391793|83298239|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
47041742|NCT01391793|83298238|FG000|Overall Study|No DMSA|73|||
46632758|NCT01814748|82805959|FG000|Overall Study|Lost to Follow-up|1|||
46919041|NCT01680016|83150862|FG000|Overall Study|The Subject went out of The Trial|1|||
46919042|NCT01680016|83150863|FG001|Overall Study|The Subject went out of The Trial|0|||
46919043|NCT01680016|83150864|FG002|Overall Study|The Subject went out of The Trial|3|||
46919044|NCT01680016|83150865|FG003|Overall Study|The Subject went out of The Trial|0|||
46919045|NCT01680016|83150862|FG000|Overall Study|Protocol Violation|0|||
47041743|NCT01391793|83298239|FG001|Overall Study|No DMSA|57|||
46919046|NCT01680016|83150863|FG001|Overall Study|Protocol Violation|1|||
46919047|NCT01680016|83150864|FG002|Overall Study|Protocol Violation|0|||
46919048|NCT01680016|83150865|FG003|Overall Study|Protocol Violation|0|||
46919049|NCT01680016|83150862|FG000|Overall Study|Withdrawal by Subject|5|||
47041744|NCT01422915|83298245|FG000|Overall Study|Adverse Event|1|||
46720185|NCT01168856|82936298|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
47041745|NCT01727024|83298250|FG000|Period 1|Lost to Follow-up|1|||
47041746|NCT01727024|83298251|FG001|Period 1|Lost to Follow-up|1|||
47041747|NCT01727024|83298250|FG000|Period 1|Withdrawal by Subject|2|||
47041748|NCT01727024|83298251|FG001|Period 1|Withdrawal by Subject|3|||
46919050|NCT01680016|83150863|FG001|Overall Study|Withdrawal by Subject|7|||
46919051|NCT01680016|83150864|FG002|Overall Study|Withdrawal by Subject|1|||
46919052|NCT01680016|83150865|FG003|Overall Study|Withdrawal by Subject|1|||
46919053|NCT01340898|83150890|FG000|Primary Phase|Serious Adverse Events|0|||
46919054|NCT01340898|83150891|FG001|Primary Phase|Serious Adverse Events|0|||
46919055|NCT01340898|83150892|FG002|Primary Phase|Serious Adverse Events|1|||
46919056|NCT01340898|83150890|FG000|Primary Phase|Withdrawal by Subject|8|||
46919057|NCT01340898|83150891|FG001|Primary Phase|Withdrawal by Subject|7|||
46919058|NCT01340898|83150892|FG002|Primary Phase|Withdrawal by Subject|5|||
46919059|NCT01340898|83150890|FG000|Primary Phase|Migrated/moved from study area|4|||
46919060|NCT01340898|83150891|FG001|Primary Phase|Migrated/moved from study area|1|||
46720186|NCT01168856|82936297|FG000|Overall Study|Participant received anti-HCV treatment|1|||
46720187|NCT01168856|82936298|FG001|Overall Study|Participant received anti-HCV treatment|0|||
46720188|NCT01168856|82936297|FG000|Overall Study|Death|0|||
46720189|NCT01168856|82936298|FG001|Overall Study|Death|2|||
46720190|NCT01168856|82936297|FG000|Overall Study|Other|1|||
46919061|NCT01340898|83150892|FG002|Primary Phase|Migrated/moved from study area|0|||
46919062|NCT01340898|83150890|FG000|Primary Phase|Lost to Follow-up|4|||
46919063|NCT01340898|83150891|FG001|Primary Phase|Lost to Follow-up|1|||
46919064|NCT01340898|83150892|FG002|Primary Phase|Lost to Follow-up|0|||
46919065|NCT01340898|83150890|FG000|Booster Phase|Withdrawal by Subject|3|||
46919066|NCT01340898|83150891|FG001|Booster Phase|Withdrawal by Subject|0|||
47041749|NCT01422213|83298260|FG000|Overall Study|Adverse Event|8|||
47041750|NCT01422213|83298261|FG001|Overall Study|Adverse Event|7|||
47041751|NCT01422213|83298262|FG002|Overall Study|Adverse Event|11|||
47041752|NCT01422213|83298260|FG000|Overall Study|Lack of Efficacy|10|||
47041753|NCT01422213|83298261|FG001|Overall Study|Lack of Efficacy|2|||
47041754|NCT01422213|83298262|FG002|Overall Study|Lack of Efficacy|2|||
47041755|NCT01422213|83298260|FG000|Overall Study|Non-compliance with study drug|0|||
47041756|NCT01422213|83298261|FG001|Overall Study|Non-compliance with study drug|1|||
47041757|NCT01422213|83298262|FG002|Overall Study|Non-compliance with study drug|0|||
47041758|NCT01422213|83298260|FG000|Overall Study|Protocol Violation|0|||
47041759|NCT01422213|83298261|FG001|Overall Study|Protocol Violation|2|||
47041760|NCT01422213|83298262|FG002|Overall Study|Protocol Violation|4|||
47041761|NCT01422213|83298260|FG000|Overall Study|Withdrawal of Consent|7|||
47041762|NCT01422213|83298261|FG001|Overall Study|Withdrawal of Consent|3|||
47041763|NCT01422213|83298262|FG002|Overall Study|Withdrawal of Consent|5|||
47041764|NCT01422213|83298260|FG000|Overall Study|Lost to Follow-up|3|||
47041765|NCT01422213|83298261|FG001|Overall Study|Lost to Follow-up|3|||
46919067|NCT01340898|83150892|FG002|Booster Phase|Withdrawal by Subject|4|||
47041766|NCT01422213|83298262|FG002|Overall Study|Lost to Follow-up|5|||
47041767|NCT01422213|83298260|FG000|Overall Study|Administrative or Other Reason(s)|5|||
47041768|NCT01422213|83298261|FG001|Overall Study|Administrative or Other Reason(s)|4|||
47041769|NCT01422213|83298262|FG002|Overall Study|Administrative or Other Reason(s)|2|||
47041770|NCT01390857|83298270|FG000|Overall Study|Protocol Violation|2|||
47041771|NCT01390857|83298270|FG000|Overall Study|Lost to Follow-up|1|||
47041772|NCT01390857|83298270|FG000|Overall Study|No Visit after the First Visit|7|||
47041773|NCT01725386|83298276|FG000|Overall Study|Death|84|||
47041774|NCT01725386|83298277|FG001|Overall Study|Death|40|||
47041775|NCT01725386|83298276|FG000|Overall Study|Lost to Follow-up|81|||
47041776|NCT01725386|83298277|FG001|Overall Study|Lost to Follow-up|6|||
47041777|NCT01725386|83298276|FG000|Overall Study|Withdrawal by Subject|10|||
47041778|NCT01725386|83298277|FG001|Overall Study|Withdrawal by Subject|0|||
47041779|NCT01402011|83298286|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
47041780|NCT01402011|83298287|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
47041781|NCT01402011|83298288|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
47041782|NCT01402011|83298286|FG000|Active Treatment Period|Withdrawal by Subject|1|||
47041783|NCT01402011|83298287|FG001|Active Treatment Period|Withdrawal by Subject|3|||
47041784|NCT01402011|83298288|FG002|Active Treatment Period|Withdrawal by Subject|0|||
47041785|NCT01402011|83298286|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
46720191|NCT01168856|82936298|FG001|Overall Study|Other|291|||
46919068|NCT01340898|83150890|FG000|Booster Phase|Migrated/moved from study area|3|||
46919069|NCT01340898|83150891|FG001|Booster Phase|Migrated/moved from study area|0|||
46919070|NCT01340898|83150892|FG002|Booster Phase|Migrated/moved from study area|0|||
46919071|NCT01340898|83150890|FG000|Booster Phase|Lost to Follow-up|4|||
47041786|NCT01402011|83298287|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
47041787|NCT01402011|83298288|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
47041788|NCT01421667|83298303|FG000|Overall Study|Withdrawal by Subject|0|||
47041789|NCT01421667|83298304|FG001|Overall Study|Withdrawal by Subject|1|||
46720192|NCT01168856|82936297|FG000|Overall Study|Protocol Violation|4|||
47041790|NCT01421667|83298305|FG002|Overall Study|Withdrawal by Subject|2|||
46720193|NCT01168856|82936298|FG001|Overall Study|Protocol Violation|6|||
47041791|NCT01421667|83298306|FG003|Overall Study|Withdrawal by Subject|1|||
47041792|NCT01421667|83298303|FG000|Overall Study|Lost to Follow-up|0|||
47041793|NCT01421667|83298304|FG001|Overall Study|Lost to Follow-up|1|||
46720194|NCT00828451|82936309|FG000|Overall Study|Death|2|||
46919072|NCT01340898|83150891|FG001|Booster Phase|Lost to Follow-up|2|||
46919073|NCT01340898|83150892|FG002|Booster Phase|Lost to Follow-up|3|||
46919074|NCT03097315|83150913|FG000|Overall Study|Withdrawal by Subject|1|||
46919075|NCT03039699|83150919|FG000|Overall Study|Incorrect inclusion|5|||
46720195|NCT00828451|82936309|FG000|Overall Study|Lack of intravenous line|7|||
46720196|NCT00828451|82936309|FG000|Overall Study|Withdrawal by Subject|1|||
46720197|NCT00828451|82936309|FG000|Overall Study|Deterioration in clinical status|1|||
46720198|NCT00839917|82936315|FG000|Overall Study|Lost to Follow-up|1|||
46720199|NCT00839917|82936316|FG001|Overall Study|Lost to Follow-up|0|||
46720200|NCT00839917|82936315|FG000|Overall Study|Did not receive vaccine|0|||
46720201|NCT00839917|82936316|FG001|Overall Study|Did not receive vaccine|1|||
46720202|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
46720203|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
46720204|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
46720205|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
46720206|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
46720207|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
46720208|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
46720209|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
46720210|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
46720211|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
46720212|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
46720213|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
46720214|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
46720215|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
46720216|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
46720217|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
46720218|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
46720219|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
46720220|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
46720221|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
46720222|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
46720223|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
46720224|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
46720225|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
46720226|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
46720227|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
46720228|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
46720229|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
46720230|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
46720231|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
46720232|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
46720233|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
46720234|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
46720235|NCT00839527|82936325|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
46720236|NCT00839527|82936326|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
46720237|NCT00839527|82936327|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
46720238|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
46720239|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
46720240|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
46720241|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
46720242|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
46720243|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
46720244|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
46720245|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
46720246|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
46720247|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
46720248|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
46720249|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
46720250|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
46720251|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
46720252|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
46720253|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
46919076|NCT03039699|83150920|FG001|Overall Study|Incorrect inclusion|4|||
46919077|NCT03039699|83150919|FG000|Overall Study|Lack of data to assess study endpoint|5|||
47041794|NCT01421667|83298305|FG002|Overall Study|Lost to Follow-up|0|||
47041795|NCT01421667|83298306|FG003|Overall Study|Lost to Follow-up|0|||
47041796|NCT01390779|83298324|FG000|Overall Study|Physician Decision|1|||
47041797|NCT01891669|83298338|FG000|Overall Study|Death|0|||
46919078|NCT03039699|83150920|FG001|Overall Study|Lack of data to assess study endpoint|3|||
46919079|NCT03039699|83150919|FG000|Overall Study|Bacterial infection|12|||
46919080|NCT03039699|83150920|FG001|Overall Study|Bacterial infection|28|||
46919081|NCT02833974|83150928|FG000|Overall Study|Lost to Follow-up|1|||
46919082|NCT02833974|83150929|FG001|Overall Study|Lost to Follow-up|0|||
46919083|NCT02833974|83150928|FG000|Overall Study|Adverse Event|0|||
46919084|NCT02833974|83150929|FG001|Overall Study|Adverse Event|3|||
46919085|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
46919086|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
46919087|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
46919088|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
46919089|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
46919090|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
46919091|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
46919092|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
46919093|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
46919094|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
46919095|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
46919096|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
46919097|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
46919098|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
46919099|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
46919100|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
46919101|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
46919102|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
46919103|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
46919104|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
46919105|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
46919106|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
46919107|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
46919108|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
46919109|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
46919110|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
46919111|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
46919112|NCT03093415|83150938|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
46919113|NCT03093415|83150939|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
46919114|NCT03093415|83150940|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
46919115|NCT03093415|83150938|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
46919116|NCT03093415|83150939|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
46919117|NCT03093415|83150940|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
46919118|NCT01358526|83150950|FG000|Open-label Titration Period|Adverse Event|95|||
46919119|NCT01358526|83150951|FG001|Open-label Titration Period|Adverse Event|0|||
46919120|NCT01358526|83150952|FG002|Open-label Titration Period|Adverse Event|0|||
46919121|NCT01358526|83150950|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
46919122|NCT01358526|83150951|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
46919123|NCT01358526|83150952|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
46919124|NCT01358526|83150950|FG000|Open-label Titration Period|Lost to Follow-up|25|||
46919125|NCT01358526|83150951|FG001|Open-label Titration Period|Lost to Follow-up|0|||
46919126|NCT01358526|83150952|FG002|Open-label Titration Period|Lost to Follow-up|0|||
46919127|NCT01358526|83150950|FG000|Open-label Titration Period|Lack of Efficacy|107|||
46919128|NCT01358526|83150951|FG001|Open-label Titration Period|Lack of Efficacy|0|||
46919129|NCT01358526|83150952|FG002|Open-label Titration Period|Lack of Efficacy|0|||
46919130|NCT01358526|83150950|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
46919131|NCT01358526|83150951|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
46919132|NCT01358526|83150952|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
46919133|NCT01358526|83150950|FG000|Open-label Titration Period|Administrative|8|||
46919134|NCT01358526|83150951|FG001|Open-label Titration Period|Administrative|0|||
46919135|NCT01358526|83150952|FG002|Open-label Titration Period|Administrative|0|||
46919136|NCT01358526|83150950|FG000|Open-label Titration Period|Did not qualify|178|||
46919137|NCT01358526|83150951|FG001|Open-label Titration Period|Did not qualify|0|||
46919138|NCT01358526|83150952|FG002|Open-label Titration Period|Did not qualify|0|||
46919139|NCT01358526|83150950|FG000|Double-blind Phase|Adverse Event|0|||
46919140|NCT01358526|83150951|FG001|Double-blind Phase|Adverse Event|24|||
46720254|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
46919141|NCT01358526|83150952|FG002|Double-blind Phase|Adverse Event|23|||
46919142|NCT01358526|83150950|FG000|Double-blind Phase|Withdrawal by Subject|0|||
46919143|NCT01358526|83150951|FG001|Double-blind Phase|Withdrawal by Subject|10|||
46919144|NCT01358526|83150952|FG002|Double-blind Phase|Withdrawal by Subject|8|||
46919145|NCT01358526|83150950|FG000|Double-blind Phase|Lost to Follow-up|0|||
46919146|NCT01358526|83150951|FG001|Double-blind Phase|Lost to Follow-up|4|||
46919147|NCT01358526|83150952|FG002|Double-blind Phase|Lost to Follow-up|1|||
46919148|NCT01358526|83150950|FG000|Double-blind Phase|Lack of Efficacy|0|||
46919149|NCT01358526|83150951|FG001|Double-blind Phase|Lack of Efficacy|31|||
46919150|NCT01358526|83150952|FG002|Double-blind Phase|Lack of Efficacy|73|||
46919151|NCT01358526|83150950|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
46919152|NCT01358526|83150951|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
46919153|NCT01358526|83150952|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
46919154|NCT01358526|83150950|FG000|Double-blind Phase|Administrative|0|||
46919155|NCT01358526|83150951|FG001|Double-blind Phase|Administrative|6|||
46919156|NCT01358526|83150952|FG002|Double-blind Phase|Administrative|10|||
46919157|NCT02830776|83150959|FG000|Overall Study|Lost to Follow-up|1|||
46919158|NCT03039621|83150966|FG000|Overall Study|Violation of inclusion criteria|3|||
46919159|NCT03039621|83150967|FG001|Overall Study|Violation of inclusion criteria|2|||
46919160|NCT03039621|83150966|FG000|Overall Study|Non-compliance with protocol requirement|4|||
46919161|NCT03039621|83150967|FG001|Overall Study|Non-compliance with protocol requirement|5|||
46919162|NCT03039621|83150966|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
46919163|NCT03039621|83150967|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
46919164|NCT03039621|83150966|FG000|Overall Study|Violation of non-inclusion criteria|1|||
46919165|NCT03039621|83150967|FG001|Overall Study|Violation of non-inclusion criteria|2|||
46919166|NCT03041181|83150975|FG000|Overall Study|Disease Progression|1|||
46919167|NCT03041181|83150976|FG001|Overall Study|Disease Progression|2|||
46919168|NCT02828436|83150982|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
46919169|NCT02828436|83150983|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
46919170|NCT02828436|83150982|FG000|Period 1|Lost to Follow-up|0|||
46919171|NCT02828436|83150983|FG001|Period 1|Lost to Follow-up|1|||
46919172|NCT02828436|83150982|FG000|Period 2|Withdrawal by Subject|4|||
46919173|NCT02828436|83150983|FG001|Period 2|Withdrawal by Subject|0|||
46919174|NCT02828436|83150982|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
46919175|NCT02828436|83150983|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
46720255|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
46720256|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
46720257|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
46720258|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
46720259|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
46720260|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
46720261|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
46720262|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
46720263|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
46720264|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
46720265|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
46720266|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
46720267|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
46720268|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
46720269|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
46720270|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
46720271|NCT00839527|82936325|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
46720272|NCT00839527|82936326|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
46720273|NCT00839527|82936327|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
46720274|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
46720275|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
46720276|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
46720277|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
46720278|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
46720279|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
46720280|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
46720281|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
46720282|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
46919176|NCT02828436|83150982|FG000|Period 2|Lost to Follow-up|1|||
46919177|NCT02828436|83150983|FG001|Period 2|Lost to Follow-up|0|||
46919178|NCT02828124|83150997|FG000|Overall Study|Disease Progression|1|||
46919179|NCT02828124|83150998|FG001|Overall Study|Disease Progression|2|||
46919180|NCT02828124|83150999|FG002|Overall Study|Disease Progression|1|||
46919181|NCT02828124|83151000|FG003|Overall Study|Disease Progression|4|||
46919182|NCT02828124|83150997|FG000|Overall Study|AE Unrelated to Study Drug|0|||
46919183|NCT02828124|83150998|FG001|Overall Study|AE Unrelated to Study Drug|0|||
46919184|NCT02828124|83150999|FG002|Overall Study|AE Unrelated to Study Drug|0|||
46919185|NCT02828124|83151000|FG003|Overall Study|AE Unrelated to Study Drug|1|||
46919186|NCT02828124|83150997|FG000|Overall Study|Subject Withdrew Consent|0|||
46919187|NCT02828124|83150998|FG001|Overall Study|Subject Withdrew Consent|0|||
46919188|NCT02828124|83150999|FG002|Overall Study|Subject Withdrew Consent|0|||
46919189|NCT02828124|83151000|FG003|Overall Study|Subject Withdrew Consent|1|||
46919190|NCT02829996|83151015|FG000|Overall Study|Withdrawal by Subject|1|||
46919191|NCT02829996|83151016|FG001|Overall Study|Withdrawal by Subject|0|||
46919192|NCT02829996|83151017|FG002|Overall Study|Withdrawal by Subject|0|||
46919193|NCT02829996|83151018|FG003|Overall Study|Withdrawal by Subject|0|||
46919194|NCT02829996|83151019|FG004|Overall Study|Withdrawal by Subject|0|||
46919195|NCT02827500|83151033|FG000|Overall Study|Death|7|||
46919196|NCT02827500|83151034|FG001|Overall Study|Death|3|||
46919197|NCT02827500|83151033|FG000|Overall Study|Lost to Follow-up|1|||
46919198|NCT02827500|83151034|FG001|Overall Study|Lost to Follow-up|1|||
46919199|NCT02827500|83151033|FG000|Overall Study|Withdrawal by Subject|3|||
46919200|NCT02827500|83151034|FG001|Overall Study|Withdrawal by Subject|1|||
46919201|NCT02827500|83151033|FG000|Overall Study|Missing primary endpoint data|3|||
46919202|NCT02827500|83151034|FG001|Overall Study|Missing primary endpoint data|1|||
46919203|NCT02827500|83151033|FG000|Overall Study|Other|5|||
46919204|NCT02827500|83151034|FG001|Overall Study|Other|1|||
46919205|NCT02826798|83151045|FG000|Overall Study|Withdrawal by Subject|0|||
46919206|NCT02826798|83151046|FG001|Overall Study|Withdrawal by Subject|1|||
46919207|NCT02826798|83151047|FG002|Overall Study|Withdrawal by Subject|0|||
46919208|NCT02826798|83151048|FG003|Overall Study|Withdrawal by Subject|1|||
46919209|NCT02826798|83151049|FG004|Overall Study|Withdrawal by Subject|0|||
46919210|NCT02829138|83151063|FG000|Overall Study|Withdrawal by Subject|1|||
46919211|NCT02829138|83151064|FG001|Overall Study|Withdrawal by Subject|0|||
46919212|NCT02825550|83151070|FG000|Overall Study|Physician Decision|1|||
46919213|NCT02744040|83151079|FG000|Overall Study|Withdrawal by Subject|3|||
46919214|NCT02744040|83151080|FG001|Overall Study|Withdrawal by Subject|2|||
46919215|NCT02744040|83151081|FG002|Overall Study|Withdrawal by Subject|2|||
46919216|NCT02744040|83151079|FG000|Overall Study|Physician Decision|0|||
46919217|NCT02744040|83151080|FG001|Overall Study|Physician Decision|8|||
46919218|NCT02744040|83151081|FG002|Overall Study|Physician Decision|13|||
46919219|NCT02744040|83151079|FG000|Overall Study|Lost to Follow-up|3|||
46919220|NCT02744040|83151080|FG001|Overall Study|Lost to Follow-up|1|||
46919221|NCT02744040|83151081|FG002|Overall Study|Lost to Follow-up|7|||
46919222|NCT02743962|83151091|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
46919223|NCT02743962|83151092|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
46919224|NCT03094416|83151101|FG000|Run-in|Screening failure|8|||
46919225|NCT03094416|83151101|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
46919226|NCT03094416|83151101|FG000|Run-in|Withdrawal by Subject|3|||
46919227|NCT03094416|83151101|FG000|Treatment Period|Withdrawal by Subject|2|||
46919228|NCT03041025|83151109|FG000|Overall Study|Adverse Event|0|||
46919229|NCT03041025|83151110|FG001|Overall Study|Adverse Event|0|||
46919230|NCT03041025|83151111|FG002|Overall Study|Adverse Event|1|||
46919231|NCT03041025|83151109|FG000|Overall Study|Lost to Follow-up|1|||
46919232|NCT03041025|83151110|FG001|Overall Study|Lost to Follow-up|0|||
46919233|NCT03041025|83151111|FG002|Overall Study|Lost to Follow-up|0|||
46919234|NCT03041025|83151109|FG000|Overall Study|Withdrawal by Subject|0|||
46919235|NCT03041025|83151110|FG001|Overall Study|Withdrawal by Subject|0|||
46919236|NCT03041025|83151111|FG002|Overall Study|Withdrawal by Subject|1|||
46919237|NCT01338870|83151128|FG000|Overall Study|Lost to Follow-up|0|||
46919238|NCT01338870|83151129|FG001|Overall Study|Lost to Follow-up|0|||
46919239|NCT01338870|83151130|FG002|Overall Study|Lost to Follow-up|1|||
46919240|NCT01338870|83151131|FG003|Overall Study|Lost to Follow-up|0|||
46720283|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
46720284|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
46720285|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
46720286|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
46720287|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
46720288|NCT00600886|82936339|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
46720289|NCT00600886|82936340|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
46919241|NCT01338870|83151132|FG004|Overall Study|Lost to Follow-up|1|||
46919242|NCT01338870|83151133|FG005|Overall Study|Lost to Follow-up|0|||
46919243|NCT01338870|83151128|FG000|Overall Study|Withdrawal by Subject|2|||
46919244|NCT01338870|83151129|FG001|Overall Study|Withdrawal by Subject|3|||
46919245|NCT01338870|83151130|FG002|Overall Study|Withdrawal by Subject|4|||
46919246|NCT01338870|83151131|FG003|Overall Study|Withdrawal by Subject|0|||
46919247|NCT01338870|83151132|FG004|Overall Study|Withdrawal by Subject|0|||
46919248|NCT01338870|83151133|FG005|Overall Study|Withdrawal by Subject|2|||
46919249|NCT01338870|83151128|FG000|Overall Study|Other|3|||
46919250|NCT01338870|83151129|FG001|Overall Study|Other|3|||
46919251|NCT01338870|83151130|FG002|Overall Study|Other|3|||
46919252|NCT01338870|83151131|FG003|Overall Study|Other|2|||
46919253|NCT01338870|83151132|FG004|Overall Study|Other|0|||
46919254|NCT01338870|83151133|FG005|Overall Study|Other|2|||
46919255|NCT01338870|83151128|FG000|Overall Study|Protocol Violation|0|||
46919256|NCT01338870|83151129|FG001|Overall Study|Protocol Violation|2|||
46919257|NCT01338870|83151130|FG002|Overall Study|Protocol Violation|2|||
46919258|NCT01338870|83151131|FG003|Overall Study|Protocol Violation|2|||
46919259|NCT01338870|83151132|FG004|Overall Study|Protocol Violation|1|||
46919260|NCT01338870|83151133|FG005|Overall Study|Protocol Violation|1|||
46919261|NCT01338870|83151128|FG000|Overall Study|Adverse Event|4|||
46919262|NCT01338870|83151129|FG001|Overall Study|Adverse Event|4|||
46919263|NCT01338870|83151130|FG002|Overall Study|Adverse Event|1|||
46919264|NCT01338870|83151131|FG003|Overall Study|Adverse Event|5|||
46919265|NCT01338870|83151132|FG004|Overall Study|Adverse Event|4|||
46919266|NCT01338870|83151133|FG005|Overall Study|Adverse Event|1|||
46919267|NCT02824224|83151149|FG000|Overall Study|Discontinued, IUS expulsion|0|||
46919268|NCT02824224|83151150|FG001|Overall Study|Discontinued, IUS expulsion|1|||
46919269|NCT02824224|83151149|FG000|Overall Study|Did not show up for allocation visit|2|||
46919270|NCT02824224|83151150|FG001|Overall Study|Did not show up for allocation visit|0|||
46919271|NCT01338792|83151156|FG000|Overall Study|Adverse Event|2|||
46919272|NCT01338792|83151156|FG000|Overall Study|Death|1|||
46919273|NCT01338792|83151156|FG000|Overall Study|Withdrawal by Subject|1|||
46919274|NCT01314105|83151162|FG000|Overall Study|Progressive Disease|6|||
46919275|NCT01314105|83151163|FG001|Overall Study|Progressive Disease|10|||
46919276|NCT01314105|83151162|FG000|Overall Study|Refused to continue taking medication|0|||
46919277|NCT01314105|83151163|FG001|Overall Study|Refused to continue taking medication|1|||
46919278|NCT01314105|83151162|FG000|Overall Study|Other Adverse Event|1|||
46919279|NCT01314105|83151163|FG001|Overall Study|Other Adverse Event|1|||
46919280|NCT03040713|83151171|FG000|Overall Study|Positive amyloid scan|3|||
46919281|NCT01966471|83151177|FG000|Overall Study|Death|44|||
46919282|NCT01966471|83151178|FG001|Overall Study|Death|56|||
46919283|NCT01966471|83151177|FG000|Overall Study|Lost to Follow-up|46|||
46919284|NCT01966471|83151178|FG001|Overall Study|Lost to Follow-up|39|||
46919285|NCT01966471|83151177|FG000|Overall Study|Various reasons|4|||
46919286|NCT01966471|83151178|FG001|Overall Study|Various reasons|4|||
46919287|NCT01966471|83151177|FG000|Overall Study|Physician Decision|7|||
46919288|NCT01966471|83151178|FG001|Overall Study|Physician Decision|5|||
46919289|NCT01966471|83151177|FG000|Overall Study|Study Terminated By Sponsor|758|||
46919290|NCT01966471|83151178|FG001|Overall Study|Study Terminated By Sponsor|773|||
46919291|NCT01966471|83151177|FG000|Overall Study|Withdrawal by Subject|59|||
46919292|NCT01966471|83151178|FG001|Overall Study|Withdrawal by Subject|51|||
46919293|NCT03227471|83151207|FG000|Overall Study|Withdrawal by Subject|0|||
46919294|NCT03227471|83151208|FG001|Overall Study|Withdrawal by Subject|0|||
46919295|NCT03227471|83151209|FG002|Overall Study|Withdrawal by Subject|0|||
46919296|NCT03227471|83151210|FG003|Overall Study|Withdrawal by Subject|0|||
46919297|NCT03227471|83151211|FG004|Overall Study|Withdrawal by Subject|1|||
46919298|NCT03227471|83151212|FG005|Overall Study|Withdrawal by Subject|0|||
46919299|NCT03227471|83151213|FG006|Overall Study|Withdrawal by Subject|0|||
46919300|NCT03227471|83151214|FG007|Overall Study|Withdrawal by Subject|0|||
46919301|NCT03227471|83151215|FG008|Overall Study|Withdrawal by Subject|0|||
46919302|NCT03227471|83151216|FG009|Overall Study|Withdrawal by Subject|0|||
46919303|NCT03227471|83151217|FG010|Overall Study|Withdrawal by Subject|0|||
46919304|NCT03227471|83151218|FG011|Overall Study|Withdrawal by Subject|0|||
46919305|NCT03227471|83151219|FG012|Overall Study|Withdrawal by Subject|1|||
46919306|NCT03227471|83151220|FG013|Overall Study|Withdrawal by Subject|0|||
46919307|NCT03227471|83151221|FG014|Overall Study|Withdrawal by Subject|0|||
46919308|NCT03227471|83151207|FG000|Overall Study|Randomized, Never Dosed|0|||
46919309|NCT03227471|83151208|FG001|Overall Study|Randomized, Never Dosed|0|||
46919310|NCT03227471|83151209|FG002|Overall Study|Randomized, Never Dosed|0|||
46919311|NCT03227471|83151210|FG003|Overall Study|Randomized, Never Dosed|0|||
46919312|NCT03227471|83151211|FG004|Overall Study|Randomized, Never Dosed|0|||
46919313|NCT03227471|83151212|FG005|Overall Study|Randomized, Never Dosed|0|||
46919314|NCT03227471|83151213|FG006|Overall Study|Randomized, Never Dosed|0|||
46919315|NCT03227471|83151214|FG007|Overall Study|Randomized, Never Dosed|0|||
46919316|NCT03227471|83151215|FG008|Overall Study|Randomized, Never Dosed|0|||
46632759|NCT01814748|82805960|FG001|Overall Study|Lost to Follow-up|2|||
46632760|NCT01814748|82805959|FG000|Overall Study|Study site terminated by sponsor|1|||
46632761|NCT01814748|82805960|FG001|Overall Study|Study site terminated by sponsor|1|||
46919317|NCT03227471|83151216|FG009|Overall Study|Randomized, Never Dosed|0|||
46919318|NCT03227471|83151217|FG010|Overall Study|Randomized, Never Dosed|0|||
46919319|NCT03227471|83151218|FG011|Overall Study|Randomized, Never Dosed|0|||
46919320|NCT03227471|83151219|FG012|Overall Study|Randomized, Never Dosed|0|||
46919321|NCT03227471|83151220|FG013|Overall Study|Randomized, Never Dosed|0|||
46919322|NCT03227471|83151221|FG014|Overall Study|Randomized, Never Dosed|1|||
46919323|NCT01354314|83151286|FG000|Overall Study|Lost to Follow-up|1|||
46919324|NCT01354314|83151287|FG001|Overall Study|Lost to Follow-up|0|||
46919325|NCT01354314|83151288|FG002|Overall Study|Lost to Follow-up|1|||
46919326|NCT01354314|83151289|FG003|Overall Study|Lost to Follow-up|1|||
46919327|NCT01354314|83151286|FG000|Overall Study|Withdrawal by Subject|0|||
46919328|NCT01354314|83151287|FG001|Overall Study|Withdrawal by Subject|0|||
47041798|NCT01891669|83298339|FG001|Overall Study|Death|0|||
47041799|NCT01891669|83298340|FG002|Overall Study|Death|0|||
46919329|NCT01354314|83151288|FG002|Overall Study|Withdrawal by Subject|1|||
46919330|NCT01354314|83151289|FG003|Overall Study|Withdrawal by Subject|0|||
46919331|NCT01354314|83151286|FG000|Overall Study|Adverse Event|0|||
46919332|NCT01354314|83151287|FG001|Overall Study|Adverse Event|0|||
46919333|NCT01354314|83151288|FG002|Overall Study|Adverse Event|0|||
46919334|NCT01354314|83151289|FG003|Overall Study|Adverse Event|1|||
46919335|NCT01354314|83151286|FG000|Overall Study|Protocol Violation|1|||
46919336|NCT01354314|83151287|FG001|Overall Study|Protocol Violation|1|||
46919337|NCT01354314|83151288|FG002|Overall Study|Protocol Violation|0|||
46919338|NCT01354314|83151289|FG003|Overall Study|Protocol Violation|0|||
46919339|NCT01354314|83151286|FG000|Overall Study|Less than 90% Adherence|4|||
46919340|NCT01354314|83151287|FG001|Overall Study|Less than 90% Adherence|2|||
46919341|NCT01354314|83151288|FG002|Overall Study|Less than 90% Adherence|6|||
46919342|NCT01354314|83151289|FG003|Overall Study|Less than 90% Adherence|4|||
46919343|NCT03194321|83151301|FG000|Overall Study|Withdrawal by Subject|1|||
46919344|NCT03194321|83151301|FG000|Overall Study|Lost to Follow-up|1|||
46919345|NCT03194321|83151301|FG000|Overall Study|Travel for Follow-up|1|||
46919346|NCT01354938|83151305|FG000|Overall Study|Lost to Follow-up|1|||
46919347|NCT03092791|83151328|FG000|Overall Study|Lost to Follow-up|0|||
46919348|NCT03092791|83151329|FG001|Overall Study|Lost to Follow-up|0|||
46919349|NCT03092791|83151330|FG002|Overall Study|Lost to Follow-up|0|||
46919350|NCT03092791|83151331|FG003|Overall Study|Lost to Follow-up|0|||
46919351|NCT03092791|83151332|FG004|Overall Study|Lost to Follow-up|0|||
46919352|NCT03092791|83151333|FG005|Overall Study|Lost to Follow-up|0|||
46919353|NCT03092791|83151334|FG006|Overall Study|Lost to Follow-up|1|||
46919354|NCT03092791|83151335|FG007|Overall Study|Lost to Follow-up|0|||
46919355|NCT03092791|83151328|FG000|Overall Study|Withdrawal of Consent|0|||
46919356|NCT03092791|83151329|FG001|Overall Study|Withdrawal of Consent|0|||
46919357|NCT03092791|83151330|FG002|Overall Study|Withdrawal of Consent|0|||
46919358|NCT03092791|83151331|FG003|Overall Study|Withdrawal of Consent|0|||
46919359|NCT03092791|83151332|FG004|Overall Study|Withdrawal of Consent|4|||
46919360|NCT03092791|83151333|FG005|Overall Study|Withdrawal of Consent|12|||
46919361|NCT03092791|83151334|FG006|Overall Study|Withdrawal of Consent|6|||
46919362|NCT03092791|83151335|FG007|Overall Study|Withdrawal of Consent|4|||
46919363|NCT03092791|83151328|FG000|Overall Study|Study Termination|0|||
46919364|NCT03092791|83151329|FG001|Overall Study|Study Termination|0|||
46919365|NCT03092791|83151330|FG002|Overall Study|Study Termination|0|||
46919366|NCT03092791|83151331|FG003|Overall Study|Study Termination|0|||
46919367|NCT03092791|83151332|FG004|Overall Study|Study Termination|55|||
46919368|NCT03092791|83151333|FG005|Overall Study|Study Termination|46|||
46919369|NCT03092791|83151334|FG006|Overall Study|Study Termination|53|||
46919370|NCT03092791|83151335|FG007|Overall Study|Study Termination|55|||
46919371|NCT03092791|83151328|FG000|Overall Study|Death|0|||
46919372|NCT03092791|83151329|FG001|Overall Study|Death|0|||
46919373|NCT03092791|83151330|FG002|Overall Study|Death|0|||
46919374|NCT03092791|83151331|FG003|Overall Study|Death|0|||
47041800|NCT01891669|83298341|FG003|Overall Study|Death|0|||
46919375|NCT03092791|83151332|FG004|Overall Study|Death|0|||
46919376|NCT03092791|83151333|FG005|Overall Study|Death|1|||
46919377|NCT03092791|83151334|FG006|Overall Study|Death|0|||
46919378|NCT03092791|83151335|FG007|Overall Study|Death|1|||
46919379|NCT03092791|83151328|FG000|Overall Study|Reason Not Specified|0|||
46919380|NCT03092791|83151329|FG001|Overall Study|Reason Not Specified|0|||
46919381|NCT03092791|83151330|FG002|Overall Study|Reason Not Specified|0|||
46919382|NCT03092791|83151331|FG003|Overall Study|Reason Not Specified|0|||
46919383|NCT03092791|83151332|FG004|Overall Study|Reason Not Specified|1|||
47041801|NCT01891669|83298342|FG004|Overall Study|Death|0|||
47041802|NCT01891669|83298343|FG005|Overall Study|Death|0|||
47041803|NCT01891669|83298344|FG006|Overall Study|Death|0|||
47041804|NCT01891669|83298345|FG007|Overall Study|Death|1|||
46919384|NCT03092791|83151333|FG005|Overall Study|Reason Not Specified|1|||
46919385|NCT03092791|83151334|FG006|Overall Study|Reason Not Specified|0|||
46919386|NCT03092791|83151335|FG007|Overall Study|Reason Not Specified|0|||
46919387|NCT02505425|83151362|FG000|Overall Study|Lost to Follow-up|41|||
46919388|NCT02505425|83151363|FG001|Overall Study|Lost to Follow-up|61|||
46919389|NCT02505425|83151364|FG002|Overall Study|Lost to Follow-up|31|||
47041805|NCT01891669|83298346|FG008|Overall Study|Death|0|||
46919390|NCT02505425|83151365|FG003|Overall Study|Lost to Follow-up|19|||
46919391|NCT02505425|83151362|FG000|Overall Study|Withdrawal by Subject|39|||
46919392|NCT02505425|83151363|FG001|Overall Study|Withdrawal by Subject|9|||
46919393|NCT02505425|83151364|FG002|Overall Study|Withdrawal by Subject|19|||
47041806|NCT01891669|83298347|FG009|Overall Study|Death|1|||
47041807|NCT01891669|83298338|FG000|Overall Study|Withdrawal by Subject|1|||
46919394|NCT02505425|83151365|FG003|Overall Study|Withdrawal by Subject|7|||
46919395|NCT02505425|83151362|FG000|Overall Study|Death|8|||
46919396|NCT02505425|83151363|FG001|Overall Study|Death|12|||
46919397|NCT02505425|83151364|FG002|Overall Study|Death|0|||
46919398|NCT02505425|83151365|FG003|Overall Study|Death|0|||
46919399|NCT03089047|83151377|FG000|Overall Study|Lost to Follow-up|1|||
46919400|NCT03089047|83151378|FG001|Overall Study|Lost to Follow-up|0|||
46919401|NCT01371006|83151386|FG000|Overall Study|Adverse Event|1|||
46919402|NCT01371006|83151387|FG001|Overall Study|Adverse Event|0|||
46919403|NCT01371552|83151422|FG000|Part 1, First 3 Days|Inconvenience|0|||
46919404|NCT01371552|83151423|FG001|Part 1, First 3 Days|Inconvenience|0|||
46919405|NCT01371552|83151424|FG002|Part 1, First 3 Days|Inconvenience|1|||
46919406|NCT01371552|83151425|FG003|Part 1, First 3 Days|Inconvenience|0|||
46919407|NCT01371552|83151426|FG004|Part 1, First 3 Days|Inconvenience|0|||
46919408|NCT01371552|83151427|FG005|Part 1, First 3 Days|Inconvenience|0|||
46919409|NCT02819310|83151436|FG000|Overall Study|Withdrawal by Subject|37|||
46919410|NCT02819310|83151436|FG000|Overall Study|Lost to Follow-up|16|||
46919411|NCT02819310|83151436|FG000|Overall Study|Adverse Event|13|||
46919412|NCT02819310|83151436|FG000|Overall Study|Lack of Efficacy|5|||
46919413|NCT02819310|83151436|FG000|Overall Study|Physician Decision|8|||
46919414|NCT02819310|83151436|FG000|Overall Study|Protocol Violation|30|||
46919415|NCT03087643|83151442|FG000|Overall Study|Withdrawal by Subject|2|||
46919416|NCT03087643|83151443|FG001|Overall Study|Withdrawal by Subject|4|||
46919417|NCT03087643|83151442|FG000|Overall Study|Death|2|||
46919418|NCT03087643|83151443|FG001|Overall Study|Death|2|||
46919419|NCT02821962|83151451|FG000|Overall Study|Lost to Follow-up|2|||
46919420|NCT02821962|83151452|FG001|Overall Study|Lost to Follow-up|0|||
46919421|NCT03092479|83151460|FG000|Overall Study|Lost to Follow-up|3|||
46919422|NCT03092479|83151461|FG001|Overall Study|Lost to Follow-up|2|||
46919423|NCT03092479|83151460|FG000|Overall Study|Withdrawal by Subject|4|||
46919424|NCT03092479|83151461|FG001|Overall Study|Withdrawal by Subject|0|||
46919425|NCT03086551|83151469|FG000|First Intervention|Failure to meet inclusion criterion|1|||
46919426|NCT03086551|83151470|FG001|First Intervention|Failure to meet inclusion criterion|0|||
46919427|NCT03086551|83151469|FG000|First Intervention|Lost to Follow-up|0|||
46919428|NCT03086551|83151470|FG001|First Intervention|Lost to Follow-up|1|||
46919429|NCT03086551|83151469|FG000|Washout|Lost to Follow-up|1|||
46919430|NCT03086551|83151470|FG001|Washout|Lost to Follow-up|2|||
46919431|NCT03086551|83151469|FG000|Washout|Withdrawal by Subject|2|||
46919432|NCT03086551|83151470|FG001|Washout|Withdrawal by Subject|1|||
46919433|NCT03265249|83151478|FG000|Overall Study|Withdrawal by Subject|0|||
46919434|NCT03265249|83151479|FG001|Overall Study|Withdrawal by Subject|1|||
46919435|NCT03093181|83151488|FG000|Overall Study|Withdrawal by Subject|2|||
46919436|NCT03093181|83151489|FG001|Overall Study|Withdrawal by Subject|1|||
46919437|NCT03093181|83151490|FG002|Overall Study|Withdrawal by Subject|2|||
46919438|NCT03093181|83151488|FG000|Overall Study|Other (Not specified)|1|||
46919439|NCT03093181|83151489|FG001|Overall Study|Other (Not specified)|0|||
46919440|NCT03093181|83151490|FG002|Overall Study|Other (Not specified)|0|||
47041808|NCT01891669|83298339|FG001|Overall Study|Withdrawal by Subject|1|||
47041809|NCT01891669|83298340|FG002|Overall Study|Withdrawal by Subject|0|||
47041810|NCT01891669|83298341|FG003|Overall Study|Withdrawal by Subject|0|||
47041811|NCT01891669|83298342|FG004|Overall Study|Withdrawal by Subject|0|||
47041812|NCT01891669|83298343|FG005|Overall Study|Withdrawal by Subject|0|||
47041813|NCT01891669|83298344|FG006|Overall Study|Withdrawal by Subject|1|||
47041814|NCT01891669|83298345|FG007|Overall Study|Withdrawal by Subject|2|||
47041815|NCT01891669|83298346|FG008|Overall Study|Withdrawal by Subject|1|||
47041816|NCT01891669|83298347|FG009|Overall Study|Withdrawal by Subject|1|||
47041817|NCT01891669|83298338|FG000|Overall Study|Other|1|||
46919441|NCT03093181|83151488|FG000|Overall Study|Adverse Event|0|||
46919442|NCT03093181|83151489|FG001|Overall Study|Adverse Event|1|||
46919443|NCT03093181|83151490|FG002|Overall Study|Adverse Event|0|||
47041818|NCT01891669|83298339|FG001|Overall Study|Other|0|||
46919444|NCT03093181|83151488|FG000|Overall Study|Other (Protocol violation)|0|||
46919445|NCT03093181|83151489|FG001|Overall Study|Other (Protocol violation)|0|||
46919446|NCT03093181|83151490|FG002|Overall Study|Other (Protocol violation)|1|||
46919447|NCT03091777|83151501|FG000|Overall Study|Pregnancy|2|||
46919448|NCT03091777|83151502|FG001|Overall Study|Pregnancy|1|||
46919449|NCT03091777|83151503|FG002|Overall Study|Pregnancy|0|||
47041819|NCT01891669|83298340|FG002|Overall Study|Other|0|||
47041820|NCT01891669|83298341|FG003|Overall Study|Other|0|||
47041821|NCT01891669|83298342|FG004|Overall Study|Other|0|||
46919450|NCT03091777|83151501|FG000|Overall Study|Adverse Event|2|||
46919451|NCT03091777|83151502|FG001|Overall Study|Adverse Event|1|||
46919452|NCT03091777|83151503|FG002|Overall Study|Adverse Event|4|||
46919453|NCT03091777|83151501|FG000|Overall Study|Withdrawal by Subject|4|||
46919454|NCT03091777|83151502|FG001|Overall Study|Withdrawal by Subject|2|||
46720290|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
46720291|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
46720292|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
46720293|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
46720294|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
46720295|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
46720296|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
46720297|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
47041822|NCT01891669|83298343|FG005|Overall Study|Other|0|||
47041823|NCT01891669|83298344|FG006|Overall Study|Other|0|||
47041824|NCT01891669|83298345|FG007|Overall Study|Other|1|||
47041825|NCT01891669|83298346|FG008|Overall Study|Other|0|||
47041826|NCT01891669|83298347|FG009|Overall Study|Other|0|||
47041827|NCT01421511|83298380|FG000|Overall Study|Lost to Follow-up|11|||
47041828|NCT01421511|83298381|FG001|Overall Study|Lost to Follow-up|14|||
47041829|NCT01421511|83298380|FG000|Overall Study|Randomized but didn't receive study drug|1|||
47041830|NCT01421511|83298381|FG001|Overall Study|Randomized but didn't receive study drug|7|||
47041831|NCT01421511|83298380|FG000|Overall Study|Physician Decision|0|||
47041832|NCT01421511|83298381|FG001|Overall Study|Physician Decision|1|||
46720298|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
46720299|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
46720300|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
47041833|NCT01421511|83298380|FG000|Overall Study|Withdrawal by Subject|6|||
46720301|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
46720302|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Death|1|||
46720303|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Death|1|||
46720304|NCT00600886|82936339|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
46720305|NCT00600886|82936340|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
46720306|NCT00600886|82936339|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
46720307|NCT00600886|82936340|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
46720308|NCT00600886|82936339|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
46720309|NCT00600886|82936340|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
46720310|NCT00600886|82936339|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
46720311|NCT00600886|82936340|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
46720312|NCT00600886|82936339|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
47041834|NCT01421511|83298381|FG001|Overall Study|Withdrawal by Subject|5|||
47041835|NCT01421511|83298380|FG000|Overall Study|Death|1|||
47041836|NCT01421511|83298381|FG001|Overall Study|Death|1|||
47041837|NCT01864525|83298390|FG000|Overall Study|Adverse Event|1|||
46632762|NCT01814748|82805959|FG000|Overall Study|Withdrawal by Subject|6|||
46632763|NCT01814748|82805960|FG001|Overall Study|Withdrawal by Subject|4|||
46632764|NCT01814670|82805966|FG000|Overall Study|Protocol Violation|12|||
46720313|NCT00600886|82936340|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
46720314|NCT00600886|82936339|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
46720315|NCT00600886|82936340|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
46720316|NCT00600886|82936339|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
46720317|NCT00600886|82936340|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
46720318|NCT00600886|82936339|FG000|Extension - After Crossover (CAS)|Death|1|||
47041838|NCT01864525|83298391|FG001|Overall Study|Adverse Event|0|||
47041839|NCT01421277|83298399|FG000|Overall Study|Lack of qualifying event|0|||
46632765|NCT01814046|82805972|FG000|Drug Administration|Death due to complications of RSV|1|||
46632766|NCT01814046|82805973|FG001|Drug Administration|Death due to complications of RSV|0|||
46632767|NCT01814046|82805974|FG002|Drug Administration|Death due to complications of RSV|0|||
46632768|NCT01813890|82805984|FG000|Overall Study|Adverse Event|0|||
46632769|NCT01813890|82805985|FG001|Overall Study|Adverse Event|3|||
46632770|NCT01813890|82805986|FG002|Overall Study|Adverse Event|4|||
46632771|NCT01813890|82805984|FG000|Overall Study|Lack of Efficacy|9|||
46632772|NCT01813890|82805985|FG001|Overall Study|Lack of Efficacy|1|||
46632773|NCT01813890|82805986|FG002|Overall Study|Lack of Efficacy|2|||
46632774|NCT01772316|82805994|FG000|Overall Study|Serious adverse event|1|||
46632775|NCT01772316|82805994|FG000|Overall Study|Inform consent withdrawn|1|||
46632776|NCT01772316|82805994|FG000|Overall Study|Withdrawn by sponsor decision|5|||
46632777|NCT01813422|82806000|FG000|Overall Study|Withdrawal by Subject|14|||
46632778|NCT01813422|82806001|FG001|Overall Study|Withdrawal by Subject|8|||
46720319|NCT00600886|82936340|FG001|Extension - After Crossover (CAS)|Death|0|||
46720320|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
46720321|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
47041840|NCT01421277|83298400|FG001|Overall Study|Lack of qualifying event|61|||
47041841|NCT01421277|83298399|FG000|Overall Study|Incomplete baseline data|0|||
47041842|NCT01421277|83298400|FG001|Overall Study|Incomplete baseline data|31|||
47041843|NCT01891357|83298406|FG000|Overall Study|Protocol Violation|3|||
47041844|NCT01420965|83298413|FG000|Overall Study|Withdrawal by Subject|1|||
47041845|NCT01420965|83298414|FG001|Overall Study|Withdrawal by Subject|0|||
47041846|NCT01420965|83298415|FG002|Overall Study|Withdrawal by Subject|0|||
47041847|NCT01420965|83298413|FG000|Overall Study|Adverse Event|0|||
47041848|NCT01420965|83298414|FG001|Overall Study|Adverse Event|1|||
46919455|NCT03091777|83151503|FG002|Overall Study|Withdrawal by Subject|6|||
46919456|NCT03091777|83151501|FG000|Overall Study|Protocol Violation|2|||
46919457|NCT03091777|83151502|FG001|Overall Study|Protocol Violation|1|||
46919458|NCT03091777|83151503|FG002|Overall Study|Protocol Violation|1|||
46919459|NCT03091777|83151501|FG000|Overall Study|Lost to Follow-up|12|||
46919460|NCT03091777|83151502|FG001|Overall Study|Lost to Follow-up|14|||
46919461|NCT03091777|83151503|FG002|Overall Study|Lost to Follow-up|7|||
46919462|NCT03091777|83151501|FG000|Overall Study|Lack of Efficacy|0|||
46919463|NCT03091777|83151502|FG001|Overall Study|Lack of Efficacy|0|||
46919464|NCT03091777|83151503|FG002|Overall Study|Lack of Efficacy|5|||
46919465|NCT03091777|83151501|FG000|Overall Study|Noncompliance with study drug|2|||
46919466|NCT03091777|83151502|FG001|Overall Study|Noncompliance with study drug|3|||
46919467|NCT03091777|83151503|FG002|Overall Study|Noncompliance with study drug|1|||
46919468|NCT03091777|83151501|FG000|Overall Study|Physician Decision|1|||
46919469|NCT03091777|83151502|FG001|Overall Study|Physician Decision|0|||
46919470|NCT03091777|83151503|FG002|Overall Study|Physician Decision|1|||
46919471|NCT03091777|83151501|FG000|Overall Study|Abnormal Laboratory Value|7|||
46919472|NCT03091777|83151502|FG001|Overall Study|Abnormal Laboratory Value|11|||
46919473|NCT03091777|83151503|FG002|Overall Study|Abnormal Laboratory Value|12|||
47041849|NCT01420965|83298415|FG002|Overall Study|Adverse Event|0|||
47041850|NCT01390389|83298425|FG000|Overall Study|Withdrawal by Subject|2|||
47041851|NCT01390389|83298426|FG001|Overall Study|Withdrawal by Subject|0|||
47041852|NCT01390389|83298425|FG000|Overall Study|Screen Fail|2|||
47041853|NCT01390389|83298426|FG001|Overall Study|Screen Fail|1|||
47041854|NCT01401465|83298438|FG000|Treatment Period 1|Adverse Event|4|||
47041855|NCT01401465|83298439|FG001|Treatment Period 1|Adverse Event|1|||
47041856|NCT01401465|83298438|FG000|Treatment Period 1|Pregnancy|0|||
47041857|NCT01401465|83298439|FG001|Treatment Period 1|Pregnancy|1|||
47041858|NCT01401465|83298438|FG000|Treatment Period 1|Protocol Violation|5|||
47041859|NCT01401465|83298439|FG001|Treatment Period 1|Protocol Violation|0|||
47041860|NCT01401465|83298438|FG000|Treatment Period 1|Withdrawal by Subject|1|||
47041861|NCT01401465|83298439|FG001|Treatment Period 1|Withdrawal by Subject|4|||
46720322|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
46720323|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
46720324|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
46919474|NCT02818998|83151514|FG000|Overall Study|Adverse Event|3|||
46720325|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
46720326|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
46720327|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
46720328|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
46720329|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
46720330|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
46720331|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
46720332|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
46720333|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
46720334|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
46720335|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
46720336|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
46720337|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
46720338|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
46720339|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
46720340|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
46720341|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
46720342|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
46720343|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
46720344|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
46919475|NCT02818998|83151515|FG001|Overall Study|Adverse Event|2|||
46919476|NCT02818998|83151516|FG002|Overall Study|Adverse Event|1|||
46919477|NCT02818998|83151514|FG000|Overall Study|Lost to Follow-up|4|||
47041862|NCT01401465|83298438|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
46919478|NCT02818998|83151515|FG001|Overall Study|Lost to Follow-up|1|||
46919479|NCT02818998|83151516|FG002|Overall Study|Lost to Follow-up|2|||
47041863|NCT01401465|83298439|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
47041864|NCT01401465|83298438|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
47041865|NCT01401465|83298439|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
47041866|NCT01401465|83298438|FG000|Treatment Period 1|Scheduling Difficulties|1|||
46720345|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
46720346|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
46919480|NCT02818998|83151514|FG000|Overall Study|Withdrawal by sponsor|0|||
46919481|NCT02818998|83151515|FG001|Overall Study|Withdrawal by sponsor|1|||
47041867|NCT01401465|83298439|FG001|Treatment Period 1|Scheduling Difficulties|1|||
46919482|NCT02818998|83151516|FG002|Overall Study|Withdrawal by sponsor|1|||
46919483|NCT02818998|83151514|FG000|Overall Study|Death|3|||
46919484|NCT02818998|83151515|FG001|Overall Study|Death|6|||
46919485|NCT02818998|83151516|FG002|Overall Study|Death|8|||
46919486|NCT02818998|83151514|FG000|Overall Study|Withdrawal by Subject|7|||
46919487|NCT02818998|83151515|FG001|Overall Study|Withdrawal by Subject|6|||
46919488|NCT02818998|83151516|FG002|Overall Study|Withdrawal by Subject|6|||
46919489|NCT02818998|83151514|FG000|Overall Study|Physician Decision|1|||
46919490|NCT02818998|83151515|FG001|Overall Study|Physician Decision|0|||
46919491|NCT02818998|83151516|FG002|Overall Study|Physician Decision|0|||
46919492|NCT02821416|83151526|FG000|Overall Study|Adverse Event|0|||
46919493|NCT02821416|83151527|FG001|Overall Study|Adverse Event|1|||
46919494|NCT02821416|83151526|FG000|Overall Study|Withdrawal by Subject|2|||
46919495|NCT02821416|83151527|FG001|Overall Study|Withdrawal by Subject|0|||
46919496|NCT02821416|83151526|FG000|Overall Study|Lost to Follow-up|1|||
46919497|NCT02821416|83151527|FG001|Overall Study|Lost to Follow-up|0|||
46919498|NCT03108521|83151536|FG000|Overall Study|Lost to Follow-up|3|||
46919499|NCT03108521|83151537|FG001|Overall Study|Lost to Follow-up|0|||
46919500|NCT03108521|83151536|FG000|Overall Study|Lack of Efficacy|2|||
46919501|NCT03108521|83151537|FG001|Overall Study|Lack of Efficacy|0|||
46919502|NCT03108521|83151536|FG000|Overall Study|Physician Decision|4|||
46919503|NCT03108521|83151537|FG001|Overall Study|Physician Decision|0|||
46919504|NCT03108521|83151536|FG000|Overall Study|Adverse Event|3|||
46919505|NCT03108521|83151537|FG001|Overall Study|Adverse Event|0|||
46919506|NCT02817828|83151560|FG000|Overall Study|Lost to Follow-up|41|||
46919507|NCT02817828|83151560|FG000|Overall Study|Adverse event not related to bleeding|104|||
46919508|NCT02817828|83151560|FG000|Overall Study|Adverse event related to bleeding|53|||
46919509|NCT02817828|83151560|FG000|Overall Study|Protocol Violation|11|||
46919510|NCT02817828|83151560|FG000|Overall Study|Pregnancy|7|||
46919511|NCT02817828|83151560|FG000|Overall Study|Pregnancy wish|15|||
46919512|NCT02817828|83151560|FG000|Overall Study|Withdrawal by Subject|78|||
46919513|NCT02817828|83151560|FG000|Overall Study|Other|26|||
46919514|NCT02817906|83151571|FG000|Overall Study|Adverse Event|3|||
46919515|NCT02817906|83151572|FG001|Overall Study|Adverse Event|0|||
46919516|NCT02817906|83151571|FG000|Overall Study|Lack of Efficacy|1|||
47041868|NCT01401465|83298438|FG000|Treatment Period 2|Lost to Follow-up|0|||
47041869|NCT01401465|83298439|FG001|Treatment Period 2|Lost to Follow-up|1|||
47041870|NCT01401465|83298438|FG000|Treatment Period 2|Withdrawal by Subject|0|||
47041871|NCT01401465|83298439|FG001|Treatment Period 2|Withdrawal by Subject|1|||
47041872|NCT01401153|83298450|FG000|First Test Day|Learning disabilities; illness|1|||
46720347|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
46919517|NCT02817906|83151572|FG001|Overall Study|Lack of Efficacy|0|||
46919518|NCT02817906|83151571|FG000|Overall Study|Protocol Violation|1|||
46919519|NCT02817906|83151572|FG001|Overall Study|Protocol Violation|1|||
46919520|NCT02817906|83151571|FG000|Overall Study|Study Terminated by Sponsor|2|||
46919521|NCT02817906|83151572|FG001|Overall Study|Study Terminated by Sponsor|2|||
46919522|NCT02817906|83151571|FG000|Overall Study|Withdrawal by Subject|7|||
46919523|NCT02817906|83151572|FG001|Overall Study|Withdrawal by Subject|0|||
46919524|NCT02817906|83151571|FG000|Overall Study|Other|2|||
46919525|NCT02817906|83151572|FG001|Overall Study|Other|2|||
46919526|NCT02817594|83151583|FG000|Overall Study|Withdrawal by Subject|1|||
46919527|NCT02817594|83151583|FG000|Overall Study|Other|1|||
46919528|NCT02817594|83151583|FG000|Overall Study|Did Not Receive Treatment|1|||
46919529|NCT02813694|83151593|FG000|Overall Study|Physician Decision|0|||
46919530|NCT02813694|83151594|FG001|Overall Study|Physician Decision|1|||
46919531|NCT02813694|83151593|FG000|Overall Study|Withdrawal by Subject|10|||
46919532|NCT02813694|83151594|FG001|Overall Study|Withdrawal by Subject|9|||
46919533|NCT02813694|83151593|FG000|Overall Study|Lost to Follow-up|1|||
46919534|NCT02813694|83151594|FG001|Overall Study|Lost to Follow-up|1|||
46919535|NCT02813694|83151593|FG000|Overall Study|Death|3|||
46919536|NCT02813694|83151594|FG001|Overall Study|Death|3|||
46919537|NCT02813694|83151593|FG000|Overall Study|Randomized- did not receive study drug|2|||
46919538|NCT02813694|83151594|FG001|Overall Study|Randomized- did not receive study drug|0|||
46919539|NCT02813694|83151593|FG000|Overall Study|Patient hospitalized|1|||
46919540|NCT02813694|83151594|FG001|Overall Study|Patient hospitalized|0|||
46919541|NCT03103919|83151602|FG000|Overall Study|Adverse Event|2|||
46919542|NCT03103919|83151603|FG001|Overall Study|Adverse Event|2|||
46919543|NCT02810964|83151613|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
46919544|NCT02810964|83151614|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
46919545|NCT02810964|83151613|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
46919546|NCT02810964|83151614|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
46919547|NCT02810964|83151613|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
47041873|NCT01401153|83298451|FG001|First Test Day|Learning disabilities; illness|10|||
46919548|NCT02810964|83151614|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
46919549|NCT02810964|83151613|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
47041874|NCT01401153|83298450|FG000|Second Test Day|illness|0|||
46919550|NCT02810964|83151614|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
46919551|NCT03103763|83151623|FG000|Overall Study|Death|15|||
46919552|NCT03103763|83151624|FG001|Overall Study|Death|5|||
46919553|NCT03103763|83151625|FG002|Overall Study|Death|5|||
46919554|NCT03103763|83151623|FG000|Overall Study|Withdrawal by Subject|0|||
46919555|NCT03103763|83151624|FG001|Overall Study|Withdrawal by Subject|3|||
46919556|NCT03103763|83151625|FG002|Overall Study|Withdrawal by Subject|2|||
46919557|NCT03101267|83151649|FG000|Primary Study Period|Withdrawal by Subject|1|||
46919558|NCT03101267|83151650|FG001|Primary Study Period|Withdrawal by Subject|2|||
46919559|NCT03101267|83151651|FG002|Primary Study Period|Withdrawal by Subject|3|||
46919560|NCT03101267|83151649|FG000|Primary Study Period|Miscellaneous|2|||
46919561|NCT03101267|83151650|FG001|Primary Study Period|Miscellaneous|0|||
46919562|NCT03101267|83151651|FG002|Primary Study Period|Miscellaneous|0|||
46919563|NCT02810418|83151666|FG000|Arm A Dose Escalation|Adverse Event|2|||
46919564|NCT02810418|83151667|FG001|Arm A Dose Escalation|Adverse Event|1|||
46919565|NCT02810418|83151668|FG002|Arm A Dose Escalation|Adverse Event|0|||
46919566|NCT02810418|83151669|FG003|Arm A Dose Escalation|Adverse Event|0|||
46919567|NCT02810418|83151670|FG004|Arm A Dose Escalation|Adverse Event|0|||
46919568|NCT02810418|83151671|FG005|Arm A Dose Escalation|Adverse Event|0|||
46919569|NCT02810418|83151672|FG006|Arm A Dose Escalation|Adverse Event|0|||
46919570|NCT02810418|83151666|FG000|Dose Expansion|Adverse Event|0|||
46919571|NCT02810418|83151667|FG001|Dose Expansion|Adverse Event|1|||
46919572|NCT02810418|83151668|FG002|Dose Expansion|Adverse Event|1|||
46919573|NCT02810418|83151669|FG003|Dose Expansion|Adverse Event|0|||
46919574|NCT02810418|83151670|FG004|Dose Expansion|Adverse Event|0|||
46919575|NCT02810418|83151671|FG005|Dose Expansion|Adverse Event|0|||
46919576|NCT02810418|83151672|FG006|Dose Expansion|Adverse Event|0|||
46919577|NCT02810418|83151666|FG000|Dose Expansion|Physician Decision|0|||
46919578|NCT02810418|83151667|FG001|Dose Expansion|Physician Decision|0|||
46919579|NCT02810418|83151668|FG002|Dose Expansion|Physician Decision|2|||
46919580|NCT02810418|83151669|FG003|Dose Expansion|Physician Decision|0|||
46919581|NCT02810418|83151670|FG004|Dose Expansion|Physician Decision|0|||
46919582|NCT02810418|83151671|FG005|Dose Expansion|Physician Decision|0|||
46919583|NCT02810418|83151672|FG006|Dose Expansion|Physician Decision|0|||
46919584|NCT02810418|83151666|FG000|Arm B Dose Escalation|Adverse Event|0|||
46919585|NCT02810418|83151667|FG001|Arm B Dose Escalation|Adverse Event|0|||
46919586|NCT02810418|83151668|FG002|Arm B Dose Escalation|Adverse Event|0|||
46919587|NCT02810418|83151669|FG003|Arm B Dose Escalation|Adverse Event|0|||
46919588|NCT02810418|83151670|FG004|Arm B Dose Escalation|Adverse Event|1|||
46919589|NCT02810418|83151671|FG005|Arm B Dose Escalation|Adverse Event|2|||
46919590|NCT02810418|83151672|FG006|Arm B Dose Escalation|Adverse Event|0|||
46919591|NCT02810340|83151738|FG000|Overall Study|Withdrawal by Subject|1|||
46919592|NCT02810340|83151739|FG001|Overall Study|Withdrawal by Subject|0|||
46919593|NCT02810340|83151740|FG002|Overall Study|Withdrawal by Subject|0|||
46919594|NCT02810340|83151738|FG000|Overall Study|Incarceration|0|||
46919595|NCT02810340|83151739|FG001|Overall Study|Incarceration|1|||
46919596|NCT02810340|83151740|FG002|Overall Study|Incarceration|0|||
46919597|NCT02810340|83151738|FG000|Overall Study|Lost to Follow-up|0|||
46919598|NCT02810340|83151739|FG001|Overall Study|Lost to Follow-up|0|||
46919599|NCT02810340|83151740|FG002|Overall Study|Lost to Follow-up|1|||
46919600|NCT02817516|83151752|FG000|Overall Study|Other|0|||
46919601|NCT02817516|83151753|FG001|Overall Study|Other|0|||
46919602|NCT02817516|83151754|FG002|Overall Study|Other|1|||
46919603|NCT02817516|83151755|FG003|Overall Study|Other|0|||
46919604|NCT02928029|83151770|FG000|Overall Study|Withdrawal by Subject|0|||
46919605|NCT02928029|83151771|FG001|Overall Study|Withdrawal by Subject|1|||
46919606|NCT02928029|83151770|FG000|Overall Study|Radiological progression|1|||
46919607|NCT02928029|83151771|FG001|Overall Study|Radiological progression|0|||
46919608|NCT02928029|83151770|FG000|Overall Study|Clinical progression|1|||
46919609|NCT02928029|83151771|FG001|Overall Study|Clinical progression|2|||
46919610|NCT02928029|83151770|FG000|Overall Study|AE not related to clinical progression|1|||
46919611|NCT02928029|83151771|FG001|Overall Study|AE not related to clinical progression|1|||
46919612|NCT02806986|83151777|FG000|Treatment Stage 1|Adverse Event|1|||
46919613|NCT02806986|83151777|FG000|Treatment Stage 2|Adverse Event|3|||
46919614|NCT02806986|83151777|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
46919615|NCT03095651|83151793|FG000|Overall Study|Lost to Follow-up|1|||
46919616|NCT03095651|83151794|FG001|Overall Study|Lost to Follow-up|1|||
47041875|NCT01401153|83298451|FG001|Second Test Day|illness|5|||
47041876|NCT01890967|83298464|FG000|Overall Study|Adverse Event|3|||
47041877|NCT01890967|83298465|FG001|Overall Study|Adverse Event|3|||
47041878|NCT01890967|83298466|FG002|Overall Study|Adverse Event|3|||
46919617|NCT03095651|83151795|FG002|Overall Study|Lost to Follow-up|0|||
46919618|NCT03095651|83151796|FG003|Overall Study|Lost to Follow-up|1|||
46919619|NCT03095651|83151797|FG004|Overall Study|Lost to Follow-up|0|||
46919620|NCT03095651|83151798|FG005|Overall Study|Lost to Follow-up|0|||
46919621|NCT03095651|83151799|FG006|Overall Study|Lost to Follow-up|0|||
46919622|NCT03095651|83151800|FG007|Overall Study|Lost to Follow-up|0|||
47041879|NCT01890967|83298467|FG003|Overall Study|Adverse Event|2|||
46919623|NCT03095651|83151793|FG000|Overall Study|Withdrawal by Subject|0|||
46919624|NCT03095651|83151794|FG001|Overall Study|Withdrawal by Subject|0|||
46919625|NCT03095651|83151795|FG002|Overall Study|Withdrawal by Subject|0|||
46919626|NCT03095651|83151796|FG003|Overall Study|Withdrawal by Subject|0|||
46919627|NCT03095651|83151797|FG004|Overall Study|Withdrawal by Subject|0|||
46919628|NCT03095651|83151798|FG005|Overall Study|Withdrawal by Subject|1|||
46919629|NCT03095651|83151799|FG006|Overall Study|Withdrawal by Subject|0|||
46919630|NCT03095651|83151800|FG007|Overall Study|Withdrawal by Subject|0|||
46919631|NCT02808312|83151823|FG000|Overall Study|Enrolled but Never Treated|0|||
46919632|NCT02808312|83151824|FG001|Overall Study|Enrolled but Never Treated|0|||
46919633|NCT02808312|83151825|FG002|Overall Study|Enrolled but Never Treated|1|||
46919634|NCT02808312|83151826|FG003|Overall Study|Enrolled but Never Treated|0|||
46919635|NCT02808312|83151827|FG004|Overall Study|Enrolled but Never Treated|0|||
46919636|NCT03099161|83151847|FG000|Overall Study|Adverse Event|0|||
46919637|NCT03099161|83151848|FG001|Overall Study|Adverse Event|0|||
46919638|NCT03099161|83151849|FG002|Overall Study|Adverse Event|2|||
46919639|NCT03099161|83151847|FG000|Overall Study|Physician Decision|2|||
46919640|NCT03099161|83151848|FG001|Overall Study|Physician Decision|0|||
46919641|NCT03099161|83151849|FG002|Overall Study|Physician Decision|0|||
46919642|NCT03099161|83151847|FG000|Overall Study|Progressive Disease|1|||
46919643|NCT03099161|83151848|FG001|Overall Study|Progressive Disease|4|||
46919644|NCT03099161|83151849|FG002|Overall Study|Progressive Disease|1|||
46919645|NCT03095027|83151857|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
46919646|NCT03095027|83151858|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
46919647|NCT04227197|83151866|FG000|Randomization|Protocol Violation|1|||
46919648|NCT04227197|83151867|FG001|Randomization|Protocol Violation|0|||
46919649|NCT04227197|83151866|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
46919650|NCT04227197|83151867|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
46919651|NCT04227197|83151866|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
46919652|NCT04227197|83151867|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
46919653|NCT04227197|83151866|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
46919654|NCT04227197|83151867|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
46919655|NCT04227197|83151866|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
46919656|NCT04227197|83151867|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
46919657|NCT04227197|83151866|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
46919658|NCT04227197|83151867|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
46919659|NCT04227197|83151866|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
46919660|NCT04227197|83151867|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
46919661|NCT03080935|83151878|FG000|Overall Study|Death|34|||
46919662|NCT03080935|83151879|FG001|Overall Study|Death|50|||
46919663|NCT03080935|83151878|FG000|Overall Study|Lost to Follow-up|5|||
46919664|NCT03080935|83151879|FG001|Overall Study|Lost to Follow-up|4|||
47041880|NCT01890967|83298468|FG004|Overall Study|Adverse Event|1|||
47041881|NCT01890967|83298469|FG005|Overall Study|Adverse Event|7|||
46919665|NCT03080935|83151878|FG000|Overall Study|Withdrawal by Subject|11|||
46919666|NCT03080935|83151879|FG001|Overall Study|Withdrawal by Subject|15|||
46919667|NCT02921789|83151891|FG000|Overall Study|Adverse Event|0|||
46919668|NCT02921789|83151892|FG001|Overall Study|Adverse Event|1|||
46919669|NCT02921789|83151891|FG000|Overall Study|Lost to Follow-up|1|||
46919670|NCT02921789|83151892|FG001|Overall Study|Lost to Follow-up|0|||
46919671|NCT02921789|83151891|FG000|Overall Study|Protocol Deviation|2|||
46919672|NCT02921789|83151892|FG001|Overall Study|Protocol Deviation|0|||
47041882|NCT01890967|83298464|FG000|Overall Study|Death|1|||
47041883|NCT01890967|83298465|FG001|Overall Study|Death|0|||
47041884|NCT01890967|83298466|FG002|Overall Study|Death|0|||
47041885|NCT01890967|83298467|FG003|Overall Study|Death|0|||
47041886|NCT01890967|83298468|FG004|Overall Study|Death|0|||
47041887|NCT01890967|83298469|FG005|Overall Study|Death|0|||
47041888|NCT01890967|83298464|FG000|Overall Study|Lost to Follow-up|1|||
47041889|NCT01890967|83298465|FG001|Overall Study|Lost to Follow-up|1|||
47041890|NCT01890967|83298466|FG002|Overall Study|Lost to Follow-up|1|||
47041891|NCT01890967|83298467|FG003|Overall Study|Lost to Follow-up|1|||
47041892|NCT01890967|83298468|FG004|Overall Study|Lost to Follow-up|0|||
47041893|NCT01890967|83298469|FG005|Overall Study|Lost to Follow-up|1|||
47041894|NCT01890967|83298464|FG000|Overall Study|Protocol Violation|0|||
46919673|NCT02921789|83151891|FG000|Overall Study|Withdrawal by Subject|2|||
46919674|NCT02921789|83151892|FG001|Overall Study|Withdrawal by Subject|1|||
46919675|NCT02921789|83151891|FG000|Overall Study|Miscellaneous|3|||
46919676|NCT02921789|83151892|FG001|Overall Study|Miscellaneous|2|||
46919677|NCT03097289|83151907|FG000|Overall Study|Adverse Event|1|||
46919678|NCT03097289|83151907|FG000|Overall Study|Equipment failure|2|||
46919679|NCT03097289|83151907|FG000|Overall Study|Collected platelet product unusable|3|||
46919680|NCT02419742|83151914|FG000|Overall Study|Adverse Event|2|||
47041895|NCT01890967|83298465|FG001|Overall Study|Protocol Violation|3|||
47041896|NCT01890967|83298466|FG002|Overall Study|Protocol Violation|3|||
47041897|NCT01890967|83298467|FG003|Overall Study|Protocol Violation|2|||
46919681|NCT02419742|83151915|FG001|Overall Study|Adverse Event|0|||
46919682|NCT02419742|83151914|FG000|Overall Study|Disease Progression|0|||
46919683|NCT02419742|83151915|FG001|Overall Study|Disease Progression|1|||
46919684|NCT02419742|83151914|FG000|Overall Study|Withdrew Consent|2|||
46919685|NCT02419742|83151915|FG001|Overall Study|Withdrew Consent|1|||
46919686|NCT02419742|83151914|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
46919687|NCT02419742|83151915|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
46919688|NCT02409290|83151925|FG000|Overall Study|Protocol Violation|3|||
46919689|NCT02409290|83151926|FG001|Overall Study|Protocol Violation|6|||
46919690|NCT02409290|83151927|FG002|Overall Study|Protocol Violation|9|||
46919691|NCT02409290|83151928|FG003|Overall Study|Protocol Violation|4|||
46919692|NCT02409290|83151925|FG000|Overall Study|No positive culture/no baseline sample|3|||
46919693|NCT02409290|83151926|FG001|Overall Study|No positive culture/no baseline sample|9|||
46919694|NCT02409290|83151927|FG002|Overall Study|No positive culture/no baseline sample|6|||
46919695|NCT02409290|83151928|FG003|Overall Study|No positive culture/no baseline sample|5|||
46919696|NCT02409290|83151925|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
46919697|NCT02409290|83151926|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
46919698|NCT02409290|83151927|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
46919699|NCT02409290|83151928|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
46919700|NCT02898077|83151940|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
47041898|NCT01890967|83298468|FG004|Overall Study|Protocol Violation|4|||
47041899|NCT01890967|83298469|FG005|Overall Study|Protocol Violation|1|||
47041900|NCT01890967|83298464|FG000|Overall Study|Sponsor Decision|2|||
46632779|NCT01813422|82806000|FG000|Overall Study|Death|2|||
46632780|NCT01813422|82806001|FG001|Overall Study|Death|3|||
46632781|NCT01813422|82806000|FG000|Overall Study|Sponsor Decision|2|||
46632782|NCT01813422|82806001|FG001|Overall Study|Sponsor Decision|1|||
46632783|NCT01813422|82806000|FG000|Overall Study|Lost to Follow-up|2|||
46919701|NCT02898077|83151941|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
46919702|NCT02898077|83151940|FG000|Overall Study|Lost to Follow-up|4|||
46919703|NCT02898077|83151941|FG001|Overall Study|Lost to Follow-up|3|||
46919704|NCT02898077|83151940|FG000|Overall Study|Physician Decision|0|||
46919705|NCT02898077|83151941|FG001|Overall Study|Physician Decision|2|||
46919706|NCT02898077|83151940|FG000|Overall Study|Sponsor Decision|32|||
46919707|NCT02898077|83151941|FG001|Overall Study|Sponsor Decision|13|||
46919708|NCT02898077|83151940|FG000|Overall Study|Withdrawal by Subject|6|||
46919709|NCT02898077|83151941|FG001|Overall Study|Withdrawal by Subject|3|||
46919710|NCT02898077|83151940|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
46919711|NCT02898077|83151941|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
46919712|NCT02898077|83151940|FG000|Overall Study|Ended extension period|3|||
46919713|NCT02898077|83151941|FG001|Overall Study|Ended extension period|0|||
46919714|NCT03097133|83151949|FG000|Overall Study|Lost to Follow-up|3|||
46919715|NCT03097133|83151950|FG001|Overall Study|Lost to Follow-up|2|||
46919716|NCT03097133|83151949|FG000|Overall Study|Withdrawal by Subject|2|||
46919717|NCT03097133|83151950|FG001|Overall Study|Withdrawal by Subject|5|||
46919718|NCT03097133|83151949|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
46919719|NCT03097133|83151950|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
46919720|NCT03097133|83151949|FG000|Overall Study|Other|3|||
46919721|NCT03097133|83151950|FG001|Overall Study|Other|2|||
46919722|NCT03097133|83151949|FG000|Overall Study|Adverse Event|1|||
46919723|NCT03097133|83151950|FG001|Overall Study|Adverse Event|0|||
46919724|NCT03889639|83151964|FG000|Overall Study|Withdrawal by Subject|0|||
46919725|NCT03889639|83151965|FG001|Overall Study|Withdrawal by Subject|0|||
46919726|NCT03889639|83151966|FG002|Overall Study|Withdrawal by Subject|0|||
46919727|NCT03889639|83151967|FG003|Overall Study|Withdrawal by Subject|0|||
46919728|NCT03889639|83151968|FG004|Overall Study|Withdrawal by Subject|0|||
46919729|NCT03889639|83151969|FG005|Overall Study|Withdrawal by Subject|0|||
46919730|NCT03889639|83151970|FG006|Overall Study|Withdrawal by Subject|0|||
46919731|NCT03889639|83151971|FG007|Overall Study|Withdrawal by Subject|1|||
46919732|NCT03265145|83151994|FG000|Overall Study|Protocol Violation|2|||
46919733|NCT03265145|83151995|FG001|Overall Study|Protocol Violation|0|||
46919734|NCT03265145|83151994|FG000|Overall Study|Adverse Event|1|||
46919735|NCT03265145|83151995|FG001|Overall Study|Adverse Event|0|||
46919736|NCT03265145|83151994|FG000|Overall Study|Withdrawal by Subject|23|||
46919737|NCT03265145|83151995|FG001|Overall Study|Withdrawal by Subject|19|||
46919738|NCT03265145|83151994|FG000|Overall Study|Death|12|||
46919739|NCT03265145|83151995|FG001|Overall Study|Death|12|||
46919740|NCT03265145|83151994|FG000|Overall Study|Lost to Follow-up|13|||
46919741|NCT03265145|83151995|FG001|Overall Study|Lost to Follow-up|9|||
46919742|NCT03265145|83151994|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
46919743|NCT03265145|83151995|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
47041901|NCT01890967|83298465|FG001|Overall Study|Sponsor Decision|0|||
46632784|NCT01813422|82806001|FG001|Overall Study|Lost to Follow-up|4|||
46919744|NCT03265145|83151994|FG000|Overall Study|Switched back to previous medication|1|||
46919745|NCT03265145|83151995|FG001|Overall Study|Switched back to previous medication|0|||
46919746|NCT03265145|83151994|FG000|Overall Study|Did not want to take medication|1|||
46919747|NCT03265145|83151995|FG001|Overall Study|Did not want to take medication|0|||
46919748|NCT03265145|83151994|FG000|Overall Study|Subject could not afford medication|0|||
46919749|NCT03265145|83151995|FG001|Overall Study|Subject could not afford medication|1|||
46919750|NCT03265145|83151994|FG000|Overall Study|Site closed|2|||
46919751|NCT03265145|83151995|FG001|Overall Study|Site closed|3|||
46919752|NCT03265145|83151994|FG000|Overall Study|Incorrectly randomized|16|||
46919753|NCT03265145|83151995|FG001|Overall Study|Incorrectly randomized|6|||
46919754|NCT03265145|83151994|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
46919755|NCT03265145|83151995|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
46919756|NCT03265145|83151994|FG000|Overall Study|Physician Decision|0|||
46919757|NCT03265145|83151995|FG001|Overall Study|Physician Decision|3|||
46919758|NCT03265145|83151994|FG000|Overall Study|Subject transferred to another facility|0|||
46919759|NCT03265145|83151995|FG001|Overall Study|Subject transferred to another facility|1|||
46919760|NCT05674344|83152006|FG000|Overall Study|Screen Fail|21|||
46919761|NCT05674344|83152006|FG000|Overall Study|Incomplete study procedures|3|||
46919762|NCT04424641|83152072|FG000|Overall Study|Death|1|||
46919763|NCT04424641|83152073|FG001|Overall Study|Death|2|||
46919764|NCT04424641|83152074|FG002|Overall Study|Death|3|||
46919765|NCT04424641|83152075|FG003|Overall Study|Death|0|||
46919766|NCT04424641|83152076|FG004|Overall Study|Death|3|||
46919767|NCT04424641|83152077|FG005|Overall Study|Death|0|||
46919768|NCT04424641|83152078|FG006|Overall Study|Death|1|||
46919769|NCT04424641|83152079|FG007|Overall Study|Death|2|||
46919770|NCT04424641|83152072|FG000|Overall Study|Sponsor decision|0|||
46919771|NCT04424641|83152073|FG001|Overall Study|Sponsor decision|2|||
46919772|NCT04424641|83152074|FG002|Overall Study|Sponsor decision|3|||
46919773|NCT04424641|83152075|FG003|Overall Study|Sponsor decision|7|||
47041902|NCT01890967|83298466|FG002|Overall Study|Sponsor Decision|1|||
47041903|NCT01890967|83298467|FG003|Overall Study|Sponsor Decision|3|||
47041904|NCT01890967|83298468|FG004|Overall Study|Sponsor Decision|2|||
47041905|NCT01890967|83298469|FG005|Overall Study|Sponsor Decision|3|||
47041906|NCT01890967|83298464|FG000|Overall Study|Withdrawal by Subject|3|||
47041907|NCT01890967|83298465|FG001|Overall Study|Withdrawal by Subject|4|||
47041908|NCT01890967|83298466|FG002|Overall Study|Withdrawal by Subject|2|||
47041909|NCT01890967|83298467|FG003|Overall Study|Withdrawal by Subject|3|||
47041910|NCT01890967|83298468|FG004|Overall Study|Withdrawal by Subject|3|||
47041911|NCT01890967|83298469|FG005|Overall Study|Withdrawal by Subject|1|||
47041912|NCT01400919|83298488|FG000|Overall Study|Withdrawal by Subject|4|||
47041913|NCT01400919|83298488|FG000|Overall Study|Lost to Follow-up|2|||
47041914|NCT01400919|83298488|FG000|Overall Study|Missed visit|2|||
47041915|NCT01864291|83298492|FG000|Overall Study|need for revision surgery|2|||
47041916|NCT01400841|83298496|FG000|Initial Study Phase (6 Months)|Death|1|||
47041917|NCT01400841|83298496|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
47041918|NCT01863667|83298502|FG000|Overall Study|Adverse Event|1|||
47041919|NCT01863667|83298503|FG001|Overall Study|Adverse Event|0|||
47041920|NCT01863667|83298502|FG000|Overall Study|Study terminated by Sponsor|30|||
47041921|NCT01863667|83298503|FG001|Overall Study|Study terminated by Sponsor|30|||
47041922|NCT01863667|83298502|FG000|Overall Study|Withdrawal by Subject|2|||
47041923|NCT01863667|83298503|FG001|Overall Study|Withdrawal by Subject|2|||
47041924|NCT01614769|83298509|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
47041925|NCT01614769|83298510|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
47041926|NCT01614769|83298511|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
47041927|NCT01614769|83298512|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
47041928|NCT01614769|83298513|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
47041929|NCT01614769|83298514|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
47041930|NCT01614769|83298509|FG000|Period 1|Protocol Violation|0|||
47041931|NCT01614769|83298510|FG001|Period 1|Protocol Violation|0|||
47041932|NCT01614769|83298511|FG002|Period 1|Protocol Violation|0|||
47041933|NCT01614769|83298512|FG003|Period 1|Protocol Violation|1|||
47041934|NCT01614769|83298513|FG004|Period 1|Protocol Violation|0|||
47041935|NCT01614769|83298514|FG005|Period 1|Protocol Violation|0|||
46720348|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
46919774|NCT04424641|83152076|FG004|Overall Study|Sponsor decision|2|||
46919775|NCT04424641|83152077|FG005|Overall Study|Sponsor decision|2|||
47041936|NCT01614769|83298509|FG000|Period 1|Withdrawal by Subject|1|||
47041937|NCT01614769|83298510|FG001|Period 1|Withdrawal by Subject|0|||
46720349|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
47041938|NCT01614769|83298511|FG002|Period 1|Withdrawal by Subject|0|||
46919776|NCT04424641|83152078|FG006|Overall Study|Sponsor decision|3|||
46919777|NCT04424641|83152079|FG007|Overall Study|Sponsor decision|4|||
46919778|NCT04424641|83152072|FG000|Overall Study|Withdrawal by Subject|0|||
46919779|NCT04424641|83152073|FG001|Overall Study|Withdrawal by Subject|0|||
47041939|NCT01614769|83298512|FG003|Period 1|Withdrawal by Subject|0|||
47041940|NCT01614769|83298513|FG004|Period 1|Withdrawal by Subject|0|||
46919780|NCT04424641|83152074|FG002|Overall Study|Withdrawal by Subject|0|||
46919781|NCT04424641|83152075|FG003|Overall Study|Withdrawal by Subject|0|||
46919782|NCT04424641|83152076|FG004|Overall Study|Withdrawal by Subject|1|||
46919783|NCT04424641|83152077|FG005|Overall Study|Withdrawal by Subject|0|||
46919784|NCT04424641|83152078|FG006|Overall Study|Withdrawal by Subject|0|||
46919785|NCT04424641|83152079|FG007|Overall Study|Withdrawal by Subject|0|||
46919786|NCT04424641|83152072|FG000|Overall Study|Other|0|||
46919787|NCT04424641|83152073|FG001|Overall Study|Other|0|||
46919788|NCT04424641|83152074|FG002|Overall Study|Other|1|||
46919789|NCT04424641|83152075|FG003|Overall Study|Other|0|||
46919790|NCT04424641|83152076|FG004|Overall Study|Other|0|||
46919791|NCT04424641|83152077|FG005|Overall Study|Other|0|||
46919792|NCT04424641|83152078|FG006|Overall Study|Other|0|||
47041941|NCT01614769|83298514|FG005|Period 1|Withdrawal by Subject|0|||
47041942|NCT01614769|83298509|FG000|Period 3|Withdrawal by Subject|0|||
47041943|NCT01614769|83298510|FG001|Period 3|Withdrawal by Subject|0|||
47041944|NCT01614769|83298511|FG002|Period 3|Withdrawal by Subject|1|||
47041945|NCT01614769|83298512|FG003|Period 3|Withdrawal by Subject|0|||
47041946|NCT01614769|83298513|FG004|Period 3|Withdrawal by Subject|0|||
47041947|NCT01614769|83298514|FG005|Period 3|Withdrawal by Subject|0|||
47041948|NCT01614457|83298524|FG000|Overall Study|Non-Compliance|1|||
47041949|NCT01614457|83298525|FG001|Overall Study|Non-Compliance|0|||
47041950|NCT01614457|83298524|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
47041951|NCT01614457|83298525|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
47041952|NCT01863433|83298531|FG000|Overall Study|Protocol Violation|1|||
46919793|NCT04424641|83152079|FG007|Overall Study|Other|0|||
46919794|NCT04276090|83152108|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
46919795|NCT04276090|83152109|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
46919796|NCT04105842|83152119|FG000|Overall Study|Withdrawal by Subject|2|||
46919797|NCT04088734|83152126|FG000|Overall Study|Other, Not Specified|5|||
46919798|NCT03868787|83152149|FG000|Overall Study|Withdrawal by Subject|2|||
46919799|NCT03868787|83152150|FG001|Overall Study|Withdrawal by Subject|1|||
46919800|NCT02694978|83152264|FG000|Overall Study|Adverse Event|10|||
46919801|NCT02694978|83152265|FG001|Overall Study|Adverse Event|9|||
46919802|NCT02694978|83152264|FG000|Overall Study|Withdrawal by Subject|22|||
46919803|NCT02694978|83152265|FG001|Overall Study|Withdrawal by Subject|19|||
46919804|NCT02694978|83152264|FG000|Overall Study|Lost to Follow-up|14|||
46919805|NCT02694978|83152265|FG001|Overall Study|Lost to Follow-up|17|||
46919806|NCT02694978|83152264|FG000|Overall Study|Death|4|||
46919807|NCT02694978|83152265|FG001|Overall Study|Death|1|||
47041953|NCT01862029|83298535|FG000|Overall Study|Physician Decision|1|||
47041954|NCT01835431|83298542|FG000|Overall Study|Adverse Event|1|||
46632785|NCT01786668|82806011|FG000|Overall Study|Adverse Event|0|||
46919808|NCT02694978|83152264|FG000|Overall Study|Other-Decision of Participant|6|||
46919809|NCT02694978|83152265|FG001|Overall Study|Other-Decision of Participant|1|||
46919810|NCT02694978|83152264|FG000|Overall Study|Other-Investigator's decision|1|||
46919811|NCT02694978|83152265|FG001|Overall Study|Other-Investigator's decision|0|||
46919812|NCT02694978|83152264|FG000|Overall Study|Other-Unable to be reached|0|||
46919813|NCT02694978|83152265|FG001|Overall Study|Other-Unable to be reached|1|||
46919814|NCT02694978|83152264|FG000|Overall Study|Other-Protocol noncompliant|2|||
46919815|NCT02694978|83152265|FG001|Overall Study|Other-Protocol noncompliant|1|||
46919816|NCT02694978|83152264|FG000|Overall Study|Other-Personal reasons|3|||
46919817|NCT02694978|83152265|FG001|Overall Study|Other-Personal reasons|3|||
46919818|NCT02694978|83152264|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
46919819|NCT02694978|83152265|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
46919820|NCT02563002|83152273|FG000|Overall Study|Death|62|||
46919821|NCT02563002|83152274|FG001|Overall Study|Death|75|||
47041955|NCT01835431|83298543|FG001|Overall Study|Adverse Event|0|||
47041956|NCT01835431|83298542|FG000|Overall Study|other|0|||
47041957|NCT01835431|83298543|FG001|Overall Study|other|2|||
47041958|NCT01835431|83298542|FG000|Overall Study|Withdrawal by Subject|6|||
46632786|NCT01786668|82806012|FG001|Overall Study|Adverse Event|1|||
46919822|NCT02563002|83152273|FG000|Overall Study|Lost to Follow-up|1|||
46919823|NCT02563002|83152274|FG001|Overall Study|Lost to Follow-up|0|||
46919824|NCT02563002|83152273|FG000|Overall Study|Withdrawal by Subject|0|||
47041959|NCT01835431|83298543|FG001|Overall Study|Withdrawal by Subject|10|||
47041960|NCT01835431|83298542|FG000|Overall Study|Protocol Violation|1|||
47041961|NCT01835431|83298543|FG001|Overall Study|Protocol Violation|0|||
47041962|NCT01880593|83298551|FG000|Overall Study|Adverse Event|1|||
47041963|NCT01880593|83298552|FG001|Overall Study|Adverse Event|0|||
46632787|NCT01786668|82806013|FG002|Overall Study|Adverse Event|1|||
46632788|NCT01786668|82806014|FG003|Overall Study|Adverse Event|2|||
46919825|NCT02563002|83152274|FG001|Overall Study|Withdrawal by Subject|9|||
46919826|NCT02563002|83152273|FG000|Overall Study|Ongoing|90|||
46919827|NCT02563002|83152274|FG001|Overall Study|Ongoing|70|||
46919828|NCT02454933|83152285|FG000|Overall Study|Progressive disease|7|||
46919829|NCT02454933|83152286|FG001|Overall Study|Progressive disease|5|||
47041964|NCT01880593|83298551|FG000|Overall Study|Lack of Efficacy|1|||
46919830|NCT02454933|83152285|FG000|Overall Study|Adverse Event|1|||
46919831|NCT02454933|83152286|FG001|Overall Study|Adverse Event|1|||
46919832|NCT02454933|83152285|FG000|Overall Study|Withdrawal by Subject|0|||
46919833|NCT02454933|83152286|FG001|Overall Study|Withdrawal by Subject|2|||
46919834|NCT02430480|83152291|FG000|Overall Study|Death|1|||
46919835|NCT02430480|83152291|FG000|Overall Study|Anesthesia concerns|1|||
46919836|NCT02430480|83152291|FG000|Overall Study|Progressed on treatment|1|||
46919837|NCT01205048|83152305|FG000|Overall Study|Withdrawal by Subject|14|||
46919838|NCT01205048|83152305|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
46919839|NCT01205048|83152305|FG000|Overall Study|Lost to Follow-up|4|||
46919840|NCT01205048|83152305|FG000|Overall Study|Other|2|||
46919841|NCT01052779|83152313|FG000|Overall Study|Adverse Event|1|||
46919842|NCT01052779|83152314|FG001|Overall Study|Adverse Event|4|||
46919843|NCT01052779|83152313|FG000|Overall Study|Withdrawal by Subject|1|||
46919844|NCT01052779|83152314|FG001|Overall Study|Withdrawal by Subject|2|||
46919845|NCT01052779|83152313|FG000|Overall Study|Other-Protocol Violation|1|||
46919846|NCT01052779|83152314|FG001|Overall Study|Other-Protocol Violation|1|||
46919847|NCT01052779|83152313|FG000|Overall Study|Other-Surgery|0|||
46919848|NCT01052779|83152314|FG001|Overall Study|Other-Surgery|2|||
46919849|NCT01052779|83152313|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
47041965|NCT01880593|83298552|FG001|Overall Study|Lack of Efficacy|5|||
47041966|NCT01880593|83298551|FG000|Overall Study|Withdrawal by Subject|6|||
47041967|NCT01880593|83298552|FG001|Overall Study|Withdrawal by Subject|1|||
47041968|NCT01400451|83298561|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
47041969|NCT01400451|83298562|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
47041970|NCT01400451|83298563|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
47041971|NCT01400451|83298561|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
46919850|NCT01052779|83152314|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
46919851|NCT00591370|83152324|FG000|Overall Study|Not Treated|2|||
46919852|NCT03064763|83152328|FG000|Overall Study|Lost to Follow-up|1|||
46919853|NCT03064763|83152328|FG000|Overall Study|Death|8|||
46919854|NCT02782676|83152332|FG000|Overall Study|Lost to Follow-up|0|||
46919855|NCT02782676|83152333|FG001|Overall Study|Lost to Follow-up|1|||
46919856|NCT02471339|83152341|FG000|Overall Study|Did not provide follow-up data|2|||
46919857|NCT02471339|83152342|FG001|Overall Study|Did not provide follow-up data|0|||
46919858|NCT00107978|83152350|FG000|Overall Study|Adverse Event|1|||
46919859|NCT00107978|83152351|FG001|Overall Study|Adverse Event|5|||
46919860|NCT00107978|83152350|FG000|Overall Study|Death|3|||
46919861|NCT00107978|83152351|FG001|Overall Study|Death|3|||
46919862|NCT00107978|83152350|FG000|Overall Study|Lost to Follow-up|20|||
46919863|NCT00107978|83152351|FG001|Overall Study|Lost to Follow-up|28|||
46919864|NCT00107978|83152350|FG000|Overall Study|Withdrawal by Subject|4|||
46919865|NCT00107978|83152351|FG001|Overall Study|Withdrawal by Subject|9|||
46919866|NCT00107978|83152350|FG000|Overall Study|Protocol Violation|0|||
46919867|NCT00107978|83152351|FG001|Overall Study|Protocol Violation|1|||
46919868|NCT00107978|83152350|FG000|Overall Study|Other|5|||
46919869|NCT00107978|83152351|FG001|Overall Study|Other|4|||
46919870|NCT02781818|83152360|FG000|Overall Study|Lost to Follow-up|4|||
46919871|NCT02781818|83152361|FG001|Overall Study|Lost to Follow-up|2|||
46919872|NCT02781818|83152362|FG002|Overall Study|Lost to Follow-up|1|||
46919873|NCT02927873|83152376|FG000|Overall Study|Lost to Follow-up|0|||
46919874|NCT02927873|83152377|FG001|Overall Study|Lost to Follow-up|1|||
46919875|NCT02927873|83152378|FG002|Overall Study|Lost to Follow-up|0|||
46919876|NCT02927873|83152379|FG003|Overall Study|Lost to Follow-up|0|||
46919877|NCT02927873|83152380|FG004|Overall Study|Lost to Follow-up|0|||
46919878|NCT02927873|83152381|FG005|Overall Study|Lost to Follow-up|0|||
46919879|NCT02927873|83152376|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46919880|NCT02927873|83152377|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
46919881|NCT02927873|83152378|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46919882|NCT02927873|83152379|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46919883|NCT02927873|83152380|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46919884|NCT02927873|83152381|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
46919885|NCT02927873|83152376|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
47041972|NCT01400451|83298562|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
46919886|NCT02927873|83152377|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46919887|NCT02927873|83152378|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46919888|NCT02927873|83152379|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
47041973|NCT01400451|83298563|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
47041974|NCT01400451|83298561|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
46919889|NCT02927873|83152380|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46919890|NCT02927873|83152381|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46919891|NCT02927873|83152376|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
46919892|NCT02927873|83152377|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
46919893|NCT02927873|83152378|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
46919894|NCT02927873|83152379|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
46919895|NCT02927873|83152380|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
46919896|NCT02927873|83152381|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
46919897|NCT02927873|83152376|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
46919898|NCT02927873|83152377|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
46919899|NCT02927873|83152378|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
46919900|NCT02927873|83152379|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
46919901|NCT02927873|83152380|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
46919902|NCT02927873|83152381|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
46919903|NCT02927873|83152376|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
46919904|NCT02927873|83152377|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
46919905|NCT02927873|83152378|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
46919906|NCT02927873|83152379|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
46919907|NCT02927873|83152380|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
46919908|NCT02927873|83152381|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
46919909|NCT01220999|83152400|FG000|Overall Study|Progressive disease|0|||
46919910|NCT01220999|83152401|FG001|Overall Study|Progressive disease|0|||
46919911|NCT01220999|83152402|FG002|Overall Study|Progressive disease|1|||
46919912|NCT01220999|83152403|FG003|Overall Study|Progressive disease|0|||
46919913|NCT01220999|83152404|FG004|Overall Study|Progressive disease|0|||
46919914|NCT00142415|83152422|FG000|Overall Study|Physician Decision|0|||
46919915|NCT00142415|83152423|FG001|Overall Study|Physician Decision|0|||
46919916|NCT00142415|83152424|FG002|Overall Study|Physician Decision|0|||
46919917|NCT00142415|83152425|FG003|Overall Study|Physician Decision|0|||
46919918|NCT00142415|83152426|FG004|Overall Study|Physician Decision|1|||
46919919|NCT00142415|83152427|FG005|Overall Study|Physician Decision|2|||
46919920|NCT02781584|83152469|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
46919921|NCT02781584|83152470|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
46919922|NCT02781584|83152471|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
46919923|NCT02781584|83152472|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
46919924|NCT02781584|83152473|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
46919925|NCT02781584|83152474|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
46919926|NCT02781584|83152475|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
46919927|NCT02781584|83152476|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
46919928|NCT02781584|83152477|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
46919929|NCT02781584|83152478|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
46919930|NCT02781584|83152479|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
46919931|NCT02781584|83152480|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
46919932|NCT02781584|83152481|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
46919933|NCT02781584|83152469|FG000|Pre-treatment Phase|Adverse Event|0|||
46919934|NCT02781584|83152470|FG001|Pre-treatment Phase|Adverse Event|0|||
46919935|NCT02781584|83152471|FG002|Pre-treatment Phase|Adverse Event|0|||
46919936|NCT02781584|83152472|FG003|Pre-treatment Phase|Adverse Event|0|||
46919937|NCT02781584|83152473|FG004|Pre-treatment Phase|Adverse Event|0|||
46919938|NCT02781584|83152474|FG005|Pre-treatment Phase|Adverse Event|0|||
46919939|NCT02781584|83152475|FG006|Pre-treatment Phase|Adverse Event|0|||
46919940|NCT02781584|83152476|FG007|Pre-treatment Phase|Adverse Event|0|||
46919941|NCT02781584|83152477|FG008|Pre-treatment Phase|Adverse Event|0|||
46919942|NCT02781584|83152478|FG009|Pre-treatment Phase|Adverse Event|0|||
46919943|NCT02781584|83152479|FG010|Pre-treatment Phase|Adverse Event|0|||
46919944|NCT02781584|83152480|FG011|Pre-treatment Phase|Adverse Event|1|||
46919945|NCT02781584|83152481|FG012|Pre-treatment Phase|Adverse Event|0|||
46919946|NCT02781584|83152469|FG000|Treatment Phase|Withdrew Consent|0|||
46919947|NCT02781584|83152470|FG001|Treatment Phase|Withdrew Consent|0|||
46919948|NCT02781584|83152471|FG002|Treatment Phase|Withdrew Consent|0|||
46919949|NCT02781584|83152472|FG003|Treatment Phase|Withdrew Consent|0|||
46919950|NCT02781584|83152473|FG004|Treatment Phase|Withdrew Consent|0|||
46919951|NCT02781584|83152474|FG005|Treatment Phase|Withdrew Consent|1|||
46919952|NCT02781584|83152475|FG006|Treatment Phase|Withdrew Consent|0|||
46919953|NCT02781584|83152476|FG007|Treatment Phase|Withdrew Consent|0|||
46919954|NCT02781584|83152477|FG008|Treatment Phase|Withdrew Consent|0|||
47041975|NCT01400451|83298562|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
47041976|NCT01400451|83298563|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
47041977|NCT01400451|83298561|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
47041978|NCT01400451|83298562|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
47041979|NCT01400451|83298563|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
46919955|NCT02781584|83152478|FG009|Treatment Phase|Withdrew Consent|0|||
47041980|NCT01400451|83298561|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
46919956|NCT02781584|83152479|FG010|Treatment Phase|Withdrew Consent|1|||
46919957|NCT02781584|83152480|FG011|Treatment Phase|Withdrew Consent|2|||
46919958|NCT02781584|83152481|FG012|Treatment Phase|Withdrew Consent|0|||
46919959|NCT02781584|83152469|FG000|Treatment Phase|Adverse Event|0|||
46919960|NCT02781584|83152470|FG001|Treatment Phase|Adverse Event|0|||
46919961|NCT02781584|83152471|FG002|Treatment Phase|Adverse Event|0|||
46919962|NCT02781584|83152472|FG003|Treatment Phase|Adverse Event|0|||
46919963|NCT02781584|83152473|FG004|Treatment Phase|Adverse Event|0|||
46919964|NCT02781584|83152474|FG005|Treatment Phase|Adverse Event|0|||
46919965|NCT02781584|83152475|FG006|Treatment Phase|Adverse Event|0|||
46919966|NCT02781584|83152476|FG007|Treatment Phase|Adverse Event|1|||
46919967|NCT02781584|83152477|FG008|Treatment Phase|Adverse Event|0|||
46919968|NCT02781584|83152478|FG009|Treatment Phase|Adverse Event|0|||
46919969|NCT02781584|83152479|FG010|Treatment Phase|Adverse Event|0|||
46919970|NCT02781584|83152480|FG011|Treatment Phase|Adverse Event|0|||
46919971|NCT02781584|83152481|FG012|Treatment Phase|Adverse Event|0|||
46919972|NCT02776670|83152511|FG000|Overall Study|Adverse Event|0|||
46919973|NCT02776670|83152512|FG001|Overall Study|Adverse Event|2|||
46919974|NCT02776670|83152511|FG000|Overall Study|Protocol Violation|0|||
46919975|NCT02776670|83152512|FG001|Overall Study|Protocol Violation|2|||
46919976|NCT02776670|83152511|FG000|Overall Study|Withdrawal by Subject|0|||
46919977|NCT02776670|83152512|FG001|Overall Study|Withdrawal by Subject|1|||
46919978|NCT02776670|83152511|FG000|Overall Study|Other - Reason not given|0|||
46919979|NCT02776670|83152512|FG001|Overall Study|Other - Reason not given|1|||
47041981|NCT01400451|83298562|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
47041982|NCT01400451|83298563|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
47041983|NCT01400139|83298576|FG000|HYD Core Study|Adverse Event|210|||
47041984|NCT01400139|83298576|FG000|HYD Core Study|Lack of Efficacy|59|||
47041985|NCT01400139|83298576|FG000|HYD Core Study|Withdrawal by Subject|114|||
47041986|NCT01400139|83298576|FG000|HYD Core Study|Lost to Follow-up|39|||
47041987|NCT01400139|83298576|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
47041988|NCT01400139|83298576|FG000|HYD Core Study|Administrative|56|||
46919980|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
46919981|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
46919982|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
46919983|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46919984|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46919985|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46919986|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46919987|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46919988|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46919989|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
46919990|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
46919991|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
46919992|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46919993|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46919994|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46919995|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46919996|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46919997|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46919998|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
46919999|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
46920000|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
46920001|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46920002|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
47041989|NCT01400139|83298576|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
47041990|NCT01400139|83298576|FG000|HYD Extension Period|Adverse Event|8|||
46632789|NCT01786668|82806011|FG000|Overall Study|Withdrawal by Subject|0|||
46632790|NCT01786668|82806012|FG001|Overall Study|Withdrawal by Subject|0|||
46632791|NCT01786668|82806013|FG002|Overall Study|Withdrawal by Subject|3|||
46632792|NCT01786668|82806014|FG003|Overall Study|Withdrawal by Subject|1|||
46632793|NCT01786668|82806011|FG000|Overall Study|Pregnancy|0|||
46632794|NCT01786668|82806012|FG001|Overall Study|Pregnancy|0|||
46632795|NCT01786668|82806013|FG002|Overall Study|Pregnancy|0|||
46920003|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46920004|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46920005|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46920006|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46920007|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
47041991|NCT01400139|83298576|FG000|HYD Extension Period|Withdrawal by Subject|5|||
47041992|NCT01400139|83298576|FG000|HYD Extension Period|Administrative|10|||
46632796|NCT01786668|82806014|FG003|Overall Study|Pregnancy|1|||
46920008|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46632797|NCT01786668|82806011|FG000|Overall Study|Lost to Follow-up|1|||
46632798|NCT01786668|82806012|FG001|Overall Study|Lost to Follow-up|0|||
46632799|NCT01786668|82806013|FG002|Overall Study|Lost to Follow-up|1|||
46632800|NCT01786668|82806014|FG003|Overall Study|Lost to Follow-up|0|||
46632801|NCT01786512|82806035|FG000|Overall Study|Lost to Follow-up|0|||
46632802|NCT01786512|82806036|FG001|Overall Study|Lost to Follow-up|0|||
46632803|NCT01786512|82806037|FG002|Overall Study|Lost to Follow-up|0|||
46632804|NCT01786512|82806038|FG003|Overall Study|Lost to Follow-up|0|||
46632805|NCT01786512|82806039|FG004|Overall Study|Lost to Follow-up|0|||
46632806|NCT01786512|82806040|FG005|Overall Study|Lost to Follow-up|0|||
46632807|NCT01786512|82806041|FG006|Overall Study|Lost to Follow-up|0|||
46632808|NCT01786512|82806042|FG007|Overall Study|Lost to Follow-up|0|||
46632809|NCT01786512|82806043|FG008|Overall Study|Lost to Follow-up|0|||
46632810|NCT01786512|82806044|FG009|Overall Study|Lost to Follow-up|1|||
46632811|NCT01786512|82806045|FG010|Overall Study|Lost to Follow-up|0|||
46632812|NCT01786512|82806035|FG000|Overall Study|Decision by sponsor|0|||
46632813|NCT01786512|82806036|FG001|Overall Study|Decision by sponsor|0|||
46632814|NCT01786512|82806037|FG002|Overall Study|Decision by sponsor|0|||
46632815|NCT01786512|82806038|FG003|Overall Study|Decision by sponsor|0|||
46632816|NCT01786512|82806039|FG004|Overall Study|Decision by sponsor|0|||
46632817|NCT01786512|82806040|FG005|Overall Study|Decision by sponsor|0|||
46632818|NCT01786512|82806041|FG006|Overall Study|Decision by sponsor|0|||
46632819|NCT01786512|82806042|FG007|Overall Study|Decision by sponsor|0|||
46632820|NCT01786512|82806043|FG008|Overall Study|Decision by sponsor|0|||
46632821|NCT01786512|82806044|FG009|Overall Study|Decision by sponsor|0|||
46632822|NCT01786512|82806045|FG010|Overall Study|Decision by sponsor|2|||
46632823|NCT01786512|82806035|FG000|Overall Study|Withdrawal by Subject|0|||
46632824|NCT01786512|82806036|FG001|Overall Study|Withdrawal by Subject|1|||
46632825|NCT01786512|82806037|FG002|Overall Study|Withdrawal by Subject|0|||
46632826|NCT01786512|82806038|FG003|Overall Study|Withdrawal by Subject|0|||
46632827|NCT01786512|82806039|FG004|Overall Study|Withdrawal by Subject|0|||
46632828|NCT01786512|82806040|FG005|Overall Study|Withdrawal by Subject|0|||
46920009|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
46920010|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46920011|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46920012|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46920013|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46920014|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46920015|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46920016|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
46920017|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
46920018|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
46920019|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46920020|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46920021|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46920022|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46920023|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46920024|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46920025|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
47041993|NCT01399905|83298584|FG000|Overall Study|Withdrawal by Subject|1|||
47041994|NCT01399905|83298585|FG001|Overall Study|Withdrawal by Subject|1|||
47041995|NCT01725308|83298599|FG000|Treatment Period I|Did Not Receive Drug|1|||
47041996|NCT01725308|83298600|FG001|Treatment Period I|Did Not Receive Drug|0|||
47041997|NCT01725308|83298601|FG002|Treatment Period I|Did Not Receive Drug|0|||
47041998|NCT01725308|83298599|FG000|Treatment Period I|Adverse Event|5|||
47041999|NCT01725308|83298600|FG001|Treatment Period I|Adverse Event|4|||
46920026|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46920027|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46920028|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46920029|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
47042000|NCT01725308|83298601|FG002|Treatment Period I|Adverse Event|21|||
47042001|NCT01725308|83298599|FG000|Treatment Period I|Insufficient Response|7|||
47042002|NCT01725308|83298600|FG001|Treatment Period I|Insufficient Response|0|||
47042003|NCT01725308|83298601|FG002|Treatment Period I|Insufficient Response|5|||
47042004|NCT01725308|83298599|FG000|Treatment Period I|Worsening of the Target Disease|8|||
46632829|NCT01786512|82806041|FG006|Overall Study|Withdrawal by Subject|1|||
46632830|NCT01786512|82806042|FG007|Overall Study|Withdrawal by Subject|0|||
46632831|NCT01786512|82806043|FG008|Overall Study|Withdrawal by Subject|0|||
46632832|NCT01786512|82806044|FG009|Overall Study|Withdrawal by Subject|3|||
46632833|NCT01786512|82806045|FG010|Overall Study|Withdrawal by Subject|7|||
46632834|NCT01786512|82806035|FG000|Overall Study|Death|0|||
46632835|NCT01786512|82806036|FG001|Overall Study|Death|0|||
46632836|NCT01786512|82806037|FG002|Overall Study|Death|0|||
46632837|NCT01786512|82806038|FG003|Overall Study|Death|0|||
46632838|NCT01786512|82806039|FG004|Overall Study|Death|0|||
47042005|NCT01725308|83298600|FG001|Treatment Period I|Worsening of the Target Disease|0|||
47042006|NCT01725308|83298601|FG002|Treatment Period I|Worsening of the Target Disease|2|||
47042007|NCT01725308|83298599|FG000|Treatment Period I|Changes in the Episodes|3|||
47042008|NCT01725308|83298600|FG001|Treatment Period I|Changes in the Episodes|0|||
47042009|NCT01725308|83298601|FG002|Treatment Period I|Changes in the Episodes|2|||
47042010|NCT01725308|83298599|FG000|Treatment Period I|Withdrawal of Consent|12|||
47042011|NCT01725308|83298600|FG001|Treatment Period I|Withdrawal of Consent|7|||
47042012|NCT01725308|83298601|FG002|Treatment Period I|Withdrawal of Consent|5|||
47042013|NCT01725308|83298599|FG000|Treatment Period I|Lost to Follow-up|3|||
47042014|NCT01725308|83298600|FG001|Treatment Period I|Lost to Follow-up|2|||
47042015|NCT01725308|83298601|FG002|Treatment Period I|Lost to Follow-up|2|||
47042016|NCT01725308|83298599|FG000|Treatment Period I|Protocol Deviations|3|||
47042017|NCT01725308|83298600|FG001|Treatment Period I|Protocol Deviations|1|||
47042018|NCT01725308|83298601|FG002|Treatment Period I|Protocol Deviations|1|||
47042019|NCT01725308|83298599|FG000|Treatment Period I|Miscellaneous|2|||
47042020|NCT01725308|83298600|FG001|Treatment Period I|Miscellaneous|0|||
47042021|NCT01725308|83298601|FG002|Treatment Period I|Miscellaneous|3|||
47042022|NCT01725308|83298599|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
47042023|NCT01725308|83298600|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
47042024|NCT01725308|83298601|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
47042025|NCT01725308|83298599|FG000|Treatment Period II|Did Not Receive Drug|4|||
47042026|NCT01725308|83298600|FG001|Treatment Period II|Did Not Receive Drug|0|||
47042027|NCT01725308|83298601|FG002|Treatment Period II|Did Not Receive Drug|0|||
46920030|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
47042028|NCT01725308|83298599|FG000|Treatment Period II|Adverse Event|13|||
47042029|NCT01725308|83298600|FG001|Treatment Period II|Adverse Event|8|||
47042030|NCT01725308|83298601|FG002|Treatment Period II|Adverse Event|20|||
47042031|NCT01725308|83298599|FG000|Treatment Period II|Insufficient Response|2|||
46920031|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46920032|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46920033|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46920034|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
46920035|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
46920036|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46920037|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46920038|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46920039|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46920040|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46920041|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46920042|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46920043|NCT01307423|83152521|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
46920044|NCT01307423|83152522|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
46920045|NCT01307423|83152523|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
46920046|NCT01307423|83152524|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
46920047|NCT01307423|83152525|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
46920048|NCT01307423|83152526|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
46920049|NCT01307423|83152527|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
46920050|NCT01307423|83152528|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
46920051|NCT01307423|83152529|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
46920052|NCT01307423|83152521|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
46920053|NCT01307423|83152522|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
46920054|NCT01307423|83152523|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
46920055|NCT01307423|83152524|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
46920056|NCT01307423|83152525|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
46920057|NCT01307423|83152526|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
46920058|NCT01307423|83152527|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
46920059|NCT01307423|83152528|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
46920060|NCT01307423|83152529|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
46920061|NCT01307423|83152521|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
46920062|NCT01307423|83152522|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
46920063|NCT01307423|83152523|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
46920064|NCT01307423|83152524|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
46920065|NCT01307423|83152525|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
47042032|NCT01725308|83298600|FG001|Treatment Period II|Insufficient Response|4|||
47042033|NCT01725308|83298601|FG002|Treatment Period II|Insufficient Response|6|||
47042034|NCT01725308|83298599|FG000|Treatment Period II|Worsening of the Target Disease|1|||
47042035|NCT01725308|83298600|FG001|Treatment Period II|Worsening of the Target Disease|4|||
46632839|NCT01786512|82806040|FG005|Overall Study|Death|0|||
46920066|NCT01307423|83152526|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
46920067|NCT01307423|83152527|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
46920068|NCT01307423|83152528|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
46920069|NCT01307423|83152529|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
46920070|NCT01307423|83152521|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920071|NCT01307423|83152522|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920072|NCT01307423|83152523|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920073|NCT01307423|83152524|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920074|NCT01307423|83152525|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920075|NCT01307423|83152526|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
46920076|NCT01307423|83152527|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920077|NCT01307423|83152528|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920078|NCT01307423|83152529|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
46920079|NCT01307423|83152521|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
46920080|NCT01307423|83152522|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
46920081|NCT01307423|83152523|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
46920082|NCT01307423|83152524|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
46920083|NCT01307423|83152525|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
46920084|NCT01307423|83152526|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
46920085|NCT01307423|83152527|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
46920086|NCT01307423|83152528|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
46920087|NCT01307423|83152529|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
46920088|NCT01307423|83152521|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920089|NCT01307423|83152522|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920090|NCT01307423|83152523|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920091|NCT01307423|83152524|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
46920092|NCT01307423|83152525|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920093|NCT01307423|83152526|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920094|NCT01307423|83152527|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920095|NCT01307423|83152528|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920096|NCT01307423|83152529|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
46920097|NCT01307423|83152521|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
46920098|NCT01307423|83152522|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
46920099|NCT01307423|83152523|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
46920100|NCT01307423|83152524|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
46920101|NCT01307423|83152525|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
46920102|NCT01307423|83152526|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
46920103|NCT01307423|83152527|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
46920104|NCT01307423|83152528|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
46920105|NCT01307423|83152529|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
46920106|NCT01307423|83152521|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
46920107|NCT01307423|83152522|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
46920108|NCT01307423|83152523|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
46920109|NCT01307423|83152524|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
46920110|NCT01307423|83152525|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
46920111|NCT01307423|83152526|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
46920112|NCT01307423|83152527|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
47042036|NCT01725308|83298601|FG002|Treatment Period II|Worsening of the Target Disease|2|||
47042037|NCT01725308|83298599|FG000|Treatment Period II|Changes in the Episodes|1|||
47042038|NCT01725308|83298600|FG001|Treatment Period II|Changes in the Episodes|0|||
47042039|NCT01725308|83298601|FG002|Treatment Period II|Changes in the Episodes|5|||
47042040|NCT01725308|83298599|FG000|Treatment Period II|Withdrawal of Consent|28|||
47042041|NCT01725308|83298600|FG001|Treatment Period II|Withdrawal of Consent|2|||
47042042|NCT01725308|83298601|FG002|Treatment Period II|Withdrawal of Consent|16|||
46720350|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
46720351|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
46720352|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
46720353|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
46720354|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
46720355|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
46720356|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
46720357|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
46720358|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
46720359|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
46720360|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
46720361|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
46720362|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
46720363|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
46720364|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
46720365|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
46720366|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
46720367|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
46720368|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
46920113|NCT01307423|83152528|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
46920114|NCT01307423|83152529|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
46920115|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46920116|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
46920117|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
46920118|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46920119|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46920120|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46920121|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
46920122|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
46920123|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
46920124|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46920125|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
46920126|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
46920127|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46920128|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46920129|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46920130|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
46920131|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
46920132|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
46920133|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920134|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920135|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
46920136|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920137|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920138|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920139|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920140|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920141|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
46920142|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46920143|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
46920144|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
46920145|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46920146|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46920147|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46920148|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46920149|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
46920150|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
46920151|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46920152|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
46920153|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46920154|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46920155|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46920156|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46920157|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
46920158|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
46920159|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
46920160|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46920161|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
46920162|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
46920163|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46920164|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46920165|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
47042043|NCT01725308|83298599|FG000|Treatment Period II|Lost to Follow-up|1|||
47042044|NCT01725308|83298600|FG001|Treatment Period II|Lost to Follow-up|5|||
46920166|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
46920167|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
46920168|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
47042045|NCT01725308|83298601|FG002|Treatment Period II|Lost to Follow-up|3|||
47042046|NCT01725308|83298599|FG000|Treatment Period II|Protocol Deviations|0|||
47042047|NCT01725308|83298600|FG001|Treatment Period II|Protocol Deviations|0|||
46920169|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46920170|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
46920171|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
46920172|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46920173|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46920174|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46920175|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
46920176|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
46920177|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
46920178|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
46920179|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
46920180|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
46920181|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
46920182|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
46920183|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
46920184|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
46920185|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
46920186|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
46920187|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46920188|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
46920189|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
46920190|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46920191|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46920192|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46920193|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46920194|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
46920195|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
46920196|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46920197|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
46920198|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
46920199|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46920200|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46920201|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46920202|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
46920203|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
46920204|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
46920205|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46920206|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
46920207|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46920208|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46920209|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46920210|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46920211|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46920212|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
46920213|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
46920214|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920215|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
46920216|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920217|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920218|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920219|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920220|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920221|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920222|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
46920223|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46920224|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
46920225|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46920226|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46920227|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46920228|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46920229|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46920230|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
46920231|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
47042048|NCT01725308|83298601|FG002|Treatment Period II|Protocol Deviations|1|||
47042049|NCT01725308|83298599|FG000|Treatment Period II|Miscellaneous|5|||
46920232|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46920233|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
47042050|NCT01725308|83298600|FG001|Treatment Period II|Miscellaneous|3|||
46920234|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
46920235|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46920236|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46920237|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46920238|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46920239|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
46920240|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
46920241|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920242|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920243|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
46920244|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920245|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920246|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920247|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920248|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920249|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
46920250|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46920251|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46920252|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46920253|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46920254|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46920255|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46720369|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
46720370|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
46720371|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
46720372|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Site closed|0|||
46632840|NCT01786512|82806041|FG006|Overall Study|Death|0|||
46632841|NCT01786512|82806042|FG007|Overall Study|Death|0|||
46632842|NCT01786512|82806043|FG008|Overall Study|Death|4|||
46632843|NCT01786512|82806044|FG009|Overall Study|Death|1|||
46632844|NCT01786512|82806045|FG010|Overall Study|Death|3|||
46632845|NCT01772160|82806077|FG000|Overall Study|Death|3|||
46632846|NCT01772160|82806077|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
46632847|NCT01772160|82806077|FG000|Overall Study|Consent withdrawal|3|||
46632848|NCT01772160|82806077|FG000|Overall Study|Migrated / moved from the study area|4|||
46632849|NCT01772160|82806077|FG000|Overall Study|Lost to Follow-up|30|||
46632850|NCT01772160|82806077|FG000|Overall Study|Other|5|||
46632851|NCT01770912|82806083|FG000|Overall Study|Lost to Follow-up|2|||
46632852|NCT01770912|82806084|FG001|Overall Study|Lost to Follow-up|0|||
46632853|NCT01811706|82806090|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
46632854|NCT01811706|82806091|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
46632855|NCT01811472|82806102|FG000|Overall Study|Adverse Event|1|||
46632856|NCT01811472|82806103|FG001|Overall Study|Adverse Event|0|||
46632857|NCT01811472|82806104|FG002|Overall Study|Adverse Event|4|||
46632858|NCT01811472|82806102|FG000|Overall Study|Lost to Follow-up|0|||
46632859|NCT01811472|82806103|FG001|Overall Study|Lost to Follow-up|0|||
46632860|NCT01811472|82806104|FG002|Overall Study|Lost to Follow-up|1|||
46632861|NCT01811472|82806102|FG000|Overall Study|Subject/guardian decision|1|||
46632862|NCT01811472|82806103|FG001|Overall Study|Subject/guardian decision|0|||
46632863|NCT01811472|82806104|FG002|Overall Study|Subject/guardian decision|0|||
46632864|NCT01811238|82806113|FG000|Overall Study|Withdrawal by Subject|42|||
46632865|NCT01811238|82806113|FG000|Overall Study|Adverse Event|25|||
46632866|NCT01811238|82806113|FG000|Overall Study|Protocol Violation|4|||
46632867|NCT01811238|82806113|FG000|Overall Study|Lack of Efficacy|4|||
46632868|NCT01811238|82806113|FG000|Overall Study|subject refused study medication|6|||
46632869|NCT01769508|82806118|FG000|Overall Study|Death|3|||
46632870|NCT01769508|82806118|FG000|Overall Study|Withdrawal by Subject|1|||
46632871|NCT01769508|82806118|FG000|Overall Study|Adverse Event|1|||
46632872|NCT01769508|82806118|FG000|Overall Study|Lost to Follow-up|1|||
46632873|NCT01810380|82806125|FG000|Overall Study|Randomised not treated|2|||
46632874|NCT01810380|82806126|FG001|Overall Study|Randomised not treated|1|||
46720373|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Site closed|0|||
46720374|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Site closed|1|||
46720375|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Site closed|0|||
46920256|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46920257|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
46632875|NCT01810380|82806127|FG002|Overall Study|Randomised not treated|1|||
46632876|NCT01810380|82806125|FG000|Overall Study|Adverse Event|11|||
46632877|NCT01810380|82806126|FG001|Overall Study|Adverse Event|14|||
46632878|NCT01810380|82806127|FG002|Overall Study|Adverse Event|4|||
46632879|NCT01810380|82806125|FG000|Overall Study|Lack of Efficacy|24|||
46632880|NCT01810380|82806126|FG001|Overall Study|Lack of Efficacy|10|||
46632881|NCT01810380|82806127|FG002|Overall Study|Lack of Efficacy|11|||
46632882|NCT01810380|82806125|FG000|Overall Study|Protocol Violation|1|||
46632883|NCT01810380|82806126|FG001|Overall Study|Protocol Violation|0|||
47042051|NCT01725308|83298601|FG002|Treatment Period II|Miscellaneous|7|||
47042052|NCT01724528|83298618|FG000|Overall Study|Death|3|||
47042053|NCT01724528|83298619|FG001|Overall Study|Death|0|||
47042054|NCT01724528|83298618|FG000|Overall Study|Withdrawal by Subject|0|||
47042055|NCT01724528|83298619|FG001|Overall Study|Withdrawal by Subject|2|||
47042056|NCT01724528|83298618|FG000|Overall Study|Protocol Violation|0|||
47042057|NCT01724528|83298619|FG001|Overall Study|Protocol Violation|1|||
47042058|NCT01724528|83298618|FG000|Overall Study|Patient refused to attend last visit|1|||
47042059|NCT01724528|83298619|FG001|Overall Study|Patient refused to attend last visit|0|||
47042060|NCT01779440|83298627|FG000|Overall Study|Withdrawal by Subject|3|||
47042061|NCT01779440|83298628|FG001|Overall Study|Withdrawal by Subject|5|||
47042062|NCT01750346|83298637|FG000|Overall Study|Adverse Event|1|||
47042063|NCT01750346|83298638|FG001|Overall Study|Adverse Event|0|||
47042064|NCT01750346|83298639|FG002|Overall Study|Adverse Event|0|||
47042065|NCT01750268|83298649|FG000|Overall Study|Lost to Follow-up|0|||
47042066|NCT01750268|83298650|FG001|Overall Study|Lost to Follow-up|2|||
47042067|NCT01750268|83298649|FG000|Overall Study|Physician Decision|0|||
47042068|NCT01750268|83298650|FG001|Overall Study|Physician Decision|3|||
47042069|NCT01750268|83298649|FG000|Overall Study|Withdrawal by Subject|2|||
47042070|NCT01750268|83298650|FG001|Overall Study|Withdrawal by Subject|0|||
47042071|NCT01880437|83298659|FG000|Overall Study|Death|12|||
47042072|NCT01880437|83298660|FG001|Overall Study|Death|4|||
47042073|NCT01880437|83298661|FG002|Overall Study|Death|17|||
47042074|NCT01880437|83298659|FG000|Overall Study|Study terminated by Sponsor|3|||
47042075|NCT01880437|83298660|FG001|Overall Study|Study terminated by Sponsor|0|||
47042076|NCT01880437|83298661|FG002|Overall Study|Study terminated by Sponsor|2|||
47042077|NCT01861717|83298671|FG000|Overall Study|Lost to Follow-up|1|||
47042078|NCT01861717|83298671|FG000|Overall Study|Withdrawal by Subject|1|||
47042079|NCT01834729|83298680|FG000|Overall Study|Did not return bowel diaries|0|||
47042080|NCT01834729|83298681|FG001|Overall Study|Did not return bowel diaries|0|||
47042081|NCT01834729|83298682|FG002|Overall Study|Did not return bowel diaries|3|||
47042082|NCT01834729|83298683|FG003|Overall Study|Did not return bowel diaries|0|||
47042083|NCT01834729|83298680|FG000|Overall Study|Withdrawal by Subject|1|||
47042084|NCT01834729|83298681|FG001|Overall Study|Withdrawal by Subject|1|||
47042085|NCT01834729|83298682|FG002|Overall Study|Withdrawal by Subject|0|||
47042086|NCT01834729|83298683|FG003|Overall Study|Withdrawal by Subject|0|||
47042087|NCT01834729|83298680|FG000|Overall Study|Adverse Event|0|||
47042088|NCT01834729|83298681|FG001|Overall Study|Adverse Event|0|||
47042089|NCT01834729|83298682|FG002|Overall Study|Adverse Event|0|||
47042090|NCT01834729|83298683|FG003|Overall Study|Adverse Event|2|||
47042091|NCT01860703|83298694|FG000|Overall Study|Adverse Event|1|||
47042092|NCT01860703|83298695|FG001|Overall Study|Adverse Event|4|||
47042093|NCT01860703|83298696|FG002|Overall Study|Adverse Event|0|||
47042094|NCT01860703|83298697|FG003|Overall Study|Adverse Event|2|||
47042095|NCT01860703|83298694|FG000|Overall Study|Withdrawal by Subject|0|||
47042096|NCT01860703|83298695|FG001|Overall Study|Withdrawal by Subject|1|||
47042097|NCT01860703|83298696|FG002|Overall Study|Withdrawal by Subject|0|||
47042098|NCT01860703|83298697|FG003|Overall Study|Withdrawal by Subject|0|||
47042099|NCT01860703|83298694|FG000|Overall Study|Personal reason|1|||
47042100|NCT01860703|83298695|FG001|Overall Study|Personal reason|0|||
47042101|NCT01860703|83298696|FG002|Overall Study|Personal reason|1|||
47042102|NCT01860703|83298697|FG003|Overall Study|Personal reason|0|||
47042103|NCT01399593|83298715|FG000|Overall Study|Physician Decision|1|||
47042104|NCT01399593|83298716|FG001|Overall Study|Physician Decision|0|||
47042105|NCT01399593|83298715|FG000|Overall Study|Adverse Event|1|||
47042106|NCT01399593|83298716|FG001|Overall Study|Adverse Event|0|||
46632884|NCT01810380|82806127|FG002|Overall Study|Protocol Violation|1|||
46632885|NCT01810380|82806125|FG000|Overall Study|Withdrawal by Subject|6|||
46632886|NCT01810380|82806126|FG001|Overall Study|Withdrawal by Subject|0|||
46632887|NCT01810380|82806127|FG002|Overall Study|Withdrawal by Subject|6|||
46632888|NCT01810380|82806125|FG000|Overall Study|Administrative or other reasons|11|||
46632889|NCT01810380|82806126|FG001|Overall Study|Administrative or other reasons|13|||
46632890|NCT01810380|82806127|FG002|Overall Study|Administrative or other reasons|9|||
46632891|NCT01769196|82806137|FG000|Overall Study|Adverse Event|24|||
46632892|NCT01769196|82806138|FG001|Overall Study|Adverse Event|20|||
46632893|NCT01769196|82806137|FG000|Overall Study|Death|21|||
46632894|NCT01769196|82806138|FG001|Overall Study|Death|26|||
46632895|NCT01769196|82806137|FG000|Overall Study|Investigator Discretion|7|||
46632896|NCT01769196|82806138|FG001|Overall Study|Investigator Discretion|3|||
47042107|NCT01399593|83298715|FG000|Overall Study|Death|1|||
47042108|NCT01399593|83298716|FG001|Overall Study|Death|1|||
47042109|NCT01399593|83298715|FG000|Overall Study|Transplantectomy|0|||
47042110|NCT01399593|83298716|FG001|Overall Study|Transplantectomy|1|||
47042111|NCT01833169|83298722|FG000|Overall Study|Disease Progression|99|||
47042112|NCT01833169|83298722|FG000|Overall Study|Adverse Event|33|||
47042113|NCT01833169|83298722|FG000|Overall Study|Withdrawal by Subject|9|||
47042114|NCT01833169|83298722|FG000|Overall Study|Death|3|||
47042115|NCT01833169|83298722|FG000|Overall Study|Physician Decision|2|||
47042116|NCT01860079|83298728|FG000|Overall Study|Physician Decision|14|||
47042117|NCT01860079|83298729|FG001|Overall Study|Physician Decision|22|||
47042118|NCT01388985|83298737|FG000|Overall Study|Death|0|||
47042119|NCT01388985|83298738|FG001|Overall Study|Death|1|||
47042120|NCT01388985|83298737|FG000|Overall Study|Lost to Follow-up|30|||
46632897|NCT01769196|82806137|FG000|Overall Study|Lack of Efficacy|3|||
46720376|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
46720377|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
46720378|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
46720379|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
46720380|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
46720381|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
46720382|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
46720383|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
46632898|NCT01769196|82806138|FG001|Overall Study|Lack of Efficacy|2|||
46632899|NCT01769196|82806137|FG000|Overall Study|Progressive disease|11|||
46632900|NCT01769196|82806138|FG001|Overall Study|Progressive disease|6|||
46720384|NCT00838903|82936364|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
46720385|NCT00838903|82936365|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
46632901|NCT01769196|82806137|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
46720386|NCT00838903|82936366|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
46720387|NCT00838903|82936367|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
46720388|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
46720389|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
46720390|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
46720391|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
46720392|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
46720393|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
46720394|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
46720395|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
46720396|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
46720397|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
46720398|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
46720399|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
46720400|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
46720401|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
46720402|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
46720403|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
46720404|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
46720405|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
46720406|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
46720407|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
46720408|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
46720409|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
46720410|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
46720411|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
46720412|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
46720413|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
46720414|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
46720415|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
46720416|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
46720417|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
46720418|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
46720419|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
46720420|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
46720421|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
46632902|NCT01769196|82806138|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
46632903|NCT01769196|82806137|FG000|Overall Study|Protocol Violation|0|||
46632904|NCT01769196|82806138|FG001|Overall Study|Protocol Violation|3|||
46632905|NCT01769196|82806137|FG000|Overall Study|Study terminated by sponsor|160|||
46632906|NCT01769196|82806138|FG001|Overall Study|Study terminated by sponsor|161|||
46720422|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
46720423|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
46720424|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
46720425|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
46720426|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
47042121|NCT01388985|83298738|FG001|Overall Study|Lost to Follow-up|30|||
46720427|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
46720428|NCT00838903|82936364|FG000|Follow-up Period (8 Weeks)|Missing|1|||
46720429|NCT00838903|82936365|FG001|Follow-up Period (8 Weeks)|Missing|2|||
46720430|NCT00838903|82936366|FG002|Follow-up Period (8 Weeks)|Missing|1|||
46720431|NCT00838903|82936367|FG003|Follow-up Period (8 Weeks)|Missing|1|||
46720432|NCT00828139|82936381|FG000|Overall Study|Adverse Event|8|||
46720433|NCT00828139|82936382|FG001|Overall Study|Adverse Event|1|||
46720434|NCT00828139|82936383|FG002|Overall Study|Adverse Event|10|||
46720435|NCT00828139|82936384|FG003|Overall Study|Adverse Event|5|||
46720436|NCT00828139|82936381|FG000|Overall Study|Death|2|||
46720437|NCT00828139|82936382|FG001|Overall Study|Death|1|||
46720438|NCT00828139|82936383|FG002|Overall Study|Death|0|||
46720439|NCT00828139|82936384|FG003|Overall Study|Death|2|||
46720440|NCT00828139|82936381|FG000|Overall Study|Refusal unrelated to toxicity|3|||
46720441|NCT00828139|82936382|FG001|Overall Study|Refusal unrelated to toxicity|4|||
46720442|NCT00828139|82936383|FG002|Overall Study|Refusal unrelated to toxicity|5|||
46920258|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
46920259|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46720443|NCT00828139|82936384|FG003|Overall Study|Refusal unrelated to toxicity|3|||
46720444|NCT00828139|82936381|FG000|Overall Study|Disease Progression|24|||
46720445|NCT00828139|82936382|FG001|Overall Study|Disease Progression|33|||
46720446|NCT00828139|82936383|FG002|Overall Study|Disease Progression|35|||
46720447|NCT00828139|82936384|FG003|Overall Study|Disease Progression|39|||
46720448|NCT00828139|82936381|FG000|Overall Study|Other|4|||
46720449|NCT00828139|82936382|FG001|Overall Study|Other|2|||
46720450|NCT00828139|82936383|FG002|Overall Study|Other|5|||
46720451|NCT00828139|82936384|FG003|Overall Study|Other|2|||
46720452|NCT00838513|82936394|FG000|Screening Period|Screen Failure|3|||
46720453|NCT00838513|82936394|FG000|Extension Treatment Period|Death|1|||
46720454|NCT00838513|82936394|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
46720455|NCT00600106|82936400|FG000|Overall Study|Withdrawal by Subject|1|||
46720456|NCT00600106|82936401|FG001|Overall Study|Withdrawal by Subject|1|||
46720457|NCT00850993|82936411|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
46920260|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
47042122|NCT01388985|83298737|FG000|Overall Study|Withdrawal by Subject|13|||
47042123|NCT01388985|83298738|FG001|Overall Study|Withdrawal by Subject|4|||
47042124|NCT01388985|83298737|FG000|Overall Study|Subject unavailable|1|||
47042125|NCT01388985|83298738|FG001|Overall Study|Subject unavailable|1|||
47042126|NCT01388985|83298737|FG000|Overall Study|Other (no reason)|0|||
47042127|NCT01388985|83298738|FG001|Overall Study|Other (no reason)|1|||
47042128|NCT01388985|83298737|FG000|Overall Study|Error of nurse|5|||
47042129|NCT01388985|83298738|FG001|Overall Study|Error of nurse|1|||
47042130|NCT01388907|83298746|FG000|Overall Study|Adverse Event|2|||
47042131|NCT01388907|83298747|FG001|Overall Study|Adverse Event|0|||
47042132|NCT01388361|83298758|FG000|Overall Study|Adverse Event|0|||
47042133|NCT01388361|83298759|FG001|Overall Study|Adverse Event|5|||
47042134|NCT01388361|83298760|FG002|Overall Study|Adverse Event|1|||
47042135|NCT01388361|83298758|FG000|Overall Study|Protocol Violation|0|||
47042136|NCT01388361|83298759|FG001|Overall Study|Protocol Violation|0|||
47042137|NCT01388361|83298760|FG002|Overall Study|Protocol Violation|2|||
47042138|NCT01388361|83298758|FG000|Overall Study|Withdrawal criteria|12|||
47042139|NCT01388361|83298759|FG001|Overall Study|Withdrawal criteria|7|||
47042140|NCT01388361|83298760|FG002|Overall Study|Withdrawal criteria|10|||
47042141|NCT01388361|83298758|FG000|Overall Study|Unclassified|0|||
47042142|NCT01388361|83298759|FG001|Overall Study|Unclassified|0|||
46632907|NCT01769196|82806137|FG000|Overall Study|Participant never dosed with study drug|1|||
46632908|NCT01769196|82806138|FG001|Overall Study|Participant never dosed with study drug|0|||
46632909|NCT01769196|82806137|FG000|Overall Study|Withdrew consent|36|||
46632910|NCT01769196|82806138|FG001|Overall Study|Withdrew consent|40|||
46632911|NCT01810302|82806146|FG000|Overall Study|Death|1|||
46632912|NCT01810302|82806147|FG001|Overall Study|Death|0|||
46632913|NCT01810302|82806146|FG000|Overall Study|Physician Decision|0|||
46632914|NCT01810302|82806147|FG001|Overall Study|Physician Decision|1|||
46920261|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
46920262|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
47042143|NCT01388361|83298760|FG002|Overall Study|Unclassified|1|||
47042144|NCT01399125|83298770|FG000|Overall Study|Adverse Event|32|||
47042145|NCT01399125|83298771|FG001|Overall Study|Adverse Event|30|||
47042146|NCT01399125|83298770|FG000|Overall Study|Abnormal Lab values|0|||
47042147|NCT01399125|83298771|FG001|Overall Study|Abnormal Lab values|1|||
46632915|NCT01783938|82806155|FG000|Overall Study|Disease Progression|18|||
46632916|NCT01783938|82806156|FG001|Overall Study|Disease Progression|41|||
46720458|NCT00850993|82936412|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
46632917|NCT01783938|82806155|FG000|Overall Study|Study Drug Toxicity|27|||
46720459|NCT00850993|82936413|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
47042148|NCT01399125|83298770|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46720460|NCT00850993|82936414|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
46720461|NCT00818779|82936426|FG000|Overall Study|Protocol Violation|1|||
47042149|NCT01399125|83298771|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
47042150|NCT01399125|83298770|FG000|Overall Study|Withdrawal by Subject|5|||
47042151|NCT01399125|83298771|FG001|Overall Study|Withdrawal by Subject|8|||
47042152|NCT01399125|83298770|FG000|Overall Study|Lost to Follow-up|2|||
47042153|NCT01399125|83298771|FG001|Overall Study|Lost to Follow-up|3|||
47042154|NCT01399125|83298770|FG000|Overall Study|Administrative Problems|7|||
47042155|NCT01399125|83298771|FG001|Overall Study|Administrative Problems|11|||
47042156|NCT01399125|83298770|FG000|Overall Study|Death|0|||
47042157|NCT01399125|83298771|FG001|Overall Study|Death|1|||
47042158|NCT01399125|83298770|FG000|Overall Study|Protocol Deviation|5|||
47042159|NCT01399125|83298771|FG001|Overall Study|Protocol Deviation|2|||
47042160|NCT01399047|83298779|FG000|Overall Study|Withdrawal by Subject|0|||
47042161|NCT01399047|83298780|FG001|Overall Study|Withdrawal by Subject|1|||
47042162|NCT01387737|83298790|FG000|Overall Study|Adverse Event|20|||
47042163|NCT01387737|83298791|FG001|Overall Study|Adverse Event|30|||
47042164|NCT01387737|83298790|FG000|Overall Study|Lack of Efficacy|1|||
47042165|NCT01387737|83298791|FG001|Overall Study|Lack of Efficacy|0|||
47042166|NCT01387737|83298790|FG000|Overall Study|Physician Decision|3|||
47042167|NCT01387737|83298791|FG001|Overall Study|Physician Decision|10|||
47042168|NCT01387737|83298790|FG000|Overall Study|Withdrawal by Subject|27|||
47042169|NCT01387737|83298791|FG001|Overall Study|Withdrawal by Subject|31|||
47042170|NCT01387737|83298790|FG000|Overall Study|Clearly not eligible for the study|1|||
47042171|NCT01387737|83298791|FG001|Overall Study|Clearly not eligible for the study|3|||
47042172|NCT01387347|83298799|FG000|Overall Study|Lost to Follow-up|2|||
47042173|NCT01387347|83298800|FG001|Overall Study|Lost to Follow-up|1|||
47042174|NCT01859923|83298814|FG000|Overall Study|Adverse Event|0|||
47042175|NCT01859923|83298815|FG001|Overall Study|Adverse Event|0|||
47042176|NCT01859923|83298816|FG002|Overall Study|Adverse Event|1|||
47042177|NCT01859923|83298817|FG003|Overall Study|Adverse Event|1|||
47042178|NCT01832155|83298832|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
47042179|NCT01832155|83298833|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
47042180|NCT01832155|83298832|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
47042181|NCT01832155|83298833|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
47042182|NCT01879579|83298847|FG000|Overall Study|Phone incompatible with texting platform|3|||
47042183|NCT01879579|83298848|FG001|Overall Study|Phone incompatible with texting platform|0|||
47042184|NCT01879579|83298847|FG000|Overall Study|Did not enroll in texting platform|1|||
47042185|NCT01879579|83298848|FG001|Overall Study|Did not enroll in texting platform|0|||
47042186|NCT01879579|83298847|FG000|Overall Study|Did not initiate insulin treatment|1|||
47042187|NCT01879579|83298848|FG001|Overall Study|Did not initiate insulin treatment|0|||
47042188|NCT01879579|83298847|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
47042189|NCT01879579|83298848|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
47042190|NCT01879579|83298847|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
46632918|NCT01783938|82806156|FG001|Overall Study|Study Drug Toxicity|14|||
46632919|NCT01783938|82806155|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
46632920|NCT01783938|82806156|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
46720462|NCT00818779|82936427|FG001|Overall Study|Protocol Violation|0|||
46720463|NCT00818779|82936426|FG000|Overall Study|Lost to Follow-up|1|||
46720464|NCT00818779|82936427|FG001|Overall Study|Lost to Follow-up|0|||
46720465|NCT00818779|82936426|FG000|Overall Study|Adverse Event|4|||
46720466|NCT00818779|82936427|FG001|Overall Study|Adverse Event|1|||
46720467|NCT00850759|82936437|FG000|Overall Study|Lost to Follow-up|7|||
46720468|NCT00850759|82936438|FG001|Overall Study|Lost to Follow-up|5|||
46720469|NCT00850759|82936439|FG002|Overall Study|Lost to Follow-up|5|||
46720470|NCT00850759|82936440|FG003|Overall Study|Lost to Follow-up|3|||
46720471|NCT00827827|82936452|FG000|Overall Study|Lost to Follow-up|3|||
46720472|NCT00827827|82936453|FG001|Overall Study|Lost to Follow-up|0|||
46720473|NCT00827827|82936452|FG000|Overall Study|Fall at home- hospitalization|1|||
46720474|NCT00827827|82936453|FG001|Overall Study|Fall at home- hospitalization|0|||
46720475|NCT00827827|82936452|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
46632921|NCT01783938|82806155|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
46632922|NCT01783938|82806156|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
46632923|NCT01783938|82806155|FG000|Overall Study|Participant Withdrew Consent|2|||
46632924|NCT01783938|82806156|FG001|Overall Study|Participant Withdrew Consent|0|||
46632925|NCT01783938|82806155|FG000|Overall Study|Maximum Clinical Benefit|1|||
47042191|NCT01879579|83298848|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
47042192|NCT01386645|83298860|FG000|Overall Study|Physician Decision|0|||
47042193|NCT01386645|83298861|FG001|Overall Study|Physician Decision|0|||
47042194|NCT01386645|83298862|FG002|Overall Study|Physician Decision|1|||
47042195|NCT01386645|83298860|FG000|Overall Study|Withdrawal by Subject|0|||
47042196|NCT01386645|83298861|FG001|Overall Study|Withdrawal by Subject|1|||
47042197|NCT01386645|83298862|FG002|Overall Study|Withdrawal by Subject|1|||
47042198|NCT01387269|83298872|FG000|Overall Study|Death|38|||
46720476|NCT00827827|82936453|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
46720477|NCT00827827|82936452|FG000|Overall Study|Gout|1|||
46720478|NCT00827827|82936453|FG001|Overall Study|Gout|0|||
46720479|NCT00827827|82936452|FG000|Overall Study|Transportation issues|1|||
47042199|NCT01387269|83298873|FG001|Overall Study|Death|20|||
47042200|NCT01387269|83298872|FG000|Overall Study|Other|8|||
47042201|NCT01387269|83298873|FG001|Overall Study|Other|7|||
47042202|NCT01387269|83298872|FG000|Overall Study|Unrelated AE|12|||
47042203|NCT01387269|83298873|FG001|Overall Study|Unrelated AE|3|||
47042204|NCT01387269|83298872|FG000|Overall Study|Withdrawal by patient|32|||
47042205|NCT01387269|83298873|FG001|Overall Study|Withdrawal by patient|10|||
47042206|NCT01387269|83298872|FG000|Overall Study|Study drug-related AE|1|||
47042207|NCT01387269|83298873|FG001|Overall Study|Study drug-related AE|0|||
47042208|NCT01387269|83298872|FG000|Overall Study|Lost to Follow-up|1|||
47042209|NCT01387269|83298873|FG001|Overall Study|Lost to Follow-up|0|||
47042210|NCT01859143|83298881|FG000|Overall Study|Lost to Follow-up|2|||
47042211|NCT01859143|83298882|FG001|Overall Study|Lost to Follow-up|0|||
47042212|NCT01878253|83298889|FG000|Overall Study|Death|1|||
47042213|NCT01878253|83298889|FG000|Overall Study|SIdus System Removal|3|||
47042214|NCT01878253|83298889|FG000|Overall Study|Withdrawal by Subject|1|||
47042215|NCT01878253|83298889|FG000|Overall Study|Lost to Follow-up|2|||
47042216|NCT01878253|83298889|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
47042217|NCT01878175|83298898|FG000|Overall Study|Developed contraindicated health problem|2|||
47042218|NCT01878097|83298905|FG000|Baseline|Surveys not fully completed|2497|||
47042219|NCT01878097|83298906|FG001|Baseline|Surveys not fully completed|1800|||
47042220|NCT01878097|83298905|FG000|Implementation Year 1|Surveys not fully completed|3202|||
47042221|NCT01878097|83298906|FG001|Implementation Year 1|Surveys not fully completed|2549|||
47042222|NCT01878097|83298905|FG000|Implementation Year 2|Surveys not fully completed|3281|||
47042223|NCT01878097|83298906|FG001|Implementation Year 2|Surveys not fully completed|2841|||
47042224|NCT01878097|83298905|FG000|Implementation Year 3|Surveys not fully completed|3494|||
47042225|NCT01878097|83298906|FG001|Implementation Year 3|Surveys not fully completed|2980|||
47042226|NCT01878097|83298905|FG000|Implementation Year 4|Surveys not fully completed|3604|||
47042227|NCT01878097|83298906|FG001|Implementation Year 4|Surveys not fully completed|3007|||
47042228|NCT01750190|83298914|FG000|Overall Study|Adverse Event|47|||
47042229|NCT01750190|83298915|FG001|Overall Study|Adverse Event|19|||
47042230|NCT01750190|83298914|FG000|Overall Study|Death|38|||
47042231|NCT01750190|83298915|FG001|Overall Study|Death|11|||
47042232|NCT01750190|83298914|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
47042233|NCT01750190|83298915|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
47042234|NCT01750190|83298914|FG000|Overall Study|Lost to Follow-up|28|||
47042235|NCT01750190|83298915|FG001|Overall Study|Lost to Follow-up|7|||
47042236|NCT01750190|83298914|FG000|Overall Study|Physician Decision|16|||
47042237|NCT01750190|83298915|FG001|Overall Study|Physician Decision|17|||
47042238|NCT01750190|83298914|FG000|Overall Study|Protocol Violation|6|||
47042239|NCT01750190|83298915|FG001|Overall Study|Protocol Violation|5|||
47042240|NCT01750190|83298914|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
47042241|NCT01750190|83298915|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
47042242|NCT01750190|83298914|FG000|Overall Study|Withdrawal by Subject|83|||
47042243|NCT01750190|83298915|FG001|Overall Study|Withdrawal by Subject|89|||
47042244|NCT01750190|83298914|FG000|Overall Study|Kidney Transplant|8|||
47042245|NCT01750190|83298915|FG001|Overall Study|Kidney Transplant|4|||
47042246|NCT01750190|83298914|FG000|Overall Study|Dialysis|22|||
46920263|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46920264|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46920265|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46920266|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
46920267|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
46920268|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46920269|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
46920270|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
46920271|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46920272|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46920273|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46920274|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46920275|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46920276|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
46920277|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46920278|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
46920279|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
46920280|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
47042247|NCT01750190|83298915|FG001|Overall Study|Dialysis|8|||
47042248|NCT01750190|83298914|FG000|Overall Study|Other than Specified|13|||
47042249|NCT01750190|83298915|FG001|Overall Study|Other than Specified|4|||
47042250|NCT01831765|83298924|FG000|Overall Study|Lack of Efficacy|1|||
47042251|NCT01831765|83298925|FG001|Overall Study|Lack of Efficacy|0|||
47042252|NCT01831765|83298926|FG002|Overall Study|Lack of Efficacy|0|||
47042253|NCT01831765|83298924|FG000|Overall Study|Other, sponsor withdrew subject|0|||
47042254|NCT01831765|83298925|FG001|Overall Study|Other, sponsor withdrew subject|1|||
47042255|NCT01831765|83298926|FG002|Overall Study|Other, sponsor withdrew subject|0|||
47042256|NCT01831765|83298924|FG000|Overall Study|Pregnancy|1|||
47042257|NCT01831765|83298925|FG001|Overall Study|Pregnancy|1|||
47042258|NCT01831765|83298926|FG002|Overall Study|Pregnancy|2|||
47042259|NCT01831765|83298924|FG000|Overall Study|Death|0|||
47042260|NCT01831765|83298925|FG001|Overall Study|Death|1|||
47042261|NCT01831765|83298926|FG002|Overall Study|Death|1|||
47042262|NCT01831765|83298924|FG000|Overall Study|Other, site closed|1|||
47042263|NCT01831765|83298925|FG001|Overall Study|Other, site closed|1|||
47042264|NCT01831765|83298926|FG002|Overall Study|Other, site closed|0|||
47042265|NCT01831765|83298924|FG000|Overall Study|Adverse Event|5|||
47042266|NCT01831765|83298925|FG001|Overall Study|Adverse Event|3|||
47042267|NCT01831765|83298926|FG002|Overall Study|Adverse Event|3|||
47042268|NCT01831765|83298924|FG000|Overall Study|Withdrawal by Subject|22|||
47042269|NCT01831765|83298925|FG001|Overall Study|Withdrawal by Subject|7|||
47042270|NCT01831765|83298926|FG002|Overall Study|Withdrawal by Subject|17|||
47042271|NCT01831765|83298924|FG000|Overall Study|Withdrawal criteria|12|||
47042272|NCT01831765|83298925|FG001|Overall Study|Withdrawal criteria|10|||
47042273|NCT01831765|83298926|FG002|Overall Study|Withdrawal criteria|16|||
47042274|NCT01831765|83298924|FG000|Overall Study|Lost to Follow-up|2|||
47042275|NCT01831765|83298925|FG001|Overall Study|Lost to Follow-up|3|||
47042276|NCT01831765|83298926|FG002|Overall Study|Lost to Follow-up|3|||
47042277|NCT01749800|83298939|FG000|Overall Study|not meeting inclusion criteria|3|||
47042278|NCT01749800|83298940|FG001|Overall Study|not meeting inclusion criteria|0|||
47042279|NCT01749800|83298941|FG002|Overall Study|not meeting inclusion criteria|0|||
47042280|NCT01749800|83298939|FG000|Overall Study|Withdrawal by Subject|0|||
47042281|NCT01749800|83298940|FG001|Overall Study|Withdrawal by Subject|1|||
47042282|NCT01749800|83298941|FG002|Overall Study|Withdrawal by Subject|0|||
47042283|NCT01830595|83298949|FG000|First Period|Withdrawal by Subject|1|||
47042284|NCT01830595|83298950|FG001|First Period|Withdrawal by Subject|3|||
47042285|NCT01830595|83298949|FG000|Washout|Withdrawal by Subject|2|||
47042286|NCT01830595|83298950|FG001|Washout|Withdrawal by Subject|2|||
47042287|NCT01748552|83298968|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
47042288|NCT01748552|83298969|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
47042289|NCT01748552|83298970|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
47042290|NCT01748552|83298971|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
47042291|NCT01748552|83298972|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
46632926|NCT01783938|82806156|FG001|Overall Study|Maximum Clinical Benefit|0|||
46632927|NCT01783938|82806155|FG000|Overall Study|Other Reasons|3|||
46632928|NCT01783938|82806156|FG001|Overall Study|Other Reasons|1|||
46632929|NCT01768572|82806165|FG000|Overall Study|Adverse Event|7|||
46632930|NCT01768572|82806166|FG001|Overall Study|Adverse Event|8|||
46632931|NCT01768572|82806167|FG002|Overall Study|Adverse Event|4|||
46632932|NCT01768572|82806165|FG000|Overall Study|Lack of Efficacy|1|||
46720480|NCT00827827|82936453|FG001|Overall Study|Transportation issues|0|||
46720481|NCT00827827|82936452|FG000|Overall Study|Burned with water at home|1|||
46720482|NCT00827827|82936453|FG001|Overall Study|Burned with water at home|0|||
46720483|NCT00600028|82936462|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
46720484|NCT00600028|82936463|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
46720485|NCT00600028|82936462|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
46720486|NCT00600028|82936463|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
46632933|NCT01768572|82806166|FG001|Overall Study|Lack of Efficacy|3|||
46632934|NCT01768572|82806167|FG002|Overall Study|Lack of Efficacy|1|||
46632935|NCT01768572|82806165|FG000|Overall Study|Other, Not due to an adverse event|1|||
46632936|NCT01768572|82806166|FG001|Overall Study|Other, Not due to an adverse event|1|||
46632937|NCT01768572|82806167|FG002|Overall Study|Other, Not due to an adverse event|1|||
46632938|NCT01783548|82806177|FG000|Overall Study|Adverse Event|8|||
46632939|NCT01783548|82806178|FG001|Overall Study|Adverse Event|4|||
46632940|NCT01783548|82806177|FG000|Overall Study|Withdrawal by Subject|11|||
46632941|NCT01783548|82806178|FG001|Overall Study|Withdrawal by Subject|8|||
46632942|NCT01783548|82806177|FG000|Overall Study|Non-compliance|4|||
46632943|NCT01783548|82806178|FG001|Overall Study|Non-compliance|0|||
46720487|NCT00600028|82936462|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
46720488|NCT00600028|82936463|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
47042292|NCT01748552|83298973|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
47042293|NCT01748552|83298974|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
47042294|NCT01748552|83298975|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
47042295|NCT01748552|83298976|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
47042296|NCT01748552|83298977|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
47042297|NCT01748552|83298978|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
47042298|NCT01748552|83298979|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
47042299|NCT01748552|83298968|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042300|NCT01748552|83298969|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042301|NCT01748552|83298970|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042302|NCT01748552|83298971|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042303|NCT01748552|83298972|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042304|NCT01748552|83298973|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042305|NCT01748552|83298974|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
47042306|NCT01748552|83298975|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
47042307|NCT01748552|83298976|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
47042308|NCT01748552|83298977|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042309|NCT01748552|83298978|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042310|NCT01748552|83298979|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
47042311|NCT01748162|83299021|FG000|Overall Study|no additional croup episodes to evaluate|2|||
47042312|NCT01748162|83299022|FG001|Overall Study|no additional croup episodes to evaluate|2|||
47042313|NCT01748162|83299021|FG000|Overall Study|participant consented but did not begin|0|||
47042314|NCT01748162|83299022|FG001|Overall Study|participant consented but did not begin|1|||
47042315|NCT01748162|83299021|FG000|Overall Study|reasons not available|3|||
47042316|NCT01748162|83299022|FG001|Overall Study|reasons not available|2|||
47042317|NCT01724216|83299028|FG000|Overall Study|Scan was not completed|1|||
47042318|NCT01723904|83299032|FG000|Overall Study|Noncompliant|3|||
47042319|NCT01723904|83299032|FG000|Overall Study|Adverse Event|5|||
47042320|NCT01723904|83299032|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
47042321|NCT01747772|83299036|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
47042322|NCT01830127|83299046|FG000|Overall Study|Adverse Event|1|||
47042323|NCT01830127|83299047|FG001|Overall Study|Adverse Event|6|||
47042324|NCT01830127|83299046|FG000|Overall Study|Lack of Efficacy|3|||
47042325|NCT01830127|83299047|FG001|Overall Study|Lack of Efficacy|0|||
47042326|NCT01830127|83299046|FG000|Overall Study|Withdrawal by Subject|1|||
47042327|NCT01830127|83299047|FG001|Overall Study|Withdrawal by Subject|1|||
47042328|NCT01830127|83299046|FG000|Overall Study|Other reason not defined above|0|||
47042329|NCT01830127|83299047|FG001|Overall Study|Other reason not defined above|2|||
47042330|NCT01614067|83299055|FG000|Overall Study|Pregnancy|1|||
47042331|NCT01614067|83299056|FG001|Overall Study|Pregnancy|0|||
47042332|NCT01614067|83299055|FG000|Overall Study|Physician Decision|6|||
47042333|NCT01614067|83299056|FG001|Overall Study|Physician Decision|5|||
47042334|NCT01614067|83299055|FG000|Overall Study|Withdrawal by Subject|0|||
47042335|NCT01614067|83299056|FG001|Overall Study|Withdrawal by Subject|1|||
47042336|NCT01614067|83299055|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
47042337|NCT01614067|83299056|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
47042338|NCT01777490|83299066|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
47042339|NCT01777490|83299067|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
47042340|NCT01777490|83299068|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
47042341|NCT01777490|83299069|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
47042342|NCT01397409|83299091|FG000|Stage 2|Adverse Event|0|||
47042343|NCT01397409|83299092|FG001|Stage 2|Adverse Event|0|||
47042344|NCT01397409|83299093|FG002|Stage 2|Adverse Event|0|||
47042345|NCT01397409|83299094|FG003|Stage 2|Adverse Event|0|||
47042346|NCT01397409|83299095|FG004|Stage 2|Adverse Event|6|||
47042347|NCT01397409|83299096|FG005|Stage 2|Adverse Event|3|||
47042348|NCT01397409|83299097|FG006|Stage 2|Adverse Event|0|||
47042349|NCT01397409|83299098|FG007|Stage 2|Adverse Event|0|||
47042350|NCT01397409|83299099|FG008|Stage 2|Adverse Event|0|||
47042351|NCT01397409|83299100|FG009|Stage 2|Adverse Event|0|||
47042352|NCT01397409|83299091|FG000|Stage 2|Personal Reasons|0|||
47042353|NCT01397409|83299092|FG001|Stage 2|Personal Reasons|0|||
47042354|NCT01397409|83299093|FG002|Stage 2|Personal Reasons|0|||
47042355|NCT01397409|83299094|FG003|Stage 2|Personal Reasons|0|||
47042356|NCT01397409|83299095|FG004|Stage 2|Personal Reasons|1|||
47042357|NCT01397409|83299096|FG005|Stage 2|Personal Reasons|0|||
47042358|NCT01397409|83299097|FG006|Stage 2|Personal Reasons|0|||
46632944|NCT01783548|82806177|FG000|Overall Study|Protocol Violation|2|||
46632945|NCT01783548|82806178|FG001|Overall Study|Protocol Violation|2|||
47042359|NCT01397409|83299098|FG007|Stage 2|Personal Reasons|0|||
47042360|NCT01397409|83299099|FG008|Stage 2|Personal Reasons|0|||
47042361|NCT01397409|83299100|FG009|Stage 2|Personal Reasons|0|||
47042362|NCT01397409|83299091|FG000|Stage 2|Other Miscellaneous Reasons|0|||
47042363|NCT01397409|83299092|FG001|Stage 2|Other Miscellaneous Reasons|0|||
47042364|NCT01397409|83299093|FG002|Stage 2|Other Miscellaneous Reasons|0|||
46632946|NCT01783548|82806177|FG000|Overall Study|Lost to Follow-up|8|||
46632947|NCT01783548|82806178|FG001|Overall Study|Lost to Follow-up|3|||
46720489|NCT03542266|82936472|FG000|Treatment Phase|Withdrawal by Subject|1|||
46920281|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
47042365|NCT01397409|83299094|FG003|Stage 2|Other Miscellaneous Reasons|0|||
47042366|NCT01397409|83299095|FG004|Stage 2|Other Miscellaneous Reasons|1|||
47042367|NCT01397409|83299096|FG005|Stage 2|Other Miscellaneous Reasons|1|||
47042368|NCT01397409|83299097|FG006|Stage 2|Other Miscellaneous Reasons|0|||
47042369|NCT01397409|83299098|FG007|Stage 2|Other Miscellaneous Reasons|0|||
47042370|NCT01397409|83299099|FG008|Stage 2|Other Miscellaneous Reasons|0|||
47042371|NCT01397409|83299100|FG009|Stage 2|Other Miscellaneous Reasons|0|||
47042372|NCT01397409|83299091|FG000|Stage 3|Adverse Event|0|||
47042373|NCT01397409|83299092|FG001|Stage 3|Adverse Event|0|||
47042374|NCT01397409|83299093|FG002|Stage 3|Adverse Event|0|||
47042375|NCT01397409|83299094|FG003|Stage 3|Adverse Event|0|||
47042376|NCT01397409|83299095|FG004|Stage 3|Adverse Event|0|||
47042377|NCT01397409|83299096|FG005|Stage 3|Adverse Event|0|||
47042378|NCT01397409|83299097|FG006|Stage 3|Adverse Event|0|||
47042379|NCT01397409|83299098|FG007|Stage 3|Adverse Event|1|||
47042380|NCT01397409|83299099|FG008|Stage 3|Adverse Event|0|||
47042381|NCT01397409|83299100|FG009|Stage 3|Adverse Event|0|||
47042382|NCT01397409|83299091|FG000|Stage 3|Other Miscellaneous Reasons|0|||
47042383|NCT01397409|83299092|FG001|Stage 3|Other Miscellaneous Reasons|0|||
47042384|NCT01397409|83299093|FG002|Stage 3|Other Miscellaneous Reasons|0|||
47042385|NCT01397409|83299094|FG003|Stage 3|Other Miscellaneous Reasons|0|||
47042386|NCT01397409|83299095|FG004|Stage 3|Other Miscellaneous Reasons|0|||
47042387|NCT01397409|83299096|FG005|Stage 3|Other Miscellaneous Reasons|0|||
47042388|NCT01397409|83299097|FG006|Stage 3|Other Miscellaneous Reasons|0|||
47042389|NCT01397409|83299098|FG007|Stage 3|Other Miscellaneous Reasons|1|||
47042390|NCT01397409|83299099|FG008|Stage 3|Other Miscellaneous Reasons|0|||
47042391|NCT01397409|83299100|FG009|Stage 3|Other Miscellaneous Reasons|0|||
47042392|NCT01397253|83299125|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
47042393|NCT01397253|83299126|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
47042394|NCT01777334|83299134|FG000|Overall Study|Adverse Event|18|||
47042395|NCT01777334|83299135|FG001|Overall Study|Adverse Event|14|||
47042396|NCT01777334|83299134|FG000|Overall Study|Lack of Efficacy|15|||
47042397|NCT01777334|83299135|FG001|Overall Study|Lack of Efficacy|29|||
47042398|NCT01777334|83299134|FG000|Overall Study|Protocol Violation|3|||
47042399|NCT01777334|83299135|FG001|Overall Study|Protocol Violation|7|||
47042400|NCT01777334|83299134|FG000|Overall Study|Lost to Follow-up|3|||
47042401|NCT01777334|83299135|FG001|Overall Study|Lost to Follow-up|2|||
47042402|NCT01777334|83299134|FG000|Overall Study|Withdrawal by Subject|14|||
47042403|NCT01777334|83299135|FG001|Overall Study|Withdrawal by Subject|11|||
47042404|NCT01383993|83299144|FG000|Overall Study|Adverse Event|1|||
47042405|NCT01383993|83299145|FG001|Overall Study|Adverse Event|1|||
47042406|NCT01383993|83299146|FG002|Overall Study|Adverse Event|0|||
47042407|NCT01383993|83299144|FG000|Overall Study|Withdrawal by Subject|0|||
47042408|NCT01383993|83299145|FG001|Overall Study|Withdrawal by Subject|0|||
47042409|NCT01383993|83299146|FG002|Overall Study|Withdrawal by Subject|1|||
47042410|NCT01383993|83299144|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
47042411|NCT01383993|83299145|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
47042412|NCT01383993|83299146|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
47042413|NCT01396395|83299157|FG000|Overall Study|Withdrawal by Subject|10|||
47042414|NCT01396395|83299158|FG001|Overall Study|Withdrawal by Subject|12|||
47042415|NCT01396395|83299157|FG000|Overall Study|Protocol Violation|3|||
47042416|NCT01396395|83299158|FG001|Overall Study|Protocol Violation|1|||
47042417|NCT01396395|83299157|FG000|Overall Study|Adverse Event|10|||
47042418|NCT01396395|83299158|FG001|Overall Study|Adverse Event|2|||
47042419|NCT01396395|83299157|FG000|Overall Study|Lost to Follow-up|17|||
47042420|NCT01396395|83299158|FG001|Overall Study|Lost to Follow-up|11|||
47042421|NCT01396395|83299157|FG000|Overall Study|Other|0|||
47042422|NCT01396395|83299158|FG001|Overall Study|Other|1|||
46720490|NCT03542266|82936472|FG000|Treatment Phase|Adverse Event|1|||
47042423|NCT01396317|83299168|FG000|Overall Study|Adverse Event|1|||
47042424|NCT01396317|83299169|FG001|Overall Study|Adverse Event|0|||
46720491|NCT03542266|82936472|FG000|Treatment Phase|PD|1|||
46720492|NCT00827359|82936476|FG000|Overall Study|Progressive Diseas|19|||
46720493|NCT00827359|82936476|FG000|Overall Study|Unacceptable Toxicity|5|||
46720494|NCT00827359|82936476|FG000|Overall Study|Ineligible|1|||
47042425|NCT01396161|83299184|FG000|Overall Study|Withdrawal by Subject|0|||
47042426|NCT01396161|83299185|FG001|Overall Study|Withdrawal by Subject|0|||
47042427|NCT01396161|83299186|FG002|Overall Study|Withdrawal by Subject|0|||
47042428|NCT01396161|83299187|FG003|Overall Study|Withdrawal by Subject|0|||
47042429|NCT01396161|83299188|FG004|Overall Study|Withdrawal by Subject|1|||
47042430|NCT01396161|83299189|FG005|Overall Study|Withdrawal by Subject|0|||
47042431|NCT01396161|83299190|FG006|Overall Study|Withdrawal by Subject|0|||
46720495|NCT00818389|82936482|FG000|Overall Study|Death|1|||
46720496|NCT00818389|82936483|FG001|Overall Study|Death|3|||
47042432|NCT01396161|83299184|FG000|Overall Study|Other|0|||
47042433|NCT01396161|83299185|FG001|Overall Study|Other|0|||
47042434|NCT01396161|83299186|FG002|Overall Study|Other|0|||
47042435|NCT01396161|83299187|FG003|Overall Study|Other|0|||
47042436|NCT01396161|83299188|FG004|Overall Study|Other|0|||
47042437|NCT01396161|83299189|FG005|Overall Study|Other|0|||
46720497|NCT00818389|82936482|FG000|Overall Study|ALS Disease Progression|1|||
47042438|NCT01396161|83299190|FG006|Overall Study|Other|1|||
47042439|NCT01396083|83299213|FG000|Overall Study|Adverse Event|2|||
47042440|NCT01396083|83299214|FG001|Overall Study|Adverse Event|28|||
47042441|NCT01396083|83299213|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
47042442|NCT01396083|83299214|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
47042443|NCT01396083|83299213|FG000|Overall Study|Consent withdrawn|4|||
47042444|NCT01396083|83299214|FG001|Overall Study|Consent withdrawn|5|||
47042445|NCT01396083|83299213|FG000|Overall Study|Protocol deviation(s)|0|||
47042446|NCT01396083|83299214|FG001|Overall Study|Protocol deviation(s)|1|||
47042447|NCT01396083|83299213|FG000|Overall Study|Abnormal laboratory value(s)|1|||
47042448|NCT01396083|83299214|FG001|Overall Study|Abnormal laboratory value(s)|0|||
47042449|NCT01396083|83299213|FG000|Overall Study|Administrative problems|1|||
47042450|NCT01396083|83299214|FG001|Overall Study|Administrative problems|0|||
47042451|NCT01396083|83299213|FG000|Overall Study|Lost to Follow-up|1|||
47042452|NCT01396083|83299214|FG001|Overall Study|Lost to Follow-up|0|||
47042453|NCT01723826|83299224|FG000|Overall Study|Adverse Event|4|||
47042454|NCT01723826|83299225|FG001|Overall Study|Adverse Event|1|||
47042455|NCT01723826|83299226|FG002|Overall Study|Adverse Event|4|||
47042456|NCT01723826|83299227|FG003|Overall Study|Adverse Event|5|||
47042457|NCT01723826|83299224|FG000|Overall Study|Death according to AE eCRF|2|||
46720498|NCT00818389|82936483|FG001|Overall Study|ALS Disease Progression|0|||
46720499|NCT00818389|82936482|FG000|Overall Study|Withdrawal by Subject|2|||
46720500|NCT00818389|82936483|FG001|Overall Study|Withdrawal by Subject|2|||
46720501|NCT00818389|82936482|FG000|Overall Study|Adverse Event|0|||
46720502|NCT00818389|82936483|FG001|Overall Study|Adverse Event|1|||
46632948|NCT01783548|82806177|FG000|Overall Study|Lack of Efficacy|1|||
46632949|NCT01783548|82806178|FG001|Overall Study|Lack of Efficacy|1|||
46720503|NCT00850135|82936489|FG000|Overall Study|Physician Decision|1|||
46720504|NCT01154816|82936507|FG000|Overall Study|Withdrawal by Subject|1|||
46720505|NCT01154816|82936508|FG001|Overall Study|Withdrawal by Subject|0|||
46720506|NCT01154816|82936509|FG002|Overall Study|Withdrawal by Subject|0|||
46720507|NCT01154816|82936510|FG003|Overall Study|Withdrawal by Subject|1|||
46720508|NCT01154816|82936511|FG004|Overall Study|Withdrawal by Subject|0|||
46720509|NCT01154816|82936512|FG005|Overall Study|Withdrawal by Subject|0|||
46720510|NCT01154816|82936513|FG006|Overall Study|Withdrawal by Subject|0|||
46720511|NCT01154816|82936514|FG007|Overall Study|Withdrawal by Subject|0|||
46720512|NCT01154816|82936515|FG008|Overall Study|Withdrawal by Subject|1|||
46720513|NCT01154816|82936516|FG009|Overall Study|Withdrawal by Subject|3|||
46720514|NCT01154816|82936517|FG010|Overall Study|Withdrawal by Subject|0|||
46720515|NCT01154816|82936518|FG011|Overall Study|Withdrawal by Subject|0|||
46720516|NCT01154816|82936507|FG000|Overall Study|Progressive Disease|13|||
46720517|NCT01154816|82936508|FG001|Overall Study|Progressive Disease|8|||
46720518|NCT01154816|82936509|FG002|Overall Study|Progressive Disease|9|||
46720519|NCT01154816|82936510|FG003|Overall Study|Progressive Disease|9|||
46720520|NCT01154816|82936511|FG004|Overall Study|Progressive Disease|8|||
46720521|NCT01154816|82936512|FG005|Overall Study|Progressive Disease|8|||
46720522|NCT01154816|82936513|FG006|Overall Study|Progressive Disease|5|||
46720523|NCT01154816|82936514|FG007|Overall Study|Progressive Disease|6|||
46720524|NCT01154816|82936515|FG008|Overall Study|Progressive Disease|8|||
46720525|NCT01154816|82936516|FG009|Overall Study|Progressive Disease|6|||
46720526|NCT01154816|82936517|FG010|Overall Study|Progressive Disease|10|||
46720527|NCT01154816|82936518|FG011|Overall Study|Progressive Disease|3|||
46720528|NCT01154816|82936507|FG000|Overall Study|Physician Decision|1|||
46632950|NCT01809210|82806191|FG000|Overall Study|Withdrawal by Subject|0|||
46632951|NCT01809210|82806192|FG001|Overall Study|Withdrawal by Subject|0|||
46632952|NCT01809210|82806193|FG002|Overall Study|Withdrawal by Subject|1|||
46632953|NCT01809210|82806194|FG003|Overall Study|Withdrawal by Subject|1|||
46632954|NCT01809210|82806195|FG004|Overall Study|Withdrawal by Subject|1|||
46632955|NCT01809210|82806196|FG005|Overall Study|Withdrawal by Subject|0|||
46632956|NCT01809210|82806197|FG006|Overall Study|Withdrawal by Subject|4|||
46632957|NCT01809210|82806191|FG000|Overall Study|Death|1|||
46720529|NCT01154816|82936508|FG001|Overall Study|Physician Decision|0|||
47042458|NCT01723826|83299225|FG001|Overall Study|Death according to AE eCRF|3|||
47042459|NCT01723826|83299226|FG002|Overall Study|Death according to AE eCRF|3|||
46632958|NCT01809210|82806192|FG001|Overall Study|Death|1|||
46632959|NCT01809210|82806193|FG002|Overall Study|Death|2|||
46720530|NCT01154816|82936509|FG002|Overall Study|Physician Decision|1|||
46720531|NCT01154816|82936510|FG003|Overall Study|Physician Decision|0|||
46720532|NCT01154816|82936511|FG004|Overall Study|Physician Decision|2|||
46720533|NCT01154816|82936512|FG005|Overall Study|Physician Decision|0|||
46720534|NCT01154816|82936513|FG006|Overall Study|Physician Decision|0|||
47042460|NCT01723826|83299227|FG003|Overall Study|Death according to AE eCRF|7|||
46720535|NCT01154816|82936514|FG007|Overall Study|Physician Decision|0|||
46720536|NCT01154816|82936515|FG008|Overall Study|Physician Decision|0|||
46720537|NCT01154816|82936516|FG009|Overall Study|Physician Decision|1|||
46720538|NCT01154816|82936517|FG010|Overall Study|Physician Decision|1|||
46720539|NCT01154816|82936518|FG011|Overall Study|Physician Decision|1|||
47042461|NCT01723826|83299224|FG000|Overall Study|Lost to Follow-up|1|||
46720540|NCT01154816|82936507|FG000|Overall Study|Adverse Event|5|||
46720541|NCT01154816|82936508|FG001|Overall Study|Adverse Event|2|||
46720542|NCT01154816|82936509|FG002|Overall Study|Adverse Event|0|||
46920282|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46920283|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
47042462|NCT01723826|83299225|FG001|Overall Study|Lost to Follow-up|3|||
47042463|NCT01723826|83299226|FG002|Overall Study|Lost to Follow-up|1|||
47042464|NCT01723826|83299227|FG003|Overall Study|Lost to Follow-up|1|||
47042465|NCT01723826|83299224|FG000|Overall Study|Non-compliance|0|||
47042466|NCT01723826|83299225|FG001|Overall Study|Non-compliance|1|||
47042467|NCT01723826|83299226|FG002|Overall Study|Non-compliance|3|||
47042468|NCT01723826|83299227|FG003|Overall Study|Non-compliance|3|||
47042469|NCT01723826|83299224|FG000|Overall Study|Non-compliance With Study Drug|0|||
47042470|NCT01723826|83299225|FG001|Overall Study|Non-compliance With Study Drug|1|||
47042471|NCT01723826|83299226|FG002|Overall Study|Non-compliance With Study Drug|0|||
47042472|NCT01723826|83299227|FG003|Overall Study|Non-compliance With Study Drug|0|||
47042473|NCT01723826|83299224|FG000|Overall Study|Other Reason|8|||
47042474|NCT01723826|83299225|FG001|Overall Study|Other Reason|6|||
47042475|NCT01723826|83299226|FG002|Overall Study|Other Reason|12|||
47042476|NCT01723826|83299227|FG003|Overall Study|Other Reason|14|||
47042477|NCT01723826|83299224|FG000|Overall Study|Physician Decision|1|||
47042478|NCT01723826|83299225|FG001|Overall Study|Physician Decision|3|||
47042479|NCT01723826|83299226|FG002|Overall Study|Physician Decision|4|||
47042480|NCT01723826|83299227|FG003|Overall Study|Physician Decision|11|||
47042481|NCT01723826|83299224|FG000|Overall Study|Protocol Violation|1|||
47042482|NCT01723826|83299225|FG001|Overall Study|Protocol Violation|1|||
47042483|NCT01723826|83299226|FG002|Overall Study|Protocol Violation|3|||
47042484|NCT01723826|83299227|FG003|Overall Study|Protocol Violation|1|||
47042485|NCT01723826|83299224|FG000|Overall Study|Withdrawal by Subject|10|||
47042486|NCT01723826|83299225|FG001|Overall Study|Withdrawal by Subject|17|||
47042487|NCT01723826|83299226|FG002|Overall Study|Withdrawal by Subject|27|||
47042488|NCT01723826|83299227|FG003|Overall Study|Withdrawal by Subject|48|||
46720543|NCT01154816|82936510|FG003|Overall Study|Adverse Event|0|||
46720544|NCT01154816|82936511|FG004|Overall Study|Adverse Event|0|||
46720545|NCT01154816|82936512|FG005|Overall Study|Adverse Event|0|||
46720546|NCT01154816|82936513|FG006|Overall Study|Adverse Event|1|||
46720547|NCT01154816|82936514|FG007|Overall Study|Adverse Event|1|||
46720548|NCT01154816|82936515|FG008|Overall Study|Adverse Event|0|||
46720549|NCT01154816|82936516|FG009|Overall Study|Adverse Event|0|||
46720550|NCT01154816|82936517|FG010|Overall Study|Adverse Event|0|||
46720551|NCT01154816|82936518|FG011|Overall Study|Adverse Event|0|||
46720552|NCT00849901|82936564|FG000|Acute Treatment Phase|Adverse Event|9|||
46720553|NCT00849901|82936565|FG001|Acute Treatment Phase|Adverse Event|1|||
46720554|NCT00849901|82936566|FG002|Acute Treatment Phase|Adverse Event|3|||
46720555|NCT00849901|82936564|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
46720556|NCT00849901|82936565|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
46720557|NCT00849901|82936566|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
46720558|NCT00849901|82936564|FG000|Acute Treatment Phase|Protocol Violation|0|||
46720559|NCT00849901|82936565|FG001|Acute Treatment Phase|Protocol Violation|2|||
46920284|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
47042489|NCT01721954|83299239|FG000|Overall Study|Death|58|||
47042490|NCT01721954|83299240|FG001|Overall Study|Death|64|||
47042491|NCT01721954|83299239|FG000|Overall Study|Withdrawal by Subject|8|||
47042492|NCT01721954|83299240|FG001|Overall Study|Withdrawal by Subject|4|||
47042493|NCT01721954|83299239|FG000|Overall Study|Adverse Event|2|||
47042494|NCT01721954|83299240|FG001|Overall Study|Adverse Event|0|||
47042495|NCT01721954|83299239|FG000|Overall Study|Lost to Follow-up|2|||
47042496|NCT01721954|83299240|FG001|Overall Study|Lost to Follow-up|1|||
47042497|NCT01776554|83299248|FG000|Overall Study|Adverse Event|1|||
47042498|NCT01776554|83299249|FG001|Overall Study|Adverse Event|0|||
47042499|NCT01776554|83299248|FG000|Overall Study|Withdrawal by Subject|3|||
47042500|NCT01776554|83299249|FG001|Overall Study|Withdrawal by Subject|8|||
47042501|NCT01776554|83299248|FG000|Overall Study|Lost to Follow-up|6|||
46720560|NCT00849901|82936566|FG002|Acute Treatment Phase|Protocol Violation|1|||
47042502|NCT01776554|83299249|FG001|Overall Study|Lost to Follow-up|9|||
47042503|NCT01776554|83299248|FG000|Overall Study|Administrative Reason|2|||
47042504|NCT01776554|83299249|FG001|Overall Study|Administrative Reason|5|||
47042505|NCT01776554|83299248|FG000|Overall Study|Protocol Violation|1|||
47042506|NCT01776554|83299249|FG001|Overall Study|Protocol Violation|0|||
47042507|NCT01776554|83299248|FG000|Overall Study|Unclassified|4|||
46720561|NCT00849901|82936564|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
46720562|NCT00849901|82936565|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
47042508|NCT01776554|83299249|FG001|Overall Study|Unclassified|1|||
47042509|NCT01776008|83299256|FG000|Overall Study|ineligible|2|||
47042510|NCT01746368|83299262|FG000|Overall Study|Lost to Follow-up|2|||
47042511|NCT01746368|83299263|FG001|Overall Study|Lost to Follow-up|0|||
47042512|NCT01746368|83299262|FG000|Overall Study|Withdrawal by Subject|0|||
47042513|NCT01746368|83299263|FG001|Overall Study|Withdrawal by Subject|1|||
47042514|NCT01381575|83299272|FG000|Overall Study|Serious Adverse Event|1|||
47042515|NCT01381575|83299273|FG001|Overall Study|Serious Adverse Event|0|||
47042516|NCT01381575|83299274|FG002|Overall Study|Serious Adverse Event|0|||
47042517|NCT01381575|83299272|FG000|Overall Study|Non-Serious Adverse Event|0|||
47042518|NCT01381575|83299273|FG001|Overall Study|Non-Serious Adverse Event|0|||
47042519|NCT01381575|83299274|FG002|Overall Study|Non-Serious Adverse Event|1|||
47042520|NCT01381575|83299272|FG000|Overall Study|Protocol Violation|0|||
47042521|NCT01381575|83299273|FG001|Overall Study|Protocol Violation|1|||
47042522|NCT01381575|83299274|FG002|Overall Study|Protocol Violation|1|||
47042523|NCT01381575|83299272|FG000|Overall Study|Withdrawal by Subject|15|||
47042524|NCT01381575|83299273|FG001|Overall Study|Withdrawal by Subject|9|||
47042525|NCT01381575|83299274|FG002|Overall Study|Withdrawal by Subject|7|||
47042526|NCT01381575|83299272|FG000|Overall Study|Migrated/moved from study area|2|||
47042527|NCT01381575|83299273|FG001|Overall Study|Migrated/moved from study area|12|||
47042528|NCT01381575|83299274|FG002|Overall Study|Migrated/moved from study area|2|||
47042529|NCT01381575|83299272|FG000|Overall Study|Lost to Follow-up|8|||
47042530|NCT01381575|83299273|FG001|Overall Study|Lost to Follow-up|17|||
46920285|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
47042531|NCT01381575|83299274|FG002|Overall Study|Lost to Follow-up|9|||
47042532|NCT01858363|83299285|FG000|Overall Study|Death|35|||
47042533|NCT01858363|83299286|FG001|Overall Study|Death|9|||
47042534|NCT01858363|83299285|FG000|Overall Study|Withdrawal by Subject|28|||
47042535|NCT01858363|83299286|FG001|Overall Study|Withdrawal by Subject|14|||
47042536|NCT01858363|83299285|FG000|Overall Study|Lost to Follow-up|13|||
47042537|NCT01858363|83299286|FG001|Overall Study|Lost to Follow-up|3|||
47042538|NCT01877551|83299294|FG000|Overall Study|Physician Decision|0|||
47042539|NCT01877551|83299295|FG001|Overall Study|Physician Decision|1|||
47042540|NCT01396005|83299303|FG000|Overall Study|Withdrawal by Subject|0|||
47042541|NCT01396005|83299304|FG001|Overall Study|Withdrawal by Subject|1|||
47042542|NCT01396005|83299303|FG000|Overall Study|Non-compliance with protocol|0|||
47042543|NCT01396005|83299304|FG001|Overall Study|Non-compliance with protocol|1|||
47042544|NCT01877239|83299312|FG000|Overall Study|Adverse Event|4|||
47042545|NCT01877239|83299312|FG000|Overall Study|Disease Remission|1|||
47042546|NCT01877239|83299312|FG000|Overall Study|Withdrawal by Subject|4|||
47042547|NCT01877239|83299312|FG000|Overall Study|Other|2|||
47042548|NCT01877239|83299312|FG000|Overall Study|Lack of Efficacy|4|||
47042549|NCT01877239|83299312|FG000|Overall Study|Data not available|35|||
47042550|NCT01877083|83299316|FG000|Treatment Phase|Disease Progression|10|||
47042551|NCT01877083|83299316|FG000|Treatment Phase|Clinical Progression|1|||
47042552|NCT01877083|83299316|FG000|Treatment Phase|Adverse Event|6|||
47042553|NCT01877083|83299316|FG000|Treatment Phase|Withdrawal by Subject|2|||
47042554|NCT01877083|83299316|FG000|Treatment Phase|Lost to Follow-up|1|||
47042555|NCT01877083|83299316|FG000|Extension Phase|Disease Progression|3|||
47042556|NCT01877083|83299316|FG000|Extension Phase|Adverse Event|2|||
47042557|NCT01380327|83299323|FG000|Overall Study|Lost to Follow-up|0|||
47042558|NCT01380327|83299324|FG001|Overall Study|Lost to Follow-up|1|||
47042559|NCT01380327|83299325|FG002|Overall Study|Lost to Follow-up|1|||
47042560|NCT01380327|83299323|FG000|Overall Study|Protocol Violation|3|||
47042561|NCT01380327|83299324|FG001|Overall Study|Protocol Violation|2|||
47042562|NCT01380327|83299325|FG002|Overall Study|Protocol Violation|3|||
47042563|NCT01380327|83299323|FG000|Overall Study|Withdrawal by Subject|0|||
47042564|NCT01380327|83299324|FG001|Overall Study|Withdrawal by Subject|0|||
47042565|NCT01380327|83299325|FG002|Overall Study|Withdrawal by Subject|1|||
47042566|NCT01380327|83299323|FG000|Overall Study|Housing situation precluded ability to k|0|||
47042567|NCT01380327|83299324|FG001|Overall Study|Housing situation precluded ability to k|0|||
47042568|NCT01380327|83299325|FG002|Overall Study|Housing situation precluded ability to k|1|||
47042569|NCT01380327|83299323|FG000|Overall Study|Questionable onset of epilepsy|0|||
47042570|NCT01380327|83299324|FG001|Overall Study|Questionable onset of epilepsy|0|||
47042571|NCT01380327|83299325|FG002|Overall Study|Questionable onset of epilepsy|1|||
47042572|NCT01829425|83299335|FG000|Overall Study|Withdrawal by Subject|4|||
47042573|NCT01829425|83299336|FG001|Overall Study|Withdrawal by Subject|3|||
46632960|NCT01809210|82806194|FG003|Overall Study|Death|0|||
46920286|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
46920287|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
47042574|NCT01829425|83299335|FG000|Overall Study|Lost to Follow-up|2|||
47042575|NCT01829425|83299336|FG001|Overall Study|Lost to Follow-up|1|||
47042576|NCT01394991|83299353|FG000|Overall Study|Adverse Event|0|||
47042577|NCT01394991|83299354|FG001|Overall Study|Adverse Event|4|||
47042578|NCT01394991|83299353|FG000|Overall Study|Lack of Efficacy|5|||
46632961|NCT01809210|82806195|FG004|Overall Study|Death|1|||
46920288|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
47042579|NCT01394991|83299354|FG001|Overall Study|Lack of Efficacy|7|||
47042580|NCT01394991|83299353|FG000|Overall Study|Lost to Follow-up|6|||
46632962|NCT01809210|82806196|FG005|Overall Study|Death|3|||
46632963|NCT01809210|82806197|FG006|Overall Study|Death|1|||
46632964|NCT01809132|82806216|FG000|Overall Study|Withdrawal by Subject|0|||
46632965|NCT01809132|82806217|FG001|Overall Study|Withdrawal by Subject|0|||
47042581|NCT01394991|83299354|FG001|Overall Study|Lost to Follow-up|8|||
47042582|NCT01394991|83299353|FG000|Overall Study|Physician Decision|1|||
47042583|NCT01394991|83299354|FG001|Overall Study|Physician Decision|3|||
47042584|NCT01394991|83299353|FG000|Overall Study|Protocol Violation|1|||
47042585|NCT01394991|83299354|FG001|Overall Study|Protocol Violation|1|||
47042586|NCT01394991|83299353|FG000|Overall Study|Withdrawal by Subject|20|||
47042587|NCT01394991|83299354|FG001|Overall Study|Withdrawal by Subject|17|||
47042588|NCT01394991|83299353|FG000|Overall Study|Chemotherapy Termination|10|||
47042589|NCT01394991|83299354|FG001|Overall Study|Chemotherapy Termination|15|||
47042590|NCT01394991|83299353|FG000|Overall Study|Disease Progression|7|||
47042591|NCT01394991|83299354|FG001|Overall Study|Disease Progression|7|||
47042592|NCT01394991|83299353|FG000|Overall Study|Prematurely Termination of Trial|9|||
47042593|NCT01394991|83299354|FG001|Overall Study|Prematurely Termination of Trial|10|||
47042594|NCT01829347|83299362|FG000|VTI-210|Death|5|||
47042595|NCT01829347|83299363|FG001|VTI-210|Death|3|||
47042596|NCT01829347|83299362|FG000|VTI-210|Withdrawal by Subject|1|||
47042597|NCT01829347|83299363|FG001|VTI-210|Withdrawal by Subject|0|||
47042598|NCT01829347|83299362|FG000|VTI-210E|Death|2|||
47042599|NCT01829347|83299363|FG001|VTI-210E|Death|1|||
47042600|NCT01829347|83299362|FG000|VTI-210E|Study terminated prematurely|1|||
47042601|NCT01829347|83299363|FG001|VTI-210E|Study terminated prematurely|5|||
47042602|NCT01394523|83299372|FG000|Overall Study|Unable to place block|1|||
47042603|NCT01394523|83299373|FG001|Overall Study|Unable to place block|0|||
47042604|NCT01394523|83299374|FG002|Overall Study|Unable to place block|0|||
47042605|NCT01857973|83299382|FG000|Overall Study|Subject did not meet required BG range|3|||
47042606|NCT01857973|83299382|FG000|Overall Study|drop out after 3 failed attempts|1|||
47042607|NCT01857973|83299382|FG000|Overall Study|Physician Decision|1|||
47042608|NCT01857583|83299390|FG000|Overall Study|Adverse Event|0|||
47042609|NCT01857583|83299391|FG001|Overall Study|Adverse Event|0|||
47042610|NCT01857583|83299392|FG002|Overall Study|Adverse Event|1|||
47042611|NCT01857583|83299393|FG003|Overall Study|Adverse Event|1|||
47042612|NCT01857583|83299390|FG000|Overall Study|Death|0|||
47042613|NCT01857583|83299391|FG001|Overall Study|Death|1|||
47042614|NCT01857583|83299392|FG002|Overall Study|Death|1|||
47042615|NCT01857583|83299393|FG003|Overall Study|Death|0|||
47042616|NCT01857583|83299390|FG000|Overall Study|Physician Decision|0|||
47042617|NCT01857583|83299391|FG001|Overall Study|Physician Decision|0|||
47042618|NCT01857583|83299392|FG002|Overall Study|Physician Decision|0|||
47042619|NCT01857583|83299393|FG003|Overall Study|Physician Decision|1|||
47042620|NCT01857583|83299390|FG000|Overall Study|Withdrawal by Subject|1|||
47042621|NCT01857583|83299391|FG001|Overall Study|Withdrawal by Subject|0|||
47042622|NCT01857583|83299392|FG002|Overall Study|Withdrawal by Subject|1|||
47042623|NCT01857583|83299393|FG003|Overall Study|Withdrawal by Subject|2|||
47042624|NCT01829191|83299405|FG000|Overall Study|Relocation|0|||
47042625|NCT01829191|83299406|FG001|Overall Study|Relocation|1|||
47042626|NCT01829191|83299405|FG000|Overall Study|Lens discomfort|0|||
47042627|NCT01829191|83299406|FG001|Overall Study|Lens discomfort|3|||
47042628|NCT01829191|83299405|FG000|Overall Study|Lens handling difficulty|1|||
47042629|NCT01829191|83299406|FG001|Overall Study|Lens handling difficulty|4|||
47042630|NCT01829191|83299405|FG000|Overall Study|Protocol Violation|4|||
47042631|NCT01829191|83299406|FG001|Overall Study|Protocol Violation|1|||
47042632|NCT01829191|83299405|FG000|Overall Study|Withdrawal by Subject|2|||
47042633|NCT01829191|83299406|FG001|Overall Study|Withdrawal by Subject|3|||
47042634|NCT01829191|83299405|FG000|Overall Study|Lost to Follow-up|0|||
47042635|NCT01829191|83299406|FG001|Overall Study|Lost to Follow-up|1|||
47042636|NCT01829191|83299405|FG000|Overall Study|Subject was fit for ortho - k|0|||
47042637|NCT01829191|83299406|FG001|Overall Study|Subject was fit for ortho - k|1|||
47042638|NCT00211185|83299411|FG000|Overall Study|Death|2|||
47042639|NCT00211185|83299411|FG000|Overall Study|Disease progression|7|||
47042640|NCT00211185|83299411|FG000|Overall Study|Withdrawal by Subject|6|||
47042641|NCT00211185|83299411|FG000|Overall Study|Physician Decision|5|||
46632966|NCT01809132|82806218|FG002|Overall Study|Withdrawal by Subject|1|||
46720563|NCT00849901|82936566|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
47042642|NCT00210639|83299417|FG000|Overall Study|Lost to Follow-up|37|||
47042643|NCT00210639|83299418|FG001|Overall Study|Lost to Follow-up|29|||
46632967|NCT01808508|82806229|FG000|Overall Study|Lost to Follow-up|1|||
47042644|NCT00210639|83299417|FG000|Overall Study|Withdrawal by Subject|8|||
47042645|NCT00210639|83299418|FG001|Overall Study|Withdrawal by Subject|1|||
47042646|NCT00210639|83299417|FG000|Overall Study|Other|18|||
47042647|NCT00210639|83299418|FG001|Overall Study|Other|12|||
47042648|NCT01829113|83299426|FG000|Overall Study|Disease Progression|37|||
47042649|NCT01829113|83299427|FG001|Overall Study|Disease Progression|48|||
47042650|NCT01829113|83299426|FG000|Overall Study|Adverse Event|14|||
47042651|NCT01829113|83299427|FG001|Overall Study|Adverse Event|10|||
47042652|NCT01829113|83299426|FG000|Overall Study|Withdrawal by Subject|17|||
47042653|NCT01829113|83299427|FG001|Overall Study|Withdrawal by Subject|10|||
47042654|NCT01829113|83299426|FG000|Overall Study|Death|4|||
47042655|NCT01829113|83299427|FG001|Overall Study|Death|6|||
47042656|NCT01829113|83299426|FG000|Overall Study|Sponsor Decision|1|||
47042657|NCT01829113|83299427|FG001|Overall Study|Sponsor Decision|1|||
47042658|NCT01829113|83299426|FG000|Overall Study|No Study Treatment Received|3|||
47042659|NCT01829113|83299427|FG001|Overall Study|No Study Treatment Received|2|||
47042660|NCT01829113|83299426|FG000|Overall Study|Physician Decision|1|||
47042661|NCT01829113|83299427|FG001|Overall Study|Physician Decision|1|||
47042662|NCT01857271|83299435|FG000|Overall Study|Lost to Follow-up|1|||
47042663|NCT01745120|83299441|FG000|Overall Study|Investigator decision|1|||
47042664|NCT01745120|83299442|FG001|Overall Study|Investigator decision|0|||
47042665|NCT01828567|83299453|FG000|Overall Study|Lost to Follow-up|27|||
47042666|NCT01828567|83299454|FG001|Overall Study|Lost to Follow-up|9|||
47042667|NCT01828567|83299453|FG000|Overall Study|Excluded - did not meet criteria|4|||
47042668|NCT01828567|83299454|FG001|Overall Study|Excluded - did not meet criteria|1|||
46720564|NCT00849901|82936564|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
46720565|NCT00849901|82936565|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
46720566|NCT00849901|82936566|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
46720567|NCT00849901|82936564|FG000|Acute Treatment Phase|Physician Decision|1|||
46720568|NCT00849901|82936565|FG001|Acute Treatment Phase|Physician Decision|1|||
46720569|NCT00849901|82936566|FG002|Acute Treatment Phase|Physician Decision|1|||
46720570|NCT00849901|82936564|FG000|Acute Treatment Phase|Sponsor Decision|1|||
46720571|NCT00849901|82936565|FG001|Acute Treatment Phase|Sponsor Decision|0|||
46720572|NCT00849901|82936566|FG002|Acute Treatment Phase|Sponsor Decision|0|||
46720573|NCT00849901|82936564|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
46720574|NCT00849901|82936565|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
46720575|NCT00849901|82936566|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
46720576|NCT00849901|82936564|FG000|Extension Phase|Adverse Event|2|||
46720577|NCT00849901|82936565|FG001|Extension Phase|Adverse Event|8|||
46720578|NCT00849901|82936566|FG002|Extension Phase|Adverse Event|4|||
46720579|NCT00849901|82936564|FG000|Extension Phase|Lost to Follow-up|3|||
46720580|NCT00849901|82936565|FG001|Extension Phase|Lost to Follow-up|0|||
47042669|NCT01721486|83299462|FG000|Overall Study|Protocol Violation|1|||
47042670|NCT01721486|83299463|FG001|Overall Study|Protocol Violation|0|||
47042671|NCT01721486|83299462|FG000|Overall Study|Physician Decision|0|||
47042672|NCT01721486|83299463|FG001|Overall Study|Physician Decision|1|||
47042673|NCT01775930|83299469|FG000|Overall Study|Futility stopping boundary met|1|||
47042674|NCT01856569|83299473|FG000|Overall Study|Other|1|||
47042675|NCT01856569|83299473|FG000|Overall Study|Changed Site/Structure|1|||
47042676|NCT01856569|83299473|FG000|Overall Study|Lost to Follow-up|3|||
47042677|NCT01856569|83299473|FG000|Overall Study|Did not met inclusion criteria|8|||
47042678|NCT01721408|83299479|FG000|Overall Study|Adverse Event|6|||
47042679|NCT01721408|83299480|FG001|Overall Study|Adverse Event|1|||
47042680|NCT01721408|83299479|FG000|Overall Study|Death|1|||
47042681|NCT01721408|83299480|FG001|Overall Study|Death|0|||
47042682|NCT01721408|83299479|FG000|Overall Study|Insufficient clinical response|15|||
47042683|NCT01721408|83299480|FG001|Overall Study|Insufficient clinical response|6|||
47042684|NCT01721408|83299479|FG000|Overall Study|No longer willing to participate study|9|||
47042685|NCT01721408|83299480|FG001|Overall Study|No longer willing to participate study|10|||
46632968|NCT01808508|82806230|FG001|Overall Study|Lost to Follow-up|0|||
46632969|NCT01808508|82806231|FG002|Overall Study|Lost to Follow-up|0|||
46632970|NCT01766778|82806241|FG000|Overall Study|Adverse Event|4|||
46632971|NCT01766778|82806242|FG001|Overall Study|Adverse Event|4|||
46632972|NCT01766778|82806241|FG000|Overall Study|Withdrawal by Subject|1|||
46632973|NCT01766778|82806242|FG001|Overall Study|Withdrawal by Subject|0|||
46632974|NCT01808196|82806248|FG000|Overall Study|Lost to Follow-up|1|||
46632975|NCT01808118|82806252|FG000|Period 1|Adverse Event|15|||
46632976|NCT01808118|82806253|FG001|Period 1|Adverse Event|0|||
46632977|NCT01808118|82806254|FG002|Period 1|Adverse Event|0|||
46632978|NCT01808118|82806252|FG000|Period 1|Withdrew consent|24|||
46632979|NCT01808118|82806253|FG001|Period 1|Withdrew consent|0|||
46632980|NCT01808118|82806254|FG002|Period 1|Withdrew consent|0|||
46632981|NCT01808118|82806252|FG000|Period 1|Lost to Follow-up|9|||
46920289|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
46920290|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
47042686|NCT01721408|83299479|FG000|Overall Study|Protocol Violation|0|||
46632982|NCT01808118|82806253|FG001|Period 1|Lost to Follow-up|0|||
47042687|NCT01721408|83299480|FG001|Overall Study|Protocol Violation|2|||
47042688|NCT01721408|83299479|FG000|Overall Study|Other|3|||
47042689|NCT01721408|83299480|FG001|Overall Study|Other|3|||
47042690|NCT01721408|83299479|FG000|Overall Study|Lost to Follow-up|1|||
47042691|NCT01721408|83299480|FG001|Overall Study|Lost to Follow-up|2|||
47042692|NCT01721408|83299479|FG000|Overall Study|Does not meet entrance criteria|1|||
46632983|NCT01808118|82806254|FG002|Period 1|Lost to Follow-up|0|||
46632984|NCT01808118|82806252|FG000|Period 1|Did not meet criteria for remission|303|||
46720581|NCT00849901|82936566|FG002|Extension Phase|Lost to Follow-up|1|||
46720582|NCT00849901|82936564|FG000|Extension Phase|Protocol Violation|2|||
47042693|NCT01721408|83299480|FG001|Overall Study|Does not meet entrance criteria|0|||
47042694|NCT01744496|83299488|FG000|Titration Period|Adverse Event|2|||
47042695|NCT01744496|83299489|FG001|Titration Period|Adverse Event|1|||
47042696|NCT01744496|83299488|FG000|Titration Period|Personal reasons|0|||
47042697|NCT01744496|83299489|FG001|Titration Period|Personal reasons|1|||
47042698|NCT01744496|83299488|FG000|Maintenance Period|Adverse Event|1|||
47042699|NCT01744496|83299489|FG001|Maintenance Period|Adverse Event|3|||
47042700|NCT01744496|83299488|FG000|Maintenance Period|Protocol Violation|1|||
47042701|NCT01744496|83299489|FG001|Maintenance Period|Protocol Violation|0|||
47042702|NCT01744496|83299488|FG000|Maintenance Period|Withdrawal by Subject|1|||
47042703|NCT01744496|83299489|FG001|Maintenance Period|Withdrawal by Subject|1|||
47042704|NCT01744496|83299488|FG000|Maintenance Period|Subject left town|1|||
47042705|NCT01744496|83299489|FG001|Maintenance Period|Subject left town|0|||
47042706|NCT01721330|83299497|FG000|Overall Study|Withdrawal by Subject|0|||
47042707|NCT01721330|83299498|FG001|Overall Study|Withdrawal by Subject|1|||
47042708|NCT01828021|83299514|FG000|Overall Study|Adverse Event|5|||
47042709|NCT01828021|83299514|FG000|Overall Study|Lack of Efficacy|17|||
47042710|NCT01828021|83299514|FG000|Overall Study|Withdrawal by Subject|2|||
47042711|NCT01828021|83299514|FG000|Overall Study|Ileal obstruction, unrelated|1|||
47042712|NCT01827943|83299518|FG000|Overall Study|Protocol Violation|8|||
47042713|NCT01827943|83299518|FG000|Overall Study|Never treated because of an rapid progression|1|||
47042714|NCT00217971|83299524|FG000|Overall Study|Adverse Event|1|||
47042715|NCT00217971|83299525|FG001|Overall Study|Adverse Event|1|||
47042716|NCT00217971|83299524|FG000|Overall Study|Lost to Follow-up|15|||
47042717|NCT00217971|83299525|FG001|Overall Study|Lost to Follow-up|19|||
47042718|NCT00217971|83299524|FG000|Overall Study|Physician Decision|0|||
47042719|NCT00217971|83299525|FG001|Overall Study|Physician Decision|1|||
47042720|NCT00217971|83299524|FG000|Overall Study|Withdrawal by Subject|7|||
47042721|NCT00217971|83299525|FG001|Overall Study|Withdrawal by Subject|12|||
47042722|NCT00217971|83299524|FG000|Overall Study|non compliant|1|||
47042723|NCT00217971|83299525|FG001|Overall Study|non compliant|0|||
47042724|NCT00217581|83299531|FG000|Overall Study|Withdrawal by Subject|1|||
47042725|NCT01856257|83299539|FG000|Overall Study|Death|2|||
47042726|NCT01856257|83299540|FG001|Overall Study|Death|0|||
47042727|NCT01856257|83299541|FG002|Overall Study|Death|0|||
47042728|NCT01856257|83299542|FG003|Overall Study|Death|0|||
47042729|NCT01856257|83299539|FG000|Overall Study|Physician Decision|0|||
47042730|NCT01856257|83299540|FG001|Overall Study|Physician Decision|0|||
47042731|NCT01856257|83299541|FG002|Overall Study|Physician Decision|0|||
47042732|NCT01856257|83299542|FG003|Overall Study|Physician Decision|1|||
47042733|NCT01856257|83299539|FG000|Overall Study|Withdrawal by Subject|1|||
47042734|NCT01856257|83299540|FG001|Overall Study|Withdrawal by Subject|1|||
47042735|NCT01856257|83299541|FG002|Overall Study|Withdrawal by Subject|0|||
47042736|NCT01856257|83299542|FG003|Overall Study|Withdrawal by Subject|0|||
47042737|NCT01856257|83299539|FG000|Overall Study|Donor complication|0|||
47042738|NCT01856257|83299540|FG001|Overall Study|Donor complication|0|||
47042739|NCT01856257|83299541|FG002|Overall Study|Donor complication|0|||
47042740|NCT01856257|83299542|FG003|Overall Study|Donor complication|1|||
47042741|NCT00215943|83299553|FG000|Overall Study|Disease Progression|3|||
47042742|NCT00215943|83299554|FG001|Overall Study|Disease Progression|5|||
47042743|NCT00215943|83299553|FG000|Overall Study|Alternate therapy|0|||
47042744|NCT00215943|83299554|FG001|Overall Study|Alternate therapy|1|||
47042745|NCT00215943|83299553|FG000|Overall Study|Adverse Event|3|||
47042746|NCT00215943|83299554|FG001|Overall Study|Adverse Event|6|||
47042747|NCT00215943|83299553|FG000|Overall Study|Other disease|0|||
47042748|NCT00215943|83299554|FG001|Overall Study|Other disease|1|||
47042749|NCT00215943|83299553|FG000|Overall Study|Other complications|3|||
47042750|NCT00215943|83299554|FG001|Overall Study|Other complications|1|||
47042751|NCT01827319|83299560|FG000|Overall Study|Lost to Follow-up|3|||
47042752|NCT01827163|83299564|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
47042753|NCT01827163|83299564|FG000|Overall Study|Adverse Event|9|||
47042754|NCT00215553|83299575|FG000|Overall Study|Adverse Event|0|||
47042755|NCT00215553|83299576|FG001|Overall Study|Adverse Event|1|||
47042756|NCT00215553|83299577|FG002|Overall Study|Adverse Event|2|||
47042757|NCT00215553|83299578|FG003|Overall Study|Adverse Event|1|||
47042758|NCT00215553|83299579|FG004|Overall Study|Adverse Event|2|||
47042759|NCT00215553|83299580|FG005|Overall Study|Adverse Event|6|||
47042760|NCT00215553|83299581|FG006|Overall Study|Adverse Event|0|||
47042761|NCT00214461|83299601|FG000|Overall Study|Adverse Event|0|||
47042762|NCT00214461|83299602|FG001|Overall Study|Adverse Event|0|||
47042763|NCT00214461|83299603|FG002|Overall Study|Adverse Event|1|||
47042764|NCT00214461|83299604|FG003|Overall Study|Adverse Event|1|||
47042765|NCT00214461|83299601|FG000|Overall Study|Withdrawal by Subject|0|||
47042766|NCT00214461|83299602|FG001|Overall Study|Withdrawal by Subject|0|||
47042767|NCT00214461|83299603|FG002|Overall Study|Withdrawal by Subject|1|||
47042768|NCT00214461|83299604|FG003|Overall Study|Withdrawal by Subject|0|||
47042769|NCT00214383|83299616|FG000|Overall Study|Lost to Follow-up|16|||
47042770|NCT00214383|83299617|FG001|Overall Study|Lost to Follow-up|26|||
47042771|NCT00212355|83299623|FG000|Overall Study|Adverse Event|1|||
47042772|NCT00212355|83299623|FG000|Overall Study|Withdrawal by Subject|1|||
47042773|NCT00212355|83299623|FG000|Overall Study|A change of address|1|||
47042774|NCT00211887|83299630|FG000|Overall Study|Adverse Event|8|||
47042775|NCT00211887|83299631|FG001|Overall Study|Adverse Event|4|||
47042776|NCT00211887|83299632|FG002|Overall Study|Adverse Event|6|||
47042777|NCT00211887|83299630|FG000|Overall Study|Death|1|||
47042778|NCT00211887|83299631|FG001|Overall Study|Death|1|||
47042779|NCT00211887|83299632|FG002|Overall Study|Death|1|||
47042780|NCT00211887|83299630|FG000|Overall Study|Lost to Follow-up|28|||
47042781|NCT00211887|83299631|FG001|Overall Study|Lost to Follow-up|13|||
47042782|NCT00211887|83299632|FG002|Overall Study|Lost to Follow-up|9|||
47042783|NCT00211887|83299630|FG000|Overall Study|Non-medical reason|31|||
47042784|NCT00211887|83299631|FG001|Overall Study|Non-medical reason|14|||
47042785|NCT00211887|83299632|FG002|Overall Study|Non-medical reason|8|||
47042786|NCT00211887|83299630|FG000|Overall Study|Other medical reason|15|||
47042787|NCT00211887|83299631|FG001|Overall Study|Other medical reason|11|||
47042788|NCT00211887|83299632|FG002|Overall Study|Other medical reason|7|||
47042789|NCT00211887|83299630|FG000|Overall Study|Side effects|19|||
47042790|NCT00211887|83299631|FG001|Overall Study|Side effects|13|||
47042791|NCT00211887|83299632|FG002|Overall Study|Side effects|5|||
47042792|NCT01855945|83299652|FG000|Overall Study|Adverse Event|0|||
47042793|NCT01855945|83299653|FG001|Overall Study|Adverse Event|0|||
47042794|NCT01855945|83299654|FG002|Overall Study|Adverse Event|0|||
47042795|NCT01855945|83299655|FG003|Overall Study|Adverse Event|0|||
47042796|NCT01855945|83299656|FG004|Overall Study|Adverse Event|0|||
47042797|NCT01855945|83299657|FG005|Overall Study|Adverse Event|0|||
47042798|NCT01855945|83299658|FG006|Overall Study|Adverse Event|1|||
46632985|NCT01808118|82806253|FG001|Period 1|Did not meet criteria for remission|0|||
46632986|NCT01808118|82806254|FG002|Period 1|Did not meet criteria for remission|0|||
46632987|NCT01808118|82806252|FG000|Period 1|Enrolled in error|7|||
46632988|NCT01808118|82806253|FG001|Period 1|Enrolled in error|0|||
46632989|NCT01808118|82806254|FG002|Period 1|Enrolled in error|0|||
46720583|NCT00849901|82936565|FG001|Extension Phase|Protocol Violation|2|||
46720584|NCT00849901|82936566|FG002|Extension Phase|Protocol Violation|4|||
46920291|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
46632990|NCT01808118|82806252|FG000|Period 1|Did not meet inclusion criteria|3|||
46632991|NCT01808118|82806253|FG001|Period 1|Did not meet inclusion criteria|0|||
46632992|NCT01808118|82806254|FG002|Period 1|Did not meet inclusion criteria|0|||
46632993|NCT01808118|82806252|FG000|Period 1|Non-conformance with inclusion criteria|3|||
46632994|NCT01808118|82806253|FG001|Period 1|Non-conformance with inclusion criteria|0|||
46632995|NCT01808118|82806254|FG002|Period 1|Non-conformance with inclusion criteria|0|||
46632996|NCT01808118|82806252|FG000|Period 1|Investigator decision: site closure|2|||
46632997|NCT01808118|82806253|FG001|Period 1|Investigator decision: site closure|0|||
46632998|NCT01808118|82806254|FG002|Period 1|Investigator decision: site closure|0|||
46632999|NCT01808118|82806252|FG000|Period 1|Non-compliance per sponsor|1|||
46633000|NCT01808118|82806253|FG001|Period 1|Non-compliance per sponsor|0|||
46633001|NCT01808118|82806254|FG002|Period 1|Non-compliance per sponsor|0|||
46633002|NCT01808118|82806252|FG000|Period 1|Lack of Efficacy|1|||
46633003|NCT01808118|82806253|FG001|Period 1|Lack of Efficacy|0|||
46633004|NCT01808118|82806254|FG002|Period 1|Lack of Efficacy|0|||
46633005|NCT01808118|82806252|FG000|Period 2|Adverse Event|0|||
46920292|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
46920293|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
46920294|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
46920295|NCT01307423|83152521|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46920296|NCT01307423|83152522|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46920297|NCT01307423|83152523|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
46920298|NCT01307423|83152524|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
47042799|NCT01855945|83299659|FG007|Overall Study|Adverse Event|0|||
47042800|NCT01855945|83299660|FG008|Overall Study|Adverse Event|0|||
47042801|NCT01855945|83299661|FG009|Overall Study|Adverse Event|0|||
47042802|NCT01855945|83299662|FG010|Overall Study|Adverse Event|0|||
47042803|NCT01855945|83299663|FG011|Overall Study|Adverse Event|0|||
47042804|NCT01855945|83299652|FG000|Overall Study|Death|0|||
47042805|NCT01855945|83299653|FG001|Overall Study|Death|0|||
46633006|NCT01808118|82806253|FG001|Period 2|Adverse Event|4|||
46720585|NCT00849901|82936564|FG000|Extension Phase|Withdrawal by Subject|7|||
46720586|NCT00849901|82936565|FG001|Extension Phase|Withdrawal by Subject|6|||
47042806|NCT01855945|83299654|FG002|Overall Study|Death|0|||
47042807|NCT01855945|83299655|FG003|Overall Study|Death|0|||
46633007|NCT01808118|82806254|FG002|Period 2|Adverse Event|0|||
46633008|NCT01808118|82806252|FG000|Period 2|Withdrew consent|0|||
46920299|NCT01307423|83152525|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
47042808|NCT01855945|83299656|FG004|Overall Study|Death|0|||
47042809|NCT01855945|83299657|FG005|Overall Study|Death|0|||
47042810|NCT01855945|83299658|FG006|Overall Study|Death|2|||
47042811|NCT01855945|83299659|FG007|Overall Study|Death|0|||
47042812|NCT01855945|83299660|FG008|Overall Study|Death|0|||
47042813|NCT01855945|83299661|FG009|Overall Study|Death|0|||
47042814|NCT01855945|83299662|FG010|Overall Study|Death|0|||
47042815|NCT01855945|83299663|FG011|Overall Study|Death|0|||
47042816|NCT01855945|83299652|FG000|Overall Study|Lost to Follow-up|11|||
47042817|NCT01855945|83299653|FG001|Overall Study|Lost to Follow-up|10|||
47042818|NCT01855945|83299654|FG002|Overall Study|Lost to Follow-up|7|||
47042819|NCT01855945|83299655|FG003|Overall Study|Lost to Follow-up|3|||
47042820|NCT01855945|83299656|FG004|Overall Study|Lost to Follow-up|0|||
47042821|NCT01855945|83299657|FG005|Overall Study|Lost to Follow-up|3|||
47042822|NCT01855945|83299658|FG006|Overall Study|Lost to Follow-up|4|||
47042823|NCT01855945|83299659|FG007|Overall Study|Lost to Follow-up|7|||
47042824|NCT01855945|83299660|FG008|Overall Study|Lost to Follow-up|2|||
47042825|NCT01855945|83299661|FG009|Overall Study|Lost to Follow-up|0|||
47042826|NCT01855945|83299662|FG010|Overall Study|Lost to Follow-up|0|||
47042827|NCT01855945|83299663|FG011|Overall Study|Lost to Follow-up|2|||
47042828|NCT01855945|83299652|FG000|Overall Study|Other - Unclassified|1|||
47042829|NCT01855945|83299653|FG001|Overall Study|Other - Unclassified|1|||
47042830|NCT01855945|83299654|FG002|Overall Study|Other - Unclassified|1|||
47042831|NCT01855945|83299655|FG003|Overall Study|Other - Unclassified|0|||
47042832|NCT01855945|83299656|FG004|Overall Study|Other - Unclassified|0|||
47042833|NCT01855945|83299657|FG005|Overall Study|Other - Unclassified|0|||
47042834|NCT01855945|83299658|FG006|Overall Study|Other - Unclassified|2|||
47042835|NCT01855945|83299659|FG007|Overall Study|Other - Unclassified|1|||
47042836|NCT01855945|83299660|FG008|Overall Study|Other - Unclassified|0|||
47042837|NCT01855945|83299661|FG009|Overall Study|Other - Unclassified|0|||
47042838|NCT01855945|83299662|FG010|Overall Study|Other - Unclassified|1|||
47042839|NCT01855945|83299663|FG011|Overall Study|Other - Unclassified|0|||
47042840|NCT01855945|83299652|FG000|Overall Study|Withdrawal by Subject|4|||
47042841|NCT01855945|83299653|FG001|Overall Study|Withdrawal by Subject|0|||
47042842|NCT01855945|83299654|FG002|Overall Study|Withdrawal by Subject|4|||
47042843|NCT01855945|83299655|FG003|Overall Study|Withdrawal by Subject|1|||
47042844|NCT01855945|83299656|FG004|Overall Study|Withdrawal by Subject|1|||
47042845|NCT01855945|83299657|FG005|Overall Study|Withdrawal by Subject|0|||
47042846|NCT01855945|83299658|FG006|Overall Study|Withdrawal by Subject|1|||
47042847|NCT01855945|83299659|FG007|Overall Study|Withdrawal by Subject|0|||
47042848|NCT01855945|83299660|FG008|Overall Study|Withdrawal by Subject|0|||
47042849|NCT01855945|83299661|FG009|Overall Study|Withdrawal by Subject|2|||
47042850|NCT01855945|83299662|FG010|Overall Study|Withdrawal by Subject|4|||
47042851|NCT01855945|83299663|FG011|Overall Study|Withdrawal by Subject|1|||
47042852|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Adverse Event|37|||
47042853|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Adverse Event|0|||
47042854|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Adverse Event|0|||
47042855|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Adverse Event|0|||
47042856|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Death|2|||
47042857|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Death|0|||
47042858|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Death|0|||
47042859|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Death|0|||
47042860|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
47042861|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
47042862|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
47042863|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
47042864|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
47042865|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
47042866|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
47042867|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
47042868|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
47042869|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
46920300|NCT01307423|83152526|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46633009|NCT01808118|82806253|FG001|Period 2|Withdrew consent|7|||
46633010|NCT01808118|82806254|FG002|Period 2|Withdrew consent|6|||
46920301|NCT01307423|83152527|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
46920302|NCT01307423|83152528|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
47042870|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
47042871|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
47042872|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
47042873|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
46633011|NCT01808118|82806252|FG000|Period 2|Lost to Follow-up|0|||
47042874|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
47042875|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
47042876|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Physician Decision|4|||
47042877|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Physician Decision|0|||
47042878|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Physician Decision|0|||
47042879|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Physician Decision|0|||
47042880|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Pregnancy|1|||
47042881|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Pregnancy|0|||
47042882|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Pregnancy|0|||
47042883|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Pregnancy|0|||
47042884|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
47042885|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
47042886|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
47042887|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
47042888|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
47042889|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
47042890|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
47042891|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
47042892|NCT01855789|83299726|FG000|1) Baseline up to Week 24|Other|4|||
47042893|NCT01855789|83299727|FG001|1) Baseline up to Week 24|Other|0|||
47042894|NCT01855789|83299728|FG002|1) Baseline up to Week 24|Other|0|||
47042895|NCT01855789|83299729|FG003|1) Baseline up to Week 24|Other|0|||
47042896|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
47042897|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
47042898|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
47042899|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
47042900|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
47042901|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
47042902|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
46720587|NCT00849901|82936566|FG002|Extension Phase|Withdrawal by Subject|3|||
46720588|NCT00849901|82936564|FG000|Extension Phase|Parent or Caregiver Decision|10|||
46720589|NCT00849901|82936565|FG001|Extension Phase|Parent or Caregiver Decision|4|||
46720590|NCT00849901|82936566|FG002|Extension Phase|Parent or Caregiver Decision|4|||
46720591|NCT00849901|82936564|FG000|Extension Phase|Physician Decision|1|||
46720592|NCT00849901|82936565|FG001|Extension Phase|Physician Decision|2|||
46720593|NCT00849901|82936566|FG002|Extension Phase|Physician Decision|0|||
46720594|NCT00849901|82936564|FG000|Extension Phase|Lack of Efficacy|2|||
46720595|NCT00849901|82936565|FG001|Extension Phase|Lack of Efficacy|4|||
46720596|NCT00849901|82936566|FG002|Extension Phase|Lack of Efficacy|1|||
46720597|NCT01168232|82936580|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
46720598|NCT01168232|82936580|FG000|Overall Study|Ineligible- Wrong cell type|6|||
46720599|NCT01168232|82936580|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
46720600|NCT00817531|82936584|FG000|Overall Study|Adverse Event|1|||
46720601|NCT00817531|82936584|FG000|Overall Study|Lack of Efficacy|1|||
46720602|NCT00817063|82936590|FG000|Overall Study|Adverse Event|32|||
46720603|NCT00817063|82936591|FG001|Overall Study|Adverse Event|13|||
46720604|NCT00817063|82936590|FG000|Overall Study|Death|1|||
46720605|NCT00817063|82936591|FG001|Overall Study|Death|1|||
46720606|NCT00817063|82936590|FG000|Overall Study|Lack of Efficacy|33|||
46720607|NCT00817063|82936591|FG001|Overall Study|Lack of Efficacy|86|||
46720608|NCT00817063|82936590|FG000|Overall Study|Failure to Return|13|||
46720609|NCT00817063|82936591|FG001|Overall Study|Failure to Return|12|||
46720610|NCT00817063|82936590|FG000|Overall Study|Violation of Selection at Entry|7|||
46720611|NCT00817063|82936591|FG001|Overall Study|Violation of Selection at Entry|4|||
46720612|NCT00817063|82936590|FG000|Overall Study|Protocol Violation|3|||
46720613|NCT00817063|82936591|FG001|Overall Study|Protocol Violation|8|||
46720614|NCT00817063|82936590|FG000|Overall Study|Withdrawal by Subject|17|||
47042903|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
47042904|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
47042905|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
47042906|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
47042907|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
47042908|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
47042909|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
47042910|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
47042911|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
47042912|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
46720615|NCT00817063|82936591|FG001|Overall Study|Withdrawal by Subject|37|||
46720616|NCT00817063|82936590|FG000|Overall Study|Early Improvement|19|||
47042913|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
47042914|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
46720617|NCT00817063|82936591|FG001|Overall Study|Early Improvement|4|||
47042915|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
46720618|NCT00817063|82936590|FG000|Overall Study|Administrative|10|||
46720619|NCT00817063|82936591|FG001|Overall Study|Administrative|4|||
46720620|NCT00817063|82936590|FG000|Overall Study|Abnormality of Laboratory Test|2|||
46720621|NCT00817063|82936591|FG001|Overall Study|Abnormality of Laboratory Test|1|||
47042916|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
47042917|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
47042918|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
47042919|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
47042920|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
47042921|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
47042922|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
47042923|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
47042924|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
47042925|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
47042926|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
47042927|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
47042928|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
47042929|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
47042930|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
47042931|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
47042932|NCT01855789|83299726|FG000|2) Week 24 up to End of Study|Other|0|||
47042933|NCT01855789|83299727|FG001|2) Week 24 up to End of Study|Other|0|||
47042934|NCT01855789|83299728|FG002|2) Week 24 up to End of Study|Other|0|||
47042935|NCT01855789|83299729|FG003|2) Week 24 up to End of Study|Other|1|||
47042936|NCT01610791|83299735|FG000|Overall Study|Lost to Follow-up|7|||
47042937|NCT01610791|83299735|FG000|Overall Study|Adverse Event|6|||
47042938|NCT01610791|83299735|FG000|Overall Study|Physician Decision|1|||
47042939|NCT01610791|83299735|FG000|Overall Study|Adverse event and Investigator decision|1|||
47042940|NCT01610791|83299735|FG000|Overall Study|Death|1|||
47042941|NCT01610791|83299735|FG000|Overall Study|Not determined|5|||
47042942|NCT01876381|83299739|FG000|Overall Study|Lack of Efficacy|5|||
47042943|NCT01876381|83299739|FG000|Overall Study|Physician Decision|1|||
47042944|NCT01876381|83299739|FG000|Overall Study|Withdrawal by Subject|1|||
47042945|NCT01855399|83299754|FG000|6 Month|Lost to Follow-up|12|||
47042946|NCT01855399|83299755|FG001|6 Month|Lost to Follow-up|9|||
47042947|NCT01855399|83299754|FG000|6 Month|Withdrawal by Subject|8|||
47042948|NCT01855399|83299755|FG001|6 Month|Withdrawal by Subject|6|||
47042949|NCT01855399|83299754|FG000|12 Month|Lost to Follow-up|7|||
47042950|NCT01855399|83299755|FG001|12 Month|Lost to Follow-up|11|||
47042951|NCT01875991|83299763|FG000|Overall Study|Withdrawal by Subject|6|||
47042952|NCT01875991|83299764|FG001|Overall Study|Withdrawal by Subject|6|||
47042953|NCT01875991|83299763|FG000|Overall Study|Sponsor Decision|1|||
47042954|NCT01875991|83299764|FG001|Overall Study|Sponsor Decision|0|||
47042955|NCT01855243|83299776|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
47042956|NCT01855243|83299777|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
47042957|NCT01855243|83299778|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
47042958|NCT01825837|83299790|FG000|PART I|Withdrawal by Subject|0|||
47042959|NCT01825837|83299791|FG001|PART I|Withdrawal by Subject|0|||
47042960|NCT01825837|83299792|FG002|PART I|Withdrawal by Subject|0|||
47042961|NCT01825837|83299793|FG003|PART I|Withdrawal by Subject|6|||
47042962|NCT01825837|83299790|FG000|PART I|Patient non-compliance|0|||
47042963|NCT01825837|83299791|FG001|PART I|Patient non-compliance|0|||
47042964|NCT01825837|83299792|FG002|PART I|Patient non-compliance|0|||
47042965|NCT01825837|83299793|FG003|PART I|Patient non-compliance|1|||
47042966|NCT01825837|83299790|FG000|PART I|Treatment failure|0|||
47042967|NCT01825837|83299791|FG001|PART I|Treatment failure|0|||
47042968|NCT01825837|83299792|FG002|PART I|Treatment failure|0|||
47042969|NCT01825837|83299793|FG003|PART I|Treatment failure|7|||
46633012|NCT01808118|82806253|FG001|Period 2|Lost to Follow-up|0|||
46633013|NCT01808118|82806254|FG002|Period 2|Lost to Follow-up|2|||
46633014|NCT01808118|82806252|FG000|Period 2|Investigator no longer conducting trials|0|||
46633015|NCT01808118|82806253|FG001|Period 2|Investigator no longer conducting trials|1|||
46633016|NCT01808118|82806254|FG002|Period 2|Investigator no longer conducting trials|0|||
46633017|NCT01808118|82806252|FG000|Period 2|Switched to other therapy|0|||
46633018|NCT01808118|82806253|FG001|Period 2|Switched to other therapy|1|||
46633019|NCT01808118|82806254|FG002|Period 2|Switched to other therapy|0|||
46633020|NCT01807650|82806268|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
46633021|NCT01807650|82806268|FG000|Overall Study|Adverse Event|5|||
47042970|NCT01825837|83299790|FG000|PART I|reason unspecified|0|||
47042971|NCT01825837|83299791|FG001|PART I|reason unspecified|0|||
47042972|NCT01825837|83299792|FG002|PART I|reason unspecified|0|||
47042973|NCT01825837|83299793|FG003|PART I|reason unspecified|3|||
47042974|NCT01825837|83299790|FG000|PART II|Withdrawal by Subject|3|||
47042975|NCT01825837|83299791|FG001|PART II|Withdrawal by Subject|3|||
47042976|NCT01825837|83299792|FG002|PART II|Withdrawal by Subject|7|||
46633022|NCT01807650|82806268|FG000|Overall Study|Other|2|||
46633023|NCT01782690|82806309|FG000|Overall Study|Not reported|7|||
46633024|NCT01782690|82806309|FG000|Overall Study|Toxicity of gemcitabine|1|||
47042977|NCT01825837|83299793|FG003|PART II|Withdrawal by Subject|0|||
47042978|NCT01825837|83299790|FG000|PART II|Patient non-compliance|5|||
47042979|NCT01825837|83299791|FG001|PART II|Patient non-compliance|2|||
47042980|NCT01825837|83299792|FG002|PART II|Patient non-compliance|4|||
47042981|NCT01825837|83299793|FG003|PART II|Patient non-compliance|0|||
47042982|NCT01825837|83299790|FG000|PART II|Adverse Event|3|||
47042983|NCT01825837|83299791|FG001|PART II|Adverse Event|3|||
47042984|NCT01825837|83299792|FG002|PART II|Adverse Event|1|||
47042985|NCT01825837|83299793|FG003|PART II|Adverse Event|0|||
47042986|NCT01825837|83299790|FG000|PART II|Treatment failure|6|||
47042987|NCT01825837|83299791|FG001|PART II|Treatment failure|4|||
47042988|NCT01825837|83299792|FG002|PART II|Treatment failure|5|||
47042989|NCT01825837|83299793|FG003|PART II|Treatment failure|0|||
47042990|NCT01825837|83299790|FG000|PART II|reason unspecified|2|||
46720622|NCT01166750|82936599|FG000|Overall Study|Lost to Follow-up|1|||
46720623|NCT01166750|82936600|FG001|Overall Study|Lost to Follow-up|0|||
46720624|NCT00826267|82936609|FG000|Overall Study|Other Adverse Event|1|||
46720625|NCT00826267|82936610|FG001|Overall Study|Other Adverse Event|0|||
46720626|NCT00826267|82936611|FG002|Overall Study|Other Adverse Event|0|||
46720627|NCT00986154|82936622|FG000|Overall Study|Death|136|||
46720628|NCT00986154|82936623|FG001|Overall Study|Death|127|||
46720629|NCT00986154|82936622|FG000|Overall Study|Lost to Follow-up|7|||
46720630|NCT00986154|82936623|FG001|Overall Study|Lost to Follow-up|4|||
46720631|NCT00986154|82936622|FG000|Overall Study|Withdrawal by Subject|32|||
46720632|NCT00986154|82936623|FG001|Overall Study|Withdrawal by Subject|33|||
46720633|NCT00986154|82936622|FG000|Overall Study|investigator/subject decide not continue|6|||
46720634|NCT00986154|82936623|FG001|Overall Study|investigator/subject decide not continue|3|||
46720635|NCT00986154|82936622|FG000|Overall Study|never received study drug|25|||
47042991|NCT01825837|83299791|FG001|PART II|reason unspecified|2|||
47042992|NCT01825837|83299792|FG002|PART II|reason unspecified|2|||
47042993|NCT01825837|83299793|FG003|PART II|reason unspecified|0|||
47042994|NCT01854697|83299806|FG000|Overall Study|Adverse Event|1|||
47042995|NCT01854697|83299807|FG001|Overall Study|Adverse Event|0|||
47042996|NCT01854697|83299808|FG002|Overall Study|Adverse Event|0|||
46720636|NCT00986154|82936623|FG001|Overall Study|never received study drug|27|||
46720637|NCT00848965|82936629|FG000|Overall Study|Adverse Event|1|||
46720638|NCT00848965|82936629|FG000|Overall Study|Withdrawal by Subject|1|||
46720639|NCT01154036|82936648|FG000|Phase I|Physician Decision|0|||
46720640|NCT01154036|82936649|FG001|Phase I|Physician Decision|1|||
46720641|NCT01154036|82936650|FG002|Phase I|Physician Decision|0|||
46720642|NCT01154036|82936651|FG003|Phase I|Physician Decision|0|||
46720643|NCT01154036|82936652|FG004|Phase I|Physician Decision|0|||
46720644|NCT01154036|82936653|FG005|Phase I|Physician Decision|0|||
46720645|NCT01154036|82936654|FG006|Phase I|Physician Decision|0|||
46720646|NCT01154036|82936655|FG007|Phase I|Physician Decision|0|||
46720647|NCT01154036|82936648|FG000|Phase I|Lost to Follow-up|0|||
46720648|NCT01154036|82936649|FG001|Phase I|Lost to Follow-up|3|||
46720649|NCT01154036|82936650|FG002|Phase I|Lost to Follow-up|6|||
46720650|NCT01154036|82936651|FG003|Phase I|Lost to Follow-up|0|||
46720651|NCT01154036|82936652|FG004|Phase I|Lost to Follow-up|0|||
46720652|NCT01154036|82936653|FG005|Phase I|Lost to Follow-up|0|||
46720653|NCT01154036|82936654|FG006|Phase I|Lost to Follow-up|0|||
46720654|NCT01154036|82936655|FG007|Phase I|Lost to Follow-up|0|||
46720655|NCT01154036|82936648|FG000|Phase I|Protocol Violation|0|||
46720656|NCT01154036|82936649|FG001|Phase I|Protocol Violation|3|||
46720657|NCT01154036|82936650|FG002|Phase I|Protocol Violation|9|||
46720658|NCT01154036|82936651|FG003|Phase I|Protocol Violation|0|||
46720659|NCT01154036|82936652|FG004|Phase I|Protocol Violation|0|||
46720660|NCT01154036|82936653|FG005|Phase I|Protocol Violation|0|||
46720661|NCT01154036|82936654|FG006|Phase I|Protocol Violation|0|||
46720662|NCT01154036|82936655|FG007|Phase I|Protocol Violation|0|||
46720663|NCT01154036|82936648|FG000|Phase I|Withdrawal by Subject|2|||
46720664|NCT01154036|82936649|FG001|Phase I|Withdrawal by Subject|10|||
46720665|NCT01154036|82936650|FG002|Phase I|Withdrawal by Subject|29|||
47042997|NCT01854697|83299809|FG003|Overall Study|Adverse Event|0|||
47042998|NCT01854697|83299810|FG004|Overall Study|Adverse Event|1|||
46720666|NCT01154036|82936651|FG003|Phase I|Withdrawal by Subject|0|||
46720667|NCT01154036|82936652|FG004|Phase I|Withdrawal by Subject|0|||
46720668|NCT01154036|82936653|FG005|Phase I|Withdrawal by Subject|0|||
46720669|NCT01154036|82936654|FG006|Phase I|Withdrawal by Subject|0|||
46720670|NCT01154036|82936655|FG007|Phase I|Withdrawal by Subject|0|||
46720671|NCT01154036|82936648|FG000|Phase I|Adverse Event|1|||
46720672|NCT01154036|82936649|FG001|Phase I|Adverse Event|11|||
46720673|NCT01154036|82936650|FG002|Phase I|Adverse Event|12|||
46720674|NCT01154036|82936651|FG003|Phase I|Adverse Event|0|||
46720675|NCT01154036|82936652|FG004|Phase I|Adverse Event|0|||
46720676|NCT01154036|82936653|FG005|Phase I|Adverse Event|0|||
46720677|NCT01154036|82936654|FG006|Phase I|Adverse Event|0|||
46720678|NCT01154036|82936655|FG007|Phase I|Adverse Event|0|||
46720679|NCT01154036|82936648|FG000|Phase II|Adverse Event|0|||
47042999|NCT01854697|83299806|FG000|Overall Study|Lost to Follow-up|4|||
47043000|NCT01854697|83299807|FG001|Overall Study|Lost to Follow-up|1|||
47043001|NCT01854697|83299808|FG002|Overall Study|Lost to Follow-up|1|||
47043002|NCT01854697|83299809|FG003|Overall Study|Lost to Follow-up|2|||
46920303|NCT01307423|83152529|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
46920304|NCT02778074|83152563|FG000|Overall Study|Lost to Follow-up|7|||
46920305|NCT02778074|83152564|FG001|Overall Study|Lost to Follow-up|10|||
46920306|NCT02775344|83152581|FG000|Overall Study|No ovarian cyst identified|3|||
46920307|NCT02775344|83152582|FG001|Overall Study|No ovarian cyst identified|2|||
46920308|NCT02777918|83152590|FG000|Overall Study|Medical reasons|1|||
46920309|NCT02777918|83152591|FG001|Overall Study|Medical reasons|2|||
46920310|NCT02777918|83152590|FG000|Overall Study|Too busy / stressed|1|||
46920311|NCT02777918|83152591|FG001|Overall Study|Too busy / stressed|1|||
46920312|NCT02777918|83152590|FG000|Overall Study|Withdrawal by Subject|1|||
46920313|NCT02777918|83152591|FG001|Overall Study|Withdrawal by Subject|1|||
46920314|NCT02927795|83152597|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
46920315|NCT02927795|83152597|FG000|Overall Study|Not Treated|4|||
47043003|NCT01854697|83299810|FG004|Overall Study|Lost to Follow-up|0|||
47043004|NCT01854697|83299806|FG000|Overall Study|To enter another AbbVie study|1|||
47043005|NCT01854697|83299807|FG001|Overall Study|To enter another AbbVie study|0|||
47043006|NCT01854697|83299808|FG002|Overall Study|To enter another AbbVie study|0|||
47043007|NCT01854697|83299809|FG003|Overall Study|To enter another AbbVie study|0|||
47043008|NCT01854697|83299810|FG004|Overall Study|To enter another AbbVie study|1|||
47043009|NCT01854697|83299806|FG000|Overall Study|Withdrew Consent|0|||
47043010|NCT01854697|83299807|FG001|Overall Study|Withdrew Consent|1|||
47043011|NCT01854697|83299808|FG002|Overall Study|Withdrew Consent|0|||
47043012|NCT01854697|83299809|FG003|Overall Study|Withdrew Consent|1|||
47043013|NCT01854697|83299810|FG004|Overall Study|Withdrew Consent|0|||
47043014|NCT01854697|83299806|FG000|Overall Study|Other|0|||
47043015|NCT01854697|83299807|FG001|Overall Study|Other|1|||
47043016|NCT01854697|83299808|FG002|Overall Study|Other|1|||
47043017|NCT01854697|83299809|FG003|Overall Study|Other|0|||
47043018|NCT01854697|83299810|FG004|Overall Study|Other|0|||
47043019|NCT01824979|83299822|FG000|Overall Study|Withdrawal by Subject|5|||
47043020|NCT01824979|83299823|FG001|Overall Study|Withdrawal by Subject|0|||
47043021|NCT01824979|83299822|FG000|Overall Study|Physician Decision|2|||
47043022|NCT01824979|83299823|FG001|Overall Study|Physician Decision|0|||
47043023|NCT01824979|83299822|FG000|Overall Study|Protocol Violation|6|||
47043024|NCT01824979|83299823|FG001|Overall Study|Protocol Violation|13|||
47043025|NCT01824823|83299831|FG000|Overall Study|Lack of Efficacy|1|||
47043026|NCT01824823|83299832|FG001|Overall Study|Lack of Efficacy|1|||
47043027|NCT01824823|83299831|FG000|Overall Study|Off-treatment reason not submitted|1|||
47043028|NCT01824823|83299832|FG001|Overall Study|Off-treatment reason not submitted|0|||
47043029|NCT01875367|83299840|FG000|Overall Study|Not complete at least 2 questionaries|4|||
47043030|NCT01875367|83299841|FG001|Overall Study|Not complete at least 2 questionaries|2|||
47043031|NCT01875367|83299840|FG000|Overall Study|Not receive study treatment|1|||
47043032|NCT01875367|83299841|FG001|Overall Study|Not receive study treatment|0|||
47043033|NCT01853839|83299851|FG000|Overall Study|Violated inclusion criteria|2|||
47043034|NCT01853839|83299851|FG000|Overall Study|Not meet ITT population definition|58|||
47043035|NCT01853839|83299851|FG000|Overall Study|End of treatment visit too early|33|||
47043036|NCT01853839|83299851|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
47043037|NCT01874665|83299861|FG000|Overall Study|Adverse Event|6|||
47043038|NCT01874665|83299862|FG001|Overall Study|Adverse Event|2|||
47043039|NCT01874665|83299861|FG000|Overall Study|Withdrawal by Subject|4|||
47043040|NCT01874665|83299862|FG001|Overall Study|Withdrawal by Subject|1|||
47043041|NCT01874665|83299861|FG000|Overall Study|Physician Decision|3|||
47043042|NCT01874665|83299862|FG001|Overall Study|Physician Decision|0|||
47043043|NCT01874665|83299861|FG000|Overall Study|Clinical Progressive Disease|4|||
47043044|NCT01874665|83299862|FG001|Overall Study|Clinical Progressive Disease|3|||
47043045|NCT01874665|83299861|FG000|Overall Study|Study Terminated by Sponsor|0|||
46633025|NCT01782690|82806309|FG000|Overall Study|Toxicity of erlotinib|1|||
46967649|NCT02185534|83210201|FG000|First Washout Period|Withdrawal by Subject|1|||
46967650|NCT02185534|83210202|FG001|First Washout Period|Withdrawal by Subject|0|||
46967651|NCT02185534|83210203|FG002|First Washout Period|Withdrawal by Subject|0|||
46967652|NCT02185534|83210204|FG003|First Washout Period|Withdrawal by Subject|0|||
46967653|NCT02185534|83210205|FG004|First Washout Period|Withdrawal by Subject|1|||
46967654|NCT02185534|83210206|FG005|First Washout Period|Withdrawal by Subject|0|||
46967655|NCT02185534|83210201|FG000|First Washout Period|Protocol Violation|0|||
46967656|NCT02185534|83210202|FG001|First Washout Period|Protocol Violation|0|||
46967657|NCT02185534|83210203|FG002|First Washout Period|Protocol Violation|0|||
46967658|NCT02185534|83210204|FG003|First Washout Period|Protocol Violation|0|||
46967659|NCT02185534|83210205|FG004|First Washout Period|Protocol Violation|0|||
46967660|NCT02185534|83210206|FG005|First Washout Period|Protocol Violation|1|||
46967661|NCT02121808|83210215|FG000|Overall Study|Technical problem|3|||
46967662|NCT02157376|83210226|FG000|Overall Study|Death|10|||
46967663|NCT02157376|83210227|FG001|Overall Study|Death|4|||
46967664|NCT02157376|83210226|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46967665|NCT02157376|83210227|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
47043046|NCT01874665|83299862|FG001|Overall Study|Study Terminated by Sponsor|2|||
47043047|NCT01874665|83299861|FG000|Overall Study|Documented Progressive Disease|11|||
46720680|NCT01154036|82936649|FG001|Phase II|Adverse Event|0|||
46720681|NCT01154036|82936650|FG002|Phase II|Adverse Event|0|||
46720682|NCT01154036|82936651|FG003|Phase II|Adverse Event|0|||
47043048|NCT01874665|83299862|FG001|Overall Study|Documented Progressive Disease|7|||
47043049|NCT01874665|83299861|FG000|Overall Study|Other|2|||
47043050|NCT01874665|83299862|FG001|Overall Study|Other|0|||
47043051|NCT01874431|83299877|FG000|Overall Study|Physician Decision|0|||
47043052|NCT01874431|83299878|FG001|Overall Study|Physician Decision|0|||
47043053|NCT01874431|83299879|FG002|Overall Study|Physician Decision|1|||
47043054|NCT01874431|83299880|FG003|Overall Study|Physician Decision|0|||
47043055|NCT01874431|83299881|FG004|Overall Study|Physician Decision|0|||
47043056|NCT01874431|83299882|FG005|Overall Study|Physician Decision|0|||
47043057|NCT01874431|83299883|FG006|Overall Study|Physician Decision|0|||
47043058|NCT01874431|83299884|FG007|Overall Study|Physician Decision|0|||
47043059|NCT01874431|83299877|FG000|Overall Study|Adverse Event|5|||
47043060|NCT01874431|83299878|FG001|Overall Study|Adverse Event|4|||
47043061|NCT01874431|83299879|FG002|Overall Study|Adverse Event|6|||
47043062|NCT01874431|83299880|FG003|Overall Study|Adverse Event|5|||
47043063|NCT01874431|83299881|FG004|Overall Study|Adverse Event|2|||
47043064|NCT01874431|83299882|FG005|Overall Study|Adverse Event|8|||
47043065|NCT01874431|83299883|FG006|Overall Study|Adverse Event|2|||
47043066|NCT01874431|83299884|FG007|Overall Study|Adverse Event|3|||
47043067|NCT01874431|83299877|FG000|Overall Study|Protocol Violation|1|||
47043068|NCT01874431|83299878|FG001|Overall Study|Protocol Violation|1|||
47043069|NCT01874431|83299879|FG002|Overall Study|Protocol Violation|1|||
47043070|NCT01874431|83299880|FG003|Overall Study|Protocol Violation|0|||
47043071|NCT01874431|83299881|FG004|Overall Study|Protocol Violation|3|||
47043072|NCT01874431|83299882|FG005|Overall Study|Protocol Violation|2|||
47043073|NCT01874431|83299883|FG006|Overall Study|Protocol Violation|1|||
47043074|NCT01874431|83299884|FG007|Overall Study|Protocol Violation|1|||
47043075|NCT01874431|83299877|FG000|Overall Study|Non-compliance|0|||
47043076|NCT01874431|83299878|FG001|Overall Study|Non-compliance|0|||
47043077|NCT01874431|83299879|FG002|Overall Study|Non-compliance|0|||
47043078|NCT01874431|83299880|FG003|Overall Study|Non-compliance|0|||
47043079|NCT01874431|83299881|FG004|Overall Study|Non-compliance|1|||
47043080|NCT01874431|83299882|FG005|Overall Study|Non-compliance|0|||
47043081|NCT01874431|83299883|FG006|Overall Study|Non-compliance|1|||
47043082|NCT01874431|83299884|FG007|Overall Study|Non-compliance|0|||
47043083|NCT01874431|83299877|FG000|Overall Study|Logistical difficulties|0|||
47043084|NCT01874431|83299878|FG001|Overall Study|Logistical difficulties|0|||
46720683|NCT01154036|82936652|FG004|Phase II|Adverse Event|1|||
46720684|NCT01154036|82936653|FG005|Phase II|Adverse Event|1|||
46720685|NCT01154036|82936654|FG006|Phase II|Adverse Event|1|||
46720686|NCT01154036|82936655|FG007|Phase II|Adverse Event|1|||
46720687|NCT01154036|82936648|FG000|Phase II|Physician Decision|0|||
46720688|NCT01154036|82936649|FG001|Phase II|Physician Decision|0|||
46720689|NCT01154036|82936650|FG002|Phase II|Physician Decision|0|||
46720690|NCT01154036|82936651|FG003|Phase II|Physician Decision|0|||
46720691|NCT01154036|82936652|FG004|Phase II|Physician Decision|0|||
46720692|NCT01154036|82936653|FG005|Phase II|Physician Decision|0|||
46720693|NCT01154036|82936654|FG006|Phase II|Physician Decision|1|||
46720694|NCT01154036|82936655|FG007|Phase II|Physician Decision|0|||
47043085|NCT01874431|83299879|FG002|Overall Study|Logistical difficulties|0|||
47043086|NCT01874431|83299880|FG003|Overall Study|Logistical difficulties|0|||
47043087|NCT01874431|83299881|FG004|Overall Study|Logistical difficulties|0|||
47043088|NCT01874431|83299882|FG005|Overall Study|Logistical difficulties|0|||
47043089|NCT01874431|83299883|FG006|Overall Study|Logistical difficulties|1|||
47043090|NCT01874431|83299884|FG007|Overall Study|Logistical difficulties|0|||
47043091|NCT01874431|83299877|FG000|Overall Study|Withdrawal by Subject|0|||
47043092|NCT01874431|83299878|FG001|Overall Study|Withdrawal by Subject|0|||
46720695|NCT01154036|82936648|FG000|Phase II|Lost to Follow-up|0|||
46720696|NCT01154036|82936649|FG001|Phase II|Lost to Follow-up|0|||
46720697|NCT01154036|82936650|FG002|Phase II|Lost to Follow-up|0|||
46720698|NCT01154036|82936651|FG003|Phase II|Lost to Follow-up|1|||
47043093|NCT01874431|83299879|FG002|Overall Study|Withdrawal by Subject|1|||
47043094|NCT01874431|83299880|FG003|Overall Study|Withdrawal by Subject|2|||
47043095|NCT01874431|83299881|FG004|Overall Study|Withdrawal by Subject|1|||
47043096|NCT01874431|83299882|FG005|Overall Study|Withdrawal by Subject|1|||
47043097|NCT01874431|83299883|FG006|Overall Study|Withdrawal by Subject|3|||
47043098|NCT01874431|83299884|FG007|Overall Study|Withdrawal by Subject|0|||
47043099|NCT01874431|83299877|FG000|Overall Study|Sponsor decision|0|||
47043100|NCT01874431|83299878|FG001|Overall Study|Sponsor decision|0|||
47043101|NCT01874431|83299879|FG002|Overall Study|Sponsor decision|0|||
47043102|NCT01874431|83299880|FG003|Overall Study|Sponsor decision|0|||
47043103|NCT01874431|83299881|FG004|Overall Study|Sponsor decision|1|||
46720699|NCT01154036|82936652|FG004|Phase II|Lost to Follow-up|2|||
47043104|NCT01874431|83299882|FG005|Overall Study|Sponsor decision|0|||
47043105|NCT01874431|83299883|FG006|Overall Study|Sponsor decision|0|||
47043106|NCT01874431|83299884|FG007|Overall Study|Sponsor decision|0|||
47043107|NCT01874431|83299877|FG000|Overall Study|Lost to Follow-up|0|||
47043108|NCT01874431|83299878|FG001|Overall Study|Lost to Follow-up|0|||
47043109|NCT01874431|83299879|FG002|Overall Study|Lost to Follow-up|1|||
47043110|NCT01874431|83299880|FG003|Overall Study|Lost to Follow-up|0|||
47043111|NCT01874431|83299881|FG004|Overall Study|Lost to Follow-up|0|||
47043112|NCT01874431|83299882|FG005|Overall Study|Lost to Follow-up|0|||
47043113|NCT01874431|83299883|FG006|Overall Study|Lost to Follow-up|0|||
47043114|NCT01874431|83299884|FG007|Overall Study|Lost to Follow-up|0|||
47043115|NCT01824355|83299902|FG000|Overall Study|Adverse Event|2|||
47043116|NCT01824355|83299902|FG000|Overall Study|unevaluable reference method results per|1|||
47043117|NCT01823341|83299910|FG000|Overall Study|Failed run-in|7|||
47043118|NCT01823341|83299910|FG000|Overall Study|Withdrawal by Subject|7|||
46720700|NCT01154036|82936653|FG005|Phase II|Lost to Follow-up|0|||
46720701|NCT01154036|82936654|FG006|Phase II|Lost to Follow-up|2|||
46720702|NCT01154036|82936655|FG007|Phase II|Lost to Follow-up|1|||
46720703|NCT01154036|82936648|FG000|Phase II|Protocol Violation|0|||
46720704|NCT01154036|82936649|FG001|Phase II|Protocol Violation|0|||
46720705|NCT01154036|82936650|FG002|Phase II|Protocol Violation|0|||
46720706|NCT01154036|82936651|FG003|Phase II|Protocol Violation|0|||
46720707|NCT01154036|82936652|FG004|Phase II|Protocol Violation|1|||
46720708|NCT01154036|82936653|FG005|Phase II|Protocol Violation|2|||
46720709|NCT01154036|82936654|FG006|Phase II|Protocol Violation|0|||
46720710|NCT01154036|82936655|FG007|Phase II|Protocol Violation|0|||
46720711|NCT01154036|82936648|FG000|Phase II|Withdrawal by Subject|0|||
46720712|NCT01154036|82936649|FG001|Phase II|Withdrawal by Subject|0|||
46720713|NCT01154036|82936650|FG002|Phase II|Withdrawal by Subject|0|||
46720714|NCT01154036|82936651|FG003|Phase II|Withdrawal by Subject|0|||
46720715|NCT01154036|82936652|FG004|Phase II|Withdrawal by Subject|4|||
46720716|NCT01154036|82936653|FG005|Phase II|Withdrawal by Subject|2|||
46720717|NCT01154036|82936654|FG006|Phase II|Withdrawal by Subject|5|||
46720718|NCT01154036|82936655|FG007|Phase II|Withdrawal by Subject|4|||
46720719|NCT00816595|82936677|FG000|Overall Study|Withdrawal by Subject|2|||
46720720|NCT00816595|82936678|FG001|Overall Study|Withdrawal by Subject|0|||
46720721|NCT01166438|82936688|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
46720722|NCT01166438|82936689|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
46720723|NCT01166438|82936688|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
46720724|NCT01166438|82936689|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
46720725|NCT01166438|82936688|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
46720726|NCT01166438|82936689|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
46720727|NCT01166438|82936688|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
46720728|NCT01166438|82936689|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
46720729|NCT01166438|82936688|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
46720730|NCT01166438|82936689|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
46720731|NCT01166438|82936688|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
46720732|NCT01166438|82936689|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
46720733|NCT01153958|82936698|FG000|Overall Study|Study Terminated|36|||
46720734|NCT01153958|82936699|FG001|Overall Study|Study Terminated|32|||
46720735|NCT00599638|82936709|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
46720736|NCT00599638|82936710|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
46720737|NCT00599638|82936711|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
46720738|NCT00599638|82936712|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
46720739|NCT00599638|82936709|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
46720740|NCT00599638|82936710|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
46720741|NCT00599638|82936711|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
46720742|NCT00599638|82936712|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
46720743|NCT00599638|82936709|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
46720744|NCT00599638|82936710|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
46920316|NCT02767856|83152603|FG000|Overall Study|Lost to Follow-up|9|||
46920317|NCT02767856|83152604|FG001|Overall Study|Lost to Follow-up|1|||
46920318|NCT02767856|83152603|FG000|Overall Study|Withdrawal by Subject|2|||
47043119|NCT01823341|83299910|FG000|Overall Study|Adverse Event|1|||
47043120|NCT01853137|83299919|FG000|Overall Study|Lost to Follow-up|4|||
47043121|NCT01853137|83299920|FG001|Overall Study|Lost to Follow-up|1|||
47043122|NCT01823107|83299927|FG000|Overall Study|Withdrawal by Subject|1|||
46720745|NCT00599638|82936711|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
46720746|NCT00599638|82936712|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
46720747|NCT00599638|82936709|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
46720748|NCT00599638|82936710|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
46720749|NCT00599638|82936711|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
46720750|NCT00599638|82936712|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
46920319|NCT02767856|83152604|FG001|Overall Study|Withdrawal by Subject|1|||
47043123|NCT01874275|83299933|FG000|Overall Study|Lost to Follow-up|1|||
47043124|NCT01874275|83299934|FG001|Overall Study|Lost to Follow-up|0|||
47043125|NCT01873729|83299946|FG000|Overall Study|Withdrawal by Subject|1|||
47043126|NCT01873495|83299950|FG000|Overall Study|Withdrawal by Subject|1|||
47043127|NCT01873495|83299950|FG000|Overall Study|Physician Decision|3|||
47043128|NCT01873495|83299950|FG000|Overall Study|Adverse Event|1|||
47043129|NCT01873495|83299950|FG000|Overall Study|Removed for Transplantation|1|||
47043130|NCT01873495|83299950|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
47043131|NCT01852825|83299957|FG000|Overall Study|Withdrawal by Subject|2|||
47043132|NCT01852825|83299958|FG001|Overall Study|Withdrawal by Subject|0|||
47043133|NCT01852825|83299959|FG002|Overall Study|Withdrawal by Subject|0|||
47043134|NCT01822561|83299967|FG000|Overall Study|Withdrawal by Subject|2|||
47043135|NCT01852591|83299992|FG000|Overall Study|Withdrawal by Subject|2|||
47043136|NCT01852591|83299992|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
47043137|NCT01852045|83299999|FG000|Overall Study|Adverse Event|1|||
47043138|NCT01852045|83300000|FG001|Overall Study|Adverse Event|0|||
47043139|NCT01852045|83300001|FG002|Overall Study|Adverse Event|0|||
47043140|NCT01852045|83299999|FG000|Overall Study|Lack of Efficacy|3|||
47043141|NCT01852045|83300000|FG001|Overall Study|Lack of Efficacy|0|||
47043142|NCT01852045|83300001|FG002|Overall Study|Lack of Efficacy|0|||
47043143|NCT01852045|83299999|FG000|Overall Study|Lost to Follow-up|0|||
47043144|NCT01852045|83300000|FG001|Overall Study|Lost to Follow-up|1|||
47043145|NCT01852045|83300001|FG002|Overall Study|Lost to Follow-up|1|||
47043146|NCT01852045|83299999|FG000|Overall Study|Withdrawal by Subject|1|||
47043147|NCT01852045|83300000|FG001|Overall Study|Withdrawal by Subject|0|||
47043148|NCT01852045|83300001|FG002|Overall Study|Withdrawal by Subject|1|||
47043149|NCT01852045|83299999|FG000|Overall Study|Other Miscellaneous Reasons|1|||
47043150|NCT01852045|83300000|FG001|Overall Study|Other Miscellaneous Reasons|3|||
47043151|NCT01852045|83300001|FG002|Overall Study|Other Miscellaneous Reasons|2|||
47043152|NCT01821937|83300020|FG000|Overall Study|Adverse Event|0|||
47043153|NCT01821937|83300021|FG001|Overall Study|Adverse Event|3|||
47043154|NCT01821625|83300029|FG000|Overall Study|Withdrawal by Subject|2|||
47043155|NCT01821625|83300029|FG000|Overall Study|Lack of Efficacy|2|||
47043156|NCT01821625|83300029|FG000|Overall Study|Adverse Event|1|||
47043157|NCT01821625|83300029|FG000|Overall Study|Medical contraindication|1|||
47043158|NCT01821391|83300035|FG000|Overall Study|Adverse Event|1|||
47043159|NCT01821391|83300036|FG001|Overall Study|Adverse Event|0|||
47043160|NCT01873417|83300044|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
47043161|NCT01873417|83300044|FG000|Overall Study|Adverse Event|24|||
47043162|NCT01873417|83300044|FG000|Overall Study|Lost to Follow-up|2|||
47043163|NCT01873417|83300044|FG000|Overall Study|Withdrawal by Subject|2|||
47043164|NCT01873417|83300044|FG000|Overall Study|Physician Decision|3|||
47043165|NCT01872715|83300048|FG000|Overall Study|Adverse Event|1|||
47043166|NCT01872715|83300048|FG000|Overall Study|Protocol Violation|1|||
47043167|NCT01872715|83300048|FG000|Overall Study|Withdrawal by Subject|2|||
47043168|NCT01871545|83300064|FG000|Overall Study|Death|2|||
47043169|NCT01871545|83300065|FG001|Overall Study|Death|0|||
47043170|NCT01871545|83300064|FG000|Overall Study|Lack of Efficacy|11|||
47043171|NCT01871545|83300065|FG001|Overall Study|Lack of Efficacy|2|||
47043172|NCT01871545|83300064|FG000|Overall Study|Physician Decision|4|||
47043173|NCT01871545|83300065|FG001|Overall Study|Physician Decision|0|||
47043174|NCT01871545|83300064|FG000|Overall Study|Withdrawal by Subject|0|||
47043175|NCT01871545|83300065|FG001|Overall Study|Withdrawal by Subject|1|||
47043176|NCT01613599|83300074|FG000|Overall Study|Death|9|||
47043177|NCT01613599|83300074|FG000|Overall Study|Lost to Follow-up|5|||
47043178|NCT01613599|83300074|FG000|Overall Study|Withdrawal by Subject|8|||
47043179|NCT01613599|83300074|FG000|Overall Study|Reason not specified|3|||
47043180|NCT01850641|83300078|FG000|Overall Study|Physician Decision|1|||
47043181|NCT01850641|83300078|FG000|Overall Study|Decrease in serum phosphorus|1|||
47043182|NCT01850641|83300078|FG000|Overall Study|Decrease in serum calcium|2|||
46720751|NCT00599638|82936709|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
46720752|NCT00599638|82936710|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
46720753|NCT00599638|82936711|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
47043183|NCT01850641|83300078|FG000|Overall Study|Increase in serum ferritin|1|||
47043184|NCT01850563|83300084|FG000|Overall Study|Not eligible|3|||
46720754|NCT00599638|82936712|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
47043185|NCT01850563|83300085|FG001|Overall Study|Not eligible|0|||
47043186|NCT04999839|83300128|FG000|Overall Study|Adverse Event|1|||
47043187|NCT04999839|83300129|FG001|Overall Study|Adverse Event|1|||
47043188|NCT04999839|83300130|FG002|Overall Study|Adverse Event|1|||
47043189|NCT04999839|83300131|FG003|Overall Study|Adverse Event|1|||
47043190|NCT04999839|83300132|FG004|Overall Study|Adverse Event|1|||
47043191|NCT04999839|83300128|FG000|Overall Study|Lost to Follow-up|2|||
47043192|NCT04999839|83300129|FG001|Overall Study|Lost to Follow-up|0|||
47043193|NCT04999839|83300130|FG002|Overall Study|Lost to Follow-up|2|||
47043194|NCT04999839|83300131|FG003|Overall Study|Lost to Follow-up|4|||
47043195|NCT04999839|83300132|FG004|Overall Study|Lost to Follow-up|1|||
47043196|NCT04999839|83300128|FG000|Overall Study|Withdrawal by Subject|6|||
47043197|NCT04999839|83300129|FG001|Overall Study|Withdrawal by Subject|5|||
47043198|NCT04999839|83300130|FG002|Overall Study|Withdrawal by Subject|3|||
47043199|NCT04999839|83300131|FG003|Overall Study|Withdrawal by Subject|2|||
47043200|NCT04999839|83300132|FG004|Overall Study|Withdrawal by Subject|2|||
47043201|NCT04999839|83300128|FG000|Overall Study|Lack of Efficacy|0|||
47043202|NCT04999839|83300129|FG001|Overall Study|Lack of Efficacy|1|||
47043203|NCT04999839|83300130|FG002|Overall Study|Lack of Efficacy|0|||
47043204|NCT04999839|83300131|FG003|Overall Study|Lack of Efficacy|0|||
47043205|NCT04999839|83300132|FG004|Overall Study|Lack of Efficacy|0|||
47043206|NCT04999839|83300128|FG000|Overall Study|Physician Decision|0|||
47043207|NCT04999839|83300129|FG001|Overall Study|Physician Decision|0|||
47043208|NCT04999839|83300130|FG002|Overall Study|Physician Decision|0|||
47043209|NCT04999839|83300131|FG003|Overall Study|Physician Decision|0|||
47043210|NCT04999839|83300132|FG004|Overall Study|Physician Decision|1|||
47043211|NCT04999839|83300128|FG000|Overall Study|Sponsor request|0|||
47043212|NCT04999839|83300129|FG001|Overall Study|Sponsor request|1|||
47043213|NCT04999839|83300130|FG002|Overall Study|Sponsor request|0|||
47043214|NCT04999839|83300131|FG003|Overall Study|Sponsor request|0|||
47043215|NCT04999839|83300132|FG004|Overall Study|Sponsor request|0|||
47043216|NCT04999839|83300128|FG000|Overall Study|Other|0|||
47043217|NCT04999839|83300129|FG001|Overall Study|Other|0|||
47043218|NCT04999839|83300130|FG002|Overall Study|Other|1|||
47043219|NCT04999839|83300131|FG003|Overall Study|Other|0|||
47043220|NCT04999839|83300132|FG004|Overall Study|Other|0|||
47043221|NCT04696146|83300176|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
47043222|NCT04696146|83300177|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
47043223|NCT04696146|83300176|FG000|Overall Study|Off hours issue with product|1|||
47043224|NCT04696146|83300177|FG001|Overall Study|Off hours issue with product|0|||
47043225|NCT04658940|83300183|FG000|Overall Study|Withdrawal by Subject|1|||
47043226|NCT04629066|83300189|FG000|Overall Study|Lost to Follow-up|3|||
47043227|NCT04629066|83300190|FG001|Overall Study|Lost to Follow-up|2|||
47043228|NCT04598269|83300198|FG000|Overall Study|Adverse Event|0|||
47043229|NCT04598269|83300199|FG001|Overall Study|Adverse Event|3|||
47043230|NCT04598269|83300198|FG000|Overall Study|Withdrawal by Subject|1|||
47043231|NCT04598269|83300199|FG001|Overall Study|Withdrawal by Subject|4|||
47043232|NCT04598269|83300198|FG000|Overall Study|Lost to Follow-up|1|||
47043233|NCT04598269|83300199|FG001|Overall Study|Lost to Follow-up|0|||
47043234|NCT04598269|83300198|FG000|Overall Study|Not Treated|2|||
47043235|NCT04598269|83300199|FG001|Overall Study|Not Treated|0|||
47043236|NCT04591015|83300207|FG000|Overall Study|Death|6|||
47043237|NCT04591015|83300208|FG001|Overall Study|Death|4|||
47043238|NCT04591015|83300207|FG000|Overall Study|Withdrawal by Subject|6|||
47043239|NCT04591015|83300208|FG001|Overall Study|Withdrawal by Subject|3|||
47043240|NCT04591015|83300207|FG000|Overall Study|Lost to Follow-up|16|||
47043241|NCT04591015|83300208|FG001|Overall Study|Lost to Follow-up|11|||
47043242|NCT04566692|83300216|FG000|Overall Study|Adverse Event|2|||
47043243|NCT04566692|83300217|FG001|Overall Study|Adverse Event|0|||
47043244|NCT04566692|83300216|FG000|Overall Study|Withdrawal by Subject|1|||
47043245|NCT04566692|83300217|FG001|Overall Study|Withdrawal by Subject|1|||
47043246|NCT04533412|83300232|FG000|Overall Study|Withdrawal by Subject|1|||
47043247|NCT04533412|83300233|FG001|Overall Study|Withdrawal by Subject|1|||
47043248|NCT04533412|83300232|FG000|Overall Study|Lost to Follow-up|1|||
47043249|NCT04533412|83300233|FG001|Overall Study|Lost to Follow-up|4|||
47043250|NCT04515147|83300245|FG000|Overall Study|Withdrawal by Subject|1|||
47043251|NCT04515147|83300246|FG001|Overall Study|Withdrawal by Subject|0|||
47043252|NCT04515147|83300247|FG002|Overall Study|Withdrawal by Subject|10|||
47043253|NCT04515147|83300248|FG003|Overall Study|Withdrawal by Subject|18|||
47043254|NCT04515147|83300249|FG004|Overall Study|Withdrawal by Subject|1|||
47043255|NCT04515147|83300250|FG005|Overall Study|Withdrawal by Subject|8|||
47043256|NCT04515147|83300245|FG000|Overall Study|Lost to Follow-up|0|||
47043257|NCT04515147|83300246|FG001|Overall Study|Lost to Follow-up|1|||
46920320|NCT03087851|83152613|FG000|Overall Study|Withdraw on medical grounds|0|||
46920321|NCT03087851|83152614|FG001|Overall Study|Withdraw on medical grounds|1|||
46920322|NCT03087851|83152615|FG002|Overall Study|Withdraw on medical grounds|2|||
47043258|NCT04515147|83300247|FG002|Overall Study|Lost to Follow-up|5|||
47043259|NCT04515147|83300248|FG003|Overall Study|Lost to Follow-up|6|||
47043260|NCT04515147|83300249|FG004|Overall Study|Lost to Follow-up|2|||
47043261|NCT04515147|83300250|FG005|Overall Study|Lost to Follow-up|1|||
47043262|NCT04515147|83300245|FG000|Overall Study|Adverse Event|0|||
47043263|NCT04515147|83300246|FG001|Overall Study|Adverse Event|0|||
47043264|NCT04515147|83300247|FG002|Overall Study|Adverse Event|0|||
47043265|NCT04515147|83300248|FG003|Overall Study|Adverse Event|2|||
47043266|NCT04515147|83300249|FG004|Overall Study|Adverse Event|0|||
47043267|NCT04515147|83300250|FG005|Overall Study|Adverse Event|0|||
47043268|NCT04515147|83300245|FG000|Overall Study|Miscellaneous|0|||
47043269|NCT04515147|83300246|FG001|Overall Study|Miscellaneous|0|||
47043270|NCT04515147|83300247|FG002|Overall Study|Miscellaneous|0|||
47043271|NCT04515147|83300248|FG003|Overall Study|Miscellaneous|1|||
46920323|NCT03092375|83152627|FG000|Overall Study|Lack of Efficacy|0|||
47043272|NCT04515147|83300249|FG004|Overall Study|Miscellaneous|0|||
46720755|NCT00599638|82936709|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
46720756|NCT00599638|82936710|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
46720757|NCT00599638|82936711|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
46720758|NCT00599638|82936712|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
46720759|NCT00599638|82936709|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
46720760|NCT00599638|82936710|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
46720761|NCT00599638|82936711|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
46720762|NCT00599638|82936712|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
46720763|NCT00599638|82936709|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
46720764|NCT00599638|82936710|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
46720765|NCT00599638|82936711|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
46720766|NCT00599638|82936712|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
46720767|NCT00599638|82936709|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
46720768|NCT00599638|82936710|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
46720769|NCT00599638|82936711|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
46720770|NCT00599638|82936712|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
46720771|NCT01166282|82936722|FG000|Open-label Period|Adverse Event|0|||
46720772|NCT01166282|82936723|FG001|Open-label Period|Adverse Event|0|||
46720773|NCT01166282|82936724|FG002|Open-label Period|Adverse Event|6|||
46720774|NCT01166282|82936722|FG000|Open-label Period|Withdrawal by Subject|0|||
46720775|NCT01166282|82936723|FG001|Open-label Period|Withdrawal by Subject|0|||
46720776|NCT01166282|82936724|FG002|Open-label Period|Withdrawal by Subject|4|||
46720777|NCT01166282|82936722|FG000|Open-label Period|Lack of Efficacy|0|||
46720778|NCT01166282|82936723|FG001|Open-label Period|Lack of Efficacy|0|||
46720779|NCT01166282|82936724|FG002|Open-label Period|Lack of Efficacy|2|||
46720780|NCT01166282|82936722|FG000|Open-label Period|Remission|0|||
46720781|NCT01166282|82936723|FG001|Open-label Period|Remission|0|||
46720782|NCT01166282|82936724|FG002|Open-label Period|Remission|4|||
46720783|NCT01166282|82936722|FG000|Open-label Period|Irregular Compliance|0|||
46720784|NCT01166282|82936723|FG001|Open-label Period|Irregular Compliance|0|||
46720785|NCT01166282|82936724|FG002|Open-label Period|Irregular Compliance|1|||
46720786|NCT01153724|82936732|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46720787|NCT01153724|82936732|FG000|Treatment Period 2|Adverse Event|1|||
46720788|NCT01153724|82936732|FG000|Treatment Period 2|Other reason not defined above|1|||
46720789|NCT01152788|82936740|FG000|Overall Study|Withdrawal by Subject|0|||
46720790|NCT01152788|82936741|FG001|Overall Study|Withdrawal by Subject|3|||
46720791|NCT01152788|82936740|FG000|Overall Study|No treatment|0|||
46720792|NCT01152788|82936741|FG001|Overall Study|No treatment|1|||
46720793|NCT01165424|82936747|FG000|Overall Study|Clinical adverse experiences|1|||
46720794|NCT01165424|82936747|FG000|Overall Study|Laboratory adverse experiences|1|||
46720795|NCT01165424|82936747|FG000|Overall Study|Did not meet entry criteria|1|||
46720796|NCT01165424|82936747|FG000|Overall Study|Participant moved (relocated)|1|||
46720797|NCT01152554|82936753|FG000|Overall Study|Withdrawal by Subject|73|||
46720798|NCT01152554|82936754|FG001|Overall Study|Withdrawal by Subject|28|||
46720799|NCT01152554|82936753|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
46720800|NCT01152554|82936754|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
46720801|NCT01152554|82936753|FG000|Overall Study|Adverse Event|67|||
46720802|NCT01152554|82936754|FG001|Overall Study|Adverse Event|14|||
46720803|NCT01152554|82936753|FG000|Overall Study|Severe non-compliance to protocol|36|||
46720804|NCT01152554|82936754|FG001|Overall Study|Severe non-compliance to protocol|14|||
46720805|NCT01152554|82936753|FG000|Overall Study|Condition under investigation worsened|5|||
46720806|NCT01152554|82936754|FG001|Overall Study|Condition under investigation worsened|2|||
46920324|NCT03092375|83152628|FG001|Overall Study|Lack of Efficacy|1|||
46633026|NCT01782690|82806309|FG000|Overall Study|Lost to Follow-up|31|||
46633027|NCT01782690|82806309|FG000|Overall Study|Withdrawal of informed consent|2|||
46633028|NCT01782690|82806309|FG000|Overall Study|Absent rash|9|||
46633029|NCT01782690|82806309|FG000|Overall Study|Physician Decision|13|||
46633030|NCT01782690|82806309|FG000|Overall Study|Patient's wish|21|||
46633031|NCT01782690|82806309|FG000|Overall Study|Tumor progression|74|||
46633032|NCT01782690|82806309|FG000|Overall Study|Death|133|||
46633033|NCT01782690|82806309|FG000|Overall Study|Study completion unknown|7|||
46633034|NCT01782378|82806315|FG000|First Series|Lost to Follow-up|7|||
46633035|NCT01782378|82806316|FG001|First Series|Lost to Follow-up|8|||
46633036|NCT01782378|82806315|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
46633037|NCT01782378|82806316|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
46633038|NCT01782378|82806315|FG000|Second Series|Lost to Follow-up|8|||
46720807|NCT01152554|82936753|FG000|Overall Study|Lack of Efficacy|20|||
46720808|NCT01152554|82936754|FG001|Overall Study|Lack of Efficacy|3|||
46720809|NCT01152554|82936753|FG000|Overall Study|Study-specific withdrawal criteria|17|||
46720810|NCT01152554|82936754|FG001|Overall Study|Study-specific withdrawal criteria|8|||
46633039|NCT01782378|82806316|FG001|Second Series|Lost to Follow-up|7|||
46633040|NCT01782378|82806315|FG000|Second Series|Did not choose to complete S2 Optional|18|||
46720811|NCT01152554|82936753|FG000|Overall Study|Lost to Follow-up|87|||
46920325|NCT03092375|83152629|FG002|Overall Study|Lack of Efficacy|1|||
47043273|NCT04515147|83300250|FG005|Overall Study|Miscellaneous|1|||
47043274|NCT04479618|83300272|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
47043275|NCT04479618|83300273|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
47043276|NCT04479618|83300274|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
47043277|NCT04479618|83300272|FG000|Overall Study|Lack of Efficacy|1|||
47043278|NCT04479618|83300273|FG001|Overall Study|Lack of Efficacy|0|||
47043279|NCT04479618|83300274|FG002|Overall Study|Lack of Efficacy|0|||
47043280|NCT04479618|83300272|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
47043281|NCT04479618|83300273|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
47043282|NCT04479618|83300274|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
47043283|NCT04479618|83300272|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
47043284|NCT04479618|83300273|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
47043285|NCT04479618|83300274|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
47043286|NCT04479618|83300272|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
47043287|NCT04479618|83300273|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
47043288|NCT04479618|83300274|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
47043289|NCT04479618|83300272|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
47043290|NCT04479618|83300273|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
47043291|NCT04479618|83300274|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
46920326|NCT03092375|83152630|FG003|Overall Study|Lack of Efficacy|0|||
46920327|NCT01995513|83152647|FG000|Period 1: First Open Label Treatment|Other|34|||
46920328|NCT01995513|83152648|FG001|Period 1: First Open Label Treatment|Other|0|||
46920329|NCT01995513|83152649|FG002|Period 1: First Open Label Treatment|Other|0|||
46920330|NCT01995513|83152650|FG003|Period 1: First Open Label Treatment|Other|0|||
46920331|NCT01995513|83152647|FG000|Period 1: First Open Label Treatment|Death|14|||
46920332|NCT01995513|83152648|FG001|Period 1: First Open Label Treatment|Death|0|||
46720812|NCT01152554|82936754|FG001|Overall Study|Lost to Follow-up|32|||
46720813|NCT01152554|82936753|FG000|Overall Study|Other|28|||
46720814|NCT01152554|82936754|FG001|Overall Study|Other|8|||
46920333|NCT01995513|83152649|FG002|Period 1: First Open Label Treatment|Death|0|||
47043292|NCT04476043|83300289|FG000|Overall Study|Withdrawal by Subject|1|||
47043293|NCT04476043|83300290|FG001|Overall Study|Withdrawal by Subject|3|||
47043294|NCT04476043|83300291|FG002|Overall Study|Withdrawal by Subject|4|||
47043295|NCT04476043|83300292|FG003|Overall Study|Withdrawal by Subject|1|||
47043296|NCT04476043|83300289|FG000|Overall Study|Lost to Follow-up|1|||
47043297|NCT04476043|83300290|FG001|Overall Study|Lost to Follow-up|1|||
47043298|NCT04476043|83300291|FG002|Overall Study|Lost to Follow-up|2|||
47043299|NCT04476043|83300292|FG003|Overall Study|Lost to Follow-up|1|||
47043300|NCT04476043|83300289|FG000|Overall Study|Adverse Event|2|||
47043301|NCT04476043|83300290|FG001|Overall Study|Adverse Event|0|||
47043302|NCT04476043|83300291|FG002|Overall Study|Adverse Event|1|||
47043303|NCT04476043|83300292|FG003|Overall Study|Adverse Event|0|||
47043304|NCT04476043|83300289|FG000|Overall Study|Protocol Violation|0|||
47043305|NCT04476043|83300290|FG001|Overall Study|Protocol Violation|1|||
47043306|NCT04476043|83300291|FG002|Overall Study|Protocol Violation|0|||
47043307|NCT04476043|83300292|FG003|Overall Study|Protocol Violation|0|||
47043308|NCT04418765|83300305|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
47043309|NCT04418765|83300306|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
47043310|NCT04418765|83300307|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
47043311|NCT04418765|83300305|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
47043312|NCT04418765|83300306|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
47043313|NCT04418765|83300307|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
47043314|NCT04418765|83300305|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
47043315|NCT04418765|83300306|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
47043316|NCT04418765|83300307|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
47043317|NCT04418765|83300305|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
47043318|NCT04418765|83300306|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
47043319|NCT04418765|83300307|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
47043320|NCT04418765|83300305|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
47043321|NCT04418765|83300306|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
46633041|NCT01782378|82806316|FG001|Second Series|Did not choose to complete S2 Optional|0|||
46920334|NCT01995513|83152650|FG003|Period 1: First Open Label Treatment|Death|0|||
46920335|NCT01995513|83152647|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
46920336|NCT01995513|83152648|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
46920337|NCT01995513|83152649|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
46920338|NCT01995513|83152650|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
46920339|NCT01995513|83152647|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
47043322|NCT04418765|83300307|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
47043323|NCT04418765|83300305|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
47043324|NCT04418765|83300306|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
47043325|NCT04418765|83300307|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
47043326|NCT04418765|83300305|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
47043327|NCT04418765|83300306|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
46633042|NCT01766310|82806324|FG000|Overall Study|Lost to Follow-up|1|||
46633043|NCT01766310|82806325|FG001|Overall Study|Lost to Follow-up|3|||
47043328|NCT04418765|83300307|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
47043329|NCT04418765|83300305|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
47043330|NCT04418765|83300306|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
47043331|NCT04418765|83300307|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
47043332|NCT04418765|83300305|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
47043333|NCT04418765|83300306|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
47043334|NCT04418765|83300307|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
47043335|NCT04418765|83300305|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
47043336|NCT04418765|83300306|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
47043337|NCT04418765|83300307|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
47043338|NCT04418765|83300305|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
47043339|NCT04418765|83300306|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
47043340|NCT04418765|83300307|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
47043341|NCT04418765|83300305|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
47043342|NCT04418765|83300306|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
47043343|NCT04418765|83300307|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
47043344|NCT04418765|83300305|FG000|Extension Period (48 Weeks)|Other than specified|0|||
47043345|NCT04418765|83300306|FG001|Extension Period (48 Weeks)|Other than specified|5|||
47043346|NCT04418765|83300307|FG002|Extension Period (48 Weeks)|Other than specified|2|||
47043347|NCT04371666|83300325|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
47043348|NCT04371666|83300326|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
47043349|NCT04371666|83300325|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
47043350|NCT04371666|83300326|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
47043351|NCT04371666|83300325|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
47043352|NCT04371666|83300326|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
47043353|NCT04371666|83300325|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
46633044|NCT01765920|82806333|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
46920340|NCT01995513|83152648|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
46920341|NCT01995513|83152649|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
46920342|NCT01995513|83152650|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
46920343|NCT01995513|83152647|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
46920344|NCT01995513|83152648|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
46920345|NCT01995513|83152649|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
46920346|NCT01995513|83152650|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
46920347|NCT01995513|83152647|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
46920348|NCT01995513|83152648|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
46920349|NCT01995513|83152649|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
46920350|NCT01995513|83152650|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
46920351|NCT01995513|83152647|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
46920352|NCT01995513|83152648|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
46920353|NCT01995513|83152649|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
46920354|NCT01995513|83152650|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
46920355|NCT01995513|83152647|FG000|Period 1: Second Open Label Treatment|Other|0|||
46920356|NCT01995513|83152648|FG001|Period 1: Second Open Label Treatment|Other|2|||
46920357|NCT01995513|83152649|FG002|Period 1: Second Open Label Treatment|Other|0|||
46920358|NCT01995513|83152650|FG003|Period 1: Second Open Label Treatment|Other|0|||
46920359|NCT01995513|83152647|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
46920360|NCT01995513|83152648|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
46920361|NCT01995513|83152649|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
46920362|NCT01995513|83152650|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
46920363|NCT01995513|83152647|FG000|Period 2: Double Blind Treatment|Death|0|||
46920364|NCT01995513|83152648|FG001|Period 2: Double Blind Treatment|Death|0|||
46920365|NCT01995513|83152649|FG002|Period 2: Double Blind Treatment|Death|0|||
46920366|NCT01995513|83152650|FG003|Period 2: Double Blind Treatment|Death|1|||
46920367|NCT01995513|83152647|FG000|Period 2: Double Blind Treatment|Other|0|||
46920368|NCT01995513|83152648|FG001|Period 2: Double Blind Treatment|Other|0|||
46920369|NCT01995513|83152649|FG002|Period 2: Double Blind Treatment|Other|3|||
46920370|NCT01995513|83152650|FG003|Period 2: Double Blind Treatment|Other|3|||
46920371|NCT01995513|83152647|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
46920372|NCT01995513|83152648|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
47043354|NCT04371666|83300326|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
47043355|NCT04371666|83300325|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
47043356|NCT04371666|83300326|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
47043357|NCT04371666|83300325|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
47043358|NCT04371666|83300326|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
47043359|NCT04212169|83300337|FG000|Overall Study|Adverse Event|0|||
47043360|NCT04212169|83300338|FG001|Overall Study|Adverse Event|0|||
47043361|NCT04212169|83300339|FG002|Overall Study|Adverse Event|0|||
46633045|NCT01765920|82806334|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
46633046|NCT01765920|82806333|FG000|Overall Study|Patient code disclosure|0|||
46633047|NCT01765920|82806334|FG001|Overall Study|Patient code disclosure|1|||
46633048|NCT01782222|82806343|FG000|Overall Study|Adverse Event|4|||
46633049|NCT01782222|82806344|FG001|Overall Study|Adverse Event|5|||
46633050|NCT01782222|82806345|FG002|Overall Study|Adverse Event|3|||
46920373|NCT01995513|83152649|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
46920374|NCT01995513|83152650|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
46920375|NCT01995513|83152647|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
46920376|NCT01995513|83152648|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
46920377|NCT01995513|83152649|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
46920378|NCT01995513|83152650|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
46920379|NCT01995513|83152647|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
46920380|NCT01995513|83152648|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
46633051|NCT01782222|82806343|FG000|Overall Study|Lack of Efficacy|2|||
46633052|NCT01782222|82806344|FG001|Overall Study|Lack of Efficacy|1|||
46633053|NCT01782222|82806345|FG002|Overall Study|Lack of Efficacy|0|||
46920381|NCT01995513|83152649|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
47043362|NCT04212169|83300340|FG003|Overall Study|Adverse Event|2|||
47043363|NCT04212169|83300337|FG000|Overall Study|Lost to Follow-up|1|||
47043364|NCT04212169|83300338|FG001|Overall Study|Lost to Follow-up|0|||
47043365|NCT04212169|83300339|FG002|Overall Study|Lost to Follow-up|0|||
47043366|NCT04212169|83300340|FG003|Overall Study|Lost to Follow-up|2|||
47043367|NCT04212169|83300337|FG000|Overall Study|Withdrawal by Subject|10|||
47043368|NCT04212169|83300338|FG001|Overall Study|Withdrawal by Subject|2|||
47043369|NCT04212169|83300339|FG002|Overall Study|Withdrawal by Subject|5|||
47043370|NCT04212169|83300340|FG003|Overall Study|Withdrawal by Subject|7|||
47043371|NCT04212169|83300337|FG000|Overall Study|Other reason, unspecified|3|||
47043372|NCT04212169|83300338|FG001|Overall Study|Other reason, unspecified|1|||
47043373|NCT04212169|83300339|FG002|Overall Study|Other reason, unspecified|0|||
47043374|NCT04212169|83300340|FG003|Overall Study|Other reason, unspecified|2|||
46633054|NCT01782222|82806343|FG000|Overall Study|Protocol Violation|1|||
46633055|NCT01782222|82806344|FG001|Overall Study|Protocol Violation|0|||
47043375|NCT04109313|83300369|FG000|Overall Study|Pregnancy|1|||
47043376|NCT04109313|83300369|FG000|Overall Study|Adverse Event|11|||
47043377|NCT04109313|83300369|FG000|Overall Study|Lack of Efficacy|11|||
47043378|NCT04109313|83300369|FG000|Overall Study|Lost to Follow-up|1|||
46633056|NCT01782222|82806345|FG002|Overall Study|Protocol Violation|0|||
46633057|NCT01782222|82806343|FG000|Overall Study|Withdrawal by Subject|1|||
46633058|NCT01782222|82806344|FG001|Overall Study|Withdrawal by Subject|4|||
46720815|NCT01152554|82936753|FG000|Overall Study|Death|1|||
46720816|NCT01152554|82936754|FG001|Overall Study|Death|1|||
46720817|NCT00598702|82936768|FG000|Overall Study|Other|0|||
47043379|NCT04109313|83300369|FG000|Overall Study|Physician Decision|2|||
47043380|NCT04109313|83300369|FG000|Overall Study|Subject Decision|13|||
47043381|NCT04109313|83300369|FG000|Overall Study|Covid-19 situation|2|||
47043382|NCT04089865|83300378|FG000|Overall Study|Withdrawal by Subject|2|||
47043383|NCT04089865|83300379|FG001|Overall Study|Withdrawal by Subject|2|||
47043384|NCT04089865|83300380|FG002|Overall Study|Withdrawal by Subject|7|||
47043385|NCT04089865|83300381|FG003|Overall Study|Withdrawal by Subject|2|||
47043386|NCT04017832|83300409|FG000|Overall Study|Withdrawal by Subject|13|||
47043387|NCT04017832|83300410|FG001|Overall Study|Withdrawal by Subject|12|||
47043388|NCT04017832|83300411|FG002|Overall Study|Withdrawal by Subject|21|||
47043389|NCT04017832|83300412|FG003|Overall Study|Withdrawal by Subject|7|||
47043390|NCT04017832|83300409|FG000|Overall Study|Lost to Follow-up|0|||
47043391|NCT04017832|83300410|FG001|Overall Study|Lost to Follow-up|3|||
47043392|NCT04017832|83300411|FG002|Overall Study|Lost to Follow-up|3|||
47043393|NCT04017832|83300412|FG003|Overall Study|Lost to Follow-up|1|||
47043394|NCT04017832|83300409|FG000|Overall Study|Physician Decision|1|||
47043395|NCT04017832|83300410|FG001|Overall Study|Physician Decision|1|||
47043396|NCT04017832|83300411|FG002|Overall Study|Physician Decision|1|||
47043397|NCT04017832|83300412|FG003|Overall Study|Physician Decision|1|||
47043398|NCT04017832|83300409|FG000|Overall Study|Death|2|||
47043399|NCT04017832|83300410|FG001|Overall Study|Death|2|||
47043400|NCT04017832|83300411|FG002|Overall Study|Death|1|||
47043401|NCT04017832|83300412|FG003|Overall Study|Death|0|||
47043402|NCT03952806|83300428|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
47043403|NCT03952806|83300429|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
47043404|NCT03952806|83300428|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
47043405|NCT03952806|83300429|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
47043406|NCT03952806|83300428|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
47043407|NCT03952806|83300429|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
47043408|NCT03952806|83300428|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
47043409|NCT03952806|83300429|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
47043410|NCT03952806|83300428|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
47043411|NCT03952806|83300429|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
47043412|NCT03952806|83300428|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
47043413|NCT03952806|83300429|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
47043414|NCT03952806|83300428|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
47043415|NCT03952806|83300429|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
47043416|NCT03952806|83300428|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
47043417|NCT03952806|83300429|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
47043418|NCT03952806|83300428|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
47043419|NCT03952806|83300429|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
47043420|NCT03952806|83300428|FG000|OLE Phase (48 Weeks)|Other|16|||
47043421|NCT03952806|83300429|FG001|OLE Phase (48 Weeks)|Other|13|||
47043422|NCT03924947|83300454|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
47043423|NCT03924947|83300455|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
47043424|NCT03924947|83300456|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
47043425|NCT03924947|83300457|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
47043426|NCT03924947|83300458|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
47043427|NCT03924947|83300459|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
47043428|NCT03845985|83300484|FG000|Overall Study|Lost to Follow-up|2|||
47043429|NCT03845985|83300485|FG001|Overall Study|Lost to Follow-up|1|||
47043430|NCT03845985|83300484|FG000|Overall Study|Physician Decision|1|||
47043431|NCT03845985|83300485|FG001|Overall Study|Physician Decision|0|||
47043432|NCT03845985|83300484|FG000|Overall Study|Withdrawal by Subject|4|||
47043433|NCT03845985|83300485|FG001|Overall Study|Withdrawal by Subject|1|||
47043434|NCT03745651|83300494|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
47043435|NCT03745651|83300495|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
47043436|NCT03745651|83300496|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043437|NCT03745651|83300497|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043438|NCT03745651|83300498|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043439|NCT03745651|83300499|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043440|NCT03745651|83300500|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043441|NCT03745651|83300494|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
47043442|NCT03745651|83300495|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
47043443|NCT03745651|83300496|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
47043444|NCT03745651|83300497|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
47043445|NCT03745651|83300498|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
47043446|NCT03745651|83300499|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46720818|NCT00598702|82936769|FG001|Overall Study|Other|2|||
46720819|NCT00598702|82936770|FG002|Overall Study|Other|0|||
46720820|NCT00598702|82936771|FG003|Overall Study|Other|0|||
46720821|NCT00598702|82936772|FG004|Overall Study|Other|0|||
47043447|NCT03745651|83300500|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
47043448|NCT03745651|83300494|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
47043449|NCT03745651|83300495|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043450|NCT03745651|83300496|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
47043451|NCT03745651|83300497|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043452|NCT03745651|83300498|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043453|NCT03745651|83300499|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043454|NCT03745651|83300500|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043455|NCT03745651|83300494|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043456|NCT03745651|83300495|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
47043457|NCT03745651|83300496|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043458|NCT03745651|83300497|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043459|NCT03745651|83300498|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
46633059|NCT01782222|82806345|FG002|Overall Study|Withdrawal by Subject|1|||
46633060|NCT01782222|82806343|FG000|Overall Study|Moved to other state|0|||
46633061|NCT01782222|82806344|FG001|Overall Study|Moved to other state|1|||
46633062|NCT01782222|82806345|FG002|Overall Study|Moved to other state|0|||
46633063|NCT01781832|82806353|FG000|Overall Study|Withdrawal by Subject|1|||
46633064|NCT01807182|82806357|FG000|Overall Study|Death|1|||
46633065|NCT01807182|82806357|FG000|Overall Study|New therapy|1|||
46633066|NCT01807182|82806357|FG000|Overall Study|Moved to hospice care|1|||
46633067|NCT01806714|82806363|FG000|Overall Study|No functioning phone number|200|||
46633068|NCT01806714|82806364|FG001|Overall Study|No functioning phone number|170|||
46633069|NCT01765764|82806373|FG000|Treatment Period|Adverse Event|1|||
46633070|NCT01765764|82806374|FG001|Treatment Period|Adverse Event|2|||
46633071|NCT01765764|82806375|FG002|Treatment Period|Adverse Event|1|||
46633072|NCT01765764|82806373|FG000|Treatment Period|Lost to Follow-up|0|||
46720822|NCT00598702|82936773|FG005|Overall Study|Other|1|||
46720823|NCT00598702|82936774|FG006|Overall Study|Other|0|||
46720824|NCT00598702|82936775|FG007|Overall Study|Other|0|||
46720825|NCT00598702|82936768|FG000|Overall Study|Early discharge from hospital|0|||
46720826|NCT00598702|82936769|FG001|Overall Study|Early discharge from hospital|0|||
46720827|NCT00598702|82936770|FG002|Overall Study|Early discharge from hospital|2|||
46720828|NCT00598702|82936771|FG003|Overall Study|Early discharge from hospital|5|||
46720829|NCT00598702|82936772|FG004|Overall Study|Early discharge from hospital|0|||
46720830|NCT00598702|82936773|FG005|Overall Study|Early discharge from hospital|10|||
46720831|NCT00598702|82936774|FG006|Overall Study|Early discharge from hospital|1|||
46720832|NCT00598702|82936775|FG007|Overall Study|Early discharge from hospital|0|||
46720833|NCT00598702|82936768|FG000|Overall Study|Adverse Event|0|||
46720834|NCT00598702|82936769|FG001|Overall Study|Adverse Event|0|||
46720835|NCT00598702|82936770|FG002|Overall Study|Adverse Event|0|||
46720836|NCT00598702|82936771|FG003|Overall Study|Adverse Event|1|||
46720837|NCT00598702|82936772|FG004|Overall Study|Adverse Event|0|||
46720838|NCT00598702|82936773|FG005|Overall Study|Adverse Event|0|||
46720839|NCT00598702|82936774|FG006|Overall Study|Adverse Event|0|||
46720840|NCT00598702|82936775|FG007|Overall Study|Adverse Event|0|||
46720841|NCT00598702|82936768|FG000|Overall Study|Withdrawal by Subject|0|||
46720842|NCT00598702|82936769|FG001|Overall Study|Withdrawal by Subject|0|||
46720843|NCT00598702|82936770|FG002|Overall Study|Withdrawal by Subject|0|||
46720844|NCT00598702|82936771|FG003|Overall Study|Withdrawal by Subject|1|||
46720845|NCT00598702|82936772|FG004|Overall Study|Withdrawal by Subject|1|||
46720846|NCT00598702|82936773|FG005|Overall Study|Withdrawal by Subject|0|||
46720847|NCT00598702|82936774|FG006|Overall Study|Withdrawal by Subject|0|||
46720848|NCT00598702|82936775|FG007|Overall Study|Withdrawal by Subject|0|||
46720849|NCT00598702|82936768|FG000|Overall Study|Physician Decision|0|||
46720850|NCT00598702|82936769|FG001|Overall Study|Physician Decision|0|||
47043460|NCT03745651|83300499|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043461|NCT03745651|83300500|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043462|NCT03745651|83300494|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
47043463|NCT03745651|83300495|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
47043464|NCT03745651|83300496|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
47043465|NCT03745651|83300497|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
47043466|NCT03745651|83300498|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
47043467|NCT03745651|83300499|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46720851|NCT00598702|82936770|FG002|Overall Study|Physician Decision|0|||
46720852|NCT00598702|82936771|FG003|Overall Study|Physician Decision|0|||
47043468|NCT03745651|83300500|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46720853|NCT00598702|82936772|FG004|Overall Study|Physician Decision|1|||
46720854|NCT00598702|82936773|FG005|Overall Study|Physician Decision|0|||
46720855|NCT00598702|82936774|FG006|Overall Study|Physician Decision|0|||
46720856|NCT00598702|82936775|FG007|Overall Study|Physician Decision|0|||
46720857|NCT00598702|82936768|FG000|Overall Study|Dose limiting toxicity|0|||
46920382|NCT01995513|83152650|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
46720858|NCT00598702|82936769|FG001|Overall Study|Dose limiting toxicity|0|||
46920383|NCT01995513|83152647|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
46720859|NCT00598702|82936770|FG002|Overall Study|Dose limiting toxicity|0|||
46720860|NCT00598702|82936771|FG003|Overall Study|Dose limiting toxicity|1|||
46720861|NCT00598702|82936772|FG004|Overall Study|Dose limiting toxicity|1|||
46720862|NCT00598702|82936773|FG005|Overall Study|Dose limiting toxicity|1|||
46720863|NCT00598702|82936774|FG006|Overall Study|Dose limiting toxicity|0|||
47043469|NCT03745651|83300494|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
47043470|NCT03745651|83300495|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
47043471|NCT03745651|83300496|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
47043472|NCT03745651|83300497|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
47043473|NCT03745651|83300498|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
47043474|NCT03745651|83300499|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
47043475|NCT03745651|83300500|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
47043476|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043477|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043478|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043479|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043480|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043481|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
47043482|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043483|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043484|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043485|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043486|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
47043487|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043488|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
47043489|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
47043490|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
47043491|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
47043492|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
46633073|NCT01765764|82806374|FG001|Treatment Period|Lost to Follow-up|3|||
46633074|NCT01765764|82806375|FG002|Treatment Period|Lost to Follow-up|2|||
46633075|NCT01765764|82806373|FG000|Treatment Period|Personal Reasons|1|||
46633076|NCT01765764|82806374|FG001|Treatment Period|Personal Reasons|2|||
46633077|NCT01765764|82806375|FG002|Treatment Period|Personal Reasons|1|||
46633078|NCT01765764|82806373|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
46633079|NCT01765764|82806374|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
46633080|NCT01765764|82806375|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
46633081|NCT01806168|82806386|FG000|Overall Study|Adverse Event|1|||
46633082|NCT01806168|82806387|FG001|Overall Study|Adverse Event|0|||
46633083|NCT01806168|82806388|FG002|Overall Study|Adverse Event|0|||
46633084|NCT01806168|82806386|FG000|Overall Study|Withdrawal by Subject|0|||
46633085|NCT01806168|82806387|FG001|Overall Study|Withdrawal by Subject|1|||
46633086|NCT01806168|82806388|FG002|Overall Study|Withdrawal by Subject|2|||
46633087|NCT01806168|82806386|FG000|Overall Study|Protocol Violation|0|||
46633088|NCT01806168|82806387|FG001|Overall Study|Protocol Violation|0|||
46633089|NCT01806168|82806388|FG002|Overall Study|Protocol Violation|1|||
46633090|NCT01804842|82806402|FG000|Overall Study|Adverse Event|1|||
46633091|NCT01804842|82806403|FG001|Overall Study|Adverse Event|1|||
46633092|NCT01804842|82806404|FG002|Overall Study|Adverse Event|0|||
46633093|NCT01804842|82806402|FG000|Overall Study|Lost to Follow-up|1|||
46633094|NCT01804842|82806403|FG001|Overall Study|Lost to Follow-up|0|||
46633095|NCT01804842|82806404|FG002|Overall Study|Lost to Follow-up|0|||
46633096|NCT01804842|82806402|FG000|Overall Study|Non-Compliance|1|||
46633097|NCT01804842|82806403|FG001|Overall Study|Non-Compliance|1|||
46633098|NCT01804842|82806404|FG002|Overall Study|Non-Compliance|0|||
46633099|NCT01804842|82806402|FG000|Overall Study|Personal Reason|0|||
46633100|NCT01804842|82806403|FG001|Overall Study|Personal Reason|0|||
46720864|NCT00598702|82936775|FG007|Overall Study|Dose limiting toxicity|0|||
46720865|NCT01148810|82936795|FG000|Overall Study|Adverse Event|0|||
46633101|NCT01804842|82806404|FG002|Overall Study|Personal Reason|1|||
47043493|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
47043494|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
47043495|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
47043496|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
47043497|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043498|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043499|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043500|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
47043501|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043502|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
47043503|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
47043504|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
47043505|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
47043506|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
47043507|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
47043508|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
47043509|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
47043510|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
47043511|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043512|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043513|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043514|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043515|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043516|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
47043517|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043518|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
47043519|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
47043520|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
47043521|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
47043522|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
47043523|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
47043524|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
47043525|NCT03745651|83300494|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
47043526|NCT03745651|83300495|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
47043527|NCT03745651|83300496|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
47043528|NCT03745651|83300497|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
47043529|NCT03745651|83300498|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
47043530|NCT03745651|83300499|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
47043531|NCT03745651|83300500|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
47043532|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
47043533|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
47043534|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
47043535|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043536|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043537|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043538|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
47043539|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
47043540|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
47043541|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
47043542|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
47043543|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
47043544|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
47043545|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
47043546|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
47043547|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
47043548|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
47043549|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46633102|NCT01781286|82806412|FG000|Overall Study|Lost to Follow-up|0|||
46633103|NCT01781286|82806413|FG001|Overall Study|Lost to Follow-up|0|||
46633104|NCT01781286|82806414|FG002|Overall Study|Lost to Follow-up|0|||
46920384|NCT01995513|83152648|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
46633105|NCT01781286|82806415|FG003|Overall Study|Lost to Follow-up|0|||
46633106|NCT01781286|82806416|FG004|Overall Study|Lost to Follow-up|0|||
46633107|NCT01781286|82806417|FG005|Overall Study|Lost to Follow-up|1|||
46920385|NCT01995513|83152649|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
47043550|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
47043551|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
47043552|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
47043553|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
47043554|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
47043555|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043556|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043557|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
46633108|NCT01781286|82806412|FG000|Overall Study|Time Constraints|2|||
46720866|NCT01148810|82936796|FG001|Overall Study|Adverse Event|2|||
46720867|NCT01148810|82936795|FG000|Overall Study|Lack of Efficacy|0|||
46720868|NCT01148810|82936796|FG001|Overall Study|Lack of Efficacy|1|||
46920386|NCT01995513|83152650|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
46920387|NCT02927171|83152666|FG000|Overall Study|Lost to Follow-up|0|||
46920388|NCT02927171|83152667|FG001|Overall Study|Lost to Follow-up|1|||
46920389|NCT03087617|83152677|FG000|Overall Study|Lost to Follow-up|32|||
46920390|NCT03087617|83152678|FG001|Overall Study|Lost to Follow-up|30|||
46920391|NCT03087617|83152679|FG002|Overall Study|Lost to Follow-up|30|||
47043558|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043559|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
47043560|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
47043561|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
47043562|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
47043563|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
47043564|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
47043565|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
47043566|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
47043567|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043568|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
47043569|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043570|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043571|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043572|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043573|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
47043574|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
47043575|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
47043576|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
47043577|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
47043578|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
47043579|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
47043580|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
47043581|NCT03745638|83300519|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
47043582|NCT03745638|83300520|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
47043583|NCT03745638|83300521|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
47043584|NCT03745638|83300522|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
47043585|NCT03745638|83300523|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
46633109|NCT01781286|82806413|FG001|Overall Study|Time Constraints|0|||
46633110|NCT01781286|82806414|FG002|Overall Study|Time Constraints|2|||
46633111|NCT01781286|82806415|FG003|Overall Study|Time Constraints|0|||
46633112|NCT01781286|82806416|FG004|Overall Study|Time Constraints|0|||
46633113|NCT01781286|82806417|FG005|Overall Study|Time Constraints|0|||
46633114|NCT01781286|82806412|FG000|Overall Study|Noncompliance|0|||
46633115|NCT01781286|82806413|FG001|Overall Study|Noncompliance|0|||
46633116|NCT01781286|82806414|FG002|Overall Study|Noncompliance|0|||
46633117|NCT01781286|82806415|FG003|Overall Study|Noncompliance|1|||
46633118|NCT01781286|82806416|FG004|Overall Study|Noncompliance|0|||
46633119|NCT01781286|82806417|FG005|Overall Study|Noncompliance|0|||
46633120|NCT01780974|82806429|FG000|Overall Study|Death|1|||
46633121|NCT01780974|82806430|FG001|Overall Study|Death|0|||
46633122|NCT01780974|82806429|FG000|Overall Study|Adverse Event|1|||
46633123|NCT01780974|82806430|FG001|Overall Study|Adverse Event|3|||
46633124|NCT01780662|82806439|FG000|Overall Study|Adverse Event|1|||
46633125|NCT01780662|82806440|FG001|Overall Study|Adverse Event|0|||
46633126|NCT01780662|82806441|FG002|Overall Study|Adverse Event|2|||
46720869|NCT01148810|82936795|FG000|Overall Study|Withdrawal by Subject|0|||
46633127|NCT01780662|82806439|FG000|Overall Study|Physician Decision|0|||
46633128|NCT01780662|82806440|FG001|Overall Study|Physician Decision|5|||
46720870|NCT01148810|82936796|FG001|Overall Study|Withdrawal by Subject|2|||
46720871|NCT01148810|82936795|FG000|Overall Study|Protocol Violation|1|||
46720872|NCT01148810|82936796|FG001|Overall Study|Protocol Violation|0|||
46720873|NCT01151618|82936803|FG000|Overall Study|Adverse Event|2|||
46720874|NCT01151618|82936803|FG000|Overall Study|Withdrawal by Subject|7|||
46720875|NCT01164956|82936807|FG000|Overall Study|Side Effects|1|||
46720876|NCT01164956|82936808|FG001|Overall Study|Side Effects|0|||
46720877|NCT01164956|82936809|FG002|Overall Study|Side Effects|1|||
46720878|NCT01164722|82936819|FG000|Overall Study|Adverse Event|0|||
46720879|NCT01164722|82936820|FG001|Overall Study|Adverse Event|1|||
46720880|NCT01164722|82936819|FG000|Overall Study|Withdrawal by Subject|3|||
46720881|NCT01164722|82936820|FG001|Overall Study|Withdrawal by Subject|4|||
46720882|NCT01164722|82936819|FG000|Overall Study|Lost to Follow-up|3|||
46720883|NCT01164722|82936820|FG001|Overall Study|Lost to Follow-up|6|||
46720884|NCT01164722|82936819|FG000|Overall Study|met protocol criteria for non-treatment|11|||
46720885|NCT01164722|82936820|FG001|Overall Study|met protocol criteria for non-treatment|1|||
46720886|NCT01164722|82936819|FG000|Overall Study|enrolled on other study, concomitant med|1|||
46720887|NCT01164722|82936820|FG001|Overall Study|enrolled on other study, concomitant med|3|||
46720888|NCT01151540|82936826|FG000|Overall Study|Other|2|||
46720889|NCT01151540|82936826|FG000|Overall Study|Adverse event, non-fatal|4|||
47043586|NCT03745638|83300524|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
47043587|NCT03745638|83300525|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
47043588|NCT03745638|83300519|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043589|NCT03745638|83300520|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043590|NCT03745638|83300521|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043591|NCT03745638|83300522|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043592|NCT03745638|83300523|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
47043593|NCT03745638|83300524|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
47043594|NCT03745638|83300525|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
47043595|NCT03745638|83300519|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043596|NCT03745638|83300520|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043597|NCT03745638|83300521|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043598|NCT03745638|83300522|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
47043599|NCT03745638|83300523|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
47043600|NCT03745638|83300524|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
47043601|NCT03745638|83300525|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
46720890|NCT01151540|82936826|FG000|Overall Study|Withdrawal by Subject|7|||
47043602|NCT03745638|83300519|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
47043603|NCT03745638|83300520|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
47043604|NCT03745638|83300521|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
47043605|NCT03745638|83300522|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
47043606|NCT03745638|83300523|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
47043607|NCT03745638|83300524|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
47043608|NCT03745638|83300525|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
47043609|NCT03745638|83300519|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043610|NCT03745638|83300520|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043611|NCT03745638|83300521|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043612|NCT03745638|83300522|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043613|NCT03745638|83300523|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
47043614|NCT03745638|83300524|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
47043615|NCT03745638|83300525|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
47043616|NCT03745638|83300519|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043617|NCT03745638|83300520|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
46633129|NCT01780662|82806441|FG002|Overall Study|Physician Decision|7|||
46633130|NCT01780662|82806439|FG000|Overall Study|Protocol Violation|0|||
46633131|NCT01780662|82806440|FG001|Overall Study|Protocol Violation|1|||
46633132|NCT01780662|82806441|FG002|Overall Study|Protocol Violation|0|||
46633133|NCT01780662|82806439|FG000|Overall Study|Ineligible|0|||
46633134|NCT01780662|82806440|FG001|Overall Study|Ineligible|0|||
46633135|NCT01780662|82806441|FG002|Overall Study|Ineligible|1|||
46633136|NCT01780584|82806453|FG000|Overall Study|Death|1|||
46720891|NCT01163786|82936830|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
47043618|NCT03745638|83300521|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
46633137|NCT01780584|82806454|FG001|Overall Study|Death|0|||
46720892|NCT01163786|82936830|FG000|Treatment With Bortezomib|Adverse Event|2|||
46720893|NCT01163786|82936830|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
46720894|NCT00984282|82936836|FG000|Double Blind Treatment|Adverse Event|40|||
46720895|NCT00984282|82936837|FG001|Double Blind Treatment|Adverse Event|6|||
46920392|NCT03087617|83152680|FG003|Overall Study|Lost to Follow-up|39|||
46633138|NCT01780584|82806455|FG002|Overall Study|Death|1|||
46720896|NCT00984282|82936836|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
46720897|NCT00984282|82936837|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
46720898|NCT00984282|82936836|FG000|Double Blind Treatment|Physician Decision|1|||
46720899|NCT00984282|82936837|FG001|Double Blind Treatment|Physician Decision|2|||
46720900|NCT00984282|82936836|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
46720901|NCT00984282|82936837|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
46720902|NCT00984282|82936836|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
46720903|NCT00984282|82936837|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
46720904|NCT00984282|82936836|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
46720905|NCT00984282|82936837|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
47043619|NCT03745638|83300522|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043620|NCT03745638|83300523|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
46720906|NCT00984282|82936836|FG000|Double Blind Treatment|Lost to Follow-up|3|||
46720907|NCT00984282|82936837|FG001|Double Blind Treatment|Lost to Follow-up|0|||
47043621|NCT03745638|83300524|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
47043622|NCT03745638|83300525|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
47043623|NCT03745638|83300519|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
47043624|NCT03745638|83300520|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
46720908|NCT00984282|82936836|FG000|Double Blind Treatment|Death|8|||
46720909|NCT00984282|82936837|FG001|Double Blind Treatment|Death|4|||
46720910|NCT00984282|82936836|FG000|Double Blind Treatment|Not treated|0|||
46720911|NCT00984282|82936837|FG001|Double Blind Treatment|Not treated|1|||
46720912|NCT00984282|82936836|FG000|Double Blind Treatment|Switched to commercial drug|6|||
46720913|NCT00984282|82936837|FG001|Double Blind Treatment|Switched to commercial drug|1|||
46720914|NCT00984282|82936836|FG000|Double Blind Treatment|protocol driven decision point|1|||
47043625|NCT03745638|83300521|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
47043626|NCT03745638|83300522|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
47043627|NCT03745638|83300523|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
47043628|NCT03745638|83300524|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
46633139|NCT01780584|82806453|FG000|Overall Study|Adverse Event|0|||
46633140|NCT01780584|82806454|FG001|Overall Study|Adverse Event|1|||
46633141|NCT01780584|82806455|FG002|Overall Study|Adverse Event|0|||
46633142|NCT01780584|82806453|FG000|Overall Study|Protocol Violation|0|||
46633143|NCT01780584|82806454|FG001|Overall Study|Protocol Violation|0|||
46633144|NCT01780584|82806455|FG002|Overall Study|Protocol Violation|1|||
46633145|NCT01780506|82806465|FG000|Double-Blind Phase|Randomized but not Treated|3|||
46633146|NCT01780506|82806466|FG001|Double-Blind Phase|Randomized but not Treated|2|||
46633147|NCT01780506|82806465|FG000|Double-Blind Phase|Adverse Event|4|||
46633148|NCT01780506|82806466|FG001|Double-Blind Phase|Adverse Event|14|||
46633149|NCT01780506|82806465|FG000|Double-Blind Phase|Death|1|||
46633150|NCT01780506|82806466|FG001|Double-Blind Phase|Death|2|||
46633151|NCT01780506|82806465|FG000|Double-Blind Phase|Pregnancy|2|||
46633152|NCT01780506|82806466|FG001|Double-Blind Phase|Pregnancy|1|||
46633153|NCT01780506|82806465|FG000|Double-Blind Phase|Lack of Efficacy|1|||
46633154|NCT01780506|82806466|FG001|Double-Blind Phase|Lack of Efficacy|1|||
46633155|NCT01780506|82806465|FG000|Double-Blind Phase|Investigator's Discretion|5|||
46633156|NCT01780506|82806466|FG001|Double-Blind Phase|Investigator's Discretion|2|||
46633157|NCT01780506|82806465|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
46633158|NCT01780506|82806466|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
46633159|NCT01780506|82806465|FG000|Double-Blind Phase|Protocol Violation|4|||
46633160|NCT01780506|82806466|FG001|Double-Blind Phase|Protocol Violation|3|||
46633161|NCT01780506|82806465|FG000|Double-Blind Phase|Withdrew Consent|23|||
46633162|NCT01780506|82806466|FG001|Double-Blind Phase|Withdrew Consent|24|||
46633163|NCT01780506|82806465|FG000|Double-Blind Phase|Lost to Follow-up|23|||
46633164|NCT01780506|82806466|FG001|Double-Blind Phase|Lost to Follow-up|26|||
46633165|NCT01780506|82806465|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
46633166|NCT01780506|82806466|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
46633167|NCT01779648|82806476|FG000|Overall Study|Protocol Violation|1|||
46633168|NCT01779648|82806477|FG001|Overall Study|Protocol Violation|0|||
46633169|NCT01762800|82806485|FG000|Overall Study|Adverse Event|8|||
46633170|NCT01762800|82806486|FG001|Overall Study|Adverse Event|13|||
46633171|NCT01762800|82806485|FG000|Overall Study|Lack of Efficacy|3|||
46633172|NCT01762800|82806486|FG001|Overall Study|Lack of Efficacy|2|||
46633173|NCT01762800|82806485|FG000|Overall Study|Study Closed/Terminated|0|||
46633174|NCT01762800|82806486|FG001|Overall Study|Study Closed/Terminated|1|||
46720915|NCT00984282|82936837|FG001|Double Blind Treatment|protocol driven decision point|1|||
46720916|NCT00984282|82936836|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
46720917|NCT00984282|82936837|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
46720918|NCT00984282|82936836|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
46720919|NCT00984282|82936837|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
46720920|NCT00984282|82936836|FG000|Open-label Treatment|Adverse Event|20|||
46720921|NCT00984282|82936837|FG001|Open-label Treatment|Adverse Event|30|||
46720922|NCT00984282|82936836|FG000|Open-label Treatment|Withdrawal by Subject|6|||
46720923|NCT00984282|82936837|FG001|Open-label Treatment|Withdrawal by Subject|21|||
46720924|NCT00984282|82936836|FG000|Open-label Treatment|Death|7|||
46720925|NCT00984282|82936837|FG001|Open-label Treatment|Death|15|||
46720926|NCT00984282|82936836|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
46720927|NCT00984282|82936837|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
46720928|NCT00984282|82936836|FG000|Open-label Treatment|Lost to Follow-up|1|||
46720929|NCT00984282|82936837|FG001|Open-label Treatment|Lost to Follow-up|1|||
46720930|NCT00984282|82936836|FG000|Open-label Treatment|Patient convenience|1|||
46720931|NCT00984282|82936837|FG001|Open-label Treatment|Patient convenience|0|||
46720932|NCT00984282|82936836|FG000|Open-label Treatment|Non-compliant with study medication|1|||
46720933|NCT00984282|82936837|FG001|Open-label Treatment|Non-compliant with study medication|0|||
46720934|NCT00984282|82936836|FG000|Open-label Treatment|Target lesion removed|0|||
46720935|NCT00984282|82936837|FG001|Open-label Treatment|Target lesion removed|1|||
46720936|NCT00984282|82936836|FG000|Open-label Treatment|Protocol driven decision point|1|||
46720937|NCT00984282|82936837|FG001|Open-label Treatment|Protocol driven decision point|1|||
46720938|NCT00984282|82936836|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
46720939|NCT00984282|82936837|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
46720940|NCT00984282|82936836|FG000|Open-label Treatment|Switched to commercial drug|6|||
46720941|NCT00984282|82936837|FG001|Open-label Treatment|Switched to commercial drug|7|||
46720942|NCT00984282|82936836|FG000|Open-label Treatment|Physician Decision|1|||
46720943|NCT00984282|82936837|FG001|Open-label Treatment|Physician Decision|0|||
46720944|NCT00984282|82936836|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
46720945|NCT00984282|82936837|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
46720946|NCT00984282|82936836|FG000|Long Term Follow-up|Death|27|||
46720947|NCT00984282|82936837|FG001|Long Term Follow-up|Death|68|||
46720948|NCT00984282|82936836|FG000|Long Term Follow-up|Lost to Follow-up|3|||
46720949|NCT00984282|82936837|FG001|Long Term Follow-up|Lost to Follow-up|6|||
46720950|NCT00984282|82936836|FG000|Long Term Follow-up|Protocol driven decision point|25|||
46720951|NCT00984282|82936837|FG001|Long Term Follow-up|Protocol driven decision point|26|||
46720952|NCT00984282|82936836|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
46720953|NCT00984282|82936837|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
46720954|NCT00984282|82936836|FG000|Long Term Follow-up|Switched to commercial drug|4|||
46720955|NCT00984282|82936837|FG001|Long Term Follow-up|Switched to commercial drug|2|||
46720956|NCT00984282|82936836|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
46720957|NCT00984282|82936837|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
46720958|NCT01147874|82936845|FG000|Overall Study|Adverse Event|5|||
46720959|NCT01147874|82936845|FG000|Overall Study|Investigator's Request|1|||
46720960|NCT01147874|82936845|FG000|Overall Study|Lost to Follow-up|25|||
46720961|NCT01147874|82936845|FG000|Overall Study|Other|5|||
46720962|NCT01147874|82936845|FG000|Overall Study|Protocol Violation|5|||
46720963|NCT01147874|82936845|FG000|Overall Study|Sponsor's Decision|2|||
46720964|NCT01147874|82936845|FG000|Overall Study|Withdrawal by Subject|24|||
46720965|NCT01147640|82936851|FG000|Overall Study|Adverse Event|2|||
46720966|NCT01147640|82936852|FG001|Overall Study|Adverse Event|0|||
46720967|NCT01147640|82936851|FG000|Overall Study|Physician Decision|1|||
46720968|NCT01147640|82936852|FG001|Overall Study|Physician Decision|0|||
46720969|NCT01147640|82936851|FG000|Overall Study|Withdrawal by Subject|1|||
46720970|NCT01147640|82936852|FG001|Overall Study|Withdrawal by Subject|0|||
46720971|NCT01147640|82936851|FG000|Overall Study|Lost to Follow-up|0|||
46720972|NCT01147640|82936852|FG001|Overall Study|Lost to Follow-up|1|||
46720973|NCT01147640|82936851|FG000|Overall Study|Didn't meet eligibility criteria|1|||
46720974|NCT01147640|82936852|FG001|Overall Study|Didn't meet eligibility criteria|0|||
46720975|NCT01121900|82936858|FG000|First Intervention Period|Adverse Event|1|||
46720976|NCT01121900|82936859|FG001|First Intervention Period|Adverse Event|1|||
46920393|NCT00103610|83152692|FG000|Overall Study|Entered Rescue Procedure|10|||
46920394|NCT00103610|83152693|FG001|Overall Study|Entered Rescue Procedure|52|||
46720977|NCT01121900|82936858|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
46720978|NCT01121900|82936859|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46720979|NCT01121666|82936867|FG000|Overall Study|Protocol Violation|29|||
46720980|NCT01121666|82936868|FG001|Overall Study|Protocol Violation|10|||
46720981|NCT00984126|82936878|FG000|Overall Study|Protocol Violation|0|||
46720982|NCT00984126|82936879|FG001|Overall Study|Protocol Violation|0|||
46720983|NCT00984126|82936880|FG002|Overall Study|Protocol Violation|1|||
46920395|NCT00103610|83152692|FG000|Overall Study|Death|16|||
46920396|NCT00103610|83152693|FG001|Overall Study|Death|12|||
46720984|NCT00984126|82936881|FG003|Overall Study|Protocol Violation|2|||
46720985|NCT00984126|82936878|FG000|Overall Study|Adverse Event|0|||
46720986|NCT00984126|82936879|FG001|Overall Study|Adverse Event|0|||
46920397|NCT00103610|83152692|FG000|Overall Study|Elective Withdrawal|4|||
46920398|NCT00103610|83152693|FG001|Overall Study|Elective Withdrawal|0|||
47043629|NCT03745638|83300525|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
47043630|NCT03745638|83300519|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
46920399|NCT00103610|83152692|FG000|Overall Study|Lost to Follow-up|3|||
46920400|NCT00103610|83152693|FG001|Overall Study|Lost to Follow-up|1|||
46920401|NCT00103610|83152692|FG000|Overall Study|Adverse Event|2|||
46920402|NCT00103610|83152693|FG001|Overall Study|Adverse Event|2|||
46920403|NCT00103610|83152692|FG000|Overall Study|Other|2|||
47043631|NCT03745638|83300520|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
46720987|NCT00984126|82936880|FG002|Overall Study|Adverse Event|0|||
46720988|NCT00984126|82936881|FG003|Overall Study|Adverse Event|2|||
46720989|NCT00984126|82936878|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
46720990|NCT00984126|82936879|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
46720991|NCT00984126|82936880|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
46720992|NCT00984126|82936881|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
46720993|NCT00984126|82936878|FG000|Overall Study|Withdrawal criteria|0|||
46720994|NCT00984126|82936879|FG001|Overall Study|Withdrawal criteria|1|||
46720995|NCT00984126|82936880|FG002|Overall Study|Withdrawal criteria|3|||
46720996|NCT00984126|82936881|FG003|Overall Study|Withdrawal criteria|9|||
46720997|NCT00979602|82936902|FG000|Overall Study|Serious Adverse Event|5|||
46720998|NCT00979602|82936903|FG001|Overall Study|Serious Adverse Event|3|||
46720999|NCT00979602|82936902|FG000|Overall Study|Protocol Violation|3|||
46721000|NCT00979602|82936903|FG001|Overall Study|Protocol Violation|0|||
46721001|NCT00979602|82936902|FG000|Overall Study|Withdrawal by Subject|31|||
46721002|NCT00979602|82936903|FG001|Overall Study|Withdrawal by Subject|25|||
46721003|NCT00979602|82936902|FG000|Overall Study|Lost to Follow-up|100|||
46721004|NCT00979602|82936903|FG001|Overall Study|Lost to Follow-up|96|||
46721005|NCT00979602|82936902|FG000|Overall Study|Migrated/moved from study area|3|||
46721006|NCT00979602|82936903|FG001|Overall Study|Migrated/moved from study area|6|||
46721007|NCT00979602|82936902|FG000|Overall Study|Others|3|||
46721008|NCT00979602|82936903|FG001|Overall Study|Others|3|||
46721009|NCT00816361|82936928|FG000|Overall Study|Withdrawal by Subject|0|||
46721010|NCT00816361|82936929|FG001|Overall Study|Withdrawal by Subject|0|||
47043632|NCT03745638|83300521|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
47043633|NCT03745638|83300522|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
47043634|NCT03745638|83300523|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
47043635|NCT03745638|83300524|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
47043636|NCT03745638|83300525|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
47043637|NCT03699475|83300555|FG000|Overall Study|Death|1|||
47043638|NCT03650413|83300559|FG000|Overall Study|Adverse Event|1|||
47043639|NCT03650413|83300559|FG000|Overall Study|Lack of Efficacy|17|||
47043640|NCT03650413|83300559|FG000|Overall Study|Other|9|||
47043641|NCT03650413|83300559|FG000|Overall Study|Physician Decision|2|||
47043642|NCT03650413|83300559|FG000|Overall Study|Study Terminated By Sponsor|16|||
46633175|NCT01762800|82806485|FG000|Overall Study|Physician Decision|1|||
46633176|NCT01762800|82806486|FG001|Overall Study|Physician Decision|1|||
46633177|NCT01762800|82806485|FG000|Overall Study|Withdrawal by Subject|7|||
46633178|NCT01762800|82806486|FG001|Overall Study|Withdrawal by Subject|4|||
46633179|NCT01597596|82806500|FG000|Overall Study|Study terminated by sponsor|1|||
46633180|NCT01597596|82806501|FG001|Overall Study|Study terminated by sponsor|0|||
46633181|NCT01597596|82806500|FG000|Overall Study|Physician Decision|0|||
46633182|NCT01597596|82806501|FG001|Overall Study|Physician Decision|1|||
46633183|NCT01778556|82806509|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
46633184|NCT01778556|82806510|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
46633185|NCT01778556|82806509|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
46633186|NCT01778556|82806510|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
46633187|NCT01778556|82806509|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
46633188|NCT01778556|82806510|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
46633189|NCT01778556|82806509|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
46633190|NCT01778556|82806510|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
46633191|NCT01761162|82806519|FG000|Overall Study|Withdrawal by Subject|3|||
46633192|NCT01778010|82806523|FG000|Overall Study|Withdrawal by Subject|2|||
46721011|NCT00816361|82936930|FG002|Overall Study|Withdrawal by Subject|0|||
46721012|NCT00816361|82936931|FG003|Overall Study|Withdrawal by Subject|0|||
47043643|NCT03650413|83300559|FG000|Overall Study|Withdrawal by Subject|16|||
46721013|NCT00816361|82936932|FG004|Overall Study|Withdrawal by Subject|1|||
46633193|NCT01778010|82806523|FG000|Overall Study|abnormal ECG before meds|1|||
46633194|NCT01778010|82806523|FG000|Overall Study|Arrested|1|||
46721014|NCT00816361|82936933|FG005|Overall Study|Withdrawal by Subject|2|||
46721015|NCT00816361|82936934|FG006|Overall Study|Withdrawal by Subject|0|||
46721016|NCT00816361|82936935|FG007|Overall Study|Withdrawal by Subject|2|||
46920404|NCT00103610|83152693|FG001|Overall Study|Other|7|||
46920405|NCT00103610|83152692|FG000|Overall Study|Failed mobilization|1|||
46920406|NCT00103610|83152693|FG001|Overall Study|Failed mobilization|5|||
47043644|NCT03596242|83300569|FG000|Overall Study|Lost to Follow-up|2|||
46721017|NCT00816361|82936936|FG008|Overall Study|Withdrawal by Subject|1|||
46721018|NCT00816361|82936928|FG000|Overall Study|Death|4|||
46721019|NCT00816361|82936929|FG001|Overall Study|Death|3|||
46721020|NCT00816361|82936930|FG002|Overall Study|Death|3|||
46721021|NCT00816361|82936931|FG003|Overall Study|Death|3|||
46721022|NCT00816361|82936932|FG004|Overall Study|Death|1|||
46721023|NCT00816361|82936933|FG005|Overall Study|Death|1|||
46721024|NCT00816361|82936934|FG006|Overall Study|Death|3|||
46721025|NCT00816361|82936935|FG007|Overall Study|Death|7|||
46721026|NCT00816361|82936936|FG008|Overall Study|Death|8|||
47043645|NCT03596242|83300570|FG001|Overall Study|Lost to Follow-up|2|||
47043646|NCT03471078|83300578|FG000|Overall Study|Withdrawal by Subject|9|||
47043647|NCT03471078|83300579|FG001|Overall Study|Withdrawal by Subject|1|||
47043648|NCT03471078|83300578|FG000|Overall Study|Adverse Event|4|||
47043649|NCT03471078|83300579|FG001|Overall Study|Adverse Event|1|||
47043650|NCT03471078|83300578|FG000|Overall Study|Physician Decision|3|||
47043651|NCT03471078|83300579|FG001|Overall Study|Physician Decision|2|||
47043652|NCT03471078|83300578|FG000|Overall Study|Death|2|||
47043653|NCT03471078|83300579|FG001|Overall Study|Death|0|||
47043654|NCT03471078|83300578|FG000|Overall Study|Other|3|||
47043655|NCT03471078|83300579|FG001|Overall Study|Other|2|||
47043656|NCT03308188|83300617|FG000|Overall Study|Withdrawal by Subject|0|||
47043657|NCT03308188|83300618|FG001|Overall Study|Withdrawal by Subject|3|||
47043658|NCT03308188|83300617|FG000|Overall Study|Death|0|||
47043659|NCT03308188|83300618|FG001|Overall Study|Death|1|||
47043660|NCT03113968|83300639|FG000|Overall Study|Withdrawal by Subject|31|||
47043661|NCT03113968|83300640|FG001|Overall Study|Withdrawal by Subject|4|||
47043662|NCT02883049|83300649|FG000|Induction|Adverse Event|52|||
47043663|NCT02883049|83300650|FG001|Induction|Adverse Event|2|||
47043664|NCT02883049|83300651|FG002|Induction|Adverse Event|0|||
47043665|NCT02883049|83300652|FG003|Induction|Adverse Event|0|||
47043666|NCT02883049|83300653|FG004|Induction|Adverse Event|0|||
47043667|NCT02883049|83300654|FG005|Induction|Adverse Event|0|||
47043668|NCT02883049|83300655|FG006|Induction|Adverse Event|0|||
47043669|NCT02883049|83300656|FG007|Induction|Adverse Event|0|||
47043670|NCT02883049|83300657|FG008|Induction|Adverse Event|0|||
47043671|NCT02883049|83300658|FG009|Induction|Adverse Event|0|||
47043672|NCT02883049|83300659|FG010|Induction|Adverse Event|0|||
47043673|NCT02883049|83300660|FG011|Induction|Adverse Event|0|||
47043674|NCT02883049|83300661|FG012|Induction|Adverse Event|0|||
47043675|NCT02883049|83300662|FG013|Induction|Adverse Event|0|||
47043676|NCT02883049|83300663|FG014|Induction|Adverse Event|0|||
47043677|NCT02883049|83300664|FG015|Induction|Adverse Event|0|||
47043678|NCT02883049|83300649|FG000|Induction|Death|76|||
47043679|NCT02883049|83300650|FG001|Induction|Death|8|||
47043680|NCT02883049|83300651|FG002|Induction|Death|0|||
47043681|NCT02883049|83300652|FG003|Induction|Death|0|||
47043682|NCT02883049|83300653|FG004|Induction|Death|0|||
47043683|NCT02883049|83300654|FG005|Induction|Death|0|||
47043684|NCT02883049|83300655|FG006|Induction|Death|0|||
47043685|NCT02883049|83300656|FG007|Induction|Death|0|||
47043686|NCT02883049|83300657|FG008|Induction|Death|0|||
47043687|NCT02883049|83300658|FG009|Induction|Death|0|||
47043688|NCT02883049|83300659|FG010|Induction|Death|0|||
47043689|NCT02883049|83300660|FG011|Induction|Death|0|||
47043690|NCT02883049|83300661|FG012|Induction|Death|0|||
46633195|NCT01778010|82806523|FG000|Overall Study|rash while on placebo|1|||
46633196|NCT01777932|82806540|FG000|Overall Study|Disease progression|136|||
46633197|NCT01777932|82806540|FG000|Overall Study|Death|3|||
46633198|NCT01777932|82806540|FG000|Overall Study|Adverse Event|34|||
47043691|NCT02883049|83300662|FG013|Induction|Death|0|||
46633199|NCT01777932|82806540|FG000|Overall Study|Lost to Follow-up|3|||
46633200|NCT01777932|82806540|FG000|Overall Study|Investigator decision|10|||
46633201|NCT01777932|82806540|FG000|Overall Study|Reimbursement limit|9|||
46633202|NCT01777932|82806540|FG000|Overall Study|Patient refused further treatment|10|||
47043692|NCT02883049|83300663|FG014|Induction|Death|0|||
47043693|NCT02883049|83300664|FG015|Induction|Death|0|||
47043694|NCT02883049|83300649|FG000|Induction|Lost to Follow-up|2|||
47043695|NCT02883049|83300650|FG001|Induction|Lost to Follow-up|0|||
47043696|NCT02883049|83300651|FG002|Induction|Lost to Follow-up|0|||
47043697|NCT02883049|83300652|FG003|Induction|Lost to Follow-up|0|||
47043698|NCT02883049|83300653|FG004|Induction|Lost to Follow-up|0|||
47043699|NCT02883049|83300654|FG005|Induction|Lost to Follow-up|0|||
46633203|NCT01777854|82806544|FG000|Overall Study|Physician Decision|3|||
46633204|NCT01777854|82806545|FG001|Overall Study|Physician Decision|3|||
46721027|NCT00816361|82936928|FG000|Overall Study|Other|0|||
46721028|NCT00816361|82936929|FG001|Overall Study|Other|0|||
46721029|NCT00816361|82936930|FG002|Overall Study|Other|0|||
47043700|NCT02883049|83300655|FG006|Induction|Lost to Follow-up|0|||
47043701|NCT02883049|83300656|FG007|Induction|Lost to Follow-up|0|||
47043702|NCT02883049|83300657|FG008|Induction|Lost to Follow-up|0|||
47043703|NCT02883049|83300658|FG009|Induction|Lost to Follow-up|0|||
47043704|NCT02883049|83300659|FG010|Induction|Lost to Follow-up|0|||
47043705|NCT02883049|83300660|FG011|Induction|Lost to Follow-up|0|||
47043706|NCT02883049|83300661|FG012|Induction|Lost to Follow-up|0|||
47043707|NCT02883049|83300662|FG013|Induction|Lost to Follow-up|0|||
47043708|NCT02883049|83300663|FG014|Induction|Lost to Follow-up|0|||
47043709|NCT02883049|83300664|FG015|Induction|Lost to Follow-up|0|||
47043710|NCT02883049|83300649|FG000|Induction|Physician Decision|1407|||
47043711|NCT02883049|83300650|FG001|Induction|Physician Decision|8|||
47043712|NCT02883049|83300651|FG002|Induction|Physician Decision|0|||
47043713|NCT02883049|83300652|FG003|Induction|Physician Decision|0|||
47043714|NCT02883049|83300653|FG004|Induction|Physician Decision|0|||
47043715|NCT02883049|83300654|FG005|Induction|Physician Decision|0|||
47043716|NCT02883049|83300655|FG006|Induction|Physician Decision|0|||
47043717|NCT02883049|83300656|FG007|Induction|Physician Decision|0|||
46633205|NCT01777776|82806553|FG000|Overall Study|Adverse Event|2|||
46633206|NCT01777776|82806554|FG001|Overall Study|Adverse Event|4|||
46633207|NCT01777776|82806555|FG002|Overall Study|Adverse Event|0|||
46633208|NCT01777776|82806556|FG003|Overall Study|Adverse Event|0|||
46633209|NCT01777776|82806553|FG000|Overall Study|Disease Progression|4|||
46633210|NCT01777776|82806554|FG001|Overall Study|Disease Progression|8|||
46633211|NCT01777776|82806555|FG002|Overall Study|Disease Progression|6|||
46633212|NCT01777776|82806556|FG003|Overall Study|Disease Progression|3|||
46721030|NCT00816361|82936931|FG003|Overall Study|Other|0|||
46721031|NCT00816361|82936932|FG004|Overall Study|Other|0|||
46721032|NCT00816361|82936933|FG005|Overall Study|Other|0|||
46721033|NCT00816361|82936934|FG006|Overall Study|Other|0|||
46721034|NCT00816361|82936935|FG007|Overall Study|Other|0|||
46721035|NCT00816361|82936936|FG008|Overall Study|Other|1|||
46633213|NCT01777776|82806553|FG000|Overall Study|Withdrawal by Subject|0|||
46633214|NCT01777776|82806554|FG001|Overall Study|Withdrawal by Subject|0|||
46633215|NCT01777776|82806555|FG002|Overall Study|Withdrawal by Subject|0|||
46633216|NCT01777776|82806556|FG003|Overall Study|Withdrawal by Subject|1|||
46633217|NCT01777620|82806577|FG000|Overall Study|Subject Withdrawal|1|||
46633218|NCT01777620|82806578|FG001|Overall Study|Subject Withdrawal|0|||
46633219|NCT01777542|82806584|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
46633220|NCT01777542|82806585|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
46633221|NCT01736124|82806594|FG000|Post-intervention Assessment|Death|2|||
46633222|NCT01736124|82806595|FG001|Post-intervention Assessment|Death|2|||
46721036|NCT00826111|82936959|FG000|Overall Study|Lost to Follow-up|0|||
46721037|NCT00826111|82936960|FG001|Overall Study|Lost to Follow-up|1|||
46721038|NCT00826111|82936959|FG000|Overall Study|Protocol Violation|1|||
46721039|NCT00826111|82936960|FG001|Overall Study|Protocol Violation|0|||
46721040|NCT00826111|82936959|FG000|Overall Study|Withdrawal by Subject|5|||
46721041|NCT00826111|82936960|FG001|Overall Study|Withdrawal by Subject|0|||
46721042|NCT00826111|82936959|FG000|Overall Study|Physician Decision|1|||
46721043|NCT00826111|82936960|FG001|Overall Study|Physician Decision|1|||
46721044|NCT00982644|82936971|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
46721045|NCT00982644|82936972|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
46721046|NCT00982644|82936971|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
46721047|NCT00982644|82936972|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
46721048|NCT00982644|82936971|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
46721049|NCT00982644|82936972|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
46721050|NCT00982644|82936971|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
46721051|NCT00982644|82936972|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
46721052|NCT00982644|82936971|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
46721053|NCT00982644|82936972|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
46721054|NCT00982644|82936971|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
46721055|NCT00982644|82936972|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
46721056|NCT00982644|82936971|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
46721057|NCT00982644|82936972|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
46721058|NCT00982644|82936971|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
46721059|NCT00982644|82936972|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
46721060|NCT00982644|82936971|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
46721061|NCT00982644|82936972|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
46721062|NCT00982644|82936971|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
46721063|NCT00982644|82936972|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
46721064|NCT00815659|82936978|FG000|Overall Study|Adverse Event|9|||
46721065|NCT00815659|82936978|FG000|Overall Study|Withdrawal by Subject|9|||
46721066|NCT00815659|82936978|FG000|Overall Study|Lost to Follow-up|4|||
46721067|NCT00815659|82936978|FG000|Overall Study|Protocol Violation|1|||
46633223|NCT01736124|82806594|FG000|Post-intervention Assessment|lost computer access|1|||
46633224|NCT01736124|82806595|FG001|Post-intervention Assessment|lost computer access|1|||
46721068|NCT00825175|82936984|FG000|Overall Study|Withdrawal by Subject|0|||
46721069|NCT00825175|82936985|FG001|Overall Study|Withdrawal by Subject|5|||
46721070|NCT00824473|82936993|FG000|Overall Study|Adverse Event|4|||
46721071|NCT00824473|82936994|FG001|Overall Study|Adverse Event|5|||
47043718|NCT02883049|83300657|FG008|Induction|Physician Decision|0|||
47043719|NCT02883049|83300658|FG009|Induction|Physician Decision|0|||
47043720|NCT02883049|83300659|FG010|Induction|Physician Decision|0|||
47043721|NCT02883049|83300660|FG011|Induction|Physician Decision|0|||
47043722|NCT02883049|83300661|FG012|Induction|Physician Decision|0|||
47043723|NCT02883049|83300662|FG013|Induction|Physician Decision|0|||
47043724|NCT02883049|83300663|FG014|Induction|Physician Decision|0|||
47043725|NCT02883049|83300664|FG015|Induction|Physician Decision|0|||
47043726|NCT02883049|83300649|FG000|Induction|Protocol Violation|6|||
47043727|NCT02883049|83300650|FG001|Induction|Protocol Violation|0|||
47043728|NCT02883049|83300651|FG002|Induction|Protocol Violation|0|||
47043729|NCT02883049|83300652|FG003|Induction|Protocol Violation|0|||
47043730|NCT02883049|83300653|FG004|Induction|Protocol Violation|0|||
47043731|NCT02883049|83300654|FG005|Induction|Protocol Violation|0|||
47043732|NCT02883049|83300655|FG006|Induction|Protocol Violation|0|||
47043733|NCT02883049|83300656|FG007|Induction|Protocol Violation|0|||
47043734|NCT02883049|83300657|FG008|Induction|Protocol Violation|0|||
47043735|NCT02883049|83300658|FG009|Induction|Protocol Violation|0|||
47043736|NCT02883049|83300659|FG010|Induction|Protocol Violation|0|||
47043737|NCT02883049|83300660|FG011|Induction|Protocol Violation|0|||
47043738|NCT02883049|83300661|FG012|Induction|Protocol Violation|0|||
47043739|NCT02883049|83300662|FG013|Induction|Protocol Violation|0|||
47043740|NCT02883049|83300663|FG014|Induction|Protocol Violation|0|||
47043741|NCT02883049|83300664|FG015|Induction|Protocol Violation|0|||
47043742|NCT02883049|83300649|FG000|Induction|Withdrawal by Subject|6|||
46920407|NCT00103610|83152692|FG000|Overall Study|Noncompliance|0|||
46920408|NCT00103610|83152693|FG001|Overall Study|Noncompliance|1|||
46920409|NCT03091439|83152702|FG000|Overall Study|Study Terminated by the Sponsor|1|||
46920410|NCT03091439|83152703|FG001|Overall Study|Study Terminated by the Sponsor|0|||
46920411|NCT03086447|83152711|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
46920412|NCT03086447|83152712|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
46920413|NCT03086447|83152711|FG000|Overall Study|Lost Lens|2|||
46920414|NCT03086447|83152712|FG001|Overall Study|Lost Lens|5|||
47043743|NCT02883049|83300650|FG001|Induction|Withdrawal by Subject|0|||
47043744|NCT02883049|83300651|FG002|Induction|Withdrawal by Subject|0|||
47043745|NCT02883049|83300652|FG003|Induction|Withdrawal by Subject|0|||
47043746|NCT02883049|83300653|FG004|Induction|Withdrawal by Subject|0|||
47043747|NCT02883049|83300654|FG005|Induction|Withdrawal by Subject|0|||
47043748|NCT02883049|83300655|FG006|Induction|Withdrawal by Subject|0|||
47043749|NCT02883049|83300656|FG007|Induction|Withdrawal by Subject|0|||
47043750|NCT02883049|83300657|FG008|Induction|Withdrawal by Subject|0|||
47043751|NCT02883049|83300658|FG009|Induction|Withdrawal by Subject|0|||
47043752|NCT02883049|83300659|FG010|Induction|Withdrawal by Subject|0|||
47043753|NCT02883049|83300660|FG011|Induction|Withdrawal by Subject|0|||
47043754|NCT02883049|83300661|FG012|Induction|Withdrawal by Subject|0|||
46920415|NCT03086447|83152711|FG000|Overall Study|Product quality complaint|0|||
46920416|NCT03086447|83152712|FG001|Overall Study|Product quality complaint|1|||
46920417|NCT03086447|83152711|FG000|Overall Study|Lens Damage|1|||
46920418|NCT03086447|83152712|FG001|Overall Study|Lens Damage|6|||
46920419|NCT03086447|83152711|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
46920420|NCT03086447|83152712|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
46920421|NCT03086447|83152711|FG000|Overall Study|Test Article No Longer Available|1|||
47043755|NCT02883049|83300662|FG013|Induction|Withdrawal by Subject|0|||
47043756|NCT02883049|83300663|FG014|Induction|Withdrawal by Subject|0|||
47043757|NCT02883049|83300664|FG015|Induction|Withdrawal by Subject|0|||
47043758|NCT02883049|83300649|FG000|Induction|Ineligible|35|||
47043759|NCT02883049|83300650|FG001|Induction|Ineligible|1|||
47043760|NCT02883049|83300651|FG002|Induction|Ineligible|0|||
47043761|NCT02883049|83300652|FG003|Induction|Ineligible|0|||
47043762|NCT02883049|83300653|FG004|Induction|Ineligible|0|||
47043763|NCT02883049|83300654|FG005|Induction|Ineligible|0|||
47043764|NCT02883049|83300655|FG006|Induction|Ineligible|0|||
47043765|NCT02883049|83300656|FG007|Induction|Ineligible|0|||
47043766|NCT02883049|83300657|FG008|Induction|Ineligible|0|||
47043767|NCT02883049|83300658|FG009|Induction|Ineligible|0|||
47043768|NCT02883049|83300659|FG010|Induction|Ineligible|0|||
47043769|NCT02883049|83300660|FG011|Induction|Ineligible|0|||
47043770|NCT02883049|83300661|FG012|Induction|Ineligible|0|||
47043771|NCT02883049|83300662|FG013|Induction|Ineligible|0|||
47043772|NCT02883049|83300663|FG014|Induction|Ineligible|0|||
47043773|NCT02883049|83300664|FG015|Induction|Ineligible|0|||
47043774|NCT02883049|83300649|FG000|Induction|Refusal of further protocol therapy|466|||
47043775|NCT02883049|83300650|FG001|Induction|Refusal of further protocol therapy|2|||
47043776|NCT02883049|83300651|FG002|Induction|Refusal of further protocol therapy|0|||
47043777|NCT02883049|83300652|FG003|Induction|Refusal of further protocol therapy|0|||
47043778|NCT02883049|83300653|FG004|Induction|Refusal of further protocol therapy|0|||
47043779|NCT02883049|83300654|FG005|Induction|Refusal of further protocol therapy|0|||
46920422|NCT03086447|83152712|FG001|Overall Study|Test Article No Longer Available|0|||
46920423|NCT03086447|83152711|FG000|Overall Study|Protocol Violation|2|||
46920424|NCT03086447|83152712|FG001|Overall Study|Protocol Violation|4|||
47043780|NCT02883049|83300655|FG006|Induction|Refusal of further protocol therapy|0|||
47043781|NCT02883049|83300656|FG007|Induction|Refusal of further protocol therapy|0|||
47043782|NCT02883049|83300657|FG008|Induction|Refusal of further protocol therapy|0|||
47043783|NCT02883049|83300658|FG009|Induction|Refusal of further protocol therapy|0|||
46721072|NCT00824473|82936993|FG000|Overall Study|Lack of Efficacy|2|||
46721073|NCT00824473|82936994|FG001|Overall Study|Lack of Efficacy|2|||
46721074|NCT00824473|82936993|FG000|Overall Study|Protocol Violation|2|||
46721075|NCT00824473|82936994|FG001|Overall Study|Protocol Violation|0|||
46721076|NCT00824473|82936993|FG000|Overall Study|Non-Compliance|4|||
46721077|NCT00824473|82936994|FG001|Overall Study|Non-Compliance|2|||
46721078|NCT00824473|82936993|FG000|Overall Study|Withdrawal by Subject|2|||
46721079|NCT00824473|82936994|FG001|Overall Study|Withdrawal by Subject|3|||
47043784|NCT02883049|83300659|FG010|Induction|Refusal of further protocol therapy|0|||
47043785|NCT02883049|83300660|FG011|Induction|Refusal of further protocol therapy|0|||
46721080|NCT00824473|82936993|FG000|Overall Study|Other|1|||
46721081|NCT00824473|82936994|FG001|Overall Study|Other|1|||
46721082|NCT00815191|82937006|FG000|Overall Study|Protocol Violation|1|||
46721083|NCT00815191|82937007|FG001|Overall Study|Protocol Violation|1|||
46721084|NCT00812929|82937013|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
46721085|NCT00812929|82937014|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
46721086|NCT00812929|82937015|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
47043786|NCT02883049|83300661|FG012|Induction|Refusal of further protocol therapy|0|||
47043787|NCT02883049|83300662|FG013|Induction|Refusal of further protocol therapy|0|||
47043788|NCT02883049|83300663|FG014|Induction|Refusal of further protocol therapy|0|||
47043789|NCT02883049|83300664|FG015|Induction|Refusal of further protocol therapy|0|||
47043790|NCT02883049|83300649|FG000|Induction|Identified as Ph+ patients|279|||
46721087|NCT00812929|82937016|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
46721088|NCT00812929|82937017|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
46721089|NCT00812929|82937018|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
46721090|NCT00812929|82937019|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
46721091|NCT00812929|82937020|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
46721092|NCT00812929|82937021|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
46721093|NCT00812929|82937022|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
46721094|NCT00812929|82937013|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
46721095|NCT00812929|82937014|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
46721096|NCT00812929|82937015|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
46721097|NCT00812929|82937016|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
46721098|NCT00812929|82937017|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
46721099|NCT00812929|82937018|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
46721100|NCT00812929|82937019|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
46721101|NCT00812929|82937020|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
46721102|NCT00812929|82937021|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
46721103|NCT00812929|82937022|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
46721104|NCT00812929|82937013|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
46721105|NCT00812929|82937014|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
46721106|NCT00812929|82937015|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
47043791|NCT02883049|83300650|FG001|Induction|Identified as Ph+ patients|1|||
46721107|NCT00812929|82937016|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
46721108|NCT00812929|82937017|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
46721109|NCT00812929|82937018|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
46721110|NCT00812929|82937019|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
46721111|NCT00812929|82937020|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
47043792|NCT02883049|83300651|FG002|Induction|Identified as Ph+ patients|0|||
47043793|NCT02883049|83300652|FG003|Induction|Identified as Ph+ patients|0|||
47043794|NCT02883049|83300653|FG004|Induction|Identified as Ph+ patients|0|||
47043795|NCT02883049|83300654|FG005|Induction|Identified as Ph+ patients|0|||
47043796|NCT02883049|83300655|FG006|Induction|Identified as Ph+ patients|0|||
47043797|NCT02883049|83300656|FG007|Induction|Identified as Ph+ patients|0|||
47043798|NCT02883049|83300657|FG008|Induction|Identified as Ph+ patients|0|||
47043799|NCT02883049|83300658|FG009|Induction|Identified as Ph+ patients|0|||
47043800|NCT02883049|83300659|FG010|Induction|Identified as Ph+ patients|0|||
47043801|NCT02883049|83300660|FG011|Induction|Identified as Ph+ patients|0|||
47043802|NCT02883049|83300661|FG012|Induction|Identified as Ph+ patients|0|||
47043803|NCT02883049|83300662|FG013|Induction|Identified as Ph+ patients|0|||
47043804|NCT02883049|83300663|FG014|Induction|Identified as Ph+ patients|0|||
47043805|NCT02883049|83300664|FG015|Induction|Identified as Ph+ patients|0|||
47043806|NCT02883049|83300649|FG000|Induction|M3 Marrow at Day29|8|||
47043807|NCT02883049|83300650|FG001|Induction|M3 Marrow at Day29|1|||
47043808|NCT02883049|83300651|FG002|Induction|M3 Marrow at Day29|0|||
47043809|NCT02883049|83300652|FG003|Induction|M3 Marrow at Day29|0|||
47043810|NCT02883049|83300653|FG004|Induction|M3 Marrow at Day29|0|||
47043811|NCT02883049|83300654|FG005|Induction|M3 Marrow at Day29|0|||
47043812|NCT02883049|83300655|FG006|Induction|M3 Marrow at Day29|0|||
47043813|NCT02883049|83300656|FG007|Induction|M3 Marrow at Day29|0|||
47043814|NCT02883049|83300657|FG008|Induction|M3 Marrow at Day29|0|||
47043815|NCT02883049|83300658|FG009|Induction|M3 Marrow at Day29|0|||
47043816|NCT02883049|83300659|FG010|Induction|M3 Marrow at Day29|0|||
47043817|NCT02883049|83300660|FG011|Induction|M3 Marrow at Day29|0|||
47043818|NCT02883049|83300661|FG012|Induction|M3 Marrow at Day29|0|||
47043819|NCT02883049|83300662|FG013|Induction|M3 Marrow at Day29|0|||
47043820|NCT02883049|83300663|FG014|Induction|M3 Marrow at Day29|0|||
47043821|NCT02883049|83300664|FG015|Induction|M3 Marrow at Day29|0|||
47043822|NCT02883049|83300649|FG000|Induction|Inevaluable|33|||
47043823|NCT02883049|83300650|FG001|Induction|Inevaluable|1|||
47043824|NCT02883049|83300651|FG002|Induction|Inevaluable|0|||
47043825|NCT02883049|83300652|FG003|Induction|Inevaluable|0|||
47043826|NCT02883049|83300653|FG004|Induction|Inevaluable|0|||
47043827|NCT02883049|83300654|FG005|Induction|Inevaluable|0|||
47043828|NCT02883049|83300655|FG006|Induction|Inevaluable|0|||
47043829|NCT02883049|83300656|FG007|Induction|Inevaluable|0|||
47043830|NCT02883049|83300657|FG008|Induction|Inevaluable|0|||
47043831|NCT02883049|83300658|FG009|Induction|Inevaluable|0|||
47043832|NCT02883049|83300659|FG010|Induction|Inevaluable|0|||
47043833|NCT02883049|83300660|FG011|Induction|Inevaluable|0|||
47043834|NCT02883049|83300661|FG012|Induction|Inevaluable|0|||
47043835|NCT02883049|83300662|FG013|Induction|Inevaluable|0|||
47043836|NCT02883049|83300663|FG014|Induction|Inevaluable|0|||
47043837|NCT02883049|83300664|FG015|Induction|Inevaluable|0|||
47043838|NCT02883049|83300649|FG000|Induction|Identified as VHR at end of Induction|244|||
47043839|NCT02883049|83300650|FG001|Induction|Identified as VHR at end of Induction|0|||
46633225|NCT01736124|82806594|FG000|Post-intervention Assessment|Moved away|3|||
46633226|NCT01736124|82806595|FG001|Post-intervention Assessment|Moved away|1|||
46633227|NCT01736124|82806594|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
47043840|NCT02883049|83300651|FG002|Induction|Identified as VHR at end of Induction|0|||
47043841|NCT02883049|83300652|FG003|Induction|Identified as VHR at end of Induction|0|||
47043842|NCT02883049|83300653|FG004|Induction|Identified as VHR at end of Induction|0|||
47043843|NCT02883049|83300654|FG005|Induction|Identified as VHR at end of Induction|0|||
47043844|NCT02883049|83300655|FG006|Induction|Identified as VHR at end of Induction|0|||
47043845|NCT02883049|83300656|FG007|Induction|Identified as VHR at end of Induction|0|||
46633228|NCT01736124|82806595|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
46633229|NCT01736124|82806594|FG000|Post-intervention Assessment|Illness|3|||
46633230|NCT01736124|82806595|FG001|Post-intervention Assessment|Illness|2|||
46633231|NCT01736124|82806594|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
47043846|NCT02883049|83300657|FG008|Induction|Identified as VHR at end of Induction|0|||
46633232|NCT01736124|82806595|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
47043847|NCT02883049|83300658|FG009|Induction|Identified as VHR at end of Induction|0|||
47043848|NCT02883049|83300659|FG010|Induction|Identified as VHR at end of Induction|0|||
47043849|NCT02883049|83300660|FG011|Induction|Identified as VHR at end of Induction|0|||
47043850|NCT02883049|83300661|FG012|Induction|Identified as VHR at end of Induction|0|||
47043851|NCT02883049|83300662|FG013|Induction|Identified as VHR at end of Induction|0|||
47043852|NCT02883049|83300663|FG014|Induction|Identified as VHR at end of Induction|0|||
47043853|NCT02883049|83300664|FG015|Induction|Identified as VHR at end of Induction|0|||
47043854|NCT02883049|83300649|FG000|Induction|Moved to another non-COG institution|3|||
47043855|NCT02883049|83300650|FG001|Induction|Moved to another non-COG institution|0|||
47043856|NCT02883049|83300651|FG002|Induction|Moved to another non-COG institution|0|||
47043857|NCT02883049|83300652|FG003|Induction|Moved to another non-COG institution|0|||
47043858|NCT02883049|83300653|FG004|Induction|Moved to another non-COG institution|0|||
47043859|NCT02883049|83300654|FG005|Induction|Moved to another non-COG institution|0|||
47043860|NCT02883049|83300655|FG006|Induction|Moved to another non-COG institution|0|||
46633233|NCT01736124|82806594|FG000|Post-intervention Assessment|Temporarily away|3|||
46633234|NCT01736124|82806595|FG001|Post-intervention Assessment|Temporarily away|1|||
46721112|NCT00812929|82937021|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
46721113|NCT00812929|82937022|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
46721114|NCT00824161|82937039|FG000|Overall Study|Withdrawal by Subject|1|||
46721115|NCT00824161|82937039|FG000|Overall Study|Screen Failure|1|||
46721116|NCT00979134|82937048|FG000|Overall Study|Disease progression|18|||
46721117|NCT00979134|82937049|FG001|Overall Study|Disease progression|2|||
46721118|NCT00979134|82937050|FG002|Overall Study|Disease progression|5|||
46721119|NCT00979134|82937048|FG000|Overall Study|Adverse Event|0|||
46721120|NCT00979134|82937049|FG001|Overall Study|Adverse Event|0|||
46721121|NCT00979134|82937050|FG002|Overall Study|Adverse Event|2|||
46721122|NCT00979134|82937048|FG000|Overall Study|Withdrawal by Subject|1|||
46721123|NCT00979134|82937049|FG001|Overall Study|Withdrawal by Subject|1|||
46721124|NCT00979134|82937050|FG002|Overall Study|Withdrawal by Subject|2|||
46721125|NCT00979134|82937048|FG000|Overall Study|Lost to Follow-up|2|||
46721126|NCT00979134|82937049|FG001|Overall Study|Lost to Follow-up|2|||
46721127|NCT00979134|82937050|FG002|Overall Study|Lost to Follow-up|0|||
46721128|NCT00979134|82937048|FG000|Overall Study|Death|4|||
46721129|NCT00979134|82937049|FG001|Overall Study|Death|0|||
46721130|NCT00979134|82937050|FG002|Overall Study|Death|26|||
46721131|NCT00979134|82937048|FG000|Overall Study|Other|8|||
46721132|NCT00979134|82937049|FG001|Overall Study|Other|1|||
46721133|NCT00979134|82937050|FG002|Overall Study|Other|5|||
46721134|NCT00824005|82937065|FG000|Overall Study|Death|0|||
46721135|NCT00824005|82937066|FG001|Overall Study|Death|1|||
46721136|NCT00824005|82937065|FG000|Overall Study|Lost to Follow-up|0|||
46721137|NCT00824005|82937066|FG001|Overall Study|Lost to Follow-up|1|||
46721138|NCT00814879|82937074|FG000|By Week 24|Cancer Diagnosis|1|||
46721139|NCT00814879|82937075|FG001|By Week 24|Cancer Diagnosis|0|||
46721140|NCT00814879|82937074|FG000|By Week 24|Incarceration|0|||
46721141|NCT00814879|82937075|FG001|By Week 24|Incarceration|1|||
47043861|NCT02883049|83300656|FG007|Induction|Moved to another non-COG institution|0|||
47043862|NCT02883049|83300657|FG008|Induction|Moved to another non-COG institution|0|||
46633235|NCT01736124|82806594|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
46633236|NCT01736124|82806595|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
46633237|NCT01736124|82806594|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
46633238|NCT01736124|82806595|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
46633239|NCT01736124|82806594|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
46633240|NCT01736124|82806595|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
46633241|NCT01736124|82806594|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
46633242|NCT01736124|82806595|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
46633243|NCT01736124|82806594|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
46633244|NCT01736124|82806595|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
46633245|NCT01736124|82806594|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
46633246|NCT01736124|82806595|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
46633247|NCT01736124|82806594|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
46721142|NCT00814879|82937074|FG000|By Week 48|Lost to Follow-up|2|||
47043863|NCT02883049|83300658|FG009|Induction|Moved to another non-COG institution|0|||
47043864|NCT02883049|83300659|FG010|Induction|Moved to another non-COG institution|0|||
47043865|NCT02883049|83300660|FG011|Induction|Moved to another non-COG institution|0|||
46721143|NCT00814879|82937075|FG001|By Week 48|Lost to Follow-up|2|||
46721144|NCT00814879|82937074|FG000|By Week 48|Death|0|||
46721145|NCT00814879|82937075|FG001|By Week 48|Death|1|||
46721146|NCT03347422|82937084|FG000|Part A (26 Weeks)|Adverse Event|3|||
47043866|NCT02883049|83300661|FG012|Induction|Moved to another non-COG institution|0|||
47043867|NCT02883049|83300662|FG013|Induction|Moved to another non-COG institution|0|||
47043868|NCT02883049|83300663|FG014|Induction|Moved to another non-COG institution|0|||
47043869|NCT02883049|83300664|FG015|Induction|Moved to another non-COG institution|0|||
47043870|NCT02883049|83300649|FG000|Induction|Randomization closed|41|||
47043871|NCT02883049|83300650|FG001|Induction|Randomization closed|0|||
47043872|NCT02883049|83300651|FG002|Induction|Randomization closed|0|||
46633248|NCT01736124|82806595|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
46633249|NCT01736124|82806594|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
46633250|NCT01736124|82806595|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
46633251|NCT01736124|82806594|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
46633252|NCT01736124|82806595|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
46633253|NCT01759446|82806608|FG000|Overall Study|Protocol Violation|1|||
46633254|NCT01759446|82806609|FG001|Overall Study|Protocol Violation|0|||
46633255|NCT01759446|82806610|FG002|Overall Study|Protocol Violation|1|||
46633256|NCT01759446|82806611|FG003|Overall Study|Protocol Violation|0|||
46633257|NCT01759446|82806612|FG004|Overall Study|Protocol Violation|0|||
46633258|NCT01759446|82806608|FG000|Overall Study|Withdrawal by Subject|0|||
46633259|NCT01759446|82806609|FG001|Overall Study|Withdrawal by Subject|1|||
46633260|NCT01759446|82806610|FG002|Overall Study|Withdrawal by Subject|0|||
46633261|NCT01759446|82806611|FG003|Overall Study|Withdrawal by Subject|1|||
46633262|NCT01759446|82806612|FG004|Overall Study|Withdrawal by Subject|0|||
46633263|NCT01777308|82806626|FG000|Overall Study|Withdrawal by Subject|5|||
46633264|NCT01777308|82806627|FG001|Overall Study|Withdrawal by Subject|1|||
46633265|NCT01777308|82806626|FG000|Overall Study|Migrated/moved from study area|1|||
46633266|NCT01777308|82806627|FG001|Overall Study|Migrated/moved from study area|0|||
46633267|NCT01777308|82806626|FG000|Overall Study|Lost to Follow-up|7|||
46633268|NCT01777308|82806627|FG001|Overall Study|Lost to Follow-up|2|||
46633269|NCT01777308|82806626|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
46920425|NCT03086447|83152711|FG000|Overall Study|Lost to Follow-up|0|||
46920426|NCT03086447|83152712|FG001|Overall Study|Lost to Follow-up|1|||
46920427|NCT03086447|83152711|FG000|Overall Study|Adverse Event|3|||
46920428|NCT03086447|83152712|FG001|Overall Study|Adverse Event|0|||
46920429|NCT03086447|83152711|FG000|Overall Study|Lens Discomfort|2|||
46920430|NCT03086447|83152712|FG001|Overall Study|Lens Discomfort|1|||
46920431|NCT03083639|83152743|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
46920432|NCT03083639|83152744|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
46920433|NCT03083639|83152743|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
46920434|NCT03083639|83152744|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
46920435|NCT02927431|83152753|FG000|Overall Study|Withdrawal by Subject|0|||
47043873|NCT02883049|83300652|FG003|Induction|Randomization closed|0|||
46633270|NCT01777308|82806627|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
46633271|NCT01759368|82806636|FG000|Overall Study|Lost to Follow-up|1|||
46633272|NCT01759368|82806637|FG001|Overall Study|Lost to Follow-up|0|||
46920436|NCT02927431|83152754|FG001|Overall Study|Withdrawal by Subject|0|||
46920437|NCT02927431|83152755|FG002|Overall Study|Withdrawal by Subject|1|||
46633273|NCT01777152|82806647|FG000|Overall Study|Withdrawal by Subject|22|||
46633274|NCT01777152|82806648|FG001|Overall Study|Withdrawal by Subject|16|||
46633275|NCT01777152|82806647|FG000|Overall Study|Lost to Follow-up|3|||
46721147|NCT03347422|82937085|FG001|Part A (26 Weeks)|Adverse Event|0|||
47043874|NCT02883049|83300653|FG004|Induction|Randomization closed|0|||
46633276|NCT01777152|82806648|FG001|Overall Study|Lost to Follow-up|5|||
46633277|NCT01777152|82806647|FG000|Overall Study|Death|68|||
46633278|NCT01777152|82806648|FG001|Overall Study|Death|89|||
46633279|NCT01777152|82806647|FG000|Overall Study|Not eligible, no study drug received|1|||
46920438|NCT03083483|83152768|FG000|Overall Study|Adverse Event|1|||
46920439|NCT03083483|83152769|FG001|Overall Study|Adverse Event|1|||
47043875|NCT02883049|83300654|FG005|Induction|Randomization closed|0|||
47043876|NCT02883049|83300655|FG006|Induction|Randomization closed|0|||
47043877|NCT02883049|83300656|FG007|Induction|Randomization closed|0|||
46721148|NCT03347422|82937084|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
46721149|NCT03347422|82937085|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
46721150|NCT03347422|82937084|FG000|Part B (149 Weeks)|Adverse Event|0|||
46721151|NCT03347422|82937085|FG001|Part B (149 Weeks)|Adverse Event|1|||
46721152|NCT03347422|82937084|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
46721153|NCT03347422|82937085|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
46721154|NCT03347422|82937084|FG000|Part B (149 Weeks)|Other|1|||
46721155|NCT03347422|82937085|FG001|Part B (149 Weeks)|Other|0|||
46721156|NCT00814801|82937101|FG000|Overall Study|Adverse Event|15|||
46721157|NCT00814801|82937102|FG001|Overall Study|Adverse Event|16|||
46721158|NCT00814801|82937103|FG002|Overall Study|Adverse Event|19|||
46721159|NCT00814801|82937101|FG000|Overall Study|Withdrawal by Subject|9|||
46721160|NCT00814801|82937102|FG001|Overall Study|Withdrawal by Subject|11|||
46721161|NCT00814801|82937103|FG002|Overall Study|Withdrawal by Subject|14|||
46721162|NCT00814801|82937101|FG000|Overall Study|Inappropriate as a subject|1|||
46721163|NCT00814801|82937102|FG001|Overall Study|Inappropriate as a subject|1|||
46721164|NCT00814801|82937103|FG002|Overall Study|Inappropriate as a subject|1|||
46721165|NCT00814801|82937101|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
46721166|NCT00814801|82937102|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
46721167|NCT00814801|82937103|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
46721168|NCT00814801|82937101|FG000|Overall Study|Missing or change of caregiver|6|||
46721169|NCT00814801|82937102|FG001|Overall Study|Missing or change of caregiver|2|||
46721170|NCT00814801|82937103|FG002|Overall Study|Missing or change of caregiver|4|||
46721171|NCT00814801|82937101|FG000|Overall Study|Non-compliance|0|||
47043878|NCT02883049|83300657|FG008|Induction|Randomization closed|0|||
47043879|NCT02883049|83300658|FG009|Induction|Randomization closed|0|||
47043880|NCT02883049|83300659|FG010|Induction|Randomization closed|0|||
47043881|NCT02883049|83300660|FG011|Induction|Randomization closed|0|||
47043882|NCT02883049|83300661|FG012|Induction|Randomization closed|0|||
47043883|NCT02883049|83300662|FG013|Induction|Randomization closed|0|||
47043884|NCT02883049|83300663|FG014|Induction|Randomization closed|0|||
47043885|NCT02883049|83300664|FG015|Induction|Randomization closed|0|||
47043886|NCT02883049|83300649|FG000|Induction|MRD negative|36|||
46721172|NCT00814801|82937102|FG001|Overall Study|Non-compliance|1|||
46721173|NCT00814801|82937103|FG002|Overall Study|Non-compliance|1|||
46721174|NCT00814801|82937101|FG000|Overall Study|Other|2|||
46721175|NCT00814801|82937102|FG001|Overall Study|Other|6|||
46721176|NCT00814801|82937103|FG002|Overall Study|Other|4|||
47043887|NCT02883049|83300650|FG001|Induction|MRD negative|0|||
47043888|NCT02883049|83300651|FG002|Induction|MRD negative|0|||
47043889|NCT02883049|83300652|FG003|Induction|MRD negative|0|||
47043890|NCT02883049|83300653|FG004|Induction|MRD negative|0|||
46721177|NCT00823615|82937111|FG000|Period 2|Lost to Follow-up|2|||
46721178|NCT00823615|82937112|FG001|Period 2|Lost to Follow-up|0|||
46721179|NCT00823615|82937111|FG000|Period 2|Time/Job Conflict|1|||
47043891|NCT02883049|83300654|FG005|Induction|MRD negative|0|||
47043892|NCT02883049|83300655|FG006|Induction|MRD negative|0|||
46633280|NCT01777152|82806648|FG001|Overall Study|Not eligible, no study drug received|0|||
47043893|NCT02883049|83300656|FG007|Induction|MRD negative|0|||
47043894|NCT02883049|83300657|FG008|Induction|MRD negative|0|||
47043895|NCT02883049|83300658|FG009|Induction|MRD negative|0|||
47043896|NCT02883049|83300659|FG010|Induction|MRD negative|0|||
47043897|NCT02883049|83300660|FG011|Induction|MRD negative|0|||
47043898|NCT02883049|83300661|FG012|Induction|MRD negative|0|||
47043899|NCT02883049|83300662|FG013|Induction|MRD negative|0|||
47043900|NCT02883049|83300663|FG014|Induction|MRD negative|0|||
47043901|NCT02883049|83300664|FG015|Induction|MRD negative|0|||
47043902|NCT02883049|83300649|FG000|Induction|Identified as HR patients|165|||
47043903|NCT02883049|83300650|FG001|Induction|Identified as HR patients|0|||
47043904|NCT02883049|83300651|FG002|Induction|Identified as HR patients|0|||
47043905|NCT02883049|83300652|FG003|Induction|Identified as HR patients|0|||
46633281|NCT01777152|82806647|FG000|Overall Study|Change of diagnosis|1|||
47043906|NCT02883049|83300653|FG004|Induction|Identified as HR patients|0|||
47043907|NCT02883049|83300654|FG005|Induction|Identified as HR patients|0|||
47043908|NCT02883049|83300655|FG006|Induction|Identified as HR patients|0|||
46633282|NCT01777152|82806648|FG001|Overall Study|Change of diagnosis|0|||
46633283|NCT01759290|82806655|FG000|Overall Study|Subjects withdrawn consent|5|||
47043909|NCT02883049|83300656|FG007|Induction|Identified as HR patients|0|||
47043910|NCT02883049|83300657|FG008|Induction|Identified as HR patients|0|||
46721180|NCT00823615|82937112|FG001|Period 2|Time/Job Conflict|2|||
46721181|NCT00812461|82937120|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
46721182|NCT00812461|82937121|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
46721183|NCT00812461|82937120|FG000|All Treated Patients|Adverse Event|8|||
47043911|NCT02883049|83300658|FG009|Induction|Identified as HR patients|0|||
47043912|NCT02883049|83300659|FG010|Induction|Identified as HR patients|0|||
47043913|NCT02883049|83300660|FG011|Induction|Identified as HR patients|0|||
47043914|NCT02883049|83300661|FG012|Induction|Identified as HR patients|0|||
46721184|NCT00812461|82937121|FG001|All Treated Patients|Adverse Event|15|||
46721185|NCT00812461|82937120|FG000|All Treated Patients|Lack of Efficacy|13|||
46721186|NCT00812461|82937121|FG001|All Treated Patients|Lack of Efficacy|7|||
46721187|NCT00812461|82937120|FG000|All Treated Patients|Non-compliance|6|||
46721188|NCT00812461|82937121|FG001|All Treated Patients|Non-compliance|9|||
46721189|NCT00812461|82937120|FG000|All Treated Patients|Protocol Violation|36|||
46721190|NCT00812461|82937121|FG001|All Treated Patients|Protocol Violation|27|||
46721191|NCT00812461|82937120|FG000|All Treated Patients|Withdrawal by Subject|45|||
46721192|NCT00812461|82937121|FG001|All Treated Patients|Withdrawal by Subject|54|||
46721193|NCT00812461|82937120|FG000|All Treated Patients|Lost to Follow-up|11|||
46721194|NCT00812461|82937121|FG001|All Treated Patients|Lost to Follow-up|14|||
46721195|NCT00812461|82937120|FG000|All Treated Patients|Other Reason|13|||
46721196|NCT00812461|82937121|FG001|All Treated Patients|Other Reason|21|||
46721197|NCT00599326|82937127|FG000|Overall Study|Lost to Follow-up|1|||
46721198|NCT00599326|82937127|FG000|Overall Study|Noncompliant|1|||
46721199|NCT00978432|82937134|FG000|Overall Study|Withdrawal by Subject|0|||
46721200|NCT00978432|82937135|FG001|Overall Study|Withdrawal by Subject|0|||
46721201|NCT00978432|82937136|FG002|Overall Study|Withdrawal by Subject|1|||
46721202|NCT00978432|82937134|FG000|Overall Study|Lack of Efficacy|1|||
46721203|NCT00978432|82937135|FG001|Overall Study|Lack of Efficacy|1|||
46721204|NCT00978432|82937136|FG002|Overall Study|Lack of Efficacy|3|||
46721205|NCT00978432|82937134|FG000|Overall Study|Adverse Event|2|||
46721206|NCT00978432|82937135|FG001|Overall Study|Adverse Event|0|||
46920440|NCT03083483|83152770|FG002|Overall Study|Adverse Event|1|||
47043915|NCT02883049|83300662|FG013|Induction|Identified as HR patients|0|||
47043916|NCT02883049|83300663|FG014|Induction|Identified as HR patients|0|||
47043917|NCT02883049|83300664|FG015|Induction|Identified as HR patients|0|||
47043918|NCT02883049|83300649|FG000|Induction|Developed SMN|0|||
47043919|NCT02883049|83300650|FG001|Induction|Developed SMN|1|||
47043920|NCT02883049|83300651|FG002|Induction|Developed SMN|0|||
46633284|NCT01759290|82806655|FG000|Overall Study|Physician Decision|2|||
46633285|NCT01759290|82806655|FG000|Overall Study|Death|17|||
46633286|NCT01759290|82806655|FG000|Overall Study|Lost to Follow-up|53|||
46633287|NCT01759290|82806655|FG000|Overall Study|Unknown reason|4|||
46633288|NCT01758900|82806661|FG000|Overall Study|difficulty for further intubation|7|||
46633289|NCT01758900|82806662|FG001|Overall Study|difficulty for further intubation|8|||
46633290|NCT01757184|82806670|FG000|Double-blind Period|Adverse Event|1|||
46633291|NCT01757184|82806671|FG001|Double-blind Period|Adverse Event|0|||
46633292|NCT01757184|82806672|FG002|Double-blind Period|Adverse Event|0|||
46633293|NCT01757184|82806673|FG003|Double-blind Period|Adverse Event|0|||
46633294|NCT01757184|82806670|FG000|Open-label Period|Lost to Follow-up|0|||
46633295|NCT01757184|82806671|FG001|Open-label Period|Lost to Follow-up|0|||
46633296|NCT01757184|82806672|FG002|Open-label Period|Lost to Follow-up|2|||
46633297|NCT01757184|82806673|FG003|Open-label Period|Lost to Follow-up|0|||
46633298|NCT01757184|82806670|FG000|Open-label Period|Withdrawal by Subject|0|||
46633299|NCT01757184|82806671|FG001|Open-label Period|Withdrawal by Subject|0|||
46633300|NCT01757184|82806672|FG002|Open-label Period|Withdrawal by Subject|1|||
46633301|NCT01757184|82806673|FG003|Open-label Period|Withdrawal by Subject|1|||
46633302|NCT01757184|82806670|FG000|Open-label Period|Discontinued by Sponsor|0|||
46633303|NCT01757184|82806671|FG001|Open-label Period|Discontinued by Sponsor|0|||
46633304|NCT01757184|82806672|FG002|Open-label Period|Discontinued by Sponsor|1|||
46633305|NCT01757184|82806673|FG003|Open-label Period|Discontinued by Sponsor|2|||
46633306|NCT01775904|82806687|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
46633307|NCT01775904|82806687|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
46633308|NCT01775670|82806699|FG000|Overall Study|Lost to Follow-up|1|||
46633309|NCT01775670|82806700|FG001|Overall Study|Lost to Follow-up|1|||
46633310|NCT01775124|82806708|FG000|Core Period|Disease Progression|0|||
46633311|NCT01775124|82806709|FG001|Core Period|Disease Progression|1|||
46633312|NCT01775124|82806708|FG000|Core Period|Physician Decision|1|||
46633313|NCT01775124|82806709|FG001|Core Period|Physician Decision|1|||
46633314|NCT01775124|82806708|FG000|Core Period|Death|0|||
46721207|NCT00978432|82937136|FG002|Overall Study|Adverse Event|1|||
46721208|NCT00975780|82937146|FG000|Follow Up|Death|88|||
46721209|NCT00975780|82937147|FG001|Follow Up|Death|122|||
46721210|NCT00975780|82937146|FG000|Follow Up|Facility Withdrawal|7|||
46721211|NCT00975780|82937147|FG001|Follow Up|Facility Withdrawal|23|||
47043921|NCT02883049|83300652|FG003|Induction|Developed SMN|0|||
47043922|NCT02883049|83300653|FG004|Induction|Developed SMN|0|||
47043923|NCT02883049|83300654|FG005|Induction|Developed SMN|0|||
47043924|NCT02883049|83300655|FG006|Induction|Developed SMN|0|||
47043925|NCT02883049|83300656|FG007|Induction|Developed SMN|0|||
47043926|NCT02883049|83300657|FG008|Induction|Developed SMN|0|||
47043927|NCT02883049|83300658|FG009|Induction|Developed SMN|0|||
47043928|NCT02883049|83300659|FG010|Induction|Developed SMN|0|||
47043929|NCT02883049|83300660|FG011|Induction|Developed SMN|0|||
47043930|NCT02883049|83300661|FG012|Induction|Developed SMN|0|||
47043931|NCT02883049|83300662|FG013|Induction|Developed SMN|0|||
47043932|NCT02883049|83300663|FG014|Induction|Developed SMN|0|||
47043933|NCT02883049|83300664|FG015|Induction|Developed SMN|0|||
47043934|NCT02883049|83300649|FG000|Induction|Enrolled onto another COG study|72|||
47043935|NCT02883049|83300650|FG001|Induction|Enrolled onto another COG study|0|||
47043936|NCT02883049|83300651|FG002|Induction|Enrolled onto another COG study|0|||
47043937|NCT02883049|83300652|FG003|Induction|Enrolled onto another COG study|0|||
47043938|NCT02883049|83300653|FG004|Induction|Enrolled onto another COG study|0|||
47043939|NCT02883049|83300654|FG005|Induction|Enrolled onto another COG study|0|||
47043940|NCT02883049|83300655|FG006|Induction|Enrolled onto another COG study|0|||
47043941|NCT02883049|83300656|FG007|Induction|Enrolled onto another COG study|0|||
47043942|NCT02883049|83300657|FG008|Induction|Enrolled onto another COG study|0|||
47043943|NCT02883049|83300658|FG009|Induction|Enrolled onto another COG study|0|||
47043944|NCT02883049|83300659|FG010|Induction|Enrolled onto another COG study|0|||
47043945|NCT02883049|83300660|FG011|Induction|Enrolled onto another COG study|0|||
47043946|NCT02883049|83300661|FG012|Induction|Enrolled onto another COG study|0|||
47043947|NCT02883049|83300662|FG013|Induction|Enrolled onto another COG study|0|||
47043948|NCT02883049|83300663|FG014|Induction|Enrolled onto another COG study|0|||
47043949|NCT02883049|83300664|FG015|Induction|Enrolled onto another COG study|0|||
47043950|NCT02883049|83300649|FG000|Induction|Incomplete induction data|17|||
47043951|NCT02883049|83300650|FG001|Induction|Incomplete induction data|0|||
47043952|NCT02883049|83300651|FG002|Induction|Incomplete induction data|0|||
47043953|NCT02883049|83300652|FG003|Induction|Incomplete induction data|0|||
47043954|NCT02883049|83300653|FG004|Induction|Incomplete induction data|0|||
47043955|NCT02883049|83300654|FG005|Induction|Incomplete induction data|0|||
47043956|NCT02883049|83300655|FG006|Induction|Incomplete induction data|0|||
47043957|NCT02883049|83300656|FG007|Induction|Incomplete induction data|0|||
47043958|NCT02883049|83300657|FG008|Induction|Incomplete induction data|0|||
47043959|NCT02883049|83300658|FG009|Induction|Incomplete induction data|0|||
47043960|NCT02883049|83300659|FG010|Induction|Incomplete induction data|0|||
47043961|NCT02883049|83300660|FG011|Induction|Incomplete induction data|0|||
47043962|NCT02883049|83300661|FG012|Induction|Incomplete induction data|0|||
47043963|NCT02883049|83300662|FG013|Induction|Incomplete induction data|0|||
47043964|NCT02883049|83300663|FG014|Induction|Incomplete induction data|0|||
47043965|NCT02883049|83300664|FG015|Induction|Incomplete induction data|0|||
47043966|NCT02883049|83300649|FG000|Post Induction|Adverse Event|0|||
47043967|NCT02883049|83300650|FG001|Post Induction|Adverse Event|0|||
47043968|NCT02883049|83300651|FG002|Post Induction|Adverse Event|0|||
47043969|NCT02883049|83300652|FG003|Post Induction|Adverse Event|7|||
47043970|NCT02883049|83300653|FG004|Post Induction|Adverse Event|8|||
47043971|NCT02883049|83300654|FG005|Post Induction|Adverse Event|3|||
47043972|NCT02883049|83300655|FG006|Post Induction|Adverse Event|4|||
47043973|NCT02883049|83300656|FG007|Post Induction|Adverse Event|5|||
47043974|NCT02883049|83300657|FG008|Post Induction|Adverse Event|6|||
47043975|NCT02883049|83300658|FG009|Post Induction|Adverse Event|7|||
47043976|NCT02883049|83300659|FG010|Post Induction|Adverse Event|2|||
47043977|NCT02883049|83300660|FG011|Post Induction|Adverse Event|2|||
47043978|NCT02883049|83300661|FG012|Post Induction|Adverse Event|0|||
47043979|NCT02883049|83300662|FG013|Post Induction|Adverse Event|0|||
47043980|NCT02883049|83300663|FG014|Post Induction|Adverse Event|5|||
47043981|NCT02883049|83300664|FG015|Post Induction|Adverse Event|2|||
47043982|NCT02883049|83300649|FG000|Post Induction|Death|0|||
47043983|NCT02883049|83300650|FG001|Post Induction|Death|0|||
47043984|NCT02883049|83300651|FG002|Post Induction|Death|0|||
47043985|NCT02883049|83300652|FG003|Post Induction|Death|9|||
47043986|NCT02883049|83300653|FG004|Post Induction|Death|9|||
47043987|NCT02883049|83300654|FG005|Post Induction|Death|0|||
47043988|NCT02883049|83300655|FG006|Post Induction|Death|1|||
47043989|NCT02883049|83300656|FG007|Post Induction|Death|6|||
46633315|NCT01775124|82806709|FG001|Core Period|Death|1|||
46633316|NCT01775124|82806708|FG000|Core Period|Administrative problems|1|||
47043990|NCT02883049|83300657|FG008|Post Induction|Death|5|||
47043991|NCT02883049|83300658|FG009|Post Induction|Death|3|||
47043992|NCT02883049|83300659|FG010|Post Induction|Death|1|||
47043993|NCT02883049|83300660|FG011|Post Induction|Death|0|||
47043994|NCT02883049|83300661|FG012|Post Induction|Death|1|||
47043995|NCT02883049|83300662|FG013|Post Induction|Death|1|||
47043996|NCT02883049|83300663|FG014|Post Induction|Death|10|||
47043997|NCT02883049|83300664|FG015|Post Induction|Death|2|||
47043998|NCT02883049|83300649|FG000|Post Induction|Lost to Follow-up|0|||
47043999|NCT02883049|83300650|FG001|Post Induction|Lost to Follow-up|0|||
47044000|NCT02883049|83300651|FG002|Post Induction|Lost to Follow-up|0|||
47044001|NCT02883049|83300652|FG003|Post Induction|Lost to Follow-up|0|||
47044002|NCT02883049|83300653|FG004|Post Induction|Lost to Follow-up|1|||
47044003|NCT02883049|83300654|FG005|Post Induction|Lost to Follow-up|1|||
47044004|NCT02883049|83300655|FG006|Post Induction|Lost to Follow-up|0|||
47044005|NCT02883049|83300656|FG007|Post Induction|Lost to Follow-up|0|||
47044006|NCT02883049|83300657|FG008|Post Induction|Lost to Follow-up|3|||
47044007|NCT02883049|83300658|FG009|Post Induction|Lost to Follow-up|0|||
47044008|NCT02883049|83300659|FG010|Post Induction|Lost to Follow-up|1|||
47044009|NCT02883049|83300660|FG011|Post Induction|Lost to Follow-up|0|||
47044010|NCT02883049|83300661|FG012|Post Induction|Lost to Follow-up|0|||
47044011|NCT02883049|83300662|FG013|Post Induction|Lost to Follow-up|0|||
47044012|NCT02883049|83300663|FG014|Post Induction|Lost to Follow-up|0|||
47044013|NCT02883049|83300664|FG015|Post Induction|Lost to Follow-up|0|||
47044014|NCT02883049|83300649|FG000|Post Induction|Physician Decision|0|||
47044015|NCT02883049|83300650|FG001|Post Induction|Physician Decision|0|||
47044016|NCT02883049|83300651|FG002|Post Induction|Physician Decision|0|||
47044017|NCT02883049|83300652|FG003|Post Induction|Physician Decision|27|||
47044018|NCT02883049|83300653|FG004|Post Induction|Physician Decision|27|||
47044019|NCT02883049|83300654|FG005|Post Induction|Physician Decision|23|||
47044020|NCT02883049|83300655|FG006|Post Induction|Physician Decision|30|||
47044021|NCT02883049|83300656|FG007|Post Induction|Physician Decision|56|||
47044022|NCT02883049|83300657|FG008|Post Induction|Physician Decision|85|||
47044023|NCT02883049|83300658|FG009|Post Induction|Physician Decision|12|||
47044024|NCT02883049|83300659|FG010|Post Induction|Physician Decision|5|||
47044025|NCT02883049|83300660|FG011|Post Induction|Physician Decision|14|||
47044026|NCT02883049|83300661|FG012|Post Induction|Physician Decision|1|||
47044027|NCT02883049|83300662|FG013|Post Induction|Physician Decision|11|||
47044028|NCT02883049|83300663|FG014|Post Induction|Physician Decision|19|||
47044029|NCT02883049|83300664|FG015|Post Induction|Physician Decision|5|||
47044030|NCT02883049|83300649|FG000|Post Induction|Protocol Violation|0|||
47044031|NCT02883049|83300650|FG001|Post Induction|Protocol Violation|0|||
47044032|NCT02883049|83300651|FG002|Post Induction|Protocol Violation|0|||
47044033|NCT02883049|83300652|FG003|Post Induction|Protocol Violation|0|||
47044034|NCT02883049|83300653|FG004|Post Induction|Protocol Violation|0|||
47044035|NCT02883049|83300654|FG005|Post Induction|Protocol Violation|0|||
47044036|NCT02883049|83300655|FG006|Post Induction|Protocol Violation|0|||
47044037|NCT02883049|83300656|FG007|Post Induction|Protocol Violation|1|||
47044038|NCT02883049|83300657|FG008|Post Induction|Protocol Violation|0|||
47044039|NCT02883049|83300658|FG009|Post Induction|Protocol Violation|0|||
47044040|NCT02883049|83300659|FG010|Post Induction|Protocol Violation|0|||
47044041|NCT02883049|83300660|FG011|Post Induction|Protocol Violation|0|||
47044042|NCT02883049|83300661|FG012|Post Induction|Protocol Violation|0|||
47044043|NCT02883049|83300662|FG013|Post Induction|Protocol Violation|0|||
47044044|NCT02883049|83300663|FG014|Post Induction|Protocol Violation|0|||
47044045|NCT02883049|83300664|FG015|Post Induction|Protocol Violation|0|||
47044046|NCT02883049|83300649|FG000|Post Induction|Withdrawal by Subject|0|||
47044047|NCT02883049|83300650|FG001|Post Induction|Withdrawal by Subject|0|||
47044048|NCT02883049|83300651|FG002|Post Induction|Withdrawal by Subject|0|||
47044049|NCT02883049|83300652|FG003|Post Induction|Withdrawal by Subject|5|||
46920441|NCT03083483|83152768|FG000|Overall Study|Lost to Follow-up|2|||
46920442|NCT03083483|83152769|FG001|Overall Study|Lost to Follow-up|1|||
46920443|NCT03083483|83152770|FG002|Overall Study|Lost to Follow-up|1|||
46920444|NCT03083483|83152768|FG000|Overall Study|technological issues|1|||
46920445|NCT03083483|83152769|FG001|Overall Study|technological issues|0|||
46920446|NCT03083483|83152770|FG002|Overall Study|technological issues|1|||
47044050|NCT02883049|83300653|FG004|Post Induction|Withdrawal by Subject|2|||
47044051|NCT02883049|83300654|FG005|Post Induction|Withdrawal by Subject|1|||
47044052|NCT02883049|83300655|FG006|Post Induction|Withdrawal by Subject|0|||
47044053|NCT02883049|83300656|FG007|Post Induction|Withdrawal by Subject|0|||
47044054|NCT02883049|83300657|FG008|Post Induction|Withdrawal by Subject|2|||
47044055|NCT02883049|83300658|FG009|Post Induction|Withdrawal by Subject|0|||
47044056|NCT02883049|83300659|FG010|Post Induction|Withdrawal by Subject|1|||
47044057|NCT02883049|83300660|FG011|Post Induction|Withdrawal by Subject|1|||
47044058|NCT02883049|83300661|FG012|Post Induction|Withdrawal by Subject|0|||
47044059|NCT02883049|83300662|FG013|Post Induction|Withdrawal by Subject|0|||
47044060|NCT02883049|83300663|FG014|Post Induction|Withdrawal by Subject|1|||
47044061|NCT02883049|83300664|FG015|Post Induction|Withdrawal by Subject|0|||
47044062|NCT02883049|83300649|FG000|Post Induction|Ineligible|0|||
47044063|NCT02883049|83300650|FG001|Post Induction|Ineligible|0|||
47044064|NCT02883049|83300651|FG002|Post Induction|Ineligible|2|||
47044065|NCT02883049|83300652|FG003|Post Induction|Ineligible|0|||
47044066|NCT02883049|83300653|FG004|Post Induction|Ineligible|0|||
47044067|NCT02883049|83300654|FG005|Post Induction|Ineligible|0|||
47044068|NCT02883049|83300655|FG006|Post Induction|Ineligible|1|||
47044069|NCT02883049|83300656|FG007|Post Induction|Ineligible|0|||
47044070|NCT02883049|83300657|FG008|Post Induction|Ineligible|0|||
47044071|NCT02883049|83300658|FG009|Post Induction|Ineligible|0|||
46920447|NCT03085927|83152782|FG000|Overall Study|Withdrawal by Subject|1|||
46920448|NCT03085927|83152783|FG001|Overall Study|Withdrawal by Subject|4|||
47044072|NCT02883049|83300659|FG010|Post Induction|Ineligible|1|||
47044073|NCT02883049|83300660|FG011|Post Induction|Ineligible|0|||
47044074|NCT02883049|83300661|FG012|Post Induction|Ineligible|0|||
47044075|NCT02883049|83300662|FG013|Post Induction|Ineligible|0|||
47044076|NCT02883049|83300663|FG014|Post Induction|Ineligible|0|||
47044077|NCT02883049|83300664|FG015|Post Induction|Ineligible|1|||
47044078|NCT02883049|83300649|FG000|Post Induction|Refusal of further protocol therapy|0|||
47044079|NCT02883049|83300650|FG001|Post Induction|Refusal of further protocol therapy|0|||
47044080|NCT02883049|83300651|FG002|Post Induction|Refusal of further protocol therapy|0|||
47044081|NCT02883049|83300652|FG003|Post Induction|Refusal of further protocol therapy|11|||
47044082|NCT02883049|83300653|FG004|Post Induction|Refusal of further protocol therapy|15|||
47044083|NCT02883049|83300654|FG005|Post Induction|Refusal of further protocol therapy|9|||
47044084|NCT02883049|83300655|FG006|Post Induction|Refusal of further protocol therapy|13|||
47044085|NCT02883049|83300656|FG007|Post Induction|Refusal of further protocol therapy|5|||
47044086|NCT02883049|83300657|FG008|Post Induction|Refusal of further protocol therapy|21|||
47044087|NCT02883049|83300658|FG009|Post Induction|Refusal of further protocol therapy|7|||
47044088|NCT02883049|83300659|FG010|Post Induction|Refusal of further protocol therapy|0|||
47044089|NCT02883049|83300660|FG011|Post Induction|Refusal of further protocol therapy|7|||
47044090|NCT02883049|83300661|FG012|Post Induction|Refusal of further protocol therapy|3|||
47044091|NCT02883049|83300662|FG013|Post Induction|Refusal of further protocol therapy|0|||
47044092|NCT02883049|83300663|FG014|Post Induction|Refusal of further protocol therapy|4|||
47044093|NCT02883049|83300664|FG015|Post Induction|Refusal of further protocol therapy|1|||
47044094|NCT02883049|83300649|FG000|Post Induction|Inevaluable|0|||
47044095|NCT02883049|83300650|FG001|Post Induction|Inevaluable|0|||
47044096|NCT02883049|83300651|FG002|Post Induction|Inevaluable|0|||
47044097|NCT02883049|83300652|FG003|Post Induction|Inevaluable|1|||
47044098|NCT02883049|83300653|FG004|Post Induction|Inevaluable|1|||
47044099|NCT02883049|83300654|FG005|Post Induction|Inevaluable|2|||
47044100|NCT02883049|83300655|FG006|Post Induction|Inevaluable|7|||
47044101|NCT02883049|83300656|FG007|Post Induction|Inevaluable|6|||
47044102|NCT02883049|83300657|FG008|Post Induction|Inevaluable|4|||
47044103|NCT02883049|83300658|FG009|Post Induction|Inevaluable|4|||
47044104|NCT02883049|83300659|FG010|Post Induction|Inevaluable|1|||
47044105|NCT02883049|83300660|FG011|Post Induction|Inevaluable|1|||
47044106|NCT02883049|83300661|FG012|Post Induction|Inevaluable|2|||
47044107|NCT02883049|83300662|FG013|Post Induction|Inevaluable|0|||
47044108|NCT02883049|83300663|FG014|Post Induction|Inevaluable|0|||
47044109|NCT02883049|83300664|FG015|Post Induction|Inevaluable|1|||
47044110|NCT02883049|83300649|FG000|Post Induction|Moved to another non-COG institution|0|||
47044111|NCT02883049|83300650|FG001|Post Induction|Moved to another non-COG institution|0|||
47044112|NCT02883049|83300651|FG002|Post Induction|Moved to another non-COG institution|0|||
47044113|NCT02883049|83300652|FG003|Post Induction|Moved to another non-COG institution|0|||
47044114|NCT02883049|83300653|FG004|Post Induction|Moved to another non-COG institution|0|||
47044115|NCT02883049|83300654|FG005|Post Induction|Moved to another non-COG institution|0|||
47044116|NCT02883049|83300655|FG006|Post Induction|Moved to another non-COG institution|0|||
47044117|NCT02883049|83300656|FG007|Post Induction|Moved to another non-COG institution|2|||
47044118|NCT02883049|83300657|FG008|Post Induction|Moved to another non-COG institution|2|||
47044119|NCT02883049|83300658|FG009|Post Induction|Moved to another non-COG institution|0|||
47044120|NCT02883049|83300659|FG010|Post Induction|Moved to another non-COG institution|0|||
47044121|NCT02883049|83300660|FG011|Post Induction|Moved to another non-COG institution|1|||
47044122|NCT02883049|83300661|FG012|Post Induction|Moved to another non-COG institution|0|||
47044123|NCT02883049|83300662|FG013|Post Induction|Moved to another non-COG institution|0|||
47044124|NCT02883049|83300663|FG014|Post Induction|Moved to another non-COG institution|0|||
47044125|NCT02883049|83300664|FG015|Post Induction|Moved to another non-COG institution|0|||
47044126|NCT02883049|83300649|FG000|Post Induction|Randomization closed|0|||
47044127|NCT02883049|83300650|FG001|Post Induction|Randomization closed|0|||
47044128|NCT02883049|83300651|FG002|Post Induction|Randomization closed|0|||
47044129|NCT02883049|83300652|FG003|Post Induction|Randomization closed|0|||
47044130|NCT02883049|83300653|FG004|Post Induction|Randomization closed|0|||
47044131|NCT02883049|83300654|FG005|Post Induction|Randomization closed|0|||
47044132|NCT02883049|83300655|FG006|Post Induction|Randomization closed|0|||
47044133|NCT02883049|83300656|FG007|Post Induction|Randomization closed|20|||
47044134|NCT02883049|83300657|FG008|Post Induction|Randomization closed|0|||
47044135|NCT02883049|83300658|FG009|Post Induction|Randomization closed|0|||
47044136|NCT02883049|83300659|FG010|Post Induction|Randomization closed|0|||
47044137|NCT02883049|83300660|FG011|Post Induction|Randomization closed|0|||
47044138|NCT02883049|83300661|FG012|Post Induction|Randomization closed|0|||
47044139|NCT02883049|83300662|FG013|Post Induction|Randomization closed|0|||
47044140|NCT02883049|83300663|FG014|Post Induction|Randomization closed|0|||
47044141|NCT02883049|83300664|FG015|Post Induction|Randomization closed|0|||
47044142|NCT02883049|83300649|FG000|Post Induction|MRD negative|0|||
47044143|NCT02883049|83300650|FG001|Post Induction|MRD negative|0|||
47044144|NCT02883049|83300651|FG002|Post Induction|MRD negative|0|||
47044145|NCT02883049|83300652|FG003|Post Induction|MRD negative|0|||
47044146|NCT02883049|83300653|FG004|Post Induction|MRD negative|0|||
47044147|NCT02883049|83300654|FG005|Post Induction|MRD negative|0|||
47044148|NCT02883049|83300655|FG006|Post Induction|MRD negative|0|||
47044149|NCT02883049|83300656|FG007|Post Induction|MRD negative|11|||
47044150|NCT02883049|83300657|FG008|Post Induction|MRD negative|0|||
47044151|NCT02883049|83300658|FG009|Post Induction|MRD negative|0|||
47044152|NCT02883049|83300659|FG010|Post Induction|MRD negative|0|||
47044153|NCT02883049|83300660|FG011|Post Induction|MRD negative|0|||
47044154|NCT02883049|83300661|FG012|Post Induction|MRD negative|0|||
47044155|NCT02883049|83300662|FG013|Post Induction|MRD negative|0|||
47044156|NCT02883049|83300663|FG014|Post Induction|MRD negative|0|||
47044157|NCT02883049|83300664|FG015|Post Induction|MRD negative|0|||
47044158|NCT02883049|83300649|FG000|Post Induction|Developed SMN|0|||
47044159|NCT02883049|83300650|FG001|Post Induction|Developed SMN|0|||
47044160|NCT02883049|83300651|FG002|Post Induction|Developed SMN|0|||
47044161|NCT02883049|83300652|FG003|Post Induction|Developed SMN|0|||
47044162|NCT02883049|83300653|FG004|Post Induction|Developed SMN|1|||
47044163|NCT02883049|83300654|FG005|Post Induction|Developed SMN|0|||
47044164|NCT02883049|83300655|FG006|Post Induction|Developed SMN|1|||
47044165|NCT02883049|83300656|FG007|Post Induction|Developed SMN|0|||
47044166|NCT02883049|83300657|FG008|Post Induction|Developed SMN|0|||
47044167|NCT02883049|83300658|FG009|Post Induction|Developed SMN|0|||
47044168|NCT02883049|83300659|FG010|Post Induction|Developed SMN|1|||
47044169|NCT02883049|83300660|FG011|Post Induction|Developed SMN|1|||
47044170|NCT02883049|83300661|FG012|Post Induction|Developed SMN|0|||
47044171|NCT02883049|83300662|FG013|Post Induction|Developed SMN|0|||
47044172|NCT02883049|83300663|FG014|Post Induction|Developed SMN|1|||
47044173|NCT02883049|83300664|FG015|Post Induction|Developed SMN|0|||
47044174|NCT02883049|83300649|FG000|Post Induction|Enrolled onto another COG study|0|||
47044175|NCT02883049|83300650|FG001|Post Induction|Enrolled onto another COG study|0|||
47044176|NCT02883049|83300651|FG002|Post Induction|Enrolled onto another COG study|0|||
47044177|NCT02883049|83300652|FG003|Post Induction|Enrolled onto another COG study|1|||
47044178|NCT02883049|83300653|FG004|Post Induction|Enrolled onto another COG study|1|||
47044179|NCT02883049|83300654|FG005|Post Induction|Enrolled onto another COG study|0|||
47044180|NCT02883049|83300655|FG006|Post Induction|Enrolled onto another COG study|0|||
47044181|NCT02883049|83300656|FG007|Post Induction|Enrolled onto another COG study|4|||
47044182|NCT02883049|83300657|FG008|Post Induction|Enrolled onto another COG study|0|||
47044183|NCT02883049|83300658|FG009|Post Induction|Enrolled onto another COG study|0|||
47044184|NCT02883049|83300659|FG010|Post Induction|Enrolled onto another COG study|0|||
47044185|NCT02883049|83300660|FG011|Post Induction|Enrolled onto another COG study|2|||
47044186|NCT02883049|83300661|FG012|Post Induction|Enrolled onto another COG study|0|||
47044187|NCT02883049|83300662|FG013|Post Induction|Enrolled onto another COG study|1|||
47044188|NCT02883049|83300663|FG014|Post Induction|Enrolled onto another COG study|0|||
47044189|NCT02883049|83300664|FG015|Post Induction|Enrolled onto another COG study|0|||
47044190|NCT02883049|83300649|FG000|Post Induction|Recurrent leukemia|0|||
47044191|NCT02883049|83300650|FG001|Post Induction|Recurrent leukemia|0|||
47044192|NCT02883049|83300651|FG002|Post Induction|Recurrent leukemia|0|||
47044193|NCT02883049|83300652|FG003|Post Induction|Recurrent leukemia|17|||
47044194|NCT02883049|83300653|FG004|Post Induction|Recurrent leukemia|12|||
47044195|NCT02883049|83300654|FG005|Post Induction|Recurrent leukemia|4|||
47044196|NCT02883049|83300655|FG006|Post Induction|Recurrent leukemia|1|||
47044197|NCT02883049|83300656|FG007|Post Induction|Recurrent leukemia|13|||
47044198|NCT02883049|83300657|FG008|Post Induction|Recurrent leukemia|27|||
47044199|NCT02883049|83300658|FG009|Post Induction|Recurrent leukemia|5|||
47044200|NCT02883049|83300659|FG010|Post Induction|Recurrent leukemia|3|||
47044201|NCT02883049|83300660|FG011|Post Induction|Recurrent leukemia|12|||
47044202|NCT02883049|83300661|FG012|Post Induction|Recurrent leukemia|1|||
47044203|NCT02883049|83300662|FG013|Post Induction|Recurrent leukemia|1|||
47044204|NCT02883049|83300663|FG014|Post Induction|Recurrent leukemia|9|||
47044205|NCT02883049|83300664|FG015|Post Induction|Recurrent leukemia|3|||
47044206|NCT02883049|83300649|FG000|Post Induction|Induction Failure|0|||
47044207|NCT02883049|83300650|FG001|Post Induction|Induction Failure|0|||
47044208|NCT02883049|83300651|FG002|Post Induction|Induction Failure|0|||
47044209|NCT02883049|83300652|FG003|Post Induction|Induction Failure|0|||
47044210|NCT02883049|83300653|FG004|Post Induction|Induction Failure|0|||
47044211|NCT02883049|83300654|FG005|Post Induction|Induction Failure|0|||
47044212|NCT02883049|83300655|FG006|Post Induction|Induction Failure|0|||
47044213|NCT02883049|83300656|FG007|Post Induction|Induction Failure|2|||
47044214|NCT02883049|83300657|FG008|Post Induction|Induction Failure|2|||
47044215|NCT02883049|83300658|FG009|Post Induction|Induction Failure|0|||
47044216|NCT02883049|83300659|FG010|Post Induction|Induction Failure|0|||
47044217|NCT02883049|83300660|FG011|Post Induction|Induction Failure|0|||
47044218|NCT02883049|83300661|FG012|Post Induction|Induction Failure|0|||
47044219|NCT02883049|83300662|FG013|Post Induction|Induction Failure|2|||
47044220|NCT02883049|83300663|FG014|Post Induction|Induction Failure|0|||
47044221|NCT02883049|83300664|FG015|Post Induction|Induction Failure|0|||
47044222|NCT02864251|83300700|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
47044223|NCT02864251|83300701|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
47044224|NCT02864251|83300702|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
47044225|NCT02864251|83300700|FG000|Pre-Treatment|Withdrawal by Participant|0|||
47044226|NCT02864251|83300701|FG001|Pre-Treatment|Withdrawal by Participant|0|||
47044227|NCT02864251|83300702|FG002|Pre-Treatment|Withdrawal by Participant|4|||
47044228|NCT02864251|83300700|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
47044229|NCT02864251|83300701|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
47044230|NCT02864251|83300702|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
47044231|NCT02864251|83300700|FG000|Pre-Treatment|Other Reasons|0|||
47044232|NCT02864251|83300701|FG001|Pre-Treatment|Other Reasons|1|||
47044233|NCT02864251|83300702|FG002|Pre-Treatment|Other Reasons|1|||
47044234|NCT02864251|83300700|FG000|Treatment|Disease Progression|109|||
47044235|NCT02864251|83300701|FG001|Treatment|Disease Progression|52|||
47044236|NCT02864251|83300702|FG002|Treatment|Disease Progression|101|||
47044237|NCT02864251|83300700|FG000|Treatment|Study Drug Toxicity|9|||
47044238|NCT02864251|83300701|FG001|Treatment|Study Drug Toxicity|4|||
47044239|NCT02864251|83300702|FG002|Treatment|Study Drug Toxicity|10|||
47044240|NCT02864251|83300700|FG000|Treatment|Death|0|||
47044241|NCT02864251|83300701|FG001|Treatment|Death|2|||
47044242|NCT02864251|83300702|FG002|Treatment|Death|3|||
47044243|NCT02864251|83300700|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
47044244|NCT02864251|83300701|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
47044245|NCT02864251|83300702|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
47044246|NCT02864251|83300700|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
47044247|NCT02864251|83300701|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
47044248|NCT02864251|83300702|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
47044249|NCT02864251|83300700|FG000|Treatment|Withdrawal by Participant|8|||
47044250|NCT02864251|83300701|FG001|Treatment|Withdrawal by Participant|5|||
47044251|NCT02864251|83300702|FG002|Treatment|Withdrawal by Participant|13|||
47044252|NCT02864251|83300700|FG000|Treatment|Maximum Clinical Benefit|1|||
47044253|NCT02864251|83300701|FG001|Treatment|Maximum Clinical Benefit|0|||
47044254|NCT02864251|83300702|FG002|Treatment|Maximum Clinical Benefit|1|||
47044255|NCT02864251|83300700|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
47044256|NCT02864251|83300701|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
47044257|NCT02864251|83300702|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
47044258|NCT02864251|83300700|FG000|Treatment|Other Reasons|1|||
47044259|NCT02864251|83300701|FG001|Treatment|Other Reasons|1|||
47044260|NCT02864251|83300702|FG002|Treatment|Other Reasons|4|||
47044261|NCT02864251|83300700|FG000|Treatment|Administrative Reason by Sponsor|1|||
47044262|NCT02864251|83300701|FG001|Treatment|Administrative Reason by Sponsor|0|||
47044263|NCT02864251|83300702|FG002|Treatment|Administrative Reason by Sponsor|0|||
47044264|NCT02570113|83300736|FG000|Overall Study|Withdrawal by Subject|3|||
47044265|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
47044266|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
47044267|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
47044268|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
47044269|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
47044270|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
47044271|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
47044272|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
47044273|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Other|18|||
47044274|NCT02565914|83300740|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
47044275|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
46633317|NCT01775124|82806709|FG001|Core Period|Administrative problems|0|||
46633318|NCT01775124|82806708|FG000|Core Period|Withdrawal by Subject|4|||
47044276|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Other|1|||
47044277|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
47044278|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
47044279|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
47044280|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
47044281|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
46633319|NCT01775124|82806709|FG001|Core Period|Withdrawal by Subject|2|||
46633320|NCT01775124|82806708|FG000|Core Period|Adverse Event|5|||
46721212|NCT00975780|82937146|FG000|Follow Up|Discharged from Facility|7|||
46721213|NCT00975780|82937147|FG001|Follow Up|Discharged from Facility|12|||
47044282|NCT02565914|83300740|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
46721214|NCT00814489|82937156|FG000|Overall Study|Other|2|||
46721215|NCT00814489|82937157|FG001|Overall Study|Other|0|||
47044283|NCT02565914|83300740|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
46721216|NCT00814489|82937158|FG002|Overall Study|Other|1|||
46721217|NCT00814333|82937170|FG000|Enrollment|Lost to Follow-up|1|||
46721218|NCT00814333|82937171|FG001|Enrollment|Lost to Follow-up|0|||
47044284|NCT02565914|83300740|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
47044285|NCT02565914|83300740|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
47044286|NCT02565914|83300740|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
46633321|NCT01775124|82806709|FG001|Core Period|Adverse Event|5|||
46721219|NCT01147250|82937179|FG000|Overall Study|Lost to Follow-up|14|||
46721220|NCT01147250|82937180|FG001|Overall Study|Lost to Follow-up|11|||
46721221|NCT01147250|82937179|FG000|Overall Study|Withdrawal by Subject|83|||
46721222|NCT01147250|82937180|FG001|Overall Study|Withdrawal by Subject|88|||
46721223|NCT01147250|82937179|FG000|Overall Study|Site termination by sponsor|13|||
47044287|NCT02565914|83300740|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
47044288|NCT02565914|83300740|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
47044289|NCT02248701|83300750|FG000|Overall Study|Withdrawal by Subject|2|||
47044290|NCT02248701|83300751|FG001|Overall Study|Withdrawal by Subject|1|||
47044291|NCT02248701|83300750|FG000|Overall Study|Physician Decision|0|||
47044292|NCT02248701|83300751|FG001|Overall Study|Physician Decision|1|||
47044293|NCT02248701|83300750|FG000|Overall Study|Adverse Event|1|||
47044294|NCT02248701|83300751|FG001|Overall Study|Adverse Event|0|||
47044295|NCT02248701|83300750|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
47044296|NCT02248701|83300751|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
47044297|NCT02204982|83300759|FG000|Overall Study|Patient ineligible-medical monitor|1|||
47044298|NCT02204982|83300760|FG001|Overall Study|Patient ineligible-medical monitor|0|||
47044299|NCT02204982|83300759|FG000|Overall Study|Withdrawal by Subject|1|||
47044300|NCT02204982|83300760|FG001|Overall Study|Withdrawal by Subject|0|||
47044301|NCT02204982|83300759|FG000|Overall Study|Adverse Event|1|||
47044302|NCT02204982|83300760|FG001|Overall Study|Adverse Event|0|||
47044303|NCT02204982|83300759|FG000|Overall Study|Adverse Event and Investigator decision|1|||
47044304|NCT02204982|83300760|FG001|Overall Study|Adverse Event and Investigator decision|0|||
47044305|NCT02204982|83300759|FG000|Overall Study|Physician Decision|0|||
47044306|NCT02204982|83300760|FG001|Overall Study|Physician Decision|2|||
47044307|NCT02204982|83300759|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
47044308|NCT02204982|83300760|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
47044309|NCT02204982|83300759|FG000|Overall Study|Termination of Study bySponsor|0|||
47044310|NCT02204982|83300760|FG001|Overall Study|Termination of Study bySponsor|1|||
47044311|NCT02101385|83300768|FG000|Study Treatment|Disease Progression|9|||
47044312|NCT02101385|83300769|FG001|Study Treatment|Disease Progression|3|||
47044313|NCT02101385|83300768|FG000|Study Treatment|Alternative therapy|0|||
47044314|NCT02101385|83300769|FG001|Study Treatment|Alternative therapy|1|||
47044315|NCT02101385|83300768|FG000|Study Treatment|No treatment, per protocol criteria|0|||
47044316|NCT02101385|83300769|FG001|Study Treatment|No treatment, per protocol criteria|4|||
47044317|NCT02101385|83300768|FG000|Study Treatment|Patient Non compliance|0|||
47044318|NCT02101385|83300769|FG001|Study Treatment|Patient Non compliance|2|||
47044319|NCT02101385|83300768|FG000|Study Treatment|Withdrawal by Subject|5|||
47044320|NCT02101385|83300769|FG001|Study Treatment|Withdrawal by Subject|2|||
47044321|NCT02101385|83300768|FG000|Study Treatment|screen failure|1|||
47044322|NCT02101385|83300769|FG001|Study Treatment|screen failure|0|||
47044323|NCT02101385|83300768|FG000|Study Treatment|AE/Side Effects/Complications|8|||
47044324|NCT02101385|83300769|FG001|Study Treatment|AE/Side Effects/Complications|0|||
47044325|NCT02101385|83300768|FG000|Study Treatment|Lost to Follow-up|1|||
47044326|NCT02101385|83300769|FG001|Study Treatment|Lost to Follow-up|0|||
47044327|NCT02101385|83300768|FG000|Study Treatment|Disease Progression before treatment|1|||
47044328|NCT02101385|83300769|FG001|Study Treatment|Disease Progression before treatment|0|||
47044329|NCT02101385|83300768|FG000|Study Treatment|Death|1|||
47044330|NCT02101385|83300769|FG001|Study Treatment|Death|0|||
47044331|NCT02101385|83300768|FG000|Follow up|Lost to Follow-up|4|||
47044332|NCT02101385|83300769|FG001|Follow up|Lost to Follow-up|9|||
47044333|NCT02101385|83300768|FG000|Follow up|Refused to follow up|5|||
47044334|NCT02101385|83300769|FG001|Follow up|Refused to follow up|4|||
47044335|NCT02101385|83300768|FG000|Follow up|Death|21|||
46721224|NCT01147250|82937180|FG001|Overall Study|Site termination by sponsor|5|||
46721225|NCT01147250|82937179|FG000|Overall Study|Other than specified|0|||
46721226|NCT01147250|82937180|FG001|Overall Study|Other than specified|1|||
46721227|NCT00813943|82937189|FG000|Overall Study|Ongoing at cut-off date|5|||
46721228|NCT00813943|82937190|FG001|Overall Study|Ongoing at cut-off date|5|||
46721229|NCT00813943|82937191|FG002|Overall Study|Ongoing at cut-off date|3|||
47044336|NCT02101385|83300769|FG001|Follow up|Death|39|||
46721230|NCT00821509|82937203|FG000|Overall Study|Withdrawal by Subject|12|||
46721231|NCT00821509|82937204|FG001|Overall Study|Withdrawal by Subject|11|||
46721232|NCT00821509|82937205|FG002|Overall Study|Withdrawal by Subject|34|||
46721233|NCT00821431|82937215|FG000|Overall Study|Adverse Event|6|||
46721234|NCT00821431|82937216|FG001|Overall Study|Adverse Event|3|||
46721235|NCT00821431|82937215|FG000|Overall Study|Withdrawal by Subject|5|||
47044337|NCT02101385|83300768|FG000|Follow up|study completed|33|||
47044338|NCT02101385|83300769|FG001|Follow up|study completed|52|||
47044339|NCT02101385|83300768|FG000|Follow up|screen failure|2|||
47044340|NCT02101385|83300769|FG001|Follow up|screen failure|0|||
47044341|NCT02101385|83300768|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
47044342|NCT02101385|83300769|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
47044343|NCT02101385|83300768|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
47044344|NCT02101385|83300769|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
47044345|NCT02101385|83300768|FG000|Follow up|Withdrawal by Subject|2|||
47044346|NCT02101385|83300769|FG001|Follow up|Withdrawal by Subject|2|||
47044347|NCT02101385|83300768|FG000|Follow up|PI requested closure of site|0|||
47044348|NCT02101385|83300769|FG001|Follow up|PI requested closure of site|5|||
47044349|NCT02068443|83300784|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
47044350|NCT02068443|83300785|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
47044351|NCT02068443|83300786|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
47044352|NCT02068443|83300784|FG000|Overall Study|Voluntary Withdrawal|4|||
47044353|NCT02068443|83300785|FG001|Overall Study|Voluntary Withdrawal|0|||
47044354|NCT02068443|83300786|FG002|Overall Study|Voluntary Withdrawal|1|||
47044355|NCT02068443|83300784|FG000|Overall Study|Lack of Efficacy|2|||
47044356|NCT02068443|83300785|FG001|Overall Study|Lack of Efficacy|1|||
47044357|NCT02068443|83300786|FG002|Overall Study|Lack of Efficacy|0|||
47044358|NCT02068443|83300784|FG000|Overall Study|Other Reason Not Specified|1|||
47044359|NCT02068443|83300785|FG001|Overall Study|Other Reason Not Specified|0|||
47044360|NCT02068443|83300786|FG002|Overall Study|Other Reason Not Specified|0|||
47044361|NCT02065869|83300794|FG000|Overall Study|Death|7|||
47044362|NCT02065869|83300794|FG000|Overall Study|Disease relapse|16|||
47044363|NCT02065869|83300794|FG000|Overall Study|Lost to Follow-up|4|||
47044364|NCT02065869|83300794|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
47044365|NCT02065869|83300794|FG000|Overall Study|Withdrawal by Subject|1|||
47044366|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
47044367|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
47044368|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
47044369|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
46920449|NCT03085927|83152782|FG000|Overall Study|Lost to Follow-up|3|||
46920450|NCT03085927|83152783|FG001|Overall Study|Lost to Follow-up|1|||
46920451|NCT03085927|83152782|FG000|Overall Study|Death|1|||
46920452|NCT03085927|83152783|FG001|Overall Study|Death|0|||
46920453|NCT03085927|83152782|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
46920454|NCT03085927|83152783|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
46920455|NCT03085927|83152782|FG000|Overall Study|Dyad Became Ineligible|0|||
46920456|NCT03085927|83152783|FG001|Overall Study|Dyad Became Ineligible|1|||
46920457|NCT04392583|83152791|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
46920458|NCT04497987|83152797|FG000|Overall Study|Adverse Event|1|||
46920459|NCT04497987|83152798|FG001|Overall Study|Adverse Event|0|||
46920460|NCT04497987|83152797|FG000|Overall Study|Death|21|||
47044370|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
47044371|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
47044372|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
47044373|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
47044374|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
47044375|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
47044376|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044377|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044378|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044379|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
47044380|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
47044381|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044382|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044383|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044384|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044385|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
47044386|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
47044387|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
47044388|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
47044389|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
46633322|NCT01775124|82806708|FG000|Extension Period|Adverse Event|3|||
47044390|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
47044391|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
47044392|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
47044393|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
47044394|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
47044395|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
47044396|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
47044397|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
47044398|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
47044399|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
47044400|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
47044401|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
47044402|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
47044403|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
47044404|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
47044405|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
47044406|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044407|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044408|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
47044409|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
47044410|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044411|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044412|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044413|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044414|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044415|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
47044416|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
47044417|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
47044418|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
47044419|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
47044420|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
47044421|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
47044422|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
47044423|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
46633323|NCT01775124|82806709|FG001|Extension Period|Adverse Event|2|||
46721236|NCT00821431|82937216|FG001|Overall Study|Withdrawal by Subject|0|||
46721237|NCT00821431|82937215|FG000|Overall Study|Lost to Follow-up|1|||
46721238|NCT00821431|82937216|FG001|Overall Study|Lost to Follow-up|0|||
46721239|NCT00821431|82937215|FG000|Overall Study|Protocol Violation|3|||
46721240|NCT00821431|82937216|FG001|Overall Study|Protocol Violation|1|||
46721241|NCT00821431|82937215|FG000|Overall Study|Physician Decision|0|||
46721242|NCT00821431|82937216|FG001|Overall Study|Physician Decision|1|||
46721243|NCT00813865|82937222|FG000|Overall Study|Failure to Respond|3|||
46721244|NCT00813865|82937222|FG000|Overall Study|Lost to Follow-up|3|||
47044424|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
46633324|NCT01775124|82806708|FG000|Extension Period|Physician Decision|0|||
46633325|NCT01775124|82806709|FG001|Extension Period|Physician Decision|2|||
46633326|NCT01775124|82806708|FG000|Extension Period|Administrative problems|0|||
46633327|NCT01775124|82806709|FG001|Extension Period|Administrative problems|1|||
46633328|NCT01775124|82806708|FG000|Extension Period|Lost to Follow-up|0|||
46633329|NCT01775124|82806709|FG001|Extension Period|Lost to Follow-up|1|||
46633330|NCT01775124|82806708|FG000|Extension Period|Withdrawal by Subject|9|||
46633331|NCT01775124|82806709|FG001|Extension Period|Withdrawal by Subject|12|||
46633332|NCT01733316|82806716|FG000|RP103 Phase|Non-compliance|1|||
46633333|NCT01733316|82806716|FG000|Long Term Extension Phase|Adverse Event|1|||
46633334|NCT01733316|82806716|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
46633335|NCT01733316|82806716|FG000|Long Term Extension Phase|Sponsor Decision|2|||
46633336|NCT01732926|82806729|FG000|Overall Study|Study Terminated by Sponsor|168|||
46633337|NCT01732926|82806730|FG001|Overall Study|Study Terminated by Sponsor|80|||
46633338|NCT01732926|82806729|FG000|Overall Study|Withdrawal by Subject|46|||
46633339|NCT01732926|82806730|FG001|Overall Study|Withdrawal by Subject|8|||
46633340|NCT01732926|82806729|FG000|Overall Study|Physician Decision|24|||
46721245|NCT00813865|82937222|FG000|Overall Study|Withdrawal by Subject|1|||
46721246|NCT01147172|82937226|FG000|Overall Study|Withdrawal by Subject|2|||
46721247|NCT01147172|82937226|FG000|Overall Study|Lost to Follow-up|2|||
46721248|NCT01120964|82937234|FG000|Overall Study|Did not receive full treatment|1|||
46920461|NCT04497987|83152798|FG001|Overall Study|Death|13|||
46920462|NCT04497987|83152797|FG000|Overall Study|Lost to Follow-up|19|||
46920463|NCT04497987|83152798|FG001|Overall Study|Lost to Follow-up|17|||
46920464|NCT04497987|83152797|FG000|Overall Study|Other - as reported by the investigator|22|||
46920465|NCT04497987|83152798|FG001|Overall Study|Other - as reported by the investigator|16|||
47044425|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
47044426|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
47044427|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
47044428|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
47044429|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
47044430|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
47044431|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
46633341|NCT01732926|82806730|FG001|Overall Study|Physician Decision|11|||
46633342|NCT01732926|82806729|FG000|Overall Study|Other Reason|21|||
46633343|NCT01732926|82806730|FG001|Overall Study|Other Reason|4|||
46633344|NCT01732926|82806729|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
46633345|NCT01732926|82806730|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
46633346|NCT01732926|82806729|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
46920466|NCT04497987|83152797|FG000|Overall Study|Physician Decision|1|||
47044432|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
46633347|NCT01732926|82806730|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
46633348|NCT01755858|82806738|FG000|Overall Study|Adverse Event|1|||
46633349|NCT01755858|82806739|FG001|Overall Study|Adverse Event|1|||
46920467|NCT04497987|83152798|FG001|Overall Study|Physician Decision|0|||
46633350|NCT01732770|82806749|FG000|Overall Study|Lost to Follow-up|2|||
46633351|NCT01732770|82806750|FG001|Overall Study|Lost to Follow-up|3|||
46633352|NCT01732770|82806749|FG000|Overall Study|Withdrawal by Subject|5|||
46721249|NCT01120964|82937235|FG001|Overall Study|Did not receive full treatment|0|||
46721250|NCT01146860|82937243|FG000|Overall Study|Withdrawal by Subject|0|||
46721251|NCT01146860|82937244|FG001|Overall Study|Withdrawal by Subject|1|||
46721252|NCT00591565|82937250|FG000|Overall Study|lost follow up, withdrawn|5|||
46721253|NCT01146782|82937254|FG000|Screening Cohort|Screen Failure|187|||
46721254|NCT01146782|82937254|FG000|Screening Cohort|Lost to Follow-up|4|||
46721255|NCT01146782|82937254|FG000|Screening Cohort|Physician Decision|1|||
46721256|NCT01146782|82937254|FG000|Screening Cohort|Withdrawal by Subject|29|||
46721257|NCT01146782|82937254|FG000|Safety Cohort|Screen Failure|61|||
46721258|NCT01146782|82937254|FG000|Safety Cohort|Withdrawal by Subject|4|||
46721259|NCT01146782|82937254|FG000|Safety Cohort|Control AHI <5|4|||
46721260|NCT01146782|82937254|FG000|Safety Cohort|TST <4 hrs|14|||
46721261|NCT01146782|82937254|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
46721262|NCT01146782|82937254|FG000|Primary Endpoint Cohort|Physician Decision|1|||
46721263|NCT00978120|82937263|FG000|Overall Study|Death|0|||
46721264|NCT00978120|82937264|FG001|Overall Study|Death|0|||
46721265|NCT00978120|82937265|FG002|Overall Study|Death|0|||
47044433|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
47044434|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
47044435|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
46721266|NCT00978120|82937266|FG003|Overall Study|Death|1|||
46721267|NCT00978120|82937263|FG000|Overall Study|Lost to Follow-up|0|||
46721268|NCT00978120|82937264|FG001|Overall Study|Lost to Follow-up|0|||
46721269|NCT00978120|82937265|FG002|Overall Study|Lost to Follow-up|3|||
46721270|NCT00978120|82937266|FG003|Overall Study|Lost to Follow-up|0|||
46721271|NCT00978120|82937263|FG000|Overall Study|Withdrawal by Subject|2|||
46721272|NCT00978120|82937264|FG001|Overall Study|Withdrawal by Subject|0|||
46721273|NCT00978120|82937265|FG002|Overall Study|Withdrawal by Subject|0|||
46721274|NCT00978120|82937266|FG003|Overall Study|Withdrawal by Subject|0|||
46721275|NCT00978120|82937263|FG000|Overall Study|Moved out of state|0|||
46721276|NCT00978120|82937264|FG001|Overall Study|Moved out of state|0|||
46721277|NCT00978120|82937265|FG002|Overall Study|Moved out of state|0|||
46721278|NCT00978120|82937266|FG003|Overall Study|Moved out of state|1|||
46721279|NCT00978042|82937282|FG000|Initial Treatment Period|Treated in Error|0|||
46721280|NCT00978042|82937283|FG001|Initial Treatment Period|Treated in Error|3|||
46721281|NCT00978042|82937282|FG000|Initial Treatment Period|Ineligibility|1|||
46721282|NCT00978042|82937283|FG001|Initial Treatment Period|Ineligibility|0|||
47044436|NCT02018861|83300809|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
47044437|NCT02018861|83300810|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
47044438|NCT02018861|83300811|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
47044439|NCT02018861|83300812|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
47044440|NCT02018861|83300813|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
47044441|NCT02018861|83300814|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
47044442|NCT02018861|83300815|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
47044443|NCT02018861|83300816|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
47044444|NCT02018861|83300817|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
47044445|NCT02018861|83300818|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
46633353|NCT01732770|82806750|FG001|Overall Study|Withdrawal by Subject|3|||
46633354|NCT01732770|82806749|FG000|Overall Study|Decision by Sponsor|2|||
46633355|NCT01732770|82806750|FG001|Overall Study|Decision by Sponsor|2|||
46633356|NCT01732770|82806749|FG000|Overall Study|Death|1|||
46633357|NCT01732770|82806750|FG001|Overall Study|Death|0|||
46633358|NCT01732692|82806758|FG000|Overall Study|Adverse Event|0|||
46633359|NCT01732692|82806759|FG001|Overall Study|Adverse Event|1|||
46633360|NCT01774968|82806767|FG000|Overall Study|Adverse Event|4|||
46633361|NCT01774968|82806768|FG001|Overall Study|Adverse Event|4|||
46633362|NCT01774968|82806767|FG000|Overall Study|Death|0|||
46633363|NCT01774968|82806768|FG001|Overall Study|Death|1|||
46721283|NCT00978042|82937282|FG000|Initial Treatment Period|Lost to Follow-up|21|||
46721284|NCT00978042|82937283|FG001|Initial Treatment Period|Lost to Follow-up|3|||
46721285|NCT00978042|82937282|FG000|Initial Treatment Period|Adverse Event|2|||
46721286|NCT00978042|82937283|FG001|Initial Treatment Period|Adverse Event|0|||
46721287|NCT00978042|82937282|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
46721288|NCT00978042|82937283|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
46721289|NCT00978042|82937282|FG000|Initial Treatment Period|Consent withdrawn|22|||
46721290|NCT00978042|82937283|FG001|Initial Treatment Period|Consent withdrawn|9|||
46633364|NCT01774968|82806767|FG000|Overall Study|Lost to Follow-up|1|||
46633365|NCT01774968|82806768|FG001|Overall Study|Lost to Follow-up|3|||
46633366|NCT01774968|82806767|FG000|Overall Study|Physician Decision|5|||
47044446|NCT02018861|83300809|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
47044447|NCT02018861|83300810|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
47044448|NCT02018861|83300811|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
47044449|NCT02018861|83300812|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
47044450|NCT02018861|83300813|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
47044451|NCT02018861|83300814|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
47044452|NCT02018861|83300815|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
46721291|NCT00978042|82937282|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
46721292|NCT00978042|82937283|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
47044453|NCT02018861|83300816|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
46721293|NCT01133678|82937291|FG000|Overall Study|Death|1|||
47044454|NCT02018861|83300817|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
46721294|NCT01133678|82937292|FG001|Overall Study|Death|1|||
46721295|NCT01133522|82937308|FG000|Overall Study|Withdrawal by Subject|0|||
46721296|NCT01133522|82937309|FG001|Overall Study|Withdrawal by Subject|1|||
47044455|NCT02018861|83300818|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
47044456|NCT02018861|83300809|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
46633367|NCT01774968|82806768|FG001|Overall Study|Physician Decision|1|||
46633368|NCT01774968|82806767|FG000|Overall Study|Protocol Violation|14|||
46633369|NCT01774968|82806768|FG001|Overall Study|Protocol Violation|13|||
47044457|NCT02018861|83300810|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
47044458|NCT02018861|83300811|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
47044459|NCT02018861|83300812|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
47044460|NCT02018861|83300813|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
47044461|NCT02018861|83300814|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
47044462|NCT02018861|83300815|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
46633370|NCT01774968|82806767|FG000|Overall Study|Sponsor Decision|0|||
46633371|NCT01774968|82806768|FG001|Overall Study|Sponsor Decision|2|||
46633372|NCT01774968|82806767|FG000|Overall Study|Withdrawal by Subject|6|||
46633373|NCT01774968|82806768|FG001|Overall Study|Withdrawal by Subject|11|||
46633374|NCT01774344|82806776|FG000|Overall Study|Withdrawal by Subject|3|||
46633375|NCT01774344|82806777|FG001|Overall Study|Withdrawal by Subject|10|||
46633376|NCT01774344|82806776|FG000|Overall Study|Protocol Violation|0|||
46633377|NCT01774344|82806777|FG001|Overall Study|Protocol Violation|1|||
46633378|NCT01774344|82806776|FG000|Overall Study|Lost to Follow-up|4|||
46633379|NCT01774344|82806777|FG001|Overall Study|Lost to Follow-up|10|||
46633380|NCT01774344|82806776|FG000|Overall Study|End of survival follow-up not available|2|||
46633381|NCT01774344|82806777|FG001|Overall Study|End of survival follow-up not available|2|||
46633382|NCT01774344|82806776|FG000|Overall Study|Data collection finished|4|||
46721297|NCT01133522|82937310|FG002|Overall Study|Withdrawal by Subject|0|||
46633383|NCT01774344|82806777|FG001|Overall Study|Data collection finished|14|||
46633384|NCT01774344|82806776|FG000|Overall Study|Other|0|||
46633385|NCT01774344|82806777|FG001|Overall Study|Other|1|||
46721298|NCT01133522|82937311|FG003|Overall Study|Withdrawal by Subject|1|||
46721299|NCT01133522|82937312|FG004|Overall Study|Withdrawal by Subject|0|||
46721300|NCT01133522|82937313|FG005|Overall Study|Withdrawal by Subject|0|||
46721301|NCT01133522|82937314|FG006|Overall Study|Withdrawal by Subject|0|||
46721302|NCT01133522|82937315|FG007|Overall Study|Withdrawal by Subject|0|||
46721303|NCT01133522|82937316|FG008|Overall Study|Withdrawal by Subject|0|||
46721304|NCT01133522|82937317|FG009|Overall Study|Withdrawal by Subject|0|||
46721305|NCT01133522|82937308|FG000|Overall Study|Physician Decision|0|||
46721306|NCT01133522|82937309|FG001|Overall Study|Physician Decision|0|||
46721307|NCT01133522|82937310|FG002|Overall Study|Physician Decision|0|||
46721308|NCT01133522|82937311|FG003|Overall Study|Physician Decision|0|||
46721309|NCT01133522|82937312|FG004|Overall Study|Physician Decision|1|||
46721310|NCT01133522|82937313|FG005|Overall Study|Physician Decision|0|||
46721311|NCT01133522|82937314|FG006|Overall Study|Physician Decision|0|||
46633386|NCT01774344|82806776|FG000|Overall Study|Did not enter Survival Follow up|49|||
46721312|NCT01133522|82937315|FG007|Overall Study|Physician Decision|0|||
46633387|NCT01774344|82806777|FG001|Overall Study|Did not enter Survival Follow up|83|||
46633388|NCT01732536|82806785|FG000|Overall Study|Withdrawal by Subject|1|||
46633389|NCT01732536|82806786|FG001|Overall Study|Withdrawal by Subject|1|||
47044463|NCT02018861|83300816|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
46633390|NCT01755702|82806795|FG000|Wash Out Period I|Other Reason|3|||
47044464|NCT02018861|83300817|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
47044465|NCT02018861|83300818|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
47044466|NCT02018861|83300809|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044467|NCT02018861|83300810|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044468|NCT02018861|83300811|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044469|NCT02018861|83300812|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044470|NCT02018861|83300813|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044471|NCT02018861|83300814|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
46633391|NCT01755702|82806795|FG000|Washout Period II|Other Reason|5|||
46721313|NCT01133522|82937316|FG008|Overall Study|Physician Decision|0|||
46633392|NCT01732458|82806809|FG000|Overall Study|Lost to Follow-up|0|||
46633393|NCT01732458|82806810|FG001|Overall Study|Lost to Follow-up|2|||
46633394|NCT01732458|82806811|FG002|Overall Study|Lost to Follow-up|0|||
46633395|NCT01732458|82806812|FG003|Overall Study|Lost to Follow-up|0|||
46721314|NCT01133522|82937317|FG009|Overall Study|Physician Decision|0|||
46721315|NCT01133288|82937346|FG000|Eligibility Assessment|met exclusion criteria|5|||
46721316|NCT01133288|82937346|FG000|Intervention Allocation|study terminated|2|||
46721317|NCT00883090|82937354|FG000|Overall Study|Sponsor's decision|1|||
46721318|NCT00883090|82937354|FG000|Overall Study|Withdrawal by Subject|1|||
46721319|NCT01132820|82937358|FG000|Overall Study|Ineligible: wrong cell type|1|||
46721320|NCT01132820|82937358|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
46721321|NCT01132820|82937358|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
46721322|NCT01132820|82937358|FG000|Overall Study|Never treated|1|||
46721323|NCT01132820|82937358|FG000|Overall Study|Inadequate data|1|||
46721324|NCT00885352|82937377|FG000|Overall Study|Adverse Event|2|||
46920468|NCT04497987|83152797|FG000|Overall Study|Withdrawal by Subject|35|||
46920469|NCT04497987|83152798|FG001|Overall Study|Withdrawal by Subject|21|||
46920470|NCT00974571|83152808|FG000|Overall Study|Adverse Event|31|||
46633396|NCT01732458|82806809|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46633397|NCT01732458|82806810|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46633398|NCT01732458|82806811|FG002|Overall Study|Non-Compliance With Study Drug|1|||
46721325|NCT00885352|82937378|FG001|Overall Study|Adverse Event|3|||
46633399|NCT01732458|82806812|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46721326|NCT00885352|82937377|FG000|Overall Study|Lost to Follow-up|2|||
46721327|NCT00885352|82937378|FG001|Overall Study|Lost to Follow-up|2|||
47044472|NCT02018861|83300815|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044473|NCT02018861|83300816|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044474|NCT02018861|83300817|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
47044475|NCT02018861|83300818|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
47044476|NCT02018861|83300809|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044477|NCT02018861|83300810|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044478|NCT02018861|83300811|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044479|NCT02018861|83300812|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044480|NCT02018861|83300813|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044481|NCT02018861|83300814|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044482|NCT02018861|83300815|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044483|NCT02018861|83300816|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044484|NCT02018861|83300817|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
47044485|NCT02018861|83300818|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
47044486|NCT02018861|83300809|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044487|NCT02018861|83300810|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044488|NCT02018861|83300811|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044489|NCT02018861|83300812|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044490|NCT02018861|83300813|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044491|NCT02018861|83300814|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044492|NCT02018861|83300815|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044493|NCT02018861|83300816|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044494|NCT02018861|83300817|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
47044495|NCT02018861|83300818|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
47044496|NCT01827384|83300870|FG000|Overall Study|Switched to alternative treatment|0|||
47044497|NCT01827384|83300871|FG001|Overall Study|Switched to alternative treatment|0|||
47044498|NCT01827384|83300872|FG002|Overall Study|Switched to alternative treatment|0|||
47044499|NCT01827384|83300873|FG003|Overall Study|Switched to alternative treatment|0|||
47044500|NCT01827384|83300874|FG004|Overall Study|Switched to alternative treatment|0|||
47044501|NCT01827384|83300875|FG005|Overall Study|Switched to alternative treatment|0|||
47044502|NCT01827384|83300876|FG006|Overall Study|Switched to alternative treatment|0|||
47044503|NCT01827384|83300877|FG007|Overall Study|Switched to alternative treatment|0|||
47044504|NCT01827384|83300878|FG008|Overall Study|Switched to alternative treatment|0|||
47044505|NCT01827384|83300879|FG009|Overall Study|Switched to alternative treatment|0|||
47044506|NCT01827384|83300880|FG010|Overall Study|Switched to alternative treatment|0|||
47044507|NCT01827384|83300881|FG011|Overall Study|Switched to alternative treatment|0|||
47044508|NCT01827384|83300882|FG012|Overall Study|Switched to alternative treatment|0|||
47044509|NCT01827384|83300883|FG013|Overall Study|Switched to alternative treatment|2|||
47044510|NCT01827384|83300870|FG000|Overall Study|Disease progression before treatment|0|||
47044511|NCT01827384|83300871|FG001|Overall Study|Disease progression before treatment|0|||
47044512|NCT01827384|83300872|FG002|Overall Study|Disease progression before treatment|0|||
47044513|NCT01827384|83300873|FG003|Overall Study|Disease progression before treatment|0|||
47044514|NCT01827384|83300874|FG004|Overall Study|Disease progression before treatment|0|||
47044515|NCT01827384|83300875|FG005|Overall Study|Disease progression before treatment|0|||
47044516|NCT01827384|83300876|FG006|Overall Study|Disease progression before treatment|0|||
47044517|NCT01827384|83300877|FG007|Overall Study|Disease progression before treatment|0|||
47044518|NCT01827384|83300878|FG008|Overall Study|Disease progression before treatment|0|||
47044519|NCT01827384|83300879|FG009|Overall Study|Disease progression before treatment|0|||
47044520|NCT01827384|83300880|FG010|Overall Study|Disease progression before treatment|0|||
47044521|NCT01827384|83300881|FG011|Overall Study|Disease progression before treatment|0|||
47044522|NCT01827384|83300882|FG012|Overall Study|Disease progression before treatment|0|||
47044523|NCT01827384|83300883|FG013|Overall Study|Disease progression before treatment|4|||
47044524|NCT01827384|83300870|FG000|Overall Study|Ineligible|0|||
46633400|NCT01732458|82806809|FG000|Overall Study|Physician Decision|1|||
46633401|NCT01732458|82806810|FG001|Overall Study|Physician Decision|2|||
46633402|NCT01732458|82806811|FG002|Overall Study|Physician Decision|2|||
46721328|NCT00885352|82937377|FG000|Overall Study|Physician Decision|0|||
46721329|NCT00885352|82937378|FG001|Overall Study|Physician Decision|3|||
46920471|NCT00974571|83152809|FG001|Overall Study|Adverse Event|4|||
46920472|NCT00974571|83152810|FG002|Overall Study|Adverse Event|27|||
46633403|NCT01732458|82806812|FG003|Overall Study|Physician Decision|0|||
46633404|NCT01732458|82806809|FG000|Overall Study|Protocol Violation|2|||
46721330|NCT00885352|82937377|FG000|Overall Study|Protocol Violation|0|||
46920473|NCT00974571|83152808|FG000|Overall Study|Lack of Efficacy|3|||
46920474|NCT00974571|83152809|FG001|Overall Study|Lack of Efficacy|2|||
46721331|NCT00885352|82937378|FG001|Overall Study|Protocol Violation|2|||
46721332|NCT00885352|82937377|FG000|Overall Study|Withdrawal by Subject|1|||
46721333|NCT00885352|82937378|FG001|Overall Study|Withdrawal by Subject|5|||
46721334|NCT00885352|82937377|FG000|Overall Study|Contradiction to study medication|0|||
46721335|NCT00885352|82937378|FG001|Overall Study|Contradiction to study medication|2|||
46721336|NCT00885352|82937377|FG000|Overall Study|Excluded medication|2|||
46721337|NCT00885352|82937378|FG001|Overall Study|Excluded medication|2|||
46721338|NCT00885352|82937377|FG000|Overall Study|Lab abnormalities|1|||
46721339|NCT00885352|82937378|FG001|Overall Study|Lab abnormalities|1|||
46721340|NCT00885118|82937389|FG000|Overall Study|Adverse Event|1|||
46721341|NCT00885118|82937390|FG001|Overall Study|Adverse Event|0|||
46721342|NCT00885118|82937391|FG002|Overall Study|Adverse Event|0|||
46721343|NCT00885118|82937392|FG003|Overall Study|Adverse Event|0|||
46721344|NCT00885118|82937393|FG004|Overall Study|Adverse Event|0|||
46721345|NCT00885118|82937389|FG000|Overall Study|Withdrawal by Subject|0|||
46721346|NCT00885118|82937390|FG001|Overall Study|Withdrawal by Subject|0|||
46721347|NCT00885118|82937391|FG002|Overall Study|Withdrawal by Subject|0|||
46721348|NCT00885118|82937392|FG003|Overall Study|Withdrawal by Subject|0|||
46721349|NCT00885118|82937393|FG004|Overall Study|Withdrawal by Subject|1|||
46721350|NCT00885118|82937389|FG000|Overall Study|Other reason not defined above|0|||
46721351|NCT00885118|82937390|FG001|Overall Study|Other reason not defined above|0|||
46721352|NCT00885118|82937391|FG002|Overall Study|Other reason not defined above|1|||
46721353|NCT00885118|82937392|FG003|Overall Study|Other reason not defined above|0|||
46721354|NCT00885118|82937393|FG004|Overall Study|Other reason not defined above|0|||
46721355|NCT00880906|82937411|FG000|Overall Study|Lost to Follow-up|0|||
46721356|NCT00880906|82937412|FG001|Overall Study|Lost to Follow-up|1|||
46721357|NCT00880906|82937411|FG000|Overall Study|Did not meet criteria following patholog|12|||
46721358|NCT00880906|82937412|FG001|Overall Study|Did not meet criteria following patholog|6|||
46721359|NCT00882310|82937418|FG000|Overall Study|Screen Failure|10|||
46721360|NCT00882310|82937418|FG000|Overall Study|Never received treatment|1|||
46721361|NCT00882310|82937418|FG000|Overall Study|Death|6|||
46721362|NCT00882310|82937418|FG000|Overall Study|Progression of disease|4|||
46721363|NCT00882310|82937418|FG000|Overall Study|Adverse Event|1|||
46721364|NCT00884650|82937424|FG000|Overall Study|Did not return complete pain diaries|7|||
46721365|NCT00884650|82937425|FG001|Overall Study|Did not return complete pain diaries|7|||
46721366|NCT00884650|82937424|FG000|Overall Study|Admitted Post-Op|1|||
46721367|NCT00884650|82937425|FG001|Overall Study|Admitted Post-Op|0|||
46721368|NCT00884650|82937424|FG000|Overall Study|Femoral Stress Fracture|1|||
46721369|NCT00884650|82937425|FG001|Overall Study|Femoral Stress Fracture|0|||
46721370|NCT00884650|82937424|FG000|Overall Study|Pain Pump Complication|0|||
46721371|NCT00884650|82937425|FG001|Overall Study|Pain Pump Complication|1|||
46721372|NCT00881608|82937437|FG000|Overall Study|Study prematurely terminated|11|||
46721373|NCT01088399|82937452|FG000|Overall Study|Adverse Event|211|||
46721374|NCT01088399|82937453|FG001|Overall Study|Adverse Event|16|||
47044525|NCT01827384|83300871|FG001|Overall Study|Ineligible|0|||
46633405|NCT01732458|82806810|FG001|Overall Study|Protocol Violation|0|||
46721375|NCT01088399|82937454|FG002|Overall Study|Adverse Event|0|||
47044526|NCT01827384|83300872|FG002|Overall Study|Ineligible|0|||
47044527|NCT01827384|83300873|FG003|Overall Study|Ineligible|0|||
47044528|NCT01827384|83300874|FG004|Overall Study|Ineligible|0|||
46633406|NCT01732458|82806811|FG002|Overall Study|Protocol Violation|0|||
46633407|NCT01732458|82806812|FG003|Overall Study|Protocol Violation|2|||
46633408|NCT01732458|82806809|FG000|Overall Study|Screen Failure|0|||
46633409|NCT01732458|82806810|FG001|Overall Study|Screen Failure|1|||
46633410|NCT01732458|82806811|FG002|Overall Study|Screen Failure|0|||
46633411|NCT01732458|82806812|FG003|Overall Study|Screen Failure|0|||
46633412|NCT01731990|82806836|FG000|Overall Study|Adverse Event|1|||
46633413|NCT01731990|82806837|FG001|Overall Study|Adverse Event|5|||
46633414|NCT01731990|82806836|FG000|Overall Study|Withdrawal by Subject|1|||
46633415|NCT01731990|82806837|FG001|Overall Study|Withdrawal by Subject|1|||
46633416|NCT01731990|82806836|FG000|Overall Study|Protocol deviation|1|||
46633417|NCT01731990|82806837|FG001|Overall Study|Protocol deviation|2|||
46633418|NCT01731990|82806836|FG000|Overall Study|Death|1|||
46633419|NCT01731990|82806837|FG001|Overall Study|Death|0|||
46633420|NCT01708902|82806850|FG000|Overall Study|Adverse Event|3|||
46633421|NCT01708902|82806851|FG001|Overall Study|Adverse Event|4|||
46633422|NCT01708902|82806852|FG002|Overall Study|Adverse Event|9|||
46633423|NCT01708902|82806853|FG003|Overall Study|Adverse Event|2|||
46633424|NCT01708902|82806854|FG004|Overall Study|Adverse Event|7|||
46721376|NCT01088399|82937452|FG000|Overall Study|Death|204|||
46721377|NCT01088399|82937453|FG001|Overall Study|Death|45|||
46721378|NCT01088399|82937454|FG002|Overall Study|Death|0|||
46721379|NCT01088399|82937452|FG000|Overall Study|Lack of Efficacy|298|||
46721380|NCT01088399|82937453|FG001|Overall Study|Lack of Efficacy|7|||
47044529|NCT01827384|83300875|FG005|Overall Study|Ineligible|0|||
47044530|NCT01827384|83300876|FG006|Overall Study|Ineligible|0|||
46633425|NCT01708902|82806855|FG005|Overall Study|Adverse Event|3|||
46633426|NCT01708902|82806856|FG006|Overall Study|Adverse Event|5|||
47044531|NCT01827384|83300877|FG007|Overall Study|Ineligible|0|||
46633427|NCT01708902|82806850|FG000|Overall Study|Lack of Efficacy|3|||
46633428|NCT01708902|82806851|FG001|Overall Study|Lack of Efficacy|1|||
46633429|NCT01708902|82806852|FG002|Overall Study|Lack of Efficacy|0|||
46633430|NCT01708902|82806853|FG003|Overall Study|Lack of Efficacy|0|||
47044532|NCT01827384|83300878|FG008|Overall Study|Ineligible|0|||
47044533|NCT01827384|83300879|FG009|Overall Study|Ineligible|0|||
47044534|NCT01827384|83300880|FG010|Overall Study|Ineligible|0|||
47044535|NCT01827384|83300881|FG011|Overall Study|Ineligible|0|||
47044536|NCT01827384|83300882|FG012|Overall Study|Ineligible|0|||
47044537|NCT01827384|83300883|FG013|Overall Study|Ineligible|19|||
47044538|NCT01827384|83300870|FG000|Overall Study|Participant died before treatment|0|||
47044539|NCT01827384|83300871|FG001|Overall Study|Participant died before treatment|0|||
47044540|NCT01827384|83300872|FG002|Overall Study|Participant died before treatment|0|||
47044541|NCT01827384|83300873|FG003|Overall Study|Participant died before treatment|0|||
47044542|NCT01827384|83300874|FG004|Overall Study|Participant died before treatment|0|||
47044543|NCT01827384|83300875|FG005|Overall Study|Participant died before treatment|0|||
47044544|NCT01827384|83300876|FG006|Overall Study|Participant died before treatment|0|||
47044545|NCT01827384|83300877|FG007|Overall Study|Participant died before treatment|0|||
47044546|NCT01827384|83300878|FG008|Overall Study|Participant died before treatment|0|||
47044547|NCT01827384|83300879|FG009|Overall Study|Participant died before treatment|0|||
47044548|NCT01827384|83300880|FG010|Overall Study|Participant died before treatment|0|||
47044549|NCT01827384|83300881|FG011|Overall Study|Participant died before treatment|0|||
47044550|NCT01827384|83300882|FG012|Overall Study|Participant died before treatment|0|||
47044551|NCT01827384|83300883|FG013|Overall Study|Participant died before treatment|5|||
47044552|NCT01827384|83300870|FG000|Overall Study|Insufficient tumor cells|0|||
47044553|NCT01827384|83300871|FG001|Overall Study|Insufficient tumor cells|0|||
47044554|NCT01827384|83300872|FG002|Overall Study|Insufficient tumor cells|0|||
47044555|NCT01827384|83300873|FG003|Overall Study|Insufficient tumor cells|0|||
47044556|NCT01827384|83300874|FG004|Overall Study|Insufficient tumor cells|0|||
47044557|NCT01827384|83300875|FG005|Overall Study|Insufficient tumor cells|0|||
47044558|NCT01827384|83300876|FG006|Overall Study|Insufficient tumor cells|0|||
47044559|NCT01827384|83300877|FG007|Overall Study|Insufficient tumor cells|0|||
47044560|NCT01827384|83300878|FG008|Overall Study|Insufficient tumor cells|0|||
47044561|NCT01827384|83300879|FG009|Overall Study|Insufficient tumor cells|0|||
47044562|NCT01827384|83300880|FG010|Overall Study|Insufficient tumor cells|0|||
47044563|NCT01827384|83300881|FG011|Overall Study|Insufficient tumor cells|0|||
47044564|NCT01827384|83300882|FG012|Overall Study|Insufficient tumor cells|0|||
47044565|NCT01827384|83300883|FG013|Overall Study|Insufficient tumor cells|13|||
47044566|NCT01827384|83300870|FG000|Overall Study|No actionable mutation|0|||
47044567|NCT01827384|83300871|FG001|Overall Study|No actionable mutation|0|||
47044568|NCT01827384|83300872|FG002|Overall Study|No actionable mutation|0|||
47044569|NCT01827384|83300873|FG003|Overall Study|No actionable mutation|0|||
47044570|NCT01827384|83300874|FG004|Overall Study|No actionable mutation|0|||
47044571|NCT01827384|83300875|FG005|Overall Study|No actionable mutation|0|||
47044572|NCT01827384|83300876|FG006|Overall Study|No actionable mutation|0|||
47044573|NCT01827384|83300877|FG007|Overall Study|No actionable mutation|0|||
47044574|NCT01827384|83300878|FG008|Overall Study|No actionable mutation|0|||
47044575|NCT01827384|83300879|FG009|Overall Study|No actionable mutation|0|||
47044576|NCT01827384|83300880|FG010|Overall Study|No actionable mutation|0|||
47044577|NCT01827384|83300881|FG011|Overall Study|No actionable mutation|0|||
47044578|NCT01827384|83300882|FG012|Overall Study|No actionable mutation|0|||
47044579|NCT01827384|83300883|FG013|Overall Study|No actionable mutation|73|||
47044580|NCT01827384|83300870|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
47044581|NCT01827384|83300871|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
47044582|NCT01827384|83300872|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
47044583|NCT01827384|83300873|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
47044584|NCT01827384|83300874|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
47044585|NCT01827384|83300875|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
47044586|NCT01827384|83300876|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
47044587|NCT01827384|83300877|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
47044588|NCT01827384|83300878|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
47044589|NCT01827384|83300879|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
47044590|NCT01827384|83300880|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
47044591|NCT01827384|83300881|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
47044592|NCT01827384|83300882|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
47044593|NCT01827384|83300883|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
47044594|NCT01377389|83300918|FG000|Overall Study|Withdrawal by Subject|1|||
47044595|NCT01377389|83300918|FG000|Overall Study|Screen failure|2|||
47044596|NCT01287611|83300924|FG000|Overall Study|Lost to Follow-up|29|||
47044597|NCT01287611|83300925|FG001|Overall Study|Lost to Follow-up|16|||
47044598|NCT01287611|83300924|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
46633431|NCT01708902|82806854|FG004|Overall Study|Lack of Efficacy|0|||
46633432|NCT01708902|82806855|FG005|Overall Study|Lack of Efficacy|1|||
46633433|NCT01708902|82806856|FG006|Overall Study|Lack of Efficacy|0|||
46633434|NCT01708902|82806850|FG000|Overall Study|Non compliance with protocol|0|||
46633435|NCT01708902|82806851|FG001|Overall Study|Non compliance with protocol|2|||
46633436|NCT01708902|82806852|FG002|Overall Study|Non compliance with protocol|1|||
46721381|NCT01088399|82937454|FG002|Overall Study|Lack of Efficacy|5|||
46721382|NCT01088399|82937452|FG000|Overall Study|Lost to Follow-up|1070|||
46721383|NCT01088399|82937453|FG001|Overall Study|Lost to Follow-up|278|||
46721384|NCT01088399|82937454|FG002|Overall Study|Lost to Follow-up|58|||
46721385|NCT01088399|82937452|FG000|Overall Study|Physician Decision|531|||
46721386|NCT01088399|82937453|FG001|Overall Study|Physician Decision|88|||
46721387|NCT01088399|82937454|FG002|Overall Study|Physician Decision|16|||
46721388|NCT01088399|82937452|FG000|Overall Study|Withdrawal by Subject|544|||
46721389|NCT01088399|82937453|FG001|Overall Study|Withdrawal by Subject|195|||
46721390|NCT01088399|82937454|FG002|Overall Study|Withdrawal by Subject|33|||
46721391|NCT01088399|82937452|FG000|Overall Study|Change to or start of somatropin therapy|234|||
46721392|NCT01088399|82937453|FG001|Overall Study|Change to or start of somatropin therapy|17|||
46721393|NCT01088399|82937454|FG002|Overall Study|Change to or start of somatropin therapy|12|||
46721394|NCT01088399|82937452|FG000|Overall Study|Sponsor decision|1573|||
46721395|NCT01088399|82937453|FG001|Overall Study|Sponsor decision|298|||
46721396|NCT01088399|82937454|FG002|Overall Study|Sponsor decision|7|||
46721397|NCT01088399|82937452|FG000|Overall Study|Protocol Violation|10|||
46721398|NCT01088399|82937453|FG001|Overall Study|Protocol Violation|1|||
46721399|NCT01088399|82937454|FG002|Overall Study|Protocol Violation|0|||
46721400|NCT01088399|82937452|FG000|Overall Study|Enrollment criteria not met|48|||
46721401|NCT01088399|82937453|FG001|Overall Study|Enrollment criteria not met|119|||
46721402|NCT01088399|82937454|FG002|Overall Study|Enrollment criteria not met|70|||
46721403|NCT01088399|82937452|FG000|Overall Study|Study summary visit not completed|2398|||
46721404|NCT01088399|82937453|FG001|Overall Study|Study summary visit not completed|283|||
46721405|NCT01088399|82937454|FG002|Overall Study|Study summary visit not completed|80|||
46721406|NCT00598078|82937462|FG000|Period 2 (Day 2)|Adverse Event|1|||
46721407|NCT00598078|82937463|FG001|Period 2 (Day 2)|Adverse Event|0|||
46721408|NCT01079195|82937471|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
46721409|NCT01079195|82937471|FG000|Overall Study|No Documentation Available|437|||
46721410|NCT01079195|82937471|FG000|Overall Study|Adverse Event|157|||
46721411|NCT01079195|82937471|FG000|Overall Study|Reason Unknown|39|||
46721412|NCT01079195|82937471|FG000|Overall Study|Withdrawal by Subject|18|||
46721413|NCT01079195|82937471|FG000|Overall Study|Financial Reasons|15|||
46721414|NCT01079195|82937471|FG000|Overall Study|Lack of Effectiveness|12|||
46721415|NCT01079195|82937471|FG000|Overall Study|Physician Decision|4|||
46721416|NCT01079195|82937471|FG000|Overall Study|Improved Status of Participant|4|||
46721417|NCT01079195|82937471|FG000|Overall Study|No Follow-up Documentation Available|4|||
46920475|NCT00974571|83152810|FG002|Overall Study|Lack of Efficacy|9|||
46633437|NCT01708902|82806853|FG003|Overall Study|Non compliance with protocol|3|||
46633438|NCT01708902|82806854|FG004|Overall Study|Non compliance with protocol|0|||
46633439|NCT01708902|82806855|FG005|Overall Study|Non compliance with protocol|0|||
46633440|NCT01708902|82806856|FG006|Overall Study|Non compliance with protocol|0|||
46633441|NCT01708902|82806850|FG000|Overall Study|Lost to Follow-up|2|||
46633442|NCT01708902|82806851|FG001|Overall Study|Lost to Follow-up|1|||
46633443|NCT01708902|82806852|FG002|Overall Study|Lost to Follow-up|2|||
46633444|NCT01708902|82806853|FG003|Overall Study|Lost to Follow-up|2|||
46721418|NCT01079195|82937471|FG000|Overall Study|Non-compliance|2|||
46721419|NCT00883558|82937475|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
46721420|NCT00883558|82937476|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
46721421|NCT00883558|82937477|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
46920476|NCT00974571|83152808|FG000|Overall Study|Lost to Follow-up|2|||
46633445|NCT01708902|82806854|FG004|Overall Study|Lost to Follow-up|0|||
46633446|NCT01708902|82806855|FG005|Overall Study|Lost to Follow-up|0|||
46633447|NCT01708902|82806856|FG006|Overall Study|Lost to Follow-up|1|||
47044599|NCT01287611|83300925|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
47044600|NCT01194271|83300933|FG000|Overall Study|Withdrawal by Subject|1|||
47044601|NCT01194271|83300933|FG000|Overall Study|Ineligible, Screen Failure|1|||
47044602|NCT01194271|83300933|FG000|Overall Study|Death|1|||
47044603|NCT01119508|83300948|FG000|Overall Study|Adverse Event|56|||
46721422|NCT00883558|82937475|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
47044604|NCT01119508|83300948|FG000|Overall Study|Withdrawal by Subject|2|||
47044605|NCT01119508|83300948|FG000|Overall Study|Died before tumor response evaluation|1|||
47044606|NCT00754338|83300960|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
47044607|NCT00754338|83300961|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
47044608|NCT00754338|83300962|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
47044609|NCT00754338|83300963|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
47044610|NCT00754338|83300960|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
47044611|NCT00754338|83300961|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
47044612|NCT00754338|83300962|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
47044613|NCT00754338|83300963|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
47044614|NCT00574496|83300989|FG000|Overall Study|Withdrawal by Subject|1|||
47044615|NCT00499083|83300993|FG000|Overall Study|Not evaluable|3|||
46633448|NCT01708902|82806850|FG000|Overall Study|Refused to continue trial medication|8|||
46633449|NCT01708902|82806851|FG001|Overall Study|Refused to continue trial medication|0|||
46633450|NCT01708902|82806852|FG002|Overall Study|Refused to continue trial medication|4|||
46633451|NCT01708902|82806853|FG003|Overall Study|Refused to continue trial medication|2|||
46721423|NCT00883558|82937476|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
46721424|NCT00883558|82937477|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
46920477|NCT00974571|83152809|FG001|Overall Study|Lost to Follow-up|1|||
46920478|NCT00974571|83152810|FG002|Overall Study|Lost to Follow-up|2|||
46920479|NCT00974571|83152808|FG000|Overall Study|Protocol Violation|13|||
46920480|NCT00974571|83152809|FG001|Overall Study|Protocol Violation|4|||
47044616|NCT00418886|83300999|FG000|Overall Study|discontinue treatment survival follow up|90|||
47044617|NCT00418886|83301000|FG001|Overall Study|discontinue treatment survival follow up|91|||
47044618|NCT00418886|83300999|FG000|Overall Study|Death|122|||
47044619|NCT00418886|83301000|FG001|Overall Study|Death|147|||
47044620|NCT00418886|83300999|FG000|Overall Study|Withdrawal by Subject|9|||
47044621|NCT00418886|83301000|FG001|Overall Study|Withdrawal by Subject|10|||
47044622|NCT00418886|83300999|FG000|Overall Study|Lost to Follow-up|4|||
47044623|NCT00418886|83301000|FG001|Overall Study|Lost to Follow-up|6|||
46721425|NCT00883558|82937475|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
46721426|NCT00883558|82937476|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
46721427|NCT00883558|82937477|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
46721428|NCT00883558|82937475|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
46721429|NCT00883558|82937476|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
46721430|NCT00883558|82937477|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
47044624|NCT00418886|83300999|FG000|Overall Study|withdrawn due to other reason|1|||
47044625|NCT00418886|83301000|FG001|Overall Study|withdrawn due to other reason|0|||
47044626|NCT00418886|83300999|FG000|Overall Study|randomised but no treatment received|0|||
47044627|NCT00418886|83301000|FG001|Overall Study|randomised but no treatment received|1|||
46633452|NCT01708902|82806854|FG004|Overall Study|Refused to continue trial medication|8|||
46633453|NCT01708902|82806855|FG005|Overall Study|Refused to continue trial medication|1|||
46633454|NCT01708902|82806856|FG006|Overall Study|Refused to continue trial medication|1|||
46633455|NCT01708902|82806850|FG000|Overall Study|Other Reason|1|||
46721431|NCT00883558|82937475|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
46721432|NCT00883558|82937476|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
46721433|NCT00883558|82937477|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
46721434|NCT00880750|82937485|FG000|First Intervention|Adverse Event|1|||
46721435|NCT00880750|82937486|FG001|First Intervention|Adverse Event|0|||
46721436|NCT00880750|82937485|FG000|First Intervention|Unable to collect urine|4|||
46721437|NCT00880750|82937486|FG001|First Intervention|Unable to collect urine|0|||
46721438|NCT00880750|82937485|FG000|First Intervention|Non-compliance with meals|0|||
46721439|NCT00880750|82937486|FG001|First Intervention|Non-compliance with meals|1|||
46721440|NCT00880750|82937485|FG000|First Intervention|Withdrawal by Subject|2|||
46721441|NCT00880750|82937486|FG001|First Intervention|Withdrawal by Subject|0|||
46721442|NCT00880750|82937485|FG000|First Intervention|Lost to Follow-up|2|||
46721443|NCT00880750|82937486|FG001|First Intervention|Lost to Follow-up|0|||
46721444|NCT00880750|82937485|FG000|Second Intervention|Withdrawal by Subject|2|||
46721445|NCT00880750|82937486|FG001|Second Intervention|Withdrawal by Subject|2|||
46721446|NCT00880750|82937485|FG000|Second Intervention|Protocol Violation|1|||
46721447|NCT00880750|82937486|FG001|Second Intervention|Protocol Violation|0|||
46721448|NCT00880750|82937485|FG000|Second Intervention|Unable to collect urine|1|||
46721449|NCT00880750|82937486|FG001|Second Intervention|Unable to collect urine|0|||
46721450|NCT00597766|82937495|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
46721451|NCT00597766|82937496|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
46721452|NCT00597766|82937497|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
46721453|NCT00597766|82937495|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
46721454|NCT00597766|82937496|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
46721455|NCT00597766|82937497|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
46721456|NCT00979992|82937505|FG000|Overall Study|Ineligible - inadequate pathology|1|||
46721457|NCT00979992|82937505|FG000|Overall Study|Ineligible - wrong cell type|2|||
46721458|NCT00979992|82937505|FG000|Overall Study|Refused - Never Treated|2|||
47044628|NCT01819129|83301012|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
47044629|NCT01819129|83301013|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
47044630|NCT01819129|83301012|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
46633456|NCT01708902|82806851|FG001|Overall Study|Other Reason|0|||
46633457|NCT01708902|82806852|FG002|Overall Study|Other Reason|1|||
46633458|NCT01708902|82806853|FG003|Overall Study|Other Reason|1|||
46633459|NCT01708902|82806854|FG004|Overall Study|Other Reason|1|||
46721459|NCT01079741|82937514|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
46721460|NCT01079741|82937515|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
46721461|NCT01079741|82937516|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
46721462|NCT01079741|82937517|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
46721463|NCT01079741|82937518|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
47044631|NCT01819129|83301013|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
46721464|NCT01079741|82937514|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
46721465|NCT01079741|82937515|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
46721466|NCT01079741|82937516|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
46920481|NCT00974571|83152810|FG002|Overall Study|Protocol Violation|18|||
46633460|NCT01708902|82806855|FG005|Overall Study|Other Reason|2|||
46633461|NCT01708902|82806856|FG006|Overall Study|Other Reason|0|||
46633462|NCT01755546|82806875|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
46633463|NCT01755546|82806875|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
46633464|NCT01755546|82806875|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
46633465|NCT01755546|82806875|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
46633466|NCT01755546|82806875|FG000|Titration Phase|Adverse Event|11|||
46633467|NCT01755546|82806875|FG000|Titration Phase|Lack of Efficacy|18|||
46633468|NCT01755546|82806875|FG000|Titration Phase|Protocol Violation|9|||
46633469|NCT01755546|82806875|FG000|Titration Phase|Lost to Follow-up|2|||
46633470|NCT01755546|82806875|FG000|Titration Phase|Other and Continuing|22|||
46633471|NCT01755546|82806875|FG000|Titration Phase|Withdrawal by Subject|8|||
46633472|NCT01755546|82806875|FG000|Long Term Treatment|Adverse Event|12|||
46633473|NCT01755546|82806875|FG000|Long Term Treatment|Lack of Efficacy|6|||
46633474|NCT01755546|82806875|FG000|Long Term Treatment|Protocol Violation|10|||
46633475|NCT01755546|82806875|FG000|Long Term Treatment|Withdrawal by Subject|35|||
46633476|NCT01755546|82806875|FG000|Long Term Treatment|Lost to Follow-up|17|||
46633477|NCT01755546|82806875|FG000|Long Term Treatment|other and ongoing|41|||
46633478|NCT01755234|82806881|FG000|Overall Study|Lost to Follow-up|11|||
46721467|NCT01079741|82937517|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
46721468|NCT01079741|82937518|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
46721469|NCT01079663|82937532|FG000|Overall Study|Adverse Event|0|||
46721470|NCT01079663|82937533|FG001|Overall Study|Adverse Event|2|||
46721471|NCT01079663|82937532|FG000|Overall Study|Protocol Violation|0|||
46721472|NCT01079663|82937533|FG001|Overall Study|Protocol Violation|2|||
46721473|NCT00879814|82937543|FG000|Overall Study|Adverse Event|0|||
46721474|NCT00879814|82937544|FG001|Overall Study|Adverse Event|1|||
46721475|NCT00879814|82937545|FG002|Overall Study|Adverse Event|0|||
46721476|NCT00879814|82937546|FG003|Overall Study|Adverse Event|0|||
46721477|NCT00879814|82937543|FG000|Overall Study|Lost to Follow-up|1|||
46721478|NCT00879814|82937544|FG001|Overall Study|Lost to Follow-up|0|||
46721479|NCT00879814|82937545|FG002|Overall Study|Lost to Follow-up|0|||
46721480|NCT00879814|82937546|FG003|Overall Study|Lost to Follow-up|2|||
46721481|NCT00879814|82937543|FG000|Overall Study|Participant Failed to Return|0|||
46721482|NCT00879814|82937544|FG001|Overall Study|Participant Failed to Return|0|||
46721483|NCT00879814|82937545|FG002|Overall Study|Participant Failed to Return|0|||
46721484|NCT00879814|82937546|FG003|Overall Study|Participant Failed to Return|1|||
46721485|NCT00879814|82937543|FG000|Overall Study|Withdrawal by Subject|3|||
46721486|NCT00879814|82937544|FG001|Overall Study|Withdrawal by Subject|1|||
47044632|NCT01819129|83301012|FG000|Overall Study|Other, Subject moved out of the country|0|||
47044633|NCT01819129|83301013|FG001|Overall Study|Other, Subject moved out of the country|1|||
47044634|NCT01819129|83301012|FG000|Overall Study|Withdrawal by Subject|15|||
47044635|NCT01819129|83301013|FG001|Overall Study|Withdrawal by Subject|15|||
47044636|NCT01819129|83301012|FG000|Overall Study|Lost to Follow-up|5|||
47044637|NCT01819129|83301013|FG001|Overall Study|Lost to Follow-up|2|||
47044638|NCT01819129|83301012|FG000|Overall Study|Lack of Efficacy|0|||
47044639|NCT01819129|83301013|FG001|Overall Study|Lack of Efficacy|1|||
47044640|NCT01819129|83301012|FG000|Overall Study|Adverse Event|1|||
47044641|NCT01819129|83301013|FG001|Overall Study|Adverse Event|4|||
47044642|NCT01819129|83301012|FG000|Overall Study|Death|1|||
47044643|NCT01819129|83301013|FG001|Overall Study|Death|1|||
47044644|NCT01819129|83301012|FG000|Overall Study|Withdrawal Criteria|20|||
47044645|NCT01819129|83301013|FG001|Overall Study|Withdrawal Criteria|15|||
47044646|NCT04022889|83301021|FG000|Stage 1: Period 1|Adverse Event|1|||
47044647|NCT04022889|83301022|FG001|Stage 1: Period 1|Adverse Event|0|||
47044648|NCT04022889|83301023|FG002|Stage 1: Period 1|Adverse Event|0|||
47044649|NCT04022889|83301021|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
47044650|NCT04022889|83301022|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
47044651|NCT04022889|83301023|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
47044652|NCT04022889|83301021|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
47044653|NCT04022889|83301022|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
47044654|NCT04022889|83301023|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
47044655|NCT04022889|83301021|FG000|Stage 2|Screen Failure|0|||
47044656|NCT04022889|83301022|FG001|Stage 2|Screen Failure|0|||
46633479|NCT01755234|82806882|FG001|Overall Study|Lost to Follow-up|6|||
46633480|NCT01755234|82806881|FG000|Overall Study|Change in surgical case|2|||
46721487|NCT00879814|82937545|FG002|Overall Study|Withdrawal by Subject|1|||
46721488|NCT00879814|82937546|FG003|Overall Study|Withdrawal by Subject|2|||
46721489|NCT00879814|82937543|FG000|Overall Study|Physician Decision|0|||
46721490|NCT00879814|82937544|FG001|Overall Study|Physician Decision|0|||
47044657|NCT04022889|83301023|FG002|Stage 2|Screen Failure|3|||
47044658|NCT04022889|83301021|FG000|Stage 2|Ineligible for apheresis donation|0|||
47044659|NCT04022889|83301022|FG001|Stage 2|Ineligible for apheresis donation|0|||
47044660|NCT04022889|83301023|FG002|Stage 2|Ineligible for apheresis donation|2|||
47044661|NCT04022889|83301021|FG000|Stage 2|Adverse Event|0|||
46633481|NCT01755234|82806882|FG001|Overall Study|Change in surgical case|1|||
46633482|NCT01755234|82806881|FG000|Overall Study|case cancelled|1|||
46920482|NCT00974571|83152808|FG000|Overall Study|Withdrawal by Subject|14|||
46920483|NCT00974571|83152809|FG001|Overall Study|Withdrawal by Subject|5|||
46920484|NCT00974571|83152810|FG002|Overall Study|Withdrawal by Subject|16|||
46920485|NCT00974571|83152808|FG000|Overall Study|Patient Moved|1|||
46633483|NCT01755234|82806882|FG001|Overall Study|case cancelled|0|||
46633484|NCT01755234|82806881|FG000|Overall Study|Withdrawal by Subject|0|||
46633485|NCT01755234|82806882|FG001|Overall Study|Withdrawal by Subject|1|||
46633486|NCT01755234|82806881|FG000|Overall Study|unblinded|1|||
46633487|NCT01755234|82806882|FG001|Overall Study|unblinded|0|||
46633488|NCT01731912|82806888|FG000|Overall Study|noncompliance|2|||
46633489|NCT01731678|82806892|FG000|Overall Study|Withdrawal by Subject|3|||
46633490|NCT01731678|82806892|FG000|Overall Study|Did not meet inclusion criteria|1|||
46633491|NCT01731678|82806892|FG000|Overall Study|RMT too high, making TMS difficult|3|||
46633492|NCT01731600|82806898|FG000|Overall Study|Adverse Event|2|||
46633493|NCT01731600|82806899|FG001|Overall Study|Adverse Event|0|||
46633494|NCT01731600|82806898|FG000|Overall Study|Withdrawal criteria|1|||
46633495|NCT01731600|82806899|FG001|Overall Study|Withdrawal criteria|0|||
46633496|NCT01731600|82806898|FG000|Overall Study|Other reasons|3|||
46633497|NCT01731600|82806899|FG001|Overall Study|Other reasons|0|||
46633498|NCT01730586|82806909|FG000|Overall Study|Progressive Disease|2|||
46633499|NCT01730586|82806909|FG000|Overall Study|Inadequate Trial|8|||
46633500|NCT01730586|82806909|FG000|Overall Study|Adverse Event|2|||
46633501|NCT01730586|82806909|FG000|Overall Study|Hospice|1|||
46633502|NCT01707030|82806917|FG000|Overall Study|Death|1|||
46633503|NCT01707030|82806918|FG001|Overall Study|Death|1|||
46633504|NCT01707030|82806917|FG000|Overall Study|Withdrawal by Subject|2|||
46633505|NCT01707030|82806918|FG001|Overall Study|Withdrawal by Subject|3|||
46633506|NCT01707030|82806917|FG000|Overall Study|Lost to Follow-up|8|||
46633507|NCT01707030|82806918|FG001|Overall Study|Lost to Follow-up|13|||
46633508|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
46633509|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
46633510|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
46633511|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
46633512|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
46633513|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
46633514|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
46633515|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
46633516|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
46633517|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
46633518|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
46633519|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
46633520|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
46633521|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
46633522|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
46633523|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
46633524|NCT01755156|82806930|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
46633525|NCT01755156|82806931|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
46633526|NCT01755156|82806930|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
46633527|NCT01755156|82806931|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
46633528|NCT01755156|82806930|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
46633529|NCT01755156|82806931|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
46633530|NCT01754922|82806943|FG000|Overall Study|Adverse Event|0|||
46633531|NCT01754922|82806944|FG001|Overall Study|Adverse Event|1|||
46633532|NCT01754766|82806954|FG000|Overall Study|Personal reasons|1|||
46633533|NCT01754766|82806955|FG001|Overall Study|Personal reasons|1|||
46633534|NCT01754766|82806956|FG002|Overall Study|Personal reasons|0|||
46633535|NCT01754376|82806964|FG000|Overall Study|Adverse Event|1|||
46633536|NCT01754376|82806964|FG000|Overall Study|Lack of Efficacy|2|||
46633537|NCT01605396|82806971|FG000|Overall Study|Adverse Event|5|||
46633538|NCT01605396|82806972|FG001|Overall Study|Adverse Event|3|||
46633539|NCT01605396|82806971|FG000|Overall Study|Lost to Follow-up|1|||
46633540|NCT01605396|82806972|FG001|Overall Study|Lost to Follow-up|0|||
46633541|NCT01605396|82806971|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46633542|NCT01605396|82806972|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46920486|NCT00974571|83152809|FG001|Overall Study|Patient Moved|0|||
46920487|NCT00974571|83152810|FG002|Overall Study|Patient Moved|1|||
46633543|NCT01605396|82806971|FG000|Overall Study|Physician Decision|2|||
46633544|NCT01605396|82806972|FG001|Overall Study|Physician Decision|2|||
46633545|NCT01605396|82806971|FG000|Overall Study|Progressive Disease|23|||
46633546|NCT01605396|82806972|FG001|Overall Study|Progressive Disease|27|||
46633547|NCT01605396|82806971|FG000|Overall Study|Withdrawal by Subject|4|||
46633548|NCT01605396|82806972|FG001|Overall Study|Withdrawal by Subject|2|||
46633549|NCT01605396|82806971|FG000|Overall Study|Transfer Off Study|4|||
46633550|NCT01605396|82806972|FG001|Overall Study|Transfer Off Study|5|||
46633551|NCT01730118|82806985|FG000|Dose Escalation|Death on study|5|||
46633552|NCT01730118|82806986|FG001|Dose Escalation|Death on study|7|||
46633553|NCT01730118|82806987|FG002|Dose Escalation|Death on study|2|||
46633554|NCT01730118|82806988|FG003|Dose Escalation|Death on study|6|||
46721491|NCT00879814|82937545|FG002|Overall Study|Physician Decision|1|||
46920488|NCT00974571|83152808|FG000|Overall Study|Other|4|||
46920489|NCT00974571|83152809|FG001|Overall Study|Other|0|||
46920490|NCT00974571|83152810|FG002|Overall Study|Other|10|||
46633555|NCT01730118|82806989|FG004|Dose Escalation|Death on study|0|||
46633556|NCT01730118|82806990|FG005|Dose Escalation|Death on study|0|||
46633557|NCT01730118|82806991|FG006|Dose Escalation|Death on study|0|||
46633558|NCT01730118|82806985|FG000|Dose Escalation|Died before treatment|0|||
46633559|NCT01730118|82806986|FG001|Dose Escalation|Died before treatment|0|||
46633560|NCT01730118|82806987|FG002|Dose Escalation|Died before treatment|0|||
46633561|NCT01730118|82806988|FG003|Dose Escalation|Died before treatment|0|||
46633562|NCT01730118|82806989|FG004|Dose Escalation|Died before treatment|0|||
46633563|NCT01730118|82806990|FG005|Dose Escalation|Died before treatment|0|||
47044662|NCT04022889|83301022|FG001|Stage 2|Adverse Event|0|||
47044663|NCT04022889|83301023|FG002|Stage 2|Adverse Event|2|||
47044664|NCT04022889|83301021|FG000|Stage 2|Protocol Violation|0|||
47044665|NCT04022889|83301022|FG001|Stage 2|Protocol Violation|0|||
47044666|NCT04022889|83301023|FG002|Stage 2|Protocol Violation|1|||
46920491|NCT02766608|83152823|FG000|Overall Study|Adverse Event|27|||
47044667|NCT04022889|83301021|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
47044668|NCT04022889|83301022|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
47044669|NCT04022889|83301023|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
46633564|NCT01730118|82806991|FG006|Dose Escalation|Died before treatment|1|||
47044670|NCT01849783|83301041|FG000|Overall Study|Adverse Event|5|||
47044671|NCT01849783|83301041|FG000|Overall Study|Death|2|||
47044672|NCT01849783|83301041|FG000|Overall Study|Physician Decision|1|||
47044673|NCT01849783|83301041|FG000|Overall Study|Withdrawal by Subject|1|||
47044674|NCT01849783|83301041|FG000|Overall Study|Unable to comply|2|||
47044675|NCT01849783|83301041|FG000|Overall Study|Disease progression|11|||
47044676|NCT01611883|83301053|FG000|Overall Study|Adverse Event|1|||
47044677|NCT01611883|83301054|FG001|Overall Study|Adverse Event|1|||
47044678|NCT01848457|83301064|FG000|Overall Study|Death|1|||
47044679|NCT01848457|83301065|FG001|Overall Study|Death|0|||
47044680|NCT01848457|83301066|FG002|Overall Study|Death|0|||
47044681|NCT01848457|83301067|FG003|Overall Study|Death|0|||
47044682|NCT01817725|83301085|FG000|Overall Study|Withdrawal by Subject|1|||
47044683|NCT01870999|83301092|FG000|Overall Study|Adverse Event|0|||
47044684|NCT01870999|83301093|FG001|Overall Study|Adverse Event|4|||
47044685|NCT01870999|83301094|FG002|Overall Study|Adverse Event|1|||
47044686|NCT01870999|83301092|FG000|Overall Study|Subject met withdrawal criteria|3|||
47044687|NCT01870999|83301093|FG001|Overall Study|Subject met withdrawal criteria|2|||
47044688|NCT01870999|83301094|FG002|Overall Study|Subject met withdrawal criteria|0|||
47044689|NCT01870999|83301092|FG000|Overall Study|Subject withdrawn by Investigator|1|||
47044690|NCT01870999|83301093|FG001|Overall Study|Subject withdrawn by Investigator|0|||
47044691|NCT01870999|83301094|FG002|Overall Study|Subject withdrawn by Investigator|0|||
47044692|NCT01870999|83301092|FG000|Overall Study|Withdrawal by Subject|0|||
46633565|NCT01730118|82806985|FG000|Dose Escalation|Chose to start a different treatment|1|||
46633566|NCT01730118|82806986|FG001|Dose Escalation|Chose to start a different treatment|0|||
46633567|NCT01730118|82806987|FG002|Dose Escalation|Chose to start a different treatment|0|||
46633568|NCT01730118|82806988|FG003|Dose Escalation|Chose to start a different treatment|0|||
46633569|NCT01730118|82806989|FG004|Dose Escalation|Chose to start a different treatment|0|||
46633570|NCT01730118|82806990|FG005|Dose Escalation|Chose to start a different treatment|0|||
46633571|NCT01730118|82806991|FG006|Dose Escalation|Chose to start a different treatment|0|||
46633572|NCT01730118|82806985|FG000|Dose Escalation|Withdrawal by Subject|0|||
46633573|NCT01730118|82806986|FG001|Dose Escalation|Withdrawal by Subject|0|||
46633574|NCT01730118|82806987|FG002|Dose Escalation|Withdrawal by Subject|1|||
46633575|NCT01730118|82806988|FG003|Dose Escalation|Withdrawal by Subject|0|||
46633576|NCT01730118|82806989|FG004|Dose Escalation|Withdrawal by Subject|0|||
46633577|NCT01730118|82806990|FG005|Dose Escalation|Withdrawal by Subject|0|||
46633578|NCT01730118|82806991|FG006|Dose Escalation|Withdrawal by Subject|0|||
46633579|NCT01730118|82806985|FG000|Dose Escalation|Disease progression prior to treatment|0|||
46633580|NCT01730118|82806986|FG001|Dose Escalation|Disease progression prior to treatment|0|||
46633581|NCT01730118|82806987|FG002|Dose Escalation|Disease progression prior to treatment|0|||
47044693|NCT01870999|83301093|FG001|Overall Study|Withdrawal by Subject|2|||
47044694|NCT01870999|83301094|FG002|Overall Study|Withdrawal by Subject|5|||
47044695|NCT01870999|83301092|FG000|Overall Study|Protocol Violation|0|||
47044696|NCT01870999|83301093|FG001|Overall Study|Protocol Violation|0|||
47044697|NCT01870999|83301094|FG002|Overall Study|Protocol Violation|1|||
46633582|NCT01730118|82806988|FG003|Dose Escalation|Disease progression prior to treatment|0|||
46633583|NCT01730118|82806989|FG004|Dose Escalation|Disease progression prior to treatment|0|||
46633584|NCT01730118|82806990|FG005|Dose Escalation|Disease progression prior to treatment|0|||
46920492|NCT02766608|83152824|FG001|Overall Study|Adverse Event|22|||
47044698|NCT01870921|83301102|FG000|Overall Study|Subject decision|80|||
46721492|NCT00879814|82937546|FG003|Overall Study|Physician Decision|0|||
46721493|NCT00879814|82937543|FG000|Overall Study|Other|0|||
46721494|NCT00879814|82937544|FG001|Overall Study|Other|0|||
46721495|NCT00879814|82937545|FG002|Overall Study|Other|1|||
46721496|NCT00879814|82937546|FG003|Overall Study|Other|0|||
46721497|NCT01132664|82937561|FG000|Phase lb|Adverse Event|0|||
46721498|NCT01132664|82937562|FG001|Phase lb|Adverse Event|1|||
46721499|NCT01132664|82937563|FG002|Phase lb|Adverse Event|0|||
46721500|NCT01132664|82937564|FG003|Phase lb|Adverse Event|0|||
46721501|NCT01132664|82937565|FG004|Phase lb|Adverse Event|0|||
46721502|NCT01132664|82937561|FG000|Phase lb|Withdrawal by Subject|1|||
46721503|NCT01132664|82937562|FG001|Phase lb|Withdrawal by Subject|2|||
46721504|NCT01132664|82937563|FG002|Phase lb|Withdrawal by Subject|0|||
46721505|NCT01132664|82937564|FG003|Phase lb|Withdrawal by Subject|0|||
46721506|NCT01132664|82937565|FG004|Phase lb|Withdrawal by Subject|0|||
46721507|NCT01132664|82937561|FG000|Phase lb|Disease Progression|4|||
46721508|NCT01132664|82937562|FG001|Phase lb|Disease Progression|9|||
46721509|NCT01132664|82937563|FG002|Phase lb|Disease Progression|0|||
46721510|NCT01132664|82937564|FG003|Phase lb|Disease Progression|0|||
46721511|NCT01132664|82937565|FG004|Phase lb|Disease Progression|0|||
46721512|NCT01132664|82937561|FG000|Phase ll|Death|0|||
46721513|NCT01132664|82937562|FG001|Phase ll|Death|0|||
46721514|NCT01132664|82937563|FG002|Phase ll|Death|2|||
46721515|NCT01132664|82937564|FG003|Phase ll|Death|0|||
46721516|NCT01132664|82937565|FG004|Phase ll|Death|0|||
46721517|NCT01132664|82937561|FG000|Phase ll|Adverse Event|0|||
46721518|NCT01132664|82937562|FG001|Phase ll|Adverse Event|0|||
46721519|NCT01132664|82937563|FG002|Phase ll|Adverse Event|10|||
46721520|NCT01132664|82937564|FG003|Phase ll|Adverse Event|0|||
46721521|NCT01132664|82937565|FG004|Phase ll|Adverse Event|0|||
46721522|NCT01132664|82937561|FG000|Phase ll|Withdrawal by Subject|0|||
46721523|NCT01132664|82937562|FG001|Phase ll|Withdrawal by Subject|0|||
46721524|NCT01132664|82937563|FG002|Phase ll|Withdrawal by Subject|3|||
46721525|NCT01132664|82937564|FG003|Phase ll|Withdrawal by Subject|0|||
47044699|NCT01870921|83301102|FG000|Overall Study|Severe non-compliance to protocol|7|||
46721526|NCT01132664|82937565|FG004|Phase ll|Withdrawal by Subject|0|||
46721527|NCT01132664|82937561|FG000|Phase ll|Disease progression|0|||
47044700|NCT01870921|83301102|FG000|Overall Study|Subject Lost to Follow up|2|||
46721528|NCT01132664|82937562|FG001|Phase ll|Disease progression|0|||
46721529|NCT01132664|82937563|FG002|Phase ll|Disease progression|35|||
46721530|NCT01132664|82937564|FG003|Phase ll|Disease progression|0|||
46721531|NCT01132664|82937565|FG004|Phase ll|Disease progression|0|||
46721532|NCT01132664|82937561|FG000|BM Cohort|Disease progression|0|||
46721533|NCT01132664|82937562|FG001|BM Cohort|Disease progression|0|||
46721534|NCT01132664|82937563|FG002|BM Cohort|Disease progression|0|||
46721535|NCT01132664|82937564|FG003|BM Cohort|Disease progression|3|||
46721536|NCT01132664|82937565|FG004|BM Cohort|Disease progression|4|||
46721537|NCT01132664|82937561|FG000|BM Cohort|Adverse Event|0|||
47044701|NCT01870921|83301102|FG000|Overall Study|Other|1|||
47044702|NCT01848145|83301115|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
47044703|NCT01848145|83301115|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
46633585|NCT01730118|82806991|FG006|Dose Escalation|Disease progression prior to treatment|1|||
46633586|NCT01730118|82806985|FG000|Dose Expansion|Death|0|||
46633587|NCT01730118|82806986|FG001|Dose Expansion|Death|0|||
46633588|NCT01730118|82806987|FG002|Dose Expansion|Death|0|||
46633589|NCT01730118|82806988|FG003|Dose Expansion|Death|0|||
46633590|NCT01730118|82806989|FG004|Dose Expansion|Death|1|||
46633591|NCT01730118|82806990|FG005|Dose Expansion|Death|0|||
46633592|NCT01730118|82806991|FG006|Dose Expansion|Death|0|||
46633593|NCT01730118|82806985|FG000|Dose Expansion|Other medical condition|0|||
46633594|NCT01730118|82806986|FG001|Dose Expansion|Other medical condition|0|||
46633595|NCT01730118|82806987|FG002|Dose Expansion|Other medical condition|0|||
46721538|NCT01132664|82937562|FG001|BM Cohort|Adverse Event|0|||
46721539|NCT01132664|82937563|FG002|BM Cohort|Adverse Event|0|||
46721540|NCT01132664|82937564|FG003|BM Cohort|Adverse Event|0|||
46721541|NCT01132664|82937565|FG004|BM Cohort|Adverse Event|1|||
46721542|NCT01132664|82937561|FG000|BM Cohort|Withdrawal by Subject|0|||
46721543|NCT01132664|82937562|FG001|BM Cohort|Withdrawal by Subject|0|||
46721544|NCT01132664|82937563|FG002|BM Cohort|Withdrawal by Subject|0|||
46721545|NCT01132664|82937564|FG003|BM Cohort|Withdrawal by Subject|0|||
46721546|NCT01132664|82937565|FG004|BM Cohort|Withdrawal by Subject|1|||
46721547|NCT00591409|82937587|FG000|Overall Study|Not Treated|0|||
46721548|NCT00591409|82937588|FG001|Overall Study|Not Treated|0|||
46721549|NCT00591409|82937589|FG002|Overall Study|Not Treated|0|||
47044704|NCT01848145|83301115|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
46633596|NCT01730118|82806988|FG003|Dose Expansion|Other medical condition|0|||
46633597|NCT01730118|82806989|FG004|Dose Expansion|Other medical condition|1|||
46633598|NCT01730118|82806990|FG005|Dose Expansion|Other medical condition|0|||
46721550|NCT00591409|82937590|FG003|Overall Study|Not Treated|0|||
46721551|NCT00591409|82937591|FG004|Overall Study|Not Treated|1|||
46721552|NCT00591409|82937592|FG005|Overall Study|Not Treated|0|||
46721553|NCT00591409|82937593|FG006|Overall Study|Not Treated|0|||
46721554|NCT00591409|82937594|FG007|Overall Study|Not Treated|0|||
46721555|NCT00591409|82937595|FG008|Overall Study|Not Treated|0|||
46721556|NCT00591409|82937596|FG009|Overall Study|Not Treated|1|||
46721557|NCT01078805|82937618|FG000|Overall Study|Clinically significant abnormal lab|5|||
46721558|NCT01078805|82937618|FG000|Overall Study|Death|134|||
46721559|NCT01078805|82937618|FG000|Overall Study|Lost to Follow-up|676|||
46721560|NCT01078805|82937618|FG000|Overall Study|Physician Decision|169|||
47044705|NCT01848145|83301115|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
47044706|NCT01848145|83301115|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
47044707|NCT01848145|83301115|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
47044708|NCT01848145|83301115|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
47044709|NCT01847755|83301119|FG000|Overall Study|Adverse Event|2|||
47044710|NCT01847755|83301119|FG000|Overall Study|Withdrawal by Subject|2|||
47044711|NCT01847755|83301119|FG000|Overall Study|Physician Decision|1|||
47044712|NCT01847443|83301150|FG000|Study Period 1|Withdrawal by Subject|0|||
47044713|NCT01847443|83301151|FG001|Study Period 1|Withdrawal by Subject|1|||
47044714|NCT01847443|83301152|FG002|Study Period 1|Withdrawal by Subject|0|||
47044715|NCT01847443|83301153|FG003|Study Period 1|Withdrawal by Subject|0|||
47044716|NCT01847443|83301150|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
47044717|NCT01847443|83301151|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
47044718|NCT01847443|83301152|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
47044719|NCT01847443|83301153|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
47044720|NCT01847443|83301150|FG000|Washout Period Before Study Period 2|Other reason|1|||
47044721|NCT01847443|83301151|FG001|Washout Period Before Study Period 2|Other reason|0|||
47044722|NCT01847443|83301152|FG002|Washout Period Before Study Period 2|Other reason|0|||
47044723|NCT01847443|83301153|FG003|Washout Period Before Study Period 2|Other reason|0|||
47044724|NCT01847443|83301150|FG000|Washout Period Before Study Period 3|Other reason|1|||
47044725|NCT01847443|83301151|FG001|Washout Period Before Study Period 3|Other reason|0|||
47044726|NCT01847443|83301152|FG002|Washout Period Before Study Period 3|Other reason|0|||
47044727|NCT01847443|83301153|FG003|Washout Period Before Study Period 3|Other reason|0|||
47044728|NCT01847443|83301150|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
47044729|NCT01847443|83301151|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
47044730|NCT01847443|83301152|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
47044731|NCT01847443|83301153|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
47044732|NCT01847443|83301150|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
46633599|NCT01730118|82806991|FG006|Dose Expansion|Other medical condition|0|||
46633600|NCT01730118|82806985|FG000|Dose Expansion|Withdrawal by Subject|0|||
46633601|NCT01730118|82806986|FG001|Dose Expansion|Withdrawal by Subject|0|||
46633602|NCT01730118|82806987|FG002|Dose Expansion|Withdrawal by Subject|0|||
46633603|NCT01730118|82806988|FG003|Dose Expansion|Withdrawal by Subject|0|||
46633604|NCT01730118|82806989|FG004|Dose Expansion|Withdrawal by Subject|1|||
46633605|NCT01730118|82806990|FG005|Dose Expansion|Withdrawal by Subject|0|||
46633606|NCT01730118|82806991|FG006|Dose Expansion|Withdrawal by Subject|0|||
46633607|NCT01730118|82806985|FG000|Dose Expansion|Disease progression|0|||
46633608|NCT01730118|82806986|FG001|Dose Expansion|Disease progression|0|||
46633609|NCT01730118|82806987|FG002|Dose Expansion|Disease progression|0|||
46633610|NCT01730118|82806988|FG003|Dose Expansion|Disease progression|0|||
46721561|NCT01078805|82937618|FG000|Overall Study|Serious adverse event|26|||
46721562|NCT01078805|82937618|FG000|Overall Study|Sponsor decision|46|||
47044733|NCT01847443|83301151|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
47044734|NCT01847443|83301152|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
47044735|NCT01847443|83301153|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
47044736|NCT01847209|83301172|FG000|Overall Study|Withdrawal by Subject|1|||
47044737|NCT01847209|83301172|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
47044738|NCT01846741|83301176|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
47044739|NCT01870843|83301215|FG000|Overall Study|Adverse Event|10|||
47044740|NCT01870843|83301215|FG000|Overall Study|Lost to Follow-up|24|||
46721563|NCT01078805|82937618|FG000|Overall Study|Withdrawal by Subject|739|||
47044741|NCT01870843|83301215|FG000|Overall Study|Death|1|||
47044742|NCT01870843|83301215|FG000|Overall Study|Withdrawal by Subject|18|||
47044743|NCT01816477|83301221|FG000|Overall Study|Withdrawal by Subject|13|||
47044744|NCT01816477|83301222|FG001|Overall Study|Withdrawal by Subject|1|||
47044745|NCT01816477|83301221|FG000|Overall Study|Unable to tolerate catheter placement|3|||
47044746|NCT01816477|83301222|FG001|Overall Study|Unable to tolerate catheter placement|0|||
47044747|NCT01846507|83301228|FG000|Overall Study|Lost to Follow-up|4|||
46721564|NCT01078805|82937618|FG000|Overall Study|Other|173|||
46721565|NCT01078805|82937618|FG000|Overall Study|Didn't take study drug|82|||
46721566|NCT00820027|82937626|FG000|Overall Study|Adverse Event|15|||
46721567|NCT00820027|82937627|FG001|Overall Study|Adverse Event|8|||
46721568|NCT00820027|82937628|FG002|Overall Study|Adverse Event|10|||
46721569|NCT00820027|82937629|FG003|Overall Study|Adverse Event|5|||
46721570|NCT00820027|82937626|FG000|Overall Study|Lack of Efficacy|2|||
46721571|NCT00820027|82937627|FG001|Overall Study|Lack of Efficacy|1|||
46721572|NCT00820027|82937628|FG002|Overall Study|Lack of Efficacy|2|||
46721573|NCT00820027|82937629|FG003|Overall Study|Lack of Efficacy|2|||
46721574|NCT00820027|82937626|FG000|Overall Study|Physician Decision|0|||
46721575|NCT00820027|82937627|FG001|Overall Study|Physician Decision|1|||
46721576|NCT00820027|82937628|FG002|Overall Study|Physician Decision|1|||
46721577|NCT00820027|82937629|FG003|Overall Study|Physician Decision|0|||
46721578|NCT00820027|82937626|FG000|Overall Study|Protocol Violation|3|||
46721579|NCT00820027|82937627|FG001|Overall Study|Protocol Violation|0|||
46721580|NCT00820027|82937628|FG002|Overall Study|Protocol Violation|4|||
46721581|NCT00820027|82937629|FG003|Overall Study|Protocol Violation|0|||
46721582|NCT00820027|82937626|FG000|Overall Study|Withdrawal by Subject|6|||
46721583|NCT00820027|82937627|FG001|Overall Study|Withdrawal by Subject|4|||
46721584|NCT00820027|82937628|FG002|Overall Study|Withdrawal by Subject|4|||
46721585|NCT00820027|82937629|FG003|Overall Study|Withdrawal by Subject|6|||
46721586|NCT01076153|82937640|FG000|Overall Study|Symptoms improved/resolved|10|||
46721587|NCT01076153|82937640|FG000|Overall Study|Adverse Event|1|||
46721588|NCT01076075|82937650|FG000|Overall Study|Adverse Event|3|||
46721589|NCT01076075|82937651|FG001|Overall Study|Adverse Event|9|||
46721590|NCT01076075|82937650|FG000|Overall Study|Lack of Efficacy|5|||
46721591|NCT01076075|82937651|FG001|Overall Study|Lack of Efficacy|4|||
46721592|NCT01076075|82937650|FG000|Overall Study|Lost to Follow-up|6|||
47044748|NCT01846507|83301228|FG000|Overall Study|Protocol Violation|1|||
47044749|NCT01846507|83301228|FG000|Overall Study|Missing data|2|||
47044750|NCT01846039|83301234|FG000|Overall Study|Protocol Violation|1|||
47044751|NCT01846039|83301234|FG000|Overall Study|Subject Withdrew Consent|1|||
47044752|NCT01610167|83301241|FG000|Overall Study|Scheduling conflict.|0|||
47044753|NCT01610167|83301242|FG001|Overall Study|Scheduling conflict.|0|||
47044754|NCT01610167|83301243|FG002|Overall Study|Scheduling conflict.|2|||
47044755|NCT01816243|83301251|FG000|Overall Study|Adverse Event|6|||
47044756|NCT01816243|83301251|FG000|Overall Study|Lost to Follow-up|1|||
47044757|NCT01816243|83301251|FG000|Overall Study|Lack of Efficacy|1|||
47044758|NCT01816243|83301251|FG000|Overall Study|Not eligible for the study|1|||
47044759|NCT01816243|83301251|FG000|Overall Study|Amputation|3|||
47044760|NCT01845805|83301257|FG000|Overall Study|Withdrawal by Subject|1|||
47044761|NCT01845805|83301258|FG001|Overall Study|Withdrawal by Subject|2|||
47044762|NCT01845805|83301257|FG000|Overall Study|Disease Progression|13|||
47044763|NCT01845805|83301258|FG001|Overall Study|Disease Progression|14|||
47044764|NCT01845805|83301257|FG000|Overall Study|Drug-related Toxicity|4|||
47044765|NCT01845805|83301258|FG001|Overall Study|Drug-related Toxicity|0|||
47044766|NCT01845025|83301266|FG000|Overall Study|Adverse Event|6|||
47044767|NCT01845025|83301267|FG001|Overall Study|Adverse Event|3|||
47044768|NCT01845025|83301266|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
47044769|NCT01845025|83301267|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46721593|NCT01076075|82937651|FG001|Overall Study|Lost to Follow-up|5|||
46721594|NCT01076075|82937650|FG000|Overall Study|other|19|||
46721595|NCT01076075|82937651|FG001|Overall Study|other|9|||
46721596|NCT01076075|82937650|FG000|Overall Study|Protocol Violation|0|||
47044770|NCT01845025|83301266|FG000|Overall Study|Withdrawal by Subject|48|||
47044771|NCT01845025|83301267|FG001|Overall Study|Withdrawal by Subject|44|||
47044772|NCT01845025|83301266|FG000|Overall Study|Lost to Follow-up|13|||
47044773|NCT01845025|83301267|FG001|Overall Study|Lost to Follow-up|13|||
46721597|NCT01076075|82937651|FG001|Overall Study|Protocol Violation|1|||
46721598|NCT01076075|82937650|FG000|Overall Study|Withdrawal by Subject|8|||
46920493|NCT02766608|83152825|FG002|Overall Study|Adverse Event|17|||
46721599|NCT01076075|82937651|FG001|Overall Study|Withdrawal by Subject|19|||
46721600|NCT01075763|82937662|FG000|Overall Study|Lost to Follow-up|2|||
46721601|NCT01075763|82937663|FG001|Overall Study|Lost to Follow-up|1|||
47044774|NCT01845025|83301266|FG000|Overall Study|Administrative problems|8|||
47044775|NCT01845025|83301267|FG001|Overall Study|Administrative problems|8|||
46721602|NCT01075763|82937662|FG000|Overall Study|Lack of Efficacy|0|||
46920494|NCT02766608|83152826|FG003|Overall Study|Adverse Event|13|||
47044776|NCT01845025|83301266|FG000|Overall Study|Death|2|||
46721603|NCT01075763|82937663|FG001|Overall Study|Lack of Efficacy|1|||
46721604|NCT01075763|82937662|FG000|Overall Study|Withdrawal by Subject|2|||
46721605|NCT01075763|82937663|FG001|Overall Study|Withdrawal by Subject|2|||
46721606|NCT00881530|82937675|FG000|Overall Study|Adverse Event|5|||
46721607|NCT00881530|82937676|FG001|Overall Study|Adverse Event|1|||
46721608|NCT00881530|82937677|FG002|Overall Study|Adverse Event|1|||
46721609|NCT00881530|82937678|FG003|Overall Study|Adverse Event|4|||
46721610|NCT00881530|82937679|FG004|Overall Study|Adverse Event|10|||
46721611|NCT00881530|82937680|FG005|Overall Study|Adverse Event|2|||
46721612|NCT00881530|82937675|FG000|Overall Study|Lack of Efficacy|1|||
46721613|NCT00881530|82937676|FG001|Overall Study|Lack of Efficacy|0|||
46721614|NCT00881530|82937677|FG002|Overall Study|Lack of Efficacy|0|||
46721615|NCT00881530|82937678|FG003|Overall Study|Lack of Efficacy|0|||
46721616|NCT00881530|82937679|FG004|Overall Study|Lack of Efficacy|1|||
46721617|NCT00881530|82937680|FG005|Overall Study|Lack of Efficacy|1|||
46721618|NCT00881530|82937675|FG000|Overall Study|Not compliant with the protocol|0|||
46721619|NCT00881530|82937676|FG001|Overall Study|Not compliant with the protocol|0|||
46721620|NCT00881530|82937677|FG002|Overall Study|Not compliant with the protocol|0|||
46721621|NCT00881530|82937678|FG003|Overall Study|Not compliant with the protocol|0|||
46721622|NCT00881530|82937679|FG004|Overall Study|Not compliant with the protocol|2|||
46721623|NCT00881530|82937680|FG005|Overall Study|Not compliant with the protocol|0|||
46633611|NCT01730118|82806989|FG004|Dose Expansion|Disease progression|0|||
46633612|NCT01730118|82806990|FG005|Dose Expansion|Disease progression|1|||
46633613|NCT01730118|82806991|FG006|Dose Expansion|Disease progression|0|||
46633614|NCT01730118|82806985|FG000|Dose Expansion|Inability to return|0|||
46633615|NCT01730118|82806986|FG001|Dose Expansion|Inability to return|0|||
46633616|NCT01730118|82806987|FG002|Dose Expansion|Inability to return|0|||
46633617|NCT01730118|82806988|FG003|Dose Expansion|Inability to return|0|||
46633618|NCT01730118|82806989|FG004|Dose Expansion|Inability to return|0|||
46633619|NCT01730118|82806990|FG005|Dose Expansion|Inability to return|1|||
46633620|NCT01730118|82806991|FG006|Dose Expansion|Inability to return|0|||
46633621|NCT01730118|82806985|FG000|Dose Expansion|Physician Decision|0|||
46633622|NCT01730118|82806986|FG001|Dose Expansion|Physician Decision|0|||
46633623|NCT01730118|82806987|FG002|Dose Expansion|Physician Decision|0|||
46633624|NCT01730118|82806988|FG003|Dose Expansion|Physician Decision|0|||
46633625|NCT01730118|82806989|FG004|Dose Expansion|Physician Decision|0|||
46633626|NCT01730118|82806990|FG005|Dose Expansion|Physician Decision|1|||
46633627|NCT01730118|82806991|FG006|Dose Expansion|Physician Decision|0|||
46633628|NCT01730040|82807015|FG000|Overall Study|Randomized but not treated|0|||
46633629|NCT01730040|82807016|FG001|Overall Study|Randomized but not treated|0|||
46633630|NCT01730040|82807017|FG002|Overall Study|Randomized but not treated|0|||
46633631|NCT01730040|82807018|FG003|Overall Study|Randomized but not treated|0|||
46633632|NCT01730040|82807019|FG004|Overall Study|Randomized but not treated|0|||
46633633|NCT01730040|82807020|FG005|Overall Study|Randomized but not treated|1|||
46633634|NCT01730040|82807021|FG006|Overall Study|Randomized but not treated|0|||
46633635|NCT01730040|82807015|FG000|Overall Study|Subject moved|0|||
46633636|NCT01730040|82807016|FG001|Overall Study|Subject moved|0|||
46633637|NCT01730040|82807017|FG002|Overall Study|Subject moved|1|||
46633638|NCT01730040|82807018|FG003|Overall Study|Subject moved|0|||
46633639|NCT01730040|82807019|FG004|Overall Study|Subject moved|0|||
46633640|NCT01730040|82807020|FG005|Overall Study|Subject moved|0|||
46633641|NCT01730040|82807021|FG006|Overall Study|Subject moved|1|||
46633642|NCT01730040|82807015|FG000|Overall Study|Physician Decision|0|||
46633643|NCT01730040|82807016|FG001|Overall Study|Physician Decision|0|||
46633644|NCT01730040|82807017|FG002|Overall Study|Physician Decision|0|||
46633645|NCT01730040|82807018|FG003|Overall Study|Physician Decision|0|||
46633646|NCT01730040|82807019|FG004|Overall Study|Physician Decision|0|||
46633647|NCT01730040|82807020|FG005|Overall Study|Physician Decision|1|||
46633648|NCT01730040|82807021|FG006|Overall Study|Physician Decision|1|||
46721624|NCT00881530|82937675|FG000|Overall Study|Lost to Follow-up|0|||
46721625|NCT00881530|82937676|FG001|Overall Study|Lost to Follow-up|1|||
46721626|NCT00881530|82937677|FG002|Overall Study|Lost to Follow-up|1|||
46721627|NCT00881530|82937678|FG003|Overall Study|Lost to Follow-up|3|||
46721628|NCT00881530|82937679|FG004|Overall Study|Lost to Follow-up|1|||
46721629|NCT00881530|82937680|FG005|Overall Study|Lost to Follow-up|0|||
46721630|NCT00881530|82937675|FG000|Overall Study|Refused to continue medication|7|||
46721631|NCT00881530|82937676|FG001|Overall Study|Refused to continue medication|2|||
46721632|NCT00881530|82937677|FG002|Overall Study|Refused to continue medication|1|||
46721633|NCT00881530|82937678|FG003|Overall Study|Refused to continue medication|2|||
46721634|NCT00881530|82937679|FG004|Overall Study|Refused to continue medication|0|||
46721635|NCT00881530|82937680|FG005|Overall Study|Refused to continue medication|0|||
46721636|NCT00881530|82937675|FG000|Overall Study|Other reason not defined above|1|||
46721637|NCT00881530|82937676|FG001|Overall Study|Other reason not defined above|1|||
46721638|NCT00881530|82937677|FG002|Overall Study|Other reason not defined above|2|||
46721639|NCT00881530|82937678|FG003|Overall Study|Other reason not defined above|0|||
46721640|NCT00881530|82937679|FG004|Overall Study|Other reason not defined above|0|||
46721641|NCT00881530|82937680|FG005|Overall Study|Other reason not defined above|2|||
46721642|NCT01075685|82937696|FG000|Overall Study|Protocol Violation|9|||
46721643|NCT01075685|82937697|FG001|Overall Study|Protocol Violation|1|||
46721644|NCT01075685|82937696|FG000|Overall Study|Withdrawal by Subject|20|||
46721645|NCT01075685|82937697|FG001|Overall Study|Withdrawal by Subject|5|||
46721646|NCT01075685|82937696|FG000|Overall Study|Lost to Follow-up|563|||
46721647|NCT01075685|82937697|FG001|Overall Study|Lost to Follow-up|220|||
46721648|NCT01075217|82937705|FG000|Overall Study|Adverse Event|1|||
46721649|NCT01075217|82937706|FG001|Overall Study|Adverse Event|1|||
46721650|NCT01075217|82937705|FG000|Overall Study|Physician Decision|1|||
46721651|NCT01075217|82937706|FG001|Overall Study|Physician Decision|0|||
46721652|NCT01078571|82937720|FG000|Overall Study|Adverse Event|36|||
46721653|NCT01078571|82937720|FG000|Overall Study|Lack of effectiveness|36|||
46721654|NCT01078571|82937720|FG000|Overall Study|Reason not reported|21|||
46721655|NCT01078571|82937720|FG000|Overall Study|Withdrawal by Subject|12|||
46721656|NCT01078571|82937720|FG000|Overall Study|Lost to Follow-up|8|||
46721657|NCT01078571|82937720|FG000|Overall Study|Protocol Violation|2|||
46721658|NCT00977106|82937731|FG000|Overall Study|Adverse Event|5|||
46721659|NCT00977106|82937732|FG001|Overall Study|Adverse Event|6|||
46721660|NCT00977106|82937731|FG000|Overall Study|Withdrawal by Subject|2|||
46633649|NCT01730040|82807015|FG000|Overall Study|Other than specified|7|||
46633650|NCT01730040|82807016|FG001|Overall Study|Other than specified|8|||
46633651|NCT01730040|82807017|FG002|Overall Study|Other than specified|5|||
46633652|NCT01730040|82807018|FG003|Overall Study|Other than specified|5|||
46633653|NCT01730040|82807019|FG004|Overall Study|Other than specified|5|||
46633654|NCT01730040|82807020|FG005|Overall Study|Other than specified|4|||
46633655|NCT01730040|82807021|FG006|Overall Study|Other than specified|4|||
46633656|NCT01730040|82807015|FG000|Overall Study|Adverse Event|4|||
46633657|NCT01730040|82807016|FG001|Overall Study|Adverse Event|3|||
46633658|NCT01730040|82807017|FG002|Overall Study|Adverse Event|5|||
46633659|NCT01730040|82807018|FG003|Overall Study|Adverse Event|3|||
46633660|NCT01730040|82807019|FG004|Overall Study|Adverse Event|1|||
46633661|NCT01730040|82807020|FG005|Overall Study|Adverse Event|1|||
46633662|NCT01730040|82807021|FG006|Overall Study|Adverse Event|2|||
46633663|NCT01730040|82807015|FG000|Overall Study|Poor compliance to protocol|2|||
46633664|NCT01730040|82807016|FG001|Overall Study|Poor compliance to protocol|4|||
46633665|NCT01730040|82807017|FG002|Overall Study|Poor compliance to protocol|0|||
46633666|NCT01730040|82807018|FG003|Overall Study|Poor compliance to protocol|0|||
46633667|NCT01730040|82807019|FG004|Overall Study|Poor compliance to protocol|0|||
46633668|NCT01730040|82807020|FG005|Overall Study|Poor compliance to protocol|0|||
46633669|NCT01730040|82807021|FG006|Overall Study|Poor compliance to protocol|1|||
46633670|NCT01706328|82807039|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
46633671|NCT01706328|82807040|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46633672|NCT01706328|82807041|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46633673|NCT01706328|82807039|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
46633674|NCT01706328|82807040|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
46721661|NCT00977106|82937732|FG001|Overall Study|Withdrawal by Subject|2|||
46721662|NCT00977106|82937731|FG000|Overall Study|Lack of Efficacy|2|||
46721663|NCT00977106|82937732|FG001|Overall Study|Lack of Efficacy|2|||
46633675|NCT01706328|82807041|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
46633676|NCT01706328|82807039|FG000|2-week Run-in Period|Physician Decision|4|||
46721664|NCT00977106|82937731|FG000|Overall Study|Protocol Violation|0|||
46633677|NCT01706328|82807040|FG001|2-week Run-in Period|Physician Decision|0|||
46633678|NCT01706328|82807041|FG002|2-week Run-in Period|Physician Decision|0|||
46721665|NCT00977106|82937732|FG001|Overall Study|Protocol Violation|1|||
46721666|NCT00977106|82937731|FG000|Overall Study|Other|1|||
46721667|NCT00977106|82937732|FG001|Overall Study|Other|0|||
46721668|NCT01077713|82937742|FG000|Overall Study|Withdrawal by Subject|1|||
46721669|NCT01077713|82937743|FG001|Overall Study|Withdrawal by Subject|2|||
46721670|NCT01077713|82937742|FG000|Overall Study|Progressive Disease (PD)|0|||
46721671|NCT01077713|82937743|FG001|Overall Study|Progressive Disease (PD)|1|||
46721672|NCT01077713|82937742|FG000|Overall Study|Death|28|||
46721673|NCT01077713|82937743|FG001|Overall Study|Death|29|||
46721674|NCT01077713|82937742|FG000|Overall Study|Lost to Follow-up|1|||
46721675|NCT01077713|82937743|FG001|Overall Study|Lost to Follow-up|1|||
46721676|NCT01077713|82937742|FG000|Overall Study|Adverse Event|2|||
46721677|NCT01077713|82937743|FG001|Overall Study|Adverse Event|1|||
46721678|NCT01077713|82937742|FG000|Overall Study|Other|4|||
46721679|NCT01077713|82937743|FG001|Overall Study|Other|2|||
46721680|NCT00813709|82937752|FG000|Double Blind Period|Adverse Event|4|||
46721681|NCT00813709|82937753|FG001|Double Blind Period|Adverse Event|1|||
46721682|NCT00813709|82937754|FG002|Double Blind Period|Adverse Event|4|||
46721683|NCT00813709|82937755|FG003|Double Blind Period|Adverse Event|0|||
46721684|NCT00813709|82937756|FG004|Double Blind Period|Adverse Event|0|||
46721685|NCT00813709|82937757|FG005|Double Blind Period|Adverse Event|0|||
46721686|NCT00813709|82937752|FG000|Double Blind Period|Lost to Follow-up|3|||
46721687|NCT00813709|82937753|FG001|Double Blind Period|Lost to Follow-up|2|||
46721688|NCT00813709|82937754|FG002|Double Blind Period|Lost to Follow-up|2|||
46721689|NCT00813709|82937755|FG003|Double Blind Period|Lost to Follow-up|0|||
46721690|NCT00813709|82937756|FG004|Double Blind Period|Lost to Follow-up|0|||
46721691|NCT00813709|82937757|FG005|Double Blind Period|Lost to Follow-up|0|||
46721692|NCT00813709|82937752|FG000|Double Blind Period|Switched to open label phase|9|||
46721693|NCT00813709|82937753|FG001|Double Blind Period|Switched to open label phase|26|||
46721694|NCT00813709|82937754|FG002|Double Blind Period|Switched to open label phase|18|||
46721695|NCT00813709|82937755|FG003|Double Blind Period|Switched to open label phase|0|||
46721696|NCT00813709|82937756|FG004|Double Blind Period|Switched to open label phase|0|||
46721697|NCT00813709|82937757|FG005|Double Blind Period|Switched to open label phase|0|||
46721698|NCT00813709|82937752|FG000|Double Blind Period|Randomized but not treated|1|||
46721699|NCT00813709|82937753|FG001|Double Blind Period|Randomized but not treated|3|||
46721700|NCT00813709|82937754|FG002|Double Blind Period|Randomized but not treated|1|||
46721701|NCT00813709|82937755|FG003|Double Blind Period|Randomized but not treated|0|||
46721702|NCT00813709|82937756|FG004|Double Blind Period|Randomized but not treated|0|||
46721703|NCT00813709|82937757|FG005|Double Blind Period|Randomized but not treated|0|||
46721704|NCT00813709|82937752|FG000|Double Blind Period|Other|14|||
46721705|NCT00813709|82937753|FG001|Double Blind Period|Other|9|||
46721706|NCT00813709|82937754|FG002|Double Blind Period|Other|6|||
46721707|NCT00813709|82937755|FG003|Double Blind Period|Other|0|||
46721708|NCT00813709|82937756|FG004|Double Blind Period|Other|0|||
46721709|NCT00813709|82937757|FG005|Double Blind Period|Other|0|||
46721710|NCT00813709|82937752|FG000|Open Label Period|Adverse Event|0|||
46721711|NCT00813709|82937753|FG001|Open Label Period|Adverse Event|0|||
46721712|NCT00813709|82937754|FG002|Open Label Period|Adverse Event|0|||
46721713|NCT00813709|82937755|FG003|Open Label Period|Adverse Event|5|||
46721714|NCT00813709|82937756|FG004|Open Label Period|Adverse Event|4|||
46721715|NCT00813709|82937757|FG005|Open Label Period|Adverse Event|3|||
46721716|NCT00813709|82937752|FG000|Open Label Period|Lack of Efficacy|0|||
46721717|NCT00813709|82937753|FG001|Open Label Period|Lack of Efficacy|0|||
46721718|NCT00813709|82937754|FG002|Open Label Period|Lack of Efficacy|0|||
46721719|NCT00813709|82937755|FG003|Open Label Period|Lack of Efficacy|3|||
46721720|NCT00813709|82937756|FG004|Open Label Period|Lack of Efficacy|1|||
46721721|NCT00813709|82937757|FG005|Open Label Period|Lack of Efficacy|1|||
46721722|NCT00813709|82937752|FG000|Open Label Period|Randomized but not treated|0|||
46721723|NCT00813709|82937753|FG001|Open Label Period|Randomized but not treated|0|||
46721724|NCT00813709|82937754|FG002|Open Label Period|Randomized but not treated|0|||
46721725|NCT00813709|82937755|FG003|Open Label Period|Randomized but not treated|1|||
46721726|NCT00813709|82937756|FG004|Open Label Period|Randomized but not treated|0|||
46721727|NCT00813709|82937757|FG005|Open Label Period|Randomized but not treated|1|||
46721728|NCT00813709|82937752|FG000|Open Label Period|Other|0|||
46721729|NCT00813709|82937753|FG001|Open Label Period|Other|0|||
46721730|NCT00813709|82937754|FG002|Open Label Period|Other|0|||
46920495|NCT02766608|83152827|FG004|Overall Study|Adverse Event|12|||
46920496|NCT02766608|83152823|FG000|Overall Study|Withdrawal by Subject|21|||
46721731|NCT00813709|82937755|FG003|Open Label Period|Other|11|||
46721732|NCT00813709|82937756|FG004|Open Label Period|Other|5|||
46721733|NCT00813709|82937757|FG005|Open Label Period|Other|6|||
46721734|NCT01077323|82937789|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
46721735|NCT01077323|82937790|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
46721736|NCT01077323|82937791|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
46721737|NCT01077323|82937789|FG000|Overall Study|Dispensing of drug in baseline period|0|||
46721738|NCT01077323|82937790|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
46721739|NCT01077323|82937791|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
46721740|NCT01077323|82937789|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
46920497|NCT02766608|83152824|FG001|Overall Study|Withdrawal by Subject|20|||
46721741|NCT01077323|82937790|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
46721742|NCT01077323|82937791|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
46721743|NCT00976950|82937799|FG000|Overall Study|Adverse Event|3|||
46721744|NCT00976950|82937799|FG000|Overall Study|Events with no relationship to Aptivus|3|||
46721745|NCT05570500|82937820|FG000|Overall Study|Lost to Follow-up|7|||
46721746|NCT05570500|82937821|FG001|Overall Study|Lost to Follow-up|5|||
46721747|NCT05466682|82937829|FG000|Overall Study|Withdrawal by Subject|0|||
46721748|NCT05466682|82937830|FG001|Overall Study|Withdrawal by Subject|2|||
46721749|NCT05466682|82937829|FG000|Overall Study|Lost to Follow-up|2|||
46721750|NCT05466682|82937830|FG001|Overall Study|Lost to Follow-up|1|||
46721751|NCT05099640|82937843|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
46721752|NCT05099640|82937844|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
46721753|NCT05099640|82937845|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
46721754|NCT05099640|82937843|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
46721755|NCT05099640|82937844|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
46721756|NCT05099640|82937845|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
46721757|NCT05099640|82937843|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
46721758|NCT05099640|82937844|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
46721759|NCT05099640|82937845|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
46721760|NCT05099640|82937843|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
46721761|NCT05099640|82937844|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
46721762|NCT05099640|82937845|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
46721763|NCT05099640|82937843|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
46721764|NCT05099640|82937844|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
46721765|NCT05099640|82937845|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
46721766|NCT05099640|82937843|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
46721767|NCT05099640|82937844|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
46721768|NCT05099640|82937845|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
46721769|NCT05020665|82937857|FG000|Overall Study|Study terminated by Sponsor|5|||
46721770|NCT05020665|82937858|FG001|Overall Study|Study terminated by Sponsor|4|||
46721771|NCT05020665|82937857|FG000|Overall Study|Death|2|||
46721772|NCT05020665|82937858|FG001|Overall Study|Death|1|||
46721773|NCT05020665|82937857|FG000|Overall Study|Physician Decision|0|||
46721774|NCT05020665|82937858|FG001|Overall Study|Physician Decision|1|||
46721775|NCT05020665|82937857|FG000|Overall Study|Withdrawal by Subject|0|||
46721776|NCT05020665|82937858|FG001|Overall Study|Withdrawal by Subject|1|||
46721777|NCT05020665|82937857|FG000|Overall Study|Reason not specified|1|||
46721778|NCT05020665|82937858|FG001|Overall Study|Reason not specified|0|||
46721779|NCT04869787|82937867|FG000|Screening|Physician Decision|1|||
46721780|NCT04869787|82937867|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
46721781|NCT04854057|82937873|FG000|Overall Study|Adverse Event|0|||
46721782|NCT04854057|82937874|FG001|Overall Study|Adverse Event|1|||
46721783|NCT04639258|82937903|FG000|Overall Study|Screen failure|5|||
46721784|NCT04639258|82937903|FG000|Overall Study|Physician Decision|2|||
46721785|NCT04639258|82937903|FG000|Overall Study|Early study termination|3|||
47044777|NCT01845025|83301267|FG001|Overall Study|Death|0|||
47044778|NCT01845025|83301266|FG000|Overall Study|Protocol deviation|3|||
47044779|NCT01845025|83301267|FG001|Overall Study|Protocol deviation|6|||
47044780|NCT01845025|83301266|FG000|Overall Study|Missing|1|||
47044781|NCT01845025|83301267|FG001|Overall Study|Missing|1|||
47044782|NCT01870297|83301308|FG000|Overall Study|Adverse Event|0|||
47044783|NCT01870297|83301309|FG001|Overall Study|Adverse Event|0|||
47044784|NCT01870297|83301310|FG002|Overall Study|Adverse Event|0|||
47044785|NCT01870297|83301311|FG003|Overall Study|Adverse Event|0|||
47044786|NCT01870297|83301312|FG004|Overall Study|Adverse Event|2|||
47044787|NCT01870297|83301313|FG005|Overall Study|Adverse Event|0|||
47044788|NCT01870297|83301314|FG006|Overall Study|Adverse Event|0|||
47044789|NCT01870297|83301308|FG000|Overall Study|Lost to Follow-up|0|||
47044790|NCT01870297|83301309|FG001|Overall Study|Lost to Follow-up|1|||
47044791|NCT01870297|83301310|FG002|Overall Study|Lost to Follow-up|1|||
47044792|NCT01870297|83301311|FG003|Overall Study|Lost to Follow-up|0|||
47044793|NCT01870297|83301312|FG004|Overall Study|Lost to Follow-up|0|||
46721786|NCT04639258|82937903|FG000|Overall Study|Withdrawal by Subject|1|||
46721787|NCT04568122|82937925|FG000|Overall Study|Lost to Follow-up|48|||
46721788|NCT04568122|82937926|FG001|Overall Study|Lost to Follow-up|44|||
46721789|NCT04568122|82937927|FG002|Overall Study|Lost to Follow-up|4|||
47044794|NCT01870297|83301313|FG005|Overall Study|Lost to Follow-up|0|||
47044795|NCT01870297|83301314|FG006|Overall Study|Lost to Follow-up|0|||
46721790|NCT04568122|82937928|FG003|Overall Study|Lost to Follow-up|0|||
46721791|NCT04568122|82937929|FG004|Overall Study|Lost to Follow-up|0|||
47044796|NCT01870297|83301308|FG000|Overall Study|Withdrawal by Subject|0|||
47044797|NCT01870297|83301309|FG001|Overall Study|Withdrawal by Subject|0|||
47044798|NCT01870297|83301310|FG002|Overall Study|Withdrawal by Subject|0|||
46721792|NCT04533815|82937945|FG000|Overall Study|Adverse Event|2|||
46721793|NCT04533815|82937945|FG000|Overall Study|Site withdrew|5|||
47044799|NCT01870297|83301311|FG003|Overall Study|Withdrawal by Subject|0|||
46721794|NCT04447755|82937956|FG000|Overall Study|Death|8|||
46721795|NCT04447755|82937957|FG001|Overall Study|Death|14|||
46721796|NCT04447755|82937958|FG002|Overall Study|Death|8|||
46721797|NCT04447755|82937959|FG003|Overall Study|Death|9|||
46721798|NCT04447755|82937960|FG004|Overall Study|Death|7|||
46721799|NCT04447755|82937961|FG005|Overall Study|Death|7|||
46721800|NCT04447755|82937962|FG006|Overall Study|Death|40|||
46721801|NCT04447755|82937956|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46721802|NCT04447755|82937957|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
46721803|NCT04447755|82937958|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
46721804|NCT04447755|82937959|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
46721805|NCT04447755|82937960|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
46721806|NCT04447755|82937961|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
46721807|NCT04447755|82937962|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
46721808|NCT04447755|82937956|FG000|Overall Study|Ongoing in Study|1|||
46721809|NCT04447755|82937957|FG001|Overall Study|Ongoing in Study|2|||
46721810|NCT04447755|82937958|FG002|Overall Study|Ongoing in Study|0|||
46721811|NCT04447755|82937959|FG003|Overall Study|Ongoing in Study|0|||
46721812|NCT04447755|82937960|FG004|Overall Study|Ongoing in Study|2|||
46721813|NCT04447755|82937961|FG005|Overall Study|Ongoing in Study|2|||
46721814|NCT04447755|82937962|FG006|Overall Study|Ongoing in Study|26|||
46721815|NCT04060680|82937997|FG000|Overall Study|Unsuccessful implant|17|||
46721816|NCT04060680|82937997|FG000|Overall Study|Adverse Event|3|||
46721817|NCT04060680|82937997|FG000|Overall Study|Death|2|||
46721818|NCT04060680|82937997|FG000|Overall Study|Study product no longer in use|1|||
46721819|NCT04060680|82937997|FG000|Overall Study|Withdrawal by Subject|1|||
46721820|NCT03981614|82938005|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
46721821|NCT03981614|82938006|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
46721822|NCT03981614|82938007|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
46721823|NCT03965689|82938018|FG000|Overall Study|Too sick to get study intervention|2|||
46721824|NCT03918629|82938037|FG000|Overall Study|Adverse Event|19|||
46721825|NCT03918629|82938038|FG001|Overall Study|Adverse Event|20|||
46721826|NCT03918629|82938037|FG000|Overall Study|Death|14|||
46721827|NCT03918629|82938038|FG001|Overall Study|Death|7|||
46721828|NCT03918629|82938037|FG000|Overall Study|Lost to Follow-up|36|||
46721829|NCT03918629|82938038|FG001|Overall Study|Lost to Follow-up|28|||
46721830|NCT03918629|82938037|FG000|Overall Study|Physician Decision|1|||
46721831|NCT03918629|82938038|FG001|Overall Study|Physician Decision|0|||
46721832|NCT03918629|82938037|FG000|Overall Study|Protocol Violation|7|||
46721833|NCT03918629|82938038|FG001|Overall Study|Protocol Violation|4|||
46721834|NCT03918629|82938037|FG000|Overall Study|Withdrawal by Subject|47|||
46721835|NCT03918629|82938038|FG001|Overall Study|Withdrawal by Subject|47|||
46721836|NCT03918629|82938037|FG000|Overall Study|Other|7|||
46721837|NCT03918629|82938038|FG001|Overall Study|Other|11|||
46920498|NCT02766608|83152825|FG002|Overall Study|Withdrawal by Subject|24|||
47044800|NCT01870297|83301312|FG004|Overall Study|Withdrawal by Subject|1|||
47044801|NCT01870297|83301313|FG005|Overall Study|Withdrawal by Subject|1|||
47044802|NCT01870297|83301314|FG006|Overall Study|Withdrawal by Subject|1|||
47044803|NCT01870297|83301308|FG000|Overall Study|Sponsor Decision|0|||
47044804|NCT01870297|83301309|FG001|Overall Study|Sponsor Decision|6|||
47044805|NCT01870297|83301310|FG002|Overall Study|Sponsor Decision|0|||
47044806|NCT01870297|83301311|FG003|Overall Study|Sponsor Decision|0|||
47044807|NCT01870297|83301312|FG004|Overall Study|Sponsor Decision|0|||
47044808|NCT01870297|83301313|FG005|Overall Study|Sponsor Decision|0|||
47044809|NCT01870297|83301314|FG006|Overall Study|Sponsor Decision|1|||
47044810|NCT01814761|83301341|FG000|Overall Study|Other Reasons|1|||
47044811|NCT01814761|83301342|FG001|Overall Study|Other Reasons|10|||
47044812|NCT01814761|83301341|FG000|Overall Study|Ocular Adverse Event|6|||
47044813|NCT01814761|83301342|FG001|Overall Study|Ocular Adverse Event|15|||
47044814|NCT01814761|83301341|FG000|Overall Study|Lost to Follow-up|1|||
47044815|NCT01814761|83301342|FG001|Overall Study|Lost to Follow-up|5|||
47044816|NCT01843933|83301350|FG000|Overall Study|Data lost|6|||
47044817|NCT01843933|83301351|FG001|Overall Study|Data lost|4|||
47044818|NCT01814371|83301359|FG000|Overall Study|Lost to Follow-up|30|||
47044819|NCT01814371|83301360|FG001|Overall Study|Lost to Follow-up|27|||
47044820|NCT01814137|83301434|FG000|Overall Study|Adverse Event|0|||
46721838|NCT03918629|82938037|FG000|Overall Study|Randomized but not vaccinated|2|||
46721839|NCT03918629|82938038|FG001|Overall Study|Randomized but not vaccinated|1|||
46721840|NCT03713593|82938050|FG000|Overall Study|Participants Ongoing|140|||
46721841|NCT03713593|82938051|FG001|Overall Study|Participants Ongoing|114|||
46721842|NCT03713593|82938050|FG000|Overall Study|Withdrawal by Subject|3|||
47044821|NCT01814137|83301435|FG001|Overall Study|Adverse Event|1|||
47044822|NCT01814137|83301434|FG000|Overall Study|Withdrawal by Subject|2|||
47044823|NCT01814137|83301435|FG001|Overall Study|Withdrawal by Subject|2|||
47044824|NCT01814137|83301434|FG000|Overall Study|Physician Decision|1|||
46721843|NCT03713593|82938051|FG001|Overall Study|Withdrawal by Subject|6|||
46721844|NCT03713593|82938050|FG000|Overall Study|Death|252|||
46721845|NCT03713593|82938051|FG001|Overall Study|Death|279|||
46721846|NCT03585270|82938059|FG000|Overall Study|Withdrawal by Subject|2|||
46721847|NCT03585270|82938060|FG001|Overall Study|Withdrawal by Subject|6|||
46721848|NCT03585270|82938059|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
46721849|NCT03585270|82938060|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
46721850|NCT03585270|82938059|FG000|Overall Study|Adverse Event|5|||
46721851|NCT03585270|82938060|FG001|Overall Study|Adverse Event|2|||
46721852|NCT03585270|82938059|FG000|Overall Study|Lost to Follow-up|1|||
46721853|NCT03585270|82938060|FG001|Overall Study|Lost to Follow-up|4|||
46721854|NCT03585270|82938059|FG000|Overall Study|Death|5|||
46721855|NCT03585270|82938060|FG001|Overall Study|Death|3|||
46721856|NCT03585270|82938059|FG000|Overall Study|Other reasons|2|||
46721857|NCT03585270|82938060|FG001|Overall Study|Other reasons|2|||
46721858|NCT03138499|82938070|FG000|Overall Study|Lost to Follow-up|1|||
46721859|NCT03138499|82938071|FG001|Overall Study|Lost to Follow-up|0|||
46721860|NCT03138499|82938070|FG000|Overall Study|Participants withdrew consent|1|||
46721861|NCT03138499|82938071|FG001|Overall Study|Participants withdrew consent|0|||
46721862|NCT03138499|82938070|FG000|Overall Study|Participant discontinued study before treatment|0|||
46721863|NCT03138499|82938071|FG001|Overall Study|Participant discontinued study before treatment|1|||
46721864|NCT03138499|82938070|FG000|Overall Study|Disease Progression|2|||
46721865|NCT03138499|82938071|FG001|Overall Study|Disease Progression|6|||
46721866|NCT03138499|82938070|FG000|Overall Study|Study drug toxicity|2|||
46721867|NCT03138499|82938071|FG001|Overall Study|Study drug toxicity|2|||
46721868|NCT03138499|82938070|FG000|Overall Study|Participant request to discontinue study treatment|1|||
46721869|NCT03138499|82938071|FG001|Overall Study|Participant request to discontinue study treatment|1|||
46721870|NCT03138499|82938070|FG000|Overall Study|Other reasons|2|||
46721871|NCT03138499|82938071|FG001|Overall Study|Other reasons|0|||
46721872|NCT03136185|82938087|FG000|Overall Study|Adverse Event|0|||
47044825|NCT01814137|83301435|FG001|Overall Study|Physician Decision|1|||
47044826|NCT01814137|83301434|FG000|Overall Study|Unclassified|2|||
46721873|NCT03136185|82938088|FG001|Overall Study|Adverse Event|1|||
46721874|NCT03136185|82938089|FG002|Overall Study|Adverse Event|3|||
46721875|NCT03136185|82938090|FG003|Overall Study|Adverse Event|1|||
47044827|NCT01814137|83301435|FG001|Overall Study|Unclassified|1|||
47044828|NCT01813435|83301452|FG000|Overall Study|did not finish experimental regimen|1902|||
47044829|NCT01813435|83301453|FG001|Overall Study|did not finish experimental regimen|770|||
47044830|NCT01813435|83301452|FG000|Overall Study|Lost to Follow-up|268|||
47044831|NCT01813435|83301453|FG001|Overall Study|Lost to Follow-up|237|||
47044832|NCT01813357|83301461|FG000|Overall Study|Lost to Follow-up|5|||
47044833|NCT01813357|83301462|FG001|Overall Study|Lost to Follow-up|6|||
47044834|NCT01812655|83301471|FG000|Overall Study|Protocol Violation|1|||
47044835|NCT01812655|83301472|FG001|Overall Study|Protocol Violation|1|||
47044836|NCT01812655|83301473|FG002|Overall Study|Protocol Violation|0|||
47044837|NCT01812109|83301494|FG000|Overall Study|research personnel delay|16|||
47044838|NCT01812109|83301494|FG000|Overall Study|NIRS Unattainable|17|||
47044839|NCT01811953|83301504|FG000|Overall Study|Adverse Event|0|||
47044840|NCT01811953|83301505|FG001|Overall Study|Adverse Event|0|||
47044841|NCT01811953|83301506|FG002|Overall Study|Adverse Event|0|||
47044842|NCT01811953|83301507|FG003|Overall Study|Adverse Event|1|||
47044843|NCT01811953|83301508|FG004|Overall Study|Adverse Event|0|||
47044844|NCT01811953|83301509|FG005|Overall Study|Adverse Event|1|||
46633679|NCT01706328|82807039|FG000|2-week Run-in Period|Adverse Event|4|||
46633680|NCT01706328|82807040|FG001|2-week Run-in Period|Adverse Event|0|||
46633681|NCT01706328|82807041|FG002|2-week Run-in Period|Adverse Event|0|||
46633682|NCT01706328|82807039|FG000|2-week Run-in Period|Lost to Follow-up|2|||
46633683|NCT01706328|82807040|FG001|2-week Run-in Period|Lost to Follow-up|0|||
46633684|NCT01706328|82807041|FG002|2-week Run-in Period|Lost to Follow-up|0|||
46633685|NCT01706328|82807039|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
46633686|NCT01706328|82807040|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
46633687|NCT01706328|82807041|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
46633688|NCT01706328|82807039|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
46633689|NCT01706328|82807040|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
46633690|NCT01706328|82807041|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
46633691|NCT01706328|82807039|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
47044845|NCT01811953|83301504|FG000|Overall Study|Protocol Violation|0|||
47044846|NCT01811953|83301505|FG001|Overall Study|Protocol Violation|0|||
47044847|NCT01811953|83301506|FG002|Overall Study|Protocol Violation|0|||
46633692|NCT01706328|82807040|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
46721876|NCT03136185|82938091|FG004|Overall Study|Adverse Event|2|||
46721877|NCT03136185|82938092|FG005|Overall Study|Adverse Event|2|||
46721878|NCT03136185|82938093|FG006|Overall Study|Adverse Event|5|||
46721879|NCT03136185|82938094|FG007|Overall Study|Adverse Event|1|||
46721880|NCT03136185|82938095|FG008|Overall Study|Adverse Event|1|||
46721881|NCT03136185|82938087|FG000|Overall Study|Death|0|||
46721882|NCT03136185|82938088|FG001|Overall Study|Death|0|||
46721883|NCT03136185|82938089|FG002|Overall Study|Death|0|||
46721884|NCT03136185|82938090|FG003|Overall Study|Death|1|||
46721885|NCT03136185|82938091|FG004|Overall Study|Death|1|||
46721886|NCT03136185|82938092|FG005|Overall Study|Death|0|||
46721887|NCT03136185|82938093|FG006|Overall Study|Death|1|||
46721888|NCT03136185|82938094|FG007|Overall Study|Death|0|||
46721889|NCT03136185|82938095|FG008|Overall Study|Death|0|||
46721890|NCT03136185|82938087|FG000|Overall Study|Physician Decision|3|||
46721891|NCT03136185|82938088|FG001|Overall Study|Physician Decision|1|||
46721892|NCT03136185|82938089|FG002|Overall Study|Physician Decision|1|||
46721893|NCT03136185|82938090|FG003|Overall Study|Physician Decision|2|||
46721894|NCT03136185|82938091|FG004|Overall Study|Physician Decision|1|||
46721895|NCT03136185|82938092|FG005|Overall Study|Physician Decision|2|||
46721896|NCT03136185|82938093|FG006|Overall Study|Physician Decision|1|||
46721897|NCT03136185|82938094|FG007|Overall Study|Physician Decision|0|||
46721898|NCT03136185|82938095|FG008|Overall Study|Physician Decision|1|||
46721899|NCT03136185|82938087|FG000|Overall Study|Protocol Defined Disease Progression|0|||
46721900|NCT03136185|82938088|FG001|Overall Study|Protocol Defined Disease Progression|0|||
46721901|NCT03136185|82938089|FG002|Overall Study|Protocol Defined Disease Progression|1|||
46721902|NCT03136185|82938090|FG003|Overall Study|Protocol Defined Disease Progression|0|||
46721903|NCT03136185|82938091|FG004|Overall Study|Protocol Defined Disease Progression|0|||
46721904|NCT03136185|82938092|FG005|Overall Study|Protocol Defined Disease Progression|1|||
46721905|NCT03136185|82938093|FG006|Overall Study|Protocol Defined Disease Progression|0|||
46721906|NCT03136185|82938094|FG007|Overall Study|Protocol Defined Disease Progression|1|||
46721907|NCT03136185|82938095|FG008|Overall Study|Protocol Defined Disease Progression|1|||
46721908|NCT03136185|82938087|FG000|Overall Study|Withdrawal by Subject|1|||
46721909|NCT03136185|82938088|FG001|Overall Study|Withdrawal by Subject|0|||
46721910|NCT03136185|82938089|FG002|Overall Study|Withdrawal by Subject|1|||
46721911|NCT03136185|82938090|FG003|Overall Study|Withdrawal by Subject|1|||
46721912|NCT03136185|82938091|FG004|Overall Study|Withdrawal by Subject|1|||
46721913|NCT03136185|82938092|FG005|Overall Study|Withdrawal by Subject|1|||
46721914|NCT03136185|82938093|FG006|Overall Study|Withdrawal by Subject|2|||
46721915|NCT03136185|82938094|FG007|Overall Study|Withdrawal by Subject|3|||
46721916|NCT03136185|82938095|FG008|Overall Study|Withdrawal by Subject|3|||
46721917|NCT03136185|82938087|FG000|Overall Study|Not Reported|4|||
46721918|NCT03136185|82938088|FG001|Overall Study|Not Reported|1|||
46721919|NCT03136185|82938089|FG002|Overall Study|Not Reported|0|||
46721920|NCT03136185|82938090|FG003|Overall Study|Not Reported|1|||
46721921|NCT03136185|82938091|FG004|Overall Study|Not Reported|0|||
46721922|NCT03136185|82938092|FG005|Overall Study|Not Reported|2|||
46721923|NCT03136185|82938093|FG006|Overall Study|Not Reported|1|||
46721924|NCT03136185|82938094|FG007|Overall Study|Not Reported|1|||
46721925|NCT03136185|82938095|FG008|Overall Study|Not Reported|0|||
46721926|NCT02985957|82938138|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46721927|NCT02985957|82938139|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46721928|NCT02985957|82938140|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46721929|NCT02985957|82938141|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46721930|NCT02985957|82938142|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
46721931|NCT02985957|82938143|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46721932|NCT02985957|82938144|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46721933|NCT02985957|82938138|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
46721934|NCT02985957|82938139|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
46721935|NCT02985957|82938140|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
47044848|NCT01811953|83301507|FG003|Overall Study|Protocol Violation|0|||
47044849|NCT01811953|83301508|FG004|Overall Study|Protocol Violation|1|||
46920499|NCT02766608|83152826|FG003|Overall Study|Withdrawal by Subject|13|||
47044850|NCT01811953|83301509|FG005|Overall Study|Protocol Violation|0|||
47044851|NCT01811563|83301525|FG000|Overall Study|Lost to Follow-up|5|||
47044852|NCT01811563|83301526|FG001|Overall Study|Lost to Follow-up|2|||
47044853|NCT01811563|83301525|FG000|Overall Study|Incorrect Randomization procedure|0|||
47044854|NCT01811563|83301526|FG001|Overall Study|Incorrect Randomization procedure|1|||
47044855|NCT01811485|83301535|FG000|Overall Study|Adverse Event|1|||
47044856|NCT01811485|83301536|FG001|Overall Study|Adverse Event|3|||
46920500|NCT02766608|83152827|FG004|Overall Study|Withdrawal by Subject|10|||
46721936|NCT02985957|82938141|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
46721937|NCT02985957|82938142|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
46721938|NCT02985957|82938143|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
46721939|NCT02985957|82938144|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
46721940|NCT02985957|82938138|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
46721941|NCT02985957|82938139|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
46721942|NCT02985957|82938140|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
46920501|NCT02766608|83152823|FG000|Overall Study|Lack of Efficacy|16|||
46721943|NCT02985957|82938141|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
46721944|NCT02985957|82938142|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
46721945|NCT02985957|82938143|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
46721946|NCT02985957|82938144|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
46721947|NCT02985957|82938138|FG000|Treatment Period|Death|0|||
46721948|NCT02985957|82938139|FG001|Treatment Period|Death|0|||
46721949|NCT02985957|82938140|FG002|Treatment Period|Death|0|||
46721950|NCT02985957|82938141|FG003|Treatment Period|Death|0|||
46721951|NCT02985957|82938142|FG004|Treatment Period|Death|1|||
46721952|NCT02985957|82938143|FG005|Treatment Period|Death|0|||
46721953|NCT02985957|82938144|FG006|Treatment Period|Death|0|||
46721954|NCT02985957|82938138|FG000|Treatment Period|Participant withdrew consent|0|||
46721955|NCT02985957|82938139|FG001|Treatment Period|Participant withdrew consent|0|||
46721956|NCT02985957|82938140|FG002|Treatment Period|Participant withdrew consent|0|||
46721957|NCT02985957|82938141|FG003|Treatment Period|Participant withdrew consent|1|||
46721958|NCT02985957|82938142|FG004|Treatment Period|Participant withdrew consent|3|||
46721959|NCT02985957|82938143|FG005|Treatment Period|Participant withdrew consent|0|||
46721960|NCT02985957|82938144|FG006|Treatment Period|Participant withdrew consent|1|||
46721961|NCT02985957|82938138|FG000|Treatment Period|Lost to Follow-up|0|||
46721962|NCT02985957|82938139|FG001|Treatment Period|Lost to Follow-up|0|||
46721963|NCT02985957|82938140|FG002|Treatment Period|Lost to Follow-up|0|||
46721964|NCT02985957|82938141|FG003|Treatment Period|Lost to Follow-up|0|||
46721965|NCT02985957|82938142|FG004|Treatment Period|Lost to Follow-up|1|||
46721966|NCT02985957|82938143|FG005|Treatment Period|Lost to Follow-up|0|||
46721967|NCT02985957|82938144|FG006|Treatment Period|Lost to Follow-up|0|||
46721968|NCT02985957|82938138|FG000|Treatment Period|Other reasons|0|||
46721969|NCT02985957|82938139|FG001|Treatment Period|Other reasons|0|||
46721970|NCT02985957|82938140|FG002|Treatment Period|Other reasons|1|||
46721971|NCT02985957|82938141|FG003|Treatment Period|Other reasons|3|||
46721972|NCT02985957|82938142|FG004|Treatment Period|Other reasons|6|||
46721973|NCT02985957|82938143|FG005|Treatment Period|Other reasons|0|||
46721974|NCT02985957|82938144|FG006|Treatment Period|Other reasons|1|||
46721975|NCT02985957|82938138|FG000|Treatment Period|Not reported|0|||
46721976|NCT02985957|82938139|FG001|Treatment Period|Not reported|1|||
46721977|NCT02985957|82938140|FG002|Treatment Period|Not reported|2|||
46721978|NCT02985957|82938141|FG003|Treatment Period|Not reported|5|||
46721979|NCT02985957|82938142|FG004|Treatment Period|Not reported|0|||
46721980|NCT02985957|82938143|FG005|Treatment Period|Not reported|0|||
46721981|NCT02985957|82938144|FG006|Treatment Period|Not reported|0|||
46721982|NCT02985957|82938138|FG000|Treatment Period|Maximum clinical benefit|0|||
46721983|NCT02985957|82938139|FG001|Treatment Period|Maximum clinical benefit|0|||
46721984|NCT02985957|82938140|FG002|Treatment Period|Maximum clinical benefit|1|||
46721985|NCT02985957|82938141|FG003|Treatment Period|Maximum clinical benefit|1|||
46721986|NCT02985957|82938142|FG004|Treatment Period|Maximum clinical benefit|0|||
46721987|NCT02985957|82938143|FG005|Treatment Period|Maximum clinical benefit|0|||
46721988|NCT02985957|82938144|FG006|Treatment Period|Maximum clinical benefit|2|||
46721989|NCT02985957|82938138|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
46721990|NCT02985957|82938139|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
46721991|NCT02985957|82938140|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
46721992|NCT02985957|82938141|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
46721993|NCT02985957|82938142|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
46721994|NCT02985957|82938143|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
46721995|NCT02985957|82938144|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
46721996|NCT02985957|82938138|FG000|Treatment Period|Study drug toxicity|1|||
46721997|NCT02985957|82938139|FG001|Treatment Period|Study drug toxicity|23|||
46721998|NCT02985957|82938140|FG002|Treatment Period|Study drug toxicity|20|||
46721999|NCT02985957|82938141|FG003|Treatment Period|Study drug toxicity|11|||
46722000|NCT02985957|82938142|FG004|Treatment Period|Study drug toxicity|19|||
46722001|NCT02985957|82938143|FG005|Treatment Period|Study drug toxicity|3|||
46722002|NCT02985957|82938144|FG006|Treatment Period|Study drug toxicity|5|||
46722003|NCT02985957|82938138|FG000|Treatment Period|Disease progression|0|||
46722004|NCT02985957|82938139|FG001|Treatment Period|Disease progression|16|||
47044857|NCT01811485|83301537|FG002|Overall Study|Adverse Event|2|||
46722005|NCT02985957|82938140|FG002|Treatment Period|Disease progression|20|||
46722006|NCT02985957|82938141|FG003|Treatment Period|Disease progression|39|||
46722007|NCT02985957|82938142|FG004|Treatment Period|Disease progression|29|||
46722008|NCT02985957|82938143|FG005|Treatment Period|Disease progression|11|||
46722009|NCT02985957|82938144|FG006|Treatment Period|Disease progression|28|||
46722010|NCT02985957|82938138|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
46722011|NCT02985957|82938139|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
46722012|NCT02985957|82938140|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
46722013|NCT02985957|82938141|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
46722014|NCT02985957|82938142|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
46722015|NCT02985957|82938143|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
46722016|NCT02985957|82938144|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
46722017|NCT02985957|82938138|FG000|Treatment Period|Poor/Non-Compliance|0|||
46722018|NCT02985957|82938139|FG001|Treatment Period|Poor/Non-Compliance|0|||
46722019|NCT02985957|82938140|FG002|Treatment Period|Poor/Non-Compliance|0|||
46722020|NCT02985957|82938141|FG003|Treatment Period|Poor/Non-Compliance|0|||
46722021|NCT02985957|82938142|FG004|Treatment Period|Poor/Non-Compliance|1|||
46722022|NCT02985957|82938143|FG005|Treatment Period|Poor/Non-Compliance|1|||
46722023|NCT02985957|82938144|FG006|Treatment Period|Poor/Non-Compliance|0|||
46722024|NCT02985957|82938138|FG000|Treatment Period|Continuing in Treatment Period|0|||
46722025|NCT02985957|82938139|FG001|Treatment Period|Continuing in Treatment Period|1|||
46722026|NCT02985957|82938140|FG002|Treatment Period|Continuing in Treatment Period|0|||
46722027|NCT02985957|82938141|FG003|Treatment Period|Continuing in Treatment Period|4|||
46722028|NCT02985957|82938142|FG004|Treatment Period|Continuing in Treatment Period|4|||
46722029|NCT02985957|82938143|FG005|Treatment Period|Continuing in Treatment Period|0|||
46722030|NCT02985957|82938144|FG006|Treatment Period|Continuing in Treatment Period|0|||
46722031|NCT02915523|82938170|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
46722032|NCT02915523|82938171|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
46722033|NCT02915523|82938172|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
46722034|NCT02915523|82938173|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
46722035|NCT02915523|82938170|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
46722036|NCT02915523|82938171|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
46722037|NCT02915523|82938172|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
46722038|NCT02915523|82938173|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
46722039|NCT02915523|82938170|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
46722040|NCT02915523|82938171|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
46722041|NCT02915523|82938172|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
46722042|NCT02915523|82938173|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
46722043|NCT02915523|82938170|FG000|Expansion Phase (Phase 2)|Death|0|||
46722044|NCT02915523|82938171|FG001|Expansion Phase (Phase 2)|Death|0|||
46722045|NCT02915523|82938172|FG002|Expansion Phase (Phase 2)|Death|26|||
46722046|NCT02915523|82938173|FG003|Expansion Phase (Phase 2)|Death|53|||
46722047|NCT02915523|82938170|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
46722048|NCT02915523|82938171|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
46722049|NCT02915523|82938172|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
46722050|NCT02915523|82938173|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
46722051|NCT02915523|82938170|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
46722052|NCT02915523|82938171|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
46722053|NCT02915523|82938172|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
46722054|NCT02915523|82938173|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
46722055|NCT02915523|82938170|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
46722056|NCT02915523|82938171|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
46722057|NCT02915523|82938172|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
46722058|NCT02915523|82938173|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
46722059|NCT02890355|82938187|FG000|Overall Study|Adverse Event|5|||
46722060|NCT02890355|82938188|FG001|Overall Study|Adverse Event|5|||
46722061|NCT02890355|82938187|FG000|Overall Study|Refusal unrelated to adverse event|5|||
46722062|NCT02890355|82938188|FG001|Overall Study|Refusal unrelated to adverse event|10|||
46722063|NCT02890355|82938187|FG000|Overall Study|Progression/relapse|46|||
46722064|NCT02890355|82938188|FG001|Overall Study|Progression/relapse|39|||
46722065|NCT02890355|82938187|FG000|Overall Study|Not protocol specified|3|||
46722066|NCT02890355|82938188|FG001|Overall Study|Not protocol specified|4|||
46722067|NCT02844816|82938198|FG000|Overall Study|No protocol treatment received|5|||
46722068|NCT02844816|82938199|FG001|Overall Study|No protocol treatment received|1|||
46722069|NCT02844816|82938198|FG000|Overall Study|Ineligible|22|||
46722070|NCT02844816|82938199|FG001|Overall Study|Ineligible|15|||
46722071|NCT02844816|82938198|FG000|Overall Study|Participant refusal|5|||
46722072|NCT02844816|82938199|FG001|Overall Study|Participant refusal|5|||
46722073|NCT02844816|82938198|FG000|Overall Study|Adverse Event|5|||
46722074|NCT02844816|82938199|FG001|Overall Study|Adverse Event|4|||
46722075|NCT02844816|82938198|FG000|Overall Study|Death|0|||
46722076|NCT02844816|82938199|FG001|Overall Study|Death|1|||
46722077|NCT02844816|82938198|FG000|Overall Study|Disease progression/recurrence|50|||
46722078|NCT02844816|82938199|FG001|Overall Study|Disease progression/recurrence|24|||
46722079|NCT02844816|82938198|FG000|Overall Study|Physician Decision|1|||
46722080|NCT02844816|82938199|FG001|Overall Study|Physician Decision|1|||
46722081|NCT02581930|82938215|FG000|Overall Study|Withdrawal by Subject|1|||
46722082|NCT02581930|82938215|FG000|Overall Study|patient declined further treatment|1|||
46722083|NCT02513563|82938228|FG000|Overall Study|Death|4|||
46722084|NCT02513563|82938228|FG000|Overall Study|Withdrawal by Subject|4|||
46722085|NCT02513563|82938228|FG000|Overall Study|Physician Decision|1|||
46722086|NCT02466971|82938234|FG000|Overall Study|eligible and never treated|14|||
46722087|NCT02466971|82938235|FG001|Overall Study|eligible and never treated|20|||
46722088|NCT02466971|82938234|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
46722089|NCT02466971|82938235|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
46722090|NCT02466971|82938234|FG000|Overall Study|ineligible and treated|1|||
46722091|NCT02466971|82938235|FG001|Overall Study|ineligible and treated|0|||
46722092|NCT02466971|82938234|FG000|Overall Study|ineligible and never treated|0|||
46722093|NCT02466971|82938235|FG001|Overall Study|ineligible and never treated|1|||
46722094|NCT02443545|82938241|FG000|Overall Study|Adverse Event|1|||
46722095|NCT02443545|82938242|FG001|Overall Study|Adverse Event|1|||
46722096|NCT02443545|82938241|FG000|Overall Study|Lost to Follow-up|0|||
46722097|NCT02443545|82938242|FG001|Overall Study|Lost to Follow-up|2|||
46722098|NCT02443545|82938241|FG000|Overall Study|Physician Decision|3|||
46722099|NCT02443545|82938242|FG001|Overall Study|Physician Decision|0|||
46722100|NCT02443545|82938241|FG000|Overall Study|Protocol Violation|8|||
46722101|NCT02443545|82938242|FG001|Overall Study|Protocol Violation|1|||
46722102|NCT02443545|82938241|FG000|Overall Study|Pregnancy|1|||
46722103|NCT02443545|82938242|FG001|Overall Study|Pregnancy|1|||
46722104|NCT02443545|82938241|FG000|Overall Study|Withdrawal by Subject|6|||
46722105|NCT02443545|82938242|FG001|Overall Study|Withdrawal by Subject|3|||
46722106|NCT02443545|82938241|FG000|Overall Study|Termination of study|20|||
46722107|NCT02443545|82938242|FG001|Overall Study|Termination of study|11|||
46722108|NCT02388906|82938265|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
46722109|NCT02388906|82938266|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
46722110|NCT02388906|82938265|FG000|Treatment Period|Disease progression|121|||
46722111|NCT02388906|82938266|FG001|Treatment Period|Disease progression|101|||
46722112|NCT02388906|82938265|FG000|Treatment Period|Study drug toxicity|41|||
46722113|NCT02388906|82938266|FG001|Treatment Period|Study drug toxicity|208|||
46722114|NCT02388906|82938265|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
46722115|NCT02388906|82938266|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
46722116|NCT02388906|82938265|FG000|Treatment Period|Participant request to stop treatment|5|||
46722117|NCT02388906|82938266|FG001|Treatment Period|Participant request to stop treatment|9|||
46722118|NCT02388906|82938265|FG000|Treatment Period|Participant withdrew consent|2|||
46722119|NCT02388906|82938266|FG001|Treatment Period|Participant withdrew consent|3|||
46722120|NCT02388906|82938265|FG000|Treatment Period|Poor/non-compliance|0|||
46722121|NCT02388906|82938266|FG001|Treatment Period|Poor/non-compliance|1|||
47044858|NCT01811485|83301535|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
47044859|NCT01811485|83301536|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
47044860|NCT01811485|83301537|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
47044861|NCT01811485|83301535|FG000|Overall Study|Administrative problems|1|||
47044862|NCT01811485|83301536|FG001|Overall Study|Administrative problems|0|||
47044863|NCT01811485|83301537|FG002|Overall Study|Administrative problems|0|||
47044864|NCT01811485|83301535|FG000|Overall Study|Protocol Deviation|0|||
47044865|NCT01811485|83301536|FG001|Overall Study|Protocol Deviation|1|||
47044866|NCT01811485|83301537|FG002|Overall Study|Protocol Deviation|0|||
47044867|NCT01810939|83301548|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
47044868|NCT01810939|83301549|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
46722122|NCT02388906|82938265|FG000|Treatment Period|Participant no longer meets study criteria|0|||
46722123|NCT02388906|82938266|FG001|Treatment Period|Participant no longer meets study criteria|1|||
46722124|NCT02388906|82938265|FG000|Treatment Period|Other reasons|3|||
46722125|NCT02388906|82938266|FG001|Treatment Period|Other reasons|3|||
46722126|NCT02375555|82938272|FG000|Induction Period|Adverse Event|7|||
46722127|NCT02375555|82938272|FG000|Induction Period|Withdrawal by Subject|2|||
46722128|NCT02375555|82938272|FG000|Induction Period|Other|1|||
46722129|NCT02375555|82938272|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
46722130|NCT02375555|82938272|FG000|Maintenance Period|Adverse Event|2|||
46722131|NCT02375555|82938272|FG000|Maintenance Period|Withdrawal by Subject|4|||
46722132|NCT02375555|82938272|FG000|Maintenance Period|Death|1|||
46722133|NCT02375555|82938272|FG000|Maintenance Period|Disease Progression|5|||
46722134|NCT02375555|82938272|FG000|Maintenance Period|Patient Non-compliance|1|||
46722135|NCT02375555|82938272|FG000|Maintenance Period|Still on maintenance|16|||
46722136|NCT02152982|82938287|FG000|Overall Study|Ineligible|4|||
46722137|NCT02152982|82938288|FG001|Overall Study|Ineligible|4|||
46722138|NCT02152982|82938287|FG000|Overall Study|Did not start treatment|12|||
46722139|NCT02152982|82938288|FG001|Overall Study|Did not start treatment|6|||
46722140|NCT01928394|82938380|FG000|Treatment Period|Disease progression|17|||
46722141|NCT01928394|82938381|FG001|Treatment Period|Disease progression|2|||
46722142|NCT01928394|82938382|FG002|Treatment Period|Disease progression|12|||
47044869|NCT01810939|83301550|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
47044870|NCT01810939|83301548|FG000|Part A Treatment Period|Protocol Violation|2|||
47044871|NCT01810939|83301549|FG001|Part A Treatment Period|Protocol Violation|0|||
47044872|NCT01810939|83301550|FG002|Part A Treatment Period|Protocol Violation|0|||
46633693|NCT01706328|82807041|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
46633694|NCT01706328|82807039|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
46633695|NCT01706328|82807040|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
46633696|NCT01706328|82807041|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
46633697|NCT01706328|82807039|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
46633698|NCT01706328|82807040|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
47044873|NCT01810939|83301548|FG000|Part A Treatment Period|Adverse Event|10|||
47044874|NCT01810939|83301549|FG001|Part A Treatment Period|Adverse Event|0|||
47044875|NCT01810939|83301550|FG002|Part A Treatment Period|Adverse Event|0|||
46633699|NCT01706328|82807041|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
46633700|NCT01706328|82807039|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
46633701|NCT01706328|82807040|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
46633702|NCT01706328|82807041|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
46633703|NCT01706328|82807039|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
46633704|NCT01706328|82807040|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
46633705|NCT01706328|82807041|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
46633706|NCT01753518|82807049|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
46633707|NCT01753518|82807050|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
46722143|NCT01928394|82938383|FG003|Treatment Period|Disease progression|48|||
46722144|NCT01928394|82938384|FG004|Treatment Period|Disease progression|3|||
46920502|NCT02766608|83152824|FG001|Overall Study|Lack of Efficacy|15|||
46920503|NCT02766608|83152825|FG002|Overall Study|Lack of Efficacy|32|||
46920504|NCT02766608|83152826|FG003|Overall Study|Lack of Efficacy|8|||
46722145|NCT01928394|82938385|FG005|Treatment Period|Disease progression|25|||
46722146|NCT01928394|82938386|FG006|Treatment Period|Disease progression|38|||
46920505|NCT02766608|83152827|FG004|Overall Study|Lack of Efficacy|2|||
46920506|NCT02766608|83152823|FG000|Overall Study|Lost to Follow-up|6|||
46920507|NCT02766608|83152824|FG001|Overall Study|Lost to Follow-up|3|||
46920508|NCT02766608|83152825|FG002|Overall Study|Lost to Follow-up|5|||
46920509|NCT02766608|83152826|FG003|Overall Study|Lost to Follow-up|2|||
46920510|NCT02766608|83152827|FG004|Overall Study|Lost to Follow-up|2|||
46920511|NCT02766608|83152823|FG000|Overall Study|Physician Decision|3|||
46920512|NCT02766608|83152824|FG001|Overall Study|Physician Decision|2|||
46920513|NCT02766608|83152825|FG002|Overall Study|Physician Decision|3|||
46920514|NCT02766608|83152826|FG003|Overall Study|Physician Decision|1|||
46920515|NCT02766608|83152827|FG004|Overall Study|Physician Decision|2|||
46920516|NCT02766608|83152823|FG000|Overall Study|Protocol disc criteria|3|||
46920517|NCT02766608|83152824|FG001|Overall Study|Protocol disc criteria|3|||
46920518|NCT02766608|83152825|FG002|Overall Study|Protocol disc criteria|4|||
46920519|NCT02766608|83152826|FG003|Overall Study|Protocol disc criteria|0|||
46920520|NCT02766608|83152827|FG004|Overall Study|Protocol disc criteria|0|||
46920521|NCT02766608|83152823|FG000|Overall Study|Protocol Violation|0|||
46920522|NCT02766608|83152824|FG001|Overall Study|Protocol Violation|4|||
46920523|NCT02766608|83152825|FG002|Overall Study|Protocol Violation|4|||
46920524|NCT02766608|83152826|FG003|Overall Study|Protocol Violation|0|||
46920525|NCT02766608|83152827|FG004|Overall Study|Protocol Violation|1|||
46920526|NCT02766608|83152823|FG000|Overall Study|Administrative Reasons|3|||
46920527|NCT02766608|83152824|FG001|Overall Study|Administrative Reasons|1|||
47044876|NCT01810939|83301548|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
47044877|NCT01810939|83301549|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
46722147|NCT01928394|82938387|FG007|Treatment Period|Disease progression|16|||
46920528|NCT02766608|83152825|FG002|Overall Study|Administrative Reasons|1|||
46920529|NCT02766608|83152826|FG003|Overall Study|Administrative Reasons|0|||
46920530|NCT02766608|83152827|FG004|Overall Study|Administrative Reasons|0|||
46722148|NCT01928394|82938388|FG008|Treatment Period|Disease progression|3|||
46722149|NCT01928394|82938389|FG009|Treatment Period|Disease progression|11|||
46722150|NCT01928394|82938390|FG010|Treatment Period|Disease progression|22|||
46722151|NCT01928394|82938391|FG011|Treatment Period|Disease progression|73|||
46722152|NCT01928394|82938392|FG012|Treatment Period|Disease progression|38|||
46722153|NCT01928394|82938393|FG013|Treatment Period|Disease progression|118|||
46722154|NCT01928394|82938394|FG014|Treatment Period|Disease progression|59|||
46722155|NCT01928394|82938395|FG015|Treatment Period|Disease progression|1|||
46722156|NCT01928394|82938396|FG016|Treatment Period|Disease progression|43|||
46722157|NCT01928394|82938397|FG017|Treatment Period|Disease progression|56|||
46722158|NCT01928394|82938398|FG018|Treatment Period|Disease progression|50|||
46722159|NCT01928394|82938399|FG019|Treatment Period|Disease progression|71|||
46722160|NCT01928394|82938400|FG020|Treatment Period|Disease progression|30|||
46722161|NCT01928394|82938401|FG021|Treatment Period|Disease progression|31|||
46722162|NCT01928394|82938402|FG022|Treatment Period|Disease progression|31|||
46722163|NCT01928394|82938380|FG000|Treatment Period|Study drug toxicity|1|||
46722164|NCT01928394|82938381|FG001|Treatment Period|Study drug toxicity|1|||
46722165|NCT01928394|82938382|FG002|Treatment Period|Study drug toxicity|3|||
46722166|NCT01928394|82938383|FG003|Treatment Period|Study drug toxicity|3|||
46722167|NCT01928394|82938384|FG004|Treatment Period|Study drug toxicity|0|||
46722168|NCT01928394|82938385|FG005|Treatment Period|Study drug toxicity|9|||
46722169|NCT01928394|82938386|FG006|Treatment Period|Study drug toxicity|7|||
46722170|NCT01928394|82938387|FG007|Treatment Period|Study drug toxicity|1|||
46722171|NCT01928394|82938388|FG008|Treatment Period|Study drug toxicity|0|||
46722172|NCT01928394|82938389|FG009|Treatment Period|Study drug toxicity|5|||
46722173|NCT01928394|82938390|FG010|Treatment Period|Study drug toxicity|2|||
46722174|NCT01928394|82938391|FG011|Treatment Period|Study drug toxicity|3|||
46722175|NCT01928394|82938392|FG012|Treatment Period|Study drug toxicity|7|||
46722176|NCT01928394|82938393|FG013|Treatment Period|Study drug toxicity|5|||
46722177|NCT01928394|82938394|FG014|Treatment Period|Study drug toxicity|12|||
46722178|NCT01928394|82938395|FG015|Treatment Period|Study drug toxicity|0|||
46633708|NCT01753518|82807049|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
46633709|NCT01753518|82807050|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
46633710|NCT01753518|82807049|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
46633711|NCT01753518|82807050|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
46633712|NCT01753518|82807049|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
46633713|NCT01753518|82807050|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
46633714|NCT01706250|82807056|FG000|Overall Study|Lost to Follow-up|2|||
46633715|NCT01729728|82807068|FG000|Overall Study|Adverse Event|0|||
46633716|NCT01729728|82807069|FG001|Overall Study|Adverse Event|6|||
46633717|NCT01729728|82807070|FG002|Overall Study|Adverse Event|0|||
46633718|NCT01729728|82807068|FG000|Overall Study|Protocol Violation|1|||
46633719|NCT01729728|82807069|FG001|Overall Study|Protocol Violation|0|||
46633720|NCT01729728|82807070|FG002|Overall Study|Protocol Violation|1|||
46633721|NCT01729026|82807203|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
46633722|NCT01729026|82807204|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
46633723|NCT01729026|82807203|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
46633724|NCT01729026|82807204|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
46633725|NCT01728792|82807218|FG000|Overall Study|Withdrawal of Consent|1|||
46633726|NCT01728792|82807219|FG001|Overall Study|Withdrawal of Consent|1|||
46633727|NCT01728792|82807220|FG002|Overall Study|Withdrawal of Consent|0|||
46633728|NCT01728792|82807221|FG003|Overall Study|Withdrawal of Consent|1|||
46633729|NCT01728792|82807222|FG004|Overall Study|Withdrawal of Consent|0|||
46633730|NCT01728792|82807218|FG000|Overall Study|Lost to Follow-up|2|||
46633731|NCT01728792|82807219|FG001|Overall Study|Lost to Follow-up|1|||
46722179|NCT01928394|82938396|FG016|Treatment Period|Study drug toxicity|3|||
46722180|NCT01928394|82938397|FG017|Treatment Period|Study drug toxicity|3|||
46633732|NCT01728792|82807220|FG002|Overall Study|Lost to Follow-up|4|||
46722181|NCT01928394|82938398|FG018|Treatment Period|Study drug toxicity|12|||
46722182|NCT01928394|82938399|FG019|Treatment Period|Study drug toxicity|15|||
46920531|NCT00960141|83152845|FG000|Overall Study|Adverse Event|4|||
46633733|NCT01728792|82807221|FG003|Overall Study|Lost to Follow-up|2|||
46633734|NCT01728792|82807222|FG004|Overall Study|Lost to Follow-up|0|||
46722183|NCT01928394|82938400|FG020|Treatment Period|Study drug toxicity|4|||
46722184|NCT01928394|82938401|FG021|Treatment Period|Study drug toxicity|7|||
46722185|NCT01928394|82938402|FG022|Treatment Period|Study drug toxicity|4|||
46722186|NCT01928394|82938380|FG000|Treatment Period|AE unrelated to study drug|0|||
46722187|NCT01928394|82938381|FG001|Treatment Period|AE unrelated to study drug|0|||
46722188|NCT01928394|82938382|FG002|Treatment Period|AE unrelated to study drug|2|||
46722189|NCT01928394|82938383|FG003|Treatment Period|AE unrelated to study drug|3|||
46722190|NCT01928394|82938384|FG004|Treatment Period|AE unrelated to study drug|0|||
46722191|NCT01928394|82938385|FG005|Treatment Period|AE unrelated to study drug|5|||
46722192|NCT01928394|82938386|FG006|Treatment Period|AE unrelated to study drug|1|||
46722193|NCT01928394|82938387|FG007|Treatment Period|AE unrelated to study drug|0|||
46722194|NCT01928394|82938388|FG008|Treatment Period|AE unrelated to study drug|0|||
46722195|NCT01928394|82938389|FG009|Treatment Period|AE unrelated to study drug|2|||
46722196|NCT01928394|82938390|FG010|Treatment Period|AE unrelated to study drug|0|||
46722197|NCT01928394|82938391|FG011|Treatment Period|AE unrelated to study drug|12|||
46722198|NCT01928394|82938392|FG012|Treatment Period|AE unrelated to study drug|6|||
46722199|NCT01928394|82938393|FG013|Treatment Period|AE unrelated to study drug|13|||
46722200|NCT01928394|82938394|FG014|Treatment Period|AE unrelated to study drug|6|||
46722201|NCT01928394|82938395|FG015|Treatment Period|AE unrelated to study drug|1|||
46722202|NCT01928394|82938396|FG016|Treatment Period|AE unrelated to study drug|1|||
46722203|NCT01928394|82938397|FG017|Treatment Period|AE unrelated to study drug|6|||
46722204|NCT01928394|82938398|FG018|Treatment Period|AE unrelated to study drug|3|||
46722205|NCT01928394|82938399|FG019|Treatment Period|AE unrelated to study drug|5|||
46722206|NCT01928394|82938400|FG020|Treatment Period|AE unrelated to study drug|1|||
46722207|NCT01928394|82938401|FG021|Treatment Period|AE unrelated to study drug|1|||
46722208|NCT01928394|82938402|FG022|Treatment Period|AE unrelated to study drug|0|||
46722209|NCT01928394|82938380|FG000|Treatment Period|Participant request to stop therapy|0|||
46722210|NCT01928394|82938381|FG001|Treatment Period|Participant request to stop therapy|0|||
46722211|NCT01928394|82938382|FG002|Treatment Period|Participant request to stop therapy|0|||
46722212|NCT01928394|82938383|FG003|Treatment Period|Participant request to stop therapy|0|||
46722213|NCT01928394|82938384|FG004|Treatment Period|Participant request to stop therapy|0|||
46722214|NCT01928394|82938385|FG005|Treatment Period|Participant request to stop therapy|3|||
46722215|NCT01928394|82938386|FG006|Treatment Period|Participant request to stop therapy|3|||
46722216|NCT01928394|82938387|FG007|Treatment Period|Participant request to stop therapy|0|||
46722217|NCT01928394|82938388|FG008|Treatment Period|Participant request to stop therapy|0|||
46722218|NCT01928394|82938389|FG009|Treatment Period|Participant request to stop therapy|0|||
46722219|NCT01928394|82938390|FG010|Treatment Period|Participant request to stop therapy|3|||
46722220|NCT01928394|82938391|FG011|Treatment Period|Participant request to stop therapy|2|||
46722221|NCT01928394|82938392|FG012|Treatment Period|Participant request to stop therapy|1|||
46722222|NCT01928394|82938393|FG013|Treatment Period|Participant request to stop therapy|2|||
46722223|NCT01928394|82938394|FG014|Treatment Period|Participant request to stop therapy|4|||
46722224|NCT01928394|82938395|FG015|Treatment Period|Participant request to stop therapy|0|||
46722225|NCT01928394|82938396|FG016|Treatment Period|Participant request to stop therapy|1|||
46722226|NCT01928394|82938397|FG017|Treatment Period|Participant request to stop therapy|3|||
46722227|NCT01928394|82938398|FG018|Treatment Period|Participant request to stop therapy|1|||
46722228|NCT01928394|82938399|FG019|Treatment Period|Participant request to stop therapy|1|||
46722229|NCT01928394|82938400|FG020|Treatment Period|Participant request to stop therapy|3|||
46722230|NCT01928394|82938401|FG021|Treatment Period|Participant request to stop therapy|1|||
46722231|NCT01928394|82938402|FG022|Treatment Period|Participant request to stop therapy|3|||
46722232|NCT01928394|82938380|FG000|Treatment Period|Participant withdrew consent|0|||
46920532|NCT00960141|83152846|FG001|Overall Study|Adverse Event|8|||
47044878|NCT01810939|83301550|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
47044879|NCT01810939|83301548|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
47044880|NCT01810939|83301549|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
46633735|NCT01752036|82807234|FG000|Overall Study|Death|2|||
46633736|NCT01728324|82807242|FG000|Termination of DBV|Adverse Event|14|||
46633737|NCT01728324|82807243|FG001|Termination of DBV|Adverse Event|13|||
46633738|NCT01728324|82807244|FG002|Termination of DBV|Adverse Event|4|||
46633739|NCT01728324|82807242|FG000|Termination of DBV|Lack of Efficacy|14|||
46633740|NCT01728324|82807243|FG001|Termination of DBV|Lack of Efficacy|12|||
46633741|NCT01728324|82807244|FG002|Termination of DBV|Lack of Efficacy|8|||
46633742|NCT01728324|82807242|FG000|Termination of DBV|Withdrawal by Subject|9|||
46633743|NCT01728324|82807243|FG001|Termination of DBV|Withdrawal by Subject|6|||
47044881|NCT01810939|83301550|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
47044882|NCT01810939|83301548|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
47044883|NCT01810939|83301549|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
47044884|NCT01810939|83301550|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
46633744|NCT01728324|82807244|FG002|Termination of DBV|Withdrawal by Subject|2|||
46633745|NCT01728324|82807242|FG000|Termination of DBV|Other than stated|1|||
46722233|NCT01928394|82938381|FG001|Treatment Period|Participant withdrew consent|0|||
46722234|NCT01928394|82938382|FG002|Treatment Period|Participant withdrew consent|1|||
46722235|NCT01928394|82938383|FG003|Treatment Period|Participant withdrew consent|1|||
46722236|NCT01928394|82938384|FG004|Treatment Period|Participant withdrew consent|0|||
46722237|NCT01928394|82938385|FG005|Treatment Period|Participant withdrew consent|1|||
46722238|NCT01928394|82938386|FG006|Treatment Period|Participant withdrew consent|0|||
46722239|NCT01928394|82938387|FG007|Treatment Period|Participant withdrew consent|1|||
46722240|NCT01928394|82938388|FG008|Treatment Period|Participant withdrew consent|0|||
46722241|NCT01928394|82938389|FG009|Treatment Period|Participant withdrew consent|0|||
46722242|NCT01928394|82938390|FG010|Treatment Period|Participant withdrew consent|1|||
46722243|NCT01928394|82938391|FG011|Treatment Period|Participant withdrew consent|1|||
46722244|NCT01928394|82938392|FG012|Treatment Period|Participant withdrew consent|1|||
46722245|NCT01928394|82938393|FG013|Treatment Period|Participant withdrew consent|0|||
46722246|NCT01928394|82938394|FG014|Treatment Period|Participant withdrew consent|2|||
46722247|NCT01928394|82938395|FG015|Treatment Period|Participant withdrew consent|0|||
46722248|NCT01928394|82938396|FG016|Treatment Period|Participant withdrew consent|2|||
46722249|NCT01928394|82938397|FG017|Treatment Period|Participant withdrew consent|1|||
46722250|NCT01928394|82938398|FG018|Treatment Period|Participant withdrew consent|1|||
46722251|NCT01928394|82938399|FG019|Treatment Period|Participant withdrew consent|1|||
46722252|NCT01928394|82938400|FG020|Treatment Period|Participant withdrew consent|0|||
46722253|NCT01928394|82938401|FG021|Treatment Period|Participant withdrew consent|2|||
46722254|NCT01928394|82938402|FG022|Treatment Period|Participant withdrew consent|0|||
46722255|NCT01928394|82938380|FG000|Treatment Period|Poor/non-compliance|0|||
46722256|NCT01928394|82938381|FG001|Treatment Period|Poor/non-compliance|0|||
46722257|NCT01928394|82938382|FG002|Treatment Period|Poor/non-compliance|0|||
46722258|NCT01928394|82938383|FG003|Treatment Period|Poor/non-compliance|1|||
46722259|NCT01928394|82938384|FG004|Treatment Period|Poor/non-compliance|0|||
46722260|NCT01928394|82938385|FG005|Treatment Period|Poor/non-compliance|0|||
46722261|NCT01928394|82938386|FG006|Treatment Period|Poor/non-compliance|0|||
46722262|NCT01928394|82938387|FG007|Treatment Period|Poor/non-compliance|0|||
46722263|NCT01928394|82938388|FG008|Treatment Period|Poor/non-compliance|0|||
46722264|NCT01928394|82938389|FG009|Treatment Period|Poor/non-compliance|0|||
46722265|NCT01928394|82938390|FG010|Treatment Period|Poor/non-compliance|0|||
46722266|NCT01928394|82938391|FG011|Treatment Period|Poor/non-compliance|0|||
46722267|NCT01928394|82938392|FG012|Treatment Period|Poor/non-compliance|1|||
46722268|NCT01928394|82938393|FG013|Treatment Period|Poor/non-compliance|0|||
46722269|NCT01928394|82938394|FG014|Treatment Period|Poor/non-compliance|1|||
46722270|NCT01928394|82938395|FG015|Treatment Period|Poor/non-compliance|0|||
46722271|NCT01928394|82938396|FG016|Treatment Period|Poor/non-compliance|0|||
46722272|NCT01928394|82938397|FG017|Treatment Period|Poor/non-compliance|1|||
46722273|NCT01928394|82938398|FG018|Treatment Period|Poor/non-compliance|0|||
46722274|NCT01928394|82938399|FG019|Treatment Period|Poor/non-compliance|1|||
46722275|NCT01928394|82938400|FG020|Treatment Period|Poor/non-compliance|0|||
46722276|NCT01928394|82938401|FG021|Treatment Period|Poor/non-compliance|0|||
46722277|NCT01928394|82938402|FG022|Treatment Period|Poor/non-compliance|0|||
46722278|NCT01928394|82938380|FG000|Treatment Period|other reason|0|||
46722279|NCT01928394|82938381|FG001|Treatment Period|other reason|0|||
46722280|NCT01928394|82938382|FG002|Treatment Period|other reason|0|||
46722281|NCT01928394|82938383|FG003|Treatment Period|other reason|0|||
46722282|NCT01928394|82938384|FG004|Treatment Period|other reason|0|||
46722283|NCT01928394|82938385|FG005|Treatment Period|other reason|0|||
46722284|NCT01928394|82938386|FG006|Treatment Period|other reason|0|||
46722285|NCT01928394|82938387|FG007|Treatment Period|other reason|0|||
46722286|NCT01928394|82938388|FG008|Treatment Period|other reason|0|||
46920533|NCT00960141|83152847|FG002|Overall Study|Adverse Event|2|||
46920534|NCT00960141|83152845|FG000|Overall Study|Lack of Efficacy|3|||
46633746|NCT01728324|82807243|FG001|Termination of DBV|Other than stated|3|||
46633747|NCT01728324|82807244|FG002|Termination of DBV|Other than stated|0|||
46633748|NCT01728324|82807242|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
46633749|NCT01728324|82807243|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
46633750|NCT01728324|82807244|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
46633751|NCT01728324|82807242|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
46722287|NCT01928394|82938389|FG009|Treatment Period|other reason|0|||
46722288|NCT01928394|82938390|FG010|Treatment Period|other reason|1|||
46722289|NCT01928394|82938391|FG011|Treatment Period|other reason|1|||
46722290|NCT01928394|82938392|FG012|Treatment Period|other reason|1|||
46633752|NCT01728324|82807243|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
46722291|NCT01928394|82938393|FG013|Treatment Period|other reason|0|||
46722292|NCT01928394|82938394|FG014|Treatment Period|other reason|1|||
46633753|NCT01728324|82807244|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
46722293|NCT01928394|82938395|FG015|Treatment Period|other reason|0|||
46722294|NCT01928394|82938396|FG016|Treatment Period|other reason|0|||
46722295|NCT01928394|82938397|FG017|Treatment Period|other reason|0|||
46722296|NCT01928394|82938398|FG018|Treatment Period|other reason|2|||
46722297|NCT01928394|82938399|FG019|Treatment Period|other reason|2|||
46722298|NCT01928394|82938400|FG020|Treatment Period|other reason|0|||
46722299|NCT01928394|82938401|FG021|Treatment Period|other reason|0|||
46722300|NCT01928394|82938402|FG022|Treatment Period|other reason|0|||
46722301|NCT01928394|82938380|FG000|Treatment Period|Maximum clinical benefit|0|||
46722302|NCT01928394|82938381|FG001|Treatment Period|Maximum clinical benefit|0|||
46722303|NCT01928394|82938382|FG002|Treatment Period|Maximum clinical benefit|0|||
46722304|NCT01928394|82938383|FG003|Treatment Period|Maximum clinical benefit|0|||
46722305|NCT01928394|82938384|FG004|Treatment Period|Maximum clinical benefit|0|||
46722306|NCT01928394|82938385|FG005|Treatment Period|Maximum clinical benefit|0|||
46722307|NCT01928394|82938386|FG006|Treatment Period|Maximum clinical benefit|0|||
46722308|NCT01928394|82938387|FG007|Treatment Period|Maximum clinical benefit|0|||
46722309|NCT01928394|82938388|FG008|Treatment Period|Maximum clinical benefit|0|||
46722310|NCT01928394|82938389|FG009|Treatment Period|Maximum clinical benefit|0|||
46722311|NCT01928394|82938390|FG010|Treatment Period|Maximum clinical benefit|1|||
46722312|NCT01928394|82938391|FG011|Treatment Period|Maximum clinical benefit|1|||
46722313|NCT01928394|82938392|FG012|Treatment Period|Maximum clinical benefit|0|||
46722314|NCT01928394|82938393|FG013|Treatment Period|Maximum clinical benefit|0|||
46722315|NCT01928394|82938394|FG014|Treatment Period|Maximum clinical benefit|1|||
46722316|NCT01928394|82938395|FG015|Treatment Period|Maximum clinical benefit|0|||
46722317|NCT01928394|82938396|FG016|Treatment Period|Maximum clinical benefit|0|||
46722318|NCT01928394|82938397|FG017|Treatment Period|Maximum clinical benefit|1|||
46722319|NCT01928394|82938398|FG018|Treatment Period|Maximum clinical benefit|1|||
46722320|NCT01928394|82938399|FG019|Treatment Period|Maximum clinical benefit|0|||
46722321|NCT01928394|82938400|FG020|Treatment Period|Maximum clinical benefit|2|||
46722322|NCT01928394|82938401|FG021|Treatment Period|Maximum clinical benefit|0|||
46722323|NCT01928394|82938402|FG022|Treatment Period|Maximum clinical benefit|0|||
46722324|NCT01928394|82938380|FG000|Treatment Period|Lost to Follow-up|0|||
46722325|NCT01928394|82938381|FG001|Treatment Period|Lost to Follow-up|0|||
46722326|NCT01928394|82938382|FG002|Treatment Period|Lost to Follow-up|0|||
46722327|NCT01928394|82938383|FG003|Treatment Period|Lost to Follow-up|0|||
46722328|NCT01928394|82938384|FG004|Treatment Period|Lost to Follow-up|0|||
46722329|NCT01928394|82938385|FG005|Treatment Period|Lost to Follow-up|0|||
46722330|NCT01928394|82938386|FG006|Treatment Period|Lost to Follow-up|0|||
46722331|NCT01928394|82938387|FG007|Treatment Period|Lost to Follow-up|0|||
46722332|NCT01928394|82938388|FG008|Treatment Period|Lost to Follow-up|0|||
46722333|NCT01928394|82938389|FG009|Treatment Period|Lost to Follow-up|0|||
46722334|NCT01928394|82938390|FG010|Treatment Period|Lost to Follow-up|0|||
46722335|NCT01928394|82938391|FG011|Treatment Period|Lost to Follow-up|0|||
46722336|NCT01928394|82938392|FG012|Treatment Period|Lost to Follow-up|0|||
46722337|NCT01928394|82938393|FG013|Treatment Period|Lost to Follow-up|0|||
46722338|NCT01928394|82938394|FG014|Treatment Period|Lost to Follow-up|0|||
46722339|NCT01928394|82938395|FG015|Treatment Period|Lost to Follow-up|0|||
46722340|NCT01928394|82938396|FG016|Treatment Period|Lost to Follow-up|0|||
46722341|NCT01928394|82938397|FG017|Treatment Period|Lost to Follow-up|0|||
46722342|NCT01928394|82938398|FG018|Treatment Period|Lost to Follow-up|0|||
46722343|NCT01928394|82938399|FG019|Treatment Period|Lost to Follow-up|0|||
46722344|NCT01928394|82938400|FG020|Treatment Period|Lost to Follow-up|0|||
46722345|NCT01928394|82938401|FG021|Treatment Period|Lost to Follow-up|0|||
46722346|NCT01928394|82938402|FG022|Treatment Period|Lost to Follow-up|1|||
46722347|NCT01928394|82938380|FG000|Treatment Period|Death|0|||
46722348|NCT01928394|82938381|FG001|Treatment Period|Death|0|||
46722349|NCT01928394|82938382|FG002|Treatment Period|Death|0|||
46722350|NCT01928394|82938383|FG003|Treatment Period|Death|0|||
46722351|NCT01928394|82938384|FG004|Treatment Period|Death|0|||
46722352|NCT01928394|82938385|FG005|Treatment Period|Death|0|||
46722353|NCT01928394|82938386|FG006|Treatment Period|Death|0|||
46722354|NCT01928394|82938387|FG007|Treatment Period|Death|0|||
46722355|NCT01928394|82938388|FG008|Treatment Period|Death|0|||
46722356|NCT01928394|82938389|FG009|Treatment Period|Death|0|||
46722357|NCT01928394|82938390|FG010|Treatment Period|Death|0|||
46722358|NCT01928394|82938391|FG011|Treatment Period|Death|0|||
46722359|NCT01928394|82938392|FG012|Treatment Period|Death|0|||
46722360|NCT01928394|82938393|FG013|Treatment Period|Death|1|||
46722361|NCT01928394|82938394|FG014|Treatment Period|Death|2|||
46722362|NCT01928394|82938395|FG015|Treatment Period|Death|0|||
46722363|NCT01928394|82938396|FG016|Treatment Period|Death|0|||
46722364|NCT01928394|82938397|FG017|Treatment Period|Death|0|||
46722365|NCT01928394|82938398|FG018|Treatment Period|Death|0|||
46722366|NCT01928394|82938399|FG019|Treatment Period|Death|0|||
46722367|NCT01928394|82938400|FG020|Treatment Period|Death|0|||
46722368|NCT01928394|82938401|FG021|Treatment Period|Death|0|||
46722369|NCT01928394|82938402|FG022|Treatment Period|Death|0|||
46722370|NCT01928394|82938380|FG000|Follow-up Period|Participant withdrew consent|3|||
46722371|NCT01928394|82938381|FG001|Follow-up Period|Participant withdrew consent|0|||
46722372|NCT01928394|82938382|FG002|Follow-up Period|Participant withdrew consent|1|||
46722373|NCT01928394|82938383|FG003|Follow-up Period|Participant withdrew consent|4|||
46722374|NCT01928394|82938384|FG004|Follow-up Period|Participant withdrew consent|0|||
46722375|NCT01928394|82938385|FG005|Follow-up Period|Participant withdrew consent|2|||
46722376|NCT01928394|82938386|FG006|Follow-up Period|Participant withdrew consent|5|||
46722377|NCT01928394|82938387|FG007|Follow-up Period|Participant withdrew consent|1|||
46722378|NCT01928394|82938388|FG008|Follow-up Period|Participant withdrew consent|0|||
46722379|NCT01928394|82938389|FG009|Follow-up Period|Participant withdrew consent|0|||
46722380|NCT01928394|82938390|FG010|Follow-up Period|Participant withdrew consent|5|||
46722381|NCT01928394|82938391|FG011|Follow-up Period|Participant withdrew consent|8|||
46722382|NCT01928394|82938392|FG012|Follow-up Period|Participant withdrew consent|2|||
46722383|NCT01928394|82938393|FG013|Follow-up Period|Participant withdrew consent|12|||
46722384|NCT01928394|82938394|FG014|Follow-up Period|Participant withdrew consent|7|||
46722385|NCT01928394|82938395|FG015|Follow-up Period|Participant withdrew consent|0|||
46722386|NCT01928394|82938396|FG016|Follow-up Period|Participant withdrew consent|5|||
46722387|NCT01928394|82938397|FG017|Follow-up Period|Participant withdrew consent|3|||
46722388|NCT01928394|82938398|FG018|Follow-up Period|Participant withdrew consent|2|||
46722389|NCT01928394|82938399|FG019|Follow-up Period|Participant withdrew consent|7|||
46722390|NCT01928394|82938400|FG020|Follow-up Period|Participant withdrew consent|4|||
46722391|NCT01928394|82938401|FG021|Follow-up Period|Participant withdrew consent|6|||
46722392|NCT01928394|82938402|FG022|Follow-up Period|Participant withdrew consent|2|||
46722393|NCT01928394|82938380|FG000|Follow-up Period|Death|0|||
46722394|NCT01928394|82938381|FG001|Follow-up Period|Death|0|||
46722395|NCT01928394|82938382|FG002|Follow-up Period|Death|2|||
46722396|NCT01928394|82938383|FG003|Follow-up Period|Death|6|||
46722397|NCT01928394|82938384|FG004|Follow-up Period|Death|0|||
46722398|NCT01928394|82938385|FG005|Follow-up Period|Death|6|||
46722399|NCT01928394|82938386|FG006|Follow-up Period|Death|6|||
46722400|NCT01928394|82938387|FG007|Follow-up Period|Death|2|||
46722401|NCT01928394|82938388|FG008|Follow-up Period|Death|1|||
46722402|NCT01928394|82938389|FG009|Follow-up Period|Death|2|||
46722403|NCT01928394|82938390|FG010|Follow-up Period|Death|4|||
46722404|NCT01928394|82938391|FG011|Follow-up Period|Death|12|||
46722405|NCT01928394|82938392|FG012|Follow-up Period|Death|11|||
46722406|NCT01928394|82938393|FG013|Follow-up Period|Death|25|||
46722407|NCT01928394|82938394|FG014|Follow-up Period|Death|18|||
46722408|NCT01928394|82938395|FG015|Follow-up Period|Death|0|||
46722409|NCT01928394|82938396|FG016|Follow-up Period|Death|6|||
46722410|NCT01928394|82938397|FG017|Follow-up Period|Death|5|||
46722411|NCT01928394|82938398|FG018|Follow-up Period|Death|13|||
47044885|NCT01810939|83301548|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
47044886|NCT01810939|83301549|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
47044887|NCT01810939|83301550|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
47044888|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
47044889|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
47044890|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
47044891|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
47044892|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
47044893|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
47044894|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
46722412|NCT01928394|82938399|FG019|Follow-up Period|Death|13|||
46722413|NCT01928394|82938400|FG020|Follow-up Period|Death|5|||
46722414|NCT01928394|82938401|FG021|Follow-up Period|Death|3|||
46722415|NCT01928394|82938402|FG022|Follow-up Period|Death|2|||
46722416|NCT01928394|82938380|FG000|Follow-up Period|other reason|0|||
46722417|NCT01928394|82938381|FG001|Follow-up Period|other reason|0|||
46722418|NCT01928394|82938382|FG002|Follow-up Period|other reason|0|||
46722419|NCT01928394|82938383|FG003|Follow-up Period|other reason|0|||
46722420|NCT01928394|82938384|FG004|Follow-up Period|other reason|0|||
46722421|NCT01928394|82938385|FG005|Follow-up Period|other reason|0|||
46722422|NCT01928394|82938386|FG006|Follow-up Period|other reason|1|||
46722423|NCT01928394|82938387|FG007|Follow-up Period|other reason|3|||
46722424|NCT01928394|82938388|FG008|Follow-up Period|other reason|0|||
46722425|NCT01928394|82938389|FG009|Follow-up Period|other reason|0|||
46722426|NCT01928394|82938390|FG010|Follow-up Period|other reason|2|||
46722427|NCT01928394|82938391|FG011|Follow-up Period|other reason|1|||
46722428|NCT01928394|82938392|FG012|Follow-up Period|other reason|0|||
46722429|NCT01928394|82938393|FG013|Follow-up Period|other reason|1|||
46722430|NCT01928394|82938394|FG014|Follow-up Period|other reason|4|||
46722431|NCT01928394|82938395|FG015|Follow-up Period|other reason|0|||
46722432|NCT01928394|82938396|FG016|Follow-up Period|other reason|2|||
46722433|NCT01928394|82938397|FG017|Follow-up Period|other reason|0|||
46722434|NCT01928394|82938398|FG018|Follow-up Period|other reason|1|||
46722435|NCT01928394|82938399|FG019|Follow-up Period|other reason|1|||
46722436|NCT01928394|82938400|FG020|Follow-up Period|other reason|0|||
46722437|NCT01928394|82938401|FG021|Follow-up Period|other reason|0|||
46722438|NCT01928394|82938402|FG022|Follow-up Period|other reason|1|||
46722439|NCT01928394|82938380|FG000|Follow-up Period|Lost to Follow-up|0|||
46722440|NCT01928394|82938381|FG001|Follow-up Period|Lost to Follow-up|0|||
46722441|NCT01928394|82938382|FG002|Follow-up Period|Lost to Follow-up|0|||
46722442|NCT01928394|82938383|FG003|Follow-up Period|Lost to Follow-up|0|||
46722443|NCT01928394|82938384|FG004|Follow-up Period|Lost to Follow-up|0|||
46722444|NCT01928394|82938385|FG005|Follow-up Period|Lost to Follow-up|0|||
46722445|NCT01928394|82938386|FG006|Follow-up Period|Lost to Follow-up|0|||
46722446|NCT01928394|82938387|FG007|Follow-up Period|Lost to Follow-up|0|||
46722447|NCT01928394|82938388|FG008|Follow-up Period|Lost to Follow-up|0|||
46722448|NCT01928394|82938389|FG009|Follow-up Period|Lost to Follow-up|0|||
46722449|NCT01928394|82938390|FG010|Follow-up Period|Lost to Follow-up|0|||
46722450|NCT01928394|82938391|FG011|Follow-up Period|Lost to Follow-up|1|||
46722451|NCT01928394|82938392|FG012|Follow-up Period|Lost to Follow-up|1|||
46722452|NCT01928394|82938393|FG013|Follow-up Period|Lost to Follow-up|0|||
46722453|NCT01928394|82938394|FG014|Follow-up Period|Lost to Follow-up|1|||
46722454|NCT01928394|82938395|FG015|Follow-up Period|Lost to Follow-up|0|||
46722455|NCT01928394|82938396|FG016|Follow-up Period|Lost to Follow-up|1|||
46722456|NCT01928394|82938397|FG017|Follow-up Period|Lost to Follow-up|0|||
46722457|NCT01928394|82938398|FG018|Follow-up Period|Lost to Follow-up|0|||
46722458|NCT01928394|82938399|FG019|Follow-up Period|Lost to Follow-up|0|||
46722459|NCT01928394|82938400|FG020|Follow-up Period|Lost to Follow-up|0|||
46722460|NCT01928394|82938401|FG021|Follow-up Period|Lost to Follow-up|0|||
46722461|NCT01928394|82938402|FG022|Follow-up Period|Lost to Follow-up|1|||
46722462|NCT01864018|82938452|FG000|Overall Study|Ineligible|3|||
47044895|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
47044896|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
47044897|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
47044898|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
47044899|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
47044900|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
46633754|NCT01728324|82807242|FG000|Termination of FDV|Adverse Event|14|||
46633755|NCT01728324|82807243|FG001|Termination of FDV|Adverse Event|13|||
46633756|NCT01728324|82807244|FG002|Termination of FDV|Adverse Event|4|||
46633757|NCT01728324|82807242|FG000|Termination of FDV|Lack of Efficacy|14|||
46633758|NCT01728324|82807243|FG001|Termination of FDV|Lack of Efficacy|12|||
46633759|NCT01728324|82807244|FG002|Termination of FDV|Lack of Efficacy|8|||
46633760|NCT01728324|82807242|FG000|Termination of FDV|Withdrawal by Subject|9|||
46633761|NCT01728324|82807243|FG001|Termination of FDV|Withdrawal by Subject|6|||
46633762|NCT01728324|82807244|FG002|Termination of FDV|Withdrawal by Subject|2|||
46633763|NCT01728324|82807242|FG000|Termination of FDV|Other than stated|1|||
46633764|NCT01728324|82807243|FG001|Termination of FDV|Other than stated|3|||
46633765|NCT01728324|82807244|FG002|Termination of FDV|Other than stated|0|||
46633766|NCT01728324|82807242|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
46633767|NCT01728324|82807243|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
46633768|NCT01728324|82807244|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
46633769|NCT01728324|82807242|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
46633770|NCT01728324|82807243|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
46633771|NCT01728324|82807244|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
46633772|NCT01728324|82807242|FG000|Termination of RBV|Adverse Event|15|||
46633773|NCT01728324|82807243|FG001|Termination of RBV|Adverse Event|16|||
46633774|NCT01728324|82807244|FG002|Termination of RBV|Adverse Event|5|||
46633775|NCT01728324|82807242|FG000|Termination of RBV|Lack of Efficacy|14|||
46633776|NCT01728324|82807243|FG001|Termination of RBV|Lack of Efficacy|11|||
46633777|NCT01728324|82807244|FG002|Termination of RBV|Lack of Efficacy|7|||
46633778|NCT01728324|82807242|FG000|Termination of RBV|Withdrawal by Subject|9|||
46633779|NCT01728324|82807243|FG001|Termination of RBV|Withdrawal by Subject|5|||
46633780|NCT01728324|82807244|FG002|Termination of RBV|Withdrawal by Subject|2|||
46633781|NCT01728324|82807242|FG000|Termination of RBV|Other than stated|1|||
46633782|NCT01728324|82807243|FG001|Termination of RBV|Other than stated|3|||
46633783|NCT01728324|82807244|FG002|Termination of RBV|Other than stated|1|||
46722463|NCT01864018|82938453|FG001|Overall Study|Ineligible|1|||
46722464|NCT01850108|82938464|FG000|Overall Study|Lost to Follow-up|4|||
46722465|NCT01850108|82938464|FG000|Overall Study|Not eligible|1|||
46722466|NCT01850108|82938464|FG000|Overall Study|Failed engraftment|2|||
46722467|NCT01850108|82938464|FG000|Overall Study|Physician Decision|1|||
46722468|NCT01844505|82938473|FG000|Overall Study|Disease progression|170|||
46722469|NCT01844505|82938474|FG001|Overall Study|Disease progression|88|||
46722470|NCT01844505|82938475|FG002|Overall Study|Disease progression|224|||
46722471|NCT01844505|82938473|FG000|Overall Study|Study drug toxicity|40|||
46722472|NCT01844505|82938474|FG001|Overall Study|Study drug toxicity|131|||
46722473|NCT01844505|82938475|FG002|Overall Study|Study drug toxicity|50|||
46722474|NCT01844505|82938473|FG000|Overall Study|Death|1|||
46722475|NCT01844505|82938474|FG001|Overall Study|Death|3|||
46722476|NCT01844505|82938475|FG002|Overall Study|Death|1|||
46722477|NCT01844505|82938473|FG000|Overall Study|Adverse event unrelated to study drug|7|||
46722478|NCT01844505|82938474|FG001|Overall Study|Adverse event unrelated to study drug|15|||
46722479|NCT01844505|82938475|FG002|Overall Study|Adverse event unrelated to study drug|6|||
46722480|NCT01844505|82938473|FG000|Overall Study|Subject request discontinue treatment|17|||
46722481|NCT01844505|82938474|FG001|Overall Study|Subject request discontinue treatment|14|||
46722482|NCT01844505|82938475|FG002|Overall Study|Subject request discontinue treatment|8|||
46722483|NCT01844505|82938473|FG000|Overall Study|Withdrawal by Subject|0|||
46722484|NCT01844505|82938474|FG001|Overall Study|Withdrawal by Subject|3|||
46722485|NCT01844505|82938475|FG002|Overall Study|Withdrawal by Subject|0|||
46722486|NCT01844505|82938473|FG000|Overall Study|Lost to Follow-up|1|||
46722487|NCT01844505|82938474|FG001|Overall Study|Lost to Follow-up|0|||
46722488|NCT01844505|82938475|FG002|Overall Study|Lost to Follow-up|0|||
46722489|NCT01844505|82938473|FG000|Overall Study|Maximum clinical benefit|8|||
46722490|NCT01844505|82938474|FG001|Overall Study|Maximum clinical benefit|11|||
46722491|NCT01844505|82938475|FG002|Overall Study|Maximum clinical benefit|2|||
46722492|NCT01844505|82938473|FG000|Overall Study|Poor/non-compliance|1|||
46722493|NCT01844505|82938474|FG001|Overall Study|Poor/non-compliance|1|||
46722494|NCT01844505|82938475|FG002|Overall Study|Poor/non-compliance|1|||
46722495|NCT01844505|82938473|FG000|Overall Study|Subject no longer meets criteria|0|||
46722496|NCT01844505|82938474|FG001|Overall Study|Subject no longer meets criteria|1|||
46722497|NCT01844505|82938475|FG002|Overall Study|Subject no longer meets criteria|0|||
46722498|NCT01844505|82938473|FG000|Overall Study|Other Reasons|4|||
46722499|NCT01844505|82938474|FG001|Overall Study|Other Reasons|2|||
46722500|NCT01844505|82938475|FG002|Overall Study|Other Reasons|2|||
46722501|NCT01844505|82938473|FG000|Overall Study|Not Reported|0|||
46633784|NCT01728324|82807242|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
46633785|NCT01728324|82807243|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
46633786|NCT01728324|82807244|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
46633787|NCT01728324|82807242|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
46722502|NCT01844505|82938474|FG001|Overall Study|Not Reported|0|||
46722503|NCT01844505|82938475|FG002|Overall Study|Not Reported|1|||
46633788|NCT01728324|82807243|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
46633789|NCT01728324|82807244|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
46633790|NCT01728246|82807256|FG000|Overall Study|Participant needed rescue medication|1|||
46722504|NCT01796171|82938497|FG000|Enrolled|Death|0|||
46722505|NCT01796171|82938498|FG001|Enrolled|Death|0|||
46722506|NCT01796171|82938499|FG002|Enrolled|Death|0|||
46722507|NCT01796171|82938500|FG003|Enrolled|Death|0|||
46722508|NCT01796171|82938501|FG004|Enrolled|Death|0|||
46722509|NCT01796171|82938502|FG005|Enrolled|Death|0|||
46722510|NCT01796171|82938503|FG006|Enrolled|Death|0|||
46722511|NCT01796171|82938504|FG007|Enrolled|Death|0|||
46722512|NCT01796171|82938505|FG008|Enrolled|Death|0|||
46722513|NCT01796171|82938506|FG009|Enrolled|Death|0|||
46722514|NCT01796171|82938507|FG010|Enrolled|Death|0|||
46722515|NCT01796171|82938508|FG011|Enrolled|Death|0|||
47044901|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
47044902|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
47044903|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
47044904|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
47044905|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
47044906|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
47044907|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
47044908|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
46722516|NCT01796171|82938509|FG012|Enrolled|Death|0|||
46722517|NCT01796171|82938510|FG013|Enrolled|Death|0|||
46722518|NCT01796171|82938511|FG014|Enrolled|Death|1|||
46722519|NCT01796171|82938497|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
46722520|NCT01796171|82938498|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
46633791|NCT01728246|82807257|FG001|Overall Study|Participant needed rescue medication|5|||
46722521|NCT01796171|82938499|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
46633792|NCT01728246|82807256|FG000|Overall Study|Protocol Violation|1|||
46722522|NCT01796171|82938500|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
46722523|NCT01796171|82938501|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
46722524|NCT01796171|82938502|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
46722525|NCT01796171|82938503|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
46722526|NCT01796171|82938504|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
46722527|NCT01796171|82938505|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
46722528|NCT01796171|82938506|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
46722529|NCT01796171|82938507|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
46722530|NCT01796171|82938508|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
46722531|NCT01796171|82938509|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
46722532|NCT01796171|82938510|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
46722533|NCT01796171|82938511|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
46722534|NCT01796171|82938497|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722535|NCT01796171|82938498|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722536|NCT01796171|82938499|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722537|NCT01796171|82938500|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722538|NCT01796171|82938501|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722539|NCT01796171|82938502|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722540|NCT01796171|82938503|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722541|NCT01796171|82938504|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722542|NCT01796171|82938505|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722543|NCT01796171|82938506|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722544|NCT01796171|82938507|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722545|NCT01796171|82938508|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722546|NCT01796171|82938509|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722547|NCT01796171|82938510|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
46722548|NCT01796171|82938511|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
46722549|NCT01796171|82938497|FG000|Treatment Period With Betalutin|Progressive disease|0|||
46722550|NCT01796171|82938498|FG001|Treatment Period With Betalutin|Progressive disease|1|||
46722551|NCT01796171|82938499|FG002|Treatment Period With Betalutin|Progressive disease|0|||
46722552|NCT01796171|82938500|FG003|Treatment Period With Betalutin|Progressive disease|0|||
46722553|NCT01796171|82938501|FG004|Treatment Period With Betalutin|Progressive disease|0|||
46722554|NCT01796171|82938502|FG005|Treatment Period With Betalutin|Progressive disease|0|||
46722555|NCT01796171|82938503|FG006|Treatment Period With Betalutin|Progressive disease|0|||
46722556|NCT01796171|82938504|FG007|Treatment Period With Betalutin|Progressive disease|0|||
46722557|NCT01796171|82938505|FG008|Treatment Period With Betalutin|Progressive disease|0|||
46722558|NCT01796171|82938506|FG009|Treatment Period With Betalutin|Progressive disease|0|||
46722559|NCT01796171|82938507|FG010|Treatment Period With Betalutin|Progressive disease|0|||
46722560|NCT01796171|82938508|FG011|Treatment Period With Betalutin|Progressive disease|0|||
46722561|NCT01796171|82938509|FG012|Treatment Period With Betalutin|Progressive disease|0|||
46722562|NCT01796171|82938510|FG013|Treatment Period With Betalutin|Progressive disease|0|||
46722563|NCT01796171|82938511|FG014|Treatment Period With Betalutin|Progressive disease|0|||
46722564|NCT01796171|82938497|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722565|NCT01796171|82938498|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722566|NCT01796171|82938499|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722567|NCT01796171|82938500|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722568|NCT01796171|82938501|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46920535|NCT00960141|83152846|FG001|Overall Study|Lack of Efficacy|4|||
47044909|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
47044910|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
47044911|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
47044912|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
47044913|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
46633793|NCT01728246|82807257|FG001|Overall Study|Protocol Violation|0|||
46633794|NCT01728246|82807256|FG000|Overall Study|Withdrawal by Subject|2|||
46633795|NCT01728246|82807257|FG001|Overall Study|Withdrawal by Subject|3|||
46920536|NCT00960141|83152847|FG002|Overall Study|Lack of Efficacy|2|||
47044914|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
47044915|NCT01810939|83301548|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
46633796|NCT01728246|82807256|FG000|Overall Study|Lost to Follow-up|23|||
46633797|NCT01728246|82807257|FG001|Overall Study|Lost to Follow-up|22|||
46633798|NCT01728246|82807256|FG000|Overall Study|Lack of Efficacy|1|||
46633799|NCT01728246|82807257|FG001|Overall Study|Lack of Efficacy|1|||
46633800|NCT01728246|82807256|FG000|Overall Study|Adverse Event|8|||
46633801|NCT01728246|82807257|FG001|Overall Study|Adverse Event|5|||
46633802|NCT01705236|82807263|FG000|Overall Study|Lost to Follow-up|1|||
46633803|NCT01705236|82807263|FG000|Overall Study|Administrative problems|2|||
46722569|NCT01796171|82938502|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722570|NCT01796171|82938503|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722571|NCT01796171|82938504|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46920537|NCT00960141|83152845|FG000|Overall Study|Lost to Follow-up|1|||
46920538|NCT00960141|83152846|FG001|Overall Study|Lost to Follow-up|0|||
46633804|NCT01705236|82807263|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
46633805|NCT01705236|82807263|FG000|Overall Study|Protocol Violation|3|||
46722572|NCT01796171|82938505|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
46722573|NCT01796171|82938506|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722574|NCT01796171|82938507|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
46722575|NCT01796171|82938508|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
46722576|NCT01796171|82938509|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722577|NCT01796171|82938510|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722578|NCT01796171|82938511|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
46722579|NCT01796171|82938497|FG000|Treatment Period With Betalutin|Physician Decision|0|||
46722580|NCT01796171|82938498|FG001|Treatment Period With Betalutin|Physician Decision|0|||
46722581|NCT01796171|82938499|FG002|Treatment Period With Betalutin|Physician Decision|0|||
46722582|NCT01796171|82938500|FG003|Treatment Period With Betalutin|Physician Decision|0|||
46722583|NCT01796171|82938501|FG004|Treatment Period With Betalutin|Physician Decision|0|||
46722584|NCT01796171|82938502|FG005|Treatment Period With Betalutin|Physician Decision|0|||
46722585|NCT01796171|82938503|FG006|Treatment Period With Betalutin|Physician Decision|0|||
46722586|NCT01796171|82938504|FG007|Treatment Period With Betalutin|Physician Decision|0|||
46722587|NCT01796171|82938505|FG008|Treatment Period With Betalutin|Physician Decision|0|||
46722588|NCT01796171|82938506|FG009|Treatment Period With Betalutin|Physician Decision|0|||
46722589|NCT01796171|82938507|FG010|Treatment Period With Betalutin|Physician Decision|5|||
46722590|NCT01796171|82938508|FG011|Treatment Period With Betalutin|Physician Decision|1|||
46722591|NCT01796171|82938509|FG012|Treatment Period With Betalutin|Physician Decision|1|||
46722592|NCT01796171|82938510|FG013|Treatment Period With Betalutin|Physician Decision|0|||
46722593|NCT01796171|82938511|FG014|Treatment Period With Betalutin|Physician Decision|0|||
46722594|NCT01796171|82938497|FG000|Treatment Period With Betalutin|Death|0|||
46722595|NCT01796171|82938498|FG001|Treatment Period With Betalutin|Death|0|||
46722596|NCT01796171|82938499|FG002|Treatment Period With Betalutin|Death|0|||
46722597|NCT01796171|82938500|FG003|Treatment Period With Betalutin|Death|0|||
46722598|NCT01796171|82938501|FG004|Treatment Period With Betalutin|Death|0|||
46722599|NCT01796171|82938502|FG005|Treatment Period With Betalutin|Death|0|||
46722600|NCT01796171|82938503|FG006|Treatment Period With Betalutin|Death|0|||
46722601|NCT01796171|82938504|FG007|Treatment Period With Betalutin|Death|0|||
46722602|NCT01796171|82938505|FG008|Treatment Period With Betalutin|Death|0|||
46722603|NCT01796171|82938506|FG009|Treatment Period With Betalutin|Death|0|||
46722604|NCT01796171|82938507|FG010|Treatment Period With Betalutin|Death|2|||
46722605|NCT01796171|82938508|FG011|Treatment Period With Betalutin|Death|0|||
46722606|NCT01796171|82938509|FG012|Treatment Period With Betalutin|Death|0|||
46722607|NCT01796171|82938510|FG013|Treatment Period With Betalutin|Death|0|||
46722608|NCT01796171|82938511|FG014|Treatment Period With Betalutin|Death|0|||
46722609|NCT01796171|82938497|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
46722610|NCT01796171|82938498|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
46722611|NCT01796171|82938499|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
46722612|NCT01796171|82938500|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
46722613|NCT01796171|82938501|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
46722614|NCT01796171|82938502|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
46722615|NCT01796171|82938503|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
46722616|NCT01796171|82938504|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
46722617|NCT01796171|82938505|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
46722618|NCT01796171|82938506|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
46722619|NCT01796171|82938507|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
46722620|NCT01796171|82938508|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
46722621|NCT01796171|82938509|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
46722622|NCT01796171|82938510|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
46722623|NCT01796171|82938511|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
46722624|NCT01796171|82938497|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722625|NCT01796171|82938498|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722626|NCT01796171|82938499|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722627|NCT01796171|82938500|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722628|NCT01796171|82938501|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722629|NCT01796171|82938502|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722630|NCT01796171|82938503|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722631|NCT01796171|82938504|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46920539|NCT00960141|83152847|FG002|Overall Study|Lost to Follow-up|0|||
46722632|NCT01796171|82938505|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722633|NCT01796171|82938506|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722634|NCT01796171|82938507|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
46722635|NCT01796171|82938508|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
46722636|NCT01796171|82938509|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722637|NCT01796171|82938510|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46920540|NCT00960141|83152845|FG000|Overall Study|Protocol Violation|1|||
46633806|NCT01705236|82807263|FG000|Overall Study|Abnormal test procedure result(s)|4|||
46633807|NCT01705236|82807263|FG000|Overall Study|Abnormal laboratory value(s)|4|||
46722638|NCT01796171|82938511|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
46722639|NCT01796171|82938497|FG000|Follow-up Period|Start of further anticancer therapy|4|||
46722640|NCT01796171|82938498|FG001|Follow-up Period|Start of further anticancer therapy|25|||
46722641|NCT01796171|82938499|FG002|Follow-up Period|Start of further anticancer therapy|2|||
46722642|NCT01796171|82938500|FG003|Follow-up Period|Start of further anticancer therapy|1|||
46722643|NCT01796171|82938501|FG004|Follow-up Period|Start of further anticancer therapy|2|||
46722644|NCT01796171|82938502|FG005|Follow-up Period|Start of further anticancer therapy|2|||
46722645|NCT01796171|82938503|FG006|Follow-up Period|Start of further anticancer therapy|1|||
46722646|NCT01796171|82938504|FG007|Follow-up Period|Start of further anticancer therapy|15|||
46722647|NCT01796171|82938505|FG008|Follow-up Period|Start of further anticancer therapy|2|||
46722648|NCT01796171|82938506|FG009|Follow-up Period|Start of further anticancer therapy|0|||
46722649|NCT01796171|82938507|FG010|Follow-up Period|Start of further anticancer therapy|0|||
46722650|NCT01796171|82938508|FG011|Follow-up Period|Start of further anticancer therapy|0|||
46722651|NCT01796171|82938509|FG012|Follow-up Period|Start of further anticancer therapy|0|||
46722652|NCT01796171|82938510|FG013|Follow-up Period|Start of further anticancer therapy|0|||
46722653|NCT01796171|82938511|FG014|Follow-up Period|Start of further anticancer therapy|0|||
46722654|NCT01796171|82938497|FG000|Follow-up Period|Progressive disease|0|||
46722655|NCT01796171|82938498|FG001|Follow-up Period|Progressive disease|1|||
46722656|NCT01796171|82938499|FG002|Follow-up Period|Progressive disease|0|||
46722657|NCT01796171|82938500|FG003|Follow-up Period|Progressive disease|0|||
46722658|NCT01796171|82938501|FG004|Follow-up Period|Progressive disease|0|||
46722659|NCT01796171|82938502|FG005|Follow-up Period|Progressive disease|0|||
46722660|NCT01796171|82938503|FG006|Follow-up Period|Progressive disease|0|||
46722661|NCT01796171|82938504|FG007|Follow-up Period|Progressive disease|3|||
46722662|NCT01796171|82938505|FG008|Follow-up Period|Progressive disease|0|||
46722663|NCT01796171|82938506|FG009|Follow-up Period|Progressive disease|0|||
46722664|NCT01796171|82938507|FG010|Follow-up Period|Progressive disease|0|||
46722665|NCT01796171|82938508|FG011|Follow-up Period|Progressive disease|0|||
46722666|NCT01796171|82938509|FG012|Follow-up Period|Progressive disease|0|||
46722667|NCT01796171|82938510|FG013|Follow-up Period|Progressive disease|0|||
46722668|NCT01796171|82938511|FG014|Follow-up Period|Progressive disease|0|||
46722669|NCT01796171|82938497|FG000|Follow-up Period|Physician Decision|0|||
46722670|NCT01796171|82938498|FG001|Follow-up Period|Physician Decision|2|||
46722671|NCT01796171|82938499|FG002|Follow-up Period|Physician Decision|0|||
46722672|NCT01796171|82938500|FG003|Follow-up Period|Physician Decision|0|||
46722673|NCT01796171|82938501|FG004|Follow-up Period|Physician Decision|0|||
46722674|NCT01796171|82938502|FG005|Follow-up Period|Physician Decision|0|||
46722675|NCT01796171|82938503|FG006|Follow-up Period|Physician Decision|0|||
46722676|NCT01796171|82938504|FG007|Follow-up Period|Physician Decision|0|||
46722677|NCT01796171|82938505|FG008|Follow-up Period|Physician Decision|0|||
46722678|NCT01796171|82938506|FG009|Follow-up Period|Physician Decision|0|||
46722679|NCT01796171|82938507|FG010|Follow-up Period|Physician Decision|5|||
46722680|NCT01796171|82938508|FG011|Follow-up Period|Physician Decision|0|||
46722681|NCT01796171|82938509|FG012|Follow-up Period|Physician Decision|0|||
46722682|NCT01796171|82938510|FG013|Follow-up Period|Physician Decision|0|||
46722683|NCT01796171|82938511|FG014|Follow-up Period|Physician Decision|0|||
46722684|NCT01796171|82938497|FG000|Follow-up Period|Withdrawal by Subject|0|||
46722685|NCT01796171|82938498|FG001|Follow-up Period|Withdrawal by Subject|1|||
46722686|NCT01796171|82938499|FG002|Follow-up Period|Withdrawal by Subject|0|||
47044916|NCT01810939|83301549|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
46633808|NCT01705236|82807263|FG000|Overall Study|Withdrawal by Subject|5|||
46633809|NCT01705236|82807263|FG000|Overall Study|Adverse Event|5|||
46633810|NCT01705080|82807270|FG000|Overall Study|Missed visit|10|||
46633811|NCT01705080|82807271|FG001|Overall Study|Missed visit|4|||
46633812|NCT01705080|82807272|FG002|Overall Study|Missed visit|1|||
46633813|NCT01705080|82807270|FG000|Overall Study|Death|4|||
46633814|NCT01705080|82807271|FG001|Overall Study|Death|4|||
46633815|NCT01705080|82807272|FG002|Overall Study|Death|6|||
46633816|NCT01705080|82807270|FG000|Overall Study|Withdrawal by Subject|61|||
46633817|NCT01705080|82807271|FG001|Overall Study|Withdrawal by Subject|44|||
46722687|NCT01796171|82938500|FG003|Follow-up Period|Withdrawal by Subject|0|||
46722688|NCT01796171|82938501|FG004|Follow-up Period|Withdrawal by Subject|0|||
46722689|NCT01796171|82938502|FG005|Follow-up Period|Withdrawal by Subject|1|||
46722690|NCT01796171|82938503|FG006|Follow-up Period|Withdrawal by Subject|0|||
46722691|NCT01796171|82938504|FG007|Follow-up Period|Withdrawal by Subject|0|||
46722692|NCT01796171|82938505|FG008|Follow-up Period|Withdrawal by Subject|0|||
46722693|NCT01796171|82938506|FG009|Follow-up Period|Withdrawal by Subject|0|||
46633818|NCT01705080|82807272|FG002|Overall Study|Withdrawal by Subject|9|||
46633819|NCT01704846|82807282|FG000|Treatment Period 2|Withdrawal by Subject|0|||
47044917|NCT01810939|83301550|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
46633820|NCT01704846|82807283|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46722694|NCT01796171|82938507|FG010|Follow-up Period|Withdrawal by Subject|3|||
46722695|NCT01796171|82938508|FG011|Follow-up Period|Withdrawal by Subject|1|||
46722696|NCT01796171|82938509|FG012|Follow-up Period|Withdrawal by Subject|0|||
46722697|NCT01796171|82938510|FG013|Follow-up Period|Withdrawal by Subject|0|||
46722698|NCT01796171|82938511|FG014|Follow-up Period|Withdrawal by Subject|0|||
46722699|NCT01796171|82938497|FG000|Follow-up Period|Death|0|||
46722700|NCT01796171|82938498|FG001|Follow-up Period|Death|0|||
46722701|NCT01796171|82938499|FG002|Follow-up Period|Death|0|||
46722702|NCT01796171|82938500|FG003|Follow-up Period|Death|0|||
46722703|NCT01796171|82938501|FG004|Follow-up Period|Death|0|||
46722704|NCT01796171|82938502|FG005|Follow-up Period|Death|0|||
46722705|NCT01796171|82938503|FG006|Follow-up Period|Death|1|||
46722706|NCT01796171|82938504|FG007|Follow-up Period|Death|0|||
46722707|NCT01796171|82938505|FG008|Follow-up Period|Death|0|||
46722708|NCT01796171|82938506|FG009|Follow-up Period|Death|0|||
46722709|NCT01796171|82938507|FG010|Follow-up Period|Death|17|||
46722710|NCT01796171|82938508|FG011|Follow-up Period|Death|9|||
46722711|NCT01796171|82938509|FG012|Follow-up Period|Death|1|||
46722712|NCT01796171|82938510|FG013|Follow-up Period|Death|0|||
46722713|NCT01796171|82938511|FG014|Follow-up Period|Death|0|||
46722714|NCT01796171|82938497|FG000|Follow-up Period|Patient transferred to other hospital|0|||
46722715|NCT01796171|82938498|FG001|Follow-up Period|Patient transferred to other hospital|1|||
46722716|NCT01796171|82938499|FG002|Follow-up Period|Patient transferred to other hospital|0|||
46722717|NCT01796171|82938500|FG003|Follow-up Period|Patient transferred to other hospital|0|||
46722718|NCT01796171|82938501|FG004|Follow-up Period|Patient transferred to other hospital|0|||
46722719|NCT01796171|82938502|FG005|Follow-up Period|Patient transferred to other hospital|0|||
46722720|NCT01796171|82938503|FG006|Follow-up Period|Patient transferred to other hospital|0|||
46722721|NCT01796171|82938504|FG007|Follow-up Period|Patient transferred to other hospital|0|||
46722722|NCT01796171|82938505|FG008|Follow-up Period|Patient transferred to other hospital|0|||
46722723|NCT01796171|82938506|FG009|Follow-up Period|Patient transferred to other hospital|0|||
46722724|NCT01796171|82938507|FG010|Follow-up Period|Patient transferred to other hospital|0|||
46722725|NCT01796171|82938508|FG011|Follow-up Period|Patient transferred to other hospital|0|||
46722726|NCT01796171|82938509|FG012|Follow-up Period|Patient transferred to other hospital|0|||
46920541|NCT00960141|83152846|FG001|Overall Study|Protocol Violation|3|||
46920542|NCT00960141|83152847|FG002|Overall Study|Protocol Violation|2|||
46920543|NCT00960141|83152845|FG000|Overall Study|Withdrawal by Subject|1|||
46920544|NCT00960141|83152846|FG001|Overall Study|Withdrawal by Subject|2|||
46920545|NCT00960141|83152847|FG002|Overall Study|Withdrawal by Subject|1|||
46920546|NCT02771522|83152855|FG000|Overall Study|Lost to Follow-up|3|||
46920547|NCT02771522|83152855|FG000|Overall Study|Withdrawal by Subject|2|||
46920548|NCT02771522|83152855|FG000|Overall Study|No white spot lesions|3|||
46920549|NCT00759655|83152864|FG000|Overall Study|Termination of the study by sponsor|1|||
47044918|NCT01810783|83301569|FG000|Overall Study|Adverse Event|32|||
47044919|NCT01810783|83301569|FG000|Overall Study|Withdrawal by Subject|22|||
47044920|NCT01810783|83301569|FG000|Overall Study|Lack of Efficacy|12|||
47044921|NCT01810783|83301569|FG000|Overall Study|Lost to Follow-up|10|||
47044922|NCT01810783|83301569|FG000|Overall Study|Protocol Violation|5|||
47044923|NCT01810783|83301569|FG000|Overall Study|Non-compliance with IMP|4|||
47044924|NCT01810783|83301569|FG000|Overall Study|Adminstrative or other reason(s)|23|||
47044925|NCT01810783|83301569|FG000|Overall Study|Enrolled, not treated|1|||
47044926|NCT01808209|83301590|FG000|Overall Study|Lost to Follow-up|0|||
47044927|NCT01808209|83301591|FG001|Overall Study|Lost to Follow-up|1|||
47044928|NCT01807117|83301601|FG000|Overall Study|Physician Decision|2|||
47044929|NCT01807117|83301601|FG000|Overall Study|Disease diagnosis not a study disease|1|||
47044930|NCT01806961|83301607|FG000|Overall Study|sponsor decision|16|||
47044931|NCT01613131|83301613|FG000|Overall Study|Withdrawal by Subject|3|||
47044932|NCT01613131|83301614|FG001|Overall Study|Withdrawal by Subject|5|||
47044933|NCT01868893|83301620|FG000|Overall Study|Adverse Event|2|||
47044934|NCT01868893|83301620|FG000|Overall Study|Commercial availability of study drug|17|||
47044935|NCT01868893|83301620|FG000|Overall Study|Neutropenia|1|||
47044936|NCT01868503|83301626|FG000|Overall Study|Withdrawal by Subject|1|||
47044937|NCT01868503|83301626|FG000|Overall Study|Protocol Violation|1|||
47044938|NCT01868035|83301636|FG000|Overall Study|Lost to Follow-up|3|||
47044939|NCT01868035|83301636|FG000|Overall Study|Withdrawal by Subject|1|||
47044940|NCT01868035|83301636|FG000|Overall Study|Progressive Disease|2|||
46722727|NCT01796171|82938510|FG013|Follow-up Period|Patient transferred to other hospital|0|||
46722728|NCT01796171|82938511|FG014|Follow-up Period|Patient transferred to other hospital|0|||
46920550|NCT02771366|83152870|FG000|Period 1|Withdrawal by Subject|0|||
46722729|NCT01796171|82938497|FG000|Follow-up Period|Sponsor Decision|0|||
46722730|NCT01796171|82938498|FG001|Follow-up Period|Sponsor Decision|0|||
46722731|NCT01796171|82938499|FG002|Follow-up Period|Sponsor Decision|0|||
46722732|NCT01796171|82938500|FG003|Follow-up Period|Sponsor Decision|0|||
46920551|NCT02771366|83152871|FG001|Period 1|Withdrawal by Subject|2|||
46920552|NCT02771366|83152870|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
47044941|NCT01868035|83301636|FG000|Overall Study|Non-compliance|1|||
46722733|NCT01796171|82938501|FG004|Follow-up Period|Sponsor Decision|0|||
46722734|NCT01796171|82938502|FG005|Follow-up Period|Sponsor Decision|0|||
46722735|NCT01796171|82938503|FG006|Follow-up Period|Sponsor Decision|0|||
46722736|NCT01796171|82938504|FG007|Follow-up Period|Sponsor Decision|0|||
46722737|NCT01796171|82938505|FG008|Follow-up Period|Sponsor Decision|0|||
46722738|NCT01796171|82938506|FG009|Follow-up Period|Sponsor Decision|0|||
46722739|NCT01796171|82938507|FG010|Follow-up Period|Sponsor Decision|40|||
46722740|NCT01796171|82938508|FG011|Follow-up Period|Sponsor Decision|15|||
46722741|NCT01796171|82938509|FG012|Follow-up Period|Sponsor Decision|7|||
46722742|NCT01796171|82938510|FG013|Follow-up Period|Sponsor Decision|0|||
46722743|NCT01796171|82938511|FG014|Follow-up Period|Sponsor Decision|0|||
46722744|NCT01620944|82938544|FG000|Overall Study|Early termination of Study|2|||
46722745|NCT01620944|82938545|FG001|Overall Study|Early termination of Study|1|||
46722746|NCT01522976|82938554|FG000|Overall Study|Ineligible|4|||
46722747|NCT01522976|82938555|FG001|Overall Study|Ineligible|0|||
46722748|NCT01522976|82938556|FG002|Overall Study|Ineligible|1|||
46722749|NCT01522976|82938554|FG000|Overall Study|Death|7|||
46722750|NCT01522976|82938555|FG001|Overall Study|Death|6|||
46722751|NCT01522976|82938556|FG002|Overall Study|Death|2|||
46722752|NCT01522976|82938554|FG000|Overall Study|Still on treatment|9|||
47044942|NCT01609933|83301640|FG000|Overall Study|Adverse Event|1|||
47044943|NCT01609933|83301640|FG000|Overall Study|Withdrawal by Subject|3|||
46722753|NCT01522976|82938555|FG001|Overall Study|Still on treatment|9|||
46920553|NCT02771366|83152871|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
46920554|NCT03396471|83152878|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
47044944|NCT01843777|83301648|FG000|Overall Study|Withdrawal by Subject|1|||
47044945|NCT01843777|83301649|FG001|Overall Study|Withdrawal by Subject|0|||
47044946|NCT01842607|83301655|FG000|Overall Study|Adverse Event|11|||
47044947|NCT01842607|83301655|FG000|Overall Study|Lack of Efficacy|19|||
47044948|NCT01842607|83301655|FG000|Overall Study|Protocol Violation|8|||
47044949|NCT01842607|83301655|FG000|Overall Study|Protocol defined stopping criteria|2|||
47044950|NCT01842607|83301655|FG000|Overall Study|Lost to Follow-up|3|||
47044951|NCT01842607|83301655|FG000|Overall Study|Physician Decision|9|||
47044952|NCT01842607|83301655|FG000|Overall Study|Withdrawal by Subject|14|||
46633821|NCT01751802|82807291|FG000|Overall Study|Adverse Event|4|||
46633822|NCT01751802|82807292|FG001|Overall Study|Adverse Event|2|||
46633823|NCT01704456|82807306|FG000|Overall Study|Lost to Follow-up|8|||
46633824|NCT01704456|82807307|FG001|Overall Study|Lost to Follow-up|14|||
46633825|NCT01703988|82807317|FG000|Overall Study|Investigator Judgment|0|||
46633826|NCT01703988|82807318|FG001|Overall Study|Investigator Judgment|0|||
46633827|NCT01703988|82807319|FG002|Overall Study|Investigator Judgment|0|||
46633828|NCT01703988|82807320|FG003|Overall Study|Investigator Judgment|1|||
46633829|NCT01703832|82807333|FG000|Overall Study|Withdrawal by Subject|1|||
46633830|NCT01703832|82807334|FG001|Overall Study|Withdrawal by Subject|0|||
46633831|NCT01703286|82807340|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
46633832|NCT01703286|82807341|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
46633833|NCT01703286|82807342|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
46633834|NCT01703286|82807343|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
46633835|NCT01703286|82807344|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
46633836|NCT01703286|82807345|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
46633837|NCT01703286|82807340|FG000|Period 2 Including Washout|Adverse Event|0|||
46633838|NCT01703286|82807341|FG001|Period 2 Including Washout|Adverse Event|0|||
46633839|NCT01703286|82807342|FG002|Period 2 Including Washout|Adverse Event|0|||
46722754|NCT01522976|82938556|FG002|Overall Study|Still on treatment|6|||
46722755|NCT01522976|82938554|FG000|Overall Study|Disease progression|28|||
46722756|NCT01522976|82938555|FG001|Overall Study|Disease progression|30|||
46722757|NCT01522976|82938556|FG002|Overall Study|Disease progression|25|||
46722758|NCT01522976|82938554|FG000|Overall Study|Adverse Event|17|||
46633840|NCT01703286|82807343|FG003|Period 2 Including Washout|Adverse Event|1|||
46633841|NCT01703286|82807344|FG004|Period 2 Including Washout|Adverse Event|0|||
46633842|NCT01703286|82807345|FG005|Period 2 Including Washout|Adverse Event|0|||
46722759|NCT01522976|82938555|FG001|Overall Study|Adverse Event|7|||
46722760|NCT01522976|82938556|FG002|Overall Study|Adverse Event|18|||
46722761|NCT01522976|82938554|FG000|Overall Study|Refusal unrelated to adverse event|10|||
46722762|NCT01522976|82938555|FG001|Overall Study|Refusal unrelated to adverse event|13|||
47044953|NCT01803607|83301661|FG000|Overall Study|Adverse Event|5|||
46920555|NCT03396471|83152878|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
46920556|NCT03396471|83152878|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
46920557|NCT03396471|83152878|FG000|Study Treatment - Up to 22 Months|Death|2|||
46920558|NCT03396471|83152878|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
46920559|NCT03396471|83152878|FG000|Follow up - Up to 2 Years|Death|9|||
46722763|NCT01522976|82938556|FG002|Overall Study|Refusal unrelated to adverse event|14|||
46722764|NCT01522976|82938554|FG000|Overall Study|Not protocol specified|22|||
47044954|NCT01803607|83301662|FG001|Overall Study|Adverse Event|3|||
47044955|NCT01803607|83301661|FG000|Overall Study|Lack of Efficacy|0|||
46722765|NCT01522976|82938555|FG001|Overall Study|Not protocol specified|27|||
46722766|NCT01522976|82938556|FG002|Overall Study|Not protocol specified|27|||
46722767|NCT01371981|82938573|FG000|Overall Study|Adverse Event|12|||
46722768|NCT01371981|82938574|FG001|Overall Study|Adverse Event|17|||
46920560|NCT03396471|83152878|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
46920561|NCT03396471|83152878|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
46920562|NCT03396471|83152878|FG000|Follow up - Up to 2 Years|study terminated|1|||
46920563|NCT03396471|83152878|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
47044956|NCT01803607|83301662|FG001|Overall Study|Lack of Efficacy|1|||
47044957|NCT01803607|83301661|FG000|Overall Study|Protocol Violation|3|||
46722769|NCT01371981|82938575|FG002|Overall Study|Adverse Event|0|||
46722770|NCT01371981|82938576|FG003|Overall Study|Adverse Event|4|||
46722771|NCT01371981|82938577|FG004|Overall Study|Adverse Event|1|||
46722772|NCT01371981|82938578|FG005|Overall Study|Adverse Event|0|||
46722773|NCT01371981|82938573|FG000|Overall Study|Death|22|||
46722774|NCT01371981|82938574|FG001|Overall Study|Death|16|||
46722775|NCT01371981|82938575|FG002|Overall Study|Death|0|||
46722776|NCT01371981|82938576|FG003|Overall Study|Death|0|||
46722777|NCT01371981|82938577|FG004|Overall Study|Death|2|||
46722778|NCT01371981|82938578|FG005|Overall Study|Death|2|||
46722779|NCT01371981|82938573|FG000|Overall Study|Lack of Efficacy|69|||
46722780|NCT01371981|82938574|FG001|Overall Study|Lack of Efficacy|61|||
46722781|NCT01371981|82938575|FG002|Overall Study|Lack of Efficacy|4|||
46722782|NCT01371981|82938576|FG003|Overall Study|Lack of Efficacy|8|||
46722783|NCT01371981|82938577|FG004|Overall Study|Lack of Efficacy|5|||
46722784|NCT01371981|82938578|FG005|Overall Study|Lack of Efficacy|0|||
46722785|NCT01371981|82938573|FG000|Overall Study|Physician Decision|48|||
46722786|NCT01371981|82938574|FG001|Overall Study|Physician Decision|63|||
46722787|NCT01371981|82938575|FG002|Overall Study|Physician Decision|1|||
46722788|NCT01371981|82938576|FG003|Overall Study|Physician Decision|7|||
46722789|NCT01371981|82938577|FG004|Overall Study|Physician Decision|14|||
46722790|NCT01371981|82938578|FG005|Overall Study|Physician Decision|3|||
46722791|NCT01371981|82938573|FG000|Overall Study|Withdrawal by Subject|12|||
46722792|NCT01371981|82938574|FG001|Overall Study|Withdrawal by Subject|19|||
46722793|NCT01371981|82938575|FG002|Overall Study|Withdrawal by Subject|1|||
46722794|NCT01371981|82938576|FG003|Overall Study|Withdrawal by Subject|2|||
46722795|NCT01371981|82938577|FG004|Overall Study|Withdrawal by Subject|10|||
46722796|NCT01371981|82938578|FG005|Overall Study|Withdrawal by Subject|3|||
46722797|NCT01371981|82938573|FG000|Overall Study|Ineligible|19|||
46722798|NCT01371981|82938574|FG001|Overall Study|Ineligible|13|||
46722799|NCT01371981|82938575|FG002|Overall Study|Ineligible|0|||
46722800|NCT01371981|82938576|FG003|Overall Study|Ineligible|0|||
46722801|NCT01371981|82938577|FG004|Overall Study|Ineligible|0|||
46722802|NCT01371981|82938578|FG005|Overall Study|Ineligible|4|||
46722803|NCT01371981|82938573|FG000|Overall Study|Did not start treatment|2|||
46722804|NCT01371981|82938574|FG001|Overall Study|Did not start treatment|3|||
46722805|NCT01371981|82938575|FG002|Overall Study|Did not start treatment|0|||
46722806|NCT01371981|82938576|FG003|Overall Study|Did not start treatment|0|||
46722807|NCT01371981|82938577|FG004|Overall Study|Did not start treatment|0|||
46722808|NCT01371981|82938578|FG005|Overall Study|Did not start treatment|2|||
46722809|NCT01274338|82938603|FG000|Overall Study|Lack of Efficacy|72|||
46920564|NCT03396471|83152878|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
47044958|NCT01803607|83301662|FG001|Overall Study|Protocol Violation|2|||
47044959|NCT01803607|83301661|FG000|Overall Study|Study terminated by sponsor|54|||
47044960|NCT01803607|83301662|FG001|Overall Study|Study terminated by sponsor|56|||
46920565|NCT00103142|83152884|FG000|Overall Study|Adverse Event|1|||
47044961|NCT01803607|83301661|FG000|Overall Study|Withdrawal by Subject|6|||
46722810|NCT01274338|82938604|FG001|Overall Study|Lack of Efficacy|108|||
46722811|NCT01274338|82938605|FG002|Overall Study|Lack of Efficacy|116|||
46722812|NCT01274338|82938606|FG003|Overall Study|Lack of Efficacy|0|||
46722813|NCT01274338|82938607|FG004|Overall Study|Lack of Efficacy|0|||
46722814|NCT01274338|82938608|FG005|Overall Study|Lack of Efficacy|0|||
46722815|NCT01274338|82938603|FG000|Overall Study|Adverse Event|272|||
46722816|NCT01274338|82938604|FG001|Overall Study|Adverse Event|105|||
46722817|NCT01274338|82938605|FG002|Overall Study|Adverse Event|180|||
46722818|NCT01274338|82938606|FG003|Overall Study|Adverse Event|1|||
46722819|NCT01274338|82938607|FG004|Overall Study|Adverse Event|0|||
46722820|NCT01274338|82938608|FG005|Overall Study|Adverse Event|0|||
46722821|NCT01274338|82938603|FG000|Overall Study|Death|8|||
47044962|NCT01803607|83301662|FG001|Overall Study|Withdrawal by Subject|5|||
47044963|NCT01867021|83301670|FG000|Overall Study|Adverse Event|0|||
47044964|NCT01867021|83301671|FG001|Overall Study|Adverse Event|1|||
46722822|NCT01274338|82938604|FG001|Overall Study|Death|1|||
46722823|NCT01274338|82938605|FG002|Overall Study|Death|0|||
46722824|NCT01274338|82938606|FG003|Overall Study|Death|0|||
46722825|NCT01274338|82938607|FG004|Overall Study|Death|0|||
46722826|NCT01274338|82938608|FG005|Overall Study|Death|0|||
46722827|NCT01274338|82938603|FG000|Overall Study|Withdrawal by Subject|27|||
46722828|NCT01274338|82938604|FG001|Overall Study|Withdrawal by Subject|99|||
46722829|NCT01274338|82938605|FG002|Overall Study|Withdrawal by Subject|17|||
46722830|NCT01274338|82938606|FG003|Overall Study|Withdrawal by Subject|0|||
46722831|NCT01274338|82938607|FG004|Overall Study|Withdrawal by Subject|0|||
46722832|NCT01274338|82938608|FG005|Overall Study|Withdrawal by Subject|0|||
46722833|NCT01274338|82938603|FG000|Overall Study|Did not start treatment|8|||
46722834|NCT01274338|82938604|FG001|Overall Study|Did not start treatment|116|||
46722835|NCT01274338|82938605|FG002|Overall Study|Did not start treatment|7|||
46722836|NCT01274338|82938606|FG003|Overall Study|Did not start treatment|0|||
46722837|NCT01274338|82938607|FG004|Overall Study|Did not start treatment|0|||
46722838|NCT01274338|82938608|FG005|Overall Study|Did not start treatment|0|||
46722839|NCT01274338|82938603|FG000|Overall Study|Alternative therapy|0|||
46722840|NCT01274338|82938604|FG001|Overall Study|Alternative therapy|1|||
46722841|NCT01274338|82938605|FG002|Overall Study|Alternative therapy|0|||
46722842|NCT01274338|82938606|FG003|Overall Study|Alternative therapy|0|||
46722843|NCT01274338|82938607|FG004|Overall Study|Alternative therapy|0|||
46722844|NCT01274338|82938608|FG005|Overall Study|Alternative therapy|0|||
46722845|NCT01274338|82938603|FG000|Overall Study|Other complicating diseases|0|||
46722846|NCT01274338|82938604|FG001|Overall Study|Other complicating diseases|3|||
46722847|NCT01274338|82938605|FG002|Overall Study|Other complicating diseases|1|||
46722848|NCT01274338|82938606|FG003|Overall Study|Other complicating diseases|0|||
46722849|NCT01274338|82938607|FG004|Overall Study|Other complicating diseases|0|||
46722850|NCT01274338|82938608|FG005|Overall Study|Other complicating diseases|0|||
46722851|NCT01274338|82938603|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
46722852|NCT01274338|82938604|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
46722853|NCT01274338|82938605|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
46722854|NCT01274338|82938606|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
46722855|NCT01274338|82938607|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
46722856|NCT01274338|82938608|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
46722857|NCT01274338|82938603|FG000|Overall Study|Pregnancy|0|||
46722858|NCT01274338|82938604|FG001|Overall Study|Pregnancy|0|||
46722859|NCT01274338|82938605|FG002|Overall Study|Pregnancy|1|||
46722860|NCT01274338|82938606|FG003|Overall Study|Pregnancy|0|||
46722861|NCT01274338|82938607|FG004|Overall Study|Pregnancy|0|||
47044965|NCT01867021|83301670|FG000|Overall Study|Not Eligible|0|||
47044966|NCT01867021|83301671|FG001|Overall Study|Not Eligible|1|||
47044967|NCT01867021|83301670|FG000|Overall Study|Death|1|||
46722862|NCT01274338|82938608|FG005|Overall Study|Pregnancy|0|||
46722863|NCT01274338|82938603|FG000|Overall Study|Reason not reported|12|||
46722864|NCT01274338|82938604|FG001|Overall Study|Reason not reported|21|||
46722865|NCT01274338|82938605|FG002|Overall Study|Reason not reported|3|||
46722866|NCT01274338|82938606|FG003|Overall Study|Reason not reported|0|||
46722867|NCT01274338|82938607|FG004|Overall Study|Reason not reported|1|||
46722868|NCT01274338|82938608|FG005|Overall Study|Reason not reported|0|||
46722869|NCT01272037|82938623|FG000|Overall Study|Death|25|||
46722870|NCT01272037|82938624|FG001|Overall Study|Death|28|||
47044968|NCT01867021|83301671|FG001|Overall Study|Death|0|||
47044969|NCT01867021|83301670|FG000|Overall Study|Lost to Follow-up|0|||
47044970|NCT01867021|83301671|FG001|Overall Study|Lost to Follow-up|2|||
47044971|NCT01867021|83301670|FG000|Overall Study|Withdrawal by Subject|1|||
47044972|NCT01867021|83301671|FG001|Overall Study|Withdrawal by Subject|6|||
47044973|NCT01866709|83301684|FG000|Overall Study|Adverse Event|1|||
47044974|NCT01866709|83301685|FG001|Overall Study|Adverse Event|0|||
47044975|NCT01841593|83301693|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
47044976|NCT01841593|83301694|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
46722871|NCT01272037|82938623|FG000|Overall Study|Adverse Event|12|||
46722872|NCT01272037|82938624|FG001|Overall Study|Adverse Event|7|||
46722873|NCT01272037|82938623|FG000|Overall Study|Withdrawal by Subject|175|||
47044977|NCT01841593|83301693|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
47044978|NCT01841593|83301694|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
46722874|NCT01272037|82938624|FG001|Overall Study|Withdrawal by Subject|93|||
46722875|NCT01272037|82938623|FG000|Overall Study|Disease progression|70|||
46722876|NCT01272037|82938624|FG001|Overall Study|Disease progression|111|||
46722877|NCT01272037|82938623|FG000|Overall Study|Other reason|42|||
46722878|NCT01272037|82938624|FG001|Overall Study|Other reason|41|||
46722879|NCT01272037|82938623|FG000|Overall Study|Delinquent data|24|||
46722880|NCT01272037|82938624|FG001|Overall Study|Delinquent data|19|||
46722881|NCT01272037|82938623|FG000|Overall Study|Reason under review|33|||
46722882|NCT01272037|82938624|FG001|Overall Study|Reason under review|29|||
46722883|NCT01272037|82938623|FG000|Overall Study|On treatment|626|||
46722884|NCT01272037|82938624|FG001|Overall Study|On treatment|632|||
46920566|NCT00103142|83152885|FG001|Overall Study|Adverse Event|0|||
46920567|NCT00103142|83152884|FG000|Overall Study|Progression of disease|2|||
46920568|NCT00103142|83152885|FG001|Overall Study|Progression of disease|1|||
47044979|NCT01866319|83301947|FG000|Overall Study|Adverse Event|12|||
47044980|NCT01866319|83301948|FG001|Overall Study|Adverse Event|5|||
47044981|NCT01866319|83301949|FG002|Overall Study|Adverse Event|9|||
47044982|NCT01866319|83301947|FG000|Overall Study|Clinical progression|3|||
47044983|NCT01866319|83301948|FG001|Overall Study|Clinical progression|2|||
47044984|NCT01866319|83301949|FG002|Overall Study|Clinical progression|2|||
47044985|NCT01866319|83301947|FG000|Overall Study|Death|153|||
47044986|NCT01866319|83301948|FG001|Overall Study|Death|154|||
47044987|NCT01866319|83301949|FG002|Overall Study|Death|147|||
47044988|NCT01866319|83301947|FG000|Overall Study|Lost to Follow-up|6|||
47044989|NCT01866319|83301948|FG001|Overall Study|Lost to Follow-up|3|||
47044990|NCT01866319|83301949|FG002|Overall Study|Lost to Follow-up|8|||
47044991|NCT01866319|83301947|FG000|Overall Study|Physician Decision|1|||
47044992|NCT01866319|83301948|FG001|Overall Study|Physician Decision|0|||
47044993|NCT01866319|83301949|FG002|Overall Study|Physician Decision|1|||
47044994|NCT01866319|83301947|FG000|Overall Study|Protocol Violation|0|||
47044995|NCT01866319|83301948|FG001|Overall Study|Protocol Violation|0|||
47044996|NCT01866319|83301949|FG002|Overall Study|Protocol Violation|1|||
46633843|NCT01703208|82807358|FG000|Overall Study|Death|61|||
46633844|NCT01703208|82807359|FG001|Overall Study|Death|48|||
46633845|NCT01703208|82807358|FG000|Overall Study|Lack of Efficacy|1|||
46633846|NCT01703208|82807359|FG001|Overall Study|Lack of Efficacy|2|||
46920569|NCT00943683|83152895|FG000|Overall Study|Adverse Event|3|||
46920570|NCT00943683|83152896|FG001|Overall Study|Adverse Event|3|||
46633847|NCT01703208|82807358|FG000|Overall Study|Lost to Follow-up|68|||
46633848|NCT01703208|82807359|FG001|Overall Study|Lost to Follow-up|62|||
46633849|NCT01703208|82807358|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46633850|NCT01703208|82807359|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46633851|NCT01703208|82807358|FG000|Overall Study|Excluded Medication|1|||
46633852|NCT01703208|82807359|FG001|Overall Study|Excluded Medication|2|||
46633853|NCT01703208|82807358|FG000|Overall Study|Site Discontinued Study Participation|23|||
46633854|NCT01703208|82807359|FG001|Overall Study|Site Discontinued Study Participation|27|||
46633855|NCT01703208|82807358|FG000|Overall Study|Physician Decision|11|||
46633856|NCT01703208|82807359|FG001|Overall Study|Physician Decision|13|||
46633857|NCT01703208|82807358|FG000|Overall Study|Progressive disease|2|||
46633858|NCT01703208|82807359|FG001|Overall Study|Progressive disease|2|||
46633859|NCT01703208|82807358|FG000|Overall Study|Protocol Violation|1|||
46633860|NCT01703208|82807359|FG001|Overall Study|Protocol Violation|1|||
46633861|NCT01703208|82807358|FG000|Overall Study|Study Terminated by Sponsor|1710|||
46633862|NCT01703208|82807359|FG001|Overall Study|Study Terminated by Sponsor|1716|||
46633863|NCT01703208|82807358|FG000|Overall Study|Withdrawal by Subject|205|||
46633864|NCT01703208|82807359|FG001|Overall Study|Withdrawal by Subject|209|||
46633865|NCT01703208|82807358|FG000|Overall Study|Adverse Event|14|||
46633866|NCT01703208|82807359|FG001|Overall Study|Adverse Event|19|||
46633867|NCT01703208|82807358|FG000|Overall Study|Technical Problems|0|||
46633868|NCT01703208|82807359|FG001|Overall Study|Technical Problems|1|||
46633869|NCT01703208|82807358|FG000|Overall Study|Protocol Deviation|2|||
46633870|NCT01703208|82807359|FG001|Overall Study|Protocol Deviation|0|||
46633871|NCT01727700|82807368|FG000|Overall Study|Adverse Event|0|||
46633872|NCT01727700|82807369|FG001|Overall Study|Adverse Event|7|||
46633873|NCT01727700|82807370|FG002|Overall Study|Adverse Event|1|||
46633874|NCT01727700|82807368|FG000|Overall Study|Particpant withdrew consent|0|||
46633875|NCT01727700|82807369|FG001|Overall Study|Particpant withdrew consent|3|||
46633876|NCT01727700|82807370|FG002|Overall Study|Particpant withdrew consent|1|||
46633877|NCT01727700|82807368|FG000|Overall Study|Protocol Violation|2|||
46633878|NCT01727700|82807369|FG001|Overall Study|Protocol Violation|0|||
46633879|NCT01727700|82807370|FG002|Overall Study|Protocol Violation|0|||
46633880|NCT01727154|82807378|FG000|Overall Study|Death|17|||
47044997|NCT01866319|83301947|FG000|Overall Study|Withdrawal by Subject|32|||
47044998|NCT01866319|83301948|FG001|Overall Study|Withdrawal by Subject|14|||
47044999|NCT01866319|83301949|FG002|Overall Study|Withdrawal by Subject|12|||
46633881|NCT01727154|82807378|FG000|Overall Study|Withdrawal by Subject|14|||
46633882|NCT01727154|82807378|FG000|Overall Study|Subject Withdrew Consent|18|||
46633883|NCT01727154|82807378|FG000|Overall Study|Study Terminated|6|||
46633884|NCT01727154|82807378|FG000|Overall Study|No Discontinuation Documentation|4|||
46633885|NCT01725750|82807384|FG000|Overall Study|Adverse Event|1|||
46633886|NCT01725750|82807385|FG001|Overall Study|Adverse Event|0|||
46633887|NCT01725750|82807384|FG000|Overall Study|Lost to Follow-up|1|||
46633888|NCT01725750|82807385|FG001|Overall Study|Lost to Follow-up|1|||
46633889|NCT01725750|82807384|FG000|Overall Study|Withdrawal by Subject|0|||
46633890|NCT01725750|82807385|FG001|Overall Study|Withdrawal by Subject|9|||
47045000|NCT01802515|83301976|FG000|Overall Study|Withdrawal by Subject|3|||
47045001|NCT01802515|83301977|FG001|Overall Study|Withdrawal by Subject|0|||
46722885|NCT01199575|82938630|FG000|Overall Study|Withdrawal by Subject|5|||
46722886|NCT01194570|82938637|FG000|Overall Study|Adverse Event|22|||
46722887|NCT01194570|82938638|FG001|Overall Study|Adverse Event|40|||
46722888|NCT01194570|82938637|FG000|Overall Study|Death|6|||
46722889|NCT01194570|82938638|FG001|Overall Study|Death|20|||
46722890|NCT01194570|82938637|FG000|Overall Study|Lack of Efficacy|32|||
46722891|NCT01194570|82938638|FG001|Overall Study|Lack of Efficacy|33|||
46722892|NCT01194570|82938637|FG000|Overall Study|Lost to Follow-up|4|||
46722893|NCT01194570|82938638|FG001|Overall Study|Lost to Follow-up|15|||
46722894|NCT01194570|82938637|FG000|Overall Study|Non-Compliance|2|||
46722895|NCT01194570|82938638|FG001|Overall Study|Non-Compliance|2|||
46722896|NCT01194570|82938637|FG000|Overall Study|Non-Compliance With Study Drug|2|||
46722897|NCT01194570|82938638|FG001|Overall Study|Non-Compliance With Study Drug|2|||
46722898|NCT01194570|82938637|FG000|Overall Study|Other|18|||
46722899|NCT01194570|82938638|FG001|Overall Study|Other|47|||
46722900|NCT01194570|82938637|FG000|Overall Study|Physician Decision|10|||
46722901|NCT01194570|82938638|FG001|Overall Study|Physician Decision|25|||
46722902|NCT01194570|82938637|FG000|Overall Study|Protocol Violation|1|||
46722903|NCT01194570|82938638|FG001|Overall Study|Protocol Violation|2|||
46722904|NCT01194570|82938637|FG000|Overall Study|Study Terminated By Sponsor|0|||
46722905|NCT01194570|82938638|FG001|Overall Study|Study Terminated By Sponsor|1|||
46722906|NCT01194570|82938637|FG000|Overall Study|Withdrawal by Subject|57|||
46722907|NCT01194570|82938638|FG001|Overall Study|Withdrawal by Subject|82|||
46722908|NCT01194570|82938637|FG000|Overall Study|Pregnancy|1|||
46722909|NCT01194570|82938638|FG001|Overall Study|Pregnancy|1|||
46722910|NCT01169337|82938651|FG000|Overall Study|Lack of Efficacy|5|||
46722911|NCT01169337|82938652|FG001|Overall Study|Lack of Efficacy|7|||
46722912|NCT01169337|82938653|FG002|Overall Study|Lack of Efficacy|0|||
46722913|NCT01169337|82938651|FG000|Overall Study|Adverse Event|12|||
46722914|NCT01169337|82938652|FG001|Overall Study|Adverse Event|18|||
46722915|NCT01169337|82938653|FG002|Overall Study|Adverse Event|0|||
46722916|NCT01169337|82938651|FG000|Overall Study|Death|2|||
46722917|NCT01169337|82938652|FG001|Overall Study|Death|0|||
46920571|NCT00943683|83152895|FG000|Overall Study|Lost to Follow-up|1|||
46920572|NCT00943683|83152896|FG001|Overall Study|Lost to Follow-up|1|||
46722918|NCT01169337|82938653|FG002|Overall Study|Death|0|||
46722919|NCT01169337|82938651|FG000|Overall Study|Withdrawal by Subject|11|||
46920573|NCT00943683|83152895|FG000|Overall Study|Protocol Violation|1|||
46920574|NCT00943683|83152896|FG001|Overall Study|Protocol Violation|2|||
46920575|NCT00943683|83152895|FG000|Overall Study|Withdrawal by Subject|1|||
47045002|NCT01802515|83301978|FG002|Overall Study|Withdrawal by Subject|0|||
47045003|NCT01802437|83301988|FG000|Overall Study|Lost to Follow-up|1|||
47045004|NCT01802437|83301989|FG001|Overall Study|Lost to Follow-up|0|||
47045005|NCT01802437|83301988|FG000|Overall Study|Withdrawal by Subject|3|||
47045006|NCT01802437|83301989|FG001|Overall Study|Withdrawal by Subject|4|||
47045007|NCT01801735|83302096|FG000|Overall Study|Adverse Event|79|||
47045008|NCT01801735|83302096|FG000|Overall Study|Lack of Efficacy|28|||
46920576|NCT00943683|83152896|FG001|Overall Study|Withdrawal by Subject|0|||
46920577|NCT00943683|83152895|FG000|Overall Study|Patient Moved|1|||
46920578|NCT00943683|83152896|FG001|Overall Study|Patient Moved|0|||
46920579|NCT00911547|83152906|FG000|Overall Study|Adverse Event|8|||
46920580|NCT00911547|83152907|FG001|Overall Study|Adverse Event|27|||
47045009|NCT01801735|83302096|FG000|Overall Study|Withdrawal by Subject|27|||
47045010|NCT01801735|83302096|FG000|Overall Study|Protocol Violation|25|||
47045011|NCT01801735|83302096|FG000|Overall Study|Lost to Follow-up|15|||
47045012|NCT01801735|83302096|FG000|Overall Study|Non-compliance with Trial Drug|13|||
47045013|NCT01801735|83302096|FG000|Overall Study|Physician Decision|3|||
46722920|NCT01169337|82938652|FG001|Overall Study|Withdrawal by Subject|11|||
46722921|NCT01169337|82938653|FG002|Overall Study|Withdrawal by Subject|6|||
46722922|NCT01169337|82938651|FG000|Overall Study|Noncompliance|2|||
46722923|NCT01169337|82938652|FG001|Overall Study|Noncompliance|0|||
46722924|NCT01169337|82938653|FG002|Overall Study|Noncompliance|0|||
46722925|NCT01169337|82938651|FG000|Overall Study|Other complicating disease|1|||
46722926|NCT01169337|82938652|FG001|Overall Study|Other complicating disease|1|||
46633891|NCT01725282|82807397|FG000|Overall Study|Adverse Event|1|||
46633892|NCT01725282|82807398|FG001|Overall Study|Adverse Event|3|||
46722927|NCT01169337|82938653|FG002|Overall Study|Other complicating disease|0|||
46722928|NCT01169337|82938651|FG000|Overall Study|Physician Decision|1|||
46722929|NCT01169337|82938652|FG001|Overall Study|Physician Decision|5|||
46722930|NCT01169337|82938653|FG002|Overall Study|Physician Decision|0|||
46722931|NCT01169337|82938651|FG000|Overall Study|Alternative therapy|0|||
46722932|NCT01169337|82938652|FG001|Overall Study|Alternative therapy|2|||
46722933|NCT01169337|82938653|FG002|Overall Study|Alternative therapy|0|||
46722934|NCT01169337|82938651|FG000|Overall Study|Changed hospital|0|||
46722935|NCT01169337|82938652|FG001|Overall Study|Changed hospital|1|||
46722936|NCT01169337|82938653|FG002|Overall Study|Changed hospital|0|||
46722937|NCT01169337|82938651|FG000|Overall Study|Never started treatment|0|||
46722938|NCT01169337|82938652|FG001|Overall Study|Never started treatment|2|||
46722939|NCT01169337|82938653|FG002|Overall Study|Never started treatment|0|||
46722940|NCT01169337|82938651|FG000|Overall Study|Reason not reported|1|||
46722941|NCT01169337|82938652|FG001|Overall Study|Reason not reported|0|||
46722942|NCT01169337|82938653|FG002|Overall Study|Reason not reported|0|||
46722943|NCT01169337|82938651|FG000|Overall Study|Continuing lenalidomide|9|||
46722944|NCT01169337|82938652|FG001|Overall Study|Continuing lenalidomide|43|||
46722945|NCT01169337|82938653|FG002|Overall Study|Continuing lenalidomide|0|||
46722946|NCT01064648|82938664|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
46722947|NCT01064648|82938665|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
46722948|NCT01064648|82938666|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
46722949|NCT01064648|82938667|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
46722950|NCT01064648|82938664|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
46722951|NCT01064648|82938665|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
46722952|NCT01064648|82938666|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
46722953|NCT01064648|82938667|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
46722954|NCT01064648|82938664|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
46722955|NCT01064648|82938665|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
46722956|NCT01064648|82938666|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
46722957|NCT01064648|82938667|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
46722958|NCT01064648|82938664|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
46722959|NCT01064648|82938665|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
46722960|NCT01064648|82938666|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
46722961|NCT01064648|82938667|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
46722962|NCT01064648|82938664|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
46722963|NCT01064648|82938665|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
46722964|NCT01064648|82938666|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
46722965|NCT01064648|82938667|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
46633893|NCT01725282|82807399|FG002|Overall Study|Adverse Event|6|||
46633894|NCT01725282|82807400|FG003|Overall Study|Adverse Event|4|||
46633895|NCT01725282|82807397|FG000|Overall Study|Exacerbation of Target Disease|1|||
46633896|NCT01725282|82807398|FG001|Overall Study|Exacerbation of Target Disease|0|||
46633897|NCT01725282|82807399|FG002|Overall Study|Exacerbation of Target Disease|0|||
46633898|NCT01725282|82807400|FG003|Overall Study|Exacerbation of Target Disease|1|||
46633899|NCT01725282|82807397|FG000|Overall Study|Met Exclusion Criteria|0|||
46633900|NCT01725282|82807398|FG001|Overall Study|Met Exclusion Criteria|0|||
46633901|NCT01725282|82807399|FG002|Overall Study|Met Exclusion Criteria|1|||
46633902|NCT01725282|82807400|FG003|Overall Study|Met Exclusion Criteria|0|||
46633903|NCT01725282|82807397|FG000|Overall Study|Study Site Withdrawal|0|||
46633904|NCT01725282|82807398|FG001|Overall Study|Study Site Withdrawal|1|||
46633905|NCT01725282|82807399|FG002|Overall Study|Study Site Withdrawal|0|||
46633906|NCT01725282|82807400|FG003|Overall Study|Study Site Withdrawal|0|||
46633907|NCT01725282|82807397|FG000|Overall Study|Withdrawal by Subject|0|||
46633908|NCT01725282|82807398|FG001|Overall Study|Withdrawal by Subject|0|||
46633909|NCT01725282|82807399|FG002|Overall Study|Withdrawal by Subject|1|||
46722966|NCT01064648|82938664|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
46722967|NCT01064648|82938665|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
46722968|NCT01064648|82938666|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
46722969|NCT01064648|82938667|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
46722970|NCT01064648|82938664|FG000|Phase II|Adverse Event|0|||
46722971|NCT01064648|82938665|FG001|Phase II|Adverse Event|0|||
46722972|NCT01064648|82938666|FG002|Phase II|Adverse Event|15|||
46722973|NCT01064648|82938667|FG003|Phase II|Adverse Event|8|||
46722974|NCT01064648|82938664|FG000|Phase II|Death|0|||
46722975|NCT01064648|82938665|FG001|Phase II|Death|0|||
46722976|NCT01064648|82938666|FG002|Phase II|Death|4|||
46920581|NCT00911547|83152908|FG002|Overall Study|Adverse Event|11|||
46920582|NCT00911547|83152909|FG003|Overall Study|Adverse Event|6|||
46722977|NCT01064648|82938667|FG003|Phase II|Death|5|||
46722978|NCT01064648|82938664|FG000|Phase II|Withdrawal by Subject|0|||
46722979|NCT01064648|82938665|FG001|Phase II|Withdrawal by Subject|0|||
46722980|NCT01064648|82938666|FG002|Phase II|Withdrawal by Subject|2|||
46722981|NCT01064648|82938667|FG003|Phase II|Withdrawal by Subject|5|||
46722982|NCT01064648|82938664|FG000|Phase II|Progression|0|||
46722983|NCT01064648|82938665|FG001|Phase II|Progression|0|||
46722984|NCT01064648|82938666|FG002|Phase II|Progression|21|||
46722985|NCT01064648|82938667|FG003|Phase II|Progression|27|||
46722986|NCT01064648|82938664|FG000|Phase II|Non-protocol specified|0|||
46722987|NCT01064648|82938665|FG001|Phase II|Non-protocol specified|0|||
46722988|NCT01064648|82938666|FG002|Phase II|Non-protocol specified|5|||
46722989|NCT01064648|82938667|FG003|Phase II|Non-protocol specified|3|||
46722990|NCT01064648|82938664|FG000|Phase II|Under Review|0|||
46722991|NCT01064648|82938665|FG001|Phase II|Under Review|0|||
46722992|NCT01064648|82938666|FG002|Phase II|Under Review|2|||
46722993|NCT01064648|82938667|FG003|Phase II|Under Review|0|||
46722994|NCT00980460|82938685|FG000|Overall Study|Death|0|||
46722995|NCT00980460|82938686|FG001|Overall Study|Death|0|||
46920583|NCT00911547|83152906|FG000|Overall Study|Lost to Follow-up|0|||
46920584|NCT00911547|83152907|FG001|Overall Study|Lost to Follow-up|0|||
46920585|NCT00911547|83152908|FG002|Overall Study|Lost to Follow-up|2|||
46920586|NCT00911547|83152909|FG003|Overall Study|Lost to Follow-up|1|||
46920587|NCT00911547|83152906|FG000|Overall Study|Protocol Violation|0|||
46920588|NCT00911547|83152907|FG001|Overall Study|Protocol Violation|5|||
46920589|NCT00911547|83152908|FG002|Overall Study|Protocol Violation|5|||
46920590|NCT00911547|83152909|FG003|Overall Study|Protocol Violation|1|||
46920591|NCT00911547|83152906|FG000|Overall Study|Withdrawal by Subject|3|||
46920592|NCT00911547|83152907|FG001|Overall Study|Withdrawal by Subject|10|||
46920593|NCT00911547|83152908|FG002|Overall Study|Withdrawal by Subject|4|||
47045014|NCT01801735|83302096|FG000|Overall Study|Death|1|||
46722996|NCT00980460|82938687|FG002|Overall Study|Death|1|||
46722997|NCT00980460|82938688|FG003|Overall Study|Death|2|||
46722998|NCT00980460|82938689|FG004|Overall Study|Death|1|||
46722999|NCT00980460|82938685|FG000|Overall Study|Lack of Efficacy|0|||
46723000|NCT00980460|82938686|FG001|Overall Study|Lack of Efficacy|0|||
46723001|NCT00980460|82938687|FG002|Overall Study|Lack of Efficacy|10|||
46723002|NCT00980460|82938688|FG003|Overall Study|Lack of Efficacy|6|||
46723003|NCT00980460|82938689|FG004|Overall Study|Lack of Efficacy|8|||
46723004|NCT00980460|82938685|FG000|Overall Study|Lost to Follow-up|0|||
46723005|NCT00980460|82938686|FG001|Overall Study|Lost to Follow-up|0|||
47045015|NCT01801735|83302096|FG000|Overall Study|Other, including site closure|19|||
47045016|NCT01840579|83302854|FG000|Overall Study|Status not recorded|0|||
47045017|NCT01840579|83302855|FG001|Overall Study|Status not recorded|0|||
47045018|NCT01840579|83302856|FG002|Overall Study|Status not recorded|2|||
47045019|NCT01840579|83302857|FG003|Overall Study|Status not recorded|3|||
47045020|NCT01840579|83302858|FG004|Overall Study|Status not recorded|4|||
47045021|NCT01840579|83302859|FG005|Overall Study|Status not recorded|3|||
47045022|NCT01840579|83302860|FG006|Overall Study|Status not recorded|0|||
47045023|NCT01840579|83302861|FG007|Overall Study|Status not recorded|3|||
46633910|NCT01725282|82807400|FG003|Overall Study|Withdrawal by Subject|1|||
46723006|NCT00980460|82938687|FG002|Overall Study|Lost to Follow-up|0|||
46920594|NCT00911547|83152909|FG003|Overall Study|Withdrawal by Subject|8|||
46920595|NCT00899379|83152924|FG000|Overall Study|Adverse Event|2|||
47045024|NCT01840579|83302862|FG008|Overall Study|Status not recorded|3|||
47045025|NCT01840579|83302863|FG009|Overall Study|Status not recorded|3|||
47045026|NCT01840579|83302854|FG000|Overall Study|Progressive disease|3|||
47045027|NCT01840579|83302855|FG001|Overall Study|Progressive disease|5|||
46633911|NCT01725282|82807397|FG000|Overall Study|Lack of Efficacy|0|||
46633912|NCT01725282|82807398|FG001|Overall Study|Lack of Efficacy|1|||
46633913|NCT01725282|82807399|FG002|Overall Study|Lack of Efficacy|0|||
46633914|NCT01725282|82807400|FG003|Overall Study|Lack of Efficacy|1|||
46633915|NCT01725126|82807416|FG000|Overall Study|Protocol Violation|0|||
46633916|NCT01725126|82807417|FG001|Overall Study|Protocol Violation|1|||
46633917|NCT01725126|82807418|FG002|Overall Study|Protocol Violation|0|||
46633918|NCT01725126|82807419|FG003|Overall Study|Protocol Violation|0|||
46633919|NCT01725126|82807420|FG004|Overall Study|Protocol Violation|0|||
46633920|NCT01725126|82807421|FG005|Overall Study|Protocol Violation|0|||
46633921|NCT01725126|82807416|FG000|Overall Study|Withdrawal by Subject|0|||
46633922|NCT01725126|82807417|FG001|Overall Study|Withdrawal by Subject|0|||
46633923|NCT01725126|82807418|FG002|Overall Study|Withdrawal by Subject|0|||
46633924|NCT01725126|82807419|FG003|Overall Study|Withdrawal by Subject|1|||
46723007|NCT00980460|82938688|FG003|Overall Study|Lost to Follow-up|1|||
46723008|NCT00980460|82938689|FG004|Overall Study|Lost to Follow-up|0|||
46723009|NCT00980460|82938685|FG000|Overall Study|Physician Decision|0|||
46723010|NCT00980460|82938686|FG001|Overall Study|Physician Decision|0|||
46723011|NCT00980460|82938687|FG002|Overall Study|Physician Decision|11|||
46723012|NCT00980460|82938688|FG003|Overall Study|Physician Decision|5|||
46920596|NCT00899379|83152925|FG001|Overall Study|Adverse Event|2|||
46920597|NCT00899379|83152926|FG002|Overall Study|Adverse Event|1|||
46920598|NCT00899379|83152927|FG003|Overall Study|Adverse Event|1|||
46920599|NCT00899379|83152928|FG004|Overall Study|Adverse Event|2|||
46920600|NCT00899379|83152924|FG000|Overall Study|Lack of Efficacy|0|||
46920601|NCT00899379|83152925|FG001|Overall Study|Lack of Efficacy|4|||
46920602|NCT00899379|83152926|FG002|Overall Study|Lack of Efficacy|3|||
46920603|NCT00899379|83152927|FG003|Overall Study|Lack of Efficacy|0|||
46920604|NCT00899379|83152928|FG004|Overall Study|Lack of Efficacy|1|||
46920605|NCT00899379|83152924|FG000|Overall Study|Lost to Follow-up|9|||
46920606|NCT00899379|83152925|FG001|Overall Study|Lost to Follow-up|3|||
46920607|NCT00899379|83152926|FG002|Overall Study|Lost to Follow-up|0|||
46920608|NCT00899379|83152927|FG003|Overall Study|Lost to Follow-up|6|||
46920609|NCT00899379|83152928|FG004|Overall Study|Lost to Follow-up|2|||
46920610|NCT00899379|83152924|FG000|Overall Study|Protocol Violation|0|||
46920611|NCT00899379|83152925|FG001|Overall Study|Protocol Violation|0|||
47045028|NCT01840579|83302856|FG002|Overall Study|Progressive disease|0|||
47045029|NCT01840579|83302857|FG003|Overall Study|Progressive disease|0|||
47045030|NCT01840579|83302858|FG004|Overall Study|Progressive disease|0|||
47045031|NCT01840579|83302859|FG005|Overall Study|Progressive disease|0|||
46723013|NCT00980460|82938689|FG004|Overall Study|Physician Decision|3|||
46723014|NCT00980460|82938685|FG000|Overall Study|Withdrawal by Subject|0|||
46723015|NCT00980460|82938686|FG001|Overall Study|Withdrawal by Subject|0|||
46723016|NCT00980460|82938687|FG002|Overall Study|Withdrawal by Subject|1|||
46723017|NCT00980460|82938688|FG003|Overall Study|Withdrawal by Subject|0|||
46723018|NCT00980460|82938689|FG004|Overall Study|Withdrawal by Subject|0|||
46723019|NCT00980460|82938685|FG000|Overall Study|Ineligible|0|||
46723020|NCT00980460|82938686|FG001|Overall Study|Ineligible|2|||
46723021|NCT00980460|82938687|FG002|Overall Study|Ineligible|3|||
46723022|NCT00980460|82938688|FG003|Overall Study|Ineligible|1|||
46723023|NCT00980460|82938689|FG004|Overall Study|Ineligible|4|||
46723024|NCT00980460|82938685|FG000|Overall Study|Refusal of further therapy|0|||
46723025|NCT00980460|82938686|FG001|Overall Study|Refusal of further therapy|2|||
46723026|NCT00980460|82938687|FG002|Overall Study|Refusal of further therapy|3|||
46723027|NCT00980460|82938688|FG003|Overall Study|Refusal of further therapy|2|||
47045032|NCT01840579|83302860|FG006|Overall Study|Progressive disease|0|||
46723028|NCT00980460|82938689|FG004|Overall Study|Refusal of further therapy|0|||
47045033|NCT01840579|83302861|FG007|Overall Study|Progressive disease|0|||
47045034|NCT01840579|83302862|FG008|Overall Study|Progressive disease|0|||
47045035|NCT01840579|83302863|FG009|Overall Study|Progressive disease|0|||
47045036|NCT01840579|83302854|FG000|Overall Study|Ongoing in study|0|||
47045037|NCT01840579|83302855|FG001|Overall Study|Ongoing in study|1|||
46633925|NCT01725126|82807420|FG004|Overall Study|Withdrawal by Subject|0|||
46633926|NCT01725126|82807421|FG005|Overall Study|Withdrawal by Subject|0|||
46633927|NCT01751724|82807446|FG000|Overall Study|extubated bef.start assigned treatment|1|||
46633928|NCT01751724|82807447|FG001|Overall Study|extubated bef.start assigned treatment|0|||
46633929|NCT01751724|82807446|FG000|Overall Study|withdrawn by parent|0|||
46633930|NCT01751724|82807447|FG001|Overall Study|withdrawn by parent|2|||
46633931|NCT01751646|82807455|FG000|Overall Study|Lost to Follow-up|5|||
46633932|NCT01751646|82807456|FG001|Overall Study|Lost to Follow-up|1|||
46633933|NCT01751646|82807455|FG000|Overall Study|Withdrawal by Subject|0|||
46723029|NCT00980460|82938685|FG000|Overall Study|No therapy within 42 days of resection|0|||
46723030|NCT00980460|82938686|FG001|Overall Study|No therapy within 42 days of resection|0|||
46723031|NCT00980460|82938687|FG002|Overall Study|No therapy within 42 days of resection|3|||
46723032|NCT00980460|82938688|FG003|Overall Study|No therapy within 42 days of resection|1|||
46723033|NCT00980460|82938689|FG004|Overall Study|No therapy within 42 days of resection|0|||
46723034|NCT00980460|82938685|FG000|Overall Study|No transplant by protocol timepoints|0|||
46723035|NCT00980460|82938686|FG001|Overall Study|No transplant by protocol timepoints|0|||
46920612|NCT00899379|83152926|FG002|Overall Study|Protocol Violation|1|||
46920613|NCT00899379|83152927|FG003|Overall Study|Protocol Violation|1|||
47045038|NCT01840579|83302856|FG002|Overall Study|Ongoing in study|0|||
47045039|NCT01840579|83302857|FG003|Overall Study|Ongoing in study|0|||
46920614|NCT00899379|83152928|FG004|Overall Study|Protocol Violation|0|||
46920615|NCT00899379|83152924|FG000|Overall Study|Withdrawal by Subject|2|||
47045040|NCT01840579|83302858|FG004|Overall Study|Ongoing in study|0|||
47045041|NCT01840579|83302859|FG005|Overall Study|Ongoing in study|0|||
46723036|NCT00980460|82938687|FG002|Overall Study|No transplant by protocol timepoints|3|||
46723037|NCT00980460|82938688|FG003|Overall Study|No transplant by protocol timepoints|0|||
46723038|NCT00980460|82938689|FG004|Overall Study|No transplant by protocol timepoints|0|||
46723039|NCT00977574|82938711|FG000|Overall Study|Never Treated|4|||
46920616|NCT00899379|83152925|FG001|Overall Study|Withdrawal by Subject|4|||
47045042|NCT01840579|83302860|FG006|Overall Study|Ongoing in study|0|||
46723040|NCT00977574|82938712|FG001|Overall Study|Never Treated|2|||
46723041|NCT00977574|82938713|FG002|Overall Study|Never Treated|4|||
46723042|NCT00972478|82938723|FG000|Overall Study|Adverse Event|3|||
46723043|NCT00972478|82938724|FG001|Overall Study|Adverse Event|16|||
46723044|NCT00972478|82938723|FG000|Overall Study|Withdrawal by Subject|1|||
46723045|NCT00972478|82938724|FG001|Overall Study|Withdrawal by Subject|8|||
46723046|NCT00972478|82938723|FG000|Overall Study|Progression/Relapse|0|||
46723047|NCT00972478|82938724|FG001|Overall Study|Progression/Relapse|2|||
46723048|NCT00972478|82938723|FG000|Overall Study|Death|0|||
46723049|NCT00972478|82938724|FG001|Overall Study|Death|2|||
46723050|NCT00972478|82938723|FG000|Overall Study|Not protocol specified|1|||
46723051|NCT00972478|82938724|FG001|Overall Study|Not protocol specified|1|||
46723052|NCT00972478|82938723|FG000|Overall Study|Ineligible|1|||
46723053|NCT00972478|82938724|FG001|Overall Study|Ineligible|7|||
46723054|NCT00972478|82938723|FG000|Overall Study|Not start protocol treatment|1|||
46723055|NCT00972478|82938724|FG001|Overall Study|Not start protocol treatment|2|||
46723056|NCT00843882|82938734|FG000|Step 1|Lack of Efficacy|14|||
46723057|NCT00843882|82938735|FG001|Step 1|Lack of Efficacy|10|||
46723058|NCT00843882|82938736|FG002|Step 1|Lack of Efficacy|21|||
46723059|NCT00843882|82938734|FG000|Step 1|Adverse Event|8|||
46723060|NCT00843882|82938735|FG001|Step 1|Adverse Event|17|||
46723061|NCT00843882|82938736|FG002|Step 1|Adverse Event|20|||
46723062|NCT00843882|82938734|FG000|Step 1|Death|1|||
46723063|NCT00843882|82938735|FG001|Step 1|Death|2|||
46723064|NCT00843882|82938736|FG002|Step 1|Death|4|||
46723065|NCT00843882|82938734|FG000|Step 1|Withdrawal by Subject|6|||
46723066|NCT00843882|82938735|FG001|Step 1|Withdrawal by Subject|12|||
46723067|NCT00843882|82938736|FG002|Step 1|Withdrawal by Subject|9|||
46723068|NCT00843882|82938734|FG000|Step 1|Physician Decision|0|||
46723069|NCT00843882|82938735|FG001|Step 1|Physician Decision|5|||
46723070|NCT00843882|82938736|FG002|Step 1|Physician Decision|1|||
46723071|NCT00843882|82938734|FG000|Step 1|Patient and physician's decision|0|||
46723072|NCT00843882|82938735|FG001|Step 1|Patient and physician's decision|0|||
46723073|NCT00843882|82938736|FG002|Step 1|Patient and physician's decision|1|||
46723074|NCT00843882|82938734|FG000|Step 1|Other complicating disease|1|||
46723075|NCT00843882|82938735|FG001|Step 1|Other complicating disease|3|||
46723076|NCT00843882|82938736|FG002|Step 1|Other complicating disease|4|||
46723077|NCT00843882|82938734|FG000|Step 1|Alternative therapy|0|||
46723078|NCT00843882|82938735|FG001|Step 1|Alternative therapy|1|||
46723079|NCT00843882|82938736|FG002|Step 1|Alternative therapy|1|||
46723080|NCT00843882|82938734|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
46723081|NCT00843882|82938735|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
47045043|NCT01840579|83302861|FG007|Overall Study|Ongoing in study|0|||
47045044|NCT01840579|83302862|FG008|Overall Study|Ongoing in study|0|||
47045045|NCT01840579|83302863|FG009|Overall Study|Ongoing in study|0|||
47045046|NCT01840579|83302854|FG000|Overall Study|Death|0|||
47045047|NCT01840579|83302855|FG001|Overall Study|Death|0|||
47045048|NCT01840579|83302856|FG002|Overall Study|Death|0|||
47045049|NCT01840579|83302857|FG003|Overall Study|Death|0|||
47045050|NCT01840579|83302858|FG004|Overall Study|Death|0|||
47045051|NCT01840579|83302859|FG005|Overall Study|Death|1|||
47045052|NCT01840579|83302860|FG006|Overall Study|Death|0|||
47045053|NCT01840579|83302861|FG007|Overall Study|Death|0|||
47045054|NCT01840579|83302862|FG008|Overall Study|Death|0|||
47045055|NCT01840579|83302863|FG009|Overall Study|Death|0|||
47045056|NCT01840579|83302854|FG000|Overall Study|Adverse Event|0|||
47045057|NCT01840579|83302855|FG001|Overall Study|Adverse Event|1|||
47045058|NCT01840579|83302856|FG002|Overall Study|Adverse Event|0|||
47045059|NCT01840579|83302857|FG003|Overall Study|Adverse Event|0|||
47045060|NCT01840579|83302858|FG004|Overall Study|Adverse Event|0|||
47045061|NCT01840579|83302859|FG005|Overall Study|Adverse Event|0|||
47045062|NCT01840579|83302860|FG006|Overall Study|Adverse Event|0|||
47045063|NCT01840579|83302861|FG007|Overall Study|Adverse Event|0|||
47045064|NCT01840579|83302862|FG008|Overall Study|Adverse Event|0|||
47045065|NCT01840579|83302863|FG009|Overall Study|Adverse Event|0|||
47045066|NCT01840579|83302854|FG000|Overall Study|Follow-up ended by Sponsor|0|||
47045067|NCT01840579|83302855|FG001|Overall Study|Follow-up ended by Sponsor|0|||
46723082|NCT00843882|82938736|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
46723083|NCT00843882|82938734|FG000|Step 1|Off treatment reason unknown|0|||
46723084|NCT00843882|82938735|FG001|Step 1|Off treatment reason unknown|1|||
46723085|NCT00843882|82938736|FG002|Step 1|Off treatment reason unknown|4|||
46723086|NCT00843882|82938734|FG000|Step 1|Never started treatment|2|||
46723087|NCT00843882|82938735|FG001|Step 1|Never started treatment|0|||
46723088|NCT00843882|82938736|FG002|Step 1|Never started treatment|0|||
46723089|NCT00843882|82938734|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
46723090|NCT00843882|82938735|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
46723091|NCT00843882|82938736|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
46723092|NCT00843882|82938734|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
47045068|NCT01840579|83302856|FG002|Overall Study|Follow-up ended by Sponsor|0|||
47045069|NCT01840579|83302857|FG003|Overall Study|Follow-up ended by Sponsor|0|||
47045070|NCT01840579|83302858|FG004|Overall Study|Follow-up ended by Sponsor|0|||
46723093|NCT00843882|82938735|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
46723094|NCT00843882|82938736|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
46723095|NCT00843882|82938734|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
46723096|NCT00843882|82938735|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
46723097|NCT00843882|82938736|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
46723098|NCT00843882|82938734|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
46723099|NCT00843882|82938735|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
46723100|NCT00843882|82938736|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
46723101|NCT00843882|82938734|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
46723102|NCT00843882|82938735|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
46723103|NCT00843882|82938736|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
46723104|NCT00843882|82938734|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
46723105|NCT00843882|82938735|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
46723106|NCT00843882|82938736|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
46723107|NCT00843882|82938734|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
46723108|NCT00843882|82938735|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
46723109|NCT00843882|82938736|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
46723110|NCT00769379|82938751|FG000|Overall Study|No follow up data mapped to Other.|3|||
46723111|NCT00769379|82938752|FG001|Overall Study|No follow up data mapped to Other.|13|||
46723112|NCT00658814|82938760|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
46723113|NCT00658814|82938761|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
46723114|NCT00658814|82938760|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
46723115|NCT00658814|82938761|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
46723116|NCT00658814|82938760|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
46723117|NCT00658814|82938761|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
46723118|NCT00658814|82938760|FG000|Remission Induction Chemotherapy|Death|1|||
46723119|NCT00658814|82938761|FG001|Remission Induction Chemotherapy|Death|4|||
46723120|NCT00658814|82938760|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
46723121|NCT00658814|82938761|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
46723122|NCT00658814|82938760|FG000|Remission Induction Chemotherapy|Not eligible|1|||
46723123|NCT00658814|82938761|FG001|Remission Induction Chemotherapy|Not eligible|2|||
46723124|NCT00658814|82938760|FG000|Consolidation Therapy|Not protocol specified|0|||
46723125|NCT00658814|82938761|FG001|Consolidation Therapy|Not protocol specified|1|||
46723126|NCT00658814|82938760|FG000|Consolidation Therapy|Not eligible|2|||
46723127|NCT00658814|82938761|FG001|Consolidation Therapy|Not eligible|2|||
46723128|NCT00658814|82938760|FG000|Maintenance Therapy|Adverse Event|1|||
46723129|NCT00658814|82938761|FG001|Maintenance Therapy|Adverse Event|1|||
46723130|NCT00658814|82938760|FG000|Maintenance Therapy|Not protocol specified|1|||
46723131|NCT00658814|82938761|FG001|Maintenance Therapy|Not protocol specified|0|||
46723132|NCT00658814|82938760|FG000|Maintenance Therapy|Not eligible|1|||
46723133|NCT00658814|82938761|FG001|Maintenance Therapy|Not eligible|0|||
46723134|NCT00644228|82938773|FG000|Randomization & Eligibility|Ineligible|31|||
46723135|NCT00644228|82938774|FG001|Randomization & Eligibility|Ineligible|21|||
46723136|NCT00644228|82938773|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
46723137|NCT00644228|82938774|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
46723138|NCT00644228|82938773|FG000|Randomization & Eligibility|Invalid Consent|0|||
46723139|NCT00644228|82938774|FG001|Randomization & Eligibility|Invalid Consent|1|||
46723140|NCT00644228|82938773|FG000|Induction Therapy|Adverse Event|22|||
46723141|NCT00644228|82938774|FG001|Induction Therapy|Adverse Event|55|||
46723142|NCT00644228|82938773|FG000|Induction Therapy|Withdrawal by Subject|10|||
46723143|NCT00644228|82938774|FG001|Induction Therapy|Withdrawal by Subject|3|||
46723144|NCT00644228|82938773|FG000|Induction Therapy|Progression/Relapse|24|||
46723145|NCT00644228|82938774|FG001|Induction Therapy|Progression/Relapse|12|||
46723146|NCT00644228|82938773|FG000|Induction Therapy|Death|3|||
46723147|NCT00644228|82938774|FG001|Induction Therapy|Death|7|||
46920617|NCT00899379|83152926|FG002|Overall Study|Withdrawal by Subject|2|||
47045071|NCT01840579|83302859|FG005|Overall Study|Follow-up ended by Sponsor|0|||
47045072|NCT01840579|83302860|FG006|Overall Study|Follow-up ended by Sponsor|2|||
47045073|NCT01840579|83302861|FG007|Overall Study|Follow-up ended by Sponsor|0|||
47045074|NCT01840579|83302862|FG008|Overall Study|Follow-up ended by Sponsor|0|||
46723148|NCT00644228|82938773|FG000|Induction Therapy|Not Protocol-Specified|24|||
46920618|NCT00899379|83152927|FG003|Overall Study|Withdrawal by Subject|3|||
46920619|NCT00899379|83152928|FG004|Overall Study|Withdrawal by Subject|6|||
47045075|NCT01840579|83302863|FG009|Overall Study|Follow-up ended by Sponsor|0|||
46723149|NCT00644228|82938774|FG001|Induction Therapy|Not Protocol-Specified|28|||
46723150|NCT00644228|82938773|FG000|Maintenance|Adverse Event|27|||
46723151|NCT00644228|82938774|FG001|Maintenance|Adverse Event|31|||
46723152|NCT00644228|82938773|FG000|Maintenance|Withdrawal by Subject|6|||
46723153|NCT00644228|82938774|FG001|Maintenance|Withdrawal by Subject|4|||
46723154|NCT00644228|82938773|FG000|Maintenance|Progression/Relapse|67|||
46723155|NCT00644228|82938774|FG001|Maintenance|Progression/Relapse|42|||
46723156|NCT00644228|82938773|FG000|Maintenance|Death|3|||
46633934|NCT01751646|82807456|FG001|Overall Study|Withdrawal by Subject|4|||
46633935|NCT01751646|82807455|FG000|Overall Study|Starting hormone therapy|1|||
46633936|NCT01751646|82807456|FG001|Overall Study|Starting hormone therapy|0|||
46723157|NCT00644228|82938774|FG001|Maintenance|Death|3|||
46723158|NCT00644228|82938773|FG000|Maintenance|Not Protocol-Specified|14|||
46723159|NCT00644228|82938774|FG001|Maintenance|Not Protocol-Specified|15|||
46723160|NCT00644228|82938773|FG000|Maintenance|On Treatment|26|||
46723161|NCT00644228|82938774|FG001|Maintenance|On Treatment|40|||
46723162|NCT00324805|82938782|FG000|Overall Study|Adverse Event|62|||
46723163|NCT00324805|82938783|FG001|Overall Study|Adverse Event|203|||
46723164|NCT00324805|82938782|FG000|Overall Study|Progression|7|||
46723165|NCT00324805|82938783|FG001|Overall Study|Progression|35|||
46723166|NCT00324805|82938782|FG000|Overall Study|Withdrawal by Subject|51|||
46723167|NCT00324805|82938783|FG001|Overall Study|Withdrawal by Subject|174|||
46723168|NCT00324805|82938782|FG000|Overall Study|Death|6|||
46723169|NCT00324805|82938783|FG001|Overall Study|Death|9|||
46723170|NCT00324805|82938782|FG000|Overall Study|Alternative therapy|4|||
46723171|NCT00324805|82938783|FG001|Overall Study|Alternative therapy|8|||
46723172|NCT00324805|82938782|FG000|Overall Study|Other complicating disease|1|||
46723173|NCT00324805|82938783|FG001|Overall Study|Other complicating disease|9|||
46723174|NCT00324805|82938782|FG000|Overall Study|Other reasons|7|||
46723175|NCT00324805|82938783|FG001|Overall Study|Other reasons|26|||
46723176|NCT00324805|82938782|FG000|Overall Study|Other|0|||
46723177|NCT00324805|82938783|FG001|Overall Study|Other|2|||
46723178|NCT00324805|82938782|FG000|Overall Study|Did not start therapy|12|||
46723179|NCT00324805|82938783|FG001|Overall Study|Did not start therapy|17|||
46723180|NCT00248040|82938792|FG000|Overall Study|transplantectomy|2|||
46920620|NCT00899379|83152924|FG000|Overall Study|Pregnancy|0|||
46920621|NCT00899379|83152925|FG001|Overall Study|Pregnancy|0|||
46920622|NCT00899379|83152926|FG002|Overall Study|Pregnancy|1|||
47045076|NCT01801111|83302942|FG000|Overall Study|Adverse Event|12|||
46633937|NCT01751646|82807455|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
46633938|NCT01751646|82807456|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
46633939|NCT01751646|82807455|FG000|Overall Study|Inadvertent enrollment|1|||
46633940|NCT01751646|82807456|FG001|Overall Study|Inadvertent enrollment|1|||
46633941|NCT01751646|82807455|FG000|Overall Study|Moved out of the area|1|||
46633942|NCT01751646|82807456|FG001|Overall Study|Moved out of the area|5|||
46633943|NCT01751646|82807455|FG000|Overall Study|Inability to attend required visits|0|||
46633944|NCT01751646|82807456|FG001|Overall Study|Inability to attend required visits|1|||
46633945|NCT01751646|82807455|FG000|Overall Study|Off study due to multiple obligations|0|||
46633946|NCT01751646|82807456|FG001|Overall Study|Off study due to multiple obligations|1|||
46633947|NCT01751646|82807455|FG000|Overall Study|Fails to comply with study requirements|0|||
46633948|NCT01751646|82807456|FG001|Overall Study|Fails to comply with study requirements|1|||
46633949|NCT01751646|82807455|FG000|Overall Study|Childcare issues|1|||
46633950|NCT01751646|82807456|FG001|Overall Study|Childcare issues|1|||
46633951|NCT01751568|82807469|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
46920623|NCT00899379|83152927|FG003|Overall Study|Pregnancy|0|||
47045077|NCT01801111|83302942|FG000|Overall Study|Death|8|||
47045078|NCT01801111|83302942|FG000|Overall Study|Physician Decision|5|||
47045079|NCT01801111|83302942|FG000|Overall Study|Other|1|||
47045080|NCT01801111|83302942|FG000|Overall Study|Withdrawal by Subject|4|||
47045081|NCT01801111|83302942|FG000|Overall Study|Study Terminated by Sponsor|27|||
47045082|NCT01801111|83302942|FG000|Overall Study|Progressive Disease|81|||
47045083|NCT01773967|83302974|FG000|Overall Study|Lost to Follow-up|15|||
47045084|NCT01773967|83302975|FG001|Overall Study|Lost to Follow-up|13|||
47045085|NCT01773889|83302985|FG000|Overall Study|lack of funding|2|||
47045086|NCT01839487|83303163|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
46633952|NCT01751568|82807470|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
46633953|NCT01751568|82807471|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
46920624|NCT00899379|83152928|FG004|Overall Study|Pregnancy|1|||
47045087|NCT01839487|83303164|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
47045088|NCT01839487|83303165|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
46633954|NCT01751412|82807479|FG000|Overall Study|Disease Progression Before Treatment|1|||
46723181|NCT00248040|82938793|FG001|Overall Study|transplantectomy|1|||
46723182|NCT00248040|82938794|FG002|Overall Study|transplantectomy|3|||
46723183|NCT00248040|82938792|FG000|Overall Study|transplant cancelled post treat start|1|||
46723184|NCT00248040|82938793|FG001|Overall Study|transplant cancelled post treat start|0|||
46723185|NCT00248040|82938794|FG002|Overall Study|transplant cancelled post treat start|0|||
46723186|NCT00248040|82938792|FG000|Overall Study|Death|0|||
46920625|NCT00899379|83152924|FG000|Overall Study|Patient Uncooperative|0|||
46723187|NCT00248040|82938793|FG001|Overall Study|Death|0|||
46723188|NCT00248040|82938794|FG002|Overall Study|Death|1|||
46723189|NCT00976716|82938803|FG000|Overall Study|Adverse Event|1|||
46723190|NCT00973674|82938810|FG000|Overall Study|Protocol Violation|2|||
46723191|NCT00973674|82938811|FG001|Overall Study|Protocol Violation|0|||
46723192|NCT00819091|82938820|FG000|Overall Study|Adverse Event|3|||
46723193|NCT00819091|82938821|FG001|Overall Study|Adverse Event|5|||
46723194|NCT00819091|82938820|FG000|Overall Study|Protocol Violation|0|||
46723195|NCT00819091|82938821|FG001|Overall Study|Protocol Violation|1|||
46723196|NCT00819091|82938820|FG000|Overall Study|Lost to Follow-up|2|||
46723197|NCT00819091|82938821|FG001|Overall Study|Lost to Follow-up|0|||
46723198|NCT00819091|82938820|FG000|Overall Study|Withdrawal by Subject|1|||
46723199|NCT00819091|82938821|FG001|Overall Study|Withdrawal by Subject|2|||
46723200|NCT00819091|82938820|FG000|Overall Study|Other|1|||
46723201|NCT00819091|82938821|FG001|Overall Study|Other|2|||
46723202|NCT00973362|82938829|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
46723203|NCT00973362|82938830|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
46723204|NCT00973362|82938829|FG000|Baseline Evaluation|No colposcopy visit|62|||
46723205|NCT00973362|82938830|FG001|Baseline Evaluation|No colposcopy visit|0|||
46723206|NCT00973362|82938829|FG000|Baseline Evaluation|Inevaluable|686|||
46723207|NCT00973362|82938830|FG001|Baseline Evaluation|Inevaluable|223|||
46723208|NCT00973362|82938829|FG000|3-Year Follow-up|Lost to Follow-up|17|||
46723209|NCT00973362|82938830|FG001|3-Year Follow-up|Lost to Follow-up|0|||
46723210|NCT00819013|82938843|FG000|Overall Study|Not meeting continuing study eligibility|2|||
46723211|NCT00819013|82938844|FG001|Overall Study|Not meeting continuing study eligibility|1|||
46723212|NCT00819013|82938845|FG002|Overall Study|Not meeting continuing study eligibility|2|||
46723213|NCT00819013|82938846|FG003|Overall Study|Not meeting continuing study eligibility|1|||
46723214|NCT00819013|82938843|FG000|Overall Study|Adverse Event|0|||
46723215|NCT00819013|82938844|FG001|Overall Study|Adverse Event|0|||
46723216|NCT00819013|82938845|FG002|Overall Study|Adverse Event|1|||
46723217|NCT00819013|82938846|FG003|Overall Study|Adverse Event|0|||
46723218|NCT00819013|82938843|FG000|Overall Study|Withdrawal by Subject|1|||
46723219|NCT00819013|82938844|FG001|Overall Study|Withdrawal by Subject|0|||
46723220|NCT00819013|82938845|FG002|Overall Study|Withdrawal by Subject|1|||
46723221|NCT00819013|82938846|FG003|Overall Study|Withdrawal by Subject|0|||
46723222|NCT00819013|82938843|FG000|Overall Study|Lost to Follow-up|0|||
46723223|NCT00819013|82938844|FG001|Overall Study|Lost to Follow-up|0|||
46723224|NCT00819013|82938845|FG002|Overall Study|Lost to Follow-up|1|||
46723225|NCT00819013|82938846|FG003|Overall Study|Lost to Follow-up|2|||
46723226|NCT00819013|82938843|FG000|Overall Study|Death|0|||
46723227|NCT00819013|82938844|FG001|Overall Study|Death|0|||
46633955|NCT01751178|82807486|FG000|Overall Study|Adverse Event|2|||
46633956|NCT01751178|82807487|FG001|Overall Study|Adverse Event|0|||
46633957|NCT01751178|82807488|FG002|Overall Study|Adverse Event|0|||
46633958|NCT01751178|82807486|FG000|Overall Study|Other Reason (unknown)|1|||
46633959|NCT01751178|82807487|FG001|Overall Study|Other Reason (unknown)|0|||
46633960|NCT01751178|82807488|FG002|Overall Study|Other Reason (unknown)|2|||
46633961|NCT01606254|82807504|FG000|Overall Study|Withdrawal by Subject|1|||
46633962|NCT01606254|82807505|FG001|Overall Study|Withdrawal by Subject|3|||
46633963|NCT01606254|82807506|FG002|Overall Study|Withdrawal by Subject|0|||
46633964|NCT01606254|82807507|FG003|Overall Study|Withdrawal by Subject|2|||
46633965|NCT01606254|82807504|FG000|Overall Study|Adverse Event|1|||
46633966|NCT01606254|82807505|FG001|Overall Study|Adverse Event|1|||
46633967|NCT01606254|82807506|FG002|Overall Study|Adverse Event|0|||
46633968|NCT01606254|82807507|FG003|Overall Study|Adverse Event|1|||
46633969|NCT01750242|82807517|FG000|Overall Study|Unreadable Images|3|||
46633970|NCT01723254|82807530|FG000|Overall Study|Conflict with work schedule|0|||
46633971|NCT01723254|82807531|FG001|Overall Study|Conflict with work schedule|0|||
46633972|NCT01723254|82807532|FG002|Overall Study|Conflict with work schedule|0|||
46633973|NCT01723254|82807533|FG003|Overall Study|Conflict with work schedule|0|||
46633974|NCT01723254|82807534|FG004|Overall Study|Conflict with work schedule|0|||
46633975|NCT01723254|82807535|FG005|Overall Study|Conflict with work schedule|0|||
46633976|NCT01723254|82807536|FG006|Overall Study|Conflict with work schedule|0|||
46633977|NCT01723254|82807537|FG007|Overall Study|Conflict with work schedule|1|||
46633978|NCT01723254|82807530|FG000|Overall Study|Personal issues|0|||
46633979|NCT01723254|82807531|FG001|Overall Study|Personal issues|0|||
46633980|NCT01723254|82807532|FG002|Overall Study|Personal issues|0|||
46723228|NCT00819013|82938845|FG002|Overall Study|Death|0|||
46633981|NCT01723254|82807533|FG003|Overall Study|Personal issues|0|||
46633982|NCT01723254|82807534|FG004|Overall Study|Personal issues|0|||
46723229|NCT00819013|82938846|FG003|Overall Study|Death|1|||
46723230|NCT00976560|82938858|FG000|Overall Study|Adverse Event|5|||
46723231|NCT00976560|82938859|FG001|Overall Study|Adverse Event|5|||
46723232|NCT00976560|82938858|FG000|Overall Study|Lack of Efficacy|3|||
46723233|NCT00976560|82938859|FG001|Overall Study|Lack of Efficacy|5|||
46723234|NCT00976560|82938858|FG000|Overall Study|Protocol Violation|1|||
46723235|NCT00976560|82938859|FG001|Overall Study|Protocol Violation|0|||
46723236|NCT00976560|82938858|FG000|Overall Study|Lost to Follow-up|1|||
46723237|NCT00976560|82938859|FG001|Overall Study|Lost to Follow-up|0|||
46723238|NCT00976560|82938858|FG000|Overall Study|Physician Decision|2|||
46723239|NCT00976560|82938859|FG001|Overall Study|Physician Decision|0|||
46723240|NCT00976560|82938858|FG000|Overall Study|Withdrawal by Subject|2|||
46723241|NCT00976560|82938859|FG001|Overall Study|Withdrawal by Subject|3|||
46723242|NCT00976482|82938865|FG000|Overall Study|Death|208|||
46723243|NCT00976482|82938865|FG000|Overall Study|Withdrawal by Subject|45|||
46723244|NCT00976482|82938865|FG000|Overall Study|Center terminated|1|||
46723245|NCT00976482|82938865|FG000|Overall Study|Protocol Violation|5|||
46723246|NCT00975156|82938871|FG000|Overall Study|Protocol Violation|0|||
46723247|NCT00975156|82938872|FG001|Overall Study|Protocol Violation|1|||
46723248|NCT00810043|82938884|FG000|Overall Study|Withdrawal by Subject|1|||
46723249|NCT00810043|82938885|FG001|Overall Study|Withdrawal by Subject|0|||
46723250|NCT00810043|82938886|FG002|Overall Study|Withdrawal by Subject|2|||
46723251|NCT00810043|82938884|FG000|Overall Study|Lost to Follow-up|1|||
46723252|NCT00810043|82938885|FG001|Overall Study|Lost to Follow-up|0|||
46723253|NCT00810043|82938886|FG002|Overall Study|Lost to Follow-up|0|||
46723254|NCT00810043|82938884|FG000|Overall Study|Physician Decision|0|||
46723255|NCT00810043|82938885|FG001|Overall Study|Physician Decision|0|||
46723256|NCT00810043|82938886|FG002|Overall Study|Physician Decision|2|||
46723257|NCT00810043|82938884|FG000|Overall Study|Death|2|||
46723258|NCT00810043|82938885|FG001|Overall Study|Death|0|||
46723259|NCT00810043|82938886|FG002|Overall Study|Death|0|||
46723260|NCT00810043|82938884|FG000|Overall Study|Unrelated medical problem|0|||
46723261|NCT00810043|82938885|FG001|Overall Study|Unrelated medical problem|1|||
46723262|NCT00810043|82938886|FG002|Overall Study|Unrelated medical problem|0|||
46723263|NCT00810043|82938884|FG000|Overall Study|Non-medical problem|0|||
46723264|NCT00810043|82938885|FG001|Overall Study|Non-medical problem|0|||
46723265|NCT00810043|82938886|FG002|Overall Study|Non-medical problem|1|||
46723266|NCT00810043|82938884|FG000|Overall Study|No longer met enrollment criteria|0|||
46723267|NCT00810043|82938885|FG001|Overall Study|No longer met enrollment criteria|0|||
46723268|NCT00810043|82938886|FG002|Overall Study|No longer met enrollment criteria|3|||
46723269|NCT01120028|82938899|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
46723270|NCT01120028|82938900|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
46723271|NCT01120028|82938901|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
46723272|NCT01120028|82938902|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
46723273|NCT01120028|82938899|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
46723274|NCT01120028|82938900|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
46723275|NCT01120028|82938901|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
46633983|NCT01723254|82807535|FG005|Overall Study|Personal issues|1|||
46633984|NCT01723254|82807536|FG006|Overall Study|Personal issues|0|||
46633985|NCT01723254|82807537|FG007|Overall Study|Personal issues|0|||
46723276|NCT01120028|82938902|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
46723277|NCT00878800|82938918|FG000|Overall Study|Adverse Event|0|||
46723278|NCT00878800|82938919|FG001|Overall Study|Adverse Event|0|||
46723279|NCT00878800|82938920|FG002|Overall Study|Adverse Event|2|||
46723280|NCT00878800|82938921|FG003|Overall Study|Adverse Event|0|||
46723281|NCT00878800|82938922|FG004|Overall Study|Adverse Event|1|||
46723282|NCT00878800|82938918|FG000|Overall Study|Progressive disease|1|||
46723283|NCT00878800|82938919|FG001|Overall Study|Progressive disease|5|||
46723284|NCT00878800|82938920|FG002|Overall Study|Progressive disease|6|||
46723285|NCT00878800|82938921|FG003|Overall Study|Progressive disease|5|||
46723286|NCT00878800|82938922|FG004|Overall Study|Progressive disease|13|||
46723287|NCT00878800|82938918|FG000|Overall Study|Withdrew consent|1|||
46723288|NCT00878800|82938919|FG001|Overall Study|Withdrew consent|1|||
46723289|NCT00878800|82938920|FG002|Overall Study|Withdrew consent|0|||
46723290|NCT00878800|82938921|FG003|Overall Study|Withdrew consent|1|||
46723291|NCT00878800|82938922|FG004|Overall Study|Withdrew consent|1|||
47045089|NCT01839487|83303166|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
47045090|NCT01839487|83303167|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
47045091|NCT01839487|83303168|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
46633986|NCT01723254|82807530|FG000|Overall Study|No longer have time to participate|0|||
46633987|NCT01723254|82807531|FG001|Overall Study|No longer have time to participate|0|||
46633988|NCT01723254|82807532|FG002|Overall Study|No longer have time to participate|0|||
46633989|NCT01723254|82807533|FG003|Overall Study|No longer have time to participate|1|||
46633990|NCT01723254|82807534|FG004|Overall Study|No longer have time to participate|0|||
46723292|NCT00878800|82938918|FG000|Overall Study|Death|0|||
46723293|NCT00878800|82938919|FG001|Overall Study|Death|0|||
46723294|NCT00878800|82938920|FG002|Overall Study|Death|1|||
46723295|NCT00878800|82938921|FG003|Overall Study|Death|0|||
46920626|NCT00899379|83152925|FG001|Overall Study|Patient Uncooperative|1|||
46723296|NCT00878800|82938922|FG004|Overall Study|Death|0|||
46723297|NCT00878800|82938918|FG000|Overall Study|Other|1|||
46633991|NCT01723254|82807535|FG005|Overall Study|No longer have time to participate|0|||
46723298|NCT00878800|82938919|FG001|Overall Study|Other|1|||
46723299|NCT00878800|82938920|FG002|Overall Study|Other|0|||
46723300|NCT00878800|82938921|FG003|Overall Study|Other|0|||
46723301|NCT00878800|82938922|FG004|Overall Study|Other|1|||
46723302|NCT01119950|82938933|FG000|Overall Study|Adverse Event|25|||
46723303|NCT01119950|82938933|FG000|Overall Study|Withdrawal by Subject|9|||
46723304|NCT01119950|82938933|FG000|Overall Study|Protocol Violation|5|||
46723305|NCT01119950|82938933|FG000|Overall Study|Lost to Follow-up|4|||
46723306|NCT01119950|82938933|FG000|Overall Study|Administrative|2|||
46723307|NCT01119950|82938933|FG000|Overall Study|Abnormal lab value|1|||
47045092|NCT01839487|83303163|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
47045093|NCT01839487|83303164|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
47045094|NCT01839487|83303165|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
47045095|NCT01839487|83303166|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
47045096|NCT01839487|83303167|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
47045097|NCT01839487|83303168|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
47045098|NCT01839487|83303163|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
47045099|NCT01839487|83303164|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
47045100|NCT01839487|83303165|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
47045101|NCT01839487|83303166|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
47045102|NCT01839487|83303167|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
46633992|NCT01723254|82807536|FG006|Overall Study|No longer have time to participate|0|||
46633993|NCT01723254|82807537|FG007|Overall Study|No longer have time to participate|0|||
46633994|NCT01723254|82807530|FG000|Overall Study|Move/Left to another country/city|0|||
46633995|NCT01723254|82807531|FG001|Overall Study|Move/Left to another country/city|0|||
46633996|NCT01723254|82807532|FG002|Overall Study|Move/Left to another country/city|2|||
46633997|NCT01723254|82807533|FG003|Overall Study|Move/Left to another country/city|1|||
46633998|NCT01723254|82807534|FG004|Overall Study|Move/Left to another country/city|1|||
46633999|NCT01723254|82807535|FG005|Overall Study|Move/Left to another country/city|0|||
46634000|NCT01723254|82807536|FG006|Overall Study|Move/Left to another country/city|0|||
46634001|NCT01723254|82807537|FG007|Overall Study|Move/Left to another country/city|0|||
46634002|NCT01723254|82807530|FG000|Overall Study|Protocol Violation|0|||
46634003|NCT01723254|82807531|FG001|Overall Study|Protocol Violation|1|||
46634004|NCT01723254|82807532|FG002|Overall Study|Protocol Violation|0|||
46634005|NCT01723254|82807533|FG003|Overall Study|Protocol Violation|0|||
46634006|NCT01723254|82807534|FG004|Overall Study|Protocol Violation|0|||
46634007|NCT01723254|82807535|FG005|Overall Study|Protocol Violation|0|||
46634008|NCT01723254|82807536|FG006|Overall Study|Protocol Violation|0|||
46634009|NCT01723254|82807537|FG007|Overall Study|Protocol Violation|0|||
46634010|NCT01723254|82807530|FG000|Overall Study|Withdrawal by Subject|1|||
46634011|NCT01723254|82807531|FG001|Overall Study|Withdrawal by Subject|2|||
46634012|NCT01723254|82807532|FG002|Overall Study|Withdrawal by Subject|1|||
46634013|NCT01723254|82807533|FG003|Overall Study|Withdrawal by Subject|0|||
46634014|NCT01723254|82807534|FG004|Overall Study|Withdrawal by Subject|1|||
46634015|NCT01723254|82807535|FG005|Overall Study|Withdrawal by Subject|1|||
46634016|NCT01723254|82807536|FG006|Overall Study|Withdrawal by Subject|1|||
46634017|NCT01723254|82807537|FG007|Overall Study|Withdrawal by Subject|2|||
46634018|NCT01722162|82807557|FG000|Overall Study|Withdrawal by Subject|1|||
46634019|NCT01722162|82807558|FG001|Overall Study|Withdrawal by Subject|1|||
46634020|NCT01722162|82807557|FG000|Overall Study|Found ineligible|1|||
46634021|NCT01722162|82807558|FG001|Overall Study|Found ineligible|0|||
46634022|NCT01722162|82807557|FG000|Overall Study|Unrelated to study adverse event|2|||
46634023|NCT01722162|82807558|FG001|Overall Study|Unrelated to study adverse event|2|||
46634024|NCT01722162|82807557|FG000|Overall Study|Adverse Event|1|||
46634025|NCT01722162|82807558|FG001|Overall Study|Adverse Event|1|||
46634026|NCT01722162|82807557|FG000|Overall Study|Insurance denial post enrollment|0|||
46634027|NCT01722162|82807558|FG001|Overall Study|Insurance denial post enrollment|1|||
46634028|NCT01722162|82807557|FG000|Overall Study|Noncompliance|0|||
46634029|NCT01722162|82807558|FG001|Overall Study|Noncompliance|1|||
46634030|NCT01721772|82807566|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
46634031|NCT01721772|82807567|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
46634032|NCT01721772|82807566|FG000|Pre-Treatment|Poor/non-compliance|0|||
46634033|NCT01721772|82807567|FG001|Pre-Treatment|Poor/non-compliance|1|||
46634034|NCT01721772|82807566|FG000|Pre-Treatment|Participant withdrew consent|0|||
46634035|NCT01721772|82807567|FG001|Pre-Treatment|Participant withdrew consent|1|||
46634036|NCT01721772|82807566|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
46634037|NCT01721772|82807567|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
46634038|NCT01721772|82807566|FG000|Treatment|Disease progression|119|||
46634039|NCT01721772|82807567|FG001|Treatment|Disease progression|168|||
46634040|NCT01721772|82807566|FG000|Treatment|Study drug toxicity|19|||
46634041|NCT01721772|82807567|FG001|Treatment|Study drug toxicity|10|||
46634042|NCT01721772|82807566|FG000|Treatment|Adverse event unrelated to study drug|7|||
46723308|NCT01119950|82938933|FG000|Overall Study|Death|1|||
46723309|NCT01145222|82938963|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
46634043|NCT01721772|82807567|FG001|Treatment|Adverse event unrelated to study drug|7|||
46634044|NCT01721772|82807566|FG000|Treatment|Maximum clinical benefit|16|||
46723310|NCT01145222|82938964|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
46723311|NCT01145222|82938965|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
46723312|NCT01145222|82938966|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
46723313|NCT01145222|82938963|FG000|Overall Study|Poor bowel preparation|0|||
46723314|NCT01145222|82938964|FG001|Overall Study|Poor bowel preparation|0|||
46723315|NCT01145222|82938965|FG002|Overall Study|Poor bowel preparation|0|||
46723316|NCT01145222|82938966|FG003|Overall Study|Poor bowel preparation|1|||
46723317|NCT01145066|82938979|FG000|Overall Study|To resume NSAIDs|2|||
46723318|NCT01145066|82938980|FG001|Overall Study|To resume NSAIDs|2|||
46723319|NCT01145066|82938981|FG002|Overall Study|To resume NSAIDs|1|||
46723320|NCT01145066|82938979|FG000|Overall Study|Non-related surgery|0|||
46723321|NCT01145066|82938980|FG001|Overall Study|Non-related surgery|0|||
46920627|NCT00899379|83152926|FG002|Overall Study|Patient Uncooperative|0|||
46920628|NCT00899379|83152927|FG003|Overall Study|Patient Uncooperative|1|||
46920629|NCT00899379|83152928|FG004|Overall Study|Patient Uncooperative|2|||
46920630|NCT00899379|83152924|FG000|Overall Study|Abnormal Baseline ECG|0|||
46920631|NCT00899379|83152925|FG001|Overall Study|Abnormal Baseline ECG|0|||
46634045|NCT01721772|82807567|FG001|Treatment|Maximum clinical benefit|4|||
46634046|NCT01721772|82807566|FG000|Treatment|Other|19|||
46634047|NCT01721772|82807567|FG001|Treatment|Other|2|||
46634048|NCT01721772|82807566|FG000|Treatment|Participant withdrew consent|2|||
46634049|NCT01721772|82807567|FG001|Treatment|Participant withdrew consent|5|||
46634050|NCT01721772|82807566|FG000|Treatment|Participant request to discontinue study treatment|21|||
46634051|NCT01721772|82807567|FG001|Treatment|Participant request to discontinue study treatment|8|||
46634052|NCT01721772|82807566|FG000|Treatment|Death|1|||
46634053|NCT01721772|82807567|FG001|Treatment|Death|0|||
46634054|NCT01721772|82807566|FG000|Treatment|Not reported|1|||
46634055|NCT01721772|82807567|FG001|Treatment|Not reported|0|||
46634056|NCT01721772|82807566|FG000|Treatment|Poor/non-compliance|1|||
46634057|NCT01721772|82807567|FG001|Treatment|Poor/non-compliance|0|||
46634058|NCT01721772|82807566|FG000|Treatment|Lost to Follow-up|0|||
46634059|NCT01721772|82807567|FG001|Treatment|Lost to Follow-up|1|||
46634060|NCT01702428|82807577|FG000|Overall Study|Adverse Event|2|||
46634061|NCT01702428|82807578|FG001|Overall Study|Adverse Event|0|||
46634062|NCT01702428|82807579|FG002|Overall Study|Adverse Event|0|||
46634063|NCT01702428|82807580|FG003|Overall Study|Adverse Event|0|||
46634064|NCT01702428|82807577|FG000|Overall Study|Lost to Follow-up|33|||
46634065|NCT01702428|82807578|FG001|Overall Study|Lost to Follow-up|41|||
46634066|NCT01702428|82807579|FG002|Overall Study|Lost to Follow-up|37|||
46634067|NCT01702428|82807580|FG003|Overall Study|Lost to Follow-up|44|||
46634068|NCT01702428|82807577|FG000|Overall Study|Parents cannot assist to site|1|||
46634069|NCT01702428|82807578|FG001|Overall Study|Parents cannot assist to site|0|||
46634070|NCT01702428|82807579|FG002|Overall Study|Parents cannot assist to site|1|||
46634071|NCT01702428|82807580|FG003|Overall Study|Parents cannot assist to site|0|||
46634072|NCT01702428|82807577|FG000|Overall Study|Lost Coverage|0|||
46634073|NCT01702428|82807578|FG001|Overall Study|Lost Coverage|0|||
46634074|NCT01702428|82807579|FG002|Overall Study|Lost Coverage|0|||
46634075|NCT01702428|82807580|FG003|Overall Study|Lost Coverage|1|||
46634076|NCT01702428|82807577|FG000|Overall Study|Lost Health Plan|3|||
46634077|NCT01702428|82807578|FG001|Overall Study|Lost Health Plan|5|||
46634078|NCT01702428|82807579|FG002|Overall Study|Lost Health Plan|0|||
46634079|NCT01702428|82807580|FG003|Overall Study|Lost Health Plan|2|||
46634080|NCT01702428|82807577|FG000|Overall Study|Mother transferred care|0|||
46634081|NCT01702428|82807578|FG001|Overall Study|Mother transferred care|1|||
46634082|NCT01702428|82807579|FG002|Overall Study|Mother transferred care|0|||
46634083|NCT01702428|82807580|FG003|Overall Study|Mother transferred care|0|||
46634084|NCT01702428|82807577|FG000|Overall Study|Parents too busy|1|||
46634085|NCT01702428|82807578|FG001|Overall Study|Parents too busy|0|||
46634086|NCT01702428|82807579|FG002|Overall Study|Parents too busy|0|||
46634087|NCT01702428|82807580|FG003|Overall Study|Parents too busy|0|||
46634088|NCT01702428|82807577|FG000|Overall Study|Protocol Violation|3|||
46723322|NCT01145066|82938981|FG002|Overall Study|Non-related surgery|1|||
46723323|NCT01145066|82938979|FG000|Overall Study|Withdrawal by Subject|0|||
46634089|NCT01702428|82807578|FG001|Overall Study|Protocol Violation|0|||
46634090|NCT01702428|82807579|FG002|Overall Study|Protocol Violation|1|||
46920632|NCT00899379|83152926|FG002|Overall Study|Abnormal Baseline ECG|0|||
46634091|NCT01702428|82807580|FG003|Overall Study|Protocol Violation|0|||
46634092|NCT01702428|82807577|FG000|Overall Study|Withdrawal by Subject|21|||
46634093|NCT01702428|82807578|FG001|Overall Study|Withdrawal by Subject|23|||
46634094|NCT01702428|82807579|FG002|Overall Study|Withdrawal by Subject|14|||
46634095|NCT01702428|82807580|FG003|Overall Study|Withdrawal by Subject|10|||
46723324|NCT01145066|82938980|FG001|Overall Study|Withdrawal by Subject|0|||
46920633|NCT00899379|83152927|FG003|Overall Study|Abnormal Baseline ECG|1|||
46634096|NCT01701258|82807601|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
46723325|NCT01145066|82938981|FG002|Overall Study|Withdrawal by Subject|2|||
46723326|NCT01145066|82938979|FG000|Overall Study|To start new med|1|||
46723327|NCT01145066|82938980|FG001|Overall Study|To start new med|0|||
46723328|NCT01145066|82938981|FG002|Overall Study|To start new med|0|||
46723329|NCT01145066|82938979|FG000|Overall Study|problems swallowing capsule|1|||
46723330|NCT01145066|82938980|FG001|Overall Study|problems swallowing capsule|0|||
46723331|NCT01145066|82938981|FG002|Overall Study|problems swallowing capsule|0|||
46723332|NCT01145066|82938979|FG000|Overall Study|Abdominal discomfort|0|||
46723333|NCT01145066|82938980|FG001|Overall Study|Abdominal discomfort|1|||
46723334|NCT01145066|82938981|FG002|Overall Study|Abdominal discomfort|0|||
46723335|NCT01145066|82938979|FG000|Overall Study|Low platelet count|0|||
46723336|NCT01145066|82938980|FG001|Overall Study|Low platelet count|1|||
46723337|NCT01145066|82938981|FG002|Overall Study|Low platelet count|0|||
46723338|NCT01132118|82938991|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
46723339|NCT01132118|82938992|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
46723340|NCT01132118|82938991|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
46723341|NCT01132118|82938992|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
46723342|NCT01132118|82938991|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
46723343|NCT01132118|82938992|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
46723344|NCT00972816|82939006|FG000|Overall Study|Adverse Event|0|||
46723345|NCT00972816|82939007|FG001|Overall Study|Adverse Event|0|||
46723346|NCT00972816|82939008|FG002|Overall Study|Adverse Event|1|||
46723347|NCT00972816|82939009|FG003|Overall Study|Adverse Event|0|||
46723348|NCT00972816|82939010|FG004|Overall Study|Adverse Event|0|||
46723349|NCT00972816|82939011|FG005|Overall Study|Adverse Event|0|||
46723350|NCT00972816|82939012|FG006|Overall Study|Adverse Event|0|||
46723351|NCT00972816|82939013|FG007|Overall Study|Adverse Event|0|||
46723352|NCT00972816|82939006|FG000|Overall Study|Withdrawal by Subject|4|||
46723353|NCT00972816|82939007|FG001|Overall Study|Withdrawal by Subject|2|||
46723354|NCT00972816|82939008|FG002|Overall Study|Withdrawal by Subject|1|||
46723355|NCT00972816|82939009|FG003|Overall Study|Withdrawal by Subject|3|||
46723356|NCT00972816|82939010|FG004|Overall Study|Withdrawal by Subject|0|||
46723357|NCT00972816|82939011|FG005|Overall Study|Withdrawal by Subject|1|||
46723358|NCT00972816|82939012|FG006|Overall Study|Withdrawal by Subject|1|||
46723359|NCT00972816|82939013|FG007|Overall Study|Withdrawal by Subject|2|||
46723360|NCT00972816|82939006|FG000|Overall Study|Lost to Follow-up|11|||
46723361|NCT00972816|82939007|FG001|Overall Study|Lost to Follow-up|9|||
46723362|NCT00972816|82939008|FG002|Overall Study|Lost to Follow-up|7|||
46723363|NCT00972816|82939009|FG003|Overall Study|Lost to Follow-up|5|||
46723364|NCT00972816|82939010|FG004|Overall Study|Lost to Follow-up|11|||
46920634|NCT00899379|83152928|FG004|Overall Study|Abnormal Baseline ECG|0|||
46920635|NCT00899379|83152924|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
46920636|NCT00899379|83152925|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
46920637|NCT00899379|83152926|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
46920638|NCT00899379|83152927|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46723365|NCT00972816|82939011|FG005|Overall Study|Lost to Follow-up|10|||
46723366|NCT00972816|82939012|FG006|Overall Study|Lost to Follow-up|7|||
46920639|NCT00899379|83152928|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46920640|NCT00899379|83152924|FG000|Overall Study|Not Completed/Entered Extn|5|||
46723367|NCT00972816|82939013|FG007|Overall Study|Lost to Follow-up|7|||
46723368|NCT00972816|82939006|FG000|Overall Study|Inappropriate enrolment|0|||
46723369|NCT00972816|82939007|FG001|Overall Study|Inappropriate enrolment|0|||
46723370|NCT00972816|82939008|FG002|Overall Study|Inappropriate enrolment|0|||
46723371|NCT00972816|82939009|FG003|Overall Study|Inappropriate enrolment|0|||
46723372|NCT00972816|82939010|FG004|Overall Study|Inappropriate enrolment|0|||
46723373|NCT00972816|82939011|FG005|Overall Study|Inappropriate enrolment|0|||
46723374|NCT00972816|82939012|FG006|Overall Study|Inappropriate enrolment|2|||
46723375|NCT00972816|82939013|FG007|Overall Study|Inappropriate enrolment|0|||
46723376|NCT00972816|82939006|FG000|Overall Study|Unable to classify|2|||
46723377|NCT00972816|82939007|FG001|Overall Study|Unable to classify|0|||
46723378|NCT00972816|82939008|FG002|Overall Study|Unable to classify|0|||
46723379|NCT00972816|82939009|FG003|Overall Study|Unable to classify|0|||
46723380|NCT00972816|82939010|FG004|Overall Study|Unable to classify|1|||
46723381|NCT00972816|82939011|FG005|Overall Study|Unable to classify|0|||
46723382|NCT00972816|82939012|FG006|Overall Study|Unable to classify|0|||
46723383|NCT00972816|82939013|FG007|Overall Study|Unable to classify|0|||
46723384|NCT00969618|82939031|FG000|Overall Study|Adverse Event|29|||
46723385|NCT00969618|82939031|FG000|Overall Study|Entry Criteria Not Met|3|||
46723386|NCT00969618|82939031|FG000|Overall Study|Lack of Efficacy|2|||
46723387|NCT00969618|82939031|FG000|Overall Study|Lost to Follow-up|7|||
46723388|NCT00969618|82939031|FG000|Overall Study|Physician Decision|1|||
46723389|NCT00969618|82939031|FG000|Overall Study|Protocol Violation|9|||
46723390|NCT00969618|82939031|FG000|Overall Study|Withdrawal by Subject|27|||
46723391|NCT00969540|82939037|FG000|Overall Study|Lost to Follow-up|1|||
46723392|NCT00969540|82939038|FG001|Overall Study|Lost to Follow-up|1|||
46723393|NCT00975000|82939058|FG000|Overall Study|Other|1|||
46723394|NCT00975000|82939059|FG001|Overall Study|Other|0|||
46723395|NCT00975000|82939058|FG000|Overall Study|Adverse Event|1|||
46723396|NCT00975000|82939059|FG001|Overall Study|Adverse Event|1|||
46723397|NCT00975000|82939058|FG000|Overall Study|Withdrawal by Subject|2|||
46723398|NCT00975000|82939059|FG001|Overall Study|Withdrawal by Subject|2|||
46723399|NCT00975000|82939058|FG000|Overall Study|Lost to Follow-up|0|||
46723400|NCT00975000|82939059|FG001|Overall Study|Lost to Follow-up|1|||
46723401|NCT00975000|82939058|FG000|Overall Study|Protocol-specified Criteria|1|||
46723402|NCT00975000|82939059|FG001|Overall Study|Protocol-specified Criteria|0|||
46723403|NCT00975000|82939058|FG000|Overall Study|Non-compliance|0|||
46723404|NCT00975000|82939059|FG001|Overall Study|Non-compliance|1|||
46723405|NCT00974922|82939065|FG000|Overall Study|study terminated|24|||
46723406|NCT00972504|82939069|FG000|Overall Study|Adverse Event|2|||
46723407|NCT00972504|82939069|FG000|Overall Study|Investigator discretion|1|||
46723408|NCT00969228|82939081|FG000|Overall Study|Adverse Event|1|||
46723409|NCT00969228|82939082|FG001|Overall Study|Adverse Event|0|||
46723410|NCT00969228|82939081|FG000|Overall Study|Withdrawal by Subject|4|||
46723411|NCT00969228|82939082|FG001|Overall Study|Withdrawal by Subject|0|||
46723412|NCT00969228|82939081|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
46723413|NCT00969228|82939082|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
46723414|NCT00969150|82939090|FG000|Overall Study|Adverse Event|4|||
46723415|NCT00969150|82939091|FG001|Overall Study|Adverse Event|14|||
46723416|NCT00969150|82939090|FG000|Overall Study|Lack of Efficacy|1|||
46723417|NCT00969150|82939091|FG001|Overall Study|Lack of Efficacy|1|||
46723418|NCT00969150|82939090|FG000|Overall Study|Protocol Violation|9|||
46723419|NCT00969150|82939091|FG001|Overall Study|Protocol Violation|12|||
46723420|NCT00969150|82939090|FG000|Overall Study|Withdrawal by Subject|13|||
46723421|NCT00969150|82939091|FG001|Overall Study|Withdrawal by Subject|9|||
46723422|NCT00969150|82939090|FG000|Overall Study|Lost to Follow-up|5|||
46723423|NCT00969150|82939091|FG001|Overall Study|Lost to Follow-up|4|||
46723424|NCT00969150|82939090|FG000|Overall Study|Other reasons|1|||
46723425|NCT00969150|82939091|FG001|Overall Study|Other reasons|0|||
46723426|NCT00974220|82939099|FG000|Treatment Period 1|Adverse Event|2|||
46723427|NCT00974220|82939100|FG001|Treatment Period 1|Adverse Event|1|||
46634097|NCT01701258|82807602|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
46723428|NCT00974220|82939099|FG000|Treatment Period 1|noncompliant subjects|0|||
46723429|NCT00974220|82939100|FG001|Treatment Period 1|noncompliant subjects|1|||
46723430|NCT00971178|82939109|FG000|Overall Study|Lost to Follow-up|2|||
46723431|NCT00971178|82939110|FG001|Overall Study|Lost to Follow-up|2|||
46723432|NCT00971178|82939111|FG002|Overall Study|Lost to Follow-up|2|||
46723433|NCT03670602|82939121|FG000|Overall Study|Lost to Follow-up|1|||
46634098|NCT01701258|82807603|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
46634099|NCT01701258|82807604|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
46634100|NCT01701258|82807605|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
46634101|NCT01701258|82807606|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
46634102|NCT01701258|82807607|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
46634103|NCT01701258|82807608|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
46634104|NCT01701258|82807609|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
46634105|NCT01701258|82807610|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
46634106|NCT01701258|82807611|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
46723434|NCT03670602|82939122|FG001|Overall Study|Lost to Follow-up|0|||
46723435|NCT03670602|82939121|FG000|Overall Study|Withdrawal by Subject|0|||
46723436|NCT03670602|82939122|FG001|Overall Study|Withdrawal by Subject|3|||
46723437|NCT00968526|82939130|FG000|Overall Study|Adverse Event|2|||
46723438|NCT00968526|82939131|FG001|Overall Study|Adverse Event|0|||
46723439|NCT00968526|82939130|FG000|Overall Study|Migrated/moved from study area|1|||
46723440|NCT00968526|82939131|FG001|Overall Study|Migrated/moved from study area|0|||
46723441|NCT03664674|82939148|FG000|Overall Study|Adverse Event|1|||
46723442|NCT03664674|82939149|FG001|Overall Study|Adverse Event|1|||
46723443|NCT03664674|82939148|FG000|Overall Study|Physician Decision|0|||
46723444|NCT03664674|82939149|FG001|Overall Study|Physician Decision|1|||
46723445|NCT03664674|82939148|FG000|Overall Study|Withdrawal by Subject|2|||
46723446|NCT03664674|82939149|FG001|Overall Study|Withdrawal by Subject|0|||
46723447|NCT00967668|82939160|FG000|Overall Study|Withdrawal by Subject|13|||
46723448|NCT00967668|82939161|FG001|Overall Study|Withdrawal by Subject|8|||
46723449|NCT00967668|82939162|FG002|Overall Study|Withdrawal by Subject|8|||
46723450|NCT00967668|82939160|FG000|Overall Study|Death|0|||
46723451|NCT00967668|82939161|FG001|Overall Study|Death|2|||
46723452|NCT00967668|82939162|FG002|Overall Study|Death|4|||
46723453|NCT00967668|82939160|FG000|Overall Study|Removed due to behavior|1|||
46723454|NCT00967668|82939161|FG001|Overall Study|Removed due to behavior|1|||
46723455|NCT00967668|82939162|FG002|Overall Study|Removed due to behavior|2|||
46723456|NCT00967668|82939160|FG000|Overall Study|Refused Year 2|11|||
46723457|NCT00967668|82939161|FG001|Overall Study|Refused Year 2|6|||
46723458|NCT00967668|82939162|FG002|Overall Study|Refused Year 2|4|||
46723459|NCT00967668|82939160|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
46723460|NCT00967668|82939161|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
46723461|NCT00967668|82939162|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
46723462|NCT00967668|82939160|FG000|Overall Study|Lost to Follow-up|15|||
46723463|NCT00967668|82939161|FG001|Overall Study|Lost to Follow-up|9|||
46723464|NCT00967668|82939162|FG002|Overall Study|Lost to Follow-up|16|||
46723465|NCT00967668|82939160|FG000|Overall Study|Refused 12-mo assessment|3|||
46723466|NCT00967668|82939161|FG001|Overall Study|Refused 12-mo assessment|1|||
46723467|NCT00967668|82939162|FG002|Overall Study|Refused 12-mo assessment|9|||
46723468|NCT00967668|82939160|FG000|Overall Study|Pregnancy|1|||
46723469|NCT00967668|82939161|FG001|Overall Study|Pregnancy|0|||
46723470|NCT00967668|82939162|FG002|Overall Study|Pregnancy|0|||
46723471|NCT00970944|82939175|FG000|Overall Study|Death|1|||
46723472|NCT00970944|82939176|FG001|Overall Study|Death|0|||
46723473|NCT00970944|82939175|FG000|Overall Study|Physician Decision|0|||
46723474|NCT00970944|82939176|FG001|Overall Study|Physician Decision|2|||
46723475|NCT04892147|82939185|FG000|Overall Study|Withdrawal by Subject|2|||
46723476|NCT04892147|82939186|FG001|Overall Study|Withdrawal by Subject|0|||
46723477|NCT04839289|82939195|FG000|Overall Study|Withdrawal by Subject|1|||
46723478|NCT04839289|82939196|FG001|Overall Study|Withdrawal by Subject|0|||
46723479|NCT04544865|82939204|FG000|Overall Study|Death|0|||
46723480|NCT04544865|82939205|FG001|Overall Study|Death|2|||
46723481|NCT04544865|82939204|FG000|Overall Study|Lost to Follow-up|11|||
46723482|NCT04544865|82939205|FG001|Overall Study|Lost to Follow-up|7|||
46723483|NCT04544865|82939204|FG000|Overall Study|Withdrawal by Subject|0|||
46723484|NCT04544865|82939205|FG001|Overall Study|Withdrawal by Subject|1|||
46723485|NCT04544865|82939204|FG000|Overall Study|Other|0|||
46723486|NCT04544865|82939205|FG001|Overall Study|Other|1|||
46723487|NCT04440813|82939214|FG000|Overall Study|Lost to Follow-up|5|||
46723488|NCT04440813|82939215|FG001|Overall Study|Lost to Follow-up|5|||
46723489|NCT04233073|82939229|FG000|Overall Study|Death|5|||
46723490|NCT04120116|82939237|FG000|Overall Study|Lost to Follow-up|0|||
46723491|NCT04120116|82939238|FG001|Overall Study|Lost to Follow-up|1|||
46723492|NCT04120116|82939239|FG002|Overall Study|Lost to Follow-up|0|||
46723493|NCT04120116|82939240|FG003|Overall Study|Lost to Follow-up|2|||
46723494|NCT04120116|82939237|FG000|Overall Study|Withdrawal by Subject|1|||
46723495|NCT04120116|82939238|FG001|Overall Study|Withdrawal by Subject|0|||
46723496|NCT04120116|82939239|FG002|Overall Study|Withdrawal by Subject|1|||
47045103|NCT01839487|83303168|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
47045104|NCT01839487|83303163|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
46723497|NCT04120116|82939240|FG003|Overall Study|Withdrawal by Subject|1|||
46723498|NCT04120116|82939237|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
46723499|NCT04120116|82939238|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
46723500|NCT04120116|82939239|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
46723501|NCT04120116|82939240|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
46723502|NCT03657810|82939263|FG000|Overall Study|Adverse Event|0|||
46723503|NCT03657810|82939264|FG001|Overall Study|Adverse Event|1|||
46723504|NCT03657810|82939265|FG002|Overall Study|Adverse Event|0|||
46723505|NCT03657810|82939263|FG000|Overall Study|Lack of Efficacy|4|||
46723506|NCT03657810|82939264|FG001|Overall Study|Lack of Efficacy|1|||
46723507|NCT03657810|82939265|FG002|Overall Study|Lack of Efficacy|3|||
46723508|NCT03657810|82939263|FG000|Overall Study|Protocol Violation|1|||
46723509|NCT03657810|82939264|FG001|Overall Study|Protocol Violation|0|||
46723510|NCT03657810|82939265|FG002|Overall Study|Protocol Violation|0|||
46723511|NCT03657810|82939263|FG000|Overall Study|Lost to Follow-up|0|||
46723512|NCT03657810|82939264|FG001|Overall Study|Lost to Follow-up|1|||
46723513|NCT03657810|82939265|FG002|Overall Study|Lost to Follow-up|0|||
46723514|NCT03657810|82939263|FG000|Overall Study|Not provided|0|||
46723515|NCT03657810|82939264|FG001|Overall Study|Not provided|1|||
46723516|NCT03657810|82939265|FG002|Overall Study|Not provided|0|||
46723517|NCT03370341|82939287|FG000|Overall Study|Lost to Follow-up|0|||
46723518|NCT03370341|82939288|FG001|Overall Study|Lost to Follow-up|1|||
46723519|NCT02502799|82939340|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
46723520|NCT02502799|82939341|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
46723521|NCT02502799|82939342|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
46723522|NCT02502799|82939343|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
46723523|NCT02502799|82939340|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
46723524|NCT02502799|82939341|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
46723525|NCT02502799|82939342|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
46723526|NCT02502799|82939343|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
46723527|NCT02502799|82939340|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
46723528|NCT02502799|82939341|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
46723529|NCT02502799|82939342|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
46723530|NCT02502799|82939343|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
46723531|NCT02502799|82939340|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
46723532|NCT02502799|82939341|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
46723533|NCT02502799|82939342|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
46723534|NCT02502799|82939343|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
46920641|NCT00899379|83152925|FG001|Overall Study|Not Completed/Entered Extn|1|||
46920642|NCT00899379|83152926|FG002|Overall Study|Not Completed/Entered Extn|6|||
46920643|NCT00899379|83152927|FG003|Overall Study|Not Completed/Entered Extn|4|||
46920644|NCT00899379|83152928|FG004|Overall Study|Not Completed/Entered Extn|3|||
46920645|NCT00899379|83152924|FG000|Overall Study|Study Terminated|3|||
46920646|NCT00899379|83152925|FG001|Overall Study|Study Terminated|0|||
46920647|NCT00899379|83152926|FG002|Overall Study|Study Terminated|3|||
46723535|NCT02502799|82939340|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
46723536|NCT02502799|82939341|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
46723537|NCT02502799|82939342|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
46723538|NCT02502799|82939343|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
46723539|NCT02086448|82939356|FG000|Overall Study|Withdrawal by Subject|1|||
46723540|NCT02086448|82939357|FG001|Overall Study|Withdrawal by Subject|0|||
46723541|NCT02086448|82939358|FG002|Overall Study|Withdrawal by Subject|0|||
46723542|NCT02086448|82939359|FG003|Overall Study|Withdrawal by Subject|2|||
46723543|NCT01993836|82939372|FG000|Overall Study|Surgery Cancelled|3|||
46723544|NCT01993836|82939373|FG001|Overall Study|Surgery Cancelled|0|||
46723545|NCT01993836|82939374|FG002|Overall Study|Surgery Cancelled|0|||
46723546|NCT01993836|82939372|FG000|Overall Study|Physician Decision|2|||
46920648|NCT00899379|83152927|FG003|Overall Study|Study Terminated|3|||
46920649|NCT00899379|83152928|FG004|Overall Study|Study Terminated|1|||
46920650|NCT00899379|83152924|FG000|Overall Study|Lost to Follow-up|3|||
46920651|NCT00899379|83152925|FG001|Overall Study|Lost to Follow-up|1|||
46920652|NCT00899379|83152926|FG002|Overall Study|Lost to Follow-up|0|||
46920653|NCT00899379|83152927|FG003|Overall Study|Lost to Follow-up|2|||
46723547|NCT01993836|82939373|FG001|Overall Study|Physician Decision|1|||
46723548|NCT01993836|82939374|FG002|Overall Study|Physician Decision|0|||
46723549|NCT01993836|82939372|FG000|Overall Study|Death|0|||
46723550|NCT01993836|82939373|FG001|Overall Study|Death|2|||
46723551|NCT01993836|82939374|FG002|Overall Study|Death|0|||
46920654|NCT00899379|83152928|FG004|Overall Study|Lost to Follow-up|5|||
46920655|NCT00899379|83152924|FG000|Overall Study|Withdrawal by Subject|4|||
46723552|NCT01993836|82939372|FG000|Overall Study|Withdrawal by Subject|12|||
46723553|NCT01993836|82939373|FG001|Overall Study|Withdrawal by Subject|10|||
46920656|NCT00899379|83152925|FG001|Overall Study|Withdrawal by Subject|7|||
46920657|NCT00899379|83152926|FG002|Overall Study|Withdrawal by Subject|4|||
46920658|NCT00899379|83152927|FG003|Overall Study|Withdrawal by Subject|7|||
46920659|NCT00899379|83152928|FG004|Overall Study|Withdrawal by Subject|2|||
47045105|NCT01839487|83303164|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
47045106|NCT01839487|83303165|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
47045107|NCT01839487|83303166|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
47045108|NCT01839487|83303167|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
47045109|NCT01839487|83303168|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
47045110|NCT01839487|83303163|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
47045111|NCT01839487|83303164|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
47045112|NCT01839487|83303165|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
47045113|NCT01839487|83303166|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
46723554|NCT01993836|82939374|FG002|Overall Study|Withdrawal by Subject|5|||
46723555|NCT00970632|82939399|FG000|Overall Study|Adverse Event|2|||
46723556|NCT00970632|82939400|FG001|Overall Study|Adverse Event|2|||
47045114|NCT01839487|83303167|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
46723557|NCT00970632|82939401|FG002|Overall Study|Adverse Event|1|||
46723558|NCT00970632|82939399|FG000|Overall Study|Lack of Efficacy|3|||
46723559|NCT00970632|82939400|FG001|Overall Study|Lack of Efficacy|0|||
46723560|NCT00970632|82939401|FG002|Overall Study|Lack of Efficacy|0|||
46723561|NCT00970632|82939399|FG000|Overall Study|Lost to Follow-up|3|||
46723562|NCT00970632|82939400|FG001|Overall Study|Lost to Follow-up|0|||
46723563|NCT00970632|82939401|FG002|Overall Study|Lost to Follow-up|2|||
46723564|NCT00970632|82939399|FG000|Overall Study|Protocol Violation|8|||
46723565|NCT00970632|82939400|FG001|Overall Study|Protocol Violation|5|||
46723566|NCT00970632|82939401|FG002|Overall Study|Protocol Violation|8|||
46723567|NCT00970632|82939399|FG000|Overall Study|Withdrawal by Subject|7|||
46723568|NCT00970632|82939400|FG001|Overall Study|Withdrawal by Subject|6|||
46723569|NCT00970632|82939401|FG002|Overall Study|Withdrawal by Subject|4|||
46723570|NCT00970632|82939399|FG000|Overall Study|Entry criteria not met|0|||
46723571|NCT00970632|82939400|FG001|Overall Study|Entry criteria not met|2|||
46634107|NCT01701258|82807612|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
46723572|NCT00970632|82939401|FG002|Overall Study|Entry criteria not met|2|||
46723573|NCT00970632|82939399|FG000|Overall Study|Sponsor decision|1|||
46723574|NCT00970632|82939400|FG001|Overall Study|Sponsor decision|0|||
46723575|NCT00970632|82939401|FG002|Overall Study|Sponsor decision|1|||
47045115|NCT01839487|83303168|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
47045116|NCT01839487|83303163|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
46634108|NCT01701258|82807613|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
46634109|NCT01701258|82807601|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
46634110|NCT01701258|82807602|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
46634111|NCT01701258|82807603|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
46634112|NCT01701258|82807604|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
46634113|NCT01701258|82807605|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
46634114|NCT01701258|82807606|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
46634115|NCT01701258|82807607|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
46634116|NCT01701258|82807608|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
46723576|NCT01144364|82939411|FG000|Induction Phase|Disease progression|14|||
46723577|NCT01144364|82939412|FG001|Induction Phase|Disease progression|0|||
46723578|NCT01144364|82939413|FG002|Induction Phase|Disease progression|0|||
46723579|NCT01144364|82939411|FG000|Induction Phase|Adverse Event|9|||
46723580|NCT01144364|82939412|FG001|Induction Phase|Adverse Event|0|||
46723581|NCT01144364|82939413|FG002|Induction Phase|Adverse Event|0|||
46723582|NCT01144364|82939411|FG000|Induction Phase|Death|1|||
46920660|NCT00899379|83152924|FG000|Overall Study|Pregnancy|1|||
46920661|NCT00899379|83152925|FG001|Overall Study|Pregnancy|0|||
46920662|NCT00899379|83152926|FG002|Overall Study|Pregnancy|0|||
46920663|NCT00899379|83152927|FG003|Overall Study|Pregnancy|0|||
46920664|NCT00899379|83152928|FG004|Overall Study|Pregnancy|0|||
47045117|NCT01839487|83303164|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
47045118|NCT01839487|83303165|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
47045119|NCT01839487|83303166|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
47045120|NCT01839487|83303167|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
46723583|NCT01144364|82939412|FG001|Induction Phase|Death|0|||
46920665|NCT00899379|83152924|FG000|Overall Study|Patient Uncooperative|0|||
46920666|NCT00899379|83152925|FG001|Overall Study|Patient Uncooperative|0|||
46723584|NCT01144364|82939413|FG002|Induction Phase|Death|0|||
46723585|NCT01144364|82939411|FG000|Induction Phase|Withdrawal by Subject|1|||
46723586|NCT01144364|82939412|FG001|Induction Phase|Withdrawal by Subject|0|||
46723587|NCT01144364|82939413|FG002|Induction Phase|Withdrawal by Subject|0|||
46723588|NCT01144364|82939411|FG000|Induction Phase|Lost to Follow-up|2|||
46723589|NCT01144364|82939412|FG001|Induction Phase|Lost to Follow-up|0|||
46723590|NCT01144364|82939413|FG002|Induction Phase|Lost to Follow-up|0|||
46723591|NCT01144364|82939411|FG000|Induction Phase|Physician Decision|1|||
46723592|NCT01144364|82939412|FG001|Induction Phase|Physician Decision|0|||
46723593|NCT01144364|82939413|FG002|Induction Phase|Physician Decision|0|||
46723594|NCT01144364|82939411|FG000|Induction Phase|Stable disease|2|||
46723595|NCT01144364|82939412|FG001|Induction Phase|Stable disease|0|||
46723596|NCT01144364|82939413|FG002|Induction Phase|Stable disease|0|||
46723597|NCT01144364|82939411|FG000|Induction Phase|Secondary neoplasia|1|||
46723598|NCT01144364|82939412|FG001|Induction Phase|Secondary neoplasia|0|||
46723599|NCT01144364|82939413|FG002|Induction Phase|Secondary neoplasia|0|||
46723600|NCT01144364|82939411|FG000|Induction Phase|Protocol Violation|1|||
46723601|NCT01144364|82939412|FG001|Induction Phase|Protocol Violation|0|||
46723602|NCT01144364|82939413|FG002|Induction Phase|Protocol Violation|0|||
46723603|NCT01144364|82939411|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
46723604|NCT01144364|82939412|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
46723605|NCT01144364|82939413|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
46723606|NCT01144364|82939411|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
47045121|NCT01839487|83303168|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
46723607|NCT01144364|82939412|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
46723608|NCT01144364|82939413|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
47045122|NCT01839487|83303163|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
46723609|NCT01144364|82939411|FG000|Follow-Up/Maintenance Phase|Death|0|||
46723610|NCT01144364|82939412|FG001|Follow-Up/Maintenance Phase|Death|2|||
46723611|NCT01144364|82939413|FG002|Follow-Up/Maintenance Phase|Death|0|||
46723612|NCT01144364|82939411|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
46723613|NCT01144364|82939412|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
46723614|NCT01144364|82939413|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
46723615|NCT01144364|82939411|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
46723616|NCT01144364|82939412|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
46723617|NCT01144364|82939413|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
46723618|NCT01144364|82939411|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
46723619|NCT01144364|82939412|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
46723620|NCT01144364|82939413|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
46723621|NCT01144364|82939411|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
46723622|NCT01144364|82939412|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
46723623|NCT01144364|82939413|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
46723624|NCT01119248|82939423|FG000|Overall Study|Physician Decision|5|||
46723625|NCT01131494|82939428|FG000|Overall Study|Withdrawal by Subject|2|||
46723626|NCT01131260|82939435|FG000|Overall Study|Randomization error|5|||
46723627|NCT01131260|82939436|FG001|Overall Study|Randomization error|1|||
46723628|NCT01131260|82939435|FG000|Overall Study|Declined to continue participation|8|||
47045123|NCT01839487|83303164|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
47045124|NCT01839487|83303165|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
47045125|NCT01839487|83303166|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
47045126|NCT01839487|83303167|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
46723629|NCT01131260|82939436|FG001|Overall Study|Declined to continue participation|13|||
46723630|NCT01131260|82939435|FG000|Overall Study|Physician Decision|22|||
46723631|NCT01131260|82939436|FG001|Overall Study|Physician Decision|24|||
46723632|NCT01131260|82939435|FG000|Overall Study|Technical problems|7|||
47045127|NCT01839487|83303168|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
46723633|NCT01131260|82939436|FG001|Overall Study|Technical problems|6|||
47045128|NCT01839487|83303163|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
47045129|NCT01839487|83303164|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
47045130|NCT01839487|83303165|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
46723634|NCT01131260|82939435|FG000|Overall Study|Staff error|2|||
46723635|NCT01131260|82939436|FG001|Overall Study|Staff error|1|||
46723636|NCT01131260|82939435|FG000|Overall Study|Ineligible|0|||
46723637|NCT01131260|82939436|FG001|Overall Study|Ineligible|2|||
46723638|NCT00965094|82939446|FG000|Overall Study|Adverse Event|5|||
46723639|NCT00965094|82939447|FG001|Overall Study|Adverse Event|0|||
46723640|NCT00965094|82939446|FG000|Overall Study|Lost to Follow-up|0|||
46723641|NCT00965094|82939447|FG001|Overall Study|Lost to Follow-up|1|||
46723642|NCT01131182|82939456|FG000|Overall Study|Withdrawal by Subject|1|||
46723643|NCT01131182|82939457|FG001|Overall Study|Withdrawal by Subject|1|||
46723644|NCT01131182|82939456|FG000|Overall Study|Lost to Follow-up|14|||
46723645|NCT01131182|82939457|FG001|Overall Study|Lost to Follow-up|15|||
46723646|NCT01131182|82939456|FG000|Overall Study|Other Reason|1|||
46723647|NCT01131182|82939457|FG001|Overall Study|Other Reason|0|||
46723648|NCT00964860|82939465|FG000|Overall Study|Withdrawal by Subject|0|||
47045131|NCT01839487|83303166|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
47045132|NCT01839487|83303167|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
47045133|NCT01839487|83303168|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
46634117|NCT01701258|82807609|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
46634118|NCT01701258|82807610|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
46634119|NCT01701258|82807611|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
46634120|NCT01701258|82807612|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
46634121|NCT01701258|82807613|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
46634122|NCT01701258|82807601|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
46634123|NCT01701258|82807602|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
46634124|NCT01701258|82807603|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
46634125|NCT01701258|82807604|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
46634126|NCT01701258|82807605|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
46634127|NCT01701258|82807606|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
46634128|NCT01701258|82807607|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
46634129|NCT01701258|82807608|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
46634130|NCT01701258|82807609|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
46634131|NCT01701258|82807610|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
46634132|NCT01701258|82807611|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
46634133|NCT01701258|82807612|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
46634134|NCT01701258|82807613|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
46634135|NCT01701258|82807601|FG000|Assessment and Scheduling|Investigator Terminated|2|||
46634136|NCT01701258|82807602|FG001|Assessment and Scheduling|Investigator Terminated|0|||
46634137|NCT01701258|82807603|FG002|Assessment and Scheduling|Investigator Terminated|0|||
46634138|NCT01701258|82807604|FG003|Assessment and Scheduling|Investigator Terminated|0|||
46634139|NCT01701258|82807605|FG004|Assessment and Scheduling|Investigator Terminated|0|||
46634140|NCT01701258|82807606|FG005|Assessment and Scheduling|Investigator Terminated|0|||
46634141|NCT01701258|82807607|FG006|Assessment and Scheduling|Investigator Terminated|0|||
46634142|NCT01701258|82807608|FG007|Assessment and Scheduling|Investigator Terminated|0|||
46634143|NCT01701258|82807609|FG008|Assessment and Scheduling|Investigator Terminated|0|||
46634144|NCT01701258|82807610|FG009|Assessment and Scheduling|Investigator Terminated|0|||
46634145|NCT01701258|82807611|FG010|Assessment and Scheduling|Investigator Terminated|0|||
46634146|NCT01701258|82807612|FG011|Assessment and Scheduling|Investigator Terminated|0|||
46634147|NCT01701258|82807613|FG012|Assessment and Scheduling|Investigator Terminated|0|||
46634148|NCT01700946|82807643|FG000|Overall Study|Lost to Follow-up|1|||
46634149|NCT01700946|82807644|FG001|Overall Study|Lost to Follow-up|0|||
46634150|NCT01700946|82807643|FG000|Overall Study|Physician Decision|7|||
46634151|NCT01700946|82807644|FG001|Overall Study|Physician Decision|12|||
46634152|NCT01700946|82807643|FG000|Overall Study|Withdrawal by Subject|0|||
46634153|NCT01700946|82807644|FG001|Overall Study|Withdrawal by Subject|2|||
46634154|NCT01700946|82807643|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
46634155|NCT01700946|82807644|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
46634156|NCT01700946|82807643|FG000|Overall Study|Relapse|2|||
46634157|NCT01700946|82807644|FG001|Overall Study|Relapse|1|||
46634158|NCT01700946|82807643|FG000|Overall Study|Unacceptable toxicity|1|||
46634159|NCT01700946|82807644|FG001|Overall Study|Unacceptable toxicity|0|||
46634160|NCT01748994|82807656|FG000|Overall Study|Lost to Follow-up|8|||
46634161|NCT01748994|82807657|FG001|Overall Study|Lost to Follow-up|6|||
46634162|NCT01721070|82807663|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
46634163|NCT01748760|82807672|FG000|Overall Study|Withdrawal by Subject|1|||
46634164|NCT01748760|82807673|FG001|Overall Study|Withdrawal by Subject|1|||
46634165|NCT01748760|82807672|FG000|Overall Study|Lost to Follow-up|5|||
46634166|NCT01748760|82807673|FG001|Overall Study|Lost to Follow-up|1|||
46634167|NCT01748292|82807681|FG000|Overall Study|Adverse Event|2|||
46723649|NCT00964860|82939466|FG001|Overall Study|Withdrawal by Subject|1|||
46723650|NCT01131104|82939472|FG000|Overall Study|Withdrawal by Subject|3|||
46634168|NCT01748292|82807682|FG001|Overall Study|Adverse Event|4|||
46723651|NCT01131104|82939472|FG000|Overall Study|Physician Decision|4|||
46723652|NCT01131104|82939472|FG000|Overall Study|Information Not Available|5|||
46723653|NCT01131104|82939472|FG000|Overall Study|No Information on Index Date of Onset|1|||
46723654|NCT01118780|82939478|FG000|Overall Study|Adverse Event|15|||
46723655|NCT01118780|82939479|FG001|Overall Study|Adverse Event|15|||
46723656|NCT01118780|82939478|FG000|Overall Study|Death|1|||
46723657|NCT01118780|82939479|FG001|Overall Study|Death|0|||
46723658|NCT01118780|82939478|FG000|Overall Study|Lack of Efficacy|2|||
46723659|NCT01118780|82939479|FG001|Overall Study|Lack of Efficacy|6|||
46723660|NCT01118780|82939478|FG000|Overall Study|Physician Decision|2|||
46723661|NCT01118780|82939479|FG001|Overall Study|Physician Decision|0|||
46723662|NCT01118780|82939478|FG000|Overall Study|Protocol Violation|3|||
46634169|NCT01748292|82807681|FG000|Overall Study|Lost to Follow-up|0|||
46634170|NCT01748292|82807682|FG001|Overall Study|Lost to Follow-up|3|||
46634171|NCT01748292|82807681|FG000|Overall Study|Death|0|||
46634172|NCT01748292|82807682|FG001|Overall Study|Death|3|||
46634173|NCT01748292|82807681|FG000|Overall Study|Withdrawal by Subject|0|||
46634174|NCT01748292|82807682|FG001|Overall Study|Withdrawal by Subject|2|||
46634175|NCT01720602|82807688|FG000|Overall Study|Adverse Event|3|||
46634176|NCT01720602|82807688|FG000|Overall Study|Progressive disease on therapy|2|||
46634177|NCT01746732|82807692|FG000|Lead-In Period|Withdrawal by Subject|1|||
46634178|NCT01746732|82807693|FG001|Lead-In Period|Withdrawal by Subject|0|||
46634179|NCT01746732|82807694|FG002|Lead-In Period|Withdrawal by Subject|0|||
46634180|NCT01746732|82807692|FG000|Period 1|Physician Decision|0|||
46634181|NCT01746732|82807693|FG001|Period 1|Physician Decision|1|||
46634182|NCT01746732|82807694|FG002|Period 1|Physician Decision|0|||
46634183|NCT01746732|82807692|FG000|Period 2|Withdrawal by Subject|0|||
46634184|NCT01746732|82807693|FG001|Period 2|Withdrawal by Subject|0|||
46634185|NCT01746732|82807694|FG002|Period 2|Withdrawal by Subject|2|||
46634186|NCT01746732|82807692|FG000|Period 2|Adverse Event|0|||
46634187|NCT01746732|82807693|FG001|Period 2|Adverse Event|0|||
46634188|NCT01746732|82807694|FG002|Period 2|Adverse Event|1|||
46634189|NCT01746732|82807692|FG000|Period 2|Lost to Follow-up|0|||
46634190|NCT01746732|82807693|FG001|Period 2|Lost to Follow-up|0|||
46634191|NCT01746732|82807694|FG002|Period 2|Lost to Follow-up|1|||
46634192|NCT01720524|82807704|FG000|Part A|Insufficient Clinical Response|2|||
46634193|NCT01720524|82807705|FG001|Part A|Insufficient Clinical Response|4|||
46634194|NCT01720524|82807704|FG000|Part A|Adverse Event|2|||
46634195|NCT01720524|82807705|FG001|Part A|Adverse Event|2|||
46634196|NCT01720524|82807704|FG000|Part A|Death|2|||
46634197|NCT01720524|82807705|FG001|Part A|Death|1|||
46634198|NCT01720524|82807704|FG000|Part A|Lost to Follow-up|0|||
46634199|NCT01720524|82807705|FG001|Part A|Lost to Follow-up|1|||
46634200|NCT01720524|82807704|FG000|Part A|Missed 28 day follow-up visit|1|||
46634201|NCT01720524|82807705|FG001|Part A|Missed 28 day follow-up visit|1|||
46634202|NCT01720524|82807704|FG000|Part A|Withdrawal by Subject|0|||
46634203|NCT01720524|82807705|FG001|Part A|Withdrawal by Subject|1|||
46634204|NCT01720524|82807704|FG000|Part A|Other|0|||
46634205|NCT01720524|82807705|FG001|Part A|Other|1|||
46634206|NCT01720524|82807704|FG000|Part A|Lost to Follow-up|0|||
46634207|NCT01720524|82807705|FG001|Part A|Lost to Follow-up|1|||
46634208|NCT01720524|82807704|FG000|Part B|No longer willing to participate in study|1|||
46634209|NCT01720524|82807705|FG001|Part B|No longer willing to participate in study|4|||
46634210|NCT01720524|82807704|FG000|Part B|Other|2|||
46634211|NCT01720524|82807705|FG001|Part B|Other|0|||
46634212|NCT01720524|82807704|FG000|Part B|Lost to Follow-up|2|||
46634213|NCT01720524|82807705|FG001|Part B|Lost to Follow-up|3|||
46634214|NCT01720524|82807704|FG000|Part B|Death|0|||
46634215|NCT01720524|82807705|FG001|Part B|Death|2|||
46634216|NCT01720446|82807717|FG000|Overall Study|Lost to Follow-up|12|||
46634217|NCT01720446|82807718|FG001|Overall Study|Lost to Follow-up|6|||
46634218|NCT01720446|82807719|FG002|Overall Study|Lost to Follow-up|16|||
46634219|NCT01720446|82807720|FG003|Overall Study|Lost to Follow-up|16|||
46634220|NCT01720446|82807717|FG000|Overall Study|Withdrawal by Subject|2|||
46723663|NCT01118780|82939479|FG001|Overall Study|Protocol Violation|6|||
46723664|NCT01118780|82939478|FG000|Overall Study|Withdrawal by Subject|13|||
46634221|NCT01720446|82807718|FG001|Overall Study|Withdrawal by Subject|5|||
46634222|NCT01720446|82807719|FG002|Overall Study|Withdrawal by Subject|4|||
46723665|NCT01118780|82939479|FG001|Overall Study|Withdrawal by Subject|8|||
46723666|NCT00964782|82939490|FG000|Overall Study|Lost to Follow-up|1|||
46634223|NCT01720446|82807720|FG003|Overall Study|Withdrawal by Subject|4|||
46634224|NCT01746108|82807736|FG000|Overall Study|Migrated /moved from study area|0|||
46634225|NCT01746108|82807737|FG001|Overall Study|Migrated /moved from study area|1|||
46634226|NCT01746108|82807738|FG002|Overall Study|Migrated /moved from study area|0|||
46634227|NCT01746108|82807736|FG000|Overall Study|Adverse event, non-fatal|0|||
46634228|NCT01746108|82807737|FG001|Overall Study|Adverse event, non-fatal|1|||
46634229|NCT01746108|82807738|FG002|Overall Study|Adverse event, non-fatal|0|||
46723667|NCT00964782|82939491|FG001|Overall Study|Lost to Follow-up|0|||
46723668|NCT00966654|82939499|FG000|Overall Study|Study was terminated,PI left institution|12|||
46723669|NCT03262116|82939511|FG000|Overall Study|Physician Decision|0|||
46634230|NCT01746108|82807736|FG000|Overall Study|Withdrawal by Subject|0|||
46723670|NCT03262116|82939512|FG001|Overall Study|Physician Decision|2|||
46723671|NCT03262116|82939513|FG002|Overall Study|Physician Decision|1|||
46723672|NCT03262116|82939514|FG003|Overall Study|Physician Decision|1|||
46723673|NCT03262116|82939515|FG004|Overall Study|Physician Decision|1|||
46723674|NCT03262116|82939516|FG005|Overall Study|Physician Decision|2|||
46723675|NCT01130168|82939524|FG000|Period 1|Withdrawal by Subject|0|||
46723676|NCT01130168|82939525|FG001|Period 1|Withdrawal by Subject|1|||
46723677|NCT01130168|82939526|FG002|Period 1|Withdrawal by Subject|0|||
46723678|NCT01130168|82939527|FG003|Period 1|Withdrawal by Subject|1|||
46723679|NCT01130168|82939528|FG004|Period 1|Withdrawal by Subject|0|||
46723680|NCT01130168|82939529|FG005|Period 1|Withdrawal by Subject|0|||
46723681|NCT01130168|82939524|FG000|Period 1|Discontinued For Other Reason|0|||
46723682|NCT01130168|82939525|FG001|Period 1|Discontinued For Other Reason|0|||
46723683|NCT01130168|82939526|FG002|Period 1|Discontinued For Other Reason|1|||
46723684|NCT01130168|82939527|FG003|Period 1|Discontinued For Other Reason|1|||
46723685|NCT01130168|82939528|FG004|Period 1|Discontinued For Other Reason|0|||
46723686|NCT01130168|82939529|FG005|Period 1|Discontinued For Other Reason|0|||
46723687|NCT01130168|82939524|FG000|Period 1|Adverse Event|0|||
46723688|NCT01130168|82939525|FG001|Period 1|Adverse Event|0|||
46723689|NCT01130168|82939526|FG002|Period 1|Adverse Event|0|||
46723690|NCT01130168|82939527|FG003|Period 1|Adverse Event|1|||
46723691|NCT01130168|82939528|FG004|Period 1|Adverse Event|0|||
46723692|NCT01130168|82939529|FG005|Period 1|Adverse Event|0|||
46723693|NCT01144052|82939540|FG000|Overall Study|Withdrawal by Subject|1|||
46723694|NCT01144052|82939541|FG001|Overall Study|Withdrawal by Subject|1|||
46723695|NCT01143896|82939551|FG000|Overall Study|Did not complete Baseline Interview|5|||
46723696|NCT01143896|82939552|FG001|Overall Study|Did not complete Baseline Interview|4|||
46723697|NCT01143896|82939551|FG000|Overall Study|Lost to Follow-up|18|||
46723698|NCT01143896|82939552|FG001|Overall Study|Lost to Follow-up|13|||
46723699|NCT01143896|82939551|FG000|Overall Study|Withdrawal by Subject|13|||
46723700|NCT01143896|82939552|FG001|Overall Study|Withdrawal by Subject|5|||
46723701|NCT01143896|82939551|FG000|Overall Study|Death|6|||
46723702|NCT01143896|82939552|FG001|Overall Study|Death|3|||
46723703|NCT01118312|82939561|FG000|Overall Study|Lost to Follow-up|33|||
46723704|NCT01118312|82939562|FG001|Overall Study|Lost to Follow-up|32|||
46723705|NCT01118312|82939561|FG000|Overall Study|Withdrawal by Subject|1|||
46723706|NCT01118312|82939562|FG001|Overall Study|Withdrawal by Subject|3|||
46723707|NCT01117766|82939568|FG000|First Intervention|Adverse Event|0|||
46723708|NCT01117766|82939569|FG001|First Intervention|Adverse Event|1|||
46723709|NCT01117766|82939568|FG000|First Intervention|Protocol Violation|1|||
46723710|NCT01117766|82939569|FG001|First Intervention|Protocol Violation|0|||
46723711|NCT01117766|82939568|FG000|Washout Period|Protocol Violation|0|||
46723712|NCT01117766|82939569|FG001|Washout Period|Protocol Violation|2|||
46723713|NCT01117766|82939568|FG000|Second Intervention|Lost to Follow-up|1|||
46723714|NCT01117766|82939569|FG001|Second Intervention|Lost to Follow-up|0|||
46723715|NCT01117766|82939568|FG000|Second Intervention|Other|1|||
46723716|NCT01117766|82939569|FG001|Second Intervention|Other|2|||
46723717|NCT01117766|82939568|FG000|Second Intervention|Adverse Event|0|||
46723718|NCT01117766|82939569|FG001|Second Intervention|Adverse Event|2|||
46723719|NCT01117766|82939568|FG000|Second Intervention|Withdrawal by Subject|0|||
46723720|NCT01117766|82939569|FG001|Second Intervention|Withdrawal by Subject|1|||
46723721|NCT01117454|82939577|FG000|Overall Study|Pregnancy|0|||
46723722|NCT01117454|82939578|FG001|Overall Study|Pregnancy|1|||
46723723|NCT01116440|82939586|FG000|Treatment|Withdrawal by Subject|2|||
46723724|NCT01116440|82939587|FG001|Treatment|Withdrawal by Subject|2|||
46920667|NCT00899379|83152926|FG002|Overall Study|Patient Uncooperative|0|||
46634231|NCT01746108|82807737|FG001|Overall Study|Withdrawal by Subject|1|||
46634232|NCT01746108|82807738|FG002|Overall Study|Withdrawal by Subject|0|||
46634233|NCT01746108|82807736|FG000|Overall Study|Lost to Follow-up|0|||
46634234|NCT01746108|82807737|FG001|Overall Study|Lost to Follow-up|1|||
46634235|NCT01746108|82807738|FG002|Overall Study|Lost to Follow-up|0|||
46634236|NCT01717638|82807767|FG000|Overall Study|Lost to Follow-up|0|||
46634237|NCT01717638|82807768|FG001|Overall Study|Lost to Follow-up|0|||
46634238|NCT01717638|82807769|FG002|Overall Study|Lost to Follow-up|0|||
46634239|NCT01717638|82807770|FG003|Overall Study|Lost to Follow-up|0|||
46634240|NCT01717638|82807771|FG004|Overall Study|Lost to Follow-up|0|||
46634241|NCT01717638|82807772|FG005|Overall Study|Lost to Follow-up|1|||
46634242|NCT01717638|82807773|FG006|Overall Study|Lost to Follow-up|0|||
46634243|NCT01717638|82807774|FG007|Overall Study|Lost to Follow-up|0|||
46634244|NCT01717638|82807775|FG008|Overall Study|Lost to Follow-up|0|||
46723725|NCT01116440|82939586|FG000|Treatment|Lost to Follow-up|1|||
46723726|NCT01116440|82939587|FG001|Treatment|Lost to Follow-up|1|||
46723727|NCT01116440|82939586|FG000|Treatment|Protocol Violation|0|||
46723728|NCT01116440|82939587|FG001|Treatment|Protocol Violation|2|||
46723729|NCT01116440|82939586|FG000|Treatment|Lack of Efficacy|0|||
46723730|NCT01116440|82939587|FG001|Treatment|Lack of Efficacy|1|||
46723731|NCT01116440|82939586|FG000|Treatment|Adverse Event|0|||
46723732|NCT01116440|82939587|FG001|Treatment|Adverse Event|1|||
46723733|NCT01116440|82939586|FG000|Withdrawal|Withdrawal by Subject|0|||
46723734|NCT01116440|82939587|FG001|Withdrawal|Withdrawal by Subject|1|||
46723735|NCT01116440|82939586|FG000|Withdrawal|Lost to Follow-up|0|||
46723736|NCT01116440|82939587|FG001|Withdrawal|Lost to Follow-up|1|||
46723737|NCT01116440|82939586|FG000|Follow-up|Lost to Follow-up|0|||
46634245|NCT01717638|82807776|FG009|Overall Study|Lost to Follow-up|0|||
46634246|NCT01717638|82807777|FG010|Overall Study|Lost to Follow-up|0|||
46723738|NCT01116440|82939587|FG001|Follow-up|Lost to Follow-up|1|||
46723739|NCT01116440|82939586|FG000|Follow-up|Withdrawal by Subject|0|||
46723740|NCT01116440|82939587|FG001|Follow-up|Withdrawal by Subject|1|||
46723741|NCT01129622|82939595|FG000|Overall Study|Withdrawal by Subject|2|||
46723742|NCT01128842|82939600|FG000|Overall Study|Adverse Event|1|||
46723743|NCT01128842|82939600|FG000|Overall Study|Disease Progression|6|||
46723744|NCT01143038|82939605|FG000|Overall Study|Withdrawal by Subject|4|||
46723745|NCT01143038|82939605|FG000|Overall Study|Requirement for alternative therapy|5|||
46723746|NCT01143038|82939605|FG000|Overall Study|Adverse Event|3|||
46723747|NCT01143038|82939605|FG000|Overall Study|Lost to Follow-up|2|||
46723748|NCT01143038|82939605|FG000|Overall Study|Protocol Deviation|1|||
46723749|NCT01143038|82939605|FG000|Overall Study|Death|1|||
46723750|NCT00966264|82939611|FG000|Overall Study|Lost to Follow-up|4|||
46723751|NCT00966264|82939612|FG001|Overall Study|Lost to Follow-up|3|||
46723752|NCT00915525|82939620|FG000|Overall Study|Protocol Violation|9|||
46723753|NCT00915525|82939621|FG001|Overall Study|Protocol Violation|4|||
46723754|NCT00915525|82939620|FG000|Overall Study|Withdrawal by Subject|59|||
46723755|NCT00915525|82939621|FG001|Overall Study|Withdrawal by Subject|21|||
46723756|NCT00915525|82939620|FG000|Overall Study|Lost to Follow-up|27|||
46723757|NCT00915525|82939621|FG001|Overall Study|Lost to Follow-up|16|||
46723758|NCT00915525|82939620|FG000|Overall Study|Pregnancy|2|||
46723759|NCT00915525|82939621|FG001|Overall Study|Pregnancy|0|||
46723760|NCT00915525|82939620|FG000|Overall Study|Lack of Efficacy|15|||
46723761|NCT00915525|82939621|FG001|Overall Study|Lack of Efficacy|32|||
46723762|NCT00915525|82939620|FG000|Overall Study|Adverse Event|29|||
46723763|NCT00915525|82939621|FG001|Overall Study|Adverse Event|13|||
46723764|NCT00915525|82939620|FG000|Overall Study|Missing|12|||
46723765|NCT00915525|82939621|FG001|Overall Study|Missing|1|||
46723766|NCT00915525|82939620|FG000|Overall Study|Other Reason|35|||
46723767|NCT00915525|82939621|FG001|Overall Study|Other Reason|12|||
46723768|NCT00915525|82939620|FG000|Overall Study|Site Closed|27|||
46723769|NCT00915525|82939621|FG001|Overall Study|Site Closed|9|||
46723770|NCT00915525|82939620|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
46723771|NCT00915525|82939621|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
46723772|NCT00915525|82939620|FG000|Overall Study|Study Burden|28|||
46723773|NCT00915525|82939621|FG001|Overall Study|Study Burden|12|||
46723774|NCT00915525|82939620|FG000|Overall Study|Non-Compliance|3|||
46723775|NCT00915525|82939621|FG001|Overall Study|Non-Compliance|1|||
46723776|NCT00915525|82939620|FG000|Overall Study|Patient Moved|15|||
46723777|NCT00915525|82939621|FG001|Overall Study|Patient Moved|9|||
46723778|NCT01074047|82939649|FG000|Treatment Phase|Adverse Event|89|||
46723779|NCT01074047|82939650|FG001|Treatment Phase|Adverse Event|66|||
46723780|NCT01074047|82939649|FG000|Treatment Phase|Disease Progression|16|||
47045134|NCT01839487|83303163|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
47045135|NCT01839487|83303164|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
47045136|NCT01839487|83303165|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
47045137|NCT01839487|83303166|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
47045138|NCT01839487|83303167|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
47045139|NCT01839487|83303168|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
47045140|NCT01799941|83303195|FG000|Overall Study|Adverse Event|34|||
47045141|NCT01799941|83303195|FG000|Overall Study|Withdrawal by Subject|21|||
46634247|NCT01717638|82807778|FG011|Overall Study|Lost to Follow-up|0|||
46634248|NCT01717638|82807779|FG012|Overall Study|Lost to Follow-up|0|||
46634249|NCT01717638|82807767|FG000|Overall Study|Father in hospital|0|||
46634250|NCT01717638|82807768|FG001|Overall Study|Father in hospital|0|||
46634251|NCT01717638|82807769|FG002|Overall Study|Father in hospital|0|||
46634252|NCT01717638|82807770|FG003|Overall Study|Father in hospital|0|||
46634253|NCT01717638|82807771|FG004|Overall Study|Father in hospital|0|||
46634254|NCT01717638|82807772|FG005|Overall Study|Father in hospital|0|||
46634255|NCT01717638|82807773|FG006|Overall Study|Father in hospital|0|||
46634256|NCT01717638|82807774|FG007|Overall Study|Father in hospital|0|||
46723781|NCT01074047|82939650|FG001|Treatment Phase|Disease Progression|21|||
46723782|NCT01074047|82939649|FG000|Treatment Phase|Withdrawal by Subject|27|||
46723783|NCT01074047|82939650|FG001|Treatment Phase|Withdrawal by Subject|48|||
46723784|NCT01074047|82939649|FG000|Treatment Phase|Death|53|||
46723785|NCT01074047|82939650|FG001|Treatment Phase|Death|58|||
46634257|NCT01717638|82807775|FG008|Overall Study|Father in hospital|0|||
46634258|NCT01717638|82807776|FG009|Overall Study|Father in hospital|0|||
46723786|NCT01074047|82939649|FG000|Treatment Phase|Lost to Follow-up|0|||
46634259|NCT01717638|82807777|FG010|Overall Study|Father in hospital|0|||
46723787|NCT01074047|82939650|FG001|Treatment Phase|Lost to Follow-up|1|||
46634260|NCT01717638|82807778|FG011|Overall Study|Father in hospital|0|||
46634261|NCT01717638|82807779|FG012|Overall Study|Father in hospital|1|||
46723788|NCT01074047|82939649|FG000|Treatment Phase|Protocol Violation|0|||
46723789|NCT01074047|82939650|FG001|Treatment Phase|Protocol Violation|1|||
46723790|NCT01074047|82939649|FG000|Treatment Phase|Miscellaneous|32|||
46723791|NCT01074047|82939650|FG001|Treatment Phase|Miscellaneous|39|||
46723792|NCT01074047|82939649|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
46723793|NCT01074047|82939650|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
46723794|NCT01074047|82939649|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
46723795|NCT01074047|82939650|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
46723796|NCT01074047|82939649|FG000|Survival Follow-Up Phase|Death|116|||
46723797|NCT01074047|82939650|FG001|Survival Follow-Up Phase|Death|124|||
46723798|NCT01074047|82939649|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
46723799|NCT01074047|82939650|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
46723800|NCT01074047|82939649|FG000|Extension Phase|Physician Decision|1|||
46723801|NCT01074047|82939650|FG001|Extension Phase|Physician Decision|0|||
46723802|NCT01074047|82939649|FG000|Extension Phase|Adverse Event|5|||
46723803|NCT01074047|82939650|FG001|Extension Phase|Adverse Event|0|||
46723804|NCT01074047|82939649|FG000|Extension Phase|Disease Progression|9|||
46723805|NCT01074047|82939650|FG001|Extension Phase|Disease Progression|0|||
46723806|NCT01074047|82939649|FG000|Extension Phase|Withdrawal by Subject|2|||
46723807|NCT01074047|82939650|FG001|Extension Phase|Withdrawal by Subject|0|||
46723808|NCT01074047|82939649|FG000|Extension Phase|Death|5|||
46723809|NCT01074047|82939650|FG001|Extension Phase|Death|0|||
46723810|NCT01142726|82939666|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
46723811|NCT01142726|82939667|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
46723812|NCT01142726|82939668|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
47045142|NCT01799941|83303195|FG000|Overall Study|Death|2|||
46723813|NCT01142726|82939666|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
47045143|NCT01799941|83303195|FG000|Overall Study|Investigator Decision|4|||
47045144|NCT01799941|83303195|FG000|Overall Study|Lack of Efficacy|3|||
47045145|NCT01799941|83303195|FG000|Overall Study|Lost to Follow-up|17|||
47045146|NCT01799941|83303195|FG000|Overall Study|Other|15|||
47045147|NCT01799239|83303223|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
47045148|NCT01799239|83303224|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
47045149|NCT01799239|83303223|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
47045150|NCT01799239|83303224|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
47045151|NCT01799239|83303223|FG000|Period 1 (7 Days)|Protocol Violation|0|||
47045152|NCT01799239|83303224|FG001|Period 1 (7 Days)|Protocol Violation|1|||
47045153|NCT01799239|83303223|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
47045154|NCT01799239|83303224|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
47045155|NCT01799239|83303223|FG000|Period 2 (7 Days)|Protocol Violation|1|||
47045156|NCT01799239|83303224|FG001|Period 2 (7 Days)|Protocol Violation|0|||
47045157|NCT02999854|83303240|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
47045158|NCT02999854|83303241|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
46634262|NCT01717638|82807767|FG000|Overall Study|Withdrawal by Subject|0|||
46634263|NCT01717638|82807768|FG001|Overall Study|Withdrawal by Subject|1|||
46634264|NCT01717638|82807769|FG002|Overall Study|Withdrawal by Subject|1|||
46634265|NCT01717638|82807770|FG003|Overall Study|Withdrawal by Subject|0|||
46634266|NCT01717638|82807771|FG004|Overall Study|Withdrawal by Subject|1|||
46634267|NCT01717638|82807772|FG005|Overall Study|Withdrawal by Subject|0|||
46634268|NCT01717638|82807773|FG006|Overall Study|Withdrawal by Subject|2|||
46634269|NCT01717638|82807774|FG007|Overall Study|Withdrawal by Subject|1|||
46634270|NCT01717638|82807775|FG008|Overall Study|Withdrawal by Subject|2|||
46723814|NCT01142726|82939667|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
46723815|NCT01142726|82939668|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
46723816|NCT01142726|82939666|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
47045159|NCT02999854|83303240|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
47045160|NCT02999854|83303241|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
46634271|NCT01717638|82807776|FG009|Overall Study|Withdrawal by Subject|1|||
46723817|NCT01142726|82939667|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
46723818|NCT01142726|82939668|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
46723819|NCT01142726|82939666|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
46723820|NCT01142726|82939667|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
46723821|NCT01142726|82939668|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
46723822|NCT01142726|82939666|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
47045161|NCT02999854|83303240|FG000|Active Study Phase (up to 18 Months)|Death|7|||
47045162|NCT02999854|83303241|FG001|Active Study Phase (up to 18 Months)|Death|5|||
47045163|NCT02999854|83303240|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
47045164|NCT02999854|83303241|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
46634272|NCT01717638|82807777|FG010|Overall Study|Withdrawal by Subject|0|||
46634273|NCT01717638|82807778|FG011|Overall Study|Withdrawal by Subject|0|||
46634274|NCT01717638|82807779|FG012|Overall Study|Withdrawal by Subject|18|||
46634275|NCT01745094|82807817|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
46634276|NCT01745094|82807818|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
46634277|NCT01745094|82807819|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
46634278|NCT01745094|82807820|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
46634279|NCT01745094|82807817|FG000|Overall Study|Adverse Event|0|||
46634280|NCT01745094|82807818|FG001|Overall Study|Adverse Event|0|||
46634281|NCT01745094|82807819|FG002|Overall Study|Adverse Event|3|||
46634282|NCT01745094|82807820|FG003|Overall Study|Adverse Event|0|||
46634283|NCT01745094|82807817|FG000|Overall Study|Withdrawal by Subject|2|||
46634284|NCT01745094|82807818|FG001|Overall Study|Withdrawal by Subject|0|||
46634285|NCT01745094|82807819|FG002|Overall Study|Withdrawal by Subject|1|||
46634286|NCT01745094|82807820|FG003|Overall Study|Withdrawal by Subject|2|||
46634287|NCT01745094|82807817|FG000|Overall Study|Protocol Violation|1|||
46634288|NCT01745094|82807818|FG001|Overall Study|Protocol Violation|0|||
46634289|NCT01745094|82807819|FG002|Overall Study|Protocol Violation|3|||
46634290|NCT01745094|82807820|FG003|Overall Study|Protocol Violation|1|||
46634291|NCT01745094|82807817|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
46634292|NCT01745094|82807818|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
46634293|NCT01745094|82807819|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
46634294|NCT01745094|82807820|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
46634295|NCT01745094|82807817|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
46634296|NCT01745094|82807818|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
46634297|NCT01745094|82807819|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
46634298|NCT01745094|82807820|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
46634299|NCT01745094|82807817|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
46634300|NCT01745094|82807818|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
46634301|NCT01745094|82807819|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
46634302|NCT01745094|82807820|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
46634303|NCT01697748|82807835|FG000|Overall Study|ineligible skin incision|1|||
46634304|NCT01697748|82807836|FG001|Overall Study|ineligible skin incision|2|||
46634305|NCT01697748|82807835|FG000|Overall Study|ineligible uterine incision|4|||
46634306|NCT01697748|82807836|FG001|Overall Study|ineligible uterine incision|1|||
46634307|NCT01697748|82807835|FG000|Overall Study|Lost to Follow-up|53|||
46634308|NCT01697748|82807836|FG001|Overall Study|Lost to Follow-up|65|||
46634309|NCT01717326|82807862|FG000|Overall Study|Death|0|||
46634310|NCT01717326|82807863|FG001|Overall Study|Death|0|||
46634311|NCT01717326|82807864|FG002|Overall Study|Death|0|||
46634312|NCT01717326|82807865|FG003|Overall Study|Death|0|||
46634313|NCT01717326|82807866|FG004|Overall Study|Death|0|||
46634314|NCT01717326|82807867|FG005|Overall Study|Death|0|||
46634315|NCT01717326|82807868|FG006|Overall Study|Death|0|||
46634316|NCT01717326|82807869|FG007|Overall Study|Death|0|||
46634317|NCT01717326|82807870|FG008|Overall Study|Death|0|||
46634318|NCT01717326|82807871|FG009|Overall Study|Death|0|||
46634319|NCT01717326|82807872|FG010|Overall Study|Death|1|||
46634320|NCT01717326|82807873|FG011|Overall Study|Death|0|||
46723823|NCT01142726|82939667|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
46723824|NCT01142726|82939668|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
47045165|NCT02999854|83303240|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
46634321|NCT01717326|82807874|FG012|Overall Study|Death|0|||
46634322|NCT01717326|82807875|FG013|Overall Study|Death|0|||
46634323|NCT01717326|82807876|FG014|Overall Study|Death|0|||
46634324|NCT01717326|82807877|FG015|Overall Study|Death|0|||
46634325|NCT01717326|82807878|FG016|Overall Study|Death|0|||
46634326|NCT01717326|82807879|FG017|Overall Study|Death|0|||
46634327|NCT01717326|82807880|FG018|Overall Study|Death|0|||
46634328|NCT01717326|82807881|FG019|Overall Study|Death|0|||
46634329|NCT01717326|82807862|FG000|Overall Study|Lost to Follow-up|3|||
46634330|NCT01717326|82807863|FG001|Overall Study|Lost to Follow-up|0|||
46634331|NCT01717326|82807864|FG002|Overall Study|Lost to Follow-up|0|||
46634332|NCT01717326|82807865|FG003|Overall Study|Lost to Follow-up|2|||
46634333|NCT01717326|82807866|FG004|Overall Study|Lost to Follow-up|1|||
46723825|NCT01142726|82939666|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
46723826|NCT01142726|82939667|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
46723827|NCT01142726|82939668|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
46723828|NCT01142726|82939666|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
46723829|NCT01142726|82939667|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
46723830|NCT01142726|82939668|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
46723831|NCT01142726|82939666|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
46723832|NCT01142726|82939667|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
46723833|NCT01142726|82939668|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
46723834|NCT01142726|82939666|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
46723835|NCT01142726|82939667|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
46723836|NCT01142726|82939668|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
46723837|NCT01142726|82939666|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
46723838|NCT01142726|82939667|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
46723839|NCT01142726|82939668|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
46723840|NCT01142726|82939666|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
46723841|NCT01142726|82939667|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
46723842|NCT01142726|82939668|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
46723843|NCT01142726|82939666|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
46723844|NCT01142726|82939667|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
46723845|NCT01142726|82939668|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
46723846|NCT01142726|82939666|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
46723847|NCT01142726|82939667|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
46723848|NCT01142726|82939668|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
46723849|NCT01142726|82939666|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
46723850|NCT01142726|82939667|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
46723851|NCT01142726|82939668|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
46723852|NCT01142726|82939666|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
46723853|NCT01142726|82939667|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
46723854|NCT01142726|82939668|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
46723855|NCT01142726|82939666|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
46723856|NCT01142726|82939667|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
46723857|NCT01142726|82939668|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
46723858|NCT01073267|82939684|FG000|Overall Study|Disease Progression|3|||
46723859|NCT01142336|82939690|FG000|Overall Study|Adverse Event|1|||
46723860|NCT01142336|82939691|FG001|Overall Study|Adverse Event|1|||
46723861|NCT01142336|82939690|FG000|Overall Study|Lost to Follow-up|0|||
46723862|NCT01142336|82939691|FG001|Overall Study|Lost to Follow-up|1|||
46723863|NCT00915681|82939700|FG000|Overall Study|Screening failures|46|||
46723864|NCT01128296|82939704|FG000|Overall Study|Physician Decision|0|||
46723865|NCT01128296|82939705|FG001|Overall Study|Physician Decision|0|||
46723866|NCT01128296|82939706|FG002|Overall Study|Physician Decision|0|||
46723867|NCT01128296|82939707|FG003|Overall Study|Physician Decision|0|||
46723868|NCT01128296|82939708|FG004|Overall Study|Physician Decision|0|||
46723869|NCT01128296|82939709|FG005|Overall Study|Physician Decision|3|||
46723870|NCT01128296|82939704|FG000|Overall Study|Withdrawal by Subject|0|||
46723871|NCT01128296|82939705|FG001|Overall Study|Withdrawal by Subject|0|||
46723872|NCT01128296|82939706|FG002|Overall Study|Withdrawal by Subject|0|||
46723873|NCT01128296|82939707|FG003|Overall Study|Withdrawal by Subject|0|||
46723874|NCT01128296|82939708|FG004|Overall Study|Withdrawal by Subject|0|||
46634334|NCT01717326|82807867|FG005|Overall Study|Lost to Follow-up|0|||
46634335|NCT01717326|82807868|FG006|Overall Study|Lost to Follow-up|1|||
46634336|NCT01717326|82807869|FG007|Overall Study|Lost to Follow-up|0|||
46634337|NCT01717326|82807870|FG008|Overall Study|Lost to Follow-up|0|||
46634338|NCT01717326|82807871|FG009|Overall Study|Lost to Follow-up|0|||
46634339|NCT01717326|82807872|FG010|Overall Study|Lost to Follow-up|1|||
46634340|NCT01717326|82807873|FG011|Overall Study|Lost to Follow-up|0|||
46634341|NCT01717326|82807874|FG012|Overall Study|Lost to Follow-up|0|||
46634342|NCT01717326|82807875|FG013|Overall Study|Lost to Follow-up|0|||
46723875|NCT01128296|82939709|FG005|Overall Study|Withdrawal by Subject|2|||
46723876|NCT01115738|82939723|FG000|Overall Study|Death|1|||
46723877|NCT01115738|82939724|FG001|Overall Study|Death|0|||
46723878|NCT01115738|82939725|FG002|Overall Study|Death|0|||
46723879|NCT01115738|82939723|FG000|Overall Study|Lost to Follow-up|0|||
46723880|NCT01115738|82939724|FG001|Overall Study|Lost to Follow-up|0|||
46723881|NCT01115738|82939725|FG002|Overall Study|Lost to Follow-up|1|||
46723882|NCT01115738|82939723|FG000|Overall Study|Physician Decision|18|||
46723883|NCT01115738|82939724|FG001|Overall Study|Physician Decision|15|||
46723884|NCT01115738|82939725|FG002|Overall Study|Physician Decision|17|||
46634343|NCT01717326|82807876|FG014|Overall Study|Lost to Follow-up|0|||
46634344|NCT01717326|82807877|FG015|Overall Study|Lost to Follow-up|2|||
46634345|NCT01717326|82807878|FG016|Overall Study|Lost to Follow-up|1|||
46723885|NCT01115738|82939723|FG000|Overall Study|Withdrawal by Subject|6|||
46723886|NCT01115738|82939724|FG001|Overall Study|Withdrawal by Subject|6|||
46920668|NCT00899379|83152927|FG003|Overall Study|Patient Uncooperative|1|||
46920669|NCT00899379|83152928|FG004|Overall Study|Patient Uncooperative|0|||
46920670|NCT00899379|83152924|FG000|Overall Study|Abnormal Prestudy Labs|0|||
46920671|NCT00899379|83152925|FG001|Overall Study|Abnormal Prestudy Labs|0|||
46920672|NCT00899379|83152926|FG002|Overall Study|Abnormal Prestudy Labs|0|||
46920673|NCT00899379|83152927|FG003|Overall Study|Abnormal Prestudy Labs|0|||
47045166|NCT02999854|83303241|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
47045167|NCT02999854|83303240|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
47045168|NCT02999854|83303241|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
47045169|NCT02999854|83303240|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
47045170|NCT02999854|83303241|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
47045171|NCT02999854|83303240|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
47045172|NCT02999854|83303241|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
47045173|NCT04146363|83303380|FG000|Induction Period|Adverse Event|1|||
47045174|NCT04146363|83303381|FG001|Induction Period|Adverse Event|2|||
47045175|NCT04146363|83303382|FG002|Induction Period|Adverse Event|0|||
47045176|NCT04146363|83303383|FG003|Induction Period|Adverse Event|0|||
47045177|NCT04146363|83303384|FG004|Induction Period|Adverse Event|0|||
47045178|NCT04146363|83303385|FG005|Induction Period|Adverse Event|0|||
47045179|NCT04146363|83303386|FG006|Induction Period|Adverse Event|0|||
47045180|NCT04146363|83303387|FG007|Induction Period|Adverse Event|0|||
47045181|NCT04146363|83303388|FG008|Induction Period|Adverse Event|0|||
47045182|NCT04146363|83303389|FG009|Induction Period|Adverse Event|0|||
47045183|NCT04146363|83303390|FG010|Induction Period|Adverse Event|0|||
46634346|NCT01717326|82807879|FG017|Overall Study|Lost to Follow-up|0|||
46634347|NCT01717326|82807880|FG018|Overall Study|Lost to Follow-up|2|||
46634348|NCT01717326|82807881|FG019|Overall Study|Lost to Follow-up|3|||
46634349|NCT01717326|82807862|FG000|Overall Study|Physician Decision|0|||
46634350|NCT01717326|82807863|FG001|Overall Study|Physician Decision|0|||
46920674|NCT00899379|83152928|FG004|Overall Study|Abnormal Prestudy Labs|2|||
46920675|NCT00899379|83152924|FG000|Overall Study|Abnormal Baseline ECG|0|||
46920676|NCT00899379|83152925|FG001|Overall Study|Abnormal Baseline ECG|0|||
46920677|NCT00899379|83152926|FG002|Overall Study|Abnormal Baseline ECG|1|||
46920678|NCT00899379|83152927|FG003|Overall Study|Abnormal Baseline ECG|1|||
46920679|NCT00899379|83152928|FG004|Overall Study|Abnormal Baseline ECG|0|||
46920680|NCT00899379|83152924|FG000|Overall Study|No Attack Pretreatment|3|||
46920681|NCT00899379|83152925|FG001|Overall Study|No Attack Pretreatment|5|||
46920682|NCT00899379|83152926|FG002|Overall Study|No Attack Pretreatment|5|||
46920683|NCT00899379|83152927|FG003|Overall Study|No Attack Pretreatment|6|||
46920684|NCT00899379|83152928|FG004|Overall Study|No Attack Pretreatment|4|||
46920685|NCT00899379|83152924|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
46920686|NCT00899379|83152925|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46920687|NCT00899379|83152926|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46920688|NCT00899379|83152927|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46920689|NCT00899379|83152928|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
46920690|NCT00899379|83152924|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
46920691|NCT00899379|83152925|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
47045184|NCT04146363|83303380|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
46634351|NCT01717326|82807864|FG002|Overall Study|Physician Decision|0|||
46634352|NCT01717326|82807865|FG003|Overall Study|Physician Decision|0|||
46634353|NCT01717326|82807866|FG004|Overall Study|Physician Decision|0|||
46634354|NCT01717326|82807867|FG005|Overall Study|Physician Decision|0|||
46723887|NCT01115738|82939725|FG002|Overall Study|Withdrawal by Subject|9|||
46723888|NCT01141478|82939743|FG000|Overall Study|Withdrawal by Subject|1|||
46920692|NCT00899379|83152926|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
46920693|NCT00899379|83152927|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
46920694|NCT00899379|83152928|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
46920695|NCT04326439|83152936|FG000|Overall Study|Withdrawal by Subject|1|||
46920696|NCT04326439|83152937|FG001|Overall Study|Withdrawal by Subject|0|||
47045185|NCT04146363|83303381|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
46634355|NCT01717326|82807868|FG006|Overall Study|Physician Decision|0|||
46634356|NCT01717326|82807869|FG007|Overall Study|Physician Decision|0|||
46634357|NCT01717326|82807870|FG008|Overall Study|Physician Decision|0|||
46634358|NCT01717326|82807871|FG009|Overall Study|Physician Decision|1|||
46920697|NCT04326439|83152936|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
46920698|NCT04326439|83152937|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
46920699|NCT04326439|83152936|FG000|Overall Study|Relapse after Induction 2|0|||
46723889|NCT01141478|82939744|FG001|Overall Study|Withdrawal by Subject|1|||
46723890|NCT01114880|82939752|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
46723891|NCT01114880|82939753|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
46723892|NCT01114880|82939752|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
46723893|NCT01114880|82939753|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
46723894|NCT01114880|82939752|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
46723895|NCT01114880|82939753|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
46723896|NCT01114880|82939752|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
46723897|NCT01114880|82939753|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
46723898|NCT01114880|82939752|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
46723899|NCT01114880|82939753|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
46723900|NCT01114880|82939752|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
46723901|NCT01114880|82939753|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
46723902|NCT01114724|82939761|FG000|Overall Study|Death|8|||
46723903|NCT01114724|82939761|FG000|Overall Study|Lost to Follow-up|1|||
46723904|NCT01114724|82939761|FG000|Overall Study|Withdrawal by Subject|1|||
46723905|NCT00964392|82939768|FG000|Overall Study|Withdrawal by Subject|4|||
46723906|NCT00964392|82939769|FG001|Overall Study|Withdrawal by Subject|6|||
46723907|NCT00964392|82939768|FG000|Overall Study|Lost to Follow-up|4|||
46723908|NCT00964392|82939769|FG001|Overall Study|Lost to Follow-up|10|||
46723909|NCT00964392|82939768|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
46723910|NCT00964392|82939769|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
46723911|NCT00964392|82939768|FG000|Overall Study|Not completed|44|||
46723912|NCT00964392|82939769|FG001|Overall Study|Not completed|168|||
46723913|NCT00914589|82939778|FG000|Overall Study|Adverse Event|1|||
46723914|NCT00914589|82939779|FG001|Overall Study|Adverse Event|0|||
46723915|NCT00914589|82939780|FG002|Overall Study|Adverse Event|1|||
46723916|NCT00914589|82939778|FG000|Overall Study|Protocol Violation|8|||
46723917|NCT00914589|82939779|FG001|Overall Study|Protocol Violation|6|||
46723918|NCT00914589|82939780|FG002|Overall Study|Protocol Violation|3|||
46723919|NCT00914589|82939778|FG000|Overall Study|unclassified|16|||
46723920|NCT00914589|82939779|FG001|Overall Study|unclassified|9|||
46723921|NCT00914589|82939780|FG002|Overall Study|unclassified|7|||
46723922|NCT00914589|82939778|FG000|Overall Study|Death|0|||
46723923|NCT00914589|82939779|FG001|Overall Study|Death|1|||
46723924|NCT00914589|82939780|FG002|Overall Study|Death|1|||
46723925|NCT00912405|82939788|FG000|Overall Study|Lost to Follow-up|5|||
46723926|NCT00878722|82939800|FG000|Overall Study|Progressive disease|3|||
46723927|NCT00878722|82939801|FG001|Overall Study|Progressive disease|3|||
46723928|NCT00878722|82939802|FG002|Overall Study|Progressive disease|3|||
46723929|NCT00878722|82939803|FG003|Overall Study|Progressive disease|7|||
46723930|NCT00878722|82939804|FG004|Overall Study|Progressive disease|7|||
46723931|NCT00878722|82939805|FG005|Overall Study|Progressive disease|1|||
46723932|NCT00878722|82939806|FG006|Overall Study|Progressive disease|4|||
46723933|NCT00878722|82939807|FG007|Overall Study|Progressive disease|3|||
47045186|NCT04146363|83303382|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
47045187|NCT04146363|83303383|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
47045188|NCT04146363|83303384|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
47045189|NCT04146363|83303385|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
47045190|NCT04146363|83303386|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
47045191|NCT04146363|83303387|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
47045192|NCT04146363|83303388|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
47045193|NCT04146363|83303389|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
47045194|NCT04146363|83303390|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
47045195|NCT04146363|83303380|FG000|Induction Period|Lack of Efficacy|7|||
47045196|NCT04146363|83303381|FG001|Induction Period|Lack of Efficacy|2|||
47045197|NCT04146363|83303382|FG002|Induction Period|Lack of Efficacy|0|||
47045198|NCT04146363|83303383|FG003|Induction Period|Lack of Efficacy|0|||
47045199|NCT04146363|83303384|FG004|Induction Period|Lack of Efficacy|0|||
47045200|NCT04146363|83303385|FG005|Induction Period|Lack of Efficacy|0|||
47045201|NCT04146363|83303386|FG006|Induction Period|Lack of Efficacy|0|||
47045202|NCT04146363|83303387|FG007|Induction Period|Lack of Efficacy|0|||
46634359|NCT01717326|82807872|FG010|Overall Study|Physician Decision|0|||
46634360|NCT01717326|82807873|FG011|Overall Study|Physician Decision|0|||
46634361|NCT01717326|82807874|FG012|Overall Study|Physician Decision|0|||
46634362|NCT01717326|82807875|FG013|Overall Study|Physician Decision|0|||
46634363|NCT01717326|82807876|FG014|Overall Study|Physician Decision|0|||
46634364|NCT01717326|82807877|FG015|Overall Study|Physician Decision|0|||
46634365|NCT01717326|82807878|FG016|Overall Study|Physician Decision|0|||
46634366|NCT01717326|82807879|FG017|Overall Study|Physician Decision|0|||
46634367|NCT01717326|82807880|FG018|Overall Study|Physician Decision|0|||
46634368|NCT01717326|82807881|FG019|Overall Study|Physician Decision|0|||
46634369|NCT01717326|82807862|FG000|Overall Study|Protocol Violation|0|||
46634370|NCT01717326|82807863|FG001|Overall Study|Protocol Violation|0|||
46634371|NCT01717326|82807864|FG002|Overall Study|Protocol Violation|0|||
46723934|NCT00878722|82939800|FG000|Overall Study|Death|0|||
46723935|NCT00878722|82939801|FG001|Overall Study|Death|0|||
47045203|NCT04146363|83303388|FG008|Induction Period|Lack of Efficacy|0|||
46723936|NCT00878722|82939802|FG002|Overall Study|Death|0|||
46723937|NCT00878722|82939803|FG003|Overall Study|Death|1|||
46723938|NCT00878722|82939804|FG004|Overall Study|Death|0|||
46723939|NCT00878722|82939805|FG005|Overall Study|Death|1|||
46723940|NCT00878722|82939806|FG006|Overall Study|Death|0|||
46723941|NCT00878722|82939807|FG007|Overall Study|Death|2|||
46723942|NCT00878722|82939800|FG000|Overall Study|Adverse Event|0|||
46723943|NCT00878722|82939801|FG001|Overall Study|Adverse Event|0|||
46723944|NCT00878722|82939802|FG002|Overall Study|Adverse Event|0|||
46723945|NCT00878722|82939803|FG003|Overall Study|Adverse Event|0|||
46723946|NCT00878722|82939804|FG004|Overall Study|Adverse Event|0|||
46723947|NCT00878722|82939805|FG005|Overall Study|Adverse Event|0|||
46723948|NCT00878722|82939806|FG006|Overall Study|Adverse Event|2|||
46723949|NCT00878722|82939807|FG007|Overall Study|Adverse Event|0|||
46723950|NCT00878722|82939800|FG000|Overall Study|Withdrawal by Subject|0|||
46723951|NCT00878722|82939801|FG001|Overall Study|Withdrawal by Subject|0|||
46723952|NCT00878722|82939802|FG002|Overall Study|Withdrawal by Subject|0|||
46723953|NCT00878722|82939803|FG003|Overall Study|Withdrawal by Subject|0|||
46723954|NCT00878722|82939804|FG004|Overall Study|Withdrawal by Subject|0|||
46723955|NCT00878722|82939805|FG005|Overall Study|Withdrawal by Subject|0|||
46723956|NCT00878722|82939806|FG006|Overall Study|Withdrawal by Subject|0|||
46723957|NCT00878722|82939807|FG007|Overall Study|Withdrawal by Subject|2|||
46723958|NCT00878722|82939800|FG000|Overall Study|Relapse|0|||
46723959|NCT00878722|82939801|FG001|Overall Study|Relapse|0|||
46723960|NCT00878722|82939802|FG002|Overall Study|Relapse|0|||
46723961|NCT00878722|82939803|FG003|Overall Study|Relapse|1|||
46723962|NCT00878722|82939804|FG004|Overall Study|Relapse|0|||
46723963|NCT00878722|82939805|FG005|Overall Study|Relapse|0|||
46723964|NCT00878722|82939806|FG006|Overall Study|Relapse|0|||
46723965|NCT00878722|82939807|FG007|Overall Study|Relapse|0|||
46723966|NCT00964158|82939835|FG000|Overall Study|Lost to Follow-up|0|||
46723967|NCT00964158|82939836|FG001|Overall Study|Lost to Follow-up|1|||
46723968|NCT00964158|82939837|FG002|Overall Study|Lost to Follow-up|2|||
46723969|NCT00964158|82939835|FG000|Overall Study|Withdrawal by Subject|0|||
46723970|NCT00964158|82939836|FG001|Overall Study|Withdrawal by Subject|0|||
46723971|NCT00964158|82939837|FG002|Overall Study|Withdrawal by Subject|6|||
46723972|NCT00961350|82939850|FG000|Overall Study|Adverse Event|18|||
46723973|NCT00961350|82939851|FG001|Overall Study|Adverse Event|33|||
46723974|NCT00961350|82939850|FG000|Overall Study|Withdrawal by Subject|10|||
46723975|NCT00961350|82939851|FG001|Overall Study|Withdrawal by Subject|10|||
46723976|NCT00961350|82939850|FG000|Overall Study|Lost to Follow-up|3|||
46723977|NCT00961350|82939851|FG001|Overall Study|Lost to Follow-up|3|||
46723978|NCT00961350|82939850|FG000|Overall Study|Misc|16|||
46723979|NCT00961350|82939851|FG001|Overall Study|Misc|21|||
46723980|NCT00963924|82939859|FG000|Overall Study|Adverse Event|1|||
46723981|NCT00963924|82939860|FG001|Overall Study|Adverse Event|0|||
46723982|NCT00963924|82939859|FG000|Overall Study|Withdrawal by Subject|0|||
46723983|NCT00963924|82939860|FG001|Overall Study|Withdrawal by Subject|1|||
46723984|NCT00963924|82939859|FG000|Overall Study|Changed antipsychotic|0|||
46723985|NCT00963924|82939860|FG001|Overall Study|Changed antipsychotic|1|||
46723986|NCT00963924|82939859|FG000|Overall Study|Lost to Follow-up|0|||
46723987|NCT00963924|82939860|FG001|Overall Study|Lost to Follow-up|1|||
46723988|NCT03265665|82939870|FG000|24-week Data Collection|Withdrawal by Subject|2|||
46723989|NCT03265665|82939871|FG001|24-week Data Collection|Withdrawal by Subject|2|||
46723990|NCT03265665|82939870|FG000|24-week Data Collection|Lost to Follow-up|4|||
46723991|NCT03265665|82939871|FG001|24-week Data Collection|Lost to Follow-up|5|||
46723992|NCT03265665|82939870|FG000|36-week Data Collection|Lost to Follow-up|6|||
46723993|NCT03265665|82939871|FG001|36-week Data Collection|Lost to Follow-up|8|||
46723994|NCT01114646|82939881|FG000|Overall Study|Withdrawal by Subject|3|||
47045204|NCT04146363|83303389|FG009|Induction Period|Lack of Efficacy|0|||
47045205|NCT04146363|83303390|FG010|Induction Period|Lack of Efficacy|0|||
47045206|NCT04146363|83303380|FG000|Induction Period|Lost to Follow-up|1|||
47045207|NCT04146363|83303381|FG001|Induction Period|Lost to Follow-up|4|||
46723995|NCT01114646|82939882|FG001|Overall Study|Withdrawal by Subject|2|||
46723996|NCT00965562|82939891|FG000|Overall Study|Lost to Follow-up|1|||
46723997|NCT00965562|82939892|FG001|Overall Study|Lost to Follow-up|2|||
46723998|NCT00965562|82939893|FG002|Overall Study|Lost to Follow-up|3|||
46723999|NCT00965562|82939891|FG000|Overall Study|Withdrawal by Subject|2|||
46724000|NCT00965562|82939892|FG001|Overall Study|Withdrawal by Subject|2|||
46724001|NCT00965562|82939893|FG002|Overall Study|Withdrawal by Subject|0|||
46724002|NCT00912093|82939907|FG000|The Controlled Phase|Death|0|||
46724003|NCT00912093|82939908|FG001|The Controlled Phase|Death|1|||
46724004|NCT00912093|82939909|FG002|The Controlled Phase|Death|0|||
46724005|NCT00912093|82939910|FG003|The Controlled Phase|Death|0|||
46724006|NCT00912093|82939911|FG004|The Controlled Phase|Death|0|||
46724007|NCT00912093|82939907|FG000|The Controlled Phase|Medical Condition|0|||
46724008|NCT00912093|82939908|FG001|The Controlled Phase|Medical Condition|1|||
46724009|NCT00912093|82939909|FG002|The Controlled Phase|Medical Condition|0|||
46724010|NCT00912093|82939910|FG003|The Controlled Phase|Medical Condition|0|||
47045208|NCT04146363|83303382|FG002|Induction Period|Lost to Follow-up|0|||
46724011|NCT00912093|82939911|FG004|The Controlled Phase|Medical Condition|0|||
46724012|NCT00912093|82939907|FG000|The Controlled Phase|Lost to Follow-up|0|||
46724013|NCT00912093|82939908|FG001|The Controlled Phase|Lost to Follow-up|0|||
46724014|NCT00912093|82939909|FG002|The Controlled Phase|Lost to Follow-up|0|||
46724015|NCT00912093|82939910|FG003|The Controlled Phase|Lost to Follow-up|0|||
46724016|NCT00912093|82939911|FG004|The Controlled Phase|Lost to Follow-up|1|||
46724017|NCT00965484|82939919|FG000|Overall Study|Protocol Violation|1|||
46724018|NCT00965484|82939919|FG000|Overall Study|Withdrawal by Subject|1|||
46724019|NCT00961116|82939923|FG000|Washout Period of 7 Days|Adverse Event|1|||
46724020|NCT00961116|82939924|FG001|Washout Period of 7 Days|Adverse Event|1|||
46724021|NCT00961116|82939923|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
46724022|NCT00961116|82939924|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46724023|NCT00961116|82939923|FG000|Washout Period of 7 Days|Protocol Violation|0|||
46724024|NCT00961116|82939924|FG001|Washout Period of 7 Days|Protocol Violation|1|||
46724025|NCT00912015|82939935|FG000|Overall Study|Lack of Efficacy|1|||
46724026|NCT00912015|82939936|FG001|Overall Study|Lack of Efficacy|0|||
46724027|NCT00912015|82939937|FG002|Overall Study|Lack of Efficacy|0|||
46724028|NCT00912015|82939938|FG003|Overall Study|Lack of Efficacy|0|||
46724029|NCT00912015|82939935|FG000|Overall Study|Withdrawal by Subject|8|||
46724030|NCT00912015|82939936|FG001|Overall Study|Withdrawal by Subject|8|||
46724031|NCT00912015|82939937|FG002|Overall Study|Withdrawal by Subject|3|||
46724032|NCT00912015|82939938|FG003|Overall Study|Withdrawal by Subject|0|||
46724033|NCT00912015|82939935|FG000|Overall Study|Protocol Violation|1|||
46724034|NCT00912015|82939936|FG001|Overall Study|Protocol Violation|0|||
46724035|NCT00912015|82939937|FG002|Overall Study|Protocol Violation|0|||
46724036|NCT00912015|82939938|FG003|Overall Study|Protocol Violation|1|||
46724037|NCT00912015|82939935|FG000|Overall Study|Adverse Event|6|||
46724038|NCT00912015|82939936|FG001|Overall Study|Adverse Event|0|||
46724039|NCT00912015|82939937|FG002|Overall Study|Adverse Event|0|||
46724040|NCT00912015|82939938|FG003|Overall Study|Adverse Event|1|||
46724041|NCT00960804|82939951|FG000|Overall Study|Adverse Event|1|||
46724042|NCT00960804|82939952|FG001|Overall Study|Adverse Event|0|||
46724043|NCT00960804|82939953|FG002|Overall Study|Adverse Event|0|||
46724044|NCT00960804|82939951|FG000|Overall Study|Withdrawal by Subject|1|||
46724045|NCT00960804|82939952|FG001|Overall Study|Withdrawal by Subject|0|||
46724046|NCT00960804|82939953|FG002|Overall Study|Withdrawal by Subject|0|||
46724047|NCT00960804|82939951|FG000|Overall Study|Study terminated by the sponsor|5|||
46724048|NCT00960804|82939952|FG001|Overall Study|Study terminated by the sponsor|4|||
47045209|NCT04146363|83303383|FG003|Induction Period|Lost to Follow-up|0|||
47045210|NCT04146363|83303384|FG004|Induction Period|Lost to Follow-up|0|||
47045211|NCT04146363|83303385|FG005|Induction Period|Lost to Follow-up|0|||
47045212|NCT04146363|83303386|FG006|Induction Period|Lost to Follow-up|0|||
47045213|NCT04146363|83303387|FG007|Induction Period|Lost to Follow-up|0|||
47045214|NCT04146363|83303388|FG008|Induction Period|Lost to Follow-up|0|||
46724049|NCT00960804|82939953|FG002|Overall Study|Study terminated by the sponsor|10|||
46724050|NCT01126580|82939964|FG000|Overall Study|Adverse Event|14|||
46724051|NCT01126580|82939965|FG001|Overall Study|Adverse Event|8|||
46724052|NCT01126580|82939966|FG002|Overall Study|Adverse Event|12|||
46724053|NCT01126580|82939964|FG000|Overall Study|Withdrawal by Subject|11|||
46724054|NCT01126580|82939965|FG001|Overall Study|Withdrawal by Subject|19|||
46724055|NCT01126580|82939966|FG002|Overall Study|Withdrawal by Subject|14|||
46724056|NCT01126580|82939964|FG000|Overall Study|Sponsor Decision|5|||
46724057|NCT01126580|82939965|FG001|Overall Study|Sponsor Decision|4|||
46724058|NCT01126580|82939966|FG002|Overall Study|Sponsor Decision|7|||
46724059|NCT01126580|82939964|FG000|Overall Study|Physician Decision|1|||
46724060|NCT01126580|82939965|FG001|Overall Study|Physician Decision|1|||
47045215|NCT04146363|83303389|FG009|Induction Period|Lost to Follow-up|0|||
47045216|NCT04146363|83303390|FG010|Induction Period|Lost to Follow-up|0|||
47045217|NCT04146363|83303380|FG000|Induction Period|Positive quantiferon test|0|||
47045218|NCT04146363|83303381|FG001|Induction Period|Positive quantiferon test|1|||
47045219|NCT04146363|83303382|FG002|Induction Period|Positive quantiferon test|0|||
47045220|NCT04146363|83303383|FG003|Induction Period|Positive quantiferon test|0|||
46724061|NCT01126580|82939966|FG002|Overall Study|Physician Decision|2|||
46724062|NCT01126580|82939964|FG000|Overall Study|Entry Criteria Not Met|1|||
46724063|NCT01126580|82939965|FG001|Overall Study|Entry Criteria Not Met|1|||
46724064|NCT01126580|82939966|FG002|Overall Study|Entry Criteria Not Met|2|||
46724065|NCT01126580|82939964|FG000|Overall Study|Lack of Efficacy|2|||
46724066|NCT01126580|82939965|FG001|Overall Study|Lack of Efficacy|3|||
46724067|NCT01126580|82939966|FG002|Overall Study|Lack of Efficacy|4|||
47045221|NCT04146363|83303384|FG004|Induction Period|Positive quantiferon test|0|||
47045222|NCT04146363|83303385|FG005|Induction Period|Positive quantiferon test|0|||
46724068|NCT01126580|82939964|FG000|Overall Study|Protocol Violation|0|||
46724069|NCT01126580|82939965|FG001|Overall Study|Protocol Violation|1|||
46724070|NCT01126580|82939966|FG002|Overall Study|Protocol Violation|2|||
46724071|NCT01126580|82939964|FG000|Overall Study|Lost to Follow-up|15|||
46724072|NCT01126580|82939965|FG001|Overall Study|Lost to Follow-up|13|||
47045223|NCT04146363|83303386|FG006|Induction Period|Positive quantiferon test|0|||
47045224|NCT04146363|83303387|FG007|Induction Period|Positive quantiferon test|0|||
47045225|NCT04146363|83303388|FG008|Induction Period|Positive quantiferon test|0|||
46724073|NCT01126580|82939966|FG002|Overall Study|Lost to Follow-up|9|||
46724074|NCT01126580|82939964|FG000|Overall Study|Treatment Non-compliance|0|||
46724075|NCT01126580|82939965|FG001|Overall Study|Treatment Non-compliance|2|||
46724076|NCT01126580|82939966|FG002|Overall Study|Treatment Non-compliance|3|||
46724077|NCT00911157|82939977|FG000|Overall Study|Adverse Event|4|||
46724078|NCT00911157|82939978|FG001|Overall Study|Adverse Event|1|||
46724079|NCT00911157|82939977|FG000|Overall Study|Withdrawal by Subject|1|||
46724080|NCT00911157|82939978|FG001|Overall Study|Withdrawal by Subject|1|||
46724081|NCT00911157|82939977|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
46724082|NCT00911157|82939978|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
46724083|NCT00911157|82939977|FG000|Overall Study|Need to treat for lung cancer|1|||
46724084|NCT00911157|82939978|FG001|Overall Study|Need to treat for lung cancer|0|||
46724085|NCT00960570|82939984|FG000|21 Day Washout Period|Adverse Event|1|||
47045226|NCT04146363|83303389|FG009|Induction Period|Positive quantiferon test|0|||
47045227|NCT04146363|83303390|FG010|Induction Period|Positive quantiferon test|0|||
47045228|NCT04146363|83303380|FG000|Induction Period|Protocol Deviation|5|||
47045229|NCT04146363|83303381|FG001|Induction Period|Protocol Deviation|6|||
47045230|NCT04146363|83303382|FG002|Induction Period|Protocol Deviation|0|||
47045231|NCT04146363|83303383|FG003|Induction Period|Protocol Deviation|0|||
47045232|NCT04146363|83303384|FG004|Induction Period|Protocol Deviation|0|||
47045233|NCT04146363|83303385|FG005|Induction Period|Protocol Deviation|0|||
47045234|NCT04146363|83303386|FG006|Induction Period|Protocol Deviation|0|||
47045235|NCT04146363|83303387|FG007|Induction Period|Protocol Deviation|0|||
47045236|NCT04146363|83303388|FG008|Induction Period|Protocol Deviation|0|||
47045237|NCT04146363|83303389|FG009|Induction Period|Protocol Deviation|0|||
47045238|NCT04146363|83303390|FG010|Induction Period|Protocol Deviation|0|||
47045239|NCT04146363|83303380|FG000|Induction Period|Withdrawal by Subject|6|||
46724086|NCT00960570|82939984|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
46724087|NCT00960570|82939984|FG000|1 Day Period Between Dosing|Adverse Event|2|||
47045240|NCT04146363|83303381|FG001|Induction Period|Withdrawal by Subject|3|||
47045241|NCT04146363|83303382|FG002|Induction Period|Withdrawal by Subject|0|||
47045242|NCT04146363|83303383|FG003|Induction Period|Withdrawal by Subject|0|||
47045243|NCT04146363|83303384|FG004|Induction Period|Withdrawal by Subject|0|||
47045244|NCT04146363|83303385|FG005|Induction Period|Withdrawal by Subject|0|||
46724088|NCT00960570|82939984|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
46724089|NCT01126424|82939997|FG000|Overall Study|Adverse Event|0|||
46724090|NCT01126424|82939998|FG001|Overall Study|Adverse Event|0|||
46724091|NCT01126424|82939999|FG002|Overall Study|Adverse Event|0|||
46724092|NCT01126424|82940000|FG003|Overall Study|Adverse Event|0|||
46724093|NCT01126424|82940001|FG004|Overall Study|Adverse Event|1|||
46724094|NCT01126424|82940002|FG005|Overall Study|Adverse Event|0|||
46724095|NCT01126424|82939997|FG000|Overall Study|Withdrawal by Subject|0|||
46724096|NCT01126424|82939998|FG001|Overall Study|Withdrawal by Subject|0|||
46724097|NCT01126424|82939999|FG002|Overall Study|Withdrawal by Subject|1|||
46724098|NCT01126424|82940000|FG003|Overall Study|Withdrawal by Subject|3|||
46724099|NCT01126424|82940001|FG004|Overall Study|Withdrawal by Subject|1|||
46724100|NCT01126424|82940002|FG005|Overall Study|Withdrawal by Subject|0|||
46724101|NCT01126268|82940010|FG000|Overall Study|Adverse Event|1|||
46724102|NCT00879658|82940021|FG000|Overall Study|Abnormal laboratory value(s)|3|||
46724103|NCT00879658|82940022|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46724104|NCT00879658|82940023|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46724105|NCT00879658|82940024|FG003|Overall Study|Abnormal laboratory value(s)|1|||
46724106|NCT00879658|82940025|FG004|Overall Study|Abnormal laboratory value(s)|0|||
46724107|NCT00879658|82940026|FG005|Overall Study|Abnormal laboratory value(s)|0|||
46724108|NCT00879658|82940027|FG006|Overall Study|Abnormal laboratory value(s)|0|||
46724109|NCT00879658|82940021|FG000|Overall Study|Administrative problems|2|||
46724110|NCT00879658|82940022|FG001|Overall Study|Administrative problems|1|||
46724111|NCT00879658|82940023|FG002|Overall Study|Administrative problems|0|||
46724112|NCT00879658|82940024|FG003|Overall Study|Administrative problems|1|||
46724113|NCT00879658|82940025|FG004|Overall Study|Administrative problems|0|||
46724114|NCT00879658|82940026|FG005|Overall Study|Administrative problems|0|||
46724115|NCT00879658|82940027|FG006|Overall Study|Administrative problems|0|||
46724116|NCT00879658|82940021|FG000|Overall Study|Adverse Event|6|||
46724117|NCT00879658|82940022|FG001|Overall Study|Adverse Event|4|||
46724118|NCT00879658|82940023|FG002|Overall Study|Adverse Event|3|||
46724119|NCT00879658|82940024|FG003|Overall Study|Adverse Event|1|||
46724120|NCT00879658|82940025|FG004|Overall Study|Adverse Event|2|||
46724121|NCT00879658|82940026|FG005|Overall Study|Adverse Event|0|||
46724122|NCT00879658|82940027|FG006|Overall Study|Adverse Event|0|||
46724123|NCT00879658|82940021|FG000|Overall Study|Protocol Violation|1|||
46724124|NCT00879658|82940022|FG001|Overall Study|Protocol Violation|0|||
46724125|NCT00879658|82940023|FG002|Overall Study|Protocol Violation|0|||
46724126|NCT00879658|82940024|FG003|Overall Study|Protocol Violation|0|||
46724127|NCT00879658|82940025|FG004|Overall Study|Protocol Violation|0|||
46724128|NCT00879658|82940026|FG005|Overall Study|Protocol Violation|0|||
46724129|NCT00879658|82940027|FG006|Overall Study|Protocol Violation|0|||
46920700|NCT04326439|83152937|FG001|Overall Study|Relapse after Induction 2|1|||
46920701|NCT04326439|83152936|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
46920702|NCT04326439|83152937|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
46920703|NCT00145795|83152951|FG000|Overall Study|Adverse Event|1|||
46920704|NCT00145795|83152952|FG001|Overall Study|Adverse Event|0|||
47045245|NCT04146363|83303386|FG006|Induction Period|Withdrawal by Subject|0|||
47045246|NCT04146363|83303387|FG007|Induction Period|Withdrawal by Subject|0|||
47045247|NCT04146363|83303388|FG008|Induction Period|Withdrawal by Subject|0|||
47045248|NCT04146363|83303389|FG009|Induction Period|Withdrawal by Subject|0|||
47045249|NCT04146363|83303390|FG010|Induction Period|Withdrawal by Subject|0|||
47045250|NCT04146363|83303380|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
47045251|NCT04146363|83303381|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
46634372|NCT01717326|82807865|FG003|Overall Study|Protocol Violation|0|||
46634373|NCT01717326|82807866|FG004|Overall Study|Protocol Violation|1|||
46634374|NCT01717326|82807867|FG005|Overall Study|Protocol Violation|0|||
46634375|NCT01717326|82807868|FG006|Overall Study|Protocol Violation|0|||
46634376|NCT01717326|82807869|FG007|Overall Study|Protocol Violation|0|||
46634377|NCT01717326|82807870|FG008|Overall Study|Protocol Violation|0|||
46634378|NCT01717326|82807871|FG009|Overall Study|Protocol Violation|0|||
46724130|NCT00879658|82940021|FG000|Overall Study|Withdrawal by Subject|3|||
46724131|NCT00879658|82940022|FG001|Overall Study|Withdrawal by Subject|0|||
47045252|NCT04146363|83303382|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
46724132|NCT00879658|82940023|FG002|Overall Study|Withdrawal by Subject|2|||
46724133|NCT00879658|82940024|FG003|Overall Study|Withdrawal by Subject|0|||
46634379|NCT01717326|82807872|FG010|Overall Study|Protocol Violation|0|||
46634380|NCT01717326|82807873|FG011|Overall Study|Protocol Violation|0|||
47045253|NCT04146363|83303383|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
47045254|NCT04146363|83303384|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
47045255|NCT04146363|83303385|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
47045256|NCT04146363|83303386|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
47045257|NCT04146363|83303387|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
47045258|NCT04146363|83303388|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
47045259|NCT04146363|83303389|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
47045260|NCT04146363|83303390|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
46920705|NCT02771210|83152960|FG000|Period 1|Adverse Event|5|||
46724134|NCT00879658|82940025|FG004|Overall Study|Withdrawal by Subject|0|||
46724135|NCT00879658|82940026|FG005|Overall Study|Withdrawal by Subject|1|||
46724136|NCT00879658|82940027|FG006|Overall Study|Withdrawal by Subject|0|||
46724137|NCT00879658|82940021|FG000|Overall Study|Lack of Efficacy|0|||
46724138|NCT00879658|82940022|FG001|Overall Study|Lack of Efficacy|0|||
46724139|NCT00879658|82940023|FG002|Overall Study|Lack of Efficacy|2|||
47045261|NCT04146363|83303380|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47045262|NCT04146363|83303381|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
46724140|NCT00879658|82940024|FG003|Overall Study|Lack of Efficacy|0|||
46724141|NCT00879658|82940025|FG004|Overall Study|Lack of Efficacy|0|||
46724142|NCT00879658|82940026|FG005|Overall Study|Lack of Efficacy|0|||
46724143|NCT00879658|82940027|FG006|Overall Study|Lack of Efficacy|0|||
46724144|NCT00879658|82940021|FG000|Overall Study|misrandomized (never received study med)|0|||
46724145|NCT00879658|82940022|FG001|Overall Study|misrandomized (never received study med)|0|||
46724146|NCT00879658|82940023|FG002|Overall Study|misrandomized (never received study med)|0|||
46724147|NCT00879658|82940024|FG003|Overall Study|misrandomized (never received study med)|1|||
46724148|NCT00879658|82940025|FG004|Overall Study|misrandomized (never received study med)|0|||
46724149|NCT00879658|82940026|FG005|Overall Study|misrandomized (never received study med)|0|||
46724150|NCT00879658|82940027|FG006|Overall Study|misrandomized (never received study med)|0|||
46724151|NCT00959946|82940057|FG000|Overall Study|Adverse Event|0|||
46724152|NCT00959946|82940058|FG001|Overall Study|Adverse Event|0|||
46724153|NCT00959946|82940059|FG002|Overall Study|Adverse Event|2|||
46724154|NCT00959946|82940060|FG003|Overall Study|Adverse Event|1|||
46724155|NCT00959946|82940061|FG004|Overall Study|Adverse Event|0|||
46724156|NCT00959946|82940062|FG005|Overall Study|Adverse Event|1|||
46724157|NCT00959946|82940063|FG006|Overall Study|Adverse Event|0|||
46724158|NCT00959946|82940064|FG007|Overall Study|Adverse Event|0|||
46724159|NCT00959946|82940057|FG000|Overall Study|Death|0|||
46724160|NCT00959946|82940058|FG001|Overall Study|Death|0|||
46724161|NCT00959946|82940059|FG002|Overall Study|Death|0|||
46920706|NCT02771210|83152961|FG001|Period 1|Adverse Event|3|||
46920707|NCT02771210|83152960|FG000|Period 1|Lack of Efficacy|3|||
46724162|NCT00959946|82940060|FG003|Overall Study|Death|0|||
47045263|NCT04146363|83303382|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
46634381|NCT01717326|82807874|FG012|Overall Study|Protocol Violation|0|||
46634382|NCT01717326|82807875|FG013|Overall Study|Protocol Violation|0|||
46634383|NCT01717326|82807876|FG014|Overall Study|Protocol Violation|0|||
46634384|NCT01717326|82807877|FG015|Overall Study|Protocol Violation|0|||
46634385|NCT01717326|82807878|FG016|Overall Study|Protocol Violation|0|||
46634386|NCT01717326|82807879|FG017|Overall Study|Protocol Violation|0|||
46634387|NCT01717326|82807880|FG018|Overall Study|Protocol Violation|0|||
46634388|NCT01717326|82807881|FG019|Overall Study|Protocol Violation|0|||
46634389|NCT01717326|82807862|FG000|Overall Study|Withdrawal by Subject|0|||
46634390|NCT01717326|82807863|FG001|Overall Study|Withdrawal by Subject|1|||
46634391|NCT01717326|82807864|FG002|Overall Study|Withdrawal by Subject|0|||
46724163|NCT00959946|82940061|FG004|Overall Study|Death|0|||
46724164|NCT00959946|82940062|FG005|Overall Study|Death|1|||
46724165|NCT00959946|82940063|FG006|Overall Study|Death|0|||
46724166|NCT00959946|82940064|FG007|Overall Study|Death|0|||
46724167|NCT00959946|82940057|FG000|Overall Study|Disease Progression|2|||
46724168|NCT00959946|82940058|FG001|Overall Study|Disease Progression|4|||
46724169|NCT00959946|82940059|FG002|Overall Study|Disease Progression|2|||
46724170|NCT00959946|82940060|FG003|Overall Study|Disease Progression|4|||
46724171|NCT00959946|82940061|FG004|Overall Study|Disease Progression|4|||
47045264|NCT04146363|83303383|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
46724172|NCT00959946|82940062|FG005|Overall Study|Disease Progression|6|||
46634392|NCT01717326|82807865|FG003|Overall Study|Withdrawal by Subject|0|||
46634393|NCT01717326|82807866|FG004|Overall Study|Withdrawal by Subject|0|||
46634394|NCT01717326|82807867|FG005|Overall Study|Withdrawal by Subject|0|||
46724173|NCT00959946|82940063|FG006|Overall Study|Disease Progression|2|||
46724174|NCT00959946|82940064|FG007|Overall Study|Disease Progression|2|||
46724175|NCT00959946|82940057|FG000|Overall Study|Withdrawal by Subject|0|||
46724176|NCT00959946|82940058|FG001|Overall Study|Withdrawal by Subject|0|||
46724177|NCT00959946|82940059|FG002|Overall Study|Withdrawal by Subject|0|||
46724178|NCT00959946|82940060|FG003|Overall Study|Withdrawal by Subject|0|||
46724179|NCT00959946|82940061|FG004|Overall Study|Withdrawal by Subject|0|||
46724180|NCT00959946|82940062|FG005|Overall Study|Withdrawal by Subject|1|||
46724181|NCT00959946|82940063|FG006|Overall Study|Withdrawal by Subject|0|||
46724182|NCT00959946|82940064|FG007|Overall Study|Withdrawal by Subject|0|||
46724183|NCT00911937|82940089|FG000|Overall Study|Death|1|||
46724184|NCT00911937|82940090|FG001|Overall Study|Death|0|||
46724185|NCT00911937|82940089|FG000|Overall Study|Lost to Follow-up|8|||
46724186|NCT00911937|82940090|FG001|Overall Study|Lost to Follow-up|5|||
46724187|NCT00911937|82940089|FG000|Overall Study|Withdrawal by Subject|10|||
46724188|NCT00911937|82940090|FG001|Overall Study|Withdrawal by Subject|7|||
46724189|NCT00911937|82940089|FG000|Overall Study|Withdrawn due to pregnancy|1|||
46724190|NCT00911937|82940090|FG001|Overall Study|Withdrawn due to pregnancy|0|||
46724191|NCT00911937|82940089|FG000|Overall Study|Adverse Event|11|||
46724192|NCT00911937|82940090|FG001|Overall Study|Adverse Event|25|||
46724193|NCT00911937|82940089|FG000|Overall Study|Lack of Efficacy|11|||
46724194|NCT00911937|82940090|FG001|Overall Study|Lack of Efficacy|6|||
46724195|NCT00911937|82940089|FG000|Overall Study|Did not meet inclusion criteria|9|||
46724196|NCT00911937|82940090|FG001|Overall Study|Did not meet inclusion criteria|11|||
46724197|NCT00911937|82940089|FG000|Overall Study|Protocol Violation|14|||
46724198|NCT00911937|82940090|FG001|Overall Study|Protocol Violation|23|||
46724199|NCT00911937|82940089|FG000|Overall Study|Randomized but not treated|13|||
46724200|NCT00911937|82940090|FG001|Overall Study|Randomized but not treated|13|||
46724201|NCT00911937|82940089|FG000|Overall Study|Other|9|||
46724202|NCT00911937|82940090|FG001|Overall Study|Other|5|||
46724203|NCT00880048|82940099|FG000|Overall Study|Adverse Event|2|||
46724204|NCT00880048|82940100|FG001|Overall Study|Adverse Event|3|||
46724205|NCT00880048|82940101|FG002|Overall Study|Adverse Event|5|||
46724206|NCT00880048|82940099|FG000|Overall Study|Lack of Efficacy|1|||
46724207|NCT00880048|82940100|FG001|Overall Study|Lack of Efficacy|2|||
46724208|NCT00880048|82940101|FG002|Overall Study|Lack of Efficacy|2|||
46724209|NCT00880048|82940099|FG000|Overall Study|Protocol Violation|4|||
46724210|NCT00880048|82940100|FG001|Overall Study|Protocol Violation|6|||
46724211|NCT00880048|82940101|FG002|Overall Study|Protocol Violation|5|||
46724212|NCT00880048|82940099|FG000|Overall Study|Lost to Follow-up|6|||
46724213|NCT00880048|82940100|FG001|Overall Study|Lost to Follow-up|6|||
46724214|NCT00880048|82940101|FG002|Overall Study|Lost to Follow-up|5|||
46724215|NCT00880048|82940099|FG000|Overall Study|Physician Decision|1|||
46724216|NCT00880048|82940100|FG001|Overall Study|Physician Decision|1|||
46920708|NCT02771210|83152961|FG001|Period 1|Lack of Efficacy|6|||
46920709|NCT02771210|83152960|FG000|Period 1|Lost to Follow-up|2|||
46920710|NCT02771210|83152961|FG001|Period 1|Lost to Follow-up|0|||
46920711|NCT02771210|83152960|FG000|Period 1|Physician Decision|0|||
46920712|NCT02771210|83152961|FG001|Period 1|Physician Decision|1|||
46920713|NCT02771210|83152960|FG000|Period 1|Withdrawal by Subject|0|||
47045265|NCT04146363|83303384|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47045266|NCT04146363|83303385|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47045267|NCT04146363|83303386|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47045268|NCT04146363|83303387|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
47045269|NCT04146363|83303388|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47045270|NCT04146363|83303389|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47045271|NCT04146363|83303390|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47045272|NCT04146363|83303380|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
46724217|NCT00880048|82940101|FG002|Overall Study|Physician Decision|7|||
46724218|NCT00880048|82940099|FG000|Overall Study|Withdrawal by Subject|5|||
46724219|NCT00880048|82940100|FG001|Overall Study|Withdrawal by Subject|8|||
46724220|NCT00880048|82940101|FG002|Overall Study|Withdrawal by Subject|5|||
46724221|NCT00880048|82940099|FG000|Overall Study|Study closed/terminated|9|||
46724222|NCT00880048|82940100|FG001|Overall Study|Study closed/terminated|7|||
46724223|NCT00880048|82940101|FG002|Overall Study|Study closed/terminated|6|||
46724224|NCT00962208|82940111|FG000|Overall Study|Could not achieve good vision|9|||
46724225|NCT00962208|82940112|FG001|Overall Study|Could not achieve good vision|0|||
46920714|NCT02771210|83152961|FG001|Period 1|Withdrawal by Subject|3|||
46724226|NCT00962208|82940111|FG000|Overall Study|Contraindicated to continue study|5|||
46724227|NCT00962208|82940112|FG001|Overall Study|Contraindicated to continue study|1|||
47045273|NCT04146363|83303381|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
46724228|NCT00962208|82940111|FG000|Overall Study|Lost to Follow-up|0|||
46724229|NCT00962208|82940112|FG001|Overall Study|Lost to Follow-up|9|||
46724230|NCT01076543|82940124|FG000|Overall Study|Withdrawal by Subject|2|||
46724231|NCT01076543|82940125|FG001|Overall Study|Withdrawal by Subject|0|||
46724232|NCT01076543|82940126|FG002|Overall Study|Withdrawal by Subject|0|||
46724233|NCT01076543|82940127|FG003|Overall Study|Withdrawal by Subject|0|||
46724234|NCT01076543|82940128|FG004|Overall Study|Withdrawal by Subject|0|||
46724235|NCT01076543|82940129|FG005|Overall Study|Withdrawal by Subject|0|||
46724236|NCT01072877|82940149|FG000|Overall Study|Lost to Follow-up|1|||
46724237|NCT01072877|82940150|FG001|Overall Study|Lost to Follow-up|1|||
46724238|NCT01072877|82940151|FG002|Overall Study|Lost to Follow-up|0|||
46724239|NCT01072877|82940152|FG003|Overall Study|Lost to Follow-up|2|||
46724240|NCT01072877|82940153|FG004|Overall Study|Lost to Follow-up|0|||
46724241|NCT00961896|82940170|FG000|Overall Study|Abnormal laboratory value|0|||
46724242|NCT00961896|82940171|FG001|Overall Study|Abnormal laboratory value|0|||
46724243|NCT00961896|82940172|FG002|Overall Study|Abnormal laboratory value|1|||
46724244|NCT00957528|82940186|FG000|Overall Study|Protocol Violation|0|||
46724245|NCT00957528|82940187|FG001|Overall Study|Protocol Violation|1|||
46724246|NCT00957528|82940188|FG002|Overall Study|Protocol Violation|0|||
46724247|NCT00957528|82940186|FG000|Overall Study|Withdrawal by Subject|0|||
46724248|NCT00957528|82940187|FG001|Overall Study|Withdrawal by Subject|0|||
46724249|NCT00957528|82940188|FG002|Overall Study|Withdrawal by Subject|1|||
46724250|NCT00958776|82940198|FG000|Overall Study|Adverse Event|0|||
46724251|NCT00958776|82940199|FG001|Overall Study|Adverse Event|1|||
46724252|NCT00958776|82940198|FG000|Overall Study|Physician Decision|1|||
46724253|NCT00958776|82940199|FG001|Overall Study|Physician Decision|0|||
46724254|NCT00958776|82940198|FG000|Overall Study|Lost to Follow-up|2|||
46724255|NCT00958776|82940199|FG001|Overall Study|Lost to Follow-up|6|||
47045274|NCT04146363|83303382|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47045275|NCT04146363|83303383|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47045276|NCT04146363|83303384|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47045277|NCT04146363|83303385|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47045278|NCT04146363|83303386|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
47045279|NCT04146363|83303387|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
47045280|NCT04146363|83303388|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47045281|NCT04146363|83303389|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47045282|NCT04146363|83303390|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47045283|NCT04146363|83303380|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045284|NCT04146363|83303381|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045285|NCT04146363|83303382|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
47045286|NCT04146363|83303383|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045287|NCT04146363|83303384|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
46724256|NCT00958776|82940198|FG000|Overall Study|Withdrawal by Subject|7|||
46724257|NCT00958776|82940199|FG001|Overall Study|Withdrawal by Subject|16|||
46724258|NCT00958776|82940198|FG000|Overall Study|Protocol Violation|1|||
46724259|NCT00958776|82940199|FG001|Overall Study|Protocol Violation|1|||
46724260|NCT00958776|82940198|FG000|Overall Study|Death|2|||
46724261|NCT00958776|82940199|FG001|Overall Study|Death|1|||
46724262|NCT00958776|82940198|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
46724263|NCT00958776|82940199|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
46724264|NCT00958776|82940198|FG000|Overall Study|Missing|1|||
46724265|NCT00958776|82940199|FG001|Overall Study|Missing|1|||
46724266|NCT00596830|82940208|FG000|Overall Study|Death|258|||
46724267|NCT00596830|82940209|FG001|Overall Study|Death|247|||
46724268|NCT00596830|82940208|FG000|Overall Study|Lost to Follow-up|7|||
46724269|NCT00596830|82940209|FG001|Overall Study|Lost to Follow-up|11|||
46724270|NCT00596830|82940208|FG000|Overall Study|Withdrawal by Subject|22|||
46724271|NCT00596830|82940209|FG001|Overall Study|Withdrawal by Subject|12|||
46724272|NCT00596830|82940208|FG000|Overall Study|Study terminated by sponsor|51|||
46724273|NCT00596830|82940209|FG001|Overall Study|Study terminated by sponsor|62|||
46724274|NCT00596830|82940208|FG000|Overall Study|Follow-up was discontinued|1|||
46724275|NCT00596830|82940209|FG001|Overall Study|Follow-up was discontinued|0|||
46724276|NCT00596830|82940208|FG000|Overall Study|Randomized but not treated|3|||
46724277|NCT00596830|82940209|FG001|Overall Study|Randomized but not treated|7|||
46724278|NCT00957372|82940218|FG000|PART I|Lost to Follow-up|0|||
46724279|NCT00957372|82940219|FG001|PART I|Lost to Follow-up|0|||
46724280|NCT00957372|82940220|FG002|PART I|Lost to Follow-up|1|||
46724281|NCT00957372|82940221|FG003|PART I|Lost to Follow-up|0|||
46724282|NCT00957372|82940218|FG000|PART II|Withdrawal by Subject|0|||
46724283|NCT00957372|82940219|FG001|PART II|Withdrawal by Subject|0|||
46724284|NCT00957372|82940220|FG002|PART II|Withdrawal by Subject|0|||
46724285|NCT00957372|82940221|FG003|PART II|Withdrawal by Subject|8|||
46724286|NCT00957372|82940218|FG000|PART II|Physician Decision|0|||
46724287|NCT00957372|82940219|FG001|PART II|Physician Decision|0|||
46724288|NCT00957372|82940220|FG002|PART II|Physician Decision|0|||
46724289|NCT00957372|82940221|FG003|PART II|Physician Decision|1|||
46724290|NCT00957372|82940218|FG000|PART II|Pregnancy|0|||
46724291|NCT00957372|82940219|FG001|PART II|Pregnancy|0|||
46724292|NCT00957372|82940220|FG002|PART II|Pregnancy|0|||
46724293|NCT00957372|82940221|FG003|PART II|Pregnancy|1|||
46724294|NCT00957372|82940218|FG000|PART II|Not Know|0|||
46724295|NCT00957372|82940219|FG001|PART II|Not Know|0|||
46724296|NCT00957372|82940220|FG002|PART II|Not Know|0|||
46724297|NCT00957372|82940221|FG003|PART II|Not Know|20|||
46724298|NCT00957372|82940218|FG000|PART II|Adverse Event|0|||
46724299|NCT00957372|82940219|FG001|PART II|Adverse Event|0|||
46724300|NCT00957372|82940220|FG002|PART II|Adverse Event|0|||
46724301|NCT00957372|82940221|FG003|PART II|Adverse Event|10|||
46724302|NCT00957372|82940218|FG000|PART II|Patient non-compliance|0|||
46724303|NCT00957372|82940219|FG001|PART II|Patient non-compliance|0|||
46724304|NCT00957372|82940220|FG002|PART II|Patient non-compliance|0|||
46724305|NCT00957372|82940221|FG003|PART II|Patient non-compliance|4|||
46724306|NCT00952848|82940237|FG000|Overall Study|Withdrawal by Subject|4|||
46724307|NCT00952614|82940241|FG000|Overall Study|Death|3|||
46724308|NCT00952614|82940241|FG000|Overall Study|Lost to Follow-up|3|||
46724309|NCT00952614|82940241|FG000|Overall Study|other reason|1|||
46724310|NCT00911859|82940249|FG000|Treatment Period|Adverse Event|3|||
46724311|NCT00911859|82940250|FG001|Treatment Period|Adverse Event|3|||
46724312|NCT00911859|82940251|FG002|Treatment Period|Adverse Event|7|||
46724313|NCT00911859|82940249|FG000|Treatment Period|Death|1|||
46724314|NCT00911859|82940250|FG001|Treatment Period|Death|3|||
46724315|NCT00911859|82940251|FG002|Treatment Period|Death|5|||
46724316|NCT00911859|82940249|FG000|Treatment Period|Lack of Efficacy|1|||
46724317|NCT00911859|82940250|FG001|Treatment Period|Lack of Efficacy|7|||
46724318|NCT00911859|82940251|FG002|Treatment Period|Lack of Efficacy|5|||
46724319|NCT00911859|82940249|FG000|Treatment Period|Physician Decision|3|||
46724320|NCT00911859|82940250|FG001|Treatment Period|Physician Decision|3|||
46724321|NCT00911859|82940251|FG002|Treatment Period|Physician Decision|3|||
46920715|NCT02771210|83152960|FG000|Period 1|Withdrawal of informed consent|1|||
46920716|NCT02771210|83152961|FG001|Period 1|Withdrawal of informed consent|5|||
46920717|NCT02771210|83152960|FG000|Period 2|Adverse Event|1|||
46920718|NCT02771210|83152961|FG001|Period 2|Adverse Event|0|||
46920719|NCT02771210|83152960|FG000|Period 2|Lack of Efficacy|0|||
46724322|NCT00911859|82940249|FG000|Treatment Period|Withdrawal by Subject|0|||
46724323|NCT00911859|82940250|FG001|Treatment Period|Withdrawal by Subject|4|||
46920720|NCT02771210|83152961|FG001|Period 2|Lack of Efficacy|1|||
46724324|NCT00911859|82940251|FG002|Treatment Period|Withdrawal by Subject|5|||
46724325|NCT00911859|82940249|FG000|Treatment Period|Did not receive study treatment|0|||
46724326|NCT00911859|82940250|FG001|Treatment Period|Did not receive study treatment|1|||
46724327|NCT00911859|82940251|FG002|Treatment Period|Did not receive study treatment|0|||
46724328|NCT00911859|82940249|FG000|Maintainance Period|Lack of Efficacy|0|||
46724329|NCT00911859|82940250|FG001|Maintainance Period|Lack of Efficacy|0|||
46724330|NCT00911859|82940251|FG002|Maintainance Period|Lack of Efficacy|9|||
46724331|NCT00911859|82940249|FG000|Maintainance Period|Physician Decision|0|||
46724332|NCT00911859|82940250|FG001|Maintainance Period|Physician Decision|0|||
46724333|NCT00911859|82940251|FG002|Maintainance Period|Physician Decision|9|||
46724334|NCT00911859|82940249|FG000|Maintainance Period|Withdrawal by Subject|0|||
46724335|NCT00911859|82940250|FG001|Maintainance Period|Withdrawal by Subject|0|||
46724336|NCT00911859|82940251|FG002|Maintainance Period|Withdrawal by Subject|3|||
46724337|NCT00911859|82940249|FG000|Follow-up Period|Death|5|||
46724338|NCT00911859|82940250|FG001|Follow-up Period|Death|8|||
46724339|NCT00911859|82940251|FG002|Follow-up Period|Death|10|||
46724340|NCT00911859|82940249|FG000|Follow-up Period|Lost to Follow-up|1|||
46724341|NCT00911859|82940250|FG001|Follow-up Period|Lost to Follow-up|1|||
46724342|NCT00911859|82940251|FG002|Follow-up Period|Lost to Follow-up|0|||
46724343|NCT00911859|82940249|FG000|Follow-up Period|Withdrawal by Subject|0|||
46724344|NCT00911859|82940250|FG001|Follow-up Period|Withdrawal by Subject|4|||
46724345|NCT00911859|82940251|FG002|Follow-up Period|Withdrawal by Subject|4|||
46724346|NCT00911859|82940249|FG000|Follow-up Period|Study terminated by sponsor|5|||
46724347|NCT00911859|82940250|FG001|Follow-up Period|Study terminated by sponsor|33|||
46724348|NCT00911859|82940251|FG002|Follow-up Period|Study terminated by sponsor|27|||
46724349|NCT00956592|82940261|FG000|Overall Study|Protocol Violation|1|||
46724350|NCT00956592|82940262|FG001|Overall Study|Protocol Violation|3|||
46724351|NCT02725593|82940272|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
46724352|NCT02725593|82940273|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
46724353|NCT02725593|82940272|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
46724354|NCT02725593|82940273|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
46724355|NCT02725593|82940272|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
46724356|NCT02725593|82940273|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
46724357|NCT02725593|82940272|FG000|Long Term Extension|Withdrawal by Subject|1|||
46724358|NCT02725593|82940273|FG001|Long Term Extension|Withdrawal by Subject|3|||
46724359|NCT00911625|82940281|FG000|Overall Study|Lost to Follow-up|7|||
46724360|NCT00911625|82940282|FG001|Overall Study|Lost to Follow-up|0|||
46724361|NCT00596752|82940290|FG000|Overall Study|Other Reason|44|||
46724362|NCT00596752|82940291|FG001|Overall Study|Other Reason|49|||
46724363|NCT00596752|82940290|FG000|Overall Study|Adverse Event|34|||
46724364|NCT00596752|82940291|FG001|Overall Study|Adverse Event|34|||
46724365|NCT00596752|82940290|FG000|Overall Study|Lost to Follow-up|22|||
46724366|NCT00596752|82940291|FG001|Overall Study|Lost to Follow-up|38|||
46724367|NCT00596752|82940290|FG000|Overall Study|Withdrawal by Subject|12|||
46724368|NCT00596752|82940291|FG001|Overall Study|Withdrawal by Subject|9|||
46724369|NCT00596752|82940290|FG000|Overall Study|Unsatisfactory Compliance|9|||
46724370|NCT00596752|82940291|FG001|Overall Study|Unsatisfactory Compliance|6|||
46724371|NCT00596752|82940290|FG000|Overall Study|Lack of Efficacy|4|||
46724372|NCT00596752|82940291|FG001|Overall Study|Lack of Efficacy|7|||
46724373|NCT00596752|82940290|FG000|Overall Study|Protocol Violation|1|||
46724374|NCT00596752|82940291|FG001|Overall Study|Protocol Violation|0|||
46724375|NCT00958074|82940299|FG000|Overall Study|Withdrawal by Subject|0|||
46724376|NCT00958074|82940300|FG001|Overall Study|Withdrawal by Subject|1|||
46724377|NCT00809965|82940309|FG000|Overall Study|Death|194|||
46724378|NCT00809965|82940310|FG001|Overall Study|Death|147|||
46724379|NCT00809965|82940311|FG002|Overall Study|Death|196|||
46724380|NCT00809965|82940309|FG000|Overall Study|Lost to Follow-up|17|||
46724381|NCT00809965|82940310|FG001|Overall Study|Lost to Follow-up|10|||
46724382|NCT00809965|82940311|FG002|Overall Study|Lost to Follow-up|18|||
46724383|NCT00809965|82940309|FG000|Overall Study|Withdrawal by Subject|405|||
46724384|NCT00809965|82940310|FG001|Overall Study|Withdrawal by Subject|448|||
46920721|NCT02771210|83152960|FG000|Period 2|Withdrawal by Subject|1|||
46920722|NCT02771210|83152961|FG001|Period 2|Withdrawal by Subject|0|||
46920723|NCT02771210|83152960|FG000|Period 2|Withdrawal of informed consent|0|||
46920724|NCT02771210|83152961|FG001|Period 2|Withdrawal of informed consent|2|||
47045288|NCT04146363|83303385|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
47045289|NCT04146363|83303386|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045290|NCT04146363|83303387|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045291|NCT04146363|83303388|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045292|NCT04146363|83303389|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045293|NCT04146363|83303390|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
47045294|NCT04146363|83303380|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47045295|NCT04146363|83303381|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47045296|NCT04146363|83303382|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47045297|NCT04146363|83303383|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47045298|NCT04146363|83303384|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
47045299|NCT04146363|83303385|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
47045300|NCT04146363|83303386|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
47045301|NCT04146363|83303387|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
47045302|NCT04146363|83303388|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47045303|NCT04146363|83303389|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47045304|NCT04146363|83303390|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47045305|NCT04146363|83303380|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
46724385|NCT00809965|82940311|FG002|Overall Study|Withdrawal by Subject|441|||
46724386|NCT00809965|82940309|FG000|Overall Study|Other Reason|167|||
46920725|NCT00898677|83152971|FG000|Overall Study|Adverse Event|0|||
46920726|NCT00898677|83152972|FG001|Overall Study|Adverse Event|0|||
46920727|NCT00898677|83152973|FG002|Overall Study|Adverse Event|1|||
46920728|NCT00898677|83152974|FG003|Overall Study|Adverse Event|0|||
46920729|NCT00898677|83152971|FG000|Overall Study|Lost to Follow-up|0|||
46920730|NCT00898677|83152972|FG001|Overall Study|Lost to Follow-up|0|||
46920731|NCT00898677|83152973|FG002|Overall Study|Lost to Follow-up|2|||
46920732|NCT00898677|83152974|FG003|Overall Study|Lost to Follow-up|0|||
46920733|NCT00898677|83152971|FG000|Overall Study|Protocol Violation|1|||
46920734|NCT00898677|83152972|FG001|Overall Study|Protocol Violation|1|||
46920735|NCT00898677|83152973|FG002|Overall Study|Protocol Violation|2|||
46920736|NCT00898677|83152974|FG003|Overall Study|Protocol Violation|0|||
46920737|NCT00898677|83152971|FG000|Overall Study|Withdrawal by Subject|0|||
46920738|NCT00898677|83152972|FG001|Overall Study|Withdrawal by Subject|0|||
46920739|NCT00898677|83152973|FG002|Overall Study|Withdrawal by Subject|0|||
46724387|NCT00809965|82940310|FG001|Overall Study|Other Reason|170|||
46724388|NCT00809965|82940311|FG002|Overall Study|Other Reason|189|||
46724389|NCT00597376|82940321|FG000|Overall Study|Withdrawal by Subject|4|||
46920740|NCT00898677|83152974|FG003|Overall Study|Withdrawal by Subject|1|||
46920741|NCT00898677|83152971|FG000|Overall Study|Not Treated: Adverse Event|0|||
46920742|NCT00898677|83152972|FG001|Overall Study|Not Treated: Adverse Event|2|||
46920743|NCT00898677|83152973|FG002|Overall Study|Not Treated: Adverse Event|1|||
46920744|NCT00898677|83152974|FG003|Overall Study|Not Treated: Adverse Event|0|||
46920745|NCT00898677|83152971|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
46724390|NCT00597376|82940322|FG001|Overall Study|Withdrawal by Subject|3|||
46724391|NCT00597376|82940321|FG000|Overall Study|Adverse Event|4|||
46724392|NCT00597376|82940322|FG001|Overall Study|Adverse Event|1|||
46724393|NCT00910689|82940358|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
46724394|NCT00910689|82940359|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
46724395|NCT00910689|82940360|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
46724396|NCT00910689|82940361|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
46724397|NCT00910689|82940358|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
46724398|NCT00910689|82940359|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
46724399|NCT00910689|82940360|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
46724400|NCT00910689|82940361|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
46920746|NCT00898677|83152972|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
46920747|NCT00898677|83152973|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
46920748|NCT00898677|83152974|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
46920749|NCT00898677|83152971|FG000|Overall Study|Not Treated: Pregnancy|0|||
46920750|NCT00898677|83152972|FG001|Overall Study|Not Treated: Pregnancy|0|||
46920751|NCT00898677|83152973|FG002|Overall Study|Not Treated: Pregnancy|1|||
46920752|NCT00898677|83152974|FG003|Overall Study|Not Treated: Pregnancy|0|||
46920753|NCT00898677|83152971|FG000|Overall Study|Not Treated: Protocol Violation|2|||
46920754|NCT00898677|83152972|FG001|Overall Study|Not Treated: Protocol Violation|0|||
46920755|NCT00898677|83152973|FG002|Overall Study|Not Treated: Protocol Violation|2|||
46920756|NCT00898677|83152974|FG003|Overall Study|Not Treated: Protocol Violation|0|||
47045306|NCT04146363|83303381|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47045307|NCT04146363|83303382|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
47045308|NCT04146363|83303383|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47045309|NCT04146363|83303384|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47045310|NCT04146363|83303385|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
47045311|NCT04146363|83303386|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
47045312|NCT04146363|83303387|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
47045313|NCT04146363|83303388|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47045314|NCT04146363|83303389|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
46634395|NCT01717326|82807868|FG006|Overall Study|Withdrawal by Subject|0|||
46634396|NCT01717326|82807869|FG007|Overall Study|Withdrawal by Subject|0|||
46634397|NCT01717326|82807870|FG008|Overall Study|Withdrawal by Subject|0|||
46634398|NCT01717326|82807871|FG009|Overall Study|Withdrawal by Subject|1|||
46634399|NCT01717326|82807872|FG010|Overall Study|Withdrawal by Subject|0|||
46634400|NCT01717326|82807873|FG011|Overall Study|Withdrawal by Subject|0|||
46634401|NCT01717326|82807874|FG012|Overall Study|Withdrawal by Subject|1|||
46634402|NCT01717326|82807875|FG013|Overall Study|Withdrawal by Subject|0|||
46634403|NCT01717326|82807876|FG014|Overall Study|Withdrawal by Subject|0|||
46634404|NCT01717326|82807877|FG015|Overall Study|Withdrawal by Subject|1|||
46634405|NCT01717326|82807878|FG016|Overall Study|Withdrawal by Subject|0|||
46634406|NCT01717326|82807879|FG017|Overall Study|Withdrawal by Subject|0|||
46634407|NCT01717326|82807880|FG018|Overall Study|Withdrawal by Subject|2|||
46634408|NCT01717326|82807881|FG019|Overall Study|Withdrawal by Subject|3|||
46634409|NCT01697592|82807933|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
46634410|NCT01697592|82807934|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46920757|NCT00898677|83152971|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
46920758|NCT00898677|83152972|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
46724401|NCT00910689|82940358|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
46724402|NCT00910689|82940359|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
46724403|NCT00910689|82940360|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
46724404|NCT00910689|82940361|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
46724405|NCT00910689|82940358|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
46724406|NCT00910689|82940359|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
47045315|NCT04146363|83303390|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
46724407|NCT00910689|82940360|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
46724408|NCT00910689|82940361|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
46724409|NCT00910689|82940358|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
46724410|NCT00910689|82940359|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
46724411|NCT00910689|82940360|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
46724412|NCT00910689|82940361|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
46724413|NCT00910689|82940358|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
46724414|NCT00910689|82940359|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
46724415|NCT00910689|82940360|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
46724416|NCT00910689|82940361|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
46724417|NCT00910689|82940358|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
46724418|NCT00910689|82940359|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
46724419|NCT00910689|82940360|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
46724420|NCT00910689|82940361|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
46724421|NCT00910689|82940358|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
46724422|NCT00910689|82940359|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
46724423|NCT00910689|82940360|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
46724424|NCT00910689|82940361|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
46724425|NCT00910689|82940358|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
46724426|NCT00910689|82940359|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
46724427|NCT00910689|82940360|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
46724428|NCT00910689|82940361|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
46724429|NCT00910689|82940358|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
46724430|NCT00910689|82940359|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
46724431|NCT00910689|82940360|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
46724432|NCT00910689|82940361|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
46724433|NCT00910689|82940358|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
46724434|NCT00910689|82940359|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
46724435|NCT00910689|82940360|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
46724436|NCT00910689|82940361|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
46724437|NCT00910689|82940358|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
46724438|NCT00910689|82940359|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
46724439|NCT00910689|82940360|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
46724440|NCT00910689|82940361|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
46724441|NCT00910689|82940358|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
46724442|NCT00910689|82940359|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
46724443|NCT00910689|82940360|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
46724444|NCT00910689|82940361|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
46724445|NCT00910689|82940358|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
46724446|NCT00910689|82940359|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
46724447|NCT00910689|82940360|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
46724448|NCT00910689|82940361|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
46724449|NCT00910689|82940358|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
46724450|NCT00910689|82940359|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
46724451|NCT00910689|82940360|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
46724452|NCT00910689|82940361|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
46724453|NCT00910689|82940358|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
46724454|NCT00910689|82940359|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
46724455|NCT00910689|82940360|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
46724456|NCT00910689|82940361|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
46724457|NCT00910689|82940358|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
46724458|NCT00910689|82940359|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
46724459|NCT00910689|82940360|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
46724460|NCT00910689|82940361|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
47045316|NCT04146363|83303380|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045317|NCT04146363|83303381|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045318|NCT04146363|83303382|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045319|NCT04146363|83303383|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045320|NCT04146363|83303384|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045321|NCT04146363|83303385|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045322|NCT04146363|83303386|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
46724461|NCT00910689|82940358|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
46724462|NCT00910689|82940359|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
46724463|NCT00910689|82940360|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
46724464|NCT00910689|82940361|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
46724465|NCT00910689|82940358|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
46724466|NCT00910689|82940359|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
46724467|NCT00910689|82940360|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
46724468|NCT00910689|82940361|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
46724469|NCT00910689|82940358|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
46724470|NCT00910689|82940359|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
46724471|NCT00910689|82940360|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
47045323|NCT04146363|83303387|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045324|NCT04146363|83303388|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
46724472|NCT00910689|82940361|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
47045325|NCT04146363|83303389|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
47045326|NCT04146363|83303390|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
47045327|NCT04146363|83303380|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47045328|NCT04146363|83303381|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46724473|NCT00910689|82940358|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
46724474|NCT00910689|82940359|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
46724475|NCT00910689|82940360|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
46724476|NCT00910689|82940361|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
46724477|NCT00807001|82940376|FG000|Overall Study|Non-compliance|0|||
46724478|NCT00807001|82940377|FG001|Overall Study|Non-compliance|1|||
46724479|NCT00807001|82940378|FG002|Overall Study|Non-compliance|0|||
46724480|NCT00807001|82940379|FG003|Overall Study|Non-compliance|0|||
46724481|NCT00807001|82940380|FG004|Overall Study|Non-compliance|0|||
46724482|NCT00809341|82940394|FG000|Overall Study|Physician Decision|0|||
46724483|NCT00809341|82940395|FG001|Overall Study|Physician Decision|1|||
46724484|NCT01125800|82940406|FG000|Phase I|Protocol Violation|0|||
46724485|NCT01125800|82940407|FG001|Phase I|Protocol Violation|3|||
46724486|NCT01125800|82940408|FG002|Phase I|Protocol Violation|1|||
46724487|NCT01125800|82940409|FG003|Phase I|Protocol Violation|1|||
46724488|NCT01125800|82940410|FG004|Phase I|Protocol Violation|0|||
46724489|NCT01125800|82940406|FG000|Phase I|Adverse Event|2|||
46724490|NCT01125800|82940407|FG001|Phase I|Adverse Event|2|||
46724491|NCT01125800|82940408|FG002|Phase I|Adverse Event|1|||
46724492|NCT01125800|82940409|FG003|Phase I|Adverse Event|7|||
46724493|NCT01125800|82940410|FG004|Phase I|Adverse Event|0|||
46724494|NCT01125800|82940406|FG000|Phase I|Administrative problems|1|||
46724495|NCT01125800|82940407|FG001|Phase I|Administrative problems|0|||
47045329|NCT04146363|83303382|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47045330|NCT04146363|83303383|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47045331|NCT04146363|83303384|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47045332|NCT04146363|83303385|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47045333|NCT04146363|83303386|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46724496|NCT01125800|82940408|FG002|Phase I|Administrative problems|0|||
46724497|NCT01125800|82940409|FG003|Phase I|Administrative problems|0|||
46920759|NCT00898677|83152973|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
46920760|NCT00898677|83152974|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
46724498|NCT01125800|82940410|FG004|Phase I|Administrative problems|0|||
46724499|NCT01125800|82940406|FG000|Phase I|Withdrawal by Subject|0|||
46724500|NCT01125800|82940407|FG001|Phase I|Withdrawal by Subject|0|||
46724501|NCT01125800|82940408|FG002|Phase I|Withdrawal by Subject|1|||
46920761|NCT00898677|83152971|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
46634411|NCT01697592|82807935|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634412|NCT01697592|82807936|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634413|NCT01697592|82807937|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634414|NCT01697592|82807938|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634415|NCT01697592|82807939|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634416|NCT01697592|82807940|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634417|NCT01697592|82807941|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634418|NCT01697592|82807942|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
46634419|NCT01697592|82807933|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46634420|NCT01697592|82807934|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46634421|NCT01697592|82807935|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46724502|NCT01125800|82940409|FG003|Phase I|Withdrawal by Subject|0|||
46724503|NCT01125800|82940410|FG004|Phase I|Withdrawal by Subject|0|||
46724504|NCT01125800|82940406|FG000|Phase I|Disease progression|5|||
46634422|NCT01697592|82807936|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46724505|NCT01125800|82940407|FG001|Phase I|Disease progression|4|||
46724506|NCT01125800|82940408|FG002|Phase I|Disease progression|1|||
46920762|NCT00898677|83152972|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
46724507|NCT01125800|82940409|FG003|Phase I|Disease progression|3|||
46724508|NCT01125800|82940410|FG004|Phase I|Disease progression|0|||
46724509|NCT01125800|82940406|FG000|Phase II|Protocol Violation|0|||
46724510|NCT01125800|82940407|FG001|Phase II|Protocol Violation|0|||
46724511|NCT01125800|82940408|FG002|Phase II|Protocol Violation|0|||
46724512|NCT01125800|82940409|FG003|Phase II|Protocol Violation|0|||
46724513|NCT01125800|82940410|FG004|Phase II|Protocol Violation|1|||
46724514|NCT01125800|82940406|FG000|Phase II|Adverse Event|0|||
46724515|NCT01125800|82940407|FG001|Phase II|Adverse Event|0|||
46724516|NCT01125800|82940408|FG002|Phase II|Adverse Event|0|||
46724517|NCT01125800|82940409|FG003|Phase II|Adverse Event|0|||
46724518|NCT01125800|82940410|FG004|Phase II|Adverse Event|2|||
46724519|NCT01125800|82940406|FG000|Phase II|Disease progression|0|||
46724520|NCT01125800|82940407|FG001|Phase II|Disease progression|0|||
46724521|NCT01125800|82940408|FG002|Phase II|Disease progression|0|||
46724522|NCT01125800|82940409|FG003|Phase II|Disease progression|1|||
46724523|NCT01125800|82940410|FG004|Phase II|Disease progression|8|||
46724524|NCT01125722|82940427|FG000|Overall Study|Withdrawal by Subject|2|||
46724525|NCT01125722|82940428|FG001|Overall Study|Withdrawal by Subject|1|||
46724526|NCT01125722|82940427|FG000|Overall Study|Lost to Follow-up|1|||
46724527|NCT01125722|82940428|FG001|Overall Study|Lost to Follow-up|0|||
46724528|NCT00811135|82940434|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
46724529|NCT00811135|82940434|FG000|Overall Study|Death|3|||
46724530|NCT00811135|82940434|FG000|Overall Study|Protocol Violation|2|||
46724531|NCT00811135|82940434|FG000|Overall Study|Violation of Selection Criteria|1|||
46724532|NCT00811135|82940434|FG000|Overall Study|Refused Treatment|1|||
46724533|NCT00811135|82940434|FG000|Overall Study|Withdrawal by Subject|3|||
46724534|NCT00811135|82940434|FG000|Overall Study|Administrative/Other Unspecified|11|||
46724535|NCT00811135|82940434|FG000|Overall Study|Ongoing|59|||
46724536|NCT00811057|82940441|FG000|Overall Study|Protocol Violation|5|||
46724537|NCT00811057|82940442|FG001|Overall Study|Protocol Violation|10|||
46724538|NCT00811057|82940443|FG002|Overall Study|Protocol Violation|10|||
46724539|NCT00879970|82940454|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
46724540|NCT00879970|82940455|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
46920763|NCT00898677|83152973|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
46920764|NCT00898677|83152974|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
46920765|NCT00898677|83152971|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
46920766|NCT00898677|83152972|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
46920767|NCT00898677|83152973|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
46920768|NCT00898677|83152974|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
46920769|NCT00898677|83152971|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
46920770|NCT00898677|83152972|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
46920771|NCT00898677|83152973|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
46920772|NCT00898677|83152974|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
46920773|NCT00898677|83152971|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
46920774|NCT00898677|83152972|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
46920775|NCT00898677|83152973|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
46634423|NCT01697592|82807937|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46634424|NCT01697592|82807938|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
46634425|NCT01697592|82807939|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46634426|NCT01697592|82807940|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46634427|NCT01697592|82807941|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46634428|NCT01697592|82807942|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
46634429|NCT01697592|82807933|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
46634430|NCT01697592|82807934|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634431|NCT01697592|82807935|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634432|NCT01697592|82807936|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634433|NCT01697592|82807937|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634434|NCT01697592|82807938|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634435|NCT01697592|82807939|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634436|NCT01697592|82807940|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634437|NCT01697592|82807941|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634438|NCT01697592|82807942|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
46634439|NCT01697592|82807933|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
46634440|NCT01697592|82807934|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
46634441|NCT01697592|82807935|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
46634442|NCT01697592|82807936|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
46634443|NCT01697592|82807937|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
46634444|NCT01697592|82807938|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
46634445|NCT01697592|82807939|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
46634446|NCT01697592|82807940|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
46634447|NCT01697592|82807941|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
46634448|NCT01697592|82807942|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
46634449|NCT01697592|82807933|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
46724541|NCT00879970|82940456|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
46724542|NCT00879970|82940457|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
46724543|NCT00879970|82940458|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
46724544|NCT00879970|82940454|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
46724545|NCT00879970|82940455|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
46724546|NCT00879970|82940456|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
46724547|NCT00879970|82940457|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
46724548|NCT00879970|82940458|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
46724549|NCT00879970|82940454|FG000|Period 1 TZD Randomization|Death|2|||
46724550|NCT00879970|82940455|FG001|Period 1 TZD Randomization|Death|1|||
46724551|NCT00879970|82940456|FG002|Period 1 TZD Randomization|Death|0|||
46724552|NCT00879970|82940457|FG003|Period 1 TZD Randomization|Death|0|||
46724553|NCT00879970|82940458|FG004|Period 1 TZD Randomization|Death|0|||
46724554|NCT00879970|82940454|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
46724555|NCT00879970|82940455|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
46724556|NCT00879970|82940456|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
46724557|NCT00879970|82940457|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
46724558|NCT00879970|82940458|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
46724559|NCT00879970|82940454|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
46724560|NCT00879970|82940455|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
46724561|NCT00879970|82940456|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
46724562|NCT00879970|82940457|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
46724563|NCT00879970|82940458|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
46724564|NCT00879970|82940454|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
46724565|NCT00879970|82940455|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
46724566|NCT00879970|82940456|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
46724567|NCT00879970|82940457|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
46724568|NCT00879970|82940458|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
46724569|NCT00879970|82940454|FG000|Period 2 Vitamin D Randomization|Death|0|||
46724570|NCT00879970|82940455|FG001|Period 2 Vitamin D Randomization|Death|0|||
46724571|NCT00879970|82940456|FG002|Period 2 Vitamin D Randomization|Death|0|||
46724572|NCT00879970|82940457|FG003|Period 2 Vitamin D Randomization|Death|2|||
46724573|NCT00879970|82940458|FG004|Period 2 Vitamin D Randomization|Death|0|||
46724574|NCT00808639|82940476|FG000|Overall Study|Disease progression before surgery.|1|||
46724575|NCT00810901|82940482|FG000|Overall Study|Lost to Follow-up|88|||
46724576|NCT00810901|82940483|FG001|Overall Study|Lost to Follow-up|58|||
46724577|NCT00910299|82940491|FG000|Overall Study|Withdrawal by Subject|16|||
46724578|NCT00910299|82940492|FG001|Overall Study|Withdrawal by Subject|13|||
46724579|NCT00910299|82940491|FG000|Overall Study|Sponsor Decision|58|||
46724580|NCT00910299|82940492|FG001|Overall Study|Sponsor Decision|60|||
46724581|NCT00910299|82940491|FG000|Overall Study|Didn't receive any study drug|2|||
46724582|NCT00910299|82940492|FG001|Overall Study|Didn't receive any study drug|1|||
46724583|NCT00595504|82940500|FG000|Overall Study|Withdrawal by Subject|1|||
46724584|NCT00595504|82940501|FG001|Overall Study|Withdrawal by Subject|3|||
46724585|NCT00595504|82940500|FG000|Overall Study|Physician Decision|1|||
46724586|NCT00595504|82940501|FG001|Overall Study|Physician Decision|0|||
46724587|NCT00808483|82940509|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
46724588|NCT00808483|82940510|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
46724589|NCT00808483|82940509|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
46724590|NCT00808483|82940510|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
46724591|NCT00808483|82940509|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
47045334|NCT04146363|83303387|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47045335|NCT04146363|83303388|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
47045336|NCT04146363|83303389|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
47045337|NCT04146363|83303390|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
47045338|NCT04146363|83303380|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045339|NCT04146363|83303381|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045340|NCT04146363|83303382|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045341|NCT04146363|83303383|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045342|NCT04146363|83303384|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46724592|NCT00808483|82940510|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
46724593|NCT00810511|82940525|FG000|Overall Study|Protocol Violation|0|||
46724594|NCT00810511|82940526|FG001|Overall Study|Protocol Violation|1|||
46724595|NCT00810511|82940525|FG000|Overall Study|Lack of Efficacy|9|||
46724596|NCT00810511|82940526|FG001|Overall Study|Lack of Efficacy|1|||
46724597|NCT00810511|82940525|FG000|Overall Study|death in the family|0|||
46724598|NCT00810511|82940526|FG001|Overall Study|death in the family|1|||
46724599|NCT00810511|82940525|FG000|Overall Study|Lost to Follow-up|1|||
46724600|NCT00810511|82940526|FG001|Overall Study|Lost to Follow-up|0|||
46724601|NCT00810511|82940525|FG000|Overall Study|deposits on contact lens|0|||
46724602|NCT00810511|82940526|FG001|Overall Study|deposits on contact lens|1|||
46724603|NCT00596362|82940532|FG000|Overall Study|Progressive Disease|1|||
46724604|NCT00907803|82940539|FG000|Overall Study|Withdrawal of consent - long commute|1|||
46724605|NCT00907803|82940540|FG001|Overall Study|Withdrawal of consent - long commute|0|||
46724606|NCT00907803|82940541|FG002|Overall Study|Withdrawal of consent - long commute|0|||
46724607|NCT00907803|82940539|FG000|Overall Study|Adverse Event|2|||
46724608|NCT00907803|82940540|FG001|Overall Study|Adverse Event|0|||
46724609|NCT00907803|82940541|FG002|Overall Study|Adverse Event|0|||
46724610|NCT00907803|82940539|FG000|Overall Study|Withdrawal by Subject|0|||
46724611|NCT00907803|82940540|FG001|Overall Study|Withdrawal by Subject|1|||
46724612|NCT00907803|82940541|FG002|Overall Study|Withdrawal by Subject|0|||
46724613|NCT00907803|82940539|FG000|Overall Study|Lost to Follow-up|0|||
46724614|NCT00907803|82940540|FG001|Overall Study|Lost to Follow-up|1|||
46724615|NCT00907803|82940541|FG002|Overall Study|Lost to Follow-up|0|||
46724616|NCT00907803|82940539|FG000|Overall Study|Protocol Violation|0|||
46724617|NCT00907803|82940540|FG001|Overall Study|Protocol Violation|1|||
46724618|NCT00907803|82940541|FG002|Overall Study|Protocol Violation|0|||
46724619|NCT00808249|82940553|FG000|Overall Study|Adverse Event|4|||
46724620|NCT00808249|82940554|FG001|Overall Study|Adverse Event|7|||
46724621|NCT00808249|82940555|FG002|Overall Study|Adverse Event|10|||
46634450|NCT01697592|82807934|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
46634451|NCT01697592|82807935|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
46634452|NCT01697592|82807936|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
46634453|NCT01697592|82807937|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
46634454|NCT01697592|82807938|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
46634455|NCT01697592|82807939|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
46634456|NCT01697592|82807940|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
46634457|NCT01697592|82807941|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
46634458|NCT01697592|82807942|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
46634459|NCT01697592|82807933|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
46634460|NCT01697592|82807934|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46634461|NCT01697592|82807935|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46724622|NCT00808249|82940556|FG003|Overall Study|Adverse Event|6|||
46724623|NCT00808249|82940553|FG000|Overall Study|Lost to Follow-up|2|||
46724624|NCT00808249|82940554|FG001|Overall Study|Lost to Follow-up|3|||
46724625|NCT00808249|82940555|FG002|Overall Study|Lost to Follow-up|3|||
46724626|NCT00808249|82940556|FG003|Overall Study|Lost to Follow-up|5|||
46724627|NCT00808249|82940553|FG000|Overall Study|Withdrawal by Subject|4|||
46724628|NCT00808249|82940554|FG001|Overall Study|Withdrawal by Subject|0|||
46724629|NCT00808249|82940555|FG002|Overall Study|Withdrawal by Subject|2|||
46724630|NCT00808249|82940556|FG003|Overall Study|Withdrawal by Subject|4|||
46724631|NCT00808249|82940553|FG000|Overall Study|Protocol Violation|3|||
46724632|NCT00808249|82940554|FG001|Overall Study|Protocol Violation|3|||
46724633|NCT00808249|82940555|FG002|Overall Study|Protocol Violation|3|||
46724634|NCT00808249|82940556|FG003|Overall Study|Protocol Violation|0|||
46724635|NCT00808249|82940553|FG000|Overall Study|Lack of Efficacy|1|||
46724636|NCT00808249|82940554|FG001|Overall Study|Lack of Efficacy|1|||
46724637|NCT00808249|82940555|FG002|Overall Study|Lack of Efficacy|0|||
46724638|NCT00808249|82940556|FG003|Overall Study|Lack of Efficacy|0|||
46724639|NCT00808249|82940553|FG000|Overall Study|study specific discontinuation criteria|1|||
46724640|NCT00808249|82940554|FG001|Overall Study|study specific discontinuation criteria|0|||
46920776|NCT00898677|83152974|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
46920777|NCT00898677|83152971|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
46920778|NCT00898677|83152972|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
46920779|NCT00898677|83152973|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
46920780|NCT00898677|83152974|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
46724641|NCT00808249|82940555|FG002|Overall Study|study specific discontinuation criteria|1|||
46724642|NCT00808249|82940556|FG003|Overall Study|study specific discontinuation criteria|0|||
46724643|NCT00808249|82940553|FG000|Overall Study|All other reasons|2|||
46724644|NCT00808249|82940554|FG001|Overall Study|All other reasons|1|||
46920781|NCT00898677|83152971|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
46634462|NCT01697592|82807936|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
46634463|NCT01697592|82807937|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46724645|NCT00808249|82940555|FG002|Overall Study|All other reasons|3|||
46724646|NCT00808249|82940556|FG003|Overall Study|All other reasons|1|||
46724647|NCT00908895|82940568|FG000|Overall Study|Lost to Follow-up|1|||
46724648|NCT00908895|82940569|FG001|Overall Study|Lost to Follow-up|3|||
46724649|NCT00908895|82940568|FG000|Overall Study|algodystrophy|2|||
46724650|NCT00908895|82940569|FG001|Overall Study|algodystrophy|2|||
46724651|NCT00908895|82940568|FG000|Overall Study|Adverse Event|1|||
46724652|NCT00908895|82940569|FG001|Overall Study|Adverse Event|1|||
46724653|NCT00591253|82940578|FG000|Overall Study|Adverse Event|3|||
46724654|NCT00591253|82940579|FG001|Overall Study|Adverse Event|3|||
46920782|NCT00898677|83152972|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
46920783|NCT00898677|83152973|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
46920784|NCT00898677|83152974|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
46920785|NCT02770820|83152984|FG000|Overall Study|Death|1|||
46920786|NCT02770820|83152984|FG000|Overall Study|Physician Decision|2|||
46920787|NCT03082729|83152988|FG000|Overall Study|Lost to Follow-up|7|||
46920788|NCT03082729|83152988|FG000|Overall Study|Physician Decision|2|||
46920789|NCT03082729|83152988|FG000|Overall Study|Withdrawal by Subject|1|||
46920790|NCT03082729|83152988|FG000|Overall Study|Lack of Efficacy|9|||
46724655|NCT00591253|82940580|FG002|Overall Study|Adverse Event|1|||
46724656|NCT00591253|82940578|FG000|Overall Study|Protocol Violation|2|||
46724657|NCT00591253|82940579|FG001|Overall Study|Protocol Violation|2|||
46724658|NCT00591253|82940580|FG002|Overall Study|Protocol Violation|2|||
46920791|NCT03082729|83152988|FG000|Overall Study|Adverse Event|4|||
46920792|NCT03082729|83152988|FG000|Overall Study|Protocol Violation|6|||
46920793|NCT03082729|83152988|FG000|Overall Study|Fear of study procedure|1|||
46920794|NCT03082729|83152988|FG000|Overall Study|Scheduling conflict|1|||
46920795|NCT02764190|83153000|FG000|Overall Study|Lost to Follow-up|17|||
46920796|NCT02764190|83153001|FG001|Overall Study|Lost to Follow-up|13|||
46920797|NCT03077659|83153010|FG000|Overall Study|Withdrawal by Subject|0|||
46920798|NCT03077659|83153011|FG001|Overall Study|Withdrawal by Subject|0|||
46920799|NCT03077659|83153012|FG002|Overall Study|Withdrawal by Subject|1|||
46920800|NCT02807883|83153023|FG000|Overall Study|Withdrawal by Subject|2|||
46920801|NCT03082261|83153027|FG000|Overall Study|Death|4|||
47045343|NCT04146363|83303385|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045344|NCT04146363|83303386|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045345|NCT04146363|83303387|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045346|NCT04146363|83303388|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
47045347|NCT04146363|83303389|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
46724659|NCT00591253|82940578|FG000|Overall Study|Lost to Follow-up|2|||
46724660|NCT00591253|82940579|FG001|Overall Study|Lost to Follow-up|4|||
46724661|NCT00591253|82940580|FG002|Overall Study|Lost to Follow-up|0|||
46724662|NCT00591253|82940578|FG000|Overall Study|Withdrawal by Subject|1|||
46724663|NCT00591253|82940579|FG001|Overall Study|Withdrawal by Subject|7|||
46724664|NCT00591253|82940580|FG002|Overall Study|Withdrawal by Subject|6|||
46724665|NCT00591253|82940578|FG000|Overall Study|Lack of Efficacy|1|||
46724666|NCT00591253|82940579|FG001|Overall Study|Lack of Efficacy|0|||
46724667|NCT00591253|82940580|FG002|Overall Study|Lack of Efficacy|3|||
46724668|NCT00591253|82940578|FG000|Overall Study|Other|5|||
46724669|NCT00591253|82940579|FG001|Overall Study|Other|5|||
46724670|NCT00591253|82940580|FG002|Overall Study|Other|3|||
46724671|NCT00908583|82940588|FG000|Phase 1|Withdrawal by Subject|1|||
46724672|NCT00908583|82940588|FG000|Phase 1|Adverse Event|4|||
46724673|NCT00908583|82940588|FG000|Phase 2|Physician Decision|1|||
46724674|NCT00908583|82940588|FG000|Phase 2|Adverse Event|1|||
46724675|NCT00908583|82940588|FG000|Phase 3|Adverse Event|2|||
46724676|NCT00908583|82940588|FG000|Phase 4|Adverse Event|1|||
46724677|NCT00908583|82940588|FG000|Phase 4|Physician Decision|1|||
46724678|NCT00908583|82940588|FG000|Phase 5|Adverse Event|3|||
46724679|NCT00909363|82940609|FG000|Overall Study|Withdrawal by Subject|1|||
46724680|NCT00909363|82940610|FG001|Overall Study|Withdrawal by Subject|0|||
46724681|NCT00909363|82940611|FG002|Overall Study|Withdrawal by Subject|0|||
46724682|NCT00909363|82940609|FG000|Overall Study|Lack of Efficacy|1|||
46724683|NCT00909363|82940610|FG001|Overall Study|Lack of Efficacy|0|||
46724684|NCT00909363|82940611|FG002|Overall Study|Lack of Efficacy|0|||
47045348|NCT04146363|83303390|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47045349|NCT04146363|83303380|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
46724685|NCT00810355|82940625|FG000|Overall Study|Lost to Follow-up|13|||
46724686|NCT00810355|82940626|FG001|Overall Study|Lost to Follow-up|17|||
46920802|NCT03082261|83153027|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
46920803|NCT03082261|83153027|FG000|Overall Study|Insurance denial|1|||
47045350|NCT04146363|83303381|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
46724687|NCT00810355|82940627|FG002|Overall Study|Lost to Follow-up|11|||
46724688|NCT00810355|82940625|FG000|Overall Study|Withdrawal by Subject|1|||
46724689|NCT00810355|82940626|FG001|Overall Study|Withdrawal by Subject|0|||
46724690|NCT00810355|82940627|FG002|Overall Study|Withdrawal by Subject|0|||
46724691|NCT00908349|82940635|FG000|Overall Study|Adverse Event|10|||
46724692|NCT00908349|82940635|FG000|Overall Study|Withdrawal by Subject|9|||
46724693|NCT00908349|82940635|FG000|Overall Study|Physician Decision|5|||
46724694|NCT00908349|82940635|FG000|Overall Study|Lost to Follow-up|5|||
46724695|NCT00908349|82940635|FG000|Overall Study|Various|6|||
46724696|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
46920804|NCT03082261|83153027|FG000|Overall Study|Peripheral lead added|1|||
46920805|NCT03082261|83153027|FG000|Overall Study|Withdrawal by Subject|40|||
46724697|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
46724698|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
46724699|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
46724700|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
46724701|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
46724702|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
46724703|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
46724704|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
46724705|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
46724706|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
46724707|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
46724708|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
46724709|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
46724710|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
46724711|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
46724712|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
46724713|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
46724714|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
46724715|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
46724716|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
46724717|NCT01125566|82940641|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
46724718|NCT01125566|82940642|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
46724719|NCT01125566|82940643|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
46724720|NCT01125566|82940641|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
46724721|NCT01125566|82940642|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
46724722|NCT01125566|82940643|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
46724723|NCT01125566|82940641|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
46724724|NCT01125566|82940642|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
46724725|NCT01125566|82940643|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
46724726|NCT01125566|82940641|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
46724727|NCT01125566|82940642|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
46724728|NCT01125566|82940643|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
46724729|NCT01125566|82940641|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
46724730|NCT01125566|82940642|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
46920806|NCT03082261|83153027|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
46920807|NCT03082261|83153027|FG000|Overall Study|Subject implanted with device other than study device|1|||
46920808|NCT03082261|83153027|FG000|Overall Study|Lost to Follow-up|14|||
47045351|NCT04146363|83303382|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
47045352|NCT04146363|83303383|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
47045353|NCT04146363|83303384|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
47045354|NCT04146363|83303385|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
47045355|NCT04146363|83303386|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
47045356|NCT04146363|83303387|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
47045357|NCT04146363|83303388|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
47045358|NCT04146363|83303389|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
47045359|NCT04146363|83303390|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
47045360|NCT04146363|83303380|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47045361|NCT04146363|83303381|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47045362|NCT04146363|83303382|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47045363|NCT04146363|83303383|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47045364|NCT04146363|83303384|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47045365|NCT04146363|83303385|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46634464|NCT01697592|82807938|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46634465|NCT01697592|82807939|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46634466|NCT01697592|82807940|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46634467|NCT01697592|82807941|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46634468|NCT01697592|82807942|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
46634469|NCT01697592|82807933|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
46634470|NCT01697592|82807934|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
46634471|NCT01697592|82807935|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
46634472|NCT01697592|82807936|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
46634473|NCT01697592|82807937|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
46634474|NCT01697592|82807938|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
46634475|NCT01697592|82807939|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
46724731|NCT01125566|82940643|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
46724732|NCT00810277|82940650|FG000|Overall Study|Adverse Event|1|||
46724733|NCT00595582|82940654|FG000|Overall Study|Pilot study that PI terminated|2|||
47045366|NCT04146363|83303386|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47045367|NCT04146363|83303387|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47045368|NCT04146363|83303388|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
47045369|NCT04146363|83303389|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
47045370|NCT04146363|83303390|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
47045371|NCT04146363|83303380|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045372|NCT04146363|83303381|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
46724734|NCT00595582|82940654|FG000|Overall Study|Lost to Follow-up|1|||
46724735|NCT00595582|82940654|FG000|Overall Study|Adverse Event|2|||
46724736|NCT00595582|82940654|FG000|Overall Study|Physician Decision|5|||
46724737|NCT00808015|82940658|FG000|Overall Study|Death|1|||
46724738|NCT00808015|82940658|FG000|Overall Study|Lack of Efficacy|58|||
46724739|NCT00808015|82940658|FG000|Overall Study|Lost to Follow-up|76|||
46724740|NCT00808015|82940658|FG000|Overall Study|Participants not willing to participate|158|||
46724741|NCT00808015|82940658|FG000|Overall Study|Adverse Event|22|||
46724742|NCT00808015|82940658|FG000|Overall Study|Other|25|||
46724743|NCT00808015|82940658|FG000|Overall Study|Enrolled but not treated|4|||
46724744|NCT00810199|82940664|FG000|Overall Study|Adverse Event|24|||
46724745|NCT00810199|82940665|FG001|Overall Study|Adverse Event|26|||
46724746|NCT00810199|82940664|FG000|Overall Study|Death|4|||
46724747|NCT00810199|82940665|FG001|Overall Study|Death|6|||
46724748|NCT00810199|82940664|FG000|Overall Study|Withdrew consent|9|||
46724749|NCT00810199|82940665|FG001|Overall Study|Withdrew consent|12|||
46724750|NCT00810199|82940664|FG000|Overall Study|Insufficient therapeutic response|5|||
46724751|NCT00810199|82940665|FG001|Overall Study|Insufficient therapeutic response|14|||
46724752|NCT00810199|82940664|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
46724753|NCT00810199|82940665|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
46724754|NCT00810199|82940664|FG000|Overall Study|Administrative/Other|5|||
46724755|NCT00810199|82940665|FG001|Overall Study|Administrative/Other|6|||
46920809|NCT03082261|83153027|FG000|Overall Study|Subject moved to a different state|1|||
46724756|NCT00810199|82940664|FG000|Overall Study|Protocol Violation|2|||
46920810|NCT03082261|83153027|FG000|Overall Study|Subject non-compliance|2|||
47045373|NCT04146363|83303382|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045374|NCT04146363|83303383|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045375|NCT04146363|83303384|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045376|NCT04146363|83303385|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045377|NCT04146363|83303386|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045378|NCT04146363|83303387|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045379|NCT04146363|83303388|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
47045380|NCT04146363|83303389|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
47045381|NCT04146363|83303390|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
46724757|NCT00810199|82940665|FG001|Overall Study|Protocol Violation|6|||
46724758|NCT00810199|82940664|FG000|Overall Study|Failure to return|1|||
46724759|NCT00810199|82940665|FG001|Overall Study|Failure to return|4|||
46724760|NCT00810199|82940664|FG000|Overall Study|Did not receive study drug|2|||
46724761|NCT00810199|82940665|FG001|Overall Study|Did not receive study drug|1|||
46724762|NCT00877006|82940679|FG000|Treatment Period|Death|2|||
46724763|NCT00877006|82940680|FG001|Treatment Period|Death|1|||
46724764|NCT00877006|82940679|FG000|Treatment Period|Adverse Event|10|||
46724765|NCT00877006|82940680|FG001|Treatment Period|Adverse Event|3|||
46724766|NCT00877006|82940679|FG000|Treatment Period|Withdrawal by Subject|2|||
46724767|NCT00877006|82940680|FG001|Treatment Period|Withdrawal by Subject|3|||
46724768|NCT00877006|82940679|FG000|Treatment Period|Protocol Violation|1|||
46724769|NCT00877006|82940680|FG001|Treatment Period|Protocol Violation|0|||
46724770|NCT00877006|82940679|FG000|Treatment Period|Lost to Follow-up|0|||
46724771|NCT00877006|82940680|FG001|Treatment Period|Lost to Follow-up|1|||
46724772|NCT00877006|82940679|FG000|Treatment Period|Disease Progression|1|||
46724773|NCT00877006|82940680|FG001|Treatment Period|Disease Progression|2|||
46724774|NCT00877006|82940679|FG000|Treatment Period|Started New Treatment Regimen|2|||
46724775|NCT00877006|82940680|FG001|Treatment Period|Started New Treatment Regimen|5|||
46724776|NCT00877006|82940679|FG000|Treatment Period|Other|4|||
46724777|NCT00877006|82940680|FG001|Treatment Period|Other|4|||
46724778|NCT00877006|82940679|FG000|Treatment Period|Randomized but Not Treated|3|||
46724779|NCT00877006|82940680|FG001|Treatment Period|Randomized but Not Treated|8|||
46724780|NCT00877006|82940679|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
46724781|NCT00877006|82940680|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
46724782|NCT00877006|82940679|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
46724783|NCT00877006|82940680|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
46724784|NCT00877006|82940679|FG000|Long-Term Follow-up Period|Death|26|||
46724785|NCT00877006|82940680|FG001|Long-Term Follow-up Period|Death|18|||
46724786|NCT00877006|82940679|FG000|Long-Term Follow-up Period|Other|7|||
46724787|NCT00877006|82940680|FG001|Long-Term Follow-up Period|Other|9|||
46724788|NCT00876928|82940690|FG000|Overall Study|Lost to Follow-up|2|||
46724789|NCT00876928|82940691|FG001|Overall Study|Lost to Follow-up|5|||
46724790|NCT00876928|82940690|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
46724791|NCT00876928|82940691|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
46724792|NCT00807937|82940701|FG000|Overall Study|Adverse Event|12|||
46724793|NCT00807937|82940702|FG001|Overall Study|Adverse Event|12|||
46724794|NCT00807937|82940703|FG002|Overall Study|Adverse Event|5|||
46724795|NCT00807937|82940704|FG003|Overall Study|Adverse Event|4|||
46724796|NCT00807937|82940701|FG000|Overall Study|Protocol Violation|4|||
46724797|NCT00807937|82940702|FG001|Overall Study|Protocol Violation|5|||
46724798|NCT00807937|82940703|FG002|Overall Study|Protocol Violation|3|||
46724799|NCT00807937|82940704|FG003|Overall Study|Protocol Violation|3|||
46724800|NCT00807937|82940701|FG000|Overall Study|Withdrawal by Subject|5|||
46724801|NCT00807937|82940702|FG001|Overall Study|Withdrawal by Subject|4|||
46724802|NCT00807937|82940703|FG002|Overall Study|Withdrawal by Subject|1|||
46724803|NCT00807937|82940704|FG003|Overall Study|Withdrawal by Subject|4|||
46724804|NCT00807937|82940701|FG000|Overall Study|Lost to Follow-up|4|||
46724805|NCT00807937|82940702|FG001|Overall Study|Lost to Follow-up|0|||
46724806|NCT00807937|82940703|FG002|Overall Study|Lost to Follow-up|2|||
46724807|NCT00807937|82940704|FG003|Overall Study|Lost to Follow-up|1|||
46724808|NCT00807937|82940701|FG000|Overall Study|Lack of Efficacy|0|||
46724809|NCT00807937|82940702|FG001|Overall Study|Lack of Efficacy|0|||
46724810|NCT00807937|82940703|FG002|Overall Study|Lack of Efficacy|1|||
46724811|NCT00807937|82940704|FG003|Overall Study|Lack of Efficacy|2|||
46724812|NCT00807937|82940701|FG000|Overall Study|Intake of prohibited medicine|0|||
46724813|NCT00807937|82940702|FG001|Overall Study|Intake of prohibited medicine|0|||
46724814|NCT00807937|82940703|FG002|Overall Study|Intake of prohibited medicine|2|||
46724815|NCT00807937|82940704|FG003|Overall Study|Intake of prohibited medicine|0|||
46724816|NCT00807937|82940701|FG000|Overall Study|All other reasons (not provided)|2|||
46724817|NCT00807937|82940702|FG001|Overall Study|All other reasons (not provided)|4|||
46724818|NCT00807937|82940703|FG002|Overall Study|All other reasons (not provided)|0|||
46634476|NCT01697592|82807940|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
46634477|NCT01697592|82807941|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
46634478|NCT01697592|82807942|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
46634479|NCT01697592|82807933|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
46634480|NCT01697592|82807934|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
46634481|NCT01697592|82807935|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
46634482|NCT01697592|82807936|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
46634483|NCT01697592|82807937|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
46634484|NCT01697592|82807938|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
46634485|NCT01697592|82807939|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
46724819|NCT00807937|82940704|FG003|Overall Study|All other reasons (not provided)|1|||
46724820|NCT00906945|82940719|FG000|Overall Study|Found to be not eligible|0|||
46724821|NCT00906945|82940720|FG001|Overall Study|Found to be not eligible|0|||
46724822|NCT00906945|82940721|FG002|Overall Study|Found to be not eligible|0|||
46724823|NCT00906945|82940722|FG003|Overall Study|Found to be not eligible|1|||
46724824|NCT00906945|82940723|FG004|Overall Study|Found to be not eligible|1|||
46724825|NCT00906945|82940724|FG005|Overall Study|Found to be not eligible|1|||
46724826|NCT00906945|82940719|FG000|Overall Study|Physician Decision|0|||
46724827|NCT00906945|82940720|FG001|Overall Study|Physician Decision|0|||
46724828|NCT00906945|82940721|FG002|Overall Study|Physician Decision|0|||
46724829|NCT00906945|82940722|FG003|Overall Study|Physician Decision|0|||
46724830|NCT00906945|82940723|FG004|Overall Study|Physician Decision|0|||
46724831|NCT00906945|82940724|FG005|Overall Study|Physician Decision|1|||
46724832|NCT00807235|82940742|FG000|Overall Study|Adverse Event|1|||
46920811|NCT03082261|83153027|FG000|Overall Study|Subject participation terminated by investigator|9|||
46634486|NCT01697592|82807940|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
46920812|NCT03082261|83153027|FG000|Overall Study|Subject participation terminated by sponsor|4|||
46920813|NCT03082261|83153027|FG000|Overall Study|System explant|19|||
46920814|NCT03082261|83153027|FG000|Overall Study|Unable to place lead(s)|2|||
46920815|NCT03082261|83153027|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
46920816|NCT00102440|83153034|FG000|Overall Study|Lost to Follow-up|25|||
46920817|NCT00102440|83153035|FG001|Overall Study|Lost to Follow-up|18|||
46920818|NCT00102440|83153036|FG002|Overall Study|Lost to Follow-up|21|||
46920819|NCT00102440|83153034|FG000|Overall Study|Adverse Event|16|||
46920820|NCT00102440|83153035|FG001|Overall Study|Adverse Event|23|||
46920821|NCT00102440|83153036|FG002|Overall Study|Adverse Event|8|||
46634487|NCT01697592|82807941|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
46634488|NCT01697592|82807942|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
46634489|NCT01744782|82807978|FG000|Overall Study|Death|1|||
46920822|NCT00102440|83153034|FG000|Overall Study|Gout Flare|10|||
46920823|NCT00102440|83153035|FG001|Overall Study|Gout Flare|28|||
46724833|NCT00807235|82940743|FG001|Overall Study|Adverse Event|0|||
46724834|NCT00876694|82940751|FG000|Overall Study|Adverse Event|10|||
46724835|NCT00876694|82940752|FG001|Overall Study|Adverse Event|7|||
46724836|NCT00876694|82940751|FG000|Overall Study|Subject withdrew consent|6|||
46724837|NCT00876694|82940752|FG001|Overall Study|Subject withdrew consent|4|||
46724838|NCT00876694|82940751|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46724839|NCT00876694|82940752|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46724840|NCT00876694|82940751|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46724841|NCT00876694|82940752|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46724842|NCT00876694|82940751|FG000|Overall Study|Administrative problems|1|||
46724843|NCT00876694|82940752|FG001|Overall Study|Administrative problems|1|||
46724844|NCT00876694|82940751|FG000|Overall Study|Death|1|||
46724845|NCT00876694|82940752|FG001|Overall Study|Death|0|||
46724846|NCT00805441|82940760|FG000|Overall Study|Adverse Event|5|||
46724847|NCT00805441|82940761|FG001|Overall Study|Adverse Event|2|||
46724848|NCT00805441|82940760|FG000|Overall Study|Lack of Efficacy|0|||
46724849|NCT00805441|82940761|FG001|Overall Study|Lack of Efficacy|2|||
46724850|NCT00805441|82940760|FG000|Overall Study|Protocol Violation|4|||
46724851|NCT00805441|82940761|FG001|Overall Study|Protocol Violation|8|||
46724852|NCT00805441|82940760|FG000|Overall Study|Lost to Follow-up|10|||
46724853|NCT00805441|82940761|FG001|Overall Study|Lost to Follow-up|13|||
46724854|NCT00805441|82940760|FG000|Overall Study|Withdrawal by Subject|15|||
46724855|NCT00805441|82940761|FG001|Overall Study|Withdrawal by Subject|9|||
46724856|NCT00805441|82940760|FG000|Overall Study|Physician Decision|0|||
46724857|NCT00805441|82940761|FG001|Overall Study|Physician Decision|1|||
46724858|NCT00805441|82940760|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
46724859|NCT00805441|82940761|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
46724860|NCT00590317|82940769|FG000|Overall Study|Lack of Efficacy|1|||
46724861|NCT00590317|82940770|FG001|Overall Study|Lack of Efficacy|5|||
46724862|NCT01139762|82940779|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
46724863|NCT01139762|82940780|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
46724864|NCT01139762|82940781|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
46724865|NCT01139762|82940779|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
46724866|NCT01139762|82940780|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
46724867|NCT01139762|82940781|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
46724868|NCT01139762|82940779|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
46724869|NCT01139762|82940780|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
46724870|NCT01139762|82940781|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
46724871|NCT01139762|82940779|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
46920824|NCT00102440|83153036|FG002|Overall Study|Gout Flare|9|||
46920825|NCT00102440|83153034|FG000|Overall Study|Personal Reason(s)|19|||
46920826|NCT00102440|83153035|FG001|Overall Study|Personal Reason(s)|13|||
46920827|NCT00102440|83153036|FG002|Overall Study|Personal Reason(s)|13|||
47045382|NCT04146363|83303380|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
46634490|NCT01744392|82807982|FG000|Overall Study|Physician Decision|1|||
47045383|NCT04146363|83303381|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
46724872|NCT01139762|82940780|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
46920828|NCT00102440|83153034|FG000|Overall Study|Other|11|||
46634491|NCT01604850|82807989|FG000|Overall Study|Enrolled but never treated|0|||
46634492|NCT01604850|82807990|FG001|Overall Study|Enrolled but never treated|1|||
46634493|NCT01604850|82807989|FG000|Overall Study|Efficacy Failure|50|||
46724873|NCT01139762|82940781|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
46724874|NCT01139762|82940779|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
46724875|NCT01139762|82940780|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
46920829|NCT00102440|83153035|FG001|Overall Study|Other|14|||
46920830|NCT00102440|83153036|FG002|Overall Study|Other|14|||
46920831|NCT00102440|83153034|FG000|Overall Study|Protocol Violation|7|||
46920832|NCT00102440|83153035|FG001|Overall Study|Protocol Violation|2|||
47045384|NCT04146363|83303382|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
46634494|NCT01604850|82807990|FG001|Overall Study|Efficacy Failure|29|||
46634495|NCT01604850|82807989|FG000|Overall Study|Lost to Follow-up|1|||
46724876|NCT01139762|82940781|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
46724877|NCT01139762|82940779|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
46724878|NCT01139762|82940780|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
46724879|NCT01139762|82940781|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
46724880|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
46724881|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
46724882|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
46724883|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Death|0|||
46724884|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Death|1|||
46724885|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Death|1|||
46724886|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
46724887|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
46724888|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
46724889|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
46724890|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
46724891|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
46724892|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
46724893|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
46724894|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
46724895|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
46724896|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
46724897|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
46724898|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
46724899|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
46724900|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
46724901|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
46724902|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
46724903|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
46724904|NCT01139762|82940779|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
46724905|NCT01139762|82940780|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
46724906|NCT01139762|82940781|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
46724907|NCT00805285|82940788|FG000|Overall Study|Lack of Efficacy|1|||
46724908|NCT01139450|82940795|FG000|Overall Study|Withdrawal by Subject|7|||
46724909|NCT01139450|82940796|FG001|Overall Study|Withdrawal by Subject|10|||
46724910|NCT01139450|82940797|FG002|Overall Study|Withdrawal by Subject|13|||
46724911|NCT01139450|82940795|FG000|Overall Study|Lack of Efficacy|3|||
46724912|NCT01139450|82940796|FG001|Overall Study|Lack of Efficacy|1|||
46724913|NCT01139450|82940797|FG002|Overall Study|Lack of Efficacy|8|||
46724914|NCT01139450|82940795|FG000|Overall Study|Protocol Violation|6|||
46724915|NCT01139450|82940796|FG001|Overall Study|Protocol Violation|5|||
46724916|NCT01139450|82940797|FG002|Overall Study|Protocol Violation|2|||
46724917|NCT01139450|82940795|FG000|Overall Study|Lost to Follow-up|9|||
46724918|NCT01139450|82940796|FG001|Overall Study|Lost to Follow-up|7|||
46724919|NCT01139450|82940797|FG002|Overall Study|Lost to Follow-up|11|||
46724920|NCT01139450|82940795|FG000|Overall Study|Administrative|0|||
46724921|NCT01139450|82940796|FG001|Overall Study|Administrative|0|||
46724922|NCT01139450|82940797|FG002|Overall Study|Administrative|1|||
46724923|NCT01139450|82940795|FG000|Overall Study|Adverse Event|2|||
46724924|NCT01139450|82940796|FG001|Overall Study|Adverse Event|2|||
46724925|NCT01139450|82940797|FG002|Overall Study|Adverse Event|3|||
46724926|NCT00805207|82940814|FG000|Overall Study|Protocol Violation|0|||
46724927|NCT00805207|82940815|FG001|Overall Study|Protocol Violation|0|||
46724928|NCT00805207|82940816|FG002|Overall Study|Protocol Violation|1|||
46724929|NCT00805207|82940817|FG003|Overall Study|Protocol Violation|0|||
46724930|NCT00805207|82940818|FG004|Overall Study|Protocol Violation|0|||
46724931|NCT00805207|82940819|FG005|Overall Study|Protocol Violation|0|||
46724932|NCT00805207|82940820|FG006|Overall Study|Protocol Violation|0|||
46724933|NCT00805207|82940821|FG007|Overall Study|Protocol Violation|0|||
46724934|NCT00805207|82940822|FG008|Overall Study|Protocol Violation|0|||
46920833|NCT00102440|83153036|FG002|Overall Study|Protocol Violation|1|||
46920834|NCT02762084|83153060|FG000|Overall Study|Withdrawal by Subject|1|||
47045385|NCT04146363|83303383|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
47045386|NCT04146363|83303384|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
46724935|NCT00805207|82940814|FG000|Overall Study|Physician Decision|0|||
46724936|NCT00805207|82940815|FG001|Overall Study|Physician Decision|1|||
46724937|NCT00805207|82940816|FG002|Overall Study|Physician Decision|0|||
46724938|NCT00805207|82940817|FG003|Overall Study|Physician Decision|0|||
46920835|NCT02762084|83153061|FG001|Overall Study|Withdrawal by Subject|0|||
47045387|NCT04146363|83303385|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
46724939|NCT00805207|82940818|FG004|Overall Study|Physician Decision|0|||
46724940|NCT00805207|82940819|FG005|Overall Study|Physician Decision|1|||
46724941|NCT00805207|82940820|FG006|Overall Study|Physician Decision|0|||
46724942|NCT00805207|82940821|FG007|Overall Study|Physician Decision|0|||
46724943|NCT00805207|82940822|FG008|Overall Study|Physician Decision|0|||
46724944|NCT00805207|82940814|FG000|Overall Study|Withdrawal by Subject|0|||
46724945|NCT00805207|82940815|FG001|Overall Study|Withdrawal by Subject|1|||
46724946|NCT00805207|82940816|FG002|Overall Study|Withdrawal by Subject|0|||
46724947|NCT00805207|82940817|FG003|Overall Study|Withdrawal by Subject|0|||
46724948|NCT00805207|82940818|FG004|Overall Study|Withdrawal by Subject|1|||
46724949|NCT00805207|82940819|FG005|Overall Study|Withdrawal by Subject|2|||
46724950|NCT00805207|82940820|FG006|Overall Study|Withdrawal by Subject|0|||
46724951|NCT00805207|82940821|FG007|Overall Study|Withdrawal by Subject|0|||
46724952|NCT00805207|82940822|FG008|Overall Study|Withdrawal by Subject|0|||
46724953|NCT00805675|82940849|FG000|Overall Study|Adverse Event|0|||
46724954|NCT00805675|82940850|FG001|Overall Study|Adverse Event|0|||
46724955|NCT00805675|82940851|FG002|Overall Study|Adverse Event|1|||
46724956|NCT00589303|82940865|FG000|Overall Study|Withdrawal by Subject|2|||
46724957|NCT00589303|82940866|FG001|Overall Study|Withdrawal by Subject|1|||
46724958|NCT00952380|82940877|FG000|Overall Study|Other|0|||
46724959|NCT00952380|82940878|FG001|Overall Study|Other|0|||
46724960|NCT00952380|82940879|FG002|Overall Study|Other|0|||
46724961|NCT00952380|82940880|FG003|Overall Study|Other|0|||
46724962|NCT00952380|82940881|FG004|Overall Study|Other|1|||
46724963|NCT00952380|82940877|FG000|Overall Study|Withdrawal by Subject|0|||
46724964|NCT00952380|82940878|FG001|Overall Study|Withdrawal by Subject|0|||
46724965|NCT00952380|82940879|FG002|Overall Study|Withdrawal by Subject|1|||
46724966|NCT00952380|82940880|FG003|Overall Study|Withdrawal by Subject|0|||
46724967|NCT00952380|82940881|FG004|Overall Study|Withdrawal by Subject|2|||
46724968|NCT00952380|82940877|FG000|Overall Study|Adverse Event|0|||
46724969|NCT00952380|82940878|FG001|Overall Study|Adverse Event|1|||
46724970|NCT00952380|82940879|FG002|Overall Study|Adverse Event|0|||
46724971|NCT00952380|82940880|FG003|Overall Study|Adverse Event|0|||
46724972|NCT00952380|82940881|FG004|Overall Study|Adverse Event|3|||
46724973|NCT00952380|82940877|FG000|Overall Study|Physician Decision|0|||
46724974|NCT00952380|82940878|FG001|Overall Study|Physician Decision|0|||
46724975|NCT00952380|82940879|FG002|Overall Study|Physician Decision|1|||
46724976|NCT00952380|82940880|FG003|Overall Study|Physician Decision|2|||
46724977|NCT00952380|82940881|FG004|Overall Study|Physician Decision|0|||
46724978|NCT00952380|82940877|FG000|Overall Study|Non-compliant to protocol|0|||
46724979|NCT00952380|82940878|FG001|Overall Study|Non-compliant to protocol|0|||
46724980|NCT00952380|82940879|FG002|Overall Study|Non-compliant to protocol|0|||
46724981|NCT00952380|82940880|FG003|Overall Study|Non-compliant to protocol|1|||
46724982|NCT00952380|82940881|FG004|Overall Study|Non-compliant to protocol|0|||
46724983|NCT00803179|82940898|FG000|Overall Study|Lost to Follow-up|3|||
46724984|NCT00804193|82940905|FG000|Overall Study|Lack of baseline fungus|32|||
46724985|NCT00804193|82940906|FG001|Overall Study|Lack of baseline fungus|31|||
46724986|NCT00804193|82940907|FG002|Overall Study|Lack of baseline fungus|19|||
46724987|NCT00804193|82940905|FG000|Overall Study|Adverse Event|0|||
46724988|NCT00804193|82940906|FG001|Overall Study|Adverse Event|0|||
46724989|NCT00804193|82940907|FG002|Overall Study|Adverse Event|2|||
46724990|NCT00804193|82940905|FG000|Overall Study|Lack of Efficacy|1|||
46724991|NCT00804193|82940906|FG001|Overall Study|Lack of Efficacy|1|||
46724992|NCT00804193|82940907|FG002|Overall Study|Lack of Efficacy|3|||
46920836|NCT02762084|83153062|FG002|Overall Study|Withdrawal by Subject|0|||
47045388|NCT04146363|83303386|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
47045389|NCT04146363|83303387|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
47045390|NCT04146363|83303388|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
47045391|NCT04146363|83303389|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
47045392|NCT04146363|83303390|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
47045393|NCT01838941|83303415|FG000|Overall Study|Adverse Event|1|||
47045394|NCT01838941|83303415|FG000|Overall Study|Withdrawal by Subject|1|||
47045395|NCT01773109|83303420|FG000|Overall Study|Symptomatic Progression|2|||
47045396|NCT01773109|83303420|FG000|Overall Study|Death|1|||
47045397|NCT01772719|83303424|FG000|Overall Study|Withdrawal by Subject|3|||
46724993|NCT00804193|82940905|FG000|Overall Study|Protocol Violation|0|||
46724994|NCT00804193|82940906|FG001|Overall Study|Protocol Violation|8|||
46724995|NCT00804193|82940907|FG002|Overall Study|Protocol Violation|2|||
46724996|NCT00804193|82940905|FG000|Overall Study|Lost to Follow-up|3|||
46724997|NCT00804193|82940906|FG001|Overall Study|Lost to Follow-up|3|||
46724998|NCT00804193|82940907|FG002|Overall Study|Lost to Follow-up|4|||
46920837|NCT02762084|83153060|FG000|Overall Study|Adverse Event|0|||
46724999|NCT00804193|82940905|FG000|Overall Study|Withdrawal by Subject|3|||
46725000|NCT00804193|82940906|FG001|Overall Study|Withdrawal by Subject|1|||
46725001|NCT00804193|82940907|FG002|Overall Study|Withdrawal by Subject|2|||
46725002|NCT00957996|82940917|FG000|Overall Study|Death|4|||
46725003|NCT00957996|82940918|FG001|Overall Study|Death|10|||
46725004|NCT00957996|82940917|FG000|Overall Study|Lost to Follow-up|4|||
46725005|NCT00957996|82940918|FG001|Overall Study|Lost to Follow-up|7|||
46725006|NCT00957996|82940917|FG000|Overall Study|Withdrawal by Subject|9|||
46920838|NCT02762084|83153061|FG001|Overall Study|Adverse Event|0|||
46725007|NCT00957996|82940918|FG001|Overall Study|Withdrawal by Subject|2|||
46725008|NCT00957996|82940917|FG000|Overall Study|Adverse Event|2|||
46725009|NCT00957996|82940918|FG001|Overall Study|Adverse Event|1|||
46725010|NCT00957996|82940917|FG000|Overall Study|Physician Decision|1|||
46725011|NCT00957996|82940918|FG001|Overall Study|Physician Decision|1|||
46725012|NCT00957996|82940917|FG000|Overall Study|Influenza-related complication|0|||
46725013|NCT00957996|82940918|FG001|Overall Study|Influenza-related complication|1|||
46725014|NCT00957996|82940917|FG000|Overall Study|Missing|1|||
46725015|NCT00957996|82940918|FG001|Overall Study|Missing|0|||
46725016|NCT00957996|82940917|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
46725017|NCT00957996|82940918|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
46725018|NCT00589693|82940928|FG000|Overall Study|randomized in error|12|||
46725019|NCT00589693|82940929|FG001|Overall Study|randomized in error|6|||
46725020|NCT00589693|82940928|FG000|Overall Study|Adverse Event|4|||
46725021|NCT00589693|82940929|FG001|Overall Study|Adverse Event|4|||
46725022|NCT00589693|82940928|FG000|Overall Study|Death|26|||
46725023|NCT00589693|82940929|FG001|Overall Study|Death|16|||
46725024|NCT00589693|82940928|FG000|Overall Study|Lack of Efficacy|0|||
46725025|NCT00589693|82940929|FG001|Overall Study|Lack of Efficacy|1|||
46725026|NCT00589693|82940928|FG000|Overall Study|Lost to Follow-up|1|||
46725027|NCT00589693|82940929|FG001|Overall Study|Lost to Follow-up|0|||
46725028|NCT00589693|82940928|FG000|Overall Study|Physician Decision|0|||
46725029|NCT00589693|82940929|FG001|Overall Study|Physician Decision|1|||
46725030|NCT00589693|82940928|FG000|Overall Study|Protocol Violation|1|||
46725031|NCT00589693|82940929|FG001|Overall Study|Protocol Violation|1|||
46725032|NCT00803101|82940937|FG000|Overall Study|Death / Serious Adverse Event|4|||
46725033|NCT00803101|82940938|FG001|Overall Study|Death / Serious Adverse Event|6|||
46725034|NCT00803101|82940937|FG000|Overall Study|Withdrawal by Subject|6|||
46725035|NCT00803101|82940938|FG001|Overall Study|Withdrawal by Subject|4|||
46725036|NCT00803101|82940937|FG000|Overall Study|Lost to Follow-up|2|||
46725037|NCT00803101|82940938|FG001|Overall Study|Lost to Follow-up|2|||
46725038|NCT00803101|82940937|FG000|Overall Study|Protocol Violation|1|||
46725039|NCT00803101|82940938|FG001|Overall Study|Protocol Violation|7|||
46725040|NCT00803101|82940937|FG000|Overall Study|Surgery finished outside protocol window|1|||
46725041|NCT00803101|82940938|FG001|Overall Study|Surgery finished outside protocol window|1|||
46725042|NCT00803101|82940937|FG000|Overall Study|Patient died outside SAE report period|1|||
46725043|NCT00803101|82940938|FG001|Overall Study|Patient died outside SAE report period|0|||
46725044|NCT00803101|82940937|FG000|Overall Study|Patient did not attend scheduled visit|2|||
46725045|NCT00803101|82940938|FG001|Overall Study|Patient did not attend scheduled visit|1|||
46725046|NCT00803101|82940937|FG000|Overall Study|Patient did not have surgery|1|||
46725047|NCT00803101|82940938|FG001|Overall Study|Patient did not have surgery|1|||
46725048|NCT00801229|82940946|FG000|Signed Consent|Withdrawal by Subject|2|||
46725049|NCT00801229|82940947|FG001|Signed Consent|Withdrawal by Subject|2|||
46725050|NCT00801229|82940946|FG000|Signed Consent|Found Ineligible|1|||
46725051|NCT00801229|82940947|FG001|Signed Consent|Found Ineligible|1|||
46725052|NCT00801229|82940946|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
46725053|NCT00801229|82940947|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
46725054|NCT00801229|82940946|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
46725055|NCT00801229|82940947|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
46725056|NCT00801229|82940946|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
46725057|NCT00801229|82940947|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
46725058|NCT00801229|82940946|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
46725059|NCT00801229|82940947|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
46725060|NCT00801229|82940946|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
46725061|NCT00801229|82940947|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
46725062|NCT00801229|82940946|FG000|Received Study Drug/Placebo|Adverse Event|1|||
46725063|NCT00801229|82940947|FG001|Received Study Drug/Placebo|Adverse Event|1|||
46725064|NCT00948246|82940953|FG000|Overall Study|Lost to Follow-up|11|||
46725065|NCT00948246|82940953|FG000|Overall Study|Adverse Event|11|||
46920839|NCT02762084|83153062|FG002|Overall Study|Adverse Event|1|||
46725066|NCT00948246|82940953|FG000|Overall Study|Death|1|||
46725067|NCT00948246|82940953|FG000|Overall Study|Withdrawal by Subject|1|||
46725068|NCT00800683|82940959|FG000|Overall Study|Adverse Event|11|||
46725069|NCT00800683|82940960|FG001|Overall Study|Adverse Event|8|||
46725070|NCT00800683|82940959|FG000|Overall Study|Lost to Follow-up|3|||
46725071|NCT00800683|82940960|FG001|Overall Study|Lost to Follow-up|1|||
46725072|NCT00800683|82940959|FG000|Overall Study|Withdrawal by Subject|1|||
46725073|NCT00800683|82940960|FG001|Overall Study|Withdrawal by Subject|7|||
46725074|NCT00800683|82940959|FG000|Overall Study|Lack of Efficacy|1|||
46725075|NCT00800683|82940960|FG001|Overall Study|Lack of Efficacy|1|||
46725076|NCT00800683|82940959|FG000|Overall Study|Other|1|||
46725077|NCT00800683|82940960|FG001|Overall Study|Other|2|||
46725078|NCT01124864|82940972|FG000|Overall Study|Follow up phase competed as per protocol|18|||
46725079|NCT01124864|82940973|FG001|Overall Study|Follow up phase competed as per protocol|22|||
46725080|NCT01124864|82940974|FG002|Overall Study|Follow up phase competed as per protocol|24|||
46725081|NCT01124864|82940975|FG003|Overall Study|Follow up phase competed as per protocol|18|||
46725082|NCT01124864|82940976|FG004|Overall Study|Follow up phase competed as per protocol|26|||
46725083|NCT01124864|82940977|FG005|Overall Study|Follow up phase competed as per protocol|2|||
46725084|NCT01124864|82940972|FG000|Overall Study|Death|6|||
46725085|NCT01124864|82940973|FG001|Overall Study|Death|9|||
46725086|NCT01124864|82940974|FG002|Overall Study|Death|6|||
46725087|NCT01124864|82940975|FG003|Overall Study|Death|2|||
46725088|NCT01124864|82940976|FG004|Overall Study|Death|1|||
46725089|NCT01124864|82940977|FG005|Overall Study|Death|0|||
46725090|NCT01124864|82940972|FG000|Overall Study|Withdrawal by Subject|2|||
46725091|NCT01124864|82940973|FG001|Overall Study|Withdrawal by Subject|3|||
46725092|NCT01124864|82940974|FG002|Overall Study|Withdrawal by Subject|4|||
46725093|NCT01124864|82940975|FG003|Overall Study|Withdrawal by Subject|0|||
46725094|NCT01124864|82940976|FG004|Overall Study|Withdrawal by Subject|2|||
46725095|NCT01124864|82940977|FG005|Overall Study|Withdrawal by Subject|1|||
46725096|NCT01124864|82940972|FG000|Overall Study|Lost to Follow-up|1|||
46725097|NCT01124864|82940973|FG001|Overall Study|Lost to Follow-up|1|||
46725098|NCT01124864|82940974|FG002|Overall Study|Lost to Follow-up|0|||
46725099|NCT01124864|82940975|FG003|Overall Study|Lost to Follow-up|1|||
46725100|NCT01124864|82940976|FG004|Overall Study|Lost to Follow-up|0|||
46725101|NCT01124864|82940977|FG005|Overall Study|Lost to Follow-up|0|||
46725102|NCT01124864|82940972|FG000|Overall Study|Protocol Violation|1|||
46725103|NCT01124864|82940973|FG001|Overall Study|Protocol Violation|0|||
46725104|NCT01124864|82940974|FG002|Overall Study|Protocol Violation|0|||
46725105|NCT01124864|82940975|FG003|Overall Study|Protocol Violation|0|||
46725106|NCT01124864|82940976|FG004|Overall Study|Protocol Violation|1|||
46725107|NCT01124864|82940977|FG005|Overall Study|Protocol Violation|0|||
46725108|NCT01113710|82940993|FG000|Overall Study|Adverse Event|64|||
46725109|NCT01113710|82940993|FG000|Overall Study|Lack of Efficacy|41|||
46725110|NCT01113710|82940993|FG000|Overall Study|No Information Available|40|||
46725111|NCT01113710|82940993|FG000|Overall Study|Withdrawal by Subject|28|||
46725112|NCT01113710|82940993|FG000|Overall Study|Lost to Follow-up|20|||
46725113|NCT01113710|82940993|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
46725114|NCT01113710|82940993|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
46725115|NCT01113710|82940993|FG000|Overall Study|Lack of Patient's Compliance|8|||
46725116|NCT01113710|82940993|FG000|Overall Study|Other|7|||
46725117|NCT01113710|82940993|FG000|Overall Study|Adverse Event/Other|5|||
46725118|NCT01113710|82940993|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
46725119|NCT01113710|82940993|FG000|Overall Study|Lack of Efficacy/Other|4|||
46725120|NCT01113710|82940993|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
46725121|NCT01113710|82940993|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
46725122|NCT01113710|82940993|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
46725123|NCT01113710|82940993|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
46725124|NCT01113710|82940993|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
46725125|NCT01113710|82940993|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
46725126|NCT01113710|82940993|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
46725127|NCT01113710|82940993|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
46725128|NCT01113710|82940993|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
46725129|NCT01113710|82940993|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
46725130|NCT01113710|82940993|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
46725131|NCT01113710|82940993|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
46725132|NCT01113710|82940993|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
46725133|NCT01124162|82940999|FG000|First Intervention|Adverse Event|2|||
46725134|NCT01124162|82941000|FG001|First Intervention|Adverse Event|0|||
46725135|NCT01124162|82940999|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
46725136|NCT01124162|82941000|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
46920840|NCT02763644|83153074|FG000|Overall Study|Patient/guardian decision|1|||
47045398|NCT01772719|83303424|FG000|Overall Study|Adverse Event|2|||
46920841|NCT02763644|83153075|FG001|Overall Study|Patient/guardian decision|0|||
46920842|NCT02763644|83153074|FG000|Overall Study|Death|1|||
47045399|NCT01772719|83303424|FG000|Overall Study|Protocol Violation|1|||
47045400|NCT01772719|83303424|FG000|Overall Study|Lost to Follow-up|1|||
47045401|NCT01798927|83303431|FG000|Overall Study|Withdrawal by Subject|1|||
47045402|NCT01276288|83303500|FG000|Overall Study|Adverse Event|1|||
47045403|NCT01276288|83303501|FG001|Overall Study|Adverse Event|1|||
47045404|NCT01276288|83303502|FG002|Overall Study|Adverse Event|0|||
46725137|NCT00906399|82941009|FG000|Year 1|Randomized But Not Treated|0|||
47045405|NCT01276288|83303503|FG003|Overall Study|Adverse Event|0|||
47045406|NCT01276288|83303500|FG000|Overall Study|not treated|1|||
46725138|NCT00906399|82941010|FG001|Year 1|Randomized But Not Treated|1|||
46725139|NCT00906399|82941011|FG002|Year 1|Randomized But Not Treated|3|||
46725140|NCT00906399|82941012|FG003|Year 1|Randomized But Not Treated|0|||
46725141|NCT00906399|82941013|FG004|Year 1|Randomized But Not Treated|0|||
46725142|NCT00906399|82941014|FG005|Year 1|Randomized But Not Treated|0|||
46725143|NCT00906399|82941015|FG006|Year 1|Randomized But Not Treated|0|||
46920843|NCT02763644|83153075|FG001|Overall Study|Death|1|||
46920844|NCT02763644|83153074|FG000|Overall Study|Adverse Event|1|||
47045407|NCT01276288|83303501|FG001|Overall Study|not treated|0|||
46725144|NCT00906399|82941009|FG000|Year 1|Adverse Event|4|||
46725145|NCT00906399|82941010|FG001|Year 1|Adverse Event|22|||
46725146|NCT00906399|82941011|FG002|Year 1|Adverse Event|24|||
46725147|NCT00906399|82941012|FG003|Year 1|Adverse Event|0|||
46725148|NCT00906399|82941013|FG004|Year 1|Adverse Event|0|||
46725149|NCT00906399|82941014|FG005|Year 1|Adverse Event|0|||
46725150|NCT00906399|82941015|FG006|Year 1|Adverse Event|0|||
46725151|NCT00906399|82941009|FG000|Year 1|Lost to Follow-up|4|||
46725152|NCT00906399|82941010|FG001|Year 1|Lost to Follow-up|4|||
46725153|NCT00906399|82941011|FG002|Year 1|Lost to Follow-up|2|||
46725154|NCT00906399|82941012|FG003|Year 1|Lost to Follow-up|0|||
46725155|NCT00906399|82941013|FG004|Year 1|Lost to Follow-up|0|||
46725156|NCT00906399|82941014|FG005|Year 1|Lost to Follow-up|0|||
46725157|NCT00906399|82941015|FG006|Year 1|Lost to Follow-up|0|||
46725158|NCT00906399|82941009|FG000|Year 1|Withdrawal by Subject|30|||
46725159|NCT00906399|82941010|FG001|Year 1|Withdrawal by Subject|32|||
46725160|NCT00906399|82941011|FG002|Year 1|Withdrawal by Subject|36|||
46725161|NCT00906399|82941012|FG003|Year 1|Withdrawal by Subject|0|||
46725162|NCT00906399|82941013|FG004|Year 1|Withdrawal by Subject|0|||
46725163|NCT00906399|82941014|FG005|Year 1|Withdrawal by Subject|0|||
46725164|NCT00906399|82941015|FG006|Year 1|Withdrawal by Subject|0|||
46725165|NCT00906399|82941009|FG000|Year 1|Physician Decision|0|||
46725166|NCT00906399|82941010|FG001|Year 1|Physician Decision|1|||
47045408|NCT01276288|83303502|FG002|Overall Study|not treated|0|||
47045409|NCT01276288|83303503|FG003|Overall Study|not treated|0|||
47045410|NCT02702271|83303527|FG000|Overall Study|Death|36|||
47045411|NCT02702271|83303528|FG001|Overall Study|Death|7|||
47045412|NCT02702271|83303527|FG000|Overall Study|Lost to Follow-up|12|||
47045413|NCT02702271|83303528|FG001|Overall Study|Lost to Follow-up|0|||
47045414|NCT02702271|83303527|FG000|Overall Study|Withdrawal by Subject|8|||
47045415|NCT02702271|83303528|FG001|Overall Study|Withdrawal by Subject|1|||
46725167|NCT00906399|82941011|FG002|Year 1|Physician Decision|3|||
46725168|NCT00906399|82941012|FG003|Year 1|Physician Decision|0|||
46725169|NCT00906399|82941013|FG004|Year 1|Physician Decision|0|||
46725170|NCT00906399|82941014|FG005|Year 1|Physician Decision|0|||
46725171|NCT00906399|82941015|FG006|Year 1|Physician Decision|0|||
46725172|NCT00906399|82941009|FG000|Year 1|Death|2|||
46725173|NCT00906399|82941010|FG001|Year 1|Death|1|||
46725174|NCT00906399|82941011|FG002|Year 1|Death|1|||
46725175|NCT00906399|82941012|FG003|Year 1|Death|0|||
46725176|NCT00906399|82941013|FG004|Year 1|Death|0|||
46725177|NCT00906399|82941014|FG005|Year 1|Death|0|||
46725178|NCT00906399|82941015|FG006|Year 1|Death|0|||
46725179|NCT00906399|82941009|FG000|Year 1|Other|4|||
46725180|NCT00906399|82941010|FG001|Year 1|Other|2|||
46725181|NCT00906399|82941011|FG002|Year 1|Other|7|||
46725182|NCT00906399|82941012|FG003|Year 1|Other|0|||
46725183|NCT00906399|82941013|FG004|Year 1|Other|0|||
46725184|NCT00906399|82941014|FG005|Year 1|Other|0|||
46725185|NCT00906399|82941015|FG006|Year 1|Other|0|||
46725186|NCT00906399|82941009|FG000|Year 2|Adverse Event|0|||
46725187|NCT00906399|82941010|FG001|Year 2|Adverse Event|0|||
46725188|NCT00906399|82941011|FG002|Year 2|Adverse Event|0|||
46725189|NCT00906399|82941012|FG003|Year 2|Adverse Event|9|||
46725190|NCT00906399|82941013|FG004|Year 2|Adverse Event|8|||
46725191|NCT00906399|82941014|FG005|Year 2|Adverse Event|11|||
46920845|NCT02763644|83153075|FG001|Overall Study|Adverse Event|1|||
46920846|NCT02807844|83153093|FG000|Overall Study|Physician Decision|0|||
46634496|NCT01604850|82807990|FG001|Overall Study|Lost to Follow-up|0|||
46634497|NCT01604850|82807989|FG000|Overall Study|Subject withdrew consent|1|||
46634498|NCT01604850|82807990|FG001|Overall Study|Subject withdrew consent|0|||
46634499|NCT01742286|82808003|FG000|Escalation Phase|Administrative problems|1|||
46634500|NCT01742286|82808004|FG001|Escalation Phase|Administrative problems|1|||
46634501|NCT01742286|82808005|FG002|Escalation Phase|Administrative problems|0|||
46634502|NCT01742286|82808006|FG003|Escalation Phase|Administrative problems|0|||
46634503|NCT01742286|82808007|FG004|Escalation Phase|Administrative problems|0|||
46634504|NCT01742286|82808008|FG005|Escalation Phase|Administrative problems|0|||
46634505|NCT01742286|82808009|FG006|Escalation Phase|Administrative problems|2|||
46634506|NCT01742286|82808003|FG000|Escalation Phase|Adverse Event|0|||
46634507|NCT01742286|82808004|FG001|Escalation Phase|Adverse Event|1|||
46725192|NCT00906399|82941015|FG006|Year 2|Adverse Event|6|||
46634508|NCT01742286|82808005|FG002|Escalation Phase|Adverse Event|2|||
46725193|NCT00906399|82941009|FG000|Year 2|Lost to Follow-up|0|||
46634509|NCT01742286|82808006|FG003|Escalation Phase|Adverse Event|0|||
46634510|NCT01742286|82808007|FG004|Escalation Phase|Adverse Event|0|||
46725194|NCT00906399|82941010|FG001|Year 2|Lost to Follow-up|0|||
46725195|NCT00906399|82941011|FG002|Year 2|Lost to Follow-up|0|||
46634511|NCT01742286|82808008|FG005|Escalation Phase|Adverse Event|1|||
46725196|NCT00906399|82941012|FG003|Year 2|Lost to Follow-up|1|||
46725197|NCT00906399|82941013|FG004|Year 2|Lost to Follow-up|4|||
46725198|NCT00906399|82941014|FG005|Year 2|Lost to Follow-up|2|||
46725199|NCT00906399|82941015|FG006|Year 2|Lost to Follow-up|4|||
46725200|NCT00906399|82941009|FG000|Year 2|Withdrawal by Subject|0|||
47045416|NCT02702271|83303527|FG000|Overall Study|Physician Decision|2|||
47045417|NCT02702271|83303528|FG001|Overall Study|Physician Decision|0|||
47045418|NCT02702271|83303527|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
46725201|NCT00906399|82941010|FG001|Year 2|Withdrawal by Subject|0|||
46725202|NCT00906399|82941011|FG002|Year 2|Withdrawal by Subject|0|||
46725203|NCT00906399|82941012|FG003|Year 2|Withdrawal by Subject|17|||
46725204|NCT00906399|82941013|FG004|Year 2|Withdrawal by Subject|18|||
46725205|NCT00906399|82941014|FG005|Year 2|Withdrawal by Subject|27|||
46725206|NCT00906399|82941015|FG006|Year 2|Withdrawal by Subject|13|||
46725207|NCT00906399|82941009|FG000|Year 2|Physician Decision|0|||
46725208|NCT00906399|82941010|FG001|Year 2|Physician Decision|0|||
46725209|NCT00906399|82941011|FG002|Year 2|Physician Decision|0|||
46725210|NCT00906399|82941012|FG003|Year 2|Physician Decision|0|||
46725211|NCT00906399|82941013|FG004|Year 2|Physician Decision|2|||
46725212|NCT00906399|82941014|FG005|Year 2|Physician Decision|6|||
46725213|NCT00906399|82941015|FG006|Year 2|Physician Decision|3|||
47045419|NCT02702271|83303528|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
46725214|NCT00906399|82941009|FG000|Year 2|Death|0|||
46725215|NCT00906399|82941010|FG001|Year 2|Death|0|||
46725216|NCT00906399|82941011|FG002|Year 2|Death|0|||
46725217|NCT00906399|82941012|FG003|Year 2|Death|1|||
46725218|NCT00906399|82941013|FG004|Year 2|Death|0|||
46725219|NCT00906399|82941014|FG005|Year 2|Death|0|||
46725220|NCT00906399|82941015|FG006|Year 2|Death|3|||
46725221|NCT00906399|82941009|FG000|Year 2|Other|0|||
46725222|NCT00906399|82941010|FG001|Year 2|Other|0|||
46725223|NCT00906399|82941011|FG002|Year 2|Other|0|||
46725224|NCT00906399|82941012|FG003|Year 2|Other|2|||
46725225|NCT00906399|82941013|FG004|Year 2|Other|3|||
46725226|NCT00906399|82941014|FG005|Year 2|Other|1|||
46725227|NCT00906399|82941015|FG006|Year 2|Other|0|||
46725228|NCT01111838|82941027|FG000|Overall Study|Patient Ineligible|2|||
46725229|NCT01111838|82941027|FG000|Overall Study|Not Treated|3|||
46725230|NCT01111838|82941027|FG000|Overall Study|Clinical deterioration|1|||
46725231|NCT01111838|82941027|FG000|Overall Study|Other Complicating Disease|1|||
46725232|NCT00947856|82941033|FG000|Treatment Period|Progressive Disease|33|||
46725233|NCT00947856|82941034|FG001|Treatment Period|Progressive Disease|12|||
46725234|NCT00947856|82941033|FG000|Treatment Period|Adverse Event|15|||
46725235|NCT00947856|82941034|FG001|Treatment Period|Adverse Event|9|||
46725236|NCT00947856|82941033|FG000|Treatment Period|Physician Decision|14|||
46725237|NCT00947856|82941034|FG001|Treatment Period|Physician Decision|6|||
46725238|NCT00947856|82941033|FG000|Treatment Period|Study Stopped by Sponsor|4|||
46725239|NCT00947856|82941034|FG001|Treatment Period|Study Stopped by Sponsor|4|||
46725240|NCT00947856|82941033|FG000|Treatment Period|Withdrawal by Subject|12|||
47045420|NCT01276054|83303613|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
47045421|NCT01276054|83303614|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
47045422|NCT01798849|83303623|FG000|Overall Study|Physician Decision|0|||
47045423|NCT01798849|83303624|FG001|Overall Study|Physician Decision|0|||
47045424|NCT01798849|83303625|FG002|Overall Study|Physician Decision|1|||
47045425|NCT01797835|83303705|FG000|Overall Study|Lost to Follow-up|31|||
47045426|NCT01797835|83303706|FG001|Overall Study|Lost to Follow-up|27|||
47045427|NCT01275430|83303712|FG000|Overall Study|Adverse Event|1|||
47045428|NCT01275430|83303712|FG000|Overall Study|No Contrast Injection|6|||
47045429|NCT01275430|83303712|FG000|Overall Study|Device Malfunction|1|||
47045430|NCT01275430|83303712|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
47045431|NCT01838551|83303717|FG000|Overall Study|Adverse Event|16|||
47045432|NCT01838551|83303717|FG000|Overall Study|Death|1|||
47045433|NCT01838551|83303717|FG000|Overall Study|Lack of Efficacy|10|||
47045434|NCT01838551|83303717|FG000|Overall Study|Physician Decision|4|||
46634512|NCT01742286|82808009|FG006|Escalation Phase|Adverse Event|0|||
46634513|NCT01742286|82808003|FG000|Escalation Phase|Disease progression|3|||
46634514|NCT01742286|82808004|FG001|Escalation Phase|Disease progression|7|||
46634515|NCT01742286|82808005|FG002|Escalation Phase|Disease progression|4|||
46634516|NCT01742286|82808006|FG003|Escalation Phase|Disease progression|1|||
46634517|NCT01742286|82808007|FG004|Escalation Phase|Disease progression|4|||
46634518|NCT01742286|82808008|FG005|Escalation Phase|Disease progression|3|||
46725241|NCT00947856|82941034|FG001|Treatment Period|Withdrawal by Subject|1|||
46725242|NCT00947856|82941033|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
46725243|NCT00947856|82941034|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
46725244|NCT00947856|82941033|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
46725245|NCT00947856|82941034|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
46725246|NCT00947856|82941033|FG000|Follow-up Period|Lost to Follow-up|7|||
46725247|NCT00947856|82941034|FG001|Follow-up Period|Lost to Follow-up|0|||
46634519|NCT01742286|82808009|FG006|Escalation Phase|Disease progression|2|||
46725248|NCT00947856|82941033|FG000|Follow-up Period|Patient unavailable for site visits|1|||
46725249|NCT00947856|82941034|FG001|Follow-up Period|Patient unavailable for site visits|0|||
46725250|NCT00947856|82941033|FG000|Follow-up Period|Withdrawal by Subject|1|||
46725251|NCT00947856|82941034|FG001|Follow-up Period|Withdrawal by Subject|0|||
46725252|NCT00947544|82941049|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
46920847|NCT02807844|83153094|FG001|Overall Study|Physician Decision|0|||
47045435|NCT01838551|83303717|FG000|Overall Study|Withdrawal by Subject|10|||
47045436|NCT01838551|83303717|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
46725253|NCT00947544|82941050|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
46725254|NCT00907335|82941062|FG000|Overall Study|Withdrawal by Subject|2|||
46725255|NCT00907335|82941063|FG001|Overall Study|Withdrawal by Subject|0|||
46725256|NCT00907335|82941062|FG000|Overall Study|Adverse Event|4|||
46725257|NCT00907335|82941063|FG001|Overall Study|Adverse Event|1|||
46725258|NCT00907335|82941062|FG000|Overall Study|Lost to Follow-up|2|||
46725259|NCT00907335|82941063|FG001|Overall Study|Lost to Follow-up|0|||
46725260|NCT00947154|82941069|FG000|Overall Study|Lost to Follow-up|1|||
46725261|NCT01124006|82941077|FG000|Overall Study|Withdrawal by Subject|2|||
46725262|NCT01124006|82941078|FG001|Overall Study|Withdrawal by Subject|2|||
46725263|NCT01124006|82941079|FG002|Overall Study|Withdrawal by Subject|0|||
46725264|NCT01124006|82941077|FG000|Overall Study|Lost to Follow-up|1|||
46725265|NCT01124006|82941078|FG001|Overall Study|Lost to Follow-up|0|||
46725266|NCT01124006|82941079|FG002|Overall Study|Lost to Follow-up|1|||
46725267|NCT01124006|82941077|FG000|Overall Study|Other|0|||
46920848|NCT02807844|83153095|FG002|Overall Study|Physician Decision|0|||
46920849|NCT02807844|83153096|FG003|Overall Study|Physician Decision|0|||
46920850|NCT02807844|83153097|FG004|Overall Study|Physician Decision|0|||
46725268|NCT01124006|82941078|FG001|Overall Study|Other|0|||
46725269|NCT01124006|82941079|FG002|Overall Study|Other|1|||
46725270|NCT00952068|82941087|FG000|Overall Study|Adverse Event|3|||
46725271|NCT00952068|82941087|FG000|Overall Study|Withdrawal by Subject|4|||
46725272|NCT01123850|82941091|FG000|Overall Study|Slow enrollment|45|||
46725273|NCT01123382|82941097|FG000|Overall Study|Withdrawal by Subject|1|||
46725274|NCT01123382|82941098|FG001|Overall Study|Withdrawal by Subject|4|||
46725275|NCT01123382|82941097|FG000|Overall Study|Lost to Follow-up|1|||
46725276|NCT01123382|82941098|FG001|Overall Study|Lost to Follow-up|2|||
46725277|NCT00951912|82941107|FG000|Overall Study|Lack of Efficacy|1|||
46725278|NCT00951912|82941108|FG001|Overall Study|Lack of Efficacy|0|||
46725279|NCT00951912|82941109|FG002|Overall Study|Lack of Efficacy|0|||
46725280|NCT00951912|82941107|FG000|Overall Study|Adverse Event|0|||
46725281|NCT00951912|82941108|FG001|Overall Study|Adverse Event|1|||
46725282|NCT00951912|82941109|FG002|Overall Study|Adverse Event|1|||
46725283|NCT00951912|82941107|FG000|Overall Study|Lost to Follow-up|2|||
46725284|NCT00951912|82941108|FG001|Overall Study|Lost to Follow-up|2|||
46725285|NCT00951912|82941109|FG002|Overall Study|Lost to Follow-up|0|||
46725286|NCT00951912|82941107|FG000|Overall Study|Physician Decision|1|||
46725287|NCT00951912|82941108|FG001|Overall Study|Physician Decision|0|||
46725288|NCT00951912|82941109|FG002|Overall Study|Physician Decision|1|||
46725289|NCT00951912|82941107|FG000|Overall Study|Withdrawal by Subject|1|||
46725290|NCT00951912|82941108|FG001|Overall Study|Withdrawal by Subject|1|||
46725291|NCT00951912|82941109|FG002|Overall Study|Withdrawal by Subject|0|||
46725292|NCT00951912|82941107|FG000|Overall Study|Other:Depression|1|||
46725293|NCT00951912|82941108|FG001|Overall Study|Other:Depression|0|||
46725294|NCT00951912|82941109|FG002|Overall Study|Other:Depression|0|||
46725295|NCT00951912|82941107|FG000|Overall Study|Other: Colon cancer|1|||
46725296|NCT00951912|82941108|FG001|Overall Study|Other: Colon cancer|0|||
46725297|NCT00951912|82941109|FG002|Overall Study|Other: Colon cancer|0|||
46725298|NCT00951912|82941107|FG000|Overall Study|Other: Stroke|0|||
46725299|NCT00951912|82941108|FG001|Overall Study|Other: Stroke|1|||
46725300|NCT00951912|82941109|FG002|Overall Study|Other: Stroke|0|||
46725301|NCT01123148|82941117|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
46725302|NCT01123148|82941117|FG000|Overall Study|Didn't meet milestone criteria|1|||
46725303|NCT01123070|82941125|FG000|Part B Double Blind Period|Protocol Violation|0|||
46920851|NCT02807844|83153098|FG005|Overall Study|Physician Decision|0|||
46920852|NCT02807844|83153099|FG006|Overall Study|Physician Decision|3|||
46725304|NCT01123070|82941126|FG001|Part B Double Blind Period|Protocol Violation|0|||
46920853|NCT02807844|83153100|FG007|Overall Study|Physician Decision|0|||
46920854|NCT02807844|83153101|FG008|Overall Study|Physician Decision|1|||
46920855|NCT02807844|83153102|FG009|Overall Study|Physician Decision|2|||
46920856|NCT02807844|83153093|FG000|Overall Study|Death|0|||
46920857|NCT02807844|83153094|FG001|Overall Study|Death|0|||
46920858|NCT02807844|83153095|FG002|Overall Study|Death|2|||
46725305|NCT01123070|82941127|FG002|Part B Double Blind Period|Protocol Violation|0|||
46725306|NCT01123070|82941128|FG003|Part B Double Blind Period|Protocol Violation|1|||
46920859|NCT02807844|83153096|FG003|Overall Study|Death|4|||
46920860|NCT02807844|83153097|FG004|Overall Study|Death|1|||
46920861|NCT02807844|83153098|FG005|Overall Study|Death|2|||
46725307|NCT01123070|82941125|FG000|Part B Double Blind Period|Adverse Event|0|||
46725308|NCT01123070|82941126|FG001|Part B Double Blind Period|Adverse Event|0|||
46725309|NCT01123070|82941127|FG002|Part B Double Blind Period|Adverse Event|2|||
46725310|NCT01123070|82941128|FG003|Part B Double Blind Period|Adverse Event|0|||
46725311|NCT01123070|82941125|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
46725312|NCT01123070|82941126|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
46725313|NCT01123070|82941127|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
46725314|NCT01123070|82941128|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
46725315|NCT01122680|82941139|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
46725316|NCT01122680|82941140|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
46920862|NCT02807844|83153099|FG006|Overall Study|Death|1|||
46725317|NCT01122680|82941141|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
46725318|NCT01122680|82941142|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
46725319|NCT01122680|82941139|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
46725320|NCT01122680|82941140|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
46725321|NCT01122680|82941141|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
46725322|NCT01122680|82941142|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
46725323|NCT01122680|82941139|FG000|Period 1 (4 Weeks)|Other|1|||
46725324|NCT01122680|82941140|FG001|Period 1 (4 Weeks)|Other|1|||
46725325|NCT01122680|82941141|FG002|Period 1 (4 Weeks)|Other|0|||
46725326|NCT01122680|82941142|FG003|Period 1 (4 Weeks)|Other|0|||
46725327|NCT01122680|82941139|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
46725328|NCT01122680|82941140|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
46725329|NCT01122680|82941141|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
46725330|NCT01122680|82941142|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
46725331|NCT01122680|82941139|FG000|Period 2 (4 Weeks)|Other|1|||
46725332|NCT01122680|82941140|FG001|Period 2 (4 Weeks)|Other|0|||
46725333|NCT01122680|82941141|FG002|Period 2 (4 Weeks)|Other|0|||
46725334|NCT01122680|82941142|FG003|Period 2 (4 Weeks)|Other|0|||
46725335|NCT01122680|82941139|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
46725336|NCT01122680|82941140|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
46725337|NCT01122680|82941141|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
46725338|NCT01122680|82941142|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
46725339|NCT01122680|82941139|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
46725340|NCT01122680|82941140|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
46725341|NCT01122680|82941141|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
46725342|NCT01122680|82941142|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
46725343|NCT00946998|82941154|FG000|Overall Study|Exited prior to first outcome assessment|5|||
46725344|NCT00946998|82941155|FG001|Overall Study|Exited prior to first outcome assessment|3|||
46725345|NCT01138826|82941161|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
46725346|NCT01138826|82941162|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
46725347|NCT01138826|82941163|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
46725348|NCT01138826|82941164|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
46725349|NCT01138826|82941165|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
46725350|NCT01138826|82941166|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
46725351|NCT00906087|82941174|FG000|Initial Washout|Withdrawal by Subject|1|||
46725352|NCT00906087|82941174|FG000|Initial Washout|Physician Decision|1|||
46725353|NCT00907257|82941183|FG000|Overall Study|Adverse Event|0|||
46725354|NCT00907257|82941184|FG001|Overall Study|Adverse Event|4|||
46725355|NCT00907257|82941183|FG000|Overall Study|Protocol Violation|1|||
46725356|NCT00907257|82941184|FG001|Overall Study|Protocol Violation|2|||
46725357|NCT00907257|82941183|FG000|Overall Study|Lost to Follow-up|3|||
46725358|NCT00907257|82941184|FG001|Overall Study|Lost to Follow-up|3|||
46725359|NCT00907257|82941183|FG000|Overall Study|Withdrawal by Subject|1|||
46725360|NCT00907257|82941184|FG001|Overall Study|Withdrawal by Subject|2|||
46725361|NCT00907257|82941183|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
46725362|NCT00907257|82941184|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
46725363|NCT00907257|82941183|FG000|Overall Study|Moved|1|||
46725364|NCT00907257|82941184|FG001|Overall Study|Moved|0|||
46725365|NCT00907257|82941183|FG000|Overall Study|Personal Reasons|6|||
46725366|NCT00907257|82941184|FG001|Overall Study|Personal Reasons|1|||
46725367|NCT01138046|82941190|FG000|Overall Study|Withdrawal due to death|6|||
46725368|NCT00876460|82941202|FG000|Combination Therapy Phase|Progressive disease|2|||
46725369|NCT00876460|82941203|FG001|Combination Therapy Phase|Progressive disease|3|||
46725370|NCT00876460|82941204|FG002|Combination Therapy Phase|Progressive disease|3|||
46725371|NCT00876460|82941205|FG003|Combination Therapy Phase|Progressive disease|3|||
46634520|NCT01742286|82808003|FG000|Escalation Phase|Death|0|||
46725372|NCT00876460|82941206|FG004|Combination Therapy Phase|Progressive disease|3|||
46725373|NCT00876460|82941207|FG005|Combination Therapy Phase|Progressive disease|1|||
46634521|NCT01742286|82808004|FG001|Escalation Phase|Death|0|||
46634522|NCT01742286|82808005|FG002|Escalation Phase|Death|0|||
46634523|NCT01742286|82808006|FG003|Escalation Phase|Death|0|||
46634524|NCT01742286|82808007|FG004|Escalation Phase|Death|0|||
46634525|NCT01742286|82808008|FG005|Escalation Phase|Death|1|||
46634526|NCT01742286|82808009|FG006|Escalation Phase|Death|0|||
46634527|NCT01742286|82808003|FG000|Escalation Phase|Physician Decision|0|||
46634528|NCT01742286|82808004|FG001|Escalation Phase|Physician Decision|3|||
46634529|NCT01742286|82808005|FG002|Escalation Phase|Physician Decision|0|||
46725374|NCT00876460|82941208|FG006|Combination Therapy Phase|Progressive disease|1|||
46725375|NCT00876460|82941209|FG007|Combination Therapy Phase|Progressive disease|1|||
46725376|NCT00876460|82941202|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
46725377|NCT00876460|82941203|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
46634530|NCT01742286|82808006|FG003|Escalation Phase|Physician Decision|1|||
46725378|NCT00876460|82941204|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
46725379|NCT00876460|82941205|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
46725380|NCT00876460|82941206|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
46725381|NCT00876460|82941207|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
46725382|NCT00876460|82941208|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
46725383|NCT00876460|82941209|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
46725384|NCT00876460|82941202|FG000|Combination Therapy Phase|Adverse Event|0|||
46725385|NCT00876460|82941203|FG001|Combination Therapy Phase|Adverse Event|2|||
46725386|NCT00876460|82941204|FG002|Combination Therapy Phase|Adverse Event|0|||
46725387|NCT00876460|82941205|FG003|Combination Therapy Phase|Adverse Event|2|||
46725388|NCT00876460|82941206|FG004|Combination Therapy Phase|Adverse Event|2|||
46725389|NCT00876460|82941207|FG005|Combination Therapy Phase|Adverse Event|0|||
46725390|NCT00876460|82941208|FG006|Combination Therapy Phase|Adverse Event|3|||
46725391|NCT00876460|82941209|FG007|Combination Therapy Phase|Adverse Event|2|||
46725392|NCT00876460|82941202|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
46725393|NCT00876460|82941203|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
46725394|NCT00876460|82941204|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
46725395|NCT00876460|82941205|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
46725396|NCT00876460|82941206|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
46725397|NCT00876460|82941207|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
46725398|NCT00876460|82941208|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
46725399|NCT00876460|82941209|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
46725400|NCT00876460|82941202|FG000|Combination Therapy Phase|Other reason not defined above|0|||
46725401|NCT00876460|82941203|FG001|Combination Therapy Phase|Other reason not defined above|0|||
46725402|NCT00876460|82941204|FG002|Combination Therapy Phase|Other reason not defined above|0|||
46725403|NCT00876460|82941205|FG003|Combination Therapy Phase|Other reason not defined above|0|||
46725404|NCT00876460|82941206|FG004|Combination Therapy Phase|Other reason not defined above|0|||
47045437|NCT01797445|83303723|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
47045438|NCT01797445|83303724|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
47045439|NCT01797445|83303723|FG000|Double-Blind Phase|Adverse Event|3|||
47045440|NCT01797445|83303724|FG001|Double-Blind Phase|Adverse Event|0|||
47045441|NCT01797445|83303723|FG000|Double-Blind Phase|Death|5|||
47045442|NCT01797445|83303724|FG001|Double-Blind Phase|Death|4|||
47045443|NCT01797445|83303723|FG000|Double-Blind Phase|Pregnancy|0|||
47045444|NCT01797445|83303724|FG001|Double-Blind Phase|Pregnancy|1|||
47045445|NCT01797445|83303723|FG000|Double-Blind Phase|Lack of Efficacy|1|||
46725405|NCT00876460|82941207|FG005|Combination Therapy Phase|Other reason not defined above|0|||
47045446|NCT01797445|83303724|FG001|Double-Blind Phase|Lack of Efficacy|2|||
47045447|NCT01797445|83303723|FG000|Double-Blind Phase|Investigator's Discretion|15|||
47045448|NCT01797445|83303724|FG001|Double-Blind Phase|Investigator's Discretion|17|||
47045449|NCT01797445|83303723|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
47045450|NCT01797445|83303724|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
47045451|NCT01797445|83303723|FG000|Double-Blind Phase|Protocol Violation|0|||
47045452|NCT01797445|83303724|FG001|Double-Blind Phase|Protocol Violation|1|||
47045453|NCT01797445|83303723|FG000|Double-Blind Phase|Withdrew Consent|20|||
47045454|NCT01797445|83303724|FG001|Double-Blind Phase|Withdrew Consent|35|||
47045455|NCT01797445|83303723|FG000|Double-Blind Phase|Lost to Follow-up|34|||
47045456|NCT01797445|83303724|FG001|Double-Blind Phase|Lost to Follow-up|26|||
47045457|NCT01797445|83303723|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
47045458|NCT01797445|83303724|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
47045459|NCT01611259|83303732|FG000|Overall Study|Physician Decision|1|||
47045460|NCT01611259|83303732|FG000|Overall Study|Lack of Efficacy|2|||
47045461|NCT01611259|83303732|FG000|Overall Study|Adverse Event|4|||
47045462|NCT01611259|83303732|FG000|Overall Study|Withdrawal by Subject|7|||
46725406|NCT00876460|82941208|FG006|Combination Therapy Phase|Other reason not defined above|1|||
47045463|NCT01795495|83303739|FG000|Overall Study|Protocol Violation|1|||
47045464|NCT01795495|83303740|FG001|Overall Study|Protocol Violation|0|||
47045465|NCT01795495|83303741|FG002|Overall Study|Protocol Violation|1|||
47045466|NCT01795495|83303739|FG000|Overall Study|Physician Decision|0|||
47045467|NCT01795495|83303740|FG001|Overall Study|Physician Decision|0|||
47045468|NCT01795495|83303741|FG002|Overall Study|Physician Decision|1|||
47045469|NCT01794949|83303751|FG000|Overall Study|Lost to Follow-up|1|||
47045470|NCT01794949|83303752|FG001|Overall Study|Lost to Follow-up|0|||
47045471|NCT01770379|83303761|FG000|Overall Study|Technical issues|1|||
47045472|NCT01770379|83303762|FG001|Overall Study|Technical issues|0|||
47045473|NCT01770379|83303763|FG002|Overall Study|Technical issues|0|||
47045474|NCT01770379|83303761|FG000|Overall Study|Withdrawal by Subject|7|||
47045475|NCT01770379|83303762|FG001|Overall Study|Withdrawal by Subject|10|||
47045476|NCT01770379|83303763|FG002|Overall Study|Withdrawal by Subject|7|||
47045477|NCT01770379|83303761|FG000|Overall Study|study terminated by sponsor|22|||
47045478|NCT01770379|83303762|FG001|Overall Study|study terminated by sponsor|23|||
47045479|NCT01770379|83303763|FG002|Overall Study|study terminated by sponsor|22|||
47045480|NCT01770379|83303761|FG000|Overall Study|Protocol Violation|0|||
47045481|NCT01770379|83303762|FG001|Overall Study|Protocol Violation|1|||
47045482|NCT01770379|83303763|FG002|Overall Study|Protocol Violation|1|||
47045483|NCT01770379|83303761|FG000|Overall Study|Physician Decision|0|||
47045484|NCT01770379|83303762|FG001|Overall Study|Physician Decision|1|||
47045485|NCT01770379|83303763|FG002|Overall Study|Physician Decision|2|||
47045486|NCT01770379|83303761|FG000|Overall Study|Lost to Follow-up|0|||
47045487|NCT01770379|83303762|FG001|Overall Study|Lost to Follow-up|0|||
47045488|NCT01770379|83303763|FG002|Overall Study|Lost to Follow-up|2|||
47045489|NCT01770379|83303761|FG000|Overall Study|Lack of Efficacy|8|||
47045490|NCT01770379|83303762|FG001|Overall Study|Lack of Efficacy|6|||
47045491|NCT01770379|83303763|FG002|Overall Study|Lack of Efficacy|6|||
47045492|NCT01770379|83303761|FG000|Overall Study|Adverse Event|1|||
46725407|NCT00876460|82941209|FG007|Combination Therapy Phase|Other reason not defined above|2|||
46725408|NCT00876460|82941202|FG000|Combination Therapy Phase|Not treated|0|||
47045493|NCT01770379|83303762|FG001|Overall Study|Adverse Event|3|||
47045494|NCT01770379|83303763|FG002|Overall Study|Adverse Event|2|||
46725409|NCT00876460|82941203|FG001|Combination Therapy Phase|Not treated|0|||
47045495|NCT01986881|83303776|FG000|Overall Study|Death|228|||
47045496|NCT01986881|83303777|FG001|Overall Study|Death|233|||
46920863|NCT02807844|83153100|FG007|Overall Study|Death|2|||
47045497|NCT01986881|83303778|FG002|Overall Study|Death|247|||
47045498|NCT01986881|83303776|FG000|Overall Study|Lost to Follow-up|51|||
47045499|NCT01986881|83303777|FG001|Overall Study|Lost to Follow-up|44|||
47045500|NCT01986881|83303778|FG002|Overall Study|Lost to Follow-up|55|||
47045501|NCT01986881|83303776|FG000|Overall Study|Physician Decision|7|||
47045502|NCT01986881|83303777|FG001|Overall Study|Physician Decision|4|||
47045503|NCT01986881|83303778|FG002|Overall Study|Physician Decision|6|||
47045504|NCT01986881|83303776|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
47045505|NCT01986881|83303777|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
47045506|NCT01986881|83303778|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
47045507|NCT01986881|83303776|FG000|Overall Study|Withdrawal by Subject|41|||
47045508|NCT01986881|83303777|FG001|Overall Study|Withdrawal by Subject|60|||
47045509|NCT01986881|83303778|FG002|Overall Study|Withdrawal by Subject|45|||
47045510|NCT01986881|83303776|FG000|Overall Study|Subject Moved|0|||
47045511|NCT01986881|83303777|FG001|Overall Study|Subject Moved|1|||
47045512|NCT01986881|83303778|FG002|Overall Study|Subject Moved|0|||
47045513|NCT01986881|83303776|FG000|Overall Study|Other|1|||
47045514|NCT01986881|83303777|FG001|Overall Study|Other|2|||
47045515|NCT01986881|83303778|FG002|Overall Study|Other|2|||
47045516|NCT01609543|83303809|FG000|Overall Study|Disease Progression|28|||
47045517|NCT01609543|83303809|FG000|Overall Study|Adverse Event|5|||
47045518|NCT01609543|83303809|FG000|Overall Study|Withdrawal by Subject|1|||
47045519|NCT01609543|83303809|FG000|Overall Study|Protocol Violation|1|||
47045520|NCT01609543|83303809|FG000|Overall Study|Death|7|||
47045521|NCT02003183|83303816|FG000|Overall Study|Lost to Follow-up|0|||
47045522|NCT02003183|83303817|FG001|Overall Study|Lost to Follow-up|2|||
47045523|NCT01986647|83303827|FG000|Overall Study|Lost to Follow-up|4|||
47045524|NCT01986647|83303828|FG001|Overall Study|Lost to Follow-up|1|||
47045525|NCT01986647|83303829|FG002|Overall Study|Lost to Follow-up|4|||
47045526|NCT01986647|83303830|FG003|Overall Study|Lost to Follow-up|4|||
47045527|NCT01986647|83303827|FG000|Overall Study|Withdrawal by Subject|1|||
47045528|NCT01986647|83303828|FG001|Overall Study|Withdrawal by Subject|3|||
47045529|NCT01986647|83303829|FG002|Overall Study|Withdrawal by Subject|2|||
47045530|NCT01986647|83303830|FG003|Overall Study|Withdrawal by Subject|3|||
47045531|NCT01986647|83303827|FG000|Overall Study|Health|5|||
47045532|NCT01986647|83303828|FG001|Overall Study|Health|3|||
47045533|NCT01986647|83303829|FG002|Overall Study|Health|6|||
47045534|NCT01986647|83303830|FG003|Overall Study|Health|4|||
46725410|NCT00876460|82941204|FG002|Combination Therapy Phase|Not treated|0|||
46725411|NCT00876460|82941205|FG003|Combination Therapy Phase|Not treated|0|||
46725412|NCT00876460|82941206|FG004|Combination Therapy Phase|Not treated|0|||
46725413|NCT00876460|82941207|FG005|Combination Therapy Phase|Not treated|0|||
46725414|NCT00876460|82941208|FG006|Combination Therapy Phase|Not treated|1|||
46725415|NCT00876460|82941209|FG007|Combination Therapy Phase|Not treated|0|||
46725416|NCT00876460|82941202|FG000|Mono Therapy Phase|Progressive disease|0|||
46725417|NCT00876460|82941203|FG001|Mono Therapy Phase|Progressive disease|0|||
46725418|NCT00876460|82941204|FG002|Mono Therapy Phase|Progressive disease|0|||
46725419|NCT00876460|82941205|FG003|Mono Therapy Phase|Progressive disease|0|||
46725420|NCT00876460|82941206|FG004|Mono Therapy Phase|Progressive disease|2|||
46725421|NCT00876460|82941207|FG005|Mono Therapy Phase|Progressive disease|0|||
46725422|NCT00876460|82941208|FG006|Mono Therapy Phase|Progressive disease|1|||
46725423|NCT00876460|82941209|FG007|Mono Therapy Phase|Progressive disease|3|||
46725424|NCT00876460|82941202|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
46725425|NCT00876460|82941203|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
46725426|NCT00876460|82941204|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
46725427|NCT00876460|82941205|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
46725428|NCT00876460|82941206|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
46725429|NCT00876460|82941207|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
46725430|NCT00876460|82941208|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
46725431|NCT00876460|82941209|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
46725432|NCT00876460|82941202|FG000|Mono Therapy Phase|Adverse Event|0|||
46725433|NCT00876460|82941203|FG001|Mono Therapy Phase|Adverse Event|0|||
47045535|NCT02002091|83303846|FG000|Screening|Lost to Follow-up|10|||
47045536|NCT02002091|83303847|FG001|Screening|Lost to Follow-up|12|||
47045537|NCT02002091|83303846|FG000|Screening|Death|3|||
46725434|NCT00876460|82941204|FG002|Mono Therapy Phase|Adverse Event|0|||
46725435|NCT00876460|82941205|FG003|Mono Therapy Phase|Adverse Event|1|||
46725436|NCT00876460|82941206|FG004|Mono Therapy Phase|Adverse Event|0|||
46725437|NCT00876460|82941207|FG005|Mono Therapy Phase|Adverse Event|0|||
46725438|NCT00876460|82941208|FG006|Mono Therapy Phase|Adverse Event|0|||
47045538|NCT02002091|83303847|FG001|Screening|Death|2|||
47045539|NCT01985321|83303884|FG000|Overall Study|Protocol Violation|4|||
47045540|NCT01985321|83303885|FG001|Overall Study|Protocol Violation|3|||
46725439|NCT00876460|82941209|FG007|Mono Therapy Phase|Adverse Event|0|||
46725440|NCT00908115|82941239|FG000|Overall Study|Other|14|||
47045541|NCT01985321|83303884|FG000|Overall Study|Withdrawal by Subject|1|||
47045542|NCT01985321|83303885|FG001|Overall Study|Withdrawal by Subject|0|||
47045543|NCT01985321|83303884|FG000|Overall Study|Lost to Follow-up|5|||
47045544|NCT01985321|83303885|FG001|Overall Study|Lost to Follow-up|2|||
47045545|NCT01985321|83303884|FG000|Overall Study|Subject treated wrong type of sore|1|||
47045546|NCT01985321|83303885|FG001|Overall Study|Subject treated wrong type of sore|0|||
47045547|NCT02000921|83303894|FG000|Overall Study|Withdrawal by Subject|3|||
46725441|NCT01137812|82941245|FG000|Overall Study|Adverse Event|21|||
46725442|NCT01137812|82941246|FG001|Overall Study|Adverse Event|14|||
46725443|NCT01137812|82941245|FG000|Overall Study|Lost to Follow-up|6|||
46725444|NCT01137812|82941246|FG001|Overall Study|Lost to Follow-up|8|||
46725445|NCT01137812|82941245|FG000|Overall Study|Physician Decision|25|||
46725446|NCT01137812|82941246|FG001|Overall Study|Physician Decision|17|||
46725447|NCT01137812|82941245|FG000|Overall Study|Protocol Violation|5|||
46725448|NCT01137812|82941246|FG001|Overall Study|Protocol Violation|4|||
46725449|NCT01137812|82941245|FG000|Overall Study|Withdrawal by Subject|5|||
46725450|NCT01137812|82941246|FG001|Overall Study|Withdrawal by Subject|13|||
46725451|NCT01137812|82941245|FG000|Overall Study|Death|2|||
46725452|NCT01137812|82941246|FG001|Overall Study|Death|0|||
47045548|NCT02000921|83303895|FG001|Overall Study|Withdrawal by Subject|10|||
47045549|NCT02000921|83303896|FG002|Overall Study|Withdrawal by Subject|5|||
47045550|NCT02000921|83303894|FG000|Overall Study|Lost to Follow-up|2|||
47045551|NCT02000921|83303895|FG001|Overall Study|Lost to Follow-up|4|||
47045552|NCT02000921|83303896|FG002|Overall Study|Lost to Follow-up|5|||
47045553|NCT02000921|83303894|FG000|Overall Study|Physician Decision|0|||
47045554|NCT02000921|83303895|FG001|Overall Study|Physician Decision|2|||
47045555|NCT02000921|83303896|FG002|Overall Study|Physician Decision|0|||
47045556|NCT01836523|83303942|FG000|Overall Study|Adverse Event|15|||
47045557|NCT01836523|83303943|FG001|Overall Study|Adverse Event|41|||
46634531|NCT01742286|82808007|FG004|Escalation Phase|Physician Decision|0|||
46634532|NCT01742286|82808008|FG005|Escalation Phase|Physician Decision|0|||
46634533|NCT01742286|82808009|FG006|Escalation Phase|Physician Decision|2|||
46634534|NCT01742286|82808003|FG000|Escalation Phase|Subject/guardian decision|1|||
46634535|NCT01742286|82808004|FG001|Escalation Phase|Subject/guardian decision|0|||
46634536|NCT01742286|82808005|FG002|Escalation Phase|Subject/guardian decision|0|||
46634537|NCT01742286|82808006|FG003|Escalation Phase|Subject/guardian decision|0|||
46634538|NCT01742286|82808007|FG004|Escalation Phase|Subject/guardian decision|0|||
46634539|NCT01742286|82808008|FG005|Escalation Phase|Subject/guardian decision|0|||
46634540|NCT01742286|82808009|FG006|Escalation Phase|Subject/guardian decision|0|||
46634541|NCT01742286|82808003|FG000|Expansion Phase|Administrative problems|0|||
46634542|NCT01742286|82808004|FG001|Expansion Phase|Administrative problems|0|||
46725453|NCT01137812|82941245|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
46725454|NCT01137812|82941246|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
46725455|NCT01137812|82941245|FG000|Overall Study|Other|19|||
46725456|NCT01137812|82941246|FG001|Overall Study|Other|27|||
47045558|NCT01836523|83303944|FG002|Overall Study|Adverse Event|49|||
47045559|NCT01836523|83303945|FG003|Overall Study|Adverse Event|14|||
47045560|NCT01836523|83303942|FG000|Overall Study|Protocol Violation|6|||
47045561|NCT01836523|83303943|FG001|Overall Study|Protocol Violation|3|||
47045562|NCT01836523|83303944|FG002|Overall Study|Protocol Violation|2|||
47045563|NCT01836523|83303945|FG003|Overall Study|Protocol Violation|4|||
47045564|NCT01836523|83303942|FG000|Overall Study|Met Withdrawal Criteria|13|||
47045565|NCT01836523|83303943|FG001|Overall Study|Met Withdrawal Criteria|13|||
46634543|NCT01742286|82808005|FG002|Expansion Phase|Administrative problems|0|||
46920864|NCT02807844|83153101|FG008|Overall Study|Death|0|||
46920865|NCT02807844|83153102|FG009|Overall Study|Death|1|||
46920866|NCT02807844|83153093|FG000|Overall Study|Withdrawal by Subject|0|||
46920867|NCT02807844|83153094|FG001|Overall Study|Withdrawal by Subject|0|||
46920868|NCT02807844|83153095|FG002|Overall Study|Withdrawal by Subject|2|||
46920869|NCT02807844|83153096|FG003|Overall Study|Withdrawal by Subject|1|||
46920870|NCT02807844|83153097|FG004|Overall Study|Withdrawal by Subject|1|||
46920871|NCT02807844|83153098|FG005|Overall Study|Withdrawal by Subject|0|||
46920872|NCT02807844|83153099|FG006|Overall Study|Withdrawal by Subject|1|||
46920873|NCT02807844|83153100|FG007|Overall Study|Withdrawal by Subject|0|||
46920874|NCT02807844|83153101|FG008|Overall Study|Withdrawal by Subject|0|||
46920875|NCT02807844|83153102|FG009|Overall Study|Withdrawal by Subject|0|||
46920876|NCT02807844|83153093|FG000|Overall Study|Progressive disease|5|||
46920877|NCT02807844|83153094|FG001|Overall Study|Progressive disease|12|||
46920878|NCT02807844|83153095|FG002|Overall Study|Progressive disease|8|||
46920879|NCT02807844|83153096|FG003|Overall Study|Progressive disease|8|||
46920880|NCT02807844|83153097|FG004|Overall Study|Progressive disease|3|||
46920881|NCT02807844|83153098|FG005|Overall Study|Progressive disease|8|||
46920882|NCT02807844|83153099|FG006|Overall Study|Progressive disease|14|||
46920883|NCT02807844|83153100|FG007|Overall Study|Progressive disease|17|||
46920884|NCT02807844|83153101|FG008|Overall Study|Progressive disease|19|||
46920885|NCT02807844|83153102|FG009|Overall Study|Progressive disease|15|||
46920886|NCT02807844|83153093|FG000|Overall Study|Adverse Event|1|||
46920887|NCT02807844|83153094|FG001|Overall Study|Adverse Event|0|||
46920888|NCT02807844|83153095|FG002|Overall Study|Adverse Event|0|||
46920889|NCT02807844|83153096|FG003|Overall Study|Adverse Event|0|||
46920890|NCT02807844|83153097|FG004|Overall Study|Adverse Event|1|||
47045566|NCT01836523|83303944|FG002|Overall Study|Met Withdrawal Criteria|21|||
47045567|NCT01836523|83303945|FG003|Overall Study|Met Withdrawal Criteria|27|||
47045568|NCT01836523|83303942|FG000|Overall Study|Unclassified|17|||
46920891|NCT02807844|83153098|FG005|Overall Study|Adverse Event|1|||
47045569|NCT01836523|83303943|FG001|Overall Study|Unclassified|28|||
47045570|NCT01836523|83303944|FG002|Overall Study|Unclassified|19|||
47045571|NCT01836523|83303945|FG003|Overall Study|Unclassified|29|||
47045572|NCT01275196|83303957|FG000|Overall Study|Adverse Event|3|||
47045573|NCT01275196|83303958|FG001|Overall Study|Adverse Event|5|||
46920892|NCT02807844|83153099|FG006|Overall Study|Adverse Event|1|||
46920893|NCT02807844|83153100|FG007|Overall Study|Adverse Event|1|||
46920894|NCT02807844|83153101|FG008|Overall Study|Adverse Event|1|||
46920895|NCT02807844|83153102|FG009|Overall Study|Adverse Event|2|||
46920896|NCT02763254|83153128|FG000|Overall Study|Adverse Event|1|||
46920897|NCT02805972|83153134|FG000|Washout Period|Lost to Follow-up|3|||
46920898|NCT02805972|83153135|FG001|Washout Period|Lost to Follow-up|0|||
46920899|NCT03032523|83153153|FG000|Overall Study|Withdrawal by Subject|2|||
46920900|NCT03032523|83153154|FG001|Overall Study|Withdrawal by Subject|2|||
46920901|NCT03032523|83153153|FG000|Overall Study|Physician Decision|1|||
47045574|NCT01275196|83303957|FG000|Overall Study|Withdrawal by Subject|4|||
47045575|NCT01275196|83303958|FG001|Overall Study|Withdrawal by Subject|5|||
47045576|NCT01275196|83303957|FG000|Overall Study|Lost to Follow-up|1|||
47045577|NCT01275196|83303958|FG001|Overall Study|Lost to Follow-up|0|||
46634544|NCT01742286|82808006|FG003|Expansion Phase|Administrative problems|0|||
46920902|NCT03032523|83153154|FG001|Overall Study|Physician Decision|0|||
46920903|NCT03031899|83153161|FG000|Overall Study|Protocol Violation|1|||
46920904|NCT03031899|83153161|FG000|Overall Study|lesion disappeared after stopping habit|1|||
47045578|NCT01275196|83303957|FG000|Overall Study|Disease Progression|6|||
47045579|NCT01275196|83303958|FG001|Overall Study|Disease Progression|5|||
47045580|NCT01275196|83303957|FG000|Overall Study|Protocol Violation|1|||
47045581|NCT01275196|83303958|FG001|Overall Study|Protocol Violation|0|||
47045582|NCT01275196|83303957|FG000|Overall Study|Suboptimal response/treatment failure|5|||
47045583|NCT01275196|83303958|FG001|Overall Study|Suboptimal response/treatment failure|6|||
47045584|NCT01984697|83303971|FG000|Overall Study|Adverse Event|0|||
47045585|NCT01984697|83303972|FG001|Overall Study|Adverse Event|0|||
47045586|NCT01984697|83303973|FG002|Overall Study|Adverse Event|2|||
47045587|NCT01984697|83303974|FG003|Overall Study|Adverse Event|0|||
47045588|NCT01984697|83303975|FG004|Overall Study|Adverse Event|0|||
47045589|NCT01984697|83303971|FG000|Overall Study|Lost to Follow-up|14|||
47045590|NCT01984697|83303972|FG001|Overall Study|Lost to Follow-up|5|||
47045591|NCT01984697|83303973|FG002|Overall Study|Lost to Follow-up|10|||
47045592|NCT01984697|83303974|FG003|Overall Study|Lost to Follow-up|6|||
47045593|NCT01984697|83303975|FG004|Overall Study|Lost to Follow-up|21|||
47045594|NCT01984697|83303971|FG000|Overall Study|Physician Decision|3|||
46725457|NCT01137578|82941252|FG000|Overall Study|Participant requested to Discontinue|3|||
46725458|NCT01137578|82941253|FG001|Overall Study|Participant requested to Discontinue|0|||
46725459|NCT01137578|82941254|FG002|Overall Study|Participant requested to Discontinue|0|||
46725460|NCT01137578|82941252|FG000|Overall Study|Withdrawal by Subject|1|||
46920905|NCT03086369|83153174|FG000|Overall Study|Lost to Follow-up|1|||
46920906|NCT03086369|83153175|FG001|Overall Study|Lost to Follow-up|0|||
46920907|NCT03086369|83153176|FG002|Overall Study|Lost to Follow-up|0|||
46920908|NCT03086369|83153177|FG003|Overall Study|Lost to Follow-up|2|||
47045595|NCT01984697|83303972|FG001|Overall Study|Physician Decision|0|||
47045596|NCT01984697|83303973|FG002|Overall Study|Physician Decision|0|||
47045597|NCT01984697|83303974|FG003|Overall Study|Physician Decision|1|||
47045598|NCT01984697|83303975|FG004|Overall Study|Physician Decision|0|||
47045599|NCT01984697|83303971|FG000|Overall Study|Protocol Violation|8|||
47045600|NCT01984697|83303972|FG001|Overall Study|Protocol Violation|5|||
46920909|NCT03086369|83153178|FG004|Overall Study|Lost to Follow-up|1|||
47045601|NCT01984697|83303973|FG002|Overall Study|Protocol Violation|3|||
47045602|NCT01984697|83303974|FG003|Overall Study|Protocol Violation|2|||
47045603|NCT01984697|83303975|FG004|Overall Study|Protocol Violation|0|||
47045604|NCT01984697|83303971|FG000|Overall Study|Withdrawal by Subject|15|||
47045605|NCT01984697|83303972|FG001|Overall Study|Withdrawal by Subject|21|||
46920910|NCT03086369|83153174|FG000|Overall Study|Physician Decision|0|||
47045606|NCT01984697|83303973|FG002|Overall Study|Withdrawal by Subject|13|||
47045607|NCT01984697|83303974|FG003|Overall Study|Withdrawal by Subject|11|||
47045608|NCT01984697|83303975|FG004|Overall Study|Withdrawal by Subject|13|||
47045609|NCT01984697|83303971|FG000|Overall Study|Missed last follow-up visit|1|||
47045610|NCT01984697|83303972|FG001|Overall Study|Missed last follow-up visit|0|||
47045611|NCT01984697|83303973|FG002|Overall Study|Missed last follow-up visit|0|||
47045612|NCT01984697|83303974|FG003|Overall Study|Missed last follow-up visit|0|||
47045613|NCT01984697|83303975|FG004|Overall Study|Missed last follow-up visit|0|||
47045614|NCT01984697|83303971|FG000|Overall Study|Death|0|||
47045615|NCT01984697|83303972|FG001|Overall Study|Death|0|||
47045616|NCT01984697|83303973|FG002|Overall Study|Death|0|||
47045617|NCT01984697|83303974|FG003|Overall Study|Death|1|||
47045618|NCT01984697|83303975|FG004|Overall Study|Death|0|||
47045619|NCT01984697|83303971|FG000|Overall Study|Pregnancy|2|||
47045620|NCT01984697|83303972|FG001|Overall Study|Pregnancy|0|||
47045621|NCT01984697|83303973|FG002|Overall Study|Pregnancy|1|||
47045622|NCT01984697|83303974|FG003|Overall Study|Pregnancy|0|||
47045623|NCT01984697|83303975|FG004|Overall Study|Pregnancy|1|||
47045624|NCT02000531|83303989|FG000|Overall Study|Lost to Follow-up|1|||
47045625|NCT02000531|83303990|FG001|Overall Study|Lost to Follow-up|0|||
47045626|NCT02000531|83303989|FG000|Overall Study|Discontinued due to data cut-off|3|||
47045627|NCT02000531|83303990|FG001|Overall Study|Discontinued due to data cut-off|8|||
47045628|NCT01609231|83303998|FG000|Overall Study|Adverse Event|1|||
47045629|NCT01609231|83303999|FG001|Overall Study|Adverse Event|3|||
47045630|NCT01609231|83303998|FG000|Overall Study|Physician Decision|1|||
47045631|NCT01609231|83303999|FG001|Overall Study|Physician Decision|0|||
47045632|NCT01609231|83303998|FG000|Overall Study|Withdrawal by Subject|1|||
47045633|NCT01609231|83303999|FG001|Overall Study|Withdrawal by Subject|0|||
47045634|NCT01793935|83304007|FG000|Overall Study|Pregnancy|1|||
47045635|NCT01793935|83304008|FG001|Overall Study|Pregnancy|0|||
47045636|NCT01793935|83304007|FG000|Overall Study|Protocol Violation|2|||
47045637|NCT01793935|83304008|FG001|Overall Study|Protocol Violation|1|||
47045638|NCT01793935|83304007|FG000|Overall Study|Adverse Event|2|||
47045639|NCT01793935|83304008|FG001|Overall Study|Adverse Event|0|||
47045640|NCT01793935|83304007|FG000|Overall Study|Patient did not take study medication|1|||
47045641|NCT01793935|83304008|FG001|Overall Study|Patient did not take study medication|1|||
47045642|NCT01793935|83304007|FG000|Overall Study|Lost to Follow-up|0|||
47045643|NCT01793935|83304008|FG001|Overall Study|Lost to Follow-up|1|||
47045644|NCT02092025|83304014|FG000|Overall Study|Case Report Forms Uncollected|44|||
47045645|NCT02092025|83304014|FG000|Overall Study|Protocol Deviation|24|||
47045646|NCT01769443|83304020|FG000|Overall Study|Study closure|1|||
47045647|NCT01769443|83304021|FG001|Overall Study|Study closure|0|||
47045648|NCT01768117|83304028|FG000|Overall Study|Lost to Follow-up|1|||
47045649|NCT01768117|83304028|FG000|Overall Study|Withdrawal by Subject|2|||
47045650|NCT01768117|83304028|FG000|Overall Study|Protocol Violation|3|||
47045651|NCT01767493|83304032|FG000|Overall Study|screen failures|3|||
47045652|NCT01274182|83304039|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
47045653|NCT01274182|83304040|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
47045654|NCT01274182|83304041|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
47045655|NCT01274182|83304039|FG000|Overall Study|Adverse Event|4|||
47045656|NCT01274182|83304040|FG001|Overall Study|Adverse Event|5|||
47045657|NCT01274182|83304041|FG002|Overall Study|Adverse Event|3|||
47045658|NCT01274182|83304039|FG000|Overall Study|Withdrawal by Subject|5|||
47045659|NCT01274182|83304040|FG001|Overall Study|Withdrawal by Subject|5|||
47045660|NCT01274182|83304041|FG002|Overall Study|Withdrawal by Subject|3|||
47045661|NCT01274182|83304039|FG000|Overall Study|Lost to Follow-up|2|||
47045662|NCT01274182|83304040|FG001|Overall Study|Lost to Follow-up|3|||
47045663|NCT01274182|83304041|FG002|Overall Study|Lost to Follow-up|1|||
47045664|NCT01274182|83304039|FG000|Overall Study|Protocol Violation|3|||
47045665|NCT01274182|83304040|FG001|Overall Study|Protocol Violation|2|||
47045666|NCT01274182|83304041|FG002|Overall Study|Protocol Violation|0|||
47045667|NCT01274182|83304039|FG000|Overall Study|Death|1|||
47045668|NCT01274182|83304040|FG001|Overall Study|Death|0|||
47045669|NCT01274182|83304041|FG002|Overall Study|Death|1|||
47045670|NCT01984229|83304055|FG000|Safety Follow-up Period|Adverse Event|1|||
47045671|NCT01984229|83304056|FG001|Safety Follow-up Period|Adverse Event|1|||
47045672|NCT01984229|83304055|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
47045673|NCT01984229|83304056|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
47045674|NCT01835899|83304071|FG000|Overall Study|Adverse Event|0|||
47045675|NCT01835899|83304072|FG001|Overall Study|Adverse Event|0|||
47045676|NCT01835899|83304073|FG002|Overall Study|Adverse Event|1|||
47045677|NCT01835899|83304071|FG000|Overall Study|Other than stated above|0|||
47045678|NCT01835899|83304072|FG001|Overall Study|Other than stated above|1|||
47045679|NCT01835899|83304073|FG002|Overall Study|Other than stated above|0|||
47045680|NCT01766401|83304085|FG000|Overall Study|Adverse Event|7|||
47045681|NCT01766401|83304086|FG001|Overall Study|Adverse Event|22|||
47045682|NCT01766401|83304085|FG000|Overall Study|Lack of Efficacy|1|||
47045683|NCT01766401|83304086|FG001|Overall Study|Lack of Efficacy|2|||
46634545|NCT01742286|82808007|FG004|Expansion Phase|Administrative problems|0|||
47045684|NCT01766401|83304085|FG000|Overall Study|Protocol Violation|3|||
47045685|NCT01766401|83304086|FG001|Overall Study|Protocol Violation|8|||
47045686|NCT01766401|83304085|FG000|Overall Study|Withdrawal by Subject|15|||
47045687|NCT01766401|83304086|FG001|Overall Study|Withdrawal by Subject|12|||
47045688|NCT01766401|83304085|FG000|Overall Study|Lost to Follow-up|10|||
47045689|NCT01766401|83304086|FG001|Overall Study|Lost to Follow-up|11|||
47045690|NCT01766401|83304085|FG000|Overall Study|Pregnancy|1|||
47045691|NCT01766401|83304086|FG001|Overall Study|Pregnancy|1|||
47045692|NCT01272934|83304094|FG000|Overall Study|Adverse Event|0|||
47045693|NCT01272934|83304095|FG001|Overall Study|Adverse Event|1|||
47045694|NCT01272934|83304094|FG000|Overall Study|Abnormal Laboratory Value|0|||
47045695|NCT01272934|83304095|FG001|Overall Study|Abnormal Laboratory Value|1|||
47045696|NCT01983683|83304113|FG000|Overall Study|Withdrawal by Subject|14|||
46634546|NCT01742286|82808008|FG005|Expansion Phase|Administrative problems|0|||
46634547|NCT01742286|82808009|FG006|Expansion Phase|Administrative problems|5|||
46634548|NCT01742286|82808003|FG000|Expansion Phase|Physician Decision|0|||
46634549|NCT01742286|82808004|FG001|Expansion Phase|Physician Decision|0|||
46634550|NCT01742286|82808005|FG002|Expansion Phase|Physician Decision|4|||
46634551|NCT01742286|82808006|FG003|Expansion Phase|Physician Decision|0|||
46634552|NCT01742286|82808007|FG004|Expansion Phase|Physician Decision|0|||
46634553|NCT01742286|82808008|FG005|Expansion Phase|Physician Decision|0|||
46634554|NCT01742286|82808009|FG006|Expansion Phase|Physician Decision|9|||
46634555|NCT01742286|82808003|FG000|Expansion Phase|Adverse Event|0|||
46634556|NCT01742286|82808004|FG001|Expansion Phase|Adverse Event|0|||
46634557|NCT01742286|82808005|FG002|Expansion Phase|Adverse Event|0|||
46634558|NCT01742286|82808006|FG003|Expansion Phase|Adverse Event|0|||
46634559|NCT01742286|82808007|FG004|Expansion Phase|Adverse Event|0|||
46634560|NCT01742286|82808008|FG005|Expansion Phase|Adverse Event|0|||
47045697|NCT01983683|83304114|FG001|Overall Study|Withdrawal by Subject|18|||
46725461|NCT01137578|82941253|FG001|Overall Study|Withdrawal by Subject|0|||
46725462|NCT01137578|82941254|FG002|Overall Study|Withdrawal by Subject|0|||
46634561|NCT01742286|82808009|FG006|Expansion Phase|Adverse Event|6|||
46634562|NCT01742286|82808003|FG000|Expansion Phase|Disease progression|0|||
46634563|NCT01742286|82808004|FG001|Expansion Phase|Disease progression|0|||
46725463|NCT01137578|82941252|FG000|Overall Study|Other|12|||
47045698|NCT01983683|83304113|FG000|Overall Study|Death|11|||
47045699|NCT01983683|83304114|FG001|Overall Study|Death|15|||
47045700|NCT01983683|83304113|FG000|Overall Study|Physician Decision|8|||
47045701|NCT01983683|83304114|FG001|Overall Study|Physician Decision|9|||
47045702|NCT01983683|83304113|FG000|Overall Study|Lost to Follow-up|4|||
47045703|NCT01983683|83304114|FG001|Overall Study|Lost to Follow-up|8|||
47045704|NCT01983683|83304113|FG000|Overall Study|Sponsor Decision|1|||
47045705|NCT01983683|83304114|FG001|Overall Study|Sponsor Decision|1|||
47045706|NCT01998893|83304120|FG000|Overall Study|Adverse Event|2|||
47045707|NCT01998893|83304120|FG000|Overall Study|Death|1|||
47045708|NCT01998893|83304120|FG000|Overall Study|Lost to Follow-up|8|||
47045709|NCT01998893|83304120|FG000|Overall Study|Physician Decision|2|||
47045710|NCT01998893|83304120|FG000|Overall Study|Protocol Violation|2|||
47045711|NCT01998893|83304120|FG000|Overall Study|Withdrawal by Subject|1|||
47045712|NCT01998893|83304120|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
47045713|NCT01791985|83304124|FG000|Overall Study|Adverse Event|7|||
46634564|NCT01742286|82808005|FG002|Expansion Phase|Disease progression|3|||
47045714|NCT01791985|83304124|FG000|Overall Study|Withdrawal by Subject|1|||
47045715|NCT01998737|83304131|FG000|Overall Study|Corrupted database|23|||
47045716|NCT01998737|83304132|FG001|Overall Study|Corrupted database|0|||
47045717|NCT01791517|83304141|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
46634565|NCT01742286|82808006|FG003|Expansion Phase|Disease progression|0|||
47045718|NCT01791517|83304142|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
47045719|NCT01791517|83304143|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
47045720|NCT01791517|83304144|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
47045721|NCT01791517|83304145|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
47045722|NCT01791517|83304146|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
47045723|NCT01791517|83304147|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
47045724|NCT01791517|83304148|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
47045725|NCT01791517|83304149|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
47045726|NCT01791517|83304150|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
47045727|NCT01791517|83304151|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
47045728|NCT01791517|83304152|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
47045729|NCT01791517|83304141|FG000|Phase I: Period 1|Adverse Event|0|||
47045730|NCT01791517|83304142|FG001|Phase I: Period 1|Adverse Event|0|||
47045731|NCT01791517|83304143|FG002|Phase I: Period 1|Adverse Event|1|||
47045732|NCT01791517|83304144|FG003|Phase I: Period 1|Adverse Event|1|||
47045733|NCT01791517|83304145|FG004|Phase I: Period 1|Adverse Event|0|||
46725464|NCT01137578|82941253|FG001|Overall Study|Other|2|||
46725465|NCT01137578|82941254|FG002|Overall Study|Other|6|||
46725466|NCT00946920|82941284|FG000|Overall Study|Withdrawal by Subject|28|||
46725467|NCT00946920|82941285|FG001|Overall Study|Withdrawal by Subject|15|||
46725468|NCT00946920|82941284|FG000|Overall Study|Lost to Follow-up|2|||
46725469|NCT00946920|82941285|FG001|Overall Study|Lost to Follow-up|2|||
46725470|NCT00946920|82941284|FG000|Overall Study|Physician Decision|5|||
46725471|NCT00946920|82941285|FG001|Overall Study|Physician Decision|2|||
46725472|NCT00946920|82941284|FG000|Overall Study|Adverse Event|41|||
46725473|NCT00946920|82941285|FG001|Overall Study|Adverse Event|14|||
46725474|NCT00946920|82941284|FG000|Overall Study|Protocol Violation|16|||
46725475|NCT00946920|82941285|FG001|Overall Study|Protocol Violation|8|||
46725476|NCT00946920|82941284|FG000|Overall Study|Miscellaneous reasons|18|||
46725477|NCT00946920|82941285|FG001|Overall Study|Miscellaneous reasons|3|||
46725478|NCT00946530|82941295|FG000|Overall Study|Withdrawal by Subject|0|||
46725479|NCT00946530|82941296|FG001|Overall Study|Withdrawal by Subject|3|||
46725480|NCT00946530|82941297|FG002|Overall Study|Withdrawal by Subject|0|||
46725481|NCT00946530|82941298|FG003|Overall Study|Withdrawal by Subject|3|||
46725482|NCT00946530|82941295|FG000|Overall Study|Physician Decision|1|||
46725483|NCT00946530|82941296|FG001|Overall Study|Physician Decision|1|||
46803641|NCT03523728|83022941|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
46803642|NCT03523728|83022942|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
46725484|NCT00946530|82941297|FG002|Overall Study|Physician Decision|1|||
46725485|NCT00946530|82941298|FG003|Overall Study|Physician Decision|1|||
46725486|NCT00946296|82941314|FG000|Overall Study|Physician Decision|3|||
47045734|NCT01791517|83304146|FG005|Phase I: Period 1|Adverse Event|0|||
47045735|NCT01791517|83304147|FG006|Phase I: Period 1|Adverse Event|0|||
47045736|NCT01791517|83304148|FG007|Phase I: Period 1|Adverse Event|0|||
46725487|NCT00946296|82941315|FG001|Overall Study|Physician Decision|0|||
46725488|NCT00945906|82941321|FG000|Overall Study|Withdrawal by Subject|1|||
46725489|NCT00945906|82941321|FG000|Overall Study|Did not want to return for last visit|2|||
46803643|NCT03523728|83022938|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
47045737|NCT01791517|83304149|FG008|Phase I: Period 1|Adverse Event|0|||
46725490|NCT00945906|82941321|FG000|Overall Study|Unable to return for last visit|2|||
46920911|NCT03086369|83153175|FG001|Overall Study|Physician Decision|0|||
46920912|NCT03086369|83153176|FG002|Overall Study|Physician Decision|0|||
46920913|NCT03086369|83153177|FG003|Overall Study|Physician Decision|1|||
47045738|NCT01791517|83304150|FG009|Phase I: Period 1|Adverse Event|0|||
47045739|NCT01791517|83304151|FG010|Phase I: Period 1|Adverse Event|0|||
47045740|NCT01791517|83304152|FG011|Phase I: Period 1|Adverse Event|0|||
47045741|NCT01791517|83304141|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
47045742|NCT01791517|83304142|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045743|NCT01791517|83304143|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045744|NCT01791517|83304144|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045745|NCT01791517|83304145|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045746|NCT01791517|83304146|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045747|NCT01791517|83304147|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045748|NCT01791517|83304148|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045749|NCT01791517|83304149|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045750|NCT01791517|83304150|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045751|NCT01791517|83304151|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045752|NCT01791517|83304152|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
47045753|NCT01791517|83304141|FG000|Phase I: Period 1|Protocol Violation|0|||
47045754|NCT01791517|83304142|FG001|Phase I: Period 1|Protocol Violation|1|||
47045755|NCT01791517|83304143|FG002|Phase I: Period 1|Protocol Violation|0|||
47045756|NCT01791517|83304144|FG003|Phase I: Period 1|Protocol Violation|0|||
47045757|NCT01791517|83304145|FG004|Phase I: Period 1|Protocol Violation|0|||
46634566|NCT01742286|82808007|FG004|Expansion Phase|Disease progression|0|||
46634567|NCT01742286|82808008|FG005|Expansion Phase|Disease progression|0|||
47045758|NCT01791517|83304146|FG005|Phase I: Period 1|Protocol Violation|0|||
47045759|NCT01791517|83304147|FG006|Phase I: Period 1|Protocol Violation|0|||
47045760|NCT01791517|83304148|FG007|Phase I: Period 1|Protocol Violation|0|||
47045761|NCT01791517|83304149|FG008|Phase I: Period 1|Protocol Violation|0|||
47045762|NCT01791517|83304150|FG009|Phase I: Period 1|Protocol Violation|0|||
46634568|NCT01742286|82808009|FG006|Expansion Phase|Disease progression|15|||
46634569|NCT01742286|82808003|FG000|Expansion Phase|Withdrawal by Subject|0|||
46634570|NCT01742286|82808004|FG001|Expansion Phase|Withdrawal by Subject|0|||
46634571|NCT01742286|82808005|FG002|Expansion Phase|Withdrawal by Subject|0|||
46634572|NCT01742286|82808006|FG003|Expansion Phase|Withdrawal by Subject|0|||
46634573|NCT01742286|82808007|FG004|Expansion Phase|Withdrawal by Subject|0|||
46634574|NCT01742286|82808008|FG005|Expansion Phase|Withdrawal by Subject|0|||
46634575|NCT01742286|82808009|FG006|Expansion Phase|Withdrawal by Subject|1|||
46634576|NCT01697358|82808034|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
46634577|NCT01697358|82808035|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
46634578|NCT01697358|82808034|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
46634579|NCT01697358|82808035|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
46634580|NCT01697358|82808034|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
46634581|NCT01697358|82808035|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
46634582|NCT01697358|82808034|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
46725491|NCT00945906|82941321|FG000|Overall Study|Moved to another country|2|||
46725492|NCT00594646|82941325|FG000|Overall Study|Withdrawal by Subject|1|||
46634583|NCT01697358|82808035|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
46725493|NCT00594646|82941325|FG000|Overall Study|Lost to Follow-up|15|||
46725494|NCT01111604|82941333|FG000|Overall Study|Lost to Follow-up|0|||
46725495|NCT01111604|82941334|FG001|Overall Study|Lost to Follow-up|0|||
46725496|NCT01111604|82941335|FG002|Overall Study|Lost to Follow-up|1|||
46725497|NCT01111604|82941333|FG000|Overall Study|Withdrew Consent|3|||
46725498|NCT01111604|82941334|FG001|Overall Study|Withdrew Consent|0|||
46725499|NCT01111604|82941335|FG002|Overall Study|Withdrew Consent|2|||
46725500|NCT01111604|82941333|FG000|Overall Study|Withdrawal by Subject|2|||
46725501|NCT01111604|82941334|FG001|Overall Study|Withdrawal by Subject|0|||
46725502|NCT01111604|82941335|FG002|Overall Study|Withdrawal by Subject|0|||
46725503|NCT01111604|82941333|FG000|Overall Study|Death|1|||
46725504|NCT01111604|82941334|FG001|Overall Study|Death|0|||
46725505|NCT01111604|82941335|FG002|Overall Study|Death|0|||
46725506|NCT01111604|82941333|FG000|Overall Study|Met Exclusion Criteria|2|||
46725507|NCT01111604|82941334|FG001|Overall Study|Met Exclusion Criteria|0|||
46725508|NCT01111604|82941335|FG002|Overall Study|Met Exclusion Criteria|0|||
47045763|NCT01791517|83304151|FG010|Phase I: Period 1|Protocol Violation|0|||
46725509|NCT00950742|82941363|FG000|Overall Study|Other Adverse Event|1|||
46725510|NCT00950742|82941364|FG001|Overall Study|Other Adverse Event|0|||
46725511|NCT00950742|82941363|FG000|Overall Study|Withdrawal by Subject|3|||
46725512|NCT00950742|82941364|FG001|Overall Study|Withdrawal by Subject|0|||
46725513|NCT00950742|82941363|FG000|Overall Study|Progressive Disease|6|||
46725514|NCT00950742|82941364|FG001|Overall Study|Progressive Disease|2|||
46725515|NCT00950742|82941363|FG000|Overall Study|Dose limiting toxicity|6|||
46725516|NCT00950742|82941364|FG001|Overall Study|Dose limiting toxicity|0|||
46725517|NCT00955110|82941374|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
46725518|NCT00955110|82941374|FG000|Treatment Phase|Adverse Event|2|||
46725519|NCT00955110|82941374|FG000|Treatment Phase|Administrative reasons|2|||
46725520|NCT00955110|82941374|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
46725521|NCT00955110|82941374|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
46725522|NCT00950664|82941388|FG000|First Intervention|Lost to Follow-up|1|||
46725523|NCT00950664|82941389|FG001|First Intervention|Lost to Follow-up|3|||
46725524|NCT00950664|82941388|FG000|First Intervention|Withdrawal by Subject|2|||
46725525|NCT00950664|82941389|FG001|First Intervention|Withdrawal by Subject|2|||
46725526|NCT01111526|82941395|FG000|Overall Study|GVHD Disease Progression|0|||
46725527|NCT01111526|82941396|FG001|Overall Study|GVHD Disease Progression|1|||
46725528|NCT01111526|82941397|FG002|Overall Study|GVHD Disease Progression|2|||
46725529|NCT01111292|82941403|FG000|Treatment|Physician Decision|1|||
46725530|NCT01111292|82941404|FG001|Treatment|Physician Decision|1|||
46725531|NCT00944658|82941412|FG000|Treatment 12 Weeks|Adverse Event|0|||
46725532|NCT00944658|82941413|FG001|Treatment 12 Weeks|Adverse Event|2|||
46920914|NCT03086369|83153178|FG004|Overall Study|Physician Decision|2|||
47045764|NCT01791517|83304152|FG011|Phase I: Period 1|Protocol Violation|0|||
47045765|NCT01791517|83304141|FG000|Phase I: Period 1|Lost to Follow-up|0|||
46920915|NCT03086369|83153174|FG000|Overall Study|Withdrawal by Subject|0|||
46920916|NCT03086369|83153175|FG001|Overall Study|Withdrawal by Subject|0|||
46920917|NCT03086369|83153176|FG002|Overall Study|Withdrawal by Subject|0|||
46920918|NCT03086369|83153177|FG003|Overall Study|Withdrawal by Subject|5|||
46920919|NCT03086369|83153178|FG004|Overall Study|Withdrawal by Subject|3|||
46920920|NCT03086369|83153174|FG000|Overall Study|Progressive Disease|0|||
46920921|NCT03086369|83153175|FG001|Overall Study|Progressive Disease|0|||
46920922|NCT03086369|83153176|FG002|Overall Study|Progressive Disease|0|||
47045766|NCT01791517|83304142|FG001|Phase I: Period 1|Lost to Follow-up|0|||
47045767|NCT01791517|83304143|FG002|Phase I: Period 1|Lost to Follow-up|0|||
47045768|NCT01791517|83304144|FG003|Phase I: Period 1|Lost to Follow-up|1|||
47045769|NCT01791517|83304145|FG004|Phase I: Period 1|Lost to Follow-up|0|||
47045770|NCT01791517|83304146|FG005|Phase I: Period 1|Lost to Follow-up|0|||
47045771|NCT01791517|83304147|FG006|Phase I: Period 1|Lost to Follow-up|1|||
47045772|NCT01791517|83304148|FG007|Phase I: Period 1|Lost to Follow-up|0|||
47045773|NCT01791517|83304149|FG008|Phase I: Period 1|Lost to Follow-up|1|||
47045774|NCT01791517|83304150|FG009|Phase I: Period 1|Lost to Follow-up|1|||
47045775|NCT01791517|83304151|FG010|Phase I: Period 1|Lost to Follow-up|0|||
47045776|NCT01791517|83304152|FG011|Phase I: Period 1|Lost to Follow-up|0|||
47045777|NCT01791517|83304141|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045778|NCT01791517|83304142|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045779|NCT01791517|83304143|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045780|NCT01791517|83304144|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045781|NCT01791517|83304145|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045782|NCT01791517|83304146|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045783|NCT01791517|83304147|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045784|NCT01791517|83304148|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045785|NCT01791517|83304149|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
47045786|NCT01791517|83304150|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
46920923|NCT03086369|83153177|FG003|Overall Study|Progressive Disease|1|||
46920924|NCT03086369|83153178|FG004|Overall Study|Progressive Disease|1|||
46920925|NCT00101582|83153194|FG000|Overall Study|Ineligibility determined|0|||
46920926|NCT00101582|83153195|FG001|Overall Study|Ineligibility determined|1|||
46920927|NCT00101582|83153194|FG000|Overall Study|Adverse Event|1|||
46920928|NCT00101582|83153195|FG001|Overall Study|Adverse Event|4|||
47045787|NCT01791517|83304151|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
46725533|NCT01110200|82941421|FG000|Overall Study|Adverse Event|28|||
46725534|NCT01110200|82941422|FG001|Overall Study|Adverse Event|28|||
47045788|NCT01791517|83304152|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
47045789|NCT01791517|83304141|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
47045790|NCT01791517|83304142|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045791|NCT01791517|83304143|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045792|NCT01791517|83304144|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045793|NCT01791517|83304145|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045794|NCT01791517|83304146|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045795|NCT01791517|83304147|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045796|NCT01791517|83304148|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045797|NCT01791517|83304149|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045798|NCT01791517|83304150|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045799|NCT01791517|83304151|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045800|NCT01791517|83304152|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
47045801|NCT01791517|83304141|FG000|Phase I: Period 2|Protocol Violation|0|||
47045802|NCT01791517|83304142|FG001|Phase I: Period 2|Protocol Violation|0|||
47045803|NCT01791517|83304143|FG002|Phase I: Period 2|Protocol Violation|0|||
47045804|NCT01791517|83304144|FG003|Phase I: Period 2|Protocol Violation|1|||
47045805|NCT01791517|83304145|FG004|Phase I: Period 2|Protocol Violation|0|||
47045806|NCT01791517|83304146|FG005|Phase I: Period 2|Protocol Violation|0|||
47045807|NCT01791517|83304147|FG006|Phase I: Period 2|Protocol Violation|0|||
47045808|NCT01791517|83304148|FG007|Phase I: Period 2|Protocol Violation|0|||
47045809|NCT01791517|83304149|FG008|Phase I: Period 2|Protocol Violation|0|||
47045810|NCT01791517|83304150|FG009|Phase I: Period 2|Protocol Violation|0|||
47045811|NCT01791517|83304151|FG010|Phase I: Period 2|Protocol Violation|0|||
47045812|NCT01791517|83304152|FG011|Phase I: Period 2|Protocol Violation|0|||
47045813|NCT01791517|83304141|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
47045814|NCT01791517|83304142|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
47045815|NCT01791517|83304143|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
46725535|NCT01110200|82941421|FG000|Overall Study|Withdrawal by Subject|25|||
46725536|NCT01110200|82941422|FG001|Overall Study|Withdrawal by Subject|32|||
46725537|NCT01110200|82941421|FG000|Overall Study|Lack of Efficacy|16|||
46725538|NCT01110200|82941422|FG001|Overall Study|Lack of Efficacy|25|||
46725539|NCT01110200|82941421|FG000|Overall Study|Protocol Violation|14|||
46725540|NCT01110200|82941422|FG001|Overall Study|Protocol Violation|12|||
47045816|NCT01791517|83304144|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
47045817|NCT01791517|83304145|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
47045818|NCT01791517|83304146|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
47045819|NCT01791517|83304147|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
47045820|NCT01791517|83304148|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
47045821|NCT01791517|83304149|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
47045822|NCT01791517|83304150|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
47045823|NCT01791517|83304151|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
47045824|NCT01791517|83304152|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
47045825|NCT01791517|83304141|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045826|NCT01791517|83304142|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045827|NCT01791517|83304143|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045828|NCT01791517|83304144|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045829|NCT01791517|83304145|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045830|NCT01791517|83304146|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045831|NCT01791517|83304147|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045832|NCT01791517|83304148|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045833|NCT01791517|83304149|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045834|NCT01791517|83304150|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045835|NCT01791517|83304151|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
47045836|NCT01791517|83304152|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
47045837|NCT01791517|83304141|FG000|Phase I: Period 2|Lens Discomfort|0|||
47045838|NCT01791517|83304142|FG001|Phase I: Period 2|Lens Discomfort|0|||
47045839|NCT01791517|83304143|FG002|Phase I: Period 2|Lens Discomfort|0|||
47045840|NCT01791517|83304144|FG003|Phase I: Period 2|Lens Discomfort|0|||
47045841|NCT01791517|83304145|FG004|Phase I: Period 2|Lens Discomfort|0|||
47045842|NCT01791517|83304146|FG005|Phase I: Period 2|Lens Discomfort|1|||
47045843|NCT01791517|83304147|FG006|Phase I: Period 2|Lens Discomfort|0|||
47045844|NCT01791517|83304148|FG007|Phase I: Period 2|Lens Discomfort|0|||
47045845|NCT01791517|83304149|FG008|Phase I: Period 2|Lens Discomfort|0|||
47045846|NCT01791517|83304150|FG009|Phase I: Period 2|Lens Discomfort|0|||
47045847|NCT01791517|83304151|FG010|Phase I: Period 2|Lens Discomfort|0|||
47045848|NCT01791517|83304152|FG011|Phase I: Period 2|Lens Discomfort|0|||
47045849|NCT01791517|83304141|FG000|Phase I: Period 2|Lost to Follow-up|0|||
47045850|NCT01791517|83304142|FG001|Phase I: Period 2|Lost to Follow-up|3|||
47045851|NCT01791517|83304143|FG002|Phase I: Period 2|Lost to Follow-up|2|||
47045852|NCT01791517|83304144|FG003|Phase I: Period 2|Lost to Follow-up|0|||
47045853|NCT01791517|83304145|FG004|Phase I: Period 2|Lost to Follow-up|0|||
47045854|NCT01791517|83304146|FG005|Phase I: Period 2|Lost to Follow-up|0|||
47045855|NCT01791517|83304147|FG006|Phase I: Period 2|Lost to Follow-up|0|||
47045856|NCT01791517|83304148|FG007|Phase I: Period 2|Lost to Follow-up|0|||
47045857|NCT01791517|83304149|FG008|Phase I: Period 2|Lost to Follow-up|0|||
47045858|NCT01791517|83304150|FG009|Phase I: Period 2|Lost to Follow-up|0|||
47045859|NCT01791517|83304151|FG010|Phase I: Period 2|Lost to Follow-up|0|||
47045860|NCT01791517|83304152|FG011|Phase I: Period 2|Lost to Follow-up|0|||
46634584|NCT01697358|82808034|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
46634585|NCT01697358|82808035|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
46634586|NCT01697358|82808034|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
47045861|NCT01791517|83304141|FG000|Phase I: Period 3|Lens Discomfort|0|||
47045862|NCT01791517|83304142|FG001|Phase I: Period 3|Lens Discomfort|0|||
47045863|NCT01791517|83304143|FG002|Phase I: Period 3|Lens Discomfort|0|||
47045864|NCT01791517|83304144|FG003|Phase I: Period 3|Lens Discomfort|0|||
47045865|NCT01791517|83304145|FG004|Phase I: Period 3|Lens Discomfort|0|||
47045866|NCT01791517|83304146|FG005|Phase I: Period 3|Lens Discomfort|0|||
47045867|NCT01791517|83304147|FG006|Phase I: Period 3|Lens Discomfort|0|||
47045868|NCT01791517|83304148|FG007|Phase I: Period 3|Lens Discomfort|0|||
47045869|NCT01791517|83304149|FG008|Phase I: Period 3|Lens Discomfort|0|||
47045870|NCT01791517|83304150|FG009|Phase I: Period 3|Lens Discomfort|0|||
47045871|NCT01791517|83304151|FG010|Phase I: Period 3|Lens Discomfort|0|||
47045872|NCT01791517|83304152|FG011|Phase I: Period 3|Lens Discomfort|1|||
46634587|NCT01697358|82808035|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
46634588|NCT01697358|82808034|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
47045873|NCT01791517|83304141|FG000|Phase I: Period 3|Lost to Follow-up|0|||
46920929|NCT00101582|83153194|FG000|Overall Study|Withdrawal by Subject|6|||
46920930|NCT00101582|83153195|FG001|Overall Study|Withdrawal by Subject|4|||
46920931|NCT00101582|83153194|FG000|Overall Study|Physician Decision|1|||
46920932|NCT00101582|83153195|FG001|Overall Study|Physician Decision|0|||
46920933|NCT00101582|83153194|FG000|Overall Study|Death|3|||
46920934|NCT00101582|83153195|FG001|Overall Study|Death|5|||
46920935|NCT00101582|83153194|FG000|Overall Study|Other|0|||
46920936|NCT00101582|83153195|FG001|Overall Study|Other|1|||
46920937|NCT03086135|83153226|FG000|Overall Study|Adverse Event|1|||
46920938|NCT03086135|83153226|FG000|Overall Study|Lost to Follow-up|2|||
46920939|NCT02762708|83153243|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
46920940|NCT02762708|83153244|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
46920941|NCT02762708|83153245|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
46920942|NCT02762708|83153246|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
46920943|NCT02760602|83153258|FG000|Overall Study|Withdrawal by Subject|1|||
46920944|NCT02760602|83153259|FG001|Overall Study|Withdrawal by Subject|0|||
46920945|NCT02760602|83153258|FG000|Overall Study|Terminated by sponsor|12|||
46920946|NCT02760602|83153259|FG001|Overall Study|Terminated by sponsor|13|||
46920947|NCT00210249|83153265|FG000|Overall Study|Lost to Follow-up|5|||
46920948|NCT00210249|83153265|FG000|Overall Study|Protocol Violation|11|||
46920949|NCT03086057|83153273|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
46920950|NCT03086057|83153274|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
46920951|NCT03086057|83153275|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
47045874|NCT01791517|83304142|FG001|Phase I: Period 3|Lost to Follow-up|1|||
47045875|NCT01791517|83304143|FG002|Phase I: Period 3|Lost to Follow-up|0|||
47045876|NCT01791517|83304144|FG003|Phase I: Period 3|Lost to Follow-up|0|||
47045877|NCT01791517|83304145|FG004|Phase I: Period 3|Lost to Follow-up|1|||
47045878|NCT01791517|83304146|FG005|Phase I: Period 3|Lost to Follow-up|0|||
47045879|NCT01791517|83304147|FG006|Phase I: Period 3|Lost to Follow-up|0|||
47045880|NCT01791517|83304148|FG007|Phase I: Period 3|Lost to Follow-up|0|||
47045881|NCT01791517|83304149|FG008|Phase I: Period 3|Lost to Follow-up|0|||
47045882|NCT01791517|83304150|FG009|Phase I: Period 3|Lost to Follow-up|0|||
47045883|NCT01791517|83304151|FG010|Phase I: Period 3|Lost to Follow-up|0|||
47045884|NCT01791517|83304152|FG011|Phase I: Period 3|Lost to Follow-up|0|||
47045885|NCT01791517|83304141|FG000|Phase I: Period 3|Adverse Event|0|||
47045886|NCT01791517|83304142|FG001|Phase I: Period 3|Adverse Event|0|||
46920952|NCT03086057|83153276|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
46920953|NCT03086057|83153273|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
46920954|NCT03086057|83153274|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
46920955|NCT03086057|83153275|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
46920956|NCT03086057|83153276|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
46920957|NCT03086057|83153273|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
46920958|NCT03086057|83153274|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
46920959|NCT03086057|83153275|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
46920960|NCT03086057|83153276|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
46920961|NCT03086057|83153273|FG000|Stage 1: PrEP Uptake|Death|1|||
46920962|NCT03086057|83153274|FG001|Stage 1: PrEP Uptake|Death|0|||
46920963|NCT03086057|83153275|FG002|Stage 1: PrEP Uptake|Death|0|||
46920964|NCT03086057|83153276|FG003|Stage 1: PrEP Uptake|Death|0|||
46920965|NCT03086057|83153273|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
46920966|NCT03086057|83153274|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
46920967|NCT03086057|83153275|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
46920968|NCT03086057|83153276|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
46920969|NCT03086057|83153273|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
46920970|NCT03086057|83153274|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
46920971|NCT03086057|83153275|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
47045887|NCT01791517|83304143|FG002|Phase I: Period 3|Adverse Event|0|||
46920972|NCT03086057|83153276|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
46920973|NCT03086057|83153273|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
47045888|NCT01791517|83304144|FG003|Phase I: Period 3|Adverse Event|1|||
47045889|NCT01791517|83304145|FG004|Phase I: Period 3|Adverse Event|0|||
47045890|NCT01791517|83304146|FG005|Phase I: Period 3|Adverse Event|0|||
47045891|NCT01791517|83304147|FG006|Phase I: Period 3|Adverse Event|0|||
47045892|NCT01791517|83304148|FG007|Phase I: Period 3|Adverse Event|0|||
47045893|NCT01791517|83304149|FG008|Phase I: Period 3|Adverse Event|0|||
47045894|NCT01791517|83304150|FG009|Phase I: Period 3|Adverse Event|0|||
47045895|NCT01791517|83304151|FG010|Phase I: Period 3|Adverse Event|0|||
47045896|NCT01791517|83304152|FG011|Phase I: Period 3|Adverse Event|0|||
47045897|NCT01791517|83304141|FG000|Phase II|Lost to Follow-up|1|||
47045898|NCT01791517|83304142|FG001|Phase II|Lost to Follow-up|0|||
47045899|NCT01791517|83304143|FG002|Phase II|Lost to Follow-up|1|||
47045900|NCT01791517|83304144|FG003|Phase II|Lost to Follow-up|0|||
47045901|NCT01791517|83304145|FG004|Phase II|Lost to Follow-up|1|||
47045902|NCT01791517|83304146|FG005|Phase II|Lost to Follow-up|2|||
47045903|NCT01791517|83304147|FG006|Phase II|Lost to Follow-up|0|||
47045904|NCT01791517|83304148|FG007|Phase II|Lost to Follow-up|1|||
47045905|NCT01791517|83304149|FG008|Phase II|Lost to Follow-up|1|||
47045906|NCT01791517|83304150|FG009|Phase II|Lost to Follow-up|1|||
47045907|NCT01791517|83304151|FG010|Phase II|Lost to Follow-up|0|||
47045908|NCT01791517|83304152|FG011|Phase II|Lost to Follow-up|0|||
47045909|NCT01791517|83304141|FG000|Phase II|Withdrawal by Subject|1|||
47045910|NCT01791517|83304142|FG001|Phase II|Withdrawal by Subject|0|||
47045911|NCT01791517|83304143|FG002|Phase II|Withdrawal by Subject|0|||
47045912|NCT01791517|83304144|FG003|Phase II|Withdrawal by Subject|0|||
47045913|NCT01791517|83304145|FG004|Phase II|Withdrawal by Subject|0|||
47045914|NCT01791517|83304146|FG005|Phase II|Withdrawal by Subject|2|||
47045915|NCT01791517|83304147|FG006|Phase II|Withdrawal by Subject|0|||
47045916|NCT01791517|83304148|FG007|Phase II|Withdrawal by Subject|1|||
47045917|NCT01791517|83304149|FG008|Phase II|Withdrawal by Subject|0|||
47045918|NCT01791517|83304150|FG009|Phase II|Withdrawal by Subject|0|||
47045919|NCT01791517|83304151|FG010|Phase II|Withdrawal by Subject|1|||
47045920|NCT01791517|83304152|FG011|Phase II|Withdrawal by Subject|0|||
47045921|NCT01791517|83304141|FG000|Phase II|Lack of Efficacy|0|||
47045922|NCT01791517|83304142|FG001|Phase II|Lack of Efficacy|0|||
47045923|NCT01791517|83304143|FG002|Phase II|Lack of Efficacy|0|||
47045924|NCT01791517|83304144|FG003|Phase II|Lack of Efficacy|0|||
47045925|NCT01791517|83304145|FG004|Phase II|Lack of Efficacy|1|||
47045926|NCT01791517|83304146|FG005|Phase II|Lack of Efficacy|0|||
47045927|NCT01791517|83304147|FG006|Phase II|Lack of Efficacy|0|||
47045928|NCT01791517|83304148|FG007|Phase II|Lack of Efficacy|0|||
47045929|NCT01791517|83304149|FG008|Phase II|Lack of Efficacy|0|||
47045930|NCT01791517|83304150|FG009|Phase II|Lack of Efficacy|0|||
47045931|NCT01791517|83304151|FG010|Phase II|Lack of Efficacy|0|||
47045932|NCT01791517|83304152|FG011|Phase II|Lack of Efficacy|0|||
47045933|NCT01791517|83304141|FG000|Phase II|Adverse Event|0|||
47045934|NCT01791517|83304142|FG001|Phase II|Adverse Event|0|||
47045935|NCT01791517|83304143|FG002|Phase II|Adverse Event|0|||
47045936|NCT01791517|83304144|FG003|Phase II|Adverse Event|0|||
47045937|NCT01791517|83304145|FG004|Phase II|Adverse Event|0|||
47045938|NCT01791517|83304146|FG005|Phase II|Adverse Event|0|||
47045939|NCT01791517|83304147|FG006|Phase II|Adverse Event|2|||
47045940|NCT01791517|83304148|FG007|Phase II|Adverse Event|1|||
47045941|NCT01791517|83304149|FG008|Phase II|Adverse Event|0|||
47045942|NCT01791517|83304150|FG009|Phase II|Adverse Event|1|||
47045943|NCT01791517|83304151|FG010|Phase II|Adverse Event|0|||
47045944|NCT01791517|83304152|FG011|Phase II|Adverse Event|0|||
47045945|NCT01791517|83304141|FG000|Phase II|Lens Handling Difficulties|0|||
47045946|NCT01791517|83304142|FG001|Phase II|Lens Handling Difficulties|0|||
47045947|NCT01791517|83304143|FG002|Phase II|Lens Handling Difficulties|0|||
47045948|NCT01791517|83304144|FG003|Phase II|Lens Handling Difficulties|0|||
47045949|NCT01791517|83304145|FG004|Phase II|Lens Handling Difficulties|0|||
47045950|NCT01791517|83304146|FG005|Phase II|Lens Handling Difficulties|0|||
46920974|NCT03086057|83153274|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
46920975|NCT03086057|83153275|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
47045951|NCT01791517|83304147|FG006|Phase II|Lens Handling Difficulties|0|||
47045952|NCT01791517|83304148|FG007|Phase II|Lens Handling Difficulties|0|||
46920976|NCT03086057|83153276|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
46920977|NCT02759120|83153288|FG000|Overall Study|Death|34|||
47045953|NCT01791517|83304149|FG008|Phase II|Lens Handling Difficulties|1|||
47045954|NCT01791517|83304150|FG009|Phase II|Lens Handling Difficulties|0|||
47045955|NCT01791517|83304151|FG010|Phase II|Lens Handling Difficulties|0|||
47045956|NCT01791517|83304152|FG011|Phase II|Lens Handling Difficulties|0|||
47045957|NCT01791517|83304141|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
47045958|NCT01791517|83304142|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
47045959|NCT01791517|83304143|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
47045960|NCT01791517|83304144|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
47045961|NCT01791517|83304145|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
47045962|NCT01791517|83304146|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
47045963|NCT01791517|83304147|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
47045964|NCT01791517|83304148|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
46634589|NCT01697358|82808035|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
46634590|NCT01697358|82808034|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
46920978|NCT02759120|83153289|FG001|Overall Study|Death|36|||
46920979|NCT02759120|83153288|FG000|Overall Study|Lost to Follow-up|4|||
47045965|NCT01791517|83304149|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
47045966|NCT01791517|83304150|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
47045967|NCT01791517|83304151|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
47045968|NCT01791517|83304152|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
47045969|NCT01791517|83304141|FG000|Phase II|Pre-Existing Ocular Issue|0|||
47045970|NCT01791517|83304142|FG001|Phase II|Pre-Existing Ocular Issue|0|||
47045971|NCT01791517|83304143|FG002|Phase II|Pre-Existing Ocular Issue|0|||
47045972|NCT01791517|83304144|FG003|Phase II|Pre-Existing Ocular Issue|0|||
47045973|NCT01791517|83304145|FG004|Phase II|Pre-Existing Ocular Issue|0|||
47045974|NCT01791517|83304146|FG005|Phase II|Pre-Existing Ocular Issue|0|||
47045975|NCT01791517|83304147|FG006|Phase II|Pre-Existing Ocular Issue|0|||
47045976|NCT01791517|83304148|FG007|Phase II|Pre-Existing Ocular Issue|0|||
47045977|NCT01791517|83304149|FG008|Phase II|Pre-Existing Ocular Issue|0|||
47045978|NCT01791517|83304150|FG009|Phase II|Pre-Existing Ocular Issue|0|||
47045979|NCT01791517|83304151|FG010|Phase II|Pre-Existing Ocular Issue|0|||
47045980|NCT01791517|83304152|FG011|Phase II|Pre-Existing Ocular Issue|1|||
47045981|NCT01998581|83304172|FG000|Overall Study|Refused repeat treatment|20|||
47045982|NCT01998581|83304173|FG001|Overall Study|Refused repeat treatment|4|||
47045983|NCT01998581|83304172|FG000|Overall Study|Protocol Violation|1|||
47045984|NCT01998581|83304173|FG001|Overall Study|Protocol Violation|0|||
47045985|NCT01998581|83304172|FG000|Overall Study|Withdrawal by Subject|8|||
47045986|NCT01998581|83304173|FG001|Overall Study|Withdrawal by Subject|1|||
47045987|NCT01998581|83304172|FG000|Overall Study|Lost to Follow-up|12|||
47045988|NCT01998581|83304173|FG001|Overall Study|Lost to Follow-up|4|||
47045989|NCT01998581|83304172|FG000|Overall Study|Adverse Event|1|||
47045990|NCT01998581|83304173|FG001|Overall Study|Adverse Event|1|||
47045991|NCT01998581|83304172|FG000|Overall Study|Other reasons|3|||
47045992|NCT01998581|83304173|FG001|Overall Study|Other reasons|2|||
47045993|NCT01998581|83304172|FG000|Overall Study|Randomized but withdrew before treatment|1|||
47045994|NCT01998581|83304173|FG001|Overall Study|Randomized but withdrew before treatment|0|||
47045995|NCT01983293|83304182|FG000|Overall Study|Withdrawal by Subject|29|||
47045996|NCT01983293|83304183|FG001|Overall Study|Withdrawal by Subject|15|||
47045997|NCT01983293|83304182|FG000|Overall Study|Missing 12-month visit|3|||
47045998|NCT01983293|83304183|FG001|Overall Study|Missing 12-month visit|3|||
47045999|NCT01983293|83304182|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
47046000|NCT01983293|83304183|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
47046001|NCT01791205|83304191|FG000|Phase II|Lack of Efficacy|6|||
47046002|NCT01791205|83304192|FG001|Phase II|Lack of Efficacy|0|||
47046003|NCT01791205|83304191|FG000|Phase II|Adverse Event|2|||
47046004|NCT01791205|83304192|FG001|Phase II|Adverse Event|0|||
47046005|NCT01791205|83304191|FG000|Phase II|Safety|1|||
47046006|NCT01791205|83304192|FG001|Phase II|Safety|0|||
47046007|NCT01791205|83304191|FG000|Phase II|Lost to Follow-up|1|||
47046008|NCT01791205|83304192|FG001|Phase II|Lost to Follow-up|0|||
47046009|NCT01791205|83304191|FG000|Phase II|Remission of disease|1|||
47046010|NCT01791205|83304192|FG001|Phase II|Remission of disease|0|||
47046011|NCT01791205|83304191|FG000|Phase II|Physician's decision|1|||
47046012|NCT01791205|83304192|FG001|Phase II|Physician's decision|0|||
47046013|NCT01272232|83304201|FG000|Weeks 0-56|Adverse Event|39|||
47046014|NCT01272232|83304202|FG001|Weeks 0-56|Adverse Event|18|||
47046015|NCT01272232|83304203|FG002|Weeks 0-56|Adverse Event|7|||
47046016|NCT01272232|83304201|FG000|Weeks 0-56|Lack of Efficacy|0|||
47046017|NCT01272232|83304202|FG001|Weeks 0-56|Lack of Efficacy|0|||
47046018|NCT01272232|83304203|FG002|Weeks 0-56|Lack of Efficacy|3|||
46634591|NCT01697358|82808035|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
46634592|NCT01697358|82808034|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
47046019|NCT01272232|83304201|FG000|Weeks 0-56|Protocol Violation|12|||
47046020|NCT01272232|83304202|FG001|Weeks 0-56|Protocol Violation|8|||
47046021|NCT01272232|83304203|FG002|Weeks 0-56|Protocol Violation|13|||
47046022|NCT01272232|83304201|FG000|Weeks 0-56|Withdrawal criteria|32|||
46634593|NCT01697358|82808035|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
46920980|NCT02759120|83153289|FG001|Overall Study|Lost to Follow-up|7|||
47046023|NCT01272232|83304202|FG001|Weeks 0-56|Withdrawal criteria|14|||
47046024|NCT01272232|83304203|FG002|Weeks 0-56|Withdrawal criteria|37|||
47046025|NCT01272232|83304201|FG000|Weeks 0-56|Unclassified|16|||
47046026|NCT01272232|83304202|FG001|Weeks 0-56|Unclassified|7|||
47046027|NCT01272232|83304203|FG002|Weeks 0-56|Unclassified|12|||
47046028|NCT01272232|83304201|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
47046029|NCT01272232|83304202|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
47046030|NCT01272232|83304203|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
46920981|NCT02759120|83153288|FG000|Overall Study|Physician Decision|3|||
46920982|NCT02759120|83153289|FG001|Overall Study|Physician Decision|0|||
47046031|NCT01272232|83304201|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
47046032|NCT01272232|83304202|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
47046033|NCT01272232|83304203|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
47046034|NCT01272232|83304201|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
47046035|NCT01272232|83304202|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
47046036|NCT01272232|83304203|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
47046037|NCT01272232|83304201|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
47046038|NCT01272232|83304202|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
47046039|NCT01272232|83304203|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
47046040|NCT01272232|83304201|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
47046041|NCT01272232|83304202|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
47046042|NCT01272232|83304203|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
47046043|NCT01791127|83304211|FG000|Overall Study|Death|356|||
47046044|NCT01791127|83304211|FG000|Overall Study|Patient has withdrawn from study|293|||
47046045|NCT01791127|83304211|FG000|Overall Study|Lost to Follow-up|42|||
47046046|NCT01791127|83304211|FG000|Overall Study|All Siello leads are explanted|31|||
47046047|NCT01791127|83304211|FG000|Overall Study|Completion of 30 day safety registry|1|||
47046048|NCT01791127|83304211|FG000|Overall Study|Study terminated for EP Passion|749|||
47046049|NCT01997333|83304242|FG000|Randomization and Treatment|Disease Progression|70|||
47046050|NCT01997333|83304243|FG001|Randomization and Treatment|Disease Progression|159|||
47046051|NCT01997333|83304242|FG000|Randomization and Treatment|Adverse Event|10|||
47046052|NCT01997333|83304243|FG001|Randomization and Treatment|Adverse Event|32|||
47046053|NCT01997333|83304242|FG000|Randomization and Treatment|Physician Decision|0|||
47046054|NCT01997333|83304243|FG001|Randomization and Treatment|Physician Decision|4|||
47046055|NCT01997333|83304242|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
46634594|NCT01697358|82808034|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
46920983|NCT02759120|83153288|FG000|Overall Study|Withdrawal by Subject|28|||
46920984|NCT02759120|83153289|FG001|Overall Study|Withdrawal by Subject|15|||
46920985|NCT02759120|83153288|FG000|Overall Study|Moved out of area|3|||
46920986|NCT02759120|83153289|FG001|Overall Study|Moved out of area|4|||
46920987|NCT02759120|83153288|FG000|Overall Study|Lung transplant|3|||
46920988|NCT02759120|83153289|FG001|Overall Study|Lung transplant|5|||
46920989|NCT02759120|83153288|FG000|Overall Study|Other reason not completed|10|||
46634595|NCT01697358|82808035|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
46920990|NCT02759120|83153289|FG001|Overall Study|Other reason not completed|12|||
46920991|NCT00101192|83153308|FG000|Overall Study|Ineligible|6|||
46920992|NCT00101192|83153308|FG000|Overall Study|Inevaluable|1|||
46920993|NCT03031431|83153312|FG000|Overall Study|Infant removed by maternal request|1|||
46920994|NCT03029247|83153318|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
47046056|NCT01997333|83304243|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
47046057|NCT01997333|83304242|FG000|Randomization and Treatment|Did not receive treatment|17|||
47046058|NCT01997333|83304243|FG001|Randomization and Treatment|Did not receive treatment|5|||
47046059|NCT01997333|83304242|FG000|Survival Follow up|Withdrawal by Subject|15|||
47046060|NCT01997333|83304243|FG001|Survival Follow up|Withdrawal by Subject|6|||
47046061|NCT01997333|83304242|FG000|Survival Follow up|Lost to Follow-up|0|||
47046062|NCT01997333|83304243|FG001|Survival Follow up|Lost to Follow-up|6|||
46634596|NCT01716234|82808048|FG000|Overall Study|Protocol Violation|0|||
46725541|NCT01110200|82941421|FG000|Overall Study|Physician Decision|13|||
46725542|NCT01110200|82941422|FG001|Overall Study|Physician Decision|17|||
46725543|NCT01110200|82941421|FG000|Overall Study|Lost to Follow-up|10|||
46725544|NCT01110200|82941422|FG001|Overall Study|Lost to Follow-up|7|||
46725545|NCT01108796|82941432|FG000|Overall Study|Adverse Event|0|||
46725546|NCT01108796|82941433|FG001|Overall Study|Adverse Event|1|||
47046063|NCT01997333|83304242|FG000|Survival Follow up|Various|1|||
47046064|NCT01997333|83304243|FG001|Survival Follow up|Various|2|||
47046065|NCT01982435|83304307|FG000|Overall Study|Adverse Event|1|||
47046066|NCT01982435|83304308|FG001|Overall Study|Adverse Event|0|||
47046067|NCT01620983|83304348|FG000|Overall Study|Lost to Follow-up|8|||
47046068|NCT01620983|83304349|FG001|Overall Study|Lost to Follow-up|4|||
47046069|NCT01620983|83304350|FG002|Overall Study|Lost to Follow-up|9|||
47046070|NCT01620983|83304348|FG000|Overall Study|Withdrawal by Subject|6|||
47046071|NCT01620983|83304349|FG001|Overall Study|Withdrawal by Subject|8|||
47046072|NCT01620983|83304350|FG002|Overall Study|Withdrawal by Subject|1|||
47046073|NCT01620983|83304348|FG000|Overall Study|Death|2|||
47046074|NCT01620983|83304349|FG001|Overall Study|Death|0|||
47046075|NCT01620983|83304350|FG002|Overall Study|Death|0|||
47046076|NCT01620983|83304348|FG000|Overall Study|Physician Decision|3|||
47046077|NCT01620983|83304349|FG001|Overall Study|Physician Decision|10|||
47046078|NCT01620983|83304350|FG002|Overall Study|Physician Decision|5|||
47046079|NCT01996709|83304360|FG000|Overall Study|Withdrawal by Subject|1|||
47046080|NCT01996709|83304361|FG001|Overall Study|Withdrawal by Subject|0|||
47046081|NCT01996709|83304360|FG000|Overall Study|Lost to Follow-up|3|||
47046082|NCT01996709|83304361|FG001|Overall Study|Lost to Follow-up|0|||
47046083|NCT01996709|83304360|FG000|Overall Study|Subject Non-Compliant|1|||
47046084|NCT01996709|83304361|FG001|Overall Study|Subject Non-Compliant|0|||
47046085|NCT01996709|83304360|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
47046086|NCT01996709|83304361|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
47046087|NCT01996319|83304386|FG000|Overall Study|Protocol Violation|1|||
47046088|NCT01996319|83304387|FG001|Overall Study|Protocol Violation|0|||
47046089|NCT01996319|83304386|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
47046090|NCT01996319|83304387|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
46634597|NCT01716234|82808049|FG001|Overall Study|Protocol Violation|0|||
47046091|NCT01996319|83304386|FG000|Overall Study|Adverse Event|2|||
47046092|NCT01996319|83304387|FG001|Overall Study|Adverse Event|2|||
47046093|NCT01279486|83304393|FG000|Overall Study|Lost to Follow-up|1|||
47046094|NCT01279954|83304399|FG000|Overall Study|Lack of Efficacy|3|||
47046095|NCT01279954|83304400|FG001|Overall Study|Lack of Efficacy|4|||
47046096|NCT01278862|83304411|FG000|Overall Study|Lost to Follow-up|1|||
47046097|NCT01278862|83304412|FG001|Overall Study|Lost to Follow-up|1|||
47046098|NCT01278394|83304427|FG000|Overall Study|Lost to Follow-up|1|||
47046099|NCT01981187|83304431|FG000|Overall Study|Participant/guardian decision|2|||
47046100|NCT01981187|83304431|FG000|Overall Study|Physician Decision|1|||
47046101|NCT01981187|83304431|FG000|Overall Study|Disease progression|2|||
47046102|NCT01981187|83304431|FG000|Overall Study|Adverse Event|7|||
47046103|NCT01278160|83304437|FG000|Overall Study|Adverse Event|1|||
47046104|NCT01278160|83304438|FG001|Overall Study|Adverse Event|1|||
47046105|NCT01278160|83304437|FG000|Overall Study|Lost to Follow-up|0|||
47046106|NCT01278160|83304438|FG001|Overall Study|Lost to Follow-up|1|||
47046107|NCT01278160|83304437|FG000|Overall Study|Withdrawal by Subject|3|||
47046108|NCT01278160|83304438|FG001|Overall Study|Withdrawal by Subject|2|||
47046109|NCT01278160|83304437|FG000|Overall Study|Unclassified|1|||
47046110|NCT01278160|83304438|FG001|Overall Study|Unclassified|2|||
47046111|NCT01996241|83304446|FG000|Overall Study|Lost to Follow-up|252|||
47046112|NCT01996241|83304447|FG001|Overall Study|Lost to Follow-up|235|||
47046113|NCT02091869|83304457|FG000|Overall Study|Withdrawal by Subject|0|||
47046114|NCT02091869|83304458|FG001|Overall Study|Withdrawal by Subject|3|||
47046115|NCT01981109|83304473|FG000|Overall Study|Death|36|||
47046116|NCT01981109|83304473|FG000|Overall Study|Withdrawal by Subject|40|||
47046117|NCT01981109|83304473|FG000|Overall Study|Lost to Follow-up|9|||
47046118|NCT01981109|83304473|FG000|Overall Study|No Discontinuation Documentation|37|||
47046119|NCT01981109|83304473|FG000|Overall Study|Study Termination|100|||
46725547|NCT01108796|82941432|FG000|Overall Study|Lost to Follow-up|7|||
46725548|NCT01108796|82941433|FG001|Overall Study|Lost to Follow-up|6|||
47046120|NCT01981109|83304473|FG000|Overall Study|No data available|2|||
47046121|NCT00248794|83304481|FG000|Overall Study|Lost to Follow-up|6|||
46634598|NCT01716234|82808050|FG002|Overall Study|Protocol Violation|0|||
47046122|NCT00248794|83304482|FG001|Overall Study|Lost to Follow-up|8|||
47046123|NCT00248794|83304483|FG002|Overall Study|Lost to Follow-up|3|||
47046124|NCT01995539|83304497|FG000|Overall Study|Screening Failure|1|||
47046125|NCT01995539|83304497|FG000|Overall Study|Withdrawal by Investigator|15|||
47046126|NCT01995539|83304497|FG000|Overall Study|Withdrawal by Subject|11|||
47046127|NCT01995539|83304497|FG000|Overall Study|Lost to Follow-up|5|||
47046128|NCT01995539|83304497|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
47046129|NCT01835587|83304505|FG000|Overall Study|Disease Recurrence or Relapse|0|||
47046130|NCT01835587|83304506|FG001|Overall Study|Disease Recurrence or Relapse|3|||
47046131|NCT01835587|83304507|FG002|Overall Study|Disease Recurrence or Relapse|0|||
47046132|NCT01835587|83304508|FG003|Overall Study|Disease Recurrence or Relapse|3|||
47046133|NCT01835587|83304505|FG000|Overall Study|Withdrawal by Subject|2|||
47046134|NCT01835587|83304506|FG001|Overall Study|Withdrawal by Subject|0|||
47046135|NCT01835587|83304507|FG002|Overall Study|Withdrawal by Subject|0|||
47046136|NCT01835587|83304508|FG003|Overall Study|Withdrawal by Subject|3|||
47046137|NCT01835587|83304505|FG000|Overall Study|Adverse Event|0|||
47046138|NCT01835587|83304506|FG001|Overall Study|Adverse Event|0|||
47046139|NCT01835587|83304507|FG002|Overall Study|Adverse Event|2|||
47046140|NCT01835587|83304508|FG003|Overall Study|Adverse Event|2|||
47046141|NCT01835587|83304505|FG000|Overall Study|Death|0|||
47046142|NCT01835587|83304506|FG001|Overall Study|Death|0|||
47046143|NCT01835587|83304507|FG002|Overall Study|Death|0|||
47046144|NCT01835587|83304508|FG003|Overall Study|Death|1|||
46725549|NCT01108718|82941443|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
46725550|NCT01108718|82941444|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
46725551|NCT01137110|82941451|FG000|Overall Study|Protocol Violation|1|||
46725552|NCT01137110|82941452|FG001|Overall Study|Protocol Violation|0|||
47046145|NCT01835587|83304505|FG000|Overall Study|Miscellaneous|0|||
47046146|NCT01835587|83304506|FG001|Overall Study|Miscellaneous|1|||
47046147|NCT01835587|83304507|FG002|Overall Study|Miscellaneous|0|||
47046148|NCT01835587|83304508|FG003|Overall Study|Miscellaneous|0|||
47046149|NCT01736917|83304525|FG000|Overall Study|Adverse Event|1|||
47046150|NCT01736917|83304525|FG000|Overall Study|Protocol Violation|10|||
47046151|NCT01277302|83304534|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
46634599|NCT01716234|82808051|FG003|Overall Study|Protocol Violation|1|||
47046152|NCT01277302|83304535|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
47046153|NCT01277302|83304536|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
47046154|NCT01277302|83304534|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
47046155|NCT01277302|83304535|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
47046156|NCT01277302|83304536|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
47046157|NCT01277302|83304534|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
47046158|NCT01277302|83304535|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
47046159|NCT01277302|83304536|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
46920995|NCT03029247|83153319|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
47046160|NCT01277302|83304534|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
47046161|NCT01277302|83304535|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
47046162|NCT01277302|83304536|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
47046163|NCT01277302|83304534|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
47046164|NCT01277302|83304535|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
47046165|NCT01277302|83304536|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
47046166|NCT01277302|83304534|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
47046167|NCT01277302|83304535|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
47046168|NCT01277302|83304536|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
47046169|NCT01277302|83304534|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
46634600|NCT01716234|82808052|FG004|Overall Study|Protocol Violation|1|||
46920996|NCT03029247|83153318|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
46920997|NCT03029247|83153319|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
46920998|NCT03029247|83153318|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
46920999|NCT03029247|83153319|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
46921000|NCT03029247|83153318|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
46921001|NCT03029247|83153319|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
47046170|NCT01277302|83304535|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
47046171|NCT01277302|83304536|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
47046172|NCT01277302|83304534|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
47046173|NCT01277302|83304535|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
47046174|NCT01277302|83304536|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
47046175|NCT01277302|83304534|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
47046176|NCT01277302|83304535|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
47046177|NCT01277302|83304536|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
47046178|NCT01980875|83304547|FG000|Overall Study|Withdrew Consent|1|||
47046179|NCT01980875|83304548|FG001|Overall Study|Withdrew Consent|1|||
47046180|NCT01980875|83304549|FG002|Overall Study|Withdrew Consent|1|||
47046181|NCT01980875|83304547|FG000|Overall Study|Study Terminated by Sponsor|7|||
47046182|NCT01980875|83304548|FG001|Overall Study|Study Terminated by Sponsor|24|||
47046183|NCT01980875|83304549|FG002|Overall Study|Study Terminated by Sponsor|22|||
47046184|NCT01980875|83304547|FG000|Overall Study|Lost to Follow-up|0|||
47046185|NCT01980875|83304548|FG001|Overall Study|Lost to Follow-up|0|||
47046186|NCT01980875|83304549|FG002|Overall Study|Lost to Follow-up|1|||
47046187|NCT01995461|83304557|FG000|Overall Study|Death|1|||
47046188|NCT01995461|83304557|FG000|Overall Study|Lost to Follow-up|2|||
47046189|NCT01995461|83304557|FG000|Overall Study|Withdrawal by Subject|2|||
47046190|NCT01980095|83304563|FG000|Overall Study|Lost to Follow-up|6|||
47046191|NCT01980095|83304564|FG001|Overall Study|Lost to Follow-up|7|||
47046192|NCT01980095|83304563|FG000|Overall Study|Withdrawal by Subject|2|||
47046193|NCT01980095|83304564|FG001|Overall Study|Withdrawal by Subject|3|||
46634601|NCT01716234|82808053|FG005|Overall Study|Protocol Violation|1|||
46634602|NCT01716234|82808054|FG006|Overall Study|Protocol Violation|0|||
46634603|NCT01716234|82808048|FG000|Overall Study|Lack of Efficacy|0|||
46725553|NCT01136954|82941460|FG000|Overall Study|Adverse Event|3|||
46725554|NCT01136954|82941461|FG001|Overall Study|Adverse Event|2|||
46725555|NCT01136954|82941460|FG000|Overall Study|Withdrawal by Subject|6|||
46725556|NCT01136954|82941461|FG001|Overall Study|Withdrawal by Subject|2|||
47046194|NCT01980095|83304563|FG000|Overall Study|Poor compliance|5|||
46634604|NCT01716234|82808049|FG001|Overall Study|Lack of Efficacy|0|||
47046195|NCT01980095|83304564|FG001|Overall Study|Poor compliance|0|||
47046196|NCT01980095|83304563|FG000|Overall Study|Safety issue|0|||
47046197|NCT01980095|83304564|FG001|Overall Study|Safety issue|1|||
47046198|NCT01980095|83304563|FG000|Overall Study|Study drug discontinued|1|||
47046199|NCT01980095|83304564|FG001|Overall Study|Study drug discontinued|0|||
47046200|NCT01980095|83304563|FG000|Overall Study|Randomized by mistake|1|||
47046201|NCT01980095|83304564|FG001|Overall Study|Randomized by mistake|0|||
47046202|NCT01980017|83304574|FG000|Overall Study|Lost to Follow-up|30|||
47046203|NCT01980017|83304575|FG001|Overall Study|Lost to Follow-up|21|||
47046204|NCT01980017|83304574|FG000|Overall Study|Death|0|||
47046205|NCT01980017|83304575|FG001|Overall Study|Death|1|||
47046206|NCT01978145|83304584|FG000|Treatment Period 1|Adverse Event|1|||
46725557|NCT01136954|82941460|FG000|Overall Study|Lack of Efficacy|14|||
46725558|NCT01136954|82941461|FG001|Overall Study|Lack of Efficacy|13|||
46725559|NCT01136954|82941460|FG000|Overall Study|Physician Decision|0|||
47046207|NCT01978145|83304585|FG001|Treatment Period 1|Adverse Event|9|||
47046208|NCT01978145|83304584|FG000|Treatment Period 1|Physician Decision|1|||
47046209|NCT01978145|83304585|FG001|Treatment Period 1|Physician Decision|0|||
47046210|NCT01978145|83304584|FG000|Treatment Period 1|Withdrawal by Subject|5|||
47046211|NCT01978145|83304585|FG001|Treatment Period 1|Withdrawal by Subject|4|||
47046212|NCT01978145|83304584|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
47046213|NCT01978145|83304585|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
46725560|NCT01136954|82941461|FG001|Overall Study|Physician Decision|1|||
46725561|NCT01136954|82941460|FG000|Overall Study|Other|1|||
46725562|NCT01136954|82941461|FG001|Overall Study|Other|3|||
46725563|NCT01136876|82941470|FG000|Overall Study|Lost to Follow-up|0|||
46725564|NCT01136876|82941471|FG001|Overall Study|Lost to Follow-up|1|||
47046214|NCT01978145|83304584|FG000|Washout Period 1|Adverse Event|0|||
47046215|NCT01978145|83304585|FG001|Washout Period 1|Adverse Event|1|||
47046216|NCT01978145|83304584|FG000|Washout Period 1|Withdrawal by Subject|1|||
47046217|NCT01978145|83304585|FG001|Washout Period 1|Withdrawal by Subject|1|||
47046218|NCT01978145|83304584|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
47046219|NCT01978145|83304585|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
47046220|NCT01978145|83304584|FG000|Treatment Period 2|Adverse Event|3|||
47046221|NCT01978145|83304585|FG001|Treatment Period 2|Adverse Event|3|||
47046222|NCT01978145|83304584|FG000|Treatment Period 2|Protocol Violation|0|||
47046223|NCT01978145|83304585|FG001|Treatment Period 2|Protocol Violation|1|||
47046224|NCT01978145|83304584|FG000|Treatment Period 2|Lost to Follow-up|1|||
47046225|NCT01978145|83304585|FG001|Treatment Period 2|Lost to Follow-up|1|||
47046226|NCT01978145|83304584|FG000|Treatment Period 2|Withdrawal by Subject|7|||
47046227|NCT01978145|83304585|FG001|Treatment Period 2|Withdrawal by Subject|4|||
47046228|NCT01978145|83304584|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
47046229|NCT01978145|83304585|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
47046230|NCT01967537|83304591|FG000|Overall Study|Withdrawal by Subject|52|||
47046231|NCT01967537|83304591|FG000|Overall Study|Refuse treatment|2|||
47046232|NCT01967537|83304591|FG000|Overall Study|Lost to Follow-up|6|||
47046233|NCT01967225|83304599|FG000|Overall Study|Adverse Event|3|||
47046234|NCT01967225|83304600|FG001|Overall Study|Adverse Event|1|||
47046235|NCT01967225|83304599|FG000|Overall Study|Withdrawal by Subject|2|||
47046236|NCT01967225|83304600|FG001|Overall Study|Withdrawal by Subject|1|||
47046237|NCT01967225|83304599|FG000|Overall Study|Lack of Efficacy|1|||
47046238|NCT01967225|83304600|FG001|Overall Study|Lack of Efficacy|1|||
47046239|NCT01967225|83304599|FG000|Overall Study|Switching to other therapy|2|||
47046240|NCT01967225|83304600|FG001|Overall Study|Switching to other therapy|0|||
47046241|NCT01967225|83304599|FG000|Overall Study|Protocol driven decision point|1|||
47046242|NCT01967225|83304600|FG001|Overall Study|Protocol driven decision point|0|||
47046243|NCT01967225|83304599|FG000|Overall Study|Logistical difficulties|1|||
47046244|NCT01967225|83304600|FG001|Overall Study|Logistical difficulties|0|||
47046245|NCT01967225|83304599|FG000|Overall Study|Protocol Violation|2|||
47046246|NCT01967225|83304600|FG001|Overall Study|Protocol Violation|0|||
47046247|NCT01967147|83304610|FG000|Overall Study|Adverse Event|5|||
47046248|NCT01967147|83304611|FG001|Overall Study|Adverse Event|2|||
47046249|NCT01967147|83304610|FG000|Overall Study|Lack of Efficacy|1|||
47046250|NCT01967147|83304611|FG001|Overall Study|Lack of Efficacy|4|||
47046251|NCT01967147|83304610|FG000|Overall Study|Lost to Follow-up|1|||
47046252|NCT01967147|83304611|FG001|Overall Study|Lost to Follow-up|2|||
47046253|NCT01967147|83304610|FG000|Overall Study|Withdrawal by Subject|2|||
47046254|NCT01967147|83304611|FG001|Overall Study|Withdrawal by Subject|4|||
47046255|NCT01967147|83304610|FG000|Overall Study|Non-compliance with Study Drug|0|||
47046256|NCT01967147|83304611|FG001|Overall Study|Non-compliance with Study Drug|3|||
47046257|NCT01967147|83304610|FG000|Overall Study|Other|4|||
47046258|NCT01967147|83304611|FG001|Overall Study|Other|5|||
47046259|NCT01790503|83304629|FG000|Overall Study|Adverse Event|1|||
47046260|NCT01790503|83304630|FG001|Overall Study|Adverse Event|0|||
47046261|NCT01790503|83304631|FG002|Overall Study|Adverse Event|0|||
47046262|NCT01790503|83304632|FG003|Overall Study|Adverse Event|0|||
47046263|NCT01790503|83304633|FG004|Overall Study|Adverse Event|0|||
47046264|NCT01790503|83304634|FG005|Overall Study|Adverse Event|2|||
47046265|NCT01790503|83304635|FG006|Overall Study|Adverse Event|0|||
47046266|NCT01790503|83304636|FG007|Overall Study|Adverse Event|0|||
47046267|NCT01790503|83304637|FG008|Overall Study|Adverse Event|2|||
47046268|NCT01790503|83304638|FG009|Overall Study|Adverse Event|4|||
47046269|NCT01790503|83304639|FG010|Overall Study|Adverse Event|7|||
47046270|NCT01790503|83304629|FG000|Overall Study|Withdrawal by Subject|0|||
47046271|NCT01790503|83304630|FG001|Overall Study|Withdrawal by Subject|0|||
47046272|NCT01790503|83304631|FG002|Overall Study|Withdrawal by Subject|1|||
47046273|NCT01790503|83304632|FG003|Overall Study|Withdrawal by Subject|1|||
47046274|NCT01790503|83304633|FG004|Overall Study|Withdrawal by Subject|1|||
47046275|NCT01790503|83304634|FG005|Overall Study|Withdrawal by Subject|2|||
47046276|NCT01790503|83304635|FG006|Overall Study|Withdrawal by Subject|1|||
47046277|NCT01790503|83304636|FG007|Overall Study|Withdrawal by Subject|0|||
47046278|NCT01790503|83304637|FG008|Overall Study|Withdrawal by Subject|0|||
47046279|NCT01790503|83304638|FG009|Overall Study|Withdrawal by Subject|0|||
47046280|NCT01790503|83304639|FG010|Overall Study|Withdrawal by Subject|1|||
46725565|NCT01136876|82941470|FG000|Overall Study|Physician Decision|3|||
46634605|NCT01716234|82808050|FG002|Overall Study|Lack of Efficacy|0|||
46634606|NCT01716234|82808051|FG003|Overall Study|Lack of Efficacy|1|||
46634607|NCT01716234|82808052|FG004|Overall Study|Lack of Efficacy|0|||
46634608|NCT01716234|82808053|FG005|Overall Study|Lack of Efficacy|0|||
46634609|NCT01716234|82808054|FG006|Overall Study|Lack of Efficacy|0|||
47046281|NCT01790503|83304629|FG000|Overall Study|Disease progression|2|||
47046282|NCT01790503|83304630|FG001|Overall Study|Disease progression|1|||
47046283|NCT01790503|83304631|FG002|Overall Study|Disease progression|0|||
47046284|NCT01790503|83304632|FG003|Overall Study|Disease progression|1|||
47046285|NCT01790503|83304633|FG004|Overall Study|Disease progression|2|||
47046286|NCT01790503|83304634|FG005|Overall Study|Disease progression|1|||
47046287|NCT01790503|83304635|FG006|Overall Study|Disease progression|0|||
47046288|NCT01790503|83304636|FG007|Overall Study|Disease progression|1|||
47046289|NCT01790503|83304637|FG008|Overall Study|Disease progression|0|||
47046290|NCT01790503|83304638|FG009|Overall Study|Disease progression|17|||
47046291|NCT01790503|83304639|FG010|Overall Study|Disease progression|7|||
47046292|NCT01790503|83304629|FG000|Overall Study|Protocol Violation|0|||
47046293|NCT01790503|83304630|FG001|Overall Study|Protocol Violation|0|||
47046294|NCT01790503|83304631|FG002|Overall Study|Protocol Violation|0|||
47046295|NCT01790503|83304632|FG003|Overall Study|Protocol Violation|0|||
46634610|NCT01716234|82808048|FG000|Overall Study|Did not meet protocol eligibility|0|||
46634611|NCT01716234|82808049|FG001|Overall Study|Did not meet protocol eligibility|0|||
47046296|NCT01790503|83304633|FG004|Overall Study|Protocol Violation|0|||
47046297|NCT01790503|83304634|FG005|Overall Study|Protocol Violation|0|||
47046298|NCT01790503|83304635|FG006|Overall Study|Protocol Violation|0|||
47046299|NCT01790503|83304636|FG007|Overall Study|Protocol Violation|0|||
47046300|NCT01790503|83304637|FG008|Overall Study|Protocol Violation|0|||
47046301|NCT01790503|83304638|FG009|Overall Study|Protocol Violation|1|||
47046302|NCT01790503|83304639|FG010|Overall Study|Protocol Violation|0|||
47046303|NCT01790503|83304629|FG000|Overall Study|Physician Decision|0|||
47046304|NCT01790503|83304630|FG001|Overall Study|Physician Decision|0|||
47046305|NCT01790503|83304631|FG002|Overall Study|Physician Decision|0|||
47046306|NCT01790503|83304632|FG003|Overall Study|Physician Decision|0|||
47046307|NCT01790503|83304633|FG004|Overall Study|Physician Decision|0|||
47046308|NCT01790503|83304634|FG005|Overall Study|Physician Decision|0|||
47046309|NCT01790503|83304635|FG006|Overall Study|Physician Decision|0|||
47046310|NCT01790503|83304636|FG007|Overall Study|Physician Decision|0|||
47046311|NCT01790503|83304637|FG008|Overall Study|Physician Decision|0|||
47046312|NCT01790503|83304638|FG009|Overall Study|Physician Decision|1|||
47046313|NCT01790503|83304639|FG010|Overall Study|Physician Decision|1|||
47046314|NCT01790503|83304629|FG000|Overall Study|Death|0|||
47046315|NCT01790503|83304630|FG001|Overall Study|Death|0|||
47046316|NCT01790503|83304631|FG002|Overall Study|Death|0|||
47046317|NCT01790503|83304632|FG003|Overall Study|Death|0|||
47046318|NCT01790503|83304633|FG004|Overall Study|Death|0|||
47046319|NCT01790503|83304634|FG005|Overall Study|Death|0|||
47046320|NCT01790503|83304635|FG006|Overall Study|Death|0|||
47046321|NCT01790503|83304636|FG007|Overall Study|Death|0|||
47046322|NCT01790503|83304637|FG008|Overall Study|Death|0|||
47046323|NCT01790503|83304638|FG009|Overall Study|Death|1|||
47046324|NCT01790503|83304639|FG010|Overall Study|Death|0|||
47046325|NCT01790503|83304629|FG000|Overall Study|Non Compliance|0|||
47046326|NCT01790503|83304630|FG001|Overall Study|Non Compliance|0|||
47046327|NCT01790503|83304631|FG002|Overall Study|Non Compliance|0|||
47046328|NCT01790503|83304632|FG003|Overall Study|Non Compliance|0|||
47046329|NCT01790503|83304633|FG004|Overall Study|Non Compliance|1|||
47046330|NCT01790503|83304634|FG005|Overall Study|Non Compliance|0|||
47046331|NCT01790503|83304635|FG006|Overall Study|Non Compliance|0|||
47046332|NCT01790503|83304636|FG007|Overall Study|Non Compliance|0|||
47046333|NCT01790503|83304637|FG008|Overall Study|Non Compliance|0|||
47046334|NCT01790503|83304638|FG009|Overall Study|Non Compliance|0|||
47046335|NCT01790503|83304639|FG010|Overall Study|Non Compliance|0|||
47046336|NCT01790503|83304629|FG000|Overall Study|Other|0|||
47046337|NCT01790503|83304630|FG001|Overall Study|Other|0|||
47046338|NCT01790503|83304631|FG002|Overall Study|Other|0|||
47046339|NCT01790503|83304632|FG003|Overall Study|Other|0|||
47046340|NCT01790503|83304633|FG004|Overall Study|Other|1|||
47046341|NCT01790503|83304634|FG005|Overall Study|Other|0|||
47046342|NCT01790503|83304635|FG006|Overall Study|Other|0|||
47046343|NCT01790503|83304636|FG007|Overall Study|Other|0|||
47046344|NCT01790503|83304637|FG008|Overall Study|Other|1|||
47046345|NCT01790503|83304638|FG009|Overall Study|Other|2|||
47046346|NCT01790503|83304639|FG010|Overall Study|Other|0|||
47046347|NCT01790113|83304678|FG000|Overall Study|Adverse Event|2|||
47046348|NCT01790113|83304679|FG001|Overall Study|Adverse Event|7|||
47046349|NCT01790113|83304678|FG000|Overall Study|Study ended due to FDA clearance|1|||
47046350|NCT01790113|83304679|FG001|Overall Study|Study ended due to FDA clearance|68|||
47046351|NCT01789567|83304685|FG000|Overall Study|Death|6|||
47046352|NCT01765543|83304689|FG000|Overall Study|Death|1|||
47046353|NCT01765543|83304689|FG000|Overall Study|Withdrawal by Subject|2|||
47046354|NCT01765153|83304699|FG000|Training Phase 1|Format of intervention differed|1|||
47046355|NCT01765153|83304700|FG001|Training Phase 1|Format of intervention differed|0|||
47046356|NCT01765153|83304699|FG000|Training Phase 1|Poor participation in intervention|0|||
47046357|NCT01765153|83304700|FG001|Training Phase 1|Poor participation in intervention|1|||
47046358|NCT01765153|83304699|FG000|Rest Phase 1|Withdrawal by Subject|0|||
47046359|NCT01765153|83304700|FG001|Rest Phase 1|Withdrawal by Subject|1|||
47046360|NCT01765153|83304699|FG000|Training Phase 2|Withdrawal by Subject|0|||
47046361|NCT01765153|83304700|FG001|Training Phase 2|Withdrawal by Subject|1|||
47046362|NCT01765153|83304699|FG000|Rest Phase 2|Lost to Follow-up|2|||
47046363|NCT01765153|83304700|FG001|Rest Phase 2|Lost to Follow-up|1|||
47046364|NCT00248170|83304712|FG000|Overall Study|Withdrawal by Subject|71|||
47046365|NCT00248170|83304713|FG001|Overall Study|Withdrawal by Subject|79|||
47046366|NCT00248170|83304712|FG000|Overall Study|Protocol Violation|35|||
47046367|NCT00248170|83304713|FG001|Overall Study|Protocol Violation|30|||
47046368|NCT00248170|83304712|FG000|Overall Study|Lost to Follow-up|28|||
47046369|NCT00248170|83304713|FG001|Overall Study|Lost to Follow-up|35|||
47046370|NCT00248170|83304712|FG000|Overall Study|Disease progression|196|||
47046371|NCT00248170|83304713|FG001|Overall Study|Disease progression|216|||
47046372|NCT00248170|83304712|FG000|Overall Study|Death|28|||
47046373|NCT00248170|83304713|FG001|Overall Study|Death|47|||
47046374|NCT00248170|83304712|FG000|Overall Study|Adverse Event|311|||
47046375|NCT00248170|83304713|FG001|Overall Study|Adverse Event|296|||
47046376|NCT00248170|83304712|FG000|Overall Study|Administrative problems|22|||
47046377|NCT00248170|83304713|FG001|Overall Study|Administrative problems|25|||
47046378|NCT00248170|83304712|FG000|Overall Study|Abnormal test procedure(s) result|49|||
47046379|NCT00248170|83304713|FG001|Overall Study|Abnormal test procedure(s) result|61|||
46725566|NCT01136876|82941471|FG001|Overall Study|Physician Decision|5|||
47046380|NCT00248170|83304712|FG000|Overall Study|Abnormal laboratory values|4|||
47046381|NCT00248170|83304713|FG001|Overall Study|Abnormal laboratory values|0|||
47046382|NCT00248170|83304712|FG000|Overall Study|Protocol deviation|17|||
47046383|NCT00248170|83304713|FG001|Overall Study|Protocol deviation|19|||
47046384|NCT01764997|83304724|FG000|Run-in Period|Adverse Event|15|||
47046385|NCT01764997|83304725|FG001|Run-in Period|Adverse Event|0|||
46725567|NCT01136876|82941470|FG000|Overall Study|Missing NGAL measurement|2|||
46725568|NCT01136876|82941471|FG001|Overall Study|Missing NGAL measurement|5|||
46725569|NCT01105130|82941482|FG000|Overall Study|Withdrawal by Subject|4|||
46725570|NCT01105130|82941483|FG001|Overall Study|Withdrawal by Subject|6|||
46725571|NCT01105130|82941484|FG002|Overall Study|Withdrawal by Subject|2|||
46725572|NCT01105130|82941482|FG000|Overall Study|Never Started|2|||
46725573|NCT01105130|82941483|FG001|Overall Study|Never Started|2|||
46725574|NCT01105130|82941484|FG002|Overall Study|Never Started|4|||
46725575|NCT01105130|82941482|FG000|Overall Study|Toxicity|1|||
46725576|NCT01105130|82941483|FG001|Overall Study|Toxicity|3|||
46725577|NCT01105130|82941484|FG002|Overall Study|Toxicity|2|||
46725578|NCT01105130|82941482|FG000|Overall Study|Multiple Reasons|3|||
46725579|NCT01105130|82941483|FG001|Overall Study|Multiple Reasons|0|||
46725580|NCT01105130|82941484|FG002|Overall Study|Multiple Reasons|2|||
46725581|NCT01108094|82941496|FG000|Overall Study|Adverse Event|2|||
46725582|NCT01108094|82941497|FG001|Overall Study|Adverse Event|0|||
46725583|NCT01108094|82941498|FG002|Overall Study|Adverse Event|0|||
46725584|NCT01108094|82941499|FG003|Overall Study|Adverse Event|0|||
46725585|NCT01108094|82941496|FG000|Overall Study|Withdrawal by Subject|1|||
46725586|NCT01108094|82941497|FG001|Overall Study|Withdrawal by Subject|0|||
46725587|NCT01108094|82941498|FG002|Overall Study|Withdrawal by Subject|0|||
46725588|NCT01108094|82941499|FG003|Overall Study|Withdrawal by Subject|0|||
46725589|NCT00954174|82941516|FG000|Overall Study|Adverse Event|28|||
46725590|NCT00954174|82941517|FG001|Overall Study|Adverse Event|23|||
46725591|NCT00954174|82941518|FG002|Overall Study|Adverse Event|4|||
46725592|NCT00954174|82941519|FG003|Overall Study|Adverse Event|9|||
46725593|NCT00954174|82941516|FG000|Overall Study|Death|4|||
46725594|NCT00954174|82941517|FG001|Overall Study|Death|2|||
46725595|NCT00954174|82941518|FG002|Overall Study|Death|0|||
46725596|NCT00954174|82941519|FG003|Overall Study|Death|0|||
46725597|NCT00954174|82941516|FG000|Overall Study|Lack of Efficacy|32|||
46725598|NCT00954174|82941517|FG001|Overall Study|Lack of Efficacy|22|||
46725599|NCT00954174|82941518|FG002|Overall Study|Lack of Efficacy|8|||
46725600|NCT00954174|82941519|FG003|Overall Study|Lack of Efficacy|6|||
46725601|NCT00954174|82941516|FG000|Overall Study|Withdrawal by Subject|14|||
46725602|NCT00954174|82941517|FG001|Overall Study|Withdrawal by Subject|10|||
46725603|NCT00954174|82941518|FG002|Overall Study|Withdrawal by Subject|4|||
46725604|NCT00954174|82941519|FG003|Overall Study|Withdrawal by Subject|3|||
46725605|NCT00954174|82941516|FG000|Overall Study|Medical Reason|4|||
46725606|NCT00954174|82941517|FG001|Overall Study|Medical Reason|2|||
46725607|NCT00954174|82941518|FG002|Overall Study|Medical Reason|1|||
46725608|NCT00954174|82941519|FG003|Overall Study|Medical Reason|0|||
46725609|NCT00954174|82941516|FG000|Overall Study|Ineligible|40|||
46725610|NCT00954174|82941517|FG001|Overall Study|Ineligible|47|||
46725611|NCT00954174|82941518|FG002|Overall Study|Ineligible|7|||
46725612|NCT00954174|82941519|FG003|Overall Study|Ineligible|4|||
46725613|NCT00954174|82941516|FG000|Overall Study|Never Treated|4|||
46725614|NCT00954174|82941517|FG001|Overall Study|Never Treated|17|||
46725615|NCT00954174|82941518|FG002|Overall Study|Never Treated|0|||
46725616|NCT00954174|82941519|FG003|Overall Study|Never Treated|3|||
46725617|NCT01136408|82941535|FG000|Overall Study|Adverse Event|4|||
46725618|NCT01136408|82941536|FG001|Overall Study|Adverse Event|8|||
46725619|NCT01136408|82941537|FG002|Overall Study|Adverse Event|4|||
46725620|NCT01136408|82941535|FG000|Overall Study|Protocol Violation|1|||
47046386|NCT01764997|83304726|FG002|Run-in Period|Adverse Event|0|||
47046387|NCT01764997|83304727|FG003|Run-in Period|Adverse Event|0|||
47046388|NCT01764997|83304728|FG004|Run-in Period|Adverse Event|0|||
47046389|NCT01764997|83304724|FG000|Run-in Period|Lack of Efficacy|5|||
47046390|NCT01764997|83304725|FG001|Run-in Period|Lack of Efficacy|0|||
47046391|NCT01764997|83304726|FG002|Run-in Period|Lack of Efficacy|0|||
46725621|NCT01136408|82941536|FG001|Overall Study|Protocol Violation|1|||
46725622|NCT01136408|82941537|FG002|Overall Study|Protocol Violation|1|||
46725623|NCT01136174|82941553|FG000|Overall Study|Adverse Event|0|||
46725624|NCT01136174|82941554|FG001|Overall Study|Adverse Event|0|||
46725625|NCT01136174|82941555|FG002|Overall Study|Adverse Event|0|||
46725626|NCT01136174|82941556|FG003|Overall Study|Adverse Event|4|||
46725627|NCT00949884|82941578|FG000|Overall Study|Adverse Event|14|||
46725628|NCT00949884|82941579|FG001|Overall Study|Adverse Event|3|||
46725629|NCT00949884|82941580|FG002|Overall Study|Adverse Event|12|||
46725630|NCT00949884|82941578|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
47046392|NCT01764997|83304727|FG003|Run-in Period|Lack of Efficacy|0|||
47046393|NCT01764997|83304728|FG004|Run-in Period|Lack of Efficacy|0|||
47046394|NCT01764997|83304724|FG000|Run-in Period|Poor compliance to protocol|1|||
47046395|NCT01764997|83304725|FG001|Run-in Period|Poor compliance to protocol|0|||
47046396|NCT01764997|83304726|FG002|Run-in Period|Poor compliance to protocol|0|||
47046397|NCT01764997|83304727|FG003|Run-in Period|Poor compliance to protocol|0|||
47046398|NCT01764997|83304728|FG004|Run-in Period|Poor compliance to protocol|0|||
47046399|NCT01764997|83304724|FG000|Run-in Period|Other than specified above|17|||
47046400|NCT01764997|83304725|FG001|Run-in Period|Other than specified above|0|||
47046401|NCT01764997|83304726|FG002|Run-in Period|Other than specified above|0|||
47046402|NCT01764997|83304727|FG003|Run-in Period|Other than specified above|0|||
47046403|NCT01764997|83304728|FG004|Run-in Period|Other than specified above|0|||
47046404|NCT01764997|83304724|FG000|Study Drug Treatment Period|Adverse Event|0|||
47046405|NCT01764997|83304725|FG001|Study Drug Treatment Period|Adverse Event|1|||
47046406|NCT01764997|83304726|FG002|Study Drug Treatment Period|Adverse Event|0|||
47046407|NCT01764997|83304727|FG003|Study Drug Treatment Period|Adverse Event|0|||
47046408|NCT01764997|83304728|FG004|Study Drug Treatment Period|Adverse Event|24|||
47046409|NCT01764997|83304724|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
47046410|NCT01764997|83304725|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
47046411|NCT01764997|83304726|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
47046412|NCT01764997|83304727|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
47046413|NCT01764997|83304728|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
47046414|NCT01764997|83304724|FG000|Study Drug Treatment Period|Other than specified above|0|||
47046415|NCT01764997|83304725|FG001|Study Drug Treatment Period|Other than specified above|0|||
47046416|NCT01764997|83304726|FG002|Study Drug Treatment Period|Other than specified above|0|||
47046417|NCT01764997|83304727|FG003|Study Drug Treatment Period|Other than specified above|0|||
47046418|NCT01764997|83304728|FG004|Study Drug Treatment Period|Other than specified above|10|||
47046419|NCT01276756|83304740|FG000|Overall Study|Lost to Follow-up|2|||
47046420|NCT01276756|83304741|FG001|Overall Study|Lost to Follow-up|0|||
47046421|NCT01276756|83304740|FG000|Overall Study|Adverse Event|3|||
47046422|NCT01276756|83304741|FG001|Overall Study|Adverse Event|2|||
47046423|NCT00246376|83304752|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
47046424|NCT00246376|83304753|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
47046425|NCT00246376|83304754|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
47046426|NCT00246376|83304755|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
47046427|NCT00246376|83304756|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
47046428|NCT00246376|83304752|FG000|Overall Study|Adverse Event|2|||
46921002|NCT04313283|83153325|FG000|Overall Study|did not complete intervention|4|||
46921003|NCT02754440|83153333|FG000|Overall Study|Protocol Violation|3|||
46921004|NCT02754440|83153334|FG001|Overall Study|Protocol Violation|2|||
46921005|NCT02754440|83153335|FG002|Overall Study|Protocol Violation|2|||
46921006|NCT02754440|83153336|FG003|Overall Study|Protocol Violation|6|||
46921007|NCT02754440|83153333|FG000|Overall Study|Adverse Event|3|||
46921008|NCT02754440|83153334|FG001|Overall Study|Adverse Event|1|||
46921009|NCT02754440|83153335|FG002|Overall Study|Adverse Event|0|||
46921010|NCT02754440|83153336|FG003|Overall Study|Adverse Event|9|||
46921011|NCT02754440|83153333|FG000|Overall Study|Withdrawal by Subject|0|||
46921012|NCT02754440|83153334|FG001|Overall Study|Withdrawal by Subject|0|||
46921013|NCT02754440|83153335|FG002|Overall Study|Withdrawal by Subject|0|||
46921014|NCT02754440|83153336|FG003|Overall Study|Withdrawal by Subject|1|||
46921015|NCT02754440|83153333|FG000|Overall Study|Equipment failure|0|||
46921016|NCT02754440|83153334|FG001|Overall Study|Equipment failure|5|||
46921017|NCT02754440|83153335|FG002|Overall Study|Equipment failure|5|||
46921018|NCT02754440|83153336|FG003|Overall Study|Equipment failure|7|||
46921019|NCT02754440|83153333|FG000|Overall Study|Subject issues not resulting in AE|0|||
46921020|NCT02754440|83153334|FG001|Overall Study|Subject issues not resulting in AE|0|||
46921021|NCT02754440|83153335|FG002|Overall Study|Subject issues not resulting in AE|0|||
46921022|NCT02754440|83153336|FG003|Overall Study|Subject issues not resulting in AE|12|||
46921023|NCT02753816|83153348|FG000|Overall Study|Protocol Violation|0|||
47046429|NCT00246376|83304753|FG001|Overall Study|Adverse Event|3|||
46921024|NCT02753816|83153349|FG001|Overall Study|Protocol Violation|1|||
47046430|NCT00246376|83304754|FG002|Overall Study|Adverse Event|1|||
46921025|NCT02753816|83153350|FG002|Overall Study|Protocol Violation|0|||
46921026|NCT02752802|83153358|FG000|Overall Study|Contrast Volume Not Collected|1|||
46921027|NCT02752802|83153359|FG001|Overall Study|Contrast Volume Not Collected|0|||
46921028|NCT02756078|83153376|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
46921029|NCT02756078|83153377|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
46921030|NCT02756078|83153376|FG000|Period 1|Lost to Follow-up|0|||
46921031|NCT02756078|83153377|FG001|Period 1|Lost to Follow-up|2|||
46634612|NCT01716234|82808050|FG002|Overall Study|Did not meet protocol eligibility|1|||
46634613|NCT01716234|82808051|FG003|Overall Study|Did not meet protocol eligibility|0|||
46634614|NCT01716234|82808052|FG004|Overall Study|Did not meet protocol eligibility|0|||
46725631|NCT00949884|82941579|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
46921032|NCT02756078|83153376|FG000|Period 1|Protocol Violation|0|||
46634615|NCT01716234|82808053|FG005|Overall Study|Did not meet protocol eligibility|4|||
46634616|NCT01716234|82808054|FG006|Overall Study|Did not meet protocol eligibility|0|||
46634617|NCT01716234|82808048|FG000|Overall Study|Adverse Event|7|||
46634618|NCT01716234|82808049|FG001|Overall Study|Adverse Event|10|||
46725632|NCT00949884|82941580|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
46921033|NCT02756078|83153377|FG001|Period 1|Protocol Violation|1|||
46921034|NCT02756078|83153376|FG000|Period 1|Adverse Event|1|||
46921035|NCT02756078|83153377|FG001|Period 1|Adverse Event|10|||
46921036|NCT02756078|83153376|FG000|Period 1|Withdrawal by Subject|6|||
46921037|NCT02756078|83153377|FG001|Period 1|Withdrawal by Subject|6|||
46921038|NCT02756078|83153376|FG000|Period 1|Lens Discomfort|2|||
46921039|NCT02756078|83153377|FG001|Period 1|Lens Discomfort|2|||
46921040|NCT02756078|83153376|FG000|Period 2|Adverse Event|3|||
46921041|NCT02756078|83153377|FG001|Period 2|Adverse Event|5|||
46921042|NCT02756078|83153376|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
46921043|NCT02756078|83153377|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
46921044|NCT02756078|83153376|FG000|Period 2|Withdrawal by Subject|3|||
46921045|NCT02756078|83153377|FG001|Period 2|Withdrawal by Subject|1|||
46921046|NCT02752958|83153383|FG000|Overall Study|Adverse Event|3|||
46921047|NCT02752958|83153383|FG000|Overall Study|Lost to Follow-up|1|||
46921048|NCT02752958|83153383|FG000|Overall Study|Protocol Violation|1|||
46921049|NCT02752958|83153383|FG000|Overall Study|Withdrawal by Subject|2|||
46921050|NCT02752958|83153383|FG000|Overall Study|Other (Reason not specified)|2|||
46921051|NCT02805660|83153396|FG000|Overall Study|Death|5|||
46921052|NCT02805660|83153397|FG001|Overall Study|Death|2|||
46921053|NCT02805660|83153398|FG002|Overall Study|Death|9|||
46921054|NCT02805660|83153399|FG003|Overall Study|Death|5|||
46921055|NCT02805660|83153400|FG004|Overall Study|Death|0|||
46921056|NCT02805660|83153401|FG005|Overall Study|Death|14|||
47046431|NCT00246376|83304755|FG003|Overall Study|Adverse Event|3|||
47046432|NCT00246376|83304756|FG004|Overall Study|Adverse Event|1|||
47046433|NCT00246376|83304752|FG000|Overall Study|Lost to Follow-up|2|||
47046434|NCT00246376|83304753|FG001|Overall Study|Lost to Follow-up|11|||
47046435|NCT00246376|83304754|FG002|Overall Study|Lost to Follow-up|11|||
47046436|NCT00246376|83304755|FG003|Overall Study|Lost to Follow-up|16|||
47046437|NCT00246376|83304756|FG004|Overall Study|Lost to Follow-up|13|||
47046438|NCT01764841|83304814|FG000|Overall Study|Logistical Difficulties|0|||
47046439|NCT01764841|83304815|FG001|Overall Study|Logistical Difficulties|1|||
47046440|NCT01764841|83304816|FG002|Overall Study|Logistical Difficulties|0|||
46634619|NCT01716234|82808050|FG002|Overall Study|Adverse Event|2|||
46921057|NCT02805660|83153402|FG006|Overall Study|Death|12|||
46921058|NCT02805660|83153396|FG000|Overall Study|Lost to Follow-up|0|||
46921059|NCT02805660|83153397|FG001|Overall Study|Lost to Follow-up|1|||
46921060|NCT02805660|83153398|FG002|Overall Study|Lost to Follow-up|1|||
46921061|NCT02805660|83153399|FG003|Overall Study|Lost to Follow-up|2|||
47046441|NCT01764841|83304817|FG003|Overall Study|Logistical Difficulties|0|||
46921062|NCT02805660|83153400|FG004|Overall Study|Lost to Follow-up|0|||
47046442|NCT01764841|83304814|FG000|Overall Study|Death|3|||
47046443|NCT01764841|83304815|FG001|Overall Study|Death|0|||
47046444|NCT01764841|83304816|FG002|Overall Study|Death|1|||
47046445|NCT01764841|83304817|FG003|Overall Study|Death|4|||
47046446|NCT01764841|83304814|FG000|Overall Study|No Follow Up|1|||
47046447|NCT01764841|83304815|FG001|Overall Study|No Follow Up|0|||
47046448|NCT01764841|83304816|FG002|Overall Study|No Follow Up|1|||
47046449|NCT01764841|83304817|FG003|Overall Study|No Follow Up|0|||
47046450|NCT01764841|83304814|FG000|Overall Study|Protocol Violation|0|||
47046451|NCT01764841|83304815|FG001|Overall Study|Protocol Violation|1|||
47046452|NCT01764841|83304816|FG002|Overall Study|Protocol Violation|0|||
47046453|NCT01764841|83304817|FG003|Overall Study|Protocol Violation|0|||
47046454|NCT01764841|83304814|FG000|Overall Study|Withdrawal by Subject|16|||
47046455|NCT01764841|83304815|FG001|Overall Study|Withdrawal by Subject|24|||
47046456|NCT01764841|83304816|FG002|Overall Study|Withdrawal by Subject|11|||
47046457|NCT01764841|83304817|FG003|Overall Study|Withdrawal by Subject|15|||
47046458|NCT01764841|83304814|FG000|Overall Study|Lost to Follow-up|3|||
47046459|NCT01764841|83304815|FG001|Overall Study|Lost to Follow-up|0|||
47046460|NCT01764841|83304816|FG002|Overall Study|Lost to Follow-up|1|||
46725633|NCT00949884|82941578|FG000|Overall Study|Lost to Follow-up|7|||
46725634|NCT00949884|82941579|FG001|Overall Study|Lost to Follow-up|5|||
46725635|NCT00949884|82941580|FG002|Overall Study|Lost to Follow-up|5|||
46725636|NCT00949884|82941578|FG000|Overall Study|Physician Decision|5|||
47046461|NCT01764841|83304817|FG003|Overall Study|Lost to Follow-up|0|||
46725637|NCT00949884|82941579|FG001|Overall Study|Physician Decision|0|||
46921063|NCT02805660|83153401|FG005|Overall Study|Lost to Follow-up|0|||
47046462|NCT00245050|83304829|FG000|Overall Study|Adverse Event|3|||
47046463|NCT00245050|83304830|FG001|Overall Study|Adverse Event|2|||
47046464|NCT00243412|83304868|FG000|Overall Study|Death|0|||
47046465|NCT00243412|83304869|FG001|Overall Study|Death|1|||
47046466|NCT00243412|83304868|FG000|Overall Study|Adverse Event|4|||
47046467|NCT00243412|83304869|FG001|Overall Study|Adverse Event|2|||
47046468|NCT00243412|83304868|FG000|Overall Study|Lost to Follow-up|0|||
47046469|NCT00243412|83304869|FG001|Overall Study|Lost to Follow-up|1|||
46921064|NCT02805660|83153402|FG006|Overall Study|Lost to Follow-up|0|||
46921065|NCT02805660|83153396|FG000|Overall Study|Withdrawal by Subject|0|||
46921066|NCT02805660|83153397|FG001|Overall Study|Withdrawal by Subject|0|||
46921067|NCT02805660|83153398|FG002|Overall Study|Withdrawal by Subject|0|||
46921068|NCT02805660|83153399|FG003|Overall Study|Withdrawal by Subject|3|||
46921069|NCT02805660|83153400|FG004|Overall Study|Withdrawal by Subject|1|||
46634620|NCT01716234|82808051|FG003|Overall Study|Adverse Event|8|||
46725638|NCT00949884|82941580|FG002|Overall Study|Physician Decision|6|||
46725639|NCT00949884|82941578|FG000|Overall Study|Treatment non-compliance|5|||
46725640|NCT00949884|82941579|FG001|Overall Study|Treatment non-compliance|0|||
46725641|NCT00949884|82941580|FG002|Overall Study|Treatment non-compliance|8|||
46921070|NCT02805660|83153401|FG005|Overall Study|Withdrawal by Subject|0|||
47046470|NCT00243412|83304868|FG000|Overall Study|Physician Decision|1|||
47046471|NCT00243412|83304869|FG001|Overall Study|Physician Decision|1|||
47046472|NCT00243412|83304868|FG000|Overall Study|Withdrawal by Subject|4|||
47046473|NCT00243412|83304869|FG001|Overall Study|Withdrawal by Subject|5|||
47046474|NCT00243412|83304868|FG000|Overall Study|Other|1|||
46921071|NCT02805660|83153402|FG006|Overall Study|Withdrawal by Subject|2|||
47046475|NCT00243412|83304869|FG001|Overall Study|Other|1|||
47046476|NCT03805750|83304884|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
47046477|NCT03805750|83304885|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
47046478|NCT03804268|83304893|FG000|Overall Study|Adverse Event|2|||
47046479|NCT03804268|83304894|FG001|Overall Study|Adverse Event|2|||
47046480|NCT03804268|83304893|FG000|Overall Study|Withdrawal by Subject|2|||
46725642|NCT00949884|82941578|FG000|Overall Study|Withdrawal by Subject|13|||
47046481|NCT03804268|83304894|FG001|Overall Study|Withdrawal by Subject|0|||
47046482|NCT03804268|83304893|FG000|Overall Study|Lost to Follow-up|1|||
47046483|NCT03804268|83304894|FG001|Overall Study|Lost to Follow-up|0|||
47046484|NCT03804268|83304893|FG000|Overall Study|Physician Decision|2|||
47046485|NCT03804268|83304894|FG001|Overall Study|Physician Decision|0|||
47046486|NCT00243022|83304919|FG000|Overall Study|Withdrawal by Subject|1|||
47046487|NCT00243022|83304920|FG001|Overall Study|Withdrawal by Subject|0|||
47046488|NCT00243022|83304919|FG000|Overall Study|Death|1|||
47046489|NCT00243022|83304920|FG001|Overall Study|Death|0|||
47046490|NCT00243022|83304919|FG000|Overall Study|Difficult Travel Distance|0|||
47046491|NCT00243022|83304920|FG001|Overall Study|Difficult Travel Distance|1|||
47046492|NCT01736683|83305005|FG000|Overall Study|Disease Relapse|0|||
47046493|NCT01736683|83305006|FG001|Overall Study|Disease Relapse|0|||
47046494|NCT01736683|83305007|FG002|Overall Study|Disease Relapse|2|||
47046495|NCT01736683|83305008|FG003|Overall Study|Disease Relapse|1|||
47046496|NCT01736683|83305009|FG004|Overall Study|Disease Relapse|0|||
47046497|NCT01736683|83305005|FG000|Overall Study|Adverse Event|0|||
47046498|NCT01736683|83305006|FG001|Overall Study|Adverse Event|2|||
47046499|NCT01736683|83305007|FG002|Overall Study|Adverse Event|2|||
47046500|NCT01736683|83305008|FG003|Overall Study|Adverse Event|3|||
47046501|NCT01736683|83305009|FG004|Overall Study|Adverse Event|2|||
47046502|NCT01736683|83305005|FG000|Overall Study|Withdrawal by Subject|0|||
47046503|NCT01736683|83305006|FG001|Overall Study|Withdrawal by Subject|0|||
47046504|NCT01736683|83305007|FG002|Overall Study|Withdrawal by Subject|3|||
47046505|NCT01736683|83305008|FG003|Overall Study|Withdrawal by Subject|1|||
47046506|NCT01736683|83305009|FG004|Overall Study|Withdrawal by Subject|1|||
47046507|NCT01736683|83305005|FG000|Overall Study|Lack of Therapeutic Effect|7|||
47046508|NCT01736683|83305006|FG001|Overall Study|Lack of Therapeutic Effect|4|||
47046509|NCT01736683|83305007|FG002|Overall Study|Lack of Therapeutic Effect|13|||
47046510|NCT01736683|83305008|FG003|Overall Study|Lack of Therapeutic Effect|20|||
46921072|NCT02805660|83153396|FG000|Overall Study|Study terminated by Sponsor|0|||
46921073|NCT02805660|83153397|FG001|Overall Study|Study terminated by Sponsor|0|||
46921074|NCT02805660|83153398|FG002|Overall Study|Study terminated by Sponsor|1|||
46921075|NCT02805660|83153399|FG003|Overall Study|Study terminated by Sponsor|4|||
46921076|NCT02805660|83153400|FG004|Overall Study|Study terminated by Sponsor|2|||
46921077|NCT02805660|83153401|FG005|Overall Study|Study terminated by Sponsor|3|||
46921078|NCT02805660|83153402|FG006|Overall Study|Study terminated by Sponsor|1|||
46921079|NCT02805660|83153396|FG000|Overall Study|Miscellaneous|0|||
46921080|NCT02805660|83153397|FG001|Overall Study|Miscellaneous|1|||
46921081|NCT02805660|83153398|FG002|Overall Study|Miscellaneous|0|||
46921082|NCT02805660|83153399|FG003|Overall Study|Miscellaneous|4|||
46921083|NCT02805660|83153400|FG004|Overall Study|Miscellaneous|0|||
46921084|NCT02805660|83153401|FG005|Overall Study|Miscellaneous|6|||
46921085|NCT02805660|83153402|FG006|Overall Study|Miscellaneous|4|||
46921086|NCT02807376|83153433|FG000|Overall Study|Intra-operative exclusion criteria|3|||
47046511|NCT01736683|83305009|FG004|Overall Study|Lack of Therapeutic Effect|1|||
47046512|NCT01736683|83305005|FG000|Overall Study|Progressive Disease|0|||
47046513|NCT01736683|83305006|FG001|Overall Study|Progressive Disease|0|||
47046514|NCT01736683|83305007|FG002|Overall Study|Progressive Disease|0|||
47046515|NCT01736683|83305008|FG003|Overall Study|Progressive Disease|1|||
47046516|NCT01736683|83305009|FG004|Overall Study|Progressive Disease|0|||
47046517|NCT01736683|83305005|FG000|Overall Study|Other|0|||
47046518|NCT01736683|83305006|FG001|Overall Study|Other|0|||
47046519|NCT01736683|83305007|FG002|Overall Study|Other|1|||
47046520|NCT01736683|83305008|FG003|Overall Study|Other|9|||
47046521|NCT01736683|83305009|FG004|Overall Study|Other|1|||
47046522|NCT01788943|83305025|FG000|Overall Study|Withdrawal by Subject|1|||
47046523|NCT01788943|83305026|FG001|Overall Study|Withdrawal by Subject|0|||
47046524|NCT01788163|83305053|FG000|Overall Study|Other|53|||
47046525|NCT01788163|83305054|FG001|Overall Study|Other|0|||
47046526|NCT01788163|83305055|FG002|Overall Study|Other|0|||
47046527|NCT01788163|83305056|FG003|Overall Study|Other|0|||
47046528|NCT01788163|83305057|FG004|Overall Study|Other|0|||
47046529|NCT01788163|83305058|FG005|Overall Study|Other|7|||
47046530|NCT01788163|83305059|FG006|Overall Study|Other|1|||
47046531|NCT01788163|83305060|FG007|Overall Study|Other|48|||
47046532|NCT01788163|83305061|FG008|Overall Study|Other|15|||
47046533|NCT01788163|83305053|FG000|Overall Study|Withdrawal by Subject|2|||
47046534|NCT01788163|83305054|FG001|Overall Study|Withdrawal by Subject|0|||
47046535|NCT01788163|83305055|FG002|Overall Study|Withdrawal by Subject|0|||
47046536|NCT01788163|83305056|FG003|Overall Study|Withdrawal by Subject|0|||
47046537|NCT01788163|83305057|FG004|Overall Study|Withdrawal by Subject|0|||
47046538|NCT01788163|83305058|FG005|Overall Study|Withdrawal by Subject|0|||
47046539|NCT01788163|83305059|FG006|Overall Study|Withdrawal by Subject|0|||
47046540|NCT01788163|83305060|FG007|Overall Study|Withdrawal by Subject|0|||
47046541|NCT01788163|83305061|FG008|Overall Study|Withdrawal by Subject|1|||
47046542|NCT01787461|83305197|FG000|Overall Study|Adverse Event|4|||
47046543|NCT01787461|83305198|FG001|Overall Study|Adverse Event|3|||
47046544|NCT01787461|83305197|FG000|Overall Study|Lost to Follow-up|3|||
47046545|NCT01787461|83305198|FG001|Overall Study|Lost to Follow-up|2|||
47046546|NCT01787461|83305197|FG000|Overall Study|No longer met eligibility criteria|1|||
47046547|NCT01787461|83305198|FG001|Overall Study|No longer met eligibility criteria|0|||
47046548|NCT01787461|83305197|FG000|Overall Study|Withdrawal by Subject|3|||
47046549|NCT01787461|83305198|FG001|Overall Study|Withdrawal by Subject|4|||
47046550|NCT01787461|83305197|FG000|Overall Study|Protocol Violation|3|||
47046551|NCT01787461|83305198|FG001|Overall Study|Protocol Violation|0|||
47046552|NCT01786993|83305223|FG000|Overall Study|Death|6|||
47046553|NCT01786993|83305224|FG001|Overall Study|Death|7|||
47046554|NCT01786993|83305223|FG000|Overall Study|Withdrawal by Subject|3|||
47046555|NCT01786993|83305224|FG001|Overall Study|Withdrawal by Subject|2|||
47046556|NCT01786993|83305223|FG000|Overall Study|Lost to Follow-up|0|||
47046557|NCT01786993|83305224|FG001|Overall Study|Lost to Follow-up|1|||
47046558|NCT01786993|83305223|FG000|Overall Study|Subject Non-Compliance|1|||
47046559|NCT01786993|83305224|FG001|Overall Study|Subject Non-Compliance|0|||
47046560|NCT01786993|83305223|FG000|Overall Study|System Explant|1|||
47046561|NCT01786993|83305224|FG001|Overall Study|System Explant|0|||
47046562|NCT01786993|83305223|FG000|Overall Study|Hospice Admission|1|||
47046563|NCT01786993|83305224|FG001|Overall Study|Hospice Admission|0|||
47046564|NCT01966445|83305249|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
47046565|NCT01966445|83305250|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
46921087|NCT02807376|83153434|FG001|Overall Study|Intra-operative exclusion criteria|0|||
46921088|NCT02807376|83153433|FG000|Overall Study|Lost to Follow-up|0|||
46921089|NCT02807376|83153434|FG001|Overall Study|Lost to Follow-up|1|||
46921090|NCT02804178|83153440|FG000|Overall Study|Adverse Event|1|||
46921091|NCT02917941|83153444|FG000|Treatment Period|Adverse Event|11|||
46921092|NCT02917941|83153444|FG000|Treatment Period|Progressive Disease|11|||
46921093|NCT02917941|83153444|FG000|Treatment Period|Reason not Specified|2|||
46921094|NCT02917941|83153444|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
46921095|NCT02917941|83153444|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
46921096|NCT01333956|83153452|FG000|Overall Study|Lost to Follow-up|1|||
46921097|NCT01333956|83153453|FG001|Overall Study|Lost to Follow-up|2|||
46921098|NCT01333956|83153454|FG002|Overall Study|Lost to Follow-up|0|||
46921099|NCT01333956|83153455|FG003|Overall Study|Lost to Follow-up|1|||
46921100|NCT01333956|83153452|FG000|Overall Study|Unable to complete study procedure|1|||
46921101|NCT01333956|83153453|FG001|Overall Study|Unable to complete study procedure|0|||
46921102|NCT01333956|83153454|FG002|Overall Study|Unable to complete study procedure|0|||
46921103|NCT01333956|83153455|FG003|Overall Study|Unable to complete study procedure|1|||
46921104|NCT01333956|83153452|FG000|Overall Study|Withdrawal by Subject|0|||
46921105|NCT01333956|83153453|FG001|Overall Study|Withdrawal by Subject|2|||
46634621|NCT01716234|82808052|FG004|Overall Study|Adverse Event|3|||
46921106|NCT01333956|83153454|FG002|Overall Study|Withdrawal by Subject|1|||
46921107|NCT01333956|83153455|FG003|Overall Study|Withdrawal by Subject|0|||
46921108|NCT01333722|83153468|FG000|Overall Study|Lack of Efficacy|0|||
46921109|NCT01333722|83153469|FG001|Overall Study|Lack of Efficacy|2|||
46921110|NCT01333722|83153468|FG000|Overall Study|Withdrawal by Subject|0|||
46921111|NCT01333722|83153469|FG001|Overall Study|Withdrawal by Subject|1|||
46921112|NCT01370694|83153477|FG000|Overall Study|Switched to rituximab|4|||
46921113|NCT01370694|83153477|FG000|Overall Study|Progressive disease|2|||
46921114|NCT03315143|83153483|FG000|Overall Study|Death|240|||
46921115|NCT03315143|83153484|FG001|Overall Study|Death|246|||
46921116|NCT03315143|83153483|FG000|Overall Study|Withdrawal by Subject|57|||
46921117|NCT03315143|83153484|FG001|Overall Study|Withdrawal by Subject|68|||
46921118|NCT03315143|83153483|FG000|Overall Study|Site Terminated by Sponsor|256|||
46921119|NCT03315143|83153484|FG001|Overall Study|Site Terminated by Sponsor|282|||
46921120|NCT03315143|83153483|FG000|Overall Study|Study Terminated by Sponsor|4723|||
46921121|NCT03315143|83153484|FG001|Overall Study|Study Terminated by Sponsor|4664|||
46921122|NCT03315143|83153483|FG000|Overall Study|Reason not Specified|16|||
46634622|NCT01716234|82808053|FG005|Overall Study|Adverse Event|6|||
46634623|NCT01716234|82808054|FG006|Overall Study|Adverse Event|0|||
46921123|NCT03315143|83153484|FG001|Overall Study|Reason not Specified|32|||
46921124|NCT02797080|83153490|FG000|Overall Study|Lost to Follow-up|1|||
46921125|NCT02797080|83153490|FG000|Overall Study|Withdrawal by Subject|1|||
46921126|NCT02915835|83153496|FG000|Overall Study|Physician Decision|1|||
46921127|NCT02915835|83153497|FG001|Overall Study|Physician Decision|0|||
46921128|NCT02915835|83153496|FG000|Overall Study|Withdrawal by Subject|0|||
46921129|NCT02915835|83153497|FG001|Overall Study|Withdrawal by Subject|1|||
46921130|NCT01370616|83153505|FG000|Overall Study|Adverse Event|11|||
46921131|NCT01370616|83153506|FG001|Overall Study|Adverse Event|16|||
46921132|NCT01370616|83153505|FG000|Overall Study|Death|1|||
46921133|NCT01370616|83153506|FG001|Overall Study|Death|0|||
47046566|NCT01966445|83305251|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
47046567|NCT01966445|83305252|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
47046568|NCT01966445|83305253|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
47046569|NCT01966445|83305254|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
47046570|NCT01966445|83305255|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
47046571|NCT01966445|83305249|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
47046572|NCT01966445|83305250|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
47046573|NCT01966445|83305251|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
47046574|NCT01966445|83305252|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
47046575|NCT01966445|83305253|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
47046576|NCT01966445|83305254|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
47046577|NCT01966445|83305255|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
47046578|NCT01966445|83305249|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
47046579|NCT01966445|83305250|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
47046580|NCT01966445|83305251|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
47046581|NCT01966445|83305252|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
47046582|NCT01966445|83305253|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
47046583|NCT01966445|83305254|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
47046584|NCT01966445|83305255|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
47046585|NCT01966445|83305249|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
47046586|NCT01966445|83305250|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
47046587|NCT01966445|83305251|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
47046588|NCT01966445|83305252|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
47046589|NCT01966445|83305253|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
47046590|NCT01966445|83305254|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
47046591|NCT01966445|83305255|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
47046592|NCT01966445|83305249|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
47046593|NCT01966445|83305250|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
47046594|NCT01966445|83305251|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
47046595|NCT01966445|83305252|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
47046596|NCT01966445|83305253|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
47046597|NCT01966445|83305254|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
47046598|NCT01966445|83305255|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
47046599|NCT01763905|83305275|FG000|Overall Study|Withdrawal by Subject|1|||
47046600|NCT01763905|83305276|FG001|Overall Study|Withdrawal by Subject|1|||
47046601|NCT01763905|83305277|FG002|Overall Study|Withdrawal by Subject|0|||
47046602|NCT01763905|83305278|FG003|Overall Study|Withdrawal by Subject|1|||
46634624|NCT01716234|82808048|FG000|Overall Study|Withdrawal by Subject|3|||
46725643|NCT00949884|82941579|FG001|Overall Study|Withdrawal by Subject|4|||
46725644|NCT00949884|82941580|FG002|Overall Study|Withdrawal by Subject|16|||
46725645|NCT00949884|82941578|FG000|Overall Study|Lack of Efficacy|4|||
46725646|NCT00949884|82941579|FG001|Overall Study|Lack of Efficacy|2|||
46725647|NCT00949884|82941580|FG002|Overall Study|Lack of Efficacy|7|||
46725648|NCT00949884|82941578|FG000|Overall Study|Study terminated by sponsor|0|||
46725649|NCT00949884|82941579|FG001|Overall Study|Study terminated by sponsor|0|||
46725650|NCT00949884|82941580|FG002|Overall Study|Study terminated by sponsor|1|||
46725651|NCT00949650|82941591|FG000|Overall Study|Progressive disease|188|||
46725652|NCT00949650|82941592|FG001|Overall Study|Progressive disease|19|||
46725653|NCT00949650|82941591|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
46725654|NCT00949650|82941592|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
46725655|NCT00949650|82941591|FG000|Overall Study|Other Adverse Event (AE)|28|||
46725656|NCT00949650|82941592|FG001|Overall Study|Other Adverse Event (AE)|17|||
46725657|NCT00949650|82941591|FG000|Overall Study|Protocol Violation|1|||
46725658|NCT00949650|82941592|FG001|Overall Study|Protocol Violation|4|||
46725659|NCT00949650|82941591|FG000|Overall Study|Refusal to continue medication|7|||
46725660|NCT00949650|82941592|FG001|Overall Study|Refusal to continue medication|11|||
46725661|NCT00949650|82941591|FG000|Overall Study|Not treated|1|||
46725662|NCT00949650|82941592|FG001|Overall Study|Not treated|4|||
46725663|NCT00949650|82941591|FG000|Overall Study|Other not specified above|5|||
46725664|NCT00949650|82941592|FG001|Overall Study|Other not specified above|0|||
46725665|NCT00908037|82941609|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725666|NCT00908037|82941610|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725667|NCT00908037|82941611|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725668|NCT00908037|82941612|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725669|NCT00908037|82941613|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
46725670|NCT00908037|82941614|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725671|NCT00908037|82941615|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
46725672|NCT00908037|82941616|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725673|NCT00908037|82941617|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
46725674|NCT00908037|82941618|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725675|NCT00908037|82941619|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725676|NCT00908037|82941620|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
46725677|NCT00908037|82941609|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725678|NCT00908037|82941610|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725679|NCT00908037|82941611|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725680|NCT00908037|82941612|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725681|NCT00908037|82941613|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
46725682|NCT00908037|82941614|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725683|NCT00908037|82941615|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725684|NCT00908037|82941616|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725685|NCT00908037|82941617|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
46725686|NCT00908037|82941618|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725687|NCT00908037|82941619|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725688|NCT00908037|82941620|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
46725689|NCT00908037|82941609|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725690|NCT00908037|82941610|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725691|NCT00908037|82941611|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725692|NCT00908037|82941612|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
46725693|NCT00908037|82941613|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725694|NCT00908037|82941614|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725695|NCT00908037|82941615|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
46725696|NCT00908037|82941616|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
47046603|NCT01763905|83305275|FG000|Overall Study|Decision by sponsor|5|||
47046604|NCT01763905|83305276|FG001|Overall Study|Decision by sponsor|0|||
47046605|NCT01763905|83305277|FG002|Overall Study|Decision by sponsor|8|||
47046606|NCT01763905|83305278|FG003|Overall Study|Decision by sponsor|0|||
47046607|NCT01763905|83305275|FG000|Overall Study|Lost to Follow-up|0|||
47046608|NCT01763905|83305276|FG001|Overall Study|Lost to Follow-up|0|||
47046609|NCT01763905|83305277|FG002|Overall Study|Lost to Follow-up|1|||
47046610|NCT01763905|83305278|FG003|Overall Study|Lost to Follow-up|0|||
47046611|NCT02091167|83305290|FG000|Overall Study|Lost to Follow-up|0|||
46725697|NCT00908037|82941617|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725698|NCT00908037|82941618|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725699|NCT00908037|82941619|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
46725700|NCT00908037|82941620|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
47046612|NCT02091167|83305291|FG001|Overall Study|Lost to Follow-up|2|||
47046613|NCT02091089|83305297|FG000|Overall Study|Lost to Follow-up|2|||
47046614|NCT01763203|83305312|FG000|Overall Study|Death|4|||
47046615|NCT01763203|83305313|FG001|Overall Study|Death|7|||
47046616|NCT01763203|83305312|FG000|Overall Study|Lost to Follow-up|12|||
47046617|NCT01763203|83305313|FG001|Overall Study|Lost to Follow-up|12|||
46725701|NCT00908037|82941609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725702|NCT00908037|82941610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725703|NCT00908037|82941611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725704|NCT00908037|82941612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725705|NCT00908037|82941613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725706|NCT00908037|82941614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
47046618|NCT01763203|83305312|FG000|Overall Study|Withdrawal by Subject|8|||
47046619|NCT01763203|83305313|FG001|Overall Study|Withdrawal by Subject|12|||
47046620|NCT01763203|83305312|FG000|Overall Study|Moved out of study region|7|||
47046621|NCT01763203|83305313|FG001|Overall Study|Moved out of study region|10|||
47046622|NCT01763203|83305312|FG000|Overall Study|Physician Decision|2|||
47046623|NCT01763203|83305313|FG001|Overall Study|Physician Decision|1|||
47046624|NCT01763047|83305330|FG000|Period 1|Test Article Not Available|4|||
47046625|NCT01763047|83305331|FG001|Period 1|Test Article Not Available|1|||
47046626|NCT01763047|83305330|FG000|Period 1|Protocol Violation|4|||
47046627|NCT01763047|83305331|FG001|Period 1|Protocol Violation|4|||
47046628|NCT01763047|83305330|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
47046629|NCT01763047|83305331|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
47046630|NCT01763047|83305330|FG000|Period 1|Adverse Event|0|||
47046631|NCT01763047|83305331|FG001|Period 1|Adverse Event|1|||
47046632|NCT01763047|83305330|FG000|Period 1|Unsatisfactory Visual Response|0|||
47046633|NCT01763047|83305331|FG001|Period 1|Unsatisfactory Visual Response|3|||
47046634|NCT01763047|83305330|FG000|Period 1|Lens Power Not Available|0|||
47046635|NCT01763047|83305331|FG001|Period 1|Lens Power Not Available|1|||
47046636|NCT01763047|83305330|FG000|Period 1|Study Site office Closed|0|||
47046637|NCT01763047|83305331|FG001|Period 1|Study Site office Closed|1|||
47046638|NCT01763047|83305330|FG000|Period 2|Lens Discomfort|1|||
47046639|NCT01763047|83305331|FG001|Period 2|Lens Discomfort|0|||
47046640|NCT01763047|83305330|FG000|Period 2|No longer meets Eligibility Criteria|1|||
47046641|NCT01763047|83305331|FG001|Period 2|No longer meets Eligibility Criteria|0|||
47046642|NCT01763047|83305330|FG000|Period 2|Study Site office Closed|1|||
47046643|NCT01763047|83305331|FG001|Period 2|Study Site office Closed|1|||
47046644|NCT01763047|83305330|FG000|Period 2|Unsatisfactory Visual Response|1|||
47046645|NCT01763047|83305331|FG001|Period 2|Unsatisfactory Visual Response|1|||
47046646|NCT01763047|83305330|FG000|Period 2|Protocol Violation|0|||
47046647|NCT01763047|83305331|FG001|Period 2|Protocol Violation|2|||
47046648|NCT01763047|83305330|FG000|Period 2|Unsatisfactory lens Fitting|0|||
47046649|NCT01763047|83305331|FG001|Period 2|Unsatisfactory lens Fitting|1|||
47046650|NCT01977677|83305343|FG000|Overall Study|Unrelated Adverse Event|0|||
47046651|NCT01977677|83305344|FG001|Overall Study|Unrelated Adverse Event|0|||
46634625|NCT01716234|82808049|FG001|Overall Study|Withdrawal by Subject|0|||
47046652|NCT01977677|83305345|FG002|Overall Study|Unrelated Adverse Event|1|||
47046653|NCT01762345|83305353|FG000|Overall Study|Adverse Event|5|||
47046654|NCT01762345|83305353|FG000|Overall Study|Protocol Violation|2|||
47046655|NCT02090855|83305358|FG000|Overall Study|no evaluable Standard of Truth results|2|||
47046656|NCT01761565|83305365|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
47046657|NCT01619579|83305375|FG000|Overall Study|Withdrawal by Subject|0|||
47046658|NCT01619579|83305376|FG001|Overall Study|Withdrawal by Subject|3|||
47046659|NCT01736215|83305382|FG000|Overall Study|Early termination of erythropoietin use|1|||
47046660|NCT01736215|83305382|FG000|Overall Study|Adverse Event|4|||
47046661|NCT01736215|83305382|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
47046662|NCT01736215|83305382|FG000|Overall Study|Insufficient data to perform analysis|8|||
46725707|NCT00908037|82941615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725708|NCT00908037|82941616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725709|NCT00908037|82941617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725710|NCT00908037|82941618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725711|NCT00908037|82941619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
46725712|NCT00908037|82941620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
46725713|NCT00908037|82941609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725714|NCT00908037|82941610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725715|NCT00908037|82941611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725716|NCT00908037|82941612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725717|NCT00908037|82941613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725718|NCT00908037|82941614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725719|NCT00908037|82941615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725720|NCT00908037|82941616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725721|NCT00908037|82941617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725722|NCT00908037|82941618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
46725723|NCT00908037|82941619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
46725724|NCT00908037|82941620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
46803644|NCT03523728|83022939|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
47046663|NCT01786603|83305388|FG000|Overall Study|Death|5|||
47046664|NCT01786603|83305389|FG001|Overall Study|Death|1|||
47046665|NCT01786603|83305388|FG000|Overall Study|Adverse Event|6|||
47046666|NCT01786603|83305389|FG001|Overall Study|Adverse Event|2|||
47046667|NCT01786603|83305388|FG000|Overall Study|Physician decision to withdraw|6|||
47046668|NCT01786603|83305389|FG001|Overall Study|Physician decision to withdraw|7|||
47046669|NCT01786603|83305388|FG000|Overall Study|Lost to Follow-up|1|||
47046670|NCT01786603|83305389|FG001|Overall Study|Lost to Follow-up|2|||
47046671|NCT01619423|83305412|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
47046672|NCT01619423|83305413|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
47046673|NCT01619423|83305414|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
47046674|NCT01619423|83305415|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
47046675|NCT01735279|83305428|FG000|Overall Study|Lost to Follow-up|11|||
46634626|NCT01716234|82808050|FG002|Overall Study|Withdrawal by Subject|2|||
46634627|NCT01716234|82808051|FG003|Overall Study|Withdrawal by Subject|2|||
46634628|NCT01716234|82808052|FG004|Overall Study|Withdrawal by Subject|1|||
46634629|NCT01716234|82808053|FG005|Overall Study|Withdrawal by Subject|3|||
46634630|NCT01716234|82808054|FG006|Overall Study|Withdrawal by Subject|0|||
46634631|NCT01716156|82808073|FG000|Overall Study|Protocol Violation|1|||
46634632|NCT01716156|82808074|FG001|Overall Study|Protocol Violation|0|||
46634633|NCT01716156|82808075|FG002|Overall Study|Protocol Violation|0|||
46634634|NCT01716156|82808073|FG000|Overall Study|Withdrawal by Subject|0|||
46634635|NCT01716156|82808074|FG001|Overall Study|Withdrawal by Subject|1|||
46634636|NCT01716156|82808075|FG002|Overall Study|Withdrawal by Subject|2|||
46634637|NCT01716156|82808073|FG000|Overall Study|Lost to Follow-up|1|||
46634638|NCT01716156|82808074|FG001|Overall Study|Lost to Follow-up|0|||
46634639|NCT01716156|82808075|FG002|Overall Study|Lost to Follow-up|0|||
46634640|NCT01739790|82808089|FG000|Overall Study|Early Trial Termination|2|||
46634641|NCT01739790|82808090|FG001|Overall Study|Early Trial Termination|4|||
46634642|NCT01696032|82808100|FG000|Overall Study|Withdrawal by Subject|0|||
47046676|NCT01735279|83305429|FG001|Overall Study|Lost to Follow-up|8|||
47046677|NCT01759381|83305437|FG000|Overall Study|Death|1|||
47046678|NCT01759381|83305438|FG001|Overall Study|Death|0|||
46634643|NCT01696032|82808101|FG001|Overall Study|Withdrawal by Subject|0|||
46634644|NCT01696032|82808102|FG002|Overall Study|Withdrawal by Subject|1|||
46634645|NCT01696032|82808103|FG003|Overall Study|Withdrawal by Subject|2|||
46634646|NCT01696032|82808100|FG000|Overall Study|Death|14|||
46634647|NCT01696032|82808101|FG001|Overall Study|Death|4|||
46634648|NCT01696032|82808102|FG002|Overall Study|Death|43|||
46725725|NCT00908037|82941609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725726|NCT00908037|82941610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725727|NCT00908037|82941611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725728|NCT00908037|82941612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725729|NCT00908037|82941613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725730|NCT00908037|82941614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725731|NCT00908037|82941615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725732|NCT00908037|82941616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725733|NCT00908037|82941617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725734|NCT00908037|82941618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
46725735|NCT00908037|82941619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725736|NCT00908037|82941620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
46725737|NCT00908037|82941609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725738|NCT00908037|82941610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725739|NCT00908037|82941611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725740|NCT00908037|82941612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725741|NCT00908037|82941613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725742|NCT00908037|82941614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725743|NCT00908037|82941615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725744|NCT00908037|82941616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725745|NCT00908037|82941617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725746|NCT00908037|82941618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725747|NCT00908037|82941619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
46725748|NCT00908037|82941620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
46725749|NCT00908037|82941609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725750|NCT00908037|82941610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725751|NCT00908037|82941611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725752|NCT00908037|82941612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725753|NCT00908037|82941613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725754|NCT00908037|82941614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725755|NCT00908037|82941615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725756|NCT00908037|82941616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725757|NCT00908037|82941617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725758|NCT00908037|82941618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
46725759|NCT00908037|82941619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725760|NCT00908037|82941620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
46725761|NCT00908037|82941609|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725762|NCT00908037|82941610|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725763|NCT00908037|82941611|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725764|NCT00908037|82941612|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725765|NCT00908037|82941613|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725766|NCT00908037|82941614|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725767|NCT00908037|82941615|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725768|NCT00908037|82941616|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725769|NCT00908037|82941617|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46803645|NCT03523728|83022940|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
46803646|NCT03523728|83022941|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
46803647|NCT03523728|83022942|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
46803648|NCT03523728|83022938|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
46921134|NCT01370616|83153505|FG000|Overall Study|Lack of Efficacy|6|||
46921135|NCT01370616|83153506|FG001|Overall Study|Lack of Efficacy|2|||
46921136|NCT01370616|83153505|FG000|Overall Study|Lost to Follow-up|0|||
46634649|NCT01696032|82808103|FG003|Overall Study|Death|18|||
46634650|NCT01696032|82808100|FG000|Overall Study|Lost to Follow-up|0|||
46634651|NCT01696032|82808101|FG001|Overall Study|Lost to Follow-up|1|||
46634652|NCT01696032|82808102|FG002|Overall Study|Lost to Follow-up|0|||
46634653|NCT01696032|82808103|FG003|Overall Study|Lost to Follow-up|0|||
46634654|NCT01696032|82808100|FG000|Overall Study|Database lock|0|||
46634655|NCT01696032|82808101|FG001|Overall Study|Database lock|1|||
46634656|NCT01696032|82808102|FG002|Overall Study|Database lock|7|||
46634657|NCT01696032|82808103|FG003|Overall Study|Database lock|2|||
46634658|NCT01695954|82808119|FG000|Overall Study|Withdrawal by Subject|4|||
46634659|NCT01695954|82808120|FG001|Overall Study|Withdrawal by Subject|0|||
46803649|NCT03523728|83022939|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
46803650|NCT03523728|83022940|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
46803651|NCT03523728|83022941|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
46803652|NCT03523728|83022942|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
46803653|NCT03523728|83022938|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
46803654|NCT03523728|83022939|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
46803655|NCT03523728|83022940|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
46803656|NCT03523728|83022941|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
46803657|NCT03523728|83022942|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
46803658|NCT03523728|83022938|FG000|Stage 2 (24 Months)|Adverse Event|0|||
46803659|NCT03523728|83022939|FG001|Stage 2 (24 Months)|Adverse Event|0|||
46803660|NCT03523728|83022940|FG002|Stage 2 (24 Months)|Adverse Event|0|||
46803661|NCT03523728|83022941|FG003|Stage 2 (24 Months)|Adverse Event|1|||
46803662|NCT03523728|83022942|FG004|Stage 2 (24 Months)|Adverse Event|2|||
46803663|NCT03523728|83022938|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
46803664|NCT03523728|83022939|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
46803665|NCT03523728|83022940|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
46803666|NCT03523728|83022941|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
46803667|NCT03523728|83022942|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
46803668|NCT03523728|83022938|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
46803669|NCT03523728|83022939|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
46803670|NCT03523728|83022940|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
46803671|NCT03523728|83022941|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
46803672|NCT03523728|83022942|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
46803673|NCT03523728|83022938|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
46803674|NCT03523728|83022939|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
46803675|NCT03523728|83022940|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
46803676|NCT03523728|83022941|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
46803677|NCT03523728|83022942|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
46803678|NCT03523728|83022938|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
46803679|NCT03523728|83022939|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
46803680|NCT03523728|83022940|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
46803681|NCT03523728|83022941|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
46803682|NCT03523728|83022942|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
46803683|NCT00538590|83022961|FG000|Overall Study|Death|1|||
46803684|NCT00538590|83022962|FG001|Overall Study|Death|0|||
46803685|NCT00466947|83022970|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
46803686|NCT00466947|83022971|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
46803687|NCT00466947|83022970|FG000|Study End Analysis Period|Adverse Event|35|||
46803688|NCT00466947|83022971|FG001|Study End Analysis Period|Adverse Event|43|||
46803689|NCT00466947|83022970|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
46803690|NCT00466947|83022971|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
46803691|NCT00466947|83022970|FG000|Study End Analysis Period|Physician Decision|29|||
46803692|NCT00466947|83022971|FG001|Study End Analysis Period|Physician Decision|29|||
46803693|NCT00466947|83022970|FG000|Study End Analysis Period|Protocol Violation|9|||
46803694|NCT00466947|83022971|FG001|Study End Analysis Period|Protocol Violation|17|||
46803695|NCT00466947|83022970|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
46803696|NCT00466947|83022971|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
46803697|NCT00466947|83022970|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
46803698|NCT00466947|83022971|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
46803699|NCT00466947|83022970|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
46803700|NCT00466947|83022971|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
46803701|NCT00466947|83022970|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
46803702|NCT00466947|83022971|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
46803703|NCT00537810|83022982|FG000|Overall Study|Withdrawal by Subject|4|||
46803704|NCT00537810|83022983|FG001|Overall Study|Withdrawal by Subject|11|||
46803705|NCT00537810|83022984|FG002|Overall Study|Withdrawal by Subject|4|||
46803706|NCT00537810|83022985|FG003|Overall Study|Withdrawal by Subject|3|||
46803707|NCT00537810|83022982|FG000|Overall Study|Medically withdrawn|2|||
46803708|NCT00537810|83022983|FG001|Overall Study|Medically withdrawn|2|||
46803709|NCT00537810|83022984|FG002|Overall Study|Medically withdrawn|0|||
46803710|NCT00537810|83022985|FG003|Overall Study|Medically withdrawn|1|||
46803711|NCT01287936|83022998|FG000|Overall Study|Lost to Follow-up|0|||
46803712|NCT01287936|83022999|FG001|Overall Study|Lost to Follow-up|1|||
46803713|NCT01287936|83023000|FG002|Overall Study|Lost to Follow-up|1|||
47046679|NCT01758523|83305457|FG000|Overall Study|Adverse Event|2|||
47046680|NCT01758523|83305458|FG001|Overall Study|Adverse Event|1|||
47046681|NCT01758523|83305457|FG000|Overall Study|Lack of Efficacy|4|||
47046682|NCT01758523|83305458|FG001|Overall Study|Lack of Efficacy|2|||
47046683|NCT01758523|83305457|FG000|Overall Study|Lost to Follow-up|3|||
46803714|NCT00090259|83023010|FG000|Overall Study|Lost to Follow-up|30|||
47046684|NCT01758523|83305458|FG001|Overall Study|Lost to Follow-up|4|||
47046685|NCT01758523|83305457|FG000|Overall Study|Withdrawal by Subject|12|||
46803715|NCT00090259|83023011|FG001|Overall Study|Lost to Follow-up|26|||
46803716|NCT00090259|83023010|FG000|Overall Study|Withdrawal by Subject|21|||
46803717|NCT00090259|83023011|FG001|Overall Study|Withdrawal by Subject|15|||
46803718|NCT00090259|83023010|FG000|Overall Study|Investigator site closed|11|||
46803719|NCT00090259|83023011|FG001|Overall Study|Investigator site closed|7|||
46803720|NCT00079183|83023017|FG000|Overall Study|Withdrawal by Subject|4|||
46803721|NCT00079183|83023017|FG000|Overall Study|Study medication non-compliance|2|||
46803722|NCT00079183|83023017|FG000|Overall Study|Specimen collection non-compliance|1|||
46803723|NCT00676403|83023028|FG000|Overall Study|Adverse Event|1|||
46803724|NCT00676403|83023029|FG001|Overall Study|Adverse Event|2|||
46803725|NCT00676403|83023030|FG002|Overall Study|Adverse Event|0|||
46803726|NCT00676403|83023031|FG003|Overall Study|Adverse Event|5|||
46803727|NCT00676403|83023032|FG004|Overall Study|Adverse Event|1|||
46803728|NCT00676403|83023033|FG005|Overall Study|Adverse Event|2|||
46803729|NCT00676403|83023028|FG000|Overall Study|Lost to Follow-up|0|||
46803730|NCT00676403|83023029|FG001|Overall Study|Lost to Follow-up|0|||
46803731|NCT00676403|83023030|FG002|Overall Study|Lost to Follow-up|0|||
46803732|NCT00676403|83023031|FG003|Overall Study|Lost to Follow-up|0|||
46803733|NCT00676403|83023032|FG004|Overall Study|Lost to Follow-up|0|||
46803734|NCT00676403|83023033|FG005|Overall Study|Lost to Follow-up|1|||
46803735|NCT00676403|83023028|FG000|Overall Study|Reason Unspecified|1|||
46803736|NCT00676403|83023029|FG001|Overall Study|Reason Unspecified|0|||
46921137|NCT01370616|83153506|FG001|Overall Study|Lost to Follow-up|3|||
47046686|NCT01758523|83305458|FG001|Overall Study|Withdrawal by Subject|7|||
47046687|NCT01758289|83305481|FG000|Overall Study|Premature Study Termination|44|||
47046688|NCT01758289|83305481|FG000|Overall Study|Adverse Event|9|||
47046689|NCT01757821|83305505|FG000|Overall Study|Adverse Event|1|||
47046690|NCT01735201|83305534|FG000|Overall Study|Adverse Event|1|||
47046691|NCT01735201|83305535|FG001|Overall Study|Adverse Event|1|||
47046692|NCT01735201|83305536|FG002|Overall Study|Adverse Event|0|||
47046693|NCT01735201|83305537|FG003|Overall Study|Adverse Event|1|||
47046694|NCT01735201|83305538|FG004|Overall Study|Adverse Event|1|||
47046695|NCT01735201|83305539|FG005|Overall Study|Adverse Event|3|||
47046696|NCT01735201|83305540|FG006|Overall Study|Adverse Event|2|||
47046697|NCT01735201|83305541|FG007|Overall Study|Adverse Event|1|||
47046698|NCT01735201|83305534|FG000|Overall Study|Personal Reasons|1|||
47046699|NCT01735201|83305535|FG001|Overall Study|Personal Reasons|0|||
47046700|NCT01735201|83305536|FG002|Overall Study|Personal Reasons|0|||
47046701|NCT01735201|83305537|FG003|Overall Study|Personal Reasons|0|||
47046702|NCT01735201|83305538|FG004|Overall Study|Personal Reasons|0|||
47046703|NCT01735201|83305539|FG005|Overall Study|Personal Reasons|0|||
47046704|NCT01735201|83305540|FG006|Overall Study|Personal Reasons|0|||
47046705|NCT01735201|83305541|FG007|Overall Study|Personal Reasons|0|||
47046706|NCT01735201|83305534|FG000|Overall Study|Protocol Violation|1|||
47046707|NCT01735201|83305535|FG001|Overall Study|Protocol Violation|0|||
47046708|NCT01735201|83305536|FG002|Overall Study|Protocol Violation|0|||
47046709|NCT01735201|83305537|FG003|Overall Study|Protocol Violation|0|||
47046710|NCT01735201|83305538|FG004|Overall Study|Protocol Violation|0|||
47046711|NCT01735201|83305539|FG005|Overall Study|Protocol Violation|0|||
47046712|NCT01735201|83305540|FG006|Overall Study|Protocol Violation|0|||
47046713|NCT01735201|83305541|FG007|Overall Study|Protocol Violation|0|||
46725770|NCT00908037|82941618|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725771|NCT00908037|82941619|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
46725772|NCT00908037|82941620|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
46725773|NCT00904215|82941672|FG000|Overall Study|Adverse Event|25|||
46725774|NCT00904215|82941672|FG000|Overall Study|Protocol Violation|10|||
46725775|NCT00904215|82941672|FG000|Overall Study|Lost to Follow-up|63|||
46725776|NCT00904215|82941672|FG000|Overall Study|Withdrawal by Subject|9|||
46725777|NCT00904215|82941672|FG000|Overall Study|Other|28|||
46725778|NCT00905307|82941682|FG000|Overall Study|Switched to Open Label Rescue|7|||
47046714|NCT01735201|83305534|FG000|Overall Study|Other Miscellaneous Reasons|0|||
47046715|NCT01735201|83305535|FG001|Overall Study|Other Miscellaneous Reasons|0|||
46725779|NCT00905307|82941683|FG001|Overall Study|Switched to Open Label Rescue|17|||
46803737|NCT00676403|83023030|FG002|Overall Study|Reason Unspecified|1|||
46803738|NCT00676403|83023031|FG003|Overall Study|Reason Unspecified|0|||
46803739|NCT00676403|83023032|FG004|Overall Study|Reason Unspecified|0|||
46803740|NCT00676403|83023033|FG005|Overall Study|Reason Unspecified|1|||
46803741|NCT00676403|83023028|FG000|Overall Study|Withdrawal by Subject|0|||
46921138|NCT01370616|83153505|FG000|Overall Study|Physician Decision|6|||
47046716|NCT01735201|83305536|FG002|Overall Study|Other Miscellaneous Reasons|0|||
47046717|NCT01735201|83305537|FG003|Overall Study|Other Miscellaneous Reasons|1|||
47046718|NCT01735201|83305538|FG004|Overall Study|Other Miscellaneous Reasons|0|||
47046719|NCT01735201|83305539|FG005|Overall Study|Other Miscellaneous Reasons|2|||
47046720|NCT01735201|83305540|FG006|Overall Study|Other Miscellaneous Reasons|1|||
46803742|NCT00676403|83023029|FG001|Overall Study|Withdrawal by Subject|0|||
46921139|NCT01370616|83153506|FG001|Overall Study|Physician Decision|6|||
47046721|NCT01735201|83305541|FG007|Overall Study|Other Miscellaneous Reasons|1|||
47046722|NCT01734811|83305561|FG000|Overall Study|Lost to Follow-up|2|||
46725780|NCT00905307|82941684|FG002|Overall Study|Switched to Open Label Rescue|11|||
46725781|NCT00905307|82941685|FG003|Overall Study|Switched to Open Label Rescue|11|||
46725782|NCT00905307|82941686|FG004|Overall Study|Switched to Open Label Rescue|4|||
46725783|NCT00905307|82941687|FG005|Overall Study|Switched to Open Label Rescue|15|||
46725784|NCT00905307|82941682|FG000|Overall Study|Lost to Follow-up|0|||
46725785|NCT00905307|82941683|FG001|Overall Study|Lost to Follow-up|0|||
46725786|NCT00905307|82941684|FG002|Overall Study|Lost to Follow-up|0|||
46725787|NCT00905307|82941685|FG003|Overall Study|Lost to Follow-up|0|||
46725788|NCT00905307|82941686|FG004|Overall Study|Lost to Follow-up|1|||
46725789|NCT00905307|82941687|FG005|Overall Study|Lost to Follow-up|1|||
46725790|NCT00905307|82941682|FG000|Overall Study|Adverse Event|3|||
46725791|NCT00905307|82941683|FG001|Overall Study|Adverse Event|4|||
46725792|NCT00905307|82941684|FG002|Overall Study|Adverse Event|5|||
46725793|NCT00905307|82941685|FG003|Overall Study|Adverse Event|11|||
46725794|NCT00905307|82941686|FG004|Overall Study|Adverse Event|3|||
46725795|NCT00905307|82941687|FG005|Overall Study|Adverse Event|5|||
46725796|NCT00905307|82941682|FG000|Overall Study|Withdrawal by Subject|5|||
46725797|NCT00905307|82941683|FG001|Overall Study|Withdrawal by Subject|13|||
46725798|NCT00905307|82941684|FG002|Overall Study|Withdrawal by Subject|15|||
46725799|NCT00905307|82941685|FG003|Overall Study|Withdrawal by Subject|11|||
46725800|NCT00905307|82941686|FG004|Overall Study|Withdrawal by Subject|4|||
46725801|NCT00905307|82941687|FG005|Overall Study|Withdrawal by Subject|13|||
46725802|NCT00905307|82941682|FG000|Overall Study|Protocol Violation|1|||
46725803|NCT00905307|82941683|FG001|Overall Study|Protocol Violation|0|||
46725804|NCT00905307|82941684|FG002|Overall Study|Protocol Violation|1|||
46725805|NCT00905307|82941685|FG003|Overall Study|Protocol Violation|0|||
46725806|NCT00905307|82941686|FG004|Overall Study|Protocol Violation|0|||
46725807|NCT00905307|82941687|FG005|Overall Study|Protocol Violation|0|||
46725808|NCT00905307|82941682|FG000|Overall Study|Lack of Efficacy|6|||
46725809|NCT00905307|82941683|FG001|Overall Study|Lack of Efficacy|3|||
46725810|NCT00905307|82941684|FG002|Overall Study|Lack of Efficacy|5|||
46725811|NCT00905307|82941685|FG003|Overall Study|Lack of Efficacy|4|||
46725812|NCT00905307|82941686|FG004|Overall Study|Lack of Efficacy|4|||
46725813|NCT00905307|82941687|FG005|Overall Study|Lack of Efficacy|8|||
47046723|NCT01734811|83305562|FG001|Overall Study|Lost to Follow-up|3|||
47046724|NCT01734811|83305561|FG000|Overall Study|Withdrawal by Subject|2|||
47046725|NCT01734811|83305562|FG001|Overall Study|Withdrawal by Subject|0|||
47046726|NCT01757275|83305570|FG000|Overall Study|Lost to Follow-up|1|||
47046727|NCT01757275|83305571|FG001|Overall Study|Lost to Follow-up|2|||
47046728|NCT01757275|83305570|FG000|Overall Study|Adverse Event|3|||
47046729|NCT01757275|83305571|FG001|Overall Study|Adverse Event|3|||
46725814|NCT00907881|82941714|FG000|Overall Study|Lost to Follow-up|59|||
47046730|NCT01757275|83305570|FG000|Overall Study|Withdrawal by Subject|2|||
47046731|NCT01757275|83305571|FG001|Overall Study|Withdrawal by Subject|4|||
47046732|NCT01757275|83305570|FG000|Overall Study|Not treated|3|||
47046733|NCT01757275|83305571|FG001|Overall Study|Not treated|4|||
47046734|NCT01757197|83305586|FG000|Overall Study|Death|2|||
47046735|NCT01784965|83305610|FG000|Overall Study|Withdrawal by Subject|6|||
46725815|NCT00907881|82941714|FG000|Overall Study|Noncompliance|5|||
46725816|NCT00907881|82941714|FG000|Overall Study|Withdrawal by Subject|5|||
46725817|NCT00907881|82941714|FG000|Overall Study|Protocol Violation|1|||
46725818|NCT00907881|82941714|FG000|Overall Study|Missing discontinuation information|15|||
46725819|NCT00904917|82941722|FG000|Overall Study|Lost to Follow-up|2|||
46725820|NCT00904917|82941723|FG001|Overall Study|Lost to Follow-up|2|||
46725821|NCT00904917|82941724|FG002|Overall Study|Lost to Follow-up|2|||
46725822|NCT00904917|82941725|FG003|Overall Study|Lost to Follow-up|2|||
47046736|NCT01784965|83305611|FG001|Overall Study|Withdrawal by Subject|3|||
47046737|NCT01784965|83305610|FG000|Overall Study|Adverse Event|0|||
47046738|NCT01784965|83305611|FG001|Overall Study|Adverse Event|8|||
47046739|NCT01784419|83305619|FG000|Overall Study|Adverse Event|3|||
47046740|NCT01784029|83305626|FG000|Overall Study|Lost to Follow-up|19|||
46921140|NCT01370616|83153505|FG000|Overall Study|Progressive Disease|0|||
46921141|NCT01370616|83153506|FG001|Overall Study|Progressive Disease|1|||
46921142|NCT01370616|83153505|FG000|Overall Study|Recovery|1|||
46921143|NCT01370616|83153506|FG001|Overall Study|Recovery|0|||
46921144|NCT01370616|83153505|FG000|Overall Study|Technical Problems|3|||
46921145|NCT01370616|83153506|FG001|Overall Study|Technical Problems|5|||
47046741|NCT01784029|83305627|FG001|Overall Study|Lost to Follow-up|20|||
47046742|NCT01784029|83305628|FG002|Overall Study|Lost to Follow-up|22|||
47046743|NCT01733329|83305650|FG000|Overall Study|Protocol Violation|1|||
47046744|NCT01733329|83305651|FG001|Overall Study|Protocol Violation|1|||
47046745|NCT01733329|83305650|FG000|Overall Study|Uterine artery injury|1|||
47046746|NCT01733329|83305651|FG001|Overall Study|Uterine artery injury|0|||
47046747|NCT01783483|83305659|FG000|Overall Study|Death|3|||
47046748|NCT01783483|83305660|FG001|Overall Study|Death|3|||
47046749|NCT01783483|83305659|FG000|Overall Study|Lost to Follow-up|14|||
47046750|NCT01783483|83305660|FG001|Overall Study|Lost to Follow-up|10|||
47046751|NCT01783483|83305659|FG000|Overall Study|Withdrawal by Subject|2|||
47046752|NCT01783483|83305660|FG001|Overall Study|Withdrawal by Subject|1|||
47046753|NCT01783483|83305659|FG000|Overall Study|Physician Decision|1|||
47046754|NCT01783483|83305660|FG001|Overall Study|Physician Decision|1|||
47046755|NCT01607593|83305679|FG000|Overall Study|Adverse Event|15|||
47046756|NCT01607593|83305679|FG000|Overall Study|Lack of Efficacy|16|||
47046757|NCT01607593|83305679|FG000|Overall Study|Lost to Follow-up|25|||
47046758|NCT01607593|83305679|FG000|Overall Study|Continuation|33|||
47046759|NCT01607593|83305679|FG000|Overall Study|Other|4|||
47046760|NCT01755637|83305692|FG000|Period 1|Adverse Event|0|||
47046761|NCT01755637|83305693|FG001|Period 1|Adverse Event|1|||
47046762|NCT01732549|83305711|FG000|Overall Study|Adverse Event|13|||
46921146|NCT01370616|83153505|FG000|Overall Study|Withdrawal by Subject|34|||
46921147|NCT01370616|83153506|FG001|Overall Study|Withdrawal by Subject|34|||
46921148|NCT02916927|83153519|FG000|Overall Study|Discharged prior to study drug receipt|0|||
46921149|NCT02916927|83153520|FG001|Overall Study|Discharged prior to study drug receipt|2|||
46921150|NCT02916927|83153519|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
46921151|NCT02916927|83153520|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
46921152|NCT02916927|83153519|FG000|Overall Study|Withdrawal before first time point|1|||
47046763|NCT01732549|83305712|FG001|Overall Study|Adverse Event|3|||
47046764|NCT01732549|83305711|FG000|Overall Study|Consent withdrawn|13|||
47046765|NCT01732549|83305712|FG001|Overall Study|Consent withdrawn|6|||
47046766|NCT01732549|83305711|FG000|Overall Study|Disease progression|37|||
47046767|NCT01732549|83305712|FG001|Overall Study|Disease progression|50|||
47046768|NCT01732549|83305711|FG000|Overall Study|Other|8|||
47046769|NCT01732549|83305712|FG001|Overall Study|Other|14|||
47046770|NCT01755091|83305731|FG000|Overall Study|Withdrawal by Subject|6|||
47046771|NCT01755091|83305732|FG001|Overall Study|Withdrawal by Subject|1|||
47046772|NCT01755091|83305733|FG002|Overall Study|Withdrawal by Subject|3|||
47046773|NCT01755091|83305731|FG000|Overall Study|Adverse Event|1|||
47046774|NCT01755091|83305732|FG001|Overall Study|Adverse Event|1|||
47046775|NCT01755091|83305733|FG002|Overall Study|Adverse Event|1|||
47046776|NCT01755091|83305731|FG000|Overall Study|Lost to Follow-up|1|||
47046777|NCT01755091|83305732|FG001|Overall Study|Lost to Follow-up|0|||
47046778|NCT01755091|83305733|FG002|Overall Study|Lost to Follow-up|1|||
47046779|NCT01755091|83305731|FG000|Overall Study|Physician Decision|1|||
47046780|NCT01755091|83305732|FG001|Overall Study|Physician Decision|1|||
47046781|NCT01755091|83305733|FG002|Overall Study|Physician Decision|2|||
47046782|NCT01754467|83305766|FG000|Overall Study|Lost to Follow-up|1|||
46725823|NCT00904839|82941740|FG000|Overall Study|Adverse Event|0|||
46725824|NCT00904839|82941741|FG001|Overall Study|Adverse Event|5|||
47046783|NCT01753999|83305770|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
47046784|NCT01753999|83305771|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
47046785|NCT01753999|83305770|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
47046786|NCT01753999|83305771|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
46725825|NCT00904839|82941742|FG002|Overall Study|Adverse Event|4|||
46725826|NCT00904839|82941740|FG000|Overall Study|Protocol Violation|0|||
46921153|NCT02916927|83153520|FG001|Overall Study|Withdrawal before first time point|0|||
47046787|NCT01753999|83305770|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
47046788|NCT01753999|83305771|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
47046789|NCT01753999|83305770|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
47046790|NCT01753999|83305771|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
47046791|NCT01753999|83305770|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
47046792|NCT01753999|83305771|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
46725827|NCT00904839|82941741|FG001|Overall Study|Protocol Violation|1|||
46725828|NCT00904839|82941742|FG002|Overall Study|Protocol Violation|1|||
46725829|NCT00904839|82941740|FG000|Overall Study|Lost to Follow-up|0|||
46725830|NCT00904839|82941741|FG001|Overall Study|Lost to Follow-up|1|||
46725831|NCT00904839|82941742|FG002|Overall Study|Lost to Follow-up|2|||
46725832|NCT00904839|82941740|FG000|Overall Study|Withdrawal by Subject|0|||
46725833|NCT00904839|82941741|FG001|Overall Study|Withdrawal by Subject|2|||
46725834|NCT00904839|82941742|FG002|Overall Study|Withdrawal by Subject|0|||
46725835|NCT00904839|82941740|FG000|Overall Study|Not treated|1|||
46725836|NCT00904839|82941741|FG001|Overall Study|Not treated|0|||
46725837|NCT00904839|82941742|FG002|Overall Study|Not treated|1|||
46725838|NCT00904839|82941740|FG000|Overall Study|Other than above|0|||
46725839|NCT00904839|82941741|FG001|Overall Study|Other than above|9|||
46725840|NCT00904839|82941742|FG002|Overall Study|Other than above|7|||
46725841|NCT00903357|82941753|FG000|First Intervention|Withdrawal by Subject|5|||
46725842|NCT00903357|82941754|FG001|First Intervention|Withdrawal by Subject|3|||
46725843|NCT00903357|82941753|FG000|First Intervention|Flu|0|||
46725844|NCT00903357|82941754|FG001|First Intervention|Flu|1|||
46725845|NCT00903357|82941753|FG000|Wash Out Period of 2 Weeks|Flu|0|||
46725846|NCT00903357|82941754|FG001|Wash Out Period of 2 Weeks|Flu|1|||
46725847|NCT00903357|82941753|FG000|Second Intervention|Lost to Follow-up|1|||
46725848|NCT00903357|82941754|FG001|Second Intervention|Lost to Follow-up|0|||
46725849|NCT00904371|82941764|FG000|Overall Study|Adverse Event|2|||
46725850|NCT00904371|82941764|FG000|Overall Study|Lost to Follow-up|4|||
46725851|NCT00904371|82941764|FG000|Overall Study|Discontinued at target blood pressure|2|||
46725852|NCT00904371|82941764|FG000|Overall Study|Continued with Tritace|1|||
46725853|NCT01104662|82941776|FG000|Overall Study|Adverse Event|2|||
46725854|NCT01104662|82941777|FG001|Overall Study|Adverse Event|2|||
46725855|NCT01104662|82941778|FG002|Overall Study|Adverse Event|0|||
46725856|NCT01104662|82941779|FG003|Overall Study|Adverse Event|1|||
46725857|NCT01104662|82941780|FG004|Overall Study|Adverse Event|1|||
46725858|NCT01104662|82941781|FG005|Overall Study|Adverse Event|1|||
46725859|NCT01104662|82941782|FG006|Overall Study|Adverse Event|0|||
46725860|NCT01104662|82941783|FG007|Overall Study|Adverse Event|0|||
46725861|NCT01104662|82941776|FG000|Overall Study|Clinical Failure|1|||
47046793|NCT01753999|83305770|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
47046794|NCT01753999|83305771|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
47046795|NCT01783015|83305791|FG000|Blinded Treatment|Adverse Event|0|||
47046796|NCT01783015|83305792|FG001|Blinded Treatment|Adverse Event|1|||
47046797|NCT01783015|83305793|FG002|Blinded Treatment|Adverse Event|0|||
47046798|NCT01783015|83305791|FG000|Blinded Treatment|Protocol Violation|0|||
47046799|NCT01783015|83305792|FG001|Blinded Treatment|Protocol Violation|1|||
47046800|NCT01783015|83305793|FG002|Blinded Treatment|Protocol Violation|0|||
47046801|NCT01783015|83305791|FG000|Blinded Treatment|Withdrawal by Subject|0|||
47046802|NCT01783015|83305792|FG001|Blinded Treatment|Withdrawal by Subject|1|||
47046803|NCT01783015|83305793|FG002|Blinded Treatment|Withdrawal by Subject|0|||
47046804|NCT01783015|83305791|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
47046805|NCT01783015|83305792|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
47046806|NCT01783015|83305793|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
47046807|NCT01783015|83305791|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
47046808|NCT01783015|83305792|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
47046809|NCT01783015|83305793|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
47046810|NCT01782859|83305803|FG000|Overall Study|Protocol Violation|6|||
47046811|NCT01782859|83305804|FG001|Overall Study|Protocol Violation|6|||
47046812|NCT01782859|83305803|FG000|Overall Study|Withdrawal by Subject|0|||
47046813|NCT01782859|83305804|FG001|Overall Study|Withdrawal by Subject|1|||
47046814|NCT01782469|83305811|FG000|Overall Study|Lost to Follow-up|1|||
47046815|NCT01782313|83305815|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
46725862|NCT01104662|82941777|FG001|Overall Study|Clinical Failure|0|||
46725863|NCT01104662|82941778|FG002|Overall Study|Clinical Failure|0|||
46725864|NCT01104662|82941779|FG003|Overall Study|Clinical Failure|0|||
46725865|NCT01104662|82941780|FG004|Overall Study|Clinical Failure|0|||
47046816|NCT01782313|83305815|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
47046817|NCT01782313|83305815|FG000|Treated Cycle 3|Progressive Disease|21|||
46725866|NCT01104662|82941781|FG005|Overall Study|Clinical Failure|1|||
46725867|NCT01104662|82941782|FG006|Overall Study|Clinical Failure|0|||
46725868|NCT01104662|82941783|FG007|Overall Study|Clinical Failure|0|||
46725869|NCT01104662|82941776|FG000|Overall Study|Participant left investigator's care|1|||
46725870|NCT01104662|82941777|FG001|Overall Study|Participant left investigator's care|1|||
46725871|NCT01104662|82941778|FG002|Overall Study|Participant left investigator's care|0|||
46725872|NCT01104662|82941779|FG003|Overall Study|Participant left investigator's care|0|||
46725873|NCT01104662|82941780|FG004|Overall Study|Participant left investigator's care|0|||
46725874|NCT01104662|82941781|FG005|Overall Study|Participant left investigator's care|0|||
46725875|NCT01104662|82941782|FG006|Overall Study|Participant left investigator's care|0|||
46725876|NCT01104662|82941783|FG007|Overall Study|Participant left investigator's care|0|||
46725877|NCT01104662|82941776|FG000|Overall Study|Reason not specified|3|||
46725878|NCT01104662|82941777|FG001|Overall Study|Reason not specified|3|||
46725879|NCT01104662|82941778|FG002|Overall Study|Reason not specified|0|||
46725880|NCT01104662|82941779|FG003|Overall Study|Reason not specified|0|||
46725881|NCT01104662|82941780|FG004|Overall Study|Reason not specified|0|||
46803743|NCT00676403|83023030|FG002|Overall Study|Withdrawal by Subject|0|||
47046818|NCT01782313|83305815|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
47046819|NCT01782313|83305815|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
47046820|NCT01782313|83305815|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
47046821|NCT01782313|83305815|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
47046822|NCT01782313|83305815|FG000|Survival Follow up|Lost to Follow-up|1|||
47046823|NCT01781611|83305838|FG000|Overall Study|Adverse Event|4|||
47046824|NCT01781611|83305839|FG001|Overall Study|Adverse Event|0|||
47046825|NCT01781299|83305856|FG000|Overall Study|Withdrawal by Subject|0|||
47046826|NCT01781299|83305857|FG001|Overall Study|Withdrawal by Subject|1|||
47046827|NCT01732471|83305863|FG000|Overall Study|Withdrawal by Subject|1|||
46634660|NCT01695954|82808119|FG000|Overall Study|Adverse Event|0|||
46634661|NCT01695954|82808120|FG001|Overall Study|Adverse Event|2|||
46634662|NCT01694706|82808128|FG000|Overall Study|Adverse Event|0|||
46634663|NCT01694706|82808129|FG001|Overall Study|Adverse Event|1|||
46634664|NCT01694706|82808130|FG002|Overall Study|Adverse Event|0|||
46634665|NCT01694706|82808128|FG000|Overall Study|other reason not defined above|1|||
46634666|NCT01694706|82808129|FG001|Overall Study|other reason not defined above|0|||
46634667|NCT01694706|82808130|FG002|Overall Study|other reason not defined above|0|||
46634668|NCT01693692|82808142|FG000|Overall Study|Withdrawal by Subject|12|||
46634669|NCT01693692|82808143|FG001|Overall Study|Withdrawal by Subject|10|||
47046828|NCT01780987|83305882|FG000|Overall Study|Adverse Event|0|||
47046829|NCT01780987|83305883|FG001|Overall Study|Adverse Event|4|||
47046830|NCT01780987|83305882|FG000|Overall Study|Withdrawal by Subject|2|||
47046831|NCT01780987|83305883|FG001|Overall Study|Withdrawal by Subject|0|||
47046832|NCT01780987|83305882|FG000|Overall Study|Request of Changing Hospital|0|||
47046833|NCT01780987|83305883|FG001|Overall Study|Request of Changing Hospital|1|||
47046834|NCT01780987|83305882|FG000|Overall Study|Changing Residence|1|||
47046835|NCT01780987|83305883|FG001|Overall Study|Changing Residence|0|||
47046836|NCT01780987|83305882|FG000|Overall Study|Not Receiving any Study Medication|0|||
47046837|NCT01780987|83305883|FG001|Overall Study|Not Receiving any Study Medication|1|||
47046838|NCT01730053|83305972|FG000|Overall Study|Participant moved|0|||
47046839|NCT01730053|83305973|FG001|Overall Study|Participant moved|0|||
46725882|NCT01104662|82941781|FG005|Overall Study|Reason not specified|1|||
46725883|NCT01104662|82941782|FG006|Overall Study|Reason not specified|0|||
46725884|NCT01104662|82941783|FG007|Overall Study|Reason not specified|0|||
46725885|NCT01104662|82941776|FG000|Overall Study|Randomized but not treated|3|||
46725886|NCT01104662|82941777|FG001|Overall Study|Randomized but not treated|4|||
46725887|NCT01104662|82941778|FG002|Overall Study|Randomized but not treated|1|||
46725888|NCT01104662|82941779|FG003|Overall Study|Randomized but not treated|0|||
46725889|NCT01104662|82941780|FG004|Overall Study|Randomized but not treated|0|||
46725890|NCT01104662|82941781|FG005|Overall Study|Randomized but not treated|1|||
46725891|NCT01104662|82941782|FG006|Overall Study|Randomized but not treated|0|||
46725892|NCT01104662|82941783|FG007|Overall Study|Randomized but not treated|0|||
46725893|NCT01104584|82941802|FG000|Overall Study|Study drug never administered|21|||
46725894|NCT01104584|82941802|FG000|Overall Study|Study prematurely discontinued|2|||
46725895|NCT01103960|82941826|FG000|Overall Study|Adverse Event|2|||
46725896|NCT01103960|82941827|FG001|Overall Study|Adverse Event|1|||
46725897|NCT01103960|82941826|FG000|Overall Study|Withdrawal by Subject|2|||
46725898|NCT01103960|82941827|FG001|Overall Study|Withdrawal by Subject|1|||
46725899|NCT01103960|82941826|FG000|Overall Study|Other|1|||
46725900|NCT01103960|82941827|FG001|Overall Study|Other|0|||
46725901|NCT01107392|82941835|FG000|Overall Study|Adverse Event|2|||
46725902|NCT01107392|82941836|FG001|Overall Study|Adverse Event|0|||
46725903|NCT01107392|82941835|FG000|Overall Study|Personal Reasons|2|||
46725904|NCT01107392|82941836|FG001|Overall Study|Personal Reasons|3|||
46725905|NCT01107392|82941835|FG000|Overall Study|Administrative decision|1|||
46725906|NCT01107392|82941836|FG001|Overall Study|Administrative decision|0|||
46725907|NCT01106846|82941844|FG000|Overall Study|Change in surgical procedure|0|||
46725908|NCT01106846|82941845|FG001|Overall Study|Change in surgical procedure|1|||
46725909|NCT00902577|82941851|FG000|Overall Study|Withdrawal by Subject|6|||
46725910|NCT00902577|82941851|FG000|Overall Study|FMISO production failure|2|||
46725911|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
46725912|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
46725913|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
46725914|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
46725915|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
46725916|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
47046840|NCT01730053|83305974|FG002|Overall Study|Participant moved|1|||
47046841|NCT01730053|83305975|FG003|Overall Study|Participant moved|0|||
47046842|NCT01730053|83305976|FG004|Overall Study|Participant moved|0|||
47046843|NCT01730053|83305977|FG005|Overall Study|Participant moved|0|||
46725917|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
46725918|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
47046844|NCT01730053|83305972|FG000|Overall Study|Physician Decision|0|||
46725919|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
46725920|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
46725921|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
46725922|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
46725923|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
46725924|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
46725925|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
46725926|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46725927|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
46725928|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46725929|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
46725930|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
46725931|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
46725932|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
46725933|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
46725934|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
46725935|NCT01106690|82941886|FG000|Core Period: Baseline to Week 26|Other|10|||
46725936|NCT01106690|82941887|FG001|Core Period: Baseline to Week 26|Other|2|||
46725937|NCT01106690|82941888|FG002|Core Period: Baseline to Week 26|Other|6|||
46725938|NCT01106690|82941886|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
46725939|NCT01106690|82941887|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
46725940|NCT01106690|82941888|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
46725941|NCT01106690|82941886|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46725942|NCT01106690|82941887|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
46725943|NCT01106690|82941888|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
46725944|NCT01106690|82941886|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46725945|NCT01106690|82941887|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
46725946|NCT01106690|82941888|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
46725947|NCT01106690|82941886|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
46725948|NCT01106690|82941887|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
46725949|NCT01106690|82941888|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
46725950|NCT01106690|82941886|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
46725951|NCT01106690|82941887|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
46725952|NCT01106690|82941888|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
46725953|NCT01106690|82941886|FG000|Extension Period: Week 26 to Week 52|Other|8|||
46725954|NCT01106690|82941887|FG001|Extension Period: Week 26 to Week 52|Other|3|||
46725955|NCT01106690|82941888|FG002|Extension Period: Week 26 to Week 52|Other|4|||
46725956|NCT01106690|82941886|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
46725957|NCT01106690|82941887|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46725958|NCT01106690|82941888|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46725959|NCT01103180|82941918|FG000|Overall Study|Withdrawal by Subject|8|||
46725960|NCT01103180|82941919|FG001|Overall Study|Withdrawal by Subject|13|||
46725961|NCT01103180|82941918|FG000|Overall Study|Lost to Follow-up|13|||
46725962|NCT01103180|82941919|FG001|Overall Study|Lost to Follow-up|7|||
46725963|NCT01103180|82941918|FG000|Overall Study|Physician Decision|1|||
46725964|NCT01103180|82941919|FG001|Overall Study|Physician Decision|0|||
46725965|NCT01103180|82941918|FG000|Overall Study|Protocol Violation|0|||
46725966|NCT01103180|82941919|FG001|Overall Study|Protocol Violation|1|||
46725967|NCT00944034|82941937|FG000|Overall Study|Inappropriate enrollment|0|||
46725968|NCT00944034|82941938|FG001|Overall Study|Inappropriate enrollment|1|||
46725969|NCT00944034|82941939|FG002|Overall Study|Inappropriate enrollment|0|||
46725970|NCT00944034|82941940|FG003|Overall Study|Inappropriate enrollment|1|||
46725971|NCT00944034|82941941|FG004|Overall Study|Inappropriate enrollment|2|||
46725972|NCT00944034|82941942|FG005|Overall Study|Inappropriate enrollment|1|||
46725973|NCT00944034|82941943|FG006|Overall Study|Inappropriate enrollment|0|||
46725974|NCT00944034|82941944|FG007|Overall Study|Inappropriate enrollment|0|||
46725975|NCT00944034|82941945|FG008|Overall Study|Inappropriate enrollment|1|||
46725976|NCT00944034|82941946|FG009|Overall Study|Inappropriate enrollment|1|||
46725977|NCT00944034|82941947|FG010|Overall Study|Inappropriate enrollment|0|||
46725978|NCT00944034|82941948|FG011|Overall Study|Inappropriate enrollment|0|||
46725979|NCT00944034|82941937|FG000|Overall Study|Withdrawal by Subject|3|||
46725980|NCT00944034|82941938|FG001|Overall Study|Withdrawal by Subject|2|||
46725981|NCT00944034|82941939|FG002|Overall Study|Withdrawal by Subject|6|||
46725982|NCT00944034|82941940|FG003|Overall Study|Withdrawal by Subject|2|||
46725983|NCT00944034|82941941|FG004|Overall Study|Withdrawal by Subject|5|||
46725984|NCT00944034|82941942|FG005|Overall Study|Withdrawal by Subject|8|||
46725985|NCT00944034|82941943|FG006|Overall Study|Withdrawal by Subject|2|||
46725986|NCT00944034|82941944|FG007|Overall Study|Withdrawal by Subject|2|||
46725987|NCT00944034|82941945|FG008|Overall Study|Withdrawal by Subject|3|||
46725988|NCT00944034|82941946|FG009|Overall Study|Withdrawal by Subject|4|||
46725989|NCT00944034|82941947|FG010|Overall Study|Withdrawal by Subject|0|||
46725990|NCT00944034|82941948|FG011|Overall Study|Withdrawal by Subject|4|||
46725991|NCT00944034|82941937|FG000|Overall Study|Lost to Follow-up|0|||
46725992|NCT00944034|82941938|FG001|Overall Study|Lost to Follow-up|4|||
46725993|NCT00944034|82941939|FG002|Overall Study|Lost to Follow-up|2|||
46725994|NCT00944034|82941940|FG003|Overall Study|Lost to Follow-up|0|||
46725995|NCT00944034|82941941|FG004|Overall Study|Lost to Follow-up|5|||
46725996|NCT00944034|82941942|FG005|Overall Study|Lost to Follow-up|7|||
46725997|NCT00944034|82941943|FG006|Overall Study|Lost to Follow-up|0|||
46725998|NCT00944034|82941944|FG007|Overall Study|Lost to Follow-up|1|||
46725999|NCT00944034|82941945|FG008|Overall Study|Lost to Follow-up|5|||
46726000|NCT00944034|82941946|FG009|Overall Study|Lost to Follow-up|1|||
46726001|NCT00944034|82941947|FG010|Overall Study|Lost to Follow-up|1|||
46726002|NCT00944034|82941948|FG011|Overall Study|Lost to Follow-up|0|||
46726003|NCT00944034|82941937|FG000|Overall Study|Death|0|||
46726004|NCT00944034|82941938|FG001|Overall Study|Death|0|||
46726005|NCT00944034|82941939|FG002|Overall Study|Death|1|||
46726006|NCT00944034|82941940|FG003|Overall Study|Death|0|||
46726007|NCT00944034|82941941|FG004|Overall Study|Death|0|||
46726008|NCT00944034|82941942|FG005|Overall Study|Death|0|||
46726009|NCT00944034|82941943|FG006|Overall Study|Death|0|||
46726010|NCT00944034|82941944|FG007|Overall Study|Death|0|||
46726011|NCT00944034|82941945|FG008|Overall Study|Death|0|||
46726012|NCT00944034|82941946|FG009|Overall Study|Death|0|||
46726013|NCT00944034|82941947|FG010|Overall Study|Death|0|||
46726014|NCT00944034|82941948|FG011|Overall Study|Death|0|||
46726015|NCT00944034|82941937|FG000|Overall Study|Protocol Violation|2|||
46726016|NCT00944034|82941938|FG001|Overall Study|Protocol Violation|0|||
46726017|NCT00944034|82941939|FG002|Overall Study|Protocol Violation|0|||
46726018|NCT00944034|82941940|FG003|Overall Study|Protocol Violation|1|||
46726019|NCT00944034|82941941|FG004|Overall Study|Protocol Violation|2|||
46726020|NCT00944034|82941942|FG005|Overall Study|Protocol Violation|3|||
46726021|NCT00944034|82941943|FG006|Overall Study|Protocol Violation|0|||
46726022|NCT00944034|82941944|FG007|Overall Study|Protocol Violation|1|||
46726023|NCT00944034|82941945|FG008|Overall Study|Protocol Violation|1|||
46726024|NCT00944034|82941946|FG009|Overall Study|Protocol Violation|4|||
46726025|NCT00944034|82941947|FG010|Overall Study|Protocol Violation|0|||
46726026|NCT00944034|82941948|FG011|Overall Study|Protocol Violation|0|||
46726027|NCT00944034|82941937|FG000|Overall Study|Unable to classify|0|||
46726028|NCT00944034|82941938|FG001|Overall Study|Unable to classify|0|||
46634670|NCT01693692|82808144|FG002|Overall Study|Withdrawal by Subject|11|||
46634671|NCT01693692|82808142|FG000|Overall Study|Adverse Event|7|||
46634672|NCT01693692|82808143|FG001|Overall Study|Adverse Event|14|||
46634673|NCT01693692|82808144|FG002|Overall Study|Adverse Event|9|||
46634674|NCT01693692|82808142|FG000|Overall Study|Physician Decision|0|||
46634675|NCT01693692|82808143|FG001|Overall Study|Physician Decision|0|||
46634676|NCT01693692|82808144|FG002|Overall Study|Physician Decision|1|||
46726029|NCT00944034|82941939|FG002|Overall Study|Unable to classify|0|||
46726030|NCT00944034|82941940|FG003|Overall Study|Unable to classify|0|||
46726031|NCT00944034|82941941|FG004|Overall Study|Unable to classify|0|||
46726032|NCT00944034|82941942|FG005|Overall Study|Unable to classify|1|||
46726033|NCT00944034|82941943|FG006|Overall Study|Unable to classify|1|||
46634677|NCT01693692|82808142|FG000|Overall Study|Protocol Violation|5|||
46726034|NCT00944034|82941944|FG007|Overall Study|Unable to classify|1|||
46726035|NCT00944034|82941945|FG008|Overall Study|Unable to classify|0|||
46726036|NCT00944034|82941946|FG009|Overall Study|Unable to classify|0|||
46726037|NCT00944034|82941947|FG010|Overall Study|Unable to classify|0|||
46726038|NCT00944034|82941948|FG011|Overall Study|Unable to classify|0|||
46726039|NCT00944034|82941937|FG000|Overall Study|Administrative reason|0|||
46726040|NCT00944034|82941938|FG001|Overall Study|Administrative reason|0|||
46726041|NCT00944034|82941939|FG002|Overall Study|Administrative reason|0|||
46726042|NCT00944034|82941940|FG003|Overall Study|Administrative reason|0|||
46726043|NCT00944034|82941941|FG004|Overall Study|Administrative reason|0|||
46726044|NCT00944034|82941942|FG005|Overall Study|Administrative reason|0|||
46726045|NCT00944034|82941943|FG006|Overall Study|Administrative reason|1|||
46726046|NCT00944034|82941944|FG007|Overall Study|Administrative reason|0|||
46726047|NCT00944034|82941945|FG008|Overall Study|Administrative reason|0|||
46726048|NCT00944034|82941946|FG009|Overall Study|Administrative reason|0|||
46726049|NCT00944034|82941947|FG010|Overall Study|Administrative reason|0|||
46726050|NCT00944034|82941948|FG011|Overall Study|Administrative reason|0|||
46726051|NCT00941304|82941996|FG000|Overall Study|Lost to Follow-up|1|||
46726052|NCT00941304|82941997|FG001|Overall Study|Lost to Follow-up|0|||
46726053|NCT00941304|82941998|FG002|Overall Study|Lost to Follow-up|0|||
46726054|NCT00941304|82941999|FG003|Overall Study|Lost to Follow-up|0|||
46726055|NCT00941304|82942000|FG004|Overall Study|Lost to Follow-up|0|||
46726056|NCT00941070|82942012|FG000|Overall Study|Patient non-compliant|1|||
46726057|NCT01098812|82942021|FG000|Overall Study|Death|2|||
46726058|NCT01098812|82942022|FG001|Overall Study|Death|0|||
46726059|NCT01098812|82942023|FG002|Overall Study|Death|1|||
47046845|NCT01730053|83305973|FG001|Overall Study|Physician Decision|0|||
47046846|NCT01730053|83305974|FG002|Overall Study|Physician Decision|0|||
47046847|NCT01730053|83305975|FG003|Overall Study|Physician Decision|1|||
47046848|NCT01730053|83305976|FG004|Overall Study|Physician Decision|0|||
47046849|NCT01730053|83305977|FG005|Overall Study|Physician Decision|0|||
46726060|NCT01098812|82942021|FG000|Overall Study|Lost to Follow-up|0|||
46726061|NCT01098812|82942022|FG001|Overall Study|Lost to Follow-up|1|||
46726062|NCT01098812|82942023|FG002|Overall Study|Lost to Follow-up|0|||
46726063|NCT00903201|82942033|FG000|Overall Study|Adverse Event|1|||
46726064|NCT00903201|82942034|FG001|Overall Study|Adverse Event|4|||
46726065|NCT00903201|82942035|FG002|Overall Study|Adverse Event|0|||
46726066|NCT00903201|82942033|FG000|Overall Study|Protocol Violation|2|||
46726067|NCT00903201|82942034|FG001|Overall Study|Protocol Violation|1|||
46726068|NCT00903201|82942035|FG002|Overall Study|Protocol Violation|0|||
46726069|NCT00903201|82942033|FG000|Overall Study|Lost to Follow-up|0|||
46726070|NCT00903201|82942034|FG001|Overall Study|Lost to Follow-up|1|||
46726071|NCT00903201|82942035|FG002|Overall Study|Lost to Follow-up|0|||
46726072|NCT00903201|82942033|FG000|Overall Study|Physician Decision|1|||
46726073|NCT00903201|82942034|FG001|Overall Study|Physician Decision|0|||
46726074|NCT00903201|82942035|FG002|Overall Study|Physician Decision|1|||
46726075|NCT00903201|82942033|FG000|Overall Study|Withdrawal by Subject|1|||
46726076|NCT00903201|82942034|FG001|Overall Study|Withdrawal by Subject|0|||
46726077|NCT00903201|82942035|FG002|Overall Study|Withdrawal by Subject|1|||
46726078|NCT00902265|82942045|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
46921154|NCT02916693|83153526|FG000|Overall Study|Lost to Follow-up|7|||
47046850|NCT01730053|83305972|FG000|Overall Study|Adverse Event|2|||
47046851|NCT01730053|83305973|FG001|Overall Study|Adverse Event|6|||
47046852|NCT01730053|83305974|FG002|Overall Study|Adverse Event|3|||
47046853|NCT01730053|83305975|FG003|Overall Study|Adverse Event|3|||
47046854|NCT01730053|83305976|FG004|Overall Study|Adverse Event|2|||
47046855|NCT01730053|83305977|FG005|Overall Study|Adverse Event|2|||
47046856|NCT01730053|83305972|FG000|Overall Study|Poor compliance to protocol|1|||
46726079|NCT00902265|82942045|FG000|Overall Study|Adverse Event|2|||
46726080|NCT00902265|82942045|FG000|Overall Study|Lack of Efficacy|2|||
46726081|NCT00902265|82942045|FG000|Overall Study|Protocol Violation|1|||
46726082|NCT00943722|82942063|FG000|Base Study|Adverse Event|0|||
46726083|NCT00943722|82942064|FG001|Base Study|Adverse Event|0|||
46726084|NCT00943722|82942065|FG002|Base Study|Adverse Event|0|||
46726085|NCT00943722|82942066|FG003|Base Study|Adverse Event|1|||
46726086|NCT00943722|82942067|FG004|Base Study|Adverse Event|0|||
46726087|NCT00943722|82942068|FG005|Base Study|Adverse Event|0|||
46726088|NCT00943722|82942069|FG006|Base Study|Adverse Event|0|||
47046857|NCT01730053|83305973|FG001|Overall Study|Poor compliance to protocol|2|||
47046858|NCT01730053|83305974|FG002|Overall Study|Poor compliance to protocol|2|||
47046859|NCT01730053|83305975|FG003|Overall Study|Poor compliance to protocol|0|||
46726089|NCT00943722|82942063|FG000|Base Study|Lost to Follow-up|12|||
47046860|NCT01730053|83305976|FG004|Overall Study|Poor compliance to protocol|0|||
47046861|NCT01730053|83305977|FG005|Overall Study|Poor compliance to protocol|2|||
47046862|NCT01730053|83305972|FG000|Overall Study|Other than specified|2|||
47046863|NCT01730053|83305973|FG001|Overall Study|Other than specified|6|||
47046864|NCT01730053|83305974|FG002|Overall Study|Other than specified|5|||
47046865|NCT01730053|83305975|FG003|Overall Study|Other than specified|4|||
46726090|NCT00943722|82942064|FG001|Base Study|Lost to Follow-up|8|||
46726091|NCT00943722|82942065|FG002|Base Study|Lost to Follow-up|10|||
46726092|NCT00943722|82942066|FG003|Base Study|Lost to Follow-up|8|||
46726093|NCT00943722|82942067|FG004|Base Study|Lost to Follow-up|11|||
46726094|NCT00943722|82942068|FG005|Base Study|Lost to Follow-up|0|||
46726095|NCT00943722|82942069|FG006|Base Study|Lost to Follow-up|0|||
46726096|NCT00943722|82942063|FG000|Base Study|Physician Decision|1|||
46726097|NCT00943722|82942064|FG001|Base Study|Physician Decision|0|||
46726098|NCT00943722|82942065|FG002|Base Study|Physician Decision|0|||
46726099|NCT00943722|82942066|FG003|Base Study|Physician Decision|0|||
46726100|NCT00943722|82942067|FG004|Base Study|Physician Decision|1|||
46726101|NCT00943722|82942068|FG005|Base Study|Physician Decision|0|||
46726102|NCT00943722|82942069|FG006|Base Study|Physician Decision|0|||
46726103|NCT00943722|82942063|FG000|Base Study|Pregnancy|0|||
46726104|NCT00943722|82942064|FG001|Base Study|Pregnancy|0|||
46726105|NCT00943722|82942065|FG002|Base Study|Pregnancy|1|||
46726106|NCT00943722|82942066|FG003|Base Study|Pregnancy|0|||
46726107|NCT00943722|82942067|FG004|Base Study|Pregnancy|2|||
46726108|NCT00943722|82942068|FG005|Base Study|Pregnancy|0|||
46726109|NCT00943722|82942069|FG006|Base Study|Pregnancy|0|||
46726110|NCT00943722|82942063|FG000|Base Study|Protocol Violation|0|||
46726111|NCT00943722|82942064|FG001|Base Study|Protocol Violation|1|||
46726112|NCT00943722|82942065|FG002|Base Study|Protocol Violation|0|||
46726113|NCT00943722|82942066|FG003|Base Study|Protocol Violation|0|||
47046866|NCT01730053|83305976|FG004|Overall Study|Other than specified|7|||
47046867|NCT01730053|83305977|FG005|Overall Study|Other than specified|9|||
47046868|NCT01752985|83306012|FG000|Treatment Period|Subject request to discontinue treatment|1|||
47046869|NCT01752985|83306013|FG001|Treatment Period|Subject request to discontinue treatment|0|||
47046870|NCT01752985|83306014|FG002|Treatment Period|Subject request to discontinue treatment|1|||
47046871|NCT01752985|83306012|FG000|Treatment Period|Subject no longer meets study criteria|0|||
47046872|NCT01752985|83306013|FG001|Treatment Period|Subject no longer meets study criteria|1|||
47046873|NCT01752985|83306014|FG002|Treatment Period|Subject no longer meets study criteria|1|||
47046874|NCT01752985|83306012|FG000|Treatment Period|Adverse Event|2|||
46726114|NCT00943722|82942067|FG004|Base Study|Protocol Violation|2|||
46726115|NCT00943722|82942068|FG005|Base Study|Protocol Violation|0|||
47046875|NCT01752985|83306013|FG001|Treatment Period|Adverse Event|1|||
46726116|NCT00943722|82942069|FG006|Base Study|Protocol Violation|0|||
46726117|NCT00943722|82942063|FG000|Base Study|Withdrawal by Subject|12|||
46726118|NCT00943722|82942064|FG001|Base Study|Withdrawal by Subject|13|||
46726119|NCT00943722|82942065|FG002|Base Study|Withdrawal by Subject|2|||
46726120|NCT00943722|82942066|FG003|Base Study|Withdrawal by Subject|13|||
46726121|NCT00943722|82942067|FG004|Base Study|Withdrawal by Subject|8|||
46726122|NCT00943722|82942068|FG005|Base Study|Withdrawal by Subject|0|||
46726123|NCT00943722|82942069|FG006|Base Study|Withdrawal by Subject|0|||
46726124|NCT00943722|82942063|FG000|Base Study|Month 12 visit not completed|0|||
46726125|NCT00943722|82942064|FG001|Base Study|Month 12 visit not completed|0|||
46726126|NCT00943722|82942065|FG002|Base Study|Month 12 visit not completed|0|||
46726127|NCT00943722|82942066|FG003|Base Study|Month 12 visit not completed|0|||
46726128|NCT00943722|82942067|FG004|Base Study|Month 12 visit not completed|2|||
47046876|NCT01752985|83306014|FG002|Treatment Period|Adverse Event|2|||
47046877|NCT01752985|83306012|FG000|Treatment Period|Withdrawal by Subject|1|||
47046878|NCT01752985|83306013|FG001|Treatment Period|Withdrawal by Subject|1|||
47046879|NCT01752985|83306014|FG002|Treatment Period|Withdrawal by Subject|0|||
46726129|NCT00943722|82942068|FG005|Base Study|Month 12 visit not completed|0|||
46726130|NCT00943722|82942069|FG006|Base Study|Month 12 visit not completed|0|||
46726131|NCT00943722|82942063|FG000|First Extension Study: EXT 1|Adverse Event|0|||
46726132|NCT00943722|82942064|FG001|First Extension Study: EXT 1|Adverse Event|0|||
46726133|NCT00943722|82942065|FG002|First Extension Study: EXT 1|Adverse Event|0|||
46726134|NCT00943722|82942066|FG003|First Extension Study: EXT 1|Adverse Event|0|||
47046880|NCT01752985|83306012|FG000|Treatment Period|Lost to Follow-up|0|||
47046881|NCT01752985|83306013|FG001|Treatment Period|Lost to Follow-up|0|||
47046882|NCT01752985|83306014|FG002|Treatment Period|Lost to Follow-up|1|||
47046883|NCT01751113|83306022|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
47046884|NCT01751113|83306023|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
47046885|NCT01751113|83306024|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
47046886|NCT01751113|83306025|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
47046887|NCT01751113|83306026|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
47046888|NCT01751113|83306027|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
47046889|NCT01751113|83306022|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
47046890|NCT01751113|83306023|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
47046891|NCT01751113|83306024|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
46726135|NCT00943722|82942067|FG004|First Extension Study: EXT 1|Adverse Event|0|||
46726136|NCT00943722|82942068|FG005|First Extension Study: EXT 1|Adverse Event|1|||
46726137|NCT00943722|82942069|FG006|First Extension Study: EXT 1|Adverse Event|0|||
46726138|NCT00943722|82942063|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
46726139|NCT00943722|82942064|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
46726140|NCT00943722|82942065|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
46726141|NCT00943722|82942066|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
46726142|NCT00943722|82942067|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
46726143|NCT00943722|82942068|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
46726144|NCT00943722|82942069|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
46803744|NCT00676403|83023031|FG003|Overall Study|Withdrawal by Subject|0|||
46921155|NCT02574455|83153536|FG000|Overall Study|Death|197|||
46921156|NCT02574455|83153537|FG001|Overall Study|Death|210|||
46921157|NCT02574455|83153536|FG000|Overall Study|Withdrawal of Consent|11|||
46921158|NCT02574455|83153537|FG001|Overall Study|Withdrawal of Consent|28|||
46921159|NCT02574455|83153536|FG000|Overall Study|Lost to Follow-up|4|||
46921160|NCT02574455|83153537|FG001|Overall Study|Lost to Follow-up|4|||
46921161|NCT02574455|83153536|FG000|Overall Study|Sponsor's Decision|55|||
46921162|NCT02574455|83153537|FG001|Overall Study|Sponsor's Decision|20|||
46921163|NCT02795832|83153549|FG000|Overall Study|Adverse Event|0|||
46921164|NCT02795832|83153550|FG001|Overall Study|Adverse Event|0|||
46921165|NCT02795832|83153551|FG002|Overall Study|Adverse Event|0|||
46921166|NCT02795832|83153552|FG003|Overall Study|Adverse Event|0|||
46921167|NCT02795832|83153553|FG004|Overall Study|Adverse Event|0|||
47046892|NCT01751113|83306025|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
47046893|NCT01751113|83306026|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
47046894|NCT01751113|83306027|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
47046895|NCT01750879|83306038|FG000|Overall Study|Adverse Event|8|||
47046896|NCT01750879|83306039|FG001|Overall Study|Adverse Event|0|||
46634678|NCT01693692|82808143|FG001|Overall Study|Protocol Violation|4|||
46634679|NCT01693692|82808144|FG002|Overall Study|Protocol Violation|6|||
46634680|NCT01693692|82808142|FG000|Overall Study|Lost to Follow-up|2|||
46634681|NCT01693692|82808143|FG001|Overall Study|Lost to Follow-up|2|||
46634682|NCT01693692|82808144|FG002|Overall Study|Lost to Follow-up|3|||
46634683|NCT01693692|82808142|FG000|Overall Study|Other|4|||
46634684|NCT01693692|82808143|FG001|Overall Study|Other|4|||
46634685|NCT01693692|82808144|FG002|Overall Study|Other|6|||
46634686|NCT01693614|82808155|FG000|Overall Study|Adverse Event|7|||
46634687|NCT01693614|82808156|FG001|Overall Study|Adverse Event|11|||
46634688|NCT01693614|82808157|FG002|Overall Study|Adverse Event|5|||
46921168|NCT02795832|83153554|FG005|Overall Study|Adverse Event|3|||
46921169|NCT02794974|83153578|FG000|Overall Study|Physician Decision|0|||
46921170|NCT02794974|83153579|FG001|Overall Study|Physician Decision|1|||
46921171|NCT02419417|83153596|FG000|Overall Study|Disease progression|5|||
46921172|NCT02419417|83153597|FG001|Overall Study|Disease progression|4|||
46921173|NCT02419417|83153598|FG002|Overall Study|Disease progression|13|||
46921174|NCT02419417|83153599|FG003|Overall Study|Disease progression|10|||
46726145|NCT00943722|82942063|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
46726146|NCT00943722|82942064|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
46726147|NCT00943722|82942065|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
46726148|NCT00943722|82942066|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
46726149|NCT00943722|82942067|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
46726150|NCT00943722|82942068|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
46726151|NCT00943722|82942069|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
46726152|NCT00943722|82942063|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
46726153|NCT00943722|82942064|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
46726154|NCT00943722|82942065|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
46726155|NCT00943722|82942066|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
46726156|NCT00943722|82942067|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
46726157|NCT00943722|82942068|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
46726158|NCT00943722|82942069|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
46726159|NCT00943722|82942063|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
46726160|NCT00943722|82942064|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
46726161|NCT00943722|82942065|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
46726162|NCT00943722|82942066|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
46726163|NCT00943722|82942067|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
46726164|NCT00943722|82942068|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
46726165|NCT00943722|82942069|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
46726166|NCT00943722|82942063|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
46726167|NCT00943722|82942064|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
46726168|NCT00943722|82942065|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
46726169|NCT00943722|82942066|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
46726170|NCT00943722|82942067|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
46726171|NCT00943722|82942068|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
46726172|NCT00943722|82942069|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
46726173|NCT00943722|82942063|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
46726174|NCT00943722|82942064|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
46726175|NCT00943722|82942065|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
46726176|NCT00943722|82942066|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
46726177|NCT00943722|82942067|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
46726178|NCT00943722|82942068|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
46726179|NCT00943722|82942069|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
46726180|NCT00943722|82942063|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
46726181|NCT00943722|82942064|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
46726182|NCT00943722|82942065|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
46726183|NCT00943722|82942066|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
46726184|NCT00943722|82942067|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
46726185|NCT00943722|82942068|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
46726186|NCT00943722|82942069|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
46726187|NCT00943722|82942063|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
46726188|NCT00943722|82942064|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
46726189|NCT00943722|82942065|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
46726190|NCT00943722|82942066|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
46726191|NCT00943722|82942067|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
46726192|NCT00943722|82942068|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
46726193|NCT00943722|82942069|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
46726194|NCT00901485|82942092|FG000|Overall Study|Lack of Efficacy|0|||
46726195|NCT00901485|82942093|FG001|Overall Study|Lack of Efficacy|2|||
46726196|NCT00901485|82942092|FG000|Overall Study|Withdrawal by Subject|1|||
46726197|NCT00901485|82942093|FG001|Overall Study|Withdrawal by Subject|2|||
46726198|NCT00896337|82942099|FG000|Overall Study|Death|7|||
46726199|NCT00896337|82942099|FG000|Overall Study|Withdrawal by Subject|7|||
46726200|NCT00896337|82942099|FG000|Overall Study|Lost to Follow-up|11|||
46726201|NCT00953706|82942110|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
46726202|NCT00953706|82942111|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
46726203|NCT00953706|82942112|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
46726204|NCT00953706|82942113|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
46726205|NCT00953706|82942110|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
46921175|NCT02419417|83153600|FG004|Overall Study|Disease progression|10|||
46726206|NCT00953706|82942111|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
46921176|NCT02419417|83153601|FG005|Overall Study|Disease progression|3|||
46726207|NCT00953706|82942112|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
46726208|NCT00953706|82942113|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
46726209|NCT00953706|82942110|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
46726210|NCT00953706|82942111|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
46726211|NCT00953706|82942112|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
46726212|NCT00953706|82942113|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
46726213|NCT00953706|82942110|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
46726214|NCT00953706|82942111|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
46726215|NCT00953706|82942112|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
46726216|NCT00953706|82942113|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
46726217|NCT00953706|82942110|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
46726218|NCT00953706|82942111|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
46726219|NCT00953706|82942112|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
46726220|NCT00953706|82942113|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
46726221|NCT00953706|82942110|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
46726222|NCT00953706|82942111|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
46726223|NCT00953706|82942112|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
46726224|NCT00953706|82942113|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
46726225|NCT00953706|82942110|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
46726226|NCT00953706|82942111|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
46726227|NCT00953706|82942112|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
46726228|NCT00953706|82942113|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
46726229|NCT00953706|82942110|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
46726230|NCT00953706|82942111|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
46726231|NCT00953706|82942112|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
46726232|NCT00953706|82942113|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
46726233|NCT00953706|82942110|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
46726234|NCT00953706|82942111|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
46726235|NCT00953706|82942112|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
47046897|NCT01750879|83306038|FG000|Overall Study|Lack of Efficacy|1|||
47046898|NCT01750879|83306039|FG001|Overall Study|Lack of Efficacy|0|||
47046899|NCT01750879|83306038|FG000|Overall Study|Withdrawal by Subject|1|||
47046900|NCT01750879|83306039|FG001|Overall Study|Withdrawal by Subject|0|||
47046901|NCT01750879|83306038|FG000|Overall Study|Did not complete per protocol|0|||
47046902|NCT01750879|83306039|FG001|Overall Study|Did not complete per protocol|3|||
47046903|NCT01719380|83306065|FG000|Overall Study|Adverse Event|0|||
47046904|NCT01719380|83306066|FG001|Overall Study|Adverse Event|0|||
47046905|NCT01719380|83306067|FG002|Overall Study|Adverse Event|1|||
47046906|NCT01719380|83306068|FG003|Overall Study|Adverse Event|2|||
47046907|NCT01719380|83306069|FG004|Overall Study|Adverse Event|0|||
47046908|NCT01719380|83306070|FG005|Overall Study|Adverse Event|1|||
47046909|NCT01719380|83306071|FG006|Overall Study|Adverse Event|0|||
47046910|NCT01719380|83306072|FG007|Overall Study|Adverse Event|1|||
47046911|NCT01719380|83306073|FG008|Overall Study|Adverse Event|4|||
47046912|NCT01719380|83306074|FG009|Overall Study|Adverse Event|3|||
47046913|NCT01719380|83306065|FG000|Overall Study|Death|0|||
47046914|NCT01719380|83306066|FG001|Overall Study|Death|1|||
47046915|NCT01719380|83306067|FG002|Overall Study|Death|0|||
47046916|NCT01719380|83306068|FG003|Overall Study|Death|0|||
47046917|NCT01719380|83306069|FG004|Overall Study|Death|0|||
47046918|NCT01719380|83306070|FG005|Overall Study|Death|0|||
47046919|NCT01719380|83306071|FG006|Overall Study|Death|0|||
47046920|NCT01719380|83306072|FG007|Overall Study|Death|0|||
47046921|NCT01719380|83306073|FG008|Overall Study|Death|3|||
46726236|NCT00953706|82942113|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
46726237|NCT00953706|82942110|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
46726238|NCT00953706|82942111|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
46921177|NCT02419417|83153602|FG006|Overall Study|Disease progression|4|||
47046922|NCT01719380|83306074|FG009|Overall Study|Death|3|||
47046923|NCT01719380|83306065|FG000|Overall Study|Participant/Guardian Decision|0|||
47046924|NCT01719380|83306066|FG001|Overall Study|Participant/Guardian Decision|0|||
47046925|NCT01719380|83306067|FG002|Overall Study|Participant/Guardian Decision|1|||
47046926|NCT01719380|83306068|FG003|Overall Study|Participant/Guardian Decision|0|||
46726239|NCT00953706|82942112|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
46726240|NCT00953706|82942113|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
46726241|NCT00953706|82942110|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
46726242|NCT00953706|82942111|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
46726243|NCT00953706|82942112|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
46726244|NCT00953706|82942113|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
46726245|NCT00940992|82942126|FG000|Overall Study|Adverse Event|2|||
46726246|NCT00940992|82942127|FG001|Overall Study|Adverse Event|0|||
46726247|NCT00940992|82942128|FG002|Overall Study|Adverse Event|1|||
46726248|NCT00940992|82942126|FG000|Overall Study|subject request|2|||
46726249|NCT00940992|82942127|FG001|Overall Study|subject request|1|||
46726250|NCT00940992|82942128|FG002|Overall Study|subject request|0|||
46726251|NCT00940992|82942126|FG000|Overall Study|Lost to Follow-up|0|||
46726252|NCT00940992|82942127|FG001|Overall Study|Lost to Follow-up|1|||
46726253|NCT00940992|82942128|FG002|Overall Study|Lost to Follow-up|1|||
46726254|NCT00938964|82942138|FG000|Overall Study|Death|3|||
46726255|NCT00938964|82942139|FG001|Overall Study|Death|3|||
46726256|NCT00938964|82942138|FG000|Overall Study|Lost to Follow-up|2|||
46726257|NCT00938964|82942139|FG001|Overall Study|Lost to Follow-up|3|||
46726258|NCT00938964|82942138|FG000|Overall Study|Withdrawal by Subject|22|||
46726259|NCT00938964|82942139|FG001|Overall Study|Withdrawal by Subject|18|||
46726260|NCT00938964|82942138|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
46726261|NCT00938964|82942139|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
46726262|NCT00938886|82942147|FG000|Overall Study|Death|0|||
46726263|NCT00938886|82942148|FG001|Overall Study|Death|1|||
46726264|NCT00938886|82942147|FG000|Overall Study|Withdrawal by Subject|4|||
46726265|NCT00938886|82942148|FG001|Overall Study|Withdrawal by Subject|7|||
46726266|NCT00938886|82942147|FG000|Overall Study|Lost to Follow-up|3|||
46726267|NCT00938886|82942148|FG001|Overall Study|Lost to Follow-up|2|||
46726268|NCT00942708|82942154|FG000|Overall Study|Withdrawal by Subject|1|||
46726269|NCT00937950|82942159|FG000|Overall Study|Withdrawal by Subject|23|||
46726270|NCT00937950|82942159|FG000|Overall Study|Migrated/moved from study area|27|||
46726271|NCT00937950|82942159|FG000|Overall Study|Lost to Follow-up|144|||
46726272|NCT00937950|82942159|FG000|Overall Study|Missing confirmed|4|||
46726273|NCT00937950|82942159|FG000|Overall Study|Other|18|||
46726274|NCT00942162|82942166|FG000|Overall Study|Death|45|||
46726275|NCT00942162|82942167|FG001|Overall Study|Death|35|||
46726276|NCT00942162|82942168|FG002|Overall Study|Death|0|||
46726277|NCT00942162|82942166|FG000|Overall Study|Withdrawal by Subject|7|||
46726278|NCT00942162|82942167|FG001|Overall Study|Withdrawal by Subject|2|||
46726279|NCT00942162|82942168|FG002|Overall Study|Withdrawal by Subject|0|||
46726280|NCT00942162|82942166|FG000|Overall Study|Lost to Follow-up|4|||
46726281|NCT00942162|82942167|FG001|Overall Study|Lost to Follow-up|0|||
46726282|NCT00942162|82942168|FG002|Overall Study|Lost to Follow-up|0|||
46726283|NCT00942162|82942166|FG000|Overall Study|Other|14|||
46726284|NCT00942162|82942167|FG001|Overall Study|Other|13|||
46726285|NCT00942162|82942168|FG002|Overall Study|Other|2|||
46726286|NCT00942084|82942178|FG000|Overall Study|Death|2|||
46726287|NCT00941928|82942182|FG000|Overall Study|Withdrawal by Subject|1|||
46921178|NCT02419417|83153603|FG007|Overall Study|Disease progression|5|||
46921179|NCT02419417|83153604|FG008|Overall Study|Disease progression|13|||
46921180|NCT02419417|83153605|FG009|Overall Study|Disease progression|9|||
46921181|NCT02419417|83153606|FG010|Overall Study|Disease progression|0|||
46921182|NCT02419417|83153596|FG000|Overall Study|Study drug toxicity|0|||
46921183|NCT02419417|83153597|FG001|Overall Study|Study drug toxicity|0|||
46921184|NCT02419417|83153598|FG002|Overall Study|Study drug toxicity|0|||
46921185|NCT02419417|83153599|FG003|Overall Study|Study drug toxicity|0|||
46921186|NCT02419417|83153600|FG004|Overall Study|Study drug toxicity|1|||
46921187|NCT02419417|83153601|FG005|Overall Study|Study drug toxicity|0|||
46921188|NCT02419417|83153602|FG006|Overall Study|Study drug toxicity|0|||
46921189|NCT02419417|83153603|FG007|Overall Study|Study drug toxicity|0|||
46921190|NCT02419417|83153604|FG008|Overall Study|Study drug toxicity|0|||
46921191|NCT02419417|83153605|FG009|Overall Study|Study drug toxicity|0|||
46726288|NCT00941928|82942182|FG000|Overall Study|Disease Progression|1|||
46921192|NCT02419417|83153606|FG010|Overall Study|Study drug toxicity|0|||
46726289|NCT00937560|82942186|FG000|Initial Treatment|Death|6|||
46726290|NCT00937560|82942186|FG000|Initial Treatment|Withdraw consent|3|||
47046927|NCT01719380|83306069|FG004|Overall Study|Participant/Guardian Decision|0|||
46921193|NCT02419417|83153596|FG000|Overall Study|Adverse event unrelated to study drug|0|||
46921194|NCT02419417|83153597|FG001|Overall Study|Adverse event unrelated to study drug|0|||
46921195|NCT02419417|83153598|FG002|Overall Study|Adverse event unrelated to study drug|0|||
47046928|NCT01719380|83306070|FG005|Overall Study|Participant/Guardian Decision|0|||
46726291|NCT00937560|82942186|FG000|Initial Treatment|Adverse Event|1|||
46726292|NCT00937560|82942186|FG000|Initial Treatment|Lost to Follow-up|1|||
46726293|NCT00937560|82942186|FG000|Initial Treatment|No end of study page|10|||
46726294|NCT00937560|82942186|FG000|Maintenance Treatment|Death|12|||
46726295|NCT00937560|82942186|FG000|Maintenance Treatment|Withdraw consent|5|||
46921196|NCT02419417|83153599|FG003|Overall Study|Adverse event unrelated to study drug|0|||
46726296|NCT00937560|82942186|FG000|Maintenance Treatment|According to protocol|1|||
46726297|NCT00594568|82942193|FG000|Initial Treatment|Adverse Event|51|||
46726298|NCT00594568|82942194|FG001|Initial Treatment|Adverse Event|121|||
46726299|NCT00594568|82942195|FG002|Initial Treatment|Adverse Event|144|||
46726300|NCT00594568|82942193|FG000|Initial Treatment|Death|6|||
46726301|NCT00594568|82942194|FG001|Initial Treatment|Death|11|||
46726302|NCT00594568|82942195|FG002|Initial Treatment|Death|15|||
46726303|NCT00594568|82942193|FG000|Initial Treatment|Lost to Follow-up|4|||
46726304|NCT00594568|82942194|FG001|Initial Treatment|Lost to Follow-up|1|||
46726305|NCT00594568|82942195|FG002|Initial Treatment|Lost to Follow-up|4|||
46726306|NCT00594568|82942193|FG000|Initial Treatment|Physician Decision|3|||
46726307|NCT00594568|82942194|FG001|Initial Treatment|Physician Decision|2|||
46726308|NCT00594568|82942195|FG002|Initial Treatment|Physician Decision|4|||
46726309|NCT00594568|82942193|FG000|Initial Treatment|Protocol Violation|2|||
46726310|NCT00594568|82942194|FG001|Initial Treatment|Protocol Violation|2|||
46726311|NCT00594568|82942195|FG002|Initial Treatment|Protocol Violation|5|||
46726312|NCT00594568|82942193|FG000|Initial Treatment|Withdrawal by Subject|25|||
46726313|NCT00594568|82942194|FG001|Initial Treatment|Withdrawal by Subject|31|||
46726314|NCT00594568|82942195|FG002|Initial Treatment|Withdrawal by Subject|46|||
46726315|NCT00594568|82942193|FG000|Initial Treatment|Sponsor decision|193|||
46726316|NCT00594568|82942194|FG001|Initial Treatment|Sponsor decision|142|||
46726317|NCT00594568|82942195|FG002|Initial Treatment|Sponsor decision|147|||
46726318|NCT00594568|82942193|FG000|Initial Treatment|Caregiver decision|21|||
46726319|NCT00594568|82942194|FG001|Initial Treatment|Caregiver decision|36|||
47046929|NCT01719380|83306071|FG006|Overall Study|Participant/Guardian Decision|0|||
47046930|NCT01719380|83306072|FG007|Overall Study|Participant/Guardian Decision|0|||
47046931|NCT01719380|83306073|FG008|Overall Study|Participant/Guardian Decision|2|||
47046932|NCT01719380|83306074|FG009|Overall Study|Participant/Guardian Decision|2|||
47046933|NCT01719380|83306065|FG000|Overall Study|Physician Decision|0|||
47046934|NCT01719380|83306066|FG001|Overall Study|Physician Decision|0|||
47046935|NCT01719380|83306067|FG002|Overall Study|Physician Decision|2|||
47046936|NCT01719380|83306068|FG003|Overall Study|Physician Decision|0|||
46726320|NCT00594568|82942195|FG002|Initial Treatment|Caregiver decision|36|||
46726321|NCT00594568|82942193|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
46726322|NCT00594568|82942194|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
46726323|NCT00594568|82942195|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
47046937|NCT01719380|83306069|FG004|Overall Study|Physician Decision|0|||
46726324|NCT00594568|82942193|FG000|Initial Treatment|Entry criteria exclusion|0|||
47046938|NCT01719380|83306070|FG005|Overall Study|Physician Decision|0|||
46726325|NCT00594568|82942194|FG001|Initial Treatment|Entry criteria exclusion|1|||
46726326|NCT00594568|82942195|FG002|Initial Treatment|Entry criteria exclusion|1|||
46726327|NCT00594568|82942193|FG000|Delayed Start|Death|0|||
46726328|NCT00594568|82942194|FG001|Delayed Start|Death|0|||
46726329|NCT00594568|82942195|FG002|Delayed Start|Death|1|||
46726330|NCT00594568|82942193|FG000|Delayed Start|Adverse Event|12|||
46726331|NCT00594568|82942194|FG001|Delayed Start|Adverse Event|2|||
46726332|NCT00594568|82942195|FG002|Delayed Start|Adverse Event|2|||
46726333|NCT00594568|82942193|FG000|Delayed Start|Withdrawal by Subject|4|||
46726334|NCT00594568|82942194|FG001|Delayed Start|Withdrawal by Subject|3|||
46726335|NCT00594568|82942195|FG002|Delayed Start|Withdrawal by Subject|0|||
46726336|NCT00594568|82942193|FG000|Delayed Start|Physician Decision|0|||
46726337|NCT00594568|82942194|FG001|Delayed Start|Physician Decision|0|||
46726338|NCT00594568|82942195|FG002|Delayed Start|Physician Decision|1|||
46726339|NCT00594568|82942193|FG000|Delayed Start|Lost to Follow-up|0|||
46726340|NCT00594568|82942194|FG001|Delayed Start|Lost to Follow-up|0|||
46726341|NCT00594568|82942195|FG002|Delayed Start|Lost to Follow-up|1|||
46726342|NCT00594568|82942193|FG000|Delayed Start|Caregiver Decision|5|||
46726343|NCT00594568|82942194|FG001|Delayed Start|Caregiver Decision|6|||
46726344|NCT00594568|82942195|FG002|Delayed Start|Caregiver Decision|2|||
46726345|NCT00594568|82942193|FG000|Delayed Start|Sponsor Decision|77|||
46726346|NCT00594568|82942194|FG001|Delayed Start|Sponsor Decision|66|||
46726347|NCT00594568|82942195|FG002|Delayed Start|Sponsor Decision|59|||
47046939|NCT01719380|83306071|FG006|Overall Study|Physician Decision|0|||
47046940|NCT01719380|83306072|FG007|Overall Study|Physician Decision|0|||
46726348|NCT00594568|82942193|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
46726349|NCT00594568|82942194|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
46726350|NCT00594568|82942195|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
46726351|NCT00594568|82942193|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
46726352|NCT00594568|82942194|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
46726353|NCT00594568|82942195|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
46726354|NCT00594568|82942193|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
46726355|NCT00594568|82942194|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
46726356|NCT00594568|82942195|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
46726357|NCT00594568|82942193|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
46921197|NCT02419417|83153600|FG004|Overall Study|Adverse event unrelated to study drug|2|||
46921198|NCT02419417|83153601|FG005|Overall Study|Adverse event unrelated to study drug|1|||
46921199|NCT02419417|83153602|FG006|Overall Study|Adverse event unrelated to study drug|0|||
46921200|NCT02419417|83153603|FG007|Overall Study|Adverse event unrelated to study drug|1|||
46921201|NCT02419417|83153604|FG008|Overall Study|Adverse event unrelated to study drug|0|||
46921202|NCT02419417|83153605|FG009|Overall Study|Adverse event unrelated to study drug|0|||
46921203|NCT02419417|83153606|FG010|Overall Study|Adverse event unrelated to study drug|0|||
46921204|NCT02419417|83153596|FG000|Overall Study|Participant request to discontinue|0|||
46921205|NCT02419417|83153597|FG001|Overall Study|Participant request to discontinue|0|||
46921206|NCT02419417|83153598|FG002|Overall Study|Participant request to discontinue|0|||
47046941|NCT01719380|83306073|FG008|Overall Study|Physician Decision|1|||
47046942|NCT01719380|83306074|FG009|Overall Study|Physician Decision|1|||
47046943|NCT01719380|83306065|FG000|Overall Study|Lack of Efficacy|2|||
47046944|NCT01719380|83306066|FG001|Overall Study|Lack of Efficacy|6|||
47046945|NCT01719380|83306067|FG002|Overall Study|Lack of Efficacy|5|||
47046946|NCT01719380|83306068|FG003|Overall Study|Lack of Efficacy|6|||
47046947|NCT01719380|83306069|FG004|Overall Study|Lack of Efficacy|3|||
47046948|NCT01719380|83306070|FG005|Overall Study|Lack of Efficacy|7|||
47046949|NCT01719380|83306071|FG006|Overall Study|Lack of Efficacy|10|||
47046950|NCT01719380|83306072|FG007|Overall Study|Lack of Efficacy|6|||
47046951|NCT01719380|83306073|FG008|Overall Study|Lack of Efficacy|39|||
46726358|NCT00594568|82942194|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
46726359|NCT00594568|82942195|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
46726360|NCT00594568|82942193|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
46726361|NCT00594568|82942194|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
46726362|NCT00594568|82942195|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
46726363|NCT00594568|82942193|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
47046952|NCT01719380|83306074|FG009|Overall Study|Lack of Efficacy|42|||
47046953|NCT01719380|83306065|FG000|Overall Study|Progressive Disease|0|||
47046954|NCT01719380|83306066|FG001|Overall Study|Progressive Disease|0|||
47046955|NCT01719380|83306067|FG002|Overall Study|Progressive Disease|0|||
46726364|NCT00594568|82942194|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
46726365|NCT00594568|82942195|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
46726366|NCT00875056|82942223|FG000|Overall Study|Adverse Event|6|||
47046956|NCT01719380|83306068|FG003|Overall Study|Progressive Disease|0|||
46726367|NCT00875056|82942224|FG001|Overall Study|Adverse Event|1|||
46726368|NCT00875056|82942225|FG002|Overall Study|Adverse Event|2|||
46726369|NCT00875056|82942223|FG000|Overall Study|Progressive Disease|14|||
46726370|NCT00875056|82942224|FG001|Overall Study|Progressive Disease|8|||
46726371|NCT00875056|82942225|FG002|Overall Study|Progressive Disease|3|||
46726372|NCT00875056|82942223|FG000|Overall Study|Withdrawal by Subject|3|||
46726373|NCT00875056|82942224|FG001|Overall Study|Withdrawal by Subject|0|||
46726374|NCT00875056|82942225|FG002|Overall Study|Withdrawal by Subject|1|||
46726375|NCT00940602|82942235|FG000|Overall Study|Administrative problems|1|||
46726376|NCT00940602|82942236|FG001|Overall Study|Administrative problems|1|||
46726377|NCT00940602|82942235|FG000|Overall Study|Patient/guardian decision|13|||
46726378|NCT00940602|82942236|FG001|Overall Study|Patient/guardian decision|28|||
46726379|NCT00940602|82942235|FG000|Overall Study|Physician Decision|8|||
46726380|NCT00940602|82942236|FG001|Overall Study|Physician Decision|5|||
46726381|NCT00940602|82942235|FG000|Overall Study|Pregnancy|1|||
46726382|NCT00940602|82942236|FG001|Overall Study|Pregnancy|0|||
46726383|NCT00940602|82942235|FG000|Overall Study|Protocol Deviation (untreated)|1|||
46726384|NCT00940602|82942236|FG001|Overall Study|Protocol Deviation (untreated)|0|||
46726385|NCT00940602|82942235|FG000|Overall Study|Disease progression|8|||
46726386|NCT00940602|82942236|FG001|Overall Study|Disease progression|2|||
46726387|NCT00940602|82942235|FG000|Overall Study|Death|38|||
46726388|NCT00940602|82942236|FG001|Overall Study|Death|19|||
46726389|NCT00940602|82942235|FG000|Overall Study|Lost to Follow-up|3|||
46726390|NCT00940602|82942236|FG001|Overall Study|Lost to Follow-up|1|||
46726391|NCT00940602|82942235|FG000|Overall Study|Patient withdrew consent|26|||
46726392|NCT00940602|82942236|FG001|Overall Study|Patient withdrew consent|13|||
46726393|NCT00940602|82942235|FG000|Overall Study|Adverse Event|7|||
46726394|NCT00940602|82942236|FG001|Overall Study|Adverse Event|2|||
46726395|NCT00940602|82942235|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
46726396|NCT00940602|82942236|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
46726397|NCT00875524|82942245|FG000|Overall Study|Serious adverse event|0|||
46726398|NCT00875524|82942246|FG001|Overall Study|Serious adverse event|1|||
46726399|NCT00875524|82942245|FG000|Overall Study|Protocol Violation|4|||
46726400|NCT00875524|82942246|FG001|Overall Study|Protocol Violation|0|||
46726401|NCT00875524|82942245|FG000|Overall Study|Lost to Follow-up|1|||
46726402|NCT00875524|82942246|FG001|Overall Study|Lost to Follow-up|0|||
46726403|NCT00875524|82942245|FG000|Overall Study|Withdrawal by Subject|3|||
46726404|NCT00875524|82942246|FG001|Overall Study|Withdrawal by Subject|5|||
46726405|NCT01094288|82942260|FG000|Overall Study|Adverse Event|0|||
46726406|NCT01094288|82942261|FG001|Overall Study|Adverse Event|3|||
46726407|NCT01094288|82942262|FG002|Overall Study|Adverse Event|1|||
46726408|NCT01094288|82942263|FG003|Overall Study|Adverse Event|1|||
46726409|NCT01094288|82942264|FG004|Overall Study|Adverse Event|0|||
46726410|NCT01094288|82942265|FG005|Overall Study|Adverse Event|0|||
46726411|NCT01094288|82942266|FG006|Overall Study|Adverse Event|0|||
46726412|NCT01094288|82942267|FG007|Overall Study|Adverse Event|0|||
46726413|NCT01094288|82942260|FG000|Overall Study|Withdrawal by Subject|0|||
46726414|NCT01094288|82942261|FG001|Overall Study|Withdrawal by Subject|1|||
46726415|NCT01094288|82942262|FG002|Overall Study|Withdrawal by Subject|2|||
46726416|NCT01094288|82942263|FG003|Overall Study|Withdrawal by Subject|0|||
46726417|NCT01094288|82942264|FG004|Overall Study|Withdrawal by Subject|0|||
46726418|NCT01094288|82942265|FG005|Overall Study|Withdrawal by Subject|0|||
46726419|NCT01094288|82942266|FG006|Overall Study|Withdrawal by Subject|0|||
46726420|NCT01094288|82942267|FG007|Overall Study|Withdrawal by Subject|2|||
46726421|NCT01094288|82942260|FG000|Overall Study|Initiation of Alternative Therapy|0|||
46726422|NCT01094288|82942261|FG001|Overall Study|Initiation of Alternative Therapy|0|||
46726423|NCT01094288|82942262|FG002|Overall Study|Initiation of Alternative Therapy|1|||
46726424|NCT01094288|82942263|FG003|Overall Study|Initiation of Alternative Therapy|0|||
46726425|NCT01094288|82942264|FG004|Overall Study|Initiation of Alternative Therapy|0|||
46726426|NCT01094288|82942265|FG005|Overall Study|Initiation of Alternative Therapy|0|||
46803745|NCT00676403|83023032|FG004|Overall Study|Withdrawal by Subject|0|||
47046957|NCT01719380|83306069|FG004|Overall Study|Progressive Disease|0|||
47046958|NCT01719380|83306070|FG005|Overall Study|Progressive Disease|0|||
47046959|NCT01719380|83306071|FG006|Overall Study|Progressive Disease|0|||
47046960|NCT01719380|83306072|FG007|Overall Study|Progressive Disease|0|||
47046961|NCT01719380|83306073|FG008|Overall Study|Progressive Disease|1|||
47046962|NCT01719380|83306074|FG009|Overall Study|Progressive Disease|0|||
47046963|NCT01743560|83306124|FG000|Overall Study|Disease progression|26|||
47046964|NCT01743560|83306124|FG000|Overall Study|Adverse Event|8|||
47046965|NCT01743560|83306124|FG000|Overall Study|Death|3|||
47046966|NCT01743560|83306124|FG000|Overall Study|Withdrawal by Subject|2|||
46726427|NCT01094288|82942266|FG006|Overall Study|Initiation of Alternative Therapy|0|||
46726428|NCT01094288|82942267|FG007|Overall Study|Initiation of Alternative Therapy|0|||
46726429|NCT01094288|82942260|FG000|Overall Study|Reason not Specified|2|||
47046967|NCT01743560|83306124|FG000|Overall Study|Protocol Violation|1|||
47046968|NCT01743560|83306124|FG000|Overall Study|>1 dose of study drug|3|||
46726430|NCT01094288|82942261|FG001|Overall Study|Reason not Specified|3|||
46726431|NCT01094288|82942262|FG002|Overall Study|Reason not Specified|0|||
46726432|NCT01094288|82942263|FG003|Overall Study|Reason not Specified|1|||
46726433|NCT01094288|82942264|FG004|Overall Study|Reason not Specified|0|||
46726434|NCT01094288|82942265|FG005|Overall Study|Reason not Specified|0|||
46726435|NCT01094288|82942266|FG006|Overall Study|Reason not Specified|0|||
46726436|NCT01094288|82942267|FG007|Overall Study|Reason not Specified|0|||
46726437|NCT01094288|82942260|FG000|Overall Study|Ongoing Participants|0|||
46726438|NCT01094288|82942261|FG001|Overall Study|Ongoing Participants|3|||
46726439|NCT01094288|82942262|FG002|Overall Study|Ongoing Participants|0|||
46726440|NCT01094288|82942263|FG003|Overall Study|Ongoing Participants|0|||
46726441|NCT01094288|82942264|FG004|Overall Study|Ongoing Participants|0|||
46726442|NCT01094288|82942265|FG005|Overall Study|Ongoing Participants|0|||
46726443|NCT01094288|82942266|FG006|Overall Study|Ongoing Participants|0|||
46726444|NCT01094288|82942267|FG007|Overall Study|Ongoing Participants|0|||
46726445|NCT00874120|82942291|FG000|First Intervention|Adverse Event|0|||
46726446|NCT00874120|82942292|FG001|First Intervention|Adverse Event|1|||
46726447|NCT00874120|82942291|FG000|First Intervention|Withdrawal by Subject|2|||
46726448|NCT00874120|82942292|FG001|First Intervention|Withdrawal by Subject|0|||
46726449|NCT00874120|82942291|FG000|First Intervention|Lost to Follow-up|0|||
46726450|NCT00874120|82942292|FG001|First Intervention|Lost to Follow-up|1|||
46726451|NCT00874120|82942291|FG000|First Intervention|Protocol Violation|3|||
46726452|NCT00874120|82942292|FG001|First Intervention|Protocol Violation|0|||
46726453|NCT00874120|82942291|FG000|First Intervention|positive drug test|1|||
46726454|NCT00874120|82942292|FG001|First Intervention|positive drug test|0|||
46726455|NCT00874120|82942291|FG000|Second Intervention|Withdrawal by Subject|1|||
46726456|NCT00874120|82942292|FG001|Second Intervention|Withdrawal by Subject|0|||
46726457|NCT00874120|82942291|FG000|Second Intervention|Protocol Violation|1|||
46726458|NCT00874120|82942292|FG001|Second Intervention|Protocol Violation|0|||
46726459|NCT00939822|82942300|FG000|Overall Study|Lost to Follow-up|1|||
46726460|NCT00939822|82942301|FG001|Overall Study|Lost to Follow-up|0|||
46726461|NCT00939822|82942300|FG000|Overall Study|withdrew from study due to busy schedule|1|||
46726462|NCT00939822|82942301|FG001|Overall Study|withdrew from study due to busy schedule|1|||
46726463|NCT00939822|82942300|FG000|Overall Study|Mental health issues|0|||
46726464|NCT00939822|82942301|FG001|Overall Study|Mental health issues|2|||
46726465|NCT00939510|82942307|FG000|Overall Study|Withdrawal by Subject|1|||
46726466|NCT01098266|82942313|FG000|Overall Study|Physician Decision|1|||
46726467|NCT01098266|82942314|FG001|Overall Study|Physician Decision|0|||
46726468|NCT01098266|82942313|FG000|Overall Study|Death|3|||
46726469|NCT01098266|82942314|FG001|Overall Study|Death|2|||
47046969|NCT01743092|83306154|FG000|Overall Study|Lost to Follow-up|14|||
47046970|NCT01743092|83306155|FG001|Overall Study|Lost to Follow-up|15|||
47046971|NCT01780831|83306188|FG000|Overall Study|Withdrawal by Subject|0|||
47046972|NCT01780831|83306189|FG001|Overall Study|Withdrawal by Subject|0|||
47046973|NCT01780831|83306190|FG002|Overall Study|Withdrawal by Subject|4|||
47046974|NCT01780831|83306191|FG003|Overall Study|Withdrawal by Subject|0|||
47046975|NCT01780831|83306188|FG000|Overall Study|Lost to Follow-up|0|||
47046976|NCT01780831|83306189|FG001|Overall Study|Lost to Follow-up|0|||
47046977|NCT01780831|83306190|FG002|Overall Study|Lost to Follow-up|0|||
47046978|NCT01780831|83306191|FG003|Overall Study|Lost to Follow-up|1|||
47046979|NCT01778023|83306250|FG000|Overall Study|Withdrawal by Subject|0|||
47046980|NCT01778023|83306251|FG001|Overall Study|Withdrawal by Subject|3|||
47046981|NCT01753297|83306259|FG000|Overall Study|Lost to Follow-up|7|||
47046982|NCT01753297|83306260|FG001|Overall Study|Lost to Follow-up|2|||
47046983|NCT01753297|83306259|FG000|Overall Study|Withdrawal by Subject|26|||
47046984|NCT01753297|83306260|FG001|Overall Study|Withdrawal by Subject|23|||
46726470|NCT01098266|82942313|FG000|Overall Study|Withdrawal by Subject|3|||
46726471|NCT01098266|82942314|FG001|Overall Study|Withdrawal by Subject|5|||
46726472|NCT00935532|82942322|FG000|Overall Study|Adverse Event|11|||
46726473|NCT00935532|82942323|FG001|Overall Study|Adverse Event|6|||
46726474|NCT00935532|82942322|FG000|Overall Study|Death|1|||
46726475|NCT00935532|82942323|FG001|Overall Study|Death|0|||
46726476|NCT00935532|82942322|FG000|Overall Study|Lost to Follow-up|1|||
46726477|NCT00935532|82942323|FG001|Overall Study|Lost to Follow-up|0|||
47046985|NCT01753297|83306259|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
47046986|NCT01753297|83306260|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
47046987|NCT01753297|83306259|FG000|Overall Study|Death|0|||
47046988|NCT01753297|83306260|FG001|Overall Study|Death|2|||
47046989|NCT01753297|83306259|FG000|Overall Study|Did not attend end of study visit|7|||
47046990|NCT01753297|83306260|FG001|Overall Study|Did not attend end of study visit|8|||
47046991|NCT01777321|83306270|FG000|Overall Study|Withdrawal by Subject|0|||
47046992|NCT01777321|83306271|FG001|Overall Study|Withdrawal by Subject|1|||
47046993|NCT01729819|83306279|FG000|Overall Study|Adverse Event|2|||
47046994|NCT01729819|83306280|FG001|Overall Study|Adverse Event|4|||
46726478|NCT00935532|82942322|FG000|Overall Study|Physician Decision|1|||
46726479|NCT00935532|82942323|FG001|Overall Study|Physician Decision|2|||
46726480|NCT00935532|82942322|FG000|Overall Study|Protocol Violation|2|||
46726481|NCT00935532|82942323|FG001|Overall Study|Protocol Violation|1|||
46726482|NCT00935532|82942322|FG000|Overall Study|Subject Decision|2|||
46726483|NCT00935532|82942323|FG001|Overall Study|Subject Decision|1|||
46726484|NCT00935532|82942322|FG000|Overall Study|Sponsor Decision|0|||
46726485|NCT00935532|82942323|FG001|Overall Study|Sponsor Decision|1|||
46726486|NCT00935532|82942322|FG000|Overall Study|Loss Glucose Control|4|||
46726487|NCT00935532|82942323|FG001|Overall Study|Loss Glucose Control|0|||
46726488|NCT01093586|82942329|FG000|Overall Study|Failed to engraft|3|||
46726489|NCT00937404|82942333|FG000|Overall Study|Protocol Violation|1|||
46726490|NCT00937404|82942333|FG000|Overall Study|Withdrawal by Subject|1|||
46726491|NCT01098110|82942340|FG000|Overall Study|Withdrawal by Subject|14|||
46726492|NCT01098110|82942341|FG001|Overall Study|Withdrawal by Subject|24|||
46726493|NCT01098110|82942342|FG002|Overall Study|Withdrawal by Subject|19|||
46726494|NCT01098110|82942340|FG000|Overall Study|Adverse Event|30|||
46726495|NCT01098110|82942341|FG001|Overall Study|Adverse Event|32|||
46726496|NCT01098110|82942342|FG002|Overall Study|Adverse Event|43|||
46726497|NCT01098110|82942340|FG000|Overall Study|Lack of Efficacy|13|||
46726498|NCT01098110|82942341|FG001|Overall Study|Lack of Efficacy|9|||
46726499|NCT01098110|82942342|FG002|Overall Study|Lack of Efficacy|27|||
46726500|NCT01098110|82942340|FG000|Overall Study|Other|4|||
46726501|NCT01098110|82942341|FG001|Overall Study|Other|7|||
46726502|NCT01098110|82942342|FG002|Overall Study|Other|5|||
46726503|NCT01098110|82942340|FG000|Overall Study|Untreated|1|||
46726504|NCT01098110|82942341|FG001|Overall Study|Untreated|1|||
46726505|NCT01098110|82942342|FG002|Overall Study|Untreated|0|||
46726506|NCT01092728|82942352|FG000|Overall Study|Withdrawal by Subject|2|||
46726507|NCT01092728|82942353|FG001|Overall Study|Withdrawal by Subject|0|||
46726508|NCT01092728|82942352|FG000|Overall Study|Adverse Event|0|||
46726509|NCT01092728|82942353|FG001|Overall Study|Adverse Event|1|||
46726510|NCT01092728|82942352|FG000|Overall Study|Disease Progression|1|||
46726511|NCT01092728|82942353|FG001|Overall Study|Disease Progression|13|||
46726512|NCT01092728|82942352|FG000|Overall Study|Prohibited Concomitant Medications|1|||
46726513|NCT01092728|82942353|FG001|Overall Study|Prohibited Concomitant Medications|0|||
46726514|NCT01096550|82942361|FG000|Overall Study|discontinued site|10|||
46726515|NCT01096550|82942362|FG001|Overall Study|discontinued site|11|||
46726516|NCT01096550|82942361|FG000|Overall Study|non-regular treatment track at clinic|1|||
46726517|NCT01096550|82942362|FG001|Overall Study|non-regular treatment track at clinic|1|||
46726518|NCT01096550|82942361|FG000|Overall Study|clinic readmission|1|||
46726519|NCT01096550|82942362|FG001|Overall Study|clinic readmission|1|||
46726520|NCT01096550|82942361|FG000|Overall Study|Withdrawal by Subject|0|||
46726521|NCT01096550|82942362|FG001|Overall Study|Withdrawal by Subject|1|||
46726522|NCT01096550|82942361|FG000|Overall Study|non-African American participant|13|||
46726523|NCT01096550|82942362|FG001|Overall Study|non-African American participant|6|||
46726524|NCT01096550|82942361|FG000|Overall Study|Lost to Follow-up|12|||
46726525|NCT01096550|82942362|FG001|Overall Study|Lost to Follow-up|9|||
46726526|NCT01101542|82942368|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
46726527|NCT01101542|82942368|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
46726528|NCT01101542|82942368|FG000|Year 4 Surveillance Period|Other|287|||
46726529|NCT01101542|82942368|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
46726530|NCT01101542|82942368|FG000|Year 5 Surveillance Period|Pregnancy|1|||
46726531|NCT01101542|82942368|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
47046995|NCT01729819|83306279|FG000|Overall Study|Lack of Efficacy|1|||
47046996|NCT01729819|83306280|FG001|Overall Study|Lack of Efficacy|0|||
47046997|NCT01729819|83306279|FG000|Overall Study|Lost to Follow-up|2|||
47046998|NCT01729819|83306280|FG001|Overall Study|Lost to Follow-up|0|||
47046999|NCT01729819|83306279|FG000|Overall Study|Other reason|1|||
47047000|NCT01729819|83306280|FG001|Overall Study|Other reason|0|||
47047001|NCT01729819|83306279|FG000|Overall Study|Protocol Violation|0|||
46726532|NCT01101542|82942368|FG000|Year 6 Surveillance Period|Pregnancy|1|||
46726533|NCT01101542|82942368|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
46726534|NCT00937326|82942377|FG000|Overall Study|Adverse Event|0|||
46726535|NCT00937326|82942378|FG001|Overall Study|Adverse Event|3|||
46726536|NCT00937326|82942379|FG002|Overall Study|Adverse Event|1|||
46726537|NCT00937326|82942380|FG003|Overall Study|Adverse Event|1|||
46726538|NCT00937326|82942381|FG004|Overall Study|Adverse Event|2|||
46803746|NCT00676403|83023033|FG005|Overall Study|Withdrawal by Subject|1|||
47047002|NCT01729819|83306280|FG001|Overall Study|Protocol Violation|1|||
47047003|NCT01729819|83306279|FG000|Overall Study|Withdrawal by Subject|0|||
47047004|NCT01729819|83306280|FG001|Overall Study|Withdrawal by Subject|2|||
46726539|NCT00937326|82942377|FG000|Overall Study|Death|0|||
46726540|NCT00937326|82942378|FG001|Overall Study|Death|0|||
46726541|NCT00937326|82942379|FG002|Overall Study|Death|1|||
46726542|NCT00937326|82942380|FG003|Overall Study|Death|0|||
46726543|NCT00937326|82942381|FG004|Overall Study|Death|0|||
46726544|NCT00937326|82942377|FG000|Overall Study|Withdrawal by Subject|3|||
46726545|NCT00937326|82942378|FG001|Overall Study|Withdrawal by Subject|4|||
46726546|NCT00937326|82942379|FG002|Overall Study|Withdrawal by Subject|1|||
46726547|NCT00937326|82942380|FG003|Overall Study|Withdrawal by Subject|4|||
47047005|NCT01776541|83306291|FG000|Overall Study|Administrative Reason|6|||
46726548|NCT00937326|82942381|FG004|Overall Study|Withdrawal by Subject|3|||
46726549|NCT00937326|82942377|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
46726550|NCT00937326|82942378|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
46726551|NCT00937326|82942379|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
46726552|NCT00937326|82942380|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
46726553|NCT00937326|82942381|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
46726554|NCT00873730|82942400|FG000|Overall Study|Protocol Deviation|5|||
46726555|NCT00873730|82942401|FG001|Overall Study|Protocol Deviation|2|||
46921207|NCT02419417|83153599|FG003|Overall Study|Participant request to discontinue|0|||
46921208|NCT02419417|83153600|FG004|Overall Study|Participant request to discontinue|0|||
46921209|NCT02419417|83153601|FG005|Overall Study|Participant request to discontinue|0|||
46921210|NCT02419417|83153602|FG006|Overall Study|Participant request to discontinue|0|||
46921211|NCT02419417|83153603|FG007|Overall Study|Participant request to discontinue|0|||
46921212|NCT02419417|83153604|FG008|Overall Study|Participant request to discontinue|0|||
46921213|NCT02419417|83153605|FG009|Overall Study|Participant request to discontinue|1|||
46921214|NCT02419417|83153606|FG010|Overall Study|Participant request to discontinue|0|||
46921215|NCT02419417|83153596|FG000|Overall Study|Withdrawal by Subject|0|||
46921216|NCT02419417|83153597|FG001|Overall Study|Withdrawal by Subject|0|||
47047006|NCT01776541|83306292|FG001|Overall Study|Administrative Reason|2|||
47047007|NCT01776541|83306291|FG000|Overall Study|Death|4|||
47047008|NCT01776541|83306292|FG001|Overall Study|Death|0|||
47047009|NCT01776541|83306291|FG000|Overall Study|Lost to Follow-up|27|||
47047010|NCT01776541|83306292|FG001|Overall Study|Lost to Follow-up|48|||
47047011|NCT01776541|83306291|FG000|Overall Study|Unclassified|5|||
47047012|NCT01776541|83306292|FG001|Overall Study|Unclassified|4|||
47047013|NCT01776541|83306291|FG000|Overall Study|Protocol Violation|2|||
47047014|NCT01776541|83306292|FG001|Overall Study|Protocol Violation|1|||
47047015|NCT01776541|83306291|FG000|Overall Study|Withdrawal by Subject|12|||
47047016|NCT01776541|83306292|FG001|Overall Study|Withdrawal by Subject|20|||
47047017|NCT01742078|83306321|FG000|Overall Study|Withdrawal by Subject|0|||
47047018|NCT01742078|83306322|FG001|Overall Study|Withdrawal by Subject|0|||
47047019|NCT01742078|83306323|FG002|Overall Study|Withdrawal by Subject|0|||
47047020|NCT01742078|83306324|FG003|Overall Study|Withdrawal by Subject|1|||
47047021|NCT01742078|83306325|FG004|Overall Study|Withdrawal by Subject|0|||
47047022|NCT01742078|83306326|FG005|Overall Study|Withdrawal by Subject|0|||
47047023|NCT01742078|83306327|FG006|Overall Study|Withdrawal by Subject|0|||
47047024|NCT01742078|83306328|FG007|Overall Study|Withdrawal by Subject|0|||
47047025|NCT01742078|83306329|FG008|Overall Study|Withdrawal by Subject|0|||
47047026|NCT01741688|83306351|FG000|Overall Study|Lack of insurance coverage|2|||
47047027|NCT01741688|83306351|FG000|Overall Study|Withdrawal by Subject|1|||
47047028|NCT01709084|83306358|FG000|Overall Study|Lost to Follow-up|4|||
47047029|NCT01709084|83306359|FG001|Overall Study|Lost to Follow-up|7|||
47047030|NCT01709084|83306358|FG000|Overall Study|Withdrawal by Subject|2|||
47047031|NCT01709084|83306359|FG001|Overall Study|Withdrawal by Subject|2|||
47047032|NCT01709084|83306358|FG000|Overall Study|Adverse Event|5|||
47047033|NCT01709084|83306359|FG001|Overall Study|Adverse Event|0|||
47047034|NCT01709084|83306358|FG000|Overall Study|Other|5|||
47047035|NCT01709084|83306359|FG001|Overall Study|Other|3|||
47047036|NCT01709084|83306358|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
47047037|NCT01709084|83306359|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
47047038|NCT01709084|83306358|FG000|Overall Study|Not Treated|0|||
47047039|NCT01709084|83306359|FG001|Overall Study|Not Treated|2|||
47047040|NCT01729039|83306367|FG000|Overall Study|disqualified|2|||
47047041|NCT01729039|83306368|FG001|Overall Study|disqualified|5|||
47047042|NCT01729039|83306367|FG000|Overall Study|Withdrawal by Subject|8|||
47047043|NCT01729039|83306368|FG001|Overall Study|Withdrawal by Subject|7|||
47047044|NCT01775995|83306379|FG000|Overall Study|Lost to Follow-up|1|||
47047045|NCT01775995|83306380|FG001|Overall Study|Lost to Follow-up|1|||
47047046|NCT01741532|83306388|FG000|Overall Study|Adverse Event|4|||
47047047|NCT01741532|83306389|FG001|Overall Study|Adverse Event|0|||
47047048|NCT01741532|83306388|FG000|Overall Study|Withdrawal by Subject|1|||
47047049|NCT01741532|83306389|FG001|Overall Study|Withdrawal by Subject|1|||
47047050|NCT01741532|83306388|FG000|Overall Study|Protocol Violation|0|||
46921217|NCT02419417|83153598|FG002|Overall Study|Withdrawal by Subject|0|||
47047051|NCT01741532|83306389|FG001|Overall Study|Protocol Violation|1|||
47047052|NCT01741532|83306388|FG000|Overall Study|Worsening of the disease|3|||
47047053|NCT01741532|83306389|FG001|Overall Study|Worsening of the disease|1|||
47047054|NCT01741532|83306388|FG000|Overall Study|Sponsor decision|1|||
47047055|NCT01741532|83306389|FG001|Overall Study|Sponsor decision|0|||
47047056|NCT01741532|83306388|FG000|Overall Study|Medical event|1|||
47047057|NCT01741532|83306389|FG001|Overall Study|Medical event|0|||
46726556|NCT00873730|82942400|FG000|Overall Study|Adverse Event|0|||
47047058|NCT01719224|83306399|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
47047059|NCT01719224|83306400|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
47047060|NCT01717976|83306411|FG000|Overall Study|Protocol Violation|0|||
46726557|NCT00873730|82942401|FG001|Overall Study|Adverse Event|2|||
46726558|NCT00873730|82942400|FG000|Overall Study|Withdrawal by Subject|0|||
46726559|NCT00873730|82942401|FG001|Overall Study|Withdrawal by Subject|1|||
46726560|NCT00873730|82942400|FG000|Overall Study|Sponsor decision|1|||
46726561|NCT00873730|82942401|FG001|Overall Study|Sponsor decision|0|||
46726562|NCT00874432|82942411|FG000|Overall Study|Withdrawal by Subject|1|||
46726563|NCT00874432|82942412|FG001|Overall Study|Withdrawal by Subject|0|||
46726564|NCT00874432|82942413|FG002|Overall Study|Withdrawal by Subject|0|||
46726565|NCT00874432|82942414|FG003|Overall Study|Withdrawal by Subject|0|||
46726566|NCT00874432|82942411|FG000|Overall Study|Physician Decision|1|||
46726567|NCT00874432|82942412|FG001|Overall Study|Physician Decision|0|||
46726568|NCT00874432|82942413|FG002|Overall Study|Physician Decision|0|||
46726569|NCT00874432|82942414|FG003|Overall Study|Physician Decision|0|||
46726570|NCT00874432|82942411|FG000|Overall Study|Other|1|||
46726571|NCT00874432|82942412|FG001|Overall Study|Other|2|||
46726572|NCT00874432|82942413|FG002|Overall Study|Other|8|||
46726573|NCT00874432|82942414|FG003|Overall Study|Other|3|||
46726574|NCT00935220|82942426|FG000|Overall Study|Adverse Event|1|||
46726575|NCT00935220|82942426|FG000|Overall Study|Other reason (not specified)|1|||
46726576|NCT00874276|82942432|FG000|Overall Study|Withdrawal by Subject|1|||
46726577|NCT00874276|82942433|FG001|Overall Study|Withdrawal by Subject|1|||
46726578|NCT00594880|82942443|FG000|Overall Study|Withdrawal by Subject|1|||
46726579|NCT00594880|82942444|FG001|Overall Study|Withdrawal by Subject|1|||
46726580|NCT00594880|82942443|FG000|Overall Study|Lost to Follow-up|1|||
46726581|NCT00594880|82942444|FG001|Overall Study|Lost to Follow-up|0|||
46726582|NCT00871858|82942456|FG000|Overall Study|Protocol Violation|3|||
46726583|NCT00871858|82942457|FG001|Overall Study|Protocol Violation|4|||
46726584|NCT00871858|82942456|FG000|Overall Study|Adverse Event|1|||
46726585|NCT00871858|82942457|FG001|Overall Study|Adverse Event|1|||
47047061|NCT01717976|83306412|FG001|Overall Study|Protocol Violation|1|||
46726586|NCT00871858|82942456|FG000|Overall Study|Withdrawal by Subject|1|||
46726587|NCT00871858|82942457|FG001|Overall Study|Withdrawal by Subject|1|||
46726588|NCT00871858|82942456|FG000|Overall Study|Lost to Follow-up|0|||
46726589|NCT00871858|82942457|FG001|Overall Study|Lost to Follow-up|1|||
46726590|NCT00871780|82942463|FG000|Overall Study|Enrolled But Not Treated|6|||
46726591|NCT00871780|82942463|FG000|Overall Study|Withdrawal by Subject|9|||
46726592|NCT00871780|82942463|FG000|Overall Study|Adverse Event|6|||
46726593|NCT00871780|82942463|FG000|Overall Study|Voluntary Discontinuation|4|||
46726594|NCT00871780|82942463|FG000|Overall Study|Death|1|||
46726595|NCT00871780|82942463|FG000|Overall Study|Physician Decision|1|||
46726596|NCT00594178|82942470|FG000|Overall Study|Physician Decision|5|||
46726597|NCT00933270|82942474|FG000|Overall Study|Withdrawal by Subject|26|||
46726598|NCT00933270|82942474|FG000|Overall Study|Insufficient Follow-up|10|||
46726599|NCT00933270|82942474|FG000|Overall Study|Lost to Follow-up|14|||
46726600|NCT00933270|82942474|FG000|Overall Study|Adverse Event|1|||
46726601|NCT00933270|82942474|FG000|Overall Study|Missed Visit|2|||
46726602|NCT00933270|82942474|FG000|Overall Study|Death|24|||
46726603|NCT00933270|82942474|FG000|Overall Study|Moved or would not return|10|||
47047062|NCT01740440|83306418|FG000|Overall Study|Lost to Follow-up|3|||
47047063|NCT01740128|83306425|FG000|Overall Study|Pregnancy|0|||
47047064|NCT01740128|83306426|FG001|Overall Study|Pregnancy|1|||
47047065|NCT01740128|83306425|FG000|Overall Study|Protocol Violation|1|||
47047066|NCT01740128|83306426|FG001|Overall Study|Protocol Violation|2|||
47047067|NCT01740128|83306425|FG000|Overall Study|Lost to Follow-up|2|||
47047068|NCT01740128|83306426|FG001|Overall Study|Lost to Follow-up|2|||
46726604|NCT00936858|82942479|FG000|Overall Study|Death|3|||
46726605|NCT00936858|82942479|FG000|Overall Study|Progression|29|||
46726606|NCT00936858|82942479|FG000|Overall Study|Withdrawal by Subject|5|||
46726607|NCT00936858|82942479|FG000|Overall Study|Adverse Event|1|||
46726608|NCT00936858|82942479|FG000|Overall Study|Physician Decision|7|||
46726609|NCT00936858|82942479|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
46726610|NCT00936858|82942479|FG000|Overall Study|Lost to Follow-up|1|||
47047069|NCT01740128|83306425|FG000|Overall Study|Withdrawal by Subject|1|||
46726611|NCT00872170|82942486|FG000|Overall Study|Adverse Event|1|||
46726612|NCT00872170|82942487|FG001|Overall Study|Adverse Event|0|||
46726613|NCT00936702|82942492|FG000|Overall Study|Disease progression|34|||
46726614|NCT00936702|82942492|FG000|Overall Study|Adverse Event|8|||
46726615|NCT00936702|82942492|FG000|Overall Study|Withdrawal by Subject|2|||
46726616|NCT00936702|82942492|FG000|Overall Study|Alternative Treatment|1|||
46726617|NCT00936702|82942492|FG000|Overall Study|Other|1|||
46726618|NCT00594100|82942496|FG000|Procedure|Technical Failure|9|||
47047070|NCT01740128|83306426|FG001|Overall Study|Withdrawal by Subject|0|||
46726619|NCT00594100|82942496|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
46726620|NCT00594100|82942496|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
46726621|NCT00594100|82942496|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
46726622|NCT01092182|82942503|FG000|Overall Study|Death|0|||
47047071|NCT01740128|83306425|FG000|Overall Study|Insufficient protocol compliance|2|||
47047072|NCT01740128|83306426|FG001|Overall Study|Insufficient protocol compliance|2|||
47047073|NCT01976741|83306442|FG000|Overall Study|Withdrawal by Subject|1|||
47047074|NCT01976741|83306443|FG001|Overall Study|Withdrawal by Subject|0|||
47047075|NCT01976741|83306444|FG002|Overall Study|Withdrawal by Subject|1|||
47047076|NCT01976741|83306445|FG003|Overall Study|Withdrawal by Subject|1|||
47047077|NCT01976741|83306446|FG004|Overall Study|Withdrawal by Subject|0|||
47047078|NCT01976741|83306447|FG005|Overall Study|Withdrawal by Subject|0|||
47047079|NCT01976741|83306448|FG006|Overall Study|Withdrawal by Subject|1|||
47047080|NCT01976741|83306449|FG007|Overall Study|Withdrawal by Subject|4|||
47047081|NCT01976741|83306450|FG008|Overall Study|Withdrawal by Subject|0|||
47047082|NCT01976741|83306451|FG009|Overall Study|Withdrawal by Subject|0|||
47047083|NCT01976741|83306442|FG000|Overall Study|Adverse Event|0|||
47047084|NCT01976741|83306443|FG001|Overall Study|Adverse Event|0|||
46726623|NCT01092182|82942504|FG001|Overall Study|Death|5|||
46726624|NCT01092182|82942505|FG002|Overall Study|Death|3|||
46726625|NCT01092182|82942503|FG000|Overall Study|participant safety|1|||
46726626|NCT01092182|82942504|FG001|Overall Study|participant safety|2|||
46726627|NCT01092182|82942505|FG002|Overall Study|participant safety|0|||
46726628|NCT01092182|82942503|FG000|Overall Study|Physician Decision|0|||
46726629|NCT01092182|82942504|FG001|Overall Study|Physician Decision|6|||
46726630|NCT01092182|82942505|FG002|Overall Study|Physician Decision|0|||
46726631|NCT01092182|82942503|FG000|Overall Study|Did not meet criteria|0|||
46726632|NCT01092182|82942504|FG001|Overall Study|Did not meet criteria|0|||
46726633|NCT01092182|82942505|FG002|Overall Study|Did not meet criteria|25|||
46726634|NCT01092182|82942503|FG000|Overall Study|Non-compliance|0|||
46726635|NCT01092182|82942504|FG001|Overall Study|Non-compliance|3|||
46726636|NCT01092182|82942505|FG002|Overall Study|Non-compliance|0|||
46726637|NCT01092182|82942503|FG000|Overall Study|Participant refused follow-up|0|||
46726638|NCT01092182|82942504|FG001|Overall Study|Participant refused follow-up|2|||
46726639|NCT01092182|82942505|FG002|Overall Study|Participant refused follow-up|0|||
46726640|NCT00932646|82942513|FG000|Overall Study|Adverse Event|2|||
46726641|NCT00932646|82942514|FG001|Overall Study|Adverse Event|1|||
46726642|NCT00932646|82942515|FG002|Overall Study|Adverse Event|1|||
46726643|NCT00932646|82942516|FG003|Overall Study|Adverse Event|1|||
46726644|NCT00932646|82942513|FG000|Overall Study|Lost to Follow-up|2|||
46726645|NCT00932646|82942514|FG001|Overall Study|Lost to Follow-up|1|||
46726646|NCT00932646|82942515|FG002|Overall Study|Lost to Follow-up|0|||
46726647|NCT00932646|82942516|FG003|Overall Study|Lost to Follow-up|0|||
46726648|NCT00932646|82942513|FG000|Overall Study|Withdrawal by Subject|1|||
46726649|NCT00932646|82942514|FG001|Overall Study|Withdrawal by Subject|1|||
46726650|NCT00932646|82942515|FG002|Overall Study|Withdrawal by Subject|3|||
46726651|NCT00932646|82942516|FG003|Overall Study|Withdrawal by Subject|0|||
46726652|NCT00871234|82942530|FG000|Overall Study|Adverse Event|2|||
46726653|NCT00871234|82942530|FG000|Overall Study|Lost to Follow-up|3|||
46726654|NCT01091246|82942537|FG000|Overall Study|Lost to Follow-up|23|||
46726655|NCT01091246|82942538|FG001|Overall Study|Lost to Follow-up|11|||
46726656|NCT01091246|82942539|FG002|Overall Study|Lost to Follow-up|7|||
46726657|NCT01091246|82942537|FG000|Overall Study|Adverse Event|1|||
46726658|NCT01091246|82942538|FG001|Overall Study|Adverse Event|0|||
46726659|NCT01091246|82942539|FG002|Overall Study|Adverse Event|1|||
46726660|NCT01091246|82942537|FG000|Overall Study|Withdrawal by Subject|9|||
46726661|NCT01091246|82942538|FG001|Overall Study|Withdrawal by Subject|5|||
46726662|NCT01091246|82942539|FG002|Overall Study|Withdrawal by Subject|4|||
46726663|NCT01091246|82942537|FG000|Overall Study|Subject not dosed|2|||
46726664|NCT01091246|82942538|FG001|Overall Study|Subject not dosed|0|||
46726665|NCT01091246|82942539|FG002|Overall Study|Subject not dosed|1|||
46726666|NCT01097330|82942551|FG000|Overall Study|Study terminated early|7|||
46726667|NCT01097330|82942552|FG001|Overall Study|Study terminated early|5|||
46726668|NCT00934440|82942558|FG000|Overall Study|Lost to Follow-up|1|||
46726669|NCT00934362|82942565|FG000|Overall Study|Adverse Event|1|||
47047085|NCT01976741|83306444|FG002|Overall Study|Adverse Event|2|||
47047086|NCT01976741|83306445|FG003|Overall Study|Adverse Event|0|||
47047087|NCT01976741|83306446|FG004|Overall Study|Adverse Event|0|||
46726670|NCT00934362|82942566|FG001|Overall Study|Adverse Event|0|||
46726671|NCT00934128|82942574|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
46726672|NCT00934128|82942575|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
46726673|NCT00934128|82942574|FG000|First Intervention (2 Hours)|Adverse Event|4|||
46726674|NCT00934128|82942575|FG001|First Intervention (2 Hours)|Adverse Event|1|||
46726675|NCT00934128|82942574|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
47047088|NCT01976741|83306447|FG005|Overall Study|Adverse Event|0|||
47047089|NCT01976741|83306448|FG006|Overall Study|Adverse Event|3|||
47047090|NCT01976741|83306449|FG007|Overall Study|Adverse Event|8|||
46726676|NCT00934128|82942575|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
46726677|NCT00934128|82942574|FG000|Washout Period (1 Hour)|Patient preference|1|||
46726678|NCT00934128|82942575|FG001|Washout Period (1 Hour)|Patient preference|3|||
46726679|NCT00934128|82942574|FG000|Washout Period (1 Hour)|Pain|1|||
46726680|NCT00934128|82942575|FG001|Washout Period (1 Hour)|Pain|0|||
46726681|NCT00934128|82942574|FG000|Washout Period (1 Hour)|Too tired|1|||
46726682|NCT00934128|82942575|FG001|Washout Period (1 Hour)|Too tired|0|||
46726683|NCT00934128|82942574|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
46726684|NCT00934128|82942575|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
46726685|NCT00934128|82942574|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
46726686|NCT00934128|82942575|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
46726687|NCT00871000|82942583|FG000|Overall Study|Withdrawal by Subject|1|||
46726688|NCT00871000|82942584|FG001|Overall Study|Withdrawal by Subject|0|||
46726689|NCT01096784|82942592|FG000|Overall Study|Withdrawal by Subject|2|||
46726690|NCT01096784|82942593|FG001|Overall Study|Withdrawal by Subject|1|||
46726691|NCT01096784|82942592|FG000|Overall Study|Adverse Event|11|||
46726692|NCT01096784|82942593|FG001|Overall Study|Adverse Event|9|||
46726693|NCT01096784|82942592|FG000|Overall Study|Protocol Deviation|2|||
46726694|NCT01096784|82942593|FG001|Overall Study|Protocol Deviation|2|||
46726695|NCT01096784|82942592|FG000|Overall Study|Administrative Decision|0|||
46726696|NCT01096784|82942593|FG001|Overall Study|Administrative Decision|1|||
46726697|NCT01096784|82942592|FG000|Overall Study|Other Unspecified|0|||
46726698|NCT01096784|82942593|FG001|Overall Study|Other Unspecified|1|||
46726699|NCT00934050|82942607|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
46726700|NCT00934050|82942608|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
46726701|NCT00934050|82942609|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
46726702|NCT00934050|82942610|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
46726703|NCT00934050|82942611|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
46726704|NCT00934050|82942612|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
46726705|NCT00934050|82942607|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
46726706|NCT00934050|82942608|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
46726707|NCT00934050|82942609|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
46726708|NCT00934050|82942610|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
46726709|NCT00934050|82942611|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
46726710|NCT00934050|82942612|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
46726711|NCT00934050|82942607|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
46726712|NCT00934050|82942608|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
46726713|NCT00934050|82942609|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
46726714|NCT00934050|82942610|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
46726715|NCT00934050|82942611|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
46726716|NCT00934050|82942612|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
46726717|NCT00934050|82942607|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
46726718|NCT00934050|82942608|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
46726719|NCT00934050|82942609|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
46726720|NCT00934050|82942610|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
46726721|NCT00934050|82942611|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
46726722|NCT00934050|82942612|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
46726723|NCT00934050|82942607|FG000|Enrolled After 15 Dec 2009|Death|0|||
46726724|NCT00934050|82942608|FG001|Enrolled After 15 Dec 2009|Death|0|||
46726725|NCT00934050|82942609|FG002|Enrolled After 15 Dec 2009|Death|0|||
46726726|NCT00934050|82942610|FG003|Enrolled After 15 Dec 2009|Death|0|||
46726727|NCT00934050|82942611|FG004|Enrolled After 15 Dec 2009|Death|0|||
46726728|NCT00934050|82942612|FG005|Enrolled After 15 Dec 2009|Death|1|||
46726729|NCT00934050|82942607|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
46726730|NCT00934050|82942608|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
46726731|NCT00934050|82942609|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
46726732|NCT00934050|82942610|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
46726733|NCT00934050|82942611|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
46726734|NCT00934050|82942612|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
46726735|NCT00934050|82942607|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
46726736|NCT00934050|82942608|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
46726737|NCT00934050|82942609|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
46726738|NCT00934050|82942610|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
46726739|NCT00934050|82942611|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
46726740|NCT00934050|82942612|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
46726741|NCT01091168|82942624|FG000|Overall Study|Progressive disease|250|||
46726742|NCT01091168|82942625|FG001|Overall Study|Progressive disease|234|||
46726743|NCT01091168|82942624|FG000|Overall Study|Adverse Event|21|||
46726744|NCT01091168|82942625|FG001|Overall Study|Adverse Event|24|||
46726745|NCT01091168|82942624|FG000|Overall Study|Lost to Follow-up|0|||
46726746|NCT01091168|82942625|FG001|Overall Study|Lost to Follow-up|1|||
46726747|NCT01091168|82942624|FG000|Overall Study|Physician, patient's decision, other|27|||
46726748|NCT01091168|82942625|FG001|Overall Study|Physician, patient's decision, other|37|||
46726749|NCT00864916|82942633|FG000|Overall Study|Lost to Follow-up|4|||
46726750|NCT00864916|82942634|FG001|Overall Study|Lost to Follow-up|4|||
46726751|NCT00864916|82942633|FG000|Overall Study|Protocol Violation|1|||
46726752|NCT00864916|82942634|FG001|Overall Study|Protocol Violation|0|||
46726753|NCT00864916|82942633|FG000|Overall Study|Withdrawal by Subject|1|||
46726754|NCT00864916|82942634|FG001|Overall Study|Withdrawal by Subject|0|||
46726755|NCT00864682|82942643|FG000|Overall Study|Protocol Violation|2|||
46726756|NCT00864682|82942644|FG001|Overall Study|Protocol Violation|1|||
46726757|NCT00864682|82942645|FG002|Overall Study|Protocol Violation|2|||
46726758|NCT00931944|82942653|FG000|Overall Study|Adverse Event|4|||
46726759|NCT00931944|82942653|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
46726760|NCT00931944|82942653|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
46726761|NCT00931944|82942653|FG000|Overall Study|Death|28|||
46726762|NCT00931944|82942653|FG000|Overall Study|Other|2|||
46726763|NCT00929994|82942657|FG000|Overall Study|Withdrawal by Subject|1|||
46726764|NCT00929994|82942657|FG000|Overall Study|medical issue unrelated to intervention|4|||
46726765|NCT00929994|82942657|FG000|Overall Study|employment|1|||
46726766|NCT01090310|82942668|FG000|Core Study|Adverse Event|2|||
46726767|NCT01090310|82942669|FG001|Core Study|Adverse Event|2|||
46726768|NCT01090310|82942670|FG002|Core Study|Adverse Event|1|||
46726769|NCT01090310|82942671|FG003|Core Study|Adverse Event|1|||
46726770|NCT01090310|82942668|FG000|Core Study|Subject withdrew consent|0|||
46726771|NCT01090310|82942669|FG001|Core Study|Subject withdrew consent|3|||
46726772|NCT01090310|82942670|FG002|Core Study|Subject withdrew consent|1|||
46726773|NCT01090310|82942671|FG003|Core Study|Subject withdrew consent|1|||
46726774|NCT01090310|82942668|FG000|Core Study|Abnormal test procedure result|0|||
46726775|NCT01090310|82942669|FG001|Core Study|Abnormal test procedure result|0|||
46726776|NCT01090310|82942670|FG002|Core Study|Abnormal test procedure result|1|||
46726777|NCT01090310|82942671|FG003|Core Study|Abnormal test procedure result|0|||
46726778|NCT01090310|82942668|FG000|Core Study|Administrative reasons|5|||
46726779|NCT01090310|82942669|FG001|Core Study|Administrative reasons|6|||
46726780|NCT01090310|82942670|FG002|Core Study|Administrative reasons|4|||
46726781|NCT01090310|82942671|FG003|Core Study|Administrative reasons|4|||
46726782|NCT01090310|82942668|FG000|Core Study|Protocol deviation|1|||
46726783|NCT01090310|82942669|FG001|Core Study|Protocol deviation|0|||
46726784|NCT01090310|82942670|FG002|Core Study|Protocol deviation|0|||
47047091|NCT01976741|83306450|FG008|Overall Study|Adverse Event|1|||
47047092|NCT01976741|83306451|FG009|Overall Study|Adverse Event|4|||
47047093|NCT01727713|83306485|FG000|Overall Study|Lost to Follow-up|5|||
47047094|NCT01727713|83306485|FG000|Overall Study|Adverse Event|10|||
47047095|NCT01727713|83306485|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
47047096|NCT01727713|83306485|FG000|Overall Study|Withdrawal by Subject|13|||
47047097|NCT01727713|83306485|FG000|Overall Study|Protocol Deviation|2|||
47047098|NCT01965431|83306489|FG000|Overall Study|Adverse Event|0|||
46726785|NCT01090310|82942671|FG003|Core Study|Protocol deviation|1|||
46726786|NCT01090310|82942668|FG000|Extension Study|Aministrative problems|13|||
46726787|NCT01090310|82942669|FG001|Extension Study|Aministrative problems|15|||
46726788|NCT01090310|82942670|FG002|Extension Study|Aministrative problems|14|||
46726789|NCT01090310|82942671|FG003|Extension Study|Aministrative problems|18|||
46726790|NCT01090310|82942668|FG000|Extension Study|Adverse Event|0|||
46726791|NCT01090310|82942669|FG001|Extension Study|Adverse Event|0|||
47047099|NCT01965431|83306490|FG001|Overall Study|Adverse Event|1|||
47047100|NCT01965431|83306491|FG002|Overall Study|Adverse Event|0|||
46726792|NCT01090310|82942670|FG002|Extension Study|Adverse Event|0|||
46726793|NCT01090310|82942671|FG003|Extension Study|Adverse Event|1|||
46726794|NCT01090310|82942668|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
46726795|NCT01090310|82942669|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
46726796|NCT01090310|82942670|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
47047101|NCT01965431|83306492|FG003|Overall Study|Adverse Event|0|||
47047102|NCT01965431|83306493|FG004|Overall Study|Adverse Event|0|||
47047103|NCT01965431|83306494|FG005|Overall Study|Adverse Event|0|||
47047104|NCT01965431|83306489|FG000|Overall Study|Other than stated above|6|||
47047105|NCT01965431|83306490|FG001|Overall Study|Other than stated above|5|||
47047106|NCT01965431|83306491|FG002|Overall Study|Other than stated above|6|||
47047107|NCT01965431|83306492|FG003|Overall Study|Other than stated above|6|||
46726797|NCT01090310|82942671|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
46726798|NCT01090310|82942668|FG000|Extension Study|Subject withdrew consent|0|||
46726799|NCT01090310|82942669|FG001|Extension Study|Subject withdrew consent|1|||
46726800|NCT01090310|82942670|FG002|Extension Study|Subject withdrew consent|0|||
46726801|NCT01090310|82942671|FG003|Extension Study|Subject withdrew consent|0|||
46726802|NCT01090076|82942683|FG000|Overall Study|Death|1|||
46726803|NCT01090076|82942684|FG001|Overall Study|Death|1|||
46726804|NCT01090076|82942683|FG000|Overall Study|Withdrawal by Subject|0|||
46726805|NCT01090076|82942684|FG001|Overall Study|Withdrawal by Subject|1|||
46726806|NCT00869050|82942692|FG000|Overall Study|Screen Failure|3|||
46726807|NCT00927186|82942698|FG000|12 Months Primary Study|Adverse Event|5|||
46726808|NCT00927186|82942699|FG001|12 Months Primary Study|Adverse Event|2|||
46726809|NCT00927186|82942698|FG000|12 Months Primary Study|Lost to Follow-up|1|||
46726810|NCT00927186|82942699|FG001|12 Months Primary Study|Lost to Follow-up|0|||
46726811|NCT00927186|82942698|FG000|12 Months Primary Study|Protocol Violation|0|||
46726812|NCT00927186|82942699|FG001|12 Months Primary Study|Protocol Violation|1|||
46726813|NCT00927186|82942698|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
46726814|NCT00927186|82942699|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
46726815|NCT00593554|82942710|FG000|Overall Study|Death|1|||
46726816|NCT00593554|82942711|FG001|Overall Study|Death|2|||
46726817|NCT00593554|82942710|FG000|Overall Study|Physician Decision|0|||
46726818|NCT00593554|82942711|FG001|Overall Study|Physician Decision|1|||
46726819|NCT00593554|82942710|FG000|Overall Study|Withdrawal by Subject|1|||
46726820|NCT00593554|82942711|FG001|Overall Study|Withdrawal by Subject|0|||
46726821|NCT00593554|82942710|FG000|Overall Study|Disease Progression|1|||
46726822|NCT00593554|82942711|FG001|Overall Study|Disease Progression|2|||
46726823|NCT01101308|82942717|FG000|Period 1|Adverse Event|2|||
46726824|NCT01101308|82942718|FG001|Period 1|Adverse Event|1|||
46726825|NCT01101308|82942717|FG000|Period 1|Positive for cotinine|1|||
46726826|NCT01101308|82942718|FG001|Period 1|Positive for cotinine|0|||
46726827|NCT00926796|82942727|FG000|Overall Study|Did not receive randomized treatment|4|||
46726828|NCT00926796|82942728|FG001|Overall Study|Did not receive randomized treatment|7|||
46726829|NCT00926796|82942727|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
46726830|NCT00926796|82942728|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
46726831|NCT00926796|82942727|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
46726832|NCT00926796|82942728|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
46726833|NCT00926796|82942727|FG000|Overall Study|Adverse Event|7|||
46726834|NCT00926796|82942728|FG001|Overall Study|Adverse Event|14|||
46726835|NCT00926796|82942727|FG000|Overall Study|Lost to Follow-up|22|||
47047108|NCT01965431|83306493|FG004|Overall Study|Other than stated above|6|||
47047109|NCT01965431|83306494|FG005|Overall Study|Other than stated above|6|||
47047110|NCT01976663|83306504|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
47047111|NCT01976663|83306504|FG000|Overall Study|Personal Reasons|6|||
47047112|NCT01976663|83306504|FG000|Overall Study|Withdrawal by Subject|4|||
46726836|NCT00926796|82942728|FG001|Overall Study|Lost to Follow-up|13|||
46726837|NCT00926796|82942727|FG000|Overall Study|Protocol Violation|15|||
46726838|NCT00926796|82942728|FG001|Overall Study|Protocol Violation|11|||
46726839|NCT00926796|82942727|FG000|Overall Study|Withdrawal by Subject|1|||
46726840|NCT00926796|82942728|FG001|Overall Study|Withdrawal by Subject|0|||
46726841|NCT01087736|82942738|FG000|Overall Study|Lost to Follow-up|1|||
46726842|NCT01087736|82942739|FG001|Overall Study|Lost to Follow-up|0|||
46726843|NCT01087736|82942738|FG000|Overall Study|Death|0|||
46726844|NCT01087736|82942739|FG001|Overall Study|Death|1|||
46726845|NCT01087736|82942738|FG000|Overall Study|Withdrawal by Subject|0|||
46726846|NCT01087736|82942739|FG001|Overall Study|Withdrawal by Subject|1|||
47047113|NCT01976663|83306504|FG000|Overall Study|Screen Failure|3|||
46726847|NCT01079936|82942749|FG000|Phase I: MTD|First Remission Status|2|||
46726848|NCT01079936|82942750|FG001|Phase I: MTD|First Remission Status|0|||
46726849|NCT01079936|82942751|FG002|Phase I: MTD|First Remission Status|0|||
46726850|NCT01079936|82942752|FG003|Phase I: MTD|First Remission Status|0|||
46726851|NCT01079936|82942753|FG004|Phase I: MTD|First Remission Status|0|||
47047114|NCT01976663|83306504|FG000|Overall Study|Adverse Event|2|||
47047115|NCT01976663|83306504|FG000|Overall Study|Lost to Follow-up|3|||
47047116|NCT01775137|83306512|FG000|Overall Study|Death|1|||
46726852|NCT01079936|82942749|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
46726853|NCT01079936|82942750|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
46726854|NCT01079936|82942751|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
46726855|NCT01079936|82942752|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
46726856|NCT01079936|82942753|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
46726857|NCT01079936|82942749|FG000|Phase II|Adverse Event|0|||
46726858|NCT01079936|82942750|FG001|Phase II|Adverse Event|0|||
46726859|NCT01079936|82942751|FG002|Phase II|Adverse Event|1|||
46726860|NCT01079936|82942752|FG003|Phase II|Adverse Event|0|||
46726861|NCT01079936|82942753|FG004|Phase II|Adverse Event|0|||
46726862|NCT01079936|82942749|FG000|Phase II|Insurance Issue|0|||
46726863|NCT01079936|82942750|FG001|Phase II|Insurance Issue|0|||
46726864|NCT01079936|82942751|FG002|Phase II|Insurance Issue|0|||
46726865|NCT01079936|82942752|FG003|Phase II|Insurance Issue|0|||
46726866|NCT01079936|82942753|FG004|Phase II|Insurance Issue|1|||
46726867|NCT00931710|82942766|FG000|Overall Study|Adverse Event|16|||
46726868|NCT00931710|82942767|FG001|Overall Study|Adverse Event|10|||
46726869|NCT00931710|82942766|FG000|Overall Study|Abnormal test procedure results|2|||
46726870|NCT00931710|82942767|FG001|Overall Study|Abnormal test procedure results|0|||
46726871|NCT00931710|82942766|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
46726872|NCT00931710|82942767|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
47047117|NCT01775137|83306512|FG000|Overall Study|Protocol deviation|2|||
47047118|NCT01775137|83306512|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
47047119|NCT01775137|83306512|FG000|Overall Study|Adverse Event|1|||
47047120|NCT01775137|83306512|FG000|Overall Study|Withdrawal by participants|5|||
47047121|NCT01976507|83306519|FG000|Overall Study|Adverse Event|6|||
47047122|NCT01976507|83306519|FG000|Overall Study|ablation not done, drug not given|1|||
47047123|NCT01964963|83306523|FG000|Overall Study|Case Report Forms Uncollected|888|||
47047124|NCT01964963|83306523|FG000|Overall Study|Protocol Deviation|50|||
47047125|NCT01964963|83306523|FG000|Overall Study|Data Reliability was not Assured|5|||
47047126|NCT01964105|83306530|FG000|Overall Study|Lost to Follow-up|2|||
47047127|NCT01964105|83306531|FG001|Overall Study|Lost to Follow-up|13|||
47047128|NCT01964105|83306532|FG002|Overall Study|Lost to Follow-up|0|||
47047129|NCT01974323|83306542|FG000|Overall Study|Other Reasons|25|||
46634689|NCT01693614|82808155|FG000|Overall Study|Disease progression|11|||
46634690|NCT01693614|82808156|FG001|Overall Study|Disease progression|8|||
46634691|NCT01693614|82808157|FG002|Overall Study|Disease progression|7|||
46634692|NCT01693614|82808155|FG000|Overall Study|Protocol Violation|5|||
47047130|NCT01974323|83306543|FG001|Overall Study|Other Reasons|28|||
47047131|NCT01974323|83306542|FG000|Overall Study|Protocol Violation|2|||
47047132|NCT01974323|83306543|FG001|Overall Study|Protocol Violation|2|||
47047133|NCT01974323|83306542|FG000|Overall Study|Personal Reasons|15|||
47047134|NCT01974323|83306543|FG001|Overall Study|Personal Reasons|19|||
47047135|NCT01974323|83306542|FG000|Overall Study|Lost to Follow-up|45|||
47047136|NCT01974323|83306543|FG001|Overall Study|Lost to Follow-up|40|||
47047137|NCT01974323|83306542|FG000|Overall Study|Pregnancy|2|||
47047138|NCT01974323|83306543|FG001|Overall Study|Pregnancy|1|||
47047139|NCT01974323|83306542|FG000|Overall Study|Lack of Efficacy|1|||
47047140|NCT01974323|83306543|FG001|Overall Study|Lack of Efficacy|1|||
46634693|NCT01693614|82808156|FG001|Overall Study|Protocol Violation|2|||
46634694|NCT01693614|82808157|FG002|Overall Study|Protocol Violation|1|||
46634695|NCT01693614|82808155|FG000|Overall Study|Death|1|||
46634696|NCT01693614|82808156|FG001|Overall Study|Death|0|||
46634697|NCT01693614|82808157|FG002|Overall Study|Death|0|||
46634698|NCT01693614|82808155|FG000|Overall Study|Physician Decision|1|||
46634699|NCT01693614|82808156|FG001|Overall Study|Physician Decision|1|||
46634700|NCT01693614|82808157|FG002|Overall Study|Physician Decision|4|||
46634701|NCT01693614|82808155|FG000|Overall Study|Withdrawal by subject/guardian|0|||
46634702|NCT01693614|82808156|FG001|Overall Study|Withdrawal by subject/guardian|0|||
46634703|NCT01693614|82808157|FG002|Overall Study|Withdrawal by subject/guardian|2|||
46634704|NCT01693614|82808155|FG000|Overall Study|Withdrawal by Subject|1|||
46634705|NCT01693614|82808156|FG001|Overall Study|Withdrawal by Subject|0|||
46634706|NCT01693614|82808157|FG002|Overall Study|Withdrawal by Subject|5|||
46634707|NCT01715298|82808168|FG000|Overall Study|Lost to Follow-up|0|||
46634708|NCT01715298|82808169|FG001|Overall Study|Lost to Follow-up|2|||
46634709|NCT01715298|82808168|FG000|Overall Study|Patient/guardian decision|7|||
46634710|NCT01715298|82808169|FG001|Overall Study|Patient/guardian decision|9|||
46634711|NCT01713582|82808196|FG000|Overall Study|Disease progression|3|||
46726873|NCT00931710|82942766|FG000|Overall Study|Patient withdrew consent|4|||
46726874|NCT00931710|82942767|FG001|Overall Study|Patient withdrew consent|9|||
47047141|NCT01974323|83306542|FG000|Overall Study|Adverse Event|2|||
47047142|NCT01974323|83306543|FG001|Overall Study|Adverse Event|2|||
46803747|NCT00078325|83023056|FG000|Overall Study|Adverse Event|15|||
46803748|NCT00078325|83023057|FG001|Overall Study|Adverse Event|10|||
46803749|NCT00078325|83023058|FG002|Overall Study|Adverse Event|5|||
46634712|NCT01713582|82808197|FG001|Overall Study|Disease progression|3|||
46634713|NCT01713582|82808198|FG002|Overall Study|Disease progression|3|||
46634714|NCT01713582|82808199|FG003|Overall Study|Disease progression|2|||
46634715|NCT01713582|82808200|FG004|Overall Study|Disease progression|3|||
46634716|NCT01713582|82808201|FG005|Overall Study|Disease progression|3|||
46634717|NCT01713582|82808202|FG006|Overall Study|Disease progression|3|||
46634718|NCT01713582|82808203|FG007|Overall Study|Disease progression|3|||
46634719|NCT01713582|82808204|FG008|Overall Study|Disease progression|3|||
46634720|NCT01713582|82808205|FG009|Overall Study|Disease progression|11|||
46726875|NCT00931710|82942766|FG000|Overall Study|Lost to Follow-up|6|||
46726876|NCT00931710|82942767|FG001|Overall Study|Lost to Follow-up|5|||
46726877|NCT00931710|82942766|FG000|Overall Study|Protocol deviation|1|||
46726878|NCT00931710|82942767|FG001|Overall Study|Protocol deviation|2|||
46726879|NCT01100528|82942773|FG000|Overall Study|Death|1|||
46726880|NCT01100528|82942773|FG000|Overall Study|Withdrawal by Subject|2|||
46726881|NCT01079234|82942780|FG000|Main: Week 0 to 26|Adverse Event|5|||
46726882|NCT01079234|82942781|FG001|Main: Week 0 to 26|Adverse Event|4|||
46726883|NCT01079234|82942782|FG002|Main: Week 0 to 26|Adverse Event|1|||
46726884|NCT01079234|82942783|FG003|Main: Week 0 to 26|Adverse Event|0|||
46726885|NCT01079234|82942780|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
46726886|NCT01079234|82942781|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
46726887|NCT01079234|82942782|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
46726888|NCT01079234|82942783|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
46726889|NCT01079234|82942780|FG000|Main: Week 0 to 26|Protocol Violation|6|||
46726890|NCT01079234|82942781|FG001|Main: Week 0 to 26|Protocol Violation|2|||
46726891|NCT01079234|82942782|FG002|Main: Week 0 to 26|Protocol Violation|4|||
46726892|NCT01079234|82942783|FG003|Main: Week 0 to 26|Protocol Violation|0|||
46726893|NCT01079234|82942780|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
46726894|NCT01079234|82942781|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
46726895|NCT01079234|82942782|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
46726896|NCT01079234|82942783|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
46726897|NCT01079234|82942780|FG000|Main: Week 0 to 26|Unclassified|7|||
46726898|NCT01079234|82942781|FG001|Main: Week 0 to 26|Unclassified|13|||
46726899|NCT01079234|82942782|FG002|Main: Week 0 to 26|Unclassified|4|||
46726900|NCT01079234|82942783|FG003|Main: Week 0 to 26|Unclassified|0|||
46726901|NCT01079234|82942780|FG000|Extension: Week 27 to 52|Adverse Event|0|||
46726902|NCT01079234|82942781|FG001|Extension: Week 27 to 52|Adverse Event|0|||
46726903|NCT01079234|82942782|FG002|Extension: Week 27 to 52|Adverse Event|1|||
46726904|NCT01079234|82942783|FG003|Extension: Week 27 to 52|Adverse Event|0|||
46726905|NCT01079234|82942780|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
46726906|NCT01079234|82942781|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
46726907|NCT01079234|82942782|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
46726908|NCT01079234|82942783|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
46726909|NCT01079234|82942780|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
46726910|NCT01079234|82942781|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
46726911|NCT01079234|82942782|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
46726912|NCT01079234|82942783|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
46726913|NCT01079234|82942780|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
46726914|NCT01079234|82942781|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
46726915|NCT01079234|82942782|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
46726916|NCT01079234|82942783|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
46726917|NCT01079234|82942780|FG000|Extension: Week 27 to 52|Unclassified|0|||
46726918|NCT01079234|82942781|FG001|Extension: Week 27 to 52|Unclassified|0|||
46726919|NCT01079234|82942782|FG002|Extension: Week 27 to 52|Unclassified|4|||
46726920|NCT01079234|82942783|FG003|Extension: Week 27 to 52|Unclassified|7|||
46726921|NCT00931632|82942794|FG000|Overall Study|Withdrawal by Subject|2|||
46726922|NCT00931632|82942795|FG001|Overall Study|Withdrawal by Subject|3|||
46726923|NCT00931632|82942794|FG000|Overall Study|Adverse Event|19|||
46726924|NCT00931632|82942795|FG001|Overall Study|Adverse Event|15|||
46726925|NCT01078922|82942801|FG000|Overall Study|Adverse Event|1|||
46726926|NCT00863746|82942808|FG000|Treatment|Not treated|4|||
46726927|NCT00863746|82942809|FG001|Treatment|Not treated|2|||
46726928|NCT00863746|82942808|FG000|Treatment|Adverse Event|41|||
46726929|NCT00863746|82942809|FG001|Treatment|Adverse Event|16|||
46726930|NCT00863746|82942808|FG000|Treatment|non-compliant with study medication|4|||
46726931|NCT00863746|82942809|FG001|Treatment|non-compliant with study medication|0|||
46726932|NCT00863746|82942808|FG000|Treatment|Consent withdrawn|15|||
46726933|NCT00863746|82942809|FG001|Treatment|Consent withdrawn|14|||
46726934|NCT00863746|82942808|FG000|Treatment|Lost to Follow-up|1|||
46726935|NCT00863746|82942809|FG001|Treatment|Lost to Follow-up|0|||
46726936|NCT00863746|82942808|FG000|Treatment|Protocol Violation|5|||
46726937|NCT00863746|82942809|FG001|Treatment|Protocol Violation|3|||
46726938|NCT00863746|82942808|FG000|Treatment|Other|1|||
46726939|NCT00863746|82942809|FG001|Treatment|Other|0|||
46726940|NCT00863746|82942808|FG000|Survival Follow up|Death|244|||
46726941|NCT00863746|82942809|FG001|Survival Follow up|Death|271|||
46726942|NCT00863746|82942808|FG000|Survival Follow up|Lost to Follow-up|2|||
46726943|NCT00863746|82942809|FG001|Survival Follow up|Lost to Follow-up|1|||
46726944|NCT00863746|82942808|FG000|Survival Follow up|Consent Withdrawn|7|||
46726945|NCT00863746|82942809|FG001|Survival Follow up|Consent Withdrawn|8|||
46726946|NCT00926328|82942817|FG000|Overall Study|Lost to Follow-up|12|||
46726947|NCT00926328|82942818|FG001|Overall Study|Lost to Follow-up|14|||
46726948|NCT00863512|82942826|FG000|Overall Study|Adverse Event|2|||
46726949|NCT00863512|82942827|FG001|Overall Study|Adverse Event|0|||
46726950|NCT00863512|82942826|FG000|Overall Study|Withdrawal by Subject|11|||
46726951|NCT00863512|82942827|FG001|Overall Study|Withdrawal by Subject|0|||
46726952|NCT00863512|82942826|FG000|Overall Study|Physician Decision|1|||
46726953|NCT00863512|82942827|FG001|Overall Study|Physician Decision|0|||
46726954|NCT00868192|82942833|FG000|Overall Study|Ineligible|4|||
46726955|NCT00930930|82942839|FG000|Overall Study|Death|1|||
46726956|NCT00930930|82942840|FG001|Overall Study|Death|0|||
46726957|NCT00930930|82942839|FG000|Overall Study|Physician Decision|1|||
46726958|NCT00930930|82942840|FG001|Overall Study|Physician Decision|0|||
46726959|NCT00930930|82942839|FG000|Overall Study|Adverse Event|13|||
46726960|NCT00930930|82942840|FG001|Overall Study|Adverse Event|3|||
46726961|NCT00930930|82942839|FG000|Overall Study|Withdrawal by Subject|3|||
46726962|NCT00930930|82942840|FG001|Overall Study|Withdrawal by Subject|1|||
46726963|NCT00930930|82942839|FG000|Overall Study|Disease progression|2|||
46726964|NCT00930930|82942840|FG001|Overall Study|Disease progression|3|||
46726965|NCT00930930|82942839|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
46726966|NCT00930930|82942840|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
46726967|NCT00930930|82942839|FG000|Overall Study|patients not compliant|1|||
46726968|NCT00930930|82942840|FG001|Overall Study|patients not compliant|1|||
46726969|NCT00862654|82942850|FG000|Overall Study|Lack of Efficacy|1|||
46726970|NCT00862654|82942851|FG001|Overall Study|Lack of Efficacy|0|||
46726971|NCT00862654|82942852|FG002|Overall Study|Lack of Efficacy|1|||
46726972|NCT00862654|82942853|FG003|Overall Study|Lack of Efficacy|0|||
46726973|NCT00862654|82942850|FG000|Overall Study|Lost to Follow-up|1|||
46726974|NCT00862654|82942851|FG001|Overall Study|Lost to Follow-up|2|||
46726975|NCT00862654|82942852|FG002|Overall Study|Lost to Follow-up|1|||
46726976|NCT00862654|82942853|FG003|Overall Study|Lost to Follow-up|3|||
46726977|NCT00862654|82942850|FG000|Overall Study|Adverse Event|0|||
46726978|NCT00862654|82942851|FG001|Overall Study|Adverse Event|1|||
46726979|NCT00862654|82942852|FG002|Overall Study|Adverse Event|1|||
46726980|NCT00862654|82942853|FG003|Overall Study|Adverse Event|0|||
46726981|NCT00862654|82942850|FG000|Overall Study|Pregnancy|1|||
46726982|NCT00862654|82942851|FG001|Overall Study|Pregnancy|1|||
46726983|NCT00862654|82942852|FG002|Overall Study|Pregnancy|0|||
46726984|NCT00862654|82942853|FG003|Overall Study|Pregnancy|0|||
46726985|NCT00862654|82942850|FG000|Overall Study|Withdrawal by Subject|2|||
46726986|NCT00862654|82942851|FG001|Overall Study|Withdrawal by Subject|2|||
46726987|NCT00862654|82942852|FG002|Overall Study|Withdrawal by Subject|2|||
46726988|NCT00862654|82942853|FG003|Overall Study|Withdrawal by Subject|3|||
46726989|NCT00862654|82942850|FG000|Overall Study|Subject mistake|0|||
46726990|NCT00862654|82942851|FG001|Overall Study|Subject mistake|1|||
46726991|NCT00862654|82942852|FG002|Overall Study|Subject mistake|0|||
46726992|NCT00862654|82942853|FG003|Overall Study|Subject mistake|0|||
46726993|NCT00862654|82942850|FG000|Overall Study|Familly constraint|0|||
46726994|NCT00862654|82942851|FG001|Overall Study|Familly constraint|1|||
46726995|NCT00862654|82942852|FG002|Overall Study|Familly constraint|0|||
46726996|NCT00862654|82942853|FG003|Overall Study|Familly constraint|0|||
46726997|NCT00862654|82942850|FG000|Overall Study|Never used study drugs|1|||
46726998|NCT00862654|82942851|FG001|Overall Study|Never used study drugs|0|||
46726999|NCT00862654|82942852|FG002|Overall Study|Never used study drugs|0|||
46727000|NCT00862654|82942853|FG003|Overall Study|Never used study drugs|0|||
46727001|NCT00862654|82942850|FG000|Overall Study|Included after end of inclusions|0|||
46727002|NCT00862654|82942851|FG001|Overall Study|Included after end of inclusions|0|||
46727003|NCT00862654|82942852|FG002|Overall Study|Included after end of inclusions|1|||
46727004|NCT00862654|82942853|FG003|Overall Study|Included after end of inclusions|0|||
46727005|NCT00867490|82942863|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
46727006|NCT00867490|82942863|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
46727007|NCT00867490|82942863|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
46634721|NCT01713582|82808206|FG010|Overall Study|Disease progression|10|||
46634722|NCT01713582|82808207|FG011|Overall Study|Disease progression|5|||
46634723|NCT01713582|82808208|FG012|Overall Study|Disease progression|3|||
46634724|NCT01713582|82808209|FG013|Overall Study|Disease progression|3|||
46634725|NCT01713582|82808210|FG014|Overall Study|Disease progression|6|||
46634726|NCT01713582|82808211|FG015|Overall Study|Disease progression|6|||
46634727|NCT01713582|82808212|FG016|Overall Study|Disease progression|5|||
46634728|NCT01713582|82808213|FG017|Overall Study|Disease progression|2|||
46634729|NCT01713582|82808214|FG018|Overall Study|Disease progression|3|||
46634730|NCT01713582|82808215|FG019|Overall Study|Disease progression|5|||
46634731|NCT01713582|82808216|FG020|Overall Study|Disease progression|15|||
46727008|NCT00867490|82942863|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
46727009|NCT00867490|82942863|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
46727010|NCT00930774|82942874|FG000|Overall Study|Withdrawal by Subject|1|||
46727011|NCT00930774|82942875|FG001|Overall Study|Withdrawal by Subject|9|||
46727012|NCT00930774|82942876|FG002|Overall Study|Withdrawal by Subject|2|||
46803750|NCT00078325|83023056|FG000|Overall Study|Protocol Violation|2|||
46727013|NCT00930774|82942877|FG003|Overall Study|Withdrawal by Subject|0|||
46727014|NCT00867334|82942890|FG000|Overall Study|Withdrawal by Subject|0|||
46727015|NCT00867334|82942891|FG001|Overall Study|Withdrawal by Subject|1|||
46727016|NCT00867334|82942890|FG000|Overall Study|Withdrawal by Subject|1|||
46727017|NCT00867334|82942891|FG001|Overall Study|Withdrawal by Subject|0|||
46727018|NCT00867334|82942890|FG000|Overall Study|Withdrawal by Subject|1|||
46727019|NCT00867334|82942891|FG001|Overall Study|Withdrawal by Subject|0|||
46727020|NCT00925704|82942903|FG000|First Intervention|Withdrew consent|0|||
46727021|NCT00925704|82942904|FG001|First Intervention|Withdrew consent|0|||
46727022|NCT00925704|82942905|FG002|First Intervention|Withdrew consent|0|||
46727023|NCT00925704|82942906|FG003|First Intervention|Withdrew consent|1|||
46727024|NCT00925704|82942907|FG004|First Intervention|Withdrew consent|1|||
46727025|NCT00925704|82942908|FG005|First Intervention|Withdrew consent|0|||
46727026|NCT00925704|82942903|FG000|Second Intervention|Withdrawal by Subject|1|||
46727027|NCT00925704|82942904|FG001|Second Intervention|Withdrawal by Subject|0|||
46727028|NCT00925704|82942905|FG002|Second Intervention|Withdrawal by Subject|0|||
46727029|NCT00925704|82942906|FG003|Second Intervention|Withdrawal by Subject|0|||
46727030|NCT00925704|82942907|FG004|Second Intervention|Withdrawal by Subject|1|||
46727031|NCT00925704|82942908|FG005|Second Intervention|Withdrawal by Subject|0|||
46727032|NCT00925704|82942903|FG000|Third Intervention|Withdrew consent|0|||
46727033|NCT00925704|82942904|FG001|Third Intervention|Withdrew consent|0|||
46727034|NCT00925704|82942905|FG002|Third Intervention|Withdrew consent|0|||
46727035|NCT00925704|82942906|FG003|Third Intervention|Withdrew consent|0|||
46727036|NCT00925704|82942907|FG004|Third Intervention|Withdrew consent|0|||
46727037|NCT00925704|82942908|FG005|Third Intervention|Withdrew consent|1|||
46727038|NCT01076192|82942919|FG000|Overall Study|Other|197|||
46727039|NCT01076036|82942924|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
46727040|NCT01075958|82942928|FG000|Overall Study|Blood sample could not be obtained|44|||
46727041|NCT01096316|82942934|FG000|Overall Study|Lost to Follow-up|15|||
46727042|NCT01096316|82942935|FG001|Overall Study|Lost to Follow-up|9|||
46727043|NCT00925548|82942943|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
46727044|NCT00925548|82942944|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
46727045|NCT00866788|82942955|FG000|Overall Study|Adverse Event|0|||
46727046|NCT00866788|82942956|FG001|Overall Study|Adverse Event|2|||
46727047|NCT00866788|82942957|FG002|Overall Study|Adverse Event|0|||
46727048|NCT00866788|82942958|FG003|Overall Study|Adverse Event|1|||
46727049|NCT00866788|82942955|FG000|Overall Study|Lost to Follow-up|1|||
46727050|NCT00866788|82942956|FG001|Overall Study|Lost to Follow-up|1|||
46727051|NCT00866788|82942957|FG002|Overall Study|Lost to Follow-up|0|||
46727052|NCT00866788|82942958|FG003|Overall Study|Lost to Follow-up|2|||
46727053|NCT00866788|82942955|FG000|Overall Study|Withdrawal by Subject|2|||
46727054|NCT00866788|82942956|FG001|Overall Study|Withdrawal by Subject|1|||
46727055|NCT00866788|82942957|FG002|Overall Study|Withdrawal by Subject|0|||
46727056|NCT00866788|82942958|FG003|Overall Study|Withdrawal by Subject|1|||
46727057|NCT00866788|82942955|FG000|Overall Study|Pregnancy|0|||
46727058|NCT00866788|82942956|FG001|Overall Study|Pregnancy|1|||
46727059|NCT00866788|82942957|FG002|Overall Study|Pregnancy|0|||
46727060|NCT00866788|82942958|FG003|Overall Study|Pregnancy|0|||
46727061|NCT00866788|82942955|FG000|Overall Study|Disease progression|3|||
46727062|NCT00866788|82942956|FG001|Overall Study|Disease progression|1|||
46727063|NCT00866788|82942957|FG002|Overall Study|Disease progression|1|||
46727064|NCT00866788|82942958|FG003|Overall Study|Disease progression|0|||
46727065|NCT00866788|82942955|FG000|Overall Study|Physician Decision|0|||
46727066|NCT00866788|82942956|FG001|Overall Study|Physician Decision|0|||
46727067|NCT00866788|82942957|FG002|Overall Study|Physician Decision|1|||
46727068|NCT00866788|82942958|FG003|Overall Study|Physician Decision|1|||
46727069|NCT00860470|82942973|FG000|Overall Study|Death|6|||
46921218|NCT02419417|83153599|FG003|Overall Study|Withdrawal by Subject|0|||
46921219|NCT02419417|83153600|FG004|Overall Study|Withdrawal by Subject|0|||
46921220|NCT02419417|83153601|FG005|Overall Study|Withdrawal by Subject|0|||
46921221|NCT02419417|83153602|FG006|Overall Study|Withdrawal by Subject|0|||
46803751|NCT00078325|83023057|FG001|Overall Study|Protocol Violation|2|||
46803752|NCT00078325|83023058|FG002|Overall Study|Protocol Violation|0|||
46803753|NCT00078325|83023056|FG000|Overall Study|Withdrawal by Subject|1|||
46803754|NCT00078325|83023057|FG001|Overall Study|Withdrawal by Subject|5|||
46803755|NCT00078325|83023058|FG002|Overall Study|Withdrawal by Subject|3|||
46803756|NCT00078325|83023056|FG000|Overall Study|Lost to Follow-up|0|||
46727070|NCT00860470|82942974|FG001|Overall Study|Death|10|||
46921222|NCT02419417|83153603|FG007|Overall Study|Withdrawal by Subject|0|||
46727071|NCT00860470|82942973|FG000|Overall Study|Moved away|8|||
46727072|NCT00860470|82942974|FG001|Overall Study|Moved away|10|||
46727073|NCT00860470|82942973|FG000|Overall Study|Lost to Follow-up|34|||
46727074|NCT00860470|82942974|FG001|Overall Study|Lost to Follow-up|39|||
46727075|NCT00923364|82942980|FG000|Overall Study|Death|3|||
46727076|NCT00923364|82942981|FG001|Overall Study|Death|0|||
46727077|NCT00923364|82942980|FG000|Overall Study|Did not go to transplant|1|||
46803757|NCT00078325|83023057|FG001|Overall Study|Lost to Follow-up|1|||
46921223|NCT02419417|83153604|FG008|Overall Study|Withdrawal by Subject|0|||
46727078|NCT00923364|82942981|FG001|Overall Study|Did not go to transplant|0|||
46727079|NCT01096160|82942996|FG000|Overall Study|Adverse Event|0|||
46727080|NCT01096160|82942997|FG001|Overall Study|Adverse Event|0|||
46727081|NCT01096160|82942998|FG002|Overall Study|Adverse Event|1|||
46727082|NCT01096160|82942999|FG003|Overall Study|Adverse Event|0|||
46727083|NCT01096160|82943000|FG004|Overall Study|Adverse Event|0|||
46727084|NCT01096160|82943001|FG005|Overall Study|Adverse Event|0|||
46727085|NCT01096160|82943002|FG006|Overall Study|Adverse Event|0|||
46727086|NCT01096160|82943003|FG007|Overall Study|Adverse Event|0|||
46727087|NCT01096160|82943004|FG008|Overall Study|Adverse Event|0|||
46727088|NCT01096160|82943005|FG009|Overall Study|Adverse Event|1|||
46727089|NCT01096160|82942996|FG000|Overall Study|Met stopping criteria per protocol|0|||
46727090|NCT01096160|82942997|FG001|Overall Study|Met stopping criteria per protocol|0|||
46727091|NCT01096160|82942998|FG002|Overall Study|Met stopping criteria per protocol|0|||
46727092|NCT01096160|82942999|FG003|Overall Study|Met stopping criteria per protocol|0|||
46727093|NCT01096160|82943000|FG004|Overall Study|Met stopping criteria per protocol|1|||
46727094|NCT01096160|82943001|FG005|Overall Study|Met stopping criteria per protocol|0|||
46727095|NCT01096160|82943002|FG006|Overall Study|Met stopping criteria per protocol|2|||
46727096|NCT01096160|82943003|FG007|Overall Study|Met stopping criteria per protocol|0|||
46727097|NCT01096160|82943004|FG008|Overall Study|Met stopping criteria per protocol|2|||
46727098|NCT01096160|82943005|FG009|Overall Study|Met stopping criteria per protocol|0|||
46727099|NCT00860158|82943040|FG000|Overall Study|Study Terminated|1|||
46727100|NCT00929526|82943046|FG000|Overall Study|Withdrawal by Subject|1|||
46727101|NCT00929526|82943047|FG001|Overall Study|Withdrawal by Subject|11|||
46727102|NCT00929526|82943046|FG000|Overall Study|Lost to Follow-up|8|||
46727103|NCT00929526|82943047|FG001|Overall Study|Lost to Follow-up|12|||
46727104|NCT00929526|82943046|FG000|Overall Study|Other|8|||
46727105|NCT00929526|82943047|FG001|Overall Study|Other|6|||
46727106|NCT00859456|82943053|FG000|Overall Study|Adverse Event|3|||
46727107|NCT00859456|82943053|FG000|Overall Study|Progressive disease|2|||
46727108|NCT00859456|82943053|FG000|Overall Study|Non-compliance|3|||
46727109|NCT01075646|82943061|FG000|Overall Study|Lost to Follow-up|4|||
46727110|NCT01075646|82943062|FG001|Overall Study|Lost to Follow-up|3|||
46727111|NCT01075646|82943063|FG002|Overall Study|Lost to Follow-up|1|||
46727112|NCT01075646|82943064|FG003|Overall Study|Lost to Follow-up|2|||
46727113|NCT01075412|82943076|FG000|Overall Study|Withdrawal by Subject|0|||
46727114|NCT01075412|82943077|FG001|Overall Study|Withdrawal by Subject|1|||
46727115|NCT00799903|82943084|FG000|Overall Study|Investigator Site Closed|25|||
46727116|NCT00799903|82943085|FG001|Overall Study|Investigator Site Closed|23|||
46727117|NCT00799903|82943084|FG000|Overall Study|Withdrawal by Subject|179|||
46727118|NCT00799903|82943085|FG001|Overall Study|Withdrawal by Subject|175|||
46727119|NCT00799903|82943084|FG000|Overall Study|Lost to Follow-up|69|||
46727120|NCT00799903|82943085|FG001|Overall Study|Lost to Follow-up|80|||
46727121|NCT01075256|82943094|FG000|Overall Study|Withdrawal by Subject|1|||
46727122|NCT01075256|82943095|FG001|Overall Study|Withdrawal by Subject|0|||
46803758|NCT00078325|83023058|FG002|Overall Study|Lost to Follow-up|1|||
46803759|NCT00078325|83023056|FG000|Overall Study|Physician Decision|2|||
46803760|NCT00078325|83023057|FG001|Overall Study|Physician Decision|0|||
46803761|NCT00078325|83023058|FG002|Overall Study|Physician Decision|1|||
46803762|NCT00078325|83023056|FG000|Overall Study|Miscellaneous|1|||
46803763|NCT00078325|83023057|FG001|Overall Study|Miscellaneous|1|||
46803764|NCT00078325|83023058|FG002|Overall Study|Miscellaneous|1|||
46803765|NCT00077857|83023068|FG000|Overall Study|Adverse Event|30|||
46803766|NCT00077857|83023069|FG001|Overall Study|Adverse Event|32|||
46803767|NCT00077857|83023068|FG000|Overall Study|Death|7|||
46803768|NCT00077857|83023069|FG001|Overall Study|Death|3|||
46803769|NCT00077857|83023068|FG000|Overall Study|Insufficient therapeutic response|112|||
46803770|NCT00077857|83023069|FG001|Overall Study|Insufficient therapeutic response|128|||
46803771|NCT00077857|83023068|FG000|Overall Study|Violation of selection criteria at entry|3|||
47047143|NCT01963403|83306551|FG000|Overall Study|Lost to Follow-up|2|||
47047144|NCT01963403|83306552|FG001|Overall Study|Lost to Follow-up|3|||
46727123|NCT01075256|82943096|FG002|Overall Study|Withdrawal by Subject|0|||
46803772|NCT00077857|83023069|FG001|Overall Study|Violation of selection criteria at entry|1|||
47047145|NCT01963403|83306551|FG000|Overall Study|Implant removal|0|||
46727124|NCT00923130|82943109|FG000|Overall Study|Stopped treatment due to progression|17|||
46727125|NCT00923130|82943109|FG000|Overall Study|Death|1|||
46803773|NCT00077857|83023068|FG000|Overall Study|Other protocol violation|0|||
46803774|NCT00077857|83023069|FG001|Overall Study|Other protocol violation|1|||
47047146|NCT01963403|83306552|FG001|Overall Study|Implant removal|1|||
47047147|NCT01973387|83306562|FG000|Overall Study|Adverse Event|14|||
47047148|NCT01973387|83306563|FG001|Overall Study|Adverse Event|4|||
47047149|NCT01973387|83306562|FG000|Overall Study|Withdrawal by Subject|7|||
47047150|NCT01973387|83306563|FG001|Overall Study|Withdrawal by Subject|4|||
47047151|NCT01973387|83306562|FG000|Overall Study|Study terminated by sponsor|63|||
47047152|NCT01973387|83306563|FG001|Overall Study|Study terminated by sponsor|0|||
47047153|NCT01973387|83306562|FG000|Overall Study|Progressive disease or relapse|16|||
46727126|NCT00923130|82943109|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
46727127|NCT00923130|82943109|FG000|Overall Study|Switched to alternative treatment|2|||
46727128|NCT00923130|82943109|FG000|Overall Study|Refused further treatment|2|||
46727129|NCT03253627|82943115|FG000|Overall Study|Lost to Follow-up|1|||
46727130|NCT03253627|82943116|FG001|Overall Study|Lost to Follow-up|2|||
46727131|NCT03253627|82943115|FG000|Overall Study|Withdrawal by Subject|0|||
46727132|NCT03253627|82943116|FG001|Overall Study|Withdrawal by Subject|2|||
46727133|NCT03253627|82943115|FG000|Overall Study|Inability to complete MRI|1|||
46727134|NCT03253627|82943116|FG001|Overall Study|Inability to complete MRI|0|||
46727135|NCT01075178|82943124|FG000|Subject Matching|eligible but not matched|130|||
46727136|NCT01075178|82943125|FG001|Subject Matching|eligible but not matched|403|||
46727137|NCT01075178|82943124|FG000|Subject Chart Review|died before chart review period|0|||
46727138|NCT01075178|82943125|FG001|Subject Chart Review|died before chart review period|2|||
46727139|NCT01075178|82943124|FG000|Subject Chart Review|no data collected due to site closure|3|||
47047154|NCT01973387|83306563|FG001|Overall Study|Progressive disease or relapse|5|||
47047155|NCT01973387|83306562|FG000|Overall Study|Death|4|||
47047156|NCT01973387|83306563|FG001|Overall Study|Death|3|||
47047157|NCT01973387|83306562|FG000|Overall Study|Randomized, not treated|2|||
47047158|NCT01973387|83306563|FG001|Overall Study|Randomized, not treated|2|||
47047159|NCT01973231|83306571|FG000|Overall Study|Protocol Violation|1|||
46727140|NCT01075178|82943125|FG001|Subject Chart Review|no data collected due to site closure|4|||
46727141|NCT01075178|82943124|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
46727142|NCT01075178|82943125|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
46727143|NCT00799825|82943131|FG000|Overall Study|Adverse Event|1|||
46727144|NCT00799825|82943131|FG000|Overall Study|Withdrawal by Subject|6|||
46727145|NCT00799825|82943131|FG000|Overall Study|Lost to Follow-up|38|||
46727146|NCT00799825|82943131|FG000|Overall Study|Pregnancy|3|||
46727147|NCT00799591|82943135|FG000|Overall Study|De-escalation of doses|20|||
46727148|NCT00799591|82943135|FG000|Overall Study|Death|14|||
46727149|NCT00799591|82943135|FG000|Overall Study|Technical failure|12|||
46727150|NCT00799591|82943135|FG000|Overall Study|Resistant germ|11|||
46727151|NCT00799591|82943135|FG000|Overall Study|New infection|4|||
46727152|NCT00799591|82943135|FG000|Overall Study|Resistance germ and technical failure|2|||
46727153|NCT00799591|82943135|FG000|Overall Study|Persistance of fever undetermined origin|1|||
46727154|NCT00799591|82943135|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
46727155|NCT00799591|82943135|FG000|Overall Study|Infectious origin not probable|1|||
46727156|NCT01075100|82943141|FG000|Overall Study|Adverse Event|15|||
46727157|NCT01075100|82943142|FG001|Overall Study|Adverse Event|18|||
46727158|NCT01075100|82943141|FG000|Overall Study|Patient Request|4|||
46727159|NCT01075100|82943142|FG001|Overall Study|Patient Request|4|||
46727160|NCT01075100|82943141|FG000|Overall Study|Investigator Request|2|||
46727161|NCT01075100|82943142|FG001|Overall Study|Investigator Request|1|||
46727162|NCT01075100|82943141|FG000|Overall Study|Disease Progression|25|||
46727163|NCT01075100|82943142|FG001|Overall Study|Disease Progression|29|||
46727164|NCT01075100|82943141|FG000|Overall Study|Other|3|||
46727165|NCT01075100|82943142|FG001|Overall Study|Other|1|||
46727166|NCT00803023|82943154|FG000|Overall Study|Adverse Event|5|||
46727167|NCT00803023|82943155|FG001|Overall Study|Adverse Event|4|||
46727168|NCT00803023|82943156|FG002|Overall Study|Adverse Event|8|||
46727169|NCT00803023|82943157|FG003|Overall Study|Adverse Event|6|||
46727170|NCT00803023|82943154|FG000|Overall Study|Withdrawal by Subject|0|||
46727171|NCT00803023|82943155|FG001|Overall Study|Withdrawal by Subject|2|||
46727172|NCT00803023|82943156|FG002|Overall Study|Withdrawal by Subject|0|||
47047160|NCT01973231|83306572|FG001|Overall Study|Protocol Violation|1|||
47047161|NCT01973231|83306571|FG000|Overall Study|Lost to Follow-up|1|||
47047162|NCT01973231|83306572|FG001|Overall Study|Lost to Follow-up|1|||
47047163|NCT01973231|83306571|FG000|Overall Study|unclassified|2|||
47047164|NCT01973231|83306572|FG001|Overall Study|unclassified|1|||
46727173|NCT00803023|82943157|FG003|Overall Study|Withdrawal by Subject|0|||
46727174|NCT00803023|82943154|FG000|Overall Study|Lost to Follow-up|0|||
46727175|NCT00803023|82943155|FG001|Overall Study|Lost to Follow-up|1|||
47047165|NCT01973231|83306571|FG000|Overall Study|Withdrawal by Subject|7|||
46727176|NCT00803023|82943156|FG002|Overall Study|Lost to Follow-up|2|||
46727177|NCT00803023|82943157|FG003|Overall Study|Lost to Follow-up|1|||
46727178|NCT00803023|82943154|FG000|Overall Study|Lack of Efficacy|0|||
46727179|NCT00803023|82943155|FG001|Overall Study|Lack of Efficacy|1|||
46727180|NCT00803023|82943156|FG002|Overall Study|Lack of Efficacy|1|||
46727181|NCT00803023|82943157|FG003|Overall Study|Lack of Efficacy|1|||
46727182|NCT00859222|82943170|FG000|Overall Study|Adverse Event|2|||
46727183|NCT00859222|82943171|FG001|Overall Study|Adverse Event|3|||
46727184|NCT00859222|82943172|FG002|Overall Study|Adverse Event|6|||
46727185|NCT00859222|82943173|FG003|Overall Study|Adverse Event|24|||
46727186|NCT00859222|82943174|FG004|Overall Study|Adverse Event|15|||
46727187|NCT00859222|82943170|FG000|Overall Study|DLT|1|||
46727188|NCT00859222|82943171|FG001|Overall Study|DLT|0|||
46727189|NCT00859222|82943172|FG002|Overall Study|DLT|0|||
46727190|NCT00859222|82943173|FG003|Overall Study|DLT|0|||
46727191|NCT00859222|82943174|FG004|Overall Study|DLT|0|||
46727192|NCT01072448|82943191|FG000|Overall Study|Adverse Event|9|||
46727193|NCT01072448|82943192|FG001|Overall Study|Adverse Event|10|||
46727194|NCT01072448|82943191|FG000|Overall Study|Subject withdrew consent|4|||
46727195|NCT01072448|82943192|FG001|Overall Study|Subject withdrew consent|9|||
46727196|NCT01072448|82943191|FG000|Overall Study|Protocol deviation|3|||
46727197|NCT01072448|82943192|FG001|Overall Study|Protocol deviation|4|||
46727198|NCT01072448|82943191|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46727199|NCT01072448|82943192|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46727200|NCT01072448|82943191|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46727201|NCT01072448|82943192|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
47047166|NCT01973231|83306572|FG001|Overall Study|Withdrawal by Subject|9|||
47047167|NCT01961687|83306578|FG000|Overall Study|Lost to Follow-up|19|||
47047168|NCT01961687|83306578|FG000|Overall Study|Re-operation|17|||
47047169|NCT01961687|83306578|FG000|Overall Study|Death|7|||
47047170|NCT01961687|83306578|FG000|Overall Study|Withdrawal by Subject|6|||
47047171|NCT01961687|83306578|FG000|Overall Study|Adverse Event|6|||
46727202|NCT01072448|82943191|FG000|Overall Study|Lost to Follow-up|1|||
46727203|NCT01072448|82943192|FG001|Overall Study|Lost to Follow-up|1|||
46727204|NCT01072448|82943191|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46727205|NCT01072448|82943192|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46727206|NCT01072448|82943191|FG000|Overall Study|Death|0|||
46727207|NCT01072448|82943192|FG001|Overall Study|Death|2|||
46727208|NCT00922974|82943201|FG000|Phase II Component|Protocol Violation|2|||
46727209|NCT00922974|82943202|FG001|Phase II Component|Protocol Violation|0|||
46727210|NCT00922974|82943201|FG000|Phase II Component|Not evaluable for treatment review|5|||
46727211|NCT00922974|82943202|FG001|Phase II Component|Not evaluable for treatment review|0|||
46727212|NCT00922974|82943201|FG000|Phase III Component|Protocol Violation|8|||
46727213|NCT00922974|82943202|FG001|Phase III Component|Protocol Violation|6|||
46727214|NCT00858988|82943212|FG000|Analysis|Lactulose unable to be detected in urine|2|||
46727215|NCT00858988|82943213|FG001|Analysis|Lactulose unable to be detected in urine|1|||
46727216|NCT00858832|82943221|FG000|Overall Study|became ineligible: delivered vaginally|1|||
46727217|NCT00858832|82943222|FG001|Overall Study|became ineligible: delivered vaginally|0|||
46727218|NCT00858832|82943221|FG000|Overall Study|Adverse Event|0|||
46727219|NCT00858832|82943222|FG001|Overall Study|Adverse Event|1|||
46727220|NCT01071512|82943228|FG000|Overall Study|Adverse Event|1|||
46727221|NCT01071512|82943228|FG000|Overall Study|Development of antibodies to drug|2|||
46727222|NCT01071512|82943228|FG000|Overall Study|positive anti-JC virus antibody test|2|||
46727223|NCT00858442|82943234|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
46727224|NCT00858442|82943235|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
46727225|NCT01071278|82943242|FG000|Overall Study|Premature Discontinuation|254|||
46727226|NCT01071278|82943242|FG000|Overall Study|Completion Status Unknown|459|||
46727227|NCT00858208|82943248|FG000|Overall Study|Adverse Event|3|||
46727228|NCT00858208|82943248|FG000|Overall Study|Lost to Follow-up|26|||
46727229|NCT00858208|82943248|FG000|Overall Study|Participant refused|40|||
46727230|NCT00858208|82943248|FG000|Overall Study|Other|10|||
47047172|NCT01961687|83306578|FG000|Overall Study|Moved to area without study site|2|||
46727231|NCT01071200|82943254|FG000|Overall Study|Lack of ovarian response|1|||
46727232|NCT01071200|82943255|FG001|Overall Study|Lack of ovarian response|1|||
46727233|NCT01071200|82943254|FG000|Overall Study|No fertilization|4|||
46727234|NCT01071200|82943255|FG001|Overall Study|No fertilization|0|||
46727235|NCT01071200|82943254|FG000|Overall Study|No oocytes retrieved|1|||
46727236|NCT01071200|82943255|FG001|Overall Study|No oocytes retrieved|1|||
47047173|NCT01961687|83306578|FG000|Overall Study|Sponsor decision|2|||
46727237|NCT01071200|82943254|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
46803775|NCT00077857|83023068|FG000|Overall Study|Refused treatment|29|||
46727238|NCT01071200|82943255|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
46727239|NCT01071200|82943254|FG000|Overall Study|No viable embryos|0|||
46727240|NCT01071200|82943255|FG001|Overall Study|No viable embryos|1|||
46727241|NCT02207569|82943261|FG000|1-Month|Death|6|||
46727242|NCT02207569|82943261|FG000|1-Month|Withdrawal by Subject|2|||
46727243|NCT02207569|82943261|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
46727244|NCT02207569|82943261|FG000|6-Month|Death|8|||
46727245|NCT02207569|82943261|FG000|6-Month|Withdrawal by Subject|2|||
46803776|NCT00077857|83023069|FG001|Overall Study|Refused treatment|21|||
46803777|NCT00077857|83023068|FG000|Overall Study|Failure to return|5|||
47047174|NCT01961687|83306578|FG000|Overall Study|Physician Decision|1|||
47047175|NCT01961687|83306578|FG000|Overall Study|Unable to meet follow-up requirements|1|||
47047176|NCT01961609|83306640|FG000|Initiation|Missing|3|||
47047177|NCT01961609|83306641|FG001|Initiation|Missing|2|||
47047178|NCT01961609|83306642|FG002|Initiation|Missing|0|||
47047179|NCT01961609|83306643|FG003|Initiation|Missing|0|||
47047180|NCT01961609|83306640|FG000|Initiation|Protocol deviation|1|||
47047181|NCT01961609|83306641|FG001|Initiation|Protocol deviation|0|||
47047182|NCT01961609|83306642|FG002|Initiation|Protocol deviation|0|||
47047183|NCT01961609|83306643|FG003|Initiation|Protocol deviation|0|||
47047184|NCT01961609|83306640|FG000|Initiation|Death|0|||
47047185|NCT01961609|83306641|FG001|Initiation|Death|1|||
47047186|NCT01961609|83306642|FG002|Initiation|Death|0|||
47047187|NCT01961609|83306643|FG003|Initiation|Death|0|||
47047188|NCT01961609|83306640|FG000|Initiation|Administrative problems|1|||
47047189|NCT01961609|83306641|FG001|Initiation|Administrative problems|0|||
47047190|NCT01961609|83306642|FG002|Initiation|Administrative problems|0|||
47047191|NCT01961609|83306643|FG003|Initiation|Administrative problems|0|||
47047192|NCT01961609|83306640|FG000|Initiation|Withdrawal by Subject|1|||
47047193|NCT01961609|83306641|FG001|Initiation|Withdrawal by Subject|2|||
47047194|NCT01961609|83306642|FG002|Initiation|Withdrawal by Subject|0|||
47047195|NCT01961609|83306643|FG003|Initiation|Withdrawal by Subject|0|||
47047196|NCT01961609|83306640|FG000|Initiation|Lack of Efficacy|2|||
47047197|NCT01961609|83306641|FG001|Initiation|Lack of Efficacy|1|||
47047198|NCT01961609|83306642|FG002|Initiation|Lack of Efficacy|0|||
47047199|NCT01961609|83306643|FG003|Initiation|Lack of Efficacy|0|||
47047200|NCT01961609|83306640|FG000|Initiation|Abnormal lab values|0|||
47047201|NCT01961609|83306641|FG001|Initiation|Abnormal lab values|1|||
47047202|NCT01961609|83306642|FG002|Initiation|Abnormal lab values|0|||
47047203|NCT01961609|83306643|FG003|Initiation|Abnormal lab values|0|||
47047204|NCT01961609|83306640|FG000|Initiation|Adverse Event|3|||
47047205|NCT01961609|83306641|FG001|Initiation|Adverse Event|5|||
47047206|NCT01961609|83306642|FG002|Initiation|Adverse Event|0|||
47047207|NCT01961609|83306643|FG003|Initiation|Adverse Event|0|||
47047208|NCT01961609|83306640|FG000|Initiation|Randomized but not treated|1|||
47047209|NCT01961609|83306641|FG001|Initiation|Randomized but not treated|1|||
47047210|NCT01961609|83306642|FG002|Initiation|Randomized but not treated|0|||
47047211|NCT01961609|83306643|FG003|Initiation|Randomized but not treated|0|||
47047212|NCT01961609|83306640|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
47047213|NCT01961609|83306641|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
47047214|NCT01961609|83306642|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
47047215|NCT01961609|83306643|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
47047216|NCT01961609|83306640|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
47047217|NCT01961609|83306641|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
47047218|NCT01961609|83306642|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
47047219|NCT01961609|83306643|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
47047220|NCT01961609|83306640|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
47047221|NCT01961609|83306641|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
47047222|NCT01961609|83306642|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
47047223|NCT01961609|83306643|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
46634732|NCT01713582|82808196|FG000|Overall Study|Death|0|||
46634733|NCT01713582|82808197|FG001|Overall Study|Death|0|||
46634734|NCT01713582|82808198|FG002|Overall Study|Death|0|||
46634735|NCT01713582|82808199|FG003|Overall Study|Death|1|||
46634736|NCT01713582|82808200|FG004|Overall Study|Death|1|||
46634737|NCT01713582|82808201|FG005|Overall Study|Death|3|||
46634738|NCT01713582|82808202|FG006|Overall Study|Death|3|||
46634739|NCT01713582|82808203|FG007|Overall Study|Death|2|||
46634740|NCT01713582|82808204|FG008|Overall Study|Death|3|||
47047224|NCT01961609|83306640|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
47047225|NCT01961609|83306641|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
47047226|NCT01961609|83306642|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
47047227|NCT01961609|83306643|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
47047228|NCT01961609|83306640|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
47047229|NCT01961609|83306641|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
46634741|NCT01713582|82808205|FG009|Overall Study|Death|4|||
46634742|NCT01713582|82808206|FG010|Overall Study|Death|3|||
47047230|NCT01961609|83306642|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
47047231|NCT01961609|83306643|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
47047232|NCT01961609|83306640|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
47047233|NCT01961609|83306641|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
47047234|NCT01961609|83306642|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
47047235|NCT01961609|83306643|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
47047236|NCT01961609|83306640|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
47047237|NCT01961609|83306641|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
47047238|NCT01961609|83306642|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
47047239|NCT01961609|83306643|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
47047240|NCT01961609|83306640|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
47047241|NCT01961609|83306641|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
47047242|NCT01961609|83306642|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
47047243|NCT01961609|83306643|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
47047244|NCT01961609|83306640|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
47047245|NCT01961609|83306641|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
47047246|NCT01961609|83306642|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
46727246|NCT02207569|82943261|FG000|12-Month|Death|14|||
46727247|NCT02207569|82943261|FG000|12-Month|Withdrawal by Subject|2|||
46727248|NCT02207569|82943261|FG000|24-Month|Death|23|||
46727249|NCT02207569|82943261|FG000|24-Month|Withdrawal by Subject|3|||
46727250|NCT02207569|82943261|FG000|36-Month|Death|23|||
46727251|NCT02207569|82943261|FG000|36-Month|Withdrawal by Subject|4|||
46727252|NCT02207569|82943261|FG000|48-Month|Death|25|||
46727253|NCT02207569|82943261|FG000|48-Month|Withdrawal by Subject|2|||
46727254|NCT02207569|82943261|FG000|48-Month|Lost to Follow-up|4|||
46727255|NCT02207569|82943261|FG000|60-Month|Death|1|||
46727256|NCT02207569|82943261|FG000|60-Month|Lost to Follow-up|1|||
47047247|NCT01961609|83306643|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
47047248|NCT01961609|83306640|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
47047249|NCT01961609|83306641|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
46727257|NCT02207569|82943261|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
46727258|NCT02207569|82943261|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
47047250|NCT01961609|83306642|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
47047251|NCT01961609|83306643|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
46727259|NCT01070966|82943265|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
46727260|NCT01070966|82943265|FG000|Participants for Safety Evaluation|Off-label use|9|||
46727261|NCT01070966|82943265|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
46727262|NCT01070966|82943265|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
46727263|NCT01070966|82943265|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
46727264|NCT01070966|82943265|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
46727265|NCT01070966|82943265|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
46727266|NCT01070966|82943265|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
46727267|NCT01070888|82943278|FG000|First Intervention (14 Days)|Adverse Event|0|||
46727268|NCT01070888|82943279|FG001|First Intervention (14 Days)|Adverse Event|1|||
46727269|NCT01070888|82943278|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
46727270|NCT01070888|82943279|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
46727271|NCT01070888|82943278|FG000|Washout (14 Days)|Physician Decision|1|||
46727272|NCT01070888|82943279|FG001|Washout (14 Days)|Physician Decision|0|||
46727273|NCT00857896|82943285|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
46727274|NCT00857818|82943292|FG000|Overall Study|Lack of Efficacy|1|||
46727275|NCT00857818|82943293|FG001|Overall Study|Lack of Efficacy|0|||
46727276|NCT00857818|82943292|FG000|Overall Study|Adverse Event|3|||
46727277|NCT00857818|82943293|FG001|Overall Study|Adverse Event|0|||
46727278|NCT00857818|82943292|FG000|Overall Study|Withdrawal by Subject|0|||
46727279|NCT00857818|82943293|FG001|Overall Study|Withdrawal by Subject|4|||
46727280|NCT00857818|82943292|FG000|Overall Study|Sponsor terminated study|6|||
46727281|NCT00857818|82943293|FG001|Overall Study|Sponsor terminated study|4|||
46727282|NCT00857818|82943292|FG000|Overall Study|Investigator decision|1|||
46727283|NCT00857818|82943293|FG001|Overall Study|Investigator decision|0|||
46727284|NCT01074944|82943299|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
46727285|NCT01074944|82943300|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
46727286|NCT01074944|82943301|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
46727287|NCT01074944|82943302|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
46727288|NCT01074944|82943303|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
46727289|NCT01074944|82943299|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
46727290|NCT01074944|82943300|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
46727291|NCT01074944|82943301|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
46727292|NCT01074944|82943302|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
46727293|NCT01074944|82943303|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
46727294|NCT01074944|82943299|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
46727295|NCT01074944|82943300|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
46727296|NCT01074944|82943301|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
46921224|NCT02419417|83153605|FG009|Overall Study|Withdrawal by Subject|0|||
47047252|NCT01961609|83306640|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
47047253|NCT01961609|83306641|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
47047254|NCT01961609|83306642|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
47047255|NCT01961609|83306643|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
47047256|NCT01961609|83306640|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
47047257|NCT01961609|83306641|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
47047258|NCT01961609|83306642|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
46634743|NCT01713582|82808207|FG011|Overall Study|Death|0|||
46634744|NCT01713582|82808208|FG012|Overall Study|Death|0|||
46634745|NCT01713582|82808209|FG013|Overall Study|Death|0|||
46634746|NCT01713582|82808210|FG014|Overall Study|Death|0|||
46634747|NCT01713582|82808211|FG015|Overall Study|Death|0|||
46634748|NCT01713582|82808212|FG016|Overall Study|Death|0|||
46634749|NCT01713582|82808213|FG017|Overall Study|Death|0|||
46634750|NCT01713582|82808214|FG018|Overall Study|Death|0|||
46634751|NCT01713582|82808215|FG019|Overall Study|Death|0|||
46634752|NCT01713582|82808216|FG020|Overall Study|Death|0|||
46634753|NCT01713582|82808196|FG000|Overall Study|Adverse event-related|0|||
46634754|NCT01713582|82808197|FG001|Overall Study|Adverse event-related|0|||
46634755|NCT01713582|82808198|FG002|Overall Study|Adverse event-related|0|||
46634756|NCT01713582|82808199|FG003|Overall Study|Adverse event-related|0|||
46634757|NCT01713582|82808200|FG004|Overall Study|Adverse event-related|0|||
46634758|NCT01713582|82808201|FG005|Overall Study|Adverse event-related|0|||
46634759|NCT01713582|82808202|FG006|Overall Study|Adverse event-related|0|||
46634760|NCT01713582|82808203|FG007|Overall Study|Adverse event-related|0|||
46634761|NCT01713582|82808204|FG008|Overall Study|Adverse event-related|0|||
46727297|NCT01074944|82943302|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
46727298|NCT01074944|82943303|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
46727299|NCT01074944|82943299|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
46727300|NCT01074944|82943300|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
46727301|NCT01074944|82943301|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
46727302|NCT01074944|82943302|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
46727303|NCT01074944|82943303|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
46727304|NCT01074944|82943299|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
46727305|NCT01074944|82943300|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
46727306|NCT01074944|82943301|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
46727307|NCT01074944|82943302|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
46727308|NCT01074944|82943303|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
46727309|NCT01074944|82943299|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
46727310|NCT01074944|82943300|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
46727311|NCT01074944|82943301|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
46727312|NCT01074944|82943302|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
46727313|NCT01074944|82943303|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
46727314|NCT01074944|82943299|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
46727315|NCT01074944|82943300|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
46727316|NCT01074944|82943301|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
46727317|NCT01074944|82943302|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
46727318|NCT01074944|82943303|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
46727319|NCT01074944|82943299|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
46727320|NCT01074944|82943300|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
46727321|NCT01074944|82943301|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
46727322|NCT01074944|82943302|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
46727323|NCT01074944|82943303|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
46727324|NCT01074944|82943299|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
46727325|NCT01074944|82943300|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
46727326|NCT01074944|82943301|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
46727327|NCT01074944|82943302|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
46727328|NCT01074944|82943303|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
46727329|NCT01074944|82943299|FG000|Long Term Treatment|Adverse Event|0|||
46727330|NCT01074944|82943300|FG001|Long Term Treatment|Adverse Event|0|||
46727331|NCT01074944|82943301|FG002|Long Term Treatment|Adverse Event|0|||
46727332|NCT01074944|82943302|FG003|Long Term Treatment|Adverse Event|3|||
46727333|NCT01074944|82943303|FG004|Long Term Treatment|Adverse Event|0|||
46727334|NCT01074944|82943299|FG000|Long Term Treatment|Lost to Follow-up|0|||
46727335|NCT01074944|82943300|FG001|Long Term Treatment|Lost to Follow-up|0|||
46727336|NCT01074944|82943301|FG002|Long Term Treatment|Lost to Follow-up|0|||
46727337|NCT01074944|82943302|FG003|Long Term Treatment|Lost to Follow-up|2|||
46727338|NCT01074944|82943303|FG004|Long Term Treatment|Lost to Follow-up|0|||
46727339|NCT01074944|82943299|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
46727340|NCT01074944|82943300|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
46727341|NCT01074944|82943301|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
46727342|NCT01074944|82943302|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
46727343|NCT01074944|82943303|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
46727344|NCT01074944|82943299|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
46727345|NCT01074944|82943300|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
46727346|NCT01074944|82943301|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
46727347|NCT01074944|82943302|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
46727348|NCT01074944|82943303|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
46727349|NCT01074944|82943299|FG000|Long Term Treatment|Withdrawal by Subject|0|||
46727350|NCT01074944|82943300|FG001|Long Term Treatment|Withdrawal by Subject|0|||
46727351|NCT01074944|82943301|FG002|Long Term Treatment|Withdrawal by Subject|0|||
46727352|NCT01074944|82943302|FG003|Long Term Treatment|Withdrawal by Subject|2|||
46727353|NCT01074944|82943303|FG004|Long Term Treatment|Withdrawal by Subject|0|||
46727354|NCT01074944|82943299|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
46727355|NCT01074944|82943300|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
46727356|NCT01074944|82943301|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
46727357|NCT01074944|82943302|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
46727358|NCT01074944|82943303|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
46727359|NCT01074944|82943299|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
46727360|NCT01074944|82943300|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
46775699|NCT00692913|82994155|FG001|Overall Study|Withdrawal by Subject|20|||
47047259|NCT01961609|83306643|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
47047260|NCT01774981|83306752|FG000|Overall Study|Adverse Event|0|||
46727361|NCT01074944|82943301|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
46727362|NCT01074944|82943302|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
46727363|NCT01074944|82943303|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
46727364|NCT00802945|82943313|FG000|Overall Study|Death|27|||
46727365|NCT00802945|82943314|FG001|Overall Study|Death|23|||
46634762|NCT01713582|82808205|FG009|Overall Study|Adverse event-related|1|||
46727366|NCT00802945|82943313|FG000|Overall Study|Terminated by sponsor|8|||
46727367|NCT00802945|82943314|FG001|Overall Study|Terminated by sponsor|12|||
46727368|NCT01074554|82943324|FG000|Overall Study|Adverse Event|3|||
46727369|NCT01074554|82943325|FG001|Overall Study|Adverse Event|3|||
47047261|NCT01774981|83306753|FG001|Overall Study|Adverse Event|0|||
47047262|NCT01774981|83306754|FG002|Overall Study|Adverse Event|0|||
47047263|NCT01774981|83306755|FG003|Overall Study|Adverse Event|0|||
47047264|NCT01774981|83306756|FG004|Overall Study|Adverse Event|0|||
47047265|NCT01774981|83306757|FG005|Overall Study|Adverse Event|1|||
47047266|NCT01774981|83306758|FG006|Overall Study|Adverse Event|0|||
47047267|NCT01774981|83306759|FG007|Overall Study|Adverse Event|0|||
46803778|NCT00077857|83023069|FG001|Overall Study|Failure to return|5|||
46803779|NCT00077857|83023068|FG000|Overall Study|Other|15|||
46727370|NCT01074554|82943324|FG000|Overall Study|Lost to Follow-up|0|||
46727371|NCT01074554|82943325|FG001|Overall Study|Lost to Follow-up|1|||
46727372|NCT00857584|82943333|FG000|Overall Study|Lack of Efficacy|1|||
46727373|NCT00857584|82943334|FG001|Overall Study|Lack of Efficacy|2|||
46727374|NCT00857584|82943333|FG000|Overall Study|Adverse Event|2|||
46727375|NCT00857584|82943334|FG001|Overall Study|Adverse Event|2|||
46727376|NCT00857584|82943333|FG000|Overall Study|Physician Decision|1|||
46727377|NCT00857584|82943334|FG001|Overall Study|Physician Decision|1|||
46727378|NCT00798967|82943342|FG000|Overall Study|Adverse Event|2|||
46727379|NCT00798967|82943343|FG001|Overall Study|Adverse Event|3|||
46727380|NCT00798967|82943342|FG000|Overall Study|Withdrawal by Subject|0|||
46727381|NCT00798967|82943343|FG001|Overall Study|Withdrawal by Subject|1|||
46727382|NCT00798967|82943342|FG000|Overall Study|Physician Decision|1|||
46727383|NCT00798967|82943343|FG001|Overall Study|Physician Decision|0|||
46727384|NCT00798967|82943342|FG000|Overall Study|Randomized in error by site|1|||
46803780|NCT00077857|83023069|FG001|Overall Study|Other|13|||
46803781|NCT00545402|83023077|FG000|Overall Study|Discontinuation of treatment|17|||
46803782|NCT00545402|83023078|FG001|Overall Study|Discontinuation of treatment|9|||
46803783|NCT00545402|83023077|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
47047268|NCT01774981|83306752|FG000|Overall Study|Withdrawal by Subject|0|||
47047269|NCT01774981|83306753|FG001|Overall Study|Withdrawal by Subject|0|||
47047270|NCT01774981|83306754|FG002|Overall Study|Withdrawal by Subject|0|||
47047271|NCT01774981|83306755|FG003|Overall Study|Withdrawal by Subject|0|||
47047272|NCT01774981|83306756|FG004|Overall Study|Withdrawal by Subject|0|||
47047273|NCT01774981|83306757|FG005|Overall Study|Withdrawal by Subject|0|||
46634763|NCT01713582|82808206|FG010|Overall Study|Adverse event-related|1|||
46634764|NCT01713582|82808207|FG011|Overall Study|Adverse event-related|0|||
47047274|NCT01774981|83306758|FG006|Overall Study|Withdrawal by Subject|0|||
47047275|NCT01774981|83306759|FG007|Overall Study|Withdrawal by Subject|1|||
47047276|NCT01774981|83306752|FG000|Overall Study|Death|0|||
47047277|NCT01774981|83306753|FG001|Overall Study|Death|0|||
47047278|NCT01774981|83306754|FG002|Overall Study|Death|0|||
47047279|NCT01774981|83306755|FG003|Overall Study|Death|0|||
47047280|NCT01774981|83306756|FG004|Overall Study|Death|1|||
47047281|NCT01774981|83306757|FG005|Overall Study|Death|0|||
47047282|NCT01774981|83306758|FG006|Overall Study|Death|0|||
46634765|NCT01713582|82808208|FG012|Overall Study|Adverse event-related|0|||
46634766|NCT01713582|82808209|FG013|Overall Study|Adverse event-related|0|||
46634767|NCT01713582|82808210|FG014|Overall Study|Adverse event-related|0|||
46634768|NCT01713582|82808211|FG015|Overall Study|Adverse event-related|0|||
46634769|NCT01713582|82808212|FG016|Overall Study|Adverse event-related|0|||
46634770|NCT01713582|82808213|FG017|Overall Study|Adverse event-related|0|||
46634771|NCT01713582|82808214|FG018|Overall Study|Adverse event-related|1|||
46634772|NCT01713582|82808215|FG019|Overall Study|Adverse event-related|0|||
46634773|NCT01713582|82808216|FG020|Overall Study|Adverse event-related|0|||
46634774|NCT01713582|82808196|FG000|Overall Study|Adverse event-unrelated|0|||
46634775|NCT01713582|82808197|FG001|Overall Study|Adverse event-unrelated|0|||
46634776|NCT01713582|82808198|FG002|Overall Study|Adverse event-unrelated|0|||
46634777|NCT01713582|82808199|FG003|Overall Study|Adverse event-unrelated|0|||
46727385|NCT00798967|82943343|FG001|Overall Study|Randomized in error by site|0|||
46727386|NCT01074242|82943350|FG000|Overall Study|Case report before date of contract|40|||
46727387|NCT01074242|82943350|FG000|Overall Study|Lost to Follow-up|1|||
46727388|NCT01074242|82943350|FG000|Overall Study|Case report unclear|6|||
46727389|NCT01074242|82943350|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
47047283|NCT01774981|83306759|FG007|Overall Study|Death|0|||
47047284|NCT01972841|83306788|FG000|Overall Study|Randomized but Never Received Treatment|2|||
47047285|NCT01972841|83306789|FG001|Overall Study|Randomized but Never Received Treatment|5|||
47047286|NCT01972841|83306790|FG002|Overall Study|Randomized but Never Received Treatment|4|||
46727390|NCT01074242|82943350|FG000|Overall Study|Duplicate Case Report Form|5|||
46727391|NCT00798889|82943354|FG000|Overall Study|Adverse Event|53|||
46727392|NCT00798889|82943354|FG000|Overall Study|Protocol Violation|2|||
46727393|NCT00798889|82943354|FG000|Overall Study|Withdrawal by Subject|31|||
46727394|NCT00798889|82943354|FG000|Overall Study|Lost to Follow-up|1|||
46727395|NCT00798889|82943354|FG000|Overall Study|Lack of Efficacy|213|||
46727396|NCT00798889|82943354|FG000|Overall Study|Decision of Sponsor|11|||
46727397|NCT00798889|82943354|FG000|Overall Study|Enrolled, Not treated|3|||
46727398|NCT00796861|82943358|FG000|Overall Study|Withdrawal by Subject|2|||
46727399|NCT00796861|82943358|FG000|Overall Study|Death|2|||
46727400|NCT00802867|82943362|FG000|Overall Study|Lost to Follow-up|6|||
46727401|NCT00802867|82943362|FG000|Overall Study|Protocol Violation|6|||
46727402|NCT00802867|82943362|FG000|Overall Study|Withdrawal by Subject|1|||
46727403|NCT00798655|82943366|FG000|Overall Study|Did not receive at least one dose of pan|2|||
46727404|NCT00796549|82943370|FG000|Overall Study|Adverse Event|11|||
46727405|NCT00796549|82943370|FG000|Overall Study|not entered|149|||
46727406|NCT00796549|82943370|FG000|Overall Study|Other|2|||
46727407|NCT00796549|82943370|FG000|Overall Study|Progressive disease|56|||
46727408|NCT00856492|82943379|FG000|Overall Study|Ineligible or withdrew consent|1|||
46727409|NCT00856492|82943380|FG001|Overall Study|Ineligible or withdrew consent|1|||
46727410|NCT00856492|82943381|FG002|Overall Study|Ineligible or withdrew consent|2|||
46727411|NCT00856180|82943392|FG000|Overall Study|Adverse Event|4|||
46727412|NCT00856180|82943392|FG000|Overall Study|Progressive Disease|16|||
46727413|NCT00900627|82943404|FG000|Overall Study|Condition under investigation worsened|4|||
46727414|NCT00900627|82943405|FG001|Overall Study|Condition under investigation worsened|0|||
46727415|NCT00900627|82943406|FG002|Overall Study|Condition under investigation worsened|5|||
46727416|NCT00900627|82943407|FG003|Overall Study|Condition under investigation worsened|3|||
46727417|NCT00900627|82943408|FG004|Overall Study|Condition under investigation worsened|0|||
46727418|NCT00900627|82943409|FG005|Overall Study|Condition under investigation worsened|0|||
46727419|NCT00900627|82943404|FG000|Overall Study|Withdrawal by Subject|1|||
46727420|NCT00900627|82943405|FG001|Overall Study|Withdrawal by Subject|0|||
46727421|NCT00900627|82943406|FG002|Overall Study|Withdrawal by Subject|1|||
46727422|NCT00900627|82943407|FG003|Overall Study|Withdrawal by Subject|0|||
46727423|NCT00900627|82943408|FG004|Overall Study|Withdrawal by Subject|1|||
46727424|NCT00900627|82943409|FG005|Overall Study|Withdrawal by Subject|2|||
46727425|NCT00900627|82943404|FG000|Overall Study|Adverse Event|1|||
46727426|NCT00900627|82943405|FG001|Overall Study|Adverse Event|2|||
46727427|NCT00900627|82943406|FG002|Overall Study|Adverse Event|0|||
46727428|NCT00900627|82943407|FG003|Overall Study|Adverse Event|3|||
46727429|NCT00900627|82943408|FG004|Overall Study|Adverse Event|0|||
46727430|NCT00900627|82943409|FG005|Overall Study|Adverse Event|0|||
46727431|NCT00900627|82943404|FG000|Overall Study|Death|0|||
46727432|NCT00900627|82943405|FG001|Overall Study|Death|0|||
46727433|NCT00900627|82943406|FG002|Overall Study|Death|0|||
46727434|NCT00900627|82943407|FG003|Overall Study|Death|0|||
46727435|NCT00900627|82943408|FG004|Overall Study|Death|28|||
46727436|NCT00900627|82943409|FG005|Overall Study|Death|24|||
46727437|NCT00866320|82943423|FG000|Overall Study|Withdrawal by Subject|4|||
46727438|NCT00866320|82943423|FG000|Overall Study|Death|2|||
46727439|NCT00869518|82943431|FG000|Overall Study|Lost to Follow-up|1|||
46727440|NCT00869518|82943432|FG001|Overall Study|Lost to Follow-up|1|||
46727441|NCT00797563|82943438|FG000|Overall Study|Adverse Event|1|||
46727442|NCT00869440|82943446|FG000|Overall Study|Withdrawal by Subject|1|||
46727443|NCT00869440|82943447|FG001|Overall Study|Withdrawal by Subject|0|||
46727444|NCT00869440|82943448|FG002|Overall Study|Withdrawal by Subject|0|||
46727445|NCT00869440|82943449|FG003|Overall Study|Withdrawal by Subject|0|||
46727446|NCT00869440|82943446|FG000|Overall Study|Physician Decision|1|||
46727447|NCT00869440|82943447|FG001|Overall Study|Physician Decision|1|||
46727448|NCT00869440|82943448|FG002|Overall Study|Physician Decision|0|||
46727449|NCT00869440|82943449|FG003|Overall Study|Physician Decision|0|||
46727450|NCT00895947|82943461|FG000|Overall Study|Adverse Event|3|||
46727451|NCT00895947|82943462|FG001|Overall Study|Adverse Event|4|||
46727452|NCT00895947|82943461|FG000|Overall Study|Lost to Follow-up|3|||
46727453|NCT00895947|82943462|FG001|Overall Study|Lost to Follow-up|4|||
46803784|NCT00545402|83023078|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
47047287|NCT01972841|83306791|FG003|Overall Study|Randomized but Never Received Treatment|2|||
47047288|NCT01972841|83306792|FG004|Overall Study|Randomized but Never Received Treatment|6|||
46727454|NCT00895947|82943461|FG000|Overall Study|Protocol Violation|4|||
46727455|NCT00895947|82943462|FG001|Overall Study|Protocol Violation|2|||
46727456|NCT00895947|82943461|FG000|Overall Study|Withdrawal by Subject|2|||
46727457|NCT00895947|82943462|FG001|Overall Study|Withdrawal by Subject|0|||
46727458|NCT00869362|82943470|FG000|Overall Study|Death|0|||
46727459|NCT00869362|82943471|FG001|Overall Study|Death|2|||
46727460|NCT00869362|82943470|FG000|Overall Study|Lost to Follow-up|1|||
46727461|NCT00869362|82943471|FG001|Overall Study|Lost to Follow-up|3|||
46727462|NCT00588445|82943478|FG000|Overall Study|Protocol Violation|1|||
46727463|NCT00588445|82943478|FG000|Overall Study|Withdrawal by Subject|3|||
46727464|NCT00588445|82943478|FG000|Overall Study|Disease Progression|1|||
46727465|NCT00588445|82943478|FG000|Overall Study|Not Treated|10|||
46727466|NCT00796315|82943484|FG000|Overall Study|Protocol Violation|0|||
46727467|NCT00796315|82943485|FG001|Overall Study|Protocol Violation|1|||
46727468|NCT00796315|82943486|FG002|Overall Study|Protocol Violation|0|||
47047289|NCT01972841|83306793|FG005|Overall Study|Randomized but Never Received Treatment|13|||
47047290|NCT01972841|83306788|FG000|Overall Study|Adverse Event|13|||
47047291|NCT01972841|83306789|FG001|Overall Study|Adverse Event|8|||
47047292|NCT01972841|83306790|FG002|Overall Study|Adverse Event|12|||
47047293|NCT01972841|83306791|FG003|Overall Study|Adverse Event|9|||
47047294|NCT01972841|83306792|FG004|Overall Study|Adverse Event|21|||
47047295|NCT01972841|83306793|FG005|Overall Study|Adverse Event|26|||
47047296|NCT01972841|83306788|FG000|Overall Study|Lack of Efficacy|1|||
47047297|NCT01972841|83306789|FG001|Overall Study|Lack of Efficacy|0|||
47047298|NCT01972841|83306790|FG002|Overall Study|Lack of Efficacy|0|||
47047299|NCT01972841|83306791|FG003|Overall Study|Lack of Efficacy|2|||
46727469|NCT00855166|82943499|FG000|Overall Study|Adverse Event|0|||
46727470|NCT00855166|82943500|FG001|Overall Study|Adverse Event|2|||
46727471|NCT00855166|82943499|FG000|Overall Study|Death|0|||
46727472|NCT00855166|82943500|FG001|Overall Study|Death|1|||
46727473|NCT00855166|82943499|FG000|Overall Study|Withdrawal by Subject|1|||
46727474|NCT00855166|82943500|FG001|Overall Study|Withdrawal by Subject|4|||
46727475|NCT00855166|82943499|FG000|Overall Study|Poor/non-compliance|2|||
46803785|NCT00545402|83023077|FG000|Overall Study|Death|5|||
47047300|NCT01972841|83306792|FG004|Overall Study|Lack of Efficacy|4|||
47047301|NCT01972841|83306793|FG005|Overall Study|Lack of Efficacy|1|||
47047302|NCT01972841|83306788|FG000|Overall Study|Lost to Follow-up|4|||
47047303|NCT01972841|83306789|FG001|Overall Study|Lost to Follow-up|2|||
46727476|NCT00855166|82943500|FG001|Overall Study|Poor/non-compliance|0|||
46727477|NCT00855166|82943499|FG000|Overall Study|Administrative reasons by sponsor|1|||
46727478|NCT00855166|82943500|FG001|Overall Study|Administrative reasons by sponsor|0|||
47047304|NCT01972841|83306790|FG002|Overall Study|Lost to Follow-up|4|||
47047305|NCT01972841|83306791|FG003|Overall Study|Lost to Follow-up|2|||
47047306|NCT01972841|83306792|FG004|Overall Study|Lost to Follow-up|9|||
46727479|NCT00855166|82943499|FG000|Overall Study|Subject no longer meets study criteria|1|||
46727480|NCT00855166|82943500|FG001|Overall Study|Subject no longer meets study criteria|1|||
46727481|NCT00587587|82943510|FG000|Overall Study|Lost to Follow-up|6|||
46727482|NCT00587587|82943511|FG001|Overall Study|Lost to Follow-up|1|||
46727483|NCT00854620|82943519|FG000|Overall Study|Adverse Event|1|||
46727484|NCT00793585|82943525|FG000|Overall Study|Adverse Event|1|||
46727485|NCT00793585|82943526|FG001|Overall Study|Adverse Event|1|||
46727486|NCT00793585|82943525|FG000|Overall Study|Protocol Violation|1|||
46727487|NCT00793585|82943526|FG001|Overall Study|Protocol Violation|2|||
46727488|NCT00898443|82943534|FG000|Overall Study|Withdrawal by Subject|1|||
46727489|NCT00898443|82943535|FG001|Overall Study|Withdrawal by Subject|0|||
46727490|NCT00900159|82943543|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
46727491|NCT00900159|82943544|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
46727492|NCT00854308|82943563|FG000|Overall Study|Disease progression|42|||
46727493|NCT00854308|82943564|FG001|Overall Study|Disease progression|50|||
46727494|NCT00854308|82943563|FG000|Overall Study|Adverse Event|8|||
46727495|NCT00854308|82943564|FG001|Overall Study|Adverse Event|3|||
46727496|NCT00854308|82943563|FG000|Overall Study|Death|2|||
46727497|NCT00854308|82943564|FG001|Overall Study|Death|5|||
46727498|NCT00854308|82943563|FG000|Overall Study|Physician Decision|6|||
46727499|NCT00854308|82943564|FG001|Overall Study|Physician Decision|6|||
46727500|NCT00854308|82943563|FG000|Overall Study|Withdrawal by Subject|4|||
46727501|NCT00854308|82943564|FG001|Overall Study|Withdrawal by Subject|2|||
46727502|NCT00854308|82943563|FG000|Overall Study|Sponsor's decision to terminate study|0|||
46727503|NCT00854308|82943564|FG001|Overall Study|Sponsor's decision to terminate study|1|||
46727504|NCT00592852|82943570|FG000|Overall Study|Non-compliance|1|||
46727505|NCT00592852|82943570|FG000|Overall Study|Adverse Event|3|||
46727506|NCT00592852|82943570|FG000|Overall Study|Found ineligible|1|||
46727507|NCT00592852|82943570|FG000|Overall Study|Withdrawal by Subject|1|||
46727508|NCT00895245|82943574|FG000|Overall Study|Lack of Efficacy|6|||
46727509|NCT00865306|82943580|FG000|Controlled Trial|Lost to Follow-up|1|||
46727510|NCT00865306|82943581|FG001|Controlled Trial|Lost to Follow-up|1|||
46727511|NCT00865306|82943580|FG000|Controlled Trial|Difficulty commuting|2|||
46727512|NCT00865306|82943581|FG001|Controlled Trial|Difficulty commuting|0|||
46727513|NCT00865306|82943580|FG000|Controlled Trial|Improved btw baseline and first session|1|||
46727514|NCT00865306|82943581|FG001|Controlled Trial|Improved btw baseline and first session|0|||
46727515|NCT00865306|82943580|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
46727516|NCT00865306|82943581|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
46727517|NCT00865306|82943580|FG000|Controlled Trial|Withdrawal by Subject|0|||
46727518|NCT00865306|82943581|FG001|Controlled Trial|Withdrawal by Subject|1|||
46727519|NCT00896649|82943587|FG000|Overall Study|Physician Decision|1|||
46727520|NCT00896649|82943587|FG000|Overall Study|Pregnancy|1|||
46727521|NCT00896649|82943587|FG000|Overall Study|missing documentation|1|||
46727522|NCT00896649|82943587|FG000|Overall Study|technical difficulties|2|||
46727523|NCT00796003|82943594|FG000|Overall Study|Disease Progression|2|||
46727524|NCT00796003|82943595|FG001|Overall Study|Disease Progression|13|||
46727525|NCT00796003|82943594|FG000|Overall Study|Adverse Event|1|||
46727526|NCT00796003|82943595|FG001|Overall Study|Adverse Event|7|||
46727527|NCT00796003|82943594|FG000|Overall Study|Specified organ function not met|0|||
46803786|NCT00545402|83023078|FG001|Overall Study|Death|7|||
46803787|NCT00545402|83023077|FG000|Overall Study|Graft loss|2|||
46803788|NCT00545402|83023078|FG001|Overall Study|Graft loss|4|||
46803789|NCT00545402|83023077|FG000|Overall Study|Withdrawal by Subject|0|||
46634778|NCT01713582|82808200|FG004|Overall Study|Adverse event-unrelated|0|||
46634779|NCT01713582|82808201|FG005|Overall Study|Adverse event-unrelated|1|||
46634780|NCT01713582|82808202|FG006|Overall Study|Adverse event-unrelated|1|||
46634781|NCT01713582|82808203|FG007|Overall Study|Adverse event-unrelated|1|||
46634782|NCT01713582|82808204|FG008|Overall Study|Adverse event-unrelated|0|||
46634783|NCT01713582|82808205|FG009|Overall Study|Adverse event-unrelated|0|||
46634784|NCT01713582|82808206|FG010|Overall Study|Adverse event-unrelated|0|||
46634785|NCT01713582|82808207|FG011|Overall Study|Adverse event-unrelated|0|||
46634786|NCT01713582|82808208|FG012|Overall Study|Adverse event-unrelated|0|||
46634787|NCT01713582|82808209|FG013|Overall Study|Adverse event-unrelated|1|||
46634788|NCT01713582|82808210|FG014|Overall Study|Adverse event-unrelated|1|||
46634789|NCT01713582|82808211|FG015|Overall Study|Adverse event-unrelated|0|||
46634790|NCT01713582|82808212|FG016|Overall Study|Adverse event-unrelated|0|||
46727528|NCT00796003|82943595|FG001|Overall Study|Specified organ function not met|1|||
46727529|NCT00796003|82943594|FG000|Overall Study|Physician Decision|0|||
46727530|NCT00796003|82943595|FG001|Overall Study|Physician Decision|4|||
46727531|NCT00796003|82943594|FG000|Overall Study|Withdrawal by Subject|0|||
46727532|NCT00796003|82943595|FG001|Overall Study|Withdrawal by Subject|1|||
46727533|NCT00796003|82943594|FG000|Overall Study|Other|0|||
46727534|NCT00796003|82943595|FG001|Overall Study|Other|1|||
46727535|NCT00796003|82943594|FG000|Overall Study|Participants Not treated|0|||
46727536|NCT00796003|82943595|FG001|Overall Study|Participants Not treated|2|||
46803790|NCT00545402|83023078|FG001|Overall Study|Withdrawal by Subject|1|||
46803791|NCT00545402|83023077|FG000|Overall Study|Protocol Violation|1|||
46727537|NCT00895011|82943607|FG000|Overall Study|Withdrawal by Subject|14|||
46727538|NCT00895011|82943608|FG001|Overall Study|Withdrawal by Subject|7|||
46727539|NCT00895011|82943609|FG002|Overall Study|Withdrawal by Subject|2|||
46727540|NCT00895011|82943607|FG000|Overall Study|Lost to Follow-up|5|||
46727541|NCT00895011|82943608|FG001|Overall Study|Lost to Follow-up|4|||
46727542|NCT00895011|82943609|FG002|Overall Study|Lost to Follow-up|1|||
46727543|NCT00895011|82943607|FG000|Overall Study|Protocol Violation|3|||
46727544|NCT00895011|82943608|FG001|Overall Study|Protocol Violation|1|||
46727545|NCT00895011|82943609|FG002|Overall Study|Protocol Violation|3|||
46727546|NCT00895011|82943607|FG000|Overall Study|Adverse Event|1|||
46727547|NCT00895011|82943608|FG001|Overall Study|Adverse Event|2|||
46727548|NCT00895011|82943609|FG002|Overall Study|Adverse Event|2|||
46727549|NCT00895011|82943607|FG000|Overall Study|schedule conflict|1|||
46727550|NCT00895011|82943608|FG001|Overall Study|schedule conflict|0|||
46727551|NCT00895011|82943609|FG002|Overall Study|schedule conflict|0|||
46727552|NCT00899847|82943618|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
46727553|NCT00795535|82943624|FG000|Overall Study|incomplete data and technical problems|20|||
46727554|NCT00853762|82943632|FG000|Overall Study|Premature Termination|16|||
46727555|NCT00853762|82943633|FG001|Overall Study|Premature Termination|15|||
46727556|NCT00853762|82943634|FG002|Overall Study|Premature Termination|14|||
46727557|NCT00853762|82943635|FG003|Overall Study|Premature Termination|21|||
46727558|NCT00853762|82943632|FG000|Overall Study|Protocol Violation|0|||
46727559|NCT00853762|82943633|FG001|Overall Study|Protocol Violation|0|||
46727560|NCT00853762|82943634|FG002|Overall Study|Protocol Violation|0|||
46727561|NCT00853762|82943635|FG003|Overall Study|Protocol Violation|1|||
47047307|NCT01972841|83306793|FG005|Overall Study|Lost to Follow-up|3|||
47047308|NCT01972841|83306788|FG000|Overall Study|Protocol Violation|2|||
46727562|NCT00853762|82943632|FG000|Overall Study|Withdrawal by Subject|0|||
46727563|NCT00853762|82943633|FG001|Overall Study|Withdrawal by Subject|0|||
46727564|NCT00853762|82943634|FG002|Overall Study|Withdrawal by Subject|1|||
46727565|NCT00853762|82943635|FG003|Overall Study|Withdrawal by Subject|0|||
46727566|NCT00853762|82943632|FG000|Overall Study|Other|0|||
46727567|NCT00853762|82943633|FG001|Overall Study|Other|2|||
46727568|NCT00853762|82943634|FG002|Overall Study|Other|0|||
47047309|NCT01972841|83306789|FG001|Overall Study|Protocol Violation|2|||
47047310|NCT01972841|83306790|FG002|Overall Study|Protocol Violation|3|||
47047311|NCT01972841|83306791|FG003|Overall Study|Protocol Violation|5|||
47047312|NCT01972841|83306792|FG004|Overall Study|Protocol Violation|9|||
47047313|NCT01972841|83306793|FG005|Overall Study|Protocol Violation|4|||
47047314|NCT01972841|83306788|FG000|Overall Study|Withdrawal by participants|21|||
47047315|NCT01972841|83306789|FG001|Overall Study|Withdrawal by participants|27|||
47047316|NCT01972841|83306790|FG002|Overall Study|Withdrawal by participants|23|||
46634791|NCT01713582|82808213|FG017|Overall Study|Adverse event-unrelated|0|||
46634792|NCT01713582|82808214|FG018|Overall Study|Adverse event-unrelated|0|||
46634793|NCT01713582|82808215|FG019|Overall Study|Adverse event-unrelated|0|||
46634794|NCT01713582|82808216|FG020|Overall Study|Adverse event-unrelated|0|||
46634795|NCT01713582|82808196|FG000|Overall Study|Withdrawal of consent|0|||
46634796|NCT01713582|82808197|FG001|Overall Study|Withdrawal of consent|0|||
46634797|NCT01713582|82808198|FG002|Overall Study|Withdrawal of consent|1|||
46634798|NCT01713582|82808199|FG003|Overall Study|Withdrawal of consent|0|||
46634799|NCT01713582|82808200|FG004|Overall Study|Withdrawal of consent|0|||
46634800|NCT01713582|82808201|FG005|Overall Study|Withdrawal of consent|1|||
46634801|NCT01713582|82808202|FG006|Overall Study|Withdrawal of consent|0|||
46634802|NCT01713582|82808203|FG007|Overall Study|Withdrawal of consent|0|||
46634803|NCT01713582|82808204|FG008|Overall Study|Withdrawal of consent|0|||
46634804|NCT01713582|82808205|FG009|Overall Study|Withdrawal of consent|1|||
46727569|NCT00853762|82943635|FG003|Overall Study|Other|0|||
46727570|NCT00853762|82943632|FG000|Overall Study|Randomised but not Treated|0|||
46727571|NCT00853762|82943633|FG001|Overall Study|Randomised but not Treated|2|||
46727572|NCT00853762|82943634|FG002|Overall Study|Randomised but not Treated|2|||
46727573|NCT00853762|82943635|FG003|Overall Study|Randomised but not Treated|0|||
46727574|NCT00789529|82943647|FG000|Overall Study|Withdrawal by Subject|0|||
46727575|NCT00789529|82943648|FG001|Overall Study|Withdrawal by Subject|1|||
47047317|NCT01972841|83306791|FG003|Overall Study|Withdrawal by participants|16|||
47047318|NCT01972841|83306792|FG004|Overall Study|Withdrawal by participants|33|||
47047319|NCT01972841|83306793|FG005|Overall Study|Withdrawal by participants|34|||
46634805|NCT01713582|82808206|FG010|Overall Study|Withdrawal of consent|0|||
46634806|NCT01713582|82808207|FG011|Overall Study|Withdrawal of consent|0|||
46727576|NCT00789529|82943647|FG000|Overall Study|Other Reason|1|||
46727577|NCT00789529|82943648|FG001|Overall Study|Other Reason|0|||
46727578|NCT00894933|82943654|FG000|Overall Study|Lost to Follow-up|2|||
46727579|NCT00894933|82943654|FG000|Overall Study|Cancelled Procedure|1|||
46727580|NCT00894933|82943654|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
46727581|NCT00792805|82943661|FG000|Overall Study|Adverse Event|12|||
46727582|NCT00792805|82943662|FG001|Overall Study|Adverse Event|10|||
46727583|NCT00792805|82943663|FG002|Overall Study|Adverse Event|10|||
46727584|NCT00792805|82943661|FG000|Overall Study|Subject withdrew consent|5|||
46727585|NCT00792805|82943662|FG001|Overall Study|Subject withdrew consent|6|||
46727586|NCT00792805|82943663|FG002|Overall Study|Subject withdrew consent|5|||
46727587|NCT00792805|82943661|FG000|Overall Study|Administrative problems|2|||
46727588|NCT00792805|82943662|FG001|Overall Study|Administrative problems|0|||
46727589|NCT00792805|82943663|FG002|Overall Study|Administrative problems|4|||
46727590|NCT00792805|82943661|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46727591|NCT00792805|82943662|FG001|Overall Study|Abnormal test procedure result(s)|2|||
46727592|NCT00792805|82943663|FG002|Overall Study|Abnormal test procedure result(s)|0|||
46727593|NCT00792805|82943661|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46727594|NCT00792805|82943662|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
46727595|NCT00792805|82943663|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
46727596|NCT00792805|82943661|FG000|Overall Study|Lost to Follow-up|1|||
46727597|NCT00792805|82943662|FG001|Overall Study|Lost to Follow-up|1|||
46727598|NCT00792805|82943663|FG002|Overall Study|Lost to Follow-up|6|||
46727599|NCT00792805|82943661|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46727600|NCT00792805|82943662|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46727601|NCT00792805|82943663|FG002|Overall Study|Abnormal laboratory value(s)|1|||
46727602|NCT00792805|82943661|FG000|Overall Study|Protocol deviation|0|||
46727603|NCT00792805|82943662|FG001|Overall Study|Protocol deviation|1|||
46727604|NCT00792805|82943663|FG002|Overall Study|Protocol deviation|1|||
46727605|NCT00925002|82943674|FG000|Overall Study|Other|1|||
46727606|NCT00925002|82943675|FG001|Overall Study|Other|4|||
46727607|NCT00925002|82943676|FG002|Overall Study|Other|0|||
46727608|NCT00925002|82943674|FG000|Overall Study|Death|1|||
46727609|NCT00925002|82943675|FG001|Overall Study|Death|1|||
46727610|NCT00925002|82943676|FG002|Overall Study|Death|5|||
46727611|NCT00925002|82943674|FG000|Overall Study|Adverse Event|3|||
46727612|NCT00925002|82943675|FG001|Overall Study|Adverse Event|1|||
46727613|NCT00925002|82943676|FG002|Overall Study|Adverse Event|2|||
46727614|NCT00925002|82943674|FG000|Overall Study|Participant withdrew consent|1|||
46727615|NCT00925002|82943675|FG001|Overall Study|Participant withdrew consent|3|||
46727616|NCT00925002|82943676|FG002|Overall Study|Participant withdrew consent|3|||
46727617|NCT00928746|82943685|FG000|Overall Study|Adverse Event|2|||
46727618|NCT00928746|82943685|FG000|Overall Study|Protocol Violation|1|||
46727619|NCT00928746|82943685|FG000|Overall Study|Withdrawal by Subject|1|||
46727620|NCT00928746|82943685|FG000|Overall Study|Other|2|||
46727621|NCT00922428|82943691|FG000|Overall Study|retrospective/extremely implausible data|2|||
46727622|NCT00922428|82943691|FG000|Overall Study|no medication use or questionable use|13|||
46727623|NCT00894543|82943703|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
46727624|NCT00894543|82943704|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
46727625|NCT00894543|82943703|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
46727626|NCT00894543|82943704|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
46727627|NCT00922272|82943710|FG000|Open-label Phase|Adverse Event|5|||
46727628|NCT00922272|82943711|FG001|Open-label Phase|Adverse Event|0|||
46727629|NCT00922272|82943710|FG000|Open-label Phase|Protocol Violation|1|||
46727630|NCT00922272|82943711|FG001|Open-label Phase|Protocol Violation|0|||
46727631|NCT00922272|82943710|FG000|Open-label Phase|Withdrawal by Subject|11|||
46727632|NCT00922272|82943711|FG001|Open-label Phase|Withdrawal by Subject|0|||
46727633|NCT00922272|82943710|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
46727634|NCT00922272|82943711|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
47047320|NCT01972841|83306788|FG000|Overall Study|Miscellaneous|0|||
47047321|NCT01972841|83306789|FG001|Overall Study|Miscellaneous|0|||
47047322|NCT01972841|83306790|FG002|Overall Study|Miscellaneous|4|||
47047323|NCT01972841|83306791|FG003|Overall Study|Miscellaneous|1|||
46727635|NCT00922272|82943710|FG000|Open-label Phase|Withdrawal criteria met|5|||
46727636|NCT00922272|82943711|FG001|Open-label Phase|Withdrawal criteria met|0|||
46921225|NCT02419417|83153606|FG010|Overall Study|Withdrawal by Subject|1|||
46921226|NCT00777491|83153647|FG000|Overall Study|Protocol Violation|0|||
46727637|NCT00922272|82943710|FG000|Double-blind Phase|Adverse Event|1|||
46727638|NCT00922272|82943711|FG001|Double-blind Phase|Adverse Event|1|||
46727639|NCT00922272|82943710|FG000|Double-blind Phase|Withdrawal by Subject|1|||
46727640|NCT00922272|82943711|FG001|Double-blind Phase|Withdrawal by Subject|1|||
46727641|NCT00922272|82943710|FG000|Double-blind Phase|Lost to Follow-up|2|||
46727642|NCT00922272|82943711|FG001|Double-blind Phase|Lost to Follow-up|1|||
46727643|NCT00922272|82943710|FG000|Double-blind Phase|Withdrawal criteria met|1|||
46727644|NCT00922272|82943711|FG001|Double-blind Phase|Withdrawal criteria met|1|||
46727645|NCT00922272|82943710|FG000|Double-blind Phase|Noncompliance|1|||
46727646|NCT00922272|82943711|FG001|Double-blind Phase|Noncompliance|1|||
46727647|NCT00922272|82943710|FG000|Double-blind Phase|Positive urine drug screen|1|||
46634807|NCT01713582|82808208|FG012|Overall Study|Withdrawal of consent|0|||
46634808|NCT01713582|82808209|FG013|Overall Study|Withdrawal of consent|0|||
46634809|NCT01713582|82808210|FG014|Overall Study|Withdrawal of consent|0|||
46634810|NCT01713582|82808211|FG015|Overall Study|Withdrawal of consent|0|||
46634811|NCT01713582|82808212|FG016|Overall Study|Withdrawal of consent|0|||
46634812|NCT01713582|82808213|FG017|Overall Study|Withdrawal of consent|0|||
46634813|NCT01713582|82808214|FG018|Overall Study|Withdrawal of consent|1|||
46634814|NCT01713582|82808215|FG019|Overall Study|Withdrawal of consent|0|||
46634815|NCT01713582|82808216|FG020|Overall Study|Withdrawal of consent|0|||
46634816|NCT01713582|82808196|FG000|Overall Study|Lack of Efficacy|0|||
46634817|NCT01713582|82808197|FG001|Overall Study|Lack of Efficacy|0|||
46634818|NCT01713582|82808198|FG002|Overall Study|Lack of Efficacy|0|||
46634819|NCT01713582|82808199|FG003|Overall Study|Lack of Efficacy|0|||
46727648|NCT00922272|82943711|FG001|Double-blind Phase|Positive urine drug screen|1|||
46727649|NCT00853372|82943721|FG000|Overall Study|Death|30|||
46727650|NCT00853372|82943722|FG001|Overall Study|Death|26|||
46727651|NCT00853372|82943721|FG000|Overall Study|Lost to Follow-up|1|||
46727652|NCT00853372|82943722|FG001|Overall Study|Lost to Follow-up|2|||
46727653|NCT00853372|82943721|FG000|Overall Study|Full Consent Withdrawn|1|||
46727654|NCT00853372|82943722|FG001|Overall Study|Full Consent Withdrawn|1|||
46727655|NCT00848536|82943730|FG000|Overall Study|Adverse Event|2|||
46727656|NCT00848536|82943731|FG001|Overall Study|Adverse Event|2|||
46727657|NCT00848536|82943730|FG000|Overall Study|Withdrawal by Subject|0|||
46727658|NCT00848536|82943731|FG001|Overall Study|Withdrawal by Subject|1|||
46727659|NCT00848536|82943730|FG000|Overall Study|Protocol Violation|0|||
46727660|NCT00848536|82943731|FG001|Overall Study|Protocol Violation|1|||
46727661|NCT00848536|82943730|FG000|Overall Study|Noncompliance|1|||
46727662|NCT00848536|82943731|FG001|Overall Study|Noncompliance|0|||
46727663|NCT00848536|82943730|FG000|Overall Study|Inadequate Control of IOP|1|||
46727664|NCT00848536|82943731|FG001|Overall Study|Inadequate Control of IOP|1|||
46727665|NCT00848536|82943730|FG000|Overall Study|Patient Moved|0|||
46727666|NCT00848536|82943731|FG001|Overall Study|Patient Moved|2|||
46727667|NCT00922116|82943737|FG000|Overall Study|Adverse Event|4|||
46727668|NCT00922116|82943737|FG000|Overall Study|Death|1|||
46727669|NCT00922116|82943737|FG000|Overall Study|Lost to Follow-up|1|||
46727670|NCT00922116|82943737|FG000|Overall Study|Withdrawal by Subject|4|||
46727671|NCT00922116|82943737|FG000|Overall Study|Other|5|||
46727672|NCT00921024|82943743|FG000|Overall Study|Lost to Follow-up|2|||
46727673|NCT00921024|82943744|FG001|Overall Study|Lost to Follow-up|0|||
46727674|NCT00921024|82943743|FG000|Overall Study|Received concomittant therapy|2|||
46727675|NCT00921024|82943744|FG001|Overall Study|Received concomittant therapy|0|||
46727676|NCT00921024|82943743|FG000|Overall Study|Withdrawal by Subject|0|||
46727677|NCT00921024|82943744|FG001|Overall Study|Withdrawal by Subject|3|||
47047324|NCT01972841|83306792|FG004|Overall Study|Miscellaneous|0|||
47047325|NCT01972841|83306793|FG005|Overall Study|Miscellaneous|4|||
47047326|NCT01972841|83306788|FG000|Overall Study|Did not have end of treatment page|0|||
47047327|NCT01972841|83306789|FG001|Overall Study|Did not have end of treatment page|0|||
47047328|NCT01972841|83306790|FG002|Overall Study|Did not have end of treatment page|0|||
47047329|NCT01972841|83306791|FG003|Overall Study|Did not have end of treatment page|0|||
47047330|NCT01972841|83306792|FG004|Overall Study|Did not have end of treatment page|1|||
47047331|NCT01972841|83306793|FG005|Overall Study|Did not have end of treatment page|0|||
47047332|NCT01774903|83306807|FG000|Overall Study|Adverse Event|7|||
47047333|NCT01774903|83306807|FG000|Overall Study|Withdrawal by Subject|2|||
47047334|NCT01774903|83306807|FG000|Overall Study|Lack of Efficacy|1|||
47047335|NCT01774903|83306807|FG000|Overall Study|Ineligible to continue the trial|1|||
47047336|NCT01774591|83306814|FG000|Overall Study|Physician Decision|1|||
47047337|NCT01774591|83306815|FG001|Overall Study|Physician Decision|1|||
47047338|NCT01774591|83306814|FG000|Overall Study|Withdrawal by Subject|0|||
47047339|NCT01774591|83306815|FG001|Overall Study|Withdrawal by Subject|1|||
47047340|NCT01774591|83306814|FG000|Overall Study|Adverse Event|0|||
47047341|NCT01774591|83306815|FG001|Overall Study|Adverse Event|2|||
47047342|NCT01708915|83306825|FG000|Overall Study|Adverse Event|1|||
47047343|NCT01708915|83306826|FG001|Overall Study|Adverse Event|0|||
47047344|NCT01708915|83306827|FG002|Overall Study|Adverse Event|9|||
47047345|NCT01708915|83306828|FG003|Overall Study|Adverse Event|13|||
47047346|NCT01708915|83306825|FG000|Overall Study|Lack of Efficacy|84|||
47047347|NCT01708915|83306826|FG001|Overall Study|Lack of Efficacy|60|||
47047348|NCT01708915|83306827|FG002|Overall Study|Lack of Efficacy|35|||
47047349|NCT01708915|83306828|FG003|Overall Study|Lack of Efficacy|15|||
47047350|NCT01708915|83306825|FG000|Overall Study|Protocol Violation|0|||
47047351|NCT01708915|83306826|FG001|Overall Study|Protocol Violation|0|||
47047352|NCT01708915|83306827|FG002|Overall Study|Protocol Violation|0|||
47047353|NCT01708915|83306828|FG003|Overall Study|Protocol Violation|1|||
46634820|NCT01713582|82808200|FG004|Overall Study|Lack of Efficacy|0|||
46634821|NCT01713582|82808201|FG005|Overall Study|Lack of Efficacy|0|||
46634822|NCT01713582|82808202|FG006|Overall Study|Lack of Efficacy|0|||
46634823|NCT01713582|82808203|FG007|Overall Study|Lack of Efficacy|0|||
46727678|NCT00928668|82943750|FG000|Overall Study|Adverse Event|1|||
47047354|NCT01708915|83306825|FG000|Overall Study|Withdrawal by Subject|0|||
47047355|NCT01708915|83306826|FG001|Overall Study|Withdrawal by Subject|1|||
47047356|NCT01708915|83306827|FG002|Overall Study|Withdrawal by Subject|2|||
47047357|NCT01708915|83306828|FG003|Overall Study|Withdrawal by Subject|2|||
47047358|NCT01708915|83306825|FG000|Overall Study|Other reasons than stated above|1|||
47047359|NCT01708915|83306826|FG001|Overall Study|Other reasons than stated above|1|||
46727679|NCT00928668|82943751|FG001|Overall Study|Adverse Event|0|||
46727680|NCT00928668|82943752|FG002|Overall Study|Adverse Event|0|||
46727681|NCT00928668|82943753|FG003|Overall Study|Adverse Event|0|||
46727682|NCT00928668|82943754|FG004|Overall Study|Adverse Event|0|||
46727683|NCT00928668|82943750|FG000|Overall Study|Protocol Violation|0|||
46727684|NCT00928668|82943751|FG001|Overall Study|Protocol Violation|0|||
46727685|NCT00928668|82943752|FG002|Overall Study|Protocol Violation|0|||
46727686|NCT00928668|82943753|FG003|Overall Study|Protocol Violation|0|||
46727687|NCT00928668|82943754|FG004|Overall Study|Protocol Violation|1|||
46727688|NCT00928668|82943750|FG000|Overall Study|Withdrawal by Subject|0|||
47047360|NCT01708915|83306827|FG002|Overall Study|Other reasons than stated above|0|||
47047361|NCT01708915|83306828|FG003|Overall Study|Other reasons than stated above|2|||
46727689|NCT00928668|82943751|FG001|Overall Study|Withdrawal by Subject|1|||
46727690|NCT00928668|82943752|FG002|Overall Study|Withdrawal by Subject|1|||
46727691|NCT00928668|82943753|FG003|Overall Study|Withdrawal by Subject|0|||
47047362|NCT01708291|83306840|FG000|Overall Study|fighting|2|||
47047363|NCT01708291|83306841|FG001|Overall Study|fighting|1|||
47047364|NCT01708057|83306847|FG000|Overall Study|Withdrawal due to study termination.|1|||
47047365|NCT01708057|83306848|FG001|Overall Study|Withdrawal due to study termination.|1|||
47047366|NCT01708057|83306849|FG002|Overall Study|Withdrawal due to study termination.|1|||
47047367|NCT01748071|83306866|FG000|Overall Study|Adverse Event|2|||
47047368|NCT01748071|83306867|FG001|Overall Study|Adverse Event|2|||
47047369|NCT01748071|83306868|FG002|Overall Study|Adverse Event|0|||
47047370|NCT01972529|83306880|FG000|Overall Study|Adverse Event|0|||
47047371|NCT01972529|83306881|FG001|Overall Study|Adverse Event|1|||
47047372|NCT01972529|83306882|FG002|Overall Study|Adverse Event|0|||
47047373|NCT01972529|83306883|FG003|Overall Study|Adverse Event|0|||
47047374|NCT01972529|83306880|FG000|Overall Study|Lost to Follow-up|1|||
47047375|NCT01972529|83306881|FG001|Overall Study|Lost to Follow-up|0|||
47047376|NCT01972529|83306882|FG002|Overall Study|Lost to Follow-up|0|||
47047377|NCT01972529|83306883|FG003|Overall Study|Lost to Follow-up|0|||
47047378|NCT01972529|83306880|FG000|Overall Study|Participant Choice|0|||
47047379|NCT01972529|83306881|FG001|Overall Study|Participant Choice|1|||
47047380|NCT01972529|83306882|FG002|Overall Study|Participant Choice|0|||
47047381|NCT01972529|83306883|FG003|Overall Study|Participant Choice|0|||
47047382|NCT01972529|83306880|FG000|Overall Study|Withdrawl of Consent|1|||
47047383|NCT01972529|83306881|FG001|Overall Study|Withdrawl of Consent|2|||
47047384|NCT01972529|83306882|FG002|Overall Study|Withdrawl of Consent|0|||
47047385|NCT01972529|83306883|FG003|Overall Study|Withdrawl of Consent|1|||
47047386|NCT01972529|83306880|FG000|Overall Study|Other|0|||
47047387|NCT01972529|83306881|FG001|Overall Study|Other|0|||
47047388|NCT01972529|83306882|FG002|Overall Study|Other|0|||
47047389|NCT01972529|83306883|FG003|Overall Study|Other|2|||
47047390|NCT01972529|83306880|FG000|Overall Study|Not treated|0|||
47047391|NCT01972529|83306881|FG001|Overall Study|Not treated|1|||
47047392|NCT01972529|83306882|FG002|Overall Study|Not treated|2|||
46727692|NCT00928668|82943754|FG004|Overall Study|Withdrawal by Subject|0|||
46727693|NCT00928668|82943750|FG000|Overall Study|Other reasons not listed above|0|||
46727694|NCT00928668|82943751|FG001|Overall Study|Other reasons not listed above|0|||
46727695|NCT00928668|82943752|FG002|Overall Study|Other reasons not listed above|0|||
46727696|NCT00928668|82943753|FG003|Overall Study|Other reasons not listed above|1|||
47047393|NCT01972529|83306883|FG003|Overall Study|Not treated|1|||
47047394|NCT01747915|83306897|FG000|Overall Study|Other|1|||
47047395|NCT01747915|83306898|FG001|Overall Study|Other|1|||
47047396|NCT01747915|83306899|FG002|Overall Study|Other|1|||
47047397|NCT01747915|83306897|FG000|Overall Study|Adverse Event|8|||
47047398|NCT01747915|83306898|FG001|Overall Study|Adverse Event|5|||
47047399|NCT01747915|83306899|FG002|Overall Study|Adverse Event|2|||
47047400|NCT01747915|83306897|FG000|Overall Study|Death|0|||
47047401|NCT01747915|83306898|FG001|Overall Study|Death|0|||
47047402|NCT01747915|83306899|FG002|Overall Study|Death|1|||
46634824|NCT01713582|82808204|FG008|Overall Study|Lack of Efficacy|0|||
46634825|NCT01713582|82808205|FG009|Overall Study|Lack of Efficacy|1|||
46634826|NCT01713582|82808206|FG010|Overall Study|Lack of Efficacy|2|||
46727697|NCT00928668|82943754|FG004|Overall Study|Other reasons not listed above|0|||
46727698|NCT00592774|82943776|FG000|Overall Study|Adverse Event|5|||
46727699|NCT00592774|82943777|FG001|Overall Study|Adverse Event|19|||
46727700|NCT00592774|82943778|FG002|Overall Study|Adverse Event|2|||
46727701|NCT00592774|82943779|FG003|Overall Study|Adverse Event|14|||
46727702|NCT00592774|82943780|FG004|Overall Study|Adverse Event|8|||
46727703|NCT00592774|82943776|FG000|Overall Study|Protocol Violation|0|||
46727704|NCT00592774|82943777|FG001|Overall Study|Protocol Violation|1|||
46727705|NCT00592774|82943778|FG002|Overall Study|Protocol Violation|0|||
46727706|NCT00592774|82943779|FG003|Overall Study|Protocol Violation|0|||
46727707|NCT00592774|82943780|FG004|Overall Study|Protocol Violation|1|||
46727708|NCT00592774|82943776|FG000|Overall Study|Withdrawal by Subject|3|||
46727709|NCT00592774|82943777|FG001|Overall Study|Withdrawal by Subject|7|||
46727710|NCT00592774|82943778|FG002|Overall Study|Withdrawal by Subject|0|||
46727711|NCT00592774|82943779|FG003|Overall Study|Withdrawal by Subject|0|||
46727712|NCT00592774|82943780|FG004|Overall Study|Withdrawal by Subject|0|||
46727713|NCT00592774|82943776|FG000|Overall Study|Lack of Efficacy|3|||
46727714|NCT00592774|82943777|FG001|Overall Study|Lack of Efficacy|3|||
46727715|NCT00592774|82943778|FG002|Overall Study|Lack of Efficacy|0|||
46727716|NCT00592774|82943779|FG003|Overall Study|Lack of Efficacy|0|||
46727717|NCT00592774|82943780|FG004|Overall Study|Lack of Efficacy|2|||
46727718|NCT00592774|82943776|FG000|Overall Study|Physician Decision|0|||
46727719|NCT00592774|82943777|FG001|Overall Study|Physician Decision|1|||
46727720|NCT00592774|82943778|FG002|Overall Study|Physician Decision|1|||
46727721|NCT00592774|82943779|FG003|Overall Study|Physician Decision|0|||
46727722|NCT00592774|82943780|FG004|Overall Study|Physician Decision|1|||
46727723|NCT00592774|82943776|FG000|Overall Study|Other|0|||
46727724|NCT00592774|82943777|FG001|Overall Study|Other|1|||
46727725|NCT00592774|82943778|FG002|Overall Study|Other|1|||
46727726|NCT00592774|82943779|FG003|Overall Study|Other|0|||
46727727|NCT00592774|82943780|FG004|Overall Study|Other|2|||
46727728|NCT00837694|82943798|FG000|Overall Study|Lost to Follow-up|2|||
46727729|NCT00837694|82943799|FG001|Overall Study|Lost to Follow-up|0|||
46727730|NCT00837694|82943800|FG002|Overall Study|Lost to Follow-up|2|||
46727731|NCT00837694|82943801|FG003|Overall Study|Lost to Follow-up|1|||
46727732|NCT00837694|82943802|FG004|Overall Study|Lost to Follow-up|1|||
46727733|NCT00837694|82943803|FG005|Overall Study|Lost to Follow-up|1|||
46727734|NCT00852202|82943820|FG000|Overall Study|Adverse Event|2|||
46727735|NCT00852202|82943821|FG001|Overall Study|Adverse Event|3|||
46727736|NCT00852202|82943822|FG002|Overall Study|Adverse Event|7|||
46727737|NCT00852202|82943820|FG000|Overall Study|Lack of Efficacy|4|||
46727738|NCT00852202|82943821|FG001|Overall Study|Lack of Efficacy|1|||
46727739|NCT00852202|82943822|FG002|Overall Study|Lack of Efficacy|2|||
46727740|NCT00852202|82943820|FG000|Overall Study|Protocol Violation|2|||
46727741|NCT00852202|82943821|FG001|Overall Study|Protocol Violation|2|||
46727742|NCT00852202|82943822|FG002|Overall Study|Protocol Violation|7|||
46727743|NCT00852202|82943820|FG000|Overall Study|Withdrawal by Subject|3|||
46727744|NCT00852202|82943821|FG001|Overall Study|Withdrawal by Subject|1|||
46727745|NCT00852202|82943822|FG002|Overall Study|Withdrawal by Subject|2|||
46727746|NCT00852202|82943820|FG000|Overall Study|Lost to Follow-up|5|||
46727747|NCT00852202|82943821|FG001|Overall Study|Lost to Follow-up|5|||
46727748|NCT00852202|82943822|FG002|Overall Study|Lost to Follow-up|6|||
46727749|NCT00852202|82943820|FG000|Overall Study|pregnancy,moving away and surgery|1|||
46727750|NCT00852202|82943821|FG001|Overall Study|pregnancy,moving away and surgery|0|||
47047403|NCT01747915|83306897|FG000|Overall Study|Lack of Efficacy|0|||
47047404|NCT01747915|83306898|FG001|Overall Study|Lack of Efficacy|1|||
47047405|NCT01747915|83306899|FG002|Overall Study|Lack of Efficacy|0|||
47047406|NCT01747915|83306897|FG000|Overall Study|Lost to Follow-up|1|||
47047407|NCT01747915|83306898|FG001|Overall Study|Lost to Follow-up|0|||
47047408|NCT01747915|83306899|FG002|Overall Study|Lost to Follow-up|0|||
47047409|NCT01747915|83306897|FG000|Overall Study|Withdrawal by Subject|4|||
47047410|NCT01747915|83306898|FG001|Overall Study|Withdrawal by Subject|4|||
47047411|NCT01747915|83306899|FG002|Overall Study|Withdrawal by Subject|1|||
46727751|NCT00852202|82943822|FG002|Overall Study|pregnancy,moving away and surgery|2|||
46727752|NCT01074008|82943840|FG000|Overall Study|Adverse Event|0|||
46727753|NCT01074008|82943841|FG001|Overall Study|Adverse Event|1|||
46727754|NCT01074008|82943842|FG002|Overall Study|Adverse Event|0|||
46727755|NCT01074008|82943843|FG003|Overall Study|Adverse Event|0|||
46727756|NCT01074008|82943844|FG004|Overall Study|Adverse Event|0|||
46727757|NCT01074008|82943845|FG005|Overall Study|Adverse Event|0|||
46727758|NCT01074008|82943846|FG006|Overall Study|Adverse Event|0|||
46727759|NCT01074008|82943847|FG007|Overall Study|Adverse Event|0|||
46727760|NCT01074008|82943848|FG008|Overall Study|Adverse Event|0|||
47047412|NCT01747915|83306897|FG000|Overall Study|Protocol Violation|1|||
47047413|NCT01747915|83306898|FG001|Overall Study|Protocol Violation|0|||
47047414|NCT01747915|83306899|FG002|Overall Study|Protocol Violation|0|||
46727761|NCT01074008|82943840|FG000|Overall Study|Withdrawal by Subject|1|||
46727762|NCT01074008|82943841|FG001|Overall Study|Withdrawal by Subject|1|||
46727763|NCT01074008|82943842|FG002|Overall Study|Withdrawal by Subject|1|||
46727764|NCT01074008|82943843|FG003|Overall Study|Withdrawal by Subject|0|||
46727765|NCT01074008|82943844|FG004|Overall Study|Withdrawal by Subject|1|||
46727766|NCT01074008|82943845|FG005|Overall Study|Withdrawal by Subject|0|||
46727767|NCT01074008|82943846|FG006|Overall Study|Withdrawal by Subject|0|||
46727768|NCT01074008|82943847|FG007|Overall Study|Withdrawal by Subject|0|||
46727769|NCT01074008|82943848|FG008|Overall Study|Withdrawal by Subject|0|||
46727770|NCT01074008|82943840|FG000|Overall Study|Lost to Follow-up|0|||
46727771|NCT01074008|82943841|FG001|Overall Study|Lost to Follow-up|1|||
46727772|NCT01074008|82943842|FG002|Overall Study|Lost to Follow-up|1|||
46727773|NCT01074008|82943843|FG003|Overall Study|Lost to Follow-up|1|||
46727774|NCT01074008|82943844|FG004|Overall Study|Lost to Follow-up|1|||
46727775|NCT01074008|82943845|FG005|Overall Study|Lost to Follow-up|0|||
46727776|NCT01074008|82943846|FG006|Overall Study|Lost to Follow-up|1|||
46727777|NCT01074008|82943847|FG007|Overall Study|Lost to Follow-up|0|||
46727778|NCT01074008|82943848|FG008|Overall Study|Lost to Follow-up|4|||
46727779|NCT01073930|82943879|FG000|Overall Study|Withdrawal by Subject|3|||
46727780|NCT01073930|82943880|FG001|Overall Study|Withdrawal by Subject|2|||
46727781|NCT01073930|82943879|FG000|Overall Study|Lost to Follow-up|0|||
46727782|NCT01073930|82943880|FG001|Overall Study|Lost to Follow-up|1|||
46727783|NCT01073930|82943879|FG000|Overall Study|Adverse Event|0|||
46727784|NCT01073930|82943880|FG001|Overall Study|Adverse Event|1|||
46727785|NCT01073930|82943879|FG000|Overall Study|Noncompliance with study drug|0|||
46727786|NCT01073930|82943880|FG001|Overall Study|Noncompliance with study drug|1|||
46727787|NCT01073930|82943879|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
46727788|NCT01073930|82943880|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
46727789|NCT01073618|82943886|FG000|Overall Study|Death|208|||
46727790|NCT01073618|82943886|FG000|Overall Study|Adverse Event|19|||
46727791|NCT01073618|82943886|FG000|Overall Study|Other|80|||
46727792|NCT01073462|82943890|FG000|Overall Study|Death|14|||
46727793|NCT01073462|82943890|FG000|Overall Study|Kidney transplant|10|||
46727794|NCT01073462|82943890|FG000|Overall Study|Low parathyroid hormone levels|8|||
46727795|NCT01073462|82943890|FG000|Overall Study|Serious adverse event|2|||
46727796|NCT01073462|82943890|FG000|Overall Study|Lost to Follow-up|7|||
46727797|NCT00789373|82943894|FG000|Induction|Adverse Event|64|||
46727798|NCT00789373|82943895|FG001|Induction|Adverse Event|0|||
46727799|NCT00789373|82943896|FG002|Induction|Adverse Event|0|||
46727800|NCT00789373|82943894|FG000|Induction|Death Due to study disease|24|||
46727801|NCT00789373|82943895|FG001|Induction|Death Due to study disease|0|||
46727802|NCT00789373|82943896|FG002|Induction|Death Due to study disease|0|||
46727803|NCT00789373|82943894|FG000|Induction|Death due to adverse event|19|||
46727804|NCT00789373|82943895|FG001|Induction|Death due to adverse event|0|||
46727805|NCT00789373|82943896|FG002|Induction|Death due to adverse event|0|||
46727806|NCT00789373|82943894|FG000|Induction|Death due to toxicity|11|||
46727807|NCT00789373|82943895|FG001|Induction|Death due to toxicity|0|||
46727808|NCT00789373|82943896|FG002|Induction|Death due to toxicity|0|||
46727809|NCT00789373|82943894|FG000|Induction|Death due to procedure|1|||
46727810|NCT00789373|82943895|FG001|Induction|Death due to procedure|0|||
46727811|NCT00789373|82943896|FG002|Induction|Death due to procedure|0|||
46727812|NCT00789373|82943894|FG000|Induction|Investigator decision|7|||
46727813|NCT00789373|82943895|FG001|Induction|Investigator decision|0|||
46727814|NCT00789373|82943896|FG002|Induction|Investigator decision|0|||
46727815|NCT00789373|82943894|FG000|Induction|Protocol entry criteria not met|9|||
46727816|NCT00789373|82943895|FG001|Induction|Protocol entry criteria not met|0|||
46727817|NCT00789373|82943896|FG002|Induction|Protocol entry criteria not met|0|||
46727818|NCT00789373|82943894|FG000|Induction|Lost to Follow-up|6|||
46727819|NCT00789373|82943895|FG001|Induction|Lost to Follow-up|0|||
46727820|NCT00789373|82943896|FG002|Induction|Lost to Follow-up|0|||
46727821|NCT00789373|82943894|FG000|Induction|Protocol Violation|1|||
46727822|NCT00789373|82943895|FG001|Induction|Protocol Violation|0|||
46727823|NCT00789373|82943896|FG002|Induction|Protocol Violation|0|||
46727824|NCT00789373|82943894|FG000|Induction|Progressive Disease|220|||
46727825|NCT00789373|82943895|FG001|Induction|Progressive Disease|0|||
46727826|NCT00789373|82943896|FG002|Induction|Progressive Disease|0|||
46727827|NCT00789373|82943894|FG000|Induction|Withdrawal by Subject|37|||
46634827|NCT01713582|82808207|FG011|Overall Study|Lack of Efficacy|0|||
46727828|NCT00789373|82943895|FG001|Induction|Withdrawal by Subject|0|||
46727829|NCT00789373|82943896|FG002|Induction|Withdrawal by Subject|0|||
46727830|NCT00789373|82943894|FG000|Maintenance|Adverse Event|0|||
46634828|NCT01713582|82808208|FG012|Overall Study|Lack of Efficacy|0|||
46634829|NCT01713582|82808209|FG013|Overall Study|Lack of Efficacy|0|||
46634830|NCT01713582|82808210|FG014|Overall Study|Lack of Efficacy|0|||
46634831|NCT01713582|82808211|FG015|Overall Study|Lack of Efficacy|0|||
46634832|NCT01713582|82808212|FG016|Overall Study|Lack of Efficacy|0|||
46634833|NCT01713582|82808213|FG017|Overall Study|Lack of Efficacy|0|||
46634834|NCT01713582|82808214|FG018|Overall Study|Lack of Efficacy|0|||
46727831|NCT00789373|82943895|FG001|Maintenance|Adverse Event|65|||
46727832|NCT00789373|82943896|FG002|Maintenance|Adverse Event|12|||
46727833|NCT00789373|82943894|FG000|Maintenance|Death due to study disease|0|||
46727834|NCT00789373|82943895|FG001|Maintenance|Death due to study disease|3|||
46634835|NCT01713582|82808215|FG019|Overall Study|Lack of Efficacy|0|||
46727835|NCT00789373|82943896|FG002|Maintenance|Death due to study disease|1|||
46727836|NCT00789373|82943894|FG000|Maintenance|Death due to adverse event|0|||
46727837|NCT00789373|82943895|FG001|Maintenance|Death due to adverse event|4|||
46727838|NCT00789373|82943896|FG002|Maintenance|Death due to adverse event|1|||
46727839|NCT00789373|82943894|FG000|Maintenance|Death due to toxicity|0|||
46727840|NCT00789373|82943895|FG001|Maintenance|Death due to toxicity|1|||
46727841|NCT00789373|82943896|FG002|Maintenance|Death due to toxicity|2|||
46727842|NCT00789373|82943894|FG000|Maintenance|Investigator Decision|0|||
46727843|NCT00789373|82943895|FG001|Maintenance|Investigator Decision|4|||
46727844|NCT00789373|82943896|FG002|Maintenance|Investigator Decision|2|||
46727845|NCT00789373|82943894|FG000|Maintenance|Protocol entry criteria not met|0|||
46727846|NCT00789373|82943895|FG001|Maintenance|Protocol entry criteria not met|2|||
46727847|NCT00789373|82943896|FG002|Maintenance|Protocol entry criteria not met|0|||
46727848|NCT00789373|82943894|FG000|Maintenance|Lost to Follow-up|0|||
46727849|NCT00789373|82943895|FG001|Maintenance|Lost to Follow-up|2|||
46727850|NCT00789373|82943896|FG002|Maintenance|Lost to Follow-up|0|||
46727851|NCT00789373|82943894|FG000|Maintenance|Progressive Disease|0|||
46727852|NCT00789373|82943895|FG001|Maintenance|Progressive Disease|253|||
46727853|NCT00789373|82943896|FG002|Maintenance|Progressive Disease|152|||
46727854|NCT00789373|82943894|FG000|Maintenance|Withdrawal by Subject|0|||
46727855|NCT00789373|82943895|FG001|Maintenance|Withdrawal by Subject|21|||
46727856|NCT00789373|82943896|FG002|Maintenance|Withdrawal by Subject|8|||
46727857|NCT00789373|82943894|FG000|Maintenance|Sponsor Decision|0|||
46727858|NCT00789373|82943895|FG001|Maintenance|Sponsor Decision|0|||
47047415|NCT01747915|83306897|FG000|Overall Study|Pregnancy|0|||
47047416|NCT01747915|83306898|FG001|Overall Study|Pregnancy|0|||
47047417|NCT01747915|83306899|FG002|Overall Study|Pregnancy|1|||
47047418|NCT01961297|83306909|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
47047419|NCT01961297|83306910|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
47047420|NCT01960907|83306918|FG000|Overall Study|Death|4|||
47047421|NCT01960907|83306919|FG001|Overall Study|Death|3|||
47047422|NCT01960907|83306918|FG000|Overall Study|Withdrawal by Subject|32|||
47047423|NCT01960907|83306919|FG001|Overall Study|Withdrawal by Subject|42|||
47047424|NCT01747837|83306930|FG000|Overall Study|Lost to Follow-up|5|||
47047425|NCT01747837|83306931|FG001|Overall Study|Lost to Follow-up|2|||
47047426|NCT01747837|83306930|FG000|Overall Study|Death|4|||
47047427|NCT01747837|83306931|FG001|Overall Study|Death|4|||
47047428|NCT01971203|83306939|FG000|Overall Study|Protocol Violation|3|||
47047429|NCT01971203|83306940|FG001|Overall Study|Protocol Violation|2|||
47047430|NCT01971203|83306939|FG000|Overall Study|Withdrawal by Subject|5|||
47047431|NCT01971203|83306940|FG001|Overall Study|Withdrawal by Subject|6|||
47047432|NCT01971203|83306939|FG000|Overall Study|Adverse Event|1|||
47047433|NCT01971203|83306940|FG001|Overall Study|Adverse Event|0|||
47047434|NCT01605877|83306946|FG000|Overall Study|Withdrawal by Subject|1|||
47047435|NCT01970501|83306970|FG000|Overall Study|Discontinuation of study by sponsor|16|||
47047436|NCT01970501|83306971|FG001|Overall Study|Discontinuation of study by sponsor|14|||
47047437|NCT01970501|83306970|FG000|Overall Study|Withdrawal by Subject|6|||
47047438|NCT01970501|83306971|FG001|Overall Study|Withdrawal by Subject|7|||
47047439|NCT01970501|83306970|FG000|Overall Study|Adverse Event|2|||
47047440|NCT01970501|83306971|FG001|Overall Study|Adverse Event|4|||
47047441|NCT01970501|83306970|FG000|Overall Study|Death|1|||
47047442|NCT01970501|83306971|FG001|Overall Study|Death|3|||
47047443|NCT01970501|83306970|FG000|Overall Study|Physician Decision|2|||
47047444|NCT01970501|83306971|FG001|Overall Study|Physician Decision|0|||
47047445|NCT01969799|83306979|FG000|Overall Study|Adverse Event|0|||
47047446|NCT01969799|83306980|FG001|Overall Study|Adverse Event|1|||
47047447|NCT01969799|83306979|FG000|Overall Study|Death|16|||
47047448|NCT01969799|83306980|FG001|Overall Study|Death|11|||
46634836|NCT01713582|82808216|FG020|Overall Study|Lack of Efficacy|0|||
46634837|NCT01713582|82808196|FG000|Overall Study|Withdrawal by Subject|0|||
46634838|NCT01713582|82808197|FG001|Overall Study|Withdrawal by Subject|0|||
46634839|NCT01713582|82808198|FG002|Overall Study|Withdrawal by Subject|0|||
46634840|NCT01713582|82808199|FG003|Overall Study|Withdrawal by Subject|0|||
46634841|NCT01713582|82808200|FG004|Overall Study|Withdrawal by Subject|0|||
46634842|NCT01713582|82808201|FG005|Overall Study|Withdrawal by Subject|0|||
46634843|NCT01713582|82808202|FG006|Overall Study|Withdrawal by Subject|0|||
46634844|NCT01713582|82808203|FG007|Overall Study|Withdrawal by Subject|0|||
46634845|NCT01713582|82808204|FG008|Overall Study|Withdrawal by Subject|0|||
46634846|NCT01713582|82808205|FG009|Overall Study|Withdrawal by Subject|0|||
46634847|NCT01713582|82808206|FG010|Overall Study|Withdrawal by Subject|0|||
46727859|NCT00789373|82943896|FG002|Maintenance|Sponsor Decision|2|||
47047449|NCT01969799|83306979|FG000|Overall Study|Lost to Follow-up|0|||
47047450|NCT01969799|83306980|FG001|Overall Study|Lost to Follow-up|2|||
46634848|NCT01713582|82808207|FG011|Overall Study|Withdrawal by Subject|0|||
46634849|NCT01713582|82808208|FG012|Overall Study|Withdrawal by Subject|0|||
46634850|NCT01713582|82808209|FG013|Overall Study|Withdrawal by Subject|0|||
46727860|NCT00789373|82943894|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
47047451|NCT01969799|83306979|FG000|Overall Study|Physician Decision|1|||
47047452|NCT01969799|83306980|FG001|Overall Study|Physician Decision|0|||
47047453|NCT01969721|83306986|FG000|Overall Study|Adverse Event|3|||
47047454|NCT01969721|83306987|FG001|Overall Study|Adverse Event|8|||
47047455|NCT01969721|83306988|FG002|Overall Study|Adverse Event|3|||
47047456|NCT01969721|83306989|FG003|Overall Study|Adverse Event|2|||
47047457|NCT01969721|83306986|FG000|Overall Study|Lack of Efficacy|0|||
47047458|NCT01969721|83306987|FG001|Overall Study|Lack of Efficacy|0|||
47047459|NCT01969721|83306988|FG002|Overall Study|Lack of Efficacy|1|||
47047460|NCT01969721|83306989|FG003|Overall Study|Lack of Efficacy|0|||
47047461|NCT01969721|83306986|FG000|Overall Study|Non compliant with protocol|1|||
47047462|NCT01969721|83306987|FG001|Overall Study|Non compliant with protocol|1|||
47047463|NCT01969721|83306988|FG002|Overall Study|Non compliant with protocol|0|||
47047464|NCT01969721|83306989|FG003|Overall Study|Non compliant with protocol|2|||
47047465|NCT01969721|83306986|FG000|Overall Study|Other not defined above|0|||
47047466|NCT01969721|83306987|FG001|Overall Study|Other not defined above|2|||
47047467|NCT01969721|83306988|FG002|Overall Study|Other not defined above|0|||
47047468|NCT01969721|83306989|FG003|Overall Study|Other not defined above|0|||
47047469|NCT01969721|83306986|FG000|Overall Study|Discontinued during washout periods.|0|||
47047470|NCT01969721|83306987|FG001|Overall Study|Discontinued during washout periods.|1|||
47047471|NCT01969721|83306988|FG002|Overall Study|Discontinued during washout periods.|1|||
47047472|NCT01969721|83306989|FG003|Overall Study|Discontinued during washout periods.|2|||
47047473|NCT01969565|83306999|FG000|Overall Study|Withdrawal by Subject|1|||
47047474|NCT01968707|83307012|FG000|Overall Study|Did not meet treatment day baseline|49|||
47047475|NCT01968707|83307013|FG001|Overall Study|Did not meet treatment day baseline|12|||
47047476|NCT01968707|83307014|FG002|Overall Study|Did not meet treatment day baseline|41|||
47047477|NCT01968707|83307015|FG003|Overall Study|Did not meet treatment day baseline|44|||
47047478|NCT01968707|83307016|FG004|Overall Study|Did not meet treatment day baseline|36|||
47047479|NCT01968707|83307017|FG005|Overall Study|Did not meet treatment day baseline|11|||
47047480|NCT01968707|83307018|FG006|Overall Study|Did not meet treatment day baseline|34|||
47047481|NCT01968707|83307019|FG007|Overall Study|Did not meet treatment day baseline|35|||
47047482|NCT01959581|83307052|FG000|Overall Study|Lost to Follow-up|5|||
46727861|NCT00789373|82943895|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
47047483|NCT01746901|83307056|FG000|Naloxone Challenge Phase|Adverse Event|2|||
47047484|NCT01746901|83307057|FG001|Naloxone Challenge Phase|Adverse Event|0|||
47047485|NCT01746901|83307058|FG002|Naloxone Challenge Phase|Adverse Event|0|||
47047486|NCT01746901|83307059|FG003|Naloxone Challenge Phase|Adverse Event|0|||
47047487|NCT01746901|83307060|FG004|Naloxone Challenge Phase|Adverse Event|0|||
47047488|NCT01746901|83307061|FG005|Naloxone Challenge Phase|Adverse Event|0|||
47047489|NCT01746901|83307062|FG006|Naloxone Challenge Phase|Adverse Event|0|||
47047490|NCT01746901|83307063|FG007|Naloxone Challenge Phase|Adverse Event|0|||
47047491|NCT01746901|83307064|FG008|Naloxone Challenge Phase|Adverse Event|0|||
47047492|NCT01746901|83307056|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
47047493|NCT01746901|83307057|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047494|NCT01746901|83307058|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047495|NCT01746901|83307059|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047496|NCT01746901|83307060|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047497|NCT01746901|83307061|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047498|NCT01746901|83307062|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047499|NCT01746901|83307063|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047500|NCT01746901|83307064|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
47047501|NCT01746901|83307056|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47047502|NCT01746901|83307057|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
47047503|NCT01746901|83307058|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47047504|NCT01746901|83307059|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
46727862|NCT00789373|82943896|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
46727863|NCT00851890|82943911|FG000|Overall Study|Lost to Follow-up|0|||
47047505|NCT01746901|83307060|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47047506|NCT01746901|83307061|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
46727864|NCT00851890|82943912|FG001|Overall Study|Lost to Follow-up|1|||
47047507|NCT01746901|83307062|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47047508|NCT01746901|83307063|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47047509|NCT01746901|83307064|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47047510|NCT01746901|83307056|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
47047511|NCT01746901|83307057|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
47047512|NCT01746901|83307058|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
47047513|NCT01746901|83307059|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
47047514|NCT01746901|83307060|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
47047515|NCT01746901|83307061|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
47047516|NCT01746901|83307062|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
47047517|NCT01746901|83307063|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
47047518|NCT01746901|83307064|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
47047519|NCT01746901|83307056|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
47047520|NCT01746901|83307057|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
47047521|NCT01746901|83307058|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
47047522|NCT01746901|83307059|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
47047523|NCT01746901|83307060|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
47047524|NCT01746901|83307061|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
47047525|NCT01746901|83307062|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
47047526|NCT01746901|83307063|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
47047527|NCT01746901|83307064|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
47047528|NCT01746901|83307056|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
46727865|NCT00851890|82943913|FG002|Overall Study|Lost to Follow-up|0|||
46634851|NCT01713582|82808210|FG014|Overall Study|Withdrawal by Subject|0|||
46634852|NCT01713582|82808211|FG015|Overall Study|Withdrawal by Subject|0|||
46634853|NCT01713582|82808212|FG016|Overall Study|Withdrawal by Subject|0|||
46634854|NCT01713582|82808213|FG017|Overall Study|Withdrawal by Subject|1|||
47047529|NCT01746901|83307057|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
47047530|NCT01746901|83307058|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
47047531|NCT01746901|83307059|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47047532|NCT01746901|83307060|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47047533|NCT01746901|83307061|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47047534|NCT01746901|83307062|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47047535|NCT01746901|83307063|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47047536|NCT01746901|83307064|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47047537|NCT01746901|83307056|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
47047538|NCT01746901|83307057|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
47047539|NCT01746901|83307058|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
47047540|NCT01746901|83307059|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
47047541|NCT01746901|83307060|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
47047542|NCT01746901|83307061|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
47047543|NCT01746901|83307062|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
47047544|NCT01746901|83307063|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
47047545|NCT01746901|83307064|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
47047546|NCT01746901|83307056|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047547|NCT01746901|83307057|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047548|NCT01746901|83307058|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047549|NCT01746901|83307059|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047550|NCT01746901|83307060|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047551|NCT01746901|83307061|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047552|NCT01746901|83307062|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047553|NCT01746901|83307063|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
47047554|NCT01746901|83307064|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
47047555|NCT01746901|83307056|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
47047556|NCT01746901|83307057|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
47047557|NCT01746901|83307058|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
47047558|NCT01746901|83307059|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
47047559|NCT01746901|83307060|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
47047560|NCT01746901|83307061|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
47047561|NCT01746901|83307062|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
47047562|NCT01746901|83307063|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
47047563|NCT01746901|83307064|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
47047564|NCT01746901|83307056|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047565|NCT01746901|83307057|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047566|NCT01746901|83307058|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047567|NCT01746901|83307059|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
47047568|NCT01746901|83307060|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047569|NCT01746901|83307061|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047570|NCT01746901|83307062|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047571|NCT01746901|83307063|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047572|NCT01746901|83307064|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
47047573|NCT01746901|83307056|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
47047574|NCT01746901|83307057|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
47047575|NCT01746901|83307058|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
47047576|NCT01746901|83307059|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
47047577|NCT01746901|83307060|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
47047578|NCT01746901|83307061|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
47047579|NCT01746901|83307062|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
47047580|NCT01746901|83307063|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
47047581|NCT01746901|83307064|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
47047582|NCT01746901|83307056|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
47047583|NCT01746901|83307057|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
47047584|NCT01746901|83307058|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
47047585|NCT01746901|83307059|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
47047586|NCT01746901|83307060|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
47047587|NCT01746901|83307061|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
47047588|NCT01746901|83307062|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
47047589|NCT01746901|83307063|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
47047590|NCT01746901|83307064|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
47047591|NCT01968551|83307103|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
47047592|NCT01968551|83307104|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
47047593|NCT01968551|83307105|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
47047594|NCT01968551|83307103|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
47047595|NCT01968551|83307104|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
47047596|NCT01968551|83307105|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
47047597|NCT01968551|83307103|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
47047598|NCT01968551|83307104|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
47047599|NCT01968551|83307105|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
47047600|NCT01968551|83307103|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
47047601|NCT01968551|83307104|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
47047602|NCT01968551|83307105|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
47047603|NCT01968551|83307103|FG000|Extension Phase|Adverse Event|0|||
47047604|NCT01968551|83307104|FG001|Extension Phase|Adverse Event|0|||
47047605|NCT01968551|83307105|FG002|Extension Phase|Adverse Event|2|||
47047606|NCT01968551|83307103|FG000|Extension Phase|Death|0|||
47047607|NCT01968551|83307104|FG001|Extension Phase|Death|1|||
47047608|NCT01968551|83307105|FG002|Extension Phase|Death|0|||
47047609|NCT01968551|83307103|FG000|Extension Phase|Withdrew Consent|0|||
47047610|NCT01968551|83307104|FG001|Extension Phase|Withdrew Consent|0|||
47047611|NCT01968551|83307105|FG002|Extension Phase|Withdrew Consent|1|||
47047612|NCT01968551|83307103|FG000|Extension Phase|Lost to Follow-up|1|||
47047613|NCT01968551|83307104|FG001|Extension Phase|Lost to Follow-up|0|||
47047614|NCT01968551|83307105|FG002|Extension Phase|Lost to Follow-up|1|||
47047615|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
47047616|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
47047617|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
47047618|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
47047619|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
46727866|NCT00851890|82943914|FG003|Overall Study|Lost to Follow-up|1|||
46727867|NCT00788827|82943924|FG000|Overall Study|Lack of Efficacy|2|||
46727868|NCT00592072|82943930|FG000|Wash Out Period|Lost to Follow-up|1|||
46727869|NCT00592072|82943931|FG001|Wash Out Period|Lost to Follow-up|1|||
46727870|NCT00792571|82943937|FG000|Overall Study|Death|1|||
46727871|NCT00792571|82943937|FG000|Overall Study|Adverse Event|4|||
46727872|NCT00792571|82943937|FG000|Overall Study|Withdrawal by Subject|1|||
46727873|NCT00792571|82943937|FG000|Overall Study|Other|4|||
46727874|NCT01069484|82943943|FG000|Overall Study|Death-in-near-family|1|||
46727875|NCT01069484|82943944|FG001|Overall Study|Death-in-near-family|0|||
46921227|NCT00777491|83153648|FG001|Overall Study|Protocol Violation|2|||
46921228|NCT00777491|83153647|FG000|Overall Study|Did not receive any protocol treatment|2|||
46921229|NCT00777491|83153648|FG001|Overall Study|Did not receive any protocol treatment|0|||
46921230|NCT02066532|83153658|FG000|Phase II|Withdrawal by Subject|1|||
46921231|NCT02066532|83153659|FG001|Phase II|Withdrawal by Subject|0|||
46921232|NCT02066532|83153660|FG002|Phase II|Withdrawal by Subject|0|||
46921233|NCT02066532|83153661|FG003|Phase II|Withdrawal by Subject|0|||
46921234|NCT03077711|83153668|FG000|Overall Study|Lost to Follow-up|2|||
46921235|NCT03077711|83153669|FG001|Overall Study|Lost to Follow-up|2|||
46921236|NCT03077711|83153668|FG000|Overall Study|noncompliant taking medication|2|||
46921237|NCT03077711|83153669|FG001|Overall Study|noncompliant taking medication|0|||
46921238|NCT04311463|83153696|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
46921239|NCT04311463|83153697|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
46921240|NCT04311463|83153696|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
46921241|NCT04311463|83153697|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
46921242|NCT04311463|83153696|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
46921243|NCT04311463|83153697|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
46921244|NCT01370538|83153710|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
46921245|NCT01370538|83153711|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
47047620|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
46727876|NCT01069484|82943943|FG000|Overall Study|No specific reason|8|||
46727877|NCT01069484|82943944|FG001|Overall Study|No specific reason|2|||
46727878|NCT01069484|82943943|FG000|Overall Study|Illness mother or child|3|||
46727879|NCT01069484|82943944|FG001|Overall Study|Illness mother or child|1|||
46727880|NCT00794365|82943951|FG000|Overall Study|Lost to Follow-up|38|||
46727881|NCT00794365|82943951|FG000|Overall Study|Other|17|||
46727882|NCT00794365|82943951|FG000|Overall Study|Poor Compliance|11|||
46921246|NCT01370538|83153710|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
47047621|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
47047622|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
46921247|NCT01370538|83153711|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
46921248|NCT01370538|83153710|FG000|Overall Study|Adverse Event|1|||
46921249|NCT01370538|83153711|FG001|Overall Study|Adverse Event|0|||
46727883|NCT00794365|82943951|FG000|Overall Study|Adverse Event|10|||
46727884|NCT00794365|82943951|FG000|Overall Study|Lack of Efficacy|3|||
46727885|NCT01067144|82943957|FG000|Treatment|Did not receive allocated intervention|4|||
46775700|NCT00694551|82994164|FG000|Overall Study|Disease Progression|1|||
46727886|NCT01067144|82943958|FG001|Treatment|Did not receive allocated intervention|7|||
46727887|NCT01067144|82943957|FG000|Follow-up|Lost to Follow-up|22|||
46727888|NCT01067144|82943958|FG001|Follow-up|Lost to Follow-up|12|||
46727889|NCT01067144|82943957|FG000|Follow-up|Censored owing to second surgery|19|||
46727890|NCT01067144|82943958|FG001|Follow-up|Censored owing to second surgery|28|||
46727891|NCT01067144|82943957|FG000|Follow-up|Withdrawal by Subject|18|||
46727892|NCT01067144|82943958|FG001|Follow-up|Withdrawal by Subject|14|||
46727893|NCT01067144|82943957|FG000|Follow-up|Surgery cancelled|0|||
46727894|NCT01067144|82943958|FG001|Follow-up|Surgery cancelled|1|||
46727895|NCT01067144|82943957|FG000|Follow-up|Death|0|||
46727896|NCT01067144|82943958|FG001|Follow-up|Death|1|||
46727897|NCT01078298|82943966|FG000|Overall Study|Lost to Follow-up|12|||
46727898|NCT01078298|82943967|FG001|Overall Study|Lost to Follow-up|13|||
46727899|NCT01078298|82943966|FG000|Overall Study|Withdrawal by Subject|31|||
46727900|NCT01078298|82943967|FG001|Overall Study|Withdrawal by Subject|33|||
46727901|NCT01078298|82943966|FG000|Overall Study|Protocol Violation|6|||
46727902|NCT01078298|82943967|FG001|Overall Study|Protocol Violation|6|||
46727903|NCT01078298|82943966|FG000|Overall Study|Adverse Event|6|||
46727904|NCT01078298|82943967|FG001|Overall Study|Adverse Event|5|||
46727905|NCT01078298|82943966|FG000|Overall Study|Death|2|||
46727906|NCT01078298|82943967|FG001|Overall Study|Death|0|||
46727907|NCT01078298|82943966|FG000|Overall Study|Did not meet entrance criteria|0|||
46727908|NCT01078298|82943967|FG001|Overall Study|Did not meet entrance criteria|1|||
46727909|NCT01078298|82943966|FG000|Overall Study|Other|24|||
46727910|NCT01078298|82943967|FG001|Overall Study|Other|32|||
47047623|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
47047624|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
47047625|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
47047626|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
47047627|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
46727911|NCT00788593|82943973|FG000|Placebo Run-in Phase|Adverse Event|2|||
46727912|NCT00788593|82943974|FG001|Placebo Run-in Phase|Adverse Event|0|||
46727913|NCT00788593|82943975|FG002|Placebo Run-in Phase|Adverse Event|0|||
46727914|NCT00788593|82943973|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
46727915|NCT00788593|82943974|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
46727916|NCT00788593|82943975|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
46727917|NCT00788593|82943973|FG000|Placebo Run-in Phase|Protocol Violation|2|||
46727918|NCT00788593|82943974|FG001|Placebo Run-in Phase|Protocol Violation|0|||
46727919|NCT00788593|82943975|FG002|Placebo Run-in Phase|Protocol Violation|0|||
46727920|NCT00788593|82943973|FG000|First Intervention Period|Adverse Event|0|||
46727921|NCT00788593|82943974|FG001|First Intervention Period|Adverse Event|1|||
46727922|NCT00788593|82943975|FG002|First Intervention Period|Adverse Event|0|||
46727923|NCT00788593|82943973|FG000|Second Intervention Period|Lost to Follow-up|0|||
46727924|NCT00788593|82943974|FG001|Second Intervention Period|Lost to Follow-up|1|||
46727925|NCT00788593|82943975|FG002|Second Intervention Period|Lost to Follow-up|0|||
46727926|NCT00788593|82943973|FG000|Second Intervention Period|Other|0|||
46727927|NCT00788593|82943974|FG001|Second Intervention Period|Other|0|||
46727928|NCT00788593|82943975|FG002|Second Intervention Period|Other|1|||
46727929|NCT00793819|82943987|FG000|Overall Study|Adverse Event|8|||
46727930|NCT00793819|82943988|FG001|Overall Study|Adverse Event|4|||
46727931|NCT00793819|82943987|FG000|Overall Study|Lack of Efficacy|1|||
46727932|NCT00793819|82943988|FG001|Overall Study|Lack of Efficacy|1|||
46727933|NCT00793819|82943987|FG000|Overall Study|Withdrawal by Subject|4|||
46727934|NCT00793819|82943988|FG001|Overall Study|Withdrawal by Subject|3|||
46727935|NCT00793819|82943987|FG000|Overall Study|Lost to Follow-up|1|||
46727936|NCT00793819|82943988|FG001|Overall Study|Lost to Follow-up|1|||
46727937|NCT00792259|82943997|FG000|Overall Study|Poor Quality Scans|1|||
46727938|NCT00792259|82943998|FG001|Overall Study|Poor Quality Scans|0|||
46727939|NCT00792259|82943999|FG002|Overall Study|Poor Quality Scans|0|||
46727940|NCT00894387|82944009|FG000|Overall Study|Adverse Event|44|||
46727941|NCT00894387|82944010|FG001|Overall Study|Adverse Event|45|||
46727942|NCT00894387|82944009|FG000|Overall Study|Abnormal Laboratory values|2|||
46727943|NCT00894387|82944010|FG001|Overall Study|Abnormal Laboratory values|2|||
46727944|NCT00894387|82944009|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
47047628|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
47047629|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
46634855|NCT01713582|82808214|FG018|Overall Study|Withdrawal by Subject|0|||
46634856|NCT01713582|82808215|FG019|Overall Study|Withdrawal by Subject|0|||
46727945|NCT00894387|82944010|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46634857|NCT01713582|82808216|FG020|Overall Study|Withdrawal by Subject|0|||
46634858|NCT01713582|82808196|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
46634859|NCT01713582|82808197|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
46634860|NCT01713582|82808198|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
46634861|NCT01713582|82808199|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
46634862|NCT01713582|82808200|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
46727946|NCT00894387|82944009|FG000|Overall Study|Lost to Follow-up|3|||
46727947|NCT00894387|82944010|FG001|Overall Study|Lost to Follow-up|5|||
46727948|NCT00894387|82944009|FG000|Overall Study|Administrative problems|2|||
46727949|NCT00894387|82944010|FG001|Overall Study|Administrative problems|2|||
46727950|NCT00894387|82944009|FG000|Overall Study|Death|77|||
47047630|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
47047631|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
47047632|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
47047633|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
47047634|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
47047635|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
47047636|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
47047637|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
47047638|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
47047639|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
47047640|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
47047641|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
47047642|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
47047643|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
47047644|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
47047645|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
47047646|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
47047647|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
47047648|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
47047649|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
47047650|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
47047651|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
47047652|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
47047653|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
46727951|NCT00894387|82944010|FG001|Overall Study|Death|76|||
46727952|NCT00894387|82944009|FG000|Overall Study|Protocol Deviation|4|||
46727953|NCT00894387|82944010|FG001|Overall Study|Protocol Deviation|0|||
46727954|NCT00894387|82944009|FG000|Overall Study|Patient's request|25|||
46727955|NCT00894387|82944010|FG001|Overall Study|Patient's request|30|||
46727956|NCT00894387|82944009|FG000|Overall Study|Other (Missing)|5|||
46727957|NCT00894387|82944010|FG001|Overall Study|Other (Missing)|3|||
46727958|NCT00894387|82944009|FG000|Overall Study|Mis-randomized|13|||
46727959|NCT00894387|82944010|FG001|Overall Study|Mis-randomized|9|||
46727960|NCT00894387|82944009|FG000|Overall Study|GCP non-compliance|0|||
46727961|NCT00894387|82944010|FG001|Overall Study|GCP non-compliance|2|||
46727962|NCT00928512|82944021|FG000|Overall Study|Adverse Event|4|||
46727963|NCT00928512|82944022|FG001|Overall Study|Adverse Event|3|||
46727964|NCT00928512|82944023|FG002|Overall Study|Adverse Event|2|||
46727965|NCT00928512|82944024|FG003|Overall Study|Adverse Event|8|||
46727966|NCT00928512|82944025|FG004|Overall Study|Adverse Event|6|||
46727967|NCT00928512|82944021|FG000|Overall Study|Lack of Efficacy|2|||
46727968|NCT00928512|82944022|FG001|Overall Study|Lack of Efficacy|0|||
46727969|NCT00928512|82944023|FG002|Overall Study|Lack of Efficacy|4|||
46727970|NCT00928512|82944024|FG003|Overall Study|Lack of Efficacy|7|||
46727971|NCT00928512|82944025|FG004|Overall Study|Lack of Efficacy|3|||
46727972|NCT00928512|82944021|FG000|Overall Study|Protocol Violation|0|||
46727973|NCT00928512|82944022|FG001|Overall Study|Protocol Violation|1|||
46727974|NCT00928512|82944023|FG002|Overall Study|Protocol Violation|0|||
46727975|NCT00928512|82944024|FG003|Overall Study|Protocol Violation|1|||
46727976|NCT00928512|82944025|FG004|Overall Study|Protocol Violation|3|||
46727977|NCT00928512|82944021|FG000|Overall Study|Withdrawal by Subject|3|||
46727978|NCT00928512|82944022|FG001|Overall Study|Withdrawal by Subject|0|||
46727979|NCT00928512|82944023|FG002|Overall Study|Withdrawal by Subject|3|||
46727980|NCT00928512|82944024|FG003|Overall Study|Withdrawal by Subject|4|||
46727981|NCT00928512|82944025|FG004|Overall Study|Withdrawal by Subject|0|||
47047654|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
47047655|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
46727982|NCT00928512|82944021|FG000|Overall Study|Lost to Follow-up|1|||
46727983|NCT00928512|82944022|FG001|Overall Study|Lost to Follow-up|1|||
46727984|NCT00928512|82944023|FG002|Overall Study|Lost to Follow-up|2|||
46727985|NCT00928512|82944024|FG003|Overall Study|Lost to Follow-up|1|||
46727986|NCT00928512|82944025|FG004|Overall Study|Lost to Follow-up|3|||
46727987|NCT00928512|82944021|FG000|Overall Study|Administrative Problems|0|||
46727988|NCT00928512|82944022|FG001|Overall Study|Administrative Problems|1|||
46727989|NCT00928512|82944023|FG002|Overall Study|Administrative Problems|0|||
46727990|NCT00928512|82944024|FG003|Overall Study|Administrative Problems|0|||
46803792|NCT00545402|83023078|FG001|Overall Study|Protocol Violation|0|||
46727991|NCT00928512|82944025|FG004|Overall Study|Administrative Problems|0|||
46727992|NCT00787891|82944043|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
46727993|NCT00787891|82944044|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
46727994|NCT00787891|82944043|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
46727995|NCT00787891|82944044|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
46727996|NCT00787891|82944043|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
46727997|NCT00787891|82944044|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
46727998|NCT00787891|82944043|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
46727999|NCT00787891|82944044|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
46728000|NCT00787891|82944043|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
46728001|NCT00787891|82944044|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
46728002|NCT00787891|82944043|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
46728003|NCT00787891|82944044|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
46728004|NCT00787891|82944043|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
46728005|NCT00787891|82944044|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
46728006|NCT00787891|82944043|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
46728007|NCT00787891|82944044|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
46728008|NCT00787891|82944043|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
46728009|NCT00787891|82944044|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
46921250|NCT01370538|83153710|FG000|Overall Study|Protocol Violation|8|||
46921251|NCT01370538|83153711|FG001|Overall Study|Protocol Violation|5|||
47047656|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
47047657|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
47047658|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
47047659|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
47047660|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
47047661|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
47047662|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
47047663|NCT01707992|83307120|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
47047664|NCT01707992|83307121|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
47047665|NCT01707992|83307122|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
46728010|NCT00787891|82944043|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
46728011|NCT00787891|82944044|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
46728012|NCT00892437|82944054|FG000|Randomized Phase|Randomized but not treated|6|||
46728013|NCT00892437|82944055|FG001|Randomized Phase|Randomized but not treated|0|||
46728014|NCT00892437|82944054|FG000|Randomized Phase|Adverse Event|2|||
46728015|NCT00892437|82944055|FG001|Randomized Phase|Adverse Event|2|||
46728016|NCT00892437|82944054|FG000|Randomized Phase|Lost to Follow-up|1|||
46728017|NCT00892437|82944055|FG001|Randomized Phase|Lost to Follow-up|3|||
46728018|NCT00892437|82944054|FG000|Randomized Phase|Investigator's Discretion|1|||
46728019|NCT00892437|82944055|FG001|Randomized Phase|Investigator's Discretion|0|||
46921252|NCT01370538|83153710|FG000|Overall Study|Development of study specific withdrawal|1|||
46921253|NCT01370538|83153711|FG001|Overall Study|Development of study specific withdrawal|1|||
46921254|NCT01370538|83153710|FG000|Overall Study|Lost to follow up|6|||
46921255|NCT01370538|83153711|FG001|Overall Study|Lost to follow up|10|||
46921256|NCT03402841|83153730|FG000|Overall Study|Withdrawal by Subject|3|||
46921257|NCT03402841|83153730|FG000|Overall Study|Lost to Follow-up|2|||
46921258|NCT03402841|83153730|FG000|Overall Study|Death|146|||
47047666|NCT01707992|83307123|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
47047667|NCT01707992|83307124|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
47047668|NCT01707992|83307125|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
47047669|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
47047670|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
47047671|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
47047672|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
47047673|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
47047674|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
46634863|NCT01713582|82808201|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
46634864|NCT01713582|82808202|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
46634865|NCT01713582|82808203|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
47047675|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
46634866|NCT01713582|82808204|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
46634867|NCT01713582|82808205|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
46634868|NCT01713582|82808206|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
46634869|NCT01713582|82808207|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
46634870|NCT01713582|82808208|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
46634871|NCT01713582|82808209|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
46634872|NCT01713582|82808210|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
46634873|NCT01713582|82808211|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
47047676|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
47047677|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
47047678|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
47047679|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
47047680|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
47047681|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
47047682|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
47047683|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
47047684|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
46728020|NCT00892437|82944054|FG000|Randomized Phase|Withdrew Consent|1|||
46728021|NCT00892437|82944055|FG001|Randomized Phase|Withdrew Consent|0|||
46728022|NCT00892437|82944054|FG000|Open-Label Extension Phase|Adverse Event|4|||
46728023|NCT00892437|82944055|FG001|Open-Label Extension Phase|Adverse Event|2|||
46728024|NCT00892437|82944054|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
46728025|NCT00892437|82944055|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
47047685|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
47047686|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
47047687|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
46728026|NCT00892437|82944054|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
46728027|NCT00892437|82944055|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
46728028|NCT00892437|82944054|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
46728029|NCT00892437|82944055|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
46728030|NCT00892437|82944054|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
46728031|NCT00892437|82944055|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
46728032|NCT00792103|82944062|FG000|Overall Study|Enrolled, not treated|15|||
46728033|NCT00792103|82944062|FG000|Overall Study|Lost to Follow-up|17|||
47047688|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
46728034|NCT00792103|82944062|FG000|Overall Study|Adverse Event|25|||
46728035|NCT00792103|82944062|FG000|Overall Study|Withdrawal by Subject|52|||
46728036|NCT00792103|82944062|FG000|Overall Study|Protocol Violation|10|||
46728037|NCT00792103|82944062|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
47047689|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
47047690|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
47047691|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
47047692|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
47047693|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
47047694|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
47047695|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
47047696|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
47047697|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
47047698|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
47047699|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Death|0|||
47047700|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Death|0|||
47047701|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Death|0|||
47047702|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Death|2|||
47047703|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Death|0|||
47047704|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Death|0|||
47047705|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
47047706|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
47047707|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
47047708|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
47047709|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
47047710|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
47047711|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
47047712|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
47047713|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
47047714|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
47047715|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
47047716|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
47047717|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
47047718|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
47047719|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
47047720|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
47047721|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
47047722|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
47047723|NCT01707992|83307120|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
47047724|NCT01707992|83307121|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
47047725|NCT01707992|83307122|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
47047726|NCT01707992|83307123|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
47047727|NCT01707992|83307124|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
47047728|NCT01707992|83307125|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
47047729|NCT01946165|83307142|FG000|Overall Study|Physician Decision|2|||
47047730|NCT01946165|83307143|FG001|Overall Study|Physician Decision|0|||
47047731|NCT01946165|83307142|FG000|Overall Study|Withdrawal by Subject|0|||
47047732|NCT01946165|83307143|FG001|Overall Study|Withdrawal by Subject|2|||
47047733|NCT01707667|83307152|FG000|Period 1|expulsion of colonic sensor catheter|1|||
47047734|NCT01707667|83307153|FG001|Period 1|expulsion of colonic sensor catheter|0|||
47047735|NCT01959503|83307161|FG000|Overall Study|Death|2|||
47047736|NCT01959503|83307162|FG001|Overall Study|Death|1|||
47047737|NCT01959503|83307161|FG000|Overall Study|Randomized but not treated|1|||
47047738|NCT01959503|83307162|FG001|Overall Study|Randomized but not treated|1|||
47047739|NCT01605799|83307170|FG000|Overall Study|Withdrawal by Subject|2|||
47047740|NCT01605799|83307171|FG001|Overall Study|Withdrawal by Subject|1|||
47047741|NCT01706575|83307177|FG000|Overall Study|Participant Withdrew Consent|4|||
47047742|NCT01706575|83307177|FG000|Overall Study|Lost to Follow-up|2|||
47047743|NCT01706575|83307177|FG000|Overall Study|Started but not Treated|6|||
47047744|NCT01959425|83307183|FG000|Overall Study|Withdrawal by Subject|5|||
47047745|NCT01959425|83307184|FG001|Overall Study|Withdrawal by Subject|4|||
47047746|NCT01959425|83307183|FG000|Overall Study|Lost to Follow-up|1|||
47047747|NCT01959425|83307184|FG001|Overall Study|Lost to Follow-up|0|||
47047748|NCT01959425|83307183|FG000|Overall Study|Discontinued Subjects|6|||
47047749|NCT01959425|83307184|FG001|Overall Study|Discontinued Subjects|4|||
47047750|NCT01725529|83307193|FG000|Overall Study|Adverse Event|1|||
47047751|NCT01725529|83307194|FG001|Overall Study|Adverse Event|0|||
47047752|NCT01725529|83307195|FG002|Overall Study|Adverse Event|0|||
47047753|NCT01725529|83307193|FG000|Overall Study|Lost to Follow-up|2|||
47047754|NCT01725529|83307194|FG001|Overall Study|Lost to Follow-up|1|||
47047755|NCT01725529|83307195|FG002|Overall Study|Lost to Follow-up|1|||
47047756|NCT01725529|83307193|FG000|Overall Study|Protocol Violation|0|||
47047757|NCT01725529|83307194|FG001|Overall Study|Protocol Violation|1|||
47047758|NCT01725529|83307195|FG002|Overall Study|Protocol Violation|1|||
47047759|NCT01725529|83307193|FG000|Overall Study|Withdrawal by Subject|12|||
47047760|NCT01725529|83307194|FG001|Overall Study|Withdrawal by Subject|14|||
47047761|NCT01725529|83307195|FG002|Overall Study|Withdrawal by Subject|8|||
47047762|NCT01605097|83307203|FG000|Overall Study|Protocol Violation|1|||
47047763|NCT01605019|83307210|FG000|Overall Study|pt did not meet transplant endpoint|3|||
47047764|NCT01605019|83307211|FG001|Overall Study|pt did not meet transplant endpoint|0|||
47047765|NCT01705717|83307219|FG000|Overall Study|Adverse Event|2|||
47047766|NCT01705717|83307220|FG001|Overall Study|Adverse Event|2|||
47047767|NCT01705717|83307219|FG000|Overall Study|Lack of Efficacy|0|||
47047768|NCT01705717|83307220|FG001|Overall Study|Lack of Efficacy|1|||
47047769|NCT01705717|83307219|FG000|Overall Study|Other|0|||
47047770|NCT01705717|83307220|FG001|Overall Study|Other|2|||
47047771|NCT01744483|83307228|FG000|Overall Study|Death|9|||
47047772|NCT01744483|83307229|FG001|Overall Study|Death|4|||
47047773|NCT01744483|83307230|FG002|Overall Study|Death|11|||
47047774|NCT01744483|83307228|FG000|Overall Study|Lost to Follow-up|8|||
47047775|NCT01744483|83307229|FG001|Overall Study|Lost to Follow-up|9|||
47047776|NCT01744483|83307230|FG002|Overall Study|Lost to Follow-up|11|||
47047777|NCT01744483|83307228|FG000|Overall Study|Protocol Violation|1|||
47047778|NCT01744483|83307229|FG001|Overall Study|Protocol Violation|2|||
47047779|NCT01744483|83307230|FG002|Overall Study|Protocol Violation|1|||
47047780|NCT01744483|83307228|FG000|Overall Study|Withdrawal by Subject|4|||
47047781|NCT01744483|83307229|FG001|Overall Study|Withdrawal by Subject|6|||
47047782|NCT01744483|83307230|FG002|Overall Study|Withdrawal by Subject|2|||
47047783|NCT01744483|83307228|FG000|Overall Study|No ICU Admit|5|||
46728038|NCT00892281|82944068|FG000|Overall Study|Adverse Event|65|||
46728039|NCT00892281|82944069|FG001|Overall Study|Adverse Event|8|||
46728040|NCT00892281|82944068|FG000|Overall Study|Lost to Follow-up|81|||
46728041|NCT00892281|82944069|FG001|Overall Study|Lost to Follow-up|8|||
46728042|NCT00892281|82944068|FG000|Overall Study|Pregnancy|1|||
46728043|NCT00892281|82944069|FG001|Overall Study|Pregnancy|0|||
47047784|NCT01744483|83307229|FG001|Overall Study|No ICU Admit|1|||
47047785|NCT01744483|83307230|FG002|Overall Study|No ICU Admit|2|||
47047786|NCT01744483|83307228|FG000|Overall Study|Routed to OSH|2|||
47047787|NCT01744483|83307229|FG001|Overall Study|Routed to OSH|0|||
47047788|NCT01744483|83307230|FG002|Overall Study|Routed to OSH|1|||
47047789|NCT01744093|83307240|FG000|Overall Study|Withdrawal by Subject|6|||
47047790|NCT01744093|83307241|FG001|Overall Study|Withdrawal by Subject|1|||
47047791|NCT01725451|83307255|FG000|Period 1|Withdrawal by Subject|1|||
47047792|NCT01725451|83307256|FG001|Period 1|Withdrawal by Subject|0|||
47047793|NCT01725451|83307257|FG002|Period 1|Withdrawal by Subject|0|||
47047794|NCT01725451|83307258|FG003|Period 1|Withdrawal by Subject|0|||
47047795|NCT01725451|83307255|FG000|Washout From Period 3|Protocol Violation|0|||
47047796|NCT01725451|83307256|FG001|Washout From Period 3|Protocol Violation|0|||
47047797|NCT01725451|83307257|FG002|Washout From Period 3|Protocol Violation|1|||
47047798|NCT01725451|83307258|FG003|Washout From Period 3|Protocol Violation|0|||
47047799|NCT01725451|83307255|FG000|Washout From Period 3|Adverse Event|0|||
47047800|NCT01725451|83307256|FG001|Washout From Period 3|Adverse Event|1|||
47047801|NCT01725451|83307257|FG002|Washout From Period 3|Adverse Event|0|||
47047802|NCT01725451|83307258|FG003|Washout From Period 3|Adverse Event|0|||
47047803|NCT01725451|83307255|FG000|Period 4|Adverse Event|0|||
47047804|NCT01725451|83307256|FG001|Period 4|Adverse Event|0|||
47047805|NCT01725451|83307257|FG002|Period 4|Adverse Event|1|||
47047806|NCT01725451|83307258|FG003|Period 4|Adverse Event|0|||
47047807|NCT01707290|83307275|FG000|Overall Study|Adverse event (AE)|1|||
47047808|NCT01707290|83307276|FG001|Overall Study|Adverse event (AE)|0|||
47047809|NCT01707290|83307275|FG000|Overall Study|Physician Decision|1|||
47047810|NCT01707290|83307276|FG001|Overall Study|Physician Decision|0|||
47047811|NCT01707290|83307275|FG000|Overall Study|Lost to Follow-up|3|||
47047812|NCT01707290|83307276|FG001|Overall Study|Lost to Follow-up|0|||
47047813|NCT01707290|83307275|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
47047814|NCT01707290|83307276|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
47047815|NCT01707290|83307275|FG000|Overall Study|Commercial drug available|60|||
47047816|NCT01707290|83307276|FG001|Overall Study|Commercial drug available|1|||
47047817|NCT01707290|83307275|FG000|Overall Study|Other unspecified|17|||
47047818|NCT01707290|83307276|FG001|Overall Study|Other unspecified|0|||
47047819|NCT01717040|83307287|FG000|Overall Study|Lost to Follow-up|2|||
47047820|NCT01717040|83307288|FG001|Overall Study|Lost to Follow-up|3|||
47047821|NCT01717040|83307287|FG000|Overall Study|Lack of Efficacy|1|||
46728044|NCT00892281|82944068|FG000|Overall Study|Protocol Violation|7|||
46728045|NCT00892281|82944069|FG001|Overall Study|Protocol Violation|2|||
47047822|NCT01717040|83307288|FG001|Overall Study|Lack of Efficacy|1|||
46728046|NCT00892281|82944068|FG000|Overall Study|Withdrawal by Subject|86|||
47047823|NCT01717040|83307287|FG000|Overall Study|Adverse Event|1|||
47047824|NCT01717040|83307288|FG001|Overall Study|Adverse Event|0|||
46728047|NCT00892281|82944069|FG001|Overall Study|Withdrawal by Subject|14|||
46728048|NCT00892281|82944068|FG000|Overall Study|Subject failed to return for final visit|2|||
46728049|NCT00892281|82944069|FG001|Overall Study|Subject failed to return for final visit|0|||
46728050|NCT00892281|82944068|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
46728051|NCT00892281|82944069|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
46728052|NCT00892281|82944068|FG000|Overall Study|Final visit completed 4 weeks late|0|||
46728053|NCT00892281|82944069|FG001|Overall Study|Final visit completed 4 weeks late|1|||
46728054|NCT00892281|82944068|FG000|Overall Study|Subject completed day after study closed|1|||
46728055|NCT00892281|82944069|FG001|Overall Study|Subject completed day after study closed|0|||
46728056|NCT00892281|82944068|FG000|Overall Study|Family emergency|1|||
46728057|NCT00892281|82944069|FG001|Overall Study|Family emergency|0|||
46728058|NCT00892281|82944068|FG000|Overall Study|Last visit not done - death in family|1|||
46728059|NCT00892281|82944069|FG001|Overall Study|Last visit not done - death in family|0|||
46728060|NCT00892281|82944068|FG000|Overall Study|Did not meet incl/excl criteria|1|||
46728061|NCT00892281|82944069|FG001|Overall Study|Did not meet incl/excl criteria|0|||
46728062|NCT00892281|82944068|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
46728063|NCT00892281|82944069|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
46728064|NCT00892281|82944068|FG000|Overall Study|Unable to redeem the drug voucher|1|||
46728065|NCT00892281|82944069|FG001|Overall Study|Unable to redeem the drug voucher|0|||
46728066|NCT00892281|82944068|FG000|Overall Study|Subject not good candidate for study|1|||
46728067|NCT00892281|82944069|FG001|Overall Study|Subject not good candidate for study|0|||
46728068|NCT00892281|82944068|FG000|Overall Study|Subject did not return for any visits|1|||
46728069|NCT00892281|82944069|FG001|Overall Study|Subject did not return for any visits|0|||
46728070|NCT00892281|82944068|FG000|Overall Study|Subject missed several visits/lost meds|1|||
46728071|NCT00892281|82944069|FG001|Overall Study|Subject missed several visits/lost meds|0|||
46728072|NCT00892281|82944068|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
46728073|NCT00892281|82944069|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
46728074|NCT00892281|82944068|FG000|Overall Study|Scheduled for knee replacement|0|||
46728075|NCT00892281|82944069|FG001|Overall Study|Scheduled for knee replacement|1|||
46728076|NCT00892281|82944068|FG000|Overall Study|PI complained of inadequate compensation|3|||
46728077|NCT00892281|82944069|FG001|Overall Study|PI complained of inadequate compensation|0|||
46728078|NCT00892281|82944068|FG000|Overall Study|Subject lost interest in program|0|||
46728079|NCT00892281|82944069|FG001|Overall Study|Subject lost interest in program|1|||
46728080|NCT00892281|82944068|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
46728081|NCT00892281|82944069|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
46728082|NCT00892281|82944068|FG000|Overall Study|Death in family|1|||
46728083|NCT00892281|82944069|FG001|Overall Study|Death in family|0|||
46728084|NCT00892281|82944068|FG000|Overall Study|Lack of efficacy of study product|2|||
46728085|NCT00892281|82944069|FG001|Overall Study|Lack of efficacy of study product|0|||
46728086|NCT00892281|82944068|FG000|Overall Study|Subject not seen by PI at final visit|1|||
46728087|NCT00892281|82944069|FG001|Overall Study|Subject not seen by PI at final visit|0|||
46728088|NCT00892281|82944068|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
46728089|NCT00892281|82944069|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
46728090|NCT00892281|82944068|FG000|Overall Study|Missed multiple visits|1|||
46728091|NCT00892281|82944069|FG001|Overall Study|Missed multiple visits|0|||
46728092|NCT00892281|82944068|FG000|Overall Study|Missed visits rescheduled out of window|1|||
46728093|NCT00892281|82944069|FG001|Overall Study|Missed visits rescheduled out of window|0|||
46728094|NCT00892281|82944068|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
46728095|NCT00892281|82944069|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
46728096|NCT00892281|82944068|FG000|Overall Study|Subject had history of drug abuse|1|||
46728097|NCT00892281|82944069|FG001|Overall Study|Subject had history of drug abuse|0|||
46728098|NCT00892281|82944068|FG000|Overall Study|Rash on hand|1|||
46728099|NCT00892281|82944069|FG001|Overall Study|Rash on hand|0|||
46728100|NCT00892281|82944068|FG000|Overall Study|Visit 4 date out of window|1|||
46728101|NCT00892281|82944069|FG001|Overall Study|Visit 4 date out of window|0|||
46728102|NCT00784693|82944077|FG000|Overall Study|Lost to Follow-up|0|||
46728103|NCT00784693|82944078|FG001|Overall Study|Lost to Follow-up|1|||
46728104|NCT00784693|82944077|FG000|Overall Study|Lack of Efficacy|1|||
46728105|NCT00784693|82944078|FG001|Overall Study|Lack of Efficacy|1|||
46728106|NCT00784693|82944077|FG000|Overall Study|Withdrawal by Subject|0|||
46728107|NCT00784693|82944078|FG001|Overall Study|Withdrawal by Subject|4|||
46728108|NCT00784693|82944077|FG000|Overall Study|Randomized but not Treated|1|||
46921259|NCT02881957|83153745|FG000|Overall Study|Comfort care|0|||
46728109|NCT00784693|82944078|FG001|Overall Study|Randomized but not Treated|0|||
46728110|NCT00784693|82944077|FG000|Overall Study|Other|1|||
46728111|NCT00784693|82944078|FG001|Overall Study|Other|0|||
46728112|NCT00893763|82944086|FG000|Overall Study|extubated|110|||
46728113|NCT00893763|82944087|FG001|Overall Study|extubated|110|||
46728114|NCT00892047|82944097|FG000|Overall Study|Adverse Event|2|||
46728115|NCT00892047|82944098|FG001|Overall Study|Adverse Event|2|||
46728116|NCT00892047|82944097|FG000|Overall Study|subject burden|2|||
46728117|NCT00892047|82944098|FG001|Overall Study|subject burden|3|||
46728118|NCT00892047|82944097|FG000|Overall Study|Lack of Efficacy|0|||
46728119|NCT00892047|82944098|FG001|Overall Study|Lack of Efficacy|2|||
46728120|NCT00787267|82944106|FG000|Overall Study|Screen failure/Ineligible|10|||
46728121|NCT00787267|82944106|FG000|Overall Study|No Reason Provided|1|||
46728122|NCT00787267|82944106|FG000|Overall Study|Withdrawal by Subject|1|||
46728123|NCT00928434|82944113|FG000|Overall Study|Adverse Event|14|||
46728124|NCT00928434|82944114|FG001|Overall Study|Adverse Event|5|||
46728125|NCT00928434|82944115|FG002|Overall Study|Adverse Event|18|||
46728126|NCT00928434|82944113|FG000|Overall Study|Protocol Violation|5|||
46728127|NCT00928434|82944114|FG001|Overall Study|Protocol Violation|0|||
46728128|NCT00928434|82944115|FG002|Overall Study|Protocol Violation|8|||
46728129|NCT00928434|82944113|FG000|Overall Study|Physician Decision|2|||
46728130|NCT00928434|82944114|FG001|Overall Study|Physician Decision|0|||
46728131|NCT00928434|82944115|FG002|Overall Study|Physician Decision|3|||
46728132|NCT00928434|82944113|FG000|Overall Study|Lost to Follow-up|1|||
46728133|NCT00928434|82944114|FG001|Overall Study|Lost to Follow-up|0|||
46728134|NCT00928434|82944115|FG002|Overall Study|Lost to Follow-up|3|||
46728135|NCT00928434|82944113|FG000|Overall Study|Withdrawal by Subject|5|||
46728136|NCT00928434|82944114|FG001|Overall Study|Withdrawal by Subject|3|||
46728137|NCT00928434|82944115|FG002|Overall Study|Withdrawal by Subject|2|||
46728138|NCT00928434|82944113|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
46728139|NCT00928434|82944114|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
46728140|NCT00928434|82944115|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
46728141|NCT00928434|82944113|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
46728142|NCT00928434|82944114|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
46728143|NCT00928434|82944115|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
46728144|NCT00928434|82944113|FG000|Overall Study|Other (not meeting above criteria)|5|||
46728145|NCT00928434|82944114|FG001|Overall Study|Other (not meeting above criteria)|1|||
46728146|NCT00928434|82944115|FG002|Overall Study|Other (not meeting above criteria)|2|||
46728147|NCT00787189|82944133|FG000|Overall Study|Lost to Follow-up|2|||
46728148|NCT00787189|82944134|FG001|Overall Study|Lost to Follow-up|2|||
46728149|NCT00784459|82944142|FG000|Overall Study|Adverse Event|0|||
46728150|NCT00784459|82944143|FG001|Overall Study|Adverse Event|2|||
46728151|NCT00786799|82944151|FG000|Overall Study|Lost to Follow-up|1|||
46728152|NCT00786799|82944152|FG001|Overall Study|Lost to Follow-up|1|||
46728153|NCT00786565|82944163|FG000|Enrollment Prior to Surgery|Site Closed|3|||
46728154|NCT00786565|82944163|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
46728155|NCT00786565|82944163|FG000|Post Surgery|Abnormal macular pucker|1|||
46728156|NCT00786565|82944163|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
46728157|NCT00784147|82944171|FG000|Overall Study|Lost to Follow-up|2|||
46728158|NCT00784147|82944172|FG001|Overall Study|Lost to Follow-up|4|||
46728159|NCT00784147|82944171|FG000|Overall Study|Withdrawal by Subject|1|||
46728160|NCT00784147|82944172|FG001|Overall Study|Withdrawal by Subject|3|||
46728161|NCT00784147|82944171|FG000|Overall Study|Physician Decision|2|||
46728162|NCT00784147|82944172|FG001|Overall Study|Physician Decision|1|||
46728163|NCT00784147|82944171|FG000|Overall Study|Protocol Violation|1|||
46728164|NCT00784147|82944172|FG001|Overall Study|Protocol Violation|1|||
46728165|NCT00784147|82944171|FG000|Overall Study|Death|2|||
46728166|NCT00784147|82944172|FG001|Overall Study|Death|0|||
46728167|NCT00891813|82944178|FG000|Overall Study|Adverse Event|3|||
46728168|NCT00891813|82944178|FG000|Overall Study|Withdrawal by Subject|1|||
46728169|NCT00891813|82944178|FG000|Overall Study|Patient Noncompliance|6|||
46728170|NCT00891813|82944178|FG000|Overall Study|Protocol Violation|2|||
46728171|NCT00783835|82944195|FG000|Overall Study|Adverse Event|3|||
46728172|NCT00783835|82944195|FG000|Overall Study|Medical Criteria|1|||
46728173|NCT00783835|82944195|FG000|Overall Study|Withdrawal by Subject|2|||
46728174|NCT00783835|82944195|FG000|Overall Study|Lost to Follow-up|1|||
46728175|NCT00783835|82944195|FG000|Overall Study|Participant not Adherent|3|||
46728176|NCT00783289|82944203|FG000|Overall Study|Protocol Violation|0|||
46728177|NCT00783289|82944204|FG001|Overall Study|Protocol Violation|1|||
46728178|NCT00783289|82944205|FG002|Overall Study|Protocol Violation|0|||
46728179|NCT00783289|82944206|FG003|Overall Study|Protocol Violation|0|||
46728180|NCT00847912|82944221|FG000|Overall Study|Protocol Violation|6|||
47047825|NCT01717040|83307287|FG000|Overall Study|Required Medication Change|0|||
46728181|NCT00847912|82944222|FG001|Overall Study|Protocol Violation|7|||
46728182|NCT00847912|82944221|FG000|Overall Study|Withdrawal by Subject|3|||
46728183|NCT00847912|82944222|FG001|Overall Study|Withdrawal by Subject|6|||
46728184|NCT00850564|82944229|FG000|Overall Study|Withdrawal by Subject|2|||
46728185|NCT00837148|82944233|FG000|Overall Study|Adverse Event|1|||
46728186|NCT00837148|82944233|FG000|Overall Study|Death|1|||
46728187|NCT00849940|82944237|FG000|Overall Study|Physician Decision|4|||
46728188|NCT00849472|82944241|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
46728189|NCT00849472|82944241|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
46728190|NCT00849472|82944241|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
46728191|NCT00849472|82944241|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
46728192|NCT00849472|82944241|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
46728193|NCT00849472|82944241|FG000|Weekly Paclitaxel|Disease Progression|1|||
46728194|NCT00849472|82944241|FG000|Weekly Paclitaxel|Adverse Event|11|||
46728195|NCT00849472|82944241|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
46728196|NCT00849472|82944241|FG000|Weekly Paclitaxel|Physician Decision|3|||
46728197|NCT00849472|82944241|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
46728198|NCT00849472|82944241|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
46728199|NCT00849472|82944241|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
46728200|NCT00849472|82944241|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
46728201|NCT00849472|82944241|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
46728202|NCT00849472|82944241|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
46728203|NCT00849472|82944241|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
46728204|NCT00849472|82944241|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
46728205|NCT00782509|82944249|FG000|Overall Study|Adverse Event|20|||
46728206|NCT00782509|82944250|FG001|Overall Study|Adverse Event|10|||
46728207|NCT00782509|82944251|FG002|Overall Study|Adverse Event|20|||
46728208|NCT00782509|82944249|FG000|Overall Study|Lost to Follow-up|1|||
46728209|NCT00782509|82944250|FG001|Overall Study|Lost to Follow-up|2|||
46728210|NCT00782509|82944251|FG002|Overall Study|Lost to Follow-up|3|||
46728211|NCT00782509|82944249|FG000|Overall Study|Withdrawal by Subject|3|||
46728212|NCT00782509|82944250|FG001|Overall Study|Withdrawal by Subject|5|||
46728213|NCT00782509|82944251|FG002|Overall Study|Withdrawal by Subject|8|||
46728214|NCT00782509|82944249|FG000|Overall Study|Non compliance with protocol|2|||
46728215|NCT00782509|82944250|FG001|Overall Study|Non compliance with protocol|0|||
46728216|NCT00782509|82944251|FG002|Overall Study|Non compliance with protocol|0|||
46728217|NCT00782509|82944249|FG000|Overall Study|Other reasons not stated above|5|||
46728218|NCT00782509|82944250|FG001|Overall Study|Other reasons not stated above|2|||
46728219|NCT00782509|82944251|FG002|Overall Study|Other reasons not stated above|3|||
46728220|NCT00782509|82944249|FG000|Overall Study|Lack of Efficacy|10|||
47047826|NCT01717040|83307288|FG001|Overall Study|Required Medication Change|1|||
47047827|NCT01717040|83307287|FG000|Overall Study|New Substance Use Disorder|1|||
47047828|NCT01717040|83307288|FG001|Overall Study|New Substance Use Disorder|0|||
47047829|NCT01743469|83307315|FG000|Active Treatment Phase|Adverse Event|10|||
47047830|NCT01743469|83307316|FG001|Active Treatment Phase|Adverse Event|5|||
46728221|NCT00782509|82944250|FG001|Overall Study|Lack of Efficacy|5|||
46728222|NCT00782509|82944251|FG002|Overall Study|Lack of Efficacy|2|||
46728223|NCT00927810|82944270|FG000|Overall Study|Withdrawal by Subject|0|||
46728224|NCT00927810|82944271|FG001|Overall Study|Withdrawal by Subject|3|||
46728225|NCT00927810|82944272|FG002|Overall Study|Withdrawal by Subject|0|||
46728226|NCT00927810|82944273|FG003|Overall Study|Withdrawal by Subject|1|||
46728227|NCT00927810|82944270|FG000|Overall Study|Lost to Follow-up|0|||
46728228|NCT00927810|82944271|FG001|Overall Study|Lost to Follow-up|2|||
46728229|NCT00927810|82944272|FG002|Overall Study|Lost to Follow-up|1|||
46728230|NCT00927810|82944273|FG003|Overall Study|Lost to Follow-up|1|||
46728231|NCT00927810|82944270|FG000|Overall Study|Death|0|||
46728232|NCT00927810|82944271|FG001|Overall Study|Death|2|||
46728233|NCT00927810|82944272|FG002|Overall Study|Death|0|||
46728234|NCT00927810|82944273|FG003|Overall Study|Death|0|||
46728235|NCT00927810|82944270|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46728236|NCT00927810|82944271|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46728237|NCT00927810|82944272|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46728238|NCT00927810|82944273|FG003|Overall Study|Abnormal laboratory value(s)|0|||
47047831|NCT01743469|83307317|FG002|Active Treatment Phase|Adverse Event|8|||
47047832|NCT01743469|83307318|FG003|Active Treatment Phase|Adverse Event|1|||
47047833|NCT01743469|83307315|FG000|Active Treatment Phase|Disease Progression|40|||
47047834|NCT01743469|83307316|FG001|Active Treatment Phase|Disease Progression|47|||
46728239|NCT00848926|82944291|FG000|Treatment Period|Progressive disease|45|||
46728240|NCT00848926|82944291|FG000|Treatment Period|Adverse Event|20|||
46728241|NCT00848926|82944291|FG000|Treatment Period|Physician Decision|12|||
46728242|NCT00848926|82944291|FG000|Treatment Period|Withdrawal by Subject|7|||
46728243|NCT00848926|82944291|FG000|Follow-up Period|Lost to Follow-up|7|||
46728244|NCT00848926|82944291|FG000|Follow-up Period|Withdrawal by Subject|3|||
47047835|NCT01743469|83307317|FG002|Active Treatment Phase|Disease Progression|30|||
47047836|NCT01743469|83307318|FG003|Active Treatment Phase|Disease Progression|20|||
46728245|NCT00848926|82944291|FG000|Follow-up Period|Other|2|||
46728246|NCT00847132|82944297|FG000|Overall Study|Death|1|||
47047837|NCT01743469|83307315|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
47047838|NCT01743469|83307316|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
46728247|NCT00847132|82944298|FG001|Overall Study|Death|1|||
46728248|NCT00918138|82944306|FG000|Overall Study|Subject withdrew consent|1|||
46728249|NCT00918138|82944307|FG001|Overall Study|Subject withdrew consent|1|||
46728250|NCT00918138|82944306|FG000|Overall Study|Death|1|||
46728251|NCT00918138|82944307|FG001|Overall Study|Death|0|||
46728252|NCT00782275|82944313|FG000|Overall Study|Adverse Event|11|||
46728253|NCT00782275|82944313|FG000|Overall Study|Withdrawal by Subject|1|||
46728254|NCT00782275|82944313|FG000|Overall Study|Progressive Disease|21|||
46728255|NCT00782275|82944313|FG000|Overall Study|Physician Decision|4|||
46728256|NCT00782275|82944313|FG000|Overall Study|Not started treatment|1|||
46728257|NCT00782275|82944313|FG000|Overall Study|Other|3|||
46728258|NCT00791557|82944317|FG000|Overall Study|Adverse Event|1|||
46728259|NCT00920790|82944321|FG000|Overall Study|aggravation of general condition|14|||
46728260|NCT00781963|82944327|FG000|Overall Study|Death|3|||
46728261|NCT00781963|82944328|FG001|Overall Study|Death|0|||
46728262|NCT00781963|82944327|FG000|Overall Study|Lost to Follow-up|2|||
46728263|NCT00781963|82944328|FG001|Overall Study|Lost to Follow-up|1|||
46728264|NCT00781963|82944327|FG000|Overall Study|Withdrawal by Subject|3|||
46728265|NCT00781963|82944328|FG001|Overall Study|Withdrawal by Subject|1|||
46728266|NCT00781963|82944327|FG000|Overall Study|Refused follow-up|9|||
46728267|NCT00781963|82944328|FG001|Overall Study|Refused follow-up|0|||
46728268|NCT00920556|82944334|FG000|Overall Study|Adverse Event|16|||
46728269|NCT00920556|82944334|FG000|Overall Study|Physician Decision|7|||
46728270|NCT00920556|82944334|FG000|Overall Study|Withdrawal by Subject|1|||
46728271|NCT00781885|82944342|FG000|Overall Study|Physician Decision|1|||
46728272|NCT00918684|82944346|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
46728273|NCT00918684|82944346|FG000|Treatment Phase|Lack of Efficacy|6|||
46728274|NCT00918684|82944346|FG000|Treatment Phase|Lost to Follow-up|2|||
46728275|NCT00918684|82944346|FG000|Treatment Phase|Physician Decision|8|||
46728276|NCT00918684|82944346|FG000|Treatment Phase|Protocol Violation|1|||
46728277|NCT00918684|82944346|FG000|Treatment Phase|Withdrawal by Subject|8|||
46728278|NCT00786409|82944350|FG000|Overall Study|Withdrawal by Subject|2|||
46728279|NCT00786409|82944350|FG000|Overall Study|Adverse Event|2|||
46728280|NCT00786409|82944350|FG000|Overall Study|Pregnancy|2|||
46728281|NCT00786409|82944350|FG000|Overall Study|Lost to Follow-up|1|||
46728282|NCT00919854|82944354|FG000|Overall Study|Adverse Event|1|||
46728283|NCT00891735|82944362|FG000|Overall Study|Adverse Event|2|||
46728284|NCT00891735|82944363|FG001|Overall Study|Adverse Event|0|||
46728285|NCT00891735|82944364|FG002|Overall Study|Adverse Event|2|||
46728286|NCT00891735|82944365|FG003|Overall Study|Adverse Event|0|||
46728287|NCT00891735|82944362|FG000|Overall Study|Death|8|||
46728288|NCT00891735|82944363|FG001|Overall Study|Death|5|||
46728289|NCT00891735|82944364|FG002|Overall Study|Death|4|||
46728290|NCT00891735|82944365|FG003|Overall Study|Death|5|||
46728291|NCT00891735|82944362|FG000|Overall Study|Lost to Follow-up|2|||
46728292|NCT00891735|82944363|FG001|Overall Study|Lost to Follow-up|2|||
46728293|NCT00891735|82944364|FG002|Overall Study|Lost to Follow-up|2|||
46728294|NCT00891735|82944365|FG003|Overall Study|Lost to Follow-up|2|||
46728295|NCT00891735|82944362|FG000|Overall Study|Physician's decision to withdraw patient|1|||
46728296|NCT00891735|82944363|FG001|Overall Study|Physician's decision to withdraw patient|0|||
46728297|NCT00891735|82944364|FG002|Overall Study|Physician's decision to withdraw patient|0|||
46728298|NCT00891735|82944365|FG003|Overall Study|Physician's decision to withdraw patient|0|||
46728299|NCT00891735|82944362|FG000|Overall Study|Patient's decision to withdraw|4|||
46728300|NCT00891735|82944363|FG001|Overall Study|Patient's decision to withdraw|9|||
46728301|NCT00891735|82944364|FG002|Overall Study|Patient's decision to withdraw|4|||
46728302|NCT00891735|82944365|FG003|Overall Study|Patient's decision to withdraw|8|||
46728303|NCT00891657|82944377|FG000|Overall Study|Withdrawal by Subject|1|||
46728304|NCT00891657|82944378|FG001|Overall Study|Withdrawal by Subject|1|||
46728305|NCT00917124|82944386|FG000|Overall Study|Protocol Violation|4|||
46728306|NCT00917124|82944387|FG001|Overall Study|Protocol Violation|6|||
46728307|NCT00889863|82944393|FG000|Part I: Open Label|Death|1|||
46728308|NCT00889863|82944394|FG001|Part I: Open Label|Death|0|||
46728309|NCT00889863|82944393|FG000|Part I: Open Label|Adverse Event|4|||
46728310|NCT00889863|82944394|FG001|Part I: Open Label|Adverse Event|0|||
46728311|NCT00889863|82944393|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
46728312|NCT00889863|82944394|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
46728313|NCT00889863|82944393|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
46728314|NCT00889863|82944394|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
46728315|NCT00889863|82944393|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
46728316|NCT00889863|82944394|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
46728317|NCT00889863|82944393|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
46728318|NCT00889863|82944394|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
46728319|NCT00889863|82944393|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
46728320|NCT00889863|82944394|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
46728321|NCT00915018|82944404|FG000|Overall Study|Death|75|||
46728322|NCT00915018|82944405|FG001|Overall Study|Death|70|||
46728323|NCT00915018|82944404|FG000|Overall Study|Lost to Follow-up|10|||
46728324|NCT00915018|82944405|FG001|Overall Study|Lost to Follow-up|5|||
46728325|NCT00915018|82944404|FG000|Overall Study|Withdrawal by Subject|38|||
46728326|NCT00915018|82944405|FG001|Overall Study|Withdrawal by Subject|27|||
46728327|NCT00915018|82944404|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
46728328|NCT00915018|82944405|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
46728329|NCT00916578|82944411|FG000|Overall Study|Physician Decision|2|||
46728330|NCT00916578|82944411|FG000|Overall Study|Withdrawal by Subject|3|||
46728331|NCT00916578|82944411|FG000|Overall Study|Insurance Denial|2|||
46728332|NCT00889707|82944417|FG000|Overall Study|Adverse Event|1|||
46728333|NCT00889707|82944418|FG001|Overall Study|Adverse Event|0|||
46728334|NCT00889707|82944417|FG000|Overall Study|Withdrawal by Subject|4|||
46728335|NCT00889707|82944418|FG001|Overall Study|Withdrawal by Subject|3|||
46728336|NCT00889707|82944417|FG000|Overall Study|Lost to Follow-up|0|||
46728337|NCT00889707|82944418|FG001|Overall Study|Lost to Follow-up|2|||
46728338|NCT00889707|82944417|FG000|Overall Study|Lack of Efficacy|2|||
46728339|NCT00889707|82944418|FG001|Overall Study|Lack of Efficacy|5|||
46728340|NCT00914940|82944424|FG000|D0 to D100 Post-transplant|Death|2|||
46921260|NCT02881957|83153746|FG001|Overall Study|Comfort care|1|||
46921261|NCT02881957|83153745|FG000|Overall Study|Concurrent trial enrollment|0|||
46921262|NCT02881957|83153746|FG001|Overall Study|Concurrent trial enrollment|1|||
46921263|NCT02881957|83153745|FG000|Overall Study|Discharged within 48 hours|0|||
46921264|NCT02881957|83153746|FG001|Overall Study|Discharged within 48 hours|1|||
46921265|NCT02881957|83153745|FG000|Overall Study|Withdrawal by Subject|2|||
46921266|NCT02881957|83153746|FG001|Overall Study|Withdrawal by Subject|1|||
46921267|NCT02881957|83153745|FG000|Overall Study|Protocol Violation|1|||
47047839|NCT01743469|83307317|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
47047840|NCT01743469|83307318|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
46634874|NCT01713582|82808212|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
46634875|NCT01713582|82808213|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
46634876|NCT01713582|82808214|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
46634877|NCT01713582|82808215|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
46634878|NCT01713582|82808216|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
46634879|NCT01713582|82808196|FG000|Overall Study|Disease progression and adverse event|0|||
46634880|NCT01713582|82808197|FG001|Overall Study|Disease progression and adverse event|0|||
46634881|NCT01713582|82808198|FG002|Overall Study|Disease progression and adverse event|0|||
46634882|NCT01713582|82808199|FG003|Overall Study|Disease progression and adverse event|0|||
46634883|NCT01713582|82808200|FG004|Overall Study|Disease progression and adverse event|0|||
46634884|NCT01713582|82808201|FG005|Overall Study|Disease progression and adverse event|0|||
46634885|NCT01713582|82808202|FG006|Overall Study|Disease progression and adverse event|0|||
46634886|NCT01713582|82808203|FG007|Overall Study|Disease progression and adverse event|0|||
46634887|NCT01713582|82808204|FG008|Overall Study|Disease progression and adverse event|0|||
46634888|NCT01713582|82808205|FG009|Overall Study|Disease progression and adverse event|0|||
46634889|NCT01713582|82808206|FG010|Overall Study|Disease progression and adverse event|0|||
46634890|NCT01713582|82808207|FG011|Overall Study|Disease progression and adverse event|0|||
46634891|NCT01713582|82808208|FG012|Overall Study|Disease progression and adverse event|0|||
46634892|NCT01713582|82808209|FG013|Overall Study|Disease progression and adverse event|0|||
46634893|NCT01713582|82808210|FG014|Overall Study|Disease progression and adverse event|0|||
46634894|NCT01713582|82808211|FG015|Overall Study|Disease progression and adverse event|0|||
46634895|NCT01713582|82808212|FG016|Overall Study|Disease progression and adverse event|1|||
46634896|NCT01713582|82808213|FG017|Overall Study|Disease progression and adverse event|0|||
46634897|NCT01713582|82808214|FG018|Overall Study|Disease progression and adverse event|0|||
46634898|NCT01713582|82808215|FG019|Overall Study|Disease progression and adverse event|0|||
46634899|NCT01713582|82808216|FG020|Overall Study|Disease progression and adverse event|0|||
46634900|NCT01739400|82808276|FG000|Overall Study|Physician Decision|3|||
46634901|NCT01739400|82808277|FG001|Overall Study|Physician Decision|0|||
46634902|NCT01739400|82808276|FG000|Overall Study|Lost to Follow-up|2|||
46634903|NCT01739400|82808277|FG001|Overall Study|Lost to Follow-up|0|||
46634904|NCT01739400|82808276|FG000|Overall Study|Death|5|||
46634905|NCT01739400|82808277|FG001|Overall Study|Death|2|||
46634906|NCT01739400|82808276|FG000|Overall Study|Withdrawal by Subject|7|||
46634907|NCT01739400|82808277|FG001|Overall Study|Withdrawal by Subject|7|||
46634908|NCT01713348|82808286|FG000|Overall Study|Withdrawal by Subject|3|||
46634909|NCT01713348|82808287|FG001|Overall Study|Withdrawal by Subject|2|||
46634910|NCT01713348|82808288|FG002|Overall Study|Withdrawal by Subject|2|||
46634911|NCT01713348|82808289|FG003|Overall Study|Withdrawal by Subject|0|||
46634912|NCT01713348|82808286|FG000|Overall Study|Lost to Follow-up|1|||
46634913|NCT01713348|82808287|FG001|Overall Study|Lost to Follow-up|0|||
46634914|NCT01713348|82808288|FG002|Overall Study|Lost to Follow-up|0|||
46634915|NCT01713348|82808289|FG003|Overall Study|Lost to Follow-up|0|||
46634916|NCT01737996|82808302|FG000|Overall Study|Adverse Event|0|||
46634917|NCT01737996|82808303|FG001|Overall Study|Adverse Event|1|||
46634918|NCT01737996|82808304|FG002|Overall Study|Adverse Event|1|||
46634919|NCT01737996|82808302|FG000|Overall Study|Withdrawal by Subject|0|||
46728341|NCT00914940|82944424|FG000|D101 to 2 Years Post-transplant|Death|8|||
46728342|NCT00914940|82944424|FG000|2 Years to 5 Years Post-transplant|Death|3|||
46728343|NCT00835978|82944432|FG000|Overall Study|Death|33|||
46728344|NCT00835978|82944433|FG001|Overall Study|Death|40|||
46728345|NCT00835978|82944434|FG002|Overall Study|Death|49|||
46728346|NCT00835978|82944435|FG003|Overall Study|Death|4|||
46728347|NCT00835978|82944432|FG000|Overall Study|Lost to Follow-up|3|||
46728348|NCT00835978|82944433|FG001|Overall Study|Lost to Follow-up|4|||
46728349|NCT00835978|82944434|FG002|Overall Study|Lost to Follow-up|2|||
46728350|NCT00835978|82944435|FG003|Overall Study|Lost to Follow-up|1|||
46728351|NCT00835978|82944432|FG000|Overall Study|Other|5|||
46728352|NCT00835978|82944433|FG001|Overall Study|Other|1|||
46728353|NCT00835978|82944434|FG002|Overall Study|Other|8|||
46728354|NCT00835978|82944435|FG003|Overall Study|Other|0|||
46728355|NCT00835978|82944432|FG000|Overall Study|Objective progression or relapse|2|||
46728356|NCT00835978|82944433|FG001|Overall Study|Objective progression or relapse|0|||
46728357|NCT00835978|82944434|FG002|Overall Study|Objective progression or relapse|1|||
46728358|NCT00835978|82944435|FG003|Overall Study|Objective progression or relapse|0|||
46728359|NCT00835978|82944432|FG000|Overall Study|Adverse Event|1|||
46728360|NCT00835978|82944433|FG001|Overall Study|Adverse Event|0|||
46728361|NCT00835978|82944434|FG002|Overall Study|Adverse Event|1|||
46728362|NCT00835978|82944435|FG003|Overall Study|Adverse Event|0|||
46728363|NCT00835978|82944432|FG000|Overall Study|Withdrawal by Subject|0|||
46728364|NCT00835978|82944433|FG001|Overall Study|Withdrawal by Subject|3|||
46728365|NCT00835978|82944434|FG002|Overall Study|Withdrawal by Subject|0|||
46728366|NCT00835978|82944435|FG003|Overall Study|Withdrawal by Subject|5|||
46728367|NCT00835978|82944432|FG000|Overall Study|Study terminated by sponsor|12|||
46728368|NCT00835978|82944433|FG001|Overall Study|Study terminated by sponsor|8|||
46728369|NCT00835978|82944434|FG002|Overall Study|Study terminated by sponsor|30|||
46728370|NCT00835978|82944435|FG003|Overall Study|Study terminated by sponsor|0|||
46728371|NCT00914628|82944452|FG000|Overall Study|Death|35|||
46728372|NCT00914628|82944453|FG001|Overall Study|Death|17|||
46728373|NCT00914628|82944452|FG000|Overall Study|Medical decision|4|||
46728374|NCT00914628|82944453|FG001|Overall Study|Medical decision|0|||
46728375|NCT00914628|82944452|FG000|Overall Study|Protocol Violation|1|||
46728376|NCT00914628|82944453|FG001|Overall Study|Protocol Violation|0|||
46728377|NCT00914628|82944452|FG000|Overall Study|Lack of Efficacy|1|||
46728378|NCT00914628|82944453|FG001|Overall Study|Lack of Efficacy|0|||
46728379|NCT00914628|82944452|FG000|Overall Study|non-randomized|1|||
46728380|NCT00914628|82944453|FG001|Overall Study|non-randomized|0|||
46728381|NCT00914628|82944452|FG000|Overall Study|Relapse|1|||
46728382|NCT00914628|82944453|FG001|Overall Study|Relapse|2|||
46728383|NCT00914628|82944452|FG000|Overall Study|Study terminated by Sponsor|14|||
46728384|NCT00914628|82944453|FG001|Overall Study|Study terminated by Sponsor|8|||
46728385|NCT00914628|82944452|FG000|Overall Study|Patients who did not receive a single dose|7|||
46728386|NCT00914628|82944453|FG001|Overall Study|Patients who did not receive a single dose|1|||
46728387|NCT01077518|82944465|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
46728388|NCT01077518|82944466|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
46728389|NCT01077518|82944467|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
46728390|NCT01077518|82944465|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
46728391|NCT01077518|82944466|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
46728392|NCT01077518|82944467|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
46728393|NCT01077518|82944465|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
46728394|NCT01077518|82944466|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
46728395|NCT01077518|82944467|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
46728396|NCT01077518|82944465|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
46728397|NCT01077518|82944466|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
46728398|NCT01077518|82944467|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
46728399|NCT01077518|82944465|FG000|Optional Ofa Phase|Physician Decision|0|||
46921268|NCT02881957|83153746|FG001|Overall Study|Protocol Violation|0|||
46921269|NCT03022461|83153752|FG000|Overall Study|Death|3|||
46728400|NCT01077518|82944466|FG001|Optional Ofa Phase|Physician Decision|0|||
46728401|NCT01077518|82944467|FG002|Optional Ofa Phase|Physician Decision|1|||
46728402|NCT01077518|82944465|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
46728403|NCT01077518|82944466|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
46728404|NCT01077518|82944467|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
46728405|NCT01077518|82944465|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
46728406|NCT01077518|82944466|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
46921270|NCT02750930|83153757|FG000|Overall Study|Study closed/terminated|8|||
46728407|NCT01077518|82944467|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
46728408|NCT00835120|82944476|FG000|Overall Study|Lack of Efficacy|1|||
46728409|NCT00835120|82944476|FG000|Overall Study|Lost to Follow-up|3|||
46728410|NCT00835120|82944476|FG000|Overall Study|Adverse Event|2|||
46728411|NCT00835120|82944476|FG000|Overall Study|Withdrawal by Subject|2|||
46728412|NCT00914316|82944484|FG000|Phase 1|Physician Decision|4|||
46921271|NCT03078907|83153763|FG000|Overall Study|Adverse Event|2|||
46728413|NCT00914316|82944485|FG001|Phase 1|Physician Decision|0|||
46921272|NCT03078907|83153764|FG001|Overall Study|Adverse Event|0|||
46921273|NCT03078907|83153763|FG000|Overall Study|Other|1|||
46921274|NCT03078907|83153764|FG001|Overall Study|Other|0|||
46921275|NCT03078907|83153763|FG000|Overall Study|Protocol Violation|0|||
46921276|NCT03078907|83153764|FG001|Overall Study|Protocol Violation|1|||
46921277|NCT03249714|83153772|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
46921278|NCT03249714|83153773|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
46921279|NCT03249714|83153772|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
46921280|NCT03249714|83153773|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
46921281|NCT03249714|83153772|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
46921282|NCT03249714|83153773|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
46921283|NCT03249714|83153772|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
46921284|NCT03249714|83153773|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
46921285|NCT02925117|83153799|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
46921286|NCT02925117|83153800|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
46921287|NCT02925117|83153801|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
46921288|NCT02925117|83153802|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
46921289|NCT02925117|83153803|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921290|NCT02925117|83153804|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921291|NCT02925117|83153805|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921292|NCT02925117|83153806|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921293|NCT02925117|83153807|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921294|NCT02925117|83153808|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921295|NCT02925117|83153809|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921296|NCT02925117|83153810|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
46921297|NCT02925117|83153799|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
46921298|NCT02925117|83153800|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
46921299|NCT02925117|83153801|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
46921300|NCT02925117|83153802|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46728414|NCT00914316|82944486|FG002|Phase 1|Physician Decision|1|||
46728415|NCT00914316|82944487|FG003|Phase 1|Physician Decision|2|||
46728416|NCT00914316|82944484|FG000|Phase 1|Withdrawal by Subject|0|||
46728417|NCT00914316|82944485|FG001|Phase 1|Withdrawal by Subject|2|||
46728418|NCT00914316|82944486|FG002|Phase 1|Withdrawal by Subject|4|||
46728419|NCT00914316|82944487|FG003|Phase 1|Withdrawal by Subject|0|||
46728420|NCT00914316|82944484|FG000|Phase 1|Adverse Event|1|||
46728421|NCT00914316|82944485|FG001|Phase 1|Adverse Event|0|||
46728422|NCT00914316|82944486|FG002|Phase 1|Adverse Event|0|||
46728423|NCT00914316|82944487|FG003|Phase 1|Adverse Event|0|||
46728424|NCT00914316|82944484|FG000|Phase 2|Withdrawal by Subject|1|||
46728425|NCT00914316|82944485|FG001|Phase 2|Withdrawal by Subject|0|||
46728426|NCT00914316|82944486|FG002|Phase 2|Withdrawal by Subject|1|||
46728427|NCT00914316|82944487|FG003|Phase 2|Withdrawal by Subject|0|||
46728428|NCT00827632|82944499|FG000|Overall Study|Lost to Follow-up|8|||
46728429|NCT00827632|82944500|FG001|Overall Study|Lost to Follow-up|12|||
46728430|NCT00827632|82944499|FG000|Overall Study|Early withdrawal|14|||
46728431|NCT00827632|82944500|FG001|Overall Study|Early withdrawal|11|||
46728432|NCT00827242|82944508|FG000|Overall Study|Withdrawal by Subject|2|||
46728433|NCT00827242|82944509|FG001|Overall Study|Withdrawal by Subject|4|||
46728434|NCT00827242|82944508|FG000|Overall Study|Protocol Violation|1|||
46728435|NCT00827242|82944509|FG001|Overall Study|Protocol Violation|3|||
46728436|NCT00827242|82944508|FG000|Overall Study|Lost to Follow-up|0|||
46728437|NCT00827242|82944509|FG001|Overall Study|Lost to Follow-up|3|||
46728438|NCT00827242|82944508|FG000|Overall Study|Adverse Event Excluding Death|2|||
46728439|NCT00827242|82944509|FG001|Overall Study|Adverse Event Excluding Death|1|||
46728440|NCT00827242|82944508|FG000|Overall Study|Entry Criteria Not Met|4|||
46921301|NCT02925117|83153803|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46728441|NCT00827242|82944509|FG001|Overall Study|Entry Criteria Not Met|1|||
46728442|NCT00827242|82944508|FG000|Overall Study|Physician Decision|2|||
46728443|NCT00827242|82944509|FG001|Overall Study|Physician Decision|0|||
46728444|NCT00827242|82944508|FG000|Overall Study|Death|1|||
46728445|NCT00827242|82944509|FG001|Overall Study|Death|0|||
46728446|NCT00827242|82944508|FG000|Overall Study|Lack of Efficacy|1|||
46728447|NCT00827242|82944509|FG001|Overall Study|Lack of Efficacy|0|||
46728448|NCT01077362|82944518|FG000|Overall Study|Lack of Efficacy|13|||
46728449|NCT01077362|82944519|FG001|Overall Study|Lack of Efficacy|8|||
46728450|NCT01077362|82944520|FG002|Overall Study|Lack of Efficacy|10|||
46728451|NCT01077362|82944518|FG000|Overall Study|Lost to Follow-up|1|||
46728452|NCT01077362|82944519|FG001|Overall Study|Lost to Follow-up|0|||
46728453|NCT01077362|82944520|FG002|Overall Study|Lost to Follow-up|3|||
46728454|NCT01077362|82944518|FG000|Overall Study|Adverse Event|12|||
46728455|NCT01077362|82944519|FG001|Overall Study|Adverse Event|7|||
46921302|NCT02925117|83153804|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46921303|NCT02925117|83153805|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46728456|NCT01077362|82944520|FG002|Overall Study|Adverse Event|4|||
46775701|NCT00694551|82994165|FG001|Overall Study|Disease Progression|0|||
46728457|NCT01077362|82944518|FG000|Overall Study|Withdrawal by Subject|5|||
46728458|NCT01077362|82944519|FG001|Overall Study|Withdrawal by Subject|3|||
46728459|NCT01077362|82944520|FG002|Overall Study|Withdrawal by Subject|5|||
46728460|NCT01077362|82944518|FG000|Overall Study|Other|0|||
46728461|NCT01077362|82944519|FG001|Overall Study|Other|1|||
46728462|NCT01077362|82944520|FG002|Overall Study|Other|2|||
46728463|NCT00846586|82944535|FG000|Overall Study|Adverse Event|20|||
46728464|NCT00846586|82944536|FG001|Overall Study|Adverse Event|10|||
46728465|NCT00846586|82944535|FG000|Overall Study|Subject withdrew consent|8|||
46728466|NCT00846586|82944536|FG001|Overall Study|Subject withdrew consent|10|||
46728467|NCT00846586|82944535|FG000|Overall Study|Administrative problems|5|||
47047841|NCT01743469|83307315|FG000|Active Treatment Phase|Missing|1|||
47047842|NCT01743469|83307316|FG001|Active Treatment Phase|Missing|0|||
47047843|NCT01743469|83307317|FG002|Active Treatment Phase|Missing|0|||
47047844|NCT01743469|83307318|FG003|Active Treatment Phase|Missing|0|||
47047845|NCT01743469|83307315|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
47047846|NCT01743469|83307316|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
47047847|NCT01743469|83307317|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
47047848|NCT01743469|83307318|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
47047849|NCT01743469|83307315|FG000|Follow-up Period - Post-Treatment|Death|43|||
47047850|NCT01743469|83307316|FG001|Follow-up Period - Post-Treatment|Death|47|||
47047851|NCT01743469|83307317|FG002|Follow-up Period - Post-Treatment|Death|22|||
47047852|NCT01743469|83307318|FG003|Follow-up Period - Post-Treatment|Death|16|||
47047853|NCT01743469|83307315|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
47047854|NCT01743469|83307316|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
47047855|NCT01743469|83307317|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
47047856|NCT01743469|83307318|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
47047857|NCT01743001|83307330|FG000|Overall Study|Physician Decision|1|||
46728468|NCT00846586|82944536|FG001|Overall Study|Administrative problems|4|||
46728469|NCT00846586|82944535|FG000|Overall Study|Death|2|||
46728470|NCT00846586|82944536|FG001|Overall Study|Death|0|||
46728471|NCT00846586|82944535|FG000|Overall Study|Protocol deviation|2|||
46728472|NCT00846586|82944536|FG001|Overall Study|Protocol deviation|6|||
46728473|NCT00846586|82944535|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46728474|NCT00846586|82944536|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46728475|NCT00846586|82944535|FG000|Overall Study|Lost to Follow-up|1|||
46728476|NCT00846586|82944536|FG001|Overall Study|Lost to Follow-up|4|||
46728477|NCT00846586|82944535|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46728478|NCT00846586|82944536|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46728479|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
46728480|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
46728481|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Adverse Event|31|||
46728482|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Adverse Event|21|||
46728483|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
46728484|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
46728485|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
46728486|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
46728487|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
46728488|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
46728489|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
46728490|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
46728491|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Administrative problems|3|||
47047858|NCT01743001|83307331|FG001|Overall Study|Physician Decision|0|||
47047859|NCT01743001|83307330|FG000|Overall Study|Pregnancy|1|||
47047860|NCT01743001|83307331|FG001|Overall Study|Pregnancy|0|||
47047861|NCT01743001|83307330|FG000|Overall Study|Death|1|||
47047862|NCT01743001|83307331|FG001|Overall Study|Death|0|||
47047863|NCT01704079|83307350|FG000|Overall Study|Withdrawal by Subject|5|||
46728492|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Administrative problems|3|||
46728493|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Death|5|||
46728494|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Death|8|||
46921304|NCT02925117|83153806|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46728495|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Disease progression|139|||
46728496|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Disease progression|119|||
46728497|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
46728498|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
47047864|NCT01704079|83307351|FG001|Overall Study|Withdrawal by Subject|7|||
47047865|NCT01704079|83307350|FG000|Overall Study|Lost to Follow-up|2|||
47047866|NCT01704079|83307351|FG001|Overall Study|Lost to Follow-up|5|||
47047867|NCT01704079|83307350|FG000|Overall Study|Adverse Event|4|||
47047868|NCT01704079|83307351|FG001|Overall Study|Adverse Event|7|||
46728499|NCT00785785|82944544|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
47047869|NCT01704079|83307350|FG000|Overall Study|Protocol Violation|1|||
47047870|NCT01704079|83307351|FG001|Overall Study|Protocol Violation|0|||
46728500|NCT00785785|82944545|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
46728501|NCT00785785|82944544|FG000|Optional Extension Phase|Adverse Event|4|||
46728502|NCT00785785|82944545|FG001|Optional Extension Phase|Adverse Event|5|||
46728503|NCT00785785|82944544|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
46728504|NCT00785785|82944545|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
46728505|NCT00785785|82944544|FG000|Optional Extension Phase|Lost to Follow-up|1|||
46728506|NCT00785785|82944545|FG001|Optional Extension Phase|Lost to Follow-up|0|||
46728507|NCT00785785|82944544|FG000|Optional Extension Phase|Administrative problems|2|||
46728508|NCT00785785|82944545|FG001|Optional Extension Phase|Administrative problems|0|||
46728509|NCT00785785|82944544|FG000|Optional Extension Phase|Death|1|||
46728510|NCT00785785|82944545|FG001|Optional Extension Phase|Death|5|||
46728511|NCT00785785|82944544|FG000|Optional Extension Phase|Disease progression|22|||
46728512|NCT00785785|82944545|FG001|Optional Extension Phase|Disease progression|70|||
46728513|NCT00785785|82944544|FG000|Optional Extension Phase|Protocol deviation|0|||
46728514|NCT00785785|82944545|FG001|Optional Extension Phase|Protocol deviation|2|||
46728515|NCT00785785|82944544|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
47047871|NCT01704079|83307350|FG000|Overall Study|Subject noncompliance|2|||
47047872|NCT01704079|83307351|FG001|Overall Study|Subject noncompliance|3|||
46728516|NCT00785785|82944545|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
46728517|NCT01077284|82944556|FG000|Overall Study|Adverse Event|2|||
46728518|NCT01077284|82944557|FG001|Overall Study|Adverse Event|0|||
46728519|NCT01077284|82944558|FG002|Overall Study|Adverse Event|1|||
46728520|NCT01077284|82944556|FG000|Overall Study|Lost to Follow-up|1|||
46728521|NCT01077284|82944557|FG001|Overall Study|Lost to Follow-up|2|||
46728522|NCT01077284|82944558|FG002|Overall Study|Lost to Follow-up|0|||
46728523|NCT01077284|82944556|FG000|Overall Study|Withdrawal by Subject|2|||
46728524|NCT01077284|82944557|FG001|Overall Study|Withdrawal by Subject|3|||
46728525|NCT01077284|82944558|FG002|Overall Study|Withdrawal by Subject|1|||
46728526|NCT01077284|82944556|FG000|Overall Study|Other|0|||
46728527|NCT01077284|82944557|FG001|Overall Study|Other|0|||
46728528|NCT01077284|82944558|FG002|Overall Study|Other|1|||
46728529|NCT00826618|82944566|FG000|Overall Study|Withdrawal by Subject|1|||
46728530|NCT01077128|82944570|FG000|Overall Study|Adverse Event|8|||
46728531|NCT01077128|82944570|FG000|Overall Study|Lack of Efficacy|1|||
46728532|NCT01077128|82944570|FG000|Overall Study|Disease exacerbation|1|||
46728533|NCT01077128|82944570|FG000|Overall Study|Adverse event and consent withdrawal|1|||
46728534|NCT01077128|82944570|FG000|Overall Study|Adverse event and disease exacerbation|1|||
46728535|NCT01077128|82944570|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
46728536|NCT01077128|82944570|FG000|Overall Study|Other|54|||
46728537|NCT00826540|82944624|FG000|Overall Study|ineligible|3|||
46728538|NCT00826540|82944624|FG000|Overall Study|Withdrawal by Subject|1|||
46728539|NCT01077050|82944628|FG000|Overall Study|Subjects signed ICF could not be located|1|||
46728540|NCT01077050|82944628|FG000|Overall Study|Screen failure|8|||
46728541|NCT00592384|82944634|FG000|Overall Study|Withdrawal by Subject|5|||
46728542|NCT00592384|82944635|FG001|Overall Study|Withdrawal by Subject|6|||
46921305|NCT02925117|83153807|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46921306|NCT02925117|83153808|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46921307|NCT02925117|83153809|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46921308|NCT02925117|83153810|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
46921309|NCT02925117|83153799|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
46921310|NCT02925117|83153800|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
46921311|NCT02925117|83153801|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921312|NCT02925117|83153802|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921313|NCT02925117|83153803|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921314|NCT02925117|83153804|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921315|NCT02925117|83153805|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921316|NCT02925117|83153806|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921317|NCT02925117|83153807|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921318|NCT02925117|83153808|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921319|NCT02925117|83153809|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46921320|NCT02925117|83153810|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
46728543|NCT00846040|82944644|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
46728544|NCT00846040|82944645|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
46728545|NCT00846040|82944646|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
46921321|NCT02925117|83153799|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
46728546|NCT00846040|82944644|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
46728547|NCT00846040|82944645|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
46775702|NCT00694551|82994166|FG002|Overall Study|Disease Progression|1|||
46921322|NCT02925117|83153800|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
46921323|NCT02925117|83153801|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
46921324|NCT02925117|83153802|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
47047873|NCT01704079|83307350|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
46728548|NCT00846040|82944646|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
46728549|NCT00826228|82944655|FG000|Overall Study|Withdrawal by Subject|1|||
46728550|NCT00825994|82944660|FG000|Overall Study|Withdrawal by Subject|2|||
46728551|NCT00825994|82944660|FG000|Overall Study|Lost to Follow-up|1|||
46728552|NCT00825994|82944660|FG000|Overall Study|Protocol Violation|1|||
46728553|NCT00825994|82944660|FG000|Overall Study|Placebo Responder at V2|1|||
46728554|NCT00825916|82944667|FG000|Overall Study|Lost to Follow-up|4|||
46728555|NCT00825916|82944668|FG001|Overall Study|Lost to Follow-up|2|||
46728556|NCT00825916|82944669|FG002|Overall Study|Lost to Follow-up|1|||
46728557|NCT00791479|82944716|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
46728558|NCT00791479|82944717|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
46728559|NCT00791479|82944718|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
46728560|NCT00791479|82944719|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
46728561|NCT00791479|82944720|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
46728562|NCT00791479|82944721|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
46728563|NCT00791479|82944716|FG000|Overall Study|Adverse Event|0|||
47047874|NCT01704079|83307351|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
47047875|NCT01703845|83307359|FG000|Overall Study|Adverse Event|1|||
47047876|NCT01703845|83307360|FG001|Overall Study|Adverse Event|0|||
47047877|NCT01703845|83307359|FG000|Overall Study|Protocol Violation|1|||
47047878|NCT01703845|83307360|FG001|Overall Study|Protocol Violation|0|||
47047879|NCT01703845|83307359|FG000|Overall Study|other than stated above|1|||
46728564|NCT00791479|82944717|FG001|Overall Study|Adverse Event|1|||
46728565|NCT00791479|82944718|FG002|Overall Study|Adverse Event|0|||
46728566|NCT00791479|82944719|FG003|Overall Study|Adverse Event|2|||
46728567|NCT00791479|82944720|FG004|Overall Study|Adverse Event|0|||
46728568|NCT00791479|82944721|FG005|Overall Study|Adverse Event|1|||
46728569|NCT00791479|82944716|FG000|Overall Study|Lost to Follow-up|0|||
46728570|NCT00791479|82944717|FG001|Overall Study|Lost to Follow-up|1|||
46728571|NCT00791479|82944718|FG002|Overall Study|Lost to Follow-up|0|||
46728572|NCT00791479|82944719|FG003|Overall Study|Lost to Follow-up|0|||
46728573|NCT00791479|82944720|FG004|Overall Study|Lost to Follow-up|0|||
46728574|NCT00791479|82944721|FG005|Overall Study|Lost to Follow-up|1|||
46728575|NCT00791479|82944716|FG000|Overall Study|Protocol Violation|2|||
46728576|NCT00791479|82944717|FG001|Overall Study|Protocol Violation|1|||
46728577|NCT00791479|82944718|FG002|Overall Study|Protocol Violation|0|||
46728578|NCT00791479|82944719|FG003|Overall Study|Protocol Violation|1|||
46728579|NCT00791479|82944720|FG004|Overall Study|Protocol Violation|0|||
46728580|NCT00791479|82944721|FG005|Overall Study|Protocol Violation|0|||
46728581|NCT00791479|82944716|FG000|Overall Study|Withdrawal by Subject|0|||
46728582|NCT00791479|82944717|FG001|Overall Study|Withdrawal by Subject|0|||
46728583|NCT00791479|82944718|FG002|Overall Study|Withdrawal by Subject|0|||
46728584|NCT00791479|82944719|FG003|Overall Study|Withdrawal by Subject|1|||
46728585|NCT00791479|82944720|FG004|Overall Study|Withdrawal by Subject|0|||
46728586|NCT00791479|82944721|FG005|Overall Study|Withdrawal by Subject|1|||
46728587|NCT00890097|82944745|FG000|Overall Study|Adverse Event|21|||
46728588|NCT00890097|82944746|FG001|Overall Study|Adverse Event|32|||
46728589|NCT00890097|82944747|FG002|Overall Study|Adverse Event|28|||
46728590|NCT00890097|82944745|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
46728591|NCT00890097|82944746|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
46728592|NCT00890097|82944747|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
46728593|NCT00890097|82944745|FG000|Overall Study|Withdrew Consent|9|||
46728594|NCT00890097|82944746|FG001|Overall Study|Withdrew Consent|6|||
46728595|NCT00890097|82944747|FG002|Overall Study|Withdrew Consent|9|||
46728596|NCT00890097|82944745|FG000|Overall Study|Lost to Follow-up|5|||
46728597|NCT00890097|82944746|FG001|Overall Study|Lost to Follow-up|5|||
46728598|NCT00890097|82944747|FG002|Overall Study|Lost to Follow-up|5|||
46728599|NCT00890097|82944745|FG000|Overall Study|Noncompliance|0|||
46728600|NCT00890097|82944746|FG001|Overall Study|Noncompliance|4|||
46728601|NCT00890097|82944747|FG002|Overall Study|Noncompliance|4|||
46728602|NCT00890097|82944745|FG000|Overall Study|Sponsor Decision|7|||
46921325|NCT02925117|83153803|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
47047880|NCT01703845|83307360|FG001|Overall Study|other than stated above|0|||
46728603|NCT00890097|82944746|FG001|Overall Study|Sponsor Decision|11|||
46728604|NCT00890097|82944747|FG002|Overall Study|Sponsor Decision|7|||
46728605|NCT00890097|82944745|FG000|Overall Study|Did not attend final visit|2|||
46728606|NCT00890097|82944746|FG001|Overall Study|Did not attend final visit|3|||
46728607|NCT00890097|82944747|FG002|Overall Study|Did not attend final visit|0|||
46728608|NCT00890097|82944745|FG000|Overall Study|Subject Decision|3|||
46728609|NCT00890097|82944746|FG001|Overall Study|Subject Decision|2|||
46728610|NCT00890097|82944747|FG002|Overall Study|Subject Decision|6|||
46728611|NCT00890097|82944745|FG000|Overall Study|Randomization Error|2|||
46728612|NCT00890097|82944746|FG001|Overall Study|Randomization Error|0|||
46728613|NCT00890097|82944747|FG002|Overall Study|Randomization Error|0|||
46728614|NCT00890097|82944745|FG000|Overall Study|Failed inclusion criteria|3|||
46728615|NCT00890097|82944746|FG001|Overall Study|Failed inclusion criteria|4|||
46728616|NCT00890097|82944747|FG002|Overall Study|Failed inclusion criteria|0|||
46728617|NCT00890097|82944745|FG000|Overall Study|Transportation|0|||
46728618|NCT00890097|82944746|FG001|Overall Study|Transportation|2|||
46728619|NCT00890097|82944747|FG002|Overall Study|Transportation|0|||
46728620|NCT00890097|82944745|FG000|Overall Study|Subject Moved|0|||
46728621|NCT00890097|82944746|FG001|Overall Study|Subject Moved|4|||
46728622|NCT00890097|82944747|FG002|Overall Study|Subject Moved|0|||
46728623|NCT00890097|82944745|FG000|Overall Study|Protocol Deviation|1|||
46728624|NCT00890097|82944746|FG001|Overall Study|Protocol Deviation|1|||
46728625|NCT00890097|82944747|FG002|Overall Study|Protocol Deviation|1|||
46728626|NCT00913458|82944755|FG000|Phase 1|Non-Responder|54|||
46728627|NCT00913458|82944756|FG001|Phase 1|Non-Responder|0|||
46728628|NCT00913458|82944757|FG002|Phase 1|Non-Responder|0|||
46728629|NCT00913458|82944758|FG003|Phase 1|Non-Responder|0|||
46728630|NCT00913458|82944759|FG004|Phase 1|Non-Responder|0|||
46728631|NCT00913458|82944760|FG005|Phase 1|Non-Responder|0|||
46728632|NCT00913458|82944761|FG006|Phase 1|Non-Responder|0|||
46728633|NCT00913458|82944755|FG000|Phase 1|Subject Request|17|||
46728634|NCT00913458|82944756|FG001|Phase 1|Subject Request|0|||
46728635|NCT00913458|82944757|FG002|Phase 1|Subject Request|0|||
46728636|NCT00913458|82944758|FG003|Phase 1|Subject Request|0|||
46728637|NCT00913458|82944759|FG004|Phase 1|Subject Request|0|||
46728638|NCT00913458|82944760|FG005|Phase 1|Subject Request|0|||
46728639|NCT00913458|82944761|FG006|Phase 1|Subject Request|0|||
46728640|NCT00913458|82944755|FG000|Phase 1|Adverse Event|20|||
46728641|NCT00913458|82944756|FG001|Phase 1|Adverse Event|0|||
46728642|NCT00913458|82944757|FG002|Phase 1|Adverse Event|0|||
46728643|NCT00913458|82944758|FG003|Phase 1|Adverse Event|0|||
46728644|NCT00913458|82944759|FG004|Phase 1|Adverse Event|0|||
46728645|NCT00913458|82944760|FG005|Phase 1|Adverse Event|0|||
46728646|NCT00913458|82944761|FG006|Phase 1|Adverse Event|0|||
46728647|NCT00913458|82944755|FG000|Phase 1|Lost to Follow-up|2|||
46728648|NCT00913458|82944756|FG001|Phase 1|Lost to Follow-up|0|||
46728649|NCT00913458|82944757|FG002|Phase 1|Lost to Follow-up|0|||
46728650|NCT00913458|82944758|FG003|Phase 1|Lost to Follow-up|0|||
46728651|NCT00913458|82944759|FG004|Phase 1|Lost to Follow-up|0|||
46728652|NCT00913458|82944760|FG005|Phase 1|Lost to Follow-up|0|||
46728653|NCT00913458|82944761|FG006|Phase 1|Lost to Follow-up|0|||
46728654|NCT00913458|82944755|FG000|Phase 1|Protocol Violation|10|||
47047881|NCT01724359|83307368|FG000|Overall Study|Adverse Event|10|||
47047882|NCT01724359|83307368|FG000|Overall Study|Death|1|||
46634920|NCT01737996|82808303|FG001|Overall Study|Withdrawal by Subject|0|||
46634921|NCT01737996|82808304|FG002|Overall Study|Withdrawal by Subject|1|||
46634922|NCT01713036|82808312|FG000|Overall Study|Death|1|||
46634923|NCT01712334|82808322|FG000|Treatment Period 1|Randomized in Error|0|||
46634924|NCT01712334|82808323|FG001|Treatment Period 1|Randomized in Error|2|||
46634925|NCT01712256|82808329|FG000|Overall Study|Lost to Follow-up|1|||
46634926|NCT01712178|82808335|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
46634927|NCT01712178|82808336|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
46634928|NCT01712178|82808335|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
46634929|NCT01712178|82808336|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
46634930|NCT01712178|82808335|FG000|Overall Study|Lost to Follow-up|0|||
46634931|NCT01712178|82808336|FG001|Overall Study|Lost to Follow-up|1|||
46634932|NCT01693068|82808344|FG000|Randomization Period|On-study|2|||
46634933|NCT01693068|82808345|FG001|Randomization Period|On-study|5|||
46634934|NCT01693068|82808346|FG002|Randomization Period|On-study|0|||
46634935|NCT01693068|82808344|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
46634936|NCT01693068|82808345|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
46634937|NCT01693068|82808346|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
46634938|NCT01691898|82808360|FG000|Overall Study|Death|34|||
46634939|NCT01691898|82808361|FG001|Overall Study|Death|32|||
46634940|NCT01691898|82808362|FG002|Overall Study|Death|6|||
46634941|NCT01691898|82808363|FG003|Overall Study|Death|3|||
46634942|NCT01691898|82808364|FG004|Overall Study|Death|8|||
46634943|NCT01691898|82808365|FG005|Overall Study|Death|31|||
46634944|NCT01691898|82808360|FG000|Overall Study|Adverse Event|0|||
46634945|NCT01691898|82808361|FG001|Overall Study|Adverse Event|1|||
46728655|NCT00913458|82944756|FG001|Phase 1|Protocol Violation|0|||
46728656|NCT00913458|82944757|FG002|Phase 1|Protocol Violation|0|||
46728657|NCT00913458|82944758|FG003|Phase 1|Protocol Violation|0|||
46728658|NCT00913458|82944759|FG004|Phase 1|Protocol Violation|0|||
46728659|NCT00913458|82944760|FG005|Phase 1|Protocol Violation|0|||
46728660|NCT00913458|82944761|FG006|Phase 1|Protocol Violation|0|||
46803793|NCT00545402|83023077|FG000|Overall Study|Reason not specified|1|||
46634946|NCT01691898|82808362|FG002|Overall Study|Adverse Event|0|||
46634947|NCT01691898|82808363|FG003|Overall Study|Adverse Event|1|||
46728661|NCT00913458|82944755|FG000|Phase 1|Sponsor|2|||
46634948|NCT01691898|82808364|FG004|Overall Study|Adverse Event|1|||
46634949|NCT01691898|82808365|FG005|Overall Study|Adverse Event|0|||
46728662|NCT00913458|82944756|FG001|Phase 1|Sponsor|0|||
46728663|NCT00913458|82944757|FG002|Phase 1|Sponsor|0|||
46728664|NCT00913458|82944758|FG003|Phase 1|Sponsor|0|||
46728665|NCT00913458|82944759|FG004|Phase 1|Sponsor|0|||
46728666|NCT00913458|82944760|FG005|Phase 1|Sponsor|0|||
46728667|NCT00913458|82944761|FG006|Phase 1|Sponsor|0|||
46728668|NCT00913458|82944755|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
46728669|NCT00913458|82944756|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
47047883|NCT01724359|83307368|FG000|Overall Study|Other|20|||
47047884|NCT01703221|83307377|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
47047885|NCT01703221|83307378|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
47047886|NCT01703221|83307379|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
47047887|NCT01703221|83307377|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
47047888|NCT01703221|83307378|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
47047889|NCT01703221|83307379|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
47047890|NCT01703221|83307377|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
47047891|NCT01703221|83307378|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
47047892|NCT01703221|83307379|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
47047893|NCT01703221|83307377|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
47047894|NCT01703221|83307378|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
47047895|NCT01703221|83307379|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
47047896|NCT01703221|83307377|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
47047897|NCT01703221|83307378|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
47047898|NCT01703221|83307379|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
47047899|NCT01703221|83307377|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
47047900|NCT01703221|83307378|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
47047901|NCT01703221|83307379|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
47047902|NCT01703221|83307377|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
47047903|NCT01703221|83307378|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
47047904|NCT01703221|83307379|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
47047905|NCT01703221|83307377|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
47047906|NCT01703221|83307378|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
47047907|NCT01703221|83307379|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
47047908|NCT01722877|83307393|FG000|Overall Study|Death|1|||
47047909|NCT01722877|83307393|FG000|Overall Study|Lost to Follow-up|1|||
47047910|NCT01703065|83307438|FG000|Overall Study|Lack of Efficacy|1|||
47047911|NCT01703065|83307439|FG001|Overall Study|Lack of Efficacy|0|||
47047912|NCT01702987|83307452|FG000|Overall Study|Withdrawal by Subject|1|||
47047913|NCT01702987|83307453|FG001|Overall Study|Withdrawal by Subject|0|||
47047914|NCT01702519|83307474|FG000|Washout Period|Lost to Follow-up|1|||
47047915|NCT01702519|83307475|FG001|Washout Period|Lost to Follow-up|0|||
47047916|NCT01702519|83307474|FG000|Washout Period|Withdrawal by Subject|0|||
47047917|NCT01702519|83307475|FG001|Washout Period|Withdrawal by Subject|2|||
47047918|NCT01739803|83307487|FG000|Overall Study|Lost to Follow-up|9|||
47047919|NCT01739803|83307488|FG001|Overall Study|Lost to Follow-up|6|||
47047920|NCT01739335|83307500|FG000|Overall Study|Lost to Follow-up|7|||
47047921|NCT01739335|83307501|FG001|Overall Study|Lost to Follow-up|4|||
47047922|NCT01739335|83307500|FG000|Overall Study|Ineligible patient randomized|0|||
47047923|NCT01739335|83307501|FG001|Overall Study|Ineligible patient randomized|1|||
47047924|NCT01702363|83307526|FG000|Overall Study|Adverse Event|14|||
47047925|NCT01702363|83307526|FG000|Overall Study|Lack of Efficacy|4|||
47047926|NCT01702363|83307526|FG000|Overall Study|Withdrawal by Subject|2|||
47047927|NCT01722097|83307533|FG000|Overall Study|Patient sheets not returned|6|||
47047928|NCT01722097|83307534|FG001|Overall Study|Patient sheets not returned|5|||
46634950|NCT01691898|82808360|FG000|Overall Study|Progression of Disease|1|||
46634951|NCT01691898|82808361|FG001|Overall Study|Progression of Disease|2|||
46634952|NCT01691898|82808362|FG002|Overall Study|Progression of Disease|1|||
46634953|NCT01691898|82808363|FG003|Overall Study|Progression of Disease|0|||
46728670|NCT00913458|82944757|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
47047929|NCT01701973|83307549|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
47047930|NCT01701973|83307550|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
47047931|NCT01701973|83307551|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
47047932|NCT01701973|83307552|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
47047933|NCT01701973|83307553|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
47047934|NCT01701973|83307554|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
47047935|NCT01701973|83307555|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
47047936|NCT01701973|83307556|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
46634954|NCT01691898|82808364|FG004|Overall Study|Progression of Disease|0|||
47047937|NCT01721317|83307607|FG000|Overall Study|Study Closed / Terminated|2|||
46728671|NCT00913458|82944758|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
46728672|NCT00913458|82944759|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
46728673|NCT00913458|82944760|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
46728674|NCT00913458|82944761|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
46728675|NCT00913458|82944755|FG000|Phase 2|Non-Responder|0|||
46728676|NCT00913458|82944756|FG001|Phase 2|Non-Responder|5|||
46728677|NCT00913458|82944757|FG002|Phase 2|Non-Responder|7|||
46728678|NCT00913458|82944758|FG003|Phase 2|Non-Responder|12|||
46728679|NCT00913458|82944759|FG004|Phase 2|Non-Responder|0|||
46728680|NCT00913458|82944760|FG005|Phase 2|Non-Responder|0|||
46728681|NCT00913458|82944761|FG006|Phase 2|Non-Responder|0|||
47047938|NCT01721317|83307608|FG001|Overall Study|Study Closed / Terminated|2|||
47047939|NCT01721317|83307607|FG000|Overall Study|Physician Decision|0|||
47047940|NCT01721317|83307608|FG001|Overall Study|Physician Decision|1|||
47047941|NCT01721317|83307607|FG000|Overall Study|Withdrawal by Subject|0|||
46803794|NCT00545402|83023078|FG001|Overall Study|Reason not specified|1|||
46803795|NCT00545792|83023084|FG000|Overall Study|Withdrawal by Subject|1|||
46803796|NCT00545168|83023091|FG000|Overall Study|Lost to Follow-up|5|||
46803797|NCT00545168|83023092|FG001|Overall Study|Lost to Follow-up|5|||
46803798|NCT00545168|83023093|FG002|Overall Study|Lost to Follow-up|5|||
46803799|NCT00545168|83023091|FG000|Overall Study|Withdrawal by Subject|9|||
46803800|NCT00545168|83023092|FG001|Overall Study|Withdrawal by Subject|0|||
46803801|NCT00545168|83023093|FG002|Overall Study|Withdrawal by Subject|13|||
46803802|NCT00545168|83023091|FG000|Overall Study|Protocol Violation|1|||
46803803|NCT00545168|83023092|FG001|Overall Study|Protocol Violation|0|||
46921326|NCT02925117|83153804|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
47047942|NCT01721317|83307608|FG001|Overall Study|Withdrawal by Subject|1|||
47047943|NCT01701193|83307618|FG000|Overall Study|Withdrawal by Subject|2|||
47047944|NCT01701193|83307619|FG001|Overall Study|Withdrawal by Subject|2|||
46728682|NCT00913458|82944755|FG000|Phase 2|Subject Request|0|||
46728683|NCT00913458|82944756|FG001|Phase 2|Subject Request|0|||
46728684|NCT00913458|82944757|FG002|Phase 2|Subject Request|1|||
46728685|NCT00913458|82944758|FG003|Phase 2|Subject Request|2|||
46728686|NCT00913458|82944759|FG004|Phase 2|Subject Request|0|||
46728687|NCT00913458|82944760|FG005|Phase 2|Subject Request|0|||
46728688|NCT00913458|82944761|FG006|Phase 2|Subject Request|0|||
46728689|NCT00913458|82944755|FG000|Phase 2|Adverse Event|0|||
46728690|NCT00913458|82944756|FG001|Phase 2|Adverse Event|3|||
46728691|NCT00913458|82944757|FG002|Phase 2|Adverse Event|0|||
46728692|NCT00913458|82944758|FG003|Phase 2|Adverse Event|1|||
46728693|NCT00913458|82944759|FG004|Phase 2|Adverse Event|0|||
46728694|NCT00913458|82944760|FG005|Phase 2|Adverse Event|0|||
46728695|NCT00913458|82944761|FG006|Phase 2|Adverse Event|0|||
46728696|NCT00913458|82944755|FG000|Phase 2|Lost to Follow-up|0|||
46728697|NCT00913458|82944756|FG001|Phase 2|Lost to Follow-up|0|||
46728698|NCT00913458|82944757|FG002|Phase 2|Lost to Follow-up|0|||
46728699|NCT00913458|82944758|FG003|Phase 2|Lost to Follow-up|1|||
46728700|NCT00913458|82944759|FG004|Phase 2|Lost to Follow-up|0|||
46728701|NCT00913458|82944760|FG005|Phase 2|Lost to Follow-up|0|||
46728702|NCT00913458|82944761|FG006|Phase 2|Lost to Follow-up|0|||
46728703|NCT00913458|82944755|FG000|Phase 2|Protocol Violation|0|||
46728704|NCT00913458|82944756|FG001|Phase 2|Protocol Violation|2|||
46728705|NCT00913458|82944757|FG002|Phase 2|Protocol Violation|0|||
46728706|NCT00913458|82944758|FG003|Phase 2|Protocol Violation|0|||
46728707|NCT00913458|82944759|FG004|Phase 2|Protocol Violation|0|||
46728708|NCT00913458|82944760|FG005|Phase 2|Protocol Violation|0|||
47047945|NCT01701193|83307620|FG002|Overall Study|Withdrawal by Subject|1|||
47047946|NCT01701193|83307621|FG003|Overall Study|Withdrawal by Subject|2|||
47047947|NCT01701193|83307618|FG000|Overall Study|Adverse Event|1|||
47047948|NCT01701193|83307619|FG001|Overall Study|Adverse Event|0|||
47047949|NCT01701193|83307620|FG002|Overall Study|Adverse Event|0|||
46803804|NCT00545168|83023093|FG002|Overall Study|Protocol Violation|1|||
46921327|NCT02925117|83153805|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
47047950|NCT01701193|83307621|FG003|Overall Study|Adverse Event|0|||
47047951|NCT01959347|83307669|FG000|Overall Study|Protocol Violation|9|||
47047952|NCT01959347|83307670|FG001|Overall Study|Protocol Violation|7|||
47047953|NCT01959035|83307696|FG000|Overall Study|Adverse Event|5|||
47047954|NCT01959035|83307696|FG000|Overall Study|Withdrawal by Subject|4|||
47047955|NCT01959035|83307696|FG000|Overall Study|Lost to Follow-up|1|||
46728709|NCT00913458|82944761|FG006|Phase 2|Protocol Violation|0|||
46728710|NCT00913458|82944755|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
46728711|NCT00913458|82944756|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
46728712|NCT00913458|82944757|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
46728713|NCT00913458|82944758|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
46728714|NCT00913458|82944759|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
46728715|NCT00913458|82944760|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
46728716|NCT00913458|82944761|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
46921328|NCT02925117|83153806|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
46728717|NCT00913458|82944755|FG000|Phase 3|Adverse Event|0|||
46728718|NCT00913458|82944756|FG001|Phase 3|Adverse Event|0|||
46728719|NCT00913458|82944757|FG002|Phase 3|Adverse Event|0|||
46728720|NCT00913458|82944758|FG003|Phase 3|Adverse Event|0|||
46728721|NCT00913458|82944759|FG004|Phase 3|Adverse Event|5|||
46728722|NCT00913458|82944760|FG005|Phase 3|Adverse Event|4|||
46728723|NCT00913458|82944761|FG006|Phase 3|Adverse Event|1|||
46728724|NCT00913458|82944755|FG000|Phase 3|Lost to Follow-up|0|||
46728725|NCT00913458|82944756|FG001|Phase 3|Lost to Follow-up|0|||
46728726|NCT00913458|82944757|FG002|Phase 3|Lost to Follow-up|0|||
46728727|NCT00913458|82944758|FG003|Phase 3|Lost to Follow-up|0|||
46728728|NCT00913458|82944759|FG004|Phase 3|Lost to Follow-up|2|||
46728729|NCT00913458|82944760|FG005|Phase 3|Lost to Follow-up|0|||
46728730|NCT00913458|82944761|FG006|Phase 3|Lost to Follow-up|0|||
46728731|NCT00913458|82944755|FG000|Phase 3|Non-Responder|0|||
46921329|NCT02925117|83153807|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
46921330|NCT02925117|83153808|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
46921331|NCT02925117|83153809|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
46921332|NCT02925117|83153810|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
46921333|NCT02925117|83153799|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921334|NCT02925117|83153800|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921335|NCT02925117|83153801|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921336|NCT02925117|83153802|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921337|NCT02925117|83153803|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921338|NCT02925117|83153804|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
46921339|NCT02925117|83153805|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921340|NCT02925117|83153806|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921341|NCT02925117|83153807|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
46921342|NCT02925117|83153808|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
47047956|NCT01959035|83307696|FG000|Overall Study|Other (no primary reason given)|1|||
47047957|NCT01700959|83307706|FG000|Overall Study|Adverse Event|0|||
47047958|NCT01700959|83307707|FG001|Overall Study|Adverse Event|1|||
47047959|NCT01700959|83307708|FG002|Overall Study|Adverse Event|1|||
47047960|NCT01700959|83307709|FG003|Overall Study|Adverse Event|2|||
47047961|NCT01700959|83307710|FG004|Overall Study|Adverse Event|0|||
47047962|NCT01700959|83307711|FG005|Overall Study|Adverse Event|2|||
47047963|NCT01700959|83307706|FG000|Overall Study|Withdrawal by Subject|15|||
47047964|NCT01700959|83307707|FG001|Overall Study|Withdrawal by Subject|9|||
47047965|NCT01700959|83307708|FG002|Overall Study|Withdrawal by Subject|12|||
47047966|NCT01700959|83307709|FG003|Overall Study|Withdrawal by Subject|11|||
47047967|NCT01700959|83307710|FG004|Overall Study|Withdrawal by Subject|8|||
47047968|NCT01700959|83307711|FG005|Overall Study|Withdrawal by Subject|12|||
47047969|NCT01700959|83307706|FG000|Overall Study|Ineligible|2|||
47047970|NCT01700959|83307707|FG001|Overall Study|Ineligible|1|||
46921343|NCT02925117|83153809|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
46921344|NCT02925117|83153810|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
46921345|NCT02925117|83153799|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
46921346|NCT02925117|83153800|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
46921347|NCT02925117|83153801|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
46921348|NCT02925117|83153802|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
46921349|NCT02925117|83153803|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
46921350|NCT02925117|83153804|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
46921351|NCT02925117|83153805|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
46921352|NCT02925117|83153806|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
46921353|NCT02925117|83153807|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
46921354|NCT02925117|83153808|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
47047971|NCT01700959|83307708|FG002|Overall Study|Ineligible|2|||
46728732|NCT00913458|82944756|FG001|Phase 3|Non-Responder|0|||
46921355|NCT02925117|83153809|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
46921356|NCT02925117|83153810|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
46921357|NCT02925117|83153799|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
46921358|NCT02925117|83153800|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
46921359|NCT02925117|83153801|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
46921360|NCT02925117|83153802|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
46921361|NCT02925117|83153803|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
46921362|NCT02925117|83153804|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
46921363|NCT02925117|83153805|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
46921364|NCT02925117|83153806|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
46921365|NCT02925117|83153807|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
46921366|NCT02925117|83153808|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
46921367|NCT02925117|83153809|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
47047972|NCT01700959|83307709|FG003|Overall Study|Ineligible|0|||
47047973|NCT01700959|83307710|FG004|Overall Study|Ineligible|0|||
47047974|NCT01700959|83307711|FG005|Overall Study|Ineligible|1|||
47047975|NCT01700959|83307706|FG000|Overall Study|Noncompliant|9|||
46728733|NCT00913458|82944757|FG002|Phase 3|Non-Responder|0|||
46728734|NCT00913458|82944758|FG003|Phase 3|Non-Responder|0|||
46728735|NCT00913458|82944759|FG004|Phase 3|Non-Responder|0|||
46728736|NCT00913458|82944760|FG005|Phase 3|Non-Responder|1|||
46728737|NCT00913458|82944761|FG006|Phase 3|Non-Responder|3|||
46921368|NCT02925117|83153810|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
46921369|NCT02925117|83153799|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
46921370|NCT02925117|83153800|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
46921371|NCT02925117|83153801|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
46921372|NCT02925117|83153802|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
46921373|NCT02925117|83153803|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
46921374|NCT02925117|83153804|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
46921375|NCT02925117|83153805|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
46921376|NCT02925117|83153806|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
47047976|NCT01700959|83307707|FG001|Overall Study|Noncompliant|9|||
47047977|NCT01700959|83307708|FG002|Overall Study|Noncompliant|17|||
47047978|NCT01700959|83307709|FG003|Overall Study|Noncompliant|18|||
47047979|NCT01700959|83307710|FG004|Overall Study|Noncompliant|15|||
47047980|NCT01700959|83307711|FG005|Overall Study|Noncompliant|9|||
47047981|NCT01700959|83307706|FG000|Overall Study|Side effects|1|||
47047982|NCT01700959|83307707|FG001|Overall Study|Side effects|4|||
47047983|NCT01700959|83307708|FG002|Overall Study|Side effects|8|||
47047984|NCT01700959|83307709|FG003|Overall Study|Side effects|4|||
47047985|NCT01700959|83307710|FG004|Overall Study|Side effects|4|||
47047986|NCT01700959|83307711|FG005|Overall Study|Side effects|1|||
47047987|NCT01738477|83307733|FG000|Overall Study|Lost to Follow-up|1|||
47047988|NCT01738477|83307734|FG001|Overall Study|Lost to Follow-up|4|||
47047989|NCT01737931|83307750|FG000|Overall Study|Withdrawal by Subject|0|||
47047990|NCT01737931|83307751|FG001|Overall Study|Withdrawal by Subject|1|||
47047991|NCT01737931|83307752|FG002|Overall Study|Withdrawal by Subject|1|||
47047992|NCT01737931|83307750|FG000|Overall Study|Physician Decision|0|||
47047993|NCT01737931|83307751|FG001|Overall Study|Physician Decision|1|||
47047994|NCT01737931|83307752|FG002|Overall Study|Physician Decision|0|||
47047995|NCT01958489|83307758|FG000|Period 2|Adverse Event|0|||
46634955|NCT01691898|82808365|FG005|Overall Study|Progression of Disease|1|||
46728738|NCT00913458|82944755|FG000|Phase 3|Withdrawal by Subject|0|||
46728739|NCT00913458|82944756|FG001|Phase 3|Withdrawal by Subject|0|||
46728740|NCT00913458|82944757|FG002|Phase 3|Withdrawal by Subject|0|||
46728741|NCT00913458|82944758|FG003|Phase 3|Withdrawal by Subject|0|||
46728742|NCT00913458|82944759|FG004|Phase 3|Withdrawal by Subject|1|||
46728743|NCT00913458|82944760|FG005|Phase 3|Withdrawal by Subject|2|||
46728744|NCT00913458|82944761|FG006|Phase 3|Withdrawal by Subject|0|||
46728745|NCT00913458|82944755|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
46728746|NCT00913458|82944756|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
46728747|NCT00913458|82944757|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
46728748|NCT00913458|82944758|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
46728749|NCT00913458|82944759|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
46728750|NCT00913458|82944760|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
46728751|NCT00913458|82944761|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
46728752|NCT00785707|82944778|FG000|Overall Study|Lost to Follow-up|7|||
46728753|NCT00913380|82944784|FG000|Clinical Outcomes|Lost to Follow-up|6|||
46728754|NCT00913380|82944785|FG001|Clinical Outcomes|Lost to Follow-up|6|||
46728755|NCT00785629|82944795|FG000|Overall Study|Adverse Event|2|||
46728756|NCT00785629|82944796|FG001|Overall Study|Adverse Event|1|||
46921377|NCT02925117|83153807|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
47047996|NCT01958489|83307759|FG001|Period 2|Adverse Event|1|||
47047997|NCT01721161|83307772|FG000|Overall Study|Adverse Event|2|||
47047998|NCT01721161|83307773|FG001|Overall Study|Adverse Event|3|||
47047999|NCT01721161|83307772|FG000|Overall Study|Lost to Follow-up|1|||
47048000|NCT01721161|83307773|FG001|Overall Study|Lost to Follow-up|2|||
47048001|NCT01721161|83307772|FG000|Overall Study|Withdrawal by Subject|1|||
47048002|NCT01721161|83307773|FG001|Overall Study|Withdrawal by Subject|1|||
47048003|NCT01721161|83307772|FG000|Overall Study|Other|0|||
46634956|NCT01691898|82808360|FG000|Overall Study|Lost to Follow-up|3|||
46634957|NCT01691898|82808361|FG001|Overall Study|Lost to Follow-up|1|||
46634958|NCT01691898|82808362|FG002|Overall Study|Lost to Follow-up|0|||
46634959|NCT01691898|82808363|FG003|Overall Study|Lost to Follow-up|0|||
46634960|NCT01691898|82808364|FG004|Overall Study|Lost to Follow-up|1|||
46634961|NCT01691898|82808365|FG005|Overall Study|Lost to Follow-up|0|||
46634962|NCT01691898|82808360|FG000|Overall Study|Withdrawal by Subject|9|||
46634963|NCT01691898|82808361|FG001|Overall Study|Withdrawal by Subject|8|||
46634964|NCT01691898|82808362|FG002|Overall Study|Withdrawal by Subject|2|||
46634965|NCT01691898|82808363|FG003|Overall Study|Withdrawal by Subject|1|||
46634966|NCT01691898|82808364|FG004|Overall Study|Withdrawal by Subject|3|||
46634967|NCT01691898|82808365|FG005|Overall Study|Withdrawal by Subject|3|||
46634968|NCT01691898|82808360|FG000|Overall Study|Non-Compliance|0|||
46728757|NCT00785629|82944797|FG002|Overall Study|Adverse Event|1|||
46728758|NCT00785629|82944798|FG003|Overall Study|Adverse Event|5|||
46921378|NCT02925117|83153808|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
47048004|NCT01721161|83307773|FG001|Overall Study|Other|1|||
47048005|NCT01699867|83307780|FG000|Overall Study|Screening Failure|3|||
47048006|NCT01699789|83307799|FG000|Overall Study|Withdrawal by Subject|18|||
46634969|NCT01691898|82808361|FG001|Overall Study|Non-Compliance|0|||
46728759|NCT00785629|82944795|FG000|Overall Study|Protocol Violation|1|||
46728760|NCT00785629|82944796|FG001|Overall Study|Protocol Violation|2|||
46728761|NCT00785629|82944797|FG002|Overall Study|Protocol Violation|4|||
46728762|NCT00785629|82944798|FG003|Overall Study|Protocol Violation|5|||
46728763|NCT00785629|82944795|FG000|Overall Study|administrative decision|5|||
46728764|NCT00785629|82944796|FG001|Overall Study|administrative decision|1|||
46728765|NCT00785629|82944797|FG002|Overall Study|administrative decision|3|||
46728766|NCT00785629|82944798|FG003|Overall Study|administrative decision|4|||
46728767|NCT00785629|82944795|FG000|Overall Study|Withdrawal by Subject|0|||
46728768|NCT00785629|82944796|FG001|Overall Study|Withdrawal by Subject|1|||
46728769|NCT00785629|82944797|FG002|Overall Study|Withdrawal by Subject|2|||
46728770|NCT00785629|82944798|FG003|Overall Study|Withdrawal by Subject|2|||
46728771|NCT00916344|82944806|FG000|Overall Study|Death|2|||
46728772|NCT00916344|82944806|FG000|Overall Study|ICD upgrade|1|||
46728773|NCT00916344|82944806|FG000|Overall Study|Drop-out|5|||
46728774|NCT00913770|82944813|FG000|Overall Study|Unable to contact|24|||
46728775|NCT00913770|82944814|FG001|Overall Study|Unable to contact|19|||
46728776|NCT00913770|82944815|FG002|Overall Study|Unable to contact|13|||
46728777|NCT00913770|82944813|FG000|Overall Study|Refused|11|||
46728778|NCT00913770|82944814|FG001|Overall Study|Refused|10|||
46728779|NCT00913770|82944815|FG002|Overall Study|Refused|8|||
46728780|NCT00780559|82944825|FG000|Overall Study|Lost to Follow-up|2|||
46728781|NCT00780559|82944826|FG001|Overall Study|Lost to Follow-up|7|||
46728782|NCT00780559|82944825|FG000|Overall Study|Death|1|||
46728783|NCT00780559|82944826|FG001|Overall Study|Death|0|||
46728784|NCT00912912|82944834|FG000|Overall Study|Withdrawal by Subject|1|||
46728785|NCT00912912|82944834|FG000|Overall Study|Disease Progression|3|||
46728786|NCT00889005|82944840|FG000|Overall Study|Lost to Follow-up|4|||
46728787|NCT00889005|82944841|FG001|Overall Study|Lost to Follow-up|2|||
46728788|NCT00889005|82944840|FG000|Overall Study|Withdrawal by Subject|4|||
46728789|NCT00889005|82944841|FG001|Overall Study|Withdrawal by Subject|0|||
46728790|NCT00779857|82944847|FG000|Overall Study|Death|1|||
46728791|NCT00779857|82944847|FG000|Overall Study|Withdrawal by Subject|3|||
46728792|NCT00779857|82944847|FG000|Overall Study|Missed Visit|2|||
46728793|NCT00913692|82944851|FG000|Screening (4 Months)|Physician Decision|3|||
46728794|NCT00913692|82944851|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
47048007|NCT01699789|83307800|FG001|Overall Study|Withdrawal by Subject|23|||
47048008|NCT01699789|83307799|FG000|Overall Study|Death|1|||
47048009|NCT01699789|83307800|FG001|Overall Study|Death|2|||
47048010|NCT01699789|83307799|FG000|Overall Study|Lost to Follow-up|83|||
47048011|NCT01699789|83307800|FG001|Overall Study|Lost to Follow-up|101|||
47048012|NCT01944059|83307830|FG000|Overall Study|Lost to Follow-up|1|||
46728795|NCT00913692|82944851|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
46728796|NCT00784927|82944858|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
46728797|NCT00784927|82944858|FG000|Overall Study|Protocol Violation|1|||
46728798|NCT00784927|82944858|FG000|Overall Study|Ineligible|1|||
46728799|NCT00779779|82944863|FG000|Overall Study|Adverse Event|1|||
46728800|NCT00779779|82944863|FG000|Overall Study|Protocol Violation|14|||
46728801|NCT00779779|82944863|FG000|Overall Study|Withdrawal by Subject|4|||
46728802|NCT00779779|82944863|FG000|Overall Study|Lost to Follow-up|5|||
46728803|NCT00845728|82944869|FG000|Overall Study|Abnormal laboratory value (s)|2|||
46728804|NCT00845728|82944870|FG001|Overall Study|Abnormal laboratory value (s)|2|||
46728805|NCT00845728|82944869|FG000|Overall Study|Patient's inability to use the device|4|||
46728806|NCT00845728|82944870|FG001|Overall Study|Patient's inability to use the device|6|||
46728807|NCT00845728|82944869|FG000|Overall Study|Abnormal test procedure result (s)|7|||
46728808|NCT00845728|82944870|FG001|Overall Study|Abnormal test procedure result (s)|2|||
46728809|NCT00845728|82944869|FG000|Overall Study|Lost to Follow-up|22|||
46728810|NCT00845728|82944870|FG001|Overall Study|Lost to Follow-up|13|||
46728811|NCT00845728|82944869|FG000|Overall Study|Death|24|||
47048013|NCT01944059|83307830|FG000|Overall Study|Physician Decision|3|||
46728812|NCT00845728|82944870|FG001|Overall Study|Death|26|||
46728813|NCT00845728|82944869|FG000|Overall Study|Administrative Problems|34|||
46728814|NCT00845728|82944870|FG001|Overall Study|Administrative Problems|26|||
46728815|NCT00845728|82944869|FG000|Overall Study|Protocol Violation|36|||
46728816|NCT00845728|82944870|FG001|Overall Study|Protocol Violation|24|||
46728817|NCT00845728|82944869|FG000|Overall Study|Lack of Efficacy|51|||
46728818|NCT00845728|82944870|FG001|Overall Study|Lack of Efficacy|39|||
46728819|NCT00845728|82944869|FG000|Overall Study|Adverse Event|101|||
46728820|NCT00845728|82944870|FG001|Overall Study|Adverse Event|96|||
46728821|NCT00845728|82944869|FG000|Overall Study|Withdrawal by Subject|105|||
46728822|NCT00845728|82944870|FG001|Overall Study|Withdrawal by Subject|108|||
46728823|NCT00779467|82944880|FG000|Overall Study|Lack of Efficacy|11|||
46728824|NCT00779467|82944881|FG001|Overall Study|Lack of Efficacy|2|||
46803805|NCT00545168|83023091|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
46728825|NCT00779467|82944882|FG002|Overall Study|Lack of Efficacy|6|||
46728826|NCT00779467|82944883|FG003|Overall Study|Lack of Efficacy|11|||
47048014|NCT01944059|83307830|FG000|Overall Study|Withdrawal by Subject|1|||
47048015|NCT01944059|83307830|FG000|Overall Study|Adverse Event|2|||
47048016|NCT01720225|83307837|FG000|Overall Study|Withdrawal by Subject|0|||
46728827|NCT00779467|82944880|FG000|Overall Study|failed inclusion criteria|3|||
46728828|NCT00779467|82944881|FG001|Overall Study|failed inclusion criteria|3|||
46728829|NCT00779467|82944882|FG002|Overall Study|failed inclusion criteria|1|||
46728830|NCT00779467|82944883|FG003|Overall Study|failed inclusion criteria|2|||
46728831|NCT00779467|82944880|FG000|Overall Study|missing data|1|||
47048017|NCT01720225|83307838|FG001|Overall Study|Withdrawal by Subject|1|||
47048018|NCT01720225|83307837|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
47048019|NCT01720225|83307838|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
46728832|NCT00779467|82944881|FG001|Overall Study|missing data|0|||
46728833|NCT00779467|82944882|FG002|Overall Study|missing data|1|||
46728834|NCT00779467|82944883|FG003|Overall Study|missing data|4|||
46728835|NCT00779467|82944880|FG000|Overall Study|technical issue|0|||
46728836|NCT00779467|82944881|FG001|Overall Study|technical issue|0|||
46728837|NCT00779467|82944882|FG002|Overall Study|technical issue|2|||
46728838|NCT00779467|82944883|FG003|Overall Study|technical issue|1|||
46728839|NCT00779467|82944880|FG000|Overall Study|unavailable research staff|0|||
46728840|NCT00779467|82944881|FG001|Overall Study|unavailable research staff|0|||
46728841|NCT00779467|82944882|FG002|Overall Study|unavailable research staff|0|||
46728842|NCT00779467|82944883|FG003|Overall Study|unavailable research staff|1|||
46728843|NCT00778921|82944896|FG000|Overall Study|Adverse Event|9|||
46728844|NCT00778921|82944897|FG001|Overall Study|Adverse Event|10|||
46728845|NCT00778921|82944898|FG002|Overall Study|Adverse Event|14|||
46728846|NCT00778921|82944896|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
46728847|NCT00778921|82944897|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
46728848|NCT00778921|82944898|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
46728849|NCT00778921|82944896|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
46728850|NCT00778921|82944897|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
46728851|NCT00778921|82944898|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
46728852|NCT00778921|82944896|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
46728853|NCT00778921|82944897|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
46728854|NCT00778921|82944898|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
46728855|NCT00778921|82944896|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
46728856|NCT00778921|82944897|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
46728857|NCT00778921|82944898|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
46728858|NCT00778921|82944896|FG000|Overall Study|Patient withdrew request|3|||
46728859|NCT00778921|82944897|FG001|Overall Study|Patient withdrew request|1|||
47048020|NCT01943591|83307846|FG000|Overall Study|Lost to Follow-up|3|||
47048021|NCT01943591|83307847|FG001|Overall Study|Lost to Follow-up|4|||
47048022|NCT01943591|83307846|FG000|Overall Study|Death|2|||
47048023|NCT01943591|83307847|FG001|Overall Study|Death|7|||
46728860|NCT00778921|82944898|FG002|Overall Study|Patient withdrew request|6|||
46728861|NCT00778921|82944896|FG000|Overall Study|Lost to Follow-up|0|||
46728862|NCT00778921|82944897|FG001|Overall Study|Lost to Follow-up|2|||
46728863|NCT00778921|82944898|FG002|Overall Study|Lost to Follow-up|1|||
46728864|NCT00778921|82944896|FG000|Overall Study|Administrative Problems|1|||
46728865|NCT00778921|82944897|FG001|Overall Study|Administrative Problems|2|||
46728866|NCT00778921|82944898|FG002|Overall Study|Administrative Problems|0|||
46728867|NCT00778921|82944896|FG000|Overall Study|Protocol Violation|3|||
46728868|NCT00778921|82944897|FG001|Overall Study|Protocol Violation|0|||
46728869|NCT00778921|82944898|FG002|Overall Study|Protocol Violation|2|||
47048024|NCT01699087|83307853|FG000|Overall Study|Lost to Follow-up|7|||
47048025|NCT01699087|83307853|FG000|Overall Study|Screen failure (prior to treatment)|15|||
47048026|NCT01699087|83307853|FG000|Overall Study|Unable to make future visits|2|||
47048027|NCT01943435|83307861|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
47048028|NCT01943435|83307862|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
47048029|NCT01943435|83307863|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
47048030|NCT01943435|83307861|FG000|Intervention Period|Withdrawal by Subject|3|||
47048031|NCT01943435|83307862|FG001|Intervention Period|Withdrawal by Subject|3|||
47048032|NCT01943435|83307863|FG002|Intervention Period|Withdrawal by Subject|4|||
47048033|NCT01943435|83307861|FG000|2 Month Follow up|Lost to Follow-up|2|||
47048034|NCT01943435|83307862|FG001|2 Month Follow up|Lost to Follow-up|3|||
47048035|NCT01943435|83307863|FG002|2 Month Follow up|Lost to Follow-up|0|||
47048036|NCT01943435|83307861|FG000|6 Month Follow up|Lost to Follow-up|12|||
47048037|NCT01943435|83307862|FG001|6 Month Follow up|Lost to Follow-up|7|||
47048038|NCT01943435|83307863|FG002|6 Month Follow up|Lost to Follow-up|15|||
46728870|NCT00778921|82944896|FG000|Overall Study|Not treated|0|||
46728871|NCT00778921|82944897|FG001|Overall Study|Not treated|2|||
46728872|NCT00778921|82944898|FG002|Overall Study|Not treated|2|||
46728873|NCT00915876|82944908|FG000|Overall Study|Adverse Event|0|||
46728874|NCT00915876|82944909|FG001|Overall Study|Adverse Event|1|||
46728875|NCT00776659|82944915|FG000|Overall Study|Lost to Follow-up|15|||
47048039|NCT01942733|83307881|FG000|Overall Study|Lost to Follow-up|1|||
47048040|NCT01942733|83307881|FG000|Overall Study|Non-compliance with IMP|1|||
47048041|NCT01942733|83307881|FG000|Overall Study|Administrative|1|||
46728876|NCT00776659|82944915|FG000|Overall Study|Withdrawal by Subject|10|||
46921379|NCT02925117|83153809|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
47048042|NCT01957865|83307897|FG000|Overall Study|Found HIV negative|0|||
47048043|NCT01957865|83307898|FG001|Overall Study|Found HIV negative|0|||
47048044|NCT01957865|83307899|FG002|Overall Study|Found HIV negative|1|||
47048045|NCT01957865|83307897|FG000|Overall Study|Lost to Follow-up|0|||
47048046|NCT01957865|83307898|FG001|Overall Study|Lost to Follow-up|2|||
47048047|NCT01957865|83307899|FG002|Overall Study|Lost to Follow-up|2|||
47048048|NCT01957787|83307908|FG000|Overall Study|Death|18|||
47048049|NCT01957787|83307908|FG000|Overall Study|Lost to Follow-up|3|||
47048050|NCT01957787|83307908|FG000|Overall Study|Withdrawal by Subject|3|||
47048051|NCT01957787|83307908|FG000|Overall Study|Entered Hospice or Similar Program|2|||
47048052|NCT01957787|83307908|FG000|Overall Study|Index Tumor(s) Resected|2|||
47048053|NCT01957787|83307908|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
47048054|NCT01957787|83307908|FG000|Overall Study|Local therapy, not cryoablation|6|||
47048055|NCT01698775|83307914|FG000|Phase A|Adverse Event|2|||
47048056|NCT01698775|83307915|FG001|Phase A|Adverse Event|1|||
47048057|NCT01698775|83307914|FG000|Phase A|Death|1|||
46728877|NCT00776659|82944915|FG000|Overall Study|Study Terminated by Sponsor|1|||
46728878|NCT00825682|82944921|FG000|Overall Study|personal reasons/ inconvenience|13|||
46728879|NCT00825682|82944922|FG001|Overall Study|personal reasons/ inconvenience|5|||
46728880|NCT00833794|82944931|FG000|Open-label Phase|Adverse Event|225|||
46728881|NCT00833794|82944932|FG001|Open-label Phase|Adverse Event|0|||
46728882|NCT00833794|82944931|FG000|Open-label Phase|Lack of Efficacy|28|||
46728883|NCT00833794|82944932|FG001|Open-label Phase|Lack of Efficacy|0|||
46728884|NCT00833794|82944931|FG000|Open-label Phase|Withdrawal by Subject|48|||
46728885|NCT00833794|82944932|FG001|Open-label Phase|Withdrawal by Subject|0|||
46728886|NCT00833794|82944931|FG000|Open-label Phase|Physician Decision|20|||
46728887|NCT00833794|82944932|FG001|Open-label Phase|Physician Decision|0|||
46728888|NCT00833794|82944931|FG000|Open-label Phase|Administrative reason|1|||
46728889|NCT00833794|82944932|FG001|Open-label Phase|Administrative reason|0|||
46728890|NCT00833794|82944931|FG000|Open-label Phase|Protocol Violation|47|||
46728891|NCT00833794|82944932|FG001|Open-label Phase|Protocol Violation|0|||
46728892|NCT00833794|82944931|FG000|Open-label Phase|Did not complete wash-out period|12|||
46728893|NCT00833794|82944932|FG001|Open-label Phase|Did not complete wash-out period|0|||
46728894|NCT00833794|82944931|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
46728895|NCT00833794|82944932|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
46728896|NCT00833794|82944931|FG000|Double-blind Phase|Adverse Event|44|||
46728897|NCT00833794|82944932|FG001|Double-blind Phase|Adverse Event|11|||
46728898|NCT00833794|82944931|FG000|Double-blind Phase|Lack of Efficacy|34|||
46728899|NCT00833794|82944932|FG001|Double-blind Phase|Lack of Efficacy|22|||
46728900|NCT00833794|82944931|FG000|Double-blind Phase|Withdrawal by Subject|23|||
46728901|NCT00833794|82944932|FG001|Double-blind Phase|Withdrawal by Subject|6|||
47048058|NCT01698775|83307915|FG001|Phase A|Death|1|||
47048059|NCT01698775|83307914|FG000|Phase A|Lack of Efficacy|1|||
47048060|NCT01698775|83307915|FG001|Phase A|Lack of Efficacy|0|||
47048061|NCT01698775|83307914|FG000|Phase A|Lost to Follow-up|1|||
47048062|NCT01698775|83307915|FG001|Phase A|Lost to Follow-up|2|||
47048063|NCT01698775|83307914|FG000|Phase A|Protocol Violation|1|||
47048064|NCT01698775|83307915|FG001|Phase A|Protocol Violation|0|||
47048065|NCT01698775|83307914|FG000|Phase A|Withdrawal by Subject|3|||
47048066|NCT01698775|83307915|FG001|Phase A|Withdrawal by Subject|4|||
47048067|NCT01698775|83307914|FG000|Phase A|Kidney [transplant]|0|||
47048068|NCT01698775|83307915|FG001|Phase A|Kidney [transplant]|1|||
47048069|NCT01698775|83307914|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
47048070|NCT01698775|83307915|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
47048071|NCT01698775|83307914|FG000|Phase B|Adverse Event|6|||
47048072|NCT01698775|83307915|FG001|Phase B|Adverse Event|3|||
47048073|NCT01698775|83307914|FG000|Phase B|Death|0|||
47048074|NCT01698775|83307915|FG001|Phase B|Death|1|||
47048075|NCT01698775|83307914|FG000|Phase B|Lack of Efficacy|0|||
47048076|NCT01698775|83307915|FG001|Phase B|Lack of Efficacy|1|||
47048077|NCT01698775|83307914|FG000|Phase B|Lost to Follow-up|0|||
47048078|NCT01698775|83307915|FG001|Phase B|Lost to Follow-up|1|||
46728902|NCT00833794|82944931|FG000|Double-blind Phase|Physician Decision|4|||
46728903|NCT00833794|82944932|FG001|Double-blind Phase|Physician Decision|7|||
46728904|NCT00833794|82944931|FG000|Double-blind Phase|Administrative reason|1|||
46728905|NCT00833794|82944932|FG001|Double-blind Phase|Administrative reason|3|||
46803806|NCT00545168|83023092|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
46921380|NCT02925117|83153810|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
47048079|NCT01698775|83307914|FG000|Phase B|Physician Decision|1|||
47048080|NCT01698775|83307915|FG001|Phase B|Physician Decision|1|||
46728906|NCT00912288|82944942|FG000|Overall Study|Death|0|||
46728907|NCT00912288|82944943|FG001|Overall Study|Death|1|||
46728908|NCT00912288|82944942|FG000|Overall Study|Adverse Event|1|||
46728909|NCT00912288|82944943|FG001|Overall Study|Adverse Event|1|||
47048081|NCT01698775|83307914|FG000|Phase B|Protocol Violation|1|||
47048082|NCT01698775|83307915|FG001|Phase B|Protocol Violation|1|||
47048083|NCT01698775|83307914|FG000|Phase B|Withdrawal by Subject|6|||
47048084|NCT01698775|83307915|FG001|Phase B|Withdrawal by Subject|2|||
46728910|NCT00912288|82944942|FG000|Overall Study|Lost to Follow-up|1|||
46728911|NCT00912288|82944943|FG001|Overall Study|Lost to Follow-up|0|||
46728912|NCT00912288|82944942|FG000|Overall Study|Protocol Violation|1|||
46728913|NCT00912288|82944943|FG001|Overall Study|Protocol Violation|0|||
46728914|NCT00912288|82944942|FG000|Overall Study|Withdrawal by Subject|3|||
46728915|NCT00912288|82944943|FG001|Overall Study|Withdrawal by Subject|3|||
46728916|NCT00912288|82944942|FG000|Overall Study|Study terminated by sponsor|34|||
46728917|NCT00912288|82944943|FG001|Overall Study|Study terminated by sponsor|35|||
46728918|NCT00912288|82944942|FG000|Overall Study|Other|1|||
46728919|NCT00912288|82944943|FG001|Overall Study|Other|0|||
46728920|NCT00778375|82944949|FG000|Overall Study|Ineligible|3|||
46728921|NCT00777829|82944955|FG000|Overall Study|Withdrawal by Subject|0|||
46728922|NCT00777829|82944956|FG001|Overall Study|Withdrawal by Subject|2|||
46728923|NCT00775021|82944964|FG000|First Intervention|Lost to Follow-up|1|||
46728924|NCT00775021|82944965|FG001|First Intervention|Lost to Follow-up|0|||
46728925|NCT00775021|82944964|FG000|Second Intervention|Adverse Event|0|||
46728926|NCT00775021|82944965|FG001|Second Intervention|Adverse Event|1|||
46728927|NCT00777205|82944973|FG000|Overall Study|Lost to Follow-up|25|||
46728928|NCT00777205|82944974|FG001|Overall Study|Lost to Follow-up|9|||
46728929|NCT00777205|82944973|FG000|Overall Study|Withdrawal by Subject|6|||
46728930|NCT00777205|82944974|FG001|Overall Study|Withdrawal by Subject|4|||
46728931|NCT00777205|82944973|FG000|Overall Study|Death|0|||
46728932|NCT00777205|82944974|FG001|Overall Study|Death|2|||
46728933|NCT00777205|82944973|FG000|Overall Study|Protocol Violation|0|||
46728934|NCT00777205|82944974|FG001|Overall Study|Protocol Violation|56|||
46728935|NCT00833638|82944985|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
46728936|NCT00833638|82944986|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
46728937|NCT00833638|82944987|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
46728938|NCT00833638|82944985|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
46728939|NCT00833638|82944986|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
46728940|NCT00833638|82944987|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
46728941|NCT00833638|82944985|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
46728942|NCT00833638|82944986|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
46728943|NCT00833638|82944987|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
46728944|NCT00833638|82944985|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
46728945|NCT00833638|82944986|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
46728946|NCT00833638|82944987|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
46728947|NCT00833638|82944985|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
46728948|NCT00833638|82944986|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
47048085|NCT01941095|83307925|FG000|Overall Study|Insufficient therapeutic response|13|||
47048086|NCT01941095|83307925|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
47048087|NCT01941095|83307925|FG000|Overall Study|Adverse Event|11|||
47048088|NCT01941095|83307925|FG000|Overall Study|Physician Decision|3|||
47048089|NCT01941095|83307925|FG000|Overall Study|Withdrawal by Subject|17|||
46728949|NCT00833638|82944987|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
46728950|NCT00833638|82944985|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
46728951|NCT00833638|82944986|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
46728952|NCT00833638|82944987|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
46728953|NCT00833638|82944985|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
46728954|NCT00833638|82944986|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
46728955|NCT00833638|82944987|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
46728956|NCT00833638|82944985|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
46728957|NCT00833638|82944986|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
46728958|NCT00833638|82944987|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
46728959|NCT00833638|82944985|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
47048090|NCT01941095|83307925|FG000|Overall Study|Lost to Follow-up|10|||
47048091|NCT01957709|83307940|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
47048092|NCT01957553|83307957|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
47048093|NCT01957553|83307958|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
46728960|NCT00833638|82944986|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
46728961|NCT00833638|82944987|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
46728962|NCT01041404|82945005|FG000|Overall Study|Adverse Event|45|||
46728963|NCT01041404|82945006|FG001|Overall Study|Adverse Event|35|||
46728964|NCT01041404|82945005|FG000|Overall Study|Lack of Efficacy|200|||
46728965|NCT01041404|82945006|FG001|Overall Study|Lack of Efficacy|210|||
46728966|NCT01041404|82945005|FG000|Overall Study|Violation of Selection Criteria|0|||
46728967|NCT01041404|82945006|FG001|Overall Study|Violation of Selection Criteria|1|||
46728968|NCT01041404|82945005|FG000|Overall Study|Protocol Violation|4|||
46728969|NCT01041404|82945006|FG001|Overall Study|Protocol Violation|0|||
46728970|NCT01041404|82945005|FG000|Overall Study|Withdrawal by Subject|29|||
46728971|NCT01041404|82945006|FG001|Overall Study|Withdrawal by Subject|23|||
47048094|NCT01957553|83307957|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
46728972|NCT01041404|82945005|FG000|Overall Study|Failure to Return|1|||
46728973|NCT01041404|82945006|FG001|Overall Study|Failure to Return|2|||
46728974|NCT01041404|82945005|FG000|Overall Study|Other|11|||
46728975|NCT01041404|82945006|FG001|Overall Study|Other|23|||
47048095|NCT01957553|83307958|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
47048096|NCT01957553|83307957|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
47048097|NCT01957553|83307958|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
47048098|NCT01957553|83307957|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
47048099|NCT01957553|83307958|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
47048100|NCT01957553|83307957|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
47048101|NCT01957553|83307958|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
47048102|NCT01957553|83307957|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
47048103|NCT01957553|83307958|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
47048104|NCT01957553|83307957|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
47048105|NCT01957553|83307958|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
47048106|NCT01957553|83307957|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
47048107|NCT01957553|83307958|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
47048108|NCT01957553|83307957|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
47048109|NCT01957553|83307958|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
47048110|NCT01957475|83307983|FG000|Test Period 1|Withdrawal by Subject|1|||
47048111|NCT01957475|83307984|FG001|Test Period 1|Withdrawal by Subject|0|||
47048112|NCT01957475|83307983|FG000|Test Period 1|Other|1|||
47048113|NCT01957475|83307984|FG001|Test Period 1|Other|0|||
47048114|NCT01957475|83307983|FG000|Test Period 1|Lack of Efficacy|0|||
47048115|NCT01957475|83307984|FG001|Test Period 1|Lack of Efficacy|1|||
47048116|NCT01957475|83307983|FG000|Test Period 2|Adverse Event|1|||
47048117|NCT01957475|83307984|FG001|Test Period 2|Adverse Event|0|||
47048118|NCT01940939|83307992|FG000|Overall Study|Withdrawal by Subject|2|||
47048119|NCT01940939|83307993|FG001|Overall Study|Withdrawal by Subject|8|||
47048120|NCT01957397|83307999|FG000|Test Period 1|sudden leakage/small bag|1|||
47048121|NCT01957397|83308000|FG001|Test Period 1|sudden leakage/small bag|1|||
47048122|NCT01957397|83307999|FG000|Test Period 1|Withdrawal by Subject|1|||
47048123|NCT01957397|83308000|FG001|Test Period 1|Withdrawal by Subject|0|||
47048124|NCT01957397|83307999|FG000|Test Period 2|Adverse Event|0|||
47048125|NCT01957397|83308000|FG001|Test Period 2|Adverse Event|1|||
47048126|NCT01957397|83307999|FG000|Test Period 3|Adverse Event|1|||
47048127|NCT01957397|83308000|FG001|Test Period 3|Adverse Event|2|||
47048128|NCT01957397|83307999|FG000|Test Period 3|the adhesive did not work|1|||
47048129|NCT01957397|83308000|FG001|Test Period 3|the adhesive did not work|0|||
47048130|NCT01940705|83308014|FG000|Overall Study|Lost to Follow-up|1|||
47048131|NCT01940705|83308015|FG001|Overall Study|Lost to Follow-up|3|||
47048132|NCT01940705|83308016|FG002|Overall Study|Lost to Follow-up|2|||
47048133|NCT01940705|83308017|FG003|Overall Study|Lost to Follow-up|2|||
47048134|NCT01940705|83308014|FG000|Overall Study|Withdrawal by Subject|2|||
47048135|NCT01940705|83308015|FG001|Overall Study|Withdrawal by Subject|2|||
47048136|NCT01940705|83308016|FG002|Overall Study|Withdrawal by Subject|3|||
47048137|NCT01940705|83308017|FG003|Overall Study|Withdrawal by Subject|2|||
47048138|NCT01940705|83308014|FG000|Overall Study|Intervention not given|0|||
47048139|NCT01940705|83308015|FG001|Overall Study|Intervention not given|3|||
47048140|NCT01940705|83308016|FG002|Overall Study|Intervention not given|3|||
47048141|NCT01940705|83308017|FG003|Overall Study|Intervention not given|0|||
47048142|NCT01940705|83308014|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
47048143|NCT01940705|83308015|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
46728976|NCT00777049|82945017|FG000|Overall Study|Withdrawal by Subject|1|||
46728977|NCT00777049|82945018|FG001|Overall Study|Withdrawal by Subject|0|||
46728978|NCT00777049|82945017|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
46728979|NCT00777049|82945018|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
47048144|NCT01940705|83308016|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
47048145|NCT01940705|83308017|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
47048146|NCT01957163|83308042|FG000|Overall Study|Adverse Event|5|||
47048147|NCT01957163|83308043|FG001|Overall Study|Adverse Event|2|||
47048148|NCT01957163|83308044|FG002|Overall Study|Adverse Event|4|||
47048149|NCT01957163|83308042|FG000|Overall Study|Lack of Efficacy|5|||
47048150|NCT01957163|83308043|FG001|Overall Study|Lack of Efficacy|4|||
47048151|NCT01957163|83308044|FG002|Overall Study|Lack of Efficacy|9|||
46728980|NCT00774787|82945024|FG000|Overall Study|Lost to Follow-up|1|||
46728981|NCT00888927|82945032|FG000|Overall Study|Adverse Event|0|||
47048152|NCT01957163|83308042|FG000|Overall Study|Protocol Violation|1|||
47048153|NCT01957163|83308043|FG001|Overall Study|Protocol Violation|2|||
47048154|NCT01957163|83308044|FG002|Overall Study|Protocol Violation|0|||
46728982|NCT00888927|82945033|FG001|Overall Study|Adverse Event|0|||
47048155|NCT01957163|83308042|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
47048156|NCT01957163|83308043|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
47048157|NCT01957163|83308044|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
47048158|NCT01957163|83308042|FG000|Overall Study|Lost to Follow-up|0|||
46728983|NCT00888927|82945034|FG002|Overall Study|Adverse Event|0|||
46728984|NCT00888927|82945035|FG003|Overall Study|Adverse Event|1|||
46728985|NCT00888927|82945032|FG000|Overall Study|Withdrawal of consent|0|||
46728986|NCT00888927|82945033|FG001|Overall Study|Withdrawal of consent|0|||
46728987|NCT00888927|82945034|FG002|Overall Study|Withdrawal of consent|0|||
46728988|NCT00888927|82945035|FG003|Overall Study|Withdrawal of consent|1|||
46728989|NCT01040780|82945047|FG000|Overall Study|Protocol Violation|1|||
46728990|NCT01040780|82945048|FG001|Overall Study|Protocol Violation|3|||
46728991|NCT00888849|82945059|FG000|Overall Study|Death|4|||
46728992|NCT00888849|82945060|FG001|Overall Study|Death|7|||
46728993|NCT00888849|82945059|FG000|Overall Study|Lost to Follow-up|1|||
46728994|NCT00888849|82945060|FG001|Overall Study|Lost to Follow-up|2|||
46728995|NCT01059812|82945068|FG000|Overall Study|Adverse Event|9|||
46728996|NCT01059812|82945069|FG001|Overall Study|Adverse Event|5|||
46728997|NCT01059812|82945068|FG000|Overall Study|Lack of Efficacy|2|||
46728998|NCT01059812|82945069|FG001|Overall Study|Lack of Efficacy|2|||
46728999|NCT01059812|82945068|FG000|Overall Study|Protocol Violation|3|||
46729000|NCT01059812|82945069|FG001|Overall Study|Protocol Violation|1|||
46729001|NCT01059812|82945068|FG000|Overall Study|Withdrawal Criteria|9|||
46729002|NCT01059812|82945069|FG001|Overall Study|Withdrawal Criteria|4|||
47048159|NCT01957163|83308043|FG001|Overall Study|Lost to Follow-up|1|||
47048160|NCT01957163|83308044|FG002|Overall Study|Lost to Follow-up|0|||
47048161|NCT01957163|83308042|FG000|Overall Study|Withdrawal by Subject|4|||
47048162|NCT01957163|83308043|FG001|Overall Study|Withdrawal by Subject|2|||
47048163|NCT01957163|83308044|FG002|Overall Study|Withdrawal by Subject|4|||
47048164|NCT01939223|83308098|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
47048165|NCT01939223|83308099|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
47048166|NCT01939223|83308098|FG000|Overall Study|Disease recurrence (radiological)|1|||
47048167|NCT01939223|83308099|FG001|Overall Study|Disease recurrence (radiological)|3|||
47048168|NCT01939223|83308098|FG000|Overall Study|Study stopped by Sponsor|5|||
47048169|NCT01939223|83308099|FG001|Overall Study|Study stopped by Sponsor|7|||
47048170|NCT01939223|83308098|FG000|Overall Study|Withdrawal by Subject|6|||
47048171|NCT01939223|83308099|FG001|Overall Study|Withdrawal by Subject|0|||
47048172|NCT01954745|83308144|FG000|Overall Study|Radiological Progression|11|||
47048173|NCT01954745|83308144|FG000|Overall Study|Clinical Progression|5|||
47048174|NCT01954745|83308144|FG000|Overall Study|Adverse Event|2|||
47048175|NCT01954745|83308144|FG000|Overall Study|Death|1|||
47048176|NCT01954121|83308159|FG000|Overall Study|Lack of Efficacy|94|||
47048177|NCT01954121|83308160|FG001|Overall Study|Lack of Efficacy|41|||
47048178|NCT01954121|83308159|FG000|Overall Study|Protocol Violation|0|||
47048179|NCT01954121|83308160|FG001|Overall Study|Protocol Violation|2|||
47048180|NCT01954121|83308159|FG000|Overall Study|Lost to Follow-up|5|||
47048181|NCT01954121|83308160|FG001|Overall Study|Lost to Follow-up|6|||
47048182|NCT01954121|83308159|FG000|Overall Study|Withdrawal by Subject|18|||
47048183|NCT01954121|83308160|FG001|Overall Study|Withdrawal by Subject|12|||
47048184|NCT01954121|83308159|FG000|Overall Study|Pregnancy|1|||
46729003|NCT01059812|82945068|FG000|Overall Study|Unclassified|14|||
46729004|NCT01059812|82945069|FG001|Overall Study|Unclassified|4|||
46729005|NCT00888615|82945075|FG000|Overall Study|No treatment|2|||
46729006|NCT00888381|82945081|FG000|Overall Study|Lost to Follow-up|0|||
46729007|NCT00888381|82945082|FG001|Overall Study|Lost to Follow-up|1|||
46729008|NCT00887913|82945088|FG000|Overall Study|Withdrawal by Subject|6|||
46729009|NCT00833560|82945092|FG000|Overall Study|Toxicity|13|||
46729010|NCT00833560|82945092|FG000|Overall Study|Adverse Event|11|||
46729011|NCT00833560|82945092|FG000|Overall Study|Protocol Violation|6|||
46729012|NCT00833560|82945092|FG000|Overall Study|Lack of Efficacy|4|||
46729013|NCT00833560|82945092|FG000|Overall Study|Death|2|||
46729014|NCT00833560|82945092|FG000|Overall Study|Pregression of other disease|1|||
46729015|NCT00833560|82945092|FG000|Overall Study|Other|5|||
46729016|NCT00887679|82945096|FG000|Overall Study|Withdrawal by Subject|1|||
46729017|NCT00887679|82945096|FG000|Overall Study|Lost to Follow-up|4|||
47048185|NCT01954121|83308160|FG001|Overall Study|Pregnancy|1|||
47048186|NCT01954121|83308159|FG000|Overall Study|AE, serious fatal|1|||
47048187|NCT01954121|83308160|FG001|Overall Study|AE, serious fatal|0|||
46729018|NCT00887679|82945096|FG000|Overall Study|Physician Decision|5|||
47048188|NCT01954121|83308159|FG000|Overall Study|AE, non-serious non-fatal|5|||
47048189|NCT01954121|83308160|FG001|Overall Study|AE, non-serious non-fatal|22|||
47048190|NCT01954121|83308159|FG000|Overall Study|SAE, non-fatal|1|||
46729019|NCT00833482|82945103|FG000|Days 11-20|Adverse Event|0|||
46729020|NCT00833482|82945104|FG001|Days 11-20|Adverse Event|2|||
46729021|NCT00833482|82945105|FG002|Days 11-20|Adverse Event|0|||
46729022|NCT00833482|82945106|FG003|Days 11-20|Adverse Event|0|||
46729023|NCT00833482|82945107|FG004|Days 11-20|Adverse Event|0|||
46729024|NCT00833482|82945108|FG005|Days 11-20|Adverse Event|0|||
46729025|NCT00833482|82945103|FG000|Days 11-20|Withdrawal by Subject|0|||
47048191|NCT01954121|83308160|FG001|Overall Study|SAE, non-fatal|4|||
46729026|NCT00833482|82945104|FG001|Days 11-20|Withdrawal by Subject|1|||
46729027|NCT00833482|82945105|FG002|Days 11-20|Withdrawal by Subject|0|||
47048192|NCT01954121|83308159|FG000|Overall Study|Non-compliant with study procedures|1|||
46729028|NCT00833482|82945106|FG003|Days 11-20|Withdrawal by Subject|0|||
46729029|NCT00833482|82945107|FG004|Days 11-20|Withdrawal by Subject|0|||
46729030|NCT00833482|82945108|FG005|Days 11-20|Withdrawal by Subject|0|||
46729031|NCT00833482|82945103|FG000|Days 21-30|Adverse Event|0|||
46729032|NCT00833482|82945104|FG001|Days 21-30|Adverse Event|0|||
46729033|NCT00833482|82945105|FG002|Days 21-30|Adverse Event|1|||
46729034|NCT00833482|82945106|FG003|Days 21-30|Adverse Event|0|||
46729035|NCT00833482|82945107|FG004|Days 21-30|Adverse Event|0|||
46729036|NCT00833482|82945108|FG005|Days 21-30|Adverse Event|0|||
46729037|NCT00833482|82945103|FG000|Days 21-30|Withdrawal by Subject|0|||
46729038|NCT00833482|82945104|FG001|Days 21-30|Withdrawal by Subject|0|||
46729039|NCT00833482|82945105|FG002|Days 21-30|Withdrawal by Subject|0|||
46729040|NCT00833482|82945106|FG003|Days 21-30|Withdrawal by Subject|0|||
46729041|NCT00833482|82945107|FG004|Days 21-30|Withdrawal by Subject|1|||
46729042|NCT00833482|82945108|FG005|Days 21-30|Withdrawal by Subject|0|||
46729043|NCT00845182|82945133|FG000|Overall Study|Lost to Follow-up|3|||
46729044|NCT00845182|82945134|FG001|Overall Study|Lost to Follow-up|3|||
46729045|NCT00845182|82945135|FG002|Overall Study|Lost to Follow-up|4|||
46729046|NCT00845182|82945133|FG000|Overall Study|Adverse Event|0|||
46729047|NCT00845182|82945134|FG001|Overall Study|Adverse Event|1|||
46729048|NCT00845182|82945135|FG002|Overall Study|Adverse Event|1|||
46729049|NCT00845182|82945133|FG000|Overall Study|Physician Decision|0|||
46729050|NCT00845182|82945134|FG001|Overall Study|Physician Decision|0|||
46729051|NCT00845182|82945135|FG002|Overall Study|Physician Decision|1|||
46729052|NCT00833248|82945149|FG000|Overall Study|Adverse Event|3|||
46729053|NCT00833248|82945150|FG001|Overall Study|Adverse Event|0|||
46729054|NCT00833248|82945149|FG000|Overall Study|Protocol Violation|1|||
46729055|NCT00833248|82945150|FG001|Overall Study|Protocol Violation|2|||
46729056|NCT00833248|82945149|FG000|Overall Study|Withdrawal by Subject|0|||
46729057|NCT00833248|82945150|FG001|Overall Study|Withdrawal by Subject|1|||
46729058|NCT00887289|82945156|FG000|Overall Study|Lack of Efficacy|14|||
46729059|NCT00887289|82945156|FG000|Overall Study|Adverse Event|27|||
46729060|NCT00887289|82945156|FG000|Overall Study|Withdrawal by Subject|26|||
46729061|NCT00887289|82945156|FG000|Overall Study|Lost to Follow-up|8|||
46729062|NCT00887289|82945156|FG000|Overall Study|Other|20|||
46729063|NCT00833092|82945162|FG000|Overall Study|Withdrawal by Subject|2|||
46729064|NCT00833092|82945163|FG001|Overall Study|Withdrawal by Subject|3|||
46729065|NCT00833092|82945162|FG000|Overall Study|Protocol Violation|2|||
46729066|NCT00833092|82945163|FG001|Overall Study|Protocol Violation|1|||
46729067|NCT00833092|82945162|FG000|Overall Study|Diarrhea|0|||
46729068|NCT00833092|82945163|FG001|Overall Study|Diarrhea|2|||
46729069|NCT00833092|82945162|FG000|Overall Study|constipation|0|||
46729070|NCT00833092|82945163|FG001|Overall Study|constipation|1|||
46729071|NCT00823264|82945171|FG000|Overall Study|Protocol Violation|2|||
46729072|NCT00823264|82945172|FG001|Overall Study|Protocol Violation|0|||
46729073|NCT00832780|82945178|FG000|Overall Study|Death|16|||
46729074|NCT00832780|82945178|FG000|Overall Study|Lost to Follow-up|4|||
46729075|NCT00832780|82945178|FG000|Overall Study|no reason given|2|||
46729076|NCT00832780|82945178|FG000|Overall Study|other complicating condition|2|||
46729077|NCT00832780|82945178|FG000|Overall Study|Physician Decision|1|||
46729078|NCT00591838|82945187|FG000|Overall Study|Withdrawal by Subject|0|||
46729079|NCT00591838|82945188|FG001|Overall Study|Withdrawal by Subject|0|||
46729080|NCT00591838|82945189|FG002|Overall Study|Withdrawal by Subject|0|||
46729081|NCT00591838|82945190|FG003|Overall Study|Withdrawal by Subject|1|||
46729082|NCT00591838|82945191|FG004|Overall Study|Withdrawal by Subject|0|||
46729083|NCT00832624|82945204|FG000|Overall Study|Study Terminated|10|||
46729084|NCT00832078|82945208|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
46729085|NCT00832078|82945209|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
46729086|NCT00832078|82945208|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
46729087|NCT00832078|82945209|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
46729088|NCT00822172|82945217|FG000|Overall Study|Adverse Event|10|||
46729089|NCT00822172|82945218|FG001|Overall Study|Adverse Event|12|||
46729090|NCT00822172|82945217|FG000|Overall Study|Death|1|||
46729091|NCT00822172|82945218|FG001|Overall Study|Death|0|||
46729092|NCT00822172|82945217|FG000|Overall Study|Lost to Follow-up|3|||
46729093|NCT00822172|82945218|FG001|Overall Study|Lost to Follow-up|1|||
46729094|NCT00822172|82945217|FG000|Overall Study|Withdrawal by Subject|1|||
46729095|NCT00822172|82945218|FG001|Overall Study|Withdrawal by Subject|4|||
46729096|NCT00822172|82945217|FG000|Overall Study|site closed|0|||
46729097|NCT00822172|82945218|FG001|Overall Study|site closed|1|||
46729098|NCT00822172|82945217|FG000|Overall Study|Other|0|||
46729099|NCT00822172|82945218|FG001|Overall Study|Other|1|||
46729100|NCT00832000|82945224|FG000|Overall Study|Adverse Event|2|||
46729101|NCT00832000|82945225|FG001|Overall Study|Adverse Event|0|||
46729102|NCT00832000|82945224|FG000|Overall Study|Withdrawal by Subject|1|||
46729103|NCT00832000|82945225|FG001|Overall Study|Withdrawal by Subject|0|||
46729104|NCT00832000|82945224|FG000|Overall Study|No calls to IVR in either period|1|||
46729105|NCT00832000|82945225|FG001|Overall Study|No calls to IVR in either period|1|||
46729106|NCT00832000|82945224|FG000|Overall Study|No calls to IVR in period 2|2|||
46729107|NCT00832000|82945225|FG001|Overall Study|No calls to IVR in period 2|0|||
46729108|NCT00911508|82945262|FG000|Overall Study|Lost to Follow-up|27|||
46729109|NCT00911508|82945263|FG001|Overall Study|Lost to Follow-up|18|||
46729110|NCT00911508|82945262|FG000|Overall Study|Withdrawal by Subject|79|||
46729111|NCT00911508|82945263|FG001|Overall Study|Withdrawal by Subject|112|||
46729112|NCT00774397|82945289|FG000|Overall Study|Adverse Event|1|||
46729113|NCT00774397|82945290|FG001|Overall Study|Adverse Event|3|||
46729114|NCT00774397|82945291|FG002|Overall Study|Adverse Event|16|||
46729115|NCT00774397|82945292|FG003|Overall Study|Adverse Event|8|||
46729116|NCT00774397|82945293|FG004|Overall Study|Adverse Event|8|||
46729117|NCT00774397|82945294|FG005|Overall Study|Adverse Event|3|||
46729118|NCT00774397|82945295|FG006|Overall Study|Adverse Event|16|||
46729119|NCT00774397|82945289|FG000|Overall Study|Lack of Efficacy|11|||
46729120|NCT00774397|82945290|FG001|Overall Study|Lack of Efficacy|4|||
46729121|NCT00774397|82945291|FG002|Overall Study|Lack of Efficacy|5|||
46729122|NCT00774397|82945292|FG003|Overall Study|Lack of Efficacy|3|||
46729123|NCT00774397|82945293|FG004|Overall Study|Lack of Efficacy|27|||
46729124|NCT00774397|82945294|FG005|Overall Study|Lack of Efficacy|15|||
46729125|NCT00774397|82945295|FG006|Overall Study|Lack of Efficacy|9|||
47048193|NCT01954121|83308160|FG001|Overall Study|Non-compliant with study procedures|0|||
47048194|NCT01954121|83308159|FG000|Overall Study|Non-compliant patient|1|||
47048195|NCT01954121|83308160|FG001|Overall Study|Non-compliant patient|1|||
47048196|NCT01954121|83308159|FG000|Overall Study|Subject did not follow instructions|0|||
47048197|NCT01954121|83308160|FG001|Overall Study|Subject did not follow instructions|2|||
47048198|NCT01952015|83308195|FG000|Induction|Protocol Violation|1|||
47048199|NCT01952015|83308195|FG000|Maintenance|Adverse Event|2|||
47048200|NCT01952015|83308195|FG000|Treatment Period 3|Physician Decision|9|||
47048201|NCT01951703|83308228|FG000|First Intervention|Withdrawal by Subject|1|||
47048202|NCT01951703|83308229|FG001|First Intervention|Withdrawal by Subject|0|||
47048203|NCT01951703|83308228|FG000|First Intervention|Subject was not compliant|1|||
47048204|NCT01951703|83308229|FG001|First Intervention|Subject was not compliant|1|||
47048205|NCT01951703|83308228|FG000|First Intervention|Physician Decision|1|||
47048206|NCT01951703|83308229|FG001|First Intervention|Physician Decision|0|||
47048207|NCT01951703|83308228|FG000|Second Intervention|Protocol Violation|0|||
47048208|NCT01951703|83308229|FG001|Second Intervention|Protocol Violation|1|||
47048209|NCT01951703|83308228|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
47048210|NCT01951703|83308229|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
47048211|NCT01937351|83308255|FG000|Overall Study|Withdrawal by Subject|4|||
47048212|NCT01937351|83308256|FG001|Overall Study|Withdrawal by Subject|2|||
47048213|NCT01937351|83308255|FG000|Overall Study|Death|1|||
46729126|NCT00774397|82945289|FG000|Overall Study|Protocol Violation|0|||
46729127|NCT00774397|82945290|FG001|Overall Study|Protocol Violation|1|||
46729128|NCT00774397|82945291|FG002|Overall Study|Protocol Violation|3|||
46729129|NCT00774397|82945292|FG003|Overall Study|Protocol Violation|1|||
46729130|NCT00774397|82945293|FG004|Overall Study|Protocol Violation|2|||
46729131|NCT00774397|82945294|FG005|Overall Study|Protocol Violation|1|||
46729132|NCT00774397|82945295|FG006|Overall Study|Protocol Violation|0|||
46729133|NCT00774397|82945289|FG000|Overall Study|Lost to Follow-up|0|||
46729134|NCT00774397|82945290|FG001|Overall Study|Lost to Follow-up|1|||
46729135|NCT00774397|82945291|FG002|Overall Study|Lost to Follow-up|1|||
46729136|NCT00774397|82945292|FG003|Overall Study|Lost to Follow-up|1|||
46729137|NCT00774397|82945293|FG004|Overall Study|Lost to Follow-up|0|||
46729138|NCT00774397|82945294|FG005|Overall Study|Lost to Follow-up|1|||
46729139|NCT00774397|82945295|FG006|Overall Study|Lost to Follow-up|0|||
46729140|NCT00774397|82945289|FG000|Overall Study|Refused to continue trial medication|1|||
46729141|NCT00774397|82945290|FG001|Overall Study|Refused to continue trial medication|3|||
46729142|NCT00774397|82945291|FG002|Overall Study|Refused to continue trial medication|2|||
46729143|NCT00774397|82945292|FG003|Overall Study|Refused to continue trial medication|2|||
46729144|NCT00774397|82945293|FG004|Overall Study|Refused to continue trial medication|6|||
46729145|NCT00774397|82945294|FG005|Overall Study|Refused to continue trial medication|2|||
46729146|NCT00774397|82945295|FG006|Overall Study|Refused to continue trial medication|3|||
47048214|NCT01937351|83308256|FG001|Overall Study|Death|0|||
47048215|NCT01937351|83308255|FG000|Overall Study|Not treated w device, per protocol fail|4|||
47048216|NCT01937351|83308256|FG001|Overall Study|Not treated w device, per protocol fail|0|||
47048217|NCT01737697|83308289|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048218|NCT01737697|83308290|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
47048219|NCT01737697|83308291|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
46729147|NCT00774397|82945289|FG000|Overall Study|Not treated|0|||
46729148|NCT00774397|82945290|FG001|Overall Study|Not treated|0|||
46729149|NCT00774397|82945291|FG002|Overall Study|Not treated|0|||
46729150|NCT00774397|82945292|FG003|Overall Study|Not treated|0|||
46729151|NCT00774397|82945293|FG004|Overall Study|Not treated|1|||
47048220|NCT01737697|83308292|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
47048221|NCT01737697|83308293|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
47048222|NCT01737697|83308294|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
46729152|NCT00774397|82945294|FG005|Overall Study|Not treated|0|||
46729153|NCT00774397|82945295|FG006|Overall Study|Not treated|1|||
46775703|NCT00689871|82994179|FG000|Overall Study|Lost to Follow-up|123|||
47048223|NCT01737697|83308295|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048224|NCT01737697|83308296|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048225|NCT01737697|83308297|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048226|NCT01737697|83308298|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
46634970|NCT01691898|82808362|FG002|Overall Study|Non-Compliance|0|||
46634971|NCT01691898|82808363|FG003|Overall Study|Non-Compliance|0|||
46729154|NCT00774397|82945289|FG000|Overall Study|Other than those stated above|1|||
46729155|NCT00774397|82945290|FG001|Overall Study|Other than those stated above|1|||
46729156|NCT00774397|82945291|FG002|Overall Study|Other than those stated above|3|||
46729157|NCT00774397|82945292|FG003|Overall Study|Other than those stated above|2|||
46729158|NCT00774397|82945293|FG004|Overall Study|Other than those stated above|2|||
46729159|NCT00774397|82945294|FG005|Overall Study|Other than those stated above|0|||
46729160|NCT00774397|82945295|FG006|Overall Study|Other than those stated above|1|||
46729161|NCT00909870|82945350|FG000|Overall Study|Adverse Event|13|||
46729162|NCT00909870|82945351|FG001|Overall Study|Adverse Event|7|||
46729163|NCT00909870|82945350|FG000|Overall Study|Protocol Violation|1|||
46729164|NCT00909870|82945351|FG001|Overall Study|Protocol Violation|2|||
46729165|NCT00909870|82945350|FG000|Overall Study|Withdrawal by Subject|5|||
46729166|NCT00909870|82945351|FG001|Overall Study|Withdrawal by Subject|8|||
46729167|NCT00909870|82945350|FG000|Overall Study|Lost to Follow-up|3|||
46729168|NCT00909870|82945351|FG001|Overall Study|Lost to Follow-up|3|||
47048227|NCT01737697|83308299|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048228|NCT01737697|83308300|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048229|NCT01737697|83308301|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048230|NCT01737697|83308302|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048231|NCT01737697|83308303|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
47048232|NCT01737697|83308289|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
47048233|NCT01737697|83308290|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
47048234|NCT01737697|83308291|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
47048235|NCT01737697|83308292|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048236|NCT01737697|83308293|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048237|NCT01737697|83308294|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048238|NCT01737697|83308295|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048239|NCT01737697|83308296|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
46729169|NCT00909870|82945350|FG000|Overall Study|Physician Decision|0|||
46729170|NCT00909870|82945351|FG001|Overall Study|Physician Decision|2|||
46729171|NCT00909870|82945350|FG000|Overall Study|Other|1|||
46729172|NCT00909870|82945351|FG001|Overall Study|Other|5|||
46729173|NCT00768469|82945360|FG000|Overall Study|Adverse Event|0|||
46729174|NCT00768469|82945361|FG001|Overall Study|Adverse Event|2|||
46729175|NCT00768469|82945360|FG000|Overall Study|Disease Progression|3|||
47048240|NCT01737697|83308297|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048241|NCT01737697|83308298|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
46921381|NCT03075163|83153834|FG000|Overall Study|not eligible for treatment limb|138|||
46921382|NCT03075163|83153835|FG001|Overall Study|not eligible for treatment limb|138|||
47048242|NCT01737697|83308299|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
46634972|NCT01691898|82808364|FG004|Overall Study|Non-Compliance|1|||
46634973|NCT01691898|82808365|FG005|Overall Study|Non-Compliance|0|||
46634974|NCT01691820|82808399|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
46634975|NCT01691820|82808400|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
46634976|NCT01691820|82808399|FG000|Overall Study|Migrated/moved from study area|7|||
46634977|NCT01691820|82808400|FG001|Overall Study|Migrated/moved from study area|4|||
46729176|NCT00768469|82945361|FG001|Overall Study|Disease Progression|4|||
46729177|NCT00768469|82945360|FG000|Overall Study|Withdrawal by Subject|0|||
46729178|NCT00768469|82945361|FG001|Overall Study|Withdrawal by Subject|1|||
47048243|NCT01737697|83308300|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048244|NCT01737697|83308301|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048245|NCT01737697|83308302|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048246|NCT01737697|83308303|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
47048247|NCT01737697|83308289|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048248|NCT01737697|83308290|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048249|NCT01737697|83308291|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048250|NCT01737697|83308292|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
47048251|NCT01737697|83308293|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048252|NCT01737697|83308294|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048253|NCT01737697|83308295|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048254|NCT01737697|83308296|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048255|NCT01737697|83308297|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048256|NCT01737697|83308298|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048257|NCT01737697|83308299|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048258|NCT01737697|83308300|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
46729179|NCT00886821|82945382|FG000|Stage 2|Adverse Event|0|||
46729180|NCT00886821|82945383|FG001|Stage 2|Adverse Event|0|||
46729181|NCT00886821|82945384|FG002|Stage 2|Adverse Event|0|||
46729182|NCT00886821|82945385|FG003|Stage 2|Adverse Event|0|||
46729183|NCT00886821|82945386|FG004|Stage 2|Adverse Event|0|||
46729184|NCT00886821|82945387|FG005|Stage 2|Adverse Event|0|||
46729185|NCT00886821|82945388|FG006|Stage 2|Adverse Event|0|||
46729186|NCT00886821|82945389|FG007|Stage 2|Adverse Event|0|||
46729187|NCT00886821|82945390|FG008|Stage 2|Adverse Event|0|||
46729188|NCT00886821|82945391|FG009|Stage 2|Adverse Event|0|||
46729189|NCT00886821|82945392|FG010|Stage 2|Adverse Event|0|||
46729190|NCT00886821|82945393|FG011|Stage 2|Adverse Event|1|||
46729191|NCT00886821|82945394|FG012|Stage 2|Adverse Event|3|||
46729192|NCT00886821|82945395|FG013|Stage 2|Adverse Event|0|||
46729193|NCT00886821|82945382|FG000|Stage 2|Lost to Follow-up|0|||
46729194|NCT00886821|82945383|FG001|Stage 2|Lost to Follow-up|0|||
46729195|NCT00886821|82945384|FG002|Stage 2|Lost to Follow-up|0|||
46729196|NCT00886821|82945385|FG003|Stage 2|Lost to Follow-up|0|||
46729197|NCT00886821|82945386|FG004|Stage 2|Lost to Follow-up|0|||
46729198|NCT00886821|82945387|FG005|Stage 2|Lost to Follow-up|0|||
46729199|NCT00886821|82945388|FG006|Stage 2|Lost to Follow-up|0|||
46729200|NCT00886821|82945389|FG007|Stage 2|Lost to Follow-up|0|||
46729201|NCT00886821|82945390|FG008|Stage 2|Lost to Follow-up|0|||
46729202|NCT00886821|82945391|FG009|Stage 2|Lost to Follow-up|0|||
46729203|NCT00886821|82945392|FG010|Stage 2|Lost to Follow-up|0|||
46729204|NCT00886821|82945393|FG011|Stage 2|Lost to Follow-up|0|||
46729205|NCT00886821|82945394|FG012|Stage 2|Lost to Follow-up|2|||
46729206|NCT00886821|82945395|FG013|Stage 2|Lost to Follow-up|1|||
46729207|NCT00886743|82945439|FG000|Overall Study|Adverse Event|3|||
46729208|NCT00886743|82945439|FG000|Overall Study|Other|1|||
46729209|NCT00886587|82945445|FG000|Overall Study|Adverse Event|2|||
46729210|NCT00886587|82945446|FG001|Overall Study|Adverse Event|1|||
46729211|NCT00886587|82945445|FG000|Overall Study|Protocol Violation|2|||
46729212|NCT00886587|82945446|FG001|Overall Study|Protocol Violation|0|||
46729213|NCT00886587|82945445|FG000|Overall Study|Withdrawal by Subject|0|||
46729214|NCT00886587|82945446|FG001|Overall Study|Withdrawal by Subject|1|||
46729215|NCT00886119|82945452|FG000|Period 1|Did not meet inclusion criteria|1|||
46729216|NCT00886119|82945453|FG001|Period 1|Did not meet inclusion criteria|0|||
47048259|NCT01737697|83308301|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
46729217|NCT00768079|82945462|FG000|Overall Study|Lost to Follow-up|2|||
46729218|NCT00768079|82945463|FG001|Overall Study|Lost to Follow-up|0|||
46729219|NCT00768079|82945464|FG002|Overall Study|Lost to Follow-up|4|||
46729220|NCT00768079|82945462|FG000|Overall Study|Participant incarcerated|0|||
46729221|NCT00768079|82945463|FG001|Overall Study|Participant incarcerated|1|||
46729222|NCT00768079|82945464|FG002|Overall Study|Participant incarcerated|0|||
47048260|NCT01737697|83308302|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
47048261|NCT01737697|83308303|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
46729223|NCT00767455|82945474|FG000|Overall Study|Investigator error|19|||
46729224|NCT00766831|82945480|FG000|Overall Study|Withdrawal by Subject|4|||
46729225|NCT00766831|82945480|FG000|Overall Study|Lost to Follow-up|3|||
47048262|NCT01737697|83308289|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
46729226|NCT00766831|82945480|FG000|Overall Study|Adverse Event|20|||
46729227|NCT00766831|82945480|FG000|Overall Study|Protocol Violation|15|||
46729228|NCT00766831|82945480|FG000|Overall Study|Physician Decision|5|||
46729229|NCT00766831|82945480|FG000|Overall Study|Withdrawal of consent|26|||
46729230|NCT00766831|82945480|FG000|Overall Study|Non cooperation by participants|14|||
46729231|NCT00766831|82945480|FG000|Overall Study|Other|28|||
46729232|NCT00766675|82945484|FG000|Overall Study|Adverse Event|16|||
46729233|NCT00766675|82945484|FG000|Overall Study|Lost to Follow-up|2|||
46729234|NCT00766675|82945484|FG000|Overall Study|Withdrawal by Subject|11|||
46729235|NCT00766675|82945484|FG000|Overall Study|Protocol Violation|8|||
46729236|NCT00766675|82945484|FG000|Overall Study|Participant took prohibited medication|1|||
46729237|NCT00766675|82945484|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
46729238|NCT00766675|82945484|FG000|Overall Study|Insufficient therapy|1|||
46729239|NCT00766597|82945488|FG000|Overall Study|Unexpected closure of study|4|||
46729240|NCT00766597|82945488|FG000|Overall Study|Without CCR5-tropic virus|5|||
46729241|NCT00910962|82945497|FG000|Overall Study|Adverse Event|5|||
46729242|NCT00910962|82945498|FG001|Overall Study|Adverse Event|20|||
47048263|NCT01737697|83308290|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
47048264|NCT01737697|83308291|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048265|NCT01737697|83308292|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048266|NCT01737697|83308293|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048267|NCT01737697|83308294|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048268|NCT01737697|83308295|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048269|NCT01737697|83308296|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048270|NCT01737697|83308297|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048271|NCT01737697|83308298|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048272|NCT01737697|83308299|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048273|NCT01737697|83308300|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
46729243|NCT00910962|82945499|FG002|Overall Study|Adverse Event|17|||
46729244|NCT00910962|82945497|FG000|Overall Study|Protocol Violation|1|||
46729245|NCT00910962|82945498|FG001|Overall Study|Protocol Violation|3|||
46729246|NCT00910962|82945499|FG002|Overall Study|Protocol Violation|3|||
46729247|NCT00910962|82945497|FG000|Overall Study|Lost to Follow-up|0|||
46729248|NCT00910962|82945498|FG001|Overall Study|Lost to Follow-up|3|||
46729249|NCT00910962|82945499|FG002|Overall Study|Lost to Follow-up|1|||
46729250|NCT00910962|82945497|FG000|Overall Study|Physician Decision|0|||
46729251|NCT00910962|82945498|FG001|Overall Study|Physician Decision|6|||
46729252|NCT00910962|82945499|FG002|Overall Study|Physician Decision|6|||
46729253|NCT00910962|82945497|FG000|Overall Study|Withdrawal by Subject|25|||
46729254|NCT00910962|82945498|FG001|Overall Study|Withdrawal by Subject|32|||
46729255|NCT00910962|82945499|FG002|Overall Study|Withdrawal by Subject|32|||
46729256|NCT00910962|82945497|FG000|Overall Study|Reached defined stopping criteria|12|||
46729257|NCT00910962|82945498|FG001|Overall Study|Reached defined stopping criteria|14|||
46729258|NCT00910962|82945499|FG002|Overall Study|Reached defined stopping criteria|17|||
46729259|NCT00773461|82945511|FG000|Overall Study|Adverse Event|1|||
46729260|NCT00773461|82945512|FG001|Overall Study|Adverse Event|3|||
46729261|NCT00773461|82945511|FG000|Overall Study|Withdrawal by Subject|4|||
46729262|NCT00773461|82945512|FG001|Overall Study|Withdrawal by Subject|1|||
46729263|NCT00773383|82945519|FG000|Overall Study|Adverse Event|4|||
46729264|NCT00773383|82945519|FG000|Overall Study|Death|1|||
46729265|NCT00773383|82945519|FG000|Overall Study|Progression of Disease|23|||
46729266|NCT00773383|82945519|FG000|Overall Study|Other|2|||
46729267|NCT00773383|82945519|FG000|Overall Study|No study dose received|1|||
46729268|NCT00757003|82945527|FG000|Overall Study|Death|33|||
46729269|NCT00757003|82945527|FG000|Overall Study|Lost to Follow-up|9|||
46729270|NCT00757003|82945527|FG000|Overall Study|Withdrawal by Subject|4|||
46729271|NCT00757003|82945527|FG000|Overall Study|Surgically explanted|2|||
46729272|NCT00757003|82945527|FG000|Overall Study|Not implanted|1|||
46729273|NCT00766363|82945536|FG000|Overall Study|Withdrawal by Subject|1|||
46729274|NCT00766363|82945537|FG001|Overall Study|Withdrawal by Subject|0|||
46729275|NCT00766363|82945538|FG002|Overall Study|Withdrawal by Subject|0|||
46729276|NCT00766363|82945539|FG003|Overall Study|Withdrawal by Subject|0|||
46729277|NCT00766363|82945536|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
46729278|NCT00766363|82945537|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
47048274|NCT01737697|83308301|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
46634978|NCT01691820|82808399|FG000|Overall Study|Lost to Follow-up|6|||
46634979|NCT01691820|82808400|FG001|Overall Study|Lost to Follow-up|17|||
46634980|NCT01691820|82808399|FG000|Overall Study|Other (unspecified)|4|||
46634981|NCT01691820|82808400|FG001|Overall Study|Other (unspecified)|1|||
46634982|NCT01711866|82808410|FG000|Overall Study|Noncompliant|3|||
46634983|NCT01711866|82808410|FG000|Overall Study|Withdrawal by Subject|3|||
46634984|NCT01711866|82808410|FG000|Overall Study|Adverse Event|2|||
46634985|NCT01737762|82808416|FG000|Overall Study|Adverse Event|2|||
46634986|NCT01737762|82808417|FG001|Overall Study|Adverse Event|2|||
46634987|NCT01737762|82808416|FG000|Overall Study|Lost to Follow-up|1|||
46634988|NCT01737762|82808417|FG001|Overall Study|Lost to Follow-up|0|||
46729279|NCT00766363|82945538|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
46729280|NCT00766363|82945539|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
46729281|NCT02636946|82945552|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
46729282|NCT02636946|82945553|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
46729283|NCT02636946|82945552|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
46729284|NCT02636946|82945553|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
46729285|NCT02636946|82945552|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
46729286|NCT02636946|82945553|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
46729287|NCT02636946|82945552|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
46729288|NCT02636946|82945553|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
46729289|NCT02636946|82945552|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
46729290|NCT02636946|82945553|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
46729291|NCT02636946|82945552|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
46729292|NCT02636946|82945553|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
46729293|NCT00766051|82945561|FG000|Overall Study|Withdrawal by Subject|2|||
46729294|NCT00766051|82945562|FG001|Overall Study|Withdrawal by Subject|0|||
46729295|NCT00909792|82945570|FG000|Period 1|Did not meet inclusion criteria|0|||
46729296|NCT00909792|82945571|FG001|Period 1|Did not meet inclusion criteria|1|||
46729297|NCT00909792|82945570|FG000|Period 2|Biomicroscopy|1|||
46729298|NCT00909792|82945571|FG001|Period 2|Biomicroscopy|0|||
46729299|NCT00909792|82945570|FG000|Period 2|Lost to Follow-up|0|||
46729300|NCT00909792|82945571|FG001|Period 2|Lost to Follow-up|1|||
47048275|NCT01737697|83308302|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048276|NCT01737697|83308303|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
47048277|NCT01737697|83308289|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048278|NCT01737697|83308290|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048279|NCT01737697|83308291|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048280|NCT01737697|83308292|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048281|NCT01737697|83308293|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
47048282|NCT01737697|83308294|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048283|NCT01737697|83308295|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048284|NCT01737697|83308296|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048285|NCT01737697|83308297|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048286|NCT01737697|83308298|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048287|NCT01737697|83308299|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048288|NCT01737697|83308300|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048289|NCT01737697|83308301|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048290|NCT01737697|83308302|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048291|NCT01737697|83308303|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
47048292|NCT01737697|83308289|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
46729301|NCT00765817|82945579|FG000|Overall Study|Adverse Event|13|||
46729302|NCT00765817|82945580|FG001|Overall Study|Adverse Event|1|||
46729303|NCT00765817|82945579|FG000|Overall Study|Death|0|||
46729304|NCT00765817|82945580|FG001|Overall Study|Death|1|||
46729305|NCT00765817|82945579|FG000|Overall Study|Entry criteria not met|2|||
47048293|NCT01737697|83308290|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
46729306|NCT00765817|82945580|FG001|Overall Study|Entry criteria not met|2|||
46729307|NCT00765817|82945579|FG000|Overall Study|Loss of glucose control|0|||
46729308|NCT00765817|82945580|FG001|Overall Study|Loss of glucose control|2|||
46729309|NCT00765817|82945579|FG000|Overall Study|Lost to Follow-up|1|||
46729310|NCT00765817|82945580|FG001|Overall Study|Lost to Follow-up|3|||
46729311|NCT00765817|82945579|FG000|Overall Study|Physician Decision|2|||
46729312|NCT00765817|82945580|FG001|Overall Study|Physician Decision|1|||
46729313|NCT00765817|82945579|FG000|Overall Study|Protocol Violation|1|||
46729314|NCT00765817|82945580|FG001|Overall Study|Protocol Violation|1|||
46729315|NCT00765817|82945579|FG000|Overall Study|Subject decision|7|||
46729316|NCT00765817|82945580|FG001|Overall Study|Subject decision|11|||
46729317|NCT00772603|82945589|FG000|Overall Study|Withdrawal by Subject|11|||
46729318|NCT00772603|82945590|FG001|Overall Study|Withdrawal by Subject|10|||
46729319|NCT00772603|82945591|FG002|Overall Study|Withdrawal by Subject|6|||
46729320|NCT00772603|82945589|FG000|Overall Study|Adverse Event|37|||
46729321|NCT00772603|82945590|FG001|Overall Study|Adverse Event|18|||
46729322|NCT00772603|82945591|FG002|Overall Study|Adverse Event|10|||
46729323|NCT00772603|82945589|FG000|Overall Study|Subject Non-compliance|1|||
47048294|NCT01737697|83308291|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
47048295|NCT01737697|83308292|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
46729324|NCT00772603|82945590|FG001|Overall Study|Subject Non-compliance|6|||
46729325|NCT00772603|82945591|FG002|Overall Study|Subject Non-compliance|4|||
46803807|NCT00545168|83023093|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
47048296|NCT01737697|83308293|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
46803808|NCT00544544|83023102|FG000|Overall Study|Withdrawal by Subject|1|||
46803809|NCT00544544|83023102|FG000|Overall Study|Adverse Event|1|||
46803810|NCT00544544|83023102|FG000|Overall Study|Lost to Follow-up|1|||
46921383|NCT03078751|83153843|FG000|Overall Study|Adverse Event|4|||
46803811|NCT00541346|83023106|FG000|Follow-up|Adverse Event|1|||
46729326|NCT00772603|82945589|FG000|Overall Study|Protocol Violation|0|||
46729327|NCT00772603|82945590|FG001|Overall Study|Protocol Violation|1|||
46729328|NCT00772603|82945591|FG002|Overall Study|Protocol Violation|1|||
46729329|NCT00772603|82945589|FG000|Overall Study|Lost to Follow-up|1|||
46729330|NCT00772603|82945590|FG001|Overall Study|Lost to Follow-up|5|||
46729331|NCT00772603|82945591|FG002|Overall Study|Lost to Follow-up|2|||
46729332|NCT00772603|82945589|FG000|Overall Study|Physician Decision|0|||
46729333|NCT00772603|82945590|FG001|Overall Study|Physician Decision|0|||
46729334|NCT00772603|82945591|FG002|Overall Study|Physician Decision|1|||
46729335|NCT00772603|82945589|FG000|Overall Study|Other|2|||
46729336|NCT00772603|82945590|FG001|Overall Study|Other|0|||
46729337|NCT00772603|82945591|FG002|Overall Study|Other|2|||
46729338|NCT00772447|82945604|FG000|Overall Study|Withdrawal by Subject|9|||
46634989|NCT01737762|82808416|FG000|Overall Study|Withdrawal by Subject|2|||
46634990|NCT01737762|82808417|FG001|Overall Study|Withdrawal by Subject|2|||
46729339|NCT00772447|82945605|FG001|Overall Study|Withdrawal by Subject|5|||
46729340|NCT00772447|82945604|FG000|Overall Study|Physician Decision|4|||
46729341|NCT00772447|82945605|FG001|Overall Study|Physician Decision|8|||
46729342|NCT00772447|82945604|FG000|Overall Study|Lost to Follow-up|2|||
46729343|NCT00772447|82945605|FG001|Overall Study|Lost to Follow-up|4|||
46729344|NCT00772447|82945604|FG000|Overall Study|incorrect enrolment|3|||
46729345|NCT00772447|82945605|FG001|Overall Study|incorrect enrolment|4|||
46729346|NCT00772447|82945604|FG000|Overall Study|Protocol Violation|0|||
46729347|NCT00772447|82945605|FG001|Overall Study|Protocol Violation|1|||
46729348|NCT00772447|82945604|FG000|Overall Study|all others|2|||
46729349|NCT00772447|82945605|FG001|Overall Study|all others|2|||
46729350|NCT00765037|82945612|FG000|Overall Study|Lost to Follow-up|5|||
46729351|NCT00765037|82945612|FG000|Overall Study|Adverse Event|1|||
46729352|NCT04682353|82945629|FG000|Overall Study|Lost to Follow-up|0|||
46729353|NCT04682353|82945630|FG001|Overall Study|Lost to Follow-up|1|||
46729354|NCT04682353|82945631|FG002|Overall Study|Lost to Follow-up|0|||
46729355|NCT04682353|82945632|FG003|Overall Study|Lost to Follow-up|1|||
46729356|NCT04682353|82945629|FG000|Overall Study|Personal reasons|0|||
46729357|NCT04682353|82945630|FG001|Overall Study|Personal reasons|1|||
46729358|NCT04682353|82945631|FG002|Overall Study|Personal reasons|0|||
46729359|NCT04682353|82945632|FG003|Overall Study|Personal reasons|0|||
46729360|NCT04227405|82945653|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
46729361|NCT04227405|82945654|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
46729362|NCT04227405|82945653|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
46729363|NCT04227405|82945654|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
46729364|NCT04227405|82945653|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
46729365|NCT04227405|82945654|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
46729366|NCT03875235|82945664|FG000|Overall Study|Ongoing study treatment|63|||
46729367|NCT03875235|82945665|FG001|Overall Study|Ongoing study treatment|20|||
46729368|NCT03875235|82945664|FG000|Overall Study|Off treatment|77|||
46729369|NCT03875235|82945665|FG001|Overall Study|Off treatment|91|||
46729370|NCT03875235|82945664|FG000|Overall Study|Withdrawal by Subject|3|||
46729371|NCT03875235|82945665|FG001|Overall Study|Withdrawal by Subject|10|||
46729372|NCT03875235|82945664|FG000|Overall Study|Death|198|||
46729373|NCT03875235|82945665|FG001|Overall Study|Death|223|||
46729374|NCT03748420|82945673|FG000|Overall Study|No 12 month medication adherence data available|0|||
46729375|NCT03748420|82945674|FG001|Overall Study|No 12 month medication adherence data available|1|||
46729376|NCT03748420|82945673|FG000|Overall Study|Death|24|||
46729377|NCT03748420|82945674|FG001|Overall Study|Death|28|||
46729378|NCT03748420|82945673|FG000|Overall Study|Lost to Follow-up|231|||
46729379|NCT03748420|82945674|FG001|Overall Study|Lost to Follow-up|230|||
46634991|NCT01737762|82808416|FG000|Overall Study|Progressive disease|1|||
46634992|NCT01737762|82808417|FG001|Overall Study|Progressive disease|2|||
46634993|NCT01737762|82808416|FG000|Overall Study|Physician Decision|1|||
46634994|NCT01737762|82808417|FG001|Overall Study|Physician Decision|1|||
46634995|NCT01737762|82808416|FG000|Overall Study|Moved from area|2|||
46634996|NCT01737762|82808417|FG001|Overall Study|Moved from area|1|||
46634997|NCT01737762|82808416|FG000|Overall Study|Trial termination|11|||
46634998|NCT01737762|82808417|FG001|Overall Study|Trial termination|9|||
46634999|NCT01691508|82808425|FG000|Overall Study|Adverse Event|3|||
46635000|NCT01691508|82808426|FG001|Overall Study|Adverse Event|3|||
46635001|NCT01691508|82808425|FG000|Overall Study|Withdrawal by Subject|1|||
46635002|NCT01691508|82808426|FG001|Overall Study|Withdrawal by Subject|0|||
46635003|NCT01682460|82808432|FG000|Overall Study|Withdrawal by Subject|2|||
46729380|NCT03631706|82945684|FG000|Overall Study|Randomized, not treated|1|||
46729381|NCT03631706|82945685|FG001|Overall Study|Randomized, not treated|0|||
46729382|NCT03631706|82945684|FG000|Overall Study|Treatment ongoing|26|||
46729383|NCT03631706|82945685|FG001|Overall Study|Treatment ongoing|57|||
46775704|NCT00689871|82994180|FG001|Overall Study|Lost to Follow-up|13|||
46635004|NCT01682460|82808432|FG000|Overall Study|Did not meet inclusion criteria|2|||
46635005|NCT01691430|82808438|FG000|Overall Study|Death|17|||
46635006|NCT01691430|82808439|FG001|Overall Study|Death|16|||
46635007|NCT01691430|82808438|FG000|Overall Study|Withdrawal by Subject|5|||
46729384|NCT03631706|82945684|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
46729385|NCT03631706|82945685|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
46729386|NCT03462030|82945693|FG000|Overall Study|Withdrawal by Subject|1|||
46729387|NCT03462030|82945694|FG001|Overall Study|Withdrawal by Subject|1|||
46729388|NCT03459729|82945700|FG000|Overall Study|Physician Decision|2|||
46729389|NCT03267277|82945708|FG000|Overall Study|Withdrawal by Subject|1|||
46729390|NCT03221751|82945714|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
46729391|NCT03221751|82945715|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
46729392|NCT03194646|82945725|FG000|Overall Study|Adverse Event|24|||
46729393|NCT03194646|82945726|FG001|Overall Study|Adverse Event|25|||
46729394|NCT03194646|82945727|FG002|Overall Study|Adverse Event|14|||
46729395|NCT03194646|82945728|FG003|Overall Study|Adverse Event|17|||
46729396|NCT03194646|82945725|FG000|Overall Study|Lack of Efficacy|4|||
46729397|NCT03194646|82945726|FG001|Overall Study|Lack of Efficacy|2|||
46729398|NCT03194646|82945727|FG002|Overall Study|Lack of Efficacy|2|||
46729399|NCT03194646|82945728|FG003|Overall Study|Lack of Efficacy|12|||
46729400|NCT03194646|82945725|FG000|Overall Study|Lost to Follow-up|30|||
46729401|NCT03194646|82945726|FG001|Overall Study|Lost to Follow-up|22|||
46729402|NCT03194646|82945727|FG002|Overall Study|Lost to Follow-up|12|||
46729403|NCT03194646|82945728|FG003|Overall Study|Lost to Follow-up|35|||
46729404|NCT03194646|82945725|FG000|Overall Study|Non-compliance with study drug|4|||
46729405|NCT03194646|82945726|FG001|Overall Study|Non-compliance with study drug|0|||
46729406|NCT03194646|82945727|FG002|Overall Study|Non-compliance with study drug|1|||
46729407|NCT03194646|82945728|FG003|Overall Study|Non-compliance with study drug|1|||
46729408|NCT03194646|82945725|FG000|Overall Study|Other|89|||
46729409|NCT03194646|82945726|FG001|Overall Study|Other|68|||
46729410|NCT03194646|82945727|FG002|Overall Study|Other|34|||
46729411|NCT03194646|82945728|FG003|Overall Study|Other|31|||
46729412|NCT03194646|82945725|FG000|Overall Study|Physician Decision|7|||
46729413|NCT03194646|82945726|FG001|Overall Study|Physician Decision|9|||
46729414|NCT03194646|82945727|FG002|Overall Study|Physician Decision|5|||
46729415|NCT03194646|82945728|FG003|Overall Study|Physician Decision|4|||
46729416|NCT03194646|82945725|FG000|Overall Study|Pregnancy|4|||
46921384|NCT03078751|83153844|FG001|Overall Study|Adverse Event|0|||
46921385|NCT03078751|83153843|FG000|Overall Study|Physician Decision|1|||
47048297|NCT01737697|83308294|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
46729417|NCT03194646|82945726|FG001|Overall Study|Pregnancy|5|||
46729418|NCT03194646|82945727|FG002|Overall Study|Pregnancy|1|||
46729419|NCT03194646|82945728|FG003|Overall Study|Pregnancy|2|||
46729420|NCT03194646|82945725|FG000|Overall Study|Protocol Violation|4|||
46729421|NCT03194646|82945726|FG001|Overall Study|Protocol Violation|2|||
46729422|NCT03194646|82945727|FG002|Overall Study|Protocol Violation|1|||
46729423|NCT03194646|82945728|FG003|Overall Study|Protocol Violation|1|||
46729424|NCT03194646|82945725|FG000|Overall Study|Site terminated by sponsor|0|||
46729425|NCT03194646|82945726|FG001|Overall Study|Site terminated by sponsor|0|||
46729426|NCT03194646|82945727|FG002|Overall Study|Site terminated by sponsor|2|||
46729427|NCT03194646|82945728|FG003|Overall Study|Site terminated by sponsor|0|||
46729428|NCT03194646|82945725|FG000|Overall Study|Study terminated by sponsor|62|||
46729429|NCT03194646|82945726|FG001|Overall Study|Study terminated by sponsor|61|||
46729430|NCT03194646|82945727|FG002|Overall Study|Study terminated by sponsor|30|||
46729431|NCT03194646|82945728|FG003|Overall Study|Study terminated by sponsor|34|||
46729432|NCT03194646|82945725|FG000|Overall Study|Withdrawal by Subject|75|||
46729433|NCT03194646|82945726|FG001|Overall Study|Withdrawal by Subject|74|||
46729434|NCT03194646|82945727|FG002|Overall Study|Withdrawal by Subject|36|||
46729435|NCT03194646|82945728|FG003|Overall Study|Withdrawal by Subject|131|||
46729436|NCT03194646|82945725|FG000|Overall Study|Missing|1|||
46729437|NCT03194646|82945726|FG001|Overall Study|Missing|0|||
46729438|NCT03194646|82945727|FG002|Overall Study|Missing|1|||
46729439|NCT03194646|82945728|FG003|Overall Study|Missing|12|||
46729440|NCT03137303|82945785|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
46729441|NCT03137303|82945786|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
46729442|NCT03137303|82945785|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
46729443|NCT03137303|82945786|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
46729444|NCT03137303|82945785|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
46729445|NCT03137303|82945786|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
46729446|NCT03137303|82945785|FG000|T3: 9-month Follow-up|Death|1|||
46729447|NCT03137303|82945786|FG001|T3: 9-month Follow-up|Death|0|||
46729448|NCT03137303|82945785|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
46729449|NCT03137303|82945786|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
46729450|NCT03137303|82945785|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
46729451|NCT03137303|82945786|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
47048298|NCT01737697|83308295|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
46729452|NCT03137303|82945785|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
46729453|NCT03137303|82945786|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
46729454|NCT03040999|82945794|FG000|Overall Study|Lost to Follow-up|1|||
46729455|NCT03040999|82945795|FG001|Overall Study|Lost to Follow-up|0|||
46729456|NCT03040999|82945794|FG000|Overall Study|Withdrawal by Subject|7|||
46729457|NCT03040999|82945795|FG001|Overall Study|Withdrawal by Subject|12|||
46729458|NCT03040999|82945794|FG000|Overall Study|Death|128|||
46729459|NCT03040999|82945795|FG001|Overall Study|Death|138|||
46729460|NCT03040999|82945794|FG000|Overall Study|Participants Ongoing in Trial|266|||
46729461|NCT03040999|82945795|FG001|Overall Study|Participants Ongoing in Trial|252|||
46729462|NCT03010176|82945807|FG000|Overall Study|Death|21|||
47048299|NCT01737697|83308296|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
47048300|NCT01737697|83308297|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
47048301|NCT01737697|83308298|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
47048302|NCT01737697|83308299|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
47048303|NCT01737697|83308300|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
47048304|NCT01737697|83308301|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
47048305|NCT01737697|83308302|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
46729463|NCT03010176|82945808|FG001|Overall Study|Death|35|||
46729464|NCT03010176|82945809|FG002|Overall Study|Death|19|||
46729465|NCT03010176|82945810|FG003|Overall Study|Death|19|||
46729466|NCT03010176|82945811|FG004|Overall Study|Death|14|||
46729467|NCT03010176|82945812|FG005|Overall Study|Death|0|||
46729468|NCT03010176|82945807|FG000|Overall Study|Lost to Follow-up|0|||
46729469|NCT03010176|82945808|FG001|Overall Study|Lost to Follow-up|0|||
46729470|NCT03010176|82945809|FG002|Overall Study|Lost to Follow-up|0|||
46729471|NCT03010176|82945810|FG003|Overall Study|Lost to Follow-up|0|||
46729472|NCT03010176|82945811|FG004|Overall Study|Lost to Follow-up|1|||
46729473|NCT03010176|82945812|FG005|Overall Study|Lost to Follow-up|0|||
46729474|NCT03010176|82945807|FG000|Overall Study|Physician Decision|0|||
46729475|NCT03010176|82945808|FG001|Overall Study|Physician Decision|4|||
46729476|NCT03010176|82945809|FG002|Overall Study|Physician Decision|0|||
46729477|NCT03010176|82945810|FG003|Overall Study|Physician Decision|1|||
46729478|NCT03010176|82945811|FG004|Overall Study|Physician Decision|0|||
46729479|NCT03010176|82945812|FG005|Overall Study|Physician Decision|0|||
46729480|NCT03010176|82945807|FG000|Overall Study|Sponsor Decision|0|||
46729481|NCT03010176|82945808|FG001|Overall Study|Sponsor Decision|4|||
46729482|NCT03010176|82945809|FG002|Overall Study|Sponsor Decision|4|||
46729483|NCT03010176|82945810|FG003|Overall Study|Sponsor Decision|1|||
46729484|NCT03010176|82945811|FG004|Overall Study|Sponsor Decision|6|||
46729485|NCT03010176|82945812|FG005|Overall Study|Sponsor Decision|0|||
46729486|NCT03010176|82945807|FG000|Overall Study|Withdrawal by Subject|11|||
46729487|NCT03010176|82945808|FG001|Overall Study|Withdrawal by Subject|9|||
46729488|NCT03010176|82945809|FG002|Overall Study|Withdrawal by Subject|3|||
46729489|NCT03010176|82945810|FG003|Overall Study|Withdrawal by Subject|0|||
46729490|NCT03010176|82945811|FG004|Overall Study|Withdrawal by Subject|4|||
46729491|NCT03010176|82945812|FG005|Overall Study|Withdrawal by Subject|0|||
46729492|NCT02954055|82945831|FG000|Overall Study|Did not initiate therapy|6|||
46729493|NCT02954055|82945832|FG001|Overall Study|Did not initiate therapy|1|||
46729494|NCT02589392|82945846|FG000|Overall Study|Adverse Event|1|||
46729495|NCT02589392|82945847|FG001|Overall Study|Adverse Event|1|||
46729496|NCT02589392|82945846|FG000|Overall Study|Withdrawal by Subject|1|||
46729497|NCT02589392|82945847|FG001|Overall Study|Withdrawal by Subject|2|||
46729498|NCT02589392|82945846|FG000|Overall Study|Protocol Violation|1|||
46729499|NCT02589392|82945847|FG001|Overall Study|Protocol Violation|1|||
46729500|NCT02589392|82945846|FG000|Overall Study|Lost to Follow-up|2|||
46729501|NCT02589392|82945847|FG001|Overall Study|Lost to Follow-up|2|||
46729502|NCT02589392|82945846|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
46729503|NCT02589392|82945847|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
46729504|NCT02536742|82945853|FG000|Overall Study|Did not start protocol therapy|1|||
46729505|NCT02536742|82945853|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
46729506|NCT02091960|82945857|FG000|Overall Study|Death|7|||
46729507|NCT02091960|82945857|FG000|Overall Study|Withdrawal by Subject|1|||
46729508|NCT02091960|82945857|FG000|Overall Study|Miscellaneous Reasons|31|||
46729509|NCT02091960|82945857|FG000|Overall Study|On Study at Data Cut-off|12|||
46729510|NCT02043678|82945863|FG000|Overall Study|Never treated|11|||
46729511|NCT02043678|82945864|FG001|Overall Study|Never treated|9|||
46729512|NCT02043678|82945863|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
46729513|NCT02043678|82945864|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
46729514|NCT02043678|82945863|FG000|Overall Study|AE without clinical PD|51|||
46803812|NCT00077623|83023113|FG000|Overall Study|Adverse Event|1|||
46729515|NCT02043678|82945864|FG001|Overall Study|AE without clinical PD|34|||
46729516|NCT02043678|82945863|FG000|Overall Study|Lost to Follow-up|1|||
46729517|NCT02043678|82945864|FG001|Overall Study|Lost to Follow-up|1|||
46729518|NCT02043678|82945863|FG000|Overall Study|Other|19|||
46729519|NCT02043678|82945864|FG001|Overall Study|Other|16|||
46729520|NCT02043678|82945863|FG000|Overall Study|Clinical PD|108|||
46729521|NCT02043678|82945864|FG001|Overall Study|Clinical PD|138|||
46729522|NCT02043678|82945863|FG000|Overall Study|Radiological PD|91|||
46803813|NCT00077623|83023114|FG001|Overall Study|Adverse Event|0|||
47048306|NCT01737697|83308303|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
47048307|NCT01737697|83308289|FG000|Subacute Phase|Adverse Event|0|||
47048308|NCT01737697|83308290|FG001|Subacute Phase|Adverse Event|0|||
46729523|NCT02043678|82945864|FG001|Overall Study|Radiological PD|80|||
46729524|NCT02043678|82945863|FG000|Overall Study|Protocol-driven decision point|56|||
46729525|NCT02043678|82945864|FG001|Overall Study|Protocol-driven decision point|56|||
46729526|NCT02043678|82945863|FG000|Overall Study|Withdrawal by Subject|12|||
46729527|NCT02043678|82945864|FG001|Overall Study|Withdrawal by Subject|15|||
46729528|NCT02043678|82945863|FG000|Overall Study|Ongoing with treatment|34|||
46729529|NCT02043678|82945864|FG001|Overall Study|Ongoing with treatment|38|||
46729530|NCT02029443|82945875|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
46729531|NCT02029443|82945876|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
47048309|NCT01737697|83308291|FG002|Subacute Phase|Adverse Event|0|||
46729532|NCT02029443|82945877|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
46729533|NCT02029443|82945878|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
46729534|NCT02029443|82945879|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
46729535|NCT02029443|82945875|FG000|Overall Study|Death|13|||
46729536|NCT02029443|82945876|FG001|Overall Study|Death|2|||
46729537|NCT02029443|82945877|FG002|Overall Study|Death|2|||
46729538|NCT02029443|82945878|FG003|Overall Study|Death|11|||
46729539|NCT02029443|82945879|FG004|Overall Study|Death|2|||
46729540|NCT02029443|82945875|FG000|Overall Study|Lost to Follow-up|1|||
46729541|NCT02029443|82945876|FG001|Overall Study|Lost to Follow-up|0|||
46729542|NCT02029443|82945877|FG002|Overall Study|Lost to Follow-up|1|||
46729543|NCT02029443|82945878|FG003|Overall Study|Lost to Follow-up|1|||
46729544|NCT02029443|82945879|FG004|Overall Study|Lost to Follow-up|0|||
46729545|NCT02029443|82945875|FG000|Overall Study|Started other anti-cancer therapy|17|||
46729546|NCT02029443|82945876|FG001|Overall Study|Started other anti-cancer therapy|4|||
46729547|NCT02029443|82945877|FG002|Overall Study|Started other anti-cancer therapy|7|||
46729548|NCT02029443|82945878|FG003|Overall Study|Started other anti-cancer therapy|9|||
46729549|NCT02029443|82945879|FG004|Overall Study|Started other anti-cancer therapy|3|||
46729550|NCT02029443|82945875|FG000|Overall Study|Withdrawal by Subject|3|||
46729551|NCT02029443|82945876|FG001|Overall Study|Withdrawal by Subject|1|||
46729552|NCT02029443|82945877|FG002|Overall Study|Withdrawal by Subject|1|||
46729553|NCT02029443|82945878|FG003|Overall Study|Withdrawal by Subject|1|||
46729554|NCT02029443|82945879|FG004|Overall Study|Withdrawal by Subject|0|||
46729555|NCT02029443|82945875|FG000|Overall Study|Other|6|||
46729556|NCT02029443|82945876|FG001|Overall Study|Other|6|||
46729557|NCT02029443|82945877|FG002|Overall Study|Other|4|||
46729558|NCT02029443|82945878|FG003|Overall Study|Other|2|||
46729559|NCT02029443|82945879|FG004|Overall Study|Other|0|||
46729560|NCT00937924|82945916|FG000|Overall Study|Lost to Follow-up|44|||
46729561|NCT00937924|82945917|FG001|Overall Study|Lost to Follow-up|44|||
46729562|NCT00937924|82945918|FG002|Overall Study|Lost to Follow-up|41|||
46729563|NCT00792948|82945929|FG000|Overall Study|Adverse Event|6|||
46729564|NCT00792948|82945929|FG000|Overall Study|Death|4|||
46729565|NCT00792948|82945929|FG000|Overall Study|Withdrawal by Subject|3|||
46729566|NCT00792948|82945929|FG000|Overall Study|Ineligible|2|||
46729567|NCT00792948|82945929|FG000|Overall Study|Insurance denial - not treated|1|||
46729568|NCT00792948|82945929|FG000|Overall Study|Physician Decision|11|||
46729569|NCT00792948|82945929|FG000|Overall Study|Protocol Violation|1|||
46729570|NCT00831844|82945959|FG000|Overall Study|Adverse Event|2|||
46729571|NCT00831844|82945960|FG001|Overall Study|Adverse Event|0|||
46729572|NCT00831844|82945961|FG002|Overall Study|Adverse Event|0|||
46729573|NCT00831844|82945962|FG003|Overall Study|Adverse Event|0|||
46729574|NCT00831844|82945963|FG004|Overall Study|Adverse Event|1|||
46729575|NCT00831844|82945964|FG005|Overall Study|Adverse Event|1|||
46729576|NCT00831844|82945965|FG006|Overall Study|Adverse Event|2|||
46729577|NCT00831844|82945966|FG007|Overall Study|Adverse Event|0|||
46729578|NCT00831844|82945967|FG008|Overall Study|Adverse Event|0|||
46729579|NCT00831844|82945968|FG009|Overall Study|Adverse Event|0|||
46729580|NCT00831844|82945959|FG000|Overall Study|Death|0|||
46729581|NCT00831844|82945960|FG001|Overall Study|Death|0|||
46729582|NCT00831844|82945961|FG002|Overall Study|Death|0|||
47048310|NCT01737697|83308292|FG003|Subacute Phase|Adverse Event|0|||
47048311|NCT01737697|83308293|FG004|Subacute Phase|Adverse Event|0|||
46729583|NCT00831844|82945962|FG003|Overall Study|Death|1|||
46729584|NCT00831844|82945963|FG004|Overall Study|Death|0|||
46729585|NCT00831844|82945964|FG005|Overall Study|Death|0|||
46729586|NCT00831844|82945965|FG006|Overall Study|Death|0|||
46729587|NCT00831844|82945966|FG007|Overall Study|Death|0|||
46729588|NCT00831844|82945967|FG008|Overall Study|Death|0|||
46729589|NCT00831844|82945968|FG009|Overall Study|Death|0|||
46729590|NCT00831844|82945959|FG000|Overall Study|Lack of Efficacy|8|||
46729591|NCT00831844|82945960|FG001|Overall Study|Lack of Efficacy|10|||
46729592|NCT00831844|82945961|FG002|Overall Study|Lack of Efficacy|15|||
46729593|NCT00831844|82945962|FG003|Overall Study|Lack of Efficacy|8|||
46729594|NCT00831844|82945963|FG004|Overall Study|Lack of Efficacy|11|||
46729595|NCT00831844|82945964|FG005|Overall Study|Lack of Efficacy|17|||
46729596|NCT00831844|82945965|FG006|Overall Study|Lack of Efficacy|8|||
46729597|NCT00831844|82945966|FG007|Overall Study|Lack of Efficacy|9|||
46729598|NCT00831844|82945967|FG008|Overall Study|Lack of Efficacy|7|||
46729599|NCT00831844|82945968|FG009|Overall Study|Lack of Efficacy|0|||
46729600|NCT00831844|82945959|FG000|Overall Study|Physician Decision|0|||
46729601|NCT00831844|82945960|FG001|Overall Study|Physician Decision|1|||
46729602|NCT00831844|82945961|FG002|Overall Study|Physician Decision|3|||
46729603|NCT00831844|82945962|FG003|Overall Study|Physician Decision|1|||
46729604|NCT00831844|82945963|FG004|Overall Study|Physician Decision|1|||
46729605|NCT00831844|82945964|FG005|Overall Study|Physician Decision|1|||
46729606|NCT00831844|82945965|FG006|Overall Study|Physician Decision|0|||
46729607|NCT00831844|82945966|FG007|Overall Study|Physician Decision|0|||
46729608|NCT00831844|82945967|FG008|Overall Study|Physician Decision|1|||
46729609|NCT00831844|82945968|FG009|Overall Study|Physician Decision|0|||
46729610|NCT00831844|82945959|FG000|Overall Study|Withdrawal by Subject|0|||
46729611|NCT00831844|82945960|FG001|Overall Study|Withdrawal by Subject|0|||
46729612|NCT00831844|82945961|FG002|Overall Study|Withdrawal by Subject|1|||
46729613|NCT00831844|82945962|FG003|Overall Study|Withdrawal by Subject|0|||
46729614|NCT00831844|82945963|FG004|Overall Study|Withdrawal by Subject|0|||
46729615|NCT00831844|82945964|FG005|Overall Study|Withdrawal by Subject|0|||
46729616|NCT00831844|82945965|FG006|Overall Study|Withdrawal by Subject|0|||
46729617|NCT00831844|82945966|FG007|Overall Study|Withdrawal by Subject|1|||
46729618|NCT00831844|82945967|FG008|Overall Study|Withdrawal by Subject|1|||
46729619|NCT00831844|82945968|FG009|Overall Study|Withdrawal by Subject|0|||
46729620|NCT00831844|82945959|FG000|Overall Study|Ineligible|0|||
46729621|NCT00831844|82945960|FG001|Overall Study|Ineligible|1|||
46729622|NCT00831844|82945961|FG002|Overall Study|Ineligible|1|||
46729623|NCT00831844|82945962|FG003|Overall Study|Ineligible|0|||
46729624|NCT00831844|82945963|FG004|Overall Study|Ineligible|1|||
46729625|NCT00831844|82945964|FG005|Overall Study|Ineligible|0|||
46729626|NCT00831844|82945965|FG006|Overall Study|Ineligible|0|||
46729627|NCT00831844|82945966|FG007|Overall Study|Ineligible|0|||
46729628|NCT00831844|82945967|FG008|Overall Study|Ineligible|0|||
46729629|NCT00831844|82945968|FG009|Overall Study|Ineligible|0|||
46729630|NCT00764881|82945992|FG000|Overall Study|Adverse Event|5|||
46729631|NCT00764881|82945993|FG001|Overall Study|Adverse Event|1|||
46729632|NCT00764881|82945992|FG000|Overall Study|Withdrawal by Subject|1|||
46729633|NCT00764881|82945993|FG001|Overall Study|Withdrawal by Subject|3|||
46729634|NCT00764881|82945992|FG000|Overall Study|Protocol Violation|2|||
46729635|NCT00764881|82945993|FG001|Overall Study|Protocol Violation|2|||
46729636|NCT00764881|82945992|FG000|Overall Study|Lost to Follow-up|2|||
46729637|NCT00764881|82945993|FG001|Overall Study|Lost to Follow-up|0|||
46729638|NCT00764881|82945992|FG000|Overall Study|Noncompliant|1|||
46729639|NCT00764881|82945993|FG001|Overall Study|Noncompliant|0|||
46729640|NCT00764881|82945992|FG000|Overall Study|Accidentally discontinued study drug|1|||
46729641|NCT00764881|82945993|FG001|Overall Study|Accidentally discontinued study drug|0|||
46729642|NCT00764881|82945992|FG000|Overall Study|Wished to become pregnant|1|||
46729643|NCT00764881|82945993|FG001|Overall Study|Wished to become pregnant|0|||
46729644|NCT00764881|82945992|FG000|Overall Study|Carcinoma detected|1|||
46729645|NCT00764881|82945993|FG001|Overall Study|Carcinoma detected|0|||
46729646|NCT00764881|82945992|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
46729647|NCT00764881|82945993|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
46729648|NCT00764881|82945992|FG000|Overall Study|no treatment or no observation|2|||
46729649|NCT00764881|82945993|FG001|Overall Study|no treatment or no observation|2|||
46729650|NCT00844558|82946001|FG000|Overall Study|Withdrawal by Subject|9|||
46729651|NCT00844558|82946002|FG001|Overall Study|Withdrawal by Subject|2|||
46729652|NCT00844558|82946001|FG000|Overall Study|Death|1|||
46729653|NCT00844558|82946002|FG001|Overall Study|Death|0|||
46729654|NCT00844558|82946001|FG000|Overall Study|Protocol Violation|1|||
46729655|NCT00844558|82946002|FG001|Overall Study|Protocol Violation|1|||
46729656|NCT00844558|82946001|FG000|Overall Study|Lost to Follow-up|0|||
46729657|NCT00844558|82946002|FG001|Overall Study|Lost to Follow-up|1|||
46729658|NCT00844558|82946001|FG000|Overall Study|Physician Decision|1|||
46729659|NCT00844558|82946002|FG001|Overall Study|Physician Decision|0|||
46729660|NCT00772369|82946013|FG000|Overall Study|Did not return record release form|1|||
46729661|NCT00821236|82946020|FG000|Overall Study|Lost to Follow-up|3|||
46729662|NCT00756457|82946030|FG000|Overall Study|Lost to Follow-up|1|||
46729663|NCT00756457|82946031|FG001|Overall Study|Lost to Follow-up|2|||
46729664|NCT00844480|82946055|FG000|Overall Study|Withdrawal by Subject|2|||
46729665|NCT00844480|82946056|FG001|Overall Study|Withdrawal by Subject|3|||
46729666|NCT00771901|82946065|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
46729667|NCT00771901|82946066|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
46729668|NCT00771901|82946067|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
46729669|NCT00843856|82946077|FG000|Overall Study|Lost to Follow-up|1|||
46729670|NCT00843856|82946078|FG001|Overall Study|Lost to Follow-up|2|||
46729671|NCT00764491|82946086|FG000|Overall Study|Lost to Follow-up|35|||
46729672|NCT00764491|82946087|FG001|Overall Study|Lost to Follow-up|17|||
46729673|NCT00843778|82946093|FG000|Overall Study|Adverse Event|15|||
46729674|NCT00843778|82946093|FG000|Overall Study|Lack of Efficacy|14|||
46729675|NCT00843778|82946093|FG000|Overall Study|Loss of efficacy|2|||
46729676|NCT00843778|82946093|FG000|Overall Study|Withdrawal by Subject|4|||
46729677|NCT00910728|82946106|FG000|Overall Study|Lack of Efficacy|2|||
46729678|NCT00910728|82946107|FG001|Overall Study|Lack of Efficacy|3|||
46729679|NCT00910728|82946108|FG002|Overall Study|Lack of Efficacy|1|||
46729680|NCT00910728|82946109|FG003|Overall Study|Lack of Efficacy|2|||
46729681|NCT00910728|82946110|FG004|Overall Study|Lack of Efficacy|1|||
46729682|NCT00910728|82946111|FG005|Overall Study|Lack of Efficacy|0|||
46729683|NCT00910728|82946112|FG006|Overall Study|Lack of Efficacy|2|||
46729684|NCT00910728|82946113|FG007|Overall Study|Lack of Efficacy|2|||
46729685|NCT00910728|82946114|FG008|Overall Study|Lack of Efficacy|2|||
46729686|NCT00910728|82946106|FG000|Overall Study|Withdrawal by Subject|0|||
46729687|NCT00910728|82946107|FG001|Overall Study|Withdrawal by Subject|0|||
46729688|NCT00910728|82946108|FG002|Overall Study|Withdrawal by Subject|0|||
46729689|NCT00910728|82946109|FG003|Overall Study|Withdrawal by Subject|0|||
46729690|NCT00910728|82946110|FG004|Overall Study|Withdrawal by Subject|3|||
46729691|NCT00910728|82946111|FG005|Overall Study|Withdrawal by Subject|1|||
46729692|NCT00910728|82946112|FG006|Overall Study|Withdrawal by Subject|2|||
46729693|NCT00910728|82946113|FG007|Overall Study|Withdrawal by Subject|0|||
46729694|NCT00910728|82946114|FG008|Overall Study|Withdrawal by Subject|0|||
46729695|NCT00910728|82946106|FG000|Overall Study|(not specified)|2|||
46729696|NCT00910728|82946107|FG001|Overall Study|(not specified)|0|||
46729697|NCT00910728|82946108|FG002|Overall Study|(not specified)|1|||
46729698|NCT00910728|82946109|FG003|Overall Study|(not specified)|0|||
46729699|NCT00910728|82946110|FG004|Overall Study|(not specified)|1|||
46729700|NCT00910728|82946111|FG005|Overall Study|(not specified)|0|||
46729701|NCT00910728|82946112|FG006|Overall Study|(not specified)|0|||
46729702|NCT00910728|82946113|FG007|Overall Study|(not specified)|0|||
46729703|NCT00910728|82946114|FG008|Overall Study|(not specified)|0|||
46729704|NCT00910728|82946106|FG000|Overall Study|Adverse Event|2|||
46729705|NCT00910728|82946107|FG001|Overall Study|Adverse Event|0|||
46729706|NCT00910728|82946108|FG002|Overall Study|Adverse Event|1|||
46729707|NCT00910728|82946109|FG003|Overall Study|Adverse Event|1|||
46729708|NCT00910728|82946110|FG004|Overall Study|Adverse Event|0|||
46729709|NCT00910728|82946111|FG005|Overall Study|Adverse Event|0|||
46729710|NCT00910728|82946112|FG006|Overall Study|Adverse Event|2|||
46729711|NCT00910728|82946113|FG007|Overall Study|Adverse Event|1|||
46729712|NCT00910728|82946114|FG008|Overall Study|Adverse Event|1|||
46729713|NCT00820222|82946136|FG000|Overall Study|Lost to Follow-up|10|||
46729714|NCT00820222|82946137|FG001|Overall Study|Lost to Follow-up|9|||
46729715|NCT00820222|82946136|FG000|Overall Study|Withdrawal by Subject|19|||
46729716|NCT00820222|82946137|FG001|Overall Study|Withdrawal by Subject|21|||
46729717|NCT00820222|82946136|FG000|Overall Study|Physician Decision|93|||
46729718|NCT00820222|82946137|FG001|Overall Study|Physician Decision|88|||
46729719|NCT00820222|82946136|FG000|Overall Study|Sponsor Terminated Study|43|||
46729720|NCT00820222|82946137|FG001|Overall Study|Sponsor Terminated Study|65|||
46729721|NCT00820222|82946136|FG000|Overall Study|Unkown|11|||
46729722|NCT00820222|82946137|FG001|Overall Study|Unkown|7|||
46729723|NCT01039688|82946146|FG000|Overall Study|Adverse Event|38|||
46729724|NCT01039688|82946147|FG001|Overall Study|Adverse Event|39|||
46729725|NCT01039688|82946148|FG002|Overall Study|Adverse Event|24|||
46729726|NCT01039688|82946146|FG000|Overall Study|Lack of Efficacy|20|||
46729727|NCT01039688|82946147|FG001|Overall Study|Lack of Efficacy|11|||
46729728|NCT01039688|82946148|FG002|Overall Study|Lack of Efficacy|26|||
46729729|NCT01039688|82946146|FG000|Overall Study|Lost to Follow-up|11|||
46729730|NCT01039688|82946147|FG001|Overall Study|Lost to Follow-up|9|||
46729731|NCT01039688|82946148|FG002|Overall Study|Lost to Follow-up|5|||
46729732|NCT01039688|82946146|FG000|Overall Study|Other|13|||
46729733|NCT01039688|82946147|FG001|Overall Study|Other|25|||
46729734|NCT01039688|82946148|FG002|Overall Study|Other|12|||
46729735|NCT01039688|82946146|FG000|Overall Study|Withdrawal by Subject|23|||
46921386|NCT03078751|83153844|FG001|Overall Study|Physician Decision|0|||
46921387|NCT03078751|83153843|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
47048312|NCT01737697|83308294|FG005|Subacute Phase|Adverse Event|1|||
47048313|NCT01737697|83308295|FG006|Subacute Phase|Adverse Event|1|||
47048314|NCT01737697|83308296|FG007|Subacute Phase|Adverse Event|1|||
46729736|NCT01039688|82946147|FG001|Overall Study|Withdrawal by Subject|27|||
46729737|NCT01039688|82946148|FG002|Overall Study|Withdrawal by Subject|13|||
46729738|NCT01039688|82946146|FG000|Overall Study|Death|2|||
46729739|NCT01039688|82946147|FG001|Overall Study|Death|0|||
46729740|NCT01039688|82946148|FG002|Overall Study|Death|0|||
46729741|NCT02237508|82946169|FG000|Overall Study|Withdrawal by Subject|0|||
46729742|NCT02237508|82946170|FG001|Overall Study|Withdrawal by Subject|2|||
46729743|NCT02237508|82946171|FG002|Overall Study|Withdrawal by Subject|0|||
46729744|NCT02237508|82946172|FG003|Overall Study|Withdrawal by Subject|1|||
46729745|NCT02237508|82946173|FG004|Overall Study|Withdrawal by Subject|0|||
46729746|NCT02237508|82946174|FG005|Overall Study|Withdrawal by Subject|1|||
46729747|NCT02237508|82946175|FG006|Overall Study|Withdrawal by Subject|1|||
46729748|NCT02237508|82946176|FG007|Overall Study|Withdrawal by Subject|0|||
46729749|NCT02237508|82946177|FG008|Overall Study|Withdrawal by Subject|1|||
46729750|NCT02237508|82946178|FG009|Overall Study|Withdrawal by Subject|0|||
46729751|NCT02237508|82946169|FG000|Overall Study|Physician Decision|0|||
46729752|NCT02237508|82946170|FG001|Overall Study|Physician Decision|1|||
46729753|NCT02237508|82946171|FG002|Overall Study|Physician Decision|0|||
46729754|NCT02237508|82946172|FG003|Overall Study|Physician Decision|0|||
46729755|NCT02237508|82946173|FG004|Overall Study|Physician Decision|0|||
46729756|NCT02237508|82946174|FG005|Overall Study|Physician Decision|0|||
46729757|NCT02237508|82946175|FG006|Overall Study|Physician Decision|0|||
46729758|NCT02237508|82946176|FG007|Overall Study|Physician Decision|0|||
46729759|NCT02237508|82946177|FG008|Overall Study|Physician Decision|0|||
46729760|NCT02237508|82946178|FG009|Overall Study|Physician Decision|0|||
46729761|NCT02237508|82946169|FG000|Overall Study|Protocol Violation|0|||
46729762|NCT02237508|82946170|FG001|Overall Study|Protocol Violation|0|||
46729763|NCT02237508|82946171|FG002|Overall Study|Protocol Violation|1|||
46729764|NCT02237508|82946172|FG003|Overall Study|Protocol Violation|0|||
46729765|NCT02237508|82946173|FG004|Overall Study|Protocol Violation|0|||
46729766|NCT02237508|82946174|FG005|Overall Study|Protocol Violation|0|||
46729767|NCT02237508|82946175|FG006|Overall Study|Protocol Violation|0|||
46729768|NCT02237508|82946176|FG007|Overall Study|Protocol Violation|0|||
46729769|NCT02237508|82946177|FG008|Overall Study|Protocol Violation|0|||
46729770|NCT02237508|82946178|FG009|Overall Study|Protocol Violation|0|||
47048315|NCT01737697|83308297|FG008|Subacute Phase|Adverse Event|1|||
46729771|NCT00909090|82946198|FG000|Overall Study|Lost to Follow-up|17|||
46729772|NCT00909090|82946199|FG001|Overall Study|Lost to Follow-up|17|||
46729773|NCT00909480|82946210|FG000|Overall Study|Adverse Event|5|||
46729774|NCT00909480|82946211|FG001|Overall Study|Adverse Event|3|||
46729775|NCT00909480|82946210|FG000|Overall Study|Protocol Violation|6|||
46729776|NCT00909480|82946211|FG001|Overall Study|Protocol Violation|8|||
46729777|NCT00909480|82946210|FG000|Overall Study|Withdrawal criteria|9|||
46729778|NCT00909480|82946211|FG001|Overall Study|Withdrawal criteria|11|||
46729779|NCT00909480|82946210|FG000|Overall Study|Unclassified|18|||
46729780|NCT00909480|82946211|FG001|Overall Study|Unclassified|19|||
46729781|NCT01058096|82946219|FG000|Double-blind Treatment Phase|Adverse Event|11|||
46729782|NCT01058096|82946220|FG001|Double-blind Treatment Phase|Adverse Event|15|||
46729783|NCT01058096|82946219|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
46729784|NCT01058096|82946220|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
46729785|NCT01058096|82946219|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
46729786|NCT01058096|82946220|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
46729787|NCT01058096|82946219|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
46729788|NCT01058096|82946220|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
46729789|NCT01058096|82946219|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
46729790|NCT01058096|82946220|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
46729791|NCT01058096|82946219|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
46729792|NCT01058096|82946220|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
46729793|NCT01057862|82946228|FG000|Overall Study|Withdrawal by Subject|1|||
46729794|NCT01057862|82946229|FG001|Overall Study|Withdrawal by Subject|2|||
46729795|NCT01038128|82946235|FG000|Overall Study|Lack of Efficacy|1|||
46729796|NCT01038128|82946235|FG000|Overall Study|Lost to Follow-up|1|||
46729797|NCT01038128|82946235|FG000|Overall Study|Withdrawal by Subject|2|||
46729798|NCT00842530|82946256|FG000|Overall Study|Serious adverse event|0|||
47048316|NCT01737697|83308298|FG009|Subacute Phase|Adverse Event|1|||
47048317|NCT01737697|83308299|FG010|Subacute Phase|Adverse Event|4|||
47048318|NCT01737697|83308300|FG011|Subacute Phase|Adverse Event|1|||
47048319|NCT01737697|83308301|FG012|Subacute Phase|Adverse Event|1|||
47048320|NCT01737697|83308302|FG013|Subacute Phase|Adverse Event|0|||
47048321|NCT01737697|83308303|FG014|Subacute Phase|Adverse Event|0|||
47048322|NCT01737697|83308289|FG000|Subacute Phase|Withdrawal by Subject|0|||
47048323|NCT01737697|83308290|FG001|Subacute Phase|Withdrawal by Subject|0|||
47048324|NCT01737697|83308291|FG002|Subacute Phase|Withdrawal by Subject|0|||
47048325|NCT01737697|83308292|FG003|Subacute Phase|Withdrawal by Subject|0|||
47048326|NCT01737697|83308293|FG004|Subacute Phase|Withdrawal by Subject|0|||
47048327|NCT01737697|83308294|FG005|Subacute Phase|Withdrawal by Subject|1|||
47048328|NCT01737697|83308295|FG006|Subacute Phase|Withdrawal by Subject|0|||
46635008|NCT01691430|82808439|FG001|Overall Study|Withdrawal by Subject|1|||
46729799|NCT00842530|82946257|FG001|Overall Study|Serious adverse event|6|||
46729800|NCT00842530|82946256|FG000|Overall Study|Other adverse event|6|||
46729801|NCT00842530|82946257|FG001|Overall Study|Other adverse event|1|||
47048329|NCT01737697|83308296|FG007|Subacute Phase|Withdrawal by Subject|2|||
47048330|NCT01737697|83308297|FG008|Subacute Phase|Withdrawal by Subject|0|||
46635009|NCT01691430|82808438|FG000|Overall Study|Lost to Follow-up|0|||
46635010|NCT01691430|82808439|FG001|Overall Study|Lost to Follow-up|3|||
46635011|NCT01709838|82808445|FG000|Overall Study|Withdrawal by Subject|21|||
46635012|NCT01709838|82808445|FG000|Overall Study|Lost to Follow-up|16|||
46635013|NCT01709838|82808445|FG000|Overall Study|Pregnancy|10|||
46635014|NCT01709838|82808445|FG000|Overall Study|Subject/guardian decision|8|||
46635015|NCT01709838|82808445|FG000|Overall Study|Adverse Event|4|||
47048331|NCT01737697|83308298|FG009|Subacute Phase|Withdrawal by Subject|1|||
47048332|NCT01737697|83308299|FG010|Subacute Phase|Withdrawal by Subject|0|||
47048333|NCT01737697|83308300|FG011|Subacute Phase|Withdrawal by Subject|1|||
47048334|NCT01737697|83308301|FG012|Subacute Phase|Withdrawal by Subject|1|||
47048335|NCT01737697|83308302|FG013|Subacute Phase|Withdrawal by Subject|1|||
47048336|NCT01737697|83308303|FG014|Subacute Phase|Withdrawal by Subject|0|||
46729802|NCT00842530|82946256|FG000|Overall Study|Protocol Violation|32|||
46729803|NCT00842530|82946257|FG001|Overall Study|Protocol Violation|14|||
46729804|NCT00842530|82946256|FG000|Overall Study|Lost to Follow-up|6|||
46729805|NCT00842530|82946257|FG001|Overall Study|Lost to Follow-up|8|||
46729806|NCT00842530|82946256|FG000|Overall Study|Withdrawal by Subject|73|||
46729807|NCT00842530|82946257|FG001|Overall Study|Withdrawal by Subject|28|||
46729808|NCT00819910|82946268|FG000|Overall Study|Adverse Event|0|||
46729809|NCT00819910|82946269|FG001|Overall Study|Adverse Event|0|||
46729810|NCT00819910|82946270|FG002|Overall Study|Adverse Event|2|||
46729811|NCT00819910|82946271|FG003|Overall Study|Adverse Event|1|||
46729812|NCT00819910|82946268|FG000|Overall Study|Withdrawal by Subject|1|||
46729813|NCT00819910|82946269|FG001|Overall Study|Withdrawal by Subject|1|||
46729814|NCT00819910|82946270|FG002|Overall Study|Withdrawal by Subject|1|||
46729815|NCT00819910|82946271|FG003|Overall Study|Withdrawal by Subject|0|||
46729816|NCT00819910|82946268|FG000|Overall Study|Lost to Follow-up|1|||
46729817|NCT00819910|82946269|FG001|Overall Study|Lost to Follow-up|0|||
46729818|NCT00819910|82946270|FG002|Overall Study|Lost to Follow-up|0|||
46729819|NCT00819910|82946271|FG003|Overall Study|Lost to Follow-up|0|||
46729820|NCT00830518|82946285|FG000|Overall Study|Progressive Disease|18|||
46729821|NCT00830518|82946286|FG001|Overall Study|Progressive Disease|8|||
46729822|NCT00830518|82946285|FG000|Overall Study|Symptomatic Deterioration|4|||
46729823|NCT00830518|82946286|FG001|Overall Study|Symptomatic Deterioration|1|||
46729824|NCT00830518|82946285|FG000|Overall Study|Adverse Event|14|||
46729825|NCT00830518|82946286|FG001|Overall Study|Adverse Event|1|||
47048337|NCT01737697|83308289|FG000|Subacute Phase|Lost to Follow-up|0|||
47048338|NCT01737697|83308290|FG001|Subacute Phase|Lost to Follow-up|0|||
47048339|NCT01737697|83308291|FG002|Subacute Phase|Lost to Follow-up|0|||
47048340|NCT01737697|83308292|FG003|Subacute Phase|Lost to Follow-up|0|||
47048341|NCT01737697|83308293|FG004|Subacute Phase|Lost to Follow-up|0|||
47048342|NCT01737697|83308294|FG005|Subacute Phase|Lost to Follow-up|0|||
47048343|NCT01737697|83308295|FG006|Subacute Phase|Lost to Follow-up|0|||
47048344|NCT01737697|83308296|FG007|Subacute Phase|Lost to Follow-up|0|||
47048345|NCT01737697|83308297|FG008|Subacute Phase|Lost to Follow-up|0|||
47048346|NCT01737697|83308298|FG009|Subacute Phase|Lost to Follow-up|0|||
47048347|NCT01737697|83308299|FG010|Subacute Phase|Lost to Follow-up|0|||
47048348|NCT01737697|83308300|FG011|Subacute Phase|Lost to Follow-up|0|||
47048349|NCT01737697|83308301|FG012|Subacute Phase|Lost to Follow-up|0|||
47048350|NCT01737697|83308302|FG013|Subacute Phase|Lost to Follow-up|0|||
47048351|NCT01737697|83308303|FG014|Subacute Phase|Lost to Follow-up|1|||
47048352|NCT01737697|83308289|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
47048353|NCT01737697|83308290|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
47048354|NCT01737697|83308291|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
47048355|NCT01737697|83308292|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
47048356|NCT01737697|83308293|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
47048357|NCT01737697|83308294|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
47048358|NCT01737697|83308295|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
47048359|NCT01737697|83308296|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
46729826|NCT00830518|82946285|FG000|Overall Study|Withdrawal by Patient|2|||
46729827|NCT00830518|82946286|FG001|Overall Study|Withdrawal by Patient|0|||
46729828|NCT00830518|82946285|FG000|Overall Study|Reason not Specified|8|||
46729829|NCT00830518|82946286|FG001|Overall Study|Reason not Specified|1|||
46729830|NCT00908544|82946295|FG000|Overall Study|Withdrawal by Subject|2|||
46729831|NCT00908544|82946296|FG001|Overall Study|Withdrawal by Subject|4|||
46729832|NCT00908544|82946295|FG000|Overall Study|Lack of Efficacy|0|||
46729833|NCT00908544|82946296|FG001|Overall Study|Lack of Efficacy|1|||
46729834|NCT00908544|82946295|FG000|Overall Study|Pregnancy|1|||
47048360|NCT01737697|83308297|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
47048361|NCT01737697|83308298|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
47048362|NCT01737697|83308299|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
47048363|NCT01737697|83308300|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
47048364|NCT01737697|83308301|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
47048365|NCT01737697|83308302|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
46729835|NCT00908544|82946296|FG001|Overall Study|Pregnancy|0|||
46729836|NCT00908544|82946295|FG000|Overall Study|Relocation abroad|1|||
46729837|NCT00908544|82946296|FG001|Overall Study|Relocation abroad|1|||
46729838|NCT00908544|82946295|FG000|Overall Study|Unable to visit sutdy center|1|||
46729839|NCT00908544|82946296|FG001|Overall Study|Unable to visit sutdy center|0|||
46729840|NCT00830440|82946304|FG000|Overall Study|Protocol Violation|1|||
46729841|NCT00830440|82946305|FG001|Overall Study|Protocol Violation|0|||
46729842|NCT00830440|82946304|FG000|Overall Study|Withdrawal by Subject|1|||
46729843|NCT00830440|82946305|FG001|Overall Study|Withdrawal by Subject|0|||
47048366|NCT01737697|83308303|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
47048367|NCT01737697|83308289|FG000|Subacute Phase|Protocol Violation|0|||
47048368|NCT01737697|83308290|FG001|Subacute Phase|Protocol Violation|0|||
47048369|NCT01737697|83308291|FG002|Subacute Phase|Protocol Violation|0|||
47048370|NCT01737697|83308292|FG003|Subacute Phase|Protocol Violation|0|||
47048371|NCT01737697|83308293|FG004|Subacute Phase|Protocol Violation|0|||
47048372|NCT01737697|83308294|FG005|Subacute Phase|Protocol Violation|1|||
47048373|NCT01737697|83308295|FG006|Subacute Phase|Protocol Violation|0|||
47048374|NCT01737697|83308296|FG007|Subacute Phase|Protocol Violation|0|||
47048375|NCT01737697|83308297|FG008|Subacute Phase|Protocol Violation|0|||
47048376|NCT01737697|83308298|FG009|Subacute Phase|Protocol Violation|0|||
47048377|NCT01737697|83308299|FG010|Subacute Phase|Protocol Violation|1|||
47048378|NCT01737697|83308300|FG011|Subacute Phase|Protocol Violation|0|||
47048379|NCT01737697|83308301|FG012|Subacute Phase|Protocol Violation|0|||
47048380|NCT01737697|83308302|FG013|Subacute Phase|Protocol Violation|0|||
47048381|NCT01737697|83308303|FG014|Subacute Phase|Protocol Violation|0|||
47048382|NCT01737697|83308289|FG000|Subacute Phase|Physician Decision|0|||
47048383|NCT01737697|83308290|FG001|Subacute Phase|Physician Decision|0|||
47048384|NCT01737697|83308291|FG002|Subacute Phase|Physician Decision|0|||
47048385|NCT01737697|83308292|FG003|Subacute Phase|Physician Decision|0|||
47048386|NCT01737697|83308293|FG004|Subacute Phase|Physician Decision|0|||
47048387|NCT01737697|83308294|FG005|Subacute Phase|Physician Decision|0|||
47048388|NCT01737697|83308295|FG006|Subacute Phase|Physician Decision|0|||
47048389|NCT01737697|83308296|FG007|Subacute Phase|Physician Decision|0|||
47048390|NCT01737697|83308297|FG008|Subacute Phase|Physician Decision|1|||
47048391|NCT01737697|83308298|FG009|Subacute Phase|Physician Decision|0|||
47048392|NCT01737697|83308299|FG010|Subacute Phase|Physician Decision|0|||
47048393|NCT01737697|83308300|FG011|Subacute Phase|Physician Decision|0|||
47048394|NCT01737697|83308301|FG012|Subacute Phase|Physician Decision|0|||
46729844|NCT00830440|82946304|FG000|Overall Study|unsuccessful procedure|4|||
46729845|NCT00830440|82946305|FG001|Overall Study|unsuccessful procedure|0|||
46729846|NCT00830440|82946304|FG000|Overall Study|Adverse Event|2|||
46729847|NCT00830440|82946305|FG001|Overall Study|Adverse Event|0|||
47048395|NCT01737697|83308302|FG013|Subacute Phase|Physician Decision|0|||
46729848|NCT00908310|82946312|FG000|Overall Study|Death|37|||
46729849|NCT00908310|82946312|FG000|Overall Study|Withdrawal by Subject|7|||
46729850|NCT00908310|82946312|FG000|Overall Study|Lost to Follow-up|7|||
46729851|NCT00908310|82946312|FG000|Overall Study|Screening failure|5|||
46921388|NCT03078751|83153844|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
47048396|NCT01737697|83308303|FG014|Subacute Phase|Physician Decision|0|||
47048397|NCT01737697|83308289|FG000|Subacute Phase|Death|0|||
47048398|NCT01737697|83308290|FG001|Subacute Phase|Death|0|||
47048399|NCT01737697|83308291|FG002|Subacute Phase|Death|0|||
47048400|NCT01737697|83308292|FG003|Subacute Phase|Death|0|||
47048401|NCT01737697|83308293|FG004|Subacute Phase|Death|0|||
47048402|NCT01737697|83308294|FG005|Subacute Phase|Death|0|||
47048403|NCT01737697|83308295|FG006|Subacute Phase|Death|0|||
47048404|NCT01737697|83308296|FG007|Subacute Phase|Death|0|||
47048405|NCT01737697|83308297|FG008|Subacute Phase|Death|0|||
47048406|NCT01737697|83308298|FG009|Subacute Phase|Death|0|||
47048407|NCT01737697|83308299|FG010|Subacute Phase|Death|1|||
47048408|NCT01737697|83308300|FG011|Subacute Phase|Death|0|||
47048409|NCT01737697|83308301|FG012|Subacute Phase|Death|0|||
47048410|NCT01737697|83308302|FG013|Subacute Phase|Death|0|||
47048411|NCT01737697|83308303|FG014|Subacute Phase|Death|0|||
47048412|NCT01682863|83308459|FG000|Overall Study|Subject/guardian decision|19|||
47048413|NCT01682863|83308460|FG001|Overall Study|Subject/guardian decision|12|||
47048414|NCT01682863|83308461|FG002|Overall Study|Subject/guardian decision|10|||
46921389|NCT03078751|83153843|FG000|Overall Study|Subject/guardian decision|8|||
46921390|NCT03078751|83153844|FG001|Overall Study|Subject/guardian decision|1|||
46921391|NCT03078751|83153843|FG000|Overall Study|Untreated|0|||
46921392|NCT03078751|83153844|FG001|Overall Study|Untreated|4|||
47048415|NCT01682863|83308459|FG000|Overall Study|Lost to Follow-up|5|||
47048416|NCT01682863|83308460|FG001|Overall Study|Lost to Follow-up|1|||
46921393|NCT02924883|83153869|FG000|Overall Study|Death|39|||
47048417|NCT01682863|83308461|FG002|Overall Study|Lost to Follow-up|6|||
47048418|NCT01682863|83308459|FG000|Overall Study|Death|1|||
47048419|NCT01682863|83308460|FG001|Overall Study|Death|3|||
47048420|NCT01682863|83308461|FG002|Overall Study|Death|4|||
47048421|NCT01682863|83308459|FG000|Overall Study|Protocol deviation|1|||
47048422|NCT01682863|83308460|FG001|Overall Study|Protocol deviation|0|||
46729852|NCT00908310|82946312|FG000|Overall Study|Other reasons|4|||
46729853|NCT00830128|82946316|FG000|Overall Study|Adverse Event|5|||
46729854|NCT00830128|82946316|FG000|Overall Study|Lack of Efficacy|7|||
47048423|NCT01682863|83308461|FG002|Overall Study|Protocol deviation|1|||
47048424|NCT01682863|83308459|FG000|Overall Study|Technical problems|1|||
47048425|NCT01682863|83308460|FG001|Overall Study|Technical problems|0|||
46921394|NCT02924883|83153870|FG001|Overall Study|Death|20|||
47048426|NCT01682863|83308461|FG002|Overall Study|Technical problems|0|||
47048427|NCT01682863|83308459|FG000|Overall Study|Adverse Event|0|||
47048428|NCT01682863|83308460|FG001|Overall Study|Adverse Event|1|||
47048429|NCT01682863|83308461|FG002|Overall Study|Adverse Event|2|||
47048430|NCT01682863|83308459|FG000|Overall Study|Physician Decision|0|||
47048431|NCT01682863|83308460|FG001|Overall Study|Physician Decision|0|||
47048432|NCT01682863|83308461|FG002|Overall Study|Physician Decision|1|||
47048433|NCT01951625|83308474|FG000|Treatment Period|Protocol Violation|2|||
47048434|NCT01951625|83308475|FG001|Treatment Period|Protocol Violation|0|||
47048435|NCT01951625|83308476|FG002|Treatment Period|Protocol Violation|1|||
47048436|NCT01951625|83308477|FG003|Treatment Period|Protocol Violation|3|||
47048437|NCT01951625|83308478|FG004|Treatment Period|Protocol Violation|2|||
47048438|NCT01951625|83308474|FG000|Treatment Period|Physician Decision|0|||
47048439|NCT01951625|83308475|FG001|Treatment Period|Physician Decision|0|||
47048440|NCT01951625|83308476|FG002|Treatment Period|Physician Decision|0|||
47048441|NCT01951625|83308477|FG003|Treatment Period|Physician Decision|0|||
46729855|NCT00830128|82946316|FG000|Overall Study|Protocol Violation|1|||
46729856|NCT00830128|82946316|FG000|Overall Study|Withdrawal by Subject|2|||
46729857|NCT00830128|82946316|FG000|Overall Study|Family obligation|1|||
46729858|NCT00830128|82946316|FG000|Overall Study|Relocation|1|||
46729859|NCT00830128|82946316|FG000|Overall Study|Work obligation|1|||
46729860|NCT00830128|82946316|FG000|Overall Study|Operating a vehicle|1|||
46729861|NCT00841906|82946322|FG000|Overall Study|Withdrawal by Subject|2|||
46729862|NCT00841906|82946323|FG001|Overall Study|Withdrawal by Subject|0|||
46729863|NCT00771667|82946335|FG000|Induction Phase|Adverse Event|5|||
46729864|NCT00771667|82946336|FG001|Induction Phase|Adverse Event|2|||
46729865|NCT00771667|82946337|FG002|Induction Phase|Adverse Event|4|||
46729866|NCT00771667|82946338|FG003|Induction Phase|Adverse Event|1|||
46729867|NCT00771667|82946339|FG004|Induction Phase|Adverse Event|0|||
46729868|NCT00771667|82946340|FG005|Induction Phase|Adverse Event|0|||
46729869|NCT00771667|82946341|FG006|Induction Phase|Adverse Event|0|||
46729870|NCT00771667|82946342|FG007|Induction Phase|Adverse Event|0|||
46729871|NCT00771667|82946343|FG008|Induction Phase|Adverse Event|0|||
46729872|NCT00771667|82946344|FG009|Induction Phase|Adverse Event|0|||
46729873|NCT00771667|82946335|FG000|Induction Phase|Lack of Efficacy|9|||
46729874|NCT00771667|82946336|FG001|Induction Phase|Lack of Efficacy|2|||
46729875|NCT00771667|82946337|FG002|Induction Phase|Lack of Efficacy|4|||
46729876|NCT00771667|82946338|FG003|Induction Phase|Lack of Efficacy|3|||
46729877|NCT00771667|82946339|FG004|Induction Phase|Lack of Efficacy|0|||
46729878|NCT00771667|82946340|FG005|Induction Phase|Lack of Efficacy|0|||
46729879|NCT00771667|82946341|FG006|Induction Phase|Lack of Efficacy|0|||
46729880|NCT00771667|82946342|FG007|Induction Phase|Lack of Efficacy|0|||
46729881|NCT00771667|82946343|FG008|Induction Phase|Lack of Efficacy|0|||
46729882|NCT00771667|82946344|FG009|Induction Phase|Lack of Efficacy|0|||
46729883|NCT00771667|82946335|FG000|Induction Phase|Lost to Follow-up|1|||
46729884|NCT00771667|82946336|FG001|Induction Phase|Lost to Follow-up|0|||
47048442|NCT01951625|83308478|FG004|Treatment Period|Physician Decision|1|||
47048443|NCT01951625|83308474|FG000|Treatment Period|Protocol driven decision point|0|||
47048444|NCT01951625|83308475|FG001|Treatment Period|Protocol driven decision point|5|||
47048445|NCT01951625|83308476|FG002|Treatment Period|Protocol driven decision point|0|||
47048446|NCT01951625|83308477|FG003|Treatment Period|Protocol driven decision point|2|||
47048447|NCT01951625|83308478|FG004|Treatment Period|Protocol driven decision point|1|||
47048448|NCT01951625|83308474|FG000|Treatment Period|Non compliance with study drug|1|||
47048449|NCT01951625|83308475|FG001|Treatment Period|Non compliance with study drug|2|||
47048450|NCT01951625|83308476|FG002|Treatment Period|Non compliance with study drug|2|||
47048451|NCT01951625|83308477|FG003|Treatment Period|Non compliance with study drug|0|||
46729885|NCT00771667|82946337|FG002|Induction Phase|Lost to Follow-up|1|||
46729886|NCT00771667|82946338|FG003|Induction Phase|Lost to Follow-up|0|||
47048452|NCT01951625|83308478|FG004|Treatment Period|Non compliance with study drug|0|||
47048453|NCT01951625|83308474|FG000|Treatment Period|Death|3|||
47048454|NCT01951625|83308475|FG001|Treatment Period|Death|2|||
47048455|NCT01951625|83308476|FG002|Treatment Period|Death|2|||
46729887|NCT00771667|82946339|FG004|Induction Phase|Lost to Follow-up|0|||
46803814|NCT00077623|83023115|FG002|Overall Study|Adverse Event|1|||
47048456|NCT01951625|83308477|FG003|Treatment Period|Death|1|||
47048457|NCT01951625|83308478|FG004|Treatment Period|Death|2|||
47048458|NCT01951625|83308474|FG000|Treatment Period|Adverse Event|7|||
46729888|NCT00771667|82946340|FG005|Induction Phase|Lost to Follow-up|0|||
46729889|NCT00771667|82946341|FG006|Induction Phase|Lost to Follow-up|0|||
46729890|NCT00771667|82946342|FG007|Induction Phase|Lost to Follow-up|0|||
46729891|NCT00771667|82946343|FG008|Induction Phase|Lost to Follow-up|0|||
46803815|NCT00077623|83023113|FG000|Overall Study|Withdrawal by Subject|2|||
46729892|NCT00771667|82946344|FG009|Induction Phase|Lost to Follow-up|0|||
46729893|NCT00771667|82946335|FG000|Induction Phase|Other|4|||
47048459|NCT01951625|83308475|FG001|Treatment Period|Adverse Event|10|||
47048460|NCT01951625|83308476|FG002|Treatment Period|Adverse Event|9|||
46729894|NCT00771667|82946336|FG001|Induction Phase|Other|6|||
46729895|NCT00771667|82946337|FG002|Induction Phase|Other|3|||
46729896|NCT00771667|82946338|FG003|Induction Phase|Other|4|||
47048461|NCT01951625|83308477|FG003|Treatment Period|Adverse Event|8|||
47048462|NCT01951625|83308478|FG004|Treatment Period|Adverse Event|8|||
47048463|NCT01951625|83308474|FG000|Treatment Period|Withdrawal by Subject|5|||
47048464|NCT01951625|83308475|FG001|Treatment Period|Withdrawal by Subject|2|||
47048465|NCT01951625|83308476|FG002|Treatment Period|Withdrawal by Subject|1|||
47048466|NCT01951625|83308477|FG003|Treatment Period|Withdrawal by Subject|7|||
47048467|NCT01951625|83308478|FG004|Treatment Period|Withdrawal by Subject|3|||
47048468|NCT01951625|83308474|FG000|Treatment Period|Lost to Follow-up|1|||
47048469|NCT01951625|83308475|FG001|Treatment Period|Lost to Follow-up|0|||
47048470|NCT01951625|83308476|FG002|Treatment Period|Lost to Follow-up|0|||
47048471|NCT01951625|83308477|FG003|Treatment Period|Lost to Follow-up|1|||
46729897|NCT00771667|82946339|FG004|Induction Phase|Other|0|||
46729898|NCT00771667|82946340|FG005|Induction Phase|Other|0|||
46729899|NCT00771667|82946341|FG006|Induction Phase|Other|0|||
46729900|NCT00771667|82946342|FG007|Induction Phase|Other|0|||
46729901|NCT00771667|82946343|FG008|Induction Phase|Other|0|||
46729902|NCT00771667|82946344|FG009|Induction Phase|Other|0|||
46729903|NCT00771667|82946335|FG000|Maintenance Phase|Adverse Event|0|||
46729904|NCT00771667|82946336|FG001|Maintenance Phase|Adverse Event|0|||
46729905|NCT00771667|82946337|FG002|Maintenance Phase|Adverse Event|0|||
46729906|NCT00771667|82946338|FG003|Maintenance Phase|Adverse Event|0|||
46729907|NCT00771667|82946339|FG004|Maintenance Phase|Adverse Event|1|||
46729908|NCT00771667|82946340|FG005|Maintenance Phase|Adverse Event|3|||
46729909|NCT00771667|82946341|FG006|Maintenance Phase|Adverse Event|5|||
47048472|NCT01951625|83308478|FG004|Treatment Period|Lost to Follow-up|0|||
47048473|NCT01951625|83308474|FG000|Follow Up Period|Non-compliance with study drug|1|||
47048474|NCT01951625|83308475|FG001|Follow Up Period|Non-compliance with study drug|0|||
47048475|NCT01951625|83308476|FG002|Follow Up Period|Non-compliance with study drug|0|||
47048476|NCT01951625|83308477|FG003|Follow Up Period|Non-compliance with study drug|0|||
47048477|NCT01951625|83308478|FG004|Follow Up Period|Non-compliance with study drug|0|||
47048478|NCT01951625|83308474|FG000|Follow Up Period|Death|1|||
47048479|NCT01951625|83308475|FG001|Follow Up Period|Death|3|||
47048480|NCT01951625|83308476|FG002|Follow Up Period|Death|2|||
47048481|NCT01951625|83308477|FG003|Follow Up Period|Death|2|||
47048482|NCT01951625|83308478|FG004|Follow Up Period|Death|1|||
47048483|NCT01951625|83308474|FG000|Follow Up Period|Logistical difficulties|1|||
47048484|NCT01951625|83308475|FG001|Follow Up Period|Logistical difficulties|2|||
47048485|NCT01951625|83308476|FG002|Follow Up Period|Logistical difficulties|0|||
47048486|NCT01951625|83308477|FG003|Follow Up Period|Logistical difficulties|0|||
47048487|NCT01951625|83308478|FG004|Follow Up Period|Logistical difficulties|0|||
47048488|NCT01951625|83308474|FG000|Follow Up Period|Adverse Event|0|||
47048489|NCT01951625|83308475|FG001|Follow Up Period|Adverse Event|3|||
47048490|NCT01951625|83308476|FG002|Follow Up Period|Adverse Event|2|||
47048491|NCT01951625|83308477|FG003|Follow Up Period|Adverse Event|3|||
47048492|NCT01951625|83308478|FG004|Follow Up Period|Adverse Event|5|||
47048493|NCT01951625|83308474|FG000|Follow Up Period|Withdrawal by Subject|4|||
47048494|NCT01951625|83308475|FG001|Follow Up Period|Withdrawal by Subject|1|||
47048495|NCT01951625|83308476|FG002|Follow Up Period|Withdrawal by Subject|0|||
47048496|NCT01951625|83308477|FG003|Follow Up Period|Withdrawal by Subject|5|||
46729910|NCT00771667|82946342|FG007|Maintenance Phase|Adverse Event|1|||
46729911|NCT00771667|82946343|FG008|Maintenance Phase|Adverse Event|8|||
46729912|NCT00771667|82946344|FG009|Maintenance Phase|Adverse Event|7|||
46729913|NCT00771667|82946335|FG000|Maintenance Phase|Lack of Efficacy|0|||
46921395|NCT02924883|83153869|FG000|Overall Study|Lost to Follow-up|1|||
46729914|NCT00771667|82946336|FG001|Maintenance Phase|Lack of Efficacy|0|||
46729915|NCT00771667|82946337|FG002|Maintenance Phase|Lack of Efficacy|0|||
46729916|NCT00771667|82946338|FG003|Maintenance Phase|Lack of Efficacy|0|||
46729917|NCT00771667|82946339|FG004|Maintenance Phase|Lack of Efficacy|1|||
46729918|NCT00771667|82946340|FG005|Maintenance Phase|Lack of Efficacy|3|||
47048497|NCT01951625|83308478|FG004|Follow Up Period|Withdrawal by Subject|3|||
47048498|NCT01951625|83308474|FG000|Follow Up Period|Lost to Follow-up|1|||
47048499|NCT01951625|83308475|FG001|Follow Up Period|Lost to Follow-up|0|||
47048500|NCT01951625|83308476|FG002|Follow Up Period|Lost to Follow-up|0|||
47048501|NCT01951625|83308477|FG003|Follow Up Period|Lost to Follow-up|1|||
47048502|NCT01951625|83308478|FG004|Follow Up Period|Lost to Follow-up|1|||
46729919|NCT00771667|82946341|FG006|Maintenance Phase|Lack of Efficacy|3|||
46729920|NCT00771667|82946342|FG007|Maintenance Phase|Lack of Efficacy|2|||
46729921|NCT00771667|82946343|FG008|Maintenance Phase|Lack of Efficacy|11|||
46729922|NCT00771667|82946344|FG009|Maintenance Phase|Lack of Efficacy|7|||
46729923|NCT00771667|82946335|FG000|Maintenance Phase|Other|0|||
46729924|NCT00771667|82946336|FG001|Maintenance Phase|Other|0|||
46729925|NCT00771667|82946337|FG002|Maintenance Phase|Other|0|||
46729926|NCT00771667|82946338|FG003|Maintenance Phase|Other|0|||
46729927|NCT00771667|82946339|FG004|Maintenance Phase|Other|0|||
46729928|NCT00771667|82946340|FG005|Maintenance Phase|Other|1|||
46729929|NCT00771667|82946341|FG006|Maintenance Phase|Other|2|||
46803816|NCT00077623|83023114|FG001|Overall Study|Withdrawal by Subject|10|||
46803817|NCT00077623|83023115|FG002|Overall Study|Withdrawal by Subject|1|||
46803818|NCT00077623|83023113|FG000|Overall Study|Other-Non safety reason|18|||
46803819|NCT00077623|83023114|FG001|Overall Study|Other-Non safety reason|15|||
46803820|NCT00077623|83023115|FG002|Overall Study|Other-Non safety reason|19|||
46803821|NCT00077623|83023113|FG000|Overall Study|Insufficient therapeutic response|2|||
46803822|NCT00077623|83023114|FG001|Overall Study|Insufficient therapeutic response|0|||
46803823|NCT00077623|83023115|FG002|Overall Study|Insufficient therapeutic response|0|||
46803824|NCT00077623|83023113|FG000|Overall Study|Death|12|||
46803825|NCT00077623|83023114|FG001|Overall Study|Death|18|||
46803826|NCT00077623|83023115|FG002|Overall Study|Death|11|||
46803827|NCT00077623|83023113|FG000|Overall Study|Failure to return|1|||
47048503|NCT04400890|83308493|FG000|Overall Study|Withdrawal by Subject|3|||
47048504|NCT04400890|83308494|FG001|Overall Study|Withdrawal by Subject|2|||
47048505|NCT01936649|83308500|FG000|Overall Study|Withdrawal by Subject|4|||
46729930|NCT00771667|82946342|FG007|Maintenance Phase|Other|2|||
46729931|NCT00771667|82946343|FG008|Maintenance Phase|Other|3|||
46729932|NCT00771667|82946344|FG009|Maintenance Phase|Other|3|||
46729933|NCT00770965|82946366|FG000|Safety Set|Withdrawal by Subject|0|||
46729934|NCT00770965|82946367|FG001|Safety Set|Withdrawal by Subject|0|||
46729935|NCT00770965|82946368|FG002|Safety Set|Withdrawal by Subject|0|||
46729936|NCT00770965|82946369|FG003|Safety Set|Withdrawal by Subject|1|||
46729937|NCT00770965|82946366|FG000|Safety Set|Protocol deviation|0|||
46729938|NCT00770965|82946367|FG001|Safety Set|Protocol deviation|0|||
46729939|NCT00770965|82946368|FG002|Safety Set|Protocol deviation|1|||
46729940|NCT00770965|82946369|FG003|Safety Set|Protocol deviation|0|||
46729941|NCT00770965|82946366|FG000|Excluded Set|Administrative problems|14|||
46729942|NCT00770965|82946367|FG001|Excluded Set|Administrative problems|12|||
46729943|NCT00770965|82946368|FG002|Excluded Set|Administrative problems|12|||
46729944|NCT00770965|82946369|FG003|Excluded Set|Administrative problems|10|||
46729945|NCT00770965|82946366|FG000|Excluded Set|Withdrawal by Subject|1|||
46729946|NCT00770965|82946367|FG001|Excluded Set|Withdrawal by Subject|1|||
46729947|NCT00770965|82946368|FG002|Excluded Set|Withdrawal by Subject|2|||
46729948|NCT00770965|82946369|FG003|Excluded Set|Withdrawal by Subject|3|||
46729949|NCT00763555|82946381|FG000|Overall Study|Adverse Event|2|||
46729950|NCT00763555|82946382|FG001|Overall Study|Adverse Event|1|||
46729951|NCT00763555|82946381|FG000|Overall Study|Withdrawal by Subject|2|||
46729952|NCT00763555|82946382|FG001|Overall Study|Withdrawal by Subject|6|||
46729953|NCT00763555|82946381|FG000|Overall Study|Lost to Follow-up|0|||
46729954|NCT00763555|82946382|FG001|Overall Study|Lost to Follow-up|3|||
46729955|NCT00763321|82946391|FG000|Open-label Period|Adverse Event|24|||
46729956|NCT00763321|82946392|FG001|Open-label Period|Adverse Event|0|||
46729957|NCT00763321|82946393|FG002|Open-label Period|Adverse Event|0|||
46729958|NCT00763321|82946391|FG000|Open-label Period|Lost to Follow-up|14|||
46729959|NCT00763321|82946392|FG001|Open-label Period|Lost to Follow-up|0|||
46729960|NCT00763321|82946393|FG002|Open-label Period|Lost to Follow-up|0|||
46729961|NCT00763321|82946391|FG000|Open-label Period|Withdrawal by Subject|7|||
46729962|NCT00763321|82946392|FG001|Open-label Period|Withdrawal by Subject|0|||
46729963|NCT00763321|82946393|FG002|Open-label Period|Withdrawal by Subject|0|||
46729964|NCT00763321|82946391|FG000|Open-label Period|Subject noncompliant|7|||
46729965|NCT00763321|82946392|FG001|Open-label Period|Subject noncompliant|0|||
46729966|NCT00763321|82946393|FG002|Open-label Period|Subject noncompliant|0|||
46729967|NCT00763321|82946391|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
46729968|NCT00763321|82946392|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
46729969|NCT00763321|82946393|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
46803828|NCT00077623|83023114|FG001|Overall Study|Failure to return|0|||
46803829|NCT00077623|83023115|FG002|Overall Study|Failure to return|0|||
46803830|NCT00541034|83023123|FG000|Overall Study|Non-Compliance|3|||
46729970|NCT00763321|82946391|FG000|Open-label Period|Lack of Efficacy|2|||
46729971|NCT00763321|82946392|FG001|Open-label Period|Lack of Efficacy|0|||
46803831|NCT00540644|83023129|FG000|Overall Study|Adverse Event|3|||
46803832|NCT00540644|83023130|FG001|Overall Study|Adverse Event|1|||
46729972|NCT00763321|82946393|FG002|Open-label Period|Lack of Efficacy|0|||
46729973|NCT00763321|82946391|FG000|Open-label Period|Other|4|||
46729974|NCT00763321|82946392|FG001|Open-label Period|Other|0|||
46729975|NCT00763321|82946393|FG002|Open-label Period|Other|0|||
46729976|NCT00763321|82946391|FG000|Double-blind Period|Lack of Efficacy|0|||
46729977|NCT00763321|82946392|FG001|Double-blind Period|Lack of Efficacy|9|||
46729978|NCT00763321|82946393|FG002|Double-blind Period|Lack of Efficacy|17|||
46729979|NCT00763321|82946391|FG000|Double-blind Period|Adverse Event|0|||
46729980|NCT00763321|82946392|FG001|Double-blind Period|Adverse Event|4|||
46729981|NCT00763321|82946393|FG002|Double-blind Period|Adverse Event|4|||
46729982|NCT00763321|82946391|FG000|Double-blind Period|Lost to Follow-up|0|||
46729983|NCT00763321|82946392|FG001|Double-blind Period|Lost to Follow-up|4|||
46729984|NCT00763321|82946393|FG002|Double-blind Period|Lost to Follow-up|2|||
46729985|NCT00763321|82946391|FG000|Double-blind Period|Withdrawal by Subject|0|||
46729986|NCT00763321|82946392|FG001|Double-blind Period|Withdrawal by Subject|2|||
46729987|NCT00763321|82946393|FG002|Double-blind Period|Withdrawal by Subject|3|||
46729988|NCT00763321|82946391|FG000|Double-blind Period|Other|0|||
46729989|NCT00763321|82946392|FG001|Double-blind Period|Other|2|||
46729990|NCT00763321|82946393|FG002|Double-blind Period|Other|3|||
46729991|NCT00770653|82946402|FG000|Overall Study|Adverse Event|13|||
46729992|NCT00770653|82946403|FG001|Overall Study|Adverse Event|5|||
46729993|NCT00770653|82946402|FG000|Overall Study|Protocol Violation|8|||
46729994|NCT00770653|82946403|FG001|Overall Study|Protocol Violation|6|||
46729995|NCT00770653|82946402|FG000|Overall Study|Withdrawal by Subject|4|||
46729996|NCT00770653|82946403|FG001|Overall Study|Withdrawal by Subject|7|||
47048506|NCT01936649|83308500|FG000|Overall Study|Physician Decision|2|||
47048507|NCT01936649|83308500|FG000|Overall Study|Protocol Violation|2|||
47048508|NCT01936649|83308500|FG000|Overall Study|Other than specified above|5|||
47048509|NCT01720069|83308507|FG000|Overall Study|Could not use e-diary correctly|0|||
47048510|NCT01720069|83308508|FG001|Overall Study|Could not use e-diary correctly|1|||
47048511|NCT01720069|83308509|FG002|Overall Study|Could not use e-diary correctly|1|||
47048512|NCT01720069|83308507|FG000|Overall Study|Randomised without baseline values|0|||
47048513|NCT01720069|83308508|FG001|Overall Study|Randomised without baseline values|0|||
47048514|NCT01720069|83308509|FG002|Overall Study|Randomised without baseline values|1|||
47048515|NCT01720069|83308507|FG000|Overall Study|Adverse Event|0|||
47048516|NCT01720069|83308508|FG001|Overall Study|Adverse Event|0|||
47048517|NCT01720069|83308509|FG002|Overall Study|Adverse Event|1|||
47048518|NCT01720069|83308507|FG000|Overall Study|Lack of Efficacy|0|||
47048519|NCT01720069|83308508|FG001|Overall Study|Lack of Efficacy|4|||
47048520|NCT01720069|83308509|FG002|Overall Study|Lack of Efficacy|0|||
47048521|NCT01720069|83308507|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
47048522|NCT01720069|83308508|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
47048523|NCT01720069|83308509|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
47048524|NCT01720069|83308507|FG000|Overall Study|Withdrawal by Subject|0|||
47048525|NCT01720069|83308508|FG001|Overall Study|Withdrawal by Subject|2|||
47048526|NCT01720069|83308509|FG002|Overall Study|Withdrawal by Subject|1|||
47048527|NCT01720069|83308507|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
47048528|NCT01720069|83308508|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
47048529|NCT01720069|83308509|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
47048530|NCT01720069|83308507|FG000|Overall Study|Non-compliance on using e-diary|0|||
47048531|NCT01720069|83308508|FG001|Overall Study|Non-compliance on using e-diary|0|||
47048532|NCT01720069|83308509|FG002|Overall Study|Non-compliance on using e-diary|1|||
47048533|NCT01720069|83308507|FG000|Overall Study|Lost to Follow-up|0|||
47048534|NCT01720069|83308508|FG001|Overall Study|Lost to Follow-up|0|||
47048535|NCT01720069|83308509|FG002|Overall Study|Lost to Follow-up|1|||
47048536|NCT01719757|83308555|FG000|Overall Study|Adverse Event|38|||
47048537|NCT01719757|83308555|FG000|Overall Study|Withdrawal by Subject|15|||
47048538|NCT01719757|83308555|FG000|Overall Study|Lost to Follow-up|20|||
47048539|NCT01719757|83308555|FG000|Overall Study|Protocol Violation|1|||
47048540|NCT01719757|83308555|FG000|Overall Study|well controlled pain|27|||
47048541|NCT01718509|83308563|FG000|Overall Study|Lost to Follow-up|18|||
47048542|NCT01718509|83308564|FG001|Overall Study|Lost to Follow-up|15|||
47048543|NCT01718509|83308563|FG000|Overall Study|Withdrawal by Subject|7|||
47048544|NCT01718509|83308564|FG001|Overall Study|Withdrawal by Subject|13|||
47048545|NCT01718509|83308563|FG000|Overall Study|Adverse Event|5|||
47048546|NCT01718509|83308564|FG001|Overall Study|Adverse Event|7|||
47048547|NCT01718509|83308563|FG000|Overall Study|Other|13|||
47048548|NCT01718509|83308564|FG001|Overall Study|Other|11|||
47048549|NCT01718509|83308563|FG000|Overall Study|Protocol Violation|4|||
47048550|NCT01718509|83308564|FG001|Overall Study|Protocol Violation|2|||
47048551|NCT01718509|83308563|FG000|Overall Study|Lack of Efficacy|1|||
47048552|NCT01718509|83308564|FG001|Overall Study|Lack of Efficacy|0|||
46729997|NCT00770653|82946402|FG000|Overall Study|Lack of Compliance|1|||
46729998|NCT00770653|82946403|FG001|Overall Study|Lack of Compliance|4|||
46729999|NCT00770653|82946402|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
46803833|NCT00540644|83023129|FG000|Overall Study|Disease Progression|3|||
47048553|NCT01604941|83308603|FG000|Overall Study|Adverse Event|1|||
47048554|NCT01604941|83308604|FG001|Overall Study|Adverse Event|2|||
47048555|NCT01604941|83308605|FG002|Overall Study|Adverse Event|0|||
47048556|NCT01604941|83308606|FG003|Overall Study|Adverse Event|0|||
47048557|NCT01604941|83308607|FG004|Overall Study|Adverse Event|1|||
47048558|NCT01604941|83308608|FG005|Overall Study|Adverse Event|5|||
47048559|NCT01604941|83308603|FG000|Overall Study|Non-compliance|1|||
47048560|NCT01604941|83308604|FG001|Overall Study|Non-compliance|0|||
47048561|NCT01604941|83308605|FG002|Overall Study|Non-compliance|0|||
47048562|NCT01604941|83308606|FG003|Overall Study|Non-compliance|0|||
47048563|NCT01604941|83308607|FG004|Overall Study|Non-compliance|0|||
47048564|NCT01604941|83308608|FG005|Overall Study|Non-compliance|0|||
47048565|NCT01604941|83308603|FG000|Overall Study|Participant Decision|0|||
47048566|NCT01604941|83308604|FG001|Overall Study|Participant Decision|0|||
47048567|NCT01604941|83308605|FG002|Overall Study|Participant Decision|0|||
46730000|NCT00770653|82946403|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
46730001|NCT00770653|82946402|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
46730002|NCT00770653|82946403|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
46730003|NCT00770653|82946402|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
46730004|NCT00770653|82946403|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
46730005|NCT00770653|82946402|FG000|Overall Study|Lost to Follow-up|1|||
46730006|NCT00770653|82946403|FG001|Overall Study|Lost to Follow-up|2|||
46730007|NCT00770653|82946402|FG000|Overall Study|Physician Decision|1|||
46730008|NCT00770653|82946403|FG001|Overall Study|Physician Decision|0|||
46730009|NCT00819052|82946411|FG000|Overall Study|Adverse Event|0|||
46730010|NCT00819052|82946412|FG001|Overall Study|Adverse Event|5|||
46730011|NCT00819052|82946411|FG000|Overall Study|Protocol Violation|1|||
46730012|NCT00819052|82946412|FG001|Overall Study|Protocol Violation|2|||
46730013|NCT00819052|82946411|FG000|Overall Study|Lost to Follow-up|1|||
46730014|NCT00819052|82946412|FG001|Overall Study|Lost to Follow-up|2|||
46730015|NCT00819052|82946411|FG000|Overall Study|Withdrawal by Subject|1|||
46730016|NCT00819052|82946412|FG001|Overall Study|Withdrawal by Subject|2|||
46730017|NCT00819052|82946411|FG000|Overall Study|Lack of Efficacy|1|||
46730018|NCT00819052|82946412|FG001|Overall Study|Lack of Efficacy|1|||
46635016|NCT01709838|82808445|FG000|Overall Study|Physician Decision|4|||
46730019|NCT00819052|82946411|FG000|Overall Study|Pregnancy|1|||
46730020|NCT00819052|82946412|FG001|Overall Study|Pregnancy|2|||
46730021|NCT00819052|82946411|FG000|Overall Study|Death or events leading to death|1|||
47048568|NCT01604941|83308606|FG003|Overall Study|Participant Decision|0|||
46730022|NCT00819052|82946412|FG001|Overall Study|Death or events leading to death|0|||
46730023|NCT00763009|82946421|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
46730024|NCT00841672|82946428|FG000|Overall Study|Adverse Event|7|||
47048569|NCT01604941|83308607|FG004|Overall Study|Participant Decision|0|||
47048570|NCT01604941|83308608|FG005|Overall Study|Participant Decision|2|||
47048571|NCT01604941|83308603|FG000|Overall Study|Early Study Termination|9|||
47048572|NCT01604941|83308604|FG001|Overall Study|Early Study Termination|2|||
47048573|NCT01604941|83308605|FG002|Overall Study|Early Study Termination|3|||
47048574|NCT01604941|83308606|FG003|Overall Study|Early Study Termination|3|||
47048575|NCT01604941|83308607|FG004|Overall Study|Early Study Termination|0|||
47048576|NCT01604941|83308608|FG005|Overall Study|Early Study Termination|0|||
47048577|NCT01604785|83308616|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
47048578|NCT01604785|83308617|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
47048579|NCT01681849|83308626|FG000|Overall Study|Protocol Violation|2|||
46730025|NCT00841672|82946429|FG001|Overall Study|Adverse Event|16|||
46730026|NCT00841672|82946428|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46730027|NCT00841672|82946429|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46635017|NCT01709838|82808445|FG000|Overall Study|Death|3|||
46635018|NCT01709838|82808445|FG000|Overall Study|Protocol Violation|1|||
46635019|NCT01682226|82808451|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
46635020|NCT01682226|82808451|FG000|Overall Study|Participants did not receive treatment|2|||
46635021|NCT01682226|82808451|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
46635022|NCT04167618|82808457|FG000|Overall Study|Trial terminated by sponsor|1|||
46635023|NCT04167618|82808458|FG001|Overall Study|Trial terminated by sponsor|1|||
46730028|NCT00841672|82946428|FG000|Overall Study|Subject withdrew consent|2|||
46730029|NCT00841672|82946429|FG001|Overall Study|Subject withdrew consent|4|||
46730030|NCT00841672|82946428|FG000|Overall Study|Lost to Follow-up|1|||
46730031|NCT00841672|82946429|FG001|Overall Study|Lost to Follow-up|1|||
47048580|NCT01681849|83308627|FG001|Overall Study|Protocol Violation|0|||
47048581|NCT01681849|83308628|FG002|Overall Study|Protocol Violation|0|||
47048582|NCT01681849|83308626|FG000|Overall Study|Withdrawal by Subject|3|||
47048583|NCT01681849|83308627|FG001|Overall Study|Withdrawal by Subject|5|||
47048584|NCT01681849|83308628|FG002|Overall Study|Withdrawal by Subject|33|||
47048585|NCT01681849|83308626|FG000|Overall Study|Lost to Follow-up|3|||
47048586|NCT01681849|83308627|FG001|Overall Study|Lost to Follow-up|2|||
47048587|NCT01681849|83308628|FG002|Overall Study|Lost to Follow-up|6|||
47048588|NCT01681771|83308637|FG000|Overall Study|Lost to Follow-up|4|||
47048589|NCT01681771|83308638|FG001|Overall Study|Lost to Follow-up|2|||
47048590|NCT04250350|83308644|FG000|Overall Study|Withdrawal by Subject|13|||
47048591|NCT04250350|83308644|FG000|Overall Study|Lost to Follow-up|8|||
47048592|NCT04250350|83308644|FG000|Overall Study|Adverse Event|5|||
47048593|NCT04250350|83308644|FG000|Overall Study|Lack of Efficacy|4|||
47048594|NCT04250350|83308644|FG000|Overall Study|Physician Decision|1|||
47048595|NCT04250350|83308644|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
47048596|NCT01718353|83308675|FG000|Overall Study|Lost to Follow-up|0|||
47048597|NCT01718353|83308676|FG001|Overall Study|Lost to Follow-up|1|||
47048598|NCT01718353|83308675|FG000|Overall Study|Principal Investigator's Decision|10|||
47048599|NCT01718353|83308676|FG001|Overall Study|Principal Investigator's Decision|4|||
47048600|NCT01718353|83308675|FG000|Overall Study|Randomized but not treated|2|||
46635024|NCT01688466|82808466|FG000|Overall Study|Withdrawal by Subject|2|||
46635025|NCT01688466|82808467|FG001|Overall Study|Withdrawal by Subject|1|||
46635026|NCT01688466|82808466|FG000|Overall Study|Death|0|||
46635027|NCT01688466|82808467|FG001|Overall Study|Death|1|||
46635028|NCT01688466|82808466|FG000|Overall Study|Adverse Event|0|||
46635029|NCT01688466|82808467|FG001|Overall Study|Adverse Event|4|||
46635030|NCT01688466|82808466|FG000|Overall Study|Not evaluable|0|||
46635031|NCT01688466|82808467|FG001|Overall Study|Not evaluable|1|||
46635032|NCT01682148|82808475|FG000|Overall Study|Withdrawal by Subject|2|||
46635033|NCT01682148|82808476|FG001|Overall Study|Withdrawal by Subject|0|||
46635034|NCT01682148|82808475|FG000|Overall Study|Lost to Follow-up|1|||
46635035|NCT01682148|82808476|FG001|Overall Study|Lost to Follow-up|2|||
46635036|NCT01682148|82808475|FG000|Overall Study|Protocol Violation|1|||
46635037|NCT01682148|82808476|FG001|Overall Study|Protocol Violation|1|||
46635038|NCT01681992|82808490|FG000|Overall Study|Adverse Event|3|||
46635039|NCT01681992|82808491|FG001|Overall Study|Adverse Event|2|||
46635040|NCT01681992|82808492|FG002|Overall Study|Adverse Event|3|||
46635041|NCT01681992|82808490|FG000|Overall Study|Lost to Follow-up|36|||
46635042|NCT01681992|82808491|FG001|Overall Study|Lost to Follow-up|38|||
46635043|NCT01681992|82808492|FG002|Overall Study|Lost to Follow-up|53|||
46635044|NCT01681992|82808490|FG000|Overall Study|As Per Sponsor Decision|0|||
46635045|NCT01681992|82808491|FG001|Overall Study|As Per Sponsor Decision|0|||
46635046|NCT01681992|82808492|FG002|Overall Study|As Per Sponsor Decision|1|||
46635047|NCT01681992|82808490|FG000|Overall Study|Protocol Violation|0|||
46635048|NCT01681992|82808491|FG001|Overall Study|Protocol Violation|0|||
46635049|NCT01681992|82808492|FG002|Overall Study|Protocol Violation|1|||
46635050|NCT01681992|82808490|FG000|Overall Study|Withdrawal by Subject|27|||
46635051|NCT01681992|82808491|FG001|Overall Study|Withdrawal by Subject|30|||
46635052|NCT01681992|82808492|FG002|Overall Study|Withdrawal by Subject|25|||
46635053|NCT01737840|82808502|FG000|Overall Study|Diagnosed with an other pathology|2|||
46635054|NCT01737840|82808503|FG001|Overall Study|Diagnosed with an other pathology|2|||
46641234|NCT04627038|82825244|FG000|Overall Study|Withdrawal by Subject|13|||
46641235|NCT04627038|82825245|FG001|Overall Study|Withdrawal by Subject|3|||
46641236|NCT04627038|82825244|FG000|Overall Study|Non-compliance with study drug|0|||
46641237|NCT04627038|82825245|FG001|Overall Study|Non-compliance with study drug|1|||
46641238|NCT04627038|82825244|FG000|Overall Study|Prohibited Concomitant Medication|1|||
46641239|NCT04627038|82825245|FG001|Overall Study|Prohibited Concomitant Medication|0|||
46641240|NCT05483686|82825459|FG000|Overall Study|Lost to Follow-up|5|||
46641241|NCT05483686|82825460|FG001|Overall Study|Lost to Follow-up|7|||
46641242|NCT05292755|82825468|FG000|Overall Study|Lost to Follow-up|5|||
46641243|NCT05292755|82825469|FG001|Overall Study|Lost to Follow-up|9|||
46641244|NCT04590781|82825483|FG000|Overall Study|Death|0|||
46641245|NCT04590781|82825484|FG001|Overall Study|Death|2|||
46641246|NCT04590781|82825483|FG000|Overall Study|Withdrawal by Subject|2|||
47048601|NCT01718353|83308676|FG001|Overall Study|Randomized but not treated|0|||
47048602|NCT01716715|83308686|FG000|Overall Study|Never Treated|2|||
47048603|NCT01716715|83308687|FG001|Overall Study|Never Treated|4|||
47048604|NCT01697449|83308695|FG000|Overall Study|Disease progression|47|||
46641247|NCT04590781|82825484|FG001|Overall Study|Withdrawal by Subject|0|||
46641248|NCT04248868|82825491|FG000|Overall Study|Death|1|||
46641249|NCT04248868|82825491|FG000|Overall Study|Lost to Follow-up|3|||
46641250|NCT04248868|82825491|FG000|Overall Study|Protocol Violation|2|||
46641251|NCT04211831|82825498|FG000|Overall Study|Withdrawal by Subject|4|||
46641252|NCT04211831|82825499|FG001|Overall Study|Withdrawal by Subject|1|||
46641253|NCT04211831|82825500|FG002|Overall Study|Withdrawal by Subject|1|||
46641254|NCT04211831|82825498|FG000|Overall Study|Protocol Violation|0|||
46641255|NCT04211831|82825499|FG001|Overall Study|Protocol Violation|0|||
46641256|NCT04211831|82825500|FG002|Overall Study|Protocol Violation|1|||
46641257|NCT04211831|82825498|FG000|Overall Study|Adverse Event|0|||
46641258|NCT04211831|82825499|FG001|Overall Study|Adverse Event|1|||
46641259|NCT04211831|82825500|FG002|Overall Study|Adverse Event|0|||
46730032|NCT00841672|82946428|FG000|Overall Study|Administrative problems|9|||
46730033|NCT00841672|82946429|FG001|Overall Study|Administrative problems|9|||
46730034|NCT00841672|82946428|FG000|Overall Study|Misrandomized|1|||
46730035|NCT00841672|82946429|FG001|Overall Study|Misrandomized|0|||
46730036|NCT00841672|82946428|FG000|Overall Study|Protocol Deviation|0|||
46730037|NCT00841672|82946429|FG001|Overall Study|Protocol Deviation|1|||
46730038|NCT00908232|82946435|FG000|Cycle 1 to 4|Death|5|||
46730039|NCT00908232|82946436|FG001|Cycle 1 to 4|Death|0|||
46730040|NCT00908232|82946437|FG002|Cycle 1 to 4|Death|0|||
46730041|NCT00908232|82946438|FG003|Cycle 1 to 4|Death|0|||
46730042|NCT00908232|82946435|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
46730043|NCT00908232|82946436|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
46730044|NCT00908232|82946437|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
46730045|NCT00908232|82946438|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
46730046|NCT00908232|82946435|FG000|Cycle 1 to 4|Progressive Disease|6|||
46730047|NCT00908232|82946436|FG001|Cycle 1 to 4|Progressive Disease|0|||
46730048|NCT00908232|82946437|FG002|Cycle 1 to 4|Progressive Disease|0|||
46730049|NCT00908232|82946438|FG003|Cycle 1 to 4|Progressive Disease|0|||
46730050|NCT00908232|82946435|FG000|Cycle 1 to 4|Adverse Event|12|||
46730051|NCT00908232|82946436|FG001|Cycle 1 to 4|Adverse Event|0|||
46730052|NCT00908232|82946437|FG002|Cycle 1 to 4|Adverse Event|0|||
46730053|NCT00908232|82946438|FG003|Cycle 1 to 4|Adverse Event|0|||
46730054|NCT00908232|82946435|FG000|Cycle 1 to 4|Other|1|||
46730055|NCT00908232|82946436|FG001|Cycle 1 to 4|Other|0|||
46730056|NCT00908232|82946437|FG002|Cycle 1 to 4|Other|0|||
46730057|NCT00908232|82946438|FG003|Cycle 1 to 4|Other|0|||
46730058|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
46730059|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
46730060|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
46730061|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
46730062|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
46730063|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
46730064|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
46730065|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
46730066|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
46730067|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
46730068|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
46730069|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
46730070|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
46730071|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
46730072|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
46730073|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
46730074|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
46730075|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
46730076|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
46730077|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
46730078|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
46730079|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
46730080|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
46730081|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
46730082|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
46730083|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
46730084|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
46730085|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
46730086|NCT00908232|82946435|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
46730087|NCT00908232|82946436|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
46730088|NCT00908232|82946437|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
46730089|NCT00908232|82946438|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
46730090|NCT00770341|82946447|FG000|Overall Study|Did not meet eligibility criteria|1|||
46730091|NCT00770341|82946448|FG001|Overall Study|Did not meet eligibility criteria|0|||
46730092|NCT00770341|82946449|FG002|Overall Study|Did not meet eligibility criteria|0|||
46730093|NCT00770341|82946447|FG000|Overall Study|Withdrawal by Subject|0|||
46730094|NCT00770341|82946448|FG001|Overall Study|Withdrawal by Subject|1|||
46730095|NCT00770341|82946449|FG002|Overall Study|Withdrawal by Subject|0|||
46730096|NCT00770341|82946447|FG000|Overall Study|Clinical Adverse Event|3|||
46730097|NCT00770341|82946448|FG001|Overall Study|Clinical Adverse Event|1|||
46730098|NCT00770341|82946449|FG002|Overall Study|Clinical Adverse Event|2|||
46730099|NCT00770341|82946447|FG000|Overall Study|Laboratory adverse event|3|||
46730100|NCT00770341|82946448|FG001|Overall Study|Laboratory adverse event|3|||
46730101|NCT00770341|82946449|FG002|Overall Study|Laboratory adverse event|0|||
46730102|NCT00770341|82946447|FG000|Overall Study|Lack of Efficacy|3|||
46730103|NCT00770341|82946448|FG001|Overall Study|Lack of Efficacy|0|||
46730104|NCT00770341|82946449|FG002|Overall Study|Lack of Efficacy|1|||
46730105|NCT00770341|82946447|FG000|Overall Study|Other|1|||
46730106|NCT00770341|82946448|FG001|Overall Study|Other|0|||
46730107|NCT00770341|82946449|FG002|Overall Study|Other|0|||
46730108|NCT00770341|82946447|FG000|Overall Study|Not treated|1|||
46730109|NCT00770341|82946448|FG001|Overall Study|Not treated|0|||
46921396|NCT02924883|83153870|FG001|Overall Study|Lost to Follow-up|0|||
46921397|NCT02924883|83153869|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
46921398|NCT02924883|83153870|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
47048605|NCT01697449|83308695|FG000|Overall Study|Adverse Event|7|||
46730110|NCT00770341|82946449|FG002|Overall Study|Not treated|0|||
46730111|NCT00762463|82946466|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
46730112|NCT00762463|82946467|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
46730113|NCT00762463|82946468|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
46730114|NCT00762463|82946469|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
46730115|NCT00762463|82946466|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
46730116|NCT00762463|82946467|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
46730117|NCT00762463|82946468|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
46730118|NCT00762463|82946469|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
46730119|NCT00762463|82946466|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
47048606|NCT01697449|83308695|FG000|Overall Study|Lost to Follow-up|5|||
47048607|NCT01697449|83308695|FG000|Overall Study|Withdrawal by Subject|2|||
47048608|NCT01697449|83308695|FG000|Overall Study|Physician Decision|1|||
47048609|NCT01697449|83308695|FG000|Overall Study|Death|2|||
47048610|NCT01697449|83308695|FG000|Overall Study|Other|1|||
47048611|NCT01697449|83308695|FG000|Overall Study|Missing|25|||
47048612|NCT01696279|83308702|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
47048613|NCT01696279|83308703|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
47048614|NCT01696279|83308704|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
47048615|NCT01696279|83308705|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
47048616|NCT01696279|83308702|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
46730120|NCT00762463|82946467|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
46730121|NCT00762463|82946468|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
46730122|NCT00762463|82946469|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
46730123|NCT00762463|82946466|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
46730124|NCT00762463|82946467|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
46730125|NCT00762463|82946468|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
46730126|NCT00762463|82946469|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
46730127|NCT00762463|82946466|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
46730128|NCT00762463|82946467|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
46730129|NCT00762463|82946468|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
46730130|NCT00762463|82946469|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
46730131|NCT00762463|82946466|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
46730132|NCT00762463|82946467|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
46730133|NCT00762463|82946468|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
46730134|NCT00762463|82946469|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
46730135|NCT00762463|82946466|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
46730136|NCT00762463|82946467|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
46730137|NCT00762463|82946468|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
46730138|NCT00762463|82946469|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
46730139|NCT00762463|82946466|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
46730140|NCT00762463|82946467|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
46730141|NCT00762463|82946468|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
46921399|NCT02924883|83153869|FG000|Overall Study|Protocol Violation|1|||
46921400|NCT02924883|83153870|FG001|Overall Study|Protocol Violation|0|||
46921401|NCT02924883|83153869|FG000|Overall Study|Withdrawal by Subject|22|||
46921402|NCT02924883|83153870|FG001|Overall Study|Withdrawal by Subject|16|||
46921403|NCT02924883|83153869|FG000|Overall Study|Progressive Disease|1|||
46921404|NCT02924883|83153870|FG001|Overall Study|Progressive Disease|0|||
46635055|NCT01687998|82808513|FG000|Overall Study|Withdrawal by Subject|49|||
46635056|NCT01687998|82808514|FG001|Overall Study|Withdrawal by Subject|51|||
46635057|NCT01687998|82808513|FG000|Overall Study|Known to be Alive at Study End|54|||
46635058|NCT01687998|82808514|FG001|Overall Study|Known to be Alive at Study End|62|||
46635059|NCT01687998|82808513|FG000|Overall Study|Lost to Follow-up|9|||
46635060|NCT01687998|82808514|FG001|Overall Study|Lost to Follow-up|7|||
46635061|NCT01681836|82808520|FG000|Second Intervention|Withdrawal by Subject|0|||
46635062|NCT01681836|82808521|FG001|Second Intervention|Withdrawal by Subject|1|||
46635063|NCT01681368|82808527|FG000|Overall Study|Refused further treatment|1|||
46635064|NCT01681368|82808527|FG000|Overall Study|Refused further follow up|1|||
46730142|NCT00762463|82946469|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
46730143|NCT00762385|82946482|FG000|First Intervention|Lens Issue|1|||
46730144|NCT00762385|82946483|FG001|First Intervention|Lens Issue|1|||
46730145|NCT00762385|82946482|FG000|First Intervention|Lost to Follow-up|0|||
46730146|NCT00762385|82946483|FG001|First Intervention|Lost to Follow-up|2|||
46730147|NCT00762385|82946482|FG000|First Intervention|Ineligible|1|||
46730148|NCT00762385|82946483|FG001|First Intervention|Ineligible|0|||
46730149|NCT00762385|82946482|FG000|First Intervention|Protocol Violation|0|||
46730150|NCT00762385|82946483|FG001|First Intervention|Protocol Violation|1|||
46730151|NCT00762385|82946482|FG000|Second Intervention|Protocol Violation|3|||
46730152|NCT00762385|82946483|FG001|Second Intervention|Protocol Violation|3|||
46730153|NCT00906282|82946492|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
46730154|NCT00906282|82946492|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
46921405|NCT02924883|83153869|FG000|Overall Study|Study Terminated by Sponsor|69|||
46730155|NCT00906282|82946492|FG000|Preoperative Chemotherapy|Progressive disease|6|||
46730156|NCT00906282|82946492|FG000|Preoperative Chemotherapy|Toxicity|1|||
46921406|NCT02924883|83153870|FG001|Overall Study|Study Terminated by Sponsor|32|||
46921407|NCT01369680|83153893|FG000|Overall Study|Lost to Follow-up|0|||
46921408|NCT01369680|83153894|FG001|Overall Study|Lost to Follow-up|0|||
46921409|NCT01369680|83153895|FG002|Overall Study|Lost to Follow-up|1|||
46921410|NCT01369680|83153896|FG003|Overall Study|Lost to Follow-up|2|||
46635065|NCT01681212|82808531|FG000|Overall Study|No longer met study criteria|5|||
46635066|NCT01681212|82808531|FG000|Overall Study|Administrative reason by sponsor|1|||
46635067|NCT01687296|82808537|FG000|Overall Study|Lack of Efficacy|1|||
46635068|NCT01687296|82808538|FG001|Overall Study|Lack of Efficacy|1|||
46635069|NCT01687296|82808537|FG000|Overall Study|Protocol Violation|0|||
46635070|NCT01687296|82808538|FG001|Overall Study|Protocol Violation|1|||
46635071|NCT01687296|82808537|FG000|Overall Study|Withdrawal by Subject|6|||
46635072|NCT01687296|82808538|FG001|Overall Study|Withdrawal by Subject|3|||
46635073|NCT01568892|82808559|FG000|Open-label Phase|Adverse Event|2|||
46635074|NCT01568892|82808560|FG001|Open-label Phase|Adverse Event|0|||
46635075|NCT01568892|82808559|FG000|Open-label Phase|Lack of Efficacy|4|||
46635076|NCT01568892|82808560|FG001|Open-label Phase|Lack of Efficacy|2|||
46635077|NCT01568892|82808559|FG000|Open-label Phase|Lost to Follow-up|0|||
46921411|NCT03074149|83153928|FG000|Overall Study|Reason unknown|22|||
46921412|NCT03074149|83153929|FG001|Overall Study|Reason unknown|35|||
46921413|NCT03074149|83153928|FG000|Overall Study|Death|10|||
47048617|NCT01696279|83308703|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
47048618|NCT01696279|83308704|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
47048619|NCT01696279|83308705|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
47048620|NCT01696279|83308702|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
47048621|NCT01696279|83308703|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
47048622|NCT01696279|83308704|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
47048623|NCT01696279|83308705|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
47048624|NCT01696279|83308702|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
47048625|NCT01696279|83308703|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
47048626|NCT01696279|83308704|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
47048627|NCT01696279|83308705|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
47048628|NCT01696279|83308702|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
47048629|NCT01696279|83308703|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
47048630|NCT01696279|83308704|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
47048631|NCT01696279|83308705|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
47048632|NCT01696279|83308702|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
47048633|NCT01696279|83308703|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
47048634|NCT01696279|83308704|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
47048635|NCT01696279|83308705|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
47048636|NCT01696279|83308702|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
47048637|NCT01696279|83308703|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
47048638|NCT01696279|83308704|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
47048639|NCT01696279|83308705|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
47048640|NCT01696279|83308702|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
47048641|NCT01696279|83308703|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
46635078|NCT01568892|82808560|FG001|Open-label Phase|Lost to Follow-up|1|||
46635079|NCT01568112|82808571|FG000|Overall Study|Randomized But Not Treated|0|||
46730157|NCT00762229|82946499|FG000|Overall Study|Lost to Follow-up|1|||
46730158|NCT00762229|82946500|FG001|Overall Study|Lost to Follow-up|1|||
46730159|NCT00762229|82946499|FG000|Overall Study|did not recveive intervention|0|||
46803834|NCT00540644|83023130|FG001|Overall Study|Disease Progression|1|||
47048642|NCT01696279|83308704|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
46635080|NCT01568112|82808572|FG001|Overall Study|Randomized But Not Treated|1|||
46775705|NCT00689871|82994181|FG002|Overall Study|Lost to Follow-up|37|||
46730160|NCT00762229|82946500|FG001|Overall Study|did not recveive intervention|1|||
46730161|NCT00907374|82946508|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
46730162|NCT00907374|82946509|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
46730163|NCT00818662|82946519|FG000|Overall Study|Adverse Event|5|||
46730164|NCT00818662|82946520|FG001|Overall Study|Adverse Event|14|||
46730165|NCT00818662|82946521|FG002|Overall Study|Adverse Event|4|||
46730166|NCT00818662|82946522|FG003|Overall Study|Adverse Event|3|||
46730167|NCT00818662|82946519|FG000|Overall Study|Withdrawal by Subject|5|||
46730168|NCT00818662|82946520|FG001|Overall Study|Withdrawal by Subject|4|||
46730169|NCT00818662|82946521|FG002|Overall Study|Withdrawal by Subject|2|||
46730170|NCT00818662|82946522|FG003|Overall Study|Withdrawal by Subject|2|||
46730171|NCT00818662|82946519|FG000|Overall Study|Death|1|||
46730172|NCT00818662|82946520|FG001|Overall Study|Death|3|||
46730173|NCT00818662|82946521|FG002|Overall Study|Death|0|||
46730174|NCT00818662|82946522|FG003|Overall Study|Death|0|||
46730175|NCT00818662|82946519|FG000|Overall Study|Physician Decision|1|||
46730176|NCT00818662|82946520|FG001|Overall Study|Physician Decision|0|||
47048643|NCT01696279|83308705|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
46730177|NCT00818662|82946521|FG002|Overall Study|Physician Decision|0|||
46730178|NCT00818662|82946522|FG003|Overall Study|Physician Decision|0|||
46730179|NCT00818662|82946519|FG000|Overall Study|Lost to Follow-up|0|||
46730180|NCT00818662|82946520|FG001|Overall Study|Lost to Follow-up|0|||
46730181|NCT00818662|82946521|FG002|Overall Study|Lost to Follow-up|0|||
46730182|NCT00818662|82946522|FG003|Overall Study|Lost to Follow-up|1|||
46730183|NCT00818662|82946519|FG000|Overall Study|Unwilling or Unable to Participate|4|||
46730184|NCT00818662|82946520|FG001|Overall Study|Unwilling or Unable to Participate|6|||
46730185|NCT00818662|82946521|FG002|Overall Study|Unwilling or Unable to Participate|2|||
46730186|NCT00818662|82946522|FG003|Overall Study|Unwilling or Unable to Participate|4|||
46730187|NCT00818662|82946519|FG000|Overall Study|Protocol Violation|1|||
46730188|NCT00818662|82946520|FG001|Overall Study|Protocol Violation|1|||
46730189|NCT00818662|82946521|FG002|Overall Study|Protocol Violation|0|||
46730190|NCT00818662|82946522|FG003|Overall Study|Protocol Violation|0|||
46730191|NCT00818662|82946519|FG000|Overall Study|Requires a Prohibited Medication|1|||
46730192|NCT00818662|82946520|FG001|Overall Study|Requires a Prohibited Medication|0|||
46730193|NCT00818662|82946521|FG002|Overall Study|Requires a Prohibited Medication|0|||
46730194|NCT00818662|82946522|FG003|Overall Study|Requires a Prohibited Medication|0|||
46730195|NCT00818662|82946519|FG000|Overall Study|Safety Risk|1|||
46730196|NCT00818662|82946520|FG001|Overall Study|Safety Risk|1|||
46730197|NCT00818662|82946521|FG002|Overall Study|Safety Risk|0|||
46730198|NCT00818662|82946522|FG003|Overall Study|Safety Risk|1|||
46730199|NCT00818662|82946519|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
46730200|NCT00818662|82946520|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
46730201|NCT00818662|82946521|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
46730202|NCT00818662|82946522|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
47048644|NCT01696279|83308702|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
47048645|NCT01696279|83308703|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
47048646|NCT01696279|83308704|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
47048647|NCT01696279|83308705|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
47048648|NCT01696279|83308702|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
47048649|NCT01696279|83308703|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
47048650|NCT01696279|83308704|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
47048651|NCT01696279|83308705|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
47048652|NCT01696279|83308702|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
47048653|NCT01696279|83308703|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
47048654|NCT01696279|83308704|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
47048655|NCT01696279|83308705|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
47048656|NCT01681069|83308716|FG000|Overall Study|Withdrawal by Subject|4|||
46730203|NCT00818662|82946519|FG000|Overall Study|Participant's health declined|0|||
46730204|NCT00818662|82946520|FG001|Overall Study|Participant's health declined|0|||
46730205|NCT00818662|82946521|FG002|Overall Study|Participant's health declined|0|||
46730206|NCT00818662|82946522|FG003|Overall Study|Participant's health declined|1|||
46730207|NCT00818662|82946519|FG000|Overall Study|Caregiver to pursue other treatment|0|||
46730208|NCT00818662|82946520|FG001|Overall Study|Caregiver to pursue other treatment|1|||
46730209|NCT00818662|82946521|FG002|Overall Study|Caregiver to pursue other treatment|0|||
46730210|NCT00818662|82946522|FG003|Overall Study|Caregiver to pursue other treatment|0|||
46730211|NCT00818662|82946519|FG000|Overall Study|Moving out of state|0|||
46730212|NCT00818662|82946520|FG001|Overall Study|Moving out of state|0|||
46730213|NCT00818662|82946521|FG002|Overall Study|Moving out of state|0|||
46730214|NCT00818662|82946522|FG003|Overall Study|Moving out of state|1|||
46730215|NCT00818662|82946519|FG000|Overall Study|Declined move to another study site|1|||
46730216|NCT00818662|82946520|FG001|Overall Study|Declined move to another study site|0|||
46730217|NCT00818662|82946521|FG002|Overall Study|Declined move to another study site|0|||
47048657|NCT01681069|83308717|FG001|Overall Study|Withdrawal by Subject|5|||
47048658|NCT01681069|83308716|FG000|Overall Study|Protocol Violation|1|||
47048659|NCT01681069|83308717|FG001|Overall Study|Protocol Violation|1|||
46730218|NCT00818662|82946522|FG003|Overall Study|Declined move to another study site|0|||
46730219|NCT00818662|82946519|FG000|Overall Study|Change in living situation|0|||
46730220|NCT00818662|82946520|FG001|Overall Study|Change in living situation|0|||
46730221|NCT00818662|82946521|FG002|Overall Study|Change in living situation|0|||
46730222|NCT00818662|82946522|FG003|Overall Study|Change in living situation|1|||
46730223|NCT00818662|82946519|FG000|Overall Study|Study partner decision|0|||
46730224|NCT00818662|82946520|FG001|Overall Study|Study partner decision|0|||
46730225|NCT00818662|82946521|FG002|Overall Study|Study partner decision|0|||
46730226|NCT00818662|82946522|FG003|Overall Study|Study partner decision|1|||
47048660|NCT01681069|83308716|FG000|Overall Study|Adverse Event|0|||
47048661|NCT01681069|83308717|FG001|Overall Study|Adverse Event|1|||
46730227|NCT00818662|82946519|FG000|Overall Study|Admitted to long term nursing care|0|||
46730228|NCT00818662|82946520|FG001|Overall Study|Admitted to long term nursing care|1|||
46730229|NCT00818662|82946521|FG002|Overall Study|Admitted to long term nursing care|0|||
46730230|NCT00818662|82946522|FG003|Overall Study|Admitted to long term nursing care|0|||
46730231|NCT00903786|82946533|FG000|Overall Study|Physician Decision|6|||
46730232|NCT00903786|82946533|FG000|Overall Study|Lack of Efficacy|5|||
46730233|NCT00903786|82946533|FG000|Overall Study|Reason other than lack of efficacy|4|||
46730234|NCT00762073|82946542|FG000|Overall Study|Lack of Efficacy|1|||
46730235|NCT00762073|82946543|FG001|Overall Study|Lack of Efficacy|1|||
46730236|NCT00762073|82946544|FG002|Overall Study|Lack of Efficacy|0|||
47048662|NCT01716559|83308723|FG000|Overall Study|Adverse Event|11|||
47048663|NCT01716559|83308723|FG000|Overall Study|Death|21|||
47048664|NCT01716559|83308723|FG000|Overall Study|Withdrawal by Subject|4|||
47048665|NCT01716559|83308723|FG000|Overall Study|Other withdrawal reason|75|||
47048666|NCT01936181|83308729|FG000|Randomised, Double-blind|Adverse Event|27|||
47048667|NCT01936181|83308730|FG001|Randomised, Double-blind|Adverse Event|21|||
47048668|NCT01936181|83308731|FG002|Randomised, Double-blind|Adverse Event|0|||
47048669|NCT01936181|83308732|FG003|Randomised, Double-blind|Adverse Event|0|||
47048670|NCT01936181|83308729|FG000|Randomised, Double-blind|Protocol Violation|1|||
47048671|NCT01936181|83308730|FG001|Randomised, Double-blind|Protocol Violation|5|||
47048672|NCT01936181|83308731|FG002|Randomised, Double-blind|Protocol Violation|0|||
47048673|NCT01936181|83308732|FG003|Randomised, Double-blind|Protocol Violation|0|||
46730237|NCT00762073|82946545|FG003|Overall Study|Lack of Efficacy|0|||
46730238|NCT00762073|82946542|FG000|Overall Study|Adverse Event|1|||
46730239|NCT00762073|82946543|FG001|Overall Study|Adverse Event|0|||
46730240|NCT00762073|82946544|FG002|Overall Study|Adverse Event|1|||
46730241|NCT00762073|82946545|FG003|Overall Study|Adverse Event|1|||
46730242|NCT00762073|82946542|FG000|Overall Study|Significant Subject Noncompliance|0|||
46730243|NCT00762073|82946543|FG001|Overall Study|Significant Subject Noncompliance|1|||
46730244|NCT00762073|82946544|FG002|Overall Study|Significant Subject Noncompliance|0|||
46730245|NCT00762073|82946545|FG003|Overall Study|Significant Subject Noncompliance|1|||
46730246|NCT00762073|82946542|FG000|Overall Study|Withdrawal by Subject|1|||
46730247|NCT00762073|82946543|FG001|Overall Study|Withdrawal by Subject|2|||
46730248|NCT00762073|82946544|FG002|Overall Study|Withdrawal by Subject|1|||
46730249|NCT00762073|82946545|FG003|Overall Study|Withdrawal by Subject|1|||
46730250|NCT00762073|82946542|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
46730251|NCT00762073|82946543|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
46730252|NCT00762073|82946544|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
47048674|NCT01936181|83308729|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
47048675|NCT01936181|83308730|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
47048676|NCT01936181|83308731|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
47048677|NCT01936181|83308732|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
47048678|NCT01936181|83308729|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
46635081|NCT01568112|82808573|FG002|Overall Study|Randomized But Not Treated|0|||
46635082|NCT01568112|82808574|FG003|Overall Study|Randomized But Not Treated|0|||
46635083|NCT01568112|82808571|FG000|Overall Study|Withdrew due to Adverse Event|2|||
46635084|NCT01568112|82808572|FG001|Overall Study|Withdrew due to Adverse Event|4|||
46635085|NCT01568112|82808573|FG002|Overall Study|Withdrew due to Adverse Event|6|||
46635086|NCT01568112|82808574|FG003|Overall Study|Withdrew due to Adverse Event|3|||
47048679|NCT01936181|83308730|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
47048680|NCT01936181|83308731|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
47048681|NCT01936181|83308732|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
47048682|NCT01936181|83308729|FG000|Randomised, Double-blind|Pregnancy|0|||
47048683|NCT01936181|83308730|FG001|Randomised, Double-blind|Pregnancy|1|||
46635087|NCT01568112|82808571|FG000|Overall Study|Lost to Follow-up|0|||
46635088|NCT01568112|82808572|FG001|Overall Study|Lost to Follow-up|0|||
46635089|NCT01568112|82808573|FG002|Overall Study|Lost to Follow-up|0|||
46635090|NCT01568112|82808574|FG003|Overall Study|Lost to Follow-up|1|||
46635091|NCT01568112|82808571|FG000|Overall Study|Withdrawal by Subject|2|||
46635092|NCT01568112|82808572|FG001|Overall Study|Withdrawal by Subject|3|||
46635093|NCT01568112|82808573|FG002|Overall Study|Withdrawal by Subject|0|||
47048684|NCT01936181|83308731|FG002|Randomised, Double-blind|Pregnancy|0|||
47048685|NCT01936181|83308732|FG003|Randomised, Double-blind|Pregnancy|0|||
47048686|NCT01936181|83308729|FG000|Randomised, Double-blind|Physician Decision|4|||
47048687|NCT01936181|83308730|FG001|Randomised, Double-blind|Physician Decision|4|||
47048688|NCT01936181|83308731|FG002|Randomised, Double-blind|Physician Decision|0|||
47048689|NCT01936181|83308732|FG003|Randomised, Double-blind|Physician Decision|0|||
46730253|NCT00762073|82946545|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
46775706|NCT00689871|82994182|FG003|Overall Study|Lost to Follow-up|1|||
46775707|NCT00689871|82994179|FG000|Overall Study|Explanted of All Study Devices|36|||
46775708|NCT00689871|82994180|FG001|Overall Study|Explanted of All Study Devices|25|||
46775709|NCT00689871|82994181|FG002|Overall Study|Explanted of All Study Devices|29|||
46775710|NCT00689871|82994182|FG003|Overall Study|Explanted of All Study Devices|3|||
46775711|NCT00689871|82994179|FG000|Overall Study|Withdrawal by Subject|13|||
46775712|NCT00689871|82994180|FG001|Overall Study|Withdrawal by Subject|3|||
46775713|NCT00689871|82994181|FG002|Overall Study|Withdrawal by Subject|4|||
46775714|NCT00689871|82994182|FG003|Overall Study|Withdrawal by Subject|1|||
46775715|NCT00689871|82994179|FG000|Overall Study|Death|1|||
46775716|NCT00689871|82994180|FG001|Overall Study|Death|10|||
46775717|NCT00689871|82994181|FG002|Overall Study|Death|2|||
46775718|NCT00689871|82994182|FG003|Overall Study|Death|2|||
46775719|NCT00689871|82994179|FG000|Overall Study|Physician Decision|2|||
46775720|NCT00689871|82994180|FG001|Overall Study|Physician Decision|1|||
47048690|NCT01936181|83308729|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
47048691|NCT01936181|83308730|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
47048692|NCT01936181|83308731|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
47048693|NCT01936181|83308732|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
47048694|NCT01936181|83308729|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
47048695|NCT01936181|83308730|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
47048696|NCT01936181|83308731|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
47048697|NCT01936181|83308732|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
47048698|NCT01936181|83308729|FG000|Transition-extension|Adverse Event|3|||
47048699|NCT01936181|83308730|FG001|Transition-extension|Adverse Event|0|||
47048700|NCT01936181|83308731|FG002|Transition-extension|Adverse Event|3|||
47048701|NCT01936181|83308732|FG003|Transition-extension|Adverse Event|1|||
47048702|NCT01936181|83308729|FG000|Transition-extension|Lost to Follow-up|3|||
47048703|NCT01936181|83308730|FG001|Transition-extension|Lost to Follow-up|0|||
47048704|NCT01936181|83308731|FG002|Transition-extension|Lost to Follow-up|1|||
47048705|NCT01936181|83308732|FG003|Transition-extension|Lost to Follow-up|2|||
47048706|NCT01936181|83308729|FG000|Transition-extension|Physician Decision|2|||
47048707|NCT01936181|83308730|FG001|Transition-extension|Physician Decision|0|||
47048708|NCT01936181|83308731|FG002|Transition-extension|Physician Decision|0|||
47048709|NCT01936181|83308732|FG003|Transition-extension|Physician Decision|1|||
47048710|NCT01936181|83308729|FG000|Transition-extension|Withdrawal by Subject|7|||
47048711|NCT01936181|83308730|FG001|Transition-extension|Withdrawal by Subject|0|||
47048712|NCT01936181|83308731|FG002|Transition-extension|Withdrawal by Subject|2|||
47048713|NCT01936181|83308732|FG003|Transition-extension|Withdrawal by Subject|1|||
47048714|NCT01696045|83308745|FG000|Overall Study|Study drug toxicity|1|||
47048715|NCT01696045|83308746|FG001|Overall Study|Study drug toxicity|5|||
47048716|NCT01696045|83308745|FG000|Overall Study|Disease progression|2|||
47048717|NCT01696045|83308746|FG001|Overall Study|Disease progression|2|||
47048718|NCT01716169|83308752|FG000|Overall Study|Adverse Event|1|||
47048719|NCT01716169|83308752|FG000|Overall Study|Lost to Follow-up|1|||
47048720|NCT01716169|83308752|FG000|Overall Study|Withdrawal by Subject|1|||
47048721|NCT01716169|83308752|FG000|Overall Study|inconsistent dressing application|1|||
47048722|NCT01935947|83308761|FG000|Overall Study|Adverse Event|0|||
47048723|NCT01935947|83308762|FG001|Overall Study|Adverse Event|2|||
47048724|NCT01935947|83308763|FG002|Overall Study|Adverse Event|0|||
47048725|NCT01935947|83308761|FG000|Overall Study|Diease Progression|2|||
47048726|NCT01935947|83308762|FG001|Overall Study|Diease Progression|2|||
47048727|NCT01935947|83308763|FG002|Overall Study|Diease Progression|2|||
47048728|NCT01935947|83308761|FG000|Overall Study|Death|1|||
47048729|NCT01935947|83308762|FG001|Overall Study|Death|0|||
46775721|NCT00689871|82994181|FG002|Overall Study|Physician Decision|1|||
47048730|NCT01935947|83308763|FG002|Overall Study|Death|0|||
47048731|NCT01618019|83308776|FG000|Overall Study|Withdrawal by Subject|14|||
47048732|NCT01618019|83308777|FG001|Overall Study|Withdrawal by Subject|14|||
47048733|NCT01593787|83308786|FG000|Overall Study|Adverse Event|1|||
46775722|NCT00689871|82994182|FG003|Overall Study|Physician Decision|0|||
46775723|NCT00793793|82994204|FG000|Overall Study|Adverse Event|0|||
46775724|NCT00793793|82994205|FG001|Overall Study|Adverse Event|0|||
47048734|NCT01593787|83308787|FG001|Overall Study|Adverse Event|0|||
47048735|NCT01593787|83308788|FG002|Overall Study|Adverse Event|0|||
47048736|NCT01951157|83308801|FG000|Overall Study|Progressive Disease|12|||
47048737|NCT01951157|83308802|FG001|Overall Study|Progressive Disease|13|||
47048738|NCT01951157|83308803|FG002|Overall Study|Progressive Disease|10|||
46775725|NCT00793793|82994206|FG002|Overall Study|Adverse Event|1|||
46730254|NCT00761761|82946564|FG000|Overall Study|Lost to Follow-up|3|||
46730255|NCT00761761|82946565|FG001|Overall Study|Lost to Follow-up|1|||
46730256|NCT00761761|82946564|FG000|Overall Study|Withdrawal by Subject|3|||
47048739|NCT01951157|83308801|FG000|Overall Study|Treatment-unrelated AE|1|||
47048740|NCT01951157|83308802|FG001|Overall Study|Treatment-unrelated AE|0|||
47048741|NCT01951157|83308803|FG002|Overall Study|Treatment-unrelated AE|3|||
47048742|NCT01951157|83308801|FG000|Overall Study|Study Termination|0|||
46730257|NCT00761761|82946565|FG001|Overall Study|Withdrawal by Subject|0|||
46730258|NCT00761605|82946573|FG000|Overall Study|Adverse Event|26|||
46730259|NCT00761605|82946573|FG000|Overall Study|Death|2|||
46730260|NCT00761605|82946573|FG000|Overall Study|Lack of Efficacy|26|||
46730261|NCT00761605|82946573|FG000|Overall Study|Lost to Follow-up|29|||
46730262|NCT00761605|82946573|FG000|Overall Study|Withdrawal by Subject|37|||
46730263|NCT00761605|82946573|FG000|Overall Study|Other|21|||
46730264|NCT00761527|82946581|FG000|Overall Study|Adverse Event|3|||
46730265|NCT00761527|82946581|FG000|Overall Study|Poor Compliance|8|||
46730266|NCT00761527|82946581|FG000|Overall Study|Lost to Follow-up|9|||
46730267|NCT00761527|82946581|FG000|Overall Study|Unknown reason|2|||
46730268|NCT00770029|82946587|FG000|Overall Study|Lost to Follow-up|2|||
46730269|NCT00770029|82946588|FG001|Overall Study|Lost to Follow-up|0|||
46730270|NCT00770029|82946587|FG000|Overall Study|Withdrawal by Subject|3|||
46730271|NCT00770029|82946588|FG001|Overall Study|Withdrawal by Subject|3|||
46730272|NCT00770029|82946587|FG000|Overall Study|Adverse Event|1|||
46730273|NCT00770029|82946588|FG001|Overall Study|Adverse Event|0|||
46730274|NCT00817414|82946599|FG000|Overall Study|Adverse Event|1|||
46730275|NCT00817414|82946600|FG001|Overall Study|Adverse Event|1|||
47048743|NCT01951157|83308802|FG001|Overall Study|Study Termination|0|||
47048744|NCT01951157|83308803|FG002|Overall Study|Study Termination|1|||
47048745|NCT01951157|83308801|FG000|Overall Study|Physician Decision|5|||
47048746|NCT01951157|83308802|FG001|Overall Study|Physician Decision|3|||
47048747|NCT01951157|83308803|FG002|Overall Study|Physician Decision|2|||
47048748|NCT01951157|83308801|FG000|Overall Study|Non-treatmentrelated death|2|||
47048749|NCT01951157|83308802|FG001|Overall Study|Non-treatmentrelated death|2|||
47048750|NCT01951157|83308803|FG002|Overall Study|Non-treatmentrelated death|2|||
47048751|NCT01951157|83308801|FG000|Overall Study|No treated|0|||
47048752|NCT01951157|83308802|FG001|Overall Study|No treated|1|||
47048753|NCT01951157|83308803|FG002|Overall Study|No treated|0|||
47048754|NCT01951157|83308801|FG000|Overall Study|Treatment-related AE|2|||
47048755|NCT01951157|83308802|FG001|Overall Study|Treatment-related AE|0|||
47048756|NCT01951157|83308803|FG002|Overall Study|Treatment-related AE|4|||
47048757|NCT01951157|83308801|FG000|Overall Study|Consent withdrawn by subject|0|||
47048758|NCT01951157|83308802|FG001|Overall Study|Consent withdrawn by subject|1|||
47048759|NCT01951157|83308803|FG002|Overall Study|Consent withdrawn by subject|3|||
47048760|NCT01951157|83308801|FG000|Overall Study|Treatment-related death|0|||
47048761|NCT01951157|83308802|FG001|Overall Study|Treatment-related death|2|||
47048762|NCT01951157|83308803|FG002|Overall Study|Treatment-related death|0|||
47048763|NCT01363349|83308814|FG000|Overall Study|Adverse Event|6|||
47048764|NCT01363349|83308815|FG001|Overall Study|Adverse Event|7|||
47048765|NCT01363349|83308814|FG000|Overall Study|Lack of Efficacy|3|||
47048766|NCT01363349|83308815|FG001|Overall Study|Lack of Efficacy|10|||
47048767|NCT01363349|83308814|FG000|Overall Study|Non compliance/Protocol deviations|2|||
47048768|NCT01363349|83308815|FG001|Overall Study|Non compliance/Protocol deviations|2|||
47048769|NCT01363349|83308814|FG000|Overall Study|Withdrawal by Subject|14|||
47048770|NCT01363349|83308815|FG001|Overall Study|Withdrawal by Subject|6|||
47048771|NCT01363349|83308814|FG000|Overall Study|Lost to Follow-up|5|||
47048772|NCT01363349|83308815|FG001|Overall Study|Lost to Follow-up|6|||
47048773|NCT01363349|83308814|FG000|Overall Study|Not reported|36|||
47048774|NCT01363349|83308815|FG001|Overall Study|Not reported|37|||
47048775|NCT01363349|83308814|FG000|Overall Study|missing|1|||
47048776|NCT01363349|83308815|FG001|Overall Study|missing|2|||
47048777|NCT01933919|83308906|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
47048778|NCT01933919|83308907|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
46730276|NCT00817414|82946601|FG002|Overall Study|Adverse Event|1|||
46730277|NCT00817414|82946602|FG003|Overall Study|Adverse Event|0|||
47048779|NCT01933919|83308906|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
46730278|NCT00817414|82946603|FG004|Overall Study|Adverse Event|0|||
46730279|NCT00817414|82946599|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
47048780|NCT01933919|83308907|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
47048781|NCT01933919|83308906|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
47048782|NCT01933919|83308907|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
47048783|NCT01933919|83308906|FG000|Open-label Long-term Phase|Adverse Event|2|||
46730280|NCT00817414|82946600|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
47048784|NCT01933919|83308907|FG001|Open-label Long-term Phase|Adverse Event|0|||
47048785|NCT01933919|83308906|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
46730281|NCT00817414|82946601|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
46775726|NCT00793793|82994207|FG003|Overall Study|Adverse Event|1|||
46730282|NCT00817414|82946602|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
46730283|NCT00817414|82946603|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
46730284|NCT00817414|82946599|FG000|Overall Study|Withdrawal by Subject|1|||
46730285|NCT00817414|82946600|FG001|Overall Study|Withdrawal by Subject|1|||
46730286|NCT00817414|82946601|FG002|Overall Study|Withdrawal by Subject|0|||
46730287|NCT00817414|82946602|FG003|Overall Study|Withdrawal by Subject|0|||
46730288|NCT00817414|82946603|FG004|Overall Study|Withdrawal by Subject|0|||
46730289|NCT00817414|82946599|FG000|Overall Study|Lost to Follow-up|0|||
46730290|NCT00817414|82946600|FG001|Overall Study|Lost to Follow-up|0|||
46730291|NCT00817414|82946601|FG002|Overall Study|Lost to Follow-up|1|||
46730292|NCT00817414|82946602|FG003|Overall Study|Lost to Follow-up|1|||
46730293|NCT00817414|82946603|FG004|Overall Study|Lost to Follow-up|1|||
46730294|NCT00817414|82946599|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
46730295|NCT00817414|82946600|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
46730296|NCT00817414|82946601|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
46730297|NCT00817414|82946602|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
46730298|NCT00817414|82946603|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
46730299|NCT00817414|82946599|FG000|Overall Study|Protocol Violation|0|||
46730300|NCT00817414|82946600|FG001|Overall Study|Protocol Violation|0|||
46730301|NCT00817414|82946601|FG002|Overall Study|Protocol Violation|0|||
46730302|NCT00817414|82946602|FG003|Overall Study|Protocol Violation|0|||
46730303|NCT00817414|82946603|FG004|Overall Study|Protocol Violation|1|||
46730304|NCT00769561|82946622|FG000|Overall Study|Withdrawal by Subject|2|||
46730305|NCT00769561|82946623|FG001|Overall Study|Withdrawal by Subject|2|||
46730306|NCT00769561|82946622|FG000|Overall Study|Lost to Follow-up|1|||
46730307|NCT00769561|82946623|FG001|Overall Study|Lost to Follow-up|3|||
46730308|NCT00817336|82946631|FG000|Overall Study|Withdrawal by Subject|1|||
46730309|NCT00817336|82946632|FG001|Overall Study|Withdrawal by Subject|1|||
46730310|NCT00761215|82946640|FG000|Overall Study|Randomized but didn't receive drug|1|||
46730311|NCT00761215|82946641|FG001|Overall Study|Randomized but didn't receive drug|1|||
46730312|NCT00761215|82946642|FG002|Overall Study|Randomized but didn't receive drug|2|||
46730313|NCT00761215|82946640|FG000|Overall Study|Lost to Follow-up|6|||
46730314|NCT00761215|82946641|FG001|Overall Study|Lost to Follow-up|3|||
46730315|NCT00761215|82946642|FG002|Overall Study|Lost to Follow-up|6|||
46730316|NCT00761215|82946640|FG000|Overall Study|Withdrawal by Subject|1|||
46730317|NCT00761215|82946641|FG001|Overall Study|Withdrawal by Subject|0|||
46730318|NCT00761215|82946642|FG002|Overall Study|Withdrawal by Subject|0|||
46730319|NCT00761215|82946640|FG000|Overall Study|Bacteremia|1|||
46730320|NCT00761215|82946641|FG001|Overall Study|Bacteremia|0|||
46730321|NCT00761215|82946642|FG002|Overall Study|Bacteremia|0|||
46730322|NCT05101122|82946675|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
46730323|NCT05101122|82946675|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
46730324|NCT05101122|82946675|FG000|AD313 80/5|Withdrawal by Subject|1|||
46730325|NCT05101122|82946675|FG000|AD313 80/10|Physician Decision|1|||
46730326|NCT05038163|82946688|FG000|Stage 1|Did not complete survey|374|||
46730327|NCT05038163|82946689|FG001|Stage 1|Did not complete survey|0|||
46730328|NCT05038163|82946690|FG002|Stage 1|Did not complete survey|0|||
46730329|NCT05038163|82946691|FG003|Stage 1|Did not complete survey|0|||
46730330|NCT05038163|82946692|FG004|Stage 1|Did not complete survey|0|||
46730331|NCT05038163|82946693|FG005|Stage 1|Did not complete survey|0|||
46730332|NCT05038163|82946688|FG000|Stage 2|Did not complete Stage 2 survey|0|||
46730333|NCT05038163|82946689|FG001|Stage 2|Did not complete Stage 2 survey|29|||
46730334|NCT05038163|82946690|FG002|Stage 2|Did not complete Stage 2 survey|30|||
46730335|NCT05038163|82946691|FG003|Stage 2|Did not complete Stage 2 survey|24|||
46730336|NCT05038163|82946692|FG004|Stage 2|Did not complete Stage 2 survey|21|||
46730337|NCT05038163|82946693|FG005|Stage 2|Did not complete Stage 2 survey|100|||
46730338|NCT04413617|82946743|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
46730339|NCT04413617|82946744|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
46730340|NCT04413617|82946745|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
46921414|NCT03074149|83153929|FG001|Overall Study|Death|45|||
46921415|NCT02751320|83153937|FG000|Overall Study|Adverse Event|2|||
46921416|NCT02751320|83153937|FG000|Overall Study|Withdrawal by Subject|1|||
46921417|NCT02206035|83153965|FG000|Overall Study|Physician Decision|10|||
46921418|NCT02206035|83153966|FG001|Overall Study|Physician Decision|0|||
46730341|NCT04413617|82946746|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
46921419|NCT02206035|83153967|FG002|Overall Study|Physician Decision|175|||
46921420|NCT02746471|83153974|FG000|Overall Study|Death|43|||
46921421|NCT02746471|83153974|FG000|Overall Study|Exited before 36 months|1119|||
47048786|NCT01933919|83308907|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
47048787|NCT01933919|83308906|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
46730342|NCT04413617|82946747|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
46730343|NCT04413617|82946743|FG000|Overall Study|Protocol Violation|0|||
46730344|NCT04413617|82946744|FG001|Overall Study|Protocol Violation|1|||
46730345|NCT04413617|82946745|FG002|Overall Study|Protocol Violation|0|||
46921422|NCT02591953|83153981|FG000|Overall Study|Lost to Follow-up|6|||
46730346|NCT04413617|82946746|FG003|Overall Study|Protocol Violation|0|||
46730347|NCT04413617|82946747|FG004|Overall Study|Protocol Violation|1|||
46730348|NCT04413617|82946743|FG000|Overall Study|Lack of Efficacy|2|||
46730349|NCT04413617|82946744|FG001|Overall Study|Lack of Efficacy|0|||
46730350|NCT04413617|82946745|FG002|Overall Study|Lack of Efficacy|2|||
46730351|NCT04413617|82946746|FG003|Overall Study|Lack of Efficacy|1|||
46730352|NCT04413617|82946747|FG004|Overall Study|Lack of Efficacy|0|||
46730353|NCT04413617|82946743|FG000|Overall Study|Withdrawal by Subject|3|||
46730354|NCT04413617|82946744|FG001|Overall Study|Withdrawal by Subject|4|||
46730355|NCT04413617|82946745|FG002|Overall Study|Withdrawal by Subject|2|||
46730356|NCT04413617|82946746|FG003|Overall Study|Withdrawal by Subject|5|||
46730357|NCT04413617|82946747|FG004|Overall Study|Withdrawal by Subject|3|||
46730358|NCT04413617|82946743|FG000|Overall Study|Death|1|||
46730359|NCT04413617|82946744|FG001|Overall Study|Death|0|||
46730360|NCT04413617|82946745|FG002|Overall Study|Death|0|||
46730361|NCT04413617|82946746|FG003|Overall Study|Death|0|||
46730362|NCT04413617|82946747|FG004|Overall Study|Death|0|||
46730363|NCT04413617|82946743|FG000|Overall Study|Adverse Event|1|||
46730364|NCT04413617|82946744|FG001|Overall Study|Adverse Event|0|||
46730365|NCT04413617|82946745|FG002|Overall Study|Adverse Event|0|||
46730366|NCT04413617|82946746|FG003|Overall Study|Adverse Event|1|||
46730367|NCT04413617|82946747|FG004|Overall Study|Adverse Event|1|||
46730368|NCT04413617|82946743|FG000|Overall Study|COVID-19|0|||
46730369|NCT04413617|82946744|FG001|Overall Study|COVID-19|1|||
46730370|NCT04413617|82946745|FG002|Overall Study|COVID-19|0|||
46730371|NCT04413617|82946746|FG003|Overall Study|COVID-19|0|||
46730372|NCT04413617|82946747|FG004|Overall Study|COVID-19|0|||
46730373|NCT04055116|82946779|FG000|First Intervention|Physician Decision|2|||
46730374|NCT04055116|82946780|FG001|First Intervention|Physician Decision|7|||
46730375|NCT03512262|82946826|FG000|Overall Study|Adverse Event|8|||
46730376|NCT03512262|82946827|FG001|Overall Study|Adverse Event|3|||
46730377|NCT03512262|82946826|FG000|Overall Study|Death (non-treatment emergent)|1|||
46730378|NCT03512262|82946827|FG001|Overall Study|Death (non-treatment emergent)|0|||
46730379|NCT03512262|82946826|FG000|Overall Study|Withdrawal by Subject|17|||
46730380|NCT03512262|82946827|FG001|Overall Study|Withdrawal by Subject|9|||
46730381|NCT03512262|82946826|FG000|Overall Study|Lost to Follow-up|7|||
46730382|NCT03512262|82946827|FG001|Overall Study|Lost to Follow-up|1|||
46730383|NCT03512262|82946826|FG000|Overall Study|Other than Specified|2|||
46730384|NCT03512262|82946827|FG001|Overall Study|Other than Specified|2|||
46730385|NCT03499600|82946835|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
46730386|NCT03499600|82946836|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
46730387|NCT03007979|82946850|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
46730388|NCT02960893|82946856|FG000|Randomization Phase (8-week)|Adverse Event|5|||
46730389|NCT02960893|82946857|FG001|Randomization Phase (8-week)|Adverse Event|0|||
46730390|NCT02960893|82946856|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
46730391|NCT02960893|82946857|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
46730392|NCT02960893|82946856|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
46730393|NCT02960893|82946857|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
46730394|NCT02960893|82946856|FG000|Extension Phase (48-week)|Adverse Event|2|||
46730395|NCT02960893|82946857|FG001|Extension Phase (48-week)|Adverse Event|3|||
46730396|NCT02960893|82946856|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
46730397|NCT02960893|82946857|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
46730398|NCT02960893|82946856|FG000|Extension Phase (48-week)|Other Reason|2|||
46730399|NCT02960893|82946857|FG001|Extension Phase (48-week)|Other Reason|1|||
46730400|NCT02960893|82946856|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
46730401|NCT02960893|82946857|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
46730402|NCT02960893|82946856|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
46730403|NCT02960893|82946857|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
46730404|NCT02867813|82946872|FG000|Overall Study|Withdrawal by Subject|57|||
46730405|NCT02867813|82946873|FG001|Overall Study|Withdrawal by Subject|56|||
46730406|NCT02867813|82946872|FG000|Overall Study|Decision by Sponsor|7|||
46730407|NCT02867813|82946873|FG001|Overall Study|Decision by Sponsor|7|||
46730408|NCT02867813|82946872|FG000|Overall Study|Lost to Follow-up|91|||
46730409|NCT02867813|82946873|FG001|Overall Study|Lost to Follow-up|78|||
46730410|NCT02867813|82946872|FG000|Overall Study|Missing|2|||
46730411|NCT02867813|82946873|FG001|Overall Study|Missing|1|||
46730412|NCT02867813|82946872|FG000|Overall Study|Death|294|||
46730413|NCT02867813|82946873|FG001|Overall Study|Death|268|||
46730414|NCT02278055|82946885|FG000|Overall Study|Adverse Event|1|||
46730415|NCT02278055|82946885|FG000|Overall Study|Lost to Follow-up|1|||
46730416|NCT02278055|82946885|FG000|Overall Study|Withdrawal by Subject|2|||
46730417|NCT02278055|82946885|FG000|Overall Study|Progressive Disease|4|||
46730418|NCT02231879|82946891|FG000|Overall Study|Adverse Event|2|||
46730419|NCT02231879|82946892|FG001|Overall Study|Adverse Event|1|||
46730420|NCT02231879|82946891|FG000|Overall Study|Lack of Efficacy|0|||
46730421|NCT02231879|82946892|FG001|Overall Study|Lack of Efficacy|1|||
46730422|NCT01833806|82946913|FG000|Overall Study|Alternative treatment|2|||
46730423|NCT01833806|82946913|FG000|Overall Study|Death|5|||
46730424|NCT01833806|82946913|FG000|Overall Study|Physician Decision|1|||
46730425|NCT01833806|82946913|FG000|Overall Study|Lost to Follow-up|1|||
46730426|NCT01439802|82946917|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
46730427|NCT01439802|82946917|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
46730428|NCT00816556|82946924|FG000|Overall Study|Adverse Event|1|||
46730429|NCT00816556|82946925|FG001|Overall Study|Adverse Event|1|||
46730430|NCT00816556|82946926|FG002|Overall Study|Adverse Event|1|||
46730431|NCT00816556|82946924|FG000|Overall Study|Withdrawal by Subject|1|||
46730432|NCT00816556|82946925|FG001|Overall Study|Withdrawal by Subject|1|||
46730433|NCT00816556|82946926|FG002|Overall Study|Withdrawal by Subject|1|||
46730434|NCT00816556|82946924|FG000|Overall Study|Lost to Follow-up|0|||
46730435|NCT00816556|82946925|FG001|Overall Study|Lost to Follow-up|0|||
46730436|NCT00816556|82946926|FG002|Overall Study|Lost to Follow-up|1|||
46730437|NCT00760747|82946936|FG000|Study Period II|Adverse Event|3|||
46730438|NCT00760747|82946937|FG001|Study Period II|Adverse Event|4|||
46730439|NCT00760747|82946936|FG000|Study Period II|Lack of Efficacy|0|||
46730440|NCT00760747|82946937|FG001|Study Period II|Lack of Efficacy|6|||
46730441|NCT00760747|82946936|FG000|Study Period II|Parent/Caregiver Decision|3|||
46730442|NCT00760747|82946937|FG001|Study Period II|Parent/Caregiver Decision|0|||
46730443|NCT00760747|82946936|FG000|Study Period II|Protocol Violation|6|||
46730444|NCT00760747|82946937|FG001|Study Period II|Protocol Violation|3|||
46730445|NCT00760747|82946936|FG000|Study Period II|Withdrawal by Subject|1|||
46730446|NCT00760747|82946937|FG001|Study Period II|Withdrawal by Subject|0|||
46730447|NCT00760747|82946936|FG000|Study Period II|No drug administered|0|||
46730448|NCT00760747|82946937|FG001|Study Period II|No drug administered|1|||
46730449|NCT00760747|82946936|FG000|Study Period III|Adverse Event|1|||
46730450|NCT00760747|82946937|FG001|Study Period III|Adverse Event|0|||
46730451|NCT00760747|82946936|FG000|Study Period III|Lack of Efficacy|1|||
46730452|NCT00760747|82946937|FG001|Study Period III|Lack of Efficacy|0|||
46730453|NCT00760747|82946936|FG000|Study Period III|Parent/Caregiver Decision|0|||
46730454|NCT00760747|82946937|FG001|Study Period III|Parent/Caregiver Decision|1|||
46730455|NCT00760747|82946936|FG000|Study Period III|Protocol Violation|1|||
46730456|NCT00760747|82946937|FG001|Study Period III|Protocol Violation|1|||
46730457|NCT00760747|82946936|FG000|Study Period III|Physician Decision|0|||
46730458|NCT00760747|82946937|FG001|Study Period III|Physician Decision|1|||
46730459|NCT00760669|82946943|FG000|Overall Study|Not assessed for overall improvement|18|||
46730460|NCT00760669|82946943|FG000|Overall Study|Participants missing efficacy assessment|6|||
46730461|NCT00760669|82946943|FG000|Overall Study|Participants with overlapping cases|1|||
46730462|NCT00760669|82946943|FG000|Overall Study|Took drug before entering in contract|5|||
46730463|NCT00769483|82946953|FG000|Overall Study|Withdrawal by Subject|0|||
46730464|NCT00769483|82946954|FG001|Overall Study|Withdrawal by Subject|1|||
46730465|NCT00769483|82946955|FG002|Overall Study|Withdrawal by Subject|0|||
46730466|NCT00769483|82946956|FG003|Overall Study|Withdrawal by Subject|0|||
46730467|NCT00769483|82946957|FG004|Overall Study|Withdrawal by Subject|1|||
46730468|NCT00769483|82946958|FG005|Overall Study|Withdrawal by Subject|0|||
46730469|NCT00760513|82946976|FG000|Overall Study|Withdrawal by Subject|5|||
46730470|NCT00760513|82946977|FG001|Overall Study|Withdrawal by Subject|7|||
46730471|NCT00907296|82946995|FG000|Overall Study|Ineligibility Determined|1|||
46730472|NCT00907296|82946996|FG001|Overall Study|Ineligibility Determined|0|||
46730473|NCT00907296|82946997|FG002|Overall Study|Ineligibility Determined|0|||
46730474|NCT00907296|82946998|FG003|Overall Study|Ineligibility Determined|1|||
46730475|NCT00907296|82946999|FG004|Overall Study|Ineligibility Determined|0|||
46730476|NCT00907296|82947000|FG005|Overall Study|Ineligibility Determined|0|||
46730477|NCT00907296|82947001|FG006|Overall Study|Ineligibility Determined|0|||
46730478|NCT00907296|82947002|FG007|Overall Study|Ineligibility Determined|1|||
46730479|NCT00907296|82947003|FG008|Overall Study|Ineligibility Determined|0|||
46730480|NCT00907296|82947004|FG009|Overall Study|Ineligibility Determined|0|||
46730481|NCT00907296|82946995|FG000|Overall Study|Protocol Deviation|0|||
46730482|NCT00907296|82946996|FG001|Overall Study|Protocol Deviation|1|||
46803835|NCT00540644|83023129|FG000|Overall Study|Physician Decision|0|||
46730483|NCT00907296|82946997|FG002|Overall Study|Protocol Deviation|0|||
46730484|NCT00907296|82946998|FG003|Overall Study|Protocol Deviation|0|||
46730485|NCT00907296|82946999|FG004|Overall Study|Protocol Deviation|0|||
46730486|NCT00907296|82947000|FG005|Overall Study|Protocol Deviation|0|||
46730487|NCT00907296|82947001|FG006|Overall Study|Protocol Deviation|0|||
46730488|NCT00907296|82947002|FG007|Overall Study|Protocol Deviation|0|||
46730489|NCT00907296|82947003|FG008|Overall Study|Protocol Deviation|0|||
46730490|NCT00907296|82947004|FG009|Overall Study|Protocol Deviation|0|||
46730491|NCT00907296|82946995|FG000|Overall Study|Noncompliance|1|||
46730492|NCT00907296|82946996|FG001|Overall Study|Noncompliance|1|||
46730493|NCT00907296|82946997|FG002|Overall Study|Noncompliance|1|||
46730494|NCT00907296|82946998|FG003|Overall Study|Noncompliance|0|||
46730495|NCT00907296|82946999|FG004|Overall Study|Noncompliance|0|||
46730496|NCT00907296|82947000|FG005|Overall Study|Noncompliance|1|||
46730497|NCT00907296|82947001|FG006|Overall Study|Noncompliance|0|||
47048788|NCT01933919|83308907|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
47048789|NCT01933919|83308906|FG000|Open-label Long-term Phase|Other|1|||
47048790|NCT01933919|83308907|FG001|Open-label Long-term Phase|Other|2|||
47048791|NCT01933217|83308936|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
47048792|NCT01933217|83308937|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
46803836|NCT00540644|83023130|FG001|Overall Study|Physician Decision|5|||
46803837|NCT00540644|83023129|FG000|Overall Study|Withdrawal by Subject|2|||
46803838|NCT00540644|83023130|FG001|Overall Study|Withdrawal by Subject|2|||
46730498|NCT00907296|82947002|FG007|Overall Study|Noncompliance|2|||
46803839|NCT00540644|83023129|FG000|Overall Study|Noncomplilance|1|||
46803840|NCT00540644|83023130|FG001|Overall Study|Noncomplilance|0|||
46803841|NCT00543296|83023136|FG000|Overall Study|Physician Decision|7|||
46803842|NCT00543140|83023140|FG000|Overall Study|Lost to Follow-up|33|||
46803843|NCT00543140|83023140|FG000|Overall Study|Withdrawal by Subject|13|||
46803844|NCT00543140|83023140|FG000|Overall Study|Protocol Violation|10|||
46803845|NCT00543140|83023140|FG000|Overall Study|Insufficient weight loss|10|||
46803846|NCT00543140|83023140|FG000|Overall Study|SAE leading to explant of SAGB|3|||
46803847|NCT00543140|83023140|FG000|Overall Study|Death|1|||
46803848|NCT00543140|83023140|FG000|Overall Study|Subject moved|1|||
46803849|NCT00543140|83023140|FG000|Overall Study|Conversion to different procedure|1|||
46803850|NCT00543062|83023144|FG000|Overall Study|Withdrawal by Subject|1|||
46803851|NCT00543062|83023145|FG001|Overall Study|Withdrawal by Subject|0|||
46730499|NCT00907296|82947003|FG008|Overall Study|Noncompliance|0|||
46730500|NCT00907296|82947004|FG009|Overall Study|Noncompliance|0|||
46730501|NCT00907296|82946995|FG000|Overall Study|Adverse Event|2|||
46730502|NCT00907296|82946996|FG001|Overall Study|Adverse Event|0|||
46730503|NCT00907296|82946997|FG002|Overall Study|Adverse Event|0|||
46730504|NCT00907296|82946998|FG003|Overall Study|Adverse Event|0|||
46730505|NCT00907296|82946999|FG004|Overall Study|Adverse Event|0|||
46730506|NCT00907296|82947000|FG005|Overall Study|Adverse Event|0|||
46730507|NCT00907296|82947001|FG006|Overall Study|Adverse Event|1|||
46730508|NCT00907296|82947002|FG007|Overall Study|Adverse Event|0|||
46730509|NCT00907296|82947003|FG008|Overall Study|Adverse Event|0|||
46730510|NCT00907296|82947004|FG009|Overall Study|Adverse Event|1|||
46730511|NCT00907296|82946995|FG000|Overall Study|Withdrawal by Subject|7|||
46730512|NCT00907296|82946996|FG001|Overall Study|Withdrawal by Subject|2|||
46730513|NCT00907296|82946997|FG002|Overall Study|Withdrawal by Subject|1|||
46730514|NCT00907296|82946998|FG003|Overall Study|Withdrawal by Subject|1|||
46730515|NCT00907296|82946999|FG004|Overall Study|Withdrawal by Subject|1|||
46730516|NCT00907296|82947000|FG005|Overall Study|Withdrawal by Subject|5|||
46730517|NCT00907296|82947001|FG006|Overall Study|Withdrawal by Subject|3|||
46730518|NCT00907296|82947002|FG007|Overall Study|Withdrawal by Subject|2|||
46730519|NCT00907296|82947003|FG008|Overall Study|Withdrawal by Subject|4|||
46730520|NCT00907296|82947004|FG009|Overall Study|Withdrawal by Subject|2|||
46730521|NCT00907296|82946995|FG000|Overall Study|Lost to Follow-up|9|||
46730522|NCT00907296|82946996|FG001|Overall Study|Lost to Follow-up|1|||
46730523|NCT00907296|82946997|FG002|Overall Study|Lost to Follow-up|0|||
46730524|NCT00907296|82946998|FG003|Overall Study|Lost to Follow-up|2|||
46730525|NCT00907296|82946999|FG004|Overall Study|Lost to Follow-up|0|||
46730526|NCT00907296|82947000|FG005|Overall Study|Lost to Follow-up|3|||
46730527|NCT00907296|82947001|FG006|Overall Study|Lost to Follow-up|2|||
46730528|NCT00907296|82947002|FG007|Overall Study|Lost to Follow-up|2|||
46730529|NCT00907296|82947003|FG008|Overall Study|Lost to Follow-up|0|||
46730530|NCT00907296|82947004|FG009|Overall Study|Lost to Follow-up|4|||
46730531|NCT00816400|82947035|FG000|Overall Study|Death|2|||
46730532|NCT00816400|82947036|FG001|Overall Study|Death|3|||
46730533|NCT00816400|82947037|FG002|Overall Study|Death|3|||
46730534|NCT00816400|82947038|FG003|Overall Study|Death|3|||
46803852|NCT00543062|83023146|FG002|Overall Study|Withdrawal by Subject|2|||
46803853|NCT00543062|83023147|FG003|Overall Study|Withdrawal by Subject|0|||
46803854|NCT00543062|83023144|FG000|Overall Study|Adverse Event|0|||
46803855|NCT00543062|83023145|FG001|Overall Study|Adverse Event|1|||
46803856|NCT00543062|83023146|FG002|Overall Study|Adverse Event|1|||
46803857|NCT00543062|83023147|FG003|Overall Study|Adverse Event|1|||
46730535|NCT00816400|82947039|FG004|Overall Study|Death|2|||
46730536|NCT00816400|82947040|FG005|Overall Study|Death|3|||
46730537|NCT00816400|82947041|FG006|Overall Study|Death|2|||
46730538|NCT00816400|82947042|FG007|Overall Study|Death|5|||
46730539|NCT00816400|82947043|FG008|Overall Study|Death|6|||
46730540|NCT00816400|82947035|FG000|Overall Study|In hospice care at the end of the study|0|||
46730541|NCT00816400|82947036|FG001|Overall Study|In hospice care at the end of the study|0|||
46730542|NCT00816400|82947037|FG002|Overall Study|In hospice care at the end of the study|2|||
46730543|NCT00816400|82947038|FG003|Overall Study|In hospice care at the end of the study|0|||
46803858|NCT00543062|83023144|FG000|Overall Study|Protocol Violation|1|||
46730544|NCT00816400|82947039|FG004|Overall Study|In hospice care at the end of the study|0|||
46730545|NCT00816400|82947040|FG005|Overall Study|In hospice care at the end of the study|0|||
46730546|NCT00816400|82947041|FG006|Overall Study|In hospice care at the end of the study|0|||
46730547|NCT00816400|82947042|FG007|Overall Study|In hospice care at the end of the study|0|||
46730548|NCT00816400|82947043|FG008|Overall Study|In hospice care at the end of the study|0|||
46730549|NCT00906204|82947066|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
46730550|NCT00906204|82947067|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
46730551|NCT00906204|82947066|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
46730552|NCT00906204|82947067|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
46730553|NCT00906204|82947066|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
46730554|NCT00906204|82947067|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
46730555|NCT00906204|82947066|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
46730556|NCT00906204|82947067|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
46730557|NCT00906204|82947066|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
46730558|NCT00906204|82947067|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
46730559|NCT00905424|82947090|FG000|Overall Study|Lost to Follow-up|3|||
46730560|NCT00905424|82947091|FG001|Overall Study|Lost to Follow-up|3|||
46730561|NCT00905424|82947090|FG000|Overall Study|Withdrawal by Subject|1|||
46730562|NCT00905424|82947091|FG001|Overall Study|Withdrawal by Subject|2|||
46730563|NCT00905424|82947090|FG000|Overall Study|Adverse Event|4|||
46730564|NCT00905424|82947091|FG001|Overall Study|Adverse Event|2|||
46730565|NCT00905424|82947090|FG000|Overall Study|Non-compliance with study medication|2|||
46730566|NCT00905424|82947091|FG001|Overall Study|Non-compliance with study medication|0|||
46730567|NCT00905424|82947090|FG000|Overall Study|Sponsor decision|1|||
46730568|NCT00905424|82947091|FG001|Overall Study|Sponsor decision|0|||
46730569|NCT00905424|82947090|FG000|Overall Study|Positive urine drug screen|0|||
46730570|NCT00905424|82947091|FG001|Overall Study|Positive urine drug screen|1|||
46730571|NCT00905424|82947090|FG000|Overall Study|Non-adherence to visit schedule|0|||
46730572|NCT00905424|82947091|FG001|Overall Study|Non-adherence to visit schedule|1|||
46730573|NCT00816166|82947101|FG000|Overall Study|Lost to Follow-up|6|||
46730574|NCT00816166|82947102|FG001|Overall Study|Lost to Follow-up|10|||
46730575|NCT00816166|82947101|FG000|Overall Study|Death|4|||
46730576|NCT00816166|82947102|FG001|Overall Study|Death|2|||
46730577|NCT00815308|82947108|FG000|Overall Study|Adverse Event|4|||
46730578|NCT00815308|82947108|FG000|Overall Study|Withdrawal by Subject|0|||
46730579|NCT00815308|82947108|FG000|Overall Study|Protocol Violation|6|||
46730580|NCT01039376|82947114|FG000|Overall Study|Lost to Follow-up|5|||
46730581|NCT01039376|82947115|FG001|Overall Study|Lost to Follow-up|12|||
46730582|NCT01039376|82947114|FG000|Overall Study|Physician Decision|15|||
46730583|NCT01039376|82947115|FG001|Overall Study|Physician Decision|10|||
46730584|NCT01039376|82947114|FG000|Overall Study|Withdrawal by Subject|20|||
46730585|NCT01039376|82947115|FG001|Overall Study|Withdrawal by Subject|32|||
46730586|NCT01039376|82947114|FG000|Overall Study|Study terminated by Sponsor|90|||
46730587|NCT01039376|82947115|FG001|Overall Study|Study terminated by Sponsor|72|||
46730588|NCT00905034|82947122|FG000|Overall Study|Withdrawal by Subject|1|||
46730589|NCT00828568|82947129|FG000|Randomized|Withdrawal by Subject|1|||
46730590|NCT00828568|82947130|FG001|Randomized|Withdrawal by Subject|0|||
46730591|NCT00828568|82947131|FG002|Randomized|Withdrawal by Subject|2|||
46730592|NCT00828568|82947129|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
46730593|NCT00828568|82947130|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
46730594|NCT00828568|82947131|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
46730595|NCT00828568|82947129|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
46730596|NCT00828568|82947130|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
46730597|NCT00828568|82947131|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
46730598|NCT00828568|82947129|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
46730599|NCT00828568|82947130|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
46730600|NCT00828568|82947131|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
46730601|NCT00828568|82947129|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
46730602|NCT00828568|82947130|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
46730603|NCT00828568|82947131|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
46730604|NCT01038752|82947142|FG000|Overall Study|Tumor Progression|2|||
46730605|NCT01038752|82947143|FG001|Overall Study|Tumor Progression|2|||
46730606|NCT01038752|82947142|FG000|Overall Study|Lost to Follow-up|3|||
46730607|NCT01038752|82947143|FG001|Overall Study|Lost to Follow-up|3|||
46730608|NCT00903630|82947152|FG000|Phase 2|Adverse Event|0|||
46803859|NCT00543062|83023145|FG001|Overall Study|Protocol Violation|0|||
46803860|NCT00543062|83023146|FG002|Overall Study|Protocol Violation|0|||
46730609|NCT00903630|82947153|FG001|Phase 2|Adverse Event|0|||
46730610|NCT00903630|82947154|FG002|Phase 2|Adverse Event|1|||
46730611|NCT01037114|82947164|FG000|Year 20|Others|1|||
46730612|NCT00840970|82947168|FG000|Overall Study|Adverse Event|0|||
46730613|NCT00840970|82947169|FG001|Overall Study|Adverse Event|0|||
46730614|NCT00840970|82947170|FG002|Overall Study|Adverse Event|1|||
46730615|NCT01054820|82947180|FG000|Overall Study|Withdrawal by Subject|2|||
46730616|NCT00840658|82947188|FG000|Overall Study|Death|2|||
46730617|NCT00840658|82947189|FG001|Overall Study|Death|2|||
46730618|NCT00840658|82947190|FG002|Overall Study|Death|3|||
46730619|NCT00840658|82947191|FG003|Overall Study|Death|3|||
46730620|NCT00840658|82947188|FG000|Overall Study|Lost to Follow-up|3|||
46730621|NCT00840658|82947189|FG001|Overall Study|Lost to Follow-up|1|||
46730622|NCT00840658|82947190|FG002|Overall Study|Lost to Follow-up|2|||
46730623|NCT00840658|82947191|FG003|Overall Study|Lost to Follow-up|1|||
46730624|NCT01036724|82947207|FG000|Overall Study|Adverse Event|1|||
46730625|NCT01036724|82947208|FG001|Overall Study|Adverse Event|2|||
46730626|NCT01036724|82947207|FG000|Overall Study|Lack of Efficacy|1|||
46730627|NCT01036724|82947208|FG001|Overall Study|Lack of Efficacy|1|||
46730628|NCT01036724|82947207|FG000|Overall Study|Protocol Violation|4|||
46730629|NCT01036724|82947208|FG001|Overall Study|Protocol Violation|5|||
46730630|NCT01052714|82947216|FG000|Overall Study|Adverse Event|6|||
46730631|NCT01052714|82947217|FG001|Overall Study|Adverse Event|3|||
46730632|NCT01052714|82947218|FG002|Overall Study|Adverse Event|0|||
46730633|NCT01052714|82947216|FG000|Overall Study|Death|1|||
46730634|NCT01052714|82947217|FG001|Overall Study|Death|2|||
46730635|NCT01052714|82947218|FG002|Overall Study|Death|0|||
46730636|NCT01052714|82947216|FG000|Overall Study|Lost to Follow-up|2|||
46730637|NCT01052714|82947217|FG001|Overall Study|Lost to Follow-up|3|||
46730638|NCT01052714|82947218|FG002|Overall Study|Lost to Follow-up|0|||
46730639|NCT01052714|82947216|FG000|Overall Study|Physician Decision|9|||
46730640|NCT01052714|82947217|FG001|Overall Study|Physician Decision|9|||
46730641|NCT01052714|82947218|FG002|Overall Study|Physician Decision|1|||
46730642|NCT01052714|82947216|FG000|Overall Study|Withdrawal by Subject|7|||
46730643|NCT01052714|82947217|FG001|Overall Study|Withdrawal by Subject|12|||
46730644|NCT01052714|82947218|FG002|Overall Study|Withdrawal by Subject|1|||
46730645|NCT01052480|82947235|FG000|Overall Study|Lost to Follow-up|3|||
46730646|NCT01052480|82947236|FG001|Overall Study|Lost to Follow-up|3|||
46730647|NCT01052480|82947235|FG000|Overall Study|Protocol Violation|1|||
46730648|NCT01052480|82947236|FG001|Overall Study|Protocol Violation|0|||
46730649|NCT01052480|82947235|FG000|Overall Study|Withdrawal by Subject|3|||
46730650|NCT01052480|82947236|FG001|Overall Study|Withdrawal by Subject|7|||
46730651|NCT01052480|82947235|FG000|Overall Study|Physician Decision|0|||
46730652|NCT01052480|82947236|FG001|Overall Study|Physician Decision|2|||
46730653|NCT01052480|82947235|FG000|Overall Study|Death|1|||
46730654|NCT01052480|82947236|FG001|Overall Study|Death|5|||
46730655|NCT00904722|82947242|FG000|Overall Study|Physician Decision|1|||
46730656|NCT01029782|82947248|FG000|Overall Study|Lost to Follow-up|2|||
46730657|NCT01029782|82947249|FG001|Overall Study|Lost to Follow-up|2|||
46730658|NCT01029782|82947248|FG000|Overall Study|Diagnosis changed|1|||
46730659|NCT01029782|82947249|FG001|Overall Study|Diagnosis changed|1|||
46730660|NCT01029782|82947248|FG000|Overall Study|Adverse Event|0|||
46730661|NCT01029782|82947249|FG001|Overall Study|Adverse Event|1|||
46730662|NCT01029782|82947248|FG000|Overall Study|Physician Decision|0|||
46730663|NCT01029782|82947249|FG001|Overall Study|Physician Decision|1|||
46730664|NCT01029782|82947248|FG000|Overall Study|Protocol Violation|0|||
46730665|NCT01029782|82947249|FG001|Overall Study|Protocol Violation|2|||
46730666|NCT01029782|82947248|FG000|Overall Study|Withdrawal by Subject|0|||
46730667|NCT01029782|82947249|FG001|Overall Study|Withdrawal by Subject|1|||
46730668|NCT01029704|82947264|FG000|Overall Study|Adverse Event|0|||
46730669|NCT01029704|82947265|FG001|Overall Study|Adverse Event|0|||
46730670|NCT01029704|82947266|FG002|Overall Study|Adverse Event|0|||
46730671|NCT01029704|82947267|FG003|Overall Study|Adverse Event|0|||
46730672|NCT01029704|82947268|FG004|Overall Study|Adverse Event|0|||
46730673|NCT01029704|82947269|FG005|Overall Study|Adverse Event|0|||
46730674|NCT01029704|82947270|FG006|Overall Study|Adverse Event|1|||
46730675|NCT01029704|82947271|FG007|Overall Study|Adverse Event|1|||
46730676|NCT01029704|82947272|FG008|Overall Study|Adverse Event|0|||
46730677|NCT01029704|82947264|FG000|Overall Study|Withdrawal by Subject|0|||
46730678|NCT01029704|82947265|FG001|Overall Study|Withdrawal by Subject|0|||
46730679|NCT01029704|82947266|FG002|Overall Study|Withdrawal by Subject|0|||
46730680|NCT01029704|82947267|FG003|Overall Study|Withdrawal by Subject|0|||
46730681|NCT01029704|82947268|FG004|Overall Study|Withdrawal by Subject|2|||
46730682|NCT01029704|82947269|FG005|Overall Study|Withdrawal by Subject|1|||
46921423|NCT02591953|83153982|FG001|Overall Study|Lost to Follow-up|6|||
46921424|NCT03073213|83153990|FG000|Multiple Dose Period|Protocol Violation|0|||
46921425|NCT03073213|83153991|FG001|Multiple Dose Period|Protocol Violation|0|||
46921426|NCT03073213|83153992|FG002|Multiple Dose Period|Protocol Violation|1|||
46730683|NCT01029704|82947270|FG006|Overall Study|Withdrawal by Subject|1|||
46730684|NCT01029704|82947271|FG007|Overall Study|Withdrawal by Subject|1|||
46730685|NCT01029704|82947272|FG008|Overall Study|Withdrawal by Subject|0|||
46730686|NCT01029704|82947264|FG000|Overall Study|Lost to Follow-up|0|||
46730687|NCT01029704|82947265|FG001|Overall Study|Lost to Follow-up|0|||
46730688|NCT01029704|82947266|FG002|Overall Study|Lost to Follow-up|0|||
46730689|NCT01029704|82947267|FG003|Overall Study|Lost to Follow-up|0|||
46730690|NCT01029704|82947268|FG004|Overall Study|Lost to Follow-up|0|||
46730691|NCT01029704|82947269|FG005|Overall Study|Lost to Follow-up|0|||
46730692|NCT01029704|82947270|FG006|Overall Study|Lost to Follow-up|1|||
46730693|NCT01029704|82947271|FG007|Overall Study|Lost to Follow-up|1|||
46730694|NCT01029704|82947272|FG008|Overall Study|Lost to Follow-up|1|||
46730695|NCT01029704|82947264|FG000|Overall Study|Lack of Efficacy|0|||
46730696|NCT01029704|82947265|FG001|Overall Study|Lack of Efficacy|0|||
46921427|NCT03070483|83154001|FG000|Overall Study|Lost to Follow-up|2|||
46921428|NCT02231762|83154006|FG000|Combination Phase|Adverse Event|10|||
46921429|NCT02231762|83154007|FG001|Combination Phase|Adverse Event|0|||
46921430|NCT02231762|83154008|FG002|Combination Phase|Adverse Event|0|||
46921431|NCT02231762|83154009|FG003|Combination Phase|Adverse Event|0|||
46921432|NCT02231762|83154006|FG000|Combination Phase|Withdrawal by Subject|2|||
46921433|NCT02231762|83154007|FG001|Combination Phase|Withdrawal by Subject|0|||
46921434|NCT02231762|83154008|FG002|Combination Phase|Withdrawal by Subject|0|||
46921435|NCT02231762|83154009|FG003|Combination Phase|Withdrawal by Subject|0|||
46921436|NCT02231762|83154006|FG000|Combination Phase|Disease Progression|6|||
46921437|NCT02231762|83154007|FG001|Combination Phase|Disease Progression|0|||
46921438|NCT02231762|83154008|FG002|Combination Phase|Disease Progression|0|||
46921439|NCT02231762|83154009|FG003|Combination Phase|Disease Progression|0|||
46921440|NCT02231762|83154006|FG000|Combination Phase|Did not meet inclusion criteria|1|||
46730697|NCT01029704|82947266|FG002|Overall Study|Lack of Efficacy|0|||
46730698|NCT01029704|82947267|FG003|Overall Study|Lack of Efficacy|0|||
46730699|NCT01029704|82947268|FG004|Overall Study|Lack of Efficacy|2|||
46730700|NCT01029704|82947269|FG005|Overall Study|Lack of Efficacy|3|||
46730701|NCT01029704|82947270|FG006|Overall Study|Lack of Efficacy|1|||
46730702|NCT01029704|82947271|FG007|Overall Study|Lack of Efficacy|2|||
46730703|NCT01029704|82947272|FG008|Overall Study|Lack of Efficacy|0|||
46730704|NCT01029704|82947264|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
46730705|NCT01029704|82947265|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
46730706|NCT01029704|82947266|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
46730707|NCT01029704|82947267|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
46730708|NCT01029704|82947268|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
46730709|NCT01029704|82947269|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
46730710|NCT01029704|82947270|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
46730711|NCT01029704|82947271|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
46730712|NCT01029704|82947272|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
46730713|NCT00840034|82947294|FG000|Acute Treatment Phase|Adverse Event|6|||
46730714|NCT00840034|82947295|FG001|Acute Treatment Phase|Adverse Event|8|||
46730715|NCT00840034|82947294|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
46730716|NCT00840034|82947295|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
46730717|NCT00840034|82947294|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
46730718|NCT00840034|82947295|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
46730719|NCT00840034|82947294|FG000|Acute Treatment Phase|Physician Decision|0|||
46730720|NCT00840034|82947295|FG001|Acute Treatment Phase|Physician Decision|1|||
46730721|NCT00840034|82947294|FG000|Acute Treatment Phase|Protocol Violation|2|||
46730722|NCT00840034|82947295|FG001|Acute Treatment Phase|Protocol Violation|4|||
46730723|NCT00840034|82947294|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
46730724|NCT00840034|82947295|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
46730725|NCT00840034|82947294|FG000|Taper Phase|Adverse Event|1|||
46730726|NCT00840034|82947295|FG001|Taper Phase|Adverse Event|0|||
46730727|NCT00840034|82947294|FG000|Taper Phase|Lost to Follow-up|1|||
46730728|NCT00840034|82947295|FG001|Taper Phase|Lost to Follow-up|1|||
46730729|NCT00840034|82947294|FG000|Taper Phase|Withdrawal by Subject|1|||
46730730|NCT00840034|82947295|FG001|Taper Phase|Withdrawal by Subject|1|||
46730731|NCT00813904|82947303|FG000|Overall Study|Death|1|||
46730732|NCT00839956|82947307|FG000|Overall Study|Adverse Event|2|||
46730733|NCT00839956|82947307|FG000|Overall Study|Lack of Efficacy|6|||
46730734|NCT00839956|82947307|FG000|Overall Study|Physician Decision|1|||
46730735|NCT00839956|82947307|FG000|Overall Study|Withdrawal by Subject|3|||
46730736|NCT00839800|82947313|FG000|Overall Study|Adverse Event|8|||
46730737|NCT00839800|82947314|FG001|Overall Study|Adverse Event|12|||
46730738|NCT00839800|82947313|FG000|Overall Study|Lost to Follow-up|31|||
46921441|NCT02231762|83154007|FG001|Combination Phase|Did not meet inclusion criteria|0|||
46803861|NCT00543062|83023147|FG003|Overall Study|Protocol Violation|0|||
46803862|NCT03911960|83023167|FG000|Overall Study|Lost to Follow-up|5|||
46803863|NCT03911960|83023168|FG001|Overall Study|Lost to Follow-up|3|||
46730739|NCT00839800|82947314|FG001|Overall Study|Lost to Follow-up|26|||
46730740|NCT00839800|82947313|FG000|Overall Study|Withdrawal by Subject|28|||
46730741|NCT00839800|82947314|FG001|Overall Study|Withdrawal by Subject|34|||
46730742|NCT00839800|82947313|FG000|Overall Study|Incorrect Enrolment|3|||
46730743|NCT00839800|82947314|FG001|Overall Study|Incorrect Enrolment|3|||
46730744|NCT00839800|82947313|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
46730745|NCT00839800|82947314|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
46730746|NCT00839800|82947313|FG000|Overall Study|Safety Reasons|2|||
46730747|NCT00839800|82947314|FG001|Overall Study|Safety Reasons|1|||
46730748|NCT00839800|82947313|FG000|Overall Study|Other|8|||
46921442|NCT02231762|83154008|FG002|Combination Phase|Did not meet inclusion criteria|0|||
46921443|NCT02231762|83154009|FG003|Combination Phase|Did not meet inclusion criteria|0|||
46730749|NCT00839800|82947314|FG001|Overall Study|Other|14|||
46730750|NCT00839800|82947313|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
46730751|NCT00839800|82947314|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
46730752|NCT00753415|82947348|FG000|Part A|Disease progression|1|||
46730753|NCT00753415|82947349|FG001|Part A|Disease progression|0|||
46730754|NCT00753415|82947350|FG002|Part A|Disease progression|1|||
46730755|NCT00753415|82947351|FG003|Part A|Disease progression|2|||
46730756|NCT00753415|82947352|FG004|Part A|Disease progression|0|||
46730757|NCT00753415|82947353|FG005|Part A|Disease progression|0|||
46730758|NCT00753415|82947354|FG006|Part A|Disease progression|0|||
46730759|NCT00753415|82947355|FG007|Part A|Disease progression|0|||
46730760|NCT00753415|82947356|FG008|Part A|Disease progression|0|||
46730761|NCT00753415|82947357|FG009|Part A|Disease progression|0|||
46730762|NCT00753415|82947348|FG000|Part A|Withdrawal by Subject|0|||
46730763|NCT00753415|82947349|FG001|Part A|Withdrawal by Subject|0|||
46730764|NCT00753415|82947350|FG002|Part A|Withdrawal by Subject|1|||
46730765|NCT00753415|82947351|FG003|Part A|Withdrawal by Subject|0|||
46730766|NCT00753415|82947352|FG004|Part A|Withdrawal by Subject|0|||
46730767|NCT00753415|82947353|FG005|Part A|Withdrawal by Subject|0|||
46730768|NCT00753415|82947354|FG006|Part A|Withdrawal by Subject|0|||
46730769|NCT00753415|82947355|FG007|Part A|Withdrawal by Subject|0|||
46730770|NCT00753415|82947356|FG008|Part A|Withdrawal by Subject|0|||
46730771|NCT00753415|82947357|FG009|Part A|Withdrawal by Subject|0|||
46730772|NCT00753415|82947348|FG000|Part B|Lost to Follow-up|0|||
46730773|NCT00753415|82947349|FG001|Part B|Lost to Follow-up|0|||
46730774|NCT00753415|82947350|FG002|Part B|Lost to Follow-up|0|||
46730775|NCT00753415|82947351|FG003|Part B|Lost to Follow-up|0|||
46730776|NCT00753415|82947352|FG004|Part B|Lost to Follow-up|0|||
46730777|NCT00753415|82947353|FG005|Part B|Lost to Follow-up|0|||
46730778|NCT00753415|82947354|FG006|Part B|Lost to Follow-up|0|||
46730779|NCT00753415|82947355|FG007|Part B|Lost to Follow-up|1|||
46730780|NCT00753415|82947356|FG008|Part B|Lost to Follow-up|1|||
46730781|NCT00753415|82947357|FG009|Part B|Lost to Follow-up|0|||
46730782|NCT00753415|82947348|FG000|Part B|Disease progression|0|||
46803864|NCT00676091|83023177|FG000|Infant Series|Parent or legal guardian request|10|||
46803865|NCT00676091|83023178|FG001|Infant Series|Parent or legal guardian request|8|||
46803866|NCT00676091|83023177|FG000|Infant Series|Protocol Violation|6|||
46803867|NCT00676091|83023178|FG001|Infant Series|Protocol Violation|3|||
46921444|NCT02231762|83154006|FG000|Combination Phase|Protocol Violation|1|||
46921445|NCT02231762|83154007|FG001|Combination Phase|Protocol Violation|0|||
46921446|NCT02231762|83154008|FG002|Combination Phase|Protocol Violation|0|||
46921447|NCT02231762|83154009|FG003|Combination Phase|Protocol Violation|0|||
46641260|NCT04211831|82825498|FG000|Overall Study|Lack of Efficacy|0|||
46641261|NCT04211831|82825499|FG001|Overall Study|Lack of Efficacy|0|||
46641262|NCT04211831|82825500|FG002|Overall Study|Lack of Efficacy|1|||
46641263|NCT04211831|82825498|FG000|Overall Study|Lost to Follow-up|0|||
46641264|NCT04211831|82825499|FG001|Overall Study|Lost to Follow-up|0|||
46641265|NCT04211831|82825500|FG002|Overall Study|Lost to Follow-up|2|||
46641266|NCT04211831|82825498|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
46641267|NCT04211831|82825499|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
46641268|NCT04211831|82825500|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
46641269|NCT04211831|82825498|FG000|Overall Study|Other|0|||
46641270|NCT04211831|82825499|FG001|Overall Study|Other|1|||
46641271|NCT04211831|82825500|FG002|Overall Study|Other|0|||
46641272|NCT04067518|82825558|FG000|Overall Study|Adverse Event|1|||
46641273|NCT04067518|82825559|FG001|Overall Study|Adverse Event|3|||
46641274|NCT04067518|82825558|FG000|Overall Study|Screen failures|0|||
46641275|NCT04067518|82825559|FG001|Overall Study|Screen failures|1|||
46641276|NCT04067518|82825558|FG000|Overall Study|Enrolled but not treated|0|||
46641277|NCT04067518|82825559|FG001|Overall Study|Enrolled but not treated|1|||
46641278|NCT03912233|82825600|FG000|Overall Study|Adverse Event|1|||
46641279|NCT03912233|82825601|FG001|Overall Study|Adverse Event|0|||
46641280|NCT03912233|82825602|FG002|Overall Study|Adverse Event|0|||
46641281|NCT03912233|82825603|FG003|Overall Study|Adverse Event|0|||
46641282|NCT03912233|82825604|FG004|Overall Study|Adverse Event|0|||
46641283|NCT03912233|82825605|FG005|Overall Study|Adverse Event|0|||
46641284|NCT03912233|82825600|FG000|Overall Study|Physician Decision|1|||
46641285|NCT03912233|82825601|FG001|Overall Study|Physician Decision|0|||
46641286|NCT03912233|82825602|FG002|Overall Study|Physician Decision|0|||
46641287|NCT03912233|82825603|FG003|Overall Study|Physician Decision|0|||
46641288|NCT03912233|82825604|FG004|Overall Study|Physician Decision|0|||
46641289|NCT03912233|82825605|FG005|Overall Study|Physician Decision|0|||
46641290|NCT03912233|82825600|FG000|Overall Study|Other|0|||
46641291|NCT03912233|82825601|FG001|Overall Study|Other|0|||
46641292|NCT03912233|82825602|FG002|Overall Study|Other|0|||
46641293|NCT03912233|82825603|FG003|Overall Study|Other|0|||
46641294|NCT03912233|82825604|FG004|Overall Study|Other|7|||
46641295|NCT03912233|82825605|FG005|Overall Study|Other|12|||
46641296|NCT03546062|82825648|FG000|Overall Study|Adverse Event|6|||
46730783|NCT00753415|82947349|FG001|Part B|Disease progression|0|||
46730784|NCT00753415|82947350|FG002|Part B|Disease progression|0|||
46730785|NCT00753415|82947351|FG003|Part B|Disease progression|0|||
46730786|NCT00753415|82947352|FG004|Part B|Disease progression|0|||
46730787|NCT00753415|82947353|FG005|Part B|Disease progression|0|||
46730788|NCT00753415|82947354|FG006|Part B|Disease progression|0|||
46730789|NCT00753415|82947355|FG007|Part B|Disease progression|0|||
46730790|NCT00753415|82947356|FG008|Part B|Disease progression|2|||
46730791|NCT00753415|82947357|FG009|Part B|Disease progression|1|||
46730792|NCT00754741|82947384|FG000|Overall Study|Died or disenrolled|57|||
46803868|NCT00676091|83023177|FG000|Infant Series|Adverse Event|2|||
46803869|NCT00676091|83023178|FG001|Infant Series|Adverse Event|3|||
46803870|NCT00676091|83023177|FG000|Infant Series|Failed to return|1|||
46730793|NCT00754741|82947385|FG001|Overall Study|Died or disenrolled|69|||
46730794|NCT00754741|82947386|FG002|Overall Study|Died or disenrolled|54|||
46730795|NCT00752791|82947394|FG000|Overall Study|Adverse Event|7|||
46730796|NCT00752791|82947394|FG000|Overall Study|Withdrawal by Subject|1|||
46803871|NCT00676091|83023178|FG001|Infant Series|Failed to return|3|||
46803872|NCT00676091|83023177|FG000|Infant Series|Lost to Follow-up|1|||
46803873|NCT00676091|83023178|FG001|Infant Series|Lost to Follow-up|0|||
46803874|NCT00676091|83023177|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
46803875|NCT00676091|83023178|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
46635094|NCT01568112|82808574|FG003|Overall Study|Withdrawal by Subject|7|||
46635095|NCT01568112|82808571|FG000|Overall Study|Withdrawal by Physician|1|||
46730797|NCT00752791|82947394|FG000|Overall Study|Physician Decision|1|||
46730798|NCT00752791|82947394|FG000|Overall Study|Death|1|||
46730799|NCT00752791|82947394|FG000|Overall Study|Renal transplant|3|||
46730800|NCT00752791|82947394|FG000|Overall Study|Switched to hemodialysis|2|||
46730801|NCT00752791|82947394|FG000|Overall Study|Protocol deviation|1|||
46730802|NCT00902304|82947405|FG000|Overall Study|Adverse Event|4|||
46730803|NCT00902304|82947406|FG001|Overall Study|Adverse Event|10|||
46730804|NCT00902304|82947407|FG002|Overall Study|Adverse Event|25|||
46730805|NCT00902304|82947405|FG000|Overall Study|Investigator discretion|3|||
46730806|NCT00902304|82947406|FG001|Overall Study|Investigator discretion|5|||
46730807|NCT00902304|82947407|FG002|Overall Study|Investigator discretion|13|||
46730808|NCT00902304|82947405|FG000|Overall Study|Lost to Follow-up|7|||
46730809|NCT00902304|82947406|FG001|Overall Study|Lost to Follow-up|7|||
46730810|NCT00902304|82947407|FG002|Overall Study|Lost to Follow-up|7|||
46730811|NCT00902304|82947405|FG000|Overall Study|Protocol Violation|9|||
46730812|NCT00902304|82947406|FG001|Overall Study|Protocol Violation|18|||
46730813|NCT00902304|82947407|FG002|Overall Study|Protocol Violation|20|||
46730814|NCT00902304|82947405|FG000|Overall Study|Withdrawal by Subject|32|||
46730815|NCT00902304|82947406|FG001|Overall Study|Withdrawal by Subject|22|||
46730816|NCT00902304|82947407|FG002|Overall Study|Withdrawal by Subject|43|||
46730817|NCT00902304|82947405|FG000|Overall Study|includes pregnancy|3|||
46730818|NCT00902304|82947406|FG001|Overall Study|includes pregnancy|9|||
46730819|NCT00902304|82947407|FG002|Overall Study|includes pregnancy|2|||
46730820|NCT00759109|82947418|FG000|Overall Study|Adverse Event|17|||
46730821|NCT00759109|82947419|FG001|Overall Study|Adverse Event|12|||
46730822|NCT00759109|82947418|FG000|Overall Study|Inability to comply|1|||
46730823|NCT00759109|82947419|FG001|Overall Study|Inability to comply|1|||
46730824|NCT00759109|82947418|FG000|Overall Study|Withdrawal by Subject|9|||
46730825|NCT00759109|82947419|FG001|Overall Study|Withdrawal by Subject|5|||
46803876|NCT00676091|83023177|FG000|After Infant Series|Adverse Event|0|||
46803877|NCT00676091|83023178|FG001|After Infant Series|Adverse Event|1|||
46803878|NCT00676091|83023177|FG000|After Infant Series|Protocol Violation|0|||
46803879|NCT00676091|83023178|FG001|After Infant Series|Protocol Violation|1|||
46803880|NCT00676091|83023177|FG000|After Infant Series|Failed to return|1|||
46803881|NCT00676091|83023178|FG001|After Infant Series|Failed to return|1|||
46803882|NCT00676091|83023177|FG000|Toddler Dose|Failed to return|2|||
46803883|NCT00676091|83023178|FG001|Toddler Dose|Failed to return|0|||
46803884|NCT00676091|83023177|FG000|Toddler Dose|Parent or legal guardian request|1|||
46635096|NCT01568112|82808572|FG001|Overall Study|Withdrawal by Physician|0|||
46803885|NCT00676091|83023178|FG001|Toddler Dose|Parent or legal guardian request|0|||
46803886|NCT00678041|83023190|FG000|Overall Study|Physician Decision|5|||
46635097|NCT01568112|82808573|FG002|Overall Study|Withdrawal by Physician|1|||
46635098|NCT01568112|82808574|FG003|Overall Study|Withdrawal by Physician|1|||
46635099|NCT01568034|82808585|FG000|Overall Study|Withdrawal by Subject|1|||
46635100|NCT01568034|82808586|FG001|Overall Study|Withdrawal by Subject|0|||
46635101|NCT01568034|82808587|FG002|Overall Study|Withdrawal by Subject|0|||
46635102|NCT01568034|82808588|FG003|Overall Study|Withdrawal by Subject|0|||
46635103|NCT01687218|82808604|FG000|Overall Study|Withdrawal by Subject|2|||
46635104|NCT01687218|82808605|FG001|Overall Study|Withdrawal by Subject|3|||
46730826|NCT00759109|82947418|FG000|Overall Study|Death|4|||
46730827|NCT00759109|82947419|FG001|Overall Study|Death|3|||
46730828|NCT00759109|82947418|FG000|Overall Study|Lost to Follow-up|4|||
46730829|NCT00759109|82947419|FG001|Overall Study|Lost to Follow-up|6|||
46730830|NCT00759109|82947418|FG000|Overall Study|Started new therapy|2|||
46803887|NCT00678041|83023191|FG001|Overall Study|Physician Decision|5|||
46730831|NCT00759109|82947419|FG001|Overall Study|Started new therapy|6|||
46730832|NCT00759109|82947418|FG000|Overall Study|HCV RNA negative|1|||
46730833|NCT00759109|82947419|FG001|Overall Study|HCV RNA negative|0|||
46730834|NCT00759109|82947418|FG000|Overall Study|Participant moved to a different city|0|||
46730835|NCT00759109|82947419|FG001|Overall Study|Participant moved to a different city|1|||
46730836|NCT00759109|82947418|FG000|Overall Study|Participant had a liver transplant|0|||
46730837|NCT00759109|82947419|FG001|Overall Study|Participant had a liver transplant|1|||
46730838|NCT00759109|82947418|FG000|Overall Study|Lost during study|1|||
46730839|NCT00759109|82947419|FG001|Overall Study|Lost during study|0|||
46730840|NCT00759031|82947427|FG000|First Intervention (1 Day)|Physician Decision|1|||
46730841|NCT00759031|82947428|FG001|First Intervention (1 Day)|Physician Decision|0|||
46730842|NCT00759031|82947427|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
46730843|NCT00759031|82947428|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
46730844|NCT00759031|82947427|FG000|First Intervention (1 Day)|Screening failure|1|||
46730845|NCT00759031|82947428|FG001|First Intervention (1 Day)|Screening failure|0|||
46730846|NCT00758485|82947436|FG000|Overall Study|Lost to Follow-up|0|||
46730847|NCT00758485|82947437|FG001|Overall Study|Lost to Follow-up|1|||
46730848|NCT00758485|82947436|FG000|Overall Study|Not Treated|1|||
46730849|NCT00758485|82947437|FG001|Overall Study|Not Treated|2|||
46730850|NCT00757783|82947446|FG000|Overall Study|Adverse Event|0|||
46730851|NCT00757783|82947447|FG001|Overall Study|Adverse Event|2|||
46730852|NCT00757783|82947446|FG000|Overall Study|Lost to Follow-up|1|||
46730853|NCT00757783|82947447|FG001|Overall Study|Lost to Follow-up|1|||
46730854|NCT00757783|82947446|FG000|Overall Study|Protocol Violation|1|||
46730855|NCT00757783|82947447|FG001|Overall Study|Protocol Violation|0|||
46730856|NCT00757783|82947446|FG000|Overall Study|Withdrawal by Subject|2|||
46730857|NCT00757783|82947447|FG001|Overall Study|Withdrawal by Subject|1|||
46730858|NCT00757783|82947446|FG000|Overall Study|Other|1|||
46730859|NCT00757783|82947447|FG001|Overall Study|Other|2|||
46730860|NCT00757705|82947453|FG000|Overall Study|Adverse Event|19|||
46730861|NCT00757705|82947453|FG000|Overall Study|Lost to Follow-up|16|||
46730862|NCT00757705|82947453|FG000|Overall Study|Withdrawal by Subject|25|||
46730863|NCT00757705|82947453|FG000|Overall Study|Insufficient Response|26|||
46730864|NCT00757705|82947453|FG000|Overall Study|Ineligible to continue|8|||
46730865|NCT00757705|82947453|FG000|Overall Study|Non-compliant|9|||
46730866|NCT00757705|82947453|FG000|Overall Study|Other|18|||
46730867|NCT00757627|82947457|FG000|Overall Study|Adverse Event|15|||
46803888|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
46803889|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
46803890|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
46803891|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
46803892|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
46803893|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
46635105|NCT01687218|82808606|FG002|Overall Study|Withdrawal by Subject|0|||
46635106|NCT01687218|82808607|FG003|Overall Study|Withdrawal by Subject|1|||
46635107|NCT01687218|82808608|FG004|Overall Study|Withdrawal by Subject|1|||
46635108|NCT01687218|82808609|FG005|Overall Study|Withdrawal by Subject|0|||
46635109|NCT01687218|82808604|FG000|Overall Study|Relocated, no follow-up planned|1|||
46635110|NCT01687218|82808605|FG001|Overall Study|Relocated, no follow-up planned|0|||
46635111|NCT01687218|82808606|FG002|Overall Study|Relocated, no follow-up planned|1|||
46635112|NCT01687218|82808607|FG003|Overall Study|Relocated, no follow-up planned|1|||
46635113|NCT01687218|82808608|FG004|Overall Study|Relocated, no follow-up planned|0|||
46635114|NCT01687218|82808609|FG005|Overall Study|Relocated, no follow-up planned|0|||
46635115|NCT01686828|82808621|FG000|Overall Study|Physician Decision|1|||
46635116|NCT01686828|82808622|FG001|Overall Study|Physician Decision|0|||
46635117|NCT01686828|82808623|FG002|Overall Study|Physician Decision|0|||
46635118|NCT01686828|82808624|FG003|Overall Study|Physician Decision|0|||
46635119|NCT01686828|82808621|FG000|Overall Study|New Job|0|||
46635120|NCT01686828|82808622|FG001|Overall Study|New Job|1|||
46635121|NCT01686828|82808623|FG002|Overall Study|New Job|0|||
46635122|NCT01686828|82808624|FG003|Overall Study|New Job|0|||
46635123|NCT01686828|82808621|FG000|Overall Study|Weight Loss|0|||
46635124|NCT01686828|82808622|FG001|Overall Study|Weight Loss|0|||
46635125|NCT01686828|82808623|FG002|Overall Study|Weight Loss|1|||
46635126|NCT01686828|82808624|FG003|Overall Study|Weight Loss|0|||
46635127|NCT01686438|82808641|FG000|Overall Study|Lost to Follow-up|8|||
46635128|NCT01686438|82808642|FG001|Overall Study|Lost to Follow-up|9|||
46635129|NCT01686438|82808643|FG002|Overall Study|Lost to Follow-up|10|||
46635130|NCT01686438|82808641|FG000|Overall Study|Adverse Event|0|||
46635131|NCT01686438|82808642|FG001|Overall Study|Adverse Event|0|||
46635132|NCT01686438|82808643|FG002|Overall Study|Adverse Event|1|||
46635133|NCT01686438|82808641|FG000|Overall Study|Protocol Violation|0|||
46635134|NCT01686438|82808642|FG001|Overall Study|Protocol Violation|0|||
46635135|NCT01686438|82808643|FG002|Overall Study|Protocol Violation|1|||
46635136|NCT01686438|82808641|FG000|Overall Study|Withdrawal by Subject|0|||
46635137|NCT01686438|82808642|FG001|Overall Study|Withdrawal by Subject|0|||
46635138|NCT01686438|82808643|FG002|Overall Study|Withdrawal by Subject|1|||
46730868|NCT00757627|82947457|FG000|Overall Study|Lack of Efficacy|10|||
46730869|NCT00757627|82947457|FG000|Overall Study|Lost to Follow-up|28|||
46730870|NCT00757627|82947457|FG000|Overall Study|Withdrawal by Subject|27|||
46730871|NCT00757627|82947457|FG000|Overall Study|Other|1|||
46730872|NCT01023308|82947468|FG000|Overall Study|Abnormal test proceedure results|3|||
46730873|NCT01023308|82947469|FG001|Overall Study|Abnormal test proceedure results|8|||
46730874|NCT01023308|82947468|FG000|Overall Study|Administrative problems|2|||
46803894|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
46803895|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
46803896|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
46803897|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
46803898|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
46921448|NCT02231762|83154006|FG000|Maintenance Phase|Disease progression|0|||
46730875|NCT01023308|82947469|FG001|Overall Study|Administrative problems|1|||
46730876|NCT01023308|82947468|FG000|Overall Study|Adverse Event|130|||
46730877|NCT01023308|82947469|FG001|Overall Study|Adverse Event|66|||
46730878|NCT01023308|82947468|FG000|Overall Study|Death|21|||
46730879|NCT01023308|82947469|FG001|Overall Study|Death|17|||
46730880|NCT01023308|82947468|FG000|Overall Study|Disease progression|82|||
46730881|NCT01023308|82947469|FG001|Overall Study|Disease progression|153|||
47048793|NCT01933217|83308936|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
47048794|NCT01933217|83308937|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
47048795|NCT01932437|83308947|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
46730882|NCT01023308|82947468|FG000|Overall Study|New Cancer therapy|4|||
46730883|NCT01023308|82947469|FG001|Overall Study|New Cancer therapy|7|||
46730884|NCT01023308|82947468|FG000|Overall Study|Protocol Violation|3|||
46730885|NCT01023308|82947469|FG001|Overall Study|Protocol Violation|4|||
46730886|NCT01023308|82947468|FG000|Overall Study|Untreated|5|||
46730887|NCT01023308|82947469|FG001|Overall Study|Untreated|5|||
47048796|NCT01932437|83308948|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
47048797|NCT01932437|83308949|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
47048798|NCT01932437|83308950|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
47048799|NCT01932437|83308951|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
47048800|NCT01932437|83308952|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
47048801|NCT01949051|83308973|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
47048802|NCT01949051|83308974|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
47048803|NCT01949051|83308975|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
47048804|NCT01949051|83308976|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
47048805|NCT01949051|83308977|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
47048806|NCT01949051|83308978|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
47048807|NCT01949051|83308973|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
47048808|NCT01949051|83308974|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47048809|NCT01949051|83308975|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47048810|NCT01949051|83308976|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47048811|NCT01949051|83308977|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47048812|NCT01949051|83308978|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47048813|NCT01949051|83308973|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
46730888|NCT01023308|82947468|FG000|Overall Study|Lost to Follow-up|1|||
46730889|NCT01023308|82947469|FG001|Overall Study|Lost to Follow-up|0|||
46730890|NCT01023308|82947468|FG000|Overall Study|Withdrawal by Subject|34|||
46730891|NCT01023308|82947469|FG001|Overall Study|Withdrawal by Subject|18|||
46730892|NCT01022996|82947475|FG000|Overall Study|Adverse Event|14|||
46730893|NCT01022996|82947475|FG000|Overall Study|Withdrawal by Subject|3|||
46730894|NCT01022996|82947475|FG000|Overall Study|Lost to Follow-up|1|||
46730895|NCT01022996|82947475|FG000|Overall Study|Administrative problems|6|||
46730896|NCT01022996|82947475|FG000|Overall Study|Disease Progression|32|||
46730897|NCT01022996|82947475|FG000|Overall Study|Protocol Violation|1|||
46921449|NCT02231762|83154007|FG001|Maintenance Phase|Disease progression|3|||
46730898|NCT00757237|82947481|FG000|Overall Study|Lost to Follow-up|0|||
46730899|NCT00757237|82947482|FG001|Overall Study|Lost to Follow-up|1|||
46730900|NCT00757237|82947481|FG000|Overall Study|Protocol Violation|0|||
46730901|NCT00757237|82947482|FG001|Overall Study|Protocol Violation|2|||
47048814|NCT01949051|83308974|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
47048815|NCT01949051|83308975|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
47048816|NCT01949051|83308976|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
47048817|NCT01949051|83308977|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
47048818|NCT01949051|83308978|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
46730902|NCT00757237|82947481|FG000|Overall Study|Physician Decision|2|||
47048819|NCT01949051|83308973|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
46730903|NCT00757237|82947482|FG001|Overall Study|Physician Decision|3|||
46730904|NCT00757237|82947481|FG000|Overall Study|Withdrawal by Subject|8|||
46730905|NCT00757237|82947482|FG001|Overall Study|Withdrawal by Subject|12|||
46730906|NCT00757237|82947481|FG000|Overall Study|Safety or Tolerability|3|||
46730907|NCT00757237|82947482|FG001|Overall Study|Safety or Tolerability|5|||
46730908|NCT00757237|82947481|FG000|Overall Study|Other|0|||
46730909|NCT00757237|82947482|FG001|Overall Study|Other|2|||
46730910|NCT01029392|82947490|FG000|Overall Study|Withdrawal by Subject|18|||
46730911|NCT01029392|82947491|FG001|Overall Study|Withdrawal by Subject|11|||
46730912|NCT01029392|82947490|FG000|Overall Study|Physician Decision|2|||
46730913|NCT01029392|82947491|FG001|Overall Study|Physician Decision|0|||
46730914|NCT00903006|82947503|FG000|Overall Study|Withdrawal by Subject|2|||
46730915|NCT00903006|82947504|FG001|Overall Study|Withdrawal by Subject|0|||
46730916|NCT00903006|82947505|FG002|Overall Study|Withdrawal by Subject|0|||
46730917|NCT00903006|82947506|FG003|Overall Study|Withdrawal by Subject|0|||
46730918|NCT00903006|82947503|FG000|Overall Study|Progressive Disease|0|||
46730919|NCT00903006|82947504|FG001|Overall Study|Progressive Disease|3|||
46730920|NCT00903006|82947505|FG002|Overall Study|Progressive Disease|1|||
46730921|NCT00903006|82947506|FG003|Overall Study|Progressive Disease|0|||
46730922|NCT00839332|82947519|FG000|Phase 1|Disease Progression|38|||
46730923|NCT00839332|82947520|FG001|Phase 1|Disease Progression|0|||
46730924|NCT00839332|82947521|FG002|Phase 1|Disease Progression|0|||
46730925|NCT00839332|82947519|FG000|Phase 1|Adverse Event|6|||
46730926|NCT00839332|82947520|FG001|Phase 1|Adverse Event|0|||
46730927|NCT00839332|82947521|FG002|Phase 1|Adverse Event|0|||
46730928|NCT00839332|82947519|FG000|Phase 1|Withdrawal by Subject|4|||
46730929|NCT00839332|82947520|FG001|Phase 1|Withdrawal by Subject|0|||
46730930|NCT00839332|82947521|FG002|Phase 1|Withdrawal by Subject|0|||
46730931|NCT00839332|82947519|FG000|Phase 1|Physician Decision|2|||
46730932|NCT00839332|82947520|FG001|Phase 1|Physician Decision|0|||
46730933|NCT00839332|82947521|FG002|Phase 1|Physician Decision|0|||
46730934|NCT00839332|82947519|FG000|Phase 2|Protocol Violation|0|||
46730935|NCT00839332|82947520|FG001|Phase 2|Protocol Violation|1|||
46730936|NCT00839332|82947521|FG002|Phase 2|Protocol Violation|0|||
46730937|NCT00839332|82947519|FG000|Phase 2|Disease Progression|0|||
46730938|NCT00839332|82947520|FG001|Phase 2|Disease Progression|46|||
46730939|NCT00839332|82947521|FG002|Phase 2|Disease Progression|21|||
46730940|NCT00839332|82947519|FG000|Phase 2|Adverse Event|0|||
46730941|NCT00839332|82947520|FG001|Phase 2|Adverse Event|8|||
46730942|NCT00839332|82947521|FG002|Phase 2|Adverse Event|6|||
46730943|NCT00839332|82947519|FG000|Phase 2|Death|0|||
46730944|NCT00839332|82947520|FG001|Phase 2|Death|4|||
46730945|NCT00839332|82947521|FG002|Phase 2|Death|2|||
46730946|NCT00839332|82947519|FG000|Phase 2|Withdrawal by Subject|0|||
46730947|NCT00839332|82947520|FG001|Phase 2|Withdrawal by Subject|5|||
46730948|NCT00839332|82947521|FG002|Phase 2|Withdrawal by Subject|8|||
46730949|NCT00839332|82947519|FG000|Phase 2|Physician Decision|0|||
46730950|NCT00839332|82947520|FG001|Phase 2|Physician Decision|4|||
46730951|NCT00839332|82947521|FG002|Phase 2|Physician Decision|1|||
46730952|NCT00839332|82947519|FG000|Phase 2|Lost to Follow-up|0|||
46730953|NCT00839332|82947520|FG001|Phase 2|Lost to Follow-up|0|||
46730954|NCT00839332|82947521|FG002|Phase 2|Lost to Follow-up|1|||
47048820|NCT01949051|83308974|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
47048821|NCT01949051|83308975|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
47048822|NCT01949051|83308976|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
46730955|NCT00902850|82947532|FG000|Overall Study|Physician Decision|2|||
46730956|NCT00902850|82947533|FG001|Overall Study|Physician Decision|2|||
46730957|NCT00902538|82947542|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
46730958|NCT00902538|82947543|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
46730959|NCT00902538|82947544|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
46730960|NCT00902538|82947545|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
47048823|NCT01949051|83308977|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
47048824|NCT01949051|83308978|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
47048825|NCT01949051|83308973|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
46730961|NCT00902538|82947546|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
46730962|NCT00902538|82947547|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
46730963|NCT00902538|82947542|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
46730964|NCT00902538|82947543|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
46730965|NCT00902538|82947544|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
46730966|NCT00902538|82947545|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
46730967|NCT00902538|82947546|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
46730968|NCT00902538|82947547|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
46730969|NCT00902538|82947542|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
46730970|NCT00902538|82947543|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
46921450|NCT02231762|83154008|FG002|Maintenance Phase|Disease progression|4|||
46921451|NCT02231762|83154009|FG003|Maintenance Phase|Disease progression|3|||
46730971|NCT00902538|82947544|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
46775727|NCT00793793|82994208|FG004|Overall Study|Adverse Event|0|||
47048826|NCT01949051|83308974|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
46730972|NCT00902538|82947545|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
46730973|NCT00902538|82947546|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
46730974|NCT00902538|82947547|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
46730975|NCT00902538|82947542|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
46730976|NCT00902538|82947543|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
46730977|NCT00902538|82947544|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
46730978|NCT00902538|82947545|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
46730979|NCT00902538|82947546|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
46730980|NCT00902538|82947547|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
46730981|NCT00902538|82947542|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
46730982|NCT00902538|82947543|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
46730983|NCT00902538|82947544|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
46730984|NCT00902538|82947545|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
46730985|NCT00902538|82947546|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
46730986|NCT00902538|82947547|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
46730987|NCT00902538|82947542|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
46730988|NCT00902538|82947543|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
46730989|NCT00902538|82947544|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
46730990|NCT00902538|82947545|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
46730991|NCT00902538|82947546|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
46730992|NCT00902538|82947547|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
46730993|NCT00902538|82947542|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
46730994|NCT00902538|82947543|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
46730995|NCT00902538|82947544|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
46730996|NCT00902538|82947545|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
46730997|NCT00902538|82947546|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
46730998|NCT00902538|82947547|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
46730999|NCT00902538|82947542|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
46731000|NCT00902538|82947543|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
46731001|NCT00902538|82947544|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
46731002|NCT00902538|82947545|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
46731003|NCT00902538|82947546|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
46731004|NCT00902538|82947547|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
46731005|NCT00902538|82947542|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
46731006|NCT00902538|82947543|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
46731007|NCT00902538|82947544|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
46731008|NCT00902538|82947545|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
46731009|NCT00902538|82947546|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
46731010|NCT00902538|82947547|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
46731011|NCT00902538|82947542|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
46731012|NCT00902538|82947543|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
46731013|NCT00902538|82947544|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
46731014|NCT00902538|82947545|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
46731015|NCT00902538|82947546|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
46731016|NCT00902538|82947547|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
46731017|NCT00902538|82947542|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
46731018|NCT00902538|82947543|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
46731019|NCT00902538|82947544|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
46731020|NCT00902538|82947545|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
47048827|NCT01949051|83308975|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
47048828|NCT01949051|83308976|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
47048829|NCT01949051|83308977|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
47048830|NCT01949051|83308978|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
47048831|NCT01948427|83308991|FG000|Overall Study|Serious Adverse Event|3|||
47048832|NCT01948427|83308992|FG001|Overall Study|Serious Adverse Event|0|||
47048833|NCT01948427|83308993|FG002|Overall Study|Serious Adverse Event|0|||
47048834|NCT01948427|83308994|FG003|Overall Study|Serious Adverse Event|0|||
47048835|NCT01948427|83308995|FG004|Overall Study|Serious Adverse Event|1|||
46635139|NCT01593696|82808657|FG000|Dose Escalation|Progressive Disease|2|||
46635140|NCT01593696|82808658|FG001|Dose Escalation|Progressive Disease|0|||
46635141|NCT01593696|82808659|FG002|Dose Escalation|Progressive Disease|0|||
46635142|NCT01593696|82808660|FG003|Dose Escalation|Progressive Disease|0|||
46635143|NCT01593696|82808657|FG000|Dose Expansion|Fungal infection|0|||
46635144|NCT01593696|82808658|FG001|Dose Expansion|Fungal infection|0|||
46635145|NCT01593696|82808659|FG002|Dose Expansion|Fungal infection|1|||
46635146|NCT01593696|82808660|FG003|Dose Expansion|Fungal infection|0|||
47048836|NCT01948427|83308991|FG000|Overall Study|Investigator Request|0|||
47048837|NCT01948427|83308992|FG001|Overall Study|Investigator Request|8|||
47048838|NCT01948427|83308993|FG002|Overall Study|Investigator Request|0|||
46731021|NCT00902538|82947546|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
47048839|NCT01948427|83308994|FG003|Overall Study|Investigator Request|0|||
47048840|NCT01948427|83308995|FG004|Overall Study|Investigator Request|6|||
47048841|NCT01948427|83308991|FG000|Overall Study|Lost to Follow-up|1|||
47048842|NCT01948427|83308992|FG001|Overall Study|Lost to Follow-up|0|||
47048843|NCT01948427|83308993|FG002|Overall Study|Lost to Follow-up|0|||
47048844|NCT01948427|83308994|FG003|Overall Study|Lost to Follow-up|0|||
47048845|NCT01948427|83308995|FG004|Overall Study|Lost to Follow-up|4|||
47048846|NCT01948427|83308991|FG000|Overall Study|Withdrawal by Subject|2|||
47048847|NCT01948427|83308992|FG001|Overall Study|Withdrawal by Subject|0|||
46731022|NCT00902538|82947547|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
46731023|NCT00902538|82947542|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
46731024|NCT00902538|82947543|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
46731025|NCT00902538|82947544|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
46731026|NCT00902538|82947545|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
46731027|NCT00902538|82947546|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
46731028|NCT00902538|82947547|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
46731029|NCT00902538|82947542|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
46731030|NCT00902538|82947543|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
46731031|NCT00902538|82947544|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
46731032|NCT00902538|82947545|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
46731033|NCT00902538|82947546|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
46731034|NCT00902538|82947547|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
46731035|NCT00902538|82947542|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
46731036|NCT00902538|82947543|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
46731037|NCT00902538|82947544|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
46731038|NCT00902538|82947545|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
46731039|NCT00902538|82947546|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
46731040|NCT00902538|82947547|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
46731041|NCT00902538|82947542|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
46731042|NCT00902538|82947543|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
46731043|NCT00902538|82947544|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
46731044|NCT00902538|82947545|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
46731045|NCT00902538|82947546|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
46731046|NCT00902538|82947547|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
46731047|NCT00902538|82947542|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
46731048|NCT00902538|82947543|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
46731049|NCT00902538|82947544|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
46731050|NCT00902538|82947545|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
46731051|NCT00902538|82947546|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
46731052|NCT00902538|82947547|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
46731053|NCT00902538|82947542|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
46731054|NCT00902538|82947543|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
46731055|NCT00902538|82947544|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
46731056|NCT00902538|82947545|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
46731057|NCT00902538|82947546|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
46731058|NCT00902538|82947547|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
46731059|NCT01036022|82947565|FG000|Overall Study|Adverse Event|1|||
46731060|NCT01036022|82947566|FG001|Overall Study|Adverse Event|3|||
46731061|NCT01036022|82947567|FG002|Overall Study|Adverse Event|2|||
46731062|NCT01036022|82947568|FG003|Overall Study|Adverse Event|1|||
46731063|NCT01036022|82947569|FG004|Overall Study|Adverse Event|0|||
46731064|NCT01036022|82947570|FG005|Overall Study|Adverse Event|2|||
46731065|NCT01036022|82947565|FG000|Overall Study|Lack of Efficacy|1|||
46731066|NCT01036022|82947566|FG001|Overall Study|Lack of Efficacy|1|||
46731067|NCT01036022|82947567|FG002|Overall Study|Lack of Efficacy|1|||
46731068|NCT01036022|82947568|FG003|Overall Study|Lack of Efficacy|0|||
47048848|NCT01948427|83308993|FG002|Overall Study|Withdrawal by Subject|0|||
47048849|NCT01948427|83308994|FG003|Overall Study|Withdrawal by Subject|0|||
47048850|NCT01948427|83308995|FG004|Overall Study|Withdrawal by Subject|1|||
47048851|NCT01948427|83308991|FG000|Overall Study|Other, Not Specified|1|||
47048852|NCT01948427|83308992|FG001|Overall Study|Other, Not Specified|9|||
46731069|NCT01036022|82947569|FG004|Overall Study|Lack of Efficacy|1|||
46731070|NCT01036022|82947570|FG005|Overall Study|Lack of Efficacy|1|||
46731071|NCT01036022|82947565|FG000|Overall Study|Physician Decision|0|||
46731072|NCT01036022|82947566|FG001|Overall Study|Physician Decision|0|||
46731073|NCT01036022|82947567|FG002|Overall Study|Physician Decision|1|||
46731074|NCT01036022|82947568|FG003|Overall Study|Physician Decision|0|||
47048853|NCT01948427|83308993|FG002|Overall Study|Other, Not Specified|0|||
47048854|NCT01948427|83308994|FG003|Overall Study|Other, Not Specified|0|||
47048855|NCT01948427|83308995|FG004|Overall Study|Other, Not Specified|2|||
47048856|NCT01948193|83309012|FG000|Overall Study|Serious event|2|||
47048857|NCT01948193|83309012|FG000|Overall Study|Lost to Follow-up|7|||
47048858|NCT01694485|83309022|FG000|Overall Study|Withdrawal by Subject|20|||
47048859|NCT01694485|83309023|FG001|Overall Study|Withdrawal by Subject|6|||
47048860|NCT01694485|83309024|FG002|Overall Study|Withdrawal by Subject|7|||
47048861|NCT01694485|83309025|FG003|Overall Study|Withdrawal by Subject|25|||
47048862|NCT01694485|83309026|FG004|Overall Study|Withdrawal by Subject|18|||
47048863|NCT01694485|83309022|FG000|Overall Study|Sponsor Decision|3|||
47048864|NCT01694485|83309023|FG001|Overall Study|Sponsor Decision|0|||
47048865|NCT01694485|83309024|FG002|Overall Study|Sponsor Decision|0|||
47048866|NCT01694485|83309025|FG003|Overall Study|Sponsor Decision|2|||
47048867|NCT01694485|83309026|FG004|Overall Study|Sponsor Decision|0|||
47048868|NCT01694485|83309022|FG000|Overall Study|Lost to Follow-up|9|||
47048869|NCT01694485|83309023|FG001|Overall Study|Lost to Follow-up|1|||
47048870|NCT01694485|83309024|FG002|Overall Study|Lost to Follow-up|6|||
47048871|NCT01694485|83309025|FG003|Overall Study|Lost to Follow-up|10|||
47048872|NCT01694485|83309026|FG004|Overall Study|Lost to Follow-up|7|||
47048873|NCT01694485|83309022|FG000|Overall Study|Death|1|||
47048874|NCT01694485|83309023|FG001|Overall Study|Death|0|||
47048875|NCT01694485|83309024|FG002|Overall Study|Death|0|||
47048876|NCT01694485|83309025|FG003|Overall Study|Death|1|||
47048877|NCT01694485|83309026|FG004|Overall Study|Death|0|||
47048878|NCT01931735|83309047|FG000|Randomized Phase|Lost to Follow-up|2|||
47048879|NCT01931735|83309048|FG001|Randomized Phase|Lost to Follow-up|2|||
47048880|NCT01931735|83309049|FG002|Randomized Phase|Lost to Follow-up|5|||
47048881|NCT01931735|83309050|FG003|Randomized Phase|Lost to Follow-up|0|||
47048882|NCT01931735|83309047|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
47048883|NCT01931735|83309048|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
47048884|NCT01931735|83309049|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
47048885|NCT01931735|83309050|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
47048886|NCT01931735|83309047|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
47048887|NCT01931735|83309048|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
47048888|NCT01931735|83309049|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
47048889|NCT01931735|83309050|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
47048890|NCT01930799|83309060|FG000|Overall Study|Withdrawal by Subject|3|||
47048891|NCT01930799|83309060|FG000|Overall Study|Lost to Follow-up|5|||
47048892|NCT01715857|83309064|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
47048893|NCT01692301|83309070|FG000|Overall Study|Adverse Event|15|||
47048894|NCT01692301|83309071|FG001|Overall Study|Adverse Event|12|||
47048895|NCT01692301|83309070|FG000|Overall Study|Death|1|||
47048896|NCT01692301|83309071|FG001|Overall Study|Death|2|||
47048897|NCT01692301|83309070|FG000|Overall Study|Lack of Efficacy|0|||
47048898|NCT01692301|83309071|FG001|Overall Study|Lack of Efficacy|5|||
47048899|NCT01692301|83309070|FG000|Overall Study|Non-compliance with study treatment|1|||
47048900|NCT01692301|83309071|FG001|Overall Study|Non-compliance with study treatment|2|||
47048901|NCT01692301|83309070|FG000|Overall Study|Protocol deviation|9|||
47048902|NCT01692301|83309071|FG001|Overall Study|Protocol deviation|2|||
47048903|NCT01692301|83309070|FG000|Overall Study|Patient/guardian decision|16|||
47048904|NCT01692301|83309071|FG001|Overall Study|Patient/guardian decision|15|||
47048905|NCT01692301|83309070|FG000|Overall Study|Technical problems|0|||
47048906|NCT01692301|83309071|FG001|Overall Study|Technical problems|1|||
47048907|NCT01692301|83309070|FG000|Overall Study|Physician Decision|2|||
47048908|NCT01692301|83309071|FG001|Overall Study|Physician Decision|2|||
47048909|NCT01692301|83309070|FG000|Overall Study|Lost to Follow-up|1|||
47048910|NCT01692301|83309071|FG001|Overall Study|Lost to Follow-up|1|||
47048911|NCT01592773|83309077|FG000|Overall Study|Study Terminated by Sponsor|582|||
47048912|NCT01592773|83309077|FG000|Overall Study|Withdrawal by Subject|35|||
47048913|NCT01592773|83309077|FG000|Overall Study|Lost to Follow-up|19|||
47048914|NCT01592773|83309077|FG000|Overall Study|Adverse Event|17|||
47048915|NCT01592773|83309077|FG000|Overall Study|Lack of Efficacy|9|||
47048916|NCT01592773|83309077|FG000|Overall Study|Protocol Violation|2|||
47048917|NCT01592773|83309077|FG000|Overall Study|Inclusion/exclusion not meet|1|||
47048918|NCT01592773|83309077|FG000|Overall Study|Other Reason|1|||
47048919|NCT01930175|83309084|FG000|Core Study|Lost to Follow-up|0|||
47048920|NCT01930175|83309085|FG001|Core Study|Lost to Follow-up|1|||
47048921|NCT01930175|83309086|FG002|Core Study|Lost to Follow-up|0|||
47048922|NCT01930175|83309084|FG000|Core Study|Adverse Event|0|||
47048923|NCT01930175|83309085|FG001|Core Study|Adverse Event|0|||
47048924|NCT01930175|83309086|FG002|Core Study|Adverse Event|1|||
47048925|NCT01592695|83309097|FG000|Overall Study|Lost to Follow-up|8|||
47048926|NCT01592695|83309098|FG001|Overall Study|Lost to Follow-up|4|||
47048927|NCT01929863|83309104|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
47048928|NCT01929863|83309105|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
47048929|NCT01929863|83309104|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
46731075|NCT01036022|82947569|FG004|Overall Study|Physician Decision|0|||
46731076|NCT01036022|82947570|FG005|Overall Study|Physician Decision|0|||
46731077|NCT01036022|82947565|FG000|Overall Study|Withdrawal by Subject|0|||
47048930|NCT01929863|83309105|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
47048931|NCT01929863|83309104|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
46731078|NCT01036022|82947566|FG001|Overall Study|Withdrawal by Subject|0|||
46731079|NCT01036022|82947567|FG002|Overall Study|Withdrawal by Subject|0|||
46731080|NCT01036022|82947568|FG003|Overall Study|Withdrawal by Subject|1|||
46731081|NCT01036022|82947569|FG004|Overall Study|Withdrawal by Subject|2|||
46731082|NCT01036022|82947570|FG005|Overall Study|Withdrawal by Subject|0|||
46731083|NCT00752557|82947595|FG000|Overall Study|Withdrawal by Subject|4|||
46731084|NCT00752557|82947596|FG001|Overall Study|Withdrawal by Subject|3|||
46731085|NCT00752557|82947597|FG002|Overall Study|Withdrawal by Subject|3|||
46731086|NCT00752557|82947595|FG000|Overall Study|Unspecified resaons|0|||
46731087|NCT00752557|82947596|FG001|Overall Study|Unspecified resaons|2|||
46731088|NCT00752557|82947597|FG002|Overall Study|Unspecified resaons|2|||
46731089|NCT00752557|82947595|FG000|Overall Study|Lost to Follow-up|1|||
47048932|NCT01929863|83309105|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
47048933|NCT01918085|83309118|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
46731090|NCT00752557|82947596|FG001|Overall Study|Lost to Follow-up|0|||
46731091|NCT00752557|82947597|FG002|Overall Study|Lost to Follow-up|1|||
46731092|NCT00747643|82947609|FG000|Overall Study|Withdrawal by Subject|36|||
46731093|NCT00747643|82947610|FG001|Overall Study|Withdrawal by Subject|27|||
46731094|NCT01022762|82947618|FG000|Overall Study|Adverse Event|3|||
46731095|NCT01022762|82947619|FG001|Overall Study|Adverse Event|1|||
46731096|NCT01022762|82947618|FG000|Overall Study|Lack of Efficacy|0|||
46731097|NCT01022762|82947619|FG001|Overall Study|Lack of Efficacy|1|||
46731098|NCT01022762|82947618|FG000|Overall Study|Protocol Violation|7|||
46731099|NCT01022762|82947619|FG001|Overall Study|Protocol Violation|6|||
46731100|NCT01022762|82947618|FG000|Overall Study|Unclassified|12|||
46731101|NCT01022762|82947619|FG001|Overall Study|Unclassified|20|||
46731102|NCT01028378|82947625|FG000|Overall Study|Lost to Follow-up|12|||
46731103|NCT01028378|82947625|FG000|Overall Study|Withdrawal by Subject|1|||
46731104|NCT01028378|82947625|FG000|Overall Study|Adminstrative Reasons|4|||
46731105|NCT00747565|82947631|FG000|Overall Study|Withdrawal by Subject|10|||
46731106|NCT00747565|82947632|FG001|Overall Study|Withdrawal by Subject|6|||
46731107|NCT00747565|82947631|FG000|Overall Study|Lost to Follow-up|4|||
46731108|NCT00747565|82947632|FG001|Overall Study|Lost to Follow-up|1|||
46731109|NCT01028300|82947638|FG000|Overall Study|Study Terminated|4|||
46731110|NCT00752089|82947642|FG000|Overall Study|Adverse Event|1|||
46731111|NCT00752089|82947642|FG000|Overall Study|Protocol Deviation|2|||
46731112|NCT00752089|82947642|FG000|Overall Study|Could not attend visit 9|1|||
46731113|NCT00752089|82947642|FG000|Overall Study|Not capable of wearing partial denture|1|||
46731114|NCT00752089|82947642|FG000|Overall Study|Cannot continue the study|1|||
46731115|NCT00751933|82947653|FG000|Overall Study|Withdrawal by Subject|0|||
46731116|NCT00751933|82947654|FG001|Overall Study|Withdrawal by Subject|1|||
46731117|NCT00751933|82947655|FG002|Overall Study|Withdrawal by Subject|0|||
46731118|NCT00751933|82947656|FG003|Overall Study|Withdrawal by Subject|0|||
46731119|NCT00751933|82947653|FG000|Overall Study|Physician Decision|0|||
46731120|NCT00751933|82947654|FG001|Overall Study|Physician Decision|0|||
46731121|NCT00751933|82947655|FG002|Overall Study|Physician Decision|1|||
46731122|NCT00751933|82947656|FG003|Overall Study|Physician Decision|1|||
46731123|NCT00751621|82947660|FG000|Overall Study|Adverse Event|1|||
46731124|NCT00751621|82947660|FG000|Overall Study|Withdrawal by Subject|1|||
46731125|NCT00751621|82947660|FG000|Overall Study|Subject moved to another country|1|||
46731126|NCT00751621|82947660|FG000|Overall Study|Poor adherence to asthma treatment|1|||
46731127|NCT01028222|82947668|FG000|Overall Study|Protocol deviation|1|||
46731128|NCT01028222|82947669|FG001|Overall Study|Protocol deviation|0|||
46803899|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
47048934|NCT01918085|83309119|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
47048935|NCT01714687|83309129|FG000|Overall Study|Withdrawal by Subject|1|||
47048936|NCT01714687|83309130|FG001|Overall Study|Withdrawal by Subject|0|||
46731129|NCT01028222|82947668|FG000|Overall Study|Disease progression|33|||
46731130|NCT01028222|82947669|FG001|Overall Study|Disease progression|9|||
46803900|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
46803901|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
46803902|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
46803903|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
46803904|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
46731131|NCT01028222|82947668|FG000|Overall Study|Administrative problems|1|||
46731132|NCT01028222|82947669|FG001|Overall Study|Administrative problems|1|||
46731133|NCT01028222|82947668|FG000|Overall Study|Lost to Follow-up|0|||
46731134|NCT01028222|82947669|FG001|Overall Study|Lost to Follow-up|1|||
46731135|NCT01028222|82947668|FG000|Overall Study|Withdrawal by Subject|1|||
46731136|NCT01028222|82947669|FG001|Overall Study|Withdrawal by Subject|0|||
46731137|NCT01028222|82947668|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
46731138|NCT01028222|82947669|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
46731139|NCT01028222|82947668|FG000|Overall Study|Adverse Event|2|||
46731140|NCT01028222|82947669|FG001|Overall Study|Adverse Event|0|||
46731141|NCT00586495|82947676|FG000|Treatment Period|Adverse Event|11|||
46731142|NCT00586495|82947676|FG000|Treatment Period|Death|1|||
46731143|NCT00586495|82947676|FG000|Treatment Period|Protocol Violation|1|||
46731144|NCT00586495|82947676|FG000|Treatment Period|Withdrawal by Subject|1|||
46731145|NCT00586495|82947676|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
46731146|NCT00586495|82947676|FG000|Treatment Period|Switch to commercial drug|10|||
46731147|NCT00586495|82947676|FG000|Follow-up|Death|40|||
46731148|NCT00586495|82947676|FG000|Follow-up|Lost to Follow-up|1|||
47048937|NCT01714687|83309129|FG000|Overall Study|Lost to Follow-up|2|||
47048938|NCT01714687|83309130|FG001|Overall Study|Lost to Follow-up|4|||
47048939|NCT01714609|83309140|FG000|Overall Study|Protocol Violation|1|||
47048940|NCT01714609|83309141|FG001|Overall Study|Protocol Violation|0|||
46731149|NCT00586495|82947676|FG000|Follow-up|Withdrawal by Subject|4|||
46731150|NCT00586495|82947676|FG000|Follow-up|Protocol driven decision point|37|||
46731151|NCT00586495|82947676|FG000|Follow-up|Switch to commercial drug|10|||
46731152|NCT01027754|82947682|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
46731153|NCT01027754|82947683|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
46731154|NCT01027754|82947682|FG000|Overall Study|Withdrawal by Subject|0|||
46731155|NCT01027754|82947683|FG001|Overall Study|Withdrawal by Subject|5|||
46731156|NCT01034540|82947695|FG000|Overall Study|Adverse Event|0|||
46731157|NCT01034540|82947696|FG001|Overall Study|Adverse Event|1|||
46731158|NCT00774930|82947706|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
46731159|NCT00774930|82947707|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
46731160|NCT00774930|82947706|FG000|DB Phase|Adverse Event|1|||
46731161|NCT00774930|82947707|FG001|DB Phase|Adverse Event|2|||
46731162|NCT00774930|82947706|FG000|DB Phase|Subject Decision|1|||
46731163|NCT00774930|82947707|FG001|DB Phase|Subject Decision|5|||
46731164|NCT00774930|82947706|FG000|DB Phase|Sponsor Decision|0|||
46731165|NCT00774930|82947707|FG001|DB Phase|Sponsor Decision|1|||
46731166|NCT00774930|82947706|FG000|DB Phase|Disease Progression|1|||
46731167|NCT00774930|82947707|FG001|DB Phase|Disease Progression|1|||
46731168|NCT00774930|82947706|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
46731169|NCT00774930|82947707|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
46731170|NCT00774930|82947706|FG000|IOL Phase|Adverse Event|1|||
46731171|NCT00774930|82947707|FG001|IOL Phase|Adverse Event|1|||
46731172|NCT00774930|82947706|FG000|IOL Phase|Subject Decision|4|||
46731173|NCT00774930|82947707|FG001|IOL Phase|Subject Decision|3|||
46731174|NCT00774930|82947706|FG000|IOL Phase|Physician Decision|3|||
46731175|NCT00774930|82947707|FG001|IOL Phase|Physician Decision|2|||
46731176|NCT00774930|82947706|FG000|IOL Phase|Sponsor Decision|1|||
46731177|NCT00774930|82947707|FG001|IOL Phase|Sponsor Decision|0|||
46731178|NCT00774930|82947706|FG000|IOL Phase|Disease Progression|2|||
46731179|NCT00774930|82947707|FG001|IOL Phase|Disease Progression|1|||
46921452|NCT02231762|83154006|FG000|Maintenance Phase|Adverse Event|0|||
47048941|NCT01929707|83309147|FG000|Intervention Period 1|Lost to Follow-up|0|||
47048942|NCT01929707|83309148|FG001|Intervention Period 1|Lost to Follow-up|0|||
47048943|NCT01929707|83309149|FG002|Intervention Period 1|Lost to Follow-up|0|||
46731180|NCT00774930|82947706|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
46731181|NCT00774930|82947707|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
46731182|NCT00774930|82947706|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
46731183|NCT00774930|82947707|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
46731184|NCT00774930|82947706|FG000|IOL Phase|Other|1|||
46731185|NCT00774930|82947707|FG001|IOL Phase|Other|0|||
46731186|NCT00774930|82947706|FG000|IOL Phase|Brain radiation|0|||
46731187|NCT00774930|82947707|FG001|IOL Phase|Brain radiation|1|||
46731188|NCT00774930|82947706|FG000|LTOLE Phase|Adverse Event|7|||
46731189|NCT00774930|82947707|FG001|LTOLE Phase|Adverse Event|3|||
46731190|NCT00774930|82947706|FG000|LTOLE Phase|Subject decision|0|||
46731191|NCT00774930|82947707|FG001|LTOLE Phase|Subject decision|5|||
46921453|NCT02231762|83154007|FG001|Maintenance Phase|Adverse Event|0|||
46921454|NCT02231762|83154008|FG002|Maintenance Phase|Adverse Event|1|||
46921455|NCT02231762|83154009|FG003|Maintenance Phase|Adverse Event|2|||
46921456|NCT03023397|83154026|FG000|Run-In|Failed screening allergen challenge|1|||
46921457|NCT03023397|83154027|FG001|Run-In|Failed screening allergen challenge|0|||
46921458|NCT03023397|83154028|FG002|Run-In|Failed screening allergen challenge|0|||
46921459|NCT03023397|83154026|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
46921460|NCT03023397|83154027|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
46921461|NCT03023397|83154028|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
46921462|NCT04325906|83154039|FG000|Overall Study|Withdrawal by Subject|2|||
46731192|NCT00774930|82947706|FG000|LTOLE Phase|Physician Decision|4|||
46731193|NCT00774930|82947707|FG001|LTOLE Phase|Physician Decision|1|||
46731194|NCT00774930|82947706|FG000|LTOLE Phase|Sponsor decision|2|||
46731195|NCT00774930|82947707|FG001|LTOLE Phase|Sponsor decision|1|||
46731196|NCT00774930|82947706|FG000|LTOLE Phase|Disease Progression|2|||
46731197|NCT00774930|82947707|FG001|LTOLE Phase|Disease Progression|5|||
46731198|NCT00774930|82947706|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
46731199|NCT00774930|82947707|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
46731200|NCT00774930|82947706|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
46731201|NCT00774930|82947707|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
46731202|NCT01027364|82947728|FG000|Overall Study|Adverse Event|1|||
46731203|NCT01027364|82947729|FG001|Overall Study|Adverse Event|0|||
46731204|NCT01027364|82947730|FG002|Overall Study|Adverse Event|1|||
46731205|NCT01027364|82947731|FG003|Overall Study|Adverse Event|0|||
46731206|NCT01027364|82947728|FG000|Overall Study|Lost to Follow-up|1|||
46731207|NCT01027364|82947729|FG001|Overall Study|Lost to Follow-up|0|||
46731208|NCT01027364|82947730|FG002|Overall Study|Lost to Follow-up|0|||
46731209|NCT01027364|82947731|FG003|Overall Study|Lost to Follow-up|0|||
46731210|NCT01027364|82947728|FG000|Overall Study|Protocol Violation|1|||
46731211|NCT01027364|82947729|FG001|Overall Study|Protocol Violation|0|||
46731212|NCT01027364|82947730|FG002|Overall Study|Protocol Violation|0|||
46731213|NCT01027364|82947731|FG003|Overall Study|Protocol Violation|1|||
46731214|NCT01027364|82947728|FG000|Overall Study|Withdrawal by Subject|1|||
46731215|NCT01027364|82947729|FG001|Overall Study|Withdrawal by Subject|2|||
46731216|NCT01027364|82947730|FG002|Overall Study|Withdrawal by Subject|0|||
46731217|NCT01027364|82947731|FG003|Overall Study|Withdrawal by Subject|0|||
46731218|NCT01027286|82947759|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
46731219|NCT01027286|82947760|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
46731220|NCT01027286|82947759|FG000|Overall Study|Lost to Follow-up|0|||
46731221|NCT01027286|82947760|FG001|Overall Study|Lost to Follow-up|1|||
46731222|NCT01026974|82947770|FG000|Overall Study|Withdrawal by Subject|0|||
46731223|NCT01026974|82947771|FG001|Overall Study|Withdrawal by Subject|1|||
46731224|NCT01026974|82947772|FG002|Overall Study|Withdrawal by Subject|7|||
46731225|NCT01026974|82947773|FG003|Overall Study|Withdrawal by Subject|2|||
46731226|NCT01026974|82947770|FG000|Overall Study|Lost to Follow-up|1|||
46731227|NCT01026974|82947771|FG001|Overall Study|Lost to Follow-up|1|||
46731228|NCT01026974|82947772|FG002|Overall Study|Lost to Follow-up|4|||
46731229|NCT01026974|82947773|FG003|Overall Study|Lost to Follow-up|0|||
46731230|NCT01026974|82947770|FG000|Overall Study|Adverse Event|0|||
46731231|NCT01026974|82947771|FG001|Overall Study|Adverse Event|0|||
46731232|NCT01026974|82947772|FG002|Overall Study|Adverse Event|0|||
46731233|NCT01026974|82947773|FG003|Overall Study|Adverse Event|1|||
46731234|NCT01026974|82947770|FG000|Overall Study|Inappropriate enrollment|0|||
46731235|NCT01026974|82947771|FG001|Overall Study|Inappropriate enrollment|0|||
46731236|NCT01026974|82947772|FG002|Overall Study|Inappropriate enrollment|1|||
46731237|NCT01026974|82947773|FG003|Overall Study|Inappropriate enrollment|0|||
46731238|NCT00897390|82947788|FG000|Overall Study|Adverse Event|2|||
46731239|NCT00897390|82947788|FG000|Overall Study|No Longer Met Study Criteria|1|||
46731240|NCT00897390|82947788|FG000|Overall Study|Personal Reasons|1|||
46731241|NCT00897390|82947788|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
46731242|NCT01034462|82947801|FG000|Overall Study|Adverse Event|7|||
46731243|NCT01034462|82947802|FG001|Overall Study|Adverse Event|17|||
46731244|NCT01034462|82947801|FG000|Overall Study|Lack of Efficacy|4|||
46731245|NCT01034462|82947802|FG001|Overall Study|Lack of Efficacy|4|||
46731246|NCT01034462|82947801|FG000|Overall Study|Protocol Violation|10|||
46731247|NCT01034462|82947802|FG001|Overall Study|Protocol Violation|7|||
46731248|NCT01034462|82947801|FG000|Overall Study|Withdrawal by Subject|9|||
46731249|NCT01034462|82947802|FG001|Overall Study|Withdrawal by Subject|8|||
46731250|NCT01034462|82947801|FG000|Overall Study|Lost to Follow-up|14|||
46731251|NCT01034462|82947802|FG001|Overall Study|Lost to Follow-up|16|||
46731252|NCT01034462|82947801|FG000|Overall Study|Other reasons|1|||
46731253|NCT01034462|82947802|FG001|Overall Study|Other reasons|2|||
46731254|NCT01033448|82947810|FG000|Overall Study|Withdrawal by Subject|4|||
46731255|NCT01033448|82947810|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
46731256|NCT01033448|82947810|FG000|Overall Study|Lost to Follow-up|3|||
46731257|NCT01033448|82947810|FG000|Overall Study|Withdrew due to other reasons|3|||
46731258|NCT01033448|82947810|FG000|Overall Study|Unknown disposition|1|||
46731259|NCT00746941|82947820|FG000|Overall Study|Death|2|||
46731260|NCT00746941|82947821|FG001|Overall Study|Death|0|||
46731261|NCT00746941|82947822|FG002|Overall Study|Death|0|||
46731262|NCT00746941|82947823|FG003|Overall Study|Death|6|||
46731263|NCT00746941|82947820|FG000|Overall Study|Physician Decision|0|||
46731264|NCT00746941|82947821|FG001|Overall Study|Physician Decision|0|||
46731265|NCT00746941|82947822|FG002|Overall Study|Physician Decision|2|||
46731266|NCT00746941|82947823|FG003|Overall Study|Physician Decision|0|||
46731267|NCT00746941|82947820|FG000|Overall Study|Withdrawal by Subject|3|||
46731268|NCT00746941|82947821|FG001|Overall Study|Withdrawal by Subject|0|||
46731269|NCT00746941|82947822|FG002|Overall Study|Withdrawal by Subject|0|||
46731270|NCT00746941|82947823|FG003|Overall Study|Withdrawal by Subject|2|||
46731271|NCT00746941|82947820|FG000|Overall Study|Other, reason not provided|2|||
46731272|NCT00746941|82947821|FG001|Overall Study|Other, reason not provided|4|||
46731273|NCT00746941|82947822|FG002|Overall Study|Other, reason not provided|0|||
46731274|NCT00746941|82947823|FG003|Overall Study|Other, reason not provided|4|||
46731275|NCT00746941|82947820|FG000|Overall Study|Adverse Event|0|||
46731276|NCT00746941|82947821|FG001|Overall Study|Adverse Event|0|||
46731277|NCT00746941|82947822|FG002|Overall Study|Adverse Event|0|||
46731278|NCT00746941|82947823|FG003|Overall Study|Adverse Event|1|||
46731279|NCT00746785|82947835|FG000|Overall Study|Lost to Follow-up|29|||
46731280|NCT00746785|82947836|FG001|Overall Study|Lost to Follow-up|25|||
46731281|NCT00746785|82947837|FG002|Overall Study|Lost to Follow-up|27|||
46731282|NCT00750919|82947845|FG000|Overall Study|Adverse Event|9|||
46731283|NCT00750919|82947845|FG000|Overall Study|Withdrawal by Subject|1|||
46731284|NCT00750919|82947845|FG000|Overall Study|Lack of Efficacy|8|||
46731285|NCT00750919|82947845|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
46731286|NCT00750919|82947845|FG000|Overall Study|Other|36|||
46731287|NCT00746551|82947851|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
46731288|NCT00746551|82947852|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
46731289|NCT00746551|82947851|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
46731290|NCT00746551|82947852|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
46731291|NCT00746551|82947851|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
46731292|NCT00746551|82947852|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
46731293|NCT00753649|82947860|FG000|Overall Study|Migrated/moved from study area|1|||
46731294|NCT00753649|82947861|FG001|Overall Study|Migrated/moved from study area|0|||
46731295|NCT00753649|82947860|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
46731296|NCT00753649|82947861|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
46731297|NCT00753649|82947860|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
46731298|NCT00753649|82947861|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
46731299|NCT00753649|82947860|FG000|Overall Study|Protocol Violation|2|||
46731300|NCT00753649|82947861|FG001|Overall Study|Protocol Violation|0|||
46731301|NCT00750139|82947871|FG000|Overall Study|Adverse Event|1|||
46731302|NCT00750139|82947872|FG001|Overall Study|Adverse Event|2|||
46731303|NCT00750139|82947873|FG002|Overall Study|Adverse Event|0|||
46731304|NCT00750139|82947874|FG003|Overall Study|Adverse Event|1|||
46731305|NCT00750139|82947871|FG000|Overall Study|Lost to Follow-up|17|||
46731306|NCT00750139|82947872|FG001|Overall Study|Lost to Follow-up|12|||
46731307|NCT00750139|82947873|FG002|Overall Study|Lost to Follow-up|15|||
46731308|NCT00750139|82947874|FG003|Overall Study|Lost to Follow-up|6|||
46731309|NCT00750139|82947871|FG000|Overall Study|Withdrawal by Subject|3|||
46731310|NCT00750139|82947872|FG001|Overall Study|Withdrawal by Subject|2|||
46731311|NCT00750139|82947873|FG002|Overall Study|Withdrawal by Subject|6|||
46731312|NCT00750139|82947874|FG003|Overall Study|Withdrawal by Subject|2|||
46731313|NCT00750139|82947871|FG000|Overall Study|Physician Decision|1|||
46731314|NCT00750139|82947872|FG001|Overall Study|Physician Decision|1|||
46731315|NCT00750139|82947873|FG002|Overall Study|Physician Decision|0|||
46731316|NCT00750139|82947874|FG003|Overall Study|Physician Decision|0|||
46731317|NCT00750139|82947871|FG000|Overall Study|Non-compliance|1|||
46731318|NCT00750139|82947872|FG001|Overall Study|Non-compliance|0|||
46731319|NCT00750139|82947873|FG002|Overall Study|Non-compliance|1|||
46731320|NCT00750139|82947874|FG003|Overall Study|Non-compliance|3|||
46731321|NCT00750139|82947871|FG000|Overall Study|Termination by sponsor|4|||
46731322|NCT00750139|82947872|FG001|Overall Study|Termination by sponsor|0|||
46731323|NCT00750139|82947873|FG002|Overall Study|Termination by sponsor|0|||
46731324|NCT00750139|82947874|FG003|Overall Study|Termination by sponsor|1|||
46731325|NCT00750139|82947871|FG000|Overall Study|Non-specific|62|||
46731326|NCT00750139|82947872|FG001|Overall Study|Non-specific|42|||
46731327|NCT00750139|82947873|FG002|Overall Study|Non-specific|79|||
46731328|NCT00750139|82947874|FG003|Overall Study|Non-specific|33|||
46731329|NCT00750061|82947888|FG000|Overall Study|Adverse Event|2|||
46731330|NCT00750061|82947889|FG001|Overall Study|Adverse Event|0|||
46731331|NCT00750061|82947888|FG000|Overall Study|Withdrawal by Subject|0|||
46921463|NCT04325906|83154040|FG001|Overall Study|Withdrawal by Subject|0|||
47048944|NCT01929707|83309150|FG003|Intervention Period 1|Lost to Follow-up|1|||
47048945|NCT01929707|83309151|FG004|Intervention Period 1|Lost to Follow-up|0|||
47048946|NCT01929707|83309152|FG005|Intervention Period 1|Lost to Follow-up|0|||
47048947|NCT01929707|83309153|FG006|Intervention Period 1|Lost to Follow-up|0|||
46921464|NCT03068455|83154048|FG000|Pre-treatment Period|Disease progression|0|||
47048948|NCT01929707|83309154|FG007|Intervention Period 1|Lost to Follow-up|0|||
47048949|NCT01929707|83309147|FG000|Intervention Period 1|Withdrawal by Subject|0|||
47048950|NCT01929707|83309148|FG001|Intervention Period 1|Withdrawal by Subject|0|||
47048951|NCT01929707|83309149|FG002|Intervention Period 1|Withdrawal by Subject|0|||
46731332|NCT00750061|82947889|FG001|Overall Study|Withdrawal by Subject|1|||
46731333|NCT00750061|82947888|FG000|Overall Study|Physician Decision|0|||
46731334|NCT00750061|82947889|FG001|Overall Study|Physician Decision|1|||
46731335|NCT00744757|82947895|FG000|Overall Study|Objective disease progression|7|||
46731336|NCT00744757|82947895|FG000|Overall Study|Physician Decision|5|||
47048952|NCT01929707|83309150|FG003|Intervention Period 1|Withdrawal by Subject|2|||
46731337|NCT00744757|82947895|FG000|Overall Study|Withdrawal by Subject|1|||
46731338|NCT00744757|82947895|FG000|Overall Study|Death|6|||
46731339|NCT00744757|82947895|FG000|Overall Study|Adverse Event|2|||
46731340|NCT00745849|82947899|FG000|First Intervention|Withdrawal by Subject|0|||
46731341|NCT00745849|82947900|FG001|First Intervention|Withdrawal by Subject|1|||
46731342|NCT00745849|82947899|FG000|First Intervention|Lost to Follow-up|1|||
46731343|NCT00745849|82947900|FG001|First Intervention|Lost to Follow-up|1|||
46731344|NCT00745849|82947899|FG000|Second Intervention|Lost to Follow-up|2|||
46731345|NCT00745849|82947900|FG001|Second Intervention|Lost to Follow-up|1|||
46731346|NCT00749203|82947917|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
46731347|NCT00749203|82947918|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
46731348|NCT00749203|82947917|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
46731349|NCT00749203|82947918|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
46731350|NCT00749203|82947917|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
46731351|NCT00749203|82947918|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
46731352|NCT00749203|82947917|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
46731353|NCT00749203|82947918|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
46731354|NCT00749203|82947917|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
46731355|NCT00749203|82947918|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
46731356|NCT00749203|82947917|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
46731357|NCT00749203|82947918|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
46731358|NCT00748969|82947926|FG000|Overall Study|Withdrawal by Subject|1|||
46731359|NCT00748969|82947927|FG001|Overall Study|Withdrawal by Subject|0|||
46731360|NCT00748969|82947926|FG000|Overall Study|Withdrawal by Subject|0|||
46731361|NCT00748969|82947927|FG001|Overall Study|Withdrawal by Subject|1|||
46731362|NCT00745615|82947937|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
46731363|NCT00745615|82947938|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
46731364|NCT00745615|82947939|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
46731365|NCT00745615|82947940|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
46731366|NCT00745615|82947941|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
46731367|NCT00745615|82947942|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
46731368|NCT00745615|82947937|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
46731369|NCT00745615|82947938|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
46731370|NCT00745615|82947939|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
46731371|NCT00745615|82947940|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
46731372|NCT00745615|82947941|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
46731373|NCT00745615|82947942|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
46731374|NCT00745615|82947937|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
46731375|NCT00745615|82947938|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
46731376|NCT00745615|82947939|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
46731377|NCT00745615|82947940|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
46731378|NCT00745615|82947941|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
46731379|NCT00745615|82947942|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
46731380|NCT00745615|82947937|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
46731381|NCT00745615|82947938|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
46731382|NCT00745615|82947939|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
46731383|NCT00745615|82947940|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
46731384|NCT00745615|82947941|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
46731385|NCT00745615|82947942|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
46731386|NCT00745615|82947937|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
46731387|NCT00745615|82947938|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
46731388|NCT00745615|82947939|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
47048953|NCT01929707|83309151|FG004|Intervention Period 1|Withdrawal by Subject|0|||
47048954|NCT01929707|83309152|FG005|Intervention Period 1|Withdrawal by Subject|0|||
47048955|NCT01929707|83309153|FG006|Intervention Period 1|Withdrawal by Subject|0|||
46731389|NCT00745615|82947940|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
47048956|NCT01929707|83309154|FG007|Intervention Period 1|Withdrawal by Subject|0|||
47048957|NCT01929707|83309147|FG000|Intervention Period 2|Withdrawal by Subject|0|||
47048958|NCT01929707|83309148|FG001|Intervention Period 2|Withdrawal by Subject|0|||
47048959|NCT01929707|83309149|FG002|Intervention Period 2|Withdrawal by Subject|0|||
47048960|NCT01929707|83309150|FG003|Intervention Period 2|Withdrawal by Subject|0|||
47048961|NCT01929707|83309151|FG004|Intervention Period 2|Withdrawal by Subject|0|||
47048962|NCT01929707|83309152|FG005|Intervention Period 2|Withdrawal by Subject|2|||
46731390|NCT00745615|82947941|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
47048963|NCT01929707|83309153|FG006|Intervention Period 2|Withdrawal by Subject|0|||
46731391|NCT00745615|82947942|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
46731392|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
46731393|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
46731394|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
46731395|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
46731396|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
46731397|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
46731398|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
46731399|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
46731400|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
46731401|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
46731402|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
46731403|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
46731404|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
46731405|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
46731406|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
46731407|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
46731408|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
46731409|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
46731410|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
46731411|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
46731412|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
46731413|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
46731414|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
46731415|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
46731416|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
46731417|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
46731418|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
46731419|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
46731420|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
46731421|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
46731422|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
46731423|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
46731424|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
46731425|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
46731426|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
46731427|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
46731428|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
46731429|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
46731430|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
46731431|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
46731432|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
46731433|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
46731434|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
46731435|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
46731436|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
46731437|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
46731438|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
46731439|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
46731440|NCT00745615|82947937|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
46731441|NCT00745615|82947938|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
46731442|NCT00745615|82947939|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
46731443|NCT00745615|82947940|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
46731444|NCT00745615|82947941|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
46731445|NCT00745615|82947942|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
46731446|NCT00744523|82947965|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
46731447|NCT00744523|82947966|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
46731448|NCT00744991|82947974|FG000|Overall Study|Progressive Disease|11|||
46731449|NCT00744991|82947974|FG000|Overall Study|Withdrawal by Subject|8|||
46731450|NCT00744991|82947974|FG000|Overall Study|Physician Decision|3|||
46731451|NCT00744991|82947974|FG000|Overall Study|Adverse Event|2|||
46731452|NCT00744991|82947974|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
46731453|NCT00839254|82947998|FG000|Overall Study|Protocol Violation|0|||
46731454|NCT00839254|82947999|FG001|Overall Study|Protocol Violation|1|||
46731455|NCT00839254|82948000|FG002|Overall Study|Protocol Violation|1|||
46731456|NCT00839254|82948001|FG003|Overall Study|Protocol Violation|1|||
46731457|NCT00839254|82948002|FG004|Overall Study|Protocol Violation|0|||
46731458|NCT00839254|82948003|FG005|Overall Study|Protocol Violation|0|||
46731459|NCT00839254|82948004|FG006|Overall Study|Protocol Violation|1|||
46731460|NCT00839254|82948005|FG007|Overall Study|Protocol Violation|2|||
46731461|NCT00839254|82947998|FG000|Overall Study|Physician Decision|0|||
46731462|NCT00839254|82947999|FG001|Overall Study|Physician Decision|1|||
46731463|NCT00839254|82948000|FG002|Overall Study|Physician Decision|0|||
46731464|NCT00839254|82948001|FG003|Overall Study|Physician Decision|0|||
46731465|NCT00839254|82948002|FG004|Overall Study|Physician Decision|0|||
46731466|NCT00839254|82948003|FG005|Overall Study|Physician Decision|0|||
46731467|NCT00839254|82948004|FG006|Overall Study|Physician Decision|0|||
46731468|NCT00839254|82948005|FG007|Overall Study|Physician Decision|1|||
46731469|NCT00839254|82947998|FG000|Overall Study|Wrong treatment number allocation|0|||
46731470|NCT00839254|82947999|FG001|Overall Study|Wrong treatment number allocation|1|||
47048964|NCT01929707|83309154|FG007|Intervention Period 2|Withdrawal by Subject|0|||
46731471|NCT00839254|82948000|FG002|Overall Study|Wrong treatment number allocation|0|||
46731472|NCT00839254|82948001|FG003|Overall Study|Wrong treatment number allocation|0|||
46731473|NCT00839254|82948002|FG004|Overall Study|Wrong treatment number allocation|0|||
46731474|NCT00839254|82948003|FG005|Overall Study|Wrong treatment number allocation|1|||
46731475|NCT00839254|82948004|FG006|Overall Study|Wrong treatment number allocation|0|||
46731476|NCT00839254|82948005|FG007|Overall Study|Wrong treatment number allocation|0|||
46731477|NCT00839254|82947998|FG000|Overall Study|Adverse Event|12|||
46731478|NCT00839254|82947999|FG001|Overall Study|Adverse Event|6|||
46731479|NCT00839254|82948000|FG002|Overall Study|Adverse Event|3|||
46731480|NCT00839254|82948001|FG003|Overall Study|Adverse Event|5|||
46731481|NCT00839254|82948002|FG004|Overall Study|Adverse Event|2|||
46731482|NCT00839254|82948003|FG005|Overall Study|Adverse Event|1|||
46731483|NCT00839254|82948004|FG006|Overall Study|Adverse Event|0|||
46731484|NCT00839254|82948005|FG007|Overall Study|Adverse Event|1|||
46731485|NCT00839254|82947998|FG000|Overall Study|Withdrawal by Subject|87|||
46731486|NCT00839254|82947999|FG001|Overall Study|Withdrawal by Subject|53|||
46731487|NCT00839254|82948000|FG002|Overall Study|Withdrawal by Subject|54|||
46731488|NCT00839254|82948001|FG003|Overall Study|Withdrawal by Subject|32|||
46731489|NCT00839254|82948002|FG004|Overall Study|Withdrawal by Subject|27|||
46731490|NCT00839254|82948003|FG005|Overall Study|Withdrawal by Subject|15|||
46731491|NCT00839254|82948004|FG006|Overall Study|Withdrawal by Subject|22|||
46731492|NCT00839254|82948005|FG007|Overall Study|Withdrawal by Subject|9|||
46731493|NCT00839254|82947998|FG000|Overall Study|Wrong group allocation|0|||
47048965|NCT01714063|83309175|FG000|Overall Study|Equipment malfunction|2|||
47048966|NCT01929395|83309186|FG000|Overall Study|Did not complete - non-related toxicity|1|||
47048967|NCT01929395|83309187|FG001|Overall Study|Did not complete - non-related toxicity|0|||
47048968|NCT01929395|83309188|FG002|Overall Study|Did not complete - non-related toxicity|0|||
47048969|NCT01929395|83309186|FG000|Overall Study|Withdrawal by Subject|0|||
47048970|NCT01929395|83309187|FG001|Overall Study|Withdrawal by Subject|1|||
47048971|NCT01929395|83309188|FG002|Overall Study|Withdrawal by Subject|0|||
47048972|NCT01929395|83309186|FG000|Overall Study|Screen Fail|0|||
47048973|NCT01929395|83309187|FG001|Overall Study|Screen Fail|0|||
47048974|NCT01929395|83309188|FG002|Overall Study|Screen Fail|1|||
47048975|NCT01713283|83309200|FG000|Overall Study|Lack of Efficacy|10|||
47048976|NCT01713283|83309201|FG001|Overall Study|Lack of Efficacy|2|||
47048977|NCT01713283|83309200|FG000|Overall Study|Lost to Follow-up|1|||
47048978|NCT01713283|83309201|FG001|Overall Study|Lost to Follow-up|1|||
46635147|NCT01592760|82808673|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
46731494|NCT00839254|82947999|FG001|Overall Study|Wrong group allocation|0|||
46731495|NCT00839254|82948000|FG002|Overall Study|Wrong group allocation|0|||
46731496|NCT00839254|82948001|FG003|Overall Study|Wrong group allocation|0|||
46731497|NCT00839254|82948002|FG004|Overall Study|Wrong group allocation|0|||
46635148|NCT01592760|82808674|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
46731498|NCT00839254|82948003|FG005|Overall Study|Wrong group allocation|0|||
46731499|NCT00839254|82948004|FG006|Overall Study|Wrong group allocation|1|||
46731500|NCT00839254|82948005|FG007|Overall Study|Wrong group allocation|0|||
47048979|NCT01592383|83309211|FG000|Overall Study|Adverse Event|1|||
47048980|NCT01691521|83309219|FG000|Overall Study|Adverse Event|4|||
46731501|NCT00839254|82947998|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
46731502|NCT00839254|82947999|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
46731503|NCT00839254|82948000|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
46731504|NCT00839254|82948001|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
46731505|NCT00839254|82948002|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
46731506|NCT00839254|82948003|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
46731507|NCT00839254|82948004|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
46731508|NCT00839254|82948005|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
46731509|NCT00839254|82947998|FG000|Overall Study|Withdrawn due to non-compliance|2|||
46731510|NCT00839254|82947999|FG001|Overall Study|Withdrawn due to non-compliance|0|||
46731511|NCT00839254|82948000|FG002|Overall Study|Withdrawn due to non-compliance|0|||
46731512|NCT00839254|82948001|FG003|Overall Study|Withdrawn due to non-compliance|0|||
46731513|NCT00839254|82948002|FG004|Overall Study|Withdrawn due to non-compliance|0|||
46731514|NCT00839254|82948003|FG005|Overall Study|Withdrawn due to non-compliance|0|||
46731515|NCT00839254|82948004|FG006|Overall Study|Withdrawn due to non-compliance|0|||
46731516|NCT00839254|82948005|FG007|Overall Study|Withdrawn due to non-compliance|0|||
46731517|NCT00839254|82947998|FG000|Overall Study|Lost to Follow-up|51|||
46731518|NCT00839254|82947999|FG001|Overall Study|Lost to Follow-up|30|||
46731519|NCT00839254|82948000|FG002|Overall Study|Lost to Follow-up|32|||
46731520|NCT00839254|82948001|FG003|Overall Study|Lost to Follow-up|24|||
46731521|NCT00839254|82948002|FG004|Overall Study|Lost to Follow-up|8|||
46731522|NCT00839254|82948003|FG005|Overall Study|Lost to Follow-up|8|||
46731523|NCT00839254|82948004|FG006|Overall Study|Lost to Follow-up|4|||
46731524|NCT00839254|82948005|FG007|Overall Study|Lost to Follow-up|2|||
46731525|NCT00586339|82948057|FG000|Overall Study|Withdrawal by Subject|1|||
46731526|NCT00586339|82948058|FG001|Overall Study|Withdrawal by Subject|3|||
46731527|NCT00586339|82948059|FG002|Overall Study|Withdrawal by Subject|1|||
46731528|NCT00586339|82948057|FG000|Overall Study|Migrated/moved from study area|3|||
46731529|NCT00586339|82948058|FG001|Overall Study|Migrated/moved from study area|2|||
46731530|NCT00586339|82948059|FG002|Overall Study|Migrated/moved from study area|4|||
46731531|NCT00586339|82948057|FG000|Overall Study|Lost to Follow-up|3|||
46731532|NCT00586339|82948058|FG001|Overall Study|Lost to Follow-up|2|||
46731533|NCT00586339|82948059|FG002|Overall Study|Lost to Follow-up|1|||
46731534|NCT00812968|82948067|FG000|Overall Study|Relapse after erythroid response|6|||
46731535|NCT00812968|82948067|FG000|Overall Study|Disease progression|1|||
46731536|NCT00812968|82948067|FG000|Overall Study|No further treatment required|1|||
46731537|NCT00812968|82948067|FG000|Overall Study|Study closed due to marketing approval|3|||
46731538|NCT00839098|82948076|FG000|Overall Study|Withdrawal by Subject|2|||
46731539|NCT00839098|82948077|FG001|Overall Study|Withdrawal by Subject|1|||
46731540|NCT00839098|82948078|FG002|Overall Study|Withdrawal by Subject|7|||
46731541|NCT00813748|82948088|FG000|Skin Test Substudy|Physician Decision|0|||
46731542|NCT00813748|82948089|FG001|Skin Test Substudy|Physician Decision|1|||
46731543|NCT00813592|82948097|FG000|Overall Study|Disease assessment was not completed per|2|||
46731544|NCT05067647|82948102|FG000|Overall Study|Lost to Follow-up|1|||
46731545|NCT04795323|82948108|FG000|Overall Study|Did not interact with TARA|1|||
46731546|NCT04795323|82948109|FG001|Overall Study|Did not interact with TARA|0|||
46731547|NCT04732871|82948127|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
46731548|NCT04732871|82948128|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
46731549|NCT04732871|82948129|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
46731550|NCT04732871|82948127|FG000|Overall Study|Lost to Follow-up|7|||
46731551|NCT04732871|82948128|FG001|Overall Study|Lost to Follow-up|4|||
46731552|NCT04732871|82948129|FG002|Overall Study|Lost to Follow-up|3|||
46731553|NCT04732871|82948127|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
46731554|NCT04732871|82948128|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
46731555|NCT04732871|82948129|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
46731556|NCT04732871|82948127|FG000|Overall Study|Migrated / moved from the study area|5|||
47048981|NCT01691521|83309220|FG001|Overall Study|Adverse Event|0|||
47048982|NCT01691521|83309221|FG002|Overall Study|Adverse Event|1|||
47048983|NCT01691521|83309219|FG000|Overall Study|Lack of Efficacy|1|||
47048984|NCT01691521|83309220|FG001|Overall Study|Lack of Efficacy|1|||
47048985|NCT01691521|83309221|FG002|Overall Study|Lack of Efficacy|2|||
47048986|NCT01691521|83309219|FG000|Overall Study|Protocol Violation|0|||
47048987|NCT01691521|83309220|FG001|Overall Study|Protocol Violation|3|||
46731557|NCT04732871|82948128|FG001|Overall Study|Migrated / moved from the study area|0|||
46731558|NCT04732871|82948129|FG002|Overall Study|Migrated / moved from the study area|0|||
46731559|NCT04732871|82948127|FG000|Overall Study|Other|1|||
46731560|NCT04732871|82948128|FG001|Overall Study|Other|0|||
46731561|NCT04732871|82948129|FG002|Overall Study|Other|1|||
47048988|NCT01691521|83309221|FG002|Overall Study|Protocol Violation|0|||
47048989|NCT01691521|83309219|FG000|Overall Study|Lost to Follow-up|0|||
46731562|NCT04732871|82948127|FG000|Overall Study|Ongoing|6|||
46731563|NCT04732871|82948128|FG001|Overall Study|Ongoing|0|||
47048990|NCT01691521|83309220|FG001|Overall Study|Lost to Follow-up|2|||
47048991|NCT01691521|83309221|FG002|Overall Study|Lost to Follow-up|2|||
46731564|NCT04732871|82948129|FG002|Overall Study|Ongoing|1|||
46731565|NCT04732871|82948127|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
46731566|NCT04732871|82948128|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
46731567|NCT04732871|82948129|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
46731568|NCT04497389|82948155|FG000|Overall Study|Withdrawal by Subject|1|||
46731569|NCT04497389|82948156|FG001|Overall Study|Withdrawal by Subject|0|||
46731570|NCT04425629|82948224|FG000|Overall Study|Adverse Event|0|||
46731571|NCT04425629|82948225|FG001|Overall Study|Adverse Event|0|||
46731572|NCT04425629|82948226|FG002|Overall Study|Adverse Event|0|||
46731573|NCT04425629|82948227|FG003|Overall Study|Adverse Event|0|||
46731574|NCT04425629|82948228|FG004|Overall Study|Adverse Event|1|||
46731575|NCT04425629|82948229|FG005|Overall Study|Adverse Event|0|||
46731576|NCT04425629|82948230|FG006|Overall Study|Adverse Event|0|||
46731577|NCT04425629|82948231|FG007|Overall Study|Adverse Event|0|||
46731578|NCT04425629|82948232|FG008|Overall Study|Adverse Event|0|||
46731579|NCT04425629|82948233|FG009|Overall Study|Adverse Event|3|||
46731580|NCT04425629|82948234|FG010|Overall Study|Adverse Event|2|||
46731581|NCT04425629|82948235|FG011|Overall Study|Adverse Event|1|||
46731582|NCT04425629|82948236|FG012|Overall Study|Adverse Event|1|||
46731583|NCT04425629|82948237|FG013|Overall Study|Adverse Event|0|||
46731584|NCT04425629|82948238|FG014|Overall Study|Adverse Event|0|||
46731585|NCT04425629|82948239|FG015|Overall Study|Adverse Event|0|||
46731586|NCT04425629|82948240|FG016|Overall Study|Adverse Event|0|||
46731587|NCT04425629|82948241|FG017|Overall Study|Adverse Event|0|||
46731588|NCT04425629|82948242|FG018|Overall Study|Adverse Event|0|||
46731589|NCT04425629|82948224|FG000|Overall Study|Lost to Follow-up|1|||
46731590|NCT04425629|82948225|FG001|Overall Study|Lost to Follow-up|3|||
46731591|NCT04425629|82948226|FG002|Overall Study|Lost to Follow-up|1|||
46731592|NCT04425629|82948227|FG003|Overall Study|Lost to Follow-up|7|||
46731593|NCT04425629|82948228|FG004|Overall Study|Lost to Follow-up|1|||
46731594|NCT04425629|82948229|FG005|Overall Study|Lost to Follow-up|2|||
46731595|NCT04425629|82948230|FG006|Overall Study|Lost to Follow-up|1|||
46731596|NCT04425629|82948231|FG007|Overall Study|Lost to Follow-up|0|||
46731597|NCT04425629|82948232|FG008|Overall Study|Lost to Follow-up|1|||
46731598|NCT04425629|82948233|FG009|Overall Study|Lost to Follow-up|64|||
46731599|NCT04425629|82948234|FG010|Overall Study|Lost to Follow-up|70|||
46731600|NCT04425629|82948235|FG011|Overall Study|Lost to Follow-up|98|||
46731601|NCT04425629|82948236|FG012|Overall Study|Lost to Follow-up|30|||
46731602|NCT04425629|82948237|FG013|Overall Study|Lost to Follow-up|0|||
46731603|NCT04425629|82948238|FG014|Overall Study|Lost to Follow-up|5|||
46731604|NCT04425629|82948239|FG015|Overall Study|Lost to Follow-up|4|||
46731605|NCT04425629|82948240|FG016|Overall Study|Lost to Follow-up|0|||
46731606|NCT04425629|82948241|FG017|Overall Study|Lost to Follow-up|3|||
46731607|NCT04425629|82948242|FG018|Overall Study|Lost to Follow-up|1|||
46731608|NCT04425629|82948224|FG000|Overall Study|Subject Decision|0|||
46731609|NCT04425629|82948225|FG001|Overall Study|Subject Decision|2|||
46731610|NCT04425629|82948226|FG002|Overall Study|Subject Decision|1|||
46731611|NCT04425629|82948227|FG003|Overall Study|Subject Decision|3|||
46731612|NCT04425629|82948228|FG004|Overall Study|Subject Decision|6|||
46731613|NCT04425629|82948229|FG005|Overall Study|Subject Decision|6|||
46731614|NCT04425629|82948230|FG006|Overall Study|Subject Decision|3|||
46731615|NCT04425629|82948231|FG007|Overall Study|Subject Decision|3|||
46731616|NCT04425629|82948232|FG008|Overall Study|Subject Decision|1|||
46731617|NCT04425629|82948233|FG009|Overall Study|Subject Decision|70|||
46731618|NCT04425629|82948234|FG010|Overall Study|Subject Decision|95|||
46731619|NCT04425629|82948235|FG011|Overall Study|Subject Decision|124|||
46731620|NCT04425629|82948236|FG012|Overall Study|Subject Decision|25|||
46731621|NCT04425629|82948237|FG013|Overall Study|Subject Decision|0|||
46731622|NCT04425629|82948238|FG014|Overall Study|Subject Decision|1|||
46731623|NCT04425629|82948239|FG015|Overall Study|Subject Decision|4|||
46731624|NCT04425629|82948240|FG016|Overall Study|Subject Decision|1|||
46731625|NCT04425629|82948241|FG017|Overall Study|Subject Decision|0|||
46731626|NCT04425629|82948242|FG018|Overall Study|Subject Decision|2|||
46635149|NCT01592760|82808675|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
46731627|NCT04425629|82948224|FG000|Overall Study|Death|0|||
46731628|NCT04425629|82948225|FG001|Overall Study|Death|0|||
46731629|NCT04425629|82948226|FG002|Overall Study|Death|0|||
46731630|NCT04425629|82948227|FG003|Overall Study|Death|0|||
46731631|NCT04425629|82948228|FG004|Overall Study|Death|0|||
46731632|NCT04425629|82948229|FG005|Overall Study|Death|0|||
46731633|NCT04425629|82948230|FG006|Overall Study|Death|0|||
46635150|NCT01696188|82808688|FG000|Overall Study|Protocol Violation|1|||
46635151|NCT01696188|82808689|FG001|Overall Study|Protocol Violation|1|||
46635152|NCT01603602|82808698|FG000|Overall Study|Adverse Event|1|||
46635153|NCT01603602|82808699|FG001|Overall Study|Adverse Event|0|||
46635154|NCT01603602|82808700|FG002|Overall Study|Adverse Event|0|||
46635155|NCT01603602|82808698|FG000|Overall Study|Personal Reasons|1|||
46635156|NCT01603602|82808699|FG001|Overall Study|Personal Reasons|0|||
46635157|NCT01603602|82808700|FG002|Overall Study|Personal Reasons|1|||
46635158|NCT01684878|82808712|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
46731634|NCT04425629|82948231|FG007|Overall Study|Death|0|||
46731635|NCT04425629|82948232|FG008|Overall Study|Death|0|||
46731636|NCT04425629|82948233|FG009|Overall Study|Death|11|||
46731637|NCT04425629|82948234|FG010|Overall Study|Death|2|||
46731638|NCT04425629|82948235|FG011|Overall Study|Death|4|||
46731639|NCT04425629|82948236|FG012|Overall Study|Death|0|||
46731640|NCT04425629|82948237|FG013|Overall Study|Death|0|||
46731641|NCT04425629|82948238|FG014|Overall Study|Death|0|||
46731642|NCT04425629|82948239|FG015|Overall Study|Death|0|||
46731643|NCT04425629|82948240|FG016|Overall Study|Death|0|||
46731644|NCT04425629|82948241|FG017|Overall Study|Death|0|||
46731645|NCT04425629|82948242|FG018|Overall Study|Death|0|||
46731646|NCT04425629|82948224|FG000|Overall Study|Sponsor Request|0|||
46731647|NCT04425629|82948225|FG001|Overall Study|Sponsor Request|0|||
46731648|NCT04425629|82948226|FG002|Overall Study|Sponsor Request|0|||
46731649|NCT04425629|82948227|FG003|Overall Study|Sponsor Request|2|||
46731650|NCT04425629|82948228|FG004|Overall Study|Sponsor Request|2|||
46731651|NCT04425629|82948229|FG005|Overall Study|Sponsor Request|2|||
46731652|NCT04425629|82948230|FG006|Overall Study|Sponsor Request|1|||
46731653|NCT04425629|82948231|FG007|Overall Study|Sponsor Request|0|||
46731654|NCT04425629|82948232|FG008|Overall Study|Sponsor Request|0|||
46731655|NCT04425629|82948233|FG009|Overall Study|Sponsor Request|9|||
46731656|NCT04425629|82948234|FG010|Overall Study|Sponsor Request|9|||
46731657|NCT04425629|82948235|FG011|Overall Study|Sponsor Request|10|||
46731658|NCT04425629|82948236|FG012|Overall Study|Sponsor Request|8|||
46731659|NCT04425629|82948237|FG013|Overall Study|Sponsor Request|0|||
46731660|NCT04425629|82948238|FG014|Overall Study|Sponsor Request|0|||
46731661|NCT04425629|82948239|FG015|Overall Study|Sponsor Request|1|||
46731662|NCT04425629|82948240|FG016|Overall Study|Sponsor Request|0|||
46731663|NCT04425629|82948241|FG017|Overall Study|Sponsor Request|0|||
46731664|NCT04425629|82948242|FG018|Overall Study|Sponsor Request|0|||
46731665|NCT04425629|82948224|FG000|Overall Study|Physician Decision|0|||
46731666|NCT04425629|82948225|FG001|Overall Study|Physician Decision|0|||
46731667|NCT04425629|82948226|FG002|Overall Study|Physician Decision|0|||
46731668|NCT04425629|82948227|FG003|Overall Study|Physician Decision|0|||
46731669|NCT04425629|82948228|FG004|Overall Study|Physician Decision|0|||
46731670|NCT04425629|82948229|FG005|Overall Study|Physician Decision|0|||
46731671|NCT04425629|82948230|FG006|Overall Study|Physician Decision|0|||
46731672|NCT04425629|82948231|FG007|Overall Study|Physician Decision|0|||
46731673|NCT04425629|82948232|FG008|Overall Study|Physician Decision|0|||
46731674|NCT04425629|82948233|FG009|Overall Study|Physician Decision|4|||
46731675|NCT04425629|82948234|FG010|Overall Study|Physician Decision|3|||
46731676|NCT04425629|82948235|FG011|Overall Study|Physician Decision|5|||
46731677|NCT04425629|82948236|FG012|Overall Study|Physician Decision|1|||
46731678|NCT04425629|82948237|FG013|Overall Study|Physician Decision|0|||
46731679|NCT04425629|82948238|FG014|Overall Study|Physician Decision|0|||
46731680|NCT04425629|82948239|FG015|Overall Study|Physician Decision|1|||
46731681|NCT04425629|82948240|FG016|Overall Study|Physician Decision|0|||
46731682|NCT04425629|82948241|FG017|Overall Study|Physician Decision|0|||
46731683|NCT04425629|82948242|FG018|Overall Study|Physician Decision|0|||
46731684|NCT04425629|82948224|FG000|Overall Study|Lack of Efficacy|0|||
46731685|NCT04425629|82948225|FG001|Overall Study|Lack of Efficacy|0|||
46731686|NCT04425629|82948226|FG002|Overall Study|Lack of Efficacy|0|||
46731687|NCT04425629|82948227|FG003|Overall Study|Lack of Efficacy|0|||
46731688|NCT04425629|82948228|FG004|Overall Study|Lack of Efficacy|0|||
46731689|NCT04425629|82948229|FG005|Overall Study|Lack of Efficacy|0|||
46731690|NCT04425629|82948230|FG006|Overall Study|Lack of Efficacy|0|||
46731691|NCT04425629|82948231|FG007|Overall Study|Lack of Efficacy|0|||
46731692|NCT04425629|82948232|FG008|Overall Study|Lack of Efficacy|0|||
46731693|NCT04425629|82948233|FG009|Overall Study|Lack of Efficacy|0|||
46731694|NCT04425629|82948234|FG010|Overall Study|Lack of Efficacy|1|||
47048992|NCT01691521|83309219|FG000|Overall Study|Physician Decision|2|||
46731695|NCT04425629|82948235|FG011|Overall Study|Lack of Efficacy|0|||
46731696|NCT04425629|82948236|FG012|Overall Study|Lack of Efficacy|0|||
46731697|NCT04425629|82948237|FG013|Overall Study|Lack of Efficacy|0|||
46731698|NCT04425629|82948238|FG014|Overall Study|Lack of Efficacy|0|||
46731699|NCT04425629|82948239|FG015|Overall Study|Lack of Efficacy|0|||
46731700|NCT04425629|82948240|FG016|Overall Study|Lack of Efficacy|0|||
46731701|NCT04425629|82948241|FG017|Overall Study|Lack of Efficacy|0|||
46731702|NCT04425629|82948242|FG018|Overall Study|Lack of Efficacy|0|||
46731703|NCT04417218|82948392|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
46731704|NCT04417218|82948393|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
46731705|NCT04134767|82948401|FG000|Overall Study|Death|0|||
46731706|NCT04134767|82948402|FG001|Overall Study|Death|1|||
46731707|NCT04134767|82948401|FG000|Overall Study|Removed for harassing staff|0|||
46731708|NCT04134767|82948402|FG001|Overall Study|Removed for harassing staff|1|||
46731709|NCT04134767|82948401|FG000|Overall Study|Lost to Follow-up|44|||
46731710|NCT04134767|82948402|FG001|Overall Study|Lost to Follow-up|40|||
46731711|NCT03960580|82948433|FG000|Overall Study|Adverse Event|2|||
46731712|NCT03960580|82948434|FG001|Overall Study|Adverse Event|1|||
46731713|NCT03960580|82948435|FG002|Overall Study|Adverse Event|1|||
46731714|NCT03960580|82948433|FG000|Overall Study|Lost to Follow-up|1|||
46731715|NCT03960580|82948434|FG001|Overall Study|Lost to Follow-up|0|||
46731716|NCT03960580|82948435|FG002|Overall Study|Lost to Follow-up|0|||
46731717|NCT03960580|82948433|FG000|Overall Study|Lack of Efficacy|2|||
46731718|NCT03960580|82948434|FG001|Overall Study|Lack of Efficacy|1|||
46731719|NCT03960580|82948435|FG002|Overall Study|Lack of Efficacy|0|||
46731720|NCT03960580|82948433|FG000|Overall Study|Protocol Violation|0|||
46731721|NCT03960580|82948434|FG001|Overall Study|Protocol Violation|0|||
46731722|NCT03960580|82948435|FG002|Overall Study|Protocol Violation|1|||
46731723|NCT03960580|82948433|FG000|Overall Study|Withdrawal by Subject|1|||
46731724|NCT03960580|82948434|FG001|Overall Study|Withdrawal by Subject|1|||
46731725|NCT03960580|82948435|FG002|Overall Study|Withdrawal by Subject|1|||
46731726|NCT03960580|82948433|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
46731727|NCT03960580|82948434|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
46731728|NCT03960580|82948435|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
46731729|NCT03803202|82948452|FG000|Overall Study|Other|0|||
46731730|NCT03803202|82948453|FG001|Overall Study|Other|1|||
46731731|NCT03803202|82948454|FG002|Overall Study|Other|0|||
46731732|NCT03803202|82948455|FG003|Overall Study|Other|0|||
46731733|NCT03803202|82948456|FG004|Overall Study|Other|0|||
46731734|NCT03803202|82948457|FG005|Overall Study|Other|0|||
46731735|NCT03803202|82948458|FG006|Overall Study|Other|0|||
46731736|NCT03803202|82948459|FG007|Overall Study|Other|0|||
46731737|NCT03803202|82948460|FG008|Overall Study|Other|0|||
46731738|NCT03803202|82948452|FG000|Overall Study|Death|0|||
46731739|NCT03803202|82948453|FG001|Overall Study|Death|0|||
46731740|NCT03803202|82948454|FG002|Overall Study|Death|0|||
46731741|NCT03803202|82948455|FG003|Overall Study|Death|0|||
46731742|NCT03803202|82948456|FG004|Overall Study|Death|0|||
46731743|NCT03803202|82948457|FG005|Overall Study|Death|1|||
46731744|NCT03803202|82948458|FG006|Overall Study|Death|0|||
46803905|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
46803906|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
46803907|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
46803908|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
46803909|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
46803910|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
46803911|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
46803912|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
46803913|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
46803914|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
47048993|NCT01691521|83309220|FG001|Overall Study|Physician Decision|1|||
47048994|NCT01691521|83309221|FG002|Overall Study|Physician Decision|0|||
47048995|NCT01691521|83309219|FG000|Overall Study|Withdrawal by Subject|5|||
47048996|NCT01691521|83309220|FG001|Overall Study|Withdrawal by Subject|9|||
47048997|NCT01691521|83309221|FG002|Overall Study|Withdrawal by Subject|4|||
47048998|NCT01929317|83309232|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
47048999|NCT01929317|83309233|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
47049000|NCT01929317|83309232|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
47049001|NCT01929317|83309233|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
47049002|NCT01929317|83309232|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
47049003|NCT01929317|83309233|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
46641297|NCT03546062|82825649|FG001|Overall Study|Adverse Event|5|||
46803915|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
46803916|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
46803917|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
46803918|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
46803919|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
46803920|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
46803921|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
46803922|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
46803923|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
46803924|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
46803925|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
46803926|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
46803927|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
46641298|NCT03546062|82825650|FG002|Overall Study|Adverse Event|8|||
46803928|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
46803929|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
46803930|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
47049004|NCT01929317|83309232|FG000|Long-term Phase|Adverse Event|5|||
46641313|NCT02929108|82825693|FG000|Overall Study|Hospice patient death|100|||
46641314|NCT02929108|82825694|FG001|Overall Study|Hospice patient death|64|||
46641315|NCT02929108|82825695|FG002|Overall Study|Hospice patient death|28|||
46641316|NCT02929108|82825696|FG003|Overall Study|Hospice patient death|46|||
46921465|NCT03068455|83154049|FG001|Pre-treatment Period|Disease progression|1|||
46731745|NCT03803202|82948459|FG007|Overall Study|Death|0|||
46731746|NCT03803202|82948460|FG008|Overall Study|Death|0|||
46731747|NCT03803202|82948452|FG000|Overall Study|Withdrawal by Subject|0|||
46731748|NCT03803202|82948453|FG001|Overall Study|Withdrawal by Subject|0|||
46731749|NCT03803202|82948454|FG002|Overall Study|Withdrawal by Subject|1|||
46731750|NCT03803202|82948455|FG003|Overall Study|Withdrawal by Subject|0|||
46731751|NCT03803202|82948456|FG004|Overall Study|Withdrawal by Subject|0|||
46731752|NCT03803202|82948457|FG005|Overall Study|Withdrawal by Subject|0|||
46921466|NCT03068455|83154048|FG000|Pre-treatment Period|Participant withdrew consent|1|||
46731753|NCT03803202|82948458|FG006|Overall Study|Withdrawal by Subject|0|||
46731754|NCT03803202|82948459|FG007|Overall Study|Withdrawal by Subject|1|||
46731755|NCT03803202|82948460|FG008|Overall Study|Withdrawal by Subject|0|||
46731756|NCT03803202|82948452|FG000|Overall Study|Lost to Follow-up|0|||
46731757|NCT03803202|82948453|FG001|Overall Study|Lost to Follow-up|0|||
46731758|NCT03803202|82948454|FG002|Overall Study|Lost to Follow-up|0|||
46731759|NCT03803202|82948455|FG003|Overall Study|Lost to Follow-up|1|||
46731760|NCT03803202|82948456|FG004|Overall Study|Lost to Follow-up|1|||
46731761|NCT03803202|82948457|FG005|Overall Study|Lost to Follow-up|0|||
46731762|NCT03803202|82948458|FG006|Overall Study|Lost to Follow-up|1|||
46731763|NCT03803202|82948459|FG007|Overall Study|Lost to Follow-up|0|||
46731764|NCT03803202|82948460|FG008|Overall Study|Lost to Follow-up|0|||
46731765|NCT03782727|82948494|FG000|Overall Study|Lost to Follow-up|32|||
46731766|NCT03737812|82948501|FG000|Overall Study|Withdrawal by Subject|1|||
46731767|NCT03737812|82948502|FG001|Overall Study|Withdrawal by Subject|2|||
46731768|NCT03737812|82948503|FG002|Overall Study|Withdrawal by Subject|1|||
46731769|NCT03737812|82948501|FG000|Overall Study|Sponsor Discontinued the Study|4|||
46731770|NCT03737812|82948502|FG001|Overall Study|Sponsor Discontinued the Study|3|||
46731771|NCT03737812|82948503|FG002|Overall Study|Sponsor Discontinued the Study|2|||
46731772|NCT03737812|82948501|FG000|Overall Study|Adverse Event|0|||
46731773|NCT03737812|82948502|FG001|Overall Study|Adverse Event|1|||
46731774|NCT03737812|82948503|FG002|Overall Study|Adverse Event|0|||
46731775|NCT03737812|82948501|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
46731776|NCT03737812|82948502|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
46731777|NCT03737812|82948503|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
46731778|NCT03635424|82948511|FG000|Overall Study|Adverse Event|1|||
46731779|NCT03635424|82948511|FG000|Overall Study|Death|1|||
46731780|NCT03635424|82948511|FG000|Overall Study|Device not implanted|1|||
46731781|NCT03565367|82948517|FG000|Overall Study|No scan due to technical issues|4|||
46731782|NCT03565367|82948518|FG001|Overall Study|No scan due to technical issues|0|||
46731783|NCT03443687|82948526|FG000|Overall Study|Lost to Follow-up|3|||
46731784|NCT03443687|82948527|FG001|Overall Study|Lost to Follow-up|5|||
46731785|NCT03443687|82948526|FG000|Overall Study|Withdrawal by Subject|1|||
46731786|NCT03443687|82948527|FG001|Overall Study|Withdrawal by Subject|0|||
46731787|NCT03443687|82948526|FG000|Overall Study|Discontinued intervention|1|||
46731788|NCT03443687|82948527|FG001|Overall Study|Discontinued intervention|1|||
46731789|NCT03384654|82948537|FG000|Overall Study|Withdrawal by Subject|0|||
46731790|NCT03384654|82948538|FG001|Overall Study|Withdrawal by Subject|0|||
46731791|NCT03384654|82948539|FG002|Overall Study|Withdrawal by Subject|1|||
46731792|NCT03384654|82948540|FG003|Overall Study|Withdrawal by Subject|0|||
46921467|NCT03068455|83154049|FG001|Pre-treatment Period|Participant withdrew consent|1|||
46921468|NCT03068455|83154048|FG000|Pre-treatment Period|Poor/non-compliance|0|||
46921469|NCT03068455|83154049|FG001|Pre-treatment Period|Poor/non-compliance|1|||
46803931|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
46803932|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
46731793|NCT03085485|82948568|FG000|Overall Study|Death|1|||
46731794|NCT03085485|82948569|FG001|Overall Study|Death|0|||
46731795|NCT03085485|82948568|FG000|Overall Study|Lost to Follow-up|1|||
46731796|NCT03085485|82948569|FG001|Overall Study|Lost to Follow-up|0|||
46731797|NCT03043872|82948587|FG000|Overall Study|Withdrawal by Subject|6|||
46731798|NCT03043872|82948588|FG001|Overall Study|Withdrawal by Subject|6|||
46731799|NCT03043872|82948589|FG002|Overall Study|Withdrawal by Subject|15|||
46731800|NCT03043872|82948587|FG000|Overall Study|Lost to Follow-up|2|||
46731801|NCT03043872|82948588|FG001|Overall Study|Lost to Follow-up|1|||
46731802|NCT03043872|82948589|FG002|Overall Study|Lost to Follow-up|1|||
46731803|NCT03043872|82948587|FG000|Overall Study|Death|270|||
46731804|NCT03043872|82948588|FG001|Overall Study|Death|269|||
46921470|NCT03068455|83154048|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
46731805|NCT03043872|82948589|FG002|Overall Study|Death|296|||
46731806|NCT02928224|82948611|FG000|Overall Study|Lost to Follow-up|1|||
46731807|NCT02928224|82948612|FG001|Overall Study|Lost to Follow-up|1|||
47049005|NCT01929317|83309233|FG001|Long-term Phase|Adverse Event|1|||
46731808|NCT02928224|82948613|FG002|Overall Study|Lost to Follow-up|3|||
46731809|NCT02928224|82948614|FG003|Overall Study|Lost to Follow-up|0|||
46731810|NCT02928224|82948611|FG000|Overall Study|Death|30|||
46731811|NCT02928224|82948612|FG001|Overall Study|Death|209|||
46731812|NCT02928224|82948613|FG002|Overall Study|Death|193|||
46731813|NCT02928224|82948614|FG003|Overall Study|Death|198|||
46731814|NCT02928224|82948611|FG000|Overall Study|Withdrawal by Subject|0|||
46731815|NCT02928224|82948612|FG001|Overall Study|Withdrawal by Subject|3|||
46731816|NCT02928224|82948613|FG002|Overall Study|Withdrawal by Subject|7|||
46731817|NCT02928224|82948614|FG003|Overall Study|Withdrawal by Subject|20|||
46731818|NCT02928224|82948611|FG000|Overall Study|Study participation terminated by sponsor|3|||
46731819|NCT02928224|82948612|FG001|Overall Study|Study participation terminated by sponsor|8|||
46731820|NCT02928224|82948613|FG002|Overall Study|Study participation terminated by sponsor|12|||
46731821|NCT02928224|82948614|FG003|Overall Study|Study participation terminated by sponsor|3|||
46731822|NCT02928224|82948611|FG000|Overall Study|Other|3|||
46731823|NCT02928224|82948612|FG001|Overall Study|Other|3|||
46731824|NCT02928224|82948613|FG002|Overall Study|Other|5|||
46731825|NCT02928224|82948614|FG003|Overall Study|Other|0|||
46731826|NCT02842086|82948633|FG000|Overall Study|Randomized but Never Treated|6|||
46731827|NCT02842086|82948634|FG001|Overall Study|Randomized but Never Treated|6|||
46731828|NCT02842086|82948633|FG000|Overall Study|Still in Double-Blind Phase|7|||
46731829|NCT02842086|82948634|FG001|Overall Study|Still in Double-Blind Phase|3|||
46731830|NCT02842086|82948633|FG000|Overall Study|Adverse Event|18|||
46731831|NCT02842086|82948634|FG001|Overall Study|Adverse Event|20|||
46731832|NCT02842086|82948633|FG000|Overall Study|Death|3|||
46731833|NCT02842086|82948634|FG001|Overall Study|Death|3|||
46731834|NCT02842086|82948633|FG000|Overall Study|Investigator's Discretion|9|||
46731835|NCT02842086|82948634|FG001|Overall Study|Investigator's Discretion|13|||
46731836|NCT02842086|82948633|FG000|Overall Study|Non-Compliance with Study Drug|9|||
46731837|NCT02842086|82948634|FG001|Overall Study|Non-Compliance with Study Drug|8|||
46731838|NCT02842086|82948633|FG000|Overall Study|Protocol Violation|8|||
46731839|NCT02842086|82948634|FG001|Overall Study|Protocol Violation|4|||
46731840|NCT02842086|82948633|FG000|Overall Study|Withdrew Consent|205|||
46731841|NCT02842086|82948634|FG001|Overall Study|Withdrew Consent|194|||
46731842|NCT02842086|82948633|FG000|Overall Study|Lost to Follow-up|274|||
46731843|NCT02842086|82948634|FG001|Overall Study|Lost to Follow-up|236|||
46731844|NCT02842086|82948633|FG000|Overall Study|HIV-1 Infection|5|||
46731845|NCT02842086|82948634|FG001|Overall Study|HIV-1 Infection|6|||
46731846|NCT02788474|82948642|FG000|Double Blind Treatment Period|Not treated|1|||
46731847|NCT02788474|82948643|FG001|Double Blind Treatment Period|Not treated|0|||
46731848|NCT02788474|82948642|FG000|Double Blind Treatment Period|Patient's refusal|3|||
46731849|NCT02788474|82948643|FG001|Double Blind Treatment Period|Patient's refusal|0|||
46731850|NCT02788474|82948642|FG000|Double Blind Treatment Period|Adverse Event|6|||
46731851|NCT02788474|82948643|FG001|Double Blind Treatment Period|Adverse Event|4|||
46731852|NCT02788474|82948642|FG000|Open Label Treatment Period|Adverse Event|29|||
46731853|NCT02788474|82948643|FG001|Open Label Treatment Period|Adverse Event|9|||
46731854|NCT02788474|82948642|FG000|Open Label Treatment Period|Other than reason specified|1|||
46731855|NCT02788474|82948643|FG001|Open Label Treatment Period|Other than reason specified|0|||
46731856|NCT02788474|82948642|FG000|Open Label Treatment Period|Patient's refusal|1|||
46731857|NCT02788474|82948643|FG001|Open Label Treatment Period|Patient's refusal|3|||
46731858|NCT02788474|82948642|FG000|Open Label Treatment Period|Non-compliance|1|||
46731859|NCT02788474|82948643|FG001|Open Label Treatment Period|Non-compliance|0|||
46731860|NCT02631746|82948650|FG000|Overall Study|Lack of Efficacy|3|||
46731861|NCT02166463|82948667|FG000|Overall Study|Lost to Follow-up|0|||
46731862|NCT02166463|82948668|FG001|Overall Study|Lost to Follow-up|1|||
46731863|NCT02166463|82948667|FG000|Overall Study|Physician Decision|10|||
46731864|NCT02166463|82948668|FG001|Overall Study|Physician Decision|10|||
46731865|NCT02166463|82948667|FG000|Overall Study|Ineligible|11|||
46731866|NCT02166463|82948668|FG001|Overall Study|Ineligible|2|||
46731867|NCT02166463|82948667|FG000|Overall Study|Progressive Disease|9|||
46731868|NCT02166463|82948668|FG001|Overall Study|Progressive Disease|6|||
46731869|NCT02166463|82948667|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
46731870|NCT02166463|82948668|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
46731871|NCT02166463|82948667|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
46731872|NCT02166463|82948668|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
46731873|NCT02166463|82948667|FG000|Overall Study|Refusal of further protocol therapy|5|||
46731874|NCT02166463|82948668|FG001|Overall Study|Refusal of further protocol therapy|6|||
46731875|NCT02101034|82948679|FG000|Overall Study|Enrolled but did not start treatment|0|||
46731876|NCT02101034|82948680|FG001|Overall Study|Enrolled but did not start treatment|0|||
46731877|NCT02101034|82948681|FG002|Overall Study|Enrolled but did not start treatment|1|||
46731878|NCT02101034|82948682|FG003|Overall Study|Enrolled but did not start treatment|0|||
46731879|NCT02101034|82948683|FG004|Overall Study|Enrolled but did not start treatment|0|||
46731880|NCT02000622|82948706|FG000|Overall Study|Withdrawal by Subject|5|||
46731881|NCT02000622|82948707|FG001|Overall Study|Withdrawal by Subject|7|||
46731882|NCT02000622|82948706|FG000|Overall Study|Lost to Follow-up|4|||
46731883|NCT02000622|82948707|FG001|Overall Study|Lost to Follow-up|0|||
47049006|NCT01929317|83309232|FG000|Long-term Phase|Physician Decision|3|||
46731884|NCT02000622|82948706|FG000|Overall Study|Death|159|||
46731885|NCT02000622|82948707|FG001|Overall Study|Death|73|||
46731886|NCT02000622|82948706|FG000|Overall Study|Withdrawn due to site closure|1|||
46731887|NCT02000622|82948707|FG001|Overall Study|Withdrawn due to site closure|0|||
46731888|NCT00798135|82948722|FG000|Overall Study|Disease progression, relapse|11|||
46731889|NCT00798135|82948722|FG000|Overall Study|Disease progression, refractory|1|||
46731890|NCT00798135|82948722|FG000|Overall Study|Physician Decision|1|||
46731891|NCT00813358|82948745|FG000|Overall Study|Death|32|||
46731892|NCT00813358|82948745|FG000|Overall Study|Lost to Follow-up|12|||
46731893|NCT00813358|82948745|FG000|Overall Study|other endpoints|5|||
46731894|NCT00813358|82948745|FG000|Overall Study|Withdrawal by Subject|20|||
46731895|NCT00812812|82948751|FG000|Overall Study|Adverse Event|2|||
46731896|NCT00812812|82948752|FG001|Overall Study|Adverse Event|1|||
46731897|NCT00812812|82948751|FG000|Overall Study|Lack of Efficacy|1|||
46731898|NCT00812812|82948752|FG001|Overall Study|Lack of Efficacy|0|||
46731899|NCT00812812|82948751|FG000|Overall Study|Lost to Follow-up|0|||
46731900|NCT00812812|82948752|FG001|Overall Study|Lost to Follow-up|1|||
46731901|NCT00812812|82948751|FG000|Overall Study|Withdrawal by Subject|0|||
46731902|NCT00812812|82948752|FG001|Overall Study|Withdrawal by Subject|2|||
46731903|NCT00810082|82948762|FG000|Overall Study|Lost to Follow-up|0|||
46731904|NCT00810082|82948763|FG001|Overall Study|Lost to Follow-up|4|||
46731905|NCT00748189|82948771|FG000|Overall Study|Death|99|||
46731906|NCT00748189|82948772|FG001|Overall Study|Death|84|||
46731907|NCT00748189|82948771|FG000|Overall Study|Withdrawal by Subject|23|||
46731908|NCT00748189|82948772|FG001|Overall Study|Withdrawal by Subject|29|||
46731909|NCT00748189|82948771|FG000|Overall Study|Physician Decision|16|||
46731910|NCT00748189|82948772|FG001|Overall Study|Physician Decision|5|||
46731911|NCT00748189|82948771|FG000|Overall Study|Lost to Follow-up|8|||
46731912|NCT00748189|82948772|FG001|Overall Study|Lost to Follow-up|15|||
46731913|NCT00748189|82948771|FG000|Overall Study|Study terminated by Sponsor|70|||
46731914|NCT00748189|82948772|FG001|Overall Study|Study terminated by Sponsor|79|||
46731915|NCT00744055|82948785|FG000|Overall Study|Withdrawal by Subject|6|||
46731916|NCT00744055|82948786|FG001|Overall Study|Withdrawal by Subject|9|||
46731917|NCT00744055|82948785|FG000|Overall Study|Lack of Efficacy|0|||
46731918|NCT00744055|82948786|FG001|Overall Study|Lack of Efficacy|1|||
46731919|NCT00744055|82948785|FG000|Overall Study|Physician Decision|0|||
46731920|NCT00744055|82948786|FG001|Overall Study|Physician Decision|2|||
46731921|NCT00744055|82948785|FG000|Overall Study|Protocol Violation|1|||
46731922|NCT00744055|82948786|FG001|Overall Study|Protocol Violation|1|||
46731923|NCT00744055|82948785|FG000|Overall Study|Lost to Follow-up|0|||
46731924|NCT00744055|82948786|FG001|Overall Study|Lost to Follow-up|1|||
46731925|NCT00748033|82948794|FG000|Overall Study|Adverse Event|0|||
46731926|NCT00748033|82948795|FG001|Overall Study|Adverse Event|1|||
46731927|NCT00735553|82948812|FG000|Overall Study|Study prematurely terminated|77|||
46731928|NCT00740779|82948823|FG000|Overall Study|Adverse Event|4|||
46731929|NCT00740779|82948824|FG001|Overall Study|Adverse Event|6|||
46731930|NCT00740779|82948825|FG002|Overall Study|Adverse Event|3|||
46731931|NCT00740779|82948823|FG000|Overall Study|Protocol Violation|1|||
46731932|NCT00740779|82948824|FG001|Overall Study|Protocol Violation|1|||
46731933|NCT00740779|82948825|FG002|Overall Study|Protocol Violation|1|||
46731934|NCT00740779|82948823|FG000|Overall Study|Lack of Efficacy|0|||
46731935|NCT00740779|82948824|FG001|Overall Study|Lack of Efficacy|0|||
46731936|NCT00740779|82948825|FG002|Overall Study|Lack of Efficacy|2|||
46731937|NCT00740779|82948823|FG000|Overall Study|Withdrawal by Subject|2|||
46731938|NCT00740779|82948824|FG001|Overall Study|Withdrawal by Subject|4|||
46731939|NCT00740779|82948825|FG002|Overall Study|Withdrawal by Subject|2|||
46731940|NCT00740779|82948823|FG000|Overall Study|Lost to Follow-up|2|||
46731941|NCT00740779|82948824|FG001|Overall Study|Lost to Follow-up|3|||
46731942|NCT00740779|82948825|FG002|Overall Study|Lost to Follow-up|5|||
46731943|NCT00735475|82948835|FG000|Overall Study|Adverse Event|0|||
46731944|NCT00735475|82948836|FG001|Overall Study|Adverse Event|1|||
46731945|NCT00735475|82948835|FG000|Overall Study|Death|1|||
46731946|NCT00735475|82948836|FG001|Overall Study|Death|1|||
46731947|NCT00735475|82948835|FG000|Overall Study|Lost to Follow-up|3|||
46731948|NCT00735475|82948836|FG001|Overall Study|Lost to Follow-up|3|||
46731949|NCT00735475|82948835|FG000|Overall Study|Physician Decision|0|||
46731950|NCT00735475|82948836|FG001|Overall Study|Physician Decision|1|||
46731951|NCT00735475|82948835|FG000|Overall Study|Withdrawal by Subject|4|||
47049007|NCT01929317|83309233|FG001|Long-term Phase|Physician Decision|0|||
47049008|NCT01929317|83309232|FG000|Long-term Phase|Withdrawal by Subject|4|||
46731952|NCT00735475|82948836|FG001|Overall Study|Withdrawal by Subject|5|||
46731953|NCT01026818|82948845|FG000|Screening Period|Entry Criteria Not Met|105|||
46731954|NCT01026818|82948846|FG001|Screening Period|Entry Criteria Not Met|0|||
46731955|NCT01026818|82948847|FG002|Screening Period|Entry Criteria Not Met|0|||
46731956|NCT01026818|82948848|FG003|Screening Period|Entry Criteria Not Met|0|||
46731957|NCT01026818|82948845|FG000|Screening Period|Withdrawal by Subject|49|||
46731958|NCT01026818|82948846|FG001|Screening Period|Withdrawal by Subject|0|||
46731959|NCT01026818|82948847|FG002|Screening Period|Withdrawal by Subject|0|||
46731960|NCT01026818|82948848|FG003|Screening Period|Withdrawal by Subject|0|||
46731961|NCT01026818|82948845|FG000|Screening Period|Protocol Deviation|3|||
46731962|NCT01026818|82948846|FG001|Screening Period|Protocol Deviation|0|||
46731963|NCT01026818|82948847|FG002|Screening Period|Protocol Deviation|0|||
46731964|NCT01026818|82948848|FG003|Screening Period|Protocol Deviation|0|||
46731965|NCT01026818|82948845|FG000|Screening Period|Adverse Event|2|||
46731966|NCT01026818|82948846|FG001|Screening Period|Adverse Event|0|||
46731967|NCT01026818|82948847|FG002|Screening Period|Adverse Event|0|||
46731968|NCT01026818|82948848|FG003|Screening Period|Adverse Event|0|||
46731969|NCT01026818|82948845|FG000|Screening Period|Physician Decision|1|||
46731970|NCT01026818|82948846|FG001|Screening Period|Physician Decision|0|||
46731971|NCT01026818|82948847|FG002|Screening Period|Physician Decision|0|||
46731972|NCT01026818|82948848|FG003|Screening Period|Physician Decision|0|||
46731973|NCT01026818|82948845|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
46731974|NCT01026818|82948846|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
46731975|NCT01026818|82948847|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
46731976|NCT01026818|82948848|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
46731977|NCT01026818|82948845|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
46731978|NCT01026818|82948846|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
46731979|NCT01026818|82948847|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
46731980|NCT01026818|82948848|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
46731981|NCT01026818|82948845|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
46731982|NCT01026818|82948846|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
46731983|NCT01026818|82948847|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
46731984|NCT01026818|82948848|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
46731985|NCT01026818|82948845|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
46731986|NCT01026818|82948846|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
46731987|NCT01026818|82948847|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
46731988|NCT01026818|82948848|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
46731989|NCT01026818|82948845|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
46731990|NCT01026818|82948846|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
46731991|NCT01026818|82948847|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
46731992|NCT01026818|82948848|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
46731993|NCT01026818|82948845|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
46731994|NCT01026818|82948846|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
46731995|NCT01026818|82948847|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
46731996|NCT01026818|82948848|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
46731997|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
46731998|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
46731999|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
46732000|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
46732001|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
46732002|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
46732003|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
46732004|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
46732005|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
46732006|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
46732007|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
46732008|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
46732009|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
46732010|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
46732011|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
46732012|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
46732013|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
47049009|NCT01929317|83309233|FG001|Long-term Phase|Withdrawal by Subject|0|||
47049010|NCT01929317|83309232|FG000|Long-term Phase|Protocol Violation|1|||
47049011|NCT01929317|83309233|FG001|Long-term Phase|Protocol Violation|0|||
47049012|NCT01929317|83309232|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
47049013|NCT01929317|83309233|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
47049014|NCT01929317|83309232|FG000|Long-term Phase|Study Closed/Terminated|5|||
47049015|NCT01929317|83309233|FG001|Long-term Phase|Study Closed/Terminated|3|||
47049016|NCT01711879|83309247|FG000|Overall Study|Death|1|||
47049017|NCT01711879|83309248|FG001|Overall Study|Death|0|||
47049018|NCT01689649|83309271|FG000|Overall Study|Lack of Efficacy|3|||
47049019|NCT01689649|83309271|FG000|Overall Study|Non-compliance|11|||
47049020|NCT01689649|83309271|FG000|Overall Study|Protocol Violation|3|||
47049021|NCT01689649|83309271|FG000|Overall Study|Lost to Follow-up|5|||
47049022|NCT01929083|83309275|FG000|Intervention 1|Lost to Follow-up|2|||
46732014|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
47049023|NCT01929083|83309276|FG001|Intervention 1|Lost to Follow-up|0|||
47049024|NCT01929083|83309275|FG000|Intervention 1|Nonadherent to study medications|1|||
47049025|NCT01929083|83309276|FG001|Intervention 1|Nonadherent to study medications|0|||
46732015|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
46732016|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
46732017|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
46732018|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
46732019|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
46732020|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
46732021|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
46732022|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
46732023|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
46732024|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
46732025|NCT01026818|82948845|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
46732026|NCT01026818|82948846|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
46732027|NCT01026818|82948847|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
46732028|NCT01026818|82948848|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
46732029|NCT01026818|82948845|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
46732030|NCT01026818|82948846|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
46732031|NCT01026818|82948847|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
46732032|NCT01026818|82948848|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
46732033|NCT01026818|82948845|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
46732034|NCT01026818|82948846|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
46732035|NCT01026818|82948847|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
46732036|NCT01026818|82948848|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
46732037|NCT01026818|82948845|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
46732038|NCT01026818|82948846|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
46732039|NCT01026818|82948847|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
46732040|NCT01026818|82948848|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
46732041|NCT01026818|82948845|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
46732042|NCT01026818|82948846|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
46732043|NCT01026818|82948847|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
46732044|NCT01026818|82948848|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
46732045|NCT01026818|82948845|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
46732046|NCT01026818|82948846|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
46732047|NCT01026818|82948847|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
46732048|NCT01026818|82948848|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
46732049|NCT00735397|82948860|FG000|Overall Study|Adverse Event|194|||
46732050|NCT00735397|82948860|FG000|Overall Study|Lost to Follow-up|33|||
46732051|NCT00735397|82948860|FG000|Overall Study|Participant choice|252|||
46732052|NCT00735397|82948860|FG000|Overall Study|Inadequate therapeutic effect|202|||
46732053|NCT00735397|82948860|FG000|Overall Study|Administrative/Other|502|||
46732054|NCT00735007|82948867|FG000|Overall Study|Adverse Event|4|||
46732055|NCT00735007|82948867|FG000|Overall Study|Protocol Violation|1|||
46732056|NCT00743509|82948871|FG000|Overall Study|Withdrawal by Subject|2|||
46732057|NCT00734929|82948877|FG000|Overall Study|Lost to Follow-up|1|||
46732058|NCT00734929|82948878|FG001|Overall Study|Lost to Follow-up|2|||
46732059|NCT00734929|82948877|FG000|Overall Study|No intervention/ screen fail|5|||
46732060|NCT00734929|82948878|FG001|Overall Study|No intervention/ screen fail|3|||
46732061|NCT00734851|82948886|FG000|Overall Study|Withdrawal by Subject|2|||
46732062|NCT00734851|82948886|FG000|Overall Study|Lost to Follow-up|1|||
46732063|NCT00734851|82948886|FG000|Overall Study|Physician Decision|18|||
46732064|NCT00734617|82948892|FG000|Overall Study|Adverse Event|4|||
46732065|NCT00734617|82948893|FG001|Overall Study|Adverse Event|7|||
46732066|NCT00734617|82948892|FG000|Overall Study|Withdrawal by Subject|103|||
46732067|NCT00734617|82948893|FG001|Overall Study|Withdrawal by Subject|95|||
46732068|NCT00743431|82948899|FG000|Overall Study|Toxicity|6|||
46803933|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
46803934|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
46921471|NCT03068455|83154049|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
46921472|NCT03068455|83154048|FG000|Pre-treatment Period|Not reported|2|||
46921473|NCT03068455|83154049|FG001|Pre-treatment Period|Not reported|1|||
46921474|NCT03068455|83154048|FG000|Treatment Period|Disease progression|166|||
46921475|NCT03068455|83154049|FG001|Treatment Period|Disease progression|208|||
47049026|NCT01929083|83309275|FG000|Intervention 2|Adverse Event|0|||
47049027|NCT01929083|83309276|FG001|Intervention 2|Adverse Event|1|||
47049028|NCT01689337|83309282|FG000|Overall Study|Study Discontinuation|1|||
47049029|NCT01688635|83309288|FG000|Washout 1|Withdrawal by Subject|1|||
46732069|NCT00743431|82948899|FG000|Overall Study|Tumor progression|56|||
46732070|NCT00743431|82948899|FG000|Overall Study|Withdrawal by Subject|13|||
46732071|NCT00743431|82948899|FG000|Overall Study|Death|9|||
46732072|NCT00743431|82948899|FG000|Overall Study|Reason for discontinuation not specified|29|||
46732073|NCT00743431|82948899|FG000|Overall Study|No documentation available|13|||
46732074|NCT00734539|82948905|FG000|Main Study|Death|33|||
47049030|NCT01688635|83309289|FG001|Washout 1|Withdrawal by Subject|0|||
46732075|NCT00734539|82948906|FG001|Main Study|Death|32|||
46732076|NCT00734539|82948905|FG000|Main Study|Physician Decision|2|||
46732077|NCT00734539|82948906|FG001|Main Study|Physician Decision|0|||
46732078|NCT00734539|82948905|FG000|Main Study|Withdrawal by Subject|1|||
46732079|NCT00734539|82948906|FG001|Main Study|Withdrawal by Subject|3|||
46732080|NCT00734539|82948905|FG000|Main Study|Enrolled in error; ineligible|1|||
46732081|NCT00734539|82948906|FG001|Main Study|Enrolled in error; ineligible|0|||
46732082|NCT00743275|82948917|FG000|Overall Study|Protocol Violation|0|||
46732083|NCT00743275|82948918|FG001|Overall Study|Protocol Violation|1|||
46732084|NCT00743197|82948926|FG000|Overall Study|Study terminated due to departure of PI.|1|||
46732085|NCT00743197|82948927|FG001|Overall Study|Study terminated due to departure of PI.|2|||
46732086|NCT00734071|82948935|FG000|Overall Study|Adverse Event|4|||
46732087|NCT00734071|82948936|FG001|Overall Study|Adverse Event|3|||
46732088|NCT00734071|82948935|FG000|Overall Study|Lack of Efficacy|3|||
46732089|NCT00734071|82948936|FG001|Overall Study|Lack of Efficacy|1|||
47049031|NCT01688635|83309288|FG000|Washout 1|Adverse Event|0|||
47049032|NCT01688635|83309289|FG001|Washout 1|Adverse Event|1|||
47049033|NCT01688635|83309288|FG000|Washout 1|Physician Decision|0|||
47049034|NCT01688635|83309289|FG001|Washout 1|Physician Decision|1|||
47049035|NCT01688635|83309288|FG000|Washout 2|Physician Decision|1|||
46732090|NCT00734071|82948935|FG000|Overall Study|Noncompliance|2|||
46732091|NCT00734071|82948936|FG001|Overall Study|Noncompliance|2|||
46732092|NCT00734071|82948935|FG000|Overall Study|Protocol Deviations|3|||
46732093|NCT00734071|82948936|FG001|Overall Study|Protocol Deviations|4|||
46732094|NCT00734071|82948935|FG000|Overall Study|Voluntary Withdrawal|9|||
46732095|NCT00734071|82948936|FG001|Overall Study|Voluntary Withdrawal|7|||
46732096|NCT00734071|82948935|FG000|Overall Study|Lost to Follow-up|16|||
46732097|NCT00734071|82948936|FG001|Overall Study|Lost to Follow-up|8|||
46732098|NCT00734071|82948935|FG000|Overall Study|Other|1|||
46732099|NCT00734071|82948936|FG001|Overall Study|Other|2|||
46732100|NCT00739297|82948942|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
46732101|NCT00739297|82948943|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
46732102|NCT00739297|82948944|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
46732103|NCT00739297|82948945|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
46732104|NCT00739297|82948946|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
46732105|NCT00739297|82948947|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
46732106|NCT00739297|82948948|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
46732107|NCT00739297|82948942|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
46732108|NCT00739297|82948943|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
46732109|NCT00739297|82948944|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
46732110|NCT00739297|82948945|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
46732111|NCT00739297|82948946|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
46732112|NCT00739297|82948947|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
46732113|NCT00739297|82948948|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
46732114|NCT00739063|82948964|FG000|Overall Study|Screen failures|8|||
46732115|NCT01026194|82948970|FG000|Period 1：Double Blind Period|Adverse Event|2|||
46732116|NCT01026194|82948971|FG001|Period 1：Double Blind Period|Adverse Event|1|||
46732117|NCT01026194|82948970|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
46732118|NCT01026194|82948971|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
46732119|NCT01026194|82948970|FG000|Period 1：Double Blind Period|Physician Decision|0|||
46732120|NCT01026194|82948971|FG001|Period 1：Double Blind Period|Physician Decision|4|||
46732121|NCT01026194|82948970|FG000|Period 2：Open-label Period|Adverse Event|4|||
46732122|NCT01026194|82948971|FG001|Period 2：Open-label Period|Adverse Event|5|||
46732123|NCT01026194|82948970|FG000|Period 2：Open-label Period|Physician Decision|3|||
46732124|NCT01026194|82948971|FG001|Period 2：Open-label Period|Physician Decision|1|||
46732125|NCT01026194|82948970|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
47049036|NCT01688635|83309289|FG001|Washout 2|Physician Decision|0|||
47049037|NCT01688635|83309288|FG000|Washout 2|Withdrawal by Subject|1|||
47049038|NCT01688635|83309289|FG001|Washout 2|Withdrawal by Subject|0|||
47049039|NCT01688635|83309288|FG000|Washout 2|Sponsor Decision|1|||
47049040|NCT01688635|83309289|FG001|Washout 2|Sponsor Decision|2|||
47049041|NCT01688635|83309288|FG000|Washout 3|Withdrawal by Subject|1|||
47049042|NCT01688635|83309289|FG001|Washout 3|Withdrawal by Subject|0|||
47049043|NCT01591681|83309296|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
47049044|NCT01591681|83309296|FG000|Overall Study|Failed to use system during run-in|1|||
46732126|NCT01026194|82948971|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
46732127|NCT01033136|82948981|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
46732128|NCT01033136|82948982|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
46732129|NCT00738673|82948992|FG000|Overall Study|Adverse Event|1|||
46732130|NCT00738673|82948993|FG001|Overall Study|Adverse Event|0|||
46732131|NCT00738673|82948992|FG000|Overall Study|Lack of Efficacy|19|||
47049045|NCT01711645|83309311|FG000|Overall Study|Withdrawal by Subject|8|||
47049046|NCT01711645|83309311|FG000|Overall Study|Lost to Follow-up|6|||
47049047|NCT01711645|83309311|FG000|Overall Study|Physician Decision|5|||
46732132|NCT00738673|82948993|FG001|Overall Study|Lack of Efficacy|8|||
46732133|NCT00738673|82948992|FG000|Overall Study|Protocol Violation|1|||
46732134|NCT00738673|82948993|FG001|Overall Study|Protocol Violation|2|||
46732135|NCT00738673|82948992|FG000|Overall Study|Withdrawal by Subject|3|||
46732136|NCT00738673|82948993|FG001|Overall Study|Withdrawal by Subject|1|||
47049048|NCT01590433|83309326|FG000|Overall Study|Lost to Follow-up|20|||
47049049|NCT01590433|83309327|FG001|Overall Study|Lost to Follow-up|8|||
46732137|NCT00811954|82949002|FG000|Overall Study|Death|10|||
46732138|NCT00811954|82949003|FG001|Overall Study|Death|6|||
46732139|NCT00811954|82949004|FG002|Overall Study|Death|13|||
46732140|NCT00811954|82949002|FG000|Overall Study|Lost to Follow-up|29|||
46732141|NCT00811954|82949003|FG001|Overall Study|Lost to Follow-up|23|||
47049050|NCT01590433|83309326|FG000|Overall Study|Withdrawal by Subject|21|||
47049051|NCT01590433|83309327|FG001|Overall Study|Withdrawal by Subject|11|||
47049052|NCT01590433|83309326|FG000|Overall Study|Adverse Event|11|||
47049053|NCT01590433|83309327|FG001|Overall Study|Adverse Event|3|||
47049054|NCT01928927|83309344|FG000|Overall Study|Lost to Follow-up|1|||
47049055|NCT01928927|83309345|FG001|Overall Study|Lost to Follow-up|0|||
47049056|NCT01928927|83309344|FG000|Overall Study|Withdrawal by Subject|1|||
47049057|NCT01928927|83309345|FG001|Overall Study|Withdrawal by Subject|1|||
47049058|NCT01710709|83309366|FG000|Overall Study|Lost to Follow-up|29|||
47049059|NCT01710709|83309366|FG000|Overall Study|Adverse Event|48|||
47049060|NCT01710709|83309366|FG000|Overall Study|Participant met withdrawal criteria|33|||
47049061|NCT01710709|83309366|FG000|Overall Study|Participant withdrawn by investigator|2|||
47049062|NCT01710709|83309366|FG000|Overall Study|Withdrawal by Subject|53|||
47049063|NCT01710709|83309366|FG000|Overall Study|Protocol Violation|5|||
47049064|NCT01710709|83309366|FG000|Overall Study|Lack of Efficacy|3|||
47049065|NCT01617629|83309371|FG000|Overall Study|Death|2|||
47049066|NCT01617629|83309371|FG000|Overall Study|Investigator's Clinical Judgement|1|||
47049067|NCT01617629|83309371|FG000|Overall Study|Reason Not Specified|1|||
47049068|NCT01617629|83309371|FG000|Overall Study|Participant Withdrew Consent|2|||
47049069|NCT01686373|83309386|FG000|Overall Study|Lost to Follow-up|3|||
47049070|NCT01686373|83309387|FG001|Overall Study|Lost to Follow-up|0|||
47049071|NCT01686373|83309386|FG000|Overall Study|Withdrawal by Subject|0|||
47049072|NCT01686373|83309387|FG001|Overall Study|Withdrawal by Subject|1|||
47049073|NCT01686373|83309386|FG000|Overall Study|Adverse Event|0|||
47049074|NCT01686373|83309387|FG001|Overall Study|Adverse Event|1|||
47049075|NCT01709695|83309395|FG000|Overall Study|Withdrawal by Subject|1|||
47049076|NCT01709695|83309396|FG001|Overall Study|Withdrawal by Subject|1|||
47049077|NCT01685983|83309406|FG000|Overall Study|Adverse Event|7|||
47049078|NCT01685983|83309406|FG000|Overall Study|Death|1|||
47049079|NCT01685983|83309406|FG000|Overall Study|Withdrawal by Subject|19|||
47049080|NCT01685983|83309406|FG000|Overall Study|Protocol Violation|2|||
47049081|NCT01685983|83309406|FG000|Overall Study|Physician Decision|13|||
47049082|NCT01685983|83309406|FG000|Overall Study|Other|7|||
47049083|NCT01685983|83309406|FG000|Overall Study|Progressive Disease|32|||
47049084|NCT01685983|83309406|FG000|Overall Study|Noncompliance with Study Drug|1|||
46732142|NCT00811954|82949004|FG002|Overall Study|Lost to Follow-up|34|||
46732143|NCT00811954|82949002|FG000|Overall Study|Not able to get to clinic|28|||
46732144|NCT00811954|82949003|FG001|Overall Study|Not able to get to clinic|35|||
46732145|NCT00811954|82949004|FG002|Overall Study|Not able to get to clinic|30|||
46732146|NCT00811954|82949002|FG000|Overall Study|Not willing to adhere to requirements|12|||
46732147|NCT00811954|82949003|FG001|Overall Study|Not willing to adhere to requirements|2|||
46732148|NCT00811954|82949004|FG002|Overall Study|Not willing to adhere to requirements|16|||
46732149|NCT00811954|82949002|FG000|Overall Study|Withdraw consent prior study completion|4|||
46732150|NCT00811954|82949003|FG001|Overall Study|Withdraw consent prior study completion|6|||
46732151|NCT00811954|82949004|FG002|Overall Study|Withdraw consent prior study completion|5|||
46732152|NCT00811954|82949002|FG000|Overall Study|Site Closure|4|||
46732153|NCT00811954|82949003|FG001|Overall Study|Site Closure|0|||
46732154|NCT00811954|82949004|FG002|Overall Study|Site Closure|1|||
46732155|NCT00811954|82949002|FG000|Overall Study|Severe Debilitation|2|||
46732156|NCT00811954|82949003|FG001|Overall Study|Severe Debilitation|0|||
46732157|NCT00811954|82949004|FG002|Overall Study|Severe Debilitation|1|||
46732158|NCT00811954|82949002|FG000|Overall Study|Complete Protocol: No follow-up|0|||
47049085|NCT01685437|83309418|FG000|Overall Study|Withdrawal by Subject|22|||
47049086|NCT01685437|83309418|FG000|Overall Study|Lost to Follow-up|3|||
47049087|NCT01685437|83309418|FG000|Overall Study|Adverse Event|1|||
47049088|NCT01685437|83309418|FG000|Overall Study|Protocol Violation|4|||
47049089|NCT01685437|83309418|FG000|Overall Study|Unable to make visits due to work|1|||
47049090|NCT01685203|83309458|FG000|Overall Study|Lost to Follow-up|3|||
47049091|NCT01685203|83309459|FG001|Overall Study|Lost to Follow-up|3|||
46732159|NCT00811954|82949003|FG001|Overall Study|Complete Protocol: No follow-up|0|||
46732160|NCT00811954|82949004|FG002|Overall Study|Complete Protocol: No follow-up|1|||
46732161|NCT01032200|82949014|FG000|Overall Study|Death|1|||
46732162|NCT01032200|82949015|FG001|Overall Study|Death|1|||
47049092|NCT01685203|83309460|FG002|Overall Study|Lost to Follow-up|0|||
46732163|NCT01032200|82949014|FG000|Overall Study|Withdrawal by Subject|1|||
46732164|NCT01032200|82949015|FG001|Overall Study|Withdrawal by Subject|3|||
46732165|NCT01032200|82949014|FG000|Overall Study|Toxicity|0|||
46732166|NCT01032200|82949015|FG001|Overall Study|Toxicity|2|||
47049093|NCT01685203|83309461|FG003|Overall Study|Lost to Follow-up|1|||
46732167|NCT01032200|82949014|FG000|Overall Study|Progression|1|||
46732168|NCT01032200|82949015|FG001|Overall Study|Progression|0|||
46732169|NCT01032200|82949014|FG000|Overall Study|Multiple|1|||
46732170|NCT01032200|82949015|FG001|Overall Study|Multiple|1|||
46732171|NCT00738283|82949021|FG000|Overall Study|Death|1|||
46732172|NCT00738283|82949021|FG000|Overall Study|Transfer to another facility|2|||
46732173|NCT00738283|82949021|FG000|Overall Study|Discharge home prior to end of study|1|||
46732174|NCT00586105|82949034|FG000|Overall Study|Adverse Event|4|||
46732175|NCT00586105|82949034|FG000|Overall Study|Death|2|||
46732176|NCT00586105|82949034|FG000|Overall Study|Protocol Violation|1|||
46732177|NCT00586105|82949034|FG000|Overall Study|Withdrawal by Subject|3|||
46732178|NCT00586105|82949034|FG000|Overall Study|Disease progression|19|||
46732179|NCT00586105|82949034|FG000|Overall Study|Switched to commercial drug|9|||
46732180|NCT00586105|82949034|FG000|Overall Study|Reason not reported|1|||
46732181|NCT00743119|82949038|FG000|Overall Study|unreliable|3|||
46732182|NCT00743119|82949038|FG000|Overall Study|Withdrawal by Subject|1|||
46732183|NCT00733369|82949052|FG000|Overall Study|Lost to Follow-up|2|||
46732184|NCT00733369|82949053|FG001|Overall Study|Lost to Follow-up|1|||
46732185|NCT00733369|82949052|FG000|Overall Study|Adverse Event|4|||
46732186|NCT00733369|82949053|FG001|Overall Study|Adverse Event|4|||
46732187|NCT00733369|82949052|FG000|Overall Study|Protocol Violation|4|||
46732188|NCT00733369|82949053|FG001|Overall Study|Protocol Violation|4|||
46732189|NCT00813124|82949059|FG000|Overall Study|Death|2|||
46732190|NCT00813124|82949059|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
46732191|NCT00813124|82949059|FG000|Overall Study|Withdrawal by Subject|1|||
46732192|NCT00733291|82949065|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
46732193|NCT00733291|82949066|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
46732194|NCT00733291|82949067|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
46732195|NCT00733291|82949068|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
46732196|NCT00732199|82949081|FG000|Overall Study|Withdrawal by Subject|25|||
46732197|NCT00732199|82949082|FG001|Overall Study|Withdrawal by Subject|18|||
46732198|NCT00732199|82949081|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
46732199|NCT00732199|82949082|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
46732200|NCT00807040|82949093|FG000|Overall Study|Death|24|||
46732201|NCT00807040|82949094|FG001|Overall Study|Death|29|||
46732202|NCT00807040|82949093|FG000|Overall Study|Withdrawal by Subject|8|||
46732203|NCT00807040|82949094|FG001|Overall Study|Withdrawal by Subject|6|||
46732204|NCT00807040|82949093|FG000|Overall Study|Lost to Follow-up|4|||
46732205|NCT00807040|82949094|FG001|Overall Study|Lost to Follow-up|6|||
46732206|NCT00811720|82949102|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
46732207|NCT00811720|82949103|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
47049094|NCT01685203|83309462|FG004|Overall Study|Lost to Follow-up|0|||
47049095|NCT01685203|83309463|FG005|Overall Study|Lost to Follow-up|0|||
47049096|NCT01685203|83309464|FG006|Overall Study|Lost to Follow-up|0|||
47049097|NCT01685203|83309458|FG000|Overall Study|Adverse Event|0|||
47049098|NCT01685203|83309459|FG001|Overall Study|Adverse Event|0|||
47049099|NCT01685203|83309460|FG002|Overall Study|Adverse Event|0|||
47049100|NCT01685203|83309461|FG003|Overall Study|Adverse Event|0|||
47049101|NCT01685203|83309462|FG004|Overall Study|Adverse Event|0|||
47049102|NCT01685203|83309463|FG005|Overall Study|Adverse Event|2|||
47049103|NCT01685203|83309464|FG006|Overall Study|Adverse Event|0|||
47049104|NCT01685203|83309458|FG000|Overall Study|Adverse event and withdrew consent|1|||
47049105|NCT01685203|83309459|FG001|Overall Study|Adverse event and withdrew consent|0|||
46732208|NCT00811720|82949102|FG000|All Treated Patients|Adverse Event|20|||
46732209|NCT00811720|82949103|FG001|All Treated Patients|Adverse Event|62|||
46732210|NCT00811720|82949102|FG000|All Treated Patients|Lack of Efficacy|22|||
47049106|NCT01685203|83309460|FG002|Overall Study|Adverse event and withdrew consent|0|||
46732211|NCT00811720|82949103|FG001|All Treated Patients|Lack of Efficacy|18|||
46732212|NCT00811720|82949102|FG000|All Treated Patients|Non-compliance|0|||
46732213|NCT00811720|82949103|FG001|All Treated Patients|Non-compliance|14|||
46732214|NCT00811720|82949102|FG000|All Treated Patients|Protocol Violation|9|||
46732215|NCT00811720|82949103|FG001|All Treated Patients|Protocol Violation|16|||
46732216|NCT00811720|82949102|FG000|All Treated Patients|Withdrawal by Subject|28|||
46732217|NCT00811720|82949103|FG001|All Treated Patients|Withdrawal by Subject|34|||
46732218|NCT00811720|82949102|FG000|All Treated Patients|Lost to Follow-up|10|||
46732219|NCT00811720|82949103|FG001|All Treated Patients|Lost to Follow-up|16|||
46732220|NCT00811720|82949102|FG000|All Treated Patients|Other Reason|7|||
47049107|NCT01685203|83309461|FG003|Overall Study|Adverse event and withdrew consent|0|||
46732221|NCT00811720|82949103|FG001|All Treated Patients|Other Reason|4|||
47049108|NCT01685203|83309462|FG004|Overall Study|Adverse event and withdrew consent|0|||
47049109|NCT01685203|83309463|FG005|Overall Study|Adverse event and withdrew consent|0|||
47049110|NCT01685203|83309464|FG006|Overall Study|Adverse event and withdrew consent|0|||
47049111|NCT01685203|83309458|FG000|Overall Study|Patient's decision|0|||
47049112|NCT01685203|83309459|FG001|Overall Study|Patient's decision|0|||
47049113|NCT01685203|83309460|FG002|Overall Study|Patient's decision|0|||
47049114|NCT01685203|83309461|FG003|Overall Study|Patient's decision|0|||
47049115|NCT01685203|83309462|FG004|Overall Study|Patient's decision|0|||
47049116|NCT01685203|83309463|FG005|Overall Study|Patient's decision|1|||
47049117|NCT01685203|83309464|FG006|Overall Study|Patient's decision|0|||
47049118|NCT01928771|83309483|FG000|Overall Study|Adverse Event|6|||
47049119|NCT01928771|83309484|FG001|Overall Study|Adverse Event|5|||
47049120|NCT01928771|83309485|FG002|Overall Study|Adverse Event|1|||
47049121|NCT01928771|83309483|FG000|Overall Study|Death|2|||
47049122|NCT01928771|83309484|FG001|Overall Study|Death|2|||
47049123|NCT01928771|83309485|FG002|Overall Study|Death|2|||
47049124|NCT01928771|83309483|FG000|Overall Study|Lost to Follow-up|5|||
47049125|NCT01928771|83309484|FG001|Overall Study|Lost to Follow-up|6|||
47049126|NCT01928771|83309485|FG002|Overall Study|Lost to Follow-up|3|||
47049127|NCT01928771|83309483|FG000|Overall Study|Withdrawal by Subject|20|||
47049128|NCT01928771|83309484|FG001|Overall Study|Withdrawal by Subject|15|||
46732222|NCT04202679|82949111|FG000|Overall Study|Adverse Event|2|||
46732223|NCT04202679|82949112|FG001|Overall Study|Adverse Event|0|||
46732224|NCT04202679|82949111|FG000|Overall Study|Poor compliance to protocol|1|||
46732225|NCT04202679|82949112|FG001|Overall Study|Poor compliance to protocol|0|||
46732226|NCT04202679|82949111|FG000|Overall Study|Withdrawal by Subject|23|||
46732227|NCT04202679|82949112|FG001|Overall Study|Withdrawal by Subject|6|||
46732228|NCT00811642|82949119|FG000|Overall Study|Adverse Event|3|||
46732229|NCT00811642|82949119|FG000|Overall Study|Protocol Violation|1|||
46732230|NCT00811642|82949119|FG000|Overall Study|Death|2|||
46732231|NCT00811642|82949119|FG000|Overall Study|Withdrawal by Subject|7|||
46732232|NCT00811642|82949119|FG000|Overall Study|Cumulative use of antifungal agent|2|||
46732233|NCT00809926|82949125|FG000|Overall Study|Adverse Event|18|||
46732234|NCT00809926|82949126|FG001|Overall Study|Adverse Event|10|||
46732235|NCT00809926|82949125|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
46732236|NCT00809926|82949126|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
46732237|NCT00809926|82949125|FG000|Overall Study|Patient withdrew consent|8|||
46732238|NCT00809926|82949126|FG001|Overall Study|Patient withdrew consent|6|||
46732239|NCT00809926|82949125|FG000|Overall Study|Lost to Follow-up|2|||
46732240|NCT00809926|82949126|FG001|Overall Study|Lost to Follow-up|1|||
46732241|NCT00809926|82949125|FG000|Overall Study|Administrative Problems|0|||
46732242|NCT00809926|82949126|FG001|Overall Study|Administrative Problems|1|||
46732243|NCT00809926|82949125|FG000|Overall Study|Protocol deviation|0|||
46732244|NCT00809926|82949126|FG001|Overall Study|Protocol deviation|2|||
46732245|NCT00590980|82949132|FG000|Overall Study|Did not meet all inclusion criteria|10|||
46732246|NCT00590824|82949140|FG000|Overall Study|Disease could not be resected|0|||
46732247|NCT00590824|82949141|FG001|Overall Study|Disease could not be resected|2|||
46732248|NCT00590824|82949142|FG002|Overall Study|Disease could not be resected|1|||
46732249|NCT00590824|82949143|FG003|Overall Study|Disease could not be resected|0|||
46732250|NCT00590824|82949140|FG000|Overall Study|Adverse Event|0|||
46732251|NCT00590824|82949141|FG001|Overall Study|Adverse Event|0|||
46732252|NCT00590824|82949142|FG002|Overall Study|Adverse Event|0|||
46732253|NCT00590824|82949143|FG003|Overall Study|Adverse Event|1|||
46732254|NCT00590590|82949156|FG000|Overall Study|Lack of Efficacy|1|||
46732255|NCT00590590|82949157|FG001|Overall Study|Lack of Efficacy|2|||
46732256|NCT00590590|82949158|FG002|Overall Study|Lack of Efficacy|0|||
46732257|NCT00590590|82949156|FG000|Overall Study|Adverse Event|1|||
46732258|NCT00590590|82949157|FG001|Overall Study|Adverse Event|0|||
46732259|NCT00590590|82949158|FG002|Overall Study|Adverse Event|0|||
46732260|NCT00590590|82949156|FG000|Overall Study|Protocol Violation|0|||
46732261|NCT00590590|82949157|FG001|Overall Study|Protocol Violation|0|||
47049129|NCT01928771|83309485|FG002|Overall Study|Withdrawal by Subject|17|||
46732262|NCT00590590|82949158|FG002|Overall Study|Protocol Violation|2|||
46732263|NCT00590590|82949156|FG000|Overall Study|Lost to Follow-up|4|||
46732264|NCT00590590|82949157|FG001|Overall Study|Lost to Follow-up|1|||
47049130|NCT01928771|83309483|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
47049131|NCT01928771|83309484|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
47049132|NCT01928771|83309485|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
47049133|NCT01928771|83309483|FG000|Overall Study|Other Reasons|9|||
46732265|NCT00590590|82949158|FG002|Overall Study|Lost to Follow-up|2|||
46732266|NCT00590590|82949156|FG000|Overall Study|Withdrawal by Subject|0|||
46732267|NCT00590590|82949157|FG001|Overall Study|Withdrawal by Subject|1|||
47049134|NCT01928771|83309484|FG001|Overall Study|Other Reasons|9|||
46732268|NCT00590590|82949158|FG002|Overall Study|Withdrawal by Subject|1|||
46732269|NCT00590590|82949156|FG000|Overall Study|Did not complete due to study closure|1|||
46732270|NCT00590590|82949157|FG001|Overall Study|Did not complete due to study closure|1|||
46732271|NCT00590590|82949158|FG002|Overall Study|Did not complete due to study closure|1|||
46732272|NCT00590590|82949156|FG000|Overall Study|Did not complete study|0|||
46732273|NCT00590590|82949157|FG001|Overall Study|Did not complete study|1|||
46732274|NCT00590590|82949158|FG002|Overall Study|Did not complete study|0|||
46732275|NCT00809614|82949168|FG000|Overall Study|Lack of Efficacy|2|||
46732276|NCT00809614|82949169|FG001|Overall Study|Lack of Efficacy|3|||
46732277|NCT00809614|82949168|FG000|Overall Study|Withdrawal by Subject|1|||
46732278|NCT00809614|82949169|FG001|Overall Study|Withdrawal by Subject|1|||
46732279|NCT00731731|82949178|FG000|Overall Study|Protocol Violation|0|||
46732280|NCT00731731|82949179|FG001|Overall Study|Protocol Violation|0|||
46732281|NCT00731731|82949180|FG002|Overall Study|Protocol Violation|1|||
46732282|NCT00731731|82949178|FG000|Overall Study|Cancel prior to treatment|0|||
46732283|NCT00731731|82949179|FG001|Overall Study|Cancel prior to treatment|0|||
46732284|NCT00731731|82949180|FG002|Overall Study|Cancel prior to treatment|2|||
46732285|NCT00806494|82949193|FG000|Overall Study|Adverse Event|29|||
46732286|NCT00806494|82949193|FG000|Overall Study|Lack of Efficacy|6|||
46732287|NCT00806494|82949193|FG000|Overall Study|Lost to Follow-up|10|||
46732288|NCT00806494|82949193|FG000|Overall Study|Other|30|||
46732289|NCT00806494|82949193|FG000|Overall Study|Withdrawal by Subject|5|||
46732290|NCT00806416|82949200|FG000|Period 1 - Part I|Adverse Event|0|||
46732291|NCT00806416|82949201|FG001|Period 1 - Part I|Adverse Event|1|||
46732292|NCT00806416|82949202|FG002|Period 1 - Part I|Adverse Event|0|||
46732293|NCT00806416|82949203|FG003|Period 1 - Part I|Adverse Event|0|||
46732294|NCT00806416|82949200|FG000|Period 1 - Part I|Lost to Follow-up|0|||
46732295|NCT00806416|82949201|FG001|Period 1 - Part I|Lost to Follow-up|2|||
46732296|NCT00806416|82949202|FG002|Period 1 - Part I|Lost to Follow-up|0|||
46732297|NCT00806416|82949203|FG003|Period 1 - Part I|Lost to Follow-up|0|||
46732298|NCT00806416|82949200|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
46732299|NCT00806416|82949201|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
46732300|NCT00806416|82949202|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
46732301|NCT00806416|82949203|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
46732302|NCT00806416|82949200|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
46732303|NCT00806416|82949201|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
46732304|NCT00806416|82949202|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
46732305|NCT00806416|82949203|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
46732306|NCT02724969|82949213|FG000|Overall Study|Lost to Follow-up|12|||
46732307|NCT02724969|82949214|FG001|Overall Study|Lost to Follow-up|6|||
46732308|NCT02724969|82949213|FG000|Overall Study|Withdrawal by Subject|3|||
46732309|NCT02724969|82949214|FG001|Overall Study|Withdrawal by Subject|3|||
46732310|NCT02724969|82949213|FG000|Overall Study|Infant demise|0|||
47049135|NCT01928771|83309485|FG002|Overall Study|Other Reasons|14|||
47049136|NCT01928771|83309483|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
47049137|NCT01928771|83309484|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
47049138|NCT01928771|83309485|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
47049139|NCT01589653|83309495|FG000|Overall Study|Protocol Violation|3|||
47049140|NCT01589653|83309496|FG001|Overall Study|Protocol Violation|1|||
47049141|NCT01589653|83309495|FG000|Overall Study|Withdrawal criteria|4|||
46732311|NCT02724969|82949214|FG001|Overall Study|Infant demise|2|||
46732312|NCT00811252|82949223|FG000|Overall Study|Adverse Event|6|||
46732313|NCT00811252|82949224|FG001|Overall Study|Adverse Event|10|||
46732314|NCT00811252|82949225|FG002|Overall Study|Adverse Event|15|||
46732315|NCT00811252|82949223|FG000|Overall Study|Lack of Efficacy|7|||
46732316|NCT00811252|82949224|FG001|Overall Study|Lack of Efficacy|2|||
46732317|NCT00811252|82949225|FG002|Overall Study|Lack of Efficacy|0|||
47049142|NCT01589653|83309496|FG001|Overall Study|Withdrawal criteria|7|||
46732318|NCT00811252|82949223|FG000|Overall Study|Protocol Violation|3|||
46732319|NCT00811252|82949224|FG001|Overall Study|Protocol Violation|3|||
47049143|NCT01589653|83309495|FG000|Overall Study|Unclassified|0|||
46732320|NCT00811252|82949225|FG002|Overall Study|Protocol Violation|2|||
47049144|NCT01589653|83309496|FG001|Overall Study|Unclassified|3|||
46732321|NCT00811252|82949223|FG000|Overall Study|Withdrawal of Consent|1|||
46732322|NCT00811252|82949224|FG001|Overall Study|Withdrawal of Consent|2|||
46803935|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
46803936|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
46732323|NCT00811252|82949225|FG002|Overall Study|Withdrawal of Consent|2|||
46732324|NCT00811252|82949223|FG000|Overall Study|Lost to Follow-up|0|||
46732325|NCT00811252|82949224|FG001|Overall Study|Lost to Follow-up|0|||
46732326|NCT00811252|82949225|FG002|Overall Study|Lost to Follow-up|2|||
46732327|NCT00811252|82949223|FG000|Overall Study|Administrative or Other Reasons|0|||
46732328|NCT00811252|82949224|FG001|Overall Study|Administrative or Other Reasons|3|||
46732329|NCT00811252|82949225|FG002|Overall Study|Administrative or Other Reasons|2|||
46732330|NCT00736957|82949242|FG000|Overall Study|Adverse Event|43|||
46732331|NCT00736957|82949242|FG000|Overall Study|Withdrawal by Subject|49|||
46732332|NCT00736957|82949242|FG000|Overall Study|violation of eligibility criteria|2|||
46732333|NCT00736957|82949242|FG000|Overall Study|did not attend hospital appointments|1|||
46732334|NCT00736957|82949242|FG000|Overall Study|not eligible for Treatment Period I|22|||
46732335|NCT00736957|82949242|FG000|Overall Study|Physician Decision|5|||
46732336|NCT00736879|82949250|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
46732337|NCT00736879|82949251|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
46732338|NCT00736879|82949252|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
46732339|NCT00736879|82949253|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
46732340|NCT00736879|82949250|FG000|Double Blind Treatment Period|Adverse Event|0|||
46732341|NCT00736879|82949251|FG001|Double Blind Treatment Period|Adverse Event|1|||
46732342|NCT00736879|82949252|FG002|Double Blind Treatment Period|Adverse Event|1|||
46732343|NCT00736879|82949253|FG003|Double Blind Treatment Period|Adverse Event|0|||
46732344|NCT00736879|82949250|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
46732345|NCT00736879|82949251|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
46732346|NCT00736879|82949252|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
46732347|NCT00736879|82949253|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
46732348|NCT00736879|82949250|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
46732349|NCT00736879|82949251|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
46732350|NCT00736879|82949252|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
46732351|NCT00736879|82949253|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
46732352|NCT00736879|82949250|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
46732353|NCT00736879|82949251|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
46732354|NCT00736879|82949252|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
46732355|NCT00736879|82949253|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
46732356|NCT00736879|82949250|FG000|Double Blind Treatment Period|No longer met criteria|0|||
46732357|NCT00736879|82949251|FG001|Double Blind Treatment Period|No longer met criteria|1|||
46732358|NCT00736879|82949252|FG002|Double Blind Treatment Period|No longer met criteria|0|||
46732359|NCT00736879|82949253|FG003|Double Blind Treatment Period|No longer met criteria|0|||
46732360|NCT00736879|82949250|FG000|Double Blind Treatment Period|non-specified|0|||
46732361|NCT00736879|82949251|FG001|Double Blind Treatment Period|non-specified|1|||
46732362|NCT00736879|82949252|FG002|Double Blind Treatment Period|non-specified|0|||
46732363|NCT00736879|82949253|FG003|Double Blind Treatment Period|non-specified|0|||
46732364|NCT00736879|82949250|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
47049145|NCT01928615|83309502|FG000|Overall Study|Study Terminated by Sponsor|2|||
47049146|NCT01589497|83309511|FG000|Overall Study|Withdrawal by Subject|0|||
47049147|NCT01589497|83309512|FG001|Overall Study|Withdrawal by Subject|1|||
47049148|NCT01589497|83309513|FG002|Overall Study|Withdrawal by Subject|0|||
47049149|NCT01589497|83309514|FG003|Overall Study|Withdrawal by Subject|1|||
47049150|NCT01589497|83309511|FG000|Overall Study|Death|1|||
47049151|NCT01589497|83309512|FG001|Overall Study|Death|0|||
47049152|NCT01589497|83309513|FG002|Overall Study|Death|0|||
46732365|NCT00736879|82949251|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
46732366|NCT00736879|82949252|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
46732367|NCT00736879|82949253|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
46732368|NCT00736879|82949250|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
46732369|NCT00736879|82949251|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
46732370|NCT00736879|82949252|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
46732371|NCT00736879|82949253|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
46732372|NCT00806260|82949272|FG000|Period 1 (1 Day)|Adverse Event|0|||
46732373|NCT00806260|82949273|FG001|Period 1 (1 Day)|Adverse Event|0|||
46732374|NCT00806260|82949274|FG002|Period 1 (1 Day)|Adverse Event|0|||
46732375|NCT00806260|82949275|FG003|Period 1 (1 Day)|Adverse Event|0|||
46732376|NCT00806260|82949276|FG004|Period 1 (1 Day)|Adverse Event|3|||
46732377|NCT00806260|82949277|FG005|Period 1 (1 Day)|Adverse Event|0|||
46732378|NCT00806260|82949272|FG000|Period 2|Adverse Event|0|||
46635159|NCT01684878|82808713|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
46732379|NCT00806260|82949273|FG001|Period 2|Adverse Event|0|||
46803937|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
47049153|NCT01589497|83309514|FG003|Overall Study|Death|0|||
46732380|NCT00806260|82949274|FG002|Period 2|Adverse Event|0|||
46732381|NCT00806260|82949275|FG003|Period 2|Adverse Event|1|||
46732382|NCT00806260|82949276|FG004|Period 2|Adverse Event|0|||
46732383|NCT00806260|82949277|FG005|Period 2|Adverse Event|0|||
46732384|NCT00806260|82949272|FG000|Period 2|Protocol Violation|1|||
46732385|NCT00806260|82949273|FG001|Period 2|Protocol Violation|0|||
46732386|NCT00806260|82949274|FG002|Period 2|Protocol Violation|1|||
46732387|NCT00806260|82949275|FG003|Period 2|Protocol Violation|0|||
46732388|NCT00806260|82949276|FG004|Period 2|Protocol Violation|0|||
46732389|NCT00806260|82949277|FG005|Period 2|Protocol Violation|0|||
46732390|NCT00806260|82949272|FG000|Period 2|Need to take concomitant medication|1|||
46732391|NCT00806260|82949273|FG001|Period 2|Need to take concomitant medication|0|||
46732392|NCT00806260|82949274|FG002|Period 2|Need to take concomitant medication|0|||
46732393|NCT00806260|82949275|FG003|Period 2|Need to take concomitant medication|0|||
46732394|NCT00806260|82949276|FG004|Period 2|Need to take concomitant medication|0|||
46732395|NCT00806260|82949277|FG005|Period 2|Need to take concomitant medication|0|||
46732396|NCT00806260|82949272|FG000|Period 2|sponsor request|0|||
46732397|NCT00806260|82949273|FG001|Period 2|sponsor request|0|||
46732398|NCT00806260|82949274|FG002|Period 2|sponsor request|1|||
46732399|NCT00806260|82949275|FG003|Period 2|sponsor request|1|||
46732400|NCT00806260|82949276|FG004|Period 2|sponsor request|0|||
46732401|NCT00806260|82949277|FG005|Period 2|sponsor request|0|||
46732402|NCT00806260|82949272|FG000|Period 3|Protocol Violation|0|||
46732403|NCT00806260|82949273|FG001|Period 3|Protocol Violation|1|||
46732404|NCT00806260|82949274|FG002|Period 3|Protocol Violation|1|||
46732405|NCT00806260|82949275|FG003|Period 3|Protocol Violation|0|||
46732406|NCT00806260|82949276|FG004|Period 3|Protocol Violation|0|||
46732407|NCT00806260|82949277|FG005|Period 3|Protocol Violation|0|||
46732408|NCT00806260|82949272|FG000|Period 3|Pregnancy|1|||
46732409|NCT00806260|82949273|FG001|Period 3|Pregnancy|0|||
46732410|NCT00806260|82949274|FG002|Period 3|Pregnancy|0|||
46732411|NCT00806260|82949275|FG003|Period 3|Pregnancy|0|||
46732412|NCT00806260|82949276|FG004|Period 3|Pregnancy|0|||
46732413|NCT00806260|82949277|FG005|Period 3|Pregnancy|0|||
46732414|NCT00742885|82949291|FG000|Overall Study|Lost to Follow-up|1|||
46732415|NCT00742885|82949292|FG001|Overall Study|Lost to Follow-up|0|||
46732416|NCT00811174|82949301|FG000|Overall Study|Protocol Violation|2|||
46732417|NCT00811174|82949301|FG000|Overall Study|Sponsors Decision|1|||
46732418|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
46732419|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
46732420|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
46732421|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
46732422|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
46732423|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
46732424|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
46803938|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
46803939|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
46803940|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
47049154|NCT01589497|83309511|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
47049155|NCT01589497|83309512|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
47049156|NCT01589497|83309513|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
47049157|NCT01589497|83309514|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
47049158|NCT01928381|83309529|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
47049159|NCT01928381|83309530|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
47049160|NCT01928381|83309531|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
47049161|NCT01928381|83309532|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
47049162|NCT01928381|83309533|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
47049163|NCT01928381|83309534|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
47049164|NCT01928381|83309535|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
47049165|NCT01928381|83309529|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
46803941|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
46803942|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
47049166|NCT01928381|83309530|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
46732425|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
46732426|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
46732427|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
46732428|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
46732429|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
46732430|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
46732431|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
46732432|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
46732433|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
46732434|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
46732435|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
46732436|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
46732437|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
46732438|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
46732439|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
46732440|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
46732441|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
46732442|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
46732443|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
46732444|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
46732445|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
46732446|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
46732447|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
46732448|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
46732449|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
46732450|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
46732451|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
46732452|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
46732453|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
46732454|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
46732455|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
46732456|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
46732457|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
46732458|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
46732459|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
46732460|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
46732461|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
46732462|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
46732463|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
46732464|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
46732465|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
46732466|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
46732467|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
46732468|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
46732469|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
46732470|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
46732471|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
46732472|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
46732473|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
46732474|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
46732475|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
46732476|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
46732477|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
46732478|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
46732479|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
46732480|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
46732481|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
46732482|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
46732483|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
46732484|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
46732485|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
46732486|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
46732487|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
46732488|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Change of location|0|||
46732489|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Change of location|0|||
46732490|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Change of location|0|||
46732491|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Change of location|1|||
46732492|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Change of location|0|||
46732493|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
46732494|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
46732495|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
46732496|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
46803943|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
46803944|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
46732497|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
46732498|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
46732499|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
46732500|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
46732501|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
46732502|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
46732503|NCT00730405|82949310|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
46732504|NCT00730405|82949311|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
46732505|NCT00730405|82949312|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
46732506|NCT00730405|82949313|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
46732507|NCT00730405|82949314|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
46732508|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
46732509|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
46732510|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
46732511|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
46732512|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
46732513|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
46732514|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
46732515|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
46732516|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
46732517|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
46732518|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
46732519|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
46732520|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
46732521|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
46732522|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
46732523|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Death|0|||
46732524|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Death|1|||
46732525|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Death|0|||
46732526|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Death|1|||
46732527|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Death|0|||
46732528|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Change of location|1|||
46732529|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Change of location|1|||
46732530|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Change of location|0|||
46732531|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Change of location|1|||
46732532|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Change of location|0|||
46732533|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
46732534|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
46732535|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
46732536|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
46732537|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
46732538|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
46732539|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
46732540|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
46732541|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
46732542|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
46732543|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
46732544|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
46732545|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
46732546|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
46732547|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
46732548|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
46732549|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
46732550|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
46732551|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
46921476|NCT03068455|83154048|FG000|Treatment Period|Study drug toxicity|317|||
46921477|NCT03068455|83154049|FG001|Treatment Period|Study drug toxicity|104|||
46921478|NCT03068455|83154048|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
47049167|NCT01928381|83309531|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
47049168|NCT01928381|83309532|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
46732552|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
47049169|NCT01928381|83309533|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
46732553|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
46775728|NCT00793793|82994209|FG005|Overall Study|Adverse Event|1|||
47049170|NCT01928381|83309534|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
46732554|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
46732555|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
46732556|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
46732557|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
46732558|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
46732559|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
46732560|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
46732561|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
46732562|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
46732563|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
46732564|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
46732565|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
46732566|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
46732567|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
46732568|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
46732569|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
46732570|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
46732571|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
47049171|NCT01928381|83309535|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
47049172|NCT01928381|83309529|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
47049173|NCT01928381|83309530|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
47049174|NCT01928381|83309531|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
46732572|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
46732573|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
46732574|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
46732575|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
46732576|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
46732577|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
46732578|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
46732579|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
46732580|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
46732581|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
46732582|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
46732583|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Missing|0|||
46732584|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Missing|0|||
46732585|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Missing|2|||
46732586|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Missing|0|||
46732587|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Missing|0|||
46732588|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
46732589|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
46732590|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
46732591|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
46732592|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
46732593|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
46732594|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
46732595|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
46732596|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
46732597|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
46732598|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
46732599|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
46732600|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
46732601|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
46732602|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
46732603|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
46732604|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
46732605|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
46732606|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
46732607|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
46732608|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
46732609|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
46775729|NCT00793793|82994210|FG006|Overall Study|Adverse Event|2|||
47049175|NCT01928381|83309532|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
47049176|NCT01928381|83309533|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
47049177|NCT01928381|83309534|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
47049178|NCT01928381|83309535|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
46732610|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
46732611|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
46732612|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
46732613|NCT00730405|82949310|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
46732614|NCT00730405|82949311|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
46732615|NCT00730405|82949312|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
46732616|NCT00730405|82949313|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
46732617|NCT00730405|82949314|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
46732618|NCT00736723|82949330|FG000|Overall Study|Withdrawal by Subject|4|||
46732619|NCT00736723|82949331|FG001|Overall Study|Withdrawal by Subject|3|||
46732620|NCT00736645|82949341|FG000|Overall Study|Adverse Event|0|||
46732621|NCT00736645|82949342|FG001|Overall Study|Adverse Event|2|||
46732622|NCT00736645|82949343|FG002|Overall Study|Adverse Event|0|||
46732623|NCT00736645|82949344|FG003|Overall Study|Adverse Event|0|||
46732624|NCT00736489|82949354|FG000|Period 1|Lost to Follow-up|1|||
46732625|NCT00736489|82949355|FG001|Period 1|Lost to Follow-up|0|||
46732626|NCT00736489|82949356|FG002|Period 1|Lost to Follow-up|0|||
46732627|NCT00736489|82949357|FG003|Period 1|Lost to Follow-up|0|||
46732628|NCT00736489|82949358|FG004|Period 1|Lost to Follow-up|0|||
46732629|NCT00736489|82949359|FG005|Period 1|Lost to Follow-up|0|||
46732630|NCT00736489|82949354|FG000|Period 1|Withdrawal by Subject|0|||
46732631|NCT00736489|82949355|FG001|Period 1|Withdrawal by Subject|0|||
46732632|NCT00736489|82949356|FG002|Period 1|Withdrawal by Subject|0|||
46732633|NCT00736489|82949357|FG003|Period 1|Withdrawal by Subject|0|||
46732634|NCT00736489|82949358|FG004|Period 1|Withdrawal by Subject|0|||
46732635|NCT00736489|82949359|FG005|Period 1|Withdrawal by Subject|1|||
46732636|NCT00730327|82949391|FG000|Overall Study|Lost to Follow-up|14|||
46732637|NCT00730327|82949392|FG001|Overall Study|Lost to Follow-up|16|||
46732638|NCT00730327|82949391|FG000|Overall Study|Adverse Event|8|||
46732639|NCT00730327|82949392|FG001|Overall Study|Adverse Event|1|||
46732640|NCT00730327|82949391|FG000|Overall Study|Withdrawal by Subject|3|||
46732641|NCT00730327|82949392|FG001|Overall Study|Withdrawal by Subject|13|||
46732642|NCT00730327|82949391|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
46732643|NCT00730327|82949392|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
46732644|NCT00742417|82949407|FG000|Randomized|Withdrawal by legal representative|0|||
46732645|NCT00742417|82949408|FG001|Randomized|Withdrawal by legal representative|1|||
46732646|NCT00742417|82949407|FG000|Randomized|Withdrawal by Subject|1|||
46732647|NCT00742417|82949408|FG001|Randomized|Withdrawal by Subject|0|||
46732648|NCT00742417|82949407|FG000|Randomized|Physician Decision|1|||
46732649|NCT00742417|82949408|FG001|Randomized|Physician Decision|0|||
46732650|NCT00742417|82949407|FG000|Intensive Period|Withdrawal by Subject|1|||
46732651|NCT00742417|82949408|FG001|Intensive Period|Withdrawal by Subject|1|||
46732652|NCT00742417|82949407|FG000|Intensive Period|Adverse Event|2|||
46732653|NCT00742417|82949408|FG001|Intensive Period|Adverse Event|0|||
46803945|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
46803946|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
47049179|NCT01928381|83309529|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
47049180|NCT01928381|83309530|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
47049181|NCT01928381|83309531|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
47049182|NCT01928381|83309532|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
47049183|NCT01928381|83309533|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
47049184|NCT01928381|83309534|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
47049185|NCT01928381|83309535|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
47049186|NCT01928381|83309529|FG000|Part 1 - Pain Training|Protocol Violation|1|||
47049187|NCT01928381|83309530|FG001|Part 1 - Pain Training|Protocol Violation|0|||
47049188|NCT01928381|83309531|FG002|Part 1 - Pain Training|Protocol Violation|0|||
47049189|NCT01928381|83309532|FG003|Part 1 - Pain Training|Protocol Violation|0|||
47049190|NCT01928381|83309533|FG004|Part 1 - Pain Training|Protocol Violation|0|||
47049191|NCT01928381|83309534|FG005|Part 1 - Pain Training|Protocol Violation|0|||
47049192|NCT01928381|83309535|FG006|Part 1 - Pain Training|Protocol Violation|0|||
47049193|NCT01928381|83309529|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
47049194|NCT01928381|83309530|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
47049195|NCT01928381|83309531|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
47049196|NCT01928381|83309532|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
46732654|NCT00811018|82949416|FG000|Overall Study|Additional Chronic Treatment|31|||
46732655|NCT00811018|82949416|FG000|Overall Study|Adverse Event|79|||
46732656|NCT00811018|82949416|FG000|Overall Study|Death|147|||
46732657|NCT00811018|82949416|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
46732658|NCT00811018|82949416|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
46732659|NCT00811018|82949416|FG000|Overall Study|Investigator Decision|57|||
46732660|NCT00811018|82949416|FG000|Overall Study|Lost to Follow-up|19|||
46635160|NCT01684878|82808714|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
46803947|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
47049197|NCT01928381|83309533|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
47049198|NCT01928381|83309534|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
47049199|NCT01928381|83309535|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
47049200|NCT01928381|83309529|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
47049201|NCT01928381|83309530|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
47049202|NCT01928381|83309531|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
47049203|NCT01928381|83309532|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
47049204|NCT01928381|83309533|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
47049205|NCT01928381|83309534|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
47049206|NCT01928381|83309535|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
47049207|NCT01928381|83309529|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
47049208|NCT01928381|83309530|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
47049209|NCT01928381|83309531|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
47049210|NCT01928381|83309532|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
47049211|NCT01928381|83309533|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
47049212|NCT01928381|83309534|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
47049213|NCT01928381|83309535|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
47049214|NCT01928381|83309529|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
47049215|NCT01928381|83309530|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
47049216|NCT01928381|83309531|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
47049217|NCT01928381|83309532|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
47049218|NCT01928381|83309533|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
47049219|NCT01928381|83309534|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
47049220|NCT01928381|83309535|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
47049221|NCT01928381|83309529|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
47049222|NCT01928381|83309530|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
47049223|NCT01928381|83309531|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
47049224|NCT01928381|83309532|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
47049225|NCT01928381|83309533|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
47049226|NCT01928381|83309534|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
47049227|NCT01928381|83309535|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
47049228|NCT01928381|83309529|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
47049229|NCT01928381|83309530|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
47049230|NCT01928381|83309531|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
47049231|NCT01928381|83309532|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
47049232|NCT01928381|83309533|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
47049233|NCT01928381|83309534|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
47049234|NCT01928381|83309535|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
47049235|NCT01928381|83309529|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
47049236|NCT01928381|83309530|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
47049237|NCT01928381|83309531|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
47049238|NCT01928381|83309532|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
47049239|NCT01928381|83309533|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
47049240|NCT01928381|83309534|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
47049241|NCT01928381|83309535|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
47049242|NCT01928381|83309529|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
47049243|NCT01928381|83309530|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
47049244|NCT01928381|83309531|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
47049245|NCT01928381|83309532|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
47049246|NCT01928381|83309533|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
47049247|NCT01928381|83309534|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
47049248|NCT01928381|83309535|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
47049249|NCT01928381|83309529|FG000|Washout First Intervention|Protocol Violation|0|||
47049250|NCT01928381|83309530|FG001|Washout First Intervention|Protocol Violation|0|||
46732661|NCT00811018|82949416|FG000|Overall Study|Pregnancy|6|||
46732662|NCT00811018|82949416|FG000|Overall Study|Sponsor Decision|450|||
46732663|NCT00811018|82949416|FG000|Overall Study|Withdrawal by Subject|70|||
46732664|NCT00811018|82949416|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
46732665|NCT00811018|82949416|FG000|Overall Study|Other|26|||
46732666|NCT00730171|82949425|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
46732667|NCT00730171|82949425|FG000|Overall Study|Adverse Event|193|||
46732668|NCT00730171|82949425|FG000|Overall Study|Protocol Violation|48|||
46732669|NCT00730171|82949425|FG000|Overall Study|Withdrawal by Subject|202|||
46732670|NCT00730171|82949425|FG000|Overall Study|Lost to Follow-up|121|||
46921479|NCT03068455|83154049|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
46732671|NCT00730171|82949425|FG000|Overall Study|Insufficient Therapeutic Response|141|||
46803948|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
46732672|NCT00730171|82949425|FG000|Overall Study|Other|61|||
46732673|NCT00730015|82949436|FG000|Overall Study|Adverse Event|11|||
46732674|NCT00730015|82949437|FG001|Overall Study|Adverse Event|10|||
46732675|NCT00730015|82949438|FG002|Overall Study|Adverse Event|8|||
46732676|NCT00730015|82949436|FG000|Overall Study|Protocol Violation|2|||
46732677|NCT00730015|82949437|FG001|Overall Study|Protocol Violation|6|||
46732678|NCT00730015|82949438|FG002|Overall Study|Protocol Violation|4|||
46732679|NCT00730015|82949436|FG000|Overall Study|Withdrawal by Subject|12|||
46732680|NCT00730015|82949437|FG001|Overall Study|Withdrawal by Subject|12|||
46732681|NCT00730015|82949438|FG002|Overall Study|Withdrawal by Subject|8|||
46732682|NCT00730015|82949436|FG000|Overall Study|Lost to Follow-up|4|||
46732683|NCT00730015|82949437|FG001|Overall Study|Lost to Follow-up|10|||
46732684|NCT00730015|82949438|FG002|Overall Study|Lost to Follow-up|3|||
46732685|NCT00730015|82949436|FG000|Overall Study|Lack of Efficacy|1|||
46732686|NCT00730015|82949437|FG001|Overall Study|Lack of Efficacy|2|||
46732687|NCT00730015|82949438|FG002|Overall Study|Lack of Efficacy|8|||
47049251|NCT01928381|83309531|FG002|Washout First Intervention|Protocol Violation|0|||
47049252|NCT01928381|83309532|FG003|Washout First Intervention|Protocol Violation|0|||
47049253|NCT01928381|83309533|FG004|Washout First Intervention|Protocol Violation|1|||
47049254|NCT01928381|83309534|FG005|Washout First Intervention|Protocol Violation|0|||
47049255|NCT01928381|83309535|FG006|Washout First Intervention|Protocol Violation|0|||
47049256|NCT01928381|83309529|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
47049257|NCT01928381|83309530|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
47049258|NCT01928381|83309531|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
47049259|NCT01928381|83309532|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
47049260|NCT01928381|83309533|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
47049261|NCT01928381|83309534|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
47049262|NCT01928381|83309535|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
47049263|NCT01928381|83309529|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
47049264|NCT01928381|83309530|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
47049265|NCT01928381|83309531|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
47049266|NCT01928381|83309532|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
47049267|NCT01928381|83309533|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
47049268|NCT01928381|83309534|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
47049269|NCT01928381|83309535|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
47049270|NCT01928225|83309547|FG000|Overall Study|Pregnancy|1|||
47049271|NCT01928225|83309548|FG001|Overall Study|Pregnancy|0|||
47049272|NCT01928225|83309547|FG000|Overall Study|basaloid cervical cancer|1|||
47049273|NCT01928225|83309548|FG001|Overall Study|basaloid cervical cancer|0|||
47049274|NCT01928225|83309547|FG000|Overall Study|Lost to Follow-up|1|||
47049275|NCT01928225|83309548|FG001|Overall Study|Lost to Follow-up|3|||
47049276|NCT01927757|83309555|FG000|Overall Study|Withdrawal by Subject|14|||
47049277|NCT01927757|83309555|FG000|Overall Study|Lost to Follow-up|2|||
47049278|NCT01927757|83309555|FG000|Overall Study|Decision by Sponsor|2|||
47049279|NCT01927757|83309555|FG000|Overall Study|Other|1|||
47049280|NCT01927757|83309555|FG000|Overall Study|Ethical Reasons|4|||
47049281|NCT01927367|83309565|FG000|Overall Study|Withdrawal by Subject|7|||
47049282|NCT01927367|83309566|FG001|Overall Study|Withdrawal by Subject|4|||
47049283|NCT01927367|83309565|FG000|Overall Study|No baseline data|0|||
47049284|NCT01927367|83309566|FG001|Overall Study|No baseline data|1|||
47049285|NCT01913639|83309572|FG000|Overall Study|Not Eligible|3|||
47049286|NCT01913483|83309578|FG000|Overall Study|Withdrawal by Subject|1|||
47049287|NCT01913483|83309579|FG001|Overall Study|Withdrawal by Subject|2|||
47049288|NCT01913483|83309578|FG000|Overall Study|Lost to Follow-up|6|||
47049289|NCT01913483|83309579|FG001|Overall Study|Lost to Follow-up|3|||
47049290|NCT01913483|83309578|FG000|Overall Study|Death|14|||
47049291|NCT01913483|83309579|FG001|Overall Study|Death|17|||
47049292|NCT01913405|83309585|FG000|Overall Study|Withdrawal by Subject|1|||
47049293|NCT01913405|83309585|FG000|Overall Study|Adverse Event|1|||
47049294|NCT01927055|83309605|FG000|Open-label|Adverse Event|6|||
47049295|NCT01927055|83309606|FG001|Open-label|Adverse Event|0|||
46732688|NCT00730015|82949436|FG000|Overall Study|Other Reason|1|||
46732689|NCT00730015|82949437|FG001|Overall Study|Other Reason|0|||
46732690|NCT00730015|82949438|FG002|Overall Study|Other Reason|1|||
46732691|NCT00806026|82949457|FG000|Overall Study|Death|0|||
46732692|NCT00806026|82949458|FG001|Overall Study|Death|0|||
46732693|NCT00806026|82949459|FG002|Overall Study|Death|0|||
46732694|NCT00806026|82949460|FG003|Overall Study|Death|1|||
46732695|NCT00806026|82949461|FG004|Overall Study|Death|0|||
46732696|NCT00806026|82949462|FG005|Overall Study|Death|0|||
46732697|NCT00806026|82949457|FG000|Overall Study|Did not meet entrance criteria|4|||
46732698|NCT00806026|82949458|FG001|Overall Study|Did not meet entrance criteria|1|||
47049296|NCT01927055|83309607|FG002|Open-label|Adverse Event|0|||
47049297|NCT01927055|83309605|FG000|Open-label|Withdrawal by Subject|1|||
47049298|NCT01927055|83309606|FG001|Open-label|Withdrawal by Subject|0|||
47049299|NCT01927055|83309607|FG002|Open-label|Withdrawal by Subject|0|||
47049300|NCT01927055|83309605|FG000|Open-label|Study Stopped|4|||
47049301|NCT01927055|83309606|FG001|Open-label|Study Stopped|0|||
46732699|NCT00806026|82949459|FG002|Overall Study|Did not meet entrance criteria|2|||
46732700|NCT00806026|82949460|FG003|Overall Study|Did not meet entrance criteria|1|||
46732701|NCT00806026|82949461|FG004|Overall Study|Did not meet entrance criteria|0|||
46732702|NCT00806026|82949462|FG005|Overall Study|Did not meet entrance criteria|0|||
46732703|NCT00806026|82949457|FG000|Overall Study|Lack of Efficacy|5|||
46732704|NCT00806026|82949458|FG001|Overall Study|Lack of Efficacy|18|||
46732705|NCT00806026|82949459|FG002|Overall Study|Lack of Efficacy|13|||
46732706|NCT00806026|82949460|FG003|Overall Study|Lack of Efficacy|4|||
46732707|NCT00806026|82949461|FG004|Overall Study|Lack of Efficacy|8|||
46732708|NCT00806026|82949462|FG005|Overall Study|Lack of Efficacy|7|||
46732709|NCT00806026|82949457|FG000|Overall Study|Lost to Follow-up|8|||
46732710|NCT00806026|82949458|FG001|Overall Study|Lost to Follow-up|15|||
46732711|NCT00806026|82949459|FG002|Overall Study|Lost to Follow-up|8|||
46732712|NCT00806026|82949460|FG003|Overall Study|Lost to Follow-up|2|||
46732713|NCT00806026|82949461|FG004|Overall Study|Lost to Follow-up|6|||
46732714|NCT00806026|82949462|FG005|Overall Study|Lost to Follow-up|6|||
46732715|NCT00806026|82949457|FG000|Overall Study|Withdrawal by Subject|14|||
46732716|NCT00806026|82949458|FG001|Overall Study|Withdrawal by Subject|17|||
46732717|NCT00806026|82949459|FG002|Overall Study|Withdrawal by Subject|9|||
46732718|NCT00806026|82949460|FG003|Overall Study|Withdrawal by Subject|2|||
46732719|NCT00806026|82949461|FG004|Overall Study|Withdrawal by Subject|5|||
46732720|NCT00806026|82949462|FG005|Overall Study|Withdrawal by Subject|3|||
46732721|NCT00806026|82949457|FG000|Overall Study|Other|3|||
46732722|NCT00806026|82949458|FG001|Overall Study|Other|6|||
46732723|NCT00806026|82949459|FG002|Overall Study|Other|8|||
46732724|NCT00806026|82949460|FG003|Overall Study|Other|2|||
46732725|NCT00806026|82949461|FG004|Overall Study|Other|0|||
46732726|NCT00806026|82949462|FG005|Overall Study|Other|4|||
46732727|NCT00806026|82949457|FG000|Overall Study|Protocol Violation|6|||
46732728|NCT00806026|82949458|FG001|Overall Study|Protocol Violation|9|||
46732729|NCT00806026|82949459|FG002|Overall Study|Protocol Violation|9|||
46732730|NCT00806026|82949460|FG003|Overall Study|Protocol Violation|0|||
46732731|NCT00806026|82949461|FG004|Overall Study|Protocol Violation|2|||
46732732|NCT00806026|82949462|FG005|Overall Study|Protocol Violation|3|||
46732733|NCT00806026|82949457|FG000|Overall Study|Adverse Event|52|||
46732734|NCT00806026|82949458|FG001|Overall Study|Adverse Event|35|||
46732735|NCT00806026|82949459|FG002|Overall Study|Adverse Event|44|||
46732736|NCT00806026|82949460|FG003|Overall Study|Adverse Event|17|||
46732737|NCT00806026|82949461|FG004|Overall Study|Adverse Event|9|||
46732738|NCT00806026|82949462|FG005|Overall Study|Adverse Event|9|||
46732739|NCT04026165|82949477|FG000|Run-in Placebo Period|Enrollment Error|13|||
46732740|NCT04026165|82949478|FG001|Run-in Placebo Period|Enrollment Error|0|||
46732741|NCT04026165|82949479|FG002|Run-in Placebo Period|Enrollment Error|0|||
46732742|NCT04026165|82949480|FG003|Run-in Placebo Period|Enrollment Error|0|||
46732743|NCT04026165|82949477|FG000|Run-in Placebo Period|Run-in Failure|4|||
46732744|NCT04026165|82949478|FG001|Run-in Placebo Period|Run-in Failure|0|||
46732745|NCT04026165|82949479|FG002|Run-in Placebo Period|Run-in Failure|0|||
46732746|NCT04026165|82949480|FG003|Run-in Placebo Period|Run-in Failure|0|||
46732747|NCT04026165|82949477|FG000|Run-in Placebo Period|Protocol Violation|2|||
46732748|NCT04026165|82949478|FG001|Run-in Placebo Period|Protocol Violation|0|||
46732749|NCT04026165|82949479|FG002|Run-in Placebo Period|Protocol Violation|0|||
46732750|NCT04026165|82949480|FG003|Run-in Placebo Period|Protocol Violation|0|||
46732751|NCT04026165|82949477|FG000|Run-in Placebo Period|Withdrew Consent|2|||
46732752|NCT04026165|82949478|FG001|Run-in Placebo Period|Withdrew Consent|0|||
46732753|NCT04026165|82949479|FG002|Run-in Placebo Period|Withdrew Consent|0|||
46732754|NCT04026165|82949480|FG003|Run-in Placebo Period|Withdrew Consent|0|||
46732755|NCT04026165|82949477|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
46732756|NCT04026165|82949478|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
46732757|NCT04026165|82949479|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
46732758|NCT04026165|82949480|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
46732759|NCT04026165|82949477|FG000|Run-in SEL Period|Run-in Failure|0|||
46732760|NCT04026165|82949478|FG001|Run-in SEL Period|Run-in Failure|26|||
46732761|NCT04026165|82949479|FG002|Run-in SEL Period|Run-in Failure|0|||
46732762|NCT04026165|82949480|FG003|Run-in SEL Period|Run-in Failure|0|||
47049302|NCT01927055|83309607|FG002|Open-label|Study Stopped|0|||
46732763|NCT04026165|82949477|FG000|Run-in SEL Period|Withdrew Consent|0|||
46732764|NCT04026165|82949478|FG001|Run-in SEL Period|Withdrew Consent|10|||
46732765|NCT04026165|82949479|FG002|Run-in SEL Period|Withdrew Consent|0|||
46732766|NCT04026165|82949480|FG003|Run-in SEL Period|Withdrew Consent|0|||
46732767|NCT04026165|82949477|FG000|Run-in SEL Period|Enrollment Error|0|||
46732768|NCT04026165|82949478|FG001|Run-in SEL Period|Enrollment Error|4|||
46732769|NCT04026165|82949479|FG002|Run-in SEL Period|Enrollment Error|0|||
46732770|NCT04026165|82949480|FG003|Run-in SEL Period|Enrollment Error|0|||
46732771|NCT04026165|82949477|FG000|Run-in SEL Period|Protocol Violation|0|||
46732772|NCT04026165|82949478|FG001|Run-in SEL Period|Protocol Violation|3|||
46732773|NCT04026165|82949479|FG002|Run-in SEL Period|Protocol Violation|0|||
46732774|NCT04026165|82949480|FG003|Run-in SEL Period|Protocol Violation|0|||
46732775|NCT04026165|82949477|FG000|Run-in SEL Period|Investigator's Discretion|0|||
46732776|NCT04026165|82949478|FG001|Run-in SEL Period|Investigator's Discretion|2|||
46732777|NCT04026165|82949479|FG002|Run-in SEL Period|Investigator's Discretion|0|||
46732778|NCT04026165|82949480|FG003|Run-in SEL Period|Investigator's Discretion|0|||
46732779|NCT04026165|82949477|FG000|Run-in SEL Period|Death|0|||
46732780|NCT04026165|82949478|FG001|Run-in SEL Period|Death|1|||
46732781|NCT04026165|82949479|FG002|Run-in SEL Period|Death|0|||
46732782|NCT04026165|82949480|FG003|Run-in SEL Period|Death|0|||
46732783|NCT04026165|82949477|FG000|Randomized Period|Withdrew Consent|0|||
46732784|NCT04026165|82949478|FG001|Randomized Period|Withdrew Consent|0|||
46732785|NCT04026165|82949479|FG002|Randomized Period|Withdrew Consent|5|||
46732786|NCT04026165|82949480|FG003|Randomized Period|Withdrew Consent|8|||
46732787|NCT04026165|82949477|FG000|Randomized Period|Death|0|||
46732788|NCT04026165|82949478|FG001|Randomized Period|Death|0|||
46732789|NCT04026165|82949479|FG002|Randomized Period|Death|5|||
46732790|NCT04026165|82949480|FG003|Randomized Period|Death|7|||
46732791|NCT04026165|82949477|FG000|Randomized Period|Investigator's Discretion|0|||
46732792|NCT04026165|82949478|FG001|Randomized Period|Investigator's Discretion|0|||
46732793|NCT04026165|82949479|FG002|Randomized Period|Investigator's Discretion|2|||
46732794|NCT04026165|82949480|FG003|Randomized Period|Investigator's Discretion|2|||
46732795|NCT04026165|82949477|FG000|Randomized Period|Lost to Follow-up|0|||
46732796|NCT04026165|82949478|FG001|Randomized Period|Lost to Follow-up|0|||
46732797|NCT04026165|82949479|FG002|Randomized Period|Lost to Follow-up|2|||
46732798|NCT04026165|82949480|FG003|Randomized Period|Lost to Follow-up|2|||
46732799|NCT00805792|82949488|FG000|Overall Study|Death|3|||
46732800|NCT00805792|82949488|FG000|Overall Study|Lost to Follow-up|2|||
46732801|NCT00590044|82949494|FG000|Overall Study|Withdrawal by Subject|2|||
46732802|NCT00590044|82949495|FG001|Overall Study|Withdrawal by Subject|2|||
46732803|NCT00590044|82949494|FG000|Overall Study|wrong insulin arm assigned|1|||
46732804|NCT00590044|82949495|FG001|Overall Study|wrong insulin arm assigned|0|||
46732805|NCT00590044|82949494|FG000|Overall Study|Protocol Violation|1|||
46732806|NCT00590044|82949495|FG001|Overall Study|Protocol Violation|0|||
46732807|NCT00805480|82949508|FG000|Overall Study|Withdrawal by Subject|13|||
46732808|NCT00805480|82949509|FG001|Overall Study|Withdrawal by Subject|5|||
46732809|NCT00805480|82949510|FG002|Overall Study|Withdrawal by Subject|11|||
46732810|NCT00805480|82949511|FG003|Overall Study|Withdrawal by Subject|5|||
46732811|NCT00805480|82949508|FG000|Overall Study|Lost to Follow-up|1|||
46732812|NCT00805480|82949509|FG001|Overall Study|Lost to Follow-up|2|||
46921480|NCT03068455|83154048|FG000|Treatment Period|Participant request to stop therapy|33|||
46921481|NCT03068455|83154049|FG001|Treatment Period|Participant request to stop therapy|20|||
46921482|NCT03068455|83154048|FG000|Treatment Period|Participant withdrew consent|5|||
46921483|NCT03068455|83154049|FG001|Treatment Period|Participant withdrew consent|10|||
46921484|NCT03068455|83154048|FG000|Treatment Period|Poor/non-compliance|3|||
47049303|NCT01927055|83309605|FG000|Open-label|Supine Hypertension|4|||
47049304|NCT01927055|83309606|FG001|Open-label|Supine Hypertension|0|||
47049305|NCT01927055|83309607|FG002|Open-label|Supine Hypertension|0|||
46732813|NCT00805480|82949510|FG002|Overall Study|Lost to Follow-up|0|||
46732814|NCT00805480|82949511|FG003|Overall Study|Lost to Follow-up|0|||
46732815|NCT00805480|82949508|FG000|Overall Study|Adverse Event|0|||
46732816|NCT00805480|82949509|FG001|Overall Study|Adverse Event|0|||
46732817|NCT00805480|82949510|FG002|Overall Study|Adverse Event|1|||
46732818|NCT00805480|82949511|FG003|Overall Study|Adverse Event|0|||
46732819|NCT00729937|82949527|FG000|Overall Study|Lost to Follow-up|49|||
46732820|NCT00729937|82949528|FG001|Overall Study|Lost to Follow-up|58|||
46732821|NCT00729937|82949529|FG002|Overall Study|Lost to Follow-up|18|||
46732822|NCT00729937|82949530|FG003|Overall Study|Lost to Follow-up|33|||
46732823|NCT00729937|82949531|FG004|Overall Study|Lost to Follow-up|18|||
46732824|NCT00729937|82949532|FG005|Overall Study|Lost to Follow-up|23|||
46732825|NCT00729937|82949527|FG000|Overall Study|Physician Decision|7|||
46732826|NCT00729937|82949528|FG001|Overall Study|Physician Decision|16|||
46732827|NCT00729937|82949529|FG002|Overall Study|Physician Decision|2|||
46732828|NCT00729937|82949530|FG003|Overall Study|Physician Decision|0|||
46921485|NCT03068455|83154049|FG001|Treatment Period|Poor/non-compliance|0|||
46921486|NCT03068455|83154048|FG000|Treatment Period|Participant no longer meets study criteria|1|||
46732829|NCT00729937|82949531|FG004|Overall Study|Physician Decision|5|||
46732830|NCT00729937|82949532|FG005|Overall Study|Physician Decision|8|||
46732831|NCT00729937|82949527|FG000|Overall Study|Death|1|||
46732832|NCT00729937|82949528|FG001|Overall Study|Death|0|||
46732833|NCT00729937|82949529|FG002|Overall Study|Death|1|||
46732834|NCT00729937|82949530|FG003|Overall Study|Death|0|||
46732835|NCT00729937|82949531|FG004|Overall Study|Death|0|||
46921487|NCT03068455|83154049|FG001|Treatment Period|Participant no longer meets study criteria|3|||
46732836|NCT00729937|82949532|FG005|Overall Study|Death|1|||
46732837|NCT00729937|82949527|FG000|Overall Study|Withdrawal by Subject|3|||
46732838|NCT00729937|82949528|FG001|Overall Study|Withdrawal by Subject|5|||
46732839|NCT00729937|82949529|FG002|Overall Study|Withdrawal by Subject|6|||
46732840|NCT00729937|82949530|FG003|Overall Study|Withdrawal by Subject|0|||
47049306|NCT01927055|83309605|FG000|Open-label|Difficulty attending study visits|1|||
46732841|NCT00729937|82949531|FG004|Overall Study|Withdrawal by Subject|4|||
46732842|NCT00729937|82949532|FG005|Overall Study|Withdrawal by Subject|2|||
46732843|NCT00729937|82949527|FG000|Overall Study|Randomized but not treated|12|||
46732844|NCT00729937|82949528|FG001|Overall Study|Randomized but not treated|6|||
46732845|NCT00729937|82949529|FG002|Overall Study|Randomized but not treated|1|||
46732846|NCT00729937|82949530|FG003|Overall Study|Randomized but not treated|0|||
46732847|NCT00729937|82949531|FG004|Overall Study|Randomized but not treated|1|||
46732848|NCT00729937|82949532|FG005|Overall Study|Randomized but not treated|3|||
46732849|NCT00729937|82949527|FG000|Overall Study|Did not meet eligibility criteria|2|||
46732850|NCT00729937|82949528|FG001|Overall Study|Did not meet eligibility criteria|1|||
46732851|NCT00729937|82949529|FG002|Overall Study|Did not meet eligibility criteria|0|||
46732852|NCT00729937|82949530|FG003|Overall Study|Did not meet eligibility criteria|0|||
46732853|NCT00729937|82949531|FG004|Overall Study|Did not meet eligibility criteria|0|||
46732854|NCT00729937|82949532|FG005|Overall Study|Did not meet eligibility criteria|0|||
46732855|NCT00729937|82949527|FG000|Overall Study|Incarcerated|0|||
46732856|NCT00729937|82949528|FG001|Overall Study|Incarcerated|2|||
46732857|NCT00729937|82949529|FG002|Overall Study|Incarcerated|1|||
46732858|NCT00729937|82949530|FG003|Overall Study|Incarcerated|1|||
46732859|NCT00729937|82949531|FG004|Overall Study|Incarcerated|0|||
46732860|NCT00729937|82949532|FG005|Overall Study|Incarcerated|0|||
46732861|NCT00729859|82949549|FG000|Overall Study|Adverse Event|0|||
46732862|NCT00729859|82949550|FG001|Overall Study|Adverse Event|1|||
46732863|NCT00729859|82949551|FG002|Overall Study|Adverse Event|0|||
46732864|NCT00729859|82949549|FG000|Overall Study|Withdrawal by Subject|0|||
46732865|NCT00729859|82949550|FG001|Overall Study|Withdrawal by Subject|1|||
46732866|NCT00729859|82949551|FG002|Overall Study|Withdrawal by Subject|0|||
46732867|NCT00810394|82949567|FG000|Overall Study|Withdrawal by Subject|3|||
46732868|NCT00736333|82949571|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
46732869|NCT00736333|82949571|FG000|Overall Study|Data Missing|2|||
46732870|NCT00736333|82949571|FG000|Overall Study|Tumor Progression|75|||
46732871|NCT00736333|82949571|FG000|Overall Study|Toxicity|6|||
46732872|NCT00736333|82949571|FG000|Overall Study|Withdrawal by Subject|10|||
46732873|NCT00736333|82949571|FG000|Overall Study|Death|7|||
46732874|NCT00736333|82949571|FG000|Overall Study|Other|4|||
46732875|NCT00736255|82949577|FG000|Overall Study|Adverse Event|1|||
46732876|NCT00736255|82949578|FG001|Overall Study|Adverse Event|0|||
46732877|NCT00736255|82949577|FG000|Overall Study|Physician Decision|1|||
46732878|NCT00736255|82949578|FG001|Overall Study|Physician Decision|0|||
46732879|NCT00736255|82949577|FG000|Overall Study|Non-compliance|1|||
46732880|NCT00736255|82949578|FG001|Overall Study|Non-compliance|1|||
46732881|NCT03920254|82949587|FG000|Overall Study|Adverse Event|1|||
46732882|NCT03920254|82949588|FG001|Overall Study|Adverse Event|0|||
46732883|NCT03920254|82949589|FG002|Overall Study|Adverse Event|0|||
46732884|NCT03920254|82949587|FG000|Overall Study|Physician Decision|0|||
46732885|NCT03920254|82949588|FG001|Overall Study|Physician Decision|1|||
46732886|NCT03920254|82949589|FG002|Overall Study|Physician Decision|2|||
46732887|NCT03920254|82949587|FG000|Overall Study|Study Terminated By Sponsor|12|||
46732888|NCT03920254|82949588|FG001|Overall Study|Study Terminated By Sponsor|17|||
46732889|NCT03920254|82949589|FG002|Overall Study|Study Terminated By Sponsor|12|||
46732890|NCT03920254|82949587|FG000|Overall Study|Withdrawal by Subject|0|||
46732891|NCT03920254|82949588|FG001|Overall Study|Withdrawal by Subject|0|||
46732892|NCT03920254|82949589|FG002|Overall Study|Withdrawal by Subject|1|||
46732893|NCT00729469|82949599|FG000|Overall Study|Adverse Event|14|||
46732894|NCT00729469|82949600|FG001|Overall Study|Adverse Event|25|||
46732895|NCT00729469|82949599|FG000|Overall Study|Lost to Follow-up|9|||
46732896|NCT00729469|82949600|FG001|Overall Study|Lost to Follow-up|9|||
46732897|NCT00729469|82949599|FG000|Overall Study|Protocol Violation|2|||
46732898|NCT00729469|82949600|FG001|Overall Study|Protocol Violation|1|||
46732899|NCT00729469|82949599|FG000|Overall Study|Withdrawal by Subject|19|||
46732900|NCT00729469|82949600|FG001|Overall Study|Withdrawal by Subject|8|||
46732901|NCT00729469|82949599|FG000|Overall Study|Other-Not mentioned|9|||
46732902|NCT00729469|82949600|FG001|Overall Study|Other-Not mentioned|4|||
46732903|NCT00742183|82949608|FG000|Overall Study|Adverse Event|2|||
46732904|NCT00742183|82949609|FG001|Overall Study|Adverse Event|2|||
46803949|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
46921488|NCT03068455|83154048|FG000|Treatment Period|Other reasons|12|||
46732905|NCT00742183|82949608|FG000|Overall Study|Death|1|||
46732906|NCT00742183|82949609|FG001|Overall Study|Death|0|||
46732907|NCT00742183|82949608|FG000|Overall Study|Physician Decision|0|||
46732908|NCT00742183|82949609|FG001|Overall Study|Physician Decision|2|||
46732909|NCT00742183|82949608|FG000|Overall Study|Lost to Follow-up|4|||
46732910|NCT00742183|82949609|FG001|Overall Study|Lost to Follow-up|4|||
46732911|NCT00742183|82949608|FG000|Overall Study|Required skin-graft|1|||
46732912|NCT00742183|82949609|FG001|Overall Study|Required skin-graft|1|||
46732913|NCT00742183|82949608|FG000|Overall Study|Withdrawal by Subject|1|||
46732914|NCT00742183|82949609|FG001|Overall Study|Withdrawal by Subject|0|||
46732915|NCT00742183|82949608|FG000|Overall Study|Lack of Efficacy|0|||
46732916|NCT00742183|82949609|FG001|Overall Study|Lack of Efficacy|3|||
46732917|NCT00808444|82949617|FG000|Overall Study|Withdrawal by Subject|1|||
46732918|NCT00808444|82949618|FG001|Overall Study|Withdrawal by Subject|0|||
46732919|NCT00808444|82949617|FG000|Overall Study|Lost to Follow-up|0|||
46732920|NCT00808444|82949618|FG001|Overall Study|Lost to Follow-up|1|||
46732921|NCT00742027|82949624|FG000|Overall Study|Disease Progression|76|||
46732922|NCT00742027|82949624|FG000|Overall Study|New Cancer Therapy|19|||
46732923|NCT00742027|82949624|FG000|Overall Study|Withdrawal by Subject|18|||
46732924|NCT00742027|82949624|FG000|Overall Study|Death|7|||
46732925|NCT00742027|82949624|FG000|Overall Study|Lost to Follow-up|4|||
46732926|NCT00742027|82949624|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
46732927|NCT00742027|82949624|FG000|Overall Study|Missing|2|||
46732928|NCT00742027|82949624|FG000|Overall Study|Administrative Problems|1|||
46732929|NCT03996369|82949630|FG000|Overall Study|Protocol deviation|1|||
46732930|NCT03996369|82949631|FG001|Overall Study|Protocol deviation|1|||
46732931|NCT03996369|82949630|FG000|Overall Study|Physician Decision|4|||
46732932|NCT03996369|82949631|FG001|Overall Study|Physician Decision|2|||
46732933|NCT03996369|82949630|FG000|Overall Study|Participant decision|0|||
46732934|NCT03996369|82949631|FG001|Overall Study|Participant decision|1|||
46732935|NCT03996369|82949630|FG000|Overall Study|Lack of Efficacy|4|||
46732936|NCT03996369|82949631|FG001|Overall Study|Lack of Efficacy|0|||
46732937|NCT03996369|82949630|FG000|Overall Study|Adverse Event|9|||
46732938|NCT03996369|82949631|FG001|Overall Study|Adverse Event|0|||
46732939|NCT03996369|82949630|FG000|Overall Study|Withdrawal by Subject|6|||
46732940|NCT03996369|82949631|FG001|Overall Study|Withdrawal by Subject|8|||
46732941|NCT03996369|82949630|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
46732942|NCT03996369|82949631|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
46732943|NCT03996369|82949630|FG000|Overall Study|Lost to Follow-up|0|||
46732944|NCT03996369|82949631|FG001|Overall Study|Lost to Follow-up|1|||
46732945|NCT00808210|82949639|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
46732946|NCT00808210|82949640|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
46732947|NCT00808210|82949639|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
46732948|NCT00808210|82949640|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
46732949|NCT00808210|82949639|FG000|Double-Blind TX Period|Adverse Event|0|||
46732950|NCT00808210|82949640|FG001|Double-Blind TX Period|Adverse Event|1|||
46732951|NCT00808210|82949639|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
46732952|NCT00808210|82949640|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
46732953|NCT00808210|82949639|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
47049307|NCT01927055|83309606|FG001|Open-label|Difficulty attending study visits|0|||
47049308|NCT01927055|83309607|FG002|Open-label|Difficulty attending study visits|0|||
47049309|NCT01927055|83309605|FG000|Double-Blind|Adverse Event|0|||
47049310|NCT01927055|83309606|FG001|Double-Blind|Adverse Event|1|||
47049311|NCT01927055|83309607|FG002|Double-Blind|Adverse Event|1|||
46732954|NCT00808210|82949640|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
46732955|NCT00808210|82949639|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
46732956|NCT00808210|82949640|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
46732957|NCT00736099|82949648|FG000|Overall Study|Adverse Event|61|||
47049312|NCT01927055|83309605|FG000|Double-Blind|Protocol Violation|0|||
47049313|NCT01927055|83309606|FG001|Double-Blind|Protocol Violation|0|||
47049314|NCT01927055|83309607|FG002|Double-Blind|Protocol Violation|1|||
46732958|NCT00736099|82949649|FG001|Overall Study|Adverse Event|18|||
46732959|NCT00736099|82949648|FG000|Overall Study|Protocol Violation|10|||
46732960|NCT00736099|82949649|FG001|Overall Study|Protocol Violation|4|||
46732961|NCT00736099|82949648|FG000|Overall Study|Lost to Follow-up|12|||
46732962|NCT00736099|82949649|FG001|Overall Study|Lost to Follow-up|5|||
46732963|NCT00736099|82949648|FG000|Overall Study|Withdrawal by Subject|42|||
46732964|NCT00736099|82949649|FG001|Overall Study|Withdrawal by Subject|13|||
46732965|NCT00736099|82949648|FG000|Overall Study|Lack of Efficacy|15|||
46732966|NCT00736099|82949649|FG001|Overall Study|Lack of Efficacy|8|||
46732967|NCT00736099|82949648|FG000|Overall Study|Other reason|43|||
46732968|NCT00736099|82949649|FG001|Overall Study|Other reason|10|||
46732969|NCT00735943|82949655|FG000|Overall Study|Lost to Follow-up|1|||
46732970|NCT00735943|82949655|FG000|Overall Study|Adverse Event|1|||
47049315|NCT01927055|83309605|FG000|Double-Blind|Withdrawal by Subject|0|||
47049316|NCT01927055|83309606|FG001|Double-Blind|Withdrawal by Subject|2|||
46732971|NCT00735709|82949663|FG000|Overall Study|Adverse Event|2|||
46732972|NCT00735709|82949664|FG001|Overall Study|Adverse Event|3|||
46732973|NCT00735709|82949665|FG002|Overall Study|Adverse Event|1|||
46732974|NCT00735709|82949666|FG003|Overall Study|Adverse Event|5|||
46732975|NCT00735709|82949663|FG000|Overall Study|Lack of Efficacy|8|||
46732976|NCT00735709|82949664|FG001|Overall Study|Lack of Efficacy|4|||
46732977|NCT00735709|82949665|FG002|Overall Study|Lack of Efficacy|2|||
47049317|NCT01927055|83309607|FG002|Double-Blind|Withdrawal by Subject|3|||
46732978|NCT00735709|82949666|FG003|Overall Study|Lack of Efficacy|3|||
46732979|NCT00735709|82949663|FG000|Overall Study|Noncompliance|0|||
46732980|NCT00735709|82949664|FG001|Overall Study|Noncompliance|0|||
46732981|NCT00735709|82949665|FG002|Overall Study|Noncompliance|1|||
46732982|NCT00735709|82949666|FG003|Overall Study|Noncompliance|0|||
46732983|NCT00735709|82949663|FG000|Overall Study|Protocol deviations|1|||
46732984|NCT00735709|82949664|FG001|Overall Study|Protocol deviations|2|||
46732985|NCT00735709|82949665|FG002|Overall Study|Protocol deviations|1|||
46732986|NCT00735709|82949666|FG003|Overall Study|Protocol deviations|1|||
46732987|NCT00735709|82949663|FG000|Overall Study|Voluntary Withdrawal|1|||
46732988|NCT00735709|82949664|FG001|Overall Study|Voluntary Withdrawal|3|||
46732989|NCT00735709|82949665|FG002|Overall Study|Voluntary Withdrawal|5|||
46732990|NCT00735709|82949666|FG003|Overall Study|Voluntary Withdrawal|7|||
46732991|NCT00735709|82949663|FG000|Overall Study|Lost to Follow-up|0|||
46732992|NCT00735709|82949664|FG001|Overall Study|Lost to Follow-up|1|||
46732993|NCT00735709|82949665|FG002|Overall Study|Lost to Follow-up|1|||
46732994|NCT00735709|82949666|FG003|Overall Study|Lost to Follow-up|1|||
46732995|NCT00735709|82949663|FG000|Overall Study|Excluded medication|1|||
46732996|NCT00735709|82949664|FG001|Overall Study|Excluded medication|0|||
46732997|NCT00735709|82949665|FG002|Overall Study|Excluded medication|0|||
46732998|NCT00735709|82949666|FG003|Overall Study|Excluded medication|1|||
46732999|NCT00729157|82949676|FG000|Overall Study|Withdrawal by Subject|1|||
46733000|NCT00728689|82949682|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
46733001|NCT00728689|82949683|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
46733002|NCT00727909|82949691|FG000|Overall Study|Withdrawal by Subject|5|||
46733003|NCT00727909|82949692|FG001|Overall Study|Withdrawal by Subject|11|||
46733004|NCT00727909|82949693|FG002|Overall Study|Withdrawal by Subject|8|||
46733005|NCT00727909|82949694|FG003|Overall Study|Withdrawal by Subject|5|||
46733006|NCT00727909|82949691|FG000|Overall Study|Death|0|||
46733007|NCT00727909|82949692|FG001|Overall Study|Death|0|||
46733008|NCT00727909|82949693|FG002|Overall Study|Death|1|||
46733009|NCT00727909|82949694|FG003|Overall Study|Death|0|||
46733010|NCT00726895|82949698|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
46733011|NCT00726895|82949699|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46733012|NCT00585325|82949708|FG000|Overall Study|Withdrawal by Subject|1|||
46733013|NCT00585325|82949709|FG001|Overall Study|Withdrawal by Subject|1|||
46733014|NCT00726661|82949717|FG000|Overall Study|Lost to Follow-up|36|||
46733015|NCT00726661|82949718|FG001|Overall Study|Lost to Follow-up|11|||
46733016|NCT00726661|82949717|FG000|Overall Study|Withdrawal by Subject|17|||
46733017|NCT00726661|82949718|FG001|Overall Study|Withdrawal by Subject|13|||
46733018|NCT00726661|82949717|FG000|Overall Study|Trial terminated by sponsor|214|||
46733019|NCT00726661|82949718|FG001|Overall Study|Trial terminated by sponsor|187|||
46733020|NCT00726661|82949717|FG000|Overall Study|Death|475|||
46733021|NCT00726661|82949718|FG001|Overall Study|Death|159|||
46733022|NCT00726661|82949717|FG000|Overall Study|Physician Decision|25|||
46733023|NCT00726661|82949718|FG001|Overall Study|Physician Decision|13|||
46635161|NCT01684878|82808715|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
46635162|NCT01684878|82808712|FG000|Part 1: Safety Run in Phase|Death|15|||
46635163|NCT01684878|82808713|FG001|Part 1: Safety Run in Phase|Death|20|||
46635164|NCT01684878|82808714|FG002|Part 1: Safety Run in Phase|Death|0|||
46635165|NCT01684878|82808715|FG003|Part 1: Safety Run in Phase|Death|0|||
46635166|NCT01684878|82808712|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
46635167|NCT01684878|82808713|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
46635168|NCT01684878|82808714|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
46635169|NCT01684878|82808715|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
46635170|NCT01684878|82808712|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
46635171|NCT01684878|82808713|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
46635172|NCT01684878|82808714|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
46635173|NCT01684878|82808715|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
46635174|NCT01684878|82808712|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
46635175|NCT01684878|82808713|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
46635176|NCT01684878|82808714|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
46635177|NCT01684878|82808715|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
46635178|NCT01684878|82808712|FG000|Part 2: Randomized Phase|Death|0|||
46635179|NCT01684878|82808713|FG001|Part 2: Randomized Phase|Death|0|||
46635180|NCT01684878|82808714|FG002|Part 2: Randomized Phase|Death|62|||
46635181|NCT01684878|82808715|FG003|Part 2: Randomized Phase|Death|68|||
46635182|NCT01684878|82808712|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
46733024|NCT00726661|82949717|FG000|Overall Study|Other|47|||
46733025|NCT00726661|82949718|FG001|Overall Study|Other|35|||
46733026|NCT00741091|82949734|FG000|Overall Study|Death|13|||
46733027|NCT00741091|82949734|FG000|Overall Study|Lost to Follow-up|16|||
46733028|NCT00741091|82949734|FG000|Overall Study|Withdrawal by Subject|6|||
46733029|NCT00741091|82949734|FG000|Overall Study|Missed Visit|22|||
46733030|NCT00741013|82949741|FG000|Overall Study|Adverse Event|1|||
46733031|NCT00741013|82949742|FG001|Overall Study|Adverse Event|0|||
46733032|NCT00741013|82949743|FG002|Overall Study|Adverse Event|0|||
46733033|NCT00741013|82949741|FG000|Overall Study|Withdrawal by Subject|0|||
46733034|NCT00741013|82949742|FG001|Overall Study|Withdrawal by Subject|0|||
46733035|NCT00741013|82949743|FG002|Overall Study|Withdrawal by Subject|1|||
46733036|NCT00741013|82949741|FG000|Overall Study|Discovered failed screen after enrolled|0|||
46733037|NCT00741013|82949742|FG001|Overall Study|Discovered failed screen after enrolled|2|||
46733038|NCT00741013|82949743|FG002|Overall Study|Discovered failed screen after enrolled|0|||
46733039|NCT00740857|82949754|FG000|Overall Study|Withdrawal by Subject|1|||
46733040|NCT00740857|82949755|FG001|Overall Study|Withdrawal by Subject|0|||
46733041|NCT00740857|82949756|FG002|Overall Study|Withdrawal by Subject|0|||
46733042|NCT00808132|82949769|FG000|Overall Study|Adverse Event|34|||
46733043|NCT00808132|82949770|FG001|Overall Study|Adverse Event|33|||
46733044|NCT00808132|82949771|FG002|Overall Study|Adverse Event|16|||
46733045|NCT00808132|82949772|FG003|Overall Study|Adverse Event|31|||
46733046|NCT00808132|82949773|FG004|Overall Study|Adverse Event|33|||
46733047|NCT00808132|82949769|FG000|Overall Study|Death|0|||
46733048|NCT00808132|82949770|FG001|Overall Study|Death|0|||
46733049|NCT00808132|82949771|FG002|Overall Study|Death|0|||
46733050|NCT00808132|82949772|FG003|Overall Study|Death|0|||
46733051|NCT00808132|82949773|FG004|Overall Study|Death|1|||
46733052|NCT00808132|82949769|FG000|Overall Study|Physician Decision|0|||
46733053|NCT00808132|82949770|FG001|Overall Study|Physician Decision|1|||
46733054|NCT00808132|82949771|FG002|Overall Study|Physician Decision|0|||
46733055|NCT00808132|82949772|FG003|Overall Study|Physician Decision|0|||
46733056|NCT00808132|82949773|FG004|Overall Study|Physician Decision|0|||
46733057|NCT00808132|82949769|FG000|Overall Study|Lost to Follow-up|8|||
46733058|NCT00808132|82949770|FG001|Overall Study|Lost to Follow-up|10|||
46733059|NCT00808132|82949771|FG002|Overall Study|Lost to Follow-up|11|||
46733060|NCT00808132|82949772|FG003|Overall Study|Lost to Follow-up|8|||
46733061|NCT00808132|82949773|FG004|Overall Study|Lost to Follow-up|9|||
46733062|NCT00808132|82949769|FG000|Overall Study|Protocol Violation|8|||
46733063|NCT00808132|82949770|FG001|Overall Study|Protocol Violation|9|||
46733064|NCT00808132|82949771|FG002|Overall Study|Protocol Violation|4|||
46733065|NCT00808132|82949772|FG003|Overall Study|Protocol Violation|9|||
46733066|NCT00808132|82949773|FG004|Overall Study|Protocol Violation|5|||
46733067|NCT00808132|82949769|FG000|Overall Study|Withdrawal by Subject|27|||
46733068|NCT00808132|82949770|FG001|Overall Study|Withdrawal by Subject|18|||
46733069|NCT00808132|82949771|FG002|Overall Study|Withdrawal by Subject|2|||
46733070|NCT00808132|82949772|FG003|Overall Study|Withdrawal by Subject|7|||
46733071|NCT00808132|82949773|FG004|Overall Study|Withdrawal by Subject|16|||
46733072|NCT00808132|82949769|FG000|Overall Study|Other|6|||
46733073|NCT00808132|82949770|FG001|Overall Study|Other|4|||
46733074|NCT00808132|82949771|FG002|Overall Study|Other|6|||
46733075|NCT00808132|82949772|FG003|Overall Study|Other|2|||
46733076|NCT00808132|82949773|FG004|Overall Study|Other|15|||
46733077|NCT00808132|82949769|FG000|Overall Study|Randomized, but not treated|10|||
46733078|NCT00808132|82949770|FG001|Overall Study|Randomized, but not treated|7|||
46733079|NCT00808132|82949771|FG002|Overall Study|Randomized, but not treated|9|||
46733080|NCT00808132|82949772|FG003|Overall Study|Randomized, but not treated|8|||
46733081|NCT00808132|82949773|FG004|Overall Study|Randomized, but not treated|9|||
46733082|NCT00808132|82949769|FG000|Overall Study|Unsatisfactory response|5|||
46733083|NCT00808132|82949770|FG001|Overall Study|Unsatisfactory response|6|||
46733084|NCT00808132|82949771|FG002|Overall Study|Unsatisfactory response|6|||
46733085|NCT00808132|82949772|FG003|Overall Study|Unsatisfactory response|4|||
46733086|NCT00808132|82949773|FG004|Overall Study|Unsatisfactory response|12|||
46733087|NCT00727441|82949788|FG000|Overall Study|Disease Progression|11|||
46733088|NCT00727441|82949789|FG001|Overall Study|Disease Progression|14|||
46733089|NCT00727441|82949790|FG002|Overall Study|Disease Progression|17|||
46733090|NCT00727441|82949788|FG000|Overall Study|Eligibility|7|||
46733091|NCT00727441|82949789|FG001|Overall Study|Eligibility|5|||
46733092|NCT00727441|82949790|FG002|Overall Study|Eligibility|7|||
46921489|NCT03068455|83154049|FG001|Treatment Period|Other reasons|4|||
46921490|NCT03067987|83154057|FG000|Overall Study|Lost to Follow-up|7|||
46921491|NCT03067987|83154058|FG001|Overall Study|Lost to Follow-up|10|||
46733093|NCT00727441|82949788|FG000|Overall Study|Death|0|||
46733094|NCT00727441|82949789|FG001|Overall Study|Death|1|||
46733095|NCT00727441|82949790|FG002|Overall Study|Death|1|||
46733096|NCT00727441|82949788|FG000|Overall Study|Physician Decision|0|||
46733097|NCT00727441|82949789|FG001|Overall Study|Physician Decision|1|||
46733098|NCT00727441|82949790|FG002|Overall Study|Physician Decision|0|||
46733099|NCT00727441|82949788|FG000|Overall Study|Withdrawal by Subject|0|||
46733100|NCT00727441|82949789|FG001|Overall Study|Withdrawal by Subject|1|||
46921492|NCT03067987|83154057|FG000|Overall Study|Protocol Violation|1|||
46921493|NCT03067987|83154058|FG001|Overall Study|Protocol Violation|2|||
46733101|NCT00727441|82949790|FG002|Overall Study|Withdrawal by Subject|0|||
46921494|NCT03067987|83154057|FG000|Overall Study|Withdrawal by Subject|2|||
46733102|NCT00717769|82949804|FG000|Overall Study|Adverse Event|9|||
46733103|NCT00717769|82949805|FG001|Overall Study|Adverse Event|6|||
46733104|NCT00717769|82949806|FG002|Overall Study|Adverse Event|1|||
46733105|NCT00717769|82949804|FG000|Overall Study|Lack of compliance|0|||
46733106|NCT00717769|82949805|FG001|Overall Study|Lack of compliance|2|||
46733107|NCT00717769|82949806|FG002|Overall Study|Lack of compliance|0|||
46733108|NCT00717769|82949804|FG000|Overall Study|Lost to Follow-up|3|||
46733109|NCT00717769|82949805|FG001|Overall Study|Lost to Follow-up|4|||
46733110|NCT00717769|82949806|FG002|Overall Study|Lost to Follow-up|0|||
46733111|NCT00717769|82949804|FG000|Overall Study|Lack of Efficacy|1|||
46733112|NCT00717769|82949805|FG001|Overall Study|Lack of Efficacy|2|||
46733113|NCT00717769|82949806|FG002|Overall Study|Lack of Efficacy|0|||
46733114|NCT00717769|82949804|FG000|Overall Study|Protocol Violation|0|||
46733115|NCT00717769|82949805|FG001|Overall Study|Protocol Violation|2|||
46733116|NCT00717769|82949806|FG002|Overall Study|Protocol Violation|0|||
46733117|NCT00717769|82949804|FG000|Overall Study|Sponsor decision|1|||
46733118|NCT00717769|82949805|FG001|Overall Study|Sponsor decision|0|||
46733119|NCT00717769|82949806|FG002|Overall Study|Sponsor decision|10|||
46733120|NCT00717769|82949804|FG000|Overall Study|Withdrew consent|2|||
46733121|NCT00717769|82949805|FG001|Overall Study|Withdrew consent|2|||
46733122|NCT00717769|82949806|FG002|Overall Study|Withdrew consent|0|||
46733123|NCT04153929|82949824|FG000|Overall Study|Other than listed|2|||
46733124|NCT04153929|82949825|FG001|Overall Study|Other than listed|2|||
46733125|NCT04153929|82949826|FG002|Overall Study|Other than listed|0|||
46733126|NCT04153929|82949827|FG003|Overall Study|Other than listed|1|||
46733127|NCT04153929|82949828|FG004|Overall Study|Other than listed|0|||
46733128|NCT04153929|82949829|FG005|Overall Study|Other than listed|2|||
46733129|NCT04153929|82949830|FG006|Overall Study|Other than listed|2|||
46733130|NCT04153929|82949831|FG007|Overall Study|Other than listed|1|||
46733131|NCT04153929|82949824|FG000|Overall Study|Lost to Follow-up|2|||
46733132|NCT04153929|82949825|FG001|Overall Study|Lost to Follow-up|1|||
46733133|NCT04153929|82949826|FG002|Overall Study|Lost to Follow-up|0|||
46733134|NCT04153929|82949827|FG003|Overall Study|Lost to Follow-up|1|||
46733135|NCT04153929|82949828|FG004|Overall Study|Lost to Follow-up|1|||
46733136|NCT04153929|82949829|FG005|Overall Study|Lost to Follow-up|0|||
46733137|NCT04153929|82949830|FG006|Overall Study|Lost to Follow-up|0|||
46733138|NCT04153929|82949831|FG007|Overall Study|Lost to Follow-up|0|||
46733139|NCT04153929|82949824|FG000|Overall Study|Withdrawal by Subject|3|||
46733140|NCT04153929|82949825|FG001|Overall Study|Withdrawal by Subject|1|||
46733141|NCT04153929|82949826|FG002|Overall Study|Withdrawal by Subject|0|||
46733142|NCT04153929|82949827|FG003|Overall Study|Withdrawal by Subject|3|||
46733143|NCT04153929|82949828|FG004|Overall Study|Withdrawal by Subject|1|||
46733144|NCT04153929|82949829|FG005|Overall Study|Withdrawal by Subject|0|||
46733145|NCT04153929|82949830|FG006|Overall Study|Withdrawal by Subject|1|||
46733146|NCT04153929|82949831|FG007|Overall Study|Withdrawal by Subject|0|||
46733147|NCT04153929|82949824|FG000|Overall Study|Protocol Violation|0|||
46733148|NCT04153929|82949825|FG001|Overall Study|Protocol Violation|0|||
46733149|NCT04153929|82949826|FG002|Overall Study|Protocol Violation|0|||
46733150|NCT04153929|82949827|FG003|Overall Study|Protocol Violation|0|||
46733151|NCT04153929|82949828|FG004|Overall Study|Protocol Violation|0|||
46733152|NCT04153929|82949829|FG005|Overall Study|Protocol Violation|0|||
46733153|NCT04153929|82949830|FG006|Overall Study|Protocol Violation|1|||
46733154|NCT04153929|82949831|FG007|Overall Study|Protocol Violation|2|||
46733155|NCT04153929|82949824|FG000|Overall Study|Adverse Event|3|||
46733156|NCT04153929|82949825|FG001|Overall Study|Adverse Event|5|||
46733157|NCT04153929|82949826|FG002|Overall Study|Adverse Event|5|||
46733158|NCT04153929|82949827|FG003|Overall Study|Adverse Event|11|||
46733159|NCT04153929|82949828|FG004|Overall Study|Adverse Event|15|||
46733160|NCT04153929|82949829|FG005|Overall Study|Adverse Event|4|||
46733161|NCT04153929|82949830|FG006|Overall Study|Adverse Event|8|||
46733162|NCT04153929|82949831|FG007|Overall Study|Adverse Event|2|||
46733163|NCT04153929|82949824|FG000|Overall Study|Not treated|1|||
46733164|NCT04153929|82949825|FG001|Overall Study|Not treated|0|||
46733165|NCT04153929|82949826|FG002|Overall Study|Not treated|0|||
46733166|NCT04153929|82949827|FG003|Overall Study|Not treated|0|||
46733167|NCT04153929|82949828|FG004|Overall Study|Not treated|0|||
46733168|NCT04153929|82949829|FG005|Overall Study|Not treated|0|||
46733169|NCT04153929|82949830|FG006|Overall Study|Not treated|1|||
47049318|NCT01927055|83309605|FG000|Double-Blind|Study Stopped|0|||
46733170|NCT04153929|82949831|FG007|Overall Study|Not treated|0|||
46733171|NCT00591214|82949849|FG000|Overall Study|Physician Decision|7|||
46733172|NCT00591214|82949849|FG000|Overall Study|Withdrawal by Subject|1|||
47049319|NCT01927055|83309606|FG001|Double-Blind|Study Stopped|7|||
47049320|NCT01927055|83309607|FG002|Double-Blind|Study Stopped|7|||
47049321|NCT01927055|83309605|FG000|Double-Blind|Supine Hypertension|0|||
46635183|NCT01684878|82808713|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
46635184|NCT01684878|82808714|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
46733173|NCT00725725|82949856|FG000|Overall Study|Adverse Event|1|||
46733174|NCT00725725|82949857|FG001|Overall Study|Adverse Event|3|||
46733175|NCT00725725|82949858|FG002|Overall Study|Adverse Event|2|||
46733176|NCT00725725|82949856|FG000|Overall Study|Lost to Follow-up|2|||
46733177|NCT00725725|82949857|FG001|Overall Study|Lost to Follow-up|0|||
46733178|NCT00725725|82949858|FG002|Overall Study|Lost to Follow-up|2|||
46733179|NCT00725725|82949856|FG000|Overall Study|Withdrawal by Subject|1|||
46733180|NCT00725725|82949857|FG001|Overall Study|Withdrawal by Subject|0|||
46733181|NCT00725725|82949858|FG002|Overall Study|Withdrawal by Subject|1|||
46733182|NCT00725725|82949856|FG000|Overall Study|Protocol Violation|0|||
46733183|NCT00725725|82949857|FG001|Overall Study|Protocol Violation|1|||
47049322|NCT01927055|83309606|FG001|Double-Blind|Supine Hypertension|0|||
46733184|NCT00725725|82949858|FG002|Overall Study|Protocol Violation|0|||
46733185|NCT00725101|82949866|FG000|Overall Study|Death|3|||
46733186|NCT00725101|82949866|FG000|Overall Study|Lost to Follow-up|353|||
46733187|NCT00725101|82949866|FG000|Overall Study|Protocol Violation|1|||
46733188|NCT00725101|82949866|FG000|Overall Study|Withdrawal by Subject|127|||
46733189|NCT00725101|82949866|FG000|Overall Study|not specified/no reason given|11|||
46733190|NCT00585169|82949870|FG000|Overall Study|Withdrawal by Subject|1|||
46733191|NCT00807742|82949878|FG000|Overall Study|Death|9|||
46733192|NCT00807742|82949879|FG001|Overall Study|Death|2|||
46733193|NCT00807742|82949878|FG000|Overall Study|Withdrawal by Subject|2|||
46733194|NCT00807742|82949879|FG001|Overall Study|Withdrawal by Subject|1|||
46733195|NCT00807742|82949878|FG000|Overall Study|Lost to Follow-up|35|||
46733196|NCT00807742|82949879|FG001|Overall Study|Lost to Follow-up|51|||
46733197|NCT00724945|82949885|FG000|Period 1|non-compliance|1|||
46733198|NCT00724945|82949886|FG001|Period 1|non-compliance|0|||
46733199|NCT00724945|82949885|FG000|Period 1|Adverse Event|1|||
46733200|NCT00724945|82949886|FG001|Period 1|Adverse Event|1|||
46733201|NCT00724945|82949885|FG000|Period 1|Lost to Follow-up|1|||
46733202|NCT00724945|82949886|FG001|Period 1|Lost to Follow-up|0|||
46733203|NCT00724945|82949885|FG000|Period 2|lens comfort issue|3|||
46733204|NCT00724945|82949886|FG001|Period 2|lens comfort issue|0|||
46733205|NCT00724945|82949885|FG000|Period 2|lens physiology issue|1|||
46733206|NCT00724945|82949886|FG001|Period 2|lens physiology issue|0|||
46733207|NCT00803452|82949894|FG000|Overall Study|Adverse Event|0|||
46733208|NCT00803452|82949895|FG001|Overall Study|Adverse Event|2|||
46733209|NCT00803452|82949894|FG000|Overall Study|Lost to Follow-up|0|||
46733210|NCT00803452|82949895|FG001|Overall Study|Lost to Follow-up|3|||
46733211|NCT00589108|82949904|FG000|Overall Study|Lost to Follow-up|1|||
46733212|NCT00589108|82949905|FG001|Overall Study|Lost to Follow-up|1|||
46733213|NCT00589108|82949906|FG002|Overall Study|Lost to Follow-up|1|||
46733214|NCT00589108|82949904|FG000|Overall Study|Death|3|||
46733215|NCT00589108|82949905|FG001|Overall Study|Death|3|||
46733216|NCT00589108|82949906|FG002|Overall Study|Death|4|||
46733217|NCT00717067|82949919|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
46733218|NCT00717067|82949920|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
46733219|NCT00717067|82949921|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
46733220|NCT00717067|82949922|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
46733221|NCT00717067|82949923|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
46733222|NCT00802438|82949945|FG000|Overall Study|Screen Failure|20|||
46733223|NCT00802438|82949945|FG000|Overall Study|Withdrawal by Subject|7|||
46733224|NCT00802438|82949945|FG000|Overall Study|Physician Decision|1|||
46733225|NCT00588952|82949955|FG000|Overall Study|Adverse Event|0|||
46733226|NCT00588952|82949956|FG001|Overall Study|Adverse Event|2|||
46733227|NCT00588952|82949955|FG000|Overall Study|Withdrawal by Subject|3|||
46733228|NCT00588952|82949956|FG001|Overall Study|Withdrawal by Subject|5|||
46733229|NCT01021748|82949971|FG000|Overall Study|Adverse Event|2|||
46733230|NCT01021748|82949972|FG001|Overall Study|Adverse Event|1|||
46733231|NCT01021748|82949973|FG002|Overall Study|Adverse Event|2|||
46733232|NCT01021748|82949974|FG003|Overall Study|Adverse Event|0|||
46733233|NCT01021748|82949975|FG004|Overall Study|Adverse Event|2|||
46733234|NCT01021748|82949976|FG005|Overall Study|Adverse Event|0|||
46733235|NCT01021748|82949977|FG006|Overall Study|Adverse Event|1|||
46733236|NCT01021748|82949978|FG007|Overall Study|Adverse Event|0|||
46733237|NCT01021748|82949979|FG008|Overall Study|Adverse Event|7|||
46733238|NCT01021748|82949971|FG000|Overall Study|Physician Decision|1|||
46733239|NCT01021748|82949972|FG001|Overall Study|Physician Decision|0|||
46733240|NCT01021748|82949973|FG002|Overall Study|Physician Decision|1|||
46733241|NCT01021748|82949974|FG003|Overall Study|Physician Decision|1|||
46733242|NCT01021748|82949975|FG004|Overall Study|Physician Decision|0|||
46803950|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
46733243|NCT01021748|82949976|FG005|Overall Study|Physician Decision|0|||
46733244|NCT01021748|82949977|FG006|Overall Study|Physician Decision|1|||
47049323|NCT01927055|83309607|FG002|Double-Blind|Supine Hypertension|1|||
46635185|NCT01684878|82808715|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
46733245|NCT01021748|82949978|FG007|Overall Study|Physician Decision|1|||
46733246|NCT01021748|82949979|FG008|Overall Study|Physician Decision|2|||
46733247|NCT01021748|82949971|FG000|Overall Study|Progressive Disease|3|||
46733248|NCT01021748|82949972|FG001|Overall Study|Progressive Disease|3|||
46733249|NCT01021748|82949973|FG002|Overall Study|Progressive Disease|4|||
47049324|NCT01927055|83309605|FG000|Double-Blind|Extended Vacation|0|||
46733250|NCT01021748|82949974|FG003|Overall Study|Progressive Disease|6|||
46733251|NCT01021748|82949975|FG004|Overall Study|Progressive Disease|7|||
46733252|NCT01021748|82949976|FG005|Overall Study|Progressive Disease|3|||
46733253|NCT01021748|82949977|FG006|Overall Study|Progressive Disease|0|||
46733254|NCT01021748|82949978|FG007|Overall Study|Progressive Disease|5|||
46733255|NCT01021748|82949979|FG008|Overall Study|Progressive Disease|6|||
46733256|NCT01021748|82949971|FG000|Overall Study|Withdrawal by Subject|0|||
46733257|NCT01021748|82949972|FG001|Overall Study|Withdrawal by Subject|0|||
46733258|NCT01021748|82949973|FG002|Overall Study|Withdrawal by Subject|0|||
46733259|NCT01021748|82949974|FG003|Overall Study|Withdrawal by Subject|0|||
46733260|NCT01021748|82949975|FG004|Overall Study|Withdrawal by Subject|0|||
46733261|NCT01021748|82949976|FG005|Overall Study|Withdrawal by Subject|0|||
46733262|NCT01021748|82949977|FG006|Overall Study|Withdrawal by Subject|1|||
46733263|NCT01021748|82949978|FG007|Overall Study|Withdrawal by Subject|0|||
46733264|NCT01021748|82949979|FG008|Overall Study|Withdrawal by Subject|1|||
46733265|NCT01021748|82949971|FG000|Overall Study|Not Treated|0|||
46733266|NCT01021748|82949972|FG001|Overall Study|Not Treated|1|||
46733267|NCT01021748|82949973|FG002|Overall Study|Not Treated|0|||
46733268|NCT01021748|82949974|FG003|Overall Study|Not Treated|0|||
46733269|NCT01021748|82949975|FG004|Overall Study|Not Treated|0|||
46733270|NCT01021748|82949976|FG005|Overall Study|Not Treated|0|||
46733271|NCT01021748|82949977|FG006|Overall Study|Not Treated|0|||
46733272|NCT01021748|82949978|FG007|Overall Study|Not Treated|0|||
46733273|NCT01021748|82949979|FG008|Overall Study|Not Treated|0|||
46733274|NCT00802360|82950003|FG000|Overall Study|Stimulation failure|4|||
46733275|NCT00802360|82950004|FG001|Overall Study|Stimulation failure|0|||
46733276|NCT00802360|82950005|FG002|Overall Study|Stimulation failure|3|||
46733277|NCT00802360|82950006|FG003|Overall Study|Stimulation failure|3|||
46733278|NCT00802360|82950003|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
46733279|NCT00802360|82950004|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
46733280|NCT00802360|82950005|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
46733281|NCT00802360|82950006|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
46733282|NCT00802360|82950003|FG000|Overall Study|Cycle cancelled|0|||
46733283|NCT00802360|82950004|FG001|Overall Study|Cycle cancelled|1|||
46733284|NCT00802360|82950005|FG002|Overall Study|Cycle cancelled|1|||
46733285|NCT00802360|82950006|FG003|Overall Study|Cycle cancelled|1|||
46733286|NCT00802360|82950003|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
46733287|NCT00802360|82950004|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
46733288|NCT00802360|82950005|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
46733289|NCT00802360|82950006|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
46733290|NCT00802360|82950003|FG000|Overall Study|No positive serum pregnancy|17|||
46733291|NCT00802360|82950004|FG001|Overall Study|No positive serum pregnancy|20|||
46733292|NCT00802360|82950005|FG002|Overall Study|No positive serum pregnancy|14|||
46733293|NCT00802360|82950006|FG003|Overall Study|No positive serum pregnancy|10|||
46733294|NCT00802360|82950003|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
46733295|NCT00802360|82950004|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
46733296|NCT00802360|82950005|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
46733297|NCT00802360|82950006|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
46733298|NCT00802360|82950003|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
46733299|NCT00802360|82950004|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
46733300|NCT00802360|82950005|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
46921495|NCT03067987|83154058|FG001|Overall Study|Withdrawal by Subject|1|||
47049325|NCT01927055|83309606|FG001|Double-Blind|Extended Vacation|1|||
47049326|NCT01927055|83309607|FG002|Double-Blind|Extended Vacation|0|||
47049327|NCT01913327|83309616|FG000|Overall Study|Withdrawal by Subject|0|||
47049328|NCT01913327|83309617|FG001|Overall Study|Withdrawal by Subject|1|||
47049329|NCT01926509|83309627|FG000|Overall Study|vital sign met discontinuation criteria|1|||
47049330|NCT01926509|83309628|FG001|Overall Study|vital sign met discontinuation criteria|0|||
46733301|NCT00802360|82950006|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
46733302|NCT00802360|82950003|FG000|Overall Study|Other|2|||
46733303|NCT00802360|82950004|FG001|Overall Study|Other|3|||
46733304|NCT00802360|82950005|FG002|Overall Study|Other|6|||
46921496|NCT04035200|83154067|FG000|Overall Study|Lost to Follow-up|0|||
46921497|NCT04035200|83154068|FG001|Overall Study|Lost to Follow-up|1|||
46921498|NCT04035200|83154069|FG002|Overall Study|Lost to Follow-up|0|||
46921499|NCT04035200|83154067|FG000|Overall Study|Withdrawal by Subject|1|||
46921500|NCT04035200|83154068|FG001|Overall Study|Withdrawal by Subject|4|||
46921501|NCT04035200|83154069|FG002|Overall Study|Withdrawal by Subject|4|||
46921502|NCT04035200|83154067|FG000|Overall Study|COVID-19|1|||
46921503|NCT04035200|83154068|FG001|Overall Study|COVID-19|0|||
46921504|NCT04035200|83154069|FG002|Overall Study|COVID-19|0|||
46921505|NCT04035200|83154067|FG000|Overall Study|Early Termination|0|||
46921506|NCT04035200|83154068|FG001|Overall Study|Early Termination|1|||
46921507|NCT04035200|83154069|FG002|Overall Study|Early Termination|0|||
46921508|NCT04035200|83154067|FG000|Overall Study|Non-compliance|0|||
47049331|NCT01926509|83309629|FG002|Overall Study|vital sign met discontinuation criteria|0|||
46733305|NCT00802360|82950006|FG003|Overall Study|Other|3|||
46921509|NCT04035200|83154068|FG001|Overall Study|Non-compliance|1|||
46733306|NCT01026038|82950021|FG000|Overall Study|Lost to Follow-up|1|||
46733307|NCT01026038|82950022|FG001|Overall Study|Lost to Follow-up|1|||
46733308|NCT01026038|82950023|FG002|Overall Study|Lost to Follow-up|0|||
46733309|NCT00801892|82950042|FG000|Main Study Period|Withdrawal by Subject|0|||
46733310|NCT00801892|82950043|FG001|Main Study Period|Withdrawal by Subject|1|||
46733311|NCT00801892|82950042|FG000|Sham Crossover Period|Lost to Follow-up|0|||
46733312|NCT00801892|82950043|FG001|Sham Crossover Period|Lost to Follow-up|2|||
46921510|NCT04035200|83154069|FG002|Overall Study|Non-compliance|0|||
46921511|NCT03197870|83154080|FG000|Overall Study|Adverse Event|9|||
46733313|NCT02680587|82950057|FG000|Overall Study|Withdrawal by Subject|1|||
46733314|NCT02680587|82950058|FG001|Overall Study|Withdrawal by Subject|0|||
46733315|NCT00589420|82950068|FG000|Overall Study|screen failure|1|||
46733316|NCT01025336|82950077|FG000|Overall Study|Protocol Violation|0|||
46733317|NCT01025336|82950078|FG001|Overall Study|Protocol Violation|0|||
46733318|NCT01025336|82950079|FG002|Overall Study|Protocol Violation|0|||
46733319|NCT01025336|82950080|FG003|Overall Study|Protocol Violation|2|||
46733320|NCT01025336|82950081|FG004|Overall Study|Protocol Violation|0|||
46733321|NCT00796978|82950115|FG000|Overall Study|Cardiac adverse event|5|||
46733322|NCT00796978|82950115|FG000|Overall Study|Adverse Event|4|||
46733323|NCT00796978|82950115|FG000|Overall Study|Withdrawal by Subject|3|||
46733324|NCT00796822|82950121|FG000|Overall Study|Lost to Follow-up|2|||
46733325|NCT00796822|82950122|FG001|Overall Study|Lost to Follow-up|0|||
46733326|NCT00796822|82950121|FG000|Overall Study|Adverse Event|1|||
46733327|NCT00796822|82950122|FG001|Overall Study|Adverse Event|0|||
46733328|NCT01020812|82950128|FG000|Overall Study|Physician Decision|1|||
46733329|NCT01020812|82950128|FG000|Overall Study|Withdrawal by Subject|1|||
46733330|NCT01020812|82950128|FG000|Overall Study|Protocol Violation|1|||
46733331|NCT01032044|82950134|FG000|Overall Study|Protocol Violation|14|||
46733332|NCT01032044|82950135|FG001|Overall Study|Protocol Violation|8|||
46733333|NCT01032044|82950134|FG000|Overall Study|Adverse Event|0|||
46733334|NCT01032044|82950135|FG001|Overall Study|Adverse Event|1|||
46733335|NCT01032044|82950134|FG000|Overall Study|Lost to Follow-up|11|||
46733336|NCT01032044|82950135|FG001|Overall Study|Lost to Follow-up|11|||
46733337|NCT01024946|82950141|FG000|Overall Study|Screen Failure|3|||
46733338|NCT01024946|82950141|FG000|Overall Study|Withdrawal by Subject|1|||
46733339|NCT01024946|82950141|FG000|Overall Study|Adverse Event|1|||
46733340|NCT00724867|82950145|FG000|Overall Study|Adverse Event|25|||
46733341|NCT00724867|82950145|FG000|Overall Study|Lack of Efficacy|14|||
46733342|NCT00724867|82950145|FG000|Overall Study|Lost to Follow-up|12|||
46733343|NCT00724867|82950145|FG000|Overall Study|Non-compliance with study drug|6|||
46733344|NCT00724867|82950145|FG000|Overall Study|Physician Decision|17|||
46733345|NCT00724867|82950145|FG000|Overall Study|Protocol Violation|1|||
46733346|NCT00724867|82950145|FG000|Overall Study|Withdrawal by Subject|31|||
46733347|NCT00724867|82950145|FG000|Overall Study|Sponsor decision to end study|14|||
46733348|NCT00724867|82950145|FG000|Overall Study|Subject incarcerated|1|||
46733349|NCT00724867|82950145|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
46733350|NCT00724867|82950145|FG000|Overall Study|Subject moved out of state|1|||
46733351|NCT00724867|82950145|FG000|Overall Study|Elected to exit due to site closure|2|||
46733352|NCT00724711|82950154|FG000|Overall Study|Adverse Event|7|||
46733353|NCT00724711|82950155|FG001|Overall Study|Adverse Event|3|||
46733354|NCT00724711|82950154|FG000|Overall Study|Pregnancy|0|||
46733355|NCT00724711|82950155|FG001|Overall Study|Pregnancy|1|||
46733356|NCT00724711|82950154|FG000|Overall Study|Lack of Efficacy|0|||
46733357|NCT00724711|82950155|FG001|Overall Study|Lack of Efficacy|1|||
46733358|NCT00724711|82950154|FG000|Overall Study|Physician Decision|0|||
46733359|NCT00724711|82950155|FG001|Overall Study|Physician Decision|3|||
46733360|NCT00724711|82950154|FG000|Overall Study|Withdrawal by Subject|5|||
46733361|NCT00724711|82950155|FG001|Overall Study|Withdrawal by Subject|4|||
46733362|NCT00724711|82950154|FG000|Overall Study|Lost to Follow-up|4|||
46733363|NCT00724711|82950155|FG001|Overall Study|Lost to Follow-up|5|||
46733364|NCT00724711|82950154|FG000|Overall Study|Protocol Violation|1|||
46733365|NCT00724711|82950155|FG001|Overall Study|Protocol Violation|0|||
46733366|NCT01024244|82950166|FG000|Overall Study|Adverse Event|1|||
46733367|NCT01024244|82950167|FG001|Overall Study|Adverse Event|2|||
46733368|NCT01024244|82950168|FG002|Overall Study|Adverse Event|0|||
46733369|NCT01024244|82950169|FG003|Overall Study|Adverse Event|1|||
47049332|NCT01926509|83309630|FG003|Overall Study|vital sign met discontinuation criteria|0|||
46733370|NCT01024244|82950170|FG004|Overall Study|Adverse Event|2|||
46733371|NCT01024244|82950166|FG000|Overall Study|Entry Criteria Not Met|0|||
47049333|NCT01926119|83309640|FG000|Overall Study|Withdrawal by Subject|1|||
46733372|NCT01024244|82950167|FG001|Overall Study|Entry Criteria Not Met|1|||
46803951|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
46921512|NCT03197870|83154081|FG001|Overall Study|Adverse Event|4|||
47049334|NCT01912781|83309646|FG000|Overall Study|Withdrawal by Subject|2|||
47049335|NCT01912781|83309647|FG001|Overall Study|Withdrawal by Subject|0|||
46733373|NCT01024244|82950168|FG002|Overall Study|Entry Criteria Not Met|0|||
46733374|NCT01024244|82950169|FG003|Overall Study|Entry Criteria Not Met|0|||
46733375|NCT01024244|82950170|FG004|Overall Study|Entry Criteria Not Met|0|||
46733376|NCT01024244|82950166|FG000|Overall Study|Lack of Efficacy|1|||
46733377|NCT01024244|82950167|FG001|Overall Study|Lack of Efficacy|0|||
46733378|NCT01024244|82950168|FG002|Overall Study|Lack of Efficacy|0|||
46733379|NCT01024244|82950169|FG003|Overall Study|Lack of Efficacy|0|||
46733380|NCT01024244|82950170|FG004|Overall Study|Lack of Efficacy|0|||
46733381|NCT01024244|82950166|FG000|Overall Study|Protocol Violation|1|||
46803952|NCT03903822|83023206|FG000|Treatment Phase (6 Weeks)|Other|2|||
46733382|NCT01024244|82950167|FG001|Overall Study|Protocol Violation|0|||
46733383|NCT01024244|82950168|FG002|Overall Study|Protocol Violation|0|||
46733384|NCT01024244|82950169|FG003|Overall Study|Protocol Violation|0|||
46733385|NCT01024244|82950170|FG004|Overall Study|Protocol Violation|2|||
46733386|NCT01024244|82950166|FG000|Overall Study|Sponsor Decision|14|||
46733387|NCT01024244|82950167|FG001|Overall Study|Sponsor Decision|7|||
46733388|NCT01024244|82950168|FG002|Overall Study|Sponsor Decision|14|||
46733389|NCT01024244|82950169|FG003|Overall Study|Sponsor Decision|12|||
46733390|NCT01024244|82950170|FG004|Overall Study|Sponsor Decision|10|||
46733391|NCT01024244|82950166|FG000|Overall Study|Withdrawal by Subject|0|||
46733392|NCT01024244|82950167|FG001|Overall Study|Withdrawal by Subject|1|||
46733393|NCT01024244|82950168|FG002|Overall Study|Withdrawal by Subject|0|||
46733394|NCT01024244|82950169|FG003|Overall Study|Withdrawal by Subject|0|||
46733395|NCT01024244|82950170|FG004|Overall Study|Withdrawal by Subject|0|||
46733396|NCT00721279|82950184|FG000|Overall Study|Lack of Efficacy|6|||
46733397|NCT00721279|82950185|FG001|Overall Study|Lack of Efficacy|3|||
46733398|NCT00721279|82950184|FG000|Overall Study|Tolerability insufficient|5|||
46733399|NCT00721279|82950185|FG001|Overall Study|Tolerability insufficient|2|||
46733400|NCT00721279|82950184|FG000|Overall Study|Withdrawal by Subject|13|||
46733401|NCT00721279|82950185|FG001|Overall Study|Withdrawal by Subject|3|||
46733402|NCT00721279|82950184|FG000|Overall Study|Other|12|||
46733403|NCT00721279|82950185|FG001|Overall Study|Other|16|||
46733404|NCT01030952|82950194|FG000|Overall Study|Protocol Violation|0|||
46733405|NCT01030952|82950195|FG001|Overall Study|Protocol Violation|1|||
46733406|NCT01030952|82950194|FG000|Overall Study|Informed consent withdrawal|1|||
46733407|NCT01030952|82950195|FG001|Overall Study|Informed consent withdrawal|0|||
46733408|NCT01030952|82950194|FG000|Overall Study|Lost to Follow-up|0|||
46733409|NCT01030952|82950195|FG001|Overall Study|Lost to Follow-up|1|||
46733410|NCT01030952|82950194|FG000|Overall Study|Unexplained|1|||
46733411|NCT01030952|82950195|FG001|Overall Study|Unexplained|1|||
46733412|NCT01030874|82950205|FG000|Overall Study|Withdrawal by Subject|1|||
46733413|NCT01030874|82950206|FG001|Overall Study|Withdrawal by Subject|0|||
46733414|NCT01030874|82950205|FG000|Overall Study|Discharged in first 2 weeks|17|||
46733415|NCT01030874|82950206|FG001|Overall Study|Discharged in first 2 weeks|16|||
46733416|NCT03611751|82950215|FG000|Pre-treatment|Randomized but not treated|1|||
46733417|NCT03611751|82950216|FG001|Pre-treatment|Randomized but not treated|1|||
46733418|NCT03611751|82950217|FG002|Pre-treatment|Randomized but not treated|0|||
46733419|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
46733420|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
46733421|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
46733422|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
46733423|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
46733424|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
46733425|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
46733426|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
46733427|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
46733428|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
46733429|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
46733430|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
46733431|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
46733432|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
46733433|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
46733434|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
46733435|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
46733436|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
46733437|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
46733438|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
46733439|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
46733440|NCT03611751|82950215|FG000|Treatment Week 0 - Week 16|Death|0|||
46733441|NCT03611751|82950216|FG001|Treatment Week 0 - Week 16|Death|0|||
46733442|NCT03611751|82950217|FG002|Treatment Week 0 - Week 16|Death|1|||
46733443|NCT03611751|82950215|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
47049336|NCT01925417|83309654|FG000|Overall Study|Withdrawal by Subject|2|||
46733444|NCT03611751|82950216|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
46733445|NCT03611751|82950217|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
46733446|NCT03611751|82950215|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
46733447|NCT03611751|82950216|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
46733448|NCT03611751|82950217|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
47049337|NCT01925417|83309654|FG000|Overall Study|Death|1|||
47049338|NCT01911845|83309659|FG000|Overall Study|Adverse Event|2|||
47049339|NCT01911845|83309659|FG000|Overall Study|Lost to Follow-up|1|||
46733449|NCT03611751|82950215|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
46733450|NCT03611751|82950216|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
46733451|NCT03611751|82950217|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
46733452|NCT03611751|82950215|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
46733453|NCT03611751|82950216|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
46733454|NCT03611751|82950217|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
46733455|NCT03611751|82950215|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
46733456|NCT03611751|82950216|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
46733457|NCT03611751|82950217|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
46733458|NCT03611751|82950215|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
46733459|NCT03611751|82950216|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
46733460|NCT03611751|82950217|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
46733461|NCT03611751|82950215|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
46733462|NCT03611751|82950216|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
46733463|NCT03611751|82950217|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
46733464|NCT03611751|82950215|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
46733465|NCT03611751|82950216|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
46733466|NCT03611751|82950217|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
46733467|NCT03611751|82950215|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
46733468|NCT03611751|82950216|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
46733469|NCT03611751|82950217|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
46733470|NCT03611751|82950215|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
46733471|NCT03611751|82950216|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
46733472|NCT03611751|82950217|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
46733473|NCT03611751|82950215|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
46733474|NCT03611751|82950216|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
46733475|NCT03611751|82950217|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
46921513|NCT03197870|83154082|FG002|Overall Study|Adverse Event|6|||
46921514|NCT03197870|83154080|FG000|Overall Study|Withdrawal by Subject|2|||
46921515|NCT03197870|83154081|FG001|Overall Study|Withdrawal by Subject|3|||
46921516|NCT03197870|83154082|FG002|Overall Study|Withdrawal by Subject|0|||
46921517|NCT03197870|83154080|FG000|Overall Study|Lost to Follow-up|2|||
46921518|NCT03197870|83154081|FG001|Overall Study|Lost to Follow-up|2|||
46921519|NCT03197870|83154082|FG002|Overall Study|Lost to Follow-up|0|||
46921520|NCT03197870|83154080|FG000|Overall Study|data not available|1|||
46921521|NCT03197870|83154081|FG001|Overall Study|data not available|1|||
46921522|NCT03197870|83154082|FG002|Overall Study|data not available|0|||
46921523|NCT04889222|83154093|FG000|Overall Study|Did not meet eligibility criteria|8|||
46921524|NCT04889222|83154093|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
46921525|NCT04889222|83154093|FG000|Overall Study|Did not proceed due to time constraints|5|||
46921526|NCT03067441|83154125|FG000|Overall Study|Withdrawal by Subject|16|||
46921527|NCT03067441|83154126|FG001|Overall Study|Withdrawal by Subject|34|||
46921528|NCT03067441|83154125|FG000|Overall Study|Lost to Follow-up|7|||
46921529|NCT03067441|83154126|FG001|Overall Study|Lost to Follow-up|5|||
46921530|NCT03067441|83154125|FG000|Overall Study|Adverse Event|7|||
46921531|NCT03067441|83154126|FG001|Overall Study|Adverse Event|14|||
46921532|NCT03067441|83154125|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
46921533|NCT03067441|83154126|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
47049340|NCT01911845|83309659|FG000|Overall Study|Other (not specified)|3|||
47049341|NCT01925183|83309667|FG000|Overall Study|Adverse Event|1|||
47049342|NCT01925183|83309668|FG001|Overall Study|Adverse Event|0|||
47049343|NCT01910519|83309676|FG000|Overall Study|Withdrawal by Subject|2|||
47049344|NCT01910519|83309677|FG001|Overall Study|Withdrawal by Subject|0|||
47049345|NCT01910519|83309676|FG000|Overall Study|Adverse Event|2|||
46733476|NCT03611751|82950215|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
46733477|NCT03611751|82950216|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
46733478|NCT03611751|82950217|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
47049346|NCT01910519|83309677|FG001|Overall Study|Adverse Event|0|||
46733479|NCT03611751|82950215|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
46733480|NCT03611751|82950216|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
46733481|NCT03611751|82950217|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
46733482|NCT03611751|82950215|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
46733483|NCT03611751|82950216|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
46733484|NCT03611751|82950217|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
46733485|NCT00721123|82950234|FG000|Overall Study|Adverse Event|96|||
46733486|NCT00721123|82950234|FG000|Overall Study|Death|10|||
46733487|NCT00721123|82950234|FG000|Overall Study|Insufficient Therapeutic Response|21|||
46733488|NCT00721123|82950234|FG000|Overall Study|Protocol Violation|1|||
46733489|NCT00721123|82950234|FG000|Overall Study|Refused Treatment|41|||
46733490|NCT00721123|82950234|FG000|Overall Study|Failure to Return|9|||
46733491|NCT00721123|82950234|FG000|Overall Study|Withdrawal by Subject|5|||
46921534|NCT03067441|83154125|FG000|Overall Study|Physician Decision|1|||
46921535|NCT03067441|83154126|FG001|Overall Study|Physician Decision|3|||
46921536|NCT03067441|83154125|FG000|Overall Study|Other|1|||
46921537|NCT03067441|83154126|FG001|Overall Study|Other|1|||
47049347|NCT01910441|83309685|FG000|Overall Study|Sponsor decision|0|||
47049348|NCT01910441|83309686|FG001|Overall Study|Sponsor decision|2|||
47049349|NCT01910441|83309685|FG000|Overall Study|Lost to Follow-up|6|||
46733492|NCT00720499|82950254|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
46733493|NCT00720499|82950255|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
46733494|NCT00720499|82950254|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
46921538|NCT02600923|83154135|FG000|Overall Study|Death|10|||
47049350|NCT01910441|83309686|FG001|Overall Study|Lost to Follow-up|5|||
47049351|NCT01910441|83309685|FG000|Overall Study|Withdrawal by Subject|0|||
47049352|NCT01910441|83309686|FG001|Overall Study|Withdrawal by Subject|1|||
47049353|NCT01910441|83309685|FG000|Overall Study|Non-compliance|0|||
47049354|NCT01910441|83309686|FG001|Overall Study|Non-compliance|1|||
47049355|NCT01910441|83309685|FG000|Overall Study|Adverse Event|1|||
47049356|NCT01910441|83309686|FG001|Overall Study|Adverse Event|0|||
47049357|NCT01910441|83309685|FG000|Overall Study|Physician Decision|0|||
47049358|NCT01910441|83309686|FG001|Overall Study|Physician Decision|1|||
47049359|NCT01923467|83309692|FG000|Overall Study|Lost to Follow-up|62|||
47049360|NCT01923467|83309692|FG000|Overall Study|Subject non-interest|479|||
47049361|NCT01910129|83309698|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
47049362|NCT01910129|83309699|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
47049363|NCT01910129|83309700|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
47049364|NCT01910129|83309698|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
47049365|NCT01910129|83309699|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
46733495|NCT00720499|82950255|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
46733496|NCT00720499|82950254|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
46733497|NCT00720499|82950255|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
46733498|NCT00724243|82950262|FG000|Overall Study|Lack of Efficacy|10|||
46733499|NCT00724243|82950262|FG000|Overall Study|Adverse Event|5|||
46733500|NCT00720343|82950266|FG000|Overall Study|Physician Decision|3|||
46733501|NCT00720343|82950266|FG000|Overall Study|No data|3|||
46733502|NCT00720109|82950272|FG000|Induction Period|Did not meet eligibility criteria|3|||
46733503|NCT00720109|82950273|FG001|Induction Period|Did not meet eligibility criteria|0|||
46733504|NCT00720109|82950274|FG002|Induction Period|Did not meet eligibility criteria|0|||
46733505|NCT00720109|82950272|FG000|Induction Period|Bone Marrow Transplant|2|||
46733506|NCT00720109|82950273|FG001|Induction Period|Bone Marrow Transplant|0|||
46733507|NCT00720109|82950274|FG002|Induction Period|Bone Marrow Transplant|0|||
46733508|NCT00720109|82950272|FG000|Induction Period|Physician Decision|1|||
46733509|NCT00720109|82950273|FG001|Induction Period|Physician Decision|0|||
46733510|NCT00720109|82950274|FG002|Induction Period|Physician Decision|0|||
46733511|NCT00720109|82950272|FG000|Risk Stratification Period|Adverse Event|0|||
46733512|NCT00720109|82950273|FG001|Risk Stratification Period|Adverse Event|1|||
46733513|NCT00720109|82950274|FG002|Risk Stratification Period|Adverse Event|0|||
46733514|NCT00720109|82950272|FG000|Risk Stratification Period|Physician Decision|0|||
46733515|NCT00720109|82950273|FG001|Risk Stratification Period|Physician Decision|2|||
47049366|NCT01910129|83309700|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
47049367|NCT01909973|83309720|FG000|Overall Study|Lost to Follow-up|1|||
47049368|NCT01909973|83309721|FG001|Overall Study|Lost to Follow-up|0|||
47049369|NCT01617005|83309727|FG000|Overall Study|Pregnancy|1|||
47049370|NCT01617005|83309727|FG000|Overall Study|Lack of motivation for treatment|1|||
47049371|NCT01925339|83309733|FG000|Overall Study|Adverse Event|2|||
47049372|NCT01925339|83309734|FG001|Overall Study|Adverse Event|0|||
47049373|NCT01908803|83309742|FG000|Overall Study|Adverse Event|1|||
47049374|NCT01908803|83309743|FG001|Overall Study|Adverse Event|0|||
47049375|NCT01908803|83309742|FG000|Overall Study|Physician Decision|0|||
47049376|NCT01908803|83309743|FG001|Overall Study|Physician Decision|1|||
47049377|NCT01908803|83309742|FG000|Overall Study|Withdrawal by Subject|1|||
47049378|NCT01908803|83309743|FG001|Overall Study|Withdrawal by Subject|0|||
47049379|NCT01908803|83309742|FG000|Overall Study|Randomization Error|1|||
47049380|NCT01908803|83309743|FG001|Overall Study|Randomization Error|0|||
47049381|NCT01908803|83309742|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
47049382|NCT01908803|83309743|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
47049383|NCT01908101|83309750|FG000|Overall Study|Physician Decision|1|||
47049384|NCT01908101|83309750|FG000|Overall Study|Withdrawal by Subject|1|||
47049385|NCT01908101|83309750|FG000|Overall Study|Incorrect Diagnosis|2|||
47049386|NCT01908101|83309750|FG000|Overall Study|Incorrect Starting Dose|1|||
47049387|NCT01908101|83309750|FG000|Overall Study|Did not complete the first cycle|4|||
47049388|NCT01923389|83309756|FG000|Overall Study|Protocol Violation|1|||
47049389|NCT01923389|83309757|FG001|Overall Study|Protocol Violation|0|||
46733516|NCT00720109|82950274|FG002|Risk Stratification Period|Physician Decision|1|||
46733517|NCT00720109|82950272|FG000|Risk Stratification Period|Bone marrow transplant|0|||
46733518|NCT00720109|82950273|FG001|Risk Stratification Period|Bone marrow transplant|9|||
47049390|NCT01907087|83309764|FG000|Overall Study|Withdrawal by Subject|1|||
47049391|NCT01616771|83309768|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
47049392|NCT01589185|83309782|FG000|Overall Study|Death|1|||
47049393|NCT01589185|83309783|FG001|Overall Study|Death|2|||
47049394|NCT01589185|83309784|FG002|Overall Study|Death|2|||
47049395|NCT01589185|83309785|FG003|Overall Study|Death|0|||
47049396|NCT01589185|83309786|FG004|Overall Study|Death|1|||
47049397|NCT01589185|83309782|FG000|Overall Study|Lost to Follow-up|1|||
46733519|NCT00720109|82950274|FG002|Risk Stratification Period|Bone marrow transplant|7|||
46733520|NCT00720109|82950272|FG000|Risk Stratification Period|Disease progression or relapse|0|||
46733521|NCT00720109|82950273|FG001|Risk Stratification Period|Disease progression or relapse|2|||
46733522|NCT00720109|82950274|FG002|Risk Stratification Period|Disease progression or relapse|0|||
46733523|NCT00720109|82950272|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
46733524|NCT00720109|82950273|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
46733525|NCT00720109|82950274|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
46733526|NCT01015118|82950285|FG000|Overall Study|Protocol Violation|5|||
46733527|NCT01015118|82950286|FG001|Overall Study|Protocol Violation|6|||
46733528|NCT01015118|82950285|FG000|Overall Study|Withdrawal by Subject|103|||
46733529|NCT01015118|82950286|FG001|Overall Study|Withdrawal by Subject|27|||
46733530|NCT01015118|82950285|FG000|Overall Study|Other Adverse Event (AE)|141|||
46733531|NCT01015118|82950286|FG001|Overall Study|Other Adverse Event (AE)|33|||
46733532|NCT01015118|82950285|FG000|Overall Study|Worsening or AE of underlying disease|5|||
46733533|NCT01015118|82950286|FG001|Overall Study|Worsening or AE of underlying disease|4|||
46733534|NCT01015118|82950285|FG000|Overall Study|Progressive disease|364|||
46733535|NCT01015118|82950286|FG001|Overall Study|Progressive disease|229|||
46733536|NCT01015118|82950285|FG000|Overall Study|Not treated|9|||
46733537|NCT01015118|82950286|FG001|Overall Study|Not treated|5|||
46733538|NCT01015118|82950285|FG000|Overall Study|Other than stated above|42|||
46733539|NCT01015118|82950286|FG001|Overall Study|Other than stated above|23|||
46733540|NCT00800176|82950298|FG000|Overall Study|Adverse Event|2|||
46733541|NCT00800176|82950299|FG001|Overall Study|Adverse Event|1|||
46733542|NCT00800176|82950300|FG002|Overall Study|Adverse Event|0|||
46733543|NCT00800176|82950301|FG003|Overall Study|Adverse Event|2|||
46733544|NCT00800176|82950302|FG004|Overall Study|Adverse Event|1|||
46733545|NCT00800176|82950303|FG005|Overall Study|Adverse Event|1|||
46733546|NCT00800176|82950298|FG000|Overall Study|Refused treatment|3|||
46733547|NCT00800176|82950299|FG001|Overall Study|Refused treatment|2|||
46733548|NCT00800176|82950300|FG002|Overall Study|Refused treatment|0|||
46733549|NCT00800176|82950301|FG003|Overall Study|Refused treatment|0|||
46733550|NCT00800176|82950302|FG004|Overall Study|Refused treatment|1|||
46733551|NCT00800176|82950303|FG005|Overall Study|Refused treatment|4|||
46733552|NCT00800176|82950298|FG000|Overall Study|Failure to return|3|||
46733553|NCT00800176|82950299|FG001|Overall Study|Failure to return|3|||
46733554|NCT00800176|82950300|FG002|Overall Study|Failure to return|0|||
46733555|NCT00800176|82950301|FG003|Overall Study|Failure to return|2|||
47049398|NCT01589185|83309783|FG001|Overall Study|Lost to Follow-up|0|||
47049399|NCT01589185|83309784|FG002|Overall Study|Lost to Follow-up|2|||
47049400|NCT01589185|83309785|FG003|Overall Study|Lost to Follow-up|3|||
47049401|NCT01589185|83309786|FG004|Overall Study|Lost to Follow-up|0|||
47049402|NCT01588951|83309802|FG000|Overall Study|Ineligible in retrospect|0|||
47049403|NCT01588951|83309803|FG001|Overall Study|Ineligible in retrospect|0|||
46733556|NCT00800176|82950302|FG004|Overall Study|Failure to return|0|||
46733557|NCT00800176|82950303|FG005|Overall Study|Failure to return|0|||
46733558|NCT00800176|82950298|FG000|Overall Study|Other|1|||
46733559|NCT00800176|82950299|FG001|Overall Study|Other|0|||
46733560|NCT00800176|82950300|FG002|Overall Study|Other|0|||
46733561|NCT00800176|82950301|FG003|Overall Study|Other|0|||
46733562|NCT00800176|82950302|FG004|Overall Study|Other|2|||
46733563|NCT00800176|82950303|FG005|Overall Study|Other|0|||
46733564|NCT00715429|82950319|FG000|Overall Study|Did not complete the study diary|0|||
46733565|NCT00715429|82950320|FG001|Overall Study|Did not complete the study diary|1|||
46733566|NCT00715117|82950342|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
46733567|NCT00715117|82950343|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
46733568|NCT00723229|82950356|FG000|First Intervention|Lost to Follow-up|7|||
46733569|NCT00723229|82950357|FG001|First Intervention|Lost to Follow-up|3|||
46733570|NCT01030718|82950372|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
46733571|NCT01030718|82950373|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
46733572|NCT01030718|82950374|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
46733573|NCT01030718|82950372|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
46733574|NCT01030718|82950373|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
46733575|NCT01030718|82950374|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
47049404|NCT01588951|83309804|FG002|Overall Study|Ineligible in retrospect|1|||
47049405|NCT01709383|83309814|FG000|Overall Study|Lost to Follow-up|1|||
46733576|NCT01030718|82950372|FG000|Studies CA180-031 and -036 Combined|Death|0|||
46733577|NCT01030718|82950373|FG001|Studies CA180-031 and -036 Combined|Death|1|||
47049406|NCT01709383|83309815|FG001|Overall Study|Lost to Follow-up|0|||
46733578|NCT01030718|82950374|FG002|Studies CA180-031 and -036 Combined|Death|0|||
46733579|NCT01030718|82950372|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
46733580|NCT01030718|82950373|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
46733581|NCT01030718|82950374|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
46733582|NCT01030718|82950372|FG000|Study CA180-036 Only|insufficient effect|1|||
46733583|NCT01030718|82950373|FG001|Study CA180-036 Only|insufficient effect|1|||
46733584|NCT01030718|82950374|FG002|Study CA180-036 Only|insufficient effect|5|||
46733585|NCT01030718|82950372|FG000|Study CA180-036 Only|Adverse Event|2|||
46733586|NCT01030718|82950373|FG001|Study CA180-036 Only|Adverse Event|3|||
46733587|NCT01030718|82950374|FG002|Study CA180-036 Only|Adverse Event|0|||
47049407|NCT01588405|83309823|FG000|Overall Study|Adverse Event|1|||
46733588|NCT01030718|82950372|FG000|Study CA180-036 Only|Death|0|||
46733589|NCT01030718|82950373|FG001|Study CA180-036 Only|Death|1|||
46733590|NCT01030718|82950374|FG002|Study CA180-036 Only|Death|0|||
46733591|NCT01030718|82950372|FG000|Study CA180-036 Only|Other Reasons|0|||
46733592|NCT01030718|82950373|FG001|Study CA180-036 Only|Other Reasons|2|||
46733593|NCT01030718|82950374|FG002|Study CA180-036 Only|Other Reasons|0|||
46733594|NCT00722761|82950394|FG000|Overall Study|Lost to Follow-up|1|||
46733595|NCT00722761|82950395|FG001|Overall Study|Lost to Follow-up|4|||
46733596|NCT00722761|82950394|FG000|Overall Study|Withdrawal by Subject|5|||
46733597|NCT00722761|82950395|FG001|Overall Study|Withdrawal by Subject|2|||
46733598|NCT00719953|82950401|FG000|Overall Study|Adverse Event|4|||
46733599|NCT01019486|82950408|FG000|Overall Study|Withdrawal by Subject|1|||
46733600|NCT01019486|82950409|FG001|Overall Study|Withdrawal by Subject|1|||
46733601|NCT01019486|82950410|FG002|Overall Study|Withdrawal by Subject|1|||
46733602|NCT02803203|82950419|FG000|Overall Study|Adverse Event|4|||
46733603|NCT02803203|82950419|FG000|Overall Study|Death|4|||
46733604|NCT02803203|82950419|FG000|Overall Study|Progressive disease|29|||
46733605|NCT02803203|82950419|FG000|Overall Study|Withdrawal by Subject|8|||
46733606|NCT02803203|82950419|FG000|Overall Study|Complete resection of target disease|2|||
46733607|NCT02803203|82950419|FG000|Overall Study|Switched to commercial Osi|1|||
46733608|NCT02803203|82950419|FG000|Overall Study|Participant moved away|1|||
46733609|NCT00714493|82950424|FG000|Overall Study|Adverse Event|11|||
46733610|NCT00714493|82950424|FG000|Overall Study|Death|3|||
46733611|NCT00714493|82950424|FG000|Overall Study|Lack of Efficacy|10|||
46733612|NCT00714493|82950424|FG000|Overall Study|Lost to Follow-up|3|||
46733613|NCT00714493|82950424|FG000|Overall Study|Protocol Violation|12|||
46733614|NCT00714493|82950424|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
46733615|NCT00714493|82950424|FG000|Overall Study|OTHER|2|||
46733616|NCT01019252|82950430|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
46733617|NCT01019252|82950431|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
46733618|NCT01019252|82950430|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
46733619|NCT01019252|82950431|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
46733620|NCT01019252|82950430|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
46733621|NCT01019252|82950431|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
46733622|NCT01019252|82950430|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
46733623|NCT01019252|82950431|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
46733624|NCT01013870|82950439|FG000|Overall Study|Lost to Follow-up|1|||
46733625|NCT01013870|82950440|FG001|Overall Study|Lost to Follow-up|3|||
46733626|NCT01013792|82950448|FG000|Overall Study|Study suspended|2|||
46733627|NCT01013792|82950449|FG001|Overall Study|Study suspended|1|||
46733628|NCT01013792|82950448|FG000|Overall Study|Adverse Event|0|||
46733629|NCT01013792|82950449|FG001|Overall Study|Adverse Event|3|||
46733630|NCT01013792|82950448|FG000|Overall Study|Lost to Follow-up|0|||
46733631|NCT01013792|82950449|FG001|Overall Study|Lost to Follow-up|1|||
46733632|NCT01018862|82950458|FG000|Overall Study|Adverse Event|2|||
46733633|NCT01018862|82950459|FG001|Overall Study|Adverse Event|0|||
46733634|NCT01018862|82950460|FG002|Overall Study|Adverse Event|6|||
46733635|NCT01018862|82950458|FG000|Overall Study|Lack of Efficacy|1|||
46733636|NCT01018862|82950459|FG001|Overall Study|Lack of Efficacy|0|||
46733637|NCT01018862|82950460|FG002|Overall Study|Lack of Efficacy|2|||
46733638|NCT01018862|82950458|FG000|Overall Study|Lost to Follow-up|3|||
46733639|NCT01018862|82950459|FG001|Overall Study|Lost to Follow-up|1|||
46733640|NCT01018862|82950460|FG002|Overall Study|Lost to Follow-up|0|||
46733641|NCT01018862|82950458|FG000|Overall Study|Protocol Violation|1|||
46733642|NCT01018862|82950459|FG001|Overall Study|Protocol Violation|3|||
46921539|NCT02600923|83154135|FG000|Overall Study|Adverse Event|3|||
46921540|NCT02600923|83154135|FG000|Overall Study|Global deterioration of health status|2|||
46921541|NCT02600923|83154135|FG000|Overall Study|Insufficient clinical response|6|||
46921542|NCT02600923|83154135|FG000|Overall Study|Lost to Follow-up|1|||
46921543|NCT02600923|83154135|FG000|Overall Study|Withdrawal by Subject|5|||
46733643|NCT01018862|82950460|FG002|Overall Study|Protocol Violation|3|||
46733644|NCT01018862|82950458|FG000|Overall Study|Withdrawal by Subject|1|||
46733645|NCT01018862|82950459|FG001|Overall Study|Withdrawal by Subject|2|||
46803953|NCT03903822|83023207|FG001|Treatment Phase (6 Weeks)|Other|1|||
46921544|NCT02600923|83154135|FG000|Overall Study|Objective progression or relapse|50|||
46733646|NCT01018862|82950460|FG002|Overall Study|Withdrawal by Subject|1|||
46733647|NCT01018862|82950458|FG000|Overall Study|administrative problems|5|||
46733648|NCT01018862|82950459|FG001|Overall Study|administrative problems|4|||
46733649|NCT01018862|82950460|FG002|Overall Study|administrative problems|4|||
46733650|NCT01018394|82950470|FG000|Overall Study|Withdrawal by Subject|5|||
46733651|NCT01018394|82950471|FG001|Overall Study|Withdrawal by Subject|5|||
46733652|NCT01018394|82950470|FG000|Overall Study|Lost to Follow-up|4|||
46733653|NCT01018394|82950471|FG001|Overall Study|Lost to Follow-up|3|||
46733654|NCT01017146|82950479|FG000|Overall Study|Adverse Event|11|||
46733655|NCT01017146|82950480|FG001|Overall Study|Adverse Event|1|||
46733656|NCT01017146|82950479|FG000|Overall Study|Lost to Follow-up|14|||
46733657|NCT01017146|82950480|FG001|Overall Study|Lost to Follow-up|14|||
46733658|NCT01017146|82950479|FG000|Overall Study|Noncompliance with Study Product|1|||
46733659|NCT01017146|82950480|FG001|Overall Study|Noncompliance with Study Product|1|||
46733660|NCT01017146|82950479|FG000|Overall Study|Withdrawal by Subject|32|||
46733661|NCT01017146|82950480|FG001|Overall Study|Withdrawal by Subject|16|||
46733662|NCT01017146|82950479|FG000|Overall Study|Relocation|0|||
46733663|NCT01017146|82950480|FG001|Overall Study|Relocation|4|||
46733664|NCT01017146|82950479|FG000|Overall Study|Pregnancy|2|||
46733665|NCT01017146|82950480|FG001|Overall Study|Pregnancy|1|||
46733666|NCT01017146|82950479|FG000|Overall Study|Protocol Violation|2|||
46733667|NCT01017146|82950480|FG001|Overall Study|Protocol Violation|0|||
46733668|NCT01017146|82950479|FG000|Overall Study|Took Excluded Medication|2|||
46733669|NCT01017146|82950480|FG001|Overall Study|Took Excluded Medication|0|||
46733670|NCT01017146|82950479|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
46733671|NCT01017146|82950480|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
46733672|NCT01017146|82950479|FG000|Overall Study|Change in Work Situation|1|||
46733673|NCT01017146|82950480|FG001|Overall Study|Change in Work Situation|0|||
46733674|NCT01010750|82950492|FG000|Second Intervention|Adverse Event|0|||
46733675|NCT01010750|82950493|FG001|Second Intervention|Adverse Event|1|||
46733676|NCT01010750|82950494|FG002|Second Intervention|Adverse Event|0|||
46733677|NCT01010750|82950495|FG003|Second Intervention|Adverse Event|0|||
46733678|NCT01010750|82950496|FG004|Second Intervention|Adverse Event|0|||
46733679|NCT01010750|82950497|FG005|Second Intervention|Adverse Event|0|||
46733680|NCT01012622|82950505|FG000|Overall Study|Withdrawal by Subject|6|||
47049408|NCT01588405|83309823|FG000|Overall Study|Clinical Worsening|1|||
47049409|NCT01923311|83309832|FG000|Overall Study|Pregnancy|1|||
47049410|NCT01923311|83309833|FG001|Overall Study|Pregnancy|0|||
47049411|NCT01923311|83309832|FG000|Overall Study|Investigator's Discretion|1|||
47049412|NCT01923311|83309833|FG001|Overall Study|Investigator's Discretion|0|||
47049413|NCT01923311|83309832|FG000|Overall Study|Non-Compliance with Study Drug|2|||
47049414|NCT01923311|83309833|FG001|Overall Study|Non-Compliance with Study Drug|1|||
47049415|NCT01923311|83309832|FG000|Overall Study|Withdrew Consent|1|||
47049416|NCT01923311|83309833|FG001|Overall Study|Withdrew Consent|0|||
47049417|NCT01923311|83309832|FG000|Overall Study|Study Terminated by Sponsor|12|||
47049418|NCT01923311|83309833|FG001|Overall Study|Study Terminated by Sponsor|0|||
46635186|NCT01684878|82808712|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
46733681|NCT01012622|82950505|FG000|Overall Study|Lost to Follow-up|5|||
46733682|NCT01012622|82950505|FG000|Overall Study|Adverse Event|7|||
46733683|NCT01012622|82950505|FG000|Overall Study|non-compliance with the drug|9|||
46733684|NCT01012622|82950505|FG000|Overall Study|Other|1|||
46733685|NCT01012622|82950505|FG000|Overall Study|screening failure|1|||
46733686|NCT01012622|82950505|FG000|Overall Study|withdrawal of consent by a parent|2|||
46733687|NCT00722371|82950516|FG000|Overall Study|Adverse Event|6|||
46733688|NCT00722371|82950517|FG001|Overall Study|Adverse Event|13|||
46733689|NCT00722371|82950518|FG002|Overall Study|Adverse Event|9|||
46733690|NCT00722371|82950519|FG003|Overall Study|Adverse Event|10|||
46733691|NCT00722371|82950520|FG004|Overall Study|Adverse Event|6|||
46733692|NCT00722371|82950521|FG005|Overall Study|Adverse Event|8|||
46733693|NCT00722371|82950522|FG006|Overall Study|Adverse Event|4|||
46733694|NCT00722371|82950516|FG000|Overall Study|Contraindication|0|||
46733695|NCT00722371|82950517|FG001|Overall Study|Contraindication|0|||
46733696|NCT00722371|82950518|FG002|Overall Study|Contraindication|1|||
46733697|NCT00722371|82950519|FG003|Overall Study|Contraindication|0|||
46733698|NCT00722371|82950520|FG004|Overall Study|Contraindication|0|||
46733699|NCT00722371|82950521|FG005|Overall Study|Contraindication|0|||
46733700|NCT00722371|82950522|FG006|Overall Study|Contraindication|0|||
46733701|NCT00722371|82950516|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
46733702|NCT00722371|82950517|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
46733703|NCT00722371|82950518|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
46635187|NCT01684878|82808713|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
46635188|NCT01684878|82808714|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
47049419|NCT01603615|83309840|FG000|Overall Study|Did not Receive Treatment|7|||
46733704|NCT00722371|82950519|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
46733705|NCT00722371|82950520|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
46733706|NCT00722371|82950521|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
46733707|NCT00722371|82950522|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
46733708|NCT00722371|82950516|FG000|Overall Study|Excluded medication|0|||
46733709|NCT00722371|82950517|FG001|Overall Study|Excluded medication|1|||
46733710|NCT00722371|82950518|FG002|Overall Study|Excluded medication|1|||
46733711|NCT00722371|82950519|FG003|Overall Study|Excluded medication|0|||
46733712|NCT00722371|82950520|FG004|Overall Study|Excluded medication|0|||
46733713|NCT00722371|82950521|FG005|Overall Study|Excluded medication|0|||
46803954|NCT03903822|83023208|FG002|Treatment Phase (6 Weeks)|Other|0|||
46733714|NCT00722371|82950522|FG006|Overall Study|Excluded medication|1|||
46733715|NCT00722371|82950516|FG000|Overall Study|Hyperglycemia|2|||
46733716|NCT00722371|82950517|FG001|Overall Study|Hyperglycemia|6|||
47049420|NCT01603615|83309840|FG000|Overall Study|Lost to Follow-up|9|||
47049421|NCT01603615|83309840|FG000|Overall Study|Personal Reasons|17|||
46733717|NCT00722371|82950518|FG002|Overall Study|Hyperglycemia|4|||
46733718|NCT00722371|82950519|FG003|Overall Study|Hyperglycemia|2|||
46733719|NCT00722371|82950520|FG004|Overall Study|Hyperglycemia|5|||
46733720|NCT00722371|82950521|FG005|Overall Study|Hyperglycemia|1|||
46733721|NCT00722371|82950522|FG006|Overall Study|Hyperglycemia|1|||
46733722|NCT00722371|82950516|FG000|Overall Study|Hypoglycemia|1|||
46733723|NCT00722371|82950517|FG001|Overall Study|Hypoglycemia|0|||
46733724|NCT00722371|82950518|FG002|Overall Study|Hypoglycemia|0|||
46733725|NCT00722371|82950519|FG003|Overall Study|Hypoglycemia|0|||
46733726|NCT00722371|82950520|FG004|Overall Study|Hypoglycemia|0|||
46733727|NCT00722371|82950521|FG005|Overall Study|Hypoglycemia|0|||
46733728|NCT00722371|82950522|FG006|Overall Study|Hypoglycemia|0|||
46733729|NCT00722371|82950516|FG000|Overall Study|Lack of Efficacy|4|||
46733730|NCT00722371|82950517|FG001|Overall Study|Lack of Efficacy|6|||
46733731|NCT00722371|82950518|FG002|Overall Study|Lack of Efficacy|6|||
46733732|NCT00722371|82950519|FG003|Overall Study|Lack of Efficacy|6|||
46733733|NCT00722371|82950520|FG004|Overall Study|Lack of Efficacy|2|||
46733734|NCT00722371|82950521|FG005|Overall Study|Lack of Efficacy|3|||
46733735|NCT00722371|82950522|FG006|Overall Study|Lack of Efficacy|0|||
46733736|NCT00722371|82950516|FG000|Overall Study|Lost to Follow-up|11|||
46733737|NCT00722371|82950517|FG001|Overall Study|Lost to Follow-up|14|||
46733738|NCT00722371|82950518|FG002|Overall Study|Lost to Follow-up|21|||
46733739|NCT00722371|82950519|FG003|Overall Study|Lost to Follow-up|13|||
46733740|NCT00722371|82950520|FG004|Overall Study|Lost to Follow-up|8|||
46733741|NCT00722371|82950521|FG005|Overall Study|Lost to Follow-up|16|||
46733742|NCT00722371|82950522|FG006|Overall Study|Lost to Follow-up|13|||
46733743|NCT00722371|82950516|FG000|Overall Study|Physician Decision|5|||
46733744|NCT00722371|82950517|FG001|Overall Study|Physician Decision|2|||
46733745|NCT00722371|82950518|FG002|Overall Study|Physician Decision|2|||
46733746|NCT00722371|82950519|FG003|Overall Study|Physician Decision|5|||
46733747|NCT00722371|82950520|FG004|Overall Study|Physician Decision|2|||
46733748|NCT00722371|82950521|FG005|Overall Study|Physician Decision|3|||
46733749|NCT00722371|82950522|FG006|Overall Study|Physician Decision|4|||
46733750|NCT00722371|82950516|FG000|Overall Study|Pregnancy|1|||
46733751|NCT00722371|82950517|FG001|Overall Study|Pregnancy|1|||
46733752|NCT00722371|82950518|FG002|Overall Study|Pregnancy|0|||
46733753|NCT00722371|82950519|FG003|Overall Study|Pregnancy|0|||
46733754|NCT00722371|82950520|FG004|Overall Study|Pregnancy|0|||
46733755|NCT00722371|82950521|FG005|Overall Study|Pregnancy|1|||
46733756|NCT00722371|82950522|FG006|Overall Study|Pregnancy|0|||
46733757|NCT00722371|82950516|FG000|Overall Study|Protocol Violation|6|||
46733758|NCT00722371|82950517|FG001|Overall Study|Protocol Violation|1|||
46733759|NCT00722371|82950518|FG002|Overall Study|Protocol Violation|0|||
46733760|NCT00722371|82950519|FG003|Overall Study|Protocol Violation|1|||
46733761|NCT00722371|82950520|FG004|Overall Study|Protocol Violation|4|||
46733762|NCT00722371|82950521|FG005|Overall Study|Protocol Violation|2|||
46733763|NCT00722371|82950522|FG006|Overall Study|Protocol Violation|1|||
46733764|NCT00722371|82950516|FG000|Overall Study|Withdrawal by Subject|18|||
46733765|NCT00722371|82950517|FG001|Overall Study|Withdrawal by Subject|27|||
46733766|NCT00722371|82950518|FG002|Overall Study|Withdrawal by Subject|19|||
46733767|NCT00722371|82950519|FG003|Overall Study|Withdrawal by Subject|23|||
46733768|NCT00722371|82950520|FG004|Overall Study|Withdrawal by Subject|19|||
46733769|NCT00722371|82950521|FG005|Overall Study|Withdrawal by Subject|18|||
46733770|NCT00722371|82950522|FG006|Overall Study|Withdrawal by Subject|26|||
46733771|NCT00722137|82950540|FG000|Overall Study|Overt Disease Progression|5|||
46733772|NCT00722137|82950541|FG001|Overall Study|Overt Disease Progression|4|||
46733773|NCT00722137|82950540|FG000|Overall Study|Adverse Event|17|||
46733774|NCT00722137|82950541|FG001|Overall Study|Adverse Event|21|||
46733775|NCT00722137|82950540|FG000|Overall Study|Death|12|||
46733776|NCT00722137|82950541|FG001|Overall Study|Death|7|||
46733777|NCT00722137|82950540|FG000|Overall Study|Withdrawal by Subject|6|||
46733778|NCT00722137|82950541|FG001|Overall Study|Withdrawal by Subject|9|||
46733779|NCT00722137|82950540|FG000|Overall Study|Other Reason Unknown|3|||
46733780|NCT00722137|82950541|FG001|Overall Study|Other Reason Unknown|4|||
46733781|NCT00722137|82950540|FG000|Overall Study|Randomized But Not Treated|2|||
46733782|NCT00722137|82950541|FG001|Overall Study|Randomized But Not Treated|3|||
46733783|NCT00796666|82950555|FG000|Overall Study|Death|2|||
46733784|NCT00796666|82950556|FG001|Overall Study|Death|4|||
46733785|NCT00796666|82950555|FG000|Overall Study|Withdrawal by Subject|2|||
46733786|NCT00796666|82950556|FG001|Overall Study|Withdrawal by Subject|0|||
46733787|NCT00796666|82950555|FG000|Overall Study|Adverse Event|7|||
46733788|NCT00796666|82950556|FG001|Overall Study|Adverse Event|5|||
46733789|NCT00796666|82950555|FG000|Overall Study|Protocol Violation|1|||
46733790|NCT00796666|82950556|FG001|Overall Study|Protocol Violation|0|||
46733791|NCT00796666|82950555|FG000|Overall Study|Other|1|||
46733792|NCT00796666|82950556|FG001|Overall Study|Other|0|||
46803955|NCT03903822|83023209|FG003|Treatment Phase (6 Weeks)|Other|0|||
46733793|NCT00796666|82950555|FG000|Overall Study|Terminated by sponsor|53|||
46733794|NCT00796666|82950556|FG001|Overall Study|Terminated by sponsor|55|||
46733795|NCT00796666|82950555|FG000|Overall Study|Randomized and not treated|1|||
46803956|NCT03903822|83023210|FG004|Treatment Phase (6 Weeks)|Other|1|||
46733796|NCT00796666|82950556|FG001|Overall Study|Randomized and not treated|0|||
46733797|NCT00799708|82950565|FG000|Overall Study|non-compliance|1|||
46733798|NCT00799708|82950566|FG001|Overall Study|non-compliance|0|||
46733799|NCT00799708|82950567|FG002|Overall Study|non-compliance|0|||
46733800|NCT00796510|82950579|FG000|Overall Study|Death|1|||
46733801|NCT00796510|82950580|FG001|Overall Study|Death|0|||
46733802|NCT00796510|82950579|FG000|Overall Study|Study Terminated|2|||
46733803|NCT00796510|82950580|FG001|Overall Study|Study Terminated|0|||
46733804|NCT00588640|82950586|FG000|Overall Study|Physician Decision|1|||
46733805|NCT00588640|82950586|FG000|Overall Study|Ineligible Patient|1|||
46733806|NCT01016912|82950595|FG000|End of Treatment Period|Lack of Efficacy|0|||
46733807|NCT01016912|82950596|FG001|End of Treatment Period|Lack of Efficacy|1|||
46733808|NCT01016912|82950597|FG002|End of Treatment Period|Lack of Efficacy|0|||
46733809|NCT01016912|82950598|FG003|End of Treatment Period|Lack of Efficacy|4|||
46733810|NCT01016912|82950599|FG004|End of Treatment Period|Lack of Efficacy|4|||
46733811|NCT01016912|82950595|FG000|End of Treatment Period|Adverse Event|0|||
46733812|NCT01016912|82950596|FG001|End of Treatment Period|Adverse Event|1|||
46733813|NCT01016912|82950597|FG002|End of Treatment Period|Adverse Event|1|||
46733814|NCT01016912|82950598|FG003|End of Treatment Period|Adverse Event|0|||
46733815|NCT01016912|82950599|FG004|End of Treatment Period|Adverse Event|0|||
46733816|NCT01016912|82950595|FG000|End of Treatment Period|Completed double-blind period only|0|||
46733817|NCT01016912|82950596|FG001|End of Treatment Period|Completed double-blind period only|1|||
46733818|NCT01016912|82950597|FG002|End of Treatment Period|Completed double-blind period only|0|||
46733819|NCT01016912|82950598|FG003|End of Treatment Period|Completed double-blind period only|0|||
46733820|NCT01016912|82950599|FG004|End of Treatment Period|Completed double-blind period only|0|||
46733821|NCT01016912|82950595|FG000|Follow-up Period|Other reason|0|||
46733822|NCT01016912|82950596|FG001|Follow-up Period|Other reason|0|||
46733823|NCT01016912|82950597|FG002|Follow-up Period|Other reason|1|||
46733824|NCT01016912|82950598|FG003|Follow-up Period|Other reason|1|||
46733825|NCT01016912|82950599|FG004|Follow-up Period|Other reason|0|||
46733826|NCT00802672|82950634|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
46733827|NCT00802672|82950635|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
46733828|NCT00802672|82950636|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
46733829|NCT00802672|82950634|FG000|Overall Study|Adverse Event|1|||
46733830|NCT00802672|82950635|FG001|Overall Study|Adverse Event|1|||
46733831|NCT00802672|82950636|FG002|Overall Study|Adverse Event|1|||
46733832|NCT00802672|82950634|FG000|Overall Study|Protocol Violation|2|||
46733833|NCT00802672|82950635|FG001|Overall Study|Protocol Violation|1|||
46733834|NCT00802672|82950636|FG002|Overall Study|Protocol Violation|1|||
46733835|NCT00802672|82950634|FG000|Overall Study|Lost to Follow-up|5|||
46733836|NCT00802672|82950635|FG001|Overall Study|Lost to Follow-up|5|||
46733837|NCT00802672|82950636|FG002|Overall Study|Lost to Follow-up|3|||
46733838|NCT00802672|82950634|FG000|Overall Study|Withdrawal by Subject|1|||
46733839|NCT00802672|82950635|FG001|Overall Study|Withdrawal by Subject|1|||
46733840|NCT00802672|82950636|FG002|Overall Study|Withdrawal by Subject|2|||
46733841|NCT00802672|82950634|FG000|Overall Study|other|3|||
46733842|NCT00802672|82950635|FG001|Overall Study|other|1|||
46733843|NCT00802672|82950636|FG002|Overall Study|other|2|||
46733844|NCT00714415|82950646|FG000|Overall Study|Lack of Efficacy|1|||
46733845|NCT00714415|82950647|FG001|Overall Study|Lack of Efficacy|0|||
46733846|NCT00714415|82950646|FG000|Overall Study|Death|1|||
46733847|NCT00714415|82950647|FG001|Overall Study|Death|0|||
46733848|NCT00714259|82950653|FG000|Overall Study|Death|2|||
46733849|NCT00796120|82950659|FG000|Overall Study|Death|3|||
46733850|NCT00796120|82950660|FG001|Overall Study|Death|0|||
46733851|NCT00796120|82950659|FG000|Overall Study|Adverse Event|11|||
46733852|NCT00796120|82950660|FG001|Overall Study|Adverse Event|6|||
46733853|NCT00796120|82950659|FG000|Overall Study|Progressive disease|22|||
46733854|NCT00796120|82950660|FG001|Overall Study|Progressive disease|13|||
46733855|NCT00796120|82950659|FG000|Overall Study|Participant refusal|3|||
46733856|NCT00796120|82950660|FG001|Overall Study|Participant refusal|4|||
46733857|NCT00796120|82950659|FG000|Overall Study|Other|6|||
46733858|NCT00796120|82950660|FG001|Overall Study|Other|17|||
46733859|NCT00796120|82950659|FG000|Overall Study|Physician Decision|16|||
46733860|NCT00796120|82950660|FG001|Overall Study|Physician Decision|17|||
46733861|NCT00796120|82950659|FG000|Overall Study|Randomized but not treated|0|||
46733862|NCT00796120|82950660|FG001|Overall Study|Randomized but not treated|3|||
46733863|NCT00795886|82950666|FG000|Overall Study|Death|10|||
46733864|NCT00719563|82950673|FG000|Overall Study|Adverse Event|16|||
46733865|NCT00719563|82950674|FG001|Overall Study|Adverse Event|13|||
46733866|NCT00719563|82950673|FG000|Overall Study|Medical condition changed|3|||
46733867|NCT00719563|82950674|FG001|Overall Study|Medical condition changed|5|||
46733868|NCT00719563|82950673|FG000|Overall Study|Lack of Efficacy|3|||
46733869|NCT00719563|82950674|FG001|Overall Study|Lack of Efficacy|7|||
46733870|NCT00719563|82950673|FG000|Overall Study|Personal reasons|6|||
46733871|NCT00719563|82950674|FG001|Overall Study|Personal reasons|7|||
46733872|NCT00719563|82950673|FG000|Overall Study|Unknown reasons|4|||
46733873|NCT00719563|82950674|FG001|Overall Study|Unknown reasons|6|||
46733874|NCT00719563|82950673|FG000|Overall Study|Noncompliant|1|||
46733875|NCT00719563|82950674|FG001|Overall Study|Noncompliant|1|||
46733876|NCT00719563|82950673|FG000|Overall Study|Lost to Follow-up|5|||
46733877|NCT00719563|82950674|FG001|Overall Study|Lost to Follow-up|3|||
46733878|NCT00795184|82950681|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
46733879|NCT00795184|82950682|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
46733880|NCT00718861|82950693|FG000|Overall Study|Withdrawal by Subject|15|||
46733881|NCT00718861|82950694|FG001|Overall Study|Withdrawal by Subject|10|||
46733882|NCT00718861|82950693|FG000|Overall Study|Adverse Event|2|||
46733883|NCT00718861|82950694|FG001|Overall Study|Adverse Event|1|||
46733884|NCT00718861|82950693|FG000|Overall Study|Lost to Follow-up|2|||
46733885|NCT00718861|82950694|FG001|Overall Study|Lost to Follow-up|1|||
46733886|NCT00718861|82950693|FG000|Overall Study|Administrative Problems|1|||
46733887|NCT00718861|82950694|FG001|Overall Study|Administrative Problems|1|||
46733888|NCT00718861|82950693|FG000|Overall Study|Death|1|||
46733889|NCT00718861|82950694|FG001|Overall Study|Death|5|||
46733890|NCT01016600|82950704|FG000|Overall Study|Did not start treatment|1|||
46733891|NCT01016600|82950705|FG001|Overall Study|Did not start treatment|0|||
46733892|NCT01016600|82950706|FG002|Overall Study|Did not start treatment|0|||
46733893|NCT01016600|82950707|FG003|Overall Study|Did not start treatment|0|||
46733894|NCT01016132|82950718|FG000|Overall Study|Discomfort|1|||
46733895|NCT01015820|82950724|FG000|Overall Study|Suboptimal measurements|1|||
46733896|NCT01015820|82950725|FG001|Overall Study|Suboptimal measurements|0|||
46733897|NCT01010204|82950748|FG000|Overall Study|Lost to Follow-up|2|||
46733898|NCT01010204|82950749|FG001|Overall Study|Lost to Follow-up|2|||
46733899|NCT01010204|82950748|FG000|Overall Study|Adverse Event|1|||
46733900|NCT01010204|82950749|FG001|Overall Study|Adverse Event|3|||
46733901|NCT01010204|82950748|FG000|Overall Study|Withdrawal by Subject|2|||
46733902|NCT01010204|82950749|FG001|Overall Study|Withdrawal by Subject|3|||
46733903|NCT01010204|82950748|FG000|Overall Study|psychiatric hospitalization|2|||
46733904|NCT01010204|82950749|FG001|Overall Study|psychiatric hospitalization|1|||
46733905|NCT00718549|82950755|FG000|Induction Phase|Disease Progression|1|||
46733906|NCT00718549|82950756|FG001|Induction Phase|Disease Progression|0|||
46733907|NCT00718549|82950757|FG002|Induction Phase|Disease Progression|0|||
46733908|NCT00718549|82950755|FG000|Induction Phase|Eligibility Criteria Violation|2|||
46733909|NCT00718549|82950756|FG001|Induction Phase|Eligibility Criteria Violation|0|||
46733910|NCT00718549|82950757|FG002|Induction Phase|Eligibility Criteria Violation|0|||
46733911|NCT00718549|82950755|FG000|Induction Phase|Early Termination - No Additional Info|59|||
46733912|NCT00718549|82950756|FG001|Induction Phase|Early Termination - No Additional Info|0|||
46733913|NCT00718549|82950757|FG002|Induction Phase|Early Termination - No Additional Info|0|||
46733914|NCT00718549|82950755|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
46733915|NCT00718549|82950756|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
46733916|NCT00718549|82950757|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
46733917|NCT00718549|82950755|FG000|Maintenance/ Observation Phase|Death|0|||
46733918|NCT00718549|82950756|FG001|Maintenance/ Observation Phase|Death|1|||
46733919|NCT00718549|82950757|FG002|Maintenance/ Observation Phase|Death|2|||
46733920|NCT00718549|82950755|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
46733921|NCT00718549|82950756|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
46733922|NCT00718549|82950757|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
46733923|NCT00718549|82950755|FG000|Maintenance/ Observation Phase|Progression|0|||
46733924|NCT00718549|82950756|FG001|Maintenance/ Observation Phase|Progression|5|||
46733925|NCT00718549|82950757|FG002|Maintenance/ Observation Phase|Progression|14|||
46733926|NCT00718549|82950755|FG000|Maintenance/ Observation Phase|Relapse|0|||
46733927|NCT00718549|82950756|FG001|Maintenance/ Observation Phase|Relapse|3|||
46733928|NCT00718549|82950757|FG002|Maintenance/ Observation Phase|Relapse|2|||
46733929|NCT00793624|82950774|FG000|Overall Study|Adverse Event|18|||
46733930|NCT00793624|82950775|FG001|Overall Study|Adverse Event|16|||
46733931|NCT00793624|82950776|FG002|Overall Study|Adverse Event|15|||
46733932|NCT00793624|82950777|FG003|Overall Study|Adverse Event|20|||
46733933|NCT00793624|82950774|FG000|Overall Study|Lost to Follow-up|2|||
46733934|NCT00793624|82950775|FG001|Overall Study|Lost to Follow-up|2|||
46733935|NCT00793624|82950776|FG002|Overall Study|Lost to Follow-up|4|||
46733936|NCT00793624|82950777|FG003|Overall Study|Lost to Follow-up|0|||
46733937|NCT00793624|82950774|FG000|Overall Study|Withdrawal by Subject|20|||
46733938|NCT00793624|82950775|FG001|Overall Study|Withdrawal by Subject|9|||
46733939|NCT00793624|82950776|FG002|Overall Study|Withdrawal by Subject|11|||
46733940|NCT00793624|82950777|FG003|Overall Study|Withdrawal by Subject|14|||
46733941|NCT00793624|82950774|FG000|Overall Study|Lack of Efficacy|9|||
46733942|NCT00793624|82950775|FG001|Overall Study|Lack of Efficacy|2|||
47049422|NCT01603615|83309840|FG000|Overall Study|Other Miscellaneous|1|||
46733943|NCT00793624|82950776|FG002|Overall Study|Lack of Efficacy|1|||
46733944|NCT00793624|82950777|FG003|Overall Study|Lack of Efficacy|3|||
46733945|NCT00793624|82950774|FG000|Overall Study|Non compliance with protocol|2|||
46733946|NCT00793624|82950775|FG001|Overall Study|Non compliance with protocol|3|||
46733947|NCT00793624|82950776|FG002|Overall Study|Non compliance with protocol|2|||
46733948|NCT00793624|82950777|FG003|Overall Study|Non compliance with protocol|3|||
46733949|NCT00793624|82950774|FG000|Overall Study|Other reason not described above|6|||
46733950|NCT00793624|82950775|FG001|Overall Study|Other reason not described above|4|||
46733951|NCT00793624|82950776|FG002|Overall Study|Other reason not described above|6|||
46733952|NCT00793624|82950777|FG003|Overall Study|Other reason not described above|3|||
46733953|NCT00794950|82950795|FG000|BCG Induction|Withdrawal by Subject|2|||
46733954|NCT00794950|82950795|FG000|BCG Induction|ineligible|3|||
46733955|NCT00794950|82950795|FG000|BCG Induction|noncompliant w. BCG|1|||
46733956|NCT00794950|82950795|FG000|BCG Induction|Adverse Event|1|||
46733957|NCT00794950|82950795|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
46733958|NCT00794950|82950795|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
46733959|NCT00794950|82950795|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
46733960|NCT00794950|82950795|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
46733961|NCT00793546|82950802|FG000|Overall Study|Death|3|||
46733962|NCT00793546|82950803|FG001|Overall Study|Death|0|||
46733963|NCT00793546|82950802|FG000|Overall Study|Lost to Follow-up|1|||
46733964|NCT00793546|82950803|FG001|Overall Study|Lost to Follow-up|0|||
46733965|NCT00793546|82950802|FG000|Overall Study|Withdrawal by Subject|1|||
46733966|NCT00793546|82950803|FG001|Overall Study|Withdrawal by Subject|1|||
46733967|NCT00793546|82950802|FG000|Overall Study|Study Terminated by Sponsor|8|||
46733968|NCT00793546|82950803|FG001|Overall Study|Study Terminated by Sponsor|27|||
46733969|NCT00793546|82950802|FG000|Overall Study|Other|1|||
46733970|NCT00793546|82950803|FG001|Overall Study|Other|0|||
46733971|NCT00798694|82950813|FG000|Overall Study|Lost to Follow-up|1|||
46733972|NCT00798694|82950814|FG001|Overall Study|Lost to Follow-up|1|||
46733973|NCT00798694|82950813|FG000|Overall Study|Physician Decision|1|||
46733974|NCT00798694|82950814|FG001|Overall Study|Physician Decision|0|||
46733975|NCT00718315|82950829|FG000|Overall Study|Adverse Event|1|||
46733976|NCT00718315|82950830|FG001|Overall Study|Adverse Event|2|||
46733977|NCT00718315|82950831|FG002|Overall Study|Adverse Event|3|||
46733978|NCT00718315|82950829|FG000|Overall Study|Death|6|||
46733979|NCT00718315|82950830|FG001|Overall Study|Death|6|||
46733980|NCT00718315|82950831|FG002|Overall Study|Death|5|||
46733981|NCT00718315|82950829|FG000|Overall Study|Lost to Follow-up|2|||
46733982|NCT00718315|82950830|FG001|Overall Study|Lost to Follow-up|3|||
46733983|NCT00718315|82950831|FG002|Overall Study|Lost to Follow-up|4|||
46733984|NCT00718315|82950829|FG000|Overall Study|Protocol Violation|5|||
46733985|NCT00718315|82950830|FG001|Overall Study|Protocol Violation|5|||
46733986|NCT00718315|82950831|FG002|Overall Study|Protocol Violation|3|||
46733987|NCT00718315|82950829|FG000|Overall Study|Erlotinib dose decreased|4|||
46733988|NCT00718315|82950830|FG001|Overall Study|Erlotinib dose decreased|3|||
46733989|NCT00718315|82950831|FG002|Overall Study|Erlotinib dose decreased|1|||
46733990|NCT00718315|82950829|FG000|Overall Study|Use of Minocyclin|1|||
46733991|NCT00718315|82950830|FG001|Overall Study|Use of Minocyclin|1|||
46733992|NCT00718315|82950831|FG002|Overall Study|Use of Minocyclin|1|||
46733993|NCT00718315|82950829|FG000|Overall Study|Disease progression|0|||
46733994|NCT00718315|82950830|FG001|Overall Study|Disease progression|1|||
46733995|NCT00718315|82950831|FG002|Overall Study|Disease progression|1|||
46733996|NCT00718315|82950829|FG000|Overall Study|Other|0|||
46803957|NCT03903822|83023211|FG005|Treatment Phase (6 Weeks)|Other|1|||
47049423|NCT01685047|83309844|FG000|Overall Study|Withdrawal by Subject|20|||
47049424|NCT01685047|83309844|FG000|Overall Study|Death|26|||
47049425|NCT01685047|83309844|FG000|Overall Study|Lost to Follow-up|8|||
47049426|NCT01685047|83309844|FG000|Overall Study|Physician Decision|25|||
47049427|NCT01685047|83309844|FG000|Overall Study|Adverse Event|5|||
47049428|NCT01685047|83309844|FG000|Overall Study|patient withdrawn by sponsor|1|||
47049429|NCT01905683|83309848|FG000|Overall Study|Protocol Violation|1|||
47049430|NCT01905683|83309848|FG000|Overall Study|Re-injection criteria not met; others|13|||
46733997|NCT00718315|82950830|FG001|Overall Study|Other|0|||
46733998|NCT00718315|82950831|FG002|Overall Study|Other|1|||
46733999|NCT00718315|82950829|FG000|Overall Study|Use of ATB and Corticoids|0|||
46734000|NCT00718315|82950830|FG001|Overall Study|Use of ATB and Corticoids|1|||
46734001|NCT00718315|82950831|FG002|Overall Study|Use of ATB and Corticoids|2|||
46803958|NCT03903822|83023212|FG006|Treatment Phase (6 Weeks)|Other|0|||
46734002|NCT00798304|82950842|FG000|Overall Study|Adverse Event|0|||
46734003|NCT00798304|82950843|FG001|Overall Study|Adverse Event|1|||
46734004|NCT00798304|82950844|FG002|Overall Study|Adverse Event|1|||
46803959|NCT03903822|83023213|FG007|Treatment Phase (6 Weeks)|Other|0|||
47049431|NCT01905683|83309848|FG000|Overall Study|Physician Decision|1|||
46734005|NCT00798304|82950842|FG000|Overall Study|Discontinuation by Sponsor|14|||
46734006|NCT00798304|82950843|FG001|Overall Study|Discontinuation by Sponsor|21|||
46734007|NCT00798304|82950844|FG002|Overall Study|Discontinuation by Sponsor|9|||
46734008|NCT00718237|82950854|FG000|Overall Study|Adverse Event|1|||
46734009|NCT00718237|82950855|FG001|Overall Study|Adverse Event|3|||
46734010|NCT00718237|82950854|FG000|Overall Study|Lost to Follow-up|2|||
46734011|NCT00718237|82950855|FG001|Overall Study|Lost to Follow-up|2|||
46734012|NCT00718237|82950854|FG000|Overall Study|Physician Decision|1|||
46734013|NCT00718237|82950855|FG001|Overall Study|Physician Decision|0|||
46734014|NCT00718237|82950854|FG000|Overall Study|Withdrawal by Subject|9|||
46734015|NCT00718237|82950855|FG001|Overall Study|Withdrawal by Subject|10|||
46734016|NCT00793780|82950865|FG000|Overall Study|Withdrawal by Subject|2|||
46734017|NCT00793780|82950866|FG001|Overall Study|Withdrawal by Subject|1|||
46734018|NCT02643303|82950881|FG000|Overall Study|Progressive Disease|4|||
46734019|NCT02643303|82950882|FG001|Overall Study|Progressive Disease|4|||
46734020|NCT02643303|82950883|FG002|Overall Study|Progressive Disease|1|||
46734021|NCT02643303|82950884|FG003|Overall Study|Progressive Disease|12|||
46734022|NCT02643303|82950885|FG004|Overall Study|Progressive Disease|6|||
46734023|NCT02643303|82950886|FG005|Overall Study|Progressive Disease|4|||
46734024|NCT02643303|82950887|FG006|Overall Study|Progressive Disease|8|||
46734025|NCT02643303|82950888|FG007|Overall Study|Progressive Disease|2|||
46734026|NCT02643303|82950889|FG008|Overall Study|Progressive Disease|6|||
46734027|NCT02643303|82950881|FG000|Overall Study|Adverse Event|0|||
46734028|NCT02643303|82950882|FG001|Overall Study|Adverse Event|1|||
46734029|NCT02643303|82950883|FG002|Overall Study|Adverse Event|0|||
46734030|NCT02643303|82950884|FG003|Overall Study|Adverse Event|0|||
46734031|NCT02643303|82950885|FG004|Overall Study|Adverse Event|1|||
46734032|NCT02643303|82950886|FG005|Overall Study|Adverse Event|0|||
46734033|NCT02643303|82950887|FG006|Overall Study|Adverse Event|0|||
46734034|NCT02643303|82950888|FG007|Overall Study|Adverse Event|0|||
46734035|NCT02643303|82950889|FG008|Overall Study|Adverse Event|0|||
46734036|NCT02643303|82950881|FG000|Overall Study|Withdrawal by Subject|0|||
46734037|NCT02643303|82950882|FG001|Overall Study|Withdrawal by Subject|0|||
46734038|NCT02643303|82950883|FG002|Overall Study|Withdrawal by Subject|0|||
46734039|NCT02643303|82950884|FG003|Overall Study|Withdrawal by Subject|1|||
46921545|NCT02600923|83154135|FG000|Overall Study|Study terminated by Sponsor|53|||
46921546|NCT02600923|83154135|FG000|Overall Study|Not treated|1|||
46921547|NCT03070171|83154141|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
46921548|NCT03070171|83154142|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
46921549|NCT03070171|83154141|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
46921550|NCT03070171|83154142|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
46921551|NCT03644017|83154148|FG000|Overall Study|Access Abandonment|5|||
46921552|NCT03644017|83154148|FG000|Overall Study|Kidney Transplant|2|||
46921553|NCT00158054|83154154|FG000|Overall Study|Refused to continue|3|||
46921554|NCT00158054|83154155|FG001|Overall Study|Refused to continue|0|||
46921555|NCT00158054|83154154|FG000|Overall Study|Unavailable for follow up|7|||
46921556|NCT00158054|83154155|FG001|Overall Study|Unavailable for follow up|3|||
46921557|NCT01337960|83154164|FG000|Overall Study|Lost to Follow-up|1|||
46921558|NCT01337960|83154165|FG001|Overall Study|Lost to Follow-up|0|||
46921559|NCT01337960|83154166|FG002|Overall Study|Lost to Follow-up|0|||
46921560|NCT01337960|83154164|FG000|Overall Study|Withdrawal by Subject|1|||
46921561|NCT01337960|83154165|FG001|Overall Study|Withdrawal by Subject|0|||
46921562|NCT01337960|83154166|FG002|Overall Study|Withdrawal by Subject|0|||
46921563|NCT02750306|83154185|FG000|Overall Study|Withdrawal by Subject|5|||
46921564|NCT02750306|83154186|FG001|Overall Study|Withdrawal by Subject|2|||
46921565|NCT02750306|83154185|FG000|Overall Study|Protocol Violation|1|||
46921566|NCT02750306|83154186|FG001|Overall Study|Protocol Violation|0|||
46921567|NCT01816165|83154194|FG000|Overall Study|Adverse Event|1|||
46921568|NCT01816165|83154195|FG001|Overall Study|Adverse Event|0|||
46921569|NCT01816165|83154196|FG002|Overall Study|Adverse Event|0|||
46921570|NCT01816165|83154197|FG003|Overall Study|Adverse Event|0|||
46921571|NCT01677988|83154226|FG000|Overall Study|Lack of Efficacy|2|||
46734040|NCT02643303|82950885|FG004|Overall Study|Withdrawal by Subject|0|||
46734041|NCT02643303|82950886|FG005|Overall Study|Withdrawal by Subject|0|||
46734042|NCT02643303|82950887|FG006|Overall Study|Withdrawal by Subject|1|||
46734043|NCT02643303|82950888|FG007|Overall Study|Withdrawal by Subject|1|||
46734044|NCT02643303|82950889|FG008|Overall Study|Withdrawal by Subject|1|||
46803960|NCT03903822|83023206|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
46803961|NCT03903822|83023207|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
46921572|NCT02926573|83154233|FG000|Overall Study|Nausea|1|||
46921573|NCT02926573|83154234|FG001|Overall Study|Nausea|0|||
46921574|NCT02926573|83154233|FG000|Overall Study|Remain intubated|2|||
46921575|NCT02926573|83154234|FG001|Overall Study|Remain intubated|2|||
46921576|NCT02926573|83154233|FG000|Overall Study|Change in surgery plan|3|||
46734045|NCT00790036|82950911|FG000|Overall Study|Abnormal lab values|3|||
46734046|NCT00790036|82950912|FG001|Overall Study|Abnormal lab values|2|||
46921577|NCT02926573|83154234|FG001|Overall Study|Change in surgery plan|1|||
46921578|NCT02926573|83154233|FG000|Overall Study|Change to outpatient status|5|||
46734047|NCT00790036|82950911|FG000|Overall Study|Administrative problems|5|||
46734048|NCT00790036|82950912|FG001|Overall Study|Administrative problems|9|||
46734049|NCT00790036|82950911|FG000|Overall Study|Adverse Event|113|||
46734050|NCT00790036|82950912|FG001|Overall Study|Adverse Event|44|||
46734051|NCT00790036|82950911|FG000|Overall Study|Death|1|||
46734052|NCT00790036|82950912|FG001|Overall Study|Death|0|||
47049432|NCT01905683|83309848|FG000|Overall Study|Lack of Efficacy|8|||
47049433|NCT01905683|83309848|FG000|Overall Study|Withdrawal by Subject|20|||
47049434|NCT01905683|83309848|FG000|Overall Study|Adverse Event|4|||
47049435|NCT01905683|83309848|FG000|Overall Study|Lost to Follow-up|4|||
47049436|NCT01921829|83309854|FG000|Overall Study|Withdrawal by Subject|0|||
47049437|NCT01921829|83309855|FG001|Overall Study|Withdrawal by Subject|1|||
47049438|NCT01904903|83309861|FG000|Overall Study|Withdrawal by Subject|1|||
47049439|NCT01921517|83309867|FG000|Overall Study|Lost to Follow-up|5|||
46734053|NCT00790036|82950911|FG000|Overall Study|Disease progression|24|||
46734054|NCT00790036|82950912|FG001|Overall Study|Disease progression|48|||
46734055|NCT00790036|82950911|FG000|Overall Study|Lost to Follow-up|1|||
46734056|NCT00790036|82950912|FG001|Overall Study|Lost to Follow-up|2|||
46734057|NCT00790036|82950911|FG000|Overall Study|Protocol Violation|10|||
46734058|NCT00790036|82950912|FG001|Overall Study|Protocol Violation|2|||
46734059|NCT00790036|82950911|FG000|Overall Study|Withdrawal by Subject|18|||
46734060|NCT00790036|82950912|FG001|Overall Study|Withdrawal by Subject|7|||
46734061|NCT00790036|82950911|FG000|Overall Study|Subject/guardian decision|20|||
46734062|NCT00790036|82950912|FG001|Overall Study|Subject/guardian decision|7|||
46734063|NCT00789958|82950919|FG000|Overall Study|Adverse Event|3|||
46734064|NCT00789958|82950919|FG000|Overall Study|Withdrawal by Subject|4|||
46734065|NCT00789958|82950919|FG000|Overall Study|Progression|3|||
46734066|NCT00789958|82950919|FG000|Overall Study|not protocol specified|1|||
46734067|NCT00789958|82950919|FG000|Overall Study|Not eligible/not analyzable|26|||
46734068|NCT00789880|82950931|FG000|Overall Study|Adverse Event|0|||
46734069|NCT00789880|82950932|FG001|Overall Study|Adverse Event|0|||
46734070|NCT00789880|82950933|FG002|Overall Study|Adverse Event|0|||
46734071|NCT00789880|82950934|FG003|Overall Study|Adverse Event|0|||
46734072|NCT00789880|82950935|FG004|Overall Study|Adverse Event|1|||
46734073|NCT00789880|82950936|FG005|Overall Study|Adverse Event|0|||
46734074|NCT00789880|82950931|FG000|Overall Study|Protocol Violation|0|||
46734075|NCT00789880|82950932|FG001|Overall Study|Protocol Violation|1|||
46734076|NCT00789880|82950933|FG002|Overall Study|Protocol Violation|0|||
46734077|NCT00789880|82950934|FG003|Overall Study|Protocol Violation|1|||
46734078|NCT00789880|82950935|FG004|Overall Study|Protocol Violation|0|||
46734079|NCT00789880|82950936|FG005|Overall Study|Protocol Violation|0|||
46734080|NCT00789880|82950931|FG000|Overall Study|Withdrawal by Subject|1|||
46734081|NCT00789880|82950932|FG001|Overall Study|Withdrawal by Subject|0|||
46734082|NCT00789880|82950933|FG002|Overall Study|Withdrawal by Subject|0|||
46734083|NCT00789880|82950934|FG003|Overall Study|Withdrawal by Subject|0|||
46734084|NCT00789880|82950935|FG004|Overall Study|Withdrawal by Subject|2|||
46734085|NCT00789880|82950936|FG005|Overall Study|Withdrawal by Subject|0|||
46734086|NCT00792298|82950950|FG000|Treatment Period 1|Adverse Event|0|||
46734087|NCT00792298|82950951|FG001|Treatment Period 1|Adverse Event|1|||
46734088|NCT00792298|82950952|FG002|Treatment Period 1|Adverse Event|0|||
46734089|NCT00792298|82950953|FG003|Treatment Period 1|Adverse Event|1|||
46734090|NCT00792298|82950954|FG004|Treatment Period 1|Adverse Event|0|||
46734091|NCT00792298|82950955|FG005|Treatment Period 1|Adverse Event|1|||
46734092|NCT00792298|82950956|FG006|Treatment Period 1|Adverse Event|1|||
46734093|NCT00792298|82950957|FG007|Treatment Period 1|Adverse Event|0|||
46734094|NCT00792298|82950950|FG000|Treatment Period 1|Lack of Efficacy|0|||
46734095|NCT00792298|82950951|FG001|Treatment Period 1|Lack of Efficacy|0|||
46734096|NCT00792298|82950952|FG002|Treatment Period 1|Lack of Efficacy|1|||
46921579|NCT02926573|83154234|FG001|Overall Study|Change to outpatient status|1|||
46734097|NCT00792298|82950953|FG003|Treatment Period 1|Lack of Efficacy|0|||
46734098|NCT00792298|82950954|FG004|Treatment Period 1|Lack of Efficacy|0|||
46734099|NCT00792298|82950955|FG005|Treatment Period 1|Lack of Efficacy|0|||
46921580|NCT02926573|83154233|FG000|Overall Study|Withdrawal by Subject|0|||
46921581|NCT02926573|83154234|FG001|Overall Study|Withdrawal by Subject|2|||
46921582|NCT02926573|83154233|FG000|Overall Study|Return to operating room|0|||
46921583|NCT02926573|83154234|FG001|Overall Study|Return to operating room|2|||
46921584|NCT02926573|83154233|FG000|Overall Study|Delirium|0|||
46921585|NCT02926573|83154234|FG001|Overall Study|Delirium|1|||
46921586|NCT00158860|83154242|FG000|Overall Study|Adverse Event|3|||
46734100|NCT00792298|82950956|FG006|Treatment Period 1|Lack of Efficacy|0|||
46734101|NCT00792298|82950957|FG007|Treatment Period 1|Lack of Efficacy|0|||
46734102|NCT00792298|82950950|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46734103|NCT00792298|82950951|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46921587|NCT00158860|83154243|FG001|Overall Study|Adverse Event|6|||
46921588|NCT00158860|83154242|FG000|Overall Study|Lost to Follow-up|11|||
46734104|NCT00792298|82950952|FG002|Treatment Period 1|Withdrawal by Subject|1|||
47049440|NCT01921517|83309868|FG001|Overall Study|Lost to Follow-up|0|||
47049441|NCT01921517|83309867|FG000|Overall Study|Newly diagnosed health concern|2|||
46734105|NCT00792298|82950953|FG003|Treatment Period 1|Withdrawal by Subject|2|||
46734106|NCT00792298|82950954|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46734107|NCT00792298|82950955|FG005|Treatment Period 1|Withdrawal by Subject|2|||
47049442|NCT01921517|83309868|FG001|Overall Study|Newly diagnosed health concern|0|||
47049443|NCT01921517|83309867|FG000|Overall Study|Physician Decision|0|||
47049444|NCT01921517|83309868|FG001|Overall Study|Physician Decision|2|||
47049445|NCT01921517|83309867|FG000|Overall Study|Withdrawal by Subject|7|||
47049446|NCT01921517|83309868|FG001|Overall Study|Withdrawal by Subject|3|||
47049447|NCT01921517|83309867|FG000|Overall Study|Subject missed final imaging|1|||
47049448|NCT01921517|83309868|FG001|Overall Study|Subject missed final imaging|4|||
47049449|NCT01921205|83309876|FG000|Overall Study|Adverse Event|12|||
47049450|NCT01921205|83309877|FG001|Overall Study|Adverse Event|7|||
47049451|NCT01921205|83309876|FG000|Overall Study|Lack of Efficacy|1|||
47049452|NCT01921205|83309877|FG001|Overall Study|Lack of Efficacy|0|||
46734108|NCT00792298|82950956|FG006|Treatment Period 1|Withdrawal by Subject|1|||
46734109|NCT00792298|82950957|FG007|Treatment Period 1|Withdrawal by Subject|0|||
46734110|NCT00792298|82950950|FG000|Treatment Period 1|Lost to Follow-up|0|||
47049453|NCT01921205|83309876|FG000|Overall Study|Protocol Violation|1|||
47049454|NCT01921205|83309877|FG001|Overall Study|Protocol Violation|3|||
47049455|NCT01921205|83309876|FG000|Overall Study|Lost to Follow-up|1|||
47049456|NCT01921205|83309877|FG001|Overall Study|Lost to Follow-up|1|||
47049457|NCT01921205|83309876|FG000|Overall Study|Withdrawal by Subject|6|||
47049458|NCT01921205|83309877|FG001|Overall Study|Withdrawal by Subject|5|||
47049459|NCT01921205|83309876|FG000|Overall Study|Use Of Prohibited Medication|0|||
47049460|NCT01921205|83309877|FG001|Overall Study|Use Of Prohibited Medication|1|||
47049461|NCT01921205|83309876|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
47049462|NCT01921205|83309877|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
46734111|NCT00792298|82950951|FG001|Treatment Period 1|Lost to Follow-up|0|||
46734112|NCT00792298|82950952|FG002|Treatment Period 1|Lost to Follow-up|0|||
46734113|NCT00792298|82950953|FG003|Treatment Period 1|Lost to Follow-up|0|||
46734114|NCT00792298|82950954|FG004|Treatment Period 1|Lost to Follow-up|0|||
46734115|NCT00792298|82950955|FG005|Treatment Period 1|Lost to Follow-up|0|||
46635189|NCT01684878|82808715|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
46635190|NCT01684722|82808729|FG000|Overall Study|Lost to Follow-up|78|||
46635191|NCT01684722|82808730|FG001|Overall Study|Lost to Follow-up|56|||
46734116|NCT00792298|82950956|FG006|Treatment Period 1|Lost to Follow-up|1|||
46635192|NCT01684722|82808731|FG002|Overall Study|Lost to Follow-up|75|||
46734117|NCT00792298|82950957|FG007|Treatment Period 1|Lost to Follow-up|0|||
46734118|NCT00792298|82950950|FG000|Treatment Period 1|Physician Decision|0|||
46734119|NCT00792298|82950951|FG001|Treatment Period 1|Physician Decision|0|||
46734120|NCT00792298|82950952|FG002|Treatment Period 1|Physician Decision|0|||
46734121|NCT00792298|82950953|FG003|Treatment Period 1|Physician Decision|1|||
46734122|NCT00792298|82950954|FG004|Treatment Period 1|Physician Decision|0|||
46734123|NCT00792298|82950955|FG005|Treatment Period 1|Physician Decision|0|||
46734124|NCT00792298|82950956|FG006|Treatment Period 1|Physician Decision|1|||
46734125|NCT00792298|82950957|FG007|Treatment Period 1|Physician Decision|0|||
46734126|NCT00792298|82950950|FG000|Treatment Period 1|Protocol Violation|0|||
46734127|NCT00792298|82950951|FG001|Treatment Period 1|Protocol Violation|0|||
46734128|NCT00792298|82950952|FG002|Treatment Period 1|Protocol Violation|0|||
46734129|NCT00792298|82950953|FG003|Treatment Period 1|Protocol Violation|0|||
46734130|NCT00792298|82950954|FG004|Treatment Period 1|Protocol Violation|0|||
46734131|NCT00792298|82950955|FG005|Treatment Period 1|Protocol Violation|0|||
46734132|NCT00792298|82950956|FG006|Treatment Period 1|Protocol Violation|0|||
46734133|NCT00792298|82950957|FG007|Treatment Period 1|Protocol Violation|1|||
46734134|NCT00792298|82950950|FG000|Washout|Adverse Event|0|||
46734135|NCT00792298|82950951|FG001|Washout|Adverse Event|0|||
46734136|NCT00792298|82950952|FG002|Washout|Adverse Event|0|||
46635193|NCT01684722|82808732|FG003|Overall Study|Lost to Follow-up|89|||
46734137|NCT00792298|82950953|FG003|Washout|Adverse Event|0|||
46734138|NCT00792298|82950954|FG004|Washout|Adverse Event|0|||
46734139|NCT00792298|82950955|FG005|Washout|Adverse Event|1|||
46734140|NCT00792298|82950956|FG006|Washout|Adverse Event|0|||
46734141|NCT00792298|82950957|FG007|Washout|Adverse Event|0|||
46734142|NCT00792298|82950950|FG000|Washout|Withdrawal by Subject|0|||
46734143|NCT00792298|82950951|FG001|Washout|Withdrawal by Subject|0|||
47049463|NCT01921205|83309876|FG000|Overall Study|Non Compliance Of The Parent|0|||
47049464|NCT01921205|83309877|FG001|Overall Study|Non Compliance Of The Parent|1|||
47049465|NCT01921205|83309876|FG000|Overall Study|Non Compliance Of Child|0|||
47049466|NCT01921205|83309877|FG001|Overall Study|Non Compliance Of Child|1|||
47049467|NCT01920893|83309885|FG000|Overall Study|Adverse Event|5|||
47049468|NCT01920893|83309886|FG001|Overall Study|Adverse Event|2|||
46734144|NCT00792298|82950952|FG002|Washout|Withdrawal by Subject|1|||
46734145|NCT00792298|82950953|FG003|Washout|Withdrawal by Subject|0|||
46734146|NCT00792298|82950954|FG004|Washout|Withdrawal by Subject|0|||
46734147|NCT00792298|82950955|FG005|Washout|Withdrawal by Subject|1|||
46734148|NCT00792298|82950956|FG006|Washout|Withdrawal by Subject|0|||
46734149|NCT00792298|82950957|FG007|Washout|Withdrawal by Subject|0|||
46734150|NCT00792298|82950950|FG000|Treatment Period 2|Lack of Efficacy|0|||
46734151|NCT00792298|82950951|FG001|Treatment Period 2|Lack of Efficacy|0|||
46734152|NCT00792298|82950952|FG002|Treatment Period 2|Lack of Efficacy|0|||
46734153|NCT00792298|82950953|FG003|Treatment Period 2|Lack of Efficacy|0|||
46734154|NCT00792298|82950954|FG004|Treatment Period 2|Lack of Efficacy|1|||
46734155|NCT00792298|82950955|FG005|Treatment Period 2|Lack of Efficacy|0|||
46734156|NCT00792298|82950956|FG006|Treatment Period 2|Lack of Efficacy|0|||
46734157|NCT00792298|82950957|FG007|Treatment Period 2|Lack of Efficacy|0|||
46734158|NCT00792298|82950950|FG000|Treatment Period 2|Physician Decision|0|||
46734159|NCT00792298|82950951|FG001|Treatment Period 2|Physician Decision|0|||
46734160|NCT00792298|82950952|FG002|Treatment Period 2|Physician Decision|0|||
46734161|NCT00792298|82950953|FG003|Treatment Period 2|Physician Decision|0|||
46734162|NCT00792298|82950954|FG004|Treatment Period 2|Physician Decision|0|||
46734163|NCT00792298|82950955|FG005|Treatment Period 2|Physician Decision|0|||
46734164|NCT00792298|82950956|FG006|Treatment Period 2|Physician Decision|1|||
46734165|NCT00792298|82950957|FG007|Treatment Period 2|Physician Decision|0|||
46734166|NCT00792298|82950950|FG000|Treatment Period 2|Pregnancy|0|||
46734167|NCT00792298|82950951|FG001|Treatment Period 2|Pregnancy|0|||
46734168|NCT00792298|82950952|FG002|Treatment Period 2|Pregnancy|1|||
46734169|NCT00792298|82950953|FG003|Treatment Period 2|Pregnancy|0|||
46734170|NCT00792298|82950954|FG004|Treatment Period 2|Pregnancy|0|||
46734171|NCT00792298|82950955|FG005|Treatment Period 2|Pregnancy|0|||
46734172|NCT00792298|82950956|FG006|Treatment Period 2|Pregnancy|0|||
46734173|NCT00792298|82950957|FG007|Treatment Period 2|Pregnancy|0|||
46734174|NCT00792298|82950950|FG000|Treatment Period 2|Withdrawal by Subject|1|||
46734175|NCT00792298|82950951|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46734176|NCT00792298|82950952|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46734177|NCT00792298|82950953|FG003|Treatment Period 2|Withdrawal by Subject|2|||
46734178|NCT00792298|82950954|FG004|Treatment Period 2|Withdrawal by Subject|1|||
46734179|NCT00792298|82950955|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46734180|NCT00792298|82950956|FG006|Treatment Period 2|Withdrawal by Subject|0|||
46734181|NCT00792298|82950957|FG007|Treatment Period 2|Withdrawal by Subject|2|||
46734182|NCT00718159|82950981|FG000|Overall Study|Progressive Disease|3|||
46734183|NCT00718159|82950982|FG001|Overall Study|Progressive Disease|3|||
46734184|NCT00718159|82950983|FG002|Overall Study|Progressive Disease|2|||
46734185|NCT00718159|82950984|FG003|Overall Study|Progressive Disease|0|||
46734186|NCT00718159|82950985|FG004|Overall Study|Progressive Disease|6|||
46734187|NCT00718159|82950986|FG005|Overall Study|Progressive Disease|0|||
46734188|NCT00718159|82950987|FG006|Overall Study|Progressive Disease|0|||
46734189|NCT00718159|82950981|FG000|Overall Study|Death due to Adverse Event|0|||
46734190|NCT00718159|82950982|FG001|Overall Study|Death due to Adverse Event|0|||
46734191|NCT00718159|82950983|FG002|Overall Study|Death due to Adverse Event|0|||
46734192|NCT00718159|82950984|FG003|Overall Study|Death due to Adverse Event|2|||
46734193|NCT00718159|82950985|FG004|Overall Study|Death due to Adverse Event|2|||
46734194|NCT00718159|82950986|FG005|Overall Study|Death due to Adverse Event|0|||
46734195|NCT00718159|82950987|FG006|Overall Study|Death due to Adverse Event|0|||
46734196|NCT00718159|82950981|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
46734197|NCT00718159|82950982|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
46734198|NCT00718159|82950983|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
46734199|NCT00718159|82950984|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
46734200|NCT00718159|82950985|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
46734201|NCT00718159|82950986|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
46734202|NCT00718159|82950987|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
46734203|NCT00718159|82950981|FG000|Overall Study|Investigator Decision|0|||
46734204|NCT00718159|82950982|FG001|Overall Study|Investigator Decision|0|||
46734205|NCT00718159|82950983|FG002|Overall Study|Investigator Decision|0|||
46734206|NCT00718159|82950984|FG003|Overall Study|Investigator Decision|0|||
46734207|NCT00718159|82950985|FG004|Overall Study|Investigator Decision|0|||
46734208|NCT00718159|82950986|FG005|Overall Study|Investigator Decision|1|||
46734209|NCT00718159|82950987|FG006|Overall Study|Investigator Decision|1|||
46734210|NCT00718081|82951006|FG000|Overall Study|Adverse Event|0|||
46734211|NCT00718081|82951007|FG001|Overall Study|Adverse Event|1|||
46734212|NCT00718081|82951008|FG002|Overall Study|Adverse Event|0|||
46734213|NCT00718081|82951006|FG000|Overall Study|Lack of Efficacy|7|||
46734214|NCT00718081|82951007|FG001|Overall Study|Lack of Efficacy|3|||
46734215|NCT00718081|82951008|FG002|Overall Study|Lack of Efficacy|21|||
46734216|NCT00788710|82951019|FG000|Overall Study|Adverse Event|1|||
46734217|NCT00788710|82951020|FG001|Overall Study|Adverse Event|3|||
46734218|NCT00788710|82951021|FG002|Overall Study|Adverse Event|4|||
46734219|NCT00788710|82951019|FG000|Overall Study|Lack of Efficacy|0|||
46734220|NCT00788710|82951020|FG001|Overall Study|Lack of Efficacy|0|||
46734221|NCT00788710|82951021|FG002|Overall Study|Lack of Efficacy|1|||
46734222|NCT00788710|82951019|FG000|Overall Study|Lost to Follow-up|0|||
46734223|NCT00788710|82951020|FG001|Overall Study|Lost to Follow-up|1|||
46734224|NCT00788710|82951021|FG002|Overall Study|Lost to Follow-up|0|||
46734225|NCT00788710|82951019|FG000|Overall Study|Physician Decision|2|||
46734226|NCT00788710|82951020|FG001|Overall Study|Physician Decision|1|||
46734227|NCT00788710|82951021|FG002|Overall Study|Physician Decision|0|||
46734228|NCT00788710|82951019|FG000|Overall Study|Protocol Violation|0|||
46734229|NCT00788710|82951020|FG001|Overall Study|Protocol Violation|1|||
46734230|NCT00788710|82951021|FG002|Overall Study|Protocol Violation|1|||
46734231|NCT00788710|82951019|FG000|Overall Study|Withdrawal by Subject|2|||
46734232|NCT00788710|82951020|FG001|Overall Study|Withdrawal by Subject|2|||
46734233|NCT00788710|82951021|FG002|Overall Study|Withdrawal by Subject|0|||
46734234|NCT00787930|82951029|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
46734235|NCT00588094|82951039|FG000|Overall Study|Adverse Event|3|||
46734236|NCT00588094|82951039|FG000|Overall Study|Progression of Disease|2|||
46734237|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
46734238|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
46734239|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
46734240|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
46734241|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
46734242|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
46734243|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
46734244|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
46734245|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
46734246|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
46734247|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
46734248|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
46734249|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
46734250|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
46734251|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
46734252|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
46734253|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
46734254|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
46734255|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
46734256|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
46734257|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
46734258|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
46734259|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
46734260|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
46734261|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
46734262|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
46734263|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
46734264|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
46734265|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
46734266|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
46734267|NCT00784654|82951043|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
46734268|NCT00784654|82951044|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
46734269|NCT00784654|82951045|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
46734270|NCT00784654|82951043|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
46734271|NCT00784654|82951044|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
46734272|NCT00784654|82951045|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
46734273|NCT00784654|82951043|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
46734274|NCT00784654|82951044|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
46734275|NCT00784654|82951045|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
46734276|NCT00784654|82951043|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46734277|NCT00784654|82951044|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
46734278|NCT00784654|82951045|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
46734279|NCT00784654|82951043|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
46734280|NCT00784654|82951044|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
46734281|NCT00784654|82951045|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
46734282|NCT00784654|82951043|FG000|Randomized Withdrawal Period|Adverse Event|0|||
46734283|NCT00784654|82951044|FG001|Randomized Withdrawal Period|Adverse Event|1|||
46734284|NCT00784654|82951045|FG002|Randomized Withdrawal Period|Adverse Event|1|||
46734285|NCT00784654|82951043|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
46734286|NCT00784654|82951044|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
46775730|NCT00793793|82994211|FG007|Overall Study|Adverse Event|0|||
46734287|NCT00784654|82951045|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
46734288|NCT00784654|82951043|FG000|Randomized Withdrawal Period|Family reasons|0|||
46734289|NCT00784654|82951044|FG001|Randomized Withdrawal Period|Family reasons|0|||
46734290|NCT00784654|82951045|FG002|Randomized Withdrawal Period|Family reasons|1|||
46734291|NCT00787150|82951059|FG000|Overall Study|Adverse Event|4|||
46734292|NCT00787150|82951060|FG001|Overall Study|Adverse Event|4|||
46734293|NCT00787150|82951061|FG002|Overall Study|Adverse Event|4|||
46734294|NCT00787150|82951059|FG000|Overall Study|Physician Decision|1|||
46734295|NCT00787150|82951060|FG001|Overall Study|Physician Decision|2|||
46734296|NCT00787150|82951061|FG002|Overall Study|Physician Decision|1|||
46734297|NCT00787150|82951059|FG000|Overall Study|Withdrawal by Subject|2|||
46734298|NCT00787150|82951060|FG001|Overall Study|Withdrawal by Subject|1|||
46734299|NCT00787150|82951061|FG002|Overall Study|Withdrawal by Subject|0|||
46734300|NCT00787150|82951059|FG000|Overall Study|Dosing incorrect study durg|2|||
46734301|NCT00787150|82951060|FG001|Overall Study|Dosing incorrect study durg|0|||
46734302|NCT00787150|82951061|FG002|Overall Study|Dosing incorrect study durg|0|||
46734303|NCT00786838|82951071|FG000|Overall Study|Physician Decision|4|||
46734304|NCT00786838|82951071|FG000|Overall Study|Death|4|||
46734305|NCT00786838|82951071|FG000|Overall Study|Adverse Event|6|||
46734306|NCT00786838|82951071|FG000|Overall Study|Progressive disease|31|||
46734307|NCT00786838|82951071|FG000|Overall Study|Withdrawal by Subject|4|||
46734308|NCT00785980|82951080|FG000|7 Day Washout Period|Protocol Violation|3|||
46734309|NCT00791518|82951087|FG000|Overall Study|Protocol Violation|93|||
46734310|NCT00785512|82951108|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
46734311|NCT00785512|82951109|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
46734312|NCT00785512|82951108|FG000|Overall Study|Adverse Event|0|||
46734313|NCT00785512|82951109|FG001|Overall Study|Adverse Event|0|||
46734314|NCT00785512|82951108|FG000|Overall Study|Lack of Efficacy|0|||
46734315|NCT00785512|82951109|FG001|Overall Study|Lack of Efficacy|2|||
46734316|NCT00785512|82951108|FG000|Overall Study|Withdrawal by Subject|0|||
46734317|NCT00785512|82951109|FG001|Overall Study|Withdrawal by Subject|1|||
46734318|NCT00785512|82951108|FG000|Overall Study|Lost to Follow-up|3|||
46734319|NCT00785512|82951109|FG001|Overall Study|Lost to Follow-up|0|||
46734320|NCT00785512|82951108|FG000|Overall Study|Precedure Refused|0|||
46734321|NCT00785512|82951109|FG001|Overall Study|Precedure Refused|0|||
46734322|NCT00785512|82951108|FG000|Overall Study|IVRS Programing Error|0|||
46734323|NCT00785512|82951109|FG001|Overall Study|IVRS Programing Error|0|||
46734324|NCT00785512|82951108|FG000|Overall Study|Physician Decision|0|||
46734325|NCT00785512|82951109|FG001|Overall Study|Physician Decision|0|||
46635194|NCT01684722|82808729|FG000|Overall Study|Death|19|||
46635195|NCT01684722|82808730|FG001|Overall Study|Death|21|||
46635196|NCT01684722|82808731|FG002|Overall Study|Death|19|||
46635197|NCT01684722|82808732|FG003|Overall Study|Death|21|||
46635198|NCT01592292|82808749|FG000|Overall Study|Follow-up loss|3|||
46635199|NCT01592292|82808750|FG001|Overall Study|Follow-up loss|3|||
46635200|NCT01592292|82808751|FG002|Overall Study|Follow-up loss|1|||
46635201|NCT01592292|82808752|FG003|Overall Study|Follow-up loss|0|||
46635202|NCT01592292|82808749|FG000|Overall Study|Withdrew consent|2|||
46635203|NCT01592292|82808750|FG001|Overall Study|Withdrew consent|1|||
46635204|NCT01592292|82808751|FG002|Overall Study|Withdrew consent|0|||
46635205|NCT01592292|82808752|FG003|Overall Study|Withdrew consent|0|||
46635206|NCT01592292|82808749|FG000|Overall Study|Other|1|||
46635207|NCT01592292|82808750|FG001|Overall Study|Other|1|||
46635208|NCT01592292|82808751|FG002|Overall Study|Other|2|||
46635209|NCT01592292|82808752|FG003|Overall Study|Other|1|||
46635210|NCT01590888|82808761|FG000|Overall Study|Adverse Event|3|||
46635211|NCT01590888|82808762|FG001|Overall Study|Adverse Event|0|||
46635212|NCT01590888|82808763|FG002|Overall Study|Adverse Event|1|||
46635213|NCT01590888|82808761|FG000|Overall Study|Lost to Follow-up|1|||
46635214|NCT01590888|82808762|FG001|Overall Study|Lost to Follow-up|0|||
46635215|NCT01590888|82808763|FG002|Overall Study|Lost to Follow-up|0|||
46734326|NCT00785512|82951108|FG000|Overall Study|Lack of compliance|0|||
46734327|NCT00785512|82951109|FG001|Overall Study|Lack of compliance|1|||
46734328|NCT00785356|82951119|FG000|Overall Study|Study prematurely terminated|8|||
46734329|NCT00785044|82951127|FG000|Overall Study|Dosed at non-participating sites|152|||
46803962|NCT03903822|83023208|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
46734330|NCT00785044|82951127|FG000|Overall Study|Death|77|||
46734331|NCT00785044|82951127|FG000|Overall Study|Lost to Follow-up|266|||
46803963|NCT03903822|83023209|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
46921589|NCT00158860|83154243|FG001|Overall Study|Lost to Follow-up|17|||
46635216|NCT01565928|82808771|FG000|Overall Study|Adverse Event|3|||
46635217|NCT01565928|82808771|FG000|Overall Study|Other|3|||
46635218|NCT01565928|82808771|FG000|Overall Study|Progressive Disease|13|||
46635219|NCT01565928|82808771|FG000|Overall Study|Withdrawal by Subject|1|||
46635220|NCT01565928|82808771|FG000|Overall Study|Death|2|||
46635221|NCT01565850|82808780|FG000|Overall Study|Adverse Event|0|||
46734332|NCT00785044|82951127|FG000|Overall Study|Withdrawal by Subject|1|||
46734333|NCT00784810|82951134|FG000|Overall Study|Adverse Event|32|||
46734334|NCT00784810|82951135|FG001|Overall Study|Adverse Event|20|||
46921590|NCT00158860|83154242|FG000|Overall Study|Protocol Violation|8|||
46734335|NCT00784810|82951134|FG000|Overall Study|Lack of Efficacy|14|||
46734336|NCT00784810|82951135|FG001|Overall Study|Lack of Efficacy|11|||
46734337|NCT00784810|82951134|FG000|Overall Study|Withdrawal by Subject|11|||
46734338|NCT00784810|82951135|FG001|Overall Study|Withdrawal by Subject|9|||
46734339|NCT00784810|82951134|FG000|Overall Study|Administrative|5|||
46734340|NCT00784810|82951135|FG001|Overall Study|Administrative|8|||
46734341|NCT00784810|82951134|FG000|Overall Study|Lost to Follow-up|1|||
46734342|NCT00784810|82951135|FG001|Overall Study|Lost to Follow-up|1|||
46734343|NCT00791128|82951141|FG000|Overall Study|Adverse Event|4|||
46734344|NCT00791128|82951141|FG000|Overall Study|Device migration|2|||
46734345|NCT00791128|82951141|FG000|Overall Study|non-compliance by subject|2|||
46734346|NCT00791128|82951141|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
46734347|NCT00776230|82951161|FG000|Overall Study|Lost to Follow-up|2|||
46734348|NCT00776230|82951162|FG001|Overall Study|Lost to Follow-up|1|||
46734349|NCT00776230|82951163|FG002|Overall Study|Lost to Follow-up|5|||
46734350|NCT00776230|82951161|FG000|Overall Study|Not vaccinated at Day 0|1|||
46734351|NCT00776230|82951162|FG001|Overall Study|Not vaccinated at Day 0|0|||
46734352|NCT00776230|82951163|FG002|Overall Study|Not vaccinated at Day 0|0|||
46734353|NCT00776230|82951161|FG000|Overall Study|Withdrawal by Subject|0|||
46734354|NCT00776230|82951162|FG001|Overall Study|Withdrawal by Subject|1|||
46734355|NCT00776230|82951163|FG002|Overall Study|Withdrawal by Subject|0|||
46734356|NCT00776230|82951161|FG000|Overall Study|Subject missed Visit 4|0|||
46734357|NCT00776230|82951162|FG001|Overall Study|Subject missed Visit 4|1|||
46734358|NCT00776230|82951163|FG002|Overall Study|Subject missed Visit 4|0|||
46734359|NCT00775606|82951173|FG000|Overall Study|Study sponsor terminated funding|3|||
46734360|NCT00775606|82951174|FG001|Overall Study|Study sponsor terminated funding|0|||
46734361|NCT02960763|82951193|FG000|Step 1|Withdrawal by Subject|10|||
46734362|NCT02960763|82951194|FG001|Step 1|Withdrawal by Subject|8|||
46734363|NCT02960763|82951195|FG002|Step 1|Withdrawal by Subject|13|||
46734364|NCT02960763|82951196|FG003|Step 1|Withdrawal by Subject|0|||
46734365|NCT02960763|82951197|FG004|Step 1|Withdrawal by Subject|0|||
46734366|NCT02960763|82951193|FG000|Step 1|Lost to Follow-up|7|||
46734367|NCT02960763|82951194|FG001|Step 1|Lost to Follow-up|9|||
46734368|NCT02960763|82951195|FG002|Step 1|Lost to Follow-up|12|||
46734369|NCT02960763|82951196|FG003|Step 1|Lost to Follow-up|0|||
46734370|NCT02960763|82951197|FG004|Step 1|Lost to Follow-up|0|||
46734371|NCT02960763|82951193|FG000|Step 1|Death|1|||
46734372|NCT02960763|82951194|FG001|Step 1|Death|1|||
46734373|NCT02960763|82951195|FG002|Step 1|Death|1|||
46734374|NCT02960763|82951196|FG003|Step 1|Death|0|||
46734375|NCT02960763|82951197|FG004|Step 1|Death|0|||
46734376|NCT02960763|82951193|FG000|Step 1|Investigator discretion|1|||
46734377|NCT02960763|82951194|FG001|Step 1|Investigator discretion|0|||
46734378|NCT02960763|82951195|FG002|Step 1|Investigator discretion|1|||
46734379|NCT02960763|82951196|FG003|Step 1|Investigator discretion|0|||
46734380|NCT02960763|82951197|FG004|Step 1|Investigator discretion|0|||
46734381|NCT02960763|82951193|FG000|Step 1|Other|0|||
46734382|NCT02960763|82951194|FG001|Step 1|Other|0|||
46734383|NCT02960763|82951195|FG002|Step 1|Other|1|||
46734384|NCT02960763|82951196|FG003|Step 1|Other|0|||
46734385|NCT02960763|82951197|FG004|Step 1|Other|0|||
46734386|NCT02960763|82951193|FG000|Step 2|Withdrawal by Subject|0|||
46734387|NCT02960763|82951194|FG001|Step 2|Withdrawal by Subject|0|||
46734388|NCT02960763|82951195|FG002|Step 2|Withdrawal by Subject|0|||
46734389|NCT02960763|82951196|FG003|Step 2|Withdrawal by Subject|7|||
46734390|NCT02960763|82951197|FG004|Step 2|Withdrawal by Subject|3|||
46734391|NCT02960763|82951193|FG000|Step 2|Lost to Follow-up|0|||
46734392|NCT02960763|82951194|FG001|Step 2|Lost to Follow-up|0|||
46734393|NCT02960763|82951195|FG002|Step 2|Lost to Follow-up|0|||
46734394|NCT02960763|82951196|FG003|Step 2|Lost to Follow-up|4|||
46734395|NCT02960763|82951197|FG004|Step 2|Lost to Follow-up|1|||
46734396|NCT02960763|82951193|FG000|Step 2|Investigator discretion|0|||
46734397|NCT02960763|82951194|FG001|Step 2|Investigator discretion|0|||
46734398|NCT02960763|82951195|FG002|Step 2|Investigator discretion|0|||
46734399|NCT02960763|82951196|FG003|Step 2|Investigator discretion|0|||
46734400|NCT02960763|82951197|FG004|Step 2|Investigator discretion|1|||
46734401|NCT00775528|82951209|FG000|Overall Study|Protocol Violation|1|||
46734402|NCT00775450|82951218|FG000|Overall Study|Serious Adverse Event|2|||
46734403|NCT00775450|82951219|FG001|Overall Study|Serious Adverse Event|0|||
46734404|NCT00775450|82951220|FG002|Overall Study|Serious Adverse Event|0|||
46734405|NCT00775450|82951221|FG003|Overall Study|Serious Adverse Event|0|||
46803964|NCT03903822|83023210|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
46734406|NCT00775450|82951222|FG004|Overall Study|Serious Adverse Event|0|||
46734407|NCT00775450|82951218|FG000|Overall Study|Protocol Violation|0|||
46734408|NCT00775450|82951219|FG001|Overall Study|Protocol Violation|0|||
46734409|NCT00775450|82951220|FG002|Overall Study|Protocol Violation|0|||
46734410|NCT00775450|82951221|FG003|Overall Study|Protocol Violation|0|||
46734411|NCT00775450|82951222|FG004|Overall Study|Protocol Violation|1|||
46734412|NCT00775450|82951218|FG000|Overall Study|Withdrawal by Subject|1|||
46734413|NCT00775450|82951219|FG001|Overall Study|Withdrawal by Subject|0|||
46734414|NCT00775450|82951220|FG002|Overall Study|Withdrawal by Subject|0|||
46734415|NCT00775450|82951221|FG003|Overall Study|Withdrawal by Subject|0|||
46734416|NCT00775450|82951222|FG004|Overall Study|Withdrawal by Subject|1|||
46734417|NCT00775138|82951238|FG000|Overall Study|Withdrawal by Subject|0|||
46734418|NCT00775138|82951239|FG001|Overall Study|Withdrawal by Subject|0|||
46734419|NCT00775138|82951240|FG002|Overall Study|Withdrawal by Subject|2|||
46734420|NCT00775138|82951241|FG003|Overall Study|Withdrawal by Subject|2|||
46734421|NCT00775138|82951238|FG000|Overall Study|Adverse Event|0|||
46734422|NCT00775138|82951239|FG001|Overall Study|Adverse Event|0|||
46734423|NCT00775138|82951240|FG002|Overall Study|Adverse Event|1|||
46734424|NCT00775138|82951241|FG003|Overall Study|Adverse Event|0|||
46734425|NCT04605991|82951253|FG000|Overall Study|Adverse Event|5|||
46734426|NCT04605991|82951253|FG000|Overall Study|Lack of Efficacy|1|||
46734427|NCT04605991|82951253|FG000|Overall Study|Lost to Follow-up|8|||
46734428|NCT04605991|82951253|FG000|Overall Study|Physician Decision|4|||
46734429|NCT04605991|82951253|FG000|Overall Study|Withdrawal by Subject|14|||
46734430|NCT04605991|82951253|FG000|Overall Study|Non-compliance with study|1|||
46734431|NCT00783796|82951257|FG000|Overall Study|Did not receive any stent|4|||
46734432|NCT00783796|82951257|FG000|Overall Study|Received non-XIENCE V stent|1|||
46734433|NCT00783796|82951257|FG000|Overall Study|Received commercial XIENCE V stent|1|||
46734434|NCT00783718|82951266|FG000|Induction Phase|Adverse Event|4|||
46734435|NCT00783718|82951267|FG001|Induction Phase|Adverse Event|0|||
46734436|NCT00783718|82951268|FG002|Induction Phase|Adverse Event|7|||
46734437|NCT00783718|82951269|FG003|Induction Phase|Adverse Event|0|||
46734438|NCT00783718|82951270|FG004|Induction Phase|Adverse Event|0|||
46734439|NCT00783718|82951271|FG005|Induction Phase|Adverse Event|0|||
46734440|NCT00783718|82951272|FG006|Induction Phase|Adverse Event|0|||
46734441|NCT00783718|82951266|FG000|Induction Phase|Protocol Violation|1|||
46734442|NCT00783718|82951267|FG001|Induction Phase|Protocol Violation|1|||
46734443|NCT00783718|82951268|FG002|Induction Phase|Protocol Violation|6|||
46734444|NCT00783718|82951269|FG003|Induction Phase|Protocol Violation|0|||
46734445|NCT00783718|82951270|FG004|Induction Phase|Protocol Violation|0|||
46734446|NCT00783718|82951271|FG005|Induction Phase|Protocol Violation|0|||
46734447|NCT00783718|82951272|FG006|Induction Phase|Protocol Violation|0|||
46734448|NCT00783718|82951266|FG000|Induction Phase|Lack of Efficacy|5|||
46734449|NCT00783718|82951267|FG001|Induction Phase|Lack of Efficacy|2|||
46734450|NCT00783718|82951268|FG002|Induction Phase|Lack of Efficacy|14|||
46734451|NCT00783718|82951269|FG003|Induction Phase|Lack of Efficacy|0|||
46734452|NCT00783718|82951270|FG004|Induction Phase|Lack of Efficacy|0|||
46734453|NCT00783718|82951271|FG005|Induction Phase|Lack of Efficacy|0|||
46734454|NCT00783718|82951272|FG006|Induction Phase|Lack of Efficacy|0|||
46734455|NCT00783718|82951266|FG000|Induction Phase|Withdrawal by Subject|3|||
46734456|NCT00783718|82951267|FG001|Induction Phase|Withdrawal by Subject|4|||
46734457|NCT00783718|82951268|FG002|Induction Phase|Withdrawal by Subject|8|||
46734458|NCT00783718|82951269|FG003|Induction Phase|Withdrawal by Subject|0|||
46734459|NCT00783718|82951270|FG004|Induction Phase|Withdrawal by Subject|0|||
46734460|NCT00783718|82951271|FG005|Induction Phase|Withdrawal by Subject|0|||
46734461|NCT00783718|82951272|FG006|Induction Phase|Withdrawal by Subject|0|||
46734462|NCT00783718|82951266|FG000|Induction Phase|Lost to Follow-up|1|||
46734463|NCT00783718|82951267|FG001|Induction Phase|Lost to Follow-up|0|||
46734464|NCT00783718|82951268|FG002|Induction Phase|Lost to Follow-up|1|||
46734465|NCT00783718|82951269|FG003|Induction Phase|Lost to Follow-up|0|||
46734466|NCT00783718|82951270|FG004|Induction Phase|Lost to Follow-up|0|||
46635222|NCT01565850|82808781|FG001|Overall Study|Adverse Event|1|||
46635223|NCT01565850|82808780|FG000|Overall Study|Lost to Follow-up|12|||
46635224|NCT01565850|82808781|FG001|Overall Study|Lost to Follow-up|4|||
46635225|NCT01565850|82808780|FG000|Overall Study|Investigator's Discretion|2|||
46635226|NCT01565850|82808781|FG001|Overall Study|Investigator's Discretion|1|||
46635227|NCT01565850|82808780|FG000|Overall Study|Participant noncompliance|2|||
46635228|NCT01565850|82808781|FG001|Overall Study|Participant noncompliance|0|||
46635229|NCT01565850|82808780|FG000|Overall Study|Withdrew Consent|4|||
46635230|NCT01565850|82808781|FG001|Overall Study|Withdrew Consent|2|||
46635231|NCT01565694|82808787|FG000|Dose-Titration Period|Adverse Event|4|||
46803965|NCT03903822|83023211|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
46803966|NCT03903822|83023212|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
46803967|NCT03903822|83023213|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
46803968|NCT03903822|83023206|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
46635232|NCT01565694|82808787|FG000|Dose-Titration Period|Protocol Violation|10|||
46635233|NCT01565694|82808787|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
46635234|NCT01543152|82808796|FG000|Overall Study|Withdrawal by Subject|0|||
46635235|NCT01543152|82808797|FG001|Overall Study|Withdrawal by Subject|2|||
46635236|NCT01543152|82808798|FG002|Overall Study|Withdrawal by Subject|0|||
46734467|NCT00783718|82951271|FG005|Induction Phase|Lost to Follow-up|0|||
46734468|NCT00783718|82951272|FG006|Induction Phase|Lost to Follow-up|0|||
46734469|NCT00783718|82951266|FG000|Maintenance Phase|Adverse Event|12|||
46734470|NCT00783718|82951267|FG001|Maintenance Phase|Adverse Event|0|||
46734471|NCT00783718|82951268|FG002|Maintenance Phase|Adverse Event|0|||
46734472|NCT00783718|82951269|FG003|Maintenance Phase|Adverse Event|15|||
46734473|NCT00783718|82951270|FG004|Maintenance Phase|Adverse Event|7|||
46734474|NCT00783718|82951271|FG005|Maintenance Phase|Adverse Event|6|||
46734475|NCT00783718|82951272|FG006|Maintenance Phase|Adverse Event|16|||
46734476|NCT00783718|82951266|FG000|Maintenance Phase|Protocol Violation|1|||
46734477|NCT00783718|82951267|FG001|Maintenance Phase|Protocol Violation|0|||
46734478|NCT00783718|82951268|FG002|Maintenance Phase|Protocol Violation|0|||
46734479|NCT00783718|82951269|FG003|Maintenance Phase|Protocol Violation|0|||
46734480|NCT00783718|82951270|FG004|Maintenance Phase|Protocol Violation|0|||
46734481|NCT00783718|82951271|FG005|Maintenance Phase|Protocol Violation|0|||
46734482|NCT00783718|82951272|FG006|Maintenance Phase|Protocol Violation|2|||
46734483|NCT00783718|82951266|FG000|Maintenance Phase|Lack of Efficacy|83|||
46734484|NCT00783718|82951267|FG001|Maintenance Phase|Lack of Efficacy|0|||
46734485|NCT00783718|82951268|FG002|Maintenance Phase|Lack of Efficacy|0|||
46734486|NCT00783718|82951269|FG003|Maintenance Phase|Lack of Efficacy|61|||
46734487|NCT00783718|82951270|FG004|Maintenance Phase|Lack of Efficacy|31|||
46734488|NCT00783718|82951271|FG005|Maintenance Phase|Lack of Efficacy|33|||
46734489|NCT00783718|82951272|FG006|Maintenance Phase|Lack of Efficacy|155|||
46734490|NCT00783718|82951266|FG000|Maintenance Phase|Withdrawal by Subject|6|||
46734491|NCT00783718|82951267|FG001|Maintenance Phase|Withdrawal by Subject|0|||
46734492|NCT00783718|82951268|FG002|Maintenance Phase|Withdrawal by Subject|0|||
46734493|NCT00783718|82951269|FG003|Maintenance Phase|Withdrawal by Subject|2|||
46734494|NCT00783718|82951270|FG004|Maintenance Phase|Withdrawal by Subject|5|||
46734495|NCT00783718|82951271|FG005|Maintenance Phase|Withdrawal by Subject|2|||
46734496|NCT00783718|82951272|FG006|Maintenance Phase|Withdrawal by Subject|20|||
46734497|NCT00783718|82951266|FG000|Maintenance Phase|Lost to Follow-up|3|||
46734498|NCT00783718|82951267|FG001|Maintenance Phase|Lost to Follow-up|0|||
46734499|NCT00783718|82951268|FG002|Maintenance Phase|Lost to Follow-up|0|||
46734500|NCT00783718|82951269|FG003|Maintenance Phase|Lost to Follow-up|0|||
46734501|NCT00783718|82951270|FG004|Maintenance Phase|Lost to Follow-up|2|||
46734502|NCT00783718|82951271|FG005|Maintenance Phase|Lost to Follow-up|0|||
46734503|NCT00783718|82951272|FG006|Maintenance Phase|Lost to Follow-up|2|||
46734504|NCT00774748|82951291|FG000|Overall Study|Lost to Follow-up|3|||
46734505|NCT00587860|82951301|FG000|Overall Study|Lost to Follow-up|2|||
46734506|NCT00587860|82951302|FG001|Overall Study|Lost to Follow-up|2|||
46734507|NCT00587860|82951301|FG000|Overall Study|Withdrawal by Subject|3|||
46734508|NCT00587860|82951302|FG001|Overall Study|Withdrawal by Subject|3|||
46635237|NCT01543152|82808799|FG003|Overall Study|Withdrawal by Subject|0|||
46734509|NCT00583453|82951310|FG000|Overall Study|discontinued intervention|0|||
46734510|NCT00583453|82951311|FG001|Overall Study|discontinued intervention|2|||
46734511|NCT00583219|82951319|FG000|Phase 2|Withdrawal by Subject|1|||
46734512|NCT01072175|82951339|FG000|Part A (Drug-Drug Interaction)|Death|1|||
46734513|NCT01072175|82951340|FG001|Part A (Drug-Drug Interaction)|Death|0|||
46734514|NCT01072175|82951341|FG002|Part A (Drug-Drug Interaction)|Death|0|||
46734515|NCT01072175|82951342|FG003|Part A (Drug-Drug Interaction)|Death|0|||
46734516|NCT01072175|82951343|FG004|Part A (Drug-Drug Interaction)|Death|0|||
46734517|NCT01072175|82951344|FG005|Part A (Drug-Drug Interaction)|Death|0|||
46734518|NCT01072175|82951345|FG006|Part A (Drug-Drug Interaction)|Death|0|||
46734519|NCT01072175|82951346|FG007|Part A (Drug-Drug Interaction)|Death|0|||
46734520|NCT01072175|82951347|FG008|Part A (Drug-Drug Interaction)|Death|0|||
46734521|NCT01072175|82951348|FG009|Part A (Drug-Drug Interaction)|Death|0|||
46734522|NCT01072175|82951349|FG010|Part A (Drug-Drug Interaction)|Death|0|||
46734523|NCT01072175|82951350|FG011|Part A (Drug-Drug Interaction)|Death|0|||
46734524|NCT01072175|82951351|FG012|Part A (Drug-Drug Interaction)|Death|0|||
46734525|NCT01072175|82951339|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
46734526|NCT01072175|82951340|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734527|NCT01072175|82951341|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734528|NCT01072175|82951342|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734529|NCT01072175|82951343|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734530|NCT01072175|82951344|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734531|NCT01072175|82951345|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734532|NCT01072175|82951346|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734533|NCT01072175|82951347|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734534|NCT01072175|82951348|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734535|NCT01072175|82951349|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734536|NCT01072175|82951350|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46803969|NCT03903822|83023207|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
46803970|NCT03903822|83023208|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
46921591|NCT00158860|83154243|FG001|Overall Study|Protocol Violation|23|||
46921592|NCT00158860|83154242|FG000|Overall Study|Withdrawal by Subject|7|||
46921593|NCT00158860|83154243|FG001|Overall Study|Withdrawal by Subject|17|||
46635238|NCT01543152|82808800|FG004|Overall Study|Withdrawal by Subject|0|||
46734537|NCT01072175|82951351|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
46734538|NCT01072175|82951339|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
46734539|NCT01072175|82951340|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46775731|NCT00793793|82994212|FG008|Overall Study|Adverse Event|0|||
46734540|NCT01072175|82951341|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734541|NCT01072175|82951342|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734542|NCT01072175|82951343|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734543|NCT01072175|82951344|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734544|NCT01072175|82951345|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734545|NCT01072175|82951346|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734546|NCT01072175|82951347|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734547|NCT01072175|82951348|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734548|NCT01072175|82951349|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734549|NCT01072175|82951350|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734550|NCT01072175|82951351|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
46734551|NCT01072175|82951339|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
46734552|NCT01072175|82951340|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
46734553|NCT01072175|82951341|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
46734554|NCT01072175|82951342|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
46734555|NCT01072175|82951343|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
46734556|NCT01072175|82951344|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
46734557|NCT01072175|82951345|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
46734558|NCT01072175|82951346|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
46734559|NCT01072175|82951347|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
46734560|NCT01072175|82951348|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
46734561|NCT01072175|82951349|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
46734562|NCT01072175|82951350|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
46734563|NCT01072175|82951351|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
46734564|NCT01072175|82951339|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734565|NCT01072175|82951340|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734566|NCT01072175|82951341|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
46734567|NCT01072175|82951342|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734568|NCT01072175|82951343|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
46734569|NCT01072175|82951344|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734570|NCT01072175|82951345|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734571|NCT01072175|82951346|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734572|NCT01072175|82951347|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734573|NCT01072175|82951348|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734574|NCT01072175|82951349|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734575|NCT01072175|82951350|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734576|NCT01072175|82951351|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
46734577|NCT01072175|82951339|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734578|NCT01072175|82951340|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
46734579|NCT01072175|82951341|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734580|NCT01072175|82951342|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
46734581|NCT01072175|82951343|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
46734582|NCT01072175|82951344|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734583|NCT01072175|82951345|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734584|NCT01072175|82951346|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734585|NCT01072175|82951347|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734586|NCT01072175|82951348|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734587|NCT01072175|82951349|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734588|NCT01072175|82951350|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734589|NCT01072175|82951351|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
46734590|NCT01072175|82951339|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734591|NCT01072175|82951340|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734592|NCT01072175|82951341|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
46734593|NCT01072175|82951342|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
46734594|NCT01072175|82951343|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
46734595|NCT01072175|82951344|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734596|NCT01072175|82951345|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734597|NCT01072175|82951346|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734598|NCT01072175|82951347|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734599|NCT01072175|82951348|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734600|NCT01072175|82951349|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734601|NCT01072175|82951350|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734602|NCT01072175|82951351|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
46734603|NCT01072175|82951339|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734604|NCT01072175|82951340|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
46734605|NCT01072175|82951341|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734606|NCT01072175|82951342|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
46734607|NCT01072175|82951343|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
46734608|NCT01072175|82951344|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734609|NCT01072175|82951345|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734610|NCT01072175|82951346|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734611|NCT01072175|82951347|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734612|NCT01072175|82951348|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734613|NCT01072175|82951349|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734614|NCT01072175|82951350|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734615|NCT01072175|82951351|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
46734616|NCT01072175|82951339|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
46734617|NCT01072175|82951340|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
46734618|NCT01072175|82951341|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
46734619|NCT01072175|82951342|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
46734620|NCT01072175|82951343|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
46734621|NCT01072175|82951344|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
46734622|NCT01072175|82951345|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
46734623|NCT01072175|82951346|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
46734624|NCT01072175|82951347|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
46734625|NCT01072175|82951348|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
46734626|NCT01072175|82951349|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
46734627|NCT01072175|82951350|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
46734628|NCT01072175|82951351|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
46734629|NCT01072175|82951339|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734630|NCT01072175|82951340|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734631|NCT01072175|82951341|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734632|NCT01072175|82951342|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734633|NCT01072175|82951343|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
47049469|NCT01920893|83309885|FG000|Overall Study|Lack of Efficacy|2|||
47049470|NCT01920893|83309886|FG001|Overall Study|Lack of Efficacy|0|||
47049471|NCT01709305|83309893|FG000|Phase 1|Clinical Adverse Event|80|||
47049472|NCT01709305|83309894|FG001|Phase 1|Clinical Adverse Event|0|||
47049473|NCT01709305|83309895|FG002|Phase 1|Clinical Adverse Event|0|||
46734634|NCT01072175|82951344|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
46734635|NCT01072175|82951345|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
46734636|NCT01072175|82951346|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
46734637|NCT01072175|82951347|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734638|NCT01072175|82951348|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734639|NCT01072175|82951349|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734640|NCT01072175|82951350|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734641|NCT01072175|82951351|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
46734642|NCT01072175|82951339|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734643|NCT01072175|82951340|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734644|NCT01072175|82951341|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734645|NCT01072175|82951342|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734646|NCT01072175|82951343|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734647|NCT01072175|82951344|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734648|NCT01072175|82951345|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
46734649|NCT01072175|82951346|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
46734650|NCT01072175|82951347|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734651|NCT01072175|82951348|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734652|NCT01072175|82951349|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734653|NCT01072175|82951350|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734654|NCT01072175|82951351|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
46734655|NCT01072175|82951339|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46803971|NCT03903822|83023209|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
47049474|NCT01709305|83309896|FG003|Phase 1|Clinical Adverse Event|0|||
47049475|NCT01709305|83309897|FG004|Phase 1|Clinical Adverse Event|0|||
47049476|NCT01709305|83309893|FG000|Phase 1|Death|2|||
47049477|NCT01709305|83309894|FG001|Phase 1|Death|0|||
47049478|NCT01709305|83309895|FG002|Phase 1|Death|0|||
46635239|NCT01590810|82808817|FG000|Overall Study|Physician Decision|0|||
46803972|NCT03903822|83023210|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
46803973|NCT03903822|83023211|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
46921594|NCT00158860|83154242|FG000|Overall Study|MOVING OUT OF STATE|1|||
47049479|NCT01709305|83309896|FG003|Phase 1|Death|0|||
47049480|NCT01709305|83309897|FG004|Phase 1|Death|0|||
47049481|NCT01709305|83309893|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
47049482|NCT01709305|83309894|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
46734656|NCT01072175|82951340|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734657|NCT01072175|82951341|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734658|NCT01072175|82951342|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734659|NCT01072175|82951343|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734660|NCT01072175|82951344|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
46734661|NCT01072175|82951345|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
46734662|NCT01072175|82951346|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
46734663|NCT01072175|82951347|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734664|NCT01072175|82951348|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734665|NCT01072175|82951349|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734666|NCT01072175|82951350|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734667|NCT01072175|82951351|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
46734668|NCT01072175|82951339|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734669|NCT01072175|82951340|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734670|NCT01072175|82951341|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734671|NCT01072175|82951342|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734672|NCT01072175|82951343|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734673|NCT01072175|82951344|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
46734674|NCT01072175|82951345|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
46734675|NCT01072175|82951346|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734676|NCT01072175|82951347|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734677|NCT01072175|82951348|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734678|NCT01072175|82951349|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734679|NCT01072175|82951350|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734680|NCT01072175|82951351|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
46734681|NCT01072175|82951339|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734682|NCT01072175|82951340|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734683|NCT01072175|82951341|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734684|NCT01072175|82951342|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734685|NCT01072175|82951343|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734686|NCT01072175|82951344|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734687|NCT01072175|82951345|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734688|NCT01072175|82951346|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734689|NCT01072175|82951347|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
46734690|NCT01072175|82951348|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734691|NCT01072175|82951349|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734692|NCT01072175|82951350|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734693|NCT01072175|82951351|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
46734694|NCT01072175|82951339|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734695|NCT01072175|82951340|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734696|NCT01072175|82951341|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734697|NCT01072175|82951342|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734698|NCT01072175|82951343|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734699|NCT01072175|82951344|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734700|NCT01072175|82951345|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734701|NCT01072175|82951346|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734702|NCT01072175|82951347|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
46734703|NCT01072175|82951348|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734704|NCT01072175|82951349|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734705|NCT01072175|82951350|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734706|NCT01072175|82951351|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
46734707|NCT01072175|82951339|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734708|NCT01072175|82951340|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
47049483|NCT01709305|83309895|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
47049484|NCT01709305|83309896|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
47049485|NCT01709305|83309897|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
47049486|NCT01709305|83309893|FG000|Phase 1|Laboratory Adverse Event|16|||
46734709|NCT01072175|82951341|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734710|NCT01072175|82951342|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734711|NCT01072175|82951343|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734712|NCT01072175|82951344|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734713|NCT01072175|82951345|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734714|NCT01072175|82951346|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734715|NCT01072175|82951347|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
47049487|NCT01709305|83309894|FG001|Phase 1|Laboratory Adverse Event|0|||
46734716|NCT01072175|82951348|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734717|NCT01072175|82951349|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734718|NCT01072175|82951350|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734719|NCT01072175|82951351|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
46734720|NCT01072175|82951339|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734721|NCT01072175|82951340|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734722|NCT01072175|82951341|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734723|NCT01072175|82951342|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734724|NCT01072175|82951343|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734725|NCT01072175|82951344|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734726|NCT01072175|82951345|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734727|NCT01072175|82951346|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
47049488|NCT01709305|83309895|FG002|Phase 1|Laboratory Adverse Event|0|||
47049489|NCT01709305|83309896|FG003|Phase 1|Laboratory Adverse Event|0|||
47049490|NCT01709305|83309897|FG004|Phase 1|Laboratory Adverse Event|0|||
47049491|NCT01709305|83309893|FG000|Phase 1|Lost to Follow-up|147|||
47049492|NCT01709305|83309894|FG001|Phase 1|Lost to Follow-up|0|||
47049493|NCT01709305|83309895|FG002|Phase 1|Lost to Follow-up|0|||
47049494|NCT01709305|83309896|FG003|Phase 1|Lost to Follow-up|0|||
47049495|NCT01709305|83309897|FG004|Phase 1|Lost to Follow-up|0|||
47049496|NCT01709305|83309893|FG000|Phase 1|Travel, moving, etc.|30|||
47049497|NCT01709305|83309894|FG001|Phase 1|Travel, moving, etc.|0|||
47049498|NCT01709305|83309895|FG002|Phase 1|Travel, moving, etc.|0|||
47049499|NCT01709305|83309896|FG003|Phase 1|Travel, moving, etc.|0|||
46734728|NCT01072175|82951347|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
46734729|NCT01072175|82951348|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734730|NCT01072175|82951349|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734731|NCT01072175|82951350|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734732|NCT01072175|82951351|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
46734733|NCT01072175|82951339|FG000|Part D (HPMC Capsules)|Death|0|||
46734734|NCT01072175|82951340|FG001|Part D (HPMC Capsules)|Death|0|||
46734735|NCT01072175|82951341|FG002|Part D (HPMC Capsules)|Death|0|||
46734736|NCT01072175|82951342|FG003|Part D (HPMC Capsules)|Death|0|||
46734737|NCT01072175|82951343|FG004|Part D (HPMC Capsules)|Death|0|||
46734738|NCT01072175|82951344|FG005|Part D (HPMC Capsules)|Death|0|||
46734739|NCT01072175|82951345|FG006|Part D (HPMC Capsules)|Death|0|||
46734740|NCT01072175|82951346|FG007|Part D (HPMC Capsules)|Death|0|||
46734741|NCT01072175|82951347|FG008|Part D (HPMC Capsules)|Death|0|||
46734742|NCT01072175|82951348|FG009|Part D (HPMC Capsules)|Death|10|||
46734743|NCT01072175|82951349|FG010|Part D (HPMC Capsules)|Death|12|||
46734744|NCT01072175|82951350|FG011|Part D (HPMC Capsules)|Death|28|||
46734745|NCT01072175|82951351|FG012|Part D (HPMC Capsules)|Death|26|||
47049500|NCT01709305|83309897|FG004|Phase 1|Travel, moving, etc.|0|||
46734746|NCT01072175|82951339|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
46734747|NCT01072175|82951340|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
46734748|NCT01072175|82951341|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
46734749|NCT01072175|82951342|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
46734750|NCT01072175|82951343|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
46734751|NCT01072175|82951344|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
46734752|NCT01072175|82951345|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
46734753|NCT01072175|82951346|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
46734754|NCT01072175|82951347|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
46734755|NCT01072175|82951348|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
46734756|NCT01072175|82951349|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
46734757|NCT01072175|82951350|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
46734758|NCT01072175|82951351|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
46734759|NCT01072175|82951339|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734760|NCT01072175|82951340|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734761|NCT01072175|82951341|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734762|NCT01072175|82951342|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734763|NCT01072175|82951343|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
47049501|NCT01709305|83309893|FG000|Phase 1|Physician Decision|13|||
47049502|NCT01709305|83309894|FG001|Phase 1|Physician Decision|0|||
46635240|NCT01590810|82808818|FG001|Overall Study|Physician Decision|1|||
46734764|NCT01072175|82951344|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734765|NCT01072175|82951345|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734766|NCT01072175|82951346|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46803974|NCT03903822|83023212|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
46803975|NCT03903822|83023213|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
47049503|NCT01709305|83309895|FG002|Phase 1|Physician Decision|0|||
47049504|NCT01709305|83309896|FG003|Phase 1|Physician Decision|0|||
47049505|NCT01709305|83309897|FG004|Phase 1|Physician Decision|0|||
47049506|NCT01709305|83309893|FG000|Phase 1|Protocol Violation|118|||
47049507|NCT01709305|83309894|FG001|Phase 1|Protocol Violation|0|||
46734767|NCT01072175|82951347|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734768|NCT01072175|82951348|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
46734769|NCT01072175|82951349|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
46734770|NCT01072175|82951350|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
46734771|NCT01072175|82951351|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
46734772|NCT01072175|82951339|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734773|NCT01072175|82951340|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734774|NCT01072175|82951341|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734775|NCT01072175|82951342|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734776|NCT01072175|82951343|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734777|NCT01072175|82951344|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734778|NCT01072175|82951345|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734779|NCT01072175|82951346|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734780|NCT01072175|82951347|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
46734781|NCT01072175|82951348|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
46734782|NCT01072175|82951349|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
46734783|NCT01072175|82951350|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
46734784|NCT01072175|82951351|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
46734785|NCT01072175|82951339|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734786|NCT01072175|82951340|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734787|NCT01072175|82951341|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734788|NCT01072175|82951342|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734789|NCT01072175|82951343|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734790|NCT01072175|82951344|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734791|NCT01072175|82951345|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734792|NCT01072175|82951346|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734793|NCT01072175|82951347|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734794|NCT01072175|82951348|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734795|NCT01072175|82951349|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
46734796|NCT01072175|82951350|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
46734797|NCT01072175|82951351|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
46734798|NCT01071317|82951385|FG000|Overall Study|Lost to Follow-up|2|||
46734799|NCT01071317|82951386|FG001|Overall Study|Lost to Follow-up|2|||
46734800|NCT00783094|82951403|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
46734801|NCT00783094|82951404|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
46734802|NCT00783094|82951405|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
46734803|NCT00783094|82951403|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
46734804|NCT00783094|82951404|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
46734805|NCT00783094|82951405|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
46734806|NCT00783094|82951403|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
46734807|NCT00783094|82951404|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
46734808|NCT00783094|82951405|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
46734809|NCT00783094|82951403|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
46734810|NCT00783094|82951404|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
46734811|NCT00783094|82951405|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
46734812|NCT00783094|82951403|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
46734813|NCT00783094|82951404|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
46734814|NCT00783094|82951405|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
46734815|NCT00783094|82951403|FG000|Open-Label Extension Period|Adverse Event|12|||
46734816|NCT00783094|82951404|FG001|Open-Label Extension Period|Adverse Event|7|||
46734817|NCT00783094|82951405|FG002|Open-Label Extension Period|Adverse Event|16|||
46734818|NCT00783094|82951403|FG000|Open-Label Extension Period|Death|0|||
46734819|NCT00783094|82951404|FG001|Open-Label Extension Period|Death|0|||
46734820|NCT00783094|82951405|FG002|Open-Label Extension Period|Death|1|||
46734821|NCT00783094|82951403|FG000|Open-Label Extension Period|Protocol Violation|4|||
46734822|NCT00783094|82951404|FG001|Open-Label Extension Period|Protocol Violation|5|||
46734823|NCT00783094|82951405|FG002|Open-Label Extension Period|Protocol Violation|7|||
46734824|NCT00783094|82951403|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
46734825|NCT00783094|82951404|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
46734826|NCT00783094|82951405|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
46734827|NCT00783094|82951403|FG000|Open-Label Extension Period|Physician Decision|4|||
47049508|NCT01709305|83309895|FG002|Phase 1|Protocol Violation|0|||
47049509|NCT01709305|83309896|FG003|Phase 1|Protocol Violation|0|||
46734828|NCT00783094|82951404|FG001|Open-Label Extension Period|Physician Decision|2|||
46734829|NCT00783094|82951405|FG002|Open-Label Extension Period|Physician Decision|3|||
46734830|NCT00783094|82951403|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
46734831|NCT00783094|82951404|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
46734832|NCT00783094|82951405|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
46734833|NCT00790582|82951418|FG000|Overall Study|Death|14|||
46734834|NCT00790582|82951419|FG001|Overall Study|Death|32|||
46734835|NCT00790582|82951418|FG000|Overall Study|Physician Decision|7|||
46734836|NCT00790582|82951419|FG001|Overall Study|Physician Decision|1|||
46734837|NCT00790582|82951418|FG000|Overall Study|Lost to Follow-up|3|||
46734838|NCT00790582|82951419|FG001|Overall Study|Lost to Follow-up|3|||
46734839|NCT00790582|82951418|FG000|Overall Study|Withdrawal by Subject|7|||
46734840|NCT00790582|82951419|FG001|Overall Study|Withdrawal by Subject|51|||
46734841|NCT01048541|82951427|FG000|Overall Study|Withdrawal by Subject|1|||
46734842|NCT01048541|82951428|FG001|Overall Study|Withdrawal by Subject|0|||
46734843|NCT00774046|82951434|FG000|Screening|Not eligible|56|||
46734844|NCT00774046|82951434|FG000|Enrollment|Desired other therapy/refused|28|||
46734845|NCT00774046|82951434|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
46734846|NCT01046903|82951438|FG000|Overall Study|Lost to Follow-up|16|||
46734847|NCT01046903|82951438|FG000|Overall Study|Adverse Event|4|||
46734848|NCT01046903|82951438|FG000|Overall Study|Withdrawal by Subject|3|||
46734849|NCT01046903|82951438|FG000|Overall Study|Other|5|||
46734850|NCT00773968|82951442|FG000|Overall Study|Adverse Event|2|||
46734851|NCT00773968|82951442|FG000|Overall Study|Death|1|||
46734852|NCT00773968|82951442|FG000|Overall Study|Failure to Return|2|||
46734853|NCT00773968|82951442|FG000|Overall Study|Lack of Efficacy|3|||
46734854|NCT00773968|82951442|FG000|Overall Study|Protocol Violation|1|||
46734855|NCT00773968|82951442|FG000|Overall Study|Withdrawal by Subject|11|||
46734856|NCT00773968|82951442|FG000|Overall Study|Screen Failure|17|||
46734857|NCT00773968|82951442|FG000|Overall Study|Other|8|||
46734858|NCT00782626|82951446|FG000|Overall Study|Adverse Event|1|||
46734859|NCT00782626|82951446|FG000|Overall Study|Progressive Disease|5|||
46734860|NCT00782626|82951446|FG000|Overall Study|Other Complicating Disease|1|||
46734861|NCT01071083|82951455|FG000|Overall Study|Adverse Event|1|||
46734862|NCT01071083|82951456|FG001|Overall Study|Adverse Event|0|||
46734863|NCT01071083|82951457|FG002|Overall Study|Adverse Event|1|||
46734864|NCT01071083|82951458|FG003|Overall Study|Adverse Event|0|||
46734865|NCT01071083|82951459|FG004|Overall Study|Adverse Event|1|||
46734866|NCT01071083|82951455|FG000|Overall Study|Withdrawal by Subject|3|||
46734867|NCT01071083|82951456|FG001|Overall Study|Withdrawal by Subject|0|||
46734868|NCT01071083|82951457|FG002|Overall Study|Withdrawal by Subject|2|||
46734869|NCT01071083|82951458|FG003|Overall Study|Withdrawal by Subject|0|||
46734870|NCT01071083|82951459|FG004|Overall Study|Withdrawal by Subject|3|||
46734871|NCT01071083|82951455|FG000|Overall Study|Physician Decision|1|||
46734872|NCT01071083|82951456|FG001|Overall Study|Physician Decision|0|||
46734873|NCT01071083|82951457|FG002|Overall Study|Physician Decision|0|||
46734874|NCT01071083|82951458|FG003|Overall Study|Physician Decision|1|||
46734875|NCT01071083|82951459|FG004|Overall Study|Physician Decision|1|||
46734876|NCT01071083|82951455|FG000|Overall Study|Early Rescue|1|||
46734877|NCT01071083|82951456|FG001|Overall Study|Early Rescue|0|||
46734878|NCT01071083|82951457|FG002|Overall Study|Early Rescue|0|||
46734879|NCT01071083|82951458|FG003|Overall Study|Early Rescue|0|||
46734880|NCT01071083|82951459|FG004|Overall Study|Early Rescue|1|||
46734881|NCT01071083|82951455|FG000|Overall Study|Subject Moved|0|||
46734882|NCT01071083|82951456|FG001|Overall Study|Subject Moved|1|||
46734883|NCT01071083|82951457|FG002|Overall Study|Subject Moved|0|||
46734884|NCT01071083|82951458|FG003|Overall Study|Subject Moved|0|||
46734885|NCT01071083|82951459|FG004|Overall Study|Subject Moved|0|||
46734886|NCT01071083|82951455|FG000|Overall Study|Images Not Usable (Motion)|0|||
46734887|NCT01071083|82951456|FG001|Overall Study|Images Not Usable (Motion)|1|||
46734888|NCT01071083|82951457|FG002|Overall Study|Images Not Usable (Motion)|0|||
46734889|NCT01071083|82951458|FG003|Overall Study|Images Not Usable (Motion)|0|||
46734890|NCT01071083|82951459|FG004|Overall Study|Images Not Usable (Motion)|0|||
46734891|NCT01071083|82951455|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
46734892|NCT01071083|82951456|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
46734893|NCT01071083|82951457|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
46734894|NCT01071083|82951458|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
46734895|NCT01071083|82951459|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
46734896|NCT01071083|82951455|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
46734897|NCT01071083|82951456|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
46734898|NCT01071083|82951457|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
46734899|NCT01071083|82951458|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
46734900|NCT01071083|82951459|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
46734901|NCT01071083|82951455|FG000|Overall Study|Subject Refused to Continue|1|||
46734902|NCT01071083|82951456|FG001|Overall Study|Subject Refused to Continue|0|||
46734903|NCT01071083|82951457|FG002|Overall Study|Subject Refused to Continue|0|||
46734904|NCT01071083|82951458|FG003|Overall Study|Subject Refused to Continue|0|||
46734905|NCT01071083|82951459|FG004|Overall Study|Subject Refused to Continue|0|||
46734906|NCT01070771|82951471|FG000|Overall Study|Adverse Event|2|||
46734907|NCT01070771|82951471|FG000|Overall Study|Protocol Violation|1|||
46734908|NCT01070381|82951476|FG000|Period 2, 1 Week of Wear|Handling|0|||
46734909|NCT01070381|82951477|FG001|Period 2, 1 Week of Wear|Handling|1|||
46734910|NCT01070381|82951476|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
46734911|NCT01070381|82951477|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
46734912|NCT01010126|82951498|FG000|Overall Study|Withdrawal by Subject|1|||
46734913|NCT01010126|82951499|FG001|Overall Study|Withdrawal by Subject|0|||
46734914|NCT01010126|82951500|FG002|Overall Study|Withdrawal by Subject|1|||
46734915|NCT01010126|82951501|FG003|Overall Study|Withdrawal by Subject|0|||
46734916|NCT01010126|82951502|FG004|Overall Study|Withdrawal by Subject|3|||
46734917|NCT01010126|82951503|FG005|Overall Study|Withdrawal by Subject|0|||
46734918|NCT01043705|82951520|FG000|Overall Study|Death|28|||
46734919|NCT01043705|82951521|FG001|Overall Study|Death|60|||
46734920|NCT01043705|82951522|FG002|Overall Study|Death|26|||
46734921|NCT01043705|82951520|FG000|Overall Study|Lost to Follow-up|27|||
46734922|NCT01043705|82951521|FG001|Overall Study|Lost to Follow-up|12|||
46734923|NCT01043705|82951522|FG002|Overall Study|Lost to Follow-up|0|||
46734924|NCT01043705|82951520|FG000|Overall Study|Multiple Reasons|4|||
46734925|NCT01043705|82951521|FG001|Overall Study|Multiple Reasons|7|||
46734926|NCT01043705|82951522|FG002|Overall Study|Multiple Reasons|0|||
46734927|NCT01043705|82951520|FG000|Overall Study|Protocol Violation|2|||
46734928|NCT01043705|82951521|FG001|Overall Study|Protocol Violation|1|||
46734929|NCT01043705|82951522|FG002|Overall Study|Protocol Violation|0|||
46734930|NCT01043705|82951520|FG000|Overall Study|Withdrawal by Subject|8|||
46734931|NCT01043705|82951521|FG001|Overall Study|Withdrawal by Subject|6|||
46734932|NCT01043705|82951522|FG002|Overall Study|Withdrawal by Subject|0|||
46734933|NCT01043705|82951520|FG000|Overall Study|Site Closure|8|||
46734934|NCT01043705|82951521|FG001|Overall Study|Site Closure|0|||
46734935|NCT01043705|82951522|FG002|Overall Study|Site Closure|0|||
46734936|NCT01043705|82951520|FG000|Overall Study|Subsequent Procedure|9|||
46734937|NCT01043705|82951521|FG001|Overall Study|Subsequent Procedure|24|||
46734938|NCT01043705|82951522|FG002|Overall Study|Subsequent Procedure|29|||
46734939|NCT01043705|82951520|FG000|Overall Study|Adverse Event|0|||
46734940|NCT01043705|82951521|FG001|Overall Study|Adverse Event|2|||
46734941|NCT01043705|82951522|FG002|Overall Study|Adverse Event|0|||
46734942|NCT01043705|82951520|FG000|Overall Study|Screen Fail|21|||
46734943|NCT01043705|82951521|FG001|Overall Study|Screen Fail|0|||
46734944|NCT01043705|82951522|FG002|Overall Study|Screen Fail|0|||
46734945|NCT01043705|82951520|FG000|Overall Study|Other|0|||
46734946|NCT01043705|82951521|FG001|Overall Study|Other|19|||
46734947|NCT01043705|82951522|FG002|Overall Study|Other|25|||
46734948|NCT01070303|82951541|FG000|Overall Study|Adverse Event|39|||
46734949|NCT01070303|82951541|FG000|Overall Study|Withdrawal by Subject|20|||
46734950|NCT01070303|82951541|FG000|Overall Study|Lost to Follow-up|9|||
46734951|NCT01070303|82951541|FG000|Overall Study|Protocol Violation|0|||
46734952|NCT01070303|82951541|FG000|Overall Study|Lack of Efficacy|2|||
46734953|NCT01070303|82951541|FG000|Overall Study|Administrative Reason|1|||
46734954|NCT01070303|82951541|FG000|Overall Study|Other|18|||
46734955|NCT01009814|82951556|FG000|Overall Study|No longer met study criteria|1|||
46734956|NCT01009814|82951557|FG001|Overall Study|No longer met study criteria|1|||
46734957|NCT01009814|82951558|FG002|Overall Study|No longer met study criteria|0|||
46734958|NCT01009814|82951559|FG003|Overall Study|No longer met study criteria|0|||
46734959|NCT01009814|82951560|FG004|Overall Study|No longer met study criteria|0|||
46734960|NCT03824587|82951578|FG000|Run-in Period|Screen Failure|0|||
46734961|NCT03824587|82951579|FG001|Run-in Period|Screen Failure|275|||
46734962|NCT03824587|82951578|FG000|Treatment Period|Adverse Event|4|||
46734963|NCT03824587|82951579|FG001|Treatment Period|Adverse Event|1|||
46734964|NCT03824587|82951578|FG000|Treatment Period|Withdrawal by Subject|0|||
46734965|NCT03824587|82951579|FG001|Treatment Period|Withdrawal by Subject|1|||
46734966|NCT03824587|82951578|FG000|Treatment Period|Kidney Transplant|1|||
46734967|NCT03824587|82951579|FG001|Treatment Period|Kidney Transplant|1|||
46734968|NCT00773734|82951589|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
46734969|NCT00773734|82951590|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
46734970|NCT00773734|82951591|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
46734971|NCT00773734|82951592|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
46734972|NCT00773734|82951593|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
46734973|NCT00773734|82951594|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
46734974|NCT00773734|82951589|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
46734975|NCT00773734|82951590|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
46921595|NCT00158860|83154243|FG001|Overall Study|MOVING OUT OF STATE|0|||
46921596|NCT00158860|83154242|FG000|Overall Study|Pregnancy|3|||
46921597|NCT00158860|83154243|FG001|Overall Study|Pregnancy|3|||
46921598|NCT00158860|83154242|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
46921599|NCT00158860|83154243|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
46921600|NCT00158860|83154242|FG000|Overall Study|SPONSOR REQUEST|0|||
46921601|NCT00158860|83154243|FG001|Overall Study|SPONSOR REQUEST|1|||
46734976|NCT00773734|82951591|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
46734977|NCT00773734|82951592|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
46734978|NCT00773734|82951593|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
46734979|NCT00773734|82951594|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
46734980|NCT00773734|82951589|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
47049510|NCT01709305|83309897|FG004|Phase 1|Protocol Violation|0|||
46734981|NCT00773734|82951590|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
46734982|NCT00773734|82951591|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
46734983|NCT00773734|82951592|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
46734984|NCT00773734|82951593|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
46734985|NCT00773734|82951594|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
46734986|NCT00773734|82951589|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
46734987|NCT00773734|82951590|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
46734988|NCT00773734|82951591|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
46734989|NCT00773734|82951592|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
46734990|NCT00773734|82951593|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
46734991|NCT00773734|82951594|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
46734992|NCT00773734|82951589|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
46734993|NCT00773734|82951590|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
46734994|NCT00773734|82951591|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
46734995|NCT00773734|82951592|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
46734996|NCT00773734|82951593|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
46734997|NCT00773734|82951594|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
46734998|NCT00773734|82951589|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
46734999|NCT00773734|82951590|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
46735000|NCT00773734|82951591|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
46735001|NCT00773734|82951592|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
46735002|NCT00773734|82951593|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
46735003|NCT00773734|82951594|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
46735004|NCT00773734|82951589|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
46735005|NCT00773734|82951590|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
46735006|NCT00773734|82951591|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
46735007|NCT00773734|82951592|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
46735008|NCT00773734|82951593|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
46735009|NCT00773734|82951594|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
46735010|NCT00773734|82951589|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
46735011|NCT00773734|82951590|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
46735012|NCT00773734|82951591|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
46735013|NCT00773734|82951592|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
46735014|NCT00773734|82951593|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
46735015|NCT00773734|82951594|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
46735016|NCT00773734|82951589|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
46735017|NCT00773734|82951590|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
46735018|NCT00773734|82951591|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
46735019|NCT00773734|82951592|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
46735020|NCT00773734|82951593|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
46735021|NCT00773734|82951594|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
46735022|NCT00773734|82951589|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
46735023|NCT00773734|82951590|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
46735024|NCT00773734|82951591|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
46735025|NCT00773734|82951592|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
46735026|NCT00773734|82951593|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
46735027|NCT00773734|82951594|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
46735028|NCT00773734|82951589|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
46735029|NCT00773734|82951590|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
46735030|NCT00773734|82951591|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
46735031|NCT00773734|82951592|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
46735032|NCT00773734|82951593|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
46735033|NCT00773734|82951594|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
46735034|NCT00773734|82951589|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
46735035|NCT00773734|82951590|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
46735036|NCT00773734|82951591|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
46735037|NCT00773734|82951592|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
46735038|NCT00773734|82951593|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
46735039|NCT00773734|82951594|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
46735040|NCT00773734|82951589|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
46635241|NCT01590810|82808819|FG002|Overall Study|Physician Decision|1|||
46635242|NCT01590810|82808820|FG003|Overall Study|Physician Decision|0|||
46635243|NCT01590810|82808821|FG004|Overall Study|Physician Decision|0|||
46635244|NCT01542528|82808856|FG000|Overall Study|Lost to Follow-up|2|||
46635245|NCT01542528|82808857|FG001|Overall Study|Lost to Follow-up|1|||
46735041|NCT00773734|82951590|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
46735042|NCT00773734|82951591|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
46735043|NCT00773734|82951592|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
46735044|NCT00773734|82951593|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
46735045|NCT00773734|82951594|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
46735046|NCT00773734|82951589|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
46735047|NCT00773734|82951590|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
46735048|NCT00773734|82951591|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
46735049|NCT00773734|82951592|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
46735050|NCT00773734|82951593|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
46735051|NCT00773734|82951594|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
46735052|NCT00773734|82951589|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
46735053|NCT00773734|82951590|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
46735054|NCT00773734|82951591|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
46735055|NCT00773734|82951592|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
46735056|NCT00773734|82951593|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
46735057|NCT00773734|82951594|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
46735058|NCT00773734|82951589|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
46735059|NCT00773734|82951590|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
46735060|NCT00773734|82951591|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
46735061|NCT00773734|82951592|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
46735062|NCT00773734|82951593|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
46735063|NCT00773734|82951594|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
46735064|NCT00773734|82951589|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
46735065|NCT00773734|82951590|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
46735066|NCT00773734|82951591|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
46735067|NCT00773734|82951592|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
46735068|NCT00773734|82951593|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
46735069|NCT00773734|82951594|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
46735070|NCT00773734|82951589|FG000|Extension: Active Treatment Week 24-52|Other|0|||
46735071|NCT00773734|82951590|FG001|Extension: Active Treatment Week 24-52|Other|0|||
46735072|NCT00773734|82951591|FG002|Extension: Active Treatment Week 24-52|Other|1|||
46735073|NCT00773734|82951592|FG003|Extension: Active Treatment Week 24-52|Other|2|||
46735074|NCT00773734|82951593|FG004|Extension: Active Treatment Week 24-52|Other|0|||
46735075|NCT00773734|82951594|FG005|Extension: Active Treatment Week 24-52|Other|1|||
46735076|NCT00773734|82951589|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
46735077|NCT00773734|82951590|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
46735078|NCT00773734|82951591|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
46735079|NCT00773734|82951592|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
46735080|NCT00773734|82951593|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
46735081|NCT00773734|82951594|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
46735082|NCT00773734|82951589|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
46735083|NCT00773734|82951590|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
46735084|NCT00773734|82951591|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
46735085|NCT00773734|82951592|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
46735086|NCT00773734|82951593|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
46735087|NCT00773734|82951594|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
46735088|NCT00773734|82951589|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
46735089|NCT00773734|82951590|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
46735090|NCT00773734|82951591|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
46735091|NCT00773734|82951592|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
46735092|NCT00773734|82951593|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
46735093|NCT00773734|82951594|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
46735094|NCT00773734|82951589|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
46735095|NCT00773734|82951590|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
46735096|NCT00773734|82951591|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
46735097|NCT00773734|82951592|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
46735098|NCT00773734|82951593|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
46735099|NCT00773734|82951594|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
47049511|NCT01709305|83309893|FG000|Phase 1|Withdrawal by Subject|218|||
47049512|NCT01709305|83309894|FG001|Phase 1|Withdrawal by Subject|0|||
46735100|NCT01009580|82951653|FG000|Overall Study|Adverse Event|4|||
46735101|NCT01009580|82951654|FG001|Overall Study|Adverse Event|4|||
46735102|NCT01009580|82951653|FG000|Overall Study|Lack of Efficacy|0|||
46735103|NCT01009580|82951654|FG001|Overall Study|Lack of Efficacy|1|||
46735104|NCT01009580|82951653|FG000|Overall Study|Protocol Violation|2|||
46735105|NCT01009580|82951654|FG001|Overall Study|Protocol Violation|3|||
46735106|NCT01009580|82951653|FG000|Overall Study|Withdrawal Criteria|4|||
47049513|NCT01709305|83309895|FG002|Phase 1|Withdrawal by Subject|0|||
46735107|NCT01009580|82951654|FG001|Overall Study|Withdrawal Criteria|6|||
46735108|NCT01009580|82951653|FG000|Overall Study|Unclassified|17|||
46735109|NCT01009580|82951654|FG001|Overall Study|Unclassified|21|||
46735110|NCT01009346|82951660|FG000|Overall Study|Adverse Event|4|||
46735111|NCT01001702|82951665|FG000|Overall Study|Lost to Follow-up|7|||
46735112|NCT01001702|82951665|FG000|Overall Study|Adverse Event|7|||
46735113|NCT01001702|82951665|FG000|Overall Study|Sponsor Discontinued Study|4|||
46735114|NCT01001702|82951665|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
46735115|NCT01001702|82951665|FG000|Overall Study|Investigator withdrew Subject|10|||
46735116|NCT01001702|82951665|FG000|Overall Study|Withdrawal by Subject|19|||
46735117|NCT01001702|82951665|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
46735118|NCT01070069|82951674|FG000|Overall Study|Death|1|||
46735119|NCT01070069|82951675|FG001|Overall Study|Death|0|||
46735120|NCT01070069|82951676|FG002|Overall Study|Death|2|||
46735121|NCT01070069|82951677|FG003|Overall Study|Death|0|||
46735122|NCT01070069|82951678|FG004|Overall Study|Death|1|||
46735123|NCT01070069|82951674|FG000|Overall Study|Withdrawal by Subject|1|||
46735124|NCT01070069|82951675|FG001|Overall Study|Withdrawal by Subject|1|||
46735125|NCT01070069|82951676|FG002|Overall Study|Withdrawal by Subject|4|||
46735126|NCT01070069|82951677|FG003|Overall Study|Withdrawal by Subject|0|||
46735127|NCT01070069|82951678|FG004|Overall Study|Withdrawal by Subject|0|||
46735128|NCT01070069|82951674|FG000|Overall Study|Lost to Follow-up|4|||
46735129|NCT01070069|82951675|FG001|Overall Study|Lost to Follow-up|1|||
46735130|NCT01070069|82951676|FG002|Overall Study|Lost to Follow-up|0|||
46735131|NCT01070069|82951677|FG003|Overall Study|Lost to Follow-up|0|||
46735132|NCT01070069|82951678|FG004|Overall Study|Lost to Follow-up|3|||
46735133|NCT01068665|82951695|FG000|Overall Study|Adverse Event|5|||
46735134|NCT01068665|82951696|FG001|Overall Study|Adverse Event|4|||
46735135|NCT01068665|82951695|FG000|Overall Study|Lack of Efficacy|0|||
46735136|NCT01068665|82951696|FG001|Overall Study|Lack of Efficacy|2|||
46735137|NCT01068665|82951695|FG000|Overall Study|Protocol Violation|5|||
46735138|NCT01068665|82951696|FG001|Overall Study|Protocol Violation|2|||
46735139|NCT01068665|82951695|FG000|Overall Study|Withdrawal Criteria|3|||
46735140|NCT01068665|82951696|FG001|Overall Study|Withdrawal Criteria|9|||
46735141|NCT01068665|82951695|FG000|Overall Study|Other|17|||
46735142|NCT01068665|82951696|FG001|Overall Study|Other|12|||
46735143|NCT01001390|82951702|FG000|Overall Study|Failure to wear AFO device|2|||
46735144|NCT01001390|82951703|FG001|Overall Study|Failure to wear AFO device|0|||
46735145|NCT00772954|82951711|FG000|Overall Study|Adverse Event|0|||
46735146|NCT00772954|82951712|FG001|Overall Study|Adverse Event|0|||
46735147|NCT00772954|82951713|FG002|Overall Study|Adverse Event|1|||
46735148|NCT00781768|82951727|FG000|Overall Study|Not transplanted.|0|||
46735149|NCT00781768|82951728|FG001|Overall Study|Not transplanted.|2|||
46735150|NCT01005680|82951736|FG000|Overall Study|Lost to Follow-up|4|||
46735151|NCT01005680|82951737|FG001|Overall Study|Lost to Follow-up|6|||
46735152|NCT01005680|82951736|FG000|Overall Study|Withdrawal by Subject|1|||
46735153|NCT01005680|82951737|FG001|Overall Study|Withdrawal by Subject|4|||
46735154|NCT01005680|82951736|FG000|Overall Study|Physician Decision|1|||
46735155|NCT01005680|82951737|FG001|Overall Study|Physician Decision|1|||
46735156|NCT01005602|82951746|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
46735157|NCT01005602|82951747|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
46735158|NCT01068509|82951763|FG000|Overall Study|Death|0|||
46735159|NCT01068509|82951764|FG001|Overall Study|Death|0|||
46735160|NCT01068509|82951765|FG002|Overall Study|Death|1|||
46735161|NCT01068509|82951763|FG000|Overall Study|Disease Progression|5|||
46735162|NCT01068509|82951764|FG001|Overall Study|Disease Progression|20|||
46735163|NCT01068509|82951765|FG002|Overall Study|Disease Progression|18|||
46735164|NCT01068509|82951763|FG000|Overall Study|Lost to Follow-up|1|||
46735165|NCT01068509|82951764|FG001|Overall Study|Lost to Follow-up|0|||
46735166|NCT01068509|82951765|FG002|Overall Study|Lost to Follow-up|0|||
46735167|NCT01068509|82951763|FG000|Overall Study|Withdrew Consent|0|||
46735168|NCT01068509|82951764|FG001|Overall Study|Withdrew Consent|1|||
46735169|NCT01068509|82951765|FG002|Overall Study|Withdrew Consent|2|||
46735170|NCT01068509|82951763|FG000|Overall Study|Reason Not Specified|0|||
46735171|NCT01068509|82951764|FG001|Overall Study|Reason Not Specified|1|||
46735172|NCT01068509|82951765|FG002|Overall Study|Reason Not Specified|0|||
46735173|NCT01009034|82951772|FG000|Overall Study|Lost to Follow-up|2|||
46735174|NCT01009034|82951772|FG000|Overall Study|Withdrawal by Subject|2|||
46735175|NCT00768430|82951778|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
46735176|NCT00768430|82951779|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
46735177|NCT01064297|82951788|FG000|Overall Study|Lost to Follow-up|791|||
46735178|NCT01064297|82951789|FG001|Overall Study|Lost to Follow-up|48|||
46735179|NCT01064297|82951790|FG002|Overall Study|Lost to Follow-up|133|||
46735180|NCT00781456|82951807|FG000|Overall Study|Adverse Event|3|||
46735181|NCT00781456|82951808|FG001|Overall Study|Adverse Event|3|||
46735182|NCT00781456|82951807|FG000|Overall Study|Withdrawal by Subject|3|||
46735183|NCT00781456|82951808|FG001|Overall Study|Withdrawal by Subject|5|||
46735184|NCT00781456|82951807|FG000|Overall Study|Protocol Violation|4|||
46735185|NCT00781456|82951808|FG001|Overall Study|Protocol Violation|1|||
46775732|NCT00793793|82994213|FG009|Overall Study|Adverse Event|0|||
46921602|NCT00158860|83154242|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
46921603|NCT00158860|83154243|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
46921604|NCT00158860|83154242|FG000|Overall Study|Closed per sponsor|0|||
46921605|NCT00158860|83154243|FG001|Overall Study|Closed per sponsor|1|||
46921606|NCT03067129|83154254|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
46921607|NCT03067129|83154255|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
46921608|NCT03067129|83154256|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
46735186|NCT00781456|82951807|FG000|Overall Study|Noncompliance With Protocol|1|||
46735187|NCT00781456|82951808|FG001|Overall Study|Noncompliance With Protocol|1|||
46735188|NCT00781456|82951807|FG000|Overall Study|Lost to Follow-up|10|||
46735189|NCT00781456|82951808|FG001|Overall Study|Lost to Follow-up|5|||
46735190|NCT00781456|82951807|FG000|Overall Study|Other Reason, Unknown|0|||
46735191|NCT00781456|82951808|FG001|Overall Study|Other Reason, Unknown|1|||
46735192|NCT00587158|82951816|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
46735193|NCT00587158|82951817|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
46735194|NCT00587158|82951816|FG000|Overall Study|Physician Decision|0|||
46735195|NCT00587158|82951817|FG001|Overall Study|Physician Decision|1|||
46735196|NCT00587158|82951816|FG000|Overall Study|Lost to Follow-up|1|||
46735197|NCT00587158|82951817|FG001|Overall Study|Lost to Follow-up|2|||
46735198|NCT00587158|82951816|FG000|Overall Study|Death|0|||
46735199|NCT00587158|82951817|FG001|Overall Study|Death|1|||
46735200|NCT00587158|82951816|FG000|Overall Study|Subject did not want to take study med|0|||
46735201|NCT00587158|82951817|FG001|Overall Study|Subject did not want to take study med|1|||
46735202|NCT00582907|82951823|FG000|1st Course|Withdrawal by Subject|1|||
46735203|NCT00582907|82951824|FG001|1st Course|Withdrawal by Subject|0|||
46735204|NCT00582907|82951825|FG002|1st Course|Withdrawal by Subject|0|||
46735205|NCT00582907|82951826|FG003|1st Course|Withdrawal by Subject|0|||
46735206|NCT00582907|82951823|FG000|1st Course|Lost to Follow-up|0|||
46735207|NCT00582907|82951824|FG001|1st Course|Lost to Follow-up|0|||
46735208|NCT00582907|82951825|FG002|1st Course|Lost to Follow-up|0|||
46735209|NCT00582907|82951826|FG003|1st Course|Lost to Follow-up|1|||
46735210|NCT00582907|82951823|FG000|2nd Course|Lack of Efficacy|1|||
46735211|NCT00582907|82951824|FG001|2nd Course|Lack of Efficacy|0|||
46735212|NCT00582907|82951825|FG002|2nd Course|Lack of Efficacy|0|||
46735213|NCT00582907|82951826|FG003|2nd Course|Lack of Efficacy|0|||
46735214|NCT01062113|82951835|FG000|Overall Study|Adverse Event|1|||
46735215|NCT01062113|82951836|FG001|Overall Study|Adverse Event|0|||
46735216|NCT01062113|82951837|FG002|Overall Study|Adverse Event|0|||
46735217|NCT01062113|82951835|FG000|Overall Study|Lack of Efficacy|38|||
46735218|NCT01062113|82951836|FG001|Overall Study|Lack of Efficacy|22|||
46735219|NCT01062113|82951837|FG002|Overall Study|Lack of Efficacy|31|||
46735220|NCT01062113|82951835|FG000|Overall Study|Withdrawal by Subject|1|||
46735221|NCT01062113|82951836|FG001|Overall Study|Withdrawal by Subject|0|||
46735222|NCT01062113|82951837|FG002|Overall Study|Withdrawal by Subject|0|||
46735223|NCT00772330|82951845|FG000|Overall Study|Lost to Follow-up|3|||
46735224|NCT01038869|82951852|FG000|Overall Study|Withdrawal by Subject|1|||
46735225|NCT01038869|82951852|FG000|Overall Study|Lost to Follow-up|6|||
46735226|NCT01038713|82951863|FG000|Overall Study|Patient to hospice|1|||
46735227|NCT01038713|82951864|FG001|Overall Study|Patient to hospice|1|||
46735228|NCT01038713|82951865|FG002|Overall Study|Patient to hospice|1|||
46735229|NCT01038713|82951863|FG000|Overall Study|Lost to Follow-up|3|||
46735230|NCT01038713|82951864|FG001|Overall Study|Lost to Follow-up|0|||
46735231|NCT01038713|82951865|FG002|Overall Study|Lost to Follow-up|0|||
46735232|NCT01038713|82951863|FG000|Overall Study|Neuroendocrine Tumor|0|||
46735233|NCT01038713|82951864|FG001|Overall Study|Neuroendocrine Tumor|1|||
46735234|NCT01038713|82951865|FG002|Overall Study|Neuroendocrine Tumor|0|||
46735235|NCT01038713|82951863|FG000|Overall Study|died from PEP|0|||
46735236|NCT01038713|82951864|FG001|Overall Study|died from PEP|1|||
46735237|NCT01038713|82951865|FG002|Overall Study|died from PEP|0|||
46735238|NCT01038713|82951863|FG000|Overall Study|Autoimmune Pancreatitis|1|||
46735239|NCT01038713|82951864|FG001|Overall Study|Autoimmune Pancreatitis|0|||
46735240|NCT01038713|82951865|FG002|Overall Study|Autoimmune Pancreatitis|0|||
46735241|NCT00768040|82951875|FG000|Overall Study|Adverse Event|3|||
46735242|NCT00768040|82951876|FG001|Overall Study|Adverse Event|2|||
46735243|NCT00768040|82951875|FG000|Overall Study|Abnormal laboratory value|1|||
46735244|NCT00768040|82951876|FG001|Overall Study|Abnormal laboratory value|1|||
46735245|NCT00767806|82951884|FG000|Overall Study|Adverse Event|30|||
46735246|NCT00767806|82951885|FG001|Overall Study|Adverse Event|11|||
46735247|NCT00767806|82951884|FG000|Overall Study|Withdrawal by Subject|8|||
46735248|NCT00767806|82951885|FG001|Overall Study|Withdrawal by Subject|13|||
46735249|NCT00767806|82951884|FG000|Overall Study|Protocol Violation|6|||
46735250|NCT00767806|82951885|FG001|Overall Study|Protocol Violation|5|||
46735251|NCT00767806|82951884|FG000|Overall Study|Lack of Efficacy|1|||
46735252|NCT00767806|82951885|FG001|Overall Study|Lack of Efficacy|9|||
46735253|NCT00767806|82951884|FG000|Overall Study|Physician Decision|4|||
46921609|NCT03067129|83154257|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
46735254|NCT00767806|82951885|FG001|Overall Study|Physician Decision|3|||
46735255|NCT00767806|82951884|FG000|Overall Study|Lost to Follow-up|1|||
46735256|NCT00767806|82951885|FG001|Overall Study|Lost to Follow-up|4|||
46735257|NCT00767806|82951884|FG000|Overall Study|Entry Criteria Not Met|1|||
46735258|NCT00767806|82951885|FG001|Overall Study|Entry Criteria Not Met|1|||
46735259|NCT00767806|82951884|FG000|Overall Study|Sponsor Decision|0|||
46735260|NCT00767806|82951885|FG001|Overall Study|Sponsor Decision|1|||
46735261|NCT00780910|82951891|FG000|Overall Study|Adverse Event|2|||
46735262|NCT00767104|82951897|FG000|Overall Study|Lost to Follow-up|1|||
46735263|NCT00767104|82951898|FG001|Overall Study|Lost to Follow-up|2|||
46735264|NCT00771472|82951906|FG000|Overall Study|Physician Decision|2|||
46735265|NCT00771472|82951907|FG001|Overall Study|Physician Decision|3|||
46735266|NCT00771472|82951906|FG000|Overall Study|Progressive Disease|3|||
46735267|NCT00771472|82951907|FG001|Overall Study|Progressive Disease|1|||
46735268|NCT00771472|82951906|FG000|Overall Study|Protocol Violation|1|||
46735269|NCT00771472|82951907|FG001|Overall Study|Protocol Violation|0|||
47049514|NCT01709305|83309896|FG003|Phase 1|Withdrawal by Subject|0|||
47049515|NCT01709305|83309897|FG004|Phase 1|Withdrawal by Subject|0|||
47049516|NCT01709305|83309893|FG000|Phase 2|Clinical Adverse Event|0|||
46735270|NCT00771316|82951914|FG000|Overall Study|Adverse Event|0|||
46735271|NCT00771316|82951915|FG001|Overall Study|Adverse Event|1|||
46735272|NCT00771316|82951914|FG000|Overall Study|Patient withdrew consent|1|||
46735273|NCT00771316|82951915|FG001|Overall Study|Patient withdrew consent|0|||
46735274|NCT00771316|82951914|FG000|Overall Study|Discontinued due to early termination|1|||
46735275|NCT00771316|82951915|FG001|Overall Study|Discontinued due to early termination|0|||
46735276|NCT05116046|82951924|FG000|Overall Study|Withdrawal by parent/guardian|2|||
46735277|NCT05116046|82951925|FG001|Overall Study|Withdrawal by parent/guardian|1|||
46735278|NCT05116046|82951926|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46735279|NCT05116046|82951924|FG000|Overall Study|Study terminated by sponsor|14|||
46735280|NCT05116046|82951925|FG001|Overall Study|Study terminated by sponsor|16|||
46735281|NCT05116046|82951926|FG002|Overall Study|Study terminated by sponsor|1|||
46735282|NCT04964414|82951946|FG000|Overall Study|Lost to Follow-up|10|||
46735283|NCT04964414|82951947|FG001|Overall Study|Lost to Follow-up|8|||
46735284|NCT04964414|82951946|FG000|Overall Study|Withdrawal by Subject|1|||
46735285|NCT04964414|82951947|FG001|Overall Study|Withdrawal by Subject|1|||
46735286|NCT04937816|82951960|FG000|Overall Study|Study drug stopped, reason missing|5|||
46735287|NCT04937816|82951961|FG001|Overall Study|Study drug stopped, reason missing|3|||
46735288|NCT04937816|82951962|FG002|Overall Study|Study drug stopped, reason missing|4|||
46735289|NCT04937816|82951963|FG003|Overall Study|Study drug stopped, reason missing|6|||
46735290|NCT04937816|82951964|FG004|Overall Study|Study drug stopped, reason missing|1|||
46735291|NCT04937816|82951965|FG005|Overall Study|Study drug stopped, reason missing|0|||
46735292|NCT04937816|82951966|FG006|Overall Study|Study drug stopped, reason missing|0|||
46735293|NCT04937816|82951960|FG000|Overall Study|Other than stated below|173|||
46735294|NCT04937816|82951961|FG001|Overall Study|Other than stated below|143|||
46735295|NCT04937816|82951962|FG002|Overall Study|Other than stated below|125|||
46735296|NCT04937816|82951963|FG003|Overall Study|Other than stated below|44|||
46735297|NCT04937816|82951964|FG004|Overall Study|Other than stated below|45|||
46735298|NCT04937816|82951965|FG005|Overall Study|Other than stated below|28|||
46735299|NCT04937816|82951966|FG006|Overall Study|Other than stated below|31|||
46735300|NCT04937816|82951960|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
46735301|NCT04937816|82951961|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
46735302|NCT04937816|82951962|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
46735303|NCT04937816|82951963|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
46735304|NCT04937816|82951964|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
46735305|NCT04937816|82951965|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
46735306|NCT04937816|82951966|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
46735307|NCT04937816|82951960|FG000|Overall Study|Lost to Follow-up|15|||
46921610|NCT03067129|83154254|FG000|Overall Study|Withdrawal by Subject|0|||
46921611|NCT03067129|83154255|FG001|Overall Study|Withdrawal by Subject|0|||
46921612|NCT03067129|83154256|FG002|Overall Study|Withdrawal by Subject|1|||
46921613|NCT03067129|83154257|FG003|Overall Study|Withdrawal by Subject|2|||
46921614|NCT03067129|83154254|FG000|Overall Study|Lost to Follow-up|5|||
46921615|NCT03067129|83154255|FG001|Overall Study|Lost to Follow-up|5|||
46921616|NCT03067129|83154256|FG002|Overall Study|Lost to Follow-up|4|||
46921617|NCT03067129|83154257|FG003|Overall Study|Lost to Follow-up|3|||
46635246|NCT01542528|82808856|FG000|Overall Study|Physician Decision|1|||
46735308|NCT04937816|82951961|FG001|Overall Study|Lost to Follow-up|9|||
46735309|NCT04937816|82951962|FG002|Overall Study|Lost to Follow-up|6|||
46735310|NCT04937816|82951963|FG003|Overall Study|Lost to Follow-up|6|||
46735311|NCT04937816|82951964|FG004|Overall Study|Lost to Follow-up|16|||
46735312|NCT04937816|82951965|FG005|Overall Study|Lost to Follow-up|11|||
46735313|NCT04937816|82951966|FG006|Overall Study|Lost to Follow-up|17|||
46735314|NCT04937816|82951960|FG000|Overall Study|Protocol Violation|15|||
46735315|NCT04937816|82951961|FG001|Overall Study|Protocol Violation|15|||
46735316|NCT04937816|82951962|FG002|Overall Study|Protocol Violation|12|||
46921618|NCT01679236|83154279|FG000|Overall Study|Lost to Follow-up|15|||
47049517|NCT01709305|83309894|FG001|Phase 2|Clinical Adverse Event|10|||
46735317|NCT04937816|82951963|FG003|Overall Study|Protocol Violation|30|||
46735318|NCT04937816|82951964|FG004|Overall Study|Protocol Violation|24|||
46735319|NCT04937816|82951965|FG005|Overall Study|Protocol Violation|5|||
46735320|NCT04937816|82951966|FG006|Overall Study|Protocol Violation|5|||
46735321|NCT04937816|82951960|FG000|Overall Study|Adverse Event|303|||
46735322|NCT04937816|82951961|FG001|Overall Study|Adverse Event|267|||
46735323|NCT04937816|82951962|FG002|Overall Study|Adverse Event|273|||
46735324|NCT04937816|82951963|FG003|Overall Study|Adverse Event|553|||
46735325|NCT04937816|82951964|FG004|Overall Study|Adverse Event|575|||
46735326|NCT04937816|82951965|FG005|Overall Study|Adverse Event|343|||
46735327|NCT04937816|82951966|FG006|Overall Study|Adverse Event|337|||
46735328|NCT04937816|82951960|FG000|Overall Study|Not treated|4|||
46735329|NCT04937816|82951961|FG001|Overall Study|Not treated|2|||
46735330|NCT04937816|82951962|FG002|Overall Study|Not treated|2|||
46735331|NCT04937816|82951963|FG003|Overall Study|Not treated|2|||
46735332|NCT04937816|82951964|FG004|Overall Study|Not treated|1|||
46735333|NCT04937816|82951965|FG005|Overall Study|Not treated|4|||
46735334|NCT04937816|82951966|FG006|Overall Study|Not treated|0|||
46735335|NCT04908683|82951992|FG000|Overall Study|Failure to meet continuation criteria|34|||
46735336|NCT04908683|82951993|FG001|Overall Study|Failure to meet continuation criteria|22|||
46735337|NCT04908683|82951992|FG000|Overall Study|Initiated prohibited medication|3|||
46735338|NCT04908683|82951993|FG001|Overall Study|Initiated prohibited medication|0|||
46735339|NCT04908683|82951992|FG000|Overall Study|Randomized by mistake|1|||
46735340|NCT04908683|82951993|FG001|Overall Study|Randomized by mistake|0|||
46735341|NCT04908683|82951992|FG000|Overall Study|Lost to Follow-up|679|||
46735342|NCT04908683|82951993|FG001|Overall Study|Lost to Follow-up|341|||
46735343|NCT04908683|82951992|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
46735344|NCT04908683|82951993|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
46735345|NCT04908683|82951992|FG000|Overall Study|Physician Decision|44|||
46735346|NCT04908683|82951993|FG001|Overall Study|Physician Decision|35|||
46735347|NCT04908683|82951992|FG000|Overall Study|Technical problems|12|||
46735348|NCT04908683|82951993|FG001|Overall Study|Technical problems|9|||
46735349|NCT04908683|82951992|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
46735350|NCT04908683|82951993|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
46735351|NCT04908683|82951992|FG000|Overall Study|Protocol Violation|2|||
46735352|NCT04908683|82951993|FG001|Overall Study|Protocol Violation|0|||
46735353|NCT04908683|82951992|FG000|Overall Study|Withdrawal by Subject|1188|||
46735354|NCT04908683|82951993|FG001|Overall Study|Withdrawal by Subject|570|||
46735355|NCT04908683|82951992|FG000|Overall Study|Site Closure by Sponsor|6|||
46735356|NCT04908683|82951993|FG001|Overall Study|Site Closure by Sponsor|3|||
46735357|NCT04908683|82951992|FG000|Overall Study|Adverse Event|21|||
46735358|NCT04908683|82951993|FG001|Overall Study|Adverse Event|11|||
46735359|NCT04908683|82951992|FG000|Overall Study|Death|101|||
46735360|NCT04908683|82951993|FG001|Overall Study|Death|61|||
46735361|NCT04908683|82951992|FG000|Overall Study|Sponsor's decision|14398|||
46735362|NCT04908683|82951993|FG001|Overall Study|Sponsor's decision|7205|||
46735363|NCT04908683|82951992|FG000|Overall Study|Other|92|||
46735364|NCT04908683|82951993|FG001|Overall Study|Other|50|||
46735365|NCT04908683|82951992|FG000|Overall Study|Randomized not vaccinated|108|||
46735366|NCT04908683|82951993|FG001|Overall Study|Randomized not vaccinated|52|||
46735367|NCT04863898|82952008|FG000|Overall Study|Away from study clinic during intervention training period|2|||
46735368|NCT04863898|82952008|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
46735369|NCT04863898|82952008|FG000|Overall Study|Lost to Follow-up|3|||
46735370|NCT04863898|82952008|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
46735371|NCT04863898|82952008|FG000|Overall Study|No longer employed at clinic|3|||
46735372|NCT04599166|82952017|FG000|Overall Study|Technological failure connecting to study app|80|||
46735373|NCT04439318|82952022|FG000|Overall Study|Ineligible|1|||
46735374|NCT04439318|82952022|FG000|Overall Study|Never Started Treatment|3|||
46735375|NCT04439318|82952022|FG000|Overall Study|Adverse Event|10|||
46735376|NCT04439318|82952022|FG000|Overall Study|Death|2|||
46735377|NCT04439318|82952022|FG000|Overall Study|Disease Progression|25|||
46735378|NCT04439318|82952022|FG000|Overall Study|Other Complicating Disease|2|||
46735379|NCT04439318|82952022|FG000|Overall Study|Withdrawal by Subject|4|||
46635247|NCT01542528|82808857|FG001|Overall Study|Physician Decision|0|||
46735380|NCT04439318|82952022|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
46735381|NCT04439318|82952022|FG000|Overall Study|Non-Compliance|1|||
46735382|NCT04439318|82952022|FG000|Overall Study|Still on Treatment|1|||
46735383|NCT04348500|82952028|FG000|Overall Study|Death|2|||
46735384|NCT04348500|82952029|FG001|Overall Study|Death|2|||
46735385|NCT04348500|82952028|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
46735386|NCT04348500|82952029|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
46735387|NCT04191616|82952035|FG000|Overall Study|Death|26|||
46735388|NCT04191616|82952035|FG000|Overall Study|Withdrawal by Subject|1|||
46735389|NCT04191616|82952035|FG000|Overall Study|Sponsor decision|2|||
46735390|NCT04191616|82952035|FG000|Overall Study|Continuing study|25|||
46735391|NCT04139317|82952041|FG000|Overall Study|Adverse Event|10|||
46735392|NCT04139317|82952042|FG001|Overall Study|Adverse Event|2|||
46735393|NCT04139317|82952041|FG000|Overall Study|Death|6|||
46735394|NCT04139317|82952042|FG001|Overall Study|Death|4|||
46735395|NCT04139317|82952041|FG000|Overall Study|Lost to Follow-up|1|||
46735396|NCT04139317|82952042|FG001|Overall Study|Lost to Follow-up|0|||
46735397|NCT04139317|82952041|FG000|Overall Study|Physician Decision|3|||
46735398|NCT04139317|82952042|FG001|Overall Study|Physician Decision|1|||
46735399|NCT04139317|82952041|FG000|Overall Study|Progressive Disease|19|||
46735400|NCT04139317|82952042|FG001|Overall Study|Progressive Disease|9|||
46735401|NCT04139317|82952041|FG000|Overall Study|Subject Decision|2|||
46735402|NCT04139317|82952042|FG001|Overall Study|Subject Decision|2|||
46735403|NCT04081337|82952053|FG000|Overall Study|Adverse Event|0|||
46735404|NCT04081337|82952054|FG001|Overall Study|Adverse Event|1|||
46735405|NCT04081337|82952053|FG000|Overall Study|Withdrawal by Subject|2|||
46735406|NCT04081337|82952054|FG001|Overall Study|Withdrawal by Subject|0|||
46735407|NCT04081337|82952053|FG000|Overall Study|Physician Decision|1|||
46735408|NCT04081337|82952054|FG001|Overall Study|Physician Decision|2|||
46735409|NCT04081337|82952053|FG000|Overall Study|Lost to Follow-up|1|||
46735410|NCT04081337|82952054|FG001|Overall Study|Lost to Follow-up|0|||
46735411|NCT03625141|82952062|FG000|Overall Study|Death|11|||
46735412|NCT03625141|82952063|FG001|Overall Study|Death|37|||
46735413|NCT03625141|82952062|FG000|Overall Study|Withdrawal by Subject|1|||
46735414|NCT03625141|82952063|FG001|Overall Study|Withdrawal by Subject|0|||
46735415|NCT03625141|82952062|FG000|Overall Study|Withdrawl of Consent|0|||
46735416|NCT03625141|82952063|FG001|Overall Study|Withdrawl of Consent|1|||
46735417|NCT03625141|82952062|FG000|Overall Study|Continuing in study|3|||
46735418|NCT03625141|82952063|FG001|Overall Study|Continuing in study|27|||
46735419|NCT03486457|82952100|FG000|Up to Month 3|Adverse Event|2|||
46735420|NCT03486457|82952101|FG001|Up to Month 3|Adverse Event|5|||
46735421|NCT03486457|82952100|FG000|Up to Month 3|Lack of Efficacy|1|||
46735422|NCT03486457|82952101|FG001|Up to Month 3|Lack of Efficacy|0|||
46735423|NCT03486457|82952100|FG000|Up to Month 3|Withdrawal by Subject|1|||
46735424|NCT03486457|82952101|FG001|Up to Month 3|Withdrawal by Subject|0|||
46735425|NCT03486457|82952100|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
46735426|NCT03486457|82952101|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
46735427|NCT03486457|82952100|FG000|Up to Month 3|Other|1|||
46735428|NCT03486457|82952101|FG001|Up to Month 3|Other|0|||
46735429|NCT03486457|82952100|FG000|Month 3 to Month 6|Adverse Event|2|||
46735430|NCT03486457|82952101|FG001|Month 3 to Month 6|Adverse Event|0|||
46735431|NCT03486457|82952100|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
46735432|NCT03486457|82952101|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
46735433|NCT03486457|82952100|FG000|Month 3 to Month 6|Pregnancy|0|||
46735434|NCT03486457|82952101|FG001|Month 3 to Month 6|Pregnancy|1|||
46735435|NCT03486457|82952100|FG000|Month 3 to Month 6|Other|1|||
46735436|NCT03486457|82952101|FG001|Month 3 to Month 6|Other|0|||
46735437|NCT03246529|82952134|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
46735438|NCT03246529|82952135|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
46735439|NCT03246529|82952136|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
46735440|NCT03246529|82952134|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
46735441|NCT03246529|82952135|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
46735442|NCT03246529|82952136|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
46735443|NCT03246529|82952134|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
46735444|NCT03246529|82952135|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
46735445|NCT03246529|82952136|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
46735446|NCT03246529|82952134|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
46735447|NCT03246529|82952135|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
46735448|NCT03246529|82952136|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
46735449|NCT03246529|82952134|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
46735450|NCT03246529|82952135|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
46735451|NCT03246529|82952136|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
46735452|NCT03246529|82952134|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
46735453|NCT03246529|82952135|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
46735454|NCT03246529|82952136|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
46735455|NCT03246529|82952134|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
46735456|NCT03246529|82952135|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
46735457|NCT03246529|82952136|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
46735458|NCT03246529|82952134|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
46735459|NCT03246529|82952135|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
46735460|NCT03246529|82952136|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
46735461|NCT03246529|82952134|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
46735462|NCT03246529|82952135|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
46735463|NCT03246529|82952136|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
46735464|NCT02568423|82952176|FG000|Overall Study|Lost to Follow-up|0|||
46735465|NCT02568423|82952177|FG001|Overall Study|Lost to Follow-up|2|||
46735466|NCT02568423|82952178|FG002|Overall Study|Lost to Follow-up|0|||
46735467|NCT02568423|82952179|FG003|Overall Study|Lost to Follow-up|0|||
46735468|NCT02568423|82952180|FG004|Overall Study|Lost to Follow-up|0|||
46735469|NCT02568423|82952181|FG005|Overall Study|Lost to Follow-up|0|||
46735470|NCT02568423|82952182|FG006|Overall Study|Lost to Follow-up|0|||
46735471|NCT02568423|82952183|FG007|Overall Study|Lost to Follow-up|0|||
46735472|NCT02568423|82952176|FG000|Overall Study|Physician Decision|0|||
46735473|NCT02568423|82952177|FG001|Overall Study|Physician Decision|0|||
46735474|NCT02568423|82952178|FG002|Overall Study|Physician Decision|0|||
46735475|NCT02568423|82952179|FG003|Overall Study|Physician Decision|0|||
46735476|NCT02568423|82952180|FG004|Overall Study|Physician Decision|0|||
46735477|NCT02568423|82952181|FG005|Overall Study|Physician Decision|1|||
46735478|NCT02568423|82952182|FG006|Overall Study|Physician Decision|0|||
46735479|NCT02568423|82952183|FG007|Overall Study|Physician Decision|0|||
46735480|NCT01970345|82952207|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
46735481|NCT01970345|82952208|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
46735482|NCT01970345|82952207|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
46735483|NCT01970345|82952208|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
46735484|NCT01735955|82952217|FG000|Overall Study|Administrative problems|1|||
46735485|NCT01735955|82952217|FG000|Overall Study|Patient/guardian decision|1|||
46735486|NCT01735955|82952217|FG000|Overall Study|Patient withdrew consent|2|||
46735487|NCT01735955|82952217|FG000|Overall Study|Physician Decision|4|||
46735488|NCT01735955|82952217|FG000|Overall Study|Disease progression|24|||
46735489|NCT01735955|82952217|FG000|Overall Study|Adverse Event|5|||
46735490|NCT01456221|82952223|FG000|Overall Study|Withdrawal by Subject|56|||
46735491|NCT01456221|82952224|FG001|Overall Study|Withdrawal by Subject|49|||
46735492|NCT01456221|82952223|FG000|Overall Study|Lost to Follow-up|1|||
46735493|NCT01456221|82952224|FG001|Overall Study|Lost to Follow-up|4|||
46735494|NCT01456221|82952223|FG000|Overall Study|Received medication|3|||
46735495|NCT01456221|82952224|FG001|Overall Study|Received medication|2|||
46735496|NCT01456221|82952223|FG000|Overall Study|Incomplete data|4|||
46735497|NCT01456221|82952224|FG001|Overall Study|Incomplete data|2|||
46735498|NCT00085202|82952232|FG000|Overall Study|Still on therapy|2|||
46735499|NCT00085202|82952233|FG001|Overall Study|Still on therapy|0|||
46735500|NCT00085202|82952232|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
46735501|NCT00085202|82952233|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
46735502|NCT00085202|82952232|FG000|Overall Study|Excessive toxicity|6|||
46735503|NCT00085202|82952233|FG001|Overall Study|Excessive toxicity|5|||
46735504|NCT00085202|82952232|FG000|Overall Study|Non-specified|3|||
46735505|NCT00085202|82952233|FG001|Overall Study|Non-specified|5|||
46735506|NCT00085202|82952232|FG000|Overall Study|Withdrawal by Subject|2|||
46735507|NCT00085202|82952233|FG001|Overall Study|Withdrawal by Subject|1|||
46735508|NCT00085202|82952232|FG000|Overall Study|Physician Decision|4|||
46735509|NCT00085202|82952233|FG001|Overall Study|Physician Decision|1|||
46735510|NCT00085202|82952232|FG000|Overall Study|Progressive disease|1|||
46735511|NCT00085202|82952233|FG001|Overall Study|Progressive disease|11|||
46735512|NCT05066165|82952263|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
46735513|NCT05066165|82952264|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
46735514|NCT05066165|82952263|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
46735515|NCT05066165|82952264|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
46735516|NCT04731298|82952276|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
46735517|NCT04731298|82952277|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
46735518|NCT04676412|82952286|FG000|Overall Study|Death|17|||
46735519|NCT04676412|82952287|FG001|Overall Study|Death|23|||
46735520|NCT04676412|82952286|FG000|Overall Study|Withdrawal by Subject|0|||
46735521|NCT04676412|82952287|FG001|Overall Study|Withdrawal by Subject|2|||
46735522|NCT04676412|82952286|FG000|Overall Study|Participants ongoing|32|||
46735523|NCT04676412|82952287|FG001|Overall Study|Participants ongoing|33|||
46735524|NCT04641975|82952297|FG000|Overall Study|Protocol Violation|1|||
46735525|NCT04641975|82952298|FG001|Overall Study|Protocol Violation|2|||
46735526|NCT04641975|82952299|FG002|Overall Study|Protocol Violation|0|||
46735527|NCT04641975|82952300|FG003|Overall Study|Protocol Violation|0|||
46735528|NCT04641975|82952297|FG000|Overall Study|Adverse Event|0|||
46735529|NCT04641975|82952298|FG001|Overall Study|Adverse Event|0|||
46735530|NCT04641975|82952299|FG002|Overall Study|Adverse Event|1|||
46735531|NCT04641975|82952300|FG003|Overall Study|Adverse Event|1|||
46735532|NCT04641975|82952297|FG000|Overall Study|Withdrawal by Subject|1|||
46735533|NCT04641975|82952298|FG001|Overall Study|Withdrawal by Subject|0|||
46735534|NCT04641975|82952299|FG002|Overall Study|Withdrawal by Subject|0|||
46735535|NCT04641975|82952300|FG003|Overall Study|Withdrawal by Subject|0|||
46735536|NCT04633200|82952315|FG000|Overall Study|Lost to Follow-up|3|||
46803976|NCT03903822|83023206|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
46803977|NCT03903822|83023207|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
46803978|NCT03903822|83023208|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
46735537|NCT04633200|82952316|FG001|Overall Study|Lost to Follow-up|5|||
46735538|NCT03439137|82952343|FG000|Overall Study|Adverse Event|16|||
46735539|NCT03439137|82952344|FG001|Overall Study|Adverse Event|12|||
46735540|NCT03439137|82952343|FG000|Overall Study|Physician Decision|0|||
46735541|NCT03439137|82952344|FG001|Overall Study|Physician Decision|5|||
46735542|NCT03439137|82952343|FG000|Overall Study|Withdrawal by Subject|14|||
46735543|NCT03439137|82952344|FG001|Overall Study|Withdrawal by Subject|4|||
46735544|NCT03439137|82952343|FG000|Overall Study|Conducting rescue therapy|2|||
46735545|NCT03439137|82952344|FG001|Overall Study|Conducting rescue therapy|1|||
46735546|NCT03439137|82952343|FG000|Overall Study|Difficult to control Hb|10|||
46735547|NCT03439137|82952344|FG001|Overall Study|Difficult to control Hb|2|||
46735548|NCT03439137|82952343|FG000|Overall Study|Initiation of a renal transplant|0|||
46735549|NCT03439137|82952344|FG001|Overall Study|Initiation of a renal transplant|2|||
46735550|NCT03402386|82952350|FG000|Overall Study|Adverse Event|3|||
46735551|NCT03402386|82952350|FG000|Overall Study|Physician Decision|1|||
46735552|NCT03402386|82952350|FG000|Overall Study|Difficult to control Hb|2|||
46735553|NCT03329196|82952356|FG000|Overall Study|Adverse Event|10|||
46735554|NCT03329196|82952357|FG001|Overall Study|Adverse Event|5|||
46735555|NCT03329196|82952356|FG000|Overall Study|Physician Decision|2|||
46735556|NCT03329196|82952357|FG001|Overall Study|Physician Decision|2|||
46735557|NCT03329196|82952356|FG000|Overall Study|Withdrawal by Subject|11|||
46735558|NCT03329196|82952357|FG001|Overall Study|Withdrawal by Subject|3|||
46735559|NCT03329196|82952356|FG000|Overall Study|Hepatic function abnormalities|0|||
46735560|NCT03329196|82952357|FG001|Overall Study|Hepatic function abnormalities|1|||
46735561|NCT03329196|82952356|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
46735562|NCT03329196|82952357|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
46735563|NCT03329196|82952356|FG000|Overall Study|Difficult to control Hb|2|||
46735564|NCT03329196|82952357|FG001|Overall Study|Difficult to control Hb|3|||
46735565|NCT03329196|82952356|FG000|Overall Study|Dialysis or renal transplant|13|||
46735566|NCT03329196|82952357|FG001|Overall Study|Dialysis or renal transplant|15|||
46735567|NCT02949219|82952363|FG000|Overall Study|Withdrawal by Subject|1|||
46735568|NCT02873195|82952373|FG000|Overall Study|Ineligible|5|||
46735569|NCT02873195|82952374|FG001|Overall Study|Ineligible|0|||
46735570|NCT02026232|82952397|FG000|Overall Study|incomplete visit/missing data|3|||
46735571|NCT02026232|82952398|FG001|Overall Study|incomplete visit/missing data|2|||
46735572|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
46735573|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
46735574|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
46735575|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
46735576|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
46735577|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
46735578|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
46735579|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
46735580|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
46735581|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
46735582|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
46735583|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
46735584|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
46735585|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
46735586|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
46735587|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
46735588|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
46735589|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
46735590|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
46735591|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
46735592|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
46735593|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
46735594|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
46735595|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
46735596|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
46735597|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
46735598|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
46735599|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
46735600|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
46735601|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
46921619|NCT01679236|83154280|FG001|Overall Study|Lost to Follow-up|15|||
46735602|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
46775733|NCT00793793|82994214|FG010|Overall Study|Adverse Event|0|||
46921620|NCT01679002|83154289|FG000|Overall Study|Adverse Event|1|||
46735603|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
46735604|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
46735605|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
46735606|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
46735607|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
46735608|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
46735609|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
46735610|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
46735611|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
46735612|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
46735613|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
46735614|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
46735615|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
46735616|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
47049518|NCT01709305|83309895|FG002|Phase 2|Clinical Adverse Event|10|||
47049519|NCT01709305|83309896|FG003|Phase 2|Clinical Adverse Event|6|||
46735617|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
46735618|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
46735619|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
46735620|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
46735621|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
46735622|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
46735623|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
46735624|NCT02008357|82952406|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
46735625|NCT02008357|82952407|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
46735626|NCT02008357|82952406|FG000|Open-label Extension Period|Adverse Event|8|||
46735627|NCT02008357|82952407|FG001|Open-label Extension Period|Adverse Event|7|||
46735628|NCT02008357|82952406|FG000|Open-label Extension Period|Death|7|||
46735629|NCT02008357|82952407|FG001|Open-label Extension Period|Death|4|||
46735630|NCT02008357|82952406|FG000|Open-label Extension Period|Lack of Efficacy|9|||
46735631|NCT02008357|82952407|FG001|Open-label Extension Period|Lack of Efficacy|5|||
46735632|NCT02008357|82952406|FG000|Open-label Extension Period|Lost to Follow-up|2|||
46735633|NCT02008357|82952407|FG001|Open-label Extension Period|Lost to Follow-up|2|||
46735634|NCT02008357|82952406|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
46735635|NCT02008357|82952407|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
46735636|NCT02008357|82952406|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
46735637|NCT02008357|82952407|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
46735638|NCT02008357|82952406|FG000|Open-label Extension Period|Safety Risk|2|||
46735639|NCT02008357|82952407|FG001|Open-label Extension Period|Safety Risk|1|||
46735640|NCT02008357|82952406|FG000|Open-label Extension Period|Non-Compliance|0|||
46735641|NCT02008357|82952407|FG001|Open-label Extension Period|Non-Compliance|1|||
46735642|NCT02008357|82952406|FG000|Open-label Extension Period|Investigator Recommendation|0|||
46735643|NCT02008357|82952407|FG001|Open-label Extension Period|Investigator Recommendation|1|||
46735644|NCT02008357|82952406|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
46735645|NCT02008357|82952407|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
46735646|NCT02008357|82952406|FG000|Open-label Extension Period|Coordinating Center Request|2|||
46735647|NCT02008357|82952407|FG001|Open-label Extension Period|Coordinating Center Request|4|||
46735648|NCT02008357|82952406|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
46735649|NCT02008357|82952407|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
47049520|NCT01709305|83309897|FG004|Phase 2|Clinical Adverse Event|11|||
47049521|NCT01709305|83309893|FG000|Phase 2|Death|0|||
47049522|NCT01709305|83309894|FG001|Phase 2|Death|0|||
47049523|NCT01709305|83309895|FG002|Phase 2|Death|1|||
47049524|NCT01709305|83309896|FG003|Phase 2|Death|0|||
47049525|NCT01709305|83309897|FG004|Phase 2|Death|0|||
47049526|NCT01709305|83309893|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
47049527|NCT01709305|83309894|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
46921621|NCT01679002|83154290|FG001|Overall Study|Adverse Event|1|||
46921622|NCT01679002|83154291|FG002|Overall Study|Adverse Event|0|||
46921623|NCT04409509|83154301|FG000|Overall Study|Failure to meet randomization requirement|1|||
47049528|NCT01709305|83309895|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
47049529|NCT01709305|83309896|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
47049530|NCT01709305|83309897|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
47049531|NCT01709305|83309893|FG000|Phase 2|Laboratory Adverse Event|0|||
47049532|NCT01709305|83309894|FG001|Phase 2|Laboratory Adverse Event|1|||
47049533|NCT01709305|83309895|FG002|Phase 2|Laboratory Adverse Event|0|||
46735650|NCT02008357|82952406|FG000|Open-label Extension Period|Study Ended|20|||
46735651|NCT02008357|82952407|FG001|Open-label Extension Period|Study Ended|25|||
46735652|NCT02008357|82952406|FG000|Open-label Extension Period|Personal Reasons|0|||
46735653|NCT02008357|82952407|FG001|Open-label Extension Period|Personal Reasons|1|||
46735654|NCT02008357|82952406|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
46735655|NCT02008357|82952407|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
46735656|NCT02008357|82952406|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
46735657|NCT02008357|82952407|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
46735658|NCT02008357|82952406|FG000|Open-label Extension Period|Other|2|||
46735659|NCT02008357|82952407|FG001|Open-label Extension Period|Other|0|||
46735660|NCT00775463|82952419|FG000|Overall Study|Withdrawal by Subject|0|||
46735661|NCT00775463|82952420|FG001|Overall Study|Withdrawal by Subject|1|||
46735662|NCT00775463|82952419|FG000|Overall Study|Adverse Event|7|||
46735663|NCT00775463|82952420|FG001|Overall Study|Adverse Event|9|||
46735664|NCT00775463|82952419|FG000|Overall Study|Protocol Violation|2|||
46735665|NCT00775463|82952420|FG001|Overall Study|Protocol Violation|2|||
46735666|NCT00775463|82952419|FG000|Overall Study|Lost to Follow-up|1|||
46735667|NCT00775463|82952420|FG001|Overall Study|Lost to Follow-up|0|||
46735668|NCT00775463|82952419|FG000|Overall Study|Lack of Efficacy|1|||
46735669|NCT00775463|82952420|FG001|Overall Study|Lack of Efficacy|1|||
46735670|NCT00406640|82952434|FG000|Acute Phase|Adverse Event|18|||
47049534|NCT01709305|83309896|FG003|Phase 2|Laboratory Adverse Event|1|||
47049535|NCT01709305|83309897|FG004|Phase 2|Laboratory Adverse Event|1|||
47049536|NCT01709305|83309893|FG000|Phase 2|Lost to Follow-up|0|||
46735671|NCT00406640|82952435|FG001|Acute Phase|Adverse Event|13|||
46735672|NCT00406640|82952434|FG000|Acute Phase|Failed to Return|5|||
46735673|NCT00406640|82952435|FG001|Acute Phase|Failed to Return|1|||
46735674|NCT00406640|82952434|FG000|Acute Phase|Physician Decision|0|||
46735675|NCT00406640|82952435|FG001|Acute Phase|Physician Decision|1|||
46735676|NCT00406640|82952434|FG000|Acute Phase|Lost to Follow-up|7|||
46735677|NCT00406640|82952435|FG001|Acute Phase|Lost to Follow-up|4|||
46735678|NCT00406640|82952434|FG000|Acute Phase|Protocol deviation|4|||
46735679|NCT00406640|82952435|FG001|Acute Phase|Protocol deviation|10|||
46735680|NCT00406640|82952434|FG000|Acute Phase|Protocol Violation|3|||
46735681|NCT00406640|82952435|FG001|Acute Phase|Protocol Violation|2|||
46735682|NCT00406640|82952434|FG000|Acute Phase|Withdrawal by Subject|11|||
46735683|NCT00406640|82952435|FG001|Acute Phase|Withdrawal by Subject|9|||
46735684|NCT00406640|82952434|FG000|Acute Phase|Lack of Efficacy|3|||
46735685|NCT00406640|82952435|FG001|Acute Phase|Lack of Efficacy|3|||
46735686|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
46735687|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
46735688|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Death|1|||
46735689|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Death|0|||
46735690|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
46735691|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
47049537|NCT01709305|83309894|FG001|Phase 2|Lost to Follow-up|10|||
47049538|NCT01709305|83309895|FG002|Phase 2|Lost to Follow-up|6|||
47049539|NCT01709305|83309896|FG003|Phase 2|Lost to Follow-up|9|||
47049540|NCT01709305|83309897|FG004|Phase 2|Lost to Follow-up|5|||
47049541|NCT01709305|83309893|FG000|Phase 2|Travel, moving, etc.|0|||
47049542|NCT01709305|83309894|FG001|Phase 2|Travel, moving, etc.|2|||
47049543|NCT01709305|83309895|FG002|Phase 2|Travel, moving, etc.|3|||
47049544|NCT01709305|83309896|FG003|Phase 2|Travel, moving, etc.|3|||
46635248|NCT01542528|82808856|FG000|Overall Study|Withdrawal by Subject|9|||
46735692|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
46735693|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
46735694|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
46735695|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
46735696|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|non-compliance|7|||
46803979|NCT03903822|83023209|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
46803980|NCT03903822|83023210|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
47049545|NCT01709305|83309897|FG004|Phase 2|Travel, moving, etc.|5|||
46735697|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|non-compliance|5|||
46735698|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
46735699|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
46803981|NCT03903822|83023211|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
47049546|NCT01709305|83309893|FG000|Phase 2|Physician Decision|0|||
47049547|NCT01709305|83309894|FG001|Phase 2|Physician Decision|2|||
47049548|NCT01709305|83309895|FG002|Phase 2|Physician Decision|0|||
47049549|NCT01709305|83309896|FG003|Phase 2|Physician Decision|1|||
47049550|NCT01709305|83309897|FG004|Phase 2|Physician Decision|2|||
46735700|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
46735701|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
47049551|NCT01709305|83309893|FG000|Phase 2|Protocol Violation|0|||
47049552|NCT01709305|83309894|FG001|Phase 2|Protocol Violation|19|||
46735702|NCT00406640|82952434|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
46735703|NCT00406640|82952435|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
46735704|NCT00406640|82952434|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
46735705|NCT00406640|82952435|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
46735706|NCT00406640|82952434|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
46735707|NCT00406640|82952435|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
46735708|NCT00406640|82952434|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
46735709|NCT00406640|82952435|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
46735710|NCT00406640|82952434|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
46735711|NCT00406640|82952435|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
46735712|NCT00406640|82952434|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
46735713|NCT00406640|82952435|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
46735714|NCT00406640|82952434|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
46735715|NCT00406640|82952435|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
46735716|NCT00406640|82952434|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
46735717|NCT00406640|82952435|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
46735718|NCT00229931|82952449|FG000|Overall Study|Death|1|||
46735719|NCT00229931|82952450|FG001|Overall Study|Death|0|||
46735720|NCT00229931|82952449|FG000|Overall Study|Lost to Follow-up|3|||
46735721|NCT00229931|82952450|FG001|Overall Study|Lost to Follow-up|2|||
46735722|NCT00150969|82952458|FG000|24 Month Main Study|Adverse Event|3|||
46735723|NCT00150969|82952459|FG001|24 Month Main Study|Adverse Event|4|||
46735724|NCT00150969|82952458|FG000|24 Month Main Study|Death|1|||
46735725|NCT00150969|82952459|FG001|24 Month Main Study|Death|1|||
46735726|NCT00150969|82952458|FG000|24 Month Main Study|Lack of Efficacy|1|||
46735727|NCT00150969|82952459|FG001|24 Month Main Study|Lack of Efficacy|8|||
46735728|NCT00150969|82952458|FG000|24 Month Main Study|Lost to Follow-up|3|||
46735729|NCT00150969|82952459|FG001|24 Month Main Study|Lost to Follow-up|2|||
46735730|NCT00150969|82952458|FG000|24 Month Main Study|Protocol Violation|4|||
46735731|NCT00150969|82952459|FG001|24 Month Main Study|Protocol Violation|2|||
46735732|NCT00150969|82952458|FG000|24 Month Main Study|Withdrawal by Subject|7|||
46735733|NCT00150969|82952459|FG001|24 Month Main Study|Withdrawal by Subject|4|||
46735734|NCT00150969|82952458|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
46735735|NCT00150969|82952459|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
46735736|NCT00150969|82952458|FG000|24-48 Month Extension|Lack of Efficacy|0|||
46735737|NCT00150969|82952459|FG001|24-48 Month Extension|Lack of Efficacy|1|||
46735738|NCT00150969|82952458|FG000|24-48 Month Extension|Adverse Event|1|||
46735739|NCT00150969|82952459|FG001|24-48 Month Extension|Adverse Event|3|||
46735740|NCT00150969|82952458|FG000|24-48 Month Extension|Other Reason|81|||
46735741|NCT00150969|82952459|FG001|24-48 Month Extension|Other Reason|91|||
46735742|NCT00770770|82952468|FG000|Overall Study|Lost to Follow-up|1|||
46735743|NCT00770770|82952469|FG001|Overall Study|Lost to Follow-up|0|||
46735744|NCT00770770|82952468|FG000|Overall Study|Withdrawal by Subject|1|||
46735745|NCT00770770|82952469|FG001|Overall Study|Withdrawal by Subject|0|||
46735746|NCT00770770|82952468|FG000|Overall Study|Death|0|||
46735747|NCT00770770|82952469|FG001|Overall Study|Death|1|||
46735748|NCT00770770|82952468|FG000|Overall Study|Study Terminated|8|||
46735749|NCT00770770|82952469|FG001|Overall Study|Study Terminated|0|||
46735750|NCT00766636|82952477|FG000|Overall Study|Withdrawal by Subject|1|||
46735751|NCT00766636|82952478|FG001|Overall Study|Withdrawal by Subject|1|||
46735752|NCT00766636|82952477|FG000|Overall Study|Incomplete Treatment|0|||
46735753|NCT00766636|82952478|FG001|Overall Study|Incomplete Treatment|1|||
46735754|NCT00766636|82952477|FG000|Overall Study|Adverse Event|1|||
46735755|NCT00766636|82952478|FG001|Overall Study|Adverse Event|0|||
46735756|NCT00766636|82952477|FG000|Overall Study|Disease Progression|1|||
46735757|NCT00766636|82952478|FG001|Overall Study|Disease Progression|0|||
46921624|NCT04409509|83154302|FG001|Overall Study|Failure to meet randomization requirement|0|||
46735758|NCT00770692|82952488|FG000|Overall Study|Withdrawal by Subject|7|||
46735759|NCT00770692|82952489|FG001|Overall Study|Withdrawal by Subject|9|||
46803982|NCT03903822|83023212|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
46921625|NCT04409509|83154301|FG000|Overall Study|Adverse Event|0|||
46921626|NCT04409509|83154302|FG001|Overall Study|Adverse Event|1|||
46921627|NCT04409509|83154301|FG000|Overall Study|Death|11|||
46921628|NCT04409509|83154302|FG001|Overall Study|Death|10|||
46735760|NCT00770692|82952490|FG002|Overall Study|Withdrawal by Subject|9|||
46735761|NCT00770692|82952491|FG003|Overall Study|Withdrawal by Subject|6|||
46735762|NCT00770692|82952488|FG000|Overall Study|Adverse Event|3|||
46735763|NCT00770692|82952489|FG001|Overall Study|Adverse Event|0|||
46735764|NCT00770692|82952490|FG002|Overall Study|Adverse Event|4|||
46735765|NCT00770692|82952491|FG003|Overall Study|Adverse Event|4|||
46735766|NCT00770692|82952488|FG000|Overall Study|Investigator judgment|2|||
46921629|NCT04409509|83154301|FG000|Overall Study|Non-compliance with study drug|0|||
46735767|NCT00770692|82952489|FG001|Overall Study|Investigator judgment|0|||
46735768|NCT00770692|82952490|FG002|Overall Study|Investigator judgment|1|||
46921630|NCT04409509|83154302|FG001|Overall Study|Non-compliance with study drug|1|||
46735769|NCT00770692|82952491|FG003|Overall Study|Investigator judgment|1|||
46735770|NCT02743819|82952505|FG000|Overall Study|Lack of Efficacy|5|||
46735771|NCT02743819|82952505|FG000|Overall Study|Death|2|||
46735772|NCT02743819|82952505|FG000|Overall Study|Adverse Event|1|||
46735773|NCT01004822|82952517|FG000|Overall Study|Objective progression or relapse|3|||
46735774|NCT01004822|82952518|FG001|Overall Study|Objective progression or relapse|3|||
46735775|NCT01004822|82952519|FG002|Overall Study|Objective progression or relapse|0|||
46735776|NCT01004822|82952520|FG003|Overall Study|Objective progression or relapse|1|||
46735777|NCT01004822|82952521|FG004|Overall Study|Objective progression or relapse|2|||
46735778|NCT01004822|82952522|FG005|Overall Study|Objective progression or relapse|2|||
46735779|NCT01004822|82952523|FG006|Overall Study|Objective progression or relapse|1|||
46735780|NCT01004822|82952524|FG007|Overall Study|Objective progression or relapse|4|||
46735781|NCT01004822|82952517|FG000|Overall Study|Global deterioration of health status|0|||
46735782|NCT01004822|82952518|FG001|Overall Study|Global deterioration of health status|0|||
46735783|NCT01004822|82952519|FG002|Overall Study|Global deterioration of health status|0|||
46735784|NCT01004822|82952520|FG003|Overall Study|Global deterioration of health status|1|||
46735785|NCT01004822|82952521|FG004|Overall Study|Global deterioration of health status|0|||
46735786|NCT01004822|82952522|FG005|Overall Study|Global deterioration of health status|0|||
46735787|NCT01004822|82952523|FG006|Overall Study|Global deterioration of health status|1|||
46735788|NCT01004822|82952524|FG007|Overall Study|Global deterioration of health status|0|||
46735789|NCT01004822|82952517|FG000|Overall Study|No longer willing to continue|0|||
46735790|NCT01004822|82952518|FG001|Overall Study|No longer willing to continue|0|||
46735791|NCT01004822|82952519|FG002|Overall Study|No longer willing to continue|0|||
46735792|NCT01004822|82952520|FG003|Overall Study|No longer willing to continue|1|||
46735793|NCT01004822|82952521|FG004|Overall Study|No longer willing to continue|2|||
46735794|NCT01004822|82952522|FG005|Overall Study|No longer willing to continue|1|||
46735795|NCT01004822|82952523|FG006|Overall Study|No longer willing to continue|1|||
46735796|NCT01004822|82952524|FG007|Overall Study|No longer willing to continue|0|||
46735797|NCT01004822|82952517|FG000|Overall Study|Adverse Event|0|||
46735798|NCT01004822|82952518|FG001|Overall Study|Adverse Event|0|||
46735799|NCT01004822|82952519|FG002|Overall Study|Adverse Event|0|||
46735800|NCT01004822|82952520|FG003|Overall Study|Adverse Event|0|||
46735801|NCT01004822|82952521|FG004|Overall Study|Adverse Event|0|||
46735802|NCT01004822|82952522|FG005|Overall Study|Adverse Event|0|||
46735803|NCT01004822|82952523|FG006|Overall Study|Adverse Event|1|||
46735804|NCT01004822|82952524|FG007|Overall Study|Adverse Event|1|||
46735805|NCT01004822|82952517|FG000|Overall Study|Other|0|||
46735806|NCT01004822|82952518|FG001|Overall Study|Other|0|||
46735807|NCT01004822|82952519|FG002|Overall Study|Other|4|||
46735808|NCT01004822|82952520|FG003|Overall Study|Other|1|||
46735809|NCT01004822|82952521|FG004|Overall Study|Other|0|||
46735810|NCT01004822|82952522|FG005|Overall Study|Other|1|||
46735811|NCT01004822|82952523|FG006|Overall Study|Other|0|||
46735812|NCT01004822|82952524|FG007|Overall Study|Other|0|||
46735813|NCT01001234|82952549|FG000|Overall Study|Withdrawal by Subject|2|||
46735814|NCT01001234|82952550|FG001|Overall Study|Withdrawal by Subject|0|||
46735815|NCT01001234|82952551|FG002|Overall Study|Withdrawal by Subject|3|||
46735816|NCT01001234|82952552|FG003|Overall Study|Withdrawal by Subject|0|||
46735817|NCT01001234|82952553|FG004|Overall Study|Withdrawal by Subject|0|||
46735818|NCT01001234|82952549|FG000|Overall Study|Protocol Violation|34|||
46735819|NCT01001234|82952550|FG001|Overall Study|Protocol Violation|3|||
46735820|NCT01001234|82952551|FG002|Overall Study|Protocol Violation|19|||
46735821|NCT01001234|82952552|FG003|Overall Study|Protocol Violation|18|||
46735822|NCT01001234|82952553|FG004|Overall Study|Protocol Violation|0|||
46735823|NCT01001234|82952549|FG000|Overall Study|Lost to Follow-up|0|||
46735824|NCT01001234|82952550|FG001|Overall Study|Lost to Follow-up|0|||
46735825|NCT01001234|82952551|FG002|Overall Study|Lost to Follow-up|1|||
46735826|NCT01001234|82952552|FG003|Overall Study|Lost to Follow-up|2|||
46735827|NCT01001234|82952553|FG004|Overall Study|Lost to Follow-up|0|||
46735828|NCT01001234|82952549|FG000|Overall Study|Physician Decision|1|||
46921631|NCT04409509|83154301|FG000|Overall Study|Lost to Follow-up|0|||
46921632|NCT04409509|83154302|FG001|Overall Study|Lost to Follow-up|3|||
46735829|NCT01001234|82952550|FG001|Overall Study|Physician Decision|0|||
46735830|NCT01001234|82952551|FG002|Overall Study|Physician Decision|0|||
46735831|NCT01001234|82952552|FG003|Overall Study|Physician Decision|0|||
46735832|NCT01001234|82952553|FG004|Overall Study|Physician Decision|0|||
46735833|NCT01001234|82952549|FG000|Overall Study|Not Treated: Adverse Event|1|||
46735834|NCT01001234|82952550|FG001|Overall Study|Not Treated: Adverse Event|0|||
46735835|NCT01001234|82952551|FG002|Overall Study|Not Treated: Adverse Event|0|||
46735836|NCT01001234|82952552|FG003|Overall Study|Not Treated: Adverse Event|0|||
46735837|NCT01001234|82952553|FG004|Overall Study|Not Treated: Adverse Event|0|||
46735838|NCT01001234|82952549|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
46735839|NCT01001234|82952550|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
46735840|NCT01001234|82952551|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
46735841|NCT01001234|82952552|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
46735842|NCT01001234|82952553|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
46735843|NCT01001234|82952549|FG000|Overall Study|Not Treated: Protocol Violation|3|||
46735844|NCT01001234|82952550|FG001|Overall Study|Not Treated: Protocol Violation|0|||
46735845|NCT01001234|82952551|FG002|Overall Study|Not Treated: Protocol Violation|0|||
46735846|NCT01001234|82952552|FG003|Overall Study|Not Treated: Protocol Violation|0|||
46735847|NCT01001234|82952553|FG004|Overall Study|Not Treated: Protocol Violation|0|||
46735848|NCT01001234|82952549|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
46735849|NCT01001234|82952550|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
46735850|NCT01001234|82952551|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
46735851|NCT01001234|82952552|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
46735852|NCT01001234|82952553|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
46735853|NCT01001234|82952549|FG000|Overall Study|Not Treated: Pregnancy|3|||
46735854|NCT01001234|82952550|FG001|Overall Study|Not Treated: Pregnancy|0|||
46735855|NCT01001234|82952551|FG002|Overall Study|Not Treated: Pregnancy|0|||
46735856|NCT01001234|82952552|FG003|Overall Study|Not Treated: Pregnancy|0|||
46735857|NCT01001234|82952553|FG004|Overall Study|Not Treated: Pregnancy|0|||
46735858|NCT01001234|82952549|FG000|Overall Study|Not Treated: Physician Decision|37|||
46735859|NCT01001234|82952550|FG001|Overall Study|Not Treated: Physician Decision|4|||
46735860|NCT01001234|82952551|FG002|Overall Study|Not Treated: Physician Decision|0|||
46735861|NCT01001234|82952552|FG003|Overall Study|Not Treated: Physician Decision|0|||
46735862|NCT01001234|82952553|FG004|Overall Study|Not Treated: Physician Decision|0|||
46735863|NCT01001234|82952549|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
46735864|NCT01001234|82952550|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
46735865|NCT01001234|82952551|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
46735866|NCT01001234|82952552|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
46735867|NCT01001234|82952553|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
46735868|NCT01004510|82952559|FG000|Overall Study|Adverse Event|1|||
46735869|NCT01004432|82952563|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
46735870|NCT01004432|82952564|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
46735871|NCT01004432|82952565|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
46735872|NCT01004432|82952566|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
46735873|NCT01004432|82952567|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
46735874|NCT01004432|82952563|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
46735875|NCT01004432|82952564|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
46735876|NCT01004432|82952565|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
46735877|NCT01004432|82952566|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
46735878|NCT01004432|82952567|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
46735879|NCT01004432|82952563|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
46735880|NCT01004432|82952564|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
46735881|NCT01004432|82952565|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
46735882|NCT01004432|82952566|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
46735883|NCT01004432|82952567|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
46735884|NCT01004432|82952563|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
46735885|NCT01004432|82952564|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
46735886|NCT01004432|82952565|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
46735887|NCT01004432|82952566|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
46735888|NCT01004432|82952567|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
46735889|NCT01004432|82952563|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
46735890|NCT01004432|82952564|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
46735891|NCT01004432|82952565|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
46735892|NCT01004432|82952566|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
46735893|NCT01004432|82952567|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
46735894|NCT01004432|82952563|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
46735895|NCT01004432|82952564|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
46735896|NCT01004432|82952565|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
46735897|NCT01004432|82952566|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
46735898|NCT01004432|82952567|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
46735899|NCT01004432|82952563|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
46735900|NCT01004432|82952564|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
46735901|NCT01004432|82952565|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
46735902|NCT01004432|82952566|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
46735903|NCT01004432|82952567|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
46735904|NCT01004432|82952563|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
46735905|NCT01004432|82952564|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
47049553|NCT01709305|83309895|FG002|Phase 2|Protocol Violation|19|||
46735906|NCT01004432|82952565|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
46735907|NCT01004432|82952566|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
46775734|NCT00793793|82994215|FG011|Overall Study|Adverse Event|2|||
46735908|NCT01004432|82952567|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
46735909|NCT01004432|82952563|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
46735910|NCT01004432|82952564|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
46735911|NCT01004432|82952565|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
46735912|NCT01004432|82952566|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
46735913|NCT01004432|82952567|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
46735914|NCT01004432|82952563|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
46735915|NCT01004432|82952564|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
46735916|NCT01004432|82952565|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
46735917|NCT01004432|82952566|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
46735918|NCT01004432|82952567|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
46735919|NCT01004432|82952563|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
46735920|NCT01004432|82952564|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
46735921|NCT01004432|82952565|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
46735922|NCT01004432|82952566|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
46735923|NCT01004432|82952567|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
46735924|NCT01004432|82952563|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
46735925|NCT01004432|82952564|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
46735926|NCT01004432|82952565|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
46735927|NCT01004432|82952566|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
46735928|NCT01004432|82952567|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
46735929|NCT01004432|82952563|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
46735930|NCT01004432|82952564|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
46735931|NCT01004432|82952565|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
46735932|NCT01004432|82952566|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
46735933|NCT01004432|82952567|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
46735934|NCT01004432|82952563|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
46735935|NCT01004432|82952564|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
46735936|NCT01004432|82952565|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
46735937|NCT01004432|82952566|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
46735938|NCT01004432|82952567|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
46735939|NCT01004432|82952563|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
46735940|NCT01004432|82952564|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
46735941|NCT01004432|82952565|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
46735942|NCT01004432|82952566|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
46735943|NCT01004432|82952567|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
46735944|NCT01000610|82952581|FG000|Overall Study|Adverse Event|1|||
46735945|NCT01000610|82952581|FG000|Overall Study|Lost to Follow-up|4|||
46735946|NCT01000610|82952581|FG000|Overall Study|Treatment failure|1|||
46735947|NCT01877655|82952587|FG000|Overall Study|Death|57|||
46735948|NCT01877655|82952588|FG001|Overall Study|Death|52|||
46735949|NCT01877655|82952587|FG000|Overall Study|Withdrawal by Subject|18|||
46803983|NCT03903822|83023213|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
46921633|NCT04409509|83154301|FG000|Overall Study|Withdrawal by Subject|0|||
46921634|NCT04409509|83154302|FG001|Overall Study|Withdrawal by Subject|3|||
46735950|NCT01877655|82952588|FG001|Overall Study|Withdrawal by Subject|26|||
46735951|NCT01877655|82952587|FG000|Overall Study|Physician Decision|11|||
46735952|NCT01877655|82952588|FG001|Overall Study|Physician Decision|10|||
46735953|NCT01877655|82952587|FG000|Overall Study|Miscellaneous|4|||
46921635|NCT04409509|83154301|FG000|Overall Study|Randomized by mistake|0|||
46735954|NCT01877655|82952588|FG001|Overall Study|Miscellaneous|4|||
46735955|NCT01877655|82952587|FG000|Overall Study|Randomized but Never Received Drug|8|||
46735956|NCT01877655|82952588|FG001|Overall Study|Randomized but Never Received Drug|5|||
46735957|NCT00586924|82952600|FG000|Overall Study|Adverse event/serious adverse event|0|||
46735958|NCT00586924|82952601|FG001|Overall Study|Adverse event/serious adverse event|0|||
46735959|NCT00586924|82952602|FG002|Overall Study|Adverse event/serious adverse event|0|||
46735960|NCT00586924|82952603|FG003|Overall Study|Adverse event/serious adverse event|1|||
46735961|NCT00586924|82952604|FG004|Overall Study|Adverse event/serious adverse event|0|||
46735962|NCT00586924|82952605|FG005|Overall Study|Adverse event/serious adverse event|2|||
46735963|NCT00586924|82952600|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
46921636|NCT04409509|83154302|FG001|Overall Study|Randomized by mistake|1|||
46735964|NCT00586924|82952601|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
46735965|NCT00586924|82952602|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
46735966|NCT00586924|82952603|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
46735967|NCT00586924|82952604|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
46735968|NCT00586924|82952605|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
46921637|NCT04409509|83154301|FG000|Overall Study|Other|1|||
46921638|NCT04409509|83154302|FG001|Overall Study|Other|1|||
46921639|NCT01678924|83154313|FG000|Overall Study|Adverse Event|1|||
46635249|NCT01542528|82808857|FG001|Overall Study|Withdrawal by Subject|6|||
46635250|NCT01565148|82808867|FG000|Overall Study|Withdrawal by Subject|1|||
46735969|NCT00586924|82952600|FG000|Overall Study|Disease progression|0|||
46735970|NCT00586924|82952601|FG001|Overall Study|Disease progression|0|||
46735971|NCT00586924|82952602|FG002|Overall Study|Disease progression|0|||
46735972|NCT00586924|82952603|FG003|Overall Study|Disease progression|1|||
46735973|NCT00586924|82952604|FG004|Overall Study|Disease progression|1|||
46921640|NCT01678924|83154314|FG001|Overall Study|Adverse Event|1|||
46921641|NCT01678924|83154315|FG002|Overall Study|Adverse Event|0|||
46921642|NCT01678924|83154316|FG003|Overall Study|Adverse Event|1|||
46921643|NCT01678924|83154313|FG000|Overall Study|Lack of Efficacy|7|||
46921644|NCT01678924|83154314|FG001|Overall Study|Lack of Efficacy|2|||
46921645|NCT01678924|83154315|FG002|Overall Study|Lack of Efficacy|0|||
47049554|NCT01709305|83309896|FG003|Phase 2|Protocol Violation|13|||
47049555|NCT01709305|83309897|FG004|Phase 2|Protocol Violation|9|||
47049556|NCT01709305|83309893|FG000|Phase 2|Withdrawal by Subject|0|||
47049557|NCT01709305|83309894|FG001|Phase 2|Withdrawal by Subject|8|||
47049558|NCT01709305|83309895|FG002|Phase 2|Withdrawal by Subject|6|||
47049559|NCT01709305|83309896|FG003|Phase 2|Withdrawal by Subject|15|||
47049560|NCT01709305|83309897|FG004|Phase 2|Withdrawal by Subject|12|||
47049561|NCT01684423|83309917|FG000|Overall Study|Withdrawal by Subject|0|||
47049562|NCT01684423|83309918|FG001|Overall Study|Withdrawal by Subject|0|||
47049563|NCT01684423|83309919|FG002|Overall Study|Withdrawal by Subject|1|||
47049564|NCT01684423|83309920|FG003|Overall Study|Withdrawal by Subject|0|||
47049565|NCT01684423|83309921|FG004|Overall Study|Withdrawal by Subject|0|||
47049566|NCT01709227|83309937|FG000|Overall Study|Physician Decision|1|||
47049567|NCT01709227|83309938|FG001|Overall Study|Physician Decision|0|||
47049568|NCT01709227|83309937|FG000|Overall Study|Pleural Peritoneal communication|0|||
47049569|NCT01709227|83309938|FG001|Overall Study|Pleural Peritoneal communication|9|||
47049570|NCT01684033|83309945|FG000|Period 1, First 30 Days|Adverse Event|1|||
47049571|NCT01684033|83309946|FG001|Period 1, First 30 Days|Adverse Event|1|||
47049572|NCT01684033|83309945|FG000|Period 1, First 30 Days|Noncompliance|1|||
47049573|NCT01684033|83309946|FG001|Period 1, First 30 Days|Noncompliance|0|||
47049574|NCT01684033|83309945|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
47049575|NCT01684033|83309946|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
47049576|NCT01684033|83309945|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
47049577|NCT01684033|83309946|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
47049578|NCT01684033|83309945|FG000|Period 2, Second 30 Days|Adverse Event|1|||
47049579|NCT01684033|83309946|FG001|Period 2, Second 30 Days|Adverse Event|0|||
46635251|NCT01565148|82808868|FG001|Overall Study|Withdrawal by Subject|1|||
46635252|NCT01565148|82808869|FG002|Overall Study|Withdrawal by Subject|1|||
46735974|NCT00586924|82952605|FG005|Overall Study|Disease progression|0|||
46735975|NCT00586924|82952600|FG000|Overall Study|Development of neutralizing antibodies|2|||
46735976|NCT00586924|82952601|FG001|Overall Study|Development of neutralizing antibodies|2|||
46735977|NCT00586924|82952602|FG002|Overall Study|Development of neutralizing antibodies|2|||
46735978|NCT00586924|82952603|FG003|Overall Study|Development of neutralizing antibodies|0|||
46735979|NCT00586924|82952604|FG004|Overall Study|Development of neutralizing antibodies|0|||
46735980|NCT00586924|82952605|FG005|Overall Study|Development of neutralizing antibodies|22|||
46735981|NCT00586924|82952600|FG000|Overall Study|Complete response|0|||
46735982|NCT00586924|82952601|FG001|Overall Study|Complete response|1|||
46735983|NCT00586924|82952602|FG002|Overall Study|Complete response|0|||
46735984|NCT00586924|82952603|FG003|Overall Study|Complete response|0|||
46735985|NCT00586924|82952604|FG004|Overall Study|Complete response|2|||
46735986|NCT00586924|82952605|FG005|Overall Study|Complete response|2|||
46735987|NCT00586924|82952600|FG000|Overall Study|Other|1|||
46735988|NCT00586924|82952601|FG001|Overall Study|Other|0|||
46735989|NCT00586924|82952602|FG002|Overall Study|Other|1|||
46735990|NCT00586924|82952603|FG003|Overall Study|Other|1|||
46735991|NCT00586924|82952604|FG004|Overall Study|Other|1|||
46921646|NCT01678924|83154316|FG003|Overall Study|Lack of Efficacy|5|||
46921647|NCT01678924|83154313|FG000|Overall Study|Lost to Follow-up|0|||
46635253|NCT01565148|82808870|FG003|Overall Study|Withdrawal by Subject|2|||
46635254|NCT01565148|82808867|FG000|Overall Study|Lost to Follow-up|4|||
46735992|NCT00586924|82952605|FG005|Overall Study|Other|6|||
46735993|NCT01000376|82952621|FG000|Cycle 1 Day 1|Adverse Event|1|||
46735994|NCT01000376|82952622|FG001|Cycle 1 Day 1|Adverse Event|0|||
46921648|NCT01678924|83154314|FG001|Overall Study|Lost to Follow-up|4|||
46735995|NCT01000376|82952621|FG000|Cycle 1 Day 1|Progressive Disease|1|||
46921649|NCT01678924|83154315|FG002|Overall Study|Lost to Follow-up|0|||
46921650|NCT01678924|83154316|FG003|Overall Study|Lost to Follow-up|2|||
47049580|NCT01903811|83309987|FG000|Overall Study|No measurable disease|1|||
47049581|NCT01903811|83309988|FG001|Overall Study|No measurable disease|1|||
47049582|NCT01903811|83309987|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
46735996|NCT01000376|82952622|FG001|Cycle 1 Day 1|Progressive Disease|0|||
46735997|NCT01038635|82952637|FG000|Overall Study|Disease Progression|2|||
46735998|NCT01038635|82952638|FG001|Overall Study|Disease Progression|0|||
46735999|NCT01038635|82952639|FG002|Overall Study|Disease Progression|0|||
46736000|NCT01038635|82952640|FG003|Overall Study|Disease Progression|0|||
46736001|NCT01038635|82952641|FG004|Overall Study|Disease Progression|0|||
46736002|NCT01038635|82952642|FG005|Overall Study|Disease Progression|0|||
46736003|NCT01038635|82952643|FG006|Overall Study|Disease Progression|1|||
46736004|NCT01038635|82952644|FG007|Overall Study|Disease Progression|4|||
46736005|NCT01038635|82952645|FG008|Overall Study|Disease Progression|0|||
46736006|NCT01038635|82952637|FG000|Overall Study|Death|0|||
46736007|NCT01038635|82952638|FG001|Overall Study|Death|0|||
46736008|NCT01038635|82952639|FG002|Overall Study|Death|0|||
46736009|NCT01038635|82952640|FG003|Overall Study|Death|0|||
46736010|NCT01038635|82952641|FG004|Overall Study|Death|1|||
46736011|NCT01038635|82952642|FG005|Overall Study|Death|0|||
46736012|NCT01038635|82952643|FG006|Overall Study|Death|1|||
46736013|NCT01038635|82952644|FG007|Overall Study|Death|1|||
46736014|NCT01038635|82952645|FG008|Overall Study|Death|2|||
46736015|NCT01000064|82952666|FG000|Overall Study|Withdrawal by Subject|1|||
46736016|NCT01000064|82952667|FG001|Overall Study|Withdrawal by Subject|1|||
46736017|NCT00766090|82952678|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736018|NCT00766090|82952679|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736019|NCT00766090|82952680|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736020|NCT00766090|82952681|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736021|NCT00766090|82952682|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736022|NCT00766090|82952683|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736023|NCT00766090|82952684|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736024|NCT00766090|82952685|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736025|NCT00766090|82952686|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
46736026|NCT00766090|82952687|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736027|NCT00766090|82952688|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
47049583|NCT01903811|83309988|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
46736028|NCT00766090|82952689|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46736029|NCT00766090|82952678|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
46736030|NCT00766090|82952679|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736031|NCT00766090|82952680|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736032|NCT00766090|82952681|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736033|NCT00766090|82952682|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736034|NCT00766090|82952683|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736035|NCT00766090|82952684|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736036|NCT00766090|82952685|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736037|NCT00766090|82952686|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736038|NCT00766090|82952687|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736039|NCT00766090|82952688|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736040|NCT00766090|82952689|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
46736041|NCT00766090|82952678|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
46736042|NCT00766090|82952679|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736043|NCT00766090|82952680|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736044|NCT00766090|82952681|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
46736045|NCT00766090|82952682|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736046|NCT00766090|82952683|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736047|NCT00766090|82952684|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736048|NCT00766090|82952685|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736049|NCT00766090|82952686|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736050|NCT00766090|82952687|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736051|NCT00766090|82952688|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736052|NCT00766090|82952689|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46736053|NCT00766090|82952678|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736054|NCT00766090|82952679|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
47049584|NCT01903811|83309987|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
47049585|NCT01903811|83309988|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
47049586|NCT01903811|83309987|FG000|Overall Study|Withdrawal by Subject|0|||
47049587|NCT01903811|83309988|FG001|Overall Study|Withdrawal by Subject|1|||
47049588|NCT01709149|83310005|FG000|Open-label Lead-in Phase|Adverse Event|109|||
46635255|NCT01565148|82808868|FG001|Overall Study|Lost to Follow-up|4|||
46736055|NCT00766090|82952680|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
46736056|NCT00766090|82952681|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736057|NCT00766090|82952682|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736058|NCT00766090|82952683|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736059|NCT00766090|82952684|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736060|NCT00766090|82952685|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
47049589|NCT01709149|83310006|FG001|Open-label Lead-in Phase|Adverse Event|0|||
46736061|NCT00766090|82952686|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736062|NCT00766090|82952687|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736063|NCT00766090|82952688|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736064|NCT00766090|82952689|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
46736065|NCT00766090|82952678|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736066|NCT00766090|82952679|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736067|NCT00766090|82952680|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736068|NCT00766090|82952681|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736069|NCT00766090|82952682|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
46736070|NCT00766090|82952683|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736071|NCT00766090|82952684|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736072|NCT00766090|82952685|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736073|NCT00766090|82952686|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736074|NCT00766090|82952687|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736075|NCT00766090|82952688|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736076|NCT00766090|82952689|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46736077|NCT00766090|82952678|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736078|NCT00766090|82952679|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736079|NCT00766090|82952680|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
46736080|NCT00766090|82952681|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736081|NCT00766090|82952682|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736082|NCT00766090|82952683|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736083|NCT00766090|82952684|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736084|NCT00766090|82952685|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736085|NCT00766090|82952686|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736086|NCT00766090|82952687|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736087|NCT00766090|82952688|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736088|NCT00766090|82952689|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
46736089|NCT00766090|82952678|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
46736090|NCT00766090|82952679|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
46736091|NCT00766090|82952680|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
46736092|NCT00766090|82952681|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
46736093|NCT00766090|82952682|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
46736094|NCT00766090|82952683|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
46736095|NCT00766090|82952684|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
46736096|NCT00766090|82952685|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
46736097|NCT00766090|82952686|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
46736098|NCT00766090|82952687|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
46736099|NCT00766090|82952688|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
46736100|NCT00766090|82952689|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
46736101|NCT00766090|82952678|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736102|NCT00766090|82952679|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736103|NCT00766090|82952680|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736104|NCT00766090|82952681|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736105|NCT00766090|82952682|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736106|NCT00766090|82952683|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
46736107|NCT00766090|82952684|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736108|NCT00766090|82952685|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736109|NCT00766090|82952686|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736110|NCT00766090|82952687|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736111|NCT00766090|82952688|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736112|NCT00766090|82952689|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
46736113|NCT00766090|82952678|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736114|NCT00766090|82952679|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
46921651|NCT01678924|83154313|FG000|Overall Study|Personal Reasons|2|||
47049590|NCT01709149|83310007|FG002|Open-label Lead-in Phase|Adverse Event|0|||
47049591|NCT01709149|83310005|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
47049592|NCT01709149|83310006|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
47049593|NCT01709149|83310007|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
47049594|NCT01709149|83310005|FG000|Open-label Lead-in Phase|Death|1|||
47049595|NCT01709149|83310006|FG001|Open-label Lead-in Phase|Death|0|||
47049596|NCT01709149|83310007|FG002|Open-label Lead-in Phase|Death|0|||
46736115|NCT00766090|82952680|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736116|NCT00766090|82952681|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
46736117|NCT00766090|82952682|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736118|NCT00766090|82952683|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736119|NCT00766090|82952684|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736120|NCT00766090|82952685|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736121|NCT00766090|82952686|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736122|NCT00766090|82952687|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
47049597|NCT01709149|83310005|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
46736123|NCT00766090|82952688|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
46736124|NCT00766090|82952689|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
46736125|NCT00766090|82952678|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736126|NCT00766090|82952679|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736127|NCT00766090|82952680|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736128|NCT00766090|82952681|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736129|NCT00766090|82952682|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
46736130|NCT00766090|82952683|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736131|NCT00766090|82952684|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736132|NCT00766090|82952685|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736133|NCT00766090|82952686|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736134|NCT00766090|82952687|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736135|NCT00766090|82952688|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736136|NCT00766090|82952689|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
46736137|NCT00580801|82952706|FG000|Overall Study|Physician Decision|1|||
46736138|NCT00580801|82952707|FG001|Overall Study|Physician Decision|0|||
46736139|NCT00580801|82952708|FG002|Overall Study|Physician Decision|0|||
46736140|NCT00580801|82952706|FG000|Overall Study|Adverse Event|2|||
46736141|NCT00580801|82952707|FG001|Overall Study|Adverse Event|0|||
46736142|NCT00580801|82952708|FG002|Overall Study|Adverse Event|0|||
46736143|NCT00580801|82952706|FG000|Overall Study|Lost to Follow-up|2|||
46736144|NCT00580801|82952707|FG001|Overall Study|Lost to Follow-up|0|||
46736145|NCT00580801|82952708|FG002|Overall Study|Lost to Follow-up|0|||
46736146|NCT00580801|82952706|FG000|Overall Study|Reached a virologic endpoint|0|||
46736147|NCT00580801|82952707|FG001|Overall Study|Reached a virologic endpoint|1|||
46736148|NCT00580801|82952708|FG002|Overall Study|Reached a virologic endpoint|2|||
46736149|NCT00580801|82952706|FG000|Overall Study|Participant non-compliant|0|||
46736150|NCT00580801|82952707|FG001|Overall Study|Participant non-compliant|0|||
46736151|NCT00580801|82952708|FG002|Overall Study|Participant non-compliant|1|||
46736152|NCT00580801|82952706|FG000|Overall Study|Travel|1|||
46736153|NCT00580801|82952707|FG001|Overall Study|Travel|0|||
46736154|NCT00580801|82952708|FG002|Overall Study|Travel|0|||
46736155|NCT01059539|82952716|FG000|Overall Study|Adverse Event|66|||
46736156|NCT01059539|82952716|FG000|Overall Study|Insufficient Therapeutic Response|26|||
46736157|NCT01059539|82952716|FG000|Overall Study|Protocol Violation|55|||
46736158|NCT01059539|82952716|FG000|Overall Study|Withdrawal of Consent|80|||
46736159|NCT01059539|82952716|FG000|Overall Study|Lost to Follow-up|42|||
46736160|NCT01059539|82952716|FG000|Overall Study|Reason Not Specified|2|||
46736161|NCT00999908|82952720|FG000|Treatment Period 1|Subject withdrew consent|2|||
46736162|NCT00999908|82952721|FG001|Treatment Period 1|Subject withdrew consent|0|||
46736163|NCT00999908|82952722|FG002|Treatment Period 1|Subject withdrew consent|0|||
46736164|NCT00999908|82952720|FG000|Treatment Period 2|Protocol Violation|1|||
46736165|NCT00999908|82952721|FG001|Treatment Period 2|Protocol Violation|0|||
46736166|NCT00999908|82952722|FG002|Treatment Period 2|Protocol Violation|0|||
46736167|NCT00580723|82952730|FG000|Overall Study|Did not want to participate in extension|3|||
46736168|NCT00580723|82952730|FG000|Overall Study|Lost to Follow-up|5|||
46736169|NCT00999596|82952734|FG000|Overall Study|Statistical population not required|101|||
46736170|NCT04676867|82952743|FG000|Overall Study|Screen failure|0|||
46736171|NCT04676867|82952744|FG001|Overall Study|Screen failure|0|||
46736172|NCT04676867|82952745|FG002|Overall Study|Screen failure|6|||
46736173|NCT04676867|82952746|FG003|Overall Study|Screen failure|2|||
46736174|NCT04676867|82952743|FG000|Overall Study|Death|0|||
46736175|NCT04676867|82952744|FG001|Overall Study|Death|0|||
46736176|NCT04676867|82952745|FG002|Overall Study|Death|1|||
46736177|NCT04676867|82952746|FG003|Overall Study|Death|0|||
46736178|NCT04676867|82952743|FG000|Overall Study|Withdrawal by Subject|2|||
46736179|NCT04676867|82952744|FG001|Overall Study|Withdrawal by Subject|2|||
46736180|NCT04676867|82952745|FG002|Overall Study|Withdrawal by Subject|4|||
46736181|NCT04676867|82952746|FG003|Overall Study|Withdrawal by Subject|4|||
46736182|NCT04676867|82952743|FG000|Overall Study|Lost to Follow-up|1|||
46736183|NCT04676867|82952744|FG001|Overall Study|Lost to Follow-up|0|||
46736184|NCT04676867|82952745|FG002|Overall Study|Lost to Follow-up|0|||
46736185|NCT04676867|82952746|FG003|Overall Study|Lost to Follow-up|0|||
46736186|NCT00770224|82952756|FG000|Step 1: Induction|Adverse Event|3|||
46736187|NCT00770224|82952757|FG001|Step 1: Induction|Adverse Event|0|||
46736188|NCT00770224|82952756|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
46736189|NCT00770224|82952757|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
46736190|NCT00770224|82952756|FG000|Step 1: Induction|Other reason not protocol specified|2|||
46736191|NCT00770224|82952757|FG001|Step 1: Induction|Other reason not protocol specified|0|||
46736192|NCT00770224|82952756|FG000|Step 1: Induction|Ineligible|2|||
46736193|NCT00770224|82952757|FG001|Step 1: Induction|Ineligible|0|||
46736194|NCT00770224|82952756|FG000|Step 1: Induction|No protocol treatment given|1|||
46736195|NCT00770224|82952757|FG001|Step 1: Induction|No protocol treatment given|0|||
46736196|NCT00770224|82952756|FG000|Step 2: Maintenance|Adverse Event|0|||
46736197|NCT00770224|82952757|FG001|Step 2: Maintenance|Adverse Event|10|||
46736198|NCT00770224|82952756|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
46736199|NCT00770224|82952757|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
46736200|NCT00770224|82952756|FG000|Step 2: Maintenance|Progression/relapse|0|||
46736201|NCT00770224|82952757|FG001|Step 2: Maintenance|Progression/relapse|1|||
46736202|NCT00770224|82952756|FG000|Step 2: Maintenance|Death|0|||
46736203|NCT00770224|82952757|FG001|Step 2: Maintenance|Death|2|||
46736204|NCT00770224|82952756|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
46736205|NCT00770224|82952757|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
46736206|NCT00770224|82952756|FG000|Step 2: Maintenance|Ineligible|0|||
47049598|NCT01709149|83310006|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
46736207|NCT00770224|82952757|FG001|Step 2: Maintenance|Ineligible|2|||
46736208|NCT02389465|82952768|FG000|Overall Study|Lost to Follow-up|1|||
46736209|NCT02389465|82952769|FG001|Overall Study|Lost to Follow-up|3|||
46736210|NCT02389465|82952770|FG002|Overall Study|Lost to Follow-up|3|||
46736211|NCT02389465|82952771|FG003|Overall Study|Lost to Follow-up|0|||
46736212|NCT02389465|82952768|FG000|Overall Study|Physician Decision|0|||
47049599|NCT01709149|83310007|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
47049600|NCT01709149|83310005|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
47049601|NCT01709149|83310006|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
46736213|NCT02389465|82952769|FG001|Overall Study|Physician Decision|0|||
46736214|NCT02389465|82952770|FG002|Overall Study|Physician Decision|0|||
46736215|NCT02389465|82952771|FG003|Overall Study|Physician Decision|1|||
46736216|NCT02389465|82952768|FG000|Overall Study|Withdrawal by Subject|0|||
46736217|NCT02389465|82952769|FG001|Overall Study|Withdrawal by Subject|1|||
46736218|NCT02389465|82952770|FG002|Overall Study|Withdrawal by Subject|2|||
46736219|NCT02389465|82952771|FG003|Overall Study|Withdrawal by Subject|2|||
46736220|NCT01057589|82952781|FG000|Overall Study|Disease Progression|35|||
46736221|NCT01057589|82952781|FG000|Overall Study|Adverse Event|10|||
46736222|NCT01057589|82952781|FG000|Overall Study|Physician Decision|8|||
46736223|NCT01057589|82952781|FG000|Overall Study|Withdrawal by Subject|3|||
46736224|NCT01057589|82952781|FG000|Overall Study|Sponsor Decision|1|||
46736225|NCT01057589|82952781|FG000|Overall Study|Death|8|||
46736226|NCT01057589|82952781|FG000|Overall Study|Lost to Follow-up|1|||
46736227|NCT01716117|82952787|FG000|Overall Study|Death|5|||
46736228|NCT01716117|82952788|FG001|Overall Study|Death|2|||
46736229|NCT01716117|82952787|FG000|Overall Study|Withdrawal by Subject|2|||
46736230|NCT01716117|82952788|FG001|Overall Study|Withdrawal by Subject|0|||
46736231|NCT00579553|82952804|FG000|Overall Study|Lost to Follow-up|16|||
46736232|NCT00579553|82952805|FG001|Overall Study|Lost to Follow-up|13|||
46736233|NCT01650831|82952811|FG000|Overall Study|Screen failure|1|||
46736234|NCT00581893|82952819|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
46736235|NCT00581893|82952820|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
46736236|NCT00770146|82952828|FG000|Treatment Period|Withdrawal by Subject|6|||
46736237|NCT00770146|82952829|FG001|Treatment Period|Withdrawal by Subject|13|||
46736238|NCT00770146|82952828|FG000|Treatment Period|Adverse Event|2|||
46736239|NCT00770146|82952829|FG001|Treatment Period|Adverse Event|26|||
46736240|NCT00770146|82952828|FG000|Treatment Period|Other|1|||
46736241|NCT00770146|82952829|FG001|Treatment Period|Other|5|||
46736242|NCT00770146|82952828|FG000|Treatment Period|Protocol non-compliance|0|||
46736243|NCT00770146|82952829|FG001|Treatment Period|Protocol non-compliance|1|||
46736244|NCT00770146|82952828|FG000|Follow-up Period|Withdrawal by Subject|7|||
46736245|NCT00770146|82952829|FG001|Follow-up Period|Withdrawal by Subject|13|||
46736246|NCT00770146|82952828|FG000|Follow-up Period|Adverse Event|0|||
46736247|NCT00770146|82952829|FG001|Follow-up Period|Adverse Event|2|||
46736248|NCT00770146|82952828|FG000|Follow-up Period|Other|4|||
46736249|NCT00770146|82952829|FG001|Follow-up Period|Other|5|||
46736250|NCT01056341|82952840|FG000|Overall Study|Treatment Intolerance|0|||
46736251|NCT01056341|82952841|FG001|Overall Study|Treatment Intolerance|2|||
46736252|NCT01056341|82952842|FG002|Overall Study|Treatment Intolerance|0|||
46803984|NCT03903822|83023206|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
46803985|NCT03903822|83023207|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
46803986|NCT03903822|83023208|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
46803987|NCT03903822|83023209|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
46921652|NCT01678924|83154314|FG001|Overall Study|Personal Reasons|2|||
46921653|NCT01678924|83154315|FG002|Overall Study|Personal Reasons|2|||
46921654|NCT01678924|83154316|FG003|Overall Study|Personal Reasons|7|||
46921655|NCT01678924|83154313|FG000|Overall Study|Withdrawal by Subject|0|||
46921656|NCT01678924|83154314|FG001|Overall Study|Withdrawal by Subject|3|||
46921657|NCT01678924|83154315|FG002|Overall Study|Withdrawal by Subject|0|||
46803988|NCT03903822|83023210|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
46803989|NCT03903822|83023211|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
47049602|NCT01709149|83310007|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
46736253|NCT01056341|82952843|FG003|Overall Study|Treatment Intolerance|2|||
46736254|NCT01056341|82952844|FG004|Overall Study|Treatment Intolerance|0|||
46736255|NCT01056341|82952840|FG000|Overall Study|Lack of Efficacy|32|||
46736256|NCT01056341|82952841|FG001|Overall Study|Lack of Efficacy|30|||
46736257|NCT01056341|82952842|FG002|Overall Study|Lack of Efficacy|7|||
46736258|NCT01056341|82952843|FG003|Overall Study|Lack of Efficacy|25|||
46736259|NCT01056341|82952844|FG004|Overall Study|Lack of Efficacy|9|||
46736260|NCT01056341|82952840|FG000|Overall Study|Other reasons|4|||
46736261|NCT01056341|82952841|FG001|Overall Study|Other reasons|4|||
46736262|NCT01056341|82952842|FG002|Overall Study|Other reasons|8|||
46736263|NCT01056341|82952843|FG003|Overall Study|Other reasons|9|||
46736264|NCT01056341|82952844|FG004|Overall Study|Other reasons|5|||
46736265|NCT00999518|82952867|FG000|Overall Study|Adverse Event|1|||
46736266|NCT00999518|82952868|FG001|Overall Study|Adverse Event|6|||
46736267|NCT00999518|82952869|FG002|Overall Study|Adverse Event|3|||
46736268|NCT00999518|82952870|FG003|Overall Study|Adverse Event|1|||
46736269|NCT00999518|82952871|FG004|Overall Study|Adverse Event|2|||
46736270|NCT00999518|82952867|FG000|Overall Study|Lack of Efficacy|2|||
46736271|NCT00999518|82952868|FG001|Overall Study|Lack of Efficacy|0|||
46736272|NCT00999518|82952869|FG002|Overall Study|Lack of Efficacy|0|||
46736273|NCT00999518|82952870|FG003|Overall Study|Lack of Efficacy|2|||
46736274|NCT00999518|82952871|FG004|Overall Study|Lack of Efficacy|2|||
46736275|NCT00999518|82952867|FG000|Overall Study|Lost to Follow-up|0|||
46736276|NCT00999518|82952868|FG001|Overall Study|Lost to Follow-up|0|||
46736277|NCT00999518|82952869|FG002|Overall Study|Lost to Follow-up|0|||
46736278|NCT00999518|82952870|FG003|Overall Study|Lost to Follow-up|4|||
46736279|NCT00999518|82952871|FG004|Overall Study|Lost to Follow-up|1|||
46736280|NCT00999518|82952867|FG000|Overall Study|Did not meet entrance criteria|0|||
46736281|NCT00999518|82952868|FG001|Overall Study|Did not meet entrance criteria|0|||
46736282|NCT00999518|82952869|FG002|Overall Study|Did not meet entrance criteria|0|||
46736283|NCT00999518|82952870|FG003|Overall Study|Did not meet entrance criteria|0|||
46736284|NCT00999518|82952871|FG004|Overall Study|Did not meet entrance criteria|1|||
46736285|NCT00999518|82952867|FG000|Overall Study|Study terminated by sponsor|10|||
46736286|NCT00999518|82952868|FG001|Overall Study|Study terminated by sponsor|6|||
46736287|NCT00999518|82952869|FG002|Overall Study|Study terminated by sponsor|5|||
46736288|NCT00999518|82952870|FG003|Overall Study|Study terminated by sponsor|5|||
46736289|NCT00999518|82952871|FG004|Overall Study|Study terminated by sponsor|9|||
46736290|NCT00999518|82952867|FG000|Overall Study|Pregnancy|0|||
46736291|NCT00999518|82952868|FG001|Overall Study|Pregnancy|0|||
46736292|NCT00999518|82952869|FG002|Overall Study|Pregnancy|1|||
46736293|NCT00999518|82952870|FG003|Overall Study|Pregnancy|0|||
46736294|NCT00999518|82952871|FG004|Overall Study|Pregnancy|0|||
46736295|NCT00999518|82952867|FG000|Overall Study|Protocol Violation|0|||
46736296|NCT00999518|82952868|FG001|Overall Study|Protocol Violation|1|||
46736297|NCT00999518|82952869|FG002|Overall Study|Protocol Violation|0|||
46736298|NCT00999518|82952870|FG003|Overall Study|Protocol Violation|0|||
46803990|NCT03903822|83023212|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
46803991|NCT03903822|83023213|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
46803992|NCT03903822|83023206|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
46803993|NCT03903822|83023207|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
46803994|NCT03903822|83023208|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
46803995|NCT03903822|83023209|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
46803996|NCT03903822|83023210|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
46803997|NCT03903822|83023211|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
46803998|NCT03903822|83023212|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
46803999|NCT03903822|83023213|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
46921658|NCT01678924|83154316|FG003|Overall Study|Withdrawal by Subject|2|||
46921659|NCT01678924|83154313|FG000|Overall Study|Unable to attend scheduled visits|0|||
47049603|NCT01709149|83310005|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
47049604|NCT01709149|83310006|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
47049605|NCT01709149|83310007|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
47049606|NCT01709149|83310005|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
47049607|NCT01709149|83310006|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
47049608|NCT01709149|83310007|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
47049609|NCT01709149|83310005|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
47049610|NCT01709149|83310006|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
46804000|NCT03903822|83023206|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
46804001|NCT03903822|83023207|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
46804002|NCT03903822|83023208|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
47049611|NCT01709149|83310007|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
46736299|NCT00999518|82952871|FG004|Overall Study|Protocol Violation|2|||
46736300|NCT00999518|82952867|FG000|Overall Study|Withdrawal by Subject|5|||
46736301|NCT00999518|82952868|FG001|Overall Study|Withdrawal by Subject|4|||
46736302|NCT00999518|82952869|FG002|Overall Study|Withdrawal by Subject|10|||
46736303|NCT00999518|82952870|FG003|Overall Study|Withdrawal by Subject|6|||
46736304|NCT00999518|82952871|FG004|Overall Study|Withdrawal by Subject|1|||
46736305|NCT00999518|82952867|FG000|Overall Study|Other|5|||
46736306|NCT00999518|82952868|FG001|Overall Study|Other|7|||
46736307|NCT00999518|82952869|FG002|Overall Study|Other|1|||
46736308|NCT00999518|82952870|FG003|Overall Study|Other|4|||
46736309|NCT00999518|82952871|FG004|Overall Study|Other|5|||
46736310|NCT00999518|82952867|FG000|Overall Study|Randomized but not Treated|1|||
47049612|NCT01709149|83310005|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
47049613|NCT01709149|83310006|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
47049614|NCT01709149|83310007|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
47049615|NCT01709149|83310005|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
47049616|NCT01709149|83310006|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
47049617|NCT01709149|83310007|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
47049618|NCT01568593|83310016|FG000|Overall Study|Lack of Efficacy|4|||
47049619|NCT01568593|83310017|FG001|Overall Study|Lack of Efficacy|1|||
47049620|NCT01568593|83310016|FG000|Overall Study|Adverse Event|3|||
47049621|NCT01568593|83310017|FG001|Overall Study|Adverse Event|2|||
47049622|NCT01683565|83310025|FG000|Overall Study|Lost to Follow-up|2|||
47049623|NCT01683565|83310026|FG001|Overall Study|Lost to Follow-up|0|||
47049624|NCT01683565|83310025|FG000|Overall Study|Discontinued Intervention|1|||
47049625|NCT01683565|83310026|FG001|Overall Study|Discontinued Intervention|1|||
47049626|NCT01903031|83310050|FG000|Overall Study|Not Able to Attend Clinic|1|||
47049627|NCT01903031|83310051|FG001|Overall Study|Not Able to Attend Clinic|1|||
47049628|NCT01903031|83310052|FG002|Overall Study|Not Able to Attend Clinic|0|||
47049629|NCT01903031|83310050|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
47049630|NCT01903031|83310051|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
47049631|NCT01903031|83310052|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
47049632|NCT01903031|83310050|FG000|Overall Study|Adverse Event|0|||
47049633|NCT01903031|83310051|FG001|Overall Study|Adverse Event|1|||
47049634|NCT01903031|83310052|FG002|Overall Study|Adverse Event|0|||
47049635|NCT01903031|83310050|FG000|Overall Study|Withdrawal by Subject|0|||
47049636|NCT01903031|83310051|FG001|Overall Study|Withdrawal by Subject|1|||
47049637|NCT01903031|83310052|FG002|Overall Study|Withdrawal by Subject|1|||
47049638|NCT01903031|83310050|FG000|Overall Study|Protocol Violation|0|||
47049639|NCT01903031|83310051|FG001|Overall Study|Protocol Violation|0|||
47049640|NCT01903031|83310052|FG002|Overall Study|Protocol Violation|2|||
47049641|NCT01903031|83310050|FG000|Overall Study|Lost to Follow-up|0|||
46635256|NCT01565148|82808869|FG002|Overall Study|Lost to Follow-up|0|||
46635257|NCT01565148|82808870|FG003|Overall Study|Lost to Follow-up|3|||
46635258|NCT01565148|82808867|FG000|Overall Study|Rescue Therapy|8|||
46635259|NCT01565148|82808868|FG001|Overall Study|Rescue Therapy|5|||
46635260|NCT01565148|82808869|FG002|Overall Study|Rescue Therapy|5|||
46635261|NCT01565148|82808870|FG003|Overall Study|Rescue Therapy|8|||
46635262|NCT01565148|82808867|FG000|Overall Study|Death|0|||
46736311|NCT00999518|82952868|FG001|Overall Study|Randomized but not Treated|1|||
46736312|NCT00999518|82952869|FG002|Overall Study|Randomized but not Treated|2|||
46736313|NCT00999518|82952870|FG003|Overall Study|Randomized but not Treated|0|||
46736314|NCT00999518|82952871|FG004|Overall Study|Randomized but not Treated|1|||
46736315|NCT01056263|82952887|FG000|Overall Study|Adverse Event|12|||
46736316|NCT01056263|82952887|FG000|Overall Study|Death|1|||
46736317|NCT01056263|82952887|FG000|Overall Study|Withdrawal by Subject|1|||
46736318|NCT01056263|82952887|FG000|Overall Study|Lack of Efficacy|29|||
46736319|NCT01056263|82952887|FG000|Overall Study|Progressive disease|2|||
46736320|NCT01056263|82952887|FG000|Overall Study|Neoplasm progression|1|||
46736321|NCT01056263|82952887|FG000|Overall Study|Objective progression or relapse|1|||
46736322|NCT01056263|82952887|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
46736323|NCT01056107|82952895|FG000|Overall Study|Withdrawal by Subject|0|||
46736324|NCT01056107|82952896|FG001|Overall Study|Withdrawal by Subject|1|||
46736325|NCT01056107|82952897|FG002|Overall Study|Withdrawal by Subject|3|||
46736326|NCT01056107|82952898|FG003|Overall Study|Withdrawal by Subject|0|||
46736327|NCT01003886|82952908|FG000|Overall Study|Lack of Efficacy|5|||
46736328|NCT01003886|82952908|FG000|Overall Study|Lost to Follow-up|169|||
46736329|NCT01003886|82952908|FG000|Overall Study|Withdrawal by Subject|39|||
46736330|NCT01003886|82952908|FG000|Overall Study|Other|14|||
47049642|NCT01903031|83310051|FG001|Overall Study|Lost to Follow-up|0|||
47049643|NCT01903031|83310052|FG002|Overall Study|Lost to Follow-up|1|||
47049644|NCT01903031|83310050|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
46635263|NCT01565148|82808868|FG001|Overall Study|Death|0|||
46635264|NCT01565148|82808869|FG002|Overall Study|Death|1|||
46635265|NCT01565148|82808870|FG003|Overall Study|Death|0|||
46736331|NCT01003886|82952908|FG000|Overall Study|Adverse Event|3|||
46736332|NCT01003184|82952914|FG000|Overall Study|Adverse Event|12|||
46736333|NCT01003184|82952915|FG001|Overall Study|Adverse Event|5|||
46736334|NCT01003184|82952914|FG000|Overall Study|Lost to Follow-up|1|||
46736335|NCT01003184|82952915|FG001|Overall Study|Lost to Follow-up|0|||
47049645|NCT01903031|83310051|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
47049646|NCT01903031|83310052|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
47049647|NCT01616693|83310084|FG000|Evaluated for Safety|Physician Decision|1|||
46736336|NCT01003184|82952914|FG000|Overall Study|Loss of glucose control|1|||
46736337|NCT01003184|82952915|FG001|Overall Study|Loss of glucose control|1|||
46736338|NCT01003184|82952914|FG000|Overall Study|Protocol Violation|3|||
46736339|NCT01003184|82952915|FG001|Overall Study|Protocol Violation|0|||
46736340|NCT01003184|82952914|FG000|Overall Study|Withdrawal by Subject|1|||
46736341|NCT01003184|82952915|FG001|Overall Study|Withdrawal by Subject|6|||
46736342|NCT01003184|82952914|FG000|Overall Study|Physician Decision|1|||
46736343|NCT01003184|82952915|FG001|Overall Study|Physician Decision|0|||
46736344|NCT01029353|82952925|FG000|Overall Study|Lost to Follow-up|4|||
46736345|NCT01029353|82952926|FG001|Overall Study|Lost to Follow-up|5|||
46736346|NCT01029353|82952927|FG002|Overall Study|Lost to Follow-up|5|||
46736347|NCT01029353|82952928|FG003|Overall Study|Lost to Follow-up|4|||
46736348|NCT01029353|82952925|FG000|Overall Study|Consent Withdrawn|2|||
46736349|NCT01029353|82952926|FG001|Overall Study|Consent Withdrawn|0|||
46736350|NCT01029353|82952927|FG002|Overall Study|Consent Withdrawn|0|||
46736351|NCT01029353|82952928|FG003|Overall Study|Consent Withdrawn|0|||
46736352|NCT01029353|82952925|FG000|Overall Study|Primary Outcome Indeterminate|1|||
46736353|NCT01029353|82952926|FG001|Overall Study|Primary Outcome Indeterminate|3|||
46736354|NCT01029353|82952927|FG002|Overall Study|Primary Outcome Indeterminate|2|||
46736355|NCT01029353|82952928|FG003|Overall Study|Primary Outcome Indeterminate|0|||
46736356|NCT01008410|82952940|FG000|Overall Study|Adverse Event|13|||
46736357|NCT01008410|82952941|FG001|Overall Study|Adverse Event|7|||
46736358|NCT01008410|82952940|FG000|Overall Study|Withdrawal by Subject|6|||
46736359|NCT01008410|82952941|FG001|Overall Study|Withdrawal by Subject|2|||
46736360|NCT01008410|82952940|FG000|Overall Study|Lost to Follow-up|1|||
46736361|NCT01008410|82952941|FG001|Overall Study|Lost to Follow-up|0|||
46736362|NCT01008410|82952940|FG000|Overall Study|Noncompliance|1|||
46736363|NCT01008410|82952941|FG001|Overall Study|Noncompliance|0|||
46736364|NCT01008410|82952940|FG000|Overall Study|Low Cortisol|2|||
46736365|NCT01008410|82952941|FG001|Overall Study|Low Cortisol|0|||
46736366|NCT01008410|82952940|FG000|Overall Study|Lack of Efficacy|2|||
46736367|NCT01008410|82952941|FG001|Overall Study|Lack of Efficacy|6|||
46736368|NCT01008410|82952940|FG000|Overall Study|Met Exclusion Criterion|0|||
46736369|NCT01008410|82952941|FG001|Overall Study|Met Exclusion Criterion|1|||
46736370|NCT01023269|82952947|FG000|Overall Study|early termination of the study|2|||
46736371|NCT01023269|82952948|FG001|Overall Study|early termination of the study|0|||
46736372|NCT01007942|82952980|FG000|Overall Study|Adverse Event|29|||
46736373|NCT01007942|82952981|FG001|Overall Study|Adverse Event|14|||
46736374|NCT01007942|82952980|FG000|Overall Study|Abnormal test procedure|0|||
46736375|NCT01007942|82952981|FG001|Overall Study|Abnormal test procedure|1|||
46736376|NCT01007942|82952980|FG000|Overall Study|Disease progression|217|||
46736377|NCT01007942|82952981|FG001|Overall Study|Disease progression|242|||
46736378|NCT01007942|82952980|FG000|Overall Study|New cancer therapy|5|||
46736379|NCT01007942|82952981|FG001|Overall Study|New cancer therapy|1|||
46736380|NCT01007942|82952980|FG000|Overall Study|Protocol Violation|1|||
46736381|NCT01007942|82952981|FG001|Overall Study|Protocol Violation|1|||
46736382|NCT01007942|82952980|FG000|Overall Study|Withdrawal by Subject|19|||
46736383|NCT01007942|82952981|FG001|Overall Study|Withdrawal by Subject|14|||
46736384|NCT01007942|82952980|FG000|Overall Study|Lost to Follow-up|1|||
46736385|NCT01007942|82952981|FG001|Overall Study|Lost to Follow-up|0|||
46736386|NCT01007942|82952980|FG000|Overall Study|Administrative problems|2|||
46736387|NCT01007942|82952981|FG001|Overall Study|Administrative problems|0|||
46736388|NCT01007942|82952980|FG000|Overall Study|Death|3|||
46736389|NCT01007942|82952981|FG001|Overall Study|Death|2|||
46736390|NCT01007942|82952980|FG000|Overall Study|Patients untreated|4|||
46736391|NCT01007942|82952981|FG001|Overall Study|Patients untreated|3|||
46736392|NCT01023035|82952994|FG000|Treatment Period|Adverse Event|27|||
46736393|NCT01023035|82952995|FG001|Treatment Period|Adverse Event|32|||
46736394|NCT01023035|82952996|FG002|Treatment Period|Adverse Event|50|||
46736395|NCT01023035|82952994|FG000|Treatment Period|Non-Medical Reasons|19|||
46736396|NCT01023035|82952995|FG001|Treatment Period|Non-Medical Reasons|22|||
46736397|NCT01023035|82952996|FG002|Treatment Period|Non-Medical Reasons|44|||
46804003|NCT03903822|83023209|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
46921660|NCT01678924|83154314|FG001|Overall Study|Unable to attend scheduled visits|0|||
46921661|NCT01678924|83154315|FG002|Overall Study|Unable to attend scheduled visits|0|||
46736398|NCT01023035|82952994|FG000|Treatment Period|Treatment Failure|26|||
46736399|NCT01023035|82952995|FG001|Treatment Period|Treatment Failure|31|||
46736400|NCT01023035|82952996|FG002|Treatment Period|Treatment Failure|24|||
46736401|NCT01023035|82952994|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
46736402|NCT01023035|82952995|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
46736403|NCT01023035|82952996|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
46736404|NCT01023035|82952994|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
46736405|NCT01023035|82952995|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
46736406|NCT01023035|82952996|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
46736407|NCT01028651|82953006|FG000|Overall Study|Death|2|||
46736408|NCT01028651|82953006|FG000|Overall Study|Adverse Event|1|||
46736409|NCT01028027|82953014|FG000|Overall Study|Lost to Follow-up|4|||
46736410|NCT01028027|82953015|FG001|Overall Study|Lost to Follow-up|1|||
46736411|NCT01028027|82953014|FG000|Overall Study|Withdrawal by Subject|5|||
46736412|NCT01028027|82953015|FG001|Overall Study|Withdrawal by Subject|3|||
46736413|NCT01028027|82953014|FG000|Overall Study|Adverse Event|4|||
46736414|NCT01028027|82953015|FG001|Overall Study|Adverse Event|7|||
46736415|NCT01028027|82953014|FG000|Overall Study|Protocol Violation|3|||
46736416|NCT01028027|82953015|FG001|Overall Study|Protocol Violation|1|||
46736417|NCT01028027|82953014|FG000|Overall Study|Lack of Efficacy|0|||
46736418|NCT01028027|82953015|FG001|Overall Study|Lack of Efficacy|1|||
46736419|NCT01007552|82953021|FG000|Overall Study|Withdrawal by Subject|1|||
46736420|NCT01007396|82953025|FG000|Overall Study|Lost to Follow-up|47|||
46736421|NCT00998738|82953029|FG000|Overall Study|Uknown|1|||
46736422|NCT00997334|82953033|FG000|Overall Study|still on therapy|12|||
46736423|NCT00997334|82953033|FG000|Overall Study|Adverse Event|3|||
46736424|NCT00997334|82953033|FG000|Overall Study|Patient non-compliance|1|||
46736425|NCT00997334|82953033|FG000|Overall Study|Withdrawal by Subject|3|||
46736426|NCT00997334|82953033|FG000|Overall Study|Death|2|||
46736427|NCT00997334|82953033|FG000|Overall Study|Urgent Palliative Care|2|||
46736428|NCT00997334|82953033|FG000|Overall Study|No lesion amenable|1|||
46736429|NCT00997334|82953033|FG000|Overall Study|Ineligible|1|||
46736430|NCT00996944|82953039|FG000|Double-blind Treatment Period|Adverse Event|2|||
46736431|NCT00996944|82953040|FG001|Double-blind Treatment Period|Adverse Event|1|||
46736432|NCT00996944|82953039|FG000|Double-blind Treatment Period|Protocol Violation|1|||
46736433|NCT00996944|82953040|FG001|Double-blind Treatment Period|Protocol Violation|0|||
46736434|NCT00996944|82953039|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
46736435|NCT00996944|82953040|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
46736436|NCT00996944|82953039|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
46736437|NCT00996944|82953040|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
46736438|NCT00996944|82953039|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
46736439|NCT00996944|82953040|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
46736440|NCT01002482|82953050|FG000|Overall Study|Withdrawal by Subject|14|||
46736441|NCT01002482|82953051|FG001|Overall Study|Withdrawal by Subject|21|||
46736442|NCT01002482|82953050|FG000|Overall Study|Included twice|1|||
46736443|NCT01002482|82953051|FG001|Overall Study|Included twice|0|||
46736444|NCT01027949|82953057|FG000|Overall Study|Death|174|||
46921662|NCT01678924|83154316|FG003|Overall Study|Unable to attend scheduled visits|1|||
46921663|NCT02925793|83154330|FG000|Overall Study|Adverse Event|3|||
46921664|NCT02925793|83154331|FG001|Overall Study|Adverse Event|3|||
46921665|NCT02925793|83154332|FG002|Overall Study|Adverse Event|6|||
46921666|NCT02925793|83154330|FG000|Overall Study|Withdrawal by Subject|16|||
46921667|NCT02925793|83154331|FG001|Overall Study|Withdrawal by Subject|15|||
46921668|NCT02925793|83154332|FG002|Overall Study|Withdrawal by Subject|13|||
46921669|NCT02925793|83154330|FG000|Overall Study|Investigator Discretion|0|||
46921670|NCT02925793|83154331|FG001|Overall Study|Investigator Discretion|1|||
46921671|NCT02925793|83154332|FG002|Overall Study|Investigator Discretion|1|||
46921672|NCT02925793|83154330|FG000|Overall Study|Lost to Follow-up|2|||
46921673|NCT02925793|83154331|FG001|Overall Study|Lost to Follow-up|3|||
46921674|NCT02925793|83154332|FG002|Overall Study|Lost to Follow-up|1|||
46921675|NCT02925793|83154330|FG000|Overall Study|Lack of Efficacy|2|||
46921676|NCT02925793|83154331|FG001|Overall Study|Lack of Efficacy|6|||
46736445|NCT01027949|82953057|FG000|Overall Study|Progressive Disease|163|||
46736446|NCT01027949|82953057|FG000|Overall Study|Adverse Event|172|||
46736447|NCT01027949|82953057|FG000|Overall Study|Withdrawal by Subject|113|||
46736448|NCT01027949|82953057|FG000|Overall Study|Lost to Follow-up|17|||
46736449|NCT01027949|82953057|FG000|Overall Study|Protocol Violation|13|||
46736450|NCT01027949|82953057|FG000|Overall Study|PI Decision|8|||
46736451|NCT01027949|82953057|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
46736452|NCT01027949|82953057|FG000|Overall Study|Non-compliance with Study Procedures|7|||
46736453|NCT01027949|82953057|FG000|Overall Study|Lung Transplant|5|||
46736454|NCT01027949|82953057|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
46736455|NCT01027949|82953057|FG000|Overall Study|Use of Excluded Medication|2|||
46736456|NCT01027949|82953057|FG000|Overall Study|Patient Self-discontinuation|1|||
46736457|NCT01027949|82953057|FG000|Overall Study|Pregnancy|1|||
46736458|NCT01027949|82953057|FG000|Overall Study|Surgery|1|||
46736459|NCT01038323|82953064|FG000|Overall Study|Withdrawal by Subject|3|||
46736460|NCT01038323|82953065|FG001|Overall Study|Withdrawal by Subject|2|||
46736461|NCT01038323|82953066|FG002|Overall Study|Withdrawal by Subject|4|||
46736462|NCT01027871|82953077|FG000|Overall Study|Physician Decision|1|||
46736463|NCT01027871|82953078|FG001|Overall Study|Physician Decision|5|||
46736464|NCT01027871|82953079|FG002|Overall Study|Physician Decision|0|||
46736465|NCT01027871|82953077|FG000|Overall Study|Protocol Violation|0|||
46736466|NCT01027871|82953078|FG001|Overall Study|Protocol Violation|2|||
46736467|NCT01027871|82953079|FG002|Overall Study|Protocol Violation|2|||
46736468|NCT01027871|82953077|FG000|Overall Study|Withdrawal by Subject|1|||
46736469|NCT01027871|82953078|FG001|Overall Study|Withdrawal by Subject|2|||
46736470|NCT01027871|82953079|FG002|Overall Study|Withdrawal by Subject|2|||
46736471|NCT01027871|82953077|FG000|Overall Study|Adverse Event|0|||
46736472|NCT01027871|82953078|FG001|Overall Study|Adverse Event|2|||
47049648|NCT01616693|83310085|FG001|Evaluated for Safety|Physician Decision|0|||
46736473|NCT01027871|82953079|FG002|Overall Study|Adverse Event|2|||
46736474|NCT01027871|82953077|FG000|Overall Study|Sponsor Decision|0|||
46736475|NCT01027871|82953078|FG001|Overall Study|Sponsor Decision|2|||
46736476|NCT01027871|82953079|FG002|Overall Study|Sponsor Decision|0|||
46736477|NCT01027871|82953077|FG000|Overall Study|Discontinued Prior to Treatment|0|||
46736478|NCT01027871|82953078|FG001|Overall Study|Discontinued Prior to Treatment|0|||
46736479|NCT01027871|82953079|FG002|Overall Study|Discontinued Prior to Treatment|1|||
46736480|NCT01021553|82953095|FG000|Overall Study|Adverse Event|1|||
46736481|NCT01021553|82953096|FG001|Overall Study|Adverse Event|0|||
46736482|NCT01021553|82953097|FG002|Overall Study|Adverse Event|0|||
46736483|NCT01021553|82953095|FG000|Overall Study|Lack of Efficacy|2|||
46736484|NCT01021553|82953096|FG001|Overall Study|Lack of Efficacy|2|||
46736485|NCT01021553|82953097|FG002|Overall Study|Lack of Efficacy|0|||
46736486|NCT01021553|82953095|FG000|Overall Study|Protocol Violation|0|||
46736487|NCT01021553|82953096|FG001|Overall Study|Protocol Violation|2|||
46736488|NCT01021553|82953097|FG002|Overall Study|Protocol Violation|2|||
46921677|NCT02925793|83154332|FG002|Overall Study|Lack of Efficacy|4|||
46921678|NCT02925793|83154330|FG000|Overall Study|Other:|2|||
46921679|NCT02925793|83154331|FG001|Overall Study|Other:|1|||
46921680|NCT02925793|83154332|FG002|Overall Study|Other:|3|||
46921681|NCT03071263|83154342|FG000|Overall Study|Adverse Event|1|||
46921682|NCT03071263|83154343|FG001|Overall Study|Adverse Event|3|||
46921683|NCT03071263|83154342|FG000|Overall Study|Withdrawal by Subject|1|||
47049649|NCT01616693|83310086|FG002|Evaluated for Safety|Physician Decision|1|||
47049650|NCT01616693|83310087|FG003|Evaluated for Safety|Physician Decision|0|||
47049651|NCT01616693|83310084|FG000|Received Both Vaccines|Adverse Event|2|||
47049652|NCT01616693|83310085|FG001|Received Both Vaccines|Adverse Event|0|||
47049653|NCT01616693|83310086|FG002|Received Both Vaccines|Adverse Event|0|||
47049654|NCT01616693|83310087|FG003|Received Both Vaccines|Adverse Event|0|||
47049655|NCT01616693|83310084|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
47049656|NCT01616693|83310085|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
47049657|NCT01616693|83310086|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
47049658|NCT01616693|83310087|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
47049659|NCT01616693|83310084|FG000|Received Both Vaccines|Lost to Follow-up|4|||
47049660|NCT01616693|83310085|FG001|Received Both Vaccines|Lost to Follow-up|3|||
46736489|NCT01021553|82953095|FG000|Overall Study|Lost to Follow-up|0|||
46736490|NCT01021553|82953096|FG001|Overall Study|Lost to Follow-up|0|||
46736491|NCT01021553|82953097|FG002|Overall Study|Lost to Follow-up|1|||
46921684|NCT03071263|83154343|FG001|Overall Study|Withdrawal by Subject|3|||
46921685|NCT03071263|83154342|FG000|Overall Study|Physician Decision|1|||
46736492|NCT01021553|82953095|FG000|Overall Study|Withdrawal by Subject|1|||
46736493|NCT01021553|82953096|FG001|Overall Study|Withdrawal by Subject|1|||
46736494|NCT01021553|82953097|FG002|Overall Study|Withdrawal by Subject|0|||
46921686|NCT03071263|83154343|FG001|Overall Study|Physician Decision|0|||
46921687|NCT03071263|83154342|FG000|Overall Study|Participant moved to another city|0|||
46736495|NCT01026389|82953112|FG000|Overall Study|Withdrawal by Subject|1|||
46736496|NCT01026389|82953113|FG001|Overall Study|Withdrawal by Subject|3|||
46736497|NCT01026389|82953112|FG000|Overall Study|change of treatment, patient moved|4|||
46736498|NCT01026389|82953113|FG001|Overall Study|change of treatment, patient moved|2|||
46736499|NCT01006616|82953123|FG000|Period 1 (6 Months)|Adverse Event|10|||
46921688|NCT03071263|83154343|FG001|Overall Study|Participant moved to another city|1|||
46921689|NCT00157196|83154355|FG000|Overall Study|Ongoing at data cut-off|9|||
46921690|NCT03066193|83154359|FG000|Overall Study|Withdrawal by Subject|1|||
46921691|NCT03922321|83154363|FG000|Overall Study|Participant Moved|1|||
46921692|NCT03922321|83154363|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
46921693|NCT01677910|83154370|FG000|Double-Blind Treatment Period|Adverse Event|6|||
46736500|NCT01006616|82953124|FG001|Period 1 (6 Months)|Adverse Event|31|||
46736501|NCT01006616|82953125|FG002|Period 1 (6 Months)|Adverse Event|37|||
46736502|NCT01006616|82953126|FG003|Period 1 (6 Months)|Adverse Event|9|||
46736503|NCT01006616|82953123|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
46736504|NCT01006616|82953124|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
46736505|NCT01006616|82953125|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
46736506|NCT01006616|82953126|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
46736507|NCT01006616|82953123|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
46736508|NCT01006616|82953124|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
46736509|NCT01006616|82953125|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
46736510|NCT01006616|82953126|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
46736511|NCT01006616|82953123|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
46736512|NCT01006616|82953124|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
46736513|NCT01006616|82953125|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
46736514|NCT01006616|82953126|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
46736515|NCT01006616|82953123|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
46736516|NCT01006616|82953124|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
46736517|NCT01006616|82953125|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
46736518|NCT01006616|82953126|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
46736519|NCT01006616|82953123|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
46736520|NCT01006616|82953124|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
46736521|NCT01006616|82953125|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
46736522|NCT01006616|82953126|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
46736523|NCT01006616|82953123|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
46736524|NCT01006616|82953124|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
46736525|NCT01006616|82953125|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
46736526|NCT01006616|82953126|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
46736527|NCT01006616|82953123|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
46736528|NCT01006616|82953124|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
46736529|NCT01006616|82953125|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
46736530|NCT01006616|82953126|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
46736531|NCT01006616|82953123|FG000|Period 1 (6 Months)|Not Treated|0|||
47049661|NCT01616693|83310086|FG002|Received Both Vaccines|Lost to Follow-up|4|||
46736532|NCT01006616|82953124|FG001|Period 1 (6 Months)|Not Treated|0|||
46736533|NCT01006616|82953125|FG002|Period 1 (6 Months)|Not Treated|1|||
46736534|NCT01006616|82953126|FG003|Period 1 (6 Months)|Not Treated|1|||
46736535|NCT01006616|82953123|FG000|Period 2 (18 Months)|Adverse Event|6|||
46736536|NCT01006616|82953124|FG001|Period 2 (18 Months)|Adverse Event|6|||
46736537|NCT01006616|82953125|FG002|Period 2 (18 Months)|Adverse Event|6|||
46736538|NCT01006616|82953126|FG003|Period 2 (18 Months)|Adverse Event|4|||
46736539|NCT01006616|82953123|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
46736540|NCT01006616|82953124|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
46736541|NCT01006616|82953125|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
46736542|NCT01006616|82953126|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
46736543|NCT01006616|82953123|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
46736544|NCT01006616|82953124|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
46736545|NCT01006616|82953125|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
46736546|NCT01006616|82953126|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
46736547|NCT01006616|82953123|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
46736548|NCT01006616|82953124|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
46736549|NCT01006616|82953125|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
47049662|NCT01616693|83310087|FG003|Received Both Vaccines|Lost to Follow-up|4|||
47049663|NCT01616693|83310084|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
47049664|NCT01616693|83310085|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
47049665|NCT01616693|83310086|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
47049666|NCT01616693|83310087|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
47049667|NCT01616459|83310194|FG000|Overall Study|Adverse Event|1|||
46736550|NCT01006616|82953126|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
46736551|NCT01006616|82953123|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
46736552|NCT01006616|82953124|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
46736553|NCT01006616|82953125|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
46736554|NCT01006616|82953126|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
46736555|NCT01006616|82953123|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
46736556|NCT01006616|82953124|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
46736557|NCT01006616|82953125|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
46736558|NCT01006616|82953126|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
46736559|NCT01006616|82953123|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
46736560|NCT01006616|82953124|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
47049668|NCT01616459|83310195|FG001|Overall Study|Adverse Event|1|||
47049669|NCT01616459|83310196|FG002|Overall Study|Adverse Event|2|||
47049670|NCT01616459|83310197|FG003|Overall Study|Adverse Event|0|||
47049671|NCT01616459|83310194|FG000|Overall Study|Lost to Follow-up|1|||
47049672|NCT01616459|83310195|FG001|Overall Study|Lost to Follow-up|11|||
47049673|NCT01616459|83310196|FG002|Overall Study|Lost to Follow-up|3|||
47049674|NCT01616459|83310197|FG003|Overall Study|Lost to Follow-up|2|||
47049675|NCT01616459|83310194|FG000|Overall Study|Protocol Violation|0|||
47049676|NCT01616459|83310195|FG001|Overall Study|Protocol Violation|0|||
46736561|NCT01006616|82953125|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
46736562|NCT01006616|82953126|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
46736563|NCT01006616|82953123|FG000|Period 2 (18 Months)|Study Terminated|63|||
46736564|NCT01006616|82953124|FG001|Period 2 (18 Months)|Study Terminated|46|||
46736565|NCT01006616|82953125|FG002|Period 2 (18 Months)|Study Terminated|44|||
46736566|NCT01006616|82953126|FG003|Period 2 (18 Months)|Study Terminated|70|||
46736567|NCT00996632|82953138|FG000|Overall Study|Physician Decision|0|||
46736568|NCT00996632|82953139|FG001|Overall Study|Physician Decision|0|||
47049677|NCT01616459|83310196|FG002|Overall Study|Protocol Violation|0|||
47049678|NCT01616459|83310197|FG003|Overall Study|Protocol Violation|2|||
47049679|NCT01616459|83310194|FG000|Overall Study|Withdrawal by Subject|2|||
47049680|NCT01616459|83310195|FG001|Overall Study|Withdrawal by Subject|4|||
47049681|NCT01616459|83310196|FG002|Overall Study|Withdrawal by Subject|4|||
47049682|NCT01616459|83310197|FG003|Overall Study|Withdrawal by Subject|4|||
46736569|NCT01025843|82953155|FG000|Washout 4|Withdrawal by Subject|0|||
46736570|NCT01025843|82953156|FG001|Washout 4|Withdrawal by Subject|0|||
46736571|NCT01025843|82953157|FG002|Washout 4|Withdrawal by Subject|1|||
46736572|NCT01025843|82953158|FG003|Washout 4|Withdrawal by Subject|1|||
46736573|NCT01025843|82953159|FG004|Washout 4|Withdrawal by Subject|0|||
46736574|NCT01025843|82953160|FG005|Washout 4|Withdrawal by Subject|0|||
46736575|NCT01025843|82953161|FG006|Washout 4|Withdrawal by Subject|0|||
46736576|NCT01025843|82953162|FG007|Washout 4|Withdrawal by Subject|0|||
46736577|NCT01025843|82953163|FG008|Washout 4|Withdrawal by Subject|0|||
46736578|NCT01025843|82953164|FG009|Washout 4|Withdrawal by Subject|0|||
46736579|NCT01036763|82953192|FG000|Overall Study|Adverse Event|25|||
46736580|NCT01036763|82953192|FG000|Overall Study|Lost to Follow-up|28|||
46736581|NCT01036763|82953192|FG000|Overall Study|Other reason (not specified)|40|||
46736582|NCT01021007|82953198|FG000|Overall Study|Lost to Follow-up|1|||
46736583|NCT01021007|82953199|FG001|Overall Study|Lost to Follow-up|1|||
46736584|NCT01021007|82953198|FG000|Overall Study|Adverse Event|1|||
46736585|NCT01021007|82953199|FG001|Overall Study|Adverse Event|3|||
46736586|NCT01020773|82953207|FG000|Overall Study|Withdrawal by Subject|4|||
46736587|NCT01020773|82953208|FG001|Overall Study|Withdrawal by Subject|3|||
47049683|NCT01616459|83310194|FG000|Overall Study|Other reason|0|||
47049684|NCT01616459|83310195|FG001|Overall Study|Other reason|1|||
47049685|NCT01616459|83310196|FG002|Overall Study|Other reason|1|||
47049686|NCT01616459|83310197|FG003|Overall Study|Other reason|0|||
47049687|NCT01919801|83310214|FG000|Overall Study|Withdrawal by Subject|1|||
47049688|NCT01919801|83310215|FG001|Overall Study|Withdrawal by Subject|0|||
47049689|NCT01919801|83310214|FG000|Overall Study|Physician Decision|0|||
46635266|NCT01565148|82808867|FG000|Overall Study|Physician Decision|2|||
46736588|NCT01020305|82953214|FG000|Overall Study|Adverse Event|2|||
46736589|NCT01036529|82953220|FG000|Overall Study|Adverse Event|0|||
46736590|NCT01036529|82953221|FG001|Overall Study|Adverse Event|1|||
46804004|NCT03903822|83023210|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
46804005|NCT03903822|83023211|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
46804006|NCT03903822|83023212|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
46804007|NCT03903822|83023213|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
46804008|NCT03903822|83023206|FG000|Follow up Phase (4 Weeks)|Other|1|||
46804009|NCT03903822|83023207|FG001|Follow up Phase (4 Weeks)|Other|1|||
46804010|NCT03903822|83023208|FG002|Follow up Phase (4 Weeks)|Other|0|||
46804011|NCT03903822|83023209|FG003|Follow up Phase (4 Weeks)|Other|0|||
46736591|NCT01036529|82953220|FG000|Overall Study|Lost to Follow-up|0|||
46736592|NCT01036529|82953221|FG001|Overall Study|Lost to Follow-up|1|||
46736593|NCT01036529|82953220|FG000|Overall Study|Physician Decision|1|||
46736594|NCT01036529|82953221|FG001|Overall Study|Physician Decision|0|||
46804012|NCT03903822|83023210|FG004|Follow up Phase (4 Weeks)|Other|0|||
46804013|NCT03903822|83023211|FG005|Follow up Phase (4 Weeks)|Other|0|||
47049690|NCT01919801|83310215|FG001|Overall Study|Physician Decision|1|||
47049691|NCT01919801|83310214|FG000|Overall Study|Lost to Follow-up|0|||
46736595|NCT01036529|82953220|FG000|Overall Study|Withdrawal by Subject|1|||
46736596|NCT01036529|82953221|FG001|Overall Study|Withdrawal by Subject|1|||
46804014|NCT03903822|83023212|FG006|Follow up Phase (4 Weeks)|Other|0|||
47049692|NCT01919801|83310215|FG001|Overall Study|Lost to Follow-up|1|||
47049693|NCT01919801|83310214|FG000|Overall Study|Other|0|||
47049694|NCT01919801|83310215|FG001|Overall Study|Other|1|||
47049695|NCT01919723|83310223|FG000|Overall Study|Blood Samples Hemolyzed|2|||
46736597|NCT01036529|82953220|FG000|Overall Study|Sponsor study termination|11|||
46736598|NCT01036529|82953221|FG001|Overall Study|Sponsor study termination|12|||
47049696|NCT01919723|83310224|FG001|Overall Study|Blood Samples Hemolyzed|2|||
47049697|NCT01919489|83310232|FG000|Overall Study|Rejected the need of injections|4|||
47049698|NCT01919489|83310233|FG001|Overall Study|Rejected the need of injections|7|||
47049699|NCT01919489|83310232|FG000|Overall Study|Adverse Event|10|||
47049700|NCT01919489|83310233|FG001|Overall Study|Adverse Event|0|||
47049701|NCT01919489|83310232|FG000|Overall Study|Hospital readmission|2|||
47049702|NCT01919489|83310233|FG001|Overall Study|Hospital readmission|9|||
47049703|NCT01919489|83310232|FG000|Overall Study|Death|2|||
46736599|NCT01024751|82953229|FG000|Enrolled Participants|Ineligible at baseline|3|||
46736600|NCT01024751|82953230|FG001|Enrolled Participants|Ineligible at baseline|4|||
46736601|NCT01024751|82953229|FG000|Eligible Participants|Withdrawal by Subject|0|||
46736602|NCT01024751|82953230|FG001|Eligible Participants|Withdrawal by Subject|1|||
46736603|NCT01024751|82953229|FG000|Eligible Participants|Lost to Follow-up|0|||
46736604|NCT01024751|82953230|FG001|Eligible Participants|Lost to Follow-up|1|||
46736605|NCT01024751|82953229|FG000|Eligible Participants|Ineligible|0|||
46736606|NCT01024751|82953230|FG001|Eligible Participants|Ineligible|1|||
46736607|NCT01019369|82953238|FG000|Overall Study|Lost to Follow-up|10|||
46736608|NCT01019369|82953239|FG001|Overall Study|Lost to Follow-up|6|||
46736609|NCT01019369|82953238|FG000|Overall Study|Withdrawal by Subject|0|||
46736610|NCT01019369|82953239|FG001|Overall Study|Withdrawal by Subject|1|||
46736611|NCT01019135|82953249|FG000|Overall Study|Did not receive allocated intervention|12|||
46736612|NCT01019135|82953250|FG001|Overall Study|Did not receive allocated intervention|6|||
47049704|NCT01919489|83310233|FG001|Overall Study|Death|1|||
46736613|NCT01019135|82953251|FG002|Overall Study|Did not receive allocated intervention|25|||
46736614|NCT01019135|82953249|FG000|Overall Study|Did not attend CR|8|||
46736615|NCT01019135|82953250|FG001|Overall Study|Did not attend CR|13|||
46804015|NCT03903822|83023213|FG007|Follow up Phase (4 Weeks)|Other|0|||
46804016|NCT00677807|83023234|FG000|Overall Study|Adverse Event|4|||
46804017|NCT00677807|83023235|FG001|Overall Study|Adverse Event|1|||
46804018|NCT00677807|83023236|FG002|Overall Study|Adverse Event|6|||
46804019|NCT00677807|83023234|FG000|Overall Study|Lack of Efficacy|0|||
46804020|NCT00677807|83023235|FG001|Overall Study|Lack of Efficacy|0|||
46804021|NCT00677807|83023236|FG002|Overall Study|Lack of Efficacy|2|||
46804022|NCT00677807|83023234|FG000|Overall Study|Participant no longer needs study drug|0|||
46804023|NCT00677807|83023235|FG001|Overall Study|Participant no longer needs study drug|0|||
46804024|NCT00677807|83023236|FG002|Overall Study|Participant no longer needs study drug|1|||
46804025|NCT00677807|83023234|FG000|Overall Study|Withdrawal by Subject|10|||
46804026|NCT00677807|83023235|FG001|Overall Study|Withdrawal by Subject|3|||
46804027|NCT00677807|83023236|FG002|Overall Study|Withdrawal by Subject|6|||
46804028|NCT00677807|83023234|FG000|Overall Study|Lost to Follow-up|2|||
46736616|NCT01019135|82953251|FG002|Overall Study|Did not attend CR|6|||
46736617|NCT01018979|82953261|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
46736618|NCT01018979|82953262|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
46736619|NCT01018979|82953261|FG000|Overall Study|Not received at least one dose|0|||
46736620|NCT01018979|82953262|FG001|Overall Study|Not received at least one dose|1|||
46736621|NCT01572493|82953280|FG000|Overall Study|Physician Decision|1|||
46736622|NCT01572493|82953281|FG001|Overall Study|Physician Decision|0|||
46736623|NCT01572493|82953282|FG002|Overall Study|Physician Decision|0|||
46736624|NCT01572493|82953283|FG003|Overall Study|Physician Decision|0|||
46736625|NCT01572493|82953284|FG004|Overall Study|Physician Decision|0|||
46736626|NCT01572493|82953285|FG005|Overall Study|Physician Decision|0|||
46736627|NCT01572493|82953286|FG006|Overall Study|Physician Decision|0|||
47049705|NCT01919489|83310232|FG000|Overall Study|Lost to Follow-up|38|||
47049706|NCT01919489|83310233|FG001|Overall Study|Lost to Follow-up|27|||
47049707|NCT01919411|83310241|FG000|Overall Study|Lost to Follow-up|2|||
47049708|NCT01919411|83310242|FG001|Overall Study|Lost to Follow-up|4|||
47049709|NCT01919411|83310241|FG000|Overall Study|Physician Decision|1|||
47049710|NCT01919411|83310242|FG001|Overall Study|Physician Decision|0|||
47049711|NCT01919411|83310241|FG000|Overall Study|Protocol Violation|2|||
46804029|NCT00677807|83023235|FG001|Overall Study|Lost to Follow-up|2|||
46736628|NCT01572493|82953287|FG007|Overall Study|Physician Decision|0|||
46736629|NCT01572493|82953288|FG008|Overall Study|Physician Decision|0|||
46804030|NCT00677807|83023236|FG002|Overall Study|Lost to Follow-up|2|||
46804031|NCT00677807|83023234|FG000|Overall Study|Administrative problems|1|||
47049712|NCT01919411|83310242|FG001|Overall Study|Protocol Violation|1|||
47049713|NCT01901393|83310250|FG000|Overall Study|Adverse Event|1|||
47049714|NCT01901393|83310251|FG001|Overall Study|Adverse Event|0|||
47049715|NCT01890707|83310259|FG000|Overall Study|Lost to Follow-up|1|||
47049716|NCT01890707|83310260|FG001|Overall Study|Lost to Follow-up|1|||
47049717|NCT01900691|83310266|FG000|Overall Study|Death|7|||
47049718|NCT01900691|83310266|FG000|Overall Study|Lost to Follow-up|4|||
46736630|NCT01572493|82953280|FG000|Overall Study|Switched to alternative treatment|0|||
46736631|NCT01572493|82953281|FG001|Overall Study|Switched to alternative treatment|1|||
46736632|NCT01572493|82953282|FG002|Overall Study|Switched to alternative treatment|2|||
46736633|NCT01572493|82953283|FG003|Overall Study|Switched to alternative treatment|1|||
46804032|NCT00677807|83023235|FG001|Overall Study|Administrative problems|1|||
46804033|NCT00677807|83023236|FG002|Overall Study|Administrative problems|2|||
47049719|NCT01900691|83310266|FG000|Overall Study|Study Device Not Placed|3|||
47049720|NCT01900691|83310266|FG000|Overall Study|Non study stent placed|2|||
46736634|NCT01572493|82953284|FG004|Overall Study|Switched to alternative treatment|2|||
46736635|NCT01572493|82953285|FG005|Overall Study|Switched to alternative treatment|0|||
46736636|NCT01572493|82953286|FG006|Overall Study|Switched to alternative treatment|2|||
46736637|NCT01572493|82953287|FG007|Overall Study|Switched to alternative treatment|0|||
46736638|NCT01572493|82953288|FG008|Overall Study|Switched to alternative treatment|2|||
46736639|NCT01572493|82953280|FG000|Overall Study|Death|0|||
46736640|NCT01572493|82953281|FG001|Overall Study|Death|0|||
46736641|NCT01572493|82953282|FG002|Overall Study|Death|0|||
46736642|NCT01572493|82953283|FG003|Overall Study|Death|1|||
46736643|NCT01572493|82953284|FG004|Overall Study|Death|0|||
46736644|NCT01572493|82953285|FG005|Overall Study|Death|1|||
46736645|NCT01572493|82953286|FG006|Overall Study|Death|0|||
46736646|NCT01572493|82953287|FG007|Overall Study|Death|0|||
46736647|NCT01572493|82953288|FG008|Overall Study|Death|0|||
46736648|NCT01572493|82953280|FG000|Overall Study|Adverse Event|0|||
46736649|NCT01572493|82953281|FG001|Overall Study|Adverse Event|0|||
46736650|NCT01572493|82953282|FG002|Overall Study|Adverse Event|0|||
46736651|NCT01572493|82953283|FG003|Overall Study|Adverse Event|0|||
46736652|NCT01572493|82953284|FG004|Overall Study|Adverse Event|0|||
46736653|NCT01572493|82953285|FG005|Overall Study|Adverse Event|0|||
46736654|NCT01572493|82953286|FG006|Overall Study|Adverse Event|1|||
46736655|NCT01572493|82953287|FG007|Overall Study|Adverse Event|0|||
46736656|NCT01572493|82953288|FG008|Overall Study|Adverse Event|0|||
46736657|NCT01018511|82953315|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
46736658|NCT01018511|82953316|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
46736659|NCT01018511|82953317|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
46736660|NCT01018511|82953318|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
46736661|NCT01018511|82953315|FG000|Overall Study|Adverse Event|5|||
46736662|NCT01018511|82953316|FG001|Overall Study|Adverse Event|9|||
46736663|NCT01018511|82953317|FG002|Overall Study|Adverse Event|13|||
46736664|NCT01018511|82953318|FG003|Overall Study|Adverse Event|10|||
46736665|NCT01018511|82953315|FG000|Overall Study|Lack of Efficacy|4|||
46736666|NCT01018511|82953316|FG001|Overall Study|Lack of Efficacy|1|||
46736667|NCT01018511|82953317|FG002|Overall Study|Lack of Efficacy|1|||
46736668|NCT01018511|82953318|FG003|Overall Study|Lack of Efficacy|2|||
46736669|NCT01018511|82953315|FG000|Overall Study|Withdrawal by Subject|6|||
46736670|NCT01018511|82953316|FG001|Overall Study|Withdrawal by Subject|5|||
46736671|NCT01018511|82953317|FG002|Overall Study|Withdrawal by Subject|11|||
46736672|NCT01018511|82953318|FG003|Overall Study|Withdrawal by Subject|9|||
46736673|NCT01018511|82953315|FG000|Overall Study|Lost to Follow-up|0|||
46736674|NCT01018511|82953316|FG001|Overall Study|Lost to Follow-up|0|||
46736675|NCT01018511|82953317|FG002|Overall Study|Lost to Follow-up|1|||
46736676|NCT01018511|82953318|FG003|Overall Study|Lost to Follow-up|0|||
46736677|NCT01018511|82953315|FG000|Overall Study|Protocol Violation|5|||
46736678|NCT01018511|82953316|FG001|Overall Study|Protocol Violation|8|||
46736679|NCT01018511|82953317|FG002|Overall Study|Protocol Violation|7|||
46736680|NCT01018511|82953318|FG003|Overall Study|Protocol Violation|9|||
46736681|NCT01018511|82953315|FG000|Overall Study|Miscellaneous|0|||
46736682|NCT01018511|82953316|FG001|Overall Study|Miscellaneous|2|||
46736683|NCT01018511|82953317|FG002|Overall Study|Miscellaneous|0|||
46736684|NCT01018511|82953318|FG003|Overall Study|Miscellaneous|0|||
46736685|NCT00996476|82953339|FG000|Overall Study|Withdrawal by Subject|1|||
46736686|NCT00996476|82953340|FG001|Overall Study|Withdrawal by Subject|2|||
46736687|NCT00996476|82953341|FG002|Overall Study|Withdrawal by Subject|1|||
46736688|NCT00996476|82953342|FG003|Overall Study|Withdrawal by Subject|0|||
46736689|NCT00996476|82953343|FG004|Overall Study|Withdrawal by Subject|1|||
46736690|NCT00996476|82953339|FG000|Overall Study|Adverse Event|0|||
46736691|NCT00996476|82953340|FG001|Overall Study|Adverse Event|1|||
46736692|NCT00996476|82953341|FG002|Overall Study|Adverse Event|0|||
47049721|NCT01900691|83310266|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
47049722|NCT01900691|83310266|FG000|Overall Study|Complete stent migration through digestive tract|1|||
47049723|NCT01890473|83310273|FG000|Overall Study|Lost to Follow-up|1|||
47049724|NCT01890473|83310274|FG001|Overall Study|Lost to Follow-up|0|||
47049725|NCT01890473|83310273|FG000|Overall Study|Poor/non-compliance|1|||
47049726|NCT01890473|83310274|FG001|Overall Study|Poor/non-compliance|0|||
47049727|NCT01889069|83310284|FG000|Overall Study|Death|18|||
46736693|NCT00996476|82953342|FG003|Overall Study|Adverse Event|0|||
46736694|NCT00996476|82953343|FG004|Overall Study|Adverse Event|1|||
46736695|NCT02269267|82953360|FG000|Overall Study|Death|5|||
46736696|NCT01017731|82953364|FG000|Overall Study|Lost to Follow-up|2|||
46736697|NCT01017731|82953364|FG000|Overall Study|Withdrawal by Subject|3|||
46736698|NCT01017731|82953364|FG000|Overall Study|Physician Decision|2|||
46736699|NCT01017731|82953364|FG000|Overall Study|Adverse Event|1|||
46736700|NCT01035905|82953371|FG000|Overall Study|Lack of Efficacy|1|||
46736701|NCT01035905|82953372|FG001|Overall Study|Lack of Efficacy|1|||
46736702|NCT00779584|82953396|FG000|Overall Study|Protocol Violation|0|||
46736703|NCT00779584|82953397|FG001|Overall Study|Protocol Violation|0|||
46736704|NCT00779584|82953398|FG002|Overall Study|Protocol Violation|0|||
47049728|NCT01889069|83310284|FG000|Overall Study|Progression of Disease|14|||
46736705|NCT00779584|82953399|FG003|Overall Study|Protocol Violation|0|||
46736706|NCT00779584|82953400|FG004|Overall Study|Protocol Violation|0|||
46736707|NCT00779584|82953401|FG005|Overall Study|Protocol Violation|1|||
46736708|NCT00779584|82953402|FG006|Overall Study|Protocol Violation|0|||
46736709|NCT00779584|82953403|FG007|Overall Study|Protocol Violation|0|||
46736710|NCT00779584|82953404|FG008|Overall Study|Protocol Violation|0|||
46736711|NCT00779584|82953396|FG000|Overall Study|Withdrawal by Subject|1|||
46736712|NCT00779584|82953397|FG001|Overall Study|Withdrawal by Subject|1|||
46736713|NCT00779584|82953398|FG002|Overall Study|Withdrawal by Subject|2|||
46736714|NCT00779584|82953399|FG003|Overall Study|Withdrawal by Subject|0|||
46736715|NCT00779584|82953400|FG004|Overall Study|Withdrawal by Subject|0|||
46736716|NCT00779584|82953401|FG005|Overall Study|Withdrawal by Subject|2|||
46736717|NCT00779584|82953402|FG006|Overall Study|Withdrawal by Subject|1|||
46736718|NCT00779584|82953403|FG007|Overall Study|Withdrawal by Subject|0|||
46736719|NCT00779584|82953404|FG008|Overall Study|Withdrawal by Subject|0|||
46736720|NCT00779584|82953396|FG000|Overall Study|Lost to Follow-up|0|||
46736721|NCT00779584|82953397|FG001|Overall Study|Lost to Follow-up|0|||
46736722|NCT00779584|82953398|FG002|Overall Study|Lost to Follow-up|0|||
46736723|NCT00779584|82953399|FG003|Overall Study|Lost to Follow-up|0|||
46736724|NCT00779584|82953400|FG004|Overall Study|Lost to Follow-up|1|||
46736725|NCT00779584|82953401|FG005|Overall Study|Lost to Follow-up|0|||
46736726|NCT00779584|82953402|FG006|Overall Study|Lost to Follow-up|0|||
46736727|NCT00779584|82953403|FG007|Overall Study|Lost to Follow-up|0|||
46736728|NCT00779584|82953404|FG008|Overall Study|Lost to Follow-up|0|||
46736729|NCT00779584|82953396|FG000|Overall Study|Progression of Disease|0|||
46736730|NCT00779584|82953397|FG001|Overall Study|Progression of Disease|1|||
46736731|NCT00779584|82953398|FG002|Overall Study|Progression of Disease|2|||
46736732|NCT00779584|82953399|FG003|Overall Study|Progression of Disease|6|||
46736733|NCT00779584|82953400|FG004|Overall Study|Progression of Disease|5|||
46736734|NCT00779584|82953401|FG005|Overall Study|Progression of Disease|1|||
46736735|NCT00779584|82953402|FG006|Overall Study|Progression of Disease|4|||
46736736|NCT00779584|82953403|FG007|Overall Study|Progression of Disease|2|||
46736737|NCT00779584|82953404|FG008|Overall Study|Progression of Disease|1|||
46736738|NCT00779584|82953396|FG000|Overall Study|Adverse Event|1|||
46736739|NCT00779584|82953397|FG001|Overall Study|Adverse Event|0|||
46736740|NCT00779584|82953398|FG002|Overall Study|Adverse Event|2|||
46736741|NCT00779584|82953399|FG003|Overall Study|Adverse Event|0|||
46736742|NCT00779584|82953400|FG004|Overall Study|Adverse Event|0|||
46736743|NCT00779584|82953401|FG005|Overall Study|Adverse Event|0|||
46736744|NCT00779584|82953402|FG006|Overall Study|Adverse Event|2|||
46736745|NCT00779584|82953403|FG007|Overall Study|Adverse Event|1|||
46736746|NCT00779584|82953404|FG008|Overall Study|Adverse Event|1|||
46736747|NCT00779584|82953396|FG000|Overall Study|Symptomatic Deterioration|1|||
46736748|NCT00779584|82953397|FG001|Overall Study|Symptomatic Deterioration|1|||
46736749|NCT00779584|82953398|FG002|Overall Study|Symptomatic Deterioration|1|||
46736750|NCT00779584|82953399|FG003|Overall Study|Symptomatic Deterioration|0|||
46736751|NCT00779584|82953400|FG004|Overall Study|Symptomatic Deterioration|0|||
46736752|NCT00779584|82953401|FG005|Overall Study|Symptomatic Deterioration|1|||
46736753|NCT00779584|82953402|FG006|Overall Study|Symptomatic Deterioration|1|||
46736754|NCT00779584|82953403|FG007|Overall Study|Symptomatic Deterioration|0|||
46736755|NCT00779584|82953404|FG008|Overall Study|Symptomatic Deterioration|0|||
46736756|NCT00779584|82953396|FG000|Overall Study|Ongoing in Study|0|||
46736757|NCT00779584|82953397|FG001|Overall Study|Ongoing in Study|0|||
46736758|NCT00779584|82953398|FG002|Overall Study|Ongoing in Study|0|||
46736759|NCT00779584|82953399|FG003|Overall Study|Ongoing in Study|0|||
46736760|NCT00779584|82953400|FG004|Overall Study|Ongoing in Study|1|||
46736761|NCT00779584|82953401|FG005|Overall Study|Ongoing in Study|1|||
46736762|NCT00779584|82953402|FG006|Overall Study|Ongoing in Study|0|||
46736763|NCT00779584|82953403|FG007|Overall Study|Ongoing in Study|0|||
46736764|NCT00779584|82953404|FG008|Overall Study|Ongoing in Study|0|||
46736765|NCT00995930|82953426|FG000|Overall Study|Protocol deviation|2|||
46736766|NCT00995930|82953427|FG001|Overall Study|Protocol deviation|5|||
46736767|NCT00995930|82953426|FG000|Overall Study|Death|0|||
46804034|NCT00677807|83023234|FG000|Overall Study|Death|0|||
46921694|NCT01677910|83154371|FG001|Double-Blind Treatment Period|Adverse Event|2|||
46921695|NCT01677910|83154372|FG002|Double-Blind Treatment Period|Adverse Event|3|||
46921696|NCT01677910|83154373|FG003|Double-Blind Treatment Period|Adverse Event|0|||
46736768|NCT00995930|82953427|FG001|Overall Study|Death|1|||
46736769|NCT00995930|82953426|FG000|Overall Study|Administrative problems|4|||
46736770|NCT00995930|82953427|FG001|Overall Study|Administrative problems|2|||
46736771|NCT00995930|82953426|FG000|Overall Study|Lost to Follow-up|1|||
46736772|NCT00995930|82953427|FG001|Overall Study|Lost to Follow-up|2|||
46736773|NCT00995930|82953426|FG000|Overall Study|Withdrawal by Subject|3|||
46736774|NCT00995930|82953427|FG001|Overall Study|Withdrawal by Subject|4|||
46736775|NCT00995930|82953426|FG000|Overall Study|Adverse Event|11|||
46736776|NCT00995930|82953427|FG001|Overall Study|Adverse Event|14|||
46736777|NCT00779506|82953434|FG000|Overall Study|Screening Failed|2|||
46804035|NCT00677807|83023235|FG001|Overall Study|Death|1|||
46736778|NCT00779506|82953434|FG000|Overall Study|Adverse Event|4|||
46736779|NCT00779506|82953434|FG000|Overall Study|Lack of Efficacy|11|||
46736780|NCT00779506|82953434|FG000|Overall Study|Protocol Violation|5|||
46736781|NCT00779506|82953434|FG000|Overall Study|Withdrawal by Subject|6|||
46736782|NCT00779506|82953434|FG000|Overall Study|Lost to Follow-up|1|||
46736783|NCT00995774|82953440|FG000|Training Period 2|Withdrawal by Subject|2|||
46736784|NCT00995774|82953441|FG001|Training Period 2|Withdrawal by Subject|0|||
46736785|NCT00765388|82953447|FG000|Period 1|Lack of Efficacy|1|||
46736786|NCT00765388|82953448|FG001|Period 1|Lack of Efficacy|2|||
46736787|NCT00765388|82953447|FG000|Period 1|Lost to Follow-up|0|||
46736788|NCT00765388|82953448|FG001|Period 1|Lost to Follow-up|1|||
46736789|NCT00765388|82953447|FG000|Period 1|Herpes Zoster|0|||
46736790|NCT00765388|82953448|FG001|Period 1|Herpes Zoster|1|||
46736791|NCT00765388|82953447|FG000|Period 1|Hip operation|0|||
46736792|NCT00765388|82953448|FG001|Period 1|Hip operation|1|||
46736793|NCT00769132|82953463|FG000|Period 1|Adverse Event|1|||
46736794|NCT00769132|82953464|FG001|Period 1|Adverse Event|0|||
46736795|NCT00769132|82953465|FG002|Period 1|Adverse Event|0|||
46736796|NCT00769132|82953466|FG003|Period 1|Adverse Event|1|||
46736797|NCT00769132|82953463|FG000|Period 2|Withdrawal by Subject|0|||
46736798|NCT00769132|82953464|FG001|Period 2|Withdrawal by Subject|0|||
46736799|NCT00769132|82953465|FG002|Period 2|Withdrawal by Subject|0|||
46736800|NCT00769132|82953466|FG003|Period 2|Withdrawal by Subject|1|||
46736801|NCT00769132|82953463|FG000|Period 3|Withdrawal by Subject|1|||
46736802|NCT00769132|82953464|FG001|Period 3|Withdrawal by Subject|0|||
46736803|NCT00769132|82953465|FG002|Period 3|Withdrawal by Subject|0|||
46736804|NCT00769132|82953466|FG003|Period 3|Withdrawal by Subject|0|||
46736805|NCT00769132|82953463|FG000|Period 4|Withdrawal by Subject|0|||
46736806|NCT00769132|82953464|FG001|Period 4|Withdrawal by Subject|1|||
46736807|NCT00769132|82953465|FG002|Period 4|Withdrawal by Subject|0|||
46736808|NCT00769132|82953466|FG003|Period 4|Withdrawal by Subject|0|||
46736809|NCT00991952|82953478|FG000|Overall Study|Adverse Event|0|||
46736810|NCT00991952|82953479|FG001|Overall Study|Adverse Event|1|||
46736811|NCT00779038|82953485|FG000|Overall Study|Study Prematurely Terminated|13|||
46736812|NCT00765076|82953492|FG000|Overall Study|Adverse Event|1|||
46736813|NCT00765076|82953493|FG001|Overall Study|Adverse Event|0|||
46736814|NCT00765076|82953494|FG002|Overall Study|Adverse Event|0|||
46736815|NCT00765076|82953492|FG000|Overall Study|Withdrawal by Subject|0|||
46736816|NCT00765076|82953493|FG001|Overall Study|Withdrawal by Subject|0|||
46736817|NCT00765076|82953494|FG002|Overall Study|Withdrawal by Subject|1|||
46736818|NCT00994682|82953504|FG000|Double Bilnd|Withdrawal by Subject|5|||
46736819|NCT00994682|82953505|FG001|Double Bilnd|Withdrawal by Subject|6|||
46736820|NCT00994682|82953504|FG000|Double Bilnd|Lost to Follow-up|3|||
46736821|NCT00994682|82953505|FG001|Double Bilnd|Lost to Follow-up|3|||
46736822|NCT00994682|82953504|FG000|Double Bilnd|Adverse Event|1|||
46736823|NCT00994682|82953505|FG001|Double Bilnd|Adverse Event|0|||
46736824|NCT00994682|82953504|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
46736825|NCT00994682|82953505|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
46736826|NCT00994682|82953504|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
46736827|NCT00994682|82953505|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
46736828|NCT00994682|82953504|FG000|Pioglitazone Open Label|Physician Decision|6|||
46736829|NCT00994682|82953505|FG001|Pioglitazone Open Label|Physician Decision|1|||
46736830|NCT00768898|82953515|FG000|Overall Study|Unrelated injury|1|||
46736831|NCT00768898|82953515|FG000|Overall Study|Headache|1|||
46736832|NCT00994448|82953526|FG000|Overall Study|Adverse Event|1|||
46736833|NCT00994448|82953527|FG001|Overall Study|Adverse Event|0|||
46736834|NCT00994448|82953526|FG000|Overall Study|Lost to Follow-up|5|||
46736835|NCT00994448|82953527|FG001|Overall Study|Lost to Follow-up|1|||
46736836|NCT00994448|82953526|FG000|Overall Study|Withdrawal by Subject|1|||
46736837|NCT00994448|82953527|FG001|Overall Study|Withdrawal by Subject|1|||
46736838|NCT00994448|82953526|FG000|Overall Study|Physician Decision|1|||
46736839|NCT00994448|82953527|FG001|Overall Study|Physician Decision|0|||
46736840|NCT00991406|82953533|FG000|Overall Study|One participant did not respond to FES.|1|||
46736841|NCT01017575|82953542|FG000|Overall Study|Lack of Efficacy|0|||
46736842|NCT01017575|82953543|FG001|Overall Study|Lack of Efficacy|1|||
46736843|NCT01017575|82953544|FG002|Overall Study|Lack of Efficacy|0|||
46736844|NCT01017575|82953545|FG003|Overall Study|Lack of Efficacy|1|||
46736845|NCT01017575|82953546|FG004|Overall Study|Lack of Efficacy|1|||
46736846|NCT01017575|82953542|FG000|Overall Study|Adverse Event|0|||
46736847|NCT01017575|82953543|FG001|Overall Study|Adverse Event|1|||
46736848|NCT01017575|82953544|FG002|Overall Study|Adverse Event|0|||
46736849|NCT01017575|82953545|FG003|Overall Study|Adverse Event|0|||
46736850|NCT01017575|82953546|FG004|Overall Study|Adverse Event|2|||
46736851|NCT01017575|82953542|FG000|Overall Study|Withdrawal by Subject|1|||
46736852|NCT01017575|82953543|FG001|Overall Study|Withdrawal by Subject|0|||
46736853|NCT01017575|82953544|FG002|Overall Study|Withdrawal by Subject|0|||
46736854|NCT01017575|82953545|FG003|Overall Study|Withdrawal by Subject|0|||
46736855|NCT01017575|82953546|FG004|Overall Study|Withdrawal by Subject|0|||
46736856|NCT01017263|82953558|FG000|Overall Study|not eligible|12|||
46736857|NCT00768664|82953562|FG000|Overall Study|Death|57|||
46736858|NCT00768664|82953562|FG000|Overall Study|Lost to Follow-up|2|||
46736859|NCT00768664|82953562|FG000|Overall Study|Other|9|||
46736860|NCT00768664|82953562|FG000|Overall Study|Participant refused|1|||
46736861|NCT00778336|82953570|FG000|Index Procedure-Discharge|Death|6|||
46736862|NCT00778336|82953571|FG001|Index Procedure-Discharge|Death|3|||
46736863|NCT00778336|82953572|FG002|Index Procedure-Discharge|Death|2|||
46736864|NCT00778336|82953573|FG003|Index Procedure-Discharge|Death|0|||
46736865|NCT00778336|82953570|FG000|3 Month Follow Up|Lost to Follow-up|15|||
46736866|NCT00778336|82953571|FG001|3 Month Follow Up|Lost to Follow-up|20|||
46736867|NCT00778336|82953572|FG002|3 Month Follow Up|Lost to Follow-up|3|||
46736868|NCT00778336|82953573|FG003|3 Month Follow Up|Lost to Follow-up|0|||
46736869|NCT00778336|82953570|FG000|3 Month Follow Up|Death|8|||
46736870|NCT00778336|82953571|FG001|3 Month Follow Up|Death|3|||
46736871|NCT00778336|82953572|FG002|3 Month Follow Up|Death|2|||
46736872|NCT00778336|82953573|FG003|3 Month Follow Up|Death|0|||
46736873|NCT01253161|82953583|FG000|Overall Study|Adverse Event|1|||
46736874|NCT00581113|82953589|FG000|Overall Study|Withdrawal by Subject|0|||
47049729|NCT01889069|83310284|FG000|Overall Study|Lost to Follow-up|6|||
47049730|NCT01889069|83310284|FG000|Overall Study|Other|4|||
46736875|NCT00581113|82953590|FG001|Overall Study|Withdrawal by Subject|1|||
46736876|NCT01016015|82953596|FG000|Overall Study|Not Treated|3|||
46736877|NCT01016015|82953596|FG000|Overall Study|Withdrawal by Subject|1|||
46736878|NCT01016015|82953596|FG000|Overall Study|Adverse Event|15|||
46736879|NCT01015703|82953605|FG000|Overall Study|Withdrawal by Subject|0|||
46736880|NCT01015703|82953606|FG001|Overall Study|Withdrawal by Subject|1|||
46736881|NCT01015703|82953607|FG002|Overall Study|Withdrawal by Subject|0|||
46736882|NCT01015703|82953608|FG003|Overall Study|Withdrawal by Subject|0|||
46736883|NCT01015703|82953609|FG004|Overall Study|Withdrawal by Subject|0|||
46736884|NCT01015703|82953605|FG000|Overall Study|Adverse Event|1|||
46736885|NCT01015703|82953606|FG001|Overall Study|Adverse Event|0|||
46736886|NCT01015703|82953607|FG002|Overall Study|Adverse Event|0|||
46736887|NCT01015703|82953608|FG003|Overall Study|Adverse Event|0|||
46736888|NCT01015703|82953609|FG004|Overall Study|Adverse Event|0|||
46736889|NCT01015703|82953605|FG000|Overall Study|Protocol Violation|1|||
46736890|NCT01015703|82953606|FG001|Overall Study|Protocol Violation|0|||
46736891|NCT01015703|82953607|FG002|Overall Study|Protocol Violation|0|||
46736892|NCT01015703|82953608|FG003|Overall Study|Protocol Violation|0|||
46736893|NCT01015703|82953609|FG004|Overall Study|Protocol Violation|0|||
46736894|NCT04439071|82953623|FG000|Overall Study|Lost to Follow-up|0|||
46736895|NCT04439071|82953624|FG001|Overall Study|Lost to Follow-up|3|||
46736896|NCT04439071|82953623|FG000|Overall Study|Withdrawal by Subject|3|||
46736897|NCT04439071|82953624|FG001|Overall Study|Withdrawal by Subject|8|||
46736898|NCT04439071|82953623|FG000|Overall Study|Death|6|||
46736899|NCT04439071|82953624|FG001|Overall Study|Death|4|||
46736900|NCT04439071|82953623|FG000|Overall Study|Other than specified|3|||
46736901|NCT04439071|82953624|FG001|Overall Study|Other than specified|3|||
46736902|NCT04439071|82953623|FG000|Overall Study|Randomized but not treated|2|||
46736903|NCT04439071|82953624|FG001|Overall Study|Randomized but not treated|0|||
46736904|NCT01017029|82953632|FG000|Overall Study|Lost to Follow-up|1|||
46736905|NCT01017029|82953633|FG001|Overall Study|Lost to Follow-up|0|||
46736906|NCT01017029|82953632|FG000|Overall Study|Administrative problem|0|||
46736907|NCT01017029|82953633|FG001|Overall Study|Administrative problem|1|||
46736908|NCT01017029|82953632|FG000|Overall Study|Death|3|||
46736909|NCT01017029|82953633|FG001|Overall Study|Death|1|||
46736910|NCT00994214|82953643|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
47049731|NCT01889069|83310284|FG000|Overall Study|Consent Withdrawal|3|||
47049732|NCT02533180|83310296|FG000|Overall Study|Death|0|||
47049733|NCT02533180|83310297|FG001|Overall Study|Death|2|||
47049734|NCT02533180|83310296|FG000|Overall Study|Lost to Follow-up|0|||
47049735|NCT02533180|83310297|FG001|Overall Study|Lost to Follow-up|1|||
47049736|NCT02533180|83310296|FG000|Overall Study|Physician Decision|0|||
47049737|NCT02533180|83310297|FG001|Overall Study|Physician Decision|1|||
46736911|NCT00994214|82953644|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
46736912|NCT00994214|82953645|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
47049738|NCT02533180|83310296|FG000|Overall Study|Withdrawal by Subject|2|||
47049739|NCT02533180|83310297|FG001|Overall Study|Withdrawal by Subject|5|||
46635267|NCT01565148|82808868|FG001|Overall Study|Physician Decision|5|||
46736913|NCT00994214|82953646|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
46736914|NCT00994214|82953643|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
46736915|NCT00994214|82953644|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
46736916|NCT00994214|82953645|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
46736917|NCT00994214|82953646|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
46736918|NCT00994214|82953643|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
46736919|NCT00994214|82953644|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
46736920|NCT00994214|82953645|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
46736921|NCT00994214|82953646|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
46775735|NCT00793793|82994204|FG000|Overall Study|Protocol Violation|0|||
47049740|NCT02533180|83310296|FG000|Overall Study|Screen Failure|37|||
46736922|NCT00994214|82953643|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
46736923|NCT00994214|82953644|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
46736924|NCT00994214|82953645|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
46736925|NCT00994214|82953646|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
46736926|NCT00994214|82953643|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
46736927|NCT00994214|82953644|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
46736928|NCT00994214|82953645|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
46736929|NCT00994214|82953646|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
46736930|NCT00994214|82953643|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
46736931|NCT00994214|82953644|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
46736932|NCT00994214|82953645|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
46736933|NCT00994214|82953646|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
46736934|NCT01034657|82953674|FG000|Core Phase|Withdrawal by Subject|1|||
46736935|NCT01034657|82953675|FG001|Core Phase|Withdrawal by Subject|0|||
46736936|NCT01034657|82953676|FG002|Core Phase|Withdrawal by Subject|0|||
46736937|NCT01034657|82953674|FG000|Core Phase|Lack of Efficacy|2|||
46736938|NCT01034657|82953675|FG001|Core Phase|Lack of Efficacy|0|||
46736939|NCT01034657|82953676|FG002|Core Phase|Lack of Efficacy|0|||
46736940|NCT01034657|82953674|FG000|Core Phase|Abnormal laboratory value|1|||
46736941|NCT01034657|82953675|FG001|Core Phase|Abnormal laboratory value|0|||
46736942|NCT01034657|82953676|FG002|Core Phase|Abnormal laboratory value|0|||
46736943|NCT01034657|82953674|FG000|Core Phase|Adverse Event|8|||
46736944|NCT01034657|82953675|FG001|Core Phase|Adverse Event|0|||
46736945|NCT01034657|82953676|FG002|Core Phase|Adverse Event|0|||
46736946|NCT01034657|82953674|FG000|Core Phase|Protocol Violation|2|||
46736947|NCT01034657|82953675|FG001|Core Phase|Protocol Violation|0|||
46736948|NCT01034657|82953676|FG002|Core Phase|Protocol Violation|0|||
46736949|NCT01034657|82953674|FG000|Randomized Phase|Withdrawal by Subject|0|||
46736950|NCT01034657|82953675|FG001|Randomized Phase|Withdrawal by Subject|2|||
46736951|NCT01034657|82953676|FG002|Randomized Phase|Withdrawal by Subject|0|||
46736952|NCT01034657|82953674|FG000|Randomized Phase|Lack of Efficacy|5|||
46736953|NCT01034657|82953675|FG001|Randomized Phase|Lack of Efficacy|1|||
46736954|NCT01034657|82953676|FG002|Randomized Phase|Lack of Efficacy|0|||
46736955|NCT01034657|82953674|FG000|Randomized Phase|Abnormal laboratory value|0|||
46736956|NCT01034657|82953675|FG001|Randomized Phase|Abnormal laboratory value|1|||
46736957|NCT01034657|82953676|FG002|Randomized Phase|Abnormal laboratory value|0|||
46736958|NCT01034657|82953674|FG000|Randomized Phase|Adverse Event|0|||
46736959|NCT01034657|82953675|FG001|Randomized Phase|Adverse Event|2|||
46736960|NCT01034657|82953676|FG002|Randomized Phase|Adverse Event|1|||
46736961|NCT01014767|82953690|FG000|Overall Study|PI left institution, data unavailable|12|||
46736962|NCT01014767|82953691|FG001|Overall Study|PI left institution, data unavailable|1|||
46736963|NCT01014767|82953692|FG002|Overall Study|PI left institution, data unavailable|4|||
46736964|NCT01014767|82953693|FG003|Overall Study|PI left institution, data unavailable|1|||
46736965|NCT02016781|82953705|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
46736966|NCT02016781|82953706|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
46736967|NCT02016781|82953705|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
46736968|NCT02016781|82953706|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
46736969|NCT02016781|82953705|FG000|Final Database Lock|Withdrawal by Subject|2|||
46736970|NCT02016781|82953706|FG001|Final Database Lock|Withdrawal by Subject|1|||
46736971|NCT02016781|82953705|FG000|Final Database Lock|Lost to Follow-up|11|||
46736972|NCT02016781|82953706|FG001|Final Database Lock|Lost to Follow-up|4|||
46736973|NCT02016781|82953705|FG000|Final Database Lock|Missing data|0|||
46736974|NCT02016781|82953706|FG001|Final Database Lock|Missing data|3|||
46736975|NCT01014689|82953714|FG000|Overall Study|Lack of Efficacy|0|||
46736976|NCT01014689|82953715|FG001|Overall Study|Lack of Efficacy|1|||
46921697|NCT01677910|83154370|FG000|Double-Blind Treatment Period|Physician Decision|0|||
47049741|NCT02533180|83310297|FG001|Overall Study|Screen Failure|0|||
47049742|NCT02533180|83310296|FG000|Overall Study|Protocol Deviation|0|||
47049743|NCT02533180|83310297|FG001|Overall Study|Protocol Deviation|1|||
47049744|NCT02533180|83310296|FG000|Overall Study|Non-compliance|0|||
47049745|NCT02533180|83310297|FG001|Overall Study|Non-compliance|1|||
47049746|NCT01739348|83310335|FG000|Part I (Base Study)|Adverse Event|41|||
46921698|NCT01677910|83154371|FG001|Double-Blind Treatment Period|Physician Decision|0|||
47049747|NCT01739348|83310336|FG001|Part I (Base Study)|Adverse Event|52|||
47049748|NCT01739348|83310337|FG002|Part I (Base Study)|Adverse Event|8|||
47049749|NCT01739348|83310338|FG003|Part I (Base Study)|Adverse Event|33|||
47049750|NCT01739348|83310335|FG000|Part I (Base Study)|Death|10|||
47049751|NCT01739348|83310336|FG001|Part I (Base Study)|Death|7|||
47049752|NCT01739348|83310337|FG002|Part I (Base Study)|Death|2|||
47049753|NCT01739348|83310338|FG003|Part I (Base Study)|Death|8|||
47049754|NCT01739348|83310335|FG000|Part I (Base Study)|Lack of Efficacy|3|||
47049755|NCT01739348|83310336|FG001|Part I (Base Study)|Lack of Efficacy|8|||
47049756|NCT01739348|83310337|FG002|Part I (Base Study)|Lack of Efficacy|0|||
46736977|NCT01014689|82953714|FG000|Overall Study|Adverse Event|3|||
46736978|NCT01014689|82953715|FG001|Overall Study|Adverse Event|0|||
46736979|NCT01014689|82953714|FG000|Overall Study|Withdrawal by Subject|5|||
46736980|NCT01014689|82953715|FG001|Overall Study|Withdrawal by Subject|4|||
46736981|NCT01014689|82953714|FG000|Overall Study|Protocol Violation|1|||
46736982|NCT01014689|82953715|FG001|Overall Study|Protocol Violation|1|||
46736983|NCT01014689|82953714|FG000|Overall Study|Lost to Follow-up|3|||
46736984|NCT01014689|82953715|FG001|Overall Study|Lost to Follow-up|7|||
46736985|NCT01014689|82953714|FG000|Overall Study|Pregnancy|1|||
46736986|NCT01014689|82953715|FG001|Overall Study|Pregnancy|0|||
46736987|NCT01014533|82953723|FG000|Overall Study|Protocol Violation|3|||
46736988|NCT01014533|82953724|FG001|Overall Study|Protocol Violation|2|||
46736989|NCT01014533|82953723|FG000|Overall Study|Withdrawal by Subject|2|||
46736990|NCT01014533|82953724|FG001|Overall Study|Withdrawal by Subject|0|||
46736991|NCT01014533|82953723|FG000|Overall Study|unable to come to appointment|0|||
46736992|NCT01014533|82953724|FG001|Overall Study|unable to come to appointment|3|||
46736993|NCT01014143|82953747|FG000|Second Intervention|Lost to Follow-up|2|||
46736994|NCT01014143|82953748|FG001|Second Intervention|Lost to Follow-up|0|||
46736995|NCT01014143|82953749|FG002|Second Intervention|Lost to Follow-up|0|||
46736996|NCT01013753|82953757|FG000|Overall Study|Adverse Event|8|||
46736997|NCT01013753|82953757|FG000|Overall Study|Protocol Violation|3|||
46736998|NCT01013753|82953757|FG000|Overall Study|Lost to Follow-up|1|||
46736999|NCT01013753|82953757|FG000|Overall Study|Withdrawal by Subject|2|||
46737000|NCT01013753|82953757|FG000|Overall Study|Other|2|||
46737001|NCT00757042|82953782|FG000|Overall Study|Lost to Follow-up|0|||
46737002|NCT00757042|82953783|FG001|Overall Study|Lost to Follow-up|0|||
46737003|NCT00757042|82953784|FG002|Overall Study|Lost to Follow-up|0|||
46737004|NCT00757042|82953785|FG003|Overall Study|Lost to Follow-up|0|||
46737005|NCT00757042|82953786|FG004|Overall Study|Lost to Follow-up|0|||
46737006|NCT00757042|82953787|FG005|Overall Study|Lost to Follow-up|0|||
46737007|NCT00757042|82953788|FG006|Overall Study|Lost to Follow-up|0|||
46737008|NCT00757042|82953789|FG007|Overall Study|Lost to Follow-up|0|||
46737009|NCT00757042|82953790|FG008|Overall Study|Lost to Follow-up|1|||
46737010|NCT00757042|82953791|FG009|Overall Study|Lost to Follow-up|0|||
46737011|NCT00757042|82953792|FG010|Overall Study|Lost to Follow-up|0|||
46737012|NCT00757042|82953782|FG000|Overall Study|Ineligibility Determined|0|||
46737013|NCT00757042|82953783|FG001|Overall Study|Ineligibility Determined|0|||
46737014|NCT00757042|82953784|FG002|Overall Study|Ineligibility Determined|0|||
46737015|NCT00757042|82953785|FG003|Overall Study|Ineligibility Determined|0|||
46737016|NCT00757042|82953786|FG004|Overall Study|Ineligibility Determined|0|||
46737017|NCT00757042|82953787|FG005|Overall Study|Ineligibility Determined|0|||
46737018|NCT00757042|82953788|FG006|Overall Study|Ineligibility Determined|0|||
46737019|NCT00757042|82953789|FG007|Overall Study|Ineligibility Determined|0|||
46737020|NCT00757042|82953790|FG008|Overall Study|Ineligibility Determined|0|||
46737021|NCT00757042|82953791|FG009|Overall Study|Ineligibility Determined|0|||
46737022|NCT00757042|82953792|FG010|Overall Study|Ineligibility Determined|1|||
46737023|NCT00757042|82953782|FG000|Overall Study|Withdrawal by Subject|0|||
46737024|NCT00757042|82953783|FG001|Overall Study|Withdrawal by Subject|0|||
46737025|NCT00757042|82953784|FG002|Overall Study|Withdrawal by Subject|0|||
46737026|NCT00757042|82953785|FG003|Overall Study|Withdrawal by Subject|0|||
46737027|NCT00757042|82953786|FG004|Overall Study|Withdrawal by Subject|0|||
46737028|NCT00757042|82953787|FG005|Overall Study|Withdrawal by Subject|0|||
46737029|NCT00757042|82953788|FG006|Overall Study|Withdrawal by Subject|0|||
46737030|NCT00757042|82953789|FG007|Overall Study|Withdrawal by Subject|0|||
46737031|NCT00757042|82953790|FG008|Overall Study|Withdrawal by Subject|0|||
46737032|NCT00757042|82953791|FG009|Overall Study|Withdrawal by Subject|1|||
46737033|NCT00757042|82953792|FG010|Overall Study|Withdrawal by Subject|0|||
46737034|NCT01013597|82953823|FG000|Overall Study|Withdrawal by Subject|1|||
46737035|NCT01013285|82953842|FG000|Overall Study|Death|48|||
46737036|NCT01013285|82953843|FG001|Overall Study|Death|89|||
46737037|NCT01033643|82953853|FG000|Overall Study|Withdrew Consent|0|||
46737038|NCT01033643|82953854|FG001|Overall Study|Withdrew Consent|3|||
46737039|NCT01033643|82953855|FG002|Overall Study|Withdrew Consent|0|||
46737040|NCT01033643|82953856|FG003|Overall Study|Withdrew Consent|0|||
46737041|NCT01033643|82953857|FG004|Overall Study|Withdrew Consent|0|||
46737042|NCT01033643|82953858|FG005|Overall Study|Withdrew Consent|1|||
46737043|NCT01013207|82953872|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
46635268|NCT01565148|82808869|FG002|Overall Study|Physician Decision|0|||
46737044|NCT01033487|82953876|FG000|Fourth Intervention Period|Adverse Event|0|||
46737045|NCT01033487|82953877|FG001|Fourth Intervention Period|Adverse Event|0|||
46737046|NCT01033487|82953878|FG002|Fourth Intervention Period|Adverse Event|0|||
46737047|NCT01033487|82953879|FG003|Fourth Intervention Period|Adverse Event|0|||
46737048|NCT01033487|82953880|FG004|Fourth Intervention Period|Adverse Event|0|||
46737049|NCT01033487|82953881|FG005|Fourth Intervention Period|Adverse Event|0|||
46737050|NCT01033487|82953882|FG006|Fourth Intervention Period|Adverse Event|0|||
46737051|NCT01033487|82953883|FG007|Fourth Intervention Period|Adverse Event|0|||
46737052|NCT01033487|82953884|FG008|Fourth Intervention Period|Adverse Event|1|||
46737053|NCT01033487|82953885|FG009|Fourth Intervention Period|Adverse Event|0|||
46737054|NCT01033019|82953901|FG000|Overall Study|Withdrawal by Subject|1|||
46737055|NCT01033019|82953902|FG001|Overall Study|Withdrawal by Subject|0|||
46737056|NCT00603447|82953916|FG000|Overall Study|Adverse Event|0|||
46737057|NCT00603447|82953917|FG001|Overall Study|Adverse Event|1|||
46737058|NCT00603447|82953918|FG002|Overall Study|Adverse Event|1|||
46737059|NCT00603447|82953919|FG003|Overall Study|Adverse Event|2|||
46737060|NCT00603447|82953920|FG004|Overall Study|Adverse Event|1|||
46737061|NCT00603447|82953921|FG005|Overall Study|Adverse Event|2|||
46737062|NCT00603447|82953922|FG006|Overall Study|Adverse Event|10|||
46737063|NCT00603447|82953916|FG000|Overall Study|Other|0|||
46737064|NCT00603447|82953917|FG001|Overall Study|Other|0|||
46737065|NCT00603447|82953918|FG002|Overall Study|Other|1|||
46737066|NCT00603447|82953919|FG003|Overall Study|Other|0|||
46737067|NCT00603447|82953920|FG004|Overall Study|Other|3|||
46737068|NCT00603447|82953921|FG005|Overall Study|Other|0|||
46737069|NCT00603447|82953922|FG006|Overall Study|Other|13|||
46737070|NCT00603447|82953916|FG000|Overall Study|Withdrew Consent|0|||
46737071|NCT00603447|82953917|FG001|Overall Study|Withdrew Consent|2|||
46737072|NCT00603447|82953918|FG002|Overall Study|Withdrew Consent|0|||
46737073|NCT00603447|82953919|FG003|Overall Study|Withdrew Consent|0|||
46737074|NCT00603447|82953920|FG004|Overall Study|Withdrew Consent|1|||
46737075|NCT00603447|82953921|FG005|Overall Study|Withdrew Consent|0|||
46737076|NCT00603447|82953922|FG006|Overall Study|Withdrew Consent|1|||
46737077|NCT00778258|82953947|FG000|Overall Study|Adverse Event|1|||
46737078|NCT00778258|82953948|FG001|Overall Study|Adverse Event|0|||
46635269|NCT01565148|82808870|FG003|Overall Study|Physician Decision|0|||
46635270|NCT01564758|82808884|FG000|Overall Study|Death|8|||
46635271|NCT01564758|82808884|FG000|Overall Study|Adverse Event|3|||
46635272|NCT01564758|82808884|FG000|Overall Study|Other|3|||
46737079|NCT00778258|82953949|FG002|Overall Study|Adverse Event|0|||
46737080|NCT00778258|82953950|FG003|Overall Study|Adverse Event|0|||
46737081|NCT00778258|82953951|FG004|Overall Study|Adverse Event|0|||
46737082|NCT00778258|82953952|FG005|Overall Study|Adverse Event|1|||
46737083|NCT00778258|82953953|FG006|Overall Study|Adverse Event|0|||
46737084|NCT00778258|82953954|FG007|Overall Study|Adverse Event|0|||
46737085|NCT00778258|82953955|FG008|Overall Study|Adverse Event|0|||
46737086|NCT00778258|82953947|FG000|Overall Study|Lost to Follow-up|0|||
46737087|NCT00778258|82953948|FG001|Overall Study|Lost to Follow-up|0|||
46737088|NCT00778258|82953949|FG002|Overall Study|Lost to Follow-up|2|||
46737089|NCT00778258|82953950|FG003|Overall Study|Lost to Follow-up|0|||
46737090|NCT00778258|82953951|FG004|Overall Study|Lost to Follow-up|0|||
46737091|NCT00778258|82953952|FG005|Overall Study|Lost to Follow-up|3|||
46737092|NCT00778258|82953953|FG006|Overall Study|Lost to Follow-up|2|||
46737093|NCT00778258|82953954|FG007|Overall Study|Lost to Follow-up|2|||
46737094|NCT00778258|82953955|FG008|Overall Study|Lost to Follow-up|0|||
46737095|NCT00778258|82953947|FG000|Overall Study|Withdrawal by Subject|6|||
46737096|NCT00778258|82953948|FG001|Overall Study|Withdrawal by Subject|2|||
46737097|NCT00778258|82953949|FG002|Overall Study|Withdrawal by Subject|8|||
46737098|NCT00778258|82953950|FG003|Overall Study|Withdrawal by Subject|2|||
46737099|NCT00778258|82953951|FG004|Overall Study|Withdrawal by Subject|0|||
46737100|NCT00778258|82953952|FG005|Overall Study|Withdrawal by Subject|6|||
46737101|NCT00778258|82953953|FG006|Overall Study|Withdrawal by Subject|12|||
46737102|NCT00778258|82953954|FG007|Overall Study|Withdrawal by Subject|12|||
46737103|NCT00778258|82953955|FG008|Overall Study|Withdrawal by Subject|4|||
46737104|NCT00778258|82953947|FG000|Overall Study|New Contraindication|0|||
46737105|NCT00778258|82953948|FG001|Overall Study|New Contraindication|0|||
46737106|NCT00778258|82953949|FG002|Overall Study|New Contraindication|0|||
46737107|NCT00778258|82953950|FG003|Overall Study|New Contraindication|0|||
46737108|NCT00778258|82953951|FG004|Overall Study|New Contraindication|0|||
46737109|NCT00778258|82953952|FG005|Overall Study|New Contraindication|0|||
46921699|NCT01677910|83154372|FG002|Double-Blind Treatment Period|Physician Decision|1|||
46921700|NCT01677910|83154373|FG003|Double-Blind Treatment Period|Physician Decision|0|||
46921701|NCT01677910|83154370|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
46921702|NCT01677910|83154371|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
46921703|NCT01677910|83154372|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
46921704|NCT01677910|83154373|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
46921705|NCT01677910|83154370|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
46921706|NCT01677910|83154371|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
46921707|NCT01677910|83154372|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
46921708|NCT01677910|83154373|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
46921709|NCT01677910|83154370|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
46635273|NCT01541826|82808891|FG000|Overall Study|Lost to Follow-up|2|||
46635274|NCT01541826|82808892|FG001|Overall Study|Lost to Follow-up|3|||
46737110|NCT00778258|82953953|FG006|Overall Study|New Contraindication|0|||
46737111|NCT00778258|82953954|FG007|Overall Study|New Contraindication|1|||
46737112|NCT00778258|82953955|FG008|Overall Study|New Contraindication|0|||
46737113|NCT00778258|82953947|FG000|Overall Study|Non-compliance|0|||
46921710|NCT01677910|83154371|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
46921711|NCT01677910|83154372|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
46921712|NCT01677910|83154373|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
46921713|NCT01677910|83154370|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
46921714|NCT01677910|83154371|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
46921715|NCT01677910|83154372|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
46921716|NCT01677910|83154373|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
46921717|NCT01677910|83154370|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
46921718|NCT01677910|83154371|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
46921719|NCT01677910|83154372|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
46921720|NCT01677910|83154373|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
46921721|NCT01677910|83154370|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
46921722|NCT01677910|83154371|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
46921723|NCT01677910|83154372|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
46921724|NCT01677910|83154373|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
46921725|NCT01677910|83154370|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
46921726|NCT01677910|83154371|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
46921727|NCT01677910|83154372|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
46921728|NCT01677910|83154373|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
46921729|NCT01677910|83154370|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
46921730|NCT01677910|83154371|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
46921731|NCT01677910|83154372|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
46921732|NCT01677910|83154373|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
46921733|NCT03911713|83154388|FG000|Overall Study|Lost to Follow-up|0|||
46737114|NCT00778258|82953948|FG001|Overall Study|Non-compliance|0|||
46737115|NCT00778258|82953949|FG002|Overall Study|Non-compliance|0|||
46737116|NCT00778258|82953950|FG003|Overall Study|Non-compliance|1|||
46737117|NCT00778258|82953951|FG004|Overall Study|Non-compliance|0|||
46737118|NCT00778258|82953952|FG005|Overall Study|Non-compliance|0|||
46737119|NCT00778258|82953953|FG006|Overall Study|Non-compliance|0|||
46737120|NCT00778258|82953954|FG007|Overall Study|Non-compliance|0|||
46737121|NCT00778258|82953955|FG008|Overall Study|Non-compliance|0|||
46737122|NCT00778258|82953947|FG000|Overall Study|Other|0|||
46737123|NCT00778258|82953948|FG001|Overall Study|Other|0|||
46737124|NCT00778258|82953949|FG002|Overall Study|Other|0|||
46737125|NCT00778258|82953950|FG003|Overall Study|Other|0|||
46737126|NCT00778258|82953951|FG004|Overall Study|Other|0|||
46737127|NCT00778258|82953952|FG005|Overall Study|Other|0|||
46737128|NCT00778258|82953953|FG006|Overall Study|Other|1|||
46737129|NCT00778258|82953954|FG007|Overall Study|Other|0|||
46737130|NCT00778258|82953955|FG008|Overall Study|Other|0|||
46737131|NCT00988208|82953983|FG000|Overall Study|Adverse Event|71|||
46737132|NCT00988208|82953984|FG001|Overall Study|Adverse Event|122|||
46737133|NCT00988208|82953983|FG000|Overall Study|Disease Progression|103|||
46737134|NCT00988208|82953984|FG001|Overall Study|Disease Progression|89|||
46737135|NCT00988208|82953983|FG000|Overall Study|Withdrawal by Subject|50|||
46737136|NCT00988208|82953984|FG001|Overall Study|Withdrawal by Subject|57|||
46737137|NCT00988208|82953983|FG000|Overall Study|Death|9|||
46737138|NCT00988208|82953984|FG001|Overall Study|Death|15|||
46737139|NCT00988208|82953983|FG000|Overall Study|Lost to Follow-up|2|||
46737140|NCT00988208|82953984|FG001|Overall Study|Lost to Follow-up|3|||
46737141|NCT00988208|82953983|FG000|Overall Study|Protocol Violation|9|||
46737142|NCT00988208|82953984|FG001|Overall Study|Protocol Violation|2|||
46737143|NCT00988208|82953983|FG000|Overall Study|Sponsor Decision|102|||
46737144|NCT00988208|82953984|FG001|Overall Study|Sponsor Decision|78|||
46737145|NCT00988208|82953983|FG000|Overall Study|Clinical Progression|17|||
46737146|NCT00988208|82953984|FG001|Overall Study|Clinical Progression|16|||
46737147|NCT00988208|82953983|FG000|Overall Study|Biochemical Progression|21|||
46737148|NCT00988208|82953984|FG001|Overall Study|Biochemical Progression|7|||
46737149|NCT00988208|82953983|FG000|Overall Study|Clinical Deterioration|7|||
46737150|NCT00988208|82953984|FG001|Overall Study|Clinical Deterioration|14|||
46737151|NCT00988208|82953983|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
46737152|NCT00988208|82953984|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
46737153|NCT00988208|82953983|FG000|Overall Study|Other|8|||
46737154|NCT00988208|82953984|FG001|Overall Study|Other|3|||
46737155|NCT00990704|82953992|FG000|Overall Study|Adverse Event|1|||
46737156|NCT00990704|82953993|FG001|Overall Study|Adverse Event|1|||
46737157|NCT00990704|82953992|FG000|Overall Study|Physician Decision|0|||
46737158|NCT00990704|82953993|FG001|Overall Study|Physician Decision|1|||
46737159|NCT04089553|82954001|FG000|Overall Study|Death|12|||
46737160|NCT04089553|82954002|FG001|Overall Study|Death|11|||
46737161|NCT04089553|82954001|FG000|Overall Study|Lost to Follow-up|2|||
46737162|NCT04089553|82954002|FG001|Overall Study|Lost to Follow-up|2|||
46804036|NCT00677807|83023236|FG002|Overall Study|Death|1|||
46737163|NCT04089553|82954001|FG000|Overall Study|Progressive disease|0|||
46737164|NCT04089553|82954002|FG001|Overall Study|Progressive disease|1|||
46737165|NCT04089553|82954001|FG000|Overall Study|Withdrawal by Subject|5|||
46737166|NCT04089553|82954002|FG001|Overall Study|Withdrawal by Subject|2|||
46737167|NCT04089553|82954001|FG000|Overall Study|Other|6|||
46737168|NCT04089553|82954002|FG001|Overall Study|Other|2|||
46737169|NCT00993668|82954011|FG000|Single-Blind Period|Adverse Event|1|||
46737170|NCT00993668|82954012|FG001|Single-Blind Period|Adverse Event|1|||
46737171|NCT00993668|82954011|FG000|Single-Blind Period|Lack of Efficacy|0|||
46737172|NCT00993668|82954012|FG001|Single-Blind Period|Lack of Efficacy|1|||
46737173|NCT00993668|82954011|FG000|Single-Blind Period|Lost to Follow-up|3|||
46737174|NCT00993668|82954012|FG001|Single-Blind Period|Lost to Follow-up|1|||
46737175|NCT00993668|82954011|FG000|Open-Label Period|Adverse Event|9|||
46737176|NCT00993668|82954012|FG001|Open-Label Period|Adverse Event|8|||
47049757|NCT01739348|83310338|FG003|Part I (Base Study)|Lack of Efficacy|7|||
46737177|NCT00993668|82954011|FG000|Open-Label Period|Lack of Efficacy|4|||
46737178|NCT00993668|82954012|FG001|Open-Label Period|Lack of Efficacy|3|||
46737179|NCT00993668|82954011|FG000|Open-Label Period|Withdrawal by Subject|4|||
46737180|NCT00993668|82954012|FG001|Open-Label Period|Withdrawal by Subject|3|||
46737181|NCT00993668|82954011|FG000|Open-Label Period|Lost to Follow-up|6|||
46737182|NCT00993668|82954012|FG001|Open-Label Period|Lost to Follow-up|1|||
46737183|NCT00778102|82954021|FG000|Overall Study|Adverse Event|8|||
46804037|NCT00677807|83023234|FG000|Overall Study|Protocol Deviation|1|||
46804038|NCT00677807|83023235|FG001|Overall Study|Protocol Deviation|3|||
46804039|NCT00677807|83023236|FG002|Overall Study|Protocol Deviation|0|||
46804040|NCT00687401|83023244|FG000|Overall Study|Protocol Violation|7|||
46804041|NCT00687401|83023244|FG000|Overall Study|Adverse Event|6|||
46804042|NCT00687401|83023244|FG000|Overall Study|Lack of Efficacy|6|||
46804043|NCT00687401|83023244|FG000|Overall Study|Withdrawal by Subject|4|||
46804044|NCT00687401|83023244|FG000|Overall Study|Did not return for visit|3|||
46804045|NCT00687401|83023244|FG000|Overall Study|For reasons different from those above|4|||
46804046|NCT00538902|83023264|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
46804047|NCT00538902|83023265|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
46804048|NCT00538902|83023266|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
46804049|NCT00538902|83023264|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
46804050|NCT00538902|83023265|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
46804051|NCT00538902|83023266|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
46804052|NCT00538902|83023264|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
46804053|NCT00538902|83023265|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
46804054|NCT00538902|83023266|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
46804055|NCT00538902|83023264|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
47049758|NCT01739348|83310335|FG000|Part I (Base Study)|Lost to Follow-up|4|||
47049759|NCT01739348|83310336|FG001|Part I (Base Study)|Lost to Follow-up|2|||
47049760|NCT01739348|83310337|FG002|Part I (Base Study)|Lost to Follow-up|4|||
47049761|NCT01739348|83310338|FG003|Part I (Base Study)|Lost to Follow-up|4|||
47049762|NCT01739348|83310335|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
47049763|NCT01739348|83310336|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
47049764|NCT01739348|83310337|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
47049765|NCT01739348|83310338|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
47049766|NCT01739348|83310335|FG000|Part I (Base Study)|Physician Decision|10|||
46737184|NCT00778102|82954022|FG001|Overall Study|Adverse Event|5|||
46737185|NCT00778102|82954021|FG000|Overall Study|Death|1|||
46737186|NCT00778102|82954022|FG001|Overall Study|Death|1|||
46737187|NCT00778102|82954021|FG000|Overall Study|Lost to Follow-up|1|||
46737188|NCT00778102|82954022|FG001|Overall Study|Lost to Follow-up|0|||
46737189|NCT00778102|82954021|FG000|Overall Study|Violation of Selection Criteria|1|||
46737190|NCT00778102|82954022|FG001|Overall Study|Violation of Selection Criteria|1|||
46737191|NCT00778102|82954021|FG000|Overall Study|Protocol Violation|0|||
46804056|NCT00538902|83023265|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
46804057|NCT00538902|83023266|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
47049767|NCT01739348|83310336|FG001|Part I (Base Study)|Physician Decision|7|||
47049768|NCT01739348|83310337|FG002|Part I (Base Study)|Physician Decision|1|||
47049769|NCT01739348|83310338|FG003|Part I (Base Study)|Physician Decision|4|||
47049770|NCT01739348|83310335|FG000|Part I (Base Study)|Protocol Violation|2|||
47049771|NCT01739348|83310336|FG001|Part I (Base Study)|Protocol Violation|0|||
46737192|NCT00778102|82954022|FG001|Overall Study|Protocol Violation|1|||
46804058|NCT00538902|83023264|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
46804059|NCT00538902|83023265|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
46921734|NCT03911713|83154389|FG001|Overall Study|Lost to Follow-up|2|||
47049772|NCT01739348|83310337|FG002|Part I (Base Study)|Protocol Violation|1|||
46737193|NCT00778102|82954021|FG000|Overall Study|Refused Treatment|2|||
46737194|NCT00778102|82954022|FG001|Overall Study|Refused Treatment|3|||
46737195|NCT00778102|82954021|FG000|Overall Study|Withdrawal by Subject|1|||
46737196|NCT00778102|82954022|FG001|Overall Study|Withdrawal by Subject|1|||
46737197|NCT00778102|82954021|FG000|Overall Study|Administrative Reason|7|||
46737198|NCT00778102|82954022|FG001|Overall Study|Administrative Reason|10|||
46737199|NCT00756886|82954030|FG000|Overall Study|Lost to Follow-up|1|||
46737200|NCT00756886|82954031|FG001|Overall Study|Lost to Follow-up|0|||
46804060|NCT00538902|83023266|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
46737201|NCT00756886|82954030|FG000|Overall Study|Adverse Event|0|||
46737202|NCT00756886|82954031|FG001|Overall Study|Adverse Event|3|||
46737203|NCT00756886|82954030|FG000|Overall Study|Lack of Efficacy|1|||
46737204|NCT00756886|82954031|FG001|Overall Study|Lack of Efficacy|0|||
46804061|NCT00538902|83023264|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
46804062|NCT00538902|83023265|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
46804063|NCT00538902|83023266|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
46804064|NCT00538902|83023264|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
46804065|NCT00538902|83023265|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
46804066|NCT00538902|83023266|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
46804067|NCT00538902|83023264|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
46804068|NCT00538902|83023265|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
46804069|NCT00538902|83023266|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
46804070|NCT00541970|83023280|FG000|Month 7|Protocol Violation|9|||
46804071|NCT00541970|83023281|FG001|Month 7|Protocol Violation|13|||
46804072|NCT00541970|83023282|FG002|Month 7|Protocol Violation|11|||
46804073|NCT00541970|83023283|FG003|Month 7|Protocol Violation|5|||
47049773|NCT01739348|83310338|FG003|Part I (Base Study)|Protocol Violation|2|||
47049774|NCT01739348|83310335|FG000|Part I (Base Study)|Screen Failure|2|||
47049775|NCT01739348|83310336|FG001|Part I (Base Study)|Screen Failure|0|||
47049776|NCT01739348|83310337|FG002|Part I (Base Study)|Screen Failure|0|||
47049777|NCT01739348|83310338|FG003|Part I (Base Study)|Screen Failure|0|||
47049778|NCT01739348|83310335|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
47049779|NCT01739348|83310336|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
47049780|NCT01739348|83310337|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
47049781|NCT01739348|83310338|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
47049782|NCT01739348|83310335|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
47049783|NCT01739348|83310336|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
47049784|NCT01739348|83310337|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
47049785|NCT01739348|83310338|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
47049786|NCT01739348|83310335|FG000|Part I (Base Study)|Participant Moved|4|||
47049787|NCT01739348|83310336|FG001|Part I (Base Study)|Participant Moved|3|||
47049788|NCT01739348|83310337|FG002|Part I (Base Study)|Participant Moved|1|||
47049789|NCT01739348|83310338|FG003|Part I (Base Study)|Participant Moved|7|||
47049790|NCT01739348|83310335|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
47049791|NCT01739348|83310336|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
47049792|NCT01739348|83310337|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
47049793|NCT01739348|83310338|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
47049794|NCT01739348|83310335|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
47049795|NCT01739348|83310336|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
47049796|NCT01739348|83310337|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
47049797|NCT01739348|83310338|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
47049798|NCT01739348|83310335|FG000|Part II (Extension Study)|Adverse Event|10|||
47049799|NCT01739348|83310336|FG001|Part II (Extension Study)|Adverse Event|11|||
47049800|NCT01739348|83310337|FG002|Part II (Extension Study)|Adverse Event|7|||
47049801|NCT01739348|83310338|FG003|Part II (Extension Study)|Adverse Event|26|||
47049802|NCT01739348|83310335|FG000|Part II (Extension Study)|Death|3|||
47049803|NCT01739348|83310336|FG001|Part II (Extension Study)|Death|3|||
47049804|NCT01739348|83310337|FG002|Part II (Extension Study)|Death|2|||
47049805|NCT01739348|83310338|FG003|Part II (Extension Study)|Death|6|||
47049806|NCT01739348|83310335|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
47049807|NCT01739348|83310336|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
47049808|NCT01739348|83310337|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
47049809|NCT01739348|83310338|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
47049810|NCT01739348|83310335|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
46635275|NCT01541826|82808893|FG002|Overall Study|Lost to Follow-up|0|||
46635276|NCT01541826|82808891|FG000|Overall Study|Withdrawal by Subject|2|||
46635277|NCT01541826|82808892|FG001|Overall Study|Withdrawal by Subject|0|||
46737205|NCT00756886|82954030|FG000|Overall Study|Ineligible|9|||
46921735|NCT03911713|83154390|FG002|Overall Study|Lost to Follow-up|0|||
46737206|NCT00756886|82954031|FG001|Overall Study|Ineligible|4|||
46804074|NCT00541970|83023280|FG000|Month 12|Adverse Event|0|||
46804075|NCT00541970|83023281|FG001|Month 12|Adverse Event|1|||
47049811|NCT01739348|83310336|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
47049812|NCT01739348|83310337|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
47049813|NCT01739348|83310338|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
47049814|NCT01739348|83310335|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
46737207|NCT00756730|82954039|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
46737208|NCT00756730|82954040|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
46737209|NCT00756730|82954039|FG000|Overall Study|persistent low-level viremmia|0|||
46737210|NCT00756730|82954040|FG001|Overall Study|persistent low-level viremmia|1|||
46737211|NCT00984620|82954048|FG000|Overall Study|Adverse Event|5|||
46737212|NCT00984620|82954049|FG001|Overall Study|Adverse Event|5|||
46737213|NCT00984620|82954048|FG000|Overall Study|Lost to Follow-up|1|||
46737214|NCT00984620|82954049|FG001|Overall Study|Lost to Follow-up|1|||
46737215|NCT00984620|82954048|FG000|Overall Study|Withdrawal by Subject|0|||
46737216|NCT00984620|82954049|FG001|Overall Study|Withdrawal by Subject|2|||
46737217|NCT00984620|82954048|FG000|Overall Study|reason other than listed above|0|||
47049815|NCT01739348|83310336|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
46635278|NCT01541826|82808893|FG002|Overall Study|Withdrawal by Subject|0|||
46635279|NCT01541748|82808901|FG000|Overall Study|Lost to Follow-up|17|||
46635280|NCT01541748|82808901|FG000|Overall Study|Moved out of state|1|||
46737218|NCT00984620|82954049|FG001|Overall Study|reason other than listed above|4|||
46737219|NCT00777946|82954060|FG000|Overall Study|Adverse Event|11|||
46737220|NCT00777946|82954061|FG001|Overall Study|Adverse Event|1|||
46737221|NCT00777946|82954062|FG002|Overall Study|Adverse Event|3|||
46737222|NCT00777946|82954060|FG000|Overall Study|Lack of Efficacy|0|||
46737223|NCT00777946|82954061|FG001|Overall Study|Lack of Efficacy|0|||
46737224|NCT00777946|82954062|FG002|Overall Study|Lack of Efficacy|9|||
46737225|NCT00777946|82954060|FG000|Overall Study|Condition no longer required study drug|1|||
46737226|NCT00777946|82954061|FG001|Overall Study|Condition no longer required study drug|0|||
46737227|NCT00777946|82954062|FG002|Overall Study|Condition no longer required study drug|0|||
46737228|NCT00777946|82954060|FG000|Overall Study|Patient withdrew consent|3|||
46737229|NCT00777946|82954061|FG001|Overall Study|Patient withdrew consent|2|||
46737230|NCT00777946|82954062|FG002|Overall Study|Patient withdrew consent|3|||
46737231|NCT00777946|82954060|FG000|Overall Study|Lost to Follow-up|3|||
46737232|NCT00777946|82954061|FG001|Overall Study|Lost to Follow-up|1|||
46737233|NCT00777946|82954062|FG002|Overall Study|Lost to Follow-up|0|||
46737234|NCT00777946|82954060|FG000|Overall Study|Protocol deviation|2|||
46737235|NCT00777946|82954061|FG001|Overall Study|Protocol deviation|1|||
46737236|NCT00777946|82954062|FG002|Overall Study|Protocol deviation|1|||
46737237|NCT00777946|82954060|FG000|Overall Study|Randomized in error|1|||
46737238|NCT00777946|82954061|FG001|Overall Study|Randomized in error|1|||
46737239|NCT00777946|82954062|FG002|Overall Study|Randomized in error|0|||
46737240|NCT00990314|82954070|FG000|Overall Study|Death|2|||
46737241|NCT00990314|82954070|FG000|Overall Study|Adverse Event|2|||
46737242|NCT00990314|82954070|FG000|Overall Study|Withdrawal by Subject|3|||
46737243|NCT00990314|82954070|FG000|Overall Study|Non-Compliance|1|||
46737244|NCT00990314|82954070|FG000|Overall Study|Physician Decision|3|||
46737245|NCT00990314|82954070|FG000|Overall Study|Lack of Efficacy|1|||
46737246|NCT00756652|82954076|FG000|Original Phase|Withdrawal by Subject|864|||
46737247|NCT00756652|82954077|FG001|Original Phase|Withdrawal by Subject|23|||
46737248|NCT00756652|82954076|FG000|Original Phase|Lost to Follow-up|601|||
46737249|NCT00756652|82954077|FG001|Original Phase|Lost to Follow-up|0|||
46737250|NCT00756652|82954076|FG000|Original Phase|Other Discontinuation|797|||
46737251|NCT00756652|82954077|FG001|Original Phase|Other Discontinuation|5|||
46737252|NCT00756652|82954076|FG000|Original Phase|Participant Noncompliance|18622|||
46737253|NCT00756652|82954077|FG001|Original Phase|Participant Noncompliance|424|||
46635281|NCT01541748|82808901|FG000|Overall Study|Withdrawal by Subject|7|||
46635282|NCT01541748|82808901|FG000|Overall Study|Screen failure|5|||
46635283|NCT01541748|82808901|FG000|Overall Study|Did not receive study device|1|||
46635284|NCT01589094|82808914|FG000|Overall Study|Did not receive treatment|2|||
46635285|NCT01563978|82808920|FG000|Overall Study|Physician Decision|1|||
46635286|NCT01563978|82808921|FG001|Overall Study|Physician Decision|0|||
46635287|NCT01563978|82808920|FG000|Overall Study|Lost to Follow-up|1|||
46635288|NCT01563978|82808921|FG001|Overall Study|Lost to Follow-up|0|||
46635289|NCT01563978|82808920|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
46635290|NCT01563978|82808921|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
46737254|NCT00756652|82954076|FG000|Original Phase|Unknown Discontinuation Reason|2|||
46737255|NCT00756652|82954077|FG001|Original Phase|Unknown Discontinuation Reason|0|||
46737256|NCT00756652|82954076|FG000|Original Phase|Participants without data|3259|||
46737257|NCT00756652|82954077|FG001|Original Phase|Participants without data|466|||
47049816|NCT01739348|83310337|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
47049817|NCT01739348|83310338|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
46737258|NCT00756652|82954076|FG000|Original Phase|Death|168|||
46635291|NCT01563978|82808920|FG000|Overall Study|Adverse Event|1|||
46635292|NCT01563978|82808921|FG001|Overall Study|Adverse Event|2|||
46737259|NCT00756652|82954077|FG001|Original Phase|Death|1|||
46737260|NCT00756652|82954076|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
46737261|NCT00756652|82954077|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
46737262|NCT00756652|82954076|FG000|Re-Op Phase|Withdrawal by Subject|62|||
46737263|NCT00756652|82954077|FG001|Re-Op Phase|Withdrawal by Subject|0|||
46737264|NCT00756652|82954076|FG000|Re-Op Phase|Death|6|||
46737265|NCT00756652|82954077|FG001|Re-Op Phase|Death|0|||
46737266|NCT00756652|82954076|FG000|Re-Op Phase|Lost to Follow-up|340|||
46737267|NCT00756652|82954077|FG001|Re-Op Phase|Lost to Follow-up|0|||
46737268|NCT00756652|82954076|FG000|Re-Op Phase|Site Closed|2454|||
46737269|NCT00756652|82954077|FG001|Re-Op Phase|Site Closed|0|||
46737270|NCT00756652|82954076|FG000|Re-Op Phase|Withdrawn after explant|14|||
46737271|NCT00756652|82954077|FG001|Re-Op Phase|Withdrawn after explant|0|||
46737272|NCT00777556|82954081|FG000|Overall Study|Inappropriate self-selection|34|||
46737273|NCT00777556|82954081|FG000|Overall Study|Dispensed but did not use product|12|||
46737274|NCT00777556|82954081|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
46737275|NCT00602979|82954090|FG000|Overall Study|Lost to Follow-up|3|||
46737276|NCT00602979|82954091|FG001|Overall Study|Lost to Follow-up|2|||
46737277|NCT00602979|82954092|FG002|Overall Study|Lost to Follow-up|3|||
46737278|NCT00602979|82954093|FG003|Overall Study|Lost to Follow-up|2|||
46737279|NCT00602979|82954094|FG004|Overall Study|Lost to Follow-up|3|||
46737280|NCT00602979|82954090|FG000|Overall Study|Failed Intubation|0|||
46737281|NCT00602979|82954091|FG001|Overall Study|Failed Intubation|1|||
46737282|NCT00602979|82954092|FG002|Overall Study|Failed Intubation|0|||
46737283|NCT00602979|82954093|FG003|Overall Study|Failed Intubation|1|||
46737284|NCT00602979|82954094|FG004|Overall Study|Failed Intubation|0|||
46737285|NCT04081363|82954108|FG000|Overall Study|Withdrawal by Subject|1|||
46737286|NCT04081363|82954109|FG001|Overall Study|Withdrawal by Subject|0|||
46737287|NCT00777088|82954124|FG000|Overall Study|PED Treatment not attempted|1|||
46737288|NCT00763282|82954140|FG000|Overall Study|Withdrawal by Subject|6|||
46737289|NCT00763282|82954141|FG001|Overall Study|Withdrawal by Subject|5|||
46737290|NCT00763282|82954140|FG000|Overall Study|Death|4|||
46737291|NCT00763282|82954141|FG001|Overall Study|Death|3|||
46737292|NCT00763282|82954140|FG000|Overall Study|Lost to Follow-up|22|||
46737293|NCT00763282|82954141|FG001|Overall Study|Lost to Follow-up|26|||
46737294|NCT00988598|82954151|FG000|Overall Study|Withdrawal by Subject|2|||
46737295|NCT00988598|82954152|FG001|Overall Study|Withdrawal by Subject|0|||
46737296|NCT00979628|82954161|FG000|Overall Study|received regimen < 24 hours|7|||
46737297|NCT00979628|82954162|FG001|Overall Study|received regimen < 24 hours|6|||
46737298|NCT00979628|82954163|FG002|Overall Study|received regimen < 24 hours|5|||
46737299|NCT00979628|82954161|FG000|Overall Study|received steroids|1|||
46737300|NCT00979628|82954162|FG001|Overall Study|received steroids|1|||
46737301|NCT00979628|82954163|FG002|Overall Study|received steroids|0|||
46737302|NCT00979628|82954161|FG000|Overall Study|transferred to ICU|1|||
46737303|NCT00979628|82954162|FG001|Overall Study|transferred to ICU|2|||
46737304|NCT00979628|82954163|FG002|Overall Study|transferred to ICU|1|||
46737305|NCT00762970|82954177|FG000|Overall Study|Withdrawal by Subject|7|||
46737306|NCT00762970|82954178|FG001|Overall Study|Withdrawal by Subject|4|||
46737307|NCT00762970|82954179|FG002|Overall Study|Withdrawal by Subject|0|||
46737308|NCT00762970|82954177|FG000|Overall Study|Protocol Violation|3|||
46737309|NCT00762970|82954178|FG001|Overall Study|Protocol Violation|1|||
46737310|NCT00762970|82954179|FG002|Overall Study|Protocol Violation|1|||
46737311|NCT00762970|82954177|FG000|Overall Study|Lost to Follow-up|1|||
46737312|NCT00762970|82954178|FG001|Overall Study|Lost to Follow-up|2|||
46737313|NCT00762970|82954179|FG002|Overall Study|Lost to Follow-up|0|||
46737314|NCT00762970|82954177|FG000|Overall Study|Difficulty of handling lens|1|||
46737315|NCT00762970|82954178|FG001|Overall Study|Difficulty of handling lens|2|||
46737316|NCT00762970|82954179|FG002|Overall Study|Difficulty of handling lens|0|||
46737317|NCT00988442|82954189|FG000|Overall Study|Death|1|||
46737318|NCT00988442|82954190|FG001|Overall Study|Death|2|||
46737319|NCT00988442|82954189|FG000|Overall Study|Lost to Follow-up|0|||
46737320|NCT00988442|82954190|FG001|Overall Study|Lost to Follow-up|1|||
46737321|NCT00988442|82954189|FG000|Overall Study|Early Study Closure|29|||
46737322|NCT00988442|82954190|FG001|Overall Study|Early Study Closure|25|||
46737323|NCT00992186|82954199|FG000|Overall Study|Withdrawal by Subject|2|||
46737324|NCT00992186|82954199|FG000|Overall Study|Protocol Violation|1|||
46737325|NCT00992186|82954199|FG000|Overall Study|Physician Decision|1|||
46737326|NCT00992186|82954199|FG000|Overall Study|Adverse Event|9|||
46737327|NCT00992186|82954199|FG000|Overall Study|Progressive Disease|30|||
46737328|NCT00992186|82954199|FG000|Overall Study|Refusal To Receive Study Agent|3|||
46737329|NCT00992108|82954206|FG000|Overall Study|Lost to Follow-up|0|||
46737330|NCT00992108|82954207|FG001|Overall Study|Lost to Follow-up|1|||
46737331|NCT00752986|82954216|FG000|Overall Study|Withdrawal by Subject|2|||
46737332|NCT00752986|82954217|FG001|Overall Study|Withdrawal by Subject|1|||
46737333|NCT00752986|82954218|FG002|Overall Study|Withdrawal by Subject|2|||
46737334|NCT00752986|82954216|FG000|Overall Study|Protocol Violation|3|||
46737335|NCT00752986|82954217|FG001|Overall Study|Protocol Violation|0|||
46737336|NCT00752986|82954218|FG002|Overall Study|Protocol Violation|0|||
46737337|NCT00762892|82954228|FG000|Overall Study|Lost to Follow-up|2|||
46737338|NCT00762892|82954229|FG001|Overall Study|Lost to Follow-up|5|||
46737339|NCT00762892|82954228|FG000|Overall Study|Withdrawal by Subject|0|||
46737340|NCT00762892|82954229|FG001|Overall Study|Withdrawal by Subject|1|||
46737341|NCT00762892|82954228|FG000|Overall Study|Death|1|||
46737342|NCT00762892|82954229|FG001|Overall Study|Death|0|||
46737343|NCT00762892|82954228|FG000|Overall Study|Pregnancy|1|||
46737344|NCT00762892|82954229|FG001|Overall Study|Pregnancy|0|||
46737345|NCT00762892|82954228|FG000|Overall Study|Incarceration|1|||
46737346|NCT00762892|82954229|FG001|Overall Study|Incarceration|0|||
46737347|NCT00755716|82954238|FG000|Overall Study|Adverse Event|1|||
46737348|NCT00755716|82954239|FG001|Overall Study|Adverse Event|4|||
46737349|NCT00755716|82954240|FG002|Overall Study|Adverse Event|1|||
46737350|NCT00755716|82954238|FG000|Overall Study|Lack of Efficacy|2|||
46737351|NCT00755716|82954239|FG001|Overall Study|Lack of Efficacy|0|||
46737352|NCT00755716|82954240|FG002|Overall Study|Lack of Efficacy|0|||
46737353|NCT00755716|82954238|FG000|Overall Study|Lost to Follow-up|5|||
46737354|NCT00755716|82954239|FG001|Overall Study|Lost to Follow-up|3|||
46737355|NCT00755716|82954240|FG002|Overall Study|Lost to Follow-up|1|||
46737356|NCT00755716|82954238|FG000|Overall Study|work schedule issues|0|||
46737357|NCT00755716|82954239|FG001|Overall Study|work schedule issues|1|||
46737358|NCT00755716|82954240|FG002|Overall Study|work schedule issues|1|||
46737359|NCT00755326|82954250|FG000|Overall Study|Lost to Follow-up|2|||
46737360|NCT00755326|82954251|FG001|Overall Study|Lost to Follow-up|3|||
46737361|NCT03084471|82954258|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
46737362|NCT03084471|82954258|FG000|Overall Study|Condition under investigation worsened|84|||
46737363|NCT03084471|82954258|FG000|Overall Study|Lack of therapeutic response|2|||
46737364|NCT03084471|82954258|FG000|Overall Study|Protocol Violation|1|||
46737365|NCT03084471|82954258|FG000|Overall Study|Adverse Event|73|||
46737366|NCT03084471|82954258|FG000|Overall Study|Withdrawal by Subject|12|||
46737367|NCT03084471|82954258|FG000|Overall Study|Disease relapse|181|||
46737368|NCT03084471|82954258|FG000|Overall Study|Subjective disease progression|359|||
46737369|NCT03084471|82954258|FG000|Overall Study|Other (as recorded)|33|||
46737370|NCT03084471|82954258|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
46737371|NCT00754936|82954265|FG000|Overall Study|Lost to Follow-up|3|||
46737372|NCT00754936|82954265|FG000|Overall Study|Physician Decision|1|||
46737373|NCT00754936|82954265|FG000|Overall Study|Withdrawal by Subject|2|||
46737374|NCT00754936|82954265|FG000|Overall Study|Side Effects|3|||
46737375|NCT00754936|82954265|FG000|Overall Study|Inter-current medical events|3|||
46737376|NCT00762502|82954272|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
46737377|NCT00762502|82954273|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
46737378|NCT00762502|82954274|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
46737379|NCT00762502|82954272|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
46737380|NCT00762502|82954273|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
46737381|NCT00762502|82954274|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
46737382|NCT00762502|82954272|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
46737383|NCT00762502|82954273|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
46737384|NCT00762502|82954274|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
46737385|NCT00762268|82954282|FG000|Overall Study|Withdrawal by Subject|3|||
46737386|NCT00762268|82954283|FG001|Overall Study|Withdrawal by Subject|3|||
46737387|NCT00975884|82954291|FG000|Overall Study|Adverse Event|1|||
46737388|NCT00975884|82954292|FG001|Overall Study|Adverse Event|0|||
46737389|NCT00975884|82954291|FG000|Overall Study|Lost to Follow-up|5|||
46737390|NCT00975884|82954292|FG001|Overall Study|Lost to Follow-up|3|||
46737391|NCT00975884|82954291|FG000|Overall Study|Withdrawal by Subject|9|||
46737392|NCT00975884|82954292|FG001|Overall Study|Withdrawal by Subject|9|||
46737393|NCT00975884|82954291|FG000|Overall Study|Other|1|||
46737394|NCT00975884|82954292|FG001|Overall Study|Other|3|||
46737395|NCT00578227|82954311|FG000|Overall Study|Lost to Follow-up|0|||
46737396|NCT00578227|82954312|FG001|Overall Study|Lost to Follow-up|1|||
46737397|NCT00578227|82954313|FG002|Overall Study|Lost to Follow-up|1|||
46737398|NCT00578227|82954311|FG000|Overall Study|Withdrawal by Subject|5|||
46737399|NCT00578227|82954312|FG001|Overall Study|Withdrawal by Subject|1|||
46737400|NCT00578227|82954313|FG002|Overall Study|Withdrawal by Subject|3|||
46737401|NCT00978380|82954323|FG000|Overall Study|Protocol Violation|2|||
46737402|NCT00978380|82954323|FG000|Overall Study|Withdrawal criteria|9|||
46737403|NCT00978380|82954323|FG000|Overall Study|Unclassified|8|||
46737404|NCT00577993|82954331|FG000|Overall Study|Adverse Event|1|||
46737405|NCT00577993|82954332|FG001|Overall Study|Adverse Event|0|||
46737406|NCT00577993|82954333|FG002|Overall Study|Adverse Event|0|||
46737407|NCT00577993|82954331|FG000|Overall Study|Death|0|||
46737408|NCT00577993|82954332|FG001|Overall Study|Death|1|||
46737409|NCT00577993|82954333|FG002|Overall Study|Death|1|||
46737410|NCT00577993|82954331|FG000|Overall Study|Lack of Efficacy|0|||
46737411|NCT00577993|82954332|FG001|Overall Study|Lack of Efficacy|1|||
46737412|NCT00577993|82954333|FG002|Overall Study|Lack of Efficacy|0|||
46737413|NCT00577993|82954331|FG000|Overall Study|Protocol Violation|2|||
46737414|NCT00577993|82954332|FG001|Overall Study|Protocol Violation|3|||
46921736|NCT03911713|83154391|FG003|Overall Study|Lost to Follow-up|0|||
46921737|NCT03911713|83154392|FG004|Overall Study|Lost to Follow-up|0|||
46737415|NCT00577993|82954333|FG002|Overall Study|Protocol Violation|0|||
46737416|NCT00577993|82954331|FG000|Overall Study|Withdrawal by Subject|1|||
46737417|NCT00577993|82954332|FG001|Overall Study|Withdrawal by Subject|0|||
46737418|NCT00577993|82954333|FG002|Overall Study|Withdrawal by Subject|2|||
46737419|NCT00577993|82954331|FG000|Overall Study|Conversion|2|||
46921738|NCT03911713|83154388|FG000|Overall Study|Other|0|||
46737420|NCT00577993|82954332|FG001|Overall Study|Conversion|5|||
46737421|NCT00577993|82954333|FG002|Overall Study|Conversion|0|||
46737422|NCT00577993|82954331|FG000|Overall Study|Uninsured|1|||
46737423|NCT00577993|82954332|FG001|Overall Study|Uninsured|0|||
46737424|NCT00577993|82954333|FG002|Overall Study|Uninsured|0|||
46737425|NCT00975806|82954342|FG000|Overall Study|Adverse Event|2|||
46737426|NCT00975806|82954343|FG001|Overall Study|Adverse Event|1|||
46737427|NCT00975806|82954344|FG002|Overall Study|Adverse Event|2|||
46737428|NCT00975806|82954342|FG000|Overall Study|Disease Progression|1|||
46737429|NCT00975806|82954343|FG001|Overall Study|Disease Progression|5|||
46737430|NCT00975806|82954344|FG002|Overall Study|Disease Progression|1|||
46737431|NCT00975806|82954342|FG000|Overall Study|Withdrawal by Subject|1|||
46737432|NCT00975806|82954343|FG001|Overall Study|Withdrawal by Subject|0|||
46737433|NCT00975806|82954344|FG002|Overall Study|Withdrawal by Subject|0|||
46737434|NCT00975806|82954342|FG000|Overall Study|Death|0|||
46737435|NCT00975806|82954343|FG001|Overall Study|Death|1|||
46737436|NCT00975806|82954344|FG002|Overall Study|Death|0|||
46737437|NCT00975806|82954342|FG000|Overall Study|Physician decision and disease related|1|||
46737438|NCT00975806|82954343|FG001|Overall Study|Physician decision and disease related|0|||
46737439|NCT00975806|82954344|FG002|Overall Study|Physician decision and disease related|1|||
46737440|NCT00978068|82954356|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
46737441|NCT00978068|82954357|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
46737442|NCT00978068|82954356|FG000|Overall Study|Death|1|||
46737443|NCT00978068|82954357|FG001|Overall Study|Death|2|||
46737444|NCT00978068|82954356|FG000|Overall Study|Lost to Follow-up|1|||
46737445|NCT00978068|82954357|FG001|Overall Study|Lost to Follow-up|2|||
46737446|NCT00978068|82954356|FG000|Overall Study|Physician Decision|0|||
46737447|NCT00978068|82954357|FG001|Overall Study|Physician Decision|1|||
46737448|NCT00978068|82954356|FG000|Overall Study|Unable to Comply with Study|0|||
46737449|NCT00978068|82954357|FG001|Overall Study|Unable to Comply with Study|2|||
46737450|NCT00603525|82954369|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
46737451|NCT00603525|82954370|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
46737452|NCT00603525|82954371|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
46737453|NCT00603525|82954369|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
46737454|NCT00603525|82954370|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
46737455|NCT00603525|82954371|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
46737456|NCT00603525|82954369|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
46737457|NCT00603525|82954370|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
46737458|NCT00603525|82954371|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
46737459|NCT00603525|82954369|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
46737460|NCT00603525|82954370|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
46737461|NCT00603525|82954371|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46737462|NCT00603525|82954369|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
46737463|NCT00603525|82954370|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
46737464|NCT00603525|82954371|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46737465|NCT00603525|82954369|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
46737466|NCT00603525|82954370|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
46737467|NCT00603525|82954371|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
46737468|NCT00603525|82954369|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
46737469|NCT00603525|82954370|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
46737470|NCT00603525|82954371|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
46737471|NCT00603525|82954369|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
46737472|NCT00603525|82954370|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
46737473|NCT00603525|82954371|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
46737474|NCT00603525|82954369|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
46737475|NCT00603525|82954370|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
47049818|NCT01739348|83310335|FG000|Part II (Extension Study)|Physician Decision|7|||
47049819|NCT01739348|83310336|FG001|Part II (Extension Study)|Physician Decision|11|||
47049820|NCT01739348|83310337|FG002|Part II (Extension Study)|Physician Decision|6|||
47049821|NCT01739348|83310338|FG003|Part II (Extension Study)|Physician Decision|12|||
47049822|NCT01739348|83310335|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
46737476|NCT00603525|82954371|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
46737477|NCT00603525|82954369|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
46737478|NCT00603525|82954370|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
46737479|NCT00603525|82954371|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
46737480|NCT00603525|82954369|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
46737481|NCT00603525|82954370|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
46737482|NCT00603525|82954371|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
46737483|NCT00603525|82954369|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
46737484|NCT00603525|82954370|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
46737485|NCT00603525|82954371|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
46775736|NCT00793793|82994205|FG001|Overall Study|Protocol Violation|0|||
46737486|NCT00603525|82954369|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
46737487|NCT00603525|82954370|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
46737488|NCT00603525|82954371|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
46737489|NCT00603525|82954369|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
46737490|NCT00603525|82954370|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
46737491|NCT00603525|82954371|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
46737492|NCT00603525|82954369|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
46737493|NCT00603525|82954370|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
46737494|NCT00603525|82954371|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
46737495|NCT00762034|82954384|FG000|Induction Period|Protocol Violation|1|||
46737496|NCT00762034|82954385|FG001|Induction Period|Protocol Violation|2|||
46737497|NCT00762034|82954384|FG000|Induction Period|Entry Criterion Not Met|12|||
46737498|NCT00762034|82954385|FG001|Induction Period|Entry Criterion Not Met|11|||
46737499|NCT00762034|82954384|FG000|Induction Period|Adverse Event|27|||
46737500|NCT00762034|82954385|FG001|Induction Period|Adverse Event|38|||
46737501|NCT00762034|82954384|FG000|Induction Period|Lost to Follow-up|1|||
46737502|NCT00762034|82954385|FG001|Induction Period|Lost to Follow-up|1|||
46737503|NCT00762034|82954384|FG000|Induction Period|Progressive Disease|73|||
46737504|NCT00762034|82954385|FG001|Induction Period|Progressive Disease|55|||
46737505|NCT00762034|82954384|FG000|Induction Period|Physician Decision|21|||
46737506|NCT00762034|82954385|FG001|Induction Period|Physician Decision|20|||
46737507|NCT00762034|82954384|FG000|Induction Period|Withdrawal by Subject|15|||
46737508|NCT00762034|82954385|FG001|Induction Period|Withdrawal by Subject|19|||
46737509|NCT00762034|82954384|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
46737510|NCT00762034|82954385|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
46737511|NCT00762034|82954384|FG000|Induction Period|Deaths Due to Study Disease|9|||
46737512|NCT00762034|82954385|FG001|Induction Period|Deaths Due to Study Disease|9|||
46737513|NCT00762034|82954384|FG000|Maintenance Period|Protocol Violation|1|||
46737514|NCT00762034|82954385|FG001|Maintenance Period|Protocol Violation|3|||
46737515|NCT00762034|82954384|FG000|Maintenance Period|Entry Criterion Not Met|0|||
46737516|NCT00762034|82954385|FG001|Maintenance Period|Entry Criterion Not Met|2|||
46737517|NCT00762034|82954384|FG000|Maintenance Period|Adverse Event|42|||
46737518|NCT00762034|82954385|FG001|Maintenance Period|Adverse Event|26|||
46737519|NCT00762034|82954384|FG000|Maintenance Period|Progressive Disease|186|||
46737520|NCT00762034|82954385|FG001|Maintenance Period|Progressive Disease|224|||
46737521|NCT00762034|82954384|FG000|Maintenance Period|Physician Decision|25|||
46737522|NCT00762034|82954385|FG001|Maintenance Period|Physician Decision|20|||
46737523|NCT00762034|82954384|FG000|Maintenance Period|Withdrawal by Subject|34|||
46737524|NCT00762034|82954385|FG001|Maintenance Period|Withdrawal by Subject|14|||
46737525|NCT00762034|82954384|FG000|Maintenance Period|Death not due to study disease|2|||
46737526|NCT00762034|82954385|FG001|Maintenance Period|Death not due to study disease|5|||
46737527|NCT00762034|82954384|FG000|Maintenance Period|Death due to study disease|3|||
46737528|NCT00762034|82954385|FG001|Maintenance Period|Death due to study disease|3|||
46737529|NCT00762034|82954384|FG000|Maintenance Period|Other|1|||
46737530|NCT00762034|82954385|FG001|Maintenance Period|Other|1|||
46737531|NCT00761956|82954417|FG000|Overall Study|Lost to Follow-up|6|||
46737532|NCT00761956|82954418|FG001|Overall Study|Lost to Follow-up|11|||
46737533|NCT00761956|82954417|FG000|Overall Study|Withdrawal by Subject|3|||
46737534|NCT00761956|82954418|FG001|Overall Study|Withdrawal by Subject|8|||
46737535|NCT00761956|82954417|FG000|Overall Study|Death|0|||
46737536|NCT00761956|82954418|FG001|Overall Study|Death|1|||
46737537|NCT00761956|82954417|FG000|Overall Study|Adverse Event|26|||
46737538|NCT00761956|82954418|FG001|Overall Study|Adverse Event|34|||
46737539|NCT00754624|82954424|FG000|Overall Study|Adverse Event|16|||
46737540|NCT00754624|82954424|FG000|Overall Study|Death|1|||
46737541|NCT00754624|82954424|FG000|Overall Study|Physician Decision|8|||
46737542|NCT00754624|82954424|FG000|Overall Study|Protocol Violation|1|||
46737543|NCT00754624|82954424|FG000|Overall Study|Withdrawal by Subject|28|||
46737544|NCT00754624|82954424|FG000|Overall Study|Various|12|||
46737545|NCT00754624|82954424|FG000|Overall Study|Lost to Follow-up|3|||
46737546|NCT00586846|82954437|FG000|Overall Study|Physician Decision|1|||
46737547|NCT00586846|82954437|FG000|Overall Study|Death|1|||
46737548|NCT00586846|82954437|FG000|Overall Study|Evaluable for Toxicity Only|4|||
46737549|NCT00973700|82954446|FG000|Overall Study|Withdrawal by Subject|2|||
46737550|NCT00973700|82954447|FG001|Overall Study|Withdrawal by Subject|2|||
46737551|NCT00973700|82954448|FG002|Overall Study|Withdrawal by Subject|8|||
46737552|NCT00973700|82954449|FG003|Overall Study|Withdrawal by Subject|4|||
46737553|NCT00973700|82954450|FG004|Overall Study|Withdrawal by Subject|4|||
46737554|NCT00973700|82954446|FG000|Overall Study|Lost to Follow-up|5|||
46737555|NCT00973700|82954447|FG001|Overall Study|Lost to Follow-up|0|||
46737556|NCT00973700|82954448|FG002|Overall Study|Lost to Follow-up|1|||
46737557|NCT00973700|82954449|FG003|Overall Study|Lost to Follow-up|8|||
46737558|NCT00973700|82954450|FG004|Overall Study|Lost to Follow-up|5|||
46737559|NCT00973700|82954446|FG000|Overall Study|Inappropriate enrolment|0|||
46737560|NCT00973700|82954447|FG001|Overall Study|Inappropriate enrolment|0|||
46737561|NCT00973700|82954448|FG002|Overall Study|Inappropriate enrolment|0|||
46737562|NCT00973700|82954449|FG003|Overall Study|Inappropriate enrolment|4|||
46737563|NCT00973700|82954450|FG004|Overall Study|Inappropriate enrolment|0|||
46737564|NCT00973700|82954446|FG000|Overall Study|Unable to Classify|0|||
46737565|NCT00973700|82954447|FG001|Overall Study|Unable to Classify|0|||
46737566|NCT00973700|82954448|FG002|Overall Study|Unable to Classify|1|||
46737567|NCT00973700|82954449|FG003|Overall Study|Unable to Classify|2|||
46737568|NCT00973700|82954450|FG004|Overall Study|Unable to Classify|1|||
46737569|NCT00754390|82954477|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
46737570|NCT00754390|82954477|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
46737571|NCT00754390|82954477|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
46737572|NCT00754390|82954477|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
46737573|NCT00754234|82954484|FG000|Overall Study|Withdrawal by Subject|3|||
46737574|NCT00753922|82954492|FG000|Overall Study|Lost to Follow-up|155|||
46737575|NCT00753922|82954493|FG001|Overall Study|Lost to Follow-up|24|||
46737576|NCT00753922|82954494|FG002|Overall Study|Lost to Follow-up|28|||
46737577|NCT00753922|82954495|FG003|Overall Study|Lost to Follow-up|5|||
46737578|NCT00753922|82954492|FG000|Overall Study|Withdrawal by Subject|9|||
46737579|NCT00753922|82954493|FG001|Overall Study|Withdrawal by Subject|11|||
46737580|NCT00753922|82954494|FG002|Overall Study|Withdrawal by Subject|4|||
46737581|NCT00753922|82954495|FG003|Overall Study|Withdrawal by Subject|2|||
46737582|NCT00753922|82954492|FG000|Overall Study|Patient Non-compliance|55|||
46737583|NCT00753922|82954493|FG001|Overall Study|Patient Non-compliance|22|||
46737584|NCT00753922|82954494|FG002|Overall Study|Patient Non-compliance|14|||
46737585|NCT00753922|82954495|FG003|Overall Study|Patient Non-compliance|11|||
46737586|NCT00753922|82954492|FG000|Overall Study|Patients Not Completing Visit|11|||
46737587|NCT00753922|82954493|FG001|Overall Study|Patients Not Completing Visit|0|||
46737588|NCT00753922|82954494|FG002|Overall Study|Patients Not Completing Visit|1|||
46737589|NCT00753922|82954495|FG003|Overall Study|Patients Not Completing Visit|0|||
46737590|NCT00753922|82954492|FG000|Overall Study|Death|2|||
46737591|NCT00753922|82954493|FG001|Overall Study|Death|23|||
46737592|NCT00753922|82954494|FG002|Overall Study|Death|2|||
46737593|NCT00753922|82954495|FG003|Overall Study|Death|1|||
46737594|NCT00753922|82954492|FG000|Overall Study|Discontinuation Due to Explantation|14|||
46737595|NCT00753922|82954493|FG001|Overall Study|Discontinuation Due to Explantation|14|||
46737596|NCT00753922|82954494|FG002|Overall Study|Discontinuation Due to Explantation|14|||
46737597|NCT00753922|82954495|FG003|Overall Study|Discontinuation Due to Explantation|4|||
46737598|NCT00761176|82954507|FG000|Overall Study|Death|1|||
46737599|NCT00761176|82954508|FG001|Overall Study|Death|0|||
46737600|NCT00761176|82954507|FG000|Overall Study|Withdrawal by Subject|1|||
46737601|NCT00761176|82954508|FG001|Overall Study|Withdrawal by Subject|1|||
46737602|NCT00760552|82954516|FG000|Overall Study|Death|2|||
46737603|NCT00760552|82954517|FG001|Overall Study|Death|0|||
46737604|NCT00760552|82954516|FG000|Overall Study|Lost to Follow-up|11|||
46737605|NCT00760552|82954517|FG001|Overall Study|Lost to Follow-up|10|||
46737606|NCT00753766|82954525|FG000|Overall Study|Physician Decision|1|||
46737607|NCT00753766|82954526|FG001|Overall Study|Physician Decision|0|||
46737608|NCT00976898|82954533|FG000|Overall Study|Protocol Violation|1|||
46737609|NCT00976898|82954533|FG000|Overall Study|Adverse Event|1|||
46737610|NCT00976898|82954533|FG000|Overall Study|Physician Decision|1|||
46737611|NCT00976898|82954533|FG000|Overall Study|Liver Transplant|1|||
46737612|NCT00976898|82954533|FG000|Overall Study|Progressive Disease|1|||
46737613|NCT02620579|82954545|FG000|Overall Study|Physician Decision|0|||
46737614|NCT02620579|82954546|FG001|Overall Study|Physician Decision|0|||
46737615|NCT02620579|82954547|FG002|Overall Study|Physician Decision|0|||
46737616|NCT02620579|82954548|FG003|Overall Study|Physician Decision|1|||
46737617|NCT02620579|82954545|FG000|Overall Study|Withdrawal by Subject|0|||
46737618|NCT02620579|82954546|FG001|Overall Study|Withdrawal by Subject|1|||
46737619|NCT02620579|82954547|FG002|Overall Study|Withdrawal by Subject|1|||
46737620|NCT02620579|82954548|FG003|Overall Study|Withdrawal by Subject|0|||
46737621|NCT00753688|82954564|FG000|Overall Study|Death|102|||
46737622|NCT00753688|82954565|FG001|Overall Study|Death|203|||
46737623|NCT00753688|82954564|FG000|Overall Study|Missing|4|||
46737624|NCT00753688|82954565|FG001|Overall Study|Missing|9|||
46737625|NCT00753688|82954564|FG000|Overall Study|Participant Withdrew Consent|2|||
46737626|NCT00753688|82954565|FG001|Overall Study|Participant Withdrew Consent|2|||
46737627|NCT00753688|82954564|FG000|Overall Study|Ongoing - in Follow-up|15|||
46737628|NCT00753688|82954565|FG001|Overall Study|Ongoing - in Follow-up|31|||
46737629|NCT00753688|82954564|FG000|Overall Study|Adverse Event|0|||
46737630|NCT00753688|82954565|FG001|Overall Study|Adverse Event|1|||
46737631|NCT00586612|82954573|FG000|Primary Phase|Protocol Violation|1|||
46804076|NCT00541970|83023282|FG002|Month 12|Adverse Event|1|||
46737632|NCT00586612|82954574|FG001|Primary Phase|Protocol Violation|0|||
46737633|NCT00586612|82954573|FG000|Primary Phase|Lost to Follow-up|0|||
46737634|NCT00586612|82954574|FG001|Primary Phase|Lost to Follow-up|1|||
46737635|NCT00586612|82954573|FG000|Primary Phase|Withdrawal by Subject|0|||
46737636|NCT00586612|82954574|FG001|Primary Phase|Withdrawal by Subject|2|||
46737637|NCT00586612|82954573|FG000|Booster Phase|Lost to Follow-up|3|||
46737638|NCT00586612|82954574|FG001|Booster Phase|Lost to Follow-up|1|||
46737639|NCT00586690|82954582|FG000|Overall Study|Death|2|||
46737640|NCT00586690|82954583|FG001|Overall Study|Death|0|||
46737641|NCT00586690|82954582|FG000|Overall Study|Disease Progression|10|||
46737642|NCT00586690|82954583|FG001|Overall Study|Disease Progression|0|||
46737643|NCT00586690|82954582|FG000|Overall Study|Adverse Event|1|||
46737644|NCT00586690|82954583|FG001|Overall Study|Adverse Event|0|||
46737645|NCT00586690|82954582|FG000|Overall Study|Lack of Efficacy|2|||
46737646|NCT00586690|82954583|FG001|Overall Study|Lack of Efficacy|0|||
46737647|NCT00586690|82954582|FG000|Overall Study|Lab can't accommodate|1|||
46737648|NCT00586690|82954583|FG001|Overall Study|Lab can't accommodate|0|||
46737649|NCT00976820|82954592|FG000|Overall Study|Lost to Follow-up|5|||
46737650|NCT00976820|82954593|FG001|Overall Study|Lost to Follow-up|16|||
46737651|NCT00976820|82954594|FG002|Overall Study|Lost to Follow-up|2|||
46737652|NCT00976820|82954595|FG003|Overall Study|Lost to Follow-up|3|||
46737653|NCT00976820|82954592|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
46737654|NCT00976820|82954593|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
46737655|NCT00976820|82954594|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
46737656|NCT00976820|82954595|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
46737657|NCT00976820|82954592|FG000|Overall Study|Withdrawal by Subject|2|||
46737658|NCT00976820|82954593|FG001|Overall Study|Withdrawal by Subject|4|||
46737659|NCT00976820|82954594|FG002|Overall Study|Withdrawal by Subject|1|||
46737660|NCT00976820|82954595|FG003|Overall Study|Withdrawal by Subject|4|||
46737661|NCT00760474|82954646|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
46737662|NCT00760474|82954647|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
46737663|NCT00760474|82954646|FG000|Placebo Washout Period|Other|0|||
46737664|NCT00760474|82954647|FG001|Placebo Washout Period|Other|1|||
46737665|NCT00760474|82954646|FG000|Period 2 (P2)|Lost to Follow-up|1|||
46737666|NCT00760474|82954647|FG001|Period 2 (P2)|Lost to Follow-up|0|||
46737667|NCT00760474|82954646|FG000|Period 2 (P2)|Adverse Event|0|||
46737668|NCT00760474|82954647|FG001|Period 2 (P2)|Adverse Event|1|||
46737669|NCT00975416|82954656|FG000|Overall Study|early discharge from tx|3|||
46737670|NCT00975416|82954657|FG001|Overall Study|early discharge from tx|5|||
46737671|NCT00760084|82954664|FG000|Overall Study|Physician Decision|5|||
46737672|NCT00760084|82954664|FG000|Overall Study|Withdrawal by Subject|2|||
46737673|NCT00760084|82954664|FG000|Overall Study|Progressive Disease|3|||
46737674|NCT00752206|82954670|FG000|Overall Study|Disease progression|8|||
46737675|NCT00752206|82954671|FG001|Overall Study|Disease progression|11|||
46737676|NCT00752206|82954670|FG000|Overall Study|Pregnancy|1|||
46737677|NCT00752206|82954671|FG001|Overall Study|Pregnancy|0|||
46737678|NCT00752128|82954677|FG000|Overall Study|Withdrawal by Subject|4|||
46737679|NCT00976508|82954684|FG000|Overall Study|Death|7|||
46737680|NCT00976508|82954685|FG001|Overall Study|Death|1|||
46737681|NCT00976508|82954684|FG000|Overall Study|Lost to Follow-up|1|||
46737682|NCT00976508|82954685|FG001|Overall Study|Lost to Follow-up|0|||
46737683|NCT00976508|82954684|FG000|Overall Study|Withdrawal by Subject|1|||
46737684|NCT00976508|82954685|FG001|Overall Study|Withdrawal by Subject|0|||
46737685|NCT00976508|82954684|FG000|Overall Study|Disease Progression|4|||
46737686|NCT00976508|82954685|FG001|Overall Study|Disease Progression|4|||
46737687|NCT00976508|82954684|FG000|Overall Study|Subject Enrolled in Hospice|1|||
46737688|NCT00976508|82954685|FG001|Overall Study|Subject Enrolled in Hospice|0|||
46737689|NCT00976508|82954684|FG000|Overall Study|Terminated by the Sponsor|0|||
46737690|NCT00976508|82954685|FG001|Overall Study|Terminated by the Sponsor|1|||
46737691|NCT00973622|82954696|FG000|Overall Study|did not attend MRI|14|||
46737692|NCT00973622|82954697|FG001|Overall Study|did not attend MRI|3|||
46737693|NCT00973622|82954696|FG000|Overall Study|did not pass MRI screen|6|||
46737694|NCT00973622|82954697|FG001|Overall Study|did not pass MRI screen|0|||
46737695|NCT00973622|82954696|FG000|Overall Study|did not complete rTMS sessions|11|||
46737696|NCT00973622|82954697|FG001|Overall Study|did not complete rTMS sessions|2|||
46737697|NCT04044716|82954705|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
46737698|NCT04044716|82954706|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
46737699|NCT04044716|82954707|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
46737700|NCT04044716|82954705|FG000|Overall Study|Lost to Follow-up|2|||
46737701|NCT04044716|82954706|FG001|Overall Study|Lost to Follow-up|3|||
46737702|NCT04044716|82954707|FG002|Overall Study|Lost to Follow-up|0|||
46737703|NCT04041284|82954716|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
46804077|NCT00541970|83023283|FG003|Month 12|Adverse Event|1|||
46804078|NCT00541970|83023280|FG000|Month 12|Protocol Violation|12|||
46804079|NCT00541970|83023281|FG001|Month 12|Protocol Violation|21|||
46804080|NCT00541970|83023282|FG002|Month 12|Protocol Violation|20|||
46737704|NCT04041284|82954717|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
46737705|NCT04041284|82954716|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
46737706|NCT04041284|82954717|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
46737707|NCT04041284|82954716|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
46737708|NCT04041284|82954717|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
46737709|NCT04041284|82954716|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
46737710|NCT04041284|82954717|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
46737711|NCT04041284|82954716|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
46737712|NCT04041284|82954717|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
46737713|NCT04041284|82954716|FG000|DB Phase (12 Weeks)|Other than specified|1|||
46737714|NCT04041284|82954717|FG001|DB Phase (12 Weeks)|Other than specified|0|||
46737715|NCT04041284|82954716|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
46737716|NCT04041284|82954717|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
46737717|NCT04041284|82954716|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
46737718|NCT04041284|82954717|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
46737719|NCT04041284|82954716|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
46737720|NCT04041284|82954717|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
46737721|NCT04041284|82954716|FG000|OL Phase (12 Weeks)|Other than specified|6|||
46737722|NCT04041284|82954717|FG001|OL Phase (12 Weeks)|Other than specified|2|||
46737723|NCT00753454|82954727|FG000|Overall Study|Adverse Event|4|||
46737724|NCT00753454|82954727|FG000|Overall Study|Lack of Efficacy|1|||
46737725|NCT00753454|82954727|FG000|Overall Study|Lost to Follow-up|3|||
46737726|NCT00753454|82954727|FG000|Overall Study|Withdrawal by Subject|5|||
46737727|NCT00753454|82954727|FG000|Overall Study|Investigator Decision|1|||
46737728|NCT00976274|82954733|FG000|Overall Study|Lost to Follow-up|5|||
46737729|NCT00976274|82954734|FG001|Overall Study|Lost to Follow-up|5|||
46737730|NCT00976274|82954733|FG000|Overall Study|Withdrawal by Subject|1|||
46737731|NCT00976274|82954734|FG001|Overall Study|Withdrawal by Subject|1|||
46737732|NCT00976274|82954733|FG000|Overall Study|Physician Decision|1|||
46737733|NCT00976274|82954734|FG001|Overall Study|Physician Decision|2|||
46737734|NCT00759148|82954742|FG000|Overall Study|Adverse Event|1|||
46737735|NCT00759148|82954743|FG001|Overall Study|Adverse Event|6|||
46737736|NCT00759148|82954742|FG000|Overall Study|Withdrawal by Subject|3|||
46737737|NCT00759148|82954743|FG001|Overall Study|Withdrawal by Subject|7|||
46737738|NCT00759148|82954742|FG000|Overall Study|Lost to Follow-up|3|||
46737739|NCT00759148|82954743|FG001|Overall Study|Lost to Follow-up|9|||
46737740|NCT00759148|82954742|FG000|Overall Study|Treatment Failure|6|||
46737741|NCT00759148|82954743|FG001|Overall Study|Treatment Failure|10|||
46737742|NCT00759148|82954742|FG000|Overall Study|Reason not given|1|||
46737743|NCT00759148|82954743|FG001|Overall Study|Reason not given|0|||
46737744|NCT02794285|82954753|FG000|Overall Study|Adverse Event|11|||
46737745|NCT02794285|82954754|FG001|Overall Study|Adverse Event|4|||
46737746|NCT02794285|82954755|FG002|Overall Study|Adverse Event|5|||
46737747|NCT02794285|82954756|FG003|Overall Study|Adverse Event|8|||
46737748|NCT02794285|82954753|FG000|Overall Study|Condition Under Investigation Improved|1|||
46737749|NCT02794285|82954754|FG001|Overall Study|Condition Under Investigation Improved|0|||
46737750|NCT02794285|82954755|FG002|Overall Study|Condition Under Investigation Improved|0|||
46737751|NCT02794285|82954756|FG003|Overall Study|Condition Under Investigation Improved|0|||
46737752|NCT02794285|82954753|FG000|Overall Study|Condition Under Investigation Worsened|0|||
46737753|NCT02794285|82954754|FG001|Overall Study|Condition Under Investigation Worsened|2|||
46737754|NCT02794285|82954755|FG002|Overall Study|Condition Under Investigation Worsened|1|||
46737755|NCT02794285|82954756|FG003|Overall Study|Condition Under Investigation Worsened|0|||
46737756|NCT02794285|82954753|FG000|Overall Study|Death|2|||
46737757|NCT02794285|82954754|FG001|Overall Study|Death|1|||
46737758|NCT02794285|82954755|FG002|Overall Study|Death|2|||
46737759|NCT02794285|82954756|FG003|Overall Study|Death|0|||
46737760|NCT02794285|82954753|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
46737761|NCT02794285|82954754|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
46737762|NCT02794285|82954755|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
46737763|NCT02794285|82954756|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
46737764|NCT02794285|82954753|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
46737765|NCT02794285|82954754|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
46737766|NCT02794285|82954755|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
46737767|NCT02794285|82954756|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
46737768|NCT02794285|82954753|FG000|Overall Study|Lack of Efficacy|10|||
46737769|NCT02794285|82954754|FG001|Overall Study|Lack of Efficacy|6|||
46737770|NCT02794285|82954755|FG002|Overall Study|Lack of Efficacy|3|||
46737771|NCT02794285|82954756|FG003|Overall Study|Lack of Efficacy|3|||
46737772|NCT02794285|82954753|FG000|Overall Study|Lost to Follow-up|5|||
46737773|NCT02794285|82954754|FG001|Overall Study|Lost to Follow-up|6|||
47049823|NCT01739348|83310336|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
47049824|NCT01739348|83310337|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
47049825|NCT01739348|83310338|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
47049826|NCT01739348|83310335|FG000|Part II (Extension Study)|Participant Moved|3|||
47049827|NCT01739348|83310336|FG001|Part II (Extension Study)|Participant Moved|3|||
47049828|NCT01739348|83310337|FG002|Part II (Extension Study)|Participant Moved|0|||
47049829|NCT01739348|83310338|FG003|Part II (Extension Study)|Participant Moved|3|||
47049830|NCT01739348|83310335|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
46737774|NCT02794285|82954755|FG002|Overall Study|Lost to Follow-up|3|||
46737775|NCT02794285|82954756|FG003|Overall Study|Lost to Follow-up|1|||
46737776|NCT02794285|82954753|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
46737777|NCT02794285|82954754|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
46737778|NCT02794285|82954755|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
46737779|NCT02794285|82954756|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
46737780|NCT02794285|82954753|FG000|Overall Study|Withdrawal by Subject|38|||
46737781|NCT02794285|82954754|FG001|Overall Study|Withdrawal by Subject|29|||
46737782|NCT02794285|82954755|FG002|Overall Study|Withdrawal by Subject|20|||
46737783|NCT02794285|82954756|FG003|Overall Study|Withdrawal by Subject|12|||
46737784|NCT02794285|82954753|FG000|Overall Study|Missing|1|||
46737785|NCT02794285|82954754|FG001|Overall Study|Missing|0|||
46737786|NCT02794285|82954755|FG002|Overall Study|Missing|0|||
46737787|NCT02794285|82954756|FG003|Overall Study|Missing|0|||
46737788|NCT02794285|82954753|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
46737789|NCT02794285|82954754|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
46737790|NCT02794285|82954755|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
46737791|NCT02794285|82954756|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
46737792|NCT02794285|82954753|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
46737793|NCT02794285|82954754|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
46737794|NCT02794285|82954755|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
46737795|NCT02794285|82954756|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
46737796|NCT00970268|82954768|FG000|Overall Study|Withdrawal by Subject|12|||
46737797|NCT00970268|82954769|FG001|Overall Study|Withdrawal by Subject|19|||
46737798|NCT00970268|82954768|FG000|Overall Study|Adverse Event|15|||
46737799|NCT00970268|82954769|FG001|Overall Study|Adverse Event|12|||
46737800|NCT00970268|82954768|FG000|Overall Study|Lack of Efficacy|3|||
46737801|NCT00970268|82954769|FG001|Overall Study|Lack of Efficacy|6|||
46737802|NCT00970268|82954768|FG000|Overall Study|Protocol Violation|4|||
46737803|NCT00970268|82954769|FG001|Overall Study|Protocol Violation|7|||
46737804|NCT00970268|82954768|FG000|Overall Study|Other Reason|3|||
46737805|NCT00970268|82954769|FG001|Overall Study|Other Reason|1|||
46737806|NCT00970268|82954768|FG000|Overall Study|COPD Exacerbation|4|||
46737807|NCT00970268|82954769|FG001|Overall Study|COPD Exacerbation|2|||
46737808|NCT00970268|82954768|FG000|Overall Study|Lost to Follow-up|1|||
46737809|NCT00970268|82954769|FG001|Overall Study|Lost to Follow-up|2|||
46737810|NCT00970268|82954768|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
46737811|NCT00970268|82954769|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
46737812|NCT00969332|82954781|FG000|Overall Study|Physician Decision|8|||
46737813|NCT00969332|82954781|FG000|Overall Study|Withdrawal by Subject|3|||
46737814|NCT00968864|82954786|FG000|Overall Study|Protocol exception/ not evaluable|1|||
46737815|NCT00758680|82954795|FG000|Overall Study|Adverse Event|0|||
46737816|NCT00758680|82954796|FG001|Overall Study|Adverse Event|0|||
46737817|NCT00758680|82954797|FG002|Overall Study|Adverse Event|0|||
46737818|NCT00758680|82954798|FG003|Overall Study|Adverse Event|0|||
46737819|NCT00758680|82954799|FG004|Overall Study|Adverse Event|0|||
46737820|NCT00758680|82954800|FG005|Overall Study|Adverse Event|0|||
46737821|NCT00758680|82954801|FG006|Overall Study|Adverse Event|0|||
46737822|NCT00758680|82954802|FG007|Overall Study|Adverse Event|1|||
46737823|NCT00758680|82954803|FG008|Overall Study|Adverse Event|0|||
46737824|NCT00758680|82954804|FG009|Overall Study|Adverse Event|1|||
46737825|NCT00758680|82954795|FG000|Overall Study|Laboratory Adverse Event|0|||
46737826|NCT00758680|82954796|FG001|Overall Study|Laboratory Adverse Event|0|||
46737827|NCT00758680|82954797|FG002|Overall Study|Laboratory Adverse Event|0|||
46737828|NCT00758680|82954798|FG003|Overall Study|Laboratory Adverse Event|0|||
46737829|NCT00758680|82954799|FG004|Overall Study|Laboratory Adverse Event|0|||
46737830|NCT00758680|82954800|FG005|Overall Study|Laboratory Adverse Event|0|||
46737831|NCT00758680|82954801|FG006|Overall Study|Laboratory Adverse Event|0|||
46737832|NCT00758680|82954802|FG007|Overall Study|Laboratory Adverse Event|0|||
46737833|NCT00758680|82954803|FG008|Overall Study|Laboratory Adverse Event|1|||
46737834|NCT00758680|82954804|FG009|Overall Study|Laboratory Adverse Event|0|||
46737835|NCT00758680|82954795|FG000|Overall Study|Withdrawal by Subject|0|||
46737836|NCT00758680|82954796|FG001|Overall Study|Withdrawal by Subject|0|||
46737837|NCT00758680|82954797|FG002|Overall Study|Withdrawal by Subject|0|||
46737838|NCT00758680|82954798|FG003|Overall Study|Withdrawal by Subject|0|||
46737839|NCT00758680|82954799|FG004|Overall Study|Withdrawal by Subject|0|||
46737840|NCT00758680|82954800|FG005|Overall Study|Withdrawal by Subject|0|||
46737841|NCT00758680|82954801|FG006|Overall Study|Withdrawal by Subject|1|||
46737842|NCT00758680|82954802|FG007|Overall Study|Withdrawal by Subject|0|||
46737843|NCT00758680|82954803|FG008|Overall Study|Withdrawal by Subject|1|||
46737844|NCT00758680|82954804|FG009|Overall Study|Withdrawal by Subject|0|||
46737845|NCT00758602|82954829|FG000|Overall Study|Adverse Event|11|||
46737846|NCT00758602|82954830|FG001|Overall Study|Adverse Event|10|||
46737847|NCT00758602|82954829|FG000|Overall Study|Lost to Follow-up|4|||
46737848|NCT00758602|82954830|FG001|Overall Study|Lost to Follow-up|3|||
46737849|NCT00758602|82954829|FG000|Overall Study|Withdrawal by Subject|1|||
46737850|NCT00758602|82954830|FG001|Overall Study|Withdrawal by Subject|3|||
46737851|NCT00758602|82954829|FG000|Overall Study|Protocol Violation|0|||
46737852|NCT00758602|82954830|FG001|Overall Study|Protocol Violation|2|||
46737853|NCT00758602|82954829|FG000|Overall Study|Death|0|||
46737854|NCT00758602|82954830|FG001|Overall Study|Death|1|||
46737855|NCT00758602|82954829|FG000|Overall Study|Reason not specified|3|||
46737856|NCT00758602|82954830|FG001|Overall Study|Reason not specified|3|||
46737857|NCT00711529|82954839|FG000|Overall Study|Protocol Violation|2|||
47049831|NCT01739348|83310336|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
47049832|NCT01739348|83310337|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
47049833|NCT01739348|83310338|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
47049834|NCT01739348|83310335|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
47049835|NCT01739348|83310336|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
47049836|NCT01739348|83310337|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
46737858|NCT00711529|82954840|FG001|Overall Study|Protocol Violation|0|||
46737859|NCT00711529|82954839|FG000|Overall Study|Withdrawal by Subject|2|||
46737860|NCT00711529|82954840|FG001|Overall Study|Withdrawal by Subject|6|||
46737861|NCT00601419|82954846|FG000|Overall Study|Lost to Follow-up|3|||
46737862|NCT00601419|82954846|FG000|Overall Study|Missed Visits|1|||
46737863|NCT00712933|82954866|FG000|Overall Study|Adverse Event|69|||
46737864|NCT00712933|82954866|FG000|Overall Study|Lack of Efficacy|6|||
46737865|NCT00712933|82954866|FG000|Overall Study|Lost to Follow-up|22|||
46737866|NCT00712933|82954866|FG000|Overall Study|Non-compliance with study drug|13|||
46737867|NCT00712933|82954866|FG000|Overall Study|Other Pregnancy|37|||
46737868|NCT00712933|82954866|FG000|Overall Study|Sponsor decision|14|||
46737869|NCT00712933|82954866|FG000|Overall Study|Withdrew consent|4|||
46737870|NCT00712933|82954866|FG000|Overall Study|Hip replacement surgery|1|||
46737871|NCT00712933|82954866|FG000|Overall Study|Involved in Clinical research|3|||
46737872|NCT00712933|82954866|FG000|Overall Study|Participant hospitalized|1|||
46737873|NCT00712933|82954866|FG000|Overall Study|Participant travelled overseas|2|||
46737874|NCT00712933|82954866|FG000|Overall Study|Death of patient|1|||
46737875|NCT00712933|82954866|FG000|Overall Study|Other Physician decision|1|||
46737876|NCT00712933|82954866|FG000|Overall Study|Not committed to contraception|1|||
46737877|NCT00712933|82954866|FG000|Overall Study|Participant received medication|1|||
46737878|NCT00712933|82954866|FG000|Overall Study|Physician Decision|36|||
46737879|NCT00712933|82954866|FG000|Overall Study|Protocol Violation|4|||
46737880|NCT00712933|82954866|FG000|Overall Study|Withdrawal by Subject|151|||
46737881|NCT00712543|82954876|FG000|Day 8-14|Lost to Follow-up|0|||
46737882|NCT00712543|82954877|FG001|Day 8-14|Lost to Follow-up|2|||
46737883|NCT00709111|82954883|FG000|Overall Study|Withdrawal by Subject|1|||
46737884|NCT00709111|82954883|FG000|Overall Study|Unable to attend clinic visits|1|||
46737885|NCT00710749|82954887|FG000|First Intervention|Withdrawal by Subject|1|||
46737886|NCT00710749|82954888|FG001|First Intervention|Withdrawal by Subject|0|||
46737887|NCT00699907|82954899|FG000|Overall Study|Withdrawal by Subject|2|||
46737888|NCT00699907|82954900|FG001|Overall Study|Withdrawal by Subject|1|||
46737889|NCT00699907|82954901|FG002|Overall Study|Withdrawal by Subject|0|||
46737890|NCT00699907|82954899|FG000|Overall Study|No usable sample|0|||
46737891|NCT00699907|82954900|FG001|Overall Study|No usable sample|9|||
46737892|NCT00699907|82954901|FG002|Overall Study|No usable sample|8|||
46737893|NCT00710593|82954911|FG000|Overall Study|Incarceration|1|||
46737894|NCT00710593|82954912|FG001|Overall Study|Incarceration|0|||
46737895|NCT00710593|82954911|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
46737896|NCT00710593|82954912|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
46737897|NCT00710593|82954911|FG000|Overall Study|Lost to Follow-up|3|||
46737898|NCT00710593|82954912|FG001|Overall Study|Lost to Follow-up|1|||
46737899|NCT00710593|82954911|FG000|Overall Study|Moved out of area|1|||
46737900|NCT00710593|82954912|FG001|Overall Study|Moved out of area|0|||
47049837|NCT01739348|83310338|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
47049838|NCT01738646|83310370|FG000|Overall Study|Still Receiving Treatment|2|||
47049839|NCT01716104|83310377|FG000|Overall Study|Do not meet inclusion criteria|6|||
47049840|NCT01716104|83310378|FG001|Overall Study|Do not meet inclusion criteria|7|||
47049841|NCT04426695|83310458|FG000|Overall Study|Death|2|||
47049842|NCT04426695|83310459|FG001|Overall Study|Death|0|||
47049843|NCT04426695|83310460|FG002|Overall Study|Death|1|||
47049844|NCT04426695|83310461|FG003|Overall Study|Death|27|||
47049845|NCT04426695|83310462|FG004|Overall Study|Death|25|||
47049846|NCT04426695|83310463|FG005|Overall Study|Death|21|||
47049847|NCT04426695|83310464|FG006|Overall Study|Death|42|||
47049848|NCT04426695|83310465|FG007|Overall Study|Death|23|||
46737901|NCT00710593|82954911|FG000|Overall Study|Failure to adhere or complete study eval|1|||
46737902|NCT00710593|82954912|FG001|Overall Study|Failure to adhere or complete study eval|1|||
46737903|NCT00710593|82954911|FG000|Overall Study|Protocol Violation|1|||
46737904|NCT00710593|82954912|FG001|Overall Study|Protocol Violation|1|||
46737905|NCT00710593|82954911|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
46737906|NCT00710593|82954912|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
46737907|NCT00599313|82954934|FG000|Overall Study|Adverse Event|19|||
46737908|NCT00599313|82954934|FG000|Overall Study|Disease Progression|12|||
47049849|NCT04426695|83310466|FG008|Overall Study|Death|37|||
47049850|NCT04426695|83310467|FG009|Overall Study|Death|14|||
46737909|NCT00599313|82954934|FG000|Overall Study|Patient Request|4|||
46737910|NCT00599313|82954934|FG000|Overall Study|Ineligible|1|||
47049851|NCT04426695|83310468|FG010|Overall Study|Death|8|||
47049852|NCT04426695|83310469|FG011|Overall Study|Death|7|||
47049853|NCT04426695|83310470|FG012|Overall Study|Death|13|||
47049854|NCT04426695|83310471|FG013|Overall Study|Death|25|||
47049855|NCT04426695|83310472|FG014|Overall Study|Death|19|||
47049856|NCT04426695|83310473|FG015|Overall Study|Death|7|||
47049857|NCT04426695|83310474|FG016|Overall Study|Death|8|||
47049858|NCT04426695|83310475|FG017|Overall Study|Death|4|||
47049859|NCT04426695|83310458|FG000|Overall Study|Lost to Follow-up|2|||
47049860|NCT04426695|83310459|FG001|Overall Study|Lost to Follow-up|4|||
47049861|NCT04426695|83310460|FG002|Overall Study|Lost to Follow-up|1|||
47049862|NCT04426695|83310461|FG003|Overall Study|Lost to Follow-up|19|||
47049863|NCT04426695|83310462|FG004|Overall Study|Lost to Follow-up|10|||
46737911|NCT00708175|82954940|FG000|Overall Study|Adverse Event|4|||
46737912|NCT00708175|82954941|FG001|Overall Study|Adverse Event|5|||
46737913|NCT00708175|82954940|FG000|Overall Study|Protocol Violation|2|||
46737914|NCT00708175|82954941|FG001|Overall Study|Protocol Violation|3|||
46737915|NCT00708175|82954940|FG000|Overall Study|Lost to Follow-up|5|||
46737916|NCT00708175|82954941|FG001|Overall Study|Lost to Follow-up|3|||
46737917|NCT00708175|82954940|FG000|Overall Study|Withdrawal by Subject|5|||
46737918|NCT00708175|82954941|FG001|Overall Study|Withdrawal by Subject|7|||
46737919|NCT00708175|82954940|FG000|Overall Study|BMD loss >7%|2|||
46737920|NCT00708175|82954941|FG001|Overall Study|BMD loss >7%|3|||
46737921|NCT00707239|82954950|FG000|Overall Study|Adverse Event|5|||
46737922|NCT00707239|82954951|FG001|Overall Study|Adverse Event|3|||
46737923|NCT00707239|82954952|FG002|Overall Study|Adverse Event|2|||
46737924|NCT00707239|82954950|FG000|Overall Study|Death|3|||
46737925|NCT00707239|82954951|FG001|Overall Study|Death|1|||
46737926|NCT00707239|82954952|FG002|Overall Study|Death|3|||
46737927|NCT00707239|82954950|FG000|Overall Study|Physician Decision|1|||
46737928|NCT00707239|82954951|FG001|Overall Study|Physician Decision|1|||
46737929|NCT00707239|82954952|FG002|Overall Study|Physician Decision|2|||
46737930|NCT00707239|82954950|FG000|Overall Study|Protocol Violation|0|||
46737931|NCT00707239|82954951|FG001|Overall Study|Protocol Violation|0|||
46737932|NCT00707239|82954952|FG002|Overall Study|Protocol Violation|1|||
46737933|NCT00707239|82954950|FG000|Overall Study|Lack of Efficacy|1|||
46737934|NCT00707239|82954951|FG001|Overall Study|Lack of Efficacy|2|||
46737935|NCT00707239|82954952|FG002|Overall Study|Lack of Efficacy|0|||
46737936|NCT00707239|82954950|FG000|Overall Study|Randomized, but not treated|1|||
46737937|NCT00707239|82954951|FG001|Overall Study|Randomized, but not treated|1|||
46737938|NCT00707239|82954952|FG002|Overall Study|Randomized, but not treated|1|||
46737939|NCT00707239|82954950|FG000|Overall Study|Other|8|||
47049864|NCT04426695|83310463|FG005|Overall Study|Lost to Follow-up|14|||
47049865|NCT04426695|83310464|FG006|Overall Study|Lost to Follow-up|5|||
47049866|NCT04426695|83310465|FG007|Overall Study|Lost to Follow-up|14|||
47049867|NCT04426695|83310466|FG008|Overall Study|Lost to Follow-up|10|||
47049868|NCT04426695|83310467|FG009|Overall Study|Lost to Follow-up|11|||
47049869|NCT04426695|83310468|FG010|Overall Study|Lost to Follow-up|12|||
47049870|NCT04426695|83310469|FG011|Overall Study|Lost to Follow-up|6|||
47049871|NCT04426695|83310470|FG012|Overall Study|Lost to Follow-up|2|||
47049872|NCT04426695|83310471|FG013|Overall Study|Lost to Follow-up|2|||
47049873|NCT04426695|83310472|FG014|Overall Study|Lost to Follow-up|2|||
47049874|NCT04426695|83310473|FG015|Overall Study|Lost to Follow-up|0|||
47049875|NCT04426695|83310474|FG016|Overall Study|Lost to Follow-up|0|||
47049876|NCT04426695|83310475|FG017|Overall Study|Lost to Follow-up|0|||
47049877|NCT04426695|83310458|FG000|Overall Study|Participant Decision|1|||
47049878|NCT04426695|83310459|FG001|Overall Study|Participant Decision|2|||
47049879|NCT04426695|83310460|FG002|Overall Study|Participant Decision|2|||
47049880|NCT04426695|83310461|FG003|Overall Study|Participant Decision|12|||
47049881|NCT04426695|83310462|FG004|Overall Study|Participant Decision|18|||
46635293|NCT01563354|82808930|FG000|Core Phase|Adverse Event|5|||
46737940|NCT00707239|82954951|FG001|Overall Study|Other|3|||
46737941|NCT00707239|82954952|FG002|Overall Study|Other|5|||
46737942|NCT00968708|82954965|FG000|Overall Study|Adverse Event|169|||
46737943|NCT00968708|82954966|FG001|Overall Study|Adverse Event|150|||
46921739|NCT03911713|83154389|FG001|Overall Study|Other|0|||
47049882|NCT04426695|83310463|FG005|Overall Study|Participant Decision|22|||
47049883|NCT04426695|83310464|FG006|Overall Study|Participant Decision|13|||
47049884|NCT04426695|83310465|FG007|Overall Study|Participant Decision|13|||
46737944|NCT00968708|82954965|FG000|Overall Study|Major Protocol Deviation|0|||
46737945|NCT00968708|82954966|FG001|Overall Study|Major Protocol Deviation|1|||
46737946|NCT00968708|82954965|FG000|Overall Study|Lost to Follow-up|19|||
46737947|NCT00968708|82954966|FG001|Overall Study|Lost to Follow-up|11|||
46737948|NCT00968708|82954965|FG000|Overall Study|Voluntary Withdrawal|104|||
46737949|NCT00968708|82954966|FG001|Overall Study|Voluntary Withdrawal|101|||
47049885|NCT04426695|83310466|FG008|Overall Study|Participant Decision|10|||
47049886|NCT04426695|83310467|FG009|Overall Study|Participant Decision|15|||
47049887|NCT04426695|83310468|FG010|Overall Study|Participant Decision|16|||
47049888|NCT04426695|83310469|FG011|Overall Study|Participant Decision|17|||
47049889|NCT04426695|83310470|FG012|Overall Study|Participant Decision|2|||
47049890|NCT04426695|83310471|FG013|Overall Study|Participant Decision|1|||
47049891|NCT04426695|83310472|FG014|Overall Study|Participant Decision|2|||
46635294|NCT01563354|82808931|FG001|Core Phase|Adverse Event|15|||
46635295|NCT01563354|82808932|FG002|Core Phase|Adverse Event|13|||
46635296|NCT01563354|82808930|FG000|Core Phase|Withdrawal by Subject|1|||
46635297|NCT01563354|82808931|FG001|Core Phase|Withdrawal by Subject|0|||
46635298|NCT01563354|82808932|FG002|Core Phase|Withdrawal by Subject|3|||
46635299|NCT01563354|82808930|FG000|Core Phase|Lost to Follow-up|1|||
46635300|NCT01563354|82808931|FG001|Core Phase|Lost to Follow-up|0|||
46635301|NCT01563354|82808932|FG002|Core Phase|Lost to Follow-up|0|||
46635302|NCT01563354|82808930|FG000|Core Phase|Death|1|||
46635303|NCT01563354|82808931|FG001|Core Phase|Death|5|||
46635304|NCT01563354|82808932|FG002|Core Phase|Death|2|||
46635305|NCT01563354|82808930|FG000|Core Phase|Diseasse progression|18|||
46635306|NCT01563354|82808931|FG001|Core Phase|Diseasse progression|7|||
46635307|NCT01563354|82808932|FG002|Core Phase|Diseasse progression|8|||
46635308|NCT01563354|82808930|FG000|Core Phase|Protocol deviation|2|||
46635309|NCT01563354|82808931|FG001|Core Phase|Protocol deviation|0|||
46635310|NCT01563354|82808932|FG002|Core Phase|Protocol deviation|0|||
46635311|NCT01563354|82808930|FG000|Core Phase|PI decision - did not enter extension|0|||
46635312|NCT01563354|82808931|FG001|Core Phase|PI decision - did not enter extension|1|||
46635313|NCT01563354|82808932|FG002|Core Phase|PI decision - did not enter extension|0|||
46635314|NCT01563354|82808930|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
46921740|NCT03911713|83154390|FG002|Overall Study|Other|0|||
46921741|NCT03911713|83154391|FG003|Overall Study|Other|1|||
46921742|NCT03911713|83154392|FG004|Overall Study|Other|0|||
46921743|NCT03911713|83154388|FG000|Overall Study|Randomized, Never Dosed|1|||
46921744|NCT03911713|83154389|FG001|Overall Study|Randomized, Never Dosed|0|||
46921745|NCT03911713|83154390|FG002|Overall Study|Randomized, Never Dosed|0|||
46921746|NCT03911713|83154391|FG003|Overall Study|Randomized, Never Dosed|1|||
46635315|NCT01563354|82808931|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
46635316|NCT01563354|82808932|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
46635317|NCT01563354|82808930|FG000|Extension Phase|Adverse Event|0|||
46635318|NCT01563354|82808931|FG001|Extension Phase|Adverse Event|3|||
46635319|NCT01563354|82808932|FG002|Extension Phase|Adverse Event|2|||
46635320|NCT01563354|82808930|FG000|Extension Phase|Withdrawal by Subject|0|||
46635321|NCT01563354|82808931|FG001|Extension Phase|Withdrawal by Subject|1|||
46635322|NCT01563354|82808932|FG002|Extension Phase|Withdrawal by Subject|0|||
46635323|NCT01563354|82808930|FG000|Extension Phase|Administration problems|3|||
46635324|NCT01563354|82808931|FG001|Extension Phase|Administration problems|2|||
46635325|NCT01563354|82808932|FG002|Extension Phase|Administration problems|3|||
46737950|NCT00968708|82954965|FG000|Overall Study|Investigator Discretion|0|||
46737951|NCT00968708|82954966|FG001|Overall Study|Investigator Discretion|1|||
46737952|NCT00968708|82954965|FG000|Overall Study|Other|26|||
46921747|NCT03911713|83154392|FG004|Overall Study|Randomized, Never Dosed|0|||
46921748|NCT03065023|83154410|FG000|Overall Study|Progressive Disease|0|||
46921749|NCT03065023|83154411|FG001|Overall Study|Progressive Disease|1|||
46921750|NCT03065023|83154412|FG002|Overall Study|Progressive Disease|0|||
46921751|NCT03065023|83154413|FG003|Overall Study|Progressive Disease|0|||
46921752|NCT03065023|83154414|FG004|Overall Study|Progressive Disease|0|||
46921753|NCT03065023|83154410|FG000|Overall Study|Death|2|||
46921754|NCT03065023|83154411|FG001|Overall Study|Death|0|||
46921755|NCT03065023|83154412|FG002|Overall Study|Death|1|||
46921756|NCT03065023|83154413|FG003|Overall Study|Death|1|||
46921757|NCT03065023|83154414|FG004|Overall Study|Death|0|||
46921758|NCT03065023|83154410|FG000|Overall Study|Lost to Follow-up|0|||
46921759|NCT03065023|83154411|FG001|Overall Study|Lost to Follow-up|1|||
46921760|NCT03065023|83154412|FG002|Overall Study|Lost to Follow-up|0|||
46921761|NCT03065023|83154413|FG003|Overall Study|Lost to Follow-up|0|||
46921762|NCT03065023|83154414|FG004|Overall Study|Lost to Follow-up|0|||
46921763|NCT03065023|83154410|FG000|Overall Study|Participant Decision|0|||
46921764|NCT03065023|83154411|FG001|Overall Study|Participant Decision|0|||
46921765|NCT03065023|83154412|FG002|Overall Study|Participant Decision|0|||
46921766|NCT03065023|83154413|FG003|Overall Study|Participant Decision|1|||
47049892|NCT04426695|83310473|FG015|Overall Study|Participant Decision|0|||
46635326|NCT01563354|82808930|FG000|Extension Phase|Disease progression|9|||
46635327|NCT01563354|82808931|FG001|Extension Phase|Disease progression|8|||
46635328|NCT01563354|82808932|FG002|Extension Phase|Disease progression|10|||
46635329|NCT01588548|82808946|FG000|Overall Study|Withdrawal by Subject|0|||
46635330|NCT01588548|82808947|FG001|Overall Study|Withdrawal by Subject|1|||
46635331|NCT01588548|82808948|FG002|Overall Study|Withdrawal by Subject|1|||
46635332|NCT01588548|82808949|FG003|Overall Study|Withdrawal by Subject|1|||
46921767|NCT03065023|83154414|FG004|Overall Study|Participant Decision|0|||
46921768|NCT03065023|83154410|FG000|Overall Study|Withdrawal by Subject|0|||
46921769|NCT03065023|83154411|FG001|Overall Study|Withdrawal by Subject|0|||
46921770|NCT03065023|83154412|FG002|Overall Study|Withdrawal by Subject|0|||
46921771|NCT03065023|83154413|FG003|Overall Study|Withdrawal by Subject|1|||
46921772|NCT03065023|83154414|FG004|Overall Study|Withdrawal by Subject|0|||
46737953|NCT00968708|82954966|FG001|Overall Study|Other|34|||
46737954|NCT00967694|82954972|FG000|Overall Study|Withdrawal by Subject|6|||
46737955|NCT00967616|82954978|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
47049893|NCT04426695|83310474|FG016|Overall Study|Participant Decision|0|||
47049894|NCT04426695|83310475|FG017|Overall Study|Participant Decision|0|||
47049895|NCT04426695|83310458|FG000|Overall Study|Adverse Event|0|||
47049896|NCT04426695|83310459|FG001|Overall Study|Adverse Event|0|||
47049897|NCT04426695|83310460|FG002|Overall Study|Adverse Event|0|||
46737956|NCT00967616|82954979|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
46737957|NCT00967616|82954978|FG000|Overall Study|Death|0|||
46737958|NCT00967616|82954979|FG001|Overall Study|Death|3|||
46737959|NCT00967616|82954978|FG000|Overall Study|Withdrawal by Subject|8|||
46737960|NCT00967616|82954979|FG001|Overall Study|Withdrawal by Subject|4|||
46737961|NCT00967616|82954978|FG000|Overall Study|Progressive Disease|31|||
46737962|NCT00967616|82954979|FG001|Overall Study|Progressive Disease|18|||
46737963|NCT00967616|82954978|FG000|Overall Study|Other|8|||
46737964|NCT00967616|82954979|FG001|Overall Study|Other|8|||
46737965|NCT00967616|82954978|FG000|Overall Study|Protocol Violation|1|||
46737966|NCT00967616|82954979|FG001|Overall Study|Protocol Violation|0|||
46737967|NCT00971204|82954989|FG000|Overall Study|Did not meet all criteria-not treated|14|||
46737968|NCT00971204|82954989|FG000|Overall Study|Lost to Follow-up|10|||
46737969|NCT00974090|82954995|FG000|Period 1: Double Blind Period|Adverse Event|2|||
46737970|NCT00974090|82954996|FG001|Period 1: Double Blind Period|Adverse Event|1|||
46737971|NCT00974090|82954995|FG000|Period 1: Double Blind Period|Physician Decision|1|||
46737972|NCT00974090|82954996|FG001|Period 1: Double Blind Period|Physician Decision|0|||
46737973|NCT00974090|82954995|FG000|Period 2: Open-label Period|Adverse Event|4|||
46737974|NCT00974090|82954996|FG001|Period 2: Open-label Period|Adverse Event|6|||
46737975|NCT00974090|82954995|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
47049898|NCT04426695|83310461|FG003|Overall Study|Adverse Event|0|||
47049899|NCT04426695|83310462|FG004|Overall Study|Adverse Event|0|||
47049900|NCT04426695|83310463|FG005|Overall Study|Adverse Event|0|||
47049901|NCT04426695|83310464|FG006|Overall Study|Adverse Event|0|||
47049902|NCT04426695|83310465|FG007|Overall Study|Adverse Event|1|||
47049903|NCT04426695|83310466|FG008|Overall Study|Adverse Event|0|||
47049904|NCT04426695|83310467|FG009|Overall Study|Adverse Event|0|||
47049905|NCT04426695|83310468|FG010|Overall Study|Adverse Event|1|||
47049906|NCT04426695|83310469|FG011|Overall Study|Adverse Event|1|||
47049907|NCT04426695|83310470|FG012|Overall Study|Adverse Event|0|||
47049908|NCT04426695|83310471|FG013|Overall Study|Adverse Event|0|||
47049909|NCT04426695|83310472|FG014|Overall Study|Adverse Event|0|||
47049910|NCT04426695|83310473|FG015|Overall Study|Adverse Event|0|||
47049911|NCT04426695|83310474|FG016|Overall Study|Adverse Event|0|||
47049912|NCT04426695|83310475|FG017|Overall Study|Adverse Event|0|||
47049913|NCT04426695|83310458|FG000|Overall Study|Sponsor Request|0|||
47049914|NCT04426695|83310459|FG001|Overall Study|Sponsor Request|0|||
47049915|NCT04426695|83310460|FG002|Overall Study|Sponsor Request|0|||
47049916|NCT04426695|83310461|FG003|Overall Study|Sponsor Request|0|||
47049917|NCT04426695|83310462|FG004|Overall Study|Sponsor Request|0|||
47049918|NCT04426695|83310463|FG005|Overall Study|Sponsor Request|0|||
47049919|NCT04426695|83310464|FG006|Overall Study|Sponsor Request|1|||
47049920|NCT04426695|83310465|FG007|Overall Study|Sponsor Request|0|||
46635333|NCT01588548|82808950|FG004|Overall Study|Withdrawal by Subject|2|||
46635334|NCT01588548|82808951|FG005|Overall Study|Withdrawal by Subject|3|||
46635335|NCT01588548|82808946|FG000|Overall Study|Adverse Event|0|||
46635336|NCT01588548|82808947|FG001|Overall Study|Adverse Event|0|||
46635337|NCT01588548|82808948|FG002|Overall Study|Adverse Event|1|||
46635338|NCT01588548|82808949|FG003|Overall Study|Adverse Event|2|||
46635339|NCT01588548|82808950|FG004|Overall Study|Adverse Event|1|||
46635340|NCT01588548|82808951|FG005|Overall Study|Adverse Event|0|||
46635341|NCT01588548|82808946|FG000|Overall Study|Condition Under Investigation Worsened|3|||
46635342|NCT01588548|82808947|FG001|Overall Study|Condition Under Investigation Worsened|6|||
47049921|NCT04426695|83310466|FG008|Overall Study|Sponsor Request|0|||
47049922|NCT04426695|83310467|FG009|Overall Study|Sponsor Request|0|||
47049923|NCT04426695|83310468|FG010|Overall Study|Sponsor Request|0|||
47049924|NCT04426695|83310469|FG011|Overall Study|Sponsor Request|0|||
46635343|NCT01588548|82808948|FG002|Overall Study|Condition Under Investigation Worsened|4|||
46635344|NCT01588548|82808949|FG003|Overall Study|Condition Under Investigation Worsened|4|||
46635345|NCT01588548|82808950|FG004|Overall Study|Condition Under Investigation Worsened|3|||
46737976|NCT00974090|82954996|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
46737977|NCT00974090|82954995|FG000|Period 2: Open-label Period|Physician Decision|0|||
46737978|NCT00974090|82954996|FG001|Period 2: Open-label Period|Physician Decision|3|||
46737979|NCT00974090|82954995|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
46737980|NCT00974090|82954996|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
47049925|NCT04426695|83310470|FG012|Overall Study|Sponsor Request|0|||
47049926|NCT04426695|83310471|FG013|Overall Study|Sponsor Request|0|||
46737981|NCT00971048|82955008|FG000|Overall Study|Protocol Violation|1|||
47049927|NCT04426695|83310472|FG014|Overall Study|Sponsor Request|0|||
46737982|NCT00971048|82955009|FG001|Overall Study|Protocol Violation|2|||
46737983|NCT00971048|82955010|FG002|Overall Study|Protocol Violation|0|||
46737984|NCT00971048|82955011|FG003|Overall Study|Protocol Violation|1|||
46737985|NCT00971048|82955008|FG000|Overall Study|Adverse Event|0|||
46737986|NCT00971048|82955009|FG001|Overall Study|Adverse Event|0|||
46737987|NCT00971048|82955010|FG002|Overall Study|Adverse Event|1|||
46737988|NCT00971048|82955011|FG003|Overall Study|Adverse Event|0|||
46737989|NCT00971048|82955008|FG000|Overall Study|Physician Decision|0|||
46737990|NCT00971048|82955009|FG001|Overall Study|Physician Decision|0|||
46737991|NCT00971048|82955010|FG002|Overall Study|Physician Decision|0|||
46737992|NCT00971048|82955011|FG003|Overall Study|Physician Decision|1|||
46737993|NCT00699751|82955025|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
46737994|NCT00699751|82955026|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
46737995|NCT00699751|82955025|FG000|Period 1: Without/Before Drug Switch|Death|28|||
46737996|NCT00699751|82955026|FG001|Period 1: Without/Before Drug Switch|Death|29|||
46737997|NCT00699751|82955025|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
46737998|NCT00699751|82955026|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
46737999|NCT00699751|82955025|FG000|Period 1: Without/Before Drug Switch|Other|30|||
46738000|NCT00699751|82955026|FG001|Period 1: Without/Before Drug Switch|Other|20|||
46738001|NCT00699751|82955025|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
46738002|NCT00699751|82955026|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
46738003|NCT00699751|82955025|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
46738004|NCT00699751|82955026|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
46738005|NCT00699751|82955025|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
46738006|NCT00699751|82955026|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
46738007|NCT00699751|82955025|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
46738008|NCT00699751|82955026|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
46738009|NCT00970502|82955033|FG000|Overall Study|Withdrawal by Subject|1|||
46738010|NCT00967226|82955043|FG000|Overall Study|Adverse Event|0|||
46738011|NCT00967226|82955044|FG001|Overall Study|Adverse Event|5|||
46738012|NCT00967226|82955043|FG000|Overall Study|Protocol Violation|2|||
46738013|NCT00967226|82955044|FG001|Overall Study|Protocol Violation|0|||
46738014|NCT00967226|82955043|FG000|Overall Study|Physician Decision|0|||
46738015|NCT00967226|82955044|FG001|Overall Study|Physician Decision|1|||
46738016|NCT00706381|82955078|FG000|Overall Study|Lost to Follow-up|0|||
46738017|NCT00706381|82955079|FG001|Overall Study|Lost to Follow-up|1|||
46738018|NCT00706381|82955080|FG002|Overall Study|Lost to Follow-up|1|||
46738019|NCT00706381|82955081|FG003|Overall Study|Lost to Follow-up|0|||
46738020|NCT00964886|82955098|FG000|Overall Study|Lost to Follow-up|2|||
46738021|NCT00964886|82955099|FG001|Overall Study|Lost to Follow-up|2|||
46738022|NCT00964886|82955100|FG002|Overall Study|Lost to Follow-up|6|||
46738023|NCT00964886|82955101|FG003|Overall Study|Lost to Follow-up|4|||
46738024|NCT00964886|82955098|FG000|Overall Study|Withdrawal by Subject|6|||
46738025|NCT00964886|82955099|FG001|Overall Study|Withdrawal by Subject|2|||
46738026|NCT00964886|82955100|FG002|Overall Study|Withdrawal by Subject|5|||
46738027|NCT00964886|82955101|FG003|Overall Study|Withdrawal by Subject|3|||
46738028|NCT00964886|82955098|FG000|Overall Study|Adverse Event|3|||
46738029|NCT00964886|82955099|FG001|Overall Study|Adverse Event|1|||
46738030|NCT00964886|82955100|FG002|Overall Study|Adverse Event|5|||
46738031|NCT00964886|82955101|FG003|Overall Study|Adverse Event|2|||
46738032|NCT00964886|82955098|FG000|Overall Study|Protocol Violation|0|||
46738033|NCT00964886|82955099|FG001|Overall Study|Protocol Violation|2|||
46738034|NCT00964886|82955100|FG002|Overall Study|Protocol Violation|0|||
46738035|NCT00964886|82955101|FG003|Overall Study|Protocol Violation|0|||
46738036|NCT00705757|82955118|FG000|Overall Study|Lack of Efficacy|5|||
46738037|NCT00705757|82955119|FG001|Overall Study|Lack of Efficacy|1|||
46738038|NCT00705757|82955120|FG002|Overall Study|Lack of Efficacy|3|||
46738039|NCT00705757|82955118|FG000|Overall Study|Lost to Follow-up|7|||
46738040|NCT00705757|82955119|FG001|Overall Study|Lost to Follow-up|6|||
46738041|NCT00705757|82955120|FG002|Overall Study|Lost to Follow-up|6|||
46738042|NCT00705757|82955118|FG000|Overall Study|Withdrawal by Subject|1|||
46738043|NCT00705757|82955119|FG001|Overall Study|Withdrawal by Subject|1|||
46738044|NCT00705757|82955120|FG002|Overall Study|Withdrawal by Subject|2|||
46921773|NCT03614923|83154427|FG000|Overall Study|Withdrawal by Subject|2|||
46921774|NCT03614923|83154428|FG001|Overall Study|Withdrawal by Subject|1|||
46738045|NCT00960752|82955148|FG000|Overall Study|Adverse Event|0|||
46738046|NCT00960752|82955149|FG001|Overall Study|Adverse Event|0|||
46738047|NCT00960752|82955150|FG002|Overall Study|Adverse Event|1|||
46738048|NCT00960752|82955148|FG000|Overall Study|Progression|0|||
46738049|NCT00960752|82955149|FG001|Overall Study|Progression|0|||
46738050|NCT00960752|82955150|FG002|Overall Study|Progression|1|||
46738051|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
46738052|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
46738053|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
46738054|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738055|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
46738056|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
46738057|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738058|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738059|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738060|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
47049928|NCT04426695|83310473|FG015|Overall Study|Sponsor Request|0|||
47049929|NCT04426695|83310474|FG016|Overall Study|Sponsor Request|0|||
47049930|NCT04426695|83310475|FG017|Overall Study|Sponsor Request|0|||
47049931|NCT04426695|83310458|FG000|Overall Study|Physician Decision|0|||
47049932|NCT04426695|83310459|FG001|Overall Study|Physician Decision|0|||
47049933|NCT04426695|83310460|FG002|Overall Study|Physician Decision|0|||
47049934|NCT04426695|83310461|FG003|Overall Study|Physician Decision|0|||
47049935|NCT04426695|83310462|FG004|Overall Study|Physician Decision|0|||
47049936|NCT04426695|83310463|FG005|Overall Study|Physician Decision|0|||
47049937|NCT04426695|83310464|FG006|Overall Study|Physician Decision|0|||
47049938|NCT04426695|83310465|FG007|Overall Study|Physician Decision|0|||
47049939|NCT04426695|83310466|FG008|Overall Study|Physician Decision|0|||
47049940|NCT04426695|83310467|FG009|Overall Study|Physician Decision|1|||
47049941|NCT04426695|83310468|FG010|Overall Study|Physician Decision|0|||
47049942|NCT04426695|83310469|FG011|Overall Study|Physician Decision|0|||
47049943|NCT04426695|83310470|FG012|Overall Study|Physician Decision|1|||
47049944|NCT04426695|83310471|FG013|Overall Study|Physician Decision|0|||
47049945|NCT04426695|83310472|FG014|Overall Study|Physician Decision|0|||
47049946|NCT04426695|83310473|FG015|Overall Study|Physician Decision|0|||
47049947|NCT04426695|83310474|FG016|Overall Study|Physician Decision|0|||
47049948|NCT04426695|83310475|FG017|Overall Study|Physician Decision|0|||
47049949|NCT04426695|83310458|FG000|Overall Study|Randomized but Never Treated|3|||
47049950|NCT04426695|83310459|FG001|Overall Study|Randomized but Never Treated|1|||
47049951|NCT04426695|83310460|FG002|Overall Study|Randomized but Never Treated|0|||
47049952|NCT04426695|83310461|FG003|Overall Study|Randomized but Never Treated|4|||
47049953|NCT04426695|83310462|FG004|Overall Study|Randomized but Never Treated|5|||
47049954|NCT04426695|83310463|FG005|Overall Study|Randomized but Never Treated|5|||
47049955|NCT04426695|83310464|FG006|Overall Study|Randomized but Never Treated|4|||
47049956|NCT04426695|83310465|FG007|Overall Study|Randomized but Never Treated|6|||
47049957|NCT04426695|83310466|FG008|Overall Study|Randomized but Never Treated|6|||
47049958|NCT04426695|83310467|FG009|Overall Study|Randomized but Never Treated|3|||
47049959|NCT04426695|83310468|FG010|Overall Study|Randomized but Never Treated|3|||
47049960|NCT04426695|83310469|FG011|Overall Study|Randomized but Never Treated|6|||
47049961|NCT04426695|83310470|FG012|Overall Study|Randomized but Never Treated|1|||
47049962|NCT04426695|83310471|FG013|Overall Study|Randomized but Never Treated|2|||
47049963|NCT04426695|83310472|FG014|Overall Study|Randomized but Never Treated|0|||
47049964|NCT04426695|83310473|FG015|Overall Study|Randomized but Never Treated|0|||
47049965|NCT04426695|83310474|FG016|Overall Study|Randomized but Never Treated|0|||
47049966|NCT04426695|83310475|FG017|Overall Study|Randomized but Never Treated|0|||
47049967|NCT01838200|83310552|FG000|Overall Study|Adverse Event|0|||
47049968|NCT01838200|83310553|FG001|Overall Study|Adverse Event|2|||
47049969|NCT01838200|83310552|FG000|Overall Study|Progressive disease|3|||
47049970|NCT01838200|83310553|FG001|Overall Study|Progressive disease|0|||
47049971|NCT03219034|83310596|FG000|Overall Study|Lost to Follow-up|9|||
47049972|NCT03219034|83310597|FG001|Overall Study|Lost to Follow-up|13|||
47049973|NCT03219034|83310596|FG000|Overall Study|Additional dental work needed|1|||
47049974|NCT03219034|83310597|FG001|Overall Study|Additional dental work needed|0|||
47049975|NCT03219034|83310596|FG000|Overall Study|UPPP Surgery|1|||
47049976|NCT03219034|83310597|FG001|Overall Study|UPPP Surgery|0|||
47049977|NCT03219034|83310596|FG000|Overall Study|Dental sensitivity|0|||
47049978|NCT03219034|83310597|FG001|Overall Study|Dental sensitivity|1|||
47049979|NCT03219034|83310596|FG000|Overall Study|Death in family|0|||
47049980|NCT03219034|83310597|FG001|Overall Study|Death in family|1|||
47049981|NCT01706198|83310621|FG000|Overall Study|Adverse Event|12|||
47049982|NCT01706198|83310622|FG001|Overall Study|Adverse Event|15|||
46738061|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738062|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738063|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
47049983|NCT01706198|83310621|FG000|Overall Study|Protocol Violation|7|||
47049984|NCT01706198|83310622|FG001|Overall Study|Protocol Violation|5|||
47049985|NCT01706198|83310621|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
47049986|NCT01706198|83310622|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
47049987|NCT01706198|83310621|FG000|Overall Study|Lost to Follow-up|97|||
47049988|NCT01706198|83310622|FG001|Overall Study|Lost to Follow-up|93|||
47049989|NCT01706198|83310621|FG000|Overall Study|Physician Decision|23|||
47049990|NCT01706198|83310622|FG001|Overall Study|Physician Decision|37|||
47049991|NCT01706198|83310621|FG000|Overall Study|Withdrawal by Subject|23|||
47049992|NCT01706198|83310622|FG001|Overall Study|Withdrawal by Subject|31|||
47049993|NCT01705730|83310628|FG000|Overall Study|Lack of Efficacy|1|||
47049994|NCT01705730|83310628|FG000|Overall Study|Adverse Event|3|||
47049995|NCT01705730|83310628|FG000|Overall Study|Lost to Follow-up|1|||
47049996|NCT01705730|83310628|FG000|Overall Study|Reason not Specified|4|||
47049997|NCT01705652|83310634|FG000|Overall Study|Adverse Event|1|||
47049998|NCT01705652|83310635|FG001|Overall Study|Adverse Event|0|||
47049999|NCT01705652|83310634|FG000|Overall Study|Withdrawal by Subject|1|||
47050000|NCT01705652|83310635|FG001|Overall Study|Withdrawal by Subject|2|||
47050001|NCT01705652|83310634|FG000|Overall Study|non-compliance|1|||
47050002|NCT01705652|83310635|FG001|Overall Study|non-compliance|1|||
46738064|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738065|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738066|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738067|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
46738068|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
46738069|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
47050003|NCT01705574|83310663|FG000|Double-Blind Phase|Lost to Follow-up|12|||
47050004|NCT01705574|83310664|FG001|Double-Blind Phase|Lost to Follow-up|16|||
47050005|NCT01705574|83310665|FG002|Double-Blind Phase|Lost to Follow-up|0|||
47050006|NCT01705574|83310666|FG003|Double-Blind Phase|Lost to Follow-up|0|||
47050007|NCT01705574|83310663|FG000|Double-Blind Phase|Adverse Event|3|||
47050008|NCT01705574|83310664|FG001|Double-Blind Phase|Adverse Event|10|||
47050009|NCT01705574|83310665|FG002|Double-Blind Phase|Adverse Event|0|||
47050010|NCT01705574|83310666|FG003|Double-Blind Phase|Adverse Event|0|||
47050011|NCT01705574|83310663|FG000|Double-Blind Phase|Withdrew Consent|8|||
47050012|NCT01705574|83310664|FG001|Double-Blind Phase|Withdrew Consent|5|||
47050013|NCT01705574|83310665|FG002|Double-Blind Phase|Withdrew Consent|0|||
47050014|NCT01705574|83310666|FG003|Double-Blind Phase|Withdrew Consent|0|||
47050015|NCT01705574|83310663|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
47050016|NCT01705574|83310664|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
47050017|NCT01705574|83310665|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
47050018|NCT01705574|83310666|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
47050019|NCT01705574|83310663|FG000|Double-Blind Phase|Pregnancy|1|||
47050020|NCT01705574|83310664|FG001|Double-Blind Phase|Pregnancy|1|||
47050021|NCT01705574|83310665|FG002|Double-Blind Phase|Pregnancy|0|||
47050022|NCT01705574|83310666|FG003|Double-Blind Phase|Pregnancy|0|||
47050023|NCT01705574|83310663|FG000|Double-Blind Phase|Protocol Violation|1|||
47050024|NCT01705574|83310664|FG001|Double-Blind Phase|Protocol Violation|0|||
47050025|NCT01705574|83310665|FG002|Double-Blind Phase|Protocol Violation|0|||
47050026|NCT01705574|83310666|FG003|Double-Blind Phase|Protocol Violation|0|||
47050027|NCT01705574|83310663|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
47050028|NCT01705574|83310664|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
47050029|NCT01705574|83310665|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
47050030|NCT01705574|83310666|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
47050031|NCT01705574|83310663|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
47050032|NCT01705574|83310664|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
47050033|NCT01705574|83310665|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
47050034|NCT01705574|83310666|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
47050035|NCT01705574|83310663|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
47050036|NCT01705574|83310664|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
47050037|NCT01705574|83310665|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
47050038|NCT01705574|83310666|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
47050039|NCT01705574|83310663|FG000|Open-Label Extension Phase|Adverse Event|3|||
47050040|NCT01705574|83310664|FG001|Open-Label Extension Phase|Adverse Event|0|||
47050041|NCT01705574|83310665|FG002|Open-Label Extension Phase|Adverse Event|0|||
47050042|NCT01705574|83310666|FG003|Open-Label Extension Phase|Adverse Event|1|||
47050043|NCT01705574|83310663|FG000|Open-Label Extension Phase|Death|2|||
47050044|NCT01705574|83310664|FG001|Open-Label Extension Phase|Death|0|||
47050045|NCT01705574|83310665|FG002|Open-Label Extension Phase|Death|1|||
47050046|NCT01705574|83310666|FG003|Open-Label Extension Phase|Death|0|||
47050047|NCT01705574|83310663|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
47050048|NCT01705574|83310664|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
46738070|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
46738071|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
46738072|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
46738073|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
47050049|NCT01705574|83310665|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
47050050|NCT01705574|83310666|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
47050051|NCT01705574|83310663|FG000|Open-Label Extension Phase|Physician Decision|0|||
47050052|NCT01705574|83310664|FG001|Open-Label Extension Phase|Physician Decision|0|||
47050053|NCT01705574|83310665|FG002|Open-Label Extension Phase|Physician Decision|2|||
47050054|NCT01705574|83310666|FG003|Open-Label Extension Phase|Physician Decision|0|||
47050055|NCT01705574|83310663|FG000|Open-Label Extension Phase|Pregnancy|0|||
47050056|NCT01705574|83310664|FG001|Open-Label Extension Phase|Pregnancy|0|||
47050057|NCT01705574|83310665|FG002|Open-Label Extension Phase|Pregnancy|1|||
47050058|NCT01705574|83310666|FG003|Open-Label Extension Phase|Pregnancy|1|||
46738074|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738075|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738076|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738077|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738078|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738079|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738080|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738081|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738082|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738083|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738084|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
46738085|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
46738086|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
46738087|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
46738088|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
46738089|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
46738090|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
46738091|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738092|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738093|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738094|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738095|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738096|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738097|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738098|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738099|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738100|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738101|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
46738102|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738103|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
46738104|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
46738105|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738106|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
46738107|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
46738108|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738109|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738110|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738111|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738112|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738113|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738114|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738115|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738116|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738117|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738118|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
46738119|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738120|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738121|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
46738122|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
47050059|NCT01737710|83310687|FG000|Overall Study|Lost to Follow-up|0|||
47050060|NCT01737710|83310688|FG001|Overall Study|Lost to Follow-up|2|||
47050061|NCT01737710|83310689|FG002|Overall Study|Lost to Follow-up|2|||
47050062|NCT01737710|83310690|FG003|Overall Study|Lost to Follow-up|0|||
47050063|NCT01737710|83310691|FG004|Overall Study|Lost to Follow-up|0|||
47050064|NCT01737710|83310687|FG000|Overall Study|Withdrawal by Subject|1|||
47050065|NCT01737710|83310688|FG001|Overall Study|Withdrawal by Subject|1|||
47050066|NCT01737710|83310689|FG002|Overall Study|Withdrawal by Subject|1|||
47050067|NCT01737710|83310690|FG003|Overall Study|Withdrawal by Subject|0|||
47050068|NCT01737710|83310691|FG004|Overall Study|Withdrawal by Subject|0|||
47050069|NCT01737710|83310687|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
47050070|NCT01737710|83310688|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
46738123|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738124|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738125|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738126|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738127|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738128|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
47050071|NCT01737710|83310689|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
47050072|NCT01737710|83310690|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
47050073|NCT01737710|83310691|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
46738129|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738130|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738131|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738132|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738133|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738134|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738135|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
46738136|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738137|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738138|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738139|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738140|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
46738141|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738142|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738143|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738144|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738145|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738146|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738147|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738148|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738149|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738150|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738151|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738152|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
46738153|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738154|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
46738155|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738156|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738157|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738158|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738159|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738160|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738161|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738162|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738163|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738164|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738165|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738166|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738167|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738168|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738169|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
46738170|NCT00758524|82955164|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738171|NCT00758524|82955165|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
46738172|NCT00758524|82955166|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738173|NCT00758524|82955167|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738174|NCT00758524|82955168|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738175|NCT00758524|82955169|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738176|NCT00758524|82955170|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738177|NCT00758524|82955171|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738178|NCT00758524|82955172|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738179|NCT00758524|82955173|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738180|NCT00758524|82955174|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46921775|NCT03614923|83154429|FG002|Overall Study|Withdrawal by Subject|1|||
46921776|NCT03614923|83154427|FG000|Overall Study|Adverse Event|0|||
46921777|NCT03614923|83154428|FG001|Overall Study|Adverse Event|2|||
46921778|NCT03614923|83154429|FG002|Overall Study|Adverse Event|1|||
46921779|NCT03614923|83154427|FG000|Overall Study|Lost to Follow-up|1|||
46921780|NCT03614923|83154428|FG001|Overall Study|Lost to Follow-up|0|||
46921781|NCT03614923|83154429|FG002|Overall Study|Lost to Follow-up|1|||
46921782|NCT03614923|83154427|FG000|Overall Study|Lack of Efficacy|2|||
46635346|NCT01588548|82808951|FG005|Overall Study|Condition Under Investigation Worsened|3|||
46635347|NCT01587924|82808969|FG000|Overall Study|Adverse Event|0|||
46738181|NCT00758524|82955175|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738182|NCT00758524|82955176|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46921783|NCT03614923|83154428|FG001|Overall Study|Lack of Efficacy|0|||
46921784|NCT03614923|83154429|FG002|Overall Study|Lack of Efficacy|1|||
46921785|NCT03614923|83154427|FG000|Overall Study|Non-compliance|0|||
46738183|NCT00758524|82955177|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738184|NCT00758524|82955178|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738185|NCT00758524|82955179|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738186|NCT00758524|82955180|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
46738187|NCT00758524|82955164|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738188|NCT00758524|82955165|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738189|NCT00758524|82955166|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738190|NCT00758524|82955167|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738191|NCT00758524|82955168|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738192|NCT00758524|82955169|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738193|NCT00758524|82955170|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738194|NCT00758524|82955171|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738195|NCT00758524|82955172|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
46738196|NCT00758524|82955173|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738197|NCT00758524|82955174|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738198|NCT00758524|82955175|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738199|NCT00758524|82955176|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738200|NCT00758524|82955177|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738201|NCT00758524|82955178|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738202|NCT00758524|82955179|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738203|NCT00758524|82955180|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
46738204|NCT00758524|82955164|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738205|NCT00758524|82955165|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738206|NCT00758524|82955166|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738207|NCT00758524|82955167|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738208|NCT00758524|82955168|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738209|NCT00758524|82955169|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738210|NCT00758524|82955170|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
46738211|NCT00758524|82955171|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738212|NCT00758524|82955172|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738213|NCT00758524|82955173|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738214|NCT00758524|82955174|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738215|NCT00758524|82955175|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738216|NCT00758524|82955176|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738217|NCT00758524|82955177|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738218|NCT00758524|82955178|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738219|NCT00758524|82955179|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738220|NCT00758524|82955180|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
46738221|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
46738222|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
46738223|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
46738224|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
46738225|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
46738226|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
46738227|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
46738228|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
46738229|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
46738230|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
47050074|NCT01682876|83310706|FG000|Overall Study|Administrative reason|4|||
47050075|NCT01682876|83310707|FG001|Overall Study|Administrative reason|4|||
47050076|NCT01682876|83310708|FG002|Overall Study|Administrative reason|0|||
47050077|NCT01682876|83310709|FG003|Overall Study|Administrative reason|3|||
47050078|NCT01682876|83310706|FG000|Overall Study|Adverse Event|0|||
47050079|NCT01682876|83310707|FG001|Overall Study|Adverse Event|0|||
47050080|NCT01682876|83310708|FG002|Overall Study|Adverse Event|0|||
47050081|NCT01682876|83310709|FG003|Overall Study|Adverse Event|1|||
47050082|NCT01682876|83310706|FG000|Overall Study|Lost to Follow-up|11|||
47050083|NCT01682876|83310707|FG001|Overall Study|Lost to Follow-up|15|||
47050084|NCT01682876|83310708|FG002|Overall Study|Lost to Follow-up|9|||
47050085|NCT01682876|83310709|FG003|Overall Study|Lost to Follow-up|11|||
47050086|NCT01682876|83310706|FG000|Overall Study|Protocol Violation|1|||
47050087|NCT01682876|83310707|FG001|Overall Study|Protocol Violation|1|||
47050088|NCT01682876|83310708|FG002|Overall Study|Protocol Violation|1|||
47050089|NCT01682876|83310709|FG003|Overall Study|Protocol Violation|1|||
47050090|NCT01682876|83310706|FG000|Overall Study|Withdrawal by Subject|4|||
47050091|NCT01682876|83310707|FG001|Overall Study|Withdrawal by Subject|0|||
46738231|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
46738232|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
46738233|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
46738234|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
46738235|NCT00757588|82955220|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
46738236|NCT00757588|82955221|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
46738237|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
46738238|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
46738239|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
46738240|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
46738241|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
46738242|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
46738243|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
46738244|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
46738245|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
46738246|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
46738247|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
46738248|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
46738249|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
46738250|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
46738251|NCT00757588|82955220|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
46738252|NCT00757588|82955221|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
46738253|NCT00744796|82955227|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
46738254|NCT00705679|82955236|FG000|Overall Study|Adverse Event|1|||
46738255|NCT00705679|82955237|FG001|Overall Study|Adverse Event|1|||
46738256|NCT00705679|82955238|FG002|Overall Study|Adverse Event|0|||
46738257|NCT00705679|82955239|FG003|Overall Study|Adverse Event|0|||
46738258|NCT00705679|82955240|FG004|Overall Study|Adverse Event|0|||
46738259|NCT00705679|82955236|FG000|Overall Study|Death|0|||
46738260|NCT00705679|82955237|FG001|Overall Study|Death|0|||
46738261|NCT00705679|82955238|FG002|Overall Study|Death|3|||
46738262|NCT00705679|82955239|FG003|Overall Study|Death|2|||
46738263|NCT00705679|82955240|FG004|Overall Study|Death|1|||
46738264|NCT00705679|82955236|FG000|Overall Study|Lost to Follow-up|32|||
46738265|NCT00705679|82955237|FG001|Overall Study|Lost to Follow-up|60|||
46738266|NCT00705679|82955238|FG002|Overall Study|Lost to Follow-up|44|||
46738267|NCT00705679|82955239|FG003|Overall Study|Lost to Follow-up|30|||
46738268|NCT00705679|82955240|FG004|Overall Study|Lost to Follow-up|35|||
46738269|NCT00705679|82955236|FG000|Overall Study|Physician Decision|0|||
46738270|NCT00705679|82955237|FG001|Overall Study|Physician Decision|1|||
46738271|NCT00705679|82955238|FG002|Overall Study|Physician Decision|0|||
46738272|NCT00705679|82955239|FG003|Overall Study|Physician Decision|1|||
46738273|NCT00705679|82955240|FG004|Overall Study|Physician Decision|0|||
46738274|NCT00705679|82955236|FG000|Overall Study|Withdrawal by Subject|32|||
46738275|NCT00705679|82955237|FG001|Overall Study|Withdrawal by Subject|77|||
46738276|NCT00705679|82955238|FG002|Overall Study|Withdrawal by Subject|68|||
46738277|NCT00705679|82955239|FG003|Overall Study|Withdrawal by Subject|47|||
46738278|NCT00705679|82955240|FG004|Overall Study|Withdrawal by Subject|33|||
46738279|NCT00751348|82955263|FG000|Overall Study|Withdrawal by Subject|5|||
46738280|NCT00751348|82955264|FG001|Overall Study|Withdrawal by Subject|2|||
46738281|NCT00751348|82955263|FG000|Overall Study|Migration from study area|1|||
46738282|NCT00751348|82955264|FG001|Overall Study|Migration from study area|0|||
46738283|NCT00751114|82955272|FG000|Overall Study|Adverse Event|2|||
46738284|NCT00751114|82955273|FG001|Overall Study|Adverse Event|4|||
46738285|NCT00751114|82955272|FG000|Overall Study|Protocol Violation|8|||
46738286|NCT00751114|82955273|FG001|Overall Study|Protocol Violation|9|||
46738287|NCT00751114|82955272|FG000|Overall Study|Withdrawal by Subject|9|||
46738288|NCT00751114|82955273|FG001|Overall Study|Withdrawal by Subject|4|||
46738289|NCT00751114|82955272|FG000|Overall Study|Lost to Follow-up|4|||
46738290|NCT00751114|82955273|FG001|Overall Study|Lost to Follow-up|7|||
46738291|NCT00751114|82955272|FG000|Overall Study|Lack of Efficacy|0|||
46738292|NCT00751114|82955273|FG001|Overall Study|Lack of Efficacy|7|||
46738293|NCT00751114|82955272|FG000|Overall Study|Not Treated|13|||
46738294|NCT00751114|82955273|FG001|Overall Study|Not Treated|1|||
46738295|NCT00751114|82955272|FG000|Overall Study|Out of country for 2 months|1|||
46738296|NCT00751114|82955273|FG001|Overall Study|Out of country for 2 months|0|||
46738297|NCT00751114|82955272|FG000|Overall Study|Move to another city|1|||
46738298|NCT00751114|82955273|FG001|Overall Study|Move to another city|0|||
46738299|NCT00960440|82955283|FG000|Overall Study|Death|0|||
46738300|NCT00960440|82955284|FG001|Overall Study|Death|0|||
46738301|NCT00960440|82955285|FG002|Overall Study|Death|0|||
46738302|NCT00960440|82955286|FG003|Overall Study|Death|1|||
46738303|NCT00960440|82955283|FG000|Overall Study|Adverse Event|12|||
46738304|NCT00960440|82955284|FG001|Overall Study|Adverse Event|12|||
46738305|NCT00960440|82955285|FG002|Overall Study|Adverse Event|4|||
46738306|NCT00960440|82955286|FG003|Overall Study|Adverse Event|4|||
46738307|NCT00960440|82955283|FG000|Overall Study|Lack of Efficacy|2|||
46738308|NCT00960440|82955284|FG001|Overall Study|Lack of Efficacy|5|||
46738309|NCT00960440|82955285|FG002|Overall Study|Lack of Efficacy|3|||
46738310|NCT00960440|82955286|FG003|Overall Study|Lack of Efficacy|8|||
46738311|NCT00960440|82955283|FG000|Overall Study|Protocol Violation|2|||
46738312|NCT00960440|82955284|FG001|Overall Study|Protocol Violation|8|||
46738313|NCT00960440|82955285|FG002|Overall Study|Protocol Violation|3|||
46738314|NCT00960440|82955286|FG003|Overall Study|Protocol Violation|4|||
46738315|NCT00960440|82955283|FG000|Overall Study|Withdrawal by Subject|9|||
46738316|NCT00960440|82955284|FG001|Overall Study|Withdrawal by Subject|5|||
46738317|NCT00960440|82955285|FG002|Overall Study|Withdrawal by Subject|2|||
46738318|NCT00960440|82955286|FG003|Overall Study|Withdrawal by Subject|1|||
46738319|NCT00960440|82955283|FG000|Overall Study|Other|1|||
46738320|NCT00960440|82955284|FG001|Overall Study|Other|1|||
46738321|NCT00960440|82955285|FG002|Overall Study|Other|1|||
46738322|NCT00960440|82955286|FG003|Overall Study|Other|0|||
46738323|NCT04909853|82955330|FG000|Part 1|Assigned but not treated|0|||
46738324|NCT04909853|82955331|FG001|Part 1|Assigned but not treated|0|||
46738325|NCT04909853|82955332|FG002|Part 1|Assigned but not treated|1|||
46738326|NCT04909853|82955333|FG003|Part 1|Assigned but not treated|0|||
46738327|NCT04909853|82955330|FG000|Part 2|Adverse Event|0|||
46738328|NCT04909853|82955331|FG001|Part 2|Adverse Event|0|||
46738329|NCT04909853|82955332|FG002|Part 2|Adverse Event|0|||
46738330|NCT04909853|82955333|FG003|Part 2|Adverse Event|1|||
46738331|NCT04811664|82955346|FG000|Overall Study|Lost to Follow-up|78|||
46738332|NCT04811664|82955347|FG001|Overall Study|Lost to Follow-up|125|||
46738333|NCT04811664|82955348|FG002|Overall Study|Lost to Follow-up|46|||
46738334|NCT04811664|82955346|FG000|Overall Study|Withdrawal by Subject|39|||
46738335|NCT04811664|82955347|FG001|Overall Study|Withdrawal by Subject|76|||
46738336|NCT04811664|82955348|FG002|Overall Study|Withdrawal by Subject|12|||
46738337|NCT04811664|82955346|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
46738338|NCT04811664|82955347|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
46738339|NCT04811664|82955348|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
46738340|NCT04811664|82955346|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
46738341|NCT04811664|82955347|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
46738342|NCT04811664|82955348|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
46738343|NCT04811664|82955346|FG000|Overall Study|Protocol Violation|0|||
46738344|NCT04811664|82955347|FG001|Overall Study|Protocol Violation|5|||
46738345|NCT04811664|82955348|FG002|Overall Study|Protocol Violation|11|||
46738346|NCT04811664|82955346|FG000|Overall Study|Study Terminated by Sponsor|4|||
46738347|NCT04811664|82955347|FG001|Overall Study|Study Terminated by Sponsor|3|||
46738348|NCT04811664|82955348|FG002|Overall Study|Study Terminated by Sponsor|34|||
46738349|NCT04811664|82955346|FG000|Overall Study|Early Study Closure|3|||
46738350|NCT04811664|82955347|FG001|Overall Study|Early Study Closure|7|||
46738351|NCT04811664|82955348|FG002|Overall Study|Early Study Closure|79|||
46738352|NCT04811664|82955346|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
46738353|NCT04811664|82955347|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
46738354|NCT04811664|82955348|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
46738355|NCT04119414|82955365|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
46738356|NCT03762265|82955385|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
46738357|NCT03762265|82955386|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
46738358|NCT03762265|82955385|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
46738359|NCT03762265|82955386|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
46738360|NCT03762265|82955385|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
46738361|NCT03762265|82955386|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
46738362|NCT03762265|82955385|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
46738363|NCT03762265|82955386|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
46738364|NCT03762265|82955385|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
46738365|NCT03762265|82955386|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
46738366|NCT03762265|82955385|FG000|BT Period: Weeks 1 to 37|Other|0|||
46738367|NCT03762265|82955386|FG001|BT Period: Weeks 1 to 37|Other|1|||
46738368|NCT03762265|82955385|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
46738369|NCT03762265|82955386|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
46738370|NCT03762265|82955385|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
46738371|NCT03762265|82955386|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
46738372|NCT03762265|82955385|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
46738373|NCT03762265|82955386|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
46738374|NCT03762265|82955385|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
46738375|NCT03762265|82955386|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
46738376|NCT03762265|82955385|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
46738377|NCT03762265|82955386|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
46738378|NCT03762265|82955385|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
46738379|NCT03762265|82955386|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
46738380|NCT03762265|82955385|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
46738381|NCT03762265|82955386|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
46738382|NCT03762265|82955385|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
46738383|NCT03762265|82955386|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
46738384|NCT03762265|82955385|FG000|LTE Period: Weeks 61 to 109|Other|1|||
46738385|NCT03762265|82955386|FG001|LTE Period: Weeks 61 to 109|Other|0|||
46738386|NCT03642938|82955427|FG000|Overall Study|Withdrawal by Subject|0|||
46738387|NCT03642938|82955428|FG001|Overall Study|Withdrawal by Subject|0|||
46738388|NCT03642938|82955429|FG002|Overall Study|Withdrawal by Subject|0|||
46738389|NCT03642938|82955430|FG003|Overall Study|Withdrawal by Subject|1|||
46738390|NCT03562767|82955443|FG000|Overall Study|Physician Decision|2|||
46738391|NCT03562767|82955444|FG001|Overall Study|Physician Decision|0|||
46738392|NCT03562767|82955445|FG002|Overall Study|Physician Decision|0|||
46738393|NCT03562767|82955443|FG000|Overall Study|Logistic Reason|1|||
46738394|NCT03562767|82955444|FG001|Overall Study|Logistic Reason|3|||
46738395|NCT03562767|82955445|FG002|Overall Study|Logistic Reason|0|||
46738396|NCT03333941|82955457|FG000|Overall Study|Lost to Follow-up|10|||
46738397|NCT03333941|82955457|FG000|Overall Study|Death|2|||
46738398|NCT03333941|82955457|FG000|Overall Study|Adverse Event|1|||
46738399|NCT03315754|82955461|FG000|Overall Study|COVID-19 complications leading to death|1|||
46738400|NCT03315754|82955461|FG000|Overall Study|insurance coverage issue|1|||
46738401|NCT02440711|82955480|FG000|Second Intervention|Lost to Follow-up|1|||
46738402|NCT02440711|82955481|FG001|Second Intervention|Lost to Follow-up|0|||
46738403|NCT02223767|82955491|FG000|Overall Study|Withdrawal by Subject|4|||
46738404|NCT02223767|82955492|FG001|Overall Study|Withdrawal by Subject|4|||
46738405|NCT01956773|82955511|FG000|Overall Study|Lost to Follow-up|628|||
46738406|NCT01956773|82955512|FG001|Overall Study|Lost to Follow-up|1|||
46738407|NCT01946529|82955521|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
46738408|NCT01946529|82955522|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
46738409|NCT01946529|82955523|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
46738410|NCT01946529|82955521|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
46738411|NCT01946529|82955522|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
46738412|NCT01946529|82955523|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
46738413|NCT01666808|82955545|FG000|Overall Study|Lost to Follow-up|9|||
46738414|NCT01666808|82955546|FG001|Overall Study|Lost to Follow-up|15|||
46738415|NCT01666808|82955545|FG000|Overall Study|Withdrawal by Subject|3|||
46738416|NCT01666808|82955546|FG001|Overall Study|Withdrawal by Subject|1|||
46738417|NCT01666808|82955545|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
46738418|NCT01666808|82955546|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
46738419|NCT00964028|82955563|FG000|Overall Study|Withdrawal by Subject|0|||
46738420|NCT00964028|82955564|FG001|Overall Study|Withdrawal by Subject|1|||
46738421|NCT00960206|82955573|FG000|Overall Study|Death|7|||
46738422|NCT00960206|82955574|FG001|Overall Study|Death|4|||
46738423|NCT00960206|82955575|FG002|Overall Study|Death|1|||
46738424|NCT00960206|82955573|FG000|Overall Study|Unwilling/Unable to return|1|||
46738425|NCT00960206|82955574|FG001|Overall Study|Unwilling/Unable to return|2|||
46738426|NCT00960206|82955575|FG002|Overall Study|Unwilling/Unable to return|0|||
46738427|NCT00960206|82955573|FG000|Overall Study|Lost to Follow-up|8|||
46738428|NCT00960206|82955574|FG001|Overall Study|Lost to Follow-up|14|||
46738429|NCT00960206|82955575|FG002|Overall Study|Lost to Follow-up|8|||
46738430|NCT00960206|82955573|FG000|Overall Study|Withdrawal by Subject|2|||
46738431|NCT00960206|82955574|FG001|Overall Study|Withdrawal by Subject|4|||
46738432|NCT00960206|82955575|FG002|Overall Study|Withdrawal by Subject|0|||
46738433|NCT00960206|82955573|FG000|Overall Study|Revision of study component|2|||
46804081|NCT00541970|83023283|FG003|Month 12|Protocol Violation|15|||
46738434|NCT00960206|82955574|FG001|Overall Study|Revision of study component|2|||
46738435|NCT00960206|82955575|FG002|Overall Study|Revision of study component|2|||
46738436|NCT00960206|82955573|FG000|Overall Study|Missing 10 year data|20|||
46738437|NCT00960206|82955574|FG001|Overall Study|Missing 10 year data|1|||
46804082|NCT00541970|83023280|FG000|Month 18|Adverse Event|0|||
47050092|NCT01682876|83310708|FG002|Overall Study|Withdrawal by Subject|0|||
47050093|NCT01682876|83310709|FG003|Overall Study|Withdrawal by Subject|2|||
47050094|NCT01682876|83310706|FG000|Overall Study|Other|1|||
47050095|NCT01682876|83310707|FG001|Overall Study|Other|0|||
47050096|NCT01682876|83310708|FG002|Overall Study|Other|1|||
47050097|NCT01682876|83310709|FG003|Overall Study|Other|1|||
47050098|NCT01682720|83310726|FG000|Overall Study|Randomized but Not Treated|0|||
46738438|NCT00960206|82955575|FG002|Overall Study|Missing 10 year data|1|||
46738439|NCT00751036|82955586|FG000|Overall Study|Disease Progression|28|||
46738440|NCT00751036|82955587|FG001|Overall Study|Disease Progression|29|||
46804083|NCT00541970|83023281|FG001|Month 18|Adverse Event|1|||
47050099|NCT01682720|83310727|FG001|Overall Study|Randomized but Not Treated|1|||
47050100|NCT01682720|83310728|FG002|Overall Study|Randomized but Not Treated|1|||
46738441|NCT00751036|82955586|FG000|Overall Study|Adverse Event|6|||
46738442|NCT00751036|82955587|FG001|Overall Study|Adverse Event|4|||
46804084|NCT00541970|83023282|FG002|Month 18|Adverse Event|1|||
46738443|NCT00751036|82955586|FG000|Overall Study|Administrative Problems|3|||
46738444|NCT00751036|82955587|FG001|Overall Study|Administrative Problems|4|||
46738445|NCT00751036|82955586|FG000|Overall Study|Withdrawal by Subject|5|||
46738446|NCT00751036|82955587|FG001|Overall Study|Withdrawal by Subject|2|||
46738447|NCT00751036|82955586|FG000|Overall Study|Death|3|||
46738448|NCT00751036|82955587|FG001|Overall Study|Death|3|||
46738449|NCT00751036|82955586|FG000|Overall Study|Lost to Follow-up|0|||
46738450|NCT00751036|82955587|FG001|Overall Study|Lost to Follow-up|1|||
46738451|NCT00751036|82955586|FG000|Overall Study|Protocol Violation|1|||
46738452|NCT00751036|82955587|FG001|Overall Study|Protocol Violation|0|||
46738453|NCT00751036|82955586|FG000|Overall Study|Missing end of Treatment Page|2|||
46738454|NCT00751036|82955587|FG001|Overall Study|Missing end of Treatment Page|3|||
46738455|NCT00961298|82955593|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
46738456|NCT00961298|82955593|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
46738457|NCT00961298|82955593|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
46738458|NCT00744328|82955600|FG000|Overall Study|Lost to Follow-up|2|||
46738459|NCT00744328|82955601|FG001|Overall Study|Lost to Follow-up|5|||
46738460|NCT00744328|82955602|FG002|Overall Study|Lost to Follow-up|3|||
46738461|NCT00744328|82955600|FG000|Overall Study|Withdrawal by Subject|5|||
46738462|NCT00744328|82955601|FG001|Overall Study|Withdrawal by Subject|3|||
46738463|NCT00744328|82955602|FG002|Overall Study|Withdrawal by Subject|4|||
46738464|NCT00744328|82955600|FG000|Overall Study|Found ineligible after randomization|0|||
46738465|NCT00744328|82955601|FG001|Overall Study|Found ineligible after randomization|0|||
46738466|NCT00744328|82955602|FG002|Overall Study|Found ineligible after randomization|1|||
46738467|NCT03245840|82955612|FG000|Overall Study|Adverse Event|6|||
46738468|NCT03245840|82955613|FG001|Overall Study|Adverse Event|0|||
46738469|NCT03245840|82955612|FG000|Overall Study|Death|2|||
46738470|NCT03245840|82955613|FG001|Overall Study|Death|0|||
46738471|NCT03245840|82955612|FG000|Overall Study|Withdrawal by Subject|31|||
46738472|NCT03245840|82955613|FG001|Overall Study|Withdrawal by Subject|1|||
46738473|NCT03245840|82955612|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
46738474|NCT03245840|82955613|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46738475|NCT03245840|82955612|FG000|Overall Study|Physician Decision|4|||
46738476|NCT03245840|82955613|FG001|Overall Study|Physician Decision|1|||
46738477|NCT03245840|82955612|FG000|Overall Study|Study Terminated by Sponsor|56|||
46738478|NCT03245840|82955613|FG001|Overall Study|Study Terminated by Sponsor|6|||
46738479|NCT03245840|82955612|FG000|Overall Study|Site Terminated by Sponsor|4|||
46738480|NCT03245840|82955613|FG001|Overall Study|Site Terminated by Sponsor|0|||
46738481|NCT03245840|82955612|FG000|Overall Study|Lost to Follow-up|12|||
46738482|NCT03245840|82955613|FG001|Overall Study|Lost to Follow-up|2|||
46738483|NCT03245840|82955612|FG000|Overall Study|Pregnancy|2|||
46738484|NCT03245840|82955613|FG001|Overall Study|Pregnancy|0|||
46738485|NCT03245840|82955612|FG000|Overall Study|Non-Compliance with Study Drug|2|||
46738486|NCT03245840|82955613|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46738487|NCT03245840|82955612|FG000|Overall Study|Not treated|1|||
46738488|NCT03245840|82955613|FG001|Overall Study|Not treated|1|||
46738489|NCT00959894|82955619|FG000|Overall Study|Lost to Follow-up|10|||
46738490|NCT00959894|82955619|FG000|Overall Study|Adverse Event|3|||
46738491|NCT00959894|82955619|FG000|Overall Study|Withdrawal by Subject|1|||
46738492|NCT00959894|82955619|FG000|Overall Study|Need for contraindicated medication|1|||
46738493|NCT00959894|82955619|FG000|Overall Study|Subject moved out of town|1|||
46738494|NCT00750880|82955624|FG000|Overall Study|Adverse Event|76|||
46738495|NCT00750880|82955624|FG000|Overall Study|Death|4|||
46738496|NCT00750880|82955624|FG000|Overall Study|Lack of Efficacy|46|||
46738497|NCT00750880|82955624|FG000|Overall Study|Lost to Follow-up|10|||
46738498|NCT00750880|82955624|FG000|Overall Study|Protocol Violation|15|||
46738499|NCT00750880|82955624|FG000|Overall Study|Withdrawal by Subject|33|||
46738500|NCT00750880|82955624|FG000|Overall Study|Physician Decision|20|||
46738501|NCT00750880|82955624|FG000|Overall Study|Administrative|11|||
46738502|NCT00746590|82955629|FG000|Overall Study|Death|1|||
46738503|NCT01032629|82955636|FG000|Overall Study|Closed Site|21|||
46738504|NCT01032629|82955637|FG001|Overall Study|Closed Site|18|||
46738505|NCT01032629|82955638|FG002|Overall Study|Closed Site|16|||
46738506|NCT01032629|82955636|FG000|Overall Study|Withdrawal by Subject|50|||
46738507|NCT01032629|82955637|FG001|Overall Study|Withdrawal by Subject|36|||
46738508|NCT01032629|82955638|FG002|Overall Study|Withdrawal by Subject|35|||
46738509|NCT01032629|82955636|FG000|Overall Study|Lost to Follow-up|74|||
46921786|NCT03614923|83154428|FG001|Overall Study|Non-compliance|1|||
46921787|NCT03614923|83154429|FG002|Overall Study|Non-compliance|0|||
46921788|NCT03614923|83154427|FG000|Overall Study|Other|0|||
46921789|NCT03614923|83154428|FG001|Overall Study|Other|1|||
46738510|NCT01032629|82955637|FG001|Overall Study|Lost to Follow-up|47|||
46738511|NCT01032629|82955638|FG002|Overall Study|Lost to Follow-up|37|||
46738512|NCT00749944|82955649|FG000|Overall Study|Lost to Follow-up|2|||
46738513|NCT00749944|82955650|FG001|Overall Study|Lost to Follow-up|1|||
46738514|NCT00749944|82955649|FG000|Overall Study|Other|1|||
46738515|NCT00749944|82955650|FG001|Overall Study|Other|0|||
46921790|NCT03614923|83154429|FG002|Overall Study|Other|1|||
46921791|NCT05098509|83154451|FG000|Overall Study|Withdrawal by Subject|0|||
46738516|NCT00749944|82955649|FG000|Overall Study|Withdrawal by Subject|2|||
46738517|NCT00749944|82955650|FG001|Overall Study|Withdrawal by Subject|0|||
46738518|NCT00749398|82955656|FG000|Overall Study|Lack of Efficacy|7|||
46738519|NCT00749398|82955656|FG000|Overall Study|Adverse Event|4|||
46738520|NCT00749398|82955656|FG000|Overall Study|Serious adverse event|11|||
46738521|NCT00749398|82955656|FG000|Overall Study|Withdrawal by Subject|17|||
46738522|NCT00749398|82955656|FG000|Overall Study|Lost to Follow-up|11|||
46738523|NCT00749398|82955656|FG000|Overall Study|Reason not specified|2|||
46738524|NCT00749398|82955656|FG000|Overall Study|Unknown reason|1|||
46738525|NCT00746356|82955660|FG000|Overall Study|Withdrawal by Subject|2|||
46738526|NCT00746356|82955661|FG001|Overall Study|Withdrawal by Subject|3|||
46738527|NCT00746356|82955660|FG000|Overall Study|Death|7|||
46738528|NCT00746356|82955661|FG001|Overall Study|Death|3|||
46738529|NCT00746356|82955660|FG000|Overall Study|Lost to Follow-up|1|||
46738530|NCT00746356|82955661|FG001|Overall Study|Lost to Follow-up|0|||
46738531|NCT00746356|82955660|FG000|Overall Study|Removal of Device|0|||
46738532|NCT00746356|82955661|FG001|Overall Study|Removal of Device|1|||
46738533|NCT00746356|82955660|FG000|Overall Study|Patient relocated|1|||
46738534|NCT00746356|82955661|FG001|Overall Study|Patient relocated|0|||
46738535|NCT01012973|82955671|FG000|Overall Study|Adverse Event|5|||
46738536|NCT01012973|82955672|FG001|Overall Study|Adverse Event|5|||
46738537|NCT01012973|82955671|FG000|Overall Study|Lack of Efficacy|0|||
46738538|NCT01012973|82955672|FG001|Overall Study|Lack of Efficacy|5|||
46738539|NCT01012973|82955671|FG000|Overall Study|Lost to Follow-up|1|||
46738540|NCT01012973|82955672|FG001|Overall Study|Lost to Follow-up|0|||
46738541|NCT01012973|82955671|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
46738542|NCT01012973|82955672|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
46738543|NCT01012973|82955671|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
46738544|NCT01012973|82955672|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
46738545|NCT01012973|82955671|FG000|Overall Study|Protocol Violation|5|||
46738546|NCT01012973|82955672|FG001|Overall Study|Protocol Violation|2|||
46738547|NCT01012973|82955671|FG000|Overall Study|Withdrawal by Subject|4|||
46738548|NCT01012973|82955672|FG001|Overall Study|Withdrawal by Subject|6|||
46738549|NCT00748540|82955682|FG000|Overall Study|Physician Decision|1|||
46738550|NCT01012739|82955686|FG000|Treatment Period 1|Adverse Event|0|||
46738551|NCT01012739|82955687|FG001|Treatment Period 1|Adverse Event|0|||
46738552|NCT01012739|82955688|FG002|Treatment Period 1|Adverse Event|0|||
46738553|NCT01012739|82955689|FG003|Treatment Period 1|Adverse Event|1|||
46738554|NCT01012739|82955686|FG000|Treatment Period 2|Abnormal test procedure results|0|||
46738555|NCT01012739|82955687|FG001|Treatment Period 2|Abnormal test procedure results|0|||
46738556|NCT01012739|82955688|FG002|Treatment Period 2|Abnormal test procedure results|0|||
46738557|NCT01012739|82955689|FG003|Treatment Period 2|Abnormal test procedure results|1|||
46738558|NCT00742924|82955704|FG000|Overall Study|Adverse Event|0|||
46738559|NCT00742924|82955705|FG001|Overall Study|Adverse Event|0|||
46738560|NCT00742924|82955706|FG002|Overall Study|Adverse Event|1|||
46738561|NCT00742924|82955707|FG003|Overall Study|Adverse Event|1|||
46738562|NCT00742924|82955704|FG000|Overall Study|Lack of Efficacy|5|||
46738563|NCT00742924|82955705|FG001|Overall Study|Lack of Efficacy|1|||
46738564|NCT00742924|82955706|FG002|Overall Study|Lack of Efficacy|2|||
46738565|NCT00742924|82955707|FG003|Overall Study|Lack of Efficacy|4|||
46738566|NCT00742924|82955704|FG000|Overall Study|Physician Decision|0|||
46738567|NCT00742924|82955705|FG001|Overall Study|Physician Decision|0|||
46738568|NCT00742924|82955706|FG002|Overall Study|Physician Decision|0|||
46738569|NCT00742924|82955707|FG003|Overall Study|Physician Decision|1|||
46738570|NCT00742924|82955704|FG000|Overall Study|Withdrawal by Subject|0|||
46738571|NCT00742924|82955705|FG001|Overall Study|Withdrawal by Subject|1|||
46738572|NCT00742924|82955706|FG002|Overall Study|Withdrawal by Subject|1|||
46738573|NCT00742924|82955707|FG003|Overall Study|Withdrawal by Subject|0|||
46738574|NCT00698815|82955720|FG000|Overall Study|Death|1|||
46738575|NCT00698815|82955721|FG001|Overall Study|Death|2|||
46738576|NCT00698815|82955722|FG002|Overall Study|Death|4|||
46738577|NCT00698815|82955720|FG000|Overall Study|Withdrawal by Subject|6|||
46738578|NCT00698815|82955721|FG001|Overall Study|Withdrawal by Subject|3|||
46738579|NCT00698815|82955722|FG002|Overall Study|Withdrawal by Subject|2|||
46921792|NCT05098509|83154452|FG001|Overall Study|Withdrawal by Subject|0|||
46921793|NCT05098509|83154453|FG002|Overall Study|Withdrawal by Subject|1|||
46921794|NCT05098509|83154454|FG003|Overall Study|Withdrawal by Subject|0|||
46738580|NCT00698815|82955720|FG000|Overall Study|MD discretion|2|||
46921795|NCT05098509|83154451|FG000|Overall Study|Early study termination|1|||
46738581|NCT00698815|82955721|FG001|Overall Study|MD discretion|7|||
46738582|NCT00698815|82955722|FG002|Overall Study|MD discretion|2|||
46738583|NCT00698815|82955720|FG000|Overall Study|Did not receive protocol treatment|1|||
46738584|NCT00698815|82955721|FG001|Overall Study|Did not receive protocol treatment|2|||
46738585|NCT00698815|82955722|FG002|Overall Study|Did not receive protocol treatment|2|||
46738586|NCT00745498|82955733|FG000|Overall Study|Lost to Follow-up|1|||
46738587|NCT00745498|82955734|FG001|Overall Study|Lost to Follow-up|1|||
46921796|NCT05098509|83154452|FG001|Overall Study|Early study termination|1|||
46738588|NCT00745498|82955735|FG002|Overall Study|Lost to Follow-up|3|||
46738589|NCT00745498|82955733|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
46738590|NCT00745498|82955734|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
46738591|NCT00745498|82955735|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
46738592|NCT00745498|82955733|FG000|Overall Study|Non-PDR related VH|0|||
46738593|NCT00745498|82955734|FG001|Overall Study|Non-PDR related VH|1|||
46738594|NCT00745498|82955735|FG002|Overall Study|Non-PDR related VH|1|||
46738595|NCT00745498|82955733|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
46738596|NCT00745498|82955734|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
46738597|NCT00745498|82955735|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
46738598|NCT00744874|82955743|FG000|Overall Study|Lost to Follow-up|1|||
46738599|NCT00744874|82955743|FG000|Overall Study|Withdrawal by Subject|1|||
46738600|NCT00744874|82955743|FG000|Overall Study|Study Device not available at procedure|1|||
46738601|NCT00744874|82955743|FG000|Overall Study|Unable to accomodate schedule|1|||
46738602|NCT00576901|82955754|FG000|Overall Study|Withdrawal by Subject|1|||
46738603|NCT00576901|82955754|FG000|Overall Study|Disease course|1|||
46738604|NCT00576901|82955754|FG000|Overall Study|Protocol Violation|1|||
46738605|NCT00699283|82955760|FG000|Overall Study|Lack of Efficacy|15|||
46738606|NCT00699283|82955761|FG001|Overall Study|Lack of Efficacy|5|||
46738607|NCT00699283|82955760|FG000|Overall Study|Lost to Follow-up|2|||
46738608|NCT00699283|82955761|FG001|Overall Study|Lost to Follow-up|0|||
46738609|NCT00699283|82955760|FG000|Overall Study|Withdrawal by Subject|1|||
46738610|NCT00699283|82955761|FG001|Overall Study|Withdrawal by Subject|0|||
46738611|NCT00699283|82955760|FG000|Overall Study|Other Reason|5|||
46738612|NCT00699283|82955761|FG001|Overall Study|Other Reason|1|||
46738613|NCT00699283|82955760|FG000|Overall Study|SAE, non-fatal|1|||
46738614|NCT00699283|82955761|FG001|Overall Study|SAE, non-fatal|1|||
46738615|NCT00699283|82955760|FG000|Overall Study|AE, non-serious non-fatal|8|||
46738616|NCT00699283|82955761|FG001|Overall Study|AE, non-serious non-fatal|1|||
46738617|NCT00699283|82955760|FG000|Overall Study|AE of unknown type|1|||
46738618|NCT00699283|82955761|FG001|Overall Study|AE of unknown type|0|||
46738619|NCT00740584|82955766|FG000|Overall Study|Withdrawal by Subject|1|||
46738620|NCT01023815|82955775|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
46738621|NCT01023815|82955776|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
46738622|NCT01023815|82955777|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
46738623|NCT01023815|82955778|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
46738624|NCT01023815|82955775|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
46738625|NCT01023815|82955776|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
46738626|NCT01023815|82955777|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
46738627|NCT01023815|82955778|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
46738628|NCT01023815|82955775|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
46738629|NCT01023815|82955776|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
46738630|NCT01023815|82955777|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
46738631|NCT01023815|82955778|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
46738632|NCT01023815|82955775|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
46738633|NCT01023815|82955776|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
46738634|NCT01023815|82955777|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
46738635|NCT01023815|82955778|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
46738636|NCT01023815|82955775|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
46738637|NCT01023815|82955776|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
46738638|NCT01023815|82955777|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
46738639|NCT01023815|82955778|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
46738640|NCT01023659|82955792|FG000|Overall Study|Lost to Follow-up|73|||
46738641|NCT01023659|82955793|FG001|Overall Study|Lost to Follow-up|228|||
46738642|NCT01023659|82955794|FG002|Overall Study|Lost to Follow-up|99|||
46738643|NCT00740116|82955805|FG000|Overall Study|Withdrawal by Subject|1|||
46738644|NCT00740116|82955806|FG001|Overall Study|Withdrawal by Subject|1|||
46738645|NCT00740116|82955805|FG000|Overall Study|Protocol Violation|1|||
46738646|NCT00740116|82955806|FG001|Overall Study|Protocol Violation|4|||
46738647|NCT00698581|82955816|FG000|Overall Study|Lack of Efficacy|23|||
46921797|NCT05098509|83154453|FG002|Overall Study|Early study termination|1|||
46921798|NCT05098509|83154454|FG003|Overall Study|Early study termination|0|||
46921799|NCT04962698|83154464|FG000|Motor Imagery|Technical difficulty|1|||
46921800|NCT04962698|83154465|FG001|Motor Imagery|Technical difficulty|0|||
46738648|NCT00698581|82955817|FG001|Overall Study|Lack of Efficacy|11|||
46738649|NCT00698581|82955816|FG000|Overall Study|Withdrawal by Subject|6|||
46738650|NCT00698581|82955817|FG001|Overall Study|Withdrawal by Subject|0|||
46738651|NCT00698581|82955816|FG000|Overall Study|Other reason|9|||
46738652|NCT00698581|82955817|FG001|Overall Study|Other reason|1|||
46738653|NCT00698581|82955816|FG000|Overall Study|SAE, non-fatal|1|||
46921801|NCT04962698|83154464|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
46738654|NCT00698581|82955817|FG001|Overall Study|SAE, non-fatal|0|||
46738655|NCT00698581|82955816|FG000|Overall Study|AE, non-serious non-fatal|4|||
46738656|NCT00698581|82955817|FG001|Overall Study|AE, non-serious non-fatal|0|||
46738657|NCT00698581|82955816|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
46738658|NCT00698581|82955817|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
46738659|NCT00698581|82955816|FG000|Overall Study|AE of unknown type|1|||
46738660|NCT00698581|82955817|FG001|Overall Study|AE of unknown type|0|||
46738661|NCT01023581|82955831|FG000|Overall Study|Adverse Event|4|||
46738662|NCT01023581|82955832|FG001|Overall Study|Adverse Event|4|||
46738663|NCT01023581|82955833|FG002|Overall Study|Adverse Event|7|||
46738664|NCT01023581|82955834|FG003|Overall Study|Adverse Event|3|||
46738665|NCT01023581|82955835|FG004|Overall Study|Adverse Event|2|||
46738666|NCT01023581|82955836|FG005|Overall Study|Adverse Event|5|||
46738667|NCT01023581|82955837|FG006|Overall Study|Adverse Event|11|||
46738668|NCT01023581|82955831|FG000|Overall Study|Major protocol deviation|2|||
46738669|NCT01023581|82955832|FG001|Overall Study|Major protocol deviation|0|||
46738670|NCT01023581|82955833|FG002|Overall Study|Major protocol deviation|3|||
46738671|NCT01023581|82955834|FG003|Overall Study|Major protocol deviation|0|||
46738672|NCT01023581|82955835|FG004|Overall Study|Major protocol deviation|0|||
46738673|NCT01023581|82955836|FG005|Overall Study|Major protocol deviation|0|||
46738674|NCT01023581|82955837|FG006|Overall Study|Major protocol deviation|0|||
46738675|NCT01023581|82955831|FG000|Overall Study|Lost to Follow-up|4|||
46738676|NCT01023581|82955832|FG001|Overall Study|Lost to Follow-up|8|||
46738677|NCT01023581|82955833|FG002|Overall Study|Lost to Follow-up|7|||
46738678|NCT01023581|82955834|FG003|Overall Study|Lost to Follow-up|2|||
46738679|NCT01023581|82955835|FG004|Overall Study|Lost to Follow-up|5|||
46738680|NCT01023581|82955836|FG005|Overall Study|Lost to Follow-up|2|||
46738681|NCT01023581|82955837|FG006|Overall Study|Lost to Follow-up|2|||
46738682|NCT01023581|82955831|FG000|Overall Study|Withdrawal by Subject|13|||
46738683|NCT01023581|82955832|FG001|Overall Study|Withdrawal by Subject|8|||
46738684|NCT01023581|82955833|FG002|Overall Study|Withdrawal by Subject|16|||
46738685|NCT01023581|82955834|FG003|Overall Study|Withdrawal by Subject|10|||
46738686|NCT01023581|82955835|FG004|Overall Study|Withdrawal by Subject|6|||
46738687|NCT01023581|82955836|FG005|Overall Study|Withdrawal by Subject|8|||
46738688|NCT01023581|82955837|FG006|Overall Study|Withdrawal by Subject|5|||
46738689|NCT01023581|82955831|FG000|Overall Study|Pregnancy|0|||
46738690|NCT01023581|82955832|FG001|Overall Study|Pregnancy|0|||
46738691|NCT01023581|82955833|FG002|Overall Study|Pregnancy|0|||
46738692|NCT01023581|82955834|FG003|Overall Study|Pregnancy|2|||
46738693|NCT01023581|82955835|FG004|Overall Study|Pregnancy|0|||
46738694|NCT01023581|82955836|FG005|Overall Study|Pregnancy|1|||
46738695|NCT01023581|82955837|FG006|Overall Study|Pregnancy|0|||
46738696|NCT01023581|82955831|FG000|Overall Study|Lack of Efficacy|9|||
46738697|NCT01023581|82955832|FG001|Overall Study|Lack of Efficacy|3|||
46738698|NCT01023581|82955833|FG002|Overall Study|Lack of Efficacy|6|||
46738699|NCT01023581|82955834|FG003|Overall Study|Lack of Efficacy|2|||
46738700|NCT01023581|82955835|FG004|Overall Study|Lack of Efficacy|1|||
46738701|NCT01023581|82955836|FG005|Overall Study|Lack of Efficacy|2|||
46738702|NCT01023581|82955837|FG006|Overall Study|Lack of Efficacy|1|||
46738703|NCT01023581|82955831|FG000|Overall Study|Physician Decision|2|||
46738704|NCT01023581|82955832|FG001|Overall Study|Physician Decision|0|||
46738705|NCT01023581|82955833|FG002|Overall Study|Physician Decision|2|||
46738706|NCT01023581|82955834|FG003|Overall Study|Physician Decision|1|||
46738707|NCT01023581|82955835|FG004|Overall Study|Physician Decision|1|||
46738708|NCT01023581|82955836|FG005|Overall Study|Physician Decision|1|||
46738709|NCT01023581|82955837|FG006|Overall Study|Physician Decision|1|||
46738710|NCT01023581|82955831|FG000|Overall Study|Other|1|||
46738711|NCT01023581|82955832|FG001|Overall Study|Other|0|||
46738712|NCT01023581|82955833|FG002|Overall Study|Other|1|||
46738713|NCT01023581|82955834|FG003|Overall Study|Other|0|||
46738714|NCT01023581|82955835|FG004|Overall Study|Other|1|||
46738715|NCT01023581|82955836|FG005|Overall Study|Other|0|||
46738716|NCT01023581|82955837|FG006|Overall Study|Other|0|||
46738717|NCT00962780|82955855|FG000|Overall Study|Death|0|||
46738718|NCT00962780|82955856|FG001|Overall Study|Death|1|||
46738719|NCT00962780|82955855|FG000|Overall Study|Protocol Violation|9|||
46738720|NCT00962780|82955856|FG001|Overall Study|Protocol Violation|4|||
46738721|NCT00962780|82955855|FG000|Overall Study|Withdrawal by Subject|1|||
46738722|NCT00962780|82955856|FG001|Overall Study|Withdrawal by Subject|8|||
46738723|NCT00962780|82955855|FG000|Overall Study|Other|0|||
46738724|NCT00962780|82955856|FG001|Overall Study|Other|1|||
46738725|NCT00739882|82955870|FG000|Double-blind Period|Adverse Event|1|||
46738726|NCT00739882|82955871|FG001|Double-blind Period|Adverse Event|2|||
46738727|NCT00739882|82955870|FG000|Double-blind Period|Protocol Violation|1|||
46738728|NCT00739882|82955871|FG001|Double-blind Period|Protocol Violation|0|||
46738729|NCT00739882|82955870|FG000|Double-blind Period|Lack of Efficacy|1|||
46635348|NCT01587924|82808970|FG001|Overall Study|Adverse Event|2|||
46738730|NCT00739882|82955871|FG001|Double-blind Period|Lack of Efficacy|1|||
46738731|NCT00739882|82955870|FG000|Double-blind Period|Other|16|||
46738732|NCT00739882|82955871|FG001|Double-blind Period|Other|8|||
46738733|NCT00739882|82955870|FG000|Open-label Period|Adverse Event|1|||
46738734|NCT00739882|82955871|FG001|Open-label Period|Adverse Event|0|||
46738735|NCT00739882|82955870|FG000|Open-label Period|Other|9|||
46738736|NCT00739882|82955871|FG001|Open-label Period|Other|5|||
46738737|NCT00961220|82955879|FG000|Overall Study|Adverse Event|3|||
46738738|NCT00961220|82955879|FG000|Overall Study|Lack of Efficacy|1|||
46738739|NCT00961220|82955879|FG000|Overall Study|No IV access for O6BG|1|||
46738740|NCT00961220|82955879|FG000|Overall Study|O6BG no longer supplied|1|||
46738741|NCT00961220|82955879|FG000|Overall Study|Complete Response prior to 12 courses|1|||
46738742|NCT00734656|82955885|FG000|Lab Session 1|Withdrawal by Subject|2|||
46738743|NCT00734656|82955886|FG001|Lab Session 1|Withdrawal by Subject|0|||
46738744|NCT00734656|82955887|FG002|Lab Session 1|Withdrawal by Subject|0|||
46738745|NCT00734656|82955888|FG003|Lab Session 1|Withdrawal by Subject|0|||
46738746|NCT00734656|82955885|FG000|Washout 1|Withdrawal by Subject|1|||
46738747|NCT00734656|82955886|FG001|Washout 1|Withdrawal by Subject|5|||
46738748|NCT00734656|82955887|FG002|Washout 1|Withdrawal by Subject|2|||
46738749|NCT00734656|82955888|FG003|Washout 1|Withdrawal by Subject|3|||
46738750|NCT00734656|82955885|FG000|Lab Session 2|Withdrawal by Subject|1|||
46738751|NCT00734656|82955886|FG001|Lab Session 2|Withdrawal by Subject|0|||
46738752|NCT00734656|82955887|FG002|Lab Session 2|Withdrawal by Subject|0|||
46738753|NCT00734656|82955888|FG003|Lab Session 2|Withdrawal by Subject|1|||
46738754|NCT00734656|82955885|FG000|Washout 2|Withdrawal by Subject|1|||
46738755|NCT00734656|82955886|FG001|Washout 2|Withdrawal by Subject|1|||
46738756|NCT00734656|82955887|FG002|Washout 2|Withdrawal by Subject|1|||
46738757|NCT00734656|82955888|FG003|Washout 2|Withdrawal by Subject|0|||
46738758|NCT00734656|82955885|FG000|Washout 3|Withdrawal by Subject|1|||
46738759|NCT00734656|82955886|FG001|Washout 3|Withdrawal by Subject|0|||
46738760|NCT00734656|82955887|FG002|Washout 3|Withdrawal by Subject|0|||
46738761|NCT00734656|82955888|FG003|Washout 3|Withdrawal by Subject|1|||
46738762|NCT00734656|82955885|FG000|Lab Session 4|Withdrawal by Subject|0|||
46738763|NCT00734656|82955886|FG001|Lab Session 4|Withdrawal by Subject|0|||
46738764|NCT00734656|82955887|FG002|Lab Session 4|Withdrawal by Subject|0|||
46738765|NCT00734656|82955888|FG003|Lab Session 4|Withdrawal by Subject|1|||
46738766|NCT00739648|82955900|FG000|Overall Study|Adverse Event|3|||
46738767|NCT00739648|82955901|FG001|Overall Study|Adverse Event|15|||
46738768|NCT00739648|82955900|FG000|Overall Study|Withdrawal by Subject|13|||
46738769|NCT00739648|82955901|FG001|Overall Study|Withdrawal by Subject|25|||
46738770|NCT00739648|82955900|FG000|Overall Study|Lost to Follow-up|4|||
46738771|NCT00739648|82955901|FG001|Overall Study|Lost to Follow-up|7|||
46738772|NCT00739648|82955900|FG000|Overall Study|Death|2|||
46738773|NCT00739648|82955901|FG001|Overall Study|Death|0|||
46738774|NCT00739648|82955900|FG000|Overall Study|Do not know|4|||
46738775|NCT00739648|82955901|FG001|Overall Study|Do not know|6|||
46738776|NCT01032239|82955913|FG000|Overall Study|Lost to Follow-up|3|||
46738777|NCT01032239|82955914|FG001|Overall Study|Lost to Follow-up|2|||
46738778|NCT01032239|82955913|FG000|Overall Study|Withdrawal by Subject|2|||
46738779|NCT01032239|82955914|FG001|Overall Study|Withdrawal by Subject|3|||
46738780|NCT01032239|82955913|FG000|Overall Study|Death|1|||
46738781|NCT01032239|82955914|FG001|Overall Study|Death|0|||
46738782|NCT01032239|82955913|FG000|Overall Study|Protocol Violation|1|||
46738783|NCT01032239|82955914|FG001|Overall Study|Protocol Violation|0|||
46738784|NCT00734578|82955923|FG000|Overall Study|Adverse Event|4|||
46738785|NCT00734578|82955924|FG001|Overall Study|Adverse Event|6|||
46738786|NCT00734578|82955925|FG002|Overall Study|Adverse Event|1|||
46738787|NCT00734578|82955923|FG000|Overall Study|Protocol Violation|8|||
46738788|NCT00734578|82955924|FG001|Overall Study|Protocol Violation|6|||
46738789|NCT00734578|82955925|FG002|Overall Study|Protocol Violation|3|||
46738790|NCT00734578|82955923|FG000|Overall Study|Withdrawal by Subject|7|||
46738791|NCT00734578|82955924|FG001|Overall Study|Withdrawal by Subject|8|||
46738792|NCT00734578|82955925|FG002|Overall Study|Withdrawal by Subject|11|||
46738793|NCT00734578|82955923|FG000|Overall Study|Lost to Follow-up|9|||
46738794|NCT00734578|82955924|FG001|Overall Study|Lost to Follow-up|3|||
46738795|NCT00734578|82955925|FG002|Overall Study|Lost to Follow-up|5|||
46738796|NCT00734578|82955923|FG000|Overall Study|Lack of Efficacy|3|||
46738797|NCT00734578|82955924|FG001|Overall Study|Lack of Efficacy|2|||
46738798|NCT00734578|82955925|FG002|Overall Study|Lack of Efficacy|5|||
46738799|NCT00734578|82955923|FG000|Overall Study|Randomized in error|1|||
46738800|NCT00734578|82955924|FG001|Overall Study|Randomized in error|0|||
46738801|NCT00734578|82955925|FG002|Overall Study|Randomized in error|0|||
46738802|NCT00734578|82955923|FG000|Overall Study|Exclusion criteria|1|||
46738803|NCT00734578|82955924|FG001|Overall Study|Exclusion criteria|0|||
46738804|NCT00734578|82955925|FG002|Overall Study|Exclusion criteria|0|||
46738805|NCT00739102|82955933|FG000|Overall Study|Death|5|||
46738806|NCT00739102|82955933|FG000|Overall Study|Withdrawal by Subject|10|||
46738807|NCT00959192|82955941|FG000|Overall Study|Adverse Event|1|||
46738808|NCT00959192|82955942|FG001|Overall Study|Adverse Event|1|||
46738809|NCT00959192|82955943|FG002|Overall Study|Adverse Event|1|||
46738810|NCT00959192|82955944|FG003|Overall Study|Adverse Event|0|||
46738811|NCT00959192|82955941|FG000|Overall Study|Investigator Request|1|||
46738812|NCT00959192|82955942|FG001|Overall Study|Investigator Request|0|||
46775737|NCT00793793|82994206|FG002|Overall Study|Protocol Violation|0|||
46738813|NCT00959192|82955943|FG002|Overall Study|Investigator Request|0|||
46738814|NCT00959192|82955944|FG003|Overall Study|Investigator Request|0|||
46738815|NCT00959192|82955941|FG000|Overall Study|Caregiver Request|0|||
46738816|NCT00959192|82955942|FG001|Overall Study|Caregiver Request|0|||
46738817|NCT00959192|82955943|FG002|Overall Study|Caregiver Request|2|||
46738818|NCT00959192|82955944|FG003|Overall Study|Caregiver Request|1|||
46738819|NCT00696787|82955958|FG000|Overall Study|Adverse Event|1|||
46738820|NCT00696787|82955959|FG001|Overall Study|Adverse Event|0|||
46738821|NCT00696787|82955960|FG002|Overall Study|Adverse Event|6|||
46738822|NCT00696787|82955958|FG000|Overall Study|Discontinuation by Sponsor|9|||
46738823|NCT00696787|82955959|FG001|Overall Study|Discontinuation by Sponsor|13|||
46738824|NCT00696787|82955960|FG002|Overall Study|Discontinuation by Sponsor|14|||
46738825|NCT00696787|82955958|FG000|Overall Study|Lack of Efficacy|0|||
46738826|NCT00696787|82955959|FG001|Overall Study|Lack of Efficacy|1|||
46738827|NCT00696787|82955960|FG002|Overall Study|Lack of Efficacy|0|||
46738828|NCT00696787|82955958|FG000|Overall Study|Lost to Follow-up|4|||
46738829|NCT00696787|82955959|FG001|Overall Study|Lost to Follow-up|0|||
46738830|NCT00696787|82955960|FG002|Overall Study|Lost to Follow-up|3|||
46738831|NCT00696787|82955958|FG000|Overall Study|Withdrawal by Subject|0|||
46738832|NCT00696787|82955959|FG001|Overall Study|Withdrawal by Subject|3|||
46738833|NCT00696787|82955960|FG002|Overall Study|Withdrawal by Subject|2|||
46738834|NCT00696787|82955958|FG000|Overall Study|Failed to return|1|||
46738835|NCT00696787|82955959|FG001|Overall Study|Failed to return|3|||
46738836|NCT00696787|82955960|FG002|Overall Study|Failed to return|1|||
46738837|NCT01012037|82955971|FG000|Overall Study|Adverse Event|0|||
46738838|NCT01012037|82955972|FG001|Overall Study|Adverse Event|8|||
46738839|NCT01012037|82955973|FG002|Overall Study|Adverse Event|3|||
46738840|NCT01012037|82955971|FG000|Overall Study|Protocol Violation|0|||
46738841|NCT01012037|82955972|FG001|Overall Study|Protocol Violation|3|||
46738842|NCT01012037|82955973|FG002|Overall Study|Protocol Violation|5|||
46738843|NCT01012037|82955971|FG000|Overall Study|Withdrawal by Subject|0|||
46738844|NCT01012037|82955972|FG001|Overall Study|Withdrawal by Subject|4|||
46738845|NCT01012037|82955973|FG002|Overall Study|Withdrawal by Subject|1|||
46738846|NCT01012037|82955971|FG000|Overall Study|Other reason (not specified)|1|||
46738847|NCT01012037|82955972|FG001|Overall Study|Other reason (not specified)|1|||
46738848|NCT01012037|82955973|FG002|Overall Study|Other reason (not specified)|1|||
46738849|NCT00734032|82955985|FG000|Overall Study|Adverse Event|0|||
46738850|NCT00734032|82955986|FG001|Overall Study|Adverse Event|1|||
46738851|NCT00734032|82955987|FG002|Overall Study|Adverse Event|0|||
46738852|NCT00734032|82955988|FG003|Overall Study|Adverse Event|0|||
46738853|NCT01010633|82956000|FG000|Overall Study|Adverse Event|1|||
46738854|NCT01010633|82956001|FG001|Overall Study|Adverse Event|1|||
46738855|NCT01010633|82956000|FG000|Overall Study|Protocol Violation|1|||
46738856|NCT01010633|82956001|FG001|Overall Study|Protocol Violation|2|||
46738857|NCT01010633|82956000|FG000|Overall Study|Withdrawal by Subject|2|||
46738858|NCT01010633|82956001|FG001|Overall Study|Withdrawal by Subject|1|||
46738859|NCT01010633|82956000|FG000|Overall Study|Investigator decision|0|||
46738860|NCT01010633|82956001|FG001|Overall Study|Investigator decision|1|||
46738861|NCT00733954|82956009|FG000|Overall Study|Lost to Follow-up|5|||
46738862|NCT00733954|82956010|FG001|Overall Study|Lost to Follow-up|2|||
46738863|NCT00733954|82956009|FG000|Overall Study|Protocol Violation|1|||
46738864|NCT00733954|82956010|FG001|Overall Study|Protocol Violation|0|||
46738865|NCT00733954|82956009|FG000|Overall Study|Withdrawal by Subject|2|||
46738866|NCT00733954|82956010|FG001|Overall Study|Withdrawal by Subject|0|||
46738867|NCT00733408|82956016|FG000|Overall Study|Adverse Event|4|||
47050101|NCT01682720|83310729|FG003|Overall Study|Randomized but Not Treated|0|||
47050102|NCT01682720|83310726|FG000|Overall Study|Terminated by Sponsor|83|||
47050103|NCT01682720|83310727|FG001|Overall Study|Terminated by Sponsor|0|||
47050104|NCT01682720|83310728|FG002|Overall Study|Terminated by Sponsor|0|||
47050105|NCT01682720|83310729|FG003|Overall Study|Terminated by Sponsor|0|||
47050106|NCT01682720|83310726|FG000|Overall Study|Efficacy Failure|0|||
47050107|NCT01682720|83310727|FG001|Overall Study|Efficacy Failure|3|||
47050108|NCT01682720|83310728|FG002|Overall Study|Efficacy Failure|3|||
46635349|NCT01587924|82808971|FG002|Overall Study|Adverse Event|0|||
46738868|NCT01010867|82956020|FG000|Overall Study|< 50% adherence to probiotic|1|||
46738869|NCT00576823|82956027|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
47050109|NCT01682720|83310729|FG003|Overall Study|Efficacy Failure|30|||
47050110|NCT01682720|83310726|FG000|Overall Study|Lost to Follow-up|1|||
47050111|NCT01682720|83310727|FG001|Overall Study|Lost to Follow-up|1|||
47050112|NCT01682720|83310728|FG002|Overall Study|Lost to Follow-up|0|||
46738870|NCT00576823|82956028|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
46738871|NCT00576823|82956029|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
46738872|NCT00576823|82956027|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
46738873|NCT00576823|82956028|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
46738874|NCT00576823|82956029|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
46738875|NCT00732940|82956042|FG000|Overall Study|Withdrawal by Subject|1|||
46738876|NCT00732940|82956043|FG001|Overall Study|Withdrawal by Subject|2|||
46738877|NCT00732940|82956042|FG000|Overall Study|Adverse Event|0|||
46738878|NCT00732940|82956043|FG001|Overall Study|Adverse Event|1|||
46738879|NCT00732940|82956042|FG000|Overall Study|Lost to Follow-up|1|||
46738880|NCT00732940|82956043|FG001|Overall Study|Lost to Follow-up|0|||
46738881|NCT00962390|82956053|FG000|Overall Study|Adverse Event|0|||
46738882|NCT00962390|82956054|FG001|Overall Study|Adverse Event|0|||
46738883|NCT00962390|82956055|FG002|Overall Study|Adverse Event|3|||
46738884|NCT00962390|82956056|FG003|Overall Study|Adverse Event|1|||
46738885|NCT00962390|82956053|FG000|Overall Study|Lost to Follow-up|2|||
46738886|NCT00962390|82956054|FG001|Overall Study|Lost to Follow-up|2|||
46738887|NCT00962390|82956055|FG002|Overall Study|Lost to Follow-up|0|||
46738888|NCT00962390|82956056|FG003|Overall Study|Lost to Follow-up|0|||
46738889|NCT00962390|82956053|FG000|Overall Study|Protocol Violation|1|||
46738890|NCT00962390|82956054|FG001|Overall Study|Protocol Violation|0|||
46738891|NCT00962390|82956055|FG002|Overall Study|Protocol Violation|0|||
46738892|NCT00962390|82956056|FG003|Overall Study|Protocol Violation|0|||
46738893|NCT00962390|82956053|FG000|Overall Study|Withdrawal by Subject|1|||
46738894|NCT00962390|82956054|FG001|Overall Study|Withdrawal by Subject|1|||
46738895|NCT00962390|82956055|FG002|Overall Study|Withdrawal by Subject|1|||
46738896|NCT00962390|82956056|FG003|Overall Study|Withdrawal by Subject|0|||
46738897|NCT00732472|82956070|FG000|Overall Study|Adverse Event|0|||
46738898|NCT00732472|82956071|FG001|Overall Study|Adverse Event|1|||
46738899|NCT00732472|82956072|FG002|Overall Study|Adverse Event|1|||
46738900|NCT00732472|82956073|FG003|Overall Study|Adverse Event|1|||
46738901|NCT00732472|82956070|FG000|Overall Study|Protocol Violation|0|||
46738902|NCT00732472|82956071|FG001|Overall Study|Protocol Violation|0|||
46738903|NCT00732472|82956072|FG002|Overall Study|Protocol Violation|0|||
46738904|NCT00732472|82956073|FG003|Overall Study|Protocol Violation|1|||
46738905|NCT00732472|82956070|FG000|Overall Study|Withdrawal by Subject|0|||
47050113|NCT01682720|83310729|FG003|Overall Study|Lost to Follow-up|6|||
47050114|NCT01682720|83310726|FG000|Overall Study|Subject Withdrew Consent|0|||
47050115|NCT01682720|83310727|FG001|Overall Study|Subject Withdrew Consent|0|||
47050116|NCT01682720|83310728|FG002|Overall Study|Subject Withdrew Consent|2|||
47050117|NCT01682720|83310729|FG003|Overall Study|Subject Withdrew Consent|2|||
47050118|NCT01682720|83310726|FG000|Overall Study|Adverse Event|1|||
47050119|NCT01682720|83310727|FG001|Overall Study|Adverse Event|0|||
47050120|NCT01682720|83310728|FG002|Overall Study|Adverse Event|1|||
47050121|NCT01682720|83310729|FG003|Overall Study|Adverse Event|1|||
47050122|NCT01714544|83310748|FG000|Overall Study|Lost to Follow-up|1|||
47050123|NCT01714544|83310748|FG000|Overall Study|Physician Decision|1|||
47050124|NCT01714544|83310748|FG000|Overall Study|Withdrawal by Subject|1|||
47050125|NCT01703858|83310755|FG000|Overall Study|Withdrawal by Subject|0|||
47050126|NCT01703858|83310756|FG001|Overall Study|Withdrawal by Subject|1|||
47050127|NCT01703858|83310757|FG002|Overall Study|Withdrawal by Subject|0|||
47050128|NCT01714310|83310773|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
47050129|NCT01714310|83310774|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
47050130|NCT01714310|83310775|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
47050131|NCT01714310|83310773|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
47050132|NCT01714310|83310774|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
47050133|NCT01714310|83310775|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
47050134|NCT01714310|83310773|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
47050135|NCT01714310|83310774|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
47050136|NCT01714310|83310775|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
47050137|NCT01714310|83310773|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
47050138|NCT01714310|83310774|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
47050139|NCT01714310|83310775|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
47050140|NCT01713998|83310796|FG000|Overall Study|Lost to Follow-up|2|||
47050141|NCT01713998|83310797|FG001|Overall Study|Lost to Follow-up|0|||
47050142|NCT01713998|83310798|FG002|Overall Study|Lost to Follow-up|2|||
47050143|NCT01713998|83310796|FG000|Overall Study|Withdrawal by Subject|1|||
47050144|NCT01713998|83310797|FG001|Overall Study|Withdrawal by Subject|0|||
46738906|NCT00732472|82956071|FG001|Overall Study|Withdrawal by Subject|2|||
46738907|NCT00732472|82956072|FG002|Overall Study|Withdrawal by Subject|0|||
46738908|NCT00732472|82956073|FG003|Overall Study|Withdrawal by Subject|1|||
46738909|NCT00960986|82956088|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
46738910|NCT00960986|82956089|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
46921802|NCT04962698|83154465|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
46921803|NCT04962698|83154464|FG000|Kinesthetic MI|Technical difficulty|1|||
47050145|NCT01713998|83310798|FG002|Overall Study|Withdrawal by Subject|0|||
47050146|NCT01681628|83310808|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
47050147|NCT01681628|83310809|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
46738911|NCT00960986|82956090|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
46738912|NCT00960986|82956091|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
46738913|NCT00960986|82956088|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
47050148|NCT01681628|83310808|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
47050149|NCT01681628|83310809|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
47050150|NCT01681628|83310808|FG000|19 Months Follow-up|Death|1|||
47050151|NCT01681628|83310809|FG001|19 Months Follow-up|Death|0|||
47050152|NCT01681628|83310808|FG000|19 Months Follow-up|Lost to Follow-up|61|||
47050153|NCT01681628|83310809|FG001|19 Months Follow-up|Lost to Follow-up|43|||
47050154|NCT00016354|83310831|FG000|Overall Study|Lack of Efficacy|0|||
47050155|NCT00016354|83310832|FG001|Overall Study|Lack of Efficacy|0|||
47050156|NCT00016354|83310833|FG002|Overall Study|Lack of Efficacy|0|||
47050157|NCT00016354|83310834|FG003|Overall Study|Lack of Efficacy|0|||
46738914|NCT00960986|82956089|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
46738915|NCT00960986|82956090|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
46738916|NCT00960986|82956091|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
46738917|NCT00960986|82956088|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
46738918|NCT00960986|82956089|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
46738919|NCT00960986|82956090|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
46738920|NCT00960986|82956091|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
46738921|NCT00960986|82956088|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
46738922|NCT00960986|82956089|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
46738923|NCT00960986|82956090|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
46738924|NCT00960986|82956091|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
46738925|NCT00960986|82956088|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
46738926|NCT00960986|82956089|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
46738927|NCT00960986|82956090|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
46738928|NCT00960986|82956091|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
46738929|NCT00960986|82956088|FG000|Period 3 (7-week Therapy Period)|Death|0|||
46738930|NCT00960986|82956089|FG001|Period 3 (7-week Therapy Period)|Death|0|||
46738931|NCT00960986|82956090|FG002|Period 3 (7-week Therapy Period)|Death|1|||
46738932|NCT00960986|82956091|FG003|Period 3 (7-week Therapy Period)|Death|0|||
46738933|NCT00960986|82956088|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
46738934|NCT00960986|82956089|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
46738935|NCT00960986|82956090|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
46738936|NCT00960986|82956091|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
46738937|NCT00960986|82956088|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
46738938|NCT00960986|82956089|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
46738939|NCT00960986|82956090|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
46738940|NCT00960986|82956091|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
46738941|NCT00960986|82956088|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
46738942|NCT00960986|82956089|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
46738943|NCT00960986|82956090|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
46738944|NCT00960986|82956091|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
46738945|NCT00960986|82956088|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
46738946|NCT00960986|82956089|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
46738947|NCT00960986|82956090|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
46738948|NCT00960986|82956091|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
46738949|NCT00732238|82956103|FG000|Overall Study|Bacteremia|4|||
46738950|NCT00732238|82956104|FG001|Overall Study|Bacteremia|1|||
46738951|NCT00732238|82956103|FG000|Overall Study|Asymptomatic bacteriuria|1|||
46738952|NCT00732238|82956104|FG001|Overall Study|Asymptomatic bacteriuria|0|||
46738953|NCT00958880|82956114|FG000|Overall Study|Lost to Follow-up|2|||
46738954|NCT00958880|82956115|FG001|Overall Study|Lost to Follow-up|2|||
46738955|NCT00732160|82956125|FG000|Overall Study|Adverse Event|1|||
46738956|NCT00732160|82956126|FG001|Overall Study|Adverse Event|0|||
46738957|NCT00732160|82956127|FG002|Overall Study|Adverse Event|1|||
46738958|NCT00732160|82956128|FG003|Overall Study|Adverse Event|1|||
46738959|NCT00732160|82956125|FG000|Overall Study|scheduling|4|||
46738960|NCT00732160|82956126|FG001|Overall Study|scheduling|4|||
46738961|NCT00732160|82956127|FG002|Overall Study|scheduling|2|||
46738962|NCT00732160|82956128|FG003|Overall Study|scheduling|1|||
46738963|NCT00958724|82956138|FG000|Overall Study|Disease Progression|6|||
46738964|NCT00738400|82956144|FG000|Overall Study|Adverse Event|3|||
46738965|NCT00738400|82956145|FG001|Overall Study|Adverse Event|1|||
46738966|NCT00738400|82956144|FG000|Overall Study|Withdrawal by Subject|0|||
46921804|NCT04962698|83154465|FG001|Kinesthetic MI|Technical difficulty|0|||
46921805|NCT04962698|83154464|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
46635350|NCT01587924|82808972|FG003|Overall Study|Adverse Event|0|||
46635351|NCT01587924|82808969|FG000|Overall Study|Protocol Violation|2|||
46635352|NCT01587924|82808970|FG001|Overall Study|Protocol Violation|1|||
46738967|NCT00738400|82956145|FG001|Overall Study|Withdrawal by Subject|1|||
46738968|NCT00738400|82956144|FG000|Overall Study|Lack of Efficacy|0|||
46738969|NCT00738400|82956145|FG001|Overall Study|Lack of Efficacy|1|||
46738970|NCT00738400|82956144|FG000|Overall Study|Lost to Follow-up|0|||
46738971|NCT00738400|82956145|FG001|Overall Study|Lost to Follow-up|3|||
46738972|NCT00738400|82956144|FG000|Overall Study|Protocol Violation|1|||
47050158|NCT00016354|83310835|FG004|Overall Study|Lack of Efficacy|0|||
47050159|NCT00016354|83310836|FG005|Overall Study|Lack of Efficacy|0|||
46738973|NCT00738400|82956145|FG001|Overall Study|Protocol Violation|0|||
46738974|NCT00738400|82956144|FG000|Overall Study|Non-compliant with study medication|0|||
46738975|NCT00738400|82956145|FG001|Overall Study|Non-compliant with study medication|1|||
46738976|NCT01009463|82956155|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
46738977|NCT01009463|82956156|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46738978|NCT01009463|82956157|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46738979|NCT01009463|82956158|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46738980|NCT01009463|82956159|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46738981|NCT01009463|82956155|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
46738982|NCT01009463|82956156|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
46738983|NCT01009463|82956157|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
46738984|NCT01009463|82956158|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
46738985|NCT01009463|82956159|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
46738986|NCT01009463|82956155|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
46738987|NCT01009463|82956156|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46738988|NCT01009463|82956157|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46738989|NCT01009463|82956158|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46738990|NCT01009463|82956159|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46738991|NCT01009463|82956155|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
46738992|NCT01009463|82956156|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
46738993|NCT01009463|82956157|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
46738994|NCT01009463|82956158|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
46738995|NCT01009463|82956159|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
46738996|NCT01009463|82956155|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
46738997|NCT01009463|82956156|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46738998|NCT01009463|82956157|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46738999|NCT01009463|82956158|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46739000|NCT01009463|82956159|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46739001|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
46739002|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
46739003|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
46739004|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
46739005|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
46739006|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
46739007|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
46739008|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
46739009|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
46739010|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
46739011|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
46739012|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
46739013|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
46739014|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
46739015|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
46804085|NCT00541970|83023283|FG003|Month 18|Adverse Event|1|||
46804086|NCT00541970|83023280|FG000|Month 18|Protocol Violation|14|||
46804087|NCT00541970|83023281|FG001|Month 18|Protocol Violation|23|||
46804088|NCT00541970|83023282|FG002|Month 18|Protocol Violation|24|||
46804089|NCT00541970|83023283|FG003|Month 18|Protocol Violation|16|||
46804090|NCT00541970|83023280|FG000|Month 24|Adverse Event|0|||
47050160|NCT00016354|83310837|FG006|Overall Study|Lack of Efficacy|0|||
47050161|NCT00016354|83310838|FG007|Overall Study|Lack of Efficacy|1|||
47050162|NCT01681472|83310846|FG000|Overall Study|Adverse Event|0|||
47050163|NCT01681472|83310847|FG001|Overall Study|Adverse Event|1|||
47050164|NCT01681472|83310848|FG002|Overall Study|Adverse Event|0|||
47050165|NCT01681472|83310849|FG003|Overall Study|Adverse Event|0|||
47050166|NCT01049308|83310878|FG000|Pill Counts|Withdrawal by Subject|83|||
47050167|NCT01713686|83310885|FG000|Overall Study|Lost to Follow-up|9|||
47050168|NCT01713686|83310885|FG000|Overall Study|Withdrawal by Subject|6|||
46635353|NCT01587924|82808971|FG002|Overall Study|Protocol Violation|2|||
46635354|NCT01587924|82808972|FG003|Overall Study|Protocol Violation|1|||
46921806|NCT04962698|83154465|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
46921807|NCT04962698|83154464|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
46921808|NCT04962698|83154465|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
46921809|NCT04962698|83154464|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
47050169|NCT01047436|83310891|FG000|Overall Study|Protocol Violation|1|||
47050170|NCT01047436|83310892|FG001|Overall Study|Protocol Violation|0|||
46635355|NCT01587924|82808969|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
47050171|NCT01681004|83310900|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
47050172|NCT01681004|83310901|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
47050173|NCT01681004|83310900|FG000|Study Completion|Lost to Follow-up|8|||
47050174|NCT01681004|83310901|FG001|Study Completion|Lost to Follow-up|3|||
47050175|NCT01681004|83310900|FG000|Study Completion|Physician Decision|1|||
47050176|NCT01681004|83310901|FG001|Study Completion|Physician Decision|3|||
47050177|NCT01681004|83310900|FG000|Study Completion|Site Termination|2|||
47050178|NCT01681004|83310901|FG001|Study Completion|Site Termination|1|||
47050179|NCT01681004|83310900|FG000|Study Completion|Death|1|||
47050180|NCT01681004|83310901|FG001|Study Completion|Death|1|||
47050181|NCT01046110|83310913|FG000|Overall Study|Adverse Event|9|||
46921810|NCT04962698|83154465|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
46921811|NCT04962698|83154464|FG000|Virtual-hand Interaction|Technical difficulty|1|||
46921812|NCT04962698|83154465|FG001|Virtual-hand Interaction|Technical difficulty|0|||
46921813|NCT04962698|83154464|FG000|Robotic Action Observation|Technical difficulty|1|||
46921814|NCT04962698|83154465|FG001|Robotic Action Observation|Technical difficulty|0|||
46921815|NCT04962698|83154464|FG000|Rest|Technical difficulty|1|||
46921816|NCT04962698|83154465|FG001|Rest|Technical difficulty|0|||
46921817|NCT04962698|83154464|FG000|Rest|Exclusion criteria met after enrollment|0|||
46921818|NCT04962698|83154465|FG001|Rest|Exclusion criteria met after enrollment|2|||
46921819|NCT04609514|83154474|FG000|Overall Study|Lost to Follow-up|5|||
46921820|NCT04609514|83154475|FG001|Overall Study|Lost to Follow-up|4|||
46921821|NCT04609514|83154474|FG000|Overall Study|Withdrawal by PI|0|||
46921822|NCT04609514|83154475|FG001|Overall Study|Withdrawal by PI|2|||
46921823|NCT04489771|83154484|FG000|Overall Study|Death|27|||
46921824|NCT04489771|83154485|FG001|Overall Study|Death|25|||
46921825|NCT04489771|83154484|FG000|Overall Study|Withdrawal by Subject|1|||
46921826|NCT04489771|83154485|FG001|Overall Study|Withdrawal by Subject|0|||
46921827|NCT04489771|83154484|FG000|Overall Study|Participants Ongoing in Study|50|||
46921828|NCT04489771|83154485|FG001|Overall Study|Participants Ongoing in Study|51|||
46921829|NCT04467840|83154493|FG000|Overall Study|Death|35|||
47050182|NCT01046110|83310914|FG001|Overall Study|Adverse Event|2|||
47050183|NCT01046110|83310913|FG000|Overall Study|Lack of Efficacy|0|||
47050184|NCT01046110|83310914|FG001|Overall Study|Lack of Efficacy|1|||
47050185|NCT01046110|83310913|FG000|Overall Study|Protocol Violation|7|||
47050186|NCT01046110|83310914|FG001|Overall Study|Protocol Violation|12|||
47050187|NCT01046110|83310913|FG000|Overall Study|Withdrawal Criteria|3|||
47050188|NCT01046110|83310914|FG001|Overall Study|Withdrawal Criteria|5|||
47050189|NCT01046110|83310913|FG000|Overall Study|Unclassified|36|||
47050190|NCT01046110|83310914|FG001|Overall Study|Unclassified|35|||
47050191|NCT01713530|83310922|FG000|Overall Study|Adverse Event|0|||
47050192|NCT01713530|83310923|FG001|Overall Study|Adverse Event|5|||
47050193|NCT01713530|83310922|FG000|Overall Study|Withdrawal criteria|21|||
47050194|NCT01713530|83310923|FG001|Overall Study|Withdrawal criteria|12|||
46921830|NCT04467840|83154494|FG001|Overall Study|Death|39|||
46921831|NCT04467840|83154493|FG000|Overall Study|Withdrawal by Subject|8|||
46921832|NCT04467840|83154494|FG001|Overall Study|Withdrawal by Subject|4|||
46921833|NCT04467840|83154493|FG000|Overall Study|Adverse Event|2|||
46921834|NCT04467840|83154494|FG001|Overall Study|Adverse Event|0|||
47050195|NCT01713530|83310922|FG000|Overall Study|Unclassified|4|||
47050196|NCT01713530|83310923|FG001|Overall Study|Unclassified|2|||
47050197|NCT01045798|83310931|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
47050198|NCT01045798|83310932|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
47050199|NCT01045798|83310931|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
47050200|NCT01045798|83310932|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
47050201|NCT01045798|83310931|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
47050202|NCT01045798|83310932|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
47050203|NCT01045798|83310931|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
47050204|NCT01045798|83310932|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
47050205|NCT01712984|83310945|FG000|Overall Study|Adverse Event|0|||
47050206|NCT01712984|83310946|FG001|Overall Study|Adverse Event|0|||
46921835|NCT04467840|83154493|FG000|Overall Study|Lost to Follow-up|1|||
47050207|NCT01712984|83310947|FG002|Overall Study|Adverse Event|1|||
46635356|NCT01587924|82808970|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
46635357|NCT01587924|82808971|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
46635358|NCT01587924|82808972|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
46921836|NCT04467840|83154494|FG001|Overall Study|Lost to Follow-up|3|||
46921837|NCT04467840|83154493|FG000|Overall Study|Physician Decision|1|||
46921838|NCT04467840|83154494|FG001|Overall Study|Physician Decision|0|||
46921839|NCT04467840|83154493|FG000|Overall Study|Other|1|||
46921840|NCT04467840|83154494|FG001|Overall Study|Other|5|||
46921841|NCT04467840|83154493|FG000|Overall Study|Missing study completion status|3|||
47050208|NCT01712984|83310945|FG000|Overall Study|Protocol Violation|2|||
47050209|NCT01712984|83310946|FG001|Overall Study|Protocol Violation|0|||
47050210|NCT01712984|83310947|FG002|Overall Study|Protocol Violation|1|||
47050211|NCT01712984|83310945|FG000|Overall Study|Lost to Follow-up|8|||
47050212|NCT01712984|83310946|FG001|Overall Study|Lost to Follow-up|10|||
47050213|NCT01712984|83310947|FG002|Overall Study|Lost to Follow-up|1|||
47050214|NCT01712984|83310945|FG000|Overall Study|Withdrawal by Subject|6|||
46635359|NCT01587924|82808969|FG000|Overall Study|Withdrawal by Subject|0|||
46635360|NCT01587924|82808970|FG001|Overall Study|Withdrawal by Subject|1|||
46635361|NCT01587924|82808971|FG002|Overall Study|Withdrawal by Subject|1|||
46635362|NCT01587924|82808972|FG003|Overall Study|Withdrawal by Subject|0|||
46635363|NCT01539642|82808984|FG000|Overall Study|Lack of Efficacy|20|||
46635364|NCT01539642|82808985|FG001|Overall Study|Lack of Efficacy|18|||
46635365|NCT01539642|82808984|FG000|Overall Study|Patient ready for early discharge|8|||
46635366|NCT01539642|82808985|FG001|Overall Study|Patient ready for early discharge|7|||
46921842|NCT04467840|83154494|FG001|Overall Study|Missing study completion status|1|||
46921843|NCT04295499|83154504|FG000|Overall Study|moving out of state|1|||
46921844|NCT04295499|83154505|FG001|Overall Study|moving out of state|0|||
46921845|NCT04295499|83154504|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
46921846|NCT04295499|83154505|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
46921847|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
46921848|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
46921849|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
46921850|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
46921851|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
46921852|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
46921853|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
46921854|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
46921855|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
46921856|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
47050215|NCT01712984|83310946|FG001|Overall Study|Withdrawal by Subject|6|||
47050216|NCT01712984|83310947|FG002|Overall Study|Withdrawal by Subject|7|||
47050217|NCT01042678|83310958|FG000|Overall Study|Physician Decision|1|||
47050218|NCT01042678|83310959|FG001|Overall Study|Physician Decision|0|||
47050219|NCT01042678|83310960|FG002|Overall Study|Physician Decision|0|||
46921857|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
46921858|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
46921859|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
46921860|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
46921861|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
46921862|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
46921863|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
46921864|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
46921865|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
46921866|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
46921867|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
46921868|NCT04021290|83154513|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
46921869|NCT04021290|83154514|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
46921870|NCT04021290|83154515|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
46921871|NCT04021290|83154513|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
46921872|NCT04021290|83154514|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
46921873|NCT04021290|83154515|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
46921874|NCT04021290|83154513|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
46921875|NCT04021290|83154514|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
46921876|NCT04021290|83154515|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
47050220|NCT01042678|83310961|FG003|Overall Study|Physician Decision|0|||
47050221|NCT01042678|83310962|FG004|Overall Study|Physician Decision|0|||
47050222|NCT01042678|83310963|FG005|Overall Study|Physician Decision|0|||
47050223|NCT01042600|83310973|FG000|Overall Study|Ineligible|1|||
46739016|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
46739017|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
46739018|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
46739019|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
46739020|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
46739021|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
46739022|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
46739023|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
46739024|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
46739025|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
46739026|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
46739027|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
46739028|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
46804091|NCT00541970|83023281|FG001|Month 24|Adverse Event|1|||
46804092|NCT00541970|83023282|FG002|Month 24|Adverse Event|1|||
46739029|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
46739030|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
46739031|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46739032|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
46739033|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
46739034|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
46739035|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
46739036|NCT01009463|82956155|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
46739037|NCT01009463|82956156|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
46739038|NCT01009463|82956157|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
46739039|NCT01009463|82956158|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
46739040|NCT01009463|82956159|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
46739041|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
46739042|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
46739043|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
46739044|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
46739045|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
46739046|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
46739047|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
46739048|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
46739049|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
46739050|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
46739051|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
46739052|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
46739053|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
46739054|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
46739055|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
46739056|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
46739057|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
46739058|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
46739059|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
46739060|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
46739061|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
46739062|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
46739063|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
46739064|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
46739065|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
46739066|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
46739067|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
46739068|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
46739069|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
46739070|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
46739071|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
46739072|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
46739073|NCT00958568|82956170|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
46739074|NCT00958568|82956171|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
46739075|NCT00958568|82956172|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
46739076|NCT00958568|82956173|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
46739077|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
46739078|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
46739079|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
46739080|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
46739081|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
46739082|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
46739083|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
46739084|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
46739085|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
46739086|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
46739087|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
46739088|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
46739089|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
46921877|NCT04021290|83154513|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
46739090|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
46739091|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
46739092|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
46739093|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
46739094|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
46739095|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
46739096|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
46739097|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
46739098|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
46739099|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
46739100|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
46739101|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
46739102|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
46739103|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
46739104|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
46739105|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
46739106|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
46739107|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
46739108|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
46739109|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
46739110|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
46739111|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
46739112|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
46739113|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
46739114|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
46739115|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
46739116|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
46739117|NCT00958568|82956170|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
46739118|NCT00958568|82956171|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
46739119|NCT00958568|82956172|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
46739120|NCT00958568|82956173|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
46739121|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
46739122|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
46739123|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
46739124|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
46739125|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
46739126|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
46739127|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
46739128|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
46739129|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
46739130|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
46739131|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
46739132|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
46739133|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
46739134|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
46739135|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
46739136|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
46739137|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
46739138|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
46739139|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
46739140|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
46739141|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
46921878|NCT04021290|83154514|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
46921879|NCT04021290|83154515|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
47050224|NCT01042600|83310974|FG001|Overall Study|Ineligible|0|||
46739142|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
46739143|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
46739144|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
46739145|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
46804093|NCT00541970|83023283|FG003|Month 24|Adverse Event|1|||
47050225|NCT01041976|83310983|FG000|Overall Study|Withdrawal by Subject|3|||
47050226|NCT01041976|83310984|FG001|Overall Study|Withdrawal by Subject|0|||
47050227|NCT01041976|83310983|FG000|Overall Study|Incarceration|2|||
47050228|NCT01041976|83310984|FG001|Overall Study|Incarceration|0|||
46804094|NCT00541970|83023280|FG000|Month 24|Protocol Violation|29|||
47050229|NCT01041976|83310983|FG000|Overall Study|Death|0|||
47050230|NCT01041976|83310984|FG001|Overall Study|Death|4|||
46739146|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
46739147|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
46739148|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
46739149|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
46739150|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
46739151|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
46739152|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
46739153|NCT00958568|82956170|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
46739154|NCT00958568|82956171|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
46739155|NCT00958568|82956172|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
46739156|NCT00958568|82956173|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
46739157|NCT00958412|82956184|FG000|Overall Study|Study prematurely terminated|18|||
46739158|NCT00958256|82956188|FG000|Overall Study|Adverse Event|3|||
46739159|NCT00696709|82956197|FG000|Overall Study|Withdrawal by Subject|1|||
46739160|NCT00696709|82956198|FG001|Overall Study|Withdrawal by Subject|2|||
46739161|NCT00696709|82956199|FG002|Overall Study|Withdrawal by Subject|1|||
46739162|NCT00696709|82956200|FG003|Overall Study|Withdrawal by Subject|4|||
46739163|NCT00696709|82956201|FG004|Overall Study|Withdrawal by Subject|3|||
46739164|NCT00696709|82956197|FG000|Overall Study|Protocol Violation|1|||
46739165|NCT00696709|82956198|FG001|Overall Study|Protocol Violation|0|||
46739166|NCT00696709|82956199|FG002|Overall Study|Protocol Violation|0|||
46739167|NCT00696709|82956200|FG003|Overall Study|Protocol Violation|0|||
46739168|NCT00696709|82956201|FG004|Overall Study|Protocol Violation|0|||
46739169|NCT00696709|82956197|FG000|Overall Study|Lost to Follow-up|1|||
46739170|NCT00696709|82956198|FG001|Overall Study|Lost to Follow-up|1|||
46739171|NCT00696709|82956199|FG002|Overall Study|Lost to Follow-up|0|||
46739172|NCT00696709|82956200|FG003|Overall Study|Lost to Follow-up|0|||
46739173|NCT00696709|82956201|FG004|Overall Study|Lost to Follow-up|0|||
46739174|NCT00696709|82956197|FG000|Overall Study|Adverse Event|0|||
46739175|NCT00696709|82956198|FG001|Overall Study|Adverse Event|0|||
46739176|NCT00696709|82956199|FG002|Overall Study|Adverse Event|0|||
46739177|NCT00696709|82956200|FG003|Overall Study|Adverse Event|1|||
46739178|NCT00696709|82956201|FG004|Overall Study|Adverse Event|0|||
46739179|NCT01006265|82956221|FG000|Overall Study|Lost to Follow-up|1|||
46739180|NCT01006265|82956222|FG001|Overall Study|Lost to Follow-up|0|||
46739181|NCT01006265|82956223|FG002|Overall Study|Lost to Follow-up|1|||
46739182|NCT01006265|82956224|FG003|Overall Study|Lost to Follow-up|0|||
46739183|NCT01006265|82956221|FG000|Overall Study|Withdrawal by Subject|4|||
46739184|NCT01006265|82956222|FG001|Overall Study|Withdrawal by Subject|7|||
47050231|NCT01712516|83311010|FG000|Overall Study|Technical problems|0|||
46804095|NCT00541970|83023281|FG001|Month 24|Protocol Violation|31|||
46804096|NCT00541970|83023282|FG002|Month 24|Protocol Violation|31|||
46804097|NCT00541970|83023283|FG003|Month 24|Protocol Violation|21|||
46804098|NCT00541970|83023280|FG000|Month 36|Protocol Violation|61|||
46804099|NCT00541970|83023281|FG001|Month 36|Protocol Violation|66|||
46804100|NCT00541970|83023282|FG002|Month 36|Protocol Violation|66|||
47050232|NCT01712516|83311011|FG001|Overall Study|Technical problems|0|||
47050233|NCT01712516|83311012|FG002|Overall Study|Technical problems|0|||
47050234|NCT01712516|83311013|FG003|Overall Study|Technical problems|2|||
47050235|NCT01712516|83311010|FG000|Overall Study|Lost to Follow-up|0|||
46804101|NCT00541970|83023283|FG003|Month 36|Protocol Violation|60|||
46804102|NCT00541970|83023280|FG000|Month 48|Withdrawal by Subject|2|||
46804103|NCT00541970|83023281|FG001|Month 48|Withdrawal by Subject|4|||
47050236|NCT01712516|83311011|FG001|Overall Study|Lost to Follow-up|0|||
47050237|NCT01712516|83311012|FG002|Overall Study|Lost to Follow-up|2|||
47050238|NCT01712516|83311013|FG003|Overall Study|Lost to Follow-up|1|||
47050239|NCT01712516|83311010|FG000|Overall Study|Death|0|||
47050240|NCT01712516|83311011|FG001|Overall Study|Death|1|||
47050241|NCT01712516|83311012|FG002|Overall Study|Death|0|||
46739185|NCT01006265|82956223|FG002|Overall Study|Withdrawal by Subject|5|||
46804104|NCT00541970|83023282|FG002|Month 48|Withdrawal by Subject|4|||
46804105|NCT00541970|83023283|FG003|Month 48|Withdrawal by Subject|2|||
46739186|NCT01006265|82956224|FG003|Overall Study|Withdrawal by Subject|5|||
46739187|NCT01006265|82956221|FG000|Overall Study|Administrative reason|1|||
46739188|NCT01006265|82956222|FG001|Overall Study|Administrative reason|2|||
46739189|NCT01006265|82956223|FG002|Overall Study|Administrative reason|3|||
46739190|NCT01006265|82956224|FG003|Overall Study|Administrative reason|0|||
46739191|NCT01008995|82956236|FG000|Controlled Period|Adverse Event|1|||
46739192|NCT01008995|82956237|FG001|Controlled Period|Adverse Event|2|||
47050242|NCT01712516|83311013|FG003|Overall Study|Death|0|||
47050243|NCT01712516|83311010|FG000|Overall Study|Protocol deviation|1|||
47050244|NCT01712516|83311011|FG001|Overall Study|Protocol deviation|0|||
46739193|NCT01008995|82956238|FG002|Controlled Period|Adverse Event|0|||
46739194|NCT01008995|82956239|FG003|Controlled Period|Adverse Event|0|||
46739195|NCT01008995|82956236|FG000|Controlled Period|Other|2|||
46739196|NCT01008995|82956237|FG001|Controlled Period|Other|1|||
46739197|NCT01008995|82956238|FG002|Controlled Period|Other|0|||
46739198|NCT01008995|82956239|FG003|Controlled Period|Other|0|||
46739199|NCT01008995|82956236|FG000|After Controlled Period|Adverse Event|0|||
46739200|NCT01008995|82956237|FG001|After Controlled Period|Adverse Event|0|||
46739201|NCT01008995|82956238|FG002|After Controlled Period|Adverse Event|1|||
46739202|NCT01008995|82956239|FG003|After Controlled Period|Adverse Event|1|||
46739203|NCT01008995|82956236|FG000|After Controlled Period|Other|0|||
46739204|NCT01008995|82956237|FG001|After Controlled Period|Other|0|||
46739205|NCT01008995|82956238|FG002|After Controlled Period|Other|1|||
46739206|NCT01008995|82956239|FG003|After Controlled Period|Other|0|||
46739207|NCT00957944|82956249|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
46739208|NCT00957944|82956250|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
46739209|NCT01005875|82956256|FG000|Overall Study|Death|3|||
46739210|NCT01005719|82956260|FG000|Period 1|Adverse Event|0|||
46739211|NCT01005719|82956261|FG001|Period 1|Adverse Event|0|||
46739212|NCT01005719|82956262|FG002|Period 1|Adverse Event|0|||
46739213|NCT01005719|82956263|FG003|Period 1|Adverse Event|1|||
46739214|NCT01005719|82956264|FG004|Period 1|Adverse Event|0|||
46739215|NCT01005719|82956265|FG005|Period 1|Adverse Event|0|||
46739216|NCT01005719|82956260|FG000|Period 1|Delay in completing study procedures|0|||
46739217|NCT01005719|82956261|FG001|Period 1|Delay in completing study procedures|0|||
46739218|NCT01005719|82956262|FG002|Period 1|Delay in completing study procedures|0|||
46739219|NCT01005719|82956263|FG003|Period 1|Delay in completing study procedures|0|||
46739220|NCT01005719|82956264|FG004|Period 1|Delay in completing study procedures|0|||
46739221|NCT01005719|82956265|FG005|Period 1|Delay in completing study procedures|1|||
46739222|NCT01005719|82956260|FG000|Period 2|Adverse Event|0|||
46739223|NCT01005719|82956261|FG001|Period 2|Adverse Event|0|||
46739224|NCT01005719|82956262|FG002|Period 2|Adverse Event|0|||
46739225|NCT01005719|82956263|FG003|Period 2|Adverse Event|0|||
47050245|NCT01712516|83311012|FG002|Overall Study|Protocol deviation|1|||
46739226|NCT01005719|82956264|FG004|Period 2|Adverse Event|1|||
46739227|NCT01005719|82956265|FG005|Period 2|Adverse Event|1|||
46739228|NCT00953576|82956276|FG000|Overall Study|Adverse Event|0|||
46739229|NCT00953576|82956277|FG001|Overall Study|Adverse Event|1|||
46739230|NCT00953576|82956276|FG000|Overall Study|Ineligible after Consent|2|||
46739231|NCT00953576|82956277|FG001|Overall Study|Ineligible after Consent|0|||
46739232|NCT01005329|82956286|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
46739233|NCT01005251|82956296|FG000|Overall Study|Withdrawal by Subject|2|||
46739234|NCT01005251|82956297|FG001|Overall Study|Withdrawal by Subject|5|||
46739235|NCT01005251|82956298|FG002|Overall Study|Withdrawal by Subject|3|||
46739236|NCT01005251|82956299|FG003|Overall Study|Withdrawal by Subject|4|||
46739237|NCT01005251|82956300|FG004|Overall Study|Withdrawal by Subject|9|||
46739238|NCT01005251|82956296|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
46739239|NCT01005251|82956297|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46739240|NCT01005251|82956298|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
47050246|NCT01712516|83311013|FG003|Overall Study|Protocol deviation|0|||
47050247|NCT01712516|83311010|FG000|Overall Study|Physician Decision|2|||
47050248|NCT01712516|83311011|FG001|Overall Study|Physician Decision|0|||
47050249|NCT01712516|83311012|FG002|Overall Study|Physician Decision|0|||
47050250|NCT01712516|83311013|FG003|Overall Study|Physician Decision|1|||
47050251|NCT01712516|83311010|FG000|Overall Study|Withdrawal by Subject|3|||
47050252|NCT01712516|83311011|FG001|Overall Study|Withdrawal by Subject|9|||
47050253|NCT01712516|83311012|FG002|Overall Study|Withdrawal by Subject|3|||
47050254|NCT01712516|83311013|FG003|Overall Study|Withdrawal by Subject|9|||
47050255|NCT01703000|83311023|FG000|Overall Study|Death|1|||
47050256|NCT01040728|83311027|FG000|Overall Study|Adverse Event|4|||
47050257|NCT01040728|83311028|FG001|Overall Study|Adverse Event|8|||
47050258|NCT01040728|83311029|FG002|Overall Study|Adverse Event|0|||
47050259|NCT01040728|83311030|FG003|Overall Study|Adverse Event|4|||
47050260|NCT01040728|83311027|FG000|Overall Study|Withdrawal by Subject|0|||
47050261|NCT01040728|83311028|FG001|Overall Study|Withdrawal by Subject|1|||
47050262|NCT01040728|83311029|FG002|Overall Study|Withdrawal by Subject|1|||
46739241|NCT01005251|82956299|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
47050263|NCT01040728|83311030|FG003|Overall Study|Withdrawal by Subject|0|||
47050264|NCT01040728|83311027|FG000|Overall Study|Protocol Violation|0|||
46739242|NCT01005251|82956300|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
46739243|NCT01005251|82956296|FG000|Overall Study|Adverse Event|2|||
47050265|NCT01040728|83311028|FG001|Overall Study|Protocol Violation|0|||
46739244|NCT01005251|82956297|FG001|Overall Study|Adverse Event|6|||
46739245|NCT01005251|82956298|FG002|Overall Study|Adverse Event|8|||
46739246|NCT01005251|82956299|FG003|Overall Study|Adverse Event|5|||
46739247|NCT01005251|82956300|FG004|Overall Study|Adverse Event|4|||
46739248|NCT01005251|82956296|FG000|Overall Study|Protocol Violation|1|||
46739249|NCT01005251|82956297|FG001|Overall Study|Protocol Violation|0|||
46739250|NCT01005251|82956298|FG002|Overall Study|Protocol Violation|0|||
47050266|NCT01040728|83311029|FG002|Overall Study|Protocol Violation|0|||
46739251|NCT01005251|82956299|FG003|Overall Study|Protocol Violation|0|||
46739252|NCT01005251|82956300|FG004|Overall Study|Protocol Violation|2|||
46739253|NCT01005251|82956296|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
46739254|NCT01005251|82956297|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
46739255|NCT01005251|82956298|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
46739256|NCT01005251|82956299|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
46739257|NCT01005251|82956300|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
46739258|NCT01005251|82956296|FG000|Overall Study|Lost to Follow-up|1|||
46739259|NCT01005251|82956297|FG001|Overall Study|Lost to Follow-up|4|||
46739260|NCT01005251|82956298|FG002|Overall Study|Lost to Follow-up|2|||
46739261|NCT01005251|82956299|FG003|Overall Study|Lost to Follow-up|0|||
46739262|NCT01005251|82956300|FG004|Overall Study|Lost to Follow-up|0|||
46739263|NCT01005251|82956296|FG000|Overall Study|Physician Decision|0|||
46739264|NCT01005251|82956297|FG001|Overall Study|Physician Decision|0|||
46739265|NCT01005251|82956298|FG002|Overall Study|Physician Decision|0|||
46739266|NCT01005251|82956299|FG003|Overall Study|Physician Decision|0|||
46739267|NCT01005251|82956300|FG004|Overall Study|Physician Decision|2|||
46739268|NCT01005251|82956296|FG000|Overall Study|Patient moved|1|||
46739269|NCT01005251|82956297|FG001|Overall Study|Patient moved|0|||
46739270|NCT01005251|82956298|FG002|Overall Study|Patient moved|0|||
46739271|NCT01005251|82956299|FG003|Overall Study|Patient moved|0|||
46739272|NCT01005251|82956300|FG004|Overall Study|Patient moved|0|||
46739273|NCT01005251|82956296|FG000|Overall Study|Wrong drug dispensed|0|||
46739274|NCT01005251|82956297|FG001|Overall Study|Wrong drug dispensed|1|||
46739275|NCT01005251|82956298|FG002|Overall Study|Wrong drug dispensed|0|||
46739276|NCT01005251|82956299|FG003|Overall Study|Wrong drug dispensed|0|||
46739277|NCT01005251|82956300|FG004|Overall Study|Wrong drug dispensed|0|||
46739278|NCT01005251|82956296|FG000|Overall Study|Randomized in error|0|||
46739279|NCT01005251|82956297|FG001|Overall Study|Randomized in error|0|||
46739280|NCT01005251|82956298|FG002|Overall Study|Randomized in error|1|||
46739281|NCT01005251|82956299|FG003|Overall Study|Randomized in error|1|||
46739282|NCT01005251|82956300|FG004|Overall Study|Randomized in error|0|||
46739283|NCT01005251|82956296|FG000|Overall Study|Lack of Efficacy|0|||
46739284|NCT01005251|82956297|FG001|Overall Study|Lack of Efficacy|0|||
46739285|NCT01005251|82956298|FG002|Overall Study|Lack of Efficacy|1|||
46739286|NCT01005251|82956299|FG003|Overall Study|Lack of Efficacy|1|||
46739287|NCT01005251|82956300|FG004|Overall Study|Lack of Efficacy|0|||
46739288|NCT03048578|82956314|FG000|Overall Study|Withdrawal by Subject|5|||
46739289|NCT03048578|82956315|FG001|Overall Study|Withdrawal by Subject|6|||
46739290|NCT03048578|82956314|FG000|Overall Study|Lost to Follow-up|22|||
46739291|NCT03048578|82956315|FG001|Overall Study|Lost to Follow-up|10|||
46739292|NCT03048578|82956314|FG000|Overall Study|Adverse Event|1|||
46739293|NCT03048578|82956315|FG001|Overall Study|Adverse Event|2|||
46739294|NCT03048578|82956314|FG000|Overall Study|Terminated|3|||
46739295|NCT03048578|82956315|FG001|Overall Study|Terminated|2|||
46739296|NCT01008449|82956323|FG000|Overall Study|Lost to Follow-up|29|||
46739297|NCT01008449|82956324|FG001|Overall Study|Lost to Follow-up|19|||
46739298|NCT00696241|82956335|FG000|Overall Study|Adverse Event|11|||
46739299|NCT00696241|82956336|FG001|Overall Study|Adverse Event|3|||
46739300|NCT00696241|82956337|FG002|Overall Study|Adverse Event|6|||
46739301|NCT00696241|82956338|FG003|Overall Study|Adverse Event|4|||
46739302|NCT00696241|82956339|FG004|Overall Study|Adverse Event|5|||
46739303|NCT00696241|82956335|FG000|Overall Study|Protocol Violation|1|||
46739304|NCT00696241|82956336|FG001|Overall Study|Protocol Violation|1|||
46739305|NCT00696241|82956337|FG002|Overall Study|Protocol Violation|2|||
46739306|NCT00696241|82956338|FG003|Overall Study|Protocol Violation|0|||
46739307|NCT00696241|82956339|FG004|Overall Study|Protocol Violation|3|||
46739308|NCT00696241|82956335|FG000|Overall Study|Lost to Follow-up|1|||
46739309|NCT00696241|82956336|FG001|Overall Study|Lost to Follow-up|4|||
46739310|NCT00696241|82956337|FG002|Overall Study|Lost to Follow-up|1|||
46739311|NCT00696241|82956338|FG003|Overall Study|Lost to Follow-up|2|||
46739312|NCT00696241|82956339|FG004|Overall Study|Lost to Follow-up|0|||
46739313|NCT00696241|82956335|FG000|Overall Study|Withdrawal by Subject|4|||
46739314|NCT00696241|82956336|FG001|Overall Study|Withdrawal by Subject|8|||
46739315|NCT00696241|82956337|FG002|Overall Study|Withdrawal by Subject|6|||
46739316|NCT00696241|82956338|FG003|Overall Study|Withdrawal by Subject|1|||
46739317|NCT00696241|82956339|FG004|Overall Study|Withdrawal by Subject|0|||
46739318|NCT00696241|82956335|FG000|Overall Study|Lack of Efficacy|1|||
46739319|NCT00696241|82956336|FG001|Overall Study|Lack of Efficacy|5|||
46739320|NCT00696241|82956337|FG002|Overall Study|Lack of Efficacy|4|||
46739321|NCT00696241|82956338|FG003|Overall Study|Lack of Efficacy|5|||
46739322|NCT00696241|82956339|FG004|Overall Study|Lack of Efficacy|3|||
46739323|NCT00696241|82956335|FG000|Overall Study|Other|6|||
46739324|NCT00696241|82956336|FG001|Overall Study|Other|1|||
46739325|NCT00696241|82956337|FG002|Overall Study|Other|5|||
46739326|NCT00696241|82956338|FG003|Overall Study|Other|2|||
46739327|NCT00696241|82956339|FG004|Overall Study|Other|1|||
46739328|NCT00957008|82956355|FG000|Overall Study|Withdrawal by Subject|13|||
46739329|NCT00957008|82956356|FG001|Overall Study|Withdrawal by Subject|10|||
46739330|NCT00957008|82956357|FG002|Overall Study|Withdrawal by Subject|12|||
46739331|NCT00957008|82956358|FG003|Overall Study|Withdrawal by Subject|16|||
46739332|NCT00957008|82956355|FG000|Overall Study|Lost to Follow-up|3|||
46739333|NCT00957008|82956356|FG001|Overall Study|Lost to Follow-up|1|||
46739334|NCT00957008|82956357|FG002|Overall Study|Lost to Follow-up|3|||
46739335|NCT00957008|82956358|FG003|Overall Study|Lost to Follow-up|4|||
46739336|NCT00957008|82956355|FG000|Overall Study|Physician Decision|1|||
46739337|NCT00957008|82956356|FG001|Overall Study|Physician Decision|0|||
46739338|NCT00957008|82956357|FG002|Overall Study|Physician Decision|1|||
46739339|NCT00957008|82956358|FG003|Overall Study|Physician Decision|1|||
46739340|NCT00957008|82956355|FG000|Overall Study|Relocated; Family conflict|4|||
46739341|NCT00957008|82956356|FG001|Overall Study|Relocated; Family conflict|1|||
46739342|NCT00957008|82956357|FG002|Overall Study|Relocated; Family conflict|1|||
46739343|NCT00957008|82956358|FG003|Overall Study|Relocated; Family conflict|3|||
46739344|NCT00952484|82956375|FG000|Overall Study|Withdrawal by Subject|0|||
46739345|NCT00952484|82956376|FG001|Overall Study|Withdrawal by Subject|1|||
46739346|NCT00952484|82956377|FG002|Overall Study|Withdrawal by Subject|0|||
46739347|NCT00689611|82956388|FG000|Overall Study|Death|6|||
46739348|NCT00689611|82956389|FG001|Overall Study|Death|9|||
46739349|NCT00689611|82956388|FG000|Overall Study|Withdrawal by Subject|8|||
46739350|NCT00689611|82956389|FG001|Overall Study|Withdrawal by Subject|9|||
46804106|NCT00541970|83023280|FG000|Month 48|Other|3|||
46804107|NCT00541970|83023281|FG001|Month 48|Other|1|||
46804108|NCT00541970|83023282|FG002|Month 48|Other|1|||
46921880|NCT04021290|83154513|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
46921881|NCT04021290|83154514|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
46921882|NCT04021290|83154515|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
46921883|NCT03630705|83154527|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
46921884|NCT03630705|83154528|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
46921885|NCT03630705|83154529|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
46921886|NCT03630705|83154530|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
46921887|NCT03630705|83154527|FG000|Overall Study|Lost to Follow-up|1|||
46921888|NCT03630705|83154528|FG001|Overall Study|Lost to Follow-up|2|||
46921889|NCT03630705|83154529|FG002|Overall Study|Lost to Follow-up|0|||
46921890|NCT03630705|83154530|FG003|Overall Study|Lost to Follow-up|0|||
46921891|NCT03539458|83154547|FG000|Overall Study|Death|1|||
46921892|NCT03534180|83154551|FG000|Overall Study|Withdrawal by Subject|1|||
46921893|NCT03494166|83154561|FG000|Overall Study|Death|0|||
46921894|NCT03494166|83154562|FG001|Overall Study|Death|0|||
46921895|NCT03494166|83154563|FG002|Overall Study|Death|0|||
46921896|NCT03494166|83154564|FG003|Overall Study|Death|1|||
46921897|NCT03494166|83154565|FG004|Overall Study|Death|3|||
46921898|NCT03494166|83154566|FG005|Overall Study|Death|0|||
46921899|NCT03494166|83154561|FG000|Overall Study|Lost to Follow-up|2|||
46921900|NCT03494166|83154562|FG001|Overall Study|Lost to Follow-up|2|||
46921901|NCT03494166|83154563|FG002|Overall Study|Lost to Follow-up|2|||
46921902|NCT03494166|83154564|FG003|Overall Study|Lost to Follow-up|2|||
46921903|NCT03494166|83154565|FG004|Overall Study|Lost to Follow-up|14|||
46921904|NCT03494166|83154566|FG005|Overall Study|Lost to Follow-up|0|||
46921905|NCT03494166|83154561|FG000|Overall Study|Withdrawal by Subject|10|||
46921906|NCT03494166|83154562|FG001|Overall Study|Withdrawal by Subject|7|||
46921907|NCT03494166|83154563|FG002|Overall Study|Withdrawal by Subject|0|||
46921908|NCT03494166|83154564|FG003|Overall Study|Withdrawal by Subject|5|||
46921909|NCT03494166|83154565|FG004|Overall Study|Withdrawal by Subject|3|||
46921910|NCT03494166|83154566|FG005|Overall Study|Withdrawal by Subject|17|||
46921911|NCT03494166|83154561|FG000|Overall Study|Screen failure|1|||
47050267|NCT01040728|83311030|FG003|Overall Study|Protocol Violation|1|||
47050268|NCT01040728|83311027|FG000|Overall Study|Lack of Efficacy|0|||
47050269|NCT01040728|83311028|FG001|Overall Study|Lack of Efficacy|1|||
47050270|NCT01040728|83311029|FG002|Overall Study|Lack of Efficacy|0|||
47050271|NCT01040728|83311030|FG003|Overall Study|Lack of Efficacy|1|||
47050272|NCT01040728|83311027|FG000|Overall Study|Other reasons not listed above|0|||
47050273|NCT01040728|83311028|FG001|Overall Study|Other reasons not listed above|1|||
47050274|NCT01040728|83311029|FG002|Overall Study|Other reasons not listed above|0|||
47050275|NCT01040728|83311030|FG003|Overall Study|Other reasons not listed above|0|||
47050276|NCT01593020|83311048|FG000|Overall Study|Adverse Event|1|||
47050277|NCT01593020|83311049|FG001|Overall Study|Adverse Event|1|||
46739351|NCT00689611|82956388|FG000|Overall Study|Lost to Follow-up|27|||
46739352|NCT00689611|82956389|FG001|Overall Study|Lost to Follow-up|28|||
46739353|NCT00689299|82956398|FG000|Overall Study|Adverse Event|2|||
46739354|NCT00689299|82956399|FG001|Overall Study|Adverse Event|1|||
46739355|NCT00689299|82956400|FG002|Overall Study|Adverse Event|1|||
46739356|NCT00689299|82956398|FG000|Overall Study|Lost to Follow-up|0|||
46739357|NCT00689299|82956399|FG001|Overall Study|Lost to Follow-up|1|||
46739358|NCT00689299|82956400|FG002|Overall Study|Lost to Follow-up|1|||
46739359|NCT00689299|82956398|FG000|Overall Study|Withdrawal by Subject|4|||
46804109|NCT00541970|83023283|FG003|Month 48|Other|0|||
46921912|NCT03494166|83154562|FG001|Overall Study|Screen failure|0|||
46921913|NCT03494166|83154563|FG002|Overall Study|Screen failure|0|||
46921914|NCT03494166|83154564|FG003|Overall Study|Screen failure|0|||
46921915|NCT03494166|83154565|FG004|Overall Study|Screen failure|1|||
46921916|NCT03494166|83154566|FG005|Overall Study|Screen failure|0|||
46921917|NCT03367156|83154588|FG000|Overall Study|Lack of interest|3|||
46921918|NCT03367156|83154589|FG001|Overall Study|Lack of interest|1|||
46921919|NCT03367156|83154588|FG000|Overall Study|Death|2|||
46921920|NCT03367156|83154589|FG001|Overall Study|Death|0|||
46921921|NCT03367156|83154588|FG000|Overall Study|Lost to Follow-up|2|||
46921922|NCT03367156|83154589|FG001|Overall Study|Lost to Follow-up|1|||
46921923|NCT03367156|83154588|FG000|Overall Study|Became ineligible|1|||
46921924|NCT03367156|83154589|FG001|Overall Study|Became ineligible|2|||
46921925|NCT03367156|83154588|FG000|Overall Study|Hospitalization|1|||
46921926|NCT03367156|83154589|FG001|Overall Study|Hospitalization|0|||
46921927|NCT03367156|83154588|FG000|Overall Study|Concerned about Treatment|11|||
46921928|NCT03367156|83154589|FG001|Overall Study|Concerned about Treatment|3|||
46921929|NCT03367156|83154588|FG000|Overall Study|Started new treatment|4|||
46921930|NCT03367156|83154589|FG001|Overall Study|Started new treatment|1|||
46921931|NCT03302299|83154597|FG000|Overall Study|Protocol Violation|1|||
46921932|NCT03262935|83154604|FG000|Overall Study|Withdrawal by Subject|6|||
46921933|NCT03262935|83154605|FG001|Overall Study|Withdrawal by Subject|7|||
46921934|NCT03262935|83154604|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
46921935|NCT03262935|83154605|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
46921936|NCT03262935|83154604|FG000|Overall Study|Death|181|||
46921937|NCT03262935|83154605|FG001|Overall Study|Death|94|||
46921938|NCT03262935|83154604|FG000|Overall Study|Lost to Follow-up|9|||
46921939|NCT03262935|83154605|FG001|Overall Study|Lost to Follow-up|4|||
46921940|NCT03262935|83154604|FG000|Overall Study|Other reason|5|||
46921941|NCT03262935|83154605|FG001|Overall Study|Other reason|0|||
46921942|NCT02603562|83154634|FG000|Overall Study|Lost to Follow-up|1|||
46921943|NCT02586727|83154640|FG000|Overall Study|Lost to Follow-up|1|||
46921944|NCT02586727|83154641|FG001|Overall Study|Lost to Follow-up|0|||
46921945|NCT02339909|83154668|FG000|Overall Study|Became ineligible after randomisation|89|||
46921946|NCT02339909|83154669|FG001|Overall Study|Became ineligible after randomisation|63|||
46921947|NCT02339909|83154670|FG002|Overall Study|Became ineligible after randomisation|71|||
46921948|NCT02076113|83154680|FG000|Overall Study|Lost to Follow-up|4|||
46921949|NCT02076113|83154681|FG001|Overall Study|Lost to Follow-up|1|||
46921950|NCT02076113|83154680|FG000|Overall Study|Withdrawal by Subject|2|||
46921951|NCT02076113|83154681|FG001|Overall Study|Withdrawal by Subject|3|||
46921952|NCT02076113|83154680|FG000|Overall Study|Death|1|||
46921953|NCT02076113|83154681|FG001|Overall Study|Death|3|||
46921954|NCT01586910|83154692|FG000|Overall Study|Death|4|||
46921955|NCT01586910|83154693|FG001|Overall Study|Death|4|||
46921956|NCT01586910|83154692|FG000|Overall Study|Withdrawal by Subject|6|||
46921957|NCT01586910|83154693|FG001|Overall Study|Withdrawal by Subject|43|||
46921958|NCT01586910|83154692|FG000|Overall Study|Physician withdrew Subject|5|||
46921959|NCT01586910|83154693|FG001|Overall Study|Physician withdrew Subject|24|||
46921960|NCT01496976|83154701|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
46921961|NCT02915016|83154724|FG000|Overall Study|Lost to Follow-up|4|||
46921962|NCT02915016|83154725|FG001|Overall Study|Lost to Follow-up|2|||
46921963|NCT02915016|83154726|FG002|Overall Study|Lost to Follow-up|5|||
46921964|NCT02915016|83154727|FG003|Overall Study|Lost to Follow-up|3|||
46921965|NCT02915016|83154728|FG004|Overall Study|Lost to Follow-up|5|||
46921966|NCT02915016|83154729|FG005|Overall Study|Lost to Follow-up|2|||
46921967|NCT02915016|83154730|FG006|Overall Study|Lost to Follow-up|8|||
46921968|NCT02915016|83154731|FG007|Overall Study|Lost to Follow-up|2|||
46921969|NCT02915016|83154724|FG000|Overall Study|Physician Decision|0|||
46921970|NCT02915016|83154725|FG001|Overall Study|Physician Decision|0|||
46921971|NCT02915016|83154726|FG002|Overall Study|Physician Decision|1|||
46921972|NCT02915016|83154727|FG003|Overall Study|Physician Decision|0|||
46921973|NCT02915016|83154728|FG004|Overall Study|Physician Decision|0|||
46921974|NCT02915016|83154729|FG005|Overall Study|Physician Decision|1|||
47050278|NCT01593020|83311048|FG000|Overall Study|Death|0|||
47050279|NCT01593020|83311049|FG001|Overall Study|Death|1|||
46921975|NCT02915016|83154730|FG006|Overall Study|Physician Decision|2|||
46921976|NCT02915016|83154731|FG007|Overall Study|Physician Decision|0|||
46921977|NCT02915016|83154724|FG000|Overall Study|Withdrawal by Subject|2|||
46921978|NCT02915016|83154725|FG001|Overall Study|Withdrawal by Subject|0|||
46921979|NCT02915016|83154726|FG002|Overall Study|Withdrawal by Subject|1|||
46921980|NCT02915016|83154727|FG003|Overall Study|Withdrawal by Subject|0|||
46921981|NCT02915016|83154728|FG004|Overall Study|Withdrawal by Subject|1|||
46921982|NCT02915016|83154729|FG005|Overall Study|Withdrawal by Subject|3|||
46921983|NCT02915016|83154730|FG006|Overall Study|Withdrawal by Subject|1|||
46921984|NCT02915016|83154731|FG007|Overall Study|Withdrawal by Subject|1|||
46921985|NCT02915016|83154724|FG000|Overall Study|Elected not to continue|0|||
46921986|NCT02915016|83154725|FG001|Overall Study|Elected not to continue|0|||
46921987|NCT02915016|83154726|FG002|Overall Study|Elected not to continue|0|||
47050280|NCT01593020|83311048|FG000|Overall Study|Ineligible|1|||
46921988|NCT02915016|83154727|FG003|Overall Study|Elected not to continue|1|||
46921989|NCT02915016|83154728|FG004|Overall Study|Elected not to continue|0|||
46921990|NCT02915016|83154729|FG005|Overall Study|Elected not to continue|0|||
46921991|NCT02915016|83154730|FG006|Overall Study|Elected not to continue|1|||
46921992|NCT02915016|83154731|FG007|Overall Study|Elected not to continue|0|||
47050281|NCT01593020|83311049|FG001|Overall Study|Ineligible|0|||
47050282|NCT01040260|83311057|FG000|Overall Study|Withdrawal by Subject|12|||
46739360|NCT00689299|82956399|FG001|Overall Study|Withdrawal by Subject|1|||
46739361|NCT00689299|82956400|FG002|Overall Study|Withdrawal by Subject|3|||
46739362|NCT00689299|82956398|FG000|Overall Study|Protocol Violation|1|||
46739363|NCT00689299|82956399|FG001|Overall Study|Protocol Violation|0|||
46739364|NCT00689299|82956400|FG002|Overall Study|Protocol Violation|0|||
46739365|NCT02506244|82956411|FG000|Overall Study|Did not undergo active monitoring|458|||
46739366|NCT02506244|82956412|FG001|Overall Study|Did not undergo active monitoring|459|||
46739367|NCT02506244|82956413|FG002|Overall Study|Did not undergo active monitoring|0|||
46739368|NCT00948974|82956423|FG000|Overall Study|Lost to Follow-up|23|||
46739369|NCT00948974|82956424|FG001|Overall Study|Lost to Follow-up|20|||
46739370|NCT01007435|82956434|FG000|Overall Study|Adverse Event|16|||
46739371|NCT01007435|82956435|FG001|Overall Study|Adverse Event|25|||
46739372|NCT01007435|82956436|FG002|Overall Study|Adverse Event|47|||
46739373|NCT01007435|82956437|FG003|Overall Study|Adverse Event|31|||
46739374|NCT01007435|82956434|FG000|Overall Study|Death|2|||
46739375|NCT01007435|82956435|FG001|Overall Study|Death|4|||
46739376|NCT01007435|82956436|FG002|Overall Study|Death|2|||
46739377|NCT01007435|82956437|FG003|Overall Study|Death|1|||
46739378|NCT01007435|82956434|FG000|Overall Study|Insufficient Therapeutic Response|21|||
46739379|NCT01007435|82956435|FG001|Overall Study|Insufficient Therapeutic Response|7|||
46739380|NCT01007435|82956436|FG002|Overall Study|Insufficient Therapeutic Response|2|||
46739381|NCT01007435|82956437|FG003|Overall Study|Insufficient Therapeutic Response|9|||
46739382|NCT01007435|82956434|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
46739383|NCT01007435|82956435|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
46739384|NCT01007435|82956436|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
46739385|NCT01007435|82956437|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
46739386|NCT01007435|82956434|FG000|Overall Study|Other Protocol Violation|2|||
46739387|NCT01007435|82956435|FG001|Overall Study|Other Protocol Violation|0|||
46739388|NCT01007435|82956436|FG002|Overall Study|Other Protocol Violation|1|||
46739389|NCT01007435|82956437|FG003|Overall Study|Other Protocol Violation|0|||
46739390|NCT01007435|82956434|FG000|Overall Study|Refused Treatment|13|||
46739391|NCT01007435|82956435|FG001|Overall Study|Refused Treatment|13|||
46739392|NCT01007435|82956436|FG002|Overall Study|Refused Treatment|5|||
46739393|NCT01007435|82956437|FG003|Overall Study|Refused Treatment|8|||
46739394|NCT01007435|82956434|FG000|Overall Study|Failure to Return|5|||
46739395|NCT01007435|82956435|FG001|Overall Study|Failure to Return|4|||
46739396|NCT01007435|82956436|FG002|Overall Study|Failure to Return|3|||
46739397|NCT01007435|82956437|FG003|Overall Study|Failure to Return|6|||
46739398|NCT01007435|82956434|FG000|Overall Study|Reason not Specified|1|||
46739399|NCT01007435|82956435|FG001|Overall Study|Reason not Specified|1|||
46739400|NCT01007435|82956436|FG002|Overall Study|Reason not Specified|2|||
46739401|NCT01007435|82956437|FG003|Overall Study|Reason not Specified|1|||
46739402|NCT00948896|82956455|FG000|Randomization to 24 Months of Age|Death|1|||
46739403|NCT00948896|82956456|FG001|Randomization to 24 Months of Age|Death|0|||
46739404|NCT00948896|82956457|FG002|Randomization to 24 Months of Age|Death|0|||
46739405|NCT00948896|82956458|FG003|Randomization to 24 Months of Age|Death|0|||
46739406|NCT00948896|82956459|FG004|Randomization to 24 Months of Age|Death|2|||
46739407|NCT00948896|82956460|FG005|Randomization to 24 Months of Age|Death|1|||
46739408|NCT00948896|82956461|FG006|Randomization to 24 Months of Age|Death|2|||
46739409|NCT00948896|82956462|FG007|Randomization to 24 Months of Age|Death|1|||
46739410|NCT00948896|82956455|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
46739411|NCT00948896|82956456|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
46739412|NCT00948896|82956457|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
46739413|NCT00948896|82956458|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
46739414|NCT00948896|82956459|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
46739415|NCT00948896|82956460|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
46739416|NCT00948896|82956461|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
46739417|NCT00948896|82956462|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
46739418|NCT00948896|82956455|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
46739419|NCT00948896|82956456|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
46739420|NCT00948896|82956457|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
46739421|NCT00948896|82956458|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
46739422|NCT00948896|82956459|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
46739423|NCT00948896|82956460|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
46739424|NCT00948896|82956461|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
46921993|NCT02915016|83154724|FG000|Overall Study|HIV infection|1|||
47050283|NCT01040260|83311058|FG001|Overall Study|Withdrawal by Subject|6|||
46921994|NCT02915016|83154725|FG001|Overall Study|HIV infection|1|||
46921995|NCT02915016|83154726|FG002|Overall Study|HIV infection|1|||
46921996|NCT02915016|83154727|FG003|Overall Study|HIV infection|0|||
46921997|NCT02915016|83154728|FG004|Overall Study|HIV infection|1|||
46739425|NCT00948896|82956462|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
46739426|NCT00948896|82956455|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
46739427|NCT00948896|82956456|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
46739428|NCT00948896|82956457|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
46739429|NCT00948896|82956458|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
46739430|NCT00948896|82956459|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
46739431|NCT00948896|82956460|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
46739432|NCT00948896|82956461|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
46739433|NCT00948896|82956462|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
46739434|NCT00948896|82956455|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
46739435|NCT00948896|82956456|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
46739436|NCT00948896|82956457|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
46739437|NCT00948896|82956458|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
46739438|NCT00948896|82956459|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
46739439|NCT00948896|82956460|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
46739440|NCT00948896|82956461|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
46739441|NCT00948896|82956462|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
46739442|NCT00948896|82956455|FG000|24 Months of Age to 36 Months of Age|Death|0|||
46739443|NCT00948896|82956456|FG001|24 Months of Age to 36 Months of Age|Death|2|||
46739444|NCT00948896|82956457|FG002|24 Months of Age to 36 Months of Age|Death|2|||
46739445|NCT00948896|82956458|FG003|24 Months of Age to 36 Months of Age|Death|0|||
46739446|NCT00948896|82956459|FG004|24 Months of Age to 36 Months of Age|Death|0|||
46739447|NCT00948896|82956460|FG005|24 Months of Age to 36 Months of Age|Death|1|||
46739448|NCT00948896|82956461|FG006|24 Months of Age to 36 Months of Age|Death|0|||
46739449|NCT00948896|82956462|FG007|24 Months of Age to 36 Months of Age|Death|0|||
46739450|NCT00948896|82956455|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
46739451|NCT00948896|82956456|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
46739452|NCT00948896|82956457|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
46739453|NCT00948896|82956458|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
46739454|NCT00948896|82956459|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
46739455|NCT00948896|82956460|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
46739456|NCT00948896|82956461|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
46739457|NCT00948896|82956462|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
46739458|NCT00948896|82956455|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
46739459|NCT00948896|82956456|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
46739460|NCT00948896|82956457|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
46739461|NCT00948896|82956458|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
46739462|NCT00948896|82956459|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
46739463|NCT00948896|82956460|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
46739464|NCT00948896|82956461|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
46739465|NCT00948896|82956462|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
46739466|NCT00948896|82956455|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
46739467|NCT00948896|82956456|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
46739468|NCT00948896|82956457|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
46739469|NCT00948896|82956458|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
46739470|NCT00948896|82956459|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
46739471|NCT00948896|82956460|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
46739472|NCT00948896|82956461|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
46739473|NCT00948896|82956462|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
46739474|NCT00948896|82956455|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
46739475|NCT00948896|82956456|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
46739476|NCT00948896|82956457|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
46739477|NCT00948896|82956458|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
46739478|NCT00948896|82956459|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
46739479|NCT00948896|82956460|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
46921998|NCT02915016|83154729|FG005|Overall Study|HIV infection|0|||
46739480|NCT00948896|82956461|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
46921999|NCT02915016|83154730|FG006|Overall Study|HIV infection|0|||
46922000|NCT02915016|83154731|FG007|Overall Study|HIV infection|0|||
46922001|NCT02915016|83154724|FG000|Overall Study|Participant unable to adhere|0|||
46739481|NCT00948896|82956462|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
46922002|NCT02915016|83154725|FG001|Overall Study|Participant unable to adhere|0|||
46739482|NCT01004159|82956484|FG000|Overall Study|Adverse Event|2|||
46739483|NCT01004159|82956484|FG000|Overall Study|Disease Progression|18|||
46739484|NCT00948818|82956490|FG000|Overall Study|Adverse Event|10|||
46739485|NCT00948818|82956491|FG001|Overall Study|Adverse Event|32|||
46739486|NCT00948818|82956490|FG000|Overall Study|Protocol Violation|9|||
46739487|NCT00948818|82956491|FG001|Overall Study|Protocol Violation|10|||
46739488|NCT00948818|82956490|FG000|Overall Study|Withdrawal by Subject|25|||
46739489|NCT00948818|82956491|FG001|Overall Study|Withdrawal by Subject|25|||
46739490|NCT00948818|82956490|FG000|Overall Study|Lost to Follow-up|10|||
46739491|NCT00948818|82956491|FG001|Overall Study|Lost to Follow-up|17|||
46739492|NCT00948818|82956490|FG000|Overall Study|Lack of Efficacy|4|||
46739493|NCT00948818|82956491|FG001|Overall Study|Lack of Efficacy|5|||
46739494|NCT00948818|82956490|FG000|Overall Study|Other Reason|4|||
46739495|NCT00948818|82956491|FG001|Overall Study|Other Reason|5|||
46739496|NCT00948506|82956502|FG000|Overall Study|Withdrawal by Subject|3|||
46739497|NCT00948506|82956503|FG001|Overall Study|Withdrawal by Subject|1|||
46739498|NCT00955682|82956514|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
46739499|NCT00955682|82956515|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
46739500|NCT00689221|82956531|FG000|Overall Study|Ongoing at cut-off date|39|||
46739501|NCT00689221|82956532|FG001|Overall Study|Ongoing at cut-off date|36|||
46739502|NCT01875445|82956540|FG000|Overall Study|Lost to Follow-up|5|||
46739503|NCT01875445|82956541|FG001|Overall Study|Lost to Follow-up|0|||
46739504|NCT01875445|82956540|FG000|Overall Study|Withdrawal by Subject|2|||
46739505|NCT01875445|82956541|FG001|Overall Study|Withdrawal by Subject|0|||
46739506|NCT00688909|82956547|FG000|Overall Study|Adverse Event|28|||
46739507|NCT00688909|82956547|FG000|Overall Study|Patient withdrew consent|2|||
46739508|NCT00688909|82956547|FG000|Overall Study|Administrative problems|1|||
46739509|NCT00688909|82956547|FG000|Overall Study|Protocol Violation|2|||
46739510|NCT00948428|82956555|FG000|Overall Study|Withdrawal by Subject|6|||
46739511|NCT00948428|82956556|FG001|Overall Study|Withdrawal by Subject|12|||
46739512|NCT00948428|82956557|FG002|Overall Study|Withdrawal by Subject|7|||
46739513|NCT00948428|82956555|FG000|Overall Study|Adverse Event|6|||
46739514|NCT00948428|82956556|FG001|Overall Study|Adverse Event|3|||
46739515|NCT00948428|82956557|FG002|Overall Study|Adverse Event|0|||
46739516|NCT00948428|82956555|FG000|Overall Study|Lost to Follow-up|2|||
46739517|NCT00948428|82956556|FG001|Overall Study|Lost to Follow-up|1|||
46739518|NCT00948428|82956557|FG002|Overall Study|Lost to Follow-up|1|||
46739519|NCT00948428|82956555|FG000|Overall Study|Death|2|||
46739520|NCT00948428|82956556|FG001|Overall Study|Death|0|||
46739521|NCT00948428|82956557|FG002|Overall Study|Death|0|||
46739522|NCT00948428|82956555|FG000|Overall Study|Intercurrent Illness|1|||
46739523|NCT00948428|82956556|FG001|Overall Study|Intercurrent Illness|0|||
46739524|NCT00948428|82956557|FG002|Overall Study|Intercurrent Illness|0|||
46739525|NCT00948428|82956555|FG000|Overall Study|Non-compliance|1|||
46739526|NCT00948428|82956556|FG001|Overall Study|Non-compliance|2|||
46739527|NCT00948428|82956557|FG002|Overall Study|Non-compliance|0|||
46739528|NCT00948194|82956567|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
46739529|NCT00948194|82956568|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
46739530|NCT00691483|82956576|FG000|Overall Study|Adverse Event|14|||
46739531|NCT00691483|82956577|FG001|Overall Study|Adverse Event|6|||
46739532|NCT00691483|82956576|FG000|Overall Study|Lost to Follow-up|17|||
46739533|NCT00691483|82956577|FG001|Overall Study|Lost to Follow-up|10|||
46739534|NCT00691483|82956576|FG000|Overall Study|Withdrawal by Subject|24|||
46739535|NCT00691483|82956577|FG001|Overall Study|Withdrawal by Subject|7|||
46739536|NCT00691483|82956576|FG000|Overall Study|Other known cause|6|||
46739537|NCT00691483|82956577|FG001|Overall Study|Other known cause|1|||
46739538|NCT00691483|82956576|FG000|Overall Study|Randomized by not treated|7|||
46739539|NCT00691483|82956577|FG001|Overall Study|Randomized by not treated|1|||
46739540|NCT00691093|82956583|FG000|Overall Study|Adverse Event|1|||
47050284|NCT01040260|83311057|FG000|Overall Study|Lost to Follow-up|3|||
46739541|NCT00691093|82956583|FG000|Overall Study|Lost to Follow-up|1|||
47050285|NCT01040260|83311058|FG001|Overall Study|Lost to Follow-up|5|||
47050286|NCT01712438|83311064|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
47050287|NCT01712438|83311064|FG000|Overall Study|Ongoing ITI treatment|6|||
47050288|NCT01712438|83311064|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
46739542|NCT00691093|82956583|FG000|Overall Study|Lack of Efficacy|1|||
46739543|NCT00691093|82956583|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
46739544|NCT00947882|82956596|FG000|Overall Study|Adverse Event|0|||
46739545|NCT00947882|82956597|FG001|Overall Study|Adverse Event|1|||
46739546|NCT00947882|82956598|FG002|Overall Study|Adverse Event|4|||
46739547|NCT00947882|82956599|FG003|Overall Study|Adverse Event|4|||
46739548|NCT00947882|82956596|FG000|Overall Study|Withdrawal by Subject|2|||
46739549|NCT00947882|82956597|FG001|Overall Study|Withdrawal by Subject|0|||
46739550|NCT00947882|82956598|FG002|Overall Study|Withdrawal by Subject|8|||
46739551|NCT00947882|82956599|FG003|Overall Study|Withdrawal by Subject|2|||
46739552|NCT00947882|82956596|FG000|Overall Study|Protocol Violation|0|||
46739553|NCT00947882|82956597|FG001|Overall Study|Protocol Violation|0|||
47050289|NCT01712438|83311064|FG000|Overall Study|Prematurely Discontinued|25|||
47050290|NCT01712204|83311075|FG000|Overall Study|Adverse Event|3|||
46739554|NCT00947882|82956598|FG002|Overall Study|Protocol Violation|1|||
46739555|NCT00947882|82956599|FG003|Overall Study|Protocol Violation|0|||
46739556|NCT00947882|82956596|FG000|Overall Study|Lost to Follow-up|0|||
46739557|NCT00947882|82956597|FG001|Overall Study|Lost to Follow-up|2|||
46739558|NCT00947882|82956598|FG002|Overall Study|Lost to Follow-up|1|||
46739559|NCT00947882|82956599|FG003|Overall Study|Lost to Follow-up|0|||
46739560|NCT00947882|82956596|FG000|Overall Study|Other/Unknown|10|||
46739561|NCT00947882|82956597|FG001|Overall Study|Other/Unknown|13|||
47050291|NCT01712204|83311076|FG001|Overall Study|Adverse Event|1|||
47050292|NCT01712204|83311075|FG000|Overall Study|Withdrawal by Subject|3|||
47050293|NCT01712204|83311076|FG001|Overall Study|Withdrawal by Subject|3|||
47050294|NCT01712204|83311075|FG000|Overall Study|Lost to Follow-up|1|||
47050295|NCT01712204|83311076|FG001|Overall Study|Lost to Follow-up|0|||
47050296|NCT01712204|83311075|FG000|Overall Study|Protocol Violation|1|||
47050297|NCT01712204|83311076|FG001|Overall Study|Protocol Violation|1|||
47050298|NCT01592864|83311084|FG000|Overall Study|Withdrawal by Subject|0|||
47050299|NCT01592864|83311085|FG001|Overall Study|Withdrawal by Subject|1|||
47050300|NCT01592786|83311091|FG000|Overall Study|Adverse Event|60|||
47050301|NCT01592786|83311091|FG000|Overall Study|Lack of Efficacy|19|||
46739562|NCT00947882|82956598|FG002|Overall Study|Other/Unknown|3|||
46739563|NCT00947882|82956599|FG003|Overall Study|Other/Unknown|6|||
46739564|NCT00947882|82956596|FG000|Overall Study|Trial Terminated by Sponsor|62|||
46739565|NCT00947882|82956597|FG001|Overall Study|Trial Terminated by Sponsor|61|||
46739566|NCT00947882|82956598|FG002|Overall Study|Trial Terminated by Sponsor|62|||
46739567|NCT00947882|82956599|FG003|Overall Study|Trial Terminated by Sponsor|70|||
46739568|NCT00688753|82956610|FG000|Overall Study|Disease progression|55|||
46739569|NCT00688753|82956610|FG000|Overall Study|Missing|1|||
46739570|NCT00688753|82956610|FG000|Overall Study|Death|9|||
46739571|NCT00688753|82956610|FG000|Overall Study|Withdrawal by Subject|3|||
46739572|NCT00688753|82956610|FG000|Overall Study|Adverse Event|20|||
46739573|NCT00688753|82956610|FG000|Overall Study|Protocol Violation|1|||
46739574|NCT00688753|82956610|FG000|Overall Study|Lost to Follow-up|3|||
47050302|NCT01592786|83311091|FG000|Overall Study|Protocol Violation|14|||
47050303|NCT01592786|83311091|FG000|Overall Study|Withdrawal by Subject|23|||
47050304|NCT01592786|83311091|FG000|Overall Study|Lost to Follow-up|19|||
47050305|NCT01592786|83311091|FG000|Overall Study|Other|3|||
46739575|NCT00951080|82956616|FG000|Overall Study|Adverse Event|3|||
46739576|NCT00951080|82956617|FG001|Overall Study|Adverse Event|3|||
46739577|NCT00951080|82956616|FG000|Overall Study|Lost to Follow-up|0|||
46739578|NCT00951080|82956617|FG001|Overall Study|Lost to Follow-up|1|||
46739579|NCT00951080|82956616|FG000|Overall Study|Physician Decision|4|||
46739580|NCT00951080|82956617|FG001|Overall Study|Physician Decision|1|||
46739581|NCT00951080|82956616|FG000|Overall Study|Other|19|||
46739582|NCT00951080|82956617|FG001|Overall Study|Other|22|||
46739583|NCT00946322|82956623|FG000|Pre-treatment|participant failure to follow up|1|||
46739584|NCT00946322|82956623|FG000|Post-treatment|participant failure to follow up|2|||
46739585|NCT00950690|82956627|FG000|Overall Study|Death|4|||
46635367|NCT01539642|82808984|FG000|Overall Study|Adverse Event|6|||
46739586|NCT00950690|82956627|FG000|Overall Study|Adverse Event|15|||
46739587|NCT00950690|82956627|FG000|Overall Study|Lack of Efficacy|22|||
46635368|NCT01539642|82808985|FG001|Overall Study|Adverse Event|4|||
46739588|NCT00950690|82956627|FG000|Overall Study|Lost to Follow-up|40|||
46635369|NCT01539642|82808984|FG000|Overall Study|Withdrawal by Subject|2|||
46739589|NCT00950690|82956627|FG000|Overall Study|Other|163|||
46739590|NCT00694369|82956636|FG000|Overall Study|Adverse Event|0|||
47050306|NCT01711736|83311097|FG000|Overall Study|Lost to Follow-up|4|||
47050307|NCT01711736|83311098|FG001|Overall Study|Lost to Follow-up|1|||
47050308|NCT01711736|83311097|FG000|Overall Study|Withdrawal by Subject|6|||
46635370|NCT01539642|82808985|FG001|Overall Study|Withdrawal by Subject|2|||
46739591|NCT00694369|82956637|FG001|Overall Study|Adverse Event|1|||
46739592|NCT00694369|82956638|FG002|Overall Study|Adverse Event|0|||
46739593|NCT00694369|82956639|FG003|Overall Study|Adverse Event|1|||
46739594|NCT00694369|82956640|FG004|Overall Study|Adverse Event|3|||
46739595|NCT00694369|82956636|FG000|Overall Study|Lost to Follow-up|0|||
47050309|NCT01711736|83311098|FG001|Overall Study|Withdrawal by Subject|6|||
46739596|NCT00694369|82956637|FG001|Overall Study|Lost to Follow-up|0|||
46739597|NCT00694369|82956638|FG002|Overall Study|Lost to Follow-up|1|||
46739598|NCT00694369|82956639|FG003|Overall Study|Lost to Follow-up|1|||
46739599|NCT00694369|82956640|FG004|Overall Study|Lost to Follow-up|0|||
46739600|NCT00694369|82956636|FG000|Overall Study|Physician Decision|0|||
46739601|NCT00694369|82956637|FG001|Overall Study|Physician Decision|0|||
46739602|NCT00694369|82956638|FG002|Overall Study|Physician Decision|0|||
46739603|NCT00694369|82956639|FG003|Overall Study|Physician Decision|0|||
46739604|NCT00694369|82956640|FG004|Overall Study|Physician Decision|1|||
46739605|NCT00694369|82956636|FG000|Overall Study|Protocol Violation|0|||
46739606|NCT00694369|82956637|FG001|Overall Study|Protocol Violation|1|||
46739607|NCT00694369|82956638|FG002|Overall Study|Protocol Violation|0|||
46739608|NCT00694369|82956639|FG003|Overall Study|Protocol Violation|0|||
46739609|NCT00694369|82956640|FG004|Overall Study|Protocol Violation|0|||
46739610|NCT00694369|82956636|FG000|Overall Study|Withdrawal by Subject|1|||
46739611|NCT00694369|82956637|FG001|Overall Study|Withdrawal by Subject|1|||
46739612|NCT00694369|82956638|FG002|Overall Study|Withdrawal by Subject|1|||
46739613|NCT00694369|82956639|FG003|Overall Study|Withdrawal by Subject|1|||
46739614|NCT00694369|82956640|FG004|Overall Study|Withdrawal by Subject|2|||
46739615|NCT00513019|82956654|FG000|Overall Study|Adverse Event|1|||
46739616|NCT00513019|82956655|FG001|Overall Study|Adverse Event|0|||
46739617|NCT00513019|82956654|FG000|Overall Study|Withdrawal by Subject|4|||
46739618|NCT00513019|82956655|FG001|Overall Study|Withdrawal by Subject|5|||
46739619|NCT00954512|82956676|FG000|Overall Study|Withdrawal by Subject|0|||
46739620|NCT00954512|82956677|FG001|Overall Study|Withdrawal by Subject|0|||
46739621|NCT00954512|82956678|FG002|Overall Study|Withdrawal by Subject|0|||
46739622|NCT00954512|82956679|FG003|Overall Study|Withdrawal by Subject|0|||
46739623|NCT00954512|82956680|FG004|Overall Study|Withdrawal by Subject|0|||
46739624|NCT00954512|82956681|FG005|Overall Study|Withdrawal by Subject|1|||
46739625|NCT00954512|82956676|FG000|Overall Study|Adverse Event|0|||
46739626|NCT00954512|82956677|FG001|Overall Study|Adverse Event|0|||
46739627|NCT00954512|82956678|FG002|Overall Study|Adverse Event|0|||
46739628|NCT00954512|82956679|FG003|Overall Study|Adverse Event|0|||
46739629|NCT00954512|82956680|FG004|Overall Study|Adverse Event|1|||
46739630|NCT00954512|82956681|FG005|Overall Study|Adverse Event|2|||
46739631|NCT00954512|82956676|FG000|Overall Study|Physician Decision|0|||
46739632|NCT00954512|82956677|FG001|Overall Study|Physician Decision|1|||
46739633|NCT00954512|82956678|FG002|Overall Study|Physician Decision|0|||
46739634|NCT00954512|82956679|FG003|Overall Study|Physician Decision|1|||
46739635|NCT00954512|82956680|FG004|Overall Study|Physician Decision|0|||
46739636|NCT00954512|82956681|FG005|Overall Study|Physician Decision|0|||
46739637|NCT00954512|82956676|FG000|Overall Study|Symptomatic Deterioration|0|||
46739638|NCT00954512|82956677|FG001|Overall Study|Symptomatic Deterioration|1|||
46739639|NCT00954512|82956678|FG002|Overall Study|Symptomatic Deterioration|0|||
46739640|NCT00954512|82956679|FG003|Overall Study|Symptomatic Deterioration|0|||
46739641|NCT00954512|82956680|FG004|Overall Study|Symptomatic Deterioration|2|||
46739642|NCT00954512|82956681|FG005|Overall Study|Symptomatic Deterioration|0|||
46739643|NCT00954512|82956676|FG000|Overall Study|Progression of Disease|2|||
46739644|NCT00954512|82956677|FG001|Overall Study|Progression of Disease|1|||
46739645|NCT00954512|82956678|FG002|Overall Study|Progression of Disease|0|||
46739646|NCT00954512|82956679|FG003|Overall Study|Progression of Disease|1|||
46739647|NCT00954512|82956680|FG004|Overall Study|Progression of Disease|1|||
46739648|NCT00954512|82956681|FG005|Overall Study|Progression of Disease|1|||
46739649|NCT00691015|82956694|FG000|Overall Study|Refused further treatment|1|||
46739650|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
46739651|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
46739652|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
46739653|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
46739654|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
46739655|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
46922003|NCT02915016|83154726|FG002|Overall Study|Participant unable to adhere|0|||
46922004|NCT02915016|83154727|FG003|Overall Study|Participant unable to adhere|0|||
46922005|NCT02915016|83154728|FG004|Overall Study|Participant unable to adhere|0|||
46922006|NCT02915016|83154729|FG005|Overall Study|Participant unable to adhere|0|||
46922007|NCT02915016|83154730|FG006|Overall Study|Participant unable to adhere|0|||
46739656|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
46739657|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
46922008|NCT02915016|83154731|FG007|Overall Study|Participant unable to adhere|1|||
46739658|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
46739659|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
46804110|NCT00541970|83023280|FG000|Month 48|Lost to Follow-up|66|||
46739660|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
46739661|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
46739662|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
46739663|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
46739664|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
46739665|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
46739666|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
46739667|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
46739668|NCT00950300|82956700|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
46739669|NCT00950300|82956701|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
46739670|NCT00950300|82956700|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
46739671|NCT00950300|82956701|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
46739672|NCT00950300|82956700|FG000|TFFU Period|Death|4|||
46739673|NCT00950300|82956701|FG001|TFFU Period|Death|1|||
46739674|NCT00950300|82956700|FG000|TFFU Period|Refused Treatment|10|||
46739675|NCT00950300|82956701|FG001|TFFU Period|Refused Treatment|11|||
46739676|NCT00950300|82956700|FG000|TFFU Period|Failure to Return|16|||
46739677|NCT00950300|82956701|FG001|TFFU Period|Failure to Return|16|||
46739678|NCT00950300|82956700|FG000|TFFU Period|Recurrence of Disease|63|||
46739679|NCT00950300|82956701|FG001|TFFU Period|Recurrence of Disease|72|||
46739680|NCT00950300|82956700|FG000|TFFU Period|Other|4|||
46739681|NCT00950300|82956701|FG001|TFFU Period|Other|3|||
46739682|NCT00950300|82956700|FG000|SFU Period|Death|44|||
46739683|NCT00950300|82956701|FG001|SFU Period|Death|42|||
46739684|NCT00950300|82956700|FG000|SFU Period|Lost to Follow-up|30|||
46739685|NCT00950300|82956701|FG001|SFU Period|Lost to Follow-up|28|||
46739686|NCT00950300|82956700|FG000|SFU Period|Withdrawal by Subject|4|||
46739687|NCT00950300|82956701|FG001|SFU Period|Withdrawal by Subject|8|||
46739688|NCT00949988|82956708|FG000|Overall Study|Withdrawal by Subject|3|||
46739689|NCT00731692|82956715|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
46739690|NCT00731692|82956716|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
46739691|NCT00731692|82956717|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
46739692|NCT00731692|82956715|FG000|Core Study (36 Months)|Physician Decision|1|||
46739693|NCT00731692|82956716|FG001|Core Study (36 Months)|Physician Decision|0|||
46739694|NCT00731692|82956717|FG002|Core Study (36 Months)|Physician Decision|2|||
46739695|NCT00731692|82956715|FG000|Core Study (36 Months)|Death|2|||
46739696|NCT00731692|82956716|FG001|Core Study (36 Months)|Death|1|||
46739697|NCT00731692|82956717|FG002|Core Study (36 Months)|Death|2|||
46739698|NCT00731692|82956715|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
46739699|NCT00731692|82956716|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
46739700|NCT00731692|82956717|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
46739701|NCT00731692|82956715|FG000|Core Study (36 Months)|Administrative|2|||
46739702|NCT00731692|82956716|FG001|Core Study (36 Months)|Administrative|2|||
46739703|NCT00731692|82956717|FG002|Core Study (36 Months)|Administrative|6|||
46739704|NCT00731692|82956715|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
46739705|NCT00731692|82956716|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
46739706|NCT00731692|82956717|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
46739707|NCT00731692|82956715|FG000|Core Study (36 Months)|Protocol Violation|4|||
46739708|NCT00731692|82956716|FG001|Core Study (36 Months)|Protocol Violation|5|||
47050310|NCT01711736|83311097|FG000|Overall Study|Migrated/moved from study area|2|||
47050311|NCT01711736|83311098|FG001|Overall Study|Migrated/moved from study area|1|||
47050312|NCT01592708|83311107|FG000|Overall Study|Protocol Violation|3|||
47050313|NCT01592708|83311108|FG001|Overall Study|Protocol Violation|0|||
47050314|NCT01042522|83311119|FG000|Overall Study|Adverse Event|1|||
47050315|NCT01042522|83311120|FG001|Overall Study|Adverse Event|2|||
47050316|NCT01042522|83311119|FG000|Overall Study|Disease Progression|5|||
47050317|NCT01042522|83311120|FG001|Overall Study|Disease Progression|0|||
47050318|NCT01042522|83311119|FG000|Overall Study|Death|1|||
47050319|NCT01042522|83311120|FG001|Overall Study|Death|0|||
47050320|NCT01042522|83311119|FG000|Overall Study|Patient Refused|0|||
47050321|NCT01042522|83311120|FG001|Overall Study|Patient Refused|3|||
47050322|NCT01042522|83311119|FG000|Overall Study|Withdrawal by Subject|1|||
47050323|NCT01042522|83311120|FG001|Overall Study|Withdrawal by Subject|1|||
47050324|NCT01702844|83311126|FG000|Overall Study|Adverse Event|9|||
47050325|NCT01702844|83311126|FG000|Overall Study|Death|1|||
46739709|NCT00731692|82956717|FG002|Core Study (36 Months)|Protocol Violation|8|||
46739710|NCT00731692|82956715|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
47050326|NCT01702844|83311126|FG000|Overall Study|Withdrawal by Subject|3|||
47050327|NCT01702844|83311126|FG000|Overall Study|Physician Decision|6|||
47050328|NCT01702532|83311132|FG000|Overall Study|Adverse Event|0|||
46739711|NCT00731692|82956716|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
46739712|NCT00731692|82956717|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
46739713|NCT00731692|82956715|FG000|Core Study (36 Months)|Adverse Event|25|||
46739714|NCT00731692|82956716|FG001|Core Study (36 Months)|Adverse Event|28|||
46739715|NCT00731692|82956717|FG002|Core Study (36 Months)|Adverse Event|29|||
46739716|NCT00731692|82956715|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
46739717|NCT00731692|82956716|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
47050329|NCT01702532|83311133|FG001|Overall Study|Adverse Event|1|||
47050330|NCT01702454|83311142|FG000|Overall Study|Consent withdrawal|0|||
47050331|NCT01702454|83311143|FG001|Overall Study|Consent withdrawal|1|||
47050332|NCT01702454|83311142|FG000|Overall Study|Migrated/moved from study area|0|||
47050333|NCT01702454|83311143|FG001|Overall Study|Migrated/moved from study area|1|||
47050334|NCT01702454|83311142|FG000|Overall Study|Lost to Follow-up|3|||
47050335|NCT01702454|83311143|FG001|Overall Study|Lost to Follow-up|6|||
47050336|NCT01702298|83311156|FG000|Overall Study|Withdrawal by Subject|1|||
47050337|NCT01701362|83311162|FG000|Overall Study|Adverse events not related to study drug|1|||
47050338|NCT01701362|83311163|FG001|Overall Study|Adverse events not related to study drug|6|||
47050339|NCT01701362|83311162|FG000|Overall Study|Adverse events related to study drug|12|||
47050340|NCT01701362|83311163|FG001|Overall Study|Adverse events related to study drug|10|||
47050341|NCT01701362|83311162|FG000|Overall Study|Protocol Violation|5|||
47050342|NCT01701362|83311163|FG001|Overall Study|Protocol Violation|3|||
47050343|NCT01701362|83311162|FG000|Overall Study|No longer willing to participate|8|||
47050344|NCT01701362|83311163|FG001|Overall Study|No longer willing to participate|14|||
46739718|NCT00731692|82956717|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
46739719|NCT00731692|82956715|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
46739720|NCT00731692|82956716|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
46739721|NCT00731692|82956717|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
46739722|NCT00731692|82956715|FG000|Extension Phase|Abnormal test procedure|0|||
46739723|NCT00731692|82956716|FG001|Extension Phase|Abnormal test procedure|0|||
46739724|NCT00731692|82956717|FG002|Extension Phase|Abnormal test procedure|1|||
46739725|NCT00731692|82956715|FG000|Extension Phase|Abnormal lab values|0|||
46739726|NCT00731692|82956716|FG001|Extension Phase|Abnormal lab values|0|||
46739727|NCT00731692|82956717|FG002|Extension Phase|Abnormal lab values|1|||
46739728|NCT00731692|82956715|FG000|Extension Phase|Lost to Follow-up|0|||
46739729|NCT00731692|82956716|FG001|Extension Phase|Lost to Follow-up|1|||
46739730|NCT00731692|82956717|FG002|Extension Phase|Lost to Follow-up|4|||
46739731|NCT00731692|82956715|FG000|Extension Phase|Withdrawal by Subject|4|||
46739732|NCT00731692|82956716|FG001|Extension Phase|Withdrawal by Subject|5|||
46922009|NCT03323749|83154751|FG000|Double-blind Period|Lost to Follow-up|4|||
46922010|NCT03323749|83154752|FG001|Double-blind Period|Lost to Follow-up|5|||
46922011|NCT03323749|83154751|FG000|Double-blind Period|Adverse Event|3|||
46922012|NCT03323749|83154752|FG001|Double-blind Period|Adverse Event|1|||
46922013|NCT03323749|83154751|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
46922014|NCT03323749|83154752|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
46922015|NCT03323749|83154751|FG000|Open-Label Period|Adverse Event|3|||
46922016|NCT03323749|83154752|FG001|Open-Label Period|Adverse Event|10|||
46922017|NCT03323749|83154751|FG000|Open-Label Period|Withdrawal by Subject|7|||
46922018|NCT03323749|83154752|FG001|Open-Label Period|Withdrawal by Subject|5|||
46922019|NCT02208024|83154771|FG000|Overall Study|Withdrawal by Subject|1|||
46922020|NCT02660086|83154777|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
46922021|NCT02660086|83154778|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
46922022|NCT02660086|83154777|FG000|Overall Study- 12-month|Left full-time employment|12|||
46922023|NCT02660086|83154778|FG001|Overall Study- 12-month|Left full-time employment|20|||
46922024|NCT02660086|83154777|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
46922025|NCT02660086|83154778|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
46922026|NCT02660086|83154777|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
46922027|NCT02660086|83154778|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
46922028|NCT02660086|83154777|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
46922029|NCT02660086|83154778|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
46922030|NCT02660086|83154777|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
46922031|NCT02660086|83154778|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
46922032|NCT01678144|83154784|FG000|Stage 1: MAR Classic|Adverse Event|1|||
46739733|NCT00731692|82956717|FG002|Extension Phase|Withdrawal by Subject|3|||
46739734|NCT00731692|82956715|FG000|Extension Phase|Adverse Event|1|||
46739735|NCT00731692|82956716|FG001|Extension Phase|Adverse Event|1|||
46739736|NCT00731692|82956717|FG002|Extension Phase|Adverse Event|15|||
46739737|NCT00687193|82956739|FG000|Overall Study|Adverse Event|0|||
46739738|NCT00687193|82956740|FG001|Overall Study|Adverse Event|1|||
46739739|NCT00687193|82956741|FG002|Overall Study|Adverse Event|2|||
46739740|NCT00687193|82956742|FG003|Overall Study|Adverse Event|3|||
46739741|NCT00687193|82956743|FG004|Overall Study|Adverse Event|0|||
47050345|NCT01701362|83311162|FG000|Overall Study|Lost to Follow-up|6|||
47050346|NCT01701362|83311163|FG001|Overall Study|Lost to Follow-up|9|||
47050347|NCT01701362|83311162|FG000|Overall Study|Insufficient clinical response|6|||
46922033|NCT00153920|83154788|FG000|Overall Study|Adverse Event|9|||
46922034|NCT00153920|83154788|FG000|Overall Study|Progressive Disease|9|||
47050348|NCT01701362|83311163|FG001|Overall Study|Insufficient clinical response|6|||
47050349|NCT01701362|83311162|FG000|Overall Study|Death|0|||
47050350|NCT01701362|83311163|FG001|Overall Study|Death|1|||
46739742|NCT00687193|82956744|FG005|Overall Study|Adverse Event|2|||
46739743|NCT00687193|82956739|FG000|Overall Study|Lack of Efficacy|1|||
46739744|NCT00687193|82956740|FG001|Overall Study|Lack of Efficacy|1|||
46739745|NCT00687193|82956741|FG002|Overall Study|Lack of Efficacy|0|||
46922035|NCT00153920|83154788|FG000|Overall Study|Physician Decision|3|||
46922036|NCT00153920|83154788|FG000|Overall Study|Lack of Response|3|||
46922037|NCT00153920|83154788|FG000|Overall Study|Death|2|||
46922038|NCT00153920|83154788|FG000|Overall Study|Withdrawal by Subject|1|||
46922039|NCT00153920|83154788|FG000|Overall Study|Non-Protocol Therapy|1|||
46922040|NCT00153920|83154788|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
46922041|NCT00153920|83154788|FG000|Overall Study|Progressive Disease before Trt|1|||
46922042|NCT02660242|83154792|FG000|Glucose Tabs|Lost to Follow-up|1|||
46922043|NCT02660242|83154792|FG000|Glucagon Injection|Lost to Follow-up|1|||
46922044|NCT03072043|83154808|FG000|Overall Study|Death|0|||
46922045|NCT03072043|83154809|FG001|Overall Study|Death|0|||
46922046|NCT03072043|83154810|FG002|Overall Study|Death|3|||
46922047|NCT03072043|83154808|FG000|Overall Study|Adverse Event|0|||
46922048|NCT03072043|83154809|FG001|Overall Study|Adverse Event|0|||
46922049|NCT03072043|83154810|FG002|Overall Study|Adverse Event|2|||
46922050|NCT03072043|83154808|FG000|Overall Study|Withdrawal by Subject|0|||
46922051|NCT03072043|83154809|FG001|Overall Study|Withdrawal by Subject|0|||
46922052|NCT03072043|83154810|FG002|Overall Study|Withdrawal by Subject|4|||
46922053|NCT03069313|83154822|FG000|Overall Study|Adverse Event|5|||
46922054|NCT03068767|83154828|FG000|Overall Study|Lost to Follow-up|7|||
46922055|NCT03068767|83154829|FG001|Overall Study|Lost to Follow-up|3|||
46922056|NCT03068767|83154828|FG000|Overall Study|Protocol Violation|3|||
46922057|NCT03068767|83154829|FG001|Overall Study|Protocol Violation|0|||
46922058|NCT03020745|83154843|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922059|NCT03020745|83154844|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922060|NCT03020745|83154845|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922061|NCT03020745|83154846|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922062|NCT03020745|83154847|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922063|NCT03020745|83154848|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922064|NCT03020745|83154849|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922065|NCT03020745|83154850|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922066|NCT03020745|83154851|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
46922067|NCT03020745|83154852|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
46922068|NCT03020745|83154843|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922069|NCT03020745|83154844|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922070|NCT03020745|83154845|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922071|NCT03020745|83154846|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922072|NCT03020745|83154847|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922073|NCT03020745|83154848|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922074|NCT03020745|83154849|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922075|NCT03020745|83154850|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
46922076|NCT03020745|83154851|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922077|NCT03020745|83154852|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
46922078|NCT03020745|83154843|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
46922079|NCT03020745|83154844|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
46922080|NCT03020745|83154845|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
46922081|NCT03020745|83154846|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
46922082|NCT03020745|83154847|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
46922083|NCT03020745|83154848|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
46922084|NCT03020745|83154849|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
46922085|NCT03020745|83154850|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
47050351|NCT01701362|83311162|FG000|Overall Study|Randomized but not treated|1|||
47050352|NCT01701362|83311163|FG001|Overall Study|Randomized but not treated|2|||
47050353|NCT01701362|83311162|FG000|Overall Study|Reasons other than those mentioned above|3|||
47050354|NCT01701362|83311163|FG001|Overall Study|Reasons other than those mentioned above|5|||
47050355|NCT01710800|83311192|FG000|Overall Study|Withdrawal by Subject|21|||
47050356|NCT01710800|83311192|FG000|Overall Study|Protocol Violation|1|||
47050357|NCT01710020|83311198|FG000|Period 1|Protocol Violation|1|||
47050358|NCT01700348|83311204|FG000|Overall Study|Withdrawal by Subject|22|||
47050359|NCT01700348|83311204|FG000|Overall Study|Lost to Follow-up|1|||
47050360|NCT01700192|83311212|FG000|Overall Study|Adverse Event|73|||
47050361|NCT01700192|83311213|FG001|Overall Study|Adverse Event|18|||
47050362|NCT01700192|83311212|FG000|Overall Study|Lack of Efficacy|1|||
47050363|NCT01700192|83311213|FG001|Overall Study|Lack of Efficacy|0|||
47050364|NCT01700192|83311212|FG000|Overall Study|Lost to Follow-up|42|||
46922086|NCT03020745|83154851|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
46922087|NCT03020745|83154852|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
46922088|NCT03020745|83154843|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922089|NCT03020745|83154844|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922090|NCT03020745|83154845|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922091|NCT03020745|83154846|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
47050365|NCT01700192|83311213|FG001|Overall Study|Lost to Follow-up|29|||
47050366|NCT01700192|83311212|FG000|Overall Study|Noncompliance with study drug|0|||
47050367|NCT01700192|83311213|FG001|Overall Study|Noncompliance with study drug|5|||
46922092|NCT03020745|83154847|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922093|NCT03020745|83154848|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922094|NCT03020745|83154849|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922095|NCT03020745|83154850|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922096|NCT03020745|83154851|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
46922097|NCT03020745|83154852|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
46922098|NCT03019965|83154887|FG000|Overall Study|Withdrawal by Subject|1|||
46922099|NCT03019965|83154888|FG001|Overall Study|Withdrawal by Subject|0|||
46922100|NCT03019965|83154887|FG000|Overall Study|Protocol Violation|1|||
46922101|NCT03019965|83154888|FG001|Overall Study|Protocol Violation|3|||
46922102|NCT03019965|83154887|FG000|Overall Study|viral or fungal infection|3|||
46922103|NCT03019965|83154888|FG001|Overall Study|viral or fungal infection|4|||
46922104|NCT03019965|83154887|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
46804111|NCT00541970|83023281|FG001|Month 48|Lost to Follow-up|68|||
46635371|NCT01586364|82808991|FG000|Overall Study|Withdrawal by Subject|40|||
46635372|NCT01586364|82808991|FG000|Overall Study|Adverse Event|37|||
46635373|NCT01586364|82808991|FG000|Overall Study|Lost to Follow-up|17|||
46635374|NCT01586364|82808991|FG000|Overall Study|Protocol Violation|16|||
46635375|NCT01586364|82808991|FG000|Overall Study|Lack of Efficacy|1|||
46635376|NCT01586364|82808991|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
46635377|NCT01586364|82808991|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
46635378|NCT01586364|82808991|FG000|Overall Study|Other-Site closure due to PI illness|1|||
46635379|NCT01586364|82808991|FG000|Overall Study|Other-PI discretion, site closing|2|||
46635380|NCT01586364|82808991|FG000|Overall Study|Other-Not specified|1|||
46635381|NCT01538628|82808997|FG000|Overall Study|Withdrawal by Subject|1|||
46635382|NCT01538628|82808998|FG001|Overall Study|Withdrawal by Subject|1|||
46635383|NCT01538628|82808997|FG000|Overall Study|Lost to Follow-up|0|||
46635384|NCT01538628|82808998|FG001|Overall Study|Lost to Follow-up|1|||
46804112|NCT00541970|83023282|FG002|Month 48|Lost to Follow-up|68|||
46804113|NCT00541970|83023283|FG003|Month 48|Lost to Follow-up|73|||
47050368|NCT01700192|83311212|FG000|Overall Study|Physician Decision|2|||
47050369|NCT01700192|83311213|FG001|Overall Study|Physician Decision|3|||
47050370|NCT01700192|83311212|FG000|Overall Study|Pregnancy|1|||
47050371|NCT01700192|83311213|FG001|Overall Study|Pregnancy|4|||
47050372|NCT01700192|83311212|FG000|Overall Study|Progressive disease|1|||
47050373|NCT01700192|83311213|FG001|Overall Study|Progressive disease|0|||
47050374|NCT01700192|83311212|FG000|Overall Study|Protocol Violation|3|||
47050375|NCT01700192|83311213|FG001|Overall Study|Protocol Violation|4|||
47050376|NCT01700192|83311212|FG000|Overall Study|Technical problems|0|||
47050377|NCT01700192|83311213|FG001|Overall Study|Technical problems|1|||
47050378|NCT01700192|83311212|FG000|Overall Study|Withdrawal by Subject|56|||
47050379|NCT01700192|83311213|FG001|Overall Study|Withdrawal by Subject|64|||
46804114|NCT00541970|83023280|FG000|Month 60|Protocol Violation|78|||
46804115|NCT00541970|83023281|FG001|Month 60|Protocol Violation|77|||
46804116|NCT00541970|83023282|FG002|Month 60|Protocol Violation|82|||
47050380|NCT01700192|83311212|FG000|Overall Study|Never received study drug|1|||
47050381|NCT01700192|83311213|FG001|Overall Study|Never received study drug|0|||
47050382|NCT01709864|83311230|FG000|Overall Study|Physician Decision|0|||
47050383|NCT01709864|83311231|FG001|Overall Study|Physician Decision|1|||
47050384|NCT01709864|83311230|FG000|Overall Study|subject/guardian decision|5|||
47050385|NCT01709864|83311231|FG001|Overall Study|subject/guardian decision|6|||
47050386|NCT01709864|83311230|FG000|Overall Study|Lost to Follow-up|1|||
47050387|NCT01709864|83311231|FG001|Overall Study|Lost to Follow-up|0|||
47050388|NCT01709864|83311230|FG000|Overall Study|non-compliance with study treatment|1|||
47050389|NCT01709864|83311231|FG001|Overall Study|non-compliance with study treatment|1|||
47050390|NCT01709864|83311230|FG000|Overall Study|Adverse Event|0|||
47050391|NCT01709864|83311231|FG001|Overall Study|Adverse Event|2|||
47050392|NCT01709864|83311230|FG000|Overall Study|Death|0|||
47050393|NCT01709864|83311231|FG001|Overall Study|Death|1|||
47050394|NCT01709708|83311239|FG000|Overall Study|Protocol Violation|1|||
47050395|NCT01709708|83311240|FG001|Overall Study|Protocol Violation|2|||
47050396|NCT01709318|83311263|FG000|Overall Study|Adverse Event|3|||
47050397|NCT01709318|83311264|FG001|Overall Study|Adverse Event|4|||
47050398|NCT01709318|83311265|FG002|Overall Study|Adverse Event|2|||
47050399|NCT01709318|83311266|FG003|Overall Study|Adverse Event|2|||
47050400|NCT01709318|83311267|FG004|Overall Study|Adverse Event|0|||
47050401|NCT01709318|83311268|FG005|Overall Study|Adverse Event|1|||
47050402|NCT01709318|83311269|FG006|Overall Study|Adverse Event|2|||
47050403|NCT01709318|83311263|FG000|Overall Study|Lost to Follow-up|2|||
47050404|NCT01709318|83311264|FG001|Overall Study|Lost to Follow-up|0|||
47050405|NCT01709318|83311265|FG002|Overall Study|Lost to Follow-up|0|||
46635385|NCT01538472|82809005|FG000|Overall Study|Disease Progression|3|||
46635386|NCT01538472|82809005|FG000|Overall Study|Death|1|||
46635387|NCT01562028|82809011|FG000|Overall Study|Withdrawal by Subject|1|||
46635388|NCT01562028|82809012|FG001|Overall Study|Withdrawal by Subject|1|||
46804117|NCT00541970|83023283|FG003|Month 60|Protocol Violation|72|||
47050406|NCT01709318|83311266|FG003|Overall Study|Lost to Follow-up|0|||
46739746|NCT00687193|82956742|FG003|Overall Study|Lack of Efficacy|0|||
46739747|NCT00687193|82956743|FG004|Overall Study|Lack of Efficacy|0|||
46739748|NCT00687193|82956744|FG005|Overall Study|Lack of Efficacy|2|||
46739749|NCT00687193|82956739|FG000|Overall Study|Protocol Violation|1|||
46739750|NCT00687193|82956740|FG001|Overall Study|Protocol Violation|2|||
46739751|NCT00687193|82956741|FG002|Overall Study|Protocol Violation|0|||
46739752|NCT00687193|82956742|FG003|Overall Study|Protocol Violation|1|||
46739753|NCT00687193|82956743|FG004|Overall Study|Protocol Violation|2|||
46739754|NCT00687193|82956744|FG005|Overall Study|Protocol Violation|0|||
46739755|NCT00730912|82956764|FG000|Overall Study|Discontinued|0|||
46739756|NCT00730912|82956765|FG001|Overall Study|Discontinued|0|||
46739757|NCT00730912|82956766|FG002|Overall Study|Discontinued|1|||
46739758|NCT00730756|82956776|FG000|Overall Study|Adverse Event|2|||
46739759|NCT00730756|82956777|FG001|Overall Study|Adverse Event|0|||
46739760|NCT00730756|82956776|FG000|Overall Study|Lack of Efficacy|1|||
46739761|NCT00730756|82956777|FG001|Overall Study|Lack of Efficacy|1|||
46739762|NCT00730756|82956776|FG000|Overall Study|Protocol Deviation|1|||
46739763|NCT00730756|82956777|FG001|Overall Study|Protocol Deviation|2|||
46739764|NCT00730756|82956776|FG000|Overall Study|Lost to Follow-up|0|||
46739765|NCT00730756|82956777|FG001|Overall Study|Lost to Follow-up|1|||
46739766|NCT00730756|82956776|FG000|Overall Study|Withdrew Consent|0|||
46739767|NCT00730756|82956777|FG001|Overall Study|Withdrew Consent|1|||
46739768|NCT00730132|82956783|FG000|Overall Study|Protocol Violation|154|||
46739769|NCT00730132|82956783|FG000|Overall Study|Death|1|||
46739770|NCT00737464|82956790|FG000|Overall Study|Adverse Event|1|||
46739771|NCT00737464|82956790|FG000|Overall Study|Death|6|||
46739772|NCT00737464|82956790|FG000|Overall Study|Other - Failure to Return|1|||
46739773|NCT00737464|82956790|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
46739774|NCT00737464|82956790|FG000|Overall Study|Other reasons|4|||
46739775|NCT00729586|82956796|FG000|Overall Study|Ineligible|0|||
46739776|NCT00729586|82956797|FG001|Overall Study|Ineligible|1|||
46739777|NCT00729586|82956796|FG000|Overall Study|never treated|1|||
46739778|NCT00729586|82956797|FG001|Overall Study|never treated|0|||
46739779|NCT00949910|82956804|FG000|Overall Study|Progressive Disease|3750|||
46739780|NCT00949910|82956804|FG000|Overall Study|Symptomatic Deterioration|1088|||
46739781|NCT00949910|82956804|FG000|Overall Study|Lost to Follow-up|100|||
46739782|NCT00949910|82956804|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
46739783|NCT00949910|82956804|FG000|Overall Study|Participant Refusal|390|||
46739784|NCT00949910|82956804|FG000|Overall Study|Death Due to Malignant Disease|456|||
46739785|NCT00949910|82956804|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
46739786|NCT00949910|82956804|FG000|Overall Study|Death Due to Adverse Event|115|||
46739787|NCT00949910|82956804|FG000|Overall Study|Death Due to Toxicity|3|||
46739788|NCT00949910|82956804|FG000|Overall Study|Death from Unknown Cause|5|||
46739789|NCT00949910|82956804|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
46739790|NCT00949910|82956804|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
46739791|NCT00949910|82956804|FG000|Overall Study|Switched to Commercial Treatment|4|||
46739792|NCT00949910|82956804|FG000|Overall Study|Violation of Eligibility|23|||
46739793|NCT00949910|82956804|FG000|Overall Study|Logistical Reasons|13|||
46739794|NCT00949910|82956804|FG000|Overall Study|Non-Compliance|10|||
46739795|NCT00949910|82956804|FG000|Overall Study|Prolonged Dosing Interruption|4|||
46739796|NCT00949910|82956804|FG000|Overall Study|Adverse Event|83|||
46739797|NCT00949910|82956804|FG000|Overall Study|Serious Adverse Event|6|||
46739798|NCT00949910|82956804|FG000|Overall Study|Physician/Participant Decision|7|||
46739799|NCT00949910|82956804|FG000|Overall Study|Other|4|||
46739800|NCT00949910|82956804|FG000|Overall Study|No Data|9|||
46739801|NCT00686959|82956810|FG000|Overall Study|Participants censored (no death events)|124|||
46739802|NCT00686959|82956811|FG001|Overall Study|Participants censored (no death events)|117|||
46739803|NCT00946088|82956819|FG000|Overall Study|Withdrawal by Subject|0|||
46739804|NCT00946088|82956820|FG001|Overall Study|Withdrawal by Subject|1|||
46739805|NCT00736996|82956831|FG000|Overall Study|Lost to Follow-up|1|||
46739806|NCT00736996|82956832|FG001|Overall Study|Lost to Follow-up|9|||
46922105|NCT03019965|83154888|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
46922106|NCT03019965|83154887|FG000|Overall Study|Physician Decision|1|||
46739807|NCT00736996|82956833|FG002|Overall Study|Lost to Follow-up|2|||
46739808|NCT00728962|82956847|FG000|Implant Placement Surgery|Adverse Event|8|||
46739809|NCT00728962|82956847|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
46739810|NCT00728962|82956847|FG000|Implant Placement Surgery|Protocol Violation|1|||
46739811|NCT00728962|82956847|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
46739812|NCT00728962|82956847|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
46739813|NCT00954122|82956851|FG000|Overall Study|Withdrawal by Subject|5|||
46739814|NCT00954122|82956851|FG000|Overall Study|Adverse Event|1|||
46739815|NCT00954122|82956851|FG000|Overall Study|Safety Reason|1|||
46739816|NCT00586066|82956858|FG000|Overall Study|Lost to Follow-up|6|||
46739817|NCT00586066|82956859|FG001|Overall Study|Lost to Follow-up|3|||
46739818|NCT00586066|82956858|FG000|Overall Study|Lack of Efficacy|5|||
46739819|NCT00586066|82956859|FG001|Overall Study|Lack of Efficacy|3|||
46739820|NCT00586066|82956858|FG000|Overall Study|Adverse Event|2|||
46739821|NCT00586066|82956859|FG001|Overall Study|Adverse Event|2|||
46739822|NCT00586066|82956858|FG000|Overall Study|Physician Decision|1|||
46739823|NCT00586066|82956859|FG001|Overall Study|Physician Decision|0|||
46739824|NCT00586066|82956858|FG000|Overall Study|Withdrawal of consent|4|||
46739825|NCT00586066|82956859|FG001|Overall Study|Withdrawal of consent|2|||
46739826|NCT00728494|82956867|FG000|Overall Study|Adverse Event|7|||
46739827|NCT00728494|82956868|FG001|Overall Study|Adverse Event|0|||
46739828|NCT00728494|82956867|FG000|Overall Study|Withdrawal by Subject|0|||
46739829|NCT00728494|82956868|FG001|Overall Study|Withdrawal by Subject|2|||
46739830|NCT00728494|82956867|FG000|Overall Study|Lack of Efficacy|2|||
46739831|NCT00728494|82956868|FG001|Overall Study|Lack of Efficacy|4|||
46739832|NCT00728494|82956867|FG000|Overall Study|No data available|0|||
46739833|NCT00728494|82956868|FG001|Overall Study|No data available|1|||
46739834|NCT00728416|82956876|FG000|Overall Study|Adverse Event|1|||
46739835|NCT00728416|82956877|FG001|Overall Study|Adverse Event|1|||
46739836|NCT00728416|82956876|FG000|Overall Study|Treatment Failure|0|||
46739837|NCT00728416|82956877|FG001|Overall Study|Treatment Failure|1|||
46739838|NCT00728416|82956876|FG000|Overall Study|Withdrawal by Subject|1|||
46739839|NCT00728416|82956877|FG001|Overall Study|Withdrawal by Subject|0|||
46739840|NCT00728182|82956885|FG000|Overall Study|Adverse Event|1|||
46739841|NCT00728182|82956886|FG001|Overall Study|Adverse Event|0|||
46739842|NCT00728182|82956885|FG000|Overall Study|Lost to Follow-up|2|||
46739843|NCT00728182|82956886|FG001|Overall Study|Lost to Follow-up|0|||
46739844|NCT00728182|82956885|FG000|Overall Study|Death|0|||
46739845|NCT00728182|82956886|FG001|Overall Study|Death|2|||
46739846|NCT00728182|82956885|FG000|Overall Study|Protocol Noncompliance|0|||
46739847|NCT00728182|82956886|FG001|Overall Study|Protocol Noncompliance|1|||
46739848|NCT00941330|82956896|FG000|Overall Study|Other|1|||
46739849|NCT00941330|82956897|FG001|Overall Study|Other|0|||
46739850|NCT00941330|82956896|FG000|Overall Study|Physician Decision|0|||
46739851|NCT00941330|82956897|FG001|Overall Study|Physician Decision|2|||
46739852|NCT00686881|82956905|FG000|Overall Study|Withdrawal by Subject|11|||
46739853|NCT00686881|82956906|FG001|Overall Study|Withdrawal by Subject|18|||
46739854|NCT00686881|82956905|FG000|Overall Study|Lost to Follow-up|0|||
46739855|NCT00686881|82956906|FG001|Overall Study|Lost to Follow-up|1|||
46739856|NCT00686881|82956905|FG000|Overall Study|Treatment-related adverse event|10|||
46739857|NCT00686881|82956906|FG001|Overall Study|Treatment-related adverse event|9|||
46739858|NCT00686881|82956905|FG000|Overall Study|Met discontinuation criteria|5|||
46739859|NCT00686881|82956906|FG001|Overall Study|Met discontinuation criteria|0|||
46739860|NCT00686881|82956905|FG000|Overall Study|Onset of malignant tumor|11|||
46739861|NCT00686881|82956906|FG001|Overall Study|Onset of malignant tumor|11|||
46739862|NCT00686881|82956905|FG000|Overall Study|Lack of Efficacy|4|||
46739863|NCT00686881|82956906|FG001|Overall Study|Lack of Efficacy|3|||
46739864|NCT00686881|82956905|FG000|Overall Study|Physician Decision|1|||
46739865|NCT00686881|82956906|FG001|Overall Study|Physician Decision|0|||
46739866|NCT00686881|82956905|FG000|Overall Study|Circumstances of site|1|||
46739867|NCT00686881|82956906|FG001|Overall Study|Circumstances of site|1|||
46739868|NCT00686881|82956905|FG000|Overall Study|Did not meet protocol eligibility|1|||
46739869|NCT00686881|82956906|FG001|Overall Study|Did not meet protocol eligibility|0|||
46739870|NCT00686881|82956905|FG000|Overall Study|Irregular visits|1|||
46739871|NCT00686881|82956906|FG001|Overall Study|Irregular visits|0|||
46739872|NCT00686881|82956905|FG000|Overall Study|Study discontinuation|35|||
46739873|NCT00686881|82956906|FG001|Overall Study|Study discontinuation|32|||
46739874|NCT00686881|82956905|FG000|Overall Study|Never received study drug|2|||
46739875|NCT00686881|82956906|FG001|Overall Study|Never received study drug|6|||
46739876|NCT00727714|82956914|FG000|Overall Study|Lost to Follow-up|2|||
46739877|NCT00727558|82956920|FG000|Overall Study|Lens issue|0|||
46739878|NCT00727558|82956921|FG001|Overall Study|Lens issue|1|||
46739879|NCT00727558|82956920|FG000|Overall Study|Adverse Event|0|||
46739880|NCT00727558|82956921|FG001|Overall Study|Adverse Event|1|||
46739881|NCT00727558|82956920|FG000|Overall Study|Subject unable to return for follow-up|1|||
46739882|NCT00727558|82956921|FG001|Overall Study|Subject unable to return for follow-up|1|||
46922107|NCT03019965|83154888|FG001|Overall Study|Physician Decision|1|||
46739883|NCT00727558|82956920|FG000|Overall Study|Lost to Follow-up|1|||
46739884|NCT00727558|82956921|FG001|Overall Study|Lost to Follow-up|0|||
46739885|NCT00688597|82956930|FG000|Overall Study|Adverse Event|2|||
46739886|NCT00688597|82956931|FG001|Overall Study|Adverse Event|0|||
46739887|NCT00688597|82956932|FG002|Overall Study|Adverse Event|0|||
46739888|NCT00688597|82956930|FG000|Overall Study|Physician Decision|1|||
46739889|NCT00688597|82956931|FG001|Overall Study|Physician Decision|0|||
46739890|NCT00688597|82956932|FG002|Overall Study|Physician Decision|0|||
46739891|NCT00735904|82956940|FG000|Overall Study|Adverse Event|3|||
46739892|NCT00735904|82956940|FG000|Overall Study|Death|20|||
46739893|NCT00735904|82956940|FG000|Overall Study|Protocol Violation|1|||
46739894|NCT00735904|82956940|FG000|Overall Study|Withdrawal by Subject|1|||
46739895|NCT00735904|82956940|FG000|Overall Study|Study Terminated by Sponsor|5|||
46739896|NCT00735904|82956940|FG000|Overall Study|Other|8|||
46739897|NCT00688519|82956946|FG000|Overall Study|Adverse Event|2|||
46739898|NCT00688519|82956947|FG001|Overall Study|Adverse Event|3|||
46739899|NCT00688519|82956946|FG000|Overall Study|Lost to Follow-up|3|||
46739900|NCT00688519|82956947|FG001|Overall Study|Lost to Follow-up|3|||
46739901|NCT00688519|82956946|FG000|Overall Study|Lack of Efficacy|3|||
46739902|NCT00688519|82956947|FG001|Overall Study|Lack of Efficacy|1|||
46739903|NCT00688519|82956946|FG000|Overall Study|Withdrawal by Subject|7|||
46739904|NCT00688519|82956947|FG001|Overall Study|Withdrawal by Subject|6|||
46739905|NCT00688519|82956946|FG000|Overall Study|Prohibited medication|1|||
46739906|NCT00688519|82956947|FG001|Overall Study|Prohibited medication|0|||
46739907|NCT00688519|82956946|FG000|Overall Study|Non-compliance|0|||
46739908|NCT00688519|82956947|FG001|Overall Study|Non-compliance|1|||
46739909|NCT00688519|82956946|FG000|Overall Study|Subject moved out of state|1|||
46739910|NCT00688519|82956947|FG001|Overall Study|Subject moved out of state|0|||
46739911|NCT00688519|82956946|FG000|Overall Study|Investigator decision|1|||
46739912|NCT00688519|82956947|FG001|Overall Study|Investigator decision|0|||
46739913|NCT00688519|82956946|FG000|Overall Study|Subject moved out of area|1|||
46739914|NCT00688519|82956947|FG001|Overall Study|Subject moved out of area|0|||
46739915|NCT00688519|82956946|FG000|Overall Study|Pregnancy|0|||
46739916|NCT00688519|82956947|FG001|Overall Study|Pregnancy|1|||
46739917|NCT00721630|82956953|FG000|Overall Study|Participant found to be ineligible|1|||
46739918|NCT00686725|82956959|FG000|Overall Study|Adverse Event|1|||
46739919|NCT00686725|82956960|FG001|Overall Study|Adverse Event|1|||
46739920|NCT00686725|82956959|FG000|Overall Study|Progressive Disease|17|||
46739921|NCT00686725|82956960|FG001|Overall Study|Progressive Disease|23|||
46739922|NCT00686725|82956959|FG000|Overall Study|Lost to Follow-up|7|||
46739923|NCT00686725|82956960|FG001|Overall Study|Lost to Follow-up|5|||
46739924|NCT00686725|82956959|FG000|Overall Study|Death|6|||
46739925|NCT00686725|82956960|FG001|Overall Study|Death|3|||
46739926|NCT00686725|82956959|FG000|Overall Study|Withdrawal by Subject|13|||
46739927|NCT00686725|82956960|FG001|Overall Study|Withdrawal by Subject|4|||
46739928|NCT00686725|82956959|FG000|Overall Study|Protocol Violation|1|||
46739929|NCT00686725|82956960|FG001|Overall Study|Protocol Violation|3|||
46739930|NCT00686725|82956959|FG000|Overall Study|Other|1|||
46739931|NCT00686725|82956960|FG001|Overall Study|Other|3|||
46739932|NCT00727402|82956966|FG000|Overall Study|Physician Decision|116|||
46739933|NCT00727246|82956974|FG000|Overall Study|could not complete MRI|0|||
46739934|NCT00727246|82956975|FG001|Overall Study|could not complete MRI|1|||
46739935|NCT00727246|82956976|FG002|Overall Study|could not complete MRI|0|||
46739936|NCT00727246|82956977|FG003|Overall Study|could not complete MRI|1|||
46739937|NCT00727246|82956974|FG000|Overall Study|incidental finding|0|||
46739938|NCT00727246|82956975|FG001|Overall Study|incidental finding|0|||
46739939|NCT00727246|82956976|FG002|Overall Study|incidental finding|0|||
46739940|NCT00727246|82956977|FG003|Overall Study|incidental finding|1|||
46739941|NCT00727246|82956974|FG000|Overall Study|withdrawn|0|||
46739942|NCT00727246|82956975|FG001|Overall Study|withdrawn|0|||
46739943|NCT00727246|82956976|FG002|Overall Study|withdrawn|1|||
46739944|NCT00727246|82956977|FG003|Overall Study|withdrawn|0|||
46739945|NCT00686647|82956987|FG000|Overall Study|Lost to Follow-up|1|||
46739946|NCT00686647|82956987|FG000|Overall Study|Death|1|||
46739947|NCT00687973|82956994|FG000|Overall Study|Adverse Event|18|||
46739948|NCT00687973|82956995|FG001|Overall Study|Adverse Event|28|||
46739949|NCT00687973|82956994|FG000|Overall Study|Lack of Efficacy|2|||
46739950|NCT00687973|82956995|FG001|Overall Study|Lack of Efficacy|3|||
46739951|NCT00687973|82956994|FG000|Overall Study|Protocol Violation|1|||
46739952|NCT00687973|82956995|FG001|Overall Study|Protocol Violation|2|||
46739953|NCT00687973|82956994|FG000|Overall Study|Administrative Reasons|0|||
46739954|NCT00687973|82956995|FG001|Overall Study|Administrative Reasons|2|||
46804118|NCT00687323|83023293|FG000|Overall Study|Death|25|||
46922108|NCT01675882|83154907|FG000|Overall Study|Adverse Event|0|||
46922109|NCT01675882|83154908|FG001|Overall Study|Adverse Event|2|||
46922110|NCT01675882|83154909|FG002|Overall Study|Adverse Event|1|||
46922111|NCT01675882|83154910|FG003|Overall Study|Adverse Event|0|||
46739955|NCT00687973|82956994|FG000|Overall Study|Withdrawal by Subject|3|||
46739956|NCT00687973|82956995|FG001|Overall Study|Withdrawal by Subject|3|||
46739957|NCT00721396|82957006|FG000|Overall Study|Adverse Event|4|||
46739958|NCT00721396|82957007|FG001|Overall Study|Adverse Event|7|||
46739959|NCT00721396|82957008|FG002|Overall Study|Adverse Event|2|||
46739960|NCT00721396|82957009|FG003|Overall Study|Adverse Event|0|||
46739961|NCT00721396|82957006|FG000|Overall Study|Withdrawal by Subject|12|||
46739962|NCT00721396|82957007|FG001|Overall Study|Withdrawal by Subject|15|||
46739963|NCT00721396|82957008|FG002|Overall Study|Withdrawal by Subject|3|||
46739964|NCT00721396|82957009|FG003|Overall Study|Withdrawal by Subject|7|||
46739965|NCT00721396|82957006|FG000|Overall Study|Lost to Follow-up|7|||
46739966|NCT00721396|82957007|FG001|Overall Study|Lost to Follow-up|9|||
46739967|NCT00721396|82957008|FG002|Overall Study|Lost to Follow-up|3|||
46739968|NCT00721396|82957009|FG003|Overall Study|Lost to Follow-up|3|||
46739969|NCT00721396|82957006|FG000|Overall Study|Protocol Violation|4|||
46739970|NCT00721396|82957007|FG001|Overall Study|Protocol Violation|3|||
46739971|NCT00721396|82957008|FG002|Overall Study|Protocol Violation|1|||
46739972|NCT00721396|82957009|FG003|Overall Study|Protocol Violation|0|||
46739973|NCT00721396|82957006|FG000|Overall Study|Inappropriate enrollment|0|||
46739974|NCT00721396|82957007|FG001|Overall Study|Inappropriate enrollment|2|||
46739975|NCT00721396|82957008|FG002|Overall Study|Inappropriate enrollment|0|||
46739976|NCT00721396|82957009|FG003|Overall Study|Inappropriate enrollment|0|||
46739977|NCT00721396|82957006|FG000|Overall Study|Administrative reason|3|||
46739978|NCT00721396|82957007|FG001|Overall Study|Administrative reason|0|||
46739979|NCT00721396|82957008|FG002|Overall Study|Administrative reason|1|||
46739980|NCT00721396|82957009|FG003|Overall Study|Administrative reason|0|||
46739981|NCT00943826|82957026|FG000|Concurrent Phase|Adverse Event|50|||
46739982|NCT00943826|82957027|FG001|Concurrent Phase|Adverse Event|27|||
46739983|NCT00943826|82957026|FG000|Concurrent Phase|Withdrew consent|3|||
46739984|NCT00943826|82957027|FG001|Concurrent Phase|Withdrew consent|7|||
46739985|NCT00943826|82957026|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
46739986|NCT00943826|82957027|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
46739987|NCT00943826|82957026|FG000|Concurrent Phase|Administrative reasons|2|||
46739988|NCT00943826|82957027|FG001|Concurrent Phase|Administrative reasons|1|||
46739989|NCT00943826|82957026|FG000|Concurrent Phase|Protocol Violation|1|||
46739990|NCT00943826|82957027|FG001|Concurrent Phase|Protocol Violation|0|||
46739991|NCT00943826|82957026|FG000|Maintenance Phase|Adverse Event|31|||
46739992|NCT00943826|82957027|FG001|Maintenance Phase|Adverse Event|30|||
46739993|NCT00943826|82957026|FG000|Maintenance Phase|Withdrew consent|2|||
46739994|NCT00943826|82957027|FG001|Maintenance Phase|Withdrew consent|4|||
46739995|NCT00943826|82957026|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
46739996|NCT00943826|82957027|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
46739997|NCT00943826|82957026|FG000|Maintenance Phase|Administrative reasons|4|||
46739998|NCT00943826|82957027|FG001|Maintenance Phase|Administrative reasons|1|||
46739999|NCT00943826|82957026|FG000|Maintenance Phase|Failure to return|0|||
46740000|NCT00943826|82957027|FG001|Maintenance Phase|Failure to return|1|||
46740001|NCT00943826|82957026|FG000|Monotherapy Phase|Adverse Event|42|||
46740002|NCT00943826|82957027|FG001|Monotherapy Phase|Adverse Event|5|||
46740003|NCT00943826|82957026|FG000|Monotherapy Phase|Administrative reasons|11|||
46740004|NCT00943826|82957027|FG001|Monotherapy Phase|Administrative reasons|5|||
46740005|NCT00943826|82957026|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
46740006|NCT00943826|82957027|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
46740007|NCT00943826|82957026|FG000|Monotherapy Phase|Withdrew Consent|2|||
46740008|NCT00943826|82957027|FG001|Monotherapy Phase|Withdrew Consent|3|||
46740009|NCT00943826|82957026|FG000|Monotherapy Phase|Failure to return|2|||
46740010|NCT00943826|82957027|FG001|Monotherapy Phase|Failure to return|1|||
46740011|NCT00943826|82957026|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
46740012|NCT00943826|82957027|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
46740013|NCT00943826|82957026|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
46740014|NCT00943826|82957027|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
46740015|NCT00943826|82957026|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
46922112|NCT01675882|83154907|FG000|Overall Study|Participant unwilling to continue|2|||
46922113|NCT01675882|83154908|FG001|Overall Study|Participant unwilling to continue|4|||
46922114|NCT01675882|83154909|FG002|Overall Study|Participant unwilling to continue|2|||
46922115|NCT01675882|83154910|FG003|Overall Study|Participant unwilling to continue|1|||
46922116|NCT01675882|83154907|FG000|Overall Study|Lost to Follow-up|0|||
46922117|NCT01675882|83154908|FG001|Overall Study|Lost to Follow-up|1|||
46922118|NCT01675882|83154909|FG002|Overall Study|Lost to Follow-up|0|||
47050407|NCT01709318|83311267|FG004|Overall Study|Lost to Follow-up|1|||
47050408|NCT01709318|83311268|FG005|Overall Study|Lost to Follow-up|1|||
47050409|NCT01709318|83311269|FG006|Overall Study|Lost to Follow-up|1|||
47050410|NCT01709318|83311263|FG000|Overall Study|Non-compliance with Study Drug|0|||
47050411|NCT01709318|83311264|FG001|Overall Study|Non-compliance with Study Drug|2|||
47050412|NCT01709318|83311265|FG002|Overall Study|Non-compliance with Study Drug|1|||
47050413|NCT01709318|83311266|FG003|Overall Study|Non-compliance with Study Drug|1|||
47050414|NCT01709318|83311267|FG004|Overall Study|Non-compliance with Study Drug|0|||
47050415|NCT01709318|83311268|FG005|Overall Study|Non-compliance with Study Drug|0|||
47050416|NCT01709318|83311269|FG006|Overall Study|Non-compliance with Study Drug|2|||
47050417|NCT01709318|83311263|FG000|Overall Study|Physician Decision|0|||
47050418|NCT01709318|83311264|FG001|Overall Study|Physician Decision|0|||
47050419|NCT01709318|83311265|FG002|Overall Study|Physician Decision|0|||
46740016|NCT00943826|82957027|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
46740017|NCT00943826|82957026|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
46740018|NCT00943826|82957027|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
47050420|NCT01709318|83311266|FG003|Overall Study|Physician Decision|0|||
47050421|NCT01709318|83311267|FG004|Overall Study|Physician Decision|0|||
47050422|NCT01709318|83311268|FG005|Overall Study|Physician Decision|0|||
46740019|NCT01004003|82957043|FG000|Overall Study|Progressive disease|2|||
46740020|NCT01004003|82957044|FG001|Overall Study|Progressive disease|1|||
46740021|NCT01004003|82957045|FG002|Overall Study|Progressive disease|1|||
46740022|NCT01004003|82957046|FG003|Overall Study|Progressive disease|0|||
46740023|NCT01004003|82957047|FG004|Overall Study|Progressive disease|2|||
46740024|NCT01004003|82957048|FG005|Overall Study|Progressive disease|1|||
46740025|NCT01004003|82957049|FG006|Overall Study|Progressive disease|1|||
46740026|NCT01004003|82957050|FG007|Overall Study|Progressive disease|39|||
46740027|NCT01004003|82957051|FG008|Overall Study|Progressive disease|22|||
46740028|NCT01004003|82957043|FG000|Overall Study|Adverse Event|4|||
46740029|NCT01004003|82957044|FG001|Overall Study|Adverse Event|2|||
46740030|NCT01004003|82957045|FG002|Overall Study|Adverse Event|3|||
46740031|NCT01004003|82957046|FG003|Overall Study|Adverse Event|3|||
46740032|NCT01004003|82957047|FG004|Overall Study|Adverse Event|2|||
46740033|NCT01004003|82957048|FG005|Overall Study|Adverse Event|2|||
46740034|NCT01004003|82957049|FG006|Overall Study|Adverse Event|7|||
46740035|NCT01004003|82957050|FG007|Overall Study|Adverse Event|21|||
46740036|NCT01004003|82957051|FG008|Overall Study|Adverse Event|6|||
46740037|NCT01004003|82957043|FG000|Overall Study|Refused to continue taking trial med.|0|||
46740038|NCT01004003|82957044|FG001|Overall Study|Refused to continue taking trial med.|0|||
46740039|NCT01004003|82957045|FG002|Overall Study|Refused to continue taking trial med.|0|||
46740040|NCT01004003|82957046|FG003|Overall Study|Refused to continue taking trial med.|0|||
46740041|NCT01004003|82957047|FG004|Overall Study|Refused to continue taking trial med.|0|||
46740042|NCT01004003|82957048|FG005|Overall Study|Refused to continue taking trial med.|0|||
46740043|NCT01004003|82957049|FG006|Overall Study|Refused to continue taking trial med.|0|||
46740044|NCT01004003|82957050|FG007|Overall Study|Refused to continue taking trial med.|0|||
46740045|NCT01004003|82957051|FG008|Overall Study|Refused to continue taking trial med.|2|||
46740046|NCT01004003|82957043|FG000|Overall Study|Other|0|||
46740047|NCT01004003|82957044|FG001|Overall Study|Other|0|||
46740048|NCT01004003|82957045|FG002|Overall Study|Other|0|||
46740049|NCT01004003|82957046|FG003|Overall Study|Other|0|||
46740050|NCT01004003|82957047|FG004|Overall Study|Other|0|||
46740051|NCT01004003|82957048|FG005|Overall Study|Other|1|||
46740052|NCT01004003|82957049|FG006|Overall Study|Other|0|||
46740053|NCT01004003|82957050|FG007|Overall Study|Other|0|||
46740054|NCT01004003|82957051|FG008|Overall Study|Other|0|||
46740055|NCT00943670|82957073|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
46740056|NCT00943670|82957073|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
46740057|NCT00943670|82957073|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
46740058|NCT00943670|82957073|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
46740059|NCT00943670|82957073|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
46740060|NCT00943670|82957073|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
46740061|NCT00943670|82957073|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
46740062|NCT00943670|82957073|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
46740063|NCT00943670|82957073|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
46740064|NCT00943670|82957073|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
46740065|NCT00938366|82957090|FG000|Overall Study|Withdrawal by Subject|1|||
46740066|NCT00938366|82957091|FG001|Overall Study|Withdrawal by Subject|0|||
46740067|NCT00943592|82957097|FG000|Overall Study|Death|3|||
46740068|NCT00943124|82957101|FG000|Period 1|Withdrawal by Subject|1|||
46740069|NCT00943124|82957102|FG001|Period 1|Withdrawal by Subject|1|||
46740070|NCT00943124|82957101|FG000|Period 1|Did Not Follow Study Procedures|1|||
46740071|NCT00943124|82957102|FG001|Period 1|Did Not Follow Study Procedures|0|||
46740072|NCT00943124|82957101|FG000|Period 1|Personal Reasons|0|||
46740073|NCT00943124|82957102|FG001|Period 1|Personal Reasons|1|||
46740074|NCT00726622|82957110|FG000|Overall Study|Withdrawal by Subject|16|||
46740075|NCT00726622|82957111|FG001|Overall Study|Withdrawal by Subject|2|||
46740076|NCT00726622|82957110|FG000|Overall Study|Physician Decision|0|||
46740077|NCT00726622|82957111|FG001|Overall Study|Physician Decision|1|||
46740078|NCT00726622|82957110|FG000|Overall Study|Metastasis|2|||
46740079|NCT00726622|82957111|FG001|Overall Study|Metastasis|0|||
46740080|NCT00940316|82957120|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
46740081|NCT00940316|82957121|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
46740082|NCT00940316|82957122|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
46740083|NCT00940316|82957120|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
46740084|NCT00940316|82957121|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
46740085|NCT00940316|82957122|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
47050423|NCT01709318|83311269|FG006|Overall Study|Physician Decision|1|||
46740086|NCT00940316|82957120|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
46740087|NCT00940316|82957121|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
46740088|NCT00940316|82957122|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
46740089|NCT00940316|82957120|FG000|Treated After Cycle 5|Adverse Event|0|||
46740090|NCT00940316|82957121|FG001|Treated After Cycle 5|Adverse Event|0|||
46740091|NCT00940316|82957122|FG002|Treated After Cycle 5|Adverse Event|1|||
47050424|NCT01709318|83311263|FG000|Overall Study|Pregnancy|0|||
46740092|NCT00940316|82957120|FG000|Treated After Cycle 5|Progressive disease|0|||
46740093|NCT00940316|82957121|FG001|Treated After Cycle 5|Progressive disease|1|||
46740094|NCT00940316|82957122|FG002|Treated After Cycle 5|Progressive disease|0|||
47050425|NCT01709318|83311264|FG001|Overall Study|Pregnancy|0|||
46740095|NCT00726388|82957138|FG000|Overall Study|Withdrawal by Subject|5|||
46740096|NCT00726388|82957138|FG000|Overall Study|Adverse Event|3|||
46740097|NCT00726388|82957138|FG000|Overall Study|Lost to Follow-up|10|||
46740098|NCT00726388|82957138|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
46740099|NCT00726388|82957138|FG000|Overall Study|Other|5|||
46740100|NCT00726388|82957138|FG000|Overall Study|Enrolled, Not Treated|79|||
46740101|NCT00572455|82957156|FG000|Stage I (14 Days)|Adverse Event|0|||
46740102|NCT00572455|82957157|FG001|Stage I (14 Days)|Adverse Event|0|||
46740103|NCT00572455|82957158|FG002|Stage I (14 Days)|Adverse Event|0|||
46740104|NCT00572455|82957159|FG003|Stage I (14 Days)|Adverse Event|0|||
46740105|NCT00572455|82957160|FG004|Stage I (14 Days)|Adverse Event|0|||
46740106|NCT00572455|82957161|FG005|Stage I (14 Days)|Adverse Event|3|||
46740107|NCT00572455|82957162|FG006|Stage I (14 Days)|Adverse Event|0|||
46740108|NCT00572455|82957163|FG007|Stage I (14 Days)|Adverse Event|0|||
46740109|NCT00572455|82957164|FG008|Stage I (14 Days)|Adverse Event|0|||
46740110|NCT00572455|82957165|FG009|Stage I (14 Days)|Adverse Event|0|||
46740111|NCT00572455|82957166|FG010|Stage I (14 Days)|Adverse Event|0|||
46740112|NCT00572455|82957167|FG011|Stage I (14 Days)|Adverse Event|0|||
46740113|NCT00572455|82957168|FG012|Stage I (14 Days)|Adverse Event|0|||
46740114|NCT00572455|82957169|FG013|Stage I (14 Days)|Adverse Event|0|||
46740115|NCT00572455|82957156|FG000|Stage I (14 Days)|Other|0|||
46740116|NCT00572455|82957157|FG001|Stage I (14 Days)|Other|0|||
46740117|NCT00572455|82957158|FG002|Stage I (14 Days)|Other|0|||
46740118|NCT00572455|82957159|FG003|Stage I (14 Days)|Other|0|||
46740119|NCT00572455|82957160|FG004|Stage I (14 Days)|Other|1|||
46740120|NCT00572455|82957161|FG005|Stage I (14 Days)|Other|0|||
46804119|NCT00687323|83023293|FG000|Overall Study|Withdrawal by Subject|1|||
46804120|NCT00687323|83023293|FG000|Overall Study|Excluded from efficacy evaluations|6|||
46740121|NCT00572455|82957162|FG006|Stage I (14 Days)|Other|0|||
46740122|NCT00572455|82957163|FG007|Stage I (14 Days)|Other|0|||
46740123|NCT00572455|82957164|FG008|Stage I (14 Days)|Other|0|||
46740124|NCT00572455|82957165|FG009|Stage I (14 Days)|Other|0|||
46740125|NCT00572455|82957166|FG010|Stage I (14 Days)|Other|0|||
46740126|NCT00572455|82957167|FG011|Stage I (14 Days)|Other|0|||
46740127|NCT00572455|82957168|FG012|Stage I (14 Days)|Other|0|||
46740128|NCT00572455|82957169|FG013|Stage I (14 Days)|Other|0|||
46740129|NCT00572455|82957156|FG000|Stage II (28 Days)|Adverse Event|0|||
46740130|NCT00572455|82957157|FG001|Stage II (28 Days)|Adverse Event|0|||
46740131|NCT00572455|82957158|FG002|Stage II (28 Days)|Adverse Event|0|||
46740132|NCT00572455|82957159|FG003|Stage II (28 Days)|Adverse Event|0|||
46740133|NCT00572455|82957160|FG004|Stage II (28 Days)|Adverse Event|0|||
46740134|NCT00572455|82957161|FG005|Stage II (28 Days)|Adverse Event|0|||
46740135|NCT00572455|82957162|FG006|Stage II (28 Days)|Adverse Event|0|||
46740136|NCT00572455|82957163|FG007|Stage II (28 Days)|Adverse Event|0|||
46740137|NCT00572455|82957164|FG008|Stage II (28 Days)|Adverse Event|1|||
46740138|NCT00572455|82957165|FG009|Stage II (28 Days)|Adverse Event|3|||
46740139|NCT00572455|82957166|FG010|Stage II (28 Days)|Adverse Event|3|||
46740140|NCT00572455|82957167|FG011|Stage II (28 Days)|Adverse Event|4|||
46740141|NCT00572455|82957168|FG012|Stage II (28 Days)|Adverse Event|5|||
46740142|NCT00572455|82957169|FG013|Stage II (28 Days)|Adverse Event|1|||
46740143|NCT00572455|82957156|FG000|Stage II (28 Days)|Death|0|||
46740144|NCT00572455|82957157|FG001|Stage II (28 Days)|Death|0|||
46740145|NCT00572455|82957158|FG002|Stage II (28 Days)|Death|0|||
46740146|NCT00572455|82957159|FG003|Stage II (28 Days)|Death|0|||
46740147|NCT00572455|82957160|FG004|Stage II (28 Days)|Death|0|||
46740148|NCT00572455|82957161|FG005|Stage II (28 Days)|Death|0|||
46740149|NCT00572455|82957162|FG006|Stage II (28 Days)|Death|0|||
46740150|NCT00572455|82957163|FG007|Stage II (28 Days)|Death|0|||
46740151|NCT00572455|82957164|FG008|Stage II (28 Days)|Death|1|||
46740152|NCT00572455|82957165|FG009|Stage II (28 Days)|Death|0|||
46922119|NCT01675882|83154910|FG003|Overall Study|Lost to Follow-up|0|||
46922120|NCT01675882|83154907|FG000|Overall Study|Non-compliance|0|||
46922121|NCT01675882|83154908|FG001|Overall Study|Non-compliance|0|||
46922122|NCT01675882|83154909|FG002|Overall Study|Non-compliance|0|||
46922123|NCT01675882|83154910|FG003|Overall Study|Non-compliance|1|||
46740153|NCT00572455|82957166|FG010|Stage II (28 Days)|Death|0|||
46740154|NCT00572455|82957167|FG011|Stage II (28 Days)|Death|0|||
46740155|NCT00572455|82957168|FG012|Stage II (28 Days)|Death|0|||
46740156|NCT00572455|82957169|FG013|Stage II (28 Days)|Death|0|||
46740157|NCT00572455|82957156|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
46740158|NCT00572455|82957157|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
46804121|NCT00687323|83023293|FG000|Overall Study|Screen failure|148|||
46740159|NCT00572455|82957158|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
46740160|NCT00572455|82957159|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
46740161|NCT00572455|82957160|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
46740162|NCT00572455|82957161|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
46740163|NCT00572455|82957162|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
46740164|NCT00572455|82957163|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
46740165|NCT00572455|82957164|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
46740166|NCT00572455|82957165|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
46740167|NCT00572455|82957166|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
46922124|NCT03018249|83154922|FG000|Overall Study|Withdrawal by Subject|2|||
46740168|NCT00572455|82957167|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
46740169|NCT00572455|82957168|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
46740170|NCT00572455|82957169|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
46740171|NCT00572455|82957156|FG000|Stage II (28 Days)|Other|0|||
46740172|NCT00572455|82957157|FG001|Stage II (28 Days)|Other|0|||
46740173|NCT00572455|82957158|FG002|Stage II (28 Days)|Other|0|||
46740174|NCT00572455|82957159|FG003|Stage II (28 Days)|Other|0|||
46740175|NCT00572455|82957160|FG004|Stage II (28 Days)|Other|0|||
46740176|NCT00572455|82957161|FG005|Stage II (28 Days)|Other|0|||
46740177|NCT00572455|82957162|FG006|Stage II (28 Days)|Other|0|||
46740178|NCT00572455|82957163|FG007|Stage II (28 Days)|Other|0|||
46740179|NCT00572455|82957164|FG008|Stage II (28 Days)|Other|1|||
46740180|NCT00572455|82957165|FG009|Stage II (28 Days)|Other|0|||
46740181|NCT00572455|82957166|FG010|Stage II (28 Days)|Other|0|||
46740182|NCT00572455|82957167|FG011|Stage II (28 Days)|Other|0|||
46740183|NCT00572455|82957168|FG012|Stage II (28 Days)|Other|0|||
46740184|NCT00572455|82957169|FG013|Stage II (28 Days)|Other|0|||
46740185|NCT00572455|82957156|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
46740186|NCT00572455|82957157|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
46740187|NCT00572455|82957158|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
46740188|NCT00572455|82957159|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
46740189|NCT00572455|82957160|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
46740190|NCT00572455|82957161|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
46740191|NCT00572455|82957162|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
46740192|NCT00572455|82957163|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
46740193|NCT00572455|82957164|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
46740194|NCT00572455|82957165|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
46740195|NCT00572455|82957166|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
46740196|NCT00572455|82957167|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
46740197|NCT00572455|82957168|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
46740198|NCT00572455|82957169|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
46740199|NCT01003691|82957203|FG000|Overall Study|Adverse Event|0|||
46740200|NCT01003691|82957204|FG001|Overall Study|Adverse Event|0|||
46740201|NCT01003691|82957205|FG002|Overall Study|Adverse Event|0|||
46740202|NCT01003691|82957206|FG003|Overall Study|Adverse Event|1|||
46740203|NCT00686335|82957217|FG000|Run-in Period|Adverse Event|1|||
46740204|NCT00686335|82957217|FG000|Run-in Period|asthma exacerbation|1|||
46740205|NCT00686335|82957217|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
46740206|NCT01002989|82957223|FG000|Overall Study|exclusion criteria, no consent|5|||
46740207|NCT00685945|82957227|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
46740208|NCT01007123|82957241|FG000|Overall Study|Adverse Event|3|||
46740209|NCT01007123|82957242|FG001|Overall Study|Adverse Event|4|||
46740210|NCT01007123|82957243|FG002|Overall Study|Adverse Event|7|||
46740211|NCT01007123|82957244|FG003|Overall Study|Adverse Event|1|||
46740212|NCT01007123|82957241|FG000|Overall Study|Lack of Efficacy|1|||
46740213|NCT01007123|82957242|FG001|Overall Study|Lack of Efficacy|0|||
46740214|NCT01007123|82957243|FG002|Overall Study|Lack of Efficacy|1|||
46740215|NCT01007123|82957244|FG003|Overall Study|Lack of Efficacy|4|||
46740216|NCT01007123|82957241|FG000|Overall Study|Protocol Violation|1|||
46740217|NCT01007123|82957242|FG001|Overall Study|Protocol Violation|1|||
46740218|NCT01007123|82957243|FG002|Overall Study|Protocol Violation|2|||
46740219|NCT01007123|82957244|FG003|Overall Study|Protocol Violation|1|||
46740220|NCT01007123|82957241|FG000|Overall Study|Withdrawal by Subject|1|||
46740221|NCT01007123|82957242|FG001|Overall Study|Withdrawal by Subject|0|||
46740222|NCT01007123|82957243|FG002|Overall Study|Withdrawal by Subject|1|||
46740223|NCT01007123|82957244|FG003|Overall Study|Withdrawal by Subject|0|||
46740224|NCT01007123|82957241|FG000|Overall Study|Lost to Follow-up|0|||
46740225|NCT01007123|82957242|FG001|Overall Study|Lost to Follow-up|1|||
47050426|NCT01709318|83311265|FG002|Overall Study|Pregnancy|0|||
47050427|NCT01709318|83311266|FG003|Overall Study|Pregnancy|0|||
47050428|NCT01709318|83311267|FG004|Overall Study|Pregnancy|1|||
47050429|NCT01709318|83311268|FG005|Overall Study|Pregnancy|0|||
47050430|NCT01709318|83311269|FG006|Overall Study|Pregnancy|0|||
47050431|NCT01709318|83311263|FG000|Overall Study|Protocol Violation|0|||
47050432|NCT01709318|83311264|FG001|Overall Study|Protocol Violation|0|||
46740226|NCT01007123|82957243|FG002|Overall Study|Lost to Follow-up|0|||
46740227|NCT01007123|82957244|FG003|Overall Study|Lost to Follow-up|0|||
46740228|NCT00687739|82957259|FG000|Overall Study|Lost to Follow-up|2|||
46740229|NCT00687739|82957260|FG001|Overall Study|Lost to Follow-up|2|||
46740230|NCT00687739|82957261|FG002|Overall Study|Lost to Follow-up|1|||
46740231|NCT00687739|82957262|FG003|Overall Study|Lost to Follow-up|2|||
46740232|NCT00687739|82957259|FG000|Overall Study|Adverse Event|0|||
47050433|NCT01709318|83311265|FG002|Overall Study|Protocol Violation|0|||
46740233|NCT00687739|82957260|FG001|Overall Study|Adverse Event|1|||
46740234|NCT00687739|82957261|FG002|Overall Study|Adverse Event|1|||
46740235|NCT00687739|82957262|FG003|Overall Study|Adverse Event|0|||
46740236|NCT01006889|82957274|FG000|Overall Study|Withdrawal by Subject|3|||
47050434|NCT01709318|83311266|FG003|Overall Study|Protocol Violation|0|||
46740237|NCT01001429|82957281|FG000|Overall Study|surgery cancelled|0|||
46740238|NCT01001429|82957282|FG001|Overall Study|surgery cancelled|1|||
46740239|NCT01000961|82957312|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
46740240|NCT01000961|82957313|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46740241|NCT01000961|82957312|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
46740242|NCT01000961|82957313|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
46740243|NCT01000805|82957323|FG000|Overall Study|Adverse Event|21|||
46740244|NCT01000805|82957324|FG001|Overall Study|Adverse Event|9|||
46740245|NCT01000805|82957323|FG000|Overall Study|Lack of Efficacy|5|||
46740246|NCT01000805|82957324|FG001|Overall Study|Lack of Efficacy|16|||
46740247|NCT01000805|82957323|FG000|Overall Study|Lost to Follow-up|16|||
46740248|NCT01000805|82957324|FG001|Overall Study|Lost to Follow-up|21|||
46740249|NCT01000805|82957323|FG000|Overall Study|Physician Decision|0|||
46740250|NCT01000805|82957324|FG001|Overall Study|Physician Decision|1|||
46740251|NCT01000805|82957323|FG000|Overall Study|Protocol Violation|12|||
46740252|NCT01000805|82957324|FG001|Overall Study|Protocol Violation|8|||
46740253|NCT01000805|82957323|FG000|Overall Study|Withdrawal by Subject|16|||
46740254|NCT01000805|82957324|FG001|Overall Study|Withdrawal by Subject|6|||
46740255|NCT01000805|82957323|FG000|Overall Study|Sponsor Decision|0|||
46740256|NCT01000805|82957324|FG001|Overall Study|Sponsor Decision|1|||
46740257|NCT00684307|82957336|FG000|Overall Study|Adverse Event|11|||
46740258|NCT00684307|82957337|FG001|Overall Study|Adverse Event|6|||
46740259|NCT00684307|82957338|FG002|Overall Study|Adverse Event|15|||
46740260|NCT00684307|82957339|FG003|Overall Study|Adverse Event|16|||
46740261|NCT00684307|82957340|FG004|Overall Study|Adverse Event|8|||
46740262|NCT00684307|82957336|FG000|Overall Study|Development of increasing Liver Function|0|||
46740263|NCT00684307|82957337|FG001|Overall Study|Development of increasing Liver Function|2|||
46740264|NCT00684307|82957338|FG002|Overall Study|Development of increasing Liver Function|0|||
46740265|NCT00684307|82957339|FG003|Overall Study|Development of increasing Liver Function|1|||
46740266|NCT00684307|82957340|FG004|Overall Study|Development of increasing Liver Function|0|||
46740267|NCT00684307|82957336|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
46740268|NCT00684307|82957337|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
46740269|NCT00684307|82957338|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
46740270|NCT00684307|82957339|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
46740271|NCT00684307|82957340|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
46740272|NCT00684307|82957336|FG000|Overall Study|Incorrect enrolment or randomization|4|||
46740273|NCT00684307|82957337|FG001|Overall Study|Incorrect enrolment or randomization|0|||
46740274|NCT00684307|82957338|FG002|Overall Study|Incorrect enrolment or randomization|0|||
46740275|NCT00684307|82957339|FG003|Overall Study|Incorrect enrolment or randomization|0|||
46740276|NCT00684307|82957340|FG004|Overall Study|Incorrect enrolment or randomization|0|||
46740277|NCT00684307|82957336|FG000|Overall Study|Interupted IP for more than 7 days|0|||
46740278|NCT00684307|82957337|FG001|Overall Study|Interupted IP for more than 7 days|4|||
46740279|NCT00684307|82957338|FG002|Overall Study|Interupted IP for more than 7 days|1|||
46740280|NCT00684307|82957339|FG003|Overall Study|Interupted IP for more than 7 days|3|||
46740281|NCT00684307|82957340|FG004|Overall Study|Interupted IP for more than 7 days|3|||
46740282|NCT00684307|82957336|FG000|Overall Study|Severe non compliance to protocol|1|||
46740283|NCT00684307|82957337|FG001|Overall Study|Severe non compliance to protocol|0|||
46740284|NCT00684307|82957338|FG002|Overall Study|Severe non compliance to protocol|0|||
46740285|NCT00684307|82957339|FG003|Overall Study|Severe non compliance to protocol|1|||
46740286|NCT00684307|82957340|FG004|Overall Study|Severe non compliance to protocol|2|||
46740287|NCT00684307|82957336|FG000|Overall Study|Participant not willing to continue|7|||
46740288|NCT00684307|82957337|FG001|Overall Study|Participant not willing to continue|10|||
46740289|NCT00684307|82957338|FG002|Overall Study|Participant not willing to continue|11|||
46740290|NCT00684307|82957339|FG003|Overall Study|Participant not willing to continue|5|||
46740291|NCT00684307|82957340|FG004|Overall Study|Participant not willing to continue|8|||
46740292|NCT00684307|82957336|FG000|Overall Study|Criteria from the CSR|0|||
46740293|NCT00684307|82957337|FG001|Overall Study|Criteria from the CSR|0|||
46740294|NCT00684307|82957338|FG002|Overall Study|Criteria from the CSR|1|||
46740295|NCT00684307|82957339|FG003|Overall Study|Criteria from the CSR|3|||
46740296|NCT00684307|82957340|FG004|Overall Study|Criteria from the CSR|3|||
46740297|NCT00683917|82957355|FG000|Overall Study|Study prematurely terminated|10|||
46740298|NCT00687271|82957367|FG000|Overall Study|Adverse Event|1|||
46740299|NCT00687271|82957368|FG001|Overall Study|Adverse Event|3|||
46740300|NCT00687271|82957369|FG002|Overall Study|Adverse Event|1|||
46740301|NCT00687271|82957370|FG003|Overall Study|Adverse Event|0|||
46804122|NCT03899064|83023310|FG000|Overall Study|Lost to Follow-up|1|||
46740302|NCT00687271|82957367|FG000|Overall Study|Lost to Follow-up|0|||
46740303|NCT00687271|82957368|FG001|Overall Study|Lost to Follow-up|1|||
46740304|NCT00687271|82957369|FG002|Overall Study|Lost to Follow-up|0|||
46740305|NCT00687271|82957370|FG003|Overall Study|Lost to Follow-up|0|||
46804123|NCT03899064|83023310|FG000|Overall Study|Protocol Violation|2|||
46804124|NCT03899064|83023310|FG000|Overall Study|Withdrawal by Subject|2|||
46740306|NCT00687271|82957367|FG000|Overall Study|Protocol Violation|2|||
46740307|NCT00687271|82957368|FG001|Overall Study|Protocol Violation|1|||
46740308|NCT00687271|82957369|FG002|Overall Study|Protocol Violation|1|||
46740309|NCT00687271|82957370|FG003|Overall Study|Protocol Violation|0|||
46740310|NCT00687271|82957367|FG000|Overall Study|Withdrawal by Subject|0|||
46740311|NCT00687271|82957368|FG001|Overall Study|Withdrawal by Subject|1|||
46740312|NCT00687271|82957369|FG002|Overall Study|Withdrawal by Subject|3|||
46740313|NCT00687271|82957370|FG003|Overall Study|Withdrawal by Subject|0|||
46740314|NCT04617275|82957388|FG000|Treatment Period|Adverse Event|1|||
46740315|NCT04617275|82957389|FG001|Treatment Period|Adverse Event|6|||
46740316|NCT04617275|82957390|FG002|Treatment Period|Adverse Event|4|||
46740317|NCT04617275|82957391|FG003|Treatment Period|Adverse Event|6|||
46740318|NCT04617275|82957392|FG004|Treatment Period|Adverse Event|7|||
46740319|NCT04617275|82957393|FG005|Treatment Period|Adverse Event|8|||
46740320|NCT04617275|82957394|FG006|Treatment Period|Adverse Event|0|||
46740321|NCT04617275|82957395|FG007|Treatment Period|Adverse Event|12|||
46740322|NCT04617275|82957388|FG000|Treatment Period|Lost to Follow-up|0|||
46740323|NCT04617275|82957389|FG001|Treatment Period|Lost to Follow-up|0|||
46740324|NCT04617275|82957390|FG002|Treatment Period|Lost to Follow-up|2|||
46740325|NCT04617275|82957391|FG003|Treatment Period|Lost to Follow-up|0|||
46740326|NCT04617275|82957392|FG004|Treatment Period|Lost to Follow-up|0|||
46740327|NCT04617275|82957393|FG005|Treatment Period|Lost to Follow-up|3|||
46740328|NCT04617275|82957394|FG006|Treatment Period|Lost to Follow-up|0|||
46740329|NCT04617275|82957395|FG007|Treatment Period|Lost to Follow-up|2|||
46740330|NCT04617275|82957388|FG000|Treatment Period|No longer meets eligibility criteria|0|||
46740331|NCT04617275|82957389|FG001|Treatment Period|No longer meets eligibility criteria|0|||
46740332|NCT04617275|82957390|FG002|Treatment Period|No longer meets eligibility criteria|0|||
46740333|NCT04617275|82957391|FG003|Treatment Period|No longer meets eligibility criteria|1|||
46635389|NCT01562028|82809011|FG000|Overall Study|Lost to Follow-up|2|||
46635390|NCT01562028|82809012|FG001|Overall Study|Lost to Follow-up|1|||
46635391|NCT01585584|82809018|FG000|Overall Study|Lack of Efficacy|1|||
46635392|NCT01585584|82809018|FG000|Overall Study|Withdrawal by Subject|1|||
46740334|NCT04617275|82957392|FG004|Treatment Period|No longer meets eligibility criteria|0|||
46740335|NCT04617275|82957393|FG005|Treatment Period|No longer meets eligibility criteria|0|||
46740336|NCT04617275|82957394|FG006|Treatment Period|No longer meets eligibility criteria|0|||
46740337|NCT04617275|82957395|FG007|Treatment Period|No longer meets eligibility criteria|0|||
46740338|NCT04617275|82957388|FG000|Treatment Period|Other|0|||
46740339|NCT04617275|82957389|FG001|Treatment Period|Other|1|||
46740340|NCT04617275|82957390|FG002|Treatment Period|Other|0|||
46740341|NCT04617275|82957391|FG003|Treatment Period|Other|0|||
46740342|NCT04617275|82957392|FG004|Treatment Period|Other|0|||
46740343|NCT04617275|82957393|FG005|Treatment Period|Other|0|||
46740344|NCT04617275|82957394|FG006|Treatment Period|Other|0|||
46740345|NCT04617275|82957395|FG007|Treatment Period|Other|0|||
46740346|NCT04617275|82957388|FG000|Treatment Period|Withdrawal by Subject|2|||
46740347|NCT04617275|82957389|FG001|Treatment Period|Withdrawal by Subject|0|||
46740348|NCT04617275|82957390|FG002|Treatment Period|Withdrawal by Subject|0|||
46740349|NCT04617275|82957391|FG003|Treatment Period|Withdrawal by Subject|2|||
46740350|NCT04617275|82957392|FG004|Treatment Period|Withdrawal by Subject|2|||
46740351|NCT04617275|82957393|FG005|Treatment Period|Withdrawal by Subject|0|||
46740352|NCT04617275|82957394|FG006|Treatment Period|Withdrawal by Subject|1|||
46740353|NCT04617275|82957395|FG007|Treatment Period|Withdrawal by Subject|2|||
46740354|NCT04617275|82957388|FG000|Follow-up Period|Adverse Event|1|||
46740355|NCT04617275|82957389|FG001|Follow-up Period|Adverse Event|1|||
46740356|NCT04617275|82957390|FG002|Follow-up Period|Adverse Event|2|||
46740357|NCT04617275|82957391|FG003|Follow-up Period|Adverse Event|3|||
46740358|NCT04617275|82957392|FG004|Follow-up Period|Adverse Event|4|||
47050435|NCT01709318|83311267|FG004|Overall Study|Protocol Violation|2|||
47050436|NCT01709318|83311268|FG005|Overall Study|Protocol Violation|0|||
47050437|NCT01709318|83311269|FG006|Overall Study|Protocol Violation|1|||
47050438|NCT01709318|83311263|FG000|Overall Study|Technical Problems|1|||
47050439|NCT01709318|83311264|FG001|Overall Study|Technical Problems|0|||
47050440|NCT01709318|83311265|FG002|Overall Study|Technical Problems|0|||
46740359|NCT04617275|82957393|FG005|Follow-up Period|Adverse Event|3|||
46740360|NCT04617275|82957394|FG006|Follow-up Period|Adverse Event|0|||
46740361|NCT04617275|82957395|FG007|Follow-up Period|Adverse Event|3|||
46740362|NCT04617275|82957388|FG000|Follow-up Period|Lost to Follow-up|0|||
46740363|NCT04617275|82957389|FG001|Follow-up Period|Lost to Follow-up|1|||
46740364|NCT04617275|82957390|FG002|Follow-up Period|Lost to Follow-up|2|||
46740365|NCT04617275|82957391|FG003|Follow-up Period|Lost to Follow-up|0|||
46740366|NCT04617275|82957392|FG004|Follow-up Period|Lost to Follow-up|0|||
46740367|NCT04617275|82957393|FG005|Follow-up Period|Lost to Follow-up|4|||
46740368|NCT04617275|82957394|FG006|Follow-up Period|Lost to Follow-up|0|||
46740369|NCT04617275|82957395|FG007|Follow-up Period|Lost to Follow-up|3|||
47050441|NCT01709318|83311266|FG003|Overall Study|Technical Problems|0|||
46635393|NCT01585584|82809018|FG000|Overall Study|Physician Decision|2|||
46740370|NCT04617275|82957388|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
46740371|NCT04617275|82957389|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
46740372|NCT04617275|82957390|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
46740373|NCT04617275|82957391|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
46740374|NCT04617275|82957392|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
46740375|NCT04617275|82957393|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
46740376|NCT04617275|82957394|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
46740377|NCT04617275|82957395|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
46740378|NCT04617275|82957388|FG000|Follow-up Period|Other|0|||
46740379|NCT04617275|82957389|FG001|Follow-up Period|Other|1|||
46740380|NCT04617275|82957390|FG002|Follow-up Period|Other|0|||
46740381|NCT04617275|82957391|FG003|Follow-up Period|Other|0|||
46740382|NCT04617275|82957392|FG004|Follow-up Period|Other|0|||
46740383|NCT04617275|82957393|FG005|Follow-up Period|Other|0|||
46740384|NCT04617275|82957394|FG006|Follow-up Period|Other|0|||
46740385|NCT04617275|82957395|FG007|Follow-up Period|Other|0|||
46740386|NCT04617275|82957388|FG000|Follow-up Period|Withdrawal by Subject|2|||
46740387|NCT04617275|82957389|FG001|Follow-up Period|Withdrawal by Subject|0|||
46740388|NCT04617275|82957390|FG002|Follow-up Period|Withdrawal by Subject|0|||
46740389|NCT04617275|82957391|FG003|Follow-up Period|Withdrawal by Subject|2|||
46740390|NCT04617275|82957392|FG004|Follow-up Period|Withdrawal by Subject|2|||
46740391|NCT04617275|82957393|FG005|Follow-up Period|Withdrawal by Subject|0|||
46740392|NCT04617275|82957394|FG006|Follow-up Period|Withdrawal by Subject|1|||
46740393|NCT04617275|82957395|FG007|Follow-up Period|Withdrawal by Subject|2|||
46740394|NCT01031537|82957430|FG000|Overall Study|medical reasons not related to study|3|||
46740395|NCT01031537|82957430|FG000|Overall Study|Lack of Efficacy|1|||
46740396|NCT01031537|82957430|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
46740397|NCT01031537|82957430|FG000|Overall Study|moved, met exclusion criteria|10|||
46740398|NCT01031537|82957430|FG000|Overall Study|Withdrawal by Subject|5|||
46740399|NCT01031537|82957430|FG000|Overall Study|PI removal, no longer met eligibility|12|||
46740400|NCT01031381|82957434|FG000|Overall Study|Physician Decision|3|||
46740401|NCT01031381|82957434|FG000|Overall Study|Withdrawal by Subject|6|||
46740402|NCT00685399|82957446|FG000|Treatment Period 1|Withdrawal by Subject|2|||
46740403|NCT00685399|82957447|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46740404|NCT00685399|82957448|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46740405|NCT00685399|82957449|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46740406|NCT00685399|82957450|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46740407|NCT00685399|82957451|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46740408|NCT00685399|82957452|FG006|Treatment Period 1|Withdrawal by Subject|0|||
46740409|NCT00685399|82957453|FG007|Treatment Period 1|Withdrawal by Subject|0|||
46740410|NCT00685399|82957446|FG000|Treatment Period 1|Protocol Violation|1|||
46740411|NCT00685399|82957447|FG001|Treatment Period 1|Protocol Violation|0|||
46740412|NCT00685399|82957448|FG002|Treatment Period 1|Protocol Violation|0|||
46740413|NCT00685399|82957449|FG003|Treatment Period 1|Protocol Violation|0|||
46740414|NCT00685399|82957450|FG004|Treatment Period 1|Protocol Violation|0|||
46740415|NCT00685399|82957451|FG005|Treatment Period 1|Protocol Violation|0|||
46740416|NCT00685399|82957452|FG006|Treatment Period 1|Protocol Violation|0|||
46740417|NCT00685399|82957453|FG007|Treatment Period 1|Protocol Violation|0|||
46740418|NCT00685399|82957446|FG000|Treatment Period 1|Administrative|2|||
46740419|NCT00685399|82957447|FG001|Treatment Period 1|Administrative|0|||
46740420|NCT00685399|82957448|FG002|Treatment Period 1|Administrative|0|||
46740421|NCT00685399|82957449|FG003|Treatment Period 1|Administrative|0|||
46740422|NCT00685399|82957450|FG004|Treatment Period 1|Administrative|0|||
46740423|NCT00685399|82957451|FG005|Treatment Period 1|Administrative|0|||
46740424|NCT00685399|82957452|FG006|Treatment Period 1|Administrative|0|||
46740425|NCT00685399|82957453|FG007|Treatment Period 1|Administrative|0|||
46740426|NCT00685399|82957446|FG000|Treatment Period 1|Lack of Efficacy|1|||
46740427|NCT00685399|82957447|FG001|Treatment Period 1|Lack of Efficacy|0|||
46740428|NCT00685399|82957448|FG002|Treatment Period 1|Lack of Efficacy|0|||
46740429|NCT00685399|82957449|FG003|Treatment Period 1|Lack of Efficacy|0|||
46740430|NCT00685399|82957450|FG004|Treatment Period 1|Lack of Efficacy|0|||
46740431|NCT00685399|82957451|FG005|Treatment Period 1|Lack of Efficacy|0|||
46740432|NCT00685399|82957452|FG006|Treatment Period 1|Lack of Efficacy|0|||
46740433|NCT00685399|82957453|FG007|Treatment Period 1|Lack of Efficacy|0|||
46740434|NCT00685399|82957446|FG000|Treatment Period 2|Administrative Problems|0|||
46740435|NCT00685399|82957447|FG001|Treatment Period 2|Administrative Problems|2|||
46740436|NCT00685399|82957448|FG002|Treatment Period 2|Administrative Problems|1|||
46740437|NCT00685399|82957449|FG003|Treatment Period 2|Administrative Problems|0|||
46740438|NCT00685399|82957450|FG004|Treatment Period 2|Administrative Problems|0|||
46740439|NCT00685399|82957451|FG005|Treatment Period 2|Administrative Problems|0|||
46740440|NCT00685399|82957452|FG006|Treatment Period 2|Administrative Problems|0|||
46740441|NCT00685399|82957453|FG007|Treatment Period 2|Administrative Problems|0|||
46740442|NCT00685399|82957446|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46740443|NCT00685399|82957447|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46740444|NCT00685399|82957448|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46740445|NCT00685399|82957449|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46740446|NCT00685399|82957450|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46740447|NCT00685399|82957451|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46740448|NCT00685399|82957452|FG006|Treatment Period 2|Withdrawal by Subject|0|||
46740449|NCT00685399|82957453|FG007|Treatment Period 2|Withdrawal by Subject|2|||
46740450|NCT00685399|82957446|FG000|Treatment Period 2|Adverse Event|0|||
46740451|NCT00685399|82957447|FG001|Treatment Period 2|Adverse Event|0|||
46740452|NCT00685399|82957448|FG002|Treatment Period 2|Adverse Event|0|||
46740453|NCT00685399|82957449|FG003|Treatment Period 2|Adverse Event|0|||
46740454|NCT00685399|82957450|FG004|Treatment Period 2|Adverse Event|0|||
46740455|NCT00685399|82957451|FG005|Treatment Period 2|Adverse Event|1|||
46740456|NCT00685399|82957452|FG006|Treatment Period 2|Adverse Event|0|||
46740457|NCT00685399|82957453|FG007|Treatment Period 2|Adverse Event|0|||
46740458|NCT00685399|82957446|FG000|Treatment Period 2|Lack of Efficacy|0|||
46740459|NCT00685399|82957447|FG001|Treatment Period 2|Lack of Efficacy|10|||
46740460|NCT00685399|82957448|FG002|Treatment Period 2|Lack of Efficacy|2|||
46740461|NCT00685399|82957449|FG003|Treatment Period 2|Lack of Efficacy|0|||
46740462|NCT00685399|82957450|FG004|Treatment Period 2|Lack of Efficacy|0|||
46740463|NCT00685399|82957451|FG005|Treatment Period 2|Lack of Efficacy|1|||
46740464|NCT00685399|82957452|FG006|Treatment Period 2|Lack of Efficacy|0|||
46740465|NCT00685399|82957453|FG007|Treatment Period 2|Lack of Efficacy|0|||
46740466|NCT00685399|82957446|FG000|Extension|Administrative Issues|0|||
46740467|NCT00685399|82957447|FG001|Extension|Administrative Issues|0|||
46740468|NCT00685399|82957448|FG002|Extension|Administrative Issues|0|||
46740469|NCT00685399|82957449|FG003|Extension|Administrative Issues|1|||
46740470|NCT00685399|82957450|FG004|Extension|Administrative Issues|0|||
46740471|NCT00685399|82957451|FG005|Extension|Administrative Issues|0|||
46740472|NCT00685399|82957452|FG006|Extension|Administrative Issues|0|||
46740473|NCT00685399|82957453|FG007|Extension|Administrative Issues|0|||
46740474|NCT00685399|82957446|FG000|Extension|Withdrawal by Subject|0|||
46740475|NCT00685399|82957447|FG001|Extension|Withdrawal by Subject|0|||
46740476|NCT00685399|82957448|FG002|Extension|Withdrawal by Subject|0|||
46740477|NCT00685399|82957449|FG003|Extension|Withdrawal by Subject|1|||
46740478|NCT00685399|82957450|FG004|Extension|Withdrawal by Subject|0|||
46740479|NCT00685399|82957451|FG005|Extension|Withdrawal by Subject|0|||
46740480|NCT00685399|82957452|FG006|Extension|Withdrawal by Subject|0|||
46740481|NCT00685399|82957453|FG007|Extension|Withdrawal by Subject|0|||
46740482|NCT00685399|82957446|FG000|Extension|Protocol Violation|0|||
46740483|NCT00685399|82957447|FG001|Extension|Protocol Violation|0|||
46740484|NCT00685399|82957448|FG002|Extension|Protocol Violation|0|||
46740485|NCT00685399|82957449|FG003|Extension|Protocol Violation|1|||
47050442|NCT01709318|83311267|FG004|Overall Study|Technical Problems|0|||
47050443|NCT01709318|83311268|FG005|Overall Study|Technical Problems|0|||
47050444|NCT01709318|83311269|FG006|Overall Study|Technical Problems|0|||
47050445|NCT01709318|83311263|FG000|Overall Study|Withdrawal by Subject|3|||
47050446|NCT01709318|83311264|FG001|Overall Study|Withdrawal by Subject|0|||
47050447|NCT01709318|83311265|FG002|Overall Study|Withdrawal by Subject|3|||
47050448|NCT01709318|83311266|FG003|Overall Study|Withdrawal by Subject|3|||
47050449|NCT01709318|83311267|FG004|Overall Study|Withdrawal by Subject|0|||
47050450|NCT01709318|83311268|FG005|Overall Study|Withdrawal by Subject|2|||
47050451|NCT01709318|83311269|FG006|Overall Study|Withdrawal by Subject|4|||
47050452|NCT01709318|83311263|FG000|Overall Study|Other Protocol Specified Criteria|0|||
47050453|NCT01709318|83311264|FG001|Overall Study|Other Protocol Specified Criteria|1|||
47050454|NCT01709318|83311265|FG002|Overall Study|Other Protocol Specified Criteria|0|||
47050455|NCT01709318|83311266|FG003|Overall Study|Other Protocol Specified Criteria|0|||
46740486|NCT00685399|82957450|FG004|Extension|Protocol Violation|0|||
46740487|NCT00685399|82957451|FG005|Extension|Protocol Violation|0|||
46740488|NCT00685399|82957452|FG006|Extension|Protocol Violation|0|||
46740489|NCT00685399|82957453|FG007|Extension|Protocol Violation|0|||
46922125|NCT03018249|83154923|FG001|Overall Study|Withdrawal by Subject|2|||
46922126|NCT02923245|83154941|FG000|Overall Study|ultrasound order was cancelled|2|||
47050456|NCT01709318|83311267|FG004|Overall Study|Other Protocol Specified Criteria|0|||
47050457|NCT01709318|83311268|FG005|Overall Study|Other Protocol Specified Criteria|0|||
47050458|NCT01709318|83311269|FG006|Overall Study|Other Protocol Specified Criteria|0|||
47050459|NCT01699178|83311287|FG000|Overall Study|Adverse Event|1|||
47050460|NCT01699178|83311288|FG001|Overall Study|Adverse Event|5|||
46922127|NCT02923245|83154942|FG001|Overall Study|ultrasound order was cancelled|1|||
46922128|NCT00905606|83154958|FG000|Period 1|Adverse Event|0|||
47050461|NCT01699178|83311287|FG000|Overall Study|Lost to Follow-up|1|||
46922129|NCT00905606|83154959|FG001|Period 1|Adverse Event|1|||
46922130|NCT00905606|83154958|FG000|Washout|Withdrawal by Subject|1|||
46740490|NCT00685399|82957446|FG000|Extension|Lack of Efficacy|0|||
46740491|NCT00685399|82957447|FG001|Extension|Lack of Efficacy|0|||
46740492|NCT00685399|82957448|FG002|Extension|Lack of Efficacy|0|||
46740493|NCT00685399|82957449|FG003|Extension|Lack of Efficacy|2|||
46740494|NCT00685399|82957450|FG004|Extension|Lack of Efficacy|0|||
46740495|NCT00685399|82957451|FG005|Extension|Lack of Efficacy|0|||
46740496|NCT00685399|82957452|FG006|Extension|Lack of Efficacy|0|||
47050462|NCT01699178|83311288|FG001|Overall Study|Lost to Follow-up|6|||
47050463|NCT01699178|83311287|FG000|Overall Study|Non-compliance with Study Drug|3|||
47050464|NCT01699178|83311288|FG001|Overall Study|Non-compliance with Study Drug|1|||
47050465|NCT01699178|83311287|FG000|Overall Study|Physician Decision|1|||
47050466|NCT01699178|83311288|FG001|Overall Study|Physician Decision|0|||
47050467|NCT01699178|83311287|FG000|Overall Study|Withdrawal by Subject|4|||
47050468|NCT01699178|83311288|FG001|Overall Study|Withdrawal by Subject|12|||
46740497|NCT00685399|82957453|FG007|Extension|Lack of Efficacy|0|||
46740498|NCT00685399|82957446|FG000|Extension|Adverse Event|0|||
46740499|NCT00685399|82957447|FG001|Extension|Adverse Event|0|||
46740500|NCT00685399|82957448|FG002|Extension|Adverse Event|0|||
46740501|NCT00685399|82957449|FG003|Extension|Adverse Event|2|||
46740502|NCT00685399|82957450|FG004|Extension|Adverse Event|0|||
46740503|NCT00685399|82957451|FG005|Extension|Adverse Event|0|||
46740504|NCT00685399|82957452|FG006|Extension|Adverse Event|0|||
46740505|NCT00685399|82957453|FG007|Extension|Adverse Event|0|||
46740506|NCT00685165|82957480|FG000|Washout Period of 14 Days|Adverse Event|1|||
46740507|NCT00685165|82957481|FG001|Washout Period of 14 Days|Adverse Event|0|||
46740508|NCT00683449|82957492|FG000|Overall Study|Lost to Follow-up|0|||
46740509|NCT00683449|82957493|FG001|Overall Study|Lost to Follow-up|1|||
46740510|NCT00683449|82957494|FG002|Overall Study|Lost to Follow-up|0|||
46740511|NCT00683449|82957495|FG003|Overall Study|Lost to Follow-up|0|||
46740512|NCT00683449|82957496|FG004|Overall Study|Lost to Follow-up|0|||
46740513|NCT00683293|82957515|FG000|Overall Study|Withdrawal by Subject|2|||
46922131|NCT00905606|83154959|FG001|Washout|Withdrawal by Subject|0|||
46922132|NCT01676896|83154966|FG000|Overall Study|Withdrawal by Subject|12|||
46922133|NCT01676896|83154967|FG001|Overall Study|Withdrawal by Subject|7|||
46922134|NCT01676896|83154968|FG002|Overall Study|Withdrawal by Subject|19|||
46922135|NCT03017235|83154978|FG000|Overall Study|Withdrawal by Subject|4|||
46922136|NCT03017235|83154979|FG001|Overall Study|Withdrawal by Subject|3|||
46922137|NCT03017235|83154978|FG000|Overall Study|Lost to Follow-up|2|||
46922138|NCT03017235|83154979|FG001|Overall Study|Lost to Follow-up|7|||
46922139|NCT03017235|83154978|FG000|Overall Study|Adverse Event|0|||
46922140|NCT03017235|83154979|FG001|Overall Study|Adverse Event|1|||
46922141|NCT03017235|83154978|FG000|Overall Study|Protocol Violation|2|||
46922142|NCT03017235|83154979|FG001|Overall Study|Protocol Violation|1|||
46922143|NCT03017235|83154978|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
47050469|NCT01699178|83311287|FG000|Overall Study|Hematocrit >54%|1|||
46740514|NCT00683293|82957516|FG001|Overall Study|Withdrawal by Subject|3|||
46740515|NCT00726232|82957528|FG000|Initial Phase (Dose-finding)|Death|0|||
46740516|NCT00726232|82957529|FG001|Initial Phase (Dose-finding)|Death|0|||
46740517|NCT00726232|82957530|FG002|Initial Phase (Dose-finding)|Death|0|||
46740518|NCT00726232|82957531|FG003|Initial Phase (Dose-finding)|Death|0|||
46740519|NCT00726232|82957532|FG004|Initial Phase (Dose-finding)|Death|1|||
46740520|NCT00726232|82957533|FG005|Initial Phase (Dose-finding)|Death|0|||
46740521|NCT00726232|82957534|FG006|Initial Phase (Dose-finding)|Death|0|||
46740522|NCT00726232|82957535|FG007|Initial Phase (Dose-finding)|Death|0|||
46740523|NCT00726232|82957528|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
46740524|NCT00726232|82957529|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
46740525|NCT00726232|82957530|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
46740526|NCT00726232|82957531|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
46740527|NCT00726232|82957532|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
46740528|NCT00726232|82957533|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
46740529|NCT00726232|82957534|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
46740530|NCT00726232|82957535|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
46740531|NCT00726232|82957528|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
46740532|NCT00726232|82957529|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
46740533|NCT00726232|82957530|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
46804125|NCT03899064|83023310|FG000|Overall Study|Other|2|||
46804126|NCT03902574|83023317|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
46804127|NCT03902574|83023318|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
46922144|NCT03017235|83154979|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
46922145|NCT03017079|83154987|FG000|Overall Study|Physician Decision|1|||
46740534|NCT00726232|82957531|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
46740535|NCT00726232|82957532|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
46740536|NCT00726232|82957533|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
46740537|NCT00726232|82957534|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
46740538|NCT00726232|82957535|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
46740539|NCT00726232|82957528|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
46740540|NCT00726232|82957529|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
46740541|NCT00726232|82957530|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
46740542|NCT00726232|82957531|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
46740543|NCT00726232|82957532|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
46740544|NCT00726232|82957533|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
46740545|NCT00726232|82957534|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
46740546|NCT00726232|82957535|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
46740547|NCT00726232|82957528|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
46740548|NCT00726232|82957529|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
46740549|NCT00726232|82957530|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
46740550|NCT00726232|82957531|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
46740551|NCT00726232|82957532|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
46740552|NCT00726232|82957533|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
46740553|NCT00726232|82957534|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
46740554|NCT00726232|82957535|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
46740555|NCT00726232|82957528|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
46740556|NCT00726232|82957529|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
46740557|NCT00726232|82957530|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
46740558|NCT00726232|82957531|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
46740559|NCT00726232|82957532|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
46740560|NCT00726232|82957533|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
46740561|NCT00726232|82957534|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
46740562|NCT00726232|82957535|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
46740563|NCT00726232|82957528|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
46740564|NCT00726232|82957529|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
46740565|NCT00726232|82957530|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
46740566|NCT00726232|82957531|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
46740567|NCT00726232|82957532|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
46740568|NCT00726232|82957533|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
46740569|NCT00726232|82957534|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
47050470|NCT01699178|83311288|FG001|Overall Study|Hematocrit >54%|1|||
47050471|NCT01699178|83311287|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
47050472|NCT01699178|83311288|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
47050473|NCT01699178|83311287|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
47050474|NCT01699178|83311288|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
47050475|NCT01683409|83311299|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
47050476|NCT01683409|83311300|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
47050477|NCT01683409|83311301|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
47050478|NCT01683409|83311302|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
47050479|NCT01683409|83311303|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
47050480|NCT01683409|83311299|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
47050481|NCT01683409|83311300|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
47050482|NCT01683409|83311301|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
47050483|NCT01683409|83311302|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
47050484|NCT01683409|83311303|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
47050485|NCT01683409|83311299|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
47050486|NCT01683409|83311300|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
47050487|NCT01683409|83311301|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
47050488|NCT01683409|83311302|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
47050489|NCT01683409|83311303|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
47050490|NCT01683409|83311299|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
47050491|NCT01683409|83311300|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
47050492|NCT01683409|83311301|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
47050493|NCT01683409|83311302|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
47050494|NCT01683409|83311303|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
47050495|NCT01683409|83311299|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
47050496|NCT01683409|83311300|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
47050497|NCT01683409|83311301|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
47050498|NCT01683409|83311302|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
47050499|NCT01683409|83311303|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
47050500|NCT01683409|83311299|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
47050501|NCT01683409|83311300|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
46740570|NCT00726232|82957535|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
46740571|NCT00726232|82957528|FG000|Expansion Phase|Death|0|||
46740572|NCT00726232|82957529|FG001|Expansion Phase|Death|0|||
46740573|NCT00726232|82957530|FG002|Expansion Phase|Death|0|||
46740574|NCT00726232|82957531|FG003|Expansion Phase|Death|0|||
46740575|NCT00726232|82957532|FG004|Expansion Phase|Death|0|||
46740576|NCT00726232|82957533|FG005|Expansion Phase|Death|0|||
46740577|NCT00726232|82957534|FG006|Expansion Phase|Death|0|||
46740578|NCT00726232|82957535|FG007|Expansion Phase|Death|1|||
46740579|NCT00726232|82957528|FG000|Expansion Phase|Adverse Event|0|||
46740580|NCT00726232|82957529|FG001|Expansion Phase|Adverse Event|0|||
46740581|NCT00726232|82957530|FG002|Expansion Phase|Adverse Event|0|||
46740582|NCT00726232|82957531|FG003|Expansion Phase|Adverse Event|0|||
46740583|NCT00726232|82957532|FG004|Expansion Phase|Adverse Event|0|||
46740584|NCT00726232|82957533|FG005|Expansion Phase|Adverse Event|0|||
46740585|NCT00726232|82957534|FG006|Expansion Phase|Adverse Event|6|||
46740586|NCT00726232|82957535|FG007|Expansion Phase|Adverse Event|11|||
46740587|NCT00726232|82957528|FG000|Expansion Phase|Withdrawal by Subject|0|||
46740588|NCT00726232|82957529|FG001|Expansion Phase|Withdrawal by Subject|0|||
46740589|NCT00726232|82957530|FG002|Expansion Phase|Withdrawal by Subject|0|||
46740590|NCT00726232|82957531|FG003|Expansion Phase|Withdrawal by Subject|0|||
46740591|NCT00726232|82957532|FG004|Expansion Phase|Withdrawal by Subject|0|||
46740592|NCT00726232|82957533|FG005|Expansion Phase|Withdrawal by Subject|0|||
46740593|NCT00726232|82957534|FG006|Expansion Phase|Withdrawal by Subject|2|||
46740594|NCT00726232|82957535|FG007|Expansion Phase|Withdrawal by Subject|3|||
46740595|NCT00726232|82957528|FG000|Expansion Phase|Disease progression|0|||
46740596|NCT00726232|82957529|FG001|Expansion Phase|Disease progression|0|||
46740597|NCT00726232|82957530|FG002|Expansion Phase|Disease progression|0|||
46740598|NCT00726232|82957531|FG003|Expansion Phase|Disease progression|0|||
46740599|NCT00726232|82957532|FG004|Expansion Phase|Disease progression|0|||
46740600|NCT00726232|82957533|FG005|Expansion Phase|Disease progression|0|||
46740601|NCT00726232|82957534|FG006|Expansion Phase|Disease progression|4|||
46740602|NCT00726232|82957535|FG007|Expansion Phase|Disease progression|0|||
46740603|NCT00726232|82957528|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
46740604|NCT00726232|82957529|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
46740605|NCT00726232|82957530|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
46740606|NCT00726232|82957531|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
46740607|NCT00726232|82957532|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
46740608|NCT00726232|82957533|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
46740609|NCT00726232|82957534|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
46740610|NCT00726232|82957535|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
46740611|NCT00726232|82957528|FG000|Expansion Phase|Per Investigator: lack of response|0|||
46740612|NCT00726232|82957529|FG001|Expansion Phase|Per Investigator: lack of response|0|||
46740613|NCT00726232|82957530|FG002|Expansion Phase|Per Investigator: lack of response|0|||
46740614|NCT00726232|82957531|FG003|Expansion Phase|Per Investigator: lack of response|0|||
46740615|NCT00726232|82957532|FG004|Expansion Phase|Per Investigator: lack of response|0|||
46740616|NCT00726232|82957533|FG005|Expansion Phase|Per Investigator: lack of response|0|||
46740617|NCT00726232|82957534|FG006|Expansion Phase|Per Investigator: lack of response|1|||
46740618|NCT00726232|82957535|FG007|Expansion Phase|Per Investigator: lack of response|7|||
46740619|NCT00726232|82957528|FG000|Expansion Phase|Unspecified reason|0|||
47050502|NCT01683409|83311301|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
47050503|NCT01683409|83311302|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
47050504|NCT01683409|83311303|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
47050505|NCT01683409|83311299|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
47050506|NCT01683409|83311300|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
47050507|NCT01683409|83311301|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
47050508|NCT01683409|83311302|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
47050509|NCT01683409|83311303|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
47050510|NCT01683409|83311299|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
47050511|NCT01683409|83311300|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
47050512|NCT01683409|83311301|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
46740620|NCT00726232|82957529|FG001|Expansion Phase|Unspecified reason|0|||
46740621|NCT00726232|82957530|FG002|Expansion Phase|Unspecified reason|0|||
46740622|NCT00726232|82957531|FG003|Expansion Phase|Unspecified reason|0|||
46740623|NCT00726232|82957532|FG004|Expansion Phase|Unspecified reason|0|||
46740624|NCT00726232|82957533|FG005|Expansion Phase|Unspecified reason|0|||
46740625|NCT00726232|82957534|FG006|Expansion Phase|Unspecified reason|1|||
46740626|NCT00726232|82957535|FG007|Expansion Phase|Unspecified reason|0|||
46740627|NCT00720382|82957556|FG000|Overall Study|Adverse Event|54|||
46740628|NCT00720382|82957557|FG001|Overall Study|Adverse Event|17|||
46740629|NCT00720382|82957556|FG000|Overall Study|Lack of Efficacy|18|||
46740630|NCT00720382|82957557|FG001|Overall Study|Lack of Efficacy|7|||
46740631|NCT00720382|82957556|FG000|Overall Study|Non-Compliance|15|||
46740632|NCT00720382|82957557|FG001|Overall Study|Non-Compliance|5|||
46740633|NCT00720382|82957556|FG000|Overall Study|Withdrawal by Subject|47|||
47050513|NCT01683409|83311302|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
46740634|NCT00720382|82957557|FG001|Overall Study|Withdrawal by Subject|11|||
46740635|NCT00720382|82957556|FG000|Overall Study|Lost to Follow-up|28|||
47050514|NCT01683409|83311303|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
46740636|NCT00720382|82957557|FG001|Overall Study|Lost to Follow-up|14|||
46740637|NCT00720382|82957556|FG000|Overall Study|administrative|14|||
46740638|NCT00720382|82957557|FG001|Overall Study|administrative|5|||
46740639|NCT00720226|82957565|FG000|Overall Study|Withdrawal by Subject|7|||
46740640|NCT00720226|82957566|FG001|Overall Study|Withdrawal by Subject|4|||
46740641|NCT00725920|82957574|FG000|Overall Study|Lack of Efficacy|3|||
46740642|NCT00725920|82957575|FG001|Overall Study|Lack of Efficacy|6|||
46740643|NCT00725842|82957581|FG000|Overall Study|Lost to Follow-up|19|||
46740644|NCT00725842|82957581|FG000|Overall Study|Death|1|||
46740645|NCT00725842|82957581|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
46740646|NCT00725842|82957581|FG000|Overall Study|Consent date prior to study start date|5|||
46740647|NCT00725842|82957581|FG000|Overall Study|Inclusion criterion not met|1|||
46740648|NCT00725842|82957581|FG000|Overall Study|No Visit 1 data|1|||
46740649|NCT00725764|82957585|FG000|Overall Study|Withdrawal by Subject|2|||
46740650|NCT00725764|82957585|FG000|Overall Study|Physician Decision|1|||
46740651|NCT00725764|82957585|FG000|Overall Study|Progressive Disease|7|||
46740652|NCT00725764|82957585|FG000|Overall Study|Lost to Follow-up|1|||
46740653|NCT00725764|82957585|FG000|Overall Study|Death|1|||
46740654|NCT00725764|82957585|FG000|Overall Study|Participant non compliant with protocol|1|||
46740655|NCT00725764|82957585|FG000|Overall Study|Decline in performance status|1|||
46740656|NCT00725608|82957590|FG000|Overall Study|Lost to Follow-up|60|||
46740657|NCT00725608|82957590|FG000|Overall Study|Adverse Event|14|||
46740658|NCT00725608|82957590|FG000|Overall Study|Individual reasons|86|||
46740659|NCT00725608|82957590|FG000|Overall Study|Other|7|||
46740660|NCT00725452|82957594|FG000|Overall Study|Adverse Event|3|||
46740661|NCT00725452|82957594|FG000|Overall Study|Lack of Efficacy|2|||
46740662|NCT00725452|82957594|FG000|Overall Study|Reason not specified|1|||
46740663|NCT00725452|82957594|FG000|Overall Study|Physician Decision|1|||
46740664|NCT00725452|82957594|FG000|Overall Study|Withdrawal by Subject|3|||
46740665|NCT00725452|82957594|FG000|Overall Study|Lost to Follow-up|1|||
46740666|NCT00725296|82957598|FG000|Overall Study|Adverse Event|11|||
46740667|NCT00725296|82957598|FG000|Overall Study|Lack of Efficacy|7|||
46740668|NCT00725296|82957598|FG000|Overall Study|Withdrawal by Subject|3|||
46740669|NCT00725296|82957598|FG000|Overall Study|Non-Compliance|2|||
46740670|NCT00725296|82957598|FG000|Overall Study|Lost to Follow-up|1|||
46740671|NCT00725296|82957598|FG000|Overall Study|Other|38|||
46740672|NCT00719680|82957603|FG000|Overall Study|Adverse Event|1|||
46740673|NCT00719680|82957603|FG000|Overall Study|Lost to Follow-up|1|||
46740674|NCT00719680|82957603|FG000|Overall Study|Withdrawal by Subject|3|||
46740675|NCT00719212|82957607|FG000|Overall Study|Death|41|||
46740676|NCT00719212|82957607|FG000|Overall Study|Lost to Follow-up|2|||
46740677|NCT00719212|82957607|FG000|Overall Study|Withdrawal by Subject|1|||
46740678|NCT00585052|82957611|FG000|Overall Study|Withdrawal by Subject|1|||
46740679|NCT00724282|82957615|FG000|Overall Study|Withdrawal by Subject|3|||
46740680|NCT00724282|82957615|FG000|Overall Study|Physician Decision|1|||
46740681|NCT00724126|82957621|FG000|Overall Study|Adverse Event|2|||
46740682|NCT00724126|82957622|FG001|Overall Study|Adverse Event|0|||
46740683|NCT00724126|82957621|FG000|Overall Study|Withdrawal by Subject|8|||
46740684|NCT00724126|82957622|FG001|Overall Study|Withdrawal by Subject|6|||
46740685|NCT00724126|82957621|FG000|Overall Study|Lost to Follow-up|6|||
46740686|NCT00724126|82957622|FG001|Overall Study|Lost to Follow-up|6|||
46740687|NCT00724126|82957621|FG000|Overall Study|Noncompliance|2|||
46740688|NCT00724126|82957622|FG001|Overall Study|Noncompliance|1|||
46740689|NCT00724126|82957621|FG000|Overall Study|Subject randomized although ineligible|1|||
46740690|NCT00724126|82957622|FG001|Overall Study|Subject randomized although ineligible|1|||
46740691|NCT00724126|82957621|FG000|Overall Study|Subject had to leave vicinity of site|0|||
46740692|NCT00724126|82957622|FG001|Overall Study|Subject had to leave vicinity of site|1|||
46740693|NCT00723892|82957630|FG000|Overall Study|Participant not tracked|33|||
46740694|NCT00723892|82957631|FG001|Overall Study|Participant not tracked|35|||
46740695|NCT00723892|82957630|FG000|Overall Study|Virological criterion|24|||
46740696|NCT00723892|82957631|FG001|Overall Study|Virological criterion|9|||
46740697|NCT00723892|82957630|FG000|Overall Study|Withdrawal by Subject|6|||
46740698|NCT00723892|82957631|FG001|Overall Study|Withdrawal by Subject|9|||
46740699|NCT00723892|82957630|FG000|Overall Study|End planned|11|||
46635394|NCT01561560|82809022|FG000|First Two Weeks of Wear|Time/job conflict|0|||
46635395|NCT01561560|82809023|FG001|First Two Weeks of Wear|Time/job conflict|1|||
46635396|NCT01561560|82809022|FG000|First Two Weeks of Wear|Adverse Event|0|||
46740700|NCT00723892|82957631|FG001|Overall Study|End planned|7|||
46740701|NCT00723892|82957630|FG000|Overall Study|Bad tolerance|5|||
46740702|NCT00723892|82957631|FG001|Overall Study|Bad tolerance|5|||
46740703|NCT00723892|82957630|FG000|Overall Study|Multiple reasons|17|||
46740704|NCT00723892|82957631|FG001|Overall Study|Multiple reasons|12|||
46740705|NCT00723892|82957630|FG000|Overall Study|Other|6|||
46740706|NCT00723892|82957631|FG001|Overall Study|Other|3|||
46740707|NCT00723892|82957630|FG000|Overall Study|Study end|1|||
46740708|NCT00723892|82957631|FG001|Overall Study|Study end|3|||
46740709|NCT00723892|82957630|FG000|Overall Study|Weight loss|1|||
46740710|NCT00723892|82957631|FG001|Overall Study|Weight loss|3|||
46740711|NCT00723892|82957630|FG000|Overall Study|Alcohol abuse|0|||
46740712|NCT00723892|82957631|FG001|Overall Study|Alcohol abuse|1|||
46740713|NCT00723892|82957630|FG000|Overall Study|Intercurrent infection|2|||
46740714|NCT00723892|82957631|FG001|Overall Study|Intercurrent infection|0|||
46740715|NCT00723892|82957630|FG000|Overall Study|Drug addiction|1|||
46740716|NCT00723892|82957631|FG001|Overall Study|Drug addiction|0|||
46740717|NCT00718666|82957640|FG000|Booster Phase Year 5|No active participation request|0|||
46775738|NCT00793793|82994207|FG003|Overall Study|Protocol Violation|1|||
46740718|NCT00718666|82957641|FG001|Booster Phase Year 5|No active participation request|0|||
46740719|NCT00718666|82957642|FG002|Booster Phase Year 5|No active participation request|1|||
46740720|NCT00718666|82957640|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
46740721|NCT00718666|82957641|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
46740722|NCT00718666|82957642|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
46740723|NCT00718666|82957640|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
46740724|NCT00718666|82957641|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
46740725|NCT00718666|82957642|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
46740726|NCT00718666|82957640|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
46740727|NCT00718666|82957641|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
46740728|NCT00718666|82957642|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
46740729|NCT03950440|82957663|FG000|Overall Study|Death|8|||
46740730|NCT03950440|82957664|FG001|Overall Study|Death|2|||
46740731|NCT03950440|82957665|FG002|Overall Study|Death|1|||
46740732|NCT00718510|82957675|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
46740733|NCT00718510|82957676|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46740734|NCT00718510|82957675|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
46740735|NCT00718510|82957676|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
46740736|NCT00585286|82957682|FG000|Overall Study|Lost to Follow-up|1|||
46740737|NCT00723190|82957686|FG000|Overall Study|Withdrawal by Subject|45|||
46740738|NCT00723190|82957686|FG000|Overall Study|Lost to Follow-up|37|||
46740739|NCT00723190|82957686|FG000|Overall Study|Adverse Event|18|||
46740740|NCT00723190|82957686|FG000|Overall Study|Lack of Efficacy|16|||
46740741|NCT00723190|82957686|FG000|Overall Study|Protocol Violation|15|||
46740742|NCT00723190|82957686|FG000|Overall Study|Other-Premature Discontinuation|9|||
46740743|NCT00723190|82957686|FG000|Overall Study|Other-Not included in safety population|2|||
46740744|NCT00722800|82957692|FG000|Overall Study|Withdrawal by Subject|1|||
46740745|NCT00722800|82957693|FG001|Overall Study|Withdrawal by Subject|0|||
46740746|NCT00722800|82957692|FG000|Overall Study|Physician Decision|1|||
46740747|NCT00722800|82957693|FG001|Overall Study|Physician Decision|0|||
46740748|NCT00718042|82957705|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
46740749|NCT00718042|82957706|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
46740750|NCT00718042|82957707|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
46740751|NCT00718042|82957708|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
46740752|NCT00718042|82957709|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
46740753|NCT00718042|82957710|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
46740754|NCT00718042|82957705|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
46740755|NCT00718042|82957706|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
46740756|NCT00718042|82957707|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
46740757|NCT00718042|82957708|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
46740758|NCT00718042|82957709|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
46740759|NCT00718042|82957710|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
46740760|NCT00718042|82957705|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
46740761|NCT00718042|82957706|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
46740762|NCT00718042|82957707|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
46740763|NCT00718042|82957708|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
46740764|NCT00718042|82957709|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
46740765|NCT00718042|82957710|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
47050515|NCT01683409|83311299|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
46740766|NCT00718042|82957705|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
46740767|NCT00718042|82957706|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
46922146|NCT03017079|83154988|FG001|Overall Study|Physician Decision|1|||
46922147|NCT03017079|83154987|FG000|Overall Study|Death|3|||
46922148|NCT03017079|83154988|FG001|Overall Study|Death|2|||
46922149|NCT03017079|83154987|FG000|Overall Study|Lack of Efficacy|2|||
46922150|NCT03017079|83154988|FG001|Overall Study|Lack of Efficacy|2|||
46922151|NCT03017079|83154987|FG000|Overall Study|Protocol Violation|0|||
46922152|NCT03017079|83154988|FG001|Overall Study|Protocol Violation|1|||
46740768|NCT00718042|82957707|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
46740769|NCT00718042|82957708|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
46740770|NCT00718042|82957709|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
46740771|NCT00718042|82957710|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
46740772|NCT00718042|82957705|FG000|Donor Follow-up|Lost to Follow-up|13|||
46922153|NCT03015363|83155001|FG000|Overall Study|Physician Decision|14|||
46922154|NCT03015363|83155001|FG000|Overall Study|Withdrawal by Subject|3|||
46922155|NCT02880371|83155013|FG000|Phase 1b|Lost to Follow-up|1|||
46922156|NCT02880371|83155014|FG001|Phase 1b|Lost to Follow-up|0|||
46922157|NCT02880371|83155015|FG002|Phase 1b|Lost to Follow-up|0|||
46922158|NCT02880371|83155016|FG003|Phase 1b|Lost to Follow-up|0|||
47050516|NCT01683409|83311300|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
46740773|NCT00718042|82957706|FG001|Donor Follow-up|Lost to Follow-up|0|||
46740774|NCT00718042|82957707|FG002|Donor Follow-up|Lost to Follow-up|0|||
46922159|NCT02880371|83155017|FG004|Phase 1b|Lost to Follow-up|0|||
46740775|NCT00718042|82957708|FG003|Donor Follow-up|Lost to Follow-up|0|||
46740776|NCT00718042|82957709|FG004|Donor Follow-up|Lost to Follow-up|19|||
46740777|NCT00718042|82957710|FG005|Donor Follow-up|Lost to Follow-up|0|||
46740778|NCT00741598|82957724|FG000|Overall Study|Lost to Follow-up|3|||
46740779|NCT00741598|82957725|FG001|Overall Study|Lost to Follow-up|4|||
46740780|NCT00741598|82957724|FG000|Overall Study|Lack of Efficacy|1|||
46740781|NCT00741598|82957725|FG001|Overall Study|Lack of Efficacy|2|||
46740782|NCT00741598|82957724|FG000|Overall Study|Physician Decision|1|||
46740783|NCT00741598|82957725|FG001|Overall Study|Physician Decision|1|||
46740784|NCT00741598|82957724|FG000|Overall Study|Pregnancy|1|||
46740785|NCT00741598|82957725|FG001|Overall Study|Pregnancy|0|||
46740786|NCT00741598|82957724|FG000|Overall Study|Withdrawal by Subject|3|||
46740787|NCT00741598|82957725|FG001|Overall Study|Withdrawal by Subject|2|||
46740788|NCT00717886|82957732|FG000|Overall Study|Withdrawal by Subject|3|||
46740789|NCT00717886|82957732|FG000|Overall Study|Treatment Failure|1|||
46740790|NCT00741286|82957738|FG000|Overall Study|Lost to Follow-up|15|||
46740791|NCT00741286|82957739|FG001|Overall Study|Lost to Follow-up|10|||
46740792|NCT00741286|82957738|FG000|Overall Study|Adverse Event|1|||
46740793|NCT00741286|82957739|FG001|Overall Study|Adverse Event|6|||
46740794|NCT00741286|82957738|FG000|Overall Study|Protocol Violation|3|||
46740795|NCT00741286|82957739|FG001|Overall Study|Protocol Violation|2|||
46740796|NCT00741286|82957738|FG000|Overall Study|Primary Outcome|1|||
46740797|NCT00741286|82957739|FG001|Overall Study|Primary Outcome|1|||
46740798|NCT00716482|82957745|FG000|Overall Study|Lost to Follow-up|6|||
46740799|NCT00716482|82957745|FG000|Overall Study|Inadequate acquisition or analysis|50|||
46740800|NCT00716482|82957745|FG000|Overall Study|no pathology obtained|10|||
46740801|NCT00716482|82957745|FG000|Overall Study|technical/machine error|28|||
46740802|NCT00716482|82957745|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
46740803|NCT00716092|82957758|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
46740804|NCT00716092|82957759|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
46740805|NCT00716092|82957760|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
46740806|NCT00715624|82957770|FG000|Overall Study|Adverse Event|12|||
46740807|NCT00715624|82957771|FG001|Overall Study|Adverse Event|37|||
46740808|NCT00715624|82957770|FG000|Overall Study|Lack of Efficacy|11|||
46740809|NCT00715624|82957771|FG001|Overall Study|Lack of Efficacy|11|||
46740810|NCT00715624|82957770|FG000|Overall Study|Lost to Follow-up|1|||
46740811|NCT00715624|82957771|FG001|Overall Study|Lost to Follow-up|2|||
46740812|NCT00715624|82957770|FG000|Overall Study|Protocol Violation|1|||
46740813|NCT00715624|82957771|FG001|Overall Study|Protocol Violation|0|||
46740814|NCT00715624|82957770|FG000|Overall Study|Withdrawal by Subject|11|||
46740815|NCT00715624|82957771|FG001|Overall Study|Withdrawal by Subject|25|||
46740816|NCT00715624|82957770|FG000|Overall Study|Familial and personal reasons|10|||
46740817|NCT00715624|82957771|FG001|Overall Study|Familial and personal reasons|22|||
46740818|NCT00715624|82957770|FG000|Overall Study|Poor compliance|6|||
46740819|NCT00715624|82957771|FG001|Overall Study|Poor compliance|13|||
46740820|NCT00715624|82957770|FG000|Overall Study|Sponsor decision|0|||
46740821|NCT00715624|82957771|FG001|Overall Study|Sponsor decision|4|||
46740822|NCT00715624|82957770|FG000|Overall Study|Incorrect randomization (not treated)|0|||
46740823|NCT00715624|82957771|FG001|Overall Study|Incorrect randomization (not treated)|1|||
46740824|NCT00715624|82957770|FG000|Overall Study|Other|0|||
46740825|NCT00715624|82957771|FG001|Overall Study|Other|1|||
46740826|NCT00576199|82957777|FG000|Overall Study|Adverse Event|12|||
46740827|NCT00576199|82957777|FG000|Overall Study|Insufficient Therapeutic Response|14|||
46740828|NCT00576199|82957777|FG000|Overall Study|Refused Treatment|2|||
46740829|NCT00576199|82957777|FG000|Overall Study|Reason Unspecified|2|||
46740830|NCT00715078|82957784|FG000|Overall Study|Death|29|||
46740831|NCT00715078|82957785|FG001|Overall Study|Death|36|||
46922160|NCT02880371|83155018|FG005|Phase 1b|Lost to Follow-up|0|||
46922161|NCT02880371|83155019|FG006|Phase 1b|Lost to Follow-up|0|||
46922162|NCT02880371|83155020|FG007|Phase 1b|Lost to Follow-up|0|||
46740832|NCT00715078|82957786|FG002|Overall Study|Death|36|||
46740833|NCT00715078|82957784|FG000|Overall Study|Withdrawal by Subject|1|||
46740834|NCT00715078|82957785|FG001|Overall Study|Withdrawal by Subject|0|||
46740835|NCT00715078|82957786|FG002|Overall Study|Withdrawal by Subject|1|||
46740836|NCT00715078|82957784|FG000|Overall Study|Unable to start due to disease prog.|0|||
46740837|NCT00715078|82957785|FG001|Overall Study|Unable to start due to disease prog.|0|||
46740838|NCT00715078|82957786|FG002|Overall Study|Unable to start due to disease prog.|1|||
46740839|NCT00679627|82957796|FG000|Overall Study|Death|41|||
46740840|NCT00679627|82957797|FG001|Overall Study|Death|29|||
46740841|NCT00679627|82957796|FG000|Overall Study|Adverse Event|43|||
46740842|NCT00679627|82957797|FG001|Overall Study|Adverse Event|53|||
46740843|NCT00679627|82957796|FG000|Overall Study|Withdrawal by Subject|168|||
46740844|NCT00679627|82957797|FG001|Overall Study|Withdrawal by Subject|172|||
46740845|NCT00679627|82957796|FG000|Overall Study|Lost to Follow-up|22|||
46740846|NCT00679627|82957797|FG001|Overall Study|Lost to Follow-up|26|||
46740847|NCT00679627|82957796|FG000|Overall Study|Early Study Closure|425|||
46922163|NCT02880371|83155013|FG000|Phase 1b|Participants terminated by Sponsor|1|||
46740848|NCT00679627|82957797|FG001|Overall Study|Early Study Closure|405|||
46740849|NCT00714688|82957806|FG000|Overall Study|Lack of Efficacy|14|||
46740850|NCT00714688|82957807|FG001|Overall Study|Lack of Efficacy|1|||
46740851|NCT00714688|82957808|FG002|Overall Study|Lack of Efficacy|4|||
46740852|NCT00714688|82957806|FG000|Overall Study|Withdrawal by Subject|4|||
46740853|NCT00714688|82957807|FG001|Overall Study|Withdrawal by Subject|3|||
46740854|NCT00714688|82957808|FG002|Overall Study|Withdrawal by Subject|3|||
46740855|NCT00714688|82957806|FG000|Overall Study|Lost to Follow-up|5|||
46740856|NCT00714688|82957807|FG001|Overall Study|Lost to Follow-up|2|||
46740857|NCT00714688|82957808|FG002|Overall Study|Lost to Follow-up|0|||
46740858|NCT00714688|82957806|FG000|Overall Study|Adverse Event|2|||
46740859|NCT00714688|82957807|FG001|Overall Study|Adverse Event|15|||
46740860|NCT00714688|82957808|FG002|Overall Study|Adverse Event|19|||
46740861|NCT00714688|82957806|FG000|Overall Study|Subject Non-compliant|3|||
46740862|NCT00714688|82957807|FG001|Overall Study|Subject Non-compliant|5|||
46740863|NCT00714688|82957808|FG002|Overall Study|Subject Non-compliant|5|||
46740864|NCT00714688|82957806|FG000|Overall Study|Ineligible to Continue the Study|0|||
46740865|NCT00714688|82957807|FG001|Overall Study|Ineligible to Continue the Study|1|||
46740866|NCT00714688|82957808|FG002|Overall Study|Ineligible to Continue the Study|1|||
46740867|NCT00714688|82957806|FG000|Overall Study|Sponsor's Decision|0|||
46740868|NCT00714688|82957807|FG001|Overall Study|Sponsor's Decision|2|||
46740869|NCT00714688|82957808|FG002|Overall Study|Sponsor's Decision|0|||
46740870|NCT00714688|82957806|FG000|Overall Study|Other|1|||
46740871|NCT00714688|82957807|FG001|Overall Study|Other|6|||
46740872|NCT00714688|82957808|FG002|Overall Study|Other|5|||
46740873|NCT00679549|82957818|FG000|Overall Study|dropout|2|||
46740874|NCT00679549|82957819|FG001|Overall Study|dropout|4|||
46740875|NCT00679549|82957818|FG000|Overall Study|missing outcome echocardiograms|4|||
46740876|NCT00679549|82957819|FG001|Overall Study|missing outcome echocardiograms|5|||
46740877|NCT01031069|82957829|FG000|Overall Study|Serious Adverse Event|0|||
46740878|NCT01031069|82957830|FG001|Overall Study|Serious Adverse Event|1|||
46740879|NCT01031069|82957831|FG002|Overall Study|Serious Adverse Event|0|||
46740880|NCT01031069|82957832|FG003|Overall Study|Serious Adverse Event|0|||
46740881|NCT01031069|82957829|FG000|Overall Study|Withdrawal by Subject|2|||
46740882|NCT01031069|82957830|FG001|Overall Study|Withdrawal by Subject|3|||
46740883|NCT01031069|82957831|FG002|Overall Study|Withdrawal by Subject|18|||
46740884|NCT01031069|82957832|FG003|Overall Study|Withdrawal by Subject|18|||
46740885|NCT01031069|82957829|FG000|Overall Study|Migrated/moved from study area|1|||
46740886|NCT01031069|82957830|FG001|Overall Study|Migrated/moved from study area|2|||
46740887|NCT01031069|82957831|FG002|Overall Study|Migrated/moved from study area|1|||
46740888|NCT01031069|82957832|FG003|Overall Study|Migrated/moved from study area|1|||
46740889|NCT01031069|82957829|FG000|Overall Study|Lost to Follow-up|9|||
46740890|NCT01031069|82957830|FG001|Overall Study|Lost to Follow-up|5|||
46740891|NCT01031069|82957831|FG002|Overall Study|Lost to Follow-up|21|||
46740892|NCT01031069|82957832|FG003|Overall Study|Lost to Follow-up|15|||
46740893|NCT01031069|82957829|FG000|Overall Study|Other|0|||
46740894|NCT01031069|82957830|FG001|Overall Study|Other|0|||
46740895|NCT01031069|82957831|FG002|Overall Study|Other|1|||
46740896|NCT01031069|82957832|FG003|Overall Study|Other|0|||
46740897|NCT00679081|82957844|FG000|Overall Study|Lost to Follow-up|1|||
46740898|NCT00682435|82957852|FG000|Overall Study|Insufficient data|5|||
46740899|NCT00682435|82957852|FG000|Overall Study|Erroneously enrolled twice|2|||
46740900|NCT00713830|82957858|FG000|Overall Study|Adverse Event|23|||
46740901|NCT00713830|82957859|FG001|Overall Study|Adverse Event|71|||
46740902|NCT00713830|82957858|FG000|Overall Study|Lack of Efficacy|24|||
46740903|NCT00713830|82957859|FG001|Overall Study|Lack of Efficacy|16|||
46740904|NCT00713830|82957858|FG000|Overall Study|Lost to Follow-up|2|||
46740905|NCT00713830|82957859|FG001|Overall Study|Lost to Follow-up|9|||
46740906|NCT00713830|82957858|FG000|Overall Study|Withdrawal by Subject|13|||
46740907|NCT00713830|82957859|FG001|Overall Study|Withdrawal by Subject|23|||
46740908|NCT00713830|82957858|FG000|Overall Study|Poor Compliance to Protocol|7|||
46740909|NCT00713830|82957859|FG001|Overall Study|Poor Compliance to Protocol|14|||
46740910|NCT00713830|82957858|FG000|Overall Study|Familial and Personal Reasons|9|||
46740911|NCT00713830|82957859|FG001|Overall Study|Familial and Personal Reasons|34|||
46740912|NCT00713830|82957858|FG000|Overall Study|Sponsor Decision|4|||
46740913|NCT00713830|82957859|FG001|Overall Study|Sponsor Decision|10|||
46740914|NCT00681811|82957867|FG000|Overall Study|Adverse Event|1|||
46740915|NCT00681811|82957868|FG001|Overall Study|Adverse Event|1|||
46740916|NCT00681811|82957867|FG000|Overall Study|Withdrawal by Subject|2|||
46740917|NCT00681811|82957868|FG001|Overall Study|Withdrawal by Subject|2|||
46740918|NCT00681811|82957867|FG000|Overall Study|Non-compliance|0|||
46740919|NCT00681811|82957868|FG001|Overall Study|Non-compliance|1|||
46740920|NCT00681187|82957887|FG000|Overall Study|Withdrawal by Subject|1|||
46740921|NCT00681187|82957888|FG001|Overall Study|Withdrawal by Subject|0|||
46740922|NCT00681187|82957887|FG000|Overall Study|Death|0|||
46740923|NCT00681187|82957888|FG001|Overall Study|Death|1|||
46740924|NCT00681187|82957887|FG000|Overall Study|Adverse Event|0|||
46740925|NCT00681187|82957888|FG001|Overall Study|Adverse Event|1|||
46740926|NCT00681109|82957910|FG000|Overall Study|Lost to Follow-up|2|||
46740927|NCT00681109|82957911|FG001|Overall Study|Lost to Follow-up|6|||
46740928|NCT00681109|82957912|FG002|Overall Study|Lost to Follow-up|0|||
46740929|NCT02588950|82957923|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
46740930|NCT02588950|82957924|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
46740931|NCT02588950|82957925|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
46740932|NCT02588950|82957926|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
46740933|NCT02588950|82957923|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
46740934|NCT02588950|82957924|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
46740935|NCT02588950|82957925|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
46740936|NCT02588950|82957926|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
46740937|NCT00680407|82957939|FG000|Overall Study|Lost to Follow-up|3|||
46740938|NCT00680407|82957940|FG001|Overall Study|Lost to Follow-up|3|||
46740939|NCT00680407|82957941|FG002|Overall Study|Lost to Follow-up|1|||
46740940|NCT00680407|82957939|FG000|Overall Study|Withdrawal by Subject|5|||
46740941|NCT00680407|82957940|FG001|Overall Study|Withdrawal by Subject|2|||
46740942|NCT00680407|82957941|FG002|Overall Study|Withdrawal by Subject|2|||
46740943|NCT00677365|82957953|FG000|Overall Study|Adverse Event|2|||
46740944|NCT00677365|82957954|FG001|Overall Study|Adverse Event|1|||
46740945|NCT00677365|82957955|FG002|Overall Study|Adverse Event|1|||
46740946|NCT00677365|82957956|FG003|Overall Study|Adverse Event|2|||
46740947|NCT00677365|82957953|FG000|Overall Study|Withdrawal by Subject|0|||
46740948|NCT00677365|82957954|FG001|Overall Study|Withdrawal by Subject|0|||
46740949|NCT00677365|82957955|FG002|Overall Study|Withdrawal by Subject|1|||
46740950|NCT00677365|82957956|FG003|Overall Study|Withdrawal by Subject|0|||
46740951|NCT00677365|82957953|FG000|Overall Study|Other reason|0|||
46740952|NCT00677365|82957954|FG001|Overall Study|Other reason|0|||
46740953|NCT00677365|82957955|FG002|Overall Study|Other reason|0|||
46740954|NCT00677365|82957956|FG003|Overall Study|Other reason|1|||
46740955|NCT00680017|82957968|FG000|Overall Study|Adverse Event|13|||
46740956|NCT00680017|82957969|FG001|Overall Study|Adverse Event|7|||
46740957|NCT00680017|82957968|FG000|Overall Study|Withdrawal by Subject|2|||
46740958|NCT00680017|82957969|FG001|Overall Study|Withdrawal by Subject|5|||
46740959|NCT00680017|82957968|FG000|Overall Study|Lost to Follow-up|2|||
46740960|NCT00680017|82957969|FG001|Overall Study|Lost to Follow-up|0|||
46740961|NCT00676663|82957977|FG000|Overall Study|Death|43|||
46740962|NCT00676663|82957978|FG001|Overall Study|Death|27|||
46740963|NCT00676663|82957977|FG000|Overall Study|Withdrew Consent|1|||
46740964|NCT00676663|82957978|FG001|Overall Study|Withdrew Consent|8|||
46740965|NCT00676663|82957977|FG000|Overall Study|Lost to Follow-up|1|||
46740966|NCT00676663|82957978|FG001|Overall Study|Lost to Follow-up|3|||
46740967|NCT00678691|82957988|FG000|Overall Study|Adverse Event|6|||
46740968|NCT00678691|82957989|FG001|Overall Study|Adverse Event|4|||
46740969|NCT00679939|82957997|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
46740970|NCT00679939|82957998|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
46740971|NCT00679939|82957997|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
46740972|NCT00679939|82957998|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
46740973|NCT00679939|82957997|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
46740974|NCT00679939|82957998|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
46740975|NCT00679939|82957997|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
46740976|NCT00679939|82957998|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
46740977|NCT00679939|82957997|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
46740978|NCT00679939|82957998|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
46740979|NCT00679939|82957997|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
46740980|NCT00679939|82957998|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
46740981|NCT00679939|82957997|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
46740982|NCT00679939|82957998|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
46740983|NCT00679939|82957997|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
46740984|NCT00679939|82957998|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
46740985|NCT00679939|82957997|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
46740986|NCT00679939|82957998|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
46740987|NCT00679939|82957997|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
46740988|NCT00679939|82957998|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
46740989|NCT00673933|82958008|FG000|Overall Study|Withdrawal by Subject|2|||
46740990|NCT00673933|82958008|FG000|Overall Study|Lost to Follow-up|1|||
46740991|NCT00571519|82958021|FG000|Overall Study|Subject withdrew consent|0|||
46740992|NCT00571519|82958022|FG001|Overall Study|Subject withdrew consent|1|||
46740993|NCT00571519|82958023|FG002|Overall Study|Subject withdrew consent|0|||
46740994|NCT00571519|82958024|FG003|Overall Study|Subject withdrew consent|2|||
46740995|NCT00571519|82958025|FG004|Overall Study|Subject withdrew consent|1|||
46740996|NCT00571519|82958026|FG005|Overall Study|Subject withdrew consent|1|||
46740997|NCT00571519|82958027|FG006|Overall Study|Subject withdrew consent|2|||
46740998|NCT00571519|82958021|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
46740999|NCT00571519|82958022|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
46741000|NCT00571519|82958023|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
46741001|NCT00571519|82958024|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
46741002|NCT00571519|82958025|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
46741003|NCT00571519|82958026|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
46741004|NCT00571519|82958027|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
46741005|NCT00571519|82958021|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
46741006|NCT00571519|82958022|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
46741007|NCT00571519|82958023|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
46741008|NCT00571519|82958024|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
46741009|NCT00571519|82958025|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
46741010|NCT00571519|82958026|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
46741011|NCT00571519|82958027|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
46741012|NCT00571519|82958021|FG000|Overall Study|Termination of study by Sponsor|2|||
46741013|NCT00571519|82958022|FG001|Overall Study|Termination of study by Sponsor|7|||
46741014|NCT00571519|82958023|FG002|Overall Study|Termination of study by Sponsor|10|||
46741015|NCT00571519|82958024|FG003|Overall Study|Termination of study by Sponsor|24|||
46741016|NCT00571519|82958025|FG004|Overall Study|Termination of study by Sponsor|8|||
46741017|NCT00571519|82958026|FG005|Overall Study|Termination of study by Sponsor|9|||
46741018|NCT00571519|82958027|FG006|Overall Study|Termination of study by Sponsor|22|||
46741019|NCT00571519|82958021|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
46741020|NCT00571519|82958022|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
46741021|NCT00571519|82958023|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
46741022|NCT00571519|82958024|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
46741023|NCT00571519|82958025|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
46741024|NCT00571519|82958026|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
46741025|NCT00571519|82958027|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
46741026|NCT00676195|82958043|FG000|Overall Study|Lost to Follow-up|1|||
46741027|NCT00676195|82958043|FG000|Overall Study|Adverse Event|1|||
46741028|NCT00676195|82958043|FG000|Overall Study|Physician Decision|1|||
46741029|NCT00675103|82958048|FG000|Overall Study|Lack of Efficacy|2|||
46741030|NCT00675103|82958048|FG000|Overall Study|Adverse Event|1|||
46741031|NCT00675025|82958054|FG000|Overall Study|Study Terminated by Sponsor|38|||
46741032|NCT00675025|82958055|FG001|Overall Study|Study Terminated by Sponsor|42|||
46741033|NCT00675025|82958054|FG000|Overall Study|Adverse Event|6|||
46741034|NCT00675025|82958055|FG001|Overall Study|Adverse Event|11|||
46741035|NCT00675025|82958054|FG000|Overall Study|Lost to Follow-up|6|||
46741036|NCT00675025|82958055|FG001|Overall Study|Lost to Follow-up|4|||
46741037|NCT00675025|82958054|FG000|Overall Study|Withdrawal by Subject|4|||
46741038|NCT00675025|82958055|FG001|Overall Study|Withdrawal by Subject|6|||
46741039|NCT00678379|82958073|FG000|Overall Study|Injection performed after tonsillectomy|2|||
46741040|NCT00678379|82958074|FG001|Overall Study|Injection performed after tonsillectomy|0|||
46741041|NCT00678379|82958075|FG002|Overall Study|Injection performed after tonsillectomy|1|||
46741042|NCT00678379|82958073|FG000|Overall Study|Incomplete Data|4|||
46741043|NCT00678379|82958074|FG001|Overall Study|Incomplete Data|3|||
46741044|NCT00678379|82958075|FG002|Overall Study|Incomplete Data|3|||
46741045|NCT00674323|82958086|FG000|Overall Study|Adverse Event|0|||
46741046|NCT00674323|82958087|FG001|Overall Study|Adverse Event|1|||
46741047|NCT00674323|82958088|FG002|Overall Study|Adverse Event|0|||
46741048|NCT00674323|82958086|FG000|Overall Study|Protocol Violation|1|||
46741049|NCT00674323|82958087|FG001|Overall Study|Protocol Violation|0|||
46741050|NCT00674323|82958088|FG002|Overall Study|Protocol Violation|0|||
46741051|NCT00678301|82958098|FG000|Overall Study|Non-compliance with study procedures|0|||
46741052|NCT00678301|82958099|FG001|Overall Study|Non-compliance with study procedures|1|||
46741053|NCT00678301|82958098|FG000|Overall Study|Adverse Event|1|||
46741054|NCT00678301|82958099|FG001|Overall Study|Adverse Event|0|||
46741055|NCT00678301|82958098|FG000|Overall Study|Withdrawal by Subject|4|||
46741056|NCT00678301|82958099|FG001|Overall Study|Withdrawal by Subject|0|||
46741057|NCT00678301|82958098|FG000|Overall Study|Lost to Follow-up|3|||
46741058|NCT00678301|82958099|FG001|Overall Study|Lost to Follow-up|1|||
46741059|NCT00939770|82958113|FG000|Overall Study|Adverse Event|1|||
46741060|NCT00939770|82958114|FG001|Overall Study|Adverse Event|1|||
46741061|NCT00939770|82958115|FG002|Overall Study|Adverse Event|0|||
46741062|NCT00939770|82958116|FG003|Overall Study|Adverse Event|0|||
46741063|NCT00939770|82958117|FG004|Overall Study|Adverse Event|6|||
46741064|NCT00939770|82958118|FG005|Overall Study|Adverse Event|2|||
46741065|NCT00939770|82958119|FG006|Overall Study|Adverse Event|1|||
46741066|NCT00939770|82958120|FG007|Overall Study|Adverse Event|1|||
46741067|NCT00939770|82958113|FG000|Overall Study|Lack of Efficacy|4|||
46741068|NCT00939770|82958114|FG001|Overall Study|Lack of Efficacy|6|||
46741069|NCT00939770|82958115|FG002|Overall Study|Lack of Efficacy|13|||
46741070|NCT00939770|82958116|FG003|Overall Study|Lack of Efficacy|9|||
46741071|NCT00939770|82958117|FG004|Overall Study|Lack of Efficacy|16|||
46741072|NCT00939770|82958118|FG005|Overall Study|Lack of Efficacy|8|||
46741073|NCT00939770|82958119|FG006|Overall Study|Lack of Efficacy|11|||
46741074|NCT00939770|82958120|FG007|Overall Study|Lack of Efficacy|1|||
46741075|NCT00939770|82958113|FG000|Overall Study|Lost to Follow-up|0|||
46741076|NCT00939770|82958114|FG001|Overall Study|Lost to Follow-up|0|||
46741077|NCT00939770|82958115|FG002|Overall Study|Lost to Follow-up|0|||
46741078|NCT00939770|82958116|FG003|Overall Study|Lost to Follow-up|0|||
46741079|NCT00939770|82958117|FG004|Overall Study|Lost to Follow-up|1|||
46741080|NCT00939770|82958118|FG005|Overall Study|Lost to Follow-up|0|||
46741081|NCT00939770|82958119|FG006|Overall Study|Lost to Follow-up|0|||
46741082|NCT00939770|82958120|FG007|Overall Study|Lost to Follow-up|0|||
46741083|NCT00939770|82958113|FG000|Overall Study|Physician Decision|0|||
46741084|NCT00939770|82958114|FG001|Overall Study|Physician Decision|0|||
46741085|NCT00939770|82958115|FG002|Overall Study|Physician Decision|2|||
46741086|NCT00939770|82958116|FG003|Overall Study|Physician Decision|0|||
46741087|NCT00939770|82958117|FG004|Overall Study|Physician Decision|7|||
46741088|NCT00939770|82958118|FG005|Overall Study|Physician Decision|1|||
46741089|NCT00939770|82958119|FG006|Overall Study|Physician Decision|0|||
46741090|NCT00939770|82958120|FG007|Overall Study|Physician Decision|6|||
46741091|NCT00939770|82958113|FG000|Overall Study|Protocol Violation|0|||
46741092|NCT00939770|82958114|FG001|Overall Study|Protocol Violation|0|||
46741093|NCT00939770|82958115|FG002|Overall Study|Protocol Violation|0|||
46741094|NCT00939770|82958116|FG003|Overall Study|Protocol Violation|0|||
46741095|NCT00939770|82958117|FG004|Overall Study|Protocol Violation|1|||
46741096|NCT00939770|82958118|FG005|Overall Study|Protocol Violation|0|||
46741097|NCT00939770|82958119|FG006|Overall Study|Protocol Violation|0|||
46741098|NCT00939770|82958120|FG007|Overall Study|Protocol Violation|0|||
46741099|NCT00939770|82958113|FG000|Overall Study|Withdrawal by Subject|0|||
46741100|NCT00939770|82958114|FG001|Overall Study|Withdrawal by Subject|1|||
46741101|NCT00939770|82958115|FG002|Overall Study|Withdrawal by Subject|5|||
46741102|NCT00939770|82958116|FG003|Overall Study|Withdrawal by Subject|2|||
46741103|NCT00939770|82958117|FG004|Overall Study|Withdrawal by Subject|6|||
46741104|NCT00939770|82958118|FG005|Overall Study|Withdrawal by Subject|0|||
46741105|NCT00939770|82958119|FG006|Overall Study|Withdrawal by Subject|2|||
46741106|NCT00939770|82958120|FG007|Overall Study|Withdrawal by Subject|2|||
46741107|NCT00939692|82958153|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
46741108|NCT00939692|82958154|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
46741109|NCT00939692|82958153|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
46741110|NCT00939692|82958154|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
46741111|NCT04672252|82958162|FG000|Overall Study|Protocol Violation|1|||
46741112|NCT04672252|82958163|FG001|Overall Study|Protocol Violation|0|||
46741113|NCT00584740|82958171|FG000|Overall Study|Adverse Event|1|||
46741114|NCT00584740|82958172|FG001|Overall Study|Adverse Event|1|||
46741115|NCT00584740|82958171|FG000|Overall Study|Lack of Efficacy|8|||
46741116|NCT00584740|82958172|FG001|Overall Study|Lack of Efficacy|2|||
46741117|NCT00584740|82958171|FG000|Overall Study|Withdrawal by Subject|3|||
46741118|NCT00584740|82958172|FG001|Overall Study|Withdrawal by Subject|2|||
46741119|NCT00584740|82958171|FG000|Overall Study|Lost to Follow-up|0|||
46741120|NCT00584740|82958172|FG001|Overall Study|Lost to Follow-up|1|||
46741121|NCT00942968|82958178|FG000|Overall Study|Adverse Event|60|||
46741122|NCT00942968|82958178|FG000|Overall Study|Death|76|||
46741123|NCT00942968|82958178|FG000|Overall Study|Protocol Violation|9|||
46741124|NCT00942968|82958178|FG000|Overall Study|Lost to Follow-up|4|||
46741125|NCT00942968|82958178|FG000|Overall Study|Withdrawal by Subject|44|||
46741126|NCT00942968|82958178|FG000|Overall Study|Sponsor request|5|||
46741127|NCT00942968|82958178|FG000|Overall Study|Physician Decision|11|||
46741128|NCT00942968|82958178|FG000|Overall Study|Progression of disease|12|||
46741129|NCT00942968|82958178|FG000|Overall Study|Inferior vena cava filter placement|4|||
46741130|NCT00942968|82958178|FG000|Overall Study|Pulmonary embolism (PE)|1|||
46741131|NCT00942968|82958178|FG000|Overall Study|Participant required pancreatic biopsy|1|||
46741132|NCT00942968|82958178|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
46741133|NCT00942734|82958182|FG000|Overall Study|Adverse Event|2|||
46741134|NCT00942734|82958182|FG000|Overall Study|Protocol Violation|3|||
46741135|NCT00942734|82958182|FG000|Overall Study|Disease Progression|2|||
46741136|NCT00942734|82958182|FG000|Overall Study|Physician Decision|1|||
46741137|NCT00584194|82958186|FG000|Overall Study|Other|135|||
46741138|NCT00942422|82958190|FG000|Overall Study|Withdrawal by Subject|1|||
46635397|NCT01561560|82809023|FG001|First Two Weeks of Wear|Adverse Event|1|||
46635398|NCT01561560|82809022|FG000|Second Two Weeks of Wear|Adverse Event|0|||
46635399|NCT01561560|82809023|FG001|Second Two Weeks of Wear|Adverse Event|1|||
46741139|NCT00942422|82958190|FG000|Overall Study|Death|1|||
46741140|NCT00942422|82958190|FG000|Overall Study|Progressive diease|1|||
46741141|NCT00677833|82958198|FG000|Overall Study|Withdrawal by Subject|4|||
46635400|NCT01537068|82809031|FG000|Overall Study|Lost to Follow-up|2|||
46741142|NCT00677833|82958199|FG001|Overall Study|Withdrawal by Subject|0|||
46741143|NCT00677833|82958200|FG002|Overall Study|Withdrawal by Subject|1|||
46741144|NCT00677833|82958201|FG003|Overall Study|Withdrawal by Subject|3|||
46741145|NCT00677833|82958198|FG000|Overall Study|Lost to Follow-up|0|||
46741146|NCT00677833|82958199|FG001|Overall Study|Lost to Follow-up|0|||
46741147|NCT00677833|82958200|FG002|Overall Study|Lost to Follow-up|1|||
46741148|NCT00677833|82958201|FG003|Overall Study|Lost to Follow-up|0|||
46741149|NCT00942266|82958211|FG000|Overall Study|Withdrawal by Subject|1|||
46741150|NCT00942266|82958212|FG001|Overall Study|Withdrawal by Subject|0|||
46741151|NCT00942266|82958211|FG000|Overall Study|Adverse Event|2|||
46741152|NCT00942266|82958212|FG001|Overall Study|Adverse Event|1|||
46741153|NCT00942266|82958211|FG000|Overall Study|Disease Progression|38|||
46741154|NCT00942266|82958212|FG001|Overall Study|Disease Progression|11|||
46741155|NCT00942266|82958211|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
46741156|NCT00942266|82958212|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
46741157|NCT00942266|82958211|FG000|Overall Study|Intercurrent illness|0|||
46741158|NCT00942266|82958212|FG001|Overall Study|Intercurrent illness|1|||
46741159|NCT00942266|82958211|FG000|Overall Study|Physician Decision|2|||
46741160|NCT00942266|82958212|FG001|Overall Study|Physician Decision|0|||
46741161|NCT00942266|82958211|FG000|Overall Study|medical deterioration (pneumonia)|0|||
46741162|NCT00942266|82958212|FG001|Overall Study|medical deterioration (pneumonia)|1|||
46741163|NCT00942188|82958222|FG000|Overall Study|Adverse Event|0|||
46741164|NCT00942188|82958223|FG001|Overall Study|Adverse Event|3|||
46741165|NCT00942188|82958224|FG002|Overall Study|Adverse Event|2|||
46741166|NCT00942188|82958225|FG003|Overall Study|Adverse Event|0|||
46741167|NCT00942188|82958222|FG000|Overall Study|Lack of Efficacy|0|||
46741168|NCT00942188|82958223|FG001|Overall Study|Lack of Efficacy|0|||
46741169|NCT00942188|82958224|FG002|Overall Study|Lack of Efficacy|0|||
46741170|NCT00942188|82958225|FG003|Overall Study|Lack of Efficacy|1|||
46741171|NCT00942188|82958222|FG000|Overall Study|Protocol Violation|1|||
46741172|NCT00942188|82958223|FG001|Overall Study|Protocol Violation|1|||
46741173|NCT00942188|82958224|FG002|Overall Study|Protocol Violation|0|||
46741174|NCT00942188|82958225|FG003|Overall Study|Protocol Violation|0|||
46741175|NCT00942188|82958222|FG000|Overall Study|Lost to Follow-up|2|||
46741176|NCT00942188|82958223|FG001|Overall Study|Lost to Follow-up|1|||
46741177|NCT00942188|82958224|FG002|Overall Study|Lost to Follow-up|2|||
46741178|NCT00942188|82958225|FG003|Overall Study|Lost to Follow-up|0|||
46741179|NCT00942188|82958222|FG000|Overall Study|Withdrawal by Subject|1|||
46741180|NCT00942188|82958223|FG001|Overall Study|Withdrawal by Subject|3|||
46922164|NCT02880371|83155014|FG001|Phase 1b|Participants terminated by Sponsor|0|||
46922165|NCT02880371|83155015|FG002|Phase 1b|Participants terminated by Sponsor|0|||
46922166|NCT02880371|83155016|FG003|Phase 1b|Participants terminated by Sponsor|0|||
46922167|NCT02880371|83155017|FG004|Phase 1b|Participants terminated by Sponsor|0|||
46922168|NCT02880371|83155018|FG005|Phase 1b|Participants terminated by Sponsor|0|||
46922169|NCT02880371|83155019|FG006|Phase 1b|Participants terminated by Sponsor|0|||
46922170|NCT02880371|83155020|FG007|Phase 1b|Participants terminated by Sponsor|0|||
46922171|NCT02880371|83155013|FG000|Phase 1b|Withdrawal by Subject|0|||
46922172|NCT02880371|83155014|FG001|Phase 1b|Withdrawal by Subject|0|||
46922173|NCT02880371|83155015|FG002|Phase 1b|Withdrawal by Subject|1|||
46922174|NCT02880371|83155016|FG003|Phase 1b|Withdrawal by Subject|0|||
46922175|NCT02880371|83155017|FG004|Phase 1b|Withdrawal by Subject|0|||
46922176|NCT02880371|83155018|FG005|Phase 1b|Withdrawal by Subject|0|||
46922177|NCT02880371|83155019|FG006|Phase 1b|Withdrawal by Subject|0|||
46741181|NCT00942188|82958224|FG002|Overall Study|Withdrawal by Subject|4|||
46741182|NCT00942188|82958225|FG003|Overall Study|Withdrawal by Subject|2|||
46741183|NCT00942188|82958222|FG000|Overall Study|Physician Decision|0|||
46741184|NCT00942188|82958223|FG001|Overall Study|Physician Decision|0|||
46741185|NCT00942188|82958224|FG002|Overall Study|Physician Decision|1|||
46741186|NCT00942188|82958225|FG003|Overall Study|Physician Decision|0|||
46741187|NCT00942188|82958222|FG000|Overall Study|Sponsor Decision|0|||
46741188|NCT00942188|82958223|FG001|Overall Study|Sponsor Decision|2|||
46922178|NCT02880371|83155020|FG007|Phase 1b|Withdrawal by Subject|0|||
46922179|NCT02880371|83155013|FG000|Phase 1b|Death|4|||
46922180|NCT02880371|83155014|FG001|Phase 1b|Death|6|||
46922181|NCT02880371|83155015|FG002|Phase 1b|Death|5|||
46922182|NCT02880371|83155016|FG003|Phase 1b|Death|1|||
46922183|NCT02880371|83155017|FG004|Phase 1b|Death|0|||
47050517|NCT01683409|83311301|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
47050518|NCT01683409|83311302|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
47050519|NCT01683409|83311303|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
47050520|NCT01683409|83311299|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
46741189|NCT00942188|82958224|FG002|Overall Study|Sponsor Decision|0|||
46741190|NCT00942188|82958225|FG003|Overall Study|Sponsor Decision|1|||
46741191|NCT00673231|82958239|FG000|Overall Study|Withdrawal by Subject|14|||
46741192|NCT00673231|82958240|FG001|Overall Study|Withdrawal by Subject|10|||
46741193|NCT00673231|82958241|FG002|Overall Study|Withdrawal by Subject|8|||
46804128|NCT03902574|83023319|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
46922184|NCT02880371|83155018|FG005|Phase 1b|Death|0|||
46741194|NCT00673231|82958242|FG003|Overall Study|Withdrawal by Subject|6|||
46741195|NCT00673231|82958239|FG000|Overall Study|Adverse Event|6|||
46922185|NCT02880371|83155019|FG006|Phase 1b|Death|0|||
46922186|NCT02880371|83155020|FG007|Phase 1b|Death|0|||
46922187|NCT02880371|83155013|FG000|Phase 1b|Enrolled but not Treated|0|||
46741196|NCT00673231|82958240|FG001|Overall Study|Adverse Event|5|||
46741197|NCT00673231|82958241|FG002|Overall Study|Adverse Event|9|||
46741198|NCT00673231|82958242|FG003|Overall Study|Adverse Event|6|||
46741199|NCT00673231|82958239|FG000|Overall Study|Lost to Follow-up|1|||
46741200|NCT00673231|82958240|FG001|Overall Study|Lost to Follow-up|2|||
46741201|NCT00673231|82958241|FG002|Overall Study|Lost to Follow-up|1|||
46741202|NCT00673231|82958242|FG003|Overall Study|Lost to Follow-up|2|||
46741203|NCT00673231|82958239|FG000|Overall Study|Death|0|||
46741204|NCT00673231|82958240|FG001|Overall Study|Death|0|||
46741205|NCT00673231|82958241|FG002|Overall Study|Death|1|||
46741206|NCT00673231|82958242|FG003|Overall Study|Death|0|||
46741207|NCT00673231|82958239|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
46741208|NCT00673231|82958240|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
46741209|NCT00673231|82958241|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
46741210|NCT00673231|82958242|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
46741211|NCT00672841|82958254|FG000|Overall Study|Comfort care|1|||
46741212|NCT00672841|82958255|FG001|Overall Study|Comfort care|4|||
46741213|NCT00672841|82958254|FG000|Overall Study|icteric specimens|0|||
46741214|NCT00672841|82958255|FG001|Overall Study|icteric specimens|3|||
46741215|NCT00672841|82958254|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
46741216|NCT00672841|82958255|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
46741217|NCT00672841|82958254|FG000|Overall Study|Adverse Event|0|||
46741218|NCT00672841|82958255|FG001|Overall Study|Adverse Event|3|||
46741219|NCT00672841|82958254|FG000|Overall Study|Pregnancy|0|||
46741220|NCT00672841|82958255|FG001|Overall Study|Pregnancy|1|||
46741221|NCT00673465|82958264|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741222|NCT00673465|82958265|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741223|NCT00673465|82958266|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741224|NCT00673465|82958267|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741225|NCT00673465|82958268|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
46741226|NCT00673465|82958269|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
46741227|NCT00673465|82958270|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741228|NCT00673465|82958271|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741229|NCT00673465|82958272|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741230|NCT00673465|82958273|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741231|NCT00673465|82958274|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741232|NCT00673465|82958275|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
46741233|NCT00673465|82958264|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741234|NCT00673465|82958265|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741235|NCT00673465|82958266|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741236|NCT00673465|82958267|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741237|NCT00673465|82958268|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
46741238|NCT00673465|82958269|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741239|NCT00673465|82958270|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741240|NCT00673465|82958271|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741241|NCT00673465|82958272|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741242|NCT00673465|82958273|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
47050521|NCT01683409|83311300|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
47050522|NCT01683409|83311301|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
47050523|NCT01683409|83311302|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
47050524|NCT01683409|83311303|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
47050525|NCT01683409|83311299|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
47050526|NCT01683409|83311300|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
47050527|NCT01683409|83311301|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
46741243|NCT00673465|82958274|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741244|NCT00673465|82958275|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
46741245|NCT00941798|82958285|FG000|Overall Study|Withdrawal by Subject|72|||
47050528|NCT01683409|83311302|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
46741246|NCT00941798|82958286|FG001|Overall Study|Withdrawal by Subject|74|||
46741247|NCT00941798|82958285|FG000|Overall Study|Adverse Event|43|||
46741248|NCT00941798|82958286|FG001|Overall Study|Adverse Event|23|||
46741249|NCT00941798|82958285|FG000|Overall Study|Lost to Follow-up|29|||
46741250|NCT00941798|82958286|FG001|Overall Study|Lost to Follow-up|23|||
46741251|NCT00941798|82958285|FG000|Overall Study|Protocol Violation|17|||
46741252|NCT00941798|82958286|FG001|Overall Study|Protocol Violation|20|||
46775739|NCT00793793|82994208|FG004|Overall Study|Protocol Violation|0|||
47050529|NCT01683409|83311303|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
47050530|NCT01699022|83311329|FG000|Overall Study|Early discontinuation from the study|3|||
47050531|NCT01683019|83311337|FG000|Overall Study|Withdrawal by Subject|2|||
47050532|NCT01683019|83311338|FG001|Overall Study|Withdrawal by Subject|1|||
47050533|NCT01683019|83311339|FG002|Overall Study|Withdrawal by Subject|4|||
47050534|NCT01709162|83311349|FG000|Overall Study|Disease progression|3|||
47050535|NCT01709162|83311350|FG001|Overall Study|Disease progression|3|||
46922188|NCT02880371|83155014|FG001|Phase 1b|Enrolled but not Treated|1|||
46922189|NCT02880371|83155015|FG002|Phase 1b|Enrolled but not Treated|0|||
46922190|NCT02880371|83155016|FG003|Phase 1b|Enrolled but not Treated|0|||
46922191|NCT02880371|83155017|FG004|Phase 1b|Enrolled but not Treated|0|||
46922192|NCT02880371|83155018|FG005|Phase 1b|Enrolled but not Treated|0|||
46922193|NCT02880371|83155019|FG006|Phase 1b|Enrolled but not Treated|0|||
46922194|NCT02880371|83155020|FG007|Phase 1b|Enrolled but not Treated|0|||
46922195|NCT02880371|83155013|FG000|Phase 2|Enrolled but not Treated|0|||
46922196|NCT02880371|83155014|FG001|Phase 2|Enrolled but not Treated|0|||
46922197|NCT02880371|83155015|FG002|Phase 2|Enrolled but not Treated|0|||
46922198|NCT02880371|83155016|FG003|Phase 2|Enrolled but not Treated|0|||
46922199|NCT02880371|83155017|FG004|Phase 2|Enrolled but not Treated|0|||
46922200|NCT02880371|83155018|FG005|Phase 2|Enrolled but not Treated|1|||
46922201|NCT02880371|83155019|FG006|Phase 2|Enrolled but not Treated|1|||
46922202|NCT02880371|83155020|FG007|Phase 2|Enrolled but not Treated|0|||
46922203|NCT02880371|83155013|FG000|Phase 2|Other|0|||
46922204|NCT02880371|83155014|FG001|Phase 2|Other|0|||
46922205|NCT02880371|83155015|FG002|Phase 2|Other|0|||
46922206|NCT02880371|83155016|FG003|Phase 2|Other|0|||
46922207|NCT02880371|83155017|FG004|Phase 2|Other|0|||
46922208|NCT02880371|83155018|FG005|Phase 2|Other|1|||
46922209|NCT02880371|83155019|FG006|Phase 2|Other|2|||
46922210|NCT02880371|83155020|FG007|Phase 2|Other|1|||
46922211|NCT02880371|83155013|FG000|Phase 2|Participants terminated by Sponsor|0|||
46922212|NCT02880371|83155014|FG001|Phase 2|Participants terminated by Sponsor|0|||
46922213|NCT02880371|83155015|FG002|Phase 2|Participants terminated by Sponsor|0|||
46922214|NCT02880371|83155016|FG003|Phase 2|Participants terminated by Sponsor|0|||
46922215|NCT02880371|83155017|FG004|Phase 2|Participants terminated by Sponsor|1|||
46922216|NCT02880371|83155018|FG005|Phase 2|Participants terminated by Sponsor|6|||
46922217|NCT02880371|83155019|FG006|Phase 2|Participants terminated by Sponsor|1|||
46922218|NCT02880371|83155020|FG007|Phase 2|Participants terminated by Sponsor|5|||
46922219|NCT02880371|83155013|FG000|Phase 2|Death|0|||
46922220|NCT02880371|83155014|FG001|Phase 2|Death|0|||
46922221|NCT02880371|83155015|FG002|Phase 2|Death|0|||
46922222|NCT02880371|83155016|FG003|Phase 2|Death|0|||
46922223|NCT02880371|83155017|FG004|Phase 2|Death|1|||
46922224|NCT02880371|83155018|FG005|Phase 2|Death|10|||
46922225|NCT02880371|83155019|FG006|Phase 2|Death|20|||
46922226|NCT02880371|83155020|FG007|Phase 2|Death|5|||
46922227|NCT02880371|83155013|FG000|Phase 2|Lost to Follow-up|0|||
46922228|NCT02880371|83155014|FG001|Phase 2|Lost to Follow-up|0|||
46922229|NCT02880371|83155015|FG002|Phase 2|Lost to Follow-up|0|||
46922230|NCT02880371|83155016|FG003|Phase 2|Lost to Follow-up|0|||
46922231|NCT02880371|83155017|FG004|Phase 2|Lost to Follow-up|0|||
46922232|NCT02880371|83155018|FG005|Phase 2|Lost to Follow-up|0|||
46922233|NCT02880371|83155019|FG006|Phase 2|Lost to Follow-up|3|||
47050536|NCT01709162|83311349|FG000|Overall Study|Study drug toxicity|2|||
47050537|NCT01709162|83311350|FG001|Overall Study|Study drug toxicity|0|||
47050538|NCT01709162|83311349|FG000|Overall Study|Administrative reason by sponsor|0|||
47050539|NCT01709162|83311350|FG001|Overall Study|Administrative reason by sponsor|1|||
46922234|NCT02880371|83155020|FG007|Phase 2|Lost to Follow-up|0|||
46922235|NCT02880371|83155013|FG000|Phase 2|Withdrawal by Subject|0|||
46922236|NCT02880371|83155014|FG001|Phase 2|Withdrawal by Subject|0|||
46922237|NCT02880371|83155015|FG002|Phase 2|Withdrawal by Subject|0|||
46922238|NCT02880371|83155016|FG003|Phase 2|Withdrawal by Subject|0|||
46922239|NCT02880371|83155017|FG004|Phase 2|Withdrawal by Subject|0|||
47050540|NCT01709162|83311349|FG000|Overall Study|Other|1|||
47050541|NCT01709162|83311350|FG001|Overall Study|Other|0|||
47050542|NCT01709162|83311349|FG000|Overall Study|Withdrawal by Subject|0|||
47050543|NCT01709162|83311350|FG001|Overall Study|Withdrawal by Subject|1|||
46922240|NCT02880371|83155018|FG005|Phase 2|Withdrawal by Subject|1|||
46922241|NCT02880371|83155019|FG006|Phase 2|Withdrawal by Subject|1|||
46922242|NCT02880371|83155020|FG007|Phase 2|Withdrawal by Subject|0|||
46922243|NCT02880371|83155013|FG000|Phase 2|End of Study page not completed by error|0|||
46922244|NCT02880371|83155014|FG001|Phase 2|End of Study page not completed by error|0|||
46922245|NCT02880371|83155015|FG002|Phase 2|End of Study page not completed by error|0|||
46922246|NCT02880371|83155016|FG003|Phase 2|End of Study page not completed by error|0|||
46922247|NCT02880371|83155017|FG004|Phase 2|End of Study page not completed by error|0|||
46922248|NCT02880371|83155018|FG005|Phase 2|End of Study page not completed by error|1|||
46741253|NCT00941798|82958285|FG000|Overall Study|Administrative problems|13|||
46741254|NCT00941798|82958286|FG001|Overall Study|Administrative problems|23|||
46741255|NCT00941798|82958285|FG000|Overall Study|Lack of Efficacy|10|||
46741256|NCT00941798|82958286|FG001|Overall Study|Lack of Efficacy|17|||
46741257|NCT00941798|82958285|FG000|Overall Study|Patient's inability to use device|6|||
46741258|NCT00941798|82958286|FG001|Overall Study|Patient's inability to use device|1|||
46741259|NCT00941798|82958285|FG000|Overall Study|Abnormal test procedure results|3|||
46741260|NCT00941798|82958286|FG001|Overall Study|Abnormal test procedure results|1|||
46741261|NCT00941798|82958285|FG000|Overall Study|Abnormal laboratory values|1|||
46741262|NCT00941798|82958286|FG001|Overall Study|Abnormal laboratory values|2|||
46741263|NCT00941798|82958285|FG000|Overall Study|Death|0|||
46741264|NCT00941798|82958286|FG001|Overall Study|Death|1|||
46741265|NCT00583102|82958292|FG000|Overall Study|Adverse Event|3|||
46741266|NCT05208866|82958300|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
46741267|NCT04745351|82958315|FG000|Overall Study|Death|51|||
46741268|NCT04745351|82958316|FG001|Overall Study|Death|25|||
46741269|NCT04745351|82958315|FG000|Overall Study|Lost to Follow-up|9|||
46741270|NCT04745351|82958316|FG001|Overall Study|Lost to Follow-up|3|||
46741271|NCT04745351|82958315|FG000|Overall Study|Randomized but Never Treated|3|||
46741272|NCT04745351|82958316|FG001|Overall Study|Randomized but Never Treated|3|||
46741273|NCT04745351|82958315|FG000|Overall Study|Adverse Event|4|||
46741274|NCT04745351|82958316|FG001|Overall Study|Adverse Event|0|||
46741275|NCT04745351|82958315|FG000|Overall Study|Withdrew Consent|1|||
46741276|NCT04745351|82958316|FG001|Overall Study|Withdrew Consent|2|||
46741277|NCT04745351|82958315|FG000|Overall Study|Investigator's Discretion|2|||
46741278|NCT04745351|82958316|FG001|Overall Study|Investigator's Discretion|0|||
46741279|NCT04745351|82958315|FG000|Overall Study|Protocol Violation|1|||
46741280|NCT04745351|82958316|FG001|Overall Study|Protocol Violation|0|||
46741281|NCT04427501|82958341|FG000|Overall Study|Death|0|||
46741282|NCT04427501|82958342|FG001|Overall Study|Death|0|||
46741283|NCT04427501|82958343|FG002|Overall Study|Death|0|||
46741284|NCT04427501|82958344|FG003|Overall Study|Death|0|||
46741285|NCT04427501|82958345|FG004|Overall Study|Death|0|||
46741286|NCT04427501|82958346|FG005|Overall Study|Death|15|||
46741287|NCT04427501|82958347|FG006|Overall Study|Death|0|||
46741288|NCT04427501|82958348|FG007|Overall Study|Death|0|||
46741289|NCT04427501|82958349|FG008|Overall Study|Death|0|||
46741290|NCT04427501|82958350|FG009|Overall Study|Death|0|||
46741291|NCT04427501|82958341|FG000|Overall Study|Lost to Follow-up|5|||
46741292|NCT04427501|82958342|FG001|Overall Study|Lost to Follow-up|1|||
46741293|NCT04427501|82958343|FG002|Overall Study|Lost to Follow-up|2|||
46741294|NCT04427501|82958344|FG003|Overall Study|Lost to Follow-up|0|||
46741295|NCT04427501|82958345|FG004|Overall Study|Lost to Follow-up|2|||
46741296|NCT04427501|82958346|FG005|Overall Study|Lost to Follow-up|11|||
46741297|NCT04427501|82958347|FG006|Overall Study|Lost to Follow-up|10|||
46741298|NCT04427501|82958348|FG007|Overall Study|Lost to Follow-up|10|||
46741299|NCT04427501|82958349|FG008|Overall Study|Lost to Follow-up|2|||
46741300|NCT04427501|82958350|FG009|Overall Study|Lost to Follow-up|5|||
46741301|NCT04427501|82958341|FG000|Overall Study|Physician Decision|0|||
46741302|NCT04427501|82958342|FG001|Overall Study|Physician Decision|3|||
46741303|NCT04427501|82958343|FG002|Overall Study|Physician Decision|0|||
47050544|NCT01698554|83311360|FG000|Overall Study|Adverse Event|2|||
47050545|NCT01698554|83311361|FG001|Overall Study|Adverse Event|5|||
47050546|NCT01698554|83311362|FG002|Overall Study|Adverse Event|0|||
47050547|NCT01698554|83311363|FG003|Overall Study|Adverse Event|1|||
47050548|NCT01698554|83311360|FG000|Overall Study|Lost to Follow-up|1|||
47050549|NCT01698554|83311361|FG001|Overall Study|Lost to Follow-up|0|||
47050550|NCT01698554|83311362|FG002|Overall Study|Lost to Follow-up|0|||
47050551|NCT01698554|83311363|FG003|Overall Study|Lost to Follow-up|0|||
47050552|NCT01698554|83311360|FG000|Overall Study|Personal Reasons|0|||
47050553|NCT01698554|83311361|FG001|Overall Study|Personal Reasons|5|||
46741304|NCT04427501|82958344|FG003|Overall Study|Physician Decision|0|||
46741305|NCT04427501|82958345|FG004|Overall Study|Physician Decision|0|||
46741306|NCT04427501|82958346|FG005|Overall Study|Physician Decision|0|||
46741307|NCT04427501|82958347|FG006|Overall Study|Physician Decision|2|||
46741308|NCT04427501|82958348|FG007|Overall Study|Physician Decision|0|||
46741309|NCT04427501|82958349|FG008|Overall Study|Physician Decision|0|||
46741310|NCT04427501|82958350|FG009|Overall Study|Physician Decision|0|||
46741311|NCT04427501|82958341|FG000|Overall Study|Withdrawal by Subject|9|||
46741312|NCT04427501|82958342|FG001|Overall Study|Withdrawal by Subject|2|||
46741313|NCT04427501|82958343|FG002|Overall Study|Withdrawal by Subject|2|||
46741314|NCT04427501|82958344|FG003|Overall Study|Withdrawal by Subject|3|||
47050554|NCT01698554|83311362|FG002|Overall Study|Personal Reasons|1|||
46741315|NCT04427501|82958345|FG004|Overall Study|Withdrawal by Subject|7|||
46741316|NCT04427501|82958346|FG005|Overall Study|Withdrawal by Subject|25|||
46741317|NCT04427501|82958347|FG006|Overall Study|Withdrawal by Subject|15|||
46741318|NCT04427501|82958348|FG007|Overall Study|Withdrawal by Subject|7|||
46741319|NCT04427501|82958349|FG008|Overall Study|Withdrawal by Subject|4|||
46741320|NCT04427501|82958350|FG009|Overall Study|Withdrawal by Subject|1|||
46741321|NCT04427501|82958341|FG000|Overall Study|Other - as reported by the investigator|1|||
46741322|NCT04427501|82958342|FG001|Overall Study|Other - as reported by the investigator|0|||
46741323|NCT04427501|82958343|FG002|Overall Study|Other - as reported by the investigator|0|||
46741324|NCT04427501|82958344|FG003|Overall Study|Other - as reported by the investigator|0|||
46741325|NCT04427501|82958345|FG004|Overall Study|Other - as reported by the investigator|0|||
46741326|NCT04427501|82958346|FG005|Overall Study|Other - as reported by the investigator|6|||
46741327|NCT04427501|82958347|FG006|Overall Study|Other - as reported by the investigator|6|||
46741328|NCT04427501|82958348|FG007|Overall Study|Other - as reported by the investigator|0|||
46741329|NCT04427501|82958349|FG008|Overall Study|Other - as reported by the investigator|0|||
46741330|NCT04427501|82958350|FG009|Overall Study|Other - as reported by the investigator|0|||
46741331|NCT03439124|82958402|FG000|Overall Study|Adverse Event|2|||
46741332|NCT03439124|82958403|FG001|Overall Study|Adverse Event|0|||
46741333|NCT03439124|82958402|FG000|Overall Study|Lost to Follow-up|1|||
46741334|NCT03439124|82958403|FG001|Overall Study|Lost to Follow-up|0|||
46741335|NCT03439124|82958402|FG000|Overall Study|Other reasons|1|||
46741336|NCT03439124|82958403|FG001|Overall Study|Other reasons|0|||
46741337|NCT03212989|82958422|FG000|Overall Study|Physician Decision|8|||
46741338|NCT03200548|82958430|FG000|Overall Study|Withdrawal by Subject|5|||
46741339|NCT03200548|82958431|FG001|Overall Study|Withdrawal by Subject|11|||
46741340|NCT03200548|82958432|FG002|Overall Study|Withdrawal by Subject|7|||
46741341|NCT03200548|82958433|FG003|Overall Study|Withdrawal by Subject|6|||
46741342|NCT03137173|82958445|FG000|Overall Study|Withdrawal by Subject|8|||
46741343|NCT03137173|82958446|FG001|Overall Study|Withdrawal by Subject|13|||
46741344|NCT03137173|82958445|FG000|Overall Study|Death|1|||
46741345|NCT03137173|82958446|FG001|Overall Study|Death|3|||
46741346|NCT03137173|82958445|FG000|Overall Study|Physician Decision|1|||
46741347|NCT03137173|82958446|FG001|Overall Study|Physician Decision|0|||
46741348|NCT03137173|82958445|FG000|Overall Study|Lost to Follow-up|13|||
46741349|NCT03137173|82958446|FG001|Overall Study|Lost to Follow-up|18|||
46741350|NCT03137173|82958445|FG000|Overall Study|Other reasons|3|||
46741351|NCT03137173|82958446|FG001|Overall Study|Other reasons|2|||
46741352|NCT01575808|82958475|FG000|Overall Study|Death|2|||
46741353|NCT01575808|82958476|FG001|Overall Study|Death|0|||
46741354|NCT01575808|82958475|FG000|Overall Study|Withdrawal by Subject|1|||
46741355|NCT01575808|82958476|FG001|Overall Study|Withdrawal by Subject|0|||
46741356|NCT01546753|82958486|FG000|Overall Study|anxiety|1|||
46741357|NCT01546753|82958487|FG001|Overall Study|anxiety|1|||
46741358|NCT01546753|82958486|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
46741359|NCT01546753|82958487|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
46741360|NCT00941720|82958500|FG000|Overall Study|Withdrawal by Subject|1|||
46741361|NCT00941720|82958500|FG000|Overall Study|Insurance denied participation|11|||
46741362|NCT00941720|82958500|FG000|Overall Study|ineligible|2|||
46741363|NCT00933686|82958506|FG000|Overall Study|Protocol Violation|0|||
46741364|NCT00933686|82958507|FG001|Overall Study|Protocol Violation|1|||
46741365|NCT00933686|82958506|FG000|Overall Study|Lost to Follow-up|2|||
46741366|NCT00933686|82958507|FG001|Overall Study|Lost to Follow-up|2|||
46741367|NCT00933686|82958506|FG000|Overall Study|Withdrawal by Subject|6|||
46741368|NCT00933686|82958507|FG001|Overall Study|Withdrawal by Subject|5|||
46741369|NCT00933686|82958506|FG000|Overall Study|Adverse Event|1|||
46741370|NCT00933686|82958507|FG001|Overall Study|Adverse Event|1|||
46741371|NCT00933686|82958506|FG000|Overall Study|Physician Decision|1|||
46741372|NCT00933686|82958507|FG001|Overall Study|Physician Decision|0|||
46741373|NCT00933686|82958506|FG000|Overall Study|Failure to show up at endpoint visits|0|||
46741374|NCT00933686|82958507|FG001|Overall Study|Failure to show up at endpoint visits|2|||
46741375|NCT00937040|82958515|FG000|Overall Study|Adverse Event|5|||
46741376|NCT00937040|82958516|FG001|Overall Study|Adverse Event|8|||
46741377|NCT00937040|82958515|FG000|Overall Study|Lost to Follow-up|12|||
46741378|NCT00937040|82958516|FG001|Overall Study|Lost to Follow-up|12|||
46741379|NCT00937040|82958515|FG000|Overall Study|Protocol Violation|3|||
46741380|NCT00937040|82958516|FG001|Overall Study|Protocol Violation|0|||
46741381|NCT00937040|82958515|FG000|Overall Study|Withdrawal by Subject|13|||
46741382|NCT00937040|82958516|FG001|Overall Study|Withdrawal by Subject|7|||
46741383|NCT00937040|82958515|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
46741384|NCT00937040|82958516|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
46741385|NCT00937040|82958515|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
46741386|NCT00937040|82958516|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
46741387|NCT00673387|82958530|FG000|Overall Study|Withdrawal by Subject|15|||
46741388|NCT00673387|82958531|FG001|Overall Study|Withdrawal by Subject|16|||
46741389|NCT00673387|82958532|FG002|Overall Study|Withdrawal by Subject|20|||
46741390|NCT00673387|82958533|FG003|Overall Study|Withdrawal by Subject|16|||
46741391|NCT00673387|82958534|FG004|Overall Study|Withdrawal by Subject|18|||
46741392|NCT00673387|82958535|FG005|Overall Study|Withdrawal by Subject|21|||
46741393|NCT00673387|82958536|FG006|Overall Study|Withdrawal by Subject|15|||
46741394|NCT00673387|82958537|FG007|Overall Study|Withdrawal by Subject|21|||
46741395|NCT00673387|82958530|FG000|Overall Study|Adverse Event|3|||
46741396|NCT00673387|82958531|FG001|Overall Study|Adverse Event|1|||
46741397|NCT00673387|82958532|FG002|Overall Study|Adverse Event|5|||
46741398|NCT00673387|82958533|FG003|Overall Study|Adverse Event|2|||
46741399|NCT00673387|82958534|FG004|Overall Study|Adverse Event|6|||
46741400|NCT00673387|82958535|FG005|Overall Study|Adverse Event|2|||
46741401|NCT00673387|82958536|FG006|Overall Study|Adverse Event|5|||
46741402|NCT00673387|82958537|FG007|Overall Study|Adverse Event|5|||
46741403|NCT00673387|82958530|FG000|Overall Study|Physician Decision|0|||
46741404|NCT00673387|82958531|FG001|Overall Study|Physician Decision|0|||
46741405|NCT00673387|82958532|FG002|Overall Study|Physician Decision|0|||
46741406|NCT00673387|82958533|FG003|Overall Study|Physician Decision|0|||
46741407|NCT00673387|82958534|FG004|Overall Study|Physician Decision|0|||
46741408|NCT00673387|82958535|FG005|Overall Study|Physician Decision|5|||
46741409|NCT00673387|82958536|FG006|Overall Study|Physician Decision|1|||
46741410|NCT00673387|82958537|FG007|Overall Study|Physician Decision|1|||
46741411|NCT00673387|82958530|FG000|Overall Study|Protocol Violation|3|||
46741412|NCT00673387|82958531|FG001|Overall Study|Protocol Violation|0|||
46741413|NCT00673387|82958532|FG002|Overall Study|Protocol Violation|1|||
46741414|NCT00673387|82958533|FG003|Overall Study|Protocol Violation|2|||
46741415|NCT00673387|82958534|FG004|Overall Study|Protocol Violation|0|||
46741416|NCT00673387|82958535|FG005|Overall Study|Protocol Violation|1|||
46741417|NCT00673387|82958536|FG006|Overall Study|Protocol Violation|1|||
46741418|NCT00673387|82958537|FG007|Overall Study|Protocol Violation|3|||
46741419|NCT00673387|82958530|FG000|Overall Study|Lost to Follow-up|8|||
46741420|NCT00673387|82958531|FG001|Overall Study|Lost to Follow-up|6|||
46741421|NCT00673387|82958532|FG002|Overall Study|Lost to Follow-up|5|||
46741422|NCT00673387|82958533|FG003|Overall Study|Lost to Follow-up|6|||
46741423|NCT00673387|82958534|FG004|Overall Study|Lost to Follow-up|6|||
46741424|NCT00673387|82958535|FG005|Overall Study|Lost to Follow-up|5|||
46741425|NCT00673387|82958536|FG006|Overall Study|Lost to Follow-up|8|||
46741426|NCT00673387|82958537|FG007|Overall Study|Lost to Follow-up|5|||
46741427|NCT00933608|82958567|FG000|Overall Study|Adverse Event|4|||
46741428|NCT00933608|82958568|FG001|Overall Study|Adverse Event|2|||
46741429|NCT00933608|82958567|FG000|Overall Study|Physician Decision|1|||
46741430|NCT00933608|82958568|FG001|Overall Study|Physician Decision|0|||
46741431|NCT00574951|82958574|FG000|Overall Study|Ineligible - improper prior treatment|1|||
46741432|NCT01557751|82958578|FG000|Overall Study|Physician Decision|3|||
46741433|NCT00936884|82958584|FG000|Double-blind|Withdrawal by Subject|6|||
46741434|NCT00936884|82958585|FG001|Double-blind|Withdrawal by Subject|4|||
46741435|NCT00936884|82958586|FG002|Double-blind|Withdrawal by Subject|0|||
46741436|NCT00936884|82958584|FG000|Double-blind|Death|2|||
46741437|NCT00936884|82958585|FG001|Double-blind|Death|1|||
46741438|NCT00936884|82958586|FG002|Double-blind|Death|0|||
46741439|NCT00936884|82958584|FG000|Double-blind|Lack of Efficacy|1|||
46741440|NCT00936884|82958585|FG001|Double-blind|Lack of Efficacy|1|||
46741441|NCT00936884|82958586|FG002|Double-blind|Lack of Efficacy|0|||
46741442|NCT00936884|82958584|FG000|Double-blind|Adverse Event|1|||
46741443|NCT00936884|82958585|FG001|Double-blind|Adverse Event|0|||
46741444|NCT00936884|82958586|FG002|Double-blind|Adverse Event|0|||
46741445|NCT00936884|82958584|FG000|Double-blind|Physician Decision|1|||
46741446|NCT00936884|82958585|FG001|Double-blind|Physician Decision|0|||
46741447|NCT00936884|82958586|FG002|Double-blind|Physician Decision|0|||
46741448|NCT00936884|82958584|FG000|Double-blind|No post baseline diary entry|1|||
46741449|NCT00936884|82958585|FG001|Double-blind|No post baseline diary entry|0|||
46741450|NCT00936884|82958586|FG002|Double-blind|No post baseline diary entry|0|||
46741451|NCT00936884|82958584|FG000|Double-blind|Did not receive study drug|0|||
46741452|NCT00936884|82958585|FG001|Double-blind|Did not receive study drug|1|||
46741453|NCT00936884|82958586|FG002|Double-blind|Did not receive study drug|0|||
46741454|NCT00668863|82958602|FG000|Overall Study|Objective Progression or Relapse|42|||
46741455|NCT00668863|82958602|FG000|Overall Study|Adverse Event|13|||
46741456|NCT00668863|82958602|FG000|Overall Study|Study Terminated by Sponsor|8|||
46804129|NCT00542828|83023331|FG000|Overall Study|Physician Decision|1|||
46804130|NCT00542828|83023331|FG000|Overall Study|Need for Prohibited Treatment|3|||
46804131|NCT00542828|83023331|FG000|Overall Study|Study Prematurely Discontinued|7|||
47050555|NCT01698554|83311363|FG003|Overall Study|Personal Reasons|1|||
46741457|NCT00668863|82958602|FG000|Overall Study|Global Deterioration of Health Status|4|||
46741458|NCT00668863|82958602|FG000|Overall Study|Withdrawal by Subject|1|||
46741459|NCT00668863|82958602|FG000|Overall Study|Surgery|1|||
46741460|NCT00668863|82958602|FG000|Overall Study|Subject's work scheduling problem|1|||
46741461|NCT00668863|82958602|FG000|Overall Study|Physician Decision|1|||
46741462|NCT00935012|82958606|FG000|Overall Study|Death|19|||
46741463|NCT00935012|82958606|FG000|Overall Study|Withdrawal by Subject|3|||
46741464|NCT00935012|82958606|FG000|Overall Study|Other|5|||
46741465|NCT00935012|82958606|FG000|Overall Study|Adverse Event|2|||
46741466|NCT00932360|82958610|FG000|Washout (One Week)|Withdrawal by Subject|0|||
46741467|NCT00932360|82958611|FG001|Washout (One Week)|Withdrawal by Subject|0|||
46741468|NCT00932360|82958612|FG002|Washout (One Week)|Withdrawal by Subject|0|||
46741469|NCT00932360|82958613|FG003|Washout (One Week)|Withdrawal by Subject|0|||
46741470|NCT00932360|82958614|FG004|Washout (One Week)|Withdrawal by Subject|2|||
46741471|NCT00932360|82958615|FG005|Washout (One Week)|Withdrawal by Subject|0|||
46741472|NCT00668707|82958631|FG000|Overall Study|Cancer Recurrence|58|||
46741473|NCT00668707|82958632|FG001|Overall Study|Cancer Recurrence|58|||
46741474|NCT00668707|82958631|FG000|Overall Study|Withdrawal by Subject|117|||
46741475|NCT00668707|82958632|FG001|Overall Study|Withdrawal by Subject|100|||
46741476|NCT00668707|82958631|FG000|Overall Study|Lost to Follow-up|3|||
46741477|NCT00668707|82958632|FG001|Overall Study|Lost to Follow-up|6|||
46741478|NCT00668707|82958631|FG000|Overall Study|Protocol Violation|10|||
46741479|NCT00668707|82958632|FG001|Overall Study|Protocol Violation|12|||
46741480|NCT00668707|82958631|FG000|Overall Study|Death|11|||
46741481|NCT00668707|82958632|FG001|Overall Study|Death|4|||
46741482|NCT00668395|82958646|FG000|Overall Study|Withdrawal by Subject|4|||
46741483|NCT00668395|82958647|FG001|Overall Study|Withdrawal by Subject|4|||
46741484|NCT00668395|82958648|FG002|Overall Study|Withdrawal by Subject|1|||
46741485|NCT00668395|82958646|FG000|Overall Study|Adverse Event|1|||
46741486|NCT00668395|82958647|FG001|Overall Study|Adverse Event|1|||
46741487|NCT00668395|82958648|FG002|Overall Study|Adverse Event|0|||
46741488|NCT00668395|82958646|FG000|Overall Study|Physician Decision|1|||
46741489|NCT00668395|82958647|FG001|Overall Study|Physician Decision|1|||
46741490|NCT00668395|82958648|FG002|Overall Study|Physician Decision|0|||
46741491|NCT00668317|82958656|FG000|Overall Study|Adverse Event|2|||
46741492|NCT00670111|82958677|FG000|Enrollment to One Month|Testing Failure|0|||
46741493|NCT00670111|82958678|FG001|Enrollment to One Month|Testing Failure|0|||
46741494|NCT00670111|82958679|FG002|Enrollment to One Month|Testing Failure|13|||
46741495|NCT00670111|82958677|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
46741496|NCT00670111|82958678|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
46741497|NCT00670111|82958679|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
46741498|NCT00670111|82958677|FG000|Enrollment to One Month|Physician Decision|1|||
46741499|NCT00670111|82958678|FG001|Enrollment to One Month|Physician Decision|0|||
46741500|NCT00670111|82958679|FG002|Enrollment to One Month|Physician Decision|0|||
46741501|NCT00672139|82958689|FG000|Overall Study|Death|14|||
46741502|NCT00672139|82958690|FG001|Overall Study|Death|23|||
46741503|NCT00672139|82958689|FG000|Overall Study|Withdrawal by Subject|2|||
46741504|NCT00672139|82958690|FG001|Overall Study|Withdrawal by Subject|11|||
46741505|NCT00672139|82958689|FG000|Overall Study|Adverse Event|4|||
46741506|NCT00672139|82958690|FG001|Overall Study|Adverse Event|7|||
46741507|NCT00672139|82958689|FG000|Overall Study|Physician Decision|2|||
46741508|NCT00672139|82958690|FG001|Overall Study|Physician Decision|0|||
46741509|NCT00672139|82958689|FG000|Overall Study|Lack of Efficacy|4|||
46741510|NCT00672139|82958690|FG001|Overall Study|Lack of Efficacy|1|||
46741511|NCT00672139|82958689|FG000|Overall Study|Protocol Violation|1|||
46741512|NCT00672139|82958690|FG001|Overall Study|Protocol Violation|1|||
46741513|NCT00672139|82958689|FG000|Overall Study|hospice discharge, caregiver requests|3|||
46741514|NCT00672139|82958690|FG001|Overall Study|hospice discharge, caregiver requests|2|||
46741515|NCT03717922|82958698|FG000|Overall Study|Lost to Follow-up|2|||
46741516|NCT03717922|82958699|FG001|Overall Study|Lost to Follow-up|2|||
46741517|NCT00570739|82958709|FG000|Overall Study|Adverse Event|8|||
46741518|NCT00570739|82958710|FG001|Overall Study|Adverse Event|6|||
46741519|NCT00570739|82958711|FG002|Overall Study|Adverse Event|2|||
46741520|NCT00570739|82958712|FG003|Overall Study|Adverse Event|2|||
46741521|NCT00570739|82958709|FG000|Overall Study|Lost to Follow-up|4|||
46741522|NCT00570739|82958710|FG001|Overall Study|Lost to Follow-up|5|||
46741523|NCT00570739|82958711|FG002|Overall Study|Lost to Follow-up|4|||
46741524|NCT00570739|82958712|FG003|Overall Study|Lost to Follow-up|1|||
46741525|NCT00570739|82958709|FG000|Overall Study|Physician Decision|1|||
46741526|NCT00570739|82958710|FG001|Overall Study|Physician Decision|1|||
46741527|NCT00570739|82958711|FG002|Overall Study|Physician Decision|0|||
46741528|NCT00570739|82958712|FG003|Overall Study|Physician Decision|0|||
46741529|NCT00570739|82958709|FG000|Overall Study|Withdrawal by Subject|7|||
46741530|NCT00570739|82958710|FG001|Overall Study|Withdrawal by Subject|7|||
47050556|NCT01698554|83311360|FG000|Overall Study|Protocol Violation|2|||
47050557|NCT01698554|83311361|FG001|Overall Study|Protocol Violation|0|||
46741531|NCT00570739|82958711|FG002|Overall Study|Withdrawal by Subject|3|||
46741532|NCT00570739|82958712|FG003|Overall Study|Withdrawal by Subject|5|||
46741533|NCT00570739|82958709|FG000|Overall Study|Required restricted medication|0|||
46741534|NCT00570739|82958710|FG001|Overall Study|Required restricted medication|0|||
46741535|NCT00570739|82958711|FG002|Overall Study|Required restricted medication|1|||
46741536|NCT00570739|82958712|FG003|Overall Study|Required restricted medication|0|||
47050558|NCT01698554|83311362|FG002|Overall Study|Protocol Violation|1|||
47050559|NCT01698554|83311363|FG003|Overall Study|Protocol Violation|0|||
46741537|NCT00570739|82958709|FG000|Overall Study|Met discontinuation criteria|1|||
46741538|NCT00570739|82958710|FG001|Overall Study|Met discontinuation criteria|0|||
46741539|NCT00570739|82958711|FG002|Overall Study|Met discontinuation criteria|1|||
46741540|NCT00570739|82958712|FG003|Overall Study|Met discontinuation criteria|1|||
46741541|NCT00570739|82958709|FG000|Overall Study|Other|0|||
46741542|NCT00570739|82958710|FG001|Overall Study|Other|2|||
46741543|NCT00570739|82958711|FG002|Overall Study|Other|5|||
46741544|NCT00570739|82958712|FG003|Overall Study|Other|3|||
46741545|NCT03689530|82958744|FG000|Overall Study|Withdrawal by Subject|53|||
46741546|NCT03689530|82958745|FG001|Overall Study|Withdrawal by Subject|16|||
46741547|NCT04188106|82958751|FG000|Overall Study|Lost to Follow-up|5|||
46741548|NCT04188106|82958751|FG000|Overall Study|Non-Compliance|1|||
46741549|NCT00669955|82958759|FG000|Overall Study|Adverse Event|3|||
46741550|NCT00669955|82958760|FG001|Overall Study|Adverse Event|5|||
46741551|NCT00669955|82958759|FG000|Overall Study|Death|0|||
46741552|NCT00669955|82958760|FG001|Overall Study|Death|1|||
46741553|NCT00669955|82958759|FG000|Overall Study|Withdrawal by Subject|2|||
46741554|NCT00669955|82958760|FG001|Overall Study|Withdrawal by Subject|3|||
46741555|NCT00669955|82958759|FG000|Overall Study|Lost to Follow-up|5|||
46741556|NCT00669955|82958760|FG001|Overall Study|Lost to Follow-up|7|||
46741557|NCT00669955|82958759|FG000|Overall Study|Protocol Violation|2|||
46741558|NCT00669955|82958760|FG001|Overall Study|Protocol Violation|7|||
46741559|NCT00669955|82958759|FG000|Overall Study|Investigator Sponsor Judgement|0|||
46741560|NCT00669955|82958760|FG001|Overall Study|Investigator Sponsor Judgement|1|||
46741561|NCT00669955|82958759|FG000|Overall Study|not compliant with study drug/visit|2|||
46741562|NCT00669955|82958760|FG001|Overall Study|not compliant with study drug/visit|3|||
46741563|NCT00671749|82958766|FG000|Overall Study|Adverse Event|2|||
46741564|NCT00671749|82958766|FG000|Overall Study|Withdrawal by Subject|4|||
46741565|NCT00671749|82958766|FG000|Overall Study|Protocol Violation|1|||
46741566|NCT00671749|82958766|FG000|Overall Study|Lost to Follow-up|1|||
46741567|NCT00669877|82958770|FG000|Overall Study|Disease Progression/Death|4|||
46741568|NCT00882999|82958781|FG000|Overall Study|Adverse Event|0|||
46741569|NCT00882999|82958782|FG001|Overall Study|Adverse Event|0|||
46741570|NCT00882999|82958783|FG002|Overall Study|Adverse Event|0|||
46741571|NCT00882999|82958784|FG003|Overall Study|Adverse Event|0|||
46741572|NCT00882999|82958785|FG004|Overall Study|Adverse Event|1|||
46741573|NCT00882999|82958786|FG005|Overall Study|Adverse Event|0|||
46741574|NCT00882999|82958787|FG006|Overall Study|Adverse Event|0|||
46741575|NCT00882999|82958781|FG000|Overall Study|Death|0|||
46741576|NCT00882999|82958782|FG001|Overall Study|Death|1|||
46741577|NCT00882999|82958783|FG002|Overall Study|Death|0|||
46741578|NCT00882999|82958784|FG003|Overall Study|Death|0|||
46741579|NCT00882999|82958785|FG004|Overall Study|Death|0|||
46741580|NCT00882999|82958786|FG005|Overall Study|Death|0|||
46741581|NCT00882999|82958787|FG006|Overall Study|Death|0|||
46741582|NCT00882999|82958781|FG000|Overall Study|Withdrawal by Subject|7|||
46741583|NCT00882999|82958782|FG001|Overall Study|Withdrawal by Subject|6|||
46741584|NCT00882999|82958783|FG002|Overall Study|Withdrawal by Subject|3|||
46741585|NCT00882999|82958784|FG003|Overall Study|Withdrawal by Subject|3|||
46741586|NCT00882999|82958785|FG004|Overall Study|Withdrawal by Subject|6|||
46741587|NCT00882999|82958786|FG005|Overall Study|Withdrawal by Subject|5|||
46741588|NCT00882999|82958787|FG006|Overall Study|Withdrawal by Subject|5|||
46741589|NCT00882999|82958781|FG000|Overall Study|Lost to Follow-up|0|||
46741590|NCT00882999|82958782|FG001|Overall Study|Lost to Follow-up|1|||
46741591|NCT00882999|82958783|FG002|Overall Study|Lost to Follow-up|1|||
46741592|NCT00882999|82958784|FG003|Overall Study|Lost to Follow-up|2|||
46741593|NCT00882999|82958785|FG004|Overall Study|Lost to Follow-up|1|||
46741594|NCT00882999|82958786|FG005|Overall Study|Lost to Follow-up|1|||
46741595|NCT00882999|82958787|FG006|Overall Study|Lost to Follow-up|2|||
46741596|NCT00882999|82958781|FG000|Overall Study|Physician Decision|1|||
46741597|NCT00882999|82958782|FG001|Overall Study|Physician Decision|0|||
46741598|NCT00882999|82958783|FG002|Overall Study|Physician Decision|0|||
46741599|NCT00882999|82958784|FG003|Overall Study|Physician Decision|0|||
46741600|NCT00882999|82958785|FG004|Overall Study|Physician Decision|0|||
46741601|NCT00882999|82958786|FG005|Overall Study|Physician Decision|1|||
46741602|NCT00882999|82958787|FG006|Overall Study|Physician Decision|1|||
46741603|NCT00671437|82958810|FG000|Overall Study|Progressive disease before C1 week 8|8|||
46741604|NCT00671437|82958810|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
46741605|NCT00671437|82958810|FG000|Overall Study|Adverse Event|3|||
46741606|NCT00671437|82958810|FG000|Overall Study|Ineligible post-hoc|1|||
46741607|NCT00882921|82958822|FG000|Overall Study|Death|2|||
46741608|NCT00882921|82958822|FG000|Overall Study|Other|3|||
46741609|NCT00882921|82958822|FG000|Overall Study|Lost to Follow-up|2|||
46741610|NCT00882921|82958822|FG000|Overall Study|Termination By Investigator|3|||
46741611|NCT00882921|82958822|FG000|Overall Study|Withdrawal Of Consent|1|||
46741612|NCT00582712|82958827|FG000|Overall Study|Adverse Event|1|||
46741613|NCT00582712|82958827|FG000|Overall Study|Lack of Efficacy|1|||
46741614|NCT00582712|82958827|FG000|Overall Study|Withdrawal by Subject|1|||
46741615|NCT00582712|82958827|FG000|Overall Study|Complicating disease requiring treatment|1|||
46741616|NCT00582790|82958831|FG000|Overall Study|Rapid progression of disease|1|||
46741617|NCT00881751|82958838|FG000|Overall Study|Physician Decision|0|||
46741618|NCT00881751|82958839|FG001|Overall Study|Physician Decision|1|||
46741619|NCT00881751|82958838|FG000|Overall Study|Adverse Event|0|||
46741620|NCT00881751|82958839|FG001|Overall Study|Adverse Event|2|||
46741621|NCT00881751|82958838|FG000|Overall Study|Withdrawal by Subject|0|||
46741622|NCT00881751|82958839|FG001|Overall Study|Withdrawal by Subject|2|||
46741623|NCT00934856|82958851|FG000|Feasibility Part|Progressive disease|4|||
46741624|NCT00934856|82958852|FG001|Feasibility Part|Progressive disease|4|||
46741625|NCT00934856|82958853|FG002|Feasibility Part|Progressive disease|2|||
46741626|NCT00934856|82958854|FG003|Feasibility Part|Progressive disease|3|||
46741627|NCT00934856|82958855|FG004|Feasibility Part|Progressive disease|0|||
46741628|NCT00934856|82958856|FG005|Feasibility Part|Progressive disease|0|||
46741629|NCT00934856|82958851|FG000|Feasibility Part|Physician Decision|0|||
46741630|NCT00934856|82958852|FG001|Feasibility Part|Physician Decision|0|||
46741631|NCT00934856|82958853|FG002|Feasibility Part|Physician Decision|1|||
46741632|NCT00934856|82958854|FG003|Feasibility Part|Physician Decision|0|||
46741633|NCT00934856|82958855|FG004|Feasibility Part|Physician Decision|0|||
46741634|NCT00934856|82958856|FG005|Feasibility Part|Physician Decision|0|||
46741635|NCT00934856|82958851|FG000|Feasibility Part|Adverse Event|1|||
46741636|NCT00934856|82958852|FG001|Feasibility Part|Adverse Event|1|||
46741637|NCT00934856|82958853|FG002|Feasibility Part|Adverse Event|0|||
46741638|NCT00934856|82958854|FG003|Feasibility Part|Adverse Event|1|||
46741639|NCT00934856|82958855|FG004|Feasibility Part|Adverse Event|0|||
46741640|NCT00934856|82958856|FG005|Feasibility Part|Adverse Event|2|||
46741641|NCT00934856|82958851|FG000|Feasibility Part|Withdrawal by Subject|0|||
46741642|NCT00934856|82958852|FG001|Feasibility Part|Withdrawal by Subject|0|||
46741643|NCT00934856|82958853|FG002|Feasibility Part|Withdrawal by Subject|0|||
46741644|NCT00934856|82958854|FG003|Feasibility Part|Withdrawal by Subject|1|||
47050560|NCT01698554|83311360|FG000|Overall Study|Other Miscellaneous Reasons|1|||
47050561|NCT01698554|83311361|FG001|Overall Study|Other Miscellaneous Reasons|0|||
47050562|NCT01698554|83311362|FG002|Overall Study|Other Miscellaneous Reasons|0|||
47050563|NCT01698554|83311363|FG003|Overall Study|Other Miscellaneous Reasons|0|||
47050564|NCT04404855|83311375|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
47050565|NCT04404855|83311376|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
47050566|NCT01698320|83311384|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
47050567|NCT01698320|83311385|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
47050568|NCT01698320|83311386|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
47050569|NCT01698320|83311384|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
47050570|NCT01698320|83311385|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
47050571|NCT01698320|83311386|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
47050572|NCT01698320|83311384|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
47050573|NCT01698320|83311385|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
46741645|NCT00934856|82958855|FG004|Feasibility Part|Withdrawal by Subject|0|||
46741646|NCT00934856|82958856|FG005|Feasibility Part|Withdrawal by Subject|1|||
46741647|NCT00934856|82958851|FG000|Extension Part|Adverse Event|0|||
46741648|NCT00934856|82958852|FG001|Extension Part|Adverse Event|0|||
46741649|NCT00934856|82958853|FG002|Extension Part|Adverse Event|0|||
46741650|NCT00934856|82958854|FG003|Extension Part|Adverse Event|1|||
46741651|NCT00934856|82958855|FG004|Extension Part|Adverse Event|4|||
46741652|NCT00934856|82958856|FG005|Extension Part|Adverse Event|4|||
46741653|NCT00934856|82958851|FG000|Extension Part|Progressive disease|0|||
46741654|NCT00934856|82958852|FG001|Extension Part|Progressive disease|0|||
46741655|NCT00934856|82958853|FG002|Extension Part|Progressive disease|0|||
46741656|NCT00934856|82958854|FG003|Extension Part|Progressive disease|1|||
46741657|NCT00934856|82958855|FG004|Extension Part|Progressive disease|0|||
46741658|NCT00934856|82958856|FG005|Extension Part|Progressive disease|0|||
46741659|NCT00934856|82958851|FG000|Extension Part|Non-compliance with drug|0|||
46741660|NCT00934856|82958852|FG001|Extension Part|Non-compliance with drug|0|||
46741661|NCT00934856|82958853|FG002|Extension Part|Non-compliance with drug|0|||
46741662|NCT00934856|82958854|FG003|Extension Part|Non-compliance with drug|0|||
46741663|NCT00934856|82958855|FG004|Extension Part|Non-compliance with drug|0|||
46741664|NCT00934856|82958856|FG005|Extension Part|Non-compliance with drug|1|||
46741665|NCT00934700|82958890|FG000|Overall Study|missing scan|5|||
46741666|NCT00934700|82958891|FG001|Overall Study|missing scan|9|||
46741667|NCT00934700|82958890|FG000|Overall Study|Death|8|||
46741668|NCT00934700|82958891|FG001|Overall Study|Death|3|||
46741669|NCT00930176|82958898|FG000|Overall Study|Death|1|||
46741670|NCT00669409|82958908|FG000|Part 2|Withdrawal by Subject|0|||
46804132|NCT00542828|83023331|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
46741671|NCT00669409|82958909|FG001|Part 2|Withdrawal by Subject|0|||
46741672|NCT00669409|82958910|FG002|Part 2|Withdrawal by Subject|0|||
46741673|NCT00669409|82958911|FG003|Part 2|Withdrawal by Subject|0|||
46741674|NCT00669409|82958912|FG004|Part 2|Withdrawal by Subject|0|||
46741675|NCT00669409|82958913|FG005|Part 2|Withdrawal by Subject|0|||
46741676|NCT00669409|82958914|FG006|Part 2|Withdrawal by Subject|0|||
46741677|NCT00669409|82958915|FG007|Part 2|Withdrawal by Subject|0|||
46741678|NCT00669409|82958916|FG008|Part 2|Withdrawal by Subject|0|||
46741679|NCT00669409|82958917|FG009|Part 2|Withdrawal by Subject|1|||
46741680|NCT00669409|82958918|FG010|Part 2|Withdrawal by Subject|0|||
46741681|NCT00669331|82958947|FG000|Randomisation to First Dose|Adverse Event|1|||
46741682|NCT00669331|82958948|FG001|Randomisation to First Dose|Adverse Event|0|||
46741683|NCT00669331|82958947|FG000|Randomisation to First Dose|Protocol Violation|1|||
46741684|NCT00669331|82958948|FG001|Randomisation to First Dose|Protocol Violation|0|||
46741685|NCT00669331|82958947|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
46741686|NCT00669331|82958948|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
46741687|NCT00669331|82958947|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
46741688|NCT00669331|82958948|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
46741689|NCT00669331|82958947|FG000|Randomisation to First Dose|Death|1|||
46741690|NCT00669331|82958948|FG001|Randomisation to First Dose|Death|0|||
46741691|NCT00669331|82958947|FG000|Randomisation to First Dose|Sponsor decision|0|||
46741692|NCT00669331|82958948|FG001|Randomisation to First Dose|Sponsor decision|1|||
46741693|NCT00669331|82958947|FG000|Randomisation to First Dose|Randomised in error|3|||
46741694|NCT00669331|82958948|FG001|Randomisation to First Dose|Randomised in error|10|||
46741695|NCT00669331|82958947|FG000|Blinded Treatment Period|Adverse Event|16|||
46741696|NCT00669331|82958948|FG001|Blinded Treatment Period|Adverse Event|10|||
46741697|NCT00669331|82958947|FG000|Blinded Treatment Period|Protocol Violation|1|||
46741698|NCT00669331|82958948|FG001|Blinded Treatment Period|Protocol Violation|1|||
46741699|NCT00669331|82958947|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
46741700|NCT00669331|82958948|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
46741701|NCT00669331|82958947|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
46741702|NCT00669331|82958948|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
46741703|NCT00669331|82958947|FG000|Blinded Treatment Period|Death|0|||
46741704|NCT00669331|82958948|FG001|Blinded Treatment Period|Death|2|||
46741705|NCT00669331|82958947|FG000|Blinded Treatment Period|Physician Decision|3|||
46741706|NCT00669331|82958948|FG001|Blinded Treatment Period|Physician Decision|3|||
46741707|NCT00669331|82958947|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
46741708|NCT00669331|82958948|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
46741709|NCT00932126|82958956|FG000|Overall Study|Adverse Event|0|||
46635401|NCT01537068|82809032|FG001|Overall Study|Lost to Follow-up|1|||
46635402|NCT01537068|82809031|FG000|Overall Study|Adverse Event|0|||
46635403|NCT01537068|82809032|FG001|Overall Study|Adverse Event|1|||
46741710|NCT00932126|82958957|FG001|Overall Study|Adverse Event|0|||
46741711|NCT00932126|82958958|FG002|Overall Study|Adverse Event|0|||
46741712|NCT00932126|82958959|FG003|Overall Study|Adverse Event|0|||
46741713|NCT00932126|82958960|FG004|Overall Study|Adverse Event|0|||
46741714|NCT00932126|82958961|FG005|Overall Study|Adverse Event|0|||
46635404|NCT01537068|82809031|FG000|Overall Study|Withdrawal by Subject|1|||
46741715|NCT00932126|82958962|FG006|Overall Study|Adverse Event|1|||
46741716|NCT00932126|82958963|FG007|Overall Study|Adverse Event|2|||
46741717|NCT00932126|82958956|FG000|Overall Study|Protocol Violation|0|||
46741718|NCT00932126|82958957|FG001|Overall Study|Protocol Violation|0|||
46741719|NCT00932126|82958958|FG002|Overall Study|Protocol Violation|0|||
46741720|NCT00932126|82958959|FG003|Overall Study|Protocol Violation|0|||
46741721|NCT00932126|82958960|FG004|Overall Study|Protocol Violation|1|||
46741722|NCT00932126|82958961|FG005|Overall Study|Protocol Violation|0|||
46741723|NCT00932126|82958962|FG006|Overall Study|Protocol Violation|0|||
46741724|NCT00932126|82958963|FG007|Overall Study|Protocol Violation|0|||
46741725|NCT00932126|82958956|FG000|Overall Study|Withdrawal by Subject|0|||
46741726|NCT00932126|82958957|FG001|Overall Study|Withdrawal by Subject|0|||
46741727|NCT00932126|82958958|FG002|Overall Study|Withdrawal by Subject|1|||
46741728|NCT00932126|82958959|FG003|Overall Study|Withdrawal by Subject|0|||
46741729|NCT00932126|82958960|FG004|Overall Study|Withdrawal by Subject|0|||
46741730|NCT00932126|82958961|FG005|Overall Study|Withdrawal by Subject|0|||
46741731|NCT00932126|82958962|FG006|Overall Study|Withdrawal by Subject|0|||
46741732|NCT00932126|82958963|FG007|Overall Study|Withdrawal by Subject|1|||
46741733|NCT00932126|82958956|FG000|Overall Study|Objective progression or relapse|3|||
46741734|NCT00932126|82958957|FG001|Overall Study|Objective progression or relapse|3|||
46741735|NCT00932126|82958958|FG002|Overall Study|Objective progression or relapse|2|||
46741736|NCT00932126|82958959|FG003|Overall Study|Objective progression or relapse|3|||
46741737|NCT00932126|82958960|FG004|Overall Study|Objective progression or relapse|3|||
46741738|NCT00932126|82958961|FG005|Overall Study|Objective progression or relapse|3|||
46741739|NCT00932126|82958962|FG006|Overall Study|Objective progression or relapse|3|||
46741740|NCT00932126|82958963|FG007|Overall Study|Objective progression or relapse|5|||
46741741|NCT00932126|82958956|FG000|Overall Study|Other|0|||
46741742|NCT00932126|82958957|FG001|Overall Study|Other|0|||
46741743|NCT00932126|82958958|FG002|Overall Study|Other|0|||
46741744|NCT00932126|82958959|FG003|Overall Study|Other|0|||
47050574|NCT01698320|83311386|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
47050575|NCT01698320|83311384|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
47050576|NCT01698320|83311385|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
47050577|NCT01698320|83311386|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
47050578|NCT01698320|83311384|FG000|12-Week Double-Blind Period|Adverse Event|0|||
47050579|NCT01698320|83311385|FG001|12-Week Double-Blind Period|Adverse Event|1|||
47050580|NCT01698320|83311386|FG002|12-Week Double-Blind Period|Adverse Event|1|||
46741745|NCT00932126|82958960|FG004|Overall Study|Other|1|||
46741746|NCT00932126|82958961|FG005|Overall Study|Other|0|||
46741747|NCT00932126|82958962|FG006|Overall Study|Other|1|||
47050581|NCT01698320|83311384|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
47050582|NCT01698320|83311385|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
47050583|NCT01698320|83311386|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
46741748|NCT00932126|82958963|FG007|Overall Study|Other|2|||
46741749|NCT00667225|82958985|FG000|Overall Study|Subject had no more lesions to treat.|1|||
46741750|NCT00667225|82958986|FG001|Overall Study|Subject had no more lesions to treat.|0|||
46741751|NCT00667225|82958985|FG000|Overall Study|Lost to Follow-up|0|||
46741752|NCT00667225|82958986|FG001|Overall Study|Lost to Follow-up|1|||
46741753|NCT00929864|82958994|FG000|Overall Study|Death|1|||
46741754|NCT00929864|82958995|FG001|Overall Study|Death|1|||
46741755|NCT00929864|82958994|FG000|Overall Study|Adverse Event|11|||
46741756|NCT00929864|82958995|FG001|Overall Study|Adverse Event|30|||
46741757|NCT00929864|82958994|FG000|Overall Study|Lack of Efficacy|19|||
46741758|NCT00929864|82958995|FG001|Overall Study|Lack of Efficacy|16|||
46741759|NCT00929864|82958994|FG000|Overall Study|Lost to Follow-up|7|||
46741760|NCT00929864|82958995|FG001|Overall Study|Lost to Follow-up|12|||
46741761|NCT00929864|82958994|FG000|Overall Study|Withdrawal by Subject|20|||
46741762|NCT00929864|82958995|FG001|Overall Study|Withdrawal by Subject|9|||
46741763|NCT00929864|82958994|FG000|Overall Study|No longer met criteria|2|||
46741764|NCT00929864|82958995|FG001|Overall Study|No longer met criteria|1|||
46741765|NCT00929864|82958994|FG000|Overall Study|Poor or non-compliance|3|||
46741766|NCT00929864|82958995|FG001|Overall Study|Poor or non-compliance|3|||
46741767|NCT00929864|82958994|FG000|Overall Study|Pregnancy|0|||
46741768|NCT00929864|82958995|FG001|Overall Study|Pregnancy|3|||
47050584|NCT01698320|83311384|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
47050585|NCT01698320|83311385|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
46741769|NCT00929864|82958994|FG000|Overall Study|Administrative reason by Sponsor|1|||
46741770|NCT00929864|82958995|FG001|Overall Study|Administrative reason by Sponsor|1|||
46741771|NCT00929864|82958994|FG000|Overall Study|Non-specified|2|||
46741772|NCT00929864|82958995|FG001|Overall Study|Non-specified|7|||
46741773|NCT00597753|82959003|FG000|Overall Study|Adverse Event|6|||
46741774|NCT00597753|82959004|FG001|Overall Study|Adverse Event|2|||
46741775|NCT00597753|82959003|FG000|Overall Study|Death|55|||
47050586|NCT01698320|83311386|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
47050587|NCT01698320|83311384|FG000|12-Week Double-Blind Period|Pregnancy|0|||
46741776|NCT00597753|82959004|FG001|Overall Study|Death|29|||
46741777|NCT00597753|82959003|FG000|Overall Study|Lack of Efficacy|2|||
47050588|NCT01698320|83311385|FG001|12-Week Double-Blind Period|Pregnancy|1|||
46741778|NCT00597753|82959004|FG001|Overall Study|Lack of Efficacy|0|||
46741779|NCT00597753|82959003|FG000|Overall Study|Lost to Follow-up|10|||
46741780|NCT00597753|82959004|FG001|Overall Study|Lost to Follow-up|3|||
46741781|NCT00597753|82959003|FG000|Overall Study|Physician Decision|5|||
46741782|NCT00597753|82959004|FG001|Overall Study|Physician Decision|1|||
46741783|NCT00597753|82959003|FG000|Overall Study|Pregnancy|1|||
46741784|NCT00597753|82959004|FG001|Overall Study|Pregnancy|0|||
46741785|NCT00597753|82959003|FG000|Overall Study|Withdrawal by Subject|35|||
46741786|NCT00597753|82959004|FG001|Overall Study|Withdrawal by Subject|12|||
46741787|NCT00597753|82959003|FG000|Overall Study|Discontinued Dialysis|0|||
46741788|NCT00597753|82959004|FG001|Overall Study|Discontinued Dialysis|1|||
46741789|NCT00597753|82959003|FG000|Overall Study|Never dosed|2|||
46741790|NCT00597753|82959004|FG001|Overall Study|Never dosed|0|||
47050589|NCT01698320|83311386|FG002|12-Week Double-Blind Period|Pregnancy|1|||
47050590|NCT01698320|83311384|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
47050591|NCT01698320|83311385|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
47050592|NCT01698320|83311386|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
47050593|NCT01698320|83311384|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
47050594|NCT01698320|83311385|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
47050595|NCT01698320|83311386|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
47050596|NCT01698320|83311384|FG000|40-Week Open-Label Period|Adverse Event|0|||
47050597|NCT01698320|83311385|FG001|40-Week Open-Label Period|Adverse Event|3|||
47050598|NCT01698320|83311386|FG002|40-Week Open-Label Period|Adverse Event|2|||
47050599|NCT01698320|83311384|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
47050600|NCT01698320|83311385|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
47050601|NCT01698320|83311386|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
47050602|NCT01698320|83311384|FG000|40-Week Open-Label Period|Pregnancy|0|||
47050603|NCT01698320|83311385|FG001|40-Week Open-Label Period|Pregnancy|2|||
47050604|NCT01698320|83311386|FG002|40-Week Open-Label Period|Pregnancy|1|||
47050605|NCT01698320|83311384|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
46741791|NCT00597753|82959003|FG000|Overall Study|Noncompliance|2|||
46741792|NCT00597753|82959004|FG001|Overall Study|Noncompliance|1|||
46741793|NCT00597753|82959003|FG000|Overall Study|Relocation|17|||
46741794|NCT00597753|82959004|FG001|Overall Study|Relocation|6|||
46741795|NCT00597753|82959003|FG000|Overall Study|Renal transplant|10|||
46741796|NCT00597753|82959004|FG001|Overall Study|Renal transplant|3|||
46741797|NCT00597753|82959003|FG000|Overall Study|Site closed by sponsor|19|||
46741798|NCT00597753|82959004|FG001|Overall Study|Site closed by sponsor|7|||
46741799|NCT00597753|82959003|FG000|Overall Study|Site elected to close|2|||
46741800|NCT00597753|82959004|FG001|Overall Study|Site elected to close|4|||
46741801|NCT00665431|82959013|FG000|Overall Study|Adverse Event|16|||
46741802|NCT00665431|82959014|FG001|Overall Study|Adverse Event|22|||
46741803|NCT00665431|82959015|FG002|Overall Study|Adverse Event|6|||
46741804|NCT00665431|82959013|FG000|Overall Study|Withdrawal by Subject|17|||
46741805|NCT00665431|82959014|FG001|Overall Study|Withdrawal by Subject|25|||
46741806|NCT00665431|82959015|FG002|Overall Study|Withdrawal by Subject|15|||
46741807|NCT00665431|82959013|FG000|Overall Study|Lost to Follow-up|3|||
47050606|NCT01698320|83311385|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
46741808|NCT00665431|82959014|FG001|Overall Study|Lost to Follow-up|3|||
46741809|NCT00665431|82959015|FG002|Overall Study|Lost to Follow-up|1|||
46741810|NCT00665431|82959013|FG000|Overall Study|Other|4|||
46741811|NCT00665431|82959014|FG001|Overall Study|Other|7|||
46741812|NCT00665431|82959015|FG002|Overall Study|Other|2|||
46741813|NCT00934622|82959023|FG000|Overall Study|Lost to Follow-up|7|||
46741814|NCT00934622|82959023|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
46741815|NCT00881361|82959029|FG000|Overall Study|Terminated prior to surgery|27|||
46741816|NCT00881361|82959030|FG001|Overall Study|Terminated prior to surgery|7|||
46741817|NCT00881361|82959031|FG002|Overall Study|Terminated prior to surgery|0|||
47050607|NCT01698320|83311386|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
47050608|NCT01698320|83311384|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
47050609|NCT01698320|83311385|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
47050610|NCT01698320|83311386|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
47050611|NCT01697696|83311404|FG000|Overall Study|Study terminated by sponsor|0|||
47050612|NCT01697696|83311405|FG001|Overall Study|Study terminated by sponsor|3|||
47050613|NCT01697696|83311404|FG000|Overall Study|Protocol deviation|1|||
46741818|NCT00881361|82959029|FG000|Overall Study|Ineligible|17|||
46741819|NCT00881361|82959030|FG001|Overall Study|Ineligible|2|||
47050614|NCT01697696|83311405|FG001|Overall Study|Protocol deviation|0|||
47050615|NCT01697696|83311404|FG000|Overall Study|Physician Decision|1|||
46741820|NCT00881361|82959031|FG002|Overall Study|Ineligible|2|||
46741821|NCT01000727|82959042|FG000|Overall Study|Lost to Follow-up|41|||
46741822|NCT01000727|82959043|FG001|Overall Study|Lost to Follow-up|43|||
46741823|NCT01000727|82959042|FG000|Overall Study|Withdrawal by Subject|111|||
46741824|NCT01000727|82959043|FG001|Overall Study|Withdrawal by Subject|109|||
46741825|NCT01000727|82959042|FG000|Overall Study|Study closed/terminated|23|||
46741826|NCT01000727|82959043|FG001|Overall Study|Study closed/terminated|24|||
47050616|NCT01697696|83311405|FG001|Overall Study|Physician Decision|0|||
47050617|NCT01697696|83311404|FG000|Overall Study|Death|4|||
47050618|NCT01697696|83311405|FG001|Overall Study|Death|2|||
47050619|NCT01697696|83311404|FG000|Overall Study|Lost to Follow-up|10|||
47050620|NCT01697696|83311405|FG001|Overall Study|Lost to Follow-up|7|||
47050621|NCT01697696|83311404|FG000|Overall Study|Subject/guardian decision|31|||
47050622|NCT01697696|83311405|FG001|Overall Study|Subject/guardian decision|35|||
47050623|NCT01569152|83311413|FG000|Phase IIa, Period 1|Early Escape|5|||
47050624|NCT01569152|83311414|FG001|Phase IIa, Period 1|Early Escape|22|||
47050625|NCT01569152|83311415|FG002|Phase IIa, Period 1|Early Escape|0|||
47050626|NCT01569152|83311413|FG000|Phase IIa, Period 1|Adverse Event|4|||
47050627|NCT01569152|83311414|FG001|Phase IIa, Period 1|Adverse Event|0|||
47050628|NCT01569152|83311415|FG002|Phase IIa, Period 1|Adverse Event|0|||
47050629|NCT01569152|83311413|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
47050630|NCT01569152|83311414|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
47050631|NCT01569152|83311415|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
47050632|NCT01569152|83311413|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
47050633|NCT01569152|83311414|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
47050634|NCT01569152|83311415|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
47050635|NCT01569152|83311413|FG000|Phase IIa, Period 1|Protocol Violation|0|||
47050636|NCT01569152|83311414|FG001|Phase IIa, Period 1|Protocol Violation|1|||
47050637|NCT01569152|83311415|FG002|Phase IIa, Period 1|Protocol Violation|0|||
47050638|NCT01569152|83311413|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
47050639|NCT01569152|83311414|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
47050640|NCT01569152|83311415|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
47050641|NCT01569152|83311413|FG000|Safety Extension, Period 3|Adverse Event|0|||
47050642|NCT01569152|83311414|FG001|Safety Extension, Period 3|Adverse Event|0|||
47050643|NCT01569152|83311415|FG002|Safety Extension, Period 3|Adverse Event|4|||
47050644|NCT01569152|83311413|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
47050645|NCT01569152|83311414|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
47050646|NCT01569152|83311415|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
47050647|NCT01569152|83311413|FG000|Safety Extension, Period 3|Physician Decision|0|||
47050648|NCT01569152|83311414|FG001|Safety Extension, Period 3|Physician Decision|0|||
47050649|NCT01569152|83311415|FG002|Safety Extension, Period 3|Physician Decision|2|||
47050650|NCT01569152|83311413|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
47050651|NCT01569152|83311414|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
46741827|NCT00881205|82959053|FG000|Overall Study|Adverse Event|8|||
46741828|NCT00881205|82959054|FG001|Overall Study|Adverse Event|3|||
46741829|NCT00881205|82959053|FG000|Overall Study|Withdrawal by Subject|1|||
46741830|NCT00881205|82959054|FG001|Overall Study|Withdrawal by Subject|2|||
46741831|NCT00881205|82959053|FG000|Overall Study|Lost to Follow-up|0|||
46741832|NCT00881205|82959054|FG001|Overall Study|Lost to Follow-up|1|||
46741833|NCT00881205|82959053|FG000|Overall Study|Administrative problems|1|||
46741834|NCT00881205|82959054|FG001|Overall Study|Administrative problems|1|||
46741835|NCT00881205|82959053|FG000|Overall Study|Condition no longer requires drug|1|||
46741836|NCT00881205|82959054|FG001|Overall Study|Condition no longer requires drug|0|||
46741837|NCT00879879|82959061|FG000|Overall Study|Death|1|||
46741838|NCT00879879|82959061|FG000|Overall Study|Withdrawal by Subject|1|||
46741839|NCT00879879|82959061|FG000|Overall Study|Physician Decision|1|||
46741840|NCT00661999|82959070|FG000|Overall Study|Adverse Event|11|||
46741841|NCT00661999|82959071|FG001|Overall Study|Adverse Event|5|||
46741842|NCT00661999|82959072|FG002|Overall Study|Adverse Event|8|||
46741843|NCT00661999|82959070|FG000|Overall Study|Death|8|||
46741844|NCT00661999|82959071|FG001|Overall Study|Death|6|||
46741845|NCT00661999|82959072|FG002|Overall Study|Death|3|||
46741846|NCT00661999|82959070|FG000|Overall Study|Other Reasons|5|||
46741847|NCT00661999|82959071|FG001|Overall Study|Other Reasons|12|||
47050652|NCT01569152|83311415|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
47050653|NCT01569074|83311440|FG000|Overall Study|Study stopped|6|||
47050654|NCT01569074|83311441|FG001|Overall Study|Study stopped|6|||
47050655|NCT01569074|83311442|FG002|Overall Study|Study stopped|8|||
47050656|NCT01569074|83311443|FG003|Overall Study|Study stopped|7|||
47050657|NCT01569074|83311444|FG004|Overall Study|Study stopped|7|||
47050658|NCT01569074|83311440|FG000|Overall Study|Study-specific discontinuation criteria|0|||
47050659|NCT01569074|83311441|FG001|Overall Study|Study-specific discontinuation criteria|1|||
47050660|NCT01569074|83311442|FG002|Overall Study|Study-specific discontinuation criteria|0|||
47050661|NCT01569074|83311443|FG003|Overall Study|Study-specific discontinuation criteria|0|||
47050662|NCT01569074|83311444|FG004|Overall Study|Study-specific discontinuation criteria|0|||
47050663|NCT01569074|83311440|FG000|Overall Study|Severe non-compliance to protocol|0|||
46741848|NCT00661999|82959072|FG002|Overall Study|Other Reasons|23|||
46741849|NCT00661999|82959070|FG000|Overall Study|Withdrawal by Subject|30|||
46741850|NCT00661999|82959071|FG001|Overall Study|Withdrawal by Subject|23|||
46741851|NCT00661999|82959072|FG002|Overall Study|Withdrawal by Subject|14|||
46741852|NCT00661999|82959070|FG000|Overall Study|Alternative Treatment|1|||
46741853|NCT00661999|82959071|FG001|Overall Study|Alternative Treatment|0|||
46741854|NCT00661999|82959072|FG002|Overall Study|Alternative Treatment|0|||
46741855|NCT00661999|82959070|FG000|Overall Study|Other Medical Problems|4|||
46741856|NCT00661999|82959071|FG001|Overall Study|Other Medical Problems|4|||
46741857|NCT00661999|82959072|FG002|Overall Study|Other Medical Problems|9|||
46741858|NCT00665353|82959080|FG000|Study Step 1|Adverse Event|1|||
46741859|NCT00665353|82959080|FG000|Study Step 1|Withdrawal by Subject|2|||
46741860|NCT00665353|82959080|FG000|Study Step 2|Lost to Follow-up|2|||
46741861|NCT00665353|82959080|FG000|Study Step 2|Lack of Efficacy|12|||
46741862|NCT00597207|82959086|FG000|Overall Study|Lost to Follow-up|5|||
46741863|NCT00597207|82959087|FG001|Overall Study|Lost to Follow-up|7|||
46741864|NCT00879645|82959097|FG000|Overall Study|Adverse Event|1|||
46741865|NCT00879645|82959098|FG001|Overall Study|Adverse Event|0|||
46741866|NCT00879645|82959099|FG002|Overall Study|Adverse Event|0|||
46741867|NCT00879645|82959100|FG003|Overall Study|Adverse Event|0|||
46741868|NCT00664105|82959110|FG000|Overall Study|Death|3|||
46741869|NCT00664105|82959110|FG000|Overall Study|Withdrawal by Subject|5|||
46741870|NCT00664105|82959110|FG000|Overall Study|Adverse Event|9|||
46741871|NCT00664105|82959110|FG000|Overall Study|Disease progression|7|||
46741872|NCT00661687|82959115|FG000|Overall Study|Study related symptoms and complaints|5|||
46741873|NCT00661687|82959115|FG000|Overall Study|Positive slit lamp findings|4|||
46741874|NCT00661687|82959115|FG000|Overall Study|Inability to maintain wearing schedule|3|||
46741875|NCT00661687|82959115|FG000|Overall Study|Physician Decision|1|||
46741876|NCT00661687|82959115|FG000|Overall Study|Adverse Event|2|||
46741877|NCT00596817|82959124|FG000|Open-label Period|Adverse Event|0|||
46741878|NCT00596817|82959125|FG001|Open-label Period|Adverse Event|49|||
46741879|NCT00596817|82959124|FG000|Open-label Period|Lack of Efficacy|0|||
46741880|NCT00596817|82959125|FG001|Open-label Period|Lack of Efficacy|33|||
46741881|NCT00596817|82959124|FG000|Open-label Period|Other Reasons|0|||
46741882|NCT00596817|82959125|FG001|Open-label Period|Other Reasons|65|||
46741883|NCT00596817|82959124|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
46741884|NCT00596817|82959125|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
46741885|NCT00596817|82959124|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
46741886|NCT00596817|82959125|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
46741887|NCT00596817|82959124|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
46741888|NCT00596817|82959125|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
46741889|NCT00596817|82959124|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
46741890|NCT00596817|82959125|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
46741891|NCT00596817|82959124|FG000|Double-blind Period|Adverse Event|5|||
46741892|NCT00596817|82959125|FG001|Double-blind Period|Adverse Event|16|||
46741893|NCT00596817|82959124|FG000|Double-blind Period|Lack of Efficacy|52|||
46741894|NCT00596817|82959125|FG001|Double-blind Period|Lack of Efficacy|28|||
46741895|NCT00596817|82959124|FG000|Double-blind Period|Non-compliance With Study Product|3|||
46741896|NCT00596817|82959125|FG001|Double-blind Period|Non-compliance With Study Product|4|||
46741897|NCT00596817|82959124|FG000|Double-blind Period|Protocol Violation|11|||
46741898|NCT00596817|82959125|FG001|Double-blind Period|Protocol Violation|8|||
46741899|NCT00596817|82959124|FG000|Double-blind Period|Withdrawal of Consent|7|||
46741900|NCT00596817|82959125|FG001|Double-blind Period|Withdrawal of Consent|3|||
46741901|NCT00596817|82959124|FG000|Double-blind Period|Lost to Follow-up|0|||
46741902|NCT00596817|82959125|FG001|Double-blind Period|Lost to Follow-up|2|||
47050664|NCT01569074|83311441|FG001|Overall Study|Severe non-compliance to protocol|0|||
47050665|NCT01569074|83311442|FG002|Overall Study|Severe non-compliance to protocol|1|||
47050666|NCT01569074|83311443|FG003|Overall Study|Severe non-compliance to protocol|0|||
47050667|NCT01569074|83311444|FG004|Overall Study|Severe non-compliance to protocol|0|||
46741903|NCT00596817|82959124|FG000|Double-blind Period|Other Reasons|10|||
46741904|NCT00596817|82959125|FG001|Double-blind Period|Other Reasons|18|||
46741905|NCT01000649|82959136|FG000|Overall Study|Adverse Event|5|||
46741906|NCT01000649|82959137|FG001|Overall Study|Adverse Event|1|||
46741907|NCT01000649|82959138|FG002|Overall Study|Adverse Event|2|||
46741908|NCT01000649|82959139|FG003|Overall Study|Adverse Event|4|||
46741909|NCT01000649|82959136|FG000|Overall Study|Lost to Follow-up|0|||
46741910|NCT01000649|82959137|FG001|Overall Study|Lost to Follow-up|2|||
46741911|NCT01000649|82959138|FG002|Overall Study|Lost to Follow-up|0|||
46741912|NCT01000649|82959139|FG003|Overall Study|Lost to Follow-up|2|||
46741913|NCT00879411|82959148|FG000|Overall Study|lost to follow-up (non-AE)|162|||
46741914|NCT01000493|82959154|FG000|Overall Study|Adverse Event|3|||
46741915|NCT01000493|82959155|FG001|Overall Study|Adverse Event|6|||
46741916|NCT01000493|82959154|FG000|Overall Study|Lack of Efficacy|1|||
46741917|NCT01000493|82959155|FG001|Overall Study|Lack of Efficacy|1|||
47050668|NCT01569074|83311440|FG000|Overall Study|eg change in circumstances|0|||
46741918|NCT01000493|82959154|FG000|Overall Study|Protocol Violation|1|||
46741919|NCT01000493|82959155|FG001|Overall Study|Protocol Violation|8|||
46741920|NCT01000493|82959154|FG000|Overall Study|Study closed/terminated|25|||
46741921|NCT01000493|82959155|FG001|Overall Study|Study closed/terminated|23|||
46741922|NCT01000493|82959154|FG000|Overall Study|Lost to Follow-up|5|||
46741923|NCT01000493|82959155|FG001|Overall Study|Lost to Follow-up|9|||
46741924|NCT01000493|82959154|FG000|Overall Study|Physician Decision|1|||
46741925|NCT01000493|82959155|FG001|Overall Study|Physician Decision|1|||
46741926|NCT01000493|82959154|FG000|Overall Study|Withdrawal by Subject|3|||
46741927|NCT01000493|82959155|FG001|Overall Study|Withdrawal by Subject|7|||
46741928|NCT00666757|82959163|FG000|Overall Study|Lost to Follow-up|39|||
46741929|NCT00666757|82959164|FG001|Overall Study|Lost to Follow-up|35|||
46741930|NCT00666757|82959163|FG000|Overall Study|Protocol Violation|23|||
46741931|NCT00666757|82959164|FG001|Overall Study|Protocol Violation|24|||
46741932|NCT00666757|82959163|FG000|Overall Study|Adverse Event|22|||
46741933|NCT00666757|82959164|FG001|Overall Study|Adverse Event|12|||
46741934|NCT00666757|82959163|FG000|Overall Study|Withdrawal by Subject|13|||
46741935|NCT00666757|82959164|FG001|Overall Study|Withdrawal by Subject|17|||
46741936|NCT00666757|82959163|FG000|Overall Study|Lack of Efficacy|3|||
46741937|NCT00666757|82959164|FG001|Overall Study|Lack of Efficacy|6|||
46741938|NCT00666757|82959163|FG000|Overall Study|Physician Decision|0|||
46741939|NCT00666757|82959164|FG001|Overall Study|Physician Decision|2|||
46741940|NCT00666757|82959163|FG000|Overall Study|Sponsor decision|0|||
46741941|NCT00666757|82959164|FG001|Overall Study|Sponsor decision|1|||
46741942|NCT01000337|82959175|FG000|Overall Study|Lost to Follow-up|4|||
46741943|NCT01000337|82959176|FG001|Overall Study|Lost to Follow-up|3|||
46741944|NCT00666679|82959184|FG000|First Intervention|Lost to Follow-up|1|||
46741945|NCT00666679|82959185|FG001|First Intervention|Lost to Follow-up|0|||
46741946|NCT00666679|82959184|FG000|First Intervention|Protocol Violation|1|||
46741947|NCT00666679|82959185|FG001|First Intervention|Protocol Violation|0|||
46741948|NCT00666679|82959184|FG000|First Intervention|Withdrawal by Subject|1|||
46741949|NCT00666679|82959185|FG001|First Intervention|Withdrawal by Subject|0|||
46741950|NCT00666679|82959184|FG000|First Intervention|Randomized did not start treatment|1|||
46741951|NCT00666679|82959185|FG001|First Intervention|Randomized did not start treatment|1|||
46741952|NCT00666679|82959184|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
46741953|NCT00666679|82959185|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
46741954|NCT00666679|82959184|FG000|Washout Period of 1 Week|Protocol Violation|0|||
46741955|NCT00666679|82959185|FG001|Washout Period of 1 Week|Protocol Violation|1|||
46741956|NCT00666679|82959184|FG000|Second Intervention|Adverse Event|1|||
46741957|NCT00666679|82959185|FG001|Second Intervention|Adverse Event|0|||
46741958|NCT00666679|82959184|FG000|Second Intervention|Death|0|||
46741959|NCT00666679|82959185|FG001|Second Intervention|Death|1|||
46741960|NCT00595413|82959195|FG000|Overall Study|Adverse Event|0|||
46741961|NCT00595413|82959196|FG001|Overall Study|Adverse Event|2|||
46741962|NCT00595413|82959197|FG002|Overall Study|Adverse Event|1|||
46741963|NCT00595413|82959198|FG003|Overall Study|Adverse Event|1|||
46741964|NCT00595413|82959195|FG000|Overall Study|Lost to Follow-up|2|||
46741965|NCT00595413|82959196|FG001|Overall Study|Lost to Follow-up|2|||
46741966|NCT00595413|82959197|FG002|Overall Study|Lost to Follow-up|1|||
46741967|NCT00595413|82959198|FG003|Overall Study|Lost to Follow-up|3|||
46741968|NCT00595413|82959195|FG000|Overall Study|Death|0|||
46741969|NCT00595413|82959196|FG001|Overall Study|Death|0|||
46741970|NCT00595413|82959197|FG002|Overall Study|Death|1|||
46741971|NCT00595413|82959198|FG003|Overall Study|Death|0|||
46741972|NCT00595413|82959195|FG000|Overall Study|Other|5|||
47050669|NCT01569074|83311441|FG001|Overall Study|eg change in circumstances|2|||
47050670|NCT01569074|83311442|FG002|Overall Study|eg change in circumstances|0|||
47050671|NCT01569074|83311443|FG003|Overall Study|eg change in circumstances|1|||
47050672|NCT01569074|83311444|FG004|Overall Study|eg change in circumstances|1|||
47050673|NCT01569074|83311440|FG000|Overall Study|Adverse Event|1|||
47050674|NCT01569074|83311441|FG001|Overall Study|Adverse Event|0|||
47050675|NCT01569074|83311442|FG002|Overall Study|Adverse Event|3|||
47050676|NCT01569074|83311443|FG003|Overall Study|Adverse Event|0|||
47050677|NCT01569074|83311444|FG004|Overall Study|Adverse Event|0|||
47050678|NCT01604408|83311462|FG000|Treatment Period 1|Protocol Violation|0|||
47050679|NCT01604408|83311463|FG001|Treatment Period 1|Protocol Violation|1|||
47050680|NCT01604408|83311462|FG000|Treatment Period 2|Withdrawal by Subject|1|||
47050681|NCT01604408|83311463|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46741973|NCT00595413|82959196|FG001|Overall Study|Other|1|||
46741974|NCT00595413|82959197|FG002|Overall Study|Other|5|||
46741975|NCT00595413|82959198|FG003|Overall Study|Other|0|||
46741976|NCT01000025|82959210|FG000|Overall Study|Adverse Event|43|||
46741977|NCT01000025|82959211|FG001|Overall Study|Adverse Event|2|||
46741978|NCT01000025|82959210|FG000|Overall Study|Withdrawal by Subject|13|||
46741979|NCT01000025|82959211|FG001|Overall Study|Withdrawal by Subject|8|||
46741980|NCT01000025|82959210|FG000|Overall Study|Death|23|||
46741981|NCT01000025|82959211|FG001|Overall Study|Death|13|||
46741982|NCT01000025|82959210|FG000|Overall Study|Lack of Efficacy|363|||
46741983|NCT01000025|82959211|FG001|Overall Study|Lack of Efficacy|208|||
46741984|NCT01000025|82959210|FG000|Overall Study|Intercurrent Illness|26|||
46741985|NCT01000025|82959211|FG001|Overall Study|Intercurrent Illness|7|||
47050682|NCT01604408|83311462|FG000|Treatment Period 2|Protocol Violation|1|||
47050683|NCT01604408|83311463|FG001|Treatment Period 2|Protocol Violation|0|||
46741986|NCT00595335|82959219|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
46741987|NCT00595335|82959220|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
46741988|NCT00595335|82959219|FG000|Baseline to Six Months|Disease Progression|1|||
46741989|NCT00595335|82959220|FG001|Baseline to Six Months|Disease Progression|1|||
46741990|NCT00595335|82959219|FG000|Baseline to Six Months|Adverse Event|1|||
46741991|NCT00595335|82959220|FG001|Baseline to Six Months|Adverse Event|0|||
46741992|NCT00595335|82959219|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
46741993|NCT00595335|82959220|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
46741994|NCT00595335|82959219|FG000|Six Months to Twelve Months|Disease Progression|1|||
46741995|NCT00595335|82959220|FG001|Six Months to Twelve Months|Disease Progression|0|||
46741996|NCT00661609|82959230|FG000|Overall Study|Adverse Event|4|||
46741997|NCT00661609|82959230|FG000|Overall Study|Death|20|||
46741998|NCT00661609|82959230|FG000|Overall Study|Withdrawal by Subject|2|||
46741999|NCT00661609|82959230|FG000|Overall Study|PI Decision|1|||
46742000|NCT00661609|82959230|FG000|Overall Study|Survival follow up stage discontinued|11|||
46742001|NCT00661609|82959230|FG000|Overall Study|Disease progression|3|||
46742002|NCT00661531|82959234|FG000|Overall Study|Withdrawal by Subject|3|||
46742003|NCT00998309|82959238|FG000|Overall Study|Protocol Violation|4|||
46742004|NCT00999713|82959292|FG000|Overall Study|Physician Decision|2|||
46742005|NCT00999713|82959293|FG001|Overall Study|Physician Decision|0|||
46742006|NCT00997373|82959301|FG000|Overall Study|Withdrawal by Subject|5|||
46742007|NCT00997373|82959302|FG001|Overall Study|Withdrawal by Subject|0|||
46742008|NCT00997373|82959301|FG000|Overall Study|wrong tumor type|4|||
46742009|NCT00997373|82959302|FG001|Overall Study|wrong tumor type|0|||
46742010|NCT00997373|82959301|FG000|Overall Study|could not have hysterectomy|6|||
46742011|NCT00997373|82959302|FG001|Overall Study|could not have hysterectomy|0|||
46742012|NCT00663871|82959310|FG000|Overall Study|Lost to Follow-up|5|||
46742013|NCT00663871|82959311|FG001|Overall Study|Lost to Follow-up|5|||
46742014|NCT00663871|82959310|FG000|Overall Study|Withdrawal by Subject|5|||
46742015|NCT00663871|82959311|FG001|Overall Study|Withdrawal by Subject|2|||
46742016|NCT04152447|82959321|FG000|Overall Study|Lost to Follow-up|1|||
46742017|NCT04152447|82959322|FG001|Overall Study|Lost to Follow-up|0|||
46742018|NCT04152447|82959321|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
46742019|NCT04152447|82959322|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
46742020|NCT04152447|82959321|FG000|Overall Study|Withdrawal by Subject|0|||
46742021|NCT04152447|82959322|FG001|Overall Study|Withdrawal by Subject|1|||
46742022|NCT04152447|82959321|FG000|Overall Study|Found ineligible after enrolling|1|||
46742023|NCT04152447|82959322|FG001|Overall Study|Found ineligible after enrolling|1|||
46742024|NCT04152447|82959321|FG000|Overall Study|Did not receive VR headset in time.|0|||
46742025|NCT04152447|82959322|FG001|Overall Study|Did not receive VR headset in time.|2|||
46742026|NCT00996593|82959328|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
46742027|NCT00996593|82959328|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
46742028|NCT00996593|82959328|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
46742029|NCT00996593|82959328|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
46742030|NCT00996593|82959328|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
46742031|NCT00996593|82959328|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
46742032|NCT00996593|82959328|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
46742033|NCT00996593|82959328|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
46742034|NCT00996593|82959328|FG000|Long-Term Follow-Up|Site Closed|1|||
46742035|NCT00570661|82959332|FG000|Overall Study|Disease worsening|5|||
46742036|NCT00570661|82959332|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
46742037|NCT00570661|82959332|FG000|Overall Study|Adverse Event|1|||
46742038|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
46742039|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
46742040|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
46742041|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
46742042|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
46742043|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
46742044|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
46742045|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
46742046|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
46742047|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
46742048|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
46742049|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
46742050|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
46742051|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
46742052|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
46742053|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
46742054|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
46742055|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
46742056|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
46742057|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
46742058|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
46742059|NCT00934544|82959339|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
46742060|NCT00934544|82959340|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
46742061|NCT00934544|82959341|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
46742062|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
46742063|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
46742064|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
46742065|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
46742066|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
46742067|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
46742068|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
46742069|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
46742070|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
46742071|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
46742072|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
46742073|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
46742074|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
46922249|NCT02880371|83155019|FG006|Phase 2|End of Study page not completed by error|0|||
46922250|NCT02880371|83155020|FG007|Phase 2|End of Study page not completed by error|0|||
46922251|NCT02837029|83155043|FG000|Screening|Failed to meet screening requirements.|7|||
46922252|NCT02837029|83155044|FG001|Screening|Failed to meet screening requirements.|3|||
46742075|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
46742076|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
46742077|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
46742078|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
46742079|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
46742080|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
46742081|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
46742082|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
46742083|NCT00934544|82959339|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
46742084|NCT00934544|82959340|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
46742085|NCT00934544|82959341|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
46742086|NCT00999167|82959360|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
46742087|NCT00999167|82959361|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
46742088|NCT00999167|82959362|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
46742089|NCT00999167|82959360|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
46742090|NCT00999167|82959361|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
46742091|NCT00999167|82959362|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
46742092|NCT00999167|82959360|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
46742093|NCT00999167|82959361|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
46742094|NCT00999167|82959362|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
46742095|NCT00999167|82959360|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
46742096|NCT00999167|82959361|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
46742097|NCT00999167|82959362|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
46742098|NCT00999167|82959360|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
46742099|NCT00999167|82959361|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
46742100|NCT00999167|82959362|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
46742101|NCT00999167|82959360|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
46742102|NCT00999167|82959361|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
46742103|NCT00999167|82959362|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
46742104|NCT00999167|82959360|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
46742105|NCT00999167|82959361|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
46742106|NCT00999167|82959362|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
46742107|NCT00999167|82959360|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
46742108|NCT00999167|82959361|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
46775740|NCT00793793|82994209|FG005|Overall Study|Protocol Violation|0|||
46922253|NCT02837029|83155045|FG002|Screening|Failed to meet screening requirements.|0|||
46922254|NCT02837029|83155043|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
46922255|NCT02837029|83155044|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
46922256|NCT02837029|83155045|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
46922257|NCT02837029|83155043|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
46742109|NCT00999167|82959362|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
46742110|NCT00570505|82959372|FG000|Overall Study|Adverse Event|7|||
46742111|NCT00570505|82959372|FG000|Overall Study|Withdrawal by Subject|7|||
46742112|NCT00570505|82959372|FG000|Overall Study|Lost to Follow-up|23|||
46742113|NCT00570505|82959372|FG000|Overall Study|Other loss to follow-up|4|||
46742114|NCT00931892|82959378|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
46742115|NCT00931892|82959379|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
46742116|NCT00666211|82959427|FG000|Overall Study|Withdrawal by Subject|10|||
46742117|NCT00666211|82959428|FG001|Overall Study|Withdrawal by Subject|13|||
46742118|NCT00666211|82959427|FG000|Overall Study|went off medication, no more pain|1|||
46742119|NCT00666211|82959428|FG001|Overall Study|went off medication, no more pain|0|||
46742120|NCT00666211|82959427|FG000|Overall Study|patient non-compliant|6|||
46742121|NCT00666211|82959428|FG001|Overall Study|patient non-compliant|6|||
46742122|NCT00666211|82959427|FG000|Overall Study|disease progression|1|||
46742123|NCT00666211|82959428|FG001|Overall Study|disease progression|8|||
46742124|NCT00666211|82959427|FG000|Overall Study|Lost to Follow-up|2|||
46742125|NCT00666211|82959428|FG001|Overall Study|Lost to Follow-up|0|||
46742126|NCT00666211|82959427|FG000|Overall Study|toxicity|0|||
46742127|NCT00666211|82959428|FG001|Overall Study|toxicity|2|||
46742128|NCT00666211|82959427|FG000|Overall Study|hospital admission|0|||
46742129|NCT00666211|82959428|FG001|Overall Study|hospital admission|5|||
46742130|NCT00666211|82959427|FG000|Overall Study|Death|0|||
46742131|NCT00666211|82959428|FG001|Overall Study|Death|2|||
46742132|NCT00666211|82959427|FG000|Overall Study|off tx for other complicating disease|0|||
46742133|NCT00666211|82959428|FG001|Overall Study|off tx for other complicating disease|1|||
46742134|NCT00666211|82959427|FG000|Overall Study|Physician Decision|0|||
46742135|NCT00666211|82959428|FG001|Overall Study|Physician Decision|1|||
46742136|NCT00878709|82959436|FG000|Overall Study|Withdrawal by Subject|197|||
47050684|NCT01604408|83311462|FG000|Treatment Period 2|Adverse Event|0|||
47050685|NCT01604408|83311463|FG001|Treatment Period 2|Adverse Event|1|||
47050686|NCT01604408|83311462|FG000|Treatment Period 3|Protocol Violation|1|||
47050687|NCT01604408|83311463|FG001|Treatment Period 3|Protocol Violation|1|||
47050688|NCT01604408|83311462|FG000|Treatment Period 3|Adverse Event|0|||
47050689|NCT01604408|83311463|FG001|Treatment Period 3|Adverse Event|3|||
47050690|NCT01604408|83311462|FG000|Treatment Period 3|Withdrawal by Subject|3|||
47050691|NCT01604408|83311463|FG001|Treatment Period 3|Withdrawal by Subject|1|||
47050692|NCT01604408|83311462|FG000|Treatment Period 3|Sponsor Decision|1|||
47050693|NCT01604408|83311463|FG001|Treatment Period 3|Sponsor Decision|0|||
47050694|NCT01604408|83311462|FG000|Treatment Period 4|Death|1|||
47050695|NCT01604408|83311463|FG001|Treatment Period 4|Death|0|||
47050696|NCT01604408|83311462|FG000|Treatment Period 4|Withdrawal by Subject|2|||
47050697|NCT01604408|83311463|FG001|Treatment Period 4|Withdrawal by Subject|1|||
46742137|NCT00878709|82959437|FG001|Overall Study|Withdrawal by Subject|120|||
47050698|NCT01604408|83311462|FG000|Treatment Period 4|Adverse Event|0|||
47050699|NCT01604408|83311463|FG001|Treatment Period 4|Adverse Event|1|||
47050700|NCT01604408|83311462|FG000|Treatment Period 5|Adverse Event|4|||
46742138|NCT00878709|82959436|FG000|Overall Study|Lost to Follow-up|35|||
46742139|NCT00878709|82959437|FG001|Overall Study|Lost to Follow-up|33|||
46742140|NCT00878709|82959436|FG000|Overall Study|Other Reasons|93|||
46742141|NCT00878709|82959437|FG001|Overall Study|Other Reasons|84|||
46742142|NCT00927758|82959444|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
46742143|NCT00927758|82959445|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
46804133|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
46804134|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
47050701|NCT01604408|83311463|FG001|Treatment Period 5|Adverse Event|0|||
47050702|NCT01604408|83311462|FG000|Treatment Period 6|Lost to Follow-up|0|||
47050703|NCT01604408|83311463|FG001|Treatment Period 6|Lost to Follow-up|1|||
47050704|NCT01604408|83311462|FG000|Treatment Period 6|Adverse Event|2|||
47050705|NCT01604408|83311463|FG001|Treatment Period 6|Adverse Event|0|||
46742144|NCT00927758|82959446|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
46742145|NCT00927758|82959447|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
46742146|NCT00927758|82959448|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
46742147|NCT00927758|82959449|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
46742148|NCT00927758|82959444|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
46742149|NCT00927758|82959445|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
46742150|NCT00927758|82959446|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
46742151|NCT00927758|82959447|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
46742152|NCT00927758|82959448|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
46742153|NCT00927758|82959449|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
46742154|NCT00927368|82959460|FG000|Overall Study|enrollment in another study|1|||
47050706|NCT01604408|83311462|FG000|Treatment Period 6|Sponsor decision|0|||
46742155|NCT00927368|82959461|FG001|Overall Study|enrollment in another study|1|||
46742156|NCT00927368|82959462|FG002|Overall Study|enrollment in another study|2|||
46742157|NCT00927368|82959460|FG000|Overall Study|Lost to Follow-up|4|||
46742158|NCT00927368|82959461|FG001|Overall Study|Lost to Follow-up|0|||
46742159|NCT00927368|82959462|FG002|Overall Study|Lost to Follow-up|0|||
46742160|NCT00927368|82959460|FG000|Overall Study|equipment failure|1|||
46742161|NCT00927368|82959461|FG001|Overall Study|equipment failure|0|||
46742162|NCT00927368|82959462|FG002|Overall Study|equipment failure|0|||
46742163|NCT00927368|82959460|FG000|Overall Study|ineligible post randomization|0|||
46742164|NCT00927368|82959461|FG001|Overall Study|ineligible post randomization|3|||
46742165|NCT00927368|82959462|FG002|Overall Study|ineligible post randomization|1|||
46742166|NCT00927368|82959460|FG000|Overall Study|cancellation of surgery|0|||
46742167|NCT00927368|82959461|FG001|Overall Study|cancellation of surgery|1|||
46742168|NCT00927368|82959462|FG002|Overall Study|cancellation of surgery|2|||
46742169|NCT00662857|82959470|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
46742170|NCT00662857|82959471|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
46742171|NCT00662857|82959470|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
46742172|NCT00662857|82959471|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
46742173|NCT00662857|82959470|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
46742174|NCT00662857|82959471|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
46742175|NCT00878553|82959484|FG000|Sleep Study|Withdrawal by Subject|2|||
46742176|NCT00878553|82959485|FG001|Sleep Study|Withdrawal by Subject|0|||
46742177|NCT00878553|82959486|FG002|Sleep Study|Withdrawal by Subject|0|||
46742178|NCT00878553|82959487|FG003|Sleep Study|Withdrawal by Subject|0|||
46742179|NCT00878553|82959488|FG004|Sleep Study|Withdrawal by Subject|0|||
46742180|NCT00878553|82959484|FG000|Sleep Study|Lost to Follow-up|1|||
46742181|NCT00878553|82959485|FG001|Sleep Study|Lost to Follow-up|0|||
46742182|NCT00878553|82959486|FG002|Sleep Study|Lost to Follow-up|0|||
46742183|NCT00878553|82959487|FG003|Sleep Study|Lost to Follow-up|0|||
46742184|NCT00878553|82959488|FG004|Sleep Study|Lost to Follow-up|0|||
46742185|NCT00878553|82959484|FG000|Sleep Study|car accident|1|||
46742186|NCT00878553|82959485|FG001|Sleep Study|car accident|0|||
46742187|NCT00878553|82959486|FG002|Sleep Study|car accident|0|||
46742188|NCT00878553|82959487|FG003|Sleep Study|car accident|0|||
46742189|NCT00878553|82959488|FG004|Sleep Study|car accident|0|||
46742190|NCT00878553|82959484|FG000|Sleep Study|family emergency|1|||
46742191|NCT00878553|82959485|FG001|Sleep Study|family emergency|0|||
46742192|NCT00878553|82959486|FG002|Sleep Study|family emergency|0|||
46742193|NCT00878553|82959487|FG003|Sleep Study|family emergency|0|||
46742194|NCT00878553|82959488|FG004|Sleep Study|family emergency|0|||
46742195|NCT00878553|82959484|FG000|PK Study|Withdrawal by Subject|0|||
47050707|NCT01604408|83311463|FG001|Treatment Period 6|Sponsor decision|1|||
47050708|NCT01604408|83311462|FG000|Observation Period|Adverse Event|1|||
47050709|NCT01604408|83311463|FG001|Observation Period|Adverse Event|1|||
46742196|NCT00878553|82959485|FG001|PK Study|Withdrawal by Subject|0|||
46742197|NCT00878553|82959486|FG002|PK Study|Withdrawal by Subject|0|||
46742198|NCT00878553|82959487|FG003|PK Study|Withdrawal by Subject|1|||
46742199|NCT00878553|82959488|FG004|PK Study|Withdrawal by Subject|0|||
46742200|NCT00996437|82959507|FG000|Overall Study|Death|1|||
46742201|NCT00996437|82959508|FG001|Overall Study|Death|0|||
46742202|NCT00996437|82959507|FG000|Overall Study|Dropped|2|||
46742203|NCT00996437|82959508|FG001|Overall Study|Dropped|2|||
47050710|NCT01604408|83311462|FG000|Observation Period|Withdrawal by Subject|0|||
47050711|NCT01604408|83311463|FG001|Observation Period|Withdrawal by Subject|2|||
47050712|NCT01567826|83311471|FG000|Overall Study|Lost to Follow-up|3|||
47050713|NCT01567826|83311472|FG001|Overall Study|Lost to Follow-up|2|||
47050714|NCT01697462|83311480|FG000|Overall Study|Disease Progression|1|||
47050715|NCT01697462|83311480|FG000|Overall Study|Adverse Event|6|||
47050716|NCT01697462|83311480|FG000|Overall Study|Lost to Follow-up|21|||
46635405|NCT01537068|82809032|FG001|Overall Study|Withdrawal by Subject|1|||
46635406|NCT01537068|82809031|FG000|Overall Study|Lack of Efficacy|1|||
46742204|NCT00996437|82959507|FG000|Overall Study|Missed|2|||
46742205|NCT00996437|82959508|FG001|Overall Study|Missed|5|||
46742206|NCT00662311|82959517|FG000|Overall Study|Respiratory Infection|1|||
46742207|NCT00662311|82959518|FG001|Overall Study|Respiratory Infection|0|||
46742208|NCT00662311|82959519|FG002|Overall Study|Respiratory Infection|0|||
46742209|NCT00929708|82959532|FG000|Overall Study|Protocol Violation|2|||
46742210|NCT00929708|82959533|FG001|Overall Study|Protocol Violation|1|||
47050717|NCT01697462|83311480|FG000|Overall Study|Withdrawal by Subject|12|||
47050718|NCT01697462|83311480|FG000|Overall Study|Investigator Decision|21|||
47050719|NCT01697462|83311480|FG000|Overall Study|Death|1|||
46742211|NCT00929708|82959534|FG002|Overall Study|Protocol Violation|1|||
46742212|NCT00929708|82959535|FG003|Overall Study|Protocol Violation|1|||
46742213|NCT00929708|82959536|FG004|Overall Study|Protocol Violation|1|||
46742214|NCT00929708|82959532|FG000|Overall Study|Withdrawal by Subject|2|||
46742215|NCT00929708|82959533|FG001|Overall Study|Withdrawal by Subject|0|||
46742216|NCT00929708|82959534|FG002|Overall Study|Withdrawal by Subject|0|||
46742217|NCT00929708|82959535|FG003|Overall Study|Withdrawal by Subject|2|||
46775741|NCT00793793|82994210|FG006|Overall Study|Protocol Violation|0|||
47050720|NCT01697462|83311480|FG000|Overall Study|Other|10|||
47050721|NCT01697462|83311480|FG000|Overall Study|Missing|5|||
47050722|NCT01592240|83311636|FG000|Overall Study|Adverse Event|1|||
47050723|NCT01592240|83311637|FG001|Overall Study|Adverse Event|0|||
47050724|NCT01592240|83311638|FG002|Overall Study|Adverse Event|0|||
47050725|NCT01592240|83311639|FG003|Overall Study|Adverse Event|1|||
47050726|NCT01592240|83311640|FG004|Overall Study|Adverse Event|1|||
47050727|NCT01592240|83311641|FG005|Overall Study|Adverse Event|0|||
47050728|NCT01592240|83311642|FG006|Overall Study|Adverse Event|0|||
47050729|NCT01592240|83311636|FG000|Overall Study|Death|0|||
47050730|NCT01592240|83311637|FG001|Overall Study|Death|1|||
47050731|NCT01592240|83311638|FG002|Overall Study|Death|0|||
47050732|NCT01592240|83311639|FG003|Overall Study|Death|0|||
47050733|NCT01592240|83311640|FG004|Overall Study|Death|0|||
47050734|NCT01592240|83311641|FG005|Overall Study|Death|0|||
47050735|NCT01592240|83311642|FG006|Overall Study|Death|0|||
47050736|NCT01592240|83311636|FG000|Overall Study|Lost to Follow-up|1|||
47050737|NCT01592240|83311637|FG001|Overall Study|Lost to Follow-up|3|||
47050738|NCT01592240|83311638|FG002|Overall Study|Lost to Follow-up|1|||
47050739|NCT01592240|83311639|FG003|Overall Study|Lost to Follow-up|0|||
47050740|NCT01592240|83311640|FG004|Overall Study|Lost to Follow-up|3|||
47050741|NCT01592240|83311641|FG005|Overall Study|Lost to Follow-up|2|||
47050742|NCT01592240|83311642|FG006|Overall Study|Lost to Follow-up|0|||
47050743|NCT01592240|83311636|FG000|Overall Study|Protocol Violation|0|||
46742218|NCT00929708|82959536|FG004|Overall Study|Withdrawal by Subject|1|||
46742219|NCT00929708|82959532|FG000|Overall Study|Adverse Event|0|||
46742220|NCT00929708|82959533|FG001|Overall Study|Adverse Event|0|||
46742221|NCT00929708|82959534|FG002|Overall Study|Adverse Event|0|||
46742222|NCT00929708|82959535|FG003|Overall Study|Adverse Event|0|||
47050744|NCT01592240|83311637|FG001|Overall Study|Protocol Violation|0|||
47050745|NCT01592240|83311638|FG002|Overall Study|Protocol Violation|0|||
47050746|NCT01592240|83311639|FG003|Overall Study|Protocol Violation|0|||
47050747|NCT01592240|83311640|FG004|Overall Study|Protocol Violation|0|||
47050748|NCT01592240|83311641|FG005|Overall Study|Protocol Violation|1|||
47050749|NCT01592240|83311642|FG006|Overall Study|Protocol Violation|0|||
46635407|NCT01537068|82809032|FG001|Overall Study|Lack of Efficacy|0|||
46635408|NCT01585428|82809040|FG000|Overall Study|Death during treatment|1|||
46742223|NCT00929708|82959536|FG004|Overall Study|Adverse Event|3|||
46742224|NCT00929708|82959532|FG000|Overall Study|Physician Decision|0|||
46742225|NCT00929708|82959533|FG001|Overall Study|Physician Decision|2|||
46742226|NCT00929708|82959534|FG002|Overall Study|Physician Decision|2|||
46742227|NCT00929708|82959535|FG003|Overall Study|Physician Decision|2|||
46742228|NCT00929708|82959536|FG004|Overall Study|Physician Decision|1|||
46742229|NCT00929708|82959532|FG000|Overall Study|Lost to Follow-up|0|||
46742230|NCT00929708|82959533|FG001|Overall Study|Lost to Follow-up|0|||
46742231|NCT00929708|82959534|FG002|Overall Study|Lost to Follow-up|0|||
46742232|NCT00929708|82959535|FG003|Overall Study|Lost to Follow-up|1|||
46742233|NCT00929708|82959536|FG004|Overall Study|Lost to Follow-up|0|||
46742234|NCT00996281|82959550|FG000|Overall Study|Adverse Event|75|||
46742235|NCT00996281|82959551|FG001|Overall Study|Adverse Event|37|||
46742236|NCT00996281|82959550|FG000|Overall Study|Major Protocol Deviation|6|||
46742237|NCT00996281|82959551|FG001|Overall Study|Major Protocol Deviation|7|||
46742238|NCT00996281|82959550|FG000|Overall Study|Lost to Follow-up|14|||
46742239|NCT00996281|82959551|FG001|Overall Study|Lost to Follow-up|16|||
46742240|NCT00996281|82959550|FG000|Overall Study|Withdrawal by Subject|31|||
46742241|NCT00996281|82959551|FG001|Overall Study|Withdrawal by Subject|20|||
46742242|NCT00996281|82959550|FG000|Overall Study|Lack of Efficacy|0|||
46742243|NCT00996281|82959551|FG001|Overall Study|Lack of Efficacy|2|||
46742244|NCT00996281|82959550|FG000|Overall Study|Other|5|||
46742245|NCT00996281|82959551|FG001|Overall Study|Other|7|||
46742246|NCT00996203|82959557|FG000|Overall Study|Adverse Event|3|||
47050750|NCT01592240|83311636|FG000|Overall Study|Withdrawal by Subject|0|||
47050751|NCT01592240|83311637|FG001|Overall Study|Withdrawal by Subject|4|||
47050752|NCT01592240|83311638|FG002|Overall Study|Withdrawal by Subject|4|||
47050753|NCT01592240|83311639|FG003|Overall Study|Withdrawal by Subject|1|||
47050754|NCT01592240|83311640|FG004|Overall Study|Withdrawal by Subject|3|||
46635409|NCT01585428|82809041|FG001|Overall Study|Death during treatment|0|||
46635410|NCT01585272|82809048|FG000|Overall Study|Adverse Event|22|||
47050755|NCT01592240|83311641|FG005|Overall Study|Withdrawal by Subject|0|||
47050756|NCT01592240|83311642|FG006|Overall Study|Withdrawal by Subject|2|||
47050757|NCT01592240|83311636|FG000|Overall Study|Other|0|||
47050758|NCT01592240|83311637|FG001|Overall Study|Other|3|||
46635411|NCT01585272|82809048|FG000|Overall Study|Protocol Violation|7|||
46742247|NCT00996203|82959557|FG000|Overall Study|Lost to Follow-up|1|||
46742248|NCT00996203|82959557|FG000|Overall Study|Lack of Efficacy|1|||
46742249|NCT00996203|82959557|FG000|Overall Study|Protocol Violation|2|||
46742250|NCT00877929|82959564|FG000|Overall Study|Adverse Event|11|||
46742251|NCT00877929|82959565|FG001|Overall Study|Adverse Event|20|||
46742252|NCT00877929|82959564|FG000|Overall Study|Protocol Violation|3|||
46742253|NCT00877929|82959565|FG001|Overall Study|Protocol Violation|3|||
47050759|NCT01592240|83311638|FG002|Overall Study|Other|1|||
46742254|NCT00877929|82959564|FG000|Overall Study|Lost to Follow-up|0|||
46742255|NCT00877929|82959565|FG001|Overall Study|Lost to Follow-up|1|||
46742256|NCT00877929|82959564|FG000|Overall Study|Withdrawal by Subject|4|||
46742257|NCT00877929|82959565|FG001|Overall Study|Withdrawal by Subject|4|||
46742258|NCT00877929|82959564|FG000|Overall Study|Lack of Efficacy|0|||
46742259|NCT00877929|82959565|FG001|Overall Study|Lack of Efficacy|1|||
46742260|NCT00877929|82959564|FG000|Overall Study|Other reason (not specified)|2|||
46742261|NCT00877929|82959565|FG001|Overall Study|Other reason (not specified)|6|||
46742262|NCT00931268|82959575|FG000|Overall Study|Lost to Follow-up|6|||
46742263|NCT00996125|82959581|FG000|Overall Study|Adverse Event|0|||
46742264|NCT00996125|82959582|FG001|Overall Study|Adverse Event|2|||
46742265|NCT00996125|82959581|FG000|Overall Study|Lost to Follow-up|1|||
46742266|NCT00996125|82959582|FG001|Overall Study|Lost to Follow-up|6|||
46742267|NCT00996125|82959581|FG000|Overall Study|Withdrawal by Subject|4|||
46742268|NCT00996125|82959582|FG001|Overall Study|Withdrawal by Subject|3|||
46742269|NCT04211363|82959590|FG000|Overall Study|Adverse Event|5|||
46742270|NCT04211363|82959591|FG001|Overall Study|Adverse Event|2|||
46742271|NCT04211363|82959590|FG000|Overall Study|Physician Decision|0|||
46742272|NCT04211363|82959591|FG001|Overall Study|Physician Decision|1|||
46742273|NCT04211363|82959590|FG000|Overall Study|Protocol Violation|1|||
46742274|NCT04211363|82959591|FG001|Overall Study|Protocol Violation|0|||
46742275|NCT04211363|82959590|FG000|Overall Study|Pregnancy|1|||
46742276|NCT04211363|82959591|FG001|Overall Study|Pregnancy|0|||
46742277|NCT04211363|82959590|FG000|Overall Study|Lost to Follow-up|12|||
46742278|NCT04211363|82959591|FG001|Overall Study|Lost to Follow-up|4|||
46742279|NCT04211363|82959590|FG000|Overall Study|Withdrawal by Subject|11|||
46742280|NCT04211363|82959591|FG001|Overall Study|Withdrawal by Subject|11|||
46742281|NCT04211363|82959590|FG000|Overall Study|Other|1|||
46742282|NCT04211363|82959591|FG001|Overall Study|Other|2|||
46742283|NCT00995345|82959602|FG000|Overall Study|Withdrawal by Subject|4|||
46742284|NCT00995345|82959603|FG001|Overall Study|Withdrawal by Subject|2|||
46742285|NCT00995345|82959604|FG002|Overall Study|Withdrawal by Subject|1|||
47050760|NCT01592240|83311639|FG003|Overall Study|Other|1|||
47050761|NCT01592240|83311640|FG004|Overall Study|Other|0|||
47050762|NCT01592240|83311641|FG005|Overall Study|Other|0|||
47050763|NCT01592240|83311642|FG006|Overall Study|Other|1|||
47050764|NCT01592240|83311636|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
47050765|NCT01592240|83311637|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
47050766|NCT01592240|83311638|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
47050767|NCT01592240|83311639|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
47050768|NCT01592240|83311640|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
47050769|NCT01592240|83311641|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
47050770|NCT01592240|83311642|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
47050771|NCT01591616|83311685|FG000|Overall Study|Withdrawal by Subject|1|||
47050772|NCT01591460|83311841|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
47050773|NCT01591460|83311841|FG000|Overall Study|Futility Rule (Week 12)|7|||
47050774|NCT01591460|83311841|FG000|Overall Study|Futility Rule (Week 24)|3|||
47050775|NCT01591460|83311841|FG000|Overall Study|Rebound or Breakthrough|3|||
47050776|NCT01591460|83311841|FG000|Overall Study|Treatment Discontinued by Error|1|||
47050777|NCT01591460|83311841|FG000|Overall Study|Lost to Follow-up|1|||
47050778|NCT01591460|83311841|FG000|Overall Study|Noncompliance|1|||
47050779|NCT01591460|83311841|FG000|Overall Study|Participant Refusal|3|||
47050780|NCT01591460|83311841|FG000|Overall Study|Withdrawal by Subject|1|||
47050781|NCT01591460|83311841|FG000|Overall Study|Protocol Violation|1|||
47050782|NCT01591382|83311864|FG000|Overall Study|Discharged Prior to Study Completion|2|||
47050783|NCT01591382|83311865|FG001|Overall Study|Discharged Prior to Study Completion|1|||
47050784|NCT01591382|83311864|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
47050785|NCT01591382|83311865|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
47050786|NCT01696214|83311883|FG000|Overall Study|Lost to Follow-up|1|||
46635412|NCT01585272|82809048|FG000|Overall Study|Withdrawal by Subject|10|||
46635413|NCT01560780|82809054|FG000|Overall Study|Death|2|||
47050787|NCT01696214|83311884|FG001|Overall Study|Lost to Follow-up|0|||
47050788|NCT01696214|83311885|FG002|Overall Study|Lost to Follow-up|0|||
47050789|NCT01696214|83311886|FG003|Overall Study|Lost to Follow-up|0|||
47050790|NCT01543087|83311919|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
47050791|NCT01543087|83311920|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
47050792|NCT01543087|83311921|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
46742286|NCT00995345|82959605|FG003|Overall Study|Withdrawal by Subject|3|||
46742287|NCT00995345|82959606|FG004|Overall Study|Withdrawal by Subject|1|||
46742288|NCT00995345|82959602|FG000|Overall Study|Adverse Event|3|||
46742289|NCT00995345|82959603|FG001|Overall Study|Adverse Event|1|||
46742290|NCT00995345|82959604|FG002|Overall Study|Adverse Event|2|||
46742291|NCT00995345|82959605|FG003|Overall Study|Adverse Event|0|||
46742292|NCT00995345|82959606|FG004|Overall Study|Adverse Event|1|||
46742293|NCT00995345|82959602|FG000|Overall Study|Lost to Follow-up|2|||
46742294|NCT00995345|82959603|FG001|Overall Study|Lost to Follow-up|2|||
46742295|NCT00995345|82959604|FG002|Overall Study|Lost to Follow-up|2|||
47050793|NCT01543087|83311922|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
47050794|NCT01543087|83311923|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
47050795|NCT01543087|83311924|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
47050796|NCT01543087|83311919|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
47050797|NCT01543087|83311920|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
46742296|NCT00995345|82959605|FG003|Overall Study|Lost to Follow-up|1|||
46742297|NCT00995345|82959606|FG004|Overall Study|Lost to Follow-up|0|||
46742298|NCT00995345|82959602|FG000|Overall Study|all other reasons combined|2|||
46742299|NCT00995345|82959603|FG001|Overall Study|all other reasons combined|2|||
46742300|NCT00995345|82959604|FG002|Overall Study|all other reasons combined|2|||
46742301|NCT00995345|82959605|FG003|Overall Study|all other reasons combined|1|||
46742302|NCT00995345|82959606|FG004|Overall Study|all other reasons combined|3|||
46742303|NCT00660907|82959620|FG000|Overall Study|Incorrect Enrollment|1|||
46742304|NCT00660907|82959621|FG001|Overall Study|Incorrect Enrollment|1|||
46742305|NCT00660907|82959620|FG000|Overall Study|Adverse Event|33|||
46742306|NCT00660907|82959621|FG001|Overall Study|Adverse Event|19|||
46742307|NCT00660907|82959620|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
46742308|NCT00660907|82959621|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
46742309|NCT00660907|82959620|FG000|Overall Study|Withdrawal by Subject|23|||
46742310|NCT00660907|82959621|FG001|Overall Study|Withdrawal by Subject|32|||
46742311|NCT00660907|82959620|FG000|Overall Study|Lost to Follow-up|3|||
46742312|NCT00660907|82959621|FG001|Overall Study|Lost to Follow-up|3|||
46742313|NCT00660907|82959620|FG000|Overall Study|Poor/Non-Compliance|5|||
46742314|NCT00660907|82959621|FG001|Overall Study|Poor/Non-Compliance|1|||
46742315|NCT00660907|82959620|FG000|Overall Study|Safety|1|||
46742316|NCT00660907|82959621|FG001|Overall Study|Safety|0|||
46742317|NCT00660907|82959620|FG000|Overall Study|Death|1|||
46742318|NCT00660907|82959621|FG001|Overall Study|Death|3|||
46742319|NCT00660907|82959620|FG000|Overall Study|Various|11|||
46742320|NCT00660907|82959621|FG001|Overall Study|Various|8|||
46742321|NCT00877773|82959627|FG000|Overall Study|Disease Progression|44|||
46742322|NCT00659815|82959633|FG000|Overall Study|Study related symptoms and complaints|2|||
46742323|NCT00659815|82959634|FG001|Overall Study|Study related symptoms and complaints|1|||
46742324|NCT00659815|82959633|FG000|Overall Study|Inability to maintain wearing schedule|1|||
46742325|NCT00659815|82959634|FG001|Overall Study|Inability to maintain wearing schedule|2|||
46742326|NCT00659815|82959633|FG000|Overall Study|Withdrawal by Subject|1|||
46742327|NCT00659815|82959634|FG001|Overall Study|Withdrawal by Subject|1|||
46742328|NCT00994643|82959640|FG000|Overall Study|Withdrawal by Subject|1|||
46742329|NCT00660829|82959646|FG000|Overall Study|Adverse Event|3|||
46742330|NCT00660829|82959647|FG001|Overall Study|Adverse Event|4|||
46742331|NCT00660829|82959646|FG000|Overall Study|Lack of Efficacy|2|||
46742332|NCT00660829|82959647|FG001|Overall Study|Lack of Efficacy|3|||
46742333|NCT00660829|82959646|FG000|Overall Study|Non-Compliance|0|||
46742334|NCT00660829|82959647|FG001|Overall Study|Non-Compliance|4|||
46742335|NCT00660829|82959646|FG000|Overall Study|Withdrawal by Subject|1|||
46742336|NCT00660829|82959647|FG001|Overall Study|Withdrawal by Subject|2|||
46742337|NCT00660829|82959646|FG000|Overall Study|Lost to Follow-up|3|||
46742338|NCT00660829|82959647|FG001|Overall Study|Lost to Follow-up|2|||
46742339|NCT00660829|82959646|FG000|Overall Study|Other|9|||
46742340|NCT00660829|82959647|FG001|Overall Study|Other|4|||
46742341|NCT00877383|82959655|FG000|Overall Study|Adverse Event|13|||
46742342|NCT00877383|82959656|FG001|Overall Study|Adverse Event|14|||
46742343|NCT00877383|82959655|FG000|Overall Study|Lost to Follow-up|5|||
46742344|NCT00877383|82959656|FG001|Overall Study|Lost to Follow-up|3|||
46742345|NCT00877383|82959655|FG000|Overall Study|Subject withdrew consent|3|||
46922258|NCT02837029|83155044|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
46922259|NCT02837029|83155045|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
46922260|NCT02837029|83155043|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
46922261|NCT02837029|83155044|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
46922262|NCT02837029|83155045|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
46922263|NCT02837029|83155043|FG000|Cycle 2 and Beyond|Adverse Event|1|||
46635414|NCT01560780|82809055|FG001|Overall Study|Death|1|||
46742346|NCT00877383|82959656|FG001|Overall Study|Subject withdrew consent|12|||
46742347|NCT00877383|82959655|FG000|Overall Study|Subject no longer requires study drug|2|||
46742348|NCT00877383|82959656|FG001|Overall Study|Subject no longer requires study drug|0|||
46742349|NCT00877383|82959655|FG000|Overall Study|Administrative problems|2|||
46742350|NCT00877383|82959656|FG001|Overall Study|Administrative problems|0|||
46742351|NCT00877383|82959655|FG000|Overall Study|Protocol deviation|2|||
46742352|NCT00877383|82959656|FG001|Overall Study|Protocol deviation|6|||
46742353|NCT00877383|82959655|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46742354|NCT00877383|82959656|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46742355|NCT00877383|82959655|FG000|Overall Study|Death|1|||
46742356|NCT00877383|82959656|FG001|Overall Study|Death|2|||
46742357|NCT00993473|82959664|FG000|Overall Study|Adverse Event|0|||
46742358|NCT00993473|82959665|FG001|Overall Study|Adverse Event|2|||
46742359|NCT00993473|82959664|FG000|Overall Study|Protocol Violation|1|||
46742360|NCT00993473|82959665|FG001|Overall Study|Protocol Violation|2|||
46742361|NCT00993473|82959664|FG000|Overall Study|Lost to Follow-up|1|||
46742362|NCT00993473|82959665|FG001|Overall Study|Lost to Follow-up|0|||
46742363|NCT00993473|82959664|FG000|Overall Study|Withdrawal by Subject|1|||
46742364|NCT00993473|82959665|FG001|Overall Study|Withdrawal by Subject|5|||
46742365|NCT00993473|82959664|FG000|Overall Study|Technical problem with CGM device|0|||
46742366|NCT00993473|82959665|FG001|Overall Study|Technical problem with CGM device|1|||
46742367|NCT00993473|82959664|FG000|Overall Study|Family event|1|||
46742368|NCT00993473|82959665|FG001|Overall Study|Family event|0|||
46742369|NCT00660595|82959673|FG000|Overall Study|Lost to Follow-up|0|||
46742370|NCT00660595|82959674|FG001|Overall Study|Lost to Follow-up|1|||
46742371|NCT00660595|82959673|FG000|Overall Study|Did not consent to participate in study|12|||
46742372|NCT00660595|82959674|FG001|Overall Study|Did not consent to participate in study|8|||
46742373|NCT00660595|82959673|FG000|Overall Study|Participant left hospital|1|||
46742374|NCT00660595|82959674|FG001|Overall Study|Participant left hospital|0|||
46742375|NCT00660595|82959673|FG000|Overall Study|Non Specified reasons|5|||
46742376|NCT00660595|82959674|FG001|Overall Study|Non Specified reasons|0|||
46742377|NCT00929240|82959680|FG000|Initial Treatment Phase|Adverse Event|31|||
46742378|NCT00929240|82959681|FG001|Initial Treatment Phase|Adverse Event|0|||
46742379|NCT00929240|82959682|FG002|Initial Treatment Phase|Adverse Event|0|||
46742380|NCT00929240|82959680|FG000|Initial Treatment Phase|Disease progression|41|||
46742381|NCT00929240|82959681|FG001|Initial Treatment Phase|Disease progression|0|||
46742382|NCT00929240|82959682|FG002|Initial Treatment Phase|Disease progression|0|||
46742383|NCT00929240|82959680|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
46742384|NCT00929240|82959681|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
46742385|NCT00929240|82959682|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
46742386|NCT00929240|82959680|FG000|Initial Treatment Phase|Protocol Violation|5|||
46742387|NCT00929240|82959681|FG001|Initial Treatment Phase|Protocol Violation|0|||
46742388|NCT00929240|82959682|FG002|Initial Treatment Phase|Protocol Violation|0|||
46742389|NCT00929240|82959680|FG000|Initial Treatment Phase|Death|2|||
46742390|NCT00929240|82959681|FG001|Initial Treatment Phase|Death|0|||
46742391|NCT00929240|82959682|FG002|Initial Treatment Phase|Death|0|||
46742392|NCT00929240|82959680|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
47050798|NCT01543087|83311921|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
47050799|NCT01543087|83311922|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
47050800|NCT01543087|83311923|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
47050801|NCT01543087|83311924|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
47050802|NCT01543087|83311919|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
47050803|NCT01543087|83311920|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
46635415|NCT01560780|82809054|FG000|Overall Study|Patient Preference|11|||
46742393|NCT00929240|82959681|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
46742394|NCT00929240|82959682|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
46742395|NCT00929240|82959680|FG000|Initial Treatment Phase|Physician Decision|4|||
46742396|NCT00929240|82959681|FG001|Initial Treatment Phase|Physician Decision|0|||
46742397|NCT00929240|82959682|FG002|Initial Treatment Phase|Physician Decision|0|||
46742398|NCT00929240|82959680|FG000|Maintenance Phase|Disease progression|0|||
46742399|NCT00929240|82959681|FG001|Maintenance Phase|Disease progression|73|||
46742400|NCT00929240|82959682|FG002|Maintenance Phase|Disease progression|60|||
46742401|NCT00929240|82959680|FG000|Maintenance Phase|Adverse Event|0|||
46742402|NCT00929240|82959681|FG001|Maintenance Phase|Adverse Event|9|||
46742403|NCT00929240|82959682|FG002|Maintenance Phase|Adverse Event|12|||
46742404|NCT00929240|82959680|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46742405|NCT00929240|82959681|FG001|Maintenance Phase|Withdrawal by Subject|2|||
46742406|NCT00929240|82959682|FG002|Maintenance Phase|Withdrawal by Subject|6|||
46742407|NCT00929240|82959680|FG000|Maintenance Phase|Protocol Violation|0|||
46742408|NCT00929240|82959681|FG001|Maintenance Phase|Protocol Violation|1|||
46742409|NCT00929240|82959682|FG002|Maintenance Phase|Protocol Violation|0|||
46742410|NCT00929240|82959680|FG000|Maintenance Phase|Health authority/Study termination|0|||
46742411|NCT00929240|82959681|FG001|Maintenance Phase|Health authority/Study termination|1|||
46742412|NCT00929240|82959682|FG002|Maintenance Phase|Health authority/Study termination|2|||
46742413|NCT00929240|82959680|FG000|Maintenance Phase|Physician Decision|0|||
46742414|NCT00929240|82959681|FG001|Maintenance Phase|Physician Decision|2|||
46742415|NCT00929240|82959682|FG002|Maintenance Phase|Physician Decision|1|||
46742416|NCT00929240|82959680|FG000|Maintenance Phase|Change of treatment|0|||
46742417|NCT00929240|82959681|FG001|Maintenance Phase|Change of treatment|4|||
46635416|NCT01560780|82809055|FG001|Overall Study|Patient Preference|11|||
47050804|NCT01543087|83311921|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
47050805|NCT01543087|83311922|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
46635417|NCT01585038|82809063|FG000|Overall Study|Adverse Event|2|||
46742418|NCT00929240|82959682|FG002|Maintenance Phase|Change of treatment|0|||
46742419|NCT00929240|82959680|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
46742420|NCT00929240|82959681|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
46742421|NCT00929240|82959682|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
46742422|NCT00929240|82959680|FG000|Maintenance Phase|Participant not treated|0|||
46742423|NCT00929240|82959681|FG001|Maintenance Phase|Participant not treated|2|||
46742424|NCT00929240|82959682|FG002|Maintenance Phase|Participant not treated|0|||
46742425|NCT00993317|82959693|FG000|Overall Study|Adverse Event|2|||
46742426|NCT00993317|82959694|FG001|Overall Study|Adverse Event|4|||
46742427|NCT00993317|82959693|FG000|Overall Study|Lack of Efficacy|18|||
46742428|NCT00993317|82959694|FG001|Overall Study|Lack of Efficacy|18|||
46742429|NCT00993317|82959693|FG000|Overall Study|Withdrawal by Subject|0|||
46742430|NCT00993317|82959694|FG001|Overall Study|Withdrawal by Subject|2|||
46742431|NCT00993317|82959693|FG000|Overall Study|Investigator's opinion|0|||
46742432|NCT00993317|82959694|FG001|Overall Study|Investigator's opinion|1|||
46742433|NCT00993317|82959693|FG000|Overall Study|Early study termination at the site|1|||
46742434|NCT00993317|82959694|FG001|Overall Study|Early study termination at the site|0|||
46742435|NCT01030133|82959702|FG000|Overall Study|failed to experience pain at level 7/10|2|||
46742436|NCT01030133|82959703|FG001|Overall Study|failed to experience pain at level 7/10|2|||
46742437|NCT00877071|82959713|FG000|Overall Study|disease progression|2|||
46742438|NCT00987389|82959719|FG000|Overall Study|Ineligible|0|||
46742439|NCT00987389|82959720|FG001|Overall Study|Ineligible|3|||
46742440|NCT00987389|82959721|FG002|Overall Study|Ineligible|0|||
46742441|NCT00987389|82959722|FG003|Overall Study|Ineligible|0|||
46742442|NCT00987389|82959719|FG000|Overall Study|Lost to Follow-up|4|||
46742443|NCT00987389|82959720|FG001|Overall Study|Lost to Follow-up|1|||
46742444|NCT00987389|82959721|FG002|Overall Study|Lost to Follow-up|3|||
46742445|NCT00987389|82959722|FG003|Overall Study|Lost to Follow-up|1|||
46742446|NCT00987389|82959719|FG000|Overall Study|Withdrawal by Subject|4|||
46742447|NCT00987389|82959720|FG001|Overall Study|Withdrawal by Subject|3|||
46742448|NCT00987389|82959721|FG002|Overall Study|Withdrawal by Subject|2|||
46742449|NCT00987389|82959722|FG003|Overall Study|Withdrawal by Subject|1|||
46742450|NCT00987389|82959719|FG000|Overall Study|Withdrawn from Treatment|0|||
46742451|NCT00987389|82959720|FG001|Overall Study|Withdrawn from Treatment|1|||
46742452|NCT00987389|82959721|FG002|Overall Study|Withdrawn from Treatment|0|||
46742453|NCT00987389|82959722|FG003|Overall Study|Withdrawn from Treatment|0|||
46742454|NCT00987389|82959719|FG000|Overall Study|Multiple different reasons|1|||
46742455|NCT00987389|82959720|FG001|Overall Study|Multiple different reasons|0|||
46742456|NCT00987389|82959721|FG002|Overall Study|Multiple different reasons|3|||
46742457|NCT00987389|82959722|FG003|Overall Study|Multiple different reasons|1|||
46742458|NCT00929162|82959732|FG000|Overall Study|Adverse Event|8|||
46742459|NCT00929162|82959733|FG001|Overall Study|Adverse Event|5|||
46742460|NCT00929162|82959732|FG000|Overall Study|Withdrawal by Subject|3|||
46742461|NCT00929162|82959733|FG001|Overall Study|Withdrawal by Subject|1|||
46742462|NCT00929162|82959732|FG000|Overall Study|Protocol Violation|32|||
46742463|NCT00929162|82959733|FG001|Overall Study|Protocol Violation|30|||
46742464|NCT00929162|82959732|FG000|Overall Study|Other termination reason|5|||
46742465|NCT00929162|82959733|FG001|Overall Study|Other termination reason|6|||
46742466|NCT00992459|82959741|FG000|Overall Study|Withdrawal by Subject|0|||
46742467|NCT00992459|82959742|FG001|Overall Study|Withdrawal by Subject|1|||
46742468|NCT00992459|82959741|FG000|Overall Study|Adverse Event|1|||
46742469|NCT00992459|82959742|FG001|Overall Study|Adverse Event|0|||
46742470|NCT00930722|82959748|FG000|Overall Study|Lost to Follow-up|16|||
46742471|NCT00930722|82959748|FG000|Overall Study|No longer willing to participate|9|||
46742472|NCT00930722|82959748|FG000|Overall Study|Study terminated by sponsor|2|||
46742473|NCT00992225|82959752|FG000|Overall Study|Entry Criteria Not Met|8|||
46742474|NCT00992225|82959752|FG000|Overall Study|Adverse Event|2|||
46742475|NCT00659581|82959756|FG000|Overall Study|Adverse Event|1006|||
46742476|NCT00659581|82959756|FG000|Overall Study|Lack of Efficacy|1183|||
46742477|NCT00659581|82959756|FG000|Overall Study|Other|6393|||
46742478|NCT00991289|82959760|FG000|Overall Study|Adverse Event|1|||
46742479|NCT00991289|82959760|FG000|Overall Study|Physician Decision|2|||
46742480|NCT00991289|82959760|FG000|Overall Study|Withdrawal by Subject|3|||
46742481|NCT00991289|82959760|FG000|Overall Study|Lost to Follow-up|4|||
46922264|NCT02837029|83155044|FG001|Cycle 2 and Beyond|Adverse Event|0|||
46742482|NCT00991289|82959760|FG000|Overall Study|Protocol Violation|2|||
46742483|NCT00930644|82959764|FG000|Overall Study|Withdrawal by Subject|4|||
46742484|NCT00930644|82959764|FG000|Overall Study|Physician Decision|2|||
46742485|NCT00930644|82959764|FG000|Overall Study|Death|1|||
46742486|NCT00930644|82959764|FG000|Overall Study|Adverse Event|16|||
46742487|NCT00990821|82959785|FG000|Overall Study|Withdrawal by Subject|0|||
46742488|NCT00990821|82959786|FG001|Overall Study|Withdrawal by Subject|2|||
46742489|NCT00990821|82959787|FG002|Overall Study|Withdrawal by Subject|0|||
46635418|NCT01585038|82809064|FG001|Overall Study|Adverse Event|2|||
46742490|NCT00990821|82959788|FG003|Overall Study|Withdrawal by Subject|0|||
46742491|NCT00990821|82959789|FG004|Overall Study|Withdrawal by Subject|3|||
46742492|NCT00990821|82959790|FG005|Overall Study|Withdrawal by Subject|3|||
46742493|NCT00990821|82959791|FG006|Overall Study|Withdrawal by Subject|1|||
46742494|NCT00990821|82959792|FG007|Overall Study|Withdrawal by Subject|0|||
46742495|NCT00990821|82959793|FG008|Overall Study|Withdrawal by Subject|0|||
46742496|NCT00990821|82959794|FG009|Overall Study|Withdrawal by Subject|1|||
46742497|NCT00990821|82959795|FG010|Overall Study|Withdrawal by Subject|3|||
46742498|NCT00990821|82959796|FG011|Overall Study|Withdrawal by Subject|5|||
46742499|NCT00990821|82959797|FG012|Overall Study|Withdrawal by Subject|2|||
46742500|NCT00990821|82959798|FG013|Overall Study|Withdrawal by Subject|1|||
46742501|NCT00990665|82959815|FG000|Overall Study|Unsuccessful Implant|8|||
46742502|NCT00990665|82959815|FG000|Overall Study|Death|29|||
46742503|NCT00990665|82959815|FG000|Overall Study|Heart Transplant|1|||
46742504|NCT00990665|82959815|FG000|Overall Study|Withdrawal by Subject|6|||
46742505|NCT00990665|82959815|FG000|Overall Study|Lost to Follow-up|1|||
46742506|NCT00990665|82959815|FG000|Overall Study|System Explant|3|||
46742507|NCT00658567|82959824|FG000|Overall Study|Adverse Event|5|||
46742508|NCT00658567|82959825|FG001|Overall Study|Adverse Event|2|||
46742509|NCT00658567|82959826|FG002|Overall Study|Adverse Event|3|||
46742510|NCT00658567|82959824|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
46742511|NCT00658567|82959825|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
46742512|NCT00658567|82959826|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
46742513|NCT00658567|82959824|FG000|Overall Study|Physician Decision|0|||
46742514|NCT00658567|82959825|FG001|Overall Study|Physician Decision|1|||
46742515|NCT00658567|82959826|FG002|Overall Study|Physician Decision|0|||
46742516|NCT00658567|82959824|FG000|Overall Study|At Discretion of Sponsor|1|||
46742517|NCT00658567|82959825|FG001|Overall Study|At Discretion of Sponsor|1|||
46742518|NCT00658567|82959826|FG002|Overall Study|At Discretion of Sponsor|1|||
46742519|NCT00875433|82959834|FG000|Overall Study|Progressive disease|41|||
46742520|NCT00875433|82959834|FG000|Overall Study|Other Adverse Event|14|||
46742521|NCT00875433|82959834|FG000|Overall Study|Withdrawal by Subject|2|||
46742522|NCT00875433|82959834|FG000|Overall Study|Other|3|||
46742523|NCT00985985|82959842|FG000|Overall Study|Adverse Event|4|||
46742524|NCT00985985|82959843|FG001|Overall Study|Adverse Event|2|||
46742525|NCT00985985|82959844|FG002|Overall Study|Adverse Event|2|||
46742526|NCT00985985|82959845|FG003|Overall Study|Adverse Event|2|||
46742527|NCT00985985|82959842|FG000|Overall Study|Lost to Follow-up|4|||
46742528|NCT00985985|82959843|FG001|Overall Study|Lost to Follow-up|11|||
46742529|NCT00985985|82959844|FG002|Overall Study|Lost to Follow-up|2|||
46742530|NCT00985985|82959845|FG003|Overall Study|Lost to Follow-up|3|||
46742531|NCT00985985|82959842|FG000|Overall Study|Protocol Violation|1|||
46742532|NCT00985985|82959843|FG001|Overall Study|Protocol Violation|2|||
46742533|NCT00985985|82959844|FG002|Overall Study|Protocol Violation|0|||
46742534|NCT00985985|82959845|FG003|Overall Study|Protocol Violation|1|||
46742535|NCT00985985|82959842|FG000|Overall Study|Lack of Efficacy|5|||
46922265|NCT02837029|83155045|FG002|Cycle 2 and Beyond|Adverse Event|0|||
47050806|NCT01543087|83311923|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
47050807|NCT01543087|83311924|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
47050808|NCT01543087|83311919|FG000|Stage 1 (48 Months)|Other than specified|5|||
47050809|NCT01543087|83311920|FG001|Stage 1 (48 Months)|Other than specified|0|||
47050810|NCT01543087|83311921|FG002|Stage 1 (48 Months)|Other than specified|9|||
47050811|NCT01543087|83311922|FG003|Stage 1 (48 Months)|Other than specified|0|||
47050812|NCT01543087|83311923|FG004|Stage 1 (48 Months)|Other than specified|0|||
47050813|NCT01543087|83311924|FG005|Stage 1 (48 Months)|Other than specified|0|||
47050814|NCT01543087|83311919|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
47050815|NCT01543087|83311920|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
47050816|NCT01543087|83311921|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
47050817|NCT01543087|83311922|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
47050818|NCT01543087|83311923|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
47050819|NCT01543087|83311924|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
47050820|NCT01543087|83311919|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
47050821|NCT01543087|83311920|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
47050822|NCT01543087|83311921|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
47050823|NCT01543087|83311922|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
47050824|NCT01543087|83311923|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
47050825|NCT01543087|83311924|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
47050826|NCT01543087|83311919|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
47050827|NCT01543087|83311920|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
47050828|NCT01543087|83311921|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
46742536|NCT00985985|82959843|FG001|Overall Study|Lack of Efficacy|6|||
46742537|NCT00985985|82959844|FG002|Overall Study|Lack of Efficacy|1|||
46742538|NCT00985985|82959845|FG003|Overall Study|Lack of Efficacy|3|||
46742539|NCT00985985|82959842|FG000|Overall Study|Withdrawal by Subject|4|||
46742540|NCT00985985|82959843|FG001|Overall Study|Withdrawal by Subject|2|||
46742541|NCT00985985|82959844|FG002|Overall Study|Withdrawal by Subject|2|||
46742542|NCT00985985|82959845|FG003|Overall Study|Withdrawal by Subject|2|||
46742543|NCT00985985|82959842|FG000|Overall Study|Other Reason|6|||
46742544|NCT00985985|82959843|FG001|Overall Study|Other Reason|1|||
46742545|NCT00985985|82959844|FG002|Overall Study|Other Reason|4|||
46742546|NCT00985985|82959845|FG003|Overall Study|Other Reason|2|||
46742547|NCT00923936|82959862|FG000|Overall Study|progressive disease on study|2|||
46742548|NCT00923936|82959863|FG001|Overall Study|progressive disease on study|1|||
46742549|NCT00923936|82959862|FG000|Overall Study|Adverse Event|2|||
46742550|NCT00923936|82959863|FG001|Overall Study|Adverse Event|1|||
46742551|NCT00923936|82959862|FG000|Overall Study|Lost to follow up|2|||
46742552|NCT00923936|82959863|FG001|Overall Study|Lost to follow up|0|||
46742553|NCT00923936|82959862|FG000|Overall Study|Continuing in follow up period|2|||
46742554|NCT00923936|82959863|FG001|Overall Study|Continuing in follow up period|1|||
46742555|NCT00924950|82959871|FG000|Overall Study|Lost to Follow-up|2|||
46742556|NCT00988637|82959880|FG000|Overall Study|Lost to Follow-up|2|||
46742557|NCT00988637|82959881|FG001|Overall Study|Lost to Follow-up|1|||
46742558|NCT00988637|82959880|FG000|Overall Study|Withdrawal by Subject|1|||
46742559|NCT00988637|82959881|FG001|Overall Study|Withdrawal by Subject|1|||
46742560|NCT00988637|82959880|FG000|Overall Study|non-compliance with study drug|0|||
46742561|NCT00988637|82959881|FG001|Overall Study|non-compliance with study drug|1|||
46742562|NCT00923156|82959890|FG000|Overall Study|Adverse Event|0|||
46742563|NCT00923156|82959891|FG001|Overall Study|Adverse Event|2|||
46742564|NCT00923156|82959892|FG002|Overall Study|Adverse Event|1|||
46742565|NCT00923156|82959890|FG000|Overall Study|Abnormal laboratory values|0|||
46742566|NCT00923156|82959891|FG001|Overall Study|Abnormal laboratory values|0|||
46742567|NCT00923156|82959892|FG002|Overall Study|Abnormal laboratory values|1|||
46742568|NCT00923156|82959890|FG000|Overall Study|Withdrawal by Subject|0|||
46742569|NCT00923156|82959891|FG001|Overall Study|Withdrawal by Subject|1|||
46742570|NCT00923156|82959892|FG002|Overall Study|Withdrawal by Subject|0|||
46742571|NCT00923156|82959890|FG000|Overall Study|Death|0|||
46742572|NCT00923156|82959891|FG001|Overall Study|Death|1|||
46742573|NCT00923156|82959892|FG002|Overall Study|Death|0|||
46922266|NCT02837029|83155043|FG000|2 Year Follow-up|Death|6|||
46922267|NCT02837029|83155044|FG001|2 Year Follow-up|Death|7|||
46922268|NCT02837029|83155045|FG002|2 Year Follow-up|Death|0|||
46922269|NCT03010527|83155057|FG000|Overall Study|Death|0|||
46922270|NCT03010527|83155058|FG001|Overall Study|Death|0|||
46922271|NCT03010527|83155059|FG002|Overall Study|Death|1|||
46922272|NCT03010527|83155057|FG000|Overall Study|Adverse Event|0|||
46922273|NCT03010527|83155058|FG001|Overall Study|Adverse Event|4|||
46922274|NCT03010527|83155059|FG002|Overall Study|Adverse Event|2|||
46922275|NCT03010527|83155057|FG000|Overall Study|Protocol Violation|0|||
46922276|NCT03010527|83155058|FG001|Overall Study|Protocol Violation|1|||
46742574|NCT00923156|82959890|FG000|Overall Study|Lack of Efficacy|0|||
46742575|NCT00923156|82959891|FG001|Overall Study|Lack of Efficacy|0|||
46742576|NCT00923156|82959892|FG002|Overall Study|Lack of Efficacy|1|||
46742577|NCT00874731|82959900|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
46742578|NCT00874731|82959901|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
46742579|NCT00874731|82959902|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
46742580|NCT00874731|82959900|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
46742581|NCT00874731|82959901|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
46742582|NCT00874731|82959902|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
46742583|NCT00874731|82959900|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
46742584|NCT00874731|82959901|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
46742585|NCT00874731|82959902|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
46742586|NCT00924638|82959912|FG000|Overall Study|Death|3|||
46742587|NCT00924638|82959913|FG001|Overall Study|Death|2|||
46742588|NCT00924638|82959912|FG000|Overall Study|Lost to Follow-up|1|||
46742589|NCT00924638|82959913|FG001|Overall Study|Lost to Follow-up|1|||
46742590|NCT00924638|82959912|FG000|Overall Study|Withdrawal by Subject|5|||
46742591|NCT00924638|82959913|FG001|Overall Study|Withdrawal by Subject|7|||
46742592|NCT00924638|82959912|FG000|Overall Study|Physician Decision|3|||
46742593|NCT00924638|82959913|FG001|Overall Study|Physician Decision|3|||
46742594|NCT00874497|82959921|FG000|Overall Study|Lost to Follow-up|2|||
46742595|NCT00874497|82959922|FG001|Overall Study|Lost to Follow-up|4|||
47050829|NCT01543087|83311922|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
47050830|NCT01543087|83311923|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
46742596|NCT00874497|82959921|FG000|Overall Study|Adverse Event|9|||
46742597|NCT00874497|82959922|FG001|Overall Study|Adverse Event|4|||
46742598|NCT00874497|82959921|FG000|Overall Study|Sponsor Discontinued Trial|7|||
46742599|NCT00874497|82959922|FG001|Overall Study|Sponsor Discontinued Trial|3|||
46742600|NCT00874497|82959921|FG000|Overall Study|Met Withdrawal Criteria|4|||
46742601|NCT00874497|82959922|FG001|Overall Study|Met Withdrawal Criteria|2|||
46742602|NCT00874497|82959921|FG000|Overall Study|Physician Decision|1|||
46742603|NCT00874497|82959922|FG001|Overall Study|Physician Decision|1|||
47050831|NCT01543087|83311924|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
46742604|NCT00874497|82959921|FG000|Overall Study|Withdrawal by Subject|5|||
46742605|NCT00874497|82959922|FG001|Overall Study|Withdrawal by Subject|4|||
46922277|NCT03010527|83155059|FG002|Overall Study|Protocol Violation|0|||
46922278|NCT03010527|83155057|FG000|Overall Study|Lost to Follow-up|0|||
47050832|NCT01696058|83311962|FG000|Overall Study|Adverse Event|21|||
46742606|NCT00924560|82959931|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
46742607|NCT00924560|82959932|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
46742608|NCT00924560|82959933|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
46742609|NCT00924560|82959931|FG000|Overall Study|Non Compliance with the Protocol|20|||
46742610|NCT00924560|82959932|FG001|Overall Study|Non Compliance with the Protocol|15|||
46742611|NCT00924560|82959933|FG002|Overall Study|Non Compliance with the Protocol|4|||
46742612|NCT00924560|82959931|FG000|Overall Study|Physician Decision|2|||
46742613|NCT00924560|82959932|FG001|Overall Study|Physician Decision|3|||
47050833|NCT01696058|83311963|FG001|Overall Study|Adverse Event|11|||
47050834|NCT01696058|83311962|FG000|Overall Study|Lack of Efficacy|2|||
47050835|NCT01696058|83311963|FG001|Overall Study|Lack of Efficacy|3|||
47050836|NCT01696058|83311962|FG000|Overall Study|Protocol Violation|9|||
47050837|NCT01696058|83311963|FG001|Overall Study|Protocol Violation|3|||
46742614|NCT00924560|82959933|FG002|Overall Study|Physician Decision|4|||
46742615|NCT00924560|82959931|FG000|Overall Study|Withdrawal by Subject|50|||
46742616|NCT00924560|82959932|FG001|Overall Study|Withdrawal by Subject|44|||
46742617|NCT00924560|82959933|FG002|Overall Study|Withdrawal by Subject|18|||
46742618|NCT00924560|82959931|FG000|Overall Study|Adverse Event|39|||
46742619|NCT00924560|82959932|FG001|Overall Study|Adverse Event|33|||
46742620|NCT00924560|82959933|FG002|Overall Study|Adverse Event|0|||
46742621|NCT00924560|82959931|FG000|Overall Study|Pregnancy|5|||
46742622|NCT00924560|82959932|FG001|Overall Study|Pregnancy|7|||
46742623|NCT00924560|82959933|FG002|Overall Study|Pregnancy|1|||
46742624|NCT00924560|82959931|FG000|Overall Study|Lost to Follow-up|78|||
46742625|NCT00924560|82959932|FG001|Overall Study|Lost to Follow-up|94|||
46742626|NCT00924560|82959933|FG002|Overall Study|Lost to Follow-up|45|||
46742627|NCT00924560|82959931|FG000|Overall Study|Miscellaneous Reasons|13|||
46742628|NCT00924560|82959932|FG001|Overall Study|Miscellaneous Reasons|10|||
46742629|NCT00924560|82959933|FG002|Overall Study|Miscellaneous Reasons|10|||
46742630|NCT00923078|82959946|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
46742631|NCT00923078|82959947|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
46742632|NCT00923078|82959948|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
46742633|NCT00923078|82959946|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
46742634|NCT00923078|82959947|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
46742635|NCT00923078|82959948|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
46742636|NCT00978731|82959959|FG000|Overall Study|Death|4|||
46742637|NCT00978731|82959960|FG001|Overall Study|Death|1|||
46742638|NCT00978731|82959961|FG002|Overall Study|Death|1|||
46742639|NCT00978731|82959962|FG003|Overall Study|Death|0|||
46742640|NCT00978731|82959959|FG000|Overall Study|Lost to Follow-up|0|||
46742641|NCT00978731|82959960|FG001|Overall Study|Lost to Follow-up|0|||
46742642|NCT00978731|82959961|FG002|Overall Study|Lost to Follow-up|0|||
46742643|NCT00978731|82959962|FG003|Overall Study|Lost to Follow-up|1|||
46742644|NCT00978731|82959959|FG000|Overall Study|Adverse Event|5|||
46742645|NCT00978731|82959960|FG001|Overall Study|Adverse Event|2|||
46742646|NCT00978731|82959961|FG002|Overall Study|Adverse Event|0|||
46742647|NCT00978731|82959962|FG003|Overall Study|Adverse Event|0|||
46742648|NCT00978731|82959959|FG000|Overall Study|Participant's request|1|||
46742649|NCT00978731|82959960|FG001|Overall Study|Participant's request|0|||
46742650|NCT00978731|82959961|FG002|Overall Study|Participant's request|0|||
46742651|NCT00978731|82959962|FG003|Overall Study|Participant's request|0|||
46742652|NCT00978731|82959959|FG000|Overall Study|Administrative reason|3|||
46742653|NCT00978731|82959960|FG001|Overall Study|Administrative reason|3|||
46742654|NCT00978731|82959961|FG002|Overall Study|Administrative reason|1|||
46742655|NCT00978731|82959962|FG003|Overall Study|Administrative reason|0|||
47050838|NCT01696058|83311962|FG000|Overall Study|Lost to Follow-up|2|||
47050839|NCT01696058|83311963|FG001|Overall Study|Lost to Follow-up|5|||
47050840|NCT01696058|83311962|FG000|Overall Study|Withdrawal by Subject|4|||
47050841|NCT01696058|83311963|FG001|Overall Study|Withdrawal by Subject|6|||
47050842|NCT01696058|83311962|FG000|Overall Study|Other reason prematurely discontinued|5|||
47050843|NCT01696058|83311963|FG001|Overall Study|Other reason prematurely discontinued|3|||
47050844|NCT01695746|83311969|FG000|Overall Study|Adverse Event|1|||
47050845|NCT01695746|83311969|FG000|Overall Study|Non-compliance by the participant|3|||
46742656|NCT00978731|82959959|FG000|Overall Study|Deterioration without progression|0|||
46742657|NCT00978731|82959960|FG001|Overall Study|Deterioration without progression|1|||
46742658|NCT00978731|82959961|FG002|Overall Study|Deterioration without progression|0|||
46742659|NCT00978731|82959962|FG003|Overall Study|Deterioration without progression|0|||
46742660|NCT00978731|82959959|FG000|Overall Study|Disease progression/relapse|5|||
46804135|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
47050846|NCT01695746|83311969|FG000|Overall Study|Protocol Violation|5|||
46742661|NCT00978731|82959960|FG001|Overall Study|Disease progression/relapse|4|||
46742662|NCT00978731|82959961|FG002|Overall Study|Disease progression/relapse|2|||
46742663|NCT00978731|82959962|FG003|Overall Study|Disease progression/relapse|2|||
46742664|NCT00978731|82959959|FG000|Overall Study|Study closure|3|||
46742665|NCT00978731|82959960|FG001|Overall Study|Study closure|4|||
47050847|NCT01695746|83311969|FG000|Overall Study|Participant not willing to participate|3|||
46742666|NCT00978731|82959961|FG002|Overall Study|Study closure|1|||
46742667|NCT00978731|82959962|FG003|Overall Study|Study closure|1|||
46742668|NCT00978731|82959959|FG000|Overall Study|No response|1|||
47050848|NCT01694420|83311980|FG000|Overall Study|Lost to Follow-up|3|||
47050849|NCT01675479|83312151|FG000|Overall Study|Lost to Follow-up|11|||
47050850|NCT00089973|83312282|FG000|Overall Study|Adverse Event|3|||
47050851|NCT00089973|83312282|FG000|Overall Study|Withdrawal by Subject|1|||
47050852|NCT00089973|83312282|FG000|Overall Study|Disease progression|45|||
47050853|NCT00089973|83312282|FG000|Overall Study|Death|1|||
47050854|NCT00089661|83312300|FG000|Overall Study|Adverse Event|0|||
47050855|NCT00089661|83312301|FG001|Overall Study|Adverse Event|2|||
47050856|NCT00089661|83312300|FG000|Overall Study|Death|1|||
47050857|NCT00089661|83312301|FG001|Overall Study|Death|0|||
47050858|NCT00089661|83312300|FG000|Overall Study|Lost to Follow-up|0|||
47050859|NCT00089661|83312301|FG001|Overall Study|Lost to Follow-up|3|||
47050860|NCT00089661|83312300|FG000|Overall Study|Withdrawal by Subject|11|||
47050861|NCT00089661|83312301|FG001|Overall Study|Withdrawal by Subject|9|||
47050862|NCT00089661|83312300|FG000|Overall Study|Disease progression|1|||
47050863|NCT00089661|83312301|FG001|Overall Study|Disease progression|3|||
47050864|NCT00089661|83312300|FG000|Overall Study|Ineligibility determined|4|||
46742669|NCT00978731|82959960|FG001|Overall Study|No response|0|||
46742670|NCT00978731|82959961|FG002|Overall Study|No response|0|||
46742671|NCT00978731|82959962|FG003|Overall Study|No response|0|||
46742672|NCT05056870|82959976|FG000|Period 1|Site COVID-19 Related|3|||
46742673|NCT05056870|82959977|FG001|Period 1|Site COVID-19 Related|3|||
46742674|NCT05056870|82959976|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
46742675|NCT05056870|82959977|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
46742676|NCT05056870|82959976|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
46742677|NCT05056870|82959977|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
46742678|NCT05056870|82959976|FG000|Period 2|COVID-19 Related|1|||
46742679|NCT05056870|82959977|FG001|Period 2|COVID-19 Related|0|||
46742680|NCT05056870|82959976|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
46742681|NCT05056870|82959977|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
46742682|NCT04488822|82960001|FG000|Overall Study|Adverse Event|8|||
46742683|NCT04488822|82960001|FG000|Overall Study|Withdrawal by Subject|1|||
46742684|NCT04396626|82960014|FG000|Overall Study|Premature termination of study|975|||
46742685|NCT04242186|82960018|FG000|Overall Study|Death|5|||
46742686|NCT03183128|82960054|FG000|Overall Study|Adverse Event|1|||
46742687|NCT03183128|82960055|FG001|Overall Study|Adverse Event|2|||
46742688|NCT03183128|82960054|FG000|Overall Study|Withdrawal by Subject|1|||
46742689|NCT03183128|82960055|FG001|Overall Study|Withdrawal by Subject|8|||
46742690|NCT03183128|82960054|FG000|Overall Study|Protocol Violation|2|||
46742691|NCT03183128|82960055|FG001|Overall Study|Protocol Violation|0|||
46742692|NCT03183128|82960054|FG000|Overall Study|Lack of Efficacy|4|||
46742693|NCT03183128|82960055|FG001|Overall Study|Lack of Efficacy|27|||
46742694|NCT03183128|82960054|FG000|Overall Study|Lost to Follow-up|1|||
46742695|NCT03183128|82960055|FG001|Overall Study|Lost to Follow-up|0|||
46742696|NCT03183128|82960054|FG000|Overall Study|Death|2|||
46742697|NCT03183128|82960055|FG001|Overall Study|Death|0|||
46742698|NCT03183128|82960054|FG000|Overall Study|Physician Decision|1|||
46742699|NCT03183128|82960055|FG001|Overall Study|Physician Decision|0|||
46742700|NCT02308488|82960088|FG000|Overall Study|Withdrawal by Subject|2|||
46742701|NCT02159950|82960094|FG000|Overall Study|Adverse Event|0|||
46742702|NCT02159950|82960095|FG001|Overall Study|Adverse Event|1|||
46742703|NCT02159950|82960094|FG000|Overall Study|Progression|0|||
46742704|NCT02159950|82960095|FG001|Overall Study|Progression|1|||
46742705|NCT02152137|82960101|FG000|Overall Study|Withdrawal by Subject|1|||
46742706|NCT02152137|82960101|FG000|Overall Study|Originally assigned to Arm B|3|||
46742707|NCT02007512|82960109|FG000|Double Blind Treatment Period|Adverse Event|4|||
46742708|NCT02007512|82960110|FG001|Double Blind Treatment Period|Adverse Event|2|||
46742709|NCT02007512|82960111|FG002|Double Blind Treatment Period|Adverse Event|6|||
46742710|NCT02007512|82960112|FG003|Double Blind Treatment Period|Adverse Event|2|||
46742711|NCT02007512|82960109|FG000|Double Blind Treatment Period|Death|1|||
46742712|NCT02007512|82960110|FG001|Double Blind Treatment Period|Death|0|||
46742713|NCT02007512|82960111|FG002|Double Blind Treatment Period|Death|0|||
46742714|NCT02007512|82960112|FG003|Double Blind Treatment Period|Death|0|||
46742715|NCT02007512|82960109|FG000|Double Blind Treatment Period|Disease progression|44|||
46742716|NCT02007512|82960110|FG001|Double Blind Treatment Period|Disease progression|49|||
46742717|NCT02007512|82960111|FG002|Double Blind Treatment Period|Disease progression|45|||
46742718|NCT02007512|82960112|FG003|Double Blind Treatment Period|Disease progression|51|||
46742719|NCT02007512|82960109|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
46742720|NCT02007512|82960110|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
46922279|NCT03010527|83155058|FG001|Overall Study|Lost to Follow-up|2|||
47050865|NCT00089661|83312301|FG001|Overall Study|Ineligibility determined|4|||
47050866|NCT00089661|83312300|FG000|Overall Study|Noncompliance|2|||
46742721|NCT02007512|82960111|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
47050867|NCT00089661|83312301|FG001|Overall Study|Noncompliance|4|||
47050868|NCT00089661|83312300|FG000|Overall Study|Other|2|||
46742722|NCT02007512|82960112|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
46742723|NCT02007512|82960109|FG000|Double Blind Treatment Period|Protocol Violation|0|||
46742724|NCT02007512|82960110|FG001|Double Blind Treatment Period|Protocol Violation|0|||
46742725|NCT02007512|82960111|FG002|Double Blind Treatment Period|Protocol Violation|0|||
46742726|NCT02007512|82960112|FG003|Double Blind Treatment Period|Protocol Violation|1|||
46742727|NCT02007512|82960109|FG000|Double Blind Treatment Period|Other|0|||
46742728|NCT02007512|82960110|FG001|Double Blind Treatment Period|Other|0|||
46742729|NCT02007512|82960111|FG002|Double Blind Treatment Period|Other|1|||
46742730|NCT02007512|82960112|FG003|Double Blind Treatment Period|Other|2|||
46742731|NCT02007512|82960109|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
46742732|NCT02007512|82960110|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
46742733|NCT02007512|82960111|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
46742734|NCT02007512|82960112|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
46742735|NCT02007512|82960109|FG000|Open Label Treatment Period|Adverse Event|0|||
46742736|NCT02007512|82960110|FG001|Open Label Treatment Period|Adverse Event|1|||
46742737|NCT02007512|82960111|FG002|Open Label Treatment Period|Adverse Event|0|||
46742738|NCT02007512|82960112|FG003|Open Label Treatment Period|Adverse Event|0|||
46742739|NCT02007512|82960109|FG000|Open Label Treatment Period|Other|0|||
46742740|NCT02007512|82960110|FG001|Open Label Treatment Period|Other|0|||
46742741|NCT02007512|82960111|FG002|Open Label Treatment Period|Other|0|||
46742742|NCT02007512|82960112|FG003|Open Label Treatment Period|Other|1|||
46742743|NCT02007512|82960109|FG000|Open Label Treatment Period|Disease progression|0|||
46742744|NCT02007512|82960110|FG001|Open Label Treatment Period|Disease progression|17|||
46742745|NCT02007512|82960111|FG002|Open Label Treatment Period|Disease progression|0|||
46742746|NCT02007512|82960112|FG003|Open Label Treatment Period|Disease progression|11|||
46742747|NCT02007512|82960109|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
46742748|NCT02007512|82960110|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
46742749|NCT02007512|82960111|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
46742750|NCT02007512|82960112|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
46742751|NCT01942135|82960127|FG000|Overall Study|Adverse Event|9|||
46742752|NCT01942135|82960128|FG001|Overall Study|Adverse Event|3|||
46742753|NCT01942135|82960127|FG000|Overall Study|Global deterioration of health status|8|||
46742754|NCT01942135|82960128|FG001|Overall Study|Global deterioration of health status|3|||
46742755|NCT01942135|82960127|FG000|Overall Study|Randomized Not Treated|2|||
46742756|NCT01942135|82960128|FG001|Overall Study|Randomized Not Treated|2|||
46742757|NCT01942135|82960127|FG000|Overall Study|Death|0|||
46742758|NCT01942135|82960128|FG001|Overall Study|Death|1|||
46742759|NCT01942135|82960127|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
46742760|NCT01942135|82960128|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
46742761|NCT01942135|82960127|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
46742762|NCT01942135|82960128|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
46742763|NCT01942135|82960127|FG000|Overall Study|Withdrawal by Subject|4|||
46742764|NCT01942135|82960128|FG001|Overall Study|Withdrawal by Subject|2|||
46742765|NCT01942135|82960127|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
46742766|NCT01942135|82960128|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
46742767|NCT00978341|82960156|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
46742768|NCT00978341|82960157|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
46742769|NCT00978029|82960167|FG000|Overall Study|Adverse Event|1|||
46742770|NCT00978029|82960168|FG001|Overall Study|Adverse Event|2|||
46742771|NCT00978029|82960169|FG002|Overall Study|Adverse Event|5|||
46742772|NCT00978029|82960167|FG000|Overall Study|Withdrawal by Subject|0|||
46742773|NCT00978029|82960168|FG001|Overall Study|Withdrawal by Subject|0|||
46742774|NCT00978029|82960169|FG002|Overall Study|Withdrawal by Subject|1|||
46742775|NCT00978029|82960167|FG000|Overall Study|Protocol Violation|0|||
46742776|NCT00978029|82960168|FG001|Overall Study|Protocol Violation|1|||
46742777|NCT00978029|82960169|FG002|Overall Study|Protocol Violation|0|||
46742778|NCT00871377|82960177|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
46742779|NCT00871377|82960178|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
46742780|NCT00871377|82960179|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
46742781|NCT00871377|82960180|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
46742782|NCT00871377|82960181|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
46742783|NCT00871377|82960182|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
46742784|NCT00871377|82960177|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
46742785|NCT00871377|82960178|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
46922280|NCT03010527|83155059|FG002|Overall Study|Lost to Follow-up|1|||
46742786|NCT00871377|82960179|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
46742787|NCT00871377|82960180|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
46742788|NCT00871377|82960181|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
46742789|NCT00871377|82960182|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
46742790|NCT00871377|82960177|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
46742791|NCT00871377|82960178|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742792|NCT00871377|82960179|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742793|NCT00871377|82960180|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742794|NCT00871377|82960181|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742795|NCT00871377|82960182|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742796|NCT00871377|82960177|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742797|NCT00871377|82960178|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742798|NCT00871377|82960179|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742799|NCT00871377|82960180|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742800|NCT00871377|82960181|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
46742801|NCT00871377|82960182|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
46742802|NCT00871377|82960177|FG000|Third Intervention (10 Weeks)|Death|0|||
46742803|NCT00871377|82960178|FG001|Third Intervention (10 Weeks)|Death|0|||
46922281|NCT03010527|83155057|FG000|Overall Study|Withdrawal by Subject|0|||
46922282|NCT03010527|83155058|FG001|Overall Study|Withdrawal by Subject|3|||
46922283|NCT03010527|83155059|FG002|Overall Study|Withdrawal by Subject|4|||
47050869|NCT00089661|83312301|FG001|Overall Study|Other|1|||
47050870|NCT00089583|83312318|FG000|Overall Study|Adverse Event|0|||
47050871|NCT00089583|83312319|FG001|Overall Study|Adverse Event|3|||
47050872|NCT00089583|83312318|FG000|Overall Study|Insufficient Viral Load Response|5|||
47050873|NCT00089583|83312319|FG001|Overall Study|Insufficient Viral Load Response|5|||
47050874|NCT00089583|83312318|FG000|Overall Study|Withdrawal by Subject|0|||
47050875|NCT00089583|83312319|FG001|Overall Study|Withdrawal by Subject|4|||
47050876|NCT00089583|83312318|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
47050877|NCT00089583|83312319|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
47050878|NCT00089583|83312318|FG000|Overall Study|Participant Refused Study Medication|0|||
47050879|NCT00089583|83312319|FG001|Overall Study|Participant Refused Study Medication|2|||
47050880|NCT00089583|83312318|FG000|Overall Study|Non-Compliance|0|||
47050881|NCT00089583|83312319|FG001|Overall Study|Non-Compliance|4|||
47050882|NCT00089583|83312318|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
47050883|NCT00089583|83312319|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
47050884|NCT00089583|83312318|FG000|Overall Study|Participant Management Criteria Met|0|||
47050885|NCT00089583|83312319|FG001|Overall Study|Participant Management Criteria Met|1|||
47050886|NCT00089583|83312318|FG000|Overall Study|Reason Not Provided|0|||
47050887|NCT00089583|83312319|FG001|Overall Study|Reason Not Provided|1|||
47050888|NCT00089583|83312318|FG000|Overall Study|Protocol Violation|0|||
47050889|NCT00089583|83312319|FG001|Overall Study|Protocol Violation|3|||
47050890|NCT00089583|83312318|FG000|Overall Study|Principal Investigator Decision|0|||
47050891|NCT00089583|83312319|FG001|Overall Study|Principal Investigator Decision|10|||
47050892|NCT00089583|83312318|FG000|Overall Study|Start of Disallowed Medication|0|||
47050893|NCT00089583|83312319|FG001|Overall Study|Start of Disallowed Medication|1|||
47050894|NCT00089583|83312318|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
47050895|NCT00089583|83312319|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
47050896|NCT00089583|83312318|FG000|Overall Study|Participant Incarcerated|0|||
47050897|NCT00089583|83312319|FG001|Overall Study|Participant Incarcerated|1|||
47050898|NCT00088881|83312331|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
47050899|NCT00088881|83312331|FG000|Step 1 - R-CHOP|Adverse Event|1|||
47050900|NCT00088881|83312331|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
47050901|NCT00088881|83312331|FG000|Step 1 - R-CHOP|Physician Decision|1|||
47050902|NCT00088881|83312331|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
47050903|NCT00088881|83312331|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
47050904|NCT00088881|83312331|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
46922284|NCT03010527|83155057|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
46922285|NCT03010527|83155058|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
46922286|NCT03010527|83155059|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
47050905|NCT00087555|83312379|FG000|Overall Study|Adverse Event|3|||
47050906|NCT00087555|83312380|FG001|Overall Study|Adverse Event|6|||
47050907|NCT00087555|83312381|FG002|Overall Study|Adverse Event|14|||
47050908|NCT00087555|83312379|FG000|Overall Study|Lost to Follow-up|0|||
47050909|NCT00087555|83312380|FG001|Overall Study|Lost to Follow-up|1|||
47050910|NCT00087555|83312381|FG002|Overall Study|Lost to Follow-up|1|||
47050911|NCT00087555|83312379|FG000|Overall Study|Non - Compliance|1|||
47050912|NCT00087555|83312380|FG001|Overall Study|Non - Compliance|0|||
47050913|NCT00087555|83312381|FG002|Overall Study|Non - Compliance|0|||
47050914|NCT00087555|83312379|FG000|Overall Study|Protocol Violation|0|||
47050915|NCT00087555|83312380|FG001|Overall Study|Protocol Violation|0|||
47050916|NCT00087555|83312381|FG002|Overall Study|Protocol Violation|2|||
46742804|NCT00871377|82960179|FG002|Third Intervention (10 Weeks)|Death|0|||
46742805|NCT00871377|82960180|FG003|Third Intervention (10 Weeks)|Death|1|||
46742806|NCT00871377|82960181|FG004|Third Intervention (10 Weeks)|Death|0|||
46742807|NCT00871377|82960182|FG005|Third Intervention (10 Weeks)|Death|0|||
47050917|NCT00087555|83312379|FG000|Overall Study|Screen Failure|1|||
47050918|NCT00087555|83312380|FG001|Overall Study|Screen Failure|1|||
47050919|NCT00087555|83312381|FG002|Overall Study|Screen Failure|0|||
47050920|NCT00087555|83312379|FG000|Overall Study|Pregnancy|0|||
47050921|NCT00087555|83312380|FG001|Overall Study|Pregnancy|1|||
47050922|NCT00087555|83312381|FG002|Overall Study|Pregnancy|1|||
47050923|NCT00087555|83312379|FG000|Overall Study|Withdrawal by Subject|3|||
47050924|NCT00087555|83312380|FG001|Overall Study|Withdrawal by Subject|2|||
47050925|NCT00087555|83312381|FG002|Overall Study|Withdrawal by Subject|1|||
47050926|NCT00087555|83312379|FG000|Overall Study|Lack of Efficacy|2|||
47050927|NCT00087555|83312380|FG001|Overall Study|Lack of Efficacy|0|||
47050928|NCT00087555|83312381|FG002|Overall Study|Lack of Efficacy|1|||
47050929|NCT00087555|83312379|FG000|Overall Study|Non Compliance|0|||
47050930|NCT00087555|83312380|FG001|Overall Study|Non Compliance|0|||
47050931|NCT00087555|83312381|FG002|Overall Study|Non Compliance|1|||
47050932|NCT00087555|83312379|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
47050933|NCT00087555|83312380|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
47050934|NCT00087555|83312381|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
47050935|NCT00087555|83312379|FG000|Overall Study|Patient wanted to go back on Med|1|||
47050936|NCT00087555|83312380|FG001|Overall Study|Patient wanted to go back on Med|0|||
47050937|NCT00087555|83312381|FG002|Overall Study|Patient wanted to go back on Med|0|||
47050938|NCT00086619|83312404|FG000|Overall Study|Withdrawal by Subject|6|||
47050939|NCT00086619|83312405|FG001|Overall Study|Withdrawal by Subject|6|||
47050940|NCT00086619|83312404|FG000|Overall Study|Adverse Event|8|||
47050941|NCT00086619|83312405|FG001|Overall Study|Adverse Event|10|||
47050942|NCT00086619|83312404|FG000|Overall Study|Protocol Violation|1|||
47050943|NCT00086619|83312405|FG001|Overall Study|Protocol Violation|1|||
47050944|NCT00085917|83312418|FG000|Overall Study|Adverse Event|4|||
47050945|NCT00085917|83312419|FG001|Overall Study|Adverse Event|3|||
47050946|NCT00084747|83312425|FG000|Overall Study|Relapsed|8|||
47050947|NCT00084747|83312425|FG000|Overall Study|Death|3|||
46742808|NCT00977561|82960192|FG000|Overall Study|Death|3|||
46742809|NCT00977561|82960193|FG001|Overall Study|Death|2|||
46742810|NCT00977561|82960192|FG000|Overall Study|Study terminated|0|||
46742811|NCT00977561|82960193|FG001|Overall Study|Study terminated|2|||
46742812|NCT00977561|82960192|FG000|Overall Study|Other|2|||
46742813|NCT00977561|82960193|FG001|Overall Study|Other|0|||
46742814|NCT00594165|82960201|FG000|Overall Study|Major protocol violation|1|||
46742815|NCT00594165|82960201|FG000|Overall Study|Lack of Efficacy|12|||
46742816|NCT00594165|82960201|FG000|Overall Study|Adverse Event|52|||
46742817|NCT00594165|82960201|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
46742818|NCT00594165|82960201|FG000|Overall Study|Subject withdrew consent|27|||
46742819|NCT00594165|82960201|FG000|Overall Study|Study ended per sponsor|102|||
46742820|NCT00594165|82960201|FG000|Overall Study|Lost to Follow-up|4|||
46742821|NCT00594165|82960201|FG000|Overall Study|Other: PI discretion|5|||
46742822|NCT00594165|82960201|FG000|Overall Study|Other: Subject moving|3|||
46742823|NCT00594165|82960201|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
46742824|NCT00594165|82960201|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
46742825|NCT00594165|82960201|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
46742826|NCT00594165|82960201|FG000|Overall Study|Other: Site terminated participation|2|||
46742827|NCT00975923|82960207|FG000|Overall Study|Withdrawal by Subject|0|||
46742828|NCT00975923|82960208|FG001|Overall Study|Withdrawal by Subject|1|||
46742829|NCT00928070|82960217|FG000|Overall Study|Lost to Follow-up|1|||
46742830|NCT00928070|82960218|FG001|Overall Study|Lost to Follow-up|2|||
46742831|NCT00928070|82960217|FG000|Overall Study|Withdrawal by Subject|10|||
46742832|NCT00928070|82960218|FG001|Overall Study|Withdrawal by Subject|3|||
46742833|NCT00928070|82960217|FG000|Overall Study|Adverse Event|14|||
46742834|NCT00928070|82960218|FG001|Overall Study|Adverse Event|26|||
46742835|NCT00928070|82960217|FG000|Overall Study|Lack of Efficacy|9|||
46742836|NCT00928070|82960218|FG001|Overall Study|Lack of Efficacy|5|||
46742837|NCT00928070|82960217|FG000|Overall Study|Did not meet entrance criteria|16|||
46742838|NCT00928070|82960218|FG001|Overall Study|Did not meet entrance criteria|9|||
46742839|NCT00928070|82960217|FG000|Overall Study|Protocol Violation|6|||
47050948|NCT00084747|83312425|FG000|Overall Study|Withdrawal by Subject|2|||
47050949|NCT00081159|83312460|FG000|Overall Study|Withdrawal by Subject|0|||
47050950|NCT00081159|83312461|FG001|Overall Study|Withdrawal by Subject|3|||
47050951|NCT00081159|83312460|FG000|Overall Study|Myelosuppression prior to treatment|0|||
47050952|NCT00081159|83312461|FG001|Overall Study|Myelosuppression prior to treatment|1|||
47050953|NCT00081159|83312460|FG000|Overall Study|Lost to Follow-up|2|||
46742840|NCT00928070|82960218|FG001|Overall Study|Protocol Violation|5|||
46742841|NCT00928070|82960217|FG000|Overall Study|Randomized but not treated|2|||
46742842|NCT00928070|82960218|FG001|Overall Study|Randomized but not treated|2|||
47050954|NCT00081159|83312461|FG001|Overall Study|Lost to Follow-up|1|||
47050955|NCT00080223|83312476|FG000|Overall Study|Adverse Event|23|||
46742843|NCT00928070|82960217|FG000|Overall Study|Other|5|||
46742844|NCT00928070|82960218|FG001|Overall Study|Other|5|||
46742845|NCT00924404|82960226|FG000|Overall Study|Lost to Follow-up|6|||
46742846|NCT00924404|82960227|FG001|Overall Study|Lost to Follow-up|4|||
46742847|NCT00976937|82960235|FG000|Overall Study|Adverse Event|4|||
46742848|NCT00976937|82960236|FG001|Overall Study|Adverse Event|5|||
46742849|NCT00976937|82960235|FG000|Overall Study|Lost to Follow-up|2|||
46742850|NCT00976937|82960236|FG001|Overall Study|Lost to Follow-up|1|||
46742851|NCT00976937|82960235|FG000|Overall Study|Withdrawal by Subject|5|||
46742852|NCT00976937|82960236|FG001|Overall Study|Withdrawal by Subject|3|||
46742853|NCT00976937|82960235|FG000|Overall Study|Poor compliance to protocol|3|||
46742854|NCT00976937|82960236|FG001|Overall Study|Poor compliance to protocol|0|||
47050956|NCT00080223|83312476|FG000|Overall Study|Death|21|||
47050957|NCT00080223|83312476|FG000|Overall Study|Withdrawal by Subject|13|||
47050958|NCT00080223|83312476|FG000|Overall Study|Lung Transplantation|9|||
47050959|NCT00080223|83312476|FG000|Overall Study|Non-compliance With Study Treatment|7|||
47050960|NCT00080223|83312476|FG000|Overall Study|Participant unwilling to continue|2|||
47050961|NCT00080223|83312476|FG000|Overall Study|Physician Decision|1|||
47050962|NCT01899053|83313087|FG000|Overall Study|Progressive Disease|4|||
47050963|NCT01899053|83313088|FG001|Overall Study|Progressive Disease|0|||
47050964|NCT01899053|83313089|FG002|Overall Study|Progressive Disease|3|||
47050965|NCT01899053|83313090|FG003|Overall Study|Progressive Disease|0|||
47050966|NCT01899053|83313091|FG004|Overall Study|Progressive Disease|3|||
46742855|NCT00976937|82960235|FG000|Overall Study|Personal and Familial Reason|2|||
46742856|NCT00976937|82960236|FG001|Overall Study|Personal and Familial Reason|2|||
46742857|NCT00976703|82960244|FG000|Overall Study|Physician Decision|1|||
46742858|NCT00976703|82960245|FG001|Overall Study|Physician Decision|1|||
46742859|NCT00976703|82960244|FG000|Overall Study|ineligible for study|2|||
46742860|NCT00976703|82960245|FG001|Overall Study|ineligible for study|2|||
46742861|NCT00975689|82960253|FG000|Overall Study|Adverse Event|0|||
46742862|NCT00975689|82960254|FG001|Overall Study|Adverse Event|3|||
46742863|NCT00975689|82960253|FG000|Overall Study|Withdrawal by Subject|1|||
46742864|NCT00975689|82960254|FG001|Overall Study|Withdrawal by Subject|0|||
46742865|NCT00975689|82960253|FG000|Overall Study|Physician Decision|1|||
46742866|NCT00975689|82960254|FG001|Overall Study|Physician Decision|0|||
46742867|NCT00922766|82960260|FG000|Overall Study|Death|3|||
46742868|NCT00922766|82960260|FG000|Overall Study|Withdrawal by Subject|2|||
46742869|NCT00922766|82960260|FG000|Overall Study|Other|1|||
46742870|NCT00922766|82960260|FG000|Overall Study|Adverse Event|1|||
46742871|NCT00917852|82960264|FG000|Overall Study|Death|6|||
46742872|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
46742873|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
46742874|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
46742875|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
46742876|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
46742877|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
46742878|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
46742879|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
46742880|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
46742881|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
46742882|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
46922287|NCT03010527|83155057|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
46922288|NCT03010527|83155058|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
46922289|NCT03010527|83155059|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
46922290|NCT03010527|83155057|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
46922291|NCT03010527|83155058|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
46922292|NCT03010527|83155059|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
46922293|NCT00794924|83155092|FG000|Overall Study|Lost to Follow-up|6|||
46922294|NCT00794924|83155093|FG001|Overall Study|Lost to Follow-up|8|||
46922295|NCT00794924|83155092|FG000|Overall Study|Withdrawal by Subject|48|||
46922296|NCT00794924|83155093|FG001|Overall Study|Withdrawal by Subject|60|||
46922297|NCT00794924|83155092|FG000|Overall Study|Adverse Event|6|||
46922298|NCT00794924|83155093|FG001|Overall Study|Adverse Event|2|||
46922299|NCT02914275|83155099|FG000|Overall Study|Lost to Follow-up|84|||
46922300|NCT02914275|83155100|FG001|Overall Study|Lost to Follow-up|29|||
46922301|NCT02914275|83155099|FG000|Overall Study|Withdrawal by Subject|26|||
47050967|NCT01899053|83313092|FG005|Overall Study|Progressive Disease|1|||
46742883|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
46742884|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
46742885|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
46922302|NCT02914275|83155100|FG001|Overall Study|Withdrawal by Subject|10|||
46922303|NCT02914275|83155099|FG000|Overall Study|Protocol Violation|1|||
46922304|NCT02914275|83155100|FG001|Overall Study|Protocol Violation|1|||
47050968|NCT01899053|83313093|FG006|Overall Study|Progressive Disease|1|||
47050969|NCT01899053|83313094|FG007|Overall Study|Progressive Disease|1|||
47050970|NCT01899053|83313095|FG008|Overall Study|Progressive Disease|4|||
47050971|NCT01899053|83313096|FG009|Overall Study|Progressive Disease|3|||
47050972|NCT01899053|83313097|FG010|Overall Study|Progressive Disease|12|||
47050973|NCT01899053|83313098|FG011|Overall Study|Progressive Disease|5|||
47050974|NCT01899053|83313099|FG012|Overall Study|Progressive Disease|8|||
47050975|NCT01899053|83313100|FG013|Overall Study|Progressive Disease|17|||
47050976|NCT01899053|83313087|FG000|Overall Study|Adverse Event|1|||
47050977|NCT01899053|83313088|FG001|Overall Study|Adverse Event|1|||
47050978|NCT01899053|83313089|FG002|Overall Study|Adverse Event|1|||
47050979|NCT01899053|83313090|FG003|Overall Study|Adverse Event|3|||
47050980|NCT01899053|83313091|FG004|Overall Study|Adverse Event|1|||
47050981|NCT01899053|83313092|FG005|Overall Study|Adverse Event|1|||
47050982|NCT01899053|83313093|FG006|Overall Study|Adverse Event|1|||
47050983|NCT01899053|83313094|FG007|Overall Study|Adverse Event|0|||
47050984|NCT01899053|83313095|FG008|Overall Study|Adverse Event|2|||
47050985|NCT01899053|83313096|FG009|Overall Study|Adverse Event|0|||
47050986|NCT01899053|83313097|FG010|Overall Study|Adverse Event|3|||
47050987|NCT01899053|83313098|FG011|Overall Study|Adverse Event|1|||
47050988|NCT01899053|83313099|FG012|Overall Study|Adverse Event|2|||
47050989|NCT01899053|83313100|FG013|Overall Study|Adverse Event|2|||
47050990|NCT01899053|83313087|FG000|Overall Study|Reason Not Specified|0|||
47050991|NCT01899053|83313088|FG001|Overall Study|Reason Not Specified|0|||
47050992|NCT01899053|83313089|FG002|Overall Study|Reason Not Specified|0|||
47050993|NCT01899053|83313090|FG003|Overall Study|Reason Not Specified|0|||
47050994|NCT01899053|83313091|FG004|Overall Study|Reason Not Specified|0|||
47050995|NCT01899053|83313092|FG005|Overall Study|Reason Not Specified|0|||
47050996|NCT01899053|83313093|FG006|Overall Study|Reason Not Specified|1|||
47050997|NCT01899053|83313094|FG007|Overall Study|Reason Not Specified|0|||
47050998|NCT01899053|83313095|FG008|Overall Study|Reason Not Specified|0|||
47050999|NCT01899053|83313096|FG009|Overall Study|Reason Not Specified|0|||
47051000|NCT01899053|83313097|FG010|Overall Study|Reason Not Specified|0|||
47051001|NCT01899053|83313098|FG011|Overall Study|Reason Not Specified|0|||
46742886|NCT00976391|82960271|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
46742887|NCT00976391|82960272|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
46742888|NCT00976391|82960271|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
46742889|NCT00976391|82960272|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
46742890|NCT00976391|82960271|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
46742891|NCT00976391|82960272|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
46742892|NCT00976391|82960271|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
46742893|NCT00976391|82960272|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
46742894|NCT00976391|82960271|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
46742895|NCT00976391|82960272|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
46742896|NCT00976391|82960271|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
46742897|NCT00976391|82960272|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
46742898|NCT00976391|82960271|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
46742899|NCT00976391|82960272|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
46742900|NCT00917462|82960278|FG000|Overall Study|Clinical Deterioration|1|||
46742901|NCT00979901|82960286|FG000|Overall Study|Adverse Event|1|||
46742902|NCT00979901|82960287|FG001|Overall Study|Adverse Event|3|||
46742903|NCT00979901|82960288|FG002|Overall Study|Adverse Event|9|||
46742904|NCT00979901|82960289|FG003|Overall Study|Adverse Event|2|||
46742905|NCT00979901|82960286|FG000|Overall Study|Lack of Efficacy|8|||
46742906|NCT00979901|82960287|FG001|Overall Study|Lack of Efficacy|4|||
46742907|NCT00979901|82960288|FG002|Overall Study|Lack of Efficacy|9|||
46742908|NCT00979901|82960289|FG003|Overall Study|Lack of Efficacy|0|||
46742909|NCT00979901|82960286|FG000|Overall Study|Lost to Follow-up|1|||
46742910|NCT00979901|82960287|FG001|Overall Study|Lost to Follow-up|1|||
46742911|NCT00979901|82960288|FG002|Overall Study|Lost to Follow-up|2|||
46742912|NCT00979901|82960289|FG003|Overall Study|Lost to Follow-up|0|||
46742913|NCT00979901|82960286|FG000|Overall Study|Protocol Violation|2|||
46742914|NCT00979901|82960287|FG001|Overall Study|Protocol Violation|2|||
46742915|NCT00979901|82960288|FG002|Overall Study|Protocol Violation|7|||
46742916|NCT00979901|82960289|FG003|Overall Study|Protocol Violation|1|||
47051002|NCT01899053|83313099|FG012|Overall Study|Reason Not Specified|1|||
47051003|NCT01899053|83313100|FG013|Overall Study|Reason Not Specified|0|||
46635419|NCT01560234|82809078|FG000|Overall Study|Lost to Follow-up|3|||
46742917|NCT00979901|82960286|FG000|Overall Study|Withdrawal by Subject|2|||
46742918|NCT00979901|82960287|FG001|Overall Study|Withdrawal by Subject|1|||
46804136|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
46804137|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
46804138|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
46804139|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
47051004|NCT01899053|83313087|FG000|Overall Study|Withdrawal by Subject|1|||
47051005|NCT01899053|83313088|FG001|Overall Study|Withdrawal by Subject|1|||
47051006|NCT01899053|83313089|FG002|Overall Study|Withdrawal by Subject|2|||
47051007|NCT01899053|83313090|FG003|Overall Study|Withdrawal by Subject|0|||
46742919|NCT00979901|82960288|FG002|Overall Study|Withdrawal by Subject|1|||
46742920|NCT00979901|82960289|FG003|Overall Study|Withdrawal by Subject|1|||
46742921|NCT00979901|82960286|FG000|Overall Study|Noncompliance|1|||
46742922|NCT00979901|82960287|FG001|Overall Study|Noncompliance|0|||
46742923|NCT00979901|82960288|FG002|Overall Study|Noncompliance|0|||
46742924|NCT00979901|82960289|FG003|Overall Study|Noncompliance|0|||
46742925|NCT00979901|82960286|FG000|Overall Study|out-of-state|1|||
46742926|NCT00979901|82960287|FG001|Overall Study|out-of-state|0|||
46742927|NCT00979901|82960288|FG002|Overall Study|out-of-state|0|||
46742928|NCT00979901|82960289|FG003|Overall Study|out-of-state|0|||
46742929|NCT00979901|82960286|FG000|Overall Study|vacation|1|||
46742930|NCT00979901|82960287|FG001|Overall Study|vacation|0|||
46742931|NCT00979901|82960288|FG002|Overall Study|vacation|0|||
46742932|NCT00979901|82960289|FG003|Overall Study|vacation|0|||
46742933|NCT00979901|82960286|FG000|Overall Study|elevated lab values pre-randomization|1|||
46742934|NCT00979901|82960287|FG001|Overall Study|elevated lab values pre-randomization|0|||
46742935|NCT00979901|82960288|FG002|Overall Study|elevated lab values pre-randomization|0|||
46742936|NCT00979901|82960289|FG003|Overall Study|elevated lab values pre-randomization|0|||
46742937|NCT00979901|82960286|FG000|Overall Study|Discontinued in Error|0|||
46742938|NCT00979901|82960287|FG001|Overall Study|Discontinued in Error|1|||
46742939|NCT00979901|82960288|FG002|Overall Study|Discontinued in Error|0|||
46742940|NCT00979901|82960289|FG003|Overall Study|Discontinued in Error|0|||
46742941|NCT00979901|82960286|FG000|Overall Study|Left Country|0|||
46742942|NCT00979901|82960287|FG001|Overall Study|Left Country|0|||
46742943|NCT00979901|82960288|FG002|Overall Study|Left Country|1|||
46742944|NCT00979901|82960289|FG003|Overall Study|Left Country|0|||
46742945|NCT00979901|82960286|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
46742946|NCT00979901|82960287|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
46742947|NCT00979901|82960288|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
46742948|NCT00979901|82960289|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
46742949|NCT00975611|82960298|FG000|Overall Study|Screen Fail|16|||
47051008|NCT01899053|83313091|FG004|Overall Study|Withdrawal by Subject|2|||
47051009|NCT01899053|83313092|FG005|Overall Study|Withdrawal by Subject|0|||
47051010|NCT01899053|83313093|FG006|Overall Study|Withdrawal by Subject|0|||
47051011|NCT01899053|83313094|FG007|Overall Study|Withdrawal by Subject|1|||
47051012|NCT01899053|83313095|FG008|Overall Study|Withdrawal by Subject|0|||
47051013|NCT01899053|83313096|FG009|Overall Study|Withdrawal by Subject|0|||
47051014|NCT01899053|83313097|FG010|Overall Study|Withdrawal by Subject|0|||
47051015|NCT01899053|83313098|FG011|Overall Study|Withdrawal by Subject|0|||
47051016|NCT01899053|83313099|FG012|Overall Study|Withdrawal by Subject|1|||
47051017|NCT01899053|83313100|FG013|Overall Study|Withdrawal by Subject|1|||
47051018|NCT01899053|83313087|FG000|Overall Study|Protocol Violation|0|||
47051019|NCT01899053|83313088|FG001|Overall Study|Protocol Violation|0|||
47051020|NCT01899053|83313089|FG002|Overall Study|Protocol Violation|1|||
47051021|NCT01899053|83313090|FG003|Overall Study|Protocol Violation|0|||
47051022|NCT01899053|83313091|FG004|Overall Study|Protocol Violation|0|||
47051023|NCT01899053|83313092|FG005|Overall Study|Protocol Violation|0|||
47051024|NCT01899053|83313093|FG006|Overall Study|Protocol Violation|0|||
47051025|NCT01899053|83313094|FG007|Overall Study|Protocol Violation|0|||
47051026|NCT01899053|83313095|FG008|Overall Study|Protocol Violation|0|||
47051027|NCT01899053|83313096|FG009|Overall Study|Protocol Violation|0|||
47051028|NCT01899053|83313097|FG010|Overall Study|Protocol Violation|0|||
47051029|NCT01899053|83313098|FG011|Overall Study|Protocol Violation|0|||
47051030|NCT01899053|83313099|FG012|Overall Study|Protocol Violation|0|||
47051031|NCT01899053|83313100|FG013|Overall Study|Protocol Violation|0|||
47051032|NCT01899053|83313087|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
47051033|NCT01899053|83313088|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
47051034|NCT01899053|83313089|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051035|NCT01899053|83313090|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051036|NCT01899053|83313091|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051037|NCT01899053|83313092|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051038|NCT01899053|83313093|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
46922305|NCT02914275|83155099|FG000|Overall Study|Physician Decision|3|||
47051039|NCT01899053|83313094|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051040|NCT01899053|83313095|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051041|NCT01899053|83313096|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051042|NCT01899053|83313097|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
47051043|NCT01899053|83313098|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051044|NCT01899053|83313099|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051045|NCT01899053|83313100|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
47051046|NCT01899053|83313087|FG000|Overall Study|Symptomatic Deterioration|0|||
46742950|NCT00975611|82960298|FG000|Overall Study|Physician Decision|1|||
46742951|NCT00970307|82960305|FG000|Overall Study|Serious Adverse Event|1|||
46742952|NCT00970307|82960306|FG001|Overall Study|Serious Adverse Event|0|||
46742953|NCT00970307|82960307|FG002|Overall Study|Serious Adverse Event|0|||
46775742|NCT00793793|82994211|FG007|Overall Study|Protocol Violation|0|||
47051047|NCT01899053|83313088|FG001|Overall Study|Symptomatic Deterioration|0|||
47051048|NCT01899053|83313089|FG002|Overall Study|Symptomatic Deterioration|0|||
47051049|NCT01899053|83313090|FG003|Overall Study|Symptomatic Deterioration|0|||
47051050|NCT01899053|83313091|FG004|Overall Study|Symptomatic Deterioration|0|||
46742954|NCT00970307|82960305|FG000|Overall Study|Withdrawal by Subject|2|||
46742955|NCT00970307|82960306|FG001|Overall Study|Withdrawal by Subject|3|||
46742956|NCT00970307|82960307|FG002|Overall Study|Withdrawal by Subject|2|||
46742957|NCT00917384|82960317|FG000|Overall Study|Lost to Follow-up|4|||
46742958|NCT00917384|82960318|FG001|Overall Study|Lost to Follow-up|2|||
46742959|NCT00917384|82960317|FG000|Overall Study|Withdrawal by Subject|10|||
46742960|NCT00917384|82960318|FG001|Overall Study|Withdrawal by Subject|2|||
46742961|NCT00864513|82960324|FG000|Overall Study|Withdrawal by Subject|3|||
46742962|NCT00917150|82960332|FG000|Overall Study|Adverse Event|12|||
46742963|NCT00917150|82960333|FG001|Overall Study|Adverse Event|7|||
46742964|NCT00917150|82960334|FG002|Overall Study|Adverse Event|12|||
46742965|NCT00917150|82960335|FG003|Overall Study|Adverse Event|11|||
46742966|NCT00917150|82960332|FG000|Overall Study|Death|1|||
46742967|NCT00917150|82960333|FG001|Overall Study|Death|4|||
46742968|NCT00917150|82960334|FG002|Overall Study|Death|3|||
46742969|NCT00917150|82960335|FG003|Overall Study|Death|2|||
46742970|NCT00917150|82960332|FG000|Overall Study|Lost to Follow-up|1|||
46742971|NCT00917150|82960333|FG001|Overall Study|Lost to Follow-up|0|||
46742972|NCT00917150|82960334|FG002|Overall Study|Lost to Follow-up|4|||
46742973|NCT00917150|82960335|FG003|Overall Study|Lost to Follow-up|2|||
46742974|NCT00917150|82960332|FG000|Overall Study|Physician Decision|0|||
46742975|NCT00917150|82960333|FG001|Overall Study|Physician Decision|2|||
46742976|NCT00917150|82960334|FG002|Overall Study|Physician Decision|0|||
46742977|NCT00917150|82960335|FG003|Overall Study|Physician Decision|1|||
46742978|NCT00917150|82960332|FG000|Overall Study|Protocol Violation|5|||
46742979|NCT00917150|82960333|FG001|Overall Study|Protocol Violation|5|||
46742980|NCT00917150|82960334|FG002|Overall Study|Protocol Violation|3|||
46742981|NCT00917150|82960335|FG003|Overall Study|Protocol Violation|5|||
46742982|NCT00917150|82960332|FG000|Overall Study|Withdrawal by Subject|15|||
46742983|NCT00917150|82960333|FG001|Overall Study|Withdrawal by Subject|16|||
46742984|NCT00917150|82960334|FG002|Overall Study|Withdrawal by Subject|18|||
46742985|NCT00917150|82960335|FG003|Overall Study|Withdrawal by Subject|11|||
46742986|NCT00917150|82960332|FG000|Overall Study|Other than specified|3|||
46742987|NCT00917150|82960333|FG001|Overall Study|Other than specified|3|||
46742988|NCT00917150|82960334|FG002|Overall Study|Other than specified|2|||
46742989|NCT00917150|82960335|FG003|Overall Study|Other than specified|2|||
46742990|NCT00659425|82960355|FG000|Overall Study|Disease progression|1|||
46742991|NCT00659425|82960356|FG001|Overall Study|Disease progression|0|||
46742992|NCT00659425|82960357|FG002|Overall Study|Disease progression|0|||
46742993|NCT00659425|82960358|FG003|Overall Study|Disease progression|1|||
46742994|NCT00659425|82960359|FG004|Overall Study|Disease progression|0|||
46742995|NCT00659425|82960360|FG005|Overall Study|Disease progression|2|||
46742996|NCT00659425|82960361|FG006|Overall Study|Disease progression|4|||
46742997|NCT00659425|82960362|FG007|Overall Study|Disease progression|3|||
46742998|NCT00659425|82960363|FG008|Overall Study|Disease progression|5|||
46742999|NCT00659425|82960364|FG009|Overall Study|Disease progression|3|||
46743000|NCT00659425|82960355|FG000|Overall Study|Death|0|||
46743001|NCT00659425|82960356|FG001|Overall Study|Death|0|||
46743002|NCT00659425|82960357|FG002|Overall Study|Death|0|||
46743003|NCT00659425|82960358|FG003|Overall Study|Death|1|||
46743004|NCT00659425|82960359|FG004|Overall Study|Death|0|||
46743005|NCT00659425|82960360|FG005|Overall Study|Death|0|||
46743006|NCT00659425|82960361|FG006|Overall Study|Death|1|||
46743007|NCT00659425|82960362|FG007|Overall Study|Death|0|||
46804140|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
46804141|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
46804142|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
47051051|NCT01899053|83313092|FG005|Overall Study|Symptomatic Deterioration|1|||
46743008|NCT00659425|82960363|FG008|Overall Study|Death|0|||
46743009|NCT00659425|82960364|FG009|Overall Study|Death|0|||
46743010|NCT00659425|82960355|FG000|Overall Study|Adverse Event|0|||
46743011|NCT00659425|82960356|FG001|Overall Study|Adverse Event|0|||
46743012|NCT00659425|82960357|FG002|Overall Study|Adverse Event|0|||
46743013|NCT00659425|82960358|FG003|Overall Study|Adverse Event|0|||
46743014|NCT00659425|82960359|FG004|Overall Study|Adverse Event|0|||
46743015|NCT00659425|82960360|FG005|Overall Study|Adverse Event|1|||
46743016|NCT00659425|82960361|FG006|Overall Study|Adverse Event|0|||
46743017|NCT00659425|82960362|FG007|Overall Study|Adverse Event|3|||
46743018|NCT00659425|82960363|FG008|Overall Study|Adverse Event|1|||
46743019|NCT00659425|82960364|FG009|Overall Study|Adverse Event|4|||
46743020|NCT00659425|82960355|FG000|Overall Study|Investigator Discretion|0|||
46743021|NCT00659425|82960356|FG001|Overall Study|Investigator Discretion|0|||
46635420|NCT01560234|82809079|FG001|Overall Study|Lost to Follow-up|0|||
46743022|NCT00659425|82960357|FG002|Overall Study|Investigator Discretion|0|||
46743023|NCT00659425|82960358|FG003|Overall Study|Investigator Discretion|0|||
46743024|NCT00659425|82960359|FG004|Overall Study|Investigator Discretion|0|||
46743025|NCT00659425|82960360|FG005|Overall Study|Investigator Discretion|1|||
46743026|NCT00659425|82960361|FG006|Overall Study|Investigator Discretion|0|||
46743027|NCT00659425|82960362|FG007|Overall Study|Investigator Discretion|3|||
46743028|NCT00659425|82960363|FG008|Overall Study|Investigator Discretion|0|||
46743029|NCT00659425|82960364|FG009|Overall Study|Investigator Discretion|0|||
46743030|NCT00659425|82960355|FG000|Overall Study|Other|0|||
46743031|NCT00659425|82960356|FG001|Overall Study|Other|1|||
46743032|NCT00659425|82960357|FG002|Overall Study|Other|1|||
46743033|NCT00659425|82960358|FG003|Overall Study|Other|2|||
46743034|NCT00659425|82960359|FG004|Overall Study|Other|4|||
46743035|NCT00659425|82960360|FG005|Overall Study|Other|0|||
46743036|NCT00659425|82960361|FG006|Overall Study|Other|3|||
46743037|NCT00659425|82960362|FG007|Overall Study|Other|2|||
46743038|NCT00659425|82960363|FG008|Overall Study|Other|0|||
46743039|NCT00659425|82960364|FG009|Overall Study|Other|6|||
46743040|NCT00656851|82960401|FG000|Overall Study|Withdrawal by Subject|0|||
46743041|NCT00656851|82960402|FG001|Overall Study|Withdrawal by Subject|4|||
46743042|NCT00656617|82960408|FG000|Overall Study|Adverse Event|1|||
46743043|NCT00656617|82960408|FG000|Overall Study|Death|2|||
46743044|NCT00656617|82960408|FG000|Overall Study|Insurance Issues|2|||
46743045|NCT00656617|82960408|FG000|Overall Study|Move to different clinical trial|2|||
46743046|NCT00659269|82960415|FG000|Overall Study|Physician Decision|1|||
46743047|NCT00659269|82960416|FG001|Overall Study|Physician Decision|1|||
46743048|NCT00658333|82960433|FG000|Overall Study|Adverse Event|2|||
46743049|NCT00658333|82960434|FG001|Overall Study|Adverse Event|1|||
46743050|NCT00570037|82960442|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
46743051|NCT00570037|82960443|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
46743052|NCT00863655|82960451|FG000|Overall Study|Protocol Violation|4|||
46743053|NCT00863655|82960452|FG001|Overall Study|Protocol Violation|0|||
46743054|NCT00863655|82960451|FG000|Overall Study|Adverse Event|52|||
46743055|NCT00863655|82960452|FG001|Overall Study|Adverse Event|8|||
46743056|NCT00863655|82960451|FG000|Overall Study|Withdrawal by Subject|47|||
46743057|NCT00863655|82960452|FG001|Overall Study|Withdrawal by Subject|7|||
46743058|NCT00863655|82960451|FG000|Overall Study|Administrative problems|1|||
46743059|NCT00863655|82960452|FG001|Overall Study|Administrative problems|0|||
46743060|NCT00863655|82960451|FG000|Overall Study|Death|7|||
46743061|NCT00863655|82960452|FG001|Overall Study|Death|1|||
46743062|NCT00863655|82960451|FG000|Overall Study|New cancer therapy|5|||
47051052|NCT01899053|83313093|FG006|Overall Study|Symptomatic Deterioration|0|||
46743063|NCT00863655|82960452|FG001|Overall Study|New cancer therapy|1|||
46743064|NCT00863655|82960451|FG000|Overall Study|Disease progression|364|||
46743065|NCT00863655|82960452|FG001|Overall Study|Disease progression|221|||
46743066|NCT00863655|82960451|FG000|Overall Study|Treatment completed as per protocol|5|||
46743067|NCT00863655|82960452|FG001|Overall Study|Treatment completed as per protocol|1|||
46743068|NCT00658723|82960460|FG000|Overall Study|Lost to Follow-up|0|||
46743069|NCT00658723|82960461|FG001|Overall Study|Lost to Follow-up|2|||
46743070|NCT00658723|82960462|FG002|Overall Study|Lost to Follow-up|2|||
46743071|NCT00658723|82960460|FG000|Overall Study|Death|2|||
46743072|NCT00658723|82960461|FG001|Overall Study|Death|1|||
46743073|NCT00658723|82960462|FG002|Overall Study|Death|4|||
46743074|NCT00658723|82960460|FG000|Overall Study|Scheduling Issue|1|||
46743075|NCT00658723|82960461|FG001|Overall Study|Scheduling Issue|1|||
46743076|NCT00658723|82960462|FG002|Overall Study|Scheduling Issue|0|||
46743077|NCT00658723|82960460|FG000|Overall Study|Withdrawal by Subject|1|||
46743078|NCT00658723|82960461|FG001|Overall Study|Withdrawal by Subject|0|||
46743079|NCT00658723|82960462|FG002|Overall Study|Withdrawal by Subject|1|||
46743080|NCT00593385|82960473|FG000|Overall Study|Death|14|||
46743081|NCT00593385|82960473|FG000|Overall Study|Lost to Follow-up|17|||
46743082|NCT00593385|82960473|FG000|Overall Study|Withdrawal by Subject|9|||
46743083|NCT00658021|82960482|FG000|28-Week Treatment Period|Adverse Event|3|||
46743084|NCT00658021|82960483|FG001|28-Week Treatment Period|Adverse Event|1|||
46743085|NCT00658021|82960484|FG002|28-Week Treatment Period|Adverse Event|0|||
47051053|NCT01899053|83313094|FG007|Overall Study|Symptomatic Deterioration|1|||
47051054|NCT01899053|83313095|FG008|Overall Study|Symptomatic Deterioration|0|||
47051055|NCT01899053|83313096|FG009|Overall Study|Symptomatic Deterioration|0|||
47051056|NCT01899053|83313097|FG010|Overall Study|Symptomatic Deterioration|0|||
47051057|NCT01899053|83313098|FG011|Overall Study|Symptomatic Deterioration|1|||
47051058|NCT01899053|83313099|FG012|Overall Study|Symptomatic Deterioration|2|||
46743086|NCT00658021|82960482|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
46743087|NCT00658021|82960483|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
46743088|NCT00658021|82960484|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
46743089|NCT00658021|82960482|FG000|28-Week Treatment Period|Protocol Violation|0|||
47051059|NCT01899053|83313100|FG013|Overall Study|Symptomatic Deterioration|0|||
46743090|NCT00658021|82960483|FG001|28-Week Treatment Period|Protocol Violation|2|||
46743091|NCT00658021|82960484|FG002|28-Week Treatment Period|Protocol Violation|1|||
46743092|NCT00658021|82960482|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
46743093|NCT00658021|82960483|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
46775743|NCT00793793|82994212|FG008|Overall Study|Protocol Violation|0|||
46743094|NCT00658021|82960484|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
46743095|NCT00658021|82960482|FG000|28-Week Treatment Period|Physician Decision|1|||
46743096|NCT00658021|82960483|FG001|28-Week Treatment Period|Physician Decision|2|||
46743097|NCT00658021|82960484|FG002|28-Week Treatment Period|Physician Decision|1|||
46743098|NCT00658021|82960482|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
46743099|NCT00658021|82960483|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
46743100|NCT00658021|82960484|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
46743101|NCT00658021|82960482|FG000|28-Week Treatment Period|Loss of glucose control|1|||
46743102|NCT00658021|82960483|FG001|28-Week Treatment Period|Loss of glucose control|1|||
46743103|NCT00658021|82960484|FG002|28-Week Treatment Period|Loss of glucose control|10|||
46743104|NCT00658021|82960482|FG000|28-Week Treatment Period|Other|2|||
46743105|NCT00658021|82960483|FG001|28-Week Treatment Period|Other|3|||
46743106|NCT00658021|82960484|FG002|28-Week Treatment Period|Other|1|||
46743107|NCT00658021|82960482|FG000|28-Week Treatment Period|Did not receive treatment|2|||
46743108|NCT00658021|82960483|FG001|28-Week Treatment Period|Did not receive treatment|0|||
46743109|NCT00658021|82960484|FG002|28-Week Treatment Period|Did not receive treatment|0|||
46743110|NCT00658021|82960482|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
46743111|NCT00658021|82960483|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
46743112|NCT00658021|82960484|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
46743113|NCT00658021|82960482|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
46743114|NCT00658021|82960483|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
46743115|NCT00658021|82960484|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
46743116|NCT00920816|82960498|FG000|Overall Study|Death|116|||
46743117|NCT00920816|82960499|FG001|Overall Study|Death|63|||
46743118|NCT00920816|82960500|FG002|Overall Study|Death|8|||
46743119|NCT00920816|82960501|FG003|Overall Study|Death|3|||
46743120|NCT00920816|82960498|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
46743121|NCT00920816|82960499|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
46743122|NCT00920816|82960500|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
46743123|NCT00920816|82960501|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
46743124|NCT00920816|82960498|FG000|Overall Study|Global deterioration of health status|2|||
46743125|NCT00920816|82960499|FG001|Overall Study|Global deterioration of health status|0|||
46743126|NCT00920816|82960500|FG002|Overall Study|Global deterioration of health status|0|||
46743127|NCT00920816|82960501|FG003|Overall Study|Global deterioration of health status|0|||
46743128|NCT00920816|82960498|FG000|Overall Study|Objective progression or relapse|6|||
46743129|NCT00920816|82960499|FG001|Overall Study|Objective progression or relapse|2|||
46743130|NCT00920816|82960500|FG002|Overall Study|Objective progression or relapse|0|||
46743131|NCT00920816|82960501|FG003|Overall Study|Objective progression or relapse|0|||
46743132|NCT00920816|82960498|FG000|Overall Study|Other|26|||
46743133|NCT00920816|82960499|FG001|Overall Study|Other|15|||
46743134|NCT00920816|82960500|FG002|Overall Study|Other|1|||
46743135|NCT00920816|82960501|FG003|Overall Study|Other|2|||
46743136|NCT00920816|82960498|FG000|Overall Study|Lost to Follow-up|11|||
46743137|NCT00920816|82960499|FG001|Overall Study|Lost to Follow-up|2|||
46743138|NCT00920816|82960500|FG002|Overall Study|Lost to Follow-up|0|||
46743139|NCT00920816|82960501|FG003|Overall Study|Lost to Follow-up|0|||
46743140|NCT00920816|82960498|FG000|Overall Study|Adverse Event|1|||
46743141|NCT00920816|82960499|FG001|Overall Study|Adverse Event|1|||
46743142|NCT00920816|82960500|FG002|Overall Study|Adverse Event|1|||
46743143|NCT00920816|82960501|FG003|Overall Study|Adverse Event|0|||
46743144|NCT00920816|82960498|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
46743145|NCT00920816|82960499|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
46743146|NCT00920816|82960500|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
46743147|NCT00920816|82960501|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
46743148|NCT00920816|82960498|FG000|Overall Study|Randomized but not treated|3|||
46743149|NCT00920816|82960499|FG001|Overall Study|Randomized but not treated|0|||
46743150|NCT00920816|82960500|FG002|Overall Study|Randomized but not treated|0|||
46743151|NCT00920816|82960501|FG003|Overall Study|Randomized but not treated|0|||
46743152|NCT00657709|82960516|FG000|Overall Study|AE or Death|7|||
46743153|NCT00657709|82960517|FG001|Overall Study|AE or Death|7|||
46743154|NCT00657709|82960518|FG002|Overall Study|AE or Death|6|||
46743155|NCT00657709|82960519|FG003|Overall Study|AE or Death|7|||
46743156|NCT00657709|82960520|FG004|Overall Study|AE or Death|1|||
46743157|NCT00657709|82960516|FG000|Overall Study|Withdrawal by Subject|7|||
46743158|NCT00657709|82960517|FG001|Overall Study|Withdrawal by Subject|15|||
46743159|NCT00657709|82960518|FG002|Overall Study|Withdrawal by Subject|15|||
46743160|NCT00657709|82960519|FG003|Overall Study|Withdrawal by Subject|5|||
46743161|NCT00657709|82960520|FG004|Overall Study|Withdrawal by Subject|9|||
46743162|NCT00657709|82960516|FG000|Overall Study|Lost to Follow-up|9|||
46743163|NCT00657709|82960517|FG001|Overall Study|Lost to Follow-up|9|||
46743164|NCT00657709|82960518|FG002|Overall Study|Lost to Follow-up|7|||
46743165|NCT00657709|82960519|FG003|Overall Study|Lost to Follow-up|1|||
46743166|NCT00657709|82960520|FG004|Overall Study|Lost to Follow-up|21|||
46743167|NCT00657709|82960516|FG000|Overall Study|Protocol Violation|0|||
46743168|NCT00657709|82960517|FG001|Overall Study|Protocol Violation|2|||
46743169|NCT00657709|82960518|FG002|Overall Study|Protocol Violation|0|||
46743170|NCT00657709|82960519|FG003|Overall Study|Protocol Violation|1|||
46743171|NCT00657709|82960520|FG004|Overall Study|Protocol Violation|2|||
46743172|NCT00915356|82960547|FG000|Overall Study|Withdrawal by Subject|1|||
46743173|NCT00915356|82960548|FG001|Overall Study|Withdrawal by Subject|0|||
46743174|NCT00915356|82960549|FG002|Overall Study|Withdrawal by Subject|0|||
46743175|NCT00915356|82960550|FG003|Overall Study|Withdrawal by Subject|0|||
46743176|NCT00915356|82960551|FG004|Overall Study|Withdrawal by Subject|0|||
46743177|NCT00657553|82960565|FG000|Overall Study|low accrual, no analysis run|5|||
46743178|NCT00657553|82960566|FG001|Overall Study|low accrual, no analysis run|5|||
46743179|NCT00862719|82960576|FG000|Overall Study|Disease Progression|5|||
46743180|NCT00862719|82960577|FG001|Overall Study|Disease Progression|0|||
46743181|NCT00862719|82960578|FG002|Overall Study|Disease Progression|1|||
46743182|NCT00862719|82960579|FG003|Overall Study|Disease Progression|0|||
46743183|NCT00862719|82960576|FG000|Overall Study|Death|5|||
46743184|NCT00862719|82960577|FG001|Overall Study|Death|6|||
46743185|NCT00862719|82960578|FG002|Overall Study|Death|1|||
46743186|NCT00862719|82960579|FG003|Overall Study|Death|1|||
46743187|NCT00862719|82960576|FG000|Overall Study|Engraftment failure|0|||
46743188|NCT00862719|82960577|FG001|Overall Study|Engraftment failure|0|||
46743189|NCT00862719|82960578|FG002|Overall Study|Engraftment failure|1|||
46743190|NCT00862719|82960579|FG003|Overall Study|Engraftment failure|0|||
46743191|NCT00862719|82960576|FG000|Overall Study|Veno-Occlusive Disease|0|||
46743192|NCT00862719|82960577|FG001|Overall Study|Veno-Occlusive Disease|0|||
46743193|NCT00862719|82960578|FG002|Overall Study|Veno-Occlusive Disease|1|||
46743194|NCT00862719|82960579|FG003|Overall Study|Veno-Occlusive Disease|0|||
46743195|NCT00862641|82960593|FG000|Overall Study|Randomized, but drug not received|1|||
46743196|NCT00862641|82960594|FG001|Overall Study|Randomized, but drug not received|4|||
46743197|NCT00862641|82960595|FG002|Overall Study|Randomized, but drug not received|1|||
46743198|NCT00862641|82960596|FG003|Overall Study|Randomized, but drug not received|4|||
46743199|NCT00861471|82960606|FG000|Overall Study|Withdrawal by Subject|1|||
46743200|NCT00861471|82960606|FG000|Overall Study|Adverse Event|2|||
46743201|NCT00861471|82960606|FG000|Overall Study|Lack of Efficacy|3|||
46743202|NCT00861471|82960606|FG000|Overall Study|treatment for lumbar laminectomy|1|||
46743203|NCT00861471|82960606|FG000|Overall Study|Physician Decision|2|||
46743204|NCT00860067|82960613|FG000|Overall Study|Lost to Follow-up|46|||
46743205|NCT00860067|82960614|FG001|Overall Study|Lost to Follow-up|9|||
46743206|NCT00860067|82960615|FG002|Overall Study|Lost to Follow-up|9|||
46743207|NCT00860067|82960613|FG000|Overall Study|Withdrawal by Subject|4|||
46743208|NCT00860067|82960614|FG001|Overall Study|Withdrawal by Subject|0|||
46743209|NCT00860067|82960615|FG002|Overall Study|Withdrawal by Subject|0|||
46743210|NCT00860067|82960613|FG000|Overall Study|Pregnancy|1|||
46743211|NCT00860067|82960614|FG001|Overall Study|Pregnancy|0|||
46743212|NCT00860067|82960615|FG002|Overall Study|Pregnancy|0|||
46743213|NCT00858117|82960626|FG000|Treatment on Study|Adverse Event|2|||
46743214|NCT00858117|82960626|FG000|Follow up for 5 Years|Death|4|||
46743215|NCT00858117|82960626|FG000|Follow up for 5 Years|No further data collected for study|9|||
46743216|NCT00652951|82960633|FG000|Booster Phase|Adverse event, non-fatal|0|||
46743217|NCT00652951|82960634|FG001|Booster Phase|Adverse event, non-fatal|1|||
46743218|NCT00652951|82960635|FG002|Booster Phase|Adverse event, non-fatal|0|||
46804143|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
46922306|NCT02914275|83155100|FG001|Overall Study|Physician Decision|1|||
46922307|NCT02914275|83155099|FG000|Overall Study|Other|4|||
46922308|NCT02914275|83155100|FG001|Overall Study|Other|1|||
46922309|NCT02914275|83155099|FG000|Overall Study|Excluded due to invalid informed consent|3|||
46922310|NCT02914275|83155100|FG001|Overall Study|Excluded due to invalid informed consent|0|||
46922311|NCT00792116|83155112|FG000|Overall Study|Lost to Follow-up|0|||
46922312|NCT00792116|83155113|FG001|Overall Study|Lost to Follow-up|1|||
47051060|NCT01888367|83313205|FG000|Overall Study|Physician Decision|3|||
46743219|NCT00652951|82960633|FG000|Booster Phase|Other|1|||
46743220|NCT00652951|82960634|FG001|Booster Phase|Other|0|||
46743221|NCT00652951|82960635|FG002|Booster Phase|Other|0|||
46743222|NCT00848211|82960647|FG000|Overall Study|Protocol Violation|0|||
46743223|NCT00848211|82960648|FG001|Overall Study|Protocol Violation|1|||
46743224|NCT00848211|82960649|FG002|Overall Study|Protocol Violation|1|||
46743225|NCT00848211|82960650|FG003|Overall Study|Protocol Violation|0|||
46743226|NCT00848211|82960647|FG000|Overall Study|Adverse Event|0|||
46743227|NCT00848211|82960648|FG001|Overall Study|Adverse Event|0|||
46743228|NCT00848211|82960649|FG002|Overall Study|Adverse Event|0|||
46743229|NCT00848211|82960650|FG003|Overall Study|Adverse Event|0|||
46743230|NCT00592683|82960662|FG000|Overall Study|Found ineligible|0|||
46743231|NCT00592683|82960663|FG001|Overall Study|Found ineligible|1|||
46922313|NCT00792116|83155112|FG000|Overall Study|Discontnued intervention|1|||
46922314|NCT00792116|83155113|FG001|Overall Study|Discontnued intervention|0|||
46743232|NCT00592683|82960662|FG000|Overall Study|Withdrawal by Subject|1|||
46922315|NCT00489827|83155128|FG000|Overall Study|Intraoperative exclusion criteria|1|||
46922316|NCT00489827|83155129|FG001|Overall Study|Intraoperative exclusion criteria|1|||
46743233|NCT00592683|82960663|FG001|Overall Study|Withdrawal by Subject|0|||
46743234|NCT00592683|82960662|FG000|Overall Study|Adverse Event|0|||
46743235|NCT00592683|82960663|FG001|Overall Study|Adverse Event|2|||
46743236|NCT00592683|82960662|FG000|Overall Study|Protocol Violation|1|||
46743237|NCT00592683|82960663|FG001|Overall Study|Protocol Violation|0|||
46743238|NCT00592683|82960662|FG000|Overall Study|Study drug expired|1|||
46743239|NCT00592683|82960663|FG001|Overall Study|Study drug expired|0|||
46743240|NCT00592683|82960662|FG000|Overall Study|Other|1|||
46743241|NCT00592683|82960663|FG001|Overall Study|Other|0|||
46743242|NCT00592683|82960662|FG000|Overall Study|Lost to Follow-up|0|||
46743243|NCT00592683|82960663|FG001|Overall Study|Lost to Follow-up|1|||
46743244|NCT00847665|82960671|FG000|Overall Study|Withdrawal by Subject|1|||
46743245|NCT00847665|82960672|FG001|Overall Study|Withdrawal by Subject|0|||
46743246|NCT00916370|82960680|FG000|Overall Study|Death|3|||
46743247|NCT00916370|82960681|FG001|Overall Study|Death|1|||
46743248|NCT00916370|82960680|FG000|Overall Study|Withdrawal by Subject|2|||
46743249|NCT00916370|82960681|FG001|Overall Study|Withdrawal by Subject|0|||
46743250|NCT00916370|82960680|FG000|Overall Study|Physician Decision|0|||
46743251|NCT00916370|82960681|FG001|Overall Study|Physician Decision|1|||
46743252|NCT00847197|82960690|FG000|Overall Study|Adverse Event|21|||
46743253|NCT00847197|82960691|FG001|Overall Study|Adverse Event|3|||
46743254|NCT00847197|82960690|FG000|Overall Study|Protocol Violation|0|||
46743255|NCT00847197|82960691|FG001|Overall Study|Protocol Violation|1|||
46743256|NCT00847197|82960690|FG000|Overall Study|Withdrawal by Subject|3|||
46743257|NCT00847197|82960691|FG001|Overall Study|Withdrawal by Subject|1|||
46743258|NCT00654901|82960701|FG000|Overall Study|Lost to Follow-up|1|||
46743259|NCT00654901|82960702|FG001|Overall Study|Lost to Follow-up|0|||
46743260|NCT00654901|82960703|FG002|Overall Study|Lost to Follow-up|1|||
46743261|NCT00654901|82960704|FG003|Overall Study|Lost to Follow-up|0|||
46743262|NCT00654901|82960701|FG000|Overall Study|Withdrawal by Subject|3|||
46743263|NCT00654901|82960702|FG001|Overall Study|Withdrawal by Subject|0|||
46743264|NCT00654901|82960703|FG002|Overall Study|Withdrawal by Subject|1|||
46743265|NCT00654901|82960704|FG003|Overall Study|Withdrawal by Subject|0|||
46743266|NCT00846807|82960714|FG000|Overall Study|Adverse Event|270|||
46743267|NCT00846807|82960714|FG000|Overall Study|Lost to Follow-up|94|||
46743268|NCT00846807|82960714|FG000|Overall Study|Withdrawal by Subject|56|||
46743269|NCT00846807|82960714|FG000|Overall Study|Non compliant with European label|7|||
46743270|NCT00846807|82960714|FG000|Overall Study|Switch to other anticoagulants|89|||
46743271|NCT00846807|82960714|FG000|Overall Study|No prescription after hospital discharge|56|||
46743272|NCT00846807|82960714|FG000|Overall Study|Other|60|||
46743273|NCT00846495|82960720|FG000|Overall Study|Lost to Follow-up|1|||
46743274|NCT00846495|82960721|FG001|Overall Study|Lost to Follow-up|0|||
46743275|NCT00846495|82960720|FG000|Overall Study|Adverse Event|5|||
46743276|NCT00846495|82960721|FG001|Overall Study|Adverse Event|1|||
46743277|NCT00846495|82960720|FG000|Overall Study|Lack of Efficacy|1|||
46743278|NCT00846495|82960721|FG001|Overall Study|Lack of Efficacy|2|||
46743279|NCT00846495|82960720|FG000|Overall Study|Physician Decision|1|||
46743280|NCT00846495|82960721|FG001|Overall Study|Physician Decision|0|||
46743281|NCT00654745|82960727|FG000|Overall Study|Adverse Event|12|||
46743282|NCT00654745|82960727|FG000|Overall Study|Lost to Follow-up|7|||
46743283|NCT00654745|82960727|FG000|Overall Study|Protocol Violation|11|||
46743284|NCT00654745|82960727|FG000|Overall Study|Withdrawal by Subject|10|||
46743285|NCT00654745|82960727|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
46743286|NCT00846027|82960737|FG000|Overall Study|Death|3|||
46743287|NCT00846027|82960737|FG000|Overall Study|Disease Progression|30|||
46743288|NCT00846027|82960737|FG000|Overall Study|Toxicity|12|||
46743289|NCT00846027|82960737|FG000|Overall Study|Patient Decision|7|||
46743290|NCT00846027|82960737|FG000|Overall Study|Investigator Discretion|29|||
46743291|NCT00846027|82960737|FG000|Overall Study|Protocol Violation|2|||
46743292|NCT00846027|82960737|FG000|Overall Study|Subject Not Treated|7|||
46743293|NCT00646399|82960743|FG000|Overall Study|Death|63|||
46743294|NCT00646399|82960744|FG001|Overall Study|Death|53|||
46743295|NCT00646399|82960743|FG000|Overall Study|Withdrawal by Subject|9|||
46743296|NCT00646399|82960744|FG001|Overall Study|Withdrawal by Subject|10|||
46743297|NCT00646399|82960743|FG000|Overall Study|Other Reason|11|||
46922317|NCT00489827|83155128|FG000|Overall Study|Intraoperative exclusion criteria|1|||
46922318|NCT00489827|83155129|FG001|Overall Study|Intraoperative exclusion criteria|1|||
46743298|NCT00646399|82960744|FG001|Overall Study|Other Reason|11|||
47051061|NCT01888367|83313206|FG001|Overall Study|Physician Decision|4|||
46743299|NCT00652327|82960752|FG000|Overall Study|Adverse Event|0|||
46743300|NCT00652327|82960753|FG001|Overall Study|Adverse Event|2|||
46743301|NCT00652327|82960752|FG000|Overall Study|Lost to Follow-up|0|||
46743302|NCT00652327|82960753|FG001|Overall Study|Lost to Follow-up|3|||
46743303|NCT00645853|82960761|FG000|Overall Study|Adverse Event|18|||
46743304|NCT00645853|82960762|FG001|Overall Study|Adverse Event|7|||
46743305|NCT00645853|82960761|FG000|Overall Study|AZ study closure in Hungary|60|||
46743306|NCT00645853|82960762|FG001|Overall Study|AZ study closure in Hungary|40|||
46743307|NCT00645853|82960761|FG000|Overall Study|Withdrawal by Subject|5|||
46743308|NCT00645853|82960762|FG001|Overall Study|Withdrawal by Subject|2|||
46743309|NCT00645853|82960761|FG000|Overall Study|Protocol Violation|0|||
46743310|NCT00645853|82960762|FG001|Overall Study|Protocol Violation|2|||
46922319|NCT02604433|83155137|FG000|Overall Study|Withdrawal by Subject|37|||
46922320|NCT02604433|83155138|FG001|Overall Study|Withdrawal by Subject|16|||
46922321|NCT02604433|83155137|FG000|Overall Study|Adverse Event|4|||
46922322|NCT02604433|83155138|FG001|Overall Study|Adverse Event|0|||
46922323|NCT02604433|83155137|FG000|Overall Study|Other reasons|3|||
46922324|NCT02604433|83155138|FG001|Overall Study|Other reasons|5|||
46922325|NCT02604433|83155137|FG000|Overall Study|Death|4|||
46922326|NCT02604433|83155138|FG001|Overall Study|Death|1|||
46922327|NCT02604433|83155137|FG000|Overall Study|Transition to Rollover Protocol|169|||
46922328|NCT02604433|83155138|FG001|Overall Study|Transition to Rollover Protocol|82|||
46922329|NCT02604433|83155137|FG000|Overall Study|Physician Decision|1|||
46922330|NCT02604433|83155138|FG001|Overall Study|Physician Decision|1|||
46922331|NCT02604433|83155137|FG000|Overall Study|Lack of Efficacy|0|||
46922332|NCT02604433|83155138|FG001|Overall Study|Lack of Efficacy|1|||
46922333|NCT02659150|83155144|FG000|Subject Enrollment|Physician Decision|3|||
46922334|NCT02659150|83155144|FG000|Subject Enrollment|Withdrawal by Subject|2|||
46922335|NCT02659150|83155144|FG000|Baseline Imaging|Withdrawal by Subject|1|||
46922336|NCT02659150|83155144|FG000|Baseline Imaging|Physician Decision|1|||
46922337|NCT02659150|83155144|FG000|Study Drug Dosing|Adverse Event|1|||
47051062|NCT01888367|83313207|FG002|Overall Study|Physician Decision|2|||
46743311|NCT00645853|82960761|FG000|Overall Study|Discontinuation criteria|2|||
47051063|NCT01888367|83313205|FG000|Overall Study|Death|2|||
46743312|NCT00645853|82960762|FG001|Overall Study|Discontinuation criteria|2|||
46743313|NCT00645853|82960761|FG000|Overall Study|recall of ICF, planned operation, death|7|||
46743314|NCT00645853|82960762|FG001|Overall Study|recall of ICF, planned operation, death|4|||
46743315|NCT00652093|82960774|FG000|Overall Study|Withdrawal by Subject|0|||
46743316|NCT00652093|82960775|FG001|Overall Study|Withdrawal by Subject|0|||
46743317|NCT00652093|82960776|FG002|Overall Study|Withdrawal by Subject|1|||
46743318|NCT00652093|82960777|FG003|Overall Study|Withdrawal by Subject|0|||
46743319|NCT00652093|82960778|FG004|Overall Study|Withdrawal by Subject|1|||
46743320|NCT00652093|82960779|FG005|Overall Study|Withdrawal by Subject|0|||
46743321|NCT00652093|82960774|FG000|Overall Study|Physician Decision|0|||
46743322|NCT00652093|82960775|FG001|Overall Study|Physician Decision|0|||
46743323|NCT00652093|82960776|FG002|Overall Study|Physician Decision|0|||
46743324|NCT00652093|82960777|FG003|Overall Study|Physician Decision|0|||
46743325|NCT00652093|82960778|FG004|Overall Study|Physician Decision|1|||
46743326|NCT00652093|82960779|FG005|Overall Study|Physician Decision|0|||
46743327|NCT00651937|82960795|FG000|Overall Study|Withdrawal by Subject|4|||
46743328|NCT00651937|82960796|FG001|Overall Study|Withdrawal by Subject|1|||
46743329|NCT00654355|82960804|FG000|Overall Study|Lost to Follow-up|2|||
46743330|NCT00654355|82960805|FG001|Overall Study|Lost to Follow-up|2|||
46743331|NCT00651313|82960813|FG000|Overall Study|Adverse Event|0|||
46743332|NCT00651313|82960814|FG001|Overall Study|Adverse Event|1|||
46743333|NCT00651313|82960813|FG000|Overall Study|Withdrawal by Subject|3|||
46743334|NCT00651313|82960814|FG001|Overall Study|Withdrawal by Subject|1|||
46743335|NCT00651313|82960813|FG000|Overall Study|Lost to Follow-up|1|||
46743336|NCT00651313|82960814|FG001|Overall Study|Lost to Follow-up|1|||
46743337|NCT00651313|82960813|FG000|Overall Study|Adminstrative Discontinuation|2|||
46743338|NCT00651313|82960814|FG001|Overall Study|Adminstrative Discontinuation|3|||
46743339|NCT00969761|82960832|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
46743340|NCT00969761|82960833|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46743341|NCT00969761|82960834|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46743342|NCT00969761|82960835|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
46743343|NCT00969761|82960836|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46743344|NCT00969761|82960837|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46743345|NCT00969761|82960838|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46743346|NCT00969761|82960839|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46743347|NCT00969761|82960840|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
46743348|NCT00969761|82960841|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
46743349|NCT00969761|82960842|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46743350|NCT00969761|82960843|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
46804144|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
46804145|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
46804146|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
46922338|NCT03006393|83155151|FG000|Overall Study|Withdrawal by Subject|1|||
46922339|NCT03006393|83155152|FG001|Overall Study|Withdrawal by Subject|1|||
46922340|NCT03006393|83155151|FG000|Overall Study|Pregnancy|0|||
46922341|NCT03006393|83155152|FG001|Overall Study|Pregnancy|1|||
46922342|NCT03006393|83155151|FG000|Overall Study|Lost to Follow-up|0|||
47051064|NCT01888367|83313206|FG001|Overall Study|Death|0|||
46743351|NCT00969761|82960832|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743352|NCT00969761|82960833|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743353|NCT00969761|82960834|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
46743354|NCT00969761|82960835|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743355|NCT00969761|82960836|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743356|NCT00969761|82960837|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743357|NCT00969761|82960838|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743358|NCT00969761|82960839|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743359|NCT00969761|82960840|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743360|NCT00969761|82960841|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743361|NCT00969761|82960842|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743362|NCT00969761|82960843|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
46743363|NCT00969761|82960832|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743364|NCT00969761|82960833|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743365|NCT00969761|82960834|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
46743366|NCT00969761|82960835|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743367|NCT00969761|82960836|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743368|NCT00969761|82960837|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743369|NCT00969761|82960838|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743370|NCT00969761|82960839|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743371|NCT00969761|82960840|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743372|NCT00969761|82960841|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743373|NCT00969761|82960842|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743374|NCT00969761|82960843|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
46743375|NCT00969761|82960832|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743376|NCT00969761|82960833|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743377|NCT00969761|82960834|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743378|NCT00969761|82960835|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743379|NCT00969761|82960836|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743380|NCT00969761|82960837|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743381|NCT00969761|82960838|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743382|NCT00969761|82960839|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743383|NCT00969761|82960840|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
46743384|NCT00969761|82960841|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743385|NCT00969761|82960842|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
47051065|NCT01888367|83313207|FG002|Overall Study|Death|1|||
47051066|NCT01888367|83313205|FG000|Overall Study|Withdrawal by Subject|1|||
47051067|NCT01888367|83313206|FG001|Overall Study|Withdrawal by Subject|0|||
46743386|NCT00969761|82960843|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
46743387|NCT00969761|82960832|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
46743388|NCT00969761|82960833|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
46743389|NCT00969761|82960834|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
46743390|NCT00969761|82960835|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
46743391|NCT00969761|82960836|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
46743392|NCT00969761|82960837|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
46743393|NCT00969761|82960838|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
46743394|NCT00969761|82960839|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
46743395|NCT00969761|82960840|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
46743396|NCT00969761|82960841|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
46804147|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
46804148|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
46804149|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
46804150|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
47051068|NCT01888367|83313207|FG002|Overall Study|Withdrawal by Subject|1|||
47051069|NCT01888367|83313205|FG000|Overall Study|Lost to Follow-up|1|||
47051070|NCT01888367|83313206|FG001|Overall Study|Lost to Follow-up|1|||
47051071|NCT01888367|83313207|FG002|Overall Study|Lost to Follow-up|0|||
46804151|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
46804152|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
46804153|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
46804154|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
46804155|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
46846453|NCT00131664|83063150|FG002|First Period (First 6 Months)|Adverse Event|5|||
46922343|NCT03006393|83155152|FG001|Overall Study|Lost to Follow-up|1|||
46922344|NCT00882440|83155169|FG000|Overall Study|Adverse Event|2|||
46922345|NCT00882440|83155170|FG001|Overall Study|Adverse Event|2|||
46922346|NCT00882440|83155171|FG002|Overall Study|Adverse Event|2|||
46922347|NCT00882440|83155172|FG003|Overall Study|Adverse Event|1|||
46743397|NCT00969761|82960842|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
46743398|NCT00969761|82960843|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
46743399|NCT00969761|82960832|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46743400|NCT00969761|82960833|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46922348|NCT00882440|83155173|FG004|Overall Study|Adverse Event|1|||
46743401|NCT00969761|82960834|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46743402|NCT00969761|82960835|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
46922349|NCT00882440|83155174|FG005|Overall Study|Adverse Event|4|||
46922350|NCT00882440|83155175|FG006|Overall Study|Adverse Event|2|||
46922351|NCT00882440|83155169|FG000|Overall Study|Lack of Efficacy|3|||
46922352|NCT00882440|83155170|FG001|Overall Study|Lack of Efficacy|5|||
46743403|NCT00969761|82960836|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
46743404|NCT00969761|82960837|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46743405|NCT00969761|82960838|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46743406|NCT00969761|82960839|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46922353|NCT00882440|83155171|FG002|Overall Study|Lack of Efficacy|2|||
46922354|NCT00882440|83155172|FG003|Overall Study|Lack of Efficacy|0|||
46922355|NCT00882440|83155173|FG004|Overall Study|Lack of Efficacy|0|||
46922356|NCT00882440|83155174|FG005|Overall Study|Lack of Efficacy|3|||
46743407|NCT00969761|82960840|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
46743408|NCT00969761|82960841|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46743409|NCT00969761|82960842|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46743410|NCT00969761|82960843|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
46743411|NCT00845871|82960869|FG000|Assessment Period|Adverse Event|2|||
46743412|NCT00845871|82960869|FG000|Assessment Period|Abnormal laboratory values|1|||
46743413|NCT00845871|82960869|FG000|Assessment Period|Abnormal test procedure results|1|||
46743414|NCT00845871|82960869|FG000|Assessment Period|Patient withdrew consent|3|||
46743415|NCT00915278|82960899|FG000|Overall Study|Death|1|||
46743416|NCT00915278|82960900|FG001|Overall Study|Death|0|||
46743417|NCT00915278|82960901|FG002|Overall Study|Death|0|||
46743418|NCT00915278|82960902|FG003|Overall Study|Death|0|||
46743419|NCT00915278|82960903|FG004|Overall Study|Death|0|||
46743420|NCT00915278|82960904|FG005|Overall Study|Death|0|||
46743421|NCT00915278|82960899|FG000|Overall Study|Lost to Follow-up|0|||
46743422|NCT00915278|82960900|FG001|Overall Study|Lost to Follow-up|1|||
46743423|NCT00915278|82960901|FG002|Overall Study|Lost to Follow-up|0|||
46743424|NCT00915278|82960902|FG003|Overall Study|Lost to Follow-up|0|||
46743425|NCT00915278|82960903|FG004|Overall Study|Lost to Follow-up|0|||
46743426|NCT00915278|82960904|FG005|Overall Study|Lost to Follow-up|0|||
46743427|NCT00915278|82960899|FG000|Overall Study|Withdrawal by Subject|0|||
46743428|NCT00915278|82960900|FG001|Overall Study|Withdrawal by Subject|1|||
46743429|NCT00915278|82960901|FG002|Overall Study|Withdrawal by Subject|0|||
46743430|NCT00915278|82960902|FG003|Overall Study|Withdrawal by Subject|0|||
46743431|NCT00915278|82960903|FG004|Overall Study|Withdrawal by Subject|1|||
46743432|NCT00915278|82960904|FG005|Overall Study|Withdrawal by Subject|4|||
46743433|NCT00915278|82960899|FG000|Overall Study|Adverse Event|4|||
46743434|NCT00915278|82960900|FG001|Overall Study|Adverse Event|1|||
46743435|NCT00915278|82960901|FG002|Overall Study|Adverse Event|0|||
46743436|NCT00915278|82960902|FG003|Overall Study|Adverse Event|0|||
46743437|NCT00915278|82960903|FG004|Overall Study|Adverse Event|0|||
46743438|NCT00915278|82960904|FG005|Overall Study|Adverse Event|0|||
46743439|NCT00915278|82960899|FG000|Overall Study|Progressive disease/clinical progression|0|||
46743440|NCT00915278|82960900|FG001|Overall Study|Progressive disease/clinical progression|0|||
46743441|NCT00915278|82960901|FG002|Overall Study|Progressive disease/clinical progression|0|||
46743442|NCT00915278|82960902|FG003|Overall Study|Progressive disease/clinical progression|3|||
46743443|NCT00915278|82960903|FG004|Overall Study|Progressive disease/clinical progression|1|||
46743444|NCT00915278|82960904|FG005|Overall Study|Progressive disease/clinical progression|2|||
46743445|NCT00915278|82960899|FG000|Overall Study|Infusion related AEs|0|||
46743446|NCT00915278|82960900|FG001|Overall Study|Infusion related AEs|0|||
46922357|NCT00882440|83155175|FG006|Overall Study|Lack of Efficacy|0|||
46922358|NCT00882440|83155169|FG000|Overall Study|Lost to Follow-up|2|||
46922359|NCT00882440|83155170|FG001|Overall Study|Lost to Follow-up|0|||
46922360|NCT00882440|83155171|FG002|Overall Study|Lost to Follow-up|1|||
46743447|NCT00915278|82960901|FG002|Overall Study|Infusion related AEs|0|||
46743448|NCT00915278|82960902|FG003|Overall Study|Infusion related AEs|0|||
46743449|NCT00915278|82960903|FG004|Overall Study|Infusion related AEs|0|||
46743450|NCT00915278|82960904|FG005|Overall Study|Infusion related AEs|2|||
46743451|NCT00915278|82960899|FG000|Overall Study|Admission to hospice|0|||
46743452|NCT00915278|82960900|FG001|Overall Study|Admission to hospice|0|||
46743453|NCT00915278|82960901|FG002|Overall Study|Admission to hospice|1|||
46922361|NCT00882440|83155172|FG003|Overall Study|Lost to Follow-up|1|||
47051072|NCT01888367|83313205|FG000|Overall Study|Protocol Violation|0|||
47051073|NCT01888367|83313206|FG001|Overall Study|Protocol Violation|0|||
47051074|NCT01888367|83313207|FG002|Overall Study|Protocol Violation|1|||
47051075|NCT01888367|83313205|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
47051076|NCT01888367|83313206|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
47051077|NCT01888367|83313207|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
47051078|NCT01898195|83313233|FG000|Smoking Abstinence|Did not have good measurements|35|||
47051079|NCT01898195|83313234|FG001|Smoking Abstinence|Did not have good measurements|38|||
47051080|NCT01898195|83313235|FG002|Smoking Abstinence|Did not have good measurements|36|||
47051081|NCT01897727|83313249|FG000|Overall Study|Exclusion: central sleep apnea|0|||
47051082|NCT01897727|83313250|FG001|Overall Study|Exclusion: central sleep apnea|1|||
47051083|NCT01897493|83313256|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
47051084|NCT01887353|83313265|FG000|Overall Study|Study stopped early|4|||
47051085|NCT01887353|83313266|FG001|Overall Study|Study stopped early|3|||
47051086|NCT01896869|83313288|FG000|Overall Study|Withdrawal by Subject|0|||
47051087|NCT01896869|83313289|FG001|Overall Study|Withdrawal by Subject|6|||
47051088|NCT01896869|83313288|FG000|Overall Study|Lost to Follow-up|1|||
47051089|NCT01896869|83313289|FG001|Overall Study|Lost to Follow-up|0|||
47051090|NCT01896557|83313299|FG000|Clopidogrel Alone|Adverse Event|1|||
47051091|NCT01896557|83313300|FG001|Clopidogrel Alone|Adverse Event|0|||
47051092|NCT01896557|83313299|FG000|Clopidogrel + GI Protector|low adherence|1|||
47051093|NCT01896557|83313300|FG001|Clopidogrel + GI Protector|low adherence|1|||
47051094|NCT01896557|83313299|FG000|Clopidogrel + GI Protector|Reading error|1|||
47051095|NCT01896557|83313300|FG001|Clopidogrel + GI Protector|Reading error|3|||
47051096|NCT01886105|83313315|FG000|Overall Study|Lack of Efficacy|3|||
47051097|NCT01895777|83313344|FG000|Overall Study|Adverse Event|1|||
47051098|NCT01895777|83313345|FG001|Overall Study|Adverse Event|2|||
47051099|NCT01895777|83313344|FG000|Overall Study|Lost to Follow-up|2|||
47051100|NCT01895777|83313345|FG001|Overall Study|Lost to Follow-up|0|||
47051101|NCT01895777|83313344|FG000|Overall Study|Not treated|1|||
47051102|NCT01895777|83313345|FG001|Overall Study|Not treated|0|||
47051103|NCT01895777|83313344|FG000|Overall Study|Other reasons|3|||
47051104|NCT01895777|83313345|FG001|Overall Study|Other reasons|2|||
47051105|NCT01895777|83313344|FG000|Overall Study|Non-compliance with the CTP|2|||
47051106|NCT01895777|83313345|FG001|Overall Study|Non-compliance with the CTP|1|||
47051107|NCT01885559|83313373|FG000|Overall Study|Lost to Follow-up|15|||
47051108|NCT01885559|83313374|FG001|Overall Study|Lost to Follow-up|16|||
47051109|NCT01885559|83313373|FG000|Overall Study|Less than full participation|9|||
46743454|NCT00915278|82960902|FG003|Overall Study|Admission to hospice|0|||
46743455|NCT00915278|82960903|FG004|Overall Study|Admission to hospice|0|||
46922362|NCT00882440|83155173|FG004|Overall Study|Lost to Follow-up|1|||
46922363|NCT00882440|83155174|FG005|Overall Study|Lost to Follow-up|0|||
46743456|NCT00915278|82960904|FG005|Overall Study|Admission to hospice|0|||
46743457|NCT00844857|82960920|FG000|Overall Study|Adverse Event|24|||
46743458|NCT00844857|82960921|FG001|Overall Study|Adverse Event|5|||
46743459|NCT00844857|82960920|FG000|Overall Study|Sponsor Decision|1|||
46743460|NCT00844857|82960921|FG001|Overall Study|Sponsor Decision|1|||
46743461|NCT00844857|82960920|FG000|Overall Study|Physician Decision|2|||
46743462|NCT00844857|82960921|FG001|Overall Study|Physician Decision|0|||
46743463|NCT00844857|82960920|FG000|Overall Study|Parent/Caregiver Decision|6|||
46743464|NCT00844857|82960921|FG001|Overall Study|Parent/Caregiver Decision|2|||
46743465|NCT00844857|82960920|FG000|Overall Study|Withdrawal by Subject|8|||
46743466|NCT00844857|82960921|FG001|Overall Study|Withdrawal by Subject|7|||
46743467|NCT00844857|82960920|FG000|Overall Study|Protocol Violation|6|||
46743468|NCT00844857|82960921|FG001|Overall Study|Protocol Violation|0|||
46743469|NCT00844857|82960920|FG000|Overall Study|Lack of Efficacy|5|||
46743470|NCT00844857|82960921|FG001|Overall Study|Lack of Efficacy|5|||
46743471|NCT00844857|82960920|FG000|Overall Study|Clinical Relapse|0|||
46743472|NCT00844857|82960921|FG001|Overall Study|Clinical Relapse|1|||
46743473|NCT00844857|82960920|FG000|Overall Study|Entry Criteria Not Met|0|||
46743474|NCT00844857|82960921|FG001|Overall Study|Entry Criteria Not Met|1|||
46743475|NCT00844857|82960920|FG000|Overall Study|Lost to Follow-up|2|||
46922364|NCT00882440|83155175|FG006|Overall Study|Lost to Follow-up|1|||
47051110|NCT01885559|83313374|FG001|Overall Study|Less than full participation|19|||
47051111|NCT01885559|83313373|FG000|Overall Study|Protocol Violation|0|||
47051112|NCT01885559|83313374|FG001|Overall Study|Protocol Violation|1|||
47051113|NCT01884545|83313384|FG000|Overall Study|Lost to Follow-up|6|||
47051114|NCT01884545|83313385|FG001|Overall Study|Lost to Follow-up|4|||
47051115|NCT01884545|83313386|FG002|Overall Study|Lost to Follow-up|9|||
47051116|NCT01884545|83313387|FG003|Overall Study|Lost to Follow-up|4|||
47051117|NCT01884545|83313384|FG000|Overall Study|Patient withdrawn|7|||
46922365|NCT00882440|83155169|FG000|Overall Study|Protocol Violation|0|||
46635421|NCT01560234|82809080|FG002|Overall Study|Lost to Follow-up|1|||
46743476|NCT00844857|82960921|FG001|Overall Study|Lost to Follow-up|3|||
46743477|NCT00844857|82960920|FG000|Overall Study|Did Not Take Study Drug|3|||
46922366|NCT00882440|83155170|FG001|Overall Study|Protocol Violation|0|||
47051118|NCT01884545|83313385|FG001|Overall Study|Patient withdrawn|12|||
47051119|NCT01884545|83313386|FG002|Overall Study|Patient withdrawn|5|||
47051120|NCT01884545|83313387|FG003|Overall Study|Patient withdrawn|5|||
47051121|NCT01884545|83313384|FG000|Overall Study|Non-adherence|0|||
46743478|NCT00844857|82960921|FG001|Overall Study|Did Not Take Study Drug|1|||
46743479|NCT00844857|82960920|FG000|Overall Study|Good Clinical Practice Violations|21|||
46743480|NCT00844857|82960921|FG001|Overall Study|Good Clinical Practice Violations|11|||
46743481|NCT00569803|82960938|FG000|Overall Study|Lost to Follow-up|1|||
46743482|NCT00569803|82960939|FG001|Overall Study|Lost to Follow-up|0|||
46743483|NCT00569803|82960940|FG002|Overall Study|Lost to Follow-up|0|||
46743484|NCT00569803|82960941|FG003|Overall Study|Lost to Follow-up|0|||
46743485|NCT00569803|82960942|FG004|Overall Study|Lost to Follow-up|0|||
46743486|NCT00569803|82960943|FG005|Overall Study|Lost to Follow-up|0|||
46743487|NCT00569803|82960944|FG006|Overall Study|Lost to Follow-up|0|||
46743488|NCT00569803|82960945|FG007|Overall Study|Lost to Follow-up|0|||
46743489|NCT00569803|82960938|FG000|Overall Study|injection syringe leaked during dosing|0|||
46743490|NCT00569803|82960939|FG001|Overall Study|injection syringe leaked during dosing|0|||
46743491|NCT00569803|82960940|FG002|Overall Study|injection syringe leaked during dosing|0|||
46743492|NCT00569803|82960941|FG003|Overall Study|injection syringe leaked during dosing|1|||
46743493|NCT00569803|82960942|FG004|Overall Study|injection syringe leaked during dosing|0|||
46743494|NCT00569803|82960943|FG005|Overall Study|injection syringe leaked during dosing|0|||
46743495|NCT00569803|82960944|FG006|Overall Study|injection syringe leaked during dosing|0|||
46743496|NCT00569803|82960945|FG007|Overall Study|injection syringe leaked during dosing|0|||
47051122|NCT01884545|83313385|FG001|Overall Study|Non-adherence|2|||
47051123|NCT01884545|83313386|FG002|Overall Study|Non-adherence|0|||
47051124|NCT01884545|83313387|FG003|Overall Study|Non-adherence|0|||
47051125|NCT01895543|83313397|FG000|Overall Study|Withdrawal by Subject|43|||
47051126|NCT01895543|83313397|FG000|Overall Study|Lost to Follow-up|25|||
47051127|NCT01895543|83313397|FG000|Overall Study|Adverse Event|28|||
47051128|NCT01895543|83313397|FG000|Overall Study|Subject's substantial non-compliance|6|||
47051129|NCT01895543|83313397|FG000|Overall Study|Protocol Violation|1|||
47051130|NCT01895543|83313397|FG000|Overall Study|Physician Decision|2|||
46743497|NCT00569803|82960938|FG000|Overall Study|Withdrawal by Subject|0|||
46743498|NCT00569803|82960939|FG001|Overall Study|Withdrawal by Subject|0|||
46743499|NCT00569803|82960940|FG002|Overall Study|Withdrawal by Subject|0|||
47051131|NCT01895543|83313397|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
47051132|NCT04828161|83313494|FG000|Overall Study|Withdrawal by Subject|0|||
47051133|NCT04828161|83313495|FG001|Overall Study|Withdrawal by Subject|3|||
47051134|NCT04828161|83313496|FG002|Overall Study|Withdrawal by Subject|3|||
46743500|NCT00569803|82960941|FG003|Overall Study|Withdrawal by Subject|0|||
46743501|NCT00569803|82960942|FG004|Overall Study|Withdrawal by Subject|0|||
46743502|NCT00569803|82960943|FG005|Overall Study|Withdrawal by Subject|0|||
46743503|NCT00569803|82960944|FG006|Overall Study|Withdrawal by Subject|0|||
46743504|NCT00569803|82960945|FG007|Overall Study|Withdrawal by Subject|1|||
46743505|NCT00920426|82960970|FG000|ITZ111451|Adverse Event|1|||
46743506|NCT00920426|82960971|FG001|ITZ111451|Adverse Event|0|||
46743507|NCT00920426|82960972|FG002|ITZ111451|Adverse Event|0|||
46743508|NCT00920426|82960973|FG003|ITZ111451|Adverse Event|0|||
46743509|NCT00644995|82960987|FG000|Overall Study|Lost to Follow-up|1|||
46743510|NCT00644995|82960988|FG001|Overall Study|Lost to Follow-up|4|||
46743511|NCT00644995|82960987|FG000|Overall Study|Refused|1|||
46743512|NCT00644995|82960988|FG001|Overall Study|Refused|0|||
46743513|NCT00914966|82960996|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
46743514|NCT00914966|82960996|FG000|Step 1: 1500 Units|Physician Decision|1|||
46743515|NCT00914966|82960996|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
46743516|NCT00914810|82961007|FG000|Overall Study|Withdrawal by Subject|1|||
47051135|NCT04828161|83313497|FG003|Overall Study|Withdrawal by Subject|4|||
47051136|NCT04828161|83313494|FG000|Overall Study|Lost to Follow-up|1|||
47051137|NCT04828161|83313495|FG001|Overall Study|Lost to Follow-up|4|||
47051138|NCT04828161|83313496|FG002|Overall Study|Lost to Follow-up|2|||
47051139|NCT04828161|83313497|FG003|Overall Study|Lost to Follow-up|2|||
47051140|NCT04828161|83313494|FG000|Overall Study|Other|2|||
47051141|NCT04828161|83313495|FG001|Overall Study|Other|0|||
47051142|NCT04828161|83313496|FG002|Overall Study|Other|2|||
46635422|NCT01560234|82809081|FG003|Overall Study|Lost to Follow-up|0|||
46743517|NCT00914810|82961008|FG001|Overall Study|Withdrawal by Subject|0|||
46743518|NCT00914810|82961007|FG000|Overall Study|Relocated out of state|1|||
46743519|NCT00914810|82961008|FG001|Overall Study|Relocated out of state|0|||
46743520|NCT00914810|82961007|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
46743521|NCT00914810|82961008|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
46743522|NCT00644917|82961014|FG000|Overall Study|Withdrawal by Subject|2|||
46743523|NCT00914732|82961025|FG000|Overall Study|Lost to Follow-up|6|||
46743524|NCT00914732|82961026|FG001|Overall Study|Lost to Follow-up|7|||
46743525|NCT00914732|82961027|FG002|Overall Study|Lost to Follow-up|9|||
47051143|NCT04828161|83313497|FG003|Overall Study|Other|0|||
47051144|NCT04828161|83313494|FG000|Overall Study|Death|0|||
47051145|NCT04828161|83313495|FG001|Overall Study|Death|0|||
47051146|NCT04828161|83313496|FG002|Overall Study|Death|0|||
47051147|NCT04828161|83313497|FG003|Overall Study|Death|2|||
47051148|NCT01895309|83313595|FG000|Overall Study|Adverse Event|13|||
47051149|NCT01895309|83313596|FG001|Overall Study|Adverse Event|17|||
47051150|NCT01895309|83313595|FG000|Overall Study|Protocol Violation|1|||
47051151|NCT01895309|83313596|FG001|Overall Study|Protocol Violation|0|||
47051152|NCT01895309|83313595|FG000|Overall Study|Lack of Efficacy|1|||
46743526|NCT00914732|82961025|FG000|Overall Study|Withdrawal by Subject|3|||
46743527|NCT00914732|82961026|FG001|Overall Study|Withdrawal by Subject|0|||
46743528|NCT00914732|82961027|FG002|Overall Study|Withdrawal by Subject|2|||
46743529|NCT00914732|82961025|FG000|Overall Study|Adverse Event|1|||
46743530|NCT00914732|82961026|FG001|Overall Study|Adverse Event|0|||
46922367|NCT00882440|83155171|FG002|Overall Study|Protocol Violation|1|||
46743531|NCT00914732|82961027|FG002|Overall Study|Adverse Event|0|||
46743532|NCT00844545|82961036|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
46743533|NCT00844545|82961036|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
46743534|NCT00844545|82961036|FG000|Extension Treatment Period|Adverse Event|2|||
46743535|NCT00844545|82961036|FG000|Post Treatment Period|Withdrawal by Subject|1|||
46743536|NCT00651157|82961041|FG000|Overall Study|Death|1|||
46743537|NCT00651157|82961041|FG000|Overall Study|Protocol Violation|1|||
46743538|NCT00843843|82961047|FG000|Overall Study|Physician Decision|1|||
46743539|NCT00843843|82961048|FG001|Overall Study|Physician Decision|1|||
46743540|NCT00843843|82961047|FG000|Overall Study|Protocol Violation|1|||
46743541|NCT00843843|82961048|FG001|Overall Study|Protocol Violation|1|||
46922368|NCT00882440|83155172|FG003|Overall Study|Protocol Violation|1|||
46922369|NCT00882440|83155173|FG004|Overall Study|Protocol Violation|1|||
46922370|NCT00882440|83155174|FG005|Overall Study|Protocol Violation|0|||
46922371|NCT00882440|83155175|FG006|Overall Study|Protocol Violation|0|||
46922372|NCT00882440|83155169|FG000|Overall Study|Withdrawal by Subject|2|||
46922373|NCT00882440|83155170|FG001|Overall Study|Withdrawal by Subject|1|||
46922374|NCT00882440|83155171|FG002|Overall Study|Withdrawal by Subject|1|||
46922375|NCT00882440|83155172|FG003|Overall Study|Withdrawal by Subject|0|||
46922376|NCT00882440|83155173|FG004|Overall Study|Withdrawal by Subject|6|||
46922377|NCT00882440|83155174|FG005|Overall Study|Withdrawal by Subject|0|||
46922378|NCT00882440|83155175|FG006|Overall Study|Withdrawal by Subject|1|||
46922379|NCT00882440|83155169|FG000|Overall Study|Patient Uncooperative|2|||
46922380|NCT00882440|83155170|FG001|Overall Study|Patient Uncooperative|0|||
46922381|NCT00882440|83155171|FG002|Overall Study|Patient Uncooperative|0|||
46922382|NCT00882440|83155172|FG003|Overall Study|Patient Uncooperative|0|||
46922383|NCT00882440|83155173|FG004|Overall Study|Patient Uncooperative|1|||
46743542|NCT00650845|82961056|FG000|Overall Study|Withdrawal by Subject|5|||
46743543|NCT00650845|82961057|FG001|Overall Study|Withdrawal by Subject|0|||
46743544|NCT00650845|82961056|FG000|Overall Study|Protocol Violation|0|||
46922384|NCT00882440|83155174|FG005|Overall Study|Patient Uncooperative|0|||
46922385|NCT00882440|83155175|FG006|Overall Study|Patient Uncooperative|0|||
46743545|NCT00650845|82961057|FG001|Overall Study|Protocol Violation|13|||
46922386|NCT03005067|83155186|FG000|Overall Study|Withdrawal by Subject|3|||
46922387|NCT03005067|83155187|FG001|Overall Study|Withdrawal by Subject|2|||
47051153|NCT01895309|83313596|FG001|Overall Study|Lack of Efficacy|3|||
47051154|NCT01895309|83313595|FG000|Overall Study|Lost to Follow-up|1|||
47051155|NCT01895309|83313596|FG001|Overall Study|Lost to Follow-up|3|||
46743546|NCT00842985|82961064|FG000|Screening|Did not meet entrance requirements|27|||
46743547|NCT00842985|82961064|FG000|First Intervention|Withdrawal by Subject|3|||
46743548|NCT00842985|82961064|FG000|First Intervention|Protocol Violation|3|||
46743549|NCT00842985|82961064|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
46743550|NCT00842985|82961064|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
46743551|NCT00842829|82961073|FG000|Dose Titration Period|Adverse Event|11|||
46743552|NCT00842829|82961074|FG001|Dose Titration Period|Adverse Event|10|||
46743553|NCT00842829|82961075|FG002|Dose Titration Period|Adverse Event|0|||
46743554|NCT00842829|82961073|FG000|Dose Titration Period|Lack of Efficacy|4|||
46743555|NCT00842829|82961074|FG001|Dose Titration Period|Lack of Efficacy|1|||
46804156|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
46804157|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
46804158|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
46804159|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
46804160|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
46804161|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
46804162|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
46804163|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
46804164|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
46804165|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
46804166|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
46804167|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
46804168|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
47051156|NCT01895309|83313595|FG000|Overall Study|Physician Decision|15|||
47051157|NCT01895309|83313596|FG001|Overall Study|Physician Decision|10|||
47051158|NCT01895309|83313595|FG000|Overall Study|Withdrawal by Subject|9|||
47051159|NCT01895309|83313596|FG001|Overall Study|Withdrawal by Subject|18|||
47051160|NCT01884311|83313606|FG000|Overall Study|Withdrawal by Subject|3|||
47051161|NCT01884311|83313606|FG000|Overall Study|withdrew consent due to AEs|1|||
47051162|NCT01884311|83313606|FG000|Overall Study|Precautionary measure|1|||
47051163|NCT01884077|83313646|FG000|Overall Study|screen fail|0|||
47051164|NCT01884077|83313647|FG001|Overall Study|screen fail|2|||
47051165|NCT01884077|83313646|FG000|Overall Study|canceled surgery|2|||
47051166|NCT01884077|83313647|FG001|Overall Study|canceled surgery|0|||
47051167|NCT01884077|83313646|FG000|Overall Study|Lost to Follow-up|0|||
47051168|NCT01884077|83313647|FG001|Overall Study|Lost to Follow-up|4|||
47051169|NCT01884077|83313646|FG000|Overall Study|study closed|6|||
47051170|NCT01884077|83313647|FG001|Overall Study|study closed|4|||
47051171|NCT01894919|83313666|FG000|Overall Study|Withdrawal by Subject|1|||
47051172|NCT01894919|83313667|FG001|Overall Study|Withdrawal by Subject|0|||
47051173|NCT01894919|83313668|FG002|Overall Study|Withdrawal by Subject|0|||
47051174|NCT01894919|83313669|FG003|Overall Study|Withdrawal by Subject|0|||
46635423|NCT01560234|82809082|FG004|Overall Study|Lost to Follow-up|0|||
46635424|NCT01560234|82809083|FG005|Overall Study|Lost to Follow-up|2|||
46743556|NCT00842829|82961075|FG002|Dose Titration Period|Lack of Efficacy|0|||
46743557|NCT00842829|82961073|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
46743558|NCT00842829|82961074|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
46743559|NCT00842829|82961075|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
46743560|NCT00842829|82961073|FG000|Dose Titration Period|Withdrawal by Subject|2|||
46743561|NCT00842829|82961074|FG001|Dose Titration Period|Withdrawal by Subject|6|||
46743562|NCT00842829|82961075|FG002|Dose Titration Period|Withdrawal by Subject|0|||
46743563|NCT00842829|82961073|FG000|Dose Titration Period|Other|5|||
46743564|NCT00842829|82961074|FG001|Dose Titration Period|Other|4|||
46743565|NCT00842829|82961075|FG002|Dose Titration Period|Other|0|||
46743566|NCT00842829|82961073|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
46743567|NCT00842829|82961074|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
46743568|NCT00842829|82961075|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
46743569|NCT00842829|82961073|FG000|Dose Titration Period|Non-compliance to study drug|2|||
46743570|NCT00842829|82961074|FG001|Dose Titration Period|Non-compliance to study drug|1|||
46743571|NCT00842829|82961075|FG002|Dose Titration Period|Non-compliance to study drug|0|||
46743572|NCT00842829|82961073|FG000|Treatment Period|Adverse Event|0|||
46743573|NCT00842829|82961074|FG001|Treatment Period|Adverse Event|0|||
46743574|NCT00842829|82961075|FG002|Treatment Period|Adverse Event|15|||
46743575|NCT00842829|82961073|FG000|Treatment Period|Lack of Efficacy|0|||
46743576|NCT00842829|82961074|FG001|Treatment Period|Lack of Efficacy|0|||
46743577|NCT00842829|82961075|FG002|Treatment Period|Lack of Efficacy|6|||
46743578|NCT00842829|82961073|FG000|Treatment Period|Unstable persistent cancer pain|0|||
46922388|NCT03005067|83155186|FG000|Overall Study|Adverse Event|4|||
46922389|NCT03005067|83155187|FG001|Overall Study|Adverse Event|3|||
46922390|NCT03005067|83155186|FG000|Overall Study|Other (reason not specified)|3|||
46922391|NCT03005067|83155187|FG001|Overall Study|Other (reason not specified)|1|||
46922392|NCT03005067|83155186|FG000|Overall Study|Protocol Violation|0|||
46922393|NCT03005067|83155187|FG001|Overall Study|Protocol Violation|1|||
46922394|NCT02658448|83155193|FG000|Overall Study|Lost to Follow-up|1|||
46922395|NCT00870818|83155202|FG000|Overall Study|Lost to Follow-up|3|||
46922396|NCT00870818|83155203|FG001|Overall Study|Lost to Follow-up|2|||
46922397|NCT00870818|83155204|FG002|Overall Study|Lost to Follow-up|1|||
46922398|NCT00870818|83155205|FG003|Overall Study|Lost to Follow-up|0|||
46922399|NCT00870818|83155206|FG004|Overall Study|Lost to Follow-up|0|||
46922400|NCT00870818|83155202|FG000|Overall Study|Withdrawal by Subject|0|||
46922401|NCT00870818|83155203|FG001|Overall Study|Withdrawal by Subject|0|||
46922402|NCT00870818|83155204|FG002|Overall Study|Withdrawal by Subject|1|||
46922403|NCT00870818|83155205|FG003|Overall Study|Withdrawal by Subject|2|||
46922404|NCT00870818|83155206|FG004|Overall Study|Withdrawal by Subject|0|||
46922405|NCT00870818|83155202|FG000|Overall Study|Terminated by sponsor|29|||
46922406|NCT00870818|83155203|FG001|Overall Study|Terminated by sponsor|70|||
46922407|NCT00870818|83155204|FG002|Overall Study|Terminated by sponsor|36|||
46743579|NCT00842829|82961074|FG001|Treatment Period|Unstable persistent cancer pain|0|||
46743580|NCT00842829|82961075|FG002|Treatment Period|Unstable persistent cancer pain|5|||
46922408|NCT00870818|83155205|FG003|Overall Study|Terminated by sponsor|36|||
46922409|NCT00870818|83155206|FG004|Overall Study|Terminated by sponsor|38|||
46922410|NCT00870818|83155202|FG000|Overall Study|Other|0|||
46922411|NCT00870818|83155203|FG001|Overall Study|Other|1|||
46922412|NCT00870818|83155204|FG002|Overall Study|Other|0|||
46922413|NCT00870818|83155205|FG003|Overall Study|Other|0|||
46922414|NCT00870818|83155206|FG004|Overall Study|Other|0|||
47051175|NCT01894919|83313670|FG004|Overall Study|Withdrawal by Subject|1|||
47051176|NCT01894919|83313671|FG005|Overall Study|Withdrawal by Subject|0|||
47051177|NCT01894919|83313672|FG006|Overall Study|Withdrawal by Subject|0|||
47051178|NCT01894919|83313673|FG007|Overall Study|Withdrawal by Subject|0|||
47051179|NCT01894919|83313674|FG008|Overall Study|Withdrawal by Subject|0|||
46743581|NCT00842829|82961073|FG000|Treatment Period|Withdrawal by Subject|0|||
46743582|NCT00842829|82961074|FG001|Treatment Period|Withdrawal by Subject|0|||
46743583|NCT00842829|82961075|FG002|Treatment Period|Withdrawal by Subject|11|||
46743584|NCT00842829|82961073|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
46743585|NCT00842829|82961074|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
46743586|NCT00842829|82961075|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
46743587|NCT00842829|82961073|FG000|Treatment Period|Protocol Violation|0|||
46743588|NCT00842829|82961074|FG001|Treatment Period|Protocol Violation|0|||
46743589|NCT00842829|82961075|FG002|Treatment Period|Protocol Violation|2|||
46743590|NCT00842829|82961073|FG000|Treatment Period|Other|0|||
46743591|NCT00842829|82961074|FG001|Treatment Period|Other|0|||
46743592|NCT00842829|82961075|FG002|Treatment Period|Other|18|||
46743593|NCT00842829|82961073|FG000|Treatment Period|Non-compliance to study procedures|0|||
46743594|NCT00842829|82961074|FG001|Treatment Period|Non-compliance to study procedures|0|||
46743595|NCT00842829|82961075|FG002|Treatment Period|Non-compliance to study procedures|4|||
46743596|NCT00842829|82961073|FG000|Treatment Period|Unclear completion status|0|||
46743597|NCT00842829|82961074|FG001|Treatment Period|Unclear completion status|0|||
46743598|NCT00842829|82961075|FG002|Treatment Period|Unclear completion status|1|||
46743599|NCT00842829|82961073|FG000|Continuation Period|Adverse Event|0|||
46743600|NCT00842829|82961074|FG001|Continuation Period|Adverse Event|0|||
46743601|NCT00842829|82961075|FG002|Continuation Period|Adverse Event|32|||
46743602|NCT00842829|82961073|FG000|Continuation Period|Lack of Efficacy|0|||
46743603|NCT00842829|82961074|FG001|Continuation Period|Lack of Efficacy|0|||
46743604|NCT00842829|82961075|FG002|Continuation Period|Lack of Efficacy|6|||
46743605|NCT00842829|82961073|FG000|Continuation Period|Unstable persistent cancer pain|0|||
46743606|NCT00842829|82961074|FG001|Continuation Period|Unstable persistent cancer pain|0|||
47051180|NCT01894919|83313675|FG009|Overall Study|Withdrawal by Subject|1|||
47051181|NCT01894919|83313676|FG010|Overall Study|Withdrawal by Subject|1|||
47051182|NCT01894919|83313677|FG011|Overall Study|Withdrawal by Subject|0|||
47051183|NCT01894919|83313678|FG012|Overall Study|Withdrawal by Subject|0|||
47051184|NCT01894919|83313666|FG000|Overall Study|Adverse Event|0|||
47051185|NCT01894919|83313667|FG001|Overall Study|Adverse Event|0|||
47051186|NCT01894919|83313668|FG002|Overall Study|Adverse Event|0|||
46743607|NCT00842829|82961075|FG002|Continuation Period|Unstable persistent cancer pain|3|||
46743608|NCT00842829|82961073|FG000|Continuation Period|Withdrawal by Subject|0|||
46743609|NCT00842829|82961074|FG001|Continuation Period|Withdrawal by Subject|0|||
46743610|NCT00842829|82961075|FG002|Continuation Period|Withdrawal by Subject|10|||
46743611|NCT00842829|82961073|FG000|Continuation Period|Other|0|||
46743612|NCT00842829|82961074|FG001|Continuation Period|Other|0|||
46743613|NCT00842829|82961075|FG002|Continuation Period|Other|7|||
46743614|NCT00842829|82961073|FG000|Continuation Period|Non-compliance to study procedures|0|||
46743615|NCT00842829|82961074|FG001|Continuation Period|Non-compliance to study procedures|0|||
46743616|NCT00842829|82961075|FG002|Continuation Period|Non-compliance to study procedures|2|||
46743617|NCT00842829|82961073|FG000|Continuation Period|Non-compliance to study drug|0|||
46743618|NCT00842829|82961074|FG001|Continuation Period|Non-compliance to study drug|0|||
46743619|NCT00842829|82961075|FG002|Continuation Period|Non-compliance to study drug|1|||
46743620|NCT00653263|82961087|FG000|Overall Study|Withdrawal by Subject|1|||
46743621|NCT00653263|82961087|FG000|Overall Study|Physician Decision|1|||
46743622|NCT00842361|82961093|FG000|Overall Study|Protocol Violation|1|||
46743623|NCT00842361|82961094|FG001|Overall Study|Protocol Violation|0|||
46743624|NCT00842361|82961093|FG000|Overall Study|Unclassified|0|||
46743625|NCT00842361|82961094|FG001|Overall Study|Unclassified|2|||
46743626|NCT00841035|82961100|FG000|Phase 1 Overall Study|Physician Decision|13|||
46743627|NCT00642811|82961111|FG000|Overall Study|Adverse Event|2|||
46743628|NCT00642811|82961112|FG001|Overall Study|Adverse Event|3|||
46743629|NCT00642811|82961113|FG002|Overall Study|Adverse Event|0|||
46743630|NCT00642811|82961114|FG003|Overall Study|Adverse Event|0|||
47051187|NCT01894919|83313669|FG003|Overall Study|Adverse Event|0|||
47051188|NCT01894919|83313670|FG004|Overall Study|Adverse Event|0|||
47051189|NCT01894919|83313671|FG005|Overall Study|Adverse Event|0|||
47051190|NCT01894919|83313672|FG006|Overall Study|Adverse Event|0|||
47051191|NCT01894919|83313673|FG007|Overall Study|Adverse Event|0|||
47051192|NCT01894919|83313674|FG008|Overall Study|Adverse Event|0|||
46743631|NCT00642811|82961115|FG004|Overall Study|Adverse Event|0|||
46743632|NCT00642811|82961116|FG005|Overall Study|Adverse Event|1|||
46775744|NCT00793793|82994213|FG009|Overall Study|Protocol Violation|0|||
46922415|NCT03075761|83155220|FG000|Overall Study|Lost to Follow-up|1|||
47051193|NCT01894919|83313675|FG009|Overall Study|Adverse Event|0|||
47051194|NCT01894919|83313676|FG010|Overall Study|Adverse Event|1|||
47051195|NCT01894919|83313677|FG011|Overall Study|Adverse Event|0|||
47051196|NCT01894919|83313678|FG012|Overall Study|Adverse Event|0|||
47051197|NCT01894919|83313666|FG000|Overall Study|Other-Unspecified|1|||
47051198|NCT01894919|83313667|FG001|Overall Study|Other-Unspecified|0|||
47051199|NCT01894919|83313668|FG002|Overall Study|Other-Unspecified|0|||
47051200|NCT01894919|83313669|FG003|Overall Study|Other-Unspecified|0|||
47051201|NCT01894919|83313670|FG004|Overall Study|Other-Unspecified|0|||
47051202|NCT01894919|83313671|FG005|Overall Study|Other-Unspecified|0|||
47051203|NCT01894919|83313672|FG006|Overall Study|Other-Unspecified|0|||
47051204|NCT01894919|83313673|FG007|Overall Study|Other-Unspecified|0|||
47051205|NCT01894919|83313674|FG008|Overall Study|Other-Unspecified|0|||
47051206|NCT01894919|83313675|FG009|Overall Study|Other-Unspecified|0|||
47051207|NCT01894919|83313676|FG010|Overall Study|Other-Unspecified|0|||
47051208|NCT01894919|83313677|FG011|Overall Study|Other-Unspecified|0|||
47051209|NCT01894919|83313678|FG012|Overall Study|Other-Unspecified|0|||
47051210|NCT01894919|83313666|FG000|Overall Study|Lost to Follow-up|0|||
47051211|NCT01894919|83313667|FG001|Overall Study|Lost to Follow-up|0|||
47051212|NCT01894919|83313668|FG002|Overall Study|Lost to Follow-up|0|||
47051213|NCT01894919|83313669|FG003|Overall Study|Lost to Follow-up|0|||
47051214|NCT01894919|83313670|FG004|Overall Study|Lost to Follow-up|2|||
47051215|NCT01894919|83313671|FG005|Overall Study|Lost to Follow-up|0|||
47051216|NCT01894919|83313672|FG006|Overall Study|Lost to Follow-up|0|||
47051217|NCT01894919|83313673|FG007|Overall Study|Lost to Follow-up|0|||
47051218|NCT01894919|83313674|FG008|Overall Study|Lost to Follow-up|0|||
47051219|NCT01894919|83313675|FG009|Overall Study|Lost to Follow-up|0|||
47051220|NCT01894919|83313676|FG010|Overall Study|Lost to Follow-up|0|||
47051221|NCT01894919|83313677|FG011|Overall Study|Lost to Follow-up|0|||
47051222|NCT01894919|83313678|FG012|Overall Study|Lost to Follow-up|0|||
47051223|NCT01894841|83313722|FG000|Overall Study|Withdrawal by Subject|9|||
47051224|NCT01894841|83313723|FG001|Overall Study|Withdrawal by Subject|4|||
47051225|NCT01894841|83313722|FG000|Overall Study|Withdrawn by investigator|2|||
47051226|NCT01894841|83313723|FG001|Overall Study|Withdrawn by investigator|2|||
47051227|NCT01894841|83313722|FG000|Overall Study|Lost to Follow-up|7|||
47051228|NCT01894841|83313723|FG001|Overall Study|Lost to Follow-up|3|||
47051229|NCT01894607|83313733|FG000|Overall Study|Ineligible|1|||
47051230|NCT01883453|83313739|FG000|Overall Study|No episode of common cold|25|||
47051231|NCT01883453|83313740|FG001|Overall Study|No episode of common cold|23|||
47051232|NCT01882985|83313774|FG000|Overall Study|Lost to Follow-up|1|||
47051233|NCT01882985|83313774|FG000|Overall Study|Withdrawal by Subject|1|||
47051234|NCT01893905|83313787|FG000|Overall Study|Withdrawal by Subject|1|||
47051235|NCT01893905|83313788|FG001|Overall Study|Withdrawal by Subject|0|||
47051236|NCT01893905|83313787|FG000|Overall Study|Adverse Event|9|||
47051237|NCT01893905|83313788|FG001|Overall Study|Adverse Event|3|||
47051238|NCT01893905|83313787|FG000|Overall Study|Lack of Efficacy|5|||
47051239|NCT01893905|83313788|FG001|Overall Study|Lack of Efficacy|7|||
47051240|NCT01893905|83313787|FG000|Overall Study|Lost to Follow-up|1|||
47051241|NCT01893905|83313788|FG001|Overall Study|Lost to Follow-up|0|||
47051242|NCT01893905|83313787|FG000|Overall Study|Protocol Violation|6|||
47051243|NCT01893905|83313788|FG001|Overall Study|Protocol Violation|1|||
47051244|NCT01893905|83313787|FG000|Overall Study|Lack of adherence to treatment|2|||
47051245|NCT01893905|83313788|FG001|Overall Study|Lack of adherence to treatment|0|||
47051246|NCT01893905|83313787|FG000|Overall Study|Other reason|1|||
47051247|NCT01893905|83313788|FG001|Overall Study|Other reason|3|||
47051248|NCT01893827|83313801|FG000|Overall Study|Lost to Follow-up|19|||
47051249|NCT01893827|83313802|FG001|Overall Study|Lost to Follow-up|26|||
47051250|NCT01882907|83313810|FG000|Overall Study|Adverse Event|3|||
47051251|NCT01882907|83313811|FG001|Overall Study|Adverse Event|1|||
47051252|NCT01882907|83313810|FG000|Overall Study|Lack of Efficacy|0|||
47051253|NCT01882907|83313811|FG001|Overall Study|Lack of Efficacy|3|||
47051254|NCT01882907|83313810|FG000|Overall Study|Lost to Follow-up|1|||
47051255|NCT01882907|83313811|FG001|Overall Study|Lost to Follow-up|4|||
47051256|NCT01882907|83313810|FG000|Overall Study|Protocol Violation|10|||
47051257|NCT01882907|83313811|FG001|Overall Study|Protocol Violation|14|||
46922416|NCT03075761|83155221|FG001|Overall Study|Lost to Follow-up|6|||
46922417|NCT03000075|83155235|FG000|Part A|Adverse Event|4|||
47051258|NCT01882907|83313810|FG000|Overall Study|Withdrawal by Subject|0|||
47051259|NCT01882907|83313811|FG001|Overall Study|Withdrawal by Subject|6|||
47051260|NCT01893281|83313833|FG000|Overall Study|Adverse Event|1|||
47051261|NCT01893281|83313833|FG000|Overall Study|Protocol Violation|1|||
47051262|NCT01893281|83313833|FG000|Overall Study|Withdrawal by Subject|1|||
47051263|NCT01893203|83313837|FG000|Overall Study|Withdrawal by Subject|1|||
47051264|NCT01882829|83313841|FG000|Overall Study|Adverse Event|4|||
47051265|NCT01882829|83313841|FG000|Overall Study|Protocol Violation|1|||
47051266|NCT01882829|83313841|FG000|Overall Study|Withdrawal by Subject|1|||
47051267|NCT01882439|83313925|FG000|Overall Study|Adverse event related to study drug|3|||
46922418|NCT03000075|83155236|FG001|Part A|Adverse Event|0|||
47051268|NCT01882439|83313926|FG001|Overall Study|Adverse event related to study drug|8|||
46743633|NCT00642811|82961111|FG000|Overall Study|Developement of discontinuation criteria|0|||
46743634|NCT00642811|82961112|FG001|Overall Study|Developement of discontinuation criteria|0|||
46743635|NCT00642811|82961113|FG002|Overall Study|Developement of discontinuation criteria|0|||
46743636|NCT00642811|82961114|FG003|Overall Study|Developement of discontinuation criteria|0|||
46743637|NCT00642811|82961115|FG004|Overall Study|Developement of discontinuation criteria|1|||
46743638|NCT00642811|82961116|FG005|Overall Study|Developement of discontinuation criteria|0|||
46743639|NCT00642811|82961111|FG000|Overall Study|Severe Non-compliance to protocol|1|||
46743640|NCT00642811|82961112|FG001|Overall Study|Severe Non-compliance to protocol|0|||
46743641|NCT00642811|82961113|FG002|Overall Study|Severe Non-compliance to protocol|0|||
46743642|NCT00642811|82961114|FG003|Overall Study|Severe Non-compliance to protocol|0|||
46743643|NCT00642811|82961115|FG004|Overall Study|Severe Non-compliance to protocol|0|||
46743644|NCT00642811|82961116|FG005|Overall Study|Severe Non-compliance to protocol|0|||
46743645|NCT00642811|82961111|FG000|Overall Study|Other|0|||
46743646|NCT00642811|82961112|FG001|Overall Study|Other|1|||
46743647|NCT00642811|82961113|FG002|Overall Study|Other|0|||
46743648|NCT00642811|82961114|FG003|Overall Study|Other|1|||
46743649|NCT00642811|82961115|FG004|Overall Study|Other|0|||
46743650|NCT00642811|82961116|FG005|Overall Study|Other|0|||
46743651|NCT00838929|82961133|FG000|Overall Study|Protocol Violation|0|||
46743652|NCT00838929|82961134|FG001|Overall Study|Protocol Violation|1|||
46743653|NCT00838929|82961135|FG002|Overall Study|Protocol Violation|0|||
46743654|NCT00838929|82961133|FG000|Overall Study|Disease progression|0|||
46743655|NCT00838929|82961134|FG001|Overall Study|Disease progression|2|||
46743656|NCT00838929|82961135|FG002|Overall Study|Disease progression|1|||
46743657|NCT00916058|82961148|FG000|Phase 1|Screen Failure|0|||
46743658|NCT00916058|82961149|FG001|Phase 1|Screen Failure|0|||
46743659|NCT00916058|82961150|FG002|Phase 1|Screen Failure|0|||
46743660|NCT00916058|82961151|FG003|Phase 1|Screen Failure|0|||
46743661|NCT00916058|82961152|FG004|Phase 1|Screen Failure|0|||
46743662|NCT00916058|82961153|FG005|Phase 1|Screen Failure|1|||
46743663|NCT00916058|82961154|FG006|Phase 1|Screen Failure|0|||
46743664|NCT00916058|82961148|FG000|Phase 2|Screen Failure|0|||
46743665|NCT00916058|82961149|FG001|Phase 2|Screen Failure|0|||
46743666|NCT00916058|82961150|FG002|Phase 2|Screen Failure|0|||
46743667|NCT00916058|82961151|FG003|Phase 2|Screen Failure|0|||
46743668|NCT00916058|82961152|FG004|Phase 2|Screen Failure|0|||
46743669|NCT00916058|82961153|FG005|Phase 2|Screen Failure|0|||
46743670|NCT00916058|82961154|FG006|Phase 2|Screen Failure|3|||
46743671|NCT00912782|82961174|FG000|Overall Study|Death|2|||
46743672|NCT00912782|82961175|FG001|Overall Study|Death|1|||
46743673|NCT00912782|82961174|FG000|Overall Study|Lost to Follow-up|0|||
46743674|NCT00912782|82961175|FG001|Overall Study|Lost to Follow-up|1|||
46743675|NCT00912782|82961174|FG000|Overall Study|Did not receive vascular access type|1|||
46743676|NCT00912782|82961175|FG001|Overall Study|Did not receive vascular access type|2|||
46743677|NCT00912782|82961174|FG000|Overall Study|Relocated before study completion|0|||
46743678|NCT00912782|82961175|FG001|Overall Study|Relocated before study completion|1|||
46743679|NCT03444038|82961181|FG000|Overall Study|Adverse Event|12|||
46743680|NCT03444038|82961181|FG000|Overall Study|Withdrawal by Subject|7|||
46743681|NCT03444038|82961181|FG000|Overall Study|Lost to Follow-up|1|||
46743682|NCT03444038|82961181|FG000|Overall Study|Physician Decision|2|||
46743683|NCT03444038|82961181|FG000|Overall Study|Lack of Efficacy|7|||
46743684|NCT00911534|82961187|FG000|Overall Study|Adverse Event|4|||
46743685|NCT00911534|82961188|FG001|Overall Study|Adverse Event|4|||
46743686|NCT00911534|82961187|FG000|Overall Study|Lost to Follow-up|2|||
46743687|NCT00911534|82961188|FG001|Overall Study|Lost to Follow-up|4|||
46743688|NCT00911534|82961187|FG000|Overall Study|Withdrawal by Subject|2|||
46743689|NCT00911534|82961188|FG001|Overall Study|Withdrawal by Subject|1|||
46743690|NCT00911534|82961187|FG000|Overall Study|Lack of Efficacy|4|||
46743691|NCT00911534|82961188|FG001|Overall Study|Lack of Efficacy|1|||
46743692|NCT00911534|82961187|FG000|Overall Study|Withdrawal of consent|1|||
46743693|NCT00911534|82961188|FG001|Overall Study|Withdrawal of consent|4|||
46743694|NCT00911534|82961187|FG000|Overall Study|Other|2|||
46743695|NCT00911534|82961188|FG001|Overall Study|Other|2|||
46743696|NCT00911300|82961196|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
46743697|NCT00911300|82961197|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
46743698|NCT00911300|82961196|FG000|Overall Study|Death|1|||
46743699|NCT00911300|82961197|FG001|Overall Study|Death|0|||
46743700|NCT00911300|82961196|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
46743701|NCT00911300|82961197|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
46743702|NCT00911300|82961196|FG000|Overall Study|Adverse Event|14|||
46743703|NCT00911300|82961197|FG001|Overall Study|Adverse Event|6|||
46743704|NCT00911300|82961196|FG000|Overall Study|Protocol Violation|3|||
46743705|NCT00911300|82961197|FG001|Overall Study|Protocol Violation|2|||
46743706|NCT00911300|82961196|FG000|Overall Study|Consent Withdrawn|4|||
46743707|NCT00911300|82961197|FG001|Overall Study|Consent Withdrawn|12|||
46743708|NCT00911300|82961196|FG000|Overall Study|Coronary Angiography Performed|1|||
46743709|NCT00911300|82961197|FG001|Overall Study|Coronary Angiography Performed|0|||
46743710|NCT00911300|82961196|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
46743711|NCT00911300|82961197|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
46743712|NCT00911300|82961196|FG000|Overall Study|Received Commercial Treatment|1|||
46743713|NCT00911300|82961197|FG001|Overall Study|Received Commercial Treatment|0|||
46743714|NCT00911300|82961196|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
46743715|NCT00911300|82961197|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
46743716|NCT00911300|82961196|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
46743717|NCT00911300|82961197|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
46743718|NCT00911300|82961196|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
46743719|NCT00911300|82961197|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
46743720|NCT00911300|82961196|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
46743721|NCT00911300|82961197|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
46743722|NCT00911300|82961196|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
46743723|NCT00911300|82961197|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
46743724|NCT00911300|82961196|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
46743725|NCT00911300|82961197|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
46743726|NCT00911300|82961196|FG000|Overall Study|International Normalized Ratio Too High|0|||
46743727|NCT00911300|82961197|FG001|Overall Study|International Normalized Ratio Too High|1|||
46743728|NCT00911300|82961196|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
46743729|NCT00911300|82961197|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
46743730|NCT00911300|82961196|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
46743731|NCT00911300|82961197|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
46804169|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
46743732|NCT00911300|82961196|FG000|Overall Study|Physician Decision|0|||
46743733|NCT00911300|82961197|FG001|Overall Study|Physician Decision|1|||
46743734|NCT00911300|82961196|FG000|Overall Study|Treatment Stopped by Mistake|0|||
46743735|NCT00911300|82961197|FG001|Overall Study|Treatment Stopped by Mistake|1|||
46743736|NCT00911300|82961196|FG000|Overall Study|Randomized; No Study Medication Received|0|||
46743737|NCT00911300|82961197|FG001|Overall Study|Randomized; No Study Medication Received|2|||
46743738|NCT00911144|82961206|FG000|Overall Study|Withdrawal by Subject|16|||
46743739|NCT00911144|82961207|FG001|Overall Study|Withdrawal by Subject|5|||
46743740|NCT00910988|82961217|FG000|Overall Study|Lost to Follow-up|2|||
46743741|NCT00910988|82961218|FG001|Overall Study|Lost to Follow-up|4|||
46743742|NCT00910988|82961219|FG002|Overall Study|Lost to Follow-up|3|||
46743743|NCT00910988|82961220|FG003|Overall Study|Lost to Follow-up|0|||
46743744|NCT00644059|82961249|FG000|Overall Study|Lost to Follow-up|37|||
46743745|NCT00644059|82961250|FG001|Overall Study|Lost to Follow-up|34|||
46743746|NCT00644059|82961251|FG002|Overall Study|Lost to Follow-up|16|||
46743747|NCT00644059|82961249|FG000|Overall Study|Withdrawal by Subject|52|||
46743748|NCT00644059|82961250|FG001|Overall Study|Withdrawal by Subject|60|||
46743749|NCT00644059|82961251|FG002|Overall Study|Withdrawal by Subject|30|||
46743750|NCT00644059|82961249|FG000|Overall Study|Adverse Event|8|||
46743751|NCT00644059|82961250|FG001|Overall Study|Adverse Event|5|||
46743752|NCT00644059|82961251|FG002|Overall Study|Adverse Event|1|||
46743753|NCT00644059|82961249|FG000|Overall Study|Inappropriate Enrollment|1|||
46743754|NCT00644059|82961250|FG001|Overall Study|Inappropriate Enrollment|3|||
46743755|NCT00644059|82961251|FG002|Overall Study|Inappropriate Enrollment|0|||
46743756|NCT00644059|82961249|FG000|Overall Study|Protocol Deviation/violation|20|||
46743757|NCT00644059|82961250|FG001|Overall Study|Protocol Deviation/violation|19|||
46743758|NCT00644059|82961251|FG002|Overall Study|Protocol Deviation/violation|15|||
46743759|NCT00644059|82961249|FG000|Overall Study|Unable to classify|6|||
46743760|NCT00644059|82961250|FG001|Overall Study|Unable to classify|2|||
46743761|NCT00644059|82961251|FG002|Overall Study|Unable to classify|3|||
46743762|NCT00910910|82961302|FG000|Overall Study|Adverse Event|63|||
46743763|NCT00910910|82961303|FG001|Overall Study|Adverse Event|35|||
46743764|NCT00910910|82961302|FG000|Overall Study|PD without histologic change|27|||
46743765|NCT00910910|82961303|FG001|Overall Study|PD without histologic change|23|||
46743766|NCT00910910|82961302|FG000|Overall Study|PD with histologic change|0|||
46743767|NCT00910910|82961303|FG001|Overall Study|PD with histologic change|2|||
46743768|NCT00910910|82961302|FG000|Overall Study|Withdrawal by Subject|7|||
46743769|NCT00910910|82961303|FG001|Overall Study|Withdrawal by Subject|5|||
46743770|NCT00910910|82961302|FG000|Overall Study|Lost to Follow-up|2|||
46743771|NCT00910910|82961303|FG001|Overall Study|Lost to Follow-up|2|||
46743772|NCT00910910|82961302|FG000|Overall Study|Death|9|||
46743773|NCT00910910|82961303|FG001|Overall Study|Death|3|||
46743774|NCT00910910|82961302|FG000|Overall Study|Protocol Violation|2|||
46743775|NCT00910910|82961303|FG001|Overall Study|Protocol Violation|2|||
46743776|NCT00910910|82961302|FG000|Overall Study|Completed 13 cycles of treatment|0|||
46743777|NCT00910910|82961303|FG001|Overall Study|Completed 13 cycles of treatment|118|||
46743778|NCT00910910|82961302|FG000|Overall Study|Other|114|||
46743779|NCT00910910|82961303|FG001|Overall Study|Other|32|||
46743780|NCT00910910|82961302|FG000|Overall Study|Untreated before cycle 1|1|||
46743781|NCT00910910|82961303|FG001|Overall Study|Untreated before cycle 1|2|||
46743782|NCT00911768|82961311|FG000|Overall Study|Protocol Violation|5|||
46743783|NCT00911768|82961312|FG001|Overall Study|Protocol Violation|4|||
46743784|NCT00911768|82961311|FG000|Overall Study|Withdrawal by Subject|1|||
46743785|NCT00911768|82961312|FG001|Overall Study|Withdrawal by Subject|0|||
46743786|NCT00909038|82961318|FG000|Overall Study|Protocol Violation|187|||
46743787|NCT00909038|82961318|FG000|Overall Study|Non-evaluable Subjects|230|||
46743788|NCT00909428|82961325|FG000|Overall Study|Lost to Follow-up|13|||
46743789|NCT00909428|82961326|FG001|Overall Study|Lost to Follow-up|10|||
46743790|NCT00909428|82961327|FG002|Overall Study|Lost to Follow-up|9|||
46743791|NCT00908960|82961337|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
46743792|NCT00908960|82961338|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
46743793|NCT00908960|82961339|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
46743794|NCT00650767|82961357|FG000|Overall Study|Adverse Event|0|||
46743795|NCT00650767|82961358|FG001|Overall Study|Adverse Event|3|||
46743796|NCT00650767|82961359|FG002|Overall Study|Adverse Event|10|||
46743797|NCT00650767|82961360|FG003|Overall Study|Adverse Event|8|||
46922419|NCT03000075|83155237|FG002|Part A|Adverse Event|0|||
46743798|NCT00650767|82961357|FG000|Overall Study|Death|1|||
46743799|NCT00650767|82961358|FG001|Overall Study|Death|0|||
46743800|NCT00650767|82961359|FG002|Overall Study|Death|0|||
46743801|NCT00650767|82961360|FG003|Overall Study|Death|0|||
46743802|NCT00650767|82961357|FG000|Overall Study|Withdrawal by Subject|2|||
46743803|NCT00650767|82961358|FG001|Overall Study|Withdrawal by Subject|4|||
46743804|NCT00650767|82961359|FG002|Overall Study|Withdrawal by Subject|3|||
46743805|NCT00650767|82961360|FG003|Overall Study|Withdrawal by Subject|3|||
46804170|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
46804171|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
46922420|NCT03000075|83155238|FG003|Part A|Adverse Event|0|||
46922421|NCT03000075|83155239|FG004|Part A|Adverse Event|0|||
46743806|NCT00650767|82961357|FG000|Overall Study|Lost to Follow-up|1|||
46743807|NCT00650767|82961358|FG001|Overall Study|Lost to Follow-up|1|||
46743808|NCT00650767|82961359|FG002|Overall Study|Lost to Follow-up|1|||
46743809|NCT00650767|82961360|FG003|Overall Study|Lost to Follow-up|0|||
46743810|NCT00650767|82961357|FG000|Overall Study|Other|1|||
46743811|NCT00650767|82961358|FG001|Overall Study|Other|1|||
46743812|NCT00650767|82961359|FG002|Overall Study|Other|0|||
46743813|NCT00650767|82961360|FG003|Overall Study|Other|0|||
46743814|NCT00973349|82961386|FG000|Overall Study|Adverse Event|0|||
46743815|NCT00973349|82961387|FG001|Overall Study|Adverse Event|0|||
46743816|NCT00973349|82961388|FG002|Overall Study|Adverse Event|0|||
46743817|NCT00973349|82961389|FG003|Overall Study|Adverse Event|0|||
46743818|NCT00973349|82961390|FG004|Overall Study|Adverse Event|1|||
46743819|NCT00973349|82961391|FG005|Overall Study|Adverse Event|0|||
46743820|NCT00973349|82961392|FG006|Overall Study|Adverse Event|0|||
46743821|NCT00973349|82961393|FG007|Overall Study|Adverse Event|0|||
46743822|NCT00973349|82961394|FG008|Overall Study|Adverse Event|1|||
46922422|NCT03000075|83155240|FG005|Part A|Adverse Event|0|||
46922423|NCT03000075|83155241|FG006|Part A|Adverse Event|0|||
46922424|NCT03000075|83155235|FG000|Part B|Not dosed due to AE|0|||
46922425|NCT03000075|83155236|FG001|Part B|Not dosed due to AE|0|||
46743823|NCT00973349|82961395|FG009|Overall Study|Adverse Event|0|||
46743824|NCT00973349|82961396|FG010|Overall Study|Adverse Event|0|||
46743825|NCT00973349|82961397|FG011|Overall Study|Adverse Event|0|||
46743826|NCT00973349|82961398|FG012|Overall Study|Adverse Event|0|||
46743827|NCT00973349|82961399|FG013|Overall Study|Adverse Event|0|||
46743828|NCT00973349|82961400|FG014|Overall Study|Adverse Event|1|||
46743829|NCT00973349|82961401|FG015|Overall Study|Adverse Event|0|||
46743830|NCT00973349|82961386|FG000|Overall Study|Withdrawal by Subject|1|||
46743831|NCT00973349|82961387|FG001|Overall Study|Withdrawal by Subject|2|||
46743832|NCT00973349|82961388|FG002|Overall Study|Withdrawal by Subject|2|||
46743833|NCT00973349|82961389|FG003|Overall Study|Withdrawal by Subject|3|||
46743834|NCT00973349|82961390|FG004|Overall Study|Withdrawal by Subject|2|||
46743835|NCT00973349|82961391|FG005|Overall Study|Withdrawal by Subject|0|||
46743836|NCT00973349|82961392|FG006|Overall Study|Withdrawal by Subject|2|||
46743837|NCT00973349|82961393|FG007|Overall Study|Withdrawal by Subject|2|||
46743838|NCT00973349|82961394|FG008|Overall Study|Withdrawal by Subject|0|||
46743839|NCT00973349|82961395|FG009|Overall Study|Withdrawal by Subject|2|||
46743840|NCT00973349|82961396|FG010|Overall Study|Withdrawal by Subject|0|||
46743841|NCT00973349|82961397|FG011|Overall Study|Withdrawal by Subject|1|||
46743842|NCT00973349|82961398|FG012|Overall Study|Withdrawal by Subject|0|||
46743843|NCT00973349|82961399|FG013|Overall Study|Withdrawal by Subject|0|||
46743844|NCT00973349|82961400|FG014|Overall Study|Withdrawal by Subject|0|||
46743845|NCT00973349|82961401|FG015|Overall Study|Withdrawal by Subject|0|||
46743846|NCT00973349|82961386|FG000|Overall Study|Lost to Follow-up|3|||
46743847|NCT00973349|82961387|FG001|Overall Study|Lost to Follow-up|1|||
46743848|NCT00973349|82961388|FG002|Overall Study|Lost to Follow-up|2|||
46743849|NCT00973349|82961389|FG003|Overall Study|Lost to Follow-up|2|||
46743850|NCT00973349|82961390|FG004|Overall Study|Lost to Follow-up|1|||
46743851|NCT00973349|82961391|FG005|Overall Study|Lost to Follow-up|3|||
46743852|NCT00973349|82961392|FG006|Overall Study|Lost to Follow-up|0|||
46743853|NCT00973349|82961393|FG007|Overall Study|Lost to Follow-up|1|||
46743854|NCT00973349|82961394|FG008|Overall Study|Lost to Follow-up|2|||
46743855|NCT00973349|82961395|FG009|Overall Study|Lost to Follow-up|1|||
46743856|NCT00973349|82961396|FG010|Overall Study|Lost to Follow-up|0|||
46743857|NCT00973349|82961397|FG011|Overall Study|Lost to Follow-up|1|||
46743858|NCT00973349|82961398|FG012|Overall Study|Lost to Follow-up|0|||
46743859|NCT00973349|82961399|FG013|Overall Study|Lost to Follow-up|0|||
46743860|NCT00973349|82961400|FG014|Overall Study|Lost to Follow-up|0|||
46743861|NCT00973349|82961401|FG015|Overall Study|Lost to Follow-up|1|||
46743862|NCT00973349|82961386|FG000|Overall Study|Inappropriate enrolment|0|||
46743863|NCT00973349|82961387|FG001|Overall Study|Inappropriate enrolment|0|||
46743864|NCT00973349|82961388|FG002|Overall Study|Inappropriate enrolment|1|||
46743865|NCT00973349|82961389|FG003|Overall Study|Inappropriate enrolment|0|||
46743866|NCT00973349|82961390|FG004|Overall Study|Inappropriate enrolment|0|||
46743867|NCT00973349|82961391|FG005|Overall Study|Inappropriate enrolment|0|||
46743868|NCT00973349|82961392|FG006|Overall Study|Inappropriate enrolment|0|||
46743869|NCT00973349|82961393|FG007|Overall Study|Inappropriate enrolment|0|||
46743870|NCT00973349|82961394|FG008|Overall Study|Inappropriate enrolment|0|||
47051269|NCT01882439|83313927|FG002|Overall Study|Adverse event related to study drug|1|||
46922426|NCT03000075|83155237|FG002|Part B|Not dosed due to AE|0|||
46922427|NCT03000075|83155238|FG003|Part B|Not dosed due to AE|0|||
46743871|NCT00973349|82961395|FG009|Overall Study|Inappropriate enrolment|2|||
46743872|NCT00973349|82961396|FG010|Overall Study|Inappropriate enrolment|0|||
46922428|NCT03000075|83155239|FG004|Part B|Not dosed due to AE|0|||
47051270|NCT01882439|83313928|FG003|Overall Study|Adverse event related to study drug|2|||
47051271|NCT01882439|83313925|FG000|Overall Study|Pregnancy|0|||
47051272|NCT01882439|83313926|FG001|Overall Study|Pregnancy|1|||
46743873|NCT00973349|82961397|FG011|Overall Study|Inappropriate enrolment|0|||
46743874|NCT00973349|82961398|FG012|Overall Study|Inappropriate enrolment|1|||
46743875|NCT00973349|82961399|FG013|Overall Study|Inappropriate enrolment|0|||
46743876|NCT00973349|82961400|FG014|Overall Study|Inappropriate enrolment|1|||
46743877|NCT00973349|82961401|FG015|Overall Study|Inappropriate enrolment|1|||
46743878|NCT00973349|82961386|FG000|Overall Study|Protocol Violation|0|||
46743879|NCT00973349|82961387|FG001|Overall Study|Protocol Violation|0|||
46743880|NCT00973349|82961388|FG002|Overall Study|Protocol Violation|0|||
46743881|NCT00973349|82961389|FG003|Overall Study|Protocol Violation|0|||
46922429|NCT03000075|83155240|FG005|Part B|Not dosed due to AE|2|||
46922430|NCT03000075|83155241|FG006|Part B|Not dosed due to AE|1|||
46743882|NCT00973349|82961390|FG004|Overall Study|Protocol Violation|0|||
46743883|NCT00973349|82961391|FG005|Overall Study|Protocol Violation|0|||
46743884|NCT00973349|82961392|FG006|Overall Study|Protocol Violation|0|||
46743885|NCT00973349|82961393|FG007|Overall Study|Protocol Violation|0|||
46743886|NCT00973349|82961394|FG008|Overall Study|Protocol Violation|1|||
46743887|NCT00973349|82961395|FG009|Overall Study|Protocol Violation|0|||
46743888|NCT00973349|82961396|FG010|Overall Study|Protocol Violation|0|||
46743889|NCT00973349|82961397|FG011|Overall Study|Protocol Violation|0|||
46743890|NCT00973349|82961398|FG012|Overall Study|Protocol Violation|0|||
46743891|NCT00973349|82961399|FG013|Overall Study|Protocol Violation|0|||
46743892|NCT00973349|82961400|FG014|Overall Study|Protocol Violation|0|||
46743893|NCT00973349|82961401|FG015|Overall Study|Protocol Violation|0|||
46743894|NCT00973349|82961386|FG000|Overall Study|Unable to classify|0|||
46743895|NCT00973349|82961387|FG001|Overall Study|Unable to classify|0|||
46743896|NCT00973349|82961388|FG002|Overall Study|Unable to classify|0|||
46743897|NCT00973349|82961389|FG003|Overall Study|Unable to classify|0|||
46743898|NCT00973349|82961390|FG004|Overall Study|Unable to classify|1|||
46743899|NCT00973349|82961391|FG005|Overall Study|Unable to classify|1|||
46743900|NCT00973349|82961392|FG006|Overall Study|Unable to classify|0|||
46743901|NCT00973349|82961393|FG007|Overall Study|Unable to classify|0|||
46743902|NCT00973349|82961394|FG008|Overall Study|Unable to classify|0|||
46743903|NCT00973349|82961395|FG009|Overall Study|Unable to classify|1|||
46743904|NCT00973349|82961396|FG010|Overall Study|Unable to classify|0|||
46743905|NCT00973349|82961397|FG011|Overall Study|Unable to classify|0|||
46743906|NCT00973349|82961398|FG012|Overall Study|Unable to classify|0|||
46743907|NCT00973349|82961399|FG013|Overall Study|Unable to classify|0|||
46743908|NCT00973349|82961400|FG014|Overall Study|Unable to classify|0|||
46743909|NCT00973349|82961401|FG015|Overall Study|Unable to classify|0|||
46743910|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Death|20|||
46743911|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Death|26|||
46743912|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
46743913|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
47051273|NCT01882439|83313927|FG002|Overall Study|Pregnancy|0|||
47051274|NCT01882439|83313928|FG003|Overall Study|Pregnancy|0|||
47051275|NCT01882439|83313925|FG000|Overall Study|Protocol Violation|2|||
47051276|NCT01882439|83313926|FG001|Overall Study|Protocol Violation|2|||
47051277|NCT01882439|83313927|FG002|Overall Study|Protocol Violation|0|||
47051278|NCT01882439|83313928|FG003|Overall Study|Protocol Violation|1|||
47051279|NCT01882439|83313925|FG000|Overall Study|No longer willing to participate|1|||
46743914|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
46743915|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
46743916|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
46743917|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
46743918|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
46743919|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
46743920|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
46743921|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
46743922|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
46743923|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
46743924|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
46743925|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
46743926|NCT00643201|82961429|FG000|Randomized, Completed 6 Months of Study|Other|107|||
46743927|NCT00643201|82961430|FG001|Randomized, Completed 6 Months of Study|Other|107|||
46743928|NCT00643201|82961429|FG000|Completed Study Follow Up|Death|28|||
46743929|NCT00643201|82961430|FG001|Completed Study Follow Up|Death|34|||
46743930|NCT00643201|82961429|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
46743931|NCT00643201|82961430|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
46743932|NCT00643201|82961429|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
46743933|NCT00643201|82961430|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
46743934|NCT00643201|82961429|FG000|Completed Study Follow Up|non-specified|1|||
46743935|NCT00643201|82961430|FG001|Completed Study Follow Up|non-specified|0|||
46743936|NCT00643123|82961440|FG000|Overall Study|Lost to Follow-up|4|||
46743937|NCT00643123|82961441|FG001|Overall Study|Lost to Follow-up|0|||
46743938|NCT00643123|82961440|FG000|Overall Study|Withdrawal by Subject|1|||
46743939|NCT00643123|82961441|FG001|Overall Study|Withdrawal by Subject|1|||
46743940|NCT00968981|82961450|FG000|Overall Study|Adverse Event|2|||
46743941|NCT00968981|82961451|FG001|Overall Study|Adverse Event|0|||
46743942|NCT00968981|82961452|FG002|Overall Study|Adverse Event|0|||
46743943|NCT00968981|82961450|FG000|Overall Study|Disease Progression|14|||
46743944|NCT00968981|82961451|FG001|Overall Study|Disease Progression|16|||
46743945|NCT00968981|82961452|FG002|Overall Study|Disease Progression|13|||
47051280|NCT01882439|83313926|FG001|Overall Study|No longer willing to participate|4|||
46743946|NCT00968981|82961450|FG000|Overall Study|Lost to Follow-up|0|||
47051281|NCT01882439|83313927|FG002|Overall Study|No longer willing to participate|2|||
46743947|NCT00968981|82961451|FG001|Overall Study|Lost to Follow-up|0|||
46743948|NCT00968981|82961452|FG002|Overall Study|Lost to Follow-up|1|||
46743949|NCT00968981|82961450|FG000|Overall Study|Physician Decision|5|||
46743950|NCT00968981|82961451|FG001|Overall Study|Physician Decision|3|||
46743951|NCT00968981|82961452|FG002|Overall Study|Physician Decision|5|||
46743952|NCT00968981|82961450|FG000|Overall Study|Withdrawal by Subject|1|||
46743953|NCT00968981|82961451|FG001|Overall Study|Withdrawal by Subject|3|||
46743954|NCT00968981|82961452|FG002|Overall Study|Withdrawal by Subject|3|||
46743955|NCT00641719|82961463|FG000|Overall Study|Lack of Efficacy|1|||
46743956|NCT00641719|82961464|FG001|Overall Study|Lack of Efficacy|2|||
46743957|NCT00641719|82961463|FG000|Overall Study|Adverse Event|24|||
46743958|NCT00641719|82961464|FG001|Overall Study|Adverse Event|29|||
46743959|NCT00641719|82961463|FG000|Overall Study|Withdrawal by Subject|4|||
46743960|NCT00641719|82961464|FG001|Overall Study|Withdrawal by Subject|4|||
46743961|NCT00641719|82961463|FG000|Overall Study|Reason Not Specified|1|||
46743962|NCT00641719|82961464|FG001|Overall Study|Reason Not Specified|2|||
46743963|NCT00648895|82961472|FG000|Overall Study|Lack of Efficacy|0|||
46743964|NCT00648895|82961473|FG001|Overall Study|Lack of Efficacy|1|||
46743965|NCT00975221|82961481|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
46743966|NCT00975221|82961482|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
46743967|NCT00975221|82961481|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
46743968|NCT00975221|82961482|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
46743969|NCT00975221|82961481|FG000|Titration Phase (Weeks 1-12)|Other|0|||
46743970|NCT00975221|82961482|FG001|Titration Phase (Weeks 1-12)|Other|1|||
46743971|NCT00975221|82961481|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
46743972|NCT00975221|82961482|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
46743973|NCT00975221|82961481|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
46743974|NCT00975221|82961482|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
46743975|NCT00975221|82961481|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
46743976|NCT00975221|82961482|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
46743977|NCT00972179|82961497|FG000|Overall Study|Noncompliance|1|||
46743978|NCT00972179|82961498|FG001|Overall Study|Noncompliance|0|||
46743979|NCT00972179|82961499|FG002|Overall Study|Noncompliance|0|||
46743980|NCT00972179|82961500|FG003|Overall Study|Noncompliance|0|||
46743981|NCT00972179|82961501|FG004|Overall Study|Noncompliance|1|||
46743982|NCT00972179|82961502|FG005|Overall Study|Noncompliance|0|||
46743983|NCT00972179|82961503|FG006|Overall Study|Noncompliance|1|||
46743984|NCT00972179|82961497|FG000|Overall Study|Withdrawal by Subject|0|||
46743985|NCT00972179|82961498|FG001|Overall Study|Withdrawal by Subject|3|||
46743986|NCT00972179|82961499|FG002|Overall Study|Withdrawal by Subject|0|||
46743987|NCT00972179|82961500|FG003|Overall Study|Withdrawal by Subject|1|||
46743988|NCT00972179|82961501|FG004|Overall Study|Withdrawal by Subject|0|||
46743989|NCT00972179|82961502|FG005|Overall Study|Withdrawal by Subject|0|||
46743990|NCT00972179|82961503|FG006|Overall Study|Withdrawal by Subject|2|||
46743991|NCT00972179|82961497|FG000|Overall Study|Administrative Decision|0|||
46743992|NCT00972179|82961498|FG001|Overall Study|Administrative Decision|0|||
46743993|NCT00972179|82961499|FG002|Overall Study|Administrative Decision|0|||
46743994|NCT00972179|82961500|FG003|Overall Study|Administrative Decision|0|||
46743995|NCT00972179|82961501|FG004|Overall Study|Administrative Decision|1|||
46743996|NCT00972179|82961502|FG005|Overall Study|Administrative Decision|0|||
46743997|NCT00972179|82961503|FG006|Overall Study|Administrative Decision|0|||
46743998|NCT00972179|82961497|FG000|Overall Study|Lost to Follow-up|0|||
46743999|NCT00972179|82961498|FG001|Overall Study|Lost to Follow-up|0|||
46744000|NCT00972179|82961499|FG002|Overall Study|Lost to Follow-up|1|||
46744001|NCT00972179|82961500|FG003|Overall Study|Lost to Follow-up|0|||
46744002|NCT00972179|82961501|FG004|Overall Study|Lost to Follow-up|0|||
46744003|NCT00972179|82961502|FG005|Overall Study|Lost to Follow-up|3|||
46744004|NCT00972179|82961503|FG006|Overall Study|Lost to Follow-up|1|||
46744005|NCT00906698|82961529|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
46744006|NCT00906698|82961530|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
46744007|NCT00906698|82961531|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
46744008|NCT00906698|82961532|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
46744009|NCT00906698|82961533|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
46744010|NCT00906698|82961534|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
46744011|NCT00906698|82961529|FG000|Overall Study|Adverse Event|0|||
46744012|NCT00906698|82961530|FG001|Overall Study|Adverse Event|0|||
46744013|NCT00906698|82961531|FG002|Overall Study|Adverse Event|2|||
46744014|NCT00906698|82961532|FG003|Overall Study|Adverse Event|0|||
46744015|NCT00906698|82961533|FG004|Overall Study|Adverse Event|4|||
46744016|NCT00906698|82961534|FG005|Overall Study|Adverse Event|1|||
46744017|NCT00906698|82961529|FG000|Overall Study|Disease progression|3|||
46744018|NCT00906698|82961530|FG001|Overall Study|Disease progression|12|||
46744019|NCT00906698|82961531|FG002|Overall Study|Disease progression|4|||
46744020|NCT00906698|82961532|FG003|Overall Study|Disease progression|4|||
46744021|NCT00906698|82961533|FG004|Overall Study|Disease progression|12|||
46744022|NCT00906698|82961534|FG005|Overall Study|Disease progression|4|||
46744023|NCT00906698|82961529|FG000|Overall Study|Withdrawal by Subject|0|||
46922431|NCT03000075|83155235|FG000|Part B|Adverse Event|0|||
46922432|NCT03000075|83155236|FG001|Part B|Adverse Event|0|||
46922433|NCT03000075|83155237|FG002|Part B|Adverse Event|0|||
46744024|NCT00906698|82961530|FG001|Overall Study|Withdrawal by Subject|0|||
46744025|NCT00906698|82961531|FG002|Overall Study|Withdrawal by Subject|0|||
46744026|NCT00906698|82961532|FG003|Overall Study|Withdrawal by Subject|0|||
46744027|NCT00906698|82961533|FG004|Overall Study|Withdrawal by Subject|1|||
46744028|NCT00906698|82961534|FG005|Overall Study|Withdrawal by Subject|0|||
46744029|NCT00906698|82961529|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
46744030|NCT00906698|82961530|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
46744031|NCT00906698|82961531|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
46744032|NCT00906698|82961532|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
46744033|NCT00906698|82961533|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
46744034|NCT00906698|82961534|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
46744035|NCT00972023|82961566|FG000|Overall Study|Withdrawal by Subject|1|||
46744036|NCT00971945|82961572|FG000|Overall Study|Progressive Disease|3|||
46744037|NCT00971945|82961572|FG000|Overall Study|Change in treatment policy|1|||
46744038|NCT00971945|82961572|FG000|Overall Study|Other reasons|2|||
46744039|NCT00971867|82961576|FG000|Overall Study|Adverse Event|4|||
46744040|NCT00971867|82961576|FG000|Overall Study|Participant Withdrew Consent|1|||
46744041|NCT00971867|82961576|FG000|Overall Study|Disease Progression|6|||
46744042|NCT00971321|82961582|FG000|Up to Month 7|Withdrawal by Subject|1|||
46744043|NCT00971321|82961583|FG001|Up to Month 7|Withdrawal by Subject|0|||
46744044|NCT00971321|82961582|FG000|Up to Month 7|Migrated/moved from study area|3|||
46922434|NCT03000075|83155238|FG003|Part B|Adverse Event|0|||
46922435|NCT03000075|83155239|FG004|Part B|Adverse Event|1|||
46922436|NCT03000075|83155240|FG005|Part B|Adverse Event|0|||
46922437|NCT03000075|83155241|FG006|Part B|Adverse Event|0|||
46744045|NCT00971321|82961583|FG001|Up to Month 7|Migrated/moved from study area|2|||
46744046|NCT00971321|82961582|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
46744047|NCT00971321|82961583|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
46744048|NCT00971321|82961582|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
46744049|NCT00971321|82961583|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
46744050|NCT00971321|82961582|FG000|Up to Month 11-12|Lost to Follow-up|1|||
46744051|NCT00971321|82961583|FG001|Up to Month 11-12|Lost to Follow-up|0|||
46744052|NCT00648739|82961589|FG000|Overall Study|Adverse Event|1|||
46744053|NCT00648739|82961590|FG001|Overall Study|Adverse Event|0|||
46744054|NCT00648739|82961591|FG002|Overall Study|Adverse Event|1|||
46744055|NCT00648739|82961592|FG003|Overall Study|Adverse Event|2|||
46744056|NCT00648739|82961593|FG004|Overall Study|Adverse Event|1|||
46744057|NCT00648739|82961594|FG005|Overall Study|Adverse Event|0|||
46744058|NCT00648739|82961595|FG006|Overall Study|Adverse Event|0|||
46744059|NCT00648739|82961589|FG000|Overall Study|Withdrawal by Subject|1|||
46744060|NCT00648739|82961590|FG001|Overall Study|Withdrawal by Subject|0|||
46744061|NCT00648739|82961591|FG002|Overall Study|Withdrawal by Subject|1|||
46922438|NCT03073109|83155259|FG000|Overall Study|Adverse Event|0|||
46922439|NCT03073109|83155260|FG001|Overall Study|Adverse Event|1|||
46922440|NCT03073109|83155259|FG000|Overall Study|Other|2|||
47051282|NCT01882439|83313928|FG003|Overall Study|No longer willing to participate|3|||
47051283|NCT01882439|83313925|FG000|Overall Study|Medication error with no associated AE|0|||
47051284|NCT01882439|83313926|FG001|Overall Study|Medication error with no associated AE|0|||
47051285|NCT01882439|83313927|FG002|Overall Study|Medication error with no associated AE|2|||
47051286|NCT01882439|83313928|FG003|Overall Study|Medication error with no associated AE|0|||
47051287|NCT01882439|83313925|FG000|Overall Study|Insufficient clinical response|1|||
47051288|NCT01882439|83313926|FG001|Overall Study|Insufficient clinical response|4|||
47051289|NCT01882439|83313927|FG002|Overall Study|Insufficient clinical response|4|||
46744062|NCT00648739|82961592|FG003|Overall Study|Withdrawal by Subject|0|||
46744063|NCT00648739|82961593|FG004|Overall Study|Withdrawal by Subject|0|||
46922441|NCT03073109|83155260|FG001|Overall Study|Other|0|||
46922442|NCT03073109|83155259|FG000|Overall Study|Lost to Follow-up|8|||
46922443|NCT03073109|83155260|FG001|Overall Study|Lost to Follow-up|1|||
46922444|NCT02371889|83155282|FG000|Overall Study|Adverse medication effect|11|||
47051290|NCT01882439|83313928|FG003|Overall Study|Insufficient clinical response|2|||
46744064|NCT00648739|82961594|FG005|Overall Study|Withdrawal by Subject|2|||
46744065|NCT00648739|82961595|FG006|Overall Study|Withdrawal by Subject|0|||
46744066|NCT00648739|82961589|FG000|Overall Study|Lack of Efficacy|0|||
46744067|NCT00648739|82961590|FG001|Overall Study|Lack of Efficacy|0|||
46744068|NCT00648739|82961591|FG002|Overall Study|Lack of Efficacy|0|||
46922445|NCT02371889|83155283|FG001|Overall Study|Adverse medication effect|2|||
46922446|NCT02371889|83155282|FG000|Overall Study|Lost to Follow-up|6|||
46922447|NCT02371889|83155283|FG001|Overall Study|Lost to Follow-up|5|||
46744069|NCT00648739|82961592|FG003|Overall Study|Lack of Efficacy|0|||
46744070|NCT00648739|82961593|FG004|Overall Study|Lack of Efficacy|1|||
46744071|NCT00648739|82961594|FG005|Overall Study|Lack of Efficacy|2|||
46744072|NCT00648739|82961595|FG006|Overall Study|Lack of Efficacy|0|||
46744073|NCT00648739|82961589|FG000|Overall Study|Investigator Considered it Advisable|0|||
46744074|NCT00648739|82961590|FG001|Overall Study|Investigator Considered it Advisable|0|||
46744075|NCT00648739|82961591|FG002|Overall Study|Investigator Considered it Advisable|0|||
46922448|NCT02371889|83155282|FG000|Overall Study|Personal time constraints|2|||
46922449|NCT02371889|83155283|FG001|Overall Study|Personal time constraints|4|||
46922450|NCT02371889|83155282|FG000|Overall Study|Lack of Efficacy|0|||
46922451|NCT02371889|83155283|FG001|Overall Study|Lack of Efficacy|2|||
46922452|NCT02371889|83155282|FG000|Overall Study|Relapse|0|||
46922453|NCT02371889|83155283|FG001|Overall Study|Relapse|1|||
46922454|NCT03072875|83155293|FG000|Overall Study|Lost to Follow-up|1|||
46922455|NCT04250077|83155301|FG000|Overall Study|Withdrawal by Subject|0|||
46922456|NCT04250077|83155302|FG001|Overall Study|Withdrawal by Subject|1|||
46922457|NCT04250077|83155303|FG002|Overall Study|Withdrawal by Subject|0|||
46922458|NCT04250077|83155301|FG000|Overall Study|Lost to Follow-up|2|||
46922459|NCT04250077|83155302|FG001|Overall Study|Lost to Follow-up|3|||
46922460|NCT04250077|83155303|FG002|Overall Study|Lost to Follow-up|0|||
46922461|NCT00859430|83155315|FG000|First Intervention|Withdrawal by Subject|0|||
46922462|NCT00859430|83155316|FG001|First Intervention|Withdrawal by Subject|1|||
46922463|NCT02913105|83155333|FG000|Overall Study|Adverse Event|11|||
47051291|NCT01882439|83313925|FG000|Overall Study|Adverse event unrelated to study drug|2|||
47051292|NCT01882439|83313926|FG001|Overall Study|Adverse event unrelated to study drug|2|||
47051293|NCT01882439|83313927|FG002|Overall Study|Adverse event unrelated to study drug|1|||
47051294|NCT01882439|83313928|FG003|Overall Study|Adverse event unrelated to study drug|1|||
46744076|NCT00648739|82961592|FG003|Overall Study|Investigator Considered it Advisable|0|||
46922464|NCT02913105|83155334|FG001|Overall Study|Adverse Event|0|||
46922465|NCT02913105|83155335|FG002|Overall Study|Adverse Event|4|||
46744077|NCT00648739|82961593|FG004|Overall Study|Investigator Considered it Advisable|0|||
46744078|NCT00648739|82961594|FG005|Overall Study|Investigator Considered it Advisable|1|||
46744079|NCT00648739|82961595|FG006|Overall Study|Investigator Considered it Advisable|1|||
46744080|NCT00648739|82961589|FG000|Overall Study|Death|0|||
46744081|NCT00648739|82961590|FG001|Overall Study|Death|1|||
46744082|NCT00648739|82961591|FG002|Overall Study|Death|0|||
46744083|NCT00648739|82961592|FG003|Overall Study|Death|0|||
46744084|NCT00648739|82961593|FG004|Overall Study|Death|0|||
46744085|NCT00648739|82961594|FG005|Overall Study|Death|0|||
46744086|NCT00648739|82961595|FG006|Overall Study|Death|0|||
46744087|NCT00648739|82961589|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
46744088|NCT00648739|82961590|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
46744089|NCT00648739|82961591|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
46744090|NCT00648739|82961592|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
46744091|NCT00648739|82961593|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
46744092|NCT00648739|82961594|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
46744093|NCT00648739|82961595|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
46744094|NCT00648739|82961589|FG000|Overall Study|Follow-up Visits Not Completed|0|||
46744095|NCT00648739|82961590|FG001|Overall Study|Follow-up Visits Not Completed|1|||
46744096|NCT00648739|82961591|FG002|Overall Study|Follow-up Visits Not Completed|0|||
46744097|NCT00648739|82961592|FG003|Overall Study|Follow-up Visits Not Completed|0|||
46744098|NCT00648739|82961593|FG004|Overall Study|Follow-up Visits Not Completed|0|||
46744099|NCT00648739|82961594|FG005|Overall Study|Follow-up Visits Not Completed|0|||
46744100|NCT00648739|82961595|FG006|Overall Study|Follow-up Visits Not Completed|0|||
46744101|NCT00648037|82961616|FG000|Overall Study|Not Treated|1|||
46744102|NCT00648037|82961616|FG000|Overall Study|Withdrawal by Subject|1|||
46744103|NCT00648037|82961616|FG000|Overall Study|Adverse Event|11|||
46744104|NCT00648037|82961616|FG000|Overall Study|Relapse|2|||
46744105|NCT00648037|82961616|FG000|Overall Study|Other|1|||
46922466|NCT02913105|83155333|FG000|Overall Study|Non-Compliance With Study Drug|0|||
47051295|NCT01892657|83313975|FG000|Overall Study|Withdrawal by Subject|6|||
46922467|NCT02913105|83155334|FG001|Overall Study|Non-Compliance With Study Drug|0|||
47051296|NCT01892657|83313975|FG000|Overall Study|Protocol Violation|12|||
46922468|NCT02913105|83155335|FG002|Overall Study|Non-Compliance With Study Drug|1|||
46922469|NCT02913105|83155333|FG000|Overall Study|Reason Not Specified|3|||
46922470|NCT02913105|83155334|FG001|Overall Study|Reason Not Specified|1|||
46922471|NCT02913105|83155335|FG002|Overall Study|Reason Not Specified|1|||
47051297|NCT01881737|83314002|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
46744106|NCT00627523|82961622|FG000|Overall Study|Lack of Efficacy|1|||
46744107|NCT00627523|82961623|FG001|Overall Study|Lack of Efficacy|0|||
46744108|NCT00627523|82961622|FG000|Overall Study|Withdrawal by Subject|0|||
46744109|NCT00627523|82961623|FG001|Overall Study|Withdrawal by Subject|2|||
46744110|NCT00627523|82961622|FG000|Overall Study|Other|1|||
46744111|NCT00627523|82961623|FG001|Overall Study|Other|0|||
46744112|NCT00640393|82961629|FG000|Part 1|Lost to Follow-up|2|||
46922472|NCT02913105|83155333|FG000|Overall Study|Physician Decision|1|||
46744113|NCT00640393|82961630|FG001|Part 1|Lost to Follow-up|0|||
46744114|NCT00640393|82961631|FG002|Part 1|Lost to Follow-up|0|||
46744115|NCT00640393|82961629|FG000|Part 1|Withdrawal by Subject|3|||
46744116|NCT00640393|82961630|FG001|Part 1|Withdrawal by Subject|0|||
46744117|NCT00640393|82961631|FG002|Part 1|Withdrawal by Subject|0|||
46744118|NCT00640393|82961629|FG000|Randomization|Withdrawn per protocol|17|||
46744119|NCT00640393|82961630|FG001|Randomization|Withdrawn per protocol|0|||
46744120|NCT00640393|82961631|FG002|Randomization|Withdrawn per protocol|0|||
46744121|NCT00640393|82961629|FG000|Randomization|Never randomized by site|2|||
46744122|NCT00640393|82961630|FG001|Randomization|Never randomized by site|0|||
46744123|NCT00640393|82961631|FG002|Randomization|Never randomized by site|0|||
46744124|NCT00640393|82961629|FG000|Part 2|Lost to Follow-up|0|||
46922473|NCT02913105|83155334|FG001|Overall Study|Physician Decision|1|||
46744125|NCT00640393|82961630|FG001|Part 2|Lost to Follow-up|2|||
46744126|NCT00640393|82961631|FG002|Part 2|Lost to Follow-up|2|||
46744127|NCT00640393|82961629|FG000|Part 2|Withdrawal by Subject|0|||
46744128|NCT00640393|82961630|FG001|Part 2|Withdrawal by Subject|6|||
46744129|NCT00640393|82961631|FG002|Part 2|Withdrawal by Subject|1|||
46744130|NCT00640393|82961629|FG000|Part 2|Non-adherence|0|||
46744131|NCT00640393|82961630|FG001|Part 2|Non-adherence|1|||
46744132|NCT00640393|82961631|FG002|Part 2|Non-adherence|0|||
46922474|NCT02913105|83155335|FG002|Overall Study|Physician Decision|0|||
46922475|NCT02913105|83155333|FG000|Overall Study|Withdrawal by Subject|0|||
46922476|NCT02913105|83155334|FG001|Overall Study|Withdrawal by Subject|3|||
46922477|NCT02913105|83155335|FG002|Overall Study|Withdrawal by Subject|1|||
46922478|NCT00840632|83155353|FG000|First Intervention|Withdrawal by Subject|0|||
46922479|NCT00840632|83155354|FG001|First Intervention|Withdrawal by Subject|1|||
46922480|NCT00840632|83155353|FG000|Washout|Withdrawal by Subject|1|||
46744133|NCT00640393|82961629|FG000|Part 2|Adverse Event|0|||
46744134|NCT00640393|82961630|FG001|Part 2|Adverse Event|1|||
46744135|NCT00640393|82961631|FG002|Part 2|Adverse Event|0|||
46744136|NCT00907478|82961642|FG000|Overall Study|Ineligibility determined|0|||
46744137|NCT00907478|82961643|FG001|Overall Study|Ineligibility determined|0|||
46744138|NCT00907478|82961644|FG002|Overall Study|Ineligibility determined|1|||
46744139|NCT00907478|82961642|FG000|Overall Study|Noncompliance|0|||
46744140|NCT00907478|82961643|FG001|Overall Study|Noncompliance|0|||
46744141|NCT00907478|82961644|FG002|Overall Study|Noncompliance|1|||
46744142|NCT00907478|82961642|FG000|Overall Study|Adverse Event|3|||
46744143|NCT00907478|82961643|FG001|Overall Study|Adverse Event|1|||
46744144|NCT00907478|82961644|FG002|Overall Study|Adverse Event|2|||
46744145|NCT00907478|82961642|FG000|Overall Study|Withdrawal by Subject|8|||
46744146|NCT00907478|82961643|FG001|Overall Study|Withdrawal by Subject|9|||
46744147|NCT00907478|82961644|FG002|Overall Study|Withdrawal by Subject|6|||
46744148|NCT00907478|82961642|FG000|Overall Study|Requirement for alternative therapy|1|||
46744149|NCT00907478|82961643|FG001|Overall Study|Requirement for alternative therapy|2|||
46922481|NCT00840632|83155354|FG001|Washout|Withdrawal by Subject|1|||
46922482|NCT01602562|83155371|FG000|Overall Study|Adverse Event|3|||
46744150|NCT00907478|82961644|FG002|Overall Study|Requirement for alternative therapy|3|||
46744151|NCT00907478|82961642|FG000|Overall Study|Physician Decision|2|||
46744152|NCT00907478|82961643|FG001|Overall Study|Physician Decision|0|||
46744153|NCT00907478|82961644|FG002|Overall Study|Physician Decision|3|||
46744154|NCT00907478|82961642|FG000|Overall Study|Death|4|||
46744155|NCT00907478|82961643|FG001|Overall Study|Death|2|||
46744156|NCT00907478|82961644|FG002|Overall Study|Death|1|||
46744157|NCT00907478|82961642|FG000|Overall Study|Protocol-specified criteria|5|||
46744158|NCT00907478|82961643|FG001|Overall Study|Protocol-specified criteria|2|||
46744159|NCT00907478|82961644|FG002|Overall Study|Protocol-specified criteria|3|||
46744160|NCT00907478|82961642|FG000|Overall Study|Pregnancy|0|||
46744161|NCT00907478|82961643|FG001|Overall Study|Pregnancy|1|||
46744162|NCT00907478|82961644|FG002|Overall Study|Pregnancy|1|||
46744163|NCT00907478|82961642|FG000|Overall Study|Lost to Follow-up|1|||
46744164|NCT00907478|82961643|FG001|Overall Study|Lost to Follow-up|0|||
46744165|NCT00907478|82961644|FG002|Overall Study|Lost to Follow-up|0|||
46744166|NCT00907478|82961642|FG000|Overall Study|Other|3|||
46744167|NCT00907478|82961643|FG001|Overall Study|Other|0|||
46744168|NCT00907478|82961644|FG002|Overall Study|Other|1|||
46744169|NCT00627445|82961656|FG000|Overall Study|Adverse Event|3|||
46744170|NCT00627445|82961657|FG001|Overall Study|Adverse Event|3|||
46744171|NCT00627445|82961656|FG000|Overall Study|Lack of Efficacy|0|||
46744172|NCT00627445|82961657|FG001|Overall Study|Lack of Efficacy|1|||
46744173|NCT00627445|82961656|FG000|Overall Study|Other|6|||
46744174|NCT00627445|82961657|FG001|Overall Study|Other|8|||
46744175|NCT00905840|82961665|FG000|Overall Study|Lost to Follow-up|11|||
46744176|NCT00905840|82961665|FG000|Overall Study|Death|3|||
46922483|NCT01602562|83155372|FG001|Overall Study|Adverse Event|1|||
46744177|NCT00905840|82961665|FG000|Overall Study|Withdrawal by Subject|1|||
46744178|NCT00905840|82961665|FG000|Overall Study|Adverse Event|1|||
46744179|NCT00626821|82961672|FG000|Overall Study|Adverse Event|44|||
46744180|NCT00626821|82961672|FG000|Overall Study|Protocol Violation|33|||
46744181|NCT00626821|82961672|FG000|Overall Study|Withdrawal by Subject|10|||
46744182|NCT00626821|82961672|FG000|Overall Study|Physician Decision|9|||
46744183|NCT00626821|82961672|FG000|Overall Study|Product dysfunction|21|||
46744184|NCT00626821|82961672|FG000|Overall Study|other/unknown reason|104|||
46744185|NCT00625183|82961676|FG000|Overall Study|Disease Progression|1|||
46744186|NCT00904982|82961686|FG000|Overall Study|Withdrawal by Subject|2|||
46744187|NCT00904982|82961687|FG001|Overall Study|Withdrawal by Subject|0|||
46744188|NCT00904982|82961688|FG002|Overall Study|Withdrawal by Subject|0|||
46744189|NCT00904982|82961689|FG003|Overall Study|Withdrawal by Subject|0|||
46744190|NCT00640315|82961701|FG000|Overall Study|Withdrawal by Subject|0|||
46744191|NCT00640315|82961702|FG001|Overall Study|Withdrawal by Subject|1|||
46922484|NCT01602562|83155371|FG000|Overall Study|Physician Decision|1|||
46922485|NCT01602562|83155372|FG001|Overall Study|Physician Decision|1|||
46922486|NCT01602562|83155371|FG000|Overall Study|Withdrawal by Subject|1|||
46744192|NCT00904748|82961708|FG000|Overall Study|Withdrawal by Subject|1|||
46744193|NCT00904748|82961709|FG001|Overall Study|Withdrawal by Subject|1|||
46744194|NCT00904748|82961710|FG002|Overall Study|Withdrawal by Subject|1|||
46744195|NCT00904748|82961711|FG003|Overall Study|Withdrawal by Subject|2|||
46744196|NCT00904748|82961712|FG004|Overall Study|Withdrawal by Subject|0|||
46744197|NCT00904748|82961713|FG005|Overall Study|Withdrawal by Subject|0|||
46744198|NCT00904748|82961708|FG000|Overall Study|Adverse Event|0|||
46744199|NCT00904748|82961709|FG001|Overall Study|Adverse Event|0|||
46744200|NCT00904748|82961710|FG002|Overall Study|Adverse Event|0|||
46744201|NCT00904748|82961711|FG003|Overall Study|Adverse Event|0|||
46744202|NCT00904748|82961712|FG004|Overall Study|Adverse Event|1|||
46744203|NCT00904748|82961713|FG005|Overall Study|Adverse Event|0|||
46744204|NCT00574405|82961724|FG000|Overall Study|Withdrawal by Subject|3|||
46744205|NCT00574405|82961725|FG001|Overall Study|Withdrawal by Subject|2|||
46744206|NCT00971243|82961736|FG000|Double Blind Period|Adverse Event|2|||
46744207|NCT00971243|82961737|FG001|Double Blind Period|Adverse Event|3|||
46744208|NCT00971243|82961738|FG002|Double Blind Period|Adverse Event|2|||
46744209|NCT00971243|82961739|FG003|Double Blind Period|Adverse Event|2|||
46744210|NCT00971243|82961740|FG004|Double Blind Period|Adverse Event|3|||
46744211|NCT00971243|82961736|FG000|Double Blind Period|Lost to Follow-up|0|||
46744212|NCT00971243|82961737|FG001|Double Blind Period|Lost to Follow-up|1|||
46744213|NCT00971243|82961738|FG002|Double Blind Period|Lost to Follow-up|1|||
46744214|NCT00971243|82961739|FG003|Double Blind Period|Lost to Follow-up|0|||
46744215|NCT00971243|82961740|FG004|Double Blind Period|Lost to Follow-up|1|||
46744216|NCT00971243|82961736|FG000|Double Blind Period|Physician Decision|10|||
46744217|NCT00971243|82961737|FG001|Double Blind Period|Physician Decision|6|||
46744218|NCT00971243|82961738|FG002|Double Blind Period|Physician Decision|7|||
46744219|NCT00971243|82961739|FG003|Double Blind Period|Physician Decision|6|||
46744220|NCT00971243|82961740|FG004|Double Blind Period|Physician Decision|7|||
46744221|NCT00971243|82961736|FG000|Double Blind Period|Protocol Violation|2|||
46744222|NCT00971243|82961737|FG001|Double Blind Period|Protocol Violation|0|||
46744223|NCT00971243|82961738|FG002|Double Blind Period|Protocol Violation|3|||
46744224|NCT00971243|82961739|FG003|Double Blind Period|Protocol Violation|2|||
46744225|NCT00971243|82961740|FG004|Double Blind Period|Protocol Violation|2|||
46744226|NCT00971243|82961736|FG000|Double Blind Period|Withdrawal by Subject|4|||
46744227|NCT00971243|82961737|FG001|Double Blind Period|Withdrawal by Subject|1|||
46744228|NCT00971243|82961738|FG002|Double Blind Period|Withdrawal by Subject|4|||
46744229|NCT00971243|82961739|FG003|Double Blind Period|Withdrawal by Subject|4|||
46744230|NCT00971243|82961740|FG004|Double Blind Period|Withdrawal by Subject|4|||
46744231|NCT00971243|82961736|FG000|Double Blind Period|Other reasons|1|||
46744232|NCT00971243|82961737|FG001|Double Blind Period|Other reasons|0|||
46744233|NCT00971243|82961738|FG002|Double Blind Period|Other reasons|2|||
46744234|NCT00971243|82961739|FG003|Double Blind Period|Other reasons|0|||
46744235|NCT00971243|82961740|FG004|Double Blind Period|Other reasons|1|||
46744236|NCT00971243|82961736|FG000|Open-label Period|Adverse Event|1|||
46922487|NCT01602562|83155372|FG001|Overall Study|Withdrawal by Subject|1|||
46922488|NCT01945775|83155381|FG000|Overall Study|Death|214|||
46744237|NCT00971243|82961737|FG001|Open-label Period|Adverse Event|0|||
46744238|NCT00971243|82961738|FG002|Open-label Period|Adverse Event|1|||
46744239|NCT00971243|82961739|FG003|Open-label Period|Adverse Event|1|||
46922489|NCT01945775|83155382|FG001|Overall Study|Death|98|||
46744240|NCT00971243|82961740|FG004|Open-label Period|Adverse Event|0|||
46744241|NCT00971243|82961736|FG000|Open-label Period|Physician Decision|5|||
46744242|NCT00971243|82961737|FG001|Open-label Period|Physician Decision|9|||
46744243|NCT00971243|82961738|FG002|Open-label Period|Physician Decision|3|||
46744244|NCT00971243|82961739|FG003|Open-label Period|Physician Decision|7|||
46744245|NCT00971243|82961740|FG004|Open-label Period|Physician Decision|2|||
46744246|NCT00971243|82961736|FG000|Open-label Period|Protocol Violation|1|||
46744247|NCT00971243|82961737|FG001|Open-label Period|Protocol Violation|1|||
46744248|NCT00971243|82961738|FG002|Open-label Period|Protocol Violation|1|||
46744249|NCT00971243|82961739|FG003|Open-label Period|Protocol Violation|0|||
46744250|NCT00971243|82961740|FG004|Open-label Period|Protocol Violation|1|||
46744251|NCT00971243|82961736|FG000|Open-label Period|Withdrawal by Subject|1|||
46744252|NCT00971243|82961737|FG001|Open-label Period|Withdrawal by Subject|0|||
46744253|NCT00971243|82961738|FG002|Open-label Period|Withdrawal by Subject|0|||
46744254|NCT00971243|82961739|FG003|Open-label Period|Withdrawal by Subject|2|||
46744255|NCT00971243|82961740|FG004|Open-label Period|Withdrawal by Subject|1|||
46744256|NCT00971243|82961736|FG000|Open-label Period|Other reason|0|||
46744257|NCT00971243|82961737|FG001|Open-label Period|Other reason|0|||
46744258|NCT00971243|82961738|FG002|Open-label Period|Other reason|0|||
46744259|NCT00971243|82961739|FG003|Open-label Period|Other reason|0|||
46744260|NCT00971243|82961740|FG004|Open-label Period|Other reason|2|||
46744261|NCT00568555|82961754|FG000|Overall Study|Withdrawal by Subject|1|||
46744262|NCT00568555|82961755|FG001|Overall Study|Withdrawal by Subject|1|||
46744263|NCT00904670|82961763|FG000|Open Label Phase|Withdrawal by Subject|2|||
46744264|NCT00904670|82961764|FG001|Open Label Phase|Withdrawal by Subject|0|||
46744265|NCT00904670|82961763|FG000|Open Label Phase|Adverse Event|2|||
46744266|NCT00904670|82961764|FG001|Open Label Phase|Adverse Event|0|||
46744267|NCT00904670|82961763|FG000|Open Label Phase|Lack of Efficacy|1|||
46744268|NCT00904670|82961764|FG001|Open Label Phase|Lack of Efficacy|0|||
46744269|NCT00904670|82961763|FG000|Open Label Phase|Lost to Follow-up|1|||
46744270|NCT00904670|82961764|FG001|Open Label Phase|Lost to Follow-up|0|||
46922490|NCT01945775|83155381|FG000|Overall Study|Lost to Follow-up|12|||
46922491|NCT01945775|83155382|FG001|Overall Study|Lost to Follow-up|7|||
46922492|NCT01945775|83155381|FG000|Overall Study|Withdrawal by Subject|11|||
46922493|NCT01945775|83155382|FG001|Overall Study|Withdrawal by Subject|21|||
46922494|NCT01945775|83155381|FG000|Overall Study|Other|50|||
46922495|NCT01945775|83155382|FG001|Overall Study|Other|18|||
46922496|NCT03072719|83155410|FG000|Overall Study|Adverse Event|1|||
46922497|NCT03072719|83155411|FG001|Overall Study|Adverse Event|1|||
46922498|NCT00835796|83155419|FG000|First Intervention|Withdrawal by Subject|0|||
46922499|NCT00835796|83155420|FG001|First Intervention|Withdrawal by Subject|1|||
46922500|NCT00835640|83155426|FG000|Second Intervention|Protocol Violation|1|||
46922501|NCT00835640|83155427|FG001|Second Intervention|Protocol Violation|0|||
46922502|NCT02942017|83155433|FG000|Overall Study|Adverse Event|0|||
46744271|NCT00638443|82961772|FG000|First Intervention|Adverse Event|2|||
46922503|NCT02942017|83155434|FG001|Overall Study|Adverse Event|1|||
46922504|NCT02942017|83155433|FG000|Overall Study|Withdrawal by Subject|0|||
46922505|NCT02942017|83155434|FG001|Overall Study|Withdrawal by Subject|1|||
46922506|NCT02942017|83155433|FG000|Overall Study|Lost to Follow-up|1|||
46922507|NCT02942017|83155434|FG001|Overall Study|Lost to Follow-up|1|||
46922508|NCT02942017|83155433|FG000|Overall Study|Randomized but not dosed|1|||
46922509|NCT02942017|83155434|FG001|Overall Study|Randomized but not dosed|3|||
46922510|NCT00835406|83155449|FG000|Period: First Intervention|Adverse Event|0|||
46922511|NCT00835406|83155450|FG001|Period: First Intervention|Adverse Event|1|||
46922512|NCT00835406|83155449|FG000|Period: First Intervention|Withdrawal by Subject|2|||
46922513|NCT00835406|83155450|FG001|Period: First Intervention|Withdrawal by Subject|0|||
46744272|NCT00638443|82961773|FG001|First Intervention|Adverse Event|1|||
46744273|NCT00636181|82961784|FG000|Overall Study|Withdrawal by Subject|8|||
46744274|NCT00636181|82961785|FG001|Overall Study|Withdrawal by Subject|6|||
46744275|NCT00636181|82961786|FG002|Overall Study|Withdrawal by Subject|10|||
46922514|NCT00835406|83155449|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
46922515|NCT00835406|83155450|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
46922516|NCT00835172|83155456|FG000|Washout|Protocol Violation|0|||
46922517|NCT00835172|83155457|FG001|Washout|Protocol Violation|1|||
46922518|NCT01676116|83155463|FG000|Overall Study|Withdrawal criteria|2|||
46922519|NCT01676116|83155464|FG001|Overall Study|Withdrawal criteria|14|||
46744276|NCT00968669|82961798|FG000|Overall Study|Lost to Follow-up|5|||
46744277|NCT00968669|82961799|FG001|Overall Study|Lost to Follow-up|2|||
46744278|NCT00968669|82961800|FG002|Overall Study|Lost to Follow-up|1|||
46744279|NCT00968669|82961801|FG003|Overall Study|Lost to Follow-up|4|||
46744280|NCT00968669|82961798|FG000|Overall Study|Withdrawal by Subject|9|||
46744281|NCT00968669|82961799|FG001|Overall Study|Withdrawal by Subject|7|||
46744282|NCT00968669|82961800|FG002|Overall Study|Withdrawal by Subject|5|||
46744283|NCT00968669|82961801|FG003|Overall Study|Withdrawal by Subject|3|||
46744284|NCT00968669|82961798|FG000|Overall Study|Pregnancy|0|||
46744285|NCT00968669|82961799|FG001|Overall Study|Pregnancy|0|||
46744286|NCT00968669|82961800|FG002|Overall Study|Pregnancy|2|||
46744287|NCT00968669|82961801|FG003|Overall Study|Pregnancy|0|||
46744288|NCT00968669|82961798|FG000|Overall Study|AE|1|||
46922520|NCT01676116|83155463|FG000|Overall Study|Adverse Event|1|||
46922521|NCT01676116|83155464|FG001|Overall Study|Adverse Event|2|||
46922522|NCT01676116|83155463|FG000|Overall Study|Unclassified|4|||
46922523|NCT01676116|83155464|FG001|Overall Study|Unclassified|10|||
46922524|NCT01676116|83155463|FG000|Overall Study|Protocol Violation|9|||
46922525|NCT01676116|83155464|FG001|Overall Study|Protocol Violation|3|||
46922526|NCT00740480|83155470|FG000|Overall Study|Adverse Event|1|||
46922527|NCT00740480|83155470|FG000|Overall Study|Physician Decision|1|||
46744289|NCT00968669|82961799|FG001|Overall Study|AE|0|||
46744290|NCT00968669|82961800|FG002|Overall Study|AE|0|||
46744291|NCT00968669|82961801|FG003|Overall Study|AE|0|||
46744292|NCT00968669|82961798|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
46922528|NCT02743520|83155473|FG000|Overall Study|Withdrawal by Subject|1|||
46922529|NCT03001557|83155492|FG000|Core Phase|Randomized but not treated|0|||
46922530|NCT03001557|83155493|FG001|Core Phase|Randomized but not treated|0|||
46922531|NCT03001557|83155494|FG002|Core Phase|Randomized but not treated|1|||
46922532|NCT03001557|83155495|FG003|Core Phase|Randomized but not treated|0|||
46922533|NCT03001557|83155496|FG004|Core Phase|Randomized but not treated|0|||
46922534|NCT03001557|83155497|FG005|Core Phase|Randomized but not treated|0|||
46922535|NCT03001557|83155498|FG006|Core Phase|Randomized but not treated|0|||
46922536|NCT03001557|83155499|FG007|Core Phase|Randomized but not treated|0|||
46922537|NCT03001557|83155492|FG000|Extension Phase|Adverse Event|0|||
46922538|NCT03001557|83155493|FG001|Extension Phase|Adverse Event|0|||
46922539|NCT03001557|83155494|FG002|Extension Phase|Adverse Event|0|||
46922540|NCT03001557|83155495|FG003|Extension Phase|Adverse Event|0|||
46922541|NCT03001557|83155496|FG004|Extension Phase|Adverse Event|0|||
46922542|NCT03001557|83155497|FG005|Extension Phase|Adverse Event|2|||
46922543|NCT03001557|83155498|FG006|Extension Phase|Adverse Event|0|||
46922544|NCT03001557|83155499|FG007|Extension Phase|Adverse Event|0|||
46922545|NCT03001557|83155492|FG000|Extension Phase|Withdrawal by Subject|0|||
46922546|NCT03001557|83155493|FG001|Extension Phase|Withdrawal by Subject|0|||
46922547|NCT03001557|83155494|FG002|Extension Phase|Withdrawal by Subject|0|||
46922548|NCT03001557|83155495|FG003|Extension Phase|Withdrawal by Subject|0|||
46922549|NCT03001557|83155496|FG004|Extension Phase|Withdrawal by Subject|0|||
46922550|NCT03001557|83155497|FG005|Extension Phase|Withdrawal by Subject|1|||
46922551|NCT03001557|83155498|FG006|Extension Phase|Withdrawal by Subject|5|||
46922552|NCT03001557|83155499|FG007|Extension Phase|Withdrawal by Subject|2|||
46922553|NCT03001557|83155492|FG000|Extension Phase|Lost to Follow-up|0|||
46922554|NCT03001557|83155493|FG001|Extension Phase|Lost to Follow-up|0|||
46922555|NCT03001557|83155494|FG002|Extension Phase|Lost to Follow-up|0|||
46922556|NCT03001557|83155495|FG003|Extension Phase|Lost to Follow-up|0|||
46922557|NCT03001557|83155496|FG004|Extension Phase|Lost to Follow-up|0|||
46922558|NCT03001557|83155497|FG005|Extension Phase|Lost to Follow-up|0|||
46922559|NCT03001557|83155498|FG006|Extension Phase|Lost to Follow-up|2|||
46922560|NCT03001557|83155499|FG007|Extension Phase|Lost to Follow-up|1|||
46744293|NCT00968669|82961799|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
46744294|NCT00968669|82961800|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
46744295|NCT00968669|82961801|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
46744296|NCT00968669|82961798|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
46744297|NCT00968669|82961799|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
46744298|NCT00968669|82961800|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
46744299|NCT00968669|82961801|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
46744300|NCT00968669|82961798|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
46744301|NCT00968669|82961799|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
46744302|NCT00968669|82961800|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
46744303|NCT00968669|82961801|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
46744304|NCT00968669|82961798|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
46744305|NCT00968669|82961799|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
46744306|NCT00968669|82961800|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
46744307|NCT00968669|82961801|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
46744308|NCT00968669|82961798|FG000|Overall Study|EARLY WITHDRAWAL|0|||
46744309|NCT00968669|82961799|FG001|Overall Study|EARLY WITHDRAWAL|1|||
46744310|NCT00968669|82961800|FG002|Overall Study|EARLY WITHDRAWAL|0|||
46744311|NCT00968669|82961801|FG003|Overall Study|EARLY WITHDRAWAL|0|||
46744312|NCT00968669|82961798|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
46744313|NCT00968669|82961799|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
46744314|NCT00968669|82961800|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
46744315|NCT00968669|82961801|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
46744316|NCT00968669|82961798|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
46744317|NCT00968669|82961799|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
46744318|NCT00968669|82961800|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
46744319|NCT00968669|82961801|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
46744320|NCT00968669|82961798|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
46744321|NCT00968669|82961799|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
46744322|NCT00968669|82961800|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
46922561|NCT03001557|83155492|FG000|Extension Phase|Administrative Reason|0|||
46922562|NCT03001557|83155493|FG001|Extension Phase|Administrative Reason|0|||
46922563|NCT03001557|83155494|FG002|Extension Phase|Administrative Reason|0|||
46922564|NCT03001557|83155495|FG003|Extension Phase|Administrative Reason|0|||
46922565|NCT03001557|83155496|FG004|Extension Phase|Administrative Reason|0|||
46922566|NCT03001557|83155497|FG005|Extension Phase|Administrative Reason|1|||
46744323|NCT00968669|82961801|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
46922567|NCT03001557|83155498|FG006|Extension Phase|Administrative Reason|3|||
46922568|NCT03001557|83155499|FG007|Extension Phase|Administrative Reason|3|||
46922569|NCT03001557|83155492|FG000|Extension Phase|Loss of caregiver|0|||
46744324|NCT00968669|82961798|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
46922570|NCT03001557|83155493|FG001|Extension Phase|Loss of caregiver|0|||
46744325|NCT00968669|82961799|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
46744326|NCT00968669|82961800|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
46744327|NCT00968669|82961801|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
46744328|NCT00968669|82961798|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
46744329|NCT00968669|82961799|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
46744330|NCT00968669|82961800|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
46744331|NCT00968669|82961801|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
46744332|NCT00968669|82961798|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
46744333|NCT00968669|82961799|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
46744334|NCT00968669|82961800|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
46744335|NCT00968669|82961801|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
46744336|NCT00968669|82961798|FG000|Overall Study|SPONSOR DECISION|0|||
46744337|NCT00968669|82961799|FG001|Overall Study|SPONSOR DECISION|1|||
46744338|NCT00968669|82961800|FG002|Overall Study|SPONSOR DECISION|0|||
46744339|NCT00968669|82961801|FG003|Overall Study|SPONSOR DECISION|0|||
46744340|NCT00968669|82961798|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
46744341|NCT00968669|82961799|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
46744342|NCT00968669|82961800|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
46744343|NCT00968669|82961801|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
46744344|NCT00968669|82961798|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
46744345|NCT00968669|82961799|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
46744346|NCT00968669|82961800|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
46744347|NCT00968669|82961801|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
46744348|NCT00968669|82961798|FG000|Overall Study|SUBJECT INCARCERATED|0|||
46744349|NCT00968669|82961799|FG001|Overall Study|SUBJECT INCARCERATED|1|||
46744350|NCT00968669|82961800|FG002|Overall Study|SUBJECT INCARCERATED|0|||
46744351|NCT00968669|82961801|FG003|Overall Study|SUBJECT INCARCERATED|0|||
46744352|NCT00968669|82961798|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
46922571|NCT03001557|83155494|FG002|Extension Phase|Loss of caregiver|0|||
46922572|NCT03001557|83155495|FG003|Extension Phase|Loss of caregiver|0|||
46922573|NCT03001557|83155496|FG004|Extension Phase|Loss of caregiver|0|||
46922574|NCT03001557|83155497|FG005|Extension Phase|Loss of caregiver|0|||
46922575|NCT03001557|83155498|FG006|Extension Phase|Loss of caregiver|1|||
46922576|NCT03001557|83155499|FG007|Extension Phase|Loss of caregiver|0|||
46922577|NCT03001557|83155492|FG000|Extension Phase|Others|0|||
46922578|NCT03001557|83155493|FG001|Extension Phase|Others|0|||
46922579|NCT03001557|83155494|FG002|Extension Phase|Others|0|||
46922580|NCT03001557|83155495|FG003|Extension Phase|Others|0|||
46922581|NCT03001557|83155496|FG004|Extension Phase|Others|0|||
46922582|NCT03001557|83155497|FG005|Extension Phase|Others|1|||
46922583|NCT03001557|83155498|FG006|Extension Phase|Others|3|||
46922584|NCT03001557|83155499|FG007|Extension Phase|Others|0|||
46922585|NCT00830336|83155536|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
46922586|NCT00830336|83155537|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
46922587|NCT00830258|83155543|FG000|First Intervention|Adverse Event|1|||
46922588|NCT00830258|83155544|FG001|First Intervention|Adverse Event|0|||
46922589|NCT00830258|83155543|FG000|Washout: 7 Days|Protocol Violation|1|||
46922590|NCT00830258|83155544|FG001|Washout: 7 Days|Protocol Violation|0|||
47051298|NCT01881737|83314002|FG000|Overall Study|Withdrawal by Subject|1|||
47051299|NCT01881737|83314002|FG000|Overall Study|Worsening of baseline behavior|1|||
47051300|NCT01892501|83314038|FG000|Overall Study|Protocol Violation|2|||
47051301|NCT01892501|83314038|FG000|Overall Study|Puncture not carried out|9|||
47051302|NCT01892501|83314038|FG000|Overall Study|Radiological monitoring not carried out|5|||
47051303|NCT01892501|83314038|FG000|Overall Study|Non-contributory histological result|12|||
47051304|NCT01892345|83314053|FG000|Overall Study|Adverse Event|0|||
47051305|NCT01892345|83314054|FG001|Overall Study|Adverse Event|2|||
47051306|NCT01892345|83314053|FG000|Overall Study|Death|1|||
47051307|NCT01892345|83314054|FG001|Overall Study|Death|0|||
47051308|NCT01892345|83314053|FG000|Overall Study|Lost to Follow-up|3|||
47051309|NCT01892345|83314054|FG001|Overall Study|Lost to Follow-up|0|||
47051310|NCT01892345|83314053|FG000|Overall Study|Withdrawal by Subject|12|||
46744353|NCT00968669|82961799|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
46744354|NCT00968669|82961800|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
46744355|NCT00968669|82961801|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
47051311|NCT01892345|83314054|FG001|Overall Study|Withdrawal by Subject|1|||
46922591|NCT03349775|83155550|FG000|Overall Study|Side Effects|1|||
47051312|NCT01892189|83314131|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
47051313|NCT01892189|83314132|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
46744356|NCT00968669|82961798|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
46922592|NCT03349775|83155551|FG001|Overall Study|Side Effects|2|||
46922593|NCT03349775|83155550|FG000|Overall Study|Withdrawal by Subject|1|||
46922594|NCT03349775|83155551|FG001|Overall Study|Withdrawal by Subject|1|||
47051314|NCT01892189|83314133|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
47051315|NCT01892189|83314134|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
46744357|NCT00968669|82961799|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
47051316|NCT01892189|83314135|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
47051317|NCT01892189|83314136|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
47051318|NCT01892189|83314137|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
46744358|NCT00968669|82961800|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
46744359|NCT00968669|82961801|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
46744360|NCT00568399|82961811|FG000|Overall Study|Death|2|||
46744361|NCT00568399|82961811|FG000|Overall Study|Adverse Event|5|||
46744362|NCT00568399|82961811|FG000|Overall Study|Withdrawal by Subject|8|||
46744363|NCT00975143|82961817|FG000|Overall Study|Adverse Event|19|||
46744364|NCT00975143|82961818|FG001|Overall Study|Adverse Event|15|||
46744365|NCT00975143|82961817|FG000|Overall Study|Withdrawal by Subject|15|||
46744366|NCT00975143|82961818|FG001|Overall Study|Withdrawal by Subject|15|||
46744367|NCT00975143|82961817|FG000|Overall Study|Lost to Follow-up|20|||
46744368|NCT00975143|82961818|FG001|Overall Study|Lost to Follow-up|16|||
46744369|NCT00975143|82961817|FG000|Overall Study|Non-compliance|5|||
46744370|NCT00975143|82961818|FG001|Overall Study|Non-compliance|8|||
46744371|NCT00975143|82961817|FG000|Overall Study|Physician Decision|1|||
46744372|NCT00975143|82961818|FG001|Overall Study|Physician Decision|2|||
46744373|NCT00975143|82961817|FG000|Overall Study|Details not available|10|||
46744374|NCT00975143|82961818|FG001|Overall Study|Details not available|4|||
46744375|NCT00974675|82961841|FG000|Overall Study|Adverse Event|2|||
46744376|NCT00974675|82961842|FG001|Overall Study|Adverse Event|1|||
46744377|NCT00974675|82961843|FG002|Overall Study|Adverse Event|1|||
46744378|NCT00974675|82961844|FG003|Overall Study|Adverse Event|1|||
46744379|NCT00974675|82961841|FG000|Overall Study|Physician Decision|0|||
46744380|NCT00974675|82961842|FG001|Overall Study|Physician Decision|0|||
46744381|NCT00974675|82961843|FG002|Overall Study|Physician Decision|1|||
46744382|NCT00974675|82961844|FG003|Overall Study|Physician Decision|0|||
46744383|NCT00974675|82961841|FG000|Overall Study|Participant on holiday; unable to attend|0|||
46744384|NCT00974675|82961842|FG001|Overall Study|Participant on holiday; unable to attend|0|||
46744385|NCT00974675|82961843|FG002|Overall Study|Participant on holiday; unable to attend|0|||
46744386|NCT00974675|82961844|FG003|Overall Study|Participant on holiday; unable to attend|1|||
46744387|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
46744388|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
46744389|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
46744390|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
46744391|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
46744392|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Death|1|||
46744393|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Death|0|||
46744394|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Death|0|||
46744395|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Death|0|||
46744396|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Death|0|||
46744397|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
46744398|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
46744399|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
46744400|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
46744401|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
46744402|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
46744403|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
46744404|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
46744405|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
46744406|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
46744407|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
46744408|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
46744409|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
46744410|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
46744411|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
46744412|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
46744413|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
46744414|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
46744415|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
46744416|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
46744417|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
46744418|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
46744419|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
47051319|NCT01892189|83314138|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
46744420|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
46744421|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
46744422|NCT00634933|82961857|FG000|Part A: Baseline to Week 24|Other|1|||
46744423|NCT00634933|82961858|FG001|Part A: Baseline to Week 24|Other|8|||
46744424|NCT00634933|82961859|FG002|Part A: Baseline to Week 24|Other|5|||
47051320|NCT01892189|83314139|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
46744425|NCT00634933|82961860|FG003|Part A: Baseline to Week 24|Other|0|||
46744426|NCT00634933|82961861|FG004|Part A: Baseline to Week 24|Other|0|||
46744427|NCT00634933|82961857|FG000|Between Part A and Part B|Physician Decision|0|||
46744428|NCT00634933|82961858|FG001|Between Part A and Part B|Physician Decision|1|||
46744429|NCT00634933|82961859|FG002|Between Part A and Part B|Physician Decision|0|||
46635425|NCT01560234|82809084|FG006|Overall Study|Lost to Follow-up|0|||
46922595|NCT03349775|83155550|FG000|Overall Study|No primary outcome measurements|0|||
46922596|NCT03349775|83155551|FG001|Overall Study|No primary outcome measurements|1|||
46922597|NCT00830024|83155559|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
46922598|NCT00830024|83155560|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
46922599|NCT00829868|83155566|FG000|Washout|Physician Decision|1|||
46922600|NCT00829868|83155567|FG001|Washout|Physician Decision|0|||
46922601|NCT00829790|83155573|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
46922602|NCT00829790|83155574|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
46922603|NCT03207815|83155580|FG000|Overall Study|Protocol Violation|3|||
46922604|NCT03207815|83155581|FG001|Overall Study|Protocol Violation|1|||
46922605|NCT03207815|83155580|FG000|Overall Study|Adverse Event|1|||
46922606|NCT03207815|83155581|FG001|Overall Study|Adverse Event|2|||
46922607|NCT03207815|83155580|FG000|Overall Study|Lost to Follow-up|1|||
46922608|NCT03207815|83155581|FG001|Overall Study|Lost to Follow-up|2|||
46922609|NCT03207815|83155580|FG000|Overall Study|Investigator's Discretion|1|||
46922610|NCT03207815|83155581|FG001|Overall Study|Investigator's Discretion|1|||
46922611|NCT03207815|83155580|FG000|Overall Study|Lack of Efficacy|0|||
46922612|NCT03207815|83155581|FG001|Overall Study|Lack of Efficacy|1|||
46922613|NCT03207815|83155580|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
46922614|NCT03207815|83155581|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
46922615|NCT03207815|83155580|FG000|Overall Study|Withdrew Consent|1|||
46922616|NCT03207815|83155581|FG001|Overall Study|Withdrew Consent|0|||
46922617|NCT02911935|83155589|FG000|Overall Study|Lost to Follow-up|5|||
46635426|NCT01560234|82809085|FG007|Overall Study|Lost to Follow-up|2|||
46635427|NCT01559844|82809103|FG000|Overall Study|Consent Withdrawn|7|||
46635428|NCT01559844|82809103|FG000|Overall Study|Death|5|||
46635429|NCT01559844|82809103|FG000|Overall Study|Efficacy Failure|10|||
46744430|NCT00634933|82961860|FG003|Between Part A and Part B|Physician Decision|0|||
46744431|NCT00634933|82961861|FG004|Between Part A and Part B|Physician Decision|0|||
46744432|NCT00634933|82961857|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
46744433|NCT00634933|82961858|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
46744434|NCT00634933|82961859|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
46744435|NCT00634933|82961860|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
46744436|NCT00634933|82961861|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
46744437|NCT00634933|82961857|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
46744438|NCT00634933|82961858|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
46744439|NCT00634933|82961859|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
46744440|NCT00634933|82961860|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
46744441|NCT00634933|82961861|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
46744442|NCT00634933|82961857|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
46744443|NCT00634933|82961858|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
46744444|NCT00634933|82961859|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
46744445|NCT00634933|82961860|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
46744446|NCT00634933|82961861|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
46744447|NCT00634933|82961857|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
46744448|NCT00634933|82961858|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
46744449|NCT00634933|82961859|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
46744450|NCT00634933|82961860|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
46744451|NCT00634933|82961861|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
46744452|NCT00634933|82961857|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
46744453|NCT00634933|82961858|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
46744454|NCT00634933|82961859|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
46744455|NCT00634933|82961860|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
46744456|NCT00634933|82961861|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
46744457|NCT00634933|82961857|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
46744458|NCT00634933|82961858|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
46744459|NCT00634933|82961859|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
46744460|NCT00634933|82961860|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
46744461|NCT00634933|82961861|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
46744462|NCT00634933|82961857|FG000|Part B: Week 24 to Week 52|Other|0|||
46744463|NCT00634933|82961858|FG001|Part B: Week 24 to Week 52|Other|0|||
46744464|NCT00634933|82961859|FG002|Part B: Week 24 to Week 52|Other|5|||
46744465|NCT00634933|82961860|FG003|Part B: Week 24 to Week 52|Other|0|||
46744466|NCT00634933|82961861|FG004|Part B: Week 24 to Week 52|Other|1|||
46744467|NCT00967499|82961875|FG000|Overall Study|Adverse Event|0|||
46922618|NCT02911935|83155590|FG001|Overall Study|Lost to Follow-up|7|||
46922619|NCT00829712|83155598|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
46922620|NCT00829712|83155599|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
46922621|NCT03069989|83155614|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
46635430|NCT01559844|82809103|FG000|Overall Study|No Longer A Transplant Candidate|3|||
46744468|NCT00967499|82961876|FG001|Overall Study|Adverse Event|1|||
46744469|NCT00967499|82961875|FG000|Overall Study|Protocol Violation|1|||
46744470|NCT00967499|82961876|FG001|Overall Study|Protocol Violation|0|||
46744471|NCT00967499|82961875|FG000|Overall Study|Sponsor Decision|1|||
46744472|NCT00967499|82961876|FG001|Overall Study|Sponsor Decision|0|||
46744473|NCT00967499|82961875|FG000|Overall Study|Randomized but not treated|63|||
46744474|NCT00967499|82961876|FG001|Overall Study|Randomized but not treated|59|||
46744475|NCT03909971|82961884|FG000|Overall Study|Other Reasons Not Specified|0|||
46744476|NCT03909971|82961885|FG001|Overall Study|Other Reasons Not Specified|1|||
46922622|NCT03069989|83155615|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
46922623|NCT02698163|83155642|FG000|Overall Study|Lost to Follow-up|0|||
46922624|NCT02698163|83155643|FG001|Overall Study|Lost to Follow-up|1|||
46922625|NCT03817190|83155651|FG000|Overall Study|Early Termination|13|||
46922626|NCT03817190|83155652|FG001|Overall Study|Early Termination|20|||
46922627|NCT03817190|83155651|FG000|Overall Study|Adverse Event|10|||
46922628|NCT03817190|83155652|FG001|Overall Study|Adverse Event|17|||
46922629|NCT03817190|83155651|FG000|Overall Study|Withdrawal by Subject|12|||
46922630|NCT03817190|83155652|FG001|Overall Study|Withdrawal by Subject|8|||
46922631|NCT03817190|83155651|FG000|Overall Study|Lost to Follow-up|11|||
46922632|NCT03817190|83155652|FG001|Overall Study|Lost to Follow-up|7|||
46922633|NCT03817190|83155651|FG000|Overall Study|Lack of Efficacy|7|||
46922634|NCT03817190|83155652|FG001|Overall Study|Lack of Efficacy|5|||
46922635|NCT03817190|83155651|FG000|Overall Study|Investigator Decision|5|||
46922636|NCT03817190|83155652|FG001|Overall Study|Investigator Decision|1|||
46922637|NCT03817190|83155651|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
46922638|NCT03817190|83155652|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
46922639|NCT03817190|83155651|FG000|Overall Study|Lack of Contact|1|||
46922640|NCT03817190|83155652|FG001|Overall Study|Lack of Contact|0|||
46922641|NCT03817190|83155651|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
46922642|NCT03817190|83155652|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
46922643|NCT03797222|83155671|FG000|Overall Study|Withdrawal by Subject|1|||
46922644|NCT02742818|83155681|FG000|Overall Study|Adverse Event|0|||
46922645|NCT02742818|83155682|FG001|Overall Study|Adverse Event|1|||
46922646|NCT02742818|83155681|FG000|Overall Study|Protocol Violation|0|||
46922647|NCT02742818|83155682|FG001|Overall Study|Protocol Violation|1|||
46922648|NCT03069365|83155690|FG000|Overall Study|Adverse Event|1|||
46922649|NCT03065933|83155694|FG000|Overall Study|study terminated|5|||
46922650|NCT04256629|83155704|FG000|Overall Study|Adverse Event|0|||
46922651|NCT04256629|83155705|FG001|Overall Study|Adverse Event|0|||
46635431|NCT01584648|82809109|FG000|Overall Study|Death|136|||
46744477|NCT03909971|82961884|FG000|Overall Study|Global Deterioration of Health Status|2|||
46744478|NCT03909971|82961885|FG001|Overall Study|Global Deterioration of Health Status|1|||
46744479|NCT03909971|82961884|FG000|Overall Study|Progressive Disease|6|||
46744480|NCT03909971|82961885|FG001|Overall Study|Progressive Disease|14|||
46744481|NCT03909971|82961884|FG000|Overall Study|Death|2|||
46744482|NCT03909971|82961885|FG001|Overall Study|Death|6|||
46744483|NCT00967343|82961892|FG000|Overall Study|Study termination by sponsor|12|||
46744484|NCT00967343|82961892|FG000|Overall Study|Death|24|||
46744485|NCT00967343|82961892|FG000|Overall Study|Relapse|1|||
46744486|NCT00967343|82961892|FG000|Overall Study|Lost to Follow-up|1|||
46744487|NCT00973973|82961898|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
46744488|NCT00973973|82961899|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
46744489|NCT00973973|82961898|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
46744490|NCT00973973|82961899|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
46744491|NCT00973973|82961898|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
46744492|NCT00973973|82961899|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
46744493|NCT00973973|82961898|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
46744494|NCT00973973|82961899|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
46744495|NCT00973973|82961898|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
46744496|NCT00973973|82961899|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
46744497|NCT00973973|82961898|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
46744498|NCT00973973|82961899|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
46635432|NCT01584648|82809110|FG001|Overall Study|Death|146|||
46744499|NCT00973973|82961898|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
46744500|NCT00973973|82961899|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
46922652|NCT04256629|83155706|FG002|Overall Study|Adverse Event|0|||
46922653|NCT04256629|83155707|FG003|Overall Study|Adverse Event|0|||
46922654|NCT04256629|83155708|FG004|Overall Study|Adverse Event|0|||
46922655|NCT04256629|83155709|FG005|Overall Study|Adverse Event|1|||
46635433|NCT01584648|82809109|FG000|Overall Study|Lost to Follow-up|9|||
46635434|NCT01584648|82809110|FG001|Overall Study|Lost to Follow-up|9|||
46744501|NCT00973973|82961898|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
46922656|NCT04256629|83155704|FG000|Overall Study|Protocol Violation|0|||
46744502|NCT00973973|82961899|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
46744503|NCT00973973|82961898|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
46744504|NCT00973973|82961899|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
46744505|NCT00973973|82961898|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
46744506|NCT00973973|82961899|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
46744507|NCT00973973|82961898|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
46744508|NCT00973973|82961899|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
46744509|NCT00973973|82961898|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
46744510|NCT00973973|82961899|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
46744511|NCT00633139|82961908|FG000|Overall Study|Non compliance|0|||
46744512|NCT00633139|82961909|FG001|Overall Study|Non compliance|0|||
47051321|NCT01892189|83314131|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47051322|NCT01892189|83314132|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47051323|NCT01892189|83314133|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
47051324|NCT01892189|83314134|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
47051325|NCT01892189|83314135|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47051326|NCT01892189|83314136|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47051327|NCT01892189|83314137|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
47051328|NCT01892189|83314138|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46744513|NCT00633139|82961910|FG002|Overall Study|Non compliance|1|||
46744514|NCT00633139|82961908|FG000|Overall Study|Withdrawal by Subject|0|||
46744515|NCT00633139|82961909|FG001|Overall Study|Withdrawal by Subject|1|||
46744516|NCT00633139|82961910|FG002|Overall Study|Withdrawal by Subject|0|||
46744517|NCT00965081|82961920|FG000|Overall Study|Adverse Event|14|||
46744518|NCT00965081|82961921|FG001|Overall Study|Adverse Event|9|||
46744519|NCT00965081|82961920|FG000|Overall Study|Lack of Efficacy|2|||
46744520|NCT00965081|82961921|FG001|Overall Study|Lack of Efficacy|5|||
46744521|NCT00965081|82961920|FG000|Overall Study|Lost to Follow-up|4|||
46744522|NCT00965081|82961921|FG001|Overall Study|Lost to Follow-up|5|||
46744523|NCT00965081|82961920|FG000|Overall Study|Physician Decision|2|||
46744524|NCT00965081|82961921|FG001|Overall Study|Physician Decision|0|||
46744525|NCT00965081|82961920|FG000|Overall Study|Protocol Violation|2|||
46744526|NCT00965081|82961921|FG001|Overall Study|Protocol Violation|5|||
46744527|NCT00965081|82961920|FG000|Overall Study|Sponsor Decision|1|||
46744528|NCT00965081|82961921|FG001|Overall Study|Sponsor Decision|0|||
46744529|NCT00965081|82961920|FG000|Overall Study|Withdrawal by Subject|4|||
46744530|NCT00965081|82961921|FG001|Overall Study|Withdrawal by Subject|7|||
46744531|NCT00965081|82961920|FG000|Overall Study|Switched to Rescue Arm|5|||
46744532|NCT00965081|82961921|FG001|Overall Study|Switched to Rescue Arm|12|||
46744533|NCT00961649|82961932|FG000|Overall Study|Adverse Event|4|||
46744534|NCT00961649|82961933|FG001|Overall Study|Adverse Event|0|||
46744535|NCT00961649|82961934|FG002|Overall Study|Adverse Event|0|||
46744536|NCT00961649|82961935|FG003|Overall Study|Adverse Event|2|||
46744537|NCT00961649|82961932|FG000|Overall Study|Inadequate control of IOP|0|||
46744538|NCT00961649|82961933|FG001|Overall Study|Inadequate control of IOP|0|||
46744539|NCT00961649|82961934|FG002|Overall Study|Inadequate control of IOP|0|||
46744540|NCT00961649|82961935|FG003|Overall Study|Inadequate control of IOP|1|||
46744541|NCT00961649|82961932|FG000|Overall Study|Patient has travel plans during holidays|0|||
46744542|NCT00961649|82961933|FG001|Overall Study|Patient has travel plans during holidays|0|||
46744543|NCT00961649|82961934|FG002|Overall Study|Patient has travel plans during holidays|1|||
46744544|NCT00961649|82961935|FG003|Overall Study|Patient has travel plans during holidays|0|||
46744545|NCT00961649|82961932|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
46744546|NCT00961649|82961933|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
46744547|NCT00961649|82961934|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
46744548|NCT00961649|82961935|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
46744549|NCT00961649|82961932|FG000|Overall Study|Study terminated by sponsor|4|||
46744550|NCT00961649|82961933|FG001|Overall Study|Study terminated by sponsor|4|||
46744551|NCT00961649|82961934|FG002|Overall Study|Study terminated by sponsor|4|||
46744552|NCT00961649|82961935|FG003|Overall Study|Study terminated by sponsor|1|||
47051329|NCT01892189|83314139|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
47051330|NCT01892189|83314131|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
46744553|NCT00632125|82961945|FG000|Overall Study|Death|82|||
46744554|NCT00632125|82961945|FG000|Overall Study|Withdrawal by Subject|44|||
46744555|NCT00632125|82961945|FG000|Overall Study|Adverse Event|36|||
46744556|NCT00632125|82961945|FG000|Overall Study|Renal transplantation|17|||
46744557|NCT00632125|82961945|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
46744558|NCT00632125|82961945|FG000|Overall Study|Non-compliance|8|||
46744559|NCT00632125|82961945|FG000|Overall Study|Development of uncontrolled hypertension|5|||
46744560|NCT00632125|82961945|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
46744561|NCT00903968|82961951|FG000|Overall Study|Adverse Event|0|||
46744562|NCT00903968|82961952|FG001|Overall Study|Adverse Event|0|||
46744563|NCT00903968|82961953|FG002|Overall Study|Adverse Event|0|||
46744564|NCT00903968|82961954|FG003|Overall Study|Adverse Event|0|||
46744565|NCT00903968|82961955|FG004|Overall Study|Adverse Event|0|||
46744566|NCT00903968|82961956|FG005|Overall Study|Adverse Event|0|||
46744567|NCT00903968|82961957|FG006|Overall Study|Adverse Event|1|||
46744568|NCT00903968|82961958|FG007|Overall Study|Adverse Event|8|||
46744569|NCT00903968|82961951|FG000|Overall Study|DLT|0|||
46744570|NCT00903968|82961952|FG001|Overall Study|DLT|0|||
46744571|NCT00903968|82961953|FG002|Overall Study|DLT|0|||
46744572|NCT00903968|82961954|FG003|Overall Study|DLT|0|||
46744573|NCT00903968|82961955|FG004|Overall Study|DLT|0|||
46744574|NCT00903968|82961956|FG005|Overall Study|DLT|0|||
46744575|NCT00903968|82961957|FG006|Overall Study|DLT|2|||
46744576|NCT00903968|82961958|FG007|Overall Study|DLT|0|||
46744577|NCT00903968|82961951|FG000|Overall Study|Withdrawal by Subject|1|||
46744578|NCT00903968|82961952|FG001|Overall Study|Withdrawal by Subject|0|||
46744579|NCT00903968|82961953|FG002|Overall Study|Withdrawal by Subject|1|||
46744580|NCT00903968|82961954|FG003|Overall Study|Withdrawal by Subject|0|||
46744581|NCT00903968|82961955|FG004|Overall Study|Withdrawal by Subject|1|||
46744582|NCT00903968|82961956|FG005|Overall Study|Withdrawal by Subject|1|||
46744583|NCT00903968|82961957|FG006|Overall Study|Withdrawal by Subject|0|||
46744584|NCT00903968|82961958|FG007|Overall Study|Withdrawal by Subject|4|||
46744585|NCT00903968|82961951|FG000|Overall Study|Non-Compliance|0|||
46744586|NCT00903968|82961952|FG001|Overall Study|Non-Compliance|0|||
46744587|NCT00903968|82961953|FG002|Overall Study|Non-Compliance|0|||
46744588|NCT00903968|82961954|FG003|Overall Study|Non-Compliance|0|||
46744589|NCT00903968|82961955|FG004|Overall Study|Non-Compliance|0|||
46744590|NCT00903968|82961956|FG005|Overall Study|Non-Compliance|1|||
46744591|NCT00903968|82961957|FG006|Overall Study|Non-Compliance|0|||
46744592|NCT00903968|82961958|FG007|Overall Study|Non-Compliance|0|||
46744593|NCT00903968|82961951|FG000|Overall Study|Physician Decision|0|||
46744594|NCT00903968|82961952|FG001|Overall Study|Physician Decision|0|||
46744595|NCT00903968|82961953|FG002|Overall Study|Physician Decision|0|||
46744596|NCT00903968|82961954|FG003|Overall Study|Physician Decision|0|||
46744597|NCT00903968|82961955|FG004|Overall Study|Physician Decision|0|||
47051331|NCT01892189|83314132|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
47051332|NCT01892189|83314133|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
46922657|NCT04256629|83155705|FG001|Overall Study|Protocol Violation|1|||
46922658|NCT04256629|83155706|FG002|Overall Study|Protocol Violation|0|||
46922659|NCT04256629|83155707|FG003|Overall Study|Protocol Violation|0|||
46922660|NCT04256629|83155708|FG004|Overall Study|Protocol Violation|0|||
46922661|NCT04256629|83155709|FG005|Overall Study|Protocol Violation|0|||
46922662|NCT01346293|83155719|FG000|Overall Study|Protocol Violation|30|||
46922663|NCT01346293|83155720|FG001|Overall Study|Protocol Violation|9|||
46922664|NCT01346293|83155719|FG000|Overall Study|Lost to Follow-up|21|||
46922665|NCT01346293|83155720|FG001|Overall Study|Lost to Follow-up|8|||
46922666|NCT01346293|83155719|FG000|Overall Study|Withdrawal by Subject|15|||
46922667|NCT01346293|83155720|FG001|Overall Study|Withdrawal by Subject|4|||
46922668|NCT01346293|83155719|FG000|Overall Study|Other|1|||
46922669|NCT01346293|83155720|FG001|Overall Study|Other|0|||
46922670|NCT03502187|83155740|FG000|Overall Study|Withdrawal by Subject|4|||
46922671|NCT03502187|83155741|FG001|Overall Study|Withdrawal by Subject|3|||
46922672|NCT03502187|83155742|FG002|Overall Study|Withdrawal by Subject|3|||
46922673|NCT03502187|83155740|FG000|Overall Study|Lost to Follow-up|5|||
46922674|NCT03502187|83155741|FG001|Overall Study|Lost to Follow-up|4|||
46922675|NCT03502187|83155742|FG002|Overall Study|Lost to Follow-up|5|||
46922676|NCT03058705|83155750|FG000|Overall Study|Withdrawal by Subject|2|||
46922677|NCT03058705|83155750|FG000|Overall Study|Physician Decision|2|||
47051333|NCT01892189|83314134|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
47051334|NCT01892189|83314135|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
46922678|NCT02998671|83155759|FG000|Period 1|Study Terminated By Sponsor|2|||
46922679|NCT02998671|83155760|FG001|Period 1|Study Terminated By Sponsor|1|||
47051335|NCT01892189|83314136|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
46744598|NCT00903968|82961956|FG005|Overall Study|Physician Decision|1|||
46744599|NCT00903968|82961957|FG006|Overall Study|Physician Decision|0|||
46744600|NCT00903968|82961958|FG007|Overall Study|Physician Decision|0|||
46744601|NCT00903968|82961951|FG000|Overall Study|Progressive Disease|2|||
46744602|NCT00903968|82961952|FG001|Overall Study|Progressive Disease|3|||
46744603|NCT00903968|82961953|FG002|Overall Study|Progressive Disease|2|||
46744604|NCT00903968|82961954|FG003|Overall Study|Progressive Disease|3|||
46744605|NCT00903968|82961955|FG004|Overall Study|Progressive Disease|3|||
46744606|NCT00903968|82961956|FG005|Overall Study|Progressive Disease|3|||
46744607|NCT00903968|82961957|FG006|Overall Study|Progressive Disease|0|||
46922680|NCT02998671|83155761|FG002|Period 1|Study Terminated By Sponsor|0|||
46922681|NCT02998671|83155762|FG003|Period 1|Study Terminated By Sponsor|0|||
46922682|NCT02998671|83155763|FG004|Period 1|Study Terminated By Sponsor|1|||
46744608|NCT00903968|82961958|FG007|Overall Study|Progressive Disease|18|||
46744609|NCT00903968|82961951|FG000|Overall Study|Lack of Efficacy|0|||
46744610|NCT00903968|82961952|FG001|Overall Study|Lack of Efficacy|0|||
46744611|NCT00903968|82961953|FG002|Overall Study|Lack of Efficacy|0|||
46744612|NCT00903968|82961954|FG003|Overall Study|Lack of Efficacy|0|||
46744613|NCT00903968|82961955|FG004|Overall Study|Lack of Efficacy|0|||
46744614|NCT00903968|82961956|FG005|Overall Study|Lack of Efficacy|0|||
46744615|NCT00903968|82961957|FG006|Overall Study|Lack of Efficacy|0|||
46744616|NCT00903968|82961958|FG007|Overall Study|Lack of Efficacy|3|||
46744617|NCT00903344|82961981|FG000|Overall Study|Pregnancy|2|||
46744618|NCT00903344|82961982|FG001|Overall Study|Pregnancy|3|||
46744619|NCT00903344|82961981|FG000|Overall Study|Lost to Follow-up|3|||
46744620|NCT00903344|82961982|FG001|Overall Study|Lost to Follow-up|0|||
46744621|NCT00903032|82961990|FG000|Overall Study|Withdrawal by Subject|5|||
46744622|NCT00903032|82961991|FG001|Overall Study|Withdrawal by Subject|3|||
46744623|NCT00903032|82961990|FG000|Overall Study|Lost to Follow-up|2|||
46744624|NCT00903032|82961991|FG001|Overall Study|Lost to Follow-up|2|||
46744625|NCT00902564|82962006|FG000|Overall Study|Withdrawal by Subject|2|||
46744626|NCT00626197|82962013|FG000|Overall Study|Did not cooperate|2|||
46744627|NCT00626197|82962014|FG001|Overall Study|Did not cooperate|6|||
46922683|NCT02998671|83155759|FG000|Period 1|Withdrawal by Subject|1|||
46922684|NCT02998671|83155760|FG001|Period 1|Withdrawal by Subject|2|||
46922685|NCT02998671|83155761|FG002|Period 1|Withdrawal by Subject|0|||
46922686|NCT02998671|83155762|FG003|Period 1|Withdrawal by Subject|0|||
46922687|NCT02998671|83155763|FG004|Period 1|Withdrawal by Subject|2|||
46922688|NCT02998671|83155759|FG000|Period 1|Pregnancy|1|||
46922689|NCT02998671|83155760|FG001|Period 1|Pregnancy|0|||
46922690|NCT02998671|83155761|FG002|Period 1|Pregnancy|0|||
46922691|NCT02998671|83155762|FG003|Period 1|Pregnancy|0|||
46922692|NCT02998671|83155763|FG004|Period 1|Pregnancy|0|||
46922693|NCT02998671|83155759|FG000|Period 1|Adverse Event|0|||
46922694|NCT02998671|83155760|FG001|Period 1|Adverse Event|0|||
46922695|NCT02998671|83155761|FG002|Period 1|Adverse Event|0|||
46922696|NCT02998671|83155762|FG003|Period 1|Adverse Event|0|||
46922697|NCT02998671|83155763|FG004|Period 1|Adverse Event|1|||
46922698|NCT02998671|83155759|FG000|Period 2|Adverse Event|0|||
46922699|NCT02998671|83155760|FG001|Period 2|Adverse Event|1|||
46922700|NCT02998671|83155761|FG002|Period 2|Adverse Event|0|||
46922701|NCT02998671|83155762|FG003|Period 2|Adverse Event|0|||
47051336|NCT01892189|83314137|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
47051337|NCT01892189|83314138|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
47051338|NCT01892189|83314139|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
46744628|NCT00626197|82962015|FG002|Overall Study|Did not cooperate|1|||
46744629|NCT00626197|82962013|FG000|Overall Study|Failure to return|6|||
46744630|NCT00626197|82962014|FG001|Overall Study|Failure to return|5|||
46744631|NCT00626197|82962015|FG002|Overall Study|Failure to return|6|||
46744632|NCT00626197|82962013|FG000|Overall Study|Adverse event, serious fatal|3|||
46744633|NCT00626197|82962014|FG001|Overall Study|Adverse event, serious fatal|6|||
46744634|NCT00626197|82962015|FG002|Overall Study|Adverse event, serious fatal|6|||
46744635|NCT00626197|82962013|FG000|Overall Study|Adverse Event|1|||
46744636|NCT00626197|82962014|FG001|Overall Study|Adverse Event|1|||
46744637|NCT00626197|82962015|FG002|Overall Study|Adverse Event|2|||
46744638|NCT00626197|82962013|FG000|Overall Study|Withdrawal by Subject|17|||
46744639|NCT00626197|82962014|FG001|Overall Study|Withdrawal by Subject|17|||
46744640|NCT00626197|82962015|FG002|Overall Study|Withdrawal by Subject|7|||
46744641|NCT00626197|82962013|FG000|Overall Study|Administrative reasons|15|||
46744642|NCT00626197|82962014|FG001|Overall Study|Administrative reasons|19|||
46744643|NCT00626197|82962015|FG002|Overall Study|Administrative reasons|55|||
46744644|NCT00626275|82962029|FG000|Part A - Treatment Period 1|Adverse Event|1|||
46744645|NCT00626275|82962030|FG001|Part A - Treatment Period 1|Adverse Event|0|||
46744646|NCT00626275|82962031|FG002|Part A - Treatment Period 1|Adverse Event|0|||
46744647|NCT00626275|82962032|FG003|Part A - Treatment Period 1|Adverse Event|0|||
46744648|NCT00626275|82962033|FG004|Part A - Treatment Period 1|Adverse Event|0|||
46922702|NCT02998671|83155763|FG004|Period 2|Adverse Event|0|||
46922703|NCT02998671|83155759|FG000|Period 2|Study Terminated By Sponsor|3|||
46922704|NCT02998671|83155760|FG001|Period 2|Study Terminated By Sponsor|5|||
46922705|NCT02998671|83155761|FG002|Period 2|Study Terminated By Sponsor|1|||
46922706|NCT02998671|83155762|FG003|Period 2|Study Terminated By Sponsor|3|||
46922707|NCT02998671|83155763|FG004|Period 2|Study Terminated By Sponsor|0|||
46922708|NCT02998671|83155759|FG000|Period 2|Withdrawal by Subject|0|||
46744649|NCT00626275|82962034|FG005|Part A - Treatment Period 1|Adverse Event|0|||
46744650|NCT00626275|82962035|FG006|Part A - Treatment Period 1|Adverse Event|0|||
46744651|NCT00626275|82962036|FG007|Part A - Treatment Period 1|Adverse Event|0|||
46744652|NCT00626275|82962029|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
46744653|NCT00626275|82962030|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
46744654|NCT00626275|82962031|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
46744655|NCT00626275|82962032|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
46744656|NCT00626275|82962033|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
46922709|NCT02998671|83155760|FG001|Period 2|Withdrawal by Subject|1|||
46922710|NCT02998671|83155761|FG002|Period 2|Withdrawal by Subject|0|||
46922711|NCT02998671|83155762|FG003|Period 2|Withdrawal by Subject|0|||
46922712|NCT02998671|83155763|FG004|Period 2|Withdrawal by Subject|0|||
46922713|NCT02998671|83155759|FG000|Period 2|Lost to Follow-up|0|||
46922714|NCT02998671|83155760|FG001|Period 2|Lost to Follow-up|0|||
46922715|NCT02998671|83155761|FG002|Period 2|Lost to Follow-up|0|||
46922716|NCT02998671|83155762|FG003|Period 2|Lost to Follow-up|1|||
46922717|NCT02998671|83155763|FG004|Period 2|Lost to Follow-up|0|||
46922718|NCT02660827|83155783|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
46922719|NCT02660827|83155783|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
46744657|NCT00626275|82962034|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
46744658|NCT00626275|82962035|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
46744659|NCT00626275|82962036|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
46744660|NCT00626275|82962029|FG000|Part B|Lost to Follow-up|0|||
46744661|NCT00626275|82962030|FG001|Part B|Lost to Follow-up|0|||
46744662|NCT00626275|82962031|FG002|Part B|Lost to Follow-up|0|||
46744663|NCT00626275|82962032|FG003|Part B|Lost to Follow-up|0|||
46744664|NCT00626275|82962033|FG004|Part B|Lost to Follow-up|0|||
46744665|NCT00626275|82962034|FG005|Part B|Lost to Follow-up|0|||
46744666|NCT00626275|82962035|FG006|Part B|Lost to Follow-up|1|||
46744667|NCT00626275|82962036|FG007|Part B|Lost to Follow-up|0|||
46744668|NCT00626275|82962029|FG000|Part B|Withdrawal by Subject|0|||
46744669|NCT00626275|82962030|FG001|Part B|Withdrawal by Subject|0|||
46744670|NCT00626275|82962031|FG002|Part B|Withdrawal by Subject|0|||
46744671|NCT00626275|82962032|FG003|Part B|Withdrawal by Subject|0|||
46744672|NCT00626275|82962033|FG004|Part B|Withdrawal by Subject|0|||
46744673|NCT00626275|82962034|FG005|Part B|Withdrawal by Subject|0|||
46744674|NCT00626275|82962035|FG006|Part B|Withdrawal by Subject|0|||
46744675|NCT00626275|82962036|FG007|Part B|Withdrawal by Subject|1|||
46744676|NCT00623935|82962050|FG000|Overall Study|Death|1|||
46744677|NCT00623935|82962050|FG000|Overall Study|Patient Declined Transplant|1|||
46744678|NCT00623779|82962057|FG000|Overall Study|Adverse Event|1|||
46744679|NCT00623779|82962058|FG001|Overall Study|Adverse Event|3|||
46744680|NCT00623779|82962059|FG002|Overall Study|Adverse Event|0|||
46744681|NCT00623779|82962057|FG000|Overall Study|Criteria from CSR|2|||
46744682|NCT00623779|82962058|FG001|Overall Study|Criteria from CSR|0|||
46744683|NCT00623779|82962059|FG002|Overall Study|Criteria from CSR|1|||
46744684|NCT00629707|82962090|FG000|Overall Study|Withdrawal by Subject|0|||
46744685|NCT00629707|82962091|FG001|Overall Study|Withdrawal by Subject|1|||
46744686|NCT00629707|82962090|FG000|Overall Study|Physician Decision|0|||
46744687|NCT00629707|82962091|FG001|Overall Study|Physician Decision|1|||
46744688|NCT00902330|82962099|FG000|Overall Study|Too overwhelmed by treatment|2|||
46744689|NCT00902330|82962100|FG001|Overall Study|Too overwhelmed by treatment|5|||
46744690|NCT00902330|82962099|FG000|Overall Study|Adverse Event|1|||
46744691|NCT00902330|82962100|FG001|Overall Study|Adverse Event|0|||
46744692|NCT00902330|82962099|FG000|Overall Study|No post baseline data|1|||
46744693|NCT00902330|82962100|FG001|Overall Study|No post baseline data|0|||
46744694|NCT00901394|82962137|FG000|Overall Study|Physician Decision|1|||
46744695|NCT00901394|82962138|FG001|Overall Study|Physician Decision|1|||
46922720|NCT02660827|83155783|FG000|From Study to End of Continued Access|Adverse Event|3|||
46922721|NCT02660827|83155783|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
46922722|NCT02660827|83155783|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
46922723|NCT02660827|83155783|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
46922724|NCT02660827|83155783|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
46922725|NCT02660827|83155783|FG000|Period 2: Continued Access Period|Adverse Event|3|||
46744696|NCT00901394|82962139|FG002|Overall Study|Physician Decision|2|||
46744697|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744698|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744699|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744700|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
46744701|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744702|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
46744703|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744704|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744705|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744706|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744707|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744708|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744709|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744710|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744711|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46922726|NCT01069419|83155804|FG000|Overall Study|Adverse Event|233|||
46922727|NCT01069419|83155804|FG000|Overall Study|Lack of Efficacy|332|||
47051339|NCT01881425|83314170|FG000|Overall Study|Death|5|||
46744712|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744713|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
47051340|NCT01881425|83314171|FG001|Overall Study|Death|1|||
47051341|NCT01881425|83314170|FG000|Overall Study|Withdrawal by Subject|8|||
47051342|NCT01881425|83314171|FG001|Overall Study|Withdrawal by Subject|3|||
47051343|NCT01881425|83314170|FG000|Overall Study|Physician Decision|2|||
47051344|NCT01881425|83314171|FG001|Overall Study|Physician Decision|1|||
47051345|NCT01881425|83314170|FG000|Overall Study|Adverse Event|3|||
47051346|NCT01881425|83314171|FG001|Overall Study|Adverse Event|0|||
47051347|NCT01881425|83314170|FG000|Overall Study|General Anesthesia panic attack|0|||
47051348|NCT01881425|83314171|FG001|Overall Study|General Anesthesia panic attack|1|||
47051349|NCT01881425|83314170|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
47051350|NCT01881425|83314171|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
47051351|NCT01881425|83314170|FG000|Overall Study|Lost to Follow-up|7|||
47051352|NCT01881425|83314171|FG001|Overall Study|Lost to Follow-up|2|||
47051353|NCT01891721|83314190|FG000|Overall Study|Lost to Follow-up|10|||
47051354|NCT01891721|83314191|FG001|Overall Study|Lost to Follow-up|5|||
47051355|NCT01891721|83314192|FG002|Overall Study|Lost to Follow-up|1|||
46744714|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744715|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744716|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744717|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744718|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744719|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
46744720|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
46744721|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
46744722|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
46744723|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
46744724|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
46744725|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
46744726|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
46744727|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744728|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744729|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744730|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744731|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744732|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744733|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744734|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744735|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744736|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744737|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744738|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744739|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744740|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744741|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744742|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
46744743|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
46744744|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
46744745|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
46744746|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
46744747|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
46744748|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
46744749|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
46744750|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
46744751|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744752|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
47051356|NCT01880957|83314211|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
47051357|NCT01880957|83314212|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
47051358|NCT01880957|83314211|FG000|Overall Study|Lost to Follow-up|11|||
46744753|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744754|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744755|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
47051359|NCT01880957|83314212|FG001|Overall Study|Lost to Follow-up|0|||
47051360|NCT01880957|83314211|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
47051361|NCT01880957|83314212|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
47051362|NCT04152837|83314227|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
46744756|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744757|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744758|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744759|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744760|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744761|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744762|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744763|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744764|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744765|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
46744766|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744767|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744768|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
46744769|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744770|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
46744771|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744772|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744773|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744774|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744775|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744776|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744777|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744778|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744779|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744780|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744781|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744782|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744783|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744784|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744785|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744786|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744787|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744788|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
46744789|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
46744790|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744791|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744792|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
46744793|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744794|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744795|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744796|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744797|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744798|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744799|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744800|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744801|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744802|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744803|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744804|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744805|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744806|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744807|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744808|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744809|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744810|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744811|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
46744812|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744813|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
47051363|NCT04152837|83314227|FG000|Maintenance Period|Adverse Event|1|||
46744814|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
46744815|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
47051364|NCT04152837|83314227|FG000|Maintenance Period|Withdrawal by Subject|1|||
47051365|NCT04152837|83314227|FG000|Maintenance Period|Sponsor Termination of Study|2|||
47051366|NCT01879553|83314246|FG000|Overall Study|Withdrawal by Subject|1|||
47051367|NCT01879553|83314247|FG001|Overall Study|Withdrawal by Subject|0|||
46744816|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744817|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744818|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744819|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744820|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744821|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744822|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744823|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744824|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744825|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744826|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744827|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744828|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
47051368|NCT01890785|83314268|FG000|Third Intervention|Withdrawal by Subject|0|||
46744829|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744830|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744831|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744832|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744833|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744834|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
46744835|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744836|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744837|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
46744838|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744839|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744840|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744841|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744842|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744843|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744844|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744845|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744846|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744847|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744848|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744849|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744850|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744851|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744852|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744853|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744854|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744855|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744856|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744857|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
46744858|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744859|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744860|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744861|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
46744862|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744863|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744864|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744865|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744866|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744867|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744868|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744869|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744870|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744871|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744872|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744873|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744874|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
47051369|NCT01890785|83314269|FG001|Third Intervention|Withdrawal by Subject|1|||
47051370|NCT01890785|83314270|FG002|Third Intervention|Withdrawal by Subject|0|||
46744875|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744876|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744877|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744878|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744879|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744880|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
46744881|NCT00896532|82962155|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744882|NCT00896532|82962156|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
46744883|NCT00896532|82962157|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46922728|NCT01069419|83155804|FG000|Overall Study|Lost to Follow-up|49|||
46922729|NCT01069419|83155804|FG000|Overall Study|Remission of disease|11|||
46922730|NCT01069419|83155804|FG000|Overall Study|Withdrawal by Subject|34|||
46922731|NCT01069419|83155804|FG000|Overall Study|Other Reason|43|||
46922732|NCT01069419|83155804|FG000|Overall Study|Missing termination information|13|||
46922733|NCT01069341|83155808|FG000|Overall Study|Lost to Follow-up|1|||
46922734|NCT02996097|83155812|FG000|Overall Study|Lost to Follow-up|11|||
46922735|NCT02996097|83155813|FG001|Overall Study|Lost to Follow-up|11|||
46922736|NCT02992899|83155829|FG000|Overall Study|Withdrawal by Subject|1|||
46744884|NCT00896532|82962158|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
46744885|NCT00896532|82962159|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
46744886|NCT00896532|82962160|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744887|NCT00896532|82962161|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744888|NCT00896532|82962162|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744889|NCT00896532|82962163|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744890|NCT00896532|82962164|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744891|NCT00896532|82962165|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744892|NCT00896532|82962166|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744893|NCT00896532|82962167|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744894|NCT00896532|82962168|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744895|NCT00896532|82962169|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744896|NCT00896532|82962170|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744897|NCT00896532|82962171|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744898|NCT00896532|82962172|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744899|NCT00896532|82962173|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744900|NCT00896532|82962174|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744901|NCT00896532|82962175|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744902|NCT00896532|82962176|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744903|NCT00896532|82962177|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
46744904|NCT00896532|82962155|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744905|NCT00896532|82962156|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744906|NCT00896532|82962157|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744907|NCT00896532|82962158|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744908|NCT00896532|82962159|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744909|NCT00896532|82962160|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744910|NCT00896532|82962161|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744911|NCT00896532|82962162|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744912|NCT00896532|82962163|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
46744913|NCT00896532|82962164|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744914|NCT00896532|82962165|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744915|NCT00896532|82962166|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744916|NCT00896532|82962167|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46922737|NCT02992899|83155830|FG001|Overall Study|Withdrawal by Subject|0|||
46922738|NCT02992899|83155829|FG000|Overall Study|Lost to Follow-up|1|||
46922739|NCT02992899|83155830|FG001|Overall Study|Lost to Follow-up|3|||
46922740|NCT01602484|83155838|FG000|Overall Study|Airway issues unrelated to study|0|||
46744917|NCT00896532|82962168|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744918|NCT00896532|82962169|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744919|NCT00896532|82962170|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744920|NCT00896532|82962171|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744921|NCT00896532|82962172|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46775745|NCT00793793|82994214|FG010|Overall Study|Protocol Violation|0|||
46922741|NCT01602484|83155839|FG001|Overall Study|Airway issues unrelated to study|1|||
46922742|NCT02989389|83155859|FG000|Period 1|Lost to Follow-up|0|||
46922743|NCT02989389|83155860|FG001|Period 1|Lost to Follow-up|1|||
47051371|NCT01890785|83314271|FG003|Third Intervention|Withdrawal by Subject|0|||
47051372|NCT01890785|83314272|FG004|Third Intervention|Withdrawal by Subject|0|||
47051373|NCT01890785|83314273|FG005|Third Intervention|Withdrawal by Subject|0|||
47051374|NCT01878383|83314297|FG000|Overall Study|Lost to Follow-up|0|||
46744922|NCT00896532|82962173|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744923|NCT00896532|82962174|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744924|NCT00896532|82962175|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744925|NCT00896532|82962176|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744926|NCT00896532|82962177|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
46744927|NCT00896532|82962155|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744928|NCT00896532|82962156|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744929|NCT00896532|82962157|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744930|NCT00896532|82962158|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744931|NCT00896532|82962159|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744932|NCT00896532|82962160|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744933|NCT00896532|82962161|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46922744|NCT02989389|83155861|FG002|Period 1|Lost to Follow-up|0|||
46922745|NCT02989389|83155862|FG003|Period 1|Lost to Follow-up|0|||
46922746|NCT02989389|83155863|FG004|Period 1|Lost to Follow-up|0|||
46922747|NCT02989389|83155864|FG005|Period 1|Lost to Follow-up|0|||
46922748|NCT02989389|83155865|FG006|Period 1|Lost to Follow-up|0|||
46922749|NCT02989389|83155866|FG007|Period 1|Lost to Follow-up|0|||
46922750|NCT02989389|83155867|FG008|Period 1|Lost to Follow-up|0|||
46922751|NCT02989389|83155868|FG009|Period 1|Lost to Follow-up|0|||
46922752|NCT02989389|83155859|FG000|Period 1|Physician Decision|0|||
46922753|NCT02989389|83155860|FG001|Period 1|Physician Decision|0|||
46744934|NCT00896532|82962162|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744935|NCT00896532|82962163|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744936|NCT00896532|82962164|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744937|NCT00896532|82962165|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744938|NCT00896532|82962166|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744939|NCT00896532|82962167|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
46744940|NCT00896532|82962168|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744941|NCT00896532|82962169|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744942|NCT00896532|82962170|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744943|NCT00896532|82962171|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744944|NCT00896532|82962172|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744945|NCT00896532|82962173|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744946|NCT00896532|82962174|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744947|NCT00896532|82962175|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744948|NCT00896532|82962176|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744949|NCT00896532|82962177|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
46744950|NCT00896532|82962155|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744951|NCT00896532|82962156|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744952|NCT00896532|82962157|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46922754|NCT02989389|83155861|FG002|Period 1|Physician Decision|0|||
46922755|NCT02989389|83155862|FG003|Period 1|Physician Decision|0|||
46922756|NCT02989389|83155863|FG004|Period 1|Physician Decision|0|||
46922757|NCT02989389|83155864|FG005|Period 1|Physician Decision|0|||
46922758|NCT02989389|83155865|FG006|Period 1|Physician Decision|0|||
46744953|NCT00896532|82962158|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744954|NCT00896532|82962159|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744955|NCT00896532|82962160|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744956|NCT00896532|82962161|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46922759|NCT02989389|83155866|FG007|Period 1|Physician Decision|0|||
46922760|NCT02989389|83155867|FG008|Period 1|Physician Decision|1|||
46922761|NCT02989389|83155868|FG009|Period 1|Physician Decision|0|||
46744957|NCT00896532|82962162|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744958|NCT00896532|82962163|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744959|NCT00896532|82962164|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744960|NCT00896532|82962165|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
46744961|NCT00896532|82962166|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744962|NCT00896532|82962167|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
46744963|NCT00896532|82962168|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744964|NCT00896532|82962169|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744965|NCT00896532|82962170|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744966|NCT00896532|82962171|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744967|NCT00896532|82962172|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744968|NCT00896532|82962173|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46922762|NCT00430508|83155912|FG000|Overall Study|Adverse Event|2|||
46922763|NCT00430508|83155913|FG001|Overall Study|Adverse Event|3|||
46775746|NCT00793793|82994215|FG011|Overall Study|Protocol Violation|0|||
46922764|NCT00430508|83155914|FG002|Overall Study|Adverse Event|5|||
46922765|NCT00430508|83155915|FG003|Overall Study|Adverse Event|3|||
47051375|NCT01878383|83314298|FG001|Overall Study|Lost to Follow-up|1499|||
47051376|NCT01878149|83314306|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
47051377|NCT01878149|83314307|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
47051378|NCT01863953|83314329|FG000|Overall Study|Adverse Event|0|||
47051379|NCT01863953|83314330|FG001|Overall Study|Adverse Event|0|||
47051380|NCT01863953|83314331|FG002|Overall Study|Adverse Event|1|||
47051381|NCT03049449|83314607|FG000|Overall Study|Did not receive treatment.|0|||
47051382|NCT03049449|83314608|FG001|Overall Study|Did not receive treatment.|0|||
46744969|NCT00896532|82962174|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744970|NCT00896532|82962175|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744971|NCT00896532|82962176|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744972|NCT00896532|82962177|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
46744973|NCT00896532|82962155|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744974|NCT00896532|82962156|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744975|NCT00896532|82962157|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744976|NCT00896532|82962158|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744977|NCT00896532|82962159|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744978|NCT00896532|82962160|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744979|NCT00896532|82962161|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744980|NCT00896532|82962162|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744981|NCT00896532|82962163|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744982|NCT00896532|82962164|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744983|NCT00896532|82962165|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744984|NCT00896532|82962166|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744985|NCT00896532|82962167|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
46744986|NCT00896532|82962168|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
46744987|NCT00896532|82962169|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744988|NCT00896532|82962170|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744989|NCT00896532|82962171|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744990|NCT00896532|82962172|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744991|NCT00896532|82962173|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744992|NCT00896532|82962174|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744993|NCT00896532|82962175|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744994|NCT00896532|82962176|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744995|NCT00896532|82962177|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
46744996|NCT00896532|82962155|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
46744997|NCT00896532|82962156|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
46744998|NCT00896532|82962157|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
46744999|NCT00896532|82962158|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
46745000|NCT00896532|82962159|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
46745001|NCT00896532|82962160|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
46745002|NCT00896532|82962161|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
46745003|NCT00896532|82962162|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
46745004|NCT00896532|82962163|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
46745005|NCT00896532|82962164|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
46745006|NCT00896532|82962165|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
46745007|NCT00896532|82962166|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
46745008|NCT00896532|82962167|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
46745009|NCT00896532|82962168|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
46745010|NCT00896532|82962169|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
46745011|NCT00896532|82962170|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
46745012|NCT00896532|82962171|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
46745013|NCT00896532|82962172|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
46745014|NCT00896532|82962173|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
46745015|NCT00896532|82962174|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
46745016|NCT00896532|82962175|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
47051383|NCT03049449|83314609|FG002|Overall Study|Did not receive treatment.|0|||
47051384|NCT03049449|83314610|FG003|Overall Study|Did not receive treatment.|0|||
47051385|NCT03049449|83314611|FG004|Overall Study|Did not receive treatment.|0|||
47051386|NCT03049449|83314612|FG005|Overall Study|Did not receive treatment.|0|||
46745017|NCT00896532|82962176|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
46745018|NCT00896532|82962177|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
46745019|NCT00896532|82962155|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745020|NCT00896532|82962156|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745021|NCT00896532|82962157|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745022|NCT00896532|82962158|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745023|NCT00896532|82962159|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745024|NCT00896532|82962160|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745025|NCT00896532|82962161|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745026|NCT00896532|82962162|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745027|NCT00896532|82962163|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745028|NCT00896532|82962164|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745029|NCT00896532|82962165|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46922766|NCT00430508|83155912|FG000|Overall Study|Withdrawal by Subject|0|||
46745030|NCT00896532|82962166|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745031|NCT00896532|82962167|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745032|NCT00896532|82962168|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745033|NCT00896532|82962169|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745034|NCT00896532|82962170|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
46745035|NCT00896532|82962171|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
46745036|NCT00896532|82962172|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745037|NCT00896532|82962173|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745038|NCT00896532|82962174|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745039|NCT00896532|82962175|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745040|NCT00896532|82962176|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745041|NCT00896532|82962177|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
46745042|NCT00896532|82962155|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745043|NCT00896532|82962156|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745044|NCT00896532|82962157|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745045|NCT00896532|82962158|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745046|NCT00896532|82962159|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745047|NCT00896532|82962160|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745048|NCT00896532|82962161|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745049|NCT00896532|82962162|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745050|NCT00896532|82962163|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745051|NCT00896532|82962164|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745052|NCT00896532|82962165|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745053|NCT00896532|82962166|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745054|NCT00896532|82962167|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745055|NCT00896532|82962168|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745056|NCT00896532|82962169|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745057|NCT00896532|82962170|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
46745058|NCT00896532|82962171|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
46745059|NCT00896532|82962172|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
46745060|NCT00896532|82962173|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745061|NCT00896532|82962174|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745062|NCT00896532|82962175|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745063|NCT00896532|82962176|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745064|NCT00896532|82962177|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
46745065|NCT00896532|82962155|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745066|NCT00896532|82962156|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46922767|NCT00430508|83155913|FG001|Overall Study|Withdrawal by Subject|1|||
46745067|NCT00896532|82962157|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745068|NCT00896532|82962158|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46635435|NCT01584648|82809109|FG000|Overall Study|Investigator discretion|3|||
46635436|NCT01584648|82809110|FG001|Overall Study|Investigator discretion|2|||
46745069|NCT00896532|82962159|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745070|NCT00896532|82962160|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745071|NCT00896532|82962161|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745072|NCT00896532|82962162|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745073|NCT00896532|82962163|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745074|NCT00896532|82962164|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745075|NCT00896532|82962165|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745076|NCT00896532|82962166|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
47051387|NCT03049449|83314613|FG006|Overall Study|Did not receive treatment.|0|||
46745077|NCT00896532|82962167|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745078|NCT00896532|82962168|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745079|NCT00896532|82962169|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745080|NCT00896532|82962170|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745081|NCT00896532|82962171|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
46745082|NCT00896532|82962172|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745083|NCT00896532|82962173|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745084|NCT00896532|82962174|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
47051388|NCT03049449|83314614|FG007|Overall Study|Did not receive treatment.|0|||
47051389|NCT03049449|83314615|FG008|Overall Study|Did not receive treatment.|1|||
46745085|NCT00896532|82962175|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745086|NCT00896532|82962176|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745087|NCT00896532|82962177|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
46745088|NCT00896532|82962155|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
46745089|NCT00896532|82962156|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
46745090|NCT00896532|82962157|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
46745091|NCT00896532|82962158|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
46745092|NCT00896532|82962159|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
46745093|NCT00896532|82962160|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
46745094|NCT00896532|82962161|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
46745095|NCT00896532|82962162|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
46745096|NCT00896532|82962163|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
46745097|NCT00896532|82962164|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
46745098|NCT00896532|82962165|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
46745099|NCT00896532|82962166|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
46745100|NCT00896532|82962167|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
46745101|NCT00896532|82962168|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
46745102|NCT00896532|82962169|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
46745103|NCT00896532|82962170|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
46745104|NCT00896532|82962171|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
46745105|NCT00896532|82962172|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
46745106|NCT00896532|82962173|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
46745107|NCT00896532|82962174|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
46745108|NCT00896532|82962175|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
46745109|NCT00896532|82962176|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
46745110|NCT00896532|82962177|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
46745111|NCT00896532|82962155|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745112|NCT00896532|82962156|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745113|NCT00896532|82962157|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745114|NCT00896532|82962158|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745115|NCT00896532|82962159|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745116|NCT00896532|82962160|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745117|NCT00896532|82962161|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745118|NCT00896532|82962162|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745119|NCT00896532|82962163|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745120|NCT00896532|82962164|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745121|NCT00896532|82962165|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745122|NCT00896532|82962166|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745123|NCT00896532|82962167|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745124|NCT00896532|82962168|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745125|NCT00896532|82962169|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745126|NCT00896532|82962170|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745127|NCT00896532|82962171|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
46745128|NCT00896532|82962172|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745129|NCT00896532|82962173|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745130|NCT00896532|82962174|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745131|NCT00896532|82962175|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745132|NCT00896532|82962176|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
47051390|NCT03049449|83314616|FG009|Overall Study|Did not receive treatment.|0|||
47051391|NCT03049449|83314607|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
47051392|NCT03049449|83314608|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
47051393|NCT03049449|83314609|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
47051394|NCT03049449|83314610|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
47051395|NCT03049449|83314611|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
47051396|NCT03049449|83314612|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
47051397|NCT03049449|83314613|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
47051398|NCT03049449|83314614|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
47051399|NCT03049449|83314615|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
46922768|NCT00430508|83155914|FG002|Overall Study|Withdrawal by Subject|1|||
47051400|NCT03049449|83314616|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
47051401|NCT03049449|83314607|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
47051402|NCT03049449|83314608|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
47051403|NCT03049449|83314609|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
47051404|NCT03049449|83314610|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
47051405|NCT03049449|83314611|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
47051406|NCT03049449|83314612|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
46745133|NCT00896532|82962177|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
46745134|NCT00896532|82962155|FG000|Months 48-72: Follow-on Phase|Death|0|||
46745135|NCT00896532|82962156|FG001|Months 48-72: Follow-on Phase|Death|0|||
46745136|NCT00896532|82962157|FG002|Months 48-72: Follow-on Phase|Death|0|||
46745137|NCT00896532|82962158|FG003|Months 48-72: Follow-on Phase|Death|0|||
46745138|NCT00896532|82962159|FG004|Months 48-72: Follow-on Phase|Death|0|||
46745139|NCT00896532|82962160|FG005|Months 48-72: Follow-on Phase|Death|0|||
46745140|NCT00896532|82962161|FG006|Months 48-72: Follow-on Phase|Death|0|||
46745141|NCT00896532|82962162|FG007|Months 48-72: Follow-on Phase|Death|0|||
46745142|NCT00896532|82962163|FG008|Months 48-72: Follow-on Phase|Death|0|||
46745143|NCT00896532|82962164|FG009|Months 48-72: Follow-on Phase|Death|0|||
46745144|NCT00896532|82962165|FG010|Months 48-72: Follow-on Phase|Death|0|||
46745145|NCT00896532|82962166|FG011|Months 48-72: Follow-on Phase|Death|0|||
46745146|NCT00896532|82962167|FG012|Months 48-72: Follow-on Phase|Death|0|||
46804172|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
46804173|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
46804174|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
46804175|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
46804176|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
46804177|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
46804178|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
46804179|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
46804180|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
46804181|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
46745147|NCT00896532|82962168|FG013|Months 48-72: Follow-on Phase|Death|0|||
46745148|NCT00896532|82962169|FG014|Months 48-72: Follow-on Phase|Death|0|||
46745149|NCT00896532|82962170|FG015|Months 48-72: Follow-on Phase|Death|0|||
46745150|NCT00896532|82962171|FG016|Months 48-72: Follow-on Phase|Death|0|||
46745151|NCT00896532|82962172|FG017|Months 48-72: Follow-on Phase|Death|0|||
46745152|NCT00896532|82962173|FG018|Months 48-72: Follow-on Phase|Death|1|||
46745153|NCT00896532|82962174|FG019|Months 48-72: Follow-on Phase|Death|0|||
46745154|NCT00896532|82962175|FG020|Months 48-72: Follow-on Phase|Death|0|||
46745155|NCT00896532|82962176|FG021|Months 48-72: Follow-on Phase|Death|0|||
46745156|NCT00896532|82962177|FG022|Months 48-72: Follow-on Phase|Death|0|||
46745157|NCT00896532|82962155|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745158|NCT00896532|82962156|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745159|NCT00896532|82962157|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745160|NCT00896532|82962158|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745161|NCT00896532|82962159|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745162|NCT00896532|82962160|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745163|NCT00896532|82962161|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46804182|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
46804183|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
46804184|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
46804185|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
46804186|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
46804187|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
46804188|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
46804189|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
46804190|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
46804191|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
46745164|NCT00896532|82962162|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745165|NCT00896532|82962163|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745166|NCT00896532|82962164|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745167|NCT00896532|82962165|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745168|NCT00896532|82962166|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745169|NCT00896532|82962167|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745170|NCT00896532|82962168|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745171|NCT00896532|82962169|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745172|NCT00896532|82962170|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745173|NCT00896532|82962171|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745174|NCT00896532|82962172|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745175|NCT00896532|82962173|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745176|NCT00896532|82962174|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745177|NCT00896532|82962175|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745178|NCT00896532|82962176|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
46745179|NCT00896532|82962177|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
46745180|NCT00896532|82962155|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745181|NCT00896532|82962156|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745182|NCT00896532|82962157|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745183|NCT00896532|82962158|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745184|NCT00896532|82962159|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745185|NCT00896532|82962160|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745186|NCT00896532|82962161|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745187|NCT00896532|82962162|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745188|NCT00896532|82962163|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745189|NCT00896532|82962164|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745190|NCT00896532|82962165|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745191|NCT00896532|82962166|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46922769|NCT00430508|83155915|FG003|Overall Study|Withdrawal by Subject|1|||
46922770|NCT00430508|83155912|FG000|Overall Study|responder at visit 4|0|||
46922771|NCT00430508|83155913|FG001|Overall Study|responder at visit 4|0|||
46922772|NCT00430508|83155914|FG002|Overall Study|responder at visit 4|2|||
46922773|NCT00430508|83155915|FG003|Overall Study|responder at visit 4|0|||
46922774|NCT00430508|83155912|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
47051407|NCT03049449|83314613|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
46745192|NCT00896532|82962167|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745193|NCT00896532|82962168|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745194|NCT00896532|82962169|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745195|NCT00896532|82962170|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745196|NCT00896532|82962171|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745197|NCT00896532|82962172|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745198|NCT00896532|82962173|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745199|NCT00896532|82962174|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745200|NCT00896532|82962175|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745201|NCT00896532|82962176|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
46745202|NCT00896532|82962177|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
46745203|NCT00574873|82962226|FG000|Overall Study|Withdrawal by Subject|18|||
46745204|NCT00574873|82962227|FG001|Overall Study|Withdrawal by Subject|19|||
46745205|NCT00574873|82962226|FG000|Overall Study|Investigator request|18|||
46745206|NCT00574873|82962227|FG001|Overall Study|Investigator request|8|||
46745207|NCT00574873|82962226|FG000|Overall Study|Death|15|||
46745208|NCT00574873|82962227|FG001|Overall Study|Death|14|||
46745209|NCT00574873|82962226|FG000|Overall Study|Lost to Follow-up|14|||
46745210|NCT00574873|82962227|FG001|Overall Study|Lost to Follow-up|5|||
46745211|NCT00574873|82962226|FG000|Overall Study|Other|40|||
46745212|NCT00574873|82962227|FG001|Overall Study|Other|4|||
46745213|NCT00574873|82962226|FG000|Overall Study|Discontinuation of study by sponsor|5|||
46745214|NCT00574873|82962227|FG001|Overall Study|Discontinuation of study by sponsor|199|||
46745215|NCT00574873|82962226|FG000|Overall Study|Blank, site closed per local regulations|2|||
46745216|NCT00574873|82962227|FG001|Overall Study|Blank, site closed per local regulations|2|||
46745217|NCT00574873|82962226|FG000|Overall Study|Extension Study|126|||
46745218|NCT00574873|82962227|FG001|Overall Study|Extension Study|0|||
46745219|NCT00902174|82962235|FG000|Overall Study|Adverse Event|27|||
46745220|NCT00902174|82962236|FG001|Overall Study|Adverse Event|7|||
46745221|NCT00902174|82962235|FG000|Overall Study|Lack of Efficacy|1|||
46745222|NCT00902174|82962236|FG001|Overall Study|Lack of Efficacy|5|||
46745223|NCT00902174|82962235|FG000|Overall Study|Death|2|||
46745224|NCT00902174|82962236|FG001|Overall Study|Death|2|||
47051408|NCT03049449|83314614|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
46745225|NCT00902174|82962235|FG000|Overall Study|Withdrawal by Subject|2|||
46745226|NCT00902174|82962236|FG001|Overall Study|Withdrawal by Subject|1|||
46745227|NCT00902174|82962235|FG000|Overall Study|Abnormal labs|1|||
46745228|NCT00902174|82962236|FG001|Overall Study|Abnormal labs|1|||
46745229|NCT00902174|82962235|FG000|Overall Study|Protocol Violation|1|||
46745230|NCT00902174|82962236|FG001|Overall Study|Protocol Violation|1|||
46745231|NCT00902174|82962235|FG000|Overall Study|Administration problem|0|||
46745232|NCT00902174|82962236|FG001|Overall Study|Administration problem|1|||
46745233|NCT00623623|82962247|FG000|Overall Study|Previous enrolment into this study|1|||
46745234|NCT00623623|82962248|FG001|Overall Study|Previous enrolment into this study|1|||
46745235|NCT00896454|82962254|FG000|Overall Study|Death|10|||
46745236|NCT00896454|82962254|FG000|Overall Study|Adverse Event|8|||
46745237|NCT00896454|82962254|FG000|Overall Study|Disease Progression|5|||
46745238|NCT00896454|82962254|FG000|Overall Study|Other|4|||
46745239|NCT00896454|82962254|FG000|Overall Study|Requirement for alternative therapy|3|||
46745240|NCT00896454|82962254|FG000|Overall Study|Ongoing in study|2|||
46745241|NCT00896454|82962254|FG000|Overall Study|Withdrawal by Subject|1|||
46745242|NCT00629239|82962260|FG000|Overall Study|Adverse Event|7|||
46745243|NCT00629239|82962261|FG001|Overall Study|Adverse Event|4|||
46745244|NCT00629239|82962260|FG000|Overall Study|Physician Decision|1|||
46745245|NCT00629239|82962261|FG001|Overall Study|Physician Decision|0|||
46745246|NCT00625807|82962269|FG000|Overall Study|schedule conflict|2|||
46745247|NCT00625807|82962270|FG001|Overall Study|schedule conflict|8|||
46745248|NCT00629083|82962280|FG000|Overall Study|Adverse Event|0|||
46745249|NCT00629083|82962281|FG001|Overall Study|Adverse Event|2|||
46745250|NCT00629083|82962280|FG000|Overall Study|Lack of Efficacy|3|||
46745251|NCT00629083|82962281|FG001|Overall Study|Lack of Efficacy|1|||
46745252|NCT00629083|82962280|FG000|Overall Study|Withdrawal by Subject|10|||
46745253|NCT00629083|82962281|FG001|Overall Study|Withdrawal by Subject|2|||
46745254|NCT00629083|82962280|FG000|Overall Study|Lost to Follow-up|12|||
46745255|NCT00629083|82962281|FG001|Overall Study|Lost to Follow-up|8|||
46745256|NCT00629083|82962280|FG000|Overall Study|Moved out of country/state|2|||
46745257|NCT00629083|82962281|FG001|Overall Study|Moved out of country/state|1|||
46745258|NCT00629083|82962280|FG000|Overall Study|Refused to return for 12 month visit|1|||
46745259|NCT00629083|82962281|FG001|Overall Study|Refused to return for 12 month visit|0|||
46745260|NCT00901628|82962291|FG000|Overall Study|disconnection of catheter|4|||
46745261|NCT00901628|82962292|FG001|Overall Study|disconnection of catheter|8|||
46745262|NCT00901628|82962291|FG000|Overall Study|disconnection of drain|0|||
46745263|NCT00901628|82962292|FG001|Overall Study|disconnection of drain|1|||
46745264|NCT00901628|82962291|FG000|Overall Study|peroneal nerve palsy|0|||
46745265|NCT00901628|82962292|FG001|Overall Study|peroneal nerve palsy|1|||
46745266|NCT00623545|82962298|FG000|Overall Study|Adverse Event|6|||
46745267|NCT00623545|82962298|FG000|Overall Study|Withdrawal by Subject|4|||
46745268|NCT00628927|82962305|FG000|Overall Study|Problems performing blood draw|6|||
46745269|NCT00628927|82962306|FG001|Overall Study|Problems performing blood draw|0|||
46745270|NCT00628927|82962305|FG000|Overall Study|Lost to Follow-up|1|||
46745271|NCT00628927|82962306|FG001|Overall Study|Lost to Follow-up|0|||
46745272|NCT00628927|82962305|FG000|Overall Study|Equipment failure|1|||
46745273|NCT00628927|82962306|FG001|Overall Study|Equipment failure|0|||
46745274|NCT00623467|82962317|FG000|Overall Study|Lost to Follow-up|1|||
46745275|NCT00623467|82962317|FG000|Overall Study|Protocol Violation|4|||
46745276|NCT00623467|82962317|FG000|Overall Study|Withdrawal by Subject|2|||
46745277|NCT00838539|82962335|FG000|Overall Study|Disease Progression|2|||
46745278|NCT00838539|82962336|FG001|Overall Study|Disease Progression|4|||
46745279|NCT00838539|82962337|FG002|Overall Study|Disease Progression|3|||
46745280|NCT00838539|82962338|FG003|Overall Study|Disease Progression|2|||
46745281|NCT00838539|82962339|FG004|Overall Study|Disease Progression|4|||
46745282|NCT00838539|82962340|FG005|Overall Study|Disease Progression|2|||
46922775|NCT00430508|83155913|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
46922776|NCT00430508|83155914|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
46922777|NCT00430508|83155915|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
46635437|NCT01584648|82809109|FG000|Overall Study|Withdrew consent|13|||
46745283|NCT00838539|82962341|FG006|Overall Study|Disease Progression|3|||
46745284|NCT00838539|82962342|FG007|Overall Study|Disease Progression|4|||
46745285|NCT00838539|82962343|FG008|Overall Study|Disease Progression|4|||
46745286|NCT00838539|82962344|FG009|Overall Study|Disease Progression|5|||
46745287|NCT00838539|82962345|FG010|Overall Study|Disease Progression|1|||
46635438|NCT01584648|82809110|FG001|Overall Study|Withdrew consent|4|||
46745288|NCT00838539|82962346|FG011|Overall Study|Disease Progression|4|||
46635439|NCT01584648|82809109|FG000|Overall Study|Study closed/terminated|50|||
46635440|NCT01584648|82809110|FG001|Overall Study|Study closed/terminated|23|||
46745289|NCT00838539|82962335|FG000|Overall Study|Adverse Event|1|||
46745290|NCT00838539|82962336|FG001|Overall Study|Adverse Event|1|||
46745291|NCT00838539|82962337|FG002|Overall Study|Adverse Event|1|||
46745292|NCT00838539|82962338|FG003|Overall Study|Adverse Event|1|||
46745293|NCT00838539|82962339|FG004|Overall Study|Adverse Event|2|||
46745294|NCT00838539|82962340|FG005|Overall Study|Adverse Event|1|||
46922778|NCT00430508|83155912|FG000|Overall Study|Other|1|||
46922779|NCT00430508|83155913|FG001|Overall Study|Other|1|||
46922780|NCT00430508|83155914|FG002|Overall Study|Other|3|||
46922781|NCT00430508|83155915|FG003|Overall Study|Other|0|||
46922782|NCT02988219|83155923|FG000|Overall Study|Lack of Efficacy|1|||
46922783|NCT02988219|83155924|FG001|Overall Study|Lack of Efficacy|1|||
46922784|NCT02988219|83155923|FG000|Overall Study|Withdrawal by Subject|0|||
46922785|NCT02988219|83155924|FG001|Overall Study|Withdrawal by Subject|2|||
46922786|NCT01346059|83155932|FG000|Overall Study|Withdrawal by Subject|1|||
46922787|NCT01346059|83155933|FG001|Overall Study|Withdrawal by Subject|0|||
46922788|NCT01318915|83155939|FG000|Overall Study|Lost to Follow-up|1|||
46922789|NCT02987205|83155945|FG000|Overall Study|Adverse Event|1|||
46922790|NCT02987205|83155945|FG000|Overall Study|Withdrawal by Subject|3|||
46922791|NCT02926937|83155967|FG000|Overall Study|Adverse Event|0|||
46922792|NCT02926937|83155968|FG001|Overall Study|Adverse Event|1|||
46922793|NCT02926937|83155969|FG002|Overall Study|Adverse Event|1|||
46922794|NCT02926937|83155967|FG000|Overall Study|Poor Compliance to Protocol|1|||
46922795|NCT02926937|83155968|FG001|Overall Study|Poor Compliance to Protocol|0|||
46922796|NCT02926937|83155969|FG002|Overall Study|Poor Compliance to Protocol|0|||
46922797|NCT02926937|83155967|FG000|Overall Study|Lost to Follow-up|4|||
46922798|NCT02926937|83155968|FG001|Overall Study|Lost to Follow-up|5|||
46922799|NCT02926937|83155969|FG002|Overall Study|Lost to Follow-up|0|||
46922800|NCT02926937|83155967|FG000|Overall Study|At the Participant's own Request|11|||
46922801|NCT02926937|83155968|FG001|Overall Study|At the Participant's own Request|5|||
46922802|NCT02926937|83155969|FG002|Overall Study|At the Participant's own Request|8|||
46922803|NCT02926937|83155967|FG000|Overall Study|Reason not Specified|3|||
46922804|NCT02926937|83155968|FG001|Overall Study|Reason not Specified|4|||
46922805|NCT02926937|83155969|FG002|Overall Study|Reason not Specified|2|||
46922806|NCT00151892|83155980|FG000|Overall Study|Lack of Efficacy|50|||
46922807|NCT00151892|83155981|FG001|Overall Study|Lack of Efficacy|57|||
46922808|NCT00151892|83155980|FG000|Overall Study|Patient request|10|||
46922809|NCT00151892|83155981|FG001|Overall Study|Patient request|7|||
46922810|NCT00151892|83155980|FG000|Overall Study|Lost to Follow-up|5|||
46922811|NCT00151892|83155981|FG001|Overall Study|Lost to Follow-up|10|||
46922812|NCT00151892|83155980|FG000|Overall Study|Adverse Event|6|||
46922813|NCT00151892|83155981|FG001|Overall Study|Adverse Event|3|||
46922814|NCT00151892|83155980|FG000|Overall Study|Protocol Violation|3|||
46922815|NCT00151892|83155981|FG001|Overall Study|Protocol Violation|3|||
46922816|NCT00151892|83155980|FG000|Overall Study|Non-compliance|0|||
46922817|NCT00151892|83155981|FG001|Overall Study|Non-compliance|1|||
46922818|NCT00151892|83155980|FG000|Overall Study|Pregnancy|0|||
46922819|NCT00151892|83155981|FG001|Overall Study|Pregnancy|1|||
46922820|NCT00151892|83155980|FG000|Overall Study|Did not return for a visit|1|||
46922821|NCT00151892|83155981|FG001|Overall Study|Did not return for a visit|0|||
46922822|NCT00151892|83155980|FG000|Overall Study|Used prohibited corticosteroids|1|||
46922823|NCT00151892|83155981|FG001|Overall Study|Used prohibited corticosteroids|0|||
46922824|NCT00151892|83155980|FG000|Overall Study|Lack of study medication at center|0|||
46922825|NCT00151892|83155981|FG001|Overall Study|Lack of study medication at center|1|||
46922826|NCT03055195|83156005|FG000|Overall Study|Lack of Efficacy|1|||
46922827|NCT03055195|83156006|FG001|Overall Study|Lack of Efficacy|0|||
46922828|NCT03055195|83156005|FG000|Overall Study|Withdrawal by Subject|6|||
46922829|NCT03055195|83156006|FG001|Overall Study|Withdrawal by Subject|7|||
46922830|NCT03055195|83156005|FG000|Overall Study|Study Terminated by Sponsor|2|||
46922831|NCT03055195|83156006|FG001|Overall Study|Study Terminated by Sponsor|6|||
46745295|NCT00838539|82962341|FG006|Overall Study|Adverse Event|0|||
46745296|NCT00838539|82962342|FG007|Overall Study|Adverse Event|2|||
46745297|NCT00838539|82962343|FG008|Overall Study|Adverse Event|0|||
46922832|NCT03055195|83156005|FG000|Overall Study|Protocol Violation|2|||
46922833|NCT03055195|83156006|FG001|Overall Study|Protocol Violation|1|||
46922834|NCT03055195|83156005|FG000|Overall Study|Physician Decision|1|||
46922835|NCT03055195|83156006|FG001|Overall Study|Physician Decision|0|||
46922836|NCT02921919|83156014|FG000|Overall Study|Other|5|||
46745298|NCT00838539|82962344|FG009|Overall Study|Adverse Event|1|||
46922837|NCT02921919|83156015|FG001|Overall Study|Other|6|||
46922838|NCT02921919|83156014|FG000|Overall Study|Lost to Follow-up|0|||
46922839|NCT02921919|83156015|FG001|Overall Study|Lost to Follow-up|1|||
46922840|NCT02921919|83156014|FG000|Overall Study|Withdrawal by Subject|5|||
46922841|NCT02921919|83156015|FG001|Overall Study|Withdrawal by Subject|1|||
46922842|NCT02921919|83156014|FG000|Overall Study|Disease Progression|47|||
46922843|NCT02921919|83156015|FG001|Overall Study|Disease Progression|38|||
46922844|NCT02921919|83156014|FG000|Overall Study|Physician Decision|3|||
46635441|NCT01584648|82809109|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
46745299|NCT00838539|82962345|FG010|Overall Study|Adverse Event|2|||
46922845|NCT02921919|83156015|FG001|Overall Study|Physician Decision|2|||
46922846|NCT02921919|83156014|FG000|Overall Study|Adverse Event|6|||
46922847|NCT02921919|83156015|FG001|Overall Study|Adverse Event|4|||
46922848|NCT02910219|83156037|FG000|Overall Study|Withdrawal by Subject|1|||
46922849|NCT02910219|83156038|FG001|Overall Study|Withdrawal by Subject|1|||
46745300|NCT00838539|82962346|FG011|Overall Study|Adverse Event|0|||
46745301|NCT00838539|82962335|FG000|Overall Study|Withdrawal by Subject|0|||
46745302|NCT00838539|82962336|FG001|Overall Study|Withdrawal by Subject|1|||
46745303|NCT00838539|82962337|FG002|Overall Study|Withdrawal by Subject|0|||
46745304|NCT00838539|82962338|FG003|Overall Study|Withdrawal by Subject|0|||
46745305|NCT00838539|82962339|FG004|Overall Study|Withdrawal by Subject|0|||
46745306|NCT00838539|82962340|FG005|Overall Study|Withdrawal by Subject|0|||
46745307|NCT00838539|82962341|FG006|Overall Study|Withdrawal by Subject|0|||
46745308|NCT00838539|82962342|FG007|Overall Study|Withdrawal by Subject|0|||
46745309|NCT00838539|82962343|FG008|Overall Study|Withdrawal by Subject|0|||
46745310|NCT00838539|82962344|FG009|Overall Study|Withdrawal by Subject|1|||
46745311|NCT00838539|82962345|FG010|Overall Study|Withdrawal by Subject|2|||
46745312|NCT00838539|82962346|FG011|Overall Study|Withdrawal by Subject|0|||
46745313|NCT00838539|82962335|FG000|Overall Study|Death|0|||
46745314|NCT00838539|82962336|FG001|Overall Study|Death|0|||
46745315|NCT00838539|82962337|FG002|Overall Study|Death|0|||
46745316|NCT00838539|82962338|FG003|Overall Study|Death|0|||
46745317|NCT00838539|82962339|FG004|Overall Study|Death|0|||
46745318|NCT00838539|82962340|FG005|Overall Study|Death|0|||
46745319|NCT00838539|82962341|FG006|Overall Study|Death|1|||
46745320|NCT00838539|82962342|FG007|Overall Study|Death|0|||
46745321|NCT00838539|82962343|FG008|Overall Study|Death|0|||
46745322|NCT00838539|82962344|FG009|Overall Study|Death|0|||
46745323|NCT00838539|82962345|FG010|Overall Study|Death|0|||
46745324|NCT00838539|82962346|FG011|Overall Study|Death|0|||
46745325|NCT00838539|82962335|FG000|Overall Study|Physician Decision|0|||
46745326|NCT00838539|82962336|FG001|Overall Study|Physician Decision|0|||
46745327|NCT00838539|82962337|FG002|Overall Study|Physician Decision|0|||
46745328|NCT00838539|82962338|FG003|Overall Study|Physician Decision|0|||
46745329|NCT00838539|82962339|FG004|Overall Study|Physician Decision|0|||
46745330|NCT00838539|82962340|FG005|Overall Study|Physician Decision|0|||
46745331|NCT00838539|82962341|FG006|Overall Study|Physician Decision|0|||
46745332|NCT00838539|82962342|FG007|Overall Study|Physician Decision|0|||
46745333|NCT00838539|82962343|FG008|Overall Study|Physician Decision|1|||
46745334|NCT00838539|82962344|FG009|Overall Study|Physician Decision|0|||
46745335|NCT00838539|82962345|FG010|Overall Study|Physician Decision|0|||
46745336|NCT00838539|82962346|FG011|Overall Study|Physician Decision|0|||
46745337|NCT00838539|82962335|FG000|Overall Study|Clinical Progression|0|||
46745338|NCT00838539|82962336|FG001|Overall Study|Clinical Progression|0|||
46745339|NCT00838539|82962337|FG002|Overall Study|Clinical Progression|0|||
46745340|NCT00838539|82962338|FG003|Overall Study|Clinical Progression|0|||
46745341|NCT00838539|82962339|FG004|Overall Study|Clinical Progression|0|||
46745342|NCT00838539|82962340|FG005|Overall Study|Clinical Progression|0|||
46745343|NCT00838539|82962341|FG006|Overall Study|Clinical Progression|1|||
46745344|NCT00838539|82962342|FG007|Overall Study|Clinical Progression|0|||
46745345|NCT00838539|82962343|FG008|Overall Study|Clinical Progression|0|||
46745346|NCT00838539|82962344|FG009|Overall Study|Clinical Progression|0|||
46745347|NCT00838539|82962345|FG010|Overall Study|Clinical Progression|0|||
46745348|NCT00838539|82962346|FG011|Overall Study|Clinical Progression|0|||
46745349|NCT00838539|82962335|FG000|Overall Study|Symptomatic Deterioration|0|||
46745350|NCT00838539|82962336|FG001|Overall Study|Symptomatic Deterioration|0|||
46745351|NCT00838539|82962337|FG002|Overall Study|Symptomatic Deterioration|1|||
46745352|NCT00838539|82962338|FG003|Overall Study|Symptomatic Deterioration|1|||
46745353|NCT00838539|82962339|FG004|Overall Study|Symptomatic Deterioration|0|||
46745354|NCT00838539|82962340|FG005|Overall Study|Symptomatic Deterioration|1|||
46745355|NCT00838539|82962341|FG006|Overall Study|Symptomatic Deterioration|0|||
46745356|NCT00838539|82962342|FG007|Overall Study|Symptomatic Deterioration|0|||
46804192|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
46804193|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
46804194|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
46804195|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
46635442|NCT01584648|82809110|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
46804196|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
46804197|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
46804198|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
46804199|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
46804200|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
46804201|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
46804202|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
46804203|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
46745357|NCT00838539|82962343|FG008|Overall Study|Symptomatic Deterioration|0|||
46745358|NCT00838539|82962344|FG009|Overall Study|Symptomatic Deterioration|1|||
46745359|NCT00838539|82962345|FG010|Overall Study|Symptomatic Deterioration|0|||
46745360|NCT00838539|82962346|FG011|Overall Study|Symptomatic Deterioration|0|||
46745361|NCT00837759|82962386|FG000|Overall Study|Protocol Violation|3|||
46745362|NCT00837759|82962386|FG000|Overall Study|Lost to Follow-up|1|||
46745363|NCT00891774|82962390|FG000|Overall Study|Lost to Follow-up|5|||
46745364|NCT00891774|82962390|FG000|Overall Study|Illness (Self/Mother)|3|||
46745365|NCT00891774|82962390|FG000|Overall Study|Withdrawal by Subject|2|||
46745366|NCT00891774|82962390|FG000|Overall Study|Protocol Violation|4|||
46745367|NCT05421754|82962394|FG000|Overall Study|Technical issue with sensor|1|||
46745368|NCT04644276|82962407|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
46745369|NCT04644276|82962408|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
46635443|NCT01559454|82809121|FG000|Overall Study|Lost to Follow-up|3|||
46635444|NCT01559454|82809122|FG001|Overall Study|Lost to Follow-up|2|||
46745370|NCT04644276|82962409|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
46745371|NCT01596621|82962475|FG000|Overall Study|Death|4|||
46745372|NCT01596621|82962475|FG000|Overall Study|Withdrawal by Subject|9|||
46745373|NCT01596621|82962475|FG000|Overall Study|Disease Progression|49|||
46745374|NCT01596621|82962475|FG000|Overall Study|Lost to Follow-up|3|||
46745375|NCT01596621|82962475|FG000|Overall Study|Other than specified|13|||
46745376|NCT01337245|82962479|FG000|Overall Study|Lost to Follow-up|1|||
46745377|NCT00566098|82962489|FG000|Collection of MILs|Withdrawal by Subject|1|||
46745378|NCT00566098|82962489|FG000|Collection of MILs|Relapsed|1|||
46745379|NCT00566098|82962489|FG000|Generation of MILs Product|Relapsed|1|||
46745380|NCT00566098|82962489|FG000|Administration of ASCT+MILs|Death|10|||
46745381|NCT00566098|82962489|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
46745382|NCT00248287|82962496|FG000|Overall Study|Adverse Event|11|||
46745383|NCT00248287|82962497|FG001|Overall Study|Adverse Event|10|||
46745384|NCT00248287|82962496|FG000|Overall Study|Death|1|||
46745385|NCT00248287|82962497|FG001|Overall Study|Death|0|||
46745386|NCT00248287|82962496|FG000|Overall Study|Lost to Follow-up|0|||
46745387|NCT00248287|82962497|FG001|Overall Study|Lost to Follow-up|1|||
46745388|NCT00248287|82962496|FG000|Overall Study|Investigator Request|4|||
46745389|NCT00248287|82962497|FG001|Overall Study|Investigator Request|3|||
46745390|NCT00248287|82962496|FG000|Overall Study|Patient Request|5|||
46745391|NCT00248287|82962497|FG001|Overall Study|Patient Request|3|||
46745392|NCT00248287|82962496|FG000|Overall Study|Other|3|||
46745393|NCT00248287|82962497|FG001|Overall Study|Other|2|||
46745394|NCT00837213|82962505|FG000|Overall Study|Lost to Follow-up|3|||
46745395|NCT00837213|82962506|FG001|Overall Study|Lost to Follow-up|2|||
46745396|NCT00837213|82962505|FG000|Overall Study|Withdrawal by Subject|2|||
46745397|NCT00837213|82962506|FG001|Overall Study|Withdrawal by Subject|2|||
46745398|NCT00837213|82962505|FG000|Overall Study|not stated|1|||
46745399|NCT00837213|82962506|FG001|Overall Study|not stated|1|||
46745400|NCT00902486|82962516|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
46745401|NCT00902486|82962517|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
46745402|NCT00902486|82962518|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
46745403|NCT00902486|82962519|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
46745404|NCT00902486|82962520|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
46745405|NCT00902486|82962521|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
46745406|NCT00902486|82962516|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
46745407|NCT00902486|82962517|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
46745408|NCT00902486|82962518|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
46745409|NCT00902486|82962519|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
46745410|NCT00902486|82962520|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
46745411|NCT00902486|82962521|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
46745412|NCT00902486|82962516|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
46745413|NCT00902486|82962517|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
46745414|NCT00902486|82962518|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
46745415|NCT00902486|82962519|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
46745416|NCT00902486|82962520|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
46745417|NCT00902486|82962521|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
46745418|NCT00902486|82962516|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
46745419|NCT00902486|82962517|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
46922850|NCT01068717|83156044|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
47073131|NCT01045161|83361496|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
46922851|NCT01068717|83156045|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
46635445|NCT01559454|82809121|FG000|Overall Study|Withdrawal by Subject|0|||
46635446|NCT01559454|82809122|FG001|Overall Study|Withdrawal by Subject|1|||
46745420|NCT00902486|82962518|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
46745421|NCT00902486|82962519|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
46745422|NCT00902486|82962520|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
46745423|NCT00902486|82962521|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
46745424|NCT00902486|82962516|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
46745425|NCT00902486|82962517|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
46745426|NCT00902486|82962518|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
46745427|NCT00902486|82962519|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
46745428|NCT00902486|82962520|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
46745429|NCT00902486|82962521|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
46745430|NCT00902486|82962516|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
46745431|NCT00902486|82962517|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
46745432|NCT00902486|82962518|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
46745433|NCT00902486|82962519|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
46745434|NCT00902486|82962520|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
47051409|NCT03049449|83314615|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
46745435|NCT00902486|82962521|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
46745436|NCT00902486|82962516|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
46745437|NCT00902486|82962517|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
46745438|NCT00902486|82962518|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
46745439|NCT00902486|82962519|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
46745440|NCT00902486|82962520|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
46745441|NCT00902486|82962521|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
46745442|NCT00902486|82962516|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
46745443|NCT00902486|82962517|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
46745444|NCT00902486|82962518|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
46745445|NCT00902486|82962519|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
46745446|NCT00902486|82962520|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
46745447|NCT00902486|82962521|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
46745448|NCT00902486|82962516|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
46745449|NCT00902486|82962517|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
46745450|NCT00902486|82962518|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
46745451|NCT00902486|82962519|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
46745452|NCT00902486|82962520|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
46745453|NCT00902486|82962521|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
46745454|NCT00902486|82962516|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
46745455|NCT00902486|82962517|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
46745456|NCT00902486|82962518|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
46745457|NCT00902486|82962519|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
47051410|NCT03049449|83314616|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
46745458|NCT00902486|82962520|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
46745459|NCT00902486|82962521|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
46745460|NCT00902486|82962516|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
46745461|NCT00902486|82962517|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
46745462|NCT00902486|82962518|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
46745463|NCT00902486|82962519|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
46745464|NCT00902486|82962520|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
46745465|NCT00902486|82962521|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
46745466|NCT00836745|82962551|FG000|Overall Study|Death|2|||
46745467|NCT00836745|82962551|FG000|Overall Study|Lost to Follow-up|10|||
46745468|NCT00836745|82962551|FG000|Overall Study|Adverse Event|3|||
46745469|NCT00836745|82962551|FG000|Overall Study|Objective progression or relapse|4|||
46745470|NCT00836745|82962551|FG000|Overall Study|Other|2|||
46745471|NCT00891618|82962555|FG000|Overall Study|Withdrawal by Subject|1|||
46745472|NCT00836589|82962559|FG000|Overall Study|Lost to Follow-up|246|||
46745473|NCT00836589|82962559|FG000|Overall Study|Death|429|||
46745474|NCT00836589|82962559|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
46745475|NCT00574795|82962571|FG000|Infant Series|Withdrawal by Subject|2|||
47051411|NCT02989857|83314739|FG000|Randomization Phase|Not Treated|3|||
47051412|NCT02989857|83314740|FG001|Randomization Phase|Not Treated|2|||
47051413|NCT02989857|83314741|FG002|Randomization Phase|Not Treated|0|||
46745476|NCT00574795|82962571|FG000|Infant Series|Protocol Violation|2|||
46745477|NCT00574795|82962571|FG000|Infant Series|Adverse Event|1|||
46745478|NCT00574795|82962571|FG000|After Infant Series|Withdrawal by Subject|1|||
46745479|NCT00574795|82962571|FG000|After Infant Series|Adverse Event|2|||
46745480|NCT00574795|82962571|FG000|Toddler Dose|Withdrawal by Subject|1|||
46745481|NCT02297516|82962588|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
46745482|NCT02297516|82962589|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
47051414|NCT01877915|83314752|FG000|Overall Study|Lost to Follow-up|10|||
46745483|NCT02297516|82962588|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
46745484|NCT02297516|82962589|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
46775747|NCT00793793|82994204|FG000|Overall Study|Lost to Follow-up|0|||
46804204|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
46922852|NCT01068717|83156046|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
46922853|NCT01068717|83156047|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
47051415|NCT01877915|83314753|FG001|Overall Study|Lost to Follow-up|9|||
46745485|NCT02297516|82962588|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
46745486|NCT02297516|82962589|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
46745487|NCT00836277|82962602|FG000|Overall Study|Not evaluable for response|6|||
46745488|NCT00835731|82962608|FG000|Overall Study|Withdrawal by Subject|1|||
46745489|NCT00835731|82962609|FG001|Overall Study|Withdrawal by Subject|0|||
46745490|NCT00835731|82962608|FG000|Overall Study|Physician Decision|1|||
46745491|NCT00835731|82962609|FG001|Overall Study|Physician Decision|1|||
46745492|NCT00835341|82962617|FG000|Overall Study|Lost to Follow-up|3|||
46745493|NCT00835341|82962618|FG001|Overall Study|Lost to Follow-up|12|||
46745494|NCT00574249|82962626|FG000|Overall Study|Adverse Event|6|||
46745495|NCT00574249|82962627|FG001|Overall Study|Adverse Event|18|||
46745496|NCT00574249|82962626|FG000|Overall Study|Lack of Efficacy|5|||
46745497|NCT00574249|82962627|FG001|Overall Study|Lack of Efficacy|3|||
46745498|NCT00574249|82962626|FG000|Overall Study|Lost to Follow-up|4|||
46745499|NCT00574249|82962627|FG001|Overall Study|Lost to Follow-up|3|||
46745500|NCT00574249|82962626|FG000|Overall Study|Protocol Violation|5|||
46745501|NCT00574249|82962627|FG001|Overall Study|Protocol Violation|2|||
46745502|NCT00574249|82962626|FG000|Overall Study|History of carcinoma|1|||
46745503|NCT00574249|82962627|FG001|Overall Study|History of carcinoma|0|||
46745504|NCT00574249|82962626|FG000|Overall Study|Withdrawal by Subject|3|||
46745505|NCT00574249|82962627|FG001|Overall Study|Withdrawal by Subject|0|||
46745506|NCT00574249|82962626|FG000|Overall Study|Physician Decision|1|||
46745507|NCT00574249|82962627|FG001|Overall Study|Physician Decision|0|||
46745508|NCT00574249|82962626|FG000|Overall Study|Pregnancy|1|||
46745509|NCT00574249|82962627|FG001|Overall Study|Pregnancy|0|||
46745510|NCT00574249|82962626|FG000|Overall Study|Excluded by company|0|||
46745511|NCT00574249|82962627|FG001|Overall Study|Excluded by company|1|||
46745512|NCT00574249|82962626|FG000|Overall Study|PPD test taken twice|0|||
46745513|NCT00574249|82962627|FG001|Overall Study|PPD test taken twice|1|||
46745514|NCT00891228|82962636|FG000|Overall Study|Adverse Event|0|||
46745515|NCT00891228|82962637|FG001|Overall Study|Adverse Event|2|||
47051416|NCT01877915|83314752|FG000|Overall Study|Withdrawal by Subject|42|||
46635447|NCT01559454|82809121|FG000|Overall Study|Physician Decision|0|||
46745516|NCT00891228|82962638|FG002|Overall Study|Adverse Event|3|||
46745517|NCT00891228|82962636|FG000|Overall Study|Withdrawal by Subject|2|||
46745518|NCT00891228|82962637|FG001|Overall Study|Withdrawal by Subject|4|||
46745519|NCT00891228|82962638|FG002|Overall Study|Withdrawal by Subject|5|||
46745520|NCT00891228|82962636|FG000|Overall Study|Protocol Violation|3|||
46745521|NCT00891228|82962637|FG001|Overall Study|Protocol Violation|1|||
46745522|NCT00891228|82962638|FG002|Overall Study|Protocol Violation|2|||
46745523|NCT00891228|82962636|FG000|Overall Study|Physician Decision|2|||
46745524|NCT00891228|82962637|FG001|Overall Study|Physician Decision|1|||
46745525|NCT00891228|82962638|FG002|Overall Study|Physician Decision|0|||
46745526|NCT00891228|82962636|FG000|Overall Study|Lost to Follow-up|4|||
46745527|NCT00891228|82962637|FG001|Overall Study|Lost to Follow-up|4|||
46745528|NCT00891228|82962638|FG002|Overall Study|Lost to Follow-up|5|||
46745529|NCT00891228|82962636|FG000|Overall Study|Pregnancy|0|||
46745530|NCT00891228|82962637|FG001|Overall Study|Pregnancy|1|||
46745531|NCT00891228|82962638|FG002|Overall Study|Pregnancy|0|||
46745532|NCT00896168|82962648|FG000|Overall Study|Adverse Event|4|||
46745533|NCT00896168|82962649|FG001|Overall Study|Adverse Event|7|||
46745534|NCT00896168|82962648|FG000|Overall Study|Treatment failure|8|||
46745535|NCT00896168|82962649|FG001|Overall Study|Treatment failure|10|||
46745536|NCT00896168|82962648|FG000|Overall Study|Lost to Follow-up|1|||
46745537|NCT00896168|82962649|FG001|Overall Study|Lost to Follow-up|1|||
46635448|NCT01559454|82809122|FG001|Overall Study|Physician Decision|1|||
46745538|NCT00896168|82962648|FG000|Overall Study|Other|1|||
46745539|NCT00896168|82962649|FG001|Overall Study|Other|1|||
46745540|NCT00833703|82962657|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
46745541|NCT00833703|82962658|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
46745542|NCT00833547|82962666|FG000|Overall Study|Withdrawal by Subject|2|||
46745543|NCT00833547|82962667|FG001|Overall Study|Withdrawal by Subject|2|||
46745544|NCT00833469|82962673|FG000|Overall Study|Withdrawal by Subject|1|||
46745545|NCT00833469|82962673|FG000|Overall Study|Lost to Follow-up|1|||
46745546|NCT00832377|82962677|FG000|Overall Study|Protocol Violation|1|||
46745547|NCT00892008|82962681|FG000|Overall Study|Death|5|||
46745548|NCT00892008|82962681|FG000|Overall Study|Lack of Efficacy|3|||
46745549|NCT00892008|82962681|FG000|Overall Study|Lost to Follow-up|142|||
46745550|NCT00892008|82962681|FG000|Overall Study|Other|378|||
46745551|NCT00892008|82962681|FG000|Overall Study|Adverse Event|37|||
46745552|NCT00623233|82962685|FG000|Overall Study|Adverse Event|10|||
46745553|NCT00623233|82962685|FG000|Overall Study|Physician Decision|10|||
46745554|NCT00623233|82962685|FG000|Overall Study|Lost to Follow-up|1|||
46635449|NCT01559454|82809121|FG000|Overall Study|Protocol Violation|0|||
46745555|NCT00623233|82962685|FG000|Overall Study|Withdrawal by Subject|3|||
46775748|NCT00793793|82994205|FG001|Overall Study|Lost to Follow-up|0|||
46745556|NCT03369236|82962700|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
46745557|NCT03369236|82962701|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
46745558|NCT03369236|82962700|FG000|Open-label Extension Period|Lack of Efficacy|2|||
46745559|NCT03369236|82962701|FG001|Open-label Extension Period|Lack of Efficacy|1|||
46745560|NCT03369236|82962700|FG000|Open-label Extension Period|Adverse Event|0|||
46745561|NCT03369236|82962701|FG001|Open-label Extension Period|Adverse Event|1|||
46745562|NCT03369236|82962700|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
46745563|NCT03369236|82962701|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
46745564|NCT00621751|82962715|FG000|Overall Study|Adverse Event|0|||
46745565|NCT00621751|82962716|FG001|Overall Study|Adverse Event|1|||
46745566|NCT00891930|82962733|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
46745567|NCT00891930|82962733|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
46745568|NCT00891930|82962733|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
46745569|NCT00891930|82962733|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
46745570|NCT00891930|82962733|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
46745571|NCT00891462|82962744|FG000|Overall Study|Withdrawal by Subject|9|||
47051417|NCT01877915|83314753|FG001|Overall Study|Withdrawal by Subject|55|||
46745572|NCT00891462|82962745|FG001|Overall Study|Withdrawal by Subject|6|||
46745573|NCT00891462|82962746|FG002|Overall Study|Withdrawal by Subject|7|||
46745574|NCT00891462|82962744|FG000|Overall Study|Adverse Event|7|||
46745575|NCT00891462|82962745|FG001|Overall Study|Adverse Event|8|||
46745576|NCT00891462|82962746|FG002|Overall Study|Adverse Event|7|||
46745577|NCT00891462|82962744|FG000|Overall Study|Lack of Efficacy|10|||
46745578|NCT00891462|82962745|FG001|Overall Study|Lack of Efficacy|5|||
47051418|NCT01877915|83314752|FG000|Overall Study|Other|2|||
47051419|NCT01877915|83314753|FG001|Overall Study|Other|4|||
47051420|NCT01876979|83314761|FG000|Overall Study|Physician Decision|2|||
47051421|NCT01876979|83314762|FG001|Overall Study|Physician Decision|3|||
47051422|NCT01860989|83314768|FG000|Overall Study|Unsatisfactory therapeutic|5|||
47051423|NCT01860677|83314784|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
47051424|NCT01860677|83314785|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
47051425|NCT01876901|83314794|FG000|Overall Study|Protocol Violation|10|||
47051426|NCT01876901|83314795|FG001|Overall Study|Protocol Violation|2|||
47051427|NCT01876901|83314794|FG000|Overall Study|No or other surgical intervention|7|||
47051428|NCT01876901|83314795|FG001|Overall Study|No or other surgical intervention|5|||
47051429|NCT01876823|83314802|FG000|Overall Study|Withdrawal by Subject|5|||
47051430|NCT01876823|83314802|FG000|Overall Study|Physician Decision|2|||
47051431|NCT01876823|83314802|FG000|Overall Study|Patients moved|2|||
47051432|NCT01876511|83314809|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
47051433|NCT01876511|83314810|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
47051434|NCT01876511|83314811|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
47051435|NCT01876511|83314809|FG000|Overall Study|Death (unrelated)|3|||
47051436|NCT01876511|83314810|FG001|Overall Study|Death (unrelated)|0|||
47051437|NCT01876511|83314811|FG002|Overall Study|Death (unrelated)|2|||
47051438|NCT01876511|83314809|FG000|Overall Study|Drug-related Toxicity|5|||
47051439|NCT01876511|83314810|FG001|Overall Study|Drug-related Toxicity|1|||
47051440|NCT01876511|83314811|FG002|Overall Study|Drug-related Toxicity|6|||
47051441|NCT01876511|83314809|FG000|Overall Study|Patient Decision|3|||
47051442|NCT01876511|83314810|FG001|Overall Study|Patient Decision|0|||
47051443|NCT01876511|83314811|FG002|Overall Study|Patient Decision|6|||
47051444|NCT01876511|83314809|FG000|Overall Study|Physician Decision|1|||
47051445|NCT01876511|83314810|FG001|Overall Study|Physician Decision|0|||
47051446|NCT01876511|83314811|FG002|Overall Study|Physician Decision|1|||
47051447|NCT01993719|83314826|FG000|First Drug Administration|Not treated|1|||
47051448|NCT01993719|83314827|FG001|First Drug Administration|Not treated|0|||
46745579|NCT00891462|82962746|FG002|Overall Study|Lack of Efficacy|1|||
46745580|NCT00891462|82962744|FG000|Overall Study|COPD exacerbation|7|||
46745581|NCT00891462|82962745|FG001|Overall Study|COPD exacerbation|4|||
46745582|NCT00891462|82962746|FG002|Overall Study|COPD exacerbation|1|||
46745583|NCT00891462|82962744|FG000|Overall Study|Other Reason|2|||
47051449|NCT01993719|83314828|FG002|First Drug Administration|Not treated|0|||
47051450|NCT01993719|83314829|FG003|First Drug Administration|Not treated|0|||
47051451|NCT01993719|83314830|FG004|First Drug Administration|Not treated|0|||
47051452|NCT00638235|83314872|FG000|Overall Study|Lost to Follow-up|31|||
47051453|NCT00638235|83314873|FG001|Overall Study|Lost to Follow-up|3|||
47051454|NCT00638235|83314874|FG002|Overall Study|Lost to Follow-up|18|||
47051455|NCT00638235|83314875|FG003|Overall Study|Lost to Follow-up|10|||
47051456|NCT00638235|83314876|FG004|Overall Study|Lost to Follow-up|13|||
46745584|NCT00891462|82962745|FG001|Overall Study|Other Reason|5|||
46745585|NCT00891462|82962746|FG002|Overall Study|Other Reason|3|||
47051457|NCT00638235|83314877|FG005|Overall Study|Lost to Follow-up|26|||
47051458|NCT00638235|83314878|FG006|Overall Study|Lost to Follow-up|0|||
47051459|NCT00638235|83314879|FG007|Overall Study|Lost to Follow-up|1|||
47051460|NCT00638235|83314880|FG008|Overall Study|Lost to Follow-up|18|||
47051461|NCT00638157|83314909|FG000|Overall Study|Adverse Event|0|||
47051462|NCT00638157|83314910|FG001|Overall Study|Adverse Event|1|||
47051463|NCT00638157|83314909|FG000|Overall Study|Clinical (symptomatic) failure|1|||
47051464|NCT00638157|83314910|FG001|Overall Study|Clinical (symptomatic) failure|1|||
47051465|NCT00638157|83314909|FG000|Overall Study|Microbiological failure|1|||
47051466|NCT00638157|83314910|FG001|Overall Study|Microbiological failure|0|||
46745586|NCT00891462|82962744|FG000|Overall Study|Protocol Violation|2|||
46745587|NCT00891462|82962745|FG001|Overall Study|Protocol Violation|1|||
46745588|NCT00891462|82962746|FG002|Overall Study|Protocol Violation|3|||
46745589|NCT00891462|82962744|FG000|Overall Study|Inclusion/exclusion criteria|0|||
46745590|NCT00891462|82962745|FG001|Overall Study|Inclusion/exclusion criteria|2|||
46745591|NCT00891462|82962746|FG002|Overall Study|Inclusion/exclusion criteria|2|||
46745592|NCT00891462|82962744|FG000|Overall Study|Lost to Follow-up|0|||
46745593|NCT00891462|82962745|FG001|Overall Study|Lost to Follow-up|2|||
46745594|NCT00891462|82962746|FG002|Overall Study|Lost to Follow-up|0|||
46745595|NCT00900146|82962761|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
46745596|NCT00900146|82962762|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
46745597|NCT00900146|82962763|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
46745598|NCT00900146|82962764|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
46745599|NCT00900146|82962765|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
46745600|NCT00900146|82962761|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
46745601|NCT00900146|82962762|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
46745602|NCT00900146|82962763|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
46745603|NCT00900146|82962764|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
46745604|NCT00900146|82962765|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
46745605|NCT00900146|82962761|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
46745606|NCT00900146|82962762|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
46745607|NCT00900146|82962763|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
46745608|NCT00900146|82962764|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
46745609|NCT00900146|82962765|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
46745610|NCT00900146|82962761|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
46745611|NCT00900146|82962762|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
46745612|NCT00900146|82962763|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
46745613|NCT00900146|82962764|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
46745614|NCT00900146|82962765|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
46745615|NCT00900146|82962761|FG000|Intermediate: Period III|Lost to Follow-up|2|||
46745616|NCT00900146|82962762|FG001|Intermediate: Period III|Lost to Follow-up|0|||
46745617|NCT00900146|82962763|FG002|Intermediate: Period III|Lost to Follow-up|0|||
46745618|NCT00900146|82962764|FG003|Intermediate: Period III|Lost to Follow-up|0|||
46745619|NCT00900146|82962765|FG004|Intermediate: Period III|Lost to Follow-up|1|||
47051467|NCT00638157|83314909|FG000|Overall Study|Lost to Follow-up|1|||
47051468|NCT00638157|83314910|FG001|Overall Study|Lost to Follow-up|0|||
47051469|NCT00638157|83314909|FG000|Overall Study|Physician Decision|1|||
47051470|NCT00638157|83314910|FG001|Overall Study|Physician Decision|0|||
47051471|NCT00638157|83314909|FG000|Overall Study|Other|1|||
47051472|NCT00638157|83314910|FG001|Overall Study|Other|2|||
47051473|NCT00638157|83314909|FG000|Overall Study|Randomized, not treated|2|||
46745620|NCT00900146|82962761|FG000|Intermediate: Period III|Administrative problems|85|||
46745621|NCT00900146|82962762|FG001|Intermediate: Period III|Administrative problems|92|||
46745622|NCT00900146|82962763|FG002|Intermediate: Period III|Administrative problems|84|||
46745623|NCT00900146|82962764|FG003|Intermediate: Period III|Administrative problems|90|||
46745624|NCT00900146|82962765|FG004|Intermediate: Period III|Administrative problems|163|||
46745625|NCT00895310|82962777|FG000|Overall Study|Withdrawal by Subject|1|||
46745626|NCT00895154|82962783|FG000|Overall Study|Lost to Follow-up|1|||
46745627|NCT00895154|82962784|FG001|Overall Study|Lost to Follow-up|1|||
46745628|NCT00895154|82962783|FG000|Overall Study|Withdrawal by Subject|0|||
46745629|NCT00895154|82962784|FG001|Overall Study|Withdrawal by Subject|1|||
46745630|NCT00888654|82962790|FG000|Overall Study|Problems swallowing oral meds.|1|||
46745631|NCT00888654|82962790|FG000|Overall Study|Not enough oral meds before surgery|3|||
46745632|NCT00888654|82962790|FG000|Overall Study|Surgery aborted|2|||
46745633|NCT00888654|82962790|FG000|Overall Study|Withdrawal by Subject|1|||
46745634|NCT00888654|82962790|FG000|Overall Study|Inelig. due to contraindication of med|1|||
46745635|NCT00888654|82962790|FG000|Overall Study|Change in surg date|1|||
46745636|NCT00888654|82962790|FG000|Overall Study|Stopped meds due to headaches|1|||
46775749|NCT00793793|82994206|FG002|Overall Study|Lost to Follow-up|1|||
47051474|NCT00638157|83314910|FG001|Overall Study|Randomized, not treated|0|||
47051475|NCT00637377|83314921|FG000|Overall Study|Adverse Event|2|||
47051476|NCT00637377|83314922|FG001|Overall Study|Adverse Event|6|||
47051477|NCT00637377|83314923|FG002|Overall Study|Adverse Event|8|||
47051478|NCT00637377|83314924|FG003|Overall Study|Adverse Event|9|||
46745637|NCT00899678|82962797|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
46745638|NCT00899678|82962798|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
46745639|NCT00899678|82962799|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
46745640|NCT00899678|82962797|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
46745641|NCT00899678|82962798|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
46745642|NCT00899678|82962799|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
46745643|NCT00899678|82962797|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
46745644|NCT00899678|82962798|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
46745645|NCT00899678|82962799|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
46745646|NCT00899678|82962797|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
46745647|NCT00899678|82962798|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
46745648|NCT00899678|82962799|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
46745649|NCT00899678|82962797|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
46745650|NCT00899678|82962798|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
46745651|NCT00899678|82962799|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
46745652|NCT00899678|82962797|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
46745653|NCT00899678|82962798|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
46745654|NCT00899678|82962799|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
46745655|NCT00899678|82962797|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
46745656|NCT00899678|82962798|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
46745657|NCT00899678|82962799|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
46745658|NCT00899678|82962797|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
46745659|NCT00899678|82962798|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
46745660|NCT00899678|82962799|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
46745661|NCT00899678|82962797|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
46745662|NCT00899678|82962798|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
46745663|NCT00899678|82962799|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
46745664|NCT00887484|82962807|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
46745665|NCT00887484|82962807|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
46745666|NCT00887484|82962807|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
46745667|NCT00886938|82962816|FG000|Overall Study|Adverse Event|1|||
46745668|NCT00886938|82962816|FG000|Overall Study|Withdrawal by Subject|1|||
46745669|NCT00620659|82962820|FG000|Treatment Period 1|Adverse Event|1|||
46745670|NCT00620659|82962821|FG001|Treatment Period 1|Adverse Event|0|||
46745671|NCT00620659|82962822|FG002|Treatment Period 1|Adverse Event|0|||
46745672|NCT00620659|82962823|FG003|Treatment Period 1|Adverse Event|3|||
46745673|NCT00620659|82962824|FG004|Treatment Period 1|Adverse Event|0|||
46745674|NCT00620659|82962825|FG005|Treatment Period 1|Adverse Event|0|||
46745675|NCT00620659|82962820|FG000|Treatment Period 1|Protocol Violation|1|||
46745676|NCT00620659|82962821|FG001|Treatment Period 1|Protocol Violation|0|||
46745677|NCT00620659|82962822|FG002|Treatment Period 1|Protocol Violation|0|||
46745678|NCT00620659|82962823|FG003|Treatment Period 1|Protocol Violation|0|||
46745679|NCT00620659|82962824|FG004|Treatment Period 1|Protocol Violation|0|||
47051479|NCT00637377|83314921|FG000|Overall Study|Death|1|||
47051480|NCT00637377|83314922|FG001|Overall Study|Death|3|||
46635450|NCT01559454|82809122|FG001|Overall Study|Protocol Violation|1|||
46635451|NCT01559454|82809121|FG000|Overall Study|Lack of Efficacy|0|||
46635452|NCT01559454|82809122|FG001|Overall Study|Lack of Efficacy|1|||
46635453|NCT01584024|82809128|FG000|Overall Study|Lost to Follow-up|10|||
46635454|NCT01584024|82809128|FG000|Overall Study|Withdrawal by Subject|3|||
46635455|NCT01583166|82809135|FG000|Overall Study|Withdrawal by Subject|4|||
46635456|NCT01583166|82809136|FG001|Overall Study|Withdrawal by Subject|6|||
46635457|NCT01535274|82809144|FG000|Overall Study|Determined to be ineligible|0|||
46635458|NCT01535274|82809145|FG001|Overall Study|Determined to be ineligible|1|||
46635459|NCT01535274|82809144|FG000|Overall Study|Misallocated to propofol intervention|0|||
46635460|NCT01535274|82809145|FG001|Overall Study|Misallocated to propofol intervention|1|||
46635461|NCT01558752|82809155|FG000|Overall Study|Physician Decision|2|||
46635462|NCT01558752|82809156|FG001|Overall Study|Physician Decision|0|||
46635463|NCT01582854|82809164|FG000|Overall Study|Death|8|||
46635464|NCT01582854|82809165|FG001|Overall Study|Death|5|||
47051481|NCT00637377|83314923|FG002|Overall Study|Death|2|||
47051482|NCT00637377|83314924|FG003|Overall Study|Death|1|||
46635465|NCT01582854|82809164|FG000|Overall Study|Adverse Event|2|||
46745680|NCT00620659|82962825|FG005|Treatment Period 1|Protocol Violation|0|||
47051483|NCT00637377|83314921|FG000|Overall Study|Lack of Efficacy|0|||
47051484|NCT00637377|83314922|FG001|Overall Study|Lack of Efficacy|0|||
47051485|NCT00637377|83314923|FG002|Overall Study|Lack of Efficacy|1|||
46635466|NCT01582854|82809165|FG001|Overall Study|Adverse Event|3|||
46635467|NCT01582854|82809164|FG000|Overall Study|Withdrawal by Participant|8|||
46635468|NCT01582854|82809165|FG001|Overall Study|Withdrawal by Participant|11|||
46635469|NCT01582854|82809164|FG000|Overall Study|Lost to Follow-up|1|||
46745681|NCT00620659|82962820|FG000|Treatment Period 1|Withdrawal by Subject|1|||
47051486|NCT00637377|83314924|FG003|Overall Study|Lack of Efficacy|1|||
46635470|NCT01582854|82809165|FG001|Overall Study|Lost to Follow-up|2|||
46635471|NCT01582854|82809164|FG000|Overall Study|Physician Decision|0|||
46635472|NCT01582854|82809165|FG001|Overall Study|Physician Decision|1|||
46635473|NCT01582854|82809164|FG000|Overall Study|Recurrent Stroke|13|||
46635474|NCT01582854|82809165|FG001|Overall Study|Recurrent Stroke|8|||
46635475|NCT01582854|82809164|FG000|Overall Study|Disallowed Concomitant Medication|3|||
46635476|NCT01582854|82809165|FG001|Overall Study|Disallowed Concomitant Medication|2|||
46635477|NCT01582854|82809164|FG000|Overall Study|Carotid or Neurosurgery|0|||
46922854|NCT02921763|83156061|FG000|Overall Study|Adverse Event|4|||
46922855|NCT02921763|83156061|FG000|Overall Study|Lost to Follow-up|4|||
46922856|NCT02921763|83156061|FG000|Overall Study|Lack of Efficacy|3|||
46922857|NCT02921763|83156061|FG000|Overall Study|Protocol Violation|2|||
46922858|NCT02921763|83156061|FG000|Overall Study|Withdrawal by Subject|2|||
46635478|NCT01582854|82809165|FG001|Overall Study|Carotid or Neurosurgery|1|||
46635479|NCT01582854|82809164|FG000|Overall Study|General Anaesthesia|0|||
46635480|NCT01582854|82809165|FG001|Overall Study|General Anaesthesia|1|||
46922859|NCT02921763|83156061|FG000|Overall Study|Physician Decision|1|||
46922860|NCT02921763|83156061|FG000|Overall Study|No data obtained|2|||
46922861|NCT01318135|83156083|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
46922862|NCT01318135|83156084|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46745682|NCT00620659|82962821|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46745683|NCT00620659|82962822|FG002|Treatment Period 1|Withdrawal by Subject|1|||
46745684|NCT00620659|82962823|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46745685|NCT00620659|82962824|FG004|Treatment Period 1|Withdrawal by Subject|1|||
46745686|NCT00620659|82962825|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46635481|NCT01582854|82809164|FG000|Overall Study|Other Miscellaneous Reason|1|||
46635482|NCT01582854|82809165|FG001|Overall Study|Other Miscellaneous Reason|0|||
46635483|NCT01582308|82809171|FG000|Period 1|Withdrawal by Subject|0|||
46635484|NCT01582308|82809172|FG001|Period 1|Withdrawal by Subject|0|||
46635485|NCT01582308|82809173|FG002|Period 1|Withdrawal by Subject|0|||
46635486|NCT01582308|82809174|FG003|Period 1|Withdrawal by Subject|0|||
46635487|NCT01582308|82809175|FG004|Period 1|Withdrawal by Subject|0|||
46635488|NCT01582308|82809176|FG005|Period 1|Withdrawal by Subject|0|||
46635489|NCT01582308|82809177|FG006|Period 1|Withdrawal by Subject|1|||
46635490|NCT01582308|82809178|FG007|Period 1|Withdrawal by Subject|0|||
46635491|NCT01582308|82809179|FG008|Period 1|Withdrawal by Subject|0|||
46635492|NCT01582308|82809180|FG009|Period 1|Withdrawal by Subject|0|||
46635493|NCT01582308|82809171|FG000|10-day Washout Following Period 1|Physician Decision|0|||
46745687|NCT00620659|82962820|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
46745688|NCT00620659|82962821|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
46745689|NCT00620659|82962822|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
46745690|NCT00620659|82962823|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
46745691|NCT00620659|82962824|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
46745692|NCT00620659|82962825|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
46635494|NCT01582308|82809172|FG001|10-day Washout Following Period 1|Physician Decision|0|||
46635495|NCT01582308|82809173|FG002|10-day Washout Following Period 1|Physician Decision|0|||
46635496|NCT01582308|82809174|FG003|10-day Washout Following Period 1|Physician Decision|0|||
46635497|NCT01582308|82809175|FG004|10-day Washout Following Period 1|Physician Decision|1|||
46635498|NCT01582308|82809176|FG005|10-day Washout Following Period 1|Physician Decision|0|||
46635499|NCT01582308|82809177|FG006|10-day Washout Following Period 1|Physician Decision|0|||
46745693|NCT00620659|82962820|FG000|Treatment Period 2|Adverse Event|0|||
46745694|NCT00620659|82962821|FG001|Treatment Period 2|Adverse Event|3|||
46745695|NCT00620659|82962822|FG002|Treatment Period 2|Adverse Event|0|||
46745696|NCT00620659|82962823|FG003|Treatment Period 2|Adverse Event|0|||
46745697|NCT00620659|82962824|FG004|Treatment Period 2|Adverse Event|2|||
46922863|NCT01318135|83156085|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46922864|NCT01318135|83156086|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46922865|NCT01318135|83156087|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
47051487|NCT00637377|83314921|FG000|Overall Study|Lost to Follow-up|4|||
46745698|NCT00620659|82962825|FG005|Treatment Period 2|Adverse Event|0|||
46745699|NCT00620659|82962820|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46745700|NCT00620659|82962821|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46745701|NCT00620659|82962822|FG002|Treatment Period 2|Withdrawal by Subject|1|||
47051488|NCT00637377|83314922|FG001|Overall Study|Lost to Follow-up|1|||
47051489|NCT00637377|83314923|FG002|Overall Study|Lost to Follow-up|2|||
47051490|NCT00637377|83314924|FG003|Overall Study|Lost to Follow-up|2|||
47051491|NCT00637377|83314921|FG000|Overall Study|Protocol Violation|2|||
46745702|NCT00620659|82962823|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46745703|NCT00620659|82962824|FG004|Treatment Period 2|Withdrawal by Subject|3|||
46745704|NCT00620659|82962825|FG005|Treatment Period 2|Withdrawal by Subject|0|||
47051492|NCT00637377|83314922|FG001|Overall Study|Protocol Violation|1|||
46635500|NCT01582308|82809178|FG007|10-day Washout Following Period 1|Physician Decision|0|||
46635501|NCT01582308|82809179|FG008|10-day Washout Following Period 1|Physician Decision|0|||
46635502|NCT01582308|82809180|FG009|10-day Washout Following Period 1|Physician Decision|0|||
46745705|NCT00620659|82962820|FG000|Placebo Washout Period 2|Adverse Event|2|||
46745706|NCT00620659|82962821|FG001|Placebo Washout Period 2|Adverse Event|0|||
46745707|NCT00620659|82962822|FG002|Placebo Washout Period 2|Adverse Event|0|||
46745708|NCT00620659|82962823|FG003|Placebo Washout Period 2|Adverse Event|0|||
46745709|NCT00620659|82962824|FG004|Placebo Washout Period 2|Adverse Event|0|||
46745710|NCT00620659|82962825|FG005|Placebo Washout Period 2|Adverse Event|0|||
46745711|NCT00620659|82962820|FG000|Treatment Period 3|Adverse Event|0|||
46745712|NCT00620659|82962821|FG001|Treatment Period 3|Adverse Event|2|||
46745713|NCT00620659|82962822|FG002|Treatment Period 3|Adverse Event|0|||
46922866|NCT01318135|83156088|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46922867|NCT01318135|83156089|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46922868|NCT01318135|83156090|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46922869|NCT01318135|83156083|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
46922870|NCT01318135|83156084|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
46922871|NCT01318135|83156085|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
46922872|NCT01318135|83156086|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
46922873|NCT01318135|83156087|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
46922874|NCT01318135|83156088|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
46922875|NCT01318135|83156089|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
46745714|NCT00620659|82962823|FG003|Treatment Period 3|Adverse Event|0|||
46745715|NCT00620659|82962824|FG004|Treatment Period 3|Adverse Event|0|||
46745716|NCT00620659|82962825|FG005|Treatment Period 3|Adverse Event|0|||
46745717|NCT00620659|82962820|FG000|Treatment Period 3|Withdrawal by Subject|0|||
46745718|NCT00620659|82962821|FG001|Treatment Period 3|Withdrawal by Subject|0|||
46745719|NCT00620659|82962822|FG002|Treatment Period 3|Withdrawal by Subject|0|||
46745720|NCT00620659|82962823|FG003|Treatment Period 3|Withdrawal by Subject|1|||
46745721|NCT00620659|82962824|FG004|Treatment Period 3|Withdrawal by Subject|0|||
46745722|NCT00620659|82962825|FG005|Treatment Period 3|Withdrawal by Subject|0|||
46745723|NCT00894686|82962838|FG000|Overall Study|Withdrawal by Subject|50|||
46745724|NCT00894686|82962838|FG000|Overall Study|Physician Decision|1|||
46745725|NCT00894686|82962838|FG000|Overall Study|Other|5|||
46745726|NCT00885846|82962845|FG000|Overall Study|Withdrawal by Subject|2|||
46745727|NCT00885846|82962846|FG001|Overall Study|Withdrawal by Subject|5|||
46745728|NCT00885846|82962847|FG002|Overall Study|Withdrawal by Subject|2|||
46745729|NCT00621517|82962857|FG000|Overall Study|Lost to Follow-up|3|||
46745730|NCT00621517|82962858|FG001|Overall Study|Lost to Follow-up|3|||
46745731|NCT00621517|82962857|FG000|Overall Study|Withdrawal by Subject|3|||
46745732|NCT00621517|82962858|FG001|Overall Study|Withdrawal by Subject|4|||
46745733|NCT00621517|82962857|FG000|Overall Study|Adverse Event|1|||
46745734|NCT00621517|82962858|FG001|Overall Study|Adverse Event|0|||
46745735|NCT05333900|82962866|FG000|Overall Study|Protocol Violation|0|||
46745736|NCT05333900|82962867|FG001|Overall Study|Protocol Violation|1|||
46745737|NCT05333900|82962866|FG000|Overall Study|Withdrawal by Subject|0|||
46745738|NCT05333900|82962867|FG001|Overall Study|Withdrawal by Subject|1|||
46745739|NCT05333900|82962866|FG000|Overall Study|COVID-19 Pandemic|1|||
46745740|NCT05333900|82962867|FG001|Overall Study|COVID-19 Pandemic|1|||
46745741|NCT00573937|82962875|FG000|Overall Study|Study Terminated|0|||
46745742|NCT00573937|82962876|FG001|Overall Study|Study Terminated|1|||
46745743|NCT00573859|82962882|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
46745744|NCT00573859|82962882|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
46745745|NCT00831441|82962888|FG000|Randomized|Death|82|||
46745746|NCT00831441|82962889|FG001|Randomized|Death|81|||
46745747|NCT00831441|82962888|FG000|Randomized|Adverse Event|248|||
46745748|NCT00831441|82962889|FG001|Randomized|Adverse Event|321|||
46745749|NCT00831441|82962888|FG000|Randomized|Emergency procedure|2|||
46745750|NCT00831441|82962889|FG001|Randomized|Emergency procedure|2|||
46745751|NCT00831441|82962888|FG000|Randomized|Elective procedure|26|||
46745752|NCT00831441|82962889|FG001|Randomized|Elective procedure|25|||
46745753|NCT00831441|82962888|FG000|Randomized|Physician Decision|26|||
46745754|NCT00831441|82962889|FG001|Randomized|Physician Decision|35|||
46745755|NCT00831441|82962888|FG000|Randomized|No longer met criteria|13|||
46745756|NCT00831441|82962889|FG001|Randomized|No longer met criteria|19|||
46745757|NCT00831441|82962888|FG000|Randomized|Withdrawal by Subject|178|||
46745758|NCT00831441|82962889|FG001|Randomized|Withdrawal by Subject|212|||
46745759|NCT00831441|82962888|FG000|Randomized|Lost to Follow-up|26|||
46745760|NCT00831441|82962889|FG001|Randomized|Lost to Follow-up|35|||
46745761|NCT00831441|82962888|FG000|Randomized|Administrative reason by sponsor|2780|||
46745762|NCT00831441|82962889|FG001|Randomized|Administrative reason by sponsor|2671|||
46745763|NCT00831441|82962888|FG000|Randomized|poor/non-compliance|30|||
46745764|NCT00831441|82962889|FG001|Randomized|poor/non-compliance|38|||
46745765|NCT00831441|82962888|FG000|Randomized|non-specified|276|||
46745766|NCT00831441|82962889|FG001|Randomized|non-specified|266|||
46745767|NCT00831441|82962888|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
47051493|NCT00637377|83314923|FG002|Overall Study|Protocol Violation|1|||
46745768|NCT00831441|82962889|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
46745769|NCT00831441|82962888|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
46745770|NCT00831441|82962889|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
46745771|NCT00831441|82962888|FG000|Follow Up (30 Days)|Death|63|||
46745772|NCT00831441|82962889|FG001|Follow Up (30 Days)|Death|86|||
46745773|NCT00831441|82962888|FG000|Follow Up (30 Days)|non-specified|16|||
46745774|NCT00831441|82962889|FG001|Follow Up (30 Days)|non-specified|26|||
46922876|NCT01318135|83156090|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
46922877|NCT01318135|83156083|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
46922878|NCT01318135|83156084|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
46922879|NCT01318135|83156085|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
46922880|NCT01318135|83156086|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
46922881|NCT01318135|83156087|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
46922882|NCT01318135|83156088|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
46922883|NCT01318135|83156089|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
46922884|NCT01318135|83156090|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
46922885|NCT01318135|83156083|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
46922886|NCT01318135|83156084|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
46922887|NCT01318135|83156085|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
46922888|NCT01318135|83156086|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
46922889|NCT01318135|83156087|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
46922890|NCT01318135|83156088|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
46922891|NCT01318135|83156089|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
46922892|NCT01318135|83156090|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
46922893|NCT01318135|83156083|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46922894|NCT01318135|83156084|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46922895|NCT01318135|83156085|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46922896|NCT01318135|83156086|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46922897|NCT01318135|83156087|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46922898|NCT01318135|83156088|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
46922899|NCT01318135|83156089|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
46922900|NCT01318135|83156090|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46922901|NCT01318135|83156083|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
46922902|NCT01318135|83156084|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
46922903|NCT01318135|83156085|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
46922904|NCT01318135|83156086|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
46922905|NCT01318135|83156087|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
46922906|NCT01318135|83156088|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
46922907|NCT01318135|83156089|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
46922908|NCT01318135|83156090|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
46922909|NCT01318135|83156083|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
46922910|NCT01318135|83156084|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
46922911|NCT01318135|83156085|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
46922912|NCT01318135|83156086|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
46922913|NCT01318135|83156087|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
46745775|NCT00831441|82962888|FG000|Follow Up (30 Days)|missing end of study status|0|||
46745776|NCT00831441|82962889|FG001|Follow Up (30 Days)|missing end of study status|1|||
46745777|NCT00831129|82962898|FG000|Overall Study|Adverse Event|0|||
46745778|NCT00831129|82962899|FG001|Overall Study|Adverse Event|1|||
46745779|NCT00831129|82962898|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
46745780|NCT00831129|82962899|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
46745781|NCT00620113|82962909|FG000|Overall Study|Adverse Event|3|||
46745782|NCT00620113|82962910|FG001|Overall Study|Adverse Event|2|||
46745783|NCT00620113|82962911|FG002|Overall Study|Adverse Event|2|||
46745784|NCT00620113|82962912|FG003|Overall Study|Adverse Event|1|||
46745785|NCT00620113|82962909|FG000|Overall Study|Lack of Efficacy|2|||
46745786|NCT00620113|82962910|FG001|Overall Study|Lack of Efficacy|3|||
46745787|NCT00620113|82962911|FG002|Overall Study|Lack of Efficacy|0|||
46745788|NCT00620113|82962912|FG003|Overall Study|Lack of Efficacy|2|||
46745789|NCT00620113|82962909|FG000|Overall Study|Physician Decision|1|||
46745790|NCT00620113|82962910|FG001|Overall Study|Physician Decision|0|||
46745791|NCT00620113|82962911|FG002|Overall Study|Physician Decision|0|||
46922914|NCT01318135|83156088|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
46922915|NCT01318135|83156089|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
46922916|NCT01318135|83156090|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
46922917|NCT02922153|83156102|FG000|Overall Study|Death|8|||
47051494|NCT00637377|83314924|FG003|Overall Study|Protocol Violation|0|||
47051495|NCT00637377|83314921|FG000|Overall Study|Withdrawal by Subject|11|||
46745792|NCT00620113|82962912|FG003|Overall Study|Physician Decision|2|||
46745793|NCT00620113|82962909|FG000|Overall Study|Protocol Violation|2|||
46745794|NCT00620113|82962910|FG001|Overall Study|Protocol Violation|1|||
46745795|NCT00620113|82962911|FG002|Overall Study|Protocol Violation|0|||
46745796|NCT00620113|82962912|FG003|Overall Study|Protocol Violation|0|||
46745797|NCT00620113|82962909|FG000|Overall Study|Withdrawal by Subject|5|||
46745798|NCT00620113|82962910|FG001|Overall Study|Withdrawal by Subject|1|||
46745799|NCT00620113|82962911|FG002|Overall Study|Withdrawal by Subject|3|||
46745800|NCT00620113|82962912|FG003|Overall Study|Withdrawal by Subject|5|||
46745801|NCT00830115|82962922|FG000|Overall Study|Adverse Event|2|||
46745802|NCT00830115|82962922|FG000|Overall Study|Improvement/recovery|1|||
46745803|NCT00830037|82962930|FG000|Overall Study|Withdrawal by Subject|2|||
46745804|NCT00830037|82962931|FG001|Overall Study|Withdrawal by Subject|3|||
46745805|NCT00830037|82962930|FG000|Overall Study|Lost to Follow-up|1|||
46745806|NCT00830037|82962931|FG001|Overall Study|Lost to Follow-up|2|||
46745807|NCT00830037|82962930|FG000|Overall Study|Active when terminated by DSMB|15|||
46745808|NCT00830037|82962931|FG001|Overall Study|Active when terminated by DSMB|14|||
46745809|NCT00829413|82962937|FG000|Overall Study|No study drug admimnistered|13|||
46745810|NCT00829413|82962937|FG000|Overall Study|Training Patients|67|||
46745811|NCT00829413|82962937|FG000|Overall Study|No truth standard procedure available|9|||
46745812|NCT00829413|82962937|FG000|Overall Study|Technically inadequate truth standard|2|||
46745813|NCT00829413|82962937|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
46745814|NCT00829179|82962948|FG000|Overall Study|Withdrawal by Subject|1|||
46745815|NCT00591591|82962954|FG000|Overall Study|Withdrawal by Subject|1|||
46745816|NCT00591591|82962955|FG001|Overall Study|Withdrawal by Subject|37|||
46745817|NCT00591591|82962954|FG000|Overall Study|Lack of Efficacy|10|||
46745818|NCT00591591|82962955|FG001|Overall Study|Lack of Efficacy|2|||
46745819|NCT00828945|82962961|FG000|Overall Study|Death|4|||
46922918|NCT02922153|83156103|FG001|Overall Study|Death|1|||
46922919|NCT02922153|83156102|FG000|Overall Study|Lost to Follow-up|1|||
46922920|NCT02922153|83156103|FG001|Overall Study|Lost to Follow-up|0|||
46922921|NCT02922153|83156102|FG000|Overall Study|Physician Decision|1|||
46745820|NCT00828945|82962961|FG000|Overall Study|Participant was missing|1|||
46745821|NCT00828945|82962961|FG000|Overall Study|Other|36|||
46922922|NCT02922153|83156103|FG001|Overall Study|Physician Decision|1|||
46922923|NCT02920983|83156109|FG000|Dispense 1|Unacceptable Lens Fit|0|||
46922924|NCT02920983|83156110|FG001|Dispense 1|Unacceptable Lens Fit|0|||
46922925|NCT02920983|83156111|FG002|Dispense 1|Unacceptable Lens Fit|0|||
46922926|NCT02920983|83156112|FG003|Dispense 1|Unacceptable Lens Fit|0|||
46922927|NCT02920983|83156113|FG004|Dispense 1|Unacceptable Lens Fit|1|||
46922928|NCT02920983|83156114|FG005|Dispense 1|Unacceptable Lens Fit|0|||
46922929|NCT02920983|83156109|FG000|Dispense 2|Unscceptable lens fit|1|||
46922930|NCT02920983|83156110|FG001|Dispense 2|Unscceptable lens fit|0|||
46922931|NCT02920983|83156111|FG002|Dispense 2|Unscceptable lens fit|0|||
46922932|NCT02920983|83156112|FG003|Dispense 2|Unscceptable lens fit|0|||
46922933|NCT02920983|83156113|FG004|Dispense 2|Unscceptable lens fit|1|||
46922934|NCT02920983|83156114|FG005|Dispense 2|Unscceptable lens fit|0|||
46922935|NCT02920983|83156109|FG000|Dispense 3|Unacceptable Lens Fit|1|||
46922936|NCT02920983|83156110|FG001|Dispense 3|Unacceptable Lens Fit|1|||
46922937|NCT02920983|83156111|FG002|Dispense 3|Unacceptable Lens Fit|0|||
46922938|NCT02920983|83156112|FG003|Dispense 3|Unacceptable Lens Fit|0|||
46922939|NCT02920983|83156113|FG004|Dispense 3|Unacceptable Lens Fit|1|||
46922940|NCT02920983|83156114|FG005|Dispense 3|Unacceptable Lens Fit|0|||
46922941|NCT02654002|83156131|FG000|Overall Study|Adverse Event|0|||
46922942|NCT02654002|83156132|FG001|Overall Study|Adverse Event|0|||
46922943|NCT02654002|83156133|FG002|Overall Study|Adverse Event|0|||
46922944|NCT02654002|83156134|FG003|Overall Study|Adverse Event|0|||
46922945|NCT02654002|83156135|FG004|Overall Study|Adverse Event|0|||
47051496|NCT00637377|83314922|FG001|Overall Study|Withdrawal by Subject|15|||
46922946|NCT02654002|83156136|FG005|Overall Study|Adverse Event|0|||
46922947|NCT02654002|83156137|FG006|Overall Study|Adverse Event|1|||
46922948|NCT02654002|83156138|FG007|Overall Study|Adverse Event|0|||
46922949|NCT02654002|83156139|FG008|Overall Study|Adverse Event|0|||
46922950|NCT02654002|83156131|FG000|Overall Study|Withdrew Consent|0|||
46922951|NCT02654002|83156132|FG001|Overall Study|Withdrew Consent|0|||
46922952|NCT02654002|83156133|FG002|Overall Study|Withdrew Consent|0|||
47051497|NCT00637377|83314923|FG002|Overall Study|Withdrawal by Subject|13|||
47051498|NCT00637377|83314924|FG003|Overall Study|Withdrawal by Subject|11|||
47051499|NCT00637377|83314921|FG000|Overall Study|Other (no further information available)|7|||
47051500|NCT00637377|83314922|FG001|Overall Study|Other (no further information available)|6|||
47051501|NCT00637377|83314923|FG002|Overall Study|Other (no further information available)|10|||
46745822|NCT00966875|82962974|FG000|Part A|Adverse Event|2|||
46745823|NCT00966875|82962975|FG001|Part A|Adverse Event|1|||
46745824|NCT00966875|82962976|FG002|Part A|Adverse Event|0|||
46745825|NCT00966875|82962977|FG003|Part A|Adverse Event|1|||
46745826|NCT00966875|82962978|FG004|Part A|Adverse Event|0|||
46745827|NCT00966875|82962979|FG005|Part A|Adverse Event|1|||
46922953|NCT02654002|83156134|FG003|Overall Study|Withdrew Consent|0|||
46922954|NCT02654002|83156135|FG004|Overall Study|Withdrew Consent|0|||
47051502|NCT00637377|83314924|FG003|Overall Study|Other (no further information available)|5|||
46745828|NCT00966875|82962980|FG006|Part A|Adverse Event|0|||
46745829|NCT00966875|82962981|FG007|Part A|Adverse Event|3|||
46745830|NCT00966875|82962982|FG008|Part A|Adverse Event|3|||
46745831|NCT00966875|82962974|FG000|Part A|Entry Criteria|0|||
46922955|NCT02654002|83156136|FG005|Overall Study|Withdrew Consent|1|||
46922956|NCT02654002|83156137|FG006|Overall Study|Withdrew Consent|0|||
46745832|NCT00966875|82962975|FG001|Part A|Entry Criteria|0|||
46745833|NCT00966875|82962976|FG002|Part A|Entry Criteria|0|||
46745834|NCT00966875|82962977|FG003|Part A|Entry Criteria|0|||
46745835|NCT00966875|82962978|FG004|Part A|Entry Criteria|0|||
46745836|NCT00966875|82962979|FG005|Part A|Entry Criteria|2|||
46745837|NCT00966875|82962980|FG006|Part A|Entry Criteria|0|||
46745838|NCT00966875|82962981|FG007|Part A|Entry Criteria|0|||
46745839|NCT00966875|82962982|FG008|Part A|Entry Criteria|0|||
46922957|NCT02654002|83156138|FG007|Overall Study|Withdrew Consent|1|||
46922958|NCT02654002|83156139|FG008|Overall Study|Withdrew Consent|0|||
46922959|NCT01675492|83156174|FG000|Overall Study|study completed early - product approval|42|||
46922960|NCT03924622|83156185|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
46922961|NCT03924622|83156186|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
46922962|NCT03924622|83156187|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
46922963|NCT03924622|83156188|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
46922964|NCT03924622|83156189|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
46922965|NCT03924622|83156190|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
46922966|NCT04044664|83156207|FG000|Stage 1|Adverse Event|3|||
46922967|NCT04044664|83156208|FG001|Stage 1|Adverse Event|3|||
46922968|NCT04044664|83156209|FG002|Stage 1|Adverse Event|1|||
46922969|NCT04044664|83156207|FG000|Stage 1|Lost to Follow-up|3|||
46922970|NCT04044664|83156208|FG001|Stage 1|Lost to Follow-up|2|||
46922971|NCT04044664|83156209|FG002|Stage 1|Lost to Follow-up|2|||
46922972|NCT04044664|83156207|FG000|Stage 1|Withdrawal by Subject|9|||
46922973|NCT04044664|83156208|FG001|Stage 1|Withdrawal by Subject|1|||
46922974|NCT04044664|83156209|FG002|Stage 1|Withdrawal by Subject|0|||
46922975|NCT04044664|83156207|FG000|Stage 1|noncompliance, personal reason|2|||
46922976|NCT04044664|83156208|FG001|Stage 1|noncompliance, personal reason|0|||
46922977|NCT04044664|83156209|FG002|Stage 1|noncompliance, personal reason|0|||
46922978|NCT04044664|83156207|FG000|Stage 1|randomization error|0|||
46922979|NCT04044664|83156208|FG001|Stage 1|randomization error|1|||
46922980|NCT04044664|83156209|FG002|Stage 1|randomization error|0|||
46922981|NCT04044664|83156207|FG000|Stage 2|Adverse Event|2|||
46922982|NCT04044664|83156208|FG001|Stage 2|Adverse Event|0|||
46922983|NCT04044664|83156209|FG002|Stage 2|Adverse Event|0|||
46922984|NCT04044664|83156207|FG000|Stage 2|Lost to Follow-up|3|||
46922985|NCT04044664|83156208|FG001|Stage 2|Lost to Follow-up|2|||
46804205|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
46804206|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
46804207|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
46804208|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
46804209|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
46804210|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
46804211|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
46804212|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
46804213|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
46922986|NCT04044664|83156209|FG002|Stage 2|Lost to Follow-up|1|||
46922987|NCT04044664|83156207|FG000|Stage 2|Withdrawal by Subject|3|||
46745840|NCT00966875|82962974|FG000|Part A|Lack of Efficacy|0|||
46745841|NCT00966875|82962975|FG001|Part A|Lack of Efficacy|1|||
46745842|NCT00966875|82962976|FG002|Part A|Lack of Efficacy|0|||
46745843|NCT00966875|82962977|FG003|Part A|Lack of Efficacy|0|||
46745844|NCT00966875|82962978|FG004|Part A|Lack of Efficacy|0|||
46745845|NCT00966875|82962979|FG005|Part A|Lack of Efficacy|0|||
46745846|NCT00966875|82962980|FG006|Part A|Lack of Efficacy|4|||
46745847|NCT00966875|82962981|FG007|Part A|Lack of Efficacy|0|||
46922988|NCT04044664|83156208|FG001|Stage 2|Withdrawal by Subject|0|||
46922989|NCT04044664|83156209|FG002|Stage 2|Withdrawal by Subject|0|||
46922990|NCT04044664|83156207|FG000|Stage 2|protocol deviation|1|||
46745848|NCT00966875|82962982|FG008|Part A|Lack of Efficacy|0|||
46745849|NCT00966875|82962974|FG000|Part A|Lost to Follow-up|2|||
46745850|NCT00966875|82962975|FG001|Part A|Lost to Follow-up|0|||
46745851|NCT00966875|82962976|FG002|Part A|Lost to Follow-up|0|||
46922991|NCT04044664|83156208|FG001|Stage 2|protocol deviation|0|||
46922992|NCT04044664|83156209|FG002|Stage 2|protocol deviation|0|||
46922993|NCT00150176|83156219|FG000|Overall Study|Adverse Event|16|||
46922994|NCT00150176|83156220|FG001|Overall Study|Adverse Event|53|||
46922995|NCT00150176|83156219|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
46922996|NCT00150176|83156220|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
46922997|NCT00150176|83156219|FG000|Overall Study|Withdrawal by Subject|19|||
46922998|NCT00150176|83156220|FG001|Overall Study|Withdrawal by Subject|12|||
46922999|NCT00150176|83156219|FG000|Overall Study|Lost to Follow-up|3|||
46923000|NCT00150176|83156220|FG001|Overall Study|Lost to Follow-up|3|||
46923001|NCT00150176|83156219|FG000|Overall Study|OTHER|11|||
46745852|NCT00966875|82962977|FG003|Part A|Lost to Follow-up|0|||
46745853|NCT00966875|82962978|FG004|Part A|Lost to Follow-up|0|||
46745854|NCT00966875|82962979|FG005|Part A|Lost to Follow-up|1|||
46745855|NCT00966875|82962980|FG006|Part A|Lost to Follow-up|0|||
46745856|NCT00966875|82962981|FG007|Part A|Lost to Follow-up|0|||
46745857|NCT00966875|82962982|FG008|Part A|Lost to Follow-up|0|||
46745858|NCT00966875|82962974|FG000|Part A|Parent/Caregiver Decision|0|||
46745859|NCT00966875|82962975|FG001|Part A|Parent/Caregiver Decision|0|||
46745860|NCT00966875|82962976|FG002|Part A|Parent/Caregiver Decision|0|||
46745861|NCT00966875|82962977|FG003|Part A|Parent/Caregiver Decision|1|||
46745862|NCT00966875|82962978|FG004|Part A|Parent/Caregiver Decision|0|||
46745863|NCT00966875|82962979|FG005|Part A|Parent/Caregiver Decision|0|||
46745864|NCT00966875|82962980|FG006|Part A|Parent/Caregiver Decision|0|||
46745865|NCT00966875|82962981|FG007|Part A|Parent/Caregiver Decision|0|||
46745866|NCT00966875|82962982|FG008|Part A|Parent/Caregiver Decision|0|||
46745867|NCT00966875|82962974|FG000|Part A|Physician Decision|0|||
46745868|NCT00966875|82962975|FG001|Part A|Physician Decision|0|||
46745869|NCT00966875|82962976|FG002|Part A|Physician Decision|0|||
46745870|NCT00966875|82962977|FG003|Part A|Physician Decision|0|||
46745871|NCT00966875|82962978|FG004|Part A|Physician Decision|1|||
46745872|NCT00966875|82962979|FG005|Part A|Physician Decision|0|||
46745873|NCT00966875|82962980|FG006|Part A|Physician Decision|1|||
46745874|NCT00966875|82962981|FG007|Part A|Physician Decision|0|||
46745875|NCT00966875|82962982|FG008|Part A|Physician Decision|2|||
46745876|NCT00966875|82962974|FG000|Part A|Sponsor Decision|0|||
46745877|NCT00966875|82962975|FG001|Part A|Sponsor Decision|0|||
46745878|NCT00966875|82962976|FG002|Part A|Sponsor Decision|1|||
46745879|NCT00966875|82962977|FG003|Part A|Sponsor Decision|0|||
46745880|NCT00966875|82962978|FG004|Part A|Sponsor Decision|1|||
46745881|NCT00966875|82962979|FG005|Part A|Sponsor Decision|0|||
47051503|NCT00636987|83314934|FG000|Overall Study|Death|44|||
47051504|NCT00636987|83314934|FG000|Overall Study|Explanted|13|||
47051505|NCT00636987|83314934|FG000|Overall Study|Lost to Follow-up|63|||
47051506|NCT00636987|83314934|FG000|Overall Study|5 year visit window not complete|69|||
47051507|NCT00636441|83315089|FG000|Overall Study|Adverse Event|0|||
47051508|NCT00636441|83315090|FG001|Overall Study|Adverse Event|1|||
47051509|NCT00636441|83315091|FG002|Overall Study|Adverse Event|1|||
47051510|NCT00636441|83315092|FG003|Overall Study|Adverse Event|0|||
47051511|NCT00636441|83315093|FG004|Overall Study|Adverse Event|0|||
47051512|NCT00636441|83315094|FG005|Overall Study|Adverse Event|1|||
47051513|NCT00636441|83315095|FG006|Overall Study|Adverse Event|0|||
47051514|NCT00636441|83315089|FG000|Overall Study|Late, ineligible|0|||
46804214|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
46923002|NCT00150176|83156220|FG001|Overall Study|OTHER|13|||
46923003|NCT02985879|83156230|FG000|Overall Study|Adverse Event|7|||
46923004|NCT02985879|83156231|FG001|Overall Study|Adverse Event|9|||
47051515|NCT00636441|83315090|FG001|Overall Study|Late, ineligible|0|||
47051516|NCT00636441|83315091|FG002|Overall Study|Late, ineligible|0|||
47051517|NCT00636441|83315092|FG003|Overall Study|Late, ineligible|0|||
47051518|NCT00636441|83315093|FG004|Overall Study|Late, ineligible|0|||
47051519|NCT00636441|83315094|FG005|Overall Study|Late, ineligible|0|||
46745882|NCT00966875|82962980|FG006|Part A|Sponsor Decision|0|||
46745883|NCT00966875|82962981|FG007|Part A|Sponsor Decision|2|||
46804215|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
46923005|NCT02985879|83156232|FG002|Overall Study|Adverse Event|7|||
46923006|NCT02985879|83156230|FG000|Overall Study|Withdrew consent|6|||
46923007|NCT02985879|83156231|FG001|Overall Study|Withdrew consent|8|||
46923008|NCT02985879|83156232|FG002|Overall Study|Withdrew consent|10|||
46923009|NCT02985879|83156230|FG000|Overall Study|Lost to Follow-up|1|||
46923010|NCT02985879|83156231|FG001|Overall Study|Lost to Follow-up|0|||
46923011|NCT02985879|83156232|FG002|Overall Study|Lost to Follow-up|2|||
46923012|NCT02985879|83156230|FG000|Overall Study|Other, not specified|62|||
46923013|NCT02985879|83156231|FG001|Overall Study|Other, not specified|58|||
47051520|NCT00636441|83315095|FG006|Overall Study|Late, ineligible|1|||
47051521|NCT00636441|83315089|FG000|Overall Study|Screen Failure|0|||
46745884|NCT00966875|82962982|FG008|Part A|Sponsor Decision|1|||
46804216|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
46804217|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
46923014|NCT02985879|83156232|FG002|Overall Study|Other, not specified|58|||
47051522|NCT00636441|83315090|FG001|Overall Study|Screen Failure|0|||
46745885|NCT00966875|82962974|FG000|Part A|Withdrawal by Subject|2|||
46923015|NCT01067469|83156248|FG000|Overall Study|Withdrawal by Subject|0|||
46745886|NCT00966875|82962975|FG001|Part A|Withdrawal by Subject|2|||
46745887|NCT00966875|82962976|FG002|Part A|Withdrawal by Subject|1|||
46745888|NCT00966875|82962977|FG003|Part A|Withdrawal by Subject|1|||
46923016|NCT01067469|83156249|FG001|Overall Study|Withdrawal by Subject|1|||
46923017|NCT01067469|83156248|FG000|Overall Study|Disease Progression|0|||
46923018|NCT01067469|83156249|FG001|Overall Study|Disease Progression|1|||
46745889|NCT00966875|82962978|FG004|Part A|Withdrawal by Subject|3|||
47051523|NCT00636441|83315091|FG002|Overall Study|Screen Failure|0|||
47051524|NCT00636441|83315092|FG003|Overall Study|Screen Failure|0|||
47051525|NCT00636441|83315093|FG004|Overall Study|Screen Failure|0|||
47051526|NCT00636441|83315094|FG005|Overall Study|Screen Failure|0|||
47051527|NCT00636441|83315095|FG006|Overall Study|Screen Failure|17|||
47051528|NCT00636363|83315118|FG000|Overall Study|Conjunctivitis|0|||
47051529|NCT00636363|83315119|FG001|Overall Study|Conjunctivitis|0|||
47051530|NCT00636363|83315120|FG002|Overall Study|Conjunctivitis|1|||
47051531|NCT00636363|83315118|FG000|Overall Study|Adverse Event|0|||
47051532|NCT00636363|83315119|FG001|Overall Study|Adverse Event|0|||
47051533|NCT00636363|83315120|FG002|Overall Study|Adverse Event|1|||
47051534|NCT00636363|83315118|FG000|Overall Study|Positive slit lamp finding|0|||
47051535|NCT00636363|83315119|FG001|Overall Study|Positive slit lamp finding|2|||
47051536|NCT00636363|83315120|FG002|Overall Study|Positive slit lamp finding|1|||
47051537|NCT00636363|83315118|FG000|Overall Study|Study related symptoms/complaints|8|||
47051538|NCT00636363|83315119|FG001|Overall Study|Study related symptoms/complaints|7|||
47051539|NCT00636363|83315120|FG002|Overall Study|Study related symptoms/complaints|4|||
47051540|NCT00636363|83315118|FG000|Overall Study|Met ineligibility criteria|0|||
47051541|NCT00636363|83315119|FG001|Overall Study|Met ineligibility criteria|0|||
47051542|NCT00636363|83315120|FG002|Overall Study|Met ineligibility criteria|3|||
47051543|NCT00636363|83315118|FG000|Overall Study|Missed > 1 visit|0|||
47051544|NCT00636363|83315119|FG001|Overall Study|Missed > 1 visit|1|||
47051545|NCT00636363|83315120|FG002|Overall Study|Missed > 1 visit|3|||
47051546|NCT00636363|83315118|FG000|Overall Study|Lack of motivation|1|||
47051547|NCT00636363|83315119|FG001|Overall Study|Lack of motivation|0|||
47051548|NCT00636363|83315120|FG002|Overall Study|Lack of motivation|1|||
47051549|NCT00636363|83315118|FG000|Overall Study|Protocol Violation|0|||
47051550|NCT00636363|83315119|FG001|Overall Study|Protocol Violation|3|||
47051551|NCT00636363|83315120|FG002|Overall Study|Protocol Violation|0|||
47051552|NCT00636363|83315118|FG000|Overall Study|Lost to Follow-up|3|||
47051553|NCT00636363|83315119|FG001|Overall Study|Lost to Follow-up|4|||
47051554|NCT00636363|83315120|FG002|Overall Study|Lost to Follow-up|2|||
47051555|NCT00636363|83315118|FG000|Overall Study|Withdrawal by Subject|1|||
47051556|NCT00636363|83315119|FG001|Overall Study|Withdrawal by Subject|3|||
47051557|NCT00636363|83315120|FG002|Overall Study|Withdrawal by Subject|2|||
47051558|NCT00636207|83315162|FG000|Overall Study|Adverse Event|1|||
47051559|NCT00636207|83315163|FG001|Overall Study|Adverse Event|0|||
47051560|NCT00636207|83315164|FG002|Overall Study|Adverse Event|0|||
47051561|NCT00636207|83315165|FG003|Overall Study|Adverse Event|0|||
47051562|NCT00636207|83315166|FG004|Overall Study|Adverse Event|0|||
47051563|NCT00636207|83315167|FG005|Overall Study|Adverse Event|0|||
47051564|NCT00636207|83315168|FG006|Overall Study|Adverse Event|0|||
47051565|NCT00636207|83315162|FG000|Overall Study|Withdrawal by Subject|0|||
47051566|NCT00636207|83315163|FG001|Overall Study|Withdrawal by Subject|1|||
47051567|NCT00636207|83315164|FG002|Overall Study|Withdrawal by Subject|0|||
47051568|NCT00636207|83315165|FG003|Overall Study|Withdrawal by Subject|0|||
47051569|NCT00636207|83315166|FG004|Overall Study|Withdrawal by Subject|1|||
47051570|NCT00636207|83315167|FG005|Overall Study|Withdrawal by Subject|0|||
47051571|NCT00636207|83315168|FG006|Overall Study|Withdrawal by Subject|0|||
47051572|NCT00635661|83315189|FG000|Overall Study|Withdrawal by Subject|4|||
47051573|NCT00635427|83315278|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
47051574|NCT00635427|83315279|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
47051575|NCT00635427|83315280|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
47051576|NCT00635427|83315281|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
47051577|NCT00635427|83315282|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
47051578|NCT00635427|83315278|FG000|Overall Study|Death|0|||
47051579|NCT00635427|83315279|FG001|Overall Study|Death|0|||
47051580|NCT00635427|83315280|FG002|Overall Study|Death|0|||
47051581|NCT00635427|83315281|FG003|Overall Study|Death|1|||
47051582|NCT00635427|83315282|FG004|Overall Study|Death|0|||
47051583|NCT00635427|83315278|FG000|Overall Study|Termination Of Study By Sponsor|12|||
47051584|NCT00635427|83315279|FG001|Overall Study|Termination Of Study By Sponsor|6|||
47051585|NCT00635427|83315280|FG002|Overall Study|Termination Of Study By Sponsor|10|||
47051586|NCT00635427|83315281|FG003|Overall Study|Termination Of Study By Sponsor|6|||
47051587|NCT00635427|83315282|FG004|Overall Study|Termination Of Study By Sponsor|6|||
46923019|NCT02985021|83156255|FG000|Overall Study|Inability to comply with study procedures|1|||
47051588|NCT00635427|83315278|FG000|Overall Study|Withdrawal Of Consent|0|||
47051589|NCT00635427|83315279|FG001|Overall Study|Withdrawal Of Consent|0|||
47051590|NCT00635427|83315280|FG002|Overall Study|Withdrawal Of Consent|0|||
47051591|NCT00635427|83315281|FG003|Overall Study|Withdrawal Of Consent|2|||
47051592|NCT00635427|83315282|FG004|Overall Study|Withdrawal Of Consent|2|||
47051593|NCT00635349|83315294|FG000|Overall Study|Other|8|||
47051594|NCT00635349|83315295|FG001|Overall Study|Other|6|||
47051595|NCT00635349|83315294|FG000|Overall Study|Protocol Violation|18|||
47051596|NCT00635349|83315295|FG001|Overall Study|Protocol Violation|22|||
47051597|NCT00635349|83315294|FG000|Overall Study|Withdrawal by Subject|3|||
47051598|NCT00635349|83315295|FG001|Overall Study|Withdrawal by Subject|8|||
47051599|NCT00635349|83315294|FG000|Overall Study|Lost to Follow-up|4|||
47051600|NCT00635349|83315295|FG001|Overall Study|Lost to Follow-up|3|||
47051601|NCT00635349|83315294|FG000|Overall Study|Adverse Event|11|||
47051602|NCT00635349|83315295|FG001|Overall Study|Adverse Event|9|||
47051603|NCT00634803|83315304|FG000|Overall Study|Lost to Follow-up|6|||
47051604|NCT00634803|83315305|FG001|Overall Study|Lost to Follow-up|7|||
47051605|NCT00634803|83315306|FG002|Overall Study|Lost to Follow-up|7|||
47051606|NCT01217385|83315322|FG000|Overall Study|Withdrawal by Subject|3|||
47051607|NCT01217385|83315322|FG000|Overall Study|DOSI not performed/not eval|12|||
46804218|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
46804219|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
46804220|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
46804221|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
46804222|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
46804223|NCT00090103|83023338|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
46804224|NCT00090103|83023339|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
46804225|NCT00090103|83023340|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
46804226|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
46804227|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
46804228|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
46804229|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
46804230|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
46804231|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
46804232|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
46804233|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
46804234|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
46804235|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
46804236|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
46804237|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
46804238|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
46804239|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
46804240|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
46804241|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
46804242|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
46804243|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
46804244|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
46804245|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
46804246|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
46804247|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
46804248|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
46804249|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
46804250|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
46804251|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
46804252|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
47051608|NCT01217385|83315322|FG000|Overall Study|Central Path not Available|1|||
47051609|NCT01217385|83315322|FG000|Overall Study|Normal Breast TOI not available|10|||
47051610|NCT01378104|83315674|FG000|Overall Study|Adverse Event|8|||
47051611|NCT01378104|83315675|FG001|Overall Study|Adverse Event|8|||
47051612|NCT01378104|83315674|FG000|Overall Study|Lack of Efficacy|7|||
47051613|NCT01378104|83315675|FG001|Overall Study|Lack of Efficacy|5|||
46745890|NCT00966875|82962979|FG005|Part A|Withdrawal by Subject|0|||
46745891|NCT00966875|82962980|FG006|Part A|Withdrawal by Subject|5|||
46745892|NCT00966875|82962981|FG007|Part A|Withdrawal by Subject|1|||
46745893|NCT00966875|82962982|FG008|Part A|Withdrawal by Subject|1|||
46745894|NCT00966875|82962974|FG000|Part A|Protocol Violation|0|||
46745895|NCT00966875|82962975|FG001|Part A|Protocol Violation|0|||
46745896|NCT00966875|82962976|FG002|Part A|Protocol Violation|0|||
46745897|NCT00966875|82962977|FG003|Part A|Protocol Violation|0|||
46745898|NCT00966875|82962978|FG004|Part A|Protocol Violation|0|||
46745899|NCT00966875|82962979|FG005|Part A|Protocol Violation|0|||
46745900|NCT00966875|82962980|FG006|Part A|Protocol Violation|2|||
46745901|NCT00966875|82962981|FG007|Part A|Protocol Violation|1|||
46745902|NCT00966875|82962982|FG008|Part A|Protocol Violation|1|||
46745903|NCT00966875|82962974|FG000|Part B|Adverse Event|0|||
46745904|NCT00966875|82962975|FG001|Part B|Adverse Event|1|||
46745905|NCT00966875|82962976|FG002|Part B|Adverse Event|1|||
46745906|NCT00966875|82962977|FG003|Part B|Adverse Event|0|||
46745907|NCT00966875|82962978|FG004|Part B|Adverse Event|1|||
46745908|NCT00966875|82962979|FG005|Part B|Adverse Event|0|||
46745909|NCT00966875|82962980|FG006|Part B|Adverse Event|5|||
46745910|NCT00966875|82962981|FG007|Part B|Adverse Event|2|||
46745911|NCT00966875|82962982|FG008|Part B|Adverse Event|2|||
46745912|NCT00966875|82962974|FG000|Part B|Death|0|||
46745913|NCT00966875|82962975|FG001|Part B|Death|0|||
46745914|NCT00966875|82962976|FG002|Part B|Death|1|||
47051614|NCT01378104|83315674|FG000|Overall Study|Withdrawal by Subject|12|||
47051615|NCT01378104|83315675|FG001|Overall Study|Withdrawal by Subject|13|||
46745915|NCT00966875|82962977|FG003|Part B|Death|0|||
46745916|NCT00966875|82962978|FG004|Part B|Death|0|||
46745917|NCT00966875|82962979|FG005|Part B|Death|0|||
46745918|NCT00966875|82962980|FG006|Part B|Death|0|||
46745919|NCT00966875|82962981|FG007|Part B|Death|1|||
46745920|NCT00966875|82962982|FG008|Part B|Death|0|||
46745921|NCT00966875|82962974|FG000|Part B|Lack of Efficacy|2|||
46745922|NCT00966875|82962975|FG001|Part B|Lack of Efficacy|1|||
46745923|NCT00966875|82962976|FG002|Part B|Lack of Efficacy|1|||
46745924|NCT00966875|82962977|FG003|Part B|Lack of Efficacy|1|||
46745925|NCT00966875|82962978|FG004|Part B|Lack of Efficacy|2|||
46923020|NCT01066923|83156263|FG000|Overall Study|Withdrawal by Subject|3|||
46923021|NCT01066923|83156264|FG001|Overall Study|Withdrawal by Subject|3|||
46745926|NCT00966875|82962979|FG005|Part B|Lack of Efficacy|3|||
46745927|NCT00966875|82962980|FG006|Part B|Lack of Efficacy|12|||
46745928|NCT00966875|82962981|FG007|Part B|Lack of Efficacy|9|||
46745929|NCT00966875|82962982|FG008|Part B|Lack of Efficacy|6|||
46745930|NCT00966875|82962974|FG000|Part B|Lost to Follow-up|0|||
46745931|NCT00966875|82962975|FG001|Part B|Lost to Follow-up|0|||
46745932|NCT00966875|82962976|FG002|Part B|Lost to Follow-up|0|||
46745933|NCT00966875|82962977|FG003|Part B|Lost to Follow-up|1|||
46745934|NCT00966875|82962978|FG004|Part B|Lost to Follow-up|0|||
46745935|NCT00966875|82962979|FG005|Part B|Lost to Follow-up|0|||
46745936|NCT00966875|82962980|FG006|Part B|Lost to Follow-up|0|||
46745937|NCT00966875|82962981|FG007|Part B|Lost to Follow-up|0|||
46745938|NCT00966875|82962982|FG008|Part B|Lost to Follow-up|1|||
46745939|NCT00966875|82962974|FG000|Part B|Physician Decision|0|||
46745940|NCT00966875|82962975|FG001|Part B|Physician Decision|0|||
46745941|NCT00966875|82962976|FG002|Part B|Physician Decision|1|||
46745942|NCT00966875|82962977|FG003|Part B|Physician Decision|0|||
46923022|NCT01066923|83156265|FG002|Overall Study|Withdrawal by Subject|8|||
46923023|NCT01066923|83156266|FG003|Overall Study|Withdrawal by Subject|8|||
46923024|NCT02919267|83156291|FG000|Overall Study|Protocol Violation|0|||
46923025|NCT02919267|83156292|FG001|Overall Study|Protocol Violation|3|||
47051616|NCT01379274|83315716|FG000|Overall Study|funding withdrawn|1|||
47051617|NCT00634569|83315917|FG000|Overall Study|Withdrawal by Subject|0|||
47051618|NCT00634569|83315918|FG001|Overall Study|Withdrawal by Subject|4|||
47051619|NCT00634569|83315917|FG000|Overall Study|Physician Decision|0|||
47051620|NCT00634569|83315918|FG001|Overall Study|Physician Decision|1|||
47051621|NCT00634179|83315963|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
47051622|NCT02874144|83316223|FG000|Overall Study|Lost to Follow-up|3|||
47051623|NCT02874144|83316224|FG001|Overall Study|Lost to Follow-up|5|||
47051624|NCT02611830|83316254|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
47051625|NCT02611830|83316255|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
47051626|NCT02611830|83316256|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
47051627|NCT02611830|83316257|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
47051628|NCT02611830|83316254|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
47051629|NCT02611830|83316255|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
46745943|NCT00966875|82962978|FG004|Part B|Physician Decision|2|||
46745944|NCT00966875|82962979|FG005|Part B|Physician Decision|1|||
46745945|NCT00966875|82962980|FG006|Part B|Physician Decision|0|||
46745946|NCT00966875|82962981|FG007|Part B|Physician Decision|0|||
46745947|NCT00966875|82962982|FG008|Part B|Physician Decision|2|||
46745948|NCT00966875|82962974|FG000|Part B|Sponsor Decision|1|||
46745949|NCT00966875|82962975|FG001|Part B|Sponsor Decision|0|||
46923026|NCT02919267|83156293|FG002|Overall Study|Protocol Violation|3|||
46923027|NCT02919267|83156294|FG003|Overall Study|Protocol Violation|4|||
47051630|NCT02611830|83316256|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
47051631|NCT02611830|83316257|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
47051632|NCT02611830|83316254|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
47051633|NCT02611830|83316255|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
46745950|NCT00966875|82962976|FG002|Part B|Sponsor Decision|0|||
46745951|NCT00966875|82962977|FG003|Part B|Sponsor Decision|0|||
47051634|NCT02611830|83316256|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
46745952|NCT00966875|82962978|FG004|Part B|Sponsor Decision|0|||
46745953|NCT00966875|82962979|FG005|Part B|Sponsor Decision|1|||
46745954|NCT00966875|82962980|FG006|Part B|Sponsor Decision|0|||
46745955|NCT00966875|82962981|FG007|Part B|Sponsor Decision|2|||
46745956|NCT00966875|82962982|FG008|Part B|Sponsor Decision|1|||
46745957|NCT00966875|82962974|FG000|Part B|Withdrawal by Subject|2|||
46745958|NCT00966875|82962975|FG001|Part B|Withdrawal by Subject|1|||
46745959|NCT00966875|82962976|FG002|Part B|Withdrawal by Subject|2|||
46745960|NCT00966875|82962977|FG003|Part B|Withdrawal by Subject|1|||
46923028|NCT01368900|83156304|FG000|Overall Study|Lost to Follow-up|7|||
46923029|NCT02910063|83156310|FG000|Phase 2|Withdrawal by Subject|3|||
46745961|NCT00966875|82962978|FG004|Part B|Withdrawal by Subject|2|||
46745962|NCT00966875|82962979|FG005|Part B|Withdrawal by Subject|1|||
46745963|NCT00966875|82962980|FG006|Part B|Withdrawal by Subject|4|||
46923030|NCT02910063|83156311|FG001|Phase 2|Withdrawal by Subject|0|||
46923031|NCT02910063|83156312|FG002|Phase 2|Withdrawal by Subject|0|||
47051635|NCT02611830|83316257|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
47051636|NCT02611830|83316254|FG000|OL Induction Phase|Lack of Efficacy|9|||
47051637|NCT02611830|83316255|FG001|OL Induction Phase|Lack of Efficacy|0|||
47051638|NCT02611830|83316256|FG002|OL Induction Phase|Lack of Efficacy|0|||
47051639|NCT02611830|83316257|FG003|OL Induction Phase|Lack of Efficacy|0|||
47051640|NCT02611830|83316254|FG000|OL Induction Phase|Reason not specified|3|||
47051641|NCT02611830|83316255|FG001|OL Induction Phase|Reason not specified|0|||
47051642|NCT02611830|83316256|FG002|OL Induction Phase|Reason not specified|0|||
47051643|NCT02611830|83316257|FG003|OL Induction Phase|Reason not specified|0|||
47051644|NCT02611830|83316254|FG000|Maintenance Phase|Lack of Efficacy|0|||
47051645|NCT02611830|83316255|FG001|Maintenance Phase|Lack of Efficacy|29|||
47051646|NCT02611830|83316256|FG002|Maintenance Phase|Lack of Efficacy|18|||
47051647|NCT02611830|83316257|FG003|Maintenance Phase|Lack of Efficacy|6|||
47051648|NCT02611830|83316254|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
46804253|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
46804254|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
46804255|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
46804256|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
46804257|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
46804258|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
46804259|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
46804260|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
46804261|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
46804262|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
46804263|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
46804264|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
46804265|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
46804266|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
46804267|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
46804268|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
46804269|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
46804270|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
46804271|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
46804272|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
46804273|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
46804274|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Death|1|||
46804275|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Death|0|||
46804276|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Death|1|||
46804277|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
46804278|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
46804279|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
46804280|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
46804281|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
46804282|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
46804283|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
46804284|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
46804285|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
46804286|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
46804287|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
46635503|NCT01582308|82809171|FG000|Period 4|Physician Decision|1|||
46745964|NCT00966875|82962981|FG007|Part B|Withdrawal by Subject|5|||
46745965|NCT00966875|82962982|FG008|Part B|Withdrawal by Subject|5|||
46745966|NCT00966875|82962974|FG000|Part B|Entry Criteria|0|||
46745967|NCT00966875|82962975|FG001|Part B|Entry Criteria|0|||
46745968|NCT00966875|82962976|FG002|Part B|Entry Criteria|0|||
46745969|NCT00966875|82962977|FG003|Part B|Entry Criteria|0|||
46745970|NCT00966875|82962978|FG004|Part B|Entry Criteria|0|||
46745971|NCT00966875|82962979|FG005|Part B|Entry Criteria|0|||
46745972|NCT00966875|82962980|FG006|Part B|Entry Criteria|1|||
46745973|NCT00966875|82962981|FG007|Part B|Entry Criteria|0|||
47051649|NCT02611830|83316255|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
46745974|NCT00966875|82962982|FG008|Part B|Entry Criteria|1|||
46745975|NCT00828711|82963058|FG000|Overall Study|Lost to Follow-up|1|||
47051650|NCT02611830|83316256|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
47051651|NCT02611830|83316257|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
46745976|NCT00828711|82963059|FG001|Overall Study|Lost to Follow-up|0|||
46745977|NCT00828711|82963060|FG002|Overall Study|Lost to Follow-up|0|||
46745978|NCT00966719|82963070|FG000|Overall Study|Lost to Follow-up|6|||
46745979|NCT00966719|82963071|FG001|Overall Study|Lost to Follow-up|11|||
46745980|NCT00818649|82963077|FG000|Overall Study|Declining performance status|2|||
46804288|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
46804289|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
47051652|NCT02611830|83316254|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
47051653|NCT02611830|83316255|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
47051654|NCT02611830|83316256|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
47051655|NCT02611830|83316257|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
47051656|NCT02611830|83316254|FG000|Maintenance Phase|Lost to Follow-up|0|||
47051657|NCT02611830|83316255|FG001|Maintenance Phase|Lost to Follow-up|0|||
47051658|NCT02611830|83316256|FG002|Maintenance Phase|Lost to Follow-up|0|||
47051659|NCT02611830|83316257|FG003|Maintenance Phase|Lost to Follow-up|1|||
47051660|NCT02611830|83316254|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
47051661|NCT02611830|83316255|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
47051662|NCT02611830|83316256|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
47051663|NCT02611830|83316257|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
47051664|NCT02611830|83316254|FG000|Maintenance Phase|Pregnancy|0|||
47051665|NCT02611830|83316255|FG001|Maintenance Phase|Pregnancy|0|||
47051666|NCT02611830|83316256|FG002|Maintenance Phase|Pregnancy|1|||
47051667|NCT02611830|83316257|FG003|Maintenance Phase|Pregnancy|0|||
47051668|NCT02611830|83316254|FG000|Maintenance Phase|Reason not specified|0|||
47051669|NCT02611830|83316255|FG001|Maintenance Phase|Reason not specified|1|||
47051670|NCT02611830|83316256|FG002|Maintenance Phase|Reason not specified|4|||
47051671|NCT02611830|83316257|FG003|Maintenance Phase|Reason not specified|0|||
47051672|NCT01328574|83316443|FG000|Overall Study|Refused further treatment|1|||
47051673|NCT01328496|83316565|FG000|Overall Study|Significant Change in Health Status|1|||
47051674|NCT01328496|83316566|FG001|Overall Study|Significant Change in Health Status|0|||
47051675|NCT02734212|83316686|FG000|Overall Study|Lost to Follow-up|5|||
47051676|NCT02734212|83316687|FG001|Overall Study|Lost to Follow-up|10|||
47051677|NCT03786432|83316733|FG000|Overall Study|Screen Failure after consent|1|||
47051678|NCT03786432|83316733|FG000|Overall Study|Lost to Follow-up|4|||
47051679|NCT03786432|83316733|FG000|Overall Study|did not complete 12 month CT scan|1|||
47051680|NCT04604184|83316769|FG000|Overall Study|Adverse Event|5|||
46635504|NCT01582308|82809172|FG001|Period 4|Physician Decision|0|||
46804290|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
46804291|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
46804292|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
46804293|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
46804294|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
46804295|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
46804296|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
46804297|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
46804298|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Depression|0|||
46804299|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Depression|1|||
46804300|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Depression|0|||
46804301|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
46804302|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
46804303|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
46804304|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Jailed|0|||
46804305|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Jailed|1|||
46804306|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Jailed|0|||
46804307|NCT00090103|83023338|FG000|16-Week Safety Follow-up Period|Other|0|||
46804308|NCT00090103|83023339|FG001|16-Week Safety Follow-up Period|Other|1|||
46804309|NCT00090103|83023340|FG002|16-Week Safety Follow-up Period|Other|0|||
46804310|NCT00087607|83023350|FG000|Overall Study|Adverse Event|14|||
46804311|NCT00087607|83023351|FG001|Overall Study|Adverse Event|24|||
46804312|NCT00087607|83023350|FG000|Overall Study|Death|0|||
46804313|NCT00087607|83023351|FG001|Overall Study|Death|1|||
46804314|NCT00087607|83023350|FG000|Overall Study|Insufficient Therapeutic Response|53|||
46804315|NCT00087607|83023351|FG001|Overall Study|Insufficient Therapeutic Response|42|||
46804316|NCT00087607|83023350|FG000|Overall Study|Failure to return|21|||
46804317|NCT00087607|83023351|FG001|Overall Study|Failure to return|17|||
46804318|NCT00087607|83023350|FG000|Overall Study|Withdrew Consent|12|||
46804319|NCT00087607|83023351|FG001|Overall Study|Withdrew Consent|16|||
46804320|NCT00087607|83023350|FG000|Overall Study|Administrative|12|||
46804321|NCT00087607|83023351|FG001|Overall Study|Administrative|12|||
46804322|NCT00087607|83023350|FG000|Overall Study|Refused Treatment|5|||
46923032|NCT02910063|83156310|FG000|Phase 2|Lost to Follow-up|1|||
46804323|NCT00087607|83023351|FG001|Overall Study|Refused Treatment|7|||
46804324|NCT00087607|83023350|FG000|Overall Study|Other Protocol Violation|5|||
46804325|NCT00087607|83023351|FG001|Overall Study|Other Protocol Violation|2|||
46804326|NCT00087607|83023350|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
46923033|NCT02910063|83156311|FG001|Phase 2|Lost to Follow-up|0|||
47051681|NCT04604184|83316770|FG001|Overall Study|Adverse Event|5|||
47051682|NCT04604184|83316769|FG000|Overall Study|Death|2|||
47051683|NCT04604184|83316770|FG001|Overall Study|Death|1|||
46923034|NCT02910063|83156312|FG002|Phase 2|Lost to Follow-up|0|||
46804327|NCT00087607|83023351|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
46804328|NCT00069823|83023363|FG000|Overall Study|Did not have follow-up diary cards|6|||
46804329|NCT00069823|83023364|FG001|Overall Study|Did not have follow-up diary cards|3|||
46804330|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
46804331|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
46804332|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
46804333|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
46804334|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
46804335|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
46804336|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
46923035|NCT02910063|83156310|FG000|Phase 2|Death|24|||
46923036|NCT02910063|83156311|FG001|Phase 2|Death|0|||
46745981|NCT00818649|82963077|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
46923037|NCT02910063|83156312|FG002|Phase 2|Death|0|||
46745982|NCT00818649|82963077|FG000|Overall Study|Adverse Event|1|||
46745983|NCT00961571|82963082|FG000|Overall Study|Physician Decision|39|||
46745984|NCT00964223|82963086|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
46745985|NCT00620815|82963094|FG000|Overall Study|Adverse Event|1|||
46745986|NCT00620815|82963095|FG001|Overall Study|Adverse Event|1|||
46745987|NCT00620815|82963096|FG002|Overall Study|Adverse Event|2|||
46745988|NCT00620815|82963094|FG000|Overall Study|Withdrawal by Subject|1|||
46745989|NCT00620815|82963095|FG001|Overall Study|Withdrawal by Subject|2|||
46745990|NCT00620815|82963096|FG002|Overall Study|Withdrawal by Subject|0|||
46745991|NCT00620815|82963094|FG000|Overall Study|Lost to Follow-up|1|||
46745992|NCT00620815|82963095|FG001|Overall Study|Lost to Follow-up|6|||
46745993|NCT00620815|82963096|FG002|Overall Study|Lost to Follow-up|3|||
46745994|NCT00620815|82963094|FG000|Overall Study|Inappropriate enrolment|0|||
46745995|NCT00620815|82963095|FG001|Overall Study|Inappropriate enrolment|0|||
46745996|NCT00620815|82963096|FG002|Overall Study|Inappropriate enrolment|1|||
46745997|NCT00620815|82963094|FG000|Overall Study|Protocol Violation|1|||
46745998|NCT00620815|82963095|FG001|Overall Study|Protocol Violation|2|||
46745999|NCT00620815|82963096|FG002|Overall Study|Protocol Violation|1|||
46746000|NCT03372941|82963122|FG000|Overall Study|Lost to Follow-up|2|||
46746001|NCT03372941|82963123|FG001|Overall Study|Lost to Follow-up|4|||
46746002|NCT00619957|82963131|FG000|Month 24 Double-Blind|Adverse Event|9|||
46746003|NCT00619957|82963132|FG001|Month 24 Double-Blind|Adverse Event|7|||
46746004|NCT00619957|82963131|FG000|Month 24 Double-Blind|Protocol Violation|1|||
46746005|NCT00619957|82963132|FG001|Month 24 Double-Blind|Protocol Violation|0|||
46746006|NCT00619957|82963131|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
46746007|NCT00619957|82963132|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
46746008|NCT00619957|82963131|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
46746009|NCT00619957|82963132|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
46635505|NCT01582308|82809173|FG002|Period 4|Physician Decision|0|||
46635506|NCT01582308|82809174|FG003|Period 4|Physician Decision|0|||
46746010|NCT00619957|82963131|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
46746011|NCT00619957|82963132|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
46746012|NCT00619957|82963131|FG000|Month 48 Open-Label|Adverse Event|4|||
46746013|NCT00619957|82963132|FG001|Month 48 Open-Label|Adverse Event|4|||
46923038|NCT02909907|83156323|FG000|Overall Study|Withdrawal by Subject|0|||
46746014|NCT00619957|82963131|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
46746015|NCT00619957|82963132|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
46746016|NCT00619957|82963131|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
46746017|NCT00619957|82963132|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
46775750|NCT00793793|82994207|FG003|Overall Study|Lost to Follow-up|0|||
46923039|NCT02909907|83156324|FG001|Overall Study|Withdrawal by Subject|1|||
46804337|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
46804338|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
46804339|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
46804340|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
46804341|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
46804342|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
46804343|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
46804344|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
46804345|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
46804346|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
46804347|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
46804348|NCT00086515|83023376|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
47051684|NCT04604184|83316769|FG000|Overall Study|Withdrawal by Subject|1|||
47051685|NCT04604184|83316770|FG001|Overall Study|Withdrawal by Subject|3|||
47051686|NCT04604184|83316769|FG000|Overall Study|Not treated|2|||
47051687|NCT04604184|83316770|FG001|Overall Study|Not treated|2|||
47051688|NCT04604184|83316769|FG000|Overall Study|Due to sponsor decision|9|||
47051689|NCT04604184|83316770|FG001|Overall Study|Due to sponsor decision|7|||
47051690|NCT04604184|83316769|FG000|Overall Study|Physician Decision|0|||
47051691|NCT04604184|83316770|FG001|Overall Study|Physician Decision|1|||
47051692|NCT04604184|83316769|FG000|Overall Study|Transfer to healthcare|1|||
47051693|NCT04604184|83316770|FG001|Overall Study|Transfer to healthcare|0|||
47051694|NCT01859741|83316941|FG000|Overall Study|Death|3|||
47051695|NCT01859741|83316942|FG001|Overall Study|Death|2|||
47051696|NCT01859741|83316943|FG002|Overall Study|Death|4|||
47051697|NCT01859741|83316944|FG003|Overall Study|Death|3|||
47051698|NCT01859741|83316945|FG004|Overall Study|Death|5|||
47051699|NCT01859741|83316946|FG005|Overall Study|Death|4|||
47051700|NCT01859741|83316947|FG006|Overall Study|Death|51|||
47051701|NCT01859741|83316948|FG007|Overall Study|Death|51|||
47051702|NCT01859741|83316941|FG000|Overall Study|Lost to Follow-up|0|||
47051703|NCT01859741|83316942|FG001|Overall Study|Lost to Follow-up|0|||
47051704|NCT01859741|83316943|FG002|Overall Study|Lost to Follow-up|0|||
46804349|NCT00086515|83023377|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
46804350|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
46804351|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
46804352|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
46804353|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
46804354|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
46804355|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
47051705|NCT01859741|83316944|FG003|Overall Study|Lost to Follow-up|0|||
46804356|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
47051706|NCT01859741|83316945|FG004|Overall Study|Lost to Follow-up|0|||
47051707|NCT01859741|83316946|FG005|Overall Study|Lost to Follow-up|1|||
47051708|NCT01859741|83316947|FG006|Overall Study|Lost to Follow-up|0|||
47051709|NCT01859741|83316948|FG007|Overall Study|Lost to Follow-up|4|||
47051710|NCT01859741|83316941|FG000|Overall Study|Withdrawal by Subject|0|||
46804357|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
46804358|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
46804359|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
46804360|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
46804361|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
46804362|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
46804363|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
46804364|NCT00086515|83023376|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
46804365|NCT00086515|83023377|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
46804366|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
46804367|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
46804368|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
46804369|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
46804370|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
46804371|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
46804372|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
46804373|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
46804374|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
46804375|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
46804376|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
46804377|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
46804378|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
46804379|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
46804380|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
46804381|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
46804382|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
46804383|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
46804384|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
46804385|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
46804386|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
46804387|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
46804388|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
46804389|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
46804390|NCT00086515|83023376|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
46804391|NCT00086515|83023377|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
46804392|NCT00541658|83023386|FG000|Overall Study|Adverse Event|28|||
46804393|NCT00541658|83023387|FG001|Overall Study|Adverse Event|37|||
46804394|NCT00541658|83023388|FG002|Overall Study|Adverse Event|25|||
46804395|NCT00541658|83023386|FG000|Overall Study|Physician Decision|0|||
46804396|NCT00541658|83023387|FG001|Overall Study|Physician Decision|0|||
46804397|NCT00541658|83023388|FG002|Overall Study|Physician Decision|4|||
46804398|NCT00541658|83023386|FG000|Overall Study|Lost to Follow-up|3|||
46804399|NCT00541658|83023387|FG001|Overall Study|Lost to Follow-up|3|||
46804400|NCT00541658|83023388|FG002|Overall Study|Lost to Follow-up|6|||
46804401|NCT00541658|83023386|FG000|Overall Study|Protocol Violation|0|||
46804402|NCT00541658|83023387|FG001|Overall Study|Protocol Violation|1|||
46804403|NCT00541658|83023388|FG002|Overall Study|Protocol Violation|1|||
46804404|NCT00541658|83023386|FG000|Overall Study|Withdrawal by Subject|28|||
46804405|NCT00541658|83023387|FG001|Overall Study|Withdrawal by Subject|32|||
46804406|NCT00541658|83023388|FG002|Overall Study|Withdrawal by Subject|32|||
46804407|NCT00541658|83023386|FG000|Overall Study|Took No Study Drug|1|||
46804408|NCT00541658|83023387|FG001|Overall Study|Took No Study Drug|0|||
46804409|NCT00541658|83023388|FG002|Overall Study|Took No Study Drug|0|||
46804410|NCT03907280|83023412|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
46746018|NCT00961415|82963142|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
46746019|NCT00961415|82963143|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
46746020|NCT00961415|82963144|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
46746021|NCT00961415|82963142|FG000|Induction Treatment Phase|Death|77|||
46746022|NCT00961415|82963143|FG001|Induction Treatment Phase|Death|0|||
46746023|NCT00961415|82963144|FG002|Induction Treatment Phase|Death|0|||
46746024|NCT00961415|82963142|FG000|Induction Treatment Phase|Protocol Violation|1|||
46746025|NCT00961415|82963143|FG001|Induction Treatment Phase|Protocol Violation|0|||
46804411|NCT03907280|83023413|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
46804412|NCT03907280|83023414|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
46804413|NCT04120376|83023426|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
46804414|NCT04120376|83023427|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
46804415|NCT03905642|83023434|FG000|Overall Study|Withdrawal by Subject|3|||
46804416|NCT03905642|83023434|FG000|Overall Study|Pregnancy|1|||
47051711|NCT01859741|83316942|FG001|Overall Study|Withdrawal by Subject|1|||
46746026|NCT00961415|82963144|FG002|Induction Treatment Phase|Protocol Violation|0|||
46746027|NCT00961415|82963142|FG000|Induction Treatment Phase|Physician Decision|2|||
46746028|NCT00961415|82963143|FG001|Induction Treatment Phase|Physician Decision|0|||
46746029|NCT00961415|82963144|FG002|Induction Treatment Phase|Physician Decision|0|||
46746030|NCT00961415|82963142|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
46923040|NCT02651194|83156330|FG000|Overall Study|Lost to Follow-up|3|||
46923041|NCT02651194|83156330|FG000|Overall Study|Other|2|||
46923042|NCT02907177|83156336|FG000|Overall Study|Death|0|||
46923043|NCT02907177|83156337|FG001|Overall Study|Death|1|||
46923044|NCT02907177|83156336|FG000|Overall Study|Physician Decision|3|||
46923045|NCT02907177|83156337|FG001|Overall Study|Physician Decision|3|||
46923046|NCT02907177|83156336|FG000|Overall Study|Withdrawal by Subject|15|||
46923047|NCT02907177|83156337|FG001|Overall Study|Withdrawal by Subject|7|||
46923048|NCT02907177|83156336|FG000|Overall Study|Sponsor's Decision|50|||
46923049|NCT02907177|83156337|FG001|Overall Study|Sponsor's Decision|57|||
46923050|NCT02652442|83156343|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
46923051|NCT02906709|83156357|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
46923052|NCT02906709|83156358|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
46923053|NCT02906709|83156357|FG000|Phase A (Week 0 to Week 16)|Death|0|||
46923054|NCT02906709|83156358|FG001|Phase A (Week 0 to Week 16)|Death|1|||
46923055|NCT02906709|83156357|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
46746031|NCT00961415|82963143|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
46746032|NCT00961415|82963144|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
46746033|NCT00961415|82963142|FG000|Induction Treatment Phase|Other Reason|5|||
46746034|NCT00961415|82963143|FG001|Induction Treatment Phase|Other Reason|0|||
46746035|NCT00961415|82963144|FG002|Induction Treatment Phase|Other Reason|0|||
46746036|NCT00961415|82963142|FG000|Maintenance Treatment Phase|Death|0|||
46746037|NCT00961415|82963143|FG001|Maintenance Treatment Phase|Death|42|||
46746038|NCT00961415|82963144|FG002|Maintenance Treatment Phase|Death|34|||
46746039|NCT00961415|82963142|FG000|Maintenance Treatment Phase|Investigators decision|0|||
46746040|NCT00961415|82963143|FG001|Maintenance Treatment Phase|Investigators decision|2|||
46746041|NCT00961415|82963144|FG002|Maintenance Treatment Phase|Investigators decision|0|||
46746042|NCT00961415|82963142|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46746043|NCT00961415|82963143|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
46746044|NCT00961415|82963144|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
46746045|NCT00961415|82963142|FG000|Maintenance Treatment Phase|Other reason|0|||
46746046|NCT00961415|82963143|FG001|Maintenance Treatment Phase|Other reason|1|||
46746047|NCT00961415|82963144|FG002|Maintenance Treatment Phase|Other reason|3|||
46746048|NCT00963599|82963162|FG000|Overall Study|Adverse Event|2|||
46746049|NCT00963599|82963163|FG001|Overall Study|Adverse Event|0|||
46746050|NCT00963599|82963164|FG002|Overall Study|Adverse Event|1|||
46746051|NCT00963599|82963165|FG003|Overall Study|Adverse Event|2|||
46746052|NCT00963599|82963162|FG000|Overall Study|Lack of Efficacy|0|||
46746053|NCT00963599|82963163|FG001|Overall Study|Lack of Efficacy|2|||
46746054|NCT00963599|82963164|FG002|Overall Study|Lack of Efficacy|1|||
46746055|NCT00963599|82963165|FG003|Overall Study|Lack of Efficacy|4|||
46746056|NCT00963599|82963162|FG000|Overall Study|Lost to Follow-up|0|||
46746057|NCT00963599|82963163|FG001|Overall Study|Lost to Follow-up|1|||
46746058|NCT00963599|82963164|FG002|Overall Study|Lost to Follow-up|1|||
46746059|NCT00963599|82963165|FG003|Overall Study|Lost to Follow-up|1|||
46746060|NCT00963599|82963162|FG000|Overall Study|Protocol Violation|2|||
46746061|NCT00963599|82963163|FG001|Overall Study|Protocol Violation|2|||
46746062|NCT00963599|82963164|FG002|Overall Study|Protocol Violation|3|||
46746063|NCT00963599|82963165|FG003|Overall Study|Protocol Violation|4|||
46746064|NCT00963599|82963162|FG000|Overall Study|Withdrawal by Subject|2|||
46746065|NCT00963599|82963163|FG001|Overall Study|Withdrawal by Subject|1|||
46746066|NCT00963599|82963164|FG002|Overall Study|Withdrawal by Subject|3|||
46746067|NCT00963599|82963165|FG003|Overall Study|Withdrawal by Subject|3|||
46746068|NCT00619801|82963177|FG000|Overall Study|Lack of Efficacy|0|||
46746069|NCT00619801|82963178|FG001|Overall Study|Lack of Efficacy|1|||
46804417|NCT03905642|83023434|FG000|Overall Study|Adverse Event|1|||
46746070|NCT00619801|82963177|FG000|Overall Study|Withdrawal by Subject|1|||
46804418|NCT03905642|83023434|FG000|Overall Study|Lack of Efficacy|1|||
46804419|NCT03905642|83023434|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
46804420|NCT00412984|83023474|FG000|Overall Study|Death|331|||
46746071|NCT00619801|82963178|FG001|Overall Study|Withdrawal by Subject|1|||
46804421|NCT00412984|83023475|FG001|Overall Study|Death|349|||
46923056|NCT02906709|83156358|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
46923057|NCT02906709|83156357|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
46923058|NCT02906709|83156358|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
46804422|NCT00412984|83023474|FG000|Overall Study|Adverse Event|679|||
46923059|NCT00318656|83156372|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
46746072|NCT00619801|82963177|FG000|Overall Study|Loss of efficacy|0|||
46746073|NCT00619801|82963178|FG001|Overall Study|Loss of efficacy|1|||
46746074|NCT00962741|82963184|FG000|Overall Study|Failed to return|3|||
46746075|NCT00962741|82963184|FG000|Overall Study|Lost to Follow-up|2|||
46746076|NCT00962741|82963184|FG000|Overall Study|Withdrawal by Subject|1|||
46746077|NCT00962741|82963184|FG000|Overall Study|Lack of Efficacy|1|||
46746078|NCT00962741|82963184|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
46746079|NCT00619645|82963188|FG000|Overall Study|Adverse Event|1|||
46746080|NCT00619177|82963192|FG000|Overall Study|Adverse Event|18|||
46746081|NCT00619177|82963192|FG000|Overall Study|Lost to Follow-up|2|||
46746082|NCT00619177|82963192|FG000|Overall Study|Lack of Efficacy|1|||
46746083|NCT00619177|82963192|FG000|Overall Study|Missing termination information|481|||
46746084|NCT00619177|82963192|FG000|Overall Study|Not specified reasons|6|||
46746085|NCT00818259|82963203|FG000|Part I|Withdrawal by Subject|1|||
46746086|NCT00818259|82963204|FG001|Part I|Withdrawal by Subject|0|||
46746087|NCT00818259|82963205|FG002|Part I|Withdrawal by Subject|0|||
46804423|NCT00412984|83023475|FG001|Overall Study|Adverse Event|738|||
46804424|NCT00412984|83023474|FG000|Overall Study|Withdrawal by Subject|921|||
46804425|NCT00412984|83023475|FG001|Overall Study|Withdrawal by Subject|989|||
46804426|NCT00412984|83023474|FG000|Overall Study|Lost to Follow-up|51|||
46804427|NCT00412984|83023475|FG001|Overall Study|Lost to Follow-up|39|||
46804428|NCT00412984|83023474|FG000|Overall Study|Poor/Noncompliance|57|||
46804429|NCT00412984|83023475|FG001|Overall Study|Poor/Noncompliance|77|||
46923060|NCT00318656|83156373|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
46923061|NCT00318656|83156372|FG000|Overall Study|Did not receive any treatment|0|||
46923062|NCT00318656|83156373|FG001|Overall Study|Did not receive any treatment|1|||
47051712|NCT01859741|83316943|FG002|Overall Study|Withdrawal by Subject|2|||
47051713|NCT01859741|83316944|FG003|Overall Study|Withdrawal by Subject|0|||
47051714|NCT01859741|83316945|FG004|Overall Study|Withdrawal by Subject|0|||
46746088|NCT00818259|82963206|FG003|Part I|Withdrawal by Subject|0|||
46746089|NCT00818259|82963207|FG004|Part I|Withdrawal by Subject|0|||
46746090|NCT00818259|82963208|FG005|Part I|Withdrawal by Subject|0|||
46746091|NCT00818259|82963209|FG006|Part I|Withdrawal by Subject|0|||
46746092|NCT00818259|82963210|FG007|Part I|Withdrawal by Subject|0|||
46746093|NCT00818259|82963211|FG008|Part I|Withdrawal by Subject|0|||
46746094|NCT00818259|82963203|FG000|Part II|Physician Decision|0|||
46746095|NCT00818259|82963204|FG001|Part II|Physician Decision|0|||
46746096|NCT00818259|82963205|FG002|Part II|Physician Decision|1|||
46746097|NCT00818259|82963206|FG003|Part II|Physician Decision|0|||
46746098|NCT00818259|82963207|FG004|Part II|Physician Decision|0|||
46746099|NCT00818259|82963208|FG005|Part II|Physician Decision|0|||
46746100|NCT00818259|82963209|FG006|Part II|Physician Decision|0|||
46923063|NCT02908347|83156379|FG000|Overall Study|Adverse Event|0|||
46923064|NCT02908347|83156380|FG001|Overall Study|Adverse Event|1|||
46923065|NCT02908347|83156379|FG000|Overall Study|Lost to Follow-up|1|||
46923066|NCT02908347|83156380|FG001|Overall Study|Lost to Follow-up|0|||
46923067|NCT02983305|83156402|FG000|Overall Study|incomplete data|2|||
46923068|NCT02983305|83156403|FG001|Overall Study|incomplete data|0|||
46923069|NCT03663166|83156409|FG000|Overall Study|Withdrawal by Subject|1|||
46923070|NCT02983227|83156416|FG000|Overall Study|Adverse Event|21|||
46923071|NCT02983227|83156417|FG001|Overall Study|Adverse Event|3|||
46923072|NCT02983227|83156416|FG000|Overall Study|Death|3|||
46923073|NCT02983227|83156417|FG001|Overall Study|Death|0|||
46923074|NCT02983227|83156416|FG000|Overall Study|Lack of Efficacy|8|||
46923075|NCT02983227|83156417|FG001|Overall Study|Lack of Efficacy|1|||
46923076|NCT02983227|83156416|FG000|Overall Study|Lost to Follow-up|3|||
46923077|NCT02983227|83156417|FG001|Overall Study|Lost to Follow-up|0|||
46923078|NCT02983227|83156416|FG000|Overall Study|Multiple Reasons|2|||
47051715|NCT01859741|83316946|FG005|Overall Study|Withdrawal by Subject|1|||
46746101|NCT00818259|82963210|FG007|Part II|Physician Decision|0|||
46746102|NCT00818259|82963211|FG008|Part II|Physician Decision|0|||
46746103|NCT00818259|82963203|FG000|Part II|Lack of Efficacy|0|||
46746104|NCT00818259|82963204|FG001|Part II|Lack of Efficacy|0|||
46746105|NCT00818259|82963205|FG002|Part II|Lack of Efficacy|0|||
46746106|NCT00818259|82963206|FG003|Part II|Lack of Efficacy|1|||
46746107|NCT00818259|82963207|FG004|Part II|Lack of Efficacy|0|||
46746108|NCT00818259|82963208|FG005|Part II|Lack of Efficacy|0|||
46746109|NCT00818259|82963209|FG006|Part II|Lack of Efficacy|0|||
46746110|NCT00818259|82963210|FG007|Part II|Lack of Efficacy|0|||
46746111|NCT00818259|82963211|FG008|Part II|Lack of Efficacy|0|||
46804430|NCT00412984|83023474|FG000|Overall Study|Pregnancy|1|||
46804431|NCT00412984|83023475|FG001|Overall Study|Pregnancy|0|||
46804432|NCT00412984|83023474|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
46923079|NCT02983227|83156417|FG001|Overall Study|Multiple Reasons|1|||
46923080|NCT02983227|83156416|FG000|Overall Study|Physician Decision|3|||
46746112|NCT00818259|82963203|FG000|Part II|Not Treated|0|||
46746113|NCT00818259|82963204|FG001|Part II|Not Treated|0|||
46746114|NCT00818259|82963205|FG002|Part II|Not Treated|0|||
46746115|NCT00818259|82963206|FG003|Part II|Not Treated|1|||
46746116|NCT00818259|82963207|FG004|Part II|Not Treated|0|||
46804433|NCT00412984|83023475|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
46923081|NCT02983227|83156417|FG001|Overall Study|Physician Decision|1|||
47051716|NCT01859741|83316947|FG006|Overall Study|Withdrawal by Subject|1|||
46746117|NCT00818259|82963208|FG005|Part II|Not Treated|0|||
47051717|NCT01859741|83316948|FG007|Overall Study|Withdrawal by Subject|1|||
47051718|NCT01859741|83316941|FG000|Overall Study|Study Terminated by Sponsor|0|||
47051719|NCT01859741|83316942|FG001|Overall Study|Study Terminated by Sponsor|0|||
47051720|NCT01859741|83316943|FG002|Overall Study|Study Terminated by Sponsor|0|||
46746118|NCT00818259|82963209|FG006|Part II|Not Treated|0|||
46746119|NCT00818259|82963210|FG007|Part II|Not Treated|0|||
46746120|NCT00818259|82963211|FG008|Part II|Not Treated|0|||
46746121|NCT00818259|82963203|FG000|Part IV|Physician Decision|0|||
46746122|NCT00818259|82963204|FG001|Part IV|Physician Decision|0|||
46746123|NCT00818259|82963205|FG002|Part IV|Physician Decision|0|||
46746124|NCT00818259|82963206|FG003|Part IV|Physician Decision|0|||
46746125|NCT00818259|82963207|FG004|Part IV|Physician Decision|0|||
46746126|NCT00818259|82963208|FG005|Part IV|Physician Decision|1|||
46746127|NCT00818259|82963209|FG006|Part IV|Physician Decision|0|||
46746128|NCT00818259|82963210|FG007|Part IV|Physician Decision|0|||
46746129|NCT00818259|82963211|FG008|Part IV|Physician Decision|0|||
46746130|NCT00818259|82963203|FG000|Part V|Adverse Event|0|||
46746131|NCT00818259|82963204|FG001|Part V|Adverse Event|0|||
46746132|NCT00818259|82963205|FG002|Part V|Adverse Event|0|||
46746133|NCT00818259|82963206|FG003|Part V|Adverse Event|0|||
46746134|NCT00818259|82963207|FG004|Part V|Adverse Event|0|||
46746135|NCT00818259|82963208|FG005|Part V|Adverse Event|0|||
46746136|NCT00818259|82963209|FG006|Part V|Adverse Event|0|||
46746137|NCT00818259|82963210|FG007|Part V|Adverse Event|1|||
46746138|NCT00818259|82963211|FG008|Part V|Adverse Event|0|||
46746139|NCT00619099|82963229|FG000|Overall Study|Progressive Disease|7|||
46746140|NCT00619099|82963230|FG001|Overall Study|Progressive Disease|5|||
46746141|NCT00619099|82963229|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
46746142|NCT00619099|82963230|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
46746143|NCT00619099|82963229|FG000|Overall Study|Adverse Event|4|||
46746144|NCT00619099|82963230|FG001|Overall Study|Adverse Event|3|||
46746145|NCT00619099|82963229|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
46746146|NCT00619099|82963230|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
46746147|NCT00619099|82963229|FG000|Overall Study|Withdrawal by Subject|10|||
46746148|NCT00619099|82963230|FG001|Overall Study|Withdrawal by Subject|2|||
46746149|NCT00619099|82963229|FG000|Overall Study|Physician Decision|9|||
46746150|NCT00619099|82963230|FG001|Overall Study|Physician Decision|6|||
46746151|NCT00962585|82963240|FG000|Overall Study|Adverse Event|0|||
46746152|NCT00962585|82963241|FG001|Overall Study|Adverse Event|2|||
46746153|NCT00962585|82963242|FG002|Overall Study|Adverse Event|1|||
46746154|NCT00962585|82963243|FG003|Overall Study|Adverse Event|0|||
46746155|NCT00962585|82963240|FG000|Overall Study|Lost to Follow-up|3|||
46746156|NCT00962585|82963241|FG001|Overall Study|Lost to Follow-up|0|||
46746157|NCT00962585|82963242|FG002|Overall Study|Lost to Follow-up|1|||
46746158|NCT00962585|82963243|FG003|Overall Study|Lost to Follow-up|0|||
46746159|NCT00962585|82963240|FG000|Overall Study|Protocol Violation|0|||
46746160|NCT00962585|82963241|FG001|Overall Study|Protocol Violation|0|||
46746161|NCT00962585|82963242|FG002|Overall Study|Protocol Violation|1|||
46746162|NCT00962585|82963243|FG003|Overall Study|Protocol Violation|0|||
46746163|NCT00962585|82963240|FG000|Overall Study|Withdrawal by Subject|1|||
46746164|NCT00962585|82963241|FG001|Overall Study|Withdrawal by Subject|0|||
46746165|NCT00962585|82963242|FG002|Overall Study|Withdrawal by Subject|0|||
46746166|NCT00962585|82963243|FG003|Overall Study|Withdrawal by Subject|0|||
46746167|NCT00962585|82963240|FG000|Overall Study|Withdrew Consent|2|||
46746168|NCT00962585|82963241|FG001|Overall Study|Withdrew Consent|0|||
46746169|NCT00962585|82963242|FG002|Overall Study|Withdrew Consent|0|||
46746170|NCT00962585|82963243|FG003|Overall Study|Withdrew Consent|0|||
46746171|NCT00621985|82963255|FG000|Dexamethasone Admission|Adverse Event|1|||
46746172|NCT00961259|82963265|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
46746173|NCT00961259|82963266|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
46746174|NCT00961259|82963267|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
46746175|NCT00961181|82963276|FG000|Overall Study|Death|2|||
46746176|NCT00961181|82963276|FG000|Overall Study|Withdrawal by Subject|2|||
46746177|NCT00961181|82963276|FG000|Overall Study|Lost to Follow-up|1|||
46746178|NCT00817635|82963285|FG000|Overall Study|Adverse Event|1|||
46746179|NCT00817635|82963286|FG001|Overall Study|Adverse Event|0|||
46746180|NCT00817635|82963287|FG002|Overall Study|Adverse Event|0|||
46746181|NCT00817635|82963288|FG003|Overall Study|Adverse Event|1|||
46746182|NCT00817635|82963289|FG004|Overall Study|Adverse Event|1|||
46746183|NCT00817635|82963285|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
46746184|NCT00817635|82963286|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
46746185|NCT00817635|82963287|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
46746186|NCT00817635|82963288|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
46746187|NCT00817635|82963289|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
46746188|NCT00817635|82963285|FG000|Overall Study|Withdrawal by Subject|2|||
46746189|NCT00817635|82963286|FG001|Overall Study|Withdrawal by Subject|1|||
46775751|NCT00793793|82994208|FG004|Overall Study|Lost to Follow-up|0|||
46746190|NCT00817635|82963287|FG002|Overall Study|Withdrawal by Subject|0|||
46746191|NCT00817635|82963288|FG003|Overall Study|Withdrawal by Subject|1|||
46746192|NCT00817635|82963289|FG004|Overall Study|Withdrawal by Subject|2|||
47051721|NCT01859741|83316944|FG003|Overall Study|Study Terminated by Sponsor|0|||
47051722|NCT01859741|83316945|FG004|Overall Study|Study Terminated by Sponsor|1|||
47051723|NCT01859741|83316946|FG005|Overall Study|Study Terminated by Sponsor|0|||
47051724|NCT01859741|83316947|FG006|Overall Study|Study Terminated by Sponsor|16|||
47051725|NCT01859741|83316948|FG007|Overall Study|Study Terminated by Sponsor|14|||
47051726|NCT01859741|83316941|FG000|Overall Study|Other|0|||
47051727|NCT01859741|83316942|FG001|Overall Study|Other|0|||
46746193|NCT00817635|82963285|FG000|Overall Study|Lost to Follow-up|0|||
46746194|NCT00817635|82963286|FG001|Overall Study|Lost to Follow-up|1|||
46746195|NCT00817635|82963287|FG002|Overall Study|Lost to Follow-up|0|||
46746196|NCT00817635|82963288|FG003|Overall Study|Lost to Follow-up|1|||
46746197|NCT00817635|82963289|FG004|Overall Study|Lost to Follow-up|0|||
46746198|NCT00817635|82963285|FG000|Overall Study|Administrative Problems|0|||
46746199|NCT00817635|82963286|FG001|Overall Study|Administrative Problems|0|||
46746200|NCT00817635|82963287|FG002|Overall Study|Administrative Problems|0|||
46746201|NCT00817635|82963288|FG003|Overall Study|Administrative Problems|0|||
46746202|NCT00817635|82963289|FG004|Overall Study|Administrative Problems|1|||
46746203|NCT00817635|82963285|FG000|Overall Study|Protocol Violation|5|||
46746204|NCT00817635|82963286|FG001|Overall Study|Protocol Violation|1|||
46746205|NCT00817635|82963287|FG002|Overall Study|Protocol Violation|3|||
46746206|NCT00817635|82963288|FG003|Overall Study|Protocol Violation|2|||
46746207|NCT00817635|82963289|FG004|Overall Study|Protocol Violation|3|||
46746208|NCT00817479|82963310|FG000|Overall Study|Physician Decision|1|||
46746209|NCT00817479|82963311|FG001|Overall Study|Physician Decision|1|||
46746210|NCT00961961|82963321|FG000|Phase I|Withdrawal by Subject|7|||
46746211|NCT00961961|82963322|FG001|Phase I|Withdrawal by Subject|0|||
46746212|NCT00961961|82963323|FG002|Phase I|Withdrawal by Subject|0|||
46746213|NCT00961961|82963324|FG003|Phase I|Withdrawal by Subject|0|||
46746214|NCT00961961|82963321|FG000|Phase I|Lost to Follow-up|10|||
46746215|NCT00961961|82963322|FG001|Phase I|Lost to Follow-up|0|||
46746216|NCT00961961|82963323|FG002|Phase I|Lost to Follow-up|0|||
46746217|NCT00961961|82963324|FG003|Phase I|Lost to Follow-up|0|||
46746218|NCT00961961|82963321|FG000|Phase I|Lack of Efficacy|94|||
46746219|NCT00961961|82963322|FG001|Phase I|Lack of Efficacy|0|||
46746220|NCT00961961|82963323|FG002|Phase I|Lack of Efficacy|0|||
46746221|NCT00961961|82963324|FG003|Phase I|Lack of Efficacy|0|||
46746222|NCT00961961|82963321|FG000|Phase I|Adverse Event|7|||
46746223|NCT00961961|82963322|FG001|Phase I|Adverse Event|0|||
46746224|NCT00961961|82963323|FG002|Phase I|Adverse Event|0|||
46746225|NCT00961961|82963324|FG003|Phase I|Adverse Event|0|||
46746226|NCT00961961|82963321|FG000|Phase I|Physician Decision|8|||
46746227|NCT00961961|82963322|FG001|Phase I|Physician Decision|0|||
46746228|NCT00961961|82963323|FG002|Phase I|Physician Decision|0|||
46746229|NCT00961961|82963324|FG003|Phase I|Physician Decision|0|||
46746230|NCT00961961|82963321|FG000|Phase II|Lost to Follow-up|0|||
46746231|NCT00961961|82963322|FG001|Phase II|Lost to Follow-up|0|||
46746232|NCT00961961|82963323|FG002|Phase II|Lost to Follow-up|10|||
46746233|NCT00961961|82963324|FG003|Phase II|Lost to Follow-up|7|||
46746234|NCT00961961|82963321|FG000|Phase II|Adverse Event|0|||
46746235|NCT00961961|82963322|FG001|Phase II|Adverse Event|0|||
46746236|NCT00961961|82963323|FG002|Phase II|Adverse Event|0|||
46746237|NCT00961961|82963324|FG003|Phase II|Adverse Event|1|||
46746238|NCT00961961|82963321|FG000|Phase II|Physician Decision|0|||
46746239|NCT00961961|82963322|FG001|Phase II|Physician Decision|0|||
46746240|NCT00961961|82963323|FG002|Phase II|Physician Decision|1|||
46746241|NCT00961961|82963324|FG003|Phase II|Physician Decision|0|||
46746242|NCT00961961|82963321|FG000|Phase II|Withdrawal by Subject|0|||
46746243|NCT00961961|82963322|FG001|Phase II|Withdrawal by Subject|0|||
46746244|NCT00961961|82963323|FG002|Phase II|Withdrawal by Subject|1|||
46804434|NCT00412984|83023474|FG000|Overall Study|Administrative Reason by Sponsor|11|||
46746245|NCT00961961|82963324|FG003|Phase II|Withdrawal by Subject|0|||
46746246|NCT00817089|82963348|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
46746247|NCT00817089|82963349|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
46746248|NCT00817089|82963350|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
47051728|NCT01859741|83316943|FG002|Overall Study|Other|0|||
46746249|NCT00817089|82963351|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
46746250|NCT00817089|82963348|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
47051729|NCT01859741|83316944|FG003|Overall Study|Other|0|||
46746251|NCT00817089|82963349|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
46746252|NCT00817089|82963350|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
46746253|NCT00817089|82963351|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
46804435|NCT00412984|83023475|FG001|Overall Study|Administrative Reason by Sponsor|8|||
47051730|NCT01859741|83316945|FG004|Overall Study|Other|0|||
47051731|NCT01859741|83316946|FG005|Overall Study|Other|0|||
47051732|NCT01859741|83316947|FG006|Overall Study|Other|2|||
47051733|NCT01859741|83316948|FG007|Overall Study|Other|0|||
47051734|NCT01859507|83316994|FG000|Overall Study|left the country|4|||
47051735|NCT01876043|83316999|FG000|Overall Study|Death|1|||
47051736|NCT01876043|83316999|FG000|Overall Study|Withdrawal by Subject|1|||
47051737|NCT01875731|83317005|FG000|Overall Study|Fail to obtain lab sample|1|||
47051738|NCT01875731|83317006|FG001|Overall Study|Fail to obtain lab sample|0|||
47051739|NCT01873859|83317014|FG000|Overall Study|Withdrawal by Subject|0|||
47051740|NCT01873859|83317015|FG001|Overall Study|Withdrawal by Subject|4|||
47051741|NCT01857869|83317032|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
47051742|NCT01857869|83317033|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
47051743|NCT01857869|83317034|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
47051744|NCT01857869|83317035|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
47051745|NCT01857869|83317036|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
47051746|NCT01857869|83317037|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
47051747|NCT01857869|83317038|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
47051748|NCT01857869|83317039|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
47051749|NCT01857869|83317040|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
46746254|NCT00815919|82963365|FG000|Overall Study|Unrelated Fungal Infection|1|||
46923082|NCT02983227|83156416|FG000|Overall Study|Withdrawal by Subject|19|||
46746255|NCT00815919|82963365|FG000|Overall Study|AML Relapse|1|||
46746256|NCT00815919|82963365|FG000|Overall Study|Lack of Efficacy|2|||
46746257|NCT00957905|82963371|FG000|Part B|Not Treated|0|||
46746258|NCT00957905|82963372|FG001|Part B|Not Treated|1|||
46923083|NCT02983227|83156417|FG001|Overall Study|Withdrawal by Subject|8|||
46923084|NCT00301262|83156425|FG000|Double Blind Phase (DB)|Adverse Event|1|||
46923085|NCT00301262|83156426|FG001|Double Blind Phase (DB)|Adverse Event|0|||
46923086|NCT00301262|83156425|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
46923087|NCT00301262|83156426|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
46923088|NCT00301262|83156425|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
46923089|NCT00301262|83156426|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
46923090|NCT00301262|83156425|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
46923091|NCT00301262|83156426|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
46746259|NCT00957905|82963371|FG000|Part B|Physician Decision|0|||
46746260|NCT00957905|82963372|FG001|Part B|Physician Decision|1|||
46746261|NCT00957905|82963371|FG000|Part B|Death|0|||
46746262|NCT00957905|82963372|FG001|Part B|Death|1|||
46746263|NCT00957905|82963371|FG000|Part B|Protocol Violation|0|||
46746264|NCT00957905|82963372|FG001|Part B|Protocol Violation|1|||
46746265|NCT00960323|82963378|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
46746266|NCT00617929|82963386|FG000|Overall Study|Physician Decision|1|||
46746267|NCT00815295|82963393|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
46746268|NCT00815295|82963394|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
46746269|NCT00815295|82963395|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
46746270|NCT00814983|82963405|FG000|Overall Study|Screen failure|1|||
46746271|NCT00814983|82963406|FG001|Overall Study|Screen failure|0|||
46746272|NCT00814983|82963405|FG000|Overall Study|Withdrawal by Subject|1|||
46746273|NCT00814983|82963406|FG001|Overall Study|Withdrawal by Subject|0|||
46746274|NCT00814983|82963405|FG000|Overall Study|Graft failure|1|||
46746275|NCT00814983|82963406|FG001|Overall Study|Graft failure|0|||
46746276|NCT00960869|82963414|FG000|Overall Study|Adverse Event|17|||
46746277|NCT00960869|82963415|FG001|Overall Study|Adverse Event|26|||
46746278|NCT00960869|82963414|FG000|Overall Study|Withdrawal by Subject|16|||
46746279|NCT00960869|82963415|FG001|Overall Study|Withdrawal by Subject|14|||
46746280|NCT00960869|82963414|FG000|Overall Study|Lost to Follow-up|1|||
46746281|NCT00960869|82963415|FG001|Overall Study|Lost to Follow-up|4|||
46746282|NCT00960869|82963414|FG000|Overall Study|Misc|19|||
46746283|NCT00960869|82963415|FG001|Overall Study|Misc|18|||
47051750|NCT01857869|83317041|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
47051751|NCT01857869|83317032|FG000|Primary/Challenge Phase|Pregnancy|1|||
47051752|NCT01857869|83317033|FG001|Primary/Challenge Phase|Pregnancy|0|||
47051753|NCT01857869|83317034|FG002|Primary/Challenge Phase|Pregnancy|0|||
46746284|NCT00618787|82963423|FG000|Overall Study|Adverse Event|0|||
46746285|NCT00618787|82963424|FG001|Overall Study|Adverse Event|1|||
47051754|NCT01857869|83317035|FG003|Primary/Challenge Phase|Pregnancy|0|||
47051755|NCT01857869|83317036|FG004|Primary/Challenge Phase|Pregnancy|0|||
47051756|NCT01857869|83317037|FG005|Primary/Challenge Phase|Pregnancy|0|||
47051757|NCT01857869|83317038|FG006|Primary/Challenge Phase|Pregnancy|0|||
46746286|NCT00618787|82963423|FG000|Overall Study|Withdrawal by Subject|2|||
46746287|NCT00618787|82963424|FG001|Overall Study|Withdrawal by Subject|1|||
46746288|NCT00618787|82963423|FG000|Overall Study|Lost to Follow-up|1|||
46746289|NCT00618787|82963424|FG001|Overall Study|Lost to Follow-up|0|||
46746290|NCT00813813|82963432|FG000|Overall Study|Withdrawal by Subject|1|||
46746291|NCT00813813|82963433|FG001|Overall Study|Withdrawal by Subject|1|||
46746292|NCT00813813|82963432|FG000|Overall Study|Lost to Follow-up|2|||
46746293|NCT00813813|82963433|FG001|Overall Study|Lost to Follow-up|7|||
47051758|NCT01857869|83317039|FG007|Primary/Challenge Phase|Pregnancy|0|||
47051759|NCT01857869|83317040|FG008|Primary/Challenge Phase|Pregnancy|0|||
47051760|NCT01857869|83317041|FG009|Primary/Challenge Phase|Pregnancy|0|||
47051761|NCT01857869|83317032|FG000|Primary/Challenge Phase|Protocol Violation|1|||
47051762|NCT01857869|83317033|FG001|Primary/Challenge Phase|Protocol Violation|0|||
47051763|NCT01857869|83317034|FG002|Primary/Challenge Phase|Protocol Violation|0|||
47051764|NCT01857869|83317035|FG003|Primary/Challenge Phase|Protocol Violation|0|||
47051765|NCT01857869|83317036|FG004|Primary/Challenge Phase|Protocol Violation|0|||
47051766|NCT01857869|83317037|FG005|Primary/Challenge Phase|Protocol Violation|0|||
47051767|NCT01857869|83317038|FG006|Primary/Challenge Phase|Protocol Violation|0|||
47051768|NCT01857869|83317039|FG007|Primary/Challenge Phase|Protocol Violation|0|||
47051769|NCT01857869|83317040|FG008|Primary/Challenge Phase|Protocol Violation|0|||
47051770|NCT01857869|83317041|FG009|Primary/Challenge Phase|Protocol Violation|0|||
47051771|NCT01857869|83317032|FG000|Primary/Challenge Phase|Other|1|||
47051772|NCT01857869|83317033|FG001|Primary/Challenge Phase|Other|1|||
47051773|NCT01857869|83317034|FG002|Primary/Challenge Phase|Other|0|||
47051774|NCT01857869|83317035|FG003|Primary/Challenge Phase|Other|0|||
47051775|NCT01857869|83317036|FG004|Primary/Challenge Phase|Other|0|||
47051776|NCT01857869|83317037|FG005|Primary/Challenge Phase|Other|0|||
47051777|NCT01857869|83317038|FG006|Primary/Challenge Phase|Other|0|||
47051778|NCT01857869|83317039|FG007|Primary/Challenge Phase|Other|0|||
47051779|NCT01857869|83317040|FG008|Primary/Challenge Phase|Other|0|||
47051780|NCT01857869|83317041|FG009|Primary/Challenge Phase|Other|0|||
47051781|NCT01857869|83317032|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
47051782|NCT01857869|83317033|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
47051783|NCT01857869|83317034|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
47051784|NCT01857869|83317035|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
47051785|NCT01857869|83317036|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
46746294|NCT00813813|82963432|FG000|Overall Study|Other|0|||
46746295|NCT00813813|82963433|FG001|Overall Study|Other|1|||
46746296|NCT05317312|82963443|FG000|Overall Study|Withdrawal by Subject|0|||
46746297|NCT05317312|82963444|FG001|Overall Study|Withdrawal by Subject|1|||
46746298|NCT05317312|82963445|FG002|Overall Study|Withdrawal by Subject|0|||
46746299|NCT05317312|82963446|FG003|Overall Study|Withdrawal by Subject|0|||
46746300|NCT05317312|82963443|FG000|Overall Study|Lost to Follow-up|0|||
46746301|NCT05317312|82963444|FG001|Overall Study|Lost to Follow-up|0|||
46746302|NCT05317312|82963445|FG002|Overall Study|Lost to Follow-up|0|||
46746303|NCT05317312|82963446|FG003|Overall Study|Lost to Follow-up|1|||
46746304|NCT05317312|82963443|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
46746305|NCT05317312|82963444|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
46746306|NCT05317312|82963445|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
46746307|NCT05317312|82963446|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
46746308|NCT04644315|82963456|FG000|Overall Study|Subject withdrawal of consent|1|||
46746309|NCT04410523|82963466|FG000|Overall Study|Study terminated by sponsor|1|||
46746310|NCT04410523|82963467|FG001|Overall Study|Study terminated by sponsor|3|||
46746311|NCT04410523|82963468|FG002|Overall Study|Study terminated by sponsor|2|||
46746312|NCT04410523|82963469|FG003|Overall Study|Study terminated by sponsor|6|||
46746313|NCT04410523|82963470|FG004|Overall Study|Study terminated by sponsor|3|||
46746314|NCT04410523|82963471|FG005|Overall Study|Study terminated by sponsor|4|||
46746315|NCT04410523|82963466|FG000|Overall Study|Adverse Event|1|||
46746316|NCT04410523|82963467|FG001|Overall Study|Adverse Event|0|||
46746317|NCT04410523|82963468|FG002|Overall Study|Adverse Event|0|||
46746318|NCT04410523|82963469|FG003|Overall Study|Adverse Event|0|||
46746319|NCT04410523|82963470|FG004|Overall Study|Adverse Event|0|||
46746320|NCT04410523|82963471|FG005|Overall Study|Adverse Event|2|||
46746321|NCT04410523|82963466|FG000|Overall Study|Lost to Follow-up|0|||
46746322|NCT04410523|82963467|FG001|Overall Study|Lost to Follow-up|1|||
47051786|NCT01857869|83317037|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
47051787|NCT01857869|83317038|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
47051788|NCT01857869|83317039|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
46746323|NCT04410523|82963468|FG002|Overall Study|Lost to Follow-up|0|||
46746324|NCT04410523|82963469|FG003|Overall Study|Lost to Follow-up|0|||
46746325|NCT04410523|82963470|FG004|Overall Study|Lost to Follow-up|0|||
46746326|NCT04410523|82963471|FG005|Overall Study|Lost to Follow-up|0|||
47051789|NCT01857869|83317040|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
47051790|NCT01857869|83317041|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
47051791|NCT01857869|83317032|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051792|NCT01857869|83317033|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051793|NCT01857869|83317034|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
46746327|NCT04410523|82963466|FG000|Overall Study|Physician Decision|0|||
46746328|NCT04410523|82963467|FG001|Overall Study|Physician Decision|1|||
47051794|NCT01857869|83317035|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
47051795|NCT01857869|83317036|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051796|NCT01857869|83317037|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051797|NCT01857869|83317038|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051798|NCT01857869|83317039|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051799|NCT01857869|83317040|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051800|NCT01857869|83317041|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
47051801|NCT04452318|83317129|FG000|Overall Study|Physician Decision|1|||
47051802|NCT04452318|83317130|FG001|Overall Study|Physician Decision|2|||
47051803|NCT04452318|83317131|FG002|Overall Study|Physician Decision|0|||
47051804|NCT04452318|83317132|FG003|Overall Study|Physician Decision|2|||
46746329|NCT04410523|82963468|FG002|Overall Study|Physician Decision|0|||
46746330|NCT04410523|82963469|FG003|Overall Study|Physician Decision|0|||
46746331|NCT04410523|82963470|FG004|Overall Study|Physician Decision|0|||
46746332|NCT04410523|82963471|FG005|Overall Study|Physician Decision|0|||
46746333|NCT04410523|82963466|FG000|Overall Study|Pregnancy|0|||
46746334|NCT04410523|82963467|FG001|Overall Study|Pregnancy|0|||
46746335|NCT04410523|82963468|FG002|Overall Study|Pregnancy|0|||
46746336|NCT04410523|82963469|FG003|Overall Study|Pregnancy|0|||
46746337|NCT04410523|82963470|FG004|Overall Study|Pregnancy|0|||
46923092|NCT00301262|83156425|FG000|Double Blind Phase (DB)|Other|1|||
46923093|NCT00301262|83156426|FG001|Double Blind Phase (DB)|Other|4|||
46923094|NCT00301262|83156425|FG000|Open Label Phase (OL)|Adverse Event|1|||
46923095|NCT00301262|83156426|FG001|Open Label Phase (OL)|Adverse Event|0|||
46923096|NCT00301262|83156425|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
46923097|NCT00301262|83156426|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
46923098|NCT00301262|83156425|FG000|Open Label Phase (OL)|Other|2|||
46923099|NCT00301262|83156426|FG001|Open Label Phase (OL)|Other|0|||
46923100|NCT02905149|83156453|FG000|Overall Study|Lost to Follow-up|2|||
46923101|NCT02905149|83156454|FG001|Overall Study|Lost to Follow-up|0|||
46923102|NCT02790606|83156460|FG000|Overall Study|Death|27|||
46923103|NCT02790606|83156460|FG000|Overall Study|Lost to Follow-up|4|||
46923104|NCT02790606|83156460|FG000|Overall Study|Physician Decision|3|||
46923105|NCT02790606|83156460|FG000|Overall Study|Withdrawal by Subject|1|||
46923106|NCT03077620|83156468|FG000|Overall Study|Unable to place lumbar catheter|1|||
46923107|NCT03077620|83156469|FG001|Overall Study|Unable to place lumbar catheter|0|||
46923108|NCT03077620|83156470|FG002|Overall Study|Unable to place lumbar catheter|1|||
46923109|NCT03077620|83156471|FG003|Overall Study|Unable to place lumbar catheter|0|||
46923110|NCT03077620|83156468|FG000|Overall Study|Withdrawal by Subject|0|||
46923111|NCT03077620|83156469|FG001|Overall Study|Withdrawal by Subject|1|||
46923112|NCT03077620|83156470|FG002|Overall Study|Withdrawal by Subject|0|||
47051805|NCT04452318|83317133|FG004|Overall Study|Physician Decision|0|||
47051806|NCT04452318|83317134|FG005|Overall Study|Physician Decision|2|||
47051807|NCT04452318|83317135|FG006|Overall Study|Physician Decision|5|||
47051808|NCT04452318|83317129|FG000|Overall Study|Death|2|||
47051809|NCT04452318|83317130|FG001|Overall Study|Death|3|||
47051810|NCT04452318|83317131|FG002|Overall Study|Death|0|||
47051811|NCT04452318|83317132|FG003|Overall Study|Death|0|||
47051812|NCT04452318|83317133|FG004|Overall Study|Death|0|||
47051813|NCT04452318|83317134|FG005|Overall Study|Death|0|||
47051814|NCT04452318|83317135|FG006|Overall Study|Death|0|||
47051815|NCT04452318|83317129|FG000|Overall Study|Lost to Follow-up|38|||
47051816|NCT04452318|83317130|FG001|Overall Study|Lost to Follow-up|28|||
47051817|NCT04452318|83317131|FG002|Overall Study|Lost to Follow-up|0|||
47051818|NCT04452318|83317132|FG003|Overall Study|Lost to Follow-up|3|||
47051819|NCT04452318|83317133|FG004|Overall Study|Lost to Follow-up|3|||
47051820|NCT04452318|83317134|FG005|Overall Study|Lost to Follow-up|2|||
47051821|NCT04452318|83317135|FG006|Overall Study|Lost to Follow-up|1|||
47051822|NCT04452318|83317129|FG000|Overall Study|Withdrawal by Subject|46|||
47051823|NCT04452318|83317130|FG001|Overall Study|Withdrawal by Subject|40|||
47051824|NCT04452318|83317131|FG002|Overall Study|Withdrawal by Subject|0|||
47051825|NCT04452318|83317132|FG003|Overall Study|Withdrawal by Subject|18|||
47051826|NCT04452318|83317133|FG004|Overall Study|Withdrawal by Subject|6|||
47051827|NCT04452318|83317134|FG005|Overall Study|Withdrawal by Subject|8|||
47051828|NCT04452318|83317135|FG006|Overall Study|Withdrawal by Subject|6|||
47051829|NCT00634101|83317312|FG000|Overall Study|Study Terminated|3|||
46746338|NCT04410523|82963471|FG005|Overall Study|Pregnancy|1|||
46746339|NCT04410523|82963466|FG000|Overall Study|Protocol deviation|0|||
46746340|NCT04410523|82963467|FG001|Overall Study|Protocol deviation|0|||
46804436|NCT00412984|83023474|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
46804437|NCT00412984|83023475|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
46804438|NCT00412984|83023474|FG000|Overall Study|Other Reason|80|||
46804439|NCT00412984|83023475|FG001|Overall Study|Other Reason|92|||
46804440|NCT00412984|83023474|FG000|Overall Study|Not Reported|11|||
46804441|NCT00412984|83023475|FG001|Overall Study|Not Reported|12|||
46804442|NCT00539864|83023483|FG000|Overall Study|Lost to Follow-up|0|||
46804443|NCT00539864|83023484|FG001|Overall Study|Lost to Follow-up|1|||
46804444|NCT00539864|83023483|FG000|Overall Study|Withdrawal by Subject|1|||
47051830|NCT00634101|83317313|FG001|Overall Study|Study Terminated|3|||
47051831|NCT00634101|83317312|FG000|Overall Study|Lost to Follow-up|2|||
47051832|NCT00634101|83317313|FG001|Overall Study|Lost to Follow-up|0|||
47051833|NCT00633477|83317330|FG000|Overall Study|Death|1|||
46804445|NCT00539864|83023484|FG001|Overall Study|Withdrawal by Subject|1|||
46804446|NCT00673049|83023492|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
46804447|NCT00673049|83023493|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
46804448|NCT00673049|83023494|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
46804449|NCT00673049|83023495|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
47051834|NCT00633477|83317331|FG001|Overall Study|Death|0|||
47051835|NCT00633477|83317330|FG000|Overall Study|Randomized but not treated|1|||
47051836|NCT00633477|83317331|FG001|Overall Study|Randomized but not treated|0|||
46804450|NCT00673049|83023492|FG000|Before Progression on Erlotinib|Death|235|||
46804451|NCT00673049|83023493|FG001|Before Progression on Erlotinib|Death|167|||
46804452|NCT00673049|83023494|FG002|Before Progression on Erlotinib|Death|1|||
46804453|NCT00673049|83023495|FG003|Before Progression on Erlotinib|Death|0|||
46804454|NCT00673049|83023492|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
46923113|NCT03077620|83156471|FG003|Overall Study|Withdrawal by Subject|0|||
46923114|NCT03077620|83156468|FG000|Overall Study|Physician Decision|0|||
46923115|NCT03077620|83156469|FG001|Overall Study|Physician Decision|0|||
46923116|NCT03077620|83156470|FG002|Overall Study|Physician Decision|1|||
47051837|NCT00331773|83317356|FG000|Overall Study|Withdrawal by Subject|6|||
46746341|NCT04410523|82963468|FG002|Overall Study|Protocol deviation|0|||
46746342|NCT04410523|82963469|FG003|Overall Study|Protocol deviation|0|||
46746343|NCT04410523|82963470|FG004|Overall Study|Protocol deviation|0|||
46746344|NCT04410523|82963471|FG005|Overall Study|Protocol deviation|2|||
46746345|NCT04410523|82963466|FG000|Overall Study|Subject decision|2|||
46746346|NCT04410523|82963467|FG001|Overall Study|Subject decision|0|||
46746347|NCT04410523|82963468|FG002|Overall Study|Subject decision|0|||
46746348|NCT04410523|82963469|FG003|Overall Study|Subject decision|1|||
46746349|NCT04410523|82963470|FG004|Overall Study|Subject decision|0|||
46746350|NCT04410523|82963471|FG005|Overall Study|Subject decision|1|||
46746351|NCT03889418|82963510|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
46746352|NCT03889418|82963511|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746353|NCT03889418|82963512|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746354|NCT03889418|82963513|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746355|NCT03889418|82963514|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746356|NCT03889418|82963515|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746357|NCT03889418|82963516|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746358|NCT03889418|82963517|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746359|NCT03889418|82963518|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746360|NCT03889418|82963519|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
46746361|NCT03889418|82963510|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46746362|NCT03889418|82963511|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
46746363|NCT03889418|82963512|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
46746364|NCT03889418|82963513|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46746365|NCT03889418|82963514|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46746366|NCT03889418|82963515|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46746367|NCT03889418|82963516|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46746368|NCT03889418|82963517|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46804455|NCT00673049|83023493|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
46804456|NCT00673049|83023494|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
46804457|NCT00673049|83023495|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
46804458|NCT00673049|83023492|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
46923117|NCT03077620|83156471|FG003|Overall Study|Physician Decision|0|||
46746369|NCT03889418|82963518|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46746370|NCT03889418|82963519|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
46746371|NCT03889418|82963510|FG000|October-December 2019 (Month 7-9)|Death|0|||
46746372|NCT03889418|82963511|FG001|October-December 2019 (Month 7-9)|Death|0|||
46746373|NCT03889418|82963512|FG002|October-December 2019 (Month 7-9)|Death|0|||
46746374|NCT03889418|82963513|FG003|October-December 2019 (Month 7-9)|Death|0|||
46746375|NCT03889418|82963514|FG004|October-December 2019 (Month 7-9)|Death|0|||
46746376|NCT03889418|82963515|FG005|October-December 2019 (Month 7-9)|Death|0|||
46746377|NCT03889418|82963516|FG006|October-December 2019 (Month 7-9)|Death|0|||
46804459|NCT00673049|83023493|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
47051838|NCT00331773|83317357|FG001|Overall Study|Withdrawal by Subject|4|||
47051839|NCT00331773|83317356|FG000|Overall Study|Protocol Violation|10|||
46746378|NCT03889418|82963517|FG007|October-December 2019 (Month 7-9)|Death|0|||
47051840|NCT00331773|83317357|FG001|Overall Study|Protocol Violation|3|||
46746379|NCT03889418|82963518|FG008|October-December 2019 (Month 7-9)|Death|1|||
46746380|NCT03889418|82963519|FG009|October-December 2019 (Month 7-9)|Death|0|||
47051841|NCT00633243|83317390|FG000|Overall Study|Withdrawal by Subject|0|||
46746381|NCT03889418|82963510|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
46746382|NCT03889418|82963511|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
46746383|NCT03889418|82963512|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
46746384|NCT03889418|82963513|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
46746385|NCT03889418|82963514|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
46746386|NCT03889418|82963515|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
46746387|NCT03889418|82963516|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
47051842|NCT00633243|83317391|FG001|Overall Study|Withdrawal by Subject|1|||
47051843|NCT00633243|83317390|FG000|Overall Study|incarceration|0|||
47051844|NCT00633243|83317391|FG001|Overall Study|incarceration|2|||
46746388|NCT03889418|82963517|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
46746389|NCT03889418|82963518|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
46746390|NCT03889418|82963519|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
46746391|NCT03889418|82963510|FG000|April - June 2020 (Month 13-15)|Death|0|||
46746392|NCT03889418|82963511|FG001|April - June 2020 (Month 13-15)|Death|1|||
46746393|NCT03889418|82963512|FG002|April - June 2020 (Month 13-15)|Death|0|||
46746394|NCT03889418|82963513|FG003|April - June 2020 (Month 13-15)|Death|0|||
46746395|NCT03889418|82963514|FG004|April - June 2020 (Month 13-15)|Death|0|||
46746396|NCT03889418|82963515|FG005|April - June 2020 (Month 13-15)|Death|0|||
46746397|NCT03889418|82963516|FG006|April - June 2020 (Month 13-15)|Death|0|||
46746398|NCT03889418|82963517|FG007|April - June 2020 (Month 13-15)|Death|0|||
46746399|NCT03889418|82963518|FG008|April - June 2020 (Month 13-15)|Death|0|||
46746400|NCT03889418|82963519|FG009|April - June 2020 (Month 13-15)|Death|0|||
46746401|NCT03889418|82963510|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746402|NCT03889418|82963511|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746403|NCT03889418|82963512|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746404|NCT03889418|82963513|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
46746405|NCT03889418|82963514|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746406|NCT03889418|82963515|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746407|NCT03889418|82963516|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746408|NCT03889418|82963517|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746409|NCT03889418|82963518|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746410|NCT03889418|82963519|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
46746411|NCT03889418|82963510|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
46746412|NCT03889418|82963511|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
46746413|NCT03889418|82963512|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
47051845|NCT00633243|83317390|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
47051846|NCT00633243|83317391|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
47051847|NCT00633243|83317390|FG000|Overall Study|Not comfortable with self-injecting|0|||
47051848|NCT00633243|83317391|FG001|Overall Study|Not comfortable with self-injecting|1|||
47051849|NCT00633243|83317390|FG000|Overall Study|Mental Health--Depression|0|||
47051850|NCT00633243|83317391|FG001|Overall Study|Mental Health--Depression|1|||
47051851|NCT00633243|83317390|FG000|Overall Study|Couldn't tolerate side-effects|1|||
47051852|NCT00633243|83317391|FG001|Overall Study|Couldn't tolerate side-effects|1|||
47051853|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
47051854|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
47051855|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
47051856|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
47051857|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
47051858|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
47051859|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
47051860|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
46746414|NCT03889418|82963513|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
46746415|NCT03889418|82963514|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
46746416|NCT03889418|82963515|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
46746417|NCT03889418|82963516|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
46746418|NCT03889418|82963517|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
46746419|NCT03889418|82963518|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
46746420|NCT03889418|82963519|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
47051861|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
47051862|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
47051863|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
46746421|NCT03889418|82963510|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
47051864|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
47051865|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
46746422|NCT03889418|82963511|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
46746423|NCT03889418|82963512|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
46746424|NCT03889418|82963513|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
46746425|NCT03889418|82963514|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
46746426|NCT03889418|82963515|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
46746427|NCT03889418|82963516|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
46746428|NCT03889418|82963517|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
46746429|NCT03889418|82963518|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
46746430|NCT03889418|82963519|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
46746431|NCT03749109|82963529|FG000|Overall Study|Adverse Event|2|||
46746432|NCT03749109|82963530|FG001|Overall Study|Adverse Event|0|||
46746433|NCT03497689|82963537|FG000|Overall Study|Adverse Event|2|||
46746434|NCT03497689|82963537|FG000|Overall Study|Death|1|||
46746435|NCT03497689|82963537|FG000|Overall Study|Physician Decision|1|||
46746436|NCT03497689|82963537|FG000|Overall Study|Withdrawal by Subject|1|||
46746437|NCT03497689|82963537|FG000|Overall Study|Protocol Violation|2|||
46746438|NCT03492437|82963541|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46746439|NCT03492437|82963542|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46746440|NCT03193853|82963548|FG000|Overall Study|Death|6|||
46746441|NCT02756637|82963554|FG000|Overall Study|Not eligible for initial SWOG study|10|||
46746442|NCT02756637|82963555|FG001|Overall Study|Not eligible for initial SWOG study|10|||
46746443|NCT02756637|82963554|FG000|Overall Study|No available NLR value|44|||
46746444|NCT02756637|82963555|FG001|Overall Study|No available NLR value|44|||
46746445|NCT02756637|82963554|FG000|Overall Study|Did not complete curative therapy|33|||
46746446|NCT02756637|82963555|FG001|Overall Study|Did not complete curative therapy|0|||
46746447|NCT02041195|82963569|FG000|Overall Study|Adverse Event|1|||
46746448|NCT02041195|82963570|FG001|Overall Study|Adverse Event|2|||
46746449|NCT02041195|82963571|FG002|Overall Study|Adverse Event|0|||
46746450|NCT02041195|82963572|FG003|Overall Study|Adverse Event|0|||
46746451|NCT02041195|82963573|FG004|Overall Study|Adverse Event|0|||
46746452|NCT02041195|82963574|FG005|Overall Study|Adverse Event|0|||
46746453|NCT02041195|82963575|FG006|Overall Study|Adverse Event|3|||
46746454|NCT02041195|82963576|FG007|Overall Study|Adverse Event|0|||
46746455|NCT02041195|82963569|FG000|Overall Study|Withdrawal by Subject|1|||
46746456|NCT02041195|82963570|FG001|Overall Study|Withdrawal by Subject|0|||
46746457|NCT02041195|82963571|FG002|Overall Study|Withdrawal by Subject|0|||
46746458|NCT02041195|82963572|FG003|Overall Study|Withdrawal by Subject|0|||
46746459|NCT02041195|82963573|FG004|Overall Study|Withdrawal by Subject|0|||
46746460|NCT02041195|82963574|FG005|Overall Study|Withdrawal by Subject|0|||
46746461|NCT02041195|82963575|FG006|Overall Study|Withdrawal by Subject|4|||
46746462|NCT02041195|82963576|FG007|Overall Study|Withdrawal by Subject|3|||
46746463|NCT02041195|82963569|FG000|Overall Study|Unable to comply with study visits|0|||
46746464|NCT02041195|82963570|FG001|Overall Study|Unable to comply with study visits|1|||
46746465|NCT02041195|82963571|FG002|Overall Study|Unable to comply with study visits|0|||
46746466|NCT02041195|82963572|FG003|Overall Study|Unable to comply with study visits|0|||
46746467|NCT02041195|82963573|FG004|Overall Study|Unable to comply with study visits|1|||
46746468|NCT02041195|82963574|FG005|Overall Study|Unable to comply with study visits|0|||
46746469|NCT02041195|82963575|FG006|Overall Study|Unable to comply with study visits|0|||
46923118|NCT02982213|83156492|FG000|Overall Study|Did not complete follow up questionnaire|5|||
46923119|NCT02982213|83156493|FG001|Overall Study|Did not complete follow up questionnaire|1|||
46923120|NCT02649634|83156501|FG000|Overall Study|Withdrawal by Subject|3|||
46923121|NCT02649634|83156502|FG001|Overall Study|Withdrawal by Subject|5|||
46923122|NCT02649634|83156501|FG000|Overall Study|Lost to Follow-up|0|||
46923123|NCT02649634|83156502|FG001|Overall Study|Lost to Follow-up|1|||
46923124|NCT01066143|83156508|FG000|Overall Study|ineligible for the study|8|||
46923125|NCT02980107|83156514|FG000|Overall Study|Withdrawal by Subject|51|||
46923126|NCT02980107|83156515|FG001|Overall Study|Withdrawal by Subject|62|||
46923127|NCT02652130|83156521|FG000|Overall Study|Death|1|||
46923128|NCT02979639|83156525|FG000|Overall Study|Withdrawal based on medical judgement|1|||
46923129|NCT02979639|83156525|FG000|Overall Study|Lost to Follow-up|8|||
46923130|NCT02979639|83156525|FG000|Overall Study|Withdrawal by Subject|3|||
46923131|NCT02979639|83156525|FG000|Overall Study|Adverse Event|2|||
46923132|NCT01674634|83156529|FG000|Overall Study|Withdrawal by Subject|3|||
46923133|NCT01674634|83156529|FG000|Overall Study|Lost to Follow-up|3|||
47051866|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
46746470|NCT02041195|82963576|FG007|Overall Study|Unable to comply with study visits|0|||
46923134|NCT02979249|83156537|FG000|Overall Study|Lost to Follow-up|2|||
46923135|NCT02979249|83156537|FG000|Overall Study|Withdrawal by Subject|4|||
46923136|NCT02112552|83156541|FG000|Overall Study|Withdrawal by Subject|1|||
46746471|NCT01583218|82963635|FG000|Overall Study|Withdrawal by Subject|43|||
46746472|NCT01583218|82963636|FG001|Overall Study|Withdrawal by Subject|29|||
46746473|NCT01583218|82963635|FG000|Overall Study|Death|206|||
46746474|NCT01583218|82963636|FG001|Overall Study|Death|211|||
46746475|NCT01583218|82963635|FG000|Overall Study|Lost to Follow-up|11|||
46923137|NCT02112552|83156541|FG000|Overall Study|Adverse Event|1|||
47051867|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
47051868|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
47051869|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
47051870|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
47051871|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
47051872|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
47051873|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
47051874|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
47051875|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
47051876|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
47051877|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
47051878|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
46746476|NCT01583218|82963636|FG001|Overall Study|Lost to Follow-up|17|||
46746477|NCT01583218|82963635|FG000|Overall Study|Adverse event or serious adverse event|3|||
46746478|NCT01583218|82963636|FG001|Overall Study|Adverse event or serious adverse event|3|||
46746479|NCT01583218|82963635|FG000|Overall Study|Patient /Family decision|3|||
46746480|NCT01583218|82963636|FG001|Overall Study|Patient /Family decision|0|||
46746481|NCT01583218|82963635|FG000|Overall Study|Cannot contact patient directly|1|||
46746482|NCT01583218|82963636|FG001|Overall Study|Cannot contact patient directly|2|||
46746483|NCT01583218|82963635|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
46746484|NCT01583218|82963636|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
46746485|NCT01583218|82963635|FG000|Overall Study|Patient did not wish to attend visits|0|||
46746486|NCT01583218|82963636|FG001|Overall Study|Patient did not wish to attend visits|1|||
46746487|NCT01583218|82963635|FG000|Overall Study|Patient randomized but not dosed|17|||
46746488|NCT01583218|82963636|FG001|Overall Study|Patient randomized but not dosed|16|||
46746489|NCT01583218|82963635|FG000|Overall Study|Patient was assessed via phone in person|1|||
46746490|NCT01583218|82963636|FG001|Overall Study|Patient was assessed via phone in person|0|||
46746491|NCT01583218|82963635|FG000|Overall Study|Patient deemed ineligible after random|2|||
46746492|NCT01583218|82963636|FG001|Overall Study|Patient deemed ineligible after random|0|||
46746493|NCT01583218|82963635|FG000|Overall Study|Patient was early terminated from study|0|||
46746494|NCT01583218|82963636|FG001|Overall Study|Patient was early terminated from study|1|||
46746495|NCT01583218|82963635|FG000|Overall Study|Patient was randomized due to mistake|1|||
46746496|NCT01583218|82963636|FG001|Overall Study|Patient was randomized due to mistake|0|||
46746497|NCT01583218|82963635|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
46746498|NCT01583218|82963636|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
46746499|NCT01583218|82963635|FG000|Overall Study|Withdraw of consent on day of random|1|||
46746500|NCT01583218|82963636|FG001|Overall Study|Withdraw of consent on day of random|0|||
46746501|NCT00742859|82963646|FG000|Overall Study|Adverse Event|5|||
46746502|NCT00742859|82963647|FG001|Overall Study|Adverse Event|6|||
46746503|NCT00742859|82963648|FG002|Overall Study|Adverse Event|3|||
46746504|NCT00742859|82963649|FG003|Overall Study|Adverse Event|1|||
46746505|NCT00742859|82963646|FG000|Overall Study|Death|1|||
46746506|NCT00742859|82963647|FG001|Overall Study|Death|0|||
46923138|NCT02976519|83156552|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
46923139|NCT02976519|83156553|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
47051879|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
47051880|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
47051881|NCT01872689|83317401|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
47051882|NCT01872689|83317402|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
47051883|NCT01872689|83317403|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
46746507|NCT00742859|82963648|FG002|Overall Study|Death|0|||
46746508|NCT00742859|82963649|FG003|Overall Study|Death|1|||
46746509|NCT00742859|82963646|FG000|Overall Study|Physician Decision|1|||
46746510|NCT00742859|82963647|FG001|Overall Study|Physician Decision|2|||
46746511|NCT00742859|82963648|FG002|Overall Study|Physician Decision|0|||
46746512|NCT00742859|82963649|FG003|Overall Study|Physician Decision|0|||
46746513|NCT00742859|82963646|FG000|Overall Study|Withdrawal by Subject|4|||
46746514|NCT00742859|82963647|FG001|Overall Study|Withdrawal by Subject|2|||
46746515|NCT00742859|82963648|FG002|Overall Study|Withdrawal by Subject|4|||
46746516|NCT00742859|82963649|FG003|Overall Study|Withdrawal by Subject|1|||
46746517|NCT00742859|82963646|FG000|Overall Study|Endpoint|0|||
46746518|NCT00742859|82963647|FG001|Overall Study|Endpoint|1|||
46746519|NCT00742859|82963648|FG002|Overall Study|Endpoint|1|||
46746520|NCT00742859|82963649|FG003|Overall Study|Endpoint|2|||
46746521|NCT00742859|82963646|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
46746522|NCT00742859|82963647|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
46923140|NCT02976519|83156554|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
46746523|NCT00742859|82963648|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
46923141|NCT02976519|83156555|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
47051884|NCT01872689|83317404|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
47051885|NCT01872689|83317401|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
47051886|NCT01872689|83317402|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
47051887|NCT01872689|83317403|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
47051888|NCT01872689|83317404|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
47051889|NCT01872689|83317401|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
47051890|NCT01872689|83317402|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
47051891|NCT01872689|83317403|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
47051892|NCT01872689|83317404|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
47051893|NCT01872689|83317401|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
47051894|NCT01872689|83317402|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
47051895|NCT01872689|83317403|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
47051896|NCT01872689|83317404|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
47051897|NCT01872689|83317401|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
47051898|NCT01872689|83317402|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
47051899|NCT01872689|83317403|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
47051900|NCT01872689|83317404|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
47051901|NCT01872689|83317401|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
47051902|NCT01872689|83317402|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
47051903|NCT01872689|83317403|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
47051904|NCT01872689|83317404|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
47051905|NCT01872689|83317401|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
47051906|NCT01872689|83317402|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
47051907|NCT01872689|83317403|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
47051908|NCT01872689|83317404|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
47051909|NCT00632931|83317417|FG000|Part 1, Period 1|Protocol Violation|1|||
47051910|NCT00632931|83317418|FG001|Part 1, Period 1|Protocol Violation|0|||
47051911|NCT00632931|83317419|FG002|Part 1, Period 1|Protocol Violation|0|||
47051912|NCT00632931|83317417|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
47051913|NCT00632931|83317418|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
47051914|NCT00632931|83317419|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
47051915|NCT00632931|83317417|FG000|Part 2|Adverse Event|0|||
47051916|NCT00632931|83317418|FG001|Part 2|Adverse Event|0|||
47051917|NCT00632931|83317419|FG002|Part 2|Adverse Event|3|||
47051918|NCT00632931|83317417|FG000|Part 2|Death|0|||
47051919|NCT00632931|83317418|FG001|Part 2|Death|0|||
46635507|NCT01582308|82809175|FG004|Period 4|Physician Decision|0|||
46746524|NCT00742859|82963649|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
46746525|NCT00742859|82963646|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
46746526|NCT00742859|82963647|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
46746527|NCT00742859|82963648|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
46746528|NCT00742859|82963649|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
46746529|NCT00742859|82963646|FG000|Overall Study|Sponsor request patient out of town|0|||
46746530|NCT00742859|82963647|FG001|Overall Study|Sponsor request patient out of town|0|||
46746531|NCT00742859|82963648|FG002|Overall Study|Sponsor request patient out of town|1|||
46746532|NCT00742859|82963649|FG003|Overall Study|Sponsor request patient out of town|1|||
46746533|NCT00742859|82963646|FG000|Overall Study|Site error|0|||
46746534|NCT00742859|82963647|FG001|Overall Study|Site error|0|||
46746535|NCT00742859|82963648|FG002|Overall Study|Site error|1|||
46923142|NCT02976519|83156556|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
46923143|NCT02976519|83156557|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
46923144|NCT02976519|83156558|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
46923145|NCT02976519|83156552|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
46923146|NCT02976519|83156553|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
46923147|NCT02976519|83156554|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
46923148|NCT02976519|83156555|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
46923149|NCT02976519|83156556|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
46923150|NCT02976519|83156557|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
46923151|NCT02976519|83156558|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
46923152|NCT02976519|83156552|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
46746536|NCT00742859|82963649|FG003|Overall Study|Site error|1|||
46923153|NCT02976519|83156553|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
46923154|NCT02976519|83156554|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
46923155|NCT02976519|83156555|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
47051920|NCT00632931|83317419|FG002|Part 2|Death|1|||
47051921|NCT00632931|83317417|FG000|Part 2|Lack of Efficacy|0|||
47051922|NCT00632931|83317418|FG001|Part 2|Lack of Efficacy|0|||
47051923|NCT00632931|83317419|FG002|Part 2|Lack of Efficacy|17|||
47051924|NCT00632931|83317417|FG000|Part 2|Withdrawal by Subject|0|||
47051925|NCT00632931|83317418|FG001|Part 2|Withdrawal by Subject|0|||
46746537|NCT00667342|82963662|FG000|Overall Study|Protocol Violation|1|||
46746538|NCT00667342|82963663|FG001|Overall Study|Protocol Violation|0|||
46746539|NCT00667342|82963664|FG002|Overall Study|Protocol Violation|0|||
46746540|NCT00667342|82963662|FG000|Overall Study|Withdrawal by Subject|1|||
46746541|NCT00667342|82963663|FG001|Overall Study|Withdrawal by Subject|0|||
46746542|NCT00667342|82963664|FG002|Overall Study|Withdrawal by Subject|0|||
46746543|NCT00667342|82963662|FG000|Overall Study|Physician Decision|3|||
46746544|NCT00667342|82963663|FG001|Overall Study|Physician Decision|0|||
46746545|NCT00667342|82963664|FG002|Overall Study|Physician Decision|0|||
46746546|NCT00667342|82963662|FG000|Overall Study|Relapse or tumor progression|9|||
46746547|NCT00667342|82963663|FG001|Overall Study|Relapse or tumor progression|0|||
46746548|NCT00667342|82963664|FG002|Overall Study|Relapse or tumor progression|7|||
46746549|NCT00667342|82963662|FG000|Overall Study|Adverse Event|0|||
46746550|NCT00667342|82963663|FG001|Overall Study|Adverse Event|0|||
46746551|NCT00667342|82963664|FG002|Overall Study|Adverse Event|1|||
46746552|NCT00667342|82963662|FG000|Overall Study|Ineligible|0|||
46746553|NCT00667342|82963663|FG001|Overall Study|Ineligible|0|||
46746554|NCT00667342|82963664|FG002|Overall Study|Ineligible|1|||
46746555|NCT00375609|82963681|FG000|Overall Study|Did not receive treatment|1|||
46746556|NCT00375609|82963682|FG001|Overall Study|Did not receive treatment|0|||
46746557|NCT00375609|82963683|FG002|Overall Study|Did not receive treatment|0|||
47051926|NCT00632931|83317419|FG002|Part 2|Withdrawal by Subject|3|||
47051927|NCT01857323|83317424|FG000|Overall Study|Adverse Event|1|||
47051928|NCT01857323|83317424|FG000|Overall Study|Withdrawal by Subject|3|||
47051929|NCT01857323|83317424|FG000|Overall Study|Non-compliance|1|||
47051930|NCT01857323|83317424|FG000|Overall Study|Protocol Violation|6|||
47051931|NCT01857323|83317424|FG000|Overall Study|Lost to Follow-up|1|||
47051932|NCT01857323|83317424|FG000|Overall Study|Other|4|||
47051933|NCT01857323|83317424|FG000|Overall Study|Did not complete 180 doses|48|||
47051934|NCT00632541|83317428|FG000|Overall Study|Adverse Event|7|||
47051935|NCT01872611|83317434|FG000|Overall Study|Adverse Event|3|||
46746558|NCT00375609|82963681|FG000|Overall Study|Adverse Event|0|||
46746559|NCT00375609|82963682|FG001|Overall Study|Adverse Event|3|||
46746560|NCT00375609|82963683|FG002|Overall Study|Adverse Event|0|||
47051936|NCT01872611|83317435|FG001|Overall Study|Adverse Event|1|||
47051937|NCT01872611|83317434|FG000|Overall Study|Adverse Event, prior to treatment|0|||
47051938|NCT01872611|83317435|FG001|Overall Study|Adverse Event, prior to treatment|1|||
47051939|NCT01872611|83317434|FG000|Overall Study|Death|0|||
47051940|NCT01872611|83317435|FG001|Overall Study|Death|1|||
47051941|NCT01872611|83317434|FG000|Overall Study|Death, prior to treatment|0|||
47051942|NCT01872611|83317435|FG001|Overall Study|Death, prior to treatment|1|||
47051943|NCT01872611|83317434|FG000|Overall Study|Lost to Follow-up|8|||
47051944|NCT01872611|83317435|FG001|Overall Study|Lost to Follow-up|1|||
47051945|NCT01872611|83317434|FG000|Overall Study|Physician Decision|1|||
47051946|NCT01872611|83317435|FG001|Overall Study|Physician Decision|0|||
47051947|NCT01872611|83317434|FG000|Overall Study|Withdrawal by Subject|6|||
47051948|NCT01872611|83317435|FG001|Overall Study|Withdrawal by Subject|1|||
47051949|NCT01872611|83317434|FG000|Overall Study|Reason not provided|6|||
47051950|NCT01872611|83317435|FG001|Overall Study|Reason not provided|6|||
47051951|NCT03089853|83317445|FG000|Overall Study|Lost to Follow-up|2|||
46804460|NCT00673049|83023494|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
46804461|NCT00673049|83023495|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
46746561|NCT00375609|82963681|FG000|Overall Study|Lost to Follow-up|1|||
46746562|NCT00375609|82963682|FG001|Overall Study|Lost to Follow-up|0|||
46746563|NCT00375609|82963683|FG002|Overall Study|Lost to Follow-up|0|||
46746564|NCT00375609|82963681|FG000|Overall Study|Physician Decision|0|||
47051952|NCT03089853|83317446|FG001|Overall Study|Lost to Follow-up|1|||
46746565|NCT00375609|82963682|FG001|Overall Study|Physician Decision|0|||
46746566|NCT00375609|82963683|FG002|Overall Study|Physician Decision|1|||
46804462|NCT00673049|83023492|FG000|Before Progression on Erlotinib|Other|1|||
46804463|NCT00673049|83023493|FG001|Before Progression on Erlotinib|Other|2|||
47051953|NCT03086967|83317454|FG000|Overall Study|Screen Failure|2|||
47051954|NCT03086967|83317455|FG001|Overall Study|Screen Failure|2|||
46746567|NCT00375609|82963681|FG000|Overall Study|Withdrawal by Subject|1|||
46746568|NCT00375609|82963682|FG001|Overall Study|Withdrawal by Subject|4|||
47051955|NCT01856543|83317463|FG000|Overall Study|Treatment discontinued|6|||
47051956|NCT01856543|83317464|FG001|Overall Study|Treatment discontinued|3|||
47051957|NCT01856543|83317463|FG000|Overall Study|Withdrawn before start|7|||
46804464|NCT00673049|83023494|FG002|Before Progression on Erlotinib|Other|0|||
46804465|NCT00673049|83023495|FG003|Before Progression on Erlotinib|Other|0|||
46804466|NCT00673049|83023492|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
46804467|NCT00673049|83023493|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
46804468|NCT00673049|83023494|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
46804469|NCT00673049|83023495|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
46804470|NCT00673049|83023492|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
46804471|NCT00673049|83023493|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
46804472|NCT00673049|83023494|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
46804473|NCT00673049|83023495|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
46804474|NCT00673049|83023492|FG000|After Progression on Erlotinib|Death|0|||
46804475|NCT00673049|83023493|FG001|After Progression on Erlotinib|Death|0|||
46804476|NCT00673049|83023494|FG002|After Progression on Erlotinib|Death|0|||
46804477|NCT00673049|83023495|FG003|After Progression on Erlotinib|Death|71|||
46804478|NCT00673049|83023492|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
46804479|NCT00673049|83023493|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
46804480|NCT00673049|83023494|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
46804481|NCT00673049|83023495|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
46804482|NCT00673049|83023492|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
46804483|NCT00673049|83023493|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
46804484|NCT00673049|83023494|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
47051958|NCT01856543|83317464|FG001|Overall Study|Withdrawn before start|3|||
46804485|NCT00673049|83023495|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
46804486|NCT00673049|83023492|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
46804487|NCT00673049|83023493|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
46804488|NCT00673049|83023494|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
46804489|NCT00673049|83023495|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
46804490|NCT00412750|83023506|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46804491|NCT00412750|83023507|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46804492|NCT00412750|83023508|FG002|Overall Study|Abnormal laboratory value(s)|0|||
47051959|NCT00632463|83317474|FG000|Overall Study|Adverse Event|0|||
47051960|NCT00632463|83317475|FG001|Overall Study|Adverse Event|1|||
47051961|NCT00632463|83317476|FG002|Overall Study|Adverse Event|0|||
47051962|NCT00632229|83317486|FG000|Overall Study|Adverse Event|6|||
46804493|NCT00412750|83023506|FG000|Overall Study|Administrative problems|21|||
46804494|NCT00412750|83023507|FG001|Overall Study|Administrative problems|17|||
46804495|NCT00412750|83023508|FG002|Overall Study|Administrative problems|14|||
46804496|NCT00412750|83023506|FG000|Overall Study|Adverse Event|8|||
46804497|NCT00412750|83023507|FG001|Overall Study|Adverse Event|3|||
46804498|NCT00412750|83023508|FG002|Overall Study|Adverse Event|3|||
46804499|NCT00412750|83023506|FG000|Overall Study|Lost to Follow-up|1|||
46804500|NCT00412750|83023507|FG001|Overall Study|Lost to Follow-up|0|||
46923156|NCT02976519|83156556|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
46923157|NCT02976519|83156557|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
46923158|NCT02976519|83156558|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
46923159|NCT02976519|83156552|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
46923160|NCT02976519|83156553|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
46923161|NCT02976519|83156554|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
46923162|NCT02976519|83156555|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
46746569|NCT00375609|82963683|FG002|Overall Study|Withdrawal by Subject|0|||
46746570|NCT00375609|82963681|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
46746571|NCT00375609|82963682|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
46746572|NCT00375609|82963683|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
46746573|NCT00960011|82963693|FG000|Overall Study|Death|5|||
46746574|NCT00960011|82963694|FG001|Overall Study|Death|0|||
46746575|NCT00960011|82963693|FG000|Overall Study|Lost to Follow-up|6|||
46746576|NCT00960011|82963694|FG001|Overall Study|Lost to Follow-up|2|||
46746577|NCT00617851|82963738|FG000|Overall Study|Death|0|||
46746578|NCT00617851|82963739|FG001|Overall Study|Death|0|||
46746579|NCT00617851|82963740|FG002|Overall Study|Death|0|||
46804501|NCT00412750|83023508|FG002|Overall Study|Lost to Follow-up|1|||
46804502|NCT00412750|83023506|FG000|Overall Study|Withdrawal by Subject|0|||
46804503|NCT00412750|83023507|FG001|Overall Study|Withdrawal by Subject|1|||
46804504|NCT00412750|83023508|FG002|Overall Study|Withdrawal by Subject|2|||
46804505|NCT00412750|83023506|FG000|Overall Study|Lack of Efficacy|0|||
46804506|NCT00412750|83023507|FG001|Overall Study|Lack of Efficacy|0|||
46804507|NCT00412750|83023508|FG002|Overall Study|Lack of Efficacy|3|||
46804508|NCT00076999|83023522|FG000|Overall Study|Adverse Event|2|||
46804509|NCT00076999|83023523|FG001|Overall Study|Adverse Event|8|||
46923163|NCT02976519|83156556|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
46746580|NCT00617851|82963741|FG003|Overall Study|Death|1|||
47051963|NCT00632229|83317487|FG001|Overall Study|Adverse Event|0|||
47051964|NCT00632229|83317486|FG000|Overall Study|Lost to Follow-up|0|||
46804510|NCT00076999|83023524|FG002|Overall Study|Adverse Event|6|||
46804511|NCT00076999|83023525|FG003|Overall Study|Adverse Event|0|||
46804512|NCT00076999|83023526|FG004|Overall Study|Adverse Event|2|||
46804513|NCT00076999|83023522|FG000|Overall Study|Protocol Violation|0|||
46804514|NCT00076999|83023523|FG001|Overall Study|Protocol Violation|3|||
46804515|NCT00076999|83023524|FG002|Overall Study|Protocol Violation|4|||
46804516|NCT00076999|83023525|FG003|Overall Study|Protocol Violation|0|||
46804517|NCT00076999|83023526|FG004|Overall Study|Protocol Violation|9|||
46804518|NCT00076999|83023522|FG000|Overall Study|Lost to Follow-up|2|||
46804519|NCT00076999|83023523|FG001|Overall Study|Lost to Follow-up|1|||
46804520|NCT00076999|83023524|FG002|Overall Study|Lost to Follow-up|0|||
46804521|NCT00076999|83023525|FG003|Overall Study|Lost to Follow-up|0|||
46804522|NCT00076999|83023526|FG004|Overall Study|Lost to Follow-up|0|||
46804523|NCT00076999|83023522|FG000|Overall Study|Withdrawal by Subject|0|||
46804524|NCT00076999|83023523|FG001|Overall Study|Withdrawal by Subject|4|||
46804525|NCT00076999|83023524|FG002|Overall Study|Withdrawal by Subject|3|||
46804526|NCT00076999|83023525|FG003|Overall Study|Withdrawal by Subject|0|||
46804527|NCT00076999|83023526|FG004|Overall Study|Withdrawal by Subject|1|||
47051965|NCT00632229|83317487|FG001|Overall Study|Lost to Follow-up|3|||
46804528|NCT00076999|83023522|FG000|Overall Study|Other reason (not specified)|8|||
46804529|NCT00076999|83023523|FG001|Overall Study|Other reason (not specified)|8|||
46804530|NCT00076999|83023524|FG002|Overall Study|Other reason (not specified)|4|||
46804531|NCT00076999|83023525|FG003|Overall Study|Other reason (not specified)|1|||
46804532|NCT00076999|83023526|FG004|Overall Study|Other reason (not specified)|13|||
46804533|NCT03905096|83023541|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
46804534|NCT03905096|83023542|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
46804535|NCT00412360|83023557|FG000|Overall Study|Lost to Follow-up|0|||
46804536|NCT00412360|83023558|FG001|Overall Study|Lost to Follow-up|1|||
46804537|NCT00412360|83023557|FG000|Overall Study|Not Transplanted|1|||
46804538|NCT00412360|83023558|FG001|Overall Study|Not Transplanted|2|||
46804539|NCT00571103|83023564|FG000|Overall Study|Withdrawal by Subject|1|||
46804540|NCT00571103|83023564|FG000|Overall Study|Lost to Follow-up|1|||
46804541|NCT00069277|83023568|FG000|Overall Study|Adverse Event|3|||
46804542|NCT00069277|83023568|FG000|Overall Study|Withdrawal by Subject|1|||
46804543|NCT00069277|83023568|FG000|Overall Study|Progressive Disease|15|||
46804544|NCT00069277|83023568|FG000|Overall Study|Physician Decision|2|||
47051966|NCT00632229|83317486|FG000|Overall Study|Lack of Efficacy|0|||
47051967|NCT00632229|83317487|FG001|Overall Study|Lack of Efficacy|2|||
47051968|NCT00632229|83317486|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
47051969|NCT00632229|83317487|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
47051970|NCT00631137|83317495|FG000|Overall Study|Withdrawal by Subject|1|||
47051971|NCT00631137|83317496|FG001|Overall Study|Withdrawal by Subject|0|||
47051972|NCT00630825|83317515|FG000|Overall Study|Adverse Event|4|||
47051973|NCT00630825|83317516|FG001|Overall Study|Adverse Event|4|||
47051974|NCT00630825|83317517|FG002|Overall Study|Adverse Event|3|||
47051975|NCT00630825|83317518|FG003|Overall Study|Adverse Event|1|||
47051976|NCT00630825|83317515|FG000|Overall Study|Entry Criteria Not Met|1|||
47051977|NCT00630825|83317516|FG001|Overall Study|Entry Criteria Not Met|0|||
47051978|NCT00630825|83317517|FG002|Overall Study|Entry Criteria Not Met|2|||
46746581|NCT00617851|82963738|FG000|Overall Study|Withdrawal by Subject|14|||
46746582|NCT00617851|82963739|FG001|Overall Study|Withdrawal by Subject|7|||
46746583|NCT00617851|82963740|FG002|Overall Study|Withdrawal by Subject|12|||
46746584|NCT00617851|82963741|FG003|Overall Study|Withdrawal by Subject|4|||
46746585|NCT00617851|82963738|FG000|Overall Study|Lost to Follow-up|27|||
46746586|NCT00617851|82963739|FG001|Overall Study|Lost to Follow-up|29|||
46746587|NCT00617851|82963740|FG002|Overall Study|Lost to Follow-up|31|||
46746588|NCT00617851|82963741|FG003|Overall Study|Lost to Follow-up|19|||
46746589|NCT00617851|82963738|FG000|Overall Study|Inappropriate Enrollment|5|||
46746590|NCT00617851|82963739|FG001|Overall Study|Inappropriate Enrollment|4|||
46746591|NCT00617851|82963740|FG002|Overall Study|Inappropriate Enrollment|1|||
46804545|NCT00418522|83023574|FG000|Overall Study|Adverse Event|7|||
46804546|NCT00418522|83023575|FG001|Overall Study|Adverse Event|1|||
46804547|NCT00418522|83023574|FG000|Overall Study|Lack of Efficacy|1|||
46804548|NCT00418522|83023575|FG001|Overall Study|Lack of Efficacy|3|||
46804549|NCT00418522|83023574|FG000|Overall Study|Lost to Follow-up|10|||
46804550|NCT00418522|83023575|FG001|Overall Study|Lost to Follow-up|4|||
46804551|NCT00418522|83023574|FG000|Overall Study|Withdrawal by Subject|31|||
46804552|NCT00418522|83023575|FG001|Overall Study|Withdrawal by Subject|7|||
46804553|NCT00418522|83023574|FG000|Overall Study|Other|27|||
46804554|NCT00418522|83023575|FG001|Overall Study|Other|23|||
47051979|NCT00630825|83317518|FG003|Overall Study|Entry Criteria Not Met|1|||
47051980|NCT00630825|83317515|FG000|Overall Study|Lost to Follow-up|1|||
46746592|NCT00617851|82963741|FG003|Overall Study|Inappropriate Enrollment|1|||
46804555|NCT00418522|83023574|FG000|Overall Study|Randomized but did not receive treatment|7|||
46804556|NCT00418522|83023575|FG001|Overall Study|Randomized but did not receive treatment|4|||
46804557|NCT00403546|83023583|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
46804558|NCT00403546|83023584|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
46746593|NCT00617851|82963738|FG000|Overall Study|Unable to classify|1|||
46746594|NCT00617851|82963739|FG001|Overall Study|Unable to classify|0|||
46746595|NCT00617851|82963740|FG002|Overall Study|Unable to classify|1|||
46746596|NCT00617851|82963741|FG003|Overall Study|Unable to classify|0|||
46746597|NCT00812955|82963765|FG000|Overall Study|Adverse Event|7|||
46746598|NCT00812955|82963766|FG001|Overall Study|Adverse Event|6|||
46746599|NCT00812955|82963767|FG002|Overall Study|Adverse Event|3|||
46746600|NCT00812955|82963768|FG003|Overall Study|Adverse Event|4|||
46746601|NCT00812955|82963765|FG000|Overall Study|Lost to Follow-up|2|||
46804559|NCT00403546|83023585|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
46804560|NCT00403546|83023583|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
46746602|NCT00812955|82963766|FG001|Overall Study|Lost to Follow-up|1|||
46746603|NCT00812955|82963767|FG002|Overall Study|Lost to Follow-up|1|||
46746604|NCT00812955|82963768|FG003|Overall Study|Lost to Follow-up|2|||
46746605|NCT00812955|82963765|FG000|Overall Study|Withdrawal by Subject|1|||
46804561|NCT00403546|83023584|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
46804562|NCT00403546|83023585|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
46746606|NCT00812955|82963766|FG001|Overall Study|Withdrawal by Subject|0|||
46746607|NCT00812955|82963767|FG002|Overall Study|Withdrawal by Subject|1|||
46804563|NCT00403546|83023583|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
46804564|NCT00403546|83023584|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
46746608|NCT00812955|82963768|FG003|Overall Study|Withdrawal by Subject|2|||
46746609|NCT00812955|82963765|FG000|Overall Study|randomized in error|0|||
46746610|NCT00812955|82963766|FG001|Overall Study|randomized in error|0|||
46746611|NCT00812955|82963767|FG002|Overall Study|randomized in error|1|||
46746612|NCT00812955|82963768|FG003|Overall Study|randomized in error|0|||
46804565|NCT00403546|83023585|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
46635508|NCT01582308|82809176|FG005|Period 4|Physician Decision|1|||
46746613|NCT00619489|82963784|FG000|Overall Study|Adverse Event|0|||
46746614|NCT00619489|82963785|FG001|Overall Study|Adverse Event|7|||
46746615|NCT00619489|82963784|FG000|Overall Study|Withdrawal by Subject|1|||
46746616|NCT00619489|82963785|FG001|Overall Study|Withdrawal by Subject|1|||
46746617|NCT00619489|82963784|FG000|Overall Study|Lack of Efficacy|0|||
46746618|NCT00619489|82963785|FG001|Overall Study|Lack of Efficacy|11|||
46746619|NCT00619489|82963784|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
46746620|NCT00619489|82963785|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
46746621|NCT00959699|82963793|FG000|Treatment Period|Adverse Event|3|||
46746622|NCT00959699|82963794|FG001|Treatment Period|Adverse Event|13|||
46746623|NCT00959699|82963793|FG000|Treatment Period|Lack of Efficacy|15|||
46746624|NCT00959699|82963794|FG001|Treatment Period|Lack of Efficacy|6|||
46746625|NCT00959699|82963793|FG000|Treatment Period|Lost to Follow-up|0|||
46746626|NCT00959699|82963794|FG001|Treatment Period|Lost to Follow-up|1|||
46746627|NCT00959699|82963793|FG000|Treatment Period|Withdrawal by Subject|1|||
46746628|NCT00959699|82963794|FG001|Treatment Period|Withdrawal by Subject|3|||
46746629|NCT00959699|82963793|FG000|Treatment Period|Non-Compliance with Protocol|0|||
46746630|NCT00959699|82963794|FG001|Treatment Period|Non-Compliance with Protocol|1|||
46746631|NCT00959699|82963793|FG000|Treatment Period|Did not receive treatment|0|||
46746632|NCT00959699|82963794|FG001|Treatment Period|Did not receive treatment|1|||
46746633|NCT00959699|82963793|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
46746634|NCT00959699|82963794|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
46746635|NCT00959699|82963793|FG000|Follow-up Period|Lost to Follow-up|3|||
46746636|NCT00959699|82963794|FG001|Follow-up Period|Lost to Follow-up|2|||
46746637|NCT00959699|82963793|FG000|Follow-up Period|Withdrawal by Subject|3|||
46746638|NCT00959699|82963794|FG001|Follow-up Period|Withdrawal by Subject|4|||
46746639|NCT00617773|82963801|FG000|Overall Study|Physician Decision|1|||
46746640|NCT00617773|82963801|FG000|Overall Study|Lack of compliance with the protocol|1|||
46746641|NCT00617773|82963801|FG000|Overall Study|Withdrawal by Subject|1|||
46923164|NCT02976519|83156557|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
46923165|NCT02976519|83156558|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
46923166|NCT02976519|83156552|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
46923167|NCT02976519|83156553|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
46923168|NCT02976519|83156554|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
46804566|NCT00403546|83023583|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
46923169|NCT02976519|83156555|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
46746642|NCT00617773|82963801|FG000|Overall Study|Death|1|||
46746643|NCT00617773|82963801|FG000|Overall Study|Progressive disease|19|||
46746644|NCT00617773|82963801|FG000|Overall Study|Protocol Violation|1|||
47051981|NCT00630825|83317516|FG001|Overall Study|Lost to Follow-up|1|||
46635509|NCT01582308|82809177|FG006|Period 4|Physician Decision|0|||
46746645|NCT00956813|82963807|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
46746646|NCT00956813|82963808|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
46746647|NCT00956813|82963807|FG000|Flaxseed and Placebo|Ineligible|3|||
46746648|NCT00956813|82963808|FG001|Flaxseed and Placebo|Ineligible|1|||
46746649|NCT00955955|82963818|FG000|Overall Study|Lost to Follow-up|2|||
46746650|NCT00955955|82963819|FG001|Overall Study|Lost to Follow-up|0|||
46746651|NCT00955955|82963820|FG002|Overall Study|Lost to Follow-up|0|||
46746652|NCT00955721|82963836|FG000|Overall Study|Physician Decision|1|||
46746653|NCT00955721|82963837|FG001|Overall Study|Physician Decision|0|||
46746654|NCT00955721|82963836|FG000|Overall Study|Death|1|||
46746655|NCT00955721|82963837|FG001|Overall Study|Death|0|||
46746656|NCT00955721|82963836|FG000|Overall Study|Withdrawal by Subject|1|||
46746657|NCT00955721|82963837|FG001|Overall Study|Withdrawal by Subject|0|||
46804567|NCT00403546|83023584|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
46746658|NCT00573469|82963847|FG000|Overall Study|Adverse Event|1|||
46746659|NCT00573469|82963848|FG001|Overall Study|Adverse Event|1|||
46746660|NCT00573469|82963849|FG002|Overall Study|Adverse Event|1|||
46746661|NCT00573469|82963847|FG000|Overall Study|Withdrawal by Subject|0|||
46746662|NCT00573469|82963848|FG001|Overall Study|Withdrawal by Subject|2|||
46746663|NCT00573469|82963849|FG002|Overall Study|Withdrawal by Subject|0|||
46746664|NCT00573469|82963847|FG000|Overall Study|Other|5|||
46746665|NCT00573469|82963848|FG001|Overall Study|Other|1|||
46746666|NCT00573469|82963849|FG002|Overall Study|Other|3|||
46746667|NCT00812565|82963865|FG000|Overall Study|Did Not Receive Study Medication|1|||
46746668|NCT00812565|82963866|FG001|Overall Study|Did Not Receive Study Medication|1|||
46746669|NCT00812565|82963867|FG002|Overall Study|Did Not Receive Study Medication|0|||
46746670|NCT00812565|82963868|FG003|Overall Study|Did Not Receive Study Medication|0|||
46804568|NCT00403546|83023585|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
46804569|NCT00403546|83023583|FG000|Screening Phase|Screening Failure|22|||
46804570|NCT00403546|83023584|FG001|Screening Phase|Screening Failure|0|||
46804571|NCT00403546|83023585|FG002|Screening Phase|Screening Failure|0|||
46804572|NCT00403546|83023583|FG000|Screening Phase|Adverse Event|1|||
46804573|NCT00403546|83023584|FG001|Screening Phase|Adverse Event|0|||
46804574|NCT00403546|83023585|FG002|Screening Phase|Adverse Event|0|||
46804575|NCT00403546|83023583|FG000|Screening Phase|Terminated Prior to Randomization|5|||
46804576|NCT00403546|83023584|FG001|Screening Phase|Terminated Prior to Randomization|0|||
46804577|NCT00403546|83023585|FG002|Screening Phase|Terminated Prior to Randomization|0|||
46804578|NCT00403546|83023583|FG000|Randomized Trial|Early Terminations|0|||
46804579|NCT00403546|83023584|FG001|Randomized Trial|Early Terminations|17|||
46804580|NCT00403546|83023585|FG002|Randomized Trial|Early Terminations|16|||
46804581|NCT00403390|83023596|FG000|Overall Study|Withdrawal by Subject|1|||
46804582|NCT00403390|83023597|FG001|Overall Study|Withdrawal by Subject|0|||
46804583|NCT00403390|83023596|FG000|Overall Study|samples lost|1|||
46804584|NCT00403390|83023597|FG001|Overall Study|samples lost|0|||
46804585|NCT00403390|83023596|FG000|Overall Study|non-compliant|1|||
46804586|NCT00403390|83023597|FG001|Overall Study|non-compliant|0|||
46804587|NCT00403234|83023607|FG000|Overall Study|Withdrawal by Subject|0|||
46804588|NCT00403234|83023608|FG001|Overall Study|Withdrawal by Subject|1|||
46804589|NCT00403234|83023609|FG002|Overall Study|Withdrawal by Subject|0|||
46804590|NCT00403234|83023610|FG003|Overall Study|Withdrawal by Subject|0|||
46804591|NCT00403234|83023607|FG000|Overall Study|Adverse Event|1|||
46804592|NCT00403234|83023608|FG001|Overall Study|Adverse Event|0|||
46804593|NCT00403234|83023609|FG002|Overall Study|Adverse Event|1|||
46804594|NCT00403234|83023610|FG003|Overall Study|Adverse Event|0|||
46804595|NCT00402688|83023623|FG000|Overall Study|Adverse Event|12|||
46804596|NCT00402688|83023624|FG001|Overall Study|Adverse Event|9|||
46804597|NCT00402688|83023625|FG002|Overall Study|Adverse Event|3|||
46804598|NCT00402688|83023623|FG000|Overall Study|Withdrawal by Subject|3|||
46804599|NCT00402688|83023624|FG001|Overall Study|Withdrawal by Subject|1|||
46804600|NCT00402688|83023625|FG002|Overall Study|Withdrawal by Subject|1|||
46804601|NCT00402688|83023623|FG000|Overall Study|Physician Decision|0|||
46804602|NCT00402688|83023624|FG001|Overall Study|Physician Decision|0|||
46804603|NCT00402688|83023625|FG002|Overall Study|Physician Decision|1|||
46804604|NCT00402688|83023623|FG000|Overall Study|Lack of Efficacy|4|||
46804605|NCT00402688|83023624|FG001|Overall Study|Lack of Efficacy|4|||
46804606|NCT00402688|83023625|FG002|Overall Study|Lack of Efficacy|5|||
46804607|NCT00402688|83023623|FG000|Overall Study|Protocol Violation|1|||
46804608|NCT00402688|83023624|FG001|Overall Study|Protocol Violation|1|||
46746671|NCT00812565|82963869|FG004|Overall Study|Did Not Receive Study Medication|0|||
46746672|NCT00812565|82963870|FG005|Overall Study|Did Not Receive Study Medication|0|||
46804609|NCT00402688|83023625|FG002|Overall Study|Protocol Violation|1|||
46804610|NCT00402688|83023623|FG000|Overall Study|Lost to Follow-up|1|||
46746673|NCT00812565|82963871|FG006|Overall Study|Did Not Receive Study Medication|0|||
46746674|NCT00812565|82963872|FG007|Overall Study|Did Not Receive Study Medication|0|||
46746675|NCT00812565|82963865|FG000|Overall Study|Adverse Event|0|||
46746676|NCT00812565|82963866|FG001|Overall Study|Adverse Event|0|||
46804611|NCT00402688|83023624|FG001|Overall Study|Lost to Follow-up|0|||
46804612|NCT00402688|83023625|FG002|Overall Study|Lost to Follow-up|2|||
46804613|NCT00402688|83023623|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
46804614|NCT00402688|83023624|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
46746677|NCT00812565|82963867|FG002|Overall Study|Adverse Event|0|||
46746678|NCT00812565|82963868|FG003|Overall Study|Adverse Event|2|||
46746679|NCT00812565|82963869|FG004|Overall Study|Adverse Event|0|||
47051982|NCT00630825|83317517|FG002|Overall Study|Lost to Follow-up|1|||
46746680|NCT00812565|82963870|FG005|Overall Study|Adverse Event|0|||
46746681|NCT00812565|82963871|FG006|Overall Study|Adverse Event|0|||
46746682|NCT00812565|82963872|FG007|Overall Study|Adverse Event|1|||
46746683|NCT00812565|82963865|FG000|Overall Study|Did Not Come to Study Visit|1|||
46746684|NCT00812565|82963866|FG001|Overall Study|Did Not Come to Study Visit|0|||
46746685|NCT00812565|82963867|FG002|Overall Study|Did Not Come to Study Visit|0|||
46746686|NCT00812565|82963868|FG003|Overall Study|Did Not Come to Study Visit|0|||
46746687|NCT00812565|82963869|FG004|Overall Study|Did Not Come to Study Visit|0|||
46746688|NCT00812565|82963870|FG005|Overall Study|Did Not Come to Study Visit|0|||
46746689|NCT00812565|82963871|FG006|Overall Study|Did Not Come to Study Visit|0|||
46746690|NCT00812565|82963872|FG007|Overall Study|Did Not Come to Study Visit|0|||
46746691|NCT00812565|82963865|FG000|Overall Study|Withdrawal of Consent|1|||
46746692|NCT00812565|82963866|FG001|Overall Study|Withdrawal of Consent|0|||
46746693|NCT00812565|82963867|FG002|Overall Study|Withdrawal of Consent|0|||
46746694|NCT00812565|82963868|FG003|Overall Study|Withdrawal of Consent|0|||
46746695|NCT00812565|82963869|FG004|Overall Study|Withdrawal of Consent|1|||
46746696|NCT00812565|82963870|FG005|Overall Study|Withdrawal of Consent|0|||
46746697|NCT00812565|82963871|FG006|Overall Study|Withdrawal of Consent|0|||
46746698|NCT00812565|82963872|FG007|Overall Study|Withdrawal of Consent|0|||
46746699|NCT00812565|82963865|FG000|Overall Study|Reason Not Specified|0|||
46746700|NCT00812565|82963866|FG001|Overall Study|Reason Not Specified|0|||
46746701|NCT00812565|82963867|FG002|Overall Study|Reason Not Specified|0|||
46746702|NCT00812565|82963868|FG003|Overall Study|Reason Not Specified|0|||
46746703|NCT00812565|82963869|FG004|Overall Study|Reason Not Specified|0|||
46746704|NCT00812565|82963870|FG005|Overall Study|Reason Not Specified|1|||
46746705|NCT00812565|82963871|FG006|Overall Study|Reason Not Specified|0|||
46746706|NCT00812565|82963872|FG007|Overall Study|Reason Not Specified|0|||
46746707|NCT00812487|82963892|FG000|Overall Study|Lost to Follow-up|2|||
46746708|NCT00812487|82963893|FG001|Overall Study|Lost to Follow-up|0|||
46746709|NCT00812487|82963892|FG000|Overall Study|Withdrawal by Subject|3|||
46746710|NCT00812487|82963893|FG001|Overall Study|Withdrawal by Subject|2|||
46746711|NCT00812487|82963892|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
46923170|NCT02976519|83156556|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
46923171|NCT02976519|83156557|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
46923172|NCT02976519|83156558|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
46923173|NCT02975973|83156663|FG000|Overall Study|Adverse Event|1|||
46746712|NCT00812487|82963893|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
46746713|NCT00812487|82963892|FG000|Overall Study|Protocol Violation|0|||
46746714|NCT00812487|82963893|FG001|Overall Study|Protocol Violation|1|||
46746715|NCT00617461|82963903|FG000|First Treatment Intervention Period|Adverse Event|2|||
46746716|NCT00617461|82963904|FG001|First Treatment Intervention Period|Adverse Event|0|||
46746717|NCT00617461|82963903|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
46746718|NCT00617461|82963904|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
46746719|NCT00617461|82963903|FG000|First Treatment Intervention Period|Protocol Violation|2|||
46746720|NCT00617461|82963904|FG001|First Treatment Intervention Period|Protocol Violation|1|||
46746721|NCT00617461|82963903|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
46746722|NCT00617461|82963904|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
46746723|NCT00617461|82963903|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
46746724|NCT00617461|82963904|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
46746725|NCT00617461|82963903|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
46746726|NCT00617461|82963904|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
46746727|NCT00617461|82963903|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
46746728|NCT00617461|82963904|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
46746729|NCT00617461|82963903|FG000|Second Treatment Intervention Period|Adverse Event|0|||
46746730|NCT00617461|82963904|FG001|Second Treatment Intervention Period|Adverse Event|1|||
46746731|NCT00617461|82963903|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
46746732|NCT00617461|82963904|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
46746733|NCT00617461|82963903|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
46746734|NCT00617461|82963904|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
46746735|NCT00617461|82963903|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
46746736|NCT00617461|82963904|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
46746737|NCT00812331|82963931|FG000|Overall Study|Adverse Event|1|||
46923174|NCT02975973|83156664|FG001|Overall Study|Adverse Event|1|||
46746738|NCT00812331|82963932|FG001|Overall Study|Adverse Event|0|||
46746739|NCT00812331|82963933|FG002|Overall Study|Adverse Event|0|||
46746740|NCT00812331|82963934|FG003|Overall Study|Adverse Event|0|||
46746741|NCT00812331|82963935|FG004|Overall Study|Adverse Event|0|||
46746742|NCT00812253|82963945|FG000|Overall Study|Withdrawal by Subject|3|||
46746743|NCT00812253|82963946|FG001|Overall Study|Withdrawal by Subject|2|||
46746744|NCT00812253|82963945|FG000|Overall Study|Protocol Violation|1|||
46746745|NCT00812253|82963946|FG001|Overall Study|Protocol Violation|1|||
46746746|NCT00812253|82963945|FG000|Overall Study|Lost to Follow-up|2|||
46746747|NCT00812253|82963946|FG001|Overall Study|Lost to Follow-up|0|||
46746748|NCT00616759|82963954|FG000|Overall Study|Physician Decision|2|||
46746749|NCT00616759|82963955|FG001|Overall Study|Physician Decision|0|||
46804615|NCT00402688|83023625|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
46746750|NCT00616759|82963954|FG000|Overall Study|Withdrawal by Subject|1|||
46746751|NCT00616759|82963955|FG001|Overall Study|Withdrawal by Subject|2|||
46746752|NCT00812097|82963965|FG000|Overall Study|Death|3|||
46746753|NCT00812097|82963966|FG001|Overall Study|Death|10|||
46746754|NCT00812097|82963967|FG002|Overall Study|Death|3|||
46804616|NCT00402688|83023623|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
46804617|NCT00402688|83023624|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
46804618|NCT00402688|83023625|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
46804619|NCT00402688|83023623|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
46804620|NCT00402688|83023624|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
46804621|NCT00402688|83023625|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
46804622|NCT00671879|83023636|FG000|Overall Study|Withdrawal by Subject|0|||
46804623|NCT00671879|83023637|FG001|Overall Study|Withdrawal by Subject|4|||
46804624|NCT00671879|83023638|FG002|Overall Study|Withdrawal by Subject|6|||
46804625|NCT00401830|83023649|FG000|Overall Study|Adverse Event|10|||
46804626|NCT00401830|83023650|FG001|Overall Study|Adverse Event|18|||
46804627|NCT00401830|83023649|FG000|Overall Study|Lack of Efficacy|11|||
46804628|NCT00401830|83023650|FG001|Overall Study|Lack of Efficacy|5|||
46804629|NCT00401830|83023649|FG000|Overall Study|Withdrawal by Subject|4|||
46804630|NCT00401830|83023650|FG001|Overall Study|Withdrawal by Subject|3|||
46804631|NCT00401830|83023649|FG000|Overall Study|Protocol Violation|3|||
46804632|NCT00401830|83023650|FG001|Overall Study|Protocol Violation|3|||
46804633|NCT00401830|83023649|FG000|Overall Study|Non-compliance with drug study|1|||
46804634|NCT00401830|83023650|FG001|Overall Study|Non-compliance with drug study|0|||
46923175|NCT02975973|83156665|FG002|Overall Study|Adverse Event|1|||
46923176|NCT02975973|83156666|FG003|Overall Study|Adverse Event|0|||
46923177|NCT01362322|83156678|FG000|Overall Study|Withdrawal by Subject|3|||
46923178|NCT01362322|83156679|FG001|Overall Study|Withdrawal by Subject|1|||
46923179|NCT01362322|83156678|FG000|Overall Study|Lost to Follow-up|2|||
46923180|NCT01362322|83156679|FG001|Overall Study|Lost to Follow-up|6|||
46923181|NCT02918877|83156687|FG000|Overall Study|Withdrawal by Subject|2|||
46923182|NCT02918877|83156688|FG001|Overall Study|Withdrawal by Subject|2|||
46923183|NCT02918877|83156687|FG000|Overall Study|Surgery cancelled|1|||
46923184|NCT02918877|83156688|FG001|Overall Study|Surgery cancelled|0|||
46923185|NCT02918877|83156687|FG000|Overall Study|Physician Decision|1|||
46923186|NCT02918877|83156688|FG001|Overall Study|Physician Decision|0|||
46923187|NCT02918877|83156687|FG000|Overall Study|Received intraoperative steroids|1|||
46923188|NCT02918877|83156688|FG001|Overall Study|Received intraoperative steroids|0|||
46746755|NCT00812097|82963968|FG003|Overall Study|Death|3|||
46746756|NCT00812097|82963965|FG000|Overall Study|Withdrawal by Subject|14|||
46746757|NCT00812097|82963966|FG001|Overall Study|Withdrawal by Subject|12|||
46746758|NCT00812097|82963967|FG002|Overall Study|Withdrawal by Subject|8|||
46746759|NCT00812097|82963968|FG003|Overall Study|Withdrawal by Subject|2|||
46746760|NCT00812097|82963965|FG000|Overall Study|Lost to Follow-up|90|||
46746761|NCT00812097|82963966|FG001|Overall Study|Lost to Follow-up|14|||
46746762|NCT00812097|82963967|FG002|Overall Study|Lost to Follow-up|17|||
46746763|NCT00812097|82963968|FG003|Overall Study|Lost to Follow-up|5|||
46923189|NCT02918877|83156687|FG000|Overall Study|Unable to obtain lab samples|1|||
46923190|NCT02918877|83156688|FG001|Overall Study|Unable to obtain lab samples|0|||
46923191|NCT02918877|83156687|FG000|Overall Study|Unsafe to perform BAL|0|||
46923192|NCT02918877|83156688|FG001|Overall Study|Unsafe to perform BAL|1|||
46923193|NCT01674712|83156699|FG000|Overall Study|Adverse Event|5|||
46923194|NCT01674712|83156700|FG001|Overall Study|Adverse Event|6|||
46923195|NCT01674712|83156701|FG002|Overall Study|Adverse Event|3|||
46746764|NCT00812097|82963965|FG000|Overall Study|Explantation of study device(s)|27|||
46746765|NCT00812097|82963966|FG001|Overall Study|Explantation of study device(s)|29|||
46804635|NCT00401830|83023649|FG000|Overall Study|Lost to Follow-up|1|||
46923196|NCT01674712|83156702|FG003|Overall Study|Adverse Event|4|||
46746766|NCT00812097|82963967|FG002|Overall Study|Explantation of study device(s)|14|||
46746767|NCT00812097|82963968|FG003|Overall Study|Explantation of study device(s)|20|||
46746768|NCT00812097|82963965|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
46746769|NCT00812097|82963966|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
46746770|NCT00812097|82963967|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
46746771|NCT00812097|82963968|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
46923197|NCT01674712|83156703|FG004|Overall Study|Adverse Event|6|||
46923198|NCT01674712|83156699|FG000|Overall Study|Lost to Follow-up|1|||
46746772|NCT00811941|82963980|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
46746773|NCT00811941|82963981|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
46746774|NCT00811941|82963980|FG000|All Treated Patients|Adverse Event|2|||
46746775|NCT00811941|82963981|FG001|All Treated Patients|Adverse Event|43|||
46746776|NCT00811941|82963980|FG000|All Treated Patients|Lack of Efficacy|2|||
46923199|NCT01674712|83156700|FG001|Overall Study|Lost to Follow-up|0|||
46746777|NCT00811941|82963981|FG001|All Treated Patients|Lack of Efficacy|3|||
46746778|NCT00811941|82963980|FG000|All Treated Patients|Non-compliance|1|||
46746779|NCT00811941|82963981|FG001|All Treated Patients|Non-compliance|8|||
46746780|NCT00811941|82963980|FG000|All Treated Patients|Protocol Violation|5|||
46746781|NCT00811941|82963981|FG001|All Treated Patients|Protocol Violation|17|||
46746782|NCT00811941|82963980|FG000|All Treated Patients|Withdrawal by Subject|35|||
46746783|NCT00811941|82963981|FG001|All Treated Patients|Withdrawal by Subject|94|||
46746784|NCT00811941|82963980|FG000|All Treated Patients|Lost to Follow-up|3|||
46746785|NCT00811941|82963981|FG001|All Treated Patients|Lost to Follow-up|12|||
46746786|NCT00811941|82963980|FG000|All Treated Patients|Other Reason|4|||
46746787|NCT00811941|82963981|FG001|All Treated Patients|Other Reason|14|||
46746788|NCT00811473|82963989|FG000|Overall Study|Adverse Event|3|||
46746789|NCT00811473|82963990|FG001|Overall Study|Adverse Event|12|||
46746790|NCT00811473|82963989|FG000|Overall Study|Lost to Follow-up|5|||
46923200|NCT01674712|83156701|FG002|Overall Study|Lost to Follow-up|0|||
46746791|NCT00811473|82963990|FG001|Overall Study|Lost to Follow-up|1|||
46746792|NCT00811473|82963989|FG000|Overall Study|Withdrawal by Subject|2|||
46746793|NCT00811473|82963990|FG001|Overall Study|Withdrawal by Subject|4|||
46746794|NCT00811473|82963989|FG000|Overall Study|Severe non-compliance to protocol|2|||
46746795|NCT00811473|82963990|FG001|Overall Study|Severe non-compliance to protocol|4|||
46746796|NCT00811473|82963989|FG000|Overall Study|Lack of therapeutic response|4|||
46746797|NCT00811473|82963990|FG001|Overall Study|Lack of therapeutic response|1|||
46746798|NCT00811473|82963989|FG000|Overall Study|Condition under investigation worsened|1|||
46746799|NCT00811473|82963990|FG001|Overall Study|Condition under investigation worsened|3|||
46746800|NCT00811473|82963989|FG000|Overall Study|Other 2|4|||
46746801|NCT00811473|82963990|FG001|Overall Study|Other 2|1|||
46746802|NCT00811473|82963989|FG000|Overall Study|Incorrect Enrollment|1|||
46746803|NCT00811473|82963990|FG001|Overall Study|Incorrect Enrollment|0|||
46746804|NCT00811473|82963989|FG000|Overall Study|Safety Reasons|1|||
46746805|NCT00811473|82963990|FG001|Overall Study|Safety Reasons|0|||
46746806|NCT00617305|82964003|FG000|Overall Study|Adverse Event|4|||
46746807|NCT00617305|82964004|FG001|Overall Study|Adverse Event|0|||
46746808|NCT00617305|82964005|FG002|Overall Study|Adverse Event|0|||
46746809|NCT00617305|82964003|FG000|Overall Study|Death|1|||
46746810|NCT00617305|82964004|FG001|Overall Study|Death|0|||
46746811|NCT00617305|82964005|FG002|Overall Study|Death|0|||
46746812|NCT00617305|82964003|FG000|Overall Study|Physician Decision|1|||
46746813|NCT00617305|82964004|FG001|Overall Study|Physician Decision|0|||
46746814|NCT00617305|82964005|FG002|Overall Study|Physician Decision|0|||
46746815|NCT00617305|82964003|FG000|Overall Study|Protocol Violation|1|||
46746816|NCT00617305|82964004|FG001|Overall Study|Protocol Violation|0|||
46746817|NCT00617305|82964005|FG002|Overall Study|Protocol Violation|1|||
46746818|NCT00617305|82964003|FG000|Overall Study|Withdrawal by Subject|1|||
46746819|NCT00617305|82964004|FG001|Overall Study|Withdrawal by Subject|0|||
46746820|NCT00617305|82964005|FG002|Overall Study|Withdrawal by Subject|0|||
46746821|NCT00811395|82964022|FG000|Extension Treatment|Adverse Event|1|||
46746822|NCT00811395|82964023|FG001|Extension Treatment|Adverse Event|2|||
46746823|NCT00811395|82964024|FG002|Extension Treatment|Adverse Event|2|||
46746824|NCT00811395|82964025|FG003|Extension Treatment|Adverse Event|2|||
46746825|NCT00811395|82964026|FG004|Extension Treatment|Adverse Event|0|||
46746826|NCT00811395|82964027|FG005|Extension Treatment|Adverse Event|1|||
46746827|NCT00811395|82964022|FG000|Extension Treatment|Progressive disease|1|||
46746828|NCT00811395|82964023|FG001|Extension Treatment|Progressive disease|1|||
46923201|NCT01674712|83156702|FG003|Overall Study|Lost to Follow-up|0|||
46923202|NCT01674712|83156703|FG004|Overall Study|Lost to Follow-up|0|||
46923203|NCT01674712|83156699|FG000|Overall Study|Protocol Violation|2|||
46923204|NCT01674712|83156700|FG001|Overall Study|Protocol Violation|0|||
46746829|NCT00811395|82964024|FG002|Extension Treatment|Progressive disease|0|||
46746830|NCT00811395|82964025|FG003|Extension Treatment|Progressive disease|0|||
46746831|NCT00811395|82964026|FG004|Extension Treatment|Progressive disease|0|||
47051983|NCT00630825|83317518|FG003|Overall Study|Lost to Follow-up|1|||
46746832|NCT00811395|82964027|FG005|Extension Treatment|Progressive disease|0|||
46746833|NCT00811395|82964022|FG000|Extension Treatment|Participant did not wish to continue|0|||
46746834|NCT00811395|82964023|FG001|Extension Treatment|Participant did not wish to continue|3|||
46746835|NCT00811395|82964024|FG002|Extension Treatment|Participant did not wish to continue|0|||
46746836|NCT00811395|82964025|FG003|Extension Treatment|Participant did not wish to continue|1|||
46746837|NCT00811395|82964026|FG004|Extension Treatment|Participant did not wish to continue|0|||
46923205|NCT01674712|83156701|FG002|Overall Study|Protocol Violation|0|||
46746838|NCT00811395|82964027|FG005|Extension Treatment|Participant did not wish to continue|1|||
46746839|NCT00811395|82964022|FG000|Extension Treatment|Other than above|0|||
46746840|NCT00811395|82964023|FG001|Extension Treatment|Other than above|0|||
46746841|NCT00811395|82964024|FG002|Extension Treatment|Other than above|1|||
46746842|NCT00811395|82964025|FG003|Extension Treatment|Other than above|0|||
46746843|NCT00811395|82964026|FG004|Extension Treatment|Other than above|0|||
46746844|NCT00811395|82964027|FG005|Extension Treatment|Other than above|0|||
46746845|NCT00955409|82964054|FG000|Overall Study|Lack of Efficacy|1|||
46746846|NCT00955409|82964055|FG001|Overall Study|Lack of Efficacy|0|||
46746847|NCT00955409|82964056|FG002|Overall Study|Lack of Efficacy|0|||
46746848|NCT00955409|82964057|FG003|Overall Study|Lack of Efficacy|0|||
46746849|NCT00955409|82964058|FG004|Overall Study|Lack of Efficacy|0|||
46746850|NCT00955409|82964059|FG005|Overall Study|Lack of Efficacy|0|||
46746851|NCT00955409|82964060|FG006|Overall Study|Lack of Efficacy|0|||
46746852|NCT00955409|82964061|FG007|Overall Study|Lack of Efficacy|0|||
46746853|NCT00955409|82964062|FG008|Overall Study|Lack of Efficacy|0|||
46746854|NCT00955409|82964063|FG009|Overall Study|Lack of Efficacy|0|||
46746855|NCT00955409|82964054|FG000|Overall Study|Withdrawal by Subject|1|||
46746856|NCT00955409|82964055|FG001|Overall Study|Withdrawal by Subject|0|||
46746857|NCT00955409|82964056|FG002|Overall Study|Withdrawal by Subject|5|||
46746858|NCT00955409|82964057|FG003|Overall Study|Withdrawal by Subject|2|||
46746859|NCT00955409|82964058|FG004|Overall Study|Withdrawal by Subject|0|||
46746860|NCT00955409|82964059|FG005|Overall Study|Withdrawal by Subject|0|||
46746861|NCT00955409|82964060|FG006|Overall Study|Withdrawal by Subject|2|||
46746862|NCT00955409|82964061|FG007|Overall Study|Withdrawal by Subject|0|||
46746863|NCT00955409|82964062|FG008|Overall Study|Withdrawal by Subject|1|||
46746864|NCT00955409|82964063|FG009|Overall Study|Withdrawal by Subject|0|||
46746865|NCT00955409|82964054|FG000|Overall Study|Caregiver Request|2|||
46746866|NCT00955409|82964055|FG001|Overall Study|Caregiver Request|0|||
46746867|NCT00955409|82964056|FG002|Overall Study|Caregiver Request|6|||
46923206|NCT01674712|83156702|FG003|Overall Study|Protocol Violation|0|||
46923207|NCT01674712|83156703|FG004|Overall Study|Protocol Violation|0|||
46923208|NCT01674712|83156699|FG000|Overall Study|Withdrawal by Subject|2|||
46923209|NCT01674712|83156700|FG001|Overall Study|Withdrawal by Subject|2|||
46923210|NCT01674712|83156701|FG002|Overall Study|Withdrawal by Subject|5|||
46923211|NCT01674712|83156702|FG003|Overall Study|Withdrawal by Subject|4|||
46923212|NCT01674712|83156703|FG004|Overall Study|Withdrawal by Subject|3|||
46923213|NCT01674712|83156699|FG000|Overall Study|Administrative|0|||
46923214|NCT01674712|83156700|FG001|Overall Study|Administrative|1|||
46923215|NCT01674712|83156701|FG002|Overall Study|Administrative|0|||
46923216|NCT01674712|83156702|FG003|Overall Study|Administrative|0|||
46923217|NCT01674712|83156703|FG004|Overall Study|Administrative|1|||
46923218|NCT01674712|83156699|FG000|Overall Study|Lack of Efficacy|0|||
46923219|NCT01674712|83156700|FG001|Overall Study|Lack of Efficacy|0|||
46923220|NCT01674712|83156701|FG002|Overall Study|Lack of Efficacy|1|||
46923221|NCT01674712|83156702|FG003|Overall Study|Lack of Efficacy|0|||
46923222|NCT01674712|83156703|FG004|Overall Study|Lack of Efficacy|1|||
46923223|NCT01368432|83156717|FG000|Overall Study|Lost to Follow-up|0|||
46923224|NCT01368432|83156718|FG001|Overall Study|Lost to Follow-up|1|||
46923225|NCT01063881|83156741|FG000|Overall Study|Adverse Event|12|||
46923226|NCT01063881|83156742|FG001|Overall Study|Adverse Event|2|||
46923227|NCT01063881|83156743|FG002|Overall Study|Adverse Event|0|||
46923228|NCT01063881|83156741|FG000|Overall Study|Lost to Follow-up|13|||
46746868|NCT00955409|82964057|FG003|Overall Study|Caregiver Request|5|||
46746869|NCT00955409|82964058|FG004|Overall Study|Caregiver Request|0|||
46746870|NCT00955409|82964059|FG005|Overall Study|Caregiver Request|2|||
46746871|NCT00955409|82964060|FG006|Overall Study|Caregiver Request|3|||
46746872|NCT00955409|82964061|FG007|Overall Study|Caregiver Request|1|||
46746873|NCT00955409|82964062|FG008|Overall Study|Caregiver Request|3|||
46746874|NCT00955409|82964063|FG009|Overall Study|Caregiver Request|0|||
46746875|NCT00955409|82964054|FG000|Overall Study|Investigator Request|0|||
46804636|NCT00401830|83023650|FG001|Overall Study|Lost to Follow-up|3|||
46804637|NCT00401830|83023649|FG000|Overall Study|Other: Personal / Family problems|1|||
46804638|NCT00401830|83023650|FG001|Overall Study|Other: Personal / Family problems|0|||
46804639|NCT00401752|83023658|FG000|Overall Study|Adverse Event|2|||
46804640|NCT00401752|83023659|FG001|Overall Study|Adverse Event|5|||
46804641|NCT00401752|83023658|FG000|Overall Study|Withdrawal by Subject|2|||
46804642|NCT00401752|83023659|FG001|Overall Study|Withdrawal by Subject|6|||
46804643|NCT00401752|83023658|FG000|Overall Study|Lost to Follow-up|1|||
46804644|NCT00401752|83023659|FG001|Overall Study|Lost to Follow-up|4|||
46804645|NCT00401752|83023658|FG000|Overall Study|Development of any exclusion criteria|4|||
46804646|NCT00401752|83023659|FG001|Overall Study|Development of any exclusion criteria|2|||
46804647|NCT00401752|83023658|FG000|Overall Study|Physician Decision|1|||
46804648|NCT00401752|83023659|FG001|Overall Study|Physician Decision|1|||
46804649|NCT00539240|83023668|FG000|Overall Study|Withdrawal by Subject|0|||
46923229|NCT01063881|83156742|FG001|Overall Study|Lost to Follow-up|7|||
46923230|NCT01063881|83156743|FG002|Overall Study|Lost to Follow-up|1|||
46923231|NCT01063881|83156741|FG000|Overall Study|Withdrawal by Subject|25|||
46923232|NCT01063881|83156742|FG001|Overall Study|Withdrawal by Subject|1|||
46923233|NCT01063881|83156743|FG002|Overall Study|Withdrawal by Subject|0|||
46923234|NCT01063881|83156741|FG000|Overall Study|Reason for not completed not specified|5|||
46923235|NCT01063881|83156742|FG001|Overall Study|Reason for not completed not specified|1|||
46923236|NCT01063881|83156743|FG002|Overall Study|Reason for not completed not specified|0|||
46923237|NCT01062555|83156760|FG000|Phase 1|Death|10|||
46923238|NCT01062555|83156761|FG001|Phase 1|Death|17|||
46923239|NCT01062555|83156762|FG002|Phase 1|Death|0|||
46923240|NCT01062555|83156763|FG003|Phase 1|Death|0|||
46923241|NCT01062555|83156760|FG000|Phase 1|Graft Failure|12|||
46923242|NCT01062555|83156761|FG001|Phase 1|Graft Failure|8|||
46923243|NCT01062555|83156762|FG002|Phase 1|Graft Failure|0|||
46746876|NCT00955409|82964055|FG001|Overall Study|Investigator Request|0|||
46746877|NCT00955409|82964056|FG002|Overall Study|Investigator Request|1|||
46923244|NCT01062555|83156763|FG003|Phase 1|Graft Failure|0|||
46923245|NCT01062555|83156760|FG000|Phase 1|Withdrawal by Subject|1|||
46923246|NCT01062555|83156761|FG001|Phase 1|Withdrawal by Subject|1|||
46923247|NCT01062555|83156762|FG002|Phase 1|Withdrawal by Subject|0|||
46923248|NCT01062555|83156763|FG003|Phase 1|Withdrawal by Subject|0|||
46923249|NCT01062555|83156760|FG000|Phase 2|Death|0|||
46923250|NCT01062555|83156761|FG001|Phase 2|Death|0|||
46923251|NCT01062555|83156762|FG002|Phase 2|Death|8|||
46746878|NCT00955409|82964057|FG003|Overall Study|Investigator Request|0|||
46746879|NCT00955409|82964058|FG004|Overall Study|Investigator Request|0|||
46746880|NCT00955409|82964059|FG005|Overall Study|Investigator Request|0|||
46746881|NCT00955409|82964060|FG006|Overall Study|Investigator Request|0|||
46746882|NCT00955409|82964061|FG007|Overall Study|Investigator Request|0|||
46746883|NCT00955409|82964062|FG008|Overall Study|Investigator Request|0|||
46746884|NCT00955409|82964063|FG009|Overall Study|Investigator Request|0|||
46746885|NCT00955409|82964054|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
46746886|NCT00955409|82964055|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
46746887|NCT00955409|82964056|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
46746888|NCT00955409|82964057|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
46746889|NCT00955409|82964058|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
46746890|NCT00955409|82964059|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
46746891|NCT00955409|82964060|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
46746892|NCT00955409|82964061|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
46746893|NCT00955409|82964062|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
46746894|NCT00955409|82964063|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
46746895|NCT00955409|82964054|FG000|Overall Study|Lost to Follow-up|0|||
46746896|NCT00955409|82964055|FG001|Overall Study|Lost to Follow-up|0|||
46746897|NCT00955409|82964056|FG002|Overall Study|Lost to Follow-up|1|||
46746898|NCT00955409|82964057|FG003|Overall Study|Lost to Follow-up|0|||
46746899|NCT00955409|82964058|FG004|Overall Study|Lost to Follow-up|0|||
46746900|NCT00955409|82964059|FG005|Overall Study|Lost to Follow-up|0|||
46746901|NCT00955409|82964060|FG006|Overall Study|Lost to Follow-up|1|||
46746902|NCT00955409|82964061|FG007|Overall Study|Lost to Follow-up|0|||
46746903|NCT00955409|82964062|FG008|Overall Study|Lost to Follow-up|0|||
46746904|NCT00955409|82964063|FG009|Overall Study|Lost to Follow-up|0|||
46746905|NCT00955409|82964054|FG000|Overall Study|Failed to Return|2|||
46746906|NCT00955409|82964055|FG001|Overall Study|Failed to Return|0|||
46746907|NCT00955409|82964056|FG002|Overall Study|Failed to Return|0|||
46746908|NCT00955409|82964057|FG003|Overall Study|Failed to Return|0|||
46746909|NCT00955409|82964058|FG004|Overall Study|Failed to Return|0|||
46746910|NCT00955409|82964059|FG005|Overall Study|Failed to Return|0|||
46746911|NCT00955409|82964060|FG006|Overall Study|Failed to Return|0|||
46746912|NCT00955409|82964061|FG007|Overall Study|Failed to Return|2|||
46746913|NCT00955409|82964062|FG008|Overall Study|Failed to Return|0|||
46746914|NCT00955409|82964063|FG009|Overall Study|Failed to Return|0|||
46746915|NCT00955409|82964054|FG000|Overall Study|Adverse Event (AE)|2|||
46746916|NCT00955409|82964055|FG001|Overall Study|Adverse Event (AE)|0|||
46923252|NCT01062555|83156763|FG003|Phase 2|Death|3|||
46923253|NCT01062555|83156760|FG000|Phase 2|Graft failure|0|||
46635510|NCT01582308|82809178|FG007|Period 4|Physician Decision|0|||
46746917|NCT00955409|82964056|FG002|Overall Study|Adverse Event (AE)|0|||
46746918|NCT00955409|82964057|FG003|Overall Study|Adverse Event (AE)|0|||
46746919|NCT00955409|82964058|FG004|Overall Study|Adverse Event (AE)|0|||
46746920|NCT00955409|82964059|FG005|Overall Study|Adverse Event (AE)|1|||
46746921|NCT00955409|82964060|FG006|Overall Study|Adverse Event (AE)|2|||
46746922|NCT00955409|82964061|FG007|Overall Study|Adverse Event (AE)|0|||
46746923|NCT00955409|82964062|FG008|Overall Study|Adverse Event (AE)|2|||
46746924|NCT00955409|82964063|FG009|Overall Study|Adverse Event (AE)|0|||
46923254|NCT01062555|83156761|FG001|Phase 2|Graft failure|0|||
47051984|NCT00630825|83317515|FG000|Overall Study|Physician Decision|1|||
46635511|NCT01582308|82809179|FG008|Period 4|Physician Decision|0|||
46923255|NCT01062555|83156762|FG002|Phase 2|Graft failure|7|||
46923256|NCT01062555|83156763|FG003|Phase 2|Graft failure|4|||
46923257|NCT01062555|83156760|FG000|Phase 2|Withdrawal by Subject|0|||
46923258|NCT01062555|83156761|FG001|Phase 2|Withdrawal by Subject|0|||
46746925|NCT00955409|82964054|FG000|Overall Study|Reason not Specified|2|||
46746926|NCT00955409|82964055|FG001|Overall Study|Reason not Specified|1|||
46746927|NCT00955409|82964056|FG002|Overall Study|Reason not Specified|13|||
46804650|NCT00539240|83023669|FG001|Overall Study|Withdrawal by Subject|2|||
46923259|NCT01062555|83156762|FG002|Phase 2|Withdrawal by Subject|0|||
46804651|NCT00539240|83023670|FG002|Overall Study|Withdrawal by Subject|0|||
46923260|NCT01062555|83156763|FG003|Phase 2|Withdrawal by Subject|7|||
46804652|NCT00539240|83023668|FG000|Overall Study|Protocol Violation|1|||
46804653|NCT00539240|83023669|FG001|Overall Study|Protocol Violation|1|||
46804654|NCT00539240|83023670|FG002|Overall Study|Protocol Violation|4|||
46923261|NCT01062555|83156760|FG000|Phase 2|Protocol Violation|0|||
46923262|NCT01062555|83156761|FG001|Phase 2|Protocol Violation|0|||
46804655|NCT00539240|83023668|FG000|Overall Study|Lost to Follow-up|2|||
46923263|NCT01062555|83156762|FG002|Phase 2|Protocol Violation|0|||
46923264|NCT01062555|83156763|FG003|Phase 2|Protocol Violation|3|||
46923265|NCT01062555|83156760|FG000|Phase 2|Physician Decision|0|||
46923266|NCT01062555|83156761|FG001|Phase 2|Physician Decision|0|||
47051985|NCT00630825|83317516|FG001|Overall Study|Physician Decision|0|||
46804656|NCT00539240|83023669|FG001|Overall Study|Lost to Follow-up|3|||
46804657|NCT00539240|83023670|FG002|Overall Study|Lost to Follow-up|1|||
46804658|NCT00539240|83023668|FG000|Overall Study|Adverse Event|3|||
46804659|NCT00539240|83023669|FG001|Overall Study|Adverse Event|1|||
46804660|NCT00539240|83023670|FG002|Overall Study|Adverse Event|10|||
46804661|NCT00417976|83023678|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
46804662|NCT00417976|83023678|FG000|Overall Study|Treatment -related toxicity|2|||
46804663|NCT00673673|83023683|FG000|Overall Study|Progressive disease|27|||
46804664|NCT00673673|83023683|FG000|Overall Study|Adverse Event|4|||
46804665|NCT00673673|83023683|FG000|Overall Study|Withdrawal by Subject|3|||
46804666|NCT00673673|83023683|FG000|Overall Study|Investigators' discretion|2|||
47051986|NCT00630825|83317517|FG002|Overall Study|Physician Decision|0|||
47051987|NCT00630825|83317518|FG003|Overall Study|Physician Decision|0|||
46804667|NCT00069121|83023689|FG000|Overall Study|Death|286|||
46804668|NCT00069121|83023690|FG001|Overall Study|Death|242|||
46804669|NCT00069121|83023689|FG000|Overall Study|Withdrawal by Subject|18|||
46804670|NCT00069121|83023690|FG001|Overall Study|Withdrawal by Subject|20|||
46804671|NCT00069121|83023689|FG000|Overall Study|Lost to Follow-up|63|||
46804672|NCT00069121|83023690|FG001|Overall Study|Lost to Follow-up|63|||
46804673|NCT00399802|83023702|FG000|Overall Study|Adverse Event|0|||
46804674|NCT00399802|83023703|FG001|Overall Study|Adverse Event|2|||
46804675|NCT00399802|83023702|FG000|Overall Study|Participant discontinued by mistake|0|||
47051988|NCT00630825|83317515|FG000|Overall Study|Withdrawal by Subject|2|||
47051989|NCT00630825|83317516|FG001|Overall Study|Withdrawal by Subject|2|||
47051990|NCT00630825|83317517|FG002|Overall Study|Withdrawal by Subject|2|||
47051991|NCT00630825|83317518|FG003|Overall Study|Withdrawal by Subject|3|||
47051992|NCT04075734|83317815|FG000|Overall Study|Lost to Follow-up|1|||
46746928|NCT00955409|82964057|FG003|Overall Study|Reason not Specified|1|||
46746929|NCT00955409|82964058|FG004|Overall Study|Reason not Specified|2|||
46746930|NCT00955409|82964059|FG005|Overall Study|Reason not Specified|0|||
46746931|NCT00955409|82964060|FG006|Overall Study|Reason not Specified|16|||
47051993|NCT04075734|83317816|FG001|Overall Study|Lost to Follow-up|1|||
47051994|NCT04075734|83317817|FG002|Overall Study|Lost to Follow-up|0|||
47051995|NCT04075734|83317815|FG000|Overall Study|Withdrawal by Subject|3|||
47051996|NCT04075734|83317816|FG001|Overall Study|Withdrawal by Subject|0|||
47051997|NCT04075734|83317817|FG002|Overall Study|Withdrawal by Subject|0|||
47051998|NCT00989781|83317862|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
47051999|NCT00989781|83317863|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
47052000|NCT00989235|83317904|FG000|Overall Study|Death|0|||
47052001|NCT00989235|83317905|FG001|Overall Study|Death|1|||
47052002|NCT00989235|83317904|FG000|Overall Study|Adverse Event|0|||
46746932|NCT00955409|82964061|FG007|Overall Study|Reason not Specified|0|||
46746933|NCT00955409|82964062|FG008|Overall Study|Reason not Specified|8|||
46746934|NCT00955409|82964063|FG009|Overall Study|Reason not Specified|1|||
46746935|NCT00615901|82964089|FG000|Overall Study|Withdrawal by Subject|2|||
46746936|NCT00615901|82964089|FG000|Overall Study|Adverse Event|7|||
46746937|NCT00616603|82964101|FG000|Overall Study|Physician Decision|2|||
46804676|NCT00399802|83023703|FG001|Overall Study|Participant discontinued by mistake|1|||
46804677|NCT00399568|83023711|FG000|Overall Study|Adverse Event|1|||
46804678|NCT00399568|83023712|FG001|Overall Study|Adverse Event|2|||
47052003|NCT00989235|83317905|FG001|Overall Study|Adverse Event|1|||
46746938|NCT00616603|82964102|FG001|Overall Study|Physician Decision|0|||
46746939|NCT00616603|82964103|FG002|Overall Study|Physician Decision|2|||
46804679|NCT00399568|83023711|FG000|Overall Study|Withdrawal by Subject|7|||
46804680|NCT00399568|83023712|FG001|Overall Study|Withdrawal by Subject|3|||
46804681|NCT00399568|83023711|FG000|Overall Study|Protocol non-compliance|2|||
46804682|NCT00399568|83023712|FG001|Overall Study|Protocol non-compliance|2|||
46923267|NCT01062555|83156762|FG002|Phase 2|Physician Decision|0|||
46923268|NCT01062555|83156763|FG003|Phase 2|Physician Decision|17|||
47052004|NCT00989235|83317904|FG000|Overall Study|Lack of Efficacy|1|||
46746940|NCT00573313|82964115|FG000|Overall Study|Protocol Violation|5|||
46804683|NCT00399568|83023711|FG000|Overall Study|Lost to Follow-up|2|||
46804684|NCT00399568|83023712|FG001|Overall Study|Lost to Follow-up|2|||
46804685|NCT03900728|83023723|FG000|Overall Study|No text responses|0|||
46804686|NCT03900728|83023724|FG001|Overall Study|No text responses|0|||
46804687|NCT03900728|83023725|FG002|Overall Study|No text responses|4|||
46804688|NCT00068419|83023733|FG000|Overall Study|Adverse Event|3|||
46804689|NCT00068419|83023733|FG000|Overall Study|Lack of Efficacy|24|||
46804690|NCT00068419|83023733|FG000|Overall Study|Lost to Follow-up|1|||
46804691|NCT00068419|83023733|FG000|Overall Study|Physician Decision|7|||
46804692|NCT00068419|83023733|FG000|Overall Study|Withdrawal by Subject|14|||
46804693|NCT00068419|83023733|FG000|Overall Study|Ineligible|11|||
46804694|NCT00068107|83023737|FG000|Overall Study|end-stage renal disease|6|||
46804695|NCT00068107|83023737|FG000|Overall Study|Death|2|||
46804696|NCT00068107|83023737|FG000|Overall Study|Withdrawal by Subject|1|||
46804697|NCT00394654|83023746|FG000|Overall Study|Lost to Follow-up|1|||
46804698|NCT00394654|83023747|FG001|Overall Study|Lost to Follow-up|0|||
46804699|NCT00394654|83023746|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
46804700|NCT00394654|83023747|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
46804701|NCT03900416|83023755|FG000|Six Week Follow-up|Lost to Follow-up|1|||
46804702|NCT03900416|83023756|FG001|Six Week Follow-up|Lost to Follow-up|0|||
46804703|NCT03900416|83023755|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
46804704|NCT03900416|83023756|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
46804705|NCT03900416|83023755|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
46804706|NCT03900416|83023756|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
46804707|NCT03900416|83023755|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
46804708|NCT03900416|83023756|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
46804709|NCT03900416|83023755|FG000|Twelve Week Follow-up|Adverse Event|1|||
46804710|NCT03900416|83023756|FG001|Twelve Week Follow-up|Adverse Event|1|||
46804711|NCT03900416|83023755|FG000|Six Month Follow-up|Lost to Follow-up|4|||
46804712|NCT03900416|83023756|FG001|Six Month Follow-up|Lost to Follow-up|3|||
46804713|NCT03900416|83023755|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
46804714|NCT03900416|83023756|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
46804715|NCT00399490|83023762|FG000|Overall Study|Adverse Event|19|||
46804716|NCT00399490|83023762|FG000|Overall Study|Lack of Efficacy|31|||
46804717|NCT00399490|83023762|FG000|Overall Study|Lost to Follow-up|5|||
46804718|NCT00399490|83023762|FG000|Overall Study|Withdrawal by Subject|18|||
46804719|NCT00399490|83023762|FG000|Overall Study|Other|25|||
46923269|NCT01064817|83156775|FG000|Study Completion|Physician Decision|1|||
46923270|NCT01064817|83156776|FG001|Study Completion|Physician Decision|0|||
46923271|NCT01064817|83156775|FG000|Study Completion|Withdrawal by Subject|1|||
46923272|NCT01064817|83156776|FG001|Study Completion|Withdrawal by Subject|0|||
46923273|NCT01368276|83156784|FG000|Overall Study|Death|1|||
46746941|NCT00573313|82964116|FG001|Overall Study|Protocol Violation|0|||
46746942|NCT00573313|82964117|FG002|Overall Study|Protocol Violation|6|||
46746943|NCT00573313|82964118|FG003|Overall Study|Protocol Violation|0|||
46746944|NCT00953615|82964125|FG000|Overall Study|Adverse Event|1|||
46746945|NCT00810615|82964131|FG000|Overall Study|Withdrawal by Subject|1|||
46746946|NCT00810615|82964132|FG001|Overall Study|Withdrawal by Subject|1|||
46746947|NCT00573391|82964152|FG000|Overall Study|study stopped|2|||
46746948|NCT00573391|82964153|FG001|Overall Study|study stopped|2|||
46746949|NCT00573391|82964152|FG000|Overall Study|Death|1|||
46746950|NCT00573391|82964153|FG001|Overall Study|Death|0|||
46746951|NCT00590967|82964161|FG000|Overall Study|Withdrawal by Subject|1|||
46746952|NCT00590967|82964162|FG001|Overall Study|Withdrawal by Subject|1|||
46746953|NCT00590967|82964161|FG000|Overall Study|Ineligible|1|||
46746954|NCT00590967|82964162|FG001|Overall Study|Ineligible|0|||
46746955|NCT00590967|82964161|FG000|Overall Study|Poor performance status|0|||
46746956|NCT00590967|82964162|FG001|Overall Study|Poor performance status|1|||
46923274|NCT01368276|83156785|FG001|Overall Study|Death|10|||
46923275|NCT01064739|83156791|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
46923276|NCT01061775|83156801|FG000|Overall Study|Physician Decision|2|||
46923277|NCT01061775|83156801|FG000|Overall Study|Lost to Follow-up|1|||
46923278|NCT02651116|83156808|FG000|Overall Study|Adverse Event|0|||
46746957|NCT00590967|82964161|FG000|Overall Study|Non-compliant|0|||
46746958|NCT00590967|82964162|FG001|Overall Study|Non-compliant|2|||
46804720|NCT00398866|83023771|FG000|Overall Study|Adverse Event|1|||
46804721|NCT00398866|83023772|FG001|Overall Study|Adverse Event|0|||
46804722|NCT00398866|83023773|FG002|Overall Study|Adverse Event|0|||
46804723|NCT00398866|83023771|FG000|Overall Study|Lack of Efficacy|0|||
46804724|NCT00398866|83023772|FG001|Overall Study|Lack of Efficacy|0|||
46804725|NCT00398866|83023773|FG002|Overall Study|Lack of Efficacy|1|||
46804726|NCT00398866|83023771|FG000|Overall Study|Lost to Follow-up|7|||
46923279|NCT02651116|83156809|FG001|Overall Study|Adverse Event|1|||
46923280|NCT02651116|83156808|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
46746959|NCT00590967|82964161|FG000|Overall Study|Did not sign consent form|0|||
46746960|NCT00590967|82964162|FG001|Overall Study|Did not sign consent form|1|||
46775752|NCT00793793|82994209|FG005|Overall Study|Lost to Follow-up|0|||
46804727|NCT00398866|83023772|FG001|Overall Study|Lost to Follow-up|6|||
46746961|NCT00590967|82964161|FG000|Overall Study|Did not receive chemo per protocol|1|||
46746962|NCT00590967|82964162|FG001|Overall Study|Did not receive chemo per protocol|0|||
46746963|NCT05102162|82964191|FG000|Overall Study|Withdrawal by Subject|3|||
46746964|NCT05102162|82964192|FG001|Overall Study|Withdrawal by Subject|0|||
46746965|NCT05102162|82964191|FG000|Overall Study|Baseline cultures negative|4|||
46746966|NCT05102162|82964192|FG001|Overall Study|Baseline cultures negative|2|||
46746967|NCT05102162|82964191|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
46746968|NCT05102162|82964192|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
46746969|NCT05102162|82964191|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
46746970|NCT05102162|82964192|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
46746971|NCT04899349|82964200|FG000|Overall Study|Study terminated by Sponsor|2|||
46746972|NCT04899349|82964201|FG001|Overall Study|Study terminated by Sponsor|0|||
46746973|NCT04891107|82964207|FG000|Overall Study|Physician Decision|1|||
46746974|NCT04891107|82964207|FG000|Overall Study|Withdrawal by Subject|1|||
46746975|NCT04891107|82964207|FG000|Overall Study|Screen failure after consent|1|||
46746976|NCT04848220|82964214|FG000|Overall Study|Unable to proceed to study procedure|0|||
46746977|NCT04848220|82964215|FG001|Overall Study|Unable to proceed to study procedure|1|||
46746978|NCT04848220|82964216|FG002|Overall Study|Unable to proceed to study procedure|0|||
46746979|NCT04848220|82964214|FG000|Overall Study|Fractional flow not significant|0|||
46746980|NCT04848220|82964215|FG001|Overall Study|Fractional flow not significant|1|||
46746981|NCT04848220|82964216|FG002|Overall Study|Fractional flow not significant|0|||
46746982|NCT04743804|82964226|FG000|Overall Study|Other|1|||
46746983|NCT04743804|82964227|FG001|Overall Study|Other|0|||
46746984|NCT04743804|82964226|FG000|Overall Study|Withdrawal by Subject|0|||
46746985|NCT04743804|82964227|FG001|Overall Study|Withdrawal by Subject|1|||
46746986|NCT04743804|82964226|FG000|Overall Study|Study Terminated by Sponsor|1|||
46746987|NCT04743804|82964227|FG001|Overall Study|Study Terminated by Sponsor|4|||
46746988|NCT04743804|82964226|FG000|Overall Study|Physician Decision|0|||
46746989|NCT04743804|82964227|FG001|Overall Study|Physician Decision|1|||
46746990|NCT04743804|82964226|FG000|Overall Study|Death|3|||
46746991|NCT04743804|82964227|FG001|Overall Study|Death|0|||
46746992|NCT04659161|82964235|FG000|Overall Study|Adverse Event|10|||
46746993|NCT04659161|82964236|FG001|Overall Study|Adverse Event|6|||
46746994|NCT04659161|82964235|FG000|Overall Study|Withdrawal by Subject|13|||
46746995|NCT04659161|82964236|FG001|Overall Study|Withdrawal by Subject|12|||
46746996|NCT04659161|82964235|FG000|Overall Study|Other|9|||
46746997|NCT04659161|82964236|FG001|Overall Study|Other|8|||
46746998|NCT04640766|82964242|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
46746999|NCT04118166|82964246|FG000|Overall Study|Adverse Event|1|||
46747000|NCT04034251|82964298|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
46747001|NCT04034251|82964299|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
46747002|NCT04034251|82964300|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
46747003|NCT03778294|82964310|FG000|Overall Study|Death|1|||
46747004|NCT03778294|82964310|FG000|Overall Study|Issues with insurance|1|||
46747005|NCT03778294|82964310|FG000|Overall Study|disease progression before treatment|2|||
46747006|NCT03662542|82964321|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
46747007|NCT03662542|82964322|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747008|NCT03662542|82964323|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747009|NCT03662542|82964324|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747010|NCT03662542|82964325|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747011|NCT03662542|82964326|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747012|NCT03662542|82964327|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747013|NCT03662542|82964328|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747014|NCT03662542|82964329|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
46747015|NCT03662542|82964321|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747016|NCT03662542|82964322|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
46747017|NCT03662542|82964323|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747018|NCT03662542|82964324|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747019|NCT03662542|82964325|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747020|NCT03662542|82964326|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747021|NCT03662542|82964327|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747022|NCT03662542|82964328|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747023|NCT03662542|82964329|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
46747024|NCT03662542|82964321|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
46747025|NCT03662542|82964322|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
46747026|NCT03662542|82964323|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
46747027|NCT03662542|82964324|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
46747028|NCT03662542|82964325|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
46804728|NCT00398866|83023773|FG002|Overall Study|Lost to Follow-up|4|||
46747029|NCT03662542|82964326|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
46747030|NCT03662542|82964327|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
46747031|NCT03662542|82964328|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
46747032|NCT03662542|82964329|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
46747033|NCT03662542|82964321|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
46747034|NCT03662542|82964322|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46747035|NCT03662542|82964323|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46923281|NCT02651116|83156809|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
46923282|NCT01061385|83156817|FG000|Overall Study|Lost to Follow-up|1|||
46923283|NCT01061385|83156818|FG001|Overall Study|Lost to Follow-up|0|||
46923284|NCT01061385|83156817|FG000|Overall Study|subject decision not related to AE|0|||
46923285|NCT01061385|83156818|FG001|Overall Study|subject decision not related to AE|1|||
46923286|NCT02973477|83156827|FG000|First Intervention|Lost to Follow-up|0|||
46923287|NCT02973477|83156828|FG001|First Intervention|Lost to Follow-up|2|||
46923288|NCT02973477|83156827|FG000|Washout|Withdrawal by Subject|1|||
46923289|NCT02973477|83156828|FG001|Washout|Withdrawal by Subject|0|||
46923290|NCT02973477|83156827|FG000|Second Intervention|Lost to Follow-up|1|||
46747036|NCT03662542|82964324|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46747037|NCT03662542|82964325|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46747038|NCT03662542|82964326|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46747039|NCT03662542|82964327|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46747040|NCT03662542|82964328|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46747041|NCT03662542|82964329|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
46747042|NCT03662542|82964321|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747043|NCT03662542|82964322|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747044|NCT03662542|82964323|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747045|NCT03662542|82964324|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747046|NCT03662542|82964325|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747047|NCT03662542|82964326|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
46747048|NCT03662542|82964327|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747049|NCT03662542|82964328|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747050|NCT03662542|82964329|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
46747051|NCT03662542|82964321|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
46747052|NCT03662542|82964322|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
46747053|NCT03662542|82964323|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
46747054|NCT03662542|82964324|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
46747055|NCT03662542|82964325|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
46747056|NCT03662542|82964326|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
46747057|NCT03662542|82964327|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
46747058|NCT03662542|82964328|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
46747059|NCT03662542|82964329|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
46747060|NCT03662542|82964321|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
46747061|NCT03662542|82964322|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
46747062|NCT03662542|82964323|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
46747063|NCT03662542|82964324|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
46747064|NCT03662542|82964325|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
46747065|NCT03662542|82964326|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
46747066|NCT03662542|82964327|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
46923291|NCT02973477|83156828|FG001|Second Intervention|Lost to Follow-up|0|||
46923292|NCT02788656|83156842|FG000|Overall Study|Withdrawal by Subject|1|||
46747067|NCT03662542|82964328|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
46747068|NCT03662542|82964329|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
46747069|NCT03662542|82964321|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
46747070|NCT03662542|82964322|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
46747071|NCT03662542|82964323|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
46747072|NCT03662542|82964324|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
46747073|NCT03662542|82964325|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
46747074|NCT03662542|82964326|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
46804729|NCT00398866|83023771|FG000|Overall Study|Withdrawal by Subject|5|||
46923293|NCT02788656|83156843|FG001|Overall Study|Withdrawal by Subject|0|||
46923294|NCT00283868|83156851|FG000|Overall Study|Lost to Follow-up|7|||
46923295|NCT00283868|83156852|FG001|Overall Study|Lost to Follow-up|8|||
46635512|NCT01582308|82809180|FG009|Period 4|Physician Decision|1|||
46635513|NCT01558674|82809195|FG000|Part 1|Study Terminated by Sponsor|10|||
46747075|NCT03662542|82964327|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
46747076|NCT03662542|82964328|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
46747077|NCT03662542|82964329|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
46747078|NCT03662542|82964321|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46804730|NCT00398866|83023772|FG001|Overall Study|Withdrawal by Subject|1|||
46923296|NCT02973087|83156858|FG000|Overall Study|Withdrawal by Subject|2|||
46923297|NCT02973087|83156859|FG001|Overall Study|Withdrawal by Subject|1|||
46923298|NCT02973087|83156858|FG000|Overall Study|Adverse Event|1|||
46747079|NCT03662542|82964322|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46747080|NCT03662542|82964323|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46747081|NCT03662542|82964324|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46747082|NCT03662542|82964325|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46923299|NCT02973087|83156859|FG001|Overall Study|Adverse Event|0|||
46923300|NCT02973087|83156858|FG000|Overall Study|other|1|||
46747083|NCT03662542|82964326|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
46923301|NCT02973087|83156859|FG001|Overall Study|other|1|||
46923302|NCT00271544|83156879|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
46923303|NCT00271544|83156879|FG000|Overall Study|Model 4196 lead not attempted|9|||
46923304|NCT00271544|83156879|FG000|Overall Study|Implant not attempted|4|||
46923305|NCT05342532|83156897|FG000|Overall Study|Adverse Event|5|||
46747084|NCT03662542|82964327|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46923306|NCT05342532|83156898|FG001|Overall Study|Adverse Event|20|||
46923307|NCT05342532|83156897|FG000|Overall Study|Lost to Follow-up|10|||
46923308|NCT05342532|83156898|FG001|Overall Study|Lost to Follow-up|15|||
46923309|NCT02984943|83156904|FG000|Overall Study|Withdrawal by Subject|3|||
46923310|NCT02984943|83156904|FG000|Overall Study|Physician Decision|1|||
46923311|NCT02787408|83156908|FG000|Overall Study|Death|16|||
46747085|NCT03662542|82964328|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46747086|NCT03662542|82964329|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
46747087|NCT03662542|82964321|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747088|NCT03662542|82964322|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747089|NCT03662542|82964323|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747090|NCT03662542|82964324|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747091|NCT03662542|82964325|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747092|NCT03662542|82964326|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747093|NCT03662542|82964327|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747094|NCT03662542|82964328|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
46747095|NCT03662542|82964329|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
46747096|NCT03662542|82964321|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
46747097|NCT03662542|82964322|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
46747098|NCT03662542|82964323|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
46923312|NCT02787408|83156908|FG000|Overall Study|Withdrawal by Subject|1|||
46923313|NCT02787408|83156908|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
46747099|NCT03662542|82964324|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
46747100|NCT03662542|82964325|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
46747101|NCT03662542|82964326|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
46747102|NCT03662542|82964327|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
46747103|NCT03662542|82964328|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
46747104|NCT03662542|82964329|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
46923314|NCT02971605|83156912|FG000|Overall Study|Withdrawal by Subject|1|||
46923315|NCT03054337|83156924|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
46923316|NCT03054337|83156925|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
46923317|NCT03054337|83156926|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
46923318|NCT03054337|83156927|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
46923319|NCT03054337|83156928|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
46923320|NCT03054337|83156929|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
46747105|NCT03662542|82964321|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
46747106|NCT03662542|82964322|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
46923321|NCT01060059|83156962|FG000|Overall Study|Adverse Event|1|||
46923322|NCT01060059|83156963|FG001|Overall Study|Adverse Event|1|||
46923323|NCT01060059|83156962|FG000|Overall Study|Death|2|||
46923324|NCT01060059|83156963|FG001|Overall Study|Death|3|||
46923325|NCT01060059|83156962|FG000|Overall Study|Lost to Follow-up|18|||
46923326|NCT01060059|83156963|FG001|Overall Study|Lost to Follow-up|34|||
46923327|NCT01060059|83156962|FG000|Overall Study|entry criteria not met|4|||
46923328|NCT01060059|83156963|FG001|Overall Study|entry criteria not met|3|||
46923329|NCT01060059|83156962|FG000|Overall Study|Withdrawal by Subject|35|||
46923330|NCT01060059|83156963|FG001|Overall Study|Withdrawal by Subject|23|||
46923331|NCT01060059|83156962|FG000|Overall Study|lack of glycemic control|2|||
46923332|NCT01060059|83156963|FG001|Overall Study|lack of glycemic control|1|||
46923333|NCT01060059|83156962|FG000|Overall Study|lack of compliance|5|||
46923334|NCT01060059|83156963|FG001|Overall Study|lack of compliance|2|||
46747107|NCT03662542|82964323|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
46747108|NCT03662542|82964324|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
46747109|NCT03662542|82964325|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
46923335|NCT02648932|83156977|FG000|Overall Study|No transplant|3|||
46923336|NCT02648932|83156978|FG001|Overall Study|No transplant|1|||
46923337|NCT02122458|83156991|FG000|Overall Study|Withdrawal by Subject|0|||
46923338|NCT02122458|83156992|FG001|Overall Study|Withdrawal by Subject|0|||
47052005|NCT00989235|83317905|FG001|Overall Study|Lack of Efficacy|0|||
46747110|NCT03662542|82964326|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
46923339|NCT02122458|83156993|FG002|Overall Study|Withdrawal by Subject|0|||
46747111|NCT03662542|82964327|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
46923340|NCT02122458|83156994|FG003|Overall Study|Withdrawal by Subject|4|||
46923341|NCT02122458|83156995|FG004|Overall Study|Withdrawal by Subject|4|||
46923342|NCT02122458|83156996|FG005|Overall Study|Withdrawal by Subject|4|||
46923343|NCT02122458|83156997|FG006|Overall Study|Withdrawal by Subject|0|||
46923344|NCT02122458|83156991|FG000|Overall Study|Lost to Follow-up|1|||
47052006|NCT00989235|83317904|FG000|Overall Study|Withdrawal of Consent|1|||
47052007|NCT00989235|83317905|FG001|Overall Study|Withdrawal of Consent|1|||
47052008|NCT00989235|83317904|FG000|Overall Study|Desire to Become Pregnant|1|||
46635514|NCT01558674|82809196|FG001|Part 1|Study Terminated by Sponsor|0|||
46923345|NCT02122458|83156992|FG001|Overall Study|Lost to Follow-up|3|||
46923346|NCT02122458|83156993|FG002|Overall Study|Lost to Follow-up|0|||
46923347|NCT02122458|83156994|FG003|Overall Study|Lost to Follow-up|7|||
46923348|NCT02122458|83156995|FG004|Overall Study|Lost to Follow-up|5|||
46923349|NCT02122458|83156996|FG005|Overall Study|Lost to Follow-up|15|||
46923350|NCT02122458|83156997|FG006|Overall Study|Lost to Follow-up|1|||
46923351|NCT02122458|83156991|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
46635515|NCT01558674|82809195|FG000|Part 1|Withdrawal by Subject|1|||
46635516|NCT01558674|82809196|FG001|Part 1|Withdrawal by Subject|0|||
46747112|NCT03662542|82964328|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
46747113|NCT03662542|82964329|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
46635517|NCT01558596|82809217|FG000|Overall Study|Withdrawal by Subject|1|||
46635518|NCT01558596|82809218|FG001|Overall Study|Withdrawal by Subject|0|||
46635519|NCT01558596|82809217|FG000|Overall Study|surgery elsewhere or cancelled|1|||
46635520|NCT01558596|82809218|FG001|Overall Study|surgery elsewhere or cancelled|1|||
46635521|NCT01558596|82809217|FG000|Overall Study|Protocol Violation|1|||
46635522|NCT01558596|82809218|FG001|Overall Study|Protocol Violation|0|||
46635523|NCT01535040|82809226|FG000|Overall Study|Physician Decision|0|||
46635524|NCT01535040|82809227|FG001|Overall Study|Physician Decision|1|||
46635525|NCT01535040|82809226|FG000|Overall Study|Withdrawal by Subject|13|||
46635526|NCT01535040|82809227|FG001|Overall Study|Withdrawal by Subject|10|||
46635527|NCT01535040|82809226|FG000|Overall Study|Never Started|9|||
46635528|NCT01535040|82809227|FG001|Overall Study|Never Started|4|||
46635529|NCT01535040|82809226|FG000|Overall Study|Toxicity|7|||
46635530|NCT01535040|82809227|FG001|Overall Study|Toxicity|5|||
46635531|NCT01535040|82809226|FG000|Overall Study|Multiple Reasons|1|||
46635532|NCT01535040|82809227|FG001|Overall Study|Multiple Reasons|1|||
46635533|NCT01534962|82809237|FG000|Overall Study|Randomized but did not start treatment|2|||
46635534|NCT01534962|82809238|FG001|Overall Study|Randomized but did not start treatment|0|||
46635535|NCT01534962|82809239|FG002|Overall Study|Randomized but did not start treatment|0|||
46635536|NCT01534962|82809240|FG003|Overall Study|Randomized but did not start treatment|1|||
46635537|NCT01534962|82809237|FG000|Overall Study|Discontinued at AF recurrence|35|||
46635538|NCT01534962|82809238|FG001|Overall Study|Discontinued at AF recurrence|26|||
46635539|NCT01534962|82809239|FG002|Overall Study|Discontinued at AF recurrence|24|||
46635540|NCT01534962|82809240|FG003|Overall Study|Discontinued at AF recurrence|31|||
46747114|NCT03662542|82964321|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
46747115|NCT03662542|82964322|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
46747116|NCT03662542|82964323|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
46747117|NCT03662542|82964324|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
46747118|NCT03662542|82964325|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
46747119|NCT03662542|82964326|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
46747120|NCT03662542|82964327|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
46747121|NCT03662542|82964328|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
46747122|NCT03662542|82964329|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
46747123|NCT03555591|82964352|FG000|Overall Study|Protocol Violation|77|||
46747124|NCT03525392|82964361|FG000|Overall Study|Adverse Event|1|||
46747125|NCT03525392|82964362|FG001|Overall Study|Adverse Event|0|||
46923352|NCT02122458|83156992|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
47052009|NCT00989235|83317905|FG001|Overall Study|Desire to Become Pregnant|0|||
46747126|NCT03525392|82964363|FG002|Overall Study|Adverse Event|2|||
46747127|NCT03525392|82964364|FG003|Overall Study|Adverse Event|0|||
46635541|NCT01582152|82809252|FG000|Overall Study|Disease Progression|4|||
46635542|NCT01582152|82809253|FG001|Overall Study|Disease Progression|5|||
46635543|NCT01582152|82809252|FG000|Overall Study|Adverse Event|2|||
46747128|NCT03525392|82964365|FG004|Overall Study|Adverse Event|0|||
46747129|NCT03525392|82964361|FG000|Overall Study|Progressive disease|0|||
46747130|NCT03525392|82964362|FG001|Overall Study|Progressive disease|1|||
46747131|NCT03525392|82964363|FG002|Overall Study|Progressive disease|1|||
46747132|NCT03525392|82964364|FG003|Overall Study|Progressive disease|3|||
46747133|NCT03525392|82964365|FG004|Overall Study|Progressive disease|1|||
46923353|NCT02122458|83156993|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
46923354|NCT02122458|83156994|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
47052010|NCT00989235|83317904|FG000|Overall Study|Randomized by Mistake|0|||
46747134|NCT03496662|82964381|FG000|Overall Study|Adverse Event|1|||
46747135|NCT03496662|82964382|FG001|Overall Study|Adverse Event|0|||
46747136|NCT03496662|82964383|FG002|Overall Study|Adverse Event|1|||
46747137|NCT03496662|82964381|FG000|Overall Study|Physician Decision|1|||
46747138|NCT03496662|82964382|FG001|Overall Study|Physician Decision|0|||
46747139|NCT03496662|82964383|FG002|Overall Study|Physician Decision|3|||
46747140|NCT03496662|82964381|FG000|Overall Study|Withdrawal by Subject|0|||
46747141|NCT03496662|82964382|FG001|Overall Study|Withdrawal by Subject|0|||
46747142|NCT03496662|82964383|FG002|Overall Study|Withdrawal by Subject|2|||
46747143|NCT03496662|82964381|FG000|Overall Study|Death|0|||
46747144|NCT03496662|82964382|FG001|Overall Study|Death|0|||
46747145|NCT03496662|82964383|FG002|Overall Study|Death|2|||
46747146|NCT03496662|82964381|FG000|Overall Study|Noncompliance|0|||
46747147|NCT03496662|82964382|FG001|Overall Study|Noncompliance|0|||
46747148|NCT03496662|82964383|FG002|Overall Study|Noncompliance|1|||
46747149|NCT03472885|82964391|FG000|24-Week Treatment Period|Adverse Event|1|||
46747150|NCT03117049|82964409|FG000|Overall Study|Continued the follow-up period|109|||
46747151|NCT03117049|82964410|FG001|Overall Study|Continued the follow-up period|129|||
46747152|NCT03117049|82964409|FG000|Overall Study|Died|82|||
46747153|NCT03117049|82964410|FG001|Overall Study|Died|93|||
46747154|NCT03117049|82964409|FG000|Overall Study|Consent withdrawal|7|||
46747155|NCT03117049|82964410|FG001|Overall Study|Consent withdrawal|6|||
46747156|NCT03117049|82964409|FG000|Overall Study|Missing contact|3|||
46747157|NCT03117049|82964410|FG001|Overall Study|Missing contact|3|||
46747158|NCT02716038|82964429|FG000|Overall Study|Not evaluable|1|||
46747159|NCT02716038|82964429|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
46747160|NCT02716038|82964429|FG000|Overall Study|Unresectable|3|||
46747161|NCT02512068|82964435|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
46747162|NCT02512068|82964436|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
46747163|NCT02512068|82964435|FG000|Overall Study|Major Protocol Deviation|1|||
46747164|NCT02512068|82964436|FG001|Overall Study|Major Protocol Deviation|0|||
46747165|NCT02512068|82964435|FG000|Overall Study|Voluntary Withdrawal|0|||
46747166|NCT02512068|82964436|FG001|Overall Study|Voluntary Withdrawal|1|||
46747167|NCT02512068|82964435|FG000|Overall Study|Lack of Efficacy|0|||
46747168|NCT02512068|82964436|FG001|Overall Study|Lack of Efficacy|1|||
46747169|NCT02512068|82964435|FG000|Overall Study|Reason Not Specified|3|||
46747170|NCT02512068|82964436|FG001|Overall Study|Reason Not Specified|5|||
46747171|NCT02324569|82964453|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
46747172|NCT02324569|82964454|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
46747173|NCT02324569|82964453|FG000|Overall Study|Voluntary Withdrawal|3|||
46747174|NCT02324569|82964454|FG001|Overall Study|Voluntary Withdrawal|6|||
46747175|NCT02324569|82964453|FG000|Overall Study|Lack of Efficacy|2|||
46747176|NCT02324569|82964454|FG001|Overall Study|Lack of Efficacy|3|||
46747177|NCT02324569|82964453|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
46747178|NCT02324569|82964454|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
46747179|NCT02324569|82964453|FG000|Overall Study|Inconvenient Schedule|2|||
46923355|NCT02122458|83156995|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
46923356|NCT02122458|83156996|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
46923357|NCT02122458|83156997|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
46923358|NCT02122458|83156991|FG000|Overall Study|Adverse Event|1|||
46923359|NCT02122458|83156992|FG001|Overall Study|Adverse Event|0|||
46923360|NCT02122458|83156993|FG002|Overall Study|Adverse Event|0|||
46923361|NCT02122458|83156994|FG003|Overall Study|Adverse Event|0|||
46923362|NCT02122458|83156995|FG004|Overall Study|Adverse Event|0|||
46923363|NCT02122458|83156996|FG005|Overall Study|Adverse Event|0|||
46923364|NCT02122458|83156997|FG006|Overall Study|Adverse Event|0|||
46923365|NCT02122458|83156991|FG000|Overall Study|Experimental Error|0|||
46923366|NCT02122458|83156992|FG001|Overall Study|Experimental Error|0|||
46923367|NCT02122458|83156993|FG002|Overall Study|Experimental Error|0|||
46923368|NCT02122458|83156994|FG003|Overall Study|Experimental Error|0|||
46923369|NCT02122458|83156995|FG004|Overall Study|Experimental Error|3|||
46923370|NCT02122458|83156996|FG005|Overall Study|Experimental Error|0|||
46635544|NCT01582152|82809253|FG001|Overall Study|Adverse Event|1|||
46747180|NCT02324569|82964454|FG001|Overall Study|Inconvenient Schedule|0|||
46747181|NCT02038075|82964492|FG000|Overall Study|Withdrawal by Subject|3|||
46747182|NCT02038075|82964493|FG001|Overall Study|Withdrawal by Subject|0|||
46747183|NCT01864746|82964501|FG000|Overall Study|Disease recurrence|25|||
46747184|NCT01864746|82964502|FG001|Overall Study|Disease recurrence|40|||
46747185|NCT01864746|82964501|FG000|Overall Study|Second primary invasive nonbreast|2|||
46747186|NCT01864746|82964502|FG001|Overall Study|Second primary invasive nonbreast|3|||
46747187|NCT01864746|82964501|FG000|Overall Study|Death|2|||
46747188|NCT01864746|82964502|FG001|Overall Study|Death|1|||
46747189|NCT01864746|82964501|FG000|Overall Study|Adverse Event|33|||
46747190|NCT01864746|82964502|FG001|Overall Study|Adverse Event|5|||
46923371|NCT02122458|83156997|FG006|Overall Study|Experimental Error|0|||
46923372|NCT02122458|83156991|FG000|Overall Study|Deployed or Moved|0|||
46923373|NCT02122458|83156992|FG001|Overall Study|Deployed or Moved|0|||
46747191|NCT01864746|82964501|FG000|Overall Study|Withdrawal by Subject|56|||
46747192|NCT01864746|82964502|FG001|Overall Study|Withdrawal by Subject|41|||
46747193|NCT01864746|82964501|FG000|Overall Study|Physician Decision|5|||
46747194|NCT01864746|82964502|FG001|Overall Study|Physician Decision|6|||
46747195|NCT00590577|82964549|FG000|Overall Study|Lack of Efficacy|31|||
46747196|NCT00590577|82964550|FG001|Overall Study|Lack of Efficacy|28|||
46747197|NCT00590577|82964551|FG002|Overall Study|Lack of Efficacy|23|||
46747198|NCT00590577|82964552|FG003|Overall Study|Lack of Efficacy|45|||
46747199|NCT00590577|82964549|FG000|Overall Study|Withdrawal by Subject|23|||
46747200|NCT00590577|82964550|FG001|Overall Study|Withdrawal by Subject|28|||
46747201|NCT00590577|82964551|FG002|Overall Study|Withdrawal by Subject|30|||
46747202|NCT00590577|82964552|FG003|Overall Study|Withdrawal by Subject|26|||
46747203|NCT00590577|82964549|FG000|Overall Study|Adverse Event|10|||
46747204|NCT00590577|82964550|FG001|Overall Study|Adverse Event|10|||
46747205|NCT00590577|82964551|FG002|Overall Study|Adverse Event|13|||
46747206|NCT00590577|82964552|FG003|Overall Study|Adverse Event|11|||
46747207|NCT00590577|82964549|FG000|Overall Study|Lost to Follow-up|12|||
46747208|NCT00590577|82964550|FG001|Overall Study|Lost to Follow-up|6|||
46747209|NCT00590577|82964551|FG002|Overall Study|Lost to Follow-up|6|||
46747210|NCT00590577|82964552|FG003|Overall Study|Lost to Follow-up|9|||
46747211|NCT00590577|82964549|FG000|Overall Study|Pregnancy|0|||
46747212|NCT00590577|82964550|FG001|Overall Study|Pregnancy|1|||
46747213|NCT00590577|82964551|FG002|Overall Study|Pregnancy|0|||
46747214|NCT00590577|82964552|FG003|Overall Study|Pregnancy|0|||
46747215|NCT00590577|82964549|FG000|Overall Study|Various reasons|1|||
46747216|NCT00590577|82964550|FG001|Overall Study|Various reasons|3|||
46747217|NCT00590577|82964551|FG002|Overall Study|Various reasons|1|||
46747218|NCT00590577|82964552|FG003|Overall Study|Various reasons|2|||
46747219|NCT00614575|82964562|FG000|Overall Study|Adverse Event|106|||
46747220|NCT00614575|82964562|FG000|Overall Study|Lost to Follow-up|55|||
46747221|NCT00614575|82964562|FG000|Overall Study|Lack of Efficacy|14|||
46747222|NCT00614575|82964562|FG000|Overall Study|Withdrawal by Subject|6|||
46747223|NCT00614575|82964562|FG000|Overall Study|Death|3|||
46747224|NCT00614575|82964562|FG000|Overall Study|Physician Decision|2|||
46747225|NCT00614575|82964562|FG000|Overall Study|No data were collected.|18|||
46747226|NCT00614575|82964562|FG000|Overall Study|Irregularly enrolled patients|23|||
46747227|NCT00614575|82964562|FG000|Overall Study|No treatment|1|||
46747228|NCT00805935|82964570|FG000|Overall Study|Stimulation Failure|1|||
46747229|NCT00805935|82964571|FG001|Overall Study|Stimulation Failure|5|||
46747230|NCT00805935|82964572|FG002|Overall Study|Stimulation Failure|2|||
46747231|NCT00805935|82964573|FG003|Overall Study|Stimulation Failure|2|||
46747232|NCT00805935|82964570|FG000|Overall Study|Cycle cancelled|0|||
46747233|NCT00805935|82964571|FG001|Overall Study|Cycle cancelled|0|||
46747234|NCT00805935|82964572|FG002|Overall Study|Cycle cancelled|2|||
46747235|NCT00805935|82964573|FG003|Overall Study|Cycle cancelled|0|||
46747236|NCT00805935|82964570|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
46747237|NCT00805935|82964571|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
46747238|NCT00805935|82964572|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
46747239|NCT00805935|82964573|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
46747240|NCT00805935|82964570|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
46747241|NCT00805935|82964571|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
46747242|NCT00805935|82964572|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
46747243|NCT00805935|82964573|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
46747244|NCT00805935|82964570|FG000|Overall Study|Lost to Follow-up|1|||
46923374|NCT02122458|83156993|FG002|Overall Study|Deployed or Moved|0|||
46923375|NCT02122458|83156994|FG003|Overall Study|Deployed or Moved|0|||
46923376|NCT02122458|83156995|FG004|Overall Study|Deployed or Moved|1|||
46923377|NCT02122458|83156996|FG005|Overall Study|Deployed or Moved|0|||
46923378|NCT02122458|83156997|FG006|Overall Study|Deployed or Moved|0|||
46923379|NCT02122458|83156991|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
46747245|NCT00805935|82964571|FG001|Overall Study|Lost to Follow-up|0|||
46923380|NCT02122458|83156992|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
46923381|NCT02122458|83156993|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
46923382|NCT02122458|83156994|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
47052011|NCT00989235|83317905|FG001|Overall Study|Randomized by Mistake|2|||
47052012|NCT00989235|83317904|FG000|Overall Study|Lost to Follow-up|0|||
46747246|NCT00805935|82964572|FG002|Overall Study|Lost to Follow-up|0|||
46747247|NCT00805935|82964573|FG003|Overall Study|Lost to Follow-up|0|||
46747248|NCT00805935|82964570|FG000|Overall Study|No positive serum pregnancy|8|||
46747249|NCT00805935|82964571|FG001|Overall Study|No positive serum pregnancy|7|||
46747250|NCT00805935|82964572|FG002|Overall Study|No positive serum pregnancy|6|||
46747251|NCT00805935|82964573|FG003|Overall Study|No positive serum pregnancy|5|||
46747252|NCT00805935|82964570|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
46747253|NCT00805935|82964571|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
46747254|NCT00805935|82964572|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
46747255|NCT00805935|82964573|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
46747256|NCT00805935|82964570|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
46635545|NCT01581684|82809269|FG000|Overall Study|Other reason not defined|0|||
46635546|NCT01581684|82809270|FG001|Overall Study|Other reason not defined|0|||
46635547|NCT01581684|82809271|FG002|Overall Study|Other reason not defined|0|||
46635548|NCT01581684|82809272|FG003|Overall Study|Other reason not defined|0|||
46635549|NCT01581684|82809273|FG004|Overall Study|Other reason not defined|0|||
46635550|NCT01581684|82809274|FG005|Overall Study|Other reason not defined|0|||
46635551|NCT01581684|82809275|FG006|Overall Study|Other reason not defined|0|||
46747257|NCT00805935|82964571|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
46747258|NCT00805935|82964572|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
46747259|NCT00805935|82964573|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
46747260|NCT00805935|82964570|FG000|Overall Study|Biochemical pregnancy|0|||
46747261|NCT00805935|82964571|FG001|Overall Study|Biochemical pregnancy|1|||
46747262|NCT00805935|82964572|FG002|Overall Study|Biochemical pregnancy|0|||
46747263|NCT00805935|82964573|FG003|Overall Study|Biochemical pregnancy|0|||
46747264|NCT00805935|82964570|FG000|Overall Study|Chemical pregnancy|0|||
46747265|NCT00805935|82964571|FG001|Overall Study|Chemical pregnancy|5|||
46747266|NCT00805935|82964572|FG002|Overall Study|Chemical pregnancy|3|||
46747267|NCT00805935|82964573|FG003|Overall Study|Chemical pregnancy|2|||
46747268|NCT00805935|82964570|FG000|Overall Study|Ectopic pregnancy|0|||
46635552|NCT01581684|82809276|FG007|Overall Study|Other reason not defined|0|||
46635553|NCT01581684|82809277|FG008|Overall Study|Other reason not defined|1|||
46635554|NCT01581684|82809278|FG009|Overall Study|Other reason not defined|0|||
46635555|NCT01557582|82809311|FG000|Overall Study|Protocol Violation|4|||
46747269|NCT00805935|82964571|FG001|Overall Study|Ectopic pregnancy|0|||
46747270|NCT00805935|82964572|FG002|Overall Study|Ectopic pregnancy|1|||
46747271|NCT00805935|82964573|FG003|Overall Study|Ectopic pregnancy|0|||
46747272|NCT00805935|82964570|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
46747273|NCT00805935|82964571|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
46747274|NCT00805935|82964572|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
46747275|NCT00805935|82964573|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
46747276|NCT00805545|82964587|FG000|Overall Study|Protocol Violation|3|||
46747277|NCT00805545|82964588|FG001|Overall Study|Protocol Violation|2|||
46747278|NCT00805545|82964587|FG000|Overall Study|Protocol Violation|3|||
46747279|NCT00805545|82964588|FG001|Overall Study|Protocol Violation|1|||
46747280|NCT00590031|82964620|FG000|Overall Study|Adverse Event|3|||
46747281|NCT00590031|82964620|FG000|Overall Study|Withdrawal by Subject|1|||
46747282|NCT00590031|82964620|FG000|Overall Study|Metastatic Disease|1|||
46747283|NCT00590031|82964620|FG000|Overall Study|Admin Hold|1|||
46747284|NCT00615199|82964628|FG000|Overall Study|Adverse Event|3|||
46747285|NCT00615199|82964629|FG001|Overall Study|Adverse Event|1|||
46747286|NCT00615199|82964630|FG002|Overall Study|Adverse Event|1|||
46747287|NCT00615199|82964631|FG003|Overall Study|Adverse Event|0|||
46747288|NCT00615199|82964628|FG000|Overall Study|Lack of Efficacy|2|||
46747289|NCT00615199|82964629|FG001|Overall Study|Lack of Efficacy|0|||
46747290|NCT00615199|82964630|FG002|Overall Study|Lack of Efficacy|0|||
46747291|NCT00615199|82964631|FG003|Overall Study|Lack of Efficacy|1|||
46747292|NCT00615199|82964628|FG000|Overall Study|Lost to Follow-up|1|||
46747293|NCT00615199|82964629|FG001|Overall Study|Lost to Follow-up|0|||
46747294|NCT00615199|82964630|FG002|Overall Study|Lost to Follow-up|0|||
46747295|NCT00615199|82964631|FG003|Overall Study|Lost to Follow-up|0|||
46747296|NCT00615199|82964628|FG000|Overall Study|Other|0|||
46747297|NCT00615199|82964629|FG001|Overall Study|Other|0|||
46747298|NCT00615199|82964630|FG002|Overall Study|Other|0|||
46747299|NCT00615199|82964631|FG003|Overall Study|Other|1|||
46747300|NCT00615199|82964628|FG000|Overall Study|Withdrawal by Subject|2|||
46747301|NCT00615199|82964629|FG001|Overall Study|Withdrawal by Subject|1|||
46747302|NCT00615199|82964630|FG002|Overall Study|Withdrawal by Subject|0|||
46747303|NCT00615199|82964631|FG003|Overall Study|Withdrawal by Subject|0|||
46635556|NCT01557582|82809311|FG000|Overall Study|Operator error|2|||
46747304|NCT00613951|82964644|FG000|Overall Study|Adverse Event|1|||
46747305|NCT00613951|82964645|FG001|Overall Study|Adverse Event|0|||
46747306|NCT00613951|82964646|FG002|Overall Study|Adverse Event|1|||
46747307|NCT00613951|82964644|FG000|Overall Study|Lack of Efficacy|0|||
46747308|NCT00613951|82964645|FG001|Overall Study|Lack of Efficacy|1|||
46747309|NCT00613951|82964646|FG002|Overall Study|Lack of Efficacy|1|||
46747310|NCT00613951|82964644|FG000|Overall Study|Protocol Violation|1|||
46747311|NCT00613951|82964645|FG001|Overall Study|Protocol Violation|1|||
46747312|NCT00613951|82964646|FG002|Overall Study|Protocol Violation|1|||
46747313|NCT00613951|82964644|FG000|Overall Study|Unclassified|5|||
46804731|NCT00398866|83023773|FG002|Overall Study|Withdrawal by Subject|2|||
46804732|NCT00398866|83023771|FG000|Overall Study|Unable to complete requirements of study|1|||
46804733|NCT00398866|83023772|FG001|Overall Study|Unable to complete requirements of study|1|||
46804734|NCT00398866|83023773|FG002|Overall Study|Unable to complete requirements of study|1|||
46804735|NCT00398632|83023782|FG000|Overall Study|Withdrawal by Subject|1|||
46804736|NCT00398632|83023782|FG000|Overall Study|Lack of Efficacy|1|||
46804737|NCT00673361|83023787|FG000|Overall Study|Screen Failure|2|||
46804738|NCT00393718|83023793|FG000|Overall Study|Adverse Event|20|||
46747314|NCT00613951|82964645|FG001|Overall Study|Unclassified|3|||
46747315|NCT00613951|82964646|FG002|Overall Study|Unclassified|2|||
46747316|NCT00805467|82964661|FG000|Overall Study|Lack of Efficacy|0|||
46747317|NCT00805467|82964662|FG001|Overall Study|Lack of Efficacy|8|||
46747318|NCT00805467|82964663|FG002|Overall Study|Lack of Efficacy|13|||
46747319|NCT00805467|82964664|FG003|Overall Study|Lack of Efficacy|86|||
46747320|NCT00805467|82964661|FG000|Overall Study|Lost to Follow-up|0|||
46747321|NCT00805467|82964662|FG001|Overall Study|Lost to Follow-up|1|||
46747322|NCT00805467|82964663|FG002|Overall Study|Lost to Follow-up|7|||
46747323|NCT00805467|82964664|FG003|Overall Study|Lost to Follow-up|21|||
46747324|NCT00805467|82964661|FG000|Overall Study|Withdrawal by Subject|0|||
46747325|NCT00805467|82964662|FG001|Overall Study|Withdrawal by Subject|6|||
46747326|NCT00805467|82964663|FG002|Overall Study|Withdrawal by Subject|45|||
46747327|NCT00805467|82964664|FG003|Overall Study|Withdrawal by Subject|50|||
46747328|NCT00805467|82964661|FG000|Overall Study|Protocol Violation|0|||
46747329|NCT00805467|82964662|FG001|Overall Study|Protocol Violation|3|||
46747330|NCT00805467|82964663|FG002|Overall Study|Protocol Violation|0|||
46747331|NCT00805467|82964664|FG003|Overall Study|Protocol Violation|5|||
46747332|NCT00805467|82964661|FG000|Overall Study|Adverse Event|0|||
46747333|NCT00805467|82964662|FG001|Overall Study|Adverse Event|13|||
46747334|NCT00805467|82964663|FG002|Overall Study|Adverse Event|26|||
46747335|NCT00805467|82964664|FG003|Overall Study|Adverse Event|57|||
46747336|NCT00805467|82964661|FG000|Overall Study|Death|0|||
46747337|NCT00805467|82964662|FG001|Overall Study|Death|2|||
46747338|NCT00805467|82964663|FG002|Overall Study|Death|7|||
46747339|NCT00805467|82964664|FG003|Overall Study|Death|5|||
46747340|NCT00805467|82964661|FG000|Overall Study|Physician Decision|0|||
46747341|NCT00805467|82964662|FG001|Overall Study|Physician Decision|1|||
46747342|NCT00805467|82964663|FG002|Overall Study|Physician Decision|2|||
46747343|NCT00805467|82964664|FG003|Overall Study|Physician Decision|6|||
46747344|NCT00805467|82964661|FG000|Overall Study|Not reported|0|||
46747345|NCT00805467|82964662|FG001|Overall Study|Not reported|0|||
46747346|NCT00805467|82964663|FG002|Overall Study|Not reported|3|||
46747347|NCT00805467|82964664|FG003|Overall Study|Not reported|7|||
46747348|NCT00958841|82964674|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46747349|NCT00958841|82964674|FG000|Overall Study|Abnormal test procedure result(s)|3|||
46747350|NCT00958841|82964674|FG000|Overall Study|Administrative problems|1|||
46747351|NCT00958841|82964674|FG000|Overall Study|Adverse Event|8|||
46747352|NCT00958841|82964674|FG000|Overall Study|New cancer therapy|5|||
46747353|NCT00958841|82964674|FG000|Overall Study|Withdrawal by Subject|1|||
46747354|NCT00958841|82964674|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
46747355|NCT00958841|82964674|FG000|Overall Study|Completed M6/did not enter extension|27|||
46747356|NCT00958841|82964674|FG000|Overall Study|Discontinued prior to M*|28|||
46747357|NCT00613327|82964737|FG000|Overall Study|Adverse Event|38|||
46747358|NCT00613327|82964737|FG000|Overall Study|Lost to Follow-up|8|||
46747359|NCT00613327|82964737|FG000|Overall Study|Withdrawal by Subject|6|||
46747360|NCT00613327|82964737|FG000|Overall Study|Protocol Violation|2|||
46747361|NCT00613327|82964737|FG000|Overall Study|Other|47|||
46747362|NCT00954941|82964743|FG000|Overall Study|Received treatment at home|1|||
46747363|NCT00954941|82964744|FG001|Overall Study|Received treatment at home|0|||
46747364|NCT00954941|82964743|FG000|Overall Study|Withdrawal by Subject|1|||
46747365|NCT00954941|82964744|FG001|Overall Study|Withdrawal by Subject|0|||
46747366|NCT00954941|82964743|FG000|Overall Study|Insurance Denial|2|||
46747367|NCT00954941|82964744|FG001|Overall Study|Insurance Denial|2|||
46747368|NCT00954941|82964743|FG000|Overall Study|Physician Decision|2|||
46747369|NCT00954941|82964744|FG001|Overall Study|Physician Decision|2|||
46747370|NCT00954941|82964743|FG000|Overall Study|Ineligible|2|||
46747371|NCT00954941|82964744|FG001|Overall Study|Ineligible|2|||
46747372|NCT00954941|82964743|FG000|Overall Study|Adverse Event|0|||
46747373|NCT00954941|82964744|FG001|Overall Study|Adverse Event|1|||
46747374|NCT00954707|82964750|FG000|Overall Study|Death|34|||
46747375|NCT00954707|82964750|FG000|Overall Study|Withdrawal by Subject|100|||
46747376|NCT00954707|82964750|FG000|Overall Study|Lost to Follow-up|33|||
46747377|NCT00589797|82964756|FG000|Overall Study|Death|1|||
46747378|NCT00589797|82964757|FG001|Overall Study|Death|0|||
46747379|NCT00589797|82964756|FG000|Overall Study|Lost to Follow-up|12|||
46747380|NCT00589797|82964757|FG001|Overall Study|Lost to Follow-up|9|||
46747381|NCT00589797|82964756|FG000|Overall Study|Physician Decision|8|||
46747382|NCT00589797|82964757|FG001|Overall Study|Physician Decision|3|||
46747383|NCT00589797|82964756|FG000|Overall Study|Withdrawal by Subject|6|||
46747384|NCT00589797|82964757|FG001|Overall Study|Withdrawal by Subject|5|||
46747385|NCT00589797|82964756|FG000|Overall Study|Non-Randomized Training Subjects|46|||
46747386|NCT00589797|82964757|FG001|Overall Study|Non-Randomized Training Subjects|6|||
46747387|NCT00613171|82964763|FG000|Overall Study|Adverse Event|7|||
46747388|NCT00613171|82964763|FG000|Overall Study|Withdrawal by Subject|3|||
46747389|NCT00613171|82964763|FG000|Overall Study|Reason not Specified|4|||
46747390|NCT00896480|82964768|FG000|Overall Study|Disease progression/recurrence|21|||
46747391|NCT00953225|82964777|FG000|Overall Study|Withdrawal by Subject|2|||
46747392|NCT00953225|82964778|FG001|Overall Study|Withdrawal by Subject|0|||
46747393|NCT00613015|82964790|FG000|Overall Study|Lost to Follow-up|0|||
46747394|NCT00613015|82964791|FG001|Overall Study|Lost to Follow-up|1|||
46747395|NCT00613015|82964792|FG002|Overall Study|Lost to Follow-up|3|||
46747396|NCT00613015|82964793|FG003|Overall Study|Lost to Follow-up|3|||
46747397|NCT00613015|82964794|FG004|Overall Study|Lost to Follow-up|2|||
46747398|NCT00613015|82964795|FG005|Overall Study|Lost to Follow-up|3|||
46747399|NCT00803595|82964812|FG000|Overall Study|Adverse Event|3|||
46747400|NCT00803595|82964813|FG001|Overall Study|Adverse Event|4|||
46747401|NCT00803595|82964814|FG002|Overall Study|Adverse Event|1|||
46747402|NCT00803595|82964812|FG000|Overall Study|Protocol Violation|7|||
46747403|NCT00803595|82964813|FG001|Overall Study|Protocol Violation|2|||
46747404|NCT00803595|82964814|FG002|Overall Study|Protocol Violation|12|||
46747405|NCT00803595|82964812|FG000|Overall Study|Withdrawal by Subject|5|||
46747406|NCT00803595|82964813|FG001|Overall Study|Withdrawal by Subject|2|||
46747407|NCT00803595|82964814|FG002|Overall Study|Withdrawal by Subject|3|||
46747408|NCT00953927|82964824|FG000|Overall Study|Lost to Follow-up|61|||
46747409|NCT00953927|82964825|FG001|Overall Study|Lost to Follow-up|65|||
46747410|NCT00953927|82964824|FG000|Overall Study|Withdrawal by Subject|36|||
46747411|NCT00953927|82964825|FG001|Overall Study|Withdrawal by Subject|25|||
46747412|NCT00953927|82964824|FG000|Overall Study|Death|7|||
46747413|NCT00953927|82964825|FG001|Overall Study|Death|4|||
46747414|NCT00953927|82964824|FG000|Overall Study|Other study discontinuation|1|||
46747415|NCT00953927|82964825|FG001|Overall Study|Other study discontinuation|1|||
46747416|NCT00611767|82964833|FG000|Overall Study|Withdrawal by Subject|4|||
46747417|NCT00611767|82964834|FG001|Overall Study|Withdrawal by Subject|1|||
46747418|NCT00611767|82964833|FG000|Overall Study|Thiopental not available|3|||
46747419|NCT00611767|82964834|FG001|Overall Study|Thiopental not available|0|||
46747420|NCT00611767|82964833|FG000|Overall Study|didn't like the medication|1|||
46923383|NCT02122458|83156995|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
46923384|NCT02122458|83156996|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
46923385|NCT02122458|83156997|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
46923386|NCT02122458|83156991|FG000|Overall Study|Noncompliance|0|||
46923387|NCT02122458|83156992|FG001|Overall Study|Noncompliance|1|||
46923388|NCT02122458|83156993|FG002|Overall Study|Noncompliance|0|||
46923389|NCT02122458|83156994|FG003|Overall Study|Noncompliance|0|||
46923390|NCT02122458|83156995|FG004|Overall Study|Noncompliance|0|||
46747421|NCT00611767|82964834|FG001|Overall Study|didn't like the medication|1|||
46747422|NCT00611767|82964833|FG000|Overall Study|Physician Decision|1|||
46747423|NCT00611767|82964834|FG001|Overall Study|Physician Decision|0|||
46747424|NCT00803361|82964842|FG000|Overall Study|Adverse Event|13|||
46747425|NCT00803361|82964843|FG001|Overall Study|Adverse Event|3|||
46747426|NCT00803361|82964842|FG000|Overall Study|Lack of Efficacy|4|||
46747427|NCT00803361|82964843|FG001|Overall Study|Lack of Efficacy|13|||
46747428|NCT00803361|82964842|FG000|Overall Study|Lost to Follow-up|1|||
46747429|NCT00803361|82964843|FG001|Overall Study|Lost to Follow-up|2|||
46747430|NCT00803361|82964842|FG000|Overall Study|Physician Decision|1|||
46747431|NCT00803361|82964843|FG001|Overall Study|Physician Decision|0|||
46747432|NCT00803361|82964842|FG000|Overall Study|Protocol Violation|2|||
46747433|NCT00803361|82964843|FG001|Overall Study|Protocol Violation|4|||
46747434|NCT00803361|82964842|FG000|Overall Study|Withdrawal by Subject|5|||
46747435|NCT00803361|82964843|FG001|Overall Study|Withdrawal by Subject|6|||
46747436|NCT00611533|82964849|FG000|First Intervention (6 Weeks)|Never started study|0|||
46747437|NCT00611533|82964850|FG001|First Intervention (6 Weeks)|Never started study|1|||
46747438|NCT00611533|82964849|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
46747439|NCT00611533|82964850|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
46747440|NCT00611533|82964849|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
46747441|NCT00611533|82964850|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
46747442|NCT00953147|82964869|FG000|Overall Study|Adverse Event|8|||
46747443|NCT00953147|82964870|FG001|Overall Study|Adverse Event|16|||
46923391|NCT02122458|83156996|FG005|Overall Study|Noncompliance|0|||
46923392|NCT02122458|83156997|FG006|Overall Study|Noncompliance|0|||
46923393|NCT02903511|83157013|FG000|Overall Study|Withdrawal by Subject|1|||
46923394|NCT02903511|83157014|FG001|Overall Study|Withdrawal by Subject|0|||
46747444|NCT00953147|82964871|FG002|Overall Study|Adverse Event|6|||
46747445|NCT00953147|82964869|FG000|Overall Study|Protocol Violation|2|||
46747446|NCT00953147|82964870|FG001|Overall Study|Protocol Violation|8|||
46747447|NCT00953147|82964871|FG002|Overall Study|Protocol Violation|4|||
46804739|NCT00393718|83023794|FG001|Overall Study|Adverse Event|8|||
46747448|NCT00953147|82964869|FG000|Overall Study|Withdrawal by Subject|13|||
46747449|NCT00953147|82964870|FG001|Overall Study|Withdrawal by Subject|15|||
46747450|NCT00953147|82964871|FG002|Overall Study|Withdrawal by Subject|12|||
46747451|NCT00953147|82964869|FG000|Overall Study|Lost to Follow-up|8|||
46747452|NCT00953147|82964870|FG001|Overall Study|Lost to Follow-up|9|||
46747453|NCT00953147|82964871|FG002|Overall Study|Lost to Follow-up|4|||
46923395|NCT02903511|83157013|FG000|Overall Study|Lost to Follow-up|3|||
46923396|NCT02903511|83157014|FG001|Overall Study|Lost to Follow-up|2|||
46923397|NCT01368042|83157031|FG000|Overall Study|Death|14|||
46747454|NCT00953147|82964869|FG000|Overall Study|Physician Decision|2|||
46747455|NCT00953147|82964870|FG001|Overall Study|Physician Decision|7|||
46747456|NCT00953147|82964871|FG002|Overall Study|Physician Decision|3|||
46747457|NCT00953147|82964869|FG000|Overall Study|Other|4|||
46747458|NCT00953147|82964870|FG001|Overall Study|Other|11|||
46747459|NCT00953147|82964871|FG002|Overall Study|Other|13|||
46747460|NCT00803205|82964881|FG000|Overall Study|Adverse Event|7|||
46747461|NCT00803205|82964882|FG001|Overall Study|Adverse Event|2|||
46747462|NCT00803205|82964881|FG000|Overall Study|Lost to Follow-up|1|||
46747463|NCT00803205|82964882|FG001|Overall Study|Lost to Follow-up|0|||
46747464|NCT00803205|82964881|FG000|Overall Study|Withdrawal by Subject|9|||
46747465|NCT00803205|82964882|FG001|Overall Study|Withdrawal by Subject|9|||
46747466|NCT00803205|82964881|FG000|Overall Study|Physician Decision|1|||
46747467|NCT00803205|82964882|FG001|Overall Study|Physician Decision|0|||
46747468|NCT00803205|82964881|FG000|Overall Study|Protocol Violation|1|||
46747469|NCT00803205|82964882|FG001|Overall Study|Protocol Violation|1|||
46747470|NCT00803205|82964881|FG000|Overall Study|Medical Monitor Decision|1|||
46747471|NCT00803205|82964882|FG001|Overall Study|Medical Monitor Decision|0|||
46747472|NCT00803205|82964881|FG000|Overall Study|Acquired a Lung Infection|0|||
46747473|NCT00803205|82964882|FG001|Overall Study|Acquired a Lung Infection|1|||
46747474|NCT00803205|82964881|FG000|Overall Study|Sponsor Decision|0|||
46747475|NCT00803205|82964882|FG001|Overall Study|Sponsor Decision|1|||
46747476|NCT00952523|82964888|FG000|Overall Study|Withdrawal by Subject|7|||
46747477|NCT02232737|82964897|FG000|Overall Study|Lost to Follow-up|18|||
46747478|NCT02232737|82964898|FG001|Overall Study|Lost to Follow-up|28|||
46747479|NCT02232737|82964899|FG002|Overall Study|Lost to Follow-up|33|||
46747480|NCT02232737|82964897|FG000|Overall Study|Personal reasons|7|||
46747481|NCT02232737|82964898|FG001|Overall Study|Personal reasons|8|||
46747482|NCT02232737|82964899|FG002|Overall Study|Personal reasons|14|||
46747483|NCT02232737|82964897|FG000|Overall Study|Adverse Event|6|||
46747484|NCT02232737|82964898|FG001|Overall Study|Adverse Event|3|||
46747485|NCT02232737|82964899|FG002|Overall Study|Adverse Event|8|||
46747486|NCT02232737|82964897|FG000|Overall Study|Incarcerated|2|||
46747487|NCT02232737|82964898|FG001|Overall Study|Incarcerated|1|||
46747488|NCT02232737|82964899|FG002|Overall Study|Incarcerated|2|||
46747489|NCT02232737|82964897|FG000|Overall Study|Withdrawal by Subject|0|||
46747490|NCT02232737|82964898|FG001|Overall Study|Withdrawal by Subject|1|||
46747491|NCT02232737|82964899|FG002|Overall Study|Withdrawal by Subject|2|||
46747492|NCT02232737|82964897|FG000|Overall Study|Death|0|||
46747493|NCT02232737|82964898|FG001|Overall Study|Death|1|||
46747494|NCT02232737|82964899|FG002|Overall Study|Death|1|||
46747495|NCT02232737|82964897|FG000|Overall Study|Physician Decision|1|||
46747496|NCT02232737|82964898|FG001|Overall Study|Physician Decision|3|||
46747497|NCT02232737|82964899|FG002|Overall Study|Physician Decision|1|||
46747498|NCT02232737|82964897|FG000|Overall Study|Protocol Violation|1|||
46747499|NCT02232737|82964898|FG001|Overall Study|Protocol Violation|0|||
46747500|NCT02232737|82964899|FG002|Overall Study|Protocol Violation|1|||
46747501|NCT02232737|82964897|FG000|Overall Study|Reason unknown|1|||
46747502|NCT02232737|82964898|FG001|Overall Study|Reason unknown|0|||
46747503|NCT02232737|82964899|FG002|Overall Study|Reason unknown|0|||
46747504|NCT00952367|82964907|FG000|Overall Study|Withdrawal by Subject|2|||
46747505|NCT00952367|82964907|FG000|Overall Study|Noncoordination|1|||
46747506|NCT00952367|82964907|FG000|Overall Study|Protocol Violation|3|||
46747507|NCT00948857|82964913|FG000|Overall Study|Lost to Follow-up|1|||
46747508|NCT00948857|82964914|FG001|Overall Study|Lost to Follow-up|0|||
46747509|NCT00948389|82964929|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
46747510|NCT00948389|82964930|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
46747511|NCT00948389|82964931|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
46747512|NCT00948389|82964932|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
46747513|NCT00948389|82964933|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
46747514|NCT00948389|82964929|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
46747515|NCT00948389|82964930|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
46747516|NCT00948389|82964931|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
46747517|NCT00948389|82964932|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
46747518|NCT00948389|82964933|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
46747519|NCT00948389|82964929|FG000|Overall Study|Both Progression and Toxicity|1|||
46747520|NCT00948389|82964930|FG001|Overall Study|Both Progression and Toxicity|0|||
46747521|NCT00948389|82964931|FG002|Overall Study|Both Progression and Toxicity|0|||
46923398|NCT01368042|83157031|FG000|Overall Study|Protocol Violation|11|||
46923399|NCT01368042|83157031|FG000|Overall Study|Lost to Follow-up|4|||
46923400|NCT01368042|83157031|FG000|Overall Study|Transplanted|1|||
46747522|NCT00948389|82964932|FG003|Overall Study|Both Progression and Toxicity|0|||
46747523|NCT00948389|82964933|FG004|Overall Study|Both Progression and Toxicity|0|||
46747524|NCT00948155|82964949|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
46923401|NCT00126776|83157037|FG000|Overall Study|follow up complete on all patients|0|||
46747525|NCT00948155|82964950|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
46747526|NCT00948155|82964949|FG000|Washout 14 Days|Lost to Follow-up|1|||
46747527|NCT00948155|82964950|FG001|Washout 14 Days|Lost to Follow-up|2|||
46747528|NCT00958217|82964960|FG000|Overall Study|Death|2|||
46747529|NCT00958217|82964961|FG001|Overall Study|Death|1|||
46747530|NCT00958217|82964960|FG000|Overall Study|Withdrawal by Subject|4|||
46747531|NCT00958217|82964961|FG001|Overall Study|Withdrawal by Subject|3|||
46747532|NCT00958217|82964960|FG000|Overall Study|Lost to Follow-up|17|||
46747533|NCT00958217|82964961|FG001|Overall Study|Lost to Follow-up|19|||
46747534|NCT00958217|82964960|FG000|Overall Study|Moved out of area|1|||
46747535|NCT00958217|82964961|FG001|Overall Study|Moved out of area|1|||
46747536|NCT00958217|82964960|FG000|Overall Study|Inpatient hospitalization|0|||
46747537|NCT00958217|82964961|FG001|Overall Study|Inpatient hospitalization|1|||
46747538|NCT00891020|82964971|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
46747539|NCT00891020|82964972|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
46747540|NCT00891020|82964973|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
46747541|NCT00891020|82964971|FG000|24 Week Treatment Period|Death|0|||
46747542|NCT00891020|82964972|FG001|24 Week Treatment Period|Death|2|||
46747543|NCT00891020|82964973|FG002|24 Week Treatment Period|Death|0|||
46747544|NCT00891020|82964971|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
46747545|NCT00891020|82964972|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
46747546|NCT00891020|82964973|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
46747547|NCT00891020|82964971|FG000|24 Week Treatment Period|Failure to return|4|||
46747548|NCT00891020|82964972|FG001|24 Week Treatment Period|Failure to return|5|||
46747549|NCT00891020|82964973|FG002|24 Week Treatment Period|Failure to return|5|||
46747550|NCT00891020|82964971|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
46923402|NCT00126776|83157038|FG001|Overall Study|follow up complete on all patients|0|||
46923403|NCT01674010|83157042|FG000|Open Treatment Phase 1|Adverse Event|10|||
46923404|NCT01674010|83157043|FG001|Open Treatment Phase 1|Adverse Event|0|||
46747551|NCT00891020|82964972|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
46747552|NCT00891020|82964973|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
46747553|NCT00891020|82964971|FG000|24 Week Treatment Period|Other protocol violation|1|||
46747554|NCT00891020|82964972|FG001|24 Week Treatment Period|Other protocol violation|1|||
46747555|NCT00891020|82964973|FG002|24 Week Treatment Period|Other protocol violation|2|||
46747556|NCT00891020|82964971|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
46747557|NCT00891020|82964972|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
46747558|NCT00891020|82964973|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
46747559|NCT00891020|82964971|FG000|24 Week Treatment Period|Withdrew consent|6|||
46747560|NCT00891020|82964972|FG001|24 Week Treatment Period|Withdrew consent|3|||
46747561|NCT00891020|82964973|FG002|24 Week Treatment Period|Withdrew consent|15|||
46747562|NCT00891020|82964971|FG000|24 Week Treatment Period|Administrative/Other|5|||
46747563|NCT00891020|82964972|FG001|24 Week Treatment Period|Administrative/Other|6|||
46747564|NCT00891020|82964973|FG002|24 Week Treatment Period|Administrative/Other|1|||
46747565|NCT00891020|82964971|FG000|Long-term Extension Period|Adverse Event|1|||
46747566|NCT00891020|82964972|FG001|Long-term Extension Period|Adverse Event|11|||
46747567|NCT00891020|82964973|FG002|Long-term Extension Period|Adverse Event|10|||
46747568|NCT00891020|82964971|FG000|Long-term Extension Period|Death|0|||
46747569|NCT00891020|82964972|FG001|Long-term Extension Period|Death|0|||
46747570|NCT00891020|82964973|FG002|Long-term Extension Period|Death|1|||
46747571|NCT00891020|82964971|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
46747572|NCT00891020|82964972|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
46747573|NCT00891020|82964973|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
46747574|NCT00891020|82964971|FG000|Long-term Extension Period|Protocol Violation|0|||
46747575|NCT00891020|82964972|FG001|Long-term Extension Period|Protocol Violation|1|||
46747576|NCT00891020|82964973|FG002|Long-term Extension Period|Protocol Violation|1|||
46747577|NCT00891020|82964971|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
46747578|NCT00891020|82964972|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
46747579|NCT00891020|82964973|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
46747580|NCT00891020|82964971|FG000|Long-term Extension Period|Failure to return|0|||
46747581|NCT00891020|82964972|FG001|Long-term Extension Period|Failure to return|2|||
46747582|NCT00891020|82964973|FG002|Long-term Extension Period|Failure to return|3|||
46923405|NCT01674010|83157044|FG002|Open Treatment Phase 1|Adverse Event|0|||
46923406|NCT01674010|83157042|FG000|Open Treatment Phase 1|Death|1|||
46747583|NCT00891020|82964971|FG000|Long-term Extension Period|Administrative|1|||
46747584|NCT00891020|82964972|FG001|Long-term Extension Period|Administrative|2|||
46747585|NCT00891020|82964973|FG002|Long-term Extension Period|Administrative|2|||
46747586|NCT00611455|82964985|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
46747587|NCT00611455|82964986|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
46747588|NCT00611455|82964987|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
46747589|NCT00611455|82964985|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
46747590|NCT00611455|82964986|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
46747591|NCT00611455|82964987|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
46775753|NCT00793793|82994210|FG006|Overall Study|Lost to Follow-up|0|||
46923407|NCT01674010|83157043|FG001|Open Treatment Phase 1|Death|0|||
46923408|NCT01674010|83157044|FG002|Open Treatment Phase 1|Death|0|||
46747592|NCT00611455|82964985|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
46747593|NCT00611455|82964986|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
46747594|NCT00611455|82964987|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
46747595|NCT00611455|82964985|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
46747596|NCT00611455|82964986|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
46747597|NCT00611455|82964987|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46747598|NCT00611455|82964985|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
46747599|NCT00611455|82964986|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
46747600|NCT00611455|82964987|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
46747601|NCT00611455|82964985|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
46747602|NCT00611455|82964986|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
46747603|NCT00611455|82964987|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
46747604|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
46747605|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
46747606|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
46747607|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
46747608|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
46747609|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
46747610|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
46747611|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
46747612|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
46747613|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
46747614|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
46747615|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
46923409|NCT01674010|83157042|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
46923410|NCT01674010|83157043|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
46747616|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
46747617|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
46747618|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
46747619|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
46747620|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
46747621|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
46747622|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
46923411|NCT01674010|83157044|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
46923412|NCT01674010|83157042|FG000|Open Treatment Phase 1|Physician Decision|9|||
46923413|NCT01674010|83157043|FG001|Open Treatment Phase 1|Physician Decision|0|||
46747623|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
46747624|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
46747625|NCT00611455|82964985|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
46747626|NCT00611455|82964986|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
46747627|NCT00611455|82964987|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
46747628|NCT00611455|82964985|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
46747629|NCT00611455|82964986|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
46747630|NCT00611455|82964987|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
46747631|NCT00611455|82964985|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
46923414|NCT01674010|83157044|FG002|Open Treatment Phase 1|Physician Decision|0|||
46923415|NCT01674010|83157042|FG000|Open Treatment Phase 1|Protocol Violation|7|||
46923416|NCT01674010|83157043|FG001|Open Treatment Phase 1|Protocol Violation|0|||
46923417|NCT01674010|83157044|FG002|Open Treatment Phase 1|Protocol Violation|0|||
46923418|NCT01674010|83157042|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
46923419|NCT01674010|83157043|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
46923420|NCT01674010|83157044|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
46923421|NCT01674010|83157042|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
46923422|NCT01674010|83157043|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
46923423|NCT01674010|83157044|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
46923424|NCT01674010|83157042|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
46923425|NCT01674010|83157043|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
46923426|NCT01674010|83157044|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
46923427|NCT01674010|83157042|FG000|Randomization Phase 2|Adverse Event|0|||
46923428|NCT01674010|83157043|FG001|Randomization Phase 2|Adverse Event|1|||
46923429|NCT01674010|83157044|FG002|Randomization Phase 2|Adverse Event|1|||
46923430|NCT01674010|83157042|FG000|Randomization Phase 2|Lost to Follow-up|0|||
46923431|NCT01674010|83157043|FG001|Randomization Phase 2|Lost to Follow-up|1|||
46923432|NCT01674010|83157044|FG002|Randomization Phase 2|Lost to Follow-up|2|||
46923433|NCT01674010|83157042|FG000|Randomization Phase 2|Mood episode recurrence|0|||
46923434|NCT01674010|83157043|FG001|Randomization Phase 2|Mood episode recurrence|8|||
46775754|NCT00793793|82994211|FG007|Overall Study|Lost to Follow-up|0|||
47052013|NCT00989235|83317905|FG001|Overall Study|Lost to Follow-up|1|||
46747632|NCT00611455|82964986|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
46747633|NCT00611455|82964987|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
46747634|NCT00611455|82964985|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
46747635|NCT00611455|82964986|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
46747636|NCT00611455|82964987|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
46747637|NCT00611455|82964985|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
46747638|NCT00611455|82964986|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
46747639|NCT00611455|82964987|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
46747640|NCT00611455|82964985|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
46747641|NCT00611455|82964986|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
46747642|NCT00611455|82964987|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
46747643|NCT00611455|82964985|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
46747644|NCT00611455|82964986|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
46747645|NCT00611455|82964987|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
46747646|NCT00611455|82964985|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
46747647|NCT00611455|82964986|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
46747648|NCT00611455|82964987|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
46747649|NCT00952289|82964999|FG000|All Participants|Death|9|||
46747650|NCT00952289|82965000|FG001|All Participants|Death|9|||
46747651|NCT00952289|82964999|FG000|All Participants|Adverse Event|8|||
46747652|NCT00952289|82965000|FG001|All Participants|Adverse Event|8|||
46747653|NCT00952289|82964999|FG000|All Participants|Disease progression|3|||
46747654|NCT00952289|82965000|FG001|All Participants|Disease progression|12|||
46923435|NCT01674010|83157044|FG002|Randomization Phase 2|Mood episode recurrence|2|||
46923436|NCT01674010|83157042|FG000|Randomization Phase 2|Physician Decision|0|||
46923437|NCT01674010|83157043|FG001|Randomization Phase 2|Physician Decision|0|||
46923438|NCT01674010|83157044|FG002|Randomization Phase 2|Physician Decision|2|||
46923439|NCT01674010|83157042|FG000|Randomization Phase 2|Pregnancy|0|||
46923440|NCT01674010|83157043|FG001|Randomization Phase 2|Pregnancy|1|||
46923441|NCT01674010|83157044|FG002|Randomization Phase 2|Pregnancy|1|||
46747655|NCT00952289|82964999|FG000|All Participants|Withdrawal by Subject|1|||
46747656|NCT00952289|82965000|FG001|All Participants|Withdrawal by Subject|10|||
46747657|NCT00952289|82964999|FG000|All Participants|Data lost during site relocation|0|||
46747658|NCT00952289|82965000|FG001|All Participants|Data lost during site relocation|1|||
46747659|NCT00952289|82964999|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
46747660|NCT00952289|82965000|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
46923442|NCT01674010|83157042|FG000|Randomization Phase 2|Protocol Violation|0|||
46923443|NCT01674010|83157043|FG001|Randomization Phase 2|Protocol Violation|1|||
46923444|NCT01674010|83157044|FG002|Randomization Phase 2|Protocol Violation|1|||
46923445|NCT01674010|83157042|FG000|Randomization Phase 2|Sponsor Decision|0|||
46923446|NCT01674010|83157043|FG001|Randomization Phase 2|Sponsor Decision|42|||
46923447|NCT01674010|83157044|FG002|Randomization Phase 2|Sponsor Decision|45|||
46923448|NCT01674010|83157042|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
46923449|NCT01674010|83157043|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
46923450|NCT01674010|83157044|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
46923451|NCT01345669|83157054|FG000|Overall Study|Primary tumour recurrence|53|||
46923452|NCT01345669|83157055|FG001|Overall Study|Primary tumour recurrence|32|||
46747661|NCT00952289|82964999|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
46747662|NCT00952289|82965000|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
46747663|NCT00952289|82964999|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
46747664|NCT00952289|82965000|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
46747665|NCT00952289|82964999|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
46747666|NCT00952289|82965000|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
46747667|NCT00952289|82964999|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
46747668|NCT00952289|82965000|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
46747669|NCT00612313|82965008|FG000|Overall Study|Withdrawal by Subject|6|||
46747670|NCT00612313|82965009|FG001|Overall Study|Withdrawal by Subject|9|||
46747671|NCT00612313|82965008|FG000|Overall Study|Lost to Follow-up|11|||
46747672|NCT00612313|82965009|FG001|Overall Study|Lost to Follow-up|4|||
46747673|NCT00890552|82965021|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
46747674|NCT00890552|82965021|FG000|On-treatment|Early prog disease/ death|10|||
46747675|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
46747676|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
46747677|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
46747678|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
46923453|NCT01345669|83157054|FG000|Overall Study|Second primary tumour|4|||
46923454|NCT01345669|83157055|FG001|Overall Study|Second primary tumour|3|||
46923455|NCT01345669|83157054|FG000|Overall Study|Adverse Event|63|||
46923456|NCT01345669|83157055|FG001|Overall Study|Adverse Event|9|||
46747679|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
46747680|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
46747681|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
46747682|NCT00946985|82965025|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
46747683|NCT00946985|82965025|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
46747684|NCT00611923|82965031|FG000|Overall Study|Withdrawal by Subject|2|||
46747685|NCT00611923|82965032|FG001|Overall Study|Withdrawal by Subject|2|||
46747686|NCT00609973|82965042|FG000|Overall Study|Adverse Event|2|||
46747687|NCT00609973|82965043|FG001|Overall Study|Adverse Event|1|||
46747688|NCT00609973|82965042|FG000|Overall Study|Protocol Violation|4|||
46747689|NCT00609973|82965043|FG001|Overall Study|Protocol Violation|3|||
46747690|NCT00609973|82965042|FG000|Overall Study|Lost to Follow-up|2|||
46747691|NCT00609973|82965043|FG001|Overall Study|Lost to Follow-up|1|||
46747692|NCT00609973|82965042|FG000|Overall Study|Withdrawal by Subject|0|||
46747693|NCT00609973|82965043|FG001|Overall Study|Withdrawal by Subject|1|||
46923457|NCT01345669|83157054|FG000|Overall Study|Protocol Violation|3|||
46923458|NCT01345669|83157055|FG001|Overall Study|Protocol Violation|1|||
46923459|NCT01345669|83157054|FG000|Overall Study|Lost to Follow-up|1|||
46923460|NCT01345669|83157055|FG001|Overall Study|Lost to Follow-up|1|||
46923461|NCT01345669|83157054|FG000|Overall Study|Withdrawal by Subject|52|||
46923462|NCT01345669|83157055|FG001|Overall Study|Withdrawal by Subject|13|||
46923463|NCT01345669|83157054|FG000|Overall Study|Other Reasons|111|||
46923464|NCT01345669|83157055|FG001|Overall Study|Other Reasons|60|||
46923465|NCT05334212|83157061|FG000|Overall Study|Study terminated prematurely|7|||
46923466|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
46923467|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
46747694|NCT00803049|82965053|FG000|Overall Study|Adverse Event|21|||
46747695|NCT00803049|82965054|FG001|Overall Study|Adverse Event|33|||
46747696|NCT00803049|82965055|FG002|Overall Study|Adverse Event|13|||
46747697|NCT00803049|82965056|FG003|Overall Study|Adverse Event|27|||
46747698|NCT00803049|82965053|FG000|Overall Study|Lack of Efficacy|10|||
46747699|NCT00803049|82965054|FG001|Overall Study|Lack of Efficacy|19|||
46747700|NCT00803049|82965055|FG002|Overall Study|Lack of Efficacy|6|||
46747701|NCT00803049|82965056|FG003|Overall Study|Lack of Efficacy|13|||
46747702|NCT00803049|82965053|FG000|Overall Study|Lost to Follow-up|0|||
46747703|NCT00803049|82965054|FG001|Overall Study|Lost to Follow-up|2|||
46747704|NCT00803049|82965055|FG002|Overall Study|Lost to Follow-up|0|||
46747705|NCT00803049|82965056|FG003|Overall Study|Lost to Follow-up|3|||
46747706|NCT00803049|82965053|FG000|Overall Study|Death|2|||
46747707|NCT00803049|82965054|FG001|Overall Study|Death|1|||
46747708|NCT00803049|82965055|FG002|Overall Study|Death|0|||
46747709|NCT00803049|82965056|FG003|Overall Study|Death|2|||
46747710|NCT00803049|82965053|FG000|Overall Study|Progressive Disease|6|||
46747711|NCT00803049|82965054|FG001|Overall Study|Progressive Disease|10|||
46747712|NCT00803049|82965055|FG002|Overall Study|Progressive Disease|6|||
46747713|NCT00803049|82965056|FG003|Overall Study|Progressive Disease|6|||
46747714|NCT00803049|82965053|FG000|Overall Study|Withdrawal by Subject|19|||
46747715|NCT00803049|82965054|FG001|Overall Study|Withdrawal by Subject|43|||
46923468|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
46923469|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
46923470|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
46923471|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
46923472|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
46747716|NCT00803049|82965055|FG002|Overall Study|Withdrawal by Subject|16|||
46747717|NCT00803049|82965056|FG003|Overall Study|Withdrawal by Subject|44|||
46747718|NCT00803049|82965053|FG000|Overall Study|Protocol Violation|0|||
46747719|NCT00803049|82965054|FG001|Overall Study|Protocol Violation|1|||
46747720|NCT00803049|82965055|FG002|Overall Study|Protocol Violation|1|||
46747721|NCT00803049|82965056|FG003|Overall Study|Protocol Violation|0|||
46747722|NCT00803049|82965053|FG000|Overall Study|Randomized and Not Treated|0|||
46747723|NCT00803049|82965054|FG001|Overall Study|Randomized and Not Treated|0|||
46923473|NCT01673854|83157065|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
46923474|NCT01673854|83157065|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
46923475|NCT01673854|83157065|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
46635557|NCT01557504|82809317|FG000|Overall Study|Physician Decision|1|||
46747724|NCT00803049|82965055|FG002|Overall Study|Randomized and Not Treated|0|||
46747725|NCT00803049|82965056|FG003|Overall Study|Randomized and Not Treated|2|||
46747726|NCT00803049|82965053|FG000|Overall Study|Other than Specified Above|3|||
46747727|NCT00803049|82965054|FG001|Overall Study|Other than Specified Above|9|||
46747728|NCT00803049|82965055|FG002|Overall Study|Other than Specified Above|2|||
46747729|NCT00803049|82965056|FG003|Overall Study|Other than Specified Above|5|||
46747730|NCT00890084|82965066|FG000|Overall Study|Adverse Event|16|||
46747731|NCT00890084|82965066|FG000|Overall Study|Lost to Follow-up|126|||
46747732|NCT00802893|82965079|FG000|Overall Study|study terminated|3|||
46747733|NCT00608569|82965100|FG000|Overall Study|Death|4|||
46747734|NCT00608569|82965101|FG001|Overall Study|Death|3|||
46923476|NCT01673854|83157065|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
46923477|NCT01673854|83157065|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
46923478|NCT01343407|83157069|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
46923479|NCT01343407|83157070|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
46747735|NCT00608569|82965100|FG000|Overall Study|Lost to Follow-up|4|||
46747736|NCT00608569|82965101|FG001|Overall Study|Lost to Follow-up|5|||
46747737|NCT00608569|82965100|FG000|Overall Study|Withdrawal by Subject|1|||
46747738|NCT00608569|82965101|FG001|Overall Study|Withdrawal by Subject|0|||
46747739|NCT00608569|82965100|FG000|Overall Study|Adverse Event|1|||
46747740|NCT00608569|82965101|FG001|Overall Study|Adverse Event|0|||
46747741|NCT00608569|82965100|FG000|Overall Study|Unable to adhere with study requirements|0|||
46923480|NCT01343407|83157071|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
46923481|NCT01343407|83157072|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
46923482|NCT01343407|83157073|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
46923483|NCT01343407|83157074|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
46923484|NCT01343407|83157069|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
46923485|NCT01343407|83157070|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
46923486|NCT01343407|83157071|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
46923487|NCT01343407|83157072|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
46923488|NCT01343407|83157073|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
46923489|NCT01343407|83157074|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
46923490|NCT01367886|83157082|FG000|Overall Study|Lost to Follow-up|4|||
46923491|NCT01367886|83157082|FG000|Overall Study|Lack of Efficacy|2|||
46923492|NCT01367886|83157082|FG000|Overall Study|Death|1|||
46923493|NCT01673698|83157089|FG000|Overall Study|Lost to Follow-up|51|||
46923494|NCT01673698|83157090|FG001|Overall Study|Lost to Follow-up|13|||
46923495|NCT02786004|83157099|FG000|Overall Study|Withdrawal by Subject|0|||
46923496|NCT02786004|83157100|FG001|Overall Study|Withdrawal by Subject|1|||
46923497|NCT03051607|83157108|FG000|Overall Study|Adverse Event|66|||
46923498|NCT01062399|83157117|FG000|Overall Study|Protocol Violation|0|||
46923499|NCT01062399|83157118|FG001|Overall Study|Protocol Violation|1|||
46923500|NCT01062399|83157119|FG002|Overall Study|Protocol Violation|0|||
46747742|NCT00608569|82965101|FG001|Overall Study|Unable to adhere with study requirements|1|||
46747743|NCT00610675|82965107|FG000|Overall Study|Untreated|4|||
46747744|NCT00610675|82965107|FG000|Overall Study|Adverse Event|67|||
46747745|NCT00610675|82965107|FG000|Overall Study|Insufficient Effect|31|||
46747746|NCT00610675|82965107|FG000|Overall Study|Withdrawal by Subject|28|||
46747747|NCT00610675|82965107|FG000|Overall Study|Reasons unrelated to trial|27|||
46747748|NCT00610675|82965107|FG000|Overall Study|Lack of Compliance|7|||
46747749|NCT00610675|82965107|FG000|Overall Study|Lost to Follow-up|31|||
46747750|NCT00610675|82965107|FG000|Overall Study|Other reason (not specified)|25|||
46747751|NCT00888134|82965111|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
46747752|NCT00888134|82965111|FG000|Follow-up|being followed for long-term survival|1|||
46747753|NCT00573157|82965118|FG000|Overall Study|Adverse Event|3|||
46923501|NCT01062399|83157120|FG003|Overall Study|Protocol Violation|6|||
46923502|NCT01062399|83157121|FG004|Overall Study|Protocol Violation|4|||
46923503|NCT01317277|83157135|FG000|Overall Study|Lost to Follow-up|3|||
46923504|NCT01317277|83157136|FG001|Overall Study|Lost to Follow-up|1|||
46923505|NCT01317277|83157135|FG000|Overall Study|Lost MEMS|1|||
46923506|NCT01317277|83157136|FG001|Overall Study|Lost MEMS|1|||
46923507|NCT01317277|83157135|FG000|Overall Study|Unable to comply with intervention|1|||
46923508|NCT01317277|83157136|FG001|Overall Study|Unable to comply with intervention|0|||
46923509|NCT01317277|83157135|FG000|Overall Study|Withdrawal by Subject|1|||
46923510|NCT01317277|83157136|FG001|Overall Study|Withdrawal by Subject|0|||
46923511|NCT01317277|83157135|FG000|Overall Study|Adverse Event|1|||
46923512|NCT01317277|83157136|FG001|Overall Study|Adverse Event|0|||
46923513|NCT04820686|83157145|FG000|Overall Study|Withdrawal by Subject|5|||
46923514|NCT04820686|83157146|FG001|Overall Study|Withdrawal by Subject|2|||
46923515|NCT04820686|83157147|FG002|Overall Study|Withdrawal by Subject|3|||
46923516|NCT04820686|83157145|FG000|Overall Study|Study Termination|25|||
46923517|NCT04820686|83157146|FG001|Overall Study|Study Termination|13|||
46923518|NCT04820686|83157147|FG002|Overall Study|Study Termination|14|||
46923519|NCT04820686|83157145|FG000|Overall Study|Adverse Event|0|||
46923520|NCT04820686|83157146|FG001|Overall Study|Adverse Event|1|||
46923521|NCT04820686|83157147|FG002|Overall Study|Adverse Event|0|||
46923522|NCT02740478|83157162|FG000|Overall Study|Withdrawal by Subject|1|||
46923523|NCT02969655|83157168|FG000|Overall Study|Withdrawal by Subject|3|||
46923524|NCT02969655|83157169|FG001|Overall Study|Withdrawal by Subject|2|||
46923525|NCT02969655|83157168|FG000|Overall Study|Physician Decision|4|||
46923526|NCT02969655|83157169|FG001|Overall Study|Physician Decision|3|||
46923527|NCT02969655|83157168|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
46923528|NCT02969655|83157169|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
46747754|NCT00573157|82965119|FG001|Overall Study|Adverse Event|1|||
46747755|NCT00573157|82965118|FG000|Overall Study|Other|1|||
46747756|NCT00573157|82965119|FG001|Overall Study|Other|1|||
46747757|NCT00802737|82965128|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
46747758|NCT00802737|82965129|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
46747759|NCT00802737|82965130|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
46747760|NCT00802737|82965128|FG000|Overall Study|Death|6|||
46747761|NCT00802737|82965129|FG001|Overall Study|Death|5|||
46747762|NCT00802737|82965130|FG002|Overall Study|Death|1|||
46747763|NCT00802737|82965128|FG000|Overall Study|Adverse Event|1|||
46747764|NCT00802737|82965129|FG001|Overall Study|Adverse Event|0|||
46747765|NCT00802737|82965130|FG002|Overall Study|Adverse Event|0|||
46747766|NCT00802737|82965128|FG000|Overall Study|Received Prohibited Therapy|1|||
46747767|NCT00802737|82965129|FG001|Overall Study|Received Prohibited Therapy|0|||
46747768|NCT00802737|82965130|FG002|Overall Study|Received Prohibited Therapy|0|||
46747769|NCT00802737|82965128|FG000|Overall Study|Ongoing CLL-Treatment|0|||
46747770|NCT00802737|82965129|FG001|Overall Study|Ongoing CLL-Treatment|1|||
46747771|NCT00802737|82965130|FG002|Overall Study|Ongoing CLL-Treatment|0|||
46747772|NCT00802737|82965128|FG000|Overall Study|Participant too Unwell|0|||
46747773|NCT00802737|82965129|FG001|Overall Study|Participant too Unwell|2|||
46747774|NCT00802737|82965130|FG002|Overall Study|Participant too Unwell|0|||
46747775|NCT00588861|82965141|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
46747776|NCT00588861|82965142|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
46747777|NCT00588861|82965141|FG000|6 Months|Patients did not return for follow-up|98|||
46747778|NCT00588861|82965142|FG001|6 Months|Patients did not return for follow-up|73|||
46747779|NCT00588861|82965141|FG000|1 Year|Patients did not return for follow-up|89|||
46747780|NCT00588861|82965142|FG001|1 Year|Patients did not return for follow-up|82|||
46747781|NCT00588861|82965141|FG000|2 Years|Patients did not return for follow-up|92|||
46747782|NCT00588861|82965142|FG001|2 Years|Patients did not return for follow-up|87|||
46747783|NCT00588861|82965141|FG000|4 Years|Patients did not return for follow-up|91|||
46747784|NCT00588861|82965142|FG001|4 Years|Patients did not return for follow-up|103|||
46747785|NCT00588861|82965141|FG000|6 Years|Patients did not return for follow-up|104|||
46747786|NCT00588861|82965142|FG001|6 Years|Patients did not return for follow-up|109|||
46747787|NCT00588861|82965141|FG000|8 Years|Patients did not return for follow-up|105|||
46747788|NCT00588861|82965142|FG001|8 Years|Patients did not return for follow-up|114|||
46747789|NCT00588861|82965141|FG000|10 Years|Incomplete due to study termination|107|||
46747790|NCT00588861|82965142|FG001|10 Years|Incomplete due to study termination|114|||
46747791|NCT00887978|82965150|FG000|Overall Study|Adverse Event|18|||
46747792|NCT00887978|82965151|FG001|Overall Study|Adverse Event|5|||
46804740|NCT00393718|83023793|FG000|Overall Study|Protocol Violation|1|||
46804741|NCT00393718|83023794|FG001|Overall Study|Protocol Violation|2|||
46804742|NCT00393718|83023793|FG000|Overall Study|Lack of Efficacy|10|||
46923529|NCT02969655|83157168|FG000|Overall Study|Adverse Event|10|||
46923530|NCT02969655|83157169|FG001|Overall Study|Adverse Event|8|||
46923531|NCT01317199|83157180|FG000|Dose-escalation Phase 1|Physician Decision|5|||
46923532|NCT01317199|83157181|FG001|Dose-escalation Phase 1|Physician Decision|0|||
46923533|NCT01317199|83157182|FG002|Dose-escalation Phase 1|Physician Decision|0|||
46923534|NCT01317199|83157183|FG003|Dose-escalation Phase 1|Physician Decision|0|||
46923535|NCT01317199|83157180|FG000|Dose-escalation Phase 1|Disease progression|1|||
46923536|NCT01317199|83157181|FG001|Dose-escalation Phase 1|Disease progression|0|||
46923537|NCT01317199|83157182|FG002|Dose-escalation Phase 1|Disease progression|0|||
46635558|NCT01557504|82809318|FG001|Overall Study|Physician Decision|0|||
46635559|NCT01557348|82809332|FG000|Overall Study|Adverse Event|6|||
46635560|NCT01557348|82809333|FG001|Overall Study|Adverse Event|16|||
46635561|NCT01557348|82809332|FG000|Overall Study|Infusion reaction event|5|||
46635562|NCT01557348|82809333|FG001|Overall Study|Infusion reaction event|5|||
46635563|NCT01557348|82809332|FG000|Overall Study|Death|7|||
46635564|NCT01557348|82809333|FG001|Overall Study|Death|4|||
46635565|NCT01557348|82809332|FG000|Overall Study|Insufficient Therapeutic Response|13|||
46635566|NCT01557348|82809333|FG001|Overall Study|Insufficient Therapeutic Response|28|||
46635567|NCT01557348|82809332|FG000|Overall Study|Withdrawal by Subject|5|||
46635568|NCT01557348|82809333|FG001|Overall Study|Withdrawal by Subject|4|||
46635569|NCT01557348|82809332|FG000|Overall Study|Lost to Follow-up|26|||
46635570|NCT01557348|82809333|FG001|Overall Study|Lost to Follow-up|22|||
46635571|NCT01557348|82809332|FG000|Overall Study|Administrative|18|||
46635572|NCT01557348|82809333|FG001|Overall Study|Administrative|11|||
46635573|NCT01580670|82809340|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
46747793|NCT00887978|82965150|FG000|Overall Study|Clinical Worsening|4|||
46747794|NCT00887978|82965151|FG001|Overall Study|Clinical Worsening|4|||
46747795|NCT00887978|82965150|FG000|Overall Study|Death|2|||
46747796|NCT00887978|82965151|FG001|Overall Study|Death|3|||
46747797|NCT00887978|82965150|FG000|Overall Study|Withdrawal by Subject|1|||
46804743|NCT00393718|83023794|FG001|Overall Study|Lack of Efficacy|9|||
46923538|NCT01317199|83157183|FG003|Dose-escalation Phase 1|Disease progression|0|||
46923539|NCT01317199|83157180|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
46635574|NCT01580670|82809340|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
46635575|NCT01534260|82809346|FG000|Overall Study|Adverse Event|1|||
46635576|NCT01534260|82809347|FG001|Overall Study|Adverse Event|8|||
46635577|NCT01534260|82809346|FG000|Overall Study|Death|2|||
46747798|NCT00887978|82965151|FG001|Overall Study|Withdrawal by Subject|2|||
46747799|NCT00887978|82965150|FG000|Overall Study|Lost to Follow-up|0|||
46747800|NCT00887978|82965151|FG001|Overall Study|Lost to Follow-up|1|||
46747801|NCT00608023|82965160|FG000|Overall Study|Withdrawal by Subject|8|||
46747802|NCT00608023|82965161|FG001|Overall Study|Withdrawal by Subject|10|||
46747803|NCT00608023|82965162|FG002|Overall Study|Withdrawal by Subject|7|||
46747804|NCT00608023|82965160|FG000|Overall Study|Adverse Event|1|||
46747805|NCT00608023|82965161|FG001|Overall Study|Adverse Event|4|||
46747806|NCT00608023|82965162|FG002|Overall Study|Adverse Event|5|||
46747807|NCT00608023|82965160|FG000|Overall Study|Lost to Follow-up|2|||
46747808|NCT00608023|82965161|FG001|Overall Study|Lost to Follow-up|2|||
46747809|NCT00608023|82965162|FG002|Overall Study|Lost to Follow-up|1|||
46747810|NCT00608023|82965160|FG000|Overall Study|Protocol Violation|1|||
46747811|NCT00608023|82965161|FG001|Overall Study|Protocol Violation|3|||
46747812|NCT00608023|82965162|FG002|Overall Study|Protocol Violation|1|||
46747813|NCT00608023|82965160|FG000|Overall Study|Unknown reason|0|||
46747814|NCT00608023|82965161|FG001|Overall Study|Unknown reason|3|||
46747815|NCT00608023|82965162|FG002|Overall Study|Unknown reason|0|||
46747816|NCT00802659|82965177|FG000|Overall Study|Physician Decision|0|||
46747817|NCT00802659|82965178|FG001|Overall Study|Physician Decision|1|||
46747818|NCT00802659|82965179|FG002|Overall Study|Physician Decision|0|||
46747819|NCT00802659|82965180|FG003|Overall Study|Physician Decision|0|||
46747820|NCT00607789|82965192|FG000|Overall Study|Adverse Event|3|||
46747821|NCT00607789|82965193|FG001|Overall Study|Adverse Event|0|||
46747822|NCT00607789|82965192|FG000|Overall Study|Lack of Efficacy|0|||
46747823|NCT00607789|82965193|FG001|Overall Study|Lack of Efficacy|1|||
46747824|NCT00607789|82965192|FG000|Overall Study|Inadequate adherence|3|||
46747825|NCT00607789|82965193|FG001|Overall Study|Inadequate adherence|0|||
46747826|NCT00607789|82965192|FG000|Overall Study|Lost to Follow-up|0|||
46747827|NCT00607789|82965193|FG001|Overall Study|Lost to Follow-up|5|||
46747828|NCT00607789|82965192|FG000|Overall Study|Withdrawal by Subject|1|||
46747829|NCT00607789|82965193|FG001|Overall Study|Withdrawal by Subject|0|||
46747830|NCT00887822|82965201|FG000|Overall Study|Insufficient therapeutic response|53|||
46747831|NCT00887822|82965202|FG001|Overall Study|Insufficient therapeutic response|55|||
46747832|NCT00887822|82965201|FG000|Overall Study|Adverse Event|14|||
46747833|NCT00887822|82965202|FG001|Overall Study|Adverse Event|17|||
46747834|NCT00887822|82965201|FG000|Overall Study|Failure to return|11|||
46747835|NCT00887822|82965202|FG001|Overall Study|Failure to return|11|||
46747836|NCT00887822|82965201|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
46747837|NCT00887822|82965202|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
46747838|NCT00887822|82965201|FG000|Overall Study|Administrative/Other than specified|5|||
46747839|NCT00887822|82965202|FG001|Overall Study|Administrative/Other than specified|4|||
46747840|NCT00887822|82965201|FG000|Overall Study|Death|2|||
46747841|NCT00887822|82965202|FG001|Overall Study|Death|3|||
46747842|NCT00887822|82965201|FG000|Overall Study|Protocol Violation|0|||
46747843|NCT00887822|82965202|FG001|Overall Study|Protocol Violation|1|||
46747844|NCT00887822|82965201|FG000|Overall Study|Randomized but not treated|0|||
46747845|NCT00887822|82965202|FG001|Overall Study|Randomized but not treated|1|||
46747846|NCT00951665|82965214|FG000|Phase 1b|Adverse Event|2|||
46747847|NCT00951665|82965215|FG001|Phase 1b|Adverse Event|1|||
46747848|NCT00951665|82965216|FG002|Phase 1b|Adverse Event|0|||
46747849|NCT00951665|82965217|FG003|Phase 1b|Adverse Event|1|||
46747850|NCT00951665|82965218|FG004|Phase 1b|Adverse Event|0|||
46747851|NCT00951665|82965219|FG005|Phase 1b|Adverse Event|0|||
46747852|NCT00951665|82965214|FG000|Phase 1b|Death|1|||
46747853|NCT00951665|82965215|FG001|Phase 1b|Death|0|||
46747854|NCT00951665|82965216|FG002|Phase 1b|Death|2|||
46747855|NCT00951665|82965217|FG003|Phase 1b|Death|0|||
46747856|NCT00951665|82965218|FG004|Phase 1b|Death|0|||
46747857|NCT00951665|82965219|FG005|Phase 1b|Death|0|||
46747858|NCT00951665|82965214|FG000|Phase 1b|Physician Decision|4|||
46747859|NCT00951665|82965215|FG001|Phase 1b|Physician Decision|0|||
46747860|NCT00951665|82965216|FG002|Phase 1b|Physician Decision|1|||
46747861|NCT00951665|82965217|FG003|Phase 1b|Physician Decision|0|||
46747862|NCT00951665|82965218|FG004|Phase 1b|Physician Decision|0|||
46747863|NCT00951665|82965219|FG005|Phase 1b|Physician Decision|0|||
46747864|NCT00951665|82965214|FG000|Phase 1b|Withdrawal by Subject|0|||
46747865|NCT00951665|82965215|FG001|Phase 1b|Withdrawal by Subject|1|||
46747866|NCT00951665|82965216|FG002|Phase 1b|Withdrawal by Subject|0|||
46747867|NCT00951665|82965217|FG003|Phase 1b|Withdrawal by Subject|0|||
46747868|NCT00951665|82965218|FG004|Phase 1b|Withdrawal by Subject|0|||
46747869|NCT00951665|82965219|FG005|Phase 1b|Withdrawal by Subject|0|||
46747870|NCT00951665|82965214|FG000|Phase 1b|Disease Progression|13|||
46747871|NCT00951665|82965215|FG001|Phase 1b|Disease Progression|2|||
46747872|NCT00951665|82965216|FG002|Phase 1b|Disease Progression|14|||
46747873|NCT00951665|82965217|FG003|Phase 1b|Disease Progression|0|||
46747874|NCT00951665|82965218|FG004|Phase 1b|Disease Progression|0|||
46747875|NCT00951665|82965219|FG005|Phase 1b|Disease Progression|0|||
46747876|NCT00951665|82965214|FG000|Phase 1b|Protocol Violation|2|||
46747877|NCT00951665|82965215|FG001|Phase 1b|Protocol Violation|0|||
46747878|NCT00951665|82965216|FG002|Phase 1b|Protocol Violation|0|||
46747879|NCT00951665|82965217|FG003|Phase 1b|Protocol Violation|0|||
46747880|NCT00951665|82965218|FG004|Phase 1b|Protocol Violation|0|||
46747881|NCT00951665|82965219|FG005|Phase 1b|Protocol Violation|0|||
46747882|NCT00951665|82965214|FG000|Phase 2a|Adverse Event|0|||
46747883|NCT00951665|82965215|FG001|Phase 2a|Adverse Event|0|||
46747884|NCT00951665|82965216|FG002|Phase 2a|Adverse Event|0|||
46747885|NCT00951665|82965217|FG003|Phase 2a|Adverse Event|0|||
46747886|NCT00951665|82965218|FG004|Phase 2a|Adverse Event|2|||
46747887|NCT00951665|82965219|FG005|Phase 2a|Adverse Event|0|||
46747888|NCT00951665|82965214|FG000|Phase 2a|Death|0|||
46747889|NCT00951665|82965215|FG001|Phase 2a|Death|0|||
46747890|NCT00951665|82965216|FG002|Phase 2a|Death|0|||
46747891|NCT00951665|82965217|FG003|Phase 2a|Death|0|||
46747892|NCT00951665|82965218|FG004|Phase 2a|Death|1|||
46747893|NCT00951665|82965219|FG005|Phase 2a|Death|1|||
46747894|NCT00951665|82965214|FG000|Phase 2a|Lost to Follow-up|0|||
46747895|NCT00951665|82965215|FG001|Phase 2a|Lost to Follow-up|0|||
46747896|NCT00951665|82965216|FG002|Phase 2a|Lost to Follow-up|0|||
46747897|NCT00951665|82965217|FG003|Phase 2a|Lost to Follow-up|0|||
46747898|NCT00951665|82965218|FG004|Phase 2a|Lost to Follow-up|1|||
46747899|NCT00951665|82965219|FG005|Phase 2a|Lost to Follow-up|0|||
46747900|NCT00951665|82965214|FG000|Phase 2a|Physician Decision|0|||
46747901|NCT00951665|82965215|FG001|Phase 2a|Physician Decision|0|||
46747902|NCT00951665|82965216|FG002|Phase 2a|Physician Decision|0|||
46747903|NCT00951665|82965217|FG003|Phase 2a|Physician Decision|0|||
46747904|NCT00951665|82965218|FG004|Phase 2a|Physician Decision|0|||
46747905|NCT00951665|82965219|FG005|Phase 2a|Physician Decision|1|||
46747906|NCT00951665|82965214|FG000|Phase 2a|Withdrawal by Subject|0|||
46747907|NCT00951665|82965215|FG001|Phase 2a|Withdrawal by Subject|0|||
46747908|NCT00951665|82965216|FG002|Phase 2a|Withdrawal by Subject|0|||
46747909|NCT00951665|82965217|FG003|Phase 2a|Withdrawal by Subject|0|||
46747910|NCT00951665|82965218|FG004|Phase 2a|Withdrawal by Subject|2|||
46747911|NCT00951665|82965219|FG005|Phase 2a|Withdrawal by Subject|0|||
46747912|NCT00951665|82965214|FG000|Phase 2a|Disease Progression|0|||
46747913|NCT00951665|82965215|FG001|Phase 2a|Disease Progression|0|||
46747914|NCT00951665|82965216|FG002|Phase 2a|Disease Progression|0|||
46747915|NCT00951665|82965217|FG003|Phase 2a|Disease Progression|0|||
46747916|NCT00951665|82965218|FG004|Phase 2a|Disease Progression|6|||
46747917|NCT00951665|82965219|FG005|Phase 2a|Disease Progression|5|||
46747918|NCT00801099|82965253|FG000|Overall Study|Lost to Follow-up|101|||
46747919|NCT00887744|82965257|FG000|Overall Study|Adverse Event|3|||
46747920|NCT00887744|82965257|FG000|Overall Study|Death|1|||
46747921|NCT00887744|82965257|FG000|Overall Study|Lost to Follow-up|3|||
46747922|NCT00887744|82965257|FG000|Overall Study|Withdrawal by Subject|18|||
46747923|NCT00887744|82965257|FG000|Overall Study|Various reasons|9|||
46747924|NCT00951509|82965261|FG000|Overall Study|Withdrawal by Subject|2|||
46747925|NCT00610441|82965273|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
46747926|NCT00610441|82965274|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
46747927|NCT00610441|82965275|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
46747928|NCT00610441|82965276|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
46747929|NCT00610441|82965273|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
46747930|NCT00610441|82965274|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
46747931|NCT00610441|82965275|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
46747932|NCT00610441|82965276|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
46747933|NCT00610441|82965273|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
46747934|NCT00610441|82965274|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
46747935|NCT00610441|82965275|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
46747936|NCT00610441|82965276|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
46747937|NCT00610441|82965273|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
46747938|NCT00610441|82965274|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
46747939|NCT00610441|82965275|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
46923540|NCT01317199|83157181|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
46923541|NCT01317199|83157182|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
46747940|NCT00610441|82965276|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
46747941|NCT00610441|82965273|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
46747942|NCT00610441|82965274|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
46747943|NCT00610441|82965275|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
46747944|NCT00610441|82965276|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
46747945|NCT00610441|82965273|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
46747946|NCT00610441|82965274|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
46747947|NCT00610441|82965275|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
46747948|NCT00610441|82965276|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
46747949|NCT00610441|82965273|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
46747950|NCT00610441|82965274|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
46747951|NCT00610441|82965275|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
46747952|NCT00610441|82965276|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
46775755|NCT00793793|82994212|FG008|Overall Study|Lost to Follow-up|1|||
46747953|NCT00610441|82965273|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
46747954|NCT00610441|82965274|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
46747955|NCT00610441|82965275|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
46747956|NCT00610441|82965276|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
46747957|NCT00610441|82965273|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
46747958|NCT00610441|82965274|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
46747959|NCT00610441|82965275|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
46747960|NCT00610441|82965276|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
46747961|NCT00799617|82965290|FG000|Main Testosterone Trial|Randomized in error|1|||
46747962|NCT00799617|82965291|FG001|Main Testosterone Trial|Randomized in error|1|||
46747963|NCT00799617|82965290|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
46747964|NCT00799617|82965291|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
46747965|NCT00799617|82965290|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
46747966|NCT00799617|82965291|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
46747967|NCT00799617|82965290|FG000|Sexual Funtion Trial|No Baseline Data|4|||
46747968|NCT00799617|82965291|FG001|Sexual Funtion Trial|No Baseline Data|7|||
46747969|NCT00799617|82965290|FG000|Physical Function Trial|Lost to Follow-up|6|||
46747970|NCT00799617|82965291|FG001|Physical Function Trial|Lost to Follow-up|11|||
46747971|NCT00799617|82965290|FG000|Vitality Trial|Lost to Follow-up|7|||
46747972|NCT00799617|82965291|FG001|Vitality Trial|Lost to Follow-up|22|||
46747973|NCT00799617|82965290|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
46635578|NCT01534260|82809347|FG001|Overall Study|Death|0|||
46635579|NCT01534260|82809346|FG000|Overall Study|Lack of Efficacy|1|||
46635580|NCT01534260|82809347|FG001|Overall Study|Lack of Efficacy|1|||
46747974|NCT00799617|82965291|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
46747975|NCT00799617|82965290|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
46747976|NCT00799617|82965291|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
46747977|NCT00799617|82965290|FG000|Bone Trial|Month 12 scan not available|6|||
46747978|NCT00799617|82965291|FG001|Bone Trial|Month 12 scan not available|16|||
46747979|NCT00799617|82965290|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
46747980|NCT00799617|82965291|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
46747981|NCT00799617|82965290|FG000|Anemia Trial|Withdrawal by Subject|3|||
46747982|NCT00799617|82965291|FG001|Anemia Trial|Withdrawal by Subject|3|||
46747983|NCT00607087|82965300|FG000|Overall Study|Withdrawal by Subject|9|||
46747984|NCT00607087|82965301|FG001|Overall Study|Withdrawal by Subject|4|||
46747985|NCT00607087|82965302|FG002|Overall Study|Withdrawal by Subject|4|||
46747986|NCT00607087|82965300|FG000|Overall Study|Adverse Event|3|||
46747987|NCT00607087|82965301|FG001|Overall Study|Adverse Event|2|||
46747988|NCT00607087|82965302|FG002|Overall Study|Adverse Event|3|||
46747989|NCT00607087|82965300|FG000|Overall Study|Other reason|1|||
46747990|NCT00607087|82965301|FG001|Overall Study|Other reason|5|||
46747991|NCT00607087|82965302|FG002|Overall Study|Other reason|2|||
46747992|NCT00607087|82965300|FG000|Overall Study|Poor compliance to protocol|1|||
46923542|NCT01317199|83157183|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
46923543|NCT01317199|83157180|FG000|Randomized Phase 2|Disease progression|0|||
46923544|NCT01317199|83157181|FG001|Randomized Phase 2|Disease progression|3|||
46747993|NCT00607087|82965301|FG001|Overall Study|Poor compliance to protocol|0|||
46747994|NCT00607087|82965302|FG002|Overall Study|Poor compliance to protocol|1|||
46747995|NCT00607087|82965300|FG000|Overall Study|Lost to Follow-up|1|||
46747996|NCT00607087|82965301|FG001|Overall Study|Lost to Follow-up|0|||
46747997|NCT00607087|82965302|FG002|Overall Study|Lost to Follow-up|0|||
46747998|NCT00607087|82965300|FG000|Period 1|Withdrawal by Subject|7|||
46747999|NCT00607087|82965301|FG001|Period 1|Withdrawal by Subject|2|||
46748000|NCT00607087|82965302|FG002|Period 1|Withdrawal by Subject|3|||
46748001|NCT00607087|82965300|FG000|Period 1|Adverse Event|3|||
46748002|NCT00607087|82965301|FG001|Period 1|Adverse Event|0|||
46748003|NCT00607087|82965302|FG002|Period 1|Adverse Event|0|||
46923545|NCT01317199|83157182|FG002|Randomized Phase 2|Disease progression|7|||
46923546|NCT01317199|83157183|FG003|Randomized Phase 2|Disease progression|5|||
46923547|NCT01317199|83157180|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
46748004|NCT00607087|82965300|FG000|Period 1|Poor compliance to protocol|1|||
46748005|NCT00607087|82965301|FG001|Period 1|Poor compliance to protocol|0|||
46748006|NCT00607087|82965302|FG002|Period 1|Poor compliance to protocol|0|||
46748007|NCT00607087|82965300|FG000|Period 1|Lost to Follow-up|1|||
46923548|NCT01317199|83157181|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
46923549|NCT01317199|83157182|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
46748008|NCT00607087|82965301|FG001|Period 1|Lost to Follow-up|0|||
46748009|NCT00607087|82965302|FG002|Period 1|Lost to Follow-up|0|||
46748010|NCT00607087|82965300|FG000|Period 1|Other reason|0|||
46748011|NCT00607087|82965301|FG001|Period 1|Other reason|4|||
46748012|NCT00607087|82965302|FG002|Period 1|Other reason|2|||
46923550|NCT01317199|83157183|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
46635581|NCT01534260|82809346|FG000|Overall Study|Withdrawal by Subject|1|||
46748013|NCT00607087|82965300|FG000|Period 2|Withdrawal by Subject|0|||
46748014|NCT00607087|82965301|FG001|Period 2|Withdrawal by Subject|1|||
46748015|NCT00607087|82965302|FG002|Period 2|Withdrawal by Subject|1|||
46748016|NCT00607087|82965300|FG000|Period 2|Other reason|1|||
46748017|NCT00607087|82965301|FG001|Period 2|Other reason|1|||
46748018|NCT00607087|82965302|FG002|Period 2|Other reason|0|||
46748019|NCT00607087|82965300|FG000|Period 2|Adverse Event|0|||
46748020|NCT00607087|82965301|FG001|Period 2|Adverse Event|1|||
46748021|NCT00607087|82965302|FG002|Period 2|Adverse Event|3|||
46748022|NCT00607087|82965300|FG000|Period 2|Poor compliance to protocol|0|||
46748023|NCT00607087|82965301|FG001|Period 2|Poor compliance to protocol|0|||
46748024|NCT00607087|82965302|FG002|Period 2|Poor compliance to protocol|1|||
46748025|NCT00607087|82965300|FG000|Period 3|Withdrawal by Subject|2|||
46748026|NCT00607087|82965301|FG001|Period 3|Withdrawal by Subject|1|||
46748027|NCT00607087|82965302|FG002|Period 3|Withdrawal by Subject|0|||
46748028|NCT00607087|82965300|FG000|Period 3|Adverse Event|0|||
46748029|NCT00607087|82965301|FG001|Period 3|Adverse Event|1|||
46748030|NCT00607087|82965302|FG002|Period 3|Adverse Event|0|||
46748031|NCT00610363|82965312|FG000|Overall Study|Non-compliance with protocol|0|||
46748032|NCT00610363|82965313|FG001|Overall Study|Non-compliance with protocol|1|||
46748033|NCT00610363|82965312|FG000|Overall Study|Adverse Event|3|||
46748034|NCT00610363|82965313|FG001|Overall Study|Adverse Event|1|||
46748035|NCT00610363|82965312|FG000|Overall Study|Lack of Efficacy|2|||
46748036|NCT00610363|82965313|FG001|Overall Study|Lack of Efficacy|0|||
46748037|NCT00610363|82965312|FG000|Overall Study|Lost to Follow-up|4|||
46748038|NCT00610363|82965313|FG001|Overall Study|Lost to Follow-up|0|||
46748039|NCT00610363|82965312|FG000|Overall Study|Withdrawal by Subject|1|||
46748040|NCT00610363|82965313|FG001|Overall Study|Withdrawal by Subject|0|||
46748041|NCT00610363|82965312|FG000|Overall Study|Other than specified above|1|||
46748042|NCT00610363|82965313|FG001|Overall Study|Other than specified above|1|||
46748043|NCT00887588|82965322|FG000|Core Period|Death|1|||
46748044|NCT00887588|82965323|FG001|Core Period|Death|1|||
46748045|NCT00887588|82965322|FG000|Core Period|Lost to Follow-up|3|||
46748046|NCT00887588|82965323|FG001|Core Period|Lost to Follow-up|1|||
46748047|NCT00887588|82965322|FG000|Core Period|Withdrawal by Subject|6|||
46748048|NCT00887588|82965323|FG001|Core Period|Withdrawal by Subject|8|||
46748049|NCT00887588|82965322|FG000|Core Period|Adverse Event|9|||
46748050|NCT00887588|82965323|FG001|Core Period|Adverse Event|11|||
46748051|NCT00887588|82965322|FG000|Extension Period|Adverse Event|4|||
46748052|NCT00887588|82965323|FG001|Extension Period|Adverse Event|4|||
46748053|NCT00887588|82965322|FG000|Extension Period|Death|0|||
46748054|NCT00887588|82965323|FG001|Extension Period|Death|1|||
46748055|NCT00887588|82965322|FG000|Extension Period|Protocol deviation|1|||
46748056|NCT00887588|82965323|FG001|Extension Period|Protocol deviation|0|||
46748057|NCT00887588|82965322|FG000|Extension Period|Lost to Follow-up|1|||
46748058|NCT00887588|82965323|FG001|Extension Period|Lost to Follow-up|0|||
46748059|NCT00945893|82965331|FG000|Overall Study|Lost to Follow-up|2|||
46748060|NCT00945893|82965332|FG001|Overall Study|Lost to Follow-up|8|||
46748061|NCT00945893|82965331|FG000|Overall Study|Withdrawal of consent|1|||
46748062|NCT00945893|82965332|FG001|Overall Study|Withdrawal of consent|2|||
46748063|NCT00799383|82965344|FG000|Overall Study|Protocol Violation|1|||
46748064|NCT00799383|82965345|FG001|Overall Study|Protocol Violation|1|||
46748065|NCT00799383|82965344|FG000|Overall Study|Adverse Event|0|||
46748066|NCT00799383|82965345|FG001|Overall Study|Adverse Event|1|||
46748067|NCT00799383|82965344|FG000|Overall Study|Lost to Follow-up|1|||
46748068|NCT00799383|82965345|FG001|Overall Study|Lost to Follow-up|2|||
46923551|NCT01317199|83157180|FG000|Randomized Phase 2|Adverse Event|0|||
46923552|NCT01317199|83157181|FG001|Randomized Phase 2|Adverse Event|0|||
46923553|NCT01317199|83157182|FG002|Randomized Phase 2|Adverse Event|0|||
46923554|NCT01317199|83157183|FG003|Randomized Phase 2|Adverse Event|1|||
46748069|NCT00799383|82965344|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
46748070|NCT00799383|82965345|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
46748071|NCT00799383|82965344|FG000|Overall Study|Withdrawal by Subject|0|||
46748072|NCT00799383|82965345|FG001|Overall Study|Withdrawal by Subject|1|||
46748073|NCT00610207|82965351|FG000|Overall Study|Lost to Follow-up|3|||
46748074|NCT00798759|82965357|FG000|Overall Study|Adverse Event|3|||
46748075|NCT00798759|82965358|FG001|Overall Study|Adverse Event|3|||
46748076|NCT00798759|82965357|FG000|Overall Study|Lost to Follow-up|1|||
46635582|NCT01534260|82809347|FG001|Overall Study|Withdrawal by Subject|3|||
46748077|NCT00798759|82965358|FG001|Overall Study|Lost to Follow-up|1|||
46748078|NCT00798759|82965357|FG000|Overall Study|Protocol Violation|4|||
46748079|NCT00798759|82965358|FG001|Overall Study|Protocol Violation|8|||
46748080|NCT00798759|82965357|FG000|Overall Study|Other|0|||
46748081|NCT00798759|82965358|FG001|Overall Study|Other|1|||
46748082|NCT00887432|82965366|FG000|Overall Study|Start Excluded Therapy|3|||
46923555|NCT01317199|83157180|FG000|Randomized Phase 2|Comorbidities|0|||
46748083|NCT00887432|82965367|FG001|Overall Study|Start Excluded Therapy|0|||
46748084|NCT00887432|82965366|FG000|Overall Study|Did not complete treatment|6|||
46748085|NCT00887432|82965367|FG001|Overall Study|Did not complete treatment|8|||
46748086|NCT00887432|82965366|FG000|Overall Study|Protocol Violation|2|||
46748087|NCT00887432|82965367|FG001|Overall Study|Protocol Violation|3|||
46748088|NCT00887432|82965366|FG000|Overall Study|Withdrawal by Subject|3|||
46748089|NCT00887432|82965367|FG001|Overall Study|Withdrawal by Subject|2|||
46748090|NCT00887432|82965366|FG000|Overall Study|Lost to Follow-up|1|||
46748091|NCT00887432|82965367|FG001|Overall Study|Lost to Follow-up|0|||
46748092|NCT00887432|82965366|FG000|Overall Study|No reason provided|0|||
46748093|NCT00887432|82965367|FG001|Overall Study|No reason provided|1|||
46748094|NCT00951275|82965373|FG000|Overall Study|Administrative Reason|1|||
46748095|NCT00951275|82965373|FG000|Overall Study|Adverse Event|7|||
46748096|NCT00951275|82965373|FG000|Overall Study|Withdrawal by Subject|4|||
46748097|NCT00951275|82965373|FG000|Overall Study|Protocol Violation|1|||
46748098|NCT00798603|82965377|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
46748099|NCT00798603|82965377|FG000|Overall Study|Withdrawal by Subject|10|||
46748100|NCT00798603|82965377|FG000|Overall Study|Adverse Event|22|||
46748101|NCT00798603|82965377|FG000|Overall Study|Physician Decision|1|||
46748102|NCT00798603|82965377|FG000|Overall Study|Lack of insurance coverage|1|||
46748103|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
46748104|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
46748105|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
47052014|NCT04969198|83317925|FG000|Overall Study|Withdrawal by Subject|20|||
47052015|NCT04969198|83317925|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
47052016|NCT04969198|83317925|FG000|Overall Study|Lost to Follow-up|20|||
47052017|NCT04778059|83317952|FG000|Overall Study|Death|2|||
47052018|NCT04778059|83317953|FG001|Overall Study|Death|2|||
47052019|NCT04778059|83317954|FG002|Overall Study|Death|1|||
47052020|NCT04778059|83317955|FG003|Overall Study|Death|1|||
47052021|NCT04778059|83317956|FG004|Overall Study|Death|1|||
47052022|NCT04778059|83317952|FG000|Overall Study|Lost to Follow-up|0|||
47052023|NCT04778059|83317953|FG001|Overall Study|Lost to Follow-up|0|||
46748106|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
46748107|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
46748108|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
46748109|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
46748110|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
46748111|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
46748112|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
46748113|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
46748114|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
46748115|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
46748116|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
46748117|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
46748118|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
46748119|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
46748120|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
46748121|NCT00887354|82965383|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
46748122|NCT00887354|82965384|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
46748123|NCT00887354|82965383|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
46748124|NCT00887354|82965384|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
46748125|NCT00887354|82965383|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
46748126|NCT00887354|82965384|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
46748127|NCT00887354|82965383|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
46748128|NCT00887354|82965384|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
46748129|NCT00887354|82965383|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
46748130|NCT00887354|82965384|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
46748131|NCT00887354|82965383|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
46748132|NCT00887354|82965384|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
46748133|NCT00951041|82965393|FG000|Overall Study|Withdrawal by Subject|1|||
46748134|NCT00951041|82965394|FG001|Overall Study|Withdrawal by Subject|1|||
46748135|NCT00951041|82965393|FG000|Overall Study|Lost to Follow-up|1|||
46748136|NCT00951041|82965394|FG001|Overall Study|Lost to Follow-up|0|||
46748137|NCT00951041|82965393|FG000|Overall Study|Other|3|||
46923556|NCT01317199|83157181|FG001|Randomized Phase 2|Comorbidities|2|||
46923557|NCT01317199|83157182|FG002|Randomized Phase 2|Comorbidities|2|||
46923558|NCT01317199|83157183|FG003|Randomized Phase 2|Comorbidities|2|||
46923559|NCT01317199|83157180|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
46923560|NCT01317199|83157181|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
46923561|NCT01317199|83157182|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
46923562|NCT01317199|83157183|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
46923563|NCT01317199|83157180|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
46923564|NCT01317199|83157181|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
46923565|NCT01317199|83157182|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
46923566|NCT01317199|83157183|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
46748138|NCT00951041|82965394|FG001|Overall Study|Other|0|||
46923567|NCT01317199|83157180|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
46923568|NCT01317199|83157181|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
47052024|NCT04778059|83317954|FG002|Overall Study|Lost to Follow-up|0|||
46748139|NCT02763462|82965401|FG000|Overall Study|Protocol Violation|6|||
46748140|NCT00610129|82965415|FG000|Overall Study|Not treated since patients ineligible|3|||
46923569|NCT01317199|83157182|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
46923570|NCT01317199|83157183|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
46923571|NCT01317199|83157180|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
46923572|NCT01317199|83157181|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
46923573|NCT01317199|83157182|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
46923574|NCT01317199|83157183|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
46748141|NCT00945815|82965419|FG000|Overall Study|Death|3|||
46748142|NCT00945815|82965419|FG000|Overall Study|Not protocol specified|1|||
46748143|NCT00945815|82965419|FG000|Overall Study|Ineligible|3|||
46748144|NCT00945815|82965419|FG000|Overall Study|Did not begin protocol therapy|1|||
46748145|NCT00606307|82965423|FG000|Overall Study|Adverse Event|2|||
46748146|NCT00606307|82965423|FG000|Overall Study|Withdrawal by Subject|2|||
46923575|NCT02648698|83157202|FG000|Overall Study|Protocol Violation|1|||
46923576|NCT02648698|83157203|FG001|Overall Study|Protocol Violation|5|||
46923577|NCT02970669|83157211|FG000|Double-blind Period|Adverse Event|4|||
46923578|NCT02970669|83157212|FG001|Double-blind Period|Adverse Event|0|||
46923579|NCT02970669|83157211|FG000|Double-blind Period|Death|1|||
46923580|NCT02970669|83157212|FG001|Double-blind Period|Death|0|||
46923581|NCT02970669|83157211|FG000|Double-blind Period|Study terminated by sponsor|1|||
46923582|NCT02970669|83157212|FG001|Double-blind Period|Study terminated by sponsor|2|||
46923583|NCT02970669|83157211|FG000|Double-blind Period|Physician Decision|0|||
46923584|NCT02970669|83157212|FG001|Double-blind Period|Physician Decision|2|||
46923585|NCT02970669|83157211|FG000|Double-blind Period|Withdrawal by Subject|2|||
46923586|NCT02970669|83157212|FG001|Double-blind Period|Withdrawal by Subject|2|||
46923587|NCT02970669|83157211|FG000|Open-label Period|Withdrawal by Subject|2|||
46923588|NCT02970669|83157212|FG001|Open-label Period|Withdrawal by Subject|2|||
46923589|NCT02970669|83157211|FG000|Open-label Period|Adverse Event|1|||
46923590|NCT02970669|83157212|FG001|Open-label Period|Adverse Event|0|||
46923591|NCT02970669|83157211|FG000|Open-label Period|Physician Decision|1|||
46923592|NCT02970669|83157212|FG001|Open-label Period|Physician Decision|0|||
46923593|NCT02902965|83157220|FG000|Overall Study|Withdrawal by Subject|10|||
46923594|NCT02902809|83157225|FG000|Overall Study|Discontinuation of asthma program|28|||
46923595|NCT01362244|83157231|FG000|Overall Study|Adverse Event|3|||
46923596|NCT01362244|83157232|FG001|Overall Study|Adverse Event|5|||
46923597|NCT01362244|83157231|FG000|Overall Study|Lack of Efficacy|5|||
46923598|NCT01362244|83157232|FG001|Overall Study|Lack of Efficacy|11|||
46923599|NCT01362244|83157231|FG000|Overall Study|Lost to Follow-up|0|||
46923600|NCT01362244|83157232|FG001|Overall Study|Lost to Follow-up|2|||
46923601|NCT01362244|83157231|FG000|Overall Study|Protocol Violation|5|||
46923602|NCT01362244|83157232|FG001|Overall Study|Protocol Violation|1|||
46923603|NCT01362244|83157231|FG000|Overall Study|Withdrawal by Subject|2|||
46923604|NCT01362244|83157232|FG001|Overall Study|Withdrawal by Subject|1|||
46923605|NCT01362244|83157231|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
46923606|NCT01362244|83157232|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
46923607|NCT01362244|83157231|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
46923608|NCT01362244|83157232|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
46923609|NCT02969187|83157240|FG000|Overall Study|Physician Decision|12|||
46923610|NCT02969187|83157241|FG001|Overall Study|Physician Decision|13|||
46923611|NCT03050359|83157251|FG000|Overall Study|Randomized But Not Treated|2|||
47052025|NCT04778059|83317955|FG003|Overall Study|Lost to Follow-up|0|||
47052026|NCT04778059|83317956|FG004|Overall Study|Lost to Follow-up|1|||
47052027|NCT04778059|83317952|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
47052028|NCT04778059|83317953|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
47052029|NCT04778059|83317954|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
47052030|NCT04778059|83317955|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
47052031|NCT04778059|83317956|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
47052032|NCT04621227|83317968|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
47052033|NCT04621227|83317968|FG000|Period 3 (29 Days)|Adverse Event|1|||
46923612|NCT03050359|83157252|FG001|Overall Study|Randomized But Not Treated|0|||
46923613|NCT03050359|83157251|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
46923614|NCT03050359|83157252|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
46923615|NCT03050359|83157251|FG000|Overall Study|Significant Protocol Deviation|2|||
46923616|NCT03050359|83157252|FG001|Overall Study|Significant Protocol Deviation|3|||
46748147|NCT00606307|82965423|FG000|Overall Study|Disease progression|6|||
46748148|NCT00606307|82965423|FG000|Overall Study|QTc prolongation|1|||
46748149|NCT00798369|82965433|FG000|Overall Study|Subject withdrew consent|0|||
46748150|NCT00798369|82965434|FG001|Overall Study|Subject withdrew consent|0|||
46748151|NCT00798369|82965435|FG002|Overall Study|Subject withdrew consent|1|||
46748152|NCT00798369|82965436|FG003|Overall Study|Subject withdrew consent|1|||
46748153|NCT00798369|82965437|FG004|Overall Study|Subject withdrew consent|0|||
46748154|NCT00798369|82965438|FG005|Overall Study|Subject withdrew consent|2|||
46748155|NCT00798369|82965433|FG000|Overall Study|Lost to Follow-up|1|||
46748156|NCT00798369|82965434|FG001|Overall Study|Lost to Follow-up|1|||
46748157|NCT00798369|82965435|FG002|Overall Study|Lost to Follow-up|1|||
46748158|NCT00798369|82965436|FG003|Overall Study|Lost to Follow-up|0|||
46748159|NCT00798369|82965437|FG004|Overall Study|Lost to Follow-up|1|||
46748160|NCT00798369|82965438|FG005|Overall Study|Lost to Follow-up|0|||
46748161|NCT00798369|82965433|FG000|Overall Study|Adminstrative problems|0|||
46748162|NCT00798369|82965434|FG001|Overall Study|Adminstrative problems|0|||
46748163|NCT00798369|82965435|FG002|Overall Study|Adminstrative problems|0|||
46748164|NCT00798369|82965436|FG003|Overall Study|Adminstrative problems|0|||
46748165|NCT00798369|82965437|FG004|Overall Study|Adminstrative problems|0|||
46748166|NCT00798369|82965438|FG005|Overall Study|Adminstrative problems|1|||
46748167|NCT00950963|82965455|FG000|Overall Study|Lost to Follow-up|29|||
46748168|NCT00950963|82965456|FG001|Overall Study|Lost to Follow-up|24|||
46748169|NCT00608959|82965464|FG000|Part 1|Did not meet eligibility criteria|1|||
46748170|NCT00945659|82965477|FG000|Overall Study|Lost to Follow-up|7|||
46748171|NCT00945659|82965478|FG001|Overall Study|Lost to Follow-up|20|||
46748172|NCT00945659|82965479|FG002|Overall Study|Lost to Follow-up|17|||
46748173|NCT00941603|82965493|FG000|Overall Study|Adverse Event|10|||
46748174|NCT00941603|82965494|FG001|Overall Study|Adverse Event|15|||
46748175|NCT00941603|82965495|FG002|Overall Study|Adverse Event|5|||
46748176|NCT00941603|82965496|FG003|Overall Study|Adverse Event|1|||
46748177|NCT00941603|82965497|FG004|Overall Study|Adverse Event|4|||
46748178|NCT00941603|82965498|FG005|Overall Study|Adverse Event|0|||
46748179|NCT00941603|82965493|FG000|Overall Study|Lost to Follow-up|0|||
46748180|NCT00941603|82965494|FG001|Overall Study|Lost to Follow-up|0|||
46748181|NCT00941603|82965495|FG002|Overall Study|Lost to Follow-up|0|||
46748182|NCT00941603|82965496|FG003|Overall Study|Lost to Follow-up|1|||
46748183|NCT00941603|82965497|FG004|Overall Study|Lost to Follow-up|0|||
46923617|NCT03050359|83157251|FG000|Overall Study|Lost to Follow-up|2|||
46923618|NCT03050359|83157252|FG001|Overall Study|Lost to Follow-up|1|||
46923619|NCT03050359|83157251|FG000|Overall Study|Voluntary Withdrawal|4|||
46923620|NCT03050359|83157252|FG001|Overall Study|Voluntary Withdrawal|6|||
46923621|NCT03050359|83157251|FG000|Overall Study|Pregnancy|1|||
46923622|NCT03050359|83157252|FG001|Overall Study|Pregnancy|0|||
46923623|NCT03050359|83157251|FG000|Overall Study|Reason Not Specified|1|||
46923624|NCT03050359|83157252|FG001|Overall Study|Reason Not Specified|0|||
46923625|NCT02785770|83157260|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
46923626|NCT02785770|83157261|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
46923627|NCT02785770|83157262|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
46923628|NCT02785770|83157263|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
46923629|NCT02785770|83157260|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
46923630|NCT02785770|83157261|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
46923631|NCT02785770|83157262|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
46923632|NCT02785770|83157263|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
46923633|NCT02785770|83157260|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
46923634|NCT02785770|83157261|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
46923635|NCT02785770|83157262|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
46923636|NCT02785770|83157263|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
46923637|NCT02965833|83157276|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
46923638|NCT02965833|83157277|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
46923639|NCT02965833|83157276|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
46923640|NCT02965833|83157277|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
46923641|NCT02965833|83157276|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
46923642|NCT02965833|83157277|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
46923643|NCT02965833|83157276|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
46923644|NCT02965833|83157277|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
46923645|NCT02965833|83157276|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
46923646|NCT02965833|83157277|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
46923647|NCT02968173|83157283|FG000|Overall Study|Withdrawal by Subject|1|||
46748184|NCT00941603|82965498|FG005|Overall Study|Lost to Follow-up|2|||
46923648|NCT02785458|83157290|FG000|1 Month|Withdrawal by Subject|2|||
46748185|NCT00941603|82965493|FG000|Overall Study|Withdrawal by Subject|0|||
46748186|NCT00941603|82965494|FG001|Overall Study|Withdrawal by Subject|0|||
46748187|NCT00941603|82965495|FG002|Overall Study|Withdrawal by Subject|0|||
46748188|NCT00941603|82965496|FG003|Overall Study|Withdrawal by Subject|2|||
46748189|NCT00941603|82965497|FG004|Overall Study|Withdrawal by Subject|0|||
46748190|NCT00941603|82965498|FG005|Overall Study|Withdrawal by Subject|1|||
46748191|NCT00941603|82965493|FG000|Overall Study|Protocol Violation|0|||
46748192|NCT00941603|82965494|FG001|Overall Study|Protocol Violation|1|||
46748193|NCT00941603|82965495|FG002|Overall Study|Protocol Violation|0|||
46748194|NCT00941603|82965496|FG003|Overall Study|Protocol Violation|0|||
46748195|NCT00941603|82965497|FG004|Overall Study|Protocol Violation|0|||
46748196|NCT00941603|82965498|FG005|Overall Study|Protocol Violation|0|||
46748197|NCT00941603|82965493|FG000|Overall Study|Did not meet protocol eligibility|1|||
46748198|NCT00941603|82965494|FG001|Overall Study|Did not meet protocol eligibility|0|||
46748199|NCT00941603|82965495|FG002|Overall Study|Did not meet protocol eligibility|0|||
46748200|NCT00941603|82965496|FG003|Overall Study|Did not meet protocol eligibility|0|||
46748201|NCT00941603|82965497|FG004|Overall Study|Did not meet protocol eligibility|0|||
46748202|NCT00941603|82965498|FG005|Overall Study|Did not meet protocol eligibility|0|||
46748203|NCT00797823|82965515|FG000|First Period (Initial Randomization)|Physician Decision|1|||
46748204|NCT00797823|82965516|FG001|First Period (Initial Randomization)|Physician Decision|0|||
46748205|NCT00797823|82965517|FG002|First Period (Initial Randomization)|Physician Decision|0|||
46923649|NCT02785458|83157291|FG001|1 Month|Withdrawal by Subject|1|||
46923650|NCT02785458|83157290|FG000|1 Month|Lost to Follow-up|38|||
46923651|NCT02785458|83157291|FG001|1 Month|Lost to Follow-up|31|||
46923652|NCT02785458|83157290|FG000|1 Month|Deemed Ineligible|1|||
46748206|NCT00797667|82965527|FG000|Overall Study|Lack of Efficacy|0|||
46748207|NCT00797667|82965528|FG001|Overall Study|Lack of Efficacy|1|||
46748208|NCT00797667|82965529|FG002|Overall Study|Lack of Efficacy|0|||
46635583|NCT01534260|82809346|FG000|Overall Study|Disease Progression|8|||
46635584|NCT01534260|82809347|FG001|Overall Study|Disease Progression|6|||
46635585|NCT01534260|82809346|FG000|Overall Study|Physician Decision|3|||
46635586|NCT01534260|82809347|FG001|Overall Study|Physician Decision|1|||
46635587|NCT01534260|82809346|FG000|Overall Study|No treatment, per protocol|0|||
46635588|NCT01534260|82809347|FG001|Overall Study|No treatment, per protocol|1|||
46635589|NCT01534182|82809355|FG000|Overall Study|Administrative problems|1|||
46748209|NCT00797667|82965527|FG000|Overall Study|Lost to Follow-up|8|||
46748210|NCT00797667|82965528|FG001|Overall Study|Lost to Follow-up|12|||
46923653|NCT02785458|83157291|FG001|1 Month|Deemed Ineligible|0|||
46923654|NCT02785458|83157290|FG000|1 Month|Completed Evaluation by Baseline|42|||
46923655|NCT02785458|83157291|FG001|1 Month|Completed Evaluation by Baseline|39|||
46923656|NCT02785458|83157290|FG000|1 Month|Partial Interview|0|||
46923657|NCT02785458|83157291|FG001|1 Month|Partial Interview|4|||
46923658|NCT02785458|83157290|FG000|3 Months|Withdrawal by Subject|3|||
46923659|NCT02785458|83157291|FG001|3 Months|Withdrawal by Subject|1|||
46923660|NCT02785458|83157290|FG000|3 Months|Lost to Follow-up|25|||
46923661|NCT02785458|83157291|FG001|3 Months|Lost to Follow-up|21|||
46923662|NCT02785458|83157290|FG000|3 Months|Completed Evaluation at 1 Month|100|||
46923663|NCT02785458|83157291|FG001|3 Months|Completed Evaluation at 1 Month|89|||
46923664|NCT02784834|83157297|FG000|Overall Study|Lack of Efficacy|1|||
46923665|NCT02966223|83157301|FG000|Overall Study|Physician Decision|3|||
46923666|NCT02966223|83157301|FG000|Overall Study|Withdrawal by Subject|11|||
46923667|NCT02966223|83157301|FG000|Overall Study|Lost to Follow-up|1|||
46923668|NCT03049735|83157308|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
46923669|NCT03049735|83157309|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
46923670|NCT03049735|83157310|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
46923671|NCT03049735|83157308|FG000|Overall Study|Other|5|||
46923672|NCT03049735|83157309|FG001|Overall Study|Other|3|||
46923673|NCT03049735|83157310|FG002|Overall Study|Other|1|||
46923674|NCT03049735|83157308|FG000|Overall Study|Lack of Efficacy|4|||
46923675|NCT03049735|83157309|FG001|Overall Study|Lack of Efficacy|0|||
46923676|NCT03049735|83157310|FG002|Overall Study|Lack of Efficacy|3|||
46923677|NCT03049735|83157308|FG000|Overall Study|Protocol deviation|1|||
46923678|NCT03049735|83157309|FG001|Overall Study|Protocol deviation|0|||
46923679|NCT03049735|83157310|FG002|Overall Study|Protocol deviation|0|||
46635590|NCT01534182|82809356|FG001|Overall Study|Administrative problems|0|||
46635591|NCT01534182|82809355|FG000|Overall Study|Withdrawal by Subject|4|||
46748211|NCT00797667|82965529|FG002|Overall Study|Lost to Follow-up|2|||
46748212|NCT00797667|82965527|FG000|Overall Study|Physician Decision|3|||
46748213|NCT00797667|82965528|FG001|Overall Study|Physician Decision|1|||
46748214|NCT00797667|82965529|FG002|Overall Study|Physician Decision|0|||
46748215|NCT00797667|82965527|FG000|Overall Study|Pregnancy|2|||
46748216|NCT00797667|82965528|FG001|Overall Study|Pregnancy|0|||
46748217|NCT00797667|82965529|FG002|Overall Study|Pregnancy|0|||
46748218|NCT00797667|82965527|FG000|Overall Study|Protocol Violation|2|||
46748219|NCT00797667|82965528|FG001|Overall Study|Protocol Violation|7|||
46923680|NCT03049735|83157308|FG000|Overall Study|Pregnancy|0|||
46923681|NCT03049735|83157309|FG001|Overall Study|Pregnancy|0|||
46635592|NCT01534182|82809356|FG001|Overall Study|Withdrawal by Subject|7|||
46635593|NCT01534182|82809355|FG000|Overall Study|Adverse Event|7|||
46923682|NCT03049735|83157310|FG002|Overall Study|Pregnancy|1|||
46923683|NCT03049735|83157308|FG000|Overall Study|Adverse Event|7|||
46923684|NCT03049735|83157309|FG001|Overall Study|Adverse Event|18|||
46923685|NCT03049735|83157310|FG002|Overall Study|Adverse Event|5|||
46923686|NCT03049735|83157308|FG000|Overall Study|Withdrawal by Subject|10|||
46923687|NCT03049735|83157309|FG001|Overall Study|Withdrawal by Subject|3|||
46923688|NCT03049735|83157310|FG002|Overall Study|Withdrawal by Subject|7|||
46923689|NCT03049735|83157308|FG000|Overall Study|Lost to Follow-up|1|||
46923690|NCT03049735|83157309|FG001|Overall Study|Lost to Follow-up|5|||
46923691|NCT03049735|83157310|FG002|Overall Study|Lost to Follow-up|5|||
46923692|NCT01295944|83157318|FG000|Overall Study|Switched to alternative treatment|1|||
46923693|NCT01295944|83157318|FG000|Overall Study|Ineligible|9|||
46923694|NCT01295944|83157318|FG000|Overall Study|Withdrawal by Subject|4|||
46635594|NCT01534182|82809356|FG001|Overall Study|Adverse Event|3|||
46635595|NCT01579812|82809363|FG000|Overall Study|Ineligible after treatment start|40|||
46748220|NCT00797667|82965529|FG002|Overall Study|Protocol Violation|0|||
46748221|NCT00797667|82965527|FG000|Overall Study|Study Terminated by Sponsor|217|||
46748222|NCT00797667|82965528|FG001|Overall Study|Study Terminated by Sponsor|216|||
46748223|NCT00797667|82965529|FG002|Overall Study|Study Terminated by Sponsor|115|||
46748224|NCT00797667|82965527|FG000|Overall Study|Withdrawal by Subject|9|||
46748225|NCT00797667|82965528|FG001|Overall Study|Withdrawal by Subject|14|||
46748226|NCT00797667|82965529|FG002|Overall Study|Withdrawal by Subject|2|||
46748227|NCT00797667|82965527|FG000|Overall Study|Adverse Event|19|||
46748228|NCT00797667|82965528|FG001|Overall Study|Adverse Event|8|||
46748229|NCT00797667|82965529|FG002|Overall Study|Adverse Event|8|||
46748230|NCT00950807|82965537|FG000|Treatment Period 1|Lack of Efficacy|1|||
46748231|NCT00950807|82965538|FG001|Treatment Period 1|Lack of Efficacy|0|||
46635596|NCT01579812|82809363|FG000|Overall Study|Patient choice|3|||
46635597|NCT01579812|82809363|FG000|Overall Study|Noncompliance|3|||
46635598|NCT01579812|82809363|FG000|Overall Study|Withdrawal by Subject|6|||
46635599|NCT01533714|82809376|FG000|Overall Study|Adverse Event|0|||
46635600|NCT01533714|82809377|FG001|Overall Study|Adverse Event|1|||
46635601|NCT01533714|82809378|FG002|Overall Study|Adverse Event|2|||
46635602|NCT01533714|82809379|FG003|Overall Study|Adverse Event|2|||
46748232|NCT00950807|82965539|FG002|Treatment Period 1|Lack of Efficacy|0|||
46748233|NCT00950807|82965540|FG003|Treatment Period 1|Lack of Efficacy|0|||
46748234|NCT00950807|82965541|FG004|Treatment Period 1|Lack of Efficacy|0|||
46748235|NCT00950807|82965542|FG005|Treatment Period 1|Lack of Efficacy|1|||
46748236|NCT00950807|82965543|FG006|Treatment Period 1|Lack of Efficacy|0|||
46748237|NCT00950807|82965544|FG007|Treatment Period 1|Lack of Efficacy|0|||
46748238|NCT00950807|82965545|FG008|Treatment Period 1|Lack of Efficacy|0|||
46748239|NCT00950807|82965546|FG009|Treatment Period 1|Lack of Efficacy|0|||
46748240|NCT00950807|82965537|FG000|Treatment Period 1|Protocol Violation|1|||
46748241|NCT00950807|82965538|FG001|Treatment Period 1|Protocol Violation|0|||
46748242|NCT00950807|82965539|FG002|Treatment Period 1|Protocol Violation|0|||
46748243|NCT00950807|82965540|FG003|Treatment Period 1|Protocol Violation|0|||
46748244|NCT00950807|82965541|FG004|Treatment Period 1|Protocol Violation|0|||
46748245|NCT00950807|82965542|FG005|Treatment Period 1|Protocol Violation|0|||
46748246|NCT00950807|82965543|FG006|Treatment Period 1|Protocol Violation|0|||
46748247|NCT00950807|82965544|FG007|Treatment Period 1|Protocol Violation|0|||
46748248|NCT00950807|82965545|FG008|Treatment Period 1|Protocol Violation|0|||
46748249|NCT00950807|82965546|FG009|Treatment Period 1|Protocol Violation|0|||
46748250|NCT00950807|82965537|FG000|Treatment Period 1|Lost to Follow-up|0|||
46748251|NCT00950807|82965538|FG001|Treatment Period 1|Lost to Follow-up|0|||
46748252|NCT00950807|82965539|FG002|Treatment Period 1|Lost to Follow-up|1|||
46748253|NCT00950807|82965540|FG003|Treatment Period 1|Lost to Follow-up|0|||
46748254|NCT00950807|82965541|FG004|Treatment Period 1|Lost to Follow-up|0|||
46748255|NCT00950807|82965542|FG005|Treatment Period 1|Lost to Follow-up|0|||
46748256|NCT00950807|82965543|FG006|Treatment Period 1|Lost to Follow-up|0|||
46748257|NCT00950807|82965544|FG007|Treatment Period 1|Lost to Follow-up|0|||
46748258|NCT00950807|82965545|FG008|Treatment Period 1|Lost to Follow-up|0|||
46748259|NCT00950807|82965546|FG009|Treatment Period 1|Lost to Follow-up|0|||
46748260|NCT00950807|82965537|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46748261|NCT00950807|82965538|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46748262|NCT00950807|82965539|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46748263|NCT00950807|82965540|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46748264|NCT00950807|82965541|FG004|Treatment Period 1|Withdrawal by Subject|1|||
46748265|NCT00950807|82965542|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46923695|NCT01295944|83157318|FG000|Overall Study|Participant chose to be treated in Peru|1|||
46923696|NCT01295944|83157318|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
46748266|NCT00950807|82965543|FG006|Treatment Period 1|Withdrawal by Subject|0|||
46748267|NCT00950807|82965544|FG007|Treatment Period 1|Withdrawal by Subject|0|||
46923697|NCT01295944|83157318|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
46635603|NCT01533714|82809380|FG004|Overall Study|Adverse Event|2|||
46635604|NCT01533714|82809381|FG005|Overall Study|Adverse Event|1|||
46748268|NCT00950807|82965545|FG008|Treatment Period 1|Withdrawal by Subject|1|||
46748269|NCT00950807|82965546|FG009|Treatment Period 1|Withdrawal by Subject|0|||
46748270|NCT00950807|82965537|FG000|Treatment Period 1|Adverse Event|0|||
46748271|NCT00950807|82965538|FG001|Treatment Period 1|Adverse Event|0|||
46748272|NCT00950807|82965539|FG002|Treatment Period 1|Adverse Event|0|||
46748273|NCT00950807|82965540|FG003|Treatment Period 1|Adverse Event|0|||
46748274|NCT00950807|82965541|FG004|Treatment Period 1|Adverse Event|0|||
46748275|NCT00950807|82965542|FG005|Treatment Period 1|Adverse Event|1|||
46748276|NCT00950807|82965543|FG006|Treatment Period 1|Adverse Event|0|||
46748277|NCT00950807|82965544|FG007|Treatment Period 1|Adverse Event|0|||
46748278|NCT00950807|82965545|FG008|Treatment Period 1|Adverse Event|0|||
46748279|NCT00950807|82965546|FG009|Treatment Period 1|Adverse Event|0|||
46748280|NCT00950807|82965537|FG000|Washout Period 1|Lack of Efficacy|0|||
46748281|NCT00950807|82965538|FG001|Washout Period 1|Lack of Efficacy|0|||
46748282|NCT00950807|82965539|FG002|Washout Period 1|Lack of Efficacy|0|||
46748283|NCT00950807|82965540|FG003|Washout Period 1|Lack of Efficacy|0|||
46748284|NCT00950807|82965541|FG004|Washout Period 1|Lack of Efficacy|0|||
46748285|NCT00950807|82965542|FG005|Washout Period 1|Lack of Efficacy|0|||
46748286|NCT00950807|82965543|FG006|Washout Period 1|Lack of Efficacy|1|||
46748287|NCT00950807|82965544|FG007|Washout Period 1|Lack of Efficacy|0|||
46748288|NCT00950807|82965545|FG008|Washout Period 1|Lack of Efficacy|0|||
46748289|NCT00950807|82965546|FG009|Washout Period 1|Lack of Efficacy|0|||
46748290|NCT00950807|82965537|FG000|Washout Period 1|Withdrawal by Subject|0|||
46748291|NCT00950807|82965538|FG001|Washout Period 1|Withdrawal by Subject|0|||
46748292|NCT00950807|82965539|FG002|Washout Period 1|Withdrawal by Subject|0|||
46748293|NCT00950807|82965540|FG003|Washout Period 1|Withdrawal by Subject|0|||
46748294|NCT00950807|82965541|FG004|Washout Period 1|Withdrawal by Subject|0|||
46748295|NCT00950807|82965542|FG005|Washout Period 1|Withdrawal by Subject|0|||
46748296|NCT00950807|82965543|FG006|Washout Period 1|Withdrawal by Subject|0|||
46748297|NCT00950807|82965544|FG007|Washout Period 1|Withdrawal by Subject|0|||
46748298|NCT00950807|82965545|FG008|Washout Period 1|Withdrawal by Subject|1|||
46748299|NCT00950807|82965546|FG009|Washout Period 1|Withdrawal by Subject|0|||
46748300|NCT00950807|82965537|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
46748301|NCT00950807|82965538|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
46748302|NCT00950807|82965539|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
46748303|NCT00950807|82965540|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
46923698|NCT01295944|83157318|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
46923699|NCT02965599|83157324|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
46923700|NCT02965599|83157325|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
46923701|NCT02898597|83157334|FG000|Overall Study|Protocol Violation|4|||
46923702|NCT02898597|83157335|FG001|Overall Study|Protocol Violation|2|||
46923703|NCT02898597|83157334|FG000|Overall Study|Lost to Follow-up|0|||
46923704|NCT02898597|83157335|FG001|Overall Study|Lost to Follow-up|9|||
46923705|NCT02898597|83157334|FG000|Overall Study|Death|0|||
46923706|NCT02898597|83157335|FG001|Overall Study|Death|1|||
46923707|NCT02899377|83157343|FG000|Overall Study|Adverse Event|1|||
46923708|NCT02899377|83157344|FG001|Overall Study|Adverse Event|0|||
46923709|NCT01316887|83157355|FG000|Overall Study|Adverse Event|13|||
46923710|NCT01316887|83157356|FG001|Overall Study|Adverse Event|21|||
46923711|NCT01316887|83157357|FG002|Overall Study|Adverse Event|17|||
46923712|NCT01316887|83157355|FG000|Overall Study|Lack of Efficacy|9|||
46923713|NCT01316887|83157356|FG001|Overall Study|Lack of Efficacy|3|||
46923714|NCT01316887|83157357|FG002|Overall Study|Lack of Efficacy|1|||
46923715|NCT01316887|83157355|FG000|Overall Study|Protocol Violation|2|||
46923716|NCT01316887|83157356|FG001|Overall Study|Protocol Violation|6|||
46923717|NCT01316887|83157357|FG002|Overall Study|Protocol Violation|6|||
46923718|NCT01316887|83157355|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
46923719|NCT01316887|83157356|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
46923720|NCT01316887|83157357|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
46923721|NCT01316887|83157355|FG000|Overall Study|Study Closed/Terminated|2|||
46923722|NCT01316887|83157356|FG001|Overall Study|Study Closed/Terminated|4|||
46923723|NCT01316887|83157357|FG002|Overall Study|Study Closed/Terminated|3|||
46748304|NCT00950807|82965541|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
46748305|NCT00950807|82965542|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
46748306|NCT00950807|82965543|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
46748307|NCT00950807|82965544|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
46748308|NCT00950807|82965545|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
46748309|NCT00950807|82965546|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
46748310|NCT00950807|82965537|FG000|Washout Period 1|Adverse Event|2|||
46923724|NCT01316887|83157355|FG000|Overall Study|Lost to Follow-up|1|||
46923725|NCT01316887|83157356|FG001|Overall Study|Lost to Follow-up|7|||
46923726|NCT01316887|83157357|FG002|Overall Study|Lost to Follow-up|5|||
46923727|NCT01316887|83157355|FG000|Overall Study|Withdrawal by Subject|8|||
46923728|NCT01316887|83157356|FG001|Overall Study|Withdrawal by Subject|16|||
46923729|NCT01316887|83157357|FG002|Overall Study|Withdrawal by Subject|15|||
46923730|NCT02897349|83157368|FG000|Overall Study|Lost to Follow-up|2|||
46923731|NCT02897349|83157369|FG001|Overall Study|Lost to Follow-up|2|||
46923732|NCT02897349|83157368|FG000|Overall Study|Adverse Event|3|||
46923733|NCT02897349|83157369|FG001|Overall Study|Adverse Event|3|||
46923734|NCT02897349|83157368|FG000|Overall Study|Other than listed above|0|||
46923735|NCT02897349|83157369|FG001|Overall Study|Other than listed above|1|||
46923736|NCT03047551|83157386|FG000|Overall Study|Did not receive TAS|1|||
46923737|NCT03047551|83157387|FG001|Overall Study|Did not receive TAS|0|||
46923738|NCT03047551|83157386|FG000|Overall Study|Physician Decision|1|||
46923739|NCT03047551|83157387|FG001|Overall Study|Physician Decision|0|||
46923740|NCT03047551|83157386|FG000|Overall Study|Withdrawal by Subject|0|||
46923741|NCT03047551|83157387|FG001|Overall Study|Withdrawal by Subject|1|||
46923742|NCT03047551|83157386|FG000|Overall Study|Probe malfunction|0|||
46923743|NCT03047551|83157387|FG001|Overall Study|Probe malfunction|1|||
46923744|NCT03047551|83157386|FG000|Overall Study|Ineligible|0|||
46923745|NCT03047551|83157387|FG001|Overall Study|Ineligible|1|||
46923746|NCT02964741|83157396|FG000|Overall Study|Protocol Violation|1|||
46923747|NCT02964741|83157397|FG001|Overall Study|Protocol Violation|0|||
46923748|NCT02964741|83157398|FG002|Overall Study|Protocol Violation|0|||
46923749|NCT02964741|83157396|FG000|Overall Study|Withdrawal by Subject|0|||
46923750|NCT02964741|83157397|FG001|Overall Study|Withdrawal by Subject|1|||
46923751|NCT02964741|83157398|FG002|Overall Study|Withdrawal by Subject|0|||
46923752|NCT02964741|83157396|FG000|Overall Study|claustrophobia|1|||
46923753|NCT02964741|83157397|FG001|Overall Study|claustrophobia|0|||
46923754|NCT02964741|83157398|FG002|Overall Study|claustrophobia|0|||
46923755|NCT01316419|83157404|FG000|Overall Study|Not treated|103|||
46923756|NCT01316419|83157404|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
46923757|NCT01316419|83157404|FG000|Overall Study|Lost to Follow-up|19|||
46748311|NCT00950807|82965538|FG001|Washout Period 1|Adverse Event|0|||
46923758|NCT02964039|83157411|FG000|Overall Study|Medical reason unrelated to study participation|1|||
46923759|NCT02964039|83157412|FG001|Overall Study|Medical reason unrelated to study participation|0|||
46923760|NCT02964039|83157413|FG002|Overall Study|Medical reason unrelated to study participation|3|||
46748312|NCT00950807|82965539|FG002|Washout Period 1|Adverse Event|0|||
46748313|NCT00950807|82965540|FG003|Washout Period 1|Adverse Event|1|||
46748314|NCT00950807|82965541|FG004|Washout Period 1|Adverse Event|1|||
46748315|NCT00950807|82965542|FG005|Washout Period 1|Adverse Event|0|||
46748316|NCT00950807|82965543|FG006|Washout Period 1|Adverse Event|0|||
46748317|NCT00950807|82965544|FG007|Washout Period 1|Adverse Event|0|||
46748318|NCT00950807|82965545|FG008|Washout Period 1|Adverse Event|0|||
46748319|NCT00950807|82965546|FG009|Washout Period 1|Adverse Event|0|||
46748320|NCT00950807|82965537|FG000|Treatment Period 2|Lack of Efficacy|1|||
46748321|NCT00950807|82965538|FG001|Treatment Period 2|Lack of Efficacy|0|||
46748322|NCT00950807|82965539|FG002|Treatment Period 2|Lack of Efficacy|0|||
46748323|NCT00950807|82965540|FG003|Treatment Period 2|Lack of Efficacy|0|||
46923761|NCT02964039|83157411|FG000|Overall Study|Research shutdown due to pandemic|2|||
46923762|NCT02964039|83157412|FG001|Overall Study|Research shutdown due to pandemic|0|||
46923763|NCT02964039|83157413|FG002|Overall Study|Research shutdown due to pandemic|1|||
46923764|NCT02964039|83157411|FG000|Overall Study|Withdrawal by Subject|0|||
46923765|NCT02964039|83157412|FG001|Overall Study|Withdrawal by Subject|1|||
46748324|NCT00950807|82965541|FG004|Treatment Period 2|Lack of Efficacy|0|||
46748325|NCT00950807|82965542|FG005|Treatment Period 2|Lack of Efficacy|0|||
46748326|NCT00950807|82965543|FG006|Treatment Period 2|Lack of Efficacy|0|||
46748327|NCT00950807|82965544|FG007|Treatment Period 2|Lack of Efficacy|0|||
46923766|NCT02964039|83157413|FG002|Overall Study|Withdrawal by Subject|0|||
46923767|NCT02964039|83157411|FG000|Overall Study|Lost to Follow-up|1|||
46923768|NCT02964039|83157412|FG001|Overall Study|Lost to Follow-up|0|||
46923769|NCT02964039|83157413|FG002|Overall Study|Lost to Follow-up|1|||
46923770|NCT02897115|83157423|FG000|Overall Study|Early termination of study by sponsor|11|||
47052034|NCT04621227|83317968|FG000|Period 8 (2 Days)|Adverse Event|1|||
46748328|NCT00950807|82965545|FG008|Treatment Period 2|Lack of Efficacy|0|||
46748329|NCT00950807|82965546|FG009|Treatment Period 2|Lack of Efficacy|0|||
46748330|NCT00950807|82965537|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46748331|NCT00950807|82965538|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46748332|NCT00950807|82965539|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46923771|NCT02897115|83157424|FG001|Overall Study|Early termination of study by sponsor|8|||
46923772|NCT02896569|83157432|FG000|Overall Study|Lost to Follow-up|2|||
46923773|NCT02896569|83157433|FG001|Overall Study|Lost to Follow-up|1|||
46923774|NCT02896569|83157432|FG000|Overall Study|Physician Decision|1|||
46923775|NCT02896569|83157433|FG001|Overall Study|Physician Decision|3|||
46923776|NCT02896569|83157432|FG000|Overall Study|Adverse Event|0|||
46923777|NCT02896569|83157433|FG001|Overall Study|Adverse Event|1|||
46923778|NCT02896569|83157432|FG000|Overall Study|Withdrawal by Subject|1|||
46923779|NCT02896569|83157433|FG001|Overall Study|Withdrawal by Subject|0|||
46923780|NCT04030195|83157442|FG000|Overall Study|Withdrawal by Subject|2|||
46748333|NCT00950807|82965540|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46748334|NCT00950807|82965541|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46748335|NCT00950807|82965542|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46748336|NCT00950807|82965543|FG006|Treatment Period 2|Withdrawal by Subject|1|||
46748337|NCT00950807|82965544|FG007|Treatment Period 2|Withdrawal by Subject|2|||
46748338|NCT00950807|82965545|FG008|Treatment Period 2|Withdrawal by Subject|0|||
46923781|NCT04030195|83157443|FG001|Overall Study|Withdrawal by Subject|0|||
46923782|NCT04030195|83157444|FG002|Overall Study|Withdrawal by Subject|0|||
46923783|NCT01673620|83157455|FG000|Overall Study|Adverse Event|1|||
46923784|NCT01673620|83157456|FG001|Overall Study|Adverse Event|0|||
46923785|NCT03044197|83157470|FG000|Overall Study|Withdrawal by Subject|3|||
46923786|NCT03044197|83157471|FG001|Overall Study|Withdrawal by Subject|1|||
46923787|NCT03043651|83157499|FG000|Overall Study|Death|1|||
46923788|NCT03043651|83157499|FG000|Overall Study|Progressive Disease|2|||
46923789|NCT03043651|83157499|FG000|Overall Study|Adverse Event|2|||
46923790|NCT03043651|83157499|FG000|Overall Study|Withdrawal by Subject|4|||
46923791|NCT03043651|83157499|FG000|Overall Study|Study Terminated by Sponsor|39|||
46923792|NCT03536143|83157503|FG000|Overall Study|Early termination, Sponsor decision|1|||
46923793|NCT01344759|83157513|FG000|Overall Study|Patients failed to reach sedation level|0|||
46923794|NCT01344759|83157514|FG001|Overall Study|Patients failed to reach sedation level|2|||
46923795|NCT05027451|83157537|FG000|Overall Study|Lost to Follow-up|1|||
46923796|NCT05027451|83157538|FG001|Overall Study|Lost to Follow-up|1|||
46923797|NCT04549454|83157572|FG000|T1 to T2|Lost to Follow-up|22|||
46748339|NCT00950807|82965546|FG009|Treatment Period 2|Withdrawal by Subject|0|||
46748340|NCT00950807|82965537|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
46748341|NCT00950807|82965538|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748342|NCT00950807|82965539|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748343|NCT00950807|82965540|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748344|NCT00950807|82965541|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748345|NCT00950807|82965542|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748346|NCT00950807|82965543|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748347|NCT00950807|82965544|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748348|NCT00950807|82965545|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748349|NCT00950807|82965546|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
46748350|NCT00950807|82965537|FG000|Treatment Period 2|Adverse Event|0|||
46748351|NCT00950807|82965538|FG001|Treatment Period 2|Adverse Event|1|||
46748352|NCT00950807|82965539|FG002|Treatment Period 2|Adverse Event|0|||
46748353|NCT00950807|82965540|FG003|Treatment Period 2|Adverse Event|1|||
46748354|NCT00950807|82965541|FG004|Treatment Period 2|Adverse Event|0|||
46748355|NCT00950807|82965542|FG005|Treatment Period 2|Adverse Event|1|||
46748356|NCT00950807|82965543|FG006|Treatment Period 2|Adverse Event|0|||
46748357|NCT00950807|82965544|FG007|Treatment Period 2|Adverse Event|1|||
46748358|NCT00950807|82965545|FG008|Treatment Period 2|Adverse Event|0|||
46748359|NCT00950807|82965546|FG009|Treatment Period 2|Adverse Event|0|||
46748360|NCT00950807|82965537|FG000|Washout Period 2|Lack of Efficacy|1|||
46748361|NCT00950807|82965538|FG001|Washout Period 2|Lack of Efficacy|0|||
46748362|NCT00950807|82965539|FG002|Washout Period 2|Lack of Efficacy|0|||
46748363|NCT00950807|82965540|FG003|Washout Period 2|Lack of Efficacy|0|||
46748364|NCT00950807|82965541|FG004|Washout Period 2|Lack of Efficacy|0|||
46748365|NCT00950807|82965542|FG005|Washout Period 2|Lack of Efficacy|0|||
46748366|NCT00950807|82965543|FG006|Washout Period 2|Lack of Efficacy|0|||
46748367|NCT00950807|82965544|FG007|Washout Period 2|Lack of Efficacy|0|||
46748368|NCT00950807|82965545|FG008|Washout Period 2|Lack of Efficacy|0|||
46748369|NCT00950807|82965546|FG009|Washout Period 2|Lack of Efficacy|0|||
46748370|NCT00950807|82965537|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
46748371|NCT00950807|82965538|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
46748372|NCT00950807|82965539|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
46748373|NCT00950807|82965540|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
46748374|NCT00950807|82965541|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
46923798|NCT04549454|83157573|FG001|T1 to T2|Lost to Follow-up|26|||
46748375|NCT00950807|82965542|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
46748376|NCT00950807|82965543|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
46748377|NCT00950807|82965544|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
46923799|NCT04549454|83157572|FG000|T1 to T3|Lost to Follow-up|31|||
46923800|NCT04549454|83157573|FG001|T1 to T3|Lost to Follow-up|36|||
46923801|NCT03519256|83157620|FG000|Overall Study|Disease recurrence|4|||
46748378|NCT00950807|82965545|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
46748379|NCT00950807|82965546|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
46748380|NCT00950807|82965537|FG000|Washout Period 2|Adverse Event|3|||
46748381|NCT00950807|82965538|FG001|Washout Period 2|Adverse Event|0|||
46748382|NCT00950807|82965539|FG002|Washout Period 2|Adverse Event|0|||
46923802|NCT03519256|83157621|FG001|Overall Study|Disease recurrence|4|||
46923803|NCT03519256|83157622|FG002|Overall Study|Disease recurrence|5|||
46923804|NCT03519256|83157623|FG003|Overall Study|Disease recurrence|2|||
46923805|NCT03519256|83157620|FG000|Overall Study|Study drug toxicity|0|||
46748383|NCT00950807|82965540|FG003|Washout Period 2|Adverse Event|1|||
46748384|NCT00950807|82965541|FG004|Washout Period 2|Adverse Event|0|||
46748385|NCT00950807|82965542|FG005|Washout Period 2|Adverse Event|0|||
46748386|NCT00950807|82965543|FG006|Washout Period 2|Adverse Event|0|||
46748387|NCT00950807|82965544|FG007|Washout Period 2|Adverse Event|0|||
46748388|NCT00950807|82965545|FG008|Washout Period 2|Adverse Event|0|||
46748389|NCT00950807|82965546|FG009|Washout Period 2|Adverse Event|0|||
46748390|NCT00950807|82965537|FG000|Treatment Period 3|Withdrawal by Subject|0|||
46748391|NCT00950807|82965538|FG001|Treatment Period 3|Withdrawal by Subject|0|||
46923806|NCT03519256|83157621|FG001|Overall Study|Study drug toxicity|2|||
46923807|NCT03519256|83157622|FG002|Overall Study|Study drug toxicity|5|||
46923808|NCT03519256|83157623|FG003|Overall Study|Study drug toxicity|2|||
46923809|NCT03519256|83157620|FG000|Overall Study|Adverse event unrelated to study drug|0|||
46923810|NCT03519256|83157621|FG001|Overall Study|Adverse event unrelated to study drug|1|||
46923811|NCT03519256|83157622|FG002|Overall Study|Adverse event unrelated to study drug|1|||
46923812|NCT03519256|83157623|FG003|Overall Study|Adverse event unrelated to study drug|0|||
46923813|NCT03519256|83157620|FG000|Overall Study|Participant request to discontinue study treatment|0|||
46923814|NCT03519256|83157621|FG001|Overall Study|Participant request to discontinue study treatment|0|||
46923815|NCT03519256|83157622|FG002|Overall Study|Participant request to discontinue study treatment|0|||
46923816|NCT03519256|83157623|FG003|Overall Study|Participant request to discontinue study treatment|2|||
46923817|NCT03519256|83157620|FG000|Overall Study|Other reasons|0|||
46923818|NCT03519256|83157621|FG001|Overall Study|Other reasons|0|||
46923819|NCT03519256|83157622|FG002|Overall Study|Other reasons|2|||
46923820|NCT03519256|83157623|FG003|Overall Study|Other reasons|0|||
46748392|NCT00950807|82965539|FG002|Treatment Period 3|Withdrawal by Subject|0|||
46748393|NCT00950807|82965540|FG003|Treatment Period 3|Withdrawal by Subject|0|||
46748394|NCT00950807|82965541|FG004|Treatment Period 3|Withdrawal by Subject|0|||
46748395|NCT00950807|82965542|FG005|Treatment Period 3|Withdrawal by Subject|0|||
46923821|NCT03519256|83157620|FG000|Overall Study|Disease progression|6|||
46923822|NCT03519256|83157621|FG001|Overall Study|Disease progression|3|||
46923823|NCT03519256|83157622|FG002|Overall Study|Disease progression|2|||
46923824|NCT03519256|83157623|FG003|Overall Study|Disease progression|1|||
46923825|NCT03519256|83157620|FG000|Overall Study|Lost to Follow-up|0|||
46923826|NCT03519256|83157621|FG001|Overall Study|Lost to Follow-up|1|||
46923827|NCT03519256|83157622|FG002|Overall Study|Lost to Follow-up|0|||
46923828|NCT03519256|83157623|FG003|Overall Study|Lost to Follow-up|0|||
46923829|NCT02799602|83157659|FG000|Overall Study|Protocol Violation|1|||
46923830|NCT02799602|83157660|FG001|Overall Study|Protocol Violation|0|||
46923831|NCT02799602|83157659|FG000|Overall Study|Physician Decision|3|||
46923832|NCT02799602|83157660|FG001|Overall Study|Physician Decision|7|||
46923833|NCT02799602|83157659|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
46923834|NCT02799602|83157660|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
46923835|NCT02799602|83157659|FG000|Overall Study|Lost to Follow-up|4|||
46923836|NCT02799602|83157660|FG001|Overall Study|Lost to Follow-up|1|||
46923837|NCT02799602|83157659|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
46923838|NCT02799602|83157660|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
46923839|NCT02799602|83157659|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
46923840|NCT02799602|83157660|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
46923841|NCT02799602|83157659|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
46748396|NCT00950807|82965543|FG006|Treatment Period 3|Withdrawal by Subject|0|||
46748397|NCT00950807|82965544|FG007|Treatment Period 3|Withdrawal by Subject|0|||
46748398|NCT00950807|82965545|FG008|Treatment Period 3|Withdrawal by Subject|0|||
46748399|NCT00950807|82965546|FG009|Treatment Period 3|Withdrawal by Subject|1|||
46748400|NCT00950807|82965537|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
46748401|NCT00950807|82965538|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46748402|NCT00950807|82965539|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46748403|NCT00950807|82965540|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46748404|NCT00950807|82965541|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46748405|NCT00950807|82965542|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46748406|NCT00950807|82965543|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46923842|NCT02799602|83157660|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
46923843|NCT02799602|83157659|FG000|Overall Study|Withdrawal by Subject|25|||
46923844|NCT02799602|83157660|FG001|Overall Study|Withdrawal by Subject|37|||
46923845|NCT02799602|83157659|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
46748407|NCT00950807|82965544|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
46748408|NCT00950807|82965545|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46748409|NCT00950807|82965546|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
46923846|NCT02799602|83157660|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
46923847|NCT02799602|83157659|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
46923848|NCT02799602|83157660|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
46748410|NCT00950807|82965537|FG000|Treatment Period 3|Adverse Event|0|||
46748411|NCT00950807|82965538|FG001|Treatment Period 3|Adverse Event|0|||
46748412|NCT00950807|82965539|FG002|Treatment Period 3|Adverse Event|0|||
46748413|NCT00950807|82965540|FG003|Treatment Period 3|Adverse Event|0|||
46748414|NCT00950807|82965541|FG004|Treatment Period 3|Adverse Event|0|||
46748415|NCT00950807|82965542|FG005|Treatment Period 3|Adverse Event|0|||
46748416|NCT00950807|82965543|FG006|Treatment Period 3|Adverse Event|1|||
46748417|NCT00950807|82965544|FG007|Treatment Period 3|Adverse Event|0|||
46748418|NCT00950807|82965545|FG008|Treatment Period 3|Adverse Event|0|||
46748419|NCT00950807|82965546|FG009|Treatment Period 3|Adverse Event|0|||
46748420|NCT00797511|82965568|FG000|Overall Study|Withdrawal by Subject|1|||
46748421|NCT00608881|82965575|FG000|Overall Study|Death|22|||
46748422|NCT00608881|82965576|FG001|Overall Study|Death|13|||
46748423|NCT00608881|82965575|FG000|Overall Study|Adverse Event|5|||
46748424|NCT00608881|82965576|FG001|Overall Study|Adverse Event|3|||
46748425|NCT00608881|82965575|FG000|Overall Study|Lost to Follow-up|28|||
46748426|NCT00608881|82965576|FG001|Overall Study|Lost to Follow-up|14|||
46748427|NCT00608881|82965575|FG000|Overall Study|Withdrawal by Subject|18|||
46748428|NCT00608881|82965576|FG001|Overall Study|Withdrawal by Subject|29|||
46748429|NCT00608881|82965575|FG000|Overall Study|Physician Decision|5|||
46748430|NCT00608881|82965576|FG001|Overall Study|Physician Decision|5|||
46748431|NCT00608881|82965575|FG000|Overall Study|Institutionalized|1|||
46748432|NCT00608881|82965576|FG001|Overall Study|Institutionalized|2|||
46748433|NCT00945191|82965582|FG000|Overall Study|Did not achieve a complete response|18|||
46748434|NCT00945191|82965582|FG000|Overall Study|Participant relocated to another state|1|||
46748435|NCT00945191|82965582|FG000|Overall Study|Disease progression|3|||
46748436|NCT00945191|82965582|FG000|Overall Study|Serious adverse event or adverse event|1|||
46748437|NCT00945191|82965582|FG000|Overall Study|Investigator's discretion|1|||
46748438|NCT00606931|82965586|FG000|Overall Study|Withdrawal by Subject|3|||
46748439|NCT00792909|82965593|FG000|Overall Study|Withdrawal by Subject|0|||
46748440|NCT00792909|82965594|FG001|Overall Study|Withdrawal by Subject|1|||
46748441|NCT00792909|82965595|FG002|Overall Study|Withdrawal by Subject|0|||
46748442|NCT00944645|82965606|FG000|Period 2|Adverse Event|1|||
46748443|NCT00944645|82965607|FG001|Period 2|Adverse Event|0|||
46748444|NCT00944645|82965606|FG000|Period 2|Lost to Follow-up|0|||
46748445|NCT00944645|82965607|FG001|Period 2|Lost to Follow-up|3|||
46748446|NCT00944645|82965606|FG000|Period 2|Withdrawal by Subject|7|||
46748447|NCT00944645|82965607|FG001|Period 2|Withdrawal by Subject|6|||
46748448|NCT00606229|82965613|FG000|Overall Study|Adverse Event|11|||
46748449|NCT00606229|82965613|FG000|Overall Study|Lack of Efficacy|1|||
46748450|NCT00606229|82965613|FG000|Overall Study|Withdrawal by Subject|4|||
46748451|NCT00606229|82965613|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
46748452|NCT00606229|82965613|FG000|Overall Study|change of residence or other commitments|2|||
46748453|NCT00950651|82965619|FG000|Overall Study|Adverse Event|17|||
46748454|NCT00950651|82965620|FG001|Overall Study|Adverse Event|20|||
46748455|NCT00950651|82965619|FG000|Overall Study|Death|1|||
46748456|NCT00950651|82965620|FG001|Overall Study|Death|0|||
46748457|NCT00950651|82965619|FG000|Overall Study|Lack of Efficacy|2|||
46748458|NCT00950651|82965620|FG001|Overall Study|Lack of Efficacy|2|||
46748459|NCT00950651|82965619|FG000|Overall Study|Protocol Violation|3|||
46748460|NCT00950651|82965620|FG001|Overall Study|Protocol Violation|4|||
46748461|NCT00950651|82965619|FG000|Overall Study|Withdrawal by Subject|8|||
46748462|NCT00950651|82965620|FG001|Overall Study|Withdrawal by Subject|9|||
46748463|NCT00605293|82965628|FG000|Overall Study|Death|2|||
46748464|NCT00605293|82965629|FG001|Overall Study|Death|1|||
46748465|NCT00605293|82965628|FG000|Overall Study|Insufficient Therapeutic Response|2|||
46748466|NCT00605293|82965629|FG001|Overall Study|Insufficient Therapeutic Response|0|||
46748467|NCT00605293|82965628|FG000|Overall Study|Adverse Event|1|||
46748468|NCT00605293|82965629|FG001|Overall Study|Adverse Event|0|||
46748469|NCT00605293|82965628|FG000|Overall Study|Holidays Dialysis Out|1|||
46748470|NCT00605293|82965629|FG001|Overall Study|Holidays Dialysis Out|0|||
46748471|NCT00605293|82965628|FG000|Overall Study|Blood Transfusion|7|||
46748472|NCT00605293|82965629|FG001|Overall Study|Blood Transfusion|1|||
46748473|NCT00605293|82965628|FG000|Overall Study|Renal Transplantation|3|||
46748474|NCT00605293|82965629|FG001|Overall Study|Renal Transplantation|1|||
46748475|NCT00605293|82965628|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
46748476|NCT00605293|82965629|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
46748477|NCT00605293|82965628|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
46748478|NCT00605293|82965629|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
46748479|NCT00605293|82965628|FG000|Overall Study|Principal Investigator Decision|0|||
46748480|NCT00605293|82965629|FG001|Overall Study|Principal Investigator Decision|1|||
46748481|NCT00572533|82965637|FG000|Overall Study|Death|4|||
46748482|NCT00572533|82965638|FG001|Overall Study|Death|1|||
46748483|NCT00572533|82965637|FG000|Overall Study|Received Kidney Transplant|2|||
46748484|NCT00572533|82965638|FG001|Overall Study|Received Kidney Transplant|1|||
46748485|NCT00572533|82965637|FG000|Overall Study|Social Issues|1|||
46748486|NCT00572533|82965638|FG001|Overall Study|Social Issues|0|||
46748487|NCT00572533|82965637|FG000|Overall Study|Transfer out of Facility|0|||
46748488|NCT00572533|82965638|FG001|Overall Study|Transfer out of Facility|1|||
46748489|NCT00949715|82965646|FG000|Overall Study|Physician Decision|1|||
46748490|NCT00949715|82965647|FG001|Overall Study|Physician Decision|0|||
46748491|NCT00949715|82965646|FG000|Overall Study|Lost to Follow-up|1|||
46748492|NCT00949715|82965647|FG001|Overall Study|Lost to Follow-up|0|||
46748493|NCT00949715|82965646|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
46748494|NCT00949715|82965647|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
46748495|NCT00791661|82965655|FG000|7 Day Wash-out|Adverse Event|0|||
46748496|NCT00791661|82965656|FG001|7 Day Wash-out|Adverse Event|0|||
46748497|NCT00791661|82965657|FG002|7 Day Wash-out|Adverse Event|1|||
46748498|NCT00791661|82965655|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
46748499|NCT00791661|82965656|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
46748500|NCT00791661|82965657|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
46748501|NCT00943787|82965681|FG000|Overall Study|Physician Decision|4|||
46923849|NCT02799602|83157659|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
46923850|NCT02799602|83157660|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
46923851|NCT02799602|83157659|FG000|Overall Study|Death|8|||
46923852|NCT02799602|83157660|FG001|Overall Study|Death|5|||
46923853|NCT02799602|83157659|FG000|Overall Study|Other|3|||
46923854|NCT02799602|83157660|FG001|Overall Study|Other|3|||
46923855|NCT02799602|83157659|FG000|Overall Study|GCP violation|1|||
46923856|NCT02799602|83157660|FG001|Overall Study|GCP violation|0|||
46923857|NCT02243709|83157677|FG000|Phase 1|Lost to Follow-up|0|||
46923858|NCT02243709|83157678|FG001|Phase 1|Lost to Follow-up|1|||
46923859|NCT02243709|83157677|FG000|Phase 1|Withdrawal by Subject|1|||
46923860|NCT02243709|83157678|FG001|Phase 1|Withdrawal by Subject|0|||
46748502|NCT00943787|82965681|FG000|Overall Study|Withdrawal by Subject|3|||
46748503|NCT00949325|82965685|FG000|Overall Study|Adverse Event|0|||
46923861|NCT02243709|83157677|FG000|Phase 1|Protocol Violation|0|||
46923862|NCT02243709|83157678|FG001|Phase 1|Protocol Violation|1|||
46923863|NCT02243709|83157677|FG000|Phase 1|Adverse Event|0|||
46923864|NCT02243709|83157678|FG001|Phase 1|Adverse Event|1|||
46748504|NCT00949325|82965686|FG001|Overall Study|Adverse Event|2|||
46748505|NCT00949325|82965687|FG002|Overall Study|Adverse Event|0|||
46748506|NCT00943319|82965703|FG000|Overall Study|Death|1|||
46748507|NCT00790647|82965707|FG000|Overall Study|Adverse Event|1|||
46748508|NCT00790569|82965716|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
46748509|NCT00790569|82965717|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
46748510|NCT00790569|82965718|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
46748511|NCT00790569|82965716|FG000|End of Treatment (6 Month Interview)|Death|0|||
46748512|NCT00790569|82965717|FG001|End of Treatment (6 Month Interview)|Death|2|||
46748513|NCT00790569|82965718|FG002|End of Treatment (6 Month Interview)|Death|1|||
46748514|NCT00790569|82965716|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
46748515|NCT00790569|82965717|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
46748516|NCT00790569|82965718|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
46748517|NCT00790569|82965716|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
46748518|NCT00790569|82965717|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
46748519|NCT00790569|82965718|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
46748520|NCT00790569|82965716|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
46748521|NCT00790569|82965717|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
46748522|NCT00790569|82965718|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
46923865|NCT01891396|83157690|FG000|Overall Study|Withdrawal by Subject|4|||
46923866|NCT01891396|83157691|FG001|Overall Study|Withdrawal by Subject|4|||
46923867|NCT01891396|83157692|FG002|Overall Study|Withdrawal by Subject|3|||
46923868|NCT01891396|83157690|FG000|Overall Study|Lost to Follow-up|0|||
46923869|NCT01891396|83157691|FG001|Overall Study|Lost to Follow-up|1|||
46923870|NCT01891396|83157692|FG002|Overall Study|Lost to Follow-up|0|||
46923871|NCT01746225|83157707|FG000|Overall Study|Death|1|||
46923872|NCT01746225|83157708|FG001|Overall Study|Death|0|||
46923873|NCT01746225|83157709|FG002|Overall Study|Death|1|||
46923874|NCT01746225|83157707|FG000|Overall Study|Withdrawal by Subject|5|||
46923875|NCT01746225|83157708|FG001|Overall Study|Withdrawal by Subject|15|||
46923876|NCT01746225|83157709|FG002|Overall Study|Withdrawal by Subject|19|||
46923877|NCT01746225|83157707|FG000|Overall Study|Physician Decision|14|||
46923878|NCT01746225|83157708|FG001|Overall Study|Physician Decision|11|||
46748523|NCT00790569|82965716|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
46748524|NCT00790569|82965717|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
46923879|NCT01746225|83157709|FG002|Overall Study|Physician Decision|3|||
46748525|NCT00790569|82965718|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
46923880|NCT01746225|83157707|FG000|Overall Study|Adverse Event|15|||
46923881|NCT01746225|83157708|FG001|Overall Study|Adverse Event|12|||
46923882|NCT01746225|83157709|FG002|Overall Study|Adverse Event|17|||
46923883|NCT01746225|83157707|FG000|Overall Study|Continuing Treatment|5|||
46923884|NCT01746225|83157708|FG001|Overall Study|Continuing Treatment|8|||
46923885|NCT01746225|83157709|FG002|Overall Study|Continuing Treatment|3|||
46923886|NCT01471522|83157730|FG000|Overall Study|Withdrawal by Subject|28|||
46923887|NCT01471522|83157731|FG001|Overall Study|Withdrawal by Subject|22|||
46923888|NCT01471522|83157730|FG000|Overall Study|Lost to Follow-up|36|||
46923889|NCT01471522|83157731|FG001|Overall Study|Lost to Follow-up|26|||
46923890|NCT01191008|83157738|FG000|Overall Study|Protocol Violation|7|||
46923891|NCT01191008|83157738|FG000|Overall Study|Lost to Follow-up|8|||
46923892|NCT00821587|83157744|FG000|Overall Study|Physician Decision|0|||
46923893|NCT00821587|83157745|FG001|Overall Study|Physician Decision|1|||
46923894|NCT00645801|83157753|FG000|Overall Study|unclear if patient took all the medication.|1|||
46923895|NCT00645801|83157754|FG001|Overall Study|unclear if patient took all the medication.|0|||
46923896|NCT00645801|83157753|FG000|Overall Study|Lost to Follow-up|19|||
46923897|NCT00645801|83157754|FG001|Overall Study|Lost to Follow-up|15|||
46923898|NCT00424099|83157768|FG000|Overall Study|Adverse Event|0|||
46923899|NCT00424099|83157769|FG001|Overall Study|Adverse Event|1|||
46923900|NCT00424099|83157770|FG002|Overall Study|Adverse Event|1|||
46923901|NCT00424099|83157771|FG003|Overall Study|Adverse Event|0|||
46923902|NCT00424099|83157768|FG000|Overall Study|Death|0|||
46923903|NCT00424099|83157769|FG001|Overall Study|Death|1|||
46923904|NCT00424099|83157770|FG002|Overall Study|Death|0|||
46923905|NCT00424099|83157771|FG003|Overall Study|Death|0|||
46923906|NCT00424099|83157768|FG000|Overall Study|Illness|2|||
46923907|NCT00424099|83157769|FG001|Overall Study|Illness|0|||
46923908|NCT00424099|83157770|FG002|Overall Study|Illness|1|||
46923909|NCT00424099|83157771|FG003|Overall Study|Illness|4|||
46923910|NCT00424099|83157768|FG000|Overall Study|Lost to Follow-up|0|||
46923911|NCT00424099|83157769|FG001|Overall Study|Lost to Follow-up|0|||
46923912|NCT00424099|83157770|FG002|Overall Study|Lost to Follow-up|3|||
46923913|NCT00424099|83157771|FG003|Overall Study|Lost to Follow-up|0|||
46923914|NCT00424099|83157768|FG000|Overall Study|Hospitalized|1|||
46923915|NCT00424099|83157769|FG001|Overall Study|Hospitalized|2|||
46923916|NCT00424099|83157770|FG002|Overall Study|Hospitalized|1|||
46923917|NCT00424099|83157771|FG003|Overall Study|Hospitalized|3|||
46923918|NCT00424099|83157768|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
46923919|NCT00424099|83157769|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
46923920|NCT00424099|83157770|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
46923921|NCT00424099|83157771|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
46923922|NCT00424099|83157768|FG000|Overall Study|Withdrawal by Subject|1|||
46923923|NCT00424099|83157769|FG001|Overall Study|Withdrawal by Subject|9|||
46923924|NCT00424099|83157770|FG002|Overall Study|Withdrawal by Subject|4|||
46923925|NCT00424099|83157771|FG003|Overall Study|Withdrawal by Subject|6|||
46923926|NCT00424099|83157768|FG000|Overall Study|Physician Decision|0|||
46923927|NCT00424099|83157769|FG001|Overall Study|Physician Decision|0|||
46923928|NCT00424099|83157770|FG002|Overall Study|Physician Decision|1|||
46923929|NCT00424099|83157771|FG003|Overall Study|Physician Decision|0|||
46923930|NCT00424099|83157768|FG000|Overall Study|Missing|0|||
46923931|NCT00424099|83157769|FG001|Overall Study|Missing|0|||
46923932|NCT00424099|83157770|FG002|Overall Study|Missing|1|||
46923933|NCT00424099|83157771|FG003|Overall Study|Missing|0|||
46923934|NCT02988661|83157794|FG000|Overall Study|Death|2|||
46923935|NCT02988661|83157795|FG001|Overall Study|Death|18|||
46923936|NCT02988661|83157794|FG000|Overall Study|Lost to Follow-up|0|||
46923937|NCT02988661|83157795|FG001|Overall Study|Lost to Follow-up|33|||
46923938|NCT02988661|83157794|FG000|Overall Study|Withdrawal by Subject|0|||
46923939|NCT02988661|83157795|FG001|Overall Study|Withdrawal by Subject|6|||
46923940|NCT02988661|83157794|FG000|Overall Study|Unable to complete the 18-month survey|1|||
46923941|NCT02988661|83157795|FG001|Overall Study|Unable to complete the 18-month survey|27|||
46923942|NCT02960217|83157803|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
46923943|NCT02960217|83157804|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
46923944|NCT02960217|83157803|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
46748526|NCT00939029|82965728|FG000|Overall Study|Withdrawal by Subject|3|||
46748527|NCT00939029|82965729|FG001|Overall Study|Withdrawal by Subject|7|||
46748528|NCT00939029|82965728|FG000|Overall Study|Lost to Follow-up|3|||
46748529|NCT00939029|82965729|FG001|Overall Study|Lost to Follow-up|4|||
46804744|NCT00393718|83023793|FG000|Overall Study|Hypoglycaemia|3|||
46923945|NCT02960217|83157804|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
46923946|NCT02960217|83157803|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
46923947|NCT02960217|83157804|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
46923948|NCT02960217|83157803|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
46923949|NCT02960217|83157804|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
46923950|NCT02960217|83157803|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
46923951|NCT02960217|83157804|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
46923952|NCT02960217|83157803|FG000|Open-Label Extension Phase|Adverse Event|1|||
46923953|NCT02960217|83157804|FG001|Open-Label Extension Phase|Adverse Event|0|||
46923954|NCT02960217|83157803|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
46923955|NCT02960217|83157804|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
46748530|NCT00939029|82965728|FG000|Overall Study|Adverse Event|0|||
46748531|NCT00939029|82965729|FG001|Overall Study|Adverse Event|1|||
46748532|NCT00587847|82965735|FG000|Overall Study|Lack of Efficacy|5|||
46748533|NCT00587847|82965735|FG000|Overall Study|Adverse Event|2|||
46748534|NCT00784563|82965743|FG000|Years 1 & 2|Withdrawal by Subject|3|||
46748535|NCT00784563|82965744|FG001|Years 1 & 2|Withdrawal by Subject|2|||
46748536|NCT00784563|82965745|FG002|Years 1 & 2|Withdrawal by Subject|0|||
46748537|NCT00784563|82965743|FG000|Years 1 & 2|Adverse Event|0|||
46748538|NCT00784563|82965744|FG001|Years 1 & 2|Adverse Event|3|||
46748539|NCT00784563|82965745|FG002|Years 1 & 2|Adverse Event|0|||
46923956|NCT02960217|83157803|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
46923957|NCT02960217|83157804|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
46923958|NCT02960217|83157803|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
46923959|NCT02960217|83157804|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
46923960|NCT02959983|83157816|FG000|Overall Study|Protocol Violation|0|||
46923961|NCT02959983|83157817|FG001|Overall Study|Protocol Violation|1|||
46748540|NCT00784563|82965743|FG000|Year 3|Withdrawal by Subject|0|||
46748541|NCT00784563|82965744|FG001|Year 3|Withdrawal by Subject|0|||
46748542|NCT00784563|82965745|FG002|Year 3|Withdrawal by Subject|2|||
46748543|NCT00784563|82965743|FG000|Year 3|Adverse Event|0|||
46748544|NCT00784563|82965744|FG001|Year 3|Adverse Event|0|||
46748545|NCT00784563|82965745|FG002|Year 3|Adverse Event|1|||
46748546|NCT00938717|82965753|FG000|Overall Study|Adverse Event|10|||
46748547|NCT00938717|82965754|FG001|Overall Study|Adverse Event|41|||
46748548|NCT00938717|82965753|FG000|Overall Study|Protocol Violation|11|||
46748549|NCT00938717|82965754|FG001|Overall Study|Protocol Violation|8|||
46748550|NCT00938717|82965753|FG000|Overall Study|Withdrawal by Subject|26|||
46748551|NCT00938717|82965754|FG001|Overall Study|Withdrawal by Subject|24|||
46748552|NCT00938717|82965753|FG000|Overall Study|Lost to Follow-up|13|||
46748553|NCT00938717|82965754|FG001|Overall Study|Lost to Follow-up|18|||
46748554|NCT00938717|82965753|FG000|Overall Study|Lack of Efficacy|33|||
46923962|NCT02959983|83157816|FG000|Overall Study|Lack of Efficacy|0|||
46923963|NCT02959983|83157817|FG001|Overall Study|Lack of Efficacy|1|||
46923964|NCT02959983|83157816|FG000|Overall Study|Lost to Follow-up|12|||
46923965|NCT02959983|83157817|FG001|Overall Study|Lost to Follow-up|9|||
46923966|NCT02959983|83157816|FG000|Overall Study|Other|1|||
46923967|NCT02959983|83157817|FG001|Overall Study|Other|1|||
46923968|NCT02959983|83157816|FG000|Overall Study|Physician Decision|1|||
46923969|NCT02959983|83157817|FG001|Overall Study|Physician Decision|0|||
46923970|NCT02959983|83157816|FG000|Overall Study|Adverse Event|5|||
46923971|NCT02959983|83157817|FG001|Overall Study|Adverse Event|1|||
46923972|NCT02959983|83157816|FG000|Overall Study|Withdrawal by Subject|7|||
46923973|NCT02959983|83157817|FG001|Overall Study|Withdrawal by Subject|12|||
46923974|NCT01344447|83157823|FG000|Overall Study|Adverse Event|1|||
46923975|NCT01344447|83157823|FG000|Overall Study|Protocol Violation|1|||
46923976|NCT01344447|83157823|FG000|Overall Study|Withdrawal by Subject|1|||
46923977|NCT01344447|83157823|FG000|Overall Study|The contrast was not seen|1|||
46923978|NCT01344447|83157823|FG000|Overall Study|Physician Decision|1|||
46923979|NCT01344447|83157823|FG000|Overall Study|MRA unsuccessful|1|||
46923980|NCT01344447|83157823|FG000|Overall Study|Bolus tracking failed|1|||
46923981|NCT01344447|83157823|FG000|Overall Study|Error of power injector|1|||
46923982|NCT03513068|83157833|FG000|Overall Study|Death|1|||
46923983|NCT03513068|83157834|FG001|Overall Study|Death|0|||
46923984|NCT03513068|83157833|FG000|Overall Study|Withdrawal by Subject|4|||
46923985|NCT03513068|83157834|FG001|Overall Study|Withdrawal by Subject|6|||
46923986|NCT01348425|83157842|FG000|Overall Study|Imaging was not taken.|1|||
46923987|NCT01348425|83157843|FG001|Overall Study|Imaging was not taken.|1|||
46923988|NCT03041701|83157851|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
46923989|NCT03041701|83157852|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
46923990|NCT03041701|83157853|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
46923991|NCT03041701|83157851|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
46923992|NCT03041701|83157852|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
46923993|NCT03041701|83157853|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
46923994|NCT02956629|83157870|FG000|Overall Study|Adverse Event|0|||
46923995|NCT02956629|83157871|FG001|Overall Study|Adverse Event|0|||
46923996|NCT02956629|83157872|FG002|Overall Study|Adverse Event|1|||
46923997|NCT02956629|83157873|FG003|Overall Study|Adverse Event|0|||
46923998|NCT02956629|83157874|FG004|Overall Study|Adverse Event|0|||
46923999|NCT02956629|83157875|FG005|Overall Study|Adverse Event|0|||
46924000|NCT02956629|83157870|FG000|Overall Study|Lost to Follow-up|2|||
46924001|NCT02956629|83157871|FG001|Overall Study|Lost to Follow-up|5|||
46924002|NCT02956629|83157872|FG002|Overall Study|Lost to Follow-up|3|||
46924003|NCT02956629|83157873|FG003|Overall Study|Lost to Follow-up|1|||
46924004|NCT02956629|83157874|FG004|Overall Study|Lost to Follow-up|0|||
46924005|NCT02956629|83157875|FG005|Overall Study|Lost to Follow-up|1|||
46924006|NCT02956629|83157870|FG000|Overall Study|Withdrawal by Subject|3|||
46748555|NCT00938717|82965754|FG001|Overall Study|Lack of Efficacy|15|||
46748556|NCT00938717|82965753|FG000|Overall Study|Other reason|5|||
46748557|NCT00938717|82965754|FG001|Overall Study|Other reason|2|||
46748558|NCT00587223|82965760|FG000|Overall Study|Adverse Event|1|||
46748559|NCT00938639|82965769|FG000|Overall Study|Moved away from study area|0|||
46748560|NCT00938639|82965770|FG001|Overall Study|Moved away from study area|1|||
46748561|NCT00938639|82965769|FG000|Overall Study|Lost to Follow-up|1|||
46748562|NCT00938639|82965770|FG001|Overall Study|Lost to Follow-up|2|||
46748563|NCT00938639|82965769|FG000|Overall Study|Family issues|1|||
46748564|NCT00938639|82965770|FG001|Overall Study|Family issues|1|||
46748565|NCT00938639|82965769|FG000|Overall Study|Participant noncompliance|1|||
46748566|NCT00938639|82965770|FG001|Overall Study|Participant noncompliance|0|||
46748567|NCT00783705|82965782|FG000|Overall Study|Adverse Event|2|||
46748568|NCT00783705|82965783|FG001|Overall Study|Adverse Event|0|||
46748569|NCT00783705|82965782|FG000|Overall Study|Withdrawal by Subject|3|||
46748570|NCT00783705|82965783|FG001|Overall Study|Withdrawal by Subject|2|||
46748571|NCT00783705|82965782|FG000|Overall Study|Lost to Follow-up|1|||
46748572|NCT00783705|82965783|FG001|Overall Study|Lost to Follow-up|3|||
46748573|NCT00604669|82965789|FG000|Overall Study|lack of information in chart|7|||
46748574|NCT00938327|82965793|FG000|Overall Study|Adverse Event|2|||
46748575|NCT00938327|82965793|FG000|Overall Study|Protocol Violation|1|||
46748576|NCT00938327|82965793|FG000|Overall Study|Withdrawal by Subject|4|||
46748577|NCT00938327|82965793|FG000|Overall Study|Lost to Follow-up|37|||
46748578|NCT00938327|82965793|FG000|Overall Study|2nd dose received outside of the study|7|||
46748579|NCT00938327|82965793|FG000|Overall Study|Vaccine not received as out of stock|9|||
46748580|NCT00887198|82965799|FG000|Randomized Period|Ongoing|42|||
46748581|NCT00887198|82965800|FG001|Randomized Period|Ongoing|0|||
46748582|NCT00887198|82965801|FG002|Randomized Period|Ongoing|0|||
46748583|NCT00887198|82965799|FG000|Randomized Period|Adverse Event|50|||
46748584|NCT00887198|82965800|FG001|Randomized Period|Adverse Event|33|||
46748585|NCT00887198|82965801|FG002|Randomized Period|Adverse Event|0|||
46748586|NCT00887198|82965799|FG000|Randomized Period|Lost to Follow-up|1|||
46748587|NCT00887198|82965800|FG001|Randomized Period|Lost to Follow-up|0|||
46748588|NCT00887198|82965801|FG002|Randomized Period|Lost to Follow-up|0|||
46748589|NCT00887198|82965799|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
46748590|NCT00887198|82965800|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
46748591|NCT00887198|82965801|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
46748592|NCT00887198|82965799|FG000|Randomized Period|Withdrawal by Subject|41|||
46748593|NCT00887198|82965800|FG001|Randomized Period|Withdrawal by Subject|56|||
46748594|NCT00887198|82965801|FG002|Randomized Period|Withdrawal by Subject|0|||
46748595|NCT00887198|82965799|FG000|Randomized Period|Progressive disease|366|||
46748596|NCT00887198|82965800|FG001|Randomized Period|Progressive disease|370|||
46748597|NCT00887198|82965801|FG002|Randomized Period|Progressive disease|0|||
46748598|NCT00887198|82965799|FG000|Randomized Period|Other|42|||
46748599|NCT00887198|82965800|FG001|Randomized Period|Other|30|||
46748600|NCT00887198|82965801|FG002|Randomized Period|Other|0|||
46924007|NCT02956629|83157871|FG001|Overall Study|Withdrawal by Subject|1|||
46924008|NCT02956629|83157872|FG002|Overall Study|Withdrawal by Subject|0|||
46924009|NCT02956629|83157873|FG003|Overall Study|Withdrawal by Subject|0|||
46924010|NCT02956629|83157874|FG004|Overall Study|Withdrawal by Subject|0|||
46924011|NCT02956629|83157875|FG005|Overall Study|Withdrawal by Subject|0|||
46924012|NCT01348347|83157892|FG000|Overall Study|Withdrawal by Subject|1|||
46924013|NCT01348347|83157893|FG001|Overall Study|Withdrawal by Subject|1|||
46924014|NCT01348347|83157894|FG002|Overall Study|Withdrawal by Subject|1|||
46748601|NCT00887198|82965799|FG000|Randomized Period|Randomized, Not treated|4|||
46748602|NCT00887198|82965800|FG001|Randomized Period|Randomized, Not treated|2|||
46748603|NCT00887198|82965801|FG002|Randomized Period|Randomized, Not treated|0|||
46748604|NCT00887198|82965799|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
46748605|NCT00887198|82965800|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
46748606|NCT00887198|82965801|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
46748607|NCT00887198|82965799|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
46924015|NCT01348347|83157892|FG000|Overall Study|Progressive disease|2|||
46924016|NCT01348347|83157893|FG001|Overall Study|Progressive disease|5|||
46924017|NCT01348347|83157894|FG002|Overall Study|Progressive disease|5|||
46924018|NCT02959671|83157903|FG000|Overall Study|Adverse Event|2|||
46924019|NCT02959671|83157903|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
46748608|NCT00887198|82965800|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
46748609|NCT00887198|82965801|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
46748610|NCT00887198|82965799|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
46748611|NCT00887198|82965800|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
46748612|NCT00887198|82965801|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
46748613|NCT00887198|82965799|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
46748614|NCT00887198|82965800|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
46748615|NCT00887198|82965801|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
46748616|NCT00887198|82965799|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
46748617|NCT00887198|82965800|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
46924020|NCT01597258|83157907|FG000|Overall Study|No Drug Administration|1|||
46748618|NCT00887198|82965801|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
46748619|NCT00887198|82965799|FG000|Cross Over (Placebo to AA)|Other|0|||
46748620|NCT00887198|82965800|FG001|Cross Over (Placebo to AA)|Other|0|||
46748621|NCT00887198|82965801|FG002|Cross Over (Placebo to AA)|Other|19|||
46748622|NCT00782067|82965809|FG000|Overall Study|Adverse Event|35|||
46748623|NCT00782067|82965809|FG000|Overall Study|Subject withdrew consent|11|||
46748624|NCT00782067|82965809|FG000|Overall Study|Lost to Follow-up|2|||
46748625|NCT00782067|82965809|FG000|Overall Study|Administrative problems|14|||
46748626|NCT00782067|82965809|FG000|Overall Study|Death|9|||
46748627|NCT00782067|82965809|FG000|Overall Study|Disease progression|43|||
46748628|NCT00782067|82965809|FG000|Overall Study|Protocol deviation|2|||
46748629|NCT00886340|82965815|FG000|Overall Study|Withdrawal by Subject|0|||
46748630|NCT00886340|82965816|FG001|Overall Study|Withdrawal by Subject|7|||
46748631|NCT00605215|82965825|FG000|Overall Study|Death|0|||
46748632|NCT00605215|82965826|FG001|Overall Study|Death|0|||
46748633|NCT00605215|82965827|FG002|Overall Study|Death|1|||
46748634|NCT00605215|82965825|FG000|Overall Study|Adverse Event|19|||
46748635|NCT00605215|82965826|FG001|Overall Study|Adverse Event|21|||
46748636|NCT00605215|82965827|FG002|Overall Study|Adverse Event|26|||
46748637|NCT00605215|82965825|FG000|Overall Study|Refusal to sign the re-consent form|8|||
46748638|NCT00605215|82965826|FG001|Overall Study|Refusal to sign the re-consent form|3|||
46748639|NCT00605215|82965827|FG002|Overall Study|Refusal to sign the re-consent form|3|||
46748640|NCT00605215|82965825|FG000|Overall Study|Withdrawal by Subject|39|||
46748641|NCT00605215|82965826|FG001|Overall Study|Withdrawal by Subject|37|||
46748642|NCT00605215|82965827|FG002|Overall Study|Withdrawal by Subject|27|||
46748643|NCT00605215|82965825|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
46748644|NCT00605215|82965826|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
46748645|NCT00605215|82965827|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
46748646|NCT00605215|82965825|FG000|Overall Study|Protocol Violation|3|||
46748647|NCT00605215|82965826|FG001|Overall Study|Protocol Violation|4|||
46748648|NCT00605215|82965827|FG002|Overall Study|Protocol Violation|1|||
46748649|NCT00605215|82965825|FG000|Overall Study|Pregnancy|8|||
46748650|NCT00605215|82965826|FG001|Overall Study|Pregnancy|5|||
46748651|NCT00605215|82965827|FG002|Overall Study|Pregnancy|4|||
46748652|NCT00605215|82965825|FG000|Overall Study|Lost to Follow-up|8|||
46748653|NCT00605215|82965826|FG001|Overall Study|Lost to Follow-up|5|||
46748654|NCT00605215|82965827|FG002|Overall Study|Lost to Follow-up|2|||
46748655|NCT00605215|82965825|FG000|Overall Study|Other than specified|0|||
46748656|NCT00605215|82965826|FG001|Overall Study|Other than specified|2|||
46748657|NCT00605215|82965827|FG002|Overall Study|Other than specified|1|||
46748658|NCT00604279|82965837|FG000|Overall Study|Lack of Efficacy|22|||
46748659|NCT00604279|82965838|FG001|Overall Study|Lack of Efficacy|9|||
46748660|NCT00604279|82965837|FG000|Overall Study|Lost to Follow-up|9|||
46748661|NCT00604279|82965838|FG001|Overall Study|Lost to Follow-up|14|||
46748662|NCT00604279|82965837|FG000|Overall Study|Pregnancy|2|||
46748663|NCT00604279|82965838|FG001|Overall Study|Pregnancy|0|||
46748664|NCT00604279|82965837|FG000|Overall Study|Protocol Violation|3|||
46748665|NCT00604279|82965838|FG001|Overall Study|Protocol Violation|1|||
46748666|NCT00604279|82965837|FG000|Overall Study|Withdrawal by Subject|16|||
46748667|NCT00604279|82965838|FG001|Overall Study|Withdrawal by Subject|5|||
46924021|NCT02958267|83157913|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
46924022|NCT02958267|83157914|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
46924023|NCT02958267|83157913|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
46924024|NCT02958267|83157914|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
47052035|NCT04597918|83317992|FG000|Overall Study|Withdrawal by Subject|6|||
47052036|NCT04597918|83317992|FG000|Overall Study|Lost to Follow-up|3|||
47052037|NCT04597918|83317992|FG000|Overall Study|Death|1|||
47052038|NCT04317586|83317996|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
47052039|NCT04317586|83317996|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
47052040|NCT03964493|83318002|FG000|Overall Study|Withdrawal by Subject|4|||
47052041|NCT03964493|83318003|FG001|Overall Study|Withdrawal by Subject|1|||
47052042|NCT03964493|83318002|FG000|Overall Study|Lost to Follow-up|13|||
46748668|NCT00604279|82965837|FG000|Overall Study|Adverse Event|4|||
46748669|NCT00604279|82965838|FG001|Overall Study|Adverse Event|5|||
46748670|NCT00604279|82965837|FG000|Overall Study|Other|8|||
46748671|NCT00604279|82965838|FG001|Overall Study|Other|4|||
46748672|NCT00938015|82965844|FG000|Overall Study|Death|2|||
46748673|NCT00938015|82965844|FG000|Overall Study|Lost to Follow-up|32|||
46748674|NCT00938015|82965844|FG000|Overall Study|Adverse Event|32|||
46748675|NCT00938015|82965844|FG000|Overall Study|Non-responder|52|||
46748676|NCT00938015|82965844|FG000|Overall Study|Reason not related to Etanercept|29|||
46748677|NCT00781911|82965850|FG000|Overall Study|Adverse Event|4|||
46748678|NCT00781911|82965851|FG001|Overall Study|Adverse Event|4|||
46748679|NCT00781911|82965850|FG000|Overall Study|Withdrawal by Subject|1|||
46748680|NCT00781911|82965851|FG001|Overall Study|Withdrawal by Subject|2|||
46748681|NCT00781911|82965850|FG000|Overall Study|Physician Decision|0|||
46924025|NCT02958267|83157913|FG000|Follow-up Visits|Additional treatment pursued|2|||
46924026|NCT02958267|83157914|FG001|Follow-up Visits|Additional treatment pursued|1|||
46924027|NCT01952574|83157924|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
46924028|NCT01952574|83157925|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
46924029|NCT01952574|83157926|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
46748682|NCT00781911|82965851|FG001|Overall Study|Physician Decision|2|||
46748683|NCT00781911|82965850|FG000|Overall Study|Sponsor Decision|1|||
46748684|NCT00781911|82965851|FG001|Overall Study|Sponsor Decision|0|||
46748685|NCT00605917|82965859|FG000|Overall Study|Protocol Violation|79|||
46748686|NCT00781599|82965896|FG000|Overall Study|Lost to Follow-up|7|||
46748687|NCT00781599|82965897|FG001|Overall Study|Lost to Follow-up|4|||
46748688|NCT00605839|82965915|FG000|Overall Study|Protocol Violation|1|||
46748689|NCT00605839|82965916|FG001|Overall Study|Protocol Violation|0|||
46748690|NCT00605839|82965917|FG002|Overall Study|Protocol Violation|0|||
46748691|NCT00781365|82965927|FG000|Overall Study|Withdrawal by Subject|13|||
46748692|NCT00781365|82965928|FG001|Overall Study|Withdrawal by Subject|8|||
46748693|NCT00781365|82965927|FG000|Overall Study|Did Not Attend Visit|20|||
46748694|NCT00781365|82965928|FG001|Overall Study|Did Not Attend Visit|28|||
46748695|NCT00781365|82965927|FG000|Overall Study|Language barrier|1|||
46924030|NCT01952574|83157927|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
46924031|NCT01952574|83157928|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46924032|NCT01952574|83157929|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46924033|NCT01952574|83157930|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46748696|NCT00781365|82965928|FG001|Overall Study|Language barrier|0|||
46748697|NCT00937547|82965937|FG000|Overall Study|misdiagnosis|1|||
46748698|NCT00937547|82965938|FG001|Overall Study|misdiagnosis|6|||
46748699|NCT00937547|82965939|FG002|Overall Study|misdiagnosis|7|||
46748700|NCT00780975|82965947|FG000|Overall Study|Progressive disease|3|||
46748701|NCT00780975|82965947|FG000|Overall Study|Toxicity|5|||
46748702|NCT00780273|82965951|FG000|Overall Study|Death|1|||
46748703|NCT00780273|82965951|FG000|Overall Study|Lost to Follow-up|1|||
46748704|NCT00779259|82965956|FG000|Quinine Alone|Adverse Event|2|||
46748705|NCT00779025|82965974|FG000|Overall Study|Withdrawal by Subject|1|||
46748706|NCT00936065|82965982|FG000|Overall Study|Adverse Event|1|||
46748707|NCT00936065|82965983|FG001|Overall Study|Adverse Event|0|||
46748708|NCT00936065|82965984|FG002|Overall Study|Adverse Event|1|||
46748709|NCT00936065|82965982|FG000|Overall Study|Lack of Efficacy|1|||
46748710|NCT00936065|82965983|FG001|Overall Study|Lack of Efficacy|0|||
46748711|NCT00936065|82965984|FG002|Overall Study|Lack of Efficacy|1|||
46748712|NCT00936065|82965982|FG000|Overall Study|Lost to Follow-up|1|||
46748713|NCT00936065|82965983|FG001|Overall Study|Lost to Follow-up|0|||
46748714|NCT00936065|82965984|FG002|Overall Study|Lost to Follow-up|0|||
46748715|NCT00936065|82965982|FG000|Overall Study|Protocol Violation|1|||
46748716|NCT00936065|82965983|FG001|Overall Study|Protocol Violation|2|||
46748717|NCT00936065|82965984|FG002|Overall Study|Protocol Violation|1|||
46748718|NCT00936065|82965982|FG000|Overall Study|Withdrawal by Subject|0|||
46748719|NCT00936065|82965983|FG001|Overall Study|Withdrawal by Subject|2|||
46748720|NCT00936065|82965984|FG002|Overall Study|Withdrawal by Subject|4|||
46748721|NCT04441788|82965995|FG000|Overall Study|Voluntary Withdrawl|0|||
46748722|NCT04441788|82965996|FG001|Overall Study|Voluntary Withdrawl|1|||
46924034|NCT01952574|83157924|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
46924035|NCT01952574|83157925|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
46924036|NCT01952574|83157926|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
46748723|NCT04441788|82965997|FG002|Overall Study|Voluntary Withdrawl|0|||
46748724|NCT04441788|82965995|FG000|Overall Study|Ineligibility|1|||
46748725|NCT04441788|82965996|FG001|Overall Study|Ineligibility|0|||
46748726|NCT04441788|82965997|FG002|Overall Study|Ineligibility|0|||
46748727|NCT04441788|82965995|FG000|Overall Study|Adverse Event|0|||
46748728|NCT04441788|82965996|FG001|Overall Study|Adverse Event|0|||
46748729|NCT04441788|82965997|FG002|Overall Study|Adverse Event|4|||
46748730|NCT04441788|82965995|FG000|Overall Study|Study Terminated by Sponsor|16|||
46748731|NCT04441788|82965996|FG001|Overall Study|Study Terminated by Sponsor|16|||
46748732|NCT04441788|82965997|FG002|Overall Study|Study Terminated by Sponsor|12|||
47052043|NCT03964493|83318003|FG001|Overall Study|Lost to Follow-up|4|||
47052044|NCT03846804|83318022|FG000|Overall Study|Refused blood draw|1|||
47052045|NCT03846804|83318022|FG000|Overall Study|Protocol Violation|1|||
46748733|NCT00604825|82966013|FG000|Overall Study|Adverse Event|2|||
46748734|NCT00604825|82966014|FG001|Overall Study|Adverse Event|6|||
46748735|NCT00604825|82966015|FG002|Overall Study|Adverse Event|7|||
46748736|NCT00604825|82966016|FG003|Overall Study|Adverse Event|4|||
46924037|NCT01952574|83157927|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
47052046|NCT03807440|83318031|FG000|Overall Study|No documentation of index date 2|320|||
46748737|NCT00604825|82966013|FG000|Overall Study|Lost to Follow-up|0|||
46748738|NCT00604825|82966014|FG001|Overall Study|Lost to Follow-up|3|||
46748739|NCT00604825|82966015|FG002|Overall Study|Lost to Follow-up|1|||
46748740|NCT00604825|82966016|FG003|Overall Study|Lost to Follow-up|0|||
46748741|NCT00604825|82966013|FG000|Overall Study|Protocol Violation|0|||
46748742|NCT00604825|82966014|FG001|Overall Study|Protocol Violation|1|||
46748743|NCT00604825|82966015|FG002|Overall Study|Protocol Violation|0|||
46748744|NCT00604825|82966016|FG003|Overall Study|Protocol Violation|0|||
46748745|NCT00604825|82966013|FG000|Overall Study|Withdrawal by Subject|4|||
46748746|NCT00604825|82966014|FG001|Overall Study|Withdrawal by Subject|3|||
46748747|NCT00604825|82966015|FG002|Overall Study|Withdrawal by Subject|5|||
46748748|NCT00604825|82966016|FG003|Overall Study|Withdrawal by Subject|5|||
46748749|NCT00604825|82966013|FG000|Overall Study|Lack of Efficacy|3|||
46748750|NCT00604825|82966014|FG001|Overall Study|Lack of Efficacy|2|||
46748751|NCT00604825|82966015|FG002|Overall Study|Lack of Efficacy|1|||
46748752|NCT00604825|82966016|FG003|Overall Study|Lack of Efficacy|0|||
46748753|NCT00604825|82966013|FG000|Overall Study|Did not meet eligibility criteria|0|||
46748754|NCT00604825|82966014|FG001|Overall Study|Did not meet eligibility criteria|0|||
46748755|NCT00604825|82966015|FG002|Overall Study|Did not meet eligibility criteria|2|||
46748756|NCT00604825|82966016|FG003|Overall Study|Did not meet eligibility criteria|0|||
46748757|NCT00604825|82966013|FG000|Overall Study|Physician Decision|0|||
46748758|NCT00604825|82966014|FG001|Overall Study|Physician Decision|0|||
46748759|NCT00604825|82966015|FG002|Overall Study|Physician Decision|0|||
46748760|NCT00604825|82966016|FG003|Overall Study|Physician Decision|1|||
46748761|NCT00604825|82966013|FG000|Overall Study|Exclusion criterion met|0|||
46748762|NCT00604825|82966014|FG001|Overall Study|Exclusion criterion met|0|||
46748763|NCT00604825|82966015|FG002|Overall Study|Exclusion criterion met|0|||
46748764|NCT00604825|82966016|FG003|Overall Study|Exclusion criterion met|1|||
46748765|NCT00937391|82966028|FG000|Stage 2|Withdrawal by Subject|1|||
46748766|NCT00937157|82966045|FG000|Overall Study|Pregnancy|1|||
46748767|NCT00937157|82966045|FG000|Overall Study|Lost to Follow-up|3|||
46748768|NCT00777153|82966052|FG000|Overall Study|Lost to Follow-up|1|||
46748769|NCT00777153|82966053|FG001|Overall Study|Lost to Follow-up|1|||
46748770|NCT00777153|82966054|FG002|Overall Study|Lost to Follow-up|0|||
46748771|NCT00777153|82966052|FG000|Overall Study|Death|85|||
46748772|NCT00777153|82966053|FG001|Overall Study|Death|73|||
46748773|NCT00777153|82966054|FG002|Overall Study|Death|33|||
46748774|NCT00777153|82966052|FG000|Overall Study|Withdrawal by Subject|3|||
46748775|NCT00777153|82966053|FG001|Overall Study|Withdrawal by Subject|4|||
46748776|NCT00777153|82966054|FG002|Overall Study|Withdrawal by Subject|3|||
46748777|NCT00777153|82966052|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
46748778|NCT00777153|82966053|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
46748779|NCT00777153|82966054|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
46748780|NCT00567541|82966068|FG000|Overall Study|Adverse Event|0|||
46748781|NCT00567541|82966069|FG001|Overall Study|Adverse Event|1|||
46748782|NCT00776997|82966075|FG000|Overall Study|Adverse Event|2|||
46748783|NCT00940823|82966081|FG000|Overall Study|Death|8|||
46748784|NCT00940823|82966082|FG001|Overall Study|Death|12|||
46748785|NCT00940823|82966081|FG000|Overall Study|Lost to Follow-up|27|||
46748786|NCT00940823|82966082|FG001|Overall Study|Lost to Follow-up|20|||
46748787|NCT00936611|82966090|FG000|Overall Study|Progressive Disease|3|||
46748788|NCT00936611|82966090|FG000|Overall Study|New Systemic Therapy|22|||
46748789|NCT00936611|82966090|FG000|Overall Study|Lost to Follow-up|1|||
46748790|NCT00936611|82966090|FG000|Overall Study|Withdrawal by Subject|2|||
46748791|NCT00936611|82966090|FG000|Overall Study|Still on Follow-up|1|||
46748792|NCT00936611|82966090|FG000|Overall Study|Still on Active Therapy|7|||
46748793|NCT00936611|82966090|FG000|Overall Study|Ineligible for Study Drug|3|||
46748794|NCT00936221|82966113|FG000|Overall Study|Withdrawal by Subject|1|||
46748795|NCT00936221|82966114|FG001|Overall Study|Withdrawal by Subject|1|||
46748796|NCT00776919|82966124|FG000|Overall Study|Withdrawal by Subject|16|||
46748797|NCT00776919|82966125|FG001|Overall Study|Withdrawal by Subject|14|||
46748798|NCT00776919|82966126|FG002|Overall Study|Withdrawal by Subject|15|||
46748799|NCT00776919|82966127|FG003|Overall Study|Withdrawal by Subject|26|||
46748800|NCT00776919|82966124|FG000|Overall Study|Lost to Follow-up|8|||
46748801|NCT00776919|82966125|FG001|Overall Study|Lost to Follow-up|12|||
46748802|NCT00776919|82966126|FG002|Overall Study|Lost to Follow-up|11|||
46748803|NCT00776919|82966127|FG003|Overall Study|Lost to Follow-up|8|||
46748804|NCT00776919|82966124|FG000|Overall Study|Adverse Event|1|||
46748805|NCT00776919|82966125|FG001|Overall Study|Adverse Event|0|||
46748806|NCT00776919|82966126|FG002|Overall Study|Adverse Event|2|||
46748807|NCT00776919|82966127|FG003|Overall Study|Adverse Event|2|||
46924038|NCT01952574|83157928|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
46748808|NCT00776919|82966124|FG000|Overall Study|Protocol Violation|1|||
46748809|NCT00776919|82966125|FG001|Overall Study|Protocol Violation|2|||
46748810|NCT00776919|82966126|FG002|Overall Study|Protocol Violation|0|||
46748811|NCT00776919|82966127|FG003|Overall Study|Protocol Violation|1|||
46748812|NCT00776919|82966124|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
46748813|NCT00776919|82966125|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
46748814|NCT00776919|82966126|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
46748815|NCT00776919|82966127|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
46748816|NCT00775983|82966154|FG000|Overall Study|Protocol Violation|1|||
46748817|NCT00775983|82966155|FG001|Overall Study|Protocol Violation|2|||
46748818|NCT00775593|82966161|FG000|Overall Study|Unmet eligibility criteria|6|||
46748819|NCT00775593|82966161|FG000|Overall Study|Death|1|||
46748820|NCT00939809|82966165|FG000|Overall Study|Adverse Event|2|||
46924039|NCT01952574|83157929|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
46924040|NCT01952574|83157930|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
46924041|NCT01952574|83157924|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
46924042|NCT01952574|83157925|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
46924043|NCT01952574|83157926|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
46748821|NCT00939809|82966165|FG000|Overall Study|Death|1|||
46748822|NCT00934661|82966171|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
46748823|NCT00934661|82966172|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
46748824|NCT00775437|82966178|FG000|Overall Study|Loss of efficacy|2|||
46748825|NCT00775437|82966178|FG000|Overall Study|Withdrawal by Subject|3|||
46748826|NCT00775437|82966178|FG000|Overall Study|Lost to Follow-up|1|||
46748827|NCT00775203|82966184|FG000|Overall Study|Adverse Event|25|||
46748828|NCT00775203|82966185|FG001|Overall Study|Adverse Event|6|||
46748829|NCT00775203|82966184|FG000|Overall Study|Lack of Efficacy|8|||
46748830|NCT00775203|82966185|FG001|Overall Study|Lack of Efficacy|9|||
46748831|NCT00775203|82966184|FG000|Overall Study|Withdrawal by Subject|11|||
46748832|NCT00775203|82966185|FG001|Overall Study|Withdrawal by Subject|9|||
46748833|NCT00775203|82966184|FG000|Overall Study|Lost to Follow-up|11|||
46748834|NCT00775203|82966185|FG001|Overall Study|Lost to Follow-up|15|||
46748835|NCT00775203|82966184|FG000|Overall Study|Administrative reason|2|||
46748836|NCT00775203|82966185|FG001|Overall Study|Administrative reason|0|||
46748837|NCT00775203|82966184|FG000|Overall Study|Noncompliance|4|||
46748838|NCT00775203|82966185|FG001|Overall Study|Noncompliance|2|||
46924044|NCT01952574|83157927|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
46924045|NCT01952574|83157928|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
46924046|NCT01952574|83157929|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
46748839|NCT00775203|82966184|FG000|Overall Study|Protocol Violation|0|||
46748840|NCT00775203|82966185|FG001|Overall Study|Protocol Violation|1|||
46748841|NCT00775203|82966184|FG000|Overall Study|Entered other study|1|||
46748842|NCT00775203|82966185|FG001|Overall Study|Entered other study|0|||
46748843|NCT00775203|82966184|FG000|Overall Study|Physician Decision|0|||
46748844|NCT00775203|82966185|FG001|Overall Study|Physician Decision|1|||
46748845|NCT00568321|82966194|FG000|Overall Study|Adverse Event|1|||
46748846|NCT00568321|82966195|FG001|Overall Study|Adverse Event|0|||
46748847|NCT00568321|82966196|FG002|Overall Study|Adverse Event|0|||
46748848|NCT00568321|82966194|FG000|Overall Study|Lack of Efficacy|8|||
46748849|NCT00568321|82966195|FG001|Overall Study|Lack of Efficacy|5|||
46748850|NCT00568321|82966196|FG002|Overall Study|Lack of Efficacy|6|||
46748851|NCT00568321|82966194|FG000|Overall Study|Lost to Follow-up|0|||
46748852|NCT00568321|82966195|FG001|Overall Study|Lost to Follow-up|0|||
46748853|NCT00568321|82966196|FG002|Overall Study|Lost to Follow-up|1|||
46748854|NCT00568321|82966194|FG000|Overall Study|Withdrawal by Subject|2|||
46748855|NCT00568321|82966195|FG001|Overall Study|Withdrawal by Subject|0|||
46748856|NCT00568321|82966196|FG002|Overall Study|Withdrawal by Subject|0|||
46748857|NCT00568321|82966194|FG000|Overall Study|Protocol Violation|0|||
46924047|NCT01952574|83157930|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
46924048|NCT01952574|83157924|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
46924049|NCT01952574|83157925|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
46924050|NCT01952574|83157926|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
46924051|NCT01952574|83157927|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
46924052|NCT01952574|83157928|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
46924053|NCT01952574|83157929|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
46748858|NCT00568321|82966195|FG001|Overall Study|Protocol Violation|0|||
46748859|NCT00568321|82966196|FG002|Overall Study|Protocol Violation|1|||
46748860|NCT00568321|82966194|FG000|Overall Study|Randomized, not treated|2|||
46748861|NCT00568321|82966195|FG001|Overall Study|Randomized, not treated|0|||
46748862|NCT00568321|82966196|FG002|Overall Study|Randomized, not treated|1|||
46748863|NCT00774345|82966208|FG000|Pre-treatment|Other reasons|2|||
46748864|NCT00774345|82966209|FG001|Pre-treatment|Other reasons|0|||
46748865|NCT00774345|82966208|FG000|Treatment|Adverse Event|61|||
46748866|NCT00774345|82966209|FG001|Treatment|Adverse Event|15|||
46748867|NCT00774345|82966208|FG000|Treatment|Progressive Disease without histologic transformation|51|||
46748868|NCT00774345|82966209|FG001|Treatment|Progressive Disease without histologic transformation|111|||
46748869|NCT00774345|82966208|FG000|Treatment|Progressive Disease with histologic transformation|4|||
46748870|NCT00774345|82966209|FG001|Treatment|Progressive Disease with histologic transformation|2|||
46748871|NCT00774345|82966208|FG000|Treatment|Withdrawal by Subject|5|||
46924054|NCT01952574|83157930|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
46748872|NCT00774345|82966209|FG001|Treatment|Withdrawal by Subject|2|||
46748873|NCT00774345|82966208|FG000|Treatment|Lost to Follow-up|1|||
46748874|NCT00774345|82966209|FG001|Treatment|Lost to Follow-up|1|||
46748875|NCT00774345|82966208|FG000|Treatment|Death|4|||
46748876|NCT00774345|82966209|FG001|Treatment|Death|0|||
46748877|NCT00774345|82966208|FG000|Treatment|Other Reasons|32|||
46924055|NCT01952574|83157924|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
46748878|NCT00774345|82966209|FG001|Treatment|Other Reasons|26|||
46748879|NCT00773253|82966221|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
46748880|NCT00773253|82966222|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
46748881|NCT00773175|82966232|FG000|Overall Study|Adverse Event|2|||
46748882|NCT00773175|82966233|FG001|Overall Study|Adverse Event|0|||
46748883|NCT00773175|82966232|FG000|Overall Study|Consent Withdrawn|0|||
46748884|NCT00773175|82966233|FG001|Overall Study|Consent Withdrawn|2|||
46748885|NCT00566527|82966247|FG000|Overall Study|Reason not provided|3|||
46748886|NCT00566527|82966248|FG001|Overall Study|Reason not provided|11|||
46748887|NCT00566527|82966249|FG002|Overall Study|Reason not provided|10|||
46748888|NCT00566527|82966247|FG000|Overall Study|Adverse Event|2|||
46748889|NCT00566527|82966248|FG001|Overall Study|Adverse Event|0|||
46748890|NCT00566527|82966249|FG002|Overall Study|Adverse Event|1|||
46748891|NCT00566527|82966247|FG000|Overall Study|Physician Decision|3|||
46748892|NCT00566527|82966248|FG001|Overall Study|Physician Decision|8|||
46748893|NCT00566527|82966249|FG002|Overall Study|Physician Decision|20|||
46748894|NCT00566527|82966247|FG000|Overall Study|Lost to Follow-up|3|||
46748895|NCT00566527|82966248|FG001|Overall Study|Lost to Follow-up|4|||
46748896|NCT00566527|82966249|FG002|Overall Study|Lost to Follow-up|4|||
46748897|NCT00566527|82966247|FG000|Overall Study|Withdrawal by Subject|6|||
46748898|NCT00566527|82966248|FG001|Overall Study|Withdrawal by Subject|43|||
46748899|NCT00566527|82966249|FG002|Overall Study|Withdrawal by Subject|43|||
46748900|NCT00773097|82966259|FG000|Overall Study|Withdrawal by Subject|1|||
46748901|NCT00773097|82966259|FG000|Overall Study|Physician Decision|6|||
46748902|NCT00933335|82966265|FG000|Overall Study|Lost to Follow-up|1|||
46748903|NCT00933335|82966266|FG001|Overall Study|Lost to Follow-up|3|||
46748904|NCT00933335|82966265|FG000|Overall Study|Withdrawal by Subject|0|||
46748905|NCT00933335|82966266|FG001|Overall Study|Withdrawal by Subject|1|||
46748906|NCT00933335|82966265|FG000|Overall Study|Progressive Disease|0|||
46748907|NCT00933335|82966266|FG001|Overall Study|Progressive Disease|11|||
46748908|NCT00933335|82966265|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
46748909|NCT00933335|82966266|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
46748910|NCT00933335|82966265|FG000|Overall Study|Co-morbid Illness|1|||
46748911|NCT00933335|82966266|FG001|Overall Study|Co-morbid Illness|0|||
46748912|NCT00772941|82966278|FG000|Overall Study|CRFs not available|195|||
46748913|NCT00772941|82966278|FG000|Overall Study|Study not completed|16|||
46748914|NCT00772941|82966278|FG000|Overall Study|Missed Visits|374|||
46748915|NCT00772941|82966278|FG000|Overall Study|Poor Compliance|7|||
46748916|NCT00772941|82966278|FG000|Overall Study|GPSP Violation|90|||
46748917|NCT00772707|82966305|FG000|Overall Study|Withdrawn|3|||
46748918|NCT00772629|82966311|FG000|Overall Study|Subject was not vaccinated|1|||
46748919|NCT00772629|82966312|FG001|Overall Study|Subject was not vaccinated|0|||
46748920|NCT00939341|82966318|FG000|Overall Study|Adverse Event|15|||
46748921|NCT00939341|82966318|FG000|Overall Study|Pregnancy|1|||
46748922|NCT00939341|82966318|FG000|Overall Study|Lost to Follow-up|23|||
46748923|NCT00939341|82966318|FG000|Overall Study|Withdrawal by Subject|13|||
46748924|NCT00939341|82966318|FG000|Overall Study|Protocol Violation|6|||
46748925|NCT00939341|82966318|FG000|Overall Study|Incorrect enrolment|8|||
46748926|NCT04292470|82966347|FG000|Overall Study|Withdrawal by Subject|0|||
46748927|NCT04292470|82966348|FG001|Overall Study|Withdrawal by Subject|1|||
46748928|NCT04217590|82966356|FG000|Overall Study|Other|1|||
46748929|NCT04217590|82966357|FG001|Overall Study|Other|1|||
46748930|NCT04217590|82966356|FG000|Overall Study|Withdrawal by Subject|3|||
46748931|NCT04217590|82966357|FG001|Overall Study|Withdrawal by Subject|1|||
46748932|NCT04217590|82966356|FG000|Overall Study|Death|0|||
46748933|NCT04217590|82966357|FG001|Overall Study|Death|1|||
46748934|NCT03963232|82966365|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
46748935|NCT03963232|82966366|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
46748936|NCT03963232|82966365|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
46924056|NCT01952574|83157925|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
46924057|NCT01952574|83157926|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
46924058|NCT01952574|83157927|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
46924059|NCT01952574|83157928|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
46748937|NCT03963232|82966366|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
46748938|NCT03963232|82966365|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
46748939|NCT03963232|82966366|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
46748940|NCT03963232|82966365|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
46748941|NCT03963232|82966366|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
46748942|NCT03963232|82966365|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
46748943|NCT03963232|82966366|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
46748944|NCT03963232|82966365|FG000|Open-Label Treatment Phase|Adverse Event|1|||
46748945|NCT03963232|82966366|FG001|Open-Label Treatment Phase|Adverse Event|2|||
46748946|NCT03963232|82966365|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
46748947|NCT03963232|82966366|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
46748948|NCT03963232|82966365|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
46748949|NCT03963232|82966366|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
46924060|NCT01952574|83157929|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
46748950|NCT03963232|82966365|FG000|Open-Label Treatment Phase|Pregnancy|1|||
46748951|NCT03963232|82966366|FG001|Open-Label Treatment Phase|Pregnancy|0|||
46748952|NCT03963232|82966365|FG000|Follow-up Phase|Withdrawal by Subject|7|||
46748953|NCT03963232|82966366|FG001|Follow-up Phase|Withdrawal by Subject|5|||
46748954|NCT03963232|82966365|FG000|Follow-up Phase|Protocol Violation|0|||
46748955|NCT03963232|82966366|FG001|Follow-up Phase|Protocol Violation|2|||
46748956|NCT03963232|82966365|FG000|Follow-up Phase|Adverse Event|0|||
46748957|NCT03963232|82966366|FG001|Follow-up Phase|Adverse Event|1|||
46748958|NCT03963232|82966365|FG000|Follow-up Phase|Lost to Follow-up|0|||
46748959|NCT03963232|82966366|FG001|Follow-up Phase|Lost to Follow-up|1|||
46924061|NCT01952574|83157930|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
46748960|NCT03856593|82966390|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
46748961|NCT03856593|82966391|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
46748962|NCT03785925|82966399|FG000|Overall Study|Withdrawal by Subject|15|||
46924062|NCT01952574|83157924|FG000|Open-label Treatment Phase|Missing|0|||
46924063|NCT01952574|83157925|FG001|Open-label Treatment Phase|Missing|0|||
46924064|NCT01952574|83157926|FG002|Open-label Treatment Phase|Missing|0|||
46924065|NCT01952574|83157927|FG003|Open-label Treatment Phase|Missing|0|||
46924066|NCT01952574|83157928|FG004|Open-label Treatment Phase|Missing|4|||
46924067|NCT01952574|83157929|FG005|Open-label Treatment Phase|Missing|0|||
46924068|NCT01952574|83157930|FG006|Open-label Treatment Phase|Missing|0|||
46924069|NCT01952574|83157924|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
46924070|NCT01952574|83157925|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
46924071|NCT01952574|83157926|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
46924072|NCT01952574|83157927|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
46924073|NCT01952574|83157928|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
46924074|NCT01952574|83157929|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
46924075|NCT01952574|83157930|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
46924076|NCT01952574|83157924|FG000|Open-label Treatment Phase|Death|0|||
46924077|NCT01952574|83157925|FG001|Open-label Treatment Phase|Death|0|||
46924078|NCT01952574|83157926|FG002|Open-label Treatment Phase|Death|0|||
46924079|NCT01952574|83157927|FG003|Open-label Treatment Phase|Death|0|||
46924080|NCT01952574|83157928|FG004|Open-label Treatment Phase|Death|1|||
46924081|NCT01952574|83157929|FG005|Open-label Treatment Phase|Death|0|||
46924082|NCT01952574|83157930|FG006|Open-label Treatment Phase|Death|0|||
46924083|NCT01952574|83157924|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
46924084|NCT01952574|83157925|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
46924085|NCT01952574|83157926|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
46924086|NCT01952574|83157927|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
46924087|NCT01952574|83157928|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
46924088|NCT01952574|83157929|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
46924089|NCT01952574|83157930|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
46924090|NCT01952574|83157924|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
46748963|NCT03785925|82966399|FG000|Overall Study|Lost to Follow-up|1|||
46748964|NCT03427411|82966410|FG000|Overall Study|Screen failure - platelets too low|0|||
46748965|NCT03427411|82966411|FG001|Overall Study|Screen failure - platelets too low|1|||
46748966|NCT03330106|82966419|FG000|Part A|Withdrawal by Subject|1|||
46748967|NCT03330106|82966420|FG001|Part A|Withdrawal by Subject|1|||
46748968|NCT03330106|82966421|FG002|Part A|Withdrawal by Subject|0|||
46748969|NCT03330106|82966422|FG003|Part A|Withdrawal by Subject|0|||
46748970|NCT03330106|82966419|FG000|Part A|Death|2|||
46748971|NCT03330106|82966420|FG001|Part A|Death|1|||
46748972|NCT03330106|82966421|FG002|Part A|Death|0|||
46748973|NCT03330106|82966422|FG003|Part A|Death|0|||
46748974|NCT03330106|82966419|FG000|Part A|Adverse Event|0|||
46748975|NCT03330106|82966420|FG001|Part A|Adverse Event|1|||
46748976|NCT03330106|82966421|FG002|Part A|Adverse Event|0|||
46748977|NCT03330106|82966422|FG003|Part A|Adverse Event|0|||
46748978|NCT03330106|82966419|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
46748979|NCT03330106|82966420|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
46924091|NCT01952574|83157925|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
46924092|NCT01952574|83157926|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
46924093|NCT01952574|83157927|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
46924094|NCT01952574|83157928|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
46924095|NCT01952574|83157929|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
46924096|NCT01952574|83157930|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
47052047|NCT03807440|83318031|FG000|Overall Study|No informed consent for index date 2|117|||
46748980|NCT03330106|82966421|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
46748981|NCT03330106|82966422|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
46924097|NCT02959437|83157959|FG000|Overall Study|Death|33|||
46924098|NCT02959437|83157960|FG001|Overall Study|Death|3|||
46924099|NCT02959437|83157961|FG002|Overall Study|Death|0|||
46924100|NCT02959437|83157962|FG003|Overall Study|Death|0|||
46748982|NCT03330106|82966419|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
46748983|NCT03330106|82966420|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
46748984|NCT03330106|82966421|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
46748985|NCT03330106|82966422|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
46748986|NCT03330106|82966419|FG000|Part A|Progressive Disease|0|||
46748987|NCT03330106|82966420|FG001|Part A|Progressive Disease|1|||
46748988|NCT03330106|82966421|FG002|Part A|Progressive Disease|0|||
46748989|NCT03330106|82966422|FG003|Part A|Progressive Disease|0|||
46748990|NCT03330106|82966419|FG000|Part B|Lost to Follow-up|0|||
46748991|NCT03330106|82966420|FG001|Part B|Lost to Follow-up|0|||
46748992|NCT03330106|82966421|FG002|Part B|Lost to Follow-up|0|||
46748993|NCT03330106|82966422|FG003|Part B|Lost to Follow-up|1|||
46748994|NCT03330106|82966419|FG000|Part B|Withdrawal by Subject|0|||
46748995|NCT03330106|82966420|FG001|Part B|Withdrawal by Subject|0|||
46748996|NCT03330106|82966421|FG002|Part B|Withdrawal by Subject|4|||
46748997|NCT03330106|82966422|FG003|Part B|Withdrawal by Subject|0|||
46748998|NCT03330106|82966419|FG000|Part B|Death|0|||
46748999|NCT03330106|82966420|FG001|Part B|Death|0|||
46749000|NCT03330106|82966421|FG002|Part B|Death|2|||
46749001|NCT03330106|82966422|FG003|Part B|Death|0|||
46749002|NCT03330106|82966419|FG000|Part B|Clinical Progression|0|||
46749003|NCT03330106|82966420|FG001|Part B|Clinical Progression|0|||
46749004|NCT03330106|82966421|FG002|Part B|Clinical Progression|1|||
46749005|NCT03330106|82966422|FG003|Part B|Clinical Progression|1|||
46749006|NCT03330106|82966419|FG000|Part B|Symptomatic Deterioration|0|||
46749007|NCT03330106|82966420|FG001|Part B|Symptomatic Deterioration|0|||
46749008|NCT03330106|82966421|FG002|Part B|Symptomatic Deterioration|0|||
46749009|NCT03330106|82966422|FG003|Part B|Symptomatic Deterioration|1|||
46749010|NCT03330106|82966419|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
46749011|NCT03330106|82966420|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
46749012|NCT03330106|82966421|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
46749013|NCT03330106|82966422|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
46749014|NCT03330106|82966419|FG000|Part B|Progressive Disease|0|||
46749015|NCT03330106|82966420|FG001|Part B|Progressive Disease|0|||
46749016|NCT03330106|82966421|FG002|Part B|Progressive Disease|11|||
46749017|NCT03330106|82966422|FG003|Part B|Progressive Disease|4|||
46749018|NCT03164564|82966434|FG000|Overall Study|Death|3|||
46749019|NCT03164564|82966435|FG001|Overall Study|Death|0|||
46749020|NCT03164564|82966434|FG000|Overall Study|Withdrawal by Subject|20|||
46749021|NCT03164564|82966435|FG001|Overall Study|Withdrawal by Subject|15|||
46749022|NCT03164564|82966434|FG000|Overall Study|Lost to Follow-up|2|||
46749023|NCT03164564|82966435|FG001|Overall Study|Lost to Follow-up|0|||
46749024|NCT03164564|82966434|FG000|Overall Study|Physician Decision|0|||
46749025|NCT03164564|82966435|FG001|Overall Study|Physician Decision|1|||
46749026|NCT03164564|82966434|FG000|Overall Study|Adverse Event|0|||
46749027|NCT03164564|82966435|FG001|Overall Study|Adverse Event|1|||
46749028|NCT03164564|82966434|FG000|Overall Study|Ongoing|1586|||
46749029|NCT03164564|82966435|FG001|Overall Study|Ongoing|1586|||
46749030|NCT02821754|82966451|FG000|Overall Study|Procedure not required prior to amendment change|13|||
46749031|NCT02821754|82966452|FG001|Overall Study|Procedure not required prior to amendment change|11|||
46749032|NCT02821754|82966453|FG002|Overall Study|Procedure not required prior to amendment change|0|||
46749033|NCT02821754|82966451|FG000|Overall Study|Participant's Clinical status|2|||
46749034|NCT02821754|82966452|FG001|Overall Study|Participant's Clinical status|0|||
46749035|NCT02821754|82966453|FG002|Overall Study|Participant's Clinical status|0|||
46749036|NCT02821754|82966451|FG000|Overall Study|Participant removed for noncompliance|1|||
46749037|NCT02821754|82966452|FG001|Overall Study|Participant removed for noncompliance|0|||
46749038|NCT02821754|82966453|FG002|Overall Study|Participant removed for noncompliance|0|||
46749039|NCT02821754|82966451|FG000|Overall Study|Drug not available.|0|||
46749040|NCT02821754|82966452|FG001|Overall Study|Drug not available.|0|||
46749041|NCT02821754|82966453|FG002|Overall Study|Drug not available.|1|||
46749042|NCT02821754|82966451|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
46749043|NCT02821754|82966452|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
46749044|NCT02821754|82966453|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
46749045|NCT02708108|82966461|FG000|Overall Study|Death|1|||
46749046|NCT02708108|82966462|FG001|Overall Study|Death|2|||
46749047|NCT02708108|82966461|FG000|Overall Study|Regimen change|1|||
46804745|NCT00393718|83023794|FG001|Overall Study|Hypoglycaemia|2|||
46804746|NCT00393718|83023793|FG000|Overall Study|Subject decision|5|||
46749048|NCT02708108|82966462|FG001|Overall Study|Regimen change|0|||
46749049|NCT02708108|82966461|FG000|Overall Study|No MRD and no imaging available|0|||
46749050|NCT02708108|82966462|FG001|Overall Study|No MRD and no imaging available|1|||
46749051|NCT02617589|82966471|FG000|Randomization|Request to Discontinue Study Treatment|1|||
46749052|NCT02617589|82966472|FG001|Randomization|Request to Discontinue Study Treatment|3|||
46749053|NCT02617589|82966471|FG000|Randomization|Participant Withdrew Consent|1|||
46749054|NCT02617589|82966472|FG001|Randomization|Participant Withdrew Consent|2|||
46749055|NCT02617589|82966471|FG000|Treatment|Other Reasons|3|||
46749056|NCT02617589|82966472|FG001|Treatment|Other Reasons|3|||
46749057|NCT02617589|82966471|FG000|Treatment|Poor/Non Compliance|1|||
46749058|NCT02617589|82966472|FG001|Treatment|Poor/Non Compliance|1|||
46749059|NCT02617589|82966471|FG000|Treatment|Maximum Clinical Benefit|0|||
46749060|NCT02617589|82966472|FG001|Treatment|Maximum Clinical Benefit|2|||
46749061|NCT02617589|82966471|FG000|Treatment|Participant Withdrew Consent|2|||
46749062|NCT02617589|82966472|FG001|Treatment|Participant Withdrew Consent|6|||
46749063|NCT02617589|82966471|FG000|Treatment|Participant Request to Discontinue|12|||
46749064|NCT02617589|82966472|FG001|Treatment|Participant Request to Discontinue|21|||
46749065|NCT02617589|82966471|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
46749066|NCT02617589|82966472|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
46749067|NCT02617589|82966471|FG000|Treatment|Death|1|||
46749068|NCT02617589|82966472|FG001|Treatment|Death|1|||
46749069|NCT02617589|82966471|FG000|Treatment|Study Drug Toxicity|27|||
46749070|NCT02617589|82966472|FG001|Treatment|Study Drug Toxicity|20|||
46749071|NCT02617589|82966471|FG000|Treatment|Disease Progression|216|||
46749072|NCT02617589|82966472|FG001|Treatment|Disease Progression|136|||
46749073|NCT02471807|82966478|FG000|Overall Study|Death|14|||
46749074|NCT02471807|82966478|FG000|Overall Study|Withdrawal by Subject|2|||
46749075|NCT02471807|82966478|FG000|Overall Study|Explant|5|||
46749076|NCT02471807|82966478|FG000|Overall Study|Lost to Follow-up|1|||
46749077|NCT01899326|82966498|FG000|Overall Study|Withdrawal by Subject|1|||
46749078|NCT01899326|82966498|FG000|Overall Study|Adverse Event|2|||
46749079|NCT01899326|82966498|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
46749080|NCT01126190|82966506|FG000|Double-Blind Phase|Death|0|||
46749081|NCT01126190|82966507|FG001|Double-Blind Phase|Death|1|||
46749082|NCT01126190|82966508|FG002|Double-Blind Phase|Death|0|||
46924101|NCT02959437|83157959|FG000|Overall Study|Lost to Follow-up|3|||
46924102|NCT02959437|83157960|FG001|Overall Study|Lost to Follow-up|1|||
46924103|NCT02959437|83157961|FG002|Overall Study|Lost to Follow-up|0|||
46924104|NCT02959437|83157962|FG003|Overall Study|Lost to Follow-up|0|||
46924105|NCT02959437|83157959|FG000|Overall Study|Withdrawal by Subject|11|||
46924106|NCT02959437|83157960|FG001|Overall Study|Withdrawal by Subject|3|||
46924107|NCT02959437|83157961|FG002|Overall Study|Withdrawal by Subject|0|||
46924108|NCT02959437|83157962|FG003|Overall Study|Withdrawal by Subject|0|||
46924109|NCT02959437|83157959|FG000|Overall Study|Progressive Disease|9|||
46924110|NCT02959437|83157960|FG001|Overall Study|Progressive Disease|1|||
46924111|NCT02959437|83157961|FG002|Overall Study|Progressive Disease|0|||
46924112|NCT02959437|83157962|FG003|Overall Study|Progressive Disease|0|||
46924113|NCT02959437|83157959|FG000|Overall Study|Study Terminated by Sponsor|4|||
46924114|NCT02959437|83157960|FG001|Overall Study|Study Terminated by Sponsor|0|||
46924115|NCT02959437|83157961|FG002|Overall Study|Study Terminated by Sponsor|0|||
46924116|NCT02959437|83157962|FG003|Overall Study|Study Terminated by Sponsor|0|||
46924117|NCT02959437|83157959|FG000|Overall Study|Other Unspecified|2|||
46924118|NCT02959437|83157960|FG001|Overall Study|Other Unspecified|0|||
46924119|NCT02959437|83157961|FG002|Overall Study|Other Unspecified|0|||
46924120|NCT02959437|83157962|FG003|Overall Study|Other Unspecified|0|||
46924121|NCT02957331|83157975|FG000|Overall Study|Protocol Violation|1|||
46924122|NCT02957331|83157976|FG001|Overall Study|Protocol Violation|0|||
46924123|NCT05212883|83157982|FG000|Overall Study|Invalid test result|125|||
46924124|NCT04995055|83157990|FG000|Period 1|COVID-19 Related|1|||
46924125|NCT04995055|83157991|FG001|Period 1|COVID-19 Related|0|||
46924126|NCT04995055|83157990|FG000|Period 1|Withdrawal by Subject|0|||
46924127|NCT04995055|83157991|FG001|Period 1|Withdrawal by Subject|1|||
46924128|NCT04995055|83157990|FG000|Period 1|Subject discontinued due to timing|4|||
46924129|NCT04995055|83157991|FG001|Period 1|Subject discontinued due to timing|4|||
46924130|NCT04743635|83157999|FG000|Overall Study|Lost to Follow-up|2|||
46924131|NCT04743635|83158000|FG001|Overall Study|Lost to Follow-up|0|||
46924132|NCT04712110|83158007|FG000|Overall Study|Lost to Follow-up|0|||
46924133|NCT04712110|83158008|FG001|Overall Study|Lost to Follow-up|1|||
46924134|NCT04712110|83158007|FG000|Overall Study|Withdrawal by Subject|0|||
46924135|NCT04712110|83158008|FG001|Overall Study|Withdrawal by Subject|4|||
46924136|NCT04712110|83158007|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
46924137|NCT04712110|83158008|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
46924138|NCT03877510|83158018|FG000|Overall Study|Death|6|||
46924139|NCT03877510|83158018|FG000|Overall Study|Lost to Follow-up|2|||
46924140|NCT03877510|83158018|FG000|Overall Study|Non-compliance with study drug|2|||
46924141|NCT03877510|83158018|FG000|Overall Study|Lack of Efficacy|14|||
46924142|NCT03877510|83158018|FG000|Overall Study|Adverse Event|20|||
47052048|NCT03746522|83318108|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
46749083|NCT01126190|82966506|FG000|Double-Blind Phase|Adverse Event|1|||
46749084|NCT01126190|82966507|FG001|Double-Blind Phase|Adverse Event|2|||
46749085|NCT01126190|82966508|FG002|Double-Blind Phase|Adverse Event|0|||
46749086|NCT01126190|82966506|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
46749087|NCT01126190|82966507|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
46749088|NCT01126190|82966508|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
46749089|NCT01126190|82966506|FG000|Double-Blind Phase|Request of Investigator|1|||
46924143|NCT03877510|83158018|FG000|Overall Study|Withdrawal by Subject|22|||
46924144|NCT03877510|83158018|FG000|Overall Study|Miscellaneous|1|||
46924145|NCT03846427|83158022|FG000|Overall Study|Death|13|||
46924146|NCT03846427|83158022|FG000|Overall Study|Withdrawal by Subject|3|||
46924147|NCT03846427|83158022|FG000|Overall Study|Physician Decision|1|||
46749090|NCT01126190|82966507|FG001|Double-Blind Phase|Request of Investigator|0|||
46749091|NCT01126190|82966508|FG002|Double-Blind Phase|Request of Investigator|0|||
46749092|NCT01126190|82966506|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
46749093|NCT01126190|82966507|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
46749094|NCT01126190|82966508|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
46749095|NCT01126190|82966506|FG000|Double-Blind Phase|Non-compliance|1|||
46749096|NCT01126190|82966507|FG001|Double-Blind Phase|Non-compliance|0|||
46749097|NCT01126190|82966508|FG002|Double-Blind Phase|Non-compliance|0|||
46749098|NCT01126190|82966506|FG000|Double-Blind Phase|Lost to Follow-up|1|||
46749099|NCT01126190|82966507|FG001|Double-Blind Phase|Lost to Follow-up|3|||
46749100|NCT01126190|82966508|FG002|Double-Blind Phase|Lost to Follow-up|0|||
46749101|NCT01126190|82966506|FG000|Open-Label Phase|Death|0|||
46749102|NCT01126190|82966507|FG001|Open-Label Phase|Death|0|||
46749103|NCT01126190|82966508|FG002|Open-Label Phase|Death|1|||
46749104|NCT01126190|82966506|FG000|Open-Label Phase|Adverse Event|0|||
46924148|NCT03706079|83158051|FG000|Predecessor Study|Death|0|||
46924149|NCT03706079|83158052|FG001|Predecessor Study|Death|2|||
46924150|NCT03706079|83158053|FG002|Predecessor Study|Death|0|||
46924151|NCT03706079|83158054|FG003|Predecessor Study|Death|1|||
46924152|NCT03706079|83158055|FG004|Predecessor Study|Death|0|||
46924153|NCT03706079|83158056|FG005|Predecessor Study|Death|0|||
46924154|NCT03706079|83158051|FG000|Predecessor Study|Lost to Follow-up|5|||
46924155|NCT03706079|83158052|FG001|Predecessor Study|Lost to Follow-up|2|||
46924156|NCT03706079|83158053|FG002|Predecessor Study|Lost to Follow-up|0|||
46924157|NCT03706079|83158054|FG003|Predecessor Study|Lost to Follow-up|0|||
46924158|NCT03706079|83158055|FG004|Predecessor Study|Lost to Follow-up|1|||
46924159|NCT03706079|83158056|FG005|Predecessor Study|Lost to Follow-up|0|||
46924160|NCT03706079|83158051|FG000|Predecessor Study|Withdrawal by Subject|8|||
46924161|NCT03706079|83158052|FG001|Predecessor Study|Withdrawal by Subject|15|||
46924162|NCT03706079|83158053|FG002|Predecessor Study|Withdrawal by Subject|0|||
46924163|NCT03706079|83158054|FG003|Predecessor Study|Withdrawal by Subject|5|||
46924164|NCT03706079|83158055|FG004|Predecessor Study|Withdrawal by Subject|2|||
46924165|NCT03706079|83158056|FG005|Predecessor Study|Withdrawal by Subject|0|||
46749105|NCT01126190|82966507|FG001|Open-Label Phase|Adverse Event|0|||
46749106|NCT01126190|82966508|FG002|Open-Label Phase|Adverse Event|4|||
46749107|NCT01126190|82966506|FG000|Open-Label Phase|Withdrawal by Subject|0|||
46749108|NCT01126190|82966507|FG001|Open-Label Phase|Withdrawal by Subject|0|||
46749109|NCT01126190|82966508|FG002|Open-Label Phase|Withdrawal by Subject|6|||
46749110|NCT00939185|82966541|FG000|Overall Study|Adverse Event|3|||
46749111|NCT00939185|82966541|FG000|Overall Study|Lack of Efficacy|1|||
46749112|NCT00939185|82966541|FG000|Overall Study|Lost to Follow-up|6|||
46749113|NCT00939185|82966541|FG000|Overall Study|Other|3|||
46749114|NCT00939185|82966541|FG000|Overall Study|Withdrawal by Subject|2|||
46749115|NCT00939185|82966541|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
46749116|NCT03977155|82966548|FG000|Overall Study|Adverse Event|3|||
46749117|NCT03977155|82966549|FG001|Overall Study|Adverse Event|0|||
46749118|NCT03977155|82966550|FG002|Overall Study|Adverse Event|0|||
46749119|NCT03977155|82966548|FG000|Overall Study|Lost to Follow-up|0|||
46749120|NCT03977155|82966549|FG001|Overall Study|Lost to Follow-up|1|||
46749121|NCT03977155|82966550|FG002|Overall Study|Lost to Follow-up|0|||
46749122|NCT03977155|82966548|FG000|Overall Study|Withdrawal by Subject|1|||
46749123|NCT03977155|82966549|FG001|Overall Study|Withdrawal by Subject|1|||
46749124|NCT03977155|82966550|FG002|Overall Study|Withdrawal by Subject|2|||
46749125|NCT03977155|82966548|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
46749126|NCT03977155|82966549|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
46749127|NCT03977155|82966550|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
46749128|NCT00930059|82966575|FG000|Overall Study|Death|1|||
46924166|NCT03706079|83158051|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
46924167|NCT03706079|83158052|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
46924168|NCT03706079|83158053|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
46749129|NCT00930059|82966576|FG001|Overall Study|Death|0|||
46924169|NCT03706079|83158054|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
46967666|NCT02157376|83210226|FG000|Overall Study|Withdrawal by Subject|3|||
46749130|NCT00930059|82966575|FG000|Overall Study|Did not meet entrance criteria|1|||
46749131|NCT00930059|82966576|FG001|Overall Study|Did not meet entrance criteria|1|||
46749132|NCT00930059|82966575|FG000|Overall Study|Withdrawal by Subject|3|||
46749133|NCT00930059|82966576|FG001|Overall Study|Withdrawal by Subject|4|||
46749134|NCT00930059|82966575|FG000|Overall Study|Other|1|||
46749135|NCT00930059|82966576|FG001|Overall Study|Other|0|||
46749136|NCT00930059|82966575|FG000|Overall Study|1 site terminated by sponsor|1|||
46924170|NCT03706079|83158055|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
46924171|NCT03706079|83158056|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
46924172|NCT03706079|83158051|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
46924173|NCT03706079|83158052|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
46924174|NCT03706079|83158053|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
46924175|NCT03706079|83158054|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
46924176|NCT03706079|83158055|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
46924177|NCT03706079|83158056|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
46924178|NCT03706079|83158051|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
46924179|NCT03706079|83158052|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
46924180|NCT03706079|83158053|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
46924181|NCT03706079|83158054|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
46749137|NCT00930059|82966576|FG001|Overall Study|1 site terminated by sponsor|1|||
46749138|NCT00930059|82966575|FG000|Overall Study|Adverse Event|1|||
46749139|NCT00930059|82966576|FG001|Overall Study|Adverse Event|6|||
46749140|NCT00772005|82966595|FG000|Overall Study|Adverse Event|9|||
46749141|NCT00772005|82966596|FG001|Overall Study|Adverse Event|14|||
46749142|NCT00772005|82966597|FG002|Overall Study|Adverse Event|10|||
46749143|NCT00772005|82966598|FG003|Overall Study|Adverse Event|13|||
46749144|NCT00772005|82966595|FG000|Overall Study|Lack of Efficacy|0|||
46749145|NCT00772005|82966596|FG001|Overall Study|Lack of Efficacy|1|||
46749146|NCT00772005|82966597|FG002|Overall Study|Lack of Efficacy|0|||
46749147|NCT00772005|82966598|FG003|Overall Study|Lack of Efficacy|0|||
47052049|NCT03746522|83318109|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
47052050|NCT03746522|83318110|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
47052051|NCT03746522|83318108|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
46635605|NCT01533714|82809376|FG000|Overall Study|Lack of Efficacy|0|||
46635606|NCT01533714|82809377|FG001|Overall Study|Lack of Efficacy|0|||
46635607|NCT01533714|82809378|FG002|Overall Study|Lack of Efficacy|0|||
46635608|NCT01533714|82809379|FG003|Overall Study|Lack of Efficacy|0|||
46635609|NCT01533714|82809380|FG004|Overall Study|Lack of Efficacy|0|||
46635610|NCT01533714|82809381|FG005|Overall Study|Lack of Efficacy|1|||
46635611|NCT01533714|82809376|FG000|Overall Study|Withdrawal by Subject|0|||
47052052|NCT03746522|83318109|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
47052053|NCT03746522|83318110|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
47052054|NCT03746522|83318108|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
47052055|NCT03746522|83318109|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
47052056|NCT03746522|83318110|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
47052057|NCT03746522|83318108|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
47052058|NCT03746522|83318109|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
47052059|NCT03746522|83318110|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
47052060|NCT03746522|83318108|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
47052061|NCT03746522|83318109|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
47052062|NCT03746522|83318110|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
47052063|NCT03710161|83318118|FG000|Overall Study|Study halted due to COVID pandemic|3|||
47052064|NCT03710161|83318119|FG001|Overall Study|Study halted due to COVID pandemic|2|||
47052065|NCT03478956|83318137|FG000|Overall Study|Adverse Event|1|||
47052066|NCT03478956|83318138|FG001|Overall Study|Adverse Event|0|||
47052067|NCT03478956|83318137|FG000|Overall Study|Withdrawal by Subject|0|||
47052068|NCT03478956|83318138|FG001|Overall Study|Withdrawal by Subject|1|||
47052069|NCT03478956|83318137|FG000|Overall Study|Ongoing in the Study|11|||
47052070|NCT03478956|83318138|FG001|Overall Study|Ongoing in the Study|11|||
47052071|NCT03347110|83318144|FG000|Overall Study|Other (Participant is incarcerated)|1|||
47052072|NCT03347110|83318144|FG000|Overall Study|Withdrawal by Subject|9|||
47052073|NCT03347110|83318144|FG000|Overall Study|Lost to Follow-up|1|||
46635612|NCT01533714|82809377|FG001|Overall Study|Withdrawal by Subject|1|||
46635613|NCT01533714|82809378|FG002|Overall Study|Withdrawal by Subject|0|||
46635614|NCT01533714|82809379|FG003|Overall Study|Withdrawal by Subject|1|||
46635615|NCT01533714|82809380|FG004|Overall Study|Withdrawal by Subject|1|||
46749148|NCT00772005|82966595|FG000|Overall Study|Withdrawal by Subject|3|||
46749149|NCT00772005|82966596|FG001|Overall Study|Withdrawal by Subject|7|||
46804747|NCT00393718|83023794|FG001|Overall Study|Subject decision|0|||
46635616|NCT01533714|82809381|FG005|Overall Study|Withdrawal by Subject|0|||
46635617|NCT01533714|82809376|FG000|Overall Study|Exclusion criteria|0|||
46635618|NCT01533714|82809377|FG001|Overall Study|Exclusion criteria|1|||
46749150|NCT00772005|82966597|FG002|Overall Study|Withdrawal by Subject|10|||
46749151|NCT00772005|82966598|FG003|Overall Study|Withdrawal by Subject|2|||
46749152|NCT00772005|82966595|FG000|Overall Study|Protocol Violation|2|||
47052074|NCT03347110|83318144|FG000|Overall Study|Lack of Efficacy|2|||
47052075|NCT03347110|83318144|FG000|Overall Study|Adverse Event, non-fatal|9|||
47052076|NCT02688400|83318165|FG000|Overall Study|Protocol Violation|2|||
47052077|NCT02688400|83318166|FG001|Overall Study|Protocol Violation|5|||
47052078|NCT02688400|83318165|FG000|Overall Study|Lack of Efficacy|7|||
47052079|NCT02688400|83318166|FG001|Overall Study|Lack of Efficacy|7|||
47052080|NCT02688400|83318165|FG000|Overall Study|Adverse Event|21|||
47052081|NCT02688400|83318166|FG001|Overall Study|Adverse Event|12|||
47052082|NCT02688400|83318165|FG000|Overall Study|Withdrawal by Subject|15|||
47052083|NCT02688400|83318166|FG001|Overall Study|Withdrawal by Subject|13|||
47052084|NCT02688400|83318165|FG000|Overall Study|No study medication intake|1|||
47052085|NCT02688400|83318166|FG001|Overall Study|No study medication intake|4|||
47052086|NCT02688400|83318165|FG000|Overall Study|Lost to Follow-up|0|||
47052087|NCT02688400|83318166|FG001|Overall Study|Lost to Follow-up|3|||
47052088|NCT02039843|83318179|FG000|Randomization and Observation Period|Adverse Event|2|||
47052089|NCT02039843|83318180|FG001|Randomization and Observation Period|Adverse Event|0|||
47052090|NCT02039843|83318179|FG000|Randomization and Observation Period|Death|1|||
47052091|NCT02039843|83318180|FG001|Randomization and Observation Period|Death|0|||
47052092|NCT02039843|83318179|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
46749153|NCT00772005|82966596|FG001|Overall Study|Protocol Violation|4|||
46749154|NCT00772005|82966597|FG002|Overall Study|Protocol Violation|1|||
46749155|NCT00772005|82966598|FG003|Overall Study|Protocol Violation|6|||
46749156|NCT00772005|82966595|FG000|Overall Study|Lost to Follow-up|7|||
46749157|NCT00772005|82966596|FG001|Overall Study|Lost to Follow-up|3|||
46749158|NCT00772005|82966597|FG002|Overall Study|Lost to Follow-up|6|||
46749159|NCT00772005|82966598|FG003|Overall Study|Lost to Follow-up|3|||
46749160|NCT00772005|82966595|FG000|Overall Study|Non-compliance with study procedures|1|||
46749161|NCT00772005|82966596|FG001|Overall Study|Non-compliance with study procedures|1|||
46749162|NCT00772005|82966597|FG002|Overall Study|Non-compliance with study procedures|0|||
46749163|NCT00772005|82966598|FG003|Overall Study|Non-compliance with study procedures|1|||
46749164|NCT00772005|82966595|FG000|Overall Study|Non-compliance with drug administration|3|||
46749165|NCT00772005|82966596|FG001|Overall Study|Non-compliance with drug administration|0|||
46749166|NCT00772005|82966597|FG002|Overall Study|Non-compliance with drug administration|1|||
46749167|NCT00772005|82966598|FG003|Overall Study|Non-compliance with drug administration|1|||
46749168|NCT00939107|82966610|FG000|Overall Study|Lost to Follow-up|14|||
46749169|NCT00939107|82966611|FG001|Overall Study|Lost to Follow-up|12|||
46749170|NCT00927485|82966619|FG000|Overall Study|Adverse Event|4|||
46749171|NCT00927485|82966620|FG001|Overall Study|Adverse Event|2|||
46749172|NCT00927485|82966619|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
46749173|NCT00927485|82966620|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
46749174|NCT00927251|82966626|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
46749175|NCT00927095|82966633|FG000|Overall Study|Adverse Event|3|||
46749176|NCT00927095|82966634|FG001|Overall Study|Adverse Event|1|||
46749177|NCT00927095|82966635|FG002|Overall Study|Adverse Event|0|||
46749178|NCT00927095|82966633|FG000|Overall Study|Withdrawal by Subject|2|||
46749179|NCT00927095|82966634|FG001|Overall Study|Withdrawal by Subject|1|||
46749180|NCT00927095|82966635|FG002|Overall Study|Withdrawal by Subject|1|||
46749181|NCT00927095|82966633|FG000|Overall Study|Physician Decision|1|||
46749182|NCT00927095|82966634|FG001|Overall Study|Physician Decision|2|||
46749183|NCT00927095|82966635|FG002|Overall Study|Physician Decision|1|||
46749184|NCT00932165|82966643|FG000|Overall Study|Lost to Follow-up|1|||
46749185|NCT04888494|82966650|FG000|Overall Study|Lost to Follow-up|2|||
46749186|NCT04888494|82966651|FG001|Overall Study|Lost to Follow-up|3|||
46749187|NCT04888494|82966650|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
46749188|NCT04888494|82966651|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
47052093|NCT02039843|83318180|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
47052094|NCT02039843|83318179|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
46749191|NCT04391309|82966742|FG000|Overall Study|Death|1|||
46749192|NCT04391309|82966743|FG001|Overall Study|Death|1|||
46749193|NCT04391309|82966742|FG000|Overall Study|Lost to Follow-up|3|||
46749194|NCT04391309|82966743|FG001|Overall Study|Lost to Follow-up|2|||
47052095|NCT02039843|83318180|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
47052096|NCT02039843|83318179|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
47052097|NCT02039843|83318180|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
46749195|NCT04391309|82966742|FG000|Overall Study|Withdrawal by Subject|2|||
46749196|NCT04391309|82966743|FG001|Overall Study|Withdrawal by Subject|2|||
47052098|NCT02039843|83318179|FG000|Pairing With a Study Dog|Death|1|||
46635619|NCT01533714|82809378|FG002|Overall Study|Exclusion criteria|0|||
46749197|NCT04202965|82966758|FG000|Overall Study|Adverse Event|3|||
47052099|NCT02039843|83318180|FG001|Pairing With a Study Dog|Death|0|||
47052100|NCT02039843|83318179|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
47052101|NCT02039843|83318180|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
47052102|NCT02039843|83318179|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
47052103|NCT02039843|83318180|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
47052104|NCT02039843|83318179|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
47052105|NCT02039843|83318180|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
47052106|NCT02004275|83318194|FG000|Phase 1|Ineligible|0|||
47052107|NCT02004275|83318195|FG001|Phase 1|Ineligible|0|||
47052108|NCT02004275|83318196|FG002|Phase 1|Ineligible|0|||
47052109|NCT02004275|83318197|FG003|Phase 1|Ineligible|1|||
47052110|NCT02004275|83318198|FG004|Phase 1|Ineligible|1|||
47052111|NCT02004275|83318199|FG005|Phase 1|Ineligible|0|||
47052112|NCT02004275|83318194|FG000|Phase 1|Protocol Violation|0|||
47052113|NCT02004275|83318195|FG001|Phase 1|Protocol Violation|0|||
47052114|NCT02004275|83318196|FG002|Phase 1|Protocol Violation|0|||
47052115|NCT02004275|83318197|FG003|Phase 1|Protocol Violation|1|||
47052116|NCT02004275|83318198|FG004|Phase 1|Protocol Violation|0|||
47052117|NCT02004275|83318199|FG005|Phase 1|Protocol Violation|5|||
47052118|NCT02004275|83318194|FG000|Phase 2 Part 1|Ineligible|6|||
47052119|NCT02004275|83318195|FG001|Phase 2 Part 1|Ineligible|9|||
47052120|NCT02004275|83318196|FG002|Phase 2 Part 1|Ineligible|0|||
47052121|NCT02004275|83318197|FG003|Phase 2 Part 1|Ineligible|0|||
47052122|NCT02004275|83318198|FG004|Phase 2 Part 1|Ineligible|0|||
47052123|NCT02004275|83318199|FG005|Phase 2 Part 1|Ineligible|0|||
47052124|NCT02004275|83318194|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
47052125|NCT02004275|83318195|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
47052126|NCT02004275|83318196|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
47052127|NCT02004275|83318197|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
47052128|NCT02004275|83318198|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
47052129|NCT02004275|83318199|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
47052130|NCT01559129|83318225|FG000|Treatment Phase|Adverse Event|0|||
47052131|NCT01559129|83318226|FG001|Treatment Phase|Adverse Event|2|||
47052132|NCT01559129|83318225|FG000|Treatment Phase|Progressive Disease|1|||
46749198|NCT04202965|82966758|FG000|Overall Study|Did not meet inclusion criteria|1|||
46749199|NCT04056624|82966766|FG000|Overall Study|Withdrawal by Subject|0|||
46749200|NCT04056624|82966767|FG001|Overall Study|Withdrawal by Subject|0|||
46749201|NCT04056624|82966768|FG002|Overall Study|Withdrawal by Subject|1|||
46749202|NCT04056624|82966766|FG000|Overall Study|Protocol Violation|1|||
46749203|NCT04056624|82966767|FG001|Overall Study|Protocol Violation|2|||
46749204|NCT04056624|82966768|FG002|Overall Study|Protocol Violation|0|||
46749205|NCT03870763|82966788|FG000|Overall Study|Study terminated by sponsor|0|||
46749206|NCT03870763|82966789|FG001|Overall Study|Study terminated by sponsor|2|||
46749207|NCT03870763|82966790|FG002|Overall Study|Study terminated by sponsor|0|||
46749208|NCT03870763|82966788|FG000|Overall Study|Withdrawal by Subject|0|||
46749209|NCT03870763|82966789|FG001|Overall Study|Withdrawal by Subject|1|||
46749210|NCT03870763|82966790|FG002|Overall Study|Withdrawal by Subject|0|||
46749211|NCT03870763|82966788|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
46749212|NCT03870763|82966789|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
46749213|NCT03870763|82966790|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
46749214|NCT03647501|82966800|FG000|Overall Study|Lost to Follow-up|1|||
46749215|NCT03647501|82966801|FG001|Overall Study|Lost to Follow-up|1|||
46749216|NCT03647501|82966800|FG000|Overall Study|Withdrawal by Subject|0|||
46749217|NCT03647501|82966801|FG001|Overall Study|Withdrawal by Subject|1|||
46749218|NCT03587142|82966833|FG000|Overall Study|Lost to Follow-up|5|||
46749219|NCT03587142|82966834|FG001|Overall Study|Lost to Follow-up|3|||
46749220|NCT03587142|82966833|FG000|Overall Study|Did not complete the f4 visit|3|||
46749221|NCT03587142|82966834|FG001|Overall Study|Did not complete the f4 visit|7|||
46749222|NCT03493854|82966842|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
46749223|NCT03493854|82966843|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
47052133|NCT01559129|83318226|FG001|Treatment Phase|Progressive Disease|1|||
47052134|NCT01559129|83318225|FG000|Treatment Phase|Lack of Efficacy|0|||
47052135|NCT01559129|83318226|FG001|Treatment Phase|Lack of Efficacy|1|||
47052136|NCT01559129|83318225|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
47052137|NCT01559129|83318226|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
46749224|NCT03493854|82966842|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
46749225|NCT03493854|82966843|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
46749226|NCT03493854|82966842|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
46749227|NCT03493854|82966843|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
46749228|NCT03493854|82966842|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
46749229|NCT03493854|82966843|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
46749230|NCT03493854|82966842|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
46749231|NCT03493854|82966843|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
46749232|NCT03493854|82966842|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
47052138|NCT01559129|83318225|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
47052139|NCT01559129|83318226|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
46749233|NCT03493854|82966843|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
46749234|NCT03493854|82966842|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
46749235|NCT03493854|82966843|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
46749236|NCT03493854|82966842|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
46749237|NCT03493854|82966843|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
46749238|NCT03493854|82966842|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
46749239|NCT03493854|82966843|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
46749240|NCT03493854|82966842|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
46749241|NCT03493854|82966843|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
46749242|NCT03493854|82966842|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
46749243|NCT03493854|82966843|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
46749244|NCT03493854|82966842|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
46749245|NCT03493854|82966843|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
46749246|NCT03493854|82966842|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
46749247|NCT03493854|82966843|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
46749248|NCT03493854|82966842|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
46749249|NCT03493854|82966843|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
46749250|NCT03493854|82966842|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
46749251|NCT03493854|82966843|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
46749252|NCT03493854|82966842|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
46749253|NCT03493854|82966843|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
46749254|NCT03188705|82966849|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
46749255|NCT03188705|82966849|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
46749256|NCT03032484|82966854|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
46749257|NCT03032484|82966855|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
46749258|NCT03032484|82966854|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
46749259|NCT03032484|82966855|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
46749260|NCT02975349|82966864|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46749261|NCT02975349|82966865|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46749262|NCT02975349|82966866|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
46749263|NCT02975349|82966867|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
46749264|NCT02975349|82966868|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46749265|NCT02975349|82966869|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46749266|NCT02975349|82966864|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
46749267|NCT02975349|82966865|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46749268|NCT02975349|82966866|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46749269|NCT02975349|82966867|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46749270|NCT02975349|82966868|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46749271|NCT02975349|82966869|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46749272|NCT02975349|82966864|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
46749273|NCT02975349|82966865|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
46749274|NCT02975349|82966866|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
46749275|NCT02975349|82966867|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
46749276|NCT02975349|82966868|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
46749277|NCT02975349|82966869|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
46749278|NCT02975349|82966864|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
46749279|NCT02975349|82966865|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
46749280|NCT02975349|82966866|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
46749281|NCT02975349|82966867|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
46749282|NCT02975349|82966868|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
46749283|NCT02975349|82966869|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
46749284|NCT02975349|82966864|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
46749285|NCT02975349|82966865|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
46749286|NCT02975349|82966866|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
46749287|NCT02975349|82966867|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
46749288|NCT02975349|82966868|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
46749289|NCT02975349|82966869|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
46749290|NCT02975349|82966864|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
46749291|NCT02975349|82966865|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
46749292|NCT02975349|82966866|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
46749293|NCT02975349|82966867|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
46749294|NCT02975349|82966868|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
46749295|NCT02975349|82966869|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
46749296|NCT02975349|82966864|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
46775756|NCT00793793|82994213|FG009|Overall Study|Lost to Follow-up|3|||
46635620|NCT01533714|82809379|FG003|Overall Study|Exclusion criteria|0|||
46635621|NCT01533714|82809380|FG004|Overall Study|Exclusion criteria|0|||
46635622|NCT01533714|82809381|FG005|Overall Study|Exclusion criteria|0|||
46635623|NCT01533714|82809376|FG000|Overall Study|Positive for purified protein derivative|0|||
46635624|NCT01533714|82809377|FG001|Overall Study|Positive for purified protein derivative|0|||
46635625|NCT01533714|82809378|FG002|Overall Study|Positive for purified protein derivative|1|||
46635626|NCT01533714|82809379|FG003|Overall Study|Positive for purified protein derivative|0|||
46635627|NCT01533714|82809380|FG004|Overall Study|Positive for purified protein derivative|1|||
46635628|NCT01533714|82809381|FG005|Overall Study|Positive for purified protein derivative|0|||
46635629|NCT01533714|82809376|FG000|Overall Study|Withdrawal criteria|0|||
46635630|NCT01533714|82809377|FG001|Overall Study|Withdrawal criteria|0|||
46635631|NCT01533714|82809378|FG002|Overall Study|Withdrawal criteria|1|||
46635632|NCT01533714|82809379|FG003|Overall Study|Withdrawal criteria|0|||
46635633|NCT01533714|82809380|FG004|Overall Study|Withdrawal criteria|3|||
46635634|NCT01533714|82809381|FG005|Overall Study|Withdrawal criteria|1|||
46635635|NCT01533714|82809376|FG000|Overall Study|Ineligibility reason|0|||
46635636|NCT01533714|82809377|FG001|Overall Study|Ineligibility reason|0|||
46635637|NCT01533714|82809378|FG002|Overall Study|Ineligibility reason|0|||
46635638|NCT01533714|82809379|FG003|Overall Study|Ineligibility reason|1|||
46635639|NCT01533714|82809380|FG004|Overall Study|Ineligibility reason|0|||
47052140|NCT01559129|83318225|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
46635640|NCT01533714|82809381|FG005|Overall Study|Ineligibility reason|0|||
46635641|NCT01533246|82809395|FG000|Overall Study|Adverse Event|1|||
46635642|NCT01533246|82809395|FG000|Overall Study|Withdrawal by Subject|1|||
46635643|NCT01579578|82809401|FG000|Overall Study|Death|4|||
47052141|NCT01559129|83318226|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
47052142|NCT01559129|83318225|FG000|Open-label Extension Period|Adverse Event|1|||
47052143|NCT01559129|83318226|FG001|Open-label Extension Period|Adverse Event|0|||
47052144|NCT01559129|83318225|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
47052145|NCT01559129|83318226|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
47052146|NCT00355238|83318251|FG000|Overall Study|Adverse event unrelated to study drug|2|||
47052147|NCT00355238|83318252|FG001|Overall Study|Adverse event unrelated to study drug|2|||
47052148|NCT00355238|83318253|FG002|Overall Study|Adverse event unrelated to study drug|0|||
47052149|NCT00355238|83318254|FG003|Overall Study|Adverse event unrelated to study drug|1|||
47052150|NCT00355238|83318251|FG000|Overall Study|Death|1|||
47052151|NCT00355238|83318252|FG001|Overall Study|Death|0|||
47052152|NCT00355238|83318253|FG002|Overall Study|Death|0|||
47052153|NCT00355238|83318254|FG003|Overall Study|Death|0|||
47052154|NCT00355238|83318251|FG000|Overall Study|Disease progression|37|||
47052155|NCT00355238|83318252|FG001|Overall Study|Disease progression|36|||
47052156|NCT00355238|83318253|FG002|Overall Study|Disease progression|16|||
47052157|NCT00355238|83318254|FG003|Overall Study|Disease progression|11|||
47052158|NCT00355238|83318251|FG000|Overall Study|Study drug toxicity|11|||
47052159|NCT00355238|83318252|FG001|Overall Study|Study drug toxicity|7|||
47052160|NCT00355238|83318253|FG002|Overall Study|Study drug toxicity|5|||
47052161|NCT00355238|83318254|FG003|Overall Study|Study drug toxicity|2|||
47052162|NCT00355238|83318251|FG000|Overall Study|Participant withdrew consent|3|||
47052163|NCT00355238|83318252|FG001|Overall Study|Participant withdrew consent|1|||
47052164|NCT00355238|83318253|FG002|Overall Study|Participant withdrew consent|0|||
47052165|NCT00355238|83318254|FG003|Overall Study|Participant withdrew consent|0|||
47052166|NCT00355238|83318251|FG000|Overall Study|Participant request to discontinue study treatment|1|||
47052167|NCT00355238|83318252|FG001|Overall Study|Participant request to discontinue study treatment|0|||
47052168|NCT00355238|83318253|FG002|Overall Study|Participant request to discontinue study treatment|1|||
47052169|NCT00355238|83318254|FG003|Overall Study|Participant request to discontinue study treatment|0|||
47052170|NCT00303303|83318269|FG000|Overall Study|Withdrawal by Subject|0|||
47052171|NCT00303303|83318270|FG001|Overall Study|Withdrawal by Subject|0|||
47052172|NCT00303303|83318271|FG002|Overall Study|Withdrawal by Subject|1|||
47052173|NCT00988533|83318316|FG000|Overall Study|Lost to Follow-up|3|||
46635644|NCT01579578|82809402|FG001|Overall Study|Death|1|||
46635645|NCT01579578|82809401|FG000|Overall Study|Lost to Follow-up|1|||
46635646|NCT01579578|82809402|FG001|Overall Study|Lost to Follow-up|1|||
46635647|NCT01579578|82809401|FG000|Overall Study|Withdrawal by Subject|2|||
46635648|NCT01579578|82809402|FG001|Overall Study|Withdrawal by Subject|1|||
46635649|NCT01579578|82809401|FG000|Overall Study|Eligibility criteria|3|||
46635650|NCT01579578|82809402|FG001|Overall Study|Eligibility criteria|9|||
46635651|NCT01579578|82809401|FG000|Overall Study|Ongoing|3|||
46635652|NCT01579578|82809402|FG001|Overall Study|Ongoing|0|||
46635653|NCT01578486|82809408|FG000|Overall Study|Physician Decision|3|||
47052174|NCT03633396|83318348|FG000|Overall Study|Withdrawal by Subject|4|||
47052175|NCT03633396|83318349|FG001|Overall Study|Withdrawal by Subject|4|||
47052176|NCT03633396|83318348|FG000|Overall Study|Adverse Event|1|||
47052177|NCT03633396|83318349|FG001|Overall Study|Adverse Event|1|||
47052178|NCT03633396|83318348|FG000|Overall Study|Lack of Efficacy|1|||
46635654|NCT01578486|82809408|FG000|Overall Study|Withdrawal by Subject|2|||
46635655|NCT01532934|82809414|FG000|Overall Study|Lost to Follow-up|11|||
46635656|NCT01532934|82809415|FG001|Overall Study|Lost to Follow-up|11|||
46635657|NCT01532934|82809414|FG000|Overall Study|In controlled environment|3|||
46635658|NCT01532934|82809415|FG001|Overall Study|In controlled environment|2|||
46635659|NCT01555164|82809425|FG000|Overall Study|Adverse Event|5|||
46635660|NCT01555164|82809426|FG001|Overall Study|Adverse Event|7|||
46635661|NCT01555164|82809425|FG000|Overall Study|Hyperglycemia|0|||
46635662|NCT01555164|82809426|FG001|Overall Study|Hyperglycemia|1|||
46635663|NCT01555164|82809425|FG000|Overall Study|Investigator's Discretion|2|||
46635664|NCT01555164|82809426|FG001|Overall Study|Investigator's Discretion|2|||
46635665|NCT01555164|82809425|FG000|Overall Study|Lost to Follow-up|4|||
46635666|NCT01555164|82809426|FG001|Overall Study|Lost to Follow-up|3|||
47052179|NCT03633396|83318349|FG001|Overall Study|Lack of Efficacy|0|||
47052180|NCT03633396|83318348|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
47052181|NCT03633396|83318349|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
47052182|NCT00988065|83318362|FG000|Overall Study|Adverse Event|4|||
47052183|NCT00988065|83318363|FG001|Overall Study|Adverse Event|10|||
47052184|NCT00988065|83318364|FG002|Overall Study|Adverse Event|2|||
47052185|NCT00988065|83318362|FG000|Overall Study|Lost to Follow-up|1|||
47052186|NCT00988065|83318363|FG001|Overall Study|Lost to Follow-up|2|||
47052187|NCT00988065|83318364|FG002|Overall Study|Lost to Follow-up|2|||
47052188|NCT00988065|83318362|FG000|Overall Study|Subject withdrew consent|3|||
47052189|NCT00988065|83318363|FG001|Overall Study|Subject withdrew consent|5|||
47052190|NCT00988065|83318364|FG002|Overall Study|Subject withdrew consent|2|||
47052191|NCT00988065|83318362|FG000|Overall Study|Noncompliance with protocol|5|||
47052192|NCT00988065|83318363|FG001|Overall Study|Noncompliance with protocol|6|||
47052193|NCT00988065|83318364|FG002|Overall Study|Noncompliance with protocol|9|||
47052194|NCT00987831|83318388|FG000|Overall Study|Never flared in 12 months|1|||
47052195|NCT00987831|83318389|FG001|Overall Study|Never flared in 12 months|0|||
46635667|NCT01555164|82809425|FG000|Overall Study|Protocol Violation|9|||
46635668|NCT01555164|82809426|FG001|Overall Study|Protocol Violation|5|||
46635669|NCT01555164|82809425|FG000|Overall Study|Subject Non-compliance|14|||
46635670|NCT01555164|82809426|FG001|Overall Study|Subject Non-compliance|6|||
46635671|NCT01555164|82809425|FG000|Overall Study|Subject Withdrew Consent|6|||
47052196|NCT00987831|83318390|FG002|Overall Study|Never flared in 12 months|0|||
47052197|NCT00987831|83318388|FG000|Overall Study|Lost to Follow-up|0|||
47052198|NCT00987831|83318389|FG001|Overall Study|Lost to Follow-up|3|||
47052199|NCT00987831|83318390|FG002|Overall Study|Lost to Follow-up|0|||
47052200|NCT00986973|83318421|FG000|Overall Study|Withdrawn by study team|1|||
47052201|NCT00986427|83318428|FG000|Overall Study|Lost to Follow-up|2|||
47052202|NCT00986427|83318429|FG001|Overall Study|Lost to Follow-up|0|||
47052203|NCT00986427|83318428|FG000|Overall Study|Lack of Efficacy|1|||
47052204|NCT00986427|83318429|FG001|Overall Study|Lack of Efficacy|0|||
47052205|NCT00986427|83318428|FG000|Overall Study|Withdrawal by Subject|1|||
47052206|NCT00986427|83318429|FG001|Overall Study|Withdrawal by Subject|0|||
47052207|NCT00986349|83318439|FG000|Overall Study|Unsuccessful implant procedure|3|||
46635672|NCT01555164|82809426|FG001|Overall Study|Subject Withdrew Consent|11|||
46635673|NCT01578330|82809432|FG000|Overall Study|Adverse Event|2|||
46635674|NCT01578330|82809432|FG000|Overall Study|Protocol Violation|5|||
46635675|NCT01577160|82809436|FG000|Overall Study|Adverse Event|9|||
46635676|NCT01577160|82809436|FG000|Overall Study|Lack of Efficacy|15|||
46635677|NCT01577160|82809436|FG000|Overall Study|Lost to Follow-up|40|||
46635678|NCT01577160|82809436|FG000|Overall Study|Withdrawal by Subject|18|||
46635679|NCT01577160|82809436|FG000|Overall Study|Subject Uncooperative|7|||
46635680|NCT01577160|82809436|FG000|Overall Study|Other|9|||
46635681|NCT01554618|82809442|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
47052208|NCT00986349|83318439|FG000|Overall Study|Adverse Event|2|||
47052209|NCT00986349|83318439|FG000|Overall Study|Physician Decision|1|||
47052210|NCT00986349|83318439|FG000|Overall Study|device migration|1|||
47052211|NCT00985959|83318462|FG000|Overall Study|Adverse Event|0|||
47052212|NCT00985959|83318463|FG001|Overall Study|Adverse Event|0|||
47052213|NCT00985959|83318464|FG002|Overall Study|Adverse Event|19|||
46635682|NCT01554618|82809443|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
46635683|NCT01554618|82809442|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
46635684|NCT01554618|82809443|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
46635685|NCT01554618|82809442|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
46635686|NCT01554618|82809443|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
46775757|NCT00793793|82994214|FG010|Overall Study|Lost to Follow-up|1|||
47052214|NCT00985959|83318462|FG000|Overall Study|Withdrawal by Subject|0|||
47052215|NCT00985959|83318463|FG001|Overall Study|Withdrawal by Subject|0|||
47052216|NCT00985959|83318464|FG002|Overall Study|Withdrawal by Subject|8|||
47052217|NCT00985959|83318462|FG000|Overall Study|Progressive disease|1|||
46635687|NCT01554618|82809442|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
46635688|NCT01554618|82809443|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
47052218|NCT00985959|83318463|FG001|Overall Study|Progressive disease|2|||
46749297|NCT02975349|82966865|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
46749298|NCT02975349|82966866|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
46749299|NCT02975349|82966867|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
46749300|NCT02975349|82966868|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
46749301|NCT02975349|82966869|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
46749302|NCT02975349|82966864|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
46749303|NCT02975349|82966865|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
46635689|NCT01554618|82809442|FG000|Open-Label Extension Period|Physician Decision|0|||
46635690|NCT01554618|82809443|FG001|Open-Label Extension Period|Physician Decision|1|||
46635691|NCT01554618|82809442|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
46635692|NCT01554618|82809443|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
46635693|NCT01531998|82809453|FG000|Overall Study|Withdrawal by Subject|3|||
46635694|NCT01576146|82809457|FG000|Extension Period 1|Adverse Event|2|||
46635695|NCT01576146|82809457|FG000|Extension Period 1|Death|2|||
46635696|NCT01576146|82809457|FG000|Extension Period 1|Physician Decision|2|||
47052219|NCT00985959|83318464|FG002|Overall Study|Progressive disease|8|||
47052220|NCT00985959|83318462|FG000|Overall Study|Unrecovered toxicity|0|||
47052221|NCT00985959|83318463|FG001|Overall Study|Unrecovered toxicity|0|||
46635697|NCT01576146|82809457|FG000|Extension Period 1|Withdrawal by Subject|1|||
46635698|NCT01576146|82809457|FG000|Extension Period 1|Lost to Follow-up|1|||
46635699|NCT01576146|82809457|FG000|Extension Period 1|Parathyroidectomy|1|||
46635700|NCT01576146|82809457|FG000|Extension Period 1|Renal Transplant|1|||
46635701|NCT01576146|82809457|FG000|Extension Period 2|Sponsor Decision|13|||
46635702|NCT01576146|82809457|FG000|Extension Period 2|Death|1|||
46635703|NCT01576146|82809457|FG000|Extension Period 2|Adverse Event|1|||
46635704|NCT01576146|82809457|FG000|Extension Period 2|Renal Transplant|1|||
46635705|NCT01576146|82809457|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
46635706|NCT01553916|82809461|FG000|Overall Study|Withdrawal by Subject|2|||
46635707|NCT01553916|82809461|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
46635708|NCT01553136|82809467|FG000|Overall Study|Adverse Event|3|||
46635709|NCT01553136|82809468|FG001|Overall Study|Adverse Event|2|||
46635710|NCT01553136|82809467|FG000|Overall Study|Withdrawal by Subject|2|||
46635711|NCT01553136|82809468|FG001|Overall Study|Withdrawal by Subject|3|||
46749304|NCT02975349|82966866|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
46749305|NCT02975349|82966867|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
46749306|NCT02975349|82966868|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
46749307|NCT02975349|82966869|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
46749308|NCT02975349|82966864|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
46749309|NCT02975349|82966865|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
46749310|NCT02975349|82966866|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
46749311|NCT02975349|82966867|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
46749312|NCT02975349|82966868|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
46749313|NCT02975349|82966869|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
46749314|NCT02520141|82966940|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
46749315|NCT02329847|82966952|FG000|Overall Study|Death|4|||
46749316|NCT02329847|82966953|FG001|Overall Study|Death|4|||
46749317|NCT02329847|82966954|FG002|Overall Study|Death|22|||
46749318|NCT02329847|82966955|FG003|Overall Study|Death|12|||
46749319|NCT02329847|82966956|FG004|Overall Study|Death|20|||
46749320|NCT02329847|82966957|FG005|Overall Study|Death|13|||
46749321|NCT02329847|82966952|FG000|Overall Study|Lost to Follow-up|0|||
46749322|NCT02329847|82966953|FG001|Overall Study|Lost to Follow-up|0|||
46749323|NCT02329847|82966954|FG002|Overall Study|Lost to Follow-up|2|||
46749324|NCT02329847|82966955|FG003|Overall Study|Lost to Follow-up|3|||
46749325|NCT02329847|82966956|FG004|Overall Study|Lost to Follow-up|0|||
46749326|NCT02329847|82966957|FG005|Overall Study|Lost to Follow-up|1|||
46749327|NCT02329847|82966952|FG000|Overall Study|Physician Decision|0|||
46749328|NCT02329847|82966953|FG001|Overall Study|Physician Decision|0|||
46749329|NCT02329847|82966954|FG002|Overall Study|Physician Decision|0|||
46749330|NCT02329847|82966955|FG003|Overall Study|Physician Decision|0|||
46635712|NCT01553136|82809467|FG000|Overall Study|Lost to Follow-up|4|||
46749331|NCT02329847|82966956|FG004|Overall Study|Physician Decision|1|||
46749332|NCT02329847|82966957|FG005|Overall Study|Physician Decision|0|||
46749333|NCT02329847|82966952|FG000|Overall Study|Withdrawal by Subject|2|||
46749334|NCT02329847|82966953|FG001|Overall Study|Withdrawal by Subject|1|||
46749335|NCT02329847|82966954|FG002|Overall Study|Withdrawal by Subject|5|||
46749336|NCT02329847|82966955|FG003|Overall Study|Withdrawal by Subject|7|||
46749337|NCT02329847|82966956|FG004|Overall Study|Withdrawal by Subject|8|||
46749338|NCT02329847|82966957|FG005|Overall Study|Withdrawal by Subject|3|||
46749339|NCT02329847|82966952|FG000|Overall Study|Other|1|||
47052222|NCT00985959|83318464|FG002|Overall Study|Unrecovered toxicity|7|||
46635713|NCT01553136|82809468|FG001|Overall Study|Lost to Follow-up|10|||
46635714|NCT01553136|82809467|FG000|Overall Study|Physician Decision|2|||
46635715|NCT01553136|82809468|FG001|Overall Study|Physician Decision|3|||
46635716|NCT01553136|82809467|FG000|Overall Study|Scheduling Difficulties|5|||
46749340|NCT02329847|82966953|FG001|Overall Study|Other|2|||
46749341|NCT02329847|82966954|FG002|Overall Study|Other|6|||
46749342|NCT02329847|82966955|FG003|Overall Study|Other|13|||
46749343|NCT02329847|82966956|FG004|Overall Study|Other|10|||
46749344|NCT02329847|82966957|FG005|Overall Study|Other|3|||
46749345|NCT02314624|82966978|FG000|Overall Study|No participating patient|16|||
46749346|NCT02314624|82966979|FG001|Overall Study|No participating patient|13|||
46749347|NCT02314624|82966978|FG000|Overall Study|Participant withdrew|7|||
46749348|NCT02314624|82966979|FG001|Overall Study|Participant withdrew|2|||
46749349|NCT02314624|82966978|FG000|Overall Study|Lost to Follow-up|2|||
46749350|NCT02314624|82966979|FG001|Overall Study|Lost to Follow-up|5|||
46749351|NCT02314624|82966978|FG000|Overall Study|Dropped/Excluded by PI|6|||
46749352|NCT02314624|82966979|FG001|Overall Study|Dropped/Excluded by PI|6|||
46749353|NCT01419080|82967008|FG000|Overall Study|Withdrawal by Subject|75|||
46749354|NCT01419080|82967008|FG000|Overall Study|Death|30|||
46749355|NCT01419080|82967008|FG000|Overall Study|Lost to Follow-up|23|||
46749356|NCT01419080|82967008|FG000|Overall Study|Too Ill|3|||
46749357|NCT01164228|82967016|FG000|Overall Study|Progression|24|||
46749358|NCT01164228|82967017|FG001|Overall Study|Progression|25|||
46749359|NCT01164228|82967016|FG000|Overall Study|Adverse Event|13|||
46749360|NCT01164228|82967017|FG001|Overall Study|Adverse Event|7|||
46749361|NCT01164228|82967016|FG000|Overall Study|Death|1|||
46749362|NCT01164228|82967017|FG001|Overall Study|Death|1|||
46749363|NCT01164228|82967016|FG000|Overall Study|Withdrawal by Subject|2|||
46749364|NCT01164228|82967017|FG001|Overall Study|Withdrawal by Subject|0|||
46749365|NCT01164228|82967016|FG000|Overall Study|Physician Decision|1|||
46749366|NCT01164228|82967017|FG001|Overall Study|Physician Decision|2|||
46749367|NCT01164228|82967016|FG000|Overall Study|Symptomatic deterioration|1|||
46749368|NCT01164228|82967017|FG001|Overall Study|Symptomatic deterioration|0|||
46749369|NCT01164228|82967016|FG000|Overall Study|Never started treatment|1|||
46749370|NCT01164228|82967017|FG001|Overall Study|Never started treatment|3|||
46749371|NCT01164228|82967016|FG000|Overall Study|Ineligible|1|||
46749372|NCT01164228|82967017|FG001|Overall Study|Ineligible|0|||
46749373|NCT00554515|82967023|FG000|Overall Study|Withdrawal by Subject|3|||
46749374|NCT00554515|82967023|FG000|Overall Study|Disease progression|52|||
46749375|NCT00554515|82967023|FG000|Overall Study|Physician Decision|18|||
46749376|NCT00554515|82967023|FG000|Overall Study|Withdrawal by Subject|11|||
46749377|NCT00554515|82967023|FG000|Overall Study|Adverse Event|9|||
46749378|NCT00554515|82967023|FG000|Overall Study|Death|2|||
46749379|NCT00554515|82967023|FG000|Overall Study|Achieved Stable Disease|7|||
46749380|NCT00554515|82967023|FG000|Overall Study|Other|1|||
46749381|NCT00554515|82967023|FG000|Overall Study|Misc|15|||
46749382|NCT00049517|82967050|FG000|Induction|Disease progression|0|||
46749383|NCT00049517|82967051|FG001|Induction|Disease progression|0|||
46749384|NCT00049517|82967052|FG002|Induction|Disease progression|0|||
46749385|NCT00049517|82967053|FG003|Induction|Disease progression|0|||
46749386|NCT00049517|82967054|FG004|Induction|Disease progression|18|||
46749387|NCT00049517|82967055|FG005|Induction|Disease progression|11|||
46749388|NCT00049517|82967050|FG000|Induction|Adverse Event|0|||
46749389|NCT00049517|82967051|FG001|Induction|Adverse Event|0|||
46749390|NCT00049517|82967052|FG002|Induction|Adverse Event|0|||
46749391|NCT00049517|82967053|FG003|Induction|Adverse Event|0|||
46749392|NCT00049517|82967054|FG004|Induction|Adverse Event|5|||
46924182|NCT03706079|83158055|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
46924183|NCT03706079|83158056|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
46924184|NCT03706079|83158051|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
46924185|NCT03706079|83158052|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
46924186|NCT03706079|83158053|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
46924187|NCT03706079|83158054|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
46924188|NCT03706079|83158055|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
46924189|NCT03706079|83158056|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
46924190|NCT03706079|83158051|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
46924191|NCT03706079|83158052|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
46924192|NCT03706079|83158053|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
46924193|NCT03706079|83158054|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
46635717|NCT01553136|82809468|FG001|Overall Study|Scheduling Difficulties|4|||
46749393|NCT00049517|82967055|FG005|Induction|Adverse Event|7|||
46749394|NCT00049517|82967050|FG000|Induction|Death|0|||
46749395|NCT00049517|82967051|FG001|Induction|Death|0|||
46749396|NCT00049517|82967052|FG002|Induction|Death|0|||
46749397|NCT00049517|82967053|FG003|Induction|Death|0|||
46749398|NCT00049517|82967054|FG004|Induction|Death|9|||
46749399|NCT00049517|82967055|FG005|Induction|Death|6|||
46749400|NCT00049517|82967050|FG000|Induction|Withdrawal by Subject|0|||
46749401|NCT00049517|82967051|FG001|Induction|Withdrawal by Subject|0|||
46635718|NCT01552902|82809477|FG000|Overall Study|Adverse Event|1|||
46749402|NCT00049517|82967052|FG002|Induction|Withdrawal by Subject|0|||
46749403|NCT00049517|82967053|FG003|Induction|Withdrawal by Subject|0|||
46749404|NCT00049517|82967054|FG004|Induction|Withdrawal by Subject|1|||
46749405|NCT00049517|82967055|FG005|Induction|Withdrawal by Subject|3|||
46749406|NCT00049517|82967050|FG000|Induction|Alternative therapy|0|||
46749407|NCT00049517|82967051|FG001|Induction|Alternative therapy|0|||
46749408|NCT00049517|82967052|FG002|Induction|Alternative therapy|0|||
46749409|NCT00049517|82967053|FG003|Induction|Alternative therapy|0|||
47052223|NCT00985959|83318462|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
47052224|NCT00985959|83318463|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
47052225|NCT00985959|83318464|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
47052226|NCT00985959|83318462|FG000|Overall Study|Complete response observed over 2 cycles|0|||
47052227|NCT00985959|83318463|FG001|Overall Study|Complete response observed over 2 cycles|1|||
47052228|NCT00985959|83318464|FG002|Overall Study|Complete response observed over 2 cycles|4|||
47052229|NCT00985959|83318462|FG000|Overall Study|Other|0|||
47052230|NCT00985959|83318463|FG001|Overall Study|Other|0|||
47052231|NCT00985959|83318464|FG002|Overall Study|Other|11|||
46749410|NCT00049517|82967054|FG004|Induction|Alternative therapy|2|||
46749411|NCT00049517|82967055|FG005|Induction|Alternative therapy|2|||
46749412|NCT00049517|82967050|FG000|Induction|Other complicating disease|0|||
46749413|NCT00049517|82967051|FG001|Induction|Other complicating disease|0|||
46749414|NCT00049517|82967052|FG002|Induction|Other complicating disease|0|||
46749415|NCT00049517|82967053|FG003|Induction|Other complicating disease|0|||
46749416|NCT00049517|82967054|FG004|Induction|Other complicating disease|3|||
46749417|NCT00049517|82967055|FG005|Induction|Other complicating disease|0|||
46749418|NCT00049517|82967050|FG000|Induction|Reasons not reported|0|||
46749419|NCT00049517|82967051|FG001|Induction|Reasons not reported|0|||
46749420|NCT00049517|82967052|FG002|Induction|Reasons not reported|0|||
46749421|NCT00049517|82967053|FG003|Induction|Reasons not reported|0|||
46749422|NCT00049517|82967054|FG004|Induction|Reasons not reported|22|||
46749423|NCT00049517|82967055|FG005|Induction|Reasons not reported|25|||
46924194|NCT03706079|83158055|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
46749424|NCT00049517|82967050|FG000|Conditioning/Transplant|Disease progression|14|||
46749425|NCT00049517|82967051|FG001|Conditioning/Transplant|Disease progression|6|||
46749426|NCT00049517|82967052|FG002|Conditioning/Transplant|Disease progression|10|||
46749427|NCT00049517|82967053|FG003|Conditioning/Transplant|Disease progression|6|||
46749428|NCT00049517|82967054|FG004|Conditioning/Transplant|Disease progression|0|||
46749429|NCT00049517|82967055|FG005|Conditioning/Transplant|Disease progression|0|||
46749430|NCT00049517|82967050|FG000|Conditioning/Transplant|Adverse Event|2|||
46749431|NCT00049517|82967051|FG001|Conditioning/Transplant|Adverse Event|1|||
46749432|NCT00049517|82967052|FG002|Conditioning/Transplant|Adverse Event|4|||
46749433|NCT00049517|82967053|FG003|Conditioning/Transplant|Adverse Event|8|||
46749434|NCT00049517|82967054|FG004|Conditioning/Transplant|Adverse Event|0|||
46749435|NCT00049517|82967055|FG005|Conditioning/Transplant|Adverse Event|0|||
46749436|NCT00049517|82967050|FG000|Conditioning/Transplant|Death|1|||
46749437|NCT00049517|82967051|FG001|Conditioning/Transplant|Death|0|||
46749438|NCT00049517|82967052|FG002|Conditioning/Transplant|Death|0|||
46749439|NCT00049517|82967053|FG003|Conditioning/Transplant|Death|2|||
46749440|NCT00049517|82967054|FG004|Conditioning/Transplant|Death|0|||
46749441|NCT00049517|82967055|FG005|Conditioning/Transplant|Death|0|||
46749442|NCT00049517|82967050|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
46749443|NCT00049517|82967051|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
46749444|NCT00049517|82967052|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
46749445|NCT00049517|82967053|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
46749446|NCT00049517|82967054|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
46749447|NCT00049517|82967055|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
46749448|NCT00049517|82967050|FG000|Conditioning/Transplant|Alternative therapy|4|||
46749449|NCT00049517|82967051|FG001|Conditioning/Transplant|Alternative therapy|4|||
46749450|NCT00049517|82967052|FG002|Conditioning/Transplant|Alternative therapy|2|||
46749451|NCT00049517|82967053|FG003|Conditioning/Transplant|Alternative therapy|1|||
46749452|NCT00049517|82967054|FG004|Conditioning/Transplant|Alternative therapy|1|||
46924195|NCT03706079|83158056|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
46924196|NCT03706079|83158051|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
46924197|NCT03706079|83158052|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
47052232|NCT00985725|83318480|FG000|Overall Study|Adverse Event|4|||
47052233|NCT00985725|83318481|FG001|Overall Study|Adverse Event|1|||
47052234|NCT00985725|83318480|FG000|Overall Study|Protocol Violation|1|||
46749453|NCT00049517|82967055|FG005|Conditioning/Transplant|Alternative therapy|0|||
46749454|NCT00049517|82967050|FG000|Conditioning/Transplant|Other complicating disease|2|||
47052235|NCT00985725|83318481|FG001|Overall Study|Protocol Violation|3|||
46924198|NCT03706079|83158053|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
46924199|NCT03706079|83158054|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
47052236|NCT00985725|83318480|FG000|Overall Study|Withdrawal by Subject|4|||
46749455|NCT00049517|82967051|FG001|Conditioning/Transplant|Other complicating disease|0|||
46749456|NCT00049517|82967052|FG002|Conditioning/Transplant|Other complicating disease|0|||
46749457|NCT00049517|82967053|FG003|Conditioning/Transplant|Other complicating disease|4|||
46749458|NCT00049517|82967054|FG004|Conditioning/Transplant|Other complicating disease|0|||
46924200|NCT03706079|83158055|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
46924201|NCT03706079|83158056|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
46924202|NCT03706079|83158051|FG000|Long Term Extension (DESTINATION)|Death|8|||
46924203|NCT03706079|83158052|FG001|Long Term Extension (DESTINATION)|Death|2|||
46924204|NCT03706079|83158053|FG002|Long Term Extension (DESTINATION)|Death|2|||
47052237|NCT00985725|83318481|FG001|Overall Study|Withdrawal by Subject|4|||
47052238|NCT00985725|83318480|FG000|Overall Study|Lost to Follow-up|1|||
47052239|NCT00985725|83318481|FG001|Overall Study|Lost to Follow-up|1|||
47052240|NCT00985725|83318480|FG000|Overall Study|Lack of Efficacy|0|||
47052241|NCT00985725|83318481|FG001|Overall Study|Lack of Efficacy|1|||
47052242|NCT00985725|83318480|FG000|Overall Study|Non-compliance|1|||
46749459|NCT00049517|82967055|FG005|Conditioning/Transplant|Other complicating disease|1|||
46749460|NCT00049517|82967050|FG000|Conditioning/Transplant|Reasons not reported|25|||
46749461|NCT00049517|82967051|FG001|Conditioning/Transplant|Reasons not reported|31|||
46749462|NCT00049517|82967052|FG002|Conditioning/Transplant|Reasons not reported|18|||
46749463|NCT00049517|82967053|FG003|Conditioning/Transplant|Reasons not reported|15|||
46749464|NCT00049517|82967054|FG004|Conditioning/Transplant|Reasons not reported|5|||
46749465|NCT00049517|82967055|FG005|Conditioning/Transplant|Reasons not reported|5|||
46749466|NCT00926783|82967065|FG000|Overall Study|Incomplete CFAE Procedures|3|||
46749467|NCT00926783|82967066|FG001|Overall Study|Incomplete CFAE Procedures|3|||
46749468|NCT00929669|82967072|FG000|Overall Study|elevated glucose levels|1|||
46749469|NCT00566995|82967076|FG000|Overall Study|Toxicity|4|||
46749470|NCT00566995|82967076|FG000|Overall Study|Withdrew consent|3|||
46749471|NCT00926393|82967082|FG000|Overall Study|Withdrawal by Subject|1|||
46749472|NCT00926393|82967083|FG001|Overall Study|Withdrawal by Subject|2|||
46749473|NCT00926393|82967082|FG000|Overall Study|Adverse Event|1|||
46749474|NCT00926393|82967083|FG001|Overall Study|Adverse Event|1|||
46749475|NCT00926237|82967089|FG000|Overall Study|Withdrawal by Subject|2|||
46749476|NCT00926237|82967090|FG001|Overall Study|Withdrawal by Subject|1|||
46749477|NCT00931463|82967102|FG000|Overall Study|Death|8|||
46749478|NCT00931463|82967103|FG001|Overall Study|Death|4|||
46749479|NCT00931463|82967102|FG000|Overall Study|Withdrawal by Subject|5|||
46749480|NCT00931463|82967103|FG001|Overall Study|Withdrawal by Subject|0|||
46749481|NCT00931463|82967102|FG000|Overall Study|Lost to Follow-up|4|||
46749482|NCT00931463|82967103|FG001|Overall Study|Lost to Follow-up|1|||
46749483|NCT00929201|82967109|FG000|Period 1|Withdrawal by Subject|0|||
46749484|NCT00929201|82967110|FG001|Period 1|Withdrawal by Subject|1|||
46749485|NCT00926003|82967120|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
46749486|NCT00926003|82967121|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
46749487|NCT00926003|82967122|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
46749488|NCT00926003|82967120|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
46749489|NCT00926003|82967121|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
46749490|NCT00926003|82967122|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
46749491|NCT00928889|82967132|FG000|Overall Study|Lost to Follow-up|3|||
46749492|NCT00928889|82967133|FG001|Overall Study|Lost to Follow-up|1|||
46749493|NCT00928889|82967132|FG000|Overall Study|Protocol Violation|0|||
46749494|NCT00928889|82967133|FG001|Overall Study|Protocol Violation|1|||
46749495|NCT00928889|82967132|FG000|Overall Study|Adverse Event|1|||
46749496|NCT00928889|82967133|FG001|Overall Study|Adverse Event|0|||
46749497|NCT00928889|82967132|FG000|Overall Study|Other|1|||
46749498|NCT00928889|82967133|FG001|Overall Study|Other|0|||
46749499|NCT03978091|82967145|FG000|Overall Study|Lost to Follow-up|0|||
46749500|NCT03978091|82967146|FG001|Overall Study|Lost to Follow-up|0|||
46749501|NCT03978091|82967147|FG002|Overall Study|Lost to Follow-up|1|||
46749502|NCT03978091|82967148|FG003|Overall Study|Lost to Follow-up|0|||
46749503|NCT03978091|82967149|FG004|Overall Study|Lost to Follow-up|0|||
46749504|NCT03978091|82967150|FG005|Overall Study|Lost to Follow-up|0|||
46749505|NCT03978091|82967145|FG000|Overall Study|Withdrawal by Subject|0|||
46749506|NCT03978091|82967146|FG001|Overall Study|Withdrawal by Subject|0|||
46749507|NCT03978091|82967147|FG002|Overall Study|Withdrawal by Subject|0|||
46924205|NCT03706079|83158054|FG003|Long Term Extension (DESTINATION)|Death|1|||
46924206|NCT03706079|83158055|FG004|Long Term Extension (DESTINATION)|Death|0|||
46924207|NCT03706079|83158056|FG005|Long Term Extension (DESTINATION)|Death|0|||
46924208|NCT03657160|83158070|FG000|Overall Study|Adverse Event|5|||
46924209|NCT03657160|83158071|FG001|Overall Study|Adverse Event|6|||
46924210|NCT03657160|83158070|FG000|Overall Study|Protocol Deviation|3|||
47052243|NCT00985725|83318481|FG001|Overall Study|Non-compliance|2|||
47052244|NCT00985725|83318480|FG000|Overall Study|Out-of-window visits|0|||
46749508|NCT03978091|82967148|FG003|Overall Study|Withdrawal by Subject|1|||
46749509|NCT03978091|82967149|FG004|Overall Study|Withdrawal by Subject|1|||
46749510|NCT03978091|82967150|FG005|Overall Study|Withdrawal by Subject|0|||
47052245|NCT00985725|83318481|FG001|Overall Study|Out-of-window visits|1|||
46749511|NCT00564733|82967173|FG000|Overall Study|Withdrawal by Subject|4|||
46749512|NCT00564733|82967173|FG000|Overall Study|Ineligible|5|||
46749513|NCT00931385|82967177|FG000|Overall Study|Adverse Event|2|||
46749514|NCT00931385|82967178|FG001|Overall Study|Adverse Event|1|||
46924211|NCT03657160|83158071|FG001|Overall Study|Protocol Deviation|0|||
46749515|NCT00931385|82967179|FG002|Overall Study|Adverse Event|0|||
46749516|NCT00931385|82967180|FG003|Overall Study|Adverse Event|3|||
46749517|NCT00931385|82967177|FG000|Overall Study|Protocol Violation|0|||
46749518|NCT00931385|82967178|FG001|Overall Study|Protocol Violation|0|||
46749519|NCT00931385|82967179|FG002|Overall Study|Protocol Violation|1|||
46749520|NCT00931385|82967180|FG003|Overall Study|Protocol Violation|0|||
46749521|NCT00931385|82967177|FG000|Overall Study|Withdrawal by Subject|0|||
46749522|NCT00931385|82967178|FG001|Overall Study|Withdrawal by Subject|1|||
46749523|NCT00931385|82967179|FG002|Overall Study|Withdrawal by Subject|0|||
46749524|NCT00931385|82967180|FG003|Overall Study|Withdrawal by Subject|1|||
46749525|NCT00931385|82967177|FG000|Overall Study|Lost to Follow-up|0|||
46749526|NCT00931385|82967178|FG001|Overall Study|Lost to Follow-up|0|||
46749527|NCT00931385|82967179|FG002|Overall Study|Lost to Follow-up|0|||
46749528|NCT00931385|82967180|FG003|Overall Study|Lost to Follow-up|1|||
46749529|NCT00565747|82967196|FG000|Overall Study|No embryo transfer|67|||
46749530|NCT00565747|82967197|FG001|Overall Study|No embryo transfer|73|||
46749531|NCT00563797|82967205|FG000|Overall Study|Lost to Follow-up|7|||
46749532|NCT00563797|82967206|FG001|Overall Study|Lost to Follow-up|2|||
46749533|NCT00771927|82967225|FG000|Overall Study|Adverse Event|100|||
46749534|NCT00771927|82967226|FG001|Overall Study|Adverse Event|105|||
46749535|NCT00771927|82967225|FG000|Overall Study|Lack of Efficacy|70|||
46749536|NCT00771927|82967226|FG001|Overall Study|Lack of Efficacy|42|||
46749537|NCT00771927|82967225|FG000|Overall Study|Lost to Follow-up|46|||
46749538|NCT00771927|82967226|FG001|Overall Study|Lost to Follow-up|46|||
46749539|NCT00771927|82967225|FG000|Overall Study|Withdrawal by Subject|16|||
46749540|NCT00771927|82967226|FG001|Overall Study|Withdrawal by Subject|17|||
46749541|NCT00771927|82967225|FG000|Overall Study|Other reason|23|||
46749542|NCT00771927|82967226|FG001|Overall Study|Other reason|27|||
46749543|NCT00771849|82967234|FG000|Overall Study|Lost to Follow-up|1|||
46749544|NCT00771849|82967235|FG001|Overall Study|Lost to Follow-up|2|||
46749545|NCT00771849|82967234|FG000|Overall Study|Withdrawal by Subject|1|||
46749546|NCT00771849|82967235|FG001|Overall Study|Withdrawal by Subject|1|||
46749547|NCT00771849|82967234|FG000|Overall Study|Not vaccinated|0|||
46749548|NCT00771849|82967235|FG001|Overall Study|Not vaccinated|1|||
46749549|NCT00564889|82967241|FG000|Overall Study|Death|7|||
47052246|NCT00985491|83318496|FG000|Overall Study|Adverse Event|8|||
47052247|NCT00985491|83318496|FG000|Overall Study|device migration|7|||
46749550|NCT00564889|82967241|FG000|Overall Study|Adverse Event|12|||
47052248|NCT00985491|83318496|FG000|Overall Study|Withdrawal by Subject|1|||
46749551|NCT00564889|82967241|FG000|Overall Study|Alternative treatment|3|||
46749552|NCT00564889|82967241|FG000|Overall Study|Disease progression|3|||
46749553|NCT00564889|82967241|FG000|Overall Study|Other, not specified|4|||
46749554|NCT00560833|82967259|FG000|Overall Study|Adverse Event|16|||
46749555|NCT00560833|82967260|FG001|Overall Study|Adverse Event|10|||
46749556|NCT00560833|82967261|FG002|Overall Study|Adverse Event|25|||
47052249|NCT00985491|83318496|FG000|Overall Study|implant failure|3|||
47052250|NCT00984867|83318531|FG000|Overall Study|Adverse Event|3|||
47052251|NCT00984867|83318532|FG001|Overall Study|Adverse Event|7|||
47052252|NCT00984867|83318531|FG000|Overall Study|Death|1|||
47052253|NCT00984867|83318532|FG001|Overall Study|Death|0|||
47052254|NCT00984867|83318531|FG000|Overall Study|Withdrawal by Subject|13|||
47052255|NCT00984867|83318532|FG001|Overall Study|Withdrawal by Subject|4|||
47052256|NCT00984867|83318531|FG000|Overall Study|Lost to Follow-up|3|||
47052257|NCT00984867|83318532|FG001|Overall Study|Lost to Follow-up|4|||
47052258|NCT00984867|83318531|FG000|Overall Study|Poor/non-compliance|0|||
47052259|NCT00984867|83318532|FG001|Overall Study|Poor/non-compliance|1|||
47052260|NCT00984867|83318531|FG000|Overall Study|Subject no longer meets study criteria|1|||
47052261|NCT00984867|83318532|FG001|Overall Study|Subject no longer meets study criteria|1|||
47052262|NCT00984867|83318531|FG000|Overall Study|site closing|1|||
47052263|NCT00984867|83318532|FG001|Overall Study|site closing|0|||
46749557|NCT00560833|82967262|FG003|Overall Study|Adverse Event|23|||
46749558|NCT00560833|82967263|FG004|Overall Study|Adverse Event|35|||
46749559|NCT00560833|82967259|FG000|Overall Study|Lost to Follow-up|0|||
46749560|NCT00560833|82967260|FG001|Overall Study|Lost to Follow-up|0|||
46749561|NCT00560833|82967261|FG002|Overall Study|Lost to Follow-up|1|||
46749562|NCT00560833|82967262|FG003|Overall Study|Lost to Follow-up|0|||
47052264|NCT00984867|83318531|FG000|Overall Study|lack of efficacy and subject compliance|1|||
46749563|NCT00560833|82967263|FG004|Overall Study|Lost to Follow-up|0|||
47052265|NCT00984867|83318532|FG001|Overall Study|lack of efficacy and subject compliance|0|||
47052266|NCT00984009|83318572|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
47052267|NCT00983931|83318579|FG000|14 Day Washout Period|Physician Decision|1|||
47052268|NCT00983853|83318591|FG000|Overall Study|Lost to Follow-up|1|||
46749564|NCT00560833|82967259|FG000|Overall Study|Lack of Efficacy|22|||
46749565|NCT00560833|82967260|FG001|Overall Study|Lack of Efficacy|9|||
46749566|NCT00560833|82967261|FG002|Overall Study|Lack of Efficacy|6|||
46749567|NCT00560833|82967262|FG003|Overall Study|Lack of Efficacy|4|||
46749568|NCT00560833|82967263|FG004|Overall Study|Lack of Efficacy|4|||
46749569|NCT00560833|82967259|FG000|Overall Study|Participant uncooperative|5|||
46749570|NCT00560833|82967260|FG001|Overall Study|Participant uncooperative|5|||
47052269|NCT00983853|83318592|FG001|Overall Study|Lost to Follow-up|1|||
47052270|NCT00983853|83318593|FG002|Overall Study|Lost to Follow-up|2|||
47052271|NCT00983853|83318594|FG003|Overall Study|Lost to Follow-up|2|||
47052272|NCT00983853|83318595|FG004|Overall Study|Lost to Follow-up|2|||
47052273|NCT00983853|83318596|FG005|Overall Study|Lost to Follow-up|1|||
47052274|NCT00983853|83318591|FG000|Overall Study|Withdrawal by Subject|0|||
47052275|NCT00983853|83318592|FG001|Overall Study|Withdrawal by Subject|0|||
47052276|NCT00983853|83318593|FG002|Overall Study|Withdrawal by Subject|1|||
47052277|NCT00983853|83318594|FG003|Overall Study|Withdrawal by Subject|0|||
47052278|NCT00983853|83318595|FG004|Overall Study|Withdrawal by Subject|1|||
47052279|NCT00983853|83318596|FG005|Overall Study|Withdrawal by Subject|0|||
46749571|NCT00560833|82967261|FG002|Overall Study|Participant uncooperative|4|||
47052280|NCT00983853|83318591|FG000|Overall Study|Unable to come to study follow-up visits|0|||
47052281|NCT00983853|83318592|FG001|Overall Study|Unable to come to study follow-up visits|1|||
46749572|NCT00560833|82967262|FG003|Overall Study|Participant uncooperative|4|||
46749573|NCT00560833|82967263|FG004|Overall Study|Participant uncooperative|2|||
46749574|NCT00560833|82967259|FG000|Overall Study|Other|1|||
46749575|NCT00560833|82967260|FG001|Overall Study|Other|1|||
46924212|NCT03657160|83158070|FG000|Overall Study|Withdrawal by Subject|18|||
46924213|NCT03657160|83158071|FG001|Overall Study|Withdrawal by Subject|16|||
46924214|NCT03657160|83158070|FG000|Overall Study|Site Termination|1|||
46924215|NCT03657160|83158071|FG001|Overall Study|Site Termination|0|||
46924216|NCT03657160|83158070|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
46924217|NCT03657160|83158071|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
46924218|NCT03657160|83158070|FG000|Overall Study|Death|33|||
46924219|NCT03657160|83158071|FG001|Overall Study|Death|26|||
46924220|NCT03657160|83158070|FG000|Overall Study|Death (COVID-19-Related)|1|||
46924221|NCT03657160|83158071|FG001|Overall Study|Death (COVID-19-Related)|0|||
46924222|NCT03657160|83158070|FG000|Overall Study|Reason Not Specified|5|||
46924223|NCT03657160|83158071|FG001|Overall Study|Reason Not Specified|5|||
46924224|NCT03657160|83158070|FG000|Overall Study|Other (COVID-19-Related)|0|||
46924225|NCT03657160|83158071|FG001|Overall Study|Other (COVID-19-Related)|1|||
46924226|NCT03635320|83158081|FG000|Overall Study|not implanted the device|1|||
46924227|NCT03635320|83158082|FG001|Overall Study|not implanted the device|2|||
46924228|NCT03635320|83158081|FG000|Overall Study|Withdrawal by Subject|11|||
46924229|NCT03635320|83158082|FG001|Overall Study|Withdrawal by Subject|6|||
46749576|NCT00560833|82967261|FG002|Overall Study|Other|3|||
46749577|NCT00560833|82967262|FG003|Overall Study|Other|0|||
46749578|NCT00560833|82967263|FG004|Overall Study|Other|0|||
46749579|NCT00560833|82967259|FG000|Overall Study|Never received drug|0|||
46749580|NCT00560833|82967260|FG001|Overall Study|Never received drug|1|||
46749581|NCT00560833|82967261|FG002|Overall Study|Never received drug|0|||
46749582|NCT00560833|82967262|FG003|Overall Study|Never received drug|0|||
46749583|NCT00560833|82967263|FG004|Overall Study|Never received drug|1|||
46749584|NCT00771615|82967284|FG000|Overall Study|Withdrawal by Subject|0|||
46749585|NCT00771615|82967285|FG001|Overall Study|Withdrawal by Subject|1|||
46749586|NCT00771615|82967286|FG002|Overall Study|Withdrawal by Subject|0|||
46749587|NCT00771615|82967287|FG003|Overall Study|Withdrawal by Subject|0|||
46749588|NCT00771615|82967288|FG004|Overall Study|Withdrawal by Subject|0|||
46749589|NCT00771615|82967289|FG005|Overall Study|Withdrawal by Subject|0|||
46749590|NCT00771615|82967290|FG006|Overall Study|Withdrawal by Subject|0|||
46749591|NCT00771615|82967291|FG007|Overall Study|Withdrawal by Subject|1|||
46749592|NCT00771615|82967292|FG008|Overall Study|Withdrawal by Subject|0|||
46749593|NCT00771615|82967284|FG000|Overall Study|Lost to Follow-up|1|||
46749594|NCT00771615|82967285|FG001|Overall Study|Lost to Follow-up|1|||
47052282|NCT00983853|83318593|FG002|Overall Study|Unable to come to study follow-up visits|0|||
47052283|NCT00983853|83318594|FG003|Overall Study|Unable to come to study follow-up visits|0|||
47052284|NCT00983853|83318595|FG004|Overall Study|Unable to come to study follow-up visits|0|||
46749595|NCT00771615|82967286|FG002|Overall Study|Lost to Follow-up|1|||
46749596|NCT00771615|82967287|FG003|Overall Study|Lost to Follow-up|1|||
46749597|NCT00771615|82967288|FG004|Overall Study|Lost to Follow-up|0|||
46749598|NCT00771615|82967289|FG005|Overall Study|Lost to Follow-up|1|||
46749599|NCT00771615|82967290|FG006|Overall Study|Lost to Follow-up|1|||
46924230|NCT03508726|83158099|FG000|Overall Study|Withdrawal by Subject|0|||
46924231|NCT03508726|83158100|FG001|Overall Study|Withdrawal by Subject|1|||
46924232|NCT03499964|83158109|FG000|Overall Study|Lack of Efficacy|6|||
46924233|NCT03499964|83158110|FG001|Overall Study|Lack of Efficacy|26|||
47052285|NCT00983853|83318596|FG005|Overall Study|Unable to come to study follow-up visits|0|||
46749600|NCT00771615|82967291|FG007|Overall Study|Lost to Follow-up|0|||
46749601|NCT00771615|82967292|FG008|Overall Study|Lost to Follow-up|0|||
47052286|NCT00983073|83318612|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
46749602|NCT02723604|82967321|FG000|Overall Study|ineligible|1|||
46749603|NCT02723604|82967321|FG000|Overall Study|never received treatment|1|||
46749604|NCT00560755|82967325|FG000|Overall Study|Protocol Violation|15|||
46749605|NCT00560755|82967325|FG000|Overall Study|Withdrawal by Subject|26|||
46749606|NCT00560755|82967325|FG000|Overall Study|Lost to Follow-up|9|||
46924234|NCT03499964|83158109|FG000|Overall Study|Adverse Event|1|||
46924235|NCT03499964|83158110|FG001|Overall Study|Adverse Event|0|||
46924236|NCT03499964|83158109|FG000|Overall Study|Death|1|||
46924237|NCT03499964|83158110|FG001|Overall Study|Death|0|||
46924238|NCT03499964|83158109|FG000|Overall Study|Withdrawal by Subject|2|||
46924239|NCT03499964|83158110|FG001|Overall Study|Withdrawal by Subject|1|||
46924240|NCT03499964|83158109|FG000|Overall Study|Lost to Follow-up|1|||
46924241|NCT03499964|83158110|FG001|Overall Study|Lost to Follow-up|0|||
46924242|NCT03279692|83158116|FG000|Overall Study|Withdrawal by Subject|1|||
46924243|NCT03001882|83158133|FG000|Overall Study|Death|1|||
46924244|NCT03001882|83158134|FG001|Overall Study|Death|0|||
46924245|NCT03001882|83158135|FG002|Overall Study|Death|0|||
46749607|NCT00560755|82967325|FG000|Overall Study|Adverse Event|8|||
46749608|NCT00560755|82967325|FG000|Overall Study|Physician Decision|2|||
46749609|NCT00770991|82967332|FG000|Overall Study|Physician Decision|2|||
46749610|NCT00770991|82967333|FG001|Overall Study|Physician Decision|0|||
46749611|NCT00770991|82967332|FG000|Overall Study|Withdrawal by Subject|1|||
46749612|NCT00770991|82967333|FG001|Overall Study|Withdrawal by Subject|0|||
46749613|NCT00770991|82967332|FG000|Overall Study|Adverse Event|1|||
46749614|NCT00770991|82967333|FG001|Overall Study|Adverse Event|5|||
46749615|NCT00770991|82967332|FG000|Overall Study|Pregnancy|1|||
46749616|NCT00770991|82967333|FG001|Overall Study|Pregnancy|0|||
46749617|NCT00925769|82967344|FG000|Overall Study|Major toxicity|1|||
46749618|NCT00925769|82967345|FG001|Overall Study|Major toxicity|0|||
46749619|NCT00925769|82967346|FG002|Overall Study|Major toxicity|1|||
46749620|NCT00925769|82967347|FG003|Overall Study|Major toxicity|1|||
46749621|NCT00925769|82967348|FG004|Overall Study|Major toxicity|0|||
46749622|NCT00925769|82967349|FG005|Overall Study|Major toxicity|0|||
46749623|NCT00925769|82967344|FG000|Overall Study|Disease progression|4|||
46749624|NCT00925769|82967345|FG001|Overall Study|Disease progression|5|||
46749625|NCT00925769|82967346|FG002|Overall Study|Disease progression|3|||
46749626|NCT00925769|82967347|FG003|Overall Study|Disease progression|4|||
46749627|NCT00925769|82967348|FG004|Overall Study|Disease progression|2|||
46749628|NCT00925769|82967349|FG005|Overall Study|Disease progression|3|||
46749629|NCT00925769|82967344|FG000|Overall Study|Death|0|||
46749630|NCT00925769|82967345|FG001|Overall Study|Death|0|||
46749631|NCT00925769|82967346|FG002|Overall Study|Death|1|||
46749632|NCT00925769|82967347|FG003|Overall Study|Death|0|||
46749633|NCT00925769|82967348|FG004|Overall Study|Death|0|||
46749634|NCT00925769|82967349|FG005|Overall Study|Death|0|||
46749635|NCT00925769|82967344|FG000|Overall Study|Physician Decision|1|||
46749636|NCT00925769|82967345|FG001|Overall Study|Physician Decision|0|||
46749637|NCT00925769|82967346|FG002|Overall Study|Physician Decision|0|||
46749638|NCT00925769|82967347|FG003|Overall Study|Physician Decision|0|||
46749639|NCT00925769|82967348|FG004|Overall Study|Physician Decision|0|||
46749640|NCT00925769|82967349|FG005|Overall Study|Physician Decision|0|||
46749641|NCT00925769|82967344|FG000|Overall Study|Missing documentation|0|||
46749642|NCT00925769|82967345|FG001|Overall Study|Missing documentation|1|||
46749643|NCT00925769|82967346|FG002|Overall Study|Missing documentation|0|||
46749644|NCT00925769|82967347|FG003|Overall Study|Missing documentation|0|||
46749645|NCT00925769|82967348|FG004|Overall Study|Missing documentation|0|||
46749646|NCT00925769|82967349|FG005|Overall Study|Missing documentation|0|||
46749647|NCT00925769|82967344|FG000|Overall Study|End of study visit not done|0|||
46749648|NCT00925769|82967345|FG001|Overall Study|End of study visit not done|0|||
46749649|NCT00925769|82967346|FG002|Overall Study|End of study visit not done|1|||
46749650|NCT00925769|82967347|FG003|Overall Study|End of study visit not done|0|||
46749651|NCT00925769|82967348|FG004|Overall Study|End of study visit not done|0|||
46924246|NCT03001882|83158136|FG003|Overall Study|Death|3|||
46924247|NCT03001882|83158133|FG000|Overall Study|Participant withdrew consent|0|||
46749652|NCT00925769|82967349|FG005|Overall Study|End of study visit not done|0|||
46804748|NCT00393718|83023793|FG000|Overall Study|Withdrawal of consent|2|||
46804749|NCT00393718|83023794|FG001|Overall Study|Withdrawal of consent|1|||
46804750|NCT00393718|83023793|FG000|Overall Study|Missed measurement|1|||
46804751|NCT00393718|83023794|FG001|Overall Study|Missed measurement|0|||
46804752|NCT00393718|83023793|FG000|Overall Study|Move|1|||
46804753|NCT00393718|83023794|FG001|Overall Study|Move|0|||
46804754|NCT00669071|83023800|FG000|Overall Study|Lost to Follow-up|3|||
46749653|NCT00925769|82967344|FG000|Overall Study|Participant is unable to swallow drug|0|||
46749654|NCT00925769|82967345|FG001|Overall Study|Participant is unable to swallow drug|0|||
46749655|NCT00925769|82967346|FG002|Overall Study|Participant is unable to swallow drug|0|||
46749656|NCT00925769|82967347|FG003|Overall Study|Participant is unable to swallow drug|1|||
46924248|NCT03001882|83158134|FG001|Overall Study|Participant withdrew consent|1|||
46924249|NCT03001882|83158135|FG002|Overall Study|Participant withdrew consent|0|||
46749657|NCT00925769|82967348|FG004|Overall Study|Participant is unable to swallow drug|0|||
46804755|NCT00669071|83023800|FG000|Overall Study|Final visit 40 days out of window|1|||
46924250|NCT03001882|83158136|FG003|Overall Study|Participant withdrew consent|5|||
46749658|NCT00925769|82967349|FG005|Overall Study|Participant is unable to swallow drug|0|||
46749659|NCT00925769|82967344|FG000|Overall Study|Adverse Event|0|||
46749660|NCT00925769|82967345|FG001|Overall Study|Adverse Event|0|||
46749661|NCT00925769|82967346|FG002|Overall Study|Adverse Event|0|||
46749662|NCT00925769|82967347|FG003|Overall Study|Adverse Event|0|||
46749663|NCT00925769|82967348|FG004|Overall Study|Adverse Event|1|||
46749664|NCT00925769|82967349|FG005|Overall Study|Adverse Event|0|||
46749665|NCT00770913|82967368|FG000|Overall Study|Adverse Event|1|||
46749666|NCT00770913|82967369|FG001|Overall Study|Adverse Event|3|||
46749667|NCT00770913|82967370|FG002|Overall Study|Adverse Event|6|||
46749668|NCT00770913|82967368|FG000|Overall Study|Refusal to continue participation|6|||
46749669|NCT00770913|82967369|FG001|Overall Study|Refusal to continue participation|4|||
46749670|NCT00770913|82967370|FG002|Overall Study|Refusal to continue participation|5|||
46749671|NCT00770913|82967368|FG000|Overall Study|Physician Decision|0|||
46749672|NCT00770913|82967369|FG001|Overall Study|Physician Decision|1|||
46749673|NCT00770913|82967370|FG002|Overall Study|Physician Decision|1|||
46749674|NCT00770913|82967368|FG000|Overall Study|Protocol Violation|3|||
46749675|NCT00770913|82967369|FG001|Overall Study|Protocol Violation|0|||
46749676|NCT00770913|82967370|FG002|Overall Study|Protocol Violation|1|||
46749677|NCT00770913|82967368|FG000|Overall Study|Incorrect drug was allocated|1|||
46749678|NCT00770913|82967369|FG001|Overall Study|Incorrect drug was allocated|0|||
46749679|NCT00770913|82967370|FG002|Overall Study|Incorrect drug was allocated|0|||
46749680|NCT00562861|82967380|FG000|Overall Study|Adverse Event|1|||
46749681|NCT00562861|82967381|FG001|Overall Study|Adverse Event|1|||
46749682|NCT00562861|82967380|FG000|Overall Study|Lack of Efficacy|5|||
46749683|NCT00562861|82967381|FG001|Overall Study|Lack of Efficacy|5|||
46749684|NCT00562861|82967380|FG000|Overall Study|noncompliance, moved|7|||
46749685|NCT00562861|82967381|FG001|Overall Study|noncompliance, moved|2|||
46749686|NCT00562861|82967380|FG000|Overall Study|Lost to Follow-up|7|||
46749687|NCT00562861|82967381|FG001|Overall Study|Lost to Follow-up|3|||
46749688|NCT00770679|82967387|FG000|Overall Study|Lost to Follow-up|3|||
46749689|NCT00770679|82967387|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
46749690|NCT00770601|82967391|FG000|Overall Study|Withdrawal by Subject|1|||
46749691|NCT00770367|82967397|FG000|First Intervention|Withdrawal by Subject|0|||
46749692|NCT00770367|82967398|FG001|First Intervention|Withdrawal by Subject|2|||
46749693|NCT00770367|82967397|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
46749694|NCT00770367|82967398|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
46749695|NCT00770367|82967397|FG000|Second Intervention|Lost to Follow-up|2|||
46749696|NCT00770367|82967398|FG001|Second Intervention|Lost to Follow-up|0|||
46749697|NCT00931307|82967406|FG000|Overall Study|Lack of Efficacy|12|||
46749698|NCT00931307|82967406|FG000|Overall Study|Biomicroscopy|1|||
46749699|NCT00930761|82967412|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
46749700|NCT00930761|82967413|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
46749701|NCT00930761|82967412|FG000|Overall Study|less than 3 music therapy sessions|0|||
47052287|NCT00983073|83318612|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
47052288|NCT00983073|83318612|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
47052289|NCT00983073|83318612|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
47052290|NCT00983073|83318612|FG000|Titration and Optimal Dose Period|Other reason|4|||
47052291|NCT00983073|83318612|FG000|Maintenance Period|Adverse Event|5|||
47052292|NCT00983073|83318612|FG000|Maintenance Period|Withdrawal by Subject|2|||
47052293|NCT00983073|83318612|FG000|Maintenance Period|Lack of Efficacy|2|||
46635719|NCT01552902|82809478|FG001|Overall Study|Adverse Event|15|||
46635720|NCT01552902|82809479|FG002|Overall Study|Adverse Event|14|||
46749702|NCT00930761|82967413|FG001|Overall Study|less than 3 music therapy sessions|3|||
46749703|NCT00770289|82967419|FG000|Overall Study|Other|6|||
46749704|NCT00770211|82967430|FG000|Overall Study|Lost to Follow-up|1|||
46749705|NCT00770211|82967431|FG001|Overall Study|Lost to Follow-up|0|||
46749706|NCT00770211|82967430|FG000|Overall Study|Withdrawal by Subject|0|||
46749707|NCT00770211|82967431|FG001|Overall Study|Withdrawal by Subject|2|||
46749708|NCT00928187|82967440|FG000|Overall Study|Death|1|||
46749709|NCT00928187|82967441|FG001|Overall Study|Death|2|||
46749710|NCT00928187|82967442|FG002|Overall Study|Death|3|||
46749711|NCT00928187|82967440|FG000|Overall Study|Lost to Follow-up|1|||
46749712|NCT00928187|82967441|FG001|Overall Study|Lost to Follow-up|2|||
46749713|NCT00928187|82967442|FG002|Overall Study|Lost to Follow-up|1|||
46749714|NCT00928187|82967440|FG000|Overall Study|Withdrawal by Subject|0|||
46749715|NCT00928187|82967441|FG001|Overall Study|Withdrawal by Subject|1|||
46749716|NCT00928187|82967442|FG002|Overall Study|Withdrawal by Subject|1|||
46749717|NCT00928187|82967440|FG000|Overall Study|Protocol Violation|0|||
46749718|NCT00928187|82967441|FG001|Overall Study|Protocol Violation|1|||
46749719|NCT00928187|82967442|FG002|Overall Study|Protocol Violation|0|||
46749720|NCT00769119|82967452|FG000|Overall Study|Voluntary discontinuation|0|||
46749721|NCT00769119|82967453|FG001|Overall Study|Voluntary discontinuation|2|||
46749722|NCT00769119|82967452|FG000|Overall Study|Adverse Event|1|||
47052294|NCT00983073|83318612|FG000|Maintenance Period|Other Reason|7|||
46635721|NCT01552902|82809477|FG000|Overall Study|Protocol Violation|3|||
46749723|NCT00769119|82967453|FG001|Overall Study|Adverse Event|1|||
46749724|NCT00769119|82967452|FG000|Overall Study|Disallowed medication|1|||
46749725|NCT00769119|82967453|FG001|Overall Study|Disallowed medication|0|||
46749726|NCT00927953|82967461|FG000|Overall Study|Death|2|||
46749727|NCT00927953|82967462|FG001|Overall Study|Death|1|||
46749728|NCT00768651|82967469|FG000|Overall Study|Withdrawal by Subject|1|||
46749729|NCT00756717|82967474|FG000|Overall Study|Withdrawal by Subject|2|||
46749730|NCT04987762|82967484|FG000|Overall Study|Study was Terminated by Sponsor|103|||
46749731|NCT04817332|82967511|FG000|Overall Study|Lost to Follow-up|3|||
46749732|NCT04817332|82967512|FG001|Overall Study|Lost to Follow-up|3|||
46749733|NCT04817332|82967511|FG000|Overall Study|Protocol Violation|2|||
46749734|NCT04817332|82967512|FG001|Overall Study|Protocol Violation|0|||
46749735|NCT04797637|82967520|FG000|Overall Study|Lost to Follow-up|23|||
46749736|NCT04797637|82967521|FG001|Overall Study|Lost to Follow-up|32|||
46749737|NCT04797637|82967520|FG000|Overall Study|Withdrawal by Subject|0|||
46749738|NCT04797637|82967521|FG001|Overall Study|Withdrawal by Subject|1|||
46749739|NCT04300296|82967554|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
46749740|NCT04300296|82967555|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
46749741|NCT04300296|82967556|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
46924251|NCT03001882|83158133|FG000|Overall Study|Other reasons|1|||
46924252|NCT03001882|83158134|FG001|Overall Study|Other reasons|2|||
46924253|NCT03001882|83158135|FG002|Overall Study|Other reasons|0|||
46924254|NCT03001882|83158136|FG003|Overall Study|Other reasons|5|||
46749742|NCT04300296|82967557|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
46749743|NCT04300296|82967558|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
46749744|NCT04300296|82967559|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
46749745|NCT04300296|82967554|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
46749746|NCT04300296|82967555|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
46749747|NCT04300296|82967556|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
46749748|NCT04300296|82967557|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
46749749|NCT04300296|82967558|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
46749750|NCT04300296|82967559|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
46749751|NCT04300296|82967554|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
46749752|NCT04300296|82967555|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
46749753|NCT04300296|82967556|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
46749754|NCT04300296|82967557|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
46749755|NCT04300296|82967558|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
46749756|NCT04300296|82967559|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
46749757|NCT04300296|82967554|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
46749758|NCT04300296|82967555|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
46749759|NCT04300296|82967556|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
46749760|NCT04300296|82967557|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
46749761|NCT04300296|82967558|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
46749762|NCT04300296|82967559|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
46749763|NCT04300296|82967554|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
46749764|NCT04300296|82967555|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
46749765|NCT04300296|82967556|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
46749766|NCT04300296|82967557|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
46749767|NCT04300296|82967558|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
46749768|NCT04300296|82967559|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
46749769|NCT04300296|82967554|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
46749770|NCT04300296|82967555|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
46749771|NCT04300296|82967556|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
46749772|NCT04300296|82967557|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
46924255|NCT03001882|83158133|FG000|Overall Study|Administrative reason by sponsor|0|||
46924256|NCT03001882|83158134|FG001|Overall Study|Administrative reason by sponsor|0|||
46924257|NCT03001882|83158135|FG002|Overall Study|Administrative reason by sponsor|0|||
46924258|NCT03001882|83158136|FG003|Overall Study|Administrative reason by sponsor|1|||
46924259|NCT03001882|83158133|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
46924260|NCT03001882|83158134|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
46924261|NCT03001882|83158135|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
47052295|NCT00982137|83318621|FG000|Overall Study|Lost to Follow-up|0|||
46924262|NCT03001882|83158136|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
46924263|NCT03001882|83158133|FG000|Overall Study|Not reported|0|||
47052296|NCT00982137|83318622|FG001|Overall Study|Lost to Follow-up|0|||
47052297|NCT00982137|83318623|FG002|Overall Study|Lost to Follow-up|0|||
47052298|NCT00982137|83318624|FG003|Overall Study|Lost to Follow-up|1|||
46749773|NCT04300296|82967558|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
46749774|NCT04300296|82967559|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
46749775|NCT04300296|82967554|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
46749776|NCT04300296|82967555|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
46749777|NCT04300296|82967556|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
46749778|NCT04300296|82967557|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
46749779|NCT04300296|82967558|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
46749780|NCT04300296|82967559|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
46749781|NCT03989440|82967603|FG000|Overall Study|COVID-19 travel restrictions|0|||
46749782|NCT03989440|82967604|FG001|Overall Study|COVID-19 travel restrictions|0|||
46749783|NCT03989440|82967605|FG002|Overall Study|COVID-19 travel restrictions|1|||
46924264|NCT03001882|83158134|FG001|Overall Study|Not reported|0|||
46924265|NCT03001882|83158135|FG002|Overall Study|Not reported|0|||
46924266|NCT03001882|83158136|FG003|Overall Study|Not reported|6|||
46924267|NCT03001882|83158133|FG000|Overall Study|Maximum clinical benefit|1|||
46924268|NCT03001882|83158134|FG001|Overall Study|Maximum clinical benefit|2|||
46924269|NCT03001882|83158135|FG002|Overall Study|Maximum clinical benefit|0|||
46749784|NCT03989440|82967606|FG003|Overall Study|COVID-19 travel restrictions|0|||
46749785|NCT03989440|82967607|FG004|Overall Study|COVID-19 travel restrictions|0|||
46749786|NCT03989440|82967608|FG005|Overall Study|COVID-19 travel restrictions|0|||
46749787|NCT03989440|82967603|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
46749788|NCT03989440|82967604|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
46749789|NCT03989440|82967605|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
46749790|NCT03989440|82967606|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
46749791|NCT03989440|82967607|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
46749792|NCT03989440|82967608|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
46749793|NCT03908437|82967626|FG000|Overall Study|Death|0|||
46924270|NCT03001882|83158136|FG003|Overall Study|Maximum clinical benefit|10|||
46924271|NCT03001882|83158133|FG000|Overall Study|AE unrelated to study drug|3|||
46924272|NCT03001882|83158134|FG001|Overall Study|AE unrelated to study drug|3|||
46924273|NCT03001882|83158135|FG002|Overall Study|AE unrelated to study drug|0|||
46924274|NCT03001882|83158136|FG003|Overall Study|AE unrelated to study drug|11|||
46749794|NCT03908437|82967627|FG001|Overall Study|Death|1|||
46749795|NCT03908437|82967626|FG000|Overall Study|Lost to Follow-up|31|||
46749796|NCT03908437|82967627|FG001|Overall Study|Lost to Follow-up|24|||
46749797|NCT03274895|82967652|FG000|Overall Study|Lack of Efficacy|1|||
46749798|NCT03274895|82967653|FG001|Overall Study|Lack of Efficacy|0|||
46749799|NCT03274895|82967652|FG000|Overall Study|Adverse Event|8|||
46749800|NCT03274895|82967653|FG001|Overall Study|Adverse Event|7|||
46749801|NCT03274895|82967652|FG000|Overall Study|Lost to Follow-up|1|||
46749802|NCT03274895|82967653|FG001|Overall Study|Lost to Follow-up|0|||
46749803|NCT03274895|82967652|FG000|Overall Study|Diagnosis not confirmed|3|||
46749804|NCT03274895|82967653|FG001|Overall Study|Diagnosis not confirmed|4|||
46749805|NCT03035201|82967666|FG000|Overall Study|Death|9|||
46749806|NCT03035201|82967667|FG001|Overall Study|Death|12|||
46749807|NCT03035201|82967668|FG002|Overall Study|Death|9|||
46749808|NCT03035201|82967669|FG003|Overall Study|Death|10|||
46749809|NCT03035201|82967666|FG000|Overall Study|Withdrawal by Subject|51|||
46749810|NCT03035201|82967667|FG001|Overall Study|Withdrawal by Subject|49|||
46749811|NCT03035201|82967668|FG002|Overall Study|Withdrawal by Subject|37|||
46749812|NCT03035201|82967669|FG003|Overall Study|Withdrawal by Subject|46|||
46749813|NCT03035201|82967666|FG000|Overall Study|Lost to Follow-up|67|||
46749814|NCT03035201|82967667|FG001|Overall Study|Lost to Follow-up|51|||
46749815|NCT03035201|82967668|FG002|Overall Study|Lost to Follow-up|64|||
46749816|NCT03035201|82967669|FG003|Overall Study|Lost to Follow-up|69|||
46749817|NCT02969915|82967691|FG000|Overall Study|Death|104|||
46749818|NCT02969915|82967692|FG001|Overall Study|Death|125|||
46924275|NCT03001882|83158133|FG000|Overall Study|Study Drug Toxicity|8|||
46924276|NCT03001882|83158134|FG001|Overall Study|Study Drug Toxicity|5|||
46924277|NCT03001882|83158135|FG002|Overall Study|Study Drug Toxicity|0|||
46924278|NCT03001882|83158136|FG003|Overall Study|Study Drug Toxicity|37|||
47052299|NCT00982137|83318621|FG000|Overall Study|Withdrawal by Subject|0|||
47052300|NCT00982137|83318622|FG001|Overall Study|Withdrawal by Subject|1|||
47052301|NCT00982137|83318623|FG002|Overall Study|Withdrawal by Subject|0|||
47052302|NCT00982137|83318624|FG003|Overall Study|Withdrawal by Subject|0|||
47052303|NCT00981747|83318641|FG000|Losartan|Withdrawal by Subject|1|||
47052304|NCT00981747|83318641|FG000|Losartan|Death|1|||
46924279|NCT03001882|83158133|FG000|Overall Study|Disease progression|15|||
46924280|NCT03001882|83158134|FG001|Overall Study|Disease progression|14|||
46924281|NCT03001882|83158135|FG002|Overall Study|Disease progression|2|||
46924282|NCT03001882|83158136|FG003|Overall Study|Disease progression|90|||
47052305|NCT00981747|83318641|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
47052306|NCT01856309|83318796|FG000|Overall Study|Death|4|||
46749819|NCT02969915|82967691|FG000|Overall Study|Lost to Follow-up|108|||
46749820|NCT02969915|82967692|FG001|Overall Study|Lost to Follow-up|112|||
46749821|NCT02969915|82967691|FG000|Overall Study|Censored due to COVID-19|481|||
46749822|NCT02969915|82967692|FG001|Overall Study|Censored due to COVID-19|471|||
46775758|NCT00793793|82994215|FG011|Overall Study|Lost to Follow-up|0|||
47052307|NCT01856309|83318797|FG001|Overall Study|Death|6|||
46924283|NCT02985151|83158153|FG000|Original Randomization|Withdrawal by Subject|0|||
46924284|NCT02985151|83158154|FG001|Original Randomization|Withdrawal by Subject|1|||
46924285|NCT02582866|83158207|FG000|Overall Study|Death|1|||
46924286|NCT02582866|83158207|FG000|Overall Study|Lack of Efficacy|2|||
46924287|NCT02582866|83158207|FG000|Overall Study|Lost to Follow-up|2|||
46924288|NCT02582866|83158207|FG000|Overall Study|Withdrawal by Subject|7|||
46924289|NCT02582866|83158207|FG000|Overall Study|Investigator decision|5|||
46924290|NCT02582866|83158207|FG000|Overall Study|Participant wants to get pregnant|1|||
47052308|NCT01856309|83318798|FG002|Overall Study|Death|11|||
47052309|NCT01856309|83318799|FG003|Overall Study|Death|6|||
47052310|NCT01856309|83318796|FG000|Overall Study|Lost to Follow-up|6|||
47052311|NCT01856309|83318797|FG001|Overall Study|Lost to Follow-up|2|||
47052312|NCT01856309|83318798|FG002|Overall Study|Lost to Follow-up|4|||
47052313|NCT01856309|83318799|FG003|Overall Study|Lost to Follow-up|8|||
46749823|NCT02906332|82967698|FG000|Overall Study|Withdrawal by Subject|1|||
46749824|NCT02755597|82967714|FG000|Overall Study|Withdrew consent|27|||
46749825|NCT02755597|82967715|FG001|Overall Study|Withdrew consent|11|||
46749826|NCT02755597|82967714|FG000|Overall Study|Lost to Follow-up|1|||
46749827|NCT02755597|82967715|FG001|Overall Study|Lost to Follow-up|0|||
46749828|NCT02755597|82967714|FG000|Overall Study|Death|78|||
46749829|NCT02755597|82967715|FG001|Overall Study|Death|36|||
46749830|NCT02755597|82967714|FG000|Overall Study|Study terminated by Sponsor|67|||
46749831|NCT02755597|82967715|FG001|Overall Study|Study terminated by Sponsor|47|||
46749832|NCT02755597|82967714|FG000|Overall Study|Other, not specified|20|||
46749833|NCT02755597|82967715|FG001|Overall Study|Other, not specified|3|||
46749834|NCT02755597|82967714|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
46749835|NCT02755597|82967715|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
46749836|NCT02598557|82967724|FG000|Overall Study|Withdrawal by Subject|1|||
46749837|NCT02598557|82967725|FG001|Overall Study|Withdrawal by Subject|0|||
46749838|NCT02598557|82967726|FG002|Overall Study|Withdrawal by Subject|1|||
46749839|NCT02598557|82967724|FG000|Overall Study|Participant did not start treatment|2|||
46749840|NCT02598557|82967725|FG001|Overall Study|Participant did not start treatment|1|||
46749841|NCT02598557|82967726|FG002|Overall Study|Participant did not start treatment|1|||
46749842|NCT02598557|82967724|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
46749843|NCT02598557|82967725|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
46749844|NCT02598557|82967726|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
46749845|NCT02598557|82967724|FG000|Overall Study|Adverse Event|1|||
46749846|NCT02598557|82967725|FG001|Overall Study|Adverse Event|1|||
46749847|NCT02598557|82967726|FG002|Overall Study|Adverse Event|0|||
46749848|NCT02340780|82967734|FG000|Overall Study|Ineligible|1|||
46749849|NCT01470417|82967749|FG000|Overall Study|Disease progression|0|||
46749850|NCT01470417|82967750|FG001|Overall Study|Disease progression|2|||
46749851|NCT00820248|82967784|FG000|Overall Study|No treated|4|||
46749852|NCT00820248|82967785|FG001|Overall Study|No treated|1|||
46749853|NCT00668642|82967802|FG000|First Off-cycle|Cancer progression|1|||
46749854|NCT00668642|82967803|FG001|First Off-cycle|Cancer progression|0|||
46749855|NCT00668642|82967802|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
46749856|NCT00668642|82967803|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
46749857|NCT00101101|82967818|FG000|Overall Study|never received vaccine|20|||
46749858|NCT03962101|82967822|FG000|Overall Study|Adverse Event|1|||
46749859|NCT03962101|82967822|FG000|Overall Study|Physician Decision|2|||
46749860|NCT03962101|82967822|FG000|Overall Study|Not related to medical events|1|||
46749861|NCT00923351|82967829|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
46749862|NCT00923351|82967830|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
46749863|NCT00923351|82967831|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
46749864|NCT00755937|82967837|FG000|Recruitment|Unknown if infliximab received|164|||
46749865|NCT00755937|82967837|FG000|Observational Follow-up|Lost to Follow-up|148|||
46804756|NCT00398320|83023806|FG000|Overall Study|Death|1|||
46804757|NCT00398320|83023806|FG000|Overall Study|Adverse Event|4|||
46804758|NCT00398320|83023806|FG000|Overall Study|Physician Decision|1|||
46804759|NCT00670007|83023810|FG000|Overall Study|Drug abuse|1|||
46804760|NCT00670007|83023810|FG000|Overall Study|Lung transplant|1|||
46804761|NCT00670007|83023810|FG000|Overall Study|Travel/Vacation|1|||
46804762|NCT00670007|83023810|FG000|Overall Study|Adverse event, serious fatal|1|||
46749866|NCT00755079|82967843|FG000|Overall Study|Lost to Follow-up|1|||
46749867|NCT00755079|82967844|FG001|Overall Study|Lost to Follow-up|3|||
46749868|NCT00755079|82967843|FG000|Overall Study|Adverse Event|0|||
46749869|NCT00755079|82967844|FG001|Overall Study|Adverse Event|1|||
46749870|NCT00755079|82967843|FG000|Overall Study|Withdrawal by Subject|0|||
46749871|NCT00755079|82967844|FG001|Overall Study|Withdrawal by Subject|2|||
46924291|NCT02582866|83158207|FG000|Overall Study|Pregnancy|2|||
46749872|NCT00925301|82967852|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
46749873|NCT00925301|82967853|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
46924292|NCT02582866|83158207|FG000|Overall Study|Sponsor decision|1|||
47052314|NCT01856309|83318796|FG000|Overall Study|Withdrawal by Subject|11|||
46804763|NCT00670007|83023810|FG000|Overall Study|Adverse Event|1|||
46749874|NCT00925301|82967854|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
46749875|NCT00925301|82967855|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
46749876|NCT00925301|82967852|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
46749877|NCT00925301|82967853|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
46749878|NCT00925301|82967854|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
46749879|NCT00925301|82967855|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
46749880|NCT00925301|82967852|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
46924293|NCT02582866|83158207|FG000|Overall Study|Withdrawal due to personal reasons|1|||
46924294|NCT01734928|83158217|FG000|Randomization|Physician Decision|0|||
46749881|NCT00925301|82967853|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
46749882|NCT00925301|82967854|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
46749883|NCT00925301|82967855|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
46749884|NCT00925301|82967852|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
46749885|NCT00925301|82967853|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
46749886|NCT00925301|82967854|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
46749887|NCT00925301|82967855|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
46749888|NCT00925301|82967852|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
46749889|NCT00925301|82967853|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
46749890|NCT00925301|82967854|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
46749891|NCT00925301|82967855|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
46749892|NCT00925301|82967852|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
46749893|NCT00925301|82967853|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
46749894|NCT00925301|82967854|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
46749895|NCT00925301|82967855|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
46749896|NCT00925301|82967852|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
46749897|NCT00925301|82967853|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
46749898|NCT00925301|82967854|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
46749899|NCT00925301|82967855|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
46749900|NCT00754065|82967868|FG000|Overall Study|Never received treatment|12|||
46749901|NCT00754065|82967869|FG001|Overall Study|Never received treatment|2|||
46749902|NCT00754065|82967868|FG000|Overall Study|Adverse Event|19|||
46749903|NCT00754065|82967869|FG001|Overall Study|Adverse Event|25|||
46749904|NCT00754065|82967868|FG000|Overall Study|Lost to Follow-up|7|||
46749905|NCT00754065|82967869|FG001|Overall Study|Lost to Follow-up|11|||
46749906|NCT00754065|82967868|FG000|Overall Study|Protocol Violation|12|||
46749907|NCT00754065|82967869|FG001|Overall Study|Protocol Violation|10|||
46749908|NCT00754065|82967868|FG000|Overall Study|Withdrawal by Subject|4|||
46749909|NCT00754065|82967869|FG001|Overall Study|Withdrawal by Subject|5|||
46749910|NCT00754065|82967868|FG000|Overall Study|Pregnancy|6|||
46749911|NCT00754065|82967869|FG001|Overall Study|Pregnancy|0|||
46749912|NCT00754065|82967868|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
46749913|NCT00754065|82967869|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
46924295|NCT01734928|83158218|FG001|Randomization|Physician Decision|1|||
46924296|NCT01734928|83158217|FG000|Randomization|clinical progression|0|||
46749914|NCT04138056|82967889|FG000|Primary Study|Lost to Follow-up|3|||
46749915|NCT04138056|82967890|FG001|Primary Study|Lost to Follow-up|4|||
46749916|NCT04138056|82967891|FG002|Primary Study|Lost to Follow-up|1|||
46749917|NCT04138056|82967892|FG003|Primary Study|Lost to Follow-up|1|||
46749918|NCT04138056|82967893|FG004|Primary Study|Lost to Follow-up|4|||
46749919|NCT04138056|82967889|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
47052315|NCT01856309|83318797|FG001|Overall Study|Withdrawal by Subject|13|||
47052316|NCT01856309|83318798|FG002|Overall Study|Withdrawal by Subject|28|||
46635722|NCT01552902|82809478|FG001|Overall Study|Protocol Violation|3|||
46635723|NCT01552902|82809479|FG002|Overall Study|Protocol Violation|3|||
46635724|NCT01552902|82809477|FG000|Overall Study|Lack of Efficacy|4|||
46635725|NCT01552902|82809478|FG001|Overall Study|Lack of Efficacy|3|||
46749920|NCT04138056|82967890|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
46749921|NCT04138056|82967891|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
46749922|NCT04138056|82967892|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
46749923|NCT04138056|82967893|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
46749924|NCT04138056|82967889|FG000|Extension Study|Lost to Follow-up|1|||
46749925|NCT04138056|82967890|FG001|Extension Study|Lost to Follow-up|2|||
46749926|NCT04138056|82967891|FG002|Extension Study|Lost to Follow-up|1|||
46749927|NCT04138056|82967892|FG003|Extension Study|Lost to Follow-up|0|||
46749928|NCT04138056|82967893|FG004|Extension Study|Lost to Follow-up|1|||
46749929|NCT00753675|82967939|FG000|Overall Study|other reason|11|||
46749930|NCT00753675|82967940|FG001|Overall Study|other reason|12|||
46749931|NCT00753675|82967941|FG002|Overall Study|other reason|13|||
46749932|NCT00753675|82967939|FG000|Overall Study|Death|1|||
46749933|NCT00753675|82967940|FG001|Overall Study|Death|2|||
46749934|NCT00753675|82967941|FG002|Overall Study|Death|4|||
46749935|NCT00753675|82967939|FG000|Overall Study|Adverse Event|11|||
46749936|NCT00753675|82967940|FG001|Overall Study|Adverse Event|9|||
46749937|NCT00753675|82967941|FG002|Overall Study|Adverse Event|4|||
46749938|NCT00753675|82967939|FG000|Overall Study|Objective progression of disease|35|||
46749939|NCT00753675|82967940|FG001|Overall Study|Objective progression of disease|35|||
46749940|NCT00753675|82967941|FG002|Overall Study|Objective progression of disease|35|||
46749941|NCT00753675|82967939|FG000|Overall Study|Withdrawal by Subject|0|||
46749942|NCT00753675|82967940|FG001|Overall Study|Withdrawal by Subject|1|||
46749943|NCT00753675|82967941|FG002|Overall Study|Withdrawal by Subject|0|||
46749944|NCT00753675|82967939|FG000|Overall Study|Lost to Follow-up|1|||
46749945|NCT00753675|82967940|FG001|Overall Study|Lost to Follow-up|0|||
46749946|NCT00753675|82967941|FG002|Overall Study|Lost to Follow-up|0|||
46749947|NCT00586521|82967949|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
46749948|NCT00923273|82967958|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
46749949|NCT00923273|82967959|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
46749950|NCT00923273|82967960|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
46749951|NCT00923273|82967961|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
46749952|NCT00923273|82967962|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
46749953|NCT00923273|82967958|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
46749954|NCT00923273|82967959|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
46749955|NCT00923273|82967960|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
46749956|NCT00923273|82967961|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
46749957|NCT00923273|82967962|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
46749958|NCT00923195|82967982|FG000|Overall Study|Death|0|||
46749959|NCT00923195|82967983|FG001|Overall Study|Death|1|||
46749960|NCT00753519|82967991|FG000|Overall Study|Withdrawal by Subject|0|||
46749961|NCT00753519|82967992|FG001|Overall Study|Withdrawal by Subject|2|||
46749962|NCT00919061|82968000|FG000|Overall Study|Adverse Event|1|||
46749963|NCT00919061|82968000|FG000|Overall Study|Withdrawal by Subject|1|||
46749964|NCT00747435|82968004|FG000|Overall Study|Lost to Follow-up|2|||
46749965|NCT00747435|82968004|FG000|Overall Study|Withdrawal by Subject|3|||
46924297|NCT01734928|83158218|FG001|Randomization|clinical progression|1|||
46924298|NCT01734928|83158217|FG000|Randomization|progressive disease|0|||
46924299|NCT01734928|83158218|FG001|Randomization|progressive disease|2|||
46924300|NCT01734928|83158217|FG000|Randomization|Withdrew informed consent|0|||
46924301|NCT01734928|83158218|FG001|Randomization|Withdrew informed consent|4|||
46924302|NCT01734928|83158217|FG000|Randomization|Death|1|||
46924303|NCT01734928|83158218|FG001|Randomization|Death|0|||
46924304|NCT01734928|83158217|FG000|Randomization|Randomization error|1|||
46924305|NCT01734928|83158218|FG001|Randomization|Randomization error|0|||
46924306|NCT01734928|83158217|FG000|Randomization|Lost to Follow-up|1|||
46924307|NCT01734928|83158218|FG001|Randomization|Lost to Follow-up|0|||
46924308|NCT01734928|83158217|FG000|Treatment Period|Lost to Follow-up|0|||
46924309|NCT01734928|83158218|FG001|Treatment Period|Lost to Follow-up|2|||
46924310|NCT01734928|83158217|FG000|Treatment Period|Progressive Disease|167|||
46924311|NCT01734928|83158218|FG001|Treatment Period|Progressive Disease|165|||
46924312|NCT01734928|83158217|FG000|Treatment Period|Adverse Event|39|||
46924313|NCT01734928|83158218|FG001|Treatment Period|Adverse Event|52|||
46924314|NCT01734928|83158217|FG000|Treatment Period|Withdrawal of Consent|25|||
46924315|NCT01734928|83158218|FG001|Treatment Period|Withdrawal of Consent|22|||
46924316|NCT01734928|83158217|FG000|Treatment Period|Death|20|||
46924317|NCT01734928|83158218|FG001|Treatment Period|Death|9|||
46924318|NCT01734928|83158217|FG000|Treatment Period|Other Reasons|27|||
46924319|NCT01734928|83158218|FG001|Treatment Period|Other Reasons|19|||
46924320|NCT01734928|83158217|FG000|Treatment Period|Pregnancy|0|||
46924321|NCT01734928|83158218|FG001|Treatment Period|Pregnancy|1|||
46924322|NCT00667459|83158226|FG000|Overall Study|Death|0|||
46924323|NCT00667459|83158227|FG001|Overall Study|Death|2|||
46924324|NCT00667459|83158226|FG000|Overall Study|Lost to Follow-up|8|||
46924325|NCT00667459|83158227|FG001|Overall Study|Lost to Follow-up|43|||
47052317|NCT01856309|83318799|FG003|Overall Study|Withdrawal by Subject|26|||
47052318|NCT01856309|83318796|FG000|Overall Study|Other|227|||
47052319|NCT01856309|83318797|FG001|Overall Study|Other|225|||
46924326|NCT00453544|83158241|FG000|Overall Study|Withdrawal by Subject|1|||
46924327|NCT00453544|83158242|FG001|Overall Study|Withdrawal by Subject|0|||
46924328|NCT00453544|83158243|FG002|Overall Study|Withdrawal by Subject|0|||
46924329|NCT00453544|83158244|FG003|Overall Study|Withdrawal by Subject|0|||
46924330|NCT00453544|83158241|FG000|Overall Study|Primary outcome measure not completed|1|||
46924331|NCT00453544|83158242|FG001|Overall Study|Primary outcome measure not completed|1|||
47052320|NCT01856309|83318798|FG002|Overall Study|Other|447|||
47052321|NCT01856309|83318799|FG003|Overall Study|Other|469|||
47052322|NCT01856309|83318796|FG000|Overall Study|Lack of Efficacy|14|||
47052323|NCT01856309|83318797|FG001|Overall Study|Lack of Efficacy|9|||
47052324|NCT01856309|83318798|FG002|Overall Study|Lack of Efficacy|40|||
47052325|NCT01856309|83318799|FG003|Overall Study|Lack of Efficacy|25|||
47052326|NCT01856309|83318796|FG000|Overall Study|Adverse Event|31|||
46924332|NCT00453544|83158243|FG002|Overall Study|Primary outcome measure not completed|0|||
46924333|NCT00453544|83158244|FG003|Overall Study|Primary outcome measure not completed|1|||
46924334|NCT02646124|83158268|FG000|Overall Study|Lost to Follow-up|0|||
46924335|NCT02646124|83158269|FG001|Overall Study|Lost to Follow-up|2|||
46635726|NCT01552902|82809479|FG002|Overall Study|Lack of Efficacy|1|||
46749966|NCT00747435|82968004|FG000|Overall Study|Still undergoing follow up|1|||
46749967|NCT00918749|82968011|FG000|Overall Study|Adverse Event|1|||
46749968|NCT00918749|82968012|FG001|Overall Study|Adverse Event|0|||
46749969|NCT00918749|82968013|FG002|Overall Study|Adverse Event|1|||
46749970|NCT00918749|82968011|FG000|Overall Study|Lost to Follow-up|0|||
46749971|NCT00918749|82968012|FG001|Overall Study|Lost to Follow-up|0|||
46749972|NCT00918749|82968013|FG002|Overall Study|Lost to Follow-up|1|||
46749973|NCT00918749|82968011|FG000|Overall Study|Withdrawal by Subject|5|||
46749974|NCT00918749|82968012|FG001|Overall Study|Withdrawal by Subject|3|||
46749975|NCT00918749|82968013|FG002|Overall Study|Withdrawal by Subject|5|||
46749976|NCT00918749|82968011|FG000|Overall Study|No Study Medication Taken|1|||
46749977|NCT00918749|82968012|FG001|Overall Study|No Study Medication Taken|0|||
46749978|NCT00918749|82968013|FG002|Overall Study|No Study Medication Taken|0|||
46749979|NCT00746733|82968021|FG000|Second Intervention|Adverse Event|1|||
46749980|NCT00746733|82968022|FG001|Second Intervention|Adverse Event|0|||
46749981|NCT00746733|82968021|FG000|Third Intervention|Withdrawal by Subject|1|||
46749982|NCT00746733|82968022|FG001|Third Intervention|Withdrawal by Subject|1|||
46749983|NCT00745875|82968037|FG000|Overall Study|Continuing study treatment|4|||
46749984|NCT00745875|82968038|FG001|Overall Study|Continuing study treatment|4|||
46924336|NCT01597492|83158277|FG000|Overall Study|Withdrawal by Subject|1|||
46924337|NCT01597492|83158278|FG001|Overall Study|Withdrawal by Subject|2|||
46749985|NCT00555217|82968046|FG000|Overall Study|Withdrawal by Subject|35|||
46749986|NCT00555217|82968047|FG001|Overall Study|Withdrawal by Subject|31|||
46749987|NCT00555217|82968046|FG000|Overall Study|Lost to Follow-up|19|||
46749988|NCT00555217|82968047|FG001|Overall Study|Lost to Follow-up|20|||
46749989|NCT00555217|82968046|FG000|Overall Study|close out sites|21|||
46749990|NCT00555217|82968047|FG001|Overall Study|close out sites|17|||
46749991|NCT00745251|82968055|FG000|Overall Study|Adverse Event|1|||
46749992|NCT00745251|82968056|FG001|Overall Study|Adverse Event|2|||
46749993|NCT00745251|82968055|FG000|Overall Study|Withdrawal by Subject|1|||
46749994|NCT00745251|82968056|FG001|Overall Study|Withdrawal by Subject|1|||
46749995|NCT00745095|82968068|FG000|Overall Study|Declined to participate|1|||
46749996|NCT00745095|82968069|FG001|Overall Study|Declined to participate|0|||
46749997|NCT00745095|82968070|FG002|Overall Study|Declined to participate|0|||
46749998|NCT00745095|82968071|FG003|Overall Study|Declined to participate|0|||
46749999|NCT00745095|82968072|FG004|Overall Study|Declined to participate|92|||
46750000|NCT00745095|82968073|FG005|Overall Study|Declined to participate|95|||
46750001|NCT00745095|82968068|FG000|Overall Study|Ineligible due to GFR criteria|0|||
46750002|NCT00745095|82968069|FG001|Overall Study|Ineligible due to GFR criteria|2|||
46750003|NCT00745095|82968070|FG002|Overall Study|Ineligible due to GFR criteria|3|||
46750004|NCT00745095|82968071|FG003|Overall Study|Ineligible due to GFR criteria|3|||
46750005|NCT00745095|82968072|FG004|Overall Study|Ineligible due to GFR criteria|30|||
46750006|NCT00745095|82968073|FG005|Overall Study|Ineligible due to GFR criteria|28|||
46750007|NCT00744939|82968094|FG000|Overall Study|Withdrawal by Subject|9|||
46750008|NCT00744939|82968094|FG000|Overall Study|Protocol Violation|13|||
46750009|NCT00744939|82968094|FG000|Overall Study|Death|24|||
46750010|NCT00744939|82968094|FG000|Overall Study|distance|4|||
46750011|NCT00744939|82968094|FG000|Overall Study|Lost to Follow-up|12|||
46750012|NCT00744939|82968094|FG000|Overall Study|Medical history exclusionary|1|||
46750013|NCT00744939|82968094|FG000|Overall Study|Did not receive Magnevist|7|||
46750014|NCT00744939|82968094|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
46750015|NCT00744939|82968094|FG000|Overall Study|coma|1|||
46750016|NCT00744939|82968094|FG000|Overall Study|incorrect race|1|||
47052327|NCT01856309|83318797|FG001|Overall Study|Adverse Event|31|||
47052328|NCT01856309|83318798|FG002|Overall Study|Adverse Event|55|||
47052329|NCT01856309|83318799|FG003|Overall Study|Adverse Event|65|||
47052330|NCT01856309|83318796|FG000|Overall Study|Pregnancy|0|||
46750017|NCT00744861|82968110|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
47052331|NCT01856309|83318797|FG001|Overall Study|Pregnancy|0|||
47052332|NCT01856309|83318798|FG002|Overall Study|Pregnancy|0|||
46750018|NCT00744861|82968111|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
46750019|NCT00744861|82968112|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
46750020|NCT00744861|82968113|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
47052333|NCT01856309|83318799|FG003|Overall Study|Pregnancy|1|||
47052334|NCT01856309|83318796|FG000|Overall Study|Physician Decision|6|||
47052335|NCT01856309|83318797|FG001|Overall Study|Physician Decision|1|||
47052336|NCT01856309|83318798|FG002|Overall Study|Physician Decision|6|||
47052337|NCT01856309|83318799|FG003|Overall Study|Physician Decision|8|||
47052338|NCT01856309|83318796|FG000|Overall Study|Noncompliance With Study Drug|0|||
47052339|NCT01856309|83318797|FG001|Overall Study|Noncompliance With Study Drug|1|||
47052340|NCT01856309|83318798|FG002|Overall Study|Noncompliance With Study Drug|4|||
47052341|NCT01856309|83318799|FG003|Overall Study|Noncompliance With Study Drug|1|||
46750021|NCT00744861|82968110|FG000|Feasibility Stage 1|Pregnancy|0|||
46750022|NCT00744861|82968111|FG001|Feasibility Stage 1|Pregnancy|1|||
46750023|NCT00744861|82968112|FG002|Feasibility Stage 1|Pregnancy|0|||
46750024|NCT00744861|82968113|FG003|Feasibility Stage 1|Pregnancy|0|||
46750025|NCT00744861|82968110|FG000|Pivotal Stage 2|Adverse Event|0|||
46750026|NCT00744861|82968111|FG001|Pivotal Stage 2|Adverse Event|0|||
46750027|NCT00744861|82968112|FG002|Pivotal Stage 2|Adverse Event|6|||
46750028|NCT00744861|82968113|FG003|Pivotal Stage 2|Adverse Event|11|||
46750029|NCT00744861|82968110|FG000|Pivotal Stage 2|Death|0|||
46750030|NCT00744861|82968111|FG001|Pivotal Stage 2|Death|0|||
46750031|NCT00744861|82968112|FG002|Pivotal Stage 2|Death|0|||
46750032|NCT00744861|82968113|FG003|Pivotal Stage 2|Death|1|||
46750033|NCT00744861|82968110|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
46750034|NCT00744861|82968111|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
46750035|NCT00744861|82968112|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
46750036|NCT00744861|82968113|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
46750037|NCT00744861|82968110|FG000|Pivotal Stage 2|Physician Decision|0|||
46750038|NCT00744861|82968111|FG001|Pivotal Stage 2|Physician Decision|0|||
46750039|NCT00744861|82968112|FG002|Pivotal Stage 2|Physician Decision|3|||
46750040|NCT00744861|82968113|FG003|Pivotal Stage 2|Physician Decision|1|||
46750041|NCT00744861|82968110|FG000|Pivotal Stage 2|Protocol Violation|0|||
46750042|NCT00744861|82968111|FG001|Pivotal Stage 2|Protocol Violation|0|||
46750043|NCT00744861|82968112|FG002|Pivotal Stage 2|Protocol Violation|0|||
46750044|NCT00744861|82968113|FG003|Pivotal Stage 2|Protocol Violation|1|||
46750045|NCT00744861|82968110|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
46750046|NCT00744861|82968111|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
46750047|NCT00744861|82968112|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
46750048|NCT00744861|82968113|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
46750049|NCT00744861|82968110|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
46750050|NCT00744861|82968111|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
46750051|NCT00744861|82968112|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
46750052|NCT00744861|82968113|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
46750053|NCT03969589|82968123|FG000|Overall Study|Lost to Follow-up|3|||
46750054|NCT03969589|82968124|FG001|Overall Study|Lost to Follow-up|2|||
46750055|NCT03969589|82968123|FG000|Overall Study|Declined Follow-Up|0|||
46750056|NCT03969589|82968124|FG001|Overall Study|Declined Follow-Up|1|||
46750057|NCT00744627|82968132|FG000|Overall Study|Adverse Event|6|||
46750058|NCT00744627|82968133|FG001|Overall Study|Adverse Event|9|||
46750059|NCT00744627|82968132|FG000|Overall Study|Lack of Efficacy|7|||
46750060|NCT00744627|82968133|FG001|Overall Study|Lack of Efficacy|3|||
46750061|NCT00744627|82968132|FG000|Overall Study|Noncompliance|0|||
46750062|NCT00744627|82968133|FG001|Overall Study|Noncompliance|1|||
46750063|NCT00744627|82968132|FG000|Overall Study|Protocol Deviations|0|||
46750064|NCT00744627|82968133|FG001|Overall Study|Protocol Deviations|2|||
46750065|NCT00744627|82968132|FG000|Overall Study|Voluntary Withdrawal|9|||
46750066|NCT00744627|82968133|FG001|Overall Study|Voluntary Withdrawal|6|||
46750067|NCT00744627|82968132|FG000|Overall Study|Lost to Follow-up|2|||
46750068|NCT00744627|82968133|FG001|Overall Study|Lost to Follow-up|1|||
46750069|NCT00744627|82968132|FG000|Overall Study|Other|1|||
46750070|NCT00744627|82968133|FG001|Overall Study|Other|0|||
46750071|NCT03959137|82968139|FG000|Overall Study|Protocol Violation|6|||
46750072|NCT00562627|82968146|FG000|Overall Study|Protocol Violation|1|||
46750073|NCT00562627|82968147|FG001|Overall Study|Protocol Violation|1|||
46750074|NCT00562627|82968148|FG002|Overall Study|Protocol Violation|1|||
46750075|NCT00562159|82968158|FG000|Overall Study|Adverse Event|11|||
46750076|NCT00562159|82968159|FG001|Overall Study|Adverse Event|8|||
47052342|NCT01855919|83318997|FG000|Overall Study|Adverse Event|16|||
47052343|NCT01855919|83318998|FG001|Overall Study|Adverse Event|8|||
47052344|NCT01855919|83318997|FG000|Overall Study|Lack of Efficacy|1|||
46635727|NCT01552902|82809477|FG000|Overall Study|Withdrawal by Subject|1|||
46635728|NCT01552902|82809478|FG001|Overall Study|Withdrawal by Subject|9|||
46635729|NCT01552902|82809479|FG002|Overall Study|Withdrawal by Subject|6|||
46750077|NCT00562159|82968158|FG000|Overall Study|Lost to Follow-up|5|||
46750078|NCT00562159|82968159|FG001|Overall Study|Lost to Follow-up|4|||
46750079|NCT00562159|82968158|FG000|Overall Study|Withdrawal by Subject|9|||
46750080|NCT00562159|82968159|FG001|Overall Study|Withdrawal by Subject|8|||
46750081|NCT00562159|82968158|FG000|Overall Study|Protocol Violation|12|||
46750082|NCT00562159|82968159|FG001|Overall Study|Protocol Violation|12|||
46750083|NCT00562159|82968158|FG000|Overall Study|Did not meet protocol eligibility|1|||
46750084|NCT00562159|82968159|FG001|Overall Study|Did not meet protocol eligibility|1|||
46635730|NCT01552902|82809477|FG000|Overall Study|Lost to Follow-up|1|||
47052345|NCT01855919|83318998|FG001|Overall Study|Lack of Efficacy|3|||
47052346|NCT01855919|83318997|FG000|Overall Study|Withdrawal by Subject|4|||
47052347|NCT01855919|83318998|FG001|Overall Study|Withdrawal by Subject|10|||
47052348|NCT01855919|83318997|FG000|Overall Study|Entry Criteria Not Met|1|||
47052349|NCT01855919|83318998|FG001|Overall Study|Entry Criteria Not Met|1|||
47052350|NCT01855919|83318997|FG000|Overall Study|Protocol Violation|1|||
47052351|NCT01855919|83318998|FG001|Overall Study|Protocol Violation|4|||
47052352|NCT01871519|83319014|FG000|Overall Study|Death|26|||
47052353|NCT01871519|83319014|FG000|Overall Study|Lost to Follow-up|15|||
47052354|NCT01871519|83319014|FG000|Overall Study|Withdrawal by Subject|49|||
47052355|NCT01871285|83319021|FG000|First Intervention (1 Day)|Adverse Event|1|||
47052356|NCT01871285|83319022|FG001|First Intervention (1 Day)|Adverse Event|0|||
46750097|NCT00921557|82968178|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
46750098|NCT00921557|82968179|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
46750099|NCT00921557|82968180|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
46750100|NCT00921557|82968178|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
46750101|NCT00921557|82968179|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
46750102|NCT00921557|82968180|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
46750103|NCT00921557|82968178|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
46750104|NCT00921557|82968179|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
46750105|NCT00921557|82968180|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
46750106|NCT00921557|82968178|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
46750107|NCT00921557|82968179|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
46750108|NCT00921557|82968180|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
46750109|NCT00921557|82968178|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
46750110|NCT00921557|82968179|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
46750111|NCT00921557|82968180|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
46750112|NCT00744471|82968197|FG000|Overall Study|Randomized but not treated|1|||
46750113|NCT00744471|82968198|FG001|Overall Study|Randomized but not treated|1|||
46750114|NCT00744471|82968199|FG002|Overall Study|Randomized but not treated|4|||
46750115|NCT00744471|82968200|FG003|Overall Study|Randomized but not treated|0|||
46750116|NCT00744471|82968197|FG000|Overall Study|Death|0|||
46750117|NCT00744471|82968198|FG001|Overall Study|Death|0|||
46750118|NCT00744471|82968199|FG002|Overall Study|Death|0|||
46750119|NCT00744471|82968200|FG003|Overall Study|Death|1|||
46750120|NCT00744471|82968197|FG000|Overall Study|Adverse Event|6|||
46750121|NCT00744471|82968198|FG001|Overall Study|Adverse Event|7|||
46750122|NCT00744471|82968199|FG002|Overall Study|Adverse Event|5|||
46750123|NCT00744471|82968200|FG003|Overall Study|Adverse Event|9|||
46750124|NCT00744471|82968197|FG000|Overall Study|Withdrawal by Subject|9|||
46750125|NCT00744471|82968198|FG001|Overall Study|Withdrawal by Subject|9|||
46750126|NCT00744471|82968199|FG002|Overall Study|Withdrawal by Subject|15|||
46750127|NCT00744471|82968200|FG003|Overall Study|Withdrawal by Subject|12|||
46750128|NCT00744471|82968197|FG000|Overall Study|Protocol Violation|1|||
46750129|NCT00744471|82968198|FG001|Overall Study|Protocol Violation|4|||
46750130|NCT00744471|82968199|FG002|Overall Study|Protocol Violation|1|||
46750131|NCT00744471|82968200|FG003|Overall Study|Protocol Violation|2|||
46750132|NCT00744471|82968197|FG000|Overall Study|Entered extension study|41|||
46750133|NCT00744471|82968198|FG001|Overall Study|Entered extension study|84|||
46750134|NCT00744471|82968199|FG002|Overall Study|Entered extension study|100|||
46750135|NCT00744471|82968200|FG003|Overall Study|Entered extension study|91|||
46750136|NCT00744471|82968197|FG000|Overall Study|Other|2|||
46750137|NCT00744471|82968198|FG001|Overall Study|Other|3|||
46750138|NCT00744471|82968199|FG002|Overall Study|Other|6|||
46750139|NCT00744471|82968200|FG003|Overall Study|Other|2|||
46750140|NCT00744471|82968197|FG000|Overall Study|Lack of Efficacy|83|||
46750141|NCT00744471|82968198|FG001|Overall Study|Lack of Efficacy|37|||
46750142|NCT00744471|82968199|FG002|Overall Study|Lack of Efficacy|19|||
46750143|NCT00744471|82968200|FG003|Overall Study|Lack of Efficacy|31|||
46750144|NCT00744471|82968197|FG000|Overall Study|Lost to Follow-up|0|||
46750145|NCT00744471|82968198|FG001|Overall Study|Lost to Follow-up|0|||
46750146|NCT00744471|82968199|FG002|Overall Study|Lost to Follow-up|2|||
46750147|NCT00744471|82968200|FG003|Overall Study|Lost to Follow-up|0|||
46750148|NCT00744237|82968213|FG000|Overall Study|Lack of Efficacy|1|||
46750149|NCT00744237|82968214|FG001|Overall Study|Lack of Efficacy|1|||
46750150|NCT00744237|82968215|FG002|Overall Study|Lack of Efficacy|0|||
46750151|NCT00744237|82968213|FG000|Overall Study|Withdrawal by Subject|9|||
46750152|NCT00744237|82968214|FG001|Overall Study|Withdrawal by Subject|5|||
46750153|NCT00744237|82968215|FG002|Overall Study|Withdrawal by Subject|3|||
46750154|NCT00744237|82968213|FG000|Overall Study|Lost to Follow-up|1|||
46750155|NCT00744237|82968214|FG001|Overall Study|Lost to Follow-up|1|||
46750156|NCT00744237|82968215|FG002|Overall Study|Lost to Follow-up|1|||
46750157|NCT00744237|82968213|FG000|Overall Study|Protocol Violation|3|||
46750158|NCT00744237|82968214|FG001|Overall Study|Protocol Violation|4|||
46750159|NCT00744237|82968215|FG002|Overall Study|Protocol Violation|3|||
46750160|NCT00744237|82968213|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
46750161|NCT00744237|82968214|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
46750162|NCT00744237|82968215|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
46750163|NCT00744237|82968213|FG000|Overall Study|Dosing Error|1|||
46750164|NCT00744237|82968214|FG001|Overall Study|Dosing Error|0|||
46750165|NCT00744237|82968215|FG002|Overall Study|Dosing Error|1|||
46750166|NCT00744237|82968213|FG000|Overall Study|Study Drug Error|1|||
46750167|NCT00744237|82968214|FG001|Overall Study|Study Drug Error|0|||
46750168|NCT00744237|82968215|FG002|Overall Study|Study Drug Error|0|||
46750169|NCT00744237|82968213|FG000|Overall Study|Prohibited Concomitant Medication|0|||
46750170|NCT00744237|82968214|FG001|Overall Study|Prohibited Concomitant Medication|0|||
46750171|NCT00744237|82968215|FG002|Overall Study|Prohibited Concomitant Medication|1|||
46750172|NCT00744237|82968213|FG000|Overall Study|Poor Compliance|0|||
46750173|NCT00744237|82968214|FG001|Overall Study|Poor Compliance|2|||
46750174|NCT00744237|82968215|FG002|Overall Study|Poor Compliance|0|||
46750175|NCT00744237|82968213|FG000|Overall Study|Administrative. Site Closed|1|||
46750176|NCT00744237|82968214|FG001|Overall Study|Administrative. Site Closed|1|||
46750177|NCT00744237|82968215|FG002|Overall Study|Administrative. Site Closed|1|||
46750178|NCT00744237|82968213|FG000|Overall Study|Adverse Event|9|||
46750179|NCT00744237|82968214|FG001|Overall Study|Adverse Event|13|||
46750180|NCT00744237|82968215|FG002|Overall Study|Adverse Event|5|||
46924338|NCT01597492|83158277|FG000|Overall Study|Adverse Event|3|||
46924339|NCT01597492|83158278|FG001|Overall Study|Adverse Event|0|||
46924340|NCT01597492|83158277|FG000|Overall Study|Lost to Follow-up|0|||
46924341|NCT01597492|83158278|FG001|Overall Study|Lost to Follow-up|2|||
46924342|NCT01597492|83158277|FG000|Overall Study|Other Reason|2|||
46924343|NCT01597492|83158278|FG001|Overall Study|Other Reason|0|||
46924344|NCT03423602|83158284|FG000|Overall Study|Death|1|||
46924345|NCT03423602|83158284|FG000|Overall Study|Lost to Follow-up|6|||
46924346|NCT03423602|83158284|FG000|Overall Study|Protocol Violation|1|||
46924347|NCT03423602|83158284|FG000|Overall Study|Withdrawal by Subject|4|||
46924348|NCT00109590|83158291|FG000|Overall Study|Lost to Follow-up|1|||
46924349|NCT00109590|83158292|FG001|Overall Study|Lost to Follow-up|0|||
46924350|NCT00109590|83158293|FG002|Overall Study|Lost to Follow-up|1|||
46924351|NCT00109590|83158291|FG000|Overall Study|Never Started Treatment|1|||
46924352|NCT00109590|83158292|FG001|Overall Study|Never Started Treatment|2|||
46924353|NCT00109590|83158293|FG002|Overall Study|Never Started Treatment|3|||
47052357|NCT01871285|83319023|FG002|First Intervention (1 Day)|Adverse Event|0|||
47052358|NCT01871285|83319024|FG003|First Intervention (1 Day)|Adverse Event|0|||
47052359|NCT01871285|83319021|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
47052360|NCT01871285|83319022|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
46635731|NCT01552902|82809478|FG001|Overall Study|Lost to Follow-up|3|||
46635732|NCT01552902|82809479|FG002|Overall Study|Lost to Follow-up|6|||
46635733|NCT01552902|82809477|FG000|Overall Study|Other|3|||
46635734|NCT01552902|82809478|FG001|Overall Study|Other|4|||
46635735|NCT01552902|82809479|FG002|Overall Study|Other|3|||
46635736|NCT01529346|82809505|FG000|Overall Study|Lost to Follow-up|2|||
46635737|NCT01529346|82809506|FG001|Overall Study|Lost to Follow-up|0|||
46635738|NCT01529346|82809507|FG002|Overall Study|Lost to Follow-up|1|||
46635739|NCT01529346|82809508|FG003|Overall Study|Lost to Follow-up|0|||
46635740|NCT01529346|82809509|FG004|Overall Study|Lost to Follow-up|0|||
46635741|NCT01529346|82809505|FG000|Overall Study|Other|0|||
46635742|NCT01529346|82809506|FG001|Overall Study|Other|1|||
46635743|NCT01529346|82809507|FG002|Overall Study|Other|1|||
46635744|NCT01529346|82809508|FG003|Overall Study|Other|0|||
46635745|NCT01529346|82809509|FG004|Overall Study|Other|0|||
46635746|NCT01529268|82809533|FG000|Overall Study|Lost to Follow-up|9|||
46635747|NCT01529268|82809534|FG001|Overall Study|Lost to Follow-up|3|||
46635748|NCT01529268|82809533|FG000|Overall Study|Moved|3|||
46635749|NCT01529268|82809534|FG001|Overall Study|Moved|0|||
46635750|NCT01529112|82809542|FG000|Overall Study|Adverse Event|2|||
46635751|NCT01529112|82809543|FG001|Overall Study|Adverse Event|0|||
46635752|NCT01529112|82809542|FG000|Overall Study|Death|59|||
46635753|NCT01529112|82809543|FG001|Overall Study|Death|38|||
46635754|NCT01529112|82809542|FG000|Overall Study|Protocol Violation|1|||
46750181|NCT00743145|82968223|FG000|Overall Study|Withdrawal by Subject|1|||
46750182|NCT00743145|82968223|FG000|Overall Study|Adverse Event|2|||
46635755|NCT01529112|82809543|FG001|Overall Study|Protocol Violation|0|||
46635756|NCT01529112|82809542|FG000|Overall Study|Withdrawal by Subject|7|||
46635757|NCT01529112|82809543|FG001|Overall Study|Withdrawal by Subject|3|||
46635758|NCT01551420|82809551|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
46750183|NCT00743145|82968223|FG000|Overall Study|Pregnancy|1|||
46924354|NCT02781558|83158317|FG000|Overall Study|Lost to Follow-up|2|||
47052361|NCT01871285|83319023|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
47052362|NCT01871285|83319024|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
47052363|NCT01870973|83319050|FG000|Overall Study|Lost to Follow-up|10|||
46635759|NCT01551420|82809552|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
46635760|NCT01551420|82809551|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
46750184|NCT00920855|82968240|FG000|Overall Study|Adverse Event|1|||
46924355|NCT02781558|83158318|FG001|Overall Study|Lost to Follow-up|2|||
46924356|NCT02781558|83158317|FG000|Overall Study|Adverse Event|1|||
46924357|NCT02781558|83158318|FG001|Overall Study|Adverse Event|0|||
47052364|NCT01870973|83319051|FG001|Overall Study|Lost to Follow-up|3|||
46635761|NCT01551420|82809552|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
46635762|NCT01551420|82809551|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
46750185|NCT00920855|82968241|FG001|Overall Study|Adverse Event|1|||
46750186|NCT00920855|82968242|FG002|Overall Study|Adverse Event|4|||
46750187|NCT00920855|82968240|FG000|Overall Study|Withdrawal by Subject|2|||
46924358|NCT03041311|83158327|FG000|Overall Study|Death|39|||
46750188|NCT00920855|82968241|FG001|Overall Study|Withdrawal by Subject|1|||
46635763|NCT01551420|82809552|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
46635764|NCT01551420|82809551|FG000|Screened for Part B Eligibility|Declined participation|8|||
46635765|NCT01551420|82809552|FG001|Screened for Part B Eligibility|Declined participation|1|||
46635766|NCT01551420|82809551|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
46635767|NCT01551420|82809552|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
46635768|NCT01551420|82809551|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
46635769|NCT01551420|82809552|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
46924359|NCT03041311|83158328|FG001|Overall Study|Death|42|||
46750189|NCT00920855|82968242|FG002|Overall Study|Withdrawal by Subject|6|||
46924360|NCT03041311|83158327|FG000|Overall Study|Lost to Follow-up|0|||
46924361|NCT03041311|83158328|FG001|Overall Study|Lost to Follow-up|1|||
46924362|NCT03041311|83158327|FG000|Overall Study|Withdrawal by Subject|8|||
46924363|NCT03041311|83158328|FG001|Overall Study|Withdrawal by Subject|5|||
46924364|NCT03041311|83158327|FG000|Overall Study|Sponsor Terminated Study|2|||
46924365|NCT03041311|83158328|FG001|Overall Study|Sponsor Terminated Study|4|||
46924366|NCT03041311|83158327|FG000|Overall Study|Disease Progression|3|||
46750190|NCT00920855|82968240|FG000|Overall Study|Disease progression|2|||
46750191|NCT00920855|82968241|FG001|Overall Study|Disease progression|1|||
46750192|NCT00920855|82968242|FG002|Overall Study|Disease progression|10|||
46750193|NCT00920855|82968240|FG000|Overall Study|Noncompliance to study medication|0|||
46750194|NCT00920855|82968241|FG001|Overall Study|Noncompliance to study medication|0|||
46750195|NCT00920855|82968242|FG002|Overall Study|Noncompliance to study medication|1|||
46750196|NCT00920855|82968240|FG000|Overall Study|Response plateau; started maintenance|0|||
46750197|NCT00920855|82968241|FG001|Overall Study|Response plateau; started maintenance|0|||
46750198|NCT00920855|82968242|FG002|Overall Study|Response plateau; started maintenance|1|||
46750199|NCT00742209|82968256|FG000|Overall Study|Adverse Event|11|||
46750200|NCT00742209|82968257|FG001|Overall Study|Adverse Event|4|||
46750201|NCT00742209|82968258|FG002|Overall Study|Adverse Event|17|||
46750202|NCT00742209|82968259|FG003|Overall Study|Adverse Event|16|||
46750203|NCT00742209|82968260|FG004|Overall Study|Adverse Event|13|||
46750204|NCT00742209|82968256|FG000|Overall Study|Participant Withdrew Consent|8|||
46750205|NCT00742209|82968257|FG001|Overall Study|Participant Withdrew Consent|4|||
46750206|NCT00742209|82968258|FG002|Overall Study|Participant Withdrew Consent|14|||
46750207|NCT00742209|82968259|FG003|Overall Study|Participant Withdrew Consent|7|||
46750208|NCT00742209|82968260|FG004|Overall Study|Participant Withdrew Consent|4|||
46750209|NCT00742209|82968256|FG000|Overall Study|Protocol Violation|6|||
46750210|NCT00742209|82968257|FG001|Overall Study|Protocol Violation|5|||
46750211|NCT00742209|82968258|FG002|Overall Study|Protocol Violation|4|||
46750212|NCT00742209|82968259|FG003|Overall Study|Protocol Violation|5|||
46750213|NCT00742209|82968260|FG004|Overall Study|Protocol Violation|3|||
46750214|NCT00742209|82968256|FG000|Overall Study|Lost to Follow-up|3|||
46750215|NCT00742209|82968257|FG001|Overall Study|Lost to Follow-up|4|||
46750216|NCT00742209|82968258|FG002|Overall Study|Lost to Follow-up|5|||
46750217|NCT00742209|82968259|FG003|Overall Study|Lost to Follow-up|5|||
46750218|NCT00742209|82968260|FG004|Overall Study|Lost to Follow-up|3|||
46750219|NCT00742209|82968256|FG000|Overall Study|Lack of Efficacy|6|||
46750220|NCT00742209|82968257|FG001|Overall Study|Lack of Efficacy|1|||
46750221|NCT00742209|82968258|FG002|Overall Study|Lack of Efficacy|1|||
46750222|NCT00742209|82968259|FG003|Overall Study|Lack of Efficacy|3|||
46750223|NCT00742209|82968260|FG004|Overall Study|Lack of Efficacy|1|||
46750224|NCT00742209|82968256|FG000|Overall Study|Investigator Discretion|0|||
46750225|NCT00742209|82968257|FG001|Overall Study|Investigator Discretion|0|||
46750226|NCT00742209|82968258|FG002|Overall Study|Investigator Discretion|5|||
46750227|NCT00742209|82968259|FG003|Overall Study|Investigator Discretion|1|||
46750228|NCT00742209|82968260|FG004|Overall Study|Investigator Discretion|1|||
46750229|NCT00741819|82968273|FG000|Overall Study|Adverse Event|3|||
46750230|NCT00741819|82968273|FG000|Overall Study|Withdrawal by Subject|3|||
47052365|NCT01854827|83319070|FG000|Overall Study|Death|1|||
46635770|NCT01551420|82809551|FG000|Home Use (Part B)|Withdrawal by staff|0|||
46635771|NCT01551420|82809552|FG001|Home Use (Part B)|Withdrawal by staff|1|||
46750231|NCT00741819|82968273|FG000|Overall Study|Death|1|||
46750232|NCT00741819|82968273|FG000|Overall Study|Disease progression|1|||
46750233|NCT00924443|82968279|FG000|Overall Study|Physician Decision|2|||
46750234|NCT00924443|82968279|FG000|Overall Study|Protocol Violation|1|||
46750235|NCT00924287|82968283|FG000|Overall Study|Death|1|||
46750236|NCT00923975|82968287|FG000|Overall Study|Did not meet inclusion criteria|1|||
46750237|NCT00918203|82968323|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
46804764|NCT00670007|83023810|FG000|Overall Study|Withdrawal by Subject|4|||
46924367|NCT03041311|83158328|FG001|Overall Study|Disease Progression|1|||
46750238|NCT00918203|82968324|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
46750239|NCT00918203|82968325|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
46750240|NCT00918203|82968323|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
46750241|NCT00918203|82968324|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
46804765|NCT00535496|83023817|FG000|Overall Study|Lost to Follow-up|0|||
46750242|NCT00918203|82968325|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
46750243|NCT00918203|82968323|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
46750244|NCT00918203|82968324|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
46750245|NCT00918203|82968325|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
46750246|NCT00918203|82968323|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
46750247|NCT00918203|82968324|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
46750248|NCT00918203|82968325|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
46750249|NCT00918281|82968337|FG000|Overall Study|Physician Decision|29|||
46750250|NCT02770716|82968346|FG000|Overall Study|Death|101|||
46750251|NCT02770716|82968347|FG001|Overall Study|Death|45|||
46750252|NCT02770716|82968346|FG000|Overall Study|Withdrawal by Subject|4|||
46750253|NCT02770716|82968347|FG001|Overall Study|Withdrawal by Subject|2|||
46750254|NCT02770716|82968346|FG000|Overall Study|Lost to Follow-up|1|||
46750255|NCT02770716|82968347|FG001|Overall Study|Lost to Follow-up|0|||
46750256|NCT02770716|82968346|FG000|Overall Study|Various reasons|6|||
46750257|NCT02770716|82968347|FG001|Overall Study|Various reasons|2|||
46750258|NCT00917579|82968353|FG000|Washout >= 2 Weeks|Adverse Event|1|||
46750259|NCT00917579|82968354|FG001|Washout >= 2 Weeks|Adverse Event|0|||
46750260|NCT00917579|82968353|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
46750261|NCT00917579|82968354|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
46750262|NCT00915551|82968362|FG000|Overall Study|Withdrawal by Subject|0|||
46750263|NCT00915551|82968363|FG001|Overall Study|Withdrawal by Subject|1|||
46750264|NCT00915473|82968371|FG000|Screening|Withdrawal by Subject|1|||
46750265|NCT00915473|82968372|FG001|Screening|Withdrawal by Subject|0|||
46750266|NCT00915473|82968371|FG000|4-week Follow Up|Lost to Follow-up|1|||
46750267|NCT00915473|82968372|FG001|4-week Follow Up|Lost to Follow-up|5|||
46750268|NCT00917501|82968380|FG000|Overall Study|Lost to Follow-up|4|||
46750269|NCT00917501|82968381|FG001|Overall Study|Lost to Follow-up|1|||
46750270|NCT00917501|82968380|FG000|Overall Study|Withdrawal by Subject|3|||
46750271|NCT00917501|82968381|FG001|Overall Study|Withdrawal by Subject|1|||
46750272|NCT00917501|82968380|FG000|Overall Study|Lack of Efficacy|1|||
46750273|NCT00917501|82968381|FG001|Overall Study|Lack of Efficacy|2|||
46750274|NCT00917501|82968380|FG000|Overall Study|trouble swollowing capsules|0|||
46750275|NCT00917501|82968381|FG001|Overall Study|trouble swollowing capsules|1|||
46750276|NCT00917267|82968400|FG000|Overall Study|Adverse Event|15|||
46750277|NCT00917267|82968401|FG001|Overall Study|Adverse Event|36|||
46750278|NCT00917267|82968400|FG000|Overall Study|Physician Decision|2|||
46750279|NCT00917267|82968401|FG001|Overall Study|Physician Decision|4|||
46750280|NCT00917267|82968400|FG000|Overall Study|Protocol Violation|9|||
46750281|NCT00917267|82968401|FG001|Overall Study|Protocol Violation|18|||
46750282|NCT00917267|82968400|FG000|Overall Study|Withdrawal by Subject|5|||
46750283|NCT00917267|82968401|FG001|Overall Study|Withdrawal by Subject|12|||
46750284|NCT00917267|82968400|FG000|Overall Study|Lost to follow up|0|||
46750285|NCT00917267|82968401|FG001|Overall Study|Lost to follow up|2|||
47052366|NCT01854047|83319213|FG000|Overall Study|Lack of Efficacy|1|||
47052367|NCT01854047|83319214|FG001|Overall Study|Lack of Efficacy|0|||
47052368|NCT01854047|83319215|FG002|Overall Study|Lack of Efficacy|0|||
47052369|NCT01854047|83319216|FG003|Overall Study|Lack of Efficacy|0|||
47052370|NCT01854047|83319217|FG004|Overall Study|Lack of Efficacy|0|||
47052371|NCT01854047|83319213|FG000|Overall Study|Poor compliance to protocol|3|||
47052372|NCT01854047|83319214|FG001|Overall Study|Poor compliance to protocol|0|||
47052373|NCT01854047|83319215|FG002|Overall Study|Poor compliance to protocol|2|||
47052374|NCT01854047|83319216|FG003|Overall Study|Poor compliance to protocol|0|||
47052375|NCT01854047|83319217|FG004|Overall Study|Poor compliance to protocol|0|||
47052376|NCT01854047|83319213|FG000|Overall Study|Adverse Event|5|||
47052377|NCT01854047|83319214|FG001|Overall Study|Adverse Event|4|||
47052378|NCT01854047|83319215|FG002|Overall Study|Adverse Event|6|||
47052379|NCT01854047|83319216|FG003|Overall Study|Adverse Event|10|||
47052380|NCT01854047|83319217|FG004|Overall Study|Adverse Event|7|||
46750286|NCT00917267|82968400|FG000|Overall Study|Entry Criteria Not Met|1|||
46750287|NCT00917267|82968401|FG001|Overall Study|Entry Criteria Not Met|0|||
46750288|NCT00917267|82968400|FG000|Overall Study|Sponsor Decision|5|||
46924368|NCT03041311|83158327|FG000|Overall Study|Randomized in error, did not receive drug|2|||
47052381|NCT01854047|83319213|FG000|Overall Study|Randomized but not treated|0|||
47052382|NCT01854047|83319214|FG001|Overall Study|Randomized but not treated|1|||
46750289|NCT00917267|82968401|FG001|Overall Study|Sponsor Decision|5|||
46750290|NCT00917267|82968400|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
46750291|NCT00917267|82968401|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
46750292|NCT00920699|82968414|FG000|Overall Study|Withdrawal by Subject|2|||
46750293|NCT00920699|82968415|FG001|Overall Study|Withdrawal by Subject|0|||
46750294|NCT00920699|82968416|FG002|Overall Study|Withdrawal by Subject|2|||
46750295|NCT00920699|82968414|FG000|Overall Study|no longer met eligibility|0|||
47052383|NCT01854047|83319215|FG002|Overall Study|Randomized but not treated|2|||
47052384|NCT01854047|83319216|FG003|Overall Study|Randomized but not treated|0|||
47052385|NCT01854047|83319217|FG004|Overall Study|Randomized but not treated|4|||
47052386|NCT01854047|83319213|FG000|Overall Study|Other than specified above|3|||
46750296|NCT00920699|82968415|FG001|Overall Study|no longer met eligibility|1|||
46750297|NCT00920699|82968416|FG002|Overall Study|no longer met eligibility|0|||
46750298|NCT00920699|82968414|FG000|Overall Study|Lost to Follow-up|0|||
47052387|NCT01854047|83319214|FG001|Overall Study|Other than specified above|3|||
46750299|NCT00920699|82968415|FG001|Overall Study|Lost to Follow-up|0|||
46750300|NCT00920699|82968416|FG002|Overall Study|Lost to Follow-up|2|||
46750301|NCT03462576|82968427|FG000|Overall Study|Protocol Violation|5|||
46750302|NCT03462576|82968428|FG001|Overall Study|Protocol Violation|11|||
46750303|NCT03462576|82968429|FG002|Overall Study|Protocol Violation|7|||
46750304|NCT03462576|82968427|FG000|Overall Study|Device Malfunction|0|||
46750305|NCT03462576|82968428|FG001|Overall Study|Device Malfunction|0|||
46750306|NCT03462576|82968429|FG002|Overall Study|Device Malfunction|1|||
46750307|NCT00916721|82968439|FG000|Overall Study|Lost to Follow-up|0|||
46750308|NCT00916721|82968440|FG001|Overall Study|Lost to Follow-up|1|||
46750309|NCT00916721|82968439|FG000|Overall Study|Adverse Event|6|||
46750310|NCT00916721|82968440|FG001|Overall Study|Adverse Event|3|||
47052388|NCT01854047|83319215|FG002|Overall Study|Other than specified above|3|||
46750311|NCT00916721|82968439|FG000|Overall Study|Withdrawal by Subject|2|||
46750312|NCT00916721|82968440|FG001|Overall Study|Withdrawal by Subject|2|||
46750313|NCT00916721|82968439|FG000|Overall Study|Protocol Violation|2|||
46750314|NCT00916721|82968440|FG001|Overall Study|Protocol Violation|4|||
46750315|NCT00915005|82968448|FG000|Overall Study|Withdrawal by Subject|4|||
46750316|NCT00915005|82968449|FG001|Overall Study|Withdrawal by Subject|4|||
46750317|NCT00915005|82968448|FG000|Overall Study|Patient preferred protons therapy|6|||
46750318|NCT00915005|82968449|FG001|Overall Study|Patient preferred protons therapy|0|||
46750319|NCT00915005|82968448|FG000|Overall Study|Insurance denial|3|||
46750320|NCT00915005|82968449|FG001|Overall Study|Insurance denial|15|||
46750321|NCT01143246|82968457|FG000|Overall Study|Adverse Event|24|||
46750322|NCT01143246|82968458|FG001|Overall Study|Adverse Event|28|||
46750323|NCT01143246|82968457|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
46750324|NCT01143246|82968458|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
46750325|NCT01143246|82968457|FG000|Overall Study|Lost to Follow-up|0|||
46750326|NCT01143246|82968458|FG001|Overall Study|Lost to Follow-up|1|||
46750327|NCT01143246|82968457|FG000|Overall Study|Death|16|||
46750328|NCT01143246|82968458|FG001|Overall Study|Death|15|||
47052389|NCT01854047|83319216|FG003|Overall Study|Other than specified above|5|||
47052390|NCT01854047|83319217|FG004|Overall Study|Other than specified above|8|||
47052391|NCT01870739|83319263|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
46750329|NCT01143246|82968457|FG000|Overall Study|Reason not Specified|3|||
46750330|NCT01143246|82968458|FG001|Overall Study|Reason not Specified|5|||
46750331|NCT00561925|82968472|FG000|14 Day Lead-In Period|Adverse Event|38|||
46750332|NCT00561925|82968473|FG001|14 Day Lead-In Period|Adverse Event|0|||
46750333|NCT00561925|82968474|FG002|14 Day Lead-In Period|Adverse Event|0|||
46750334|NCT00561925|82968475|FG003|14 Day Lead-In Period|Adverse Event|0|||
46750335|NCT00561925|82968476|FG004|14 Day Lead-In Period|Adverse Event|0|||
46750336|NCT00561925|82968472|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
46750337|NCT00561925|82968473|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
46750338|NCT00561925|82968474|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
46750339|NCT00561925|82968475|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
46750340|NCT00561925|82968476|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
46750341|NCT00561925|82968472|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
46750342|NCT00561925|82968473|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
46750343|NCT00561925|82968474|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
46750344|NCT00561925|82968475|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
46750345|NCT00561925|82968476|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
46750346|NCT00561925|82968472|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
46750347|NCT00561925|82968473|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
46750348|NCT00561925|82968474|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
46750349|NCT00561925|82968475|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
46750350|NCT00561925|82968476|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
46750351|NCT00561925|82968472|FG000|14 Day Lead-In Period|Other|5|||
46750352|NCT00561925|82968473|FG001|14 Day Lead-In Period|Other|0|||
46750353|NCT00561925|82968474|FG002|14 Day Lead-In Period|Other|0|||
46750354|NCT00561925|82968475|FG003|14 Day Lead-In Period|Other|0|||
46750355|NCT00561925|82968476|FG004|14 Day Lead-In Period|Other|0|||
46750356|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
46750357|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
46750358|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
46750359|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
46750360|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
46750361|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
46750362|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
46750363|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
46750364|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
46804766|NCT00535496|83023818|FG001|Overall Study|Lost to Follow-up|1|||
46750365|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
46750366|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
46750367|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
46750368|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
46750369|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
46750370|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
46750371|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
46750372|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
46750373|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
46750374|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
46750375|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
46924369|NCT03041311|83158328|FG001|Overall Study|Randomized in error, did not receive drug|0|||
46924370|NCT02644096|83158344|FG000|Overall Study|Withdrawal by Subject|28|||
46924371|NCT02644096|83158345|FG001|Overall Study|Withdrawal by Subject|25|||
46924372|NCT02643628|83158353|FG000|Overall Study|Lost to Follow-up|1|||
47052392|NCT01870739|83319264|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
47052393|NCT01870739|83319263|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
47052394|NCT01870739|83319264|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
47052395|NCT01870739|83319263|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
47052396|NCT01870739|83319264|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
47052397|NCT01870739|83319263|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
47052398|NCT01870739|83319264|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
47052399|NCT01870739|83319263|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
47052400|NCT01870739|83319264|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
47052401|NCT01870739|83319263|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
47052402|NCT01870739|83319264|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
47052403|NCT01870739|83319263|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
47052404|NCT01870739|83319264|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
47052405|NCT01613417|83319291|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
47052406|NCT01613417|83319292|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
47052407|NCT01870583|83319320|FG000|Overall Study|Protocol Violation|0|||
47052408|NCT01870583|83319321|FG001|Overall Study|Protocol Violation|5|||
47052409|NCT01870583|83319322|FG002|Overall Study|Protocol Violation|3|||
47052410|NCT01870583|83319320|FG000|Overall Study|Lost to Follow-up|11|||
47052411|NCT01870583|83319321|FG001|Overall Study|Lost to Follow-up|13|||
47052412|NCT01870583|83319322|FG002|Overall Study|Lost to Follow-up|5|||
47052413|NCT01869959|83319380|FG000|Randomization Period|Physician Decision|0|||
47052414|NCT01869959|83319381|FG001|Randomization Period|Physician Decision|0|||
47052415|NCT01869959|83319382|FG002|Randomization Period|Physician Decision|0|||
47052416|NCT01869959|83319383|FG003|Randomization Period|Physician Decision|0|||
47052417|NCT01869959|83319384|FG004|Randomization Period|Physician Decision|1|||
47052418|NCT01869959|83319380|FG000|Treatment Period|Adverse Event|1|||
47052419|NCT01869959|83319381|FG001|Treatment Period|Adverse Event|0|||
47052420|NCT01869959|83319382|FG002|Treatment Period|Adverse Event|3|||
47052421|NCT01869959|83319383|FG003|Treatment Period|Adverse Event|1|||
47052422|NCT01869959|83319384|FG004|Treatment Period|Adverse Event|0|||
47052423|NCT01869959|83319380|FG000|Treatment Period|Sponsor decision|0|||
47052424|NCT01869959|83319381|FG001|Treatment Period|Sponsor decision|1|||
47052425|NCT01869959|83319382|FG002|Treatment Period|Sponsor decision|0|||
47052426|NCT01869959|83319383|FG003|Treatment Period|Sponsor decision|1|||
47052427|NCT01869959|83319384|FG004|Treatment Period|Sponsor decision|0|||
47052428|NCT01869959|83319380|FG000|Treatment Period|Withdrawal by Subject|0|||
47052429|NCT01869959|83319381|FG001|Treatment Period|Withdrawal by Subject|1|||
47052430|NCT01869959|83319382|FG002|Treatment Period|Withdrawal by Subject|0|||
46750376|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
46750377|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
46750378|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
46750379|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
46804767|NCT00535496|83023819|FG002|Overall Study|Lost to Follow-up|0|||
46804768|NCT00535496|83023820|FG003|Overall Study|Lost to Follow-up|0|||
46804769|NCT00535496|83023817|FG000|Overall Study|Not treated with sugammadex|0|||
46804770|NCT00535496|83023818|FG001|Overall Study|Not treated with sugammadex|1|||
46804771|NCT00535496|83023819|FG002|Overall Study|Not treated with sugammadex|0|||
46804772|NCT00535496|83023820|FG003|Overall Study|Not treated with sugammadex|0|||
46804773|NCT00539006|83023831|FG000|Pre-treatment|Other|0|||
46804774|NCT00539006|83023832|FG001|Pre-treatment|Other|1|||
46804775|NCT00539006|83023833|FG002|Pre-treatment|Other|0|||
46804776|NCT00539006|83023834|FG003|Pre-treatment|Other|0|||
46804777|NCT00539006|83023831|FG000|Treatment Period 1|Lost to Follow-up|0|||
46804778|NCT00539006|83023832|FG001|Treatment Period 1|Lost to Follow-up|0|||
46924373|NCT02643628|83158354|FG001|Overall Study|Lost to Follow-up|4|||
47052431|NCT01869959|83319383|FG003|Treatment Period|Withdrawal by Subject|0|||
46804779|NCT00539006|83023833|FG002|Treatment Period 1|Lost to Follow-up|1|||
46924374|NCT02643628|83158353|FG000|Overall Study|Withdrawal by Subject|0|||
46924375|NCT02643628|83158354|FG001|Overall Study|Withdrawal by Subject|1|||
46924376|NCT02643628|83158353|FG000|Overall Study|Relocated out of state|0|||
46924377|NCT02643628|83158354|FG001|Overall Study|Relocated out of state|1|||
46924378|NCT02643472|83158364|FG000|Overall Study|Death|2|||
46924379|NCT02643472|83158365|FG001|Overall Study|Death|5|||
46924380|NCT02643472|83158364|FG000|Overall Study|Withdrawal by Subject|3|||
46924381|NCT02643472|83158365|FG001|Overall Study|Withdrawal by Subject|2|||
46924382|NCT02643472|83158364|FG000|Overall Study|Protocol Violation|0|||
46924383|NCT02643472|83158365|FG001|Overall Study|Protocol Violation|1|||
46924384|NCT02643472|83158364|FG000|Overall Study|Lost to Follow-up|22|||
46924385|NCT02643472|83158365|FG001|Overall Study|Lost to Follow-up|26|||
46924386|NCT02738840|83158373|FG000|Overall Study|MRI Scan not Performed|5|||
46924387|NCT02738840|83158373|FG000|Overall Study|Lost to Follow-up|1|||
46924388|NCT02738840|83158373|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
46924389|NCT02738840|83158373|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
46924390|NCT02643394|83158379|FG000|Overall Study|Protocol Violation|4|||
46924391|NCT02643394|83158380|FG001|Overall Study|Protocol Violation|5|||
46924392|NCT03538158|83158388|FG000|Overall Study|Lost to Follow-up|13|||
46924393|NCT03538158|83158389|FG001|Overall Study|Lost to Follow-up|7|||
46924394|NCT03538158|83158388|FG000|Overall Study|Withdrawal by Subject|2|||
46924395|NCT03538158|83158389|FG001|Overall Study|Withdrawal by Subject|1|||
46924396|NCT02643082|83158395|FG000|Period 1|Adverse Event|1|||
46924397|NCT02643082|83158396|FG001|Period 1|Adverse Event|0|||
46924398|NCT00353496|83158405|FG000|Overall Study|Adverse Event|1|||
46924399|NCT00353496|83158406|FG001|Overall Study|Adverse Event|0|||
46924400|NCT00353496|83158405|FG000|Overall Study|Protocol Violation|2|||
46924401|NCT00353496|83158406|FG001|Overall Study|Protocol Violation|2|||
46924402|NCT00353496|83158405|FG000|Overall Study|Withdrawal by Subject|3|||
46924403|NCT00353496|83158406|FG001|Overall Study|Withdrawal by Subject|4|||
46924404|NCT00353496|83158405|FG000|Overall Study|Physician Decision|6|||
46924405|NCT00353496|83158406|FG001|Overall Study|Physician Decision|9|||
46924406|NCT00353496|83158405|FG000|Overall Study|Not otherwise specified|4|||
46924407|NCT00353496|83158406|FG001|Overall Study|Not otherwise specified|2|||
46924408|NCT01361464|83158422|FG000|Overall Study|Death|1|||
46924409|NCT01361464|83158422|FG000|Overall Study|Withdrawal by Subject|2|||
46924410|NCT03486912|83158430|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
46924411|NCT03486912|83158431|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
46924412|NCT03486912|83158432|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
46924413|NCT03486912|83158433|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
46924414|NCT03486912|83158430|FG000|Treatment Period|Withdrawal by Subject|3|||
46924415|NCT03486912|83158431|FG001|Treatment Period|Withdrawal by Subject|3|||
46924416|NCT03486912|83158432|FG002|Treatment Period|Withdrawal by Subject|3|||
46924417|NCT03486912|83158433|FG003|Treatment Period|Withdrawal by Subject|2|||
46924418|NCT03486912|83158430|FG000|Treatment Period|Other Reasons|0|||
46924419|NCT03486912|83158431|FG001|Treatment Period|Other Reasons|2|||
46924420|NCT03486912|83158432|FG002|Treatment Period|Other Reasons|1|||
46924421|NCT03486912|83158433|FG003|Treatment Period|Other Reasons|1|||
46924422|NCT03486912|83158430|FG000|Treatment Period|Adverse Event|0|||
46924423|NCT03486912|83158431|FG001|Treatment Period|Adverse Event|1|||
46924424|NCT03486912|83158432|FG002|Treatment Period|Adverse Event|1|||
46924425|NCT03486912|83158433|FG003|Treatment Period|Adverse Event|0|||
46924426|NCT03486912|83158430|FG000|Treatment Period|Lost to Follow-up|1|||
46924427|NCT03486912|83158431|FG001|Treatment Period|Lost to Follow-up|0|||
46924428|NCT03486912|83158432|FG002|Treatment Period|Lost to Follow-up|0|||
46924429|NCT03486912|83158433|FG003|Treatment Period|Lost to Follow-up|2|||
46924430|NCT02642614|83158447|FG000|Overall Study|Adverse Event|1|||
46924431|NCT02642614|83158448|FG001|Overall Study|Adverse Event|1|||
47052432|NCT01869959|83319384|FG004|Treatment Period|Withdrawal by Subject|0|||
47052433|NCT01613027|83319445|FG000|Overall Study|Lost to Follow-up|5|||
47052434|NCT01613027|83319445|FG000|Overall Study|Switched Physician|1|||
46924432|NCT02642614|83158449|FG002|Overall Study|Adverse Event|2|||
46924433|NCT02642614|83158450|FG003|Overall Study|Adverse Event|2|||
46924434|NCT02642614|83158447|FG000|Overall Study|Lost to Follow-up|1|||
46924435|NCT02642614|83158448|FG001|Overall Study|Lost to Follow-up|0|||
46924436|NCT02642614|83158449|FG002|Overall Study|Lost to Follow-up|0|||
46924437|NCT02642614|83158450|FG003|Overall Study|Lost to Follow-up|0|||
46924438|NCT02642614|83158447|FG000|Overall Study|Withdrawal by Subject|1|||
46924439|NCT02642614|83158448|FG001|Overall Study|Withdrawal by Subject|1|||
46924440|NCT02642614|83158449|FG002|Overall Study|Withdrawal by Subject|0|||
46924441|NCT02642614|83158450|FG003|Overall Study|Withdrawal by Subject|0|||
46924442|NCT02781324|83158465|FG000|Overall Study|Withdrawal by Subject|1|||
46924443|NCT02781324|83158466|FG001|Overall Study|Withdrawal by Subject|0|||
46924444|NCT02781324|83158465|FG000|Overall Study|Physician Decision|1|||
47052435|NCT01613027|83319445|FG000|Overall Study|Lack of Efficacy|1|||
46924445|NCT02781324|83158466|FG001|Overall Study|Physician Decision|2|||
46924446|NCT03292146|83158476|FG000|Baseline to 12 Months|Relocation|1|||
47052436|NCT01613027|83319445|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
46924447|NCT03292146|83158477|FG001|Baseline to 12 Months|Relocation|0|||
46924448|NCT03292146|83158476|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
46924449|NCT03292146|83158477|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
46924450|NCT03292146|83158476|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
46924451|NCT03292146|83158477|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
46924452|NCT03292146|83158476|FG000|12 Months to 24 Months|Planning pregnancy|2|||
46924453|NCT03292146|83158477|FG001|12 Months to 24 Months|Planning pregnancy|2|||
46924454|NCT03292146|83158476|FG000|12 Months to 24 Months|Personal reasons|1|||
46924455|NCT03292146|83158477|FG001|12 Months to 24 Months|Personal reasons|0|||
46924456|NCT03292146|83158476|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
46924457|NCT03292146|83158477|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
46924458|NCT01360996|83158486|FG000|Overall Study|Withdrawal by Subject|4|||
46924459|NCT01360996|83158487|FG001|Overall Study|Withdrawal by Subject|3|||
46924460|NCT01360996|83158488|FG002|Overall Study|Withdrawal by Subject|2|||
46924461|NCT01360996|83158486|FG000|Overall Study|Noncompliant|2|||
46924462|NCT01360996|83158487|FG001|Overall Study|Noncompliant|0|||
46924463|NCT01360996|83158488|FG002|Overall Study|Noncompliant|0|||
46804780|NCT00539006|83023834|FG003|Treatment Period 1|Lost to Follow-up|0|||
46804781|NCT00539006|83023831|FG000|Treatment Period 1|Protocol Violation|0|||
46924464|NCT02639338|83158497|FG000|Overall Study|Lost to Follow-up|2|||
46924465|NCT02639338|83158498|FG001|Overall Study|Lost to Follow-up|2|||
46924466|NCT02639338|83158497|FG000|Overall Study|Withdrew Consent|1|||
46924467|NCT02639338|83158498|FG001|Overall Study|Withdrew Consent|2|||
46924468|NCT02639338|83158497|FG000|Overall Study|Death|1|||
46924469|NCT02639338|83158498|FG001|Overall Study|Death|0|||
46924470|NCT02639338|83158497|FG000|Overall Study|Randomized but Not Treated|0|||
46924471|NCT02639338|83158498|FG001|Overall Study|Randomized but Not Treated|1|||
46924472|NCT01754857|83158504|FG000|Overall Study|Adverse Event|7|||
46924473|NCT01754857|83158504|FG000|Overall Study|Disease progression|3|||
46924474|NCT01754857|83158504|FG000|Overall Study|Physician Decision|2|||
46924475|NCT01754857|83158504|FG000|Overall Study|Withdrawal by Subject|3|||
46924476|NCT01754857|83158504|FG000|Overall Study|other complicating disease|1|||
46635772|NCT01575054|82809560|FG000|Overall Study|Other Reasons|5|||
46635773|NCT01575054|82809561|FG001|Overall Study|Other Reasons|3|||
46635774|NCT01575054|82809560|FG000|Overall Study|Protocol Violation|2|||
46635775|NCT01575054|82809561|FG001|Overall Study|Protocol Violation|1|||
46635776|NCT01575054|82809560|FG000|Overall Study|Personal Reasons|10|||
46635777|NCT01575054|82809561|FG001|Overall Study|Personal Reasons|11|||
46635778|NCT01575054|82809560|FG000|Overall Study|Lost to Follow-up|3|||
46635779|NCT01575054|82809561|FG001|Overall Study|Lost to Follow-up|3|||
46635780|NCT01575054|82809560|FG000|Overall Study|Adverse Event|9|||
46635781|NCT01575054|82809561|FG001|Overall Study|Adverse Event|8|||
46635782|NCT01528254|82809569|FG000|Overall Study|Administrative problems|96|||
46635783|NCT01528254|82809570|FG001|Overall Study|Administrative problems|94|||
46635784|NCT01528254|82809569|FG000|Overall Study|Adverse Event|28|||
46635785|NCT01528254|82809570|FG001|Overall Study|Adverse Event|44|||
46635786|NCT01528254|82809569|FG000|Overall Study|Lost to Follow-up|17|||
46635787|NCT01528254|82809570|FG001|Overall Study|Lost to Follow-up|24|||
46635788|NCT01528254|82809569|FG000|Overall Study|Death|13|||
46635789|NCT01528254|82809570|FG001|Overall Study|Death|9|||
46635790|NCT01528254|82809569|FG000|Overall Study|Protocol deviation|9|||
46635791|NCT01528254|82809570|FG001|Overall Study|Protocol deviation|19|||
46635792|NCT01528254|82809569|FG000|Overall Study|New therapy for study indication|8|||
46635793|NCT01528254|82809570|FG001|Overall Study|New therapy for study indication|6|||
46635794|NCT01528254|82809569|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
46635795|NCT01528254|82809570|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
46635796|NCT01528254|82809569|FG000|Overall Study|Withdrawal by Subject|5|||
46635797|NCT01528254|82809570|FG001|Overall Study|Withdrawal by Subject|4|||
46635798|NCT01528254|82809569|FG000|Overall Study|Abnormal laboratory value(s)|3|||
46635799|NCT01528254|82809570|FG001|Overall Study|Abnormal laboratory value(s)|7|||
46635800|NCT01528254|82809569|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46635801|NCT01528254|82809570|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46924477|NCT01754857|83158504|FG000|Overall Study|ineligible to continue onto maintenance|1|||
46924478|NCT01754857|83158504|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
46924479|NCT01754857|83158504|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
46924480|NCT02900352|83158510|FG000|Overall Study|Lost to Follow-up|28|||
46924481|NCT02900352|83158511|FG001|Overall Study|Lost to Follow-up|17|||
46635802|NCT01528254|82809569|FG000|Overall Study|No longer requires study drug|1|||
46924482|NCT03040687|83158520|FG000|Overall Study|Withdrawal by Subject|1|||
46635803|NCT01528254|82809570|FG001|Overall Study|No longer requires study drug|1|||
46635804|NCT01574352|82809579|FG000|Overall Study|Withdrawal by Subject|6|||
46635805|NCT01574352|82809580|FG001|Overall Study|Withdrawal by Subject|13|||
46635806|NCT01574352|82809579|FG000|Overall Study|Injury in non-camp related sport|1|||
46635807|NCT01574352|82809580|FG001|Overall Study|Injury in non-camp related sport|0|||
46635808|NCT01527006|82809588|FG000|Core Study|Adverse Event|0|||
46635809|NCT01527006|82809589|FG001|Core Study|Adverse Event|2|||
46635810|NCT01527006|82809588|FG000|Core Study|Lost to Follow-up|0|||
46635811|NCT01527006|82809589|FG001|Core Study|Lost to Follow-up|1|||
46635812|NCT01527006|82809588|FG000|Core Study|Subject Choice|1|||
46635813|NCT01527006|82809589|FG001|Core Study|Subject Choice|0|||
46635814|NCT01527006|82809588|FG000|Core Study|Inadequate Therapeutic Effect|1|||
46635815|NCT01527006|82809589|FG001|Core Study|Inadequate Therapeutic Effect|0|||
46635816|NCT01527006|82809588|FG000|Core Study|Withdrawal by Subject|0|||
46635817|NCT01527006|82809589|FG001|Core Study|Withdrawal by Subject|1|||
46635818|NCT01527006|82809588|FG000|Core Study|Other|0|||
46635819|NCT01527006|82809589|FG001|Core Study|Other|2|||
46635820|NCT01527006|82809588|FG000|Extension Phase|Adverse Event|4|||
46635821|NCT01527006|82809589|FG001|Extension Phase|Adverse Event|2|||
46635822|NCT01527006|82809588|FG000|Extension Phase|Lost to Follow-up|0|||
46635823|NCT01527006|82809589|FG001|Extension Phase|Lost to Follow-up|1|||
46635824|NCT01527006|82809588|FG000|Extension Phase|Subject Choice|1|||
46635825|NCT01527006|82809589|FG001|Extension Phase|Subject Choice|1|||
46635826|NCT01527006|82809588|FG000|Extension Phase|Inadequate therapeutic effect|1|||
46635827|NCT01527006|82809589|FG001|Extension Phase|Inadequate therapeutic effect|1|||
46635828|NCT01527006|82809588|FG000|Extension Phase|Other|0|||
46635829|NCT01527006|82809589|FG001|Extension Phase|Other|3|||
46635830|NCT01526928|82809607|FG000|Overall Study|Progressive Disease|35|||
46635831|NCT01526928|82809608|FG001|Overall Study|Progressive Disease|17|||
46750380|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
46750381|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
46750382|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
46750383|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
46750384|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
46750385|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
46750386|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Death|0|||
46750387|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Death|6|||
46750388|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Death|3|||
46750389|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Death|0|||
46750390|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Death|0|||
46750391|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
46750392|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
46750393|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
46750394|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
46750395|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
46750396|NCT00561925|82968472|FG000|144-week Double-blind, Double-dummy|Other|0|||
46750397|NCT00561925|82968473|FG001|144-week Double-blind, Double-dummy|Other|8|||
46750398|NCT00561925|82968474|FG002|144-week Double-blind, Double-dummy|Other|11|||
46750399|NCT00561925|82968475|FG003|144-week Double-blind, Double-dummy|Other|0|||
46750400|NCT00561925|82968476|FG004|144-week Double-blind, Double-dummy|Other|0|||
46750401|NCT00561925|82968472|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
46750402|NCT00561925|82968473|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
46750403|NCT00561925|82968474|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
46750404|NCT00561925|82968475|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
46750405|NCT00561925|82968476|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
46750406|NCT00549445|82968496|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
46750407|NCT00549445|82968497|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
46750408|NCT00601107|82968507|FG000|Overall Study|Adverse Event|0|||
46750409|NCT00601107|82968508|FG001|Overall Study|Adverse Event|1|||
46750410|NCT00601107|82968509|FG002|Overall Study|Adverse Event|3|||
46750411|NCT00601107|82968510|FG003|Overall Study|Adverse Event|0|||
46750412|NCT00601107|82968507|FG000|Overall Study|Withdrawal by Subject|5|||
46750413|NCT00601107|82968508|FG001|Overall Study|Withdrawal by Subject|4|||
46750414|NCT00601107|82968509|FG002|Overall Study|Withdrawal by Subject|7|||
46804782|NCT00539006|83023832|FG001|Treatment Period 1|Protocol Violation|0|||
46635832|NCT01526928|82809609|FG002|Overall Study|Progressive Disease|150|||
46635833|NCT01526928|82809610|FG003|Overall Study|Progressive Disease|182|||
46635834|NCT01526928|82809611|FG004|Overall Study|Progressive Disease|76|||
46635835|NCT01526928|82809612|FG005|Overall Study|Progressive Disease|4|||
46750415|NCT00601107|82968510|FG003|Overall Study|Withdrawal by Subject|4|||
46750416|NCT00601107|82968507|FG000|Overall Study|Lost to Follow-up|3|||
46750417|NCT00601107|82968508|FG001|Overall Study|Lost to Follow-up|3|||
46750418|NCT00601107|82968509|FG002|Overall Study|Lost to Follow-up|0|||
46750419|NCT00601107|82968510|FG003|Overall Study|Lost to Follow-up|3|||
46750420|NCT00601107|82968507|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
46635836|NCT01526928|82809607|FG000|Overall Study|Adverse Event|2|||
46635837|NCT01526928|82809608|FG001|Overall Study|Adverse Event|1|||
46635838|NCT01526928|82809609|FG002|Overall Study|Adverse Event|29|||
46635839|NCT01526928|82809610|FG003|Overall Study|Adverse Event|40|||
46635840|NCT01526928|82809611|FG004|Overall Study|Adverse Event|13|||
46750421|NCT00601107|82968508|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
46750422|NCT00601107|82968509|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
46750423|NCT00601107|82968510|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
46750424|NCT00601107|82968507|FG000|Overall Study|Worsening of Psoriasis|4|||
46750425|NCT00601107|82968508|FG001|Overall Study|Worsening of Psoriasis|1|||
46750426|NCT00601107|82968509|FG002|Overall Study|Worsening of Psoriasis|1|||
46750427|NCT00601107|82968510|FG003|Overall Study|Worsening of Psoriasis|4|||
46750428|NCT00601107|82968507|FG000|Overall Study|Undefined|1|||
46750429|NCT00601107|82968508|FG001|Overall Study|Undefined|0|||
46750430|NCT00601107|82968509|FG002|Overall Study|Undefined|1|||
46750431|NCT00601107|82968510|FG003|Overall Study|Undefined|0|||
46750432|NCT00914927|82968527|FG000|Overall Study|Adverse Event|0|||
46750433|NCT00914927|82968528|FG001|Overall Study|Adverse Event|0|||
46750434|NCT00914927|82968529|FG002|Overall Study|Adverse Event|0|||
46750435|NCT00914927|82968530|FG003|Overall Study|Adverse Event|0|||
46750436|NCT00914927|82968531|FG004|Overall Study|Adverse Event|1|||
46750437|NCT00914927|82968532|FG005|Overall Study|Adverse Event|0|||
46750438|NCT00914927|82968533|FG006|Overall Study|Adverse Event|0|||
46750439|NCT00914927|82968527|FG000|Overall Study|Withdrawal by Subject|0|||
46750440|NCT00914927|82968528|FG001|Overall Study|Withdrawal by Subject|1|||
46750441|NCT00914927|82968529|FG002|Overall Study|Withdrawal by Subject|0|||
46750442|NCT00914927|82968530|FG003|Overall Study|Withdrawal by Subject|1|||
46750443|NCT00914927|82968531|FG004|Overall Study|Withdrawal by Subject|0|||
46750444|NCT00914927|82968532|FG005|Overall Study|Withdrawal by Subject|0|||
46750445|NCT00914927|82968533|FG006|Overall Study|Withdrawal by Subject|0|||
46750446|NCT00914927|82968527|FG000|Overall Study|Lost to Follow-up|0|||
46750447|NCT00914927|82968528|FG001|Overall Study|Lost to Follow-up|0|||
46750448|NCT00914927|82968529|FG002|Overall Study|Lost to Follow-up|0|||
46750449|NCT00914927|82968530|FG003|Overall Study|Lost to Follow-up|1|||
46750450|NCT00914927|82968531|FG004|Overall Study|Lost to Follow-up|0|||
46750451|NCT00914927|82968532|FG005|Overall Study|Lost to Follow-up|0|||
46750452|NCT00914927|82968533|FG006|Overall Study|Lost to Follow-up|0|||
46750453|NCT00914927|82968527|FG000|Overall Study|Administrative/Other|2|||
46750454|NCT00914927|82968528|FG001|Overall Study|Administrative/Other|1|||
46750455|NCT00914927|82968529|FG002|Overall Study|Administrative/Other|0|||
46750456|NCT00914927|82968530|FG003|Overall Study|Administrative/Other|0|||
46750457|NCT00914927|82968531|FG004|Overall Study|Administrative/Other|1|||
46750458|NCT00914927|82968532|FG005|Overall Study|Administrative/Other|0|||
46750459|NCT00914927|82968533|FG006|Overall Study|Administrative/Other|0|||
46750460|NCT00914849|82968560|FG000|Overall Study|Withdrawal by Subject|1|||
46750461|NCT00914849|82968561|FG001|Overall Study|Withdrawal by Subject|0|||
46750462|NCT00914849|82968560|FG000|Overall Study|Not eligible|0|||
46750463|NCT00914849|82968561|FG001|Overall Study|Not eligible|1|||
46750464|NCT00912743|82968569|FG000|Overall Study|Adverse Event|3|||
46750465|NCT00912743|82968570|FG001|Overall Study|Adverse Event|1|||
46750466|NCT00912743|82968569|FG000|Overall Study|Lack of Efficacy|9|||
46750467|NCT00912743|82968570|FG001|Overall Study|Lack of Efficacy|18|||
46750468|NCT00912743|82968569|FG000|Overall Study|Toxicity|0|||
46750469|NCT00912743|82968570|FG001|Overall Study|Toxicity|1|||
46750470|NCT00912743|82968569|FG000|Overall Study|End of treatment form was not collected|1|||
46750471|NCT00912743|82968570|FG001|Overall Study|End of treatment form was not collected|0|||
46750472|NCT00914459|82968578|FG000|Overall Study|Protocol Violation|0|||
46750473|NCT00914459|82968579|FG001|Overall Study|Protocol Violation|1|||
46750474|NCT00914459|82968578|FG000|Overall Study|Parent/Legal guardian request|1|||
46750475|NCT00914459|82968579|FG001|Overall Study|Parent/Legal guardian request|0|||
46750476|NCT00912509|82968589|FG000|Overall Study|Lost to Follow-up|1|||
46750477|NCT00912509|82968590|FG001|Overall Study|Lost to Follow-up|0|||
46750478|NCT00912509|82968589|FG000|Overall Study|Lack of Efficacy|4|||
46750479|NCT00912509|82968590|FG001|Overall Study|Lack of Efficacy|3|||
46750480|NCT00913835|82968610|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
46635841|NCT01526928|82809612|FG005|Overall Study|Adverse Event|2|||
46635842|NCT01526928|82809607|FG000|Overall Study|Death|0|||
46750481|NCT00913835|82968611|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
46750482|NCT00913835|82968610|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
46750483|NCT00913835|82968611|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
46750484|NCT00913835|82968610|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
46635843|NCT01526928|82809608|FG001|Overall Study|Death|0|||
46750485|NCT00913835|82968611|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
46750486|NCT00913835|82968610|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
46750487|NCT00913835|82968611|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
46750488|NCT00913835|82968610|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
46750489|NCT00913835|82968611|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
46750490|NCT00913523|82968636|FG000|Overall Study|Withdrawal by Subject|3|||
46750491|NCT00913523|82968637|FG001|Overall Study|Withdrawal by Subject|2|||
46750492|NCT00913523|82968638|FG002|Overall Study|Withdrawal by Subject|2|||
46635844|NCT01526928|82809609|FG002|Overall Study|Death|3|||
47052437|NCT01869725|83319463|FG000|Overall Study|ineligible after registration|1|||
47052438|NCT01869725|83319463|FG000|Overall Study|Death|1|||
47052439|NCT01869725|83319463|FG000|Overall Study|Lost to Follow-up|2|||
46750493|NCT00913523|82968636|FG000|Overall Study|Lost to Follow-up|1|||
46635845|NCT01526928|82809610|FG003|Overall Study|Death|0|||
46635846|NCT01526928|82809611|FG004|Overall Study|Death|0|||
46750494|NCT00913523|82968637|FG001|Overall Study|Lost to Follow-up|1|||
46750495|NCT00913523|82968638|FG002|Overall Study|Lost to Follow-up|1|||
46750496|NCT00913523|82968636|FG000|Overall Study|Adverse Event|1|||
46750497|NCT00913523|82968637|FG001|Overall Study|Adverse Event|0|||
46750498|NCT00913523|82968638|FG002|Overall Study|Adverse Event|0|||
46750499|NCT00913523|82968636|FG000|Overall Study|Protocol Violation|5|||
46750500|NCT00913523|82968637|FG001|Overall Study|Protocol Violation|8|||
46750501|NCT00913523|82968638|FG002|Overall Study|Protocol Violation|8|||
46750502|NCT00913523|82968636|FG000|Overall Study|Pregnancy|1|||
46750503|NCT00913523|82968637|FG001|Overall Study|Pregnancy|3|||
46750504|NCT00913523|82968638|FG002|Overall Study|Pregnancy|0|||
46750505|NCT00913523|82968636|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
46750506|NCT00913523|82968637|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
46750507|NCT00913523|82968638|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
46750508|NCT00912197|82968648|FG000|Overall Study|Withdrawal by Subject|3|||
46750509|NCT00912197|82968649|FG001|Overall Study|Withdrawal by Subject|3|||
46750510|NCT00910247|82968657|FG000|Overall Study|Adverse Event|15|||
46750511|NCT00910247|82968657|FG000|Overall Study|Death|2|||
46750512|NCT00910247|82968657|FG000|Overall Study|Lost to Follow-up|10|||
46750513|NCT00910247|82968657|FG000|Overall Study|Physician Decision|3|||
46750514|NCT00910247|82968657|FG000|Overall Study|Protocol Violation|10|||
46750515|NCT00910247|82968657|FG000|Overall Study|Withdrawal by Subject|25|||
46750516|NCT00910247|82968657|FG000|Overall Study|Not collected|4|||
46750517|NCT00659334|82968668|FG000|Overall Study|Screen Failure|8|||
46750518|NCT00659334|82968669|FG001|Overall Study|Screen Failure|5|||
46750519|NCT00659334|82968670|FG002|Overall Study|Screen Failure|0|||
46750520|NCT00659334|82968671|FG003|Overall Study|Screen Failure|0|||
46750521|NCT00659334|82968672|FG004|Overall Study|Screen Failure|0|||
46750522|NCT00659334|82968673|FG005|Overall Study|Screen Failure|0|||
46750523|NCT00659334|82968674|FG006|Overall Study|Screen Failure|1|||
46750524|NCT00910091|82968696|FG000|Pre-assignment|Withdrawal by Subject|0|||
46750525|NCT00910091|82968697|FG001|Pre-assignment|Withdrawal by Subject|2|||
46750526|NCT00910091|82968696|FG000|Treatment and Survival|Withdrawal by Subject|3|||
46750527|NCT00910091|82968697|FG001|Treatment and Survival|Withdrawal by Subject|4|||
46750528|NCT00910091|82968696|FG000|Treatment and Survival|Adverse Event|1|||
46750529|NCT00910091|82968697|FG001|Treatment and Survival|Adverse Event|0|||
46750530|NCT00909857|82968706|FG000|Overall Study|Withdrawal by Subject|6|||
46750531|NCT00909857|82968707|FG001|Overall Study|Withdrawal by Subject|10|||
46750532|NCT00909857|82968706|FG000|Overall Study|Adverse Event|5|||
47052440|NCT01851863|83319484|FG000|Overall Study|Did not receive study medication|2|||
47052441|NCT01851863|83319485|FG001|Overall Study|Did not receive study medication|5|||
47052442|NCT01851863|83319486|FG002|Overall Study|Did not receive study medication|3|||
47052443|NCT01851863|83319487|FG003|Overall Study|Did not receive study medication|0|||
47052444|NCT01851863|83319484|FG000|Overall Study|Lost to Follow-up|3|||
47052445|NCT01851863|83319485|FG001|Overall Study|Lost to Follow-up|4|||
47052446|NCT01851863|83319486|FG002|Overall Study|Lost to Follow-up|2|||
47052447|NCT01851863|83319487|FG003|Overall Study|Lost to Follow-up|3|||
47052448|NCT01850615|83319515|FG000|Overall Study|Protocol Violation|4|||
47052449|NCT01850615|83319516|FG001|Overall Study|Protocol Violation|1|||
47052450|NCT01850615|83319515|FG000|Overall Study|Adverse Event|2|||
47052451|NCT01850615|83319516|FG001|Overall Study|Adverse Event|1|||
47052452|NCT01850615|83319515|FG000|Overall Study|Withdrawal by Subject|3|||
47052453|NCT01850615|83319516|FG001|Overall Study|Withdrawal by Subject|1|||
47052454|NCT01850615|83319515|FG000|Overall Study|Lost to Follow-up|0|||
47052455|NCT01850615|83319516|FG001|Overall Study|Lost to Follow-up|1|||
47052456|NCT01850615|83319515|FG000|Overall Study|Unclassified|0|||
47052457|NCT01850615|83319516|FG001|Overall Study|Unclassified|1|||
47052458|NCT01868477|83319601|FG000|Overall Study|Adverse Event|2|||
47052459|NCT01868477|83319602|FG001|Overall Study|Adverse Event|4|||
47052460|NCT01868477|83319601|FG000|Overall Study|Disease progression|1|||
47052461|NCT01868477|83319602|FG001|Overall Study|Disease progression|1|||
47052462|NCT01868477|83319601|FG000|Overall Study|Withdrawal by Subject|1|||
47052463|NCT01868477|83319602|FG001|Overall Study|Withdrawal by Subject|0|||
47052464|NCT01849289|83319617|FG000|Overall Study|Adverse Event|3|||
46750533|NCT00909857|82968707|FG001|Overall Study|Adverse Event|5|||
46750534|NCT00909857|82968706|FG000|Overall Study|Lost to Follow-up|2|||
46750535|NCT00909857|82968707|FG001|Overall Study|Lost to Follow-up|5|||
47052465|NCT01849289|83319618|FG001|Overall Study|Adverse Event|3|||
47052466|NCT01849289|83319617|FG000|Overall Study|Protocol Violation|3|||
47052467|NCT01849289|83319618|FG001|Overall Study|Protocol Violation|3|||
47052468|NCT01849289|83319617|FG000|Overall Study|Withdrawal criteria|1|||
47052469|NCT01849289|83319618|FG001|Overall Study|Withdrawal criteria|0|||
46635847|NCT01526928|82809612|FG005|Overall Study|Death|0|||
46750536|NCT00909857|82968706|FG000|Overall Study|Protocol Violation|2|||
46750537|NCT00909857|82968707|FG001|Overall Study|Protocol Violation|1|||
46750538|NCT00909857|82968706|FG000|Overall Study|Pregnancy|1|||
46750539|NCT00909857|82968707|FG001|Overall Study|Pregnancy|0|||
46750540|NCT00909857|82968706|FG000|Overall Study|Other|1|||
46750541|NCT00909857|82968707|FG001|Overall Study|Other|0|||
46750542|NCT00909857|82968706|FG000|Overall Study|Did not receive study medication|19|||
46750543|NCT00909857|82968707|FG001|Overall Study|Did not receive study medication|24|||
46750544|NCT00911807|82968716|FG000|Overall Study|Adverse Event|2|||
46750545|NCT00911807|82968717|FG001|Overall Study|Adverse Event|1|||
46750546|NCT00911807|82968718|FG002|Overall Study|Adverse Event|5|||
46750547|NCT00911807|82968716|FG000|Overall Study|Death|0|||
46750548|NCT00911807|82968717|FG001|Overall Study|Death|0|||
46750549|NCT00911807|82968718|FG002|Overall Study|Death|1|||
46750550|NCT00911807|82968716|FG000|Overall Study|Protocol Violation|6|||
46750551|NCT00911807|82968717|FG001|Overall Study|Protocol Violation|4|||
46750552|NCT00911807|82968718|FG002|Overall Study|Protocol Violation|9|||
46750553|NCT00911807|82968716|FG000|Overall Study|Withdrawal by Subject|8|||
46750554|NCT00911807|82968717|FG001|Overall Study|Withdrawal by Subject|10|||
46750555|NCT00911807|82968718|FG002|Overall Study|Withdrawal by Subject|7|||
46750556|NCT00911807|82968716|FG000|Overall Study|Organizational reasons|1|||
46750557|NCT00911807|82968717|FG001|Overall Study|Organizational reasons|3|||
46750558|NCT00911807|82968718|FG002|Overall Study|Organizational reasons|1|||
46750559|NCT04287920|82968745|FG000|Overall Study|Lost to Follow-up|1|||
46750560|NCT04287920|82968746|FG001|Overall Study|Lost to Follow-up|1|||
46750561|NCT04287920|82968745|FG000|Overall Study|Withdrawal by Subject|0|||
46750562|NCT04287920|82968746|FG001|Overall Study|Withdrawal by Subject|3|||
46750563|NCT00909779|82968754|FG000|Overall Study|Adverse Event|53|||
46750564|NCT00909779|82968755|FG001|Overall Study|Adverse Event|55|||
46750565|NCT00909779|82968754|FG000|Overall Study|Lack of Efficacy|7|||
46750566|NCT00909779|82968755|FG001|Overall Study|Lack of Efficacy|4|||
46750567|NCT00909779|82968754|FG000|Overall Study|Lost to Follow-up|19|||
46750568|NCT00909779|82968755|FG001|Overall Study|Lost to Follow-up|15|||
46750569|NCT00909779|82968754|FG000|Overall Study|Physician Decision|8|||
46750570|NCT00909779|82968755|FG001|Overall Study|Physician Decision|2|||
46750571|NCT00909779|82968754|FG000|Overall Study|Protocol Violation|2|||
46750572|NCT00909779|82968755|FG001|Overall Study|Protocol Violation|5|||
46750573|NCT00909779|82968754|FG000|Overall Study|Withdrawal by Subject|116|||
46750574|NCT00909779|82968755|FG001|Overall Study|Withdrawal by Subject|80|||
46750575|NCT00909779|82968754|FG000|Overall Study|Site Ceasing Operation|2|||
46750576|NCT00909779|82968755|FG001|Overall Study|Site Ceasing Operation|2|||
46750577|NCT00909779|82968754|FG000|Overall Study|Medical Monitor Decision|1|||
46750578|NCT00909779|82968755|FG001|Overall Study|Medical Monitor Decision|0|||
46750579|NCT00909779|82968754|FG000|Overall Study|Noncompliance|1|||
46750580|NCT00909779|82968755|FG001|Overall Study|Noncompliance|1|||
46750581|NCT00909779|82968754|FG000|Overall Study|Randomized in error|1|||
46750582|NCT00909779|82968755|FG001|Overall Study|Randomized in error|1|||
46750583|NCT00910871|82968763|FG000|Overall Study|Adverse Event|5|||
46750584|NCT00910871|82968763|FG000|Overall Study|Death|12|||
46750585|NCT00910871|82968763|FG000|Overall Study|Lost to Follow-up|8|||
46750586|NCT00910871|82968763|FG000|Overall Study|Protocol Violation|11|||
46750587|NCT00910871|82968763|FG000|Overall Study|Withdrawal by Subject|12|||
46750588|NCT00910871|82968763|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
46750589|NCT00910871|82968763|FG000|Overall Study|Undefined|1|||
46750590|NCT02631941|82968788|FG000|Overall Study|Physician Decision|0|||
46750591|NCT02631941|82968789|FG001|Overall Study|Physician Decision|1|||
46750592|NCT02631941|82968790|FG002|Overall Study|Physician Decision|0|||
46750593|NCT02631941|82968791|FG003|Overall Study|Physician Decision|0|||
46750594|NCT02631941|82968792|FG004|Overall Study|Physician Decision|0|||
46750595|NCT02631941|82968793|FG005|Overall Study|Physician Decision|0|||
46750596|NCT02631941|82968794|FG006|Overall Study|Physician Decision|0|||
46750597|NCT02631941|82968795|FG007|Overall Study|Physician Decision|0|||
46750598|NCT02631941|82968796|FG008|Overall Study|Physician Decision|0|||
46750599|NCT02631941|82968797|FG009|Overall Study|Physician Decision|0|||
46750600|NCT02631941|82968788|FG000|Overall Study|Adverse Event|0|||
46750601|NCT02631941|82968789|FG001|Overall Study|Adverse Event|1|||
46750602|NCT02631941|82968790|FG002|Overall Study|Adverse Event|0|||
46750603|NCT02631941|82968791|FG003|Overall Study|Adverse Event|0|||
46750604|NCT02631941|82968792|FG004|Overall Study|Adverse Event|0|||
46750605|NCT02631941|82968793|FG005|Overall Study|Adverse Event|0|||
46750606|NCT02631941|82968794|FG006|Overall Study|Adverse Event|0|||
46750607|NCT02631941|82968795|FG007|Overall Study|Adverse Event|0|||
46750608|NCT02631941|82968796|FG008|Overall Study|Adverse Event|0|||
46750609|NCT02631941|82968797|FG009|Overall Study|Adverse Event|0|||
46750610|NCT02631941|82968788|FG000|Overall Study|Withdrawal by Subject|0|||
46750611|NCT02631941|82968789|FG001|Overall Study|Withdrawal by Subject|0|||
46750612|NCT02631941|82968790|FG002|Overall Study|Withdrawal by Subject|0|||
46750613|NCT02631941|82968791|FG003|Overall Study|Withdrawal by Subject|0|||
46750614|NCT02631941|82968792|FG004|Overall Study|Withdrawal by Subject|1|||
46750615|NCT02631941|82968793|FG005|Overall Study|Withdrawal by Subject|0|||
46750616|NCT02631941|82968794|FG006|Overall Study|Withdrawal by Subject|0|||
46750617|NCT02631941|82968795|FG007|Overall Study|Withdrawal by Subject|1|||
46750618|NCT02631941|82968796|FG008|Overall Study|Withdrawal by Subject|0|||
46750619|NCT02631941|82968797|FG009|Overall Study|Withdrawal by Subject|0|||
46750620|NCT02631941|82968788|FG000|Overall Study|Lost to Follow-up|0|||
46750621|NCT02631941|82968789|FG001|Overall Study|Lost to Follow-up|0|||
46750622|NCT02631941|82968790|FG002|Overall Study|Lost to Follow-up|0|||
46750623|NCT02631941|82968791|FG003|Overall Study|Lost to Follow-up|0|||
46750624|NCT02631941|82968792|FG004|Overall Study|Lost to Follow-up|0|||
46750625|NCT02631941|82968793|FG005|Overall Study|Lost to Follow-up|0|||
46750626|NCT02631941|82968794|FG006|Overall Study|Lost to Follow-up|0|||
46750627|NCT02631941|82968795|FG007|Overall Study|Lost to Follow-up|0|||
46750628|NCT02631941|82968796|FG008|Overall Study|Lost to Follow-up|1|||
46750629|NCT02631941|82968797|FG009|Overall Study|Lost to Follow-up|0|||
46750630|NCT00908375|82968809|FG000|Overall Study|Withdrawal by Subject|2|||
46750631|NCT00908375|82968810|FG001|Overall Study|Withdrawal by Subject|4|||
46750632|NCT00908375|82968809|FG000|Overall Study|Lost to Follow-up|8|||
46750633|NCT00908375|82968810|FG001|Overall Study|Lost to Follow-up|6|||
46750634|NCT00909389|82968816|FG000|Overall Study|Adverse Event|6|||
46750635|NCT00909389|82968816|FG000|Overall Study|Death|4|||
46750636|NCT00909389|82968816|FG000|Overall Study|Poor Compliance|16|||
46750637|NCT00909389|82968816|FG000|Overall Study|Lost to Follow-up|4|||
46750638|NCT00909389|82968816|FG000|Overall Study|No Information|103|||
46750639|NCT00910715|82968823|FG000|Overall Study|Lost to Follow-up|22|||
46750640|NCT00910715|82968824|FG001|Overall Study|Lost to Follow-up|26|||
46635848|NCT01526928|82809607|FG000|Overall Study|Withdrawal by Subject|1|||
46750641|NCT00910715|82968825|FG002|Overall Study|Lost to Follow-up|0|||
46750642|NCT00600483|82968887|FG000|Overall Study|Lost to Follow-up|26|||
46750643|NCT00600483|82968888|FG001|Overall Study|Lost to Follow-up|47|||
46750644|NCT00600483|82968887|FG000|Overall Study|Randomized but not treated|10|||
46635849|NCT01526928|82809608|FG001|Overall Study|Withdrawal by Subject|0|||
46635850|NCT01526928|82809609|FG002|Overall Study|Withdrawal by Subject|13|||
46635851|NCT01526928|82809610|FG003|Overall Study|Withdrawal by Subject|11|||
46635852|NCT01526928|82809611|FG004|Overall Study|Withdrawal by Subject|3|||
46635853|NCT01526928|82809612|FG005|Overall Study|Withdrawal by Subject|0|||
46635854|NCT01526928|82809607|FG000|Overall Study|Physician Decision|0|||
46635855|NCT01526928|82809608|FG001|Overall Study|Physician Decision|0|||
46635856|NCT01526928|82809609|FG002|Overall Study|Physician Decision|2|||
46635857|NCT01526928|82809610|FG003|Overall Study|Physician Decision|5|||
46635858|NCT01526928|82809611|FG004|Overall Study|Physician Decision|0|||
46635859|NCT01526928|82809612|FG005|Overall Study|Physician Decision|0|||
46635860|NCT01526928|82809607|FG000|Overall Study|Other Reason|0|||
46635861|NCT01526928|82809608|FG001|Overall Study|Other Reason|1|||
46635862|NCT01526928|82809609|FG002|Overall Study|Other Reason|11|||
46635863|NCT01526928|82809610|FG003|Overall Study|Other Reason|4|||
46635864|NCT01526928|82809611|FG004|Overall Study|Other Reason|1|||
46635865|NCT01526928|82809612|FG005|Overall Study|Other Reason|0|||
46635866|NCT01526928|82809607|FG000|Overall Study|Lost to Follow-up|0|||
46635867|NCT01526928|82809608|FG001|Overall Study|Lost to Follow-up|0|||
46635868|NCT01526928|82809609|FG002|Overall Study|Lost to Follow-up|0|||
46635869|NCT01526928|82809610|FG003|Overall Study|Lost to Follow-up|1|||
46635870|NCT01526928|82809611|FG004|Overall Study|Lost to Follow-up|0|||
46635871|NCT01526928|82809612|FG005|Overall Study|Lost to Follow-up|0|||
46635872|NCT01526928|82809607|FG000|Overall Study|Protocol Deviation|0|||
46635873|NCT01526928|82809608|FG001|Overall Study|Protocol Deviation|0|||
46635874|NCT01526928|82809609|FG002|Overall Study|Protocol Deviation|0|||
46635875|NCT01526928|82809610|FG003|Overall Study|Protocol Deviation|2|||
46750645|NCT00600483|82968888|FG001|Overall Study|Randomized but not treated|0|||
46750646|NCT00600171|82968900|FG000|Overall Study|Adverse Event|0|||
46750647|NCT00600171|82968901|FG001|Overall Study|Adverse Event|1|||
46750648|NCT00600171|82968902|FG002|Overall Study|Adverse Event|0|||
46750649|NCT00600171|82968903|FG003|Overall Study|Adverse Event|0|||
46804783|NCT00539006|83023833|FG002|Treatment Period 1|Protocol Violation|1|||
46635876|NCT01526928|82809611|FG004|Overall Study|Protocol Deviation|0|||
46635877|NCT01526928|82809612|FG005|Overall Study|Protocol Deviation|0|||
46750650|NCT00600171|82968904|FG004|Overall Study|Adverse Event|1|||
46750651|NCT00600171|82968905|FG005|Overall Study|Adverse Event|0|||
46750652|NCT00600171|82968900|FG000|Overall Study|Lack of Efficacy|9|||
46750653|NCT00600171|82968901|FG001|Overall Study|Lack of Efficacy|12|||
46635878|NCT01526928|82809607|FG000|Overall Study|Missing|0|||
46635879|NCT01526928|82809608|FG001|Overall Study|Missing|0|||
46635880|NCT01526928|82809609|FG002|Overall Study|Missing|1|||
46635881|NCT01526928|82809610|FG003|Overall Study|Missing|0|||
46635882|NCT01526928|82809611|FG004|Overall Study|Missing|2|||
46750654|NCT00600171|82968902|FG002|Overall Study|Lack of Efficacy|3|||
46635883|NCT01526928|82809612|FG005|Overall Study|Missing|0|||
46635884|NCT01549860|82809670|FG000|Overall Study|Withdrawal by Subject|1|||
46635885|NCT01549860|82809671|FG001|Overall Study|Withdrawal by Subject|0|||
46635886|NCT01549860|82809670|FG000|Overall Study|Physician Decision|1|||
46635887|NCT01549860|82809671|FG001|Overall Study|Physician Decision|1|||
46635888|NCT01549392|82809679|FG000|Overall Study|Withdrawal by Subject|1|||
46635889|NCT01549392|82809680|FG001|Overall Study|Withdrawal by Subject|0|||
46635890|NCT01526148|82809688|FG000|Overall Study|Adverse Event|6|||
46635891|NCT01526148|82809689|FG001|Overall Study|Adverse Event|5|||
46635892|NCT01526148|82809688|FG000|Overall Study|Lost to Follow-up|3|||
46635893|NCT01526148|82809689|FG001|Overall Study|Lost to Follow-up|6|||
46635894|NCT01526148|82809688|FG000|Overall Study|Withdrawal by Subject|2|||
46635895|NCT01526148|82809689|FG001|Overall Study|Withdrawal by Subject|0|||
46635896|NCT01526148|82809688|FG000|Overall Study|Unstable Medical Condition|1|||
46635897|NCT01526148|82809689|FG001|Overall Study|Unstable Medical Condition|0|||
46635898|NCT01526148|82809688|FG000|Overall Study|Unable to discontinue concomitant med|1|||
46635899|NCT01526148|82809689|FG001|Overall Study|Unable to discontinue concomitant med|0|||
46750655|NCT00600171|82968903|FG003|Overall Study|Lack of Efficacy|5|||
46750656|NCT00600171|82968904|FG004|Overall Study|Lack of Efficacy|4|||
46635900|NCT01526148|82809688|FG000|Overall Study|Moved out of state|1|||
46635901|NCT01526148|82809689|FG001|Overall Study|Moved out of state|0|||
46635902|NCT01526148|82809688|FG000|Overall Study|Incarcerated|0|||
46635903|NCT01526148|82809689|FG001|Overall Study|Incarcerated|2|||
46635904|NCT01572948|82809697|FG000|Overall Study|Lost to Follow-up|1|||
46635905|NCT01572948|82809698|FG001|Overall Study|Lost to Follow-up|0|||
46635906|NCT01572948|82809697|FG000|Overall Study|unable to contact|0|||
46635907|NCT01572948|82809698|FG001|Overall Study|unable to contact|1|||
46635908|NCT01525602|82809716|FG000|Overall Study|Adverse Event|1|||
46635909|NCT01525602|82809717|FG001|Overall Study|Adverse Event|0|||
46750657|NCT00600171|82968905|FG005|Overall Study|Lack of Efficacy|0|||
46750658|NCT00600171|82968900|FG000|Overall Study|Protocol Violation|1|||
46750659|NCT00600171|82968901|FG001|Overall Study|Protocol Violation|2|||
46750660|NCT00600171|82968902|FG002|Overall Study|Protocol Violation|0|||
46750661|NCT00600171|82968903|FG003|Overall Study|Protocol Violation|1|||
46750662|NCT00600171|82968904|FG004|Overall Study|Protocol Violation|0|||
46750663|NCT00600171|82968905|FG005|Overall Study|Protocol Violation|0|||
46750664|NCT00600171|82968900|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
46750665|NCT00600171|82968901|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
46750666|NCT00600171|82968902|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
46750667|NCT00600171|82968903|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
46750668|NCT00600171|82968904|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
46750669|NCT00600171|82968905|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
46750670|NCT00600171|82968900|FG000|Overall Study|Withdrawal by Subject|3|||
46750671|NCT00600171|82968901|FG001|Overall Study|Withdrawal by Subject|0|||
46750672|NCT00600171|82968902|FG002|Overall Study|Withdrawal by Subject|0|||
46750673|NCT00600171|82968903|FG003|Overall Study|Withdrawal by Subject|1|||
46750674|NCT00600171|82968904|FG004|Overall Study|Withdrawal by Subject|1|||
46750675|NCT00600171|82968905|FG005|Overall Study|Withdrawal by Subject|1|||
46750676|NCT00600171|82968900|FG000|Overall Study|Physician Decision|0|||
46750677|NCT00600171|82968901|FG001|Overall Study|Physician Decision|1|||
46750678|NCT00600171|82968902|FG002|Overall Study|Physician Decision|0|||
46750679|NCT00600171|82968903|FG003|Overall Study|Physician Decision|1|||
46750680|NCT00600171|82968904|FG004|Overall Study|Physician Decision|0|||
46750681|NCT00600171|82968905|FG005|Overall Study|Physician Decision|2|||
46750682|NCT00600171|82968900|FG000|Overall Study|Lost to Follow-up|0|||
46924483|NCT03040687|83158521|FG001|Overall Study|Withdrawal by Subject|0|||
46924484|NCT03040687|83158522|FG002|Overall Study|Withdrawal by Subject|0|||
46635910|NCT01525602|82809718|FG002|Overall Study|Adverse Event|1|||
46635911|NCT01525602|82809719|FG003|Overall Study|Adverse Event|1|||
46635912|NCT01525602|82809720|FG004|Overall Study|Adverse Event|3|||
46635913|NCT01525602|82809721|FG005|Overall Study|Adverse Event|3|||
46635914|NCT01525602|82809722|FG006|Overall Study|Adverse Event|0|||
46635915|NCT01525602|82809723|FG007|Overall Study|Adverse Event|1|||
46635916|NCT01525602|82809716|FG000|Overall Study|Disease progression|6|||
46635917|NCT01525602|82809717|FG001|Overall Study|Disease progression|3|||
46635918|NCT01525602|82809718|FG002|Overall Study|Disease progression|2|||
46635919|NCT01525602|82809719|FG003|Overall Study|Disease progression|5|||
46635920|NCT01525602|82809720|FG004|Overall Study|Disease progression|22|||
46635921|NCT01525602|82809721|FG005|Overall Study|Disease progression|2|||
46750683|NCT00600171|82968901|FG001|Overall Study|Lost to Follow-up|0|||
46750684|NCT00600171|82968902|FG002|Overall Study|Lost to Follow-up|0|||
46750685|NCT00600171|82968903|FG003|Overall Study|Lost to Follow-up|1|||
46750686|NCT00600171|82968904|FG004|Overall Study|Lost to Follow-up|0|||
46750687|NCT00600171|82968905|FG005|Overall Study|Lost to Follow-up|0|||
46750688|NCT04035668|82968924|FG000|Overall Study|Adverse Event|3|||
46750689|NCT04035668|82968925|FG001|Overall Study|Adverse Event|4|||
46750690|NCT04035668|82968926|FG002|Overall Study|Adverse Event|2|||
46750691|NCT04035668|82968924|FG000|Overall Study|Lost to Follow-up|0|||
46750692|NCT04035668|82968925|FG001|Overall Study|Lost to Follow-up|1|||
46750693|NCT04035668|82968926|FG002|Overall Study|Lost to Follow-up|0|||
46750694|NCT04035668|82968924|FG000|Overall Study|Physician Decision|2|||
46750695|NCT04035668|82968925|FG001|Overall Study|Physician Decision|1|||
46750696|NCT04035668|82968926|FG002|Overall Study|Physician Decision|1|||
46750697|NCT04035668|82968924|FG000|Overall Study|Subject Decision|2|||
46750698|NCT04035668|82968925|FG001|Overall Study|Subject Decision|2|||
46750699|NCT04035668|82968926|FG002|Overall Study|Subject Decision|0|||
46750700|NCT00885495|82968946|FG000|Overall Study|Adverse Event|1|||
46750701|NCT00885495|82968947|FG001|Overall Study|Adverse Event|2|||
46750702|NCT00885495|82968946|FG000|Overall Study|Protocol Violation|0|||
46750703|NCT00885495|82968947|FG001|Overall Study|Protocol Violation|1|||
46750704|NCT00885495|82968946|FG000|Overall Study|Withdrawal by Subject|1|||
46750705|NCT00885495|82968947|FG001|Overall Study|Withdrawal by Subject|0|||
46750706|NCT00885105|82968960|FG000|Overall Study|Withdrawal by Subject|0|||
46750707|NCT00885105|82968961|FG001|Overall Study|Withdrawal by Subject|8|||
46750708|NCT00885105|82968960|FG000|Overall Study|Adverse Event|1|||
46750709|NCT00885105|82968961|FG001|Overall Study|Adverse Event|0|||
46750710|NCT00885105|82968960|FG000|Overall Study|Protocol Violation|0|||
46750711|NCT00885105|82968961|FG001|Overall Study|Protocol Violation|2|||
46750712|NCT03945188|82968969|FG000|Overall Study|Protocol Violation|1|||
46750713|NCT03945188|82968970|FG001|Overall Study|Protocol Violation|0|||
46750714|NCT03945188|82968969|FG000|Overall Study|Disease worsening|79|||
46750715|NCT03945188|82968970|FG001|Overall Study|Disease worsening|73|||
46750716|NCT03945188|82968969|FG000|Overall Study|Physician Decision|2|||
46750717|NCT03945188|82968970|FG001|Overall Study|Physician Decision|2|||
46750718|NCT03945188|82968969|FG000|Overall Study|Lack of Efficacy|7|||
46750719|NCT03945188|82968970|FG001|Overall Study|Lack of Efficacy|4|||
46750720|NCT03945188|82968969|FG000|Overall Study|Pregnancy|2|||
46750721|NCT03945188|82968970|FG001|Overall Study|Pregnancy|0|||
46750722|NCT03945188|82968969|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
46750723|NCT03945188|82968970|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
46750724|NCT03945188|82968969|FG000|Overall Study|Adverse Event|10|||
46750725|NCT03945188|82968970|FG001|Overall Study|Adverse Event|5|||
46750726|NCT03945188|82968969|FG000|Overall Study|Other|2|||
46750727|NCT03945188|82968970|FG001|Overall Study|Other|2|||
46750728|NCT03945188|82968969|FG000|Overall Study|Lost to Follow-up|1|||
46750729|NCT03945188|82968970|FG001|Overall Study|Lost to Follow-up|2|||
46750730|NCT00884949|82968976|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
46750731|NCT00884949|82968976|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
46750732|NCT00884793|82968989|FG000|Overall Study|Withdrawal by Subject|1|||
46750733|NCT00884325|82968995|FG000|Overall Study|Lost to Follow-up|1|||
46750734|NCT00884325|82968996|FG001|Overall Study|Lost to Follow-up|2|||
46750735|NCT00884325|82968995|FG000|Overall Study|Lack of Efficacy|0|||
46750736|NCT00884325|82968996|FG001|Overall Study|Lack of Efficacy|1|||
46750737|NCT00884325|82968995|FG000|Overall Study|Withdrawal by Subject|1|||
46750738|NCT00884325|82968996|FG001|Overall Study|Withdrawal by Subject|1|||
46750739|NCT00884325|82968995|FG000|Overall Study|Not provided|1|||
46750740|NCT00884325|82968996|FG001|Overall Study|Not provided|0|||
46750741|NCT00883779|82969004|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
46750742|NCT00883779|82969005|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
46750743|NCT00883779|82969004|FG000|Primary Study Treatment Phase|Disease progression|75|||
46750744|NCT00883779|82969005|FG001|Primary Study Treatment Phase|Disease progression|59|||
46750745|NCT00883779|82969004|FG000|Primary Study Treatment Phase|Adverse Event|16|||
46750746|NCT00883779|82969005|FG001|Primary Study Treatment Phase|Adverse Event|16|||
46750747|NCT00883779|82969004|FG000|Primary Study Treatment Phase|Death|2|||
46750748|NCT00883779|82969005|FG001|Primary Study Treatment Phase|Death|3|||
46750749|NCT00883779|82969004|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
46750750|NCT00883779|82969005|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
46750751|NCT00883779|82969004|FG000|Primary Study Treatment Phase|Other|3|||
46750752|NCT00883779|82969005|FG001|Primary Study Treatment Phase|Other|0|||
46750753|NCT00883779|82969004|FG000|Post-Study Treatment Phase|Adverse Event|2|||
46750754|NCT00883779|82969005|FG001|Post-Study Treatment Phase|Adverse Event|3|||
46750755|NCT00883779|82969004|FG000|Post-Study Treatment Phase|Death|1|||
46750756|NCT00883779|82969005|FG001|Post-Study Treatment Phase|Death|3|||
46750757|NCT00883779|82969004|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
46750758|NCT00883779|82969005|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
46750759|NCT00883779|82969004|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
46750760|NCT00883779|82969005|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
46750761|NCT00883779|82969004|FG000|Post-Study Treatment Phase|Disease progression|103|||
46750762|NCT00883779|82969005|FG001|Post-Study Treatment Phase|Disease progression|122|||
46750763|NCT00883779|82969004|FG000|Post-Study Treatment Phase|Other|3|||
46750764|NCT00883779|82969005|FG001|Post-Study Treatment Phase|Other|0|||
46750765|NCT00883779|82969004|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
46750766|NCT00883779|82969005|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
46750767|NCT00883779|82969004|FG000|Off-study Phase|Death|185|||
46750768|NCT00883779|82969005|FG001|Off-study Phase|Death|174|||
46750769|NCT00883779|82969004|FG000|Off-study Phase|Refused treatment|1|||
46750770|NCT00883779|82969005|FG001|Off-study Phase|Refused treatment|1|||
46750771|NCT00883779|82969004|FG000|Off-study Phase|Failure to return|5|||
46750772|NCT00883779|82969005|FG001|Off-study Phase|Failure to return|6|||
46750773|NCT00883779|82969004|FG000|Off-study Phase|Other|18|||
46750774|NCT00883779|82969005|FG001|Off-study Phase|Other|21|||
46750775|NCT04159701|82969013|FG000|Period 1: Treatment Period|Pregnancy|1|||
46750776|NCT04159701|82969014|FG001|Period 1: Treatment Period|Pregnancy|0|||
46750777|NCT04159701|82969013|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
46750778|NCT04159701|82969014|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
46750779|NCT04159701|82969013|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
46750780|NCT04159701|82969014|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
46750781|NCT04159701|82969013|FG000|Washout Period|site terminated by sponsor|0|||
46750782|NCT04159701|82969014|FG001|Washout Period|site terminated by sponsor|1|||
46750783|NCT04159701|82969013|FG000|Washout Period|study terminated by sponsor|10|||
46750784|NCT04159701|82969014|FG001|Washout Period|study terminated by sponsor|3|||
46750785|NCT04159701|82969013|FG000|Washout Period|Withdrawal by Subject|1|||
46750786|NCT04159701|82969014|FG001|Washout Period|Withdrawal by Subject|0|||
46750787|NCT04159701|82969013|FG000|Washout Period|Inadvertent Enrollment|1|||
46750788|NCT04159701|82969014|FG001|Washout Period|Inadvertent Enrollment|0|||
46750789|NCT04159701|82969013|FG000|Washout Period|Miscellaneous|1|||
46750790|NCT04159701|82969014|FG001|Washout Period|Miscellaneous|0|||
46750791|NCT04159701|82969013|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
46750792|NCT04159701|82969014|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
46750793|NCT04159701|82969013|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
46750794|NCT04159701|82969014|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
46750795|NCT04159701|82969013|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
46750796|NCT04159701|82969014|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
46750797|NCT04159701|82969013|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
46750798|NCT04159701|82969014|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
46750799|NCT04159701|82969013|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
46750800|NCT04159701|82969014|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
46750801|NCT00880269|82969026|FG000|Overall Study|Protocol Violation|1|||
46750802|NCT00880269|82969027|FG001|Overall Study|Protocol Violation|0|||
46750803|NCT00880269|82969026|FG000|Overall Study|Disease Progression|13|||
46750804|NCT00880269|82969027|FG001|Overall Study|Disease Progression|11|||
46750805|NCT00880269|82969026|FG000|Overall Study|New Cancer Therapy|1|||
46750806|NCT00880269|82969027|FG001|Overall Study|New Cancer Therapy|0|||
46750807|NCT00880269|82969026|FG000|Overall Study|Death|4|||
46750808|NCT00880269|82969027|FG001|Overall Study|Death|2|||
46924485|NCT03042559|83158532|FG000|Overall Study|drop out|1|||
46924486|NCT03042559|83158533|FG001|Overall Study|drop out|1|||
46924487|NCT02780856|83158539|FG000|Overall Study|Lost to Follow-up|1|||
46924488|NCT02321540|83158552|FG000|Overall Study|Death|0|||
46924489|NCT02321540|83158553|FG001|Overall Study|Death|1|||
46924490|NCT02321540|83158552|FG000|Overall Study|Progression|3|||
46924491|NCT02321540|83158553|FG001|Overall Study|Progression|9|||
46924492|NCT00108732|83158583|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
46924493|NCT00108732|83158583|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
46924494|NCT00108732|83158583|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
46924495|NCT00108732|83158583|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
46924496|NCT00108732|83158583|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
46924497|NCT00108732|83158583|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
46924498|NCT00108732|83158583|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
46924499|NCT00107952|83158589|FG000|Overall Study|Death|75|||
46924500|NCT00107952|83158590|FG001|Overall Study|Death|61|||
46924501|NCT00107952|83158589|FG000|Overall Study|Lost to Follow-up|0|||
46924502|NCT00107952|83158590|FG001|Overall Study|Lost to Follow-up|3|||
46924503|NCT00107952|83158589|FG000|Overall Study|Withdrawal by Subject|9|||
46924504|NCT00107952|83158590|FG001|Overall Study|Withdrawal by Subject|6|||
46924505|NCT00107952|83158589|FG000|Overall Study|Other|2|||
46924506|NCT00107952|83158590|FG001|Overall Study|Other|5|||
46924507|NCT00107952|83158589|FG000|Overall Study|Never received study treatment|9|||
46924508|NCT00107952|83158590|FG001|Overall Study|Never received study treatment|6|||
46924509|NCT01366638|83158608|FG000|Overall Study|Withdrawal by Subject|0|||
46750809|NCT00880269|82969026|FG000|Overall Study|Lost to Follow-up|0|||
46924510|NCT01366638|83158609|FG001|Overall Study|Withdrawal by Subject|0|||
46924511|NCT01366638|83158610|FG002|Overall Study|Withdrawal by Subject|6|||
46924512|NCT01366638|83158608|FG000|Overall Study|Other|1|||
46750810|NCT00880269|82969027|FG001|Overall Study|Lost to Follow-up|1|||
46750811|NCT00880269|82969026|FG000|Overall Study|Withdrawal by Subject|3|||
46750812|NCT00880269|82969027|FG001|Overall Study|Withdrawal by Subject|4|||
46750813|NCT00880269|82969026|FG000|Overall Study|Adverse Event|10|||
46750814|NCT00880269|82969027|FG001|Overall Study|Adverse Event|9|||
46750815|NCT00880191|82969035|FG000|Overall Study|Refused further treatment|4|||
46924513|NCT01366638|83158609|FG001|Overall Study|Other|0|||
46924514|NCT01366638|83158610|FG002|Overall Study|Other|0|||
46924515|NCT02780700|83158618|FG000|Overall Study|Progressive disease|1|||
46924516|NCT04230122|83158656|FG000|Overall Study|Lost to Follow-up|1|||
46924517|NCT04230122|83158657|FG001|Overall Study|Lost to Follow-up|0|||
46924518|NCT02780388|83158668|FG000|Overall Study|Lost to Follow-up|0|||
46924519|NCT02780388|83158669|FG001|Overall Study|Lost to Follow-up|1|||
46924520|NCT02780388|83158670|FG002|Overall Study|Lost to Follow-up|0|||
46924521|NCT02780388|83158671|FG003|Overall Study|Lost to Follow-up|0|||
46924522|NCT02780388|83158672|FG004|Overall Study|Lost to Follow-up|0|||
46924523|NCT02780388|83158668|FG000|Overall Study|Withdrawal by Subject|1|||
46924524|NCT02780388|83158669|FG001|Overall Study|Withdrawal by Subject|1|||
46924525|NCT02780388|83158670|FG002|Overall Study|Withdrawal by Subject|0|||
46924526|NCT02780388|83158671|FG003|Overall Study|Withdrawal by Subject|0|||
46924527|NCT02780388|83158672|FG004|Overall Study|Withdrawal by Subject|0|||
46635922|NCT01525602|82809722|FG006|Overall Study|Disease progression|3|||
46635923|NCT01525602|82809723|FG007|Overall Study|Disease progression|3|||
46635924|NCT01525602|82809716|FG000|Overall Study|Clinical progression|2|||
46635925|NCT01525602|82809717|FG001|Overall Study|Clinical progression|0|||
46750816|NCT00880191|82969036|FG001|Overall Study|Refused further treatment|1|||
46750817|NCT00880191|82969035|FG000|Overall Study|Adverse Event|8|||
46750818|NCT00880191|82969036|FG001|Overall Study|Adverse Event|6|||
46750819|NCT00880191|82969035|FG000|Overall Study|Hospitalization/efficacy|1|||
46750820|NCT00880191|82969036|FG001|Overall Study|Hospitalization/efficacy|1|||
46750821|NCT00597519|82969042|FG000|Overall Study|Death|1|||
46750822|NCT00879333|82969048|FG000|Overall Study|Adverse Event|94|||
46750823|NCT00879333|82969049|FG001|Overall Study|Adverse Event|34|||
46750824|NCT00879333|82969048|FG000|Overall Study|Abnormal Laboratory Value|1|||
46750825|NCT00879333|82969049|FG001|Overall Study|Abnormal Laboratory Value|0|||
46750826|NCT00879333|82969048|FG000|Overall Study|Withdrawal by Subject|20|||
46750827|NCT00879333|82969049|FG001|Overall Study|Withdrawal by Subject|7|||
46750828|NCT00879333|82969048|FG000|Overall Study|Lost to Follow-up|2|||
46750829|NCT00879333|82969049|FG001|Overall Study|Lost to Follow-up|1|||
46750830|NCT00879333|82969048|FG000|Overall Study|Administrative Problems|2|||
46750831|NCT00879333|82969049|FG001|Overall Study|Administrative Problems|0|||
46750832|NCT00879333|82969048|FG000|Overall Study|Death|16|||
46750833|NCT00879333|82969049|FG001|Overall Study|Death|5|||
46750834|NCT00879333|82969048|FG000|Overall Study|Disease Progression|292|||
46750835|NCT00879333|82969049|FG001|Overall Study|Disease Progression|169|||
46750836|NCT00879333|82969048|FG000|Overall Study|Protocol Violation|1|||
46750837|NCT00879333|82969049|FG001|Overall Study|Protocol Violation|1|||
46750838|NCT03481556|82969061|FG000|Overall Study|Adverse Event|1|||
46750839|NCT03481556|82969062|FG001|Overall Study|Adverse Event|0|||
46750840|NCT03481556|82969063|FG002|Overall Study|Adverse Event|0|||
46750841|NCT03481556|82969064|FG003|Overall Study|Adverse Event|0|||
46750842|NCT03481556|82969061|FG000|Overall Study|Death|4|||
46750843|NCT03481556|82969062|FG001|Overall Study|Death|2|||
46750844|NCT03481556|82969063|FG002|Overall Study|Death|3|||
46750845|NCT03481556|82969064|FG003|Overall Study|Death|16|||
46750846|NCT03481556|82969061|FG000|Overall Study|Study Terminated by Sponsor|10|||
46750847|NCT03481556|82969062|FG001|Overall Study|Study Terminated by Sponsor|5|||
46750848|NCT03481556|82969063|FG002|Overall Study|Study Terminated by Sponsor|2|||
46750849|NCT03481556|82969064|FG003|Overall Study|Study Terminated by Sponsor|9|||
46750850|NCT00596427|82969082|FG000|Overall Study|Withdrawal by Subject|2|||
46750851|NCT00596427|82969083|FG001|Overall Study|Withdrawal by Subject|2|||
46750852|NCT00596427|82969082|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
46750853|NCT00596427|82969083|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
46750854|NCT00596427|82969082|FG000|Overall Study|Protocol Violation|1|||
46750855|NCT00596427|82969083|FG001|Overall Study|Protocol Violation|0|||
46750856|NCT02732210|82969092|FG000|Overall Study|Site Closed|0|||
46750857|NCT02732210|82969093|FG001|Overall Study|Site Closed|11|||
46750858|NCT02732210|82969092|FG000|Overall Study|Study Ended|13|||
46750859|NCT02732210|82969093|FG001|Overall Study|Study Ended|13|||
46750860|NCT02732210|82969092|FG000|Overall Study|Withdrawal by Subject|28|||
46750861|NCT02732210|82969093|FG001|Overall Study|Withdrawal by Subject|87|||
46750862|NCT02732210|82969092|FG000|Overall Study|Lost to Follow-up|5|||
46750863|NCT02732210|82969093|FG001|Overall Study|Lost to Follow-up|57|||
46924528|NCT03491462|83158690|FG000|Overall Study|Lost to Follow-up|2|||
46924529|NCT03491462|83158691|FG001|Overall Study|Lost to Follow-up|0|||
46750864|NCT02732210|82969092|FG000|Overall Study|Death|4|||
46750865|NCT02732210|82969093|FG001|Overall Study|Death|15|||
46924530|NCT03491462|83158690|FG000|Overall Study|Adverse Event|11|||
46924531|NCT03491462|83158691|FG001|Overall Study|Adverse Event|1|||
46924532|NCT03491462|83158690|FG000|Overall Study|Physician Decision|3|||
46924533|NCT03491462|83158691|FG001|Overall Study|Physician Decision|0|||
46750866|NCT02732210|82969092|FG000|Overall Study|Other|35|||
46750867|NCT02732210|82969093|FG001|Overall Study|Other|103|||
46750868|NCT02732210|82969092|FG000|Overall Study|Missing|0|||
46750869|NCT02732210|82969093|FG001|Overall Study|Missing|8|||
46750870|NCT00595959|82969099|FG000|Overall Study|Withdrawal by Subject|1|||
46750871|NCT00595959|82969099|FG000|Overall Study|Lost to Follow-up|1|||
46750872|NCT00436748|82969137|FG000|Overall Study|Ineligibility Determined|1|||
46750873|NCT00436748|82969138|FG001|Overall Study|Ineligibility Determined|1|||
46750874|NCT00436748|82969137|FG000|Overall Study|Adverse Event|0|||
46750875|NCT00436748|82969138|FG001|Overall Study|Adverse Event|2|||
46750876|NCT00436748|82969137|FG000|Overall Study|Consent Withdrawn|1|||
46750877|NCT00436748|82969138|FG001|Overall Study|Consent Withdrawn|4|||
46750878|NCT00436748|82969137|FG000|Overall Study|Administrative Decision|1|||
46750879|NCT00436748|82969138|FG001|Overall Study|Administrative Decision|0|||
46635926|NCT01525602|82809718|FG002|Overall Study|Clinical progression|0|||
46635927|NCT01525602|82809719|FG003|Overall Study|Clinical progression|0|||
46635928|NCT01525602|82809720|FG004|Overall Study|Clinical progression|0|||
46635929|NCT01525602|82809721|FG005|Overall Study|Clinical progression|0|||
46635930|NCT01525602|82809722|FG006|Overall Study|Clinical progression|1|||
46635931|NCT01525602|82809723|FG007|Overall Study|Clinical progression|1|||
46635932|NCT01525602|82809716|FG000|Overall Study|Non-compliance|0|||
46635933|NCT01525602|82809717|FG001|Overall Study|Non-compliance|0|||
46635934|NCT01525602|82809718|FG002|Overall Study|Non-compliance|0|||
46635935|NCT01525602|82809719|FG003|Overall Study|Non-compliance|0|||
46750880|NCT00436748|82969137|FG000|Overall Study|Lost to Follow-up|0|||
46750881|NCT00436748|82969138|FG001|Overall Study|Lost to Follow-up|1|||
46750882|NCT00436748|82969137|FG000|Overall Study|Protocol-specified Criteria|5|||
46750883|NCT00436748|82969138|FG001|Overall Study|Protocol-specified Criteria|4|||
46750884|NCT00436748|82969137|FG000|Overall Study|Other|3|||
46750885|NCT00436748|82969138|FG001|Overall Study|Other|0|||
46750886|NCT02703272|82969148|FG000|Overall Study|Death|4|||
46750887|NCT02703272|82969149|FG001|Overall Study|Death|9|||
46750888|NCT02703272|82969150|FG002|Overall Study|Death|19|||
46750889|NCT02703272|82969151|FG003|Overall Study|Death|10|||
46750890|NCT02703272|82969148|FG000|Overall Study|Withdrawal by Subject|0|||
46750891|NCT02703272|82969149|FG001|Overall Study|Withdrawal by Subject|0|||
46750892|NCT02703272|82969150|FG002|Overall Study|Withdrawal by Subject|4|||
46750893|NCT02703272|82969151|FG003|Overall Study|Withdrawal by Subject|2|||
46750894|NCT02703272|82969148|FG000|Overall Study|Study Terminated by Sponsor|6|||
46750895|NCT02703272|82969149|FG001|Overall Study|Study Terminated by Sponsor|1|||
46750896|NCT02703272|82969150|FG002|Overall Study|Study Terminated by Sponsor|12|||
46750897|NCT02703272|82969151|FG003|Overall Study|Study Terminated by Sponsor|4|||
46750898|NCT02703272|82969148|FG000|Overall Study|Other|1|||
46750899|NCT02703272|82969149|FG001|Overall Study|Other|0|||
46750900|NCT02703272|82969150|FG002|Overall Study|Other|0|||
46635936|NCT01525602|82809720|FG004|Overall Study|Non-compliance|1|||
46635937|NCT01525602|82809721|FG005|Overall Study|Non-compliance|0|||
46635938|NCT01525602|82809722|FG006|Overall Study|Non-compliance|0|||
46635939|NCT01525602|82809723|FG007|Overall Study|Non-compliance|0|||
46635940|NCT01525602|82809716|FG000|Overall Study|Withdrawal by Subject|0|||
46635941|NCT01525602|82809717|FG001|Overall Study|Withdrawal by Subject|0|||
46635942|NCT01525602|82809718|FG002|Overall Study|Withdrawal by Subject|0|||
46635943|NCT01525602|82809719|FG003|Overall Study|Withdrawal by Subject|0|||
46635944|NCT01525602|82809720|FG004|Overall Study|Withdrawal by Subject|3|||
46635945|NCT01525602|82809721|FG005|Overall Study|Withdrawal by Subject|1|||
46635946|NCT01525602|82809722|FG006|Overall Study|Withdrawal by Subject|0|||
46635947|NCT01525602|82809723|FG007|Overall Study|Withdrawal by Subject|1|||
46635948|NCT01525602|82809716|FG000|Overall Study|Physician Decision|0|||
46635949|NCT01525602|82809717|FG001|Overall Study|Physician Decision|0|||
46635950|NCT01525602|82809718|FG002|Overall Study|Physician Decision|0|||
46635951|NCT01525602|82809719|FG003|Overall Study|Physician Decision|0|||
46635952|NCT01525602|82809720|FG004|Overall Study|Physician Decision|3|||
46635953|NCT01525602|82809721|FG005|Overall Study|Physician Decision|0|||
46750901|NCT02703272|82969151|FG003|Overall Study|Other|0|||
46750902|NCT02568215|82969191|FG000|Overall Study|Death|1|||
46750903|NCT02568215|82969192|FG001|Overall Study|Death|2|||
46750904|NCT02568215|82969193|FG002|Overall Study|Death|0|||
46750905|NCT02568215|82969191|FG000|Overall Study|Physician Decision|2|||
46750906|NCT02568215|82969192|FG001|Overall Study|Physician Decision|2|||
46750907|NCT02568215|82969193|FG002|Overall Study|Physician Decision|2|||
46635954|NCT01525602|82809722|FG006|Overall Study|Physician Decision|1|||
46635955|NCT01525602|82809723|FG007|Overall Study|Physician Decision|0|||
46635956|NCT01525602|82809716|FG000|Overall Study|Death|0|||
46635957|NCT01525602|82809717|FG001|Overall Study|Death|0|||
46635958|NCT01525602|82809718|FG002|Overall Study|Death|0|||
46750908|NCT02568215|82969191|FG000|Overall Study|Lost to Follow-up|29|||
46750909|NCT02568215|82969192|FG001|Overall Study|Lost to Follow-up|32|||
46750910|NCT02568215|82969193|FG002|Overall Study|Lost to Follow-up|41|||
46750911|NCT02568215|82969191|FG000|Overall Study|Withdrawal by Subject|21|||
46924534|NCT03491462|83158690|FG000|Overall Study|Withdrawal by Subject|22|||
46750912|NCT02568215|82969192|FG001|Overall Study|Withdrawal by Subject|19|||
46750913|NCT02568215|82969193|FG002|Overall Study|Withdrawal by Subject|22|||
46750914|NCT02568215|82969191|FG000|Overall Study|Protocol Violation|1|||
46750915|NCT02568215|82969192|FG001|Overall Study|Protocol Violation|1|||
46635959|NCT01525602|82809719|FG003|Overall Study|Death|0|||
46635960|NCT01525602|82809720|FG004|Overall Study|Death|1|||
46750916|NCT02568215|82969193|FG002|Overall Study|Protocol Violation|0|||
46750917|NCT02568215|82969191|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
46750918|NCT02568215|82969192|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
46750919|NCT02568215|82969193|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
46750920|NCT02568215|82969191|FG000|Overall Study|Other|0|||
46750921|NCT02568215|82969192|FG001|Overall Study|Other|1|||
46750922|NCT02568215|82969193|FG002|Overall Study|Other|4|||
46750923|NCT00908141|82969230|FG000|Overall Study|Withdrawal by Subject|0|||
46750924|NCT00908141|82969231|FG001|Overall Study|Withdrawal by Subject|1|||
46750925|NCT00906347|82969239|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
46750926|NCT00906347|82969240|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
46750927|NCT00906347|82969239|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
46750928|NCT00906347|82969240|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
46750929|NCT00906347|82969239|FG000|Received Study Drug|Refused study drug|1|||
46750930|NCT00906347|82969240|FG001|Received Study Drug|Refused study drug|0|||
46750931|NCT00906347|82969239|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
46750932|NCT00906347|82969240|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
46750933|NCT00906035|82969249|FG000|Overall Study|Withdrawal by Subject|2|||
46750934|NCT00906035|82969250|FG001|Overall Study|Withdrawal by Subject|3|||
46750935|NCT00906035|82969251|FG002|Overall Study|Withdrawal by Subject|0|||
46750936|NCT00905489|82969259|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
46750937|NCT00905489|82969259|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
46750938|NCT00905489|82969259|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
46750939|NCT02704754|82969270|FG000|Overall Study|Lost to Follow-up|1|||
46750940|NCT02704754|82969271|FG001|Overall Study|Lost to Follow-up|1|||
46750941|NCT02704754|82969270|FG000|Overall Study|Lack of Efficacy|1|||
46750942|NCT02704754|82969271|FG001|Overall Study|Lack of Efficacy|0|||
46750943|NCT02704754|82969270|FG000|Overall Study|Withdrawal by Subject|1|||
46750944|NCT02704754|82969271|FG001|Overall Study|Withdrawal by Subject|0|||
46750945|NCT03170882|82969279|FG000|Overall Study|Death|17|||
46750946|NCT03170882|82969280|FG001|Overall Study|Death|29|||
46750947|NCT03170882|82969279|FG000|Overall Study|Lost to Follow-up|0|||
46750948|NCT03170882|82969280|FG001|Overall Study|Lost to Follow-up|1|||
46750949|NCT03170882|82969279|FG000|Overall Study|Withdrawal by Subject|4|||
46750950|NCT03170882|82969280|FG001|Overall Study|Withdrawal by Subject|7|||
46750951|NCT03170882|82969279|FG000|Overall Study|Reason not Specified|28|||
46750952|NCT03170882|82969280|FG001|Overall Study|Reason not Specified|36|||
46750953|NCT00907517|82969291|FG000|Overall Study|Progressive Disease|3|||
46750954|NCT00907517|82969292|FG001|Overall Study|Progressive Disease|3|||
46750955|NCT00907517|82969293|FG002|Overall Study|Progressive Disease|4|||
46750956|NCT00907517|82969294|FG003|Overall Study|Progressive Disease|4|||
46750957|NCT00907517|82969295|FG004|Overall Study|Progressive Disease|4|||
46750958|NCT00907517|82969291|FG000|Overall Study|Symptomatic Deterioration|0|||
46750959|NCT00907517|82969292|FG001|Overall Study|Symptomatic Deterioration|0|||
46750960|NCT00907517|82969293|FG002|Overall Study|Symptomatic Deterioration|0|||
46750961|NCT00907517|82969294|FG003|Overall Study|Symptomatic Deterioration|0|||
46750962|NCT00907517|82969295|FG004|Overall Study|Symptomatic Deterioration|1|||
46750963|NCT00905255|82969309|FG000|Overall Study|Adverse Event|7|||
46750964|NCT00905255|82969310|FG001|Overall Study|Adverse Event|5|||
46750965|NCT00905255|82969309|FG000|Overall Study|Withdrawal by Subject|5|||
46750966|NCT00905255|82969310|FG001|Overall Study|Withdrawal by Subject|4|||
46750967|NCT00905255|82969309|FG000|Overall Study|Familial and Personal Reasons|1|||
46750968|NCT00905255|82969310|FG001|Overall Study|Familial and Personal Reasons|0|||
46750969|NCT00905021|82969317|FG000|Overall Study|Adverse Event|2|||
46750970|NCT00906971|82969324|FG000|Overall Study|Withdrawal by Subject|8|||
46750971|NCT00906971|82969325|FG001|Overall Study|Withdrawal by Subject|2|||
46750972|NCT00906971|82969324|FG000|Overall Study|Lost to Follow-up|0|||
46750973|NCT00906971|82969325|FG001|Overall Study|Lost to Follow-up|1|||
46750974|NCT00903929|82969331|FG000|Overall Study|Withdrawal by Subject|0|||
46750975|NCT00903929|82969332|FG001|Overall Study|Withdrawal by Subject|0|||
46750976|NCT00903929|82969333|FG002|Overall Study|Withdrawal by Subject|1|||
46750977|NCT00903929|82969334|FG003|Overall Study|Withdrawal by Subject|2|||
46750978|NCT00903929|82969331|FG000|Overall Study|Adverse Event|0|||
46750979|NCT00903929|82969332|FG001|Overall Study|Adverse Event|0|||
46750980|NCT00903929|82969333|FG002|Overall Study|Adverse Event|0|||
46750981|NCT00903929|82969334|FG003|Overall Study|Adverse Event|1|||
46750982|NCT00903695|82969341|FG000|Overall Study|medical exclusion after 1st testing|1|||
46750983|NCT00903695|82969342|FG001|Overall Study|medical exclusion after 1st testing|0|||
46750984|NCT00903695|82969341|FG000|Overall Study|lung cancer|1|||
46750985|NCT00903695|82969342|FG001|Overall Study|lung cancer|0|||
46750986|NCT00903617|82969354|FG000|Overall Study|Adverse Event|0|||
46750987|NCT00903617|82969355|FG001|Overall Study|Adverse Event|1|||
46750988|NCT00903617|82969356|FG002|Overall Study|Adverse Event|1|||
46750989|NCT00903617|82969357|FG003|Overall Study|Adverse Event|0|||
46750990|NCT00903617|82969354|FG000|Overall Study|Protocol-defined stopping criteria|0|||
46750991|NCT00903617|82969355|FG001|Overall Study|Protocol-defined stopping criteria|2|||
46750992|NCT00903617|82969356|FG002|Overall Study|Protocol-defined stopping criteria|0|||
46750993|NCT00903617|82969357|FG003|Overall Study|Protocol-defined stopping criteria|0|||
46750994|NCT00903617|82969354|FG000|Overall Study|Lost to Follow-up|2|||
46750995|NCT00903617|82969355|FG001|Overall Study|Lost to Follow-up|0|||
46750996|NCT00903617|82969356|FG002|Overall Study|Lost to Follow-up|1|||
46750997|NCT00903617|82969357|FG003|Overall Study|Lost to Follow-up|1|||
46750998|NCT00903617|82969354|FG000|Overall Study|Withdrawal by Subject|1|||
46750999|NCT00903617|82969355|FG001|Overall Study|Withdrawal by Subject|2|||
46751000|NCT00903617|82969356|FG002|Overall Study|Withdrawal by Subject|3|||
46751001|NCT00903617|82969357|FG003|Overall Study|Withdrawal by Subject|0|||
46751002|NCT00903383|82969372|FG000|Overall Study|Adverse Event|1|||
46751003|NCT00903383|82969373|FG001|Overall Study|Adverse Event|2|||
46751004|NCT00903383|82969374|FG002|Overall Study|Adverse Event|3|||
46751005|NCT00903383|82969375|FG003|Overall Study|Adverse Event|1|||
46751006|NCT00903383|82969372|FG000|Overall Study|Physician Decision|1|||
46751007|NCT00903383|82969373|FG001|Overall Study|Physician Decision|2|||
46751008|NCT00903383|82969374|FG002|Overall Study|Physician Decision|0|||
46751009|NCT00903383|82969375|FG003|Overall Study|Physician Decision|0|||
46751010|NCT00903383|82969372|FG000|Overall Study|Lost to Follow-up|0|||
46751011|NCT00903383|82969373|FG001|Overall Study|Lost to Follow-up|0|||
46751012|NCT00903383|82969374|FG002|Overall Study|Lost to Follow-up|0|||
46751013|NCT00903383|82969375|FG003|Overall Study|Lost to Follow-up|1|||
46751014|NCT00903383|82969372|FG000|Overall Study|Decision of Sponsor|1|||
46751015|NCT00903383|82969373|FG001|Overall Study|Decision of Sponsor|0|||
46635961|NCT01525602|82809721|FG005|Overall Study|Death|1|||
46751016|NCT00903383|82969374|FG002|Overall Study|Decision of Sponsor|0|||
46751017|NCT00903383|82969375|FG003|Overall Study|Decision of Sponsor|0|||
46751018|NCT00903383|82969372|FG000|Overall Study|Withdrawal by Subject|4|||
46751019|NCT00903383|82969373|FG001|Overall Study|Withdrawal by Subject|1|||
46751020|NCT00903383|82969374|FG002|Overall Study|Withdrawal by Subject|0|||
46751021|NCT00903383|82969375|FG003|Overall Study|Withdrawal by Subject|2|||
46751022|NCT00903383|82969372|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
46751023|NCT00903383|82969373|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
46924535|NCT03491462|83158691|FG001|Overall Study|Withdrawal by Subject|15|||
46635962|NCT01525602|82809722|FG006|Overall Study|Death|0|||
46635963|NCT01525602|82809723|FG007|Overall Study|Death|0|||
46635964|NCT01525602|82809716|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
46635965|NCT01525602|82809717|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
46635966|NCT01525602|82809718|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
46635967|NCT01525602|82809719|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
46635968|NCT01525602|82809720|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
46635969|NCT01525602|82809721|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
46635970|NCT01525602|82809722|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
46635971|NCT01525602|82809723|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
46635972|NCT01549002|82809750|FG000|Overall Study|Excessive pain|0|||
46635973|NCT01549002|82809751|FG001|Overall Study|Excessive pain|2|||
46635974|NCT01549002|82809750|FG000|Overall Study|Moderate sedation required|0|||
46635975|NCT01549002|82809751|FG001|Overall Study|Moderate sedation required|2|||
46635976|NCT01548768|82809761|FG000|Overall Study|Withdrawal by Subject|0|||
46635977|NCT01548768|82809762|FG001|Overall Study|Withdrawal by Subject|2|||
46635978|NCT01548768|82809763|FG002|Overall Study|Withdrawal by Subject|1|||
46635979|NCT01548768|82809764|FG003|Overall Study|Withdrawal by Subject|0|||
46635980|NCT01548768|82809761|FG000|Overall Study|Physician Decision|1|||
46635981|NCT01548768|82809762|FG001|Overall Study|Physician Decision|0|||
46635982|NCT01548768|82809763|FG002|Overall Study|Physician Decision|0|||
46635983|NCT01548768|82809764|FG003|Overall Study|Physician Decision|0|||
46635984|NCT01548768|82809761|FG000|Overall Study|Adverse Event|0|||
46635985|NCT01548768|82809762|FG001|Overall Study|Adverse Event|0|||
46635986|NCT01548768|82809763|FG002|Overall Study|Adverse Event|0|||
46635987|NCT01548768|82809764|FG003|Overall Study|Adverse Event|1|||
46635988|NCT01548768|82809761|FG000|Overall Study|Non-Compliance|0|||
46635989|NCT01548768|82809762|FG001|Overall Study|Non-Compliance|0|||
46635990|NCT01548768|82809763|FG002|Overall Study|Non-Compliance|0|||
46635991|NCT01548768|82809764|FG003|Overall Study|Non-Compliance|3|||
46635992|NCT01572792|82809781|FG000|Lead-in Study|Lost to Follow-up|5|||
46635993|NCT01572792|82809782|FG001|Lead-in Study|Lost to Follow-up|9|||
46635994|NCT01572792|82809783|FG002|Lead-in Study|Lost to Follow-up|4|||
46635995|NCT01572792|82809784|FG003|Lead-in Study|Lost to Follow-up|2|||
46751024|NCT00903383|82969374|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
46751025|NCT00903383|82969375|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
46751026|NCT00903383|82969372|FG000|Overall Study|Patient Decision|0|||
46751027|NCT00903383|82969373|FG001|Overall Study|Patient Decision|0|||
46751028|NCT00903383|82969374|FG002|Overall Study|Patient Decision|0|||
46751029|NCT00903383|82969375|FG003|Overall Study|Patient Decision|1|||
46751030|NCT02314026|82969385|FG000|Overall Study|Protocol Violation|28|||
46751031|NCT01617096|82969395|FG000|Overall Study|Withdrawal by Subject|96|||
46751032|NCT01617096|82969396|FG001|Overall Study|Withdrawal by Subject|81|||
46635996|NCT01572792|82809785|FG004|Lead-in Study|Lost to Follow-up|4|||
46635997|NCT01572792|82809781|FG000|Lead-in Study|Withdrawal by Subject|22|||
46635998|NCT01572792|82809782|FG001|Lead-in Study|Withdrawal by Subject|11|||
46635999|NCT01572792|82809783|FG002|Lead-in Study|Withdrawal by Subject|12|||
46636000|NCT01572792|82809784|FG003|Lead-in Study|Withdrawal by Subject|24|||
46636001|NCT01572792|82809785|FG004|Lead-in Study|Withdrawal by Subject|11|||
46636002|NCT01572792|82809781|FG000|Lead-in Study|Protocol Violation|19|||
46636003|NCT01572792|82809782|FG001|Lead-in Study|Protocol Violation|10|||
46636004|NCT01572792|82809783|FG002|Lead-in Study|Protocol Violation|12|||
46636005|NCT01572792|82809784|FG003|Lead-in Study|Protocol Violation|13|||
46636006|NCT01572792|82809785|FG004|Lead-in Study|Protocol Violation|21|||
46636007|NCT01572792|82809781|FG000|Lead-in Study|Lack of Efficacy|20|||
46636008|NCT01572792|82809782|FG001|Lead-in Study|Lack of Efficacy|5|||
46636009|NCT01572792|82809783|FG002|Lead-in Study|Lack of Efficacy|4|||
46636010|NCT01572792|82809784|FG003|Lead-in Study|Lack of Efficacy|8|||
46636011|NCT01572792|82809785|FG004|Lead-in Study|Lack of Efficacy|10|||
46636012|NCT01572792|82809781|FG000|Lead-in Study|Adverse Event|21|||
46636013|NCT01572792|82809782|FG001|Lead-in Study|Adverse Event|21|||
46636014|NCT01572792|82809783|FG002|Lead-in Study|Adverse Event|22|||
46636015|NCT01572792|82809784|FG003|Lead-in Study|Adverse Event|16|||
46636016|NCT01572792|82809785|FG004|Lead-in Study|Adverse Event|14|||
46636017|NCT01572792|82809781|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
46636018|NCT01572792|82809782|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
46636019|NCT01572792|82809783|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
46636020|NCT01572792|82809784|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
46636021|NCT01572792|82809785|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
46636022|NCT01572792|82809781|FG000|Extension Study|Lost to Follow-up|6|||
46636023|NCT01572792|82809782|FG001|Extension Study|Lost to Follow-up|2|||
46636024|NCT01572792|82809783|FG002|Extension Study|Lost to Follow-up|0|||
46636025|NCT01572792|82809784|FG003|Extension Study|Lost to Follow-up|3|||
46636026|NCT01572792|82809785|FG004|Extension Study|Lost to Follow-up|3|||
46636027|NCT01572792|82809781|FG000|Extension Study|Withdrawal by Subject|7|||
46636028|NCT01572792|82809782|FG001|Extension Study|Withdrawal by Subject|6|||
46636029|NCT01572792|82809783|FG002|Extension Study|Withdrawal by Subject|11|||
46636030|NCT01572792|82809784|FG003|Extension Study|Withdrawal by Subject|8|||
46636031|NCT01572792|82809785|FG004|Extension Study|Withdrawal by Subject|14|||
46636032|NCT01572792|82809781|FG000|Extension Study|Protocol Violation|0|||
46636033|NCT01572792|82809782|FG001|Extension Study|Protocol Violation|4|||
46636034|NCT01572792|82809783|FG002|Extension Study|Protocol Violation|3|||
46636035|NCT01572792|82809784|FG003|Extension Study|Protocol Violation|4|||
46636036|NCT01572792|82809785|FG004|Extension Study|Protocol Violation|3|||
46636037|NCT01572792|82809781|FG000|Extension Study|Lack of Efficacy|2|||
46636038|NCT01572792|82809782|FG001|Extension Study|Lack of Efficacy|3|||
46636039|NCT01572792|82809783|FG002|Extension Study|Lack of Efficacy|3|||
46636040|NCT01572792|82809784|FG003|Extension Study|Lack of Efficacy|2|||
46636041|NCT01572792|82809785|FG004|Extension Study|Lack of Efficacy|2|||
46636042|NCT01572792|82809781|FG000|Extension Study|Adverse Event|7|||
46636043|NCT01572792|82809782|FG001|Extension Study|Adverse Event|6|||
46636044|NCT01572792|82809783|FG002|Extension Study|Adverse Event|5|||
46636045|NCT01572792|82809784|FG003|Extension Study|Adverse Event|6|||
46636046|NCT01572792|82809785|FG004|Extension Study|Adverse Event|4|||
46636047|NCT01572792|82809781|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
46636048|NCT01572792|82809782|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
46636049|NCT01572792|82809783|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
46636050|NCT01572792|82809784|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
46636051|NCT01572792|82809785|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
46636052|NCT01547598|82809800|FG000|Overall Study|Withdrew consent|1|||
46636053|NCT01547598|82809801|FG001|Overall Study|Withdrew consent|1|||
46636054|NCT01547598|82809800|FG000|Overall Study|Lost to Follow-up|1|||
46636055|NCT01547598|82809801|FG001|Overall Study|Lost to Follow-up|1|||
46751033|NCT01617096|82969395|FG000|Overall Study|Lost to Follow-up|37|||
46751034|NCT01617096|82969396|FG001|Overall Study|Lost to Follow-up|32|||
46751035|NCT01617096|82969395|FG000|Overall Study|Physician Decision|10|||
46751036|NCT01617096|82969396|FG001|Overall Study|Physician Decision|18|||
46751037|NCT01617096|82969395|FG000|Overall Study|Death|4|||
46636056|NCT01547598|82809800|FG000|Overall Study|Adverse Event|1|||
46751038|NCT01617096|82969396|FG001|Overall Study|Death|3|||
46636057|NCT01547598|82809801|FG001|Overall Study|Adverse Event|1|||
46636058|NCT01547598|82809800|FG000|Overall Study|Protocol Violation|1|||
46636059|NCT01547598|82809801|FG001|Overall Study|Protocol Violation|1|||
46636060|NCT01547598|82809800|FG000|Overall Study|Other Miscellaneous Reasons|2|||
46636061|NCT01547598|82809801|FG001|Overall Study|Other Miscellaneous Reasons|1|||
46636062|NCT01547286|82809808|FG000|Overall Study|Did not meet all eligibility criteria|1|||
46636063|NCT01547286|82809808|FG000|Overall Study|Physician Decision|1|||
46636064|NCT01547130|82809815|FG000|Overall Study|Lost to Follow-up|9|||
46751039|NCT01617096|82969395|FG000|Overall Study|Other|1|||
46751040|NCT01617096|82969396|FG001|Overall Study|Other|3|||
46751041|NCT00900731|82969425|FG000|Overall Study|Adverse Event|31|||
46636065|NCT01547130|82809816|FG001|Overall Study|Lost to Follow-up|5|||
46636066|NCT01524978|82809841|FG000|Overall Study|Other|16|||
46636067|NCT01524978|82809842|FG001|Overall Study|Other|2|||
46636068|NCT01524978|82809843|FG002|Overall Study|Other|1|||
46751042|NCT00900731|82969426|FG001|Overall Study|Adverse Event|27|||
46751043|NCT00900731|82969425|FG000|Overall Study|Withdrawal by Subject|8|||
46751044|NCT00900731|82969426|FG001|Overall Study|Withdrawal by Subject|7|||
46751045|NCT00900731|82969425|FG000|Overall Study|Protocol Deviation|8|||
46751046|NCT00900731|82969426|FG001|Overall Study|Protocol Deviation|11|||
46751047|NCT00900731|82969425|FG000|Overall Study|Administrative Problems|5|||
46751048|NCT00900731|82969426|FG001|Overall Study|Administrative Problems|4|||
46636069|NCT01524978|82809844|FG003|Overall Study|Other|2|||
46751049|NCT00900731|82969425|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
46751050|NCT00900731|82969426|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
46751051|NCT00900731|82969425|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
46751052|NCT00900731|82969426|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
46751053|NCT00900731|82969425|FG000|Overall Study|Lost to Follow-up|2|||
46751054|NCT00900731|82969426|FG001|Overall Study|Lost to Follow-up|3|||
46751055|NCT00900731|82969425|FG000|Overall Study|Lack of Efficacy|1|||
46751056|NCT00900731|82969426|FG001|Overall Study|Lack of Efficacy|3|||
46751057|NCT00900731|82969425|FG000|Overall Study|Death|0|||
46751058|NCT00900731|82969426|FG001|Overall Study|Death|2|||
46751059|NCT03842436|82969432|FG000|Overall Study|Lost to Follow-up|1|||
46751060|NCT00602472|82969472|FG000|Overall Study|Adverse Event|5|||
46751061|NCT00602472|82969473|FG001|Overall Study|Adverse Event|23|||
46751062|NCT00602472|82969472|FG000|Overall Study|Protocol Violation|4|||
46751063|NCT00602472|82969473|FG001|Overall Study|Protocol Violation|19|||
46751064|NCT00602472|82969472|FG000|Overall Study|Withdrawal by Subject|8|||
46751065|NCT00602472|82969473|FG001|Overall Study|Withdrawal by Subject|14|||
46751066|NCT00602472|82969472|FG000|Overall Study|Other incl. lack of efficacy|4|||
46751067|NCT00602472|82969473|FG001|Overall Study|Other incl. lack of efficacy|2|||
46751068|NCT00901901|82969508|FG000|Treatment Period|Adverse Event|120|||
46751069|NCT00901901|82969509|FG001|Treatment Period|Adverse Event|128|||
46751070|NCT00901901|82969508|FG000|Treatment Period|Withdrawal by Subject|26|||
46751071|NCT00901901|82969509|FG001|Treatment Period|Withdrawal by Subject|24|||
46751072|NCT00901901|82969508|FG000|Treatment Period|Physician Decision|2|||
46751073|NCT00901901|82969509|FG001|Treatment Period|Physician Decision|2|||
46751074|NCT00901901|82969508|FG000|Treatment Period|Lost to Follow-up|3|||
46751075|NCT00901901|82969509|FG001|Treatment Period|Lost to Follow-up|5|||
46751076|NCT00901901|82969508|FG000|Treatment Period|Noncompliance with study medication|4|||
46751077|NCT00901901|82969509|FG001|Treatment Period|Noncompliance with study medication|1|||
46751078|NCT00901901|82969508|FG000|Treatment Period|Missing|1|||
46751079|NCT00901901|82969509|FG001|Treatment Period|Missing|0|||
46751080|NCT00901901|82969508|FG000|Treatment Period|Never treated|0|||
46751081|NCT00901901|82969509|FG001|Treatment Period|Never treated|3|||
46751082|NCT00901901|82969508|FG000|Treatment Period|Protocol driven decision point|0|||
46751083|NCT00901901|82969509|FG001|Treatment Period|Protocol driven decision point|2|||
46751084|NCT00901901|82969508|FG000|Treatment Period|Study terminated by sponsor|2|||
46751085|NCT00901901|82969509|FG001|Treatment Period|Study terminated by sponsor|0|||
46751086|NCT00901901|82969508|FG000|Treatment Period|Protocol Violation|5|||
46751087|NCT00901901|82969509|FG001|Treatment Period|Protocol Violation|9|||
46751088|NCT00901901|82969508|FG000|Treatment Period|Switch to commercial drug|1|||
46751089|NCT00901901|82969509|FG001|Treatment Period|Switch to commercial drug|1|||
46751090|NCT00901901|82969508|FG000|Treatment Period|Transfer to treatment continuation study|5|||
46751091|NCT00901901|82969509|FG001|Treatment Period|Transfer to treatment continuation study|2|||
46751092|NCT00901901|82969508|FG000|Follow-up Period|Death|181|||
46751093|NCT00901901|82969509|FG001|Follow-up Period|Death|208|||
46751094|NCT00901901|82969508|FG000|Follow-up Period|Protocol driven decision point|47|||
46751095|NCT00901901|82969509|FG001|Follow-up Period|Protocol driven decision point|36|||
46751096|NCT00901901|82969508|FG000|Follow-up Period|Withdrawal by Subject|6|||
46751097|NCT00901901|82969509|FG001|Follow-up Period|Withdrawal by Subject|9|||
46636070|NCT01524978|82809845|FG004|Overall Study|Other|1|||
46636071|NCT01524978|82809846|FG005|Overall Study|Other|3|||
46636072|NCT01524978|82809847|FG006|Overall Study|Other|17|||
46636073|NCT01524978|82809848|FG007|Overall Study|Other|1|||
46636074|NCT01524978|82809849|FG008|Overall Study|Other|2|||
46751098|NCT00901901|82969508|FG000|Follow-up Period|Lost to Follow-up|12|||
46751099|NCT00901901|82969509|FG001|Follow-up Period|Lost to Follow-up|8|||
46751100|NCT00901901|82969508|FG000|Follow-up Period|Missing|94|||
46751101|NCT00901901|82969509|FG001|Follow-up Period|Missing|80|||
46751102|NCT02143778|82969517|FG000|Overall Study|Withdrawal by Subject|2|||
46751103|NCT02143778|82969517|FG000|Overall Study|Device malfunction|1|||
46751104|NCT00896363|82969561|FG000|Overall Study|Adverse Event|3|||
46751105|NCT00896363|82969562|FG001|Overall Study|Adverse Event|4|||
46636075|NCT01524978|82809850|FG009|Overall Study|Other|2|||
46636076|NCT01524978|82809851|FG010|Overall Study|Other|5|||
46751106|NCT00896363|82969563|FG002|Overall Study|Adverse Event|2|||
46751107|NCT00896363|82969561|FG000|Overall Study|Lack of Efficacy|0|||
46751108|NCT00896363|82969562|FG001|Overall Study|Lack of Efficacy|2|||
46751109|NCT00896363|82969563|FG002|Overall Study|Lack of Efficacy|1|||
46751110|NCT00896363|82969561|FG000|Overall Study|Withdrawal by Subject|3|||
46751111|NCT00896363|82969562|FG001|Overall Study|Withdrawal by Subject|5|||
46751112|NCT00896363|82969563|FG002|Overall Study|Withdrawal by Subject|5|||
46751113|NCT00900029|82969579|FG000|Overall Study|Lost to Follow-up|0|||
46751114|NCT00900029|82969580|FG001|Overall Study|Lost to Follow-up|2|||
46751115|NCT00900029|82969581|FG002|Overall Study|Lost to Follow-up|1|||
46751116|NCT00900029|82969582|FG003|Overall Study|Lost to Follow-up|4|||
46751117|NCT00900029|82969583|FG004|Overall Study|Lost to Follow-up|4|||
46751118|NCT00900029|82969579|FG000|Overall Study|Withdrawal by Subject|2|||
46751119|NCT00900029|82969580|FG001|Overall Study|Withdrawal by Subject|2|||
46751120|NCT00900029|82969581|FG002|Overall Study|Withdrawal by Subject|1|||
46751121|NCT00900029|82969582|FG003|Overall Study|Withdrawal by Subject|1|||
46751122|NCT00900029|82969583|FG004|Overall Study|Withdrawal by Subject|1|||
46751123|NCT00900029|82969579|FG000|Overall Study|Adverse Event|0|||
46751124|NCT00900029|82969580|FG001|Overall Study|Adverse Event|0|||
46751125|NCT00900029|82969581|FG002|Overall Study|Adverse Event|1|||
46751126|NCT00900029|82969582|FG003|Overall Study|Adverse Event|1|||
46751127|NCT00900029|82969583|FG004|Overall Study|Adverse Event|1|||
46751128|NCT00900029|82969579|FG000|Overall Study|Death|1|||
46751129|NCT00900029|82969580|FG001|Overall Study|Death|0|||
46751130|NCT00900029|82969581|FG002|Overall Study|Death|0|||
46751131|NCT00900029|82969582|FG003|Overall Study|Death|1|||
46751132|NCT00900029|82969583|FG004|Overall Study|Death|0|||
46751133|NCT00896051|82969601|FG000|Overall Study|Adverse Event|2|||
46751134|NCT00896051|82969602|FG001|Overall Study|Adverse Event|1|||
46636077|NCT01524978|82809841|FG000|Overall Study|Withdrawal by Subject|12|||
46636078|NCT01524978|82809842|FG001|Overall Study|Withdrawal by Subject|0|||
46636079|NCT01524978|82809843|FG002|Overall Study|Withdrawal by Subject|1|||
46636080|NCT01524978|82809844|FG003|Overall Study|Withdrawal by Subject|1|||
46636081|NCT01524978|82809845|FG004|Overall Study|Withdrawal by Subject|3|||
46751135|NCT00896051|82969601|FG000|Overall Study|Lost to Follow-up|3|||
46751136|NCT00896051|82969602|FG001|Overall Study|Lost to Follow-up|2|||
46751137|NCT00896051|82969601|FG000|Overall Study|Withdrawal by Subject|3|||
46751138|NCT00896051|82969602|FG001|Overall Study|Withdrawal by Subject|2|||
46751139|NCT00896051|82969601|FG000|Overall Study|Subject noncompliant|1|||
46751140|NCT00896051|82969602|FG001|Overall Study|Subject noncompliant|3|||
46751141|NCT00896051|82969601|FG000|Overall Study|Other|1|||
46751142|NCT00896051|82969602|FG001|Overall Study|Other|1|||
46751143|NCT00894647|82969619|FG000|Overall Study|Adverse Event|5|||
46751144|NCT00894647|82969620|FG001|Overall Study|Adverse Event|4|||
46751145|NCT00894647|82969619|FG000|Overall Study|Withdrawal by Subject|4|||
46751146|NCT00894647|82969620|FG001|Overall Study|Withdrawal by Subject|4|||
46751147|NCT00894647|82969619|FG000|Overall Study|Lost to Follow-up|0|||
46751148|NCT00894647|82969620|FG001|Overall Study|Lost to Follow-up|2|||
46751149|NCT00894647|82969619|FG000|Overall Study|Non-compliance with study procedures|0|||
46804784|NCT00539006|83023834|FG003|Treatment Period 1|Protocol Violation|0|||
46804785|NCT00539006|83023831|FG000|Treatment Period 1|Lack of Efficacy|0|||
46804786|NCT00539006|83023832|FG001|Treatment Period 1|Lack of Efficacy|0|||
46804787|NCT00539006|83023833|FG002|Treatment Period 1|Lack of Efficacy|0|||
46804788|NCT00539006|83023834|FG003|Treatment Period 1|Lack of Efficacy|1|||
46804789|NCT00539006|83023831|FG000|Washout|Adverse Event|2|||
46804790|NCT00539006|83023832|FG001|Washout|Adverse Event|1|||
46804791|NCT00539006|83023833|FG002|Washout|Adverse Event|0|||
46804792|NCT00539006|83023834|FG003|Washout|Adverse Event|0|||
46804793|NCT00539006|83023831|FG000|Washout|Protocol Violation|1|||
46804794|NCT00539006|83023832|FG001|Washout|Protocol Violation|1|||
46636082|NCT01524978|82809846|FG005|Overall Study|Withdrawal by Subject|1|||
46636083|NCT01524978|82809847|FG006|Overall Study|Withdrawal by Subject|6|||
46636084|NCT01524978|82809848|FG007|Overall Study|Withdrawal by Subject|2|||
46636085|NCT01524978|82809849|FG008|Overall Study|Withdrawal by Subject|4|||
46636086|NCT01524978|82809850|FG009|Overall Study|Withdrawal by Subject|0|||
46636087|NCT01524978|82809851|FG010|Overall Study|Withdrawal by Subject|5|||
46751150|NCT00894647|82969620|FG001|Overall Study|Non-compliance with study procedures|2|||
46751151|NCT00894647|82969619|FG000|Overall Study|Other, not due to AE|1|||
46751152|NCT00894647|82969620|FG001|Overall Study|Other, not due to AE|2|||
46751153|NCT00892775|82969628|FG000|Overall Study|Protocol Violation|1|||
46751154|NCT00892775|82969629|FG001|Overall Study|Protocol Violation|0|||
46751155|NCT00892775|82969628|FG000|Overall Study|Subject difficulties with blood drawing|1|||
46751156|NCT00892775|82969629|FG001|Overall Study|Subject difficulties with blood drawing|0|||
46804795|NCT00539006|83023833|FG002|Washout|Protocol Violation|0|||
46804796|NCT00539006|83023834|FG003|Washout|Protocol Violation|0|||
46804797|NCT00539006|83023831|FG000|Washout|Withdrawal by Subject|0|||
46751157|NCT00892775|82969628|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
46751158|NCT00892775|82969629|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
46804798|NCT00539006|83023832|FG001|Washout|Withdrawal by Subject|2|||
46804799|NCT00539006|83023833|FG002|Washout|Withdrawal by Subject|0|||
46804800|NCT00539006|83023834|FG003|Washout|Withdrawal by Subject|0|||
46804801|NCT00539006|83023831|FG000|Washout|Failed to meet continuation criteria|16|||
46804802|NCT00539006|83023832|FG001|Washout|Failed to meet continuation criteria|5|||
46804803|NCT00539006|83023833|FG002|Washout|Failed to meet continuation criteria|14|||
46804804|NCT00539006|83023834|FG003|Washout|Failed to meet continuation criteria|6|||
46804805|NCT00539006|83023831|FG000|Washout|Other|1|||
46804806|NCT00539006|83023832|FG001|Washout|Other|1|||
46804807|NCT00539006|83023833|FG002|Washout|Other|2|||
46804808|NCT00539006|83023834|FG003|Washout|Other|3|||
46804809|NCT00539006|83023831|FG000|Treatment Period 2|Protocol Violation|1|||
46804810|NCT00539006|83023832|FG001|Treatment Period 2|Protocol Violation|0|||
46804811|NCT00539006|83023833|FG002|Treatment Period 2|Protocol Violation|0|||
46804812|NCT00539006|83023834|FG003|Treatment Period 2|Protocol Violation|0|||
46804813|NCT00539006|83023831|FG000|Treatment Period 2|Other|0|||
46804814|NCT00539006|83023832|FG001|Treatment Period 2|Other|1|||
46804815|NCT00539006|83023833|FG002|Treatment Period 2|Other|0|||
46804816|NCT00539006|83023834|FG003|Treatment Period 2|Other|0|||
46804817|NCT00537056|83023850|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
46804818|NCT00535262|83023856|FG000|Overall Study|No funding|3|||
46804819|NCT00074581|83023862|FG000|Overall Study|Death|15|||
46804820|NCT00074581|83023863|FG001|Overall Study|Death|16|||
46804821|NCT00074581|83023862|FG000|Overall Study|Withdrawal by Subject|50|||
46804822|NCT00074581|83023863|FG001|Overall Study|Withdrawal by Subject|49|||
46804823|NCT00074581|83023862|FG000|Overall Study|Unable to adhere to visit schedule|13|||
46804824|NCT00074581|83023863|FG001|Overall Study|Unable to adhere to visit schedule|14|||
46804825|NCT00074581|83023862|FG000|Overall Study|Relocated|14|||
46804826|NCT00074581|83023863|FG001|Overall Study|Relocated|9|||
46804827|NCT00074581|83023862|FG000|Overall Study|Were withdrawn by investigator|5|||
46804828|NCT00074581|83023863|FG001|Overall Study|Were withdrawn by investigator|2|||
46804829|NCT00074581|83023862|FG000|Overall Study|Lost to Follow-up|16|||
46804830|NCT00074581|83023863|FG001|Overall Study|Lost to Follow-up|11|||
46804831|NCT00074581|83023862|FG000|Overall Study|Ended relationship w. index participant|117|||
46804832|NCT00074581|83023863|FG001|Overall Study|Ended relationship w. index participant|106|||
46804833|NCT00074581|83023862|FG000|Overall Study|Other|14|||
46804834|NCT00074581|83023863|FG001|Overall Study|Other|19|||
46804835|NCT03895034|83023869|FG000|Overall Study|Lost to Follow-up|2|||
46804836|NCT00536978|83023873|FG000|Overall Study|Not eligible for Adback Infusion|22|||
46804837|NCT03809611|83023879|FG000|Overall Study|Withdrawal by Subject|1|||
46804838|NCT03809611|83023880|FG001|Overall Study|Withdrawal by Subject|1|||
46804839|NCT03807739|83023891|FG000|Overall Study|Adverse Event|1|||
46804840|NCT03807739|83023892|FG001|Overall Study|Adverse Event|0|||
46804841|NCT03807739|83023893|FG002|Overall Study|Adverse Event|0|||
46804842|NCT03807739|83023894|FG003|Overall Study|Adverse Event|0|||
46804843|NCT03807739|83023891|FG000|Overall Study|Withdrawal by Subject|1|||
46804844|NCT03807739|83023892|FG001|Overall Study|Withdrawal by Subject|0|||
46804845|NCT03807739|83023893|FG002|Overall Study|Withdrawal by Subject|0|||
46751159|NCT00892775|82969628|FG000|Overall Study|Migrated/ moved from study area|1|||
46751160|NCT00892775|82969629|FG001|Overall Study|Migrated/ moved from study area|0|||
46751161|NCT00892775|82969628|FG000|Overall Study|Withdrawal by Subject|0|||
46751162|NCT00892775|82969629|FG001|Overall Study|Withdrawal by Subject|1|||
46751163|NCT00892775|82969628|FG000|Overall Study|Lost to Follow-up|1|||
46751164|NCT00892775|82969629|FG001|Overall Study|Lost to Follow-up|0|||
46751165|NCT00895895|82969640|FG000|Period 1|Adverse Event|7|||
46751166|NCT00895895|82969641|FG001|Period 1|Adverse Event|6|||
46751167|NCT00895895|82969642|FG002|Period 1|Adverse Event|4|||
46751168|NCT00895895|82969643|FG003|Period 1|Adverse Event|6|||
46751169|NCT00895895|82969644|FG004|Period 1|Adverse Event|7|||
46751170|NCT00895895|82969640|FG000|Period 1|Death|0|||
46751171|NCT00895895|82969641|FG001|Period 1|Death|0|||
46751172|NCT00895895|82969642|FG002|Period 1|Death|0|||
46751173|NCT00895895|82969643|FG003|Period 1|Death|0|||
46751174|NCT00895895|82969644|FG004|Period 1|Death|1|||
46751175|NCT00895895|82969640|FG000|Period 1|discontinued by sponsor|2|||
46751176|NCT00895895|82969641|FG001|Period 1|discontinued by sponsor|1|||
46804846|NCT03807739|83023894|FG003|Overall Study|Withdrawal by Subject|0|||
46804847|NCT00536744|83023906|FG000|Overall Study|Adverse Event|13|||
46804848|NCT00536744|83023907|FG001|Overall Study|Adverse Event|10|||
46804849|NCT00536744|83023906|FG000|Overall Study|Death|2|||
46751177|NCT00895895|82969642|FG002|Period 1|discontinued by sponsor|2|||
46751178|NCT00895895|82969643|FG003|Period 1|discontinued by sponsor|1|||
46804850|NCT00536744|83023907|FG001|Overall Study|Death|1|||
46804851|NCT00536744|83023906|FG000|Overall Study|Physician Decision|3|||
46751179|NCT00895895|82969644|FG004|Period 1|discontinued by sponsor|1|||
46751180|NCT00895895|82969640|FG000|Period 1|failed to return|0|||
46751181|NCT00895895|82969641|FG001|Period 1|failed to return|0|||
46751182|NCT00895895|82969642|FG002|Period 1|failed to return|1|||
46751183|NCT00895895|82969643|FG003|Period 1|failed to return|0|||
46751184|NCT00895895|82969644|FG004|Period 1|failed to return|1|||
46804852|NCT00536744|83023907|FG001|Overall Study|Physician Decision|1|||
46804853|NCT00536744|83023906|FG000|Overall Study|Lost to Follow-up|3|||
46804854|NCT00536744|83023907|FG001|Overall Study|Lost to Follow-up|5|||
46804855|NCT00536744|83023906|FG000|Overall Study|Withdrawal by Subject|7|||
46804856|NCT00536744|83023907|FG001|Overall Study|Withdrawal by Subject|8|||
46804857|NCT00536744|83023906|FG000|Overall Study|PI tried alternative treatment|1|||
46804858|NCT00536744|83023907|FG001|Overall Study|PI tried alternative treatment|3|||
46804859|NCT00536510|83023924|FG000|Overall Study|Adverse Event|27|||
46804860|NCT00536510|83023925|FG001|Overall Study|Adverse Event|4|||
46804861|NCT00536510|83023924|FG000|Overall Study|Lost to Follow-up|11|||
46804862|NCT00536510|83023925|FG001|Overall Study|Lost to Follow-up|8|||
46804863|NCT00536510|83023924|FG000|Overall Study|Protocol Violation|4|||
46804864|NCT00536510|83023925|FG001|Overall Study|Protocol Violation|5|||
46804865|NCT00536510|83023924|FG000|Overall Study|Withdrawal by Subject|16|||
46804866|NCT00536510|83023925|FG001|Overall Study|Withdrawal by Subject|9|||
46804867|NCT00536510|83023924|FG000|Overall Study|Flushing with Product|20|||
46804868|NCT00536510|83023925|FG001|Overall Study|Flushing with Product|0|||
46804869|NCT00536510|83023924|FG000|Overall Study|Laboratory Adverse Event|2|||
46804870|NCT00536510|83023925|FG001|Overall Study|Laboratory Adverse Event|1|||
46804871|NCT00536510|83023924|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
46804872|NCT00536510|83023925|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
46804873|NCT00398086|83023934|FG000|Overall Study|Unacceptable Toxicity|2|||
46804874|NCT00398086|83023935|FG001|Overall Study|Unacceptable Toxicity|8|||
46804875|NCT00398086|83023936|FG002|Overall Study|Unacceptable Toxicity|2|||
46804876|NCT00398086|83023934|FG000|Overall Study|Adverse Event|1|||
46804877|NCT00398086|83023935|FG001|Overall Study|Adverse Event|4|||
46804878|NCT00398086|83023936|FG002|Overall Study|Adverse Event|0|||
46804879|NCT00398086|83023934|FG000|Overall Study|Physician Decision|1|||
46804880|NCT00398086|83023935|FG001|Overall Study|Physician Decision|4|||
46804881|NCT00398086|83023936|FG002|Overall Study|Physician Decision|0|||
46804882|NCT00398086|83023934|FG000|Overall Study|Withdrawal by Subject|5|||
46804883|NCT00398086|83023935|FG001|Overall Study|Withdrawal by Subject|7|||
46804884|NCT00398086|83023936|FG002|Overall Study|Withdrawal by Subject|0|||
47052470|NCT01849289|83319617|FG000|Overall Study|Unclassified|25|||
47052471|NCT01849289|83319618|FG001|Overall Study|Unclassified|18|||
47052472|NCT01868243|83319626|FG000|Overall Study|Death|0|||
47052473|NCT01868243|83319627|FG001|Overall Study|Death|1|||
47052474|NCT01611935|83319635|FG000|Overall Study|Family Declined Participation|1|||
47052475|NCT01611935|83319636|FG001|Overall Study|Family Declined Participation|0|||
47052476|NCT01868165|83319642|FG000|Overall Study|Withdrawal by Subject|36|||
46751185|NCT00895895|82969640|FG000|Period 1|investigator request|0|||
47052477|NCT01868165|83319642|FG000|Overall Study|Physician Decision|2|||
47052478|NCT01868165|83319642|FG000|Overall Study|Lost to Follow-up|3|||
47052479|NCT01868165|83319642|FG000|Overall Study|Death|4|||
47052480|NCT01868009|83319681|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
47052481|NCT01868009|83319682|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
47052482|NCT01868009|83319681|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
47052483|NCT01868009|83319682|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
47052484|NCT01868009|83319681|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
47052485|NCT01868009|83319682|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
47052486|NCT01849055|83319736|FG000|Overall Study|Withdrawal by Subject|0|||
47052487|NCT01849055|83319737|FG001|Overall Study|Withdrawal by Subject|0|||
47052488|NCT01849055|83319738|FG002|Overall Study|Withdrawal by Subject|1|||
47052489|NCT01849055|83319739|FG003|Overall Study|Withdrawal by Subject|0|||
47052490|NCT01849055|83319740|FG004|Overall Study|Withdrawal by Subject|0|||
47052491|NCT01849055|83319741|FG005|Overall Study|Withdrawal by Subject|0|||
47052492|NCT01848353|83319767|FG000|Phase 1|Withdrawal by Subject|3|||
47052493|NCT01848353|83319768|FG001|Phase 1|Withdrawal by Subject|1|||
47052494|NCT01848353|83319769|FG002|Phase 1|Withdrawal by Subject|0|||
47052495|NCT01848353|83319770|FG003|Phase 1|Withdrawal by Subject|0|||
47052496|NCT01848353|83319767|FG000|Phase 2|Withdrawal by Subject|3|||
47052497|NCT01848353|83319768|FG001|Phase 2|Withdrawal by Subject|2|||
47052498|NCT01848353|83319769|FG002|Phase 2|Withdrawal by Subject|0|||
46751186|NCT00895895|82969641|FG001|Period 1|investigator request|1|||
46751187|NCT00895895|82969642|FG002|Period 1|investigator request|0|||
46751188|NCT00895895|82969643|FG003|Period 1|investigator request|0|||
46751189|NCT00895895|82969644|FG004|Period 1|investigator request|0|||
46751190|NCT00895895|82969640|FG000|Period 1|Lost to Follow-up|2|||
46751191|NCT00895895|82969641|FG001|Period 1|Lost to Follow-up|1|||
46751192|NCT00895895|82969642|FG002|Period 1|Lost to Follow-up|3|||
46636088|NCT01524978|82809841|FG000|Overall Study|Lost to Follow-up|0|||
46636089|NCT01524978|82809842|FG001|Overall Study|Lost to Follow-up|0|||
46751193|NCT00895895|82969643|FG003|Period 1|Lost to Follow-up|2|||
46804885|NCT00536198|83023946|FG000|Overall Study|Lost to Follow-up|15|||
46804886|NCT00536198|83023947|FG001|Overall Study|Lost to Follow-up|14|||
46804887|NCT00536198|83023946|FG000|Overall Study|Withdrawal by Subject|16|||
46804888|NCT00536198|83023947|FG001|Overall Study|Withdrawal by Subject|12|||
46804889|NCT00536198|83023946|FG000|Overall Study|Adverse Event|2|||
46804890|NCT00536198|83023947|FG001|Overall Study|Adverse Event|2|||
47052499|NCT01848353|83319770|FG003|Phase 2|Withdrawal by Subject|0|||
47052500|NCT01848353|83319767|FG000|Phase 3|Withdrawal by Subject|1|||
47052501|NCT01848353|83319768|FG001|Phase 3|Withdrawal by Subject|1|||
47052502|NCT01848353|83319769|FG002|Phase 3|Withdrawal by Subject|0|||
47052503|NCT01848353|83319770|FG003|Phase 3|Withdrawal by Subject|0|||
47052504|NCT01847885|83319799|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
47052505|NCT01847885|83319800|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
46804891|NCT00536198|83023946|FG000|Overall Study|Rescue|3|||
46804892|NCT00536198|83023947|FG001|Overall Study|Rescue|9|||
46804893|NCT00536198|83023946|FG000|Overall Study|Pregnancy|1|||
46804894|NCT00536198|83023947|FG001|Overall Study|Pregnancy|1|||
46804895|NCT00536198|83023946|FG000|Overall Study|Protocol Violation|0|||
46804896|NCT00536198|83023947|FG001|Overall Study|Protocol Violation|1|||
46804897|NCT00393484|83023957|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
46804898|NCT00393484|83023958|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
46804899|NCT00393484|83023957|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
46804900|NCT00393484|83023958|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
46804901|NCT00393484|83023957|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
46804902|NCT00393484|83023958|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
46804903|NCT00393484|83023957|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
46804904|NCT00393484|83023958|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
46804905|NCT00393484|83023957|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
46804906|NCT00393484|83023958|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
46804907|NCT00393484|83023957|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
46804908|NCT00393484|83023958|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
46804909|NCT00393484|83023957|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
46804910|NCT00393484|83023958|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
46804911|NCT00393484|83023957|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
46804912|NCT00393484|83023958|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
46804913|NCT00393484|83023957|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
46804914|NCT00393484|83023958|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
46804915|NCT00393484|83023957|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
46804916|NCT00393484|83023958|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
46804917|NCT00667823|83023966|FG000|Overall Study|Lost to Follow-up|5|||
46804918|NCT00667823|83023966|FG000|Overall Study|Adverse Event|7|||
46804919|NCT00667823|83023966|FG000|Overall Study|Death|182|||
46804920|NCT00667823|83023966|FG000|Overall Study|Withdrawal by Subject|12|||
46804921|NCT00667823|83023966|FG000|Overall Study|Other|8|||
46804922|NCT00667823|83023966|FG000|Overall Study|Missing (completion page missing)|2|||
46804923|NCT00397930|83023972|FG000|Overall Study|Personal reasons|14|||
46804924|NCT00397930|83023973|FG001|Overall Study|Personal reasons|8|||
46804925|NCT00397930|83023972|FG000|Overall Study|Other medical|9|||
46804926|NCT00397930|83023973|FG001|Overall Study|Other medical|4|||
46804927|NCT00397930|83023972|FG000|Overall Study|Unknown reasons|9|||
46804928|NCT00397930|83023973|FG001|Overall Study|Unknown reasons|14|||
46804929|NCT00397930|83023972|FG000|Overall Study|Noncompliant|3|||
46804930|NCT00397930|83023973|FG001|Overall Study|Noncompliant|2|||
46804931|NCT00397930|83023972|FG000|Overall Study|Too time-consuming|2|||
46804932|NCT00397930|83023973|FG001|Overall Study|Too time-consuming|9|||
46804933|NCT00397930|83023972|FG000|Overall Study|Started own yoga program|1|||
46804934|NCT00397930|83023973|FG001|Overall Study|Started own yoga program|1|||
46804935|NCT00397930|83023972|FG000|Overall Study|Did not want to be in control group|0|||
46804936|NCT00397930|83023973|FG001|Overall Study|Did not want to be in control group|1|||
46804937|NCT00397930|83023972|FG000|Overall Study|Withdrawal by Subject|0|||
46804938|NCT00397930|83023973|FG001|Overall Study|Withdrawal by Subject|8|||
46804939|NCT00397930|83023972|FG000|Overall Study|Missing data|0|||
46804940|NCT00397930|83023973|FG001|Overall Study|Missing data|4|||
46804941|NCT00397540|83023981|FG000|Overall Study|short follow-up duration < 12 months|1|||
46804942|NCT00397540|83023982|FG001|Overall Study|short follow-up duration < 12 months|0|||
46804943|NCT00536120|83023991|FG000|Overall Study|Lost to Follow-up|1|||
46804944|NCT00536120|83023992|FG001|Overall Study|Lost to Follow-up|0|||
46804945|NCT00536120|83023991|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
46804946|NCT00536120|83023992|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
46804947|NCT00536120|83023991|FG000|Overall Study|Non-compliance|1|||
46804948|NCT00536120|83023992|FG001|Overall Study|Non-compliance|0|||
46804949|NCT00536120|83023991|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
46804950|NCT00536120|83023992|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
46804951|NCT00536120|83023991|FG000|Overall Study|Steroid Use|0|||
46804952|NCT00536120|83023992|FG001|Overall Study|Steroid Use|2|||
46804953|NCT00536120|83023991|FG000|Overall Study|Missed Study Visit|0|||
46804954|NCT00536120|83023992|FG001|Overall Study|Missed Study Visit|1|||
46804955|NCT00057811|83024000|FG000|Overall Study|Lack of Efficacy|1|||
46804956|NCT00057811|83024001|FG001|Overall Study|Lack of Efficacy|4|||
47052506|NCT01847885|83319801|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
46804957|NCT00057811|83024000|FG000|Overall Study|Physician Decision|1|||
46804958|NCT00057811|83024001|FG001|Overall Study|Physician Decision|0|||
46804959|NCT00057811|83024000|FG000|Overall Study|Withdrawal by Subject|3|||
46804960|NCT00057811|83024001|FG001|Overall Study|Withdrawal by Subject|4|||
46804961|NCT00057811|83024000|FG000|Overall Study|Ineligible|4|||
46804962|NCT00057811|83024001|FG001|Overall Study|Ineligible|2|||
46804963|NCT00057811|83024000|FG000|Overall Study|Inevaluable|1|||
46804964|NCT00057811|83024001|FG001|Overall Study|Inevaluable|2|||
46804965|NCT02866682|83024014|FG000|Overall Study|Death|0|||
46804966|NCT02866682|83024015|FG001|Overall Study|Death|1|||
46804967|NCT02866682|83024014|FG000|Overall Study|Lost to Follow-up|0|||
46804968|NCT02866682|83024015|FG001|Overall Study|Lost to Follow-up|4|||
46804969|NCT02866682|83024014|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
46804970|NCT02866682|83024015|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
46804971|NCT02866682|83024014|FG000|Overall Study|Other|0|||
46804972|NCT02866682|83024015|FG001|Overall Study|Other|1|||
46804973|NCT00570713|83024032|FG000|Overall Study|Adverse Event|16|||
46804974|NCT00570713|83024033|FG001|Overall Study|Adverse Event|9|||
46804975|NCT00570713|83024032|FG000|Overall Study|Death|7|||
46804976|NCT00570713|83024033|FG001|Overall Study|Death|7|||
46804977|NCT00570713|83024032|FG000|Overall Study|Lack of Efficacy|40|||
46804978|NCT00570713|83024033|FG001|Overall Study|Lack of Efficacy|49|||
46804979|NCT00570713|83024032|FG000|Overall Study|Physician Decision|2|||
46804980|NCT00570713|83024033|FG001|Overall Study|Physician Decision|2|||
46804981|NCT00570713|83024032|FG000|Overall Study|Withdrawal by Subject|3|||
46804982|NCT00570713|83024033|FG001|Overall Study|Withdrawal by Subject|3|||
46804983|NCT00570713|83024032|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
46804984|NCT00570713|83024033|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
46804985|NCT00669617|83024043|FG000|Period 1|Withdrawal by Subject|0|||
46804986|NCT00669617|83024044|FG001|Period 1|Withdrawal by Subject|0|||
46804987|NCT00669617|83024045|FG002|Period 1|Withdrawal by Subject|1|||
46804988|NCT00669617|83024046|FG003|Period 1|Withdrawal by Subject|0|||
46804989|NCT00669617|83024047|FG004|Period 1|Withdrawal by Subject|0|||
46804990|NCT00669617|83024043|FG000|Period 1|Protocol Deviation|0|||
46804991|NCT00669617|83024044|FG001|Period 1|Protocol Deviation|0|||
46804992|NCT00669617|83024045|FG002|Period 1|Protocol Deviation|0|||
46804993|NCT00669617|83024046|FG003|Period 1|Protocol Deviation|0|||
46804994|NCT00669617|83024047|FG004|Period 1|Protocol Deviation|1|||
46804995|NCT00669617|83024043|FG000|Period 3|Lost to Follow-up|1|||
46804996|NCT00669617|83024044|FG001|Period 3|Lost to Follow-up|0|||
46804997|NCT00669617|83024045|FG002|Period 3|Lost to Follow-up|0|||
46804998|NCT00669617|83024046|FG003|Period 3|Lost to Follow-up|0|||
46804999|NCT00669617|83024047|FG004|Period 3|Lost to Follow-up|0|||
47052507|NCT01847885|83319799|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
47052508|NCT01847885|83319800|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
47052509|NCT01847885|83319801|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
47052510|NCT01847885|83319799|FG000|Initial Enrollment (Consented)|Screen failure|39|||
47052511|NCT01847885|83319800|FG001|Initial Enrollment (Consented)|Screen failure|0|||
47052512|NCT01847885|83319801|FG002|Initial Enrollment (Consented)|Screen failure|0|||
47052513|NCT01847885|83319799|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
47052514|NCT01847885|83319800|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
47052515|NCT01847885|83319801|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
46636090|NCT01524978|82809843|FG002|Overall Study|Lost to Follow-up|3|||
46636091|NCT01524978|82809844|FG003|Overall Study|Lost to Follow-up|0|||
46751194|NCT00895895|82969644|FG004|Period 1|Lost to Follow-up|3|||
46751195|NCT00895895|82969640|FG000|Period 1|Other|1|||
46751196|NCT00895895|82969641|FG001|Period 1|Other|2|||
46751197|NCT00895895|82969642|FG002|Period 1|Other|1|||
46751198|NCT00895895|82969643|FG003|Period 1|Other|1|||
46751199|NCT00895895|82969644|FG004|Period 1|Other|1|||
46751200|NCT00895895|82969640|FG000|Period 1|Protocol Violation|0|||
46751201|NCT00895895|82969641|FG001|Period 1|Protocol Violation|1|||
46751202|NCT00895895|82969642|FG002|Period 1|Protocol Violation|0|||
46751203|NCT00895895|82969643|FG003|Period 1|Protocol Violation|0|||
46751204|NCT00895895|82969644|FG004|Period 1|Protocol Violation|0|||
46751205|NCT00895895|82969640|FG000|Period 1|Withdrawal by Subject|6|||
46751206|NCT00895895|82969641|FG001|Period 1|Withdrawal by Subject|6|||
46805000|NCT00535730|83024061|FG000|Overall Study|Adverse Event|1|||
46805001|NCT00535730|83024062|FG001|Overall Study|Adverse Event|1|||
46805002|NCT00535730|83024061|FG000|Overall Study|Lost to Follow-up|0|||
46751207|NCT00895895|82969642|FG002|Period 1|Withdrawal by Subject|8|||
46805003|NCT00535730|83024062|FG001|Overall Study|Lost to Follow-up|1|||
46805004|NCT00535730|83024061|FG000|Overall Study|Physician Decision|0|||
46805005|NCT00535730|83024062|FG001|Overall Study|Physician Decision|1|||
46805006|NCT00535730|83024061|FG000|Overall Study|Protocol Violation|1|||
46751208|NCT00895895|82969643|FG003|Period 1|Withdrawal by Subject|2|||
46751209|NCT00895895|82969644|FG004|Period 1|Withdrawal by Subject|4|||
46751210|NCT00895895|82969640|FG000|Period 1|unsatisfactory response-efficacy|2|||
46805007|NCT00535730|83024062|FG001|Overall Study|Protocol Violation|0|||
46805008|NCT00535730|83024061|FG000|Overall Study|Withdrawal by Subject|0|||
46805009|NCT00535730|83024062|FG001|Overall Study|Withdrawal by Subject|4|||
46805010|NCT00666965|83024073|FG000|Overall Study|Adverse Event|0|||
46805011|NCT00666965|83024074|FG001|Overall Study|Adverse Event|2|||
46805012|NCT00666965|83024075|FG002|Overall Study|Adverse Event|1|||
46805013|NCT00666965|83024076|FG003|Overall Study|Adverse Event|9|||
46805014|NCT00666965|83024073|FG000|Overall Study|Lack of Efficacy|1|||
46805015|NCT00666965|83024074|FG001|Overall Study|Lack of Efficacy|1|||
46805016|NCT00666965|83024075|FG002|Overall Study|Lack of Efficacy|0|||
46805017|NCT00666965|83024076|FG003|Overall Study|Lack of Efficacy|0|||
46805018|NCT00666965|83024073|FG000|Overall Study|Protocol Violation|0|||
46805019|NCT00666965|83024074|FG001|Overall Study|Protocol Violation|0|||
46805020|NCT00666965|83024075|FG002|Overall Study|Protocol Violation|0|||
46805021|NCT00666965|83024076|FG003|Overall Study|Protocol Violation|2|||
46805022|NCT00666965|83024073|FG000|Overall Study|Discontinuation criteria|2|||
46805023|NCT00666965|83024074|FG001|Overall Study|Discontinuation criteria|1|||
46805024|NCT00666965|83024075|FG002|Overall Study|Discontinuation criteria|1|||
46805025|NCT00666965|83024076|FG003|Overall Study|Discontinuation criteria|2|||
46751211|NCT00895895|82969641|FG001|Period 1|unsatisfactory response-efficacy|0|||
46751212|NCT00895895|82969642|FG002|Period 1|unsatisfactory response-efficacy|0|||
46751213|NCT00895895|82969643|FG003|Period 1|unsatisfactory response-efficacy|0|||
46751214|NCT00895895|82969644|FG004|Period 1|unsatisfactory response-efficacy|0|||
46751215|NCT00895895|82969640|FG000|Period 1|randomized and not treated|1|||
46751216|NCT00895895|82969641|FG001|Period 1|randomized and not treated|3|||
46751217|NCT00895895|82969642|FG002|Period 1|randomized and not treated|1|||
46751218|NCT00895895|82969643|FG003|Period 1|randomized and not treated|1|||
46751219|NCT00895895|82969644|FG004|Period 1|randomized and not treated|2|||
46751220|NCT00895895|82969640|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
46751221|NCT00895895|82969641|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
46751222|NCT00895895|82969642|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
46751223|NCT00895895|82969643|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
46751224|NCT00895895|82969644|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
46751225|NCT00895895|82969640|FG000|After Period 1, Prior to Period 2|Other|0|||
46751226|NCT00895895|82969641|FG001|After Period 1, Prior to Period 2|Other|0|||
46751227|NCT00895895|82969642|FG002|After Period 1, Prior to Period 2|Other|1|||
46751228|NCT00895895|82969643|FG003|After Period 1, Prior to Period 2|Other|0|||
46751229|NCT00895895|82969644|FG004|After Period 1, Prior to Period 2|Other|0|||
46751230|NCT00895895|82969640|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
46751231|NCT00895895|82969641|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
46751232|NCT00895895|82969642|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
46751233|NCT00895895|82969643|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
46751234|NCT00895895|82969644|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
46751235|NCT00895895|82969640|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
46751236|NCT00895895|82969641|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
46751237|NCT00895895|82969642|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
46751238|NCT00895895|82969643|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
46751239|NCT00895895|82969644|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
46751240|NCT00895895|82969640|FG000|Period 2|Adverse Event|3|||
46751241|NCT00895895|82969641|FG001|Period 2|Adverse Event|3|||
46751242|NCT00895895|82969642|FG002|Period 2|Adverse Event|5|||
46751243|NCT00895895|82969643|FG003|Period 2|Adverse Event|2|||
46751244|NCT00895895|82969644|FG004|Period 2|Adverse Event|5|||
46751245|NCT00895895|82969640|FG000|Period 2|Death|0|||
46751246|NCT00895895|82969641|FG001|Period 2|Death|0|||
46751247|NCT00895895|82969642|FG002|Period 2|Death|1|||
46751248|NCT00895895|82969643|FG003|Period 2|Death|0|||
46751249|NCT00895895|82969644|FG004|Period 2|Death|0|||
46751250|NCT00895895|82969640|FG000|Period 2|discontinued by sponsor|44|||
46751251|NCT00895895|82969641|FG001|Period 2|discontinued by sponsor|44|||
46751252|NCT00895895|82969642|FG002|Period 2|discontinued by sponsor|38|||
46751253|NCT00895895|82969643|FG003|Period 2|discontinued by sponsor|46|||
46751254|NCT00895895|82969644|FG004|Period 2|discontinued by sponsor|37|||
46751255|NCT00895895|82969640|FG000|Period 2|failed to return|2|||
46751256|NCT00895895|82969641|FG001|Period 2|failed to return|0|||
46751257|NCT00895895|82969642|FG002|Period 2|failed to return|0|||
46751258|NCT00895895|82969643|FG003|Period 2|failed to return|0|||
46751259|NCT00895895|82969644|FG004|Period 2|failed to return|0|||
46751260|NCT00895895|82969640|FG000|Period 2|investigator request|2|||
46751261|NCT00895895|82969641|FG001|Period 2|investigator request|0|||
46805026|NCT00666965|83024073|FG000|Overall Study|Withdrawal by Subject|0|||
46805027|NCT00666965|83024074|FG001|Overall Study|Withdrawal by Subject|0|||
47052516|NCT01847885|83319799|FG000|Randomization|Protocol Violation|0|||
46751262|NCT00895895|82969642|FG002|Period 2|investigator request|0|||
46805028|NCT00666965|83024075|FG002|Overall Study|Withdrawal by Subject|0|||
46805029|NCT00666965|83024076|FG003|Overall Study|Withdrawal by Subject|2|||
46805030|NCT03889886|83024090|FG000|Overall Study|Other|0|||
46805031|NCT03889886|83024091|FG001|Overall Study|Other|1|||
47052517|NCT01847885|83319800|FG001|Randomization|Protocol Violation|1|||
46751263|NCT00895895|82969643|FG003|Period 2|investigator request|0|||
46805032|NCT03889886|83024092|FG002|Overall Study|Other|0|||
46805033|NCT03889886|83024093|FG003|Overall Study|Other|1|||
46805034|NCT03889886|83024090|FG000|Overall Study|Withdrawal by Subject|0|||
46805035|NCT03889886|83024091|FG001|Overall Study|Withdrawal by Subject|0|||
46805036|NCT03889886|83024092|FG002|Overall Study|Withdrawal by Subject|1|||
46805037|NCT03889886|83024093|FG003|Overall Study|Withdrawal by Subject|0|||
46805038|NCT03889886|83024090|FG000|Overall Study|Adverse Event|0|||
46805039|NCT03889886|83024091|FG001|Overall Study|Adverse Event|0|||
46805040|NCT03889886|83024092|FG002|Overall Study|Adverse Event|0|||
46805041|NCT03889886|83024093|FG003|Overall Study|Adverse Event|6|||
46805042|NCT03888482|83024105|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
46805043|NCT03888482|83024106|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
46805044|NCT03888482|83024105|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
46805045|NCT03888482|83024106|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
46751264|NCT00895895|82969644|FG004|Period 2|investigator request|0|||
46751265|NCT00895895|82969640|FG000|Period 2|Lost to Follow-up|1|||
46751266|NCT00895895|82969641|FG001|Period 2|Lost to Follow-up|2|||
46751267|NCT00895895|82969642|FG002|Period 2|Lost to Follow-up|1|||
46751268|NCT00895895|82969643|FG003|Period 2|Lost to Follow-up|1|||
46751269|NCT00895895|82969644|FG004|Period 2|Lost to Follow-up|0|||
46751270|NCT00895895|82969640|FG000|Period 2|Other|1|||
46751271|NCT00895895|82969641|FG001|Period 2|Other|1|||
46751272|NCT00895895|82969642|FG002|Period 2|Other|3|||
46751273|NCT00895895|82969643|FG003|Period 2|Other|1|||
46751274|NCT00895895|82969644|FG004|Period 2|Other|1|||
46751275|NCT00895895|82969640|FG000|Period 2|Protocol Violation|1|||
46636092|NCT01524978|82809845|FG004|Overall Study|Lost to Follow-up|1|||
46636093|NCT01524978|82809846|FG005|Overall Study|Lost to Follow-up|1|||
46636094|NCT01524978|82809847|FG006|Overall Study|Lost to Follow-up|2|||
46636095|NCT01524978|82809848|FG007|Overall Study|Lost to Follow-up|0|||
46636096|NCT01524978|82809849|FG008|Overall Study|Lost to Follow-up|1|||
46636097|NCT01524978|82809850|FG009|Overall Study|Lost to Follow-up|1|||
46636098|NCT01524978|82809851|FG010|Overall Study|Lost to Follow-up|1|||
46636099|NCT01524978|82809841|FG000|Overall Study|Death|34|||
46636100|NCT01524978|82809842|FG001|Overall Study|Death|2|||
46636101|NCT01524978|82809843|FG002|Overall Study|Death|5|||
46636102|NCT01524978|82809844|FG003|Overall Study|Death|24|||
46636103|NCT01524978|82809845|FG004|Overall Study|Death|4|||
46636104|NCT01524978|82809846|FG005|Overall Study|Death|4|||
46636105|NCT01524978|82809847|FG006|Overall Study|Death|1|||
46636106|NCT01524978|82809848|FG007|Overall Study|Death|9|||
46751276|NCT00895895|82969641|FG001|Period 2|Protocol Violation|0|||
46751277|NCT00895895|82969642|FG002|Period 2|Protocol Violation|1|||
46805046|NCT00667355|83024114|FG000|Overall Study|Adverse Event|5|||
46805047|NCT00667355|83024114|FG000|Overall Study|Lost to Follow-up|1|||
46805048|NCT00667355|83024114|FG000|Overall Study|Other reason was not specified|5|||
46924536|NCT02224573|83158699|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
46924537|NCT02224573|83158700|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
46924538|NCT02224573|83158699|FG000|Treatment Phase|Started on Other IMP|1|||
46924539|NCT02224573|83158700|FG001|Treatment Phase|Started on Other IMP|0|||
46924540|NCT02224573|83158699|FG000|Treatment Phase|Participant Discontinued IMP|0|||
46805049|NCT00532844|83024120|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
46805050|NCT00532844|83024121|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
46924541|NCT02224573|83158700|FG001|Treatment Phase|Participant Discontinued IMP|1|||
46924542|NCT02224573|83158699|FG000|Treatment Phase|Lack of Efficacy|15|||
46924543|NCT02224573|83158700|FG001|Treatment Phase|Lack of Efficacy|8|||
46924544|NCT02224573|83158699|FG000|Treatment Phase|Began Commercial Product|1|||
46805051|NCT00532844|83024120|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
46805052|NCT00532844|83024121|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
46805053|NCT00532844|83024120|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
46924545|NCT02224573|83158700|FG001|Treatment Phase|Began Commercial Product|0|||
46751278|NCT00895895|82969643|FG003|Period 2|Protocol Violation|1|||
46751279|NCT00895895|82969644|FG004|Period 2|Protocol Violation|1|||
46751280|NCT00895895|82969640|FG000|Period 2|Withdrawal by Subject|0|||
46751281|NCT00895895|82969641|FG001|Period 2|Withdrawal by Subject|2|||
46636107|NCT01524978|82809849|FG008|Overall Study|Death|5|||
46636108|NCT01524978|82809850|FG009|Overall Study|Death|6|||
46636109|NCT01524978|82809851|FG010|Overall Study|Death|17|||
46636110|NCT01524900|82809871|FG000|Overall Study|Lost to Follow-up|3|||
46805054|NCT00532844|83024121|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
46924546|NCT02224573|83158699|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
46751282|NCT00895895|82969642|FG002|Period 2|Withdrawal by Subject|0|||
46751283|NCT00895895|82969643|FG003|Period 2|Withdrawal by Subject|3|||
46805055|NCT00532844|83024120|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
46805056|NCT00532844|83024121|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
46805057|NCT00532844|83024120|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
46805058|NCT00532844|83024121|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
47052518|NCT01847885|83319801|FG002|Randomization|Protocol Violation|0|||
46805059|NCT00666263|83024149|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
46805060|NCT00666263|83024150|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
46805061|NCT00666263|83024149|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
46805062|NCT00666263|83024150|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
46805063|NCT00666263|83024149|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
46805064|NCT00666263|83024150|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
46805065|NCT00667277|83024195|FG000|Overall Study|Withdrawal by Subject|2|||
46805066|NCT00534638|83024201|FG000|Overall Study|Withdrawal by Subject|3|||
46805067|NCT00534638|83024202|FG001|Overall Study|Withdrawal by Subject|4|||
46805068|NCT00534638|83024201|FG000|Overall Study|Migrated/moved from study area|13|||
46805069|NCT00534638|83024202|FG001|Overall Study|Migrated/moved from study area|11|||
46805070|NCT00534638|83024201|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
46924547|NCT02224573|83158700|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
46924548|NCT02224573|83158699|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
46924549|NCT02224573|83158700|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
46924550|NCT02224573|83158699|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
46924551|NCT02224573|83158700|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
46924552|NCT02224573|83158699|FG000|Treatment Phase|Continued Compassionate Use|1|||
46924553|NCT02224573|83158700|FG001|Treatment Phase|Continued Compassionate Use|0|||
46924554|NCT02224573|83158699|FG000|Treatment Phase|Lack of Efficiency|2|||
46924555|NCT02224573|83158700|FG001|Treatment Phase|Lack of Efficiency|1|||
46924556|NCT02224573|83158699|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
46924557|NCT02224573|83158700|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
46924558|NCT02224573|83158699|FG000|Treatment Phase|Participant Moved|2|||
46924559|NCT02224573|83158700|FG001|Treatment Phase|Participant Moved|0|||
46924560|NCT02224573|83158699|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
46924561|NCT02224573|83158700|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
46924562|NCT02224573|83158699|FG000|Treatment Phase|Refused Medication|1|||
46924563|NCT02224573|83158700|FG001|Treatment Phase|Refused Medication|1|||
46924564|NCT02224573|83158699|FG000|Treatment Phase|Adverse Event|26|||
46924565|NCT02224573|83158700|FG001|Treatment Phase|Adverse Event|38|||
46924566|NCT02224573|83158699|FG000|Treatment Phase|Placed in Group Home|0|||
47052519|NCT01847885|83319799|FG000|Randomization|Withdrawal by Subject|0|||
47052520|NCT01847885|83319800|FG001|Randomization|Withdrawal by Subject|0|||
47052521|NCT01847885|83319801|FG002|Randomization|Withdrawal by Subject|2|||
47052522|NCT01847885|83319799|FG000|Randomization|Screen Failure|0|||
47052523|NCT01847885|83319800|FG001|Randomization|Screen Failure|3|||
47052524|NCT01847885|83319801|FG002|Randomization|Screen Failure|0|||
46805071|NCT00534638|83024202|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
46805072|NCT00534638|83024201|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
46805073|NCT00534638|83024202|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
46805074|NCT00534638|83024201|FG000|Overall Study|Other|1685|||
46805075|NCT00534638|83024202|FG001|Overall Study|Other|902|||
46805076|NCT00662129|83024213|FG000|Overall Study|Protocol Violation|1|||
46805077|NCT00662129|83024213|FG000|Overall Study|Cancel prior to beginning treatment|1|||
47052525|NCT01867307|83319839|FG000|Overall Study|Protocol Violation|2|||
46805078|NCT00662129|83024213|FG000|Overall Study|Ineligible|1|||
46805079|NCT00664859|83024220|FG000|Overall Study|Adverse Event|2|||
47052526|NCT01867307|83319840|FG001|Overall Study|Protocol Violation|0|||
46636111|NCT01524900|82809872|FG001|Overall Study|Lost to Follow-up|12|||
46924567|NCT02224573|83158700|FG001|Treatment Phase|Placed in Group Home|1|||
47052527|NCT01867307|83319839|FG000|Overall Study|Other Adverse Event|1|||
46924568|NCT02224573|83158699|FG000|Treatment Phase|Pursued Other Trials|1|||
46924569|NCT02224573|83158700|FG001|Treatment Phase|Pursued Other Trials|0|||
46751284|NCT00895895|82969644|FG004|Period 2|Withdrawal by Subject|5|||
46751285|NCT00895895|82969640|FG000|Period 2|unsatisfactory response-efficacy|2|||
46751286|NCT00895895|82969641|FG001|Period 2|unsatisfactory response-efficacy|1|||
46751287|NCT00895895|82969642|FG002|Period 2|unsatisfactory response-efficacy|0|||
46751288|NCT00895895|82969643|FG003|Period 2|unsatisfactory response-efficacy|0|||
46751289|NCT00895895|82969644|FG004|Period 2|unsatisfactory response-efficacy|0|||
46751290|NCT00895661|82969662|FG000|Overall Study|Death|1|||
46751291|NCT00895661|82969662|FG000|Overall Study|reason unknown|2|||
46751292|NCT00895583|82969668|FG000|Overall Study|Adverse Event|28|||
46751293|NCT00895583|82969669|FG001|Overall Study|Adverse Event|4|||
46751294|NCT00895583|82969668|FG000|Overall Study|Death|2|||
46751295|NCT00895583|82969669|FG001|Overall Study|Death|1|||
46751296|NCT00895583|82969668|FG000|Overall Study|Physician Decision|3|||
46751297|NCT00895583|82969669|FG001|Overall Study|Physician Decision|1|||
46751298|NCT00895583|82969668|FG000|Overall Study|Lost to Follow-up|1|||
46751299|NCT00895583|82969669|FG001|Overall Study|Lost to Follow-up|3|||
46751300|NCT00895583|82969668|FG000|Overall Study|Protocol Violation|1|||
46751301|NCT00895583|82969669|FG001|Overall Study|Protocol Violation|0|||
46751302|NCT00895583|82969668|FG000|Overall Study|Withdrawal by Subject|4|||
46751303|NCT00895583|82969669|FG001|Overall Study|Withdrawal by Subject|2|||
46751304|NCT00895583|82969668|FG000|Overall Study|Lack of Efficacy|5|||
46751305|NCT00895583|82969669|FG001|Overall Study|Lack of Efficacy|0|||
46751306|NCT00895583|82969668|FG000|Overall Study|Other|0|||
46751307|NCT00895583|82969669|FG001|Overall Study|Other|1|||
46751308|NCT00894413|82969686|FG000|Overall Study|Physician Decision|0|||
46751309|NCT00894413|82969687|FG001|Overall Study|Physician Decision|2|||
46751310|NCT00894413|82969686|FG000|Overall Study|Adverse Event|0|||
46751311|NCT00894413|82969687|FG001|Overall Study|Adverse Event|2|||
46751312|NCT00894413|82969686|FG000|Overall Study|Withdrawal by Subject|0|||
46751313|NCT00894413|82969687|FG001|Overall Study|Withdrawal by Subject|4|||
46751314|NCT00895037|82969696|FG000|Overall Study|Death|0|||
46751315|NCT00895037|82969697|FG001|Overall Study|Death|2|||
46751316|NCT00895037|82969698|FG002|Overall Study|Death|1|||
46751317|NCT00892151|82969706|FG000|Overall Study|Protocol Violation|1|||
46805080|NCT00664859|83024221|FG001|Overall Study|Adverse Event|1|||
46805081|NCT00664859|83024222|FG002|Overall Study|Adverse Event|3|||
46805082|NCT00664859|83024220|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
46805083|NCT00664859|83024221|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
46805084|NCT00664859|83024222|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
46805085|NCT00664859|83024220|FG000|Overall Study|Noncompliance with protocol|1|||
46805086|NCT00664859|83024221|FG001|Overall Study|Noncompliance with protocol|0|||
46805087|NCT00664859|83024222|FG002|Overall Study|Noncompliance with protocol|4|||
46805088|NCT00664859|83024220|FG000|Overall Study|Laboratory abnormality|2|||
46805089|NCT00664859|83024221|FG001|Overall Study|Laboratory abnormality|1|||
46751318|NCT01706705|82969710|FG000|Overall Study|Death|1|||
46751319|NCT01706705|82969710|FG000|Overall Study|Lack of Efficacy|13|||
46805090|NCT00664859|83024222|FG002|Overall Study|Laboratory abnormality|4|||
46805091|NCT00664859|83024220|FG000|Overall Study|Withdrawal by Subject|4|||
46805092|NCT00664859|83024221|FG001|Overall Study|Withdrawal by Subject|1|||
46805093|NCT00664859|83024222|FG002|Overall Study|Withdrawal by Subject|3|||
46751320|NCT01706705|82969710|FG000|Overall Study|Non-clinical|6|||
46751321|NCT00894803|82969726|FG000|Overall Study|Death|20|||
46751322|NCT00894803|82969727|FG001|Overall Study|Death|4|||
46805094|NCT00664859|83024220|FG000|Overall Study|Lost to Follow-up|2|||
46805095|NCT00664859|83024221|FG001|Overall Study|Lost to Follow-up|2|||
46805096|NCT00664859|83024222|FG002|Overall Study|Lost to Follow-up|1|||
46805097|NCT00664859|83024220|FG000|Overall Study|Other|0|||
46924570|NCT02224573|83158699|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
46924571|NCT02224573|83158700|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
47052528|NCT01867307|83319840|FG001|Overall Study|Other Adverse Event|3|||
47052529|NCT01845077|83319849|FG000|Washout Period|Lost to Follow-up|0|||
46751323|NCT00894803|82969726|FG000|Overall Study|Lost to Follow-up|0|||
46751324|NCT00894803|82969727|FG001|Overall Study|Lost to Follow-up|1|||
46751325|NCT00601458|82969736|FG000|Overall Study|Dosing Error|1|||
47052530|NCT01845077|83319850|FG001|Washout Period|Lost to Follow-up|1|||
46751326|NCT00601458|82969737|FG001|Overall Study|Dosing Error|0|||
46805098|NCT00664859|83024221|FG001|Overall Study|Other|1|||
46805099|NCT00664859|83024222|FG002|Overall Study|Other|2|||
46751327|NCT00601458|82969738|FG002|Overall Study|Dosing Error|0|||
46805100|NCT00570401|83024230|FG000|Overall Study|Adverse Event|2|||
46751328|NCT00601458|82969736|FG000|Overall Study|Incomplete Data|0|||
46805101|NCT00532298|83024240|FG000|Overall Study|Adverse Event|1|||
46805102|NCT00532298|83024241|FG001|Overall Study|Adverse Event|0|||
47052531|NCT01845077|83319851|FG002|Washout Period|Lost to Follow-up|0|||
46751329|NCT00601458|82969737|FG001|Overall Study|Incomplete Data|2|||
46751330|NCT00601458|82969738|FG002|Overall Study|Incomplete Data|0|||
46751331|NCT00601458|82969736|FG000|Overall Study|Protocol Violation|3|||
46751332|NCT00601458|82969737|FG001|Overall Study|Protocol Violation|2|||
46805103|NCT00532298|83024242|FG002|Overall Study|Adverse Event|0|||
46805104|NCT00532298|83024243|FG003|Overall Study|Adverse Event|0|||
46805105|NCT00532298|83024244|FG004|Overall Study|Adverse Event|1|||
46805106|NCT00532298|83024245|FG005|Overall Study|Adverse Event|1|||
46805107|NCT00532298|83024240|FG000|Overall Study|Lost to Follow-up|1|||
46805108|NCT00532298|83024241|FG001|Overall Study|Lost to Follow-up|1|||
46805109|NCT00532298|83024242|FG002|Overall Study|Lost to Follow-up|1|||
46805110|NCT00532298|83024243|FG003|Overall Study|Lost to Follow-up|0|||
46805111|NCT00532298|83024244|FG004|Overall Study|Lost to Follow-up|0|||
46805112|NCT00532298|83024245|FG005|Overall Study|Lost to Follow-up|1|||
47052532|NCT01845077|83319852|FG003|Washout Period|Lost to Follow-up|1|||
47052533|NCT01845077|83319853|FG004|Washout Period|Lost to Follow-up|0|||
47052534|NCT01845077|83319854|FG005|Washout Period|Lost to Follow-up|1|||
47052535|NCT01845077|83319849|FG000|Washout Period|Adverse Event|1|||
46805113|NCT00410410|83024265|FG000|Induction Period (IP)|Death|1|||
46805114|NCT00410410|83024266|FG001|Induction Period (IP)|Death|0|||
46805115|NCT00410410|83024267|FG002|Induction Period (IP)|Death|0|||
46805116|NCT00410410|83024268|FG003|Induction Period (IP)|Death|0|||
46805117|NCT00410410|83024269|FG004|Induction Period (IP)|Death|0|||
46805118|NCT00410410|83024270|FG005|Induction Period (IP)|Death|0|||
46805119|NCT00410410|83024271|FG006|Induction Period (IP)|Death|0|||
46805120|NCT00410410|83024272|FG007|Induction Period (IP)|Death|0|||
46805121|NCT00410410|83024273|FG008|Induction Period (IP)|Death|0|||
46805122|NCT00410410|83024265|FG000|Induction Period (IP)|Adverse Event|3|||
46805123|NCT00410410|83024266|FG001|Induction Period (IP)|Adverse Event|4|||
46805124|NCT00410410|83024267|FG002|Induction Period (IP)|Adverse Event|2|||
46805125|NCT00410410|83024268|FG003|Induction Period (IP)|Adverse Event|4|||
46805126|NCT00410410|83024269|FG004|Induction Period (IP)|Adverse Event|1|||
46805127|NCT00410410|83024270|FG005|Induction Period (IP)|Adverse Event|0|||
46805128|NCT00410410|83024271|FG006|Induction Period (IP)|Adverse Event|0|||
46805129|NCT00410410|83024272|FG007|Induction Period (IP)|Adverse Event|0|||
46924572|NCT02224573|83158699|FG000|Treatment Phase|Lost to Follow-up|2|||
46924573|NCT02224573|83158700|FG001|Treatment Phase|Lost to Follow-up|1|||
47052536|NCT01845077|83319850|FG001|Washout Period|Adverse Event|0|||
46751333|NCT00601458|82969738|FG002|Overall Study|Protocol Violation|1|||
46805130|NCT00410410|83024273|FG008|Induction Period (IP)|Adverse Event|0|||
46751334|NCT00601458|82969736|FG000|Overall Study|Early Termination|0|||
46751335|NCT00601458|82969737|FG001|Overall Study|Early Termination|1|||
46751336|NCT00601458|82969738|FG002|Overall Study|Early Termination|1|||
46751337|NCT02141282|82969750|FG000|Overall Study|Adverse event, not related to progression|8|||
46751338|NCT02141282|82969751|FG001|Overall Study|Adverse event, not related to progression|1|||
46751339|NCT02141282|82969752|FG002|Overall Study|Adverse event, not related to progression|3|||
46751340|NCT02141282|82969753|FG003|Overall Study|Adverse event, not related to progression|1|||
46751341|NCT02141282|82969750|FG000|Overall Study|Adverse event, related to progression|1|||
46751342|NCT02141282|82969751|FG001|Overall Study|Adverse event, related to progression|0|||
46751343|NCT02141282|82969752|FG002|Overall Study|Adverse event, related to progression|2|||
46751344|NCT02141282|82969753|FG003|Overall Study|Adverse event, related to progression|0|||
46751345|NCT02141282|82969750|FG000|Overall Study|COVID-19 infection|1|||
46751346|NCT02141282|82969751|FG001|Overall Study|COVID-19 infection|0|||
46751347|NCT02141282|82969752|FG002|Overall Study|COVID-19 infection|0|||
46751348|NCT02141282|82969753|FG003|Overall Study|COVID-19 infection|0|||
46751349|NCT02141282|82969750|FG000|Overall Study|Lost to Follow-up|0|||
46751350|NCT02141282|82969751|FG001|Overall Study|Lost to Follow-up|0|||
46805131|NCT00410410|83024265|FG000|Induction Period (IP)|Lack of Efficacy|26|||
46805132|NCT00410410|83024266|FG001|Induction Period (IP)|Lack of Efficacy|24|||
46805133|NCT00410410|83024267|FG002|Induction Period (IP)|Lack of Efficacy|8|||
46805134|NCT00410410|83024268|FG003|Induction Period (IP)|Lack of Efficacy|8|||
46805135|NCT00410410|83024269|FG004|Induction Period (IP)|Lack of Efficacy|7|||
46805136|NCT00410410|83024270|FG005|Induction Period (IP)|Lack of Efficacy|7|||
46805137|NCT00410410|83024271|FG006|Induction Period (IP)|Lack of Efficacy|0|||
46805138|NCT00410410|83024272|FG007|Induction Period (IP)|Lack of Efficacy|0|||
46805139|NCT00410410|83024273|FG008|Induction Period (IP)|Lack of Efficacy|0|||
46805140|NCT00410410|83024265|FG000|Induction Period (IP)|Lost to Follow-up|2|||
46924574|NCT02224573|83158699|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
47052537|NCT01845077|83319851|FG002|Washout Period|Adverse Event|0|||
47052538|NCT01845077|83319852|FG003|Washout Period|Adverse Event|0|||
46751351|NCT02141282|82969752|FG002|Overall Study|Lost to Follow-up|4|||
46751352|NCT02141282|82969753|FG003|Overall Study|Lost to Follow-up|2|||
46751353|NCT02141282|82969750|FG000|Overall Study|Other, not specified|14|||
46805141|NCT00410410|83024266|FG001|Induction Period (IP)|Lost to Follow-up|2|||
46805142|NCT00410410|83024267|FG002|Induction Period (IP)|Lost to Follow-up|2|||
46805143|NCT00410410|83024268|FG003|Induction Period (IP)|Lost to Follow-up|3|||
46805144|NCT00410410|83024269|FG004|Induction Period (IP)|Lost to Follow-up|0|||
46805145|NCT00410410|83024270|FG005|Induction Period (IP)|Lost to Follow-up|1|||
46805146|NCT00410410|83024271|FG006|Induction Period (IP)|Lost to Follow-up|0|||
46924575|NCT02224573|83158700|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
47052539|NCT01845077|83319853|FG004|Washout Period|Adverse Event|0|||
46805147|NCT00410410|83024272|FG007|Induction Period (IP)|Lost to Follow-up|0|||
46805148|NCT00410410|83024273|FG008|Induction Period (IP)|Lost to Follow-up|0|||
46805149|NCT00410410|83024265|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
46805150|NCT00410410|83024266|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
46805151|NCT00410410|83024267|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
46805152|NCT00410410|83024268|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
46805153|NCT00410410|83024269|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
46805154|NCT00410410|83024270|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
46805155|NCT00410410|83024271|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
46805156|NCT00410410|83024272|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
46805157|NCT00410410|83024273|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
46805158|NCT00410410|83024265|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805159|NCT00410410|83024266|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805160|NCT00410410|83024267|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
46805161|NCT00410410|83024268|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805162|NCT00410410|83024269|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805163|NCT00410410|83024270|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805164|NCT00410410|83024271|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805165|NCT00410410|83024272|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805166|NCT00410410|83024273|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
46805167|NCT00410410|83024265|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
46805168|NCT00410410|83024266|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
46805169|NCT00410410|83024267|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
46805170|NCT00410410|83024268|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
46805171|NCT00410410|83024269|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
46805172|NCT00410410|83024270|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
46805173|NCT00410410|83024271|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
46805174|NCT00410410|83024272|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
46805175|NCT00410410|83024273|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
46805176|NCT00410410|83024265|FG000|Induction Period (IP)|Other|0|||
46805177|NCT00410410|83024266|FG001|Induction Period (IP)|Other|0|||
46805178|NCT00410410|83024267|FG002|Induction Period (IP)|Other|1|||
46805179|NCT00410410|83024268|FG003|Induction Period (IP)|Other|0|||
46805180|NCT00410410|83024269|FG004|Induction Period (IP)|Other|0|||
46805181|NCT00410410|83024270|FG005|Induction Period (IP)|Other|0|||
46805182|NCT00410410|83024271|FG006|Induction Period (IP)|Other|0|||
46805183|NCT00410410|83024272|FG007|Induction Period (IP)|Other|0|||
46805184|NCT00410410|83024273|FG008|Induction Period (IP)|Other|0|||
46805185|NCT00410410|83024265|FG000|Maintenance Period (MP)|Death|0|||
46805186|NCT00410410|83024266|FG001|Maintenance Period (MP)|Death|0|||
46805187|NCT00410410|83024267|FG002|Maintenance Period (MP)|Death|0|||
46805188|NCT00410410|83024268|FG003|Maintenance Period (MP)|Death|0|||
46805189|NCT00410410|83024269|FG004|Maintenance Period (MP)|Death|0|||
46805190|NCT00410410|83024270|FG005|Maintenance Period (MP)|Death|0|||
46805191|NCT00410410|83024271|FG006|Maintenance Period (MP)|Death|1|||
46805192|NCT00410410|83024272|FG007|Maintenance Period (MP)|Death|0|||
46805193|NCT00410410|83024273|FG008|Maintenance Period (MP)|Death|0|||
47052540|NCT01845077|83319854|FG005|Washout Period|Adverse Event|0|||
47052541|NCT01845077|83319849|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
47052542|NCT01845077|83319850|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
47052543|NCT01845077|83319851|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
46751354|NCT02141282|82969751|FG001|Overall Study|Other, not specified|11|||
46751355|NCT02141282|82969752|FG002|Overall Study|Other, not specified|23|||
46751356|NCT02141282|82969753|FG003|Overall Study|Other, not specified|9|||
46751357|NCT02141282|82969750|FG000|Overall Study|Progressive disease, Richter's|4|||
46751358|NCT02141282|82969751|FG001|Overall Study|Progressive disease, Richter's|1|||
46751359|NCT02141282|82969752|FG002|Overall Study|Progressive disease, Richter's|1|||
46751360|NCT02141282|82969753|FG003|Overall Study|Progressive disease, Richter's|1|||
46751361|NCT02141282|82969750|FG000|Overall Study|Progressive disease per protocol|12|||
46751362|NCT02141282|82969751|FG001|Overall Study|Progressive disease per protocol|7|||
46751363|NCT02141282|82969752|FG002|Overall Study|Progressive disease per protocol|9|||
46751364|NCT02141282|82969753|FG003|Overall Study|Progressive disease per protocol|2|||
47052544|NCT01845077|83319852|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
47052545|NCT01845077|83319853|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
46751365|NCT02141282|82969750|FG000|Overall Study|Stem cell transplant|1|||
46751366|NCT02141282|82969751|FG001|Overall Study|Stem cell transplant|0|||
46751367|NCT02141282|82969752|FG002|Overall Study|Stem cell transplant|1|||
46751368|NCT02141282|82969753|FG003|Overall Study|Stem cell transplant|0|||
46805194|NCT00410410|83024265|FG000|Maintenance Period (MP)|Adverse Event|0|||
46805195|NCT00410410|83024266|FG001|Maintenance Period (MP)|Adverse Event|0|||
46805196|NCT00410410|83024267|FG002|Maintenance Period (MP)|Adverse Event|0|||
46751369|NCT02141282|82969750|FG000|Overall Study|Study terminated by Sponsor|0|||
46751370|NCT02141282|82969751|FG001|Overall Study|Study terminated by Sponsor|1|||
46751371|NCT02141282|82969752|FG002|Overall Study|Study terminated by Sponsor|0|||
46751372|NCT02141282|82969753|FG003|Overall Study|Study terminated by Sponsor|0|||
46751373|NCT02141282|82969750|FG000|Overall Study|Subject non-compliance|0|||
46751374|NCT02141282|82969751|FG001|Overall Study|Subject non-compliance|0|||
46751375|NCT02141282|82969752|FG002|Overall Study|Subject non-compliance|1|||
46751376|NCT02141282|82969753|FG003|Overall Study|Subject non-compliance|0|||
46751377|NCT02141282|82969750|FG000|Overall Study|Withdrew consent|2|||
46751378|NCT02141282|82969751|FG001|Overall Study|Withdrew consent|0|||
46751379|NCT02141282|82969752|FG002|Overall Study|Withdrew consent|4|||
46751380|NCT02141282|82969753|FG003|Overall Study|Withdrew consent|0|||
46751381|NCT00003479|82969766|FG000|Overall Study|Not evaluable|3|||
46751382|NCT00891839|82969770|FG000|Overall Study|Adverse Event|2|||
46751383|NCT00891839|82969770|FG000|Overall Study|Withdrawal by Subject|2|||
46751384|NCT00891839|82969770|FG000|Overall Study|Disease progression|3|||
46751385|NCT00600756|82969776|FG000|Analysis After 6 Months|Adverse Event|43|||
46751386|NCT00600756|82969777|FG001|Analysis After 6 Months|Adverse Event|33|||
46751387|NCT00600756|82969776|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
46751388|NCT00600756|82969777|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
46751389|NCT00600756|82969776|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
46751390|NCT00600756|82969777|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
46751391|NCT00600756|82969776|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
46751392|NCT00600756|82969777|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
46751393|NCT00600756|82969776|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
46751394|NCT00600756|82969777|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
46751395|NCT00600756|82969776|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
46751396|NCT00600756|82969777|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
46751397|NCT00600756|82969776|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
46751398|NCT00600756|82969777|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
46751399|NCT00600756|82969776|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
46751400|NCT00600756|82969777|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
46751401|NCT00600756|82969776|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
46751402|NCT00600756|82969777|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
46751403|NCT00600756|82969776|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
46751404|NCT00600756|82969777|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
46751405|NCT00600756|82969776|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
46751406|NCT00600756|82969777|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
46751407|NCT00600756|82969776|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
46751408|NCT00600756|82969777|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
46751409|NCT00600756|82969776|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
46751410|NCT00600756|82969777|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
46751411|NCT00600756|82969776|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
46751412|NCT00600756|82969777|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
46751413|NCT00890825|82969789|FG000|Overall Study|Withdrawal by Subject|1|||
46751414|NCT00890825|82969790|FG001|Overall Study|Withdrawal by Subject|0|||
46751415|NCT00890825|82969789|FG000|Overall Study|Alive at data cut off (DCO)|13|||
46751416|NCT00890825|82969790|FG001|Overall Study|Alive at data cut off (DCO)|14|||
46751417|NCT00890201|82969798|FG000|Overall Study|Protocol Violation|5|||
46751418|NCT00890201|82969799|FG001|Overall Study|Protocol Violation|56|||
46751419|NCT00891527|82969805|FG000|Overall Study|Withdrawal by Subject|2|||
46751420|NCT03861078|82969810|FG000|Overall Study|COVID-19 shut down|4|||
46751421|NCT03861078|82969810|FG000|Overall Study|Lost to Follow-up|1|||
46751422|NCT03861078|82969810|FG000|Overall Study|Protocol Violation|2|||
46751423|NCT03861078|82969810|FG000|Overall Study|lack of venous access|1|||
46751424|NCT04950465|82969821|FG000|Overall Study|Lost to Follow-up|1|||
46751425|NCT04950465|82969822|FG001|Overall Study|Lost to Follow-up|0|||
46751426|NCT04950465|82969823|FG002|Overall Study|Lost to Follow-up|0|||
46751427|NCT04495816|82969845|FG000|Overall Study|Lost to Follow-up|10|||
46805197|NCT00410410|83024268|FG003|Maintenance Period (MP)|Adverse Event|0|||
46805198|NCT00410410|83024269|FG004|Maintenance Period (MP)|Adverse Event|0|||
46924576|NCT02224573|83158699|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
46751428|NCT04495816|82969846|FG001|Overall Study|Lost to Follow-up|4|||
46751429|NCT04495816|82969845|FG000|Overall Study|Withdrawal by Subject|3|||
46805199|NCT00410410|83024270|FG005|Maintenance Period (MP)|Adverse Event|0|||
46751430|NCT04495816|82969846|FG001|Overall Study|Withdrawal by Subject|5|||
46751431|NCT04267562|82969861|FG000|Assessed for Eligibility|Screen Failure|64|||
46751432|NCT04267562|82969861|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
46805200|NCT00410410|83024271|FG006|Maintenance Period (MP)|Adverse Event|1|||
46924577|NCT02224573|83158700|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
46636112|NCT01524900|82809873|FG002|Overall Study|Lost to Follow-up|1|||
46751433|NCT04267562|82969861|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
46751434|NCT04267562|82969861|FG000|Assessed for Eligibility|Site closure|6|||
46751435|NCT04267562|82969861|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
46805201|NCT00410410|83024272|FG007|Maintenance Period (MP)|Adverse Event|3|||
46805202|NCT00410410|83024273|FG008|Maintenance Period (MP)|Adverse Event|0|||
46805203|NCT00410410|83024265|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
46805204|NCT00410410|83024266|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
46924578|NCT02224573|83158699|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
46924579|NCT02224573|83158700|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
46924580|NCT02224573|83158699|FG000|Taper Phase|Adverse Event|1|||
46924581|NCT02224573|83158700|FG001|Taper Phase|Adverse Event|1|||
46924582|NCT01360840|83158710|FG000|Overall Study|Ongoing at data cut-off|10|||
46924583|NCT01360840|83158711|FG001|Overall Study|Ongoing at data cut-off|10|||
46924584|NCT01360840|83158712|FG002|Overall Study|Ongoing at data cut-off|9|||
46924585|NCT03350984|83158724|FG000|Overall Study|Death|1|||
46924586|NCT03350984|83158725|FG001|Overall Study|Death|0|||
46924587|NCT03350984|83158724|FG000|Overall Study|Lost to Follow-up|5|||
46924588|NCT03350984|83158725|FG001|Overall Study|Lost to Follow-up|6|||
46924589|NCT03350984|83158724|FG000|Overall Study|Protocol Violation|1|||
46924590|NCT03350984|83158725|FG001|Overall Study|Protocol Violation|2|||
46924591|NCT03350984|83158724|FG000|Overall Study|Physician Decision|1|||
46751436|NCT04267562|82969861|FG000|Assessed for Eligibility|Physician Decision|1|||
46751437|NCT03891901|82969872|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
46751438|NCT03891901|82969873|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751439|NCT03891901|82969874|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751440|NCT03891901|82969875|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751441|NCT03891901|82969876|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751442|NCT03891901|82969877|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751443|NCT03891901|82969878|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751444|NCT03891901|82969879|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751445|NCT03891901|82969880|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
46751446|NCT03891901|82969872|FG000|Overall Study|Adverse Event|2|||
46751447|NCT03891901|82969873|FG001|Overall Study|Adverse Event|2|||
46751448|NCT03891901|82969874|FG002|Overall Study|Adverse Event|0|||
46751449|NCT03891901|82969875|FG003|Overall Study|Adverse Event|0|||
46751450|NCT03891901|82969876|FG004|Overall Study|Adverse Event|0|||
46924592|NCT03350984|83158725|FG001|Overall Study|Physician Decision|0|||
46924593|NCT05176717|83158743|FG000|Overall Study|Sponsor Decision|1|||
46751451|NCT03891901|82969877|FG005|Overall Study|Adverse Event|0|||
46751452|NCT03891901|82969878|FG006|Overall Study|Adverse Event|0|||
46751453|NCT03891901|82969879|FG007|Overall Study|Adverse Event|0|||
46751454|NCT03891901|82969880|FG008|Overall Study|Adverse Event|0|||
46751455|NCT03891901|82969872|FG000|Overall Study|Poor venous access|1|||
46751456|NCT03891901|82969873|FG001|Overall Study|Poor venous access|0|||
46751457|NCT03891901|82969874|FG002|Overall Study|Poor venous access|0|||
46751458|NCT03891901|82969875|FG003|Overall Study|Poor venous access|0|||
46751459|NCT03891901|82969876|FG004|Overall Study|Poor venous access|0|||
46924594|NCT05176717|83158744|FG001|Overall Study|Sponsor Decision|2|||
46924595|NCT05176717|83158745|FG002|Overall Study|Sponsor Decision|2|||
46924596|NCT02770248|83158755|FG000|Overall Study|Adverse Event|0|||
46924597|NCT02770248|83158756|FG001|Overall Study|Adverse Event|1|||
46751460|NCT03891901|82969877|FG005|Overall Study|Poor venous access|0|||
46751461|NCT03891901|82969878|FG006|Overall Study|Poor venous access|0|||
46751462|NCT03891901|82969879|FG007|Overall Study|Poor venous access|0|||
46751463|NCT03891901|82969880|FG008|Overall Study|Poor venous access|0|||
46805205|NCT00410410|83024267|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
46751464|NCT03891901|82969872|FG000|Overall Study|Withdrawal by Subject|0|||
46924598|NCT02770248|83158755|FG000|Overall Study|Randomized in error, prior to treatment|0|||
46924599|NCT02770248|83158756|FG001|Overall Study|Randomized in error, prior to treatment|1|||
46924600|NCT01344369|83158764|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
46924601|NCT01344369|83158765|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
46924602|NCT01344369|83158764|FG000|Washout of 28 Days|Physician Decision|0|||
46924603|NCT01344369|83158765|FG001|Washout of 28 Days|Physician Decision|1|||
46924604|NCT01344369|83158764|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
46924605|NCT01344369|83158765|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
46924606|NCT03179462|83158774|FG000|Overall Study|screening failure|1|||
46751465|NCT03891901|82969873|FG001|Overall Study|Withdrawal by Subject|2|||
46751466|NCT03891901|82969874|FG002|Overall Study|Withdrawal by Subject|0|||
46751467|NCT03891901|82969875|FG003|Overall Study|Withdrawal by Subject|0|||
46805206|NCT00410410|83024268|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
46805207|NCT00410410|83024269|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
46805208|NCT00410410|83024270|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
46805209|NCT00410410|83024271|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
46805210|NCT00410410|83024272|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
46805211|NCT00410410|83024273|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
46805212|NCT00410410|83024265|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
46805213|NCT00410410|83024266|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
46805214|NCT00410410|83024267|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
46805215|NCT00410410|83024268|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
46805216|NCT00410410|83024269|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
46805217|NCT00410410|83024270|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
46805218|NCT00410410|83024271|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
46805219|NCT00410410|83024272|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
46805220|NCT00410410|83024273|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
46805221|NCT00410410|83024265|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
46805222|NCT00410410|83024266|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
46805223|NCT00410410|83024267|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
46805224|NCT00410410|83024268|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
46805225|NCT00410410|83024269|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
46805226|NCT00410410|83024270|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
46805227|NCT00410410|83024271|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
46805228|NCT00410410|83024272|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
46805229|NCT00410410|83024273|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
46805230|NCT00410410|83024265|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
46751468|NCT03891901|82969876|FG004|Overall Study|Withdrawal by Subject|0|||
46751469|NCT03891901|82969877|FG005|Overall Study|Withdrawal by Subject|0|||
46751470|NCT03891901|82969878|FG006|Overall Study|Withdrawal by Subject|0|||
46751471|NCT03891901|82969879|FG007|Overall Study|Withdrawal by Subject|0|||
46751472|NCT03891901|82969880|FG008|Overall Study|Withdrawal by Subject|0|||
46751473|NCT03827018|82969892|FG000|Overall Study|Adverse Event|1|||
46751474|NCT03827018|82969893|FG001|Overall Study|Adverse Event|0|||
46751475|NCT03827018|82969892|FG000|Overall Study|Withdrawal by Subject|2|||
46751476|NCT03827018|82969893|FG001|Overall Study|Withdrawal by Subject|2|||
46751477|NCT03827018|82969892|FG000|Overall Study|Lack of Efficacy|0|||
46751478|NCT03827018|82969893|FG001|Overall Study|Lack of Efficacy|1|||
47052546|NCT01845077|83319854|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
46751480|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
46751481|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
46751482|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
46751483|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
46751484|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
46751485|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
46751486|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
46751487|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
46751488|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
46751489|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
46751490|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
46805231|NCT00410410|83024266|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
46805232|NCT00410410|83024267|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
46924607|NCT03179462|83158775|FG001|Overall Study|screening failure|2|||
46805233|NCT00410410|83024268|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
46805234|NCT00410410|83024269|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
46805235|NCT00410410|83024270|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
46805236|NCT00410410|83024271|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
46924608|NCT03179462|83158776|FG002|Overall Study|screening failure|0|||
46924609|NCT01314703|83158784|FG000|Overall Study|screen failure and closed enrollment|8|||
46751491|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
46751492|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Death|1|||
46751493|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Death|2|||
46751494|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Death|2|||
46751495|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Death|0|||
46751496|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Death|0|||
46751497|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Death|0|||
46751498|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
46751499|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
46751500|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
46751501|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
46751502|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
46751503|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
46751504|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
46805237|NCT00410410|83024272|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
46805238|NCT00410410|83024273|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
46805239|NCT00410410|83024265|FG000|Open-Label Period (OL)|Death|0|||
46805240|NCT00410410|83024266|FG001|Open-Label Period (OL)|Death|0|||
46805241|NCT00410410|83024267|FG002|Open-Label Period (OL)|Death|0|||
46805242|NCT00410410|83024268|FG003|Open-Label Period (OL)|Death|0|||
46805243|NCT00410410|83024269|FG004|Open-Label Period (OL)|Death|0|||
46805244|NCT00410410|83024270|FG005|Open-Label Period (OL)|Death|0|||
46805245|NCT00410410|83024271|FG006|Open-Label Period (OL)|Death|0|||
46805246|NCT00410410|83024272|FG007|Open-Label Period (OL)|Death|0|||
46805247|NCT00410410|83024273|FG008|Open-Label Period (OL)|Death|1|||
46805248|NCT00410410|83024265|FG000|Open-Label Period (OL)|Adverse Event|0|||
46805249|NCT00410410|83024266|FG001|Open-Label Period (OL)|Adverse Event|0|||
46805250|NCT00410410|83024267|FG002|Open-Label Period (OL)|Adverse Event|0|||
46805251|NCT00410410|83024268|FG003|Open-Label Period (OL)|Adverse Event|0|||
46805252|NCT00410410|83024269|FG004|Open-Label Period (OL)|Adverse Event|0|||
46805253|NCT00410410|83024270|FG005|Open-Label Period (OL)|Adverse Event|0|||
46805254|NCT00410410|83024271|FG006|Open-Label Period (OL)|Adverse Event|0|||
46805255|NCT00410410|83024272|FG007|Open-Label Period (OL)|Adverse Event|0|||
46805256|NCT00410410|83024273|FG008|Open-Label Period (OL)|Adverse Event|10|||
47052547|NCT01845077|83319849|FG000|Washout Period|Protocol Violation|0|||
47052548|NCT01845077|83319850|FG001|Washout Period|Protocol Violation|0|||
47052549|NCT01845077|83319851|FG002|Washout Period|Protocol Violation|0|||
47052550|NCT01845077|83319852|FG003|Washout Period|Protocol Violation|1|||
47052551|NCT01845077|83319853|FG004|Washout Period|Protocol Violation|1|||
47052552|NCT01845077|83319854|FG005|Washout Period|Protocol Violation|0|||
47052553|NCT01866917|83319871|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
47052554|NCT01866917|83319872|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
46805257|NCT00410410|83024265|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
46805258|NCT00410410|83024266|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
46805259|NCT00410410|83024267|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
46805260|NCT00410410|83024268|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
46805261|NCT00410410|83024269|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
46805262|NCT00410410|83024270|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
46805263|NCT00410410|83024271|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
46805264|NCT00410410|83024272|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
46805265|NCT00410410|83024273|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
46751505|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
46751506|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
46751507|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
46751508|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
46751509|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
46751510|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
46805266|NCT00410410|83024265|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
46805267|NCT00410410|83024266|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
46805268|NCT00410410|83024267|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
46805269|NCT00410410|83024268|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
46805270|NCT00410410|83024269|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
46805271|NCT00410410|83024270|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
46805272|NCT00410410|83024271|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
47052555|NCT01844765|83320007|FG000|Overall Study|Adverse Event|6|||
47052556|NCT01844765|83320008|FG001|Overall Study|Adverse Event|8|||
46805273|NCT00410410|83024272|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
46805274|NCT00410410|83024273|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
46805275|NCT00410410|83024265|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
46924610|NCT01360762|83158789|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
46751511|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
46805276|NCT00410410|83024266|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
46805277|NCT00410410|83024267|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
47052557|NCT01844765|83320007|FG000|Overall Study|Withdrawal by Subject|2|||
46636113|NCT01524900|82809874|FG003|Overall Study|Lost to Follow-up|0|||
46751512|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
46751513|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
46751514|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
46751515|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
46751516|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
46751517|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
46751518|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
46751519|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
46751520|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
46751521|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
46751522|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
46751523|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
46751524|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
46751525|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
46805278|NCT00410410|83024268|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
46805279|NCT00410410|83024269|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
46805280|NCT00410410|83024270|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
46805281|NCT00410410|83024271|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
46805282|NCT00410410|83024272|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
46805283|NCT00410410|83024273|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
46805284|NCT00410410|83024265|FG000|Open-Label Period (OL)|Pregnancy|0|||
46805285|NCT00410410|83024266|FG001|Open-Label Period (OL)|Pregnancy|0|||
46805286|NCT00410410|83024267|FG002|Open-Label Period (OL)|Pregnancy|0|||
46805287|NCT00410410|83024268|FG003|Open-Label Period (OL)|Pregnancy|0|||
46805288|NCT00410410|83024269|FG004|Open-Label Period (OL)|Pregnancy|0|||
46805289|NCT00410410|83024270|FG005|Open-Label Period (OL)|Pregnancy|0|||
46805290|NCT00410410|83024271|FG006|Open-Label Period (OL)|Pregnancy|0|||
46805291|NCT00410410|83024272|FG007|Open-Label Period (OL)|Pregnancy|0|||
46805292|NCT00410410|83024273|FG008|Open-Label Period (OL)|Pregnancy|1|||
46805293|NCT00410410|83024265|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805294|NCT00410410|83024266|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805295|NCT00410410|83024267|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805296|NCT00410410|83024268|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805297|NCT00410410|83024269|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805298|NCT00410410|83024270|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805299|NCT00410410|83024271|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805300|NCT00410410|83024272|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
46805301|NCT00410410|83024273|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
46805302|NCT00410410|83024265|FG000|Open-Label Period (OL)|Other|0|||
46805303|NCT00410410|83024266|FG001|Open-Label Period (OL)|Other|0|||
46805304|NCT00410410|83024267|FG002|Open-Label Period (OL)|Other|0|||
46805305|NCT00410410|83024268|FG003|Open-Label Period (OL)|Other|0|||
46805306|NCT00410410|83024269|FG004|Open-Label Period (OL)|Other|0|||
46805307|NCT00410410|83024270|FG005|Open-Label Period (OL)|Other|0|||
46805308|NCT00410410|83024271|FG006|Open-Label Period (OL)|Other|0|||
46805309|NCT00410410|83024272|FG007|Open-Label Period (OL)|Other|0|||
46805310|NCT00410410|83024273|FG008|Open-Label Period (OL)|Other|7|||
46805311|NCT00534404|83024311|FG000|Overall Study|Death|0|||
46805312|NCT00534404|83024312|FG001|Overall Study|Death|0|||
46805313|NCT00534404|83024313|FG002|Overall Study|Death|2|||
46805314|NCT00534404|83024311|FG000|Overall Study|Withdrawal by Subject|8|||
46805315|NCT00534404|83024312|FG001|Overall Study|Withdrawal by Subject|2|||
46805316|NCT00534404|83024313|FG002|Overall Study|Withdrawal by Subject|38|||
47052558|NCT01844765|83320008|FG001|Overall Study|Withdrawal by Subject|3|||
46805317|NCT00534404|83024311|FG000|Overall Study|Removed by study staff|2|||
46805318|NCT00534404|83024312|FG001|Overall Study|Removed by study staff|3|||
46805319|NCT00534404|83024313|FG002|Overall Study|Removed by study staff|1|||
46805320|NCT00534404|83024311|FG000|Overall Study|Lost to Follow-up|170|||
46805321|NCT00534404|83024312|FG001|Overall Study|Lost to Follow-up|138|||
47052559|NCT01844765|83320007|FG000|Overall Study|Disease progression|1|||
47052560|NCT01844765|83320008|FG001|Overall Study|Disease progression|0|||
47052561|NCT01844765|83320007|FG000|Overall Study|Administrative problems|3|||
47052562|NCT01844765|83320008|FG001|Overall Study|Administrative problems|4|||
46805322|NCT00534404|83024313|FG002|Overall Study|Lost to Follow-up|201|||
46805323|NCT00393094|83024321|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
47052563|NCT01844765|83320007|FG000|Overall Study|Protocol deviation|2|||
46805324|NCT00393094|83024321|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
46805325|NCT00409786|83024327|FG000|Overall Study|Withdrawal by Subject|3|||
46805326|NCT00409708|83024333|FG000|Treatment|Abnormal test procedure result(s)|1|||
46805327|NCT00409708|83024334|FG001|Treatment|Abnormal test procedure result(s)|0|||
46805328|NCT00409708|83024333|FG000|Treatment|Lack of Efficacy|0|||
46805329|NCT00409708|83024334|FG001|Treatment|Lack of Efficacy|1|||
46805330|NCT00409708|83024333|FG000|Treatment|Protocol Violation|6|||
46805331|NCT00409708|83024334|FG001|Treatment|Protocol Violation|2|||
46805332|NCT00409708|83024333|FG000|Treatment|Withdrawal by Subject|3|||
46805333|NCT00409708|83024334|FG001|Treatment|Withdrawal by Subject|8|||
46805334|NCT00409708|83024333|FG000|Treatment|Lost to Follow-up|0|||
46805335|NCT00409708|83024334|FG001|Treatment|Lost to Follow-up|6|||
46805336|NCT00409708|83024333|FG000|Treatment|Administrative problems|5|||
46805337|NCT00409708|83024334|FG001|Treatment|Administrative problems|0|||
46805338|NCT00409708|83024333|FG000|Washout|Lack of Efficacy|9|||
46805339|NCT00409708|83024334|FG001|Washout|Lack of Efficacy|1|||
46805340|NCT00409708|83024333|FG000|Washout|Protocol Violation|0|||
46805341|NCT00409708|83024334|FG001|Washout|Protocol Violation|1|||
46805342|NCT00409708|83024333|FG000|Washout|Withdrawal by Subject|11|||
46805343|NCT00409708|83024334|FG001|Washout|Withdrawal by Subject|5|||
46805344|NCT00409708|83024333|FG000|Washout|Lost to Follow-up|1|||
46805345|NCT00409708|83024334|FG001|Washout|Lost to Follow-up|3|||
46805346|NCT00391846|83024351|FG000|Overall Study|Adverse Event|4|||
46805347|NCT00391846|83024352|FG001|Overall Study|Adverse Event|1|||
46805348|NCT00391846|83024351|FG000|Overall Study|Did not meet the required elig. crit|2|||
46805349|NCT00391846|83024352|FG001|Overall Study|Did not meet the required elig. crit|2|||
46805350|NCT00391846|83024351|FG000|Overall Study|Withdrawal by Subject|2|||
46805351|NCT00391846|83024352|FG001|Overall Study|Withdrawal by Subject|3|||
46805352|NCT00391846|83024351|FG000|Overall Study|Developed study specific DC criteria|0|||
46805353|NCT00391846|83024352|FG001|Overall Study|Developed study specific DC criteria|1|||
46805354|NCT00534248|83024377|FG000|Overall Study|Adverse Event|19|||
46805355|NCT00534248|83024378|FG001|Overall Study|Adverse Event|29|||
46805356|NCT00534248|83024377|FG000|Overall Study|Lost to Follow-up|353|||
46805357|NCT00534248|83024378|FG001|Overall Study|Lost to Follow-up|375|||
46805358|NCT00534248|83024377|FG000|Overall Study|Other protocol specified criteria|13|||
46924611|NCT01360762|83158789|FG000|Main Study Period (12-month Treatment)|Death|5|||
46924612|NCT01360762|83158789|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
46924613|NCT01360762|83158789|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
46924614|NCT01360762|83158789|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
46924615|NCT01360762|83158789|FG000|Whole Study Period|Lost to Follow-up|10|||
46924616|NCT01360762|83158789|FG000|Whole Study Period|Death|7|||
46924617|NCT01360762|83158789|FG000|Whole Study Period|Patient relapsed|18|||
46924618|NCT01360762|83158789|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
46924619|NCT04382924|83158796|FG000|Overall Study|Death|2|||
46924620|NCT04382924|83158797|FG001|Overall Study|Death|5|||
46924621|NCT04382924|83158798|FG002|Overall Study|Death|4|||
46924622|NCT04382924|83158796|FG000|Overall Study|Protocol Violation|0|||
47052564|NCT01844765|83320008|FG001|Overall Study|Protocol deviation|0|||
47052565|NCT01844765|83320007|FG000|Overall Study|Untreated|1|||
47052566|NCT01844765|83320008|FG001|Overall Study|Untreated|0|||
47052567|NCT01866293|83320023|FG000|Overall Study|Adverse Event|2|||
46636114|NCT01524900|82809875|FG004|Overall Study|Lost to Follow-up|0|||
46751526|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
46751527|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
46751528|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
46751529|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
46751530|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
46751531|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
46751532|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
46751533|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
46751534|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
46751535|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
46751536|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
46751537|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
46751538|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
46751539|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
46805359|NCT00534248|83024378|FG001|Overall Study|Other protocol specified criteria|3|||
46805360|NCT00534248|83024377|FG000|Overall Study|Physician Decision|10|||
46805361|NCT00534248|83024378|FG001|Overall Study|Physician Decision|7|||
46805362|NCT00534248|83024377|FG000|Overall Study|Protocol Violation|3|||
46805363|NCT00534248|83024378|FG001|Overall Study|Protocol Violation|4|||
46924623|NCT04382924|83158797|FG001|Overall Study|Protocol Violation|1|||
46924624|NCT04382924|83158798|FG002|Overall Study|Protocol Violation|1|||
46924625|NCT04382924|83158796|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
47052568|NCT01844687|83320027|FG000|Visit 1|Protocol Violation|3|||
46805364|NCT00534248|83024377|FG000|Overall Study|Withdrawal by Subject|263|||
46805365|NCT00534248|83024378|FG001|Overall Study|Withdrawal by Subject|255|||
46805366|NCT00391768|83024391|FG000|Overall Study|Withdrawal by Subject|0|||
46805367|NCT00391768|83024392|FG001|Overall Study|Withdrawal by Subject|0|||
46805368|NCT00391768|83024393|FG002|Overall Study|Withdrawal by Subject|1|||
46805369|NCT00391768|83024394|FG003|Overall Study|Withdrawal by Subject|0|||
46805370|NCT00391768|83024395|FG004|Overall Study|Withdrawal by Subject|0|||
46805371|NCT00391768|83024396|FG005|Overall Study|Withdrawal by Subject|1|||
46805372|NCT00391768|83024397|FG006|Overall Study|Withdrawal by Subject|1|||
46805373|NCT00391768|83024391|FG000|Overall Study|Lost to Follow-up|0|||
46805374|NCT00391768|83024392|FG001|Overall Study|Lost to Follow-up|0|||
46805375|NCT00391768|83024393|FG002|Overall Study|Lost to Follow-up|0|||
46805376|NCT00391768|83024394|FG003|Overall Study|Lost to Follow-up|1|||
46805377|NCT00391768|83024395|FG004|Overall Study|Lost to Follow-up|2|||
46805378|NCT00391768|83024396|FG005|Overall Study|Lost to Follow-up|2|||
46805379|NCT00391768|83024397|FG006|Overall Study|Lost to Follow-up|3|||
46805380|NCT00391222|83024434|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
46805381|NCT00391222|83024435|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
46805382|NCT00391222|83024436|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
46805383|NCT00391222|83024437|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
46805384|NCT00391222|83024434|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
46805385|NCT00391222|83024435|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
46805386|NCT00391222|83024436|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
46805387|NCT00391222|83024437|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
46805388|NCT00391222|83024434|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
46805389|NCT00391222|83024435|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
46805390|NCT00391222|83024436|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
46805391|NCT00391222|83024437|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
46805392|NCT00391222|83024434|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
46805393|NCT00391222|83024435|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
46805394|NCT00391222|83024436|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
46805395|NCT00391222|83024437|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
46805396|NCT00391222|83024434|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
46805397|NCT00391222|83024435|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
46805398|NCT00391222|83024436|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
46805399|NCT00391222|83024437|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
46924626|NCT04382924|83158797|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
46924627|NCT04382924|83158798|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
46924628|NCT04382924|83158796|FG000|Overall Study|Withdrawal by Subject|6|||
46924629|NCT04382924|83158797|FG001|Overall Study|Withdrawal by Subject|3|||
46924630|NCT04382924|83158798|FG002|Overall Study|Withdrawal by Subject|6|||
46924631|NCT03044431|83158812|FG000|Overall Study|Lost to Follow-up|59|||
47052569|NCT01844687|83320027|FG000|Visit 1|Lost to Follow-up|5|||
47052570|NCT01844687|83320027|FG000|Visit 2|Withdrawal by Subject|1|||
47052571|NCT01844687|83320027|FG000|Visit 2|Protocol Violation|1|||
47052572|NCT01844687|83320027|FG000|Visit 3|Lost to Follow-up|1|||
47052573|NCT01844687|83320027|FG000|Visit 3|Withdrawal by Subject|3|||
47052574|NCT01844687|83320027|FG000|Visit 3|child care problems|1|||
47052575|NCT01844687|83320027|FG000|Visit 4|Pregnancy|1|||
47052576|NCT01844687|83320027|FG000|Visit 4|Lost to Follow-up|1|||
47052577|NCT01844687|83320027|FG000|Visit 4|Withdrawal by Subject|2|||
47052578|NCT01844531|83320053|FG000|Overall Study|Withdrawal by Subject|0|||
46751540|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Site closure|0|||
46751541|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Site closure|0|||
46751542|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Site closure|1|||
46751543|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Site closure|0|||
46751544|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Site closure|0|||
46751545|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Site closure|0|||
46751546|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
46751547|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
46751548|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
46751549|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
46751550|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
46751551|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
46751552|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
46751553|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
46751554|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
46751555|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
46751556|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
46751557|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
46751558|NCT03439254|82969926|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
46805400|NCT00391222|83024434|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
46805401|NCT00391222|83024435|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
47052579|NCT01844531|83320054|FG001|Overall Study|Withdrawal by Subject|1|||
47052580|NCT01844531|83320055|FG002|Overall Study|Withdrawal by Subject|0|||
47052581|NCT01844531|83320056|FG003|Overall Study|Withdrawal by Subject|0|||
47052582|NCT01844375|83320068|FG000|Overall Study|Protocol Violation|1|||
47052583|NCT01844375|83320069|FG001|Overall Study|Protocol Violation|1|||
47052584|NCT02367456|83320078|FG000|Overall Study|Death|8|||
47052585|NCT02367456|83320079|FG001|Overall Study|Death|24|||
47052586|NCT02367456|83320080|FG002|Overall Study|Death|17|||
47052587|NCT02367456|83320078|FG000|Overall Study|Lost to Follow-up|1|||
47052588|NCT02367456|83320079|FG001|Overall Study|Lost to Follow-up|3|||
47052589|NCT02367456|83320080|FG002|Overall Study|Lost to Follow-up|1|||
47052590|NCT02367456|83320078|FG000|Overall Study|Other reason|3|||
47052591|NCT02367456|83320079|FG001|Overall Study|Other reason|3|||
47052592|NCT02367456|83320080|FG002|Overall Study|Other reason|9|||
47052593|NCT02367456|83320078|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
47052594|NCT02367456|83320079|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
47052595|NCT02367456|83320080|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
47052596|NCT01865747|83320111|FG000|Overall Study (ITT)|Adverse Event|32|||
47052597|NCT01865747|83320112|FG001|Overall Study (ITT)|Adverse Event|31|||
47052598|NCT01865747|83320111|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
47052599|NCT01865747|83320112|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
47052600|NCT01865747|83320111|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
47052601|NCT01865747|83320112|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
47052602|NCT01865747|83320111|FG000|Overall Study (ITT)|Protocol Violation|1|||
47052603|NCT01865747|83320112|FG001|Overall Study (ITT)|Protocol Violation|1|||
47052604|NCT01865747|83320111|FG000|Overall Study (ITT)|Physician Decision|5|||
47052605|NCT01865747|83320112|FG001|Overall Study (ITT)|Physician Decision|2|||
47052606|NCT01865747|83320111|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
47052607|NCT01865747|83320112|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
47052608|NCT01865747|83320111|FG000|Overall Study (ITT)|Sponsor Decision|0|||
47052609|NCT01865747|83320112|FG001|Overall Study (ITT)|Sponsor Decision|1|||
47052610|NCT01865747|83320111|FG000|Overall Study (ITT)|Progressive Disease|122|||
47052611|NCT01865747|83320112|FG001|Overall Study (ITT)|Progressive Disease|158|||
47052612|NCT01865747|83320111|FG000|Overall Study (ITT)|Reason Not Provided|0|||
47052613|NCT01865747|83320112|FG001|Overall Study (ITT)|Reason Not Provided|1|||
47052614|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
47052615|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
47052616|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
47052617|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
47052618|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
47052619|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
47052620|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
47052621|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
47052622|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
47052623|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
47052624|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
47052625|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
47052626|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
47052627|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
46751559|NCT03439254|82969927|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
46751560|NCT03439254|82969928|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
46751561|NCT03439254|82969929|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
46751562|NCT03439254|82969930|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
46751563|NCT03439254|82969931|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
46751564|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
46751565|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
46751566|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
46751567|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
47052628|NCT01865747|83320111|FG000|Primary Intent to Treat (PITT)|Other|0|||
47052629|NCT01865747|83320112|FG001|Primary Intent to Treat (PITT)|Other|1|||
47052630|NCT01843673|83320153|FG000|Overall Study|Lack of Efficacy|2|||
47052631|NCT01843673|83320153|FG000|Overall Study|Withdrawal by Subject|4|||
47052632|NCT01843205|83320172|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
47052633|NCT01843205|83320173|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
47052634|NCT01835015|83320260|FG000|Overall Study|Adverse Event|0|||
46751568|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
46751569|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
47052635|NCT01835015|83320261|FG001|Overall Study|Adverse Event|0|||
47052636|NCT01835015|83320262|FG002|Overall Study|Adverse Event|1|||
47052637|NCT01835015|83320263|FG003|Overall Study|Adverse Event|0|||
47052638|NCT01835015|83320264|FG004|Overall Study|Adverse Event|0|||
46805402|NCT00391222|83024436|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
46805403|NCT00391222|83024437|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
46805404|NCT00391222|83024434|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
46805405|NCT00391222|83024435|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
46805406|NCT00391222|83024436|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
46805407|NCT00391222|83024437|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
46805408|NCT00391222|83024434|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
46805409|NCT00391222|83024435|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
46805410|NCT00391222|83024436|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
46805411|NCT00391222|83024437|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
46805412|NCT00391222|83024434|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
46805413|NCT00391222|83024435|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
46805414|NCT00391222|83024436|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
46805415|NCT00391222|83024437|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
46805416|NCT00391222|83024434|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
46805417|NCT00391222|83024435|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
46805418|NCT00391222|83024436|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
46805419|NCT00391222|83024437|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
46805420|NCT00391222|83024434|FG000|Period III (Double-Blind Treatment)|Other|6|||
46805421|NCT00391222|83024435|FG001|Period III (Double-Blind Treatment)|Other|1|||
46805422|NCT00391222|83024436|FG002|Period III (Double-Blind Treatment)|Other|6|||
46805423|NCT00391222|83024437|FG003|Period III (Double-Blind Treatment)|Other|0|||
46805424|NCT00409006|83024449|FG000|Overall Study|Death|15|||
46805425|NCT00409006|83024450|FG001|Overall Study|Death|6|||
46805426|NCT00409006|83024449|FG000|Overall Study|Lost to Follow-up|1|||
46805427|NCT00409006|83024450|FG001|Overall Study|Lost to Follow-up|2|||
46805428|NCT00409006|83024449|FG000|Overall Study|Withdrawal by Subject|3|||
46805429|NCT00409006|83024450|FG001|Overall Study|Withdrawal by Subject|2|||
46805430|NCT00409006|83024449|FG000|Overall Study|Physician Decision|1|||
46805431|NCT00409006|83024450|FG001|Overall Study|Physician Decision|2|||
46805432|NCT00534092|83024458|FG000|Overall Study|Lost to Follow-up|1|||
46805433|NCT00534092|83024459|FG001|Overall Study|Lost to Follow-up|0|||
46805434|NCT00534092|83024458|FG000|Overall Study|personal reasons/family concerns|1|||
46805435|NCT00534092|83024459|FG001|Overall Study|personal reasons/family concerns|0|||
46805436|NCT00408928|83024467|FG000|Overall Study|Withdrawal by Subject|1|||
46805437|NCT00408928|83024467|FG000|Overall Study|Death|1|||
46805438|NCT00408928|83024467|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
46805439|NCT00390910|83024474|FG000|Overall Study|Adverse Event|1|||
46805440|NCT00390910|83024475|FG001|Overall Study|Adverse Event|0|||
46805441|NCT00390910|83024476|FG002|Overall Study|Adverse Event|0|||
46805442|NCT00390910|83024474|FG000|Overall Study|Lost to Follow-up|0|||
46805443|NCT00390910|83024475|FG001|Overall Study|Lost to Follow-up|1|||
46805444|NCT00390910|83024476|FG002|Overall Study|Lost to Follow-up|5|||
46805445|NCT00390910|83024474|FG000|Overall Study|Withdrawal by Subject|1|||
46805446|NCT00390910|83024475|FG001|Overall Study|Withdrawal by Subject|3|||
46805447|NCT00390910|83024476|FG002|Overall Study|Withdrawal by Subject|2|||
46805448|NCT00390910|83024474|FG000|Overall Study|Migrated/moved from study area|0|||
46805449|NCT00390910|83024475|FG001|Overall Study|Migrated/moved from study area|0|||
46805450|NCT00390910|83024476|FG002|Overall Study|Migrated/moved from study area|3|||
46805451|NCT00533702|83024488|FG000|Overall Study|Withdrawal by Subject|3|||
46805452|NCT00533702|83024489|FG001|Overall Study|Withdrawal by Subject|1|||
46805453|NCT00533702|83024488|FG000|Overall Study|Found ineligible after randomization|2|||
46805454|NCT00533702|83024489|FG001|Overall Study|Found ineligible after randomization|1|||
46805455|NCT00408694|83024495|FG000|Overall Study|Ineligible|1|||
46805456|NCT00408694|83024495|FG000|Overall Study|No protocol treatment|1|||
46805457|NCT00396136|83024499|FG000|Overall Study|Death|43|||
46805458|NCT00396136|83024499|FG000|Overall Study|Withdrawal by Subject|59|||
46805459|NCT00396136|83024499|FG000|Overall Study|Lost to Follow-up|15|||
46805460|NCT00396136|83024499|FG000|Overall Study|Study device explanted|8|||
46805461|NCT00530894|83024507|FG000|Overall Study|Death|84|||
46805462|NCT00530894|83024508|FG001|Overall Study|Death|89|||
46805463|NCT00530894|83024509|FG002|Overall Study|Death|55|||
46805464|NCT00530894|83024510|FG003|Overall Study|Death|89|||
46805465|NCT00530894|83024507|FG000|Overall Study|Lost to Follow-up|1|||
46805466|NCT00530894|83024508|FG001|Overall Study|Lost to Follow-up|3|||
46805467|NCT00530894|83024509|FG002|Overall Study|Lost to Follow-up|0|||
46805468|NCT00530894|83024510|FG003|Overall Study|Lost to Follow-up|0|||
46805469|NCT00530894|83024507|FG000|Overall Study|Withdrawal by Subject|1|||
46805470|NCT00530894|83024508|FG001|Overall Study|Withdrawal by Subject|23|||
46805471|NCT00530894|83024509|FG002|Overall Study|Withdrawal by Subject|0|||
46805472|NCT00530894|83024510|FG003|Overall Study|Withdrawal by Subject|5|||
46805473|NCT00530894|83024507|FG000|Overall Study|Alive and censored prior to 1 year|2|||
46805474|NCT00530894|83024508|FG001|Overall Study|Alive and censored prior to 1 year|0|||
46805475|NCT00530894|83024509|FG002|Overall Study|Alive and censored prior to 1 year|0|||
46805476|NCT00530894|83024510|FG003|Overall Study|Alive and censored prior to 1 year|0|||
46805477|NCT00056407|83024524|FG000|Overall Study|Adverse Event|282|||
46805478|NCT00056407|83024525|FG001|Overall Study|Adverse Event|364|||
46805479|NCT00056407|83024524|FG000|Overall Study|Withdrawal by Subject|377|||
46805480|NCT00056407|83024525|FG001|Overall Study|Withdrawal by Subject|361|||
46805481|NCT00056407|83024524|FG000|Overall Study|Lost to Follow-up|123|||
46805482|NCT00056407|83024525|FG001|Overall Study|Lost to Follow-up|113|||
46805483|NCT00056407|83024524|FG000|Overall Study|Protocol Violation|104|||
46805484|NCT00056407|83024525|FG001|Overall Study|Protocol Violation|95|||
46805485|NCT00056407|83024524|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
46805486|NCT00056407|83024525|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
46805487|NCT00056407|83024524|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
46805488|NCT00056407|83024525|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
46805489|NCT00056407|83024524|FG000|Overall Study|Missing|25|||
46805490|NCT00056407|83024525|FG001|Overall Study|Missing|34|||
46805491|NCT00388726|83024533|FG000|Overall Study|Adverse Event|50|||
46805492|NCT00388726|83024534|FG001|Overall Study|Adverse Event|24|||
46805493|NCT00388726|83024533|FG000|Overall Study|Progressive Disease|336|||
46805494|NCT00388726|83024534|FG001|Overall Study|Progressive Disease|153|||
46805495|NCT00388726|83024533|FG000|Overall Study|Clinical Progression|61|||
46805496|NCT00388726|83024534|FG001|Overall Study|Clinical Progression|36|||
46805497|NCT00388726|83024533|FG000|Overall Study|Withdrawal by Subject|10|||
46805498|NCT00388726|83024534|FG001|Overall Study|Withdrawal by Subject|7|||
46805499|NCT00388726|83024533|FG000|Overall Study|Administrative|6|||
47052639|NCT01842581|83320292|FG000|Overall Study|Adverse Event|6|||
47052640|NCT01842581|83320293|FG001|Overall Study|Adverse Event|4|||
47052641|NCT01842581|83320292|FG000|Overall Study|HE breakthrough|26|||
47052642|NCT01842581|83320293|FG001|Overall Study|HE breakthrough|13|||
46805500|NCT00388726|83024534|FG001|Overall Study|Administrative|9|||
46805501|NCT00388726|83024533|FG000|Overall Study|Physician Decision|18|||
46805502|NCT00388726|83024534|FG001|Overall Study|Physician Decision|13|||
46805503|NCT00388726|83024533|FG000|Overall Study|Death|3|||
46805504|NCT00388726|83024534|FG001|Overall Study|Death|2|||
46805505|NCT00387790|83024540|FG000|Overall Study|Adverse Event|5|||
46805506|NCT00387790|83024540|FG000|Overall Study|Lack of Efficacy|2|||
46805507|NCT00387790|83024540|FG000|Overall Study|Physician Decision|2|||
46805508|NCT00387790|83024540|FG000|Overall Study|Withdrawal by Subject|3|||
46805509|NCT00387790|83024540|FG000|Overall Study|Ineligible for study|2|||
47052643|NCT01842581|83320292|FG000|Overall Study|Liver transplant|2|||
47052644|NCT01842581|83320293|FG001|Overall Study|Liver transplant|0|||
47052645|NCT01842581|83320292|FG000|Overall Study|Lost to Follow-up|2|||
47052646|NCT01842581|83320293|FG001|Overall Study|Lost to Follow-up|5|||
46805510|NCT00073021|83024546|FG000|Overall Study|Protocol Violation|2|||
46924632|NCT02770170|83158820|FG000|Overall Study|Withdrawal by Subject|0|||
47052647|NCT01842581|83320292|FG000|Overall Study|Withdrawal by Subject|5|||
47052648|NCT01842581|83320293|FG001|Overall Study|Withdrawal by Subject|7|||
47052649|NCT01842581|83320292|FG000|Overall Study|Other than specified|3|||
47052650|NCT01842581|83320293|FG001|Overall Study|Other than specified|1|||
47052651|NCT01833533|83320301|FG000|Overall Study|Adverse Event|0|||
47052652|NCT01833533|83320302|FG001|Overall Study|Adverse Event|1|||
47052653|NCT01833533|83320301|FG000|Overall Study|Lost to Follow-up|4|||
46751570|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
46751571|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
46751572|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
46751573|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
46751574|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
46751575|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
46751576|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
46751577|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
46751578|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
46751579|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
46751580|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
46751581|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
46751582|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
46751583|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
46751584|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
46751585|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
46751586|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
46751587|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
46805511|NCT00073021|83024547|FG001|Overall Study|Protocol Violation|1|||
46805512|NCT00073021|83024546|FG000|Overall Study|Adverse Event|4|||
46805513|NCT00073021|83024547|FG001|Overall Study|Adverse Event|4|||
47052654|NCT01833533|83320302|FG001|Overall Study|Lost to Follow-up|9|||
47052655|NCT01833533|83320301|FG000|Overall Study|To Enter an Extension Study|0|||
46805514|NCT00073021|83024546|FG000|Overall Study|Withdrawal by Subject|6|||
46805515|NCT00073021|83024547|FG001|Overall Study|Withdrawal by Subject|5|||
46924633|NCT02770170|83158821|FG001|Overall Study|Withdrawal by Subject|0|||
46924634|NCT02770170|83158822|FG002|Overall Study|Withdrawal by Subject|0|||
46924635|NCT02770170|83158823|FG003|Overall Study|Withdrawal by Subject|2|||
47052656|NCT01833533|83320302|FG001|Overall Study|To Enter an Extension Study|4|||
47052657|NCT01833533|83320301|FG000|Overall Study|Other|2|||
47052658|NCT01833533|83320302|FG001|Overall Study|Other|7|||
47052659|NCT01833455|83320310|FG000|Overall Study|Withdrawal by Subject|1|||
47052660|NCT01833455|83320311|FG001|Overall Study|Withdrawal by Subject|0|||
47052661|NCT01833143|83320329|FG000|Overall Study|Not Treated|1|||
47052662|NCT01841567|83320333|FG000|Overall Study|Adverse Event|3|||
47052663|NCT01833065|83320340|FG000|Overall Study|Adverse Event|6|||
47052664|NCT01833065|83320341|FG001|Overall Study|Adverse Event|1|||
47052665|NCT01833065|83320342|FG002|Overall Study|Adverse Event|0|||
47052666|NCT01833065|83320343|FG003|Overall Study|Adverse Event|2|||
47052667|NCT01833065|83320344|FG004|Overall Study|Adverse Event|3|||
46924636|NCT02770170|83158820|FG000|Overall Study|due to pregnancy|1|||
46924637|NCT02770170|83158821|FG001|Overall Study|due to pregnancy|0|||
46924638|NCT02770170|83158822|FG002|Overall Study|due to pregnancy|0|||
46924639|NCT02770170|83158823|FG003|Overall Study|due to pregnancy|0|||
46924640|NCT02770170|83158820|FG000|Overall Study|Lack of Efficacy|2|||
46924641|NCT02770170|83158821|FG001|Overall Study|Lack of Efficacy|0|||
46924642|NCT02770170|83158822|FG002|Overall Study|Lack of Efficacy|0|||
46924643|NCT02770170|83158823|FG003|Overall Study|Lack of Efficacy|1|||
46924644|NCT02770170|83158820|FG000|Overall Study|Adverse Event|4|||
46924645|NCT02770170|83158821|FG001|Overall Study|Adverse Event|3|||
46924646|NCT02770170|83158822|FG002|Overall Study|Adverse Event|5|||
46924647|NCT02770170|83158823|FG003|Overall Study|Adverse Event|3|||
46924648|NCT02770170|83158820|FG000|Overall Study|due to disease worsening|0|||
46924649|NCT02770170|83158821|FG001|Overall Study|due to disease worsening|0|||
46924650|NCT02770170|83158822|FG002|Overall Study|due to disease worsening|0|||
46924651|NCT02770170|83158823|FG003|Overall Study|due to disease worsening|1|||
46924652|NCT02769858|83158833|FG000|Overall Study|Withdrawal by Subject|2|||
46924653|NCT02769624|83158837|FG000|Overall Study|Lost to Follow-up|0|||
46924654|NCT02769624|83158838|FG001|Overall Study|Lost to Follow-up|1|||
46924655|NCT03446768|83158846|FG000|Overall Study|Withdrawal by Subject|0|||
46924656|NCT03446768|83158847|FG001|Overall Study|Withdrawal by Subject|1|||
46924657|NCT02676284|83158853|FG000|Overall Study|Withdrawal by Subject|1|||
46924658|NCT02769312|83158859|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
46924659|NCT02769312|83158860|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
46924660|NCT02769312|83158859|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
46924661|NCT02769312|83158860|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
46924662|NCT02769312|83158859|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
46924663|NCT02769312|83158860|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
46924664|NCT02769312|83158859|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
46924665|NCT02769312|83158860|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
46924666|NCT02769312|83158859|FG000|Follow-up|Lost to Follow-up|1|||
46924667|NCT02769312|83158860|FG001|Follow-up|Lost to Follow-up|1|||
46924668|NCT01673386|83158867|FG000|Overall Study|Study terminated by sponsor|16|||
46924669|NCT01673386|83158868|FG001|Overall Study|Study terminated by sponsor|22|||
46924670|NCT01673386|83158867|FG000|Overall Study|Adverse Event|5|||
46924671|NCT01673386|83158868|FG001|Overall Study|Adverse Event|2|||
46924672|NCT01673386|83158867|FG000|Overall Study|Progressive disease|4|||
46924673|NCT01673386|83158868|FG001|Overall Study|Progressive disease|1|||
46924674|NCT01673386|83158867|FG000|Overall Study|Withdrawal by Subject|0|||
46924675|NCT01673386|83158868|FG001|Overall Study|Withdrawal by Subject|2|||
46924676|NCT00103740|83158876|FG000|Period 1 - Core|Adverse Event|1|||
46924677|NCT00103740|83158877|FG001|Period 1 - Core|Adverse Event|0|||
46924678|NCT00103740|83158876|FG000|Period 1 - Core|Protocol Violation|3|||
47052668|NCT01833065|83320340|FG000|Overall Study|Protocol Violation|1|||
47052669|NCT01833065|83320341|FG001|Overall Study|Protocol Violation|0|||
47052670|NCT01833065|83320342|FG002|Overall Study|Protocol Violation|0|||
47052671|NCT01833065|83320343|FG003|Overall Study|Protocol Violation|0|||
47052672|NCT01833065|83320344|FG004|Overall Study|Protocol Violation|2|||
47052673|NCT01833065|83320340|FG000|Overall Study|Lost to Follow-up|1|||
47052674|NCT01833065|83320341|FG001|Overall Study|Lost to Follow-up|0|||
47052675|NCT01833065|83320342|FG002|Overall Study|Lost to Follow-up|0|||
47052676|NCT01833065|83320343|FG003|Overall Study|Lost to Follow-up|0|||
46924679|NCT00103740|83158877|FG001|Period 1 - Core|Protocol Violation|2|||
46924680|NCT00103740|83158876|FG000|Period 1 - Core|Patient withdrew consent|3|||
46924681|NCT00103740|83158877|FG001|Period 1 - Core|Patient withdrew consent|2|||
46924682|NCT00103740|83158876|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
46924683|NCT00103740|83158877|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
46924684|NCT00103740|83158876|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
46924685|NCT00103740|83158877|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
47052677|NCT01833065|83320344|FG004|Overall Study|Lost to Follow-up|3|||
46805516|NCT00073021|83024546|FG000|Overall Study|Physician Decision|3|||
46805517|NCT00073021|83024547|FG001|Overall Study|Physician Decision|1|||
46805518|NCT00073021|83024546|FG000|Overall Study|Lack of Efficacy|11|||
46805519|NCT00073021|83024547|FG001|Overall Study|Lack of Efficacy|5|||
46805520|NCT00407758|83024553|FG000|Overall Study|ineligible -improper prior treatment|1|||
46805521|NCT00531752|83024561|FG000|First Double-blind Intervention Period|Adverse Event|2|||
46805522|NCT00531752|83024562|FG001|First Double-blind Intervention Period|Adverse Event|0|||
46805523|NCT00531752|83024563|FG002|First Double-blind Intervention Period|Adverse Event|1|||
46805524|NCT00531752|83024564|FG003|First Double-blind Intervention Period|Adverse Event|1|||
46805525|NCT00531752|83024561|FG000|First Double-blind Intervention Period|Other|1|||
46805526|NCT00531752|83024562|FG001|First Double-blind Intervention Period|Other|4|||
46805527|NCT00531752|83024563|FG002|First Double-blind Intervention Period|Other|4|||
46805528|NCT00531752|83024564|FG003|First Double-blind Intervention Period|Other|0|||
46805529|NCT00531752|83024561|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
46924686|NCT00103740|83158876|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
46924687|NCT00103740|83158877|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
46924688|NCT00103740|83158876|FG000|Period 2 - Extended Observation Period|Death|6|||
46924689|NCT00103740|83158877|FG001|Period 2 - Extended Observation Period|Death|2|||
46924690|NCT00103740|83158876|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
46924691|NCT00103740|83158877|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
46924692|NCT01281644|83158883|FG000|Overall Study|Lost to Follow-up|3|||
46924693|NCT01281644|83158883|FG000|Overall Study|Withdrawal by Subject|2|||
46924694|NCT02869893|83158889|FG000|Overall Study|participant aversion to IV|5|||
46924695|NCT02869893|83158889|FG000|Overall Study|participant fear of MRI scanner|2|||
46924696|NCT02872311|83158913|FG000|Overall Study|Death|2|||
46924697|NCT02872311|83158914|FG001|Overall Study|Death|0|||
46924698|NCT02872311|83158915|FG002|Overall Study|Death|0|||
46924699|NCT02872311|83158916|FG003|Overall Study|Death|0|||
46924700|NCT02872311|83158917|FG004|Overall Study|Death|0|||
46805530|NCT00531752|83024562|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
46805531|NCT00531752|83024563|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
46924701|NCT02872311|83158913|FG000|Overall Study|Lost to Follow-up|2|||
46924702|NCT02872311|83158914|FG001|Overall Study|Lost to Follow-up|0|||
46924703|NCT02872311|83158915|FG002|Overall Study|Lost to Follow-up|0|||
46924704|NCT02872311|83158916|FG003|Overall Study|Lost to Follow-up|0|||
46924705|NCT02872311|83158917|FG004|Overall Study|Lost to Follow-up|0|||
46924706|NCT02872311|83158913|FG000|Overall Study|Protocol Violation|0|||
46924707|NCT02872311|83158914|FG001|Overall Study|Protocol Violation|2|||
46924708|NCT02872311|83158915|FG002|Overall Study|Protocol Violation|1|||
46924709|NCT02872311|83158916|FG003|Overall Study|Protocol Violation|0|||
46924710|NCT02872311|83158917|FG004|Overall Study|Protocol Violation|0|||
46924711|NCT02871375|83158945|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
46924712|NCT02871375|83158946|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
46924713|NCT02867709|83158957|FG000|Treatment Period|Adverse Event|1|||
46924714|NCT02867709|83158958|FG001|Treatment Period|Adverse Event|1|||
46924715|NCT02867709|83158959|FG002|Treatment Period|Adverse Event|2|||
46924716|NCT02867709|83158957|FG000|Treatment Period|Withdrawal of Consent|7|||
46924717|NCT02867709|83158958|FG001|Treatment Period|Withdrawal of Consent|9|||
46924718|NCT02867709|83158959|FG002|Treatment Period|Withdrawal of Consent|8|||
46924719|NCT02867709|83158957|FG000|Treatment Period|Lost to Follow-up|17|||
46924720|NCT02867709|83158958|FG001|Treatment Period|Lost to Follow-up|20|||
46924721|NCT02867709|83158959|FG002|Treatment Period|Lost to Follow-up|20|||
47052678|NCT01833065|83320340|FG000|Overall Study|Withdrawal by Subject|6|||
47052679|NCT01833065|83320341|FG001|Overall Study|Withdrawal by Subject|2|||
47052680|NCT01833065|83320342|FG002|Overall Study|Withdrawal by Subject|4|||
47052681|NCT01833065|83320343|FG003|Overall Study|Withdrawal by Subject|3|||
47052682|NCT01833065|83320344|FG004|Overall Study|Withdrawal by Subject|11|||
47052683|NCT01833065|83320340|FG000|Overall Study|Subject's substantial non-compliance|0|||
47052684|NCT01833065|83320341|FG001|Overall Study|Subject's substantial non-compliance|1|||
47052685|NCT01833065|83320342|FG002|Overall Study|Subject's substantial non-compliance|0|||
47052686|NCT01833065|83320343|FG003|Overall Study|Subject's substantial non-compliance|0|||
47052687|NCT01833065|83320344|FG004|Overall Study|Subject's substantial non-compliance|0|||
47052688|NCT01833065|83320340|FG000|Overall Study|Trial terminated by sponsor|8|||
47052689|NCT01833065|83320341|FG001|Overall Study|Trial terminated by sponsor|8|||
47052690|NCT01833065|83320342|FG002|Overall Study|Trial terminated by sponsor|7|||
47052691|NCT01833065|83320343|FG003|Overall Study|Trial terminated by sponsor|3|||
46924722|NCT02867709|83158957|FG000|Treatment Period|Lack of Qualifying Event|42|||
46924723|NCT02867709|83158958|FG001|Treatment Period|Lack of Qualifying Event|55|||
46924724|NCT02867709|83158959|FG002|Treatment Period|Lack of Qualifying Event|42|||
46924725|NCT02867709|83158957|FG000|Treatment Period|Protocol Violation|3|||
46924726|NCT02867709|83158958|FG001|Treatment Period|Protocol Violation|2|||
46805532|NCT00531752|83024564|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
46805533|NCT00531752|83024561|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
46805534|NCT00531752|83024562|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
46805535|NCT00531752|83024563|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
46805536|NCT00531752|83024564|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
46805537|NCT00531752|83024561|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
46805538|NCT00531752|83024562|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
46805539|NCT00531752|83024563|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
46805540|NCT00531752|83024564|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
46805541|NCT00531752|83024561|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
46805542|NCT00531752|83024562|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
46805543|NCT00531752|83024563|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
46924727|NCT02867709|83158959|FG002|Treatment Period|Protocol Violation|3|||
46924728|NCT02867709|83158957|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
46924729|NCT02867709|83158958|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
46924730|NCT02867709|83158959|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
46924731|NCT02867709|83158957|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
46924732|NCT02867709|83158958|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
46924733|NCT02867709|83158959|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
46924734|NCT02867709|83158957|FG000|Safety Follow-up Period|Pregnancy|0|||
46751588|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
46751589|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
46805544|NCT00531752|83024564|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
46805545|NCT00531752|83024561|FG000|Second Double-blind Intervention Period|Other|1|||
46805546|NCT00531752|83024562|FG001|Second Double-blind Intervention Period|Other|1|||
46805547|NCT00531752|83024563|FG002|Second Double-blind Intervention Period|Other|0|||
46805548|NCT00531752|83024564|FG003|Second Double-blind Intervention Period|Other|0|||
46805549|NCT00531752|83024561|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
46805550|NCT00531752|83024562|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
46805551|NCT00531752|83024563|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
46805552|NCT00531752|83024564|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
46805553|NCT00531752|83024561|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
46805554|NCT00531752|83024562|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
46924735|NCT02867709|83158958|FG001|Safety Follow-up Period|Pregnancy|1|||
46924736|NCT02867709|83158959|FG002|Safety Follow-up Period|Pregnancy|0|||
46924737|NCT02867709|83158957|FG000|Safety Follow-up Period|Protocol Violation|0|||
46924738|NCT02867709|83158958|FG001|Safety Follow-up Period|Protocol Violation|1|||
46924739|NCT02867709|83158959|FG002|Safety Follow-up Period|Protocol Violation|1|||
46924740|NCT03044353|83158970|FG000|Overall Study|Adverse Event|0|||
46924741|NCT03044353|83158971|FG001|Overall Study|Adverse Event|1|||
46924742|NCT03044353|83158972|FG002|Overall Study|Adverse Event|0|||
46924743|NCT01361308|83158981|FG000|Overall Study|Withdrawal by Subject|9|||
46751590|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
46751591|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
46751592|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
46751593|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
46751594|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
46751595|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
46751596|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
46751597|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
46751598|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
46751599|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
46751600|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
46751601|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
46751602|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
46751603|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
46751604|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
46805555|NCT00531752|83024563|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
46805556|NCT00531752|83024564|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
46805557|NCT00395746|83024575|FG000|Overall Study|Adverse Event|5|||
46924744|NCT01361308|83158982|FG001|Overall Study|Withdrawal by Subject|13|||
46924745|NCT01361308|83158981|FG000|Overall Study|Physician Decision|3|||
46805558|NCT00395746|83024576|FG001|Overall Study|Adverse Event|2|||
46805559|NCT00395746|83024577|FG002|Overall Study|Adverse Event|2|||
46805560|NCT00395746|83024575|FG000|Overall Study|Protocol Violation|0|||
46805561|NCT00395746|83024576|FG001|Overall Study|Protocol Violation|1|||
46805562|NCT00395746|83024577|FG002|Overall Study|Protocol Violation|0|||
46805563|NCT00395746|83024575|FG000|Overall Study|Lack of Efficacy|2|||
46805564|NCT00395746|83024576|FG001|Overall Study|Lack of Efficacy|0|||
46805565|NCT00395746|83024577|FG002|Overall Study|Lack of Efficacy|17|||
46805566|NCT00395746|83024575|FG000|Overall Study|Hypoglycaemia|2|||
46805567|NCT00395746|83024576|FG001|Overall Study|Hypoglycaemia|1|||
46805568|NCT00395746|83024577|FG002|Overall Study|Hypoglycaemia|0|||
46805569|NCT00395746|83024575|FG000|Overall Study|Subject decision|0|||
46805570|NCT00395746|83024576|FG001|Overall Study|Subject decision|0|||
46805571|NCT00395746|83024577|FG002|Overall Study|Subject decision|1|||
46805572|NCT00395746|83024575|FG000|Overall Study|Withdrawal of consent|0|||
46805573|NCT00395746|83024576|FG001|Overall Study|Withdrawal of consent|0|||
46805574|NCT00395746|83024577|FG002|Overall Study|Withdrawal of consent|1|||
46805575|NCT00395746|83024575|FG000|Overall Study|Difficultulty in use of device|0|||
46805576|NCT00395746|83024576|FG001|Overall Study|Difficultulty in use of device|0|||
46805577|NCT00395746|83024577|FG002|Overall Study|Difficultulty in use of device|1|||
46805578|NCT00395746|83024575|FG000|Overall Study|Unable to visit site on schedule|1|||
46805579|NCT00395746|83024576|FG001|Overall Study|Unable to visit site on schedule|0|||
46805580|NCT00395746|83024577|FG002|Overall Study|Unable to visit site on schedule|0|||
46805581|NCT00055471|83024588|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
46805582|NCT00055471|83024589|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
46924746|NCT01361308|83158982|FG001|Overall Study|Physician Decision|3|||
46924747|NCT01361308|83158981|FG000|Overall Study|Lack of Efficacy|2|||
47052692|NCT01833065|83320344|FG004|Overall Study|Trial terminated by sponsor|13|||
47052693|NCT01833065|83320340|FG000|Overall Study|Others|2|||
47052694|NCT01833065|83320341|FG001|Overall Study|Others|1|||
46805583|NCT00055471|83024590|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
46805584|NCT00055471|83024588|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
47052695|NCT01833065|83320342|FG002|Overall Study|Others|1|||
47052696|NCT01833065|83320343|FG003|Overall Study|Others|1|||
47052697|NCT01833065|83320344|FG004|Overall Study|Others|4|||
47052698|NCT01831817|83320358|FG000|Overall Study|Lost to Follow-up|1|||
47052699|NCT01831817|83320359|FG001|Overall Study|Lost to Follow-up|0|||
47052700|NCT01831817|83320360|FG002|Overall Study|Lost to Follow-up|0|||
47052701|NCT01831817|83320361|FG003|Overall Study|Lost to Follow-up|0|||
47052702|NCT01831817|83320358|FG000|Overall Study|Withdrawl of Consent|3|||
46805585|NCT00055471|83024589|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
47052703|NCT01831817|83320359|FG001|Overall Study|Withdrawl of Consent|0|||
47052704|NCT01831817|83320360|FG002|Overall Study|Withdrawl of Consent|0|||
47052705|NCT01831817|83320361|FG003|Overall Study|Withdrawl of Consent|0|||
47052706|NCT01840943|83320386|FG000|Overall Study|Withdrawal by Subject|5|||
47052707|NCT01840943|83320387|FG001|Overall Study|Withdrawal by Subject|6|||
46924748|NCT01361308|83158982|FG001|Overall Study|Lack of Efficacy|0|||
46924749|NCT01361308|83158981|FG000|Overall Study|Protocol Violation|1|||
47052708|NCT01840943|83320386|FG000|Overall Study|Physician Decision|4|||
47052709|NCT01840943|83320387|FG001|Overall Study|Physician Decision|2|||
47052710|NCT01840943|83320386|FG000|Overall Study|Lost to Follow-up|4|||
46805586|NCT00055471|83024590|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
46805587|NCT00055471|83024588|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
46805588|NCT00055471|83024589|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
46805589|NCT00055471|83024590|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
46805590|NCT00395512|83024602|FG000|Overall Study|Adverse Event|3|||
46805591|NCT00395512|83024603|FG001|Overall Study|Adverse Event|8|||
46805592|NCT00395512|83024604|FG002|Overall Study|Adverse Event|6|||
46805593|NCT00395512|83024605|FG003|Overall Study|Adverse Event|6|||
46805594|NCT00395512|83024602|FG000|Overall Study|Protocol Violation|2|||
46805595|NCT00395512|83024603|FG001|Overall Study|Protocol Violation|3|||
46805596|NCT00395512|83024604|FG002|Overall Study|Protocol Violation|6|||
46805597|NCT00395512|83024605|FG003|Overall Study|Protocol Violation|7|||
46805598|NCT00395512|83024602|FG000|Overall Study|Lost to Follow-up|2|||
46805599|NCT00395512|83024603|FG001|Overall Study|Lost to Follow-up|6|||
46805600|NCT00395512|83024604|FG002|Overall Study|Lost to Follow-up|5|||
46805601|NCT00395512|83024605|FG003|Overall Study|Lost to Follow-up|5|||
46805602|NCT00395512|83024602|FG000|Overall Study|Withdrawal by Subject|6|||
46805603|NCT00395512|83024603|FG001|Overall Study|Withdrawal by Subject|5|||
46805604|NCT00395512|83024604|FG002|Overall Study|Withdrawal by Subject|5|||
46805605|NCT00395512|83024605|FG003|Overall Study|Withdrawal by Subject|12|||
46805606|NCT00395512|83024602|FG000|Overall Study|Physician Decision|6|||
46805607|NCT00395512|83024603|FG001|Overall Study|Physician Decision|4|||
46805608|NCT00395512|83024604|FG002|Overall Study|Physician Decision|2|||
46805609|NCT00395512|83024605|FG003|Overall Study|Physician Decision|2|||
46805610|NCT00395512|83024602|FG000|Overall Study|Other|1|||
46805611|NCT00395512|83024603|FG001|Overall Study|Other|1|||
46805612|NCT00395512|83024604|FG002|Overall Study|Other|0|||
46805613|NCT00395512|83024605|FG003|Overall Study|Other|0|||
46805614|NCT00395512|83024602|FG000|Overall Study|Hyperglycemic Rescue|18|||
46805615|NCT00395512|83024603|FG001|Overall Study|Hyperglycemic Rescue|10|||
46805616|NCT00395512|83024604|FG002|Overall Study|Hyperglycemic Rescue|4|||
46805617|NCT00395512|83024605|FG003|Overall Study|Hyperglycemic Rescue|6|||
46805618|NCT00054691|83024615|FG000|Overall Study|Unmeasurable Disease|2|||
46805619|NCT00054691|83024615|FG000|Overall Study|Noncompliant|1|||
46805620|NCT00387712|83024621|FG000|Overall Study|Physician Decision|6|||
46805621|NCT00387712|83024622|FG001|Overall Study|Physician Decision|4|||
46805622|NCT00387712|83024621|FG000|Overall Study|Lost to Follow-up|17|||
46805623|NCT00387712|83024622|FG001|Overall Study|Lost to Follow-up|20|||
46805624|NCT00387712|83024621|FG000|Overall Study|Withdrawal by Subject|6|||
46805625|NCT00387712|83024622|FG001|Overall Study|Withdrawal by Subject|12|||
46805626|NCT00072475|83024628|FG000|Overall Study|Adverse Event|44|||
46805627|NCT00072475|83024628|FG000|Overall Study|Death|3|||
46805628|NCT00072475|83024628|FG000|Overall Study|Withdrawal by Subject|46|||
46805629|NCT00072475|83024628|FG000|Overall Study|Patient/Investigator Decision|4|||
46805630|NCT00066469|83024632|FG000|Overall Study|Death|3|||
46805631|NCT00066469|83024632|FG000|Overall Study|Lack of Efficacy|9|||
46805632|NCT00066469|83024632|FG000|Overall Study|Lost to Follow-up|1|||
46805633|NCT00066469|83024632|FG000|Overall Study|Physician Decision|1|||
46805634|NCT00066469|83024632|FG000|Overall Study|Withdrawal by Subject|1|||
46805635|NCT00066469|83024632|FG000|Overall Study|ineligible|1|||
47052711|NCT01840943|83320387|FG001|Overall Study|Lost to Follow-up|4|||
47052712|NCT01840163|83320395|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
47052713|NCT01840163|83320396|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
47052714|NCT01840163|83320395|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
47052715|NCT01840163|83320396|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
47052716|NCT01840163|83320395|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
47052717|NCT01840163|83320396|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
47052718|NCT01831427|83320549|FG000|Overall Study|Adverse Event|0|||
47052719|NCT01831427|83320550|FG001|Overall Study|Adverse Event|1|||
47052720|NCT01831427|83320551|FG002|Overall Study|Adverse Event|0|||
47052721|NCT01831427|83320552|FG003|Overall Study|Adverse Event|0|||
47052722|NCT01831427|83320553|FG004|Overall Study|Adverse Event|0|||
47052723|NCT01831427|83320554|FG005|Overall Study|Adverse Event|1|||
47052724|NCT01831427|83320555|FG006|Overall Study|Adverse Event|0|||
47052725|NCT01831427|83320556|FG007|Overall Study|Adverse Event|1|||
47052726|NCT01831427|83320557|FG008|Overall Study|Adverse Event|0|||
46805636|NCT00387088|83024638|FG000|Overall Study|Adverse Event|143|||
46805637|NCT00387088|83024639|FG001|Overall Study|Adverse Event|156|||
46805638|NCT00387088|83024638|FG000|Overall Study|Protocol Violation|47|||
46805639|NCT00387088|83024639|FG001|Overall Study|Protocol Violation|35|||
46805640|NCT00387088|83024638|FG000|Overall Study|Withdrawal by Subject|20|||
46805641|NCT00387088|83024639|FG001|Overall Study|Withdrawal by Subject|35|||
46805642|NCT00387088|83024638|FG000|Overall Study|Lack of Efficacy|28|||
46805643|NCT00387088|83024639|FG001|Overall Study|Lack of Efficacy|67|||
46805644|NCT00387088|83024638|FG000|Overall Study|Lost to Follow-up|22|||
46805645|NCT00387088|83024639|FG001|Overall Study|Lost to Follow-up|28|||
46805646|NCT00387088|83024638|FG000|Overall Study|Other|58|||
46805647|NCT00387088|83024639|FG001|Overall Study|Other|52|||
46924750|NCT01361308|83158982|FG001|Overall Study|Protocol Violation|0|||
46924751|NCT01361308|83158981|FG000|Overall Study|Lost to Follow-up|5|||
46924752|NCT01361308|83158982|FG001|Overall Study|Lost to Follow-up|4|||
46924753|NCT01361308|83158981|FG000|Overall Study|Adverse Event|8|||
46924754|NCT01361308|83158982|FG001|Overall Study|Adverse Event|4|||
46924755|NCT01361308|83158981|FG000|Overall Study|Eligibility Criteria Not Met|2|||
46924756|NCT01361308|83158982|FG001|Overall Study|Eligibility Criteria Not Met|3|||
46924757|NCT01361308|83158981|FG000|Overall Study|Failed C-SSRS|5|||
46924758|NCT01361308|83158982|FG001|Overall Study|Failed C-SSRS|2|||
46924759|NCT01361308|83158981|FG000|Overall Study|Other|0|||
46924760|NCT01361308|83158982|FG001|Overall Study|Other|1|||
46924761|NCT02872935|83158994|FG000|Overall Study|Other|0|||
46924762|NCT02872935|83158995|FG001|Overall Study|Other|1|||
46924763|NCT00103662|83159003|FG000|Overall Study|Entered Rescue Procedure|0|||
47052727|NCT01831427|83320558|FG009|Overall Study|Adverse Event|0|||
47052728|NCT01831427|83320559|FG010|Overall Study|Adverse Event|2|||
47052729|NCT01831427|83320549|FG000|Overall Study|Investigator's Discretion|0|||
47052730|NCT01831427|83320550|FG001|Overall Study|Investigator's Discretion|0|||
47052731|NCT01831427|83320551|FG002|Overall Study|Investigator's Discretion|0|||
47052732|NCT01831427|83320552|FG003|Overall Study|Investigator's Discretion|1|||
46924764|NCT00103662|83159004|FG001|Overall Study|Entered Rescue Procedure|7|||
46924765|NCT00103662|83159003|FG000|Overall Study|Death|7|||
46924766|NCT00103662|83159004|FG001|Overall Study|Death|7|||
46924767|NCT00103662|83159003|FG000|Overall Study|Elective Withdrawal|5|||
46924768|NCT00103662|83159004|FG001|Overall Study|Elective Withdrawal|5|||
46924769|NCT00103662|83159003|FG000|Overall Study|Lost to Follow-up|0|||
46924770|NCT00103662|83159004|FG001|Overall Study|Lost to Follow-up|1|||
46924771|NCT00103662|83159003|FG000|Overall Study|Other|6|||
46924772|NCT00103662|83159004|FG001|Overall Study|Other|9|||
46751605|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
46751606|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
46751607|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
46751608|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
46924773|NCT00103662|83159003|FG000|Overall Study|Failed mobilization|0|||
46924774|NCT00103662|83159004|FG001|Overall Study|Failed mobilization|4|||
46924775|NCT00103662|83159003|FG000|Overall Study|Intercurrent illness|1|||
46924776|NCT00103662|83159004|FG001|Overall Study|Intercurrent illness|0|||
46924777|NCT02865915|83159012|FG000|Overall Study|Pregnancy|1|||
46924778|NCT02865915|83159013|FG001|Overall Study|Pregnancy|0|||
46751609|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
46751610|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
46751611|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
46751612|NCT03439254|82969926|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
46751613|NCT03439254|82969927|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
46751614|NCT03439254|82969928|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
46751615|NCT03439254|82969929|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
46751616|NCT03439254|82969930|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
46751617|NCT03439254|82969931|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
46751618|NCT03434379|82969947|FG000|Global Period|Lost to Follow-up|3|||
46751619|NCT03434379|82969948|FG001|Global Period|Lost to Follow-up|6|||
46924779|NCT02865915|83159012|FG000|Overall Study|Withdrawal by Subject|1|||
46924780|NCT02865915|83159013|FG001|Overall Study|Withdrawal by Subject|1|||
46924781|NCT02865915|83159012|FG000|Overall Study|Adverse Event|0|||
47052733|NCT01831427|83320553|FG004|Overall Study|Investigator's Discretion|0|||
47052734|NCT01831427|83320554|FG005|Overall Study|Investigator's Discretion|0|||
47052735|NCT01831427|83320555|FG006|Overall Study|Investigator's Discretion|0|||
47052736|NCT01831427|83320556|FG007|Overall Study|Investigator's Discretion|0|||
47052737|NCT01831427|83320557|FG008|Overall Study|Investigator's Discretion|0|||
47052738|NCT01831427|83320558|FG009|Overall Study|Investigator's Discretion|0|||
47052739|NCT01831427|83320559|FG010|Overall Study|Investigator's Discretion|0|||
47052740|NCT01831427|83320549|FG000|Overall Study|Withdrew Consent|0|||
47052741|NCT01831427|83320550|FG001|Overall Study|Withdrew Consent|0|||
47052742|NCT01831427|83320551|FG002|Overall Study|Withdrew Consent|0|||
47052743|NCT01831427|83320552|FG003|Overall Study|Withdrew Consent|0|||
46924782|NCT02865915|83159013|FG001|Overall Study|Adverse Event|4|||
46924783|NCT02865915|83159012|FG000|Overall Study|Lost to Follow-up|0|||
46924784|NCT02865915|83159013|FG001|Overall Study|Lost to Follow-up|1|||
46924785|NCT02865915|83159012|FG000|Overall Study|Protocol Violation|0|||
46924786|NCT02865915|83159013|FG001|Overall Study|Protocol Violation|1|||
47052744|NCT01831427|83320553|FG004|Overall Study|Withdrew Consent|0|||
47052745|NCT01831427|83320554|FG005|Overall Study|Withdrew Consent|0|||
47052746|NCT01831427|83320555|FG006|Overall Study|Withdrew Consent|2|||
47052747|NCT01831427|83320556|FG007|Overall Study|Withdrew Consent|0|||
46805648|NCT00053365|83024645|FG000|Overall Study|Incorrect cell type|1|||
46805649|NCT00053365|83024645|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
46805650|NCT00053365|83024645|FG000|Overall Study|Never treated|4|||
46805651|NCT00387010|83024651|FG000|Dose Titration Period|Adverse Event|12|||
46805652|NCT00387010|83024651|FG000|Dose Titration Period|Lack of Efficacy|5|||
46805653|NCT00387010|83024651|FG000|Dose Titration Period|Withdrawal by Subject|3|||
46805654|NCT00387010|83024651|FG000|Dose Titration Period|Protocol Violation|1|||
46805655|NCT00387010|83024651|FG000|Dose Titration Period|Lost to Follow-up|2|||
46805656|NCT00387010|83024651|FG000|Dose Titration Period|Noncompliance with study medication|8|||
46805657|NCT00387010|83024651|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
46805658|NCT00387010|83024651|FG000|Treatment Period|Adverse Event|4|||
46805659|NCT00387010|83024651|FG000|Treatment Period|Withdrawal by Subject|1|||
46805660|NCT00387010|83024651|FG000|Treatment Period|Noncompliance with study medication|2|||
46805661|NCT00387010|83024651|FG000|Treatment Period|Noncompliance with study procedures|3|||
46805662|NCT00387010|83024651|FG000|Treatment Period|Participant reported study drug stolen|1|||
46805663|NCT00386776|83024655|FG000|Overall Study|Withdrawal by Subject|8|||
46805664|NCT00065065|83024663|FG000|Overall Study|Adverse Event|3|||
46805665|NCT00065065|83024664|FG001|Overall Study|Adverse Event|2|||
46805666|NCT00065065|83024663|FG000|Overall Study|Withdrawal by Subject|1|||
46805667|NCT00065065|83024664|FG001|Overall Study|Withdrawal by Subject|5|||
46805668|NCT00065065|83024663|FG000|Overall Study|Lack of Efficacy|4|||
46805669|NCT00065065|83024664|FG001|Overall Study|Lack of Efficacy|11|||
46805670|NCT00065065|83024663|FG000|Overall Study|Other|2|||
46805671|NCT00065065|83024664|FG001|Overall Study|Other|2|||
46805672|NCT00386308|83024674|FG000|Overall Study|Adverse Event|3|||
46805673|NCT00386308|83024675|FG001|Overall Study|Adverse Event|3|||
46805674|NCT00386308|83024674|FG000|Overall Study|Protocol Violation|2|||
46805675|NCT00386308|83024675|FG001|Overall Study|Protocol Violation|5|||
47052748|NCT01831427|83320557|FG008|Overall Study|Withdrew Consent|0|||
47052749|NCT01831427|83320558|FG009|Overall Study|Withdrew Consent|1|||
46805676|NCT00386308|83024674|FG000|Overall Study|Lack of Efficacy|0|||
46805677|NCT00386308|83024675|FG001|Overall Study|Lack of Efficacy|2|||
46805678|NCT00386308|83024674|FG000|Overall Study|Lost to Follow-up|10|||
46805679|NCT00386308|83024675|FG001|Overall Study|Lost to Follow-up|6|||
46805680|NCT00386308|83024674|FG000|Overall Study|Withdrawal by Subject|6|||
46805681|NCT00386308|83024675|FG001|Overall Study|Withdrawal by Subject|2|||
46805682|NCT00386308|83024674|FG000|Overall Study|Other Event|8|||
46805683|NCT00386308|83024675|FG001|Overall Study|Other Event|1|||
46805684|NCT00064987|83024683|FG000|Overall Study|Physician Decision|3|||
46805685|NCT00064987|83024684|FG001|Overall Study|Physician Decision|0|||
46805686|NCT00374452|83024692|FG000|Overall Study|Left clinic before intervention started|4|||
46805687|NCT00374452|83024693|FG001|Overall Study|Left clinic before intervention started|1|||
46805688|NCT00374452|83024692|FG000|Overall Study|Change in job role before intervention|0|||
46805689|NCT00374452|83024693|FG001|Overall Study|Change in job role before intervention|1|||
46805690|NCT00374452|83024692|FG000|Overall Study|Left clinic after intervention started|1|||
46805691|NCT00374452|83024693|FG001|Overall Study|Left clinic after intervention started|1|||
47052750|NCT01831427|83320559|FG010|Overall Study|Withdrew Consent|1|||
47052751|NCT01830881|83320605|FG000|Overall Study|Changed decision to have an abortion|0|||
47052752|NCT01830881|83320606|FG001|Overall Study|Changed decision to have an abortion|1|||
47052753|NCT01838681|83320642|FG000|Period A|Adverse Event|39|||
47052754|NCT01838681|83320643|FG001|Period A|Adverse Event|0|||
47052755|NCT01838681|83320644|FG002|Period A|Adverse Event|0|||
46805692|NCT00374452|83024692|FG000|Overall Study|Withdrawal by Subject|0|||
46805693|NCT00374452|83024693|FG001|Overall Study|Withdrawal by Subject|2|||
46805694|NCT00064753|83024701|FG000|Overall Study|Death|251|||
46805695|NCT00064753|83024702|FG001|Overall Study|Death|242|||
46805696|NCT00064753|83024701|FG000|Overall Study|Withdrawal by Subject|198|||
46805697|NCT00064753|83024702|FG001|Overall Study|Withdrawal by Subject|171|||
46805698|NCT00064753|83024701|FG000|Overall Study|Lost to Follow-up|225|||
46805699|NCT00064753|83024702|FG001|Overall Study|Lost to Follow-up|235|||
46805700|NCT00374140|83024708|FG000|Overall Study|Lost to Follow-up|1|||
46805701|NCT00374140|83024708|FG000|Overall Study|Protocol Violation|1|||
46805702|NCT00665561|83024714|FG000|Overall Study|Death recorded on subject summary pages|75|||
46805703|NCT00665561|83024715|FG001|Overall Study|Death recorded on subject summary pages|75|||
46805704|NCT00665561|83024714|FG000|Overall Study|Does not meet entrance criteria|19|||
46805705|NCT00665561|83024715|FG001|Overall Study|Does not meet entrance criteria|21|||
46805706|NCT00665561|83024714|FG000|Overall Study|Lost to Follow-up|203|||
46805707|NCT00665561|83024715|FG001|Overall Study|Lost to Follow-up|264|||
46805708|NCT00665561|83024714|FG000|Overall Study|Withdrawal by Subject|74|||
46805709|NCT00665561|83024715|FG001|Overall Study|Withdrawal by Subject|65|||
46805710|NCT00665561|83024714|FG000|Overall Study|Other|123|||
47052756|NCT01838681|83320645|FG003|Period A|Adverse Event|0|||
46805711|NCT00665561|83024715|FG001|Overall Study|Other|108|||
46805712|NCT00665561|83024714|FG000|Overall Study|Site closed|8|||
46924787|NCT02865915|83159012|FG000|Overall Study|Study terminated by sponsor|23|||
47052757|NCT01838681|83320642|FG000|Period A|Lack of Efficacy|21|||
47052758|NCT01838681|83320643|FG001|Period A|Lack of Efficacy|0|||
47052759|NCT01838681|83320644|FG002|Period A|Lack of Efficacy|0|||
47052760|NCT01838681|83320645|FG003|Period A|Lack of Efficacy|0|||
46751620|NCT03434379|82969949|FG002|Global Period|Lost to Follow-up|0|||
46751621|NCT03434379|82969950|FG003|Global Period|Lost to Follow-up|0|||
46751622|NCT03434379|82969947|FG000|Global Period|Death|115|||
46751623|NCT03434379|82969948|FG001|Global Period|Death|228|||
46751624|NCT03434379|82969949|FG002|Global Period|Death|0|||
46751625|NCT03434379|82969950|FG003|Global Period|Death|0|||
47052761|NCT01838681|83320642|FG000|Period A|Early response|148|||
47052762|NCT01838681|83320643|FG001|Period A|Early response|0|||
47052763|NCT01838681|83320644|FG002|Period A|Early response|0|||
47052764|NCT01838681|83320645|FG003|Period A|Early response|0|||
47052765|NCT01838681|83320642|FG000|Period A|Withdrawal by Subject|70|||
47052766|NCT01838681|83320643|FG001|Period A|Withdrawal by Subject|0|||
47052767|NCT01838681|83320644|FG002|Period A|Withdrawal by Subject|0|||
47052768|NCT01838681|83320645|FG003|Period A|Withdrawal by Subject|0|||
46636115|NCT01524900|82809871|FG000|Overall Study|Other reason than stated above|1|||
46751626|NCT03434379|82969947|FG000|Global Period|Withdrawal by Subject|20|||
46751627|NCT03434379|82969948|FG001|Global Period|Withdrawal by Subject|21|||
46751628|NCT03434379|82969949|FG002|Global Period|Withdrawal by Subject|0|||
46751629|NCT03434379|82969950|FG003|Global Period|Withdrawal by Subject|0|||
46751630|NCT03434379|82969947|FG000|Global Period|Reason Unspecified|0|||
46751631|NCT03434379|82969948|FG001|Global Period|Reason Unspecified|1|||
46751632|NCT03434379|82969949|FG002|Global Period|Reason Unspecified|0|||
46751633|NCT03434379|82969950|FG003|Global Period|Reason Unspecified|0|||
46751634|NCT03434379|82969947|FG000|Global Period|Study Ended by Sponsor|26|||
46751635|NCT03434379|82969948|FG001|Global Period|Study Ended by Sponsor|80|||
46751636|NCT03434379|82969949|FG002|Global Period|Study Ended by Sponsor|0|||
46751637|NCT03434379|82969950|FG003|Global Period|Study Ended by Sponsor|0|||
46751638|NCT03434379|82969947|FG000|Global Period|Physician Decision|1|||
46751639|NCT03434379|82969948|FG001|Global Period|Physician Decision|0|||
46751640|NCT03434379|82969949|FG002|Global Period|Physician Decision|0|||
46751641|NCT03434379|82969950|FG003|Global Period|Physician Decision|0|||
46751642|NCT03434379|82969947|FG000|China Extension Period|Lost to Follow-up|0|||
46751643|NCT03434379|82969948|FG001|China Extension Period|Lost to Follow-up|0|||
46751644|NCT03434379|82969949|FG002|China Extension Period|Lost to Follow-up|2|||
46751645|NCT03434379|82969950|FG003|China Extension Period|Lost to Follow-up|3|||
46751646|NCT03434379|82969947|FG000|China Extension Period|Death|0|||
46751647|NCT03434379|82969948|FG001|China Extension Period|Death|0|||
46751648|NCT03434379|82969949|FG002|China Extension Period|Death|46|||
46751649|NCT03434379|82969950|FG003|China Extension Period|Death|88|||
46751650|NCT03434379|82969947|FG000|China Extension Period|Withdrawal by Subject|0|||
46751651|NCT03434379|82969948|FG001|China Extension Period|Withdrawal by Subject|0|||
46751652|NCT03434379|82969949|FG002|China Extension Period|Withdrawal by Subject|8|||
46751653|NCT03434379|82969950|FG003|China Extension Period|Withdrawal by Subject|6|||
46751654|NCT03434379|82969947|FG000|China Extension Period|Study Ended by Sponsor|0|||
46751655|NCT03434379|82969948|FG001|China Extension Period|Study Ended by Sponsor|0|||
46751656|NCT03434379|82969949|FG002|China Extension Period|Study Ended by Sponsor|5|||
46751657|NCT03434379|82969950|FG003|China Extension Period|Study Ended by Sponsor|36|||
46751658|NCT03309046|82969964|FG000|Overall Study|Withdrawal by Subject|4|||
46751659|NCT03309046|82969965|FG001|Overall Study|Withdrawal by Subject|17|||
46751660|NCT03228186|82969971|FG000|Overall Study|Patient never started treatment|1|||
46751661|NCT02869633|82969977|FG000|Overall Study|Death|2|||
46805713|NCT00665561|83024715|FG001|Overall Study|Site closed|0|||
46805714|NCT00665561|83024714|FG000|Overall Study|Withdrawn due to pregnancy|0|||
46805715|NCT00665561|83024715|FG001|Overall Study|Withdrawn due to pregnancy|1|||
46805716|NCT00663923|83024721|FG000|Overall Study|Lost to Follow-up|2|||
46805717|NCT00386152|83024730|FG000|Overall Study|Adverse Event|6|||
46805718|NCT00386152|83024731|FG001|Overall Study|Adverse Event|5|||
46805719|NCT00386152|83024732|FG002|Overall Study|Adverse Event|4|||
46805720|NCT00386152|83024730|FG000|Overall Study|Chang from original chemo stratification|4|||
46805721|NCT00386152|83024731|FG001|Overall Study|Chang from original chemo stratification|5|||
46805722|NCT00386152|83024732|FG002|Overall Study|Chang from original chemo stratification|6|||
46805723|NCT00386152|83024730|FG000|Overall Study|Death|3|||
46805724|NCT00386152|83024731|FG001|Overall Study|Death|0|||
46805725|NCT00386152|83024732|FG002|Overall Study|Death|1|||
46636116|NCT01524900|82809872|FG001|Overall Study|Other reason than stated above|1|||
46751662|NCT02869633|82969978|FG001|Overall Study|Death|1|||
46751663|NCT02869633|82969977|FG000|Overall Study|Patient refused follow-up|1|||
46805726|NCT00386152|83024730|FG000|Overall Study|Disease progression|7|||
46924788|NCT02865915|83159013|FG001|Overall Study|Study terminated by sponsor|18|||
46751664|NCT02869633|82969978|FG001|Overall Study|Patient refused follow-up|0|||
46751665|NCT02869633|82969977|FG000|Overall Study|Provider discretion|1|||
47052769|NCT01838681|83320642|FG000|Period A|Protocol Violation|16|||
46924789|NCT02865915|83159012|FG000|Overall Study|Dosing group discontinued|0|||
46924790|NCT02865915|83159013|FG001|Overall Study|Dosing group discontinued|5|||
46805727|NCT00386152|83024731|FG001|Overall Study|Disease progression|4|||
46805728|NCT00386152|83024732|FG002|Overall Study|Disease progression|5|||
46805729|NCT00386152|83024730|FG000|Overall Study|Physician Decision|13|||
46805730|NCT00386152|83024731|FG001|Overall Study|Physician Decision|10|||
46805731|NCT00386152|83024732|FG002|Overall Study|Physician Decision|4|||
46924791|NCT00354835|83159021|FG000|Overall Study|Death|1|||
47052770|NCT01838681|83320643|FG001|Period A|Protocol Violation|0|||
47052771|NCT01838681|83320644|FG002|Period A|Protocol Violation|0|||
47052772|NCT01838681|83320645|FG003|Period A|Protocol Violation|0|||
47052773|NCT01838681|83320642|FG000|Period A|Non-compliance with IMP|6|||
47052774|NCT01838681|83320643|FG001|Period A|Non-compliance with IMP|0|||
47052775|NCT01838681|83320644|FG002|Period A|Non-compliance with IMP|0|||
47052776|NCT01838681|83320645|FG003|Period A|Non-compliance with IMP|0|||
47052777|NCT01838681|83320642|FG000|Period A|Lost to Follow-up|4|||
47052778|NCT01838681|83320643|FG001|Period A|Lost to Follow-up|0|||
47052779|NCT01838681|83320644|FG002|Period A|Lost to Follow-up|0|||
47052780|NCT01838681|83320645|FG003|Period A|Lost to Follow-up|0|||
47052781|NCT01838681|83320642|FG000|Period A|Withdrawal before treatment|4|||
47052782|NCT01838681|83320643|FG001|Period A|Withdrawal before treatment|0|||
46751666|NCT02869633|82969978|FG001|Overall Study|Provider discretion|0|||
46751667|NCT02869633|82969977|FG000|Overall Study|Investigator decision|1|||
46751668|NCT02869633|82969978|FG001|Overall Study|Investigator decision|0|||
47052783|NCT01838681|83320644|FG002|Period A|Withdrawal before treatment|0|||
47052784|NCT01838681|83320645|FG003|Period A|Withdrawal before treatment|0|||
47052785|NCT01838681|83320642|FG000|Period A|Administrative or other reasons|17|||
47052786|NCT01838681|83320643|FG001|Period A|Administrative or other reasons|0|||
46751669|NCT02869633|82969977|FG000|Overall Study|Lost to Follow-up|0|||
46751670|NCT02869633|82969978|FG001|Overall Study|Lost to Follow-up|1|||
46751671|NCT02869633|82969977|FG000|Overall Study|Not eligible|6|||
46751672|NCT02869633|82969978|FG001|Overall Study|Not eligible|1|||
46751673|NCT02869633|82969977|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
46751674|NCT02869633|82969978|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
46751675|NCT02869633|82969977|FG000|Overall Study|Withdrawal by Subject|0|||
46751676|NCT02869633|82969978|FG001|Overall Study|Withdrawal by Subject|1|||
46805732|NCT00386152|83024730|FG000|Overall Study|Lost to Follow-up|1|||
46924792|NCT00354835|83159022|FG001|Overall Study|Death|1|||
46805733|NCT00386152|83024731|FG001|Overall Study|Lost to Follow-up|0|||
46924793|NCT00354835|83159021|FG000|Overall Study|Physician Decision|8|||
47052787|NCT01838681|83320644|FG002|Period A|Administrative or other reasons|0|||
47052788|NCT01838681|83320645|FG003|Period A|Administrative or other reasons|0|||
47052789|NCT01838681|83320642|FG000|Period B/A+|Adverse Event|0|||
46751677|NCT02855268|82969988|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
46805734|NCT00386152|83024732|FG002|Overall Study|Lost to Follow-up|0|||
47052790|NCT01838681|83320643|FG001|Period B/A+|Adverse Event|13|||
46751678|NCT02855268|82969989|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
46751679|NCT02855268|82969988|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
46751680|NCT02855268|82969989|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
46751681|NCT02855268|82969988|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
46751682|NCT02855268|82969989|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
46751683|NCT02855268|82969988|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
46751684|NCT02855268|82969989|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
46751685|NCT02855268|82969988|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
46751686|NCT02855268|82969989|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
46805735|NCT00386152|83024730|FG000|Overall Study|Completed chemotherapy|4|||
46805736|NCT00386152|83024731|FG001|Overall Study|Completed chemotherapy|5|||
46805737|NCT00386152|83024732|FG002|Overall Study|Completed chemotherapy|1|||
46805738|NCT00386152|83024730|FG000|Overall Study|Protocol Violation|3|||
46805739|NCT00386152|83024731|FG001|Overall Study|Protocol Violation|5|||
46805740|NCT00386152|83024732|FG002|Overall Study|Protocol Violation|2|||
46805741|NCT00386152|83024730|FG000|Overall Study|Withdrawal by Subject|3|||
46805742|NCT00386152|83024731|FG001|Overall Study|Withdrawal by Subject|6|||
46805743|NCT00386152|83024732|FG002|Overall Study|Withdrawal by Subject|10|||
47052791|NCT01838681|83320644|FG002|Period B/A+|Adverse Event|27|||
47052792|NCT01838681|83320645|FG003|Period B/A+|Adverse Event|16|||
47052793|NCT01838681|83320642|FG000|Period B/A+|Lack of Efficacy|0|||
47052794|NCT01838681|83320643|FG001|Period B/A+|Lack of Efficacy|9|||
47052795|NCT01838681|83320644|FG002|Period B/A+|Lack of Efficacy|11|||
47052796|NCT01838681|83320645|FG003|Period B/A+|Lack of Efficacy|6|||
47052797|NCT01838681|83320642|FG000|Period B/A+|Withdrawal by Subject|0|||
47052798|NCT01838681|83320643|FG001|Period B/A+|Withdrawal by Subject|28|||
47052799|NCT01838681|83320644|FG002|Period B/A+|Withdrawal by Subject|35|||
47052800|NCT01838681|83320645|FG003|Period B/A+|Withdrawal by Subject|47|||
47052801|NCT01838681|83320642|FG000|Period B/A+|Protocol Violation|0|||
47052802|NCT01838681|83320643|FG001|Period B/A+|Protocol Violation|1|||
47052803|NCT01838681|83320644|FG002|Period B/A+|Protocol Violation|4|||
47052804|NCT01838681|83320645|FG003|Period B/A+|Protocol Violation|6|||
47052805|NCT01838681|83320642|FG000|Period B/A+|Non-compliance with IMP|0|||
47052806|NCT01838681|83320643|FG001|Period B/A+|Non-compliance with IMP|2|||
46636117|NCT01524900|82809873|FG002|Overall Study|Other reason than stated above|0|||
46751687|NCT02855268|82969988|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
46805744|NCT00385918|83024742|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
46924794|NCT00354835|83159022|FG001|Overall Study|Physician Decision|13|||
47052807|NCT01838681|83320644|FG002|Period B/A+|Non-compliance with IMP|3|||
47052808|NCT01838681|83320645|FG003|Period B/A+|Non-compliance with IMP|3|||
47052809|NCT01838681|83320642|FG000|Period B/A+|Lost to Follow-up|0|||
46751688|NCT02855268|82969989|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
46751689|NCT02840721|82970004|FG000|Treatment Period|Adverse Event|1|||
46751690|NCT02840721|82970004|FG000|Follow-Up|Lack of Efficacy|1|||
46751691|NCT02840721|82970004|FG000|Follow-Up|Withdrawal by Subject|4|||
46751692|NCT02840721|82970004|FG000|Follow-Up|Withdrawal of Consent|2|||
46751693|NCT02777593|82970013|FG000|Overall Study|Still in study|28|||
46751694|NCT02777593|82970014|FG001|Overall Study|Still in study|71|||
46805745|NCT00385918|83024743|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
46805746|NCT00385918|83024744|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
46805747|NCT00385918|83024742|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
46924795|NCT00354835|83159021|FG000|Overall Study|Withdrawal by Subject|2|||
46924796|NCT00354835|83159022|FG001|Overall Study|Withdrawal by Subject|1|||
46924797|NCT00354835|83159021|FG000|Overall Study|Ineligible|17|||
46924798|NCT00354835|83159022|FG001|Overall Study|Ineligible|16|||
46924799|NCT00354835|83159021|FG000|Overall Study|Disease progression or relapse|15|||
46924800|NCT00354835|83159022|FG001|Overall Study|Disease progression or relapse|22|||
46924801|NCT00354835|83159021|FG000|Overall Study|Adverse Event|6|||
46924802|NCT00354835|83159022|FG001|Overall Study|Adverse Event|0|||
46924803|NCT00354835|83159021|FG000|Overall Study|Refusal of further therapy|3|||
46924804|NCT00354835|83159022|FG001|Overall Study|Refusal of further therapy|8|||
46924805|NCT02768298|83159045|FG000|Overall Study|Adverse Event|1|||
46924806|NCT02768298|83159046|FG001|Overall Study|Adverse Event|4|||
46924807|NCT02768298|83159045|FG000|Overall Study|Death|2|||
46924808|NCT02768298|83159046|FG001|Overall Study|Death|1|||
46924809|NCT02768298|83159045|FG000|Overall Study|Non-compliance with study treatment|0|||
46924810|NCT02768298|83159046|FG001|Overall Study|Non-compliance with study treatment|1|||
46924811|NCT02768298|83159045|FG000|Overall Study|Subject/guardian decision|1|||
46924812|NCT02768298|83159046|FG001|Overall Study|Subject/guardian decision|0|||
46924813|NCT02768298|83159045|FG000|Overall Study|Withdrawal of informed consent|0|||
46924814|NCT02768298|83159046|FG001|Overall Study|Withdrawal of informed consent|1|||
46924815|NCT02775864|83159056|FG000|Overall Study|Data ended end of 2010|1764|||
46924816|NCT02775864|83159057|FG001|Overall Study|Data ended end of 2010|2880|||
46751695|NCT02777593|82970015|FG002|Overall Study|Still in study|5|||
46751696|NCT02777593|82970016|FG003|Overall Study|Still in study|6|||
46751697|NCT02777593|82970017|FG004|Overall Study|Still in study|6|||
46751698|NCT02777593|82970013|FG000|Overall Study|Death|19|||
46751699|NCT02777593|82970014|FG001|Overall Study|Death|24|||
46751700|NCT02777593|82970015|FG002|Overall Study|Death|0|||
46751701|NCT02777593|82970016|FG003|Overall Study|Death|5|||
46751702|NCT02777593|82970017|FG004|Overall Study|Death|0|||
46751703|NCT02777593|82970013|FG000|Overall Study|Withdrawal by Subject|6|||
46751704|NCT02777593|82970014|FG001|Overall Study|Withdrawal by Subject|3|||
46751705|NCT02777593|82970015|FG002|Overall Study|Withdrawal by Subject|1|||
46751706|NCT02777593|82970016|FG003|Overall Study|Withdrawal by Subject|1|||
46751707|NCT02777593|82970017|FG004|Overall Study|Withdrawal by Subject|0|||
46751708|NCT02777593|82970013|FG000|Overall Study|Lost to Follow-up|4|||
46751709|NCT02777593|82970014|FG001|Overall Study|Lost to Follow-up|12|||
46751710|NCT02777593|82970015|FG002|Overall Study|Lost to Follow-up|4|||
46751711|NCT02777593|82970016|FG003|Overall Study|Lost to Follow-up|0|||
46751712|NCT02777593|82970017|FG004|Overall Study|Lost to Follow-up|0|||
46751713|NCT02777593|82970013|FG000|Overall Study|Physician Decision|2|||
46805748|NCT00385918|83024743|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
46805749|NCT00385918|83024744|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
46805750|NCT00385918|83024742|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
46805751|NCT00385918|83024743|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
46805752|NCT00385918|83024744|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
46805753|NCT00385918|83024742|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
46805754|NCT00385918|83024743|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
46805755|NCT00385918|83024744|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
46805756|NCT00385918|83024742|FG000|Intervention Phase After Randomization|Physician Decision|1|||
46924817|NCT02775864|83159058|FG002|Overall Study|Data ended end of 2010|1140|||
46924818|NCT02775864|83159059|FG003|Overall Study|Data ended end of 2010|1194|||
46924819|NCT02775864|83159056|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
46924820|NCT02775864|83159057|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
46924821|NCT02775864|83159058|FG002|Overall Study|Medicaid eligibility discontinued|720|||
46751714|NCT02777593|82970014|FG001|Overall Study|Physician Decision|2|||
46751715|NCT02777593|82970015|FG002|Overall Study|Physician Decision|0|||
46751716|NCT02777593|82970016|FG003|Overall Study|Physician Decision|0|||
46751717|NCT02777593|82970017|FG004|Overall Study|Physician Decision|0|||
46751718|NCT02777593|82970013|FG000|Overall Study|Discontinued due to Other|3|||
46751719|NCT02777593|82970014|FG001|Overall Study|Discontinued due to Other|0|||
46751720|NCT02777593|82970015|FG002|Overall Study|Discontinued due to Other|0|||
46751721|NCT02777593|82970016|FG003|Overall Study|Discontinued due to Other|0|||
46751722|NCT02777593|82970017|FG004|Overall Study|Discontinued due to Other|0|||
46805757|NCT00385918|83024743|FG001|Intervention Phase After Randomization|Physician Decision|0|||
46805758|NCT00385918|83024744|FG002|Intervention Phase After Randomization|Physician Decision|0|||
46805759|NCT00385918|83024742|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
46805760|NCT00385918|83024743|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
46805761|NCT00385918|83024744|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
46805762|NCT00385840|83024753|FG000|Overall Study|Adverse Event|1|||
46805763|NCT00385840|83024754|FG001|Overall Study|Adverse Event|1|||
46805764|NCT00385840|83024753|FG000|Overall Study|Lost to Follow-up|3|||
46805765|NCT00385840|83024754|FG001|Overall Study|Lost to Follow-up|13|||
46805766|NCT00385762|83024760|FG000|Overall Study|Adverse Event|1|||
46805767|NCT00385762|83024760|FG000|Overall Study|Lost to Follow-up|1|||
46805768|NCT00385684|83024764|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
46805769|NCT00385684|83024765|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
46805770|NCT00385684|83024764|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
46805771|NCT00385684|83024765|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
46805772|NCT00385684|83024764|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
46805773|NCT00385684|83024765|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
46805774|NCT00661661|83024773|FG000|Overall Study|Adverse Event|99|||
46924822|NCT02775864|83159059|FG003|Overall Study|Medicaid eligibility discontinued|890|||
46924823|NCT02964273|83159072|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
46924824|NCT02964273|83159073|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
46924825|NCT02964273|83159074|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
46924826|NCT02964273|83159075|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
46924827|NCT02964273|83159072|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
46924828|NCT02964273|83159073|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
46924829|NCT02964273|83159074|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
46805775|NCT00661661|83024774|FG001|Overall Study|Adverse Event|24|||
46805776|NCT00661661|83024773|FG000|Overall Study|Lack of Efficacy|3|||
46805777|NCT00661661|83024774|FG001|Overall Study|Lack of Efficacy|2|||
46805778|NCT00661661|83024773|FG000|Overall Study|Lost to Follow-up|0|||
46805779|NCT00661661|83024774|FG001|Overall Study|Lost to Follow-up|1|||
46805780|NCT00661661|83024773|FG000|Overall Study|Withdrawal by Subject|15|||
46805781|NCT00661661|83024774|FG001|Overall Study|Withdrawal by Subject|5|||
46805782|NCT00661661|83024773|FG000|Overall Study|Other|22|||
46805783|NCT00661661|83024774|FG001|Overall Study|Other|7|||
46805784|NCT00661661|83024773|FG000|Overall Study|Not assigned treatment|1|||
46805785|NCT00661661|83024774|FG001|Overall Study|Not assigned treatment|0|||
46805786|NCT00038467|83024784|FG000|Overall Study|Adverse Event|170|||
46805787|NCT00038467|83024785|FG001|Overall Study|Adverse Event|145|||
46805788|NCT00038467|83024784|FG000|Overall Study|Withdrawal by Subject|150|||
46805789|NCT00038467|83024785|FG001|Overall Study|Withdrawal by Subject|107|||
46805790|NCT00038467|83024784|FG000|Overall Study|Protocol Violation|19|||
46805791|NCT00038467|83024785|FG001|Overall Study|Protocol Violation|22|||
46805792|NCT00038467|83024784|FG000|Overall Study|Death|22|||
46805793|NCT00038467|83024785|FG001|Overall Study|Death|16|||
46805794|NCT00038467|83024784|FG000|Overall Study|Lost to Follow-up|15|||
46805795|NCT00038467|83024785|FG001|Overall Study|Lost to Follow-up|10|||
46805796|NCT00038467|83024784|FG000|Overall Study|Recurrence|109|||
46805797|NCT00038467|83024785|FG001|Overall Study|Recurrence|179|||
46924830|NCT02964273|83159075|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
46924831|NCT02964273|83159072|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
46924832|NCT02964273|83159073|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
46924833|NCT02964273|83159074|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
46924834|NCT02964273|83159075|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
46924835|NCT02964273|83159072|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
46924836|NCT02964273|83159073|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
46924837|NCT02964273|83159074|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
46924838|NCT02964273|83159075|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
46924839|NCT02964273|83159072|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
46924840|NCT02964273|83159073|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
46924841|NCT02964273|83159074|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
46924842|NCT02964273|83159075|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
46924843|NCT02964273|83159072|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
46924844|NCT02964273|83159073|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
46924845|NCT02964273|83159074|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
46636118|NCT01524900|82809874|FG003|Overall Study|Other reason than stated above|0|||
46805798|NCT00038467|83024784|FG000|Overall Study|Randomized, but not treated|31|||
46805799|NCT00038467|83024785|FG001|Overall Study|Randomized, but not treated|35|||
46805800|NCT00038467|83024784|FG000|Overall Study|Other|26|||
46805801|NCT00038467|83024785|FG001|Overall Study|Other|28|||
46805802|NCT00051025|83024793|FG000|Overall Study|Progressive Disease|1|||
47052810|NCT01838681|83320643|FG001|Period B/A+|Lost to Follow-up|2|||
46805803|NCT00051025|83024794|FG001|Overall Study|Progressive Disease|1|||
46805804|NCT00051025|83024793|FG000|Overall Study|Adverse Event|1|||
46805805|NCT00051025|83024794|FG001|Overall Study|Adverse Event|1|||
46805806|NCT00051025|83024793|FG000|Overall Study|Withdrawal by Subject|0|||
46805807|NCT00051025|83024794|FG001|Overall Study|Withdrawal by Subject|1|||
46805808|NCT00051025|83024793|FG000|Overall Study|Death|0|||
46805809|NCT00051025|83024794|FG001|Overall Study|Death|1|||
46805810|NCT00660179|83024803|FG000|Overall Study|Death|44|||
46751723|NCT02701283|82970032|FG000|Overall Study|Death|25|||
46751724|NCT02701283|82970033|FG001|Overall Study|Death|29|||
46751725|NCT02701283|82970034|FG002|Overall Study|Death|19|||
46751726|NCT02701283|82970032|FG000|Overall Study|Lost to Follow-up|3|||
46751727|NCT02701283|82970033|FG001|Overall Study|Lost to Follow-up|8|||
46751728|NCT02701283|82970034|FG002|Overall Study|Lost to Follow-up|1|||
46751729|NCT02701283|82970032|FG000|Overall Study|Withdrawal by Subject|12|||
46751730|NCT02701283|82970033|FG001|Overall Study|Withdrawal by Subject|41|||
46751731|NCT02701283|82970034|FG002|Overall Study|Withdrawal by Subject|1|||
46751732|NCT02701283|82970032|FG000|Overall Study|Missed 2-year visit|22|||
46751733|NCT02701283|82970033|FG001|Overall Study|Missed 2-year visit|27|||
46751734|NCT02701283|82970034|FG002|Overall Study|Missed 2-year visit|0|||
47052811|NCT01838681|83320644|FG002|Period B/A+|Lost to Follow-up|5|||
47052812|NCT01838681|83320645|FG003|Period B/A+|Lost to Follow-up|11|||
47052813|NCT01838681|83320642|FG000|Period B/A+|Withdrawal before treatment|0|||
47052814|NCT01838681|83320643|FG001|Period B/A+|Withdrawal before treatment|1|||
46751735|NCT02701283|82970032|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
46751736|NCT02701283|82970033|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
46751737|NCT02701283|82970034|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
46751738|NCT02399085|82970054|FG000|Overall Study|Adverse Event|16|||
46751739|NCT02399085|82970054|FG000|Overall Study|Death|2|||
46751740|NCT02399085|82970054|FG000|Overall Study|Withdrawal by Subject|8|||
46751741|NCT02399085|82970054|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
46751742|NCT02399085|82970054|FG000|Overall Study|Physician Decision|5|||
46751743|NCT00891371|82970060|FG000|Pre-assignment|Inclusion/exclusion|5|||
46751744|NCT00891371|82970060|FG000|Pre-assignment|Consent withdrawal|1|||
46751745|NCT00891371|82970060|FG000|Treatment|Lack of Efficacy|5|||
46751746|NCT00891371|82970060|FG000|Treatment|Adverse Event|2|||
46751747|NCT00891371|82970060|FG000|Treatment|Death|1|||
46751748|NCT00891371|82970060|FG000|Treatment|Lost to Follow-up|1|||
46751749|NCT00891293|82970064|FG000|Overall Study|Adverse Event|2|||
46751750|NCT00891293|82970064|FG000|Overall Study|Protocol Violation|2|||
46751751|NCT00891293|82970064|FG000|Overall Study|Laboratory abnormality|4|||
46751752|NCT00891293|82970064|FG000|Overall Study|Lost to Follow-up|7|||
46751753|NCT00891293|82970064|FG000|Overall Study|Subject withdrew consent|7|||
46751754|NCT00891293|82970064|FG000|Overall Study|Sponsor termination|62|||
47052815|NCT01838681|83320644|FG002|Period B/A+|Withdrawal before treatment|0|||
47052816|NCT01838681|83320645|FG003|Period B/A+|Withdrawal before treatment|0|||
47052817|NCT01838681|83320642|FG000|Period B/A+|Administrative or other reasons|0|||
47052818|NCT01838681|83320643|FG001|Period B/A+|Administrative or other reasons|6|||
46751755|NCT00889421|82970068|FG000|Overall Study|Lack of Efficacy|3|||
46751756|NCT00889265|82970072|FG000|Overall Study|Adverse Event|1|||
46751757|NCT00889265|82970072|FG000|Overall Study|Lost to Follow-up|5|||
46751758|NCT00889265|82970072|FG000|Overall Study|Protocol Violation|1|||
46751759|NCT00603746|82970082|FG000|Overall Study|Adverse Event|2|||
46751760|NCT00603746|82970083|FG001|Overall Study|Adverse Event|3|||
46751761|NCT00603746|82970084|FG002|Overall Study|Adverse Event|0|||
46751762|NCT00603746|82970085|FG003|Overall Study|Adverse Event|1|||
46751763|NCT00603746|82970086|FG004|Overall Study|Adverse Event|0|||
46805811|NCT00660179|83024804|FG001|Overall Study|Death|47|||
46805812|NCT00660179|83024805|FG002|Overall Study|Death|34|||
46805813|NCT00660179|83024803|FG000|Overall Study|Withdrawal of consent|4|||
47052819|NCT01838681|83320644|FG002|Period B/A+|Administrative or other reasons|10|||
47052820|NCT01838681|83320645|FG003|Period B/A+|Administrative or other reasons|28|||
46751764|NCT00603746|82970087|FG005|Overall Study|Adverse Event|4|||
46751765|NCT00603746|82970082|FG000|Overall Study|Lack of Efficacy|34|||
46751766|NCT00603746|82970083|FG001|Overall Study|Lack of Efficacy|11|||
46751767|NCT00603746|82970084|FG002|Overall Study|Lack of Efficacy|6|||
46751768|NCT00603746|82970085|FG003|Overall Study|Lack of Efficacy|11|||
46751769|NCT00603746|82970086|FG004|Overall Study|Lack of Efficacy|12|||
46751770|NCT00603746|82970087|FG005|Overall Study|Lack of Efficacy|8|||
46751771|NCT00603746|82970082|FG000|Overall Study|Protocol Violation|0|||
46751772|NCT00603746|82970083|FG001|Overall Study|Protocol Violation|3|||
46751773|NCT00603746|82970084|FG002|Overall Study|Protocol Violation|1|||
46805814|NCT00660179|83024804|FG001|Overall Study|Withdrawal of consent|6|||
46751774|NCT00603746|82970085|FG003|Overall Study|Protocol Violation|0|||
46751775|NCT00603746|82970086|FG004|Overall Study|Protocol Violation|1|||
46751776|NCT00603746|82970087|FG005|Overall Study|Protocol Violation|0|||
46751777|NCT00603746|82970082|FG000|Overall Study|Lost to Follow-up|0|||
46751778|NCT00603746|82970083|FG001|Overall Study|Lost to Follow-up|1|||
46751779|NCT00603746|82970084|FG002|Overall Study|Lost to Follow-up|1|||
46751780|NCT00603746|82970085|FG003|Overall Study|Lost to Follow-up|0|||
46751781|NCT00603746|82970086|FG004|Overall Study|Lost to Follow-up|0|||
46751782|NCT00603746|82970087|FG005|Overall Study|Lost to Follow-up|0|||
46751783|NCT00603746|82970082|FG000|Overall Study|Physician Decision|1|||
46751784|NCT00603746|82970083|FG001|Overall Study|Physician Decision|0|||
46751785|NCT00603746|82970084|FG002|Overall Study|Physician Decision|0|||
46751786|NCT00603746|82970085|FG003|Overall Study|Physician Decision|0|||
46751787|NCT00603746|82970086|FG004|Overall Study|Physician Decision|1|||
46751788|NCT00603746|82970087|FG005|Overall Study|Physician Decision|0|||
46805815|NCT00660179|83024805|FG002|Overall Study|Withdrawal of consent|4|||
46805816|NCT00660179|83024803|FG000|Overall Study|Lost to Follow-up|7|||
46805817|NCT00660179|83024804|FG001|Overall Study|Lost to Follow-up|5|||
46805818|NCT00660179|83024805|FG002|Overall Study|Lost to Follow-up|2|||
46805819|NCT00660179|83024803|FG000|Overall Study|Administrative reason|0|||
46805820|NCT00660179|83024804|FG001|Overall Study|Administrative reason|0|||
46805821|NCT00660179|83024805|FG002|Overall Study|Administrative reason|1|||
46805822|NCT00660179|83024803|FG000|Overall Study|Incorrect randomization|1|||
46805823|NCT00660179|83024804|FG001|Overall Study|Incorrect randomization|0|||
46805824|NCT00660179|83024805|FG002|Overall Study|Incorrect randomization|0|||
46805825|NCT00050167|83024815|FG000|Overall Study|not eligible not invasive|1|||
46805826|NCT00050167|83024816|FG001|Overall Study|not eligible not invasive|1|||
46805827|NCT00660023|83024822|FG000|Overall Study|Adverse Event|2|||
46805828|NCT00660023|83024822|FG000|Overall Study|Death|8|||
46805829|NCT00660023|83024822|FG000|Overall Study|Blood Transfusion|5|||
46805830|NCT00660023|83024822|FG000|Overall Study|Renal Transplantation|3|||
46924846|NCT02964273|83159075|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
46924847|NCT02773446|83159094|FG000|First Admission|Withdrawal by Subject|0|||
46924848|NCT02773446|83159095|FG001|First Admission|Withdrawal by Subject|0|||
46805831|NCT00660023|83024822|FG000|Overall Study|Withdrawal by Subject|1|||
46805832|NCT00660023|83024822|FG000|Overall Study|Missed Pregnancy Test|1|||
46924849|NCT02773446|83159096|FG002|First Admission|Withdrawal by Subject|0|||
46924850|NCT02773446|83159097|FG003|First Admission|Withdrawal by Subject|1|||
46924851|NCT02773446|83159098|FG004|First Admission|Withdrawal by Subject|0|||
46805833|NCT00660023|83024822|FG000|Overall Study|Other Screening Failure|9|||
46805834|NCT00062647|83024828|FG000|Overall Study|Death|2|||
46805835|NCT00062647|83024829|FG001|Overall Study|Death|2|||
46805836|NCT00062647|83024828|FG000|Overall Study|Adverse Event|1|||
46805837|NCT00062647|83024829|FG001|Overall Study|Adverse Event|1|||
46805838|NCT00062647|83024828|FG000|Overall Study|Withdrawal by Subject|2|||
46805839|NCT00062647|83024829|FG001|Overall Study|Withdrawal by Subject|1|||
46805840|NCT00062647|83024828|FG000|Overall Study|Protocol Violation|1|||
46805841|NCT00062647|83024829|FG001|Overall Study|Protocol Violation|0|||
46805842|NCT00062647|83024828|FG000|Overall Study|Lost to Follow-up|1|||
46805843|NCT00062647|83024829|FG001|Overall Study|Lost to Follow-up|2|||
46805844|NCT00062647|83024828|FG000|Overall Study|Failed continuation criteria|4|||
47052821|NCT01611857|83320703|FG000|Overall Study|Withdrawal by Subject|0|||
47052822|NCT01611857|83320704|FG001|Overall Study|Withdrawal by Subject|2|||
47052823|NCT01829477|83320727|FG000|Overall Study|Study Terminated by Sponsor|15|||
47052824|NCT01829477|83320728|FG001|Overall Study|Study Terminated by Sponsor|15|||
47052825|NCT01829477|83320727|FG000|Overall Study|Withdrawal by Subject|1|||
47052826|NCT01829477|83320728|FG001|Overall Study|Withdrawal by Subject|0|||
47052827|NCT01611155|83320744|FG000|Overall Study|Adverse Event|1|||
47052828|NCT01611155|83320745|FG001|Overall Study|Adverse Event|1|||
46636119|NCT01524900|82809875|FG004|Overall Study|Other reason than stated above|0|||
46751789|NCT00603746|82970082|FG000|Overall Study|Withdrawal by Subject|1|||
46751790|NCT00603746|82970083|FG001|Overall Study|Withdrawal by Subject|0|||
46805845|NCT00062647|83024829|FG001|Overall Study|Failed continuation criteria|2|||
46805846|NCT00062647|83024828|FG000|Overall Study|Other|4|||
46805847|NCT00062647|83024829|FG001|Overall Study|Other|4|||
46805848|NCT00062647|83024828|FG000|Overall Study|Never received study treatment|1|||
46805849|NCT00062647|83024829|FG001|Overall Study|Never received study treatment|1|||
46805850|NCT00570323|83024837|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
46805851|NCT00570323|83024838|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
46924852|NCT02773446|83159099|FG005|First Admission|Withdrawal by Subject|0|||
47052829|NCT01611155|83320744|FG000|Overall Study|Refused further treatment|6|||
46751791|NCT00603746|82970084|FG002|Overall Study|Withdrawal by Subject|0|||
46751792|NCT00603746|82970085|FG003|Overall Study|Withdrawal by Subject|1|||
46751793|NCT00603746|82970086|FG004|Overall Study|Withdrawal by Subject|3|||
46751794|NCT00603746|82970087|FG005|Overall Study|Withdrawal by Subject|1|||
47052830|NCT01611155|83320745|FG001|Overall Study|Refused further treatment|4|||
46751795|NCT00888329|82970103|FG000|Overall Study|Physician Decision|6|||
46924853|NCT02773446|83159094|FG000|First Admission|Lost to Follow-up|1|||
46924854|NCT02773446|83159095|FG001|First Admission|Lost to Follow-up|0|||
46924855|NCT02773446|83159096|FG002|First Admission|Lost to Follow-up|0|||
46924856|NCT02773446|83159097|FG003|First Admission|Lost to Follow-up|0|||
46924857|NCT02773446|83159098|FG004|First Admission|Lost to Follow-up|0|||
46924858|NCT02773446|83159099|FG005|First Admission|Lost to Follow-up|0|||
46924859|NCT02773368|83159118|FG000|Overall Study|Lost to Follow-up|4|||
46924860|NCT02773368|83159119|FG001|Overall Study|Lost to Follow-up|1|||
46924861|NCT02773368|83159118|FG000|Overall Study|Withdrawal by Subject|5|||
46924862|NCT02773368|83159119|FG001|Overall Study|Withdrawal by Subject|1|||
46924863|NCT02773368|83159118|FG000|Overall Study|Unclassified|1|||
46924864|NCT02773368|83159119|FG001|Overall Study|Unclassified|1|||
46924865|NCT02773368|83159118|FG000|Overall Study|Missing|0|||
46924866|NCT02773368|83159119|FG001|Overall Study|Missing|1|||
46924867|NCT01336647|83159128|FG000|Overall Study|Lost to Follow-up|4|||
46924868|NCT01336647|83159129|FG001|Overall Study|Lost to Follow-up|1|||
46924869|NCT01336647|83159130|FG002|Overall Study|Lost to Follow-up|3|||
46924870|NCT01336569|83159140|FG000|Overall Study|Lost to Follow-up|4|||
46924871|NCT02772978|83159144|FG000|Overall Study|Withdrawal by Subject|1|||
46924872|NCT02772978|83159145|FG001|Overall Study|Withdrawal by Subject|1|||
46924873|NCT00104052|83159150|FG000|Overall Study|Adverse Event|1|||
46924874|NCT00104052|83159150|FG000|Overall Study|Lack of Efficacy|26|||
46924875|NCT00104052|83159150|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
46924876|NCT02777970|83159157|FG000|Overall Study|Lost to Follow-up|0|||
46636120|NCT01524900|82809871|FG000|Overall Study|No reason documented|2|||
46636121|NCT01524900|82809872|FG001|Overall Study|No reason documented|1|||
46636122|NCT01524900|82809873|FG002|Overall Study|No reason documented|0|||
46636123|NCT01524900|82809874|FG003|Overall Study|No reason documented|1|||
46636124|NCT01524900|82809875|FG004|Overall Study|No reason documented|0|||
46636125|NCT01524198|82809890|FG000|Overall Study|Protocol Violation|8|||
46636126|NCT01524198|82809891|FG001|Overall Study|Protocol Violation|6|||
46636127|NCT01524198|82809890|FG000|Overall Study|Withdrawal by Subject|15|||
46636128|NCT01524198|82809891|FG001|Overall Study|Withdrawal by Subject|10|||
46636129|NCT01523886|82809899|FG000|Overall Study|surgery cancelled|0|||
46636130|NCT01523886|82809900|FG001|Overall Study|surgery cancelled|1|||
46636131|NCT01546038|82809912|FG000|Overall Study|Death|15|||
46636132|NCT01546038|82809913|FG001|Overall Study|Death|6|||
46751796|NCT00888329|82970104|FG001|Overall Study|Physician Decision|9|||
46751797|NCT00603590|82970112|FG000|Overall Study|Did not attend study clinic|39|||
46751798|NCT00603590|82970113|FG001|Overall Study|Did not attend study clinic|30|||
46751799|NCT00603590|82970112|FG000|Overall Study|Refused blood test|5|||
46751800|NCT00603590|82970113|FG001|Overall Study|Refused blood test|1|||
46751801|NCT00603590|82970112|FG000|Overall Study|Patient discontinued study drug|22|||
47052831|NCT01611155|83320744|FG000|Overall Study|Disease progression|1|||
47052832|NCT01611155|83320745|FG001|Overall Study|Disease progression|0|||
46805852|NCT00570323|83024837|FG000|Started Treatment After Randomization|Protocol Violation|1|||
46805853|NCT00570323|83024838|FG001|Started Treatment After Randomization|Protocol Violation|0|||
46805854|NCT00570323|83024837|FG000|Started Treatment After Randomization|Physician Decision|1|||
46805855|NCT00570323|83024838|FG001|Started Treatment After Randomization|Physician Decision|0|||
46805856|NCT00570323|83024837|FG000|Complete Study After Start|Lost to Follow-up|0|||
46805857|NCT00570323|83024838|FG001|Complete Study After Start|Lost to Follow-up|1|||
46751802|NCT00603590|82970113|FG001|Overall Study|Patient discontinued study drug|15|||
46751803|NCT00603590|82970112|FG000|Overall Study|Adverse Event|2|||
46805858|NCT00570323|83024837|FG000|Complete Study After Start|Withdrawal by Subject|2|||
46805859|NCT00570323|83024838|FG001|Complete Study After Start|Withdrawal by Subject|0|||
46805860|NCT00570323|83024837|FG000|Complete Study After Start|Physician Decision|1|||
46805861|NCT00570323|83024838|FG001|Complete Study After Start|Physician Decision|0|||
46805862|NCT00661505|83024846|FG000|Overall Study|Adverse Event|3|||
46805863|NCT00661505|83024846|FG000|Overall Study|Protocol Violation|14|||
46805864|NCT00661505|83024846|FG000|Overall Study|Withdrawal by Subject|8|||
46805865|NCT00661505|83024846|FG000|Overall Study|Lost to Follow-up|3|||
46636133|NCT01546038|82809914|FG002|Overall Study|Death|4|||
46636134|NCT01546038|82809915|FG003|Overall Study|Death|2|||
46636135|NCT01546038|82809916|FG004|Overall Study|Death|9|||
46751804|NCT00603590|82970113|FG001|Overall Study|Adverse Event|0|||
46751805|NCT00603590|82970112|FG000|Overall Study|Lost to Follow-up|8|||
47052833|NCT01611155|83320744|FG000|Overall Study|Withdrawal by Subject|1|||
46636136|NCT01546038|82809917|FG005|Overall Study|Death|3|||
46805866|NCT00661505|83024846|FG000|Overall Study|Other|2|||
46805867|NCT00662909|83024854|FG000|Overall Study|Adverse Event|17|||
46805868|NCT00662909|83024855|FG001|Overall Study|Adverse Event|18|||
46805869|NCT00662909|83024856|FG002|Overall Study|Adverse Event|19|||
46924877|NCT02777970|83159158|FG001|Overall Study|Lost to Follow-up|1|||
46924878|NCT02777970|83159159|FG002|Overall Study|Lost to Follow-up|0|||
46924879|NCT02777970|83159157|FG000|Overall Study|Protocol Violation|1|||
46924880|NCT02777970|83159158|FG001|Overall Study|Protocol Violation|0|||
46636137|NCT01546038|82809918|FG006|Overall Study|Death|46|||
46636138|NCT01546038|82809919|FG007|Overall Study|Death|76|||
46751806|NCT00603590|82970113|FG001|Overall Study|Lost to Follow-up|4|||
46751807|NCT00603590|82970112|FG000|Overall Study|Cardiovascular event|0|||
46805870|NCT00662909|83024854|FG000|Overall Study|Lack of Efficacy|9|||
46805871|NCT00662909|83024855|FG001|Overall Study|Lack of Efficacy|1|||
46805872|NCT00662909|83024856|FG002|Overall Study|Lack of Efficacy|5|||
46924881|NCT02777970|83159159|FG002|Overall Study|Protocol Violation|0|||
46924882|NCT03037489|83159171|FG000|Overall Study|Adverse Event|4|||
46924883|NCT03037489|83159172|FG001|Overall Study|Adverse Event|0|||
46924884|NCT03037489|83159171|FG000|Overall Study|Withdrawal by Subject|3|||
46924885|NCT03037489|83159172|FG001|Overall Study|Withdrawal by Subject|0|||
46924886|NCT01336023|83159181|FG000|Week 0 to Week 26|Adverse Event|8|||
46924887|NCT01336023|83159182|FG001|Week 0 to Week 26|Adverse Event|10|||
46924888|NCT01336023|83159183|FG002|Week 0 to Week 26|Adverse Event|24|||
46924889|NCT01336023|83159181|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
46924890|NCT01336023|83159182|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
46805873|NCT00662909|83024854|FG000|Overall Study|Withdrawal by Subject|29|||
46805874|NCT00662909|83024855|FG001|Overall Study|Withdrawal by Subject|22|||
46805875|NCT00662909|83024856|FG002|Overall Study|Withdrawal by Subject|16|||
46924891|NCT01336023|83159183|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
46924892|NCT01336023|83159181|FG000|Week 0 to Week 26|Protocol Violation|1|||
46924893|NCT01336023|83159182|FG001|Week 0 to Week 26|Protocol Violation|2|||
47052834|NCT01611155|83320745|FG001|Overall Study|Withdrawal by Subject|0|||
47052835|NCT01611155|83320744|FG000|Overall Study|Alternative treatment|0|||
47052836|NCT01611155|83320745|FG001|Overall Study|Alternative treatment|1|||
47052837|NCT01611155|83320744|FG000|Overall Study|Ineligible patient|0|||
46924894|NCT01336023|83159183|FG002|Week 0 to Week 26|Protocol Violation|0|||
46751808|NCT00603590|82970113|FG001|Overall Study|Cardiovascular event|1|||
46751809|NCT00888173|82970119|FG000|Overall Study|Wrong Primary|1|||
46924895|NCT01336023|83159181|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
46924896|NCT01336023|83159182|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
46924897|NCT01336023|83159183|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
46924898|NCT01336023|83159181|FG000|Week 0 to Week 26|Unclassified|5|||
46924899|NCT01336023|83159182|FG001|Week 0 to Week 26|Unclassified|16|||
46924900|NCT01336023|83159183|FG002|Week 0 to Week 26|Unclassified|9|||
46924901|NCT01336023|83159181|FG000|Week 27 to 52|Adverse Event|1|||
46924902|NCT01336023|83159182|FG001|Week 27 to 52|Adverse Event|5|||
46924903|NCT01336023|83159183|FG002|Week 27 to 52|Adverse Event|2|||
46924904|NCT01336023|83159181|FG000|Week 27 to 52|Protocol Violation|0|||
46924905|NCT01336023|83159182|FG001|Week 27 to 52|Protocol Violation|2|||
46924906|NCT01336023|83159183|FG002|Week 27 to 52|Protocol Violation|1|||
46924907|NCT01336023|83159181|FG000|Week 27 to 52|Withdrawal Criteria|14|||
46924908|NCT01336023|83159182|FG001|Week 27 to 52|Withdrawal Criteria|19|||
46924909|NCT01336023|83159183|FG002|Week 27 to 52|Withdrawal Criteria|16|||
46924910|NCT01336023|83159181|FG000|Week 27 to 52|Unclassified|13|||
46924911|NCT01336023|83159182|FG001|Week 27 to 52|Unclassified|18|||
46924912|NCT01336023|83159183|FG002|Week 27 to 52|Unclassified|9|||
46924913|NCT03039283|83159191|FG000|Overall Study|Protocol Violation|2|||
46924914|NCT02863575|83159213|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
46924915|NCT02863575|83159214|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
46924916|NCT02863575|83159215|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
46924917|NCT02863575|83159213|FG000|Overall Study|Withdrawal by Subject|0|||
46924918|NCT02863575|83159214|FG001|Overall Study|Withdrawal by Subject|1|||
46924919|NCT02863575|83159215|FG002|Overall Study|Withdrawal by Subject|1|||
46924920|NCT02863575|83159213|FG000|Overall Study|Adverse Event|0|||
47052838|NCT01611155|83320745|FG001|Overall Study|Ineligible patient|1|||
46751810|NCT00888173|82970119|FG000|Overall Study|Ineligible: required test not done|1|||
46751811|NCT00887549|82970132|FG000|Induction Therapy|Adverse Event|8|||
46751812|NCT00887549|82970132|FG000|Induction Therapy|Physician Decision|1|||
46751813|NCT00887549|82970132|FG000|Induction Therapy|Progressive Disease|13|||
46751814|NCT00887549|82970132|FG000|Induction Therapy|Death due to Study Disease|4|||
46751815|NCT00887549|82970132|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
46751816|NCT00887549|82970132|FG000|Maintenance Therapy|Adverse Event|16|||
46751817|NCT00887549|82970132|FG000|Maintenance Therapy|Physician Decision|1|||
46751818|NCT00887549|82970132|FG000|Maintenance Therapy|Progressive Disease|25|||
46751819|NCT00887549|82970132|FG000|Maintenance Therapy|Death due to adverse event|1|||
46924921|NCT02863575|83159214|FG001|Overall Study|Adverse Event|1|||
46751820|NCT00887315|82970138|FG000|Overall Study|Study termination|7|||
46924922|NCT02863575|83159215|FG002|Overall Study|Adverse Event|0|||
46924923|NCT01227187|83159227|FG000|Overall Study|Physician Decision|0|||
46751821|NCT00887315|82970139|FG001|Overall Study|Study termination|4|||
46751822|NCT03608826|82970145|FG000|Overall Study|Death|3|||
46805876|NCT00662909|83024854|FG000|Overall Study|Lost to Follow-up|2|||
46805877|NCT00662909|83024855|FG001|Overall Study|Lost to Follow-up|9|||
46805878|NCT00662909|83024856|FG002|Overall Study|Lost to Follow-up|3|||
46924924|NCT01227187|83159228|FG001|Overall Study|Physician Decision|0|||
46751823|NCT03608826|82970145|FG000|Overall Study|Heart Transplant|3|||
46924925|NCT01227187|83159229|FG002|Overall Study|Physician Decision|0|||
47052839|NCT01829243|83320760|FG000|First Intervention|Screen Failure|4|||
46751824|NCT03608826|82970145|FG000|Overall Study|Physician Decision|4|||
46924926|NCT01227187|83159230|FG003|Overall Study|Physician Decision|1|||
46924927|NCT02638012|83159251|FG000|Overall Study|Lost to Follow-up|1|||
46924928|NCT00103506|83159257|FG000|Overall Study|Study closed by sponsor|34|||
46924929|NCT00103506|83159258|FG001|Overall Study|Study closed by sponsor|37|||
46924930|NCT00103506|83159257|FG000|Overall Study|Death|257|||
46924931|NCT00103506|83159258|FG001|Overall Study|Death|253|||
46924932|NCT00103506|83159257|FG000|Overall Study|Lost to Follow-up|13|||
46924933|NCT00103506|83159258|FG001|Overall Study|Lost to Follow-up|13|||
46924934|NCT00103506|83159257|FG000|Overall Study|Withdrawal by Subject|18|||
46924935|NCT00103506|83159258|FG001|Overall Study|Withdrawal by Subject|21|||
46924936|NCT02765490|83159266|FG000|Overall Study|Lost to Follow-up|1|||
46924937|NCT02765490|83159267|FG001|Overall Study|Lost to Follow-up|1|||
46924938|NCT02765490|83159266|FG000|Overall Study|Other|0|||
46924939|NCT02765490|83159267|FG001|Overall Study|Other|1|||
46924940|NCT02765490|83159266|FG000|Overall Study|Death|0|||
46924941|NCT02765490|83159267|FG001|Overall Study|Death|1|||
46924942|NCT02639182|83159275|FG000|Overall Study|Disease Progression|50|||
46924943|NCT02639182|83159276|FG001|Overall Study|Disease Progression|49|||
46924944|NCT02639182|83159275|FG000|Overall Study|Adverse Event|7|||
46924945|NCT02639182|83159276|FG001|Overall Study|Adverse Event|5|||
46924946|NCT02639182|83159275|FG000|Overall Study|Physician Decision|3|||
46924947|NCT02639182|83159276|FG001|Overall Study|Physician Decision|3|||
46924948|NCT02639182|83159275|FG000|Overall Study|Withdrew Consent|5|||
46924949|NCT02639182|83159276|FG001|Overall Study|Withdrew Consent|4|||
46924950|NCT02639182|83159275|FG000|Overall Study|Lost to Follow-up|0|||
46924951|NCT02639182|83159276|FG001|Overall Study|Lost to Follow-up|1|||
46924952|NCT02639182|83159275|FG000|Overall Study|Study Closure|1|||
46924953|NCT02639182|83159276|FG001|Overall Study|Study Closure|2|||
46924954|NCT02639182|83159275|FG000|Overall Study|Sponsor Ended Study|0|||
46924955|NCT02639182|83159276|FG001|Overall Study|Sponsor Ended Study|1|||
46924956|NCT02639182|83159275|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
46924957|NCT02639182|83159276|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
46924958|NCT02863419|83159285|FG000|Overall Study|Lost to Follow-up|0|||
46924959|NCT02863419|83159286|FG001|Overall Study|Lost to Follow-up|1|||
46924960|NCT02863419|83159287|FG002|Overall Study|Lost to Follow-up|4|||
46924961|NCT02863419|83159285|FG000|Overall Study|Withdrawal by Subject|5|||
46924962|NCT02863419|83159286|FG001|Overall Study|Withdrawal by Subject|5|||
46924963|NCT02863419|83159287|FG002|Overall Study|Withdrawal by Subject|3|||
46751825|NCT00887159|82970152|FG000|Overall Study|Disease progression|6|||
46924964|NCT02863419|83159285|FG000|Overall Study|Died|3|||
46924965|NCT02863419|83159286|FG001|Overall Study|Died|4|||
46924966|NCT02863419|83159287|FG002|Overall Study|Died|1|||
46924967|NCT02765100|83159297|FG000|Overall Study|subject found ineligible after baseline|1|||
46924968|NCT02765100|83159298|FG001|Overall Study|subject found ineligible after baseline|1|||
46924969|NCT02765100|83159297|FG000|Overall Study|Lost to Follow-up|0|||
46924970|NCT02765100|83159298|FG001|Overall Study|Lost to Follow-up|1|||
46924971|NCT02761980|83159308|FG000|Overall Study|Adverse Event|4|||
46924972|NCT02761980|83159309|FG001|Overall Study|Adverse Event|6|||
46924973|NCT02761980|83159310|FG002|Overall Study|Adverse Event|5|||
46924974|NCT02761980|83159311|FG003|Overall Study|Adverse Event|6|||
46924975|NCT02761980|83159308|FG000|Overall Study|Withdrawal by Subject|0|||
46924976|NCT02761980|83159309|FG001|Overall Study|Withdrawal by Subject|1|||
46924977|NCT02761980|83159310|FG002|Overall Study|Withdrawal by Subject|0|||
46924978|NCT02761980|83159311|FG003|Overall Study|Withdrawal by Subject|0|||
46924979|NCT02761980|83159308|FG000|Overall Study|Other|0|||
46924980|NCT02761980|83159309|FG001|Overall Study|Other|0|||
46924981|NCT02761980|83159310|FG002|Overall Study|Other|1|||
46924982|NCT02761980|83159311|FG003|Overall Study|Other|0|||
46924983|NCT02862171|83159330|FG000|Overall Study|Death|1|||
46924984|NCT02862171|83159330|FG000|Overall Study|Lost to Follow-up|13|||
46924985|NCT02862171|83159330|FG000|Overall Study|Withdrawal by Subject|57|||
46924986|NCT02862171|83159330|FG000|Overall Study|Non-compliance|4|||
46924987|NCT02862171|83159330|FG000|Overall Study|HIV-1 seroconversion|18|||
46924988|NCT02638948|83159338|FG000|Overall Study|Withdrawal by Subject|4|||
46924989|NCT02638948|83159339|FG001|Overall Study|Withdrawal by Subject|5|||
46924990|NCT02638948|83159340|FG002|Overall Study|Withdrawal by Subject|3|||
46924991|NCT02638948|83159341|FG003|Overall Study|Withdrawal by Subject|1|||
46924992|NCT02638948|83159338|FG000|Overall Study|Administrative Reason by Sponsor|0|||
46924993|NCT02638948|83159339|FG001|Overall Study|Administrative Reason by Sponsor|1|||
46924994|NCT02638948|83159340|FG002|Overall Study|Administrative Reason by Sponsor|0|||
46924995|NCT02638948|83159341|FG003|Overall Study|Administrative Reason by Sponsor|4|||
46924996|NCT02638948|83159338|FG000|Overall Study|Adverse Event|0|||
46924997|NCT02638948|83159339|FG001|Overall Study|Adverse Event|0|||
46924998|NCT02638948|83159340|FG002|Overall Study|Adverse Event|1|||
46924999|NCT02638948|83159341|FG003|Overall Study|Adverse Event|1|||
46925000|NCT02638948|83159338|FG000|Overall Study|Lack of Efficacy|1|||
46925001|NCT02638948|83159339|FG001|Overall Study|Lack of Efficacy|1|||
46751826|NCT00887159|82970153|FG001|Overall Study|Disease progression|39|||
47052840|NCT01829243|83320761|FG001|First Intervention|Screen Failure|2|||
47052841|NCT01838447|83320771|FG000|Overall Study|Change in surgical plan|1|||
47052842|NCT01838447|83320772|FG001|Overall Study|Change in surgical plan|2|||
47052843|NCT01838447|83320771|FG000|Overall Study|Withdrawal by Subject|1|||
47052844|NCT01838447|83320772|FG001|Overall Study|Withdrawal by Subject|1|||
47052845|NCT01829165|83320780|FG000|Overall Study|Did not complete intervention|2|||
47052846|NCT01829165|83320781|FG001|Overall Study|Did not complete intervention|0|||
47052847|NCT01838213|83320789|FG000|Overall Study|Ineligible|166|||
47052848|NCT01838213|83320790|FG001|Overall Study|Ineligible|191|||
47052849|NCT01837823|83320796|FG000|Overall Study|Lost to Follow-up|6|||
47052850|NCT01828073|83320806|FG000|Overall Study|Lost to Follow-up|1|||
47052851|NCT01828073|83320807|FG001|Overall Study|Lost to Follow-up|2|||
47052852|NCT03819114|83320827|FG000|Overall Study|Protocol Violation|0|||
47052853|NCT03819114|83320828|FG001|Overall Study|Protocol Violation|1|||
47052854|NCT03819114|83320829|FG002|Overall Study|Protocol Violation|1|||
47052855|NCT03819114|83320830|FG003|Overall Study|Protocol Violation|0|||
47052856|NCT03819114|83320827|FG000|Overall Study|Lost to Follow-up|0|||
47052857|NCT03819114|83320828|FG001|Overall Study|Lost to Follow-up|0|||
47052858|NCT03819114|83320829|FG002|Overall Study|Lost to Follow-up|1|||
47052859|NCT03819114|83320830|FG003|Overall Study|Lost to Follow-up|0|||
47052860|NCT01827839|83320842|FG000|Overall Study|Adverse Event|1|||
47052861|NCT01827839|83320842|FG000|Overall Study|Consent Withdrawal|2|||
47052862|NCT01827371|83320857|FG000|Overall Study|Adverse Event|0|||
47052863|NCT01827371|83320858|FG001|Overall Study|Adverse Event|0|||
47052864|NCT01827371|83320859|FG002|Overall Study|Adverse Event|4|||
47052865|NCT01827371|83320860|FG003|Overall Study|Adverse Event|2|||
47052866|NCT01827371|83320857|FG000|Overall Study|Lost to Follow-up|0|||
47052867|NCT01827371|83320858|FG001|Overall Study|Lost to Follow-up|2|||
47052868|NCT01827371|83320859|FG002|Overall Study|Lost to Follow-up|0|||
47052869|NCT01827371|83320860|FG003|Overall Study|Lost to Follow-up|4|||
47052870|NCT01827371|83320857|FG000|Overall Study|Protocol Violation|1|||
47052871|NCT01827371|83320858|FG001|Overall Study|Protocol Violation|0|||
47052872|NCT01827371|83320859|FG002|Overall Study|Protocol Violation|0|||
47052873|NCT01827371|83320860|FG003|Overall Study|Protocol Violation|0|||
47052874|NCT01827371|83320857|FG000|Overall Study|Withdrawal by Subject|1|||
47052875|NCT01827371|83320858|FG001|Overall Study|Withdrawal by Subject|2|||
47052876|NCT01827371|83320859|FG002|Overall Study|Withdrawal by Subject|2|||
47052877|NCT01827371|83320860|FG003|Overall Study|Withdrawal by Subject|3|||
47052878|NCT01827371|83320857|FG000|Overall Study|Physician Decision|0|||
46751827|NCT00887159|82970154|FG002|Overall Study|Disease progression|33|||
46751828|NCT00887159|82970152|FG000|Overall Study|Adverse Event|3|||
46751829|NCT00887159|82970153|FG001|Overall Study|Adverse Event|4|||
46751830|NCT00887159|82970154|FG002|Overall Study|Adverse Event|17|||
46751831|NCT00887159|82970152|FG000|Overall Study|Death|2|||
46751832|NCT00887159|82970153|FG001|Overall Study|Death|2|||
46751833|NCT00887159|82970154|FG002|Overall Study|Death|0|||
46751834|NCT00887159|82970152|FG000|Overall Study|Withdrawal by Subject|4|||
46751835|NCT00887159|82970153|FG001|Overall Study|Withdrawal by Subject|4|||
46751836|NCT00887159|82970154|FG002|Overall Study|Withdrawal by Subject|2|||
46751837|NCT00887159|82970152|FG000|Overall Study|Alternative therapy|2|||
46751838|NCT00887159|82970153|FG001|Overall Study|Alternative therapy|0|||
46751839|NCT00887159|82970154|FG002|Overall Study|Alternative therapy|0|||
46751840|NCT00887159|82970152|FG000|Overall Study|Physician Decision|1|||
46751841|NCT00887159|82970153|FG001|Overall Study|Physician Decision|1|||
46751842|NCT00887159|82970154|FG002|Overall Study|Physician Decision|0|||
46751843|NCT00887159|82970152|FG000|Overall Study|Sympomatic deterioration|1|||
46751844|NCT00887159|82970153|FG001|Overall Study|Sympomatic deterioration|0|||
46751845|NCT00887159|82970154|FG002|Overall Study|Sympomatic deterioration|0|||
46751846|NCT00887159|82970152|FG000|Overall Study|Treatment delayed|1|||
46751847|NCT00887159|82970153|FG001|Overall Study|Treatment delayed|1|||
46751848|NCT00887159|82970154|FG002|Overall Study|Treatment delayed|0|||
47052879|NCT01827371|83320858|FG001|Overall Study|Physician Decision|1|||
46751849|NCT00887159|82970152|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
46751850|NCT00887159|82970153|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
46751851|NCT00887159|82970154|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
46751852|NCT00887159|82970152|FG000|Overall Study|Received more tx instead of observation|1|||
46751853|NCT00887159|82970153|FG001|Overall Study|Received more tx instead of observation|0|||
46751854|NCT00887159|82970154|FG002|Overall Study|Received more tx instead of observation|0|||
46751855|NCT00887159|82970152|FG000|Overall Study|Ineligible|5|||
46751856|NCT00887159|82970153|FG001|Overall Study|Ineligible|1|||
46751857|NCT00887159|82970154|FG002|Overall Study|Ineligible|0|||
47052880|NCT01827371|83320859|FG002|Overall Study|Physician Decision|0|||
47052881|NCT01827371|83320860|FG003|Overall Study|Physician Decision|1|||
47052882|NCT01827371|83320857|FG000|Overall Study|Temporary study halt to vaccinations|11|||
47052883|NCT01827371|83320858|FG001|Overall Study|Temporary study halt to vaccinations|2|||
47052884|NCT01827371|83320859|FG002|Overall Study|Temporary study halt to vaccinations|5|||
47052885|NCT01827371|83320860|FG003|Overall Study|Temporary study halt to vaccinations|13|||
47052886|NCT04409262|83321039|FG000|Overall Study|Adverse Event|0|||
47052887|NCT04409262|83321040|FG001|Overall Study|Adverse Event|2|||
47052888|NCT04409262|83321039|FG000|Overall Study|Death|55|||
47052889|NCT04409262|83321040|FG001|Overall Study|Death|97|||
47052890|NCT04409262|83321039|FG000|Overall Study|Lost to Follow-up|12|||
47052891|NCT04409262|83321040|FG001|Overall Study|Lost to Follow-up|23|||
47052892|NCT04409262|83321039|FG000|Overall Study|Lack of Staff|0|||
47052893|NCT04409262|83321040|FG001|Overall Study|Lack of Staff|1|||
46751858|NCT00887159|82970152|FG000|Overall Study|Never started assigned therapy|3|||
46751859|NCT00887159|82970153|FG001|Overall Study|Never started assigned therapy|3|||
46751860|NCT00887159|82970154|FG002|Overall Study|Never started assigned therapy|4|||
46751861|NCT00886769|82970166|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
46751862|NCT00886769|82970167|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
46751863|NCT00886613|82970176|FG000|Overall Study|Protocol deviation (Part B)|1|||
46751864|NCT00886613|82970177|FG001|Overall Study|Protocol deviation (Part B)|0|||
46751865|NCT00886613|82970178|FG002|Overall Study|Protocol deviation (Part B)|0|||
46751866|NCT00886613|82970176|FG000|Overall Study|Lost to follow-up (Part B)|1|||
46751867|NCT00886613|82970177|FG001|Overall Study|Lost to follow-up (Part B)|0|||
46751868|NCT00886613|82970178|FG002|Overall Study|Lost to follow-up (Part B)|1|||
46751869|NCT00886613|82970176|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
46751870|NCT00886613|82970177|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
46751871|NCT00886613|82970178|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
46751872|NCT00886379|82970194|FG000|Overall Study|Transferred Schools|0|||
46751873|NCT00886379|82970195|FG001|Overall Study|Transferred Schools|0|||
47052894|NCT04409262|83321039|FG000|Overall Study|Protocol Violation|3|||
47052895|NCT04409262|83321040|FG001|Overall Study|Protocol Violation|1|||
47052896|NCT04409262|83321039|FG000|Overall Study|Withdrawal by Subject|5|||
47052897|NCT04409262|83321040|FG001|Overall Study|Withdrawal by Subject|10|||
47052898|NCT04305912|83321084|FG000|First Intervention|COVID-19 Suspension|2|||
47052899|NCT04305912|83321085|FG001|First Intervention|COVID-19 Suspension|0|||
47052900|NCT04305912|83321084|FG000|First Intervention|Withdrawal by Subject|0|||
47052901|NCT04305912|83321085|FG001|First Intervention|Withdrawal by Subject|1|||
47052902|NCT04305912|83321084|FG000|Second Intervention|Adverse Event|0|||
47052903|NCT04305912|83321085|FG001|Second Intervention|Adverse Event|1|||
47052904|NCT00782184|83321314|FG000|Overall Study|Adverse Event|1|||
47052905|NCT00782184|83321315|FG001|Overall Study|Adverse Event|2|||
47052906|NCT00782184|83321314|FG000|Overall Study|Protocol Violation|0|||
47052907|NCT00782184|83321315|FG001|Overall Study|Protocol Violation|1|||
47052908|NCT00782184|83321314|FG000|Overall Study|Withdrawal by Subject|3|||
47052909|NCT00782184|83321315|FG001|Overall Study|Withdrawal by Subject|2|||
47052910|NCT02731638|83321342|FG000|Overall Study|Lost to Follow-up|6|||
47052911|NCT02731638|83321343|FG001|Overall Study|Lost to Follow-up|9|||
47052912|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
46751874|NCT00886379|82970196|FG002|Overall Study|Transferred Schools|2|||
46751875|NCT00886379|82970197|FG003|Overall Study|Transferred Schools|1|||
46751876|NCT00886379|82970198|FG004|Overall Study|Transferred Schools|1|||
46751877|NCT00886379|82970194|FG000|Overall Study|Final blood draw not obtained|3|||
46751878|NCT00886379|82970195|FG001|Overall Study|Final blood draw not obtained|3|||
46751879|NCT00886379|82970196|FG002|Overall Study|Final blood draw not obtained|4|||
46751880|NCT00886379|82970197|FG003|Overall Study|Final blood draw not obtained|2|||
47052913|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
47052914|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
47052915|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
47052916|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
47052917|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
47052918|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
47052919|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
47052920|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Death|6|||
47052921|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Death|2|||
47052922|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Death|2|||
47052923|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Death|9|||
47052924|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
47052925|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
47052926|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
47052927|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
46751881|NCT00886379|82970198|FG004|Overall Study|Final blood draw not obtained|2|||
46751882|NCT00599196|82970210|FG000|Overall Study|Lack of Efficacy|22|||
46751883|NCT00599196|82970210|FG000|Overall Study|Adverse Event|93|||
46805879|NCT00662909|83024854|FG000|Overall Study|Protocol Violation|7|||
47052928|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
47052929|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
47052930|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
47052931|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
47052932|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
47052933|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
47052934|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
47052935|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
47052936|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
47052937|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
47052938|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
47052939|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
47052940|NCT03730662|83321779|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
47052941|NCT03730662|83321780|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
47052942|NCT03730662|83321781|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
47052943|NCT03730662|83321782|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
47052944|NCT03730662|83321779|FG000|Variable Treatment Period|Adverse Event|1|||
47052945|NCT03730662|83321780|FG001|Variable Treatment Period|Adverse Event|2|||
46751884|NCT00599196|82970210|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
46751885|NCT00599196|82970210|FG000|Overall Study|Subject withdrew consent|43|||
46751886|NCT00599196|82970210|FG000|Overall Study|Study ended per sponsor|197|||
46751887|NCT00599196|82970210|FG000|Overall Study|Lost to Follow-up|17|||
46751888|NCT00599196|82970210|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
47052946|NCT03730662|83321781|FG002|Variable Treatment Period|Adverse Event|0|||
47052947|NCT03730662|83321782|FG003|Variable Treatment Period|Adverse Event|7|||
47052948|NCT03730662|83321779|FG000|Variable Treatment Period|Death|9|||
47052949|NCT03730662|83321780|FG001|Variable Treatment Period|Death|0|||
47052950|NCT03730662|83321781|FG002|Variable Treatment Period|Death|6|||
47052951|NCT03730662|83321782|FG003|Variable Treatment Period|Death|26|||
47052952|NCT03730662|83321779|FG000|Variable Treatment Period|Lost to Follow-up|2|||
47052953|NCT03730662|83321780|FG001|Variable Treatment Period|Lost to Follow-up|1|||
47052954|NCT03730662|83321781|FG002|Variable Treatment Period|Lost to Follow-up|4|||
47052955|NCT03730662|83321782|FG003|Variable Treatment Period|Lost to Follow-up|11|||
47052956|NCT03730662|83321779|FG000|Variable Treatment Period|Personal Reason|0|||
47052957|NCT03730662|83321780|FG001|Variable Treatment Period|Personal Reason|2|||
47052958|NCT03730662|83321781|FG002|Variable Treatment Period|Personal Reason|1|||
47052959|NCT03730662|83321782|FG003|Variable Treatment Period|Personal Reason|6|||
47052960|NCT03730662|83321779|FG000|Variable Treatment Period|Physician Decision|0|||
47052961|NCT03730662|83321780|FG001|Variable Treatment Period|Physician Decision|0|||
46925002|NCT02638948|83159340|FG002|Overall Study|Lack of Efficacy|0|||
46925003|NCT02638948|83159341|FG003|Overall Study|Lack of Efficacy|0|||
46925004|NCT02638948|83159338|FG000|Overall Study|Lost to Follow-up|0|||
46925005|NCT02638948|83159339|FG001|Overall Study|Lost to Follow-up|0|||
46925006|NCT02638948|83159340|FG002|Overall Study|Lost to Follow-up|1|||
46925007|NCT02638948|83159341|FG003|Overall Study|Lost to Follow-up|1|||
46925008|NCT02638948|83159338|FG000|Overall Study|Poor/Non-Compliance|0|||
46925009|NCT02638948|83159339|FG001|Overall Study|Poor/Non-Compliance|2|||
46925010|NCT02638948|83159340|FG002|Overall Study|Poor/Non-Compliance|1|||
46925011|NCT02638948|83159341|FG003|Overall Study|Poor/Non-Compliance|0|||
46925012|NCT02638948|83159338|FG000|Overall Study|Participant no longer met study criteria|0|||
46925013|NCT02638948|83159339|FG001|Overall Study|Participant no longer met study criteria|1|||
46925014|NCT02638948|83159340|FG002|Overall Study|Participant no longer met study criteria|0|||
46925015|NCT02638948|83159341|FG003|Overall Study|Participant no longer met study criteria|0|||
46925016|NCT02638948|83159338|FG000|Overall Study|Other than specified above|4|||
46925017|NCT02638948|83159339|FG001|Overall Study|Other than specified above|1|||
46925018|NCT02638948|83159340|FG002|Overall Study|Other than specified above|1|||
46925019|NCT02638948|83159341|FG003|Overall Study|Other than specified above|1|||
46925020|NCT00102960|83159357|FG000|Overall Study|Death|23|||
46925021|NCT00102960|83159358|FG001|Overall Study|Death|11|||
46925022|NCT00102960|83159359|FG002|Overall Study|Death|11|||
47052962|NCT03730662|83321781|FG002|Variable Treatment Period|Physician Decision|0|||
47052963|NCT03730662|83321782|FG003|Variable Treatment Period|Physician Decision|3|||
47052964|NCT03730662|83321779|FG000|Variable Treatment Period|Protocol Violation|0|||
47052965|NCT03730662|83321780|FG001|Variable Treatment Period|Protocol Violation|1|||
47052966|NCT03730662|83321781|FG002|Variable Treatment Period|Protocol Violation|1|||
47052967|NCT03730662|83321782|FG003|Variable Treatment Period|Protocol Violation|1|||
47052968|NCT03730662|83321779|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
46925023|NCT00102960|83159357|FG000|Overall Study|Lost to Follow-up|6|||
46925024|NCT00102960|83159358|FG001|Overall Study|Lost to Follow-up|12|||
46925025|NCT00102960|83159359|FG002|Overall Study|Lost to Follow-up|16|||
46925026|NCT00102960|83159357|FG000|Overall Study|Withdrawal by Subject|1|||
47052969|NCT03730662|83321780|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
47052970|NCT03730662|83321781|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
46751889|NCT00599196|82970210|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
46925027|NCT00102960|83159358|FG001|Overall Study|Withdrawal by Subject|0|||
46925028|NCT00102960|83159359|FG002|Overall Study|Withdrawal by Subject|1|||
47052971|NCT03730662|83321782|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
47052972|NCT03185832|83321880|FG000|Overall Study|Death|9|||
47052973|NCT03185832|83321881|FG001|Overall Study|Death|14|||
47052974|NCT03185832|83321882|FG002|Overall Study|Death|9|||
47052975|NCT03185832|83321883|FG003|Overall Study|Death|7|||
46925029|NCT02858895|83159371|FG000|Overall Study|Disease progression|31|||
46925030|NCT02858895|83159371|FG000|Overall Study|Death|2|||
46925031|NCT02858895|83159371|FG000|Overall Study|Adverse Event|1|||
46925032|NCT02858895|83159371|FG000|Overall Study|Withdrawal by Subject|3|||
46925033|NCT02858895|83159371|FG000|Overall Study|hospice,|1|||
46925034|NCT02858895|83159371|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
46925035|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
46925036|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
46925037|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
46925038|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
46925039|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
46925040|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
46925041|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
46925042|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
46925043|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
46925044|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
46925045|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
46925046|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
46925047|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
46925048|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
46925049|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
46925050|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
46925051|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
46925052|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
46925053|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
46925054|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
46925055|NCT02637856|83159382|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
46925056|NCT02637856|83159383|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
47052976|NCT03185832|83321880|FG000|Overall Study|Withdrawn - vital status available|0|||
47052977|NCT03185832|83321881|FG001|Overall Study|Withdrawn - vital status available|1|||
47052978|NCT03185832|83321882|FG002|Overall Study|Withdrawn - vital status available|1|||
47052979|NCT03185832|83321883|FG003|Overall Study|Withdrawn - vital status available|4|||
47052980|NCT04569786|83321935|FG000|Overall Study|Lost to Follow-up|1|||
47052981|NCT04569786|83321936|FG001|Overall Study|Lost to Follow-up|0|||
47052982|NCT04569786|83321937|FG002|Overall Study|Lost to Follow-up|4|||
46925057|NCT02637856|83159382|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
46925058|NCT02637856|83159383|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
46925059|NCT02637856|83159382|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
46925060|NCT02637856|83159383|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
46925061|NCT02858037|83159389|FG000|Overall Study|Death|1|||
46925062|NCT02858037|83159389|FG000|Overall Study|Withdrawal by Subject|18|||
46925063|NCT02858037|83159389|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
46925064|NCT02858037|83159389|FG000|Overall Study|Lost to Follow-up|3|||
46925065|NCT02858037|83159389|FG000|Overall Study|Other|4|||
46925066|NCT02856555|83159396|FG000|Overall Study|Adverse Event|1|||
46925067|NCT02856555|83159397|FG001|Overall Study|Adverse Event|0|||
46925068|NCT02856555|83159398|FG002|Overall Study|Adverse Event|0|||
47052983|NCT04569786|83321938|FG003|Overall Study|Lost to Follow-up|1|||
47052984|NCT04569786|83321939|FG004|Overall Study|Lost to Follow-up|0|||
47052985|NCT04569786|83321935|FG000|Overall Study|Withdrawal by Subject|0|||
47052986|NCT04569786|83321936|FG001|Overall Study|Withdrawal by Subject|0|||
47052987|NCT04569786|83321937|FG002|Overall Study|Withdrawal by Subject|0|||
47052988|NCT04569786|83321938|FG003|Overall Study|Withdrawal by Subject|5|||
47052989|NCT04569786|83321939|FG004|Overall Study|Withdrawal by Subject|1|||
47052990|NCT04569786|83321935|FG000|Overall Study|Physician Decision|0|||
46925069|NCT02856555|83159396|FG000|Overall Study|Lost to Follow-up|1|||
46925070|NCT02856555|83159397|FG001|Overall Study|Lost to Follow-up|3|||
46925071|NCT02856555|83159398|FG002|Overall Study|Lost to Follow-up|0|||
46925072|NCT02856555|83159396|FG000|Overall Study|Withdrawal by Subject|3|||
46925073|NCT02856555|83159397|FG001|Overall Study|Withdrawal by Subject|0|||
46925074|NCT02856555|83159398|FG002|Overall Study|Withdrawal by Subject|0|||
46925075|NCT02856555|83159396|FG000|Overall Study|Randomized but Never Treated|0|||
46925076|NCT02856555|83159397|FG001|Overall Study|Randomized but Never Treated|1|||
46925077|NCT02856555|83159398|FG002|Overall Study|Randomized but Never Treated|0|||
46925078|NCT02637232|83159436|FG000|Overall Study|Lost to Follow-up|42|||
46925079|NCT02637232|83159436|FG000|Overall Study|Adverse Event|11|||
46925080|NCT02637232|83159436|FG000|Overall Study|patient 's decision|2|||
46925081|NCT02855541|83159440|FG000|Overall Study|Change in health status|2|||
46925082|NCT02855541|83159440|FG000|Overall Study|Withdrawal by Subject|2|||
46925083|NCT02635984|83159446|FG000|Overall Study|Lost to Follow-up|2|||
46925084|NCT02635984|83159447|FG001|Overall Study|Lost to Follow-up|4|||
46925085|NCT02635984|83159446|FG000|Overall Study|Study Arm Closed|1|||
46925086|NCT02635984|83159447|FG001|Overall Study|Study Arm Closed|0|||
46925087|NCT01147653|83159455|FG000|Year 2|Withdrawal by Subject|2|||
46925088|NCT01147653|83159456|FG001|Year 2|Withdrawal by Subject|3|||
46925089|NCT02747043|83159477|FG000|Overall Study|Other|1|||
46925090|NCT02747043|83159478|FG001|Overall Study|Other|1|||
46925091|NCT02747043|83159477|FG000|Overall Study|Adverse Event|3|||
46925092|NCT02747043|83159478|FG001|Overall Study|Adverse Event|1|||
46925093|NCT02747043|83159477|FG000|Overall Study|Withdrawal by Subject|1|||
46925094|NCT02747043|83159478|FG001|Overall Study|Withdrawal by Subject|1|||
46925095|NCT02747043|83159477|FG000|Overall Study|Physician Decision|1|||
46925096|NCT02747043|83159478|FG001|Overall Study|Physician Decision|1|||
46925097|NCT02747043|83159477|FG000|Overall Study|Protocol Violation|0|||
46925098|NCT02747043|83159478|FG001|Overall Study|Protocol Violation|1|||
46925099|NCT02747043|83159477|FG000|Overall Study|Disease progression|4|||
46925100|NCT02747043|83159478|FG001|Overall Study|Disease progression|0|||
46925101|NCT02637076|83159486|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
46925102|NCT02637076|83159487|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
46925103|NCT02637076|83159486|FG000|Overall Study|Withdrawal by Subject|0|||
46925104|NCT02637076|83159487|FG001|Overall Study|Withdrawal by Subject|4|||
46925105|NCT02854605|83159496|FG000|Overall Study|Adverse Event|1|||
46925106|NCT02854605|83159497|FG001|Overall Study|Adverse Event|5|||
46925107|NCT02854605|83159498|FG002|Overall Study|Adverse Event|2|||
46925108|NCT02854605|83159496|FG000|Overall Study|Lost to Follow-up|0|||
46925109|NCT02854605|83159497|FG001|Overall Study|Lost to Follow-up|2|||
46925110|NCT02854605|83159498|FG002|Overall Study|Lost to Follow-up|0|||
46925111|NCT02854605|83159496|FG000|Overall Study|Withdrew Consent|1|||
46925112|NCT02854605|83159497|FG001|Overall Study|Withdrew Consent|0|||
46925113|NCT02854605|83159498|FG002|Overall Study|Withdrew Consent|1|||
46925114|NCT02854605|83159496|FG000|Overall Study|Investigator's Discretion|1|||
46925115|NCT02854605|83159497|FG001|Overall Study|Investigator's Discretion|0|||
46925116|NCT02854605|83159498|FG002|Overall Study|Investigator's Discretion|0|||
46925117|NCT02854605|83159496|FG000|Overall Study|Protocol Violation|0|||
46925118|NCT02854605|83159497|FG001|Overall Study|Protocol Violation|0|||
46925119|NCT02854605|83159498|FG002|Overall Study|Protocol Violation|1|||
46925120|NCT05059977|83159516|FG000|Overall Study|Withdrawal by Subject|0|||
46925121|NCT05059977|83159517|FG001|Overall Study|Withdrawal by Subject|0|||
46925122|NCT05059977|83159518|FG002|Overall Study|Withdrawal by Subject|1|||
47052991|NCT04569786|83321936|FG001|Overall Study|Physician Decision|0|||
47052992|NCT04569786|83321937|FG002|Overall Study|Physician Decision|0|||
47052993|NCT04569786|83321938|FG003|Overall Study|Physician Decision|1|||
47052994|NCT04569786|83321939|FG004|Overall Study|Physician Decision|0|||
47052995|NCT03125382|83322029|FG000|Randomization|screening failure|1|||
47052996|NCT03125382|83322030|FG001|Randomization|screening failure|4|||
47052997|NCT03125382|83322031|FG002|Randomization|screening failure|2|||
47052998|NCT03125382|83322032|FG003|Randomization|screening failure|0|||
47052999|NCT03125382|83322029|FG000|Follow-up|Death|1|||
47053000|NCT03125382|83322030|FG001|Follow-up|Death|2|||
46925123|NCT04803305|83159532|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
46925124|NCT04803305|83159533|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
46925125|NCT04803305|83159532|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
46925126|NCT04803305|83159533|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
46925127|NCT04803305|83159532|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
46925128|NCT04803305|83159533|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
46925129|NCT04803305|83159532|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
46925130|NCT04803305|83159533|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
46925131|NCT04803305|83159532|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
47053001|NCT03125382|83322031|FG002|Follow-up|Death|1|||
47053002|NCT03125382|83322032|FG003|Follow-up|Death|2|||
47053003|NCT03125382|83322029|FG000|Follow-up|Lost to Follow-up|1|||
46925132|NCT04803305|83159533|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
46925133|NCT04803305|83159532|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
46925134|NCT04803305|83159533|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
46925135|NCT04803305|83159532|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
46925136|NCT04803305|83159533|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
46925137|NCT04803305|83159532|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
46925138|NCT04803305|83159533|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
46925139|NCT04607135|83159551|FG000|Overall Study|Physician Decision|1|||
46925140|NCT04607135|83159551|FG000|Overall Study|Withdrawal by Subject|1|||
46925141|NCT04607135|83159551|FG000|Overall Study|Equipment not working|3|||
46925142|NCT04525885|83159566|FG000|Overall Study|Screen Failure|1|||
46925143|NCT04525885|83159567|FG001|Overall Study|Screen Failure|0|||
46925144|NCT04525885|83159568|FG002|Overall Study|Screen Failure|0|||
46925145|NCT04525885|83159566|FG000|Overall Study|Withdrawal by Subject|14|||
46925146|NCT04525885|83159567|FG001|Overall Study|Withdrawal by Subject|6|||
46925147|NCT04525885|83159568|FG002|Overall Study|Withdrawal by Subject|20|||
46925148|NCT04525885|83159566|FG000|Overall Study|Physician Decision|1|||
46925149|NCT04525885|83159567|FG001|Overall Study|Physician Decision|0|||
46925150|NCT04525885|83159568|FG002|Overall Study|Physician Decision|1|||
46925151|NCT04426006|83159581|FG000|Inclusion|Protocol Violation|1|||
46925152|NCT04426006|83159581|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
46925153|NCT04426006|83159581|FG000|Inclusion|Blood sample at inclusion not done|1|||
46925154|NCT04426006|83159581|FG000|3 Months|Lost to Follow-up|17|||
46925155|NCT04426006|83159581|FG000|12 Months|Lost to Follow-up|38|||
46925156|NCT03959241|83159588|FG000|Overall Study|Withdrawal by Subject|7|||
46925157|NCT03959241|83159589|FG001|Overall Study|Withdrawal by Subject|8|||
46925158|NCT03959241|83159588|FG000|Overall Study|Lost to Follow-up|1|||
46925159|NCT03959241|83159589|FG001|Overall Study|Lost to Follow-up|0|||
46925160|NCT03959241|83159588|FG000|Overall Study|Move to Hospice Care|1|||
46925161|NCT03959241|83159589|FG001|Overall Study|Move to Hospice Care|0|||
46925162|NCT03959241|83159588|FG000|Overall Study|Screen Failure|1|||
46925163|NCT03959241|83159589|FG001|Overall Study|Screen Failure|0|||
46925164|NCT03959241|83159588|FG000|Overall Study|Disease Relapse|0|||
46636139|NCT01546038|82809920|FG008|Overall Study|Death|39|||
46636140|NCT01546038|82809912|FG000|Overall Study|Lost to Follow-up|0|||
46636141|NCT01546038|82809913|FG001|Overall Study|Lost to Follow-up|0|||
46636142|NCT01546038|82809914|FG002|Overall Study|Lost to Follow-up|0|||
46636143|NCT01546038|82809915|FG003|Overall Study|Lost to Follow-up|0|||
46636144|NCT01546038|82809916|FG004|Overall Study|Lost to Follow-up|1|||
46636145|NCT01546038|82809917|FG005|Overall Study|Lost to Follow-up|0|||
46636146|NCT01546038|82809918|FG006|Overall Study|Lost to Follow-up|2|||
46636147|NCT01546038|82809919|FG007|Overall Study|Lost to Follow-up|1|||
46636148|NCT01546038|82809920|FG008|Overall Study|Lost to Follow-up|0|||
46636149|NCT01546038|82809912|FG000|Overall Study|Withdrawal by Subject|1|||
46636150|NCT01546038|82809913|FG001|Overall Study|Withdrawal by Subject|0|||
46636151|NCT01546038|82809914|FG002|Overall Study|Withdrawal by Subject|0|||
46636152|NCT01546038|82809915|FG003|Overall Study|Withdrawal by Subject|1|||
46636153|NCT01546038|82809916|FG004|Overall Study|Withdrawal by Subject|0|||
46636154|NCT01546038|82809917|FG005|Overall Study|Withdrawal by Subject|1|||
46636155|NCT01546038|82809918|FG006|Overall Study|Withdrawal by Subject|3|||
46636156|NCT01546038|82809919|FG007|Overall Study|Withdrawal by Subject|3|||
46636157|NCT01546038|82809920|FG008|Overall Study|Withdrawal by Subject|1|||
46636158|NCT01546038|82809912|FG000|Overall Study|: Randomized, not treated|0|||
46636159|NCT01546038|82809913|FG001|Overall Study|: Randomized, not treated|0|||
46636160|NCT01546038|82809914|FG002|Overall Study|: Randomized, not treated|0|||
46636161|NCT01546038|82809915|FG003|Overall Study|: Randomized, not treated|0|||
46636162|NCT01546038|82809916|FG004|Overall Study|: Randomized, not treated|0|||
46636163|NCT01546038|82809917|FG005|Overall Study|: Randomized, not treated|0|||
46636164|NCT01546038|82809918|FG006|Overall Study|: Randomized, not treated|2|||
46636165|NCT01546038|82809919|FG007|Overall Study|: Randomized, not treated|4|||
46925165|NCT03959241|83159589|FG001|Overall Study|Disease Relapse|1|||
46636166|NCT01546038|82809920|FG008|Overall Study|: Randomized, not treated|3|||
46636167|NCT01571232|82809972|FG000|Overall Study|Lost to Follow-up|0|||
46925166|NCT03959241|83159588|FG000|Overall Study|Off Study|1|||
46925167|NCT03959241|83159589|FG001|Overall Study|Off Study|0|||
46925168|NCT03705169|83159609|FG000|Overall Study|Lost to Follow-up|0|||
46925169|NCT03705169|83159610|FG001|Overall Study|Lost to Follow-up|0|||
46925170|NCT03705169|83159611|FG002|Overall Study|Lost to Follow-up|0|||
46925171|NCT03705169|83159612|FG003|Overall Study|Lost to Follow-up|2|||
46636168|NCT01571232|82809973|FG001|Overall Study|Lost to Follow-up|1|||
46636169|NCT01571232|82809972|FG000|Overall Study|Withdrawal by Subject|1|||
46636170|NCT01571232|82809973|FG001|Overall Study|Withdrawal by Subject|0|||
46636171|NCT01544478|82809980|FG000|Overall Study|Adverse Event|1|||
46636172|NCT01544478|82809980|FG000|Overall Study|Death|1|||
46925172|NCT03705169|83159613|FG004|Overall Study|Lost to Follow-up|0|||
46925173|NCT03705169|83159614|FG005|Overall Study|Lost to Follow-up|2|||
46925174|NCT03705169|83159615|FG006|Overall Study|Lost to Follow-up|1|||
46925175|NCT03705169|83159616|FG007|Overall Study|Lost to Follow-up|0|||
46925176|NCT03705169|83159617|FG008|Overall Study|Lost to Follow-up|0|||
46751890|NCT00599196|82970210|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
46751891|NCT00599196|82970210|FG000|Overall Study|Other: Pt Moved To Australia|1|||
46751892|NCT00599196|82970210|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
47053004|NCT03125382|83322030|FG001|Follow-up|Lost to Follow-up|4|||
47053005|NCT03125382|83322031|FG002|Follow-up|Lost to Follow-up|3|||
46751893|NCT00599196|82970210|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
46751894|NCT00603512|82970219|FG000|Overall Study|Adverse Event|0|||
46751895|NCT00603512|82970220|FG001|Overall Study|Adverse Event|2|||
46751896|NCT00603512|82970221|FG002|Overall Study|Adverse Event|4|||
46751897|NCT00603512|82970222|FG003|Overall Study|Adverse Event|4|||
46925177|NCT03705169|83159618|FG009|Overall Study|Lost to Follow-up|1|||
47053006|NCT03125382|83322032|FG003|Follow-up|Lost to Follow-up|1|||
47053007|NCT01826981|83322138|FG000|Overall Study|Lack of Efficacy|0|||
47053008|NCT01826981|83322139|FG001|Overall Study|Lack of Efficacy|1|||
47053009|NCT01826981|83322140|FG002|Overall Study|Lack of Efficacy|0|||
47053010|NCT01826981|83322141|FG003|Overall Study|Lack of Efficacy|0|||
47053011|NCT01826981|83322142|FG004|Overall Study|Lack of Efficacy|5|||
47053012|NCT01826981|83322143|FG005|Overall Study|Lack of Efficacy|0|||
47053013|NCT01826981|83322144|FG006|Overall Study|Lack of Efficacy|0|||
47053014|NCT01826981|83322145|FG007|Overall Study|Lack of Efficacy|8|||
46925178|NCT03705169|83159609|FG000|Overall Study|Adverse Event|0|||
47053015|NCT01826981|83322146|FG008|Overall Study|Lack of Efficacy|7|||
47053016|NCT01826981|83322147|FG009|Overall Study|Lack of Efficacy|0|||
47053017|NCT01826981|83322148|FG010|Overall Study|Lack of Efficacy|1|||
47053018|NCT01826981|83322149|FG011|Overall Study|Lack of Efficacy|0|||
47053019|NCT01826981|83322150|FG012|Overall Study|Lack of Efficacy|0|||
47053020|NCT01826981|83322151|FG013|Overall Study|Lack of Efficacy|3|||
47053021|NCT01826981|83322152|FG014|Overall Study|Lack of Efficacy|0|||
47053022|NCT01826981|83322138|FG000|Overall Study|Lost to Follow-up|0|||
47053023|NCT01826981|83322139|FG001|Overall Study|Lost to Follow-up|0|||
47053024|NCT01826981|83322140|FG002|Overall Study|Lost to Follow-up|0|||
47053025|NCT01826981|83322141|FG003|Overall Study|Lost to Follow-up|0|||
47053026|NCT01826981|83322142|FG004|Overall Study|Lost to Follow-up|1|||
47053027|NCT01826981|83322143|FG005|Overall Study|Lost to Follow-up|1|||
47053028|NCT01826981|83322144|FG006|Overall Study|Lost to Follow-up|0|||
47053029|NCT01826981|83322145|FG007|Overall Study|Lost to Follow-up|1|||
47053030|NCT01826981|83322146|FG008|Overall Study|Lost to Follow-up|0|||
47053031|NCT01826981|83322147|FG009|Overall Study|Lost to Follow-up|1|||
47053032|NCT01826981|83322148|FG010|Overall Study|Lost to Follow-up|1|||
47053033|NCT01826981|83322149|FG011|Overall Study|Lost to Follow-up|1|||
46925179|NCT03705169|83159610|FG001|Overall Study|Adverse Event|0|||
46925180|NCT03705169|83159611|FG002|Overall Study|Adverse Event|0|||
46925181|NCT03705169|83159612|FG003|Overall Study|Adverse Event|1|||
47053034|NCT01826981|83322150|FG012|Overall Study|Lost to Follow-up|1|||
47053035|NCT01826981|83322151|FG013|Overall Study|Lost to Follow-up|0|||
47053036|NCT01826981|83322152|FG014|Overall Study|Lost to Follow-up|0|||
47053037|NCT01826981|83322138|FG000|Overall Study|Withdrew Consent|0|||
47053038|NCT01826981|83322139|FG001|Overall Study|Withdrew Consent|0|||
47053039|NCT01826981|83322140|FG002|Overall Study|Withdrew Consent|0|||
47053040|NCT01826981|83322141|FG003|Overall Study|Withdrew Consent|0|||
47053041|NCT01826981|83322142|FG004|Overall Study|Withdrew Consent|0|||
47053042|NCT01826981|83322143|FG005|Overall Study|Withdrew Consent|0|||
47053043|NCT01826981|83322144|FG006|Overall Study|Withdrew Consent|1|||
46925182|NCT03705169|83159613|FG004|Overall Study|Adverse Event|0|||
46925183|NCT03705169|83159614|FG005|Overall Study|Adverse Event|0|||
46925184|NCT03705169|83159615|FG006|Overall Study|Adverse Event|0|||
46925185|NCT03705169|83159616|FG007|Overall Study|Adverse Event|0|||
46925186|NCT03705169|83159617|FG008|Overall Study|Adverse Event|0|||
46751898|NCT00603512|82970223|FG004|Overall Study|Adverse Event|2|||
46751899|NCT00603512|82970219|FG000|Overall Study|Lack of Efficacy|0|||
46751900|NCT00603512|82970220|FG001|Overall Study|Lack of Efficacy|1|||
46751901|NCT00603512|82970221|FG002|Overall Study|Lack of Efficacy|0|||
46925187|NCT03705169|83159618|FG009|Overall Study|Adverse Event|0|||
47053044|NCT01826981|83322145|FG007|Overall Study|Withdrew Consent|1|||
47053045|NCT01826981|83322146|FG008|Overall Study|Withdrew Consent|0|||
47053046|NCT01826981|83322147|FG009|Overall Study|Withdrew Consent|0|||
47053047|NCT01826981|83322148|FG010|Overall Study|Withdrew Consent|0|||
47053048|NCT01826981|83322149|FG011|Overall Study|Withdrew Consent|1|||
47053049|NCT01826981|83322150|FG012|Overall Study|Withdrew Consent|0|||
47053050|NCT01826981|83322151|FG013|Overall Study|Withdrew Consent|1|||
47053051|NCT01826981|83322152|FG014|Overall Study|Withdrew Consent|0|||
46751902|NCT00603512|82970222|FG003|Overall Study|Lack of Efficacy|0|||
46925188|NCT03705169|83159609|FG000|Overall Study|Site Closure|0|||
47053052|NCT01826981|83322138|FG000|Overall Study|Adverse Event|0|||
47053053|NCT01826981|83322139|FG001|Overall Study|Adverse Event|0|||
46925189|NCT03705169|83159610|FG001|Overall Study|Site Closure|0|||
46925190|NCT03705169|83159611|FG002|Overall Study|Site Closure|0|||
46925191|NCT03705169|83159612|FG003|Overall Study|Site Closure|1|||
46925192|NCT03705169|83159613|FG004|Overall Study|Site Closure|0|||
46925193|NCT03705169|83159614|FG005|Overall Study|Site Closure|0|||
46925194|NCT03705169|83159615|FG006|Overall Study|Site Closure|0|||
46925195|NCT03705169|83159616|FG007|Overall Study|Site Closure|0|||
46925196|NCT03705169|83159617|FG008|Overall Study|Site Closure|0|||
46925197|NCT03705169|83159618|FG009|Overall Study|Site Closure|0|||
46925198|NCT03705169|83159609|FG000|Overall Study|Did not receive study treatment|0|||
46925199|NCT03705169|83159610|FG001|Overall Study|Did not receive study treatment|0|||
46925200|NCT03705169|83159611|FG002|Overall Study|Did not receive study treatment|0|||
46925201|NCT03705169|83159612|FG003|Overall Study|Did not receive study treatment|1|||
46925202|NCT03705169|83159613|FG004|Overall Study|Did not receive study treatment|0|||
46925203|NCT03705169|83159614|FG005|Overall Study|Did not receive study treatment|0|||
46925204|NCT03705169|83159615|FG006|Overall Study|Did not receive study treatment|0|||
46925205|NCT03705169|83159616|FG007|Overall Study|Did not receive study treatment|0|||
46925206|NCT03705169|83159617|FG008|Overall Study|Did not receive study treatment|0|||
46925207|NCT03705169|83159618|FG009|Overall Study|Did not receive study treatment|0|||
46925208|NCT03705169|83159609|FG000|Overall Study|Concerns about study visit compliance|0|||
46925209|NCT03705169|83159610|FG001|Overall Study|Concerns about study visit compliance|0|||
46925210|NCT03705169|83159611|FG002|Overall Study|Concerns about study visit compliance|0|||
46925211|NCT03705169|83159612|FG003|Overall Study|Concerns about study visit compliance|1|||
46925212|NCT03705169|83159613|FG004|Overall Study|Concerns about study visit compliance|0|||
46925213|NCT03705169|83159614|FG005|Overall Study|Concerns about study visit compliance|0|||
46925214|NCT03705169|83159615|FG006|Overall Study|Concerns about study visit compliance|0|||
46925215|NCT03705169|83159616|FG007|Overall Study|Concerns about study visit compliance|0|||
46925216|NCT03705169|83159617|FG008|Overall Study|Concerns about study visit compliance|0|||
46925217|NCT03705169|83159618|FG009|Overall Study|Concerns about study visit compliance|0|||
46925218|NCT03414684|83159655|FG000|First-course Treatment|Complete response|0|||
46925219|NCT03414684|83159656|FG001|First-course Treatment|Complete response|1|||
46925220|NCT03414684|83159655|FG000|First-course Treatment|Intercurrent illness|1|||
46925221|NCT03414684|83159656|FG001|First-course Treatment|Intercurrent illness|0|||
46925222|NCT03414684|83159655|FG000|First-course Treatment|Progressive Disease|31|||
46925223|NCT03414684|83159656|FG001|First-course Treatment|Progressive Disease|32|||
46925224|NCT03414684|83159655|FG000|First-course Treatment|Adverse Event|1|||
46925225|NCT03414684|83159656|FG001|First-course Treatment|Adverse Event|2|||
46925226|NCT03414684|83159655|FG000|First-course Treatment|Physician Decision|0|||
46925227|NCT03414684|83159656|FG001|First-course Treatment|Physician Decision|1|||
46925228|NCT03414684|83159655|FG000|First-course Treatment|Withdrawal by Subject|0|||
46925229|NCT03414684|83159656|FG001|First-course Treatment|Withdrawal by Subject|1|||
46925230|NCT03414684|83159655|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
46925231|NCT03414684|83159656|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
46925232|NCT03414684|83159655|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
46925233|NCT03414684|83159656|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
46925234|NCT03414684|83159655|FG000|First-course Treatment|Still on treatment|3|||
46925235|NCT03414684|83159656|FG001|First-course Treatment|Still on treatment|0|||
46925236|NCT03414684|83159655|FG000|First-course Treatment|Never started protocol therapy|2|||
46925237|NCT03414684|83159656|FG001|First-course Treatment|Never started protocol therapy|1|||
46925238|NCT03414684|83159655|FG000|Crossover Treatment|Progressive disease|0|||
46925239|NCT03414684|83159656|FG001|Crossover Treatment|Progressive disease|12|||
46925240|NCT03414684|83159655|FG000|Crossover Treatment|Adverse Event|0|||
46925241|NCT03414684|83159656|FG001|Crossover Treatment|Adverse Event|3|||
46925242|NCT03414684|83159655|FG000|Crossover Treatment|Physician Decision|0|||
46925243|NCT03414684|83159656|FG001|Crossover Treatment|Physician Decision|1|||
47053054|NCT01826981|83322140|FG002|Overall Study|Adverse Event|0|||
47053055|NCT01826981|83322141|FG003|Overall Study|Adverse Event|0|||
47053056|NCT01826981|83322142|FG004|Overall Study|Adverse Event|1|||
47053057|NCT01826981|83322143|FG005|Overall Study|Adverse Event|0|||
47053058|NCT01826981|83322144|FG006|Overall Study|Adverse Event|0|||
46751903|NCT00603512|82970223|FG004|Overall Study|Lack of Efficacy|1|||
46751904|NCT00603512|82970219|FG000|Overall Study|Other|2|||
46751905|NCT00603512|82970220|FG001|Overall Study|Other|1|||
46751906|NCT00603512|82970221|FG002|Overall Study|Other|0|||
47053059|NCT01826981|83322145|FG007|Overall Study|Adverse Event|0|||
47053060|NCT01826981|83322146|FG008|Overall Study|Adverse Event|0|||
47053061|NCT01826981|83322147|FG009|Overall Study|Adverse Event|0|||
47053062|NCT01826981|83322148|FG010|Overall Study|Adverse Event|0|||
47053063|NCT01826981|83322149|FG011|Overall Study|Adverse Event|0|||
46751907|NCT00603512|82970222|FG003|Overall Study|Other|1|||
46751908|NCT00603512|82970223|FG004|Overall Study|Other|1|||
46751909|NCT00603512|82970219|FG000|Overall Study|Withdrawal by Subject|0|||
46751910|NCT00603512|82970220|FG001|Overall Study|Withdrawal by Subject|0|||
46925244|NCT03414684|83159655|FG000|Crossover Treatment|Still on treatment|0|||
46925245|NCT03414684|83159656|FG001|Crossover Treatment|Still on treatment|2|||
46925246|NCT03298451|83159677|FG000|Overall Study|Death|275|||
46925247|NCT03298451|83159678|FG001|Overall Study|Death|260|||
46925248|NCT03298451|83159679|FG002|Overall Study|Death|122|||
46925249|NCT03298451|83159680|FG003|Overall Study|Death|280|||
46925250|NCT03298451|83159677|FG000|Overall Study|Lost to Follow-up|1|||
46925251|NCT03298451|83159678|FG001|Overall Study|Lost to Follow-up|1|||
46751911|NCT00603512|82970221|FG002|Overall Study|Withdrawal by Subject|0|||
46751912|NCT00603512|82970222|FG003|Overall Study|Withdrawal by Subject|0|||
46751913|NCT00603512|82970223|FG004|Overall Study|Withdrawal by Subject|1|||
46751914|NCT00603512|82970219|FG000|Overall Study|Randomized but not treated|0|||
46751915|NCT00603512|82970220|FG001|Overall Study|Randomized but not treated|1|||
46751916|NCT00603512|82970221|FG002|Overall Study|Randomized but not treated|1|||
46751917|NCT00603512|82970222|FG003|Overall Study|Randomized but not treated|2|||
46925252|NCT03298451|83159679|FG002|Overall Study|Lost to Follow-up|0|||
46925253|NCT03298451|83159680|FG003|Overall Study|Lost to Follow-up|7|||
46751918|NCT00603512|82970223|FG004|Overall Study|Randomized but not treated|0|||
46751919|NCT04242875|82970235|FG000|Overall Study|Adverse Event|2|||
46751920|NCT00603278|82970249|FG000|Overall Study|Lack of Efficacy|35|||
46751921|NCT00603278|82970250|FG001|Overall Study|Lack of Efficacy|10|||
46751922|NCT00603278|82970251|FG002|Overall Study|Lack of Efficacy|11|||
46751923|NCT00603278|82970252|FG003|Overall Study|Lack of Efficacy|8|||
46751924|NCT00603278|82970253|FG004|Overall Study|Lack of Efficacy|7|||
46751925|NCT00603278|82970254|FG005|Overall Study|Lack of Efficacy|14|||
46751926|NCT00603278|82970249|FG000|Overall Study|Adverse Event|0|||
46751927|NCT00603278|82970250|FG001|Overall Study|Adverse Event|3|||
46751928|NCT00603278|82970251|FG002|Overall Study|Adverse Event|1|||
46751929|NCT00603278|82970252|FG003|Overall Study|Adverse Event|0|||
46751930|NCT00603278|82970253|FG004|Overall Study|Adverse Event|2|||
46751931|NCT00603278|82970254|FG005|Overall Study|Adverse Event|1|||
46751932|NCT00603278|82970249|FG000|Overall Study|Withdrawal by Subject|2|||
46751933|NCT00603278|82970250|FG001|Overall Study|Withdrawal by Subject|3|||
46751934|NCT00603278|82970251|FG002|Overall Study|Withdrawal by Subject|1|||
46751935|NCT00603278|82970252|FG003|Overall Study|Withdrawal by Subject|2|||
46751936|NCT00603278|82970253|FG004|Overall Study|Withdrawal by Subject|1|||
46751937|NCT00603278|82970254|FG005|Overall Study|Withdrawal by Subject|2|||
46751938|NCT00603278|82970249|FG000|Overall Study|Protocol Violation|3|||
46751939|NCT00603278|82970250|FG001|Overall Study|Protocol Violation|0|||
46751940|NCT00603278|82970251|FG002|Overall Study|Protocol Violation|1|||
46751941|NCT00603278|82970252|FG003|Overall Study|Protocol Violation|1|||
46751942|NCT00603278|82970253|FG004|Overall Study|Protocol Violation|0|||
46751943|NCT00603278|82970254|FG005|Overall Study|Protocol Violation|1|||
46751944|NCT00603278|82970249|FG000|Overall Study|Physician Decision|0|||
46751945|NCT00603278|82970250|FG001|Overall Study|Physician Decision|1|||
46751946|NCT00603278|82970251|FG002|Overall Study|Physician Decision|0|||
46751947|NCT00603278|82970252|FG003|Overall Study|Physician Decision|0|||
46751948|NCT00603278|82970253|FG004|Overall Study|Physician Decision|2|||
46751949|NCT00603278|82970254|FG005|Overall Study|Physician Decision|1|||
46751950|NCT00603278|82970249|FG000|Overall Study|Lost to Follow-up|1|||
46751951|NCT00603278|82970250|FG001|Overall Study|Lost to Follow-up|0|||
46751952|NCT00603278|82970251|FG002|Overall Study|Lost to Follow-up|0|||
46751953|NCT00603278|82970252|FG003|Overall Study|Lost to Follow-up|0|||
46751954|NCT00603278|82970253|FG004|Overall Study|Lost to Follow-up|1|||
46751955|NCT00603278|82970254|FG005|Overall Study|Lost to Follow-up|0|||
46751956|NCT00876447|82970270|FG000|Overall Study|Other miscellaneous reasons|3|||
46751957|NCT00876447|82970271|FG001|Overall Study|Other miscellaneous reasons|8|||
46751958|NCT00876447|82970270|FG000|Overall Study|Site closure|19|||
46751959|NCT00876447|82970271|FG001|Overall Study|Site closure|14|||
46751960|NCT00876447|82970270|FG000|Overall Study|Protocol Violation|9|||
46925254|NCT03298451|83159677|FG000|Overall Study|Withdrawal by Subject|9|||
46925255|NCT03298451|83159678|FG001|Overall Study|Withdrawal by Subject|7|||
46751961|NCT00876447|82970271|FG001|Overall Study|Protocol Violation|3|||
46925256|NCT03298451|83159679|FG002|Overall Study|Withdrawal by Subject|1|||
46751962|NCT00876447|82970270|FG000|Overall Study|Personal reasons|30|||
46925257|NCT03298451|83159680|FG003|Overall Study|Withdrawal by Subject|20|||
46925258|NCT02244463|83159723|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
46925259|NCT02244463|83159724|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
46925260|NCT02244463|83159725|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
46751963|NCT00876447|82970271|FG001|Overall Study|Personal reasons|28|||
46751964|NCT00876447|82970270|FG000|Overall Study|Lost to Follow-up|6|||
46751965|NCT00876447|82970271|FG001|Overall Study|Lost to Follow-up|15|||
46751966|NCT00876447|82970270|FG000|Overall Study|Pregnancy|4|||
46751967|NCT00876447|82970271|FG001|Overall Study|Pregnancy|2|||
46751968|NCT00876447|82970270|FG000|Overall Study|Lack of Efficacy|5|||
46925261|NCT02244463|83159726|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
46925262|NCT02244463|83159727|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
47053064|NCT01826981|83322150|FG012|Overall Study|Adverse Event|0|||
47053065|NCT01826981|83322151|FG013|Overall Study|Adverse Event|0|||
47053066|NCT01826981|83322152|FG014|Overall Study|Adverse Event|0|||
47053067|NCT01826981|83322138|FG000|Overall Study|Upper G-I Haemorrhage|0|||
47053068|NCT01826981|83322139|FG001|Overall Study|Upper G-I Haemorrhage|0|||
47053069|NCT01826981|83322140|FG002|Overall Study|Upper G-I Haemorrhage|0|||
47053070|NCT01826981|83322141|FG003|Overall Study|Upper G-I Haemorrhage|0|||
47053071|NCT01826981|83322142|FG004|Overall Study|Upper G-I Haemorrhage|0|||
47053072|NCT01826981|83322143|FG005|Overall Study|Upper G-I Haemorrhage|0|||
47053073|NCT01826981|83322144|FG006|Overall Study|Upper G-I Haemorrhage|0|||
47053074|NCT01826981|83322145|FG007|Overall Study|Upper G-I Haemorrhage|0|||
47053075|NCT01826981|83322146|FG008|Overall Study|Upper G-I Haemorrhage|0|||
47053076|NCT01826981|83322147|FG009|Overall Study|Upper G-I Haemorrhage|0|||
47053077|NCT01826981|83322148|FG010|Overall Study|Upper G-I Haemorrhage|0|||
47053078|NCT01826981|83322149|FG011|Overall Study|Upper G-I Haemorrhage|0|||
47053079|NCT01826981|83322150|FG012|Overall Study|Upper G-I Haemorrhage|0|||
47053080|NCT01826981|83322151|FG013|Overall Study|Upper G-I Haemorrhage|1|||
46636173|NCT01544478|82809980|FG000|Overall Study|Lost to Follow-up|48|||
46636174|NCT01544478|82809980|FG000|Overall Study|Physician Decision|15|||
46805880|NCT00662909|83024855|FG001|Overall Study|Protocol Violation|4|||
46805881|NCT00662909|83024856|FG002|Overall Study|Protocol Violation|5|||
46805882|NCT00662909|83024854|FG000|Overall Study|Randomized- never received study drug|1|||
46805883|NCT00662909|83024855|FG001|Overall Study|Randomized- never received study drug|0|||
46805884|NCT00662909|83024856|FG002|Overall Study|Randomized- never received study drug|0|||
46805885|NCT00662909|83024854|FG000|Overall Study|Non-compliance with study procedures|3|||
46805886|NCT00662909|83024855|FG001|Overall Study|Non-compliance with study procedures|3|||
46805887|NCT00662909|83024856|FG002|Overall Study|Non-compliance with study procedures|2|||
46805888|NCT00662909|83024854|FG000|Overall Study|Physician Decision|1|||
46805889|NCT00662909|83024855|FG001|Overall Study|Physician Decision|1|||
46805890|NCT00662909|83024856|FG002|Overall Study|Physician Decision|2|||
46805891|NCT00662909|83024854|FG000|Overall Study|Eligibility criterion not met|0|||
46805892|NCT00662909|83024855|FG001|Overall Study|Eligibility criterion not met|1|||
46805893|NCT00662909|83024856|FG002|Overall Study|Eligibility criterion not met|1|||
46805894|NCT00050011|83024866|FG000|Overall Study|Adverse Event|41|||
46805895|NCT00050011|83024867|FG001|Overall Study|Adverse Event|46|||
46805896|NCT00050011|83024866|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46805897|NCT00050011|83024867|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46925263|NCT02244463|83159728|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
46636175|NCT01544478|82809980|FG000|Overall Study|Pregnancy|1|||
46636176|NCT01544478|82809980|FG000|Overall Study|Withdrawal by Subject|52|||
46636177|NCT01522950|82809987|FG000|Overall Study|Withdrawal by Subject|3|||
46636178|NCT01522950|82809988|FG001|Overall Study|Withdrawal by Subject|2|||
46636179|NCT01522950|82809989|FG002|Overall Study|Withdrawal by Subject|1|||
46925264|NCT02244463|83159723|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
46925265|NCT02244463|83159724|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
46925266|NCT02244463|83159725|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
46925267|NCT02244463|83159726|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
46925268|NCT02244463|83159727|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
46925269|NCT02244463|83159728|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
46636180|NCT01522950|82809987|FG000|Overall Study|Adverse Event|3|||
46636181|NCT01522950|82809988|FG001|Overall Study|Adverse Event|1|||
46636182|NCT01522950|82809989|FG002|Overall Study|Adverse Event|1|||
46636183|NCT01522950|82809987|FG000|Overall Study|Protocol Violation|0|||
46751969|NCT00876447|82970271|FG001|Overall Study|Lack of Efficacy|3|||
46751970|NCT00876447|82970270|FG000|Overall Study|Adverse Event|4|||
46751971|NCT00876447|82970271|FG001|Overall Study|Adverse Event|8|||
46751972|NCT00598650|82970301|FG000|Overall Study|Withdrawal by Subject|3|||
46751973|NCT00598650|82970301|FG000|Overall Study|Adverse Event|18|||
46751974|NCT00598650|82970301|FG000|Overall Study|No treatment for 3 weeks|1|||
46751975|NCT00598650|82970301|FG000|Overall Study|Not eligible|1|||
46751976|NCT00598650|82970301|FG000|Overall Study|Prohibited Concomitant Medication|2|||
46805898|NCT00050011|83024866|FG000|Overall Study|Abnormal test procedure results|0|||
46805899|NCT00050011|83024867|FG001|Overall Study|Abnormal test procedure results|1|||
46636184|NCT01522950|82809988|FG001|Overall Study|Protocol Violation|0|||
46805900|NCT00050011|83024866|FG000|Overall Study|Lack of Efficacy|16|||
46805901|NCT00050011|83024867|FG001|Overall Study|Lack of Efficacy|21|||
46925270|NCT02244463|83159723|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
46925271|NCT02244463|83159724|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
46636185|NCT01522950|82809989|FG002|Overall Study|Protocol Violation|2|||
46751977|NCT00598650|82970301|FG000|Overall Study|Physician Decision|2|||
46805902|NCT00050011|83024866|FG000|Overall Study|Participant condition no longer required|1|||
47053081|NCT01826981|83322152|FG014|Overall Study|Upper G-I Haemorrhage|0|||
47053082|NCT01826981|83322138|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
46636186|NCT01522950|82809987|FG000|Overall Study|Death|0|||
46925272|NCT02244463|83159725|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
46925273|NCT02244463|83159726|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
46925274|NCT02244463|83159727|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
46925275|NCT02244463|83159728|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
46925276|NCT02244463|83159723|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
46925277|NCT02244463|83159724|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
46925278|NCT02244463|83159725|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
46925279|NCT02244463|83159726|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
46925280|NCT02244463|83159727|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
46925281|NCT02244463|83159728|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
46925282|NCT02244463|83159723|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
46925283|NCT02244463|83159724|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
46925284|NCT02244463|83159725|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
46925285|NCT02244463|83159726|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
46925286|NCT02244463|83159727|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
46925287|NCT02244463|83159728|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
46925288|NCT02244463|83159723|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
46925289|NCT02244463|83159724|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
46925290|NCT02244463|83159725|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
46925291|NCT02244463|83159726|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
46925292|NCT02244463|83159727|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
46925293|NCT02244463|83159728|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
46925294|NCT02244463|83159723|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
46925295|NCT02244463|83159724|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
46925296|NCT02244463|83159725|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
46925297|NCT02244463|83159726|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
46805903|NCT00050011|83024867|FG001|Overall Study|Participant condition no longer required|0|||
46805904|NCT00050011|83024866|FG000|Overall Study|Protocol Violation|4|||
46925298|NCT02244463|83159727|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
46925299|NCT02244463|83159728|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
46925300|NCT02244463|83159723|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
47053083|NCT01826981|83322139|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
47053084|NCT01826981|83322140|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
47053085|NCT01826981|83322141|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
47053086|NCT01826981|83322142|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
46751978|NCT04249076|82970308|FG000|Overall Study|Adverse Event|1|||
46751979|NCT04249076|82970309|FG001|Overall Study|Adverse Event|1|||
46751980|NCT04249076|82970308|FG000|Overall Study|Protocol Violation|1|||
46751981|NCT04249076|82970309|FG001|Overall Study|Protocol Violation|2|||
46751982|NCT04249076|82970308|FG000|Overall Study|Lack of Efficacy|0|||
46751983|NCT04249076|82970309|FG001|Overall Study|Lack of Efficacy|1|||
46751984|NCT04249076|82970308|FG000|Overall Study|Withdrawal by Subject|0|||
46751985|NCT04249076|82970309|FG001|Overall Study|Withdrawal by Subject|1|||
46751986|NCT04150107|82970317|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
46751987|NCT04150107|82970318|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
46751988|NCT04150107|82970317|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
46751989|NCT04150107|82970318|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
46751990|NCT00875979|82970328|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
46751991|NCT00875979|82970329|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
46751992|NCT00875979|82970328|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
46751993|NCT00875979|82970329|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
46751994|NCT00875979|82970328|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
46751995|NCT00875979|82970329|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
46751996|NCT00875979|82970328|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
46751997|NCT00875979|82970329|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
46751998|NCT00875979|82970328|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
46751999|NCT00875979|82970329|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
46752000|NCT00875979|82970328|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
46752001|NCT00875979|82970329|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
46752002|NCT00875979|82970328|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
46752003|NCT00875979|82970329|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
46752004|NCT00875979|82970328|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
46752005|NCT00875979|82970329|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
46752006|NCT00875979|82970328|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
46752007|NCT00875979|82970329|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
46752008|NCT00602420|82970337|FG000|Overall Study|Death|1|||
46752009|NCT00602420|82970338|FG001|Overall Study|Death|4|||
46752010|NCT00602420|82970337|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
46805905|NCT00050011|83024867|FG001|Overall Study|Protocol Violation|10|||
46805906|NCT00050011|83024866|FG000|Overall Study|Withdrawal by Subject|34|||
46805907|NCT00050011|83024867|FG001|Overall Study|Withdrawal by Subject|26|||
46805908|NCT00050011|83024866|FG000|Overall Study|Lost to Follow-up|7|||
46805909|NCT00050011|83024867|FG001|Overall Study|Lost to Follow-up|9|||
46805910|NCT00050011|83024866|FG000|Overall Study|Administrative problems|10|||
46805911|NCT00050011|83024867|FG001|Overall Study|Administrative problems|6|||
46805912|NCT00050011|83024866|FG000|Overall Study|Death|7|||
46805913|NCT00050011|83024867|FG001|Overall Study|Death|4|||
46805914|NCT00050011|83024866|FG000|Overall Study|Unknown - Reason is missing|0|||
46805915|NCT00050011|83024867|FG001|Overall Study|Unknown - Reason is missing|2|||
46805916|NCT00661427|83024876|FG000|Overall Study|Adverse Event|5|||
46805917|NCT00661427|83024877|FG001|Overall Study|Adverse Event|5|||
46805918|NCT00661427|83024876|FG000|Overall Study|Patient not treated|0|||
46805919|NCT00661427|83024877|FG001|Overall Study|Patient not treated|2|||
46805920|NCT00049543|83024885|FG000|Overall Study|still on treatment|2|||
46805921|NCT00049543|83024886|FG001|Overall Study|still on treatment|9|||
46805922|NCT00048997|83024894|FG000|Overall Study|Protocol Violation|7|||
46805923|NCT00048997|83024895|FG001|Overall Study|Protocol Violation|2|||
46805924|NCT00048997|83024894|FG000|Overall Study|Withdrawal by Subject|6|||
46805925|NCT00048997|83024895|FG001|Overall Study|Withdrawal by Subject|1|||
46805926|NCT00035815|83024902|FG000|Overall Study|Withdrawal by Subject|17|||
46805927|NCT00035815|83024903|FG001|Overall Study|Withdrawal by Subject|11|||
46805928|NCT00662831|83024911|FG000|Overall Study|Death|4|||
46805929|NCT00662831|83024912|FG001|Overall Study|Death|1|||
46805930|NCT00662831|83024911|FG000|Overall Study|Lack of Efficacy|6|||
46805931|NCT00662831|83024912|FG001|Overall Study|Lack of Efficacy|6|||
46805932|NCT00662831|83024911|FG000|Overall Study|Lost to Follow-up|1|||
46805933|NCT00662831|83024912|FG001|Overall Study|Lost to Follow-up|0|||
46805934|NCT00662831|83024911|FG000|Overall Study|Withdrawal by Subject|2|||
46805935|NCT00662831|83024912|FG001|Overall Study|Withdrawal by Subject|1|||
46805936|NCT00662831|83024911|FG000|Overall Study|Other|62|||
46805937|NCT00662831|83024912|FG001|Overall Study|Other|31|||
46805938|NCT00662831|83024911|FG000|Overall Study|Protocol Violation|8|||
46805939|NCT00662831|83024912|FG001|Overall Study|Protocol Violation|4|||
46805940|NCT00662831|83024911|FG000|Overall Study|Adverse Event|23|||
46805941|NCT00662831|83024912|FG001|Overall Study|Adverse Event|16|||
46805942|NCT00662363|83024920|FG000|Overall Study|Withdrawal by Subject|6|||
46805943|NCT00662363|83024921|FG001|Overall Study|Withdrawal by Subject|5|||
46805944|NCT00662363|83024920|FG000|Overall Study|Adverse Event|0|||
46805945|NCT00662363|83024921|FG001|Overall Study|Adverse Event|3|||
46805946|NCT00662363|83024920|FG000|Overall Study|Discharged early from rehab|4|||
46805947|NCT00662363|83024921|FG001|Overall Study|Discharged early from rehab|1|||
46805948|NCT00662363|83024920|FG000|Overall Study|Protocol Violation|1|||
46805949|NCT00662363|83024921|FG001|Overall Study|Protocol Violation|1|||
46805950|NCT00661271|83024931|FG000|Overall Study|Lost to Follow-up|28|||
46805951|NCT00661271|83024932|FG001|Overall Study|Lost to Follow-up|25|||
46805952|NCT00661193|83024940|FG000|Overall Study|Adverse Event|2|||
46805953|NCT00661193|83024941|FG001|Overall Study|Adverse Event|1|||
46805954|NCT00661193|83024940|FG000|Overall Study|Withdrawal by Subject|3|||
46805955|NCT00661193|83024941|FG001|Overall Study|Withdrawal by Subject|1|||
46925301|NCT02244463|83159724|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
46752011|NCT00602420|82970338|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
46752012|NCT00602420|82970337|FG000|Overall Study|Withdrawal by Subject|18|||
46752013|NCT00602420|82970338|FG001|Overall Study|Withdrawal by Subject|17|||
46752014|NCT00602420|82970337|FG000|Overall Study|Adverse Event|1|||
46752015|NCT00602420|82970338|FG001|Overall Study|Adverse Event|0|||
46752016|NCT00875667|82970352|FG000|Overall Study|Adverse Event|29|||
46752017|NCT00875667|82970353|FG001|Overall Study|Adverse Event|10|||
46752018|NCT00875667|82970352|FG000|Overall Study|Withdrawal by Subject|17|||
46752019|NCT00875667|82970353|FG001|Overall Study|Withdrawal by Subject|5|||
46752020|NCT00875667|82970352|FG000|Overall Study|Death|7|||
46752021|NCT00875667|82970353|FG001|Overall Study|Death|2|||
46752022|NCT00875667|82970352|FG000|Overall Study|Protocol Violation|2|||
46752023|NCT00875667|82970353|FG001|Overall Study|Protocol Violation|0|||
46805956|NCT00661193|83024940|FG000|Overall Study|Progression|27|||
46805957|NCT00661193|83024941|FG001|Overall Study|Progression|24|||
46805958|NCT00661193|83024940|FG000|Overall Study|Not protocol specified|1|||
46805959|NCT00661193|83024941|FG001|Overall Study|Not protocol specified|0|||
46805960|NCT00658541|83024947|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
46805961|NCT00658541|83024948|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46805962|NCT00658541|83024947|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
46752024|NCT00875667|82970352|FG000|Overall Study|Disease Progression|100|||
46752025|NCT00875667|82970353|FG001|Overall Study|Disease Progression|49|||
46752026|NCT00875667|82970352|FG000|Overall Study|Miscellaneous|12|||
46805963|NCT00658541|83024948|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46805964|NCT00048061|83024958|FG000|Overall Study|Adverse Event|41|||
46805965|NCT00048061|83024959|FG001|Overall Study|Adverse Event|32|||
46805966|NCT00048061|83024960|FG002|Overall Study|Adverse Event|44|||
46805967|NCT00048061|83024961|FG003|Overall Study|Adverse Event|37|||
46805968|NCT00048061|83024958|FG000|Overall Study|Lost to Follow-up|3|||
46805969|NCT00048061|83024959|FG001|Overall Study|Lost to Follow-up|2|||
46805970|NCT00048061|83024960|FG002|Overall Study|Lost to Follow-up|4|||
46805971|NCT00048061|83024961|FG003|Overall Study|Lost to Follow-up|5|||
46805972|NCT00048061|83024958|FG000|Overall Study|Withdrawal by Subject|20|||
46805973|NCT00048061|83024959|FG001|Overall Study|Withdrawal by Subject|29|||
46805974|NCT00048061|83024960|FG002|Overall Study|Withdrawal by Subject|29|||
46805975|NCT00048061|83024961|FG003|Overall Study|Withdrawal by Subject|32|||
46805976|NCT00048061|83024958|FG000|Overall Study|Did not follow-up|5|||
46805977|NCT00048061|83024959|FG001|Overall Study|Did not follow-up|5|||
46805978|NCT00048061|83024960|FG002|Overall Study|Did not follow-up|4|||
46805979|NCT00048061|83024961|FG003|Overall Study|Did not follow-up|5|||
46805980|NCT00048061|83024958|FG000|Overall Study|Early improvement|6|||
46805981|NCT00048061|83024959|FG001|Overall Study|Early improvement|5|||
46805982|NCT00048061|83024960|FG002|Overall Study|Early improvement|3|||
46805983|NCT00048061|83024961|FG003|Overall Study|Early improvement|0|||
46805984|NCT00656513|83024974|FG000|Overall Study|Protocol Violation|1|||
46805985|NCT00656513|83024975|FG001|Overall Study|Protocol Violation|0|||
46805986|NCT00656513|83024976|FG002|Overall Study|Protocol Violation|2|||
46805987|NCT00656513|83024974|FG000|Overall Study|Withdrawal by Subject|0|||
46805988|NCT00656513|83024975|FG001|Overall Study|Withdrawal by Subject|11|||
46805989|NCT00656513|83024976|FG002|Overall Study|Withdrawal by Subject|4|||
46805990|NCT00656513|83024974|FG000|Overall Study|Death|0|||
46805991|NCT00656513|83024975|FG001|Overall Study|Death|0|||
46805992|NCT00656513|83024976|FG002|Overall Study|Death|1|||
46805993|NCT00656513|83024974|FG000|Overall Study|Missing data|0|||
46805994|NCT00656513|83024975|FG001|Overall Study|Missing data|11|||
46805995|NCT00656513|83024976|FG002|Overall Study|Missing data|9|||
46805996|NCT00656513|83024974|FG000|Overall Study|Incomplete treatment|3|||
46805997|NCT00656513|83024975|FG001|Overall Study|Incomplete treatment|0|||
46805998|NCT00656513|83024976|FG002|Overall Study|Incomplete treatment|0|||
46805999|NCT00656513|83024974|FG000|Overall Study|Treatment completed outside of timeframe|0|||
46806000|NCT00656513|83024975|FG001|Overall Study|Treatment completed outside of timeframe|3|||
46806001|NCT00656513|83024976|FG002|Overall Study|Treatment completed outside of timeframe|1|||
46806002|NCT00656513|83024974|FG000|Overall Study|Missing baseline form|0|||
46806003|NCT00656513|83024975|FG001|Overall Study|Missing baseline form|5|||
46806004|NCT00656513|83024976|FG002|Overall Study|Missing baseline form|5|||
46806005|NCT00655889|83024984|FG000|Overall Study|Inadequate cell growth|1|||
46806006|NCT00655889|83024984|FG000|Overall Study|Protocol Violation|1|||
46806007|NCT00655733|83024990|FG000|Overall Study|Lost to Follow-up|2|||
46806008|NCT00655733|83024991|FG001|Overall Study|Lost to Follow-up|2|||
46806009|NCT00655733|83024990|FG000|Overall Study|Adverse Event|2|||
46806010|NCT00655733|83024991|FG001|Overall Study|Adverse Event|2|||
46806011|NCT00655733|83024990|FG000|Overall Study|Withdrawal by Subject|3|||
46806012|NCT00655733|83024991|FG001|Overall Study|Withdrawal by Subject|3|||
46806013|NCT00655733|83024990|FG000|Overall Study|Physician Decision|0|||
46752027|NCT00875667|82970353|FG001|Overall Study|Miscellaneous|6|||
46752028|NCT00875667|82970352|FG000|Overall Study|Randomized but no Study Drug Given|3|||
46752029|NCT00875667|82970353|FG001|Overall Study|Randomized but no Study Drug Given|1|||
46752030|NCT00602030|82970363|FG000|Lead-in Phase|Disease Progression|2|||
46752031|NCT00602030|82970364|FG001|Lead-in Phase|Disease Progression|3|||
46752032|NCT00602030|82970365|FG002|Lead-in Phase|Disease Progression|0|||
46752033|NCT00602030|82970366|FG003|Lead-in Phase|Disease Progression|0|||
46752034|NCT00602030|82970367|FG004|Lead-in Phase|Disease Progression|0|||
46752035|NCT00602030|82970363|FG000|Lead-in Phase|Adverse Event|0|||
46752036|NCT00602030|82970364|FG001|Lead-in Phase|Adverse Event|2|||
46752037|NCT00602030|82970365|FG002|Lead-in Phase|Adverse Event|0|||
46752038|NCT00602030|82970366|FG003|Lead-in Phase|Adverse Event|0|||
46752039|NCT00602030|82970367|FG004|Lead-in Phase|Adverse Event|0|||
46752040|NCT00602030|82970363|FG000|Double-blind Phase|Disease progression|0|||
46752041|NCT00602030|82970364|FG001|Double-blind Phase|Disease progression|0|||
46806014|NCT00655733|83024991|FG001|Overall Study|Physician Decision|1|||
46806015|NCT00657371|83024999|FG000|Overall Study|Poor bowel preparation|15|||
46806016|NCT00657371|83024999|FG000|Overall Study|Unable to intubate the cecum|5|||
46806017|NCT00657371|83024999|FG000|Overall Study|Protocol Violation|2|||
47053087|NCT01826981|83322143|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
46752042|NCT00602030|82970365|FG002|Double-blind Phase|Disease progression|33|||
46806018|NCT00657371|83024999|FG000|Overall Study|Device- related reasons|13|||
46806019|NCT00657371|83024999|FG000|Overall Study|Pre-existing medical condition|4|||
46806020|NCT00658775|83025005|FG000|Overall Study|Adverse Event|4|||
46806021|NCT00658775|83025006|FG001|Overall Study|Adverse Event|6|||
46806022|NCT00658775|83025005|FG000|Overall Study|Lost to Follow-up|17|||
46806023|NCT00658775|83025006|FG001|Overall Study|Lost to Follow-up|18|||
46806024|NCT00658775|83025005|FG000|Overall Study|Withdrawal by Subject|6|||
46752043|NCT00602030|82970366|FG003|Double-blind Phase|Disease progression|30|||
46752044|NCT00602030|82970367|FG004|Double-blind Phase|Disease progression|0|||
46752045|NCT00602030|82970363|FG000|Double-blind Phase|Adverse Event|0|||
46806025|NCT00658775|83025006|FG001|Overall Study|Withdrawal by Subject|4|||
46806026|NCT00658775|83025005|FG000|Overall Study|Withdrawal of consent|8|||
46806027|NCT00658775|83025006|FG001|Overall Study|Withdrawal of consent|7|||
46806028|NCT00658775|83025005|FG000|Overall Study|Other|7|||
46806029|NCT00658775|83025006|FG001|Overall Study|Other|8|||
46806030|NCT00488631|83025018|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
46806031|NCT00488631|83025019|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
46806032|NCT00488631|83025020|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
46806033|NCT00488631|83025021|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
46806034|NCT00488631|83025022|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
46806035|NCT00488631|83025023|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
46806036|NCT00488631|83025024|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
46806037|NCT00488631|83025025|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
46806038|NCT00488631|83025026|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
46806039|NCT00488631|83025027|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
46806040|NCT00488631|83025018|FG000|Double Blind Period (Week 0-54)|Death|0|||
46806041|NCT00488631|83025019|FG001|Double Blind Period (Week 0-54)|Death|0|||
46806042|NCT00488631|83025020|FG002|Double Blind Period (Week 0-54)|Death|0|||
46806043|NCT00488631|83025021|FG003|Double Blind Period (Week 0-54)|Death|0|||
46806044|NCT00488631|83025022|FG004|Double Blind Period (Week 0-54)|Death|0|||
46806045|NCT00488631|83025023|FG005|Double Blind Period (Week 0-54)|Death|1|||
46806046|NCT00488631|83025024|FG006|Double Blind Period (Week 0-54)|Death|0|||
46806047|NCT00488631|83025025|FG007|Double Blind Period (Week 0-54)|Death|0|||
46806048|NCT00488631|83025026|FG008|Double Blind Period (Week 0-54)|Death|0|||
46806049|NCT00488631|83025027|FG009|Double Blind Period (Week 0-54)|Death|0|||
46806050|NCT00488631|83025018|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
46806051|NCT00488631|83025019|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
46806052|NCT00488631|83025020|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
46806053|NCT00488631|83025021|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
46806054|NCT00488631|83025022|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
46806055|NCT00488631|83025023|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
46806056|NCT00488631|83025024|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
46806057|NCT00488631|83025025|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
46806058|NCT00488631|83025026|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
46806059|NCT00488631|83025027|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
46806060|NCT00488631|83025018|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
46806061|NCT00488631|83025019|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
46806062|NCT00488631|83025020|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
46806063|NCT00488631|83025021|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
46806064|NCT00488631|83025022|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
46806065|NCT00488631|83025023|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
46806066|NCT00488631|83025024|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
46806067|NCT00488631|83025025|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
46806068|NCT00488631|83025026|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
46925302|NCT02244463|83159725|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
46752046|NCT00602030|82970364|FG001|Double-blind Phase|Adverse Event|0|||
46752047|NCT00602030|82970365|FG002|Double-blind Phase|Adverse Event|9|||
46752048|NCT00602030|82970366|FG003|Double-blind Phase|Adverse Event|18|||
46752049|NCT00602030|82970367|FG004|Double-blind Phase|Adverse Event|0|||
46752050|NCT00602030|82970363|FG000|Double-blind Phase|Consent withdrawal|0|||
46752051|NCT00602030|82970364|FG001|Double-blind Phase|Consent withdrawal|0|||
46752052|NCT00602030|82970365|FG002|Double-blind Phase|Consent withdrawal|4|||
46752053|NCT00602030|82970366|FG003|Double-blind Phase|Consent withdrawal|3|||
46752054|NCT00602030|82970367|FG004|Double-blind Phase|Consent withdrawal|0|||
46752055|NCT00602030|82970363|FG000|Double-blind Phase|Death|0|||
46752056|NCT00602030|82970364|FG001|Double-blind Phase|Death|0|||
46752057|NCT00602030|82970365|FG002|Double-blind Phase|Death|3|||
46752058|NCT00602030|82970366|FG003|Double-blind Phase|Death|3|||
46806069|NCT00488631|83025027|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
46925303|NCT02244463|83159726|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
47053088|NCT01826981|83322144|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
46752059|NCT00602030|82970367|FG004|Double-blind Phase|Death|0|||
46752060|NCT00602030|82970363|FG000|Double-blind Phase|Administrative decision|0|||
46752061|NCT00602030|82970364|FG001|Double-blind Phase|Administrative decision|0|||
46806070|NCT00488631|83025018|FG000|Double Blind Period (Week 0-54)|Other|6|||
46806071|NCT00488631|83025019|FG001|Double Blind Period (Week 0-54)|Other|12|||
46806072|NCT00488631|83025020|FG002|Double Blind Period (Week 0-54)|Other|10|||
46806073|NCT00488631|83025021|FG003|Double Blind Period (Week 0-54)|Other|11|||
47053089|NCT01826981|83322145|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
46752062|NCT00602030|82970365|FG002|Double-blind Phase|Administrative decision|0|||
46752063|NCT00602030|82970366|FG003|Double-blind Phase|Administrative decision|2|||
46752064|NCT00602030|82970367|FG004|Double-blind Phase|Administrative decision|0|||
46806074|NCT00488631|83025022|FG004|Double Blind Period (Week 0-54)|Other|14|||
46806075|NCT00488631|83025023|FG005|Double Blind Period (Week 0-54)|Other|34|||
46806076|NCT00488631|83025024|FG006|Double Blind Period (Week 0-54)|Other|0|||
46806077|NCT00488631|83025025|FG007|Double Blind Period (Week 0-54)|Other|0|||
46806078|NCT00488631|83025026|FG008|Double Blind Period (Week 0-54)|Other|0|||
46806079|NCT00488631|83025027|FG009|Double Blind Period (Week 0-54)|Other|0|||
46806080|NCT00488631|83025018|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
46806081|NCT00488631|83025019|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
46806082|NCT00488631|83025020|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
46806083|NCT00488631|83025021|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
46806084|NCT00488631|83025022|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
46806085|NCT00488631|83025023|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
46806086|NCT00488631|83025024|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
46806087|NCT00488631|83025025|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
46806088|NCT00488631|83025026|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
46806089|NCT00488631|83025027|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
46806090|NCT00488631|83025018|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
46806091|NCT00488631|83025019|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
46806092|NCT00488631|83025020|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
46806093|NCT00488631|83025021|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
46806094|NCT00488631|83025022|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
46806095|NCT00488631|83025023|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
46806096|NCT00488631|83025024|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
46806097|NCT00488631|83025025|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
46806098|NCT00488631|83025026|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
46806099|NCT00488631|83025027|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
46806100|NCT00488631|83025018|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
46806101|NCT00488631|83025019|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
46806102|NCT00488631|83025020|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
46806103|NCT00488631|83025021|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
46806104|NCT00488631|83025022|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
46806105|NCT00488631|83025023|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
46806106|NCT00488631|83025024|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
46806107|NCT00488631|83025025|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
46806108|NCT00488631|83025026|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
46806109|NCT00488631|83025027|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
46806110|NCT00488631|83025018|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806111|NCT00488631|83025019|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806112|NCT00488631|83025020|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806113|NCT00488631|83025021|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806114|NCT00488631|83025022|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806115|NCT00488631|83025023|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806116|NCT00488631|83025024|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
46806117|NCT00488631|83025025|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806118|NCT00488631|83025026|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
46806119|NCT00488631|83025027|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
46806120|NCT00488631|83025018|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
46806121|NCT00488631|83025019|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
46806122|NCT00488631|83025020|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
46806123|NCT00488631|83025021|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
46806124|NCT00488631|83025022|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
46806125|NCT00488631|83025023|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
46806126|NCT00488631|83025024|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
46806127|NCT00488631|83025025|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
46806128|NCT00488631|83025026|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
46806129|NCT00488631|83025027|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
46806130|NCT00655499|83025050|FG000|Overall Study|not eligible|4|||
46806131|NCT00654875|83025057|FG000|Overall Study|Adverse Event|5|||
46806132|NCT00654875|83025058|FG001|Overall Study|Adverse Event|5|||
46925304|NCT02244463|83159727|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
46925305|NCT02244463|83159728|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
46925306|NCT02244463|83159723|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
46925307|NCT02244463|83159724|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
46636187|NCT01522950|82809988|FG001|Overall Study|Death|1|||
46806133|NCT00654875|83025057|FG000|Overall Study|Withdrawal by Subject|4|||
46806134|NCT00654875|83025058|FG001|Overall Study|Withdrawal by Subject|4|||
46806135|NCT00654875|83025057|FG000|Overall Study|Protocol Violation|3|||
46806136|NCT00654875|83025058|FG001|Overall Study|Protocol Violation|3|||
46806137|NCT00654875|83025057|FG000|Overall Study|Lack of Efficacy|2|||
46806138|NCT00654875|83025058|FG001|Overall Study|Lack of Efficacy|2|||
46806139|NCT00654875|83025057|FG000|Overall Study|Lost to Follow-up|1|||
46806140|NCT00654875|83025058|FG001|Overall Study|Lost to Follow-up|3|||
46806141|NCT00654875|83025057|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
46806142|NCT00654875|83025058|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
46806143|NCT00654875|83025057|FG000|Overall Study|Administrative Problems|1|||
46806144|NCT00654875|83025058|FG001|Overall Study|Administrative Problems|0|||
46806145|NCT00651755|83025064|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
46806146|NCT00651755|83025065|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
46806147|NCT00651755|83025064|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
46806148|NCT00651755|83025065|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
46806149|NCT00654641|83025074|FG000|Overall Study|Lost to Follow-up|2|||
46806150|NCT00654641|83025075|FG001|Overall Study|Lost to Follow-up|3|||
46806151|NCT00569777|83025083|FG000|Overall Study|Withdrawal by Subject|4|||
46806152|NCT00569777|83025084|FG001|Overall Study|Withdrawal by Subject|0|||
46806153|NCT00569777|83025083|FG000|Overall Study|Adverse Event|3|||
46806154|NCT00569777|83025084|FG001|Overall Study|Adverse Event|0|||
46806155|NCT00569777|83025083|FG000|Overall Study|Lost to Follow-up|1|||
46806156|NCT00569777|83025084|FG001|Overall Study|Lost to Follow-up|0|||
46806157|NCT00569777|83025083|FG000|Overall Study|scheduled eye surgery|0|||
46806158|NCT00569777|83025084|FG001|Overall Study|scheduled eye surgery|1|||
46806159|NCT00569777|83025083|FG000|Overall Study|did not meet exclusion criteria|1|||
46925308|NCT02244463|83159725|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
46925309|NCT02244463|83159726|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
46925310|NCT02244463|83159727|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
46925311|NCT02244463|83159728|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
47053090|NCT01826981|83322146|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
46636188|NCT01522950|82809989|FG002|Overall Study|Death|1|||
46636189|NCT01522950|82809987|FG000|Overall Study|Study Medication Sensitivity|0|||
46636190|NCT01522950|82809988|FG001|Overall Study|Study Medication Sensitivity|1|||
46636191|NCT01522950|82809989|FG002|Overall Study|Study Medication Sensitivity|0|||
46636192|NCT01522404|82809999|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
46636193|NCT01522404|82810000|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
46636194|NCT01522404|82809999|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
46752065|NCT00602030|82970363|FG000|Double-blind Phase|Ineligibility|0|||
46752066|NCT00602030|82970364|FG001|Double-blind Phase|Ineligibility|0|||
46752067|NCT00602030|82970365|FG002|Double-blind Phase|Ineligibility|0|||
46752068|NCT00602030|82970366|FG003|Double-blind Phase|Ineligibility|1|||
46752069|NCT00602030|82970367|FG004|Double-blind Phase|Ineligibility|0|||
46752070|NCT00602030|82970363|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
46752071|NCT00602030|82970364|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
46752072|NCT00602030|82970365|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
46752073|NCT00602030|82970366|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
46752074|NCT00602030|82970367|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
46752075|NCT00602030|82970363|FG000|Double-blind Phase|Reason not specified|0|||
46752076|NCT00602030|82970364|FG001|Double-blind Phase|Reason not specified|0|||
46752077|NCT00602030|82970365|FG002|Double-blind Phase|Reason not specified|4|||
46752078|NCT00602030|82970366|FG003|Double-blind Phase|Reason not specified|2|||
46752079|NCT00602030|82970367|FG004|Double-blind Phase|Reason not specified|0|||
46806160|NCT00569777|83025084|FG001|Overall Study|did not meet exclusion criteria|2|||
46806161|NCT00569777|83025083|FG000|Overall Study|pregnant|1|||
46636195|NCT01522404|82810000|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
46636196|NCT01522404|82809999|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
46636197|NCT01522404|82810000|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
46636198|NCT01570686|82810016|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46636199|NCT01570686|82810017|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46806162|NCT00569777|83025084|FG001|Overall Study|pregnant|0|||
46806163|NCT00569231|83025090|FG000|Overall Study|Study unrelated surgery|1|||
46806164|NCT00569231|83025090|FG000|Overall Study|Airfare expense|2|||
46636200|NCT01570686|82810016|FG000|Overall Study|Administrative problems|0|||
46636201|NCT01570686|82810017|FG001|Overall Study|Administrative problems|1|||
46752080|NCT00602030|82970363|FG000|Crossover Phase|Disease Progression|0|||
46752081|NCT00602030|82970364|FG001|Crossover Phase|Disease Progression|0|||
46806165|NCT00569231|83025090|FG000|Overall Study|Withdrawal by Subject|1|||
46806166|NCT00569231|83025090|FG000|Overall Study|Car accident injury|1|||
46806167|NCT00569231|83025090|FG000|Overall Study|Non-compliance|2|||
46806168|NCT00654095|83025094|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
46806169|NCT00654095|83025094|FG000|Overall Study|Elevated triglyceride level (2)|1|||
46925312|NCT02244463|83159723|FG000|Period 5: Phase II|Disease Progression|0|||
46636202|NCT01570686|82810016|FG000|Overall Study|Adverse Event|8|||
46636203|NCT01570686|82810017|FG001|Overall Study|Adverse Event|6|||
46636204|NCT01570686|82810016|FG000|Overall Study|Lost to Follow-up|4|||
46636205|NCT01570686|82810017|FG001|Overall Study|Lost to Follow-up|3|||
46636206|NCT01570686|82810016|FG000|Overall Study|Protocol Deviation|3|||
46636207|NCT01570686|82810017|FG001|Overall Study|Protocol Deviation|0|||
46636208|NCT01570686|82810016|FG000|Overall Study|Withdrawal by Subject|4|||
46636209|NCT01570686|82810017|FG001|Overall Study|Withdrawal by Subject|4|||
46636210|NCT01570686|82810016|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46636211|NCT01570686|82810017|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46636212|NCT01522248|82810025|FG000|Overall Study|Lost to Follow-up|1|||
46752082|NCT00602030|82970365|FG002|Crossover Phase|Disease Progression|0|||
46752083|NCT00602030|82970366|FG003|Crossover Phase|Disease Progression|0|||
46752084|NCT00602030|82970367|FG004|Crossover Phase|Disease Progression|11|||
46806170|NCT00654095|83025094|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
46806171|NCT00654095|83025094|FG000|Overall Study|Adverse Event|11|||
46806172|NCT00654095|83025094|FG000|Overall Study|Withdrawal by Subject|5|||
46806173|NCT00654095|83025094|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
46806174|NCT00654095|83025094|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
46806175|NCT00654095|83025094|FG000|Overall Study|Did not meet inclusion criteria|1|||
46806176|NCT00650585|83025100|FG000|Overall Study|Lost to Follow-up|505|||
46806177|NCT00650585|83025101|FG001|Overall Study|Lost to Follow-up|482|||
46806178|NCT00650585|83025100|FG000|Overall Study|No parental consent|935|||
46806179|NCT00650585|83025101|FG001|Overall Study|No parental consent|866|||
46806180|NCT00650585|83025100|FG000|Overall Study|Excluded/ruled ineligible|357|||
46806181|NCT00650585|83025101|FG001|Overall Study|Excluded/ruled ineligible|129|||
46806182|NCT00653939|83025109|FG000|Overall Study|Adverse Event|1|||
46806183|NCT00653939|83025110|FG001|Overall Study|Adverse Event|3|||
46806184|NCT00653939|83025109|FG000|Overall Study|Withdrawal by Subject|3|||
46925313|NCT02244463|83159724|FG001|Period 5: Phase II|Disease Progression|0|||
46925314|NCT02244463|83159725|FG002|Period 5: Phase II|Disease Progression|0|||
46925315|NCT02244463|83159726|FG003|Period 5: Phase II|Disease Progression|0|||
46925316|NCT02244463|83159727|FG004|Period 5: Phase II|Disease Progression|10|||
46925317|NCT02244463|83159728|FG005|Period 5: Phase II|Disease Progression|11|||
46925318|NCT02244463|83159723|FG000|Period 5: Phase II|Physician Decision|0|||
46925319|NCT02244463|83159724|FG001|Period 5: Phase II|Physician Decision|0|||
46636213|NCT01522248|82810026|FG001|Overall Study|Lost to Follow-up|0|||
46636214|NCT01543776|82810039|FG000|Overall Study|Withdrawal by Subject|2|||
46636215|NCT01543776|82810040|FG001|Overall Study|Withdrawal by Subject|2|||
46752085|NCT00602030|82970363|FG000|Crossover Phase|Adverse Event|0|||
46752086|NCT00602030|82970364|FG001|Crossover Phase|Adverse Event|0|||
46752087|NCT00602030|82970365|FG002|Crossover Phase|Adverse Event|0|||
46752088|NCT00602030|82970366|FG003|Crossover Phase|Adverse Event|0|||
46752089|NCT00602030|82970367|FG004|Crossover Phase|Adverse Event|3|||
46752090|NCT00602030|82970363|FG000|Crossover Phase|Consent withdrawal|0|||
46752091|NCT00602030|82970364|FG001|Crossover Phase|Consent withdrawal|0|||
46752092|NCT00602030|82970365|FG002|Crossover Phase|Consent withdrawal|0|||
46752093|NCT00602030|82970366|FG003|Crossover Phase|Consent withdrawal|0|||
46752094|NCT00602030|82970367|FG004|Crossover Phase|Consent withdrawal|2|||
46752095|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
46752096|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
46752097|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
46752098|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
46752099|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
46752100|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
46752101|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
46752102|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
46752103|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
46752104|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
46806185|NCT00653939|83025110|FG001|Overall Study|Withdrawal by Subject|3|||
46925320|NCT02244463|83159725|FG002|Period 5: Phase II|Physician Decision|0|||
46925321|NCT02244463|83159726|FG003|Period 5: Phase II|Physician Decision|0|||
46925322|NCT02244463|83159727|FG004|Period 5: Phase II|Physician Decision|3|||
46636216|NCT01518192|82810049|FG000|Overall Study|Lost to Follow-up|29|||
46636217|NCT01518192|82810050|FG001|Overall Study|Lost to Follow-up|26|||
46752105|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
46752106|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
46806186|NCT00653939|83025109|FG000|Overall Study|Physician Decision|4|||
46806187|NCT00653939|83025110|FG001|Overall Study|Physician Decision|0|||
46806188|NCT00653939|83025109|FG000|Overall Study|Disease Progression|2|||
46806189|NCT00653939|83025110|FG001|Overall Study|Disease Progression|3|||
46925323|NCT02244463|83159728|FG005|Period 5: Phase II|Physician Decision|2|||
46925324|NCT02244463|83159723|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
46806190|NCT00653939|83025109|FG000|Overall Study|Other|2|||
46806191|NCT00653939|83025110|FG001|Overall Study|Other|6|||
46806192|NCT00646451|83025118|FG000|Overall Study|Adverse Event|3|||
46806193|NCT00646451|83025119|FG001|Overall Study|Adverse Event|0|||
46806194|NCT00646451|83025118|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
47053091|NCT01826981|83322147|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
47053092|NCT01826981|83322148|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
47053093|NCT01826981|83322149|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
46806195|NCT00646451|83025119|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
46806196|NCT00642707|83025131|FG000|Overall Study|Adverse Event|0|||
46806197|NCT00642707|83025132|FG001|Overall Study|Adverse Event|0|||
46806198|NCT00642707|83025133|FG002|Overall Study|Adverse Event|0|||
46806199|NCT00642707|83025134|FG003|Overall Study|Adverse Event|2|||
46806200|NCT00642707|83025131|FG000|Overall Study|Withdrawal by Subject|1|||
46806201|NCT00642707|83025132|FG001|Overall Study|Withdrawal by Subject|0|||
46806202|NCT00642707|83025133|FG002|Overall Study|Withdrawal by Subject|0|||
46806203|NCT00642707|83025134|FG003|Overall Study|Withdrawal by Subject|0|||
46806204|NCT00568685|83025147|FG000|Overall Study|Adverse Event|2|||
46806205|NCT00568685|83025148|FG001|Overall Study|Adverse Event|3|||
46806206|NCT00568685|83025149|FG002|Overall Study|Adverse Event|3|||
46806207|NCT00568685|83025147|FG000|Overall Study|Withdrawal by Subject|7|||
46806208|NCT00568685|83025148|FG001|Overall Study|Withdrawal by Subject|2|||
46806209|NCT00568685|83025149|FG002|Overall Study|Withdrawal by Subject|2|||
46806210|NCT00568685|83025147|FG000|Overall Study|Protocol Violation|1|||
46806211|NCT00568685|83025148|FG001|Overall Study|Protocol Violation|0|||
46806212|NCT00568685|83025149|FG002|Overall Study|Protocol Violation|0|||
46806213|NCT00061945|83025163|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
46806214|NCT00061945|83025164|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
46806215|NCT00061945|83025163|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
46806216|NCT00061945|83025164|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
46806217|NCT00061945|83025163|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
46806218|NCT00061945|83025164|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
46806219|NCT00061945|83025163|FG000|Course IV: Alemtuzumab|Early exits|6|||
46806220|NCT00061945|83025164|FG001|Course IV: Alemtuzumab|Early exits|15|||
46806221|NCT00642473|83025175|FG000|Overall Study|Withdrawal by Subject|0|||
46806222|NCT00642473|83025176|FG001|Overall Study|Withdrawal by Subject|5|||
46806223|NCT00642473|83025175|FG000|Overall Study|Progression or death|2|||
46806224|NCT00642473|83025176|FG001|Overall Study|Progression or death|4|||
46806225|NCT00642473|83025175|FG000|Overall Study|Other|2|||
46806226|NCT00642473|83025176|FG001|Overall Study|Other|2|||
46806227|NCT00645671|83025187|FG000|Overall Study|Protocol Violation|1|||
46806228|NCT00645671|83025188|FG001|Overall Study|Protocol Violation|0|||
46806229|NCT00645671|83025187|FG000|Overall Study|Withdrawal by Subject|0|||
46806230|NCT00645671|83025188|FG001|Overall Study|Withdrawal by Subject|4|||
46806231|NCT00645671|83025187|FG000|Overall Study|Adverse Event|0|||
46806232|NCT00645671|83025188|FG001|Overall Study|Adverse Event|1|||
46806233|NCT00645671|83025187|FG000|Overall Study|Physician Decision|0|||
46806234|NCT00645671|83025188|FG001|Overall Study|Physician Decision|1|||
46806235|NCT00366340|83025196|FG000|Infant Series|Protocol Violation|3|||
46806236|NCT00366340|83025197|FG001|Infant Series|Protocol Violation|4|||
46806237|NCT00366340|83025196|FG000|Infant Series|Withdrawal by Subject|3|||
46806238|NCT00366340|83025197|FG001|Infant Series|Withdrawal by Subject|3|||
47053094|NCT01826981|83322150|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
47053095|NCT01826981|83322151|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
47053096|NCT01826981|83322152|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
46806239|NCT00366340|83025196|FG000|Infant Series|Adverse Event|0|||
46806240|NCT00366340|83025197|FG001|Infant Series|Adverse Event|2|||
46806241|NCT00366340|83025196|FG000|Infant Series|Lost to Follow-up|1|||
46806242|NCT00366340|83025197|FG001|Infant Series|Lost to Follow-up|1|||
46806243|NCT00366340|83025196|FG000|Infant Series|Failure to return|1|||
46806244|NCT00366340|83025197|FG001|Infant Series|Failure to return|0|||
46806245|NCT00366340|83025196|FG000|After the Infant Series|Parent/legal guardian request|1|||
46806246|NCT00366340|83025197|FG001|After the Infant Series|Parent/legal guardian request|1|||
46806247|NCT00366340|83025196|FG000|After the Infant Series|Failed to return|0|||
46806248|NCT00366340|83025197|FG001|After the Infant Series|Failed to return|1|||
46806249|NCT00366340|83025196|FG000|After the Infant Series|Protocol Violation|2|||
46806250|NCT00366340|83025197|FG001|After the Infant Series|Protocol Violation|2|||
46806251|NCT00366340|83025196|FG000|After the Infant Series|Adverse Event|0|||
46806252|NCT00366340|83025197|FG001|After the Infant Series|Adverse Event|1|||
46806253|NCT00366340|83025196|FG000|After the Infant Series|Lost to Follow-up|0|||
46806254|NCT00366340|83025197|FG001|After the Infant Series|Lost to Follow-up|1|||
46806255|NCT00366340|83025196|FG000|Toddler Dose|Failed to return|1|||
46806256|NCT00366340|83025197|FG001|Toddler Dose|Failed to return|0|||
46806257|NCT00366340|83025196|FG000|Toddler Dose|Parent/legal guardian request|0|||
46806258|NCT00366340|83025197|FG001|Toddler Dose|Parent/legal guardian request|1|||
47053097|NCT01804049|83322224|FG000|Overall Study|Adverse Event|2|||
47053098|NCT01804049|83322225|FG001|Overall Study|Adverse Event|10|||
47053099|NCT01804049|83322224|FG000|Overall Study|Lost to Follow-up|2|||
47053100|NCT01804049|83322225|FG001|Overall Study|Lost to Follow-up|1|||
46806259|NCT00061633|83025229|FG000|Overall Study|Adverse Event|1|||
46806260|NCT00061633|83025230|FG001|Overall Study|Adverse Event|2|||
46925325|NCT02244463|83159724|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
47053101|NCT01804049|83322224|FG000|Overall Study|Decreased interest/personal|4|||
47053102|NCT01804049|83322225|FG001|Overall Study|Decreased interest/personal|5|||
47053103|NCT01804049|83322224|FG000|Overall Study|Other health concerns|2|||
47053104|NCT01804049|83322225|FG001|Overall Study|Other health concerns|7|||
47053105|NCT01804049|83322224|FG000|Overall Study|Moved out of area|0|||
47053106|NCT01804049|83322225|FG001|Overall Study|Moved out of area|7|||
47053107|NCT01804049|83322224|FG000|Overall Study|other MD recommended|1|||
47053108|NCT01804049|83322225|FG001|Overall Study|other MD recommended|1|||
47053109|NCT01804049|83322224|FG000|Overall Study|Enrollment in dual studies|0|||
47053110|NCT01804049|83322225|FG001|Overall Study|Enrollment in dual studies|1|||
47053111|NCT01826825|83322235|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
46752107|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
46752108|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
47053112|NCT01826825|83322236|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
47053113|NCT01803737|83322246|FG000|Overall Study|Lack of Time|1|||
47053114|NCT01803737|83322247|FG001|Overall Study|Lack of Time|0|||
47053115|NCT01803737|83322246|FG000|Overall Study|Medical Reason|0|||
47053116|NCT01803737|83322247|FG001|Overall Study|Medical Reason|1|||
47053117|NCT01803737|83322246|FG000|Overall Study|Lost to Follow-up|0|||
47053118|NCT01803737|83322247|FG001|Overall Study|Lost to Follow-up|2|||
47053119|NCT01826201|83322253|FG000|Overall Study|Non compliance with protocol|4|||
47053120|NCT01803269|83322284|FG000|Overall Study|Withdrawal by Subject|3|||
47053121|NCT01803269|83322285|FG001|Overall Study|Withdrawal by Subject|0|||
47053122|NCT01803269|83322286|FG002|Overall Study|Withdrawal by Subject|0|||
47053123|NCT01802879|83322294|FG000|Overall Study|Administrative problems|2|||
47053124|NCT01802879|83322294|FG000|Overall Study|Disease progression|6|||
47053125|NCT01825577|83322298|FG000|Overall Study|Physician Decision|2|||
47053126|NCT01825577|83322298|FG000|Overall Study|Withdrawal by Subject|1|||
47053127|NCT01825577|83322298|FG000|Overall Study|Withdrawn by family members|2|||
47053128|NCT01825577|83322298|FG000|Overall Study|Lack of Efficacy|3|||
47053129|NCT01802411|83322304|FG000|Overall Study|Death|2|||
46752109|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
46752110|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
47053130|NCT01802411|83322305|FG001|Overall Study|Death|1|||
47053131|NCT01802411|83322304|FG000|Overall Study|Adverse Event|2|||
47053132|NCT01802411|83322305|FG001|Overall Study|Adverse Event|7|||
47053133|NCT01802411|83322304|FG000|Overall Study|Lack of Efficacy|8|||
47053134|NCT01802411|83322305|FG001|Overall Study|Lack of Efficacy|10|||
47053135|NCT01802411|83322304|FG000|Overall Study|Withdrawal by Subject|0|||
47053136|NCT01802411|83322305|FG001|Overall Study|Withdrawal by Subject|2|||
47053137|NCT01802411|83322304|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
47053138|NCT01802411|83322305|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
47053139|NCT01802411|83322304|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
47053140|NCT01802411|83322305|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
47053141|NCT01802411|83322304|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
47053142|NCT01802411|83322305|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
47053143|NCT02963610|83322346|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
47053144|NCT01802333|83322567|FG000|Overall Study|Ineligible|2|||
46752111|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
46752112|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
46752113|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
46806261|NCT00061633|83025229|FG000|Overall Study|Withdrawal by Subject|2|||
46806262|NCT00061633|83025230|FG001|Overall Study|Withdrawal by Subject|2|||
46925326|NCT02244463|83159725|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
46925327|NCT02244463|83159726|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
46925328|NCT02244463|83159727|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
46925329|NCT02244463|83159728|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
46925330|NCT02244463|83159723|FG000|Period 5: Phase II|Intercurrent Illness|0|||
46806263|NCT00061633|83025229|FG000|Overall Study|Lost to Follow-up|1|||
46925331|NCT02244463|83159724|FG001|Period 5: Phase II|Intercurrent Illness|0|||
46925332|NCT02244463|83159725|FG002|Period 5: Phase II|Intercurrent Illness|0|||
46925333|NCT02244463|83159726|FG003|Period 5: Phase II|Intercurrent Illness|0|||
46925334|NCT02244463|83159727|FG004|Period 5: Phase II|Intercurrent Illness|2|||
46925335|NCT02244463|83159728|FG005|Period 5: Phase II|Intercurrent Illness|0|||
47053145|NCT01802333|83322568|FG001|Overall Study|Ineligible|6|||
47053146|NCT01802333|83322569|FG002|Overall Study|Ineligible|8|||
47053147|NCT01802333|83322567|FG000|Overall Study|Adverse Event|1|||
47053148|NCT01802333|83322568|FG001|Overall Study|Adverse Event|8|||
46752114|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
46752115|NCT00549757|82970381|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
46752116|NCT00549757|82970382|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
46752117|NCT00549757|82970381|FG000|Extension Period (in Average 9 Months)|Death|143|||
46752118|NCT00549757|82970382|FG001|Extension Period (in Average 9 Months)|Death|136|||
46752119|NCT00549757|82970381|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
46752120|NCT00549757|82970382|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
46806264|NCT00061633|83025230|FG001|Overall Study|Lost to Follow-up|4|||
46806265|NCT00061633|83025229|FG000|Overall Study|Other|1|||
46806266|NCT00061633|83025230|FG001|Overall Study|Other|1|||
46925336|NCT02244463|83159723|FG000|Period 5: Phase II|Adverse Event|0|||
46925337|NCT02244463|83159724|FG001|Period 5: Phase II|Adverse Event|0|||
46925338|NCT02244463|83159725|FG002|Period 5: Phase II|Adverse Event|0|||
46925339|NCT02244463|83159726|FG003|Period 5: Phase II|Adverse Event|0|||
46925340|NCT02244463|83159727|FG004|Period 5: Phase II|Adverse Event|0|||
46925341|NCT02244463|83159728|FG005|Period 5: Phase II|Adverse Event|2|||
46925342|NCT02244463|83159723|FG000|Period 5: Phase II|Still On treatment|0|||
46925343|NCT02244463|83159724|FG001|Period 5: Phase II|Still On treatment|0|||
46925344|NCT02244463|83159725|FG002|Period 5: Phase II|Still On treatment|0|||
46925345|NCT02244463|83159726|FG003|Period 5: Phase II|Still On treatment|0|||
46806267|NCT00061633|83025229|FG000|Overall Study|Never received study treatment|0|||
46806268|NCT00061633|83025230|FG001|Overall Study|Never received study treatment|2|||
46806269|NCT00645593|83025238|FG000|Overall Study|Later found to be ineligible|1|||
46806270|NCT00645593|83025239|FG001|Overall Study|Later found to be ineligible|0|||
46806271|NCT03832738|83025248|FG000|Overall Study|Withdrawal by Subject|6|||
46806272|NCT03832738|83025249|FG001|Overall Study|Withdrawal by Subject|7|||
46806273|NCT03832738|83025250|FG002|Overall Study|Withdrawal by Subject|16|||
46806274|NCT03832738|83025248|FG000|Overall Study|Physician Decision|0|||
46806275|NCT03832738|83025249|FG001|Overall Study|Physician Decision|1|||
46806276|NCT03832738|83025250|FG002|Overall Study|Physician Decision|2|||
46806277|NCT03832738|83025248|FG000|Overall Study|Adverse Event|2|||
46806278|NCT03832738|83025249|FG001|Overall Study|Adverse Event|3|||
46806279|NCT03832738|83025250|FG002|Overall Study|Adverse Event|1|||
46806280|NCT03832738|83025248|FG000|Overall Study|Pregnancy|0|||
46806281|NCT03832738|83025249|FG001|Overall Study|Pregnancy|1|||
46806282|NCT03832738|83025250|FG002|Overall Study|Pregnancy|0|||
46806283|NCT00046891|83025260|FG000|Overall Study|Cancels|5|||
46806284|NCT00046891|83025261|FG001|Overall Study|Cancels|9|||
46806285|NCT00046891|83025260|FG000|Overall Study|Ineligible|1|||
46806286|NCT00046891|83025261|FG001|Overall Study|Ineligible|1|||
46806287|NCT00046891|83025260|FG000|Overall Study|Withdrawal by Subject|18|||
46806288|NCT00046891|83025261|FG001|Overall Study|Withdrawal by Subject|15|||
46806289|NCT00046891|83025260|FG000|Overall Study|Adverse Event|5|||
46806290|NCT00046891|83025261|FG001|Overall Study|Adverse Event|5|||
46806291|NCT00365794|83025275|FG000|Overall Study|Withdrawal by Subject|2|||
46806292|NCT00383500|83025283|FG000|Overall Study|Withdrawal by Subject|8|||
46806293|NCT00383500|83025284|FG001|Overall Study|Withdrawal by Subject|3|||
46806294|NCT00383500|83025285|FG002|Overall Study|Withdrawal by Subject|0|||
46806295|NCT00383500|83025283|FG000|Overall Study|Lost to Follow-up|0|||
46806296|NCT00383500|83025284|FG001|Overall Study|Lost to Follow-up|0|||
46806297|NCT00383500|83025285|FG002|Overall Study|Lost to Follow-up|2|||
46806298|NCT00365716|83025299|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
46806299|NCT00365716|83025300|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
46806300|NCT00365716|83025301|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
46806301|NCT00365716|83025302|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
46925346|NCT02244463|83159727|FG004|Period 5: Phase II|Still On treatment|0|||
46925347|NCT02244463|83159728|FG005|Period 5: Phase II|Still On treatment|3|||
46925348|NCT02038777|83159765|FG000|Overall Study|Death|0|||
46925349|NCT02038777|83159766|FG001|Overall Study|Death|2|||
46925350|NCT02038777|83159767|FG002|Overall Study|Death|0|||
46636218|NCT01518192|82810051|FG002|Overall Study|Lost to Follow-up|35|||
46636219|NCT01517802|82810065|FG000|Overall Study|Death|1|||
46636220|NCT01520922|82810071|FG000|Treatment Phase|Physician Decision|2|||
46636221|NCT01520922|82810072|FG001|Treatment Phase|Physician Decision|1|||
46636222|NCT01520922|82810071|FG000|Treatment Phase|Progression|0|||
46636223|NCT01520922|82810072|FG001|Treatment Phase|Progression|2|||
46752121|NCT00549757|82970381|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
46752122|NCT00549757|82970382|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
46806302|NCT00365716|83025303|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
46806303|NCT00365716|83025304|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
46806304|NCT00365716|83025305|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
46806305|NCT00365716|83025299|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
46806306|NCT00365716|83025300|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
46806307|NCT00365716|83025301|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
46806308|NCT00365716|83025302|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
46925351|NCT02038777|83159768|FG003|Overall Study|Death|1|||
46925352|NCT02038777|83159769|FG004|Overall Study|Death|2|||
46925353|NCT02038777|83159770|FG005|Overall Study|Death|4|||
46925354|NCT02038777|83159771|FG006|Overall Study|Death|0|||
46752123|NCT00549757|82970381|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
46752124|NCT00549757|82970382|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
46752125|NCT00549601|82970397|FG000|Randomized|Protocol Violation|0|||
46752126|NCT00549601|82970398|FG001|Randomized|Protocol Violation|0|||
46752127|NCT00549601|82970399|FG002|Randomized|Protocol Violation|1|||
46752128|NCT00549601|82970397|FG000|Randomized|Withdrawal by Subject|0|||
46752129|NCT00549601|82970398|FG001|Randomized|Withdrawal by Subject|1|||
46752130|NCT00549601|82970399|FG002|Randomized|Withdrawal by Subject|1|||
46752131|NCT00549601|82970397|FG000|Received Study Drug|Adverse Event|2|||
46752132|NCT00549601|82970398|FG001|Received Study Drug|Adverse Event|5|||
46752133|NCT00549601|82970399|FG002|Received Study Drug|Adverse Event|1|||
46752134|NCT00549601|82970397|FG000|Received Study Drug|Death|0|||
46752135|NCT00549601|82970398|FG001|Received Study Drug|Death|1|||
46752136|NCT00549601|82970399|FG002|Received Study Drug|Death|0|||
46752137|NCT00549601|82970397|FG000|Received Study Drug|Lost to Follow-up|0|||
46752138|NCT00549601|82970398|FG001|Received Study Drug|Lost to Follow-up|1|||
46752139|NCT00549601|82970399|FG002|Received Study Drug|Lost to Follow-up|1|||
46752140|NCT00549601|82970397|FG000|Received Study Drug|Protocol Violation|3|||
46752141|NCT00549601|82970398|FG001|Received Study Drug|Protocol Violation|4|||
46752142|NCT00549601|82970399|FG002|Received Study Drug|Protocol Violation|1|||
46752143|NCT00549601|82970397|FG000|Received Study Drug|Withdrawal by Subject|2|||
46752144|NCT00549601|82970398|FG001|Received Study Drug|Withdrawal by Subject|0|||
46752145|NCT00549601|82970399|FG002|Received Study Drug|Withdrawal by Subject|1|||
46752146|NCT00601640|82970425|FG000|Overall Study|Withdrawal by Subject|3|||
46752147|NCT00601640|82970426|FG001|Overall Study|Withdrawal by Subject|0|||
46752148|NCT00601640|82970427|FG002|Overall Study|Withdrawal by Subject|7|||
46752149|NCT00601640|82970425|FG000|Overall Study|Death|1|||
46752150|NCT00601640|82970426|FG001|Overall Study|Death|0|||
46752151|NCT00601640|82970427|FG002|Overall Study|Death|0|||
46752152|NCT00601640|82970425|FG000|Overall Study|Adverse Event|0|||
46752153|NCT00601640|82970426|FG001|Overall Study|Adverse Event|4|||
46752154|NCT00601640|82970427|FG002|Overall Study|Adverse Event|2|||
46752155|NCT00601640|82970425|FG000|Overall Study|intercurrent illness|1|||
46752156|NCT00601640|82970426|FG001|Overall Study|intercurrent illness|0|||
46752157|NCT00601640|82970427|FG002|Overall Study|intercurrent illness|0|||
46752158|NCT00601640|82970425|FG000|Overall Study|change in eligibility status|0|||
46752159|NCT00601640|82970426|FG001|Overall Study|change in eligibility status|1|||
46752160|NCT00601640|82970427|FG002|Overall Study|change in eligibility status|1|||
46752161|NCT02805725|82970442|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
46752162|NCT02805725|82970443|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
46752163|NCT02805725|82970444|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
46752164|NCT02805725|82970445|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
46752165|NCT02805725|82970446|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
46752166|NCT02805725|82970442|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
46752167|NCT02805725|82970443|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
46752168|NCT02805725|82970444|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
46752169|NCT02805725|82970445|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
46752170|NCT02805725|82970446|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
46752171|NCT02805725|82970442|FG000|Phase II|Protocol Violation|0|||
46752172|NCT02805725|82970443|FG001|Phase II|Protocol Violation|0|||
46752173|NCT02805725|82970444|FG002|Phase II|Protocol Violation|0|||
46752174|NCT02805725|82970445|FG003|Phase II|Protocol Violation|0|||
46752175|NCT02805725|82970446|FG004|Phase II|Protocol Violation|6|||
46752176|NCT00546871|82970463|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
46752177|NCT00546871|82970464|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
46752178|NCT00546871|82970463|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
46752179|NCT00546871|82970464|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
46752180|NCT00546871|82970463|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
46752181|NCT00546871|82970464|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
46752182|NCT00546871|82970463|FG000|Study Extension Period|Protocol Violation|1|||
46752183|NCT00546871|82970464|FG001|Study Extension Period|Protocol Violation|0|||
46752184|NCT00546871|82970463|FG000|Study Extension Period|Withdrawal by Subject|0|||
46752185|NCT00546871|82970464|FG001|Study Extension Period|Withdrawal by Subject|1|||
46752186|NCT03951805|82970497|FG000|Overall Study|Adverse Event|1|||
46752187|NCT03951805|82970498|FG001|Overall Study|Adverse Event|0|||
46752188|NCT03951805|82970499|FG002|Overall Study|Adverse Event|0|||
46752189|NCT03951805|82970500|FG003|Overall Study|Adverse Event|0|||
46925355|NCT02038777|83159772|FG007|Overall Study|Death|10|||
46925356|NCT02038777|83159765|FG000|Overall Study|Lost to Follow-up|0|||
46806309|NCT00365716|83025303|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
46806310|NCT00365716|83025304|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
46806311|NCT00365716|83025305|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
46806312|NCT00365716|83025299|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
46806313|NCT00365716|83025300|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
46806314|NCT00365716|83025301|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
46806315|NCT00365716|83025302|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
46806316|NCT00365716|83025303|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
46806317|NCT00365716|83025304|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
46806318|NCT00365716|83025305|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
46806319|NCT00365716|83025299|FG000|Base Study (Day 1 to Month 7)|Other|0|||
46806320|NCT00365716|83025300|FG001|Base Study (Day 1 to Month 7)|Other|1|||
46806321|NCT00365716|83025301|FG002|Base Study (Day 1 to Month 7)|Other|0|||
46806322|NCT00365716|83025302|FG003|Base Study (Day 1 to Month 7)|Other|0|||
46806323|NCT00365716|83025303|FG004|Base Study (Day 1 to Month 7)|Other|0|||
46806324|NCT00365716|83025304|FG005|Base Study (Day 1 to Month 7)|Other|0|||
46806325|NCT00365716|83025305|FG006|Base Study (Day 1 to Month 7)|Other|0|||
46806326|NCT00365716|83025299|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
46806327|NCT00365716|83025300|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
46806328|NCT00365716|83025301|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
46806329|NCT00365716|83025302|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
46806330|NCT00365716|83025303|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
46806331|NCT00365716|83025304|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
46806332|NCT00365716|83025305|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
46806333|NCT00365716|83025299|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
46806334|NCT00365716|83025300|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
46806335|NCT00365716|83025301|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
46806336|NCT00365716|83025302|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
46806337|NCT00365716|83025303|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
46806338|NCT00365716|83025304|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
46752190|NCT03944707|82970512|FG000|Overall Study|Adverse Event|0|||
46752191|NCT03944707|82970513|FG001|Overall Study|Adverse Event|2|||
46752192|NCT03944707|82970512|FG000|Overall Study|Study terminated by sponsor|12|||
46752193|NCT03944707|82970513|FG001|Overall Study|Study terminated by sponsor|7|||
46752194|NCT03944707|82970512|FG000|Overall Study|Subject decision|0|||
46752195|NCT03944707|82970513|FG001|Overall Study|Subject decision|1|||
46752196|NCT00549055|82970519|FG000|Overall Study|Adverse Event|4|||
46752197|NCT00549055|82970519|FG000|Overall Study|Lack of Efficacy|18|||
46806339|NCT00365716|83025305|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
46752198|NCT00549055|82970519|FG000|Overall Study|Stabilization|5|||
46806340|NCT00365716|83025299|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
46752199|NCT00549055|82970519|FG000|Overall Study|Progression to fibrosis|2|||
46752200|NCT00549055|82970519|FG000|Overall Study|Decrease of size|1|||
46752201|NCT00549055|82970519|FG000|Overall Study|Active choroidal neovascula increased|1|||
46752202|NCT00549055|82970519|FG000|Overall Study|Vitreous hemorrhage|1|||
46752203|NCT00549055|82970519|FG000|Overall Study|Growth choroidal neovascularisation|1|||
46752204|NCT00549055|82970519|FG000|Overall Study|Choroidal neovascularization|1|||
46752205|NCT00549055|82970519|FG000|Overall Study|Very low visual acuity (VA)|1|||
46752206|NCT00883116|82970525|FG000|Overall Study|Adverse event unrelated to study drug|5|||
46752207|NCT00883116|82970526|FG001|Overall Study|Adverse event unrelated to study drug|10|||
46752208|NCT00883116|82970525|FG000|Overall Study|Death|6|||
46925357|NCT02038777|83159766|FG001|Overall Study|Lost to Follow-up|0|||
46925358|NCT02038777|83159767|FG002|Overall Study|Lost to Follow-up|0|||
46925359|NCT02038777|83159768|FG003|Overall Study|Lost to Follow-up|1|||
46925360|NCT02038777|83159769|FG004|Overall Study|Lost to Follow-up|0|||
46925361|NCT02038777|83159770|FG005|Overall Study|Lost to Follow-up|0|||
46752209|NCT00883116|82970526|FG001|Overall Study|Death|2|||
46925362|NCT02038777|83159771|FG006|Overall Study|Lost to Follow-up|0|||
46925363|NCT02038777|83159772|FG007|Overall Study|Lost to Follow-up|0|||
46925364|NCT02038777|83159765|FG000|Overall Study|Other|0|||
47053149|NCT01802333|83322569|FG002|Overall Study|Adverse Event|8|||
47053150|NCT01802333|83322567|FG000|Overall Study|Withdrawal by Subject|6|||
46752210|NCT00883116|82970525|FG000|Overall Study|Disease progression|130|||
46752211|NCT00883116|82970526|FG001|Overall Study|Disease progression|128|||
46752212|NCT00883116|82970525|FG000|Overall Study|Lost to Follow-up|0|||
46752213|NCT00883116|82970526|FG001|Overall Study|Lost to Follow-up|1|||
46752214|NCT00883116|82970525|FG000|Overall Study|Maximum clinical benefit|13|||
46752215|NCT00883116|82970526|FG001|Overall Study|Maximum clinical benefit|46|||
46752216|NCT00883116|82970525|FG000|Overall Study|Not identified|3|||
46752217|NCT00883116|82970526|FG001|Overall Study|Not identified|6|||
46752218|NCT00883116|82970525|FG000|Overall Study|Study drug toxicity|36|||
46752219|NCT00883116|82970526|FG001|Overall Study|Study drug toxicity|16|||
46752220|NCT00883116|82970525|FG000|Overall Study|Withdrawal by Subject|14|||
46806341|NCT00365716|83025300|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
46806342|NCT00365716|83025301|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
46752221|NCT00883116|82970526|FG001|Overall Study|Withdrawal by Subject|8|||
46752222|NCT00883116|82970525|FG000|Overall Study|No longer meets study criteria|2|||
46752223|NCT00883116|82970526|FG001|Overall Study|No longer meets study criteria|2|||
46752224|NCT00594399|82970545|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
46752225|NCT00594399|82970546|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
46752226|NCT00594399|82970547|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
46752227|NCT00594399|82970545|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
46752228|NCT00594399|82970546|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
46752229|NCT00594399|82970547|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
46752230|NCT00594399|82970545|FG000|Initial 3 Month Counseling|Personal issues|2|||
46752231|NCT00594399|82970546|FG001|Initial 3 Month Counseling|Personal issues|0|||
46752232|NCT00594399|82970547|FG002|Initial 3 Month Counseling|Personal issues|0|||
46752233|NCT00594399|82970545|FG000|Initial 3 Month Counseling|Too busy|7|||
46752234|NCT00594399|82970546|FG001|Initial 3 Month Counseling|Too busy|1|||
46752235|NCT00594399|82970547|FG002|Initial 3 Month Counseling|Too busy|0|||
46752236|NCT00594399|82970545|FG000|Initial 3 Month Counseling|Pain|2|||
46752237|NCT00594399|82970546|FG001|Initial 3 Month Counseling|Pain|0|||
46752238|NCT00594399|82970547|FG002|Initial 3 Month Counseling|Pain|0|||
46752239|NCT00594399|82970545|FG000|Initial 3 Month Counseling|Moved|1|||
46752240|NCT00594399|82970546|FG001|Initial 3 Month Counseling|Moved|0|||
46752241|NCT00594399|82970547|FG002|Initial 3 Month Counseling|Moved|0|||
46752242|NCT00594399|82970545|FG000|Initial 3 Month Counseling|Family illness|1|||
46752243|NCT00594399|82970546|FG001|Initial 3 Month Counseling|Family illness|0|||
46752244|NCT00594399|82970547|FG002|Initial 3 Month Counseling|Family illness|0|||
46752245|NCT00594399|82970545|FG000|Rerandomization Arm 1 Only|Death|2|||
46752246|NCT00594399|82970546|FG001|Rerandomization Arm 1 Only|Death|1|||
46752247|NCT00594399|82970547|FG002|Rerandomization Arm 1 Only|Death|0|||
46752248|NCT00594399|82970545|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
46752249|NCT00594399|82970546|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
46752250|NCT00594399|82970547|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
46752251|NCT00546715|82970557|FG000|Overall Study|Withdrawal by Subject|0|||
46752252|NCT00546715|82970558|FG001|Overall Study|Withdrawal by Subject|1|||
46752253|NCT00546715|82970559|FG002|Overall Study|Withdrawal by Subject|0|||
46752254|NCT00546715|82970560|FG003|Overall Study|Withdrawal by Subject|0|||
46752255|NCT00874029|82970570|FG000|Overall Study|Withdrawal by Subject|10|||
46752256|NCT00874029|82970570|FG000|Overall Study|Pregnancy|4|||
46752257|NCT00874029|82970570|FG000|Overall Study|Physician Decision|1|||
46752258|NCT00874029|82970570|FG000|Overall Study|Adverse Event|1|||
46752259|NCT00874029|82970570|FG000|Overall Study|Lost to Follow-up|5|||
46752260|NCT00546637|82970586|FG000|Overall Study|Adverse Event|46|||
46752261|NCT00546637|82970587|FG001|Overall Study|Adverse Event|20|||
46752262|NCT00546637|82970586|FG000|Overall Study|Lack of Efficacy|5|||
46752263|NCT00546637|82970587|FG001|Overall Study|Lack of Efficacy|5|||
46752264|NCT00546637|82970586|FG000|Overall Study|Lost to Follow-up|2|||
46752265|NCT00546637|82970587|FG001|Overall Study|Lost to Follow-up|2|||
46752266|NCT00546637|82970586|FG000|Overall Study|Other|10|||
46752267|NCT00546637|82970587|FG001|Overall Study|Other|12|||
46752268|NCT00546637|82970586|FG000|Overall Study|Withdrawal by Subject|7|||
46752269|NCT00546637|82970587|FG001|Overall Study|Withdrawal by Subject|9|||
46752270|NCT00546637|82970586|FG000|Overall Study|Randomized, but not treated|3|||
46752271|NCT00546637|82970587|FG001|Overall Study|Randomized, but not treated|1|||
46752272|NCT00546481|82970595|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
46752273|NCT00546481|82970596|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
46752274|NCT00546481|82970597|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
46752275|NCT00546481|82970595|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
46752276|NCT00546481|82970596|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
46752277|NCT00546481|82970597|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
46752278|NCT00546481|82970595|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
46752279|NCT00546481|82970596|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
46752280|NCT00546481|82970597|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
46752281|NCT00546481|82970595|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
46752282|NCT00546481|82970596|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
46752283|NCT00546481|82970597|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
46752284|NCT00546481|82970595|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
46752285|NCT00546481|82970596|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
46752286|NCT00546481|82970597|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
46752287|NCT00546481|82970595|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
46752288|NCT00546481|82970596|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
46752289|NCT00546481|82970597|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
46752290|NCT00546481|82970595|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
46752291|NCT00546481|82970596|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
46752292|NCT00546481|82970597|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
46752293|NCT00546481|82970595|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
46752294|NCT00546481|82970596|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
46752295|NCT00546481|82970597|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
46752296|NCT00546481|82970595|FG000|Maintenance Phase (CERA)|Other Reason|0|||
46752297|NCT00546481|82970596|FG001|Maintenance Phase (CERA)|Other Reason|0|||
46752298|NCT00546481|82970597|FG002|Maintenance Phase (CERA)|Other Reason|1|||
46752299|NCT00880698|82970609|FG000|Overall Study|Death|0|||
46752300|NCT00880698|82970610|FG001|Overall Study|Death|0|||
46752301|NCT00880698|82970611|FG002|Overall Study|Death|1|||
46752302|NCT00880698|82970612|FG003|Overall Study|Death|2|||
46752303|NCT00880698|82970609|FG000|Overall Study|Lost to Follow-up|1|||
46752304|NCT00880698|82970610|FG001|Overall Study|Lost to Follow-up|3|||
46752305|NCT00880698|82970611|FG002|Overall Study|Lost to Follow-up|0|||
46752306|NCT00880698|82970612|FG003|Overall Study|Lost to Follow-up|1|||
46752307|NCT05742841|82970624|FG000|Overall Study|Withdrawal by Subject|1|||
46752308|NCT05742841|82970624|FG000|Overall Study|Lost to Follow-up|1|||
46752309|NCT04668144|82970667|FG000|Overall Study|Protocol Violation|0|||
46752310|NCT04668144|82970668|FG001|Overall Study|Protocol Violation|1|||
46752311|NCT04668144|82970669|FG002|Overall Study|Protocol Violation|2|||
46752312|NCT04640194|82970684|FG000|Overall Study|Adverse Event|3|||
46752313|NCT04640194|82970685|FG001|Overall Study|Adverse Event|7|||
46752314|NCT04640194|82970686|FG002|Overall Study|Adverse Event|0|||
46752315|NCT04640194|82970687|FG003|Overall Study|Adverse Event|5|||
46752316|NCT04640194|82970688|FG004|Overall Study|Adverse Event|0|||
46752317|NCT04640194|82970689|FG005|Overall Study|Adverse Event|4|||
46752318|NCT04640194|82970690|FG006|Overall Study|Adverse Event|0|||
46752319|NCT04640194|82970684|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
46752320|NCT04640194|82970685|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
46752321|NCT04640194|82970686|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
46752322|NCT04640194|82970687|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
46752323|NCT04640194|82970688|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
46752324|NCT04640194|82970689|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
46752325|NCT04640194|82970690|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
46752326|NCT04640194|82970684|FG000|Overall Study|fibrinogen level too low|0|||
46752327|NCT04640194|82970685|FG001|Overall Study|fibrinogen level too low|0|||
46752328|NCT04640194|82970686|FG002|Overall Study|fibrinogen level too low|0|||
46752329|NCT04640194|82970687|FG003|Overall Study|fibrinogen level too low|1|||
46752330|NCT04640194|82970688|FG004|Overall Study|fibrinogen level too low|0|||
46752331|NCT04640194|82970689|FG005|Overall Study|fibrinogen level too low|0|||
46752332|NCT04640194|82970690|FG006|Overall Study|fibrinogen level too low|0|||
46752333|NCT04640194|82970684|FG000|Overall Study|mild bleeding|0|||
46752334|NCT04640194|82970685|FG001|Overall Study|mild bleeding|0|||
46752335|NCT04640194|82970686|FG002|Overall Study|mild bleeding|0|||
46752336|NCT04640194|82970687|FG003|Overall Study|mild bleeding|1|||
46752337|NCT04640194|82970688|FG004|Overall Study|mild bleeding|0|||
46752338|NCT04640194|82970689|FG005|Overall Study|mild bleeding|0|||
46752339|NCT04640194|82970690|FG006|Overall Study|mild bleeding|0|||
46806343|NCT00365716|83025302|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
46806344|NCT00365716|83025303|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
46806345|NCT00365716|83025304|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
46806346|NCT00365716|83025305|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
46806347|NCT00365716|83025299|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
46806348|NCT00365716|83025300|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
46806349|NCT00365716|83025301|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
46806350|NCT00365716|83025302|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
46806351|NCT00365716|83025303|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
46806352|NCT00365716|83025304|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
46806353|NCT00365716|83025305|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
46806354|NCT00365716|83025299|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
46806355|NCT00365716|83025300|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
47053151|NCT01802333|83322568|FG001|Overall Study|Withdrawal by Subject|6|||
46806356|NCT00365716|83025301|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
46806357|NCT00365716|83025302|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
46806358|NCT00365716|83025303|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
47053152|NCT01802333|83322569|FG002|Overall Study|Withdrawal by Subject|5|||
46752340|NCT04640194|82970684|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
46752341|NCT04640194|82970685|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
46752342|NCT04640194|82970686|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
47053153|NCT01802333|83322567|FG000|Overall Study|Progression/relapse|1|||
46752343|NCT04640194|82970687|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
46752344|NCT04640194|82970688|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
46752345|NCT04640194|82970689|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
46806359|NCT00365716|83025304|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
46806360|NCT00365716|83025305|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
46806361|NCT00365716|83025299|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
46806362|NCT00365716|83025300|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
46806363|NCT00365716|83025301|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
46806364|NCT00365716|83025302|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
46806365|NCT00365716|83025303|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
46806366|NCT00365716|83025304|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
46806367|NCT00365716|83025305|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
46806368|NCT00365716|83025299|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
46806369|NCT00365716|83025300|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
46752346|NCT04640194|82970690|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
46752347|NCT04590014|82970719|FG000|Overall Study|Withdrawal by Subject|1|||
46752348|NCT04590014|82970720|FG001|Overall Study|Withdrawal by Subject|0|||
46752349|NCT04588259|82970729|FG000|Run-in Period|Run-in failure|0|||
46752350|NCT04588259|82970730|FG001|Run-in Period|Run-in failure|23|||
46752351|NCT04588259|82970729|FG000|Run-in Period|Withdrawn before randomisation|0|||
46752352|NCT04588259|82970730|FG001|Run-in Period|Withdrawn before randomisation|8|||
46752353|NCT04588259|82970729|FG000|Treatment Period|Withdrawal by Subject|6|||
46806370|NCT00365716|83025301|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
46806371|NCT00365716|83025302|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
46806372|NCT00365716|83025303|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
46806373|NCT00365716|83025304|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
46806374|NCT00365716|83025305|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
46806375|NCT00365716|83025299|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
46806376|NCT00365716|83025300|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
46806377|NCT00365716|83025301|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
46806378|NCT00365716|83025302|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
46806379|NCT00365716|83025303|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
46806380|NCT00365716|83025304|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
46806381|NCT00365716|83025305|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
46806382|NCT00365716|83025299|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
46806383|NCT00365716|83025300|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
46806384|NCT00365716|83025301|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
46806385|NCT00365716|83025302|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
46806386|NCT00365716|83025303|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
46806387|NCT00365716|83025304|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
46806388|NCT00365716|83025305|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
46806389|NCT00365716|83025299|FG000|Extension 1|Lost to Follow-up|0|||
46806390|NCT00365716|83025300|FG001|Extension 1|Lost to Follow-up|0|||
46806391|NCT00365716|83025301|FG002|Extension 1|Lost to Follow-up|0|||
46806392|NCT00365716|83025302|FG003|Extension 1|Lost to Follow-up|0|||
46806393|NCT00365716|83025303|FG004|Extension 1|Lost to Follow-up|0|||
46806394|NCT00365716|83025304|FG005|Extension 1|Lost to Follow-up|1|||
46806395|NCT00365716|83025305|FG006|Extension 1|Lost to Follow-up|0|||
46806396|NCT00365716|83025299|FG000|Extension 1|Other|0|||
46806397|NCT00365716|83025300|FG001|Extension 1|Other|0|||
46806398|NCT00365716|83025301|FG002|Extension 1|Other|0|||
46806399|NCT00365716|83025302|FG003|Extension 1|Other|0|||
46806400|NCT00365716|83025303|FG004|Extension 1|Other|0|||
46806401|NCT00365716|83025304|FG005|Extension 1|Other|9|||
46806402|NCT00365716|83025305|FG006|Extension 1|Other|0|||
46806403|NCT00365716|83025299|FG000|Extension 1|Moved|0|||
46806404|NCT00365716|83025300|FG001|Extension 1|Moved|0|||
46806405|NCT00365716|83025301|FG002|Extension 1|Moved|0|||
46806406|NCT00365716|83025302|FG003|Extension 1|Moved|0|||
46806407|NCT00365716|83025303|FG004|Extension 1|Moved|0|||
46806408|NCT00365716|83025304|FG005|Extension 1|Moved|4|||
46806409|NCT00365716|83025305|FG006|Extension 1|Moved|0|||
46806410|NCT00365716|83025299|FG000|Extension 1|Withdrawal by Subject|0|||
46806411|NCT00365716|83025300|FG001|Extension 1|Withdrawal by Subject|0|||
46806412|NCT00365716|83025301|FG002|Extension 1|Withdrawal by Subject|0|||
46806413|NCT00365716|83025302|FG003|Extension 1|Withdrawal by Subject|0|||
46806414|NCT00365716|83025303|FG004|Extension 1|Withdrawal by Subject|0|||
47053154|NCT01802333|83322568|FG001|Overall Study|Progression/relapse|3|||
47053155|NCT01802333|83322569|FG002|Overall Study|Progression/relapse|0|||
46752354|NCT04588259|82970730|FG001|Treatment Period|Withdrawal by Subject|6|||
46636224|NCT01520922|82810071|FG000|Treatment Phase|Adverse Event|3|||
46752355|NCT04493424|82970737|FG000|Overall Study|Termination of the trial by the sponsor|89|||
46752356|NCT04493424|82970737|FG000|Overall Study|Withdrawal by Subject|9|||
46806415|NCT00365716|83025304|FG005|Extension 1|Withdrawal by Subject|3|||
46806416|NCT00365716|83025305|FG006|Extension 1|Withdrawal by Subject|0|||
46806417|NCT00365716|83025299|FG000|Extension 1|Pregnancy|0|||
46806418|NCT00365716|83025300|FG001|Extension 1|Pregnancy|0|||
46806419|NCT00365716|83025301|FG002|Extension 1|Pregnancy|0|||
46806420|NCT00365716|83025302|FG003|Extension 1|Pregnancy|0|||
46806421|NCT00365716|83025303|FG004|Extension 1|Pregnancy|0|||
46806422|NCT00365716|83025304|FG005|Extension 1|Pregnancy|4|||
46806423|NCT00365716|83025305|FG006|Extension 1|Pregnancy|0|||
46806424|NCT00365716|83025299|FG000|Extension 1|Protocol Violation|0|||
46806425|NCT00365716|83025300|FG001|Extension 1|Protocol Violation|0|||
46806426|NCT00365716|83025301|FG002|Extension 1|Protocol Violation|0|||
46806427|NCT00365716|83025302|FG003|Extension 1|Protocol Violation|0|||
46806428|NCT00365716|83025303|FG004|Extension 1|Protocol Violation|0|||
46806429|NCT00365716|83025304|FG005|Extension 1|Protocol Violation|1|||
46806430|NCT00365716|83025305|FG006|Extension 1|Protocol Violation|0|||
46806431|NCT00365716|83025299|FG000|Extension 2|Lost to Follow-up|0|||
46806432|NCT00365716|83025300|FG001|Extension 2|Lost to Follow-up|0|||
46806433|NCT00365716|83025301|FG002|Extension 2|Lost to Follow-up|0|||
46806434|NCT00365716|83025302|FG003|Extension 2|Lost to Follow-up|0|||
46806435|NCT00365716|83025303|FG004|Extension 2|Lost to Follow-up|0|||
46806436|NCT00365716|83025304|FG005|Extension 2|Lost to Follow-up|0|||
46806437|NCT00365716|83025305|FG006|Extension 2|Lost to Follow-up|2|||
46806438|NCT00365716|83025299|FG000|Extension 2|Other|0|||
46806439|NCT00365716|83025300|FG001|Extension 2|Other|0|||
46806440|NCT00365716|83025301|FG002|Extension 2|Other|0|||
46806441|NCT00365716|83025302|FG003|Extension 2|Other|0|||
46806442|NCT00365716|83025303|FG004|Extension 2|Other|0|||
46806443|NCT00365716|83025304|FG005|Extension 2|Other|0|||
46806444|NCT00365716|83025305|FG006|Extension 2|Other|3|||
46806445|NCT00365716|83025299|FG000|Extension 2|Withdrawal by Subject|0|||
46806446|NCT00365716|83025300|FG001|Extension 2|Withdrawal by Subject|0|||
46806447|NCT00365716|83025301|FG002|Extension 2|Withdrawal by Subject|0|||
46806448|NCT00365716|83025302|FG003|Extension 2|Withdrawal by Subject|0|||
46925365|NCT02038777|83159766|FG001|Overall Study|Other|1|||
46925366|NCT02038777|83159767|FG002|Overall Study|Other|0|||
47053156|NCT01802333|83322567|FG000|Overall Study|Death|7|||
47053157|NCT01802333|83322568|FG001|Overall Study|Death|14|||
47053158|NCT01802333|83322569|FG002|Overall Study|Death|13|||
47053159|NCT01802333|83322567|FG000|Overall Study|Other - not protocol specified|32|||
47053160|NCT01802333|83322568|FG001|Overall Study|Other - not protocol specified|22|||
47053161|NCT01802333|83322569|FG002|Overall Study|Other - not protocol specified|24|||
47053162|NCT01802333|83322567|FG000|Overall Study|Did not start treatment|0|||
47053163|NCT01802333|83322568|FG001|Overall Study|Did not start treatment|2|||
47053164|NCT01802333|83322569|FG002|Overall Study|Did not start treatment|5|||
47053165|NCT00980655|83322614|FG000|Overall Study|Adverse Event|13|||
47053166|NCT00980655|83322615|FG001|Overall Study|Adverse Event|31|||
47053167|NCT00980655|83322614|FG000|Overall Study|Death|0|||
47053168|NCT00980655|83322615|FG001|Overall Study|Death|7|||
47053169|NCT00980655|83322614|FG000|Overall Study|Protocol Violation|2|||
47053170|NCT00980655|83322615|FG001|Overall Study|Protocol Violation|7|||
47053171|NCT00980655|83322614|FG000|Overall Study|Withdrawal by Subject|0|||
47053172|NCT00980655|83322615|FG001|Overall Study|Withdrawal by Subject|4|||
47053173|NCT00980655|83322614|FG000|Overall Study|Lost to Follow-up|0|||
47053174|NCT00980655|83322615|FG001|Overall Study|Lost to Follow-up|1|||
47053175|NCT00980655|83322614|FG000|Overall Study|Parent/legal guardian request|1|||
47053176|NCT00980655|83322615|FG001|Overall Study|Parent/legal guardian request|0|||
47053177|NCT00980655|83322614|FG000|Overall Study|Other|0|||
47053178|NCT00980655|83322615|FG001|Overall Study|Other|1|||
47053179|NCT01801865|83322657|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
47053180|NCT01801865|83322657|FG000|Overall Study|Physician Decision|7|||
47053181|NCT00980343|83322667|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
47053182|NCT00980343|83322668|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
47053183|NCT01801475|83322678|FG000|Overall Study|Withdrawal by Subject|0|||
47053184|NCT01801475|83322679|FG001|Overall Study|Withdrawal by Subject|0|||
47053185|NCT01801475|83322680|FG002|Overall Study|Withdrawal by Subject|0|||
47053186|NCT01801475|83322681|FG003|Overall Study|Withdrawal by Subject|0|||
47053187|NCT01801475|83322682|FG004|Overall Study|Withdrawal by Subject|1|||
47053188|NCT01822925|83322741|FG000|Overall Study|Adverse Event|1|||
47053189|NCT01822925|83322742|FG001|Overall Study|Adverse Event|1|||
47053190|NCT01822925|83322743|FG002|Overall Study|Adverse Event|1|||
47053191|NCT01822925|83322744|FG003|Overall Study|Adverse Event|1|||
46806449|NCT00365716|83025303|FG004|Extension 2|Withdrawal by Subject|0|||
46925367|NCT02038777|83159768|FG003|Overall Study|Other|2|||
47053192|NCT01822925|83322741|FG000|Overall Study|Lost to Follow-up|0|||
47053193|NCT01822925|83322742|FG001|Overall Study|Lost to Follow-up|1|||
46806450|NCT00365716|83025304|FG005|Extension 2|Withdrawal by Subject|0|||
46806451|NCT00365716|83025305|FG006|Extension 2|Withdrawal by Subject|5|||
46806452|NCT00059839|83025321|FG000|Overall Study|Death|1|||
46806453|NCT00059839|83025322|FG001|Overall Study|Death|1|||
46806454|NCT00059839|83025321|FG000|Overall Study|Lack of Efficacy|6|||
46806455|NCT00059839|83025322|FG001|Overall Study|Lack of Efficacy|5|||
46806456|NCT00059839|83025321|FG000|Overall Study|Lost to Follow-up|2|||
47053194|NCT01822925|83322743|FG002|Overall Study|Lost to Follow-up|0|||
47053195|NCT01822925|83322744|FG003|Overall Study|Lost to Follow-up|0|||
47053196|NCT01822925|83322741|FG000|Overall Study|Protocol Violation|1|||
47053197|NCT01822925|83322742|FG001|Overall Study|Protocol Violation|0|||
46925368|NCT02038777|83159769|FG004|Overall Study|Other|1|||
46925369|NCT02038777|83159770|FG005|Overall Study|Other|0|||
46925370|NCT02038777|83159771|FG006|Overall Study|Other|0|||
47053198|NCT01822925|83322743|FG002|Overall Study|Protocol Violation|0|||
47053199|NCT01822925|83322744|FG003|Overall Study|Protocol Violation|1|||
47053200|NCT01822925|83322741|FG000|Overall Study|Withdrawal by Subject|2|||
47053201|NCT01822925|83322742|FG001|Overall Study|Withdrawal by Subject|0|||
47053202|NCT01822925|83322743|FG002|Overall Study|Withdrawal by Subject|2|||
47053203|NCT01822925|83322744|FG003|Overall Study|Withdrawal by Subject|2|||
47053204|NCT01822925|83322741|FG000|Overall Study|Taking prohibited medication|2|||
47053205|NCT01822925|83322742|FG001|Overall Study|Taking prohibited medication|0|||
47053206|NCT01822925|83322743|FG002|Overall Study|Taking prohibited medication|0|||
47053207|NCT01822925|83322744|FG003|Overall Study|Taking prohibited medication|1|||
46752357|NCT04493424|82970737|FG000|Overall Study|Lost to Follow-up|2|||
46752358|NCT04493424|82970737|FG000|Overall Study|Lack of Efficacy|3|||
46752359|NCT04493424|82970737|FG000|Overall Study|Adverse Event|5|||
46752360|NCT04142658|82970743|FG000|Overall Study|Death|2|||
46806457|NCT00059839|83025322|FG001|Overall Study|Lost to Follow-up|0|||
46806458|NCT00059839|83025321|FG000|Overall Study|Physician Decision|1|||
46806459|NCT00059839|83025322|FG001|Overall Study|Physician Decision|2|||
46806460|NCT00059839|83025321|FG000|Overall Study|Withdrawal by Subject|1|||
46806461|NCT00059839|83025322|FG001|Overall Study|Withdrawal by Subject|6|||
46806462|NCT00059839|83025321|FG000|Overall Study|Ineligible|1|||
46806463|NCT00059839|83025322|FG001|Overall Study|Ineligible|3|||
46806464|NCT00059215|83025332|FG000|Overall Study|Adverse Event|5|||
46806465|NCT00059215|83025333|FG001|Overall Study|Adverse Event|5|||
46806466|NCT00059215|83025334|FG002|Overall Study|Adverse Event|9|||
46806467|NCT00059215|83025335|FG003|Overall Study|Adverse Event|9|||
46806468|NCT00059215|83025332|FG000|Overall Study|Death|0|||
46925371|NCT02038777|83159772|FG007|Overall Study|Other|0|||
46925372|NCT02038777|83159765|FG000|Overall Study|Randomized but not treated|0|||
46925373|NCT02038777|83159766|FG001|Overall Study|Randomized but not treated|1|||
46925374|NCT02038777|83159767|FG002|Overall Study|Randomized but not treated|0|||
46925375|NCT02038777|83159768|FG003|Overall Study|Randomized but not treated|0|||
46925376|NCT02038777|83159769|FG004|Overall Study|Randomized but not treated|0|||
46925377|NCT02038777|83159770|FG005|Overall Study|Randomized but not treated|0|||
46925378|NCT02038777|83159771|FG006|Overall Study|Randomized but not treated|0|||
46925379|NCT02038777|83159772|FG007|Overall Study|Randomized but not treated|0|||
46925380|NCT02038777|83159765|FG000|Overall Study|Started Chemotherapy|1|||
46925381|NCT02038777|83159766|FG001|Overall Study|Started Chemotherapy|0|||
46925382|NCT02038777|83159767|FG002|Overall Study|Started Chemotherapy|3|||
46925383|NCT02038777|83159768|FG003|Overall Study|Started Chemotherapy|0|||
46925384|NCT02038777|83159769|FG004|Overall Study|Started Chemotherapy|0|||
46925385|NCT02038777|83159770|FG005|Overall Study|Started Chemotherapy|0|||
46925386|NCT02038777|83159771|FG006|Overall Study|Started Chemotherapy|0|||
46925387|NCT02038777|83159772|FG007|Overall Study|Started Chemotherapy|0|||
46925388|NCT02853435|83159809|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
46925389|NCT02853435|83159810|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
46925390|NCT02853435|83159811|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
46752361|NCT04142658|82970744|FG001|Overall Study|Death|1|||
46752362|NCT04142658|82970743|FG000|Overall Study|Lost to Follow-up|4|||
46752363|NCT04142658|82970744|FG001|Overall Study|Lost to Follow-up|13|||
46752364|NCT04142658|82970743|FG000|Overall Study|Withdrawal by Subject|9|||
46752365|NCT04142658|82970744|FG001|Overall Study|Withdrawal by Subject|16|||
46752366|NCT04112823|82970752|FG000|Overall Study|Lost to Follow-up|2|||
46752367|NCT04112823|82970753|FG001|Overall Study|Lost to Follow-up|3|||
46752368|NCT03980184|82970761|FG000|Overall Study|Dropped out before treatment|2|||
46752369|NCT03980184|82970762|FG001|Overall Study|Dropped out before treatment|2|||
46752370|NCT03980184|82970761|FG000|Overall Study|Lost to Follow-up|11|||
46752371|NCT03980184|82970762|FG001|Overall Study|Lost to Follow-up|13|||
46806469|NCT00059215|83025333|FG001|Overall Study|Death|0|||
46806470|NCT00059215|83025334|FG002|Overall Study|Death|3|||
46925391|NCT02853435|83159812|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
46925392|NCT02853435|83159813|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
47053208|NCT01801007|83322777|FG000|Overall Study|Adverse Event|2|||
46752372|NCT03971071|82970771|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
46752373|NCT03971071|82970772|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
47053209|NCT01801007|83322777|FG000|Overall Study|Lost to Follow-up|4|||
46752374|NCT03971071|82970773|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
46806471|NCT00059215|83025335|FG003|Overall Study|Death|0|||
46806472|NCT00059215|83025332|FG000|Overall Study|Lost to Follow-up|1|||
47053210|NCT01801007|83322777|FG000|Overall Study|Withdrawal by Subject|5|||
46806473|NCT00059215|83025333|FG001|Overall Study|Lost to Follow-up|2|||
47053211|NCT01822691|83322781|FG000|Overall Study|Withdrawal by Subject|2|||
46806474|NCT00059215|83025334|FG002|Overall Study|Lost to Follow-up|0|||
46806475|NCT00059215|83025335|FG003|Overall Study|Lost to Follow-up|0|||
46806476|NCT00059215|83025332|FG000|Overall Study|Withdrawal by Subject|4|||
46806477|NCT00059215|83025333|FG001|Overall Study|Withdrawal by Subject|4|||
46806478|NCT00059215|83025334|FG002|Overall Study|Withdrawal by Subject|1|||
46806479|NCT00059215|83025335|FG003|Overall Study|Withdrawal by Subject|3|||
46806480|NCT00059215|83025332|FG000|Overall Study|Protocol Violation|1|||
46806481|NCT00059215|83025333|FG001|Overall Study|Protocol Violation|0|||
46806482|NCT00059215|83025334|FG002|Overall Study|Protocol Violation|1|||
46806483|NCT00059215|83025335|FG003|Overall Study|Protocol Violation|0|||
46806484|NCT00059215|83025332|FG000|Overall Study|Protocol entry criteria not met|1|||
46806485|NCT00059215|83025333|FG001|Overall Study|Protocol entry criteria not met|1|||
46806486|NCT00059215|83025334|FG002|Overall Study|Protocol entry criteria not met|0|||
46806487|NCT00059215|83025335|FG003|Overall Study|Protocol entry criteria not met|2|||
46806488|NCT00059215|83025332|FG000|Overall Study|Physician Decision|1|||
46806489|NCT00059215|83025333|FG001|Overall Study|Physician Decision|2|||
46806490|NCT00059215|83025334|FG002|Overall Study|Physician Decision|1|||
46806491|NCT00059215|83025335|FG003|Overall Study|Physician Decision|1|||
46806492|NCT00058825|83025346|FG000|Overall Study|Relapse|9|||
46806493|NCT00058825|83025346|FG000|Overall Study|Progressive Disease|5|||
46806494|NCT00058825|83025346|FG000|Overall Study|Graft Failure|5|||
46806495|NCT00058825|83025346|FG000|Overall Study|Death|3|||
46806496|NCT00364858|83025354|FG000|Overall Study|Adverse Event|1|||
46806497|NCT00364858|83025355|FG001|Overall Study|Adverse Event|5|||
46806498|NCT00364858|83025354|FG000|Overall Study|Withdrawal by Subject|1|||
46806499|NCT00364858|83025355|FG001|Overall Study|Withdrawal by Subject|1|||
46806500|NCT00364858|83025354|FG000|Overall Study|Pregnancy|1|||
46806501|NCT00364858|83025355|FG001|Overall Study|Pregnancy|1|||
46806502|NCT00364858|83025354|FG000|Overall Study|Clinical failure|2|||
46806503|NCT00364858|83025355|FG001|Overall Study|Clinical failure|13|||
46806504|NCT00364858|83025354|FG000|Overall Study|Discontinuation at baseline|1|||
46806505|NCT00364858|83025355|FG001|Overall Study|Discontinuation at baseline|0|||
46806506|NCT00364858|83025354|FG000|Overall Study|Non-compliant|1|||
46806507|NCT00364858|83025355|FG001|Overall Study|Non-compliant|0|||
46806508|NCT00364858|83025354|FG000|Overall Study|Return to Q2 regimen|0|||
46806509|NCT00364858|83025355|FG001|Overall Study|Return to Q2 regimen|1|||
46806510|NCT00364858|83025354|FG000|Overall Study|Clinical baseline issue|0|||
46806511|NCT00364858|83025355|FG001|Overall Study|Clinical baseline issue|1|||
46806512|NCT03803059|83025362|FG000|Overall Study|Protocol Violation|2|||
46806513|NCT03803059|83025362|FG000|Overall Study|Lost to Follow-up|1|||
46925393|NCT02853435|83159814|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
46806514|NCT00372424|83025367|FG000|Overall Study|Adverse Event|2|||
46806515|NCT00372424|83025367|FG000|Overall Study|Withdrawal by Subject|1|||
46806516|NCT00372424|83025367|FG000|Overall Study|Death|1|||
46806517|NCT00372424|83025367|FG000|Overall Study|Objective Progression or Relapse|14|||
46806518|NCT00372424|83025367|FG000|Overall Study|Other|7|||
46806519|NCT00372424|83025367|FG000|Overall Study|Enrolled, Not Treated|1|||
46925394|NCT02635204|83159846|FG000|Overall Study|Adverse Event|1|||
46925395|NCT02635204|83159847|FG001|Overall Study|Adverse Event|0|||
46925396|NCT02635204|83159846|FG000|Overall Study|Lost to Follow-up|1|||
46925397|NCT02635204|83159847|FG001|Overall Study|Lost to Follow-up|1|||
46925398|NCT00102804|83159855|FG000|Overall Study|Progressive Disease (PD)|307|||
46925399|NCT00102804|83159856|FG001|Overall Study|Progressive Disease (PD)|196|||
46925400|NCT00102804|83159855|FG000|Overall Study|Withdrawal by Subject|46|||
46925401|NCT00102804|83159856|FG001|Overall Study|Withdrawal by Subject|7|||
46925402|NCT00102804|83159855|FG000|Overall Study|Adverse Event|37|||
46925403|NCT00102804|83159856|FG001|Overall Study|Adverse Event|3|||
46925404|NCT00102804|83159855|FG000|Overall Study|Physician Decision|24|||
46925405|NCT00102804|83159856|FG001|Overall Study|Physician Decision|6|||
46925406|NCT00102804|83159855|FG000|Overall Study|Death|5|||
46925407|NCT00102804|83159856|FG001|Overall Study|Death|6|||
46806520|NCT00372190|83025373|FG000|Overall Study|Lost to Follow-up|3|||
46806521|NCT00372190|83025374|FG001|Overall Study|Lost to Follow-up|1|||
46806522|NCT00044083|83025384|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
46806523|NCT00044083|83025385|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
46925408|NCT00102804|83159855|FG000|Overall Study|Enrollment Criteria Not Met|6|||
46925409|NCT00102804|83159856|FG001|Overall Study|Enrollment Criteria Not Met|0|||
46925410|NCT00102804|83159855|FG000|Overall Study|Lost to Follow-up|4|||
46925411|NCT00102804|83159856|FG001|Overall Study|Lost to Follow-up|1|||
46925412|NCT00102804|83159855|FG000|Overall Study|Protocol Violation|2|||
46806524|NCT00044083|83025384|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
46806525|NCT00044083|83025385|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
46806526|NCT00044083|83025384|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
46806527|NCT00044083|83025385|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
46806528|NCT00044083|83025384|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
46925413|NCT00102804|83159856|FG001|Overall Study|Protocol Violation|1|||
46925414|NCT00102804|83159855|FG000|Overall Study|Satisfactory Response|2|||
46806529|NCT00044083|83025385|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
46806530|NCT00044083|83025384|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
46806531|NCT00044083|83025385|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
46925415|NCT00102804|83159856|FG001|Overall Study|Satisfactory Response|0|||
46925416|NCT00102804|83159855|FG000|Overall Study|Sponsor Decision|1|||
46925417|NCT00102804|83159856|FG001|Overall Study|Sponsor Decision|0|||
46925418|NCT00102804|83159855|FG000|Overall Study|Alive, Receiving Treatment|7|||
46925419|NCT00102804|83159856|FG001|Overall Study|Alive, Receiving Treatment|2|||
46925420|NCT01814072|83159894|FG000|Overall Study|Lost to Follow-up|2|||
46925421|NCT01814072|83159895|FG001|Overall Study|Lost to Follow-up|2|||
46925422|NCT01814072|83159896|FG002|Overall Study|Lost to Follow-up|2|||
46925423|NCT01814072|83159897|FG003|Overall Study|Lost to Follow-up|0|||
46925424|NCT01814072|83159898|FG004|Overall Study|Lost to Follow-up|2|||
46925425|NCT01814072|83159899|FG005|Overall Study|Lost to Follow-up|3|||
46925426|NCT01814072|83159900|FG006|Overall Study|Lost to Follow-up|3|||
46925427|NCT01814072|83159901|FG007|Overall Study|Lost to Follow-up|1|||
46925428|NCT01814072|83159902|FG008|Overall Study|Lost to Follow-up|2|||
46806532|NCT00044083|83025384|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
46806533|NCT00044083|83025385|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
46806534|NCT00044083|83025384|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
46806535|NCT00044083|83025385|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
46806536|NCT00044083|83025384|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
46806537|NCT00044083|83025385|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
46806538|NCT00044083|83025384|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
46806539|NCT00044083|83025385|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
46806540|NCT00044083|83025384|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
46806541|NCT00044083|83025385|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
46806542|NCT00058123|83025418|FG000|Overall Study|Wrong histology|9|||
46806543|NCT00058123|83025418|FG000|Overall Study|Received >3 prior treatments|1|||
47053212|NCT01822535|83322787|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
47053213|NCT01822535|83322788|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
47053214|NCT01822535|83322787|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
46752375|NCT03971071|82970774|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
46752376|NCT03971071|82970775|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
46752377|NCT03971071|82970771|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
46752378|NCT03971071|82970772|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
46752379|NCT03971071|82970773|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
46752380|NCT03971071|82970774|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46806544|NCT00022633|83025425|FG000|Overall Study|Adverse Event|11|||
46806545|NCT00022633|83025426|FG001|Overall Study|Adverse Event|1|||
46806546|NCT00022633|83025425|FG000|Overall Study|Refusal unrelated to adverse event|1|||
46925429|NCT01814072|83159903|FG009|Overall Study|Lost to Follow-up|3|||
46925430|NCT01814072|83159904|FG010|Overall Study|Lost to Follow-up|1|||
46925431|NCT01814072|83159905|FG011|Overall Study|Lost to Follow-up|2|||
46752381|NCT03971071|82970775|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46752382|NCT03971071|82970771|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
46752383|NCT03971071|82970772|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
46752384|NCT03971071|82970773|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
46752385|NCT03971071|82970774|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
46752386|NCT03971071|82970775|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
47053215|NCT01822535|83322788|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
46752387|NCT03971071|82970771|FG000|Open-label Treatment Period|Sponsor decision|0|||
46752388|NCT03971071|82970772|FG001|Open-label Treatment Period|Sponsor decision|0|||
46752389|NCT03971071|82970773|FG002|Open-label Treatment Period|Sponsor decision|0|||
46752390|NCT03971071|82970774|FG003|Open-label Treatment Period|Sponsor decision|0|||
46752391|NCT03971071|82970775|FG004|Open-label Treatment Period|Sponsor decision|1|||
46752392|NCT03971071|82970771|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
46752393|NCT03971071|82970772|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
46752394|NCT03971071|82970773|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
46752395|NCT03971071|82970774|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
46752396|NCT03971071|82970775|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
46752397|NCT03971071|82970771|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
46752398|NCT03971071|82970772|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
46752399|NCT03971071|82970773|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
46806547|NCT00022633|83025426|FG001|Overall Study|Refusal unrelated to adverse event|0|||
46806548|NCT00022633|83025425|FG000|Overall Study|Progression/relapse|9|||
46806549|NCT00022633|83025426|FG001|Overall Study|Progression/relapse|2|||
46806550|NCT00022633|83025425|FG000|Overall Study|Death|4|||
46806551|NCT00022633|83025426|FG001|Overall Study|Death|0|||
46925432|NCT01814072|83159906|FG012|Overall Study|Lost to Follow-up|2|||
46925433|NCT01814072|83159907|FG013|Overall Study|Lost to Follow-up|1|||
46806552|NCT00022633|83025425|FG000|Overall Study|Other - not protocol specified|3|||
46806553|NCT00022633|83025426|FG001|Overall Study|Other - not protocol specified|2|||
46806554|NCT00022633|83025425|FG000|Overall Study|Ineligible|4|||
46752400|NCT03971071|82970774|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
46925434|NCT01814072|83159908|FG014|Overall Study|Lost to Follow-up|2|||
46925435|NCT01814072|83159909|FG015|Overall Study|Lost to Follow-up|1|||
46925436|NCT01814072|83159910|FG016|Overall Study|Lost to Follow-up|3|||
46925437|NCT01814072|83159911|FG017|Overall Study|Lost to Follow-up|1|||
46925438|NCT01814072|83159912|FG018|Overall Study|Lost to Follow-up|3|||
46925439|NCT01814072|83159913|FG019|Overall Study|Lost to Follow-up|3|||
46752401|NCT03971071|82970775|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
46752402|NCT03881371|82970794|FG000|Overall Study|Adverse Event|8|||
46752403|NCT03881371|82970795|FG001|Overall Study|Adverse Event|9|||
46752404|NCT03881371|82970794|FG000|Overall Study|Death|1|||
46752405|NCT03881371|82970795|FG001|Overall Study|Death|0|||
46752406|NCT03881371|82970794|FG000|Overall Study|Lost to Follow-up|1|||
46806555|NCT00022633|83025426|FG001|Overall Study|Ineligible|0|||
46806556|NCT00021541|83025433|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
46806557|NCT00021541|83025434|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
46806558|NCT00021541|83025433|FG000|Period 1-First Treatment|Adverse Event|2|||
46806559|NCT00021541|83025434|FG001|Period 1-First Treatment|Adverse Event|1|||
46806560|NCT00021541|83025433|FG000|Period 1-First Treatment|non-adherence|3|||
46806561|NCT00021541|83025434|FG001|Period 1-First Treatment|non-adherence|0|||
46806562|NCT00021541|83025433|FG000|Period 1-First Treatment|Death|1|||
46806563|NCT00021541|83025434|FG001|Period 1-First Treatment|Death|0|||
46806564|NCT00021541|83025433|FG000|Period 1-First Treatment|Pts that did not progress|2|||
46806565|NCT00021541|83025434|FG001|Period 1-First Treatment|Pts that did not progress|2|||
46806566|NCT00021541|83025433|FG000|Period 1-First Treatment|Ineligible|0|||
46806567|NCT00021541|83025434|FG001|Period 1-First Treatment|Ineligible|2|||
46806568|NCT00021541|83025433|FG000|Period 2-crossover|refused phase B|2|||
46806569|NCT00021541|83025434|FG001|Period 2-crossover|refused phase B|2|||
46806570|NCT00021541|83025433|FG000|Period 2-crossover|Withdrawal by Subject|3|||
46806571|NCT00021541|83025434|FG001|Period 2-crossover|Withdrawal by Subject|4|||
46806572|NCT00021541|83025433|FG000|Period 2-crossover|Adverse Event|2|||
46806573|NCT00021541|83025434|FG001|Period 2-crossover|Adverse Event|2|||
46806574|NCT00021541|83025433|FG000|Period 2-crossover|non-adherence|1|||
46806575|NCT00021541|83025434|FG001|Period 2-crossover|non-adherence|0|||
46806576|NCT00021541|83025433|FG000|Period 2-crossover|Pts that did not progress|2|||
46806577|NCT00021541|83025434|FG001|Period 2-crossover|Pts that did not progress|3|||
46806578|NCT00021229|83025445|FG000|Overall Study|Adverse Event|10|||
46806579|NCT00021229|83025446|FG001|Overall Study|Adverse Event|5|||
46806580|NCT00021229|83025447|FG002|Overall Study|Adverse Event|2|||
46806581|NCT00021229|83025445|FG000|Overall Study|Death|0|||
46806582|NCT00021229|83025446|FG001|Overall Study|Death|1|||
47053216|NCT01822535|83322787|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
47053217|NCT01822535|83322788|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
47053218|NCT01799993|83322874|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
47053219|NCT01799993|83322875|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
46636225|NCT01520922|82810072|FG001|Treatment Phase|Adverse Event|5|||
46636226|NCT01520922|82810071|FG000|Follow up|Lost to Follow-up|0|||
46752407|NCT03881371|82970795|FG001|Overall Study|Lost to Follow-up|0|||
46806583|NCT00021229|83025447|FG002|Overall Study|Death|0|||
46806584|NCT00021229|83025445|FG000|Overall Study|Withdrawal by Subject|7|||
46806585|NCT00021229|83025446|FG001|Overall Study|Withdrawal by Subject|7|||
46806586|NCT00021229|83025447|FG002|Overall Study|Withdrawal by Subject|1|||
46806587|NCT00021229|83025445|FG000|Overall Study|Progressive Disease|15|||
46806588|NCT00021229|83025446|FG001|Overall Study|Progressive Disease|19|||
46806589|NCT00021229|83025447|FG002|Overall Study|Progressive Disease|12|||
46806590|NCT00021229|83025445|FG000|Overall Study|Protocol Violation|1|||
46925440|NCT01814072|83159914|FG020|Overall Study|Lost to Follow-up|2|||
46925441|NCT01814072|83159915|FG021|Overall Study|Lost to Follow-up|1|||
46752408|NCT03881371|82970794|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46752409|NCT03881371|82970795|FG001|Overall Study|Non-Compliance with Study Drug|2|||
46752410|NCT03881371|82970794|FG000|Overall Study|Physician Decision|3|||
46925442|NCT01814072|83159916|FG022|Overall Study|Lost to Follow-up|3|||
47053220|NCT01799993|83322874|FG000|Overall Study|Death|61|||
46806591|NCT00021229|83025446|FG001|Overall Study|Protocol Violation|1|||
46806592|NCT00021229|83025447|FG002|Overall Study|Protocol Violation|0|||
46806593|NCT00021229|83025445|FG000|Overall Study|Physician Decision|0|||
46806594|NCT00021229|83025446|FG001|Overall Study|Physician Decision|0|||
46806595|NCT00021229|83025447|FG002|Overall Study|Physician Decision|1|||
46806596|NCT00021229|83025445|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
46806597|NCT00021229|83025446|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
46806598|NCT00021229|83025447|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
46806599|NCT00372112|83025461|FG000|Overall Study|Adverse Event|0|||
46925443|NCT01814072|83159917|FG023|Overall Study|Lost to Follow-up|1|||
46752411|NCT03881371|82970795|FG001|Overall Study|Physician Decision|3|||
46806600|NCT00372112|83025462|FG001|Overall Study|Adverse Event|1|||
46806601|NCT00372112|83025463|FG002|Overall Study|Adverse Event|1|||
46806602|NCT00372112|83025464|FG003|Overall Study|Adverse Event|1|||
46806603|NCT00372112|83025461|FG000|Overall Study|Withdrawal by Subject|0|||
46806604|NCT00372112|83025462|FG001|Overall Study|Withdrawal by Subject|0|||
46806605|NCT00372112|83025463|FG002|Overall Study|Withdrawal by Subject|2|||
46806606|NCT00372112|83025464|FG003|Overall Study|Withdrawal by Subject|1|||
46806607|NCT00372112|83025461|FG000|Overall Study|Exacerbation|0|||
46806608|NCT00372112|83025462|FG001|Overall Study|Exacerbation|0|||
46806609|NCT00372112|83025463|FG002|Overall Study|Exacerbation|0|||
46806610|NCT00372112|83025464|FG003|Overall Study|Exacerbation|1|||
46752412|NCT03881371|82970794|FG000|Overall Study|Withdrawal by Subject|2|||
46752413|NCT03881371|82970795|FG001|Overall Study|Withdrawal by Subject|10|||
46752414|NCT03881371|82970794|FG000|Overall Study|Discontinuation from Study|1|||
46752415|NCT03881371|82970795|FG001|Overall Study|Discontinuation from Study|0|||
46752416|NCT03759379|82970817|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
46752417|NCT03759379|82970818|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
46806611|NCT00372112|83025461|FG000|Overall Study|PR >240 at Visit 3|0|||
46806612|NCT00372112|83025462|FG001|Overall Study|PR >240 at Visit 3|0|||
46806613|NCT00372112|83025463|FG002|Overall Study|PR >240 at Visit 3|0|||
46806614|NCT00372112|83025464|FG003|Overall Study|PR >240 at Visit 3|1|||
46806615|NCT00372112|83025461|FG000|Overall Study|Hepatitis B|1|||
46806616|NCT00372112|83025462|FG001|Overall Study|Hepatitis B|0|||
46806617|NCT00372112|83025463|FG002|Overall Study|Hepatitis B|0|||
46806618|NCT00372112|83025464|FG003|Overall Study|Hepatitis B|0|||
46806619|NCT00372112|83025461|FG000|Overall Study|Other-protocol violation|0|||
46806620|NCT00372112|83025462|FG001|Overall Study|Other-protocol violation|0|||
46806621|NCT00372112|83025463|FG002|Overall Study|Other-protocol violation|1|||
46806622|NCT00372112|83025464|FG003|Overall Study|Other-protocol violation|0|||
46806623|NCT00488475|83025477|FG000|Overall Study|Other|1754|||
46806624|NCT00042991|83025488|FG000|Overall Study|Adverse Event|1|||
46806625|NCT00042991|83025489|FG001|Overall Study|Adverse Event|4|||
46806626|NCT00042991|83025490|FG002|Overall Study|Adverse Event|2|||
46806627|NCT00042991|83025491|FG003|Overall Study|Adverse Event|0|||
46806628|NCT00042991|83025492|FG004|Overall Study|Adverse Event|0|||
46806629|NCT00042991|83025493|FG005|Overall Study|Adverse Event|1|||
46925444|NCT01814072|83159918|FG024|Overall Study|Lost to Follow-up|4|||
46925445|NCT01814072|83159919|FG025|Overall Study|Lost to Follow-up|1|||
46925446|NCT01814072|83159920|FG026|Overall Study|Lost to Follow-up|1|||
46925447|NCT01814072|83159921|FG027|Overall Study|Lost to Follow-up|2|||
46925448|NCT01814072|83159922|FG028|Overall Study|Lost to Follow-up|3|||
46925449|NCT01814072|83159923|FG029|Overall Study|Lost to Follow-up|3|||
46925450|NCT01814072|83159924|FG030|Overall Study|Lost to Follow-up|2|||
46925451|NCT01814072|83159925|FG031|Overall Study|Lost to Follow-up|0|||
46925452|NCT01814072|83159894|FG000|Overall Study|Withdrawal by Subject|2|||
46925453|NCT01814072|83159895|FG001|Overall Study|Withdrawal by Subject|0|||
46925454|NCT01814072|83159896|FG002|Overall Study|Withdrawal by Subject|1|||
46925455|NCT01814072|83159897|FG003|Overall Study|Withdrawal by Subject|0|||
47053221|NCT01799993|83322875|FG001|Overall Study|Death|45|||
47053222|NCT01799993|83322874|FG000|Overall Study|Withdrawal by Subject|23|||
47053223|NCT01799993|83322875|FG001|Overall Study|Withdrawal by Subject|24|||
47053224|NCT01799993|83322874|FG000|Overall Study|Lost to Follow-up|5|||
46752418|NCT03759379|82970817|FG000|Treatment Period|Death|2|||
46752419|NCT03759379|82970818|FG001|Treatment Period|Death|3|||
46752420|NCT03759379|82970817|FG000|Treatment Period|Lost to Follow-up|1|||
46752421|NCT03759379|82970818|FG001|Treatment Period|Lost to Follow-up|0|||
46752422|NCT03759379|82970817|FG000|Treatment Period|Physician Decision|0|||
46752423|NCT03759379|82970818|FG001|Treatment Period|Physician Decision|1|||
46806630|NCT00042991|83025494|FG006|Overall Study|Adverse Event|0|||
46806631|NCT00042991|83025488|FG000|Overall Study|Withdrawal by Subject|0|||
46806632|NCT00042991|83025489|FG001|Overall Study|Withdrawal by Subject|7|||
46806633|NCT00042991|83025490|FG002|Overall Study|Withdrawal by Subject|2|||
46806634|NCT00042991|83025491|FG003|Overall Study|Withdrawal by Subject|0|||
46806635|NCT00042991|83025492|FG004|Overall Study|Withdrawal by Subject|1|||
46806636|NCT00042991|83025493|FG005|Overall Study|Withdrawal by Subject|0|||
46806637|NCT00042991|83025494|FG006|Overall Study|Withdrawal by Subject|0|||
46806638|NCT00042991|83025488|FG000|Overall Study|Disease Progression|5|||
46806639|NCT00042991|83025489|FG001|Overall Study|Disease Progression|29|||
46806640|NCT00042991|83025490|FG002|Overall Study|Disease Progression|2|||
46806641|NCT00042991|83025491|FG003|Overall Study|Disease Progression|2|||
46806642|NCT00042991|83025492|FG004|Overall Study|Disease Progression|1|||
46806643|NCT00042991|83025493|FG005|Overall Study|Disease Progression|4|||
46752424|NCT03668613|82970826|FG000|Overall Study|Adverse Event|1|||
46752425|NCT03668613|82970827|FG001|Overall Study|Adverse Event|2|||
46806644|NCT00042991|83025494|FG006|Overall Study|Disease Progression|2|||
46806645|NCT00042991|83025488|FG000|Overall Study|Alternative Therapy|0|||
46806646|NCT00042991|83025489|FG001|Overall Study|Alternative Therapy|0|||
46806647|NCT00042991|83025490|FG002|Overall Study|Alternative Therapy|0|||
47053225|NCT01799993|83322875|FG001|Overall Study|Lost to Follow-up|8|||
46925456|NCT01814072|83159898|FG004|Overall Study|Withdrawal by Subject|2|||
46925457|NCT01814072|83159899|FG005|Overall Study|Withdrawal by Subject|3|||
46925458|NCT01814072|83159900|FG006|Overall Study|Withdrawal by Subject|1|||
46925459|NCT01814072|83159901|FG007|Overall Study|Withdrawal by Subject|0|||
46925460|NCT01814072|83159902|FG008|Overall Study|Withdrawal by Subject|1|||
46925461|NCT01814072|83159903|FG009|Overall Study|Withdrawal by Subject|2|||
46925462|NCT01814072|83159904|FG010|Overall Study|Withdrawal by Subject|0|||
46925463|NCT01814072|83159905|FG011|Overall Study|Withdrawal by Subject|0|||
46925464|NCT01814072|83159906|FG012|Overall Study|Withdrawal by Subject|1|||
47053226|NCT01799993|83322874|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
47053227|NCT01799993|83322875|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
47053228|NCT01799993|83322874|FG000|Overall Study|Protocol driven decision point|0|||
47053229|NCT01799993|83322875|FG001|Overall Study|Protocol driven decision point|3|||
47053230|NCT01799993|83322874|FG000|Overall Study|Protocol Violation|1|||
47053231|NCT01799993|83322875|FG001|Overall Study|Protocol Violation|1|||
47053232|NCT01799993|83322874|FG000|Overall Study|Deterioration of general conditions|2|||
47053233|NCT01799993|83322875|FG001|Overall Study|Deterioration of general conditions|0|||
47053234|NCT01799993|83322874|FG000|Overall Study|Screen failure|0|||
47053235|NCT01799993|83322875|FG001|Overall Study|Screen failure|1|||
47053236|NCT01799993|83322874|FG000|Overall Study|Adverse Event|1|||
46806648|NCT00042991|83025491|FG003|Overall Study|Alternative Therapy|0|||
46806649|NCT00042991|83025492|FG004|Overall Study|Alternative Therapy|1|||
46806650|NCT00042991|83025493|FG005|Overall Study|Alternative Therapy|0|||
46806651|NCT00042991|83025494|FG006|Overall Study|Alternative Therapy|0|||
46806652|NCT00466167|83025515|FG000|Overall Study|Adverse Event|8|||
46806653|NCT00466167|83025516|FG001|Overall Study|Adverse Event|8|||
46806654|NCT00466167|83025517|FG002|Overall Study|Adverse Event|7|||
46806655|NCT00466167|83025515|FG000|Overall Study|Lack of Efficacy|2|||
46806656|NCT00466167|83025516|FG001|Overall Study|Lack of Efficacy|0|||
46806657|NCT00466167|83025517|FG002|Overall Study|Lack of Efficacy|3|||
46806658|NCT00466167|83025515|FG000|Overall Study|Protocol Violation|1|||
46806659|NCT00466167|83025516|FG001|Overall Study|Protocol Violation|1|||
46806660|NCT00466167|83025517|FG002|Overall Study|Protocol Violation|2|||
46806661|NCT00466167|83025515|FG000|Overall Study|Lost to Follow-up|3|||
46806662|NCT00466167|83025516|FG001|Overall Study|Lost to Follow-up|2|||
46806663|NCT00466167|83025517|FG002|Overall Study|Lost to Follow-up|2|||
46806664|NCT00466167|83025515|FG000|Overall Study|Withdrawal by Subject|4|||
46806665|NCT00466167|83025516|FG001|Overall Study|Withdrawal by Subject|1|||
46806666|NCT00466167|83025517|FG002|Overall Study|Withdrawal by Subject|6|||
46806667|NCT00466167|83025515|FG000|Overall Study|patient did not meet inclusion criteria|1|||
46806668|NCT00466167|83025516|FG001|Overall Study|patient did not meet inclusion criteria|0|||
46806669|NCT00466167|83025517|FG002|Overall Study|patient did not meet inclusion criteria|1|||
46806670|NCT00466167|83025515|FG000|Overall Study|Not treated|1|||
46806671|NCT00466167|83025516|FG001|Overall Study|Not treated|0|||
46806672|NCT00466167|83025517|FG002|Overall Study|Not treated|0|||
46806673|NCT00480441|83025527|FG000|Screening|Not Eligible|37|||
46806674|NCT00480441|83025528|FG001|Screening|Not Eligible|0|||
46806675|NCT00480441|83025529|FG002|Screening|Not Eligible|0|||
46806676|NCT00480441|83025527|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
46806677|NCT00480441|83025528|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
46806678|NCT00480441|83025529|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
46806679|NCT00480441|83025527|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
46806680|NCT00480441|83025528|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
46806681|NCT00480441|83025529|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
46806682|NCT00480441|83025527|FG000|Baseline Functional MRI|physical contraindication|4|||
46806683|NCT00480441|83025528|FG001|Baseline Functional MRI|physical contraindication|0|||
46806684|NCT00480441|83025529|FG002|Baseline Functional MRI|physical contraindication|0|||
46806685|NCT00480441|83025527|FG000|Randomization|Lost to Follow-up|0|||
46806686|NCT00480441|83025528|FG001|Randomization|Lost to Follow-up|7|||
46806687|NCT00480441|83025529|FG002|Randomization|Lost to Follow-up|2|||
46806688|NCT00488319|83025539|FG000|Overall Study|Adverse Event|1|||
46806689|NCT00488319|83025540|FG001|Overall Study|Adverse Event|2|||
46925465|NCT01814072|83159907|FG013|Overall Study|Withdrawal by Subject|1|||
46925466|NCT01814072|83159908|FG014|Overall Study|Withdrawal by Subject|1|||
46925467|NCT01814072|83159909|FG015|Overall Study|Withdrawal by Subject|1|||
47053237|NCT01799993|83322875|FG001|Overall Study|Adverse Event|0|||
47053238|NCT01799993|83322874|FG000|Overall Study|Lack of Efficacy|1|||
46925468|NCT01814072|83159910|FG016|Overall Study|Withdrawal by Subject|0|||
46806690|NCT00488319|83025541|FG002|Overall Study|Adverse Event|23|||
46806691|NCT00488319|83025539|FG000|Overall Study|Lack of Efficacy|6|||
46806692|NCT00488319|83025540|FG001|Overall Study|Lack of Efficacy|12|||
46806693|NCT00488319|83025541|FG002|Overall Study|Lack of Efficacy|27|||
46806694|NCT00488319|83025539|FG000|Overall Study|Lost to Follow-up|3|||
46806695|NCT00488319|83025540|FG001|Overall Study|Lost to Follow-up|5|||
46806696|NCT00488319|83025541|FG002|Overall Study|Lost to Follow-up|16|||
46806697|NCT00488319|83025539|FG000|Overall Study|Withdrawal by Subject|5|||
47053239|NCT01799993|83322875|FG001|Overall Study|Lack of Efficacy|0|||
46925469|NCT01814072|83159911|FG017|Overall Study|Withdrawal by Subject|0|||
46925470|NCT01814072|83159912|FG018|Overall Study|Withdrawal by Subject|0|||
46925471|NCT01814072|83159913|FG019|Overall Study|Withdrawal by Subject|2|||
46925472|NCT01814072|83159914|FG020|Overall Study|Withdrawal by Subject|0|||
46925473|NCT01814072|83159915|FG021|Overall Study|Withdrawal by Subject|0|||
46925474|NCT01814072|83159916|FG022|Overall Study|Withdrawal by Subject|1|||
46925475|NCT01814072|83159917|FG023|Overall Study|Withdrawal by Subject|0|||
46925476|NCT01814072|83159918|FG024|Overall Study|Withdrawal by Subject|2|||
46925477|NCT01814072|83159919|FG025|Overall Study|Withdrawal by Subject|1|||
46925478|NCT01814072|83159920|FG026|Overall Study|Withdrawal by Subject|1|||
46925479|NCT01814072|83159921|FG027|Overall Study|Withdrawal by Subject|2|||
46925480|NCT01814072|83159922|FG028|Overall Study|Withdrawal by Subject|1|||
46925481|NCT01814072|83159923|FG029|Overall Study|Withdrawal by Subject|0|||
46925482|NCT01814072|83159924|FG030|Overall Study|Withdrawal by Subject|0|||
46925483|NCT01814072|83159925|FG031|Overall Study|Withdrawal by Subject|0|||
46925484|NCT03038113|83159980|FG000|Overall Study|Withdrawal by Subject|0|||
46925485|NCT03038113|83159981|FG001|Overall Study|Withdrawal by Subject|0|||
46925486|NCT03038113|83159982|FG002|Overall Study|Withdrawal by Subject|1|||
46925487|NCT03038113|83159983|FG003|Overall Study|Withdrawal by Subject|0|||
46925488|NCT03038113|83159984|FG004|Overall Study|Withdrawal by Subject|0|||
46925489|NCT03038113|83159985|FG005|Overall Study|Withdrawal by Subject|0|||
46925490|NCT03038113|83159986|FG006|Overall Study|Withdrawal by Subject|0|||
46925491|NCT03038113|83159987|FG007|Overall Study|Withdrawal by Subject|0|||
46925492|NCT03038113|83159988|FG008|Overall Study|Withdrawal by Subject|0|||
46925493|NCT03038113|83159989|FG009|Overall Study|Withdrawal by Subject|0|||
46925494|NCT03038113|83159990|FG010|Overall Study|Withdrawal by Subject|0|||
46925495|NCT03038113|83159991|FG011|Overall Study|Withdrawal by Subject|0|||
46925496|NCT03038113|83159992|FG012|Overall Study|Withdrawal by Subject|0|||
46925497|NCT03038113|83159993|FG013|Overall Study|Withdrawal by Subject|1|||
46925498|NCT03038113|83159980|FG000|Overall Study|Lost to Follow-up|0|||
46925499|NCT03038113|83159981|FG001|Overall Study|Lost to Follow-up|0|||
46925500|NCT03038113|83159982|FG002|Overall Study|Lost to Follow-up|0|||
46925501|NCT03038113|83159983|FG003|Overall Study|Lost to Follow-up|0|||
46925502|NCT03038113|83159984|FG004|Overall Study|Lost to Follow-up|0|||
46925503|NCT03038113|83159985|FG005|Overall Study|Lost to Follow-up|0|||
46925504|NCT03038113|83159986|FG006|Overall Study|Lost to Follow-up|1|||
46925505|NCT03038113|83159987|FG007|Overall Study|Lost to Follow-up|0|||
46925506|NCT03038113|83159988|FG008|Overall Study|Lost to Follow-up|0|||
46925507|NCT03038113|83159989|FG009|Overall Study|Lost to Follow-up|0|||
46925508|NCT03038113|83159990|FG010|Overall Study|Lost to Follow-up|0|||
46925509|NCT03038113|83159991|FG011|Overall Study|Lost to Follow-up|0|||
46925510|NCT03038113|83159992|FG012|Overall Study|Lost to Follow-up|0|||
46925511|NCT03038113|83159993|FG013|Overall Study|Lost to Follow-up|0|||
46925512|NCT00968149|83160042|FG000|Overall Study|Adverse Event|5|||
46925513|NCT00968149|83160043|FG001|Overall Study|Adverse Event|1|||
46925514|NCT00968149|83160042|FG000|Overall Study|Lack of Efficacy|0|||
46925515|NCT00968149|83160043|FG001|Overall Study|Lack of Efficacy|4|||
46925516|NCT00968149|83160042|FG000|Overall Study|Lost to Follow-up|0|||
46925517|NCT00968149|83160043|FG001|Overall Study|Lost to Follow-up|1|||
46925518|NCT00968149|83160042|FG000|Overall Study|Protocol Violation|4|||
46925519|NCT00968149|83160043|FG001|Overall Study|Protocol Violation|0|||
46925520|NCT00968149|83160042|FG000|Overall Study|Withdrawal by Subject|2|||
46925521|NCT00968149|83160043|FG001|Overall Study|Withdrawal by Subject|0|||
46925522|NCT00963469|83160052|FG000|Overall Study|Adverse Event|15|||
46636227|NCT01520922|82810072|FG001|Follow up|Lost to Follow-up|1|||
46752426|NCT03668613|82970826|FG000|Overall Study|Lack of Efficacy|5|||
46752427|NCT03668613|82970827|FG001|Overall Study|Lack of Efficacy|1|||
46752428|NCT03668613|82970826|FG000|Overall Study|Pregnancy|0|||
46752429|NCT03668613|82970827|FG001|Overall Study|Pregnancy|2|||
46752430|NCT03668613|82970826|FG000|Overall Study|Protocol Violation|1|||
46752431|NCT03668613|82970827|FG001|Overall Study|Protocol Violation|0|||
46752432|NCT03668613|82970826|FG000|Overall Study|Physician Decision|1|||
46925523|NCT00963469|83160053|FG001|Overall Study|Adverse Event|11|||
46925524|NCT00963469|83160054|FG002|Overall Study|Adverse Event|1|||
46925525|NCT00963469|83160052|FG000|Overall Study|Lack of Efficacy|10|||
46636228|NCT01520922|82810071|FG000|Survival Follow-up|Withdrawal by Subject|1|||
46752433|NCT03668613|82970827|FG001|Overall Study|Physician Decision|0|||
46752434|NCT03668613|82970826|FG000|Overall Study|Withdrawal by Subject|2|||
46752435|NCT03668613|82970827|FG001|Overall Study|Withdrawal by Subject|1|||
46752436|NCT03668613|82970826|FG000|Overall Study|Guardian decision|1|||
46925526|NCT00963469|83160053|FG001|Overall Study|Lack of Efficacy|7|||
47053240|NCT01799993|83322874|FG000|Overall Study|Recovery|0|||
46925527|NCT00963469|83160054|FG002|Overall Study|Lack of Efficacy|2|||
46925528|NCT00963469|83160052|FG000|Overall Study|Lost to Follow-up|1|||
46925529|NCT00963469|83160053|FG001|Overall Study|Lost to Follow-up|1|||
46925530|NCT00963469|83160054|FG002|Overall Study|Lost to Follow-up|0|||
46925531|NCT00963469|83160052|FG000|Overall Study|Protocol Violation|5|||
46925532|NCT00963469|83160053|FG001|Overall Study|Protocol Violation|5|||
46925533|NCT00963469|83160054|FG002|Overall Study|Protocol Violation|3|||
46925534|NCT00963469|83160052|FG000|Overall Study|Withdrawal by Subject|4|||
46925535|NCT00963469|83160053|FG001|Overall Study|Withdrawal by Subject|1|||
46925536|NCT00963469|83160054|FG002|Overall Study|Withdrawal by Subject|1|||
46925537|NCT00963469|83160052|FG000|Overall Study|Pre-randomization Adverse Event|1|||
46925538|NCT00963469|83160053|FG001|Overall Study|Pre-randomization Adverse Event|2|||
46925539|NCT00963469|83160054|FG002|Overall Study|Pre-randomization Adverse Event|0|||
46925540|NCT00963469|83160052|FG000|Overall Study|Moved|1|||
46925541|NCT00963469|83160053|FG001|Overall Study|Moved|0|||
46925542|NCT00963469|83160054|FG002|Overall Study|Moved|0|||
47053241|NCT01799993|83322875|FG001|Overall Study|Recovery|1|||
46925543|NCT00963469|83160052|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
46925544|NCT00963469|83160053|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
46925545|NCT00963469|83160054|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
46925546|NCT00897949|83160065|FG000|Overall Study|Adverse Event|1|||
46925547|NCT00897949|83160066|FG001|Overall Study|Adverse Event|1|||
46925548|NCT00897949|83160067|FG002|Overall Study|Adverse Event|0|||
46925549|NCT00897949|83160065|FG000|Overall Study|Lost to Follow-up|0|||
46925550|NCT00897949|83160066|FG001|Overall Study|Lost to Follow-up|2|||
46925551|NCT00897949|83160067|FG002|Overall Study|Lost to Follow-up|1|||
46925552|NCT00897949|83160065|FG000|Overall Study|Protocol Violation|6|||
47053242|NCT01799993|83322874|FG000|Overall Study|Logistical difficulties|1|||
47053243|NCT01799993|83322875|FG001|Overall Study|Logistical difficulties|0|||
47053244|NCT01799993|83322874|FG000|Overall Study|Protocol deviation|1|||
46806698|NCT00488319|83025540|FG001|Overall Study|Withdrawal by Subject|20|||
46806699|NCT00488319|83025541|FG002|Overall Study|Withdrawal by Subject|44|||
46806700|NCT00488319|83025539|FG000|Overall Study|Other reasons for withdrawal|0|||
46925553|NCT00897949|83160066|FG001|Overall Study|Protocol Violation|3|||
46925554|NCT00897949|83160067|FG002|Overall Study|Protocol Violation|1|||
46925555|NCT00897949|83160065|FG000|Overall Study|Withdrawal by Subject|1|||
46925556|NCT00897949|83160066|FG001|Overall Study|Withdrawal by Subject|2|||
46925557|NCT00897949|83160067|FG002|Overall Study|Withdrawal by Subject|0|||
46925558|NCT00897949|83160065|FG000|Overall Study|Patient Uncoorperative|0|||
46925559|NCT00897949|83160066|FG001|Overall Study|Patient Uncoorperative|2|||
46925560|NCT00897949|83160067|FG002|Overall Study|Patient Uncoorperative|1|||
46925561|NCT00897949|83160065|FG000|Overall Study|Lost to Follow-up|30|||
46925562|NCT00897949|83160066|FG001|Overall Study|Lost to Follow-up|23|||
46925563|NCT00897949|83160067|FG002|Overall Study|Lost to Follow-up|17|||
46925564|NCT00897949|83160065|FG000|Overall Study|Withdrawal by Subject|24|||
46925565|NCT00897949|83160066|FG001|Overall Study|Withdrawal by Subject|31|||
46925566|NCT00897949|83160067|FG002|Overall Study|Withdrawal by Subject|17|||
46925567|NCT00897949|83160065|FG000|Overall Study|Abnormal Prestudy Labs|2|||
46925568|NCT00897949|83160066|FG001|Overall Study|Abnormal Prestudy Labs|3|||
46925569|NCT00897949|83160067|FG002|Overall Study|Abnormal Prestudy Labs|4|||
46925570|NCT00897949|83160065|FG000|Overall Study|Abnormal Baseline ECG|2|||
47053245|NCT01799993|83322875|FG001|Overall Study|Protocol deviation|0|||
47053246|NCT01799993|83322874|FG000|Overall Study|Non-compliance with medical device|1|||
46806701|NCT00488319|83025540|FG001|Overall Study|Other reasons for withdrawal|4|||
46806702|NCT00488319|83025541|FG002|Overall Study|Other reasons for withdrawal|12|||
46806703|NCT00463047|83025550|FG000|Titration Period 1|Adverse Event|10|||
46806704|NCT00463047|83025551|FG001|Titration Period 1|Adverse Event|8|||
46806705|NCT00463047|83025550|FG000|Titration Period 1|Lack of Efficacy|10|||
46806706|NCT00463047|83025551|FG001|Titration Period 1|Lack of Efficacy|4|||
46806707|NCT00463047|83025550|FG000|Titration Period 1|Lost to Follow-up|2|||
46806708|NCT00463047|83025551|FG001|Titration Period 1|Lost to Follow-up|0|||
46806709|NCT00463047|83025550|FG000|Titration Period 1|Non-compliance with study medication|3|||
46806710|NCT00463047|83025551|FG001|Titration Period 1|Non-compliance with study medication|5|||
46806711|NCT00463047|83025550|FG000|Titration Period 1|Protocol Violation|5|||
46806712|NCT00463047|83025551|FG001|Titration Period 1|Protocol Violation|5|||
46806713|NCT00463047|83025550|FG000|Titration Period 1|Withdrawal by Subject|3|||
46806714|NCT00463047|83025551|FG001|Titration Period 1|Withdrawal by Subject|5|||
46806715|NCT00463047|83025550|FG000|Titration Period 1|Non-compliance procedures|4|||
46806716|NCT00463047|83025551|FG001|Titration Period 1|Non-compliance procedures|10|||
46806717|NCT00463047|83025550|FG000|Titration Period 1|Other|0|||
46806718|NCT00463047|83025551|FG001|Titration Period 1|Other|2|||
46925571|NCT00897949|83160066|FG001|Overall Study|Abnormal Baseline ECG|2|||
47053247|NCT01799993|83322875|FG001|Overall Study|Non-compliance with medical device|0|||
46806719|NCT00463047|83025550|FG000|Titration Period 2|Adverse Event|9|||
46806720|NCT00463047|83025551|FG001|Titration Period 2|Adverse Event|9|||
46806721|NCT00463047|83025550|FG000|Titration Period 2|Lack of Efficacy|6|||
46806722|NCT00463047|83025551|FG001|Titration Period 2|Lack of Efficacy|4|||
46806723|NCT00463047|83025550|FG000|Titration Period 2|Withdrawal by Subject|1|||
46925572|NCT00897949|83160067|FG002|Overall Study|Abnormal Baseline ECG|4|||
46925573|NCT00897949|83160065|FG000|Overall Study|Need for Concom. Med.|0|||
46925574|NCT00897949|83160066|FG001|Overall Study|Need for Concom. Med.|1|||
46925575|NCT00897949|83160067|FG002|Overall Study|Need for Concom. Med.|1|||
47053248|NCT01799993|83322874|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46925576|NCT00897949|83160065|FG000|Overall Study|Lack of Migraine Attack|29|||
46925577|NCT00897949|83160066|FG001|Overall Study|Lack of Migraine Attack|30|||
46925578|NCT00897949|83160067|FG002|Overall Study|Lack of Migraine Attack|19|||
46925579|NCT00897949|83160065|FG000|Overall Study|Did not take study drug|9|||
46925580|NCT00897949|83160066|FG001|Overall Study|Did not take study drug|3|||
46925581|NCT00897949|83160067|FG002|Overall Study|Did not take study drug|4|||
46925582|NCT02760810|83160081|FG000|Overall Study|Protocol Violation|1|||
46925583|NCT02760654|83160087|FG000|Overall Study|Lost to Follow-up|3|||
46925584|NCT02760654|83160088|FG001|Overall Study|Lost to Follow-up|3|||
46925585|NCT02760654|83160087|FG000|Overall Study|Withdrawal by Subject|4|||
46925586|NCT02760654|83160088|FG001|Overall Study|Withdrawal by Subject|3|||
46925587|NCT00725491|83160096|FG000|Overall Study|Adverse Event|3|||
46925588|NCT00725491|83160097|FG001|Overall Study|Adverse Event|2|||
46925589|NCT00725491|83160096|FG000|Overall Study|Pregnancy|0|||
46925590|NCT00725491|83160097|FG001|Overall Study|Pregnancy|3|||
46925591|NCT00725491|83160096|FG000|Overall Study|Risk for hyperstimulation|2|||
46925592|NCT00725491|83160097|FG001|Overall Study|Risk for hyperstimulation|9|||
46925593|NCT00725491|83160096|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
46925594|NCT00725491|83160097|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
46925595|NCT00725491|83160096|FG000|Overall Study|Fertilization failure|0|||
46925596|NCT00725491|83160097|FG001|Overall Study|Fertilization failure|1|||
46925597|NCT00725491|83160096|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
46925598|NCT00725491|83160097|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
46925599|NCT02634580|83160107|FG000|Double-blind Treatment Period|Subject Request|1|||
46925600|NCT02634580|83160108|FG001|Double-blind Treatment Period|Subject Request|0|||
46925601|NCT02634580|83160109|FG002|Double-blind Treatment Period|Subject Request|1|||
46925602|NCT02634580|83160110|FG003|Double-blind Treatment Period|Subject Request|1|||
46925603|NCT02634580|83160107|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
46925604|NCT02634580|83160108|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
46925605|NCT02634580|83160109|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
46925606|NCT02634580|83160110|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
46925607|NCT02225366|83160121|FG000|Overall Study|Lack of Efficacy|1|||
46925608|NCT02225366|83160122|FG001|Overall Study|Lack of Efficacy|0|||
46925609|NCT00697255|83160130|FG000|Stage 1a|Insufficient ovarian response|1|||
46925610|NCT00697255|83160131|FG001|Stage 1a|Insufficient ovarian response|0|||
46925611|NCT00697255|83160130|FG000|Stage 1a|Multifollicular growth|1|||
46925612|NCT00697255|83160131|FG001|Stage 1a|Multifollicular growth|0|||
46752437|NCT03668613|82970827|FG001|Overall Study|Guardian decision|0|||
46752438|NCT03602066|82970854|FG000|Overall Study|Withdrawal by Subject|2|||
46752439|NCT03602066|82970855|FG001|Overall Study|Withdrawal by Subject|0|||
46752440|NCT03602066|82970854|FG000|Overall Study|Physician Decision|1|||
46925613|NCT00697255|83160130|FG000|Stage 1a|Not growing of dominant follicle|1|||
46925614|NCT00697255|83160131|FG001|Stage 1a|Not growing of dominant follicle|0|||
46925615|NCT00697255|83160130|FG000|Stage 1b|Not growing of dominant follicle|0|||
46925616|NCT00697255|83160131|FG001|Stage 1b|Not growing of dominant follicle|1|||
46925617|NCT00697255|83160130|FG000|Stage 1b|Insufficient ovarian response|0|||
46925618|NCT00697255|83160131|FG001|Stage 1b|Insufficient ovarian response|1|||
46806724|NCT00463047|83025551|FG001|Titration Period 2|Withdrawal by Subject|0|||
46925619|NCT05350423|83160139|FG000|Overall Study|Lost to Follow-up|3|||
46925620|NCT05350423|83160140|FG001|Overall Study|Lost to Follow-up|3|||
46925621|NCT05350423|83160139|FG000|Overall Study|screen failure|5|||
46925622|NCT05350423|83160140|FG001|Overall Study|screen failure|6|||
46925623|NCT04896385|83160148|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
47053249|NCT01799993|83322875|FG001|Overall Study|Withdrawal by parent/guardian|1|||
47053250|NCT01799993|83322874|FG000|Overall Study|Other|1|||
47053251|NCT01799993|83322875|FG001|Overall Study|Other|0|||
46752441|NCT03602066|82970855|FG001|Overall Study|Physician Decision|0|||
46752442|NCT03527732|82970867|FG000|Overall Study|Lost to Follow-up|21|||
46752443|NCT03527732|82970868|FG001|Overall Study|Lost to Follow-up|23|||
46752444|NCT03527732|82970869|FG002|Overall Study|Lost to Follow-up|80|||
46752445|NCT03527732|82970870|FG003|Overall Study|Lost to Follow-up|62|||
46806725|NCT00463047|83025550|FG000|Titration Period 2|Protocol Violation|2|||
46925624|NCT04896385|83160149|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
46925625|NCT04896385|83160150|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
46925626|NCT04896385|83160151|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
47053252|NCT01799993|83322874|FG000|Overall Study|Subject didn't return for follow-up|0|||
46925627|NCT04896385|83160148|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
47053253|NCT01799993|83322875|FG001|Overall Study|Subject didn't return for follow-up|1|||
46752446|NCT03527732|82970871|FG004|Overall Study|Lost to Follow-up|12|||
46752447|NCT03527732|82970872|FG005|Overall Study|Lost to Follow-up|20|||
46806726|NCT00463047|83025551|FG001|Titration Period 2|Protocol Violation|3|||
46752448|NCT02975934|82970900|FG000|Treatment Phase|Ongoing at data-analysis|33|||
46925628|NCT04896385|83160149|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
46925629|NCT04896385|83160150|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
46925630|NCT04896385|83160151|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
46925631|NCT04896385|83160148|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
46752449|NCT02975934|82970901|FG001|Treatment Phase|Ongoing at data-analysis|5|||
46752450|NCT02975934|82970900|FG000|Treatment Phase|Discontinued prior to study drug|0|||
46752451|NCT02975934|82970901|FG001|Treatment Phase|Discontinued prior to study drug|5|||
46752452|NCT02975934|82970900|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
46752453|NCT02975934|82970901|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
46752454|NCT02797171|82970913|FG000|Overall Study|Lost to Follow-up|2|||
46752455|NCT02797171|82970914|FG001|Overall Study|Lost to Follow-up|0|||
46752456|NCT02797171|82970915|FG002|Overall Study|Lost to Follow-up|2|||
46752457|NCT02797171|82970916|FG003|Overall Study|Lost to Follow-up|1|||
46752458|NCT02797171|82970917|FG004|Overall Study|Lost to Follow-up|2|||
46752459|NCT02797171|82970918|FG005|Overall Study|Lost to Follow-up|0|||
46752460|NCT02797171|82970913|FG000|Overall Study|Withdrawal by Subject|1|||
46752461|NCT02797171|82970914|FG001|Overall Study|Withdrawal by Subject|1|||
46752462|NCT02797171|82970915|FG002|Overall Study|Withdrawal by Subject|0|||
46752463|NCT02797171|82970916|FG003|Overall Study|Withdrawal by Subject|0|||
46752464|NCT02797171|82970917|FG004|Overall Study|Withdrawal by Subject|0|||
46752465|NCT02797171|82970918|FG005|Overall Study|Withdrawal by Subject|0|||
46752466|NCT02797171|82970913|FG000|Overall Study|Protocol Violation|1|||
46752467|NCT02797171|82970914|FG001|Overall Study|Protocol Violation|0|||
46806727|NCT00463047|83025550|FG000|Titration Period 2|Lost to Follow-up|1|||
46806728|NCT00463047|83025551|FG001|Titration Period 2|Lost to Follow-up|2|||
46806729|NCT00463047|83025550|FG000|Titration Period 2|Non-compliance study medication|4|||
46806730|NCT00463047|83025551|FG001|Titration Period 2|Non-compliance study medication|2|||
46636229|NCT01520922|82810072|FG001|Survival Follow-up|Withdrawal by Subject|0|||
46636230|NCT01569438|82810080|FG000|Overall Study|Lack of Efficacy|1|||
46636231|NCT01569438|82810081|FG001|Overall Study|Lack of Efficacy|2|||
46752468|NCT02797171|82970915|FG002|Overall Study|Protocol Violation|0|||
46752469|NCT02797171|82970916|FG003|Overall Study|Protocol Violation|0|||
46806731|NCT00463047|83025550|FG000|Titration Period 2|Non-compliance procedures|4|||
46806732|NCT00463047|83025551|FG001|Titration Period 2|Non-compliance procedures|1|||
46806733|NCT00463047|83025550|FG000|Titration Period 2|Other|3|||
46806734|NCT00463047|83025551|FG001|Titration Period 2|Other|2|||
46806735|NCT00463047|83025550|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
46806736|NCT00463047|83025551|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
46806737|NCT00463047|83025550|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
46806738|NCT00463047|83025551|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
46806739|NCT00463047|83025550|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
46806740|NCT00463047|83025551|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
46806741|NCT00463047|83025550|FG000|Double-Blind Treatment Period 1|Other|1|||
46806742|NCT00463047|83025551|FG001|Double-Blind Treatment Period 1|Other|0|||
46806743|NCT00463047|83025550|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
46806744|NCT00463047|83025551|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
46806745|NCT00463047|83025550|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
46806746|NCT00463047|83025551|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
46806747|NCT00463047|83025550|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
46806748|NCT00463047|83025551|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
46806749|NCT00487695|83025558|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
46806750|NCT00487695|83025559|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
46806751|NCT00487695|83025558|FG000|First Procedure|active wheezing (did not have procedure)|1|||
46806752|NCT00487695|83025559|FG001|First Procedure|active wheezing (did not have procedure)|0|||
46806753|NCT00487695|83025558|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
46806754|NCT00487695|83025559|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
46806755|NCT00487695|83025558|FG000|Second Procedure|active wheezing|0|||
46806756|NCT00487695|83025559|FG001|Second Procedure|active wheezing|1|||
46806757|NCT00487695|83025558|FG000|Second Procedure|Withdrawal by Subject|1|||
46806758|NCT00487695|83025559|FG001|Second Procedure|Withdrawal by Subject|2|||
46806759|NCT00487539|83025569|FG000|Overall Study|Adverse Event|3|||
46806760|NCT00487539|83025570|FG001|Overall Study|Adverse Event|2|||
46806761|NCT00487539|83025571|FG002|Overall Study|Adverse Event|1|||
46636232|NCT01569438|82810080|FG000|Overall Study|Withdrawal by Subject|0|||
46806762|NCT00487539|83025572|FG003|Overall Study|Adverse Event|1|||
46806763|NCT00487539|83025569|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46925632|NCT04896385|83160149|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
46636233|NCT01569438|82810081|FG001|Overall Study|Withdrawal by Subject|3|||
46752470|NCT02797171|82970917|FG004|Overall Study|Protocol Violation|0|||
46752471|NCT02797171|82970918|FG005|Overall Study|Protocol Violation|0|||
46752472|NCT02797171|82970913|FG000|Overall Study|Participant unable to adhere|0|||
46752473|NCT02797171|82970914|FG001|Overall Study|Participant unable to adhere|1|||
46806764|NCT00487539|83025570|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46806765|NCT00487539|83025571|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
46806766|NCT00487539|83025572|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
46806767|NCT00487539|83025569|FG000|Overall Study|Other|3|||
46806768|NCT00487539|83025570|FG001|Overall Study|Other|1|||
46925633|NCT04896385|83160150|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
47053254|NCT01822223|83322892|FG000|Overall Study|Death|0|||
46806769|NCT00487539|83025571|FG002|Overall Study|Other|2|||
46806770|NCT00487539|83025572|FG003|Overall Study|Other|2|||
46806771|NCT00486837|83025583|FG000|Overall Study|Withdrawal by Subject|1|||
46806772|NCT00486837|83025584|FG001|Overall Study|Withdrawal by Subject|0|||
46806773|NCT00486837|83025583|FG000|Overall Study|Adverse Event|1|||
46806774|NCT00486837|83025584|FG001|Overall Study|Adverse Event|1|||
46806775|NCT00486837|83025583|FG000|Overall Study|Protocol Violation|4|||
46806776|NCT00486837|83025584|FG001|Overall Study|Protocol Violation|2|||
46806777|NCT00486837|83025583|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
46806778|NCT00486837|83025584|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
46806779|NCT00486759|83025594|FG000|Treatment|Adverse event/intercurrent illness|86|||
46806780|NCT00486759|83025595|FG001|Treatment|Adverse event/intercurrent illness|39|||
46806781|NCT00486759|83025594|FG000|Treatment|Insufficient therapeutic response|37|||
46806782|NCT00486759|83025595|FG001|Treatment|Insufficient therapeutic response|39|||
46806783|NCT00486759|83025594|FG000|Treatment|Death|17|||
46806784|NCT00486759|83025595|FG001|Treatment|Death|10|||
46806785|NCT00486759|83025594|FG000|Treatment|Withdrew consent|15|||
46806786|NCT00486759|83025595|FG001|Treatment|Withdrew consent|12|||
46806787|NCT00486759|83025594|FG000|Treatment|Administrative/reason not specified|17|||
46806788|NCT00486759|83025595|FG001|Treatment|Administrative/reason not specified|21|||
46806789|NCT00486759|83025594|FG000|Treatment|Refused treatment|10|||
46806790|NCT00486759|83025595|FG001|Treatment|Refused treatment|7|||
46806791|NCT00486759|83025594|FG000|Treatment|Violation of selection criteria at entry|3|||
46806792|NCT00486759|83025595|FG001|Treatment|Violation of selection criteria at entry|3|||
46806793|NCT00486759|83025594|FG000|Treatment|Other protocol violation|1|||
46806794|NCT00486759|83025595|FG001|Treatment|Other protocol violation|5|||
46806795|NCT00486759|83025594|FG000|Treatment|Failure to return|1|||
47053255|NCT01822223|83322893|FG001|Overall Study|Death|1|||
47053256|NCT02228382|83322979|FG000|Overall Study|Death|5|||
46752474|NCT02797171|82970915|FG002|Overall Study|Participant unable to adhere|0|||
46752475|NCT02797171|82970916|FG003|Overall Study|Participant unable to adhere|0|||
46752476|NCT02797171|82970917|FG004|Overall Study|Participant unable to adhere|0|||
46752477|NCT02797171|82970918|FG005|Overall Study|Participant unable to adhere|0|||
46752478|NCT02797171|82970913|FG000|Overall Study|Not Randomized|0|||
46752479|NCT02797171|82970914|FG001|Overall Study|Not Randomized|0|||
46752480|NCT02797171|82970915|FG002|Overall Study|Not Randomized|0|||
46752481|NCT02797171|82970916|FG003|Overall Study|Not Randomized|0|||
46752482|NCT02797171|82970917|FG004|Overall Study|Not Randomized|0|||
46752483|NCT02797171|82970918|FG005|Overall Study|Not Randomized|1|||
46752484|NCT02782715|82970933|FG000|Overall Study|Withdrawal by Subject|1|||
46752485|NCT02764541|82970945|FG000|Overall Study|Withdrawal by Subject|0|||
46752486|NCT02764541|82970946|FG001|Overall Study|Withdrawal by Subject|0|||
46752487|NCT02764541|82970947|FG002|Overall Study|Withdrawal by Subject|0|||
46752488|NCT02764541|82970948|FG003|Overall Study|Withdrawal by Subject|0|||
46752489|NCT02764541|82970949|FG004|Overall Study|Withdrawal by Subject|1|||
46752490|NCT02764541|82970950|FG005|Overall Study|Withdrawal by Subject|1|||
46752491|NCT02764541|82970951|FG006|Overall Study|Withdrawal by Subject|0|||
46752492|NCT02764541|82970952|FG007|Overall Study|Withdrawal by Subject|1|||
46752493|NCT02764541|82970945|FG000|Overall Study|Adverse Event|1|||
46752494|NCT02764541|82970946|FG001|Overall Study|Adverse Event|0|||
46752495|NCT02764541|82970947|FG002|Overall Study|Adverse Event|0|||
46752496|NCT02764541|82970948|FG003|Overall Study|Adverse Event|0|||
46752497|NCT02764541|82970949|FG004|Overall Study|Adverse Event|0|||
46752498|NCT02764541|82970950|FG005|Overall Study|Adverse Event|0|||
46806796|NCT00486759|83025595|FG001|Treatment|Failure to return|1|||
46806797|NCT00486759|83025594|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
46806798|NCT00486759|83025595|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
46806799|NCT00486759|83025594|FG000|Safety Follow-up|Death|40|||
47053257|NCT02228382|83322980|FG001|Overall Study|Death|7|||
46752499|NCT02764541|82970951|FG006|Overall Study|Adverse Event|1|||
46752500|NCT02764541|82970952|FG007|Overall Study|Adverse Event|0|||
46752501|NCT02764541|82970945|FG000|Overall Study|Metastasis|1|||
46752502|NCT02764541|82970946|FG001|Overall Study|Metastasis|0|||
46806800|NCT00486759|83025595|FG001|Safety Follow-up|Death|29|||
46806801|NCT00486759|83025594|FG000|Safety Follow-up|Withdrew consent|32|||
47053258|NCT02228382|83322981|FG002|Overall Study|Death|5|||
46636234|NCT01569438|82810080|FG000|Overall Study|Adverse Event|2|||
46806802|NCT00486759|83025595|FG001|Safety Follow-up|Withdrew consent|23|||
46806803|NCT00486759|83025594|FG000|Safety Follow-up|Failure to return|9|||
46806804|NCT00486759|83025595|FG001|Safety Follow-up|Failure to return|6|||
46806805|NCT00486759|83025594|FG000|Safety Follow-up|Administrative/not specified|8|||
46752503|NCT02764541|82970947|FG002|Overall Study|Metastasis|0|||
46752504|NCT02764541|82970948|FG003|Overall Study|Metastasis|0|||
46806806|NCT00486759|83025595|FG001|Safety Follow-up|Administrative/not specified|6|||
46806807|NCT00486759|83025594|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
46806808|NCT00486759|83025595|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
46806809|NCT00486759|83025594|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
46806810|NCT00486759|83025595|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
46925634|NCT04896385|83160151|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
46925635|NCT04896385|83160148|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
46806811|NCT00486603|83025603|FG000|Overall Study|Withdrawal by Subject|1|||
46806812|NCT00486603|83025604|FG001|Overall Study|Withdrawal by Subject|0|||
46925636|NCT04896385|83160149|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
46925637|NCT04896385|83160150|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
46925638|NCT04896385|83160151|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
46925639|NCT04896385|83160148|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
47053259|NCT02228382|83322982|FG003|Overall Study|Death|0|||
47053260|NCT02228382|83322983|FG004|Overall Study|Death|2|||
47053261|NCT02228382|83322979|FG000|Overall Study|Participant refused further follow-up|0|||
47053262|NCT02228382|83322980|FG001|Overall Study|Participant refused further follow-up|0|||
47053263|NCT02228382|83322981|FG002|Overall Study|Participant refused further follow-up|1|||
47053264|NCT02228382|83322982|FG003|Overall Study|Participant refused further follow-up|0|||
47053265|NCT02228382|83322983|FG004|Overall Study|Participant refused further follow-up|0|||
47053266|NCT02228382|83322979|FG000|Overall Study|Study terminated by sponsor|3|||
47053267|NCT02228382|83322980|FG001|Overall Study|Study terminated by sponsor|5|||
47053268|NCT02228382|83322981|FG002|Overall Study|Study terminated by sponsor|7|||
47053269|NCT02228382|83322982|FG003|Overall Study|Study terminated by sponsor|0|||
47053270|NCT02228382|83322983|FG004|Overall Study|Study terminated by sponsor|0|||
47053271|NCT02228382|83322979|FG000|Overall Study|Lost to Follow-up|0|||
47053272|NCT02228382|83322980|FG001|Overall Study|Lost to Follow-up|0|||
47053273|NCT02228382|83322981|FG002|Overall Study|Lost to Follow-up|3|||
47053274|NCT02228382|83322982|FG003|Overall Study|Lost to Follow-up|1|||
47053275|NCT02228382|83322983|FG004|Overall Study|Lost to Follow-up|0|||
47053276|NCT02228382|83322979|FG000|Overall Study|Withdrawal by Subject|0|||
47053277|NCT02228382|83322980|FG001|Overall Study|Withdrawal by Subject|3|||
47053278|NCT02228382|83322981|FG002|Overall Study|Withdrawal by Subject|2|||
46752505|NCT02764541|82970949|FG004|Overall Study|Metastasis|0|||
46925640|NCT04896385|83160149|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
46925641|NCT04896385|83160150|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
46925642|NCT04896385|83160151|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
46925643|NCT04896385|83160148|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
46925644|NCT04896385|83160149|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
46925645|NCT04896385|83160150|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
46925646|NCT04896385|83160151|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
46925647|NCT04359823|83160172|FG000|Overall Study|Lost to Follow-up|0|||
46925648|NCT04359823|83160173|FG001|Overall Study|Lost to Follow-up|1|||
46925649|NCT04359823|83160172|FG000|Overall Study|Withdrawal by Subject|0|||
46925650|NCT04359823|83160173|FG001|Overall Study|Withdrawal by Subject|1|||
46925651|NCT04229446|83160192|FG000|Overall Study|Death|12|||
46925652|NCT04229446|83160193|FG001|Overall Study|Death|10|||
46925653|NCT04229446|83160192|FG000|Overall Study|Lost to Follow-up|5|||
46925654|NCT04229446|83160193|FG001|Overall Study|Lost to Follow-up|8|||
46925655|NCT03701763|83160228|FG000|Placebo-controlled Phase|Adverse Event|1|||
46925656|NCT03701763|83160229|FG001|Placebo-controlled Phase|Adverse Event|5|||
46925657|NCT03701763|83160230|FG002|Placebo-controlled Phase|Adverse Event|0|||
46925658|NCT03701763|83160231|FG003|Placebo-controlled Phase|Adverse Event|0|||
46925659|NCT03701763|83160228|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
47053279|NCT02228382|83322982|FG003|Overall Study|Withdrawal by Subject|1|||
46752506|NCT02764541|82970950|FG005|Overall Study|Metastasis|0|||
46752507|NCT02764541|82970951|FG006|Overall Study|Metastasis|0|||
46752508|NCT02764541|82970952|FG007|Overall Study|Metastasis|0|||
46752509|NCT02764541|82970945|FG000|Overall Study|Disease progression|1|||
46752510|NCT02764541|82970946|FG001|Overall Study|Disease progression|1|||
46752511|NCT02764541|82970947|FG002|Overall Study|Disease progression|0|||
46925660|NCT03701763|83160229|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
46636235|NCT01569438|82810081|FG001|Overall Study|Adverse Event|15|||
46752512|NCT02764541|82970948|FG003|Overall Study|Disease progression|0|||
46752513|NCT02764541|82970949|FG004|Overall Study|Disease progression|0|||
46752514|NCT02764541|82970950|FG005|Overall Study|Disease progression|0|||
46752515|NCT02764541|82970951|FG006|Overall Study|Disease progression|0|||
46752516|NCT02764541|82970952|FG007|Overall Study|Disease progression|1|||
46752517|NCT02764541|82970945|FG000|Overall Study|Protocol Violation|0|||
46752518|NCT02764541|82970946|FG001|Overall Study|Protocol Violation|0|||
46752519|NCT02764541|82970947|FG002|Overall Study|Protocol Violation|0|||
46752520|NCT02764541|82970948|FG003|Overall Study|Protocol Violation|1|||
46752521|NCT02764541|82970949|FG004|Overall Study|Protocol Violation|0|||
46806813|NCT00486603|83025605|FG002|Overall Study|Withdrawal by Subject|0|||
46806814|NCT00486603|83025606|FG003|Overall Study|Withdrawal by Subject|0|||
46806815|NCT00486603|83025607|FG004|Overall Study|Withdrawal by Subject|0|||
46925661|NCT03701763|83160230|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
46925662|NCT03701763|83160231|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
46925663|NCT03701763|83160228|FG000|Placebo-controlled Phase|Miscellaneous|2|||
46925664|NCT03701763|83160229|FG001|Placebo-controlled Phase|Miscellaneous|0|||
46925665|NCT03701763|83160230|FG002|Placebo-controlled Phase|Miscellaneous|0|||
46925666|NCT03701763|83160231|FG003|Placebo-controlled Phase|Miscellaneous|0|||
46925667|NCT03701763|83160228|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
46925668|NCT03701763|83160229|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
46925669|NCT03701763|83160230|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
46925670|NCT03701763|83160231|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
46925671|NCT03701763|83160228|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
46925672|NCT03701763|83160229|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
46806816|NCT00486603|83025603|FG000|Overall Study|Physician Decision|0|||
46806817|NCT00486603|83025604|FG001|Overall Study|Physician Decision|1|||
46806818|NCT00486603|83025605|FG002|Overall Study|Physician Decision|0|||
46806819|NCT00486603|83025606|FG003|Overall Study|Physician Decision|0|||
46806820|NCT00486603|83025607|FG004|Overall Study|Physician Decision|0|||
46806821|NCT00486291|83025624|FG000|Overall Study|Adverse Event|3|||
46806822|NCT00486291|83025625|FG001|Overall Study|Adverse Event|4|||
46806823|NCT00486291|83025624|FG000|Overall Study|Lost to Follow-up|3|||
46806824|NCT00486291|83025625|FG001|Overall Study|Lost to Follow-up|7|||
46806825|NCT00486291|83025624|FG000|Overall Study|protocol non-compliance|10|||
46806826|NCT00486291|83025625|FG001|Overall Study|protocol non-compliance|15|||
46806827|NCT00486291|83025624|FG000|Overall Study|requirement for restricted medication|0|||
46806828|NCT00486291|83025625|FG001|Overall Study|requirement for restricted medication|3|||
46806829|NCT00474045|83025633|FG000|Overall Study|Adverse Event|18|||
46806830|NCT00474045|83025634|FG001|Overall Study|Adverse Event|8|||
46806831|NCT00474045|83025633|FG000|Overall Study|Unclassified|1|||
46806832|NCT00474045|83025634|FG001|Overall Study|Unclassified|3|||
46806833|NCT00474045|83025633|FG000|Overall Study|Lack of Efficacy|0|||
46806834|NCT00474045|83025634|FG001|Overall Study|Lack of Efficacy|9|||
46806835|NCT00474045|83025633|FG000|Overall Study|Lost to Follow-up|1|||
46806836|NCT00474045|83025634|FG001|Overall Study|Lost to Follow-up|1|||
46806837|NCT00474045|83025633|FG000|Overall Study|Protocol Violation|10|||
46806838|NCT00474045|83025634|FG001|Overall Study|Protocol Violation|12|||
46806839|NCT00474045|83025633|FG000|Overall Study|Withdrawal by Subject|16|||
46806840|NCT00474045|83025634|FG001|Overall Study|Withdrawal by Subject|18|||
46806841|NCT00474045|83025633|FG000|Overall Study|Withdrawal criteria|60|||
46806842|NCT00474045|83025634|FG001|Overall Study|Withdrawal criteria|50|||
46806843|NCT00462501|83025640|FG000|Overall Study|Not treated|3|||
46806844|NCT00462501|83025640|FG000|Overall Study|Adverse Event|2|||
46806845|NCT00383188|83025649|FG000|Overall Study|Adverse Event|4|||
46806846|NCT00383188|83025650|FG001|Overall Study|Adverse Event|7|||
46806847|NCT00383188|83025651|FG002|Overall Study|Adverse Event|9|||
46806848|NCT00383188|83025652|FG003|Overall Study|Adverse Event|8|||
46806849|NCT00383188|83025653|FG004|Overall Study|Adverse Event|8|||
46806850|NCT00383188|83025649|FG000|Overall Study|Lack of Efficacy|9|||
46806851|NCT00383188|83025650|FG001|Overall Study|Lack of Efficacy|3|||
46806852|NCT00383188|83025651|FG002|Overall Study|Lack of Efficacy|3|||
46806853|NCT00383188|83025652|FG003|Overall Study|Lack of Efficacy|2|||
46806854|NCT00383188|83025653|FG004|Overall Study|Lack of Efficacy|6|||
46806855|NCT00383188|83025649|FG000|Overall Study|Other|3|||
46806856|NCT00383188|83025650|FG001|Overall Study|Other|1|||
46806857|NCT00383188|83025651|FG002|Overall Study|Other|0|||
46806858|NCT00383188|83025652|FG003|Overall Study|Other|2|||
46806859|NCT00383188|83025653|FG004|Overall Study|Other|6|||
46806860|NCT00383188|83025649|FG000|Overall Study|No longer willing to participate|1|||
46806861|NCT00383188|83025650|FG001|Overall Study|No longer willing to participate|0|||
46806862|NCT00383188|83025651|FG002|Overall Study|No longer willing to participate|1|||
46806863|NCT00383188|83025652|FG003|Overall Study|No longer willing to participate|0|||
46925673|NCT03701763|83160230|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
46925674|NCT03701763|83160231|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
47053280|NCT02228382|83322983|FG004|Overall Study|Withdrawal by Subject|0|||
47053281|NCT02228382|83322979|FG000|Overall Study|Other|2|||
46806864|NCT00383188|83025653|FG004|Overall Study|No longer willing to participate|2|||
46806865|NCT00383188|83025649|FG000|Overall Study|Lost to Follow-up|0|||
46806866|NCT00383188|83025650|FG001|Overall Study|Lost to Follow-up|0|||
46806867|NCT00383188|83025651|FG002|Overall Study|Lost to Follow-up|0|||
46806868|NCT00383188|83025652|FG003|Overall Study|Lost to Follow-up|0|||
46806869|NCT00383188|83025653|FG004|Overall Study|Lost to Follow-up|1|||
46806870|NCT00462345|83025667|FG000|Overall Study|Withdrawal by Subject|2|||
46806871|NCT00462345|83025667|FG000|Overall Study|Did not complete second course|1|||
46806872|NCT00453999|83025674|FG000|Overall Study|Adverse Event|1|||
46806873|NCT00453999|83025675|FG001|Overall Study|Adverse Event|2|||
46806874|NCT00453999|83025676|FG002|Overall Study|Adverse Event|1|||
46806875|NCT00453999|83025674|FG000|Overall Study|Lost to Follow-up|0|||
46806876|NCT00453999|83025675|FG001|Overall Study|Lost to Follow-up|1|||
46806877|NCT00453999|83025676|FG002|Overall Study|Lost to Follow-up|1|||
46806878|NCT00453999|83025674|FG000|Overall Study|Withdrawal by Subject|2|||
46806879|NCT00453999|83025675|FG001|Overall Study|Withdrawal by Subject|1|||
46806880|NCT00453999|83025676|FG002|Overall Study|Withdrawal by Subject|1|||
46806881|NCT00453999|83025674|FG000|Overall Study|Subject Request|2|||
46806882|NCT00453999|83025675|FG001|Overall Study|Subject Request|1|||
46806883|NCT00453999|83025676|FG002|Overall Study|Subject Request|0|||
46806884|NCT00453921|83025689|FG000|Overall Study|Withdrawal by Subject|1|||
46806885|NCT00453921|83025690|FG001|Overall Study|Withdrawal by Subject|1|||
46806886|NCT00453921|83025691|FG002|Overall Study|Withdrawal by Subject|1|||
46806887|NCT00453921|83025692|FG003|Overall Study|Withdrawal by Subject|1|||
46806888|NCT00453921|83025689|FG000|Overall Study|Lost to Follow-up|0|||
46806889|NCT00453921|83025690|FG001|Overall Study|Lost to Follow-up|0|||
46806890|NCT00453921|83025691|FG002|Overall Study|Lost to Follow-up|1|||
46806891|NCT00453921|83025692|FG003|Overall Study|Lost to Follow-up|0|||
46806892|NCT00382720|83025709|FG000|Overall Study|Adverse Event|21|||
46806893|NCT00382720|83025710|FG001|Overall Study|Adverse Event|23|||
46806894|NCT00382720|83025711|FG002|Overall Study|Adverse Event|15|||
46806895|NCT00382720|83025709|FG000|Overall Study|Protocol Violation|2|||
46806896|NCT00382720|83025710|FG001|Overall Study|Protocol Violation|5|||
46806897|NCT00382720|83025711|FG002|Overall Study|Protocol Violation|1|||
46806898|NCT00382720|83025709|FG000|Overall Study|Death|0|||
46806899|NCT00382720|83025710|FG001|Overall Study|Death|1|||
46806900|NCT00382720|83025711|FG002|Overall Study|Death|2|||
46806901|NCT00382720|83025709|FG000|Overall Study|Progressive disease|37|||
46806902|NCT00382720|83025710|FG001|Overall Study|Progressive disease|28|||
46806903|NCT00382720|83025711|FG002|Overall Study|Progressive disease|38|||
46806904|NCT00382720|83025709|FG000|Overall Study|Withdrew consent|1|||
46806905|NCT00382720|83025710|FG001|Overall Study|Withdrew consent|1|||
46806906|NCT00382720|83025711|FG002|Overall Study|Withdrew consent|2|||
46806907|NCT00382720|83025709|FG000|Overall Study|Withdrawal by Subject|11|||
46806908|NCT00382720|83025710|FG001|Overall Study|Withdrawal by Subject|20|||
46806909|NCT00382720|83025711|FG002|Overall Study|Withdrawal by Subject|12|||
46806910|NCT00382720|83025709|FG000|Overall Study|Surgery|1|||
46806911|NCT00382720|83025710|FG001|Overall Study|Surgery|1|||
46806912|NCT00382720|83025711|FG002|Overall Study|Surgery|4|||
46806913|NCT00382720|83025709|FG000|Overall Study|Patient did not receive study medication|1|||
46806914|NCT00382720|83025710|FG001|Overall Study|Patient did not receive study medication|1|||
46806915|NCT00382720|83025711|FG002|Overall Study|Patient did not receive study medication|4|||
46806916|NCT00382720|83025709|FG000|Overall Study|Clinically progressive disease|0|||
46806917|NCT00382720|83025710|FG001|Overall Study|Clinically progressive disease|1|||
46806918|NCT00382720|83025711|FG002|Overall Study|Clinically progressive disease|0|||
46806919|NCT00382720|83025709|FG000|Overall Study|Good prognosis|0|||
46925675|NCT03701763|83160228|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
46925676|NCT03701763|83160229|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
46925677|NCT03701763|83160230|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
46925678|NCT03701763|83160231|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
46925679|NCT03701763|83160228|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
46925680|NCT03701763|83160229|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
46925681|NCT03701763|83160230|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
46752522|NCT02764541|82970950|FG005|Overall Study|Protocol Violation|1|||
46752523|NCT02764541|82970951|FG006|Overall Study|Protocol Violation|0|||
46752524|NCT02764541|82970952|FG007|Overall Study|Protocol Violation|0|||
46752525|NCT02764541|82970945|FG000|Overall Study|Physician Decision|0|||
46752526|NCT02764541|82970946|FG001|Overall Study|Physician Decision|0|||
46752527|NCT02764541|82970947|FG002|Overall Study|Physician Decision|0|||
46752528|NCT02764541|82970948|FG003|Overall Study|Physician Decision|1|||
46752529|NCT02764541|82970949|FG004|Overall Study|Physician Decision|0|||
46752530|NCT02764541|82970950|FG005|Overall Study|Physician Decision|0|||
46752531|NCT02764541|82970951|FG006|Overall Study|Physician Decision|0|||
46752532|NCT02764541|82970952|FG007|Overall Study|Physician Decision|1|||
46752533|NCT02764541|82970945|FG000|Overall Study|Three Cycles completed before surgery|0|||
46752534|NCT02764541|82970946|FG001|Overall Study|Three Cycles completed before surgery|0|||
46752535|NCT02764541|82970947|FG002|Overall Study|Three Cycles completed before surgery|0|||
46752536|NCT02764541|82970948|FG003|Overall Study|Three Cycles completed before surgery|1|||
46752537|NCT02764541|82970949|FG004|Overall Study|Three Cycles completed before surgery|0|||
46806920|NCT00382720|83025710|FG001|Overall Study|Good prognosis|1|||
46806921|NCT00382720|83025711|FG002|Overall Study|Good prognosis|0|||
46806922|NCT00382720|83025709|FG000|Overall Study|Investigator/Clinical decision|5|||
46806923|NCT00382720|83025710|FG001|Overall Study|Investigator/Clinical decision|6|||
46806924|NCT00382720|83025711|FG002|Overall Study|Investigator/Clinical decision|6|||
46806925|NCT00382720|83025709|FG000|Overall Study|Discontinued at end of study|0|||
46806926|NCT00382720|83025710|FG001|Overall Study|Discontinued at end of study|1|||
46806927|NCT00382720|83025711|FG002|Overall Study|Discontinued at end of study|2|||
46806928|NCT00453063|83025721|FG000|Overall Study|Adverse Event|1|||
46806929|NCT00453063|83025722|FG001|Overall Study|Adverse Event|2|||
46806930|NCT00453063|83025721|FG000|Overall Study|Withdrawal by Subject|1|||
46806931|NCT00453063|83025722|FG001|Overall Study|Withdrawal by Subject|1|||
46806932|NCT00453063|83025721|FG000|Overall Study|Protocol Violation|1|||
46806933|NCT00453063|83025722|FG001|Overall Study|Protocol Violation|0|||
46806934|NCT00371566|83025730|FG000|Treatment Phase|Withdrawal by Subject|0|||
46806935|NCT00371566|83025731|FG001|Treatment Phase|Withdrawal by Subject|1|||
46806936|NCT00371566|83025730|FG000|Treatment Phase|Adverse Event|0|||
46806937|NCT00371566|83025731|FG001|Treatment Phase|Adverse Event|1|||
46806938|NCT00371566|83025730|FG000|Treatment Phase|Protocol Violation|0|||
46806939|NCT00371566|83025731|FG001|Treatment Phase|Protocol Violation|1|||
46806940|NCT00371566|83025730|FG000|Chemoradiation Phase|Physician Decision|2|||
46806941|NCT00371566|83025731|FG001|Chemoradiation Phase|Physician Decision|0|||
46806942|NCT00371566|83025730|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
46806943|NCT00371566|83025731|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
46806944|NCT00371566|83025730|FG000|Chemoradiation Phase|Non compliant|0|||
46806945|NCT00371566|83025731|FG001|Chemoradiation Phase|Non compliant|1|||
46806946|NCT00371566|83025730|FG000|Chemoradiation Phase|Progressive Disease|1|||
46806947|NCT00371566|83025731|FG001|Chemoradiation Phase|Progressive Disease|1|||
46806948|NCT00371566|83025730|FG000|Chemoradiation Phase|Death|2|||
46806949|NCT00371566|83025731|FG001|Chemoradiation Phase|Death|0|||
46806950|NCT00371566|83025730|FG000|Follow Up Phase|Death|0|||
46806951|NCT00371566|83025731|FG001|Follow Up Phase|Death|5|||
46925682|NCT03701763|83160231|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
46925683|NCT03701763|83160228|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
46925684|NCT03701763|83160229|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
46925685|NCT03701763|83160230|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
46925686|NCT03701763|83160231|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
46925687|NCT03701763|83160228|FG000|Apremilast Extension Phase|Adverse Event|0|||
46925688|NCT03701763|83160229|FG001|Apremilast Extension Phase|Adverse Event|0|||
46925689|NCT03701763|83160230|FG002|Apremilast Extension Phase|Adverse Event|3|||
46925690|NCT03701763|83160231|FG003|Apremilast Extension Phase|Adverse Event|1|||
46752538|NCT02764541|82970950|FG005|Overall Study|Three Cycles completed before surgery|0|||
46806952|NCT00371566|83025730|FG000|Follow Up Phase|Disease progression|1|||
46806953|NCT00371566|83025731|FG001|Follow Up Phase|Disease progression|0|||
46806954|NCT00371566|83025730|FG000|Follow Up Phase|Withdrawal by Subject|0|||
46806955|NCT00371566|83025731|FG001|Follow Up Phase|Withdrawal by Subject|1|||
46806956|NCT00371566|83025730|FG000|Follow Up Phase|Physician Decision|1|||
46806957|NCT00371566|83025731|FG001|Follow Up Phase|Physician Decision|1|||
46806958|NCT00371566|83025730|FG000|Follow Up Phase|Lost to Follow-up|1|||
46806959|NCT00371566|83025731|FG001|Follow Up Phase|Lost to Follow-up|0|||
46806960|NCT00382408|83025739|FG000|Overall Study|Did not meet protocol requirement|3|||
46806961|NCT00382408|83025740|FG001|Overall Study|Did not meet protocol requirement|3|||
46806962|NCT00382408|83025739|FG000|Overall Study|Protocol Violation|2|||
46806963|NCT00382408|83025740|FG001|Overall Study|Protocol Violation|2|||
46806964|NCT00382408|83025739|FG000|Overall Study|Physician Decision|1|||
46806965|NCT00382408|83025740|FG001|Overall Study|Physician Decision|0|||
46806966|NCT00382408|83025739|FG000|Overall Study|Withdrawal by Subject|17|||
46752539|NCT02764541|82970951|FG006|Overall Study|Three Cycles completed before surgery|0|||
46752540|NCT02764541|82970952|FG007|Overall Study|Three Cycles completed before surgery|0|||
46752541|NCT02764541|82970945|FG000|Overall Study|Patient Compliance|0|||
46752542|NCT02764541|82970946|FG001|Overall Study|Patient Compliance|0|||
46752543|NCT02764541|82970947|FG002|Overall Study|Patient Compliance|1|||
46752544|NCT02764541|82970948|FG003|Overall Study|Patient Compliance|0|||
46752545|NCT02764541|82970949|FG004|Overall Study|Patient Compliance|0|||
46752546|NCT02764541|82970950|FG005|Overall Study|Patient Compliance|0|||
46752547|NCT02764541|82970951|FG006|Overall Study|Patient Compliance|0|||
46752548|NCT02764541|82970952|FG007|Overall Study|Patient Compliance|0|||
46752549|NCT02764541|82970945|FG000|Overall Study|Death|0|||
46806967|NCT00382408|83025740|FG001|Overall Study|Withdrawal by Subject|6|||
46806968|NCT00382408|83025739|FG000|Overall Study|Pregnancy|2|||
46806969|NCT00382408|83025740|FG001|Overall Study|Pregnancy|0|||
46806970|NCT00382408|83025739|FG000|Overall Study|Lost to Follow-up|19|||
46806971|NCT00382408|83025740|FG001|Overall Study|Lost to Follow-up|8|||
46925691|NCT03701763|83160228|FG000|Apremilast Extension Phase|Miscellaneous|0|||
46925692|NCT03701763|83160229|FG001|Apremilast Extension Phase|Miscellaneous|0|||
46806972|NCT00382408|83025739|FG000|Overall Study|Other|100|||
46806973|NCT00382408|83025740|FG001|Overall Study|Other|35|||
46806974|NCT00371254|83025748|FG000|Overall Study|Disease progression|13|||
46806975|NCT00371254|83025749|FG001|Overall Study|Disease progression|13|||
46806976|NCT00371254|83025748|FG000|Overall Study|Study drug toxicity|3|||
46806977|NCT00371254|83025749|FG001|Overall Study|Study drug toxicity|5|||
46806978|NCT00371254|83025748|FG000|Overall Study|Subject request|5|||
46752550|NCT02764541|82970946|FG001|Overall Study|Death|0|||
46752551|NCT02764541|82970947|FG002|Overall Study|Death|0|||
46752552|NCT02764541|82970948|FG003|Overall Study|Death|0|||
46752553|NCT02764541|82970949|FG004|Overall Study|Death|0|||
46806979|NCT00371254|83025749|FG001|Overall Study|Subject request|0|||
46806980|NCT00371254|83025748|FG000|Overall Study|Investigator Decision|2|||
46806981|NCT00371254|83025749|FG001|Overall Study|Investigator Decision|0|||
46806982|NCT00371254|83025748|FG000|Overall Study|Adverse event unrelated to study drug|0|||
46806983|NCT00371254|83025749|FG001|Overall Study|Adverse event unrelated to study drug|1|||
46806984|NCT00371254|83025748|FG000|Overall Study|Lost to Follow-up|0|||
46806985|NCT00371254|83025749|FG001|Overall Study|Lost to Follow-up|1|||
46806986|NCT00371254|83025748|FG000|Overall Study|Withdrawal by Subject|0|||
46806987|NCT00371254|83025749|FG001|Overall Study|Withdrawal by Subject|1|||
46806988|NCT00452673|83025759|FG000|Dose Escalation Period|Disease Progression|6|||
46806989|NCT00452673|83025760|FG001|Dose Escalation Period|Disease Progression|6|||
46806990|NCT00452673|83025761|FG002|Dose Escalation Period|Disease Progression|2|||
46806991|NCT00452673|83025762|FG003|Dose Escalation Period|Disease Progression|6|||
46806992|NCT00452673|83025763|FG004|Dose Escalation Period|Disease Progression|0|||
46806993|NCT00452673|83025759|FG000|Dose Escalation Period|study drug toxicity|1|||
46806994|NCT00452673|83025760|FG001|Dose Escalation Period|study drug toxicity|3|||
46806995|NCT00452673|83025761|FG002|Dose Escalation Period|study drug toxicity|3|||
46806996|NCT00452673|83025762|FG003|Dose Escalation Period|study drug toxicity|1|||
46806997|NCT00452673|83025763|FG004|Dose Escalation Period|study drug toxicity|0|||
46806998|NCT00452673|83025759|FG000|Dose Escalation Period|Other|0|||
46806999|NCT00452673|83025760|FG001|Dose Escalation Period|Other|0|||
46807000|NCT00452673|83025761|FG002|Dose Escalation Period|Other|1|||
46807001|NCT00452673|83025762|FG003|Dose Escalation Period|Other|0|||
46807002|NCT00452673|83025763|FG004|Dose Escalation Period|Other|0|||
46807003|NCT00452673|83025759|FG000|Dose Escalation Period|Adverse Event|0|||
46807004|NCT00452673|83025760|FG001|Dose Escalation Period|Adverse Event|0|||
46807005|NCT00452673|83025761|FG002|Dose Escalation Period|Adverse Event|0|||
46807006|NCT00452673|83025762|FG003|Dose Escalation Period|Adverse Event|1|||
46807007|NCT00452673|83025763|FG004|Dose Escalation Period|Adverse Event|0|||
46807008|NCT00452673|83025759|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
46807009|NCT00452673|83025760|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
46807010|NCT00452673|83025761|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
46807011|NCT00452673|83025762|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
46807012|NCT00452673|83025763|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
46807013|NCT00452673|83025759|FG000|Dose Expansion Period|Disease Progression|0|||
46807014|NCT00452673|83025760|FG001|Dose Expansion Period|Disease Progression|0|||
46807015|NCT00452673|83025761|FG002|Dose Expansion Period|Disease Progression|0|||
46807016|NCT00452673|83025762|FG003|Dose Expansion Period|Disease Progression|0|||
46807017|NCT00452673|83025763|FG004|Dose Expansion Period|Disease Progression|19|||
46807018|NCT00452673|83025759|FG000|Dose Expansion Period|Other|0|||
46807019|NCT00452673|83025760|FG001|Dose Expansion Period|Other|0|||
46807020|NCT00452673|83025761|FG002|Dose Expansion Period|Other|0|||
46807021|NCT00452673|83025762|FG003|Dose Expansion Period|Other|0|||
46807022|NCT00452673|83025763|FG004|Dose Expansion Period|Other|2|||
46807023|NCT00461253|83025776|FG000|Overall Study|Death|985|||
46807024|NCT00461253|83025777|FG001|Overall Study|Death|0|||
46807025|NCT00461253|83025776|FG000|Overall Study|Protocol Violation|613|||
46807026|NCT00461253|83025777|FG001|Overall Study|Protocol Violation|236|||
46807027|NCT00461253|83025776|FG000|Overall Study|no response|2609|||
46807028|NCT00461253|83025777|FG001|Overall Study|no response|11789|||
46807029|NCT00461253|83025776|FG000|Overall Study|administrative|773|||
46807030|NCT00461253|83025777|FG001|Overall Study|administrative|7773|||
46807031|NCT00469833|83025783|FG000|Overall Study|No IV access|2|||
46807032|NCT00382174|83025795|FG000|Overall Study|Lost to Follow-up|1|||
46807033|NCT00382174|83025796|FG001|Overall Study|Lost to Follow-up|4|||
46807034|NCT00382174|83025797|FG002|Overall Study|Lost to Follow-up|5|||
46807035|NCT00382174|83025795|FG000|Overall Study|Adverse Event|1|||
46807036|NCT00382174|83025796|FG001|Overall Study|Adverse Event|4|||
46807037|NCT00382174|83025797|FG002|Overall Study|Adverse Event|5|||
46807038|NCT00382174|83025795|FG000|Overall Study|Withdrawal by Subject|1|||
46807039|NCT00382174|83025796|FG001|Overall Study|Withdrawal by Subject|4|||
46807040|NCT00382174|83025797|FG002|Overall Study|Withdrawal by Subject|5|||
46636236|NCT01569438|82810080|FG000|Overall Study|Protocol Violation|2|||
46807041|NCT00382174|83025795|FG000|Overall Study|Non compliance|1|||
46807042|NCT00382174|83025796|FG001|Overall Study|Non compliance|0|||
46807043|NCT00382174|83025797|FG002|Overall Study|Non compliance|1|||
46807044|NCT00382174|83025795|FG000|Overall Study|Physician Decision|0|||
46807045|NCT00382174|83025796|FG001|Overall Study|Physician Decision|2|||
46807046|NCT00382174|83025797|FG002|Overall Study|Physician Decision|2|||
46807047|NCT00382174|83025795|FG000|Overall Study|Failed to meet criteria|0|||
46807048|NCT00382174|83025796|FG001|Overall Study|Failed to meet criteria|1|||
46807049|NCT00382174|83025797|FG002|Overall Study|Failed to meet criteria|1|||
46807050|NCT00382174|83025795|FG000|Overall Study|Wounds merged|0|||
46807051|NCT00382174|83025796|FG001|Overall Study|Wounds merged|2|||
46807052|NCT00382174|83025797|FG002|Overall Study|Wounds merged|2|||
46807053|NCT00641537|83025810|FG000|96-week Period|Adverse Event|0|||
46807054|NCT00641537|83025811|FG001|96-week Period|Adverse Event|1|||
46807055|NCT00641537|83025812|FG002|96-week Period|Adverse Event|3|||
46807056|NCT00641537|83025813|FG003|96-week Period|Adverse Event|0|||
46807057|NCT00641537|83025814|FG004|96-week Period|Adverse Event|2|||
46807058|NCT00641537|83025815|FG005|96-week Period|Adverse Event|0|||
46807059|NCT00641537|83025816|FG006|96-week Period|Adverse Event|0|||
46807060|NCT00641537|83025817|FG007|96-week Period|Adverse Event|0|||
46807061|NCT00641537|83025810|FG000|96-week Period|Lost to Follow-up|3|||
46807062|NCT00641537|83025811|FG001|96-week Period|Lost to Follow-up|1|||
46807063|NCT00641537|83025812|FG002|96-week Period|Lost to Follow-up|2|||
46807064|NCT00641537|83025813|FG003|96-week Period|Lost to Follow-up|2|||
46807065|NCT00641537|83025814|FG004|96-week Period|Lost to Follow-up|4|||
46807066|NCT00641537|83025815|FG005|96-week Period|Lost to Follow-up|0|||
46807067|NCT00641537|83025816|FG006|96-week Period|Lost to Follow-up|1|||
46807068|NCT00641537|83025817|FG007|96-week Period|Lost to Follow-up|0|||
46807069|NCT00641537|83025810|FG000|96-week Period|Protocol Violation|0|||
46807070|NCT00641537|83025811|FG001|96-week Period|Protocol Violation|1|||
46807071|NCT00641537|83025812|FG002|96-week Period|Protocol Violation|0|||
46807072|NCT00641537|83025813|FG003|96-week Period|Protocol Violation|1|||
46807073|NCT00641537|83025814|FG004|96-week Period|Protocol Violation|0|||
46807074|NCT00641537|83025815|FG005|96-week Period|Protocol Violation|1|||
46807075|NCT00641537|83025816|FG006|96-week Period|Protocol Violation|0|||
46807076|NCT00641537|83025817|FG007|96-week Period|Protocol Violation|0|||
46807077|NCT00641537|83025810|FG000|96-week Period|Death|2|||
46807078|NCT00641537|83025811|FG001|96-week Period|Death|0|||
46807079|NCT00641537|83025812|FG002|96-week Period|Death|1|||
46807080|NCT00641537|83025813|FG003|96-week Period|Death|0|||
46807081|NCT00641537|83025814|FG004|96-week Period|Death|0|||
46807082|NCT00641537|83025815|FG005|96-week Period|Death|0|||
46807083|NCT00641537|83025816|FG006|96-week Period|Death|0|||
46807084|NCT00641537|83025817|FG007|96-week Period|Death|0|||
46807085|NCT00641537|83025810|FG000|96-week Period|Other|4|||
46807086|NCT00641537|83025811|FG001|96-week Period|Other|7|||
46807087|NCT00641537|83025812|FG002|96-week Period|Other|14|||
46807088|NCT00641537|83025813|FG003|96-week Period|Other|9|||
46807089|NCT00641537|83025814|FG004|96-week Period|Other|11|||
46807090|NCT00641537|83025815|FG005|96-week Period|Other|6|||
46807091|NCT00641537|83025816|FG006|96-week Period|Other|4|||
46807092|NCT00641537|83025817|FG007|96-week Period|Other|6|||
46807093|NCT00641537|83025810|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
46807094|NCT00641537|83025811|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
46807095|NCT00641537|83025812|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
46807096|NCT00641537|83025813|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
46807097|NCT00641537|83025814|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
46807098|NCT00641537|83025815|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
46807099|NCT00641537|83025816|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
46807100|NCT00641537|83025817|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
46807101|NCT00641537|83025810|FG000|24-Week Supplemental Follow-up Period|Other|0|||
46807102|NCT00641537|83025811|FG001|24-Week Supplemental Follow-up Period|Other|2|||
46807103|NCT00641537|83025812|FG002|24-Week Supplemental Follow-up Period|Other|2|||
46807104|NCT00641537|83025813|FG003|24-Week Supplemental Follow-up Period|Other|1|||
46807105|NCT00641537|83025814|FG004|24-Week Supplemental Follow-up Period|Other|3|||
46807106|NCT00641537|83025815|FG005|24-Week Supplemental Follow-up Period|Other|0|||
46807107|NCT00641537|83025816|FG006|24-Week Supplemental Follow-up Period|Other|1|||
46807108|NCT00641537|83025817|FG007|24-Week Supplemental Follow-up Period|Other|1|||
46807109|NCT03840135|83025837|FG000|Overall Study|Protocol Violation|6|||
46807110|NCT03840135|83025838|FG001|Overall Study|Protocol Violation|1|||
46807111|NCT03840135|83025837|FG000|Overall Study|Withdrawal by Subject|1|||
46807112|NCT03840135|83025838|FG001|Overall Study|Withdrawal by Subject|0|||
46807113|NCT00461175|83025850|FG000|Overall Study|Protocol Violation|522|||
46807114|NCT00461175|83025851|FG001|Overall Study|Protocol Violation|365|||
46807115|NCT00641147|83025859|FG000|Completed 4 Months.|Physician Decision|1|||
46807116|NCT00641147|83025860|FG001|Completed 4 Months.|Physician Decision|0|||
46807117|NCT00641147|83025859|FG000|Completed 4 Months.|Adverse Event|1|||
46807118|NCT00641147|83025860|FG001|Completed 4 Months.|Adverse Event|0|||
46807119|NCT00641147|83025859|FG000|Completed 8 Months.|Physician Decision|2|||
46807120|NCT00641147|83025860|FG001|Completed 8 Months.|Physician Decision|1|||
46807121|NCT00641147|83025859|FG000|Completed 8 Months.|non compliance|1|||
46807122|NCT00641147|83025860|FG001|Completed 8 Months.|non compliance|0|||
46807123|NCT00641147|83025859|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
46807124|NCT00641147|83025860|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
46807125|NCT00641147|83025859|FG000|Completed 12 Months.|Physician Decision|1|||
46807126|NCT00641147|83025860|FG001|Completed 12 Months.|Physician Decision|1|||
46807127|NCT00641147|83025859|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
46807128|NCT00641147|83025860|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
46807129|NCT00641147|83025859|FG000|Completed 16 Months.|Physician Decision|1|||
46807130|NCT00641147|83025860|FG001|Completed 16 Months.|Physician Decision|0|||
46807131|NCT00641147|83025859|FG000|Completed 16 Months.|Lost to Follow-up|1|||
46807132|NCT00641147|83025860|FG001|Completed 16 Months.|Lost to Follow-up|0|||
46807133|NCT00460239|83025870|FG000|Overall Study|Physician Decision|0|||
47053282|NCT02228382|83322980|FG001|Overall Study|Other|3|||
47053283|NCT02228382|83322981|FG002|Overall Study|Other|3|||
46636237|NCT01569438|82810081|FG001|Overall Study|Protocol Violation|0|||
46636238|NCT01569438|82810080|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
46636239|NCT01569438|82810081|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
46636240|NCT01569438|82810080|FG000|Overall Study|Sponsor/Physician decision|1|||
46752554|NCT02764541|82970950|FG005|Overall Study|Death|0|||
46752555|NCT02764541|82970951|FG006|Overall Study|Death|1|||
46752556|NCT02764541|82970952|FG007|Overall Study|Death|0|||
46752557|NCT02764541|82970945|FG000|Overall Study|Insurance reasons|0|||
46752558|NCT02764541|82970946|FG001|Overall Study|Insurance reasons|0|||
46752559|NCT02764541|82970947|FG002|Overall Study|Insurance reasons|0|||
46752560|NCT02764541|82970948|FG003|Overall Study|Insurance reasons|0|||
46752561|NCT02764541|82970949|FG004|Overall Study|Insurance reasons|0|||
46752562|NCT02764541|82970950|FG005|Overall Study|Insurance reasons|0|||
46752563|NCT02764541|82970951|FG006|Overall Study|Insurance reasons|1|||
46752564|NCT02764541|82970952|FG007|Overall Study|Insurance reasons|0|||
46752565|NCT02576574|82970975|FG000|Overall Study|still ongoing|65|||
46752566|NCT02576574|82970976|FG001|Overall Study|still ongoing|66|||
46752567|NCT02576574|82970977|FG002|Overall Study|still ongoing|73|||
46752568|NCT02576574|82970975|FG000|Overall Study|Randomized, not treated|5|||
46752569|NCT02576574|82970976|FG001|Overall Study|Randomized, not treated|4|||
46752570|NCT02576574|82970977|FG002|Overall Study|Randomized, not treated|26|||
46752571|NCT02414139|82971025|FG000|Treatment Period|Adverse Event|11|||
46752572|NCT02414139|82971026|FG001|Treatment Period|Adverse Event|6|||
46752573|NCT02414139|82971027|FG002|Treatment Period|Adverse Event|8|||
46752574|NCT02414139|82971028|FG003|Treatment Period|Adverse Event|5|||
46752575|NCT02414139|82971029|FG004|Treatment Period|Adverse Event|14|||
46752576|NCT02414139|82971030|FG005|Treatment Period|Adverse Event|3|||
46752577|NCT02414139|82971031|FG006|Treatment Period|Adverse Event|6|||
46752578|NCT02414139|82971032|FG007|Treatment Period|Adverse Event|1|||
46752579|NCT02414139|82971033|FG008|Treatment Period|Adverse Event|6|||
46752580|NCT02414139|82971034|FG009|Treatment Period|Adverse Event|8|||
46752581|NCT02414139|82971025|FG000|Treatment Period|Death|0|||
46752582|NCT02414139|82971026|FG001|Treatment Period|Death|0|||
46752583|NCT02414139|82971027|FG002|Treatment Period|Death|1|||
46925693|NCT03701763|83160230|FG002|Apremilast Extension Phase|Miscellaneous|2|||
46925694|NCT03701763|83160231|FG003|Apremilast Extension Phase|Miscellaneous|1|||
46925695|NCT03701763|83160228|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
46925696|NCT03701763|83160229|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
46925697|NCT03701763|83160230|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
46925698|NCT03701763|83160231|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
46925699|NCT03701763|83160228|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
46925700|NCT03701763|83160229|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
46925701|NCT03701763|83160230|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
46925702|NCT03701763|83160231|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
46925703|NCT03701763|83160228|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
46925704|NCT03701763|83160229|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
46925705|NCT03701763|83160230|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
46925706|NCT03701763|83160231|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
46925707|NCT03701763|83160228|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
46925708|NCT03701763|83160229|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
46925709|NCT03701763|83160230|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
46925710|NCT03701763|83160231|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
46925711|NCT03701763|83160228|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
46925712|NCT03701763|83160229|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
46925713|NCT03701763|83160230|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
46925714|NCT03701763|83160231|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
46925715|NCT03701763|83160228|FG000|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
46925716|NCT03701763|83160229|FG001|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
46925717|NCT03701763|83160230|FG002|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|1|||
46925718|NCT03701763|83160231|FG003|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
46925719|NCT03701763|83160228|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
47053284|NCT02228382|83322982|FG003|Overall Study|Other|0|||
47053285|NCT02228382|83322983|FG004|Overall Study|Other|0|||
47053286|NCT01900002|83323027|FG000|Overall Study|Withdrawal by Subject|2|||
47053287|NCT01900002|83323027|FG000|Overall Study|ineligible for Y-90|4|||
46636241|NCT01569438|82810081|FG001|Overall Study|Sponsor/Physician decision|1|||
46752584|NCT02414139|82971028|FG003|Treatment Period|Death|1|||
46752585|NCT02414139|82971029|FG004|Treatment Period|Death|0|||
46752586|NCT02414139|82971030|FG005|Treatment Period|Death|0|||
46752587|NCT02414139|82971031|FG006|Treatment Period|Death|0|||
46752588|NCT02414139|82971032|FG007|Treatment Period|Death|0|||
46752589|NCT02414139|82971033|FG008|Treatment Period|Death|0|||
46752590|NCT02414139|82971034|FG009|Treatment Period|Death|1|||
46925720|NCT03701763|83160229|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
46925721|NCT03701763|83160230|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
46925722|NCT03701763|83160231|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
46925723|NCT03701763|83160228|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
47053288|NCT01377012|83323057|FG000|Core Study|Study terminated by Sponsor|47|||
47053289|NCT01377012|83323058|FG001|Core Study|Study terminated by Sponsor|54|||
46752591|NCT02414139|82971025|FG000|Treatment Period|Physician Decision|5|||
46752592|NCT02414139|82971026|FG001|Treatment Period|Physician Decision|4|||
46752593|NCT02414139|82971027|FG002|Treatment Period|Physician Decision|6|||
46752594|NCT02414139|82971028|FG003|Treatment Period|Physician Decision|1|||
46752595|NCT02414139|82971029|FG004|Treatment Period|Physician Decision|4|||
46752596|NCT02414139|82971030|FG005|Treatment Period|Physician Decision|0|||
46752597|NCT02414139|82971031|FG006|Treatment Period|Physician Decision|2|||
46752598|NCT02414139|82971032|FG007|Treatment Period|Physician Decision|0|||
46752599|NCT02414139|82971033|FG008|Treatment Period|Physician Decision|1|||
46752600|NCT02414139|82971034|FG009|Treatment Period|Physician Decision|4|||
46752601|NCT02414139|82971025|FG000|Treatment Period|Progressive disease|48|||
46752602|NCT02414139|82971026|FG001|Treatment Period|Progressive disease|31|||
46752603|NCT02414139|82971027|FG002|Treatment Period|Progressive disease|37|||
46752604|NCT02414139|82971028|FG003|Treatment Period|Progressive disease|21|||
46752605|NCT02414139|82971029|FG004|Treatment Period|Progressive disease|43|||
46752606|NCT02414139|82971030|FG005|Treatment Period|Progressive disease|12|||
46752607|NCT02414139|82971031|FG006|Treatment Period|Progressive disease|16|||
46752608|NCT02414139|82971032|FG007|Treatment Period|Progressive disease|2|||
46752609|NCT02414139|82971033|FG008|Treatment Period|Progressive disease|20|||
46752610|NCT02414139|82971034|FG009|Treatment Period|Progressive disease|14|||
46752611|NCT02414139|82971025|FG000|Treatment Period|Protocol deviation|0|||
46752612|NCT02414139|82971026|FG001|Treatment Period|Protocol deviation|0|||
46752613|NCT02414139|82971027|FG002|Treatment Period|Protocol deviation|1|||
46752614|NCT02414139|82971028|FG003|Treatment Period|Protocol deviation|0|||
46752615|NCT02414139|82971029|FG004|Treatment Period|Protocol deviation|0|||
46752616|NCT02414139|82971030|FG005|Treatment Period|Protocol deviation|0|||
46752617|NCT02414139|82971031|FG006|Treatment Period|Protocol deviation|0|||
46752618|NCT02414139|82971032|FG007|Treatment Period|Protocol deviation|0|||
46752619|NCT02414139|82971033|FG008|Treatment Period|Protocol deviation|0|||
46752620|NCT02414139|82971034|FG009|Treatment Period|Protocol deviation|0|||
46752621|NCT02414139|82971025|FG000|Treatment Period|Subject/Guardian decision|5|||
46752622|NCT02414139|82971026|FG001|Treatment Period|Subject/Guardian decision|1|||
46752623|NCT02414139|82971027|FG002|Treatment Period|Subject/Guardian decision|1|||
46752624|NCT02414139|82971028|FG003|Treatment Period|Subject/Guardian decision|2|||
46752625|NCT02414139|82971029|FG004|Treatment Period|Subject/Guardian decision|5|||
46752626|NCT02414139|82971030|FG005|Treatment Period|Subject/Guardian decision|0|||
46752627|NCT02414139|82971031|FG006|Treatment Period|Subject/Guardian decision|2|||
46752628|NCT02414139|82971032|FG007|Treatment Period|Subject/Guardian decision|0|||
46752629|NCT02414139|82971033|FG008|Treatment Period|Subject/Guardian decision|1|||
46752630|NCT02414139|82971034|FG009|Treatment Period|Subject/Guardian decision|1|||
46752631|NCT02414139|82971025|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
46752632|NCT02414139|82971026|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
46752633|NCT02414139|82971027|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
46752634|NCT02414139|82971028|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
46752635|NCT02414139|82971029|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
46752636|NCT02414139|82971030|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
46752637|NCT02414139|82971031|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
46752638|NCT02414139|82971032|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
46752639|NCT02414139|82971033|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
46752640|NCT02414139|82971034|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
46752641|NCT02414139|82971025|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
46752642|NCT02414139|82971026|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752643|NCT02414139|82971027|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752644|NCT02414139|82971028|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752645|NCT02414139|82971029|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
46752646|NCT02414139|82971030|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752647|NCT02414139|82971031|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752648|NCT02414139|82971032|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752649|NCT02414139|82971033|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752650|NCT02414139|82971034|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46752651|NCT02414139|82971025|FG000|Post-treatment Efficacy Follow-up|Death|0|||
46752652|NCT02414139|82971026|FG001|Post-treatment Efficacy Follow-up|Death|1|||
46752653|NCT02414139|82971027|FG002|Post-treatment Efficacy Follow-up|Death|0|||
46752654|NCT02414139|82971028|FG003|Post-treatment Efficacy Follow-up|Death|0|||
46752655|NCT02414139|82971029|FG004|Post-treatment Efficacy Follow-up|Death|1|||
46807134|NCT00460239|83025871|FG001|Overall Study|Physician Decision|1|||
46807135|NCT00460239|83025872|FG002|Overall Study|Physician Decision|0|||
46807136|NCT00460239|83025873|FG003|Overall Study|Physician Decision|0|||
46925724|NCT03701763|83160229|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
46925725|NCT03701763|83160230|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
46925726|NCT03701763|83160231|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
46925727|NCT03575897|83160270|FG000|Overall Study|Lost to Follow-up|12|||
46925728|NCT03575897|83160271|FG001|Overall Study|Lost to Follow-up|13|||
46925729|NCT03439748|83160279|FG000|Overall Study|Withdrawal by Subject|11|||
46925730|NCT03439748|83160280|FG001|Overall Study|Withdrawal by Subject|17|||
46925731|NCT03433001|83160286|FG000|Overall Study|Lack of Efficacy|109|||
46925732|NCT03433001|83160286|FG000|Overall Study|Adverse Event|69|||
46925733|NCT03433001|83160286|FG000|Overall Study|Withdrawal by Subject|10|||
46925734|NCT03433001|83160286|FG000|Overall Study|Death|12|||
46925735|NCT03433001|83160286|FG000|Overall Study|Lost to Follow-up|4|||
46925736|NCT03433001|83160286|FG000|Overall Study|Other|25|||
46925737|NCT03314935|83160305|FG000|Phase 1|Death|4|||
46925738|NCT03314935|83160306|FG001|Phase 1|Death|2|||
46925739|NCT03314935|83160307|FG002|Phase 1|Death|5|||
46925740|NCT03314935|83160308|FG003|Phase 1|Death|4|||
46925741|NCT03314935|83160309|FG004|Phase 1|Death|3|||
46925742|NCT03314935|83160310|FG005|Phase 1|Death|4|||
46925743|NCT03314935|83160311|FG006|Phase 1|Death|5|||
46925744|NCT03314935|83160312|FG007|Phase 1|Death|4|||
46925745|NCT03314935|83160313|FG008|Phase 1|Death|3|||
46925746|NCT03314935|83160314|FG009|Phase 1|Death|0|||
46925747|NCT03314935|83160315|FG010|Phase 1|Death|0|||
46925748|NCT03314935|83160316|FG011|Phase 1|Death|0|||
46925749|NCT03314935|83160317|FG012|Phase 1|Death|0|||
46925750|NCT03314935|83160318|FG013|Phase 1|Death|0|||
46925751|NCT03314935|83160319|FG014|Phase 1|Death|0|||
46925752|NCT03314935|83160305|FG000|Phase 1|Withdrawal by Subject|2|||
46925753|NCT03314935|83160306|FG001|Phase 1|Withdrawal by Subject|1|||
46925754|NCT03314935|83160307|FG002|Phase 1|Withdrawal by Subject|1|||
46925755|NCT03314935|83160308|FG003|Phase 1|Withdrawal by Subject|2|||
47053290|NCT01377012|83323059|FG002|Core Study|Study terminated by Sponsor|46|||
47053291|NCT01377012|83323057|FG000|Core Study|Technical problems|1|||
47053292|NCT01377012|83323058|FG001|Core Study|Technical problems|0|||
47053293|NCT01377012|83323059|FG002|Core Study|Technical problems|0|||
47053294|NCT01377012|83323057|FG000|Core Study|Withdrawal by Subject|15|||
46636242|NCT01569438|82810080|FG000|Overall Study|Unable to adhere to study schedule|0|||
46752656|NCT02414139|82971030|FG005|Post-treatment Efficacy Follow-up|Death|0|||
46752657|NCT02414139|82971031|FG006|Post-treatment Efficacy Follow-up|Death|0|||
46752658|NCT02414139|82971032|FG007|Post-treatment Efficacy Follow-up|Death|0|||
46752659|NCT02414139|82971033|FG008|Post-treatment Efficacy Follow-up|Death|0|||
46752660|NCT02414139|82971034|FG009|Post-treatment Efficacy Follow-up|Death|1|||
46752661|NCT02414139|82971025|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
46752662|NCT02414139|82971026|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752663|NCT02414139|82971027|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752664|NCT02414139|82971028|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752665|NCT02414139|82971029|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752666|NCT02414139|82971030|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752667|NCT02414139|82971031|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752668|NCT02414139|82971032|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752669|NCT02414139|82971033|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46752670|NCT02414139|82971034|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
46807137|NCT00460239|83025874|FG004|Overall Study|Physician Decision|0|||
46807138|NCT00460239|83025875|FG005|Overall Study|Physician Decision|2|||
46807139|NCT00460239|83025876|FG006|Overall Study|Physician Decision|0|||
46807140|NCT00460239|83025877|FG007|Overall Study|Physician Decision|0|||
46807141|NCT00460239|83025878|FG008|Overall Study|Physician Decision|0|||
46807142|NCT00460239|83025870|FG000|Overall Study|Withdrawal by Subject|0|||
46807143|NCT00460239|83025871|FG001|Overall Study|Withdrawal by Subject|0|||
46807144|NCT00460239|83025872|FG002|Overall Study|Withdrawal by Subject|0|||
46925756|NCT03314935|83160309|FG004|Phase 1|Withdrawal by Subject|1|||
46925757|NCT03314935|83160310|FG005|Phase 1|Withdrawal by Subject|0|||
46925758|NCT03314935|83160311|FG006|Phase 1|Withdrawal by Subject|1|||
46925759|NCT03314935|83160312|FG007|Phase 1|Withdrawal by Subject|0|||
47053295|NCT01377012|83323058|FG001|Core Study|Withdrawal by Subject|23|||
46807145|NCT00460239|83025873|FG003|Overall Study|Withdrawal by Subject|0|||
46807146|NCT00460239|83025874|FG004|Overall Study|Withdrawal by Subject|0|||
46807147|NCT00460239|83025875|FG005|Overall Study|Withdrawal by Subject|1|||
46807148|NCT00460239|83025876|FG006|Overall Study|Withdrawal by Subject|0|||
46925760|NCT03314935|83160313|FG008|Phase 1|Withdrawal by Subject|1|||
46925761|NCT03314935|83160314|FG009|Phase 1|Withdrawal by Subject|0|||
46925762|NCT03314935|83160315|FG010|Phase 1|Withdrawal by Subject|0|||
46925763|NCT03314935|83160316|FG011|Phase 1|Withdrawal by Subject|0|||
46925764|NCT03314935|83160317|FG012|Phase 1|Withdrawal by Subject|0|||
47053296|NCT01377012|83323059|FG002|Core Study|Withdrawal by Subject|18|||
46925765|NCT03314935|83160318|FG013|Phase 1|Withdrawal by Subject|0|||
46925766|NCT03314935|83160319|FG014|Phase 1|Withdrawal by Subject|0|||
46925767|NCT03314935|83160305|FG000|Phase 1|Progressive Disease|2|||
46925768|NCT03314935|83160306|FG001|Phase 1|Progressive Disease|0|||
46925769|NCT03314935|83160307|FG002|Phase 1|Progressive Disease|0|||
46925770|NCT03314935|83160308|FG003|Phase 1|Progressive Disease|1|||
46925771|NCT03314935|83160309|FG004|Phase 1|Progressive Disease|0|||
46925772|NCT03314935|83160310|FG005|Phase 1|Progressive Disease|0|||
46925773|NCT03314935|83160311|FG006|Phase 1|Progressive Disease|0|||
46925774|NCT03314935|83160312|FG007|Phase 1|Progressive Disease|0|||
46925775|NCT03314935|83160313|FG008|Phase 1|Progressive Disease|0|||
46925776|NCT03314935|83160314|FG009|Phase 1|Progressive Disease|0|||
46925777|NCT03314935|83160315|FG010|Phase 1|Progressive Disease|0|||
46925778|NCT03314935|83160316|FG011|Phase 1|Progressive Disease|0|||
46925779|NCT03314935|83160317|FG012|Phase 1|Progressive Disease|0|||
46925780|NCT03314935|83160318|FG013|Phase 1|Progressive Disease|0|||
46925781|NCT03314935|83160319|FG014|Phase 1|Progressive Disease|0|||
46925782|NCT03314935|83160305|FG000|Phase 1|Study Terminated by Sponsor|0|||
46925783|NCT03314935|83160306|FG001|Phase 1|Study Terminated by Sponsor|1|||
46925784|NCT03314935|83160307|FG002|Phase 1|Study Terminated by Sponsor|0|||
46925785|NCT03314935|83160308|FG003|Phase 1|Study Terminated by Sponsor|0|||
46925786|NCT03314935|83160309|FG004|Phase 1|Study Terminated by Sponsor|0|||
46925787|NCT03314935|83160310|FG005|Phase 1|Study Terminated by Sponsor|0|||
46925788|NCT03314935|83160311|FG006|Phase 1|Study Terminated by Sponsor|0|||
46925789|NCT03314935|83160312|FG007|Phase 1|Study Terminated by Sponsor|0|||
46925790|NCT03314935|83160313|FG008|Phase 1|Study Terminated by Sponsor|1|||
46807149|NCT00460239|83025877|FG007|Overall Study|Withdrawal by Subject|0|||
46807150|NCT00460239|83025878|FG008|Overall Study|Withdrawal by Subject|0|||
46807151|NCT05612724|83025891|FG000|Overall Study|Lost to Follow-up|4|||
46807152|NCT05376397|83025895|FG000|Overall Study|Lost to Follow-up|1|||
46807153|NCT04969250|83025912|FG000|Overall Study|Protocol Violation|0|||
46807154|NCT04969250|83025913|FG001|Overall Study|Protocol Violation|2|||
46807155|NCT04969250|83025914|FG002|Overall Study|Protocol Violation|3|||
46807156|NCT04969250|83025915|FG003|Overall Study|Protocol Violation|8|||
46807157|NCT04969250|83025912|FG000|Overall Study|Withdrawal by Subject|0|||
46807158|NCT04969250|83025913|FG001|Overall Study|Withdrawal by Subject|1|||
46925791|NCT03314935|83160314|FG009|Phase 1|Study Terminated by Sponsor|0|||
46925792|NCT03314935|83160315|FG010|Phase 1|Study Terminated by Sponsor|0|||
46925793|NCT03314935|83160316|FG011|Phase 1|Study Terminated by Sponsor|0|||
46925794|NCT03314935|83160317|FG012|Phase 1|Study Terminated by Sponsor|0|||
46925795|NCT03314935|83160318|FG013|Phase 1|Study Terminated by Sponsor|0|||
46925796|NCT03314935|83160319|FG014|Phase 1|Study Terminated by Sponsor|0|||
46752671|NCT02414139|82971025|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
46752672|NCT02414139|82971026|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
46752673|NCT02414139|82971027|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
46752674|NCT02414139|82971028|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
46752675|NCT02414139|82971029|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
46752676|NCT02414139|82971030|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
46752677|NCT02414139|82971031|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
46752678|NCT02414139|82971032|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
46752679|NCT02414139|82971033|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
46752680|NCT02414139|82971034|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
46752681|NCT02414139|82971025|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
46752682|NCT02414139|82971026|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
46752683|NCT02414139|82971027|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
46752684|NCT02414139|82971028|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
46752685|NCT02414139|82971029|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
46752686|NCT02414139|82971030|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
46752687|NCT02414139|82971031|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
46752688|NCT02414139|82971032|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
46752689|NCT02414139|82971033|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
46925797|NCT03314935|83160305|FG000|Phase 1|"Captured as Other in Database"|0|||
46925798|NCT03314935|83160306|FG001|Phase 1|"Captured as Other in Database"|2|||
46925799|NCT03314935|83160307|FG002|Phase 1|"Captured as Other in Database"|0|||
46636243|NCT01569438|82810081|FG001|Overall Study|Unable to adhere to study schedule|1|||
46752690|NCT02414139|82971034|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
46807159|NCT04969250|83025914|FG002|Overall Study|Withdrawal by Subject|0|||
46925800|NCT03314935|83160308|FG003|Phase 1|"Captured as Other in Database"|0|||
46636244|NCT01517412|82810089|FG000|Overall Study|Adverse Event|10|||
46807160|NCT04969250|83025915|FG003|Overall Study|Withdrawal by Subject|0|||
46807161|NCT04644237|83025965|FG000|Overall Study|Death|3|||
46925801|NCT03314935|83160309|FG004|Phase 1|"Captured as Other in Database"|0|||
46925802|NCT03314935|83160310|FG005|Phase 1|"Captured as Other in Database"|0|||
46925803|NCT03314935|83160311|FG006|Phase 1|"Captured as Other in Database"|1|||
46925804|NCT03314935|83160312|FG007|Phase 1|"Captured as Other in Database"|1|||
46925805|NCT03314935|83160313|FG008|Phase 1|"Captured as Other in Database"|1|||
46925806|NCT03314935|83160314|FG009|Phase 1|"Captured as Other in Database"|0|||
46925807|NCT03314935|83160315|FG010|Phase 1|"Captured as Other in Database"|0|||
46925808|NCT03314935|83160316|FG011|Phase 1|"Captured as Other in Database"|0|||
46925809|NCT03314935|83160317|FG012|Phase 1|"Captured as Other in Database"|0|||
46925810|NCT03314935|83160318|FG013|Phase 1|"Captured as Other in Database"|0|||
46925811|NCT03314935|83160319|FG014|Phase 1|"Captured as Other in Database"|0|||
46925812|NCT03314935|83160305|FG000|Phase 1|Lost to Follow-up|0|||
46925813|NCT03314935|83160306|FG001|Phase 1|Lost to Follow-up|0|||
46925814|NCT03314935|83160307|FG002|Phase 1|Lost to Follow-up|0|||
46925815|NCT03314935|83160308|FG003|Phase 1|Lost to Follow-up|0|||
46925816|NCT03314935|83160309|FG004|Phase 1|Lost to Follow-up|0|||
46925817|NCT03314935|83160310|FG005|Phase 1|Lost to Follow-up|0|||
46925818|NCT03314935|83160311|FG006|Phase 1|Lost to Follow-up|0|||
46925819|NCT03314935|83160312|FG007|Phase 1|Lost to Follow-up|0|||
46925820|NCT03314935|83160313|FG008|Phase 1|Lost to Follow-up|1|||
47053297|NCT01377012|83323057|FG000|Core Study|Protocol Violation|7|||
47053298|NCT01377012|83323058|FG001|Core Study|Protocol Violation|3|||
47053299|NCT01377012|83323059|FG002|Core Study|Protocol Violation|2|||
47053300|NCT01377012|83323057|FG000|Core Study|Pregnancy|0|||
47053301|NCT01377012|83323058|FG001|Core Study|Pregnancy|0|||
47053302|NCT01377012|83323059|FG002|Core Study|Pregnancy|1|||
46925821|NCT03314935|83160314|FG009|Phase 1|Lost to Follow-up|0|||
46636245|NCT01517412|82810090|FG001|Overall Study|Adverse Event|11|||
46636246|NCT01517412|82810089|FG000|Overall Study|Lack of Efficacy|10|||
46636247|NCT01517412|82810090|FG001|Overall Study|Lack of Efficacy|5|||
46636248|NCT01517412|82810089|FG000|Overall Study|Poor compliance to protocol|8|||
46636249|NCT01517412|82810090|FG001|Overall Study|Poor compliance to protocol|3|||
46925822|NCT03314935|83160315|FG010|Phase 1|Lost to Follow-up|0|||
46925823|NCT03314935|83160316|FG011|Phase 1|Lost to Follow-up|0|||
46925824|NCT03314935|83160317|FG012|Phase 1|Lost to Follow-up|0|||
46925825|NCT03314935|83160318|FG013|Phase 1|Lost to Follow-up|0|||
46925826|NCT03314935|83160319|FG014|Phase 1|Lost to Follow-up|0|||
46925827|NCT03314935|83160305|FG000|Phase 2|Death|0|||
46925828|NCT03314935|83160306|FG001|Phase 2|Death|0|||
46925829|NCT03314935|83160307|FG002|Phase 2|Death|0|||
47053303|NCT01377012|83323057|FG000|Core Study|Physician Decision|5|||
47053304|NCT01377012|83323058|FG001|Core Study|Physician Decision|4|||
47053305|NCT01377012|83323059|FG002|Core Study|Physician Decision|10|||
47053306|NCT01377012|83323057|FG000|Core Study|Non-Compliant with study treatment|0|||
47053307|NCT01377012|83323058|FG001|Core Study|Non-Compliant with study treatment|0|||
47053308|NCT01377012|83323059|FG002|Core Study|Non-Compliant with study treatment|1|||
47053309|NCT01377012|83323057|FG000|Core Study|No Longer require treatment|0|||
47053310|NCT01377012|83323058|FG001|Core Study|No Longer require treatment|0|||
47053311|NCT01377012|83323059|FG002|Core Study|No Longer require treatment|1|||
47053312|NCT01377012|83323057|FG000|Core Study|Lost to Follow-up|7|||
47053313|NCT01377012|83323058|FG001|Core Study|Lost to Follow-up|5|||
46752691|NCT02414139|82971025|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46752692|NCT02414139|82971026|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
46752693|NCT02414139|82971027|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46752694|NCT02414139|82971028|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46752695|NCT02414139|82971029|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46752696|NCT02414139|82971030|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46807162|NCT04644237|83025966|FG001|Overall Study|Death|2|||
46925830|NCT03314935|83160308|FG003|Phase 2|Death|0|||
46925831|NCT03314935|83160309|FG004|Phase 2|Death|0|||
46925832|NCT03314935|83160310|FG005|Phase 2|Death|0|||
46925833|NCT03314935|83160311|FG006|Phase 2|Death|0|||
46925834|NCT03314935|83160312|FG007|Phase 2|Death|0|||
46925835|NCT03314935|83160313|FG008|Phase 2|Death|0|||
46925836|NCT03314935|83160314|FG009|Phase 2|Death|5|||
46925837|NCT03314935|83160315|FG010|Phase 2|Death|20|||
46925838|NCT03314935|83160316|FG011|Phase 2|Death|6|||
46925839|NCT03314935|83160317|FG012|Phase 2|Death|7|||
46925840|NCT03314935|83160318|FG013|Phase 2|Death|6|||
46925841|NCT03314935|83160319|FG014|Phase 2|Death|17|||
46925842|NCT03314935|83160305|FG000|Phase 2|Withdrawal by Subject|0|||
46925843|NCT03314935|83160306|FG001|Phase 2|Withdrawal by Subject|0|||
46925844|NCT03314935|83160307|FG002|Phase 2|Withdrawal by Subject|0|||
46925845|NCT03314935|83160308|FG003|Phase 2|Withdrawal by Subject|0|||
46925846|NCT03314935|83160309|FG004|Phase 2|Withdrawal by Subject|0|||
46925847|NCT03314935|83160310|FG005|Phase 2|Withdrawal by Subject|0|||
46925848|NCT03314935|83160311|FG006|Phase 2|Withdrawal by Subject|0|||
46925849|NCT03314935|83160312|FG007|Phase 2|Withdrawal by Subject|0|||
46925850|NCT03314935|83160313|FG008|Phase 2|Withdrawal by Subject|0|||
46925851|NCT03314935|83160314|FG009|Phase 2|Withdrawal by Subject|1|||
46925852|NCT03314935|83160315|FG010|Phase 2|Withdrawal by Subject|4|||
47053314|NCT01377012|83323059|FG002|Core Study|Lost to Follow-up|4|||
47053315|NCT01377012|83323057|FG000|Core Study|Lack of Efficacy|41|||
47053316|NCT01377012|83323058|FG001|Core Study|Lack of Efficacy|28|||
47053317|NCT01377012|83323059|FG002|Core Study|Lack of Efficacy|37|||
46807163|NCT04644237|83025965|FG000|Overall Study|Adverse Event|15|||
46807164|NCT04644237|83025966|FG001|Overall Study|Adverse Event|12|||
46807165|NCT04644237|83025965|FG000|Overall Study|Progressive Disease|47|||
47053318|NCT01377012|83323057|FG000|Core Study|Death|1|||
46807166|NCT04644237|83025966|FG001|Overall Study|Progressive Disease|19|||
46807167|NCT04644237|83025965|FG000|Overall Study|Clinical Progression|4|||
46807168|NCT04644237|83025966|FG001|Overall Study|Clinical Progression|1|||
46807169|NCT04644237|83025965|FG000|Overall Study|Withdrawal by Subject|1|||
46807170|NCT04644237|83025966|FG001|Overall Study|Withdrawal by Subject|2|||
46807171|NCT04644237|83025965|FG000|Overall Study|Physician Decision|3|||
46807172|NCT04644237|83025966|FG001|Overall Study|Physician Decision|0|||
46807173|NCT04644237|83025965|FG000|Overall Study|Other|1|||
46807174|NCT04644237|83025966|FG001|Overall Study|Other|0|||
46807175|NCT04644237|83025965|FG000|Overall Study|Randomized but not Treated|1|||
47053319|NCT01377012|83323058|FG001|Core Study|Death|1|||
46807176|NCT04644237|83025966|FG001|Overall Study|Randomized but not Treated|0|||
46807177|NCT04592341|83026025|FG000|Overall Study|Physician Decision|5|||
46807178|NCT04592341|83026025|FG000|Overall Study|Study Terminated by Sponsor|5|||
46925853|NCT03314935|83160316|FG011|Phase 2|Withdrawal by Subject|0|||
46807179|NCT04592341|83026025|FG000|Overall Study|Withdrawal by Subject|53|||
46807180|NCT04592341|83026025|FG000|Overall Study|Lost to Follow-up|3|||
46925854|NCT03314935|83160317|FG012|Phase 2|Withdrawal by Subject|1|||
46925855|NCT03314935|83160318|FG013|Phase 2|Withdrawal by Subject|0|||
46925856|NCT03314935|83160319|FG014|Phase 2|Withdrawal by Subject|1|||
46925857|NCT03314935|83160305|FG000|Phase 2|Progressive Disease|0|||
46925858|NCT03314935|83160306|FG001|Phase 2|Progressive Disease|0|||
46925859|NCT03314935|83160307|FG002|Phase 2|Progressive Disease|0|||
46925860|NCT03314935|83160308|FG003|Phase 2|Progressive Disease|0|||
47053320|NCT01377012|83323059|FG002|Core Study|Death|1|||
47053321|NCT01377012|83323057|FG000|Core Study|Adverse Event|10|||
47053322|NCT01377012|83323058|FG001|Core Study|Adverse Event|14|||
47053323|NCT01377012|83323059|FG002|Core Study|Adverse Event|13|||
47053324|NCT01377012|83323057|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
47053325|NCT01377012|83323058|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
47053326|NCT01377012|83323059|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
47053327|NCT01377012|83323057|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
47053328|NCT01377012|83323058|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
47053329|NCT01377012|83323059|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
47053330|NCT01377012|83323057|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
47053331|NCT01377012|83323058|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
47053332|NCT01377012|83323059|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
47053333|NCT01377012|83323057|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
47053334|NCT01377012|83323058|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
47053335|NCT01377012|83323059|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
47053336|NCT01377012|83323057|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
47053337|NCT01377012|83323058|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
47053338|NCT01377012|83323059|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
47053339|NCT01377012|83323057|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
47053340|NCT01377012|83323058|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
47053341|NCT01377012|83323059|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
47053342|NCT01376310|83323308|FG000|Overall Study|Study closed/terminated|1|||
47053343|NCT01376310|83323309|FG001|Overall Study|Study closed/terminated|2|||
47053344|NCT01376310|83323308|FG000|Overall Study|Withdrawal by Subject|8|||
47053345|NCT01376310|83323309|FG001|Overall Study|Withdrawal by Subject|2|||
47053346|NCT01376310|83323308|FG000|Overall Study|Physician Decision|26|||
47053347|NCT01376310|83323309|FG001|Overall Study|Physician Decision|7|||
47053348|NCT01376310|83323308|FG000|Overall Study|Lost to Follow-up|1|||
47053349|NCT01376310|83323309|FG001|Overall Study|Lost to Follow-up|0|||
47053350|NCT01949506|83323315|FG000|Overall Study|Physician Decision|1|||
47053351|NCT00709098|83323412|FG000|Double-blind Period|Withdrawal of consent|3|||
47053352|NCT00709098|83323413|FG001|Double-blind Period|Withdrawal of consent|3|||
47053353|NCT00709098|83323414|FG002|Double-blind Period|Withdrawal of consent|0|||
47053354|NCT00709098|83323412|FG000|Double-blind Period|Administrative reason|1|||
46807181|NCT04592341|83026025|FG000|Overall Study|Death|1|||
46807182|NCT04592341|83026025|FG000|Overall Study|Adverse Event|5|||
46807183|NCT04592341|83026025|FG000|Overall Study|other|4|||
46807184|NCT04577118|83026029|FG000|Overall Study|Withdrawal by Subject|4|||
46807185|NCT04535037|83026035|FG000|Overall Study|Protocol Violation|1|||
46807186|NCT04535037|83026036|FG001|Overall Study|Protocol Violation|0|||
46807187|NCT04535037|83026035|FG000|Overall Study|Withdrawal by Subject|8|||
46807188|NCT04535037|83026036|FG001|Overall Study|Withdrawal by Subject|9|||
46925861|NCT03314935|83160309|FG004|Phase 2|Progressive Disease|0|||
46925862|NCT03314935|83160310|FG005|Phase 2|Progressive Disease|0|||
47053355|NCT00709098|83323413|FG001|Double-blind Period|Administrative reason|3|||
47053356|NCT00709098|83323414|FG002|Double-blind Period|Administrative reason|0|||
47053357|NCT00709098|83323412|FG000|Double-blind Period|Death|1|||
47053358|NCT00709098|83323413|FG001|Double-blind Period|Death|1|||
46807189|NCT04535037|83026035|FG000|Overall Study|Migrated / moved from the study area|1|||
46807190|NCT04535037|83026036|FG001|Overall Study|Migrated / moved from the study area|4|||
46807191|NCT04535037|83026035|FG000|Overall Study|Other|2|||
46807192|NCT04535037|83026036|FG001|Overall Study|Other|5|||
46807193|NCT04389970|83026042|FG000|Overall Study|Lost to Follow-up|1|||
46807194|NCT04377672|83026046|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
46807195|NCT04325828|83026050|FG000|Overall Study|Ongoing|26|||
46807196|NCT04177108|83026068|FG000|Overall Study|Withdrawal by Subject|4|||
46807197|NCT04177108|83026069|FG001|Overall Study|Withdrawal by Subject|8|||
46807198|NCT04177108|83026070|FG002|Overall Study|Withdrawal by Subject|9|||
46807199|NCT04177108|83026071|FG003|Overall Study|Withdrawal by Subject|11|||
46807200|NCT04177108|83026072|FG004|Overall Study|Withdrawal by Subject|13|||
46807201|NCT04177108|83026068|FG000|Overall Study|Physician Decision|23|||
46807202|NCT04177108|83026069|FG001|Overall Study|Physician Decision|15|||
46807203|NCT04177108|83026070|FG002|Overall Study|Physician Decision|18|||
46807204|NCT04177108|83026071|FG003|Overall Study|Physician Decision|29|||
46807205|NCT04177108|83026072|FG004|Overall Study|Physician Decision|23|||
46807206|NCT04177108|83026068|FG000|Overall Study|Reason Not Specified|0|||
46807207|NCT04177108|83026069|FG001|Overall Study|Reason Not Specified|1|||
46807208|NCT04177108|83026070|FG002|Overall Study|Reason Not Specified|0|||
46807209|NCT04177108|83026071|FG003|Overall Study|Reason Not Specified|0|||
46807210|NCT04177108|83026072|FG004|Overall Study|Reason Not Specified|2|||
46807211|NCT04177108|83026068|FG000|Overall Study|Lost to Follow-up|0|||
46807212|NCT04177108|83026069|FG001|Overall Study|Lost to Follow-up|0|||
46807213|NCT04177108|83026070|FG002|Overall Study|Lost to Follow-up|1|||
46807214|NCT04177108|83026071|FG003|Overall Study|Lost to Follow-up|1|||
46807215|NCT04177108|83026072|FG004|Overall Study|Lost to Follow-up|1|||
46807216|NCT04177108|83026068|FG000|Overall Study|Death|16|||
46807217|NCT04177108|83026069|FG001|Overall Study|Death|19|||
46807218|NCT04177108|83026070|FG002|Overall Study|Death|13|||
46807219|NCT04177108|83026071|FG003|Overall Study|Death|17|||
46807220|NCT04177108|83026072|FG004|Overall Study|Death|18|||
46807221|NCT04110054|83026097|FG000|Overall Study|COVID-19 reason other than AE|0|||
46807222|NCT04110054|83026098|FG001|Overall Study|COVID-19 reason other than AE|0|||
46807223|NCT04110054|83026099|FG002|Overall Study|COVID-19 reason other than AE|2|||
46807224|NCT04110054|83026100|FG003|Overall Study|COVID-19 reason other than AE|0|||
46807225|NCT04110054|83026097|FG000|Overall Study|Withdrawal by Subject|0|||
47053359|NCT00709098|83323414|FG002|Double-blind Period|Death|0|||
46752697|NCT02414139|82971031|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46752698|NCT02414139|82971032|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46752699|NCT02414139|82971033|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
46752700|NCT02414139|82971034|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
46752701|NCT02414139|82971025|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
46752702|NCT02414139|82971026|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
46752703|NCT02414139|82971027|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
46752704|NCT02414139|82971028|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
46752705|NCT02414139|82971029|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
46752706|NCT02414139|82971030|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
46752707|NCT02414139|82971031|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
46752708|NCT02414139|82971032|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
46752709|NCT02414139|82971033|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
46752710|NCT02414139|82971034|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
46752711|NCT02400281|82971083|FG000|Overall Study|Adverse Event|0|||
46752712|NCT02400281|82971084|FG001|Overall Study|Adverse Event|0|||
46752713|NCT02400281|82971085|FG002|Overall Study|Adverse Event|1|||
46752714|NCT02400281|82971086|FG003|Overall Study|Adverse Event|0|||
46752715|NCT02400281|82971087|FG004|Overall Study|Adverse Event|1|||
46752716|NCT02400281|82971088|FG005|Overall Study|Adverse Event|0|||
46752717|NCT02400281|82971083|FG000|Overall Study|Physician Decision|0|||
46752718|NCT02400281|82971084|FG001|Overall Study|Physician Decision|0|||
46752719|NCT02400281|82971085|FG002|Overall Study|Physician Decision|1|||
46752720|NCT02400281|82971086|FG003|Overall Study|Physician Decision|0|||
46807226|NCT04110054|83026098|FG001|Overall Study|Withdrawal by Subject|3|||
46807227|NCT04110054|83026099|FG002|Overall Study|Withdrawal by Subject|2|||
46807228|NCT04110054|83026100|FG003|Overall Study|Withdrawal by Subject|0|||
46807229|NCT04110054|83026097|FG000|Overall Study|Adverse Event|1|||
46807230|NCT04110054|83026098|FG001|Overall Study|Adverse Event|1|||
46807231|NCT04110054|83026099|FG002|Overall Study|Adverse Event|4|||
46807232|NCT04110054|83026100|FG003|Overall Study|Adverse Event|3|||
46807233|NCT04070105|83026110|FG000|Overall Study|Lost to Follow-up|0|||
46807234|NCT04070105|83026111|FG001|Overall Study|Lost to Follow-up|0|||
46807235|NCT04070105|83026112|FG002|Overall Study|Lost to Follow-up|0|||
46807236|NCT04070105|83026113|FG003|Overall Study|Lost to Follow-up|0|||
46807237|NCT04070105|83026114|FG004|Overall Study|Lost to Follow-up|0|||
47053360|NCT00709098|83323412|FG000|Double-blind Period|Lost to Follow-up|1|||
46807238|NCT04070105|83026115|FG005|Overall Study|Lost to Follow-up|1|||
46807239|NCT04021706|83026124|FG000|Overall Study|Adverse Event|2|||
46807240|NCT04021706|83026125|FG001|Overall Study|Adverse Event|0|||
46807241|NCT04021706|83026124|FG000|Overall Study|Withdrawal by Subject|1|||
46807242|NCT04021706|83026125|FG001|Overall Study|Withdrawal by Subject|2|||
46807243|NCT04021706|83026124|FG000|Overall Study|Physician Decision|1|||
46807244|NCT04021706|83026125|FG001|Overall Study|Physician Decision|0|||
46807245|NCT03991936|83026131|FG000|Overall Study|Lost to Follow-up|1|||
47053361|NCT00709098|83323413|FG001|Double-blind Period|Lost to Follow-up|1|||
47053362|NCT00709098|83323414|FG002|Double-blind Period|Lost to Follow-up|0|||
47053363|NCT00709098|83323412|FG000|Open-label Period|Withdrawal of consent|0|||
46752721|NCT02400281|82971087|FG004|Overall Study|Physician Decision|0|||
46752722|NCT02400281|82971088|FG005|Overall Study|Physician Decision|0|||
46752723|NCT02294461|82971104|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
46807246|NCT03991936|83026132|FG001|Overall Study|Lost to Follow-up|1|||
46807247|NCT03991936|83026133|FG002|Overall Study|Lost to Follow-up|1|||
46807248|NCT03991936|83026134|FG003|Overall Study|Lost to Follow-up|1|||
46807249|NCT03991936|83026135|FG004|Overall Study|Lost to Follow-up|1|||
46807250|NCT03980483|83026160|FG000|Overall Study|Adverse Event|13|||
46925863|NCT03314935|83160311|FG006|Phase 2|Progressive Disease|0|||
46925864|NCT03314935|83160312|FG007|Phase 2|Progressive Disease|0|||
46925865|NCT03314935|83160313|FG008|Phase 2|Progressive Disease|0|||
46925866|NCT03314935|83160314|FG009|Phase 2|Progressive Disease|1|||
46925867|NCT03314935|83160315|FG010|Phase 2|Progressive Disease|1|||
46925868|NCT03314935|83160316|FG011|Phase 2|Progressive Disease|1|||
46925869|NCT03314935|83160317|FG012|Phase 2|Progressive Disease|2|||
46752724|NCT02294461|82971105|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
46752725|NCT02294461|82971104|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
46752726|NCT02294461|82971105|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
46807251|NCT03980483|83026161|FG001|Overall Study|Adverse Event|29|||
46807252|NCT03980483|83026162|FG002|Overall Study|Adverse Event|11|||
46807253|NCT03980483|83026163|FG003|Overall Study|Adverse Event|2|||
46807254|NCT03980483|83026164|FG004|Overall Study|Adverse Event|2|||
46807255|NCT03980483|83026165|FG005|Overall Study|Adverse Event|2|||
46807256|NCT03980483|83026160|FG000|Overall Study|Lack of Efficacy|7|||
46807257|NCT03980483|83026161|FG001|Overall Study|Lack of Efficacy|6|||
46807258|NCT03980483|83026162|FG002|Overall Study|Lack of Efficacy|0|||
46807259|NCT03980483|83026163|FG003|Overall Study|Lack of Efficacy|3|||
46807260|NCT03980483|83026164|FG004|Overall Study|Lack of Efficacy|1|||
46807261|NCT03980483|83026165|FG005|Overall Study|Lack of Efficacy|1|||
46807262|NCT03980483|83026160|FG000|Overall Study|Lost to Follow-up|2|||
46807263|NCT03980483|83026161|FG001|Overall Study|Lost to Follow-up|4|||
46807264|NCT03980483|83026162|FG002|Overall Study|Lost to Follow-up|2|||
46807265|NCT03980483|83026163|FG003|Overall Study|Lost to Follow-up|1|||
46925870|NCT03314935|83160318|FG013|Phase 2|Progressive Disease|0|||
46925871|NCT03314935|83160319|FG014|Phase 2|Progressive Disease|1|||
46925872|NCT03314935|83160305|FG000|Phase 2|Study Terminated by Sponsor|0|||
47053364|NCT00709098|83323413|FG001|Open-label Period|Withdrawal of consent|0|||
46752727|NCT02294461|82971104|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
46752728|NCT02294461|82971105|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
46752729|NCT02294461|82971104|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
46752730|NCT02294461|82971105|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
46752731|NCT02294461|82971104|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
46752732|NCT02294461|82971105|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
46752733|NCT02294461|82971104|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
46752734|NCT02294461|82971105|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
46752735|NCT02294461|82971104|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
46752736|NCT02294461|82971105|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
46752737|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
46752738|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
46807266|NCT03980483|83026164|FG004|Overall Study|Lost to Follow-up|2|||
46807267|NCT03980483|83026165|FG005|Overall Study|Lost to Follow-up|0|||
46807268|NCT03980483|83026160|FG000|Overall Study|Protocol Violation|4|||
46807269|NCT03980483|83026161|FG001|Overall Study|Protocol Violation|2|||
46807270|NCT03980483|83026162|FG002|Overall Study|Protocol Violation|1|||
46807271|NCT03980483|83026163|FG003|Overall Study|Protocol Violation|1|||
46807272|NCT03980483|83026164|FG004|Overall Study|Protocol Violation|0|||
46807273|NCT03980483|83026165|FG005|Overall Study|Protocol Violation|0|||
46807274|NCT03980483|83026160|FG000|Overall Study|Physician Decision|14|||
46807275|NCT03980483|83026161|FG001|Overall Study|Physician Decision|10|||
46807276|NCT03980483|83026162|FG002|Overall Study|Physician Decision|7|||
46807277|NCT03980483|83026163|FG003|Overall Study|Physician Decision|4|||
46925873|NCT03314935|83160306|FG001|Phase 2|Study Terminated by Sponsor|0|||
46925874|NCT03314935|83160307|FG002|Phase 2|Study Terminated by Sponsor|0|||
46925875|NCT03314935|83160308|FG003|Phase 2|Study Terminated by Sponsor|0|||
46925876|NCT03314935|83160309|FG004|Phase 2|Study Terminated by Sponsor|0|||
46925877|NCT03314935|83160310|FG005|Phase 2|Study Terminated by Sponsor|0|||
46925878|NCT03314935|83160311|FG006|Phase 2|Study Terminated by Sponsor|0|||
46925879|NCT03314935|83160312|FG007|Phase 2|Study Terminated by Sponsor|0|||
46752739|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
46752740|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
46752741|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
46752742|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
46752743|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
46752744|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
46752745|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
46752746|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
46752747|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
46752748|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
46752749|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
46925880|NCT03314935|83160313|FG008|Phase 2|Study Terminated by Sponsor|0|||
46925881|NCT03314935|83160314|FG009|Phase 2|Study Terminated by Sponsor|0|||
46925882|NCT03314935|83160315|FG010|Phase 2|Study Terminated by Sponsor|7|||
46925883|NCT03314935|83160316|FG011|Phase 2|Study Terminated by Sponsor|2|||
46752750|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
46752751|NCT02294461|82971104|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
46752752|NCT02294461|82971105|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
46752753|NCT02052778|82971159|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
46925884|NCT03314935|83160317|FG012|Phase 2|Study Terminated by Sponsor|1|||
46925885|NCT03314935|83160318|FG013|Phase 2|Study Terminated by Sponsor|4|||
46925886|NCT03314935|83160319|FG014|Phase 2|Study Terminated by Sponsor|4|||
46925887|NCT03314935|83160305|FG000|Phase 2|Lost to Follow-up|0|||
46925888|NCT03314935|83160306|FG001|Phase 2|Lost to Follow-up|0|||
46752754|NCT02052778|82971160|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
46752755|NCT02052778|82971161|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
46925889|NCT03314935|83160307|FG002|Phase 2|Lost to Follow-up|0|||
46925890|NCT03314935|83160308|FG003|Phase 2|Lost to Follow-up|0|||
46925891|NCT03314935|83160309|FG004|Phase 2|Lost to Follow-up|0|||
46925892|NCT03314935|83160310|FG005|Phase 2|Lost to Follow-up|0|||
46925893|NCT03314935|83160311|FG006|Phase 2|Lost to Follow-up|0|||
46925894|NCT03314935|83160312|FG007|Phase 2|Lost to Follow-up|0|||
46925895|NCT03314935|83160313|FG008|Phase 2|Lost to Follow-up|0|||
46752756|NCT02052778|82971162|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
46752757|NCT02052778|82971163|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
46752758|NCT02052778|82971164|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
46752759|NCT02052778|82971165|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752760|NCT02052778|82971166|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
46752761|NCT02052778|82971167|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
46752762|NCT02052778|82971168|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
46752763|NCT02052778|82971169|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
46752764|NCT02052778|82971170|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
46752765|NCT02052778|82971171|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
46752766|NCT02052778|82971172|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
46752767|NCT02052778|82971173|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752768|NCT02052778|82971174|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752769|NCT02052778|82971175|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752770|NCT02052778|82971176|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752771|NCT02052778|82971177|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752772|NCT02052778|82971178|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752773|NCT02052778|82971179|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752774|NCT02052778|82971180|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752775|NCT02052778|82971181|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
46752776|NCT02052778|82971159|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
46752777|NCT02052778|82971160|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
46752778|NCT02052778|82971161|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
46752779|NCT02052778|82971162|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
46752780|NCT02052778|82971163|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
46752781|NCT02052778|82971164|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
46807278|NCT03980483|83026164|FG004|Overall Study|Physician Decision|4|||
46925896|NCT03314935|83160314|FG009|Phase 2|Lost to Follow-up|1|||
46925897|NCT03314935|83160315|FG010|Phase 2|Lost to Follow-up|0|||
46925898|NCT03314935|83160316|FG011|Phase 2|Lost to Follow-up|0|||
46925899|NCT03314935|83160317|FG012|Phase 2|Lost to Follow-up|0|||
46925900|NCT03314935|83160318|FG013|Phase 2|Lost to Follow-up|0|||
46807279|NCT03980483|83026165|FG005|Overall Study|Physician Decision|2|||
46807280|NCT03980483|83026160|FG000|Overall Study|Withdrawal by Subject|38|||
46807281|NCT03980483|83026161|FG001|Overall Study|Withdrawal by Subject|21|||
46807282|NCT03980483|83026162|FG002|Overall Study|Withdrawal by Subject|15|||
46807283|NCT03980483|83026163|FG003|Overall Study|Withdrawal by Subject|5|||
46807284|NCT03980483|83026164|FG004|Overall Study|Withdrawal by Subject|3|||
46807285|NCT03980483|83026165|FG005|Overall Study|Withdrawal by Subject|4|||
46807286|NCT03980483|83026160|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
46807287|NCT03980483|83026161|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
46807288|NCT03980483|83026162|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
46807289|NCT03980483|83026163|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
46807290|NCT03980483|83026164|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
46807291|NCT03980483|83026165|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
46807292|NCT03980483|83026160|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
46807293|NCT03980483|83026161|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
46807294|NCT03980483|83026162|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
46807295|NCT03980483|83026163|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
46807296|NCT03980483|83026164|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
46807297|NCT03980483|83026165|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
46807298|NCT03980483|83026160|FG000|Overall Study|Other|0|||
46807299|NCT03980483|83026161|FG001|Overall Study|Other|1|||
46807300|NCT03980483|83026162|FG002|Overall Study|Other|0|||
46807301|NCT03980483|83026163|FG003|Overall Study|Other|0|||
46807302|NCT03980483|83026164|FG004|Overall Study|Other|0|||
46807303|NCT03980483|83026165|FG005|Overall Study|Other|0|||
46807304|NCT03972709|83026187|FG000|Overall Study|Withdrawal by Subject|18|||
46807305|NCT03972709|83026188|FG001|Overall Study|Withdrawal by Subject|7|||
46807306|NCT03972709|83026189|FG002|Overall Study|Withdrawal by Subject|14|||
46807307|NCT03972709|83026187|FG000|Overall Study|Study Terminated by Sponsor|48|||
46807308|NCT03972709|83026188|FG001|Overall Study|Study Terminated by Sponsor|25|||
46807309|NCT03972709|83026189|FG002|Overall Study|Study Terminated by Sponsor|50|||
46807310|NCT03972709|83026187|FG000|Overall Study|Physician Decision|1|||
46807311|NCT03972709|83026188|FG001|Overall Study|Physician Decision|0|||
46807312|NCT03972709|83026189|FG002|Overall Study|Physician Decision|0|||
46807313|NCT03972709|83026187|FG000|Overall Study|COVID-19|0|||
46807314|NCT03972709|83026188|FG001|Overall Study|COVID-19|1|||
46807315|NCT03972709|83026189|FG002|Overall Study|COVID-19|1|||
46807316|NCT03972709|83026187|FG000|Overall Study|Lost to Follow-up|6|||
46807317|NCT03972709|83026188|FG001|Overall Study|Lost to Follow-up|1|||
46807318|NCT03972709|83026189|FG002|Overall Study|Lost to Follow-up|2|||
46807319|NCT03972709|83026187|FG000|Overall Study|Death|5|||
46807320|NCT03972709|83026188|FG001|Overall Study|Death|1|||
46807321|NCT03972709|83026189|FG002|Overall Study|Death|4|||
46925901|NCT03314935|83160319|FG014|Phase 2|Lost to Follow-up|1|||
47053365|NCT00709098|83323414|FG002|Open-label Period|Withdrawal of consent|7|||
47053366|NCT00709098|83323412|FG000|Open-label Period|Administrative reason|0|||
47053367|NCT00709098|83323413|FG001|Open-label Period|Administrative reason|0|||
47053368|NCT00709098|83323414|FG002|Open-label Period|Administrative reason|5|||
47053369|NCT00709098|83323412|FG000|Open-label Period|Death|0|||
47053370|NCT00709098|83323413|FG001|Open-label Period|Death|0|||
47053371|NCT00709098|83323414|FG002|Open-label Period|Death|1|||
47053372|NCT00709098|83323412|FG000|Open-label Period|Lost to Follow-up|0|||
47053373|NCT00709098|83323413|FG001|Open-label Period|Lost to Follow-up|0|||
47053374|NCT00709098|83323414|FG002|Open-label Period|Lost to Follow-up|1|||
47053375|NCT01376700|83323423|FG000|Overall Study|Sponsor terminated study early|8|||
47053376|NCT01376700|83323423|FG000|Overall Study|Low or high titer inhibitor|8|||
47053377|NCT01797965|83323434|FG000|Overall Study|Adverse Event|104|||
47053378|NCT01797965|83323435|FG001|Overall Study|Adverse Event|129|||
47053379|NCT01797965|83323436|FG002|Overall Study|Adverse Event|4|||
47053380|NCT01797965|83323437|FG003|Overall Study|Adverse Event|21|||
47053381|NCT01797965|83323434|FG000|Overall Study|Lost to Follow-up|9|||
46807322|NCT03972709|83026187|FG000|Overall Study|Adverse Event|3|||
46807323|NCT03972709|83026188|FG001|Overall Study|Adverse Event|1|||
46925902|NCT03314935|83160305|FG000|Phase 2|Physician Decision|0|||
46807324|NCT03972709|83026189|FG002|Overall Study|Adverse Event|4|||
46807325|NCT03972709|83026187|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
46807326|NCT03972709|83026188|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
46807327|NCT03972709|83026189|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
46807328|NCT03972709|83026187|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
46807329|NCT03972709|83026188|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
46807330|NCT03972709|83026189|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
47053382|NCT01797965|83323435|FG001|Overall Study|Lost to Follow-up|8|||
47053383|NCT01797965|83323436|FG002|Overall Study|Lost to Follow-up|1|||
47053384|NCT01797965|83323437|FG003|Overall Study|Lost to Follow-up|2|||
47053385|NCT01797965|83323434|FG000|Overall Study|Consent withdrawn|130|||
47053386|NCT01797965|83323435|FG001|Overall Study|Consent withdrawn|117|||
46807331|NCT03972709|83026187|FG000|Overall Study|Subject Unable to be Contacted|0|||
46925903|NCT03314935|83160306|FG001|Phase 2|Physician Decision|0|||
46925904|NCT03314935|83160307|FG002|Phase 2|Physician Decision|0|||
46807332|NCT03972709|83026188|FG001|Overall Study|Subject Unable to be Contacted|1|||
46807333|NCT03972709|83026189|FG002|Overall Study|Subject Unable to be Contacted|0|||
46807334|NCT03972709|83026187|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
46807335|NCT03972709|83026188|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
46925905|NCT03314935|83160308|FG003|Phase 2|Physician Decision|0|||
46925906|NCT03314935|83160309|FG004|Phase 2|Physician Decision|0|||
46925907|NCT03314935|83160310|FG005|Phase 2|Physician Decision|0|||
46925908|NCT03314935|83160311|FG006|Phase 2|Physician Decision|0|||
46925909|NCT03314935|83160312|FG007|Phase 2|Physician Decision|0|||
47053387|NCT01797965|83323436|FG002|Overall Study|Consent withdrawn|3|||
47053388|NCT01797965|83323437|FG003|Overall Study|Consent withdrawn|35|||
47053389|NCT01797965|83323434|FG000|Overall Study|Investigator decision|21|||
46807336|NCT03972709|83026189|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
46925910|NCT03314935|83160313|FG008|Phase 2|Physician Decision|0|||
46925911|NCT03314935|83160314|FG009|Phase 2|Physician Decision|0|||
46925912|NCT03314935|83160315|FG010|Phase 2|Physician Decision|1|||
46925913|NCT03314935|83160316|FG011|Phase 2|Physician Decision|0|||
47053390|NCT01797965|83323435|FG001|Overall Study|Investigator decision|15|||
46807337|NCT03972709|83026187|FG000|Overall Study|Subject Moved|0|||
46807338|NCT03972709|83026188|FG001|Overall Study|Subject Moved|1|||
46807339|NCT03972709|83026189|FG002|Overall Study|Subject Moved|0|||
46807340|NCT03972709|83026187|FG000|Overall Study|Missed Study Visits|1|||
46807341|NCT03972709|83026188|FG001|Overall Study|Missed Study Visits|0|||
46807342|NCT03972709|83026189|FG002|Overall Study|Missed Study Visits|0|||
46807343|NCT03904147|83026200|FG000|Overall Study|Death|16|||
46807344|NCT03904147|83026201|FG001|Overall Study|Death|14|||
46807345|NCT03904147|83026202|FG002|Overall Study|Death|15|||
46807346|NCT03904147|83026200|FG000|Overall Study|Withdrawal by Subject|7|||
46807347|NCT03904147|83026201|FG001|Overall Study|Withdrawal by Subject|12|||
46807348|NCT03904147|83026202|FG002|Overall Study|Withdrawal by Subject|1|||
46807349|NCT03861273|83026213|FG000|Screening Phase (3 Weeks)|Other|1|||
46807350|NCT03861273|83026213|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
46807351|NCT03861273|83026213|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
46807352|NCT03861273|83026213|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
46807353|NCT03861273|83026213|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
46807354|NCT03847610|83026220|FG000|Overall Study|Withdrawal by Subject|1|||
46807355|NCT03634488|83026227|FG000|Overall Study|Death|1|||
46807356|NCT03634488|83026228|FG001|Overall Study|Death|0|||
46807357|NCT03634488|83026229|FG002|Overall Study|Death|0|||
46807358|NCT03634488|83026227|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
46807359|NCT03634488|83026228|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
46807360|NCT03634488|83026229|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
46807361|NCT03633058|83026248|FG000|Overall Study|Adverse Event|0|||
46807362|NCT03633058|83026249|FG001|Overall Study|Adverse Event|0|||
46807363|NCT03633058|83026250|FG002|Overall Study|Adverse Event|1|||
46807364|NCT03633058|83026251|FG003|Overall Study|Adverse Event|0|||
46807365|NCT03605368|83026265|FG000|Overall Study|Lost to Follow-up|2|||
46807366|NCT03605368|83026266|FG001|Overall Study|Lost to Follow-up|1|||
46807367|NCT03605368|83026267|FG002|Overall Study|Lost to Follow-up|3|||
46807368|NCT03605368|83026268|FG003|Overall Study|Lost to Follow-up|2|||
46807369|NCT03605368|83026265|FG000|Overall Study|Withdrawal by Subject|0|||
46807370|NCT03605368|83026266|FG001|Overall Study|Withdrawal by Subject|0|||
46807371|NCT03605368|83026267|FG002|Overall Study|Withdrawal by Subject|4|||
46807372|NCT03605368|83026268|FG003|Overall Study|Withdrawal by Subject|3|||
46807373|NCT03516812|83026286|FG000|Overall Study|Adverse Event|4|||
46807374|NCT03516812|83026286|FG000|Overall Study|Lack of Efficacy|2|||
46807375|NCT03472586|83026290|FG000|Overall Study|Physician Decision|6|||
46807376|NCT03472586|83026290|FG000|Overall Study|Death|6|||
46807377|NCT03472586|83026290|FG000|Overall Study|Adverse Event|1|||
46925914|NCT03314935|83160317|FG012|Phase 2|Physician Decision|0|||
47053391|NCT01797965|83323436|FG002|Overall Study|Investigator decision|0|||
46807378|NCT03457701|83026296|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
46807379|NCT03457701|83026297|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
46807380|NCT03457701|83026296|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
46807381|NCT03457701|83026297|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
46807382|NCT03446612|83026307|FG000|Overall Study|Protocol defined stopping criteria|0|||
46807383|NCT03446612|83026308|FG001|Overall Study|Protocol defined stopping criteria|1|||
46807384|NCT03433781|83026319|FG000|Overall Study|Progression of Disease|1|||
46925915|NCT03314935|83160318|FG013|Phase 2|Physician Decision|0|||
47053392|NCT01797965|83323437|FG003|Overall Study|Investigator decision|0|||
47053393|NCT01797965|83323434|FG000|Overall Study|Death|2|||
46807385|NCT03433781|83026320|FG001|Overall Study|Progression of Disease|0|||
46807386|NCT03433781|83026321|FG002|Overall Study|Progression of Disease|0|||
46807387|NCT03433781|83026319|FG000|Overall Study|Physician Decision|0|||
46807388|NCT03433781|83026320|FG001|Overall Study|Physician Decision|1|||
46752782|NCT02052778|82971165|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
46752783|NCT02052778|82971166|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
46807389|NCT03433781|83026321|FG002|Overall Study|Physician Decision|0|||
46807390|NCT03353220|83026329|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
46807391|NCT03353220|83026330|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
46807392|NCT03321630|83026336|FG000|Overall Study|Adverse Event|1|||
46925916|NCT03314935|83160319|FG014|Phase 2|Physician Decision|0|||
46925917|NCT03169361|83160362|FG000|Overall Study|Protocol Violation|32|||
46752784|NCT02052778|82971167|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
46752785|NCT02052778|82971168|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752786|NCT02052778|82971169|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752787|NCT02052778|82971170|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
46752788|NCT02052778|82971171|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
46752789|NCT02052778|82971172|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
46752790|NCT02052778|82971173|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752791|NCT02052778|82971174|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752792|NCT02052778|82971175|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752793|NCT02052778|82971176|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752794|NCT02052778|82971177|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752795|NCT02052778|82971178|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752796|NCT02052778|82971179|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752797|NCT02052778|82971180|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752798|NCT02052778|82971181|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
46752799|NCT02052778|82971159|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752800|NCT02052778|82971160|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752801|NCT02052778|82971161|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752802|NCT02052778|82971162|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752803|NCT02052778|82971163|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752804|NCT02052778|82971164|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752805|NCT02052778|82971165|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752806|NCT02052778|82971166|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752807|NCT02052778|82971167|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752808|NCT02052778|82971168|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46807393|NCT03321630|83026336|FG000|Overall Study|Investigator Discretion|2|||
46807394|NCT03321630|83026336|FG000|Overall Study|Withdrawal by Subject|1|||
46925918|NCT03031847|83160379|FG000|Overall Study|Death|1|||
46807395|NCT03237858|83026340|FG000|Overall Study|Death|19|||
46807396|NCT03237858|83026340|FG000|Overall Study|Withdrawal by Subject|37|||
46807397|NCT03056755|83026369|FG000|Treatment- Core Phase|Progressive disease|89|||
46807398|NCT03056755|83026370|FG001|Treatment- Core Phase|Progressive disease|88|||
46925919|NCT03031847|83160380|FG001|Overall Study|Death|1|||
46925920|NCT03031847|83160381|FG002|Overall Study|Death|2|||
46925921|NCT03031847|83160382|FG003|Overall Study|Death|3|||
46925922|NCT03031847|83160379|FG000|Overall Study|Lost to Follow-up|1|||
46925923|NCT03031847|83160380|FG001|Overall Study|Lost to Follow-up|1|||
47053394|NCT01797965|83323435|FG001|Overall Study|Death|4|||
46752809|NCT02052778|82971169|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752810|NCT02052778|82971170|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752811|NCT02052778|82971171|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752812|NCT02052778|82971172|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
46752813|NCT02052778|82971173|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752814|NCT02052778|82971174|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752815|NCT02052778|82971175|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752816|NCT02052778|82971176|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752817|NCT02052778|82971177|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752818|NCT02052778|82971178|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752819|NCT02052778|82971179|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752820|NCT02052778|82971180|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752821|NCT02052778|82971181|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
46752822|NCT02052778|82971159|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
46752823|NCT02052778|82971160|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
46752824|NCT02052778|82971161|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
46752825|NCT02052778|82971162|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
46752826|NCT02052778|82971163|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
46752827|NCT02052778|82971164|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
46752828|NCT02052778|82971165|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
46752829|NCT02052778|82971166|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
46752830|NCT02052778|82971167|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
46752831|NCT02052778|82971168|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
46752832|NCT02052778|82971169|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
46752833|NCT02052778|82971170|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
46752834|NCT02052778|82971171|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
46752835|NCT02052778|82971172|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
46752836|NCT02052778|82971173|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
46752837|NCT02052778|82971174|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
46752838|NCT02052778|82971175|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
47053395|NCT01797965|83323436|FG002|Overall Study|Death|0|||
47053396|NCT01797965|83323437|FG003|Overall Study|Death|0|||
47053397|NCT01797965|83323434|FG000|Overall Study|Disease progression, defined by protocol|3|||
47053398|NCT01797965|83323435|FG001|Overall Study|Disease progression, defined by protocol|1|||
47053399|NCT01797965|83323436|FG002|Overall Study|Disease progression, defined by protocol|0|||
47053400|NCT01797965|83323437|FG003|Overall Study|Disease progression, defined by protocol|0|||
47053401|NCT01797965|83323434|FG000|Overall Study|Reason Not Specified|280|||
47053402|NCT01797965|83323435|FG001|Overall Study|Reason Not Specified|295|||
47053403|NCT01797965|83323436|FG002|Overall Study|Reason Not Specified|0|||
46752839|NCT02052778|82971176|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
46752840|NCT02052778|82971177|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
46807399|NCT03056755|83026371|FG002|Treatment- Core Phase|Progressive disease|90|||
46925924|NCT03031847|83160381|FG002|Overall Study|Lost to Follow-up|2|||
46925925|NCT03031847|83160382|FG003|Overall Study|Lost to Follow-up|3|||
47053404|NCT01797965|83323437|FG003|Overall Study|Reason Not Specified|15|||
47053405|NCT01376388|83323482|FG000|Overall Study|Adverse Event|13|||
47053406|NCT01376388|83323482|FG000|Overall Study|Lack of Efficacy|2|||
46752841|NCT02052778|82971178|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
46752842|NCT02052778|82971179|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
46752843|NCT02052778|82971180|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
46752844|NCT02052778|82971181|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
46752845|NCT02052778|82971159|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752846|NCT02052778|82971160|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752847|NCT02052778|82971161|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752848|NCT02052778|82971162|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752849|NCT02052778|82971163|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752850|NCT02052778|82971164|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752851|NCT02052778|82971165|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752852|NCT02052778|82971166|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752853|NCT02052778|82971167|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
46752854|NCT02052778|82971168|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752855|NCT02052778|82971169|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752856|NCT02052778|82971170|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752857|NCT02052778|82971171|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752858|NCT02052778|82971172|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
46752859|NCT02052778|82971173|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752860|NCT02052778|82971174|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46925926|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
46925927|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
47053407|NCT01376388|83323482|FG000|Overall Study|Withdrawal by Subject|3|||
47053408|NCT01821677|83323499|FG000|Overall Study|Adverse Event|4|||
47053409|NCT01821677|83323500|FG001|Overall Study|Adverse Event|6|||
47053410|NCT01821677|83323501|FG002|Overall Study|Adverse Event|5|||
47053411|NCT01821677|83323499|FG000|Overall Study|Physician Decision|1|||
46752861|NCT02052778|82971175|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752862|NCT02052778|82971176|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752863|NCT02052778|82971177|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752864|NCT02052778|82971178|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752865|NCT02052778|82971179|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752866|NCT02052778|82971180|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752867|NCT02052778|82971181|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
46752868|NCT02052778|82971159|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752869|NCT02052778|82971160|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752870|NCT02052778|82971161|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752871|NCT02052778|82971162|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752872|NCT02052778|82971163|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752873|NCT02052778|82971164|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
46752874|NCT02052778|82971165|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
47053412|NCT01821677|83323500|FG001|Overall Study|Physician Decision|4|||
47053413|NCT01821677|83323501|FG002|Overall Study|Physician Decision|1|||
47053414|NCT01821677|83323499|FG000|Overall Study|Non-compliance|0|||
47053415|NCT01821677|83323500|FG001|Overall Study|Non-compliance|1|||
47053416|NCT01821677|83323501|FG002|Overall Study|Non-compliance|2|||
46752875|NCT02052778|82971166|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752876|NCT02052778|82971167|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752877|NCT02052778|82971168|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752878|NCT02052778|82971169|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46925928|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
47053417|NCT01821677|83323499|FG000|Overall Study|Lost to Follow-up|2|||
47053418|NCT01821677|83323500|FG001|Overall Study|Lost to Follow-up|1|||
47053419|NCT01821677|83323501|FG002|Overall Study|Lost to Follow-up|3|||
46807400|NCT03056755|83026369|FG000|Treatment- Core Phase|Adverse Event|20|||
46807401|NCT03056755|83026370|FG001|Treatment- Core Phase|Adverse Event|14|||
46807402|NCT03056755|83026371|FG002|Treatment- Core Phase|Adverse Event|13|||
46752879|NCT02052778|82971170|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46807403|NCT03056755|83026369|FG000|Treatment- Core Phase|Physician Decision|7|||
46807404|NCT03056755|83026370|FG001|Treatment- Core Phase|Physician Decision|13|||
46807405|NCT03056755|83026371|FG002|Treatment- Core Phase|Physician Decision|5|||
46807406|NCT03056755|83026369|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
46807407|NCT03056755|83026370|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
46807408|NCT03056755|83026371|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
46807409|NCT03056755|83026369|FG000|Treatment- Core Phase|Death|3|||
46807410|NCT03056755|83026370|FG001|Treatment- Core Phase|Death|2|||
46807411|NCT03056755|83026371|FG002|Treatment- Core Phase|Death|4|||
46807412|NCT03056755|83026369|FG000|Treatment- Core Phase|Protocol deviation|1|||
46807413|NCT03056755|83026370|FG001|Treatment- Core Phase|Protocol deviation|1|||
46807414|NCT03056755|83026371|FG002|Treatment- Core Phase|Protocol deviation|0|||
46807415|NCT03056755|83026369|FG000|Treatment- Core Phase|Technical problems|1|||
46925929|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
46925930|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
47053420|NCT01821677|83323499|FG000|Overall Study|Protocol Violation|0|||
47053421|NCT01821677|83323500|FG001|Overall Study|Protocol Violation|0|||
47053422|NCT01821677|83323501|FG002|Overall Study|Protocol Violation|2|||
47053423|NCT01821677|83323499|FG000|Overall Study|Withdrawal by Subject|7|||
47053424|NCT01821677|83323500|FG001|Overall Study|Withdrawal by Subject|3|||
47053425|NCT01821677|83323501|FG002|Overall Study|Withdrawal by Subject|2|||
47053426|NCT01821677|83323499|FG000|Overall Study|Other|9|||
47053427|NCT01821677|83323500|FG001|Overall Study|Other|0|||
47053428|NCT01821677|83323501|FG002|Overall Study|Other|0|||
47053429|NCT01797731|83323512|FG000|Overall Study|Didn't have proper radiographs required|3|||
46752880|NCT02052778|82971171|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
46752881|NCT02052778|82971172|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752882|NCT02052778|82971173|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752883|NCT02052778|82971174|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752884|NCT02052778|82971175|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752885|NCT02052778|82971176|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752886|NCT02052778|82971177|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46807416|NCT03056755|83026370|FG001|Treatment- Core Phase|Technical problems|0|||
46752887|NCT02052778|82971178|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46807417|NCT03056755|83026371|FG002|Treatment- Core Phase|Technical problems|0|||
46807418|NCT03056755|83026369|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
47053430|NCT01797731|83323513|FG001|Overall Study|Didn't have proper radiographs required|3|||
47053431|NCT00709722|83323519|FG000|Overall Study|Adverse Event|1|||
46807419|NCT03056755|83026370|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
46807420|NCT03056755|83026371|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
46807421|NCT03056755|83026369|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
46807422|NCT03056755|83026370|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
46807423|NCT03056755|83026371|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
46807424|NCT03056755|83026369|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
46925931|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
46925932|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
46925933|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
46925934|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
46925935|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
46925936|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
46925937|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
46925938|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
46925939|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
46925940|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
46925941|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
46925942|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
46925943|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
46925944|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
46925945|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
46925946|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
46925947|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
46925948|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
46925949|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
46925950|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
46925951|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
46925952|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
46925953|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
46925954|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
46925955|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
46925956|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
46925957|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
46925958|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
46925959|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
46925960|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
46925961|NCT02831764|83160394|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
46925962|NCT02831764|83160395|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
46925963|NCT02831764|83160396|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
46752888|NCT02052778|82971179|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752889|NCT02052778|82971180|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752890|NCT02052778|82971181|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
46752891|NCT02052778|82971159|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752892|NCT02052778|82971160|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752893|NCT02052778|82971161|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752894|NCT02052778|82971162|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46807425|NCT03056755|83026370|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
46807426|NCT03056755|83026371|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
46807427|NCT03056755|83026369|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
46807428|NCT03056755|83026370|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
46807429|NCT03056755|83026371|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
46807430|NCT02919683|83026384|FG000|Post-Surgery Follow-Up|Death|2|||
46807431|NCT02919683|83026385|FG001|Post-Surgery Follow-Up|Death|2|||
46807432|NCT02919683|83026384|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
46807433|NCT02919683|83026385|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
46807434|NCT02603432|83026403|FG000|Overall Study|Adverse Event|1|||
46925964|NCT02831764|83160397|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
46752895|NCT02052778|82971163|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752896|NCT02052778|82971164|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752897|NCT02052778|82971165|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752898|NCT02052778|82971166|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46807435|NCT02603432|83026404|FG001|Overall Study|Adverse Event|0|||
46925965|NCT02831764|83160398|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
46925966|NCT02831764|83160394|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
46807436|NCT02603432|83026403|FG000|Overall Study|Death|221|||
46807437|NCT02603432|83026404|FG001|Overall Study|Death|242|||
46925967|NCT02831764|83160395|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
46925968|NCT02831764|83160396|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
46925969|NCT02831764|83160397|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
46925970|NCT02831764|83160398|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
46925971|NCT02831764|83160394|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
47053432|NCT01820585|83323540|FG000|Overall Study|Adverse Event|9|||
47053433|NCT01820585|83323541|FG001|Overall Study|Adverse Event|13|||
46752899|NCT02052778|82971167|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752900|NCT02052778|82971168|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752901|NCT02052778|82971169|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752902|NCT02052778|82971170|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752903|NCT02052778|82971171|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752904|NCT02052778|82971172|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752905|NCT02052778|82971173|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
46752906|NCT02052778|82971174|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
46807438|NCT02603432|83026403|FG000|Overall Study|Lost to Follow-up|3|||
46752907|NCT02052778|82971175|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
46807439|NCT02603432|83026404|FG001|Overall Study|Lost to Follow-up|9|||
46807440|NCT02603432|83026403|FG000|Overall Study|Progressive Disease|7|||
46807441|NCT02603432|83026404|FG001|Overall Study|Progressive Disease|5|||
46807442|NCT02603432|83026403|FG000|Overall Study|Withdrawal by Subject|12|||
46807443|NCT02603432|83026404|FG001|Overall Study|Withdrawal by Subject|18|||
46807444|NCT02603432|83026403|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
46807445|NCT02603432|83026404|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46807446|NCT02603432|83026403|FG000|Overall Study|Study terminated by sponsor|74|||
46807447|NCT02603432|83026404|FG001|Overall Study|Study terminated by sponsor|75|||
46807448|NCT02603432|83026403|FG000|Overall Study|Other|13|||
46807449|NCT02603432|83026404|FG001|Overall Study|Other|0|||
47053434|NCT01820585|83323542|FG002|Overall Study|Adverse Event|23|||
47053435|NCT01820585|83323543|FG003|Overall Study|Adverse Event|34|||
46807452|NCT01361711|83026486|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
46807453|NCT01361711|83026486|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
46807454|NCT01361711|83026486|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
46807455|NCT01361711|83026486|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
46807456|NCT01361711|83026486|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
46807457|NCT01361711|83026486|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
46807458|NCT01361711|83026486|FG000|Completed Week 18 of Treatment|Other|9|||
46807459|NCT01361711|83026486|FG000|10 Year Follow-up|Still in follow-up|22|||
46807460|NCT01361711|83026486|FG000|10 Year Follow-up|Death|7|||
46807461|NCT01361711|83026486|FG000|10 Year Follow-up|Developed new cancer|1|||
46752908|NCT02052778|82971176|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
46807462|NCT01361711|83026486|FG000|10 Year Follow-up|Lost to Follow-up|2|||
46807463|NCT01361711|83026486|FG000|10 Year Follow-up|New treatment started|6|||
46807464|NCT01361711|83026486|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
46807465|NCT01361711|83026486|FG000|10 Year Follow-up|Progressive Disease|1|||
46807466|NCT01144468|83026492|FG000|Overall Study|Lost to Follow-up|4|||
46807467|NCT01144468|83026493|FG001|Overall Study|Lost to Follow-up|7|||
46807468|NCT01144468|83026492|FG000|Overall Study|Adverse Event|3|||
46807469|NCT01144468|83026493|FG001|Overall Study|Adverse Event|2|||
46807470|NCT01144468|83026492|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
46807471|NCT01144468|83026493|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
46846454|NCT00131664|83063151|FG003|First Period (First 6 Months)|Adverse Event|0|||
46846455|NCT00131664|83063152|FG004|First Period (First 6 Months)|Adverse Event|0|||
46846456|NCT00131664|83063153|FG005|First Period (First 6 Months)|Adverse Event|0|||
46846457|NCT00131664|83063148|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
46846458|NCT00131664|83063149|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
46846459|NCT00131664|83063150|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
46846460|NCT00131664|83063151|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
46846461|NCT00131664|83063152|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
46846462|NCT00131664|83063153|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
46846463|NCT00131664|83063148|FG000|First Period (First 6 Months)|Administrative reasons|2|||
46846464|NCT00131664|83063149|FG001|First Period (First 6 Months)|Administrative reasons|0|||
46846465|NCT00131664|83063150|FG002|First Period (First 6 Months)|Administrative reasons|5|||
46846466|NCT00131664|83063151|FG003|First Period (First 6 Months)|Administrative reasons|0|||
46846467|NCT00131664|83063152|FG004|First Period (First 6 Months)|Administrative reasons|0|||
46846468|NCT00131664|83063153|FG005|First Period (First 6 Months)|Administrative reasons|0|||
46807472|NCT00640835|83026514|FG000|Overall Study|Adverse Event|5|||
46807473|NCT00640835|83026515|FG001|Overall Study|Adverse Event|3|||
46807474|NCT00640835|83026514|FG000|Overall Study|Withdrawal by Subject|12|||
46807475|NCT00640835|83026515|FG001|Overall Study|Withdrawal by Subject|14|||
46807476|NCT00640835|83026514|FG000|Overall Study|Physician Decision|10|||
46807477|NCT00640835|83026515|FG001|Overall Study|Physician Decision|14|||
46807478|NCT00640835|83026514|FG000|Overall Study|Sponsor's Decision|11|||
46807479|NCT00640835|83026515|FG001|Overall Study|Sponsor's Decision|7|||
46807480|NCT00640835|83026514|FG000|Overall Study|Protocol Violation|2|||
46807481|NCT00640835|83026515|FG001|Overall Study|Protocol Violation|2|||
46807482|NCT00640835|83026514|FG000|Overall Study|Lost to Follow-up|17|||
46807483|NCT00640835|83026515|FG001|Overall Study|Lost to Follow-up|13|||
46807484|NCT00640835|83026514|FG000|Overall Study|Other Reason|19|||
46807485|NCT00640835|83026515|FG001|Overall Study|Other Reason|4|||
46807486|NCT03839355|83026523|FG000|Overall Study|Withdrawal by Subject|1|||
46807487|NCT03839355|83026524|FG001|Overall Study|Withdrawal by Subject|0|||
46807488|NCT00382018|83026534|FG000|Overall Study|Progression|0|||
46807489|NCT00382018|83026535|FG001|Overall Study|Progression|136|||
46807490|NCT00382018|83026536|FG002|Overall Study|Progression|51|||
46807491|NCT00382018|83026537|FG003|Overall Study|Progression|43|||
46807492|NCT00382018|83026534|FG000|Overall Study|Death|0|||
46807493|NCT00382018|83026535|FG001|Overall Study|Death|9|||
46807494|NCT00382018|83026536|FG002|Overall Study|Death|7|||
46807495|NCT00382018|83026537|FG003|Overall Study|Death|11|||
46807496|NCT00382018|83026534|FG000|Overall Study|Withdrawal by Subject|0|||
46807497|NCT00382018|83026535|FG001|Overall Study|Withdrawal by Subject|4|||
46807498|NCT00382018|83026536|FG002|Overall Study|Withdrawal by Subject|3|||
46807499|NCT00382018|83026537|FG003|Overall Study|Withdrawal by Subject|4|||
46807500|NCT00382018|83026534|FG000|Overall Study|Other, not protocol specified|0|||
46807501|NCT00382018|83026535|FG001|Overall Study|Other, not protocol specified|16|||
46807502|NCT00382018|83026536|FG002|Overall Study|Other, not protocol specified|3|||
46807503|NCT00382018|83026537|FG003|Overall Study|Other, not protocol specified|1|||
46807504|NCT00640601|83026550|FG000|Overall Study|Adverse Event|43|||
46807505|NCT00640601|83026550|FG000|Overall Study|Withdrawal by Subject|20|||
46807506|NCT00640601|83026550|FG000|Overall Study|Protocol Violation|6|||
46807507|NCT00640601|83026550|FG000|Overall Study|Lack of Efficacy|16|||
46807508|NCT00640601|83026550|FG000|Overall Study|Lost to Follow-up|9|||
46807509|NCT00640601|83026550|FG000|Overall Study|Physician Decision|8|||
46807510|NCT00640601|83026550|FG000|Overall Study|treatment naive, combination therapy|10|||
46807511|NCT03838731|83026556|FG000|Overall Study|Pregnancy|0|||
46807512|NCT03838731|83026557|FG001|Overall Study|Pregnancy|1|||
46807513|NCT03838731|83026556|FG000|Overall Study|Withdrawal of consent|1|||
46807514|NCT03838731|83026557|FG001|Overall Study|Withdrawal of consent|0|||
46807515|NCT00452439|83026565|FG000|Overall Study|Lost to Follow-up|1|||
46807516|NCT00452439|83026566|FG001|Overall Study|Lost to Follow-up|1|||
46807517|NCT00452439|83026565|FG000|Overall Study|Refused Treatment|4|||
46807518|NCT00452439|83026566|FG001|Overall Study|Refused Treatment|3|||
46925972|NCT02831764|83160395|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
46925973|NCT02831764|83160396|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
46925974|NCT02831764|83160397|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
46925975|NCT02831764|83160398|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
46925976|NCT02831764|83160394|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
46925977|NCT02831764|83160395|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
46925978|NCT02831764|83160396|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
47053436|NCT01820585|83323540|FG000|Overall Study|Lack of Efficacy|9|||
46752909|NCT02052778|82971177|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
46752910|NCT02052778|82971178|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
46752911|NCT02052778|82971179|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
46752912|NCT02052778|82971180|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
46752913|NCT02052778|82971181|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
46752914|NCT02052778|82971159|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752915|NCT02052778|82971160|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752916|NCT02052778|82971161|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46807519|NCT00452439|83026565|FG000|Overall Study|Death|3|||
46807520|NCT00452439|83026566|FG001|Overall Study|Death|1|||
46925979|NCT02831764|83160397|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
46925980|NCT02831764|83160398|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
46807521|NCT00452439|83026565|FG000|Overall Study|Bone Marrow Transplant|0|||
46807522|NCT00452439|83026566|FG001|Overall Study|Bone Marrow Transplant|1|||
46807523|NCT00452439|83026565|FG000|Overall Study|Too Ill to Continue|0|||
46807524|NCT00452439|83026566|FG001|Overall Study|Too Ill to Continue|1|||
46807525|NCT00452439|83026565|FG000|Overall Study|Failed to achieve complete response|2|||
46807526|NCT00452439|83026566|FG001|Overall Study|Failed to achieve complete response|0|||
46807527|NCT00452439|83026565|FG000|Overall Study|Relapse|3|||
46807528|NCT00452439|83026566|FG001|Overall Study|Relapse|0|||
46925981|NCT02831764|83160394|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
46925982|NCT02831764|83160395|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
46925983|NCT02831764|83160396|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
46636250|NCT01517412|82810089|FG000|Overall Study|Other than specified above|8|||
46752917|NCT02052778|82971162|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46807529|NCT00452439|83026565|FG000|Overall Study|Fracture|1|||
46807530|NCT00452439|83026566|FG001|Overall Study|Fracture|0|||
46807531|NCT00381940|83026572|FG000|Overall Study|Lack of Efficacy|3|||
46807532|NCT00381940|83026572|FG000|Overall Study|Protocol Violation|1|||
46807533|NCT00381940|83026572|FG000|Overall Study|Ineligible|1|||
46807534|NCT00364156|83026578|FG000|Overall Study|Withdrawal by Subject|73|||
46807535|NCT00364156|83026579|FG001|Overall Study|Withdrawal by Subject|80|||
46807536|NCT00364156|83026578|FG000|Overall Study|Protocol Violation|6|||
46807537|NCT00364156|83026579|FG001|Overall Study|Protocol Violation|1|||
46807538|NCT00452361|83026587|FG000|Overall Study|Adverse Event|8|||
46807539|NCT00452361|83026588|FG001|Overall Study|Adverse Event|0|||
46807540|NCT00452361|83026587|FG000|Overall Study|Withdrawal by Subject|0|||
46807541|NCT00452361|83026588|FG001|Overall Study|Withdrawal by Subject|1|||
46807542|NCT00452361|83026587|FG000|Overall Study|Premature termination|13|||
46807543|NCT00452361|83026588|FG001|Overall Study|Premature termination|9|||
46807544|NCT00640289|83026594|FG000|Overall Study|Death|3|||
46807545|NCT00640289|83026594|FG000|Overall Study|Withdrawal by Subject|1|||
46807546|NCT00640289|83026594|FG000|Overall Study|Lost to Follow-up|1|||
46807547|NCT00640289|83026594|FG000|Overall Study|Data collected under different amendment|2|||
46807548|NCT00640289|83026594|FG000|Overall Study|Transferred to another center|1|||
46807549|NCT00640289|83026594|FG000|Overall Study|Missing status|5|||
46807550|NCT00568451|83026602|FG000|Overall Study|Disease Progression|0|||
46807551|NCT00568451|83026603|FG001|Overall Study|Disease Progression|0|||
46807552|NCT00568451|83026604|FG002|Overall Study|Disease Progression|2|||
46807553|NCT00568451|83026605|FG003|Overall Study|Disease Progression|7|||
46807554|NCT00459537|83026618|FG000|Overall Study|Adverse Event|1|||
46807555|NCT00459537|83026619|FG001|Overall Study|Adverse Event|6|||
46807556|NCT00459537|83026618|FG000|Overall Study|Lack of Efficacy|10|||
46807557|NCT00459537|83026619|FG001|Overall Study|Lack of Efficacy|11|||
46807558|NCT00459537|83026618|FG000|Overall Study|Withdrawal by Subject|20|||
46807559|NCT00459537|83026619|FG001|Overall Study|Withdrawal by Subject|26|||
46807560|NCT00459537|83026618|FG000|Overall Study|Lost to Follow-up|27|||
46807561|NCT00459537|83026619|FG001|Overall Study|Lost to Follow-up|30|||
46807562|NCT00459537|83026618|FG000|Overall Study|Administrative problems|3|||
46807563|NCT00459537|83026619|FG001|Overall Study|Administrative problems|0|||
46807564|NCT00459537|83026618|FG000|Overall Study|Protocol Violation|4|||
46807565|NCT00459537|83026619|FG001|Overall Study|Protocol Violation|3|||
46807566|NCT00459537|83026618|FG000|Overall Study|Missing|1|||
46807567|NCT00459537|83026619|FG001|Overall Study|Missing|0|||
46807568|NCT03850509|83026627|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
46807569|NCT03850509|83026628|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
46807570|NCT00635999|83026637|FG000|Overall Study|Withdrawal by Subject|4|||
46807571|NCT00635999|83026638|FG001|Overall Study|Withdrawal by Subject|2|||
46807572|NCT00635999|83026639|FG002|Overall Study|Withdrawal by Subject|1|||
46752918|NCT02052778|82971163|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752919|NCT02052778|82971164|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752920|NCT02052778|82971165|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752921|NCT02052778|82971166|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752922|NCT02052778|82971167|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752923|NCT02052778|82971168|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752924|NCT02052778|82971169|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752925|NCT02052778|82971170|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752926|NCT02052778|82971171|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46807573|NCT00469209|83026650|FG000|Overall Study|Adverse Event|1|||
46807574|NCT00469209|83026651|FG001|Overall Study|Adverse Event|0|||
46807575|NCT00469209|83026652|FG002|Overall Study|Adverse Event|1|||
46807576|NCT00635219|83026665|FG000|Overall Study|Adverse Event|12|||
46807577|NCT00635219|83026666|FG001|Overall Study|Adverse Event|10|||
46807578|NCT00635219|83026667|FG002|Overall Study|Adverse Event|18|||
46807579|NCT00635219|83026668|FG003|Overall Study|Adverse Event|15|||
46807580|NCT00635219|83026669|FG004|Overall Study|Adverse Event|19|||
46636251|NCT01517412|82810090|FG001|Overall Study|Other than specified above|5|||
46807581|NCT00635219|83026665|FG000|Overall Study|Lack of Efficacy|5|||
46636252|NCT01517178|82810096|FG000|Period 1|Adverse Event|1|||
46807582|NCT00635219|83026666|FG001|Overall Study|Lack of Efficacy|6|||
46807583|NCT00635219|83026667|FG002|Overall Study|Lack of Efficacy|3|||
46807584|NCT00635219|83026668|FG003|Overall Study|Lack of Efficacy|4|||
46807585|NCT00635219|83026669|FG004|Overall Study|Lack of Efficacy|6|||
46807586|NCT00635219|83026665|FG000|Overall Study|Non-compliance With Study Product|0|||
46807587|NCT00635219|83026666|FG001|Overall Study|Non-compliance With Study Product|0|||
46807588|NCT00635219|83026667|FG002|Overall Study|Non-compliance With Study Product|0|||
46807589|NCT00635219|83026668|FG003|Overall Study|Non-compliance With Study Product|2|||
46807590|NCT00635219|83026669|FG004|Overall Study|Non-compliance With Study Product|1|||
46807591|NCT00635219|83026665|FG000|Overall Study|Protocol Violation|0|||
46807592|NCT00635219|83026666|FG001|Overall Study|Protocol Violation|2|||
46807593|NCT00635219|83026667|FG002|Overall Study|Protocol Violation|3|||
46807594|NCT00635219|83026668|FG003|Overall Study|Protocol Violation|2|||
46807595|NCT00635219|83026669|FG004|Overall Study|Protocol Violation|4|||
46807596|NCT00635219|83026665|FG000|Overall Study|Withdrawal of Consent|8|||
46807597|NCT00635219|83026666|FG001|Overall Study|Withdrawal of Consent|6|||
46807598|NCT00635219|83026667|FG002|Overall Study|Withdrawal of Consent|8|||
46807599|NCT00635219|83026668|FG003|Overall Study|Withdrawal of Consent|11|||
46807600|NCT00635219|83026669|FG004|Overall Study|Withdrawal of Consent|8|||
46807601|NCT00635219|83026665|FG000|Overall Study|Lost to Follow-up|0|||
46807602|NCT00635219|83026666|FG001|Overall Study|Lost to Follow-up|0|||
46807603|NCT00635219|83026667|FG002|Overall Study|Lost to Follow-up|2|||
46807604|NCT00635219|83026668|FG003|Overall Study|Lost to Follow-up|0|||
46807605|NCT00635219|83026669|FG004|Overall Study|Lost to Follow-up|3|||
46807606|NCT00635219|83026665|FG000|Overall Study|Administrative or Other Reasons|0|||
46807607|NCT00635219|83026666|FG001|Overall Study|Administrative or Other Reasons|1|||
46807608|NCT00635219|83026667|FG002|Overall Study|Administrative or Other Reasons|1|||
46807609|NCT00635219|83026668|FG003|Overall Study|Administrative or Other Reasons|0|||
46807610|NCT00635219|83026669|FG004|Overall Study|Administrative or Other Reasons|1|||
46807611|NCT00363766|83026683|FG000|Overall Study|Progressive Disease|15|||
46807612|NCT00363766|83026684|FG001|Overall Study|Progressive Disease|9|||
46807613|NCT00363766|83026683|FG000|Overall Study|Adverse Event|10|||
46807614|NCT00363766|83026684|FG001|Overall Study|Adverse Event|2|||
46807615|NCT00363766|83026683|FG000|Overall Study|Disease Related Death|1|||
46807616|NCT00363766|83026684|FG001|Overall Study|Disease Related Death|3|||
46807617|NCT00363766|83026683|FG000|Overall Study|Not Disease Related Death|3|||
46807618|NCT00363766|83026684|FG001|Overall Study|Not Disease Related Death|4|||
46807619|NCT00363766|83026683|FG000|Overall Study|Withdrawal by Subject|2|||
46807620|NCT00363766|83026684|FG001|Overall Study|Withdrawal by Subject|0|||
46807621|NCT00363766|83026683|FG000|Overall Study|Physician Decision|1|||
46807622|NCT00363766|83026684|FG001|Overall Study|Physician Decision|2|||
46807623|NCT00468819|83026694|FG000|Overall Study|Withdrawal by Subject|4|||
46807624|NCT00468819|83026695|FG001|Overall Study|Withdrawal by Subject|0|||
46807625|NCT00468819|83026696|FG002|Overall Study|Withdrawal by Subject|1|||
46807626|NCT00468819|83026694|FG000|Overall Study|Lost to Follow-up|0|||
46807627|NCT00468819|83026695|FG001|Overall Study|Lost to Follow-up|0|||
46807628|NCT00468819|83026696|FG002|Overall Study|Lost to Follow-up|1|||
46807629|NCT00468819|83026694|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
46807630|NCT00468819|83026695|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
46807631|NCT00468819|83026696|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
46807632|NCT00451191|83026708|FG000|Overall Study|withdrawal or received alternate tx|15|||
46807633|NCT00451191|83026709|FG001|Overall Study|withdrawal or received alternate tx|11|||
46807634|NCT00451035|83026715|FG000|Overall Study|Disease progression|11|||
46752927|NCT02052778|82971172|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752928|NCT02052778|82971173|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
46752929|NCT02052778|82971174|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
46752930|NCT02052778|82971175|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752931|NCT02052778|82971176|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
46752932|NCT02052778|82971177|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
46752933|NCT02052778|82971178|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
46752934|NCT02052778|82971179|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
46752935|NCT02052778|82971180|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
46752936|NCT02052778|82971181|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
46752937|NCT02052778|82971159|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752938|NCT02052778|82971160|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752939|NCT02052778|82971161|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752940|NCT02052778|82971162|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752941|NCT02052778|82971163|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752942|NCT02052778|82971164|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46807635|NCT00451035|83026715|FG000|Overall Study|Death|3|||
46807636|NCT00451035|83026715|FG000|Overall Study|New anti-neoplastic therapy|3|||
46807637|NCT00468585|83026724|FG000|Overall Study|Patient not treated|1|||
46807638|NCT00468585|83026725|FG001|Overall Study|Patient not treated|0|||
46807639|NCT00468585|83026726|FG002|Overall Study|Patient not treated|1|||
46807640|NCT00468585|83026727|FG003|Overall Study|Patient not treated|0|||
46636253|NCT01517178|82810097|FG001|Period 1|Adverse Event|2|||
46807641|NCT00468585|83026724|FG000|Overall Study|Patient found to be ineligible|0|||
46925984|NCT02831764|83160397|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
46925985|NCT02831764|83160398|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
47053437|NCT01820585|83323541|FG001|Overall Study|Lack of Efficacy|7|||
47053438|NCT01820585|83323542|FG002|Overall Study|Lack of Efficacy|5|||
47053439|NCT01820585|83323543|FG003|Overall Study|Lack of Efficacy|1|||
47053440|NCT01820585|83323540|FG000|Overall Study|Withdrawal by Subject|3|||
46925986|NCT02831764|83160394|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
47053441|NCT01820585|83323541|FG001|Overall Study|Withdrawal by Subject|7|||
47053442|NCT01820585|83323542|FG002|Overall Study|Withdrawal by Subject|3|||
46807642|NCT00468585|83026725|FG001|Overall Study|Patient found to be ineligible|0|||
47053443|NCT01820585|83323543|FG003|Overall Study|Withdrawal by Subject|8|||
47053444|NCT01820585|83323540|FG000|Overall Study|Lost to Follow-up|3|||
47053445|NCT01820585|83323541|FG001|Overall Study|Lost to Follow-up|3|||
47053446|NCT01820585|83323542|FG002|Overall Study|Lost to Follow-up|0|||
47053447|NCT01820585|83323543|FG003|Overall Study|Lost to Follow-up|3|||
47053448|NCT01820585|83323540|FG000|Overall Study|Protocol Violation|3|||
47053449|NCT01820585|83323541|FG001|Overall Study|Protocol Violation|1|||
47053450|NCT01820585|83323542|FG002|Overall Study|Protocol Violation|1|||
47053451|NCT01820585|83323543|FG003|Overall Study|Protocol Violation|1|||
47053452|NCT01820585|83323540|FG000|Overall Study|Subject non-compliance|0|||
47053453|NCT01820585|83323541|FG001|Overall Study|Subject non-compliance|0|||
47053454|NCT01820585|83323542|FG002|Overall Study|Subject non-compliance|1|||
47053455|NCT01820585|83323543|FG003|Overall Study|Subject non-compliance|2|||
47053456|NCT01820585|83323540|FG000|Overall Study|at sponsor request|0|||
47053457|NCT01820585|83323541|FG001|Overall Study|at sponsor request|0|||
47053458|NCT01820585|83323542|FG002|Overall Study|at sponsor request|1|||
47053459|NCT01820585|83323543|FG003|Overall Study|at sponsor request|0|||
47053460|NCT01820585|83323540|FG000|Overall Study|Pregnancy|0|||
47053461|NCT01820585|83323541|FG001|Overall Study|Pregnancy|1|||
47053462|NCT01820585|83323542|FG002|Overall Study|Pregnancy|0|||
47053463|NCT01820585|83323543|FG003|Overall Study|Pregnancy|0|||
47053464|NCT01797263|83323555|FG000|Overall Study|Withdrawal by Subject|21|||
47053465|NCT01797263|83323556|FG001|Overall Study|Withdrawal by Subject|25|||
47053466|NCT01797263|83323555|FG000|Overall Study|Death|1|||
47053467|NCT01797263|83323556|FG001|Overall Study|Death|0|||
47053468|NCT01797263|83323555|FG000|Overall Study|Lost to Follow-up|15|||
47053469|NCT01797263|83323556|FG001|Overall Study|Lost to Follow-up|15|||
47053470|NCT01797185|83323611|FG000|Overall Study|Adverse Event|5|||
46752943|NCT02052778|82971165|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752944|NCT02052778|82971166|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752945|NCT02052778|82971167|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752946|NCT02052778|82971168|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752947|NCT02052778|82971169|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752948|NCT02052778|82971170|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752949|NCT02052778|82971171|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752950|NCT02052778|82971172|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752951|NCT02052778|82971173|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
46752952|NCT02052778|82971174|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
46752953|NCT02052778|82971175|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
46752954|NCT02052778|82971176|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752955|NCT02052778|82971177|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
46752956|NCT02052778|82971178|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
46752957|NCT02052778|82971179|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752958|NCT02052778|82971180|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752959|NCT02052778|82971181|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
46752960|NCT02052778|82971159|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752961|NCT02052778|82971160|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752962|NCT02052778|82971161|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752963|NCT02052778|82971162|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752964|NCT02052778|82971163|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752965|NCT02052778|82971164|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46807643|NCT00468585|83026726|FG002|Overall Study|Patient found to be ineligible|1|||
46807644|NCT00468585|83026727|FG003|Overall Study|Patient found to be ineligible|0|||
46807645|NCT00468585|83026724|FG000|Overall Study|Adverse Event|0|||
47053471|NCT01797185|83323612|FG001|Overall Study|Adverse Event|15|||
46807646|NCT00468585|83026725|FG001|Overall Study|Adverse Event|0|||
47053472|NCT01797185|83323613|FG002|Overall Study|Adverse Event|6|||
47053473|NCT01797185|83323611|FG000|Overall Study|Withdrawal by Subject|6|||
47053474|NCT01797185|83323612|FG001|Overall Study|Withdrawal by Subject|9|||
47053475|NCT01797185|83323613|FG002|Overall Study|Withdrawal by Subject|5|||
47053476|NCT01797185|83323611|FG000|Overall Study|Site terminated|8|||
47053477|NCT01797185|83323612|FG001|Overall Study|Site terminated|4|||
47053478|NCT01797185|83323613|FG002|Overall Study|Site terminated|0|||
46807647|NCT00468585|83026726|FG002|Overall Study|Adverse Event|1|||
47053479|NCT01797185|83323611|FG000|Overall Study|Lost to Follow-up|2|||
47053480|NCT01797185|83323612|FG001|Overall Study|Lost to Follow-up|6|||
47053481|NCT01797185|83323613|FG002|Overall Study|Lost to Follow-up|1|||
46752966|NCT02052778|82971165|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752967|NCT02052778|82971166|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46807648|NCT00468585|83026727|FG003|Overall Study|Adverse Event|0|||
46807649|NCT00468585|83026724|FG000|Overall Study|Withdrawal by Subject|0|||
46807650|NCT00468585|83026725|FG001|Overall Study|Withdrawal by Subject|0|||
46807651|NCT00468585|83026726|FG002|Overall Study|Withdrawal by Subject|2|||
46807652|NCT00468585|83026727|FG003|Overall Study|Withdrawal by Subject|1|||
46807653|NCT00450801|83026737|FG000|Overall Study|Death|1|||
46807654|NCT00458211|83026746|FG000|Overall Study|Lack of Efficacy|12|||
46807655|NCT00458211|83026746|FG000|Overall Study|Withdrawal by Subject|2|||
46807656|NCT00458211|83026746|FG000|Overall Study|Protocol Violation|2|||
46807657|NCT00450723|83026754|FG000|Overall Study|Physician Decision|5|||
46807658|NCT00467961|83026759|FG000|Overall Study|Technical Failures|5|||
46807659|NCT00467961|83026759|FG000|Overall Study|Disease Progression|2|||
46807660|NCT00457821|83026771|FG000|Part 2|Withdrawal by Subject|0|||
46807661|NCT00457821|83026772|FG001|Part 2|Withdrawal by Subject|0|||
46807662|NCT00457821|83026773|FG002|Part 2|Withdrawal by Subject|0|||
46807663|NCT00457821|83026774|FG003|Part 2|Withdrawal by Subject|0|||
46807664|NCT00457821|83026775|FG004|Part 2|Withdrawal by Subject|0|||
46807665|NCT00457821|83026776|FG005|Part 2|Withdrawal by Subject|0|||
46807666|NCT00457821|83026777|FG006|Part 2|Withdrawal by Subject|0|||
46752968|NCT02052778|82971167|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752969|NCT02052778|82971168|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752970|NCT02052778|82971169|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46807667|NCT00457821|83026778|FG007|Part 2|Withdrawal by Subject|1|||
46807668|NCT00633893|83026798|FG000|Overall Study|Death|1|||
46807669|NCT00633893|83026799|FG001|Overall Study|Death|3|||
46807670|NCT00633893|83026800|FG002|Overall Study|Death|9|||
46807671|NCT00633893|83026798|FG000|Overall Study|Adverse Event|65|||
46807672|NCT00633893|83026799|FG001|Overall Study|Adverse Event|58|||
46807673|NCT00633893|83026800|FG002|Overall Study|Adverse Event|126|||
46807674|NCT00633893|83026798|FG000|Overall Study|Withdrawal by Subject|7|||
46807675|NCT00633893|83026799|FG001|Overall Study|Withdrawal by Subject|12|||
46807676|NCT00633893|83026800|FG002|Overall Study|Withdrawal by Subject|6|||
46807677|NCT00633893|83026798|FG000|Overall Study|Lost to Follow-up|2|||
46807678|NCT00633893|83026799|FG001|Overall Study|Lost to Follow-up|4|||
46807679|NCT00633893|83026800|FG002|Overall Study|Lost to Follow-up|8|||
46807680|NCT00633893|83026798|FG000|Overall Study|Poor/non-compliance|5|||
46807681|NCT00633893|83026799|FG001|Overall Study|Poor/non-compliance|12|||
46807682|NCT00633893|83026800|FG002|Overall Study|Poor/non-compliance|3|||
46807683|NCT00633893|83026798|FG000|Overall Study|Pregnancy|2|||
46807684|NCT00633893|83026799|FG001|Overall Study|Pregnancy|1|||
46807685|NCT00633893|83026800|FG002|Overall Study|Pregnancy|1|||
46807686|NCT00633893|83026798|FG000|Overall Study|Not meet/no longer meets criteria|4|||
46807687|NCT00633893|83026799|FG001|Overall Study|Not meet/no longer meets criteria|6|||
46807688|NCT00633893|83026800|FG002|Overall Study|Not meet/no longer meets criteria|4|||
46807689|NCT00633893|83026798|FG000|Overall Study|Other|28|||
46807690|NCT00633893|83026799|FG001|Overall Study|Other|33|||
46807691|NCT00633893|83026800|FG002|Overall Study|Other|31|||
46807692|NCT00457743|83026811|FG000|Overall Study|Adverse Event|0|||
46807693|NCT00457743|83026812|FG001|Overall Study|Adverse Event|4|||
46807694|NCT00457743|83026813|FG002|Overall Study|Adverse Event|0|||
46807695|NCT00457743|83026811|FG000|Overall Study|Lack of Efficacy|3|||
46807696|NCT00457743|83026812|FG001|Overall Study|Lack of Efficacy|23|||
46752971|NCT02052778|82971170|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752972|NCT02052778|82971171|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46807697|NCT00457743|83026813|FG002|Overall Study|Lack of Efficacy|3|||
46807698|NCT00450411|83026822|FG000|Overall Study|Protocol Violation|6|||
46807699|NCT00450411|83026822|FG000|Overall Study|No protocol treatment|2|||
46807700|NCT00644969|83026828|FG000|Treatment Phase|Randomized, not treated|1|||
46807701|NCT00644969|83026829|FG001|Treatment Phase|Randomized, not treated|0|||
46807702|NCT00644969|83026828|FG000|Treatment Phase|Adverse Event|3|||
46807703|NCT00644969|83026829|FG001|Treatment Phase|Adverse Event|0|||
46807704|NCT00644969|83026828|FG000|Treatment Phase|Withdrawal by Subject|4|||
46807705|NCT00644969|83026829|FG001|Treatment Phase|Withdrawal by Subject|0|||
46807706|NCT00644969|83026828|FG000|Treatment Phase|Lost to Follow-up|2|||
46807707|NCT00644969|83026829|FG001|Treatment Phase|Lost to Follow-up|2|||
46807708|NCT00644969|83026828|FG000|Treatment Phase|Other|4|||
46807709|NCT00644969|83026829|FG001|Treatment Phase|Other|1|||
46807710|NCT00644969|83026828|FG000|Post Treatment Phase|Death|1|||
46807711|NCT00644969|83026829|FG001|Post Treatment Phase|Death|0|||
46807712|NCT00644969|83026828|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
46807713|NCT00644969|83026829|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
47053482|NCT01797185|83323611|FG000|Overall Study|Withdrawn per sponsor|5|||
46807714|NCT00644969|83026828|FG000|Post Treatment Phase|Lost to Follow-up|4|||
46807715|NCT00644969|83026829|FG001|Post Treatment Phase|Lost to Follow-up|1|||
46807716|NCT00644969|83026828|FG000|Post Treatment Phase|Other|1|||
46807717|NCT00644969|83026829|FG001|Post Treatment Phase|Other|0|||
46807718|NCT00644423|83026837|FG000|Overall Study|Lost to Follow-up|1|||
46807719|NCT00644423|83026838|FG001|Overall Study|Lost to Follow-up|1|||
46807720|NCT00628355|83026846|FG000|Overall Study|Withdrawal by Subject|1|||
46807721|NCT00628355|83026847|FG001|Overall Study|Withdrawal by Subject|1|||
46807722|NCT00627497|83026858|FG000|Overall Study|Lost to Follow-up|1|||
46807723|NCT00627497|83026859|FG001|Overall Study|Lost to Follow-up|1|||
46807724|NCT00627497|83026860|FG002|Overall Study|Lost to Follow-up|0|||
46807725|NCT00627497|83026861|FG003|Overall Study|Lost to Follow-up|0|||
46807726|NCT00648167|83026871|FG000|Overall Study|Adverse Event|6|||
46807727|NCT00648167|83026871|FG000|Overall Study|unable to swallow tablets|1|||
46807728|NCT00647699|83026905|FG000|Overall Study|Lost to Follow-up|5|||
46807729|NCT00647699|83026906|FG001|Overall Study|Lost to Follow-up|4|||
46807730|NCT00647699|83026905|FG000|Overall Study|Withdrawal by Subject|3|||
46807731|NCT00647699|83026906|FG001|Overall Study|Withdrawal by Subject|8|||
46807732|NCT00467649|83026914|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
46807733|NCT00467649|83026915|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
46807734|NCT00467649|83026916|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
46807735|NCT00467649|83026917|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
46807736|NCT00467649|83026918|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
46807737|NCT00467649|83026919|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
46807738|NCT00467649|83026914|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
46807739|NCT00467649|83026915|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
46807740|NCT00467649|83026916|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
46807741|NCT00467649|83026917|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
46807742|NCT00467649|83026918|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
46807743|NCT00467649|83026919|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
46807744|NCT00467649|83026914|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
46807745|NCT00467649|83026915|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
46807746|NCT00467649|83026916|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
46807747|NCT00467649|83026917|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
46807748|NCT00467649|83026918|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
46807749|NCT00467649|83026919|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
46807750|NCT00467649|83026914|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
46807751|NCT00467649|83026915|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
46807752|NCT00467649|83026916|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
46807753|NCT00467649|83026917|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
46807754|NCT00467649|83026918|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
46807755|NCT00467649|83026919|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
46807756|NCT00467649|83026914|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
46807757|NCT00467649|83026915|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
46807758|NCT00467649|83026916|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
46807759|NCT00467649|83026917|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
46807760|NCT00467649|83026918|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
46807761|NCT00467649|83026919|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
46807762|NCT00467649|83026914|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
46807763|NCT00467649|83026915|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
46807764|NCT00467649|83026916|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
46807765|NCT00467649|83026917|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
46807766|NCT00467649|83026918|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
46807767|NCT00467649|83026919|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
46807768|NCT00467649|83026914|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
46807769|NCT00467649|83026915|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
46807770|NCT00467649|83026916|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
46807771|NCT00467649|83026917|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
46807772|NCT00467649|83026918|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
46807773|NCT00467649|83026919|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
47053483|NCT01797185|83323612|FG001|Overall Study|Withdrawn per sponsor|0|||
47053484|NCT01797185|83323613|FG002|Overall Study|Withdrawn per sponsor|0|||
47053485|NCT01797185|83323611|FG000|Overall Study|Physician Decision|1|||
47053486|NCT01797185|83323612|FG001|Overall Study|Physician Decision|3|||
46636254|NCT01517178|82810096|FG000|Period 1|Lack of Efficacy|0|||
47053487|NCT01797185|83323613|FG002|Overall Study|Physician Decision|0|||
47053488|NCT01797185|83323611|FG000|Overall Study|Protocol Violation|1|||
46636255|NCT01517178|82810097|FG001|Period 1|Lack of Efficacy|1|||
46636256|NCT01517178|82810096|FG000|Period 1|E.g. study termination|3|||
46636257|NCT01517178|82810097|FG001|Period 1|E.g. study termination|1|||
46636258|NCT01517178|82810096|FG000|Period 1|Withdrawal by Subject|0|||
46807774|NCT00450333|83026941|FG000|Overall Study|Study terminated|47|||
46807775|NCT00450333|83026942|FG001|Overall Study|Study terminated|54|||
46807776|NCT00450333|83026943|FG002|Overall Study|Study terminated|16|||
46807777|NCT00450333|83026944|FG003|Overall Study|Study terminated|21|||
46807778|NCT00450333|83026941|FG000|Overall Study|Adverse Event|1|||
46807779|NCT00450333|83026942|FG001|Overall Study|Adverse Event|7|||
46807780|NCT00450333|83026943|FG002|Overall Study|Adverse Event|2|||
46807781|NCT00450333|83026944|FG003|Overall Study|Adverse Event|2|||
46807782|NCT00450333|83026941|FG000|Overall Study|Protocol Violation|1|||
46807783|NCT00450333|83026942|FG001|Overall Study|Protocol Violation|0|||
46807784|NCT00450333|83026943|FG002|Overall Study|Protocol Violation|1|||
46807785|NCT00450333|83026944|FG003|Overall Study|Protocol Violation|0|||
46807786|NCT00450333|83026941|FG000|Overall Study|Withdrawal by Subject|1|||
46807787|NCT00450333|83026942|FG001|Overall Study|Withdrawal by Subject|0|||
46807788|NCT00450333|83026943|FG002|Overall Study|Withdrawal by Subject|3|||
46807789|NCT00450333|83026944|FG003|Overall Study|Withdrawal by Subject|0|||
46807790|NCT00450333|83026941|FG000|Overall Study|Kidney transplant|1|||
46807791|NCT00450333|83026942|FG001|Overall Study|Kidney transplant|0|||
46807792|NCT00450333|83026943|FG002|Overall Study|Kidney transplant|1|||
46807793|NCT00450333|83026944|FG003|Overall Study|Kidney transplant|3|||
46807794|NCT00450333|83026941|FG000|Overall Study|Death|3|||
46807795|NCT00450333|83026942|FG001|Overall Study|Death|2|||
46807796|NCT00450333|83026943|FG002|Overall Study|Death|2|||
46807797|NCT00450333|83026944|FG003|Overall Study|Death|2|||
46807798|NCT00643565|83026956|FG000|Overall Study|Death|12|||
46807799|NCT00643565|83026957|FG001|Overall Study|Death|11|||
46807800|NCT00643565|83026956|FG000|Overall Study|Withdrawal by Subject|4|||
46807801|NCT00643565|83026957|FG001|Overall Study|Withdrawal by Subject|1|||
46807802|NCT00643565|83026956|FG000|Overall Study|Lost to Follow-up|0|||
46807803|NCT00643565|83026957|FG001|Overall Study|Lost to Follow-up|6|||
46807804|NCT00643565|83026956|FG000|Overall Study|Other|7|||
46807805|NCT00643565|83026957|FG001|Overall Study|Other|8|||
46807806|NCT00643565|83026956|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
46807807|NCT00643565|83026957|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
46807808|NCT00643565|83026956|FG000|Overall Study|Recurrence of Disease|2|||
46807809|NCT00643565|83026957|FG001|Overall Study|Recurrence of Disease|1|||
46807810|NCT00643565|83026956|FG000|Overall Study|Progression of Disease|18|||
46807811|NCT00643565|83026957|FG001|Overall Study|Progression of Disease|14|||
46807812|NCT00643565|83026956|FG000|Overall Study|Protocol Violation|3|||
46807813|NCT00643565|83026957|FG001|Overall Study|Protocol Violation|0|||
46807814|NCT00643565|83026956|FG000|Overall Study|Did Not Cooperate|0|||
46807815|NCT00643565|83026957|FG001|Overall Study|Did Not Cooperate|1|||
46807816|NCT00643565|83026956|FG000|Overall Study|Administrative|22|||
46807817|NCT00643565|83026957|FG001|Overall Study|Administrative|16|||
46807818|NCT00643565|83026956|FG000|Overall Study|Adverse Event|5|||
46807819|NCT00643565|83026957|FG001|Overall Study|Adverse Event|8|||
46807820|NCT00643487|83026964|FG000|Overall Study|Technical difficulty|3|||
46807821|NCT00450255|83026968|FG000|Overall Study|Prior RFA ablation of liver|1|||
46807822|NCT00450177|83026975|FG000|Overall Study|Adverse Event|7|||
46807823|NCT00450177|83026976|FG001|Overall Study|Adverse Event|4|||
46807824|NCT00450177|83026975|FG000|Overall Study|Withdrawal by Subject|1|||
46807825|NCT00450177|83026976|FG001|Overall Study|Withdrawal by Subject|6|||
46807826|NCT00450177|83026975|FG000|Overall Study|Withdrawal by Primary Team|1|||
46807827|NCT00450177|83026976|FG001|Overall Study|Withdrawal by Primary Team|1|||
46925987|NCT02831764|83160395|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
46925988|NCT02831764|83160396|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
46925989|NCT02831764|83160397|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
46925990|NCT02831764|83160398|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
46925991|NCT02831764|83160394|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
46925992|NCT02831764|83160395|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
47053489|NCT01797185|83323612|FG001|Overall Study|Protocol Violation|1|||
47053490|NCT01797185|83323613|FG002|Overall Study|Protocol Violation|0|||
47053491|NCT01819727|83323669|FG000|Overall Study|Adverse Event|8|||
46807828|NCT03848949|83026984|FG000|Overall Study|Lost to Follow-up|5|||
46807829|NCT03848949|83026985|FG001|Overall Study|Lost to Follow-up|7|||
46807830|NCT00467259|83026993|FG000|Overall Study|Adverse Event|24|||
46807831|NCT00467259|83026994|FG001|Overall Study|Adverse Event|90|||
46807832|NCT00467259|83026993|FG000|Overall Study|Protocol Violation|1|||
46807833|NCT00467259|83026994|FG001|Overall Study|Protocol Violation|7|||
46807834|NCT00467259|83026993|FG000|Overall Study|Withdrawal by Subject|34|||
46807835|NCT00467259|83026994|FG001|Overall Study|Withdrawal by Subject|108|||
46807836|NCT00467259|83026993|FG000|Overall Study|Physician Decision|0|||
46807837|NCT00467259|83026994|FG001|Overall Study|Physician Decision|2|||
46807838|NCT00467259|83026993|FG000|Overall Study|Lost to Follow-up|14|||
46807839|NCT00467259|83026994|FG001|Overall Study|Lost to Follow-up|34|||
46807840|NCT00467259|83026993|FG000|Overall Study|Site Closed|2|||
46807841|NCT00467259|83026994|FG001|Overall Study|Site Closed|1|||
46807842|NCT00449865|83027002|FG000|Overall Study|Withdrawal by Subject|110|||
47053492|NCT01819727|83323670|FG001|Overall Study|Adverse Event|9|||
46807843|NCT00449865|83027003|FG001|Overall Study|Withdrawal by Subject|110|||
46807844|NCT00449865|83027002|FG000|Overall Study|Lost to Follow-up|36|||
46807845|NCT00449865|83027003|FG001|Overall Study|Lost to Follow-up|37|||
46807846|NCT00449865|83027002|FG000|Overall Study|Physician Decision|13|||
46807847|NCT00449865|83027003|FG001|Overall Study|Physician Decision|12|||
46807848|NCT00449865|83027002|FG000|Overall Study|Death|31|||
46807849|NCT00449865|83027003|FG001|Overall Study|Death|40|||
46807850|NCT00449865|83027002|FG000|Overall Study|Protocol Violation|8|||
46807851|NCT00449865|83027003|FG001|Overall Study|Protocol Violation|7|||
46807852|NCT00449865|83027002|FG000|Overall Study|Study was stopped|324|||
46807853|NCT00449865|83027003|FG001|Overall Study|Study was stopped|328|||
46807854|NCT00449787|83027011|FG000|Overall Study|Lost to Follow-up|10|||
46807855|NCT00449787|83027012|FG001|Overall Study|Lost to Follow-up|8|||
46807856|NCT00449787|83027011|FG000|Overall Study|Did not require medication|95|||
46807857|NCT00449787|83027012|FG001|Overall Study|Did not require medication|92|||
46807858|NCT00449163|83027020|FG000|Overall Study|Physician Decision|3|||
46807859|NCT00448539|83027026|FG000|Overall Study|Medication non-compliance|4|||
46807860|NCT00448539|83027027|FG001|Overall Study|Medication non-compliance|1|||
46807861|NCT00448539|83027026|FG000|Overall Study|Protocol Violation|1|||
46807862|NCT00448539|83027027|FG001|Overall Study|Protocol Violation|0|||
46925993|NCT02831764|83160396|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
46925994|NCT02831764|83160397|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
46925995|NCT02831764|83160398|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
46925996|NCT02831764|83160394|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
46925997|NCT02831764|83160395|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
47053493|NCT01819727|83323669|FG000|Overall Study|Death|1|||
47053494|NCT01819727|83323670|FG001|Overall Study|Death|0|||
47053495|NCT01819727|83323669|FG000|Overall Study|Lost to Follow-up|1|||
46925998|NCT02831764|83160396|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
46925999|NCT02831764|83160397|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
46926000|NCT02831764|83160398|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
46926001|NCT02831764|83160394|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46926002|NCT02831764|83160395|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46926003|NCT02831764|83160396|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46926004|NCT02831764|83160397|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46926005|NCT02831764|83160398|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
46926006|NCT02831764|83160394|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46926007|NCT02831764|83160395|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46926008|NCT02831764|83160396|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46926009|NCT02831764|83160397|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46926010|NCT02831764|83160398|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
46636259|NCT01517178|82810097|FG001|Period 1|Withdrawal by Subject|1|||
46636260|NCT01517178|82810096|FG000|Period 2|Adverse Event|1|||
46926011|NCT02831764|83160394|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46926012|NCT02831764|83160395|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46926013|NCT02831764|83160396|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46926014|NCT02831764|83160397|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46926015|NCT02831764|83160398|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
46926016|NCT02831764|83160394|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
46926017|NCT02831764|83160395|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
47053496|NCT01819727|83323670|FG001|Overall Study|Lost to Follow-up|1|||
47053497|NCT01819727|83323669|FG000|Overall Study|Physician Decision|3|||
47053498|NCT01819727|83323670|FG001|Overall Study|Physician Decision|2|||
46636261|NCT01517178|82810097|FG001|Period 2|Adverse Event|0|||
46752973|NCT02052778|82971172|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752974|NCT02052778|82971173|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
46752975|NCT02052778|82971174|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
46752976|NCT02052778|82971175|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752977|NCT02052778|82971176|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752978|NCT02052778|82971177|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752979|NCT02052778|82971178|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46752980|NCT02052778|82971179|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46636262|NCT01517178|82810096|FG000|Period 2|Withdrawal by Subject|3|||
46807863|NCT00448539|83027026|FG000|Overall Study|Request of the investigator or sponsor|67|||
47053499|NCT01819727|83323669|FG000|Overall Study|Pregnancy|1|||
47053500|NCT01819727|83323670|FG001|Overall Study|Pregnancy|0|||
47053501|NCT01819727|83323669|FG000|Overall Study|Protocol Violation|0|||
47053502|NCT01819727|83323670|FG001|Overall Study|Protocol Violation|2|||
46636263|NCT01517178|82810097|FG001|Period 2|Withdrawal by Subject|0|||
46807864|NCT00448539|83027027|FG001|Overall Study|Request of the investigator or sponsor|54|||
46926018|NCT02831764|83160396|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
46926019|NCT02831764|83160397|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
46926020|NCT02831764|83160398|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
46926021|NCT02396199|83160407|FG000|Overall Study|Lost to Follow-up|1|||
46926022|NCT02396199|83160407|FG000|Overall Study|Death|4|||
46926023|NCT01661881|83160420|FG000|Overall Study|Disease Progression|1|||
46926024|NCT01353313|83160426|FG000|Overall Study|Lost to Follow-up|22|||
46926025|NCT01353313|83160427|FG001|Overall Study|Lost to Follow-up|23|||
46926026|NCT01353313|83160426|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
46926027|NCT01353313|83160427|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
46926028|NCT02764320|83160435|FG000|Overall Study|Withdrawal by Subject|35|||
46752981|NCT02052778|82971180|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46926029|NCT02764320|83160436|FG001|Overall Study|Withdrawal by Subject|38|||
46926030|NCT02764320|83160435|FG000|Overall Study|Protocol Violation|11|||
46926031|NCT02764320|83160436|FG001|Overall Study|Protocol Violation|6|||
46926032|NCT02764320|83160435|FG000|Overall Study|Adverse Event|2|||
46926033|NCT02764320|83160436|FG001|Overall Study|Adverse Event|0|||
46752982|NCT02052778|82971181|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
46926034|NCT02764320|83160435|FG000|Overall Study|Health Issues unable to continue|2|||
46926035|NCT02764320|83160436|FG001|Overall Study|Health Issues unable to continue|0|||
46926036|NCT02764320|83160435|FG000|Overall Study|Did not meet inclusion criteria|1|||
46926037|NCT02764320|83160436|FG001|Overall Study|Did not meet inclusion criteria|0|||
46926038|NCT02764320|83160435|FG000|Overall Study|Subject moved|0|||
46926039|NCT02764320|83160436|FG001|Overall Study|Subject moved|2|||
46926040|NCT02764320|83160435|FG000|Overall Study|Overused medication unavailable|0|||
46926041|NCT02764320|83160436|FG001|Overall Study|Overused medication unavailable|1|||
46926042|NCT02764320|83160435|FG000|Overall Study|Seeking care outside site|0|||
46926043|NCT02764320|83160436|FG001|Overall Study|Seeking care outside site|1|||
46926044|NCT02764320|83160435|FG000|Overall Study|Technology barriers|0|||
46926045|NCT02764320|83160436|FG001|Overall Study|Technology barriers|1|||
46926046|NCT02851407|83160444|FG000|Overall Study|Withdrawal by parent/guardian|2|||
46926047|NCT02851407|83160445|FG001|Overall Study|Withdrawal by parent/guardian|7|||
46926048|NCT02851407|83160444|FG000|Overall Study|Protocol deviation|0|||
46926049|NCT02851407|83160445|FG001|Overall Study|Protocol deviation|1|||
46926050|NCT02851407|83160444|FG000|Overall Study|Transferred to another hospital to continue|1|||
46926051|NCT02851407|83160445|FG001|Overall Study|Transferred to another hospital to continue|0|||
46926052|NCT02851407|83160444|FG000|Overall Study|Other Death|30|||
46926053|NCT02851407|83160445|FG001|Overall Study|Other Death|20|||
46926054|NCT02851407|83160444|FG000|Overall Study|Adverse event, serious fatal|6|||
46926055|NCT02851407|83160445|FG001|Overall Study|Adverse event, serious fatal|8|||
46926056|NCT02851407|83160444|FG000|Overall Study|Consent withdrawn by participant|5|||
46926057|NCT02851407|83160445|FG001|Overall Study|Consent withdrawn by participant|3|||
46926058|NCT02851407|83160444|FG000|Overall Study|Screen failure|2|||
46926059|NCT02851407|83160445|FG001|Overall Study|Screen failure|1|||
46926060|NCT02851407|83160444|FG000|Overall Study|Disease relapse|9|||
46926061|NCT02851407|83160445|FG001|Overall Study|Disease relapse|6|||
46926062|NCT02851407|83160444|FG000|Overall Study|Physician Decision|7|||
46926063|NCT02851407|83160445|FG001|Overall Study|Physician Decision|6|||
46926064|NCT02851407|83160444|FG000|Overall Study|Transferred to hospital closer to home|0|||
46926065|NCT02851407|83160445|FG001|Overall Study|Transferred to hospital closer to home|1|||
46926066|NCT02851407|83160444|FG000|Overall Study|Enrolled in an investigational study|0|||
46926067|NCT02851407|83160445|FG001|Overall Study|Enrolled in an investigational study|1|||
46752983|NCT02052778|82971159|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752984|NCT02052778|82971160|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752985|NCT02052778|82971161|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752986|NCT02052778|82971162|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752987|NCT02052778|82971163|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752988|NCT02052778|82971164|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752989|NCT02052778|82971165|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752990|NCT02052778|82971166|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46926068|NCT02851407|83160444|FG000|Overall Study|Early recovery|1|||
46926069|NCT02851407|83160445|FG001|Overall Study|Early recovery|0|||
46926070|NCT02851407|83160444|FG000|Overall Study|Adverse event, non-fatal|7|||
46926071|NCT02851407|83160445|FG001|Overall Study|Adverse event, non-fatal|5|||
46926072|NCT02851407|83160444|FG000|Overall Study|Lost to Follow-up|0|||
46926073|NCT02851407|83160445|FG001|Overall Study|Lost to Follow-up|2|||
46926074|NCT02636608|83160451|FG000|Overall Study|Failure to Return|4|||
46926075|NCT02636608|83160451|FG000|Overall Study|Insufficient Virological Response|1|||
46926076|NCT02636608|83160451|FG000|Overall Study|Death|3|||
46926077|NCT02636608|83160451|FG000|Overall Study|Other|2|||
46926078|NCT02636608|83160451|FG000|Overall Study|Did Not Receive Treatment|1|||
46926079|NCT02759562|83160460|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
46926080|NCT02759562|83160461|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
46807865|NCT00448539|83027026|FG000|Overall Study|Withdrawal by Subject|20|||
46807866|NCT00448539|83027027|FG001|Overall Study|Withdrawal by Subject|24|||
46807867|NCT00448539|83027026|FG000|Overall Study|Diary non-compliance|1|||
46807868|NCT00448539|83027027|FG001|Overall Study|Diary non-compliance|0|||
46807869|NCT00448539|83027026|FG000|Overall Study|Adverse Event|9|||
46807870|NCT00448539|83027027|FG001|Overall Study|Adverse Event|26|||
46807871|NCT00448539|83027026|FG000|Overall Study|Lack of Efficacy|27|||
46807872|NCT00448539|83027027|FG001|Overall Study|Lack of Efficacy|40|||
46807873|NCT00448539|83027026|FG000|Overall Study|Miscellaneous|2|||
46807874|NCT00448539|83027027|FG001|Overall Study|Miscellaneous|1|||
46807875|NCT00448539|83027026|FG000|Overall Study|Change of meds|2|||
46807876|NCT00448539|83027027|FG001|Overall Study|Change of meds|3|||
46926081|NCT02759562|83160460|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
47053503|NCT01819727|83323669|FG000|Overall Study|Study Terminated by Sponsor|0|||
47053504|NCT01819727|83323670|FG001|Overall Study|Study Terminated by Sponsor|1|||
47053505|NCT01819727|83323669|FG000|Overall Study|Withdrawal by Subject|6|||
47053506|NCT01819727|83323670|FG001|Overall Study|Withdrawal by Subject|11|||
46807877|NCT00448539|83027026|FG000|Overall Study|Lost to Follow-up|1|||
46807878|NCT00448539|83027027|FG001|Overall Study|Lost to Follow-up|3|||
46807879|NCT00457665|83027035|FG000|12 Months|Drug allergy|1|||
46807880|NCT00457665|83027036|FG001|12 Months|Drug allergy|1|||
46807881|NCT00457665|83027035|FG000|12 Months|High HIV viral load|5|||
46807882|NCT00457665|83027036|FG001|12 Months|High HIV viral load|1|||
46807883|NCT00457665|83027035|FG000|12 Months|Lipodystrophy|2|||
46807884|NCT00457665|83027036|FG001|12 Months|Lipodystrophy|0|||
46807885|NCT00457665|83027035|FG000|12 Months|Withdrawal by Subject|0|||
46807886|NCT00457665|83027036|FG001|12 Months|Withdrawal by Subject|2|||
46807887|NCT00457665|83027035|FG000|12 Months|Abnormal Liver function tests|0|||
46807888|NCT00457665|83027036|FG001|12 Months|Abnormal Liver function tests|5|||
46807889|NCT00457665|83027035|FG000|24 Months|Withdrawal by Subject|3|||
46807890|NCT00457665|83027036|FG001|24 Months|Withdrawal by Subject|2|||
46807891|NCT00457665|83027035|FG000|24 Months|Lipodystrophy|1|||
46807892|NCT00457665|83027036|FG001|24 Months|Lipodystrophy|1|||
46807893|NCT00457665|83027035|FG000|24 Months|Abnormal liver function tests|1|||
46807894|NCT00457665|83027036|FG001|24 Months|Abnormal liver function tests|5|||
46807895|NCT00447603|83027042|FG000|Screening|Withdrawal by Subject|1|||
46807896|NCT00447603|83027043|FG001|Screening|Withdrawal by Subject|0|||
46807897|NCT00447603|83027044|FG002|Screening|Withdrawal by Subject|0|||
47053507|NCT01819727|83323669|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
47053508|NCT01819727|83323670|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
47053509|NCT01819727|83323669|FG000|Overall Study|Quit due to lack of health benifits|0|||
47053510|NCT01819727|83323670|FG001|Overall Study|Quit due to lack of health benifits|1|||
46807898|NCT00447603|83027042|FG000|Screening|Protocol Violation|1|||
46807899|NCT00447603|83027043|FG001|Screening|Protocol Violation|0|||
46807900|NCT00447603|83027044|FG002|Screening|Protocol Violation|0|||
46807901|NCT00447603|83027042|FG000|Screening|Screen Failure|4|||
46807902|NCT00447603|83027043|FG001|Screening|Screen Failure|0|||
46807903|NCT00447603|83027044|FG002|Screening|Screen Failure|0|||
46807904|NCT00447603|83027042|FG000|Screening|Study Terminated by Sponsor|15|||
46807905|NCT00447603|83027043|FG001|Screening|Study Terminated by Sponsor|0|||
46807906|NCT00447603|83027044|FG002|Screening|Study Terminated by Sponsor|0|||
46807907|NCT00447603|83027042|FG000|Filter Period|Adverse Event|0|||
46807908|NCT00447603|83027043|FG001|Filter Period|Adverse Event|0|||
46807909|NCT00447603|83027044|FG002|Filter Period|Adverse Event|1|||
46807910|NCT00447603|83027042|FG000|Filter Period|Screen Failure|0|||
46807911|NCT00447603|83027043|FG001|Filter Period|Screen Failure|3|||
46807912|NCT00447603|83027044|FG002|Filter Period|Screen Failure|4|||
46807913|NCT00447603|83027042|FG000|Filter Period|Study terminated by Sponsor|0|||
46807914|NCT00447603|83027043|FG001|Filter Period|Study terminated by Sponsor|1|||
46807915|NCT00447603|83027044|FG002|Filter Period|Study terminated by Sponsor|10|||
46807916|NCT00447057|83027056|FG000|Overall Study|Adverse Event|4|||
46807917|NCT00447057|83027057|FG001|Overall Study|Adverse Event|10|||
46807918|NCT00447057|83027058|FG002|Overall Study|Adverse Event|0|||
46807919|NCT00447057|83027059|FG003|Overall Study|Adverse Event|3|||
46807920|NCT00447057|83027056|FG000|Overall Study|Death due to study disease|6|||
46807921|NCT00447057|83027057|FG001|Overall Study|Death due to study disease|4|||
46807922|NCT00447057|83027058|FG002|Overall Study|Death due to study disease|1|||
46807923|NCT00447057|83027059|FG003|Overall Study|Death due to study disease|1|||
46807924|NCT00447057|83027056|FG000|Overall Study|Lost to Follow-up|0|||
46807925|NCT00447057|83027057|FG001|Overall Study|Lost to Follow-up|1|||
46807926|NCT00447057|83027058|FG002|Overall Study|Lost to Follow-up|0|||
46807927|NCT00447057|83027059|FG003|Overall Study|Lost to Follow-up|0|||
46807928|NCT00447057|83027056|FG000|Overall Study|Entry criteria not met|1|||
46807929|NCT00447057|83027057|FG001|Overall Study|Entry criteria not met|1|||
46807930|NCT00447057|83027058|FG002|Overall Study|Entry criteria not met|0|||
46807931|NCT00447057|83027059|FG003|Overall Study|Entry criteria not met|0|||
46807932|NCT00447057|83027056|FG000|Overall Study|Protocol Violation|0|||
46807933|NCT00447057|83027057|FG001|Overall Study|Protocol Violation|1|||
46807934|NCT00447057|83027058|FG002|Overall Study|Protocol Violation|0|||
46807935|NCT00447057|83027059|FG003|Overall Study|Protocol Violation|0|||
46807936|NCT00447057|83027056|FG000|Overall Study|Withdrawal by Subject|4|||
46807937|NCT00447057|83027057|FG001|Overall Study|Withdrawal by Subject|5|||
46807938|NCT00447057|83027058|FG002|Overall Study|Withdrawal by Subject|1|||
46807939|NCT00447057|83027059|FG003|Overall Study|Withdrawal by Subject|1|||
46807940|NCT00447057|83027056|FG000|Overall Study|Physician Decision|9|||
46807941|NCT00447057|83027057|FG001|Overall Study|Physician Decision|6|||
46807942|NCT00447057|83027058|FG002|Overall Study|Physician Decision|3|||
46807943|NCT00447057|83027059|FG003|Overall Study|Physician Decision|1|||
46752991|NCT02052778|82971167|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752992|NCT02052778|82971168|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46807944|NCT00447057|83027056|FG000|Overall Study|Sponsor decision|1|||
46807945|NCT00447057|83027057|FG001|Overall Study|Sponsor decision|1|||
46807946|NCT00447057|83027058|FG002|Overall Study|Sponsor decision|0|||
46807947|NCT00447057|83027059|FG003|Overall Study|Sponsor decision|0|||
46807948|NCT00447057|83027056|FG000|Overall Study|Progressive disease|58|||
46807949|NCT00447057|83027057|FG001|Overall Study|Progressive disease|43|||
46807950|NCT00447057|83027058|FG002|Overall Study|Progressive disease|13|||
46807951|NCT00447057|83027059|FG003|Overall Study|Progressive disease|18|||
46807952|NCT00447057|83027056|FG000|Overall Study|Death due to adverse event|0|||
46807953|NCT00447057|83027057|FG001|Overall Study|Death due to adverse event|0|||
46807954|NCT00447057|83027058|FG002|Overall Study|Death due to adverse event|1|||
46807955|NCT00447057|83027059|FG003|Overall Study|Death due to adverse event|2|||
46807956|NCT00447057|83027056|FG000|Overall Study|Death, study drug related|0|||
46807957|NCT00447057|83027057|FG001|Overall Study|Death, study drug related|1|||
46752993|NCT02052778|82971169|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752994|NCT02052778|82971170|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752995|NCT02052778|82971171|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46807958|NCT00447057|83027058|FG002|Overall Study|Death, study drug related|0|||
46807959|NCT00447057|83027059|FG003|Overall Study|Death, study drug related|0|||
47053511|NCT01795937|83323729|FG000|Overall Study|Withdrawal by Subject|1|||
47053512|NCT01795937|83323730|FG001|Overall Study|Withdrawal by Subject|0|||
47053513|NCT01795937|83323731|FG002|Overall Study|Withdrawal by Subject|0|||
47053514|NCT01795937|83323729|FG000|Overall Study|Physician Decision|0|||
47053515|NCT01795937|83323730|FG001|Overall Study|Physician Decision|1|||
47053516|NCT01795937|83323731|FG002|Overall Study|Physician Decision|0|||
46752996|NCT02052778|82971172|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46752997|NCT02052778|82971173|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
46752998|NCT02052778|82971174|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
46752999|NCT02052778|82971175|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46753000|NCT02052778|82971176|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46753001|NCT02052778|82971177|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46807960|NCT00446511|83027071|FG000|Overall Study|Adverse Event|7|||
46807961|NCT00446511|83027072|FG001|Overall Study|Adverse Event|2|||
46807962|NCT00446511|83027073|FG002|Overall Study|Adverse Event|3|||
46807963|NCT00446511|83027074|FG003|Overall Study|Adverse Event|1|||
46807964|NCT00446511|83027071|FG000|Overall Study|Protocol Violation|0|||
47053517|NCT01817777|83323773|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
46807965|NCT00446511|83027072|FG001|Overall Study|Protocol Violation|0|||
46807966|NCT00446511|83027073|FG002|Overall Study|Protocol Violation|0|||
46807967|NCT00446511|83027074|FG003|Overall Study|Protocol Violation|1|||
46807968|NCT00446511|83027071|FG000|Overall Study|Withdrawal by Subject|0|||
46807969|NCT00446511|83027072|FG001|Overall Study|Withdrawal by Subject|0|||
46807970|NCT00446511|83027073|FG002|Overall Study|Withdrawal by Subject|0|||
46807971|NCT00446511|83027074|FG003|Overall Study|Withdrawal by Subject|3|||
46807972|NCT00446511|83027071|FG000|Overall Study|Administrative Problems|3|||
46807973|NCT00446511|83027072|FG001|Overall Study|Administrative Problems|0|||
46807974|NCT00446511|83027073|FG002|Overall Study|Administrative Problems|4|||
46807975|NCT00446511|83027074|FG003|Overall Study|Administrative Problems|1|||
46807976|NCT00446199|83027090|FG000|Overall Study|Adverse Event|7|||
46807977|NCT00446199|83027091|FG001|Overall Study|Adverse Event|4|||
46807978|NCT00446199|83027092|FG002|Overall Study|Adverse Event|6|||
46807979|NCT00446199|83027093|FG003|Overall Study|Adverse Event|4|||
46807980|NCT00446199|83027090|FG000|Overall Study|Lost to Follow-up|4|||
46807981|NCT00446199|83027091|FG001|Overall Study|Lost to Follow-up|5|||
46807982|NCT00446199|83027092|FG002|Overall Study|Lost to Follow-up|2|||
46807983|NCT00446199|83027093|FG003|Overall Study|Lost to Follow-up|6|||
46807984|NCT00446199|83027090|FG000|Overall Study|Protocol Violation|1|||
46807985|NCT00446199|83027091|FG001|Overall Study|Protocol Violation|2|||
46807986|NCT00446199|83027092|FG002|Overall Study|Protocol Violation|1|||
46807987|NCT00446199|83027093|FG003|Overall Study|Protocol Violation|3|||
46807988|NCT00446199|83027090|FG000|Overall Study|Withdrawal by Subject|2|||
46807989|NCT00446199|83027091|FG001|Overall Study|Withdrawal by Subject|5|||
46807990|NCT00446199|83027092|FG002|Overall Study|Withdrawal by Subject|9|||
46807991|NCT00446199|83027093|FG003|Overall Study|Withdrawal by Subject|10|||
46807992|NCT00446199|83027090|FG000|Overall Study|Site termination|2|||
46807993|NCT00446199|83027091|FG001|Overall Study|Site termination|0|||
46807994|NCT00446199|83027092|FG002|Overall Study|Site termination|0|||
46807995|NCT00446199|83027093|FG003|Overall Study|Site termination|1|||
46807996|NCT00446199|83027090|FG000|Overall Study|Randomization in Error|2|||
46807997|NCT00446199|83027091|FG001|Overall Study|Randomization in Error|0|||
46807998|NCT00446199|83027092|FG002|Overall Study|Randomization in Error|1|||
46807999|NCT00446199|83027093|FG003|Overall Study|Randomization in Error|1|||
46808000|NCT00446199|83027090|FG000|Overall Study|Lack of Efficacy|1|||
46808001|NCT00446199|83027091|FG001|Overall Study|Lack of Efficacy|0|||
46808002|NCT00446199|83027092|FG002|Overall Study|Lack of Efficacy|0|||
46808003|NCT00446199|83027093|FG003|Overall Study|Lack of Efficacy|1|||
46808004|NCT00446199|83027090|FG000|Overall Study|Non-compliant with study drug|1|||
46808005|NCT00446199|83027091|FG001|Overall Study|Non-compliant with study drug|0|||
46808006|NCT00446199|83027092|FG002|Overall Study|Non-compliant with study drug|5|||
46808007|NCT00446199|83027093|FG003|Overall Study|Non-compliant with study drug|0|||
46808008|NCT00446199|83027090|FG000|Overall Study|Non-compliant with visit schedule|1|||
46808009|NCT00446199|83027091|FG001|Overall Study|Non-compliant with visit schedule|1|||
46808010|NCT00446199|83027092|FG002|Overall Study|Non-compliant with visit schedule|1|||
46808011|NCT00446199|83027093|FG003|Overall Study|Non-compliant with visit schedule|2|||
46808012|NCT00446199|83027090|FG000|Overall Study|Hormone fear|0|||
46808013|NCT00446199|83027091|FG001|Overall Study|Hormone fear|0|||
46808014|NCT00446199|83027092|FG002|Overall Study|Hormone fear|0|||
46808015|NCT00446199|83027093|FG003|Overall Study|Hormone fear|1|||
46808016|NCT00446199|83027090|FG000|Overall Study|Lost interest in study participation|0|||
46808017|NCT00446199|83027091|FG001|Overall Study|Lost interest in study participation|1|||
46808018|NCT00446199|83027092|FG002|Overall Study|Lost interest in study participation|0|||
46753002|NCT02052778|82971178|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
46753003|NCT02052778|82971179|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46753004|NCT02052778|82971180|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46753005|NCT02052778|82971181|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
46753006|NCT02052778|82971159|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
46753007|NCT02052778|82971160|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
46753008|NCT02052778|82971161|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
46753009|NCT02052778|82971162|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
46753010|NCT02052778|82971163|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
46753011|NCT02052778|82971164|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
46753012|NCT02052778|82971165|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
46753013|NCT02052778|82971166|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
46753014|NCT02052778|82971167|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
46753015|NCT02052778|82971168|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
46753016|NCT02052778|82971169|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
46753017|NCT02052778|82971170|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
46753018|NCT02052778|82971171|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
46753019|NCT02052778|82971172|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
46753020|NCT02052778|82971173|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
46808019|NCT00446199|83027093|FG003|Overall Study|Lost interest in study participation|0|||
46808020|NCT00446199|83027090|FG000|Overall Study|In-/Exclusion criterion violated|2|||
46808021|NCT00446199|83027091|FG001|Overall Study|In-/Exclusion criterion violated|1|||
46808022|NCT00446199|83027092|FG002|Overall Study|In-/Exclusion criterion violated|2|||
46808023|NCT00446199|83027093|FG003|Overall Study|In-/Exclusion criterion violated|1|||
46808024|NCT00446199|83027090|FG000|Overall Study|Move|0|||
46808025|NCT00446199|83027091|FG001|Overall Study|Move|1|||
46808026|NCT00446199|83027092|FG002|Overall Study|Move|0|||
46808027|NCT00446199|83027093|FG003|Overall Study|Move|0|||
46808028|NCT00456495|83027103|FG000|Overall Study|Physician Decision|2|||
46808029|NCT00445341|83027108|FG000|Overall Study|refused further treatment|1|||
46808030|NCT00445341|83027108|FG000|Overall Study|taken off treatment too early|1|||
46808031|NCT03846453|83027114|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
46808032|NCT03846453|83027115|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
46808033|NCT03846453|83027116|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
46808034|NCT03846453|83027114|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
46808035|NCT03846453|83027115|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
46808036|NCT03846453|83027116|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
46808037|NCT03846453|83027114|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
46808038|NCT03846453|83027115|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
46808039|NCT03846453|83027116|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
46808040|NCT03846453|83027114|FG000|Placebo Run-in (14 Days)|Other|2|||
46808041|NCT03846453|83027115|FG001|Placebo Run-in (14 Days)|Other|0|||
46808042|NCT03846453|83027116|FG002|Placebo Run-in (14 Days)|Other|0|||
46808043|NCT03846453|83027114|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
46808044|NCT03846453|83027115|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
46808045|NCT03846453|83027116|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
46808046|NCT03846453|83027114|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
46808047|NCT03846453|83027115|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
46808048|NCT03846453|83027116|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
46808049|NCT03846453|83027114|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
46808050|NCT03846453|83027115|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
46808051|NCT03846453|83027116|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
46808052|NCT03846453|83027114|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
46808053|NCT03846453|83027115|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
46808054|NCT03846453|83027116|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
46808055|NCT03846453|83027114|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
46808056|NCT03846453|83027115|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
46808057|NCT03846453|83027116|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
46808058|NCT00444951|83027127|FG000|Overall Study|Lost to Follow-up|1|||
46808059|NCT00444951|83027128|FG001|Overall Study|Lost to Follow-up|1|||
46808060|NCT00444951|83027129|FG002|Overall Study|Lost to Follow-up|0|||
46808061|NCT00444951|83027127|FG000|Overall Study|Withdrawal by Subject|4|||
46808062|NCT00444951|83027128|FG001|Overall Study|Withdrawal by Subject|5|||
46808063|NCT00444951|83027129|FG002|Overall Study|Withdrawal by Subject|3|||
46808064|NCT00444795|83027137|FG000|Overall Study|Not Treated|1|||
46808065|NCT00444795|83027137|FG000|Overall Study|Treated Prior to the Contract Date|2|||
46808066|NCT03846219|83027144|FG000|Overall Study|Withdrawal by Subject|3|||
46808067|NCT03846219|83027145|FG001|Overall Study|Withdrawal by Subject|2|||
46808068|NCT03846219|83027146|FG002|Overall Study|Withdrawal by Subject|2|||
46808069|NCT03846219|83027144|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
46808070|NCT03846219|83027145|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
46808071|NCT03846219|83027146|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
46808072|NCT03846219|83027144|FG000|Overall Study|Physician Decision|0|||
46808073|NCT03846219|83027145|FG001|Overall Study|Physician Decision|0|||
46808074|NCT03846219|83027146|FG002|Overall Study|Physician Decision|2|||
46636264|NCT01517178|82810096|FG000|Period 2|E.g. study termination|2|||
46753021|NCT02052778|82971174|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
46753022|NCT02052778|82971175|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
46753023|NCT02052778|82971176|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
46753024|NCT02052778|82971177|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
46753025|NCT02052778|82971178|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
46753026|NCT02052778|82971179|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
46753027|NCT02052778|82971180|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
46753028|NCT02052778|82971181|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
46753029|NCT02052778|82971159|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753030|NCT02052778|82971160|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753031|NCT02052778|82971161|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753032|NCT02052778|82971162|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753033|NCT02052778|82971163|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753034|NCT02052778|82971164|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753035|NCT02052778|82971165|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46808075|NCT00455325|83027162|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
46808076|NCT00455325|83027163|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
46808077|NCT00455325|83027164|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
46808078|NCT00455325|83027165|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
46808079|NCT00455325|83027162|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
46808080|NCT00455325|83027163|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
46808081|NCT00455325|83027164|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
46753036|NCT02052778|82971166|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753037|NCT02052778|82971167|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753038|NCT02052778|82971168|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753039|NCT02052778|82971169|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753040|NCT02052778|82971170|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753041|NCT02052778|82971171|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753042|NCT02052778|82971172|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753043|NCT02052778|82971173|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
46753044|NCT02052778|82971174|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
46753045|NCT02052778|82971175|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
46753046|NCT02052778|82971176|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753047|NCT02052778|82971177|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
46753048|NCT02052778|82971178|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753049|NCT02052778|82971179|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753050|NCT02052778|82971180|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753051|NCT02052778|82971181|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
46753052|NCT02052778|82971159|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753053|NCT02052778|82971160|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753054|NCT02052778|82971161|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753055|NCT02052778|82971162|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753056|NCT02052778|82971163|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753057|NCT02052778|82971164|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753058|NCT02052778|82971165|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753059|NCT02052778|82971166|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753060|NCT02052778|82971167|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753061|NCT02052778|82971168|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753062|NCT02052778|82971169|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753063|NCT02052778|82971170|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753064|NCT02052778|82971171|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753065|NCT02052778|82971172|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753066|NCT02052778|82971173|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753067|NCT02052778|82971174|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753068|NCT02052778|82971175|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753069|NCT02052778|82971176|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753070|NCT02052778|82971177|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
47053518|NCT01817777|83323774|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
47053519|NCT01817777|83323775|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
47053520|NCT01817777|83323773|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
47053521|NCT01817777|83323774|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
47053522|NCT01817777|83323775|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
47053523|NCT01817777|83323773|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
47053524|NCT01817777|83323774|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
47053525|NCT01817777|83323775|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
47053526|NCT01817777|83323773|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
47053527|NCT01817777|83323774|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
47053528|NCT01817777|83323775|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
47053529|NCT01817777|83323773|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
47053530|NCT01817777|83323774|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
47053531|NCT01817777|83323775|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
47053532|NCT01795547|83323801|FG000|Overall Study|Adverse Event|16|||
47053533|NCT01795547|83323802|FG001|Overall Study|Adverse Event|27|||
47053534|NCT01795547|83323801|FG000|Overall Study|Lack of Efficacy|8|||
47053535|NCT01795547|83323802|FG001|Overall Study|Lack of Efficacy|3|||
47053536|NCT01795547|83323801|FG000|Overall Study|Protocol Violation|6|||
47053537|NCT01795547|83323802|FG001|Overall Study|Protocol Violation|4|||
47053538|NCT01795547|83323801|FG000|Overall Study|Lost to Follow-up|2|||
46753071|NCT02052778|82971178|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753072|NCT02052778|82971179|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753073|NCT02052778|82971180|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
46753074|NCT02052778|82971181|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
46753075|NCT02052778|82971159|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753076|NCT02052778|82971160|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753077|NCT02052778|82971161|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753078|NCT02052778|82971162|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753079|NCT02052778|82971163|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753080|NCT02052778|82971164|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
47053539|NCT01795547|83323802|FG001|Overall Study|Lost to Follow-up|5|||
47053540|NCT01795547|83323801|FG000|Overall Study|Withdrawal of consent|7|||
47053541|NCT01795547|83323802|FG001|Overall Study|Withdrawal of consent|12|||
46753081|NCT02052778|82971165|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753082|NCT02052778|82971166|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753083|NCT02052778|82971167|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753084|NCT02052778|82971168|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753085|NCT02052778|82971169|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753086|NCT02052778|82971170|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753087|NCT02052778|82971171|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753088|NCT02052778|82971172|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753089|NCT02052778|82971173|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753090|NCT02052778|82971174|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753091|NCT02052778|82971175|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753092|NCT02052778|82971176|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753093|NCT02052778|82971177|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753094|NCT02052778|82971178|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753095|NCT02052778|82971179|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753096|NCT02052778|82971180|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
46753097|NCT02052778|82971181|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
46753098|NCT02052778|82971159|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753099|NCT02052778|82971160|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753100|NCT02052778|82971161|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753101|NCT02052778|82971162|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753102|NCT02052778|82971163|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753103|NCT02052778|82971164|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753104|NCT02052778|82971165|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753105|NCT02052778|82971166|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753106|NCT02052778|82971167|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753107|NCT02052778|82971168|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753108|NCT02052778|82971169|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753109|NCT02052778|82971170|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753110|NCT02052778|82971171|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753111|NCT02052778|82971172|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753112|NCT02052778|82971173|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753113|NCT02052778|82971174|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753114|NCT02052778|82971175|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753115|NCT02052778|82971176|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753116|NCT02052778|82971177|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753117|NCT02052778|82971178|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753118|NCT02052778|82971179|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753119|NCT02052778|82971180|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
46753120|NCT02052778|82971181|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
46926082|NCT02759562|83160461|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
47053542|NCT01795547|83323801|FG000|Overall Study|Not Treated|4|||
47053543|NCT01795547|83323802|FG001|Overall Study|Not Treated|10|||
47053544|NCT01795547|83323801|FG000|Overall Study|Non-compliance with IMP|1|||
47053545|NCT01795547|83323802|FG001|Overall Study|Non-compliance with IMP|1|||
47053546|NCT01795547|83323801|FG000|Overall Study|Others|4|||
47053547|NCT01795547|83323802|FG001|Overall Study|Others|1|||
47053548|NCT01795547|83323801|FG000|Overall Study|Not stated|0|||
47053549|NCT01795547|83323802|FG001|Overall Study|Not stated|1|||
47053550|NCT01794923|83323828|FG000|Overall Study|Adverse Event|0|||
47053551|NCT01794923|83323829|FG001|Overall Study|Adverse Event|0|||
47053552|NCT01794923|83323830|FG002|Overall Study|Adverse Event|1|||
47053553|NCT01794845|83323838|FG000|Overall Study|Withdrawal by Subject|1|||
47053554|NCT01794689|83323846|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
47053555|NCT01794689|83323847|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
47053556|NCT01794689|83323848|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
47053557|NCT01794689|83323849|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
47053558|NCT01794689|83323846|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
47053559|NCT01794689|83323847|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
46808082|NCT00455325|83027165|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
46808083|NCT00455325|83027162|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
46808084|NCT00455325|83027163|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
46808085|NCT00455325|83027164|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
46808086|NCT00455325|83027165|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
46808087|NCT00455325|83027162|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
46808088|NCT00455325|83027163|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
46808089|NCT00455325|83027164|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
46808090|NCT00455325|83027165|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
46808091|NCT00455325|83027162|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
46808092|NCT00455325|83027163|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
46808093|NCT00455325|83027164|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
46808094|NCT00455325|83027165|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
46808095|NCT00455325|83027162|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
46808096|NCT00455325|83027163|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
46808097|NCT00455325|83027164|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
46926083|NCT02746575|83160468|FG000|Overall Study|Surgery cancelled or time chaned|13|||
46926084|NCT02746575|83160468|FG000|Overall Study|Received epidural|10|||
46926085|NCT02746575|83160468|FG000|Overall Study|Withdrawal by Subject|3|||
46926086|NCT02746575|83160468|FG000|Overall Study|Bradycardia/hypotension|9|||
46926087|NCT02746575|83160468|FG000|Overall Study|Study paused|8|||
46926088|NCT02746575|83160468|FG000|Overall Study|put on beta-blocker|3|||
46926089|NCT02746575|83160468|FG000|Overall Study|type of surgery|1|||
46926090|NCT02746575|83160468|FG000|Overall Study|typ of surgery|1|||
46926091|NCT02746575|83160468|FG000|Overall Study|PI unavailable|1|||
46926092|NCT02746575|83160468|FG000|Overall Study|Unknown history of CVA|1|||
46926093|NCT03625466|83160474|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
46926094|NCT03625466|83160475|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
46926095|NCT03625466|83160476|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
46926096|NCT03625466|83160474|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
46926097|NCT03625466|83160475|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
47053560|NCT01794689|83323848|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
47053561|NCT01794689|83323849|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
47053562|NCT01794689|83323846|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
47053563|NCT01794689|83323847|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
47053564|NCT01794689|83323848|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
47053565|NCT01794689|83323849|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
47053566|NCT01794689|83323846|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
47053567|NCT01794689|83323847|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
47053568|NCT01794689|83323848|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
47053569|NCT01794689|83323849|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
47053570|NCT01794299|83323865|FG000|Overall Study|ATIR manufacturing not possible|1|||
46636265|NCT01517178|82810097|FG001|Period 2|E.g. study termination|2|||
46926098|NCT03625466|83160476|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
46926099|NCT03625466|83160474|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
46926100|NCT03625466|83160475|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
46926101|NCT03625466|83160476|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
46926102|NCT02853123|83160483|FG000|Treatment Period 1|Adverse Event|0|||
46926103|NCT02853123|83160484|FG001|Treatment Period 1|Adverse Event|3|||
47053571|NCT01794299|83323865|FG000|Overall Study|Death|14|||
46636266|NCT01489956|82810105|FG000|Overall Study|Lost to Follow-up|1|||
46753121|NCT02052778|82971159|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753122|NCT02052778|82971160|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753123|NCT02052778|82971161|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753124|NCT02052778|82971162|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753125|NCT02052778|82971163|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753126|NCT02052778|82971164|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753127|NCT02052778|82971165|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753128|NCT02052778|82971166|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753129|NCT02052778|82971167|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753130|NCT02052778|82971168|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46808098|NCT00455325|83027165|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
46808099|NCT00455325|83027162|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
46808100|NCT00455325|83027163|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
46808101|NCT00455325|83027164|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
46808102|NCT00455325|83027165|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
46808103|NCT00443781|83027176|FG000|Overall Study|Lost to Follow-up|10|||
46808104|NCT00443781|83027176|FG000|Overall Study|Physician Decision|2|||
46808105|NCT00443781|83027176|FG000|Overall Study|Protocol Violation|1|||
46808106|NCT00443781|83027176|FG000|Overall Study|Withdrawal by Subject|6|||
46808107|NCT00443781|83027176|FG000|Overall Study|Unable to comply with study follow up|2|||
46808108|NCT00443781|83027176|FG000|Overall Study|Investigator terminated participation|1|||
46808109|NCT00443781|83027176|FG000|Overall Study|Insurance not covered|2|||
46808110|NCT00443781|83027176|FG000|Overall Study|PD/FAD not done|1|||
46808111|NCT00443703|83027182|FG000|Overall Study|Never Treated|3|||
46926104|NCT02853123|83160483|FG000|Washout Period|Worsening of COPD|0|||
46808112|NCT00443703|83027183|FG001|Overall Study|Never Treated|1|||
46808113|NCT00443703|83027182|FG000|Overall Study|Adverse Event|7|||
46808114|NCT00443703|83027183|FG001|Overall Study|Adverse Event|3|||
46808115|NCT00443703|83027182|FG000|Overall Study|Lack of Efficacy|3|||
46808116|NCT00443703|83027183|FG001|Overall Study|Lack of Efficacy|1|||
46808117|NCT00443703|83027182|FG000|Overall Study|Lost to Follow-up|0|||
46808118|NCT00443703|83027183|FG001|Overall Study|Lost to Follow-up|4|||
46808119|NCT00443703|83027182|FG000|Overall Study|Physician Decision|4|||
46808120|NCT00443703|83027183|FG001|Overall Study|Physician Decision|2|||
46808121|NCT00443703|83027182|FG000|Overall Study|Protocol Violation|1|||
46808122|NCT00443703|83027183|FG001|Overall Study|Protocol Violation|1|||
46808123|NCT00443703|83027182|FG000|Overall Study|Withdrawal by Subject|9|||
46808124|NCT00443703|83027183|FG001|Overall Study|Withdrawal by Subject|6|||
46808125|NCT00443703|83027182|FG000|Overall Study|Progressive Disease|1|||
46808126|NCT00443703|83027183|FG001|Overall Study|Progressive Disease|0|||
46808127|NCT00381706|83027195|FG000|Overall Study|Never treated|7|||
46808128|NCT00381706|83027196|FG001|Overall Study|Never treated|2|||
46808129|NCT00381706|83027197|FG002|Overall Study|Never treated|1|||
46808130|NCT00535236|83027221|FG000|Overall Study|Adverse Event|1|||
46808131|NCT00535236|83027222|FG001|Overall Study|Adverse Event|0|||
46808132|NCT00535236|83027223|FG002|Overall Study|Adverse Event|9|||
46808133|NCT00535236|83027224|FG003|Overall Study|Adverse Event|3|||
46808134|NCT00535236|83027225|FG004|Overall Study|Adverse Event|3|||
46808135|NCT00535236|83027226|FG005|Overall Study|Adverse Event|0|||
46808136|NCT00535236|83027227|FG006|Overall Study|Adverse Event|5|||
46808137|NCT00535236|83027228|FG007|Overall Study|Adverse Event|1|||
46808138|NCT00535236|83027229|FG008|Overall Study|Adverse Event|2|||
46808139|NCT00535236|83027230|FG009|Overall Study|Adverse Event|1|||
46808140|NCT00535236|83027221|FG000|Overall Study|Lost to Follow-up|1|||
46808141|NCT00535236|83027222|FG001|Overall Study|Lost to Follow-up|2|||
46808142|NCT00535236|83027223|FG002|Overall Study|Lost to Follow-up|0|||
46808143|NCT00535236|83027224|FG003|Overall Study|Lost to Follow-up|0|||
46808144|NCT00535236|83027225|FG004|Overall Study|Lost to Follow-up|2|||
46808145|NCT00535236|83027226|FG005|Overall Study|Lost to Follow-up|0|||
46808146|NCT00535236|83027227|FG006|Overall Study|Lost to Follow-up|0|||
46808147|NCT00535236|83027228|FG007|Overall Study|Lost to Follow-up|0|||
46808148|NCT00535236|83027229|FG008|Overall Study|Lost to Follow-up|6|||
46808149|NCT00535236|83027230|FG009|Overall Study|Lost to Follow-up|1|||
46808150|NCT00535236|83027221|FG000|Overall Study|Physician Decision|0|||
46808151|NCT00535236|83027222|FG001|Overall Study|Physician Decision|0|||
46808152|NCT00535236|83027223|FG002|Overall Study|Physician Decision|0|||
46808153|NCT00535236|83027224|FG003|Overall Study|Physician Decision|0|||
46808154|NCT00535236|83027225|FG004|Overall Study|Physician Decision|1|||
46808155|NCT00535236|83027226|FG005|Overall Study|Physician Decision|0|||
46808156|NCT00535236|83027227|FG006|Overall Study|Physician Decision|1|||
46926105|NCT02853123|83160484|FG001|Washout Period|Worsening of COPD|3|||
46926106|NCT02853123|83160483|FG000|Washout Period|Adverse Event|1|||
46808157|NCT00535236|83027228|FG007|Overall Study|Physician Decision|0|||
46808158|NCT00535236|83027229|FG008|Overall Study|Physician Decision|0|||
46808159|NCT00535236|83027230|FG009|Overall Study|Physician Decision|0|||
46808160|NCT00535236|83027221|FG000|Overall Study|Protocol Violation|2|||
46808161|NCT00535236|83027222|FG001|Overall Study|Protocol Violation|0|||
46808162|NCT00535236|83027223|FG002|Overall Study|Protocol Violation|1|||
47053572|NCT01794299|83323865|FG000|Overall Study|Graft failure|1|||
46926107|NCT02853123|83160484|FG001|Washout Period|Adverse Event|0|||
47053573|NCT01794299|83323865|FG000|Overall Study|ATIR batch rejected|2|||
47053574|NCT01794299|83323865|FG000|Overall Study|Relapse|2|||
46808163|NCT00535236|83027224|FG003|Overall Study|Protocol Violation|0|||
46808164|NCT00535236|83027225|FG004|Overall Study|Protocol Violation|0|||
46808165|NCT00535236|83027226|FG005|Overall Study|Protocol Violation|0|||
46808166|NCT00535236|83027227|FG006|Overall Study|Protocol Violation|0|||
46808167|NCT00535236|83027228|FG007|Overall Study|Protocol Violation|0|||
46808168|NCT00535236|83027229|FG008|Overall Study|Protocol Violation|1|||
46808169|NCT00535236|83027230|FG009|Overall Study|Protocol Violation|0|||
46808170|NCT00535236|83027221|FG000|Overall Study|Withdrawal by Subject|3|||
46808171|NCT00535236|83027222|FG001|Overall Study|Withdrawal by Subject|0|||
46808172|NCT00535236|83027223|FG002|Overall Study|Withdrawal by Subject|2|||
46808173|NCT00535236|83027224|FG003|Overall Study|Withdrawal by Subject|1|||
46808174|NCT00535236|83027225|FG004|Overall Study|Withdrawal by Subject|6|||
46808175|NCT00535236|83027226|FG005|Overall Study|Withdrawal by Subject|1|||
46808176|NCT00535236|83027227|FG006|Overall Study|Withdrawal by Subject|5|||
46808177|NCT00535236|83027228|FG007|Overall Study|Withdrawal by Subject|0|||
46808178|NCT00535236|83027229|FG008|Overall Study|Withdrawal by Subject|4|||
46636267|NCT01489956|82810106|FG001|Overall Study|Lost to Follow-up|0|||
46636268|NCT01489956|82810107|FG002|Overall Study|Lost to Follow-up|0|||
46636269|NCT01489956|82810105|FG000|Overall Study|Withdrawal by Subject|0|||
46753131|NCT02052778|82971169|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46808179|NCT00535236|83027230|FG009|Overall Study|Withdrawal by Subject|2|||
46808180|NCT00370552|83027258|FG000|Overall Study|Adverse Event|2|||
46808181|NCT00370552|83027259|FG001|Overall Study|Adverse Event|2|||
46808182|NCT00370552|83027260|FG002|Overall Study|Adverse Event|2|||
46808183|NCT00370552|83027258|FG000|Overall Study|Disease progression|23|||
46808184|NCT00370552|83027259|FG001|Overall Study|Disease progression|23|||
46808185|NCT00370552|83027260|FG002|Overall Study|Disease progression|15|||
46808186|NCT00370552|83027258|FG000|Overall Study|Maximum clinical benefit|3|||
46808187|NCT00370552|83027259|FG001|Overall Study|Maximum clinical benefit|5|||
46808188|NCT00370552|83027260|FG002|Overall Study|Maximum clinical benefit|5|||
46808189|NCT00370552|83027258|FG000|Overall Study|Poor or noncompliance|0|||
46808190|NCT00370552|83027259|FG001|Overall Study|Poor or noncompliance|0|||
46808191|NCT00370552|83027260|FG002|Overall Study|Poor or noncompliance|1|||
46808192|NCT00370552|83027258|FG000|Overall Study|Study drug toxicity|11|||
46808193|NCT00370552|83027259|FG001|Overall Study|Study drug toxicity|8|||
46808194|NCT00370552|83027260|FG002|Overall Study|Study drug toxicity|6|||
46808195|NCT00370552|83027258|FG000|Overall Study|Withdrawal by Subject|2|||
46808196|NCT00370552|83027259|FG001|Overall Study|Withdrawal by Subject|0|||
46808197|NCT00370552|83027260|FG002|Overall Study|Withdrawal by Subject|1|||
46808198|NCT00370552|83027258|FG000|Overall Study|Still on treatment|1|||
46808199|NCT00370552|83027259|FG001|Overall Study|Still on treatment|3|||
46808200|NCT00370552|83027260|FG002|Overall Study|Still on treatment|2|||
46808201|NCT00370552|83027258|FG000|Overall Study|Never treated|1|||
46808202|NCT00370552|83027259|FG001|Overall Study|Never treated|0|||
47053575|NCT01794299|83323865|FG000|Overall Study|Discontinued from active follow-up|1|||
46808203|NCT00370552|83027260|FG002|Overall Study|Never treated|0|||
46808204|NCT00370552|83027258|FG000|Overall Study|Physician Decision|1|||
46808205|NCT00370552|83027259|FG001|Overall Study|Physician Decision|1|||
46808206|NCT00370552|83027260|FG002|Overall Study|Physician Decision|0|||
46808207|NCT00370552|83027258|FG000|Overall Study|Investigator decision|2|||
46808208|NCT00370552|83027259|FG001|Overall Study|Investigator decision|1|||
46808209|NCT00370552|83027260|FG002|Overall Study|Investigator decision|0|||
47053576|NCT01794299|83323865|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
47053577|NCT01817075|83323871|FG000|Overall Study|Adverse Event|7|||
47053578|NCT01817075|83323872|FG001|Overall Study|Adverse Event|5|||
47053579|NCT01817075|83323871|FG000|Overall Study|Physician Decision|9|||
47053580|NCT01817075|83323872|FG001|Overall Study|Physician Decision|12|||
47053581|NCT01817075|83323871|FG000|Overall Study|Withdrawal by Subject|31|||
47053582|NCT01817075|83323872|FG001|Overall Study|Withdrawal by Subject|15|||
47053583|NCT01817075|83323871|FG000|Overall Study|Received Sorafenib after enrollment|0|||
47053584|NCT01817075|83323872|FG001|Overall Study|Received Sorafenib after enrollment|1|||
46636270|NCT01489956|82810106|FG001|Overall Study|Withdrawal by Subject|0|||
46753132|NCT02052778|82971170|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753133|NCT02052778|82971171|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753134|NCT02052778|82971172|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753135|NCT02052778|82971173|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753136|NCT02052778|82971174|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753137|NCT02052778|82971175|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753138|NCT02052778|82971176|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753139|NCT02052778|82971177|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753140|NCT02052778|82971178|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46753141|NCT02052778|82971179|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46808210|NCT00370552|83027258|FG000|Overall Study|High risk of allergic reaction|0|||
47053585|NCT01817075|83323871|FG000|Overall Study|Ineligible|0|||
47053586|NCT01817075|83323872|FG001|Overall Study|Ineligible|2|||
46808211|NCT00370552|83027259|FG001|Overall Study|High risk of allergic reaction|1|||
46808212|NCT00370552|83027260|FG002|Overall Study|High risk of allergic reaction|0|||
46808213|NCT00370552|83027258|FG000|Overall Study|Planned radiation for palliation|0|||
46808214|NCT00370552|83027259|FG001|Overall Study|Planned radiation for palliation|1|||
46808215|NCT00370552|83027260|FG002|Overall Study|Planned radiation for palliation|0|||
46808216|NCT00537030|83027268|FG000|Overall Study|Physician Decision|2|||
46808217|NCT00537030|83027268|FG000|Overall Study|Withdrawal by Subject|2|||
46808218|NCT00537030|83027268|FG000|Overall Study|≥ Grade 2 allergy|7|||
46808219|NCT00537030|83027268|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
46808220|NCT00537030|83027268|FG000|Overall Study|Ineligible|2|||
46808221|NCT00537030|83027268|FG000|Overall Study|Inevaluable|2|||
46808222|NCT00381238|83027272|FG000|Overall Study|Adverse Event|3|||
46808223|NCT00381238|83027272|FG000|Overall Study|Protocol Violation|1|||
46808224|NCT00381238|83027272|FG000|Overall Study|Withdrawal by Subject|4|||
46808225|NCT00381238|83027272|FG000|Overall Study|Lack of Efficacy|2|||
46808226|NCT00381238|83027272|FG000|Overall Study|Withdrew by physician|1|||
46808227|NCT00381238|83027272|FG000|Overall Study|Disease progression|1|||
46808228|NCT03896022|83027279|FG000|Overall Study|Withdrawal by Subject|1|||
46808229|NCT03896022|83027280|FG001|Overall Study|Withdrawal by Subject|0|||
46808230|NCT03896022|83027281|FG002|Overall Study|Withdrawal by Subject|0|||
46808231|NCT03896022|83027279|FG000|Overall Study|Did not have procedure|3|||
46808232|NCT03896022|83027280|FG001|Overall Study|Did not have procedure|0|||
46808233|NCT03896022|83027281|FG002|Overall Study|Did not have procedure|0|||
46808234|NCT03831880|83027293|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
46808235|NCT03831880|83027294|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
46808236|NCT03831880|83027293|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
46808237|NCT03831880|83027294|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
46808238|NCT00380692|83027317|FG000|Study Period II - Double Blind|Adverse Event|1|||
46808239|NCT00380692|83027318|FG001|Study Period II - Double Blind|Adverse Event|0|||
46808240|NCT00380692|83027317|FG000|Study Period II - Double Blind|Protocol Violation|2|||
46808241|NCT00380692|83027318|FG001|Study Period II - Double Blind|Protocol Violation|2|||
46808242|NCT00380692|83027317|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
46808243|NCT00380692|83027318|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
46808244|NCT00380692|83027317|FG000|Study Period II - Double Blind|Physician Decision|0|||
46808245|NCT00380692|83027318|FG001|Study Period II - Double Blind|Physician Decision|1|||
46808246|NCT00380692|83027317|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
46808247|NCT00380692|83027318|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
46808248|NCT00380692|83027317|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
46808249|NCT00380692|83027318|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
46808250|NCT00380692|83027317|FG000|Study Period III - Open Label|Adverse Event|5|||
46808251|NCT00380692|83027318|FG001|Study Period III - Open Label|Adverse Event|3|||
46808252|NCT00380692|83027317|FG000|Study Period III - Open Label|Protocol Violation|0|||
46808253|NCT00380692|83027318|FG001|Study Period III - Open Label|Protocol Violation|0|||
46808254|NCT00380692|83027317|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
46808255|NCT00380692|83027318|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
46808256|NCT00380692|83027317|FG000|Study Period III - Open Label|Physician Decision|0|||
46808257|NCT00380692|83027318|FG001|Study Period III - Open Label|Physician Decision|3|||
46808258|NCT00380692|83027317|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
46808259|NCT00380692|83027318|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
46808260|NCT00380692|83027317|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
46926108|NCT02634346|83160494|FG000|Overall Study|Withdrawal by Subject|8|||
46926109|NCT02634346|83160495|FG001|Overall Study|Withdrawal by Subject|9|||
46926110|NCT02634346|83160496|FG002|Overall Study|Withdrawal by Subject|8|||
46926111|NCT02634346|83160494|FG000|Overall Study|Adverse Event|2|||
47053587|NCT01816763|83323881|FG000|Overall Study|The main reason for an incomplete survey|4|||
47053588|NCT01816763|83323882|FG001|Overall Study|The main reason for an incomplete survey|15|||
46808261|NCT00380692|83027318|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
46808262|NCT00536874|83027324|FG000|Overall Study|Adverse Event|1|||
46808263|NCT00536874|83027324|FG000|Overall Study|Death|2|||
46926112|NCT02634346|83160495|FG001|Overall Study|Adverse Event|2|||
46926113|NCT02634346|83160496|FG002|Overall Study|Adverse Event|7|||
46926114|NCT02634346|83160494|FG000|Overall Study|Lack of Efficacy|1|||
47053589|NCT01816763|83323883|FG002|Overall Study|The main reason for an incomplete survey|11|||
47053590|NCT01816685|83323896|FG000|Overall Study|Lost to Follow-up|7|||
47053591|NCT01816685|83323897|FG001|Overall Study|Lost to Follow-up|9|||
47053592|NCT01816685|83323896|FG000|Overall Study|Surgery Cancelled|3|||
47053593|NCT01816685|83323897|FG001|Overall Study|Surgery Cancelled|2|||
46808264|NCT00536874|83027324|FG000|Overall Study|Withdrawal by Subject|1|||
46808265|NCT00380068|83027328|FG000|Overall Study|Adverse Event|40|||
46808266|NCT00380068|83027328|FG000|Overall Study|Withdrawal by Subject|10|||
46808267|NCT00380068|83027328|FG000|Overall Study|Not compliant|6|||
46808268|NCT00380068|83027328|FG000|Overall Study|Lost to Follow-up|1|||
46808269|NCT00380068|83027328|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
47053594|NCT00708552|83323928|FG000|Overall Study|Adverse Event|10|||
46808270|NCT00380068|83027328|FG000|Overall Study|Lung transplant|3|||
46926115|NCT02634346|83160495|FG001|Overall Study|Lack of Efficacy|2|||
46926116|NCT02634346|83160496|FG002|Overall Study|Lack of Efficacy|8|||
46808271|NCT00380068|83027328|FG000|Overall Study|Physician Decision|2|||
46808272|NCT00380068|83027328|FG000|Overall Study|Partipant moved away|1|||
46808273|NCT00380068|83027328|FG000|Overall Study|Lack of Efficacy|5|||
46808274|NCT00536484|83027334|FG000|Overall Study|Adverse Event|21|||
46808275|NCT00536484|83027335|FG001|Overall Study|Adverse Event|34|||
46808276|NCT00536484|83027334|FG000|Overall Study|Withdrawal by Subject|11|||
46808277|NCT00536484|83027335|FG001|Overall Study|Withdrawal by Subject|11|||
46808278|NCT00536484|83027334|FG000|Overall Study|Lost to Follow-up|8|||
46808279|NCT00536484|83027335|FG001|Overall Study|Lost to Follow-up|6|||
46808280|NCT00536484|83027334|FG000|Overall Study|Lack of Efficacy|16|||
46808281|NCT00536484|83027335|FG001|Overall Study|Lack of Efficacy|5|||
46808282|NCT00536484|83027334|FG000|Overall Study|Other|4|||
46808283|NCT00536484|83027335|FG001|Overall Study|Other|0|||
46808284|NCT00370396|83027344|FG000|Overall Study|Withdrawal by Subject|0|||
46808285|NCT00370396|83027345|FG001|Overall Study|Withdrawal by Subject|0|||
46808286|NCT00370396|83027346|FG002|Overall Study|Withdrawal by Subject|1|||
46808287|NCT00370396|83027344|FG000|Overall Study|Lost to Follow-up|11|||
46808288|NCT00370396|83027345|FG001|Overall Study|Lost to Follow-up|1|||
46808289|NCT00370396|83027346|FG002|Overall Study|Lost to Follow-up|0|||
46808290|NCT00455013|83027357|FG000|Short Term Period|Adverse Event|2|||
46808291|NCT00455013|83027358|FG001|Short Term Period|Adverse Event|5|||
46808292|NCT00455013|83027359|FG002|Short Term Period|Adverse Event|0|||
46808293|NCT00455013|83027357|FG000|Short Term Period|Withdrawal by Subject|0|||
46808294|NCT00455013|83027358|FG001|Short Term Period|Withdrawal by Subject|0|||
46808295|NCT00455013|83027359|FG002|Short Term Period|Withdrawal by Subject|1|||
46808296|NCT00455013|83027357|FG000|Short Term Period|Lack of Efficacy|4|||
46808297|NCT00455013|83027358|FG001|Short Term Period|Lack of Efficacy|0|||
46808298|NCT00455013|83027359|FG002|Short Term Period|Lack of Efficacy|0|||
46808299|NCT00455013|83027357|FG000|Short Term Period|Other|0|||
46808300|NCT00455013|83027358|FG001|Short Term Period|Other|0|||
46808301|NCT00455013|83027359|FG002|Short Term Period|Other|1|||
46808302|NCT00455013|83027357|FG000|Long Term Extension (LTE)|Adverse Event|0|||
46808303|NCT00455013|83027358|FG001|Long Term Extension (LTE)|Adverse Event|1|||
46808304|NCT00455013|83027359|FG002|Long Term Extension (LTE)|Adverse Event|1|||
46808305|NCT00455013|83027357|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
46808306|NCT00455013|83027358|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
46808307|NCT00455013|83027359|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
46808308|NCT00455013|83027357|FG000|Long Term Extension (LTE)|Death|1|||
46808309|NCT00455013|83027358|FG001|Long Term Extension (LTE)|Death|1|||
46808310|NCT00455013|83027359|FG002|Long Term Extension (LTE)|Death|0|||
46808311|NCT00455013|83027357|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
46808312|NCT00455013|83027358|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
46808313|NCT00455013|83027359|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
46808314|NCT00455013|83027357|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
46808315|NCT00455013|83027358|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
46808316|NCT00455013|83027359|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
46808317|NCT00455013|83027357|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
46808318|NCT00455013|83027358|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
46808319|NCT00455013|83027359|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
46808320|NCT00455013|83027357|FG000|Long Term Extension (LTE)|non-specified|0|||
46808321|NCT00455013|83027358|FG001|Long Term Extension (LTE)|non-specified|0|||
46808322|NCT00455013|83027359|FG002|Long Term Extension (LTE)|non-specified|1|||
46808323|NCT00363298|83027369|FG000|First Study Week|Lack of Efficacy|6|||
46808324|NCT00363298|83027370|FG001|First Study Week|Lack of Efficacy|5|||
46808325|NCT00363298|83027369|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
46808326|NCT00363298|83027370|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
46808327|NCT00363142|83027379|FG000|Overall Study|Adverse Event|2|||
46808328|NCT00363142|83027380|FG001|Overall Study|Adverse Event|0|||
46808329|NCT00363142|83027379|FG000|Overall Study|Lack of Efficacy|0|||
46808330|NCT00363142|83027380|FG001|Overall Study|Lack of Efficacy|1|||
46808331|NCT00363142|83027379|FG000|Overall Study|Lost to Follow-up|1|||
46808332|NCT00363142|83027380|FG001|Overall Study|Lost to Follow-up|0|||
46808333|NCT00363142|83027379|FG000|Overall Study|Non-compliance|1|||
46808334|NCT00363142|83027380|FG001|Overall Study|Non-compliance|1|||
46808335|NCT00363142|83027379|FG000|Overall Study|Withdrawal by Subject|3|||
46808336|NCT00363142|83027380|FG001|Overall Study|Withdrawal by Subject|1|||
46808337|NCT00454857|83027389|FG000|Overall Study|Withdrawal by Subject|15|||
46808338|NCT00454857|83027389|FG000|Overall Study|Lost to Follow-up|16|||
46808339|NCT00454857|83027389|FG000|Overall Study|Noncompliance|6|||
46808340|NCT00454857|83027389|FG000|Overall Study|Death|5|||
46636271|NCT01489956|82810107|FG002|Overall Study|Withdrawal by Subject|1|||
46926117|NCT02634346|83160494|FG000|Overall Study|Lost to Follow-up|1|||
46636272|NCT01516008|82810118|FG000|Overall Study|Adverse Event|0|||
46808341|NCT00454857|83027389|FG000|Overall Study|Other|11|||
46808342|NCT00454857|83027389|FG000|Overall Study|Reason unknown|1|||
46808343|NCT00379912|83027395|FG000|Overall Study|Lack of Efficacy|1|||
46808344|NCT00379912|83027396|FG001|Overall Study|Lack of Efficacy|0|||
46926118|NCT02634346|83160495|FG001|Overall Study|Lost to Follow-up|0|||
46808345|NCT00379834|83027408|FG000|Overall Study|Time constraints|2|||
46808346|NCT00379210|83027414|FG000|Overall Study|Withdrawal by Subject|10|||
46808347|NCT00379210|83027415|FG001|Overall Study|Withdrawal by Subject|7|||
46808348|NCT00378898|83027423|FG000|Overall Study|Withdrawal by Subject|10|||
46808349|NCT00378898|83027424|FG001|Overall Study|Withdrawal by Subject|5|||
46808350|NCT00378898|83027423|FG000|Overall Study|Protocol Violation|1|||
46808351|NCT00378898|83027424|FG001|Overall Study|Protocol Violation|1|||
46808352|NCT00378508|83027434|FG000|Overall Study|Withdrawal by Subject|1|||
46808353|NCT00378508|83027435|FG001|Overall Study|Withdrawal by Subject|3|||
46808354|NCT00378508|83027434|FG000|Overall Study|Lost to Follow-up|1|||
46808355|NCT00378508|83027435|FG001|Overall Study|Lost to Follow-up|0|||
46808356|NCT00454779|83027444|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
46808357|NCT00454779|83027445|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
46808358|NCT00454779|83027444|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
46808359|NCT00454779|83027445|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
46808360|NCT00454779|83027444|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
46808361|NCT00454779|83027445|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
46808362|NCT00454779|83027444|FG000|First-line Treatment Phase|Protocol Violation|0|||
46808363|NCT00454779|83027445|FG001|First-line Treatment Phase|Protocol Violation|1|||
46808364|NCT00454779|83027444|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
46808365|NCT00454779|83027445|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
46808366|NCT00454779|83027444|FG000|First-line Treatment Phase|Ongoing|1|||
46808367|NCT00454779|83027445|FG001|First-line Treatment Phase|Ongoing|0|||
46808368|NCT00454779|83027444|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
46808369|NCT00454779|83027445|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
46808370|NCT00454779|83027444|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
46808371|NCT00454779|83027445|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
46808372|NCT00454779|83027444|FG000|Second-line Treatment Phase|Ongoing|0|||
46808373|NCT00454779|83027445|FG001|Second-line Treatment Phase|Ongoing|1|||
46808374|NCT00439569|83027455|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
46808375|NCT00439569|83027455|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
46808376|NCT00439569|83027455|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
46808377|NCT00443079|83027461|FG000|Overall Study|Lost to Follow-up|0|||
46808378|NCT00443079|83027462|FG001|Overall Study|Lost to Follow-up|1|||
46808379|NCT00427635|83027498|FG000|Treatment Phase|Withdrawal by Subject|1|||
46808380|NCT00427635|83027499|FG001|Treatment Phase|Withdrawal by Subject|0|||
46808381|NCT00427635|83027498|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
46808382|NCT00427635|83027499|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
46808383|NCT00427011|83027505|FG000|Overall Study|Adverse Event|10|||
46808384|NCT00427011|83027505|FG000|Overall Study|Withdrawal by Subject|1|||
46808385|NCT00427011|83027505|FG000|Overall Study|Lack of Efficacy|2|||
46808386|NCT00427011|83027505|FG000|Overall Study|Other|12|||
46808387|NCT03891264|83027510|FG000|Overall Study|Adverse Event|1|||
46808388|NCT03891264|83027510|FG000|Overall Study|Withdrawal by Subject|2|||
46808389|NCT03891264|83027510|FG000|Overall Study|Physician Decision|2|||
46808390|NCT00439179|83027518|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
46808391|NCT00439179|83027519|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
46808392|NCT00439179|83027520|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
46808393|NCT00439179|83027521|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
46808394|NCT00438633|83027536|FG000|Overall Study|Withdrawal by Subject|1|||
46808395|NCT00438633|83027537|FG001|Overall Study|Withdrawal by Subject|0|||
46808396|NCT00438633|83027536|FG000|Overall Study|Lost to Follow-up|15|||
46808397|NCT00438633|83027537|FG001|Overall Study|Lost to Follow-up|17|||
46808398|NCT00438399|83027546|FG000|Overall Study|Lost to Follow-up|2|||
46808399|NCT00438399|83027547|FG001|Overall Study|Lost to Follow-up|2|||
46808400|NCT00438399|83027548|FG002|Overall Study|Lost to Follow-up|1|||
46808401|NCT00438399|83027549|FG003|Overall Study|Lost to Follow-up|1|||
46808402|NCT00438399|83027550|FG004|Overall Study|Lost to Follow-up|1|||
46808403|NCT00438399|83027551|FG005|Overall Study|Lost to Follow-up|1|||
46808404|NCT00438399|83027546|FG000|Overall Study|Adverse Event|0|||
46808405|NCT00438399|83027547|FG001|Overall Study|Adverse Event|0|||
46808406|NCT00438399|83027548|FG002|Overall Study|Adverse Event|1|||
46808407|NCT00438399|83027549|FG003|Overall Study|Adverse Event|1|||
46808408|NCT00438399|83027550|FG004|Overall Study|Adverse Event|0|||
46926119|NCT02634346|83160496|FG002|Overall Study|Lost to Follow-up|0|||
46926120|NCT02634346|83160494|FG000|Overall Study|Protocol Violation|0|||
46926121|NCT02634346|83160495|FG001|Overall Study|Protocol Violation|1|||
46808409|NCT00438399|83027551|FG005|Overall Study|Adverse Event|1|||
46808410|NCT00438399|83027546|FG000|Overall Study|Withdrawal by Subject|5|||
46808411|NCT00438399|83027547|FG001|Overall Study|Withdrawal by Subject|6|||
46808412|NCT00438399|83027548|FG002|Overall Study|Withdrawal by Subject|3|||
46808413|NCT00438399|83027549|FG003|Overall Study|Withdrawal by Subject|2|||
46926122|NCT02634346|83160496|FG002|Overall Study|Protocol Violation|0|||
46926123|NCT00849147|83160504|FG000|Overall Study|Withdrawal by Subject|1|||
47053595|NCT00708552|83323929|FG001|Overall Study|Adverse Event|3|||
46808414|NCT00438399|83027550|FG004|Overall Study|Withdrawal by Subject|2|||
46808415|NCT00438399|83027551|FG005|Overall Study|Withdrawal by Subject|2|||
46808416|NCT00438399|83027546|FG000|Overall Study|Protocol Violation|0|||
46808417|NCT00438399|83027547|FG001|Overall Study|Protocol Violation|0|||
46808418|NCT00438399|83027548|FG002|Overall Study|Protocol Violation|1|||
46808419|NCT00438399|83027549|FG003|Overall Study|Protocol Violation|0|||
46808420|NCT00438399|83027550|FG004|Overall Study|Protocol Violation|0|||
46808421|NCT00438399|83027551|FG005|Overall Study|Protocol Violation|1|||
46808422|NCT00438399|83027546|FG000|Overall Study|Subje stopped study|0|||
46808423|NCT00438399|83027547|FG001|Overall Study|Subje stopped study|0|||
46808424|NCT00438399|83027548|FG002|Overall Study|Subje stopped study|1|||
46808425|NCT00438399|83027549|FG003|Overall Study|Subje stopped study|0|||
46808426|NCT00438399|83027550|FG004|Overall Study|Subje stopped study|0|||
46808427|NCT00438399|83027551|FG005|Overall Study|Subje stopped study|0|||
46808428|NCT00438399|83027546|FG000|Overall Study|Pregnancy|0|||
46808429|NCT00438399|83027547|FG001|Overall Study|Pregnancy|0|||
46808430|NCT00438399|83027548|FG002|Overall Study|Pregnancy|0|||
46808431|NCT00438399|83027549|FG003|Overall Study|Pregnancy|0|||
46808432|NCT00438399|83027550|FG004|Overall Study|Pregnancy|0|||
46808433|NCT00438399|83027551|FG005|Overall Study|Pregnancy|1|||
46808434|NCT00438399|83027546|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
46808435|NCT00438399|83027547|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
46808436|NCT00438399|83027548|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
46808437|NCT00438399|83027549|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
46808438|NCT00438399|83027550|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
46808439|NCT00438399|83027551|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
46808440|NCT00426231|83027562|FG000|Overall Study|Withdrawal by Subject|9|||
46926124|NCT00849147|83160504|FG000|Overall Study|Protocol Violation|2|||
46926125|NCT00849147|83160504|FG000|Overall Study|Disease Relapse/Progression|2|||
46926126|NCT00101166|83160508|FG000|Overall Study|progressive disease|10|||
46926127|NCT02759016|83160514|FG000|Overall Study|Not treated with BI 836826|1|||
46926128|NCT02759016|83160515|FG001|Overall Study|Not treated with BI 836826|0|||
46926129|NCT02759016|83160514|FG000|Overall Study|Progressive disease|1|||
46926130|NCT02759016|83160515|FG001|Overall Study|Progressive disease|0|||
46926131|NCT02759016|83160514|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
46926132|NCT02759016|83160515|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
46926133|NCT02759016|83160514|FG000|Overall Study|Other not defined above|2|||
46926134|NCT02759016|83160515|FG001|Overall Study|Other not defined above|1|||
46926135|NCT02852967|83160527|FG000|Overall Study|Adverse Event|3|||
46926136|NCT02852967|83160528|FG001|Overall Study|Adverse Event|1|||
46926137|NCT02852967|83160529|FG002|Overall Study|Adverse Event|0|||
46926138|NCT02852967|83160530|FG003|Overall Study|Adverse Event|1|||
46926139|NCT02852967|83160531|FG004|Overall Study|Adverse Event|0|||
46926140|NCT02852967|83160527|FG000|Overall Study|Death|1|||
46926141|NCT02852967|83160528|FG001|Overall Study|Death|0|||
46926142|NCT02852967|83160529|FG002|Overall Study|Death|0|||
46926143|NCT02852967|83160530|FG003|Overall Study|Death|0|||
46926144|NCT02852967|83160531|FG004|Overall Study|Death|0|||
46808441|NCT00426231|83027563|FG001|Overall Study|Withdrawal by Subject|12|||
46808442|NCT00425607|83027569|FG000|Overall Study|Death|1|||
46808443|NCT00425607|83027569|FG000|Overall Study|Withdrawal by Subject|1|||
46808444|NCT00437073|83027575|FG000|Overall Study|Sponsor Terminated Study|1|||
46808445|NCT00437073|83027576|FG001|Overall Study|Sponsor Terminated Study|0|||
46808446|NCT00437073|83027575|FG000|Overall Study|Physician Decision|0|||
46808447|NCT00437073|83027576|FG001|Overall Study|Physician Decision|1|||
46808448|NCT00425373|83027591|FG000|Overall Study|Adverse Event|2|||
46808449|NCT00425373|83027592|FG001|Overall Study|Adverse Event|2|||
46808450|NCT00425373|83027593|FG002|Overall Study|Adverse Event|0|||
46808451|NCT00425373|83027594|FG003|Overall Study|Adverse Event|1|||
46926145|NCT02852967|83160527|FG000|Overall Study|Lost to Follow-up|1|||
46926146|NCT02852967|83160528|FG001|Overall Study|Lost to Follow-up|2|||
46926147|NCT02852967|83160529|FG002|Overall Study|Lost to Follow-up|3|||
46926148|NCT02852967|83160530|FG003|Overall Study|Lost to Follow-up|4|||
46753142|NCT02052778|82971180|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
46926149|NCT02852967|83160531|FG004|Overall Study|Lost to Follow-up|4|||
46926150|NCT02852967|83160527|FG000|Overall Study|Withdrawal by Subject|6|||
46636273|NCT01516008|82810119|FG001|Overall Study|Adverse Event|2|||
46753143|NCT02052778|82971181|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
46753144|NCT02052778|82971159|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753145|NCT02052778|82971160|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753146|NCT02052778|82971161|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753147|NCT02052778|82971162|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753148|NCT02052778|82971163|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753149|NCT02052778|82971164|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46808452|NCT00425373|83027595|FG004|Overall Study|Adverse Event|4|||
46926151|NCT02852967|83160528|FG001|Overall Study|Withdrawal by Subject|12|||
46926152|NCT02852967|83160529|FG002|Overall Study|Withdrawal by Subject|7|||
46808453|NCT00425373|83027596|FG005|Overall Study|Adverse Event|6|||
46808454|NCT00425373|83027597|FG006|Overall Study|Adverse Event|2|||
46808455|NCT00425373|83027598|FG007|Overall Study|Adverse Event|3|||
46808456|NCT00425373|83027599|FG008|Overall Study|Adverse Event|8|||
46808457|NCT00425373|83027591|FG000|Overall Study|Lost to Follow-up|0|||
46808458|NCT00425373|83027592|FG001|Overall Study|Lost to Follow-up|1|||
46808459|NCT00425373|83027593|FG002|Overall Study|Lost to Follow-up|0|||
46808460|NCT00425373|83027594|FG003|Overall Study|Lost to Follow-up|0|||
46808461|NCT00425373|83027595|FG004|Overall Study|Lost to Follow-up|1|||
46808462|NCT00425373|83027596|FG005|Overall Study|Lost to Follow-up|0|||
46808463|NCT00425373|83027597|FG006|Overall Study|Lost to Follow-up|0|||
46808464|NCT00425373|83027598|FG007|Overall Study|Lost to Follow-up|0|||
46808465|NCT00425373|83027599|FG008|Overall Study|Lost to Follow-up|0|||
46808466|NCT00425373|83027591|FG000|Overall Study|Protocol Violation|1|||
46808467|NCT00425373|83027592|FG001|Overall Study|Protocol Violation|0|||
46808468|NCT00425373|83027593|FG002|Overall Study|Protocol Violation|1|||
46808469|NCT00425373|83027594|FG003|Overall Study|Protocol Violation|0|||
46808470|NCT00425373|83027595|FG004|Overall Study|Protocol Violation|0|||
46808471|NCT00425373|83027596|FG005|Overall Study|Protocol Violation|0|||
46808472|NCT00425373|83027597|FG006|Overall Study|Protocol Violation|0|||
46808473|NCT00425373|83027598|FG007|Overall Study|Protocol Violation|5|||
46808474|NCT00425373|83027599|FG008|Overall Study|Protocol Violation|3|||
46808475|NCT00425373|83027591|FG000|Overall Study|Withdrawal by Subject|2|||
46808476|NCT00425373|83027592|FG001|Overall Study|Withdrawal by Subject|0|||
46808477|NCT00425373|83027593|FG002|Overall Study|Withdrawal by Subject|2|||
46808478|NCT00425373|83027594|FG003|Overall Study|Withdrawal by Subject|1|||
46808479|NCT00425373|83027595|FG004|Overall Study|Withdrawal by Subject|4|||
46808480|NCT00425373|83027596|FG005|Overall Study|Withdrawal by Subject|0|||
46808481|NCT00425373|83027597|FG006|Overall Study|Withdrawal by Subject|2|||
46808482|NCT00425373|83027598|FG007|Overall Study|Withdrawal by Subject|2|||
46808483|NCT00425373|83027599|FG008|Overall Study|Withdrawal by Subject|2|||
46808484|NCT00425373|83027591|FG000|Overall Study|Lack of Efficacy|0|||
46808485|NCT00425373|83027592|FG001|Overall Study|Lack of Efficacy|0|||
46808486|NCT00425373|83027593|FG002|Overall Study|Lack of Efficacy|0|||
46808487|NCT00425373|83027594|FG003|Overall Study|Lack of Efficacy|0|||
46808488|NCT00425373|83027595|FG004|Overall Study|Lack of Efficacy|1|||
46808489|NCT00425373|83027596|FG005|Overall Study|Lack of Efficacy|3|||
46808490|NCT00425373|83027597|FG006|Overall Study|Lack of Efficacy|3|||
46808491|NCT00425373|83027598|FG007|Overall Study|Lack of Efficacy|0|||
46808492|NCT00425373|83027599|FG008|Overall Study|Lack of Efficacy|5|||
46808493|NCT03894540|83027625|FG000|Overall Study|Adverse Event|0|||
46808494|NCT03894540|83027626|FG001|Overall Study|Adverse Event|0|||
46808495|NCT03894540|83027627|FG002|Overall Study|Adverse Event|0|||
46808496|NCT03894540|83027628|FG003|Overall Study|Adverse Event|0|||
46808497|NCT03894540|83027629|FG004|Overall Study|Adverse Event|1|||
46808498|NCT03894540|83027630|FG005|Overall Study|Adverse Event|0|||
46808499|NCT03894540|83027625|FG000|Overall Study|Withdrawal by Subject|0|||
46808500|NCT03894540|83027626|FG001|Overall Study|Withdrawal by Subject|0|||
46808501|NCT03894540|83027627|FG002|Overall Study|Withdrawal by Subject|0|||
46808502|NCT03894540|83027628|FG003|Overall Study|Withdrawal by Subject|0|||
46808503|NCT03894540|83027629|FG004|Overall Study|Withdrawal by Subject|1|||
46808504|NCT03894540|83027630|FG005|Overall Study|Withdrawal by Subject|0|||
46808505|NCT03894540|83027625|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
46808506|NCT03894540|83027626|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
46808507|NCT03894540|83027627|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
46808508|NCT03894540|83027628|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
46808509|NCT03894540|83027629|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
46808510|NCT03894540|83027630|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
46808511|NCT03894540|83027625|FG000|Overall Study|Progressive Disease Clinical|1|||
46808512|NCT03894540|83027626|FG001|Overall Study|Progressive Disease Clinical|1|||
46808513|NCT03894540|83027627|FG002|Overall Study|Progressive Disease Clinical|0|||
46808514|NCT03894540|83027628|FG003|Overall Study|Progressive Disease Clinical|1|||
46808515|NCT03894540|83027629|FG004|Overall Study|Progressive Disease Clinical|5|||
46808516|NCT03894540|83027630|FG005|Overall Study|Progressive Disease Clinical|1|||
46808517|NCT03894540|83027625|FG000|Overall Study|Study termination by sponsor|0|||
46808518|NCT03894540|83027626|FG001|Overall Study|Study termination by sponsor|0|||
46808519|NCT03894540|83027627|FG002|Overall Study|Study termination by sponsor|0|||
46808520|NCT03894540|83027628|FG003|Overall Study|Study termination by sponsor|0|||
46808521|NCT03894540|83027629|FG004|Overall Study|Study termination by sponsor|2|||
46808522|NCT03894540|83027630|FG005|Overall Study|Study termination by sponsor|0|||
46808523|NCT00535626|83027648|FG000|Overall Study|Death|15|||
46808524|NCT00535626|83027648|FG000|Overall Study|Lost to Follow-up|29|||
46808525|NCT00535626|83027648|FG000|Overall Study|Withdrawal by Subject|20|||
46808526|NCT00535626|83027648|FG000|Overall Study|Removal/revision of study component|8|||
46808527|NCT00535626|83027648|FG000|Overall Study|Subject terminated|31|||
46808528|NCT00535626|83027648|FG000|Overall Study|Unable to return|2|||
46808529|NCT03889704|83027671|FG000|Overall Study|Study terminated due to pandemic|1|||
46808530|NCT03887442|83027677|FG000|Overall Study|Adverse Event|1|||
46808531|NCT03887442|83027678|FG001|Overall Study|Adverse Event|0|||
46808532|NCT00425061|83027693|FG000|Overall Study|Adverse Event|1|||
46808533|NCT00425061|83027694|FG001|Overall Study|Adverse Event|0|||
46808534|NCT00425061|83027695|FG002|Overall Study|Adverse Event|0|||
46808535|NCT00425061|83027696|FG003|Overall Study|Adverse Event|2|||
46808536|NCT00425061|83027697|FG004|Overall Study|Adverse Event|2|||
46808537|NCT00425061|83027698|FG005|Overall Study|Adverse Event|0|||
46808538|NCT00425061|83027699|FG006|Overall Study|Adverse Event|0|||
46808539|NCT00425061|83027693|FG000|Overall Study|Lost to Follow-up|0|||
46808540|NCT00425061|83027694|FG001|Overall Study|Lost to Follow-up|1|||
46808541|NCT00425061|83027695|FG002|Overall Study|Lost to Follow-up|0|||
46808542|NCT00425061|83027696|FG003|Overall Study|Lost to Follow-up|0|||
46808543|NCT00425061|83027697|FG004|Overall Study|Lost to Follow-up|0|||
46808544|NCT00425061|83027698|FG005|Overall Study|Lost to Follow-up|0|||
46808545|NCT00425061|83027699|FG006|Overall Study|Lost to Follow-up|0|||
46808546|NCT00425061|83027693|FG000|Overall Study|Protocol Violation|1|||
46926153|NCT02852967|83160530|FG003|Overall Study|Withdrawal by Subject|10|||
46926154|NCT02852967|83160531|FG004|Overall Study|Withdrawal by Subject|10|||
46926155|NCT02852967|83160527|FG000|Overall Study|SAE|0|||
46926156|NCT02852967|83160528|FG001|Overall Study|SAE|0|||
46926157|NCT02852967|83160529|FG002|Overall Study|SAE|0|||
46926158|NCT02852967|83160530|FG003|Overall Study|SAE|3|||
46926159|NCT02852967|83160531|FG004|Overall Study|SAE|0|||
46926160|NCT02852967|83160527|FG000|Overall Study|Elevated Liver Enzymes|2|||
46926161|NCT02852967|83160528|FG001|Overall Study|Elevated Liver Enzymes|0|||
46926162|NCT02852967|83160529|FG002|Overall Study|Elevated Liver Enzymes|0|||
46926163|NCT02852967|83160530|FG003|Overall Study|Elevated Liver Enzymes|2|||
46926164|NCT02852967|83160531|FG004|Overall Study|Elevated Liver Enzymes|2|||
46926165|NCT02852967|83160527|FG000|Overall Study|Physician Decision|0|||
46926166|NCT02852967|83160528|FG001|Overall Study|Physician Decision|0|||
46926167|NCT02852967|83160529|FG002|Overall Study|Physician Decision|0|||
46808547|NCT00425061|83027694|FG001|Overall Study|Protocol Violation|0|||
46808548|NCT00425061|83027695|FG002|Overall Study|Protocol Violation|0|||
46808549|NCT00425061|83027696|FG003|Overall Study|Protocol Violation|0|||
46808550|NCT00425061|83027697|FG004|Overall Study|Protocol Violation|0|||
46808551|NCT00425061|83027698|FG005|Overall Study|Protocol Violation|0|||
46808552|NCT00425061|83027699|FG006|Overall Study|Protocol Violation|0|||
46808553|NCT00425061|83027693|FG000|Overall Study|Withdrawal by Subject|0|||
46808554|NCT00425061|83027694|FG001|Overall Study|Withdrawal by Subject|1|||
46808555|NCT00425061|83027695|FG002|Overall Study|Withdrawal by Subject|0|||
46808556|NCT00425061|83027696|FG003|Overall Study|Withdrawal by Subject|0|||
46808557|NCT00425061|83027697|FG004|Overall Study|Withdrawal by Subject|1|||
46808558|NCT00425061|83027698|FG005|Overall Study|Withdrawal by Subject|0|||
46926168|NCT02852967|83160530|FG003|Overall Study|Physician Decision|1|||
46926169|NCT02852967|83160531|FG004|Overall Study|Physician Decision|0|||
46926170|NCT02852967|83160527|FG000|Overall Study|Lack of Efficacy|0|||
46926171|NCT02852967|83160528|FG001|Overall Study|Lack of Efficacy|1|||
46926172|NCT02852967|83160529|FG002|Overall Study|Lack of Efficacy|0|||
46926173|NCT02852967|83160530|FG003|Overall Study|Lack of Efficacy|0|||
46808559|NCT00425061|83027699|FG006|Overall Study|Withdrawal by Subject|3|||
46808560|NCT00425061|83027693|FG000|Overall Study|Sponsor's request|0|||
46808561|NCT00425061|83027694|FG001|Overall Study|Sponsor's request|0|||
46808562|NCT00425061|83027695|FG002|Overall Study|Sponsor's request|0|||
46808563|NCT00425061|83027696|FG003|Overall Study|Sponsor's request|0|||
46808564|NCT00425061|83027697|FG004|Overall Study|Sponsor's request|19|||
46926174|NCT02852967|83160531|FG004|Overall Study|Lack of Efficacy|0|||
46926175|NCT02852967|83160527|FG000|Overall Study|Non-compliance|0|||
46926176|NCT02852967|83160528|FG001|Overall Study|Non-compliance|0|||
46926177|NCT02852967|83160529|FG002|Overall Study|Non-compliance|1|||
46926178|NCT02852967|83160530|FG003|Overall Study|Non-compliance|1|||
46926179|NCT02852967|83160531|FG004|Overall Study|Non-compliance|0|||
46808565|NCT00425061|83027698|FG005|Overall Study|Sponsor's request|4|||
46808566|NCT00425061|83027699|FG006|Overall Study|Sponsor's request|15|||
46808567|NCT00425061|83027693|FG000|Overall Study|Physician Decision|0|||
46808568|NCT00425061|83027694|FG001|Overall Study|Physician Decision|0|||
46808569|NCT00425061|83027695|FG002|Overall Study|Physician Decision|0|||
46808570|NCT00425061|83027696|FG003|Overall Study|Physician Decision|0|||
46926180|NCT02852967|83160527|FG000|Overall Study|Dispensing Drug Violation|0|||
46926181|NCT02852967|83160528|FG001|Overall Study|Dispensing Drug Violation|0|||
46926182|NCT02852967|83160529|FG002|Overall Study|Dispensing Drug Violation|1|||
46926183|NCT02852967|83160530|FG003|Overall Study|Dispensing Drug Violation|0|||
46926184|NCT02852967|83160531|FG004|Overall Study|Dispensing Drug Violation|0|||
46808571|NCT00425061|83027697|FG004|Overall Study|Physician Decision|1|||
46808572|NCT00425061|83027698|FG005|Overall Study|Physician Decision|0|||
46808573|NCT00425061|83027699|FG006|Overall Study|Physician Decision|0|||
46926185|NCT02852967|83160527|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
46808574|NCT00425061|83027693|FG000|Overall Study|Other|0|||
46808575|NCT00425061|83027694|FG001|Overall Study|Other|0|||
46808576|NCT00425061|83027695|FG002|Overall Study|Other|0|||
46808577|NCT00425061|83027696|FG003|Overall Study|Other|0|||
46808578|NCT00425061|83027697|FG004|Overall Study|Other|3|||
46808579|NCT00425061|83027698|FG005|Overall Study|Other|0|||
46808580|NCT00425061|83027699|FG006|Overall Study|Other|1|||
46808581|NCT00424827|83027717|FG000|Overall Study|Adverse Event|1|||
46808582|NCT03885726|83027722|FG000|Overall Study|Staffing issues/lost interest|1|||
46808583|NCT03885726|83027722|FG000|Overall Study|Early discharge from hospital|3|||
46808584|NCT00377962|83027732|FG000|Core Study: 0-12 Months|Adverse Event|18|||
46808585|NCT00377962|83027733|FG001|Core Study: 0-12 Months|Adverse Event|2|||
46808586|NCT00377962|83027732|FG000|Core Study: 0-12 Months|Death|3|||
46808587|NCT00377962|83027733|FG001|Core Study: 0-12 Months|Death|0|||
46808588|NCT00377962|83027732|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
46808589|NCT00377962|83027733|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
46926186|NCT02852967|83160528|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
46926187|NCT02852967|83160529|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
46926188|NCT02852967|83160530|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
46926189|NCT02852967|83160531|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
46926190|NCT02762994|83160559|FG000|Overall Study|Withdrawal by Subject|0|||
46926191|NCT02762994|83160560|FG001|Overall Study|Withdrawal by Subject|1|||
46808590|NCT00377962|83027732|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
46808591|NCT00377962|83027733|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
46808592|NCT00377962|83027732|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
46808593|NCT00377962|83027733|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
46808594|NCT00377962|83027732|FG000|Extension Study: 12-24 Months|Death|1|||
46808595|NCT00377962|83027733|FG001|Extension Study: 12-24 Months|Death|1|||
46808596|NCT00377962|83027732|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
46808597|NCT00377962|83027733|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
46808598|NCT00377962|83027732|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
46808599|NCT00377962|83027733|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
46808600|NCT00377962|83027732|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
46808601|NCT00377962|83027733|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
46808602|NCT00424749|83027745|FG000|Overall Study|Withdrawal by Subject|1|||
46808603|NCT00424593|83027751|FG000|Acute Double-Blind Period|Adverse Event|16|||
46808604|NCT00424593|83027752|FG001|Acute Double-Blind Period|Adverse Event|7|||
46808605|NCT00424593|83027751|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
46808606|NCT00424593|83027752|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
46808607|NCT00424593|83027751|FG000|Acute Double-Blind Period|Protocol Violation|2|||
46808608|NCT00424593|83027752|FG001|Acute Double-Blind Period|Protocol Violation|2|||
46808609|NCT00424593|83027751|FG000|Acute Double-Blind Period|Physician Decision|1|||
46808610|NCT00424593|83027752|FG001|Acute Double-Blind Period|Physician Decision|2|||
46808611|NCT00424593|83027751|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
46808612|NCT00424593|83027752|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
46808613|NCT00424593|83027751|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
46808614|NCT00424593|83027752|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
46808615|NCT00424593|83027751|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
46926192|NCT02762994|83160561|FG002|Overall Study|Withdrawal by Subject|2|||
46926193|NCT02762994|83160562|FG003|Overall Study|Withdrawal by Subject|0|||
46926194|NCT02762994|83160559|FG000|Overall Study|Protocol Violation|1|||
46926195|NCT02762994|83160560|FG001|Overall Study|Protocol Violation|0|||
46926196|NCT02762994|83160561|FG002|Overall Study|Protocol Violation|0|||
46926197|NCT02762994|83160562|FG003|Overall Study|Protocol Violation|2|||
46926198|NCT02852265|83160578|FG000|3-month Follow-up|Lost to Follow-up|1|||
46926199|NCT02852265|83160579|FG001|3-month Follow-up|Lost to Follow-up|1|||
46926200|NCT02633800|83160591|FG000|Overall Study|Death|3|||
46926201|NCT02633800|83160592|FG001|Overall Study|Death|3|||
46926202|NCT02633800|83160591|FG000|Overall Study|Reason not provided|1|||
46636274|NCT01516008|82810120|FG002|Overall Study|Adverse Event|7|||
46808616|NCT00424593|83027752|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
46808617|NCT00424593|83027751|FG000|Dose-Blind Extension Period|Adverse Event|18|||
46808618|NCT00424593|83027752|FG001|Dose-Blind Extension Period|Adverse Event|0|||
46808619|NCT00424593|83027751|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
46808620|NCT00424593|83027752|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
46808621|NCT00424593|83027751|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
46808622|NCT00424593|83027752|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
46926203|NCT02633800|83160592|FG001|Overall Study|Reason not provided|0|||
46808623|NCT00424593|83027751|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
46808624|NCT00424593|83027752|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
46808625|NCT00424593|83027751|FG000|Dose-Blind Extension Period|Physician Decision|3|||
46808626|NCT00424593|83027752|FG001|Dose-Blind Extension Period|Physician Decision|0|||
46808627|NCT00369382|83027760|FG000|Overall Study|Death|0|||
46636275|NCT01516008|82810118|FG000|Overall Study|Lack of Efficacy|44|||
46636276|NCT01516008|82810119|FG001|Overall Study|Lack of Efficacy|14|||
46808628|NCT00369382|83027761|FG001|Overall Study|Death|2|||
46808629|NCT00369382|83027760|FG000|Overall Study|Physician Decision|2|||
46808630|NCT00369382|83027761|FG001|Overall Study|Physician Decision|1|||
46808631|NCT00369382|83027760|FG000|Overall Study|Withdrawal by Subject|5|||
46808632|NCT00369382|83027761|FG001|Overall Study|Withdrawal by Subject|0|||
46808633|NCT00369382|83027760|FG000|Overall Study|Randomized, not treated|2|||
46808634|NCT00369382|83027761|FG001|Overall Study|Randomized, not treated|0|||
46808635|NCT00369382|83027760|FG000|Overall Study|Other|1|||
46808636|NCT00369382|83027761|FG001|Overall Study|Other|0|||
46808637|NCT00424515|83027770|FG000|Overall Study|Progressive Disease|10|||
46808638|NCT00424515|83027771|FG001|Overall Study|Progressive Disease|11|||
46808639|NCT00424515|83027770|FG000|Overall Study|Adverse Event|0|||
46808640|NCT00424515|83027771|FG001|Overall Study|Adverse Event|1|||
46808641|NCT00424515|83027770|FG000|Overall Study|Intercurrent Illness|0|||
46753150|NCT02052778|82971165|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753151|NCT02052778|82971166|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46636277|NCT01516008|82810120|FG002|Overall Study|Lack of Efficacy|10|||
46753152|NCT02052778|82971167|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46808642|NCT00424515|83027771|FG001|Overall Study|Intercurrent Illness|1|||
46808643|NCT00424515|83027770|FG000|Overall Study|Withdrawal by Subject|1|||
46808644|NCT00424515|83027771|FG001|Overall Study|Withdrawal by Subject|0|||
46808645|NCT00377260|83027779|FG000|Overall Study|Lost to Follow-up|0|||
46808646|NCT00377260|83027780|FG001|Overall Study|Lost to Follow-up|1|||
46808647|NCT00377260|83027779|FG000|Overall Study|Withdrawal by Subject|2|||
46808648|NCT00377260|83027780|FG001|Overall Study|Withdrawal by Subject|4|||
46808649|NCT00441441|83027788|FG000|Overall Study|Adverse Event|2|||
46808650|NCT00441441|83027789|FG001|Overall Study|Adverse Event|1|||
46808651|NCT00441441|83027788|FG000|Overall Study|Protocol Violation|4|||
46808652|NCT00441441|83027789|FG001|Overall Study|Protocol Violation|6|||
46808653|NCT00441441|83027788|FG000|Overall Study|Exacerbation of asthma|1|||
46808654|NCT00441441|83027789|FG001|Overall Study|Exacerbation of asthma|2|||
46808655|NCT00441441|83027788|FG000|Overall Study|Withdrawal by Subject|1|||
46808656|NCT00441441|83027789|FG001|Overall Study|Withdrawal by Subject|2|||
46808657|NCT00441441|83027788|FG000|Overall Study|Other|3|||
46808658|NCT00441441|83027789|FG001|Overall Study|Other|3|||
46808659|NCT00436917|83027809|FG000|Overall Study|Withdrawal by Subject|13|||
46808660|NCT00436917|83027809|FG000|Overall Study|Adverse Event|2|||
46808661|NCT00436917|83027809|FG000|Overall Study|Physician Decision|1|||
46926204|NCT02633800|83160591|FG000|Overall Study|Radiologic(al) progression|23|||
46926205|NCT02633800|83160592|FG001|Overall Study|Radiologic(al) progression|23|||
46753153|NCT02052778|82971168|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753154|NCT02052778|82971169|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753155|NCT02052778|82971170|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753156|NCT02052778|82971171|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753157|NCT02052778|82971172|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753158|NCT02052778|82971173|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753159|NCT02052778|82971174|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753160|NCT02052778|82971175|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753161|NCT02052778|82971176|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753162|NCT02052778|82971177|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753163|NCT02052778|82971178|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753164|NCT02052778|82971179|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753165|NCT02052778|82971180|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
46753166|NCT02052778|82971181|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
46753167|NCT02052778|82971159|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
46753168|NCT02052778|82971160|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
46753169|NCT02052778|82971161|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
46808662|NCT00436917|83027809|FG000|Overall Study|Death|1|||
46808663|NCT00436917|83027809|FG000|Overall Study|Lost to Follow-up|1|||
46808664|NCT00436917|83027809|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
46808665|NCT00436917|83027809|FG000|Overall Study|Increased creatinine|1|||
46808666|NCT00436917|83027809|FG000|Overall Study|Personal conflicts of patient|1|||
46808667|NCT00436605|83027813|FG000|Overall Study|Protocol Violation|3|||
46808668|NCT00368992|83027817|FG000|Overall Study|Ineligible|5|||
46636278|NCT01516008|82810118|FG000|Overall Study|Protocol Violation|1|||
46808669|NCT00368992|83027817|FG000|Overall Study|Refused treatment|3|||
46808670|NCT00368992|83027817|FG000|Overall Study|Lack of Efficacy|63|||
46808671|NCT00368992|83027817|FG000|Overall Study|Adverse Event|26|||
46808672|NCT00368992|83027817|FG000|Overall Study|Death|4|||
46636279|NCT01516008|82810119|FG001|Overall Study|Protocol Violation|0|||
46808673|NCT00368992|83027817|FG000|Overall Study|Other|9|||
46808674|NCT00376246|83027822|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
46808675|NCT00376246|83027823|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
46808676|NCT00376246|83027822|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
46926206|NCT02633800|83160591|FG000|Overall Study|Clinical progression|3|||
46926207|NCT02633800|83160592|FG001|Overall Study|Clinical progression|6|||
46926208|NCT02633800|83160591|FG000|Overall Study|Study terminated by sponsor|6|||
47053596|NCT00708552|83323930|FG002|Overall Study|Adverse Event|4|||
47053597|NCT00708552|83323931|FG003|Overall Study|Adverse Event|6|||
47053598|NCT00708552|83323928|FG000|Overall Study|Lack of Efficacy|0|||
47053599|NCT00708552|83323929|FG001|Overall Study|Lack of Efficacy|4|||
47053600|NCT00708552|83323930|FG002|Overall Study|Lack of Efficacy|1|||
47053601|NCT00708552|83323931|FG003|Overall Study|Lack of Efficacy|0|||
47053602|NCT00708552|83323928|FG000|Overall Study|Protocol Violation|0|||
47053603|NCT00708552|83323929|FG001|Overall Study|Protocol Violation|0|||
47053604|NCT00708552|83323930|FG002|Overall Study|Protocol Violation|2|||
47053605|NCT00708552|83323931|FG003|Overall Study|Protocol Violation|4|||
47053606|NCT00708552|83323928|FG000|Overall Study|Lost to Follow-up|4|||
47053607|NCT00708552|83323929|FG001|Overall Study|Lost to Follow-up|2|||
47053608|NCT00708552|83323930|FG002|Overall Study|Lost to Follow-up|0|||
47053609|NCT00708552|83323931|FG003|Overall Study|Lost to Follow-up|1|||
47053610|NCT00708552|83323928|FG000|Overall Study|Physician Decision|1|||
47053611|NCT00708552|83323929|FG001|Overall Study|Physician Decision|2|||
47053612|NCT00708552|83323930|FG002|Overall Study|Physician Decision|0|||
47053613|NCT00708552|83323931|FG003|Overall Study|Physician Decision|0|||
47053614|NCT00708552|83323928|FG000|Overall Study|Withdrawal by Subject|12|||
47053615|NCT00708552|83323929|FG001|Overall Study|Withdrawal by Subject|7|||
47053616|NCT00708552|83323930|FG002|Overall Study|Withdrawal by Subject|8|||
47053617|NCT00708552|83323931|FG003|Overall Study|Withdrawal by Subject|10|||
47053618|NCT01816295|83324061|FG000|Double Blind Phase|Adverse Event|11|||
47053619|NCT01816295|83324062|FG001|Double Blind Phase|Adverse Event|8|||
47053620|NCT01816295|83324061|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
47053621|NCT01816295|83324062|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
47053622|NCT01816295|83324061|FG000|Double Blind Phase|Lost to Follow-up|3|||
47053623|NCT01816295|83324062|FG001|Double Blind Phase|Lost to Follow-up|5|||
47053624|NCT01816295|83324061|FG000|Double Blind Phase|Physician Decision|2|||
47053625|NCT01816295|83324062|FG001|Double Blind Phase|Physician Decision|2|||
47053626|NCT01816295|83324061|FG000|Double Blind Phase|Protocol Violation|17|||
47053627|NCT01816295|83324062|FG001|Double Blind Phase|Protocol Violation|11|||
47053628|NCT01816295|83324061|FG000|Double Blind Phase|Sponsor Decision|8|||
47053629|NCT01816295|83324062|FG001|Double Blind Phase|Sponsor Decision|8|||
46926209|NCT02633800|83160592|FG001|Overall Study|Study terminated by sponsor|5|||
46926210|NCT02633800|83160591|FG000|Overall Study|Adverse event, non-fatal|7|||
46926211|NCT02633800|83160592|FG001|Overall Study|Adverse event, non-fatal|2|||
46926212|NCT02633800|83160591|FG000|Overall Study|Withdrawal by Subject|0|||
46926213|NCT02633800|83160592|FG001|Overall Study|Withdrawal by Subject|3|||
46926214|NCT02633800|83160591|FG000|Overall Study|Patient Request|1|||
46926215|NCT02633800|83160592|FG001|Overall Study|Patient Request|1|||
46926216|NCT03829657|83160601|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
46926217|NCT03829657|83160602|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
46926218|NCT03829657|83160603|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
46926219|NCT03829657|83160604|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
46926220|NCT03829657|83160605|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
46926221|NCT03829657|83160601|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
46926222|NCT03829657|83160602|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
46926223|NCT03829657|83160603|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
46926224|NCT03829657|83160604|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
46926225|NCT03829657|83160605|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
46926226|NCT03829657|83160601|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
46926227|NCT03829657|83160602|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
46926228|NCT03829657|83160603|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
46926229|NCT03829657|83160604|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
46926230|NCT03829657|83160605|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
46926231|NCT03829657|83160601|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
46926232|NCT03829657|83160602|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
46926233|NCT03829657|83160603|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
46926234|NCT03829657|83160604|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
47053630|NCT01816295|83324061|FG000|Double Blind Phase|Withdrawal by Subject|22|||
47053631|NCT01816295|83324062|FG001|Double Blind Phase|Withdrawal by Subject|20|||
47053632|NCT01816295|83324061|FG000|OLE Phase|Adverse Event|17|||
47053633|NCT01816295|83324062|FG001|OLE Phase|Adverse Event|15|||
47053634|NCT01816295|83324061|FG000|OLE Phase|Death|1|||
47053635|NCT01816295|83324062|FG001|OLE Phase|Death|0|||
47053636|NCT01816295|83324061|FG000|OLE Phase|Entry Criteria Not Met|3|||
47053637|NCT01816295|83324062|FG001|OLE Phase|Entry Criteria Not Met|5|||
47053638|NCT01816295|83324061|FG000|OLE Phase|Lost to Follow-up|5|||
47053639|NCT01816295|83324062|FG001|OLE Phase|Lost to Follow-up|5|||
46636280|NCT01516008|82810120|FG002|Overall Study|Protocol Violation|0|||
46926235|NCT03829657|83160605|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
46926236|NCT03829657|83160601|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
46926237|NCT03829657|83160602|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
46926238|NCT03829657|83160603|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
47053640|NCT01816295|83324061|FG000|OLE Phase|Physician Decision|3|||
47053641|NCT01816295|83324062|FG001|OLE Phase|Physician Decision|1|||
47053642|NCT01816295|83324061|FG000|OLE Phase|Protocol Violation|4|||
47053643|NCT01816295|83324062|FG001|OLE Phase|Protocol Violation|4|||
47053644|NCT01816295|83324061|FG000|OLE Phase|Sponsor Decision|7|||
46753170|NCT02052778|82971162|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
46753171|NCT02052778|82971163|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
46753172|NCT02052778|82971164|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
46753173|NCT02052778|82971165|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
46753174|NCT02052778|82971166|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
46753175|NCT02052778|82971167|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
46753176|NCT02052778|82971168|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
46753177|NCT02052778|82971169|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
46753178|NCT02052778|82971170|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
46753179|NCT02052778|82971171|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
46753180|NCT02052778|82971172|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
46753181|NCT02052778|82971173|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
46753182|NCT02052778|82971174|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
46753183|NCT02052778|82971175|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
46753184|NCT02052778|82971176|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
46753185|NCT02052778|82971177|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
46753186|NCT02052778|82971178|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
46753187|NCT02052778|82971179|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
46753188|NCT02052778|82971180|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
46753189|NCT02052778|82971181|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
46753190|NCT02052778|82971159|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753191|NCT02052778|82971160|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753192|NCT02052778|82971161|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753193|NCT02052778|82971162|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753194|NCT02052778|82971163|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753195|NCT02052778|82971164|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753196|NCT02052778|82971165|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753197|NCT02052778|82971166|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753198|NCT02052778|82971167|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753199|NCT02052778|82971168|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753200|NCT02052778|82971169|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753201|NCT02052778|82971170|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753202|NCT02052778|82971171|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753203|NCT02052778|82971172|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753204|NCT02052778|82971173|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753205|NCT02052778|82971174|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753206|NCT02052778|82971175|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753207|NCT02052778|82971176|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753208|NCT02052778|82971177|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753209|NCT02052778|82971178|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753210|NCT02052778|82971179|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753211|NCT02052778|82971180|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
46753212|NCT02052778|82971181|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
46753213|NCT01614990|82971221|FG000|Overall Study|Protocol Violation|1|||
46753214|NCT01614990|82971222|FG001|Overall Study|Protocol Violation|1|||
46753215|NCT01585194|82971228|FG000|Overall Study|Withdrawal by Subject|1|||
46753216|NCT01585194|82971228|FG000|Overall Study|Physician Decision|2|||
46753217|NCT01585194|82971228|FG000|Overall Study|Lack of insurance|1|||
46753218|NCT01120249|82971234|FG000|Overall Study|No protocol treatment received|21|||
46753219|NCT01120249|82971235|FG001|Overall Study|No protocol treatment received|15|||
46753220|NCT01120249|82971234|FG000|Overall Study|Disease recurrence|107|||
46753221|NCT01120249|82971235|FG001|Overall Study|Disease recurrence|57|||
46753222|NCT01120249|82971234|FG000|Overall Study|Death|1|||
46753223|NCT01120249|82971235|FG001|Overall Study|Death|0|||
46753224|NCT01120249|82971234|FG000|Overall Study|Adverse Event|40|||
46753225|NCT01120249|82971235|FG001|Overall Study|Adverse Event|276|||
46753226|NCT01120249|82971234|FG000|Overall Study|Participant refusal|34|||
46753227|NCT01120249|82971235|FG001|Overall Study|Participant refusal|42|||
46753228|NCT01120249|82971234|FG000|Overall Study|Other reasons, not protocol specified|29|||
46753229|NCT01120249|82971235|FG001|Overall Study|Other reasons, not protocol specified|22|||
46753230|NCT00981058|82971244|FG000|Overall Study|Adverse Event|1|||
46753231|NCT00981058|82971245|FG001|Overall Study|Adverse Event|1|||
46753232|NCT00981058|82971244|FG000|Overall Study|Progressive Disease|61|||
46753233|NCT00981058|82971245|FG001|Overall Study|Progressive Disease|49|||
46926239|NCT03829657|83160604|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
46926240|NCT03829657|83160605|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
46926241|NCT03829657|83160601|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
46926242|NCT03829657|83160602|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
46926243|NCT03829657|83160603|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
46926244|NCT03829657|83160604|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
46926245|NCT03829657|83160605|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
46926246|NCT03829657|83160601|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
46926247|NCT03829657|83160602|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
46926248|NCT03829657|83160603|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
46926249|NCT03829657|83160604|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
46926250|NCT03829657|83160605|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
46926251|NCT03829657|83160601|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
46926252|NCT03829657|83160602|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
46926253|NCT03829657|83160603|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
46926254|NCT03829657|83160604|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
46926255|NCT03829657|83160605|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
46926256|NCT03829657|83160601|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
46926257|NCT03829657|83160602|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
46926258|NCT03829657|83160603|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
46926259|NCT03829657|83160604|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
46926260|NCT03829657|83160605|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
46926261|NCT03829657|83160601|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
46926262|NCT03829657|83160602|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
46926263|NCT03829657|83160603|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
46926264|NCT03829657|83160604|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
47053645|NCT01816295|83324062|FG001|OLE Phase|Sponsor Decision|9|||
47053646|NCT01816295|83324061|FG000|OLE Phase|Withdrawal by Subject|10|||
47053647|NCT01816295|83324062|FG001|OLE Phase|Withdrawal by Subject|10|||
47053648|NCT01816295|83324061|FG000|OLE Phase|Lack of Efficacy|3|||
47053649|NCT01816295|83324062|FG001|OLE Phase|Lack of Efficacy|7|||
47053650|NCT01610297|83324087|FG000|Overall Study|Lost to Follow-up|1|||
46753234|NCT00981058|82971244|FG000|Overall Study|Lost to Follow-up|16|||
46753235|NCT00981058|82971245|FG001|Overall Study|Lost to Follow-up|15|||
46753236|NCT00981058|82971244|FG000|Overall Study|New Anticancer Therapy|6|||
46753237|NCT00981058|82971245|FG001|Overall Study|New Anticancer Therapy|6|||
46753238|NCT00981058|82971244|FG000|Overall Study|Noncompliance|1|||
46753239|NCT00981058|82971245|FG001|Overall Study|Noncompliance|0|||
46753240|NCT00981058|82971244|FG000|Overall Study|Radiologist Error|0|||
46753241|NCT00981058|82971245|FG001|Overall Study|Radiologist Error|1|||
46753242|NCT00981058|82971244|FG000|Overall Study|Randomization Error|1|||
46753243|NCT00981058|82971245|FG001|Overall Study|Randomization Error|2|||
46753244|NCT00981058|82971244|FG000|Overall Study|Withdrawal by Subject|25|||
46753245|NCT00981058|82971245|FG001|Overall Study|Withdrawal by Subject|23|||
46753246|NCT00981058|82971244|FG000|Overall Study|On study treatment at conclusion|9|||
46753247|NCT00981058|82971245|FG001|Overall Study|On study treatment at conclusion|0|||
46753248|NCT00093470|82971279|FG000|Overall Study|Disease progression|39|||
46753249|NCT00093470|82971280|FG001|Overall Study|Disease progression|0|||
46753250|NCT00093470|82971279|FG000|Overall Study|Adverse Event|15|||
46753251|NCT00093470|82971280|FG001|Overall Study|Adverse Event|0|||
46753252|NCT00093470|82971279|FG000|Overall Study|Death|2|||
46753253|NCT00093470|82971280|FG001|Overall Study|Death|0|||
46753254|NCT00093470|82971279|FG000|Overall Study|Withdrawal by Subject|8|||
46753255|NCT00093470|82971280|FG001|Overall Study|Withdrawal by Subject|0|||
46753256|NCT00093470|82971279|FG000|Overall Study|Alternative therapy|2|||
46753257|NCT00093470|82971280|FG001|Overall Study|Alternative therapy|0|||
46753258|NCT00093470|82971279|FG000|Overall Study|Other complicating disease|3|||
46753259|NCT00093470|82971280|FG001|Overall Study|Other complicating disease|0|||
46753260|NCT00093470|82971279|FG000|Overall Study|Physician Decision|2|||
46753261|NCT00093470|82971280|FG001|Overall Study|Physician Decision|0|||
46808677|NCT00376246|83027823|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
47053651|NCT01793051|83324098|FG000|Overall Study|Withdrawal by Subject|6|||
47053652|NCT01793051|83324099|FG001|Overall Study|Withdrawal by Subject|4|||
47053653|NCT01793051|83324098|FG000|Overall Study|Adverse Event|0|||
47053654|NCT01793051|83324099|FG001|Overall Study|Adverse Event|2|||
46753262|NCT00093470|82971279|FG000|Overall Study|Never started treatment|1|||
46753263|NCT00093470|82971280|FG001|Overall Study|Never started treatment|0|||
46753264|NCT00093470|82971279|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
46753265|NCT00093470|82971280|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
46753266|NCT00880620|82971299|FG000|Overall Study|Adverse Event|4|||
46753267|NCT00880620|82971300|FG001|Overall Study|Adverse Event|5|||
46808678|NCT00376246|83027822|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
46808679|NCT00376246|83027823|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
46808680|NCT00368836|83027833|FG000|Phase II|Screen Failure|1|||
46808681|NCT00368836|83027833|FG000|Phase II|Withdrawal by Subject|1|||
46808682|NCT00368836|83027833|FG000|Phase II|unable to collect blood and/or breath|17|||
46808683|NCT00368836|83027833|FG000|Phase II|Protocol Violation|2|||
46808684|NCT00376168|83027842|FG000|Overall Study|Adverse Event|1|||
46808685|NCT00376168|83027843|FG001|Overall Study|Adverse Event|1|||
46808686|NCT00376168|83027842|FG000|Overall Study|Pregnancy|1|||
46808687|NCT00376168|83027843|FG001|Overall Study|Pregnancy|0|||
46808688|NCT00375934|83027851|FG000|Overall Study|Adverse Event|1|||
46808689|NCT00375934|83027852|FG001|Overall Study|Adverse Event|1|||
46808690|NCT00375934|83027851|FG000|Overall Study|Withdrawal by Subject|2|||
46808691|NCT00375934|83027852|FG001|Overall Study|Withdrawal by Subject|2|||
46808692|NCT00375934|83027851|FG000|Overall Study|Lack of Efficacy|0|||
46808693|NCT00375934|83027852|FG001|Overall Study|Lack of Efficacy|2|||
46808694|NCT00375934|83027851|FG000|Overall Study|Physician Decision|0|||
46808695|NCT00375934|83027852|FG001|Overall Study|Physician Decision|1|||
46808696|NCT00642941|83027870|FG000|Overall Study|Physician Decision|3|||
46808697|NCT00642941|83027871|FG001|Overall Study|Physician Decision|1|||
46808698|NCT00642941|83027872|FG002|Overall Study|Physician Decision|0|||
46808699|NCT00642941|83027873|FG003|Overall Study|Physician Decision|0|||
46808700|NCT00642941|83027874|FG004|Overall Study|Physician Decision|0|||
46808701|NCT00642941|83027875|FG005|Overall Study|Physician Decision|0|||
46808702|NCT00642941|83027876|FG006|Overall Study|Physician Decision|1|||
46808703|NCT00642941|83027877|FG007|Overall Study|Physician Decision|0|||
46808704|NCT00642941|83027878|FG008|Overall Study|Physician Decision|0|||
46808705|NCT00642941|83027879|FG009|Overall Study|Physician Decision|1|||
46808706|NCT00642941|83027880|FG010|Overall Study|Physician Decision|0|||
46808707|NCT00642941|83027881|FG011|Overall Study|Physician Decision|1|||
46808708|NCT00642941|83027870|FG000|Overall Study|Death|4|||
46808709|NCT00642941|83027871|FG001|Overall Study|Death|0|||
46926265|NCT03829657|83160605|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
46926266|NCT03035227|83160616|FG000|Overall Study|study stopped due to PI leaving institut|1|||
46926267|NCT03035227|83160617|FG001|Overall Study|study stopped due to PI leaving institut|1|||
46926268|NCT00100932|83160627|FG000|Overall Study|Adverse Event|11|||
46926269|NCT00100932|83160628|FG001|Overall Study|Adverse Event|2|||
46926270|NCT00100932|83160627|FG000|Overall Study|Withdrawal by Subject|6|||
46926271|NCT00100932|83160628|FG001|Overall Study|Withdrawal by Subject|0|||
46926272|NCT00100932|83160627|FG000|Overall Study|Progressive Disease|44|||
46926273|NCT00100932|83160628|FG001|Overall Study|Progressive Disease|18|||
46926274|NCT00100932|83160627|FG000|Overall Study|Physician Decision|7|||
46926275|NCT00100932|83160628|FG001|Overall Study|Physician Decision|5|||
46926276|NCT00100932|83160627|FG000|Overall Study|Other|5|||
46926277|NCT00100932|83160628|FG001|Overall Study|Other|2|||
46926278|NCT03180307|83160636|FG000|Overall Study|Lost to Follow-up|2|||
46926279|NCT03180307|83160637|FG001|Overall Study|Lost to Follow-up|0|||
46926280|NCT03180307|83160636|FG000|Overall Study|Death|1|||
46926281|NCT03180307|83160637|FG001|Overall Study|Death|0|||
46926282|NCT03180307|83160636|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
46926283|NCT03180307|83160637|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
46926284|NCT02848833|83160641|FG000|Overall Study|subject who are duplicated|1|||
46926285|NCT02848833|83160641|FG000|Overall Study|have not taken the study drug|11|||
47053655|NCT01793051|83324098|FG000|Overall Study|Too ill to continue|1|||
46753268|NCT00880620|82971301|FG002|Overall Study|Adverse Event|15|||
46808710|NCT00642941|83027872|FG002|Overall Study|Death|1|||
46808711|NCT00642941|83027873|FG003|Overall Study|Death|1|||
46753269|NCT00880620|82971302|FG003|Overall Study|Adverse Event|15|||
46753270|NCT00880620|82971299|FG000|Overall Study|Death|0|||
46753271|NCT00880620|82971300|FG001|Overall Study|Death|0|||
46753272|NCT00880620|82971301|FG002|Overall Study|Death|1|||
46753273|NCT00880620|82971302|FG003|Overall Study|Death|0|||
46753274|NCT00880620|82971299|FG000|Overall Study|Lack of Efficacy|12|||
46753275|NCT00880620|82971300|FG001|Overall Study|Lack of Efficacy|4|||
46753276|NCT00880620|82971301|FG002|Overall Study|Lack of Efficacy|0|||
46926286|NCT02848833|83160641|FG000|Overall Study|follow-up failure|6|||
46926287|NCT02848833|83160641|FG000|Overall Study|Protocol Violation|119|||
46926288|NCT03361189|83160647|FG000|Overall Study|Received heart transplant|1|||
46926289|NCT03361189|83160648|FG001|Overall Study|Received heart transplant|0|||
46753277|NCT00880620|82971302|FG003|Overall Study|Lack of Efficacy|1|||
46753278|NCT00880620|82971299|FG000|Overall Study|Lost to Follow-up|0|||
46753279|NCT00880620|82971300|FG001|Overall Study|Lost to Follow-up|1|||
46753280|NCT00880620|82971301|FG002|Overall Study|Lost to Follow-up|1|||
46753281|NCT00880620|82971302|FG003|Overall Study|Lost to Follow-up|0|||
46753282|NCT00880620|82971299|FG000|Overall Study|Protocol Violation|0|||
46753283|NCT00880620|82971300|FG001|Overall Study|Protocol Violation|1|||
46808712|NCT00642941|83027874|FG004|Overall Study|Death|2|||
46808713|NCT00642941|83027875|FG005|Overall Study|Death|1|||
46808714|NCT00642941|83027876|FG006|Overall Study|Death|0|||
46808715|NCT00642941|83027877|FG007|Overall Study|Death|0|||
47053656|NCT01793051|83324099|FG001|Overall Study|Too ill to continue|0|||
47053657|NCT01793051|83324098|FG000|Overall Study|Switched chemo|1|||
46753284|NCT00880620|82971301|FG002|Overall Study|Protocol Violation|0|||
46753285|NCT00880620|82971302|FG003|Overall Study|Protocol Violation|2|||
46753286|NCT00880620|82971299|FG000|Overall Study|Withdrawal by Subject|4|||
46808716|NCT00642941|83027878|FG008|Overall Study|Death|0|||
46808717|NCT00642941|83027879|FG009|Overall Study|Death|0|||
46808718|NCT00642941|83027880|FG010|Overall Study|Death|0|||
46808719|NCT00642941|83027881|FG011|Overall Study|Death|1|||
46808720|NCT00642941|83027870|FG000|Overall Study|Study closed by Sponsor|0|||
46808721|NCT00642941|83027871|FG001|Overall Study|Study closed by Sponsor|1|||
46808722|NCT00642941|83027872|FG002|Overall Study|Study closed by Sponsor|0|||
46808723|NCT00642941|83027873|FG003|Overall Study|Study closed by Sponsor|0|||
46808724|NCT00642941|83027874|FG004|Overall Study|Study closed by Sponsor|0|||
46808725|NCT00642941|83027875|FG005|Overall Study|Study closed by Sponsor|0|||
46753287|NCT00880620|82971300|FG001|Overall Study|Withdrawal by Subject|3|||
46753288|NCT00880620|82971301|FG002|Overall Study|Withdrawal by Subject|1|||
46753289|NCT00880620|82971302|FG003|Overall Study|Withdrawal by Subject|3|||
46753290|NCT00880620|82971299|FG000|Overall Study|Noncompliance|0|||
46753291|NCT00880620|82971300|FG001|Overall Study|Noncompliance|0|||
46753292|NCT00880620|82971301|FG002|Overall Study|Noncompliance|1|||
46753293|NCT00880620|82971302|FG003|Overall Study|Noncompliance|1|||
46753294|NCT00880620|82971299|FG000|Overall Study|Other|1|||
46808726|NCT00642941|83027876|FG006|Overall Study|Study closed by Sponsor|0|||
46808727|NCT00642941|83027877|FG007|Overall Study|Study closed by Sponsor|0|||
46808728|NCT00642941|83027878|FG008|Overall Study|Study closed by Sponsor|0|||
46808729|NCT00642941|83027879|FG009|Overall Study|Study closed by Sponsor|0|||
46808730|NCT00642941|83027880|FG010|Overall Study|Study closed by Sponsor|0|||
46808731|NCT00642941|83027881|FG011|Overall Study|Study closed by Sponsor|0|||
46808732|NCT00642941|83027870|FG000|Overall Study|Withdrawal by Subject|1|||
46808733|NCT00642941|83027871|FG001|Overall Study|Withdrawal by Subject|0|||
46808734|NCT00642941|83027872|FG002|Overall Study|Withdrawal by Subject|0|||
46753295|NCT00880620|82971300|FG001|Overall Study|Other|1|||
46753296|NCT00880620|82971301|FG002|Overall Study|Other|2|||
46753297|NCT00880620|82971302|FG003|Overall Study|Other|2|||
46753298|NCT00881868|82971328|FG000|Overall Study|Adverse Event|0|||
46753299|NCT00881868|82971329|FG001|Overall Study|Adverse Event|1|||
46753300|NCT00881868|82971328|FG000|Overall Study|Lost to Follow-up|2|||
46753301|NCT00881868|82971329|FG001|Overall Study|Lost to Follow-up|1|||
46753302|NCT00881868|82971328|FG000|Overall Study|Physician Decision|4|||
46753303|NCT00881868|82971329|FG001|Overall Study|Physician Decision|0|||
46753304|NCT00881868|82971328|FG000|Overall Study|Protocol Violation|2|||
46753305|NCT00881868|82971329|FG001|Overall Study|Protocol Violation|0|||
46753306|NCT00881712|82971338|FG000|Overall Study|Death|1|||
46753307|NCT00881712|82971339|FG001|Overall Study|Death|0|||
46753308|NCT00881712|82971340|FG002|Overall Study|Death|0|||
46753309|NCT00881712|82971338|FG000|Overall Study|Withdrawal by Subject|1|||
46753310|NCT00881712|82971339|FG001|Overall Study|Withdrawal by Subject|0|||
46753311|NCT00881712|82971340|FG002|Overall Study|Withdrawal by Subject|0|||
46753312|NCT03955471|82971348|FG000|Overall Study|Death|22|||
46808735|NCT00642941|83027873|FG003|Overall Study|Withdrawal by Subject|2|||
46808736|NCT00642941|83027874|FG004|Overall Study|Withdrawal by Subject|0|||
46808737|NCT00642941|83027875|FG005|Overall Study|Withdrawal by Subject|0|||
46808738|NCT00642941|83027876|FG006|Overall Study|Withdrawal by Subject|2|||
46808739|NCT00642941|83027877|FG007|Overall Study|Withdrawal by Subject|0|||
46808740|NCT00642941|83027878|FG008|Overall Study|Withdrawal by Subject|1|||
46808741|NCT00642941|83027879|FG009|Overall Study|Withdrawal by Subject|0|||
46808742|NCT00642941|83027880|FG010|Overall Study|Withdrawal by Subject|0|||
46808743|NCT00642941|83027881|FG011|Overall Study|Withdrawal by Subject|1|||
46808744|NCT00642941|83027870|FG000|Overall Study|Protocol Violation|0|||
46808745|NCT00642941|83027871|FG001|Overall Study|Protocol Violation|0|||
46808746|NCT00642941|83027872|FG002|Overall Study|Protocol Violation|0|||
46808747|NCT00642941|83027873|FG003|Overall Study|Protocol Violation|0|||
46808748|NCT00642941|83027874|FG004|Overall Study|Protocol Violation|0|||
46808749|NCT00642941|83027875|FG005|Overall Study|Protocol Violation|0|||
46808750|NCT00642941|83027876|FG006|Overall Study|Protocol Violation|1|||
46808751|NCT00642941|83027877|FG007|Overall Study|Protocol Violation|0|||
46808752|NCT00642941|83027878|FG008|Overall Study|Protocol Violation|0|||
46808753|NCT00642941|83027879|FG009|Overall Study|Protocol Violation|0|||
46808754|NCT00642941|83027880|FG010|Overall Study|Protocol Violation|0|||
46808755|NCT00642941|83027881|FG011|Overall Study|Protocol Violation|0|||
46753313|NCT03955471|82971348|FG000|Overall Study|Lost to Follow-up|1|||
46808756|NCT00642941|83027870|FG000|Overall Study|Adverse Event|1|||
46808757|NCT00642941|83027871|FG001|Overall Study|Adverse Event|1|||
46753314|NCT03955471|82971348|FG000|Overall Study|Withdrawal by Subject|6|||
46753315|NCT03955471|82971348|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
46753316|NCT00880542|82971352|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
46753317|NCT00880542|82971352|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
47053658|NCT01793051|83324099|FG001|Overall Study|Switched chemo|1|||
46926290|NCT03361189|83160647|FG000|Overall Study|Pacemake replacement|0|||
46926291|NCT03361189|83160648|FG001|Overall Study|Pacemake replacement|1|||
46926292|NCT00092131|83160656|FG000|Treatment Period I|Adverse Event|1|||
46926293|NCT00092131|83160657|FG001|Treatment Period I|Adverse Event|0|||
46926294|NCT00092131|83160656|FG000|Treatment Period II|Adverse Event|0|||
46926295|NCT00092131|83160657|FG001|Treatment Period II|Adverse Event|1|||
46926296|NCT02668783|83160665|FG000|Overall Study|Pregnancy|0|||
46926297|NCT02668783|83160666|FG001|Overall Study|Pregnancy|1|||
46926298|NCT02668783|83160665|FG000|Overall Study|Protocol Violation|2|||
46926299|NCT02668783|83160666|FG001|Overall Study|Protocol Violation|1|||
46926300|NCT02668783|83160665|FG000|Overall Study|Study terminated by sponsor|9|||
46926301|NCT02668783|83160666|FG001|Overall Study|Study terminated by sponsor|10|||
46926302|NCT02668783|83160665|FG000|Overall Study|Subject moved|1|||
46926303|NCT02668783|83160666|FG001|Overall Study|Subject moved|0|||
46926304|NCT02668783|83160665|FG000|Overall Study|Withdrawal by Subject|1|||
46926305|NCT02668783|83160666|FG001|Overall Study|Withdrawal by Subject|0|||
46926306|NCT00101010|83160672|FG000|Overall Study|Physician Decision|1|||
46926307|NCT02848599|83160678|FG000|Overall Study|Protocol Violation|7|||
46926308|NCT02848599|83160679|FG001|Overall Study|Protocol Violation|9|||
46926309|NCT00778999|83160710|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
46926310|NCT00778999|83160711|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
46926311|NCT00778999|83160710|FG000|Overall Study|Did not receive recFSH|14|||
46926312|NCT00778999|83160711|FG001|Overall Study|Did not receive recFSH|20|||
46926313|NCT02631850|83160721|FG000|Treatment Period|Lost to Follow-up|0|||
46926314|NCT02631850|83160722|FG001|Treatment Period|Lost to Follow-up|1|||
46926315|NCT02631850|83160723|FG002|Treatment Period|Lost to Follow-up|0|||
46926316|NCT02631850|83160724|FG003|Treatment Period|Lost to Follow-up|0|||
46926317|NCT02631850|83160721|FG000|Treatment Period|Protocol Violation|1|||
46926318|NCT02631850|83160722|FG001|Treatment Period|Protocol Violation|0|||
46926319|NCT02631850|83160723|FG002|Treatment Period|Protocol Violation|0|||
46926320|NCT02631850|83160724|FG003|Treatment Period|Protocol Violation|0|||
46926321|NCT02631850|83160721|FG000|Treatment Period|Withdrawal by Subject|0|||
46926322|NCT02631850|83160722|FG001|Treatment Period|Withdrawal by Subject|5|||
46926323|NCT02631850|83160723|FG002|Treatment Period|Withdrawal by Subject|2|||
46926324|NCT02631850|83160724|FG003|Treatment Period|Withdrawal by Subject|2|||
46926325|NCT02631850|83160721|FG000|Treatment Period|Adverse Event|1|||
46926326|NCT02631850|83160722|FG001|Treatment Period|Adverse Event|0|||
46926327|NCT02631850|83160723|FG002|Treatment Period|Adverse Event|2|||
46926328|NCT02631850|83160724|FG003|Treatment Period|Adverse Event|3|||
46926329|NCT02631850|83160721|FG000|Treatment Period|Family medical issue|1|||
46926330|NCT02631850|83160722|FG001|Treatment Period|Family medical issue|0|||
46926331|NCT02631850|83160723|FG002|Treatment Period|Family medical issue|0|||
46926332|NCT02631850|83160724|FG003|Treatment Period|Family medical issue|0|||
46926333|NCT02631850|83160721|FG000|6 Month Follow up|Lost to Follow-up|5|||
46926334|NCT02631850|83160722|FG001|6 Month Follow up|Lost to Follow-up|8|||
46926335|NCT02631850|83160723|FG002|6 Month Follow up|Lost to Follow-up|3|||
46926336|NCT02631850|83160724|FG003|6 Month Follow up|Lost to Follow-up|5|||
46926337|NCT02631850|83160721|FG000|6 Month Follow up|Withdrawal by Subject|1|||
46753318|NCT00880542|82971352|FG000|REP: Surgical Resection|progressive disease|1|||
46753319|NCT00885534|82971356|FG000|Overall Study|Patient deemed ineligible|1|||
46753320|NCT00885378|82971362|FG000|Overall Study|Lack of Efficacy|2|||
46753321|NCT00885378|82971363|FG001|Overall Study|Lack of Efficacy|2|||
46753322|NCT00885378|82971362|FG000|Overall Study|Withdrawal by Subject|1|||
46753323|NCT00885378|82971363|FG001|Overall Study|Withdrawal by Subject|2|||
46753324|NCT00885378|82971362|FG000|Overall Study|Lost to Follow-up|1|||
46753325|NCT00885378|82971363|FG001|Overall Study|Lost to Follow-up|2|||
46753326|NCT00885378|82971362|FG000|Overall Study|Poor/Noncompliance|2|||
46753327|NCT00885378|82971363|FG001|Overall Study|Poor/Noncompliance|2|||
46753328|NCT00885378|82971362|FG000|Overall Study|Protocol Violation|2|||
46753329|NCT00885378|82971363|FG001|Overall Study|Protocol Violation|0|||
46753330|NCT00545779|82971369|FG000|Overall Study|Violation of selection criteria at entry|8|||
46753331|NCT00545779|82971369|FG000|Overall Study|Other protocol violation|1|||
46753332|NCT00545779|82971369|FG000|Overall Study|Did not cooperate|7|||
46753333|NCT00545779|82971369|FG000|Overall Study|Withdrawal by Subject|20|||
46926338|NCT02631850|83160722|FG001|6 Month Follow up|Withdrawal by Subject|0|||
46926339|NCT02631850|83160723|FG002|6 Month Follow up|Withdrawal by Subject|0|||
46926340|NCT02631850|83160724|FG003|6 Month Follow up|Withdrawal by Subject|2|||
46926341|NCT02631850|83160721|FG000|6 Month Follow up|Adverse Event|1|||
46926342|NCT02631850|83160722|FG001|6 Month Follow up|Adverse Event|4|||
46926343|NCT02631850|83160723|FG002|6 Month Follow up|Adverse Event|1|||
46926344|NCT02631850|83160724|FG003|6 Month Follow up|Adverse Event|3|||
46926345|NCT02631850|83160721|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
46753334|NCT00545779|82971369|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
46753335|NCT00545779|82971369|FG000|Overall Study|Failure to return|3|||
46753336|NCT00597714|82971379|FG000|Overall Study|Death|56|||
46753337|NCT00597714|82971380|FG001|Overall Study|Death|46|||
46753338|NCT00597714|82971381|FG002|Overall Study|Death|0|||
46926346|NCT02631850|83160722|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
46926347|NCT02631850|83160723|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
46808758|NCT00642941|83027872|FG002|Overall Study|Adverse Event|0|||
46808759|NCT00642941|83027873|FG003|Overall Study|Adverse Event|0|||
46808760|NCT00642941|83027874|FG004|Overall Study|Adverse Event|0|||
46808761|NCT00642941|83027875|FG005|Overall Study|Adverse Event|0|||
46808762|NCT00642941|83027876|FG006|Overall Study|Adverse Event|1|||
46808763|NCT00642941|83027877|FG007|Overall Study|Adverse Event|1|||
46808764|NCT00642941|83027878|FG008|Overall Study|Adverse Event|0|||
46808765|NCT00642941|83027879|FG009|Overall Study|Adverse Event|1|||
46808766|NCT00642941|83027880|FG010|Overall Study|Adverse Event|0|||
46808767|NCT00642941|83027881|FG011|Overall Study|Adverse Event|0|||
46808768|NCT00642941|83027870|FG000|Overall Study|Other|1|||
46808769|NCT00642941|83027871|FG001|Overall Study|Other|1|||
46808770|NCT00642941|83027872|FG002|Overall Study|Other|1|||
46808771|NCT00642941|83027873|FG003|Overall Study|Other|1|||
46808772|NCT00642941|83027874|FG004|Overall Study|Other|0|||
46808773|NCT00642941|83027875|FG005|Overall Study|Other|1|||
46808774|NCT00642941|83027876|FG006|Overall Study|Other|0|||
46808775|NCT00642941|83027877|FG007|Overall Study|Other|1|||
46808776|NCT00642941|83027878|FG008|Overall Study|Other|0|||
46808777|NCT00642941|83027879|FG009|Overall Study|Other|0|||
46808778|NCT00642941|83027880|FG010|Overall Study|Other|0|||
46808779|NCT00642941|83027881|FG011|Overall Study|Other|1|||
46808780|NCT00642941|83027870|FG000|Overall Study|Disease progression|60|||
46808781|NCT00642941|83027871|FG001|Overall Study|Disease progression|50|||
46808782|NCT00642941|83027872|FG002|Overall Study|Disease progression|5|||
46808783|NCT00642941|83027873|FG003|Overall Study|Disease progression|36|||
46808784|NCT00642941|83027874|FG004|Overall Study|Disease progression|23|||
46808785|NCT00642941|83027875|FG005|Overall Study|Disease progression|39|||
46808786|NCT00642941|83027876|FG006|Overall Study|Disease progression|18|||
46808787|NCT00642941|83027877|FG007|Overall Study|Disease progression|12|||
46808788|NCT00642941|83027878|FG008|Overall Study|Disease progression|10|||
46808789|NCT00642941|83027879|FG009|Overall Study|Disease progression|7|||
46808790|NCT00642941|83027880|FG010|Overall Study|Disease progression|12|||
46808791|NCT00642941|83027881|FG011|Overall Study|Disease progression|7|||
46808792|NCT00531960|83027930|FG000|Overall Study|Adverse Event|5|||
46808793|NCT00531960|83027931|FG001|Overall Study|Adverse Event|4|||
46808794|NCT00531960|83027930|FG000|Overall Study|Death|3|||
46808795|NCT00531960|83027931|FG001|Overall Study|Death|2|||
46808796|NCT00531960|83027930|FG000|Overall Study|Lack of Efficacy|42|||
46808797|NCT00531960|83027931|FG001|Overall Study|Lack of Efficacy|41|||
46808798|NCT00531960|83027930|FG000|Overall Study|Violation of Selection Criteria|2|||
46808799|NCT00531960|83027931|FG001|Overall Study|Violation of Selection Criteria|0|||
46808800|NCT00531960|83027930|FG000|Overall Study|Refused Treatment|5|||
46808801|NCT00531960|83027931|FG001|Overall Study|Refused Treatment|6|||
46808802|NCT00531960|83027930|FG000|Overall Study|Other|4|||
46808803|NCT00531960|83027931|FG001|Overall Study|Other|10|||
46808804|NCT00361504|83027939|FG000|Overall Study|Withdrawal by Subject|94|||
46808805|NCT00361504|83027940|FG001|Overall Study|Withdrawal by Subject|31|||
46808806|NCT00361504|83027939|FG000|Overall Study|Lost to Follow-up|40|||
46808807|NCT00361504|83027940|FG001|Overall Study|Lost to Follow-up|7|||
46808808|NCT00361504|83027939|FG000|Overall Study|Adverse Event|203|||
46808809|NCT00361504|83027940|FG001|Overall Study|Adverse Event|82|||
46808810|NCT00361504|83027939|FG000|Overall Study|Lack of Efficacy|72|||
46808811|NCT00361504|83027940|FG001|Overall Study|Lack of Efficacy|7|||
46808812|NCT00361504|83027939|FG000|Overall Study|Resolution of Pain|2|||
46808813|NCT00361504|83027940|FG001|Overall Study|Resolution of Pain|0|||
46808814|NCT00361504|83027939|FG000|Overall Study|Study medication non compliant|42|||
46808815|NCT00361504|83027940|FG001|Overall Study|Study medication non compliant|15|||
46926348|NCT02631850|83160724|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
46926349|NCT00103038|83160735|FG000|Overall Study|Withdrawal by Subject|8|||
46636281|NCT01516008|82810118|FG000|Overall Study|Reason not specified|0|||
46808816|NCT00361504|83027939|FG000|Overall Study|All other|28|||
46808817|NCT00361504|83027940|FG001|Overall Study|All other|3|||
46808818|NCT00361270|83027950|FG000|Overall Study|Death|0|||
46808819|NCT00361270|83027951|FG001|Overall Study|Death|0|||
46808820|NCT00361270|83027952|FG002|Overall Study|Death|0|||
46808821|NCT00361270|83027953|FG003|Overall Study|Death|2|||
46808822|NCT00361270|83027950|FG000|Overall Study|Lost to Follow-up|4|||
46808823|NCT00361270|83027951|FG001|Overall Study|Lost to Follow-up|1|||
46808824|NCT00361270|83027952|FG002|Overall Study|Lost to Follow-up|0|||
46636282|NCT01516008|82810119|FG001|Overall Study|Reason not specified|0|||
46808825|NCT00361270|83027953|FG003|Overall Study|Lost to Follow-up|0|||
46808826|NCT00361270|83027950|FG000|Overall Study|Physician Decision|0|||
46808827|NCT00361270|83027951|FG001|Overall Study|Physician Decision|0|||
46808828|NCT00361270|83027952|FG002|Overall Study|Physician Decision|1|||
46808829|NCT00361270|83027953|FG003|Overall Study|Physician Decision|0|||
46808830|NCT00361270|83027950|FG000|Overall Study|Protocol Violation|9|||
46808831|NCT00361270|83027951|FG001|Overall Study|Protocol Violation|4|||
46808832|NCT00361270|83027952|FG002|Overall Study|Protocol Violation|5|||
46808833|NCT00361270|83027953|FG003|Overall Study|Protocol Violation|4|||
46808834|NCT00361270|83027950|FG000|Overall Study|Withdrawal by Subject|6|||
46808835|NCT00361270|83027951|FG001|Overall Study|Withdrawal by Subject|6|||
46808836|NCT00361270|83027952|FG002|Overall Study|Withdrawal by Subject|3|||
46808837|NCT00361270|83027953|FG003|Overall Study|Withdrawal by Subject|7|||
46808838|NCT00361270|83027950|FG000|Overall Study|Afraid of Hypnosis|1|||
46808839|NCT00361270|83027951|FG001|Overall Study|Afraid of Hypnosis|2|||
46808840|NCT00361270|83027952|FG002|Overall Study|Afraid of Hypnosis|0|||
46808841|NCT00361270|83027953|FG003|Overall Study|Afraid of Hypnosis|0|||
46808842|NCT00361270|83027950|FG000|Overall Study|Problems with Transportation|4|||
46808843|NCT00361270|83027951|FG001|Overall Study|Problems with Transportation|0|||
46808844|NCT00361270|83027952|FG002|Overall Study|Problems with Transportation|0|||
46808845|NCT00361270|83027953|FG003|Overall Study|Problems with Transportation|0|||
46808846|NCT00361270|83027950|FG000|Overall Study|Adverse Event|0|||
46808847|NCT00361270|83027951|FG001|Overall Study|Adverse Event|1|||
46808848|NCT00361270|83027952|FG002|Overall Study|Adverse Event|1|||
46808849|NCT00361270|83027953|FG003|Overall Study|Adverse Event|0|||
46808850|NCT00367744|83027972|FG000|Overall Study|Lost to Follow-up|4|||
46808851|NCT00367744|83027973|FG001|Overall Study|Lost to Follow-up|5|||
46808852|NCT03883386|83027982|FG000|First Assignment|Lost to Follow-up|1|||
46808853|NCT03883386|83027983|FG001|First Assignment|Lost to Follow-up|0|||
46808854|NCT03883386|83027982|FG000|First Assignment|Withdrawal by Subject|1|||
46808855|NCT03883386|83027983|FG001|First Assignment|Withdrawal by Subject|1|||
46808856|NCT00530946|83027993|FG000|Overall Study|Adverse Event|1|||
46808857|NCT00530946|83027994|FG001|Overall Study|Adverse Event|2|||
46808858|NCT00530946|83027995|FG002|Overall Study|Adverse Event|1|||
46808859|NCT00530946|83027996|FG003|Overall Study|Adverse Event|1|||
46808860|NCT00530946|83027993|FG000|Overall Study|Protocol Violation|0|||
46808861|NCT00530946|83027994|FG001|Overall Study|Protocol Violation|0|||
46808862|NCT00530946|83027995|FG002|Overall Study|Protocol Violation|0|||
46808863|NCT00530946|83027996|FG003|Overall Study|Protocol Violation|1|||
46808864|NCT00530946|83027993|FG000|Overall Study|Noncompliance|1|||
46808865|NCT00530946|83027994|FG001|Overall Study|Noncompliance|0|||
46808866|NCT00530946|83027995|FG002|Overall Study|Noncompliance|0|||
46808867|NCT00530946|83027996|FG003|Overall Study|Noncompliance|0|||
46808868|NCT00424047|83028008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
46808869|NCT00424047|83028009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
46808870|NCT00424047|83028008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
46808871|NCT00424047|83028009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
46808872|NCT00424047|83028008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
46808873|NCT00424047|83028009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
46926350|NCT00103038|83160735|FG000|Overall Study|Screen failure|3|||
46926351|NCT00103038|83160735|FG000|Overall Study|Death|1|||
46926352|NCT00103038|83160735|FG000|Overall Study|Physician Decision|1|||
46926353|NCT00620035|83160742|FG000|Overall Study|Adverse Event|106|||
46636283|NCT01516008|82810120|FG002|Overall Study|Reason not specified|1|||
46753339|NCT00597714|82971379|FG000|Overall Study|Recipient death|0|||
46753340|NCT00597714|82971380|FG001|Overall Study|Recipient death|0|||
46753341|NCT00597714|82971381|FG002|Overall Study|Recipient death|10|||
46753342|NCT03938857|82971394|FG000|Overall Study|Physician Decision|1|||
46753343|NCT03938857|82971395|FG001|Overall Study|Physician Decision|0|||
46753344|NCT03938857|82971396|FG002|Overall Study|Physician Decision|0|||
46753345|NCT03938857|82971397|FG003|Overall Study|Physician Decision|0|||
46753346|NCT00884832|82971409|FG000|Overall Study|Withdrawal by Subject|0|||
46753347|NCT00884832|82971410|FG001|Overall Study|Withdrawal by Subject|1|||
46753348|NCT03938545|82971420|FG000|Overall Study|Lost to Follow-up|0|||
46753349|NCT03938545|82971421|FG001|Overall Study|Lost to Follow-up|0|||
46753350|NCT03938545|82971422|FG002|Overall Study|Lost to Follow-up|0|||
46753351|NCT03938545|82971423|FG003|Overall Study|Lost to Follow-up|1|||
46753352|NCT03938545|82971420|FG000|Overall Study|Non-compliance with study drug|0|||
46753353|NCT03938545|82971421|FG001|Overall Study|Non-compliance with study drug|0|||
46753354|NCT03938545|82971422|FG002|Overall Study|Non-compliance with study drug|1|||
46753355|NCT03938545|82971423|FG003|Overall Study|Non-compliance with study drug|0|||
46753356|NCT03938545|82971420|FG000|Overall Study|Pregnancy|1|||
46753357|NCT03938545|82971421|FG001|Overall Study|Pregnancy|0|||
46808874|NCT00424047|83028008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
46808875|NCT00424047|83028009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
46808876|NCT00424047|83028008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
46926354|NCT00620035|83160742|FG000|Overall Study|Withdrawal of Informed Consent|1|||
46926355|NCT00620035|83160742|FG000|Overall Study|Other Reason|38|||
46636284|NCT01489254|82810131|FG000|Double-blind Part|Adverse Event|7|||
46808877|NCT00424047|83028009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
46808878|NCT00424047|83028008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
46926356|NCT03034057|83160746|FG000|Overall Study|Withdrawal by Subject|10|||
46926357|NCT03034057|83160746|FG000|Overall Study|Protocol Violation|1|||
46808879|NCT00424047|83028009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
46808880|NCT00424047|83028008|FG000|On Study at Time of Unblinding|Adverse Event|22|||
46808881|NCT00424047|83028009|FG001|On Study at Time of Unblinding|Adverse Event|12|||
46808882|NCT00424047|83028008|FG000|On Study at Time of Unblinding|Progression of disease|92|||
46808883|NCT00424047|83028009|FG001|On Study at Time of Unblinding|Progression of disease|128|||
46808884|NCT00424047|83028008|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
46808885|NCT00424047|83028009|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
46808886|NCT00424047|83028008|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
46808887|NCT00424047|83028009|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
47053659|NCT01793051|83324098|FG000|Overall Study|Lack of compliance|1|||
47053660|NCT01793051|83324099|FG001|Overall Study|Lack of compliance|0|||
47053661|NCT01793051|83324098|FG000|Overall Study|Requested to be removed from the study|1|||
47053662|NCT01793051|83324099|FG001|Overall Study|Requested to be removed from the study|1|||
47053663|NCT01816061|83324132|FG000|Overall Study|Lost to Follow-up|13|||
47053664|NCT01816061|83324133|FG001|Overall Study|Lost to Follow-up|24|||
47053665|NCT01792115|83324159|FG000|Overall Study|Lost to Follow-up|0|||
47053666|NCT01792115|83324160|FG001|Overall Study|Lost to Follow-up|1|||
47053667|NCT01792115|83324161|FG002|Overall Study|Lost to Follow-up|0|||
47053668|NCT01791803|83324173|FG000|Overall Study|Withdrawal by Subject|0|||
47053669|NCT01791803|83324174|FG001|Overall Study|Withdrawal by Subject|0|||
47053670|NCT01791803|83324175|FG002|Overall Study|Withdrawal by Subject|0|||
47053671|NCT01791803|83324176|FG003|Overall Study|Withdrawal by Subject|2|||
47053672|NCT01791803|83324173|FG000|Overall Study|Physician Decision|0|||
47053673|NCT01791803|83324174|FG001|Overall Study|Physician Decision|2|||
47053674|NCT01791803|83324175|FG002|Overall Study|Physician Decision|0|||
47053675|NCT01791803|83324176|FG003|Overall Study|Physician Decision|1|||
47053676|NCT01791803|83324173|FG000|Overall Study|Death|0|||
47053677|NCT01791803|83324174|FG001|Overall Study|Death|0|||
47053678|NCT01791803|83324175|FG002|Overall Study|Death|2|||
47053679|NCT01791803|83324176|FG003|Overall Study|Death|2|||
47053680|NCT01791725|83324201|FG000|Overall Study|Withdrawal by Subject|0|||
47053681|NCT01791725|83324202|FG001|Overall Study|Withdrawal by Subject|1|||
47053682|NCT01791725|83324203|FG002|Overall Study|Withdrawal by Subject|0|||
47053683|NCT01791413|83324213|FG000|Overall Study|Lost to Follow-up|5|||
47053684|NCT01791413|83324214|FG001|Overall Study|Lost to Follow-up|1|||
47053685|NCT01610063|83324227|FG000|Overall Study|Lost to Follow-up|42|||
47053686|NCT01610063|83324228|FG001|Overall Study|Lost to Follow-up|20|||
47053687|NCT01813721|83324234|FG000|Overall Study|Ineligibility determined|63|||
47053688|NCT01813721|83324234|FG000|Overall Study|Withdrawal by Subject|1|||
47053689|NCT01790633|83324258|FG000|Overall Study|Protocol Violation|1|||
47053690|NCT01790633|83324259|FG001|Overall Study|Protocol Violation|2|||
47053691|NCT01790633|83324258|FG000|Overall Study|Did not have serology performed|47|||
47053692|NCT01790633|83324259|FG001|Overall Study|Did not have serology performed|0|||
47053693|NCT01790633|83324258|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
47053694|NCT01790633|83324259|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
47053695|NCT01788215|83324268|FG000|Overall Study|Withdrawal by Subject|0|||
47053696|NCT01788215|83324269|FG001|Overall Study|Withdrawal by Subject|1|||
47053697|NCT01788215|83324268|FG000|Overall Study|Lost to Follow-up|2|||
47053698|NCT01788215|83324269|FG001|Overall Study|Lost to Follow-up|0|||
47053699|NCT01787825|83324275|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
47053700|NCT01787825|83324276|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
47053701|NCT01787825|83324275|FG000|Overall Study|Data Not Analyzable|5|||
47053702|NCT01787825|83324276|FG001|Overall Study|Data Not Analyzable|1|||
47053703|NCT01813019|83324285|FG000|Overall Study|Adverse Event|0|||
47053704|NCT01813019|83324286|FG001|Overall Study|Adverse Event|3|||
47053705|NCT01813019|83324285|FG000|Overall Study|Withdrawal by Subject|3|||
47053706|NCT01813019|83324286|FG001|Overall Study|Withdrawal by Subject|2|||
47053707|NCT01813019|83324285|FG000|Overall Study|administrative problems|2|||
47053708|NCT01813019|83324286|FG001|Overall Study|administrative problems|0|||
47053709|NCT01813019|83324285|FG000|Overall Study|Protocol Deviation|2|||
47053710|NCT01813019|83324286|FG001|Overall Study|Protocol Deviation|1|||
47053711|NCT01787591|83324294|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
47053712|NCT01787591|83324295|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
47053713|NCT01787591|83324296|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
46808888|NCT00424047|83028008|FG000|On Study at Time of Unblinding|Death|11|||
46808889|NCT00424047|83028009|FG001|On Study at Time of Unblinding|Death|11|||
46808890|NCT00424047|83028008|FG000|On Study at Time of Unblinding|Other|5|||
46808891|NCT00424047|83028009|FG001|On Study at Time of Unblinding|Other|4|||
46808892|NCT00424047|83028008|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
47053714|NCT01787591|83324297|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
47053715|NCT01812707|83324312|FG000|Overall Study|Adverse Event|0|||
47053716|NCT01812707|83324313|FG001|Overall Study|Adverse Event|0|||
47053717|NCT01812707|83324314|FG002|Overall Study|Adverse Event|0|||
47053718|NCT01812707|83324315|FG003|Overall Study|Adverse Event|2|||
47053719|NCT01812707|83324312|FG000|Overall Study|Poor compliance to protocol|1|||
47053720|NCT01812707|83324313|FG001|Overall Study|Poor compliance to protocol|0|||
46808893|NCT00424047|83028009|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
46808894|NCT00424047|83028008|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
46808895|NCT00424047|83028009|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
46808896|NCT00424047|83028008|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
46808897|NCT00424047|83028009|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
46808898|NCT00424047|83028008|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
46926358|NCT03034057|83160746|FG000|Overall Study|Not defined|2|||
46926359|NCT03034057|83160746|FG000|Overall Study|Lost to Follow-up|19|||
46926360|NCT03034057|83160746|FG000|Overall Study|Adverse Event|22|||
46926361|NCT03034057|83160746|FG000|Overall Study|Medication error without associated AE|1|||
46926362|NCT02757768|83160752|FG000|Overall Study|Randomized Never Received Study Drug|3|||
46926363|NCT02757768|83160753|FG001|Overall Study|Randomized Never Received Study Drug|4|||
46926364|NCT02757768|83160752|FG000|Overall Study|Adverse Event|5|||
46926365|NCT02757768|83160753|FG001|Overall Study|Adverse Event|3|||
46926366|NCT02757768|83160752|FG000|Overall Study|Lack of Efficacy|2|||
46926367|NCT02757768|83160753|FG001|Overall Study|Lack of Efficacy|1|||
46926368|NCT02757768|83160752|FG000|Overall Study|Lost to Follow-up|1|||
47053721|NCT01812707|83324314|FG002|Overall Study|Poor compliance to protocol|0|||
46753358|NCT03938545|82971422|FG002|Overall Study|Pregnancy|0|||
46753359|NCT03938545|82971423|FG003|Overall Study|Pregnancy|0|||
46753360|NCT03938545|82971420|FG000|Overall Study|Study terminated by sponsor|6|||
46753361|NCT03938545|82971421|FG001|Overall Study|Study terminated by sponsor|4|||
47053722|NCT01812707|83324315|FG003|Overall Study|Poor compliance to protocol|0|||
46753362|NCT03938545|82971422|FG002|Overall Study|Study terminated by sponsor|2|||
46753363|NCT03938545|82971423|FG003|Overall Study|Study terminated by sponsor|4|||
46753364|NCT03938545|82971420|FG000|Overall Study|Withdrawal by Subject|0|||
46753365|NCT03938545|82971421|FG001|Overall Study|Withdrawal by Subject|1|||
46753366|NCT03938545|82971422|FG002|Overall Study|Withdrawal by Subject|0|||
46753367|NCT03938545|82971423|FG003|Overall Study|Withdrawal by Subject|0|||
46753368|NCT03938545|82971420|FG000|Overall Study|Adverse Event|1|||
46753369|NCT03938545|82971421|FG001|Overall Study|Adverse Event|0|||
46753370|NCT03938545|82971422|FG002|Overall Study|Adverse Event|0|||
46753371|NCT03938545|82971423|FG003|Overall Study|Adverse Event|0|||
46753372|NCT00879996|82971435|FG000|Overall Study|Lost to Follow-up|7|||
46753373|NCT00879996|82971436|FG001|Overall Study|Lost to Follow-up|6|||
46753374|NCT00879996|82971435|FG000|Overall Study|non-compliance|6|||
46753375|NCT00879996|82971436|FG001|Overall Study|non-compliance|4|||
46753376|NCT00879996|82971435|FG000|Overall Study|Physician Decision|1|||
46753377|NCT00879996|82971436|FG001|Overall Study|Physician Decision|2|||
46753378|NCT00879996|82971435|FG000|Overall Study|psychiatric problem|0|||
46753379|NCT00879996|82971436|FG001|Overall Study|psychiatric problem|1|||
46753380|NCT00879996|82971435|FG000|Overall Study|put on parole|1|||
46753381|NCT00879996|82971436|FG001|Overall Study|put on parole|0|||
46753382|NCT00873093|82971449|FG000|Overall Study|Adverse Event|0|||
46753383|NCT00873093|82971450|FG001|Overall Study|Adverse Event|2|||
46753384|NCT00873093|82971451|FG002|Overall Study|Adverse Event|0|||
46753385|NCT00873093|82971452|FG003|Overall Study|Adverse Event|0|||
46753386|NCT00873093|82971453|FG004|Overall Study|Adverse Event|0|||
46753387|NCT00873093|82971449|FG000|Overall Study|Death|0|||
46753388|NCT00873093|82971450|FG001|Overall Study|Death|3|||
46753389|NCT00873093|82971451|FG002|Overall Study|Death|2|||
46753390|NCT00873093|82971452|FG003|Overall Study|Death|0|||
46753391|NCT00873093|82971453|FG004|Overall Study|Death|0|||
46753392|NCT00873093|82971449|FG000|Overall Study|Physician Decision|0|||
46808899|NCT00424047|83028009|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
46808900|NCT00424047|83028008|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
46808901|NCT00424047|83028009|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
46808902|NCT00530790|83028020|FG000|Overall Study|Adverse Event|2|||
46808903|NCT00530790|83028020|FG000|Overall Study|Withdrawal by Subject|2|||
46808904|NCT00530790|83028020|FG000|Overall Study|Physician Decision|1|||
46808905|NCT00530088|83028024|FG000|Overall Study|Disease Progression|4|||
46808906|NCT00530088|83028024|FG000|Overall Study|Physician Decision|4|||
46808907|NCT00530088|83028024|FG000|Overall Study|Other Not Specified|2|||
46808908|NCT00360568|83028030|FG000|Overall Study|Adverse Event|1|||
46808909|NCT00360568|83028031|FG001|Overall Study|Adverse Event|2|||
46808910|NCT00360568|83028030|FG000|Overall Study|Lack of Efficacy|1|||
46808911|NCT00360568|83028031|FG001|Overall Study|Lack of Efficacy|0|||
46753393|NCT00873093|82971450|FG001|Overall Study|Physician Decision|17|||
46808912|NCT00360568|83028030|FG000|Overall Study|Withdrawal by Subject|0|||
46808913|NCT00360568|83028031|FG001|Overall Study|Withdrawal by Subject|3|||
46753394|NCT00873093|82971451|FG002|Overall Study|Physician Decision|10|||
46753395|NCT00873093|82971452|FG003|Overall Study|Physician Decision|10|||
46753396|NCT00873093|82971453|FG004|Overall Study|Physician Decision|2|||
46753397|NCT00873093|82971449|FG000|Overall Study|Withdrawal by Subject|1|||
46926369|NCT02757768|83160753|FG001|Overall Study|Lost to Follow-up|0|||
46753398|NCT00873093|82971450|FG001|Overall Study|Withdrawal by Subject|4|||
46753399|NCT00873093|82971451|FG002|Overall Study|Withdrawal by Subject|4|||
46753400|NCT00873093|82971452|FG003|Overall Study|Withdrawal by Subject|0|||
46808914|NCT00436215|83028039|FG000|Overall Study|Refused further treatment|3|||
46808915|NCT00436215|83028039|FG000|Overall Study|Small bowel obstruction|1|||
46808916|NCT00441363|83028045|FG000|Overall Study|Adverse Event|4|||
46808917|NCT00441363|83028046|FG001|Overall Study|Adverse Event|2|||
46808918|NCT00441363|83028045|FG000|Overall Study|Withdrawal by Subject|3|||
46808919|NCT00441363|83028046|FG001|Overall Study|Withdrawal by Subject|4|||
46808920|NCT00441363|83028045|FG000|Overall Study|Physician Decision|6|||
46808921|NCT00441363|83028046|FG001|Overall Study|Physician Decision|7|||
46808922|NCT00441363|83028045|FG000|Overall Study|Lost to Follow-up|2|||
46808923|NCT00441363|83028046|FG001|Overall Study|Lost to Follow-up|2|||
46636285|NCT01489254|82810132|FG001|Double-blind Part|Adverse Event|2|||
46636286|NCT01489254|82810133|FG002|Double-blind Part|Adverse Event|2|||
46636287|NCT01489254|82810134|FG003|Double-blind Part|Adverse Event|0|||
46636288|NCT01489254|82810131|FG000|Double-blind Part|Pregnancy|1|||
46636289|NCT01489254|82810132|FG001|Double-blind Part|Pregnancy|3|||
46636290|NCT01489254|82810133|FG002|Double-blind Part|Pregnancy|0|||
46636291|NCT01489254|82810134|FG003|Double-blind Part|Pregnancy|0|||
46636292|NCT01489254|82810131|FG000|Double-blind Part|Withdrawal by Subject|12|||
46636293|NCT01489254|82810132|FG001|Double-blind Part|Withdrawal by Subject|20|||
46636294|NCT01489254|82810133|FG002|Double-blind Part|Withdrawal by Subject|1|||
46636295|NCT01489254|82810134|FG003|Double-blind Part|Withdrawal by Subject|0|||
46753401|NCT00873093|82971453|FG004|Overall Study|Withdrawal by Subject|0|||
46753402|NCT00873093|82971449|FG000|Overall Study|Ineligible|0|||
46753403|NCT00873093|82971450|FG001|Overall Study|Ineligible|1|||
46808924|NCT00441363|83028045|FG000|Overall Study|Other|2|||
46808925|NCT00441363|83028046|FG001|Overall Study|Other|0|||
46808926|NCT00530712|83028052|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
46808927|NCT00530712|83028052|FG000|30 Day Follow-up Visit|Missed Visit|5|||
46808928|NCT00530712|83028052|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
46808929|NCT00530712|83028052|FG000|6 Month Follow-up Visit|Missed Visit|3|||
46808930|NCT00530712|83028052|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
46808931|NCT00530712|83028052|FG000|6 Month Follow-up Visit|Death|2|||
46808932|NCT00530712|83028052|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
46808933|NCT00530712|83028052|FG000|12 Month Follow-up Visit|Missed Visit|3|||
46808934|NCT00530712|83028052|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
46808935|NCT00530712|83028052|FG000|12 Month Follow-up Visit|Death|9|||
46808936|NCT00626795|83028060|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
46808937|NCT00626795|83028061|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
46808938|NCT00626795|83028062|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
46808939|NCT00626795|83028060|FG000|Blinded Treatment|Lack of Efficacy|2|||
47053723|NCT01812707|83324312|FG000|Overall Study|Consent withdrawn by participant|1|||
47053724|NCT01812707|83324313|FG001|Overall Study|Consent withdrawn by participant|0|||
46808940|NCT00626795|83028061|FG001|Blinded Treatment|Lack of Efficacy|0|||
46808941|NCT00626795|83028062|FG002|Blinded Treatment|Lack of Efficacy|0|||
46808942|NCT00626795|83028060|FG000|Blinded Treatment|Unacceptable adverse event|0|||
46808943|NCT00626795|83028061|FG001|Blinded Treatment|Unacceptable adverse event|0|||
46808944|NCT00626795|83028062|FG002|Blinded Treatment|Unacceptable adverse event|1|||
46808945|NCT00626795|83028060|FG000|Blinded Treatment|Protocol Violation|0|||
46808946|NCT00626795|83028061|FG001|Blinded Treatment|Protocol Violation|1|||
46808947|NCT00626795|83028062|FG002|Blinded Treatment|Protocol Violation|1|||
46753404|NCT00873093|82971451|FG002|Overall Study|Ineligible|0|||
46753405|NCT00873093|82971452|FG003|Overall Study|Ineligible|1|||
46753406|NCT00873093|82971453|FG004|Overall Study|Ineligible|0|||
46753407|NCT00884286|82971477|FG000|Overall Study|Progressive disease|21|||
46753408|NCT00884286|82971478|FG001|Overall Study|Progressive disease|28|||
46753409|NCT00884286|82971477|FG000|Overall Study|Toxicity|4|||
46753410|NCT00884286|82971478|FG001|Overall Study|Toxicity|1|||
46753411|NCT00884286|82971477|FG000|Overall Study|Death|2|||
46753412|NCT00884286|82971478|FG001|Overall Study|Death|2|||
46753413|NCT00884286|82971477|FG000|Overall Study|Physician Decision|1|||
46808948|NCT00626795|83028060|FG000|Blinded Treatment|Withdrawal by Subject|1|||
46636296|NCT01489254|82810131|FG000|Double-blind Part|Lost to Follow-up|1|||
46808949|NCT00626795|83028061|FG001|Blinded Treatment|Withdrawal by Subject|1|||
46808950|NCT00626795|83028062|FG002|Blinded Treatment|Withdrawal by Subject|0|||
46926370|NCT02757768|83160752|FG000|Overall Study|Protocol Deviation|2|||
46808951|NCT00626795|83028060|FG000|Blinded Treatment|Other reasons|2|||
46808952|NCT00626795|83028061|FG001|Blinded Treatment|Other reasons|0|||
46808953|NCT00626795|83028062|FG002|Blinded Treatment|Other reasons|2|||
46808954|NCT00626795|83028060|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
46636297|NCT01489254|82810132|FG001|Double-blind Part|Lost to Follow-up|2|||
46926371|NCT02757768|83160753|FG001|Overall Study|Protocol Deviation|9|||
46636298|NCT01489254|82810133|FG002|Double-blind Part|Lost to Follow-up|0|||
46753414|NCT00884286|82971478|FG001|Overall Study|Physician Decision|0|||
46753415|NCT00884286|82971477|FG000|Overall Study|Septic shock|1|||
46753416|NCT00884286|82971478|FG001|Overall Study|Septic shock|0|||
46753417|NCT00884286|82971477|FG000|Overall Study|Thrombus in right auricle|1|||
46808955|NCT00626795|83028061|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
46808956|NCT00626795|83028062|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
46808957|NCT00626639|83028076|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
46808958|NCT00626639|83028077|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
46808959|NCT00626561|83028085|FG000|Overall Study|Withdrawal by Subject|2|||
46808960|NCT00626561|83028085|FG000|Overall Study|Disease Progression|2|||
46808961|NCT03880266|83028097|FG000|Overall Study|Withdrawal by Subject|0|||
46808962|NCT03880266|83028098|FG001|Overall Study|Withdrawal by Subject|1|||
46808963|NCT03880266|83028099|FG002|Overall Study|Withdrawal by Subject|1|||
46808964|NCT03880266|83028100|FG003|Overall Study|Withdrawal by Subject|0|||
46808965|NCT03880266|83028101|FG004|Overall Study|Withdrawal by Subject|0|||
46808966|NCT03880266|83028102|FG005|Overall Study|Withdrawal by Subject|0|||
46808967|NCT03880266|83028103|FG006|Overall Study|Withdrawal by Subject|0|||
46808968|NCT03880266|83028104|FG007|Overall Study|Withdrawal by Subject|0|||
46808969|NCT00423891|83028125|FG000|Enrolled|Withdrawal by Subject|0|||
46808970|NCT00423891|83028126|FG001|Enrolled|Withdrawal by Subject|0|||
46808971|NCT00423891|83028127|FG002|Enrolled|Withdrawal by Subject|1|||
46808972|NCT00423891|83028125|FG000|Enrolled|Lost to Follow-up|0|||
46808973|NCT00423891|83028126|FG001|Enrolled|Lost to Follow-up|0|||
46808974|NCT00423891|83028127|FG002|Enrolled|Lost to Follow-up|1|||
46808975|NCT00423891|83028125|FG000|Enrolled|No longer met criteria|11|||
46808976|NCT00423891|83028126|FG001|Enrolled|No longer met criteria|2|||
46808977|NCT00423891|83028127|FG002|Enrolled|No longer met criteria|1|||
46808978|NCT00423891|83028125|FG000|Treatment|Withdrawal by Subject|1|||
46808979|NCT00423891|83028126|FG001|Treatment|Withdrawal by Subject|0|||
46808980|NCT00423891|83028127|FG002|Treatment|Withdrawal by Subject|0|||
46808981|NCT00423891|83028125|FG000|Treatment|Lost to Follow-up|1|||
46808982|NCT00423891|83028126|FG001|Treatment|Lost to Follow-up|0|||
46808983|NCT00423891|83028127|FG002|Treatment|Lost to Follow-up|0|||
46808984|NCT00423891|83028125|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
46808985|NCT00423891|83028126|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
46808986|NCT00423891|83028127|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
46808987|NCT00423891|83028125|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
46808988|NCT00423891|83028126|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
46926372|NCT02757768|83160752|FG000|Overall Study|Withdrawal by Subject|16|||
46926373|NCT02757768|83160753|FG001|Overall Study|Withdrawal by Subject|9|||
46808989|NCT00423891|83028127|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
46808990|NCT00423813|83028140|FG000|Overall Study|Adverse Event|11|||
46808991|NCT00423813|83028141|FG001|Overall Study|Adverse Event|30|||
46808992|NCT00423813|83028142|FG002|Overall Study|Adverse Event|40|||
46808993|NCT00423813|83028140|FG000|Overall Study|Withdrawal by Subject|6|||
46808994|NCT00423813|83028141|FG001|Overall Study|Withdrawal by Subject|8|||
46808995|NCT00423813|83028142|FG002|Overall Study|Withdrawal by Subject|5|||
46808996|NCT00423813|83028140|FG000|Overall Study|Lost to Follow-up|5|||
46808997|NCT00423813|83028141|FG001|Overall Study|Lost to Follow-up|4|||
46808998|NCT00423813|83028142|FG002|Overall Study|Lost to Follow-up|4|||
46808999|NCT00423813|83028140|FG000|Overall Study|Lack of Efficacy|23|||
46809000|NCT00423813|83028141|FG001|Overall Study|Lack of Efficacy|18|||
46809001|NCT00423813|83028142|FG002|Overall Study|Lack of Efficacy|19|||
46926374|NCT02757768|83160752|FG000|Overall Study|Miscellaneous|4|||
46809002|NCT00423813|83028140|FG000|Overall Study|Physician Decision|2|||
46809003|NCT00423813|83028141|FG001|Overall Study|Physician Decision|0|||
46926375|NCT02757768|83160753|FG001|Overall Study|Miscellaneous|2|||
46926376|NCT05225389|83160761|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
46926377|NCT02753946|83160767|FG000|Overall Study|Adverse Event|7|||
46926378|NCT02753946|83160768|FG001|Overall Study|Adverse Event|6|||
46926379|NCT02753946|83160767|FG000|Overall Study|Withdrawal by Subject|6|||
46926380|NCT02753946|83160768|FG001|Overall Study|Withdrawal by Subject|1|||
46809004|NCT00423813|83028142|FG002|Overall Study|Physician Decision|0|||
46809005|NCT00423813|83028140|FG000|Overall Study|Sponsor Decision|0|||
46809006|NCT00423813|83028141|FG001|Overall Study|Sponsor Decision|1|||
46809007|NCT00423813|83028142|FG002|Overall Study|Sponsor Decision|0|||
46809008|NCT00423813|83028140|FG000|Overall Study|Protocol Violation|9|||
47053725|NCT01812707|83324314|FG002|Overall Study|Consent withdrawn by participant|0|||
47053726|NCT01812707|83324315|FG003|Overall Study|Consent withdrawn by participant|0|||
46809009|NCT00423813|83028141|FG001|Overall Study|Protocol Violation|4|||
46809010|NCT00423813|83028142|FG002|Overall Study|Protocol Violation|4|||
46809011|NCT00423813|83028140|FG000|Overall Study|Pregnancy|0|||
46809012|NCT00423813|83028141|FG001|Overall Study|Pregnancy|0|||
46809013|NCT00423813|83028142|FG002|Overall Study|Pregnancy|1|||
46809014|NCT00423813|83028140|FG000|Overall Study|Subject started night shift work|1|||
47053727|NCT01787279|83324326|FG000|Overall Study|Lost to Follow-up|2|||
47053728|NCT01787279|83324326|FG000|Overall Study|Lack of Efficacy|1|||
46809015|NCT00423813|83028141|FG001|Overall Study|Subject started night shift work|0|||
46809016|NCT00423813|83028142|FG002|Overall Study|Subject started night shift work|0|||
46809017|NCT00423813|83028140|FG000|Overall Study|Will start exclusionary medications|0|||
46809018|NCT00423813|83028141|FG001|Overall Study|Will start exclusionary medications|1|||
46926381|NCT02753946|83160767|FG000|Overall Study|Lack of Efficacy|1|||
46809019|NCT00423813|83028142|FG002|Overall Study|Will start exclusionary medications|0|||
46809020|NCT00423813|83028140|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
46809021|NCT00423813|83028141|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
46809022|NCT00423813|83028142|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
46926382|NCT02753946|83160768|FG001|Overall Study|Lack of Efficacy|0|||
46926383|NCT02753946|83160767|FG000|Overall Study|Physician Decision|0|||
46926384|NCT02753946|83160768|FG001|Overall Study|Physician Decision|2|||
46926385|NCT02756832|83160774|FG000|Overall Study|Lost for Observation after Baseline|6|||
46926386|NCT02756832|83160774|FG000|Overall Study|Lost for Observation|13|||
46926387|NCT02756832|83160774|FG000|Overall Study|Patient's Unwillingness|12|||
46926388|NCT02756832|83160774|FG000|Overall Study|Insufficient Efficacy|2|||
46926389|NCT02756832|83160774|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
46926390|NCT02756832|83160774|FG000|Overall Study|Reason not Specified|9|||
46926391|NCT02756832|83160774|FG000|Overall Study|Protocol Deviation|10|||
46926392|NCT00106080|83160780|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
46753418|NCT00884286|82971478|FG001|Overall Study|Thrombus in right auricle|0|||
46753419|NCT00884286|82971477|FG000|Overall Study|Not treated|2|||
46753420|NCT00884286|82971478|FG001|Overall Study|Not treated|1|||
46809023|NCT03687372|83028152|FG000|Overall Study|Lost to Follow-up|12|||
46809024|NCT03687372|83028153|FG001|Overall Study|Lost to Follow-up|21|||
46809025|NCT03687372|83028152|FG000|Overall Study|Withdrawal by Subject|4|||
46809026|NCT03687372|83028153|FG001|Overall Study|Withdrawal by Subject|17|||
46753421|NCT00884286|82971477|FG000|Overall Study|Comprised lung carcinoma|0|||
46753422|NCT00884286|82971478|FG001|Overall Study|Comprised lung carcinoma|1|||
46753423|NCT00873015|82971489|FG000|Overall Study|Withdrawal by Subject|0|||
46753424|NCT00873015|82971490|FG001|Overall Study|Withdrawal by Subject|1|||
46753425|NCT00873015|82971491|FG002|Overall Study|Withdrawal by Subject|0|||
46753426|NCT00873015|82971492|FG003|Overall Study|Withdrawal by Subject|0|||
46809027|NCT03687372|83028152|FG000|Overall Study|Investigator Decision|1|||
46809028|NCT03687372|83028153|FG001|Overall Study|Investigator Decision|1|||
46809029|NCT00626405|83028163|FG000|Overall Study|Deemed Ineligible|1|||
46809030|NCT00626405|83028164|FG001|Overall Study|Deemed Ineligible|0|||
46809031|NCT00626405|83028163|FG000|Overall Study|Withdrawal by Subject|0|||
46809032|NCT00626405|83028164|FG001|Overall Study|Withdrawal by Subject|1|||
46809033|NCT00358150|83028170|FG000|Overall Study|Adverse Event|3|||
46809034|NCT00358150|83028170|FG000|Overall Study|Withdrawal by Subject|1|||
46809035|NCT00358150|83028170|FG000|Overall Study|Undefined|3|||
46809036|NCT05061966|83028197|FG000|Overall Study|Lost to Follow-up|13|||
46809037|NCT05061966|83028198|FG001|Overall Study|Lost to Follow-up|13|||
46809038|NCT05027815|83028206|FG000|Overall Study|Death|2|||
46809039|NCT05027815|83028207|FG001|Overall Study|Death|1|||
46809040|NCT04827134|83028217|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
46809041|NCT04827134|83028218|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
46809042|NCT04827134|83028219|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
46809043|NCT04827134|83028220|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
46809044|NCT04818593|83028234|FG000|Overall Study|Low Oocyte Yield|8|||
46753427|NCT03921151|82971507|FG000|Overall Study|Withdrawal by Subject|11|||
46753428|NCT03921151|82971508|FG001|Overall Study|Withdrawal by Subject|16|||
46753429|NCT00872001|82971520|FG000|Overall Study|Adverse Event|34|||
46753430|NCT00872001|82971521|FG001|Overall Study|Adverse Event|23|||
46753431|NCT00872001|82971520|FG000|Overall Study|Protocol Defined Clinical Event|5|||
46753432|NCT00872001|82971521|FG001|Overall Study|Protocol Defined Clinical Event|7|||
46753433|NCT00872001|82971520|FG000|Overall Study|Lost to Follow-up|13|||
46753434|NCT00872001|82971521|FG001|Overall Study|Lost to Follow-up|12|||
46753435|NCT00872001|82971520|FG000|Overall Study|Withdrawal by Subject|18|||
46753436|NCT00872001|82971521|FG001|Overall Study|Withdrawal by Subject|30|||
46753437|NCT00872001|82971520|FG000|Overall Study|Protocol Violation|5|||
46753438|NCT00872001|82971521|FG001|Overall Study|Protocol Violation|8|||
46753439|NCT00872001|82971520|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
46753440|NCT00872001|82971521|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
46753441|NCT00872001|82971520|FG000|Overall Study|Administrative|23|||
46753442|NCT00872001|82971521|FG001|Overall Study|Administrative|15|||
46809045|NCT04818593|83028235|FG001|Overall Study|Low Oocyte Yield|8|||
46809046|NCT04818593|83028234|FG000|Overall Study|Not ICSI Insemination|7|||
46926393|NCT00106080|83160781|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
46926394|NCT02633020|83160789|FG000|Overall Study|Adverse Event|1|||
46926395|NCT02633020|83160790|FG001|Overall Study|Adverse Event|0|||
46926396|NCT00106626|83160800|FG000|Overall Study|Adverse Event|5|||
46926397|NCT00106626|83160801|FG001|Overall Study|Adverse Event|4|||
46753443|NCT00871923|82971529|FG000|Overall Study|Death|1|||
46753444|NCT00871923|82971529|FG000|Overall Study|Withdrawal by Subject|1|||
46753445|NCT03922945|82971536|FG000|Overall Study|Adverse Event|1|||
46753446|NCT03922945|82971537|FG001|Overall Study|Adverse Event|1|||
46753447|NCT03922945|82971538|FG002|Overall Study|Adverse Event|2|||
46753448|NCT03922945|82971536|FG000|Overall Study|Lost to Follow-up|13|||
46753449|NCT03922945|82971537|FG001|Overall Study|Lost to Follow-up|9|||
46809047|NCT04818593|83028235|FG001|Overall Study|Not ICSI Insemination|7|||
46926398|NCT00106626|83160802|FG002|Overall Study|Adverse Event|3|||
46926399|NCT00106626|83160803|FG003|Overall Study|Adverse Event|3|||
46926400|NCT00106626|83160800|FG000|Overall Study|Progressive Disease|4|||
46753450|NCT03922945|82971538|FG002|Overall Study|Lost to Follow-up|20|||
46753451|NCT03922945|82971536|FG000|Overall Study|Lack of Efficacy|2|||
46809048|NCT04818593|83028234|FG000|Overall Study|Poor Sperm Quality|2|||
46809049|NCT04818593|83028235|FG001|Overall Study|Poor Sperm Quality|2|||
46809050|NCT04818593|83028234|FG000|Overall Study|Withdrawal by Subject|2|||
46926401|NCT00106626|83160801|FG001|Overall Study|Progressive Disease|1|||
46926402|NCT00106626|83160802|FG002|Overall Study|Progressive Disease|9|||
46926403|NCT00106626|83160803|FG003|Overall Study|Progressive Disease|10|||
46926404|NCT00106626|83160800|FG000|Overall Study|Received radiation on new therapy|1|||
46926405|NCT00106626|83160801|FG001|Overall Study|Received radiation on new therapy|0|||
46926406|NCT00106626|83160802|FG002|Overall Study|Received radiation on new therapy|0|||
46926407|NCT00106626|83160803|FG003|Overall Study|Received radiation on new therapy|0|||
46926408|NCT00106626|83160800|FG000|Overall Study|> 14 day delay in therapy start|0|||
46926409|NCT00106626|83160801|FG001|Overall Study|> 14 day delay in therapy start|1|||
46926410|NCT00106626|83160802|FG002|Overall Study|> 14 day delay in therapy start|0|||
46926411|NCT00106626|83160803|FG003|Overall Study|> 14 day delay in therapy start|0|||
46926412|NCT02632786|83160820|FG000|Overall Study|Adverse Event|2|||
46926413|NCT02632786|83160821|FG001|Overall Study|Adverse Event|1|||
46926414|NCT02632786|83160820|FG000|Overall Study|Death|3|||
46926415|NCT02632786|83160821|FG001|Overall Study|Death|2|||
46926416|NCT02632786|83160820|FG000|Overall Study|Physician Decision|5|||
46926417|NCT02632786|83160821|FG001|Overall Study|Physician Decision|4|||
46926418|NCT02632786|83160820|FG000|Overall Study|Withdrawal by Subject|1|||
46926419|NCT02632786|83160821|FG001|Overall Study|Withdrawal by Subject|0|||
46926420|NCT02755818|83160832|FG000|Overall Study|Withdrawal by Subject|0|||
46809051|NCT04818593|83028235|FG001|Overall Study|Withdrawal by Subject|2|||
46809052|NCT04818593|83028234|FG000|Overall Study|Conversion to IUI due to low response|1|||
46809053|NCT04818593|83028235|FG001|Overall Study|Conversion to IUI due to low response|1|||
46809054|NCT04680975|83028241|FG000|Overall Study|Adverse Event|3|||
46753452|NCT03922945|82971537|FG001|Overall Study|Lack of Efficacy|0|||
46753453|NCT03922945|82971538|FG002|Overall Study|Lack of Efficacy|1|||
46753454|NCT03922945|82971536|FG000|Overall Study|Protocol Non-Compliance|0|||
46753455|NCT03922945|82971537|FG001|Overall Study|Protocol Non-Compliance|0|||
46809055|NCT04680975|83028241|FG000|Overall Study|Death|1|||
46809056|NCT04680975|83028241|FG000|Overall Study|Progressive Disease|1|||
46809057|NCT04680975|83028241|FG000|Overall Study|Withdrawal by Subject|1|||
46809058|NCT04673786|83028247|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
46809059|NCT04673786|83028248|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
46809060|NCT04673786|83028249|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
46809061|NCT04673786|83028247|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
46809062|NCT04673786|83028248|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
46809063|NCT04673786|83028249|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
46809064|NCT04673786|83028247|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
46809065|NCT04673786|83028248|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
46809066|NCT04673786|83028249|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
46809067|NCT04673786|83028247|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
46809068|NCT04673786|83028248|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
46809069|NCT04673786|83028249|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
46809070|NCT04673786|83028247|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
46809071|NCT04673786|83028248|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
46809072|NCT04673786|83028249|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
46809073|NCT04673786|83028247|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
46809074|NCT04673786|83028248|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
46753456|NCT03922945|82971538|FG002|Overall Study|Protocol Non-Compliance|1|||
46753457|NCT03922945|82971536|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
46753458|NCT03922945|82971537|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
46753459|NCT03922945|82971538|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
46753460|NCT03922945|82971536|FG000|Overall Study|All Other Personal Reasons|1|||
46809075|NCT04673786|83028249|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
46809076|NCT04583969|83028273|FG000|Overall Study|Death|31|||
46809077|NCT04583969|83028274|FG001|Overall Study|Death|38|||
46809078|NCT04583969|83028273|FG000|Overall Study|Lost to Follow-up|16|||
46809079|NCT04583969|83028274|FG001|Overall Study|Lost to Follow-up|13|||
46926421|NCT02755818|83160833|FG001|Overall Study|Withdrawal by Subject|0|||
46926422|NCT02755818|83160834|FG002|Overall Study|Withdrawal by Subject|0|||
46926423|NCT02755818|83160835|FG003|Overall Study|Withdrawal by Subject|2|||
46926424|NCT02755818|83160832|FG000|Overall Study|withdrawal by PI|0|||
46926425|NCT02755818|83160833|FG001|Overall Study|withdrawal by PI|0|||
46753461|NCT03922945|82971537|FG001|Overall Study|All Other Personal Reasons|1|||
46926426|NCT02755818|83160834|FG002|Overall Study|withdrawal by PI|1|||
46809080|NCT04583969|83028273|FG000|Overall Study|Protocol Violation|1|||
46926427|NCT02755818|83160835|FG003|Overall Study|withdrawal by PI|1|||
46926428|NCT03033745|83160850|FG000|Overall Study|Protocol Violation|0|||
46809081|NCT04583969|83028274|FG001|Overall Study|Protocol Violation|0|||
46809082|NCT04583969|83028273|FG000|Overall Study|Withdrawal by Subject|3|||
46809083|NCT04583969|83028274|FG001|Overall Study|Withdrawal by Subject|3|||
46809084|NCT04583969|83028273|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
46809085|NCT04583969|83028274|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
46809086|NCT04583969|83028273|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
46809087|NCT04583969|83028274|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
46809088|NCT04583969|83028273|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
46809089|NCT04583969|83028274|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
46809090|NCT04583969|83028273|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
46809091|NCT04583969|83028274|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
46809092|NCT04583969|83028273|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
46809093|NCT04583969|83028274|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
46809094|NCT04561115|83028280|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
46809095|NCT04561115|83028281|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
46809096|NCT04561115|83028280|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
46809097|NCT04561115|83028281|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
46809098|NCT04561115|83028280|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
46809099|NCT04561115|83028281|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
46809100|NCT04366258|83028287|FG000|Baseline Assessments|Screen Failure|21|||
46809101|NCT04366258|83028287|FG000|Baseline Assessments|Early Termination|3|||
46809102|NCT03891667|83028337|FG000|Overall Study|Physician Decision|1|||
46636299|NCT01489254|82810134|FG003|Double-blind Part|Lost to Follow-up|0|||
46636300|NCT01489254|82810131|FG000|Double-blind Part|Other reasons for not completing study|4|||
46636301|NCT01489254|82810132|FG001|Double-blind Part|Other reasons for not completing study|6|||
46636302|NCT01489254|82810133|FG002|Double-blind Part|Other reasons for not completing study|0|||
46636303|NCT01489254|82810134|FG003|Double-blind Part|Other reasons for not completing study|0|||
46636304|NCT01489254|82810131|FG000|Open-label Extension Part|Adverse Event|0|||
46636305|NCT01489254|82810132|FG001|Open-label Extension Part|Adverse Event|0|||
46753462|NCT03922945|82971538|FG002|Overall Study|All Other Personal Reasons|2|||
46753463|NCT03922477|82971549|FG000|Overall Study|Death|9|||
46809103|NCT03891667|83028338|FG001|Overall Study|Physician Decision|0|||
46809104|NCT03891667|83028337|FG000|Overall Study|COVID related pause|1|||
46809105|NCT03891667|83028338|FG001|Overall Study|COVID related pause|1|||
46809106|NCT03891667|83028337|FG000|Overall Study|Withdrawal by Subject|0|||
46926429|NCT03033745|83160851|FG001|Overall Study|Protocol Violation|0|||
46926430|NCT03033745|83160852|FG002|Overall Study|Protocol Violation|1|||
46926431|NCT03033745|83160850|FG000|Overall Study|Adverse Event|1|||
46926432|NCT03033745|83160851|FG001|Overall Study|Adverse Event|0|||
46926433|NCT03033745|83160852|FG002|Overall Study|Adverse Event|1|||
46926434|NCT03033745|83160850|FG000|Overall Study|Withdrawal by Subject|0|||
46926435|NCT03033745|83160851|FG001|Overall Study|Withdrawal by Subject|1|||
47053729|NCT02728206|83324330|FG000|Overall Study|Death|1|||
46636306|NCT01489254|82810133|FG002|Open-label Extension Part|Adverse Event|0|||
46636307|NCT01489254|82810134|FG003|Open-label Extension Part|Adverse Event|10|||
46636308|NCT01489254|82810131|FG000|Open-label Extension Part|Pregnancy|0|||
46753464|NCT03922477|82971549|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
46753465|NCT03922477|82971549|FG000|Overall Study|Physician Decision|1|||
46753466|NCT03922477|82971549|FG000|Overall Study|Withdrawal by Subject|2|||
46753467|NCT00867165|82971555|FG000|Overall Study|Adverse Event|3|||
46753468|NCT00867165|82971556|FG001|Overall Study|Adverse Event|0|||
46753469|NCT00867165|82971555|FG000|Overall Study|Withdrawal by Subject|1|||
46753470|NCT00867165|82971556|FG001|Overall Study|Withdrawal by Subject|0|||
46753471|NCT00867087|82971562|FG000|Overall Study|Other|1|||
46753472|NCT00867087|82971562|FG000|Overall Study|Withdrawal by Subject|4|||
46753473|NCT00867087|82971562|FG000|Overall Study|Death|37|||
46753474|NCT00545233|82971568|FG000|Overall Study|Adverse Event|10|||
46753475|NCT00545233|82971569|FG001|Overall Study|Adverse Event|5|||
46753476|NCT00545233|82971568|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
46753477|NCT00545233|82971569|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
46753478|NCT00545233|82971568|FG000|Overall Study|Protocol Violation|2|||
47053730|NCT01811225|83324334|FG000|Treatment Period 1|Adverse Event|2|||
46753479|NCT00545233|82971569|FG001|Overall Study|Protocol Violation|0|||
46753480|NCT00545233|82971568|FG000|Overall Study|Refused Treatment|9|||
46753481|NCT00545233|82971569|FG001|Overall Study|Refused Treatment|7|||
46753482|NCT00545233|82971568|FG000|Overall Study|Failure to Return|4|||
46753483|NCT00545233|82971569|FG001|Overall Study|Failure to Return|6|||
46753484|NCT00545233|82971568|FG000|Overall Study|Insufficient response|14|||
46809107|NCT03891667|83028338|FG001|Overall Study|Withdrawal by Subject|1|||
46809108|NCT03891667|83028337|FG000|Overall Study|Adverse Event|0|||
46809109|NCT03891667|83028338|FG001|Overall Study|Adverse Event|1|||
46809110|NCT03715153|83028362|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
46809111|NCT03715153|83028363|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
46809112|NCT03715153|83028362|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
46809113|NCT03715153|83028363|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
46809114|NCT03715153|83028362|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
46753485|NCT00545233|82971569|FG001|Overall Study|Insufficient response|15|||
46753486|NCT00545233|82971568|FG000|Overall Study|Physician Decision|2|||
46753487|NCT00545233|82971569|FG001|Overall Study|Physician Decision|1|||
46753488|NCT02393248|82971601|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46809115|NCT03715153|83028363|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
46809116|NCT03715153|83028362|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
46809117|NCT03715153|83028363|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
47053731|NCT01811225|83324335|FG001|Treatment Period 1|Adverse Event|3|||
47053732|NCT01811225|83324334|FG000|Treatment Period 1|Lost to Follow-up|12|||
47053733|NCT01811225|83324335|FG001|Treatment Period 1|Lost to Follow-up|8|||
47053734|NCT01811225|83324334|FG000|Treatment Period 1|transporation|1|||
47053735|NCT01811225|83324335|FG001|Treatment Period 1|transporation|0|||
47053736|NCT01811225|83324334|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
47053737|NCT01811225|83324335|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
46753489|NCT02393248|82971602|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
46753490|NCT02393248|82971603|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753491|NCT02393248|82971604|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753492|NCT02393248|82971605|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46809118|NCT03715153|83028362|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
46809119|NCT03715153|83028363|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
46809120|NCT03715153|83028362|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
46809121|NCT03715153|83028363|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
46809122|NCT03464136|83028388|FG000|Overall Study|Lost to Follow-up|5|||
46809123|NCT03464136|83028389|FG001|Overall Study|Lost to Follow-up|8|||
46809124|NCT03464136|83028388|FG000|Overall Study|Withdrawal by Subject|16|||
46809125|NCT03464136|83028389|FG001|Overall Study|Withdrawal by Subject|13|||
46809126|NCT03464136|83028388|FG000|Overall Study|Death|1|||
46809127|NCT03464136|83028389|FG001|Overall Study|Death|0|||
46809128|NCT03464136|83028388|FG000|Overall Study|Other|8|||
46809129|NCT03464136|83028389|FG001|Overall Study|Other|4|||
46809130|NCT03020823|83028413|FG000|Overall Study|Physician Decision|4|||
46809131|NCT03020823|83028413|FG000|Overall Study|Lack of Efficacy|4|||
46809132|NCT03020823|83028413|FG000|Overall Study|Adverse Event|2|||
46809133|NCT02969369|83028421|FG000|Study|Adverse Event|1|||
46809134|NCT02969369|83028422|FG001|Study|Adverse Event|6|||
46809135|NCT02969369|83028421|FG000|Study|Lack of Efficacy|0|||
46809136|NCT02969369|83028422|FG001|Study|Lack of Efficacy|1|||
46809137|NCT02969369|83028421|FG000|Study|Lost to Follow-up|0|||
46809138|NCT02969369|83028422|FG001|Study|Lost to Follow-up|1|||
46809139|NCT02969369|83028421|FG000|Study|Withdrawal by Subject|3|||
46809140|NCT02969369|83028422|FG001|Study|Withdrawal by Subject|5|||
46809141|NCT02969369|83028421|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
46809142|NCT02969369|83028422|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
46809143|NCT02969369|83028421|FG000|Double-blind Period|Adverse Event|1|||
46809144|NCT02969369|83028422|FG001|Double-blind Period|Adverse Event|5|||
46809145|NCT02969369|83028421|FG000|Double-blind Period|Lost to Follow-up|0|||
46809146|NCT02969369|83028422|FG001|Double-blind Period|Lost to Follow-up|1|||
46809147|NCT02969369|83028421|FG000|Double-blind Period|Withdrawal by Subject|2|||
46809148|NCT02969369|83028422|FG001|Double-blind Period|Withdrawal by Subject|3|||
46809149|NCT02969369|83028421|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
46753493|NCT02393248|82971606|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
46753494|NCT02393248|82971607|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
46753495|NCT02393248|82971608|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753496|NCT02393248|82971609|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46926436|NCT03033745|83160852|FG002|Overall Study|Withdrawal by Subject|0|||
46926437|NCT01672294|83160871|FG000|Overall Study|Withdrawal by Subject|4|||
46926438|NCT01672294|83160872|FG001|Overall Study|Withdrawal by Subject|4|||
46753497|NCT02393248|82971610|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753498|NCT02393248|82971611|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753499|NCT02393248|82971612|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46809150|NCT02969369|83028422|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
46809151|NCT02969369|83028421|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
46809152|NCT02969369|83028422|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
46809153|NCT02969369|83028421|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
46926439|NCT01672294|83160873|FG002|Overall Study|Withdrawal by Subject|4|||
46809154|NCT02969369|83028422|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
46809155|NCT02969369|83028421|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
46809156|NCT02969369|83028422|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
46809157|NCT02583269|83028442|FG000|Overall Study|Patient hospitalized prior to start|1|||
46809158|NCT02583269|83028443|FG001|Overall Study|Patient hospitalized prior to start|0|||
46809159|NCT02583269|83028444|FG002|Overall Study|Patient hospitalized prior to start|0|||
46809160|NCT02583269|83028445|FG003|Overall Study|Patient hospitalized prior to start|0|||
46809161|NCT02583269|83028446|FG004|Overall Study|Patient hospitalized prior to start|0|||
46809162|NCT02546921|83028466|FG000|Overall Study|Adverse Event|0|||
46809163|NCT02546921|83028467|FG001|Overall Study|Adverse Event|5|||
46809164|NCT02546921|83028468|FG002|Overall Study|Adverse Event|2|||
46809165|NCT02546921|83028469|FG003|Overall Study|Adverse Event|0|||
46809166|NCT02546921|83028470|FG004|Overall Study|Adverse Event|0|||
46809167|NCT02546921|83028471|FG005|Overall Study|Adverse Event|0|||
46809168|NCT02546921|83028472|FG006|Overall Study|Adverse Event|0|||
46809169|NCT02546921|83028466|FG000|Overall Study|Evidence of Disease Progression|1|||
46809170|NCT02546921|83028467|FG001|Overall Study|Evidence of Disease Progression|0|||
46809171|NCT02546921|83028468|FG002|Overall Study|Evidence of Disease Progression|0|||
46809172|NCT02546921|83028469|FG003|Overall Study|Evidence of Disease Progression|0|||
46809173|NCT02546921|83028470|FG004|Overall Study|Evidence of Disease Progression|1|||
46809174|NCT02546921|83028471|FG005|Overall Study|Evidence of Disease Progression|0|||
46809175|NCT02546921|83028472|FG006|Overall Study|Evidence of Disease Progression|0|||
46809176|NCT02546921|83028466|FG000|Overall Study|Patient Choice|0|||
46809177|NCT02546921|83028467|FG001|Overall Study|Patient Choice|1|||
46809178|NCT02546921|83028468|FG002|Overall Study|Patient Choice|0|||
46809179|NCT02546921|83028469|FG003|Overall Study|Patient Choice|0|||
46809180|NCT02546921|83028470|FG004|Overall Study|Patient Choice|0|||
46809181|NCT02546921|83028471|FG005|Overall Study|Patient Choice|1|||
46809182|NCT02546921|83028472|FG006|Overall Study|Patient Choice|0|||
46809183|NCT02513329|83028506|FG000|Overall Study|Lost to Follow-up|5|||
46809184|NCT02513329|83028507|FG001|Overall Study|Lost to Follow-up|2|||
46809185|NCT02425826|83028517|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
46809186|NCT02425826|83028518|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
46809187|NCT02425826|83028519|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
46809188|NCT02425826|83028517|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
46809189|NCT02425826|83028518|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
46809190|NCT02425826|83028519|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
46809191|NCT02425826|83028517|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
46753500|NCT02393248|82971613|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753501|NCT02393248|82971614|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753502|NCT02393248|82971615|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753503|NCT02393248|82971616|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753504|NCT02393248|82971617|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753505|NCT02393248|82971618|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753506|NCT02393248|82971619|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753507|NCT02393248|82971620|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753508|NCT02393248|82971621|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753509|NCT02393248|82971622|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753510|NCT02393248|82971623|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753511|NCT02393248|82971624|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753512|NCT02393248|82971625|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
46753513|NCT02393248|82971601|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753514|NCT02393248|82971602|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
46753515|NCT02393248|82971603|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753516|NCT02393248|82971604|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753517|NCT02393248|82971605|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753518|NCT02393248|82971606|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753519|NCT02393248|82971607|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753520|NCT02393248|82971608|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753521|NCT02393248|82971609|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46809192|NCT02425826|83028518|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
46809193|NCT02425826|83028519|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
46809194|NCT02425826|83028517|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
46809195|NCT02425826|83028518|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
46809196|NCT02425826|83028519|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
46809197|NCT02425826|83028517|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
46809198|NCT02425826|83028518|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
46809199|NCT02425826|83028519|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
46809200|NCT02425826|83028517|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
46926440|NCT01672294|83160874|FG003|Overall Study|Withdrawal by Subject|4|||
46926441|NCT01672294|83160871|FG000|Overall Study|Excluded by study|1|||
46926442|NCT01672294|83160872|FG001|Overall Study|Excluded by study|1|||
46926443|NCT01672294|83160873|FG002|Overall Study|Excluded by study|0|||
46926444|NCT01672294|83160874|FG003|Overall Study|Excluded by study|0|||
46926445|NCT01672294|83160871|FG000|Overall Study|Lost to Follow-up|1|||
46926446|NCT01672294|83160872|FG001|Overall Study|Lost to Follow-up|16|||
46926447|NCT01672294|83160873|FG002|Overall Study|Lost to Follow-up|7|||
46926448|NCT01672294|83160874|FG003|Overall Study|Lost to Follow-up|9|||
46926449|NCT02755116|83160886|FG000|Overall Study|surgery converted to open, pt admitted|3|||
46926450|NCT02755116|83160887|FG001|Overall Study|surgery converted to open, pt admitted|1|||
46926451|NCT02754492|83160897|FG000|Overall Study|Protocol Violation|2|||
46926452|NCT02754492|83160898|FG001|Overall Study|Protocol Violation|2|||
46926453|NCT02754492|83160899|FG002|Overall Study|Protocol Violation|0|||
46926454|NCT02754492|83160900|FG003|Overall Study|Protocol Violation|1|||
46926455|NCT02754492|83160897|FG000|Overall Study|Withdrawal by Subject|2|||
46926456|NCT02754492|83160898|FG001|Overall Study|Withdrawal by Subject|0|||
46926457|NCT02754492|83160899|FG002|Overall Study|Withdrawal by Subject|0|||
46926458|NCT02754492|83160900|FG003|Overall Study|Withdrawal by Subject|0|||
47053738|NCT01811225|83324334|FG000|Treatment Period 2|Lost to Follow-up|1|||
47053739|NCT01811225|83324335|FG001|Treatment Period 2|Lost to Follow-up|2|||
47053740|NCT01811225|83324334|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
47053741|NCT01811225|83324335|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
47053742|NCT01809197|83324343|FG000|Overall Study|Lost to Follow-up|4|||
47053743|NCT01809197|83324344|FG001|Overall Study|Lost to Follow-up|2|||
47053744|NCT01809197|83324343|FG000|Overall Study|Adverse Event|2|||
47053745|NCT01809197|83324344|FG001|Overall Study|Adverse Event|3|||
47053746|NCT01809197|83324343|FG000|Overall Study|Failed slit lamp exam|1|||
47053747|NCT01809197|83324344|FG001|Overall Study|Failed slit lamp exam|0|||
47053748|NCT01809197|83324343|FG000|Overall Study|Non-Compliance|1|||
47053749|NCT01809197|83324344|FG001|Overall Study|Non-Compliance|1|||
47053750|NCT01809197|83324343|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
47053751|NCT01809197|83324344|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
47053752|NCT01809197|83324343|FG000|Overall Study|Withdrawal by Subject|1|||
47053753|NCT01809197|83324344|FG001|Overall Study|Withdrawal by Subject|1|||
46753522|NCT02393248|82971610|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753523|NCT02393248|82971611|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753524|NCT02393248|82971612|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753525|NCT02393248|82971613|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753526|NCT02393248|82971614|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753527|NCT02393248|82971615|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753528|NCT02393248|82971616|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753529|NCT02393248|82971617|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753530|NCT02393248|82971618|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753531|NCT02393248|82971619|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753532|NCT02393248|82971620|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753533|NCT02393248|82971621|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753534|NCT02393248|82971622|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753535|NCT02393248|82971623|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753536|NCT02393248|82971624|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753537|NCT02393248|82971625|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
46753538|NCT02393248|82971601|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
46753539|NCT02393248|82971602|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
46753540|NCT02393248|82971603|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
46753541|NCT02393248|82971604|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
46753542|NCT02393248|82971605|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
46753543|NCT02393248|82971606|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
46753544|NCT02393248|82971607|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
46926459|NCT02754492|83160897|FG000|Overall Study|Equipment malfuntion|0|||
46926460|NCT02754492|83160898|FG001|Overall Study|Equipment malfuntion|0|||
46926461|NCT02754492|83160899|FG002|Overall Study|Equipment malfuntion|2|||
46926462|NCT02754492|83160900|FG003|Overall Study|Equipment malfuntion|5|||
47053754|NCT01809197|83324343|FG000|Overall Study|Product not available|0|||
46926463|NCT02754492|83160897|FG000|Overall Study|Adverse Event|0|||
46926464|NCT02754492|83160898|FG001|Overall Study|Adverse Event|0|||
47053755|NCT01809197|83324344|FG001|Overall Study|Product not available|1|||
47053756|NCT01786109|83324353|FG000|Overall Study|fail manometry barostat tube placement|1|||
47053757|NCT01786109|83324354|FG001|Overall Study|fail manometry barostat tube placement|0|||
46926465|NCT02754492|83160899|FG002|Overall Study|Adverse Event|0|||
46926466|NCT02754492|83160900|FG003|Overall Study|Adverse Event|13|||
47053758|NCT01786109|83324355|FG002|Overall Study|fail manometry barostat tube placement|0|||
46753545|NCT02393248|82971608|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
46753546|NCT02393248|82971609|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
47053759|NCT01786109|83324353|FG000|Overall Study|unrelated illness|0|||
46926467|NCT02754492|83160897|FG000|Overall Study|Venous access issues not resulting in AE|0|||
46926468|NCT02754492|83160898|FG001|Overall Study|Venous access issues not resulting in AE|0|||
46926469|NCT02754492|83160899|FG002|Overall Study|Venous access issues not resulting in AE|0|||
46926470|NCT02754492|83160900|FG003|Overall Study|Venous access issues not resulting in AE|4|||
47053760|NCT01786109|83324354|FG001|Overall Study|unrelated illness|0|||
46809201|NCT02425826|83028518|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
46809202|NCT02425826|83028519|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
46809203|NCT02425826|83028517|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
46809204|NCT02425826|83028518|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
46809205|NCT02425826|83028519|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
46809206|NCT02425826|83028517|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
46809207|NCT02425826|83028518|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
46809208|NCT02425826|83028519|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
46809209|NCT02425826|83028517|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
46809210|NCT02425826|83028518|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
46809211|NCT02425826|83028519|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
46809212|NCT02425826|83028517|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
46809213|NCT02425826|83028518|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
46809214|NCT02425826|83028519|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
46809215|NCT02406027|83028532|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
46809216|NCT02406027|83028533|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
46809217|NCT02406027|83028534|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
46809218|NCT02406027|83028535|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
46809219|NCT02406027|83028536|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
46809220|NCT02406027|83028537|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
46809221|NCT02406027|83028538|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
46809222|NCT02406027|83028532|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
46809223|NCT02406027|83028533|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
46809224|NCT02406027|83028534|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
46809225|NCT02406027|83028535|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
46809226|NCT02406027|83028536|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
46809227|NCT02406027|83028537|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
46809228|NCT02406027|83028538|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
46809229|NCT02406027|83028532|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
46809230|NCT02406027|83028533|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
46809231|NCT02406027|83028534|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
46809232|NCT02406027|83028535|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
46809233|NCT02406027|83028536|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
46926471|NCT04068688|83160919|FG000|Overall Study|Lost to Follow-up|1|||
46926472|NCT04068688|83160920|FG001|Overall Study|Lost to Follow-up|1|||
46926473|NCT04068688|83160921|FG002|Overall Study|Lost to Follow-up|0|||
46926474|NCT04068688|83160922|FG003|Overall Study|Lost to Follow-up|0|||
46926475|NCT04068688|83160923|FG004|Overall Study|Lost to Follow-up|5|||
46926476|NCT04068688|83160924|FG005|Overall Study|Lost to Follow-up|5|||
46926477|NCT04068688|83160925|FG006|Overall Study|Lost to Follow-up|0|||
47053761|NCT01786109|83324355|FG002|Overall Study|unrelated illness|1|||
47053762|NCT01786109|83324353|FG000|Overall Study|adverse effects colon preparation|0|||
47053763|NCT01786109|83324354|FG001|Overall Study|adverse effects colon preparation|0|||
47053764|NCT01786109|83324355|FG002|Overall Study|adverse effects colon preparation|1|||
47053765|NCT02728596|83324489|FG000|Overall Study|Refusal unrelated to adverse event|3|||
47053766|NCT02728596|83324490|FG001|Overall Study|Refusal unrelated to adverse event|6|||
47053767|NCT02728596|83324491|FG002|Overall Study|Refusal unrelated to adverse event|7|||
47053768|NCT02728596|83324492|FG003|Overall Study|Refusal unrelated to adverse event|7|||
46753547|NCT02393248|82971610|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
46753548|NCT02393248|82971611|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
46753549|NCT02393248|82971612|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
46753550|NCT02393248|82971613|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
46753551|NCT02393248|82971614|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
46753552|NCT02393248|82971615|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
46753553|NCT02393248|82971616|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
46753554|NCT02393248|82971617|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
46753555|NCT02393248|82971618|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
46753556|NCT02393248|82971619|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
46753557|NCT02393248|82971620|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
46753558|NCT02393248|82971621|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
46809234|NCT02406027|83028537|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
46753559|NCT02393248|82971622|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
46809235|NCT02406027|83028538|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
46809236|NCT02406027|83028532|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
46809237|NCT02406027|83028533|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
46809238|NCT02406027|83028534|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
46809239|NCT02406027|83028535|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
46809240|NCT02406027|83028536|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
46809241|NCT02406027|83028537|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
46809242|NCT02406027|83028538|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
46809243|NCT02406027|83028532|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
46809244|NCT02406027|83028533|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
46809245|NCT02406027|83028534|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
46809246|NCT02406027|83028535|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
46809247|NCT02406027|83028536|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
46809248|NCT02406027|83028537|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
46809249|NCT02406027|83028538|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
46809250|NCT02406027|83028532|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
46809251|NCT02406027|83028533|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
46809252|NCT02406027|83028534|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
46809253|NCT02406027|83028535|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
46809254|NCT02406027|83028536|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
46809255|NCT02406027|83028537|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
46809256|NCT02406027|83028538|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
46809257|NCT02406027|83028532|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
46809258|NCT02406027|83028533|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
46809259|NCT02406027|83028534|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
46809260|NCT02406027|83028535|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
46809261|NCT02406027|83028536|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
46809262|NCT02406027|83028537|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
46809263|NCT02406027|83028538|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
46809264|NCT02406027|83028532|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
46809265|NCT02406027|83028533|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
46809266|NCT02406027|83028534|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
46809267|NCT02406027|83028535|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
46809268|NCT02406027|83028536|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
46809269|NCT02406027|83028537|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
46809270|NCT02406027|83028538|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
46809271|NCT02406027|83028532|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
46809272|NCT02406027|83028533|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
46809273|NCT02406027|83028534|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
46809274|NCT02406027|83028535|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
46809275|NCT02406027|83028536|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
46809276|NCT02406027|83028537|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
46809277|NCT02406027|83028538|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
46809278|NCT02406027|83028532|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
46809279|NCT02406027|83028533|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
46809280|NCT02406027|83028534|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
46809281|NCT02406027|83028535|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
46809282|NCT02406027|83028536|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
46809283|NCT02406027|83028537|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
46809284|NCT02406027|83028538|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
46809285|NCT02255357|83028556|FG000|Overall Study|Physician Decision|10|||
46809286|NCT02255357|83028557|FG001|Overall Study|Physician Decision|24|||
46809287|NCT02211131|83028565|FG000|Overall Study|Death|26|||
46809288|NCT02211131|83028566|FG001|Overall Study|Death|16|||
46809289|NCT02211131|83028565|FG000|Overall Study|Lost to Follow-up|4|||
46809290|NCT02211131|83028566|FG001|Overall Study|Lost to Follow-up|3|||
46809291|NCT02211131|83028565|FG000|Overall Study|Decision by Sponsor|1|||
46809292|NCT02211131|83028566|FG001|Overall Study|Decision by Sponsor|1|||
46809293|NCT02211131|83028565|FG000|Overall Study|Withdrawal by Subject|3|||
46809294|NCT02211131|83028566|FG001|Overall Study|Withdrawal by Subject|8|||
46809295|NCT02134587|83028583|FG000|Overall Study|Did not completed all meetings|30|||
46809296|NCT01752920|83028596|FG000|Overall Study|Adverse Event|1|||
46809297|NCT01752920|83028597|FG001|Overall Study|Adverse Event|0|||
46809298|NCT01752920|83028598|FG002|Overall Study|Adverse Event|5|||
46809299|NCT01752920|83028599|FG003|Overall Study|Adverse Event|10|||
46809300|NCT01752920|83028596|FG000|Overall Study|Clinical Disease Progression|6|||
46809301|NCT01752920|83028597|FG001|Overall Study|Clinical Disease Progression|4|||
46926478|NCT04068688|83160926|FG007|Overall Study|Lost to Follow-up|0|||
46809302|NCT01752920|83028598|FG002|Overall Study|Clinical Disease Progression|1|||
46809303|NCT01752920|83028599|FG003|Overall Study|Clinical Disease Progression|13|||
46809304|NCT01752920|83028596|FG000|Overall Study|Physician Decision|1|||
46809305|NCT01752920|83028597|FG001|Overall Study|Physician Decision|0|||
46809306|NCT01752920|83028598|FG002|Overall Study|Physician Decision|0|||
46809307|NCT01752920|83028599|FG003|Overall Study|Physician Decision|3|||
46809308|NCT01752920|83028596|FG000|Overall Study|Radiographic Disease Progression|20|||
46809309|NCT01752920|83028597|FG001|Overall Study|Radiographic Disease Progression|7|||
46809310|NCT01752920|83028598|FG002|Overall Study|Radiographic Disease Progression|12|||
46809311|NCT01752920|83028599|FG003|Overall Study|Radiographic Disease Progression|29|||
46809312|NCT01752920|83028596|FG000|Overall Study|Study Terminated by Sponsor|0|||
46809313|NCT01752920|83028597|FG001|Overall Study|Study Terminated by Sponsor|0|||
46809314|NCT01752920|83028598|FG002|Overall Study|Study Terminated by Sponsor|0|||
46809315|NCT01752920|83028599|FG003|Overall Study|Study Terminated by Sponsor|1|||
46809316|NCT01752920|83028596|FG000|Overall Study|Withdrawal by Subject|0|||
46809317|NCT01752920|83028597|FG001|Overall Study|Withdrawal by Subject|1|||
46809318|NCT01752920|83028598|FG002|Overall Study|Withdrawal by Subject|0|||
46926479|NCT04068688|83160927|FG008|Overall Study|Lost to Follow-up|1|||
46926480|NCT04068688|83160928|FG009|Overall Study|Lost to Follow-up|0|||
46926481|NCT04068688|83160919|FG000|Overall Study|Withdrawal by Subject|1|||
46926482|NCT04068688|83160920|FG001|Overall Study|Withdrawal by Subject|1|||
46926483|NCT04068688|83160921|FG002|Overall Study|Withdrawal by Subject|0|||
46926484|NCT04068688|83160922|FG003|Overall Study|Withdrawal by Subject|0|||
46926485|NCT04068688|83160923|FG004|Overall Study|Withdrawal by Subject|0|||
46926486|NCT04068688|83160924|FG005|Overall Study|Withdrawal by Subject|0|||
46926487|NCT04068688|83160925|FG006|Overall Study|Withdrawal by Subject|0|||
46926488|NCT04068688|83160926|FG007|Overall Study|Withdrawal by Subject|0|||
46926489|NCT04068688|83160927|FG008|Overall Study|Withdrawal by Subject|0|||
46926490|NCT04068688|83160928|FG009|Overall Study|Withdrawal by Subject|0|||
46926491|NCT04068688|83160919|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
46926492|NCT04068688|83160920|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
46926493|NCT04068688|83160921|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
46926494|NCT04068688|83160922|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
47053769|NCT02728596|83324489|FG000|Overall Study|Death|44|||
47053770|NCT02728596|83324490|FG001|Overall Study|Death|42|||
47053771|NCT02728596|83324491|FG002|Overall Study|Death|123|||
47053772|NCT02728596|83324492|FG003|Overall Study|Death|68|||
47053773|NCT00708162|83324866|FG000|Randomized Phase|Randomized but Not Treated|7|||
46753560|NCT02393248|82971623|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
46753561|NCT02393248|82971624|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
46753562|NCT02393248|82971625|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
46753563|NCT02393248|82971601|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
46753564|NCT02393248|82971602|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753565|NCT02393248|82971603|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753566|NCT02393248|82971604|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753567|NCT02393248|82971605|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753568|NCT02393248|82971606|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753569|NCT02393248|82971607|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753570|NCT02393248|82971608|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753571|NCT02393248|82971609|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753572|NCT02393248|82971610|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753573|NCT02393248|82971611|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753574|NCT02393248|82971612|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753575|NCT02393248|82971613|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753576|NCT02393248|82971614|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753577|NCT02393248|82971615|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753578|NCT02393248|82971616|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753579|NCT02393248|82971617|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753580|NCT02393248|82971618|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753581|NCT02393248|82971619|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46809319|NCT01752920|83028599|FG003|Overall Study|Withdrawal by Subject|1|||
46809320|NCT01752920|83028596|FG000|Overall Study|Lack of clinical benefit|1|||
46809321|NCT01752920|83028597|FG001|Overall Study|Lack of clinical benefit|1|||
46809322|NCT01752920|83028598|FG002|Overall Study|Lack of clinical benefit|1|||
46809323|NCT01752920|83028599|FG003|Overall Study|Lack of clinical benefit|1|||
46809324|NCT00976963|83028613|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
46809325|NCT00976963|83028614|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
46809326|NCT00976963|83028613|FG000|Overall Study|administrative error|1|||
46809327|NCT00976963|83028614|FG001|Overall Study|administrative error|0|||
46809328|NCT00976963|83028613|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
46809329|NCT00976963|83028614|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
46809330|NCT00423735|83028631|FG000|Overall Study|Ineligible / No protocol treatment|8|||
46809331|NCT00423735|83028632|FG001|Overall Study|Ineligible / No protocol treatment|6|||
46809332|NCT00423735|83028633|FG002|Overall Study|Ineligible / No protocol treatment|0|||
46809333|NCT00626327|83028646|FG000|Overall Study|Withdrawal by Subject|21|||
46809334|NCT00626327|83028647|FG001|Overall Study|Withdrawal by Subject|29|||
46809335|NCT00626327|83028648|FG002|Overall Study|Withdrawal by Subject|30|||
46809336|NCT00626327|83028646|FG000|Overall Study|Adverse Event|1|||
46809337|NCT00626327|83028647|FG001|Overall Study|Adverse Event|0|||
46809338|NCT00626327|83028648|FG002|Overall Study|Adverse Event|0|||
46809339|NCT00626327|83028646|FG000|Overall Study|Lost to Follow-up|24|||
46809340|NCT00626327|83028647|FG001|Overall Study|Lost to Follow-up|21|||
46809341|NCT00626327|83028648|FG002|Overall Study|Lost to Follow-up|23|||
46809342|NCT00626327|83028646|FG000|Overall Study|Inappropriate enrollment|4|||
46809343|NCT00626327|83028647|FG001|Overall Study|Inappropriate enrollment|5|||
46809344|NCT00626327|83028648|FG002|Overall Study|Inappropriate enrollment|3|||
46809345|NCT00626327|83028646|FG000|Overall Study|Administrative Reason|2|||
46809346|NCT00626327|83028647|FG001|Overall Study|Administrative Reason|0|||
46809347|NCT00626327|83028648|FG002|Overall Study|Administrative Reason|6|||
46809348|NCT00626327|83028646|FG000|Overall Study|Protocol Violation|26|||
46809349|NCT00626327|83028647|FG001|Overall Study|Protocol Violation|4|||
46809350|NCT00626327|83028648|FG002|Overall Study|Protocol Violation|26|||
46809351|NCT00357994|83028666|FG000|Overall Study|Adverse Event|1|||
46809352|NCT00357994|83028667|FG001|Overall Study|Adverse Event|2|||
46809353|NCT00357994|83028666|FG000|Overall Study|Lack of Efficacy|0|||
46809354|NCT00357994|83028667|FG001|Overall Study|Lack of Efficacy|1|||
46809355|NCT00357994|83028666|FG000|Overall Study|Protocol Violation|1|||
46809356|NCT00357994|83028667|FG001|Overall Study|Protocol Violation|0|||
46809357|NCT00423657|83028675|FG000|Overall Study|Withdrew consent|10|||
46809358|NCT00423657|83028676|FG001|Overall Study|Withdrew consent|8|||
46809359|NCT00423657|83028675|FG000|Overall Study|Non-compliance|0|||
46809360|NCT00423657|83028676|FG001|Overall Study|Non-compliance|1|||
46809361|NCT00423657|83028675|FG000|Overall Study|Other|15|||
46809362|NCT00423657|83028676|FG001|Overall Study|Other|16|||
46926495|NCT04068688|83160923|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
46926496|NCT04068688|83160924|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
46967667|NCT02157376|83210227|FG001|Overall Study|Withdrawal by Subject|8|||
46809363|NCT00423657|83028675|FG000|Overall Study|Request of sponsor/investigator|1|||
46809364|NCT00423657|83028676|FG001|Overall Study|Request of sponsor/investigator|0|||
46809365|NCT00367432|83028682|FG000|First Period (16 Weeks)|Adverse Event|6|||
46809366|NCT00367432|83028683|FG001|First Period (16 Weeks)|Adverse Event|0|||
46809367|NCT00367432|83028682|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
46809368|NCT00367432|83028683|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
46809369|NCT00367432|83028682|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
46809370|NCT00367432|83028683|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
46809371|NCT00367432|83028682|FG000|First Period (16 Weeks)|Other Reason|2|||
46809372|NCT00367432|83028683|FG001|First Period (16 Weeks)|Other Reason|0|||
46809373|NCT00367432|83028682|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
46809374|NCT00367432|83028683|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
46809375|NCT00367432|83028682|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
46809376|NCT00367432|83028683|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
46967668|NCT02157376|83210226|FG000|Overall Study|Not treated|8|||
46753582|NCT02393248|82971620|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753583|NCT02393248|82971621|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753584|NCT02393248|82971622|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753585|NCT02393248|82971623|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753586|NCT02393248|82971624|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753587|NCT02393248|82971625|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
46753588|NCT02393248|82971601|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46809377|NCT00367432|83028682|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
46809378|NCT00367432|83028683|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
46809379|NCT00367432|83028682|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
46809380|NCT00367432|83028683|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
46809381|NCT00367432|83028682|FG000|Second Period (up to 54 Months)|Other Reason|6|||
46809382|NCT00367432|83028683|FG001|Second Period (up to 54 Months)|Other Reason|2|||
46809383|NCT00623363|83028689|FG000|Overall Study|Adverse Event|2|||
46809384|NCT00623363|83028690|FG001|Overall Study|Adverse Event|2|||
46809385|NCT00423267|83028699|FG000|Period A|Withdrawal by Subject|0|||
46809386|NCT00423267|83028700|FG001|Period A|Withdrawal by Subject|1|||
46809387|NCT00423267|83028699|FG000|Period A|Non-compliance with protocol|1|||
46809388|NCT00423267|83028700|FG001|Period A|Non-compliance with protocol|0|||
46809389|NCT00423267|83028699|FG000|Period A|Administrative|1|||
46809390|NCT00423267|83028700|FG001|Period A|Administrative|0|||
46967669|NCT02157376|83210227|FG001|Overall Study|Not treated|3|||
46809391|NCT00626093|83028708|FG000|Overall Study|Lost to Follow-up|5|||
46809392|NCT00626093|83028708|FG000|Overall Study|Death|1|||
46809393|NCT00626093|83028708|FG000|Overall Study|Physician Decision|4|||
46809394|NCT00626093|83028708|FG000|Overall Study|Withdrawal by Subject|6|||
46809395|NCT00626093|83028708|FG000|Overall Study|Protocol Violation|1|||
46809396|NCT00626093|83028708|FG000|Overall Study|One of the required devices not implante|6|||
46809397|NCT00357760|83028714|FG000|Overall Study|Disease progression|44|||
46809398|NCT00357760|83028715|FG001|Overall Study|Disease progression|17|||
46809399|NCT00357760|83028714|FG000|Overall Study|Adverse Event|10|||
46809400|NCT00357760|83028715|FG001|Overall Study|Adverse Event|7|||
46809401|NCT00357760|83028714|FG000|Overall Study|Death|0|||
46809402|NCT00357760|83028715|FG001|Overall Study|Death|3|||
46809403|NCT00357760|83028714|FG000|Overall Study|Alternative therapy|1|||
46809404|NCT00357760|83028715|FG001|Overall Study|Alternative therapy|0|||
46809405|NCT00357760|83028714|FG000|Overall Study|Withdrawal by Subject|0|||
46809406|NCT00357760|83028715|FG001|Overall Study|Withdrawal by Subject|2|||
46809407|NCT00357760|83028714|FG000|Overall Study|Never started treatment|2|||
46809408|NCT00357760|83028715|FG001|Overall Study|Never started treatment|1|||
46809409|NCT00357760|83028714|FG000|Overall Study|Ineligible|0|||
46809410|NCT00357760|83028715|FG001|Overall Study|Ineligible|2|||
46809411|NCT00357760|83028714|FG000|Overall Study|Physician Decision|2|||
46809412|NCT00357760|83028715|FG001|Overall Study|Physician Decision|1|||
46809413|NCT00357760|83028714|FG000|Overall Study|Protocol Violation|0|||
46809414|NCT00357760|83028715|FG001|Overall Study|Protocol Violation|1|||
46809415|NCT00357760|83028714|FG000|Overall Study|To receive hospice care|0|||
46809416|NCT00357760|83028715|FG001|Overall Study|To receive hospice care|1|||
46809417|NCT00622739|83028723|FG000|Overall Study|Physician Decision|1|||
46809418|NCT00622739|83028724|FG001|Overall Study|Physician Decision|0|||
46809419|NCT00622739|83028723|FG000|Overall Study|Adverse Event|1|||
46809420|NCT00622739|83028724|FG001|Overall Study|Adverse Event|2|||
46809421|NCT00622739|83028723|FG000|Overall Study|Lack of Efficacy|0|||
46809422|NCT00622739|83028724|FG001|Overall Study|Lack of Efficacy|2|||
46809423|NCT00622739|83028723|FG000|Overall Study|Withdrawal by Subject|0|||
46809424|NCT00622739|83028724|FG001|Overall Study|Withdrawal by Subject|1|||
46809425|NCT00622739|83028723|FG000|Overall Study|Lost to Follow-up|0|||
46809426|NCT00622739|83028724|FG001|Overall Study|Lost to Follow-up|1|||
46809427|NCT00435825|83028736|FG000|Overall Study|Abnormality of Laboratory Test|0|||
46809428|NCT00435825|83028737|FG001|Overall Study|Abnormality of Laboratory Test|1|||
47053774|NCT00708162|83324867|FG001|Randomized Phase|Randomized but Not Treated|5|||
47053775|NCT00708162|83324866|FG000|Randomized Phase|Participant Noncompliance|40|||
47053776|NCT00708162|83324867|FG001|Randomized Phase|Participant Noncompliance|32|||
47053777|NCT00708162|83324866|FG000|Randomized Phase|Lost to Follow-up|34|||
47053778|NCT00708162|83324867|FG001|Randomized Phase|Lost to Follow-up|34|||
47053779|NCT00708162|83324866|FG000|Randomized Phase|Withdrew Consent|31|||
46753589|NCT02393248|82971602|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753590|NCT02393248|82971603|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753591|NCT02393248|82971604|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753592|NCT02393248|82971605|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753593|NCT02393248|82971606|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
46753594|NCT02393248|82971607|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
46753595|NCT02393248|82971608|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753596|NCT02393248|82971609|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753597|NCT02393248|82971610|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
46753598|NCT02393248|82971611|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753599|NCT02393248|82971612|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753600|NCT02393248|82971613|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753601|NCT02393248|82971614|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753602|NCT02393248|82971615|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753603|NCT02393248|82971616|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753604|NCT02393248|82971617|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753605|NCT02393248|82971618|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46809429|NCT00435825|83028738|FG002|Overall Study|Abnormality of Laboratory Test|0|||
46809430|NCT00435825|83028739|FG003|Overall Study|Abnormality of Laboratory Test|0|||
46809431|NCT00435825|83028736|FG000|Overall Study|Insufficient Therapeutic Response|3|||
46809432|NCT00435825|83028737|FG001|Overall Study|Insufficient Therapeutic Response|1|||
46809433|NCT00435825|83028738|FG002|Overall Study|Insufficient Therapeutic Response|0|||
46809434|NCT00435825|83028739|FG003|Overall Study|Insufficient Therapeutic Response|3|||
46809435|NCT00435825|83028736|FG000|Overall Study|Other Protocol Violation|1|||
46809436|NCT00435825|83028737|FG001|Overall Study|Other Protocol Violation|0|||
46809437|NCT00435825|83028738|FG002|Overall Study|Other Protocol Violation|0|||
46809438|NCT00435825|83028739|FG003|Overall Study|Other Protocol Violation|0|||
46809439|NCT00435825|83028736|FG000|Overall Study|Refused treatment|2|||
46809440|NCT00435825|83028737|FG001|Overall Study|Refused treatment|0|||
46926497|NCT04068688|83160925|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
46926498|NCT04068688|83160926|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
46926499|NCT04068688|83160927|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
46926500|NCT04068688|83160928|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
46926501|NCT01671748|83160956|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
46926502|NCT01671748|83160957|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
46926503|NCT01671748|83160956|FG000|4 Week run-in Phase|Adverse Event|1|||
46926504|NCT01671748|83160957|FG001|4 Week run-in Phase|Adverse Event|0|||
46926505|NCT01671748|83160956|FG000|4 Week run-in Phase|Not eligible|9|||
46926506|NCT01671748|83160957|FG001|4 Week run-in Phase|Not eligible|0|||
46926507|NCT02657889|83160967|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
46926508|NCT02657889|83160968|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
46926509|NCT02657889|83160969|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
46926510|NCT02657889|83160970|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
46926511|NCT02657889|83160967|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
46926512|NCT02657889|83160968|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
46926513|NCT02657889|83160969|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
46926514|NCT02657889|83160970|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
46926515|NCT02657889|83160967|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
46926516|NCT02657889|83160968|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
46926517|NCT02657889|83160969|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
46926518|NCT02657889|83160970|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
46926519|NCT02657889|83160967|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
46926520|NCT02657889|83160968|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
46926521|NCT02657889|83160969|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
46926522|NCT02657889|83160970|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
46926523|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
46926524|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
46926525|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
46926526|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
46926527|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
46926528|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
46926529|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
46926530|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
46926531|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
46926532|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
46926533|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
46926534|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
46926535|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
46926536|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
46926537|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
46926538|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
46926539|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
46926540|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
46636309|NCT01489254|82810132|FG001|Open-label Extension Part|Pregnancy|0|||
46753606|NCT02393248|82971619|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753607|NCT02393248|82971620|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753608|NCT02393248|82971621|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753609|NCT02393248|82971622|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753610|NCT02393248|82971623|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753611|NCT02393248|82971624|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753612|NCT02393248|82971625|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
46753613|NCT02393248|82971601|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753614|NCT02393248|82971602|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753615|NCT02393248|82971603|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753616|NCT02393248|82971604|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753617|NCT02393248|82971605|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753618|NCT02393248|82971606|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753619|NCT02393248|82971607|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
46753620|NCT02393248|82971608|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753621|NCT02393248|82971609|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753622|NCT02393248|82971610|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46926541|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
46926542|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
46926543|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
46926544|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
46926545|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
46926546|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
46926547|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
46926548|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
46926549|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
46926550|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
46926551|NCT02657889|83160967|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
46926552|NCT02657889|83160968|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
46926553|NCT02657889|83160969|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
46926554|NCT02657889|83160970|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
46926555|NCT03034915|83160985|FG000|Overall Study|Adverse Event|29|||
46926556|NCT03034915|83160986|FG001|Overall Study|Adverse Event|32|||
46926557|NCT03034915|83160987|FG002|Overall Study|Adverse Event|22|||
46926558|NCT03034915|83160985|FG000|Overall Study|Lost to Follow-up|5|||
46926559|NCT03034915|83160986|FG001|Overall Study|Lost to Follow-up|13|||
46926560|NCT03034915|83160987|FG002|Overall Study|Lost to Follow-up|3|||
46926561|NCT03034915|83160985|FG000|Overall Study|Withdrawal by Subject|29|||
46926562|NCT03034915|83160986|FG001|Overall Study|Withdrawal by Subject|46|||
46926563|NCT03034915|83160987|FG002|Overall Study|Withdrawal by Subject|41|||
46926564|NCT03034915|83160985|FG000|Overall Study|Protocol Deviation|2|||
46926565|NCT03034915|83160986|FG001|Overall Study|Protocol Deviation|14|||
46926566|NCT03034915|83160987|FG002|Overall Study|Protocol Deviation|7|||
46926567|NCT03034915|83160985|FG000|Overall Study|Lack of Efficacy|8|||
46926568|NCT03034915|83160986|FG001|Overall Study|Lack of Efficacy|16|||
46926569|NCT03034915|83160987|FG002|Overall Study|Lack of Efficacy|18|||
46926570|NCT03034915|83160985|FG000|Overall Study|Site closed|2|||
46926571|NCT03034915|83160986|FG001|Overall Study|Site closed|2|||
46926572|NCT03034915|83160987|FG002|Overall Study|Site closed|4|||
46926573|NCT03034915|83160985|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
46926574|NCT03034915|83160986|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
46926575|NCT03034915|83160987|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
46926576|NCT03034915|83160985|FG000|Overall Study|Physician Decision|1|||
46926577|NCT03034915|83160986|FG001|Overall Study|Physician Decision|5|||
46926578|NCT03034915|83160987|FG002|Overall Study|Physician Decision|2|||
46926579|NCT02631538|83160999|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
46926580|NCT02631538|83161000|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
46926581|NCT02631538|83161001|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
46926582|NCT02631538|83161002|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
46926583|NCT02631538|83160999|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
46926584|NCT02631538|83161000|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
46926585|NCT02631538|83161001|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
46926586|NCT02631538|83161002|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
46926587|NCT02631538|83160999|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
46926588|NCT02631538|83161000|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
46926589|NCT02631538|83161001|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
46926590|NCT02631538|83161002|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
46926591|NCT02631538|83160999|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
46926592|NCT02631538|83161000|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
46926593|NCT02631538|83161001|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
46926594|NCT02631538|83161002|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
46926595|NCT02631538|83160999|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
46926596|NCT02631538|83161000|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
46926597|NCT02631538|83161001|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
46926598|NCT02631538|83161002|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
46926599|NCT02631538|83160999|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
46926600|NCT02631538|83161000|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
46926601|NCT02631538|83161001|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
46926602|NCT02631538|83161002|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
46926603|NCT04587271|83161027|FG000|Overall Study|Lost to Follow-up|2|||
46926604|NCT04587271|83161028|FG001|Overall Study|Lost to Follow-up|2|||
46926605|NCT04587271|83161029|FG002|Overall Study|Lost to Follow-up|0|||
46926606|NCT04587271|83161030|FG003|Overall Study|Lost to Follow-up|2|||
46926607|NCT04587271|83161031|FG004|Overall Study|Lost to Follow-up|2|||
46926608|NCT04587271|83161032|FG005|Overall Study|Lost to Follow-up|0|||
46926609|NCT04587271|83161027|FG000|Overall Study|Caregiver brought child to visits|0|||
46926610|NCT04587271|83161028|FG001|Overall Study|Caregiver brought child to visits|0|||
46926611|NCT04587271|83161029|FG002|Overall Study|Caregiver brought child to visits|0|||
46926612|NCT04587271|83161030|FG003|Overall Study|Caregiver brought child to visits|1|||
46926613|NCT04587271|83161031|FG004|Overall Study|Caregiver brought child to visits|0|||
46926614|NCT04587271|83161032|FG005|Overall Study|Caregiver brought child to visits|0|||
46926615|NCT02631148|83161047|FG000|Overall Study|8 were ineligible|8|||
46926616|NCT02631148|83161048|FG001|Overall Study|8 were ineligible|0|||
46926617|NCT02631148|83161047|FG000|Overall Study|Withdrawal by Subject|1|||
46926618|NCT02631148|83161048|FG001|Overall Study|Withdrawal by Subject|0|||
46926619|NCT02631148|83161047|FG000|Overall Study|PAH not available to study participant|1|||
46926620|NCT02631148|83161048|FG001|Overall Study|PAH not available to study participant|0|||
46926621|NCT02753400|83161056|FG000|Overall Study|Adverse Event|3|||
46926622|NCT02753400|83161057|FG001|Overall Study|Adverse Event|0|||
46926623|NCT02753400|83161056|FG000|Overall Study|Withdrawal by Subject|2|||
46926624|NCT02753400|83161057|FG001|Overall Study|Withdrawal by Subject|1|||
46926625|NCT03943147|83161074|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
46926626|NCT03943147|83161075|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
46926627|NCT03943147|83161074|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
46926628|NCT03943147|83161075|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
46926629|NCT03943147|83161074|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
46926630|NCT03943147|83161075|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
46926631|NCT03943147|83161074|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
46926632|NCT03943147|83161075|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
46926633|NCT03943147|83161074|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
46926634|NCT03943147|83161075|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
46926635|NCT03943147|83161074|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
46926636|NCT03943147|83161075|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
46926637|NCT03730987|83161093|FG000|Overall Study|Lost to Follow-up|2|||
46926638|NCT03730987|83161094|FG001|Overall Study|Lost to Follow-up|0|||
46926639|NCT03730987|83161095|FG002|Overall Study|Lost to Follow-up|2|||
46926640|NCT03730987|83161096|FG003|Overall Study|Lost to Follow-up|0|||
46926641|NCT02844543|83161107|FG000|Overall Study|Withdrawal by Subject|4|||
46926642|NCT02844543|83161107|FG000|Overall Study|Did not meet eligibility criteria|1|||
46926643|NCT03034135|83161111|FG000|Overall Study|Withdrawal by Subject|2|||
46926644|NCT01671280|83161115|FG000|Overall Study|Withdrawal by Subject|2|||
46926645|NCT01405963|83161121|FG000|Overall Study|Moved Away|2|||
46926646|NCT01405963|83161122|FG001|Overall Study|Moved Away|0|||
46926647|NCT01405963|83161121|FG000|Overall Study|Adverse Event|0|||
46926648|NCT01405963|83161122|FG001|Overall Study|Adverse Event|1|||
46926649|NCT01405963|83161121|FG000|Overall Study|Lost to Follow-up|0|||
46753623|NCT02393248|82971611|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753624|NCT02393248|82971612|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753625|NCT02393248|82971613|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753626|NCT02393248|82971614|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753627|NCT02393248|82971615|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753628|NCT02393248|82971616|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753629|NCT02393248|82971617|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753630|NCT02393248|82971618|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753631|NCT02393248|82971619|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753632|NCT02393248|82971620|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753633|NCT02393248|82971621|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753634|NCT02393248|82971622|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753635|NCT02393248|82971623|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753636|NCT02393248|82971624|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753637|NCT02393248|82971625|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
46753638|NCT02393248|82971601|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46809441|NCT00435825|83028738|FG002|Overall Study|Refused treatment|0|||
46926650|NCT01405963|83161122|FG001|Overall Study|Lost to Follow-up|1|||
46926651|NCT02628418|83161142|FG000|Overall Study|Lost to Follow-up|1|||
46926652|NCT02628418|83161143|FG001|Overall Study|Lost to Follow-up|2|||
46926653|NCT02752776|83161171|FG000|Overall Study|Adverse Event|15|||
46926654|NCT02752776|83161172|FG001|Overall Study|Adverse Event|23|||
46926655|NCT02752776|83161173|FG002|Overall Study|Adverse Event|11|||
46926656|NCT02752776|83161171|FG000|Overall Study|Lack of Efficacy|2|||
46926657|NCT02752776|83161172|FG001|Overall Study|Lack of Efficacy|6|||
46926658|NCT02752776|83161173|FG002|Overall Study|Lack of Efficacy|14|||
46926659|NCT02752776|83161171|FG000|Overall Study|Lost to Follow-up|11|||
46926660|NCT02752776|83161172|FG001|Overall Study|Lost to Follow-up|12|||
46926661|NCT02752776|83161173|FG002|Overall Study|Lost to Follow-up|4|||
46926662|NCT02752776|83161171|FG000|Overall Study|Non-compliance with study treatment|0|||
46926663|NCT02752776|83161172|FG001|Overall Study|Non-compliance with study treatment|0|||
46926664|NCT02752776|83161173|FG002|Overall Study|Non-compliance with study treatment|1|||
46926665|NCT02752776|83161171|FG000|Overall Study|Physician Decision|2|||
46926666|NCT02752776|83161172|FG001|Overall Study|Physician Decision|6|||
46926667|NCT02752776|83161173|FG002|Overall Study|Physician Decision|2|||
46926668|NCT02752776|83161171|FG000|Overall Study|Pregnancy|1|||
46926669|NCT02752776|83161172|FG001|Overall Study|Pregnancy|6|||
46926670|NCT02752776|83161173|FG002|Overall Study|Pregnancy|3|||
46926671|NCT02752776|83161171|FG000|Overall Study|Protocol Violation|10|||
46926672|NCT02752776|83161172|FG001|Overall Study|Protocol Violation|13|||
46926673|NCT02752776|83161173|FG002|Overall Study|Protocol Violation|6|||
46926674|NCT02752776|83161171|FG000|Overall Study|Subject/guardian decision|8|||
46926675|NCT02752776|83161172|FG001|Overall Study|Subject/guardian decision|6|||
46926676|NCT02752776|83161173|FG002|Overall Study|Subject/guardian decision|4|||
46926677|NCT02752776|83161171|FG000|Overall Study|Death|0|||
46926678|NCT02752776|83161172|FG001|Overall Study|Death|0|||
46926679|NCT02752776|83161173|FG002|Overall Study|Death|1|||
46926680|NCT02752776|83161171|FG000|Overall Study|Withdrawal by Subject|3|||
46926681|NCT02752776|83161172|FG001|Overall Study|Withdrawal by Subject|4|||
46926682|NCT02752776|83161173|FG002|Overall Study|Withdrawal by Subject|2|||
46926683|NCT01342965|83161185|FG000|Overall Study|Death|58|||
46926684|NCT01342965|83161186|FG001|Overall Study|Death|57|||
46926685|NCT01342965|83161185|FG000|Overall Study|Lost to Follow-up|5|||
46926686|NCT01342965|83161186|FG001|Overall Study|Lost to Follow-up|3|||
46926687|NCT01342965|83161185|FG000|Overall Study|Other Reasons- Unspecified|44|||
46926688|NCT01342965|83161186|FG001|Overall Study|Other Reasons- Unspecified|38|||
47053780|NCT00708162|83324867|FG001|Randomized Phase|Withdrew Consent|22|||
47053781|NCT00708162|83324866|FG000|Randomized Phase|Lack of Efficacy|14|||
47053782|NCT00708162|83324867|FG001|Randomized Phase|Lack of Efficacy|19|||
47053783|NCT00708162|83324866|FG000|Randomized Phase|Protocol Violation|10|||
46753639|NCT02393248|82971602|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753640|NCT02393248|82971603|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46926689|NCT01342965|83161185|FG000|Overall Study|Withdrawal by Subject|2|||
46926690|NCT01342965|83161186|FG001|Overall Study|Withdrawal by Subject|9|||
46926691|NCT02629822|83161192|FG000|Base Study|Lost to Follow-up|2|||
46926692|NCT02629822|83161192|FG000|Base Study|Non-Compliance With Study Drug|1|||
46926693|NCT02629822|83161192|FG000|Extension Study|Adverse Event|1|||
46926694|NCT02629822|83161192|FG000|Extension Study|Lost to Follow-up|1|||
46926695|NCT03462706|83161201|FG000|Overall Study|Polyp was pedunculated|1|||
46926696|NCT03462706|83161202|FG001|Overall Study|Polyp was pedunculated|0|||
46926697|NCT03462706|83161203|FG002|Overall Study|Polyp was pedunculated|1|||
46926698|NCT03462706|83161204|FG003|Overall Study|Polyp was pedunculated|0|||
46926699|NCT03462706|83161201|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
46926700|NCT03462706|83161202|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
46926701|NCT03462706|83161203|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
46926702|NCT03462706|83161204|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
46926703|NCT02840253|83161214|FG000|Overall Study|Unsuccessful block|4|||
46926704|NCT02752074|83161220|FG000|Overall Study|Lost to Follow-up|1|||
46926705|NCT02752074|83161221|FG001|Overall Study|Lost to Follow-up|4|||
46926706|NCT02752074|83161220|FG000|Overall Study|Death|146|||
46926707|NCT02752074|83161221|FG001|Overall Study|Death|129|||
46926708|NCT02752074|83161220|FG000|Overall Study|Withdrawal by Subject|9|||
46926709|NCT02752074|83161221|FG001|Overall Study|Withdrawal by Subject|10|||
46926710|NCT02835495|83161229|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
46926711|NCT02835495|83161230|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
46926712|NCT02835495|83161229|FG000|Overall Study|Declined in-person follow-up visit|4|||
46926713|NCT02835495|83161230|FG001|Overall Study|Declined in-person follow-up visit|2|||
46926714|NCT02835339|83161240|FG000|Overall Study|Did not receive allocated intervention|13|||
46926715|NCT02835339|83161241|FG001|Overall Study|Did not receive allocated intervention|16|||
46753641|NCT02393248|82971604|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753642|NCT02393248|82971605|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753643|NCT02393248|82971606|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753644|NCT02393248|82971607|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
47053784|NCT00708162|83324867|FG001|Randomized Phase|Protocol Violation|11|||
46753645|NCT02393248|82971608|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753646|NCT02393248|82971609|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46926716|NCT02832063|83161249|FG000|Overall Study|Adverse Event|2|||
46926717|NCT02832063|83161250|FG001|Overall Study|Adverse Event|1|||
46926718|NCT02832063|83161249|FG000|Overall Study|Physician Decision|5|||
46926719|NCT02832063|83161250|FG001|Overall Study|Physician Decision|7|||
46926720|NCT02832063|83161249|FG000|Overall Study|Lost to Follow-up|15|||
46926721|NCT02832063|83161250|FG001|Overall Study|Lost to Follow-up|8|||
47053785|NCT00708162|83324866|FG000|Randomized Phase|Adverse Event|8|||
46926722|NCT02832063|83161249|FG000|Overall Study|Withdrawal by Subject|10|||
46926723|NCT02832063|83161250|FG001|Overall Study|Withdrawal by Subject|21|||
46926724|NCT02832063|83161249|FG000|Overall Study|Other|2|||
46926725|NCT02832063|83161250|FG001|Overall Study|Other|1|||
46926726|NCT04412707|83161269|FG000|Cycle 1|Death|0|||
46926727|NCT04412707|83161270|FG001|Cycle 1|Death|3|||
46926728|NCT04412707|83161269|FG000|Cycle 1|Disease progression|1|||
46926729|NCT04412707|83161270|FG001|Cycle 1|Disease progression|2|||
46926730|NCT04412707|83161269|FG000|Cycle 2|Death|0|||
46926731|NCT04412707|83161270|FG001|Cycle 2|Death|1|||
46926732|NCT04412707|83161269|FG000|Cycle 2|Disease progression|3|||
46926733|NCT04412707|83161270|FG001|Cycle 2|Disease progression|0|||
46926734|NCT04412707|83161269|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
46926735|NCT04412707|83161270|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
46926736|NCT04412707|83161269|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
46926737|NCT04412707|83161270|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
46926738|NCT04412707|83161269|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
47053786|NCT00708162|83324867|FG001|Randomized Phase|Adverse Event|12|||
47053787|NCT00708162|83324866|FG000|Randomized Phase|Investigator's Discretion|7|||
47053788|NCT00708162|83324867|FG001|Randomized Phase|Investigator's Discretion|10|||
47053789|NCT00708162|83324866|FG000|Randomized Phase|Death|2|||
47053790|NCT00708162|83324867|FG001|Randomized Phase|Death|9|||
47053791|NCT00708162|83324866|FG000|Randomized Phase|Pregnancy|3|||
47053792|NCT00708162|83324867|FG001|Randomized Phase|Pregnancy|0|||
47053793|NCT00708162|83324866|FG000|Open-Label Phase|Lost to Follow-up|10|||
47053794|NCT00708162|83324867|FG001|Open-Label Phase|Lost to Follow-up|8|||
47053795|NCT00708162|83324866|FG000|Open-Label Phase|Withdrew Consent|12|||
47053796|NCT00708162|83324867|FG001|Open-Label Phase|Withdrew Consent|6|||
47053797|NCT00708162|83324866|FG000|Open-Label Phase|Participant Noncompliance|7|||
47053798|NCT00708162|83324867|FG001|Open-Label Phase|Participant Noncompliance|7|||
47053799|NCT00708162|83324866|FG000|Open-Label Phase|Lack of Efficacy|7|||
47053800|NCT00708162|83324867|FG001|Open-Label Phase|Lack of Efficacy|4|||
47053801|NCT00708162|83324866|FG000|Open-Label Phase|Investigator's Discretion|3|||
47053802|NCT00708162|83324867|FG001|Open-Label Phase|Investigator's Discretion|2|||
47053803|NCT00708162|83324866|FG000|Open-Label Phase|Death|3|||
47053804|NCT00708162|83324867|FG001|Open-Label Phase|Death|1|||
47053805|NCT00708162|83324866|FG000|Open-Label Phase|Adverse Event|1|||
47053806|NCT00708162|83324867|FG001|Open-Label Phase|Adverse Event|2|||
47053807|NCT00708162|83324866|FG000|Open-Label Phase|Other|1|||
46753647|NCT02393248|82971610|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753648|NCT02393248|82971611|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753649|NCT02393248|82971612|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
46753650|NCT02393248|82971613|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
46753651|NCT02393248|82971614|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
46753652|NCT02393248|82971615|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
46753653|NCT02393248|82971616|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753654|NCT02393248|82971617|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753655|NCT02393248|82971618|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753656|NCT02393248|82971619|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753657|NCT02393248|82971620|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753658|NCT02393248|82971621|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753659|NCT02393248|82971622|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753660|NCT02393248|82971623|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753661|NCT02393248|82971624|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753662|NCT02393248|82971625|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
46753663|NCT02393248|82971601|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753664|NCT02393248|82971602|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753665|NCT02393248|82971603|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753666|NCT02393248|82971604|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753667|NCT02393248|82971605|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753668|NCT02393248|82971606|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753669|NCT02393248|82971607|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753670|NCT02393248|82971608|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753671|NCT02393248|82971609|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753672|NCT02393248|82971610|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753673|NCT02393248|82971611|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
46753674|NCT02393248|82971612|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
46753675|NCT02393248|82971613|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753676|NCT02393248|82971614|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46926739|NCT04412707|83161270|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
46926740|NCT04412707|83161269|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
47053808|NCT00708162|83324867|FG001|Open-Label Phase|Other|0|||
46926741|NCT04412707|83161270|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
46926742|NCT01358721|83161289|FG000|Overall Study|Withdrawal by Subject|0|||
46926743|NCT01358721|83161290|FG001|Overall Study|Withdrawal by Subject|0|||
46926744|NCT01358721|83161291|FG002|Overall Study|Withdrawal by Subject|0|||
46926745|NCT01358721|83161292|FG003|Overall Study|Withdrawal by Subject|1|||
46926746|NCT01358721|83161289|FG000|Overall Study|Death|0|||
46926747|NCT01358721|83161290|FG001|Overall Study|Death|2|||
46926748|NCT01358721|83161291|FG002|Overall Study|Death|0|||
46926749|NCT01358721|83161292|FG003|Overall Study|Death|0|||
46926750|NCT01358721|83161289|FG000|Overall Study|Study Drug Toxicity|1|||
46926751|NCT01358721|83161290|FG001|Overall Study|Study Drug Toxicity|3|||
46926752|NCT01358721|83161291|FG002|Overall Study|Study Drug Toxicity|4|||
46926753|NCT01358721|83161292|FG003|Overall Study|Study Drug Toxicity|5|||
46926754|NCT01358721|83161289|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
46926755|NCT01358721|83161290|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
46926756|NCT01358721|83161291|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
46926757|NCT01358721|83161292|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
46926758|NCT01358721|83161289|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
46926759|NCT01358721|83161290|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
46926760|NCT01358721|83161291|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
46926761|NCT01358721|83161292|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
46926762|NCT01358721|83161289|FG000|Overall Study|Adverse Event related to study drug|1|||
46926763|NCT01358721|83161290|FG001|Overall Study|Adverse Event related to study drug|0|||
46926764|NCT01358721|83161291|FG002|Overall Study|Adverse Event related to study drug|0|||
46926765|NCT01358721|83161292|FG003|Overall Study|Adverse Event related to study drug|1|||
46926766|NCT01358721|83161289|FG000|Overall Study|Disease Progression|19|||
46926767|NCT01358721|83161290|FG001|Overall Study|Disease Progression|15|||
46926768|NCT01358721|83161291|FG002|Overall Study|Disease Progression|17|||
47053809|NCT02245672|83324952|FG000|Overall Study|Adverse Event|4|||
47053810|NCT02245672|83324953|FG001|Overall Study|Adverse Event|4|||
46753677|NCT02393248|82971615|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753678|NCT02393248|82971616|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753679|NCT02393248|82971617|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753680|NCT02393248|82971618|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753681|NCT02393248|82971619|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753682|NCT02393248|82971620|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753683|NCT02393248|82971621|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753684|NCT02393248|82971622|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753685|NCT02393248|82971623|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753686|NCT02393248|82971624|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753687|NCT02393248|82971625|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
46753688|NCT02393248|82971601|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
46753689|NCT02393248|82971602|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
46753690|NCT02393248|82971603|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
46753691|NCT02393248|82971604|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
46753692|NCT02393248|82971605|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
46753693|NCT02393248|82971606|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
46753694|NCT02393248|82971607|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
46753695|NCT02393248|82971608|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
46753696|NCT02393248|82971609|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
46753697|NCT02393248|82971610|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
46753698|NCT02393248|82971611|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
46753699|NCT02393248|82971612|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
46753700|NCT02393248|82971613|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
46753701|NCT02393248|82971614|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
46753702|NCT02393248|82971615|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
46753703|NCT02393248|82971616|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
46753704|NCT02393248|82971617|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
46753705|NCT02393248|82971618|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
46753706|NCT02393248|82971619|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
46809442|NCT00435825|83028739|FG003|Overall Study|Refused treatment|5|||
46809443|NCT00435825|83028736|FG000|Overall Study|Failure to return|5|||
46926769|NCT01358721|83161292|FG003|Overall Study|Disease Progression|15|||
46926770|NCT01358721|83161289|FG000|Overall Study|Out of State/Unmet Criteria|0|||
46926771|NCT01358721|83161290|FG001|Overall Study|Out of State/Unmet Criteria|0|||
47053811|NCT02245672|83324954|FG002|Overall Study|Adverse Event|4|||
47053812|NCT02245672|83324952|FG000|Overall Study|Lost to Follow-up|3|||
46753707|NCT02393248|82971620|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
46753708|NCT02393248|82971621|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
46753709|NCT02393248|82971622|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
46809444|NCT00435825|83028737|FG001|Overall Study|Failure to return|0|||
46926772|NCT01358721|83161291|FG002|Overall Study|Out of State/Unmet Criteria|1|||
47053813|NCT02245672|83324953|FG001|Overall Study|Lost to Follow-up|5|||
47053814|NCT02245672|83324954|FG002|Overall Study|Lost to Follow-up|1|||
46809445|NCT00435825|83028738|FG002|Overall Study|Failure to return|4|||
46809446|NCT00435825|83028739|FG003|Overall Study|Failure to return|0|||
46809447|NCT00435825|83028736|FG000|Overall Study|Did not receive study drug|1|||
46809448|NCT00435825|83028737|FG001|Overall Study|Did not receive study drug|0|||
46809449|NCT00435825|83028738|FG002|Overall Study|Did not receive study drug|2|||
46809450|NCT00435825|83028739|FG003|Overall Study|Did not receive study drug|0|||
46809451|NCT00435825|83028736|FG000|Overall Study|Did not enter follow-up|0|||
46809452|NCT00435825|83028737|FG001|Overall Study|Did not enter follow-up|4|||
46809453|NCT00435825|83028738|FG002|Overall Study|Did not enter follow-up|1|||
46809454|NCT00435825|83028739|FG003|Overall Study|Did not enter follow-up|3|||
46809455|NCT00435825|83028736|FG000|Overall Study|Did not complete full follow-up period|6|||
46809456|NCT00435825|83028737|FG001|Overall Study|Did not complete full follow-up period|6|||
46809457|NCT00435825|83028738|FG002|Overall Study|Did not complete full follow-up period|4|||
46809458|NCT00435825|83028739|FG003|Overall Study|Did not complete full follow-up period|5|||
46809459|NCT00574145|83028751|FG000|Overall Study|Withdrawal by Subject|2|||
46809460|NCT00574145|83028752|FG001|Overall Study|Withdrawal by Subject|1|||
46809461|NCT00423189|83028761|FG000|Overall Study|Death|0|||
46809462|NCT00423189|83028762|FG001|Overall Study|Death|1|||
46809463|NCT00423189|83028763|FG002|Overall Study|Death|0|||
46809464|NCT00422799|83028776|FG000|Overall Study|Withdrawal by Subject|6|||
46809465|NCT00422799|83028776|FG000|Overall Study|Adverse Event|7|||
46809466|NCT00435045|83028782|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
46809467|NCT00435045|83028783|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
46809468|NCT00435045|83028782|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
46809469|NCT00435045|83028783|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
46809470|NCT00435045|83028782|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
46809471|NCT00435045|83028783|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
46809472|NCT00435045|83028782|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
46809473|NCT00435045|83028783|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
46809474|NCT00435045|83028782|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
46809475|NCT00435045|83028783|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
46809476|NCT00435045|83028782|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
46809477|NCT00435045|83028783|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
46809478|NCT00435045|83028782|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
46809479|NCT00435045|83028783|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
46809480|NCT00435045|83028782|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
46809481|NCT00435045|83028783|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
46809482|NCT00435045|83028782|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
46809483|NCT00435045|83028783|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
46809484|NCT00435045|83028782|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
46809485|NCT00435045|83028783|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
46809486|NCT00435045|83028782|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
46809487|NCT00435045|83028783|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
46809488|NCT00441129|83028791|FG000|Overall Study|Withdrawal by Subject|6|||
46809489|NCT00441129|83028792|FG001|Overall Study|Withdrawal by Subject|14|||
46809490|NCT00622505|83028800|FG000|Overall Study|Adverse Event|9|||
46809491|NCT00622505|83028801|FG001|Overall Study|Adverse Event|7|||
46809492|NCT00622505|83028800|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
46809493|NCT00622505|83028801|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
46809494|NCT00622505|83028800|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
46809495|NCT00622505|83028801|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
46809496|NCT00622505|83028800|FG000|Overall Study|Withdrawal by Subject|12|||
46809497|NCT00622505|83028801|FG001|Overall Study|Withdrawal by Subject|5|||
46809498|NCT00622505|83028800|FG000|Overall Study|Administrative Problems|2|||
46809499|NCT00622505|83028801|FG001|Overall Study|Administrative Problems|4|||
46809500|NCT00622505|83028800|FG000|Overall Study|Death|2|||
46809501|NCT00622505|83028801|FG001|Overall Study|Death|2|||
46809502|NCT00357370|83028810|FG000|Cohort 2|Lack of Efficacy|0|||
46809503|NCT00357370|83028811|FG001|Cohort 2|Lack of Efficacy|2|||
46809504|NCT00357370|83028812|FG002|Cohort 2|Lack of Efficacy|1|||
46809505|NCT00357370|83028810|FG000|Cohort 2|Adverse Event|1|||
46809506|NCT00357370|83028811|FG001|Cohort 2|Adverse Event|1|||
46809507|NCT00357370|83028812|FG002|Cohort 2|Adverse Event|1|||
46809508|NCT00357370|83028810|FG000|Cohort 2|Lost to Follow-up|0|||
46809509|NCT00357370|83028811|FG001|Cohort 2|Lost to Follow-up|1|||
46809510|NCT00357370|83028812|FG002|Cohort 2|Lost to Follow-up|0|||
46809511|NCT00357370|83028810|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
46809512|NCT00357370|83028811|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
46809513|NCT00357370|83028812|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
46809514|NCT00357370|83028810|FG000|Cohort 2|Withdrawal by Subject|0|||
46809515|NCT00357370|83028811|FG001|Cohort 2|Withdrawal by Subject|2|||
46809516|NCT00357370|83028812|FG002|Cohort 2|Withdrawal by Subject|0|||
46809517|NCT00574847|83028822|FG000|Overall Study|Adverse Event|2|||
46809518|NCT00574847|83028823|FG001|Overall Study|Adverse Event|0|||
46809519|NCT00574847|83028822|FG000|Overall Study|Death|1|||
46809520|NCT00574847|83028823|FG001|Overall Study|Death|0|||
46809521|NCT00574847|83028822|FG000|Overall Study|Withdrawal by Subject|2|||
46809522|NCT00574847|83028823|FG001|Overall Study|Withdrawal by Subject|2|||
46809523|NCT00574847|83028822|FG000|Overall Study|Physician Decision|1|||
46809524|NCT00574847|83028823|FG001|Overall Study|Physician Decision|0|||
46809525|NCT00574847|83028822|FG000|Overall Study|Did not receive medication (declined)|2|||
46809526|NCT00574847|83028823|FG001|Overall Study|Did not receive medication (declined)|5|||
47053815|NCT02245672|83324952|FG000|Overall Study|Withdrawal by Subject|6|||
47053816|NCT02245672|83324953|FG001|Overall Study|Withdrawal by Subject|3|||
47053817|NCT02245672|83324954|FG002|Overall Study|Withdrawal by Subject|0|||
47053818|NCT02245672|83324952|FG000|Overall Study|Randomized in error (not treated)|0|||
47053819|NCT02245672|83324953|FG001|Overall Study|Randomized in error (not treated)|1|||
47053820|NCT02245672|83324954|FG002|Overall Study|Randomized in error (not treated)|0|||
46809527|NCT00348790|83028829|FG000|Completed Treatment|Withdrawal by Subject|4|||
46809528|NCT00348790|83028829|FG000|Completed Treatment|Disease progression|14|||
46809529|NCT00348790|83028829|FG000|Completed Treatment|Adverse Event|4|||
46809530|NCT00348790|83028829|FG000|Completed Treatment|Required surgery|2|||
46809531|NCT00348790|83028829|FG000|Completed Treatment|Unable to travel to study site|1|||
46809532|NCT00360490|83028836|FG000|Overall Study|Adverse Event|4|||
46809533|NCT00360490|83028837|FG001|Overall Study|Adverse Event|2|||
46809534|NCT00360490|83028836|FG000|Overall Study|Lost to Follow-up|2|||
46809535|NCT00360490|83028837|FG001|Overall Study|Lost to Follow-up|1|||
46809536|NCT00360490|83028836|FG000|Overall Study|Physician Decision|2|||
46809537|NCT00360490|83028837|FG001|Overall Study|Physician Decision|1|||
46809538|NCT00360490|83028836|FG000|Overall Study|Protocol Violation|0|||
46809539|NCT00360490|83028837|FG001|Overall Study|Protocol Violation|4|||
46809540|NCT00360490|83028836|FG000|Overall Study|Withdrawal by Subject|1|||
46809541|NCT00360490|83028837|FG001|Overall Study|Withdrawal by Subject|3|||
46809542|NCT00624377|83028843|FG000|Overall Study|Lost to Follow-up|355|||
46809543|NCT00624377|83028843|FG000|Overall Study|Withdrawal by Subject|100|||
46809544|NCT00624377|83028843|FG000|Overall Study|Adverse Event|14|||
46809545|NCT00624377|83028843|FG000|Overall Study|Other|91|||
46809546|NCT00624377|83028843|FG000|Overall Study|Non-evaluable population|84|||
46809547|NCT00624065|83028849|FG000|Overall Study|Adverse Event|5|||
46809548|NCT00624065|83028850|FG001|Overall Study|Adverse Event|6|||
46809549|NCT00624065|83028849|FG000|Overall Study|Lost to Follow-up|4|||
46809550|NCT00624065|83028850|FG001|Overall Study|Lost to Follow-up|1|||
46809551|NCT00624065|83028849|FG000|Overall Study|Consent withdrawn|6|||
46809552|NCT00624065|83028850|FG001|Overall Study|Consent withdrawn|5|||
46809553|NCT00624065|83028849|FG000|Overall Study|Lack of Efficacy|0|||
46809554|NCT00624065|83028850|FG001|Overall Study|Lack of Efficacy|3|||
46809555|NCT00624065|83028849|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
46809556|NCT00624065|83028850|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
46809557|NCT00360412|83028858|FG000|Overall Study|Adverse Event|37|||
46809558|NCT00360412|83028859|FG001|Overall Study|Adverse Event|65|||
46809559|NCT00360412|83028858|FG000|Overall Study|Protocol Violation|2|||
46809560|NCT00360412|83028859|FG001|Overall Study|Protocol Violation|5|||
46809561|NCT00360412|83028858|FG000|Overall Study|Patient withdrew consent|27|||
46809562|NCT00360412|83028859|FG001|Overall Study|Patient withdrew consent|52|||
46809563|NCT00360412|83028858|FG000|Overall Study|Lack of therapeutic efficacy|46|||
46809564|NCT00360412|83028859|FG001|Overall Study|Lack of therapeutic efficacy|61|||
46809565|NCT00360412|83028858|FG000|Overall Study|Physician Decision|2|||
46809566|NCT00360412|83028859|FG001|Overall Study|Physician Decision|4|||
46809567|NCT00360412|83028858|FG000|Overall Study|Other|5|||
46809568|NCT00360412|83028859|FG001|Overall Study|Other|6|||
46809569|NCT00360412|83028858|FG000|Overall Study|Study termination by Sponsor|214|||
46809570|NCT00360412|83028859|FG001|Overall Study|Study termination by Sponsor|469|||
46809571|NCT00623831|83028867|FG000|Overall Study|Withdrawal by Subject|1|||
46809572|NCT00623831|83028868|FG001|Overall Study|Withdrawal by Subject|0|||
46809573|NCT00623831|83028867|FG000|Overall Study|Progressive Disease|0|||
47053821|NCT00706992|83325099|FG000|Overall Study|Study termination|5|||
47053822|NCT00706992|83325100|FG001|Overall Study|Study termination|5|||
47053823|NCT00706992|83325101|FG002|Overall Study|Study termination|6|||
47053824|NCT00706992|83325102|FG003|Overall Study|Study termination|2|||
47053825|NCT00706992|83325103|FG004|Overall Study|Study termination|3|||
46809574|NCT00623831|83028868|FG001|Overall Study|Progressive Disease|1|||
46809575|NCT00360334|83028879|FG000|Overall Study|Adverse Event|7|||
46809576|NCT00360334|83028880|FG001|Overall Study|Adverse Event|4|||
46809577|NCT00360334|83028879|FG000|Overall Study|Protocol Violation|1|||
46809578|NCT00360334|83028880|FG001|Overall Study|Protocol Violation|1|||
46809579|NCT00360334|83028879|FG000|Overall Study|Physician Decision|2|||
46809580|NCT00360334|83028880|FG001|Overall Study|Physician Decision|3|||
46809581|NCT00360334|83028879|FG000|Overall Study|Lack of Efficacy|0|||
46809582|NCT00360334|83028880|FG001|Overall Study|Lack of Efficacy|1|||
46809583|NCT00360334|83028879|FG000|Overall Study|Entry criterion not met|1|||
46809584|NCT00360334|83028880|FG001|Overall Study|Entry criterion not met|2|||
46809585|NCT00360334|83028879|FG000|Overall Study|Subject decision|8|||
46926773|NCT01358721|83161292|FG003|Overall Study|Out of State/Unmet Criteria|0|||
46926774|NCT01341639|83161304|FG000|Infant Series|Protocol Violation|1|||
46926775|NCT01341639|83161305|FG001|Infant Series|Protocol Violation|0|||
46926776|NCT01341639|83161304|FG000|Infant Series|Not Vaccinated|0|||
46926777|NCT01341639|83161305|FG001|Infant Series|Not Vaccinated|1|||
46926778|NCT01341639|83161304|FG000|Infant Series|Adverse Event|0|||
46926779|NCT01341639|83161305|FG001|Infant Series|Adverse Event|5|||
46926780|NCT01341639|83161304|FG000|Infant Series|Withdrawal by Subject|11|||
46926781|NCT01341639|83161305|FG001|Infant Series|Withdrawal by Subject|8|||
46926782|NCT01341639|83161304|FG000|Infant Series|Lost to Follow-up|0|||
46926783|NCT01341639|83161305|FG001|Infant Series|Lost to Follow-up|2|||
46926784|NCT01341639|83161304|FG000|Infant Series|Site 0048 Participants|17|||
46926785|NCT01341639|83161305|FG001|Infant Series|Site 0048 Participants|16|||
46926786|NCT01341639|83161304|FG000|Interim Period|Withdrawal by Subject|6|||
46926787|NCT01341639|83161305|FG001|Interim Period|Withdrawal by Subject|7|||
46926788|NCT01341639|83161304|FG000|Interim Period|Lost to Follow-up|2|||
46926789|NCT01341639|83161305|FG001|Interim Period|Lost to Follow-up|0|||
46926790|NCT01341639|83161304|FG000|Interim Period|Physician Decision|0|||
46926791|NCT01341639|83161305|FG001|Interim Period|Physician Decision|1|||
46926792|NCT01341639|83161304|FG000|Interim Period|Protocol Violation|0|||
46926793|NCT01341639|83161305|FG001|Interim Period|Protocol Violation|1|||
46926794|NCT01341639|83161304|FG000|Post-Treatment|Withdrawal by Subject|0|||
46926795|NCT01341639|83161305|FG001|Post-Treatment|Withdrawal by Subject|1|||
46926796|NCT01341639|83161304|FG000|Post-Treatment|Adverse Event|0|||
46926797|NCT01341639|83161305|FG001|Post-Treatment|Adverse Event|2|||
46926798|NCT02628028|83161319|FG000|Dosing Period|Withdrawal by Subject|0|||
46926799|NCT02628028|83161320|FG001|Dosing Period|Withdrawal by Subject|0|||
46926800|NCT02628028|83161321|FG002|Dosing Period|Withdrawal by Subject|1|||
46753710|NCT02393248|82971623|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
46753711|NCT02393248|82971624|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
46926801|NCT02628028|83161322|FG003|Dosing Period|Withdrawal by Subject|0|||
46926802|NCT02628028|83161323|FG004|Dosing Period|Withdrawal by Subject|2|||
46926803|NCT02628028|83161324|FG005|Dosing Period|Withdrawal by Subject|4|||
46926804|NCT02628028|83161325|FG006|Dosing Period|Withdrawal by Subject|1|||
46926805|NCT02628028|83161326|FG007|Dosing Period|Withdrawal by Subject|1|||
46926806|NCT02628028|83161319|FG000|Dosing Period|Adverse Event|0|||
46636310|NCT01489254|82810133|FG002|Open-label Extension Part|Pregnancy|0|||
46636311|NCT01489254|82810134|FG003|Open-label Extension Part|Pregnancy|3|||
46753712|NCT02393248|82971625|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
46753713|NCT02393248|82971601|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753714|NCT02393248|82971602|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753715|NCT02393248|82971603|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753716|NCT02393248|82971604|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753717|NCT02393248|82971605|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753718|NCT02393248|82971606|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753719|NCT02393248|82971607|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753720|NCT02393248|82971608|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753721|NCT02393248|82971609|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753722|NCT02393248|82971610|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753723|NCT02393248|82971611|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753724|NCT02393248|82971612|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
46753725|NCT02393248|82971613|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753726|NCT02393248|82971614|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
46753727|NCT02393248|82971615|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753728|NCT02393248|82971616|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753729|NCT02393248|82971617|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753730|NCT02393248|82971618|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753731|NCT02393248|82971619|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753732|NCT02393248|82971620|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753733|NCT02393248|82971621|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753734|NCT02393248|82971622|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753735|NCT02393248|82971623|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753736|NCT02393248|82971624|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753737|NCT02393248|82971625|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
46753738|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753739|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753740|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753741|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753742|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46926807|NCT02628028|83161320|FG001|Dosing Period|Adverse Event|0|||
47053826|NCT00706992|83325104|FG005|Overall Study|Study termination|2|||
46809586|NCT00360334|83028880|FG001|Overall Study|Subject decision|2|||
46809587|NCT00422097|83028892|FG000|Dose Level 2|Still on treatment|0|||
46809588|NCT00422097|83028893|FG001|Dose Level 2|Still on treatment|1|||
46809589|NCT00422097|83028894|FG002|Dose Level 2|Still on treatment|0|||
46809590|NCT00422097|83028895|FG003|Dose Level 2|Still on treatment|0|||
46809591|NCT00422097|83028896|FG004|Dose Level 2|Still on treatment|0|||
46809592|NCT00422097|83028897|FG005|Dose Level 2|Still on treatment|0|||
46809593|NCT00422097|83028898|FG006|Dose Level 2|Still on treatment|0|||
46809594|NCT00422097|83028899|FG007|Dose Level 2|Still on treatment|0|||
46809595|NCT00348556|83028923|FG000|Overall Study|Adverse Event|1|||
46809596|NCT00434967|83028931|FG000|Overall Study|Adverse Event|2|||
46809597|NCT00434967|83028932|FG001|Overall Study|Adverse Event|4|||
46809598|NCT00434967|83028933|FG002|Overall Study|Adverse Event|3|||
46809599|NCT00434967|83028934|FG003|Overall Study|Adverse Event|3|||
46809600|NCT00434967|83028931|FG000|Overall Study|Lost to Follow-up|0|||
46809601|NCT00434967|83028932|FG001|Overall Study|Lost to Follow-up|0|||
46809602|NCT00434967|83028933|FG002|Overall Study|Lost to Follow-up|1|||
46809603|NCT00434967|83028934|FG003|Overall Study|Lost to Follow-up|0|||
46809604|NCT00434967|83028931|FG000|Overall Study|Withdrawal by Subject|2|||
46809605|NCT00434967|83028932|FG001|Overall Study|Withdrawal by Subject|2|||
46809606|NCT00434967|83028933|FG002|Overall Study|Withdrawal by Subject|4|||
46809607|NCT00434967|83028934|FG003|Overall Study|Withdrawal by Subject|6|||
46809608|NCT00434967|83028931|FG000|Overall Study|Randomized in error|0|||
46809609|NCT00434967|83028932|FG001|Overall Study|Randomized in error|0|||
46809610|NCT00434967|83028933|FG002|Overall Study|Randomized in error|0|||
46809611|NCT00434967|83028934|FG003|Overall Study|Randomized in error|1|||
46926808|NCT02628028|83161321|FG002|Dosing Period|Adverse Event|0|||
46926809|NCT02628028|83161322|FG003|Dosing Period|Adverse Event|0|||
46926810|NCT02628028|83161323|FG004|Dosing Period|Adverse Event|2|||
46926811|NCT02628028|83161324|FG005|Dosing Period|Adverse Event|1|||
46809612|NCT00434967|83028931|FG000|Overall Study|Protocol Violation|0|||
46809613|NCT00434967|83028932|FG001|Overall Study|Protocol Violation|1|||
46809614|NCT00434967|83028933|FG002|Overall Study|Protocol Violation|0|||
46809615|NCT00434967|83028934|FG003|Overall Study|Protocol Violation|1|||
46809616|NCT00434967|83028931|FG000|Overall Study|Physician Decision|1|||
46809617|NCT00434967|83028932|FG001|Overall Study|Physician Decision|1|||
46809618|NCT00434967|83028933|FG002|Overall Study|Physician Decision|1|||
46809619|NCT00434967|83028934|FG003|Overall Study|Physician Decision|0|||
46926812|NCT02628028|83161325|FG006|Dosing Period|Adverse Event|3|||
46926813|NCT02628028|83161326|FG007|Dosing Period|Adverse Event|2|||
46926814|NCT02628028|83161319|FG000|Dosing Period|Death|0|||
46926815|NCT02628028|83161320|FG001|Dosing Period|Death|0|||
46926816|NCT02628028|83161321|FG002|Dosing Period|Death|0|||
46926817|NCT02628028|83161322|FG003|Dosing Period|Death|0|||
46926818|NCT02628028|83161323|FG004|Dosing Period|Death|0|||
46926819|NCT02628028|83161324|FG005|Dosing Period|Death|0|||
47053827|NCT00706992|83325105|FG006|Overall Study|Study termination|3|||
47053828|NCT00706992|83325099|FG000|Overall Study|Disease progression before treatment|0|||
47053829|NCT00706992|83325100|FG001|Overall Study|Disease progression before treatment|0|||
47053830|NCT00706992|83325101|FG002|Overall Study|Disease progression before treatment|0|||
47053831|NCT00706992|83325102|FG003|Overall Study|Disease progression before treatment|0|||
47053832|NCT00706992|83325103|FG004|Overall Study|Disease progression before treatment|1|||
47053833|NCT00706992|83325104|FG005|Overall Study|Disease progression before treatment|0|||
47053834|NCT00706992|83325105|FG006|Overall Study|Disease progression before treatment|0|||
47053835|NCT01785875|83325158|FG000|Overall Study|Withdrawal by Subject|41|||
47053836|NCT01785875|83325159|FG001|Overall Study|Withdrawal by Subject|34|||
47053837|NCT01785875|83325160|FG002|Overall Study|Withdrawal by Subject|36|||
47053838|NCT01785875|83325158|FG000|Overall Study|Lost to Follow-up|19|||
47053839|NCT01785875|83325159|FG001|Overall Study|Lost to Follow-up|22|||
47053840|NCT01785875|83325160|FG002|Overall Study|Lost to Follow-up|6|||
47053841|NCT01785875|83325158|FG000|Overall Study|Death|27|||
47053842|NCT01785875|83325159|FG001|Overall Study|Death|16|||
47053843|NCT01785875|83325160|FG002|Overall Study|Death|7|||
47053844|NCT01785875|83325158|FG000|Overall Study|Sponsor Decision|0|||
47053845|NCT01785875|83325159|FG001|Overall Study|Sponsor Decision|2|||
47053846|NCT01785875|83325160|FG002|Overall Study|Sponsor Decision|0|||
46809620|NCT00434967|83028931|FG000|Overall Study|Patient Disposition Challenges|2|||
46926820|NCT02628028|83161325|FG006|Dosing Period|Death|0|||
46926821|NCT02628028|83161326|FG007|Dosing Period|Death|1|||
46809621|NCT00434967|83028932|FG001|Overall Study|Patient Disposition Challenges|0|||
46809622|NCT00434967|83028933|FG002|Overall Study|Patient Disposition Challenges|0|||
46809623|NCT00434967|83028934|FG003|Overall Study|Patient Disposition Challenges|3|||
46809624|NCT00356590|83028944|FG000|Overall Study|Adverse Event|54|||
46809625|NCT00356590|83028944|FG000|Overall Study|Death|10|||
46926822|NCT02628028|83161319|FG000|Dosing Period|Lack of Efficacy|0|||
47053847|NCT01785875|83325158|FG000|Overall Study|Protocol Specified Criteria|207|||
46809626|NCT00356590|83028944|FG000|Overall Study|Lost to Follow-up|35|||
46809627|NCT00356590|83028944|FG000|Overall Study|Physician Decision|46|||
46926823|NCT02628028|83161320|FG001|Dosing Period|Lack of Efficacy|0|||
46809628|NCT00356590|83028944|FG000|Overall Study|Withdrawal by Subject|41|||
46809629|NCT00356590|83028944|FG000|Overall Study|Completed month 12 only|2|||
46809630|NCT00356590|83028944|FG000|Overall Study|Protocol issues|6|||
46809631|NCT00356590|83028944|FG000|Overall Study|Response status|28|||
46809632|NCT00356590|83028944|FG000|Overall Study|Other|52|||
46809633|NCT00356278|83028951|FG000|Overall Study|Withdrawal by Subject|25|||
46809634|NCT00356278|83028952|FG001|Overall Study|Withdrawal by Subject|15|||
46809635|NCT00356278|83028953|FG002|Overall Study|Withdrawal by Subject|19|||
46926824|NCT02628028|83161321|FG002|Dosing Period|Lack of Efficacy|0|||
46926825|NCT02628028|83161322|FG003|Dosing Period|Lack of Efficacy|0|||
46926826|NCT02628028|83161323|FG004|Dosing Period|Lack of Efficacy|3|||
46926827|NCT02628028|83161324|FG005|Dosing Period|Lack of Efficacy|0|||
46926828|NCT02628028|83161325|FG006|Dosing Period|Lack of Efficacy|1|||
46926829|NCT02628028|83161326|FG007|Dosing Period|Lack of Efficacy|0|||
46926830|NCT02628028|83161319|FG000|Dosing Period|Study Terminated by Sponsor|0|||
46926831|NCT02628028|83161320|FG001|Dosing Period|Study Terminated by Sponsor|0|||
46926832|NCT02628028|83161321|FG002|Dosing Period|Study Terminated by Sponsor|0|||
46926833|NCT02628028|83161322|FG003|Dosing Period|Study Terminated by Sponsor|0|||
46926834|NCT02628028|83161323|FG004|Dosing Period|Study Terminated by Sponsor|7|||
46926835|NCT02628028|83161324|FG005|Dosing Period|Study Terminated by Sponsor|6|||
46926836|NCT02628028|83161325|FG006|Dosing Period|Study Terminated by Sponsor|7|||
46926837|NCT02628028|83161326|FG007|Dosing Period|Study Terminated by Sponsor|7|||
46926838|NCT02628028|83161319|FG000|Dosing Period|Physician Decision|0|||
46926839|NCT02628028|83161320|FG001|Dosing Period|Physician Decision|0|||
46926840|NCT02628028|83161321|FG002|Dosing Period|Physician Decision|0|||
46926841|NCT02628028|83161322|FG003|Dosing Period|Physician Decision|0|||
46926842|NCT02628028|83161323|FG004|Dosing Period|Physician Decision|0|||
46926843|NCT02628028|83161324|FG005|Dosing Period|Physician Decision|1|||
46926844|NCT02628028|83161325|FG006|Dosing Period|Physician Decision|0|||
46926845|NCT02628028|83161326|FG007|Dosing Period|Physician Decision|0|||
46926846|NCT02628028|83161319|FG000|Dosing Period|Site Terminated by Sponsor|0|||
46926847|NCT02628028|83161320|FG001|Dosing Period|Site Terminated by Sponsor|0|||
46926848|NCT02628028|83161321|FG002|Dosing Period|Site Terminated by Sponsor|0|||
46926849|NCT02628028|83161322|FG003|Dosing Period|Site Terminated by Sponsor|0|||
46926850|NCT02628028|83161323|FG004|Dosing Period|Site Terminated by Sponsor|0|||
46926851|NCT02628028|83161324|FG005|Dosing Period|Site Terminated by Sponsor|1|||
46926852|NCT02628028|83161325|FG006|Dosing Period|Site Terminated by Sponsor|1|||
46926853|NCT02628028|83161326|FG007|Dosing Period|Site Terminated by Sponsor|0|||
46926854|NCT02628028|83161319|FG000|Dosing Period|Lost to Follow-up|0|||
46926855|NCT02628028|83161320|FG001|Dosing Period|Lost to Follow-up|0|||
46926856|NCT02628028|83161321|FG002|Dosing Period|Lost to Follow-up|0|||
46809636|NCT00356200|83028963|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
46809637|NCT00356200|83028964|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
46809638|NCT00356200|83028963|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
46809639|NCT00356200|83028964|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
46809640|NCT00356122|83028976|FG000|TREATMENT|Lack of Efficacy|26|||
46926857|NCT02628028|83161322|FG003|Dosing Period|Lost to Follow-up|0|||
46926858|NCT02628028|83161323|FG004|Dosing Period|Lost to Follow-up|0|||
46753743|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753744|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753745|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753746|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753747|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753748|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753749|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753750|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753751|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753752|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753753|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753754|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753755|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753756|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
46753757|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753758|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
46753759|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
46753760|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46809641|NCT00356122|83028976|FG000|TREATMENT|Adverse Event|10|||
46809642|NCT00356122|83028976|FG000|TREATMENT|Subject's request|4|||
46809643|NCT00356122|83028976|FG000|TREATMENT|Other|4|||
46926859|NCT02628028|83161324|FG005|Dosing Period|Lost to Follow-up|0|||
46926860|NCT02628028|83161325|FG006|Dosing Period|Lost to Follow-up|1|||
46926861|NCT02628028|83161326|FG007|Dosing Period|Lost to Follow-up|0|||
46926862|NCT02628028|83161319|FG000|Dosing Period|Other|0|||
46926863|NCT02628028|83161320|FG001|Dosing Period|Other|0|||
46753761|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
46926864|NCT02628028|83161321|FG002|Dosing Period|Other|0|||
46809644|NCT00356122|83028976|FG000|TREATMENT|Did not receive study medication|1|||
46809645|NCT00356122|83028976|FG000|FOLLOW-UP|Death|37|||
46809646|NCT00356122|83028976|FG000|FOLLOW-UP|Lost to Follow-up|2|||
46809647|NCT00356122|83028976|FG000|FOLLOW-UP|Other|2|||
46809648|NCT00347932|83028982|FG000|Overall Study|Adverse Event|4|||
46809649|NCT00347932|83028983|FG001|Overall Study|Adverse Event|5|||
46809650|NCT00347932|83028982|FG000|Overall Study|Lack of Efficacy|3|||
46809651|NCT00347932|83028983|FG001|Overall Study|Lack of Efficacy|14|||
46809652|NCT00347932|83028982|FG000|Overall Study|Lost to Follow-up|10|||
46809653|NCT00347932|83028983|FG001|Overall Study|Lost to Follow-up|9|||
46809654|NCT00347932|83028982|FG000|Overall Study|Withdrawal by Subject|10|||
46809655|NCT00347932|83028983|FG001|Overall Study|Withdrawal by Subject|16|||
46809656|NCT00347932|83028982|FG000|Overall Study|Did not meet inclusion criteria|4|||
46809657|NCT00347932|83028983|FG001|Overall Study|Did not meet inclusion criteria|8|||
46809658|NCT00528996|83028994|FG000|Overall Study|Other reasons than listing|6|||
46809659|NCT00528996|83028995|FG001|Overall Study|Other reasons than listing|7|||
46809660|NCT00528996|83028996|FG002|Overall Study|Other reasons than listing|14|||
46809661|NCT00528996|83028997|FG003|Overall Study|Other reasons than listing|11|||
46809662|NCT00528996|83028998|FG004|Overall Study|Other reasons than listing|5|||
46809663|NCT00528996|83028994|FG000|Overall Study|Refused continue medication|16|||
46809664|NCT00528996|83028995|FG001|Overall Study|Refused continue medication|0|||
46809665|NCT00528996|83028996|FG002|Overall Study|Refused continue medication|3|||
46809666|NCT00528996|83028997|FG003|Overall Study|Refused continue medication|3|||
46809667|NCT00528996|83028998|FG004|Overall Study|Refused continue medication|6|||
46809668|NCT00528996|83028994|FG000|Overall Study|Lost to Follow-up|2|||
46809669|NCT00528996|83028995|FG001|Overall Study|Lost to Follow-up|0|||
46809670|NCT00528996|83028996|FG002|Overall Study|Lost to Follow-up|4|||
46809671|NCT00528996|83028997|FG003|Overall Study|Lost to Follow-up|1|||
46809672|NCT00528996|83028998|FG004|Overall Study|Lost to Follow-up|3|||
46809673|NCT00528996|83028994|FG000|Overall Study|Protocol Violation|1|||
46809674|NCT00528996|83028995|FG001|Overall Study|Protocol Violation|2|||
46809675|NCT00528996|83028996|FG002|Overall Study|Protocol Violation|3|||
46809676|NCT00528996|83028997|FG003|Overall Study|Protocol Violation|3|||
46809677|NCT00528996|83028998|FG004|Overall Study|Protocol Violation|2|||
46809678|NCT00528996|83028994|FG000|Overall Study|Lack of Efficacy|7|||
46809679|NCT00528996|83028995|FG001|Overall Study|Lack of Efficacy|2|||
46809680|NCT00528996|83028996|FG002|Overall Study|Lack of Efficacy|1|||
46809681|NCT00528996|83028997|FG003|Overall Study|Lack of Efficacy|3|||
46809682|NCT00528996|83028998|FG004|Overall Study|Lack of Efficacy|3|||
46809683|NCT00528996|83028994|FG000|Overall Study|Adverse Event|32|||
46809684|NCT00528996|83028995|FG001|Overall Study|Adverse Event|13|||
46809685|NCT00528996|83028996|FG002|Overall Study|Adverse Event|18|||
46809686|NCT00528996|83028997|FG003|Overall Study|Adverse Event|29|||
46809687|NCT00528996|83028998|FG004|Overall Study|Adverse Event|18|||
46809688|NCT00359788|83029015|FG000|Overall Study|Adverse Event|11|||
46809689|NCT00359788|83029016|FG001|Overall Study|Adverse Event|10|||
46809690|NCT00359788|83029015|FG000|Overall Study|Lack of Efficacy|1|||
46809691|NCT00359788|83029016|FG001|Overall Study|Lack of Efficacy|2|||
46809692|NCT00359788|83029015|FG000|Overall Study|Lost to Follow-up|3|||
46809693|NCT00359788|83029016|FG001|Overall Study|Lost to Follow-up|2|||
46809694|NCT00359788|83029015|FG000|Overall Study|Withdrawal by Subject|4|||
46809695|NCT00359788|83029016|FG001|Overall Study|Withdrawal by Subject|1|||
46809696|NCT00359788|83029015|FG000|Overall Study|Protocol Violation|4|||
46809697|NCT00359788|83029016|FG001|Overall Study|Protocol Violation|2|||
46809698|NCT03878160|83029025|FG000|Overall Study|Lost to Follow-up|1|||
46809699|NCT03878160|83029026|FG001|Overall Study|Lost to Follow-up|1|||
46809700|NCT03878160|83029027|FG002|Overall Study|Lost to Follow-up|1|||
47053848|NCT01785875|83325159|FG001|Overall Study|Protocol Specified Criteria|214|||
47053849|NCT01785875|83325160|FG002|Overall Study|Protocol Specified Criteria|55|||
47053850|NCT01785875|83325158|FG000|Overall Study|Missing|0|||
46636312|NCT01489254|82810131|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
46809701|NCT03878160|83029025|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
46809702|NCT03878160|83029026|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
46809703|NCT03878160|83029027|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
46809704|NCT00623597|83029037|FG000|Overall Study|Failed to return|1|||
46809705|NCT00623597|83029038|FG001|Overall Study|Failed to return|0|||
46809706|NCT00347776|83029049|FG000|1.5 Month Follow-up|Death|2|||
46809707|NCT00347776|83029050|FG001|1.5 Month Follow-up|Death|0|||
46809708|NCT00347776|83029051|FG002|1.5 Month Follow-up|Death|0|||
46809709|NCT00347776|83029049|FG000|1.5 Month Follow-up|reached the endpoint|12|||
46809710|NCT00347776|83029050|FG001|1.5 Month Follow-up|reached the endpoint|8|||
46809711|NCT00347776|83029051|FG002|1.5 Month Follow-up|reached the endpoint|12|||
46809712|NCT00347776|83029049|FG000|6 Month Follow-up|Death|2|||
46809713|NCT00347776|83029050|FG001|6 Month Follow-up|Death|1|||
46809714|NCT00347776|83029051|FG002|6 Month Follow-up|Death|3|||
46809715|NCT00347776|83029049|FG000|6 Month Follow-up|reached endpont|20|||
46809716|NCT00347776|83029050|FG001|6 Month Follow-up|reached endpont|12|||
46809717|NCT00347776|83029051|FG002|6 Month Follow-up|reached endpont|15|||
46809718|NCT00347776|83029049|FG000|12 Month Follow-up|Lost to Follow-up|7|||
46926865|NCT02628028|83161322|FG003|Dosing Period|Other|0|||
46926866|NCT02628028|83161323|FG004|Dosing Period|Other|2|||
46926867|NCT02628028|83161324|FG005|Dosing Period|Other|1|||
46926868|NCT02628028|83161325|FG006|Dosing Period|Other|2|||
46926869|NCT02628028|83161326|FG007|Dosing Period|Other|4|||
46926870|NCT02628028|83161319|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
46926871|NCT02628028|83161320|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
46926872|NCT02628028|83161321|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
46926873|NCT02628028|83161322|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
46926874|NCT02628028|83161323|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
46926875|NCT02628028|83161324|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
46926876|NCT02628028|83161325|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
46926877|NCT02628028|83161326|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
46926878|NCT02628028|83161319|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
46926879|NCT02628028|83161320|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
46926880|NCT02628028|83161321|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
46926881|NCT02628028|83161322|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
46926882|NCT02628028|83161323|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
46926883|NCT02628028|83161324|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
46926884|NCT02628028|83161325|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
46926885|NCT02628028|83161326|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
46926886|NCT02628028|83161319|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
46926887|NCT02628028|83161320|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
46926888|NCT02628028|83161321|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
46926889|NCT02628028|83161322|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
46926890|NCT02628028|83161323|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
46926891|NCT02628028|83161324|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
46926892|NCT02628028|83161325|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
46926893|NCT02628028|83161326|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
46926894|NCT02628028|83161319|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
46926895|NCT02628028|83161320|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
46926896|NCT02628028|83161321|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
46926897|NCT02628028|83161322|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
46926898|NCT02628028|83161323|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
46926899|NCT02628028|83161324|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
46926900|NCT02628028|83161325|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
46926901|NCT02628028|83161326|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
46926902|NCT02628028|83161319|FG000|Long-term Extension (LTE) Period|Other|0|||
46926903|NCT02628028|83161320|FG001|Long-term Extension (LTE) Period|Other|0|||
46926904|NCT02628028|83161321|FG002|Long-term Extension (LTE) Period|Other|0|||
46926905|NCT02628028|83161322|FG003|Long-term Extension (LTE) Period|Other|0|||
46926906|NCT02628028|83161323|FG004|Long-term Extension (LTE) Period|Other|0|||
46926907|NCT02628028|83161324|FG005|Long-term Extension (LTE) Period|Other|3|||
46926908|NCT02628028|83161325|FG006|Long-term Extension (LTE) Period|Other|4|||
46926909|NCT02628028|83161326|FG007|Long-term Extension (LTE) Period|Other|3|||
46926910|NCT03977701|83161358|FG000|Overall Study|COVID-19 pandemic|0|||
46926911|NCT03977701|83161359|FG001|Overall Study|COVID-19 pandemic|0|||
46926912|NCT03977701|83161360|FG002|Overall Study|COVID-19 pandemic|0|||
46926913|NCT03977701|83161361|FG003|Overall Study|COVID-19 pandemic|0|||
46926914|NCT03977701|83161362|FG004|Overall Study|COVID-19 pandemic|0|||
46926915|NCT03977701|83161363|FG005|Overall Study|COVID-19 pandemic|1|||
46926916|NCT03977701|83161364|FG006|Overall Study|COVID-19 pandemic|0|||
46926917|NCT03977701|83161365|FG007|Overall Study|COVID-19 pandemic|1|||
46926918|NCT03977701|83161366|FG008|Overall Study|COVID-19 pandemic|0|||
46926919|NCT03977701|83161367|FG009|Overall Study|COVID-19 pandemic|0|||
46926920|NCT02814526|83161406|FG000|Overall Study|Adverse Event|4|||
46926921|NCT02814526|83161407|FG001|Overall Study|Adverse Event|3|||
46926922|NCT02814526|83161406|FG000|Overall Study|Death|1|||
46926923|NCT02814526|83161407|FG001|Overall Study|Death|1|||
46926924|NCT02814526|83161406|FG000|Overall Study|Lost to Follow-up|3|||
46926925|NCT02814526|83161407|FG001|Overall Study|Lost to Follow-up|4|||
46926926|NCT02814526|83161406|FG000|Overall Study|non site physician decision|1|||
46926927|NCT02814526|83161407|FG001|Overall Study|non site physician decision|0|||
46926928|NCT02814526|83161406|FG000|Overall Study|participant noncompliance|1|||
46926929|NCT02814526|83161407|FG001|Overall Study|participant noncompliance|1|||
46926930|NCT02814526|83161406|FG000|Overall Study|Withdrawal by Subject|20|||
46926931|NCT02814526|83161407|FG001|Overall Study|Withdrawal by Subject|14|||
46926932|NCT02814526|83161406|FG000|Overall Study|safety risk|2|||
46926933|NCT02814526|83161407|FG001|Overall Study|safety risk|1|||
46926934|NCT02814526|83161406|FG000|Overall Study|early termination-study terminated|1|||
46926935|NCT02814526|83161407|FG001|Overall Study|early termination-study terminated|2|||
46926936|NCT02814526|83161406|FG000|Overall Study|Other|0|||
46926937|NCT02814526|83161407|FG001|Overall Study|Other|4|||
46926938|NCT02329834|83161415|FG000|Overall Study|Physician Decision|1|||
46926939|NCT02329834|83161416|FG001|Overall Study|Physician Decision|0|||
46926940|NCT01340937|83161427|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
46926941|NCT01340937|83161428|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
46926942|NCT01340937|83161429|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
46926943|NCT01340937|83161430|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
46926944|NCT01340937|83161427|FG000|Period 1: Infant Series|Adverse Event|0|||
46926945|NCT01340937|83161428|FG001|Period 1: Infant Series|Adverse Event|1|||
46636313|NCT01489254|82810132|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
46926946|NCT01340937|83161429|FG002|Period 1: Infant Series|Adverse Event|4|||
46926947|NCT01340937|83161430|FG003|Period 1: Infant Series|Adverse Event|0|||
46926948|NCT01340937|83161427|FG000|Period 1: Infant Series|Death|2|||
46926949|NCT01340937|83161428|FG001|Period 1: Infant Series|Death|0|||
46926950|NCT01340937|83161429|FG002|Period 1: Infant Series|Death|2|||
46926951|NCT01340937|83161430|FG003|Period 1: Infant Series|Death|0|||
46926952|NCT01340937|83161427|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
46926953|NCT01340937|83161428|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
46926954|NCT01340937|83161429|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
46926955|NCT01340937|83161430|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
46926956|NCT01340937|83161427|FG000|Period 1: Infant Series|Physician Decision|2|||
46926957|NCT01340937|83161428|FG001|Period 1: Infant Series|Physician Decision|3|||
46926958|NCT01340937|83161429|FG002|Period 1: Infant Series|Physician Decision|1|||
46926959|NCT01340937|83161430|FG003|Period 1: Infant Series|Physician Decision|0|||
46926960|NCT01340937|83161427|FG000|Period 1: Infant Series|Protocol Violation|1|||
46926961|NCT01340937|83161428|FG001|Period 1: Infant Series|Protocol Violation|4|||
46926962|NCT01340937|83161429|FG002|Period 1: Infant Series|Protocol Violation|4|||
46926963|NCT01340937|83161430|FG003|Period 1: Infant Series|Protocol Violation|3|||
46926964|NCT01340937|83161427|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
46926965|NCT01340937|83161428|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
46926966|NCT01340937|83161429|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
46926967|NCT01340937|83161430|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
46636314|NCT01489254|82810133|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
46809719|NCT00347776|83029050|FG001|12 Month Follow-up|Lost to Follow-up|6|||
46809720|NCT00347776|83029051|FG002|12 Month Follow-up|Lost to Follow-up|6|||
46809721|NCT00347776|83029049|FG000|12 Month Follow-up|Death|3|||
46809722|NCT00347776|83029050|FG001|12 Month Follow-up|Death|4|||
46809723|NCT00347776|83029051|FG002|12 Month Follow-up|Death|4|||
46809724|NCT00347776|83029049|FG000|12 Month Follow-up|Reached endpoint|13|||
46809725|NCT00347776|83029050|FG001|12 Month Follow-up|Reached endpoint|6|||
46809726|NCT00347776|83029051|FG002|12 Month Follow-up|Reached endpoint|9|||
46809727|NCT03829228|83029059|FG000|Overall Study|Protocol Violation|1|||
46809728|NCT00529542|83029065|FG000|Overall Study|Withdrawal by Subject|1|||
46809729|NCT00529542|83029066|FG001|Overall Study|Withdrawal by Subject|0|||
46809730|NCT00529542|83029065|FG000|Overall Study|Lost to Follow-up|0|||
46809731|NCT00529542|83029066|FG001|Overall Study|Lost to Follow-up|1|||
46809732|NCT00621959|83029074|FG000|Overall Study|Adverse Event|4|||
46809733|NCT00621959|83029075|FG001|Overall Study|Adverse Event|2|||
46809734|NCT00621959|83029074|FG000|Overall Study|Lack of Efficacy|1|||
46809735|NCT00621959|83029075|FG001|Overall Study|Lack of Efficacy|1|||
46809736|NCT00621959|83029074|FG000|Overall Study|Lost to Follow-up|0|||
46809737|NCT00621959|83029075|FG001|Overall Study|Lost to Follow-up|2|||
46809738|NCT00621959|83029074|FG000|Overall Study|Withdrawal by Subject|1|||
46809739|NCT00621959|83029075|FG001|Overall Study|Withdrawal by Subject|1|||
46809740|NCT00621959|83029074|FG000|Overall Study|Other|1|||
46809741|NCT00621959|83029075|FG001|Overall Study|Other|3|||
46809742|NCT03877224|83029083|FG000|Overall Study|Death|3|||
46809743|NCT03877224|83029084|FG001|Overall Study|Death|2|||
46809744|NCT03877224|83029083|FG000|Overall Study|Withdrawal by Subject|1|||
46809745|NCT03877224|83029084|FG001|Overall Study|Withdrawal by Subject|6|||
46809746|NCT03877224|83029083|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
46809747|NCT03877224|83029084|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
46809748|NCT00528606|83029092|FG000|Overall Study|Withdrew consent|4|||
46809749|NCT00528606|83029093|FG001|Overall Study|Withdrew consent|3|||
46926968|NCT01340937|83161427|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
46926969|NCT01340937|83161428|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
46926970|NCT01340937|83161429|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
46926971|NCT01340937|83161430|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
46926972|NCT01340937|83161427|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
46809750|NCT00528606|83029092|FG000|Overall Study|Lost to Follow-up|4|||
46809751|NCT00528606|83029093|FG001|Overall Study|Lost to Follow-up|1|||
46809752|NCT00528606|83029092|FG000|Overall Study|Adverse Event|3|||
46809753|NCT00528606|83029093|FG001|Overall Study|Adverse Event|0|||
46809754|NCT00528606|83029092|FG000|Overall Study|Other|2|||
46809755|NCT00528606|83029093|FG001|Overall Study|Other|0|||
46809756|NCT00621257|83029104|FG000|Overall Study|Lost to Follow-up|4|||
46809757|NCT00621257|83029105|FG001|Overall Study|Lost to Follow-up|0|||
46809758|NCT00621257|83029106|FG002|Overall Study|Lost to Follow-up|2|||
46809759|NCT00621257|83029107|FG003|Overall Study|Lost to Follow-up|4|||
46809760|NCT00621257|83029108|FG004|Overall Study|Lost to Follow-up|7|||
46809761|NCT00621257|83029104|FG000|Overall Study|Adverse Event|0|||
46809762|NCT00621257|83029105|FG001|Overall Study|Adverse Event|1|||
46809763|NCT00621257|83029106|FG002|Overall Study|Adverse Event|1|||
46809764|NCT00621257|83029107|FG003|Overall Study|Adverse Event|0|||
46809765|NCT00621257|83029108|FG004|Overall Study|Adverse Event|0|||
46926973|NCT01340937|83161428|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
46926974|NCT01340937|83161429|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
46926975|NCT01340937|83161430|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
46926976|NCT01340937|83161427|FG000|Period 2: Interim Period|Adverse Event|1|||
46926977|NCT01340937|83161428|FG001|Period 2: Interim Period|Adverse Event|0|||
46926978|NCT01340937|83161429|FG002|Period 2: Interim Period|Adverse Event|1|||
46753762|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
46753763|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Death|0|||
46753764|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Death|0|||
46753765|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Death|0|||
46753766|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Death|0|||
46753767|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Death|0|||
46753768|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Death|0|||
46753769|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Death|0|||
46753770|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Death|0|||
46753771|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Death|0|||
46753772|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Death|0|||
46753773|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Death|0|||
46753774|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Death|0|||
46753775|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Death|0|||
46753776|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Death|0|||
46753777|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Death|0|||
46753778|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Death|1|||
46753779|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Death|7|||
46753780|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Death|5|||
46753781|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Death|5|||
46753782|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Death|3|||
46809766|NCT00621257|83029104|FG000|Overall Study|Physician Decision|0|||
46809767|NCT00621257|83029105|FG001|Overall Study|Physician Decision|2|||
46809768|NCT00621257|83029106|FG002|Overall Study|Physician Decision|0|||
46809769|NCT00621257|83029107|FG003|Overall Study|Physician Decision|1|||
46809770|NCT00621257|83029108|FG004|Overall Study|Physician Decision|1|||
46809771|NCT00621257|83029104|FG000|Overall Study|Withdrawal by Subject|0|||
46809772|NCT00621257|83029105|FG001|Overall Study|Withdrawal by Subject|0|||
46809773|NCT00621257|83029106|FG002|Overall Study|Withdrawal by Subject|0|||
46809774|NCT00621257|83029107|FG003|Overall Study|Withdrawal by Subject|1|||
46809775|NCT00621257|83029108|FG004|Overall Study|Withdrawal by Subject|1|||
46809776|NCT00528840|83029120|FG000|Overall Study|Lost to Follow-up|10|||
46809777|NCT00528840|83029120|FG000|Overall Study|Adverse Event|1|||
46809778|NCT00528840|83029120|FG000|Overall Study|Withdrawal by Subject|17|||
46809779|NCT00528840|83029120|FG000|Overall Study|Death|2|||
46809780|NCT00528840|83029120|FG000|Overall Study|Administrative Reasons|1|||
46809781|NCT00528840|83029120|FG000|Overall Study|Other|2|||
46809782|NCT00528528|83029128|FG000|Overall Study|Lost to Follow-up|0|||
46809783|NCT00528528|83029129|FG001|Overall Study|Lost to Follow-up|0|||
46809784|NCT00528528|83029130|FG002|Overall Study|Lost to Follow-up|1|||
46809785|NCT00528528|83029131|FG003|Overall Study|Lost to Follow-up|1|||
46809786|NCT00528528|83029128|FG000|Overall Study|Ineligible to continue the trial|0|||
46809787|NCT00528528|83029129|FG001|Overall Study|Ineligible to continue the trial|0|||
46809788|NCT00528528|83029130|FG002|Overall Study|Ineligible to continue the trial|0|||
46809789|NCT00528528|83029131|FG003|Overall Study|Ineligible to continue the trial|1|||
46809790|NCT00528528|83029128|FG000|Overall Study|Other|0|||
46809791|NCT00528528|83029129|FG001|Overall Study|Other|1|||
46809792|NCT00528528|83029130|FG002|Overall Study|Other|0|||
46753783|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Death|7|||
46809793|NCT00528528|83029131|FG003|Overall Study|Other|0|||
46809794|NCT00528528|83029128|FG000|Overall Study|Withdrawal by Subject|3|||
46809795|NCT00528528|83029129|FG001|Overall Study|Withdrawal by Subject|2|||
46809796|NCT00528528|83029130|FG002|Overall Study|Withdrawal by Subject|1|||
46809797|NCT00528528|83029131|FG003|Overall Study|Withdrawal by Subject|1|||
46809798|NCT00528528|83029128|FG000|Overall Study|Ongoing participant|0|||
46809799|NCT00528528|83029129|FG001|Overall Study|Ongoing participant|0|||
46809800|NCT00528528|83029130|FG002|Overall Study|Ongoing participant|1|||
46753784|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Death|5|||
46753785|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Death|6|||
46753786|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Death|3|||
46753787|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Death|0|||
46753788|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753789|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753790|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46809801|NCT00528528|83029131|FG003|Overall Study|Ongoing participant|0|||
46809802|NCT00620555|83029143|FG000|Overall Study|Adverse Event|4|||
46809803|NCT00620555|83029143|FG000|Overall Study|Protocol Violation|2|||
46809804|NCT00620555|83029143|FG000|Overall Study|Lack of Efficacy|12|||
46809805|NCT00620555|83029143|FG000|Overall Study|Withdrawal by Subject|1|||
46809806|NCT00620555|83029143|FG000|Overall Study|Choice of other treatment|1|||
46809807|NCT00620555|83029143|FG000|Overall Study|Visit failure against planned|1|||
46809808|NCT00529386|83029147|FG000|Overall Study|Lost to Follow-up|1|||
46809809|NCT03875118|83029153|FG000|Overall Study|Withdrawal by Subject|4|||
46809810|NCT03875118|83029154|FG001|Overall Study|Withdrawal by Subject|4|||
46926979|NCT01340937|83161430|FG003|Period 2: Interim Period|Adverse Event|0|||
46926980|NCT01340937|83161427|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
46926981|NCT01340937|83161428|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
46926982|NCT01340937|83161429|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
46926983|NCT01340937|83161430|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
46926984|NCT01340937|83161427|FG000|Period 2: Interim Period|Physician Decision|0|||
46926985|NCT01340937|83161428|FG001|Period 2: Interim Period|Physician Decision|1|||
46926986|NCT01340937|83161429|FG002|Period 2: Interim Period|Physician Decision|1|||
46926987|NCT01340937|83161430|FG003|Period 2: Interim Period|Physician Decision|0|||
46926988|NCT01340937|83161427|FG000|Period 2: Interim Period|Protocol Violation|5|||
46926989|NCT01340937|83161428|FG001|Period 2: Interim Period|Protocol Violation|3|||
46926990|NCT01340937|83161429|FG002|Period 2: Interim Period|Protocol Violation|6|||
46926991|NCT01340937|83161430|FG003|Period 2: Interim Period|Protocol Violation|3|||
46926992|NCT01340937|83161427|FG000|Period 2: Interim Period|Technical problems|4|||
46926993|NCT01340937|83161428|FG001|Period 2: Interim Period|Technical problems|4|||
46926994|NCT01340937|83161429|FG002|Period 2: Interim Period|Technical problems|6|||
46926995|NCT01340937|83161430|FG003|Period 2: Interim Period|Technical problems|3|||
46926996|NCT01340937|83161427|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
46926997|NCT01340937|83161428|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
46926998|NCT01340937|83161429|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
46926999|NCT01340937|83161430|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
47053851|NCT01785875|83325159|FG001|Overall Study|Missing|1|||
47053852|NCT01785875|83325160|FG002|Overall Study|Missing|3|||
47053853|NCT05567393|83325189|FG000|Overall Study|Voluntary Withdrawal|0|||
47053854|NCT05567393|83325190|FG001|Overall Study|Voluntary Withdrawal|0|||
47053855|NCT05567393|83325191|FG002|Overall Study|Voluntary Withdrawal|0|||
47053856|NCT05567393|83325192|FG003|Overall Study|Voluntary Withdrawal|0|||
47053857|NCT05567393|83325193|FG004|Overall Study|Voluntary Withdrawal|0|||
47053858|NCT05567393|83325194|FG005|Overall Study|Voluntary Withdrawal|0|||
47053859|NCT05567393|83325195|FG006|Overall Study|Voluntary Withdrawal|0|||
47053860|NCT05567393|83325196|FG007|Overall Study|Voluntary Withdrawal|0|||
47053861|NCT05567393|83325197|FG008|Overall Study|Voluntary Withdrawal|0|||
47053862|NCT05567393|83325198|FG009|Overall Study|Voluntary Withdrawal|0|||
47053863|NCT05567393|83325199|FG010|Overall Study|Voluntary Withdrawal|0|||
47053864|NCT05567393|83325200|FG011|Overall Study|Voluntary Withdrawal|0|||
47053865|NCT05567393|83325201|FG012|Overall Study|Voluntary Withdrawal|0|||
46753791|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753792|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753793|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753794|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753795|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753796|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753797|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753798|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753799|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753800|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753801|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753802|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753803|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753804|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753805|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
46809811|NCT00529308|83029162|FG000|Overall Study|Withdrawal by Subject|1|||
46809812|NCT00529308|83029163|FG001|Overall Study|Withdrawal by Subject|1|||
46809813|NCT03875508|83029169|FG000|Overall Study|Adverse Event|1|||
46809814|NCT03875508|83029169|FG000|Overall Study|Lost to Follow-up|8|||
46809815|NCT03875508|83029169|FG000|Overall Study|Lack of Efficacy|1|||
46927000|NCT01340937|83161427|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
47053866|NCT05567393|83325202|FG013|Overall Study|Voluntary Withdrawal|1|||
47053867|NCT05567393|83325203|FG014|Overall Study|Voluntary Withdrawal|0|||
47053868|NCT05567393|83325204|FG015|Overall Study|Voluntary Withdrawal|0|||
46753806|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
46927001|NCT01340937|83161428|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
46927002|NCT01340937|83161429|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
46927003|NCT01340937|83161430|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
46809816|NCT03875508|83029169|FG000|Overall Study|Other, not specified|2|||
46809817|NCT00620321|83029175|FG000|Overall Study|Adverse Event|1|||
46809818|NCT00620321|83029176|FG001|Overall Study|Adverse Event|1|||
46809819|NCT00620321|83029175|FG000|Overall Study|Death|1|||
46809820|NCT00620321|83029176|FG001|Overall Study|Death|1|||
46809821|NCT00620321|83029175|FG000|Overall Study|Physician Decision|0|||
46809822|NCT00620321|83029176|FG001|Overall Study|Physician Decision|7|||
46809823|NCT00620321|83029175|FG000|Overall Study|Progressive Disease|5|||
46927004|NCT01340937|83161427|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
46927005|NCT01340937|83161428|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
46927006|NCT01340937|83161429|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
46927007|NCT01340937|83161430|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
46927008|NCT01340937|83161427|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
46927009|NCT01340937|83161428|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
46927010|NCT01340937|83161429|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
46927011|NCT01340937|83161430|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
46927012|NCT03028129|83161448|FG000|Overall Study|Adverse Event|13|||
46927013|NCT03028129|83161449|FG001|Overall Study|Adverse Event|2|||
46927014|NCT03028129|83161448|FG000|Overall Study|Lost to Follow-up|50|||
46927015|NCT03028129|83161449|FG001|Overall Study|Lost to Follow-up|38|||
46927016|NCT03028129|83161448|FG000|Overall Study|Physician Decision|0|||
46927017|NCT03028129|83161449|FG001|Overall Study|Physician Decision|1|||
46927018|NCT03028129|83161448|FG000|Overall Study|Protocol Violation|1|||
46927019|NCT03028129|83161449|FG001|Overall Study|Protocol Violation|1|||
46927020|NCT03028129|83161448|FG000|Overall Study|Withdrawal by Subject|62|||
46927021|NCT03028129|83161449|FG001|Overall Study|Withdrawal by Subject|45|||
46927022|NCT03026257|83161461|FG000|Overall Study|Adverse Event|3|||
47053869|NCT05567393|83325205|FG016|Overall Study|Voluntary Withdrawal|0|||
47053870|NCT05567393|83325206|FG017|Overall Study|Voluntary Withdrawal|0|||
47053871|NCT04973085|83325279|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
47053872|NCT04973085|83325280|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
47053873|NCT04542070|83325330|FG000|Overall Study|Adverse Event|10|||
47053874|NCT04542070|83325331|FG001|Overall Study|Adverse Event|3|||
47053875|NCT04542070|83325332|FG002|Overall Study|Adverse Event|1|||
47053876|NCT04542070|83325330|FG000|Overall Study|Lack of Efficacy|1|||
46753807|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
46753808|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
46753809|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
46753810|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
46753811|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
46753812|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
46753813|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Disease Progression|0|||
46753814|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Disease Progression|0|||
46753815|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Disease Progression|0|||
46809824|NCT00620321|83029176|FG001|Overall Study|Progressive Disease|5|||
46809825|NCT00620321|83029175|FG000|Overall Study|Sponsor Decision|0|||
46809826|NCT00620321|83029176|FG001|Overall Study|Sponsor Decision|1|||
46809827|NCT00620321|83029175|FG000|Overall Study|Withdrawal by Subject|1|||
46927023|NCT03026257|83161462|FG001|Overall Study|Adverse Event|0|||
46927024|NCT03026257|83161463|FG002|Overall Study|Adverse Event|0|||
46927025|NCT03026257|83161464|FG003|Overall Study|Adverse Event|0|||
46927026|NCT03026257|83161465|FG004|Overall Study|Adverse Event|0|||
46927027|NCT03026257|83161466|FG005|Overall Study|Adverse Event|0|||
46927028|NCT03026257|83161461|FG000|Overall Study|Lost to Follow-up|1|||
46927029|NCT03026257|83161462|FG001|Overall Study|Lost to Follow-up|0|||
46927030|NCT03026257|83161463|FG002|Overall Study|Lost to Follow-up|0|||
46927031|NCT03026257|83161464|FG003|Overall Study|Lost to Follow-up|0|||
46927032|NCT03026257|83161465|FG004|Overall Study|Lost to Follow-up|0|||
46927033|NCT03026257|83161466|FG005|Overall Study|Lost to Follow-up|0|||
46927034|NCT03026257|83161461|FG000|Overall Study|Protocol Violation|1|||
46927035|NCT03026257|83161462|FG001|Overall Study|Protocol Violation|0|||
46927036|NCT03026257|83161463|FG002|Overall Study|Protocol Violation|0|||
46927037|NCT03026257|83161464|FG003|Overall Study|Protocol Violation|1|||
46927038|NCT03026257|83161465|FG004|Overall Study|Protocol Violation|1|||
46927039|NCT03026257|83161466|FG005|Overall Study|Protocol Violation|0|||
46927040|NCT03026257|83161461|FG000|Overall Study|Withdrawal by Subject|1|||
46927041|NCT03026257|83161462|FG001|Overall Study|Withdrawal by Subject|1|||
46927042|NCT03026257|83161463|FG002|Overall Study|Withdrawal by Subject|0|||
47053877|NCT04542070|83325331|FG001|Overall Study|Lack of Efficacy|2|||
47053878|NCT04542070|83325332|FG002|Overall Study|Lack of Efficacy|0|||
47053879|NCT04542070|83325330|FG000|Overall Study|Lost to Follow-up|3|||
47053880|NCT04542070|83325331|FG001|Overall Study|Lost to Follow-up|4|||
46753816|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Disease Progression|0|||
47053881|NCT04542070|83325332|FG002|Overall Study|Lost to Follow-up|2|||
46809828|NCT00620321|83029176|FG001|Overall Study|Withdrawal by Subject|1|||
46809829|NCT00621023|83029182|FG000|Overall Study|Death|5|||
46809830|NCT00621023|83029182|FG000|Overall Study|Follow up discontinued|1|||
46809831|NCT00852371|83029190|FG000|Overall Study|Lost to Follow-up|2|||
46809832|NCT00852371|83029191|FG001|Overall Study|Lost to Follow-up|3|||
46809833|NCT00852371|83029192|FG002|Overall Study|Lost to Follow-up|4|||
46809834|NCT00852371|83029193|FG003|Overall Study|Lost to Follow-up|2|||
46809835|NCT00528372|83029212|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
46809836|NCT00528372|83029213|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809837|NCT00528372|83029214|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809838|NCT00528372|83029215|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809839|NCT00528372|83029216|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809840|NCT00528372|83029217|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809841|NCT00528372|83029218|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809842|NCT00528372|83029219|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809843|NCT00528372|83029220|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
46809844|NCT00528372|83029212|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
46809845|NCT00528372|83029213|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
46809846|NCT00528372|83029214|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
46809847|NCT00528372|83029215|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
46809848|NCT00528372|83029216|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
46809849|NCT00528372|83029217|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
46809850|NCT00528372|83029218|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
46809851|NCT00528372|83029219|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
46809852|NCT00528372|83029220|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
46809853|NCT00528372|83029212|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
46809854|NCT00528372|83029213|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
46809855|NCT00528372|83029214|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
46809856|NCT00528372|83029215|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
46809857|NCT00528372|83029216|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
46809858|NCT00528372|83029217|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
46809859|NCT00528372|83029218|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
46809860|NCT00528372|83029219|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
46809861|NCT00528372|83029220|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
46809862|NCT00528372|83029212|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
46809863|NCT00528372|83029213|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
46809864|NCT00528372|83029214|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
46809865|NCT00528372|83029215|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
47053882|NCT04542070|83325330|FG000|Overall Study|Physician Decision|1|||
47053883|NCT04542070|83325331|FG001|Overall Study|Physician Decision|0|||
47053884|NCT04542070|83325332|FG002|Overall Study|Physician Decision|1|||
47053885|NCT04542070|83325330|FG000|Overall Study|Withdrawal by Subject|5|||
47053886|NCT04542070|83325331|FG001|Overall Study|Withdrawal by Subject|8|||
46753817|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Disease Progression|0|||
46753818|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Disease Progression|0|||
46753819|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Disease Progression|0|||
46753820|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Disease Progression|0|||
46753821|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Disease Progression|0|||
46753822|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Disease Progression|0|||
46753823|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Disease Progression|0|||
46753824|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Disease Progression|0|||
46753825|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Disease Progression|0|||
46753826|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Disease Progression|0|||
46753827|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Disease Progression|0|||
46753828|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Disease Progression|0|||
46753829|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Disease Progression|0|||
46809866|NCT00528372|83029216|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
46809867|NCT00528372|83029217|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
46809868|NCT00528372|83029218|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
46809869|NCT00528372|83029219|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
46809870|NCT00528372|83029220|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
46809871|NCT00528372|83029212|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
46809872|NCT00528372|83029213|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
47053887|NCT04542070|83325332|FG002|Overall Study|Withdrawal by Subject|9|||
47053888|NCT04542070|83325330|FG000|Overall Study|Protocol Deviation|2|||
46753830|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Disease Progression|0|||
46753831|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Disease Progression|0|||
46809873|NCT00528372|83029214|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
46809874|NCT00528372|83029215|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
46809875|NCT00528372|83029216|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
46809876|NCT00528372|83029217|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
46809877|NCT00528372|83029218|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
46809878|NCT00528372|83029219|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
46809879|NCT00528372|83029220|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
46809880|NCT00528372|83029212|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
46809881|NCT00528372|83029213|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
46809882|NCT00528372|83029214|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
46809883|NCT00528372|83029215|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
46809884|NCT00528372|83029216|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
46809885|NCT00528372|83029217|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
46809886|NCT00528372|83029218|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
46809887|NCT00528372|83029219|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
46809888|NCT00528372|83029220|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
46809889|NCT00528372|83029212|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
46809890|NCT00528372|83029213|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
46809891|NCT00528372|83029214|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
46809892|NCT00528372|83029215|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
46809893|NCT00528372|83029216|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
46809894|NCT00528372|83029217|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
46809895|NCT00528372|83029218|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
46809896|NCT00528372|83029219|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
46809897|NCT00528372|83029220|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
46809898|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
46809899|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
46809900|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
46809901|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
46927043|NCT03026257|83161464|FG003|Overall Study|Withdrawal by Subject|0|||
46927044|NCT03026257|83161465|FG004|Overall Study|Withdrawal by Subject|0|||
46927045|NCT03026257|83161466|FG005|Overall Study|Withdrawal by Subject|0|||
46927046|NCT01670188|83161482|FG000|Overall Study|Death|0|||
46927047|NCT01670188|83161483|FG001|Overall Study|Death|1|||
46927048|NCT01933048|83161491|FG000|Overall Study|Lost to Follow-up|15|||
46927049|NCT01933048|83161492|FG001|Overall Study|Lost to Follow-up|18|||
46927050|NCT01933048|83161491|FG000|Overall Study|personal reasons|1|||
46927051|NCT01933048|83161492|FG001|Overall Study|personal reasons|1|||
46927052|NCT01933048|83161491|FG000|Overall Study|Protocol Violation|7|||
47053889|NCT04542070|83325331|FG001|Overall Study|Protocol Deviation|6|||
47053890|NCT04542070|83325332|FG002|Overall Study|Protocol Deviation|1|||
47053891|NCT04542070|83325330|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
47053892|NCT04542070|83325331|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
47053893|NCT04542070|83325332|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
47053894|NCT04538950|83325341|FG000|Overall Study|Pulmonary Issues|2|||
47053895|NCT04538950|83325341|FG000|Overall Study|illness|2|||
46753832|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Disease Progression|0|||
46753833|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Disease Progression|2|||
46753834|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Disease Progression|1|||
46753835|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Disease Progression|0|||
46753836|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Disease Progression|0|||
46753837|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Disease Progression|0|||
46753838|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753839|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
46809902|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
46809903|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
46927053|NCT01933048|83161492|FG001|Overall Study|Protocol Violation|8|||
46927054|NCT01933048|83161491|FG000|Overall Study|Physician Decision|1|||
46927055|NCT01933048|83161492|FG001|Overall Study|Physician Decision|0|||
47053896|NCT04445688|83325354|FG000|Washout (One Week)|Adverse Event|2|||
47053897|NCT04445688|83325354|FG000|Washout (One Week)|Withdrawal by Subject|1|||
47053898|NCT04382755|83325364|FG000|Overall Study|Withdrawal by Subject|1|||
46809904|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
46809905|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
46809906|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
46809907|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
46809908|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
46809909|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
46809910|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
46809911|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
46809912|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
47053899|NCT04382755|83325365|FG001|Overall Study|Withdrawal by Subject|0|||
47053900|NCT04382755|83325364|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
47053901|NCT04382755|83325365|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
47053902|NCT04382755|83325364|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
47053903|NCT04382755|83325365|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
47053904|NCT04322539|83325374|FG000|Overall Study|Withdrawal of consent|14|||
47053905|NCT04322539|83325375|FG001|Overall Study|Withdrawal of consent|8|||
47053906|NCT04322539|83325374|FG000|Overall Study|Death|317|||
47053907|NCT04322539|83325375|FG001|Overall Study|Death|173|||
46809913|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
46809914|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
46809915|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
46809916|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
46809917|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
46809918|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
46809919|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
46809920|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
46927056|NCT01933048|83161491|FG000|Overall Study|unknown reasons|1|||
46927057|NCT01933048|83161492|FG001|Overall Study|unknown reasons|1|||
46927058|NCT02751450|83161503|FG000|Overall Study|Adverse Event|1|||
46927059|NCT02751450|83161504|FG001|Overall Study|Adverse Event|0|||
47053908|NCT04322539|83325374|FG000|Overall Study|Adverse Event|1|||
47053909|NCT04322539|83325375|FG001|Overall Study|Adverse Event|0|||
47053910|NCT04322539|83325374|FG000|Overall Study|Lost to Follow-up|3|||
47053911|NCT04322539|83325375|FG001|Overall Study|Lost to Follow-up|0|||
47053912|NCT04322539|83325374|FG000|Overall Study|Other|2|||
47053913|NCT04322539|83325375|FG001|Overall Study|Other|3|||
47053914|NCT04322539|83325374|FG000|Overall Study|Ongoing|124|||
47053915|NCT04322539|83325375|FG001|Overall Study|Ongoing|46|||
47053916|NCT03928418|83325410|FG000|Overall Study|Lost to Follow-up|5|||
47053917|NCT03928418|83325411|FG001|Overall Study|Lost to Follow-up|3|||
47053918|NCT03928418|83325412|FG002|Overall Study|Lost to Follow-up|5|||
47053919|NCT03928418|83325410|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
47053920|NCT03928418|83325411|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
47053921|NCT03928418|83325412|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
47053922|NCT03757130|83325471|FG000|Overall Study|Lost to Follow-up|0|||
47053923|NCT03757130|83325472|FG001|Overall Study|Lost to Follow-up|0|||
47053924|NCT03757130|83325473|FG002|Overall Study|Lost to Follow-up|0|||
47053925|NCT03757130|83325474|FG003|Overall Study|Lost to Follow-up|1|||
47053926|NCT03757130|83325475|FG004|Overall Study|Lost to Follow-up|0|||
47053927|NCT03757130|83325476|FG005|Overall Study|Lost to Follow-up|0|||
47053928|NCT03757130|83325477|FG006|Overall Study|Lost to Follow-up|0|||
47053929|NCT03757130|83325478|FG007|Overall Study|Lost to Follow-up|1|||
47053930|NCT03757130|83325471|FG000|Overall Study|Withdrawal by Subject|0|||
47053931|NCT03757130|83325472|FG001|Overall Study|Withdrawal by Subject|0|||
46927060|NCT01358175|83161515|FG000|Overall Study|Death|1|||
46927061|NCT01358175|83161516|FG001|Overall Study|Death|0|||
46927062|NCT01358175|83161517|FG002|Overall Study|Death|1|||
46927063|NCT01358175|83161515|FG000|Overall Study|Withdrawal by Subject|9|||
47053932|NCT03757130|83325473|FG002|Overall Study|Withdrawal by Subject|0|||
47053933|NCT03757130|83325474|FG003|Overall Study|Withdrawal by Subject|0|||
47053934|NCT03757130|83325475|FG004|Overall Study|Withdrawal by Subject|0|||
47053935|NCT03757130|83325476|FG005|Overall Study|Withdrawal by Subject|0|||
47053936|NCT03757130|83325477|FG006|Overall Study|Withdrawal by Subject|1|||
47053937|NCT03757130|83325478|FG007|Overall Study|Withdrawal by Subject|0|||
47053938|NCT03555565|83325519|FG000|Overall Study|Case Report Forms Uncollected|2|||
47053939|NCT03555565|83325519|FG000|Overall Study|Protocol Deviation|13|||
47053940|NCT03519386|83325526|FG000|Overall Study|Withdrawal by Subject|4|||
47053941|NCT03519386|83325527|FG001|Overall Study|Withdrawal by Subject|1|||
47053942|NCT03519386|83325528|FG002|Overall Study|Withdrawal by Subject|2|||
47053943|NCT03519386|83325526|FG000|Overall Study|Physician Decision|1|||
47053944|NCT03519386|83325527|FG001|Overall Study|Physician Decision|1|||
47053945|NCT03519386|83325528|FG002|Overall Study|Physician Decision|1|||
47053946|NCT03519386|83325526|FG000|Overall Study|Lost to Follow-up|0|||
46927064|NCT01358175|83161516|FG001|Overall Study|Withdrawal by Subject|5|||
46927065|NCT01358175|83161517|FG002|Overall Study|Withdrawal by Subject|10|||
46927066|NCT01358175|83161515|FG000|Overall Study|Technical issues|0|||
46927067|NCT01358175|83161516|FG001|Overall Study|Technical issues|1|||
46927068|NCT01358175|83161517|FG002|Overall Study|Technical issues|0|||
46927069|NCT01358175|83161515|FG000|Overall Study|Pregnancy|0|||
46927070|NCT01358175|83161516|FG001|Overall Study|Pregnancy|1|||
46927071|NCT01358175|83161517|FG002|Overall Study|Pregnancy|0|||
46809921|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
46809922|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
46809923|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
46809924|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
46809925|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
46809926|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
46809927|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
46809928|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
46809929|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
46809930|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
46809931|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
46809932|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
46809933|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
46809934|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
46927072|NCT01358175|83161515|FG000|Overall Study|Physician Decision|1|||
46927073|NCT01358175|83161516|FG001|Overall Study|Physician Decision|0|||
46927074|NCT01358175|83161517|FG002|Overall Study|Physician Decision|0|||
46927075|NCT01358175|83161515|FG000|Overall Study|Non Compliance with Study Treatment|0|||
47053947|NCT03519386|83325527|FG001|Overall Study|Lost to Follow-up|1|||
47053948|NCT03519386|83325528|FG002|Overall Study|Lost to Follow-up|1|||
47053949|NCT03519386|83325526|FG000|Overall Study|Death|1|||
47053950|NCT03519386|83325527|FG001|Overall Study|Death|0|||
47053951|NCT03519386|83325528|FG002|Overall Study|Death|4|||
47053952|NCT03519386|83325526|FG000|Overall Study|Adverse Event|2|||
47053953|NCT03519386|83325527|FG001|Overall Study|Adverse Event|1|||
47053954|NCT03519386|83325528|FG002|Overall Study|Adverse Event|2|||
47053955|NCT03519386|83325526|FG000|Overall Study|Explanted|2|||
47053956|NCT03519386|83325527|FG001|Overall Study|Explanted|1|||
47053957|NCT03519386|83325528|FG002|Overall Study|Explanted|0|||
47053958|NCT03519386|83325526|FG000|Overall Study|Ongoing in study|190|||
46753840|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753841|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753842|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753843|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753844|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753845|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
46927076|NCT01358175|83161516|FG001|Overall Study|Non Compliance with Study Treatment|1|||
46927077|NCT01358175|83161517|FG002|Overall Study|Non Compliance with Study Treatment|1|||
46927078|NCT01358175|83161515|FG000|Overall Study|Lost to Follow-up|1|||
46927079|NCT01358175|83161516|FG001|Overall Study|Lost to Follow-up|1|||
46927080|NCT01358175|83161517|FG002|Overall Study|Lost to Follow-up|3|||
46753846|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753847|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753848|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753849|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753850|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753851|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
46809935|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
46809936|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
46927081|NCT01358175|83161515|FG000|Overall Study|Lack of Efficacy|3|||
46927082|NCT01358175|83161516|FG001|Overall Study|Lack of Efficacy|8|||
46927083|NCT01358175|83161517|FG002|Overall Study|Lack of Efficacy|6|||
46927084|NCT01358175|83161515|FG000|Overall Study|Adverse Event|6|||
47053959|NCT03519386|83325527|FG001|Overall Study|Ongoing in study|192|||
47053960|NCT03519386|83325528|FG002|Overall Study|Ongoing in study|183|||
47053961|NCT03369665|83325545|FG000|Overall Study|Adverse Event|3|||
47053962|NCT03369665|83325545|FG000|Overall Study|Lost to Follow-up|7|||
47053963|NCT03369665|83325545|FG000|Overall Study|Withdrawal by Subject|15|||
47053964|NCT03369665|83325545|FG000|Overall Study|Progression Disease|2|||
47053965|NCT03369665|83325545|FG000|Overall Study|Not classified|3|||
47053966|NCT03304249|83325562|FG000|Overall Study|Lost to Follow-up|8|||
47053967|NCT03304249|83325563|FG001|Overall Study|Lost to Follow-up|10|||
47053968|NCT03304249|83325562|FG000|Overall Study|Withdrawal by Subject|12|||
47053969|NCT03304249|83325563|FG001|Overall Study|Withdrawal by Subject|2|||
46809937|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
46809938|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
46809939|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
46809940|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
46809941|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
46809942|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
46809943|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
46809944|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
46809945|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
46809946|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
46809947|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
46809948|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
46809949|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
46809950|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
46809951|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
46809952|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
46809953|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
46809954|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
46809955|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
46809956|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
46809957|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
46809958|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
46927085|NCT01358175|83161516|FG001|Overall Study|Adverse Event|11|||
46927086|NCT01358175|83161517|FG002|Overall Study|Adverse Event|11|||
46753852|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753853|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753854|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753855|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753856|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753857|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753858|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
46753859|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
46753860|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753861|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753862|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
46753863|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753864|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753865|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753866|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753867|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753868|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753869|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753870|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753871|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753872|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753873|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753874|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753875|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753876|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753877|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753878|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753879|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753880|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753881|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753882|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753883|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
46809959|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
46809960|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
46809961|NCT00528372|83029212|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
46809962|NCT00528372|83029213|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
46809963|NCT00528372|83029214|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
46809964|NCT00528372|83029215|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
46809965|NCT00528372|83029216|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
46809966|NCT00528372|83029217|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
46809967|NCT00528372|83029218|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
46809968|NCT00528372|83029219|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
46809969|NCT00528372|83029220|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
46809970|NCT00527982|83029268|FG000|Overall Study|Physician Decision|1|||
46809971|NCT00527982|83029269|FG001|Overall Study|Physician Decision|0|||
46809972|NCT00527904|83029275|FG000|Overall Study|Adverse Event|45|||
46809973|NCT00527904|83029275|FG000|Overall Study|Withdrawal by Subject|21|||
46809974|NCT00527904|83029275|FG000|Overall Study|Lost to Follow-up|8|||
46809975|NCT00527904|83029275|FG000|Overall Study|misc|22|||
46809976|NCT00619619|83029287|FG000|Overall Study|Physician Decision|0|||
46809977|NCT00619619|83029288|FG001|Overall Study|Physician Decision|0|||
46809978|NCT00619619|83029289|FG002|Overall Study|Physician Decision|1|||
46809979|NCT00619619|83029290|FG003|Overall Study|Physician Decision|0|||
46809980|NCT00619619|83029291|FG004|Overall Study|Physician Decision|0|||
46809981|NCT00619619|83029292|FG005|Overall Study|Physician Decision|0|||
46809982|NCT00619619|83029293|FG006|Overall Study|Physician Decision|0|||
46809983|NCT00619619|83029294|FG007|Overall Study|Physician Decision|0|||
46809984|NCT00619619|83029287|FG000|Overall Study|Protocol Violation|0|||
46809985|NCT00619619|83029288|FG001|Overall Study|Protocol Violation|0|||
46809986|NCT00619619|83029289|FG002|Overall Study|Protocol Violation|0|||
46809987|NCT00619619|83029290|FG003|Overall Study|Protocol Violation|1|||
46809988|NCT00619619|83029291|FG004|Overall Study|Protocol Violation|0|||
46809989|NCT00619619|83029292|FG005|Overall Study|Protocol Violation|0|||
46753884|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753885|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753886|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753887|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
46753888|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Adverse Event|0|||
46753889|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Adverse Event|0|||
46753890|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Adverse Event|0|||
46753891|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Adverse Event|0|||
46753892|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Adverse Event|0|||
46753893|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Adverse Event|0|||
46753894|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Adverse Event|0|||
46753895|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Adverse Event|0|||
46753896|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Adverse Event|0|||
46753897|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Adverse Event|0|||
46753898|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Adverse Event|0|||
46753899|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Adverse Event|0|||
46753900|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Adverse Event|0|||
46753901|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Adverse Event|0|||
46753902|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Adverse Event|0|||
46753903|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Adverse Event|0|||
46753904|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Adverse Event|0|||
46753905|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Adverse Event|0|||
46753906|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Adverse Event|0|||
46753907|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Adverse Event|0|||
46753908|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Adverse Event|0|||
46753909|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Adverse Event|0|||
46809990|NCT00619619|83029293|FG006|Overall Study|Protocol Violation|1|||
46809991|NCT00619619|83029294|FG007|Overall Study|Protocol Violation|1|||
46809992|NCT00619619|83029287|FG000|Overall Study|Adverse Event|0|||
46809993|NCT00619619|83029288|FG001|Overall Study|Adverse Event|0|||
46809994|NCT00619619|83029289|FG002|Overall Study|Adverse Event|0|||
46927087|NCT04116229|83161531|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
46809995|NCT00619619|83029290|FG003|Overall Study|Adverse Event|0|||
46809996|NCT00619619|83029291|FG004|Overall Study|Adverse Event|2|||
46927088|NCT04116229|83161532|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
47053970|NCT03304249|83325562|FG000|Overall Study|Moved Out of District|4|||
46753910|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Adverse Event|0|||
46809997|NCT00619619|83029292|FG005|Overall Study|Adverse Event|0|||
46809998|NCT00619619|83029293|FG006|Overall Study|Adverse Event|0|||
46809999|NCT00619619|83029294|FG007|Overall Study|Adverse Event|2|||
46753911|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Adverse Event|1|||
46753912|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Adverse Event|0|||
46810000|NCT00527826|83029317|FG000|Overall Study|Adverse Event|10|||
46810001|NCT00527826|83029318|FG001|Overall Study|Adverse Event|10|||
46810002|NCT00527826|83029317|FG000|Overall Study|Lost to Follow-up|3|||
46810003|NCT00527826|83029318|FG001|Overall Study|Lost to Follow-up|2|||
46810004|NCT00527826|83029317|FG000|Overall Study|Withdrawal by Subject|5|||
46810005|NCT00527826|83029318|FG001|Overall Study|Withdrawal by Subject|8|||
46810006|NCT00527826|83029317|FG000|Overall Study|Inclusion Criteria Not Met|3|||
46810007|NCT00527826|83029318|FG001|Overall Study|Inclusion Criteria Not Met|3|||
46810008|NCT00527826|83029317|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
46810009|NCT00527826|83029318|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
46810010|NCT00527826|83029317|FG000|Overall Study|Additional Intake of Viani forte|0|||
47053971|NCT03304249|83325563|FG001|Overall Study|Moved Out of District|2|||
47053972|NCT03181893|83325619|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053973|NCT03181893|83325620|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
47053974|NCT03181893|83325621|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053975|NCT03181893|83325622|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
46636315|NCT01489254|82810134|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
46636316|NCT01489254|82810131|FG000|Open-label Extension Part|Protocol Violation|0|||
46636317|NCT01489254|82810132|FG001|Open-label Extension Part|Protocol Violation|0|||
46636318|NCT01489254|82810133|FG002|Open-label Extension Part|Protocol Violation|0|||
46753913|NCT02393248|82971601|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753914|NCT02393248|82971602|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753915|NCT02393248|82971603|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753916|NCT02393248|82971604|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753917|NCT02393248|82971605|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753918|NCT02393248|82971606|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753919|NCT02393248|82971607|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46810011|NCT00527826|83029318|FG001|Overall Study|Additional Intake of Viani forte|1|||
46810012|NCT00527826|83029317|FG000|Overall Study|Participant moved away|0|||
46810013|NCT00527826|83029318|FG001|Overall Study|Participant moved away|1|||
47053976|NCT03181893|83325623|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053977|NCT03181893|83325624|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
46927089|NCT04116229|83161531|FG000|Overall Study|Scheduling not possible.|0|||
46927090|NCT04116229|83161532|FG001|Overall Study|Scheduling not possible.|1|||
46927091|NCT02210832|83161541|FG000|Overall Study|Pregnancy termination .|3|||
46927092|NCT02210832|83161542|FG001|Overall Study|Pregnancy termination .|4|||
46927093|NCT02210832|83161543|FG002|Overall Study|Pregnancy termination .|1|||
46927094|NCT02210832|83161541|FG000|Overall Study|Lost to Follow-up|26|||
46927095|NCT02210832|83161542|FG001|Overall Study|Lost to Follow-up|32|||
46927096|NCT02210832|83161543|FG002|Overall Study|Lost to Follow-up|17|||
46927097|NCT02833077|83161556|FG000|Overall Study|Adverse Event|1|||
46927098|NCT02833077|83161557|FG001|Overall Study|Adverse Event|2|||
46927099|NCT02833077|83161556|FG000|Overall Study|Lost to Follow-up|10|||
46927100|NCT02833077|83161557|FG001|Overall Study|Lost to Follow-up|1|||
46927101|NCT02833077|83161556|FG000|Overall Study|Personal Reasons|6|||
46927102|NCT02833077|83161557|FG001|Overall Study|Personal Reasons|4|||
46927103|NCT02833077|83161556|FG000|Overall Study|Protocol Deviation|0|||
46927104|NCT02833077|83161557|FG001|Overall Study|Protocol Deviation|1|||
46927105|NCT01355679|83161564|FG000|Overall Study|benign tumor types found at biopsy|2|||
46927106|NCT02832375|83161571|FG000|Overall Study|Lost to Follow-up|1|||
46927107|NCT02832375|83161572|FG001|Overall Study|Lost to Follow-up|0|||
46927108|NCT02832375|83161571|FG000|Overall Study|Withdrawal of Consent|1|||
46927109|NCT02832375|83161572|FG001|Overall Study|Withdrawal of Consent|0|||
46927110|NCT02925403|83161581|FG000|Overall Study|Lost to Follow-up|0|||
46927111|NCT02925403|83161582|FG001|Overall Study|Lost to Follow-up|1|||
46927112|NCT02626780|83161588|FG000|Overall Study|Withdrawal by Subject|3|||
46927113|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
46927114|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
46927115|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
46927116|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
46927117|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
47053978|NCT03181893|83325625|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053979|NCT03181893|83325626|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053980|NCT03181893|83325627|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053981|NCT03181893|83325628|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053982|NCT03181893|83325629|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
47053983|NCT03181893|83325619|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
47053984|NCT03181893|83325620|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
47053985|NCT03181893|83325621|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053986|NCT03181893|83325622|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053987|NCT03181893|83325623|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053988|NCT03181893|83325624|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053989|NCT03181893|83325625|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053990|NCT03181893|83325626|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053991|NCT03181893|83325627|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053992|NCT03181893|83325628|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053993|NCT03181893|83325629|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
47053994|NCT03181893|83325619|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47053995|NCT03181893|83325620|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47053996|NCT03181893|83325621|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47053997|NCT03181893|83325622|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47053998|NCT03181893|83325623|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47053999|NCT03181893|83325624|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47054000|NCT03181893|83325625|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47054001|NCT03181893|83325626|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
47054002|NCT03181893|83325627|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
47054003|NCT03181893|83325628|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47054004|NCT03181893|83325629|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
47054005|NCT03181893|83325619|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054006|NCT03181893|83325620|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054007|NCT03181893|83325621|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054008|NCT03181893|83325622|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054009|NCT03181893|83325623|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054010|NCT03181893|83325624|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054011|NCT03181893|83325625|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054012|NCT03181893|83325626|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054013|NCT03181893|83325627|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
46927118|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
47054014|NCT03181893|83325628|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
47054015|NCT03181893|83325629|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
47054016|NCT03181893|83325619|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
46927119|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
46927120|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
46927121|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
46927122|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
46927123|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
46927124|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
46927125|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
46927126|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
46927127|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
46927128|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
46927129|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
46927130|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
46927131|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
46927132|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
46927133|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
46927134|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
46927135|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
46927136|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
46927137|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
46927138|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
46927139|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
46927140|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
46927141|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
46927142|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
46927143|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
46927144|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
46927145|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
46927146|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
46927147|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
46927148|NCT02831673|83161603|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
46927149|NCT02831673|83161604|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
46927150|NCT02831673|83161605|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
46927151|NCT02831673|83161606|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
46927152|NCT02831673|83161607|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
46636319|NCT01489254|82810134|FG003|Open-label Extension Part|Protocol Violation|1|||
46636320|NCT01489254|82810131|FG000|Open-label Extension Part|Lost to Follow-up|0|||
46636321|NCT01489254|82810132|FG001|Open-label Extension Part|Lost to Follow-up|0|||
46636322|NCT01489254|82810133|FG002|Open-label Extension Part|Lost to Follow-up|0|||
46636323|NCT01489254|82810134|FG003|Open-label Extension Part|Lost to Follow-up|9|||
46636324|NCT01489254|82810131|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
46636325|NCT01489254|82810132|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
46810014|NCT00527748|83029327|FG000|Overall Study|Other|3|||
46927153|NCT02831673|83161603|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
46927154|NCT02831673|83161604|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
46927155|NCT02831673|83161605|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
46927156|NCT02831673|83161606|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
46927157|NCT02831673|83161607|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
46927158|NCT02831673|83161603|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
46927159|NCT02831673|83161604|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
46927160|NCT02831673|83161605|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
46927161|NCT02831673|83161606|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
46927162|NCT02831673|83161607|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
46927163|NCT02831673|83161603|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
46927164|NCT02831673|83161604|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
46927165|NCT02831673|83161605|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
46927166|NCT02831673|83161606|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
46927167|NCT02831673|83161607|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
46927168|NCT02831673|83161603|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
46927169|NCT02831673|83161604|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
46927170|NCT02831673|83161605|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
46927171|NCT02831673|83161606|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
46927172|NCT02831673|83161607|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
46927173|NCT02831673|83161603|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
46927174|NCT02831673|83161604|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
46810015|NCT00619385|83029334|FG000|Overall Study|Adverse Event|0|||
46927175|NCT02831673|83161605|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
46927176|NCT02831673|83161606|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
46927177|NCT02831673|83161607|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
46927178|NCT02831673|83161603|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
46927179|NCT02831673|83161604|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
46927180|NCT02831673|83161605|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
46927181|NCT02831673|83161606|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
46927182|NCT02831673|83161607|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
46927183|NCT02831673|83161603|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
46927184|NCT02831673|83161604|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
46927185|NCT02831673|83161605|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
46927186|NCT02831673|83161606|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
46927187|NCT02831673|83161607|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
46927188|NCT02831673|83161603|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
46927189|NCT02831673|83161604|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
46927190|NCT02831673|83161605|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
46927191|NCT02831673|83161606|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
46927192|NCT02831673|83161607|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
46927193|NCT02831673|83161603|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46927194|NCT02831673|83161604|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46927195|NCT02831673|83161605|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46927196|NCT02831673|83161606|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
46927197|NCT02831673|83161607|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
46927198|NCT02831673|83161603|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46927199|NCT02831673|83161604|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46927200|NCT02831673|83161605|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46927201|NCT02831673|83161606|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
46927202|NCT02831673|83161607|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
46927203|NCT02831673|83161603|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46927204|NCT02831673|83161604|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46927205|NCT02831673|83161605|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46927206|NCT02831673|83161606|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
46927207|NCT02831673|83161607|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
46927208|NCT02831673|83161603|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
46927209|NCT02831673|83161604|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
46927210|NCT02831673|83161605|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
46927211|NCT02831673|83161606|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
46927212|NCT02831673|83161607|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
46927213|NCT02830893|83161625|FG000|Overall Study|Relocation to out of the country|1|||
46927214|NCT02830893|83161626|FG001|Overall Study|Relocation to out of the country|0|||
46927215|NCT02830893|83161625|FG000|Overall Study|Lost to Follow-up|0|||
46927216|NCT02830893|83161626|FG001|Overall Study|Lost to Follow-up|2|||
46927217|NCT02830893|83161625|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
46927218|NCT02830893|83161626|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
46927219|NCT02625922|83161634|FG000|Overall Study|Non-availability of IMP|1|||
46927220|NCT02625922|83161635|FG001|Overall Study|Non-availability of IMP|1|||
46927221|NCT02625922|83161634|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
46927222|NCT02625922|83161635|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
46636326|NCT01489254|82810133|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
46636327|NCT01489254|82810134|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
46636328|NCT01489020|82810149|FG000|Overall Study|Withdrawal by Subject|1|||
46636329|NCT01489020|82810150|FG001|Overall Study|Withdrawal by Subject|0|||
46753920|NCT02393248|82971608|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753921|NCT02393248|82971609|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753922|NCT02393248|82971610|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46927223|NCT03350035|83161647|FG000|Overall Study|Lack of Efficacy|2|||
46927224|NCT03350035|83161648|FG001|Overall Study|Lack of Efficacy|0|||
46927225|NCT03350035|83161649|FG002|Overall Study|Lack of Efficacy|0|||
46636330|NCT01489020|82810151|FG002|Overall Study|Withdrawal by Subject|0|||
47054017|NCT03181893|83325620|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054018|NCT03181893|83325621|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054019|NCT03181893|83325622|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054020|NCT03181893|83325623|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054021|NCT03181893|83325624|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054022|NCT03181893|83325625|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054023|NCT03181893|83325626|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054024|NCT03181893|83325627|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054025|NCT03181893|83325628|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
47054026|NCT03181893|83325629|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
47054027|NCT03180840|83325654|FG000|Overall Study|Withdrawal by Subject|1|||
47054028|NCT03064035|83325665|FG000|Overall Study|Did not receive allocated intervention|4|||
47054029|NCT03064035|83325666|FG001|Overall Study|Did not receive allocated intervention|2|||
47054030|NCT03064035|83325665|FG000|Overall Study|Lost to Follow-up|1|||
47054031|NCT03064035|83325666|FG001|Overall Study|Lost to Follow-up|1|||
47054032|NCT03014206|83325679|FG000|Overall Study|Registration Violation|12|||
47054033|NCT02822573|83325694|FG000|Overall Study|Lost to Follow-up|5|||
47054034|NCT02822573|83325695|FG001|Overall Study|Lost to Follow-up|3|||
46636331|NCT01489020|82810152|FG003|Overall Study|Withdrawal by Subject|0|||
46636332|NCT01489020|82810153|FG004|Overall Study|Withdrawal by Subject|0|||
46927226|NCT03350035|83161647|FG000|Overall Study|Subject discharged to hospice|0|||
46927227|NCT03350035|83161648|FG001|Overall Study|Subject discharged to hospice|0|||
46636333|NCT01489020|82810154|FG005|Overall Study|Withdrawal by Subject|0|||
46753923|NCT02393248|82971611|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46927228|NCT03350035|83161649|FG002|Overall Study|Subject discharged to hospice|1|||
46927229|NCT01358331|83161683|FG000|Overall Study|Lost to Follow-up|0|||
46927230|NCT01358331|83161684|FG001|Overall Study|Lost to Follow-up|0|||
46927231|NCT01358331|83161685|FG002|Overall Study|Lost to Follow-up|0|||
46927232|NCT01358331|83161686|FG003|Overall Study|Lost to Follow-up|1|||
46927233|NCT01358331|83161687|FG004|Overall Study|Lost to Follow-up|0|||
46927234|NCT01358331|83161688|FG005|Overall Study|Lost to Follow-up|0|||
46927235|NCT01358331|83161683|FG000|Overall Study|Withdrawal by Subject|0|||
46927236|NCT01358331|83161684|FG001|Overall Study|Withdrawal by Subject|0|||
46927237|NCT01358331|83161685|FG002|Overall Study|Withdrawal by Subject|0|||
46927238|NCT01358331|83161686|FG003|Overall Study|Withdrawal by Subject|1|||
46927239|NCT01358331|83161687|FG004|Overall Study|Withdrawal by Subject|1|||
46927240|NCT01358331|83161688|FG005|Overall Study|Withdrawal by Subject|1|||
46927241|NCT01358331|83161683|FG000|Overall Study|Adverse Events|1|||
46927242|NCT01358331|83161684|FG001|Overall Study|Adverse Events|1|||
46927243|NCT01358331|83161685|FG002|Overall Study|Adverse Events|1|||
46927244|NCT01358331|83161686|FG003|Overall Study|Adverse Events|0|||
46927245|NCT01358331|83161687|FG004|Overall Study|Adverse Events|1|||
46927246|NCT01358331|83161688|FG005|Overall Study|Adverse Events|5|||
46927247|NCT01358331|83161683|FG000|Overall Study|Symptomatic Deterioration|0|||
46927248|NCT01358331|83161684|FG001|Overall Study|Symptomatic Deterioration|0|||
46927249|NCT01358331|83161685|FG002|Overall Study|Symptomatic Deterioration|0|||
46927250|NCT01358331|83161686|FG003|Overall Study|Symptomatic Deterioration|0|||
46927251|NCT01358331|83161687|FG004|Overall Study|Symptomatic Deterioration|1|||
46927252|NCT01358331|83161688|FG005|Overall Study|Symptomatic Deterioration|0|||
46753924|NCT02393248|82971612|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753925|NCT02393248|82971613|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753926|NCT02393248|82971614|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753927|NCT02393248|82971615|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46775759|NCT00793793|82994204|FG000|Overall Study|Withdrawal by Subject|0|||
46927253|NCT01358331|83161683|FG000|Overall Study|Participants did not wish to continue|0|||
46927254|NCT01358331|83161684|FG001|Overall Study|Participants did not wish to continue|0|||
47054035|NCT02822573|83325694|FG000|Overall Study|Physician Decision|1|||
47054036|NCT02822573|83325695|FG001|Overall Study|Physician Decision|1|||
46636334|NCT01489020|82810149|FG000|Overall Study|Adverse Event|0|||
46927255|NCT01358331|83161685|FG002|Overall Study|Participants did not wish to continue|0|||
46927256|NCT01358331|83161686|FG003|Overall Study|Participants did not wish to continue|0|||
46927257|NCT01358331|83161687|FG004|Overall Study|Participants did not wish to continue|1|||
47054037|NCT02822573|83325694|FG000|Overall Study|Withdrawal by Subject|9|||
46636335|NCT01489020|82810150|FG001|Overall Study|Adverse Event|0|||
46810016|NCT00619385|83029335|FG001|Overall Study|Adverse Event|0|||
46810017|NCT00619385|83029336|FG002|Overall Study|Adverse Event|3|||
46810018|NCT00619385|83029334|FG000|Overall Study|Other|1|||
46810019|NCT00619385|83029335|FG001|Overall Study|Other|2|||
46810020|NCT00619385|83029336|FG002|Overall Study|Other|1|||
46810021|NCT00619307|83029349|FG000|Overall Study|Adverse Event|0|||
46810022|NCT00619307|83029350|FG001|Overall Study|Adverse Event|1|||
46810023|NCT00619307|83029349|FG000|Overall Study|Lost to Follow-up|0|||
46810024|NCT00619307|83029350|FG001|Overall Study|Lost to Follow-up|1|||
46810025|NCT00619307|83029349|FG000|Overall Study|Protocol Violation|3|||
46810026|NCT00619307|83029350|FG001|Overall Study|Protocol Violation|0|||
46810027|NCT00619307|83029349|FG000|Overall Study|Withdrew consent|1|||
46810028|NCT00619307|83029350|FG001|Overall Study|Withdrew consent|0|||
46810029|NCT00619307|83029349|FG000|Overall Study|Severe migraine|0|||
46810030|NCT00619307|83029350|FG001|Overall Study|Severe migraine|1|||
46810031|NCT00619307|83029349|FG000|Overall Study|MS attack plus steroids|0|||
46810032|NCT00619307|83029350|FG001|Overall Study|MS attack plus steroids|1|||
46810033|NCT00619229|83029358|FG000|Overall Study|Withdrawal by Subject|1|||
46810034|NCT00619229|83029359|FG001|Overall Study|Withdrawal by Subject|1|||
46810035|NCT00619229|83029358|FG000|Overall Study|Lost to Follow-up|1|||
46810036|NCT00619229|83029359|FG001|Overall Study|Lost to Follow-up|0|||
46810037|NCT00619229|83029358|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
46810038|NCT00619229|83029359|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
46810039|NCT00619229|83029358|FG000|Overall Study|Investigator planned Cataract Operation|1|||
46810040|NCT00619229|83029359|FG001|Overall Study|Investigator planned Cataract Operation|0|||
46810041|NCT00619151|83029367|FG000|Overall Study|Study terminated prior to followup|1|||
46810042|NCT00619151|83029368|FG001|Overall Study|Study terminated prior to followup|0|||
46810043|NCT00618995|83029374|FG000|Period 1|Adverse Event|0|||
46810044|NCT00618995|83029375|FG001|Period 1|Adverse Event|0|||
46810045|NCT00618995|83029376|FG002|Period 1|Adverse Event|1|||
46810046|NCT00618995|83029377|FG003|Period 1|Adverse Event|0|||
46810047|NCT00618995|83029374|FG000|Period 1|Protocol Violation|0|||
46810048|NCT00618995|83029375|FG001|Period 1|Protocol Violation|1|||
46810049|NCT00618995|83029376|FG002|Period 1|Protocol Violation|1|||
46810050|NCT00618995|83029377|FG003|Period 1|Protocol Violation|0|||
46810051|NCT00618995|83029374|FG000|Period 2|Protocol Violation|0|||
46810052|NCT00618995|83029375|FG001|Period 2|Protocol Violation|0|||
46810053|NCT00618995|83029376|FG002|Period 2|Protocol Violation|1|||
46810054|NCT00618995|83029377|FG003|Period 2|Protocol Violation|0|||
46810055|NCT00618995|83029374|FG000|Period 4|Adverse Event|1|||
46810056|NCT00618995|83029375|FG001|Period 4|Adverse Event|0|||
46810057|NCT00618995|83029376|FG002|Period 4|Adverse Event|0|||
46810058|NCT00618995|83029377|FG003|Period 4|Adverse Event|0|||
46810059|NCT03685344|83029391|FG000|Overall Study|Withdrawal by Subject|1|||
46810060|NCT03685344|83029392|FG001|Overall Study|Withdrawal by Subject|1|||
46810061|NCT03685344|83029393|FG002|Overall Study|Withdrawal by Subject|2|||
46810062|NCT03685344|83029394|FG003|Overall Study|Withdrawal by Subject|0|||
46810063|NCT03685344|83029391|FG000|Overall Study|Physician Decision|1|||
46810064|NCT03685344|83029392|FG001|Overall Study|Physician Decision|1|||
46810065|NCT03685344|83029393|FG002|Overall Study|Physician Decision|5|||
46810066|NCT03685344|83029394|FG003|Overall Study|Physician Decision|0|||
46810067|NCT03685344|83029391|FG000|Overall Study|Death|1|||
46810068|NCT03685344|83029392|FG001|Overall Study|Death|1|||
46810069|NCT03685344|83029393|FG002|Overall Study|Death|0|||
46810070|NCT03685344|83029394|FG003|Overall Study|Death|0|||
46810071|NCT00520572|83029410|FG000|Overall Study|Adverse Event|9|||
46810072|NCT00520572|83029411|FG001|Overall Study|Adverse Event|3|||
46810073|NCT00520572|83029412|FG002|Overall Study|Adverse Event|6|||
46810074|NCT00520572|83029413|FG003|Overall Study|Adverse Event|9|||
46810075|NCT00520572|83029414|FG004|Overall Study|Adverse Event|7|||
46810076|NCT00520572|83029415|FG005|Overall Study|Adverse Event|2|||
46810077|NCT00520572|83029410|FG000|Overall Study|Withdrawal by Subject|0|||
46810078|NCT00520572|83029411|FG001|Overall Study|Withdrawal by Subject|9|||
46810079|NCT00520572|83029412|FG002|Overall Study|Withdrawal by Subject|5|||
46810080|NCT00520572|83029413|FG003|Overall Study|Withdrawal by Subject|2|||
46810081|NCT00520572|83029414|FG004|Overall Study|Withdrawal by Subject|2|||
46810082|NCT00520572|83029415|FG005|Overall Study|Withdrawal by Subject|0|||
46810083|NCT00520572|83029410|FG000|Overall Study|Protocol Violation|0|||
46810084|NCT00520572|83029411|FG001|Overall Study|Protocol Violation|0|||
46810085|NCT00520572|83029412|FG002|Overall Study|Protocol Violation|1|||
46810086|NCT00520572|83029413|FG003|Overall Study|Protocol Violation|0|||
46810087|NCT00520572|83029414|FG004|Overall Study|Protocol Violation|0|||
46636336|NCT01489020|82810151|FG002|Overall Study|Adverse Event|3|||
46810088|NCT00520572|83029415|FG005|Overall Study|Protocol Violation|0|||
46810089|NCT00520572|83029410|FG000|Overall Study|Lack of Efficacy|1|||
46810090|NCT00520572|83029411|FG001|Overall Study|Lack of Efficacy|1|||
46810091|NCT00520572|83029412|FG002|Overall Study|Lack of Efficacy|1|||
46810092|NCT00520572|83029413|FG003|Overall Study|Lack of Efficacy|2|||
46810093|NCT00520572|83029414|FG004|Overall Study|Lack of Efficacy|1|||
46810094|NCT00520572|83029415|FG005|Overall Study|Lack of Efficacy|0|||
46810095|NCT00520572|83029410|FG000|Overall Study|Lost to Follow-up|0|||
46810096|NCT00520572|83029411|FG001|Overall Study|Lost to Follow-up|0|||
46810097|NCT00520572|83029412|FG002|Overall Study|Lost to Follow-up|0|||
46810098|NCT00520572|83029413|FG003|Overall Study|Lost to Follow-up|0|||
46810099|NCT00520572|83029414|FG004|Overall Study|Lost to Follow-up|1|||
46810100|NCT00520572|83029415|FG005|Overall Study|Lost to Follow-up|0|||
46810101|NCT00520572|83029410|FG000|Overall Study|Incorrect enrollment|1|||
46810102|NCT00520572|83029411|FG001|Overall Study|Incorrect enrollment|0|||
46810103|NCT00520572|83029412|FG002|Overall Study|Incorrect enrollment|1|||
46810104|NCT00520572|83029413|FG003|Overall Study|Incorrect enrollment|0|||
46810105|NCT00520572|83029414|FG004|Overall Study|Incorrect enrollment|1|||
46810106|NCT00520572|83029415|FG005|Overall Study|Incorrect enrollment|0|||
46810107|NCT00520572|83029410|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
46810108|NCT00520572|83029411|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
46810109|NCT00520572|83029412|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
46810110|NCT00520572|83029413|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
46810111|NCT00520572|83029414|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
46927258|NCT01358331|83161688|FG005|Overall Study|Participants did not wish to continue|0|||
46927259|NCT01358331|83161683|FG000|Overall Study|Progress of disease under investigation|1|||
46927260|NCT01358331|83161684|FG001|Overall Study|Progress of disease under investigation|2|||
46927261|NCT01358331|83161685|FG002|Overall Study|Progress of disease under investigation|3|||
46927262|NCT01358331|83161686|FG003|Overall Study|Progress of disease under investigation|1|||
46927263|NCT01358331|83161687|FG004|Overall Study|Progress of disease under investigation|3|||
46927264|NCT01358331|83161688|FG005|Overall Study|Progress of disease under investigation|0|||
46927265|NCT02828241|83161704|FG000|Overall Study|Adverse Event|7|||
46927266|NCT02828241|83161705|FG001|Overall Study|Adverse Event|2|||
46810112|NCT00520572|83029415|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
46810113|NCT00520572|83029410|FG000|Overall Study|Long break in taking Medication|0|||
46810114|NCT00520572|83029411|FG001|Overall Study|Long break in taking Medication|0|||
46810115|NCT00520572|83029412|FG002|Overall Study|Long break in taking Medication|0|||
46810116|NCT00520572|83029413|FG003|Overall Study|Long break in taking Medication|1|||
46810117|NCT00520572|83029414|FG004|Overall Study|Long break in taking Medication|0|||
46810118|NCT00520572|83029415|FG005|Overall Study|Long break in taking Medication|0|||
46810119|NCT00520572|83029410|FG000|Overall Study|Did not receive Treatment|1|||
46810120|NCT00520572|83029411|FG001|Overall Study|Did not receive Treatment|0|||
46810121|NCT00520572|83029412|FG002|Overall Study|Did not receive Treatment|1|||
46810122|NCT00520572|83029413|FG003|Overall Study|Did not receive Treatment|0|||
46810123|NCT00520572|83029414|FG004|Overall Study|Did not receive Treatment|0|||
46810124|NCT00520572|83029415|FG005|Overall Study|Did not receive Treatment|0|||
46810125|NCT00573833|83029429|FG000|Overall Study|Not Treated|2|||
46810126|NCT00520494|83029433|FG000|Overall Study|Withdrawal by Subject|1|||
46810127|NCT00527514|83029437|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
46810128|NCT00527514|83029437|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
46810129|NCT00527514|83029437|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
46810130|NCT00527514|83029437|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
46810131|NCT00527514|83029437|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
46810132|NCT00527514|83029437|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
46810133|NCT00527514|83029437|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
46810134|NCT00618449|83029450|FG000|Overall Study|Lost to Follow-up|98|||
46810135|NCT00618449|83029451|FG001|Overall Study|Lost to Follow-up|110|||
46810136|NCT03684642|83029460|FG000|Overall Study|Adverse Event|6|||
46810137|NCT03684642|83029461|FG001|Overall Study|Adverse Event|15|||
46810138|NCT03684642|83029462|FG002|Overall Study|Adverse Event|11|||
46810139|NCT03684642|83029460|FG000|Overall Study|Withdrawal by Subject|35|||
46810140|NCT03684642|83029461|FG001|Overall Study|Withdrawal by Subject|53|||
46810141|NCT03684642|83029462|FG002|Overall Study|Withdrawal by Subject|23|||
46927267|NCT02828241|83161704|FG000|Overall Study|Protocol Violation|1|||
46927268|NCT02828241|83161705|FG001|Overall Study|Protocol Violation|0|||
47054038|NCT02822573|83325695|FG001|Overall Study|Withdrawal by Subject|5|||
47054039|NCT02822573|83325694|FG000|Overall Study|Protocol Violation|6|||
47054040|NCT02822573|83325695|FG001|Overall Study|Protocol Violation|4|||
46810142|NCT03684642|83029460|FG000|Overall Study|Lack of Efficacy|0|||
46810143|NCT03684642|83029461|FG001|Overall Study|Lack of Efficacy|0|||
46810144|NCT03684642|83029462|FG002|Overall Study|Lack of Efficacy|1|||
46810145|NCT03684642|83029460|FG000|Overall Study|Poor compliance to protocol|0|||
46810146|NCT03684642|83029461|FG001|Overall Study|Poor compliance to protocol|4|||
46810147|NCT03684642|83029462|FG002|Overall Study|Poor compliance to protocol|1|||
46810148|NCT03684642|83029460|FG000|Overall Study|Other than specified|62|||
46927269|NCT01355523|83161714|FG000|Overall Study|Withdrawal by Subject|1|||
46927270|NCT01355523|83161715|FG001|Overall Study|Withdrawal by Subject|4|||
46927271|NCT01355523|83161714|FG000|Overall Study|Lost to Follow-up|0|||
46927272|NCT01355523|83161715|FG001|Overall Study|Lost to Follow-up|2|||
47054041|NCT02822573|83325694|FG000|Overall Study|Too sick or ill|2|||
46810149|NCT03684642|83029461|FG001|Overall Study|Other than specified|60|||
46810150|NCT03684642|83029462|FG002|Overall Study|Other than specified|67|||
46810151|NCT03684642|83029460|FG000|Overall Study|Randomized and not treated|0|||
46810152|NCT03684642|83029461|FG001|Overall Study|Randomized and not treated|0|||
46810153|NCT03684642|83029462|FG002|Overall Study|Randomized and not treated|1|||
46810154|NCT03684642|83029460|FG000|Overall Study|Missing completion status but alive at last contact|0|||
46810155|NCT03684642|83029461|FG001|Overall Study|Missing completion status but alive at last contact|1|||
46810156|NCT03684642|83029462|FG002|Overall Study|Missing completion status but alive at last contact|2|||
46810157|NCT00519636|83029474|FG000|Treatment Period 1|Adverse Event|1|||
46810158|NCT00519636|83029475|FG001|Treatment Period 1|Adverse Event|0|||
46810159|NCT00519636|83029476|FG002|Treatment Period 1|Adverse Event|1|||
46810160|NCT00519636|83029477|FG003|Treatment Period 1|Adverse Event|0|||
46810161|NCT00519636|83029474|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
46810162|NCT00519636|83029475|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
47054042|NCT02822573|83325695|FG001|Overall Study|Too sick or ill|1|||
47054043|NCT02822573|83325694|FG000|Overall Study|Disease Progression|1|||
47054044|NCT02822573|83325695|FG001|Overall Study|Disease Progression|1|||
47054045|NCT02822573|83325694|FG000|Overall Study|No reason given|6|||
47054046|NCT02822573|83325695|FG001|Overall Study|No reason given|4|||
47054047|NCT02795676|83325703|FG000|Overall Study|Adverse Event|2|||
47054048|NCT02795676|83325704|FG001|Overall Study|Adverse Event|0|||
47054049|NCT02795676|83325703|FG000|Overall Study|Withdrawal by Subject|3|||
46810163|NCT00519636|83029476|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
46810164|NCT00519636|83029477|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
46810165|NCT00519636|83029474|FG000|Washout Period|Adverse Event|2|||
47054050|NCT02795676|83325704|FG001|Overall Study|Withdrawal by Subject|1|||
47054051|NCT02784535|83325710|FG000|Overall Study|Adverse Event|1|||
47054052|NCT02784535|83325711|FG001|Overall Study|Adverse Event|0|||
46753928|NCT02393248|82971616|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46810166|NCT00519636|83029475|FG001|Washout Period|Adverse Event|1|||
46810167|NCT00519636|83029476|FG002|Washout Period|Adverse Event|1|||
46810168|NCT00519636|83029477|FG003|Washout Period|Adverse Event|0|||
46810169|NCT00519636|83029474|FG000|Washout Period|Lost to Follow-up|1|||
46810170|NCT00519636|83029475|FG001|Washout Period|Lost to Follow-up|0|||
46810171|NCT00519636|83029476|FG002|Washout Period|Lost to Follow-up|0|||
46810172|NCT00519636|83029477|FG003|Washout Period|Lost to Follow-up|0|||
46810173|NCT00519636|83029474|FG000|Washout Period|Protocol Violation|0|||
46810174|NCT00519636|83029475|FG001|Washout Period|Protocol Violation|0|||
46810175|NCT00519636|83029476|FG002|Washout Period|Protocol Violation|1|||
46810176|NCT00519636|83029477|FG003|Washout Period|Protocol Violation|2|||
46753929|NCT02393248|82971617|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753930|NCT02393248|82971618|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753931|NCT02393248|82971619|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753932|NCT02393248|82971620|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753933|NCT02393248|82971621|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753934|NCT02393248|82971622|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753935|NCT02393248|82971623|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753936|NCT02393248|82971624|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
46753937|NCT02393248|82971625|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
46753938|NCT00601484|82971688|FG000|Overall Study|Adverse Event|0|||
46753939|NCT00601484|82971689|FG001|Overall Study|Adverse Event|1|||
46753940|NCT00601484|82971688|FG000|Overall Study|Lost to Follow-up|4|||
46753941|NCT00601484|82971689|FG001|Overall Study|Lost to Follow-up|3|||
46753942|NCT00601484|82971688|FG000|Overall Study|Lack of Efficacy|0|||
46753943|NCT00601484|82971689|FG001|Overall Study|Lack of Efficacy|2|||
46753944|NCT00601484|82971688|FG000|Overall Study|Withdrawal by Subject|1|||
46810177|NCT00519636|83029474|FG000|Washout Period|Withdrawal by Subject|1|||
46810178|NCT00519636|83029475|FG001|Washout Period|Withdrawal by Subject|0|||
46810179|NCT00519636|83029476|FG002|Washout Period|Withdrawal by Subject|1|||
46810180|NCT00519636|83029477|FG003|Washout Period|Withdrawal by Subject|0|||
46810181|NCT00519636|83029474|FG000|Washout Period|Failed to meet continuation criteria|14|||
46810182|NCT00519636|83029475|FG001|Washout Period|Failed to meet continuation criteria|11|||
46810183|NCT00519636|83029476|FG002|Washout Period|Failed to meet continuation criteria|9|||
46810184|NCT00519636|83029477|FG003|Washout Period|Failed to meet continuation criteria|3|||
46810185|NCT00519636|83029474|FG000|Washout Period|Out of pollen area > 48 hours|1|||
46810186|NCT00519636|83029475|FG001|Washout Period|Out of pollen area > 48 hours|0|||
46810187|NCT00519636|83029476|FG002|Washout Period|Out of pollen area > 48 hours|0|||
46810188|NCT00519636|83029477|FG003|Washout Period|Out of pollen area > 48 hours|0|||
47054053|NCT02784535|83325710|FG000|Overall Study|Withdrawal by Subject|0|||
47054054|NCT02784535|83325711|FG001|Overall Study|Withdrawal by Subject|1|||
46753945|NCT00601484|82971689|FG001|Overall Study|Withdrawal by Subject|1|||
46753946|NCT00601484|82971688|FG000|Overall Study|Randomized, but not treated|0|||
46810189|NCT00519636|83029474|FG000|Washout Period|Participating in study at another site|1|||
46810190|NCT00519636|83029475|FG001|Washout Period|Participating in study at another site|0|||
46810191|NCT00519636|83029476|FG002|Washout Period|Participating in study at another site|0|||
46810192|NCT00519636|83029477|FG003|Washout Period|Participating in study at another site|0|||
46810193|NCT00519636|83029474|FG000|Washout Period|Non-compliant|0|||
46810194|NCT00519636|83029475|FG001|Washout Period|Non-compliant|1|||
46810195|NCT00519636|83029476|FG002|Washout Period|Non-compliant|0|||
46810196|NCT00519636|83029477|FG003|Washout Period|Non-compliant|0|||
46810197|NCT00519636|83029474|FG000|Washout Period|Per doctors request|0|||
46810198|NCT00519636|83029475|FG001|Washout Period|Per doctors request|1|||
46810199|NCT00519636|83029476|FG002|Washout Period|Per doctors request|0|||
46810200|NCT00519636|83029477|FG003|Washout Period|Per doctors request|0|||
46810201|NCT00519636|83029474|FG000|Washout Period|Subject randomized in error|0|||
46810202|NCT00519636|83029475|FG001|Washout Period|Subject randomized in error|0|||
46810203|NCT00519636|83029476|FG002|Washout Period|Subject randomized in error|1|||
46810204|NCT00519636|83029477|FG003|Washout Period|Subject randomized in error|0|||
46810205|NCT00519636|83029474|FG000|Washout Period|Prohibited medications|0|||
46810206|NCT00519636|83029475|FG001|Washout Period|Prohibited medications|0|||
46810207|NCT00519636|83029476|FG002|Washout Period|Prohibited medications|1|||
46810208|NCT00519636|83029477|FG003|Washout Period|Prohibited medications|0|||
46810209|NCT00519636|83029474|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
46810210|NCT00519636|83029475|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
46810211|NCT00519636|83029476|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
46810212|NCT00519636|83029477|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
46810213|NCT00519636|83029474|FG000|Treatment Period 2|Subject randomized in error|0|||
46810214|NCT00519636|83029475|FG001|Treatment Period 2|Subject randomized in error|1|||
46810215|NCT00519636|83029476|FG002|Treatment Period 2|Subject randomized in error|0|||
46810216|NCT00519636|83029477|FG003|Treatment Period 2|Subject randomized in error|0|||
47054055|NCT02784535|83325710|FG000|Overall Study|Physician Decision|0|||
46753947|NCT00601484|82971689|FG001|Overall Study|Randomized, but not treated|1|||
46753948|NCT00883896|82971699|FG000|Overall Study|Lost to Follow-up|0|||
46753949|NCT00883896|82971700|FG001|Overall Study|Lost to Follow-up|0|||
46753950|NCT00883896|82971701|FG002|Overall Study|Lost to Follow-up|0|||
46753951|NCT00883896|82971702|FG003|Overall Study|Lost to Follow-up|2|||
46753952|NCT00883896|82971699|FG000|Overall Study|Withdrawal by Subject|5|||
46753953|NCT00883896|82971700|FG001|Overall Study|Withdrawal by Subject|0|||
46753954|NCT00883896|82971701|FG002|Overall Study|Withdrawal by Subject|1|||
46753955|NCT00883896|82971702|FG003|Overall Study|Withdrawal by Subject|3|||
46753956|NCT00883896|82971699|FG000|Overall Study|Lack of Efficacy|0|||
46753957|NCT00883896|82971700|FG001|Overall Study|Lack of Efficacy|0|||
46753958|NCT00883896|82971701|FG002|Overall Study|Lack of Efficacy|0|||
46753959|NCT00883896|82971702|FG003|Overall Study|Lack of Efficacy|2|||
46753960|NCT00883896|82971699|FG000|Overall Study|Other|1|||
46753961|NCT00883896|82971700|FG001|Overall Study|Other|0|||
46753962|NCT00883896|82971701|FG002|Overall Study|Other|0|||
46753963|NCT00883896|82971702|FG003|Overall Study|Other|0|||
46753964|NCT00867009|82971712|FG000|Induction Period|Nonserious Adverse Event|5|||
46753965|NCT00867009|82971712|FG000|Induction Period|Serious Adverse Event|10|||
46753966|NCT00867009|82971712|FG000|Induction Period|Death due to serious adverse event|6|||
46753967|NCT00867009|82971712|FG000|Induction Period|Death due to Study Disease|4|||
46753968|NCT00867009|82971712|FG000|Induction Period|Protocol Violation|1|||
46753969|NCT00867009|82971712|FG000|Induction Period|Withdrawal by Subject|8|||
46753970|NCT00867009|82971712|FG000|Induction Period|Physician Decision|3|||
46753971|NCT00867009|82971712|FG000|Induction Period|Progressive Disease (PD)|25|||
46753972|NCT00867009|82971712|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
46775760|NCT00793793|82994205|FG001|Overall Study|Withdrawal by Subject|0|||
46775761|NCT00793793|82994206|FG002|Overall Study|Withdrawal by Subject|0|||
46775762|NCT00793793|82994207|FG003|Overall Study|Withdrawal by Subject|0|||
46775763|NCT00793793|82994208|FG004|Overall Study|Withdrawal by Subject|1|||
46775764|NCT00793793|82994209|FG005|Overall Study|Withdrawal by Subject|0|||
46775765|NCT00793793|82994210|FG006|Overall Study|Withdrawal by Subject|0|||
46775766|NCT00793793|82994211|FG007|Overall Study|Withdrawal by Subject|0|||
46775767|NCT00793793|82994212|FG008|Overall Study|Withdrawal by Subject|1|||
46775768|NCT00793793|82994213|FG009|Overall Study|Withdrawal by Subject|0|||
46810217|NCT00519636|83029474|FG000|Treatment Period 2|Per doctors request|0|||
46810218|NCT00519636|83029475|FG001|Treatment Period 2|Per doctors request|0|||
46810219|NCT00519636|83029476|FG002|Treatment Period 2|Per doctors request|1|||
46810220|NCT00519636|83029477|FG003|Treatment Period 2|Per doctors request|0|||
47054056|NCT02784535|83325711|FG001|Overall Study|Physician Decision|1|||
46775769|NCT00793793|82994214|FG010|Overall Study|Withdrawal by Subject|0|||
46775770|NCT00793793|82994215|FG011|Overall Study|Withdrawal by Subject|0|||
46775771|NCT00793793|82994204|FG000|Overall Study|reason not specified|0|||
46775772|NCT00793793|82994205|FG001|Overall Study|reason not specified|1|||
46775773|NCT00793793|82994206|FG002|Overall Study|reason not specified|0|||
46775774|NCT00793793|82994207|FG003|Overall Study|reason not specified|1|||
46810221|NCT00519636|83029474|FG000|Treatment Period 2|Subject misrandomized|0|||
46810222|NCT00519636|83029475|FG001|Treatment Period 2|Subject misrandomized|0|||
46810223|NCT00519636|83029476|FG002|Treatment Period 2|Subject misrandomized|0|||
46810224|NCT00519636|83029477|FG003|Treatment Period 2|Subject misrandomized|1|||
46810225|NCT00519636|83029474|FG000|Post Study Period|Subject randomized in error|0|||
46810226|NCT00519636|83029475|FG001|Post Study Period|Subject randomized in error|0|||
46927273|NCT01355523|83161714|FG000|Overall Study|Protocol Violation|0|||
46927274|NCT01355523|83161715|FG001|Overall Study|Protocol Violation|2|||
46927275|NCT01355523|83161714|FG000|Overall Study|Adverse Event|0|||
46927276|NCT01355523|83161715|FG001|Overall Study|Adverse Event|2|||
46927277|NCT02625220|83161721|FG000|Overall Study|Adverse Event|2|||
46927278|NCT02625220|83161721|FG000|Overall Study|Lost to Follow-up|2|||
46927279|NCT02625220|83161721|FG000|Overall Study|Protocol Violation|1|||
46927280|NCT02625220|83161721|FG000|Overall Study|Study discontinued at site|2|||
46810227|NCT00519636|83029476|FG002|Post Study Period|Subject randomized in error|0|||
46810228|NCT00519636|83029477|FG003|Post Study Period|Subject randomized in error|1|||
46810229|NCT00618371|83029491|FG000|Overall Study|Withdrawal by Subject|2|||
46810230|NCT00526890|83029496|FG000|Overall Study|Adverse Event|2|||
46810231|NCT03864900|83029502|FG000|Overall Study|Withdrawal by Subject|1|||
46927281|NCT02826603|83161727|FG000|Overall Study|Adverse Event|17|||
46927282|NCT02826603|83161728|FG001|Overall Study|Adverse Event|9|||
46927283|NCT02826603|83161727|FG000|Overall Study|Lack of Efficacy|4|||
46927284|NCT02826603|83161728|FG001|Overall Study|Lack of Efficacy|9|||
46927285|NCT02826603|83161727|FG000|Overall Study|Lost to Follow-up|13|||
46927286|NCT02826603|83161728|FG001|Overall Study|Lost to Follow-up|12|||
46927287|NCT02826603|83161727|FG000|Overall Study|Noncompliance with treatment|0|||
46927288|NCT02826603|83161728|FG001|Overall Study|Noncompliance with treatment|2|||
46927289|NCT02826603|83161727|FG000|Overall Study|Physician Decision|1|||
46927290|NCT02826603|83161728|FG001|Overall Study|Physician Decision|7|||
46927291|NCT02826603|83161727|FG000|Overall Study|Pregnancy|1|||
46927292|NCT02826603|83161728|FG001|Overall Study|Pregnancy|2|||
46927293|NCT02826603|83161727|FG000|Overall Study|Protocol Violation|3|||
46927294|NCT02826603|83161728|FG001|Overall Study|Protocol Violation|3|||
46927295|NCT02826603|83161727|FG000|Overall Study|Withdrawal by Subject|20|||
46927296|NCT02826603|83161728|FG001|Overall Study|Withdrawal by Subject|19|||
46927297|NCT02826603|83161727|FG000|Overall Study|Death|2|||
46927298|NCT02826603|83161728|FG001|Overall Study|Death|0|||
46927299|NCT02826603|83161727|FG000|Overall Study|New therapy for study indication|0|||
46927300|NCT02826603|83161728|FG001|Overall Study|New therapy for study indication|1|||
46927301|NCT05270460|83161744|FG000|Overall Study|Adverse Event|0|||
46927302|NCT05270460|83161745|FG001|Overall Study|Adverse Event|1|||
46927303|NCT05270460|83161746|FG002|Overall Study|Adverse Event|0|||
46927304|NCT05270460|83161744|FG000|Overall Study|Early Termination|0|||
46927305|NCT05270460|83161745|FG001|Overall Study|Early Termination|1|||
46927306|NCT05270460|83161746|FG002|Overall Study|Early Termination|0|||
46927307|NCT04622592|83161771|FG000|Overall Study|Death|0|||
46927308|NCT04622592|83161772|FG001|Overall Study|Death|0|||
47054057|NCT02617511|83325722|FG000|Overall Study|Withdrawal by Subject|1|||
47054058|NCT02617511|83325723|FG001|Overall Study|Withdrawal by Subject|0|||
46810232|NCT03864900|83029503|FG001|Overall Study|Withdrawal by Subject|1|||
46810233|NCT03864900|83029502|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
46810234|NCT03864900|83029503|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
46810235|NCT00526656|83029509|FG000|Overall Study|Death|1|||
46810236|NCT00526656|83029509|FG000|Overall Study|Refused surgery|1|||
46810237|NCT00617903|83029516|FG000|Overall Study|Withdrawal by Subject|2|||
46810238|NCT00617903|83029517|FG001|Overall Study|Withdrawal by Subject|3|||
46810239|NCT00617903|83029516|FG000|Overall Study|Lost to Follow-up|1|||
46810240|NCT00617903|83029517|FG001|Overall Study|Lost to Follow-up|1|||
46810241|NCT00617903|83029516|FG000|Overall Study|Lack of Efficacy|0|||
46810242|NCT00617903|83029517|FG001|Overall Study|Lack of Efficacy|1|||
46810243|NCT00617903|83029516|FG000|Overall Study|Adverse Event|0|||
46810244|NCT00617903|83029517|FG001|Overall Study|Adverse Event|1|||
46810245|NCT00617903|83029516|FG000|Overall Study|noncompliance|0|||
46810246|NCT00617903|83029517|FG001|Overall Study|noncompliance|1|||
46927309|NCT04622592|83161773|FG002|Overall Study|Death|1|||
46927310|NCT04622592|83161774|FG003|Overall Study|Death|0|||
46927311|NCT04622592|83161775|FG004|Overall Study|Death|0|||
46927312|NCT04622592|83161776|FG005|Overall Study|Death|0|||
46927313|NCT04622592|83161777|FG006|Overall Study|Death|0|||
46927314|NCT04622592|83161778|FG007|Overall Study|Death|1|||
46927315|NCT04622592|83161771|FG000|Overall Study|Lost to Follow-up|0|||
47054059|NCT02587234|83325731|FG000|Overall Study|Withdrawal by Subject|1|||
46810247|NCT00526110|83029525|FG000|Overall Study|Adverse Event|2|||
46810248|NCT00526110|83029526|FG001|Overall Study|Adverse Event|9|||
46927316|NCT04622592|83161772|FG001|Overall Study|Lost to Follow-up|0|||
46927317|NCT04622592|83161773|FG002|Overall Study|Lost to Follow-up|0|||
46927318|NCT04622592|83161774|FG003|Overall Study|Lost to Follow-up|3|||
46927319|NCT04622592|83161775|FG004|Overall Study|Lost to Follow-up|1|||
46927320|NCT04622592|83161776|FG005|Overall Study|Lost to Follow-up|0|||
46810249|NCT00526110|83029525|FG000|Overall Study|Disease Progression|0|||
46810250|NCT00526110|83029526|FG001|Overall Study|Disease Progression|19|||
46810251|NCT00526110|83029525|FG000|Overall Study|Maximal Response|0|||
46810252|NCT00526110|83029526|FG001|Overall Study|Maximal Response|6|||
46810253|NCT00526110|83029525|FG000|Overall Study|Withdrawal by Subject|0|||
46810254|NCT00526110|83029526|FG001|Overall Study|Withdrawal by Subject|2|||
46810255|NCT00526110|83029525|FG000|Overall Study|Poor Tolerance|0|||
46810256|NCT00526110|83029526|FG001|Overall Study|Poor Tolerance|5|||
46810257|NCT00512148|83029532|FG000|Primay Study Period|Withdrawal by Subject|1|||
46810258|NCT00511836|83029540|FG000|Double-blind Period|Lost to Follow-up|1|||
46810259|NCT00511836|83029541|FG001|Double-blind Period|Lost to Follow-up|0|||
46810260|NCT00573755|83029563|FG000|Overall Study|Still receiving treatment|1|||
46810261|NCT00573755|83029564|FG001|Overall Study|Still receiving treatment|0|||
46810262|NCT00524316|83029570|FG000|Overall Study|Withdrawal by Subject|2|||
46810263|NCT00524316|83029570|FG000|Overall Study|Adverse Event|7|||
46810264|NCT00524316|83029570|FG000|Overall Study|Disease Progression|7|||
46810265|NCT03861936|83029587|FG000|Overall Study|Withdrawal by Subject|4|||
46927321|NCT04622592|83161777|FG006|Overall Study|Lost to Follow-up|2|||
46810266|NCT03861936|83029588|FG001|Overall Study|Withdrawal by Subject|1|||
46810267|NCT03861936|83029589|FG002|Overall Study|Withdrawal by Subject|3|||
46810268|NCT03861936|83029587|FG000|Overall Study|Lost to Follow-up|5|||
46810269|NCT03861936|83029588|FG001|Overall Study|Lost to Follow-up|3|||
46810270|NCT03861936|83029589|FG002|Overall Study|Lost to Follow-up|3|||
46810271|NCT03861936|83029587|FG000|Overall Study|Physician Decision|0|||
46810272|NCT03861936|83029588|FG001|Overall Study|Physician Decision|1|||
46810273|NCT03861936|83029589|FG002|Overall Study|Physician Decision|0|||
46810274|NCT03861936|83029587|FG000|Overall Study|Protocol Deviation|0|||
46810275|NCT03861936|83029588|FG001|Overall Study|Protocol Deviation|0|||
46810276|NCT03861936|83029589|FG002|Overall Study|Protocol Deviation|1|||
46810277|NCT03861936|83029587|FG000|Overall Study|Reason not Specified|5|||
46810278|NCT03861936|83029588|FG001|Overall Study|Reason not Specified|5|||
46810279|NCT03861936|83029589|FG002|Overall Study|Reason not Specified|3|||
46810280|NCT00434577|83029602|FG000|Months 0-3|Serious Adverse Event|0|||
46810281|NCT00434577|83029603|FG001|Months 0-3|Serious Adverse Event|0|||
46810282|NCT00434577|83029604|FG002|Months 0-3|Serious Adverse Event|1|||
46810283|NCT00434577|83029605|FG003|Months 0-3|Serious Adverse Event|0|||
46927322|NCT04622592|83161778|FG007|Overall Study|Lost to Follow-up|2|||
47054060|NCT02587234|83325732|FG001|Overall Study|Withdrawal by Subject|1|||
46810284|NCT00434577|83029606|FG004|Months 0-3|Serious Adverse Event|0|||
46810285|NCT00434577|83029602|FG000|Months 0-3|Adverse Event|0|||
46810286|NCT00434577|83029603|FG001|Months 0-3|Adverse Event|1|||
46810287|NCT00434577|83029604|FG002|Months 0-3|Adverse Event|1|||
46810288|NCT00434577|83029605|FG003|Months 0-3|Adverse Event|0|||
46810289|NCT00434577|83029606|FG004|Months 0-3|Adverse Event|0|||
46810290|NCT00434577|83029602|FG000|Months 0-3|Lost to Follow-up|0|||
46810291|NCT00434577|83029603|FG001|Months 0-3|Lost to Follow-up|0|||
46810292|NCT00434577|83029604|FG002|Months 0-3|Lost to Follow-up|0|||
46810293|NCT00434577|83029605|FG003|Months 0-3|Lost to Follow-up|0|||
46810294|NCT00434577|83029606|FG004|Months 0-3|Lost to Follow-up|2|||
46810295|NCT00434577|83029602|FG000|Months 0-3|Protocol Violation|1|||
46810296|NCT00434577|83029603|FG001|Months 0-3|Protocol Violation|0|||
46810297|NCT00434577|83029604|FG002|Months 0-3|Protocol Violation|1|||
46810298|NCT00434577|83029605|FG003|Months 0-3|Protocol Violation|0|||
46810299|NCT00434577|83029606|FG004|Months 0-3|Protocol Violation|0|||
46810300|NCT00434577|83029602|FG000|Months 0-3|Withdrawal by Subject|2|||
46810301|NCT00434577|83029603|FG001|Months 0-3|Withdrawal by Subject|1|||
46810302|NCT00434577|83029604|FG002|Months 0-3|Withdrawal by Subject|1|||
46810303|NCT00434577|83029605|FG003|Months 0-3|Withdrawal by Subject|1|||
46810304|NCT00434577|83029606|FG004|Months 0-3|Withdrawal by Subject|1|||
46810305|NCT00434421|83029618|FG000|Overall Study|Withdrawal by Subject|1|||
46810306|NCT00434421|83029618|FG000|Overall Study|Non-compliance with study treatment|1|||
46810307|NCT00421707|83029624|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
46810308|NCT00421707|83029625|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
46927323|NCT04622592|83161771|FG000|Overall Study|Physician Decision|0|||
46927324|NCT04622592|83161772|FG001|Overall Study|Physician Decision|0|||
47054061|NCT02587234|83325731|FG000|Overall Study|Lost to Follow-up|0|||
46810309|NCT00421707|83029624|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
46810310|NCT00421707|83029625|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
46810311|NCT00421707|83029624|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
46810312|NCT00421707|83029625|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
46810313|NCT00421707|83029624|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
46810314|NCT00421707|83029625|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
46810315|NCT00421707|83029624|FG000|Period 2: Washout|Adverse Event|1|||
46810316|NCT00421707|83029625|FG001|Period 2: Washout|Adverse Event|1|||
46810317|NCT00421707|83029624|FG000|Period 2: Washout|Withdrawal by Subject|0|||
46810318|NCT00421707|83029625|FG001|Period 2: Washout|Withdrawal by Subject|1|||
46927325|NCT04622592|83161773|FG002|Overall Study|Physician Decision|0|||
47054062|NCT02587234|83325732|FG001|Overall Study|Lost to Follow-up|2|||
46810319|NCT00421707|83029624|FG000|Period 2: Washout|Lost to Follow-up|0|||
46810320|NCT00421707|83029625|FG001|Period 2: Washout|Lost to Follow-up|1|||
46810321|NCT00421707|83029624|FG000|Period 2: Washout|Other: Pregnancy|0|||
46810322|NCT00421707|83029625|FG001|Period 2: Washout|Other: Pregnancy|1|||
46810323|NCT00421707|83029624|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
46810324|NCT00421707|83029625|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
46810325|NCT00421707|83029624|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
46810326|NCT00421707|83029625|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
46810327|NCT00421707|83029624|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
46810328|NCT00421707|83029625|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
46810329|NCT00518622|83029651|FG000|Overall Study|Lost to Follow-up|0|||
47054063|NCT02184195|83325740|FG000|Overall Study|Patient decision|5|||
46810330|NCT00518622|83029652|FG001|Overall Study|Lost to Follow-up|0|||
46810331|NCT00518622|83029653|FG002|Overall Study|Lost to Follow-up|1|||
46810332|NCT00518622|83029654|FG003|Overall Study|Lost to Follow-up|0|||
46810333|NCT00518622|83029655|FG004|Overall Study|Lost to Follow-up|0|||
46810334|NCT00518622|83029656|FG005|Overall Study|Lost to Follow-up|0|||
46810335|NCT00518622|83029657|FG006|Overall Study|Lost to Follow-up|0|||
46810336|NCT00518622|83029658|FG007|Overall Study|Lost to Follow-up|0|||
46810337|NCT00518622|83029651|FG000|Overall Study|Study medication taken incorrectly|0|||
46810338|NCT00518622|83029652|FG001|Overall Study|Study medication taken incorrectly|1|||
46810339|NCT00518622|83029653|FG002|Overall Study|Study medication taken incorrectly|0|||
46810340|NCT00518622|83029654|FG003|Overall Study|Study medication taken incorrectly|0|||
46810341|NCT00518622|83029655|FG004|Overall Study|Study medication taken incorrectly|0|||
46810342|NCT00518622|83029656|FG005|Overall Study|Study medication taken incorrectly|0|||
46810343|NCT00518622|83029657|FG006|Overall Study|Study medication taken incorrectly|0|||
46636337|NCT01489020|82810152|FG003|Overall Study|Adverse Event|0|||
46636338|NCT01489020|82810153|FG004|Overall Study|Adverse Event|3|||
46636339|NCT01489020|82810154|FG005|Overall Study|Adverse Event|0|||
46636340|NCT01489020|82810149|FG000|Overall Study|Concomitant disease|0|||
46636341|NCT01489020|82810150|FG001|Overall Study|Concomitant disease|0|||
46636342|NCT01489020|82810151|FG002|Overall Study|Concomitant disease|0|||
46636343|NCT01489020|82810152|FG003|Overall Study|Concomitant disease|0|||
46636344|NCT01489020|82810153|FG004|Overall Study|Concomitant disease|3|||
46810344|NCT00518622|83029658|FG007|Overall Study|Study medication taken incorrectly|0|||
46810345|NCT00517296|83029678|FG000|Overall Study|Withdrawal by Subject|1|||
47054064|NCT02184195|83325741|FG001|Overall Study|Patient decision|2|||
47054065|NCT02184195|83325740|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46810346|NCT00517296|83029679|FG001|Overall Study|Withdrawal by Subject|0|||
46810347|NCT00516906|83029687|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
46810348|NCT00516906|83029688|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
46810349|NCT00523848|83029694|FG000|Overall Study|Adverse Event|11|||
47054066|NCT02184195|83325741|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
47054067|NCT02184195|83325740|FG000|Overall Study|Death|67|||
47054068|NCT02184195|83325741|FG001|Overall Study|Death|44|||
47054069|NCT02184195|83325740|FG000|Overall Study|Lost to Follow-up|1|||
47054070|NCT02184195|83325741|FG001|Overall Study|Lost to Follow-up|5|||
46636345|NCT01489020|82810154|FG005|Overall Study|Concomitant disease|0|||
46810350|NCT00523848|83029694|FG000|Overall Study|Withdrawal by Subject|2|||
46810351|NCT00523848|83029694|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
46810352|NCT00523848|83029694|FG000|Overall Study|Disease Progression|5|||
46810353|NCT00523848|83029694|FG000|Overall Study|Other, unspecified|4|||
46810354|NCT00617669|83029700|FG000|Overall Study|Withdrawal by Subject|71|||
46810355|NCT00617669|83029701|FG001|Overall Study|Withdrawal by Subject|77|||
46810356|NCT00617669|83029700|FG000|Overall Study|Lost to Follow-up|3|||
46927326|NCT04622592|83161774|FG003|Overall Study|Physician Decision|0|||
46927327|NCT04622592|83161775|FG004|Overall Study|Physician Decision|1|||
46927328|NCT04622592|83161776|FG005|Overall Study|Physician Decision|0|||
47054071|NCT02184195|83325740|FG000|Overall Study|Other|0|||
47054072|NCT02184195|83325741|FG001|Overall Study|Other|3|||
47054073|NCT02181413|83325749|FG000|Overall Study|Adverse Event|7|||
47054074|NCT02181413|83325750|FG001|Overall Study|Adverse Event|24|||
46636346|NCT01514760|82810174|FG000|Overall Study|Lost to Follow-up|2|||
46636347|NCT01514682|82810180|FG000|Overall Study|Withdrawal by Subject|2|||
46810357|NCT00617669|83029701|FG001|Overall Study|Lost to Follow-up|2|||
46810358|NCT00617669|83029700|FG000|Overall Study|Adverse Event|87|||
46810359|NCT00617669|83029701|FG001|Overall Study|Adverse Event|76|||
46810360|NCT00617669|83029700|FG000|Overall Study|Protocol Violation|2|||
46810361|NCT00617669|83029701|FG001|Overall Study|Protocol Violation|3|||
46810362|NCT00617669|83029700|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
46810363|NCT00617669|83029701|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
46810364|NCT00617669|83029700|FG000|Overall Study|Patients randomized but not treated|2|||
46810365|NCT00617669|83029701|FG001|Overall Study|Patients randomized but not treated|3|||
46927329|NCT04622592|83161777|FG006|Overall Study|Physician Decision|0|||
47054075|NCT02181413|83325749|FG000|Overall Study|Progressive Disease|121|||
47054076|NCT02181413|83325750|FG001|Overall Study|Progressive Disease|143|||
47054077|NCT02181413|83325749|FG000|Overall Study|Withdrawal by Subject|5|||
46810366|NCT00510510|83029710|FG000|Overall Study|Adverse Event|4|||
46810367|NCT00510510|83029711|FG001|Overall Study|Adverse Event|3|||
46810368|NCT00510510|83029712|FG002|Overall Study|Adverse Event|6|||
46810369|NCT00510510|83029710|FG000|Overall Study|Lack of Efficacy|0|||
46810370|NCT00510510|83029711|FG001|Overall Study|Lack of Efficacy|1|||
46810371|NCT00510510|83029712|FG002|Overall Study|Lack of Efficacy|1|||
46810372|NCT00510510|83029710|FG000|Overall Study|Subjects no longer requires study drug|0|||
46810373|NCT00510510|83029711|FG001|Overall Study|Subjects no longer requires study drug|0|||
46810374|NCT00510510|83029712|FG002|Overall Study|Subjects no longer requires study drug|2|||
46810375|NCT00510510|83029710|FG000|Overall Study|Withdrawal by Subject|1|||
46810376|NCT00510510|83029711|FG001|Overall Study|Withdrawal by Subject|2|||
46810377|NCT00510510|83029712|FG002|Overall Study|Withdrawal by Subject|3|||
46810378|NCT00510510|83029710|FG000|Overall Study|Lost to Follow-up|0|||
46810379|NCT00510510|83029711|FG001|Overall Study|Lost to Follow-up|0|||
46810380|NCT00510510|83029712|FG002|Overall Study|Lost to Follow-up|1|||
46810381|NCT00510510|83029710|FG000|Overall Study|Protocol Violation|0|||
46810382|NCT00510510|83029711|FG001|Overall Study|Protocol Violation|3|||
46810383|NCT00510510|83029712|FG002|Overall Study|Protocol Violation|4|||
47054078|NCT02181413|83325750|FG001|Overall Study|Withdrawal by Subject|8|||
47054079|NCT02181413|83325749|FG000|Overall Study|Reason Not Specified|19|||
47054080|NCT02181413|83325750|FG001|Overall Study|Reason Not Specified|20|||
46810384|NCT00617591|83029720|FG000|Overall Study|Withdrew consent during Induction|4|||
46810385|NCT00617591|83029720|FG000|Overall Study|Withdrew consent during Maintenance|6|||
46810386|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Adverse Event|21|||
46810387|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Adverse Event|6|||
46810388|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
46810389|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
46810390|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
46810391|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
46810392|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
46810393|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
46810394|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Physician Decision|0|||
46810395|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Physician Decision|3|||
46810396|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
46810397|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
46810398|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
46927330|NCT04622592|83161778|FG007|Overall Study|Physician Decision|0|||
46927331|NCT04622592|83161771|FG000|Overall Study|Withdrawal by Subject|1|||
46927332|NCT04622592|83161772|FG001|Overall Study|Withdrawal by Subject|0|||
47054081|NCT02181413|83325749|FG000|Overall Study|Ongoing Study Treatment|0|||
47054082|NCT02181413|83325750|FG001|Overall Study|Ongoing Study Treatment|1|||
47054083|NCT02181413|83325749|FG000|Overall Study|Lost to Follow-up|0|||
47054084|NCT02181413|83325750|FG001|Overall Study|Lost to Follow-up|1|||
47054085|NCT02151981|83325758|FG000|Overall Study|Death|184|||
47054086|NCT02151981|83325759|FG001|Overall Study|Death|88|||
47054087|NCT02151981|83325758|FG000|Overall Study|Lost to Follow-up|7|||
47054088|NCT02151981|83325759|FG001|Overall Study|Lost to Follow-up|1|||
46753973|NCT00601250|82971718|FG000|Overall Study|Adverse Event|3|||
46753974|NCT00601250|82971719|FG001|Overall Study|Adverse Event|9|||
46753975|NCT00601250|82971718|FG000|Overall Study|Protocol Violation|3|||
46753976|NCT00601250|82971719|FG001|Overall Study|Protocol Violation|2|||
46753977|NCT00601250|82971718|FG000|Overall Study|Lost to Follow-up|2|||
46753978|NCT00601250|82971719|FG001|Overall Study|Lost to Follow-up|6|||
46753979|NCT00601250|82971718|FG000|Overall Study|Withdrawal by Subject|4|||
46753980|NCT00601250|82971719|FG001|Overall Study|Withdrawal by Subject|13|||
46753981|NCT00601250|82971718|FG000|Overall Study|Other incl. lack of efficacy|2|||
46753982|NCT00601250|82971719|FG001|Overall Study|Other incl. lack of efficacy|9|||
46753983|NCT00866775|82971727|FG000|Overall Study|Adverse Event|5|||
46753984|NCT00866775|82971728|FG001|Overall Study|Adverse Event|19|||
46810399|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
46810400|NCT00510276|83029727|FG000|Acute Double-Blind Phase|Subject Decision|26|||
46927333|NCT04622592|83161773|FG002|Overall Study|Withdrawal by Subject|2|||
46927334|NCT04622592|83161774|FG003|Overall Study|Withdrawal by Subject|0|||
46927335|NCT04622592|83161775|FG004|Overall Study|Withdrawal by Subject|0|||
46753985|NCT00866775|82971727|FG000|Overall Study|Death|1|||
46753986|NCT00866775|82971728|FG001|Overall Study|Death|0|||
46810401|NCT00510276|83029728|FG001|Acute Double-Blind Phase|Subject Decision|28|||
46810402|NCT00510276|83029727|FG000|Extension Open-Label Phase|Adverse Event|9|||
46753987|NCT00866775|82971727|FG000|Overall Study|Lost to Follow-up|0|||
46810403|NCT00510276|83029728|FG001|Extension Open-Label Phase|Adverse Event|18|||
46810404|NCT00510276|83029727|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
46810405|NCT00510276|83029728|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
46810406|NCT00510276|83029727|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
46927336|NCT04622592|83161776|FG005|Overall Study|Withdrawal by Subject|0|||
47054089|NCT02151981|83325758|FG000|Overall Study|Withdrawal by Subject|27|||
47054090|NCT02151981|83325759|FG001|Overall Study|Withdrawal by Subject|21|||
46810407|NCT00510276|83029728|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
46810408|NCT00510276|83029727|FG000|Extension Open-Label Phase|Physician Decision|2|||
46810409|NCT00510276|83029728|FG001|Extension Open-Label Phase|Physician Decision|3|||
46810410|NCT00510276|83029727|FG000|Extension Open-Label Phase|Protocol Violation|0|||
46810411|NCT00510276|83029728|FG001|Extension Open-Label Phase|Protocol Violation|1|||
46810412|NCT00510276|83029727|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
46810413|NCT00510276|83029728|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
46810414|NCT00510276|83029727|FG000|Extension Open-Label Phase|Subject Decision|7|||
46810415|NCT00510276|83029728|FG001|Extension Open-Label Phase|Subject Decision|9|||
46810416|NCT00616655|83029744|FG000|Overall Study|Adverse Event|10|||
46927337|NCT04622592|83161777|FG006|Overall Study|Withdrawal by Subject|1|||
46927338|NCT04622592|83161778|FG007|Overall Study|Withdrawal by Subject|4|||
46927339|NCT04622592|83161771|FG000|Overall Study|Other than specified above|0|||
46927340|NCT04622592|83161772|FG001|Overall Study|Other than specified above|0|||
46927341|NCT04622592|83161773|FG002|Overall Study|Other than specified above|1|||
46927342|NCT04622592|83161774|FG003|Overall Study|Other than specified above|0|||
46810417|NCT00616655|83029745|FG001|Overall Study|Adverse Event|7|||
46810418|NCT00616655|83029746|FG002|Overall Study|Adverse Event|12|||
46810419|NCT00616655|83029744|FG000|Overall Study|Lack of Efficacy|5|||
46810420|NCT00616655|83029745|FG001|Overall Study|Lack of Efficacy|5|||
46810421|NCT00616655|83029746|FG002|Overall Study|Lack of Efficacy|5|||
46810422|NCT00616655|83029744|FG000|Overall Study|Lost to Follow-up|3|||
46810423|NCT00616655|83029745|FG001|Overall Study|Lost to Follow-up|12|||
46810424|NCT00616655|83029746|FG002|Overall Study|Lost to Follow-up|10|||
46810425|NCT00616655|83029744|FG000|Overall Study|Protocol Violation|2|||
46927343|NCT04622592|83161775|FG004|Overall Study|Other than specified above|0|||
46927344|NCT04622592|83161776|FG005|Overall Study|Other than specified above|0|||
46927345|NCT04622592|83161777|FG006|Overall Study|Other than specified above|0|||
46927346|NCT04622592|83161778|FG007|Overall Study|Other than specified above|0|||
46927347|NCT04523220|83161799|FG000|Main Treatment Period|Physician Decision|1|||
46927348|NCT04523220|83161800|FG001|Main Treatment Period|Physician Decision|1|||
46927349|NCT04523220|83161801|FG002|Main Treatment Period|Physician Decision|0|||
46927350|NCT04523220|83161799|FG000|Main Treatment Period|Other|5|||
46927351|NCT04523220|83161800|FG001|Main Treatment Period|Other|2|||
46927352|NCT04523220|83161801|FG002|Main Treatment Period|Other|4|||
46927353|NCT04523220|83161799|FG000|Main Treatment Period|Subject Decision|5|||
46927354|NCT04523220|83161800|FG001|Main Treatment Period|Subject Decision|7|||
46927355|NCT04523220|83161801|FG002|Main Treatment Period|Subject Decision|3|||
46927356|NCT04523220|83161799|FG000|Main Treatment Period|Death|5|||
46753988|NCT00866775|82971728|FG001|Overall Study|Lost to Follow-up|4|||
46753989|NCT00866775|82971727|FG000|Overall Study|Physician Decision|0|||
46753990|NCT00866775|82971728|FG001|Overall Study|Physician Decision|3|||
46753991|NCT00866775|82971727|FG000|Overall Study|Protocol Violation|3|||
46753992|NCT00866775|82971728|FG001|Overall Study|Protocol Violation|4|||
46753993|NCT00866775|82971727|FG000|Overall Study|Withdrawal by Subject|4|||
46753994|NCT00866775|82971728|FG001|Overall Study|Withdrawal by Subject|4|||
46753995|NCT00866775|82971727|FG000|Overall Study|met exit criteria|23|||
46753996|NCT00866775|82971728|FG001|Overall Study|met exit criteria|17|||
46753997|NCT00866775|82971727|FG000|Overall Study|discontinued due to communication error|0|||
46753998|NCT00866775|82971728|FG001|Overall Study|discontinued due to communication error|1|||
46810426|NCT00616655|83029745|FG001|Overall Study|Protocol Violation|4|||
46810427|NCT00616655|83029746|FG002|Overall Study|Protocol Violation|3|||
46810428|NCT00616655|83029744|FG000|Overall Study|Withdrawal by Subject|9|||
46810429|NCT00616655|83029745|FG001|Overall Study|Withdrawal by Subject|7|||
46810430|NCT00616655|83029746|FG002|Overall Study|Withdrawal by Subject|11|||
46810431|NCT00616655|83029744|FG000|Overall Study|Does not meet in/ex criteria|0|||
46810432|NCT00616655|83029745|FG001|Overall Study|Does not meet in/ex criteria|0|||
46810433|NCT00616655|83029746|FG002|Overall Study|Does not meet in/ex criteria|2|||
46810434|NCT00616655|83029744|FG000|Overall Study|Other|6|||
46810435|NCT00616655|83029745|FG001|Overall Study|Other|6|||
46810436|NCT00616655|83029746|FG002|Overall Study|Other|5|||
46810437|NCT00510198|83029756|FG000|Overall Study|Withdrawal by Subject|5|||
46810438|NCT00510198|83029757|FG001|Overall Study|Withdrawal by Subject|4|||
46810439|NCT00516048|83029767|FG000|Overall Study|Death|0|||
46810440|NCT00516048|83029768|FG001|Overall Study|Death|0|||
46810441|NCT00516048|83029769|FG002|Overall Study|Death|1|||
46810442|NCT00516048|83029767|FG000|Overall Study|Subject Decision|0|||
46810443|NCT00516048|83029768|FG001|Overall Study|Subject Decision|2|||
46810444|NCT00516048|83029769|FG002|Overall Study|Subject Decision|0|||
46753999|NCT03265210|82971738|FG000|Overall Study|Withdrawal by Subject|7|||
46754000|NCT03265210|82971739|FG001|Overall Study|Withdrawal by Subject|9|||
46810445|NCT00617357|83029777|FG000|Overall Study|Lost to Follow-up|7|||
46810446|NCT00617357|83029777|FG000|Overall Study|Death|5|||
46927357|NCT04523220|83161800|FG001|Main Treatment Period|Death|11|||
46927358|NCT04523220|83161801|FG002|Main Treatment Period|Death|4|||
46927359|NCT04523220|83161799|FG000|Main Treatment Period|Adverse Event|11|||
46927360|NCT04523220|83161800|FG001|Main Treatment Period|Adverse Event|9|||
46927361|NCT04523220|83161801|FG002|Main Treatment Period|Adverse Event|9|||
46927362|NCT04523220|83161799|FG000|Main Treatment Period|Withdrawal by Subject|3|||
46927363|NCT04523220|83161800|FG001|Main Treatment Period|Withdrawal by Subject|3|||
46927364|NCT04523220|83161801|FG002|Main Treatment Period|Withdrawal by Subject|4|||
46927365|NCT04523220|83161799|FG000|Main Treatment Period|Study drug never adminstered|10|||
46927366|NCT04523220|83161800|FG001|Main Treatment Period|Study drug never adminstered|3|||
46927367|NCT04523220|83161801|FG002|Main Treatment Period|Study drug never adminstered|5|||
46927368|NCT04523220|83161799|FG000|Extension Treatment Period|Physician Decision|1|||
46927369|NCT04523220|83161800|FG001|Extension Treatment Period|Physician Decision|0|||
46927370|NCT04523220|83161801|FG002|Extension Treatment Period|Physician Decision|3|||
46927371|NCT04523220|83161799|FG000|Extension Treatment Period|Other|2|||
46927372|NCT04523220|83161800|FG001|Extension Treatment Period|Other|6|||
46927373|NCT04523220|83161801|FG002|Extension Treatment Period|Other|6|||
46927374|NCT04523220|83161799|FG000|Extension Treatment Period|Subject Decision|5|||
46927375|NCT04523220|83161800|FG001|Extension Treatment Period|Subject Decision|2|||
46927376|NCT04523220|83161801|FG002|Extension Treatment Period|Subject Decision|4|||
46927377|NCT04523220|83161799|FG000|Extension Treatment Period|Death|6|||
46927378|NCT04523220|83161800|FG001|Extension Treatment Period|Death|4|||
46927379|NCT04523220|83161801|FG002|Extension Treatment Period|Death|7|||
46927380|NCT04523220|83161799|FG000|Extension Treatment Period|Adverse Event|6|||
46927381|NCT04523220|83161800|FG001|Extension Treatment Period|Adverse Event|7|||
46927382|NCT04523220|83161801|FG002|Extension Treatment Period|Adverse Event|9|||
46927383|NCT04523220|83161799|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
46927384|NCT04523220|83161800|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
46927385|NCT04523220|83161801|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
46927386|NCT04523220|83161799|FG000|Extension Treatment Period|Study drug never administered|0|||
46927387|NCT04523220|83161800|FG001|Extension Treatment Period|Study drug never administered|1|||
46927388|NCT04523220|83161801|FG002|Extension Treatment Period|Study drug never administered|0|||
46927389|NCT04222088|83161832|FG000|Overall Study|Lost to Follow-up|5|||
46927390|NCT04222088|83161833|FG001|Overall Study|Lost to Follow-up|1|||
46927391|NCT04222088|83161832|FG000|Overall Study|Withdrawal by Subject|4|||
46927392|NCT04222088|83161833|FG001|Overall Study|Withdrawal by Subject|0|||
47054091|NCT02151981|83325758|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
47054092|NCT02151981|83325759|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
46636348|NCT01514682|82810181|FG001|Overall Study|Withdrawal by Subject|3|||
46636349|NCT01514682|82810180|FG000|Overall Study|Physician Decision|4|||
46636350|NCT01514682|82810181|FG001|Overall Study|Physician Decision|3|||
46636351|NCT01514448|82810189|FG000|Overall Study|Death|7|||
46636352|NCT01514448|82810190|FG001|Overall Study|Death|8|||
46636353|NCT01514448|82810189|FG000|Overall Study|Withdrawal by Subject|2|||
46636354|NCT01514448|82810190|FG001|Overall Study|Withdrawal by Subject|0|||
46636355|NCT01514448|82810189|FG000|Overall Study|Lost to Follow-up|2|||
46636356|NCT01514448|82810190|FG001|Overall Study|Lost to Follow-up|0|||
46636357|NCT01514448|82810189|FG000|Overall Study|New Cancer Therapy|1|||
46636358|NCT01514448|82810190|FG001|Overall Study|New Cancer Therapy|0|||
47054093|NCT02151981|83325758|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
47054094|NCT02151981|83325759|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
47054095|NCT02151981|83325758|FG000|Overall Study|Patient had no clinical benefit|1|||
47054096|NCT02151981|83325759|FG001|Overall Study|Patient had no clinical benefit|0|||
47054097|NCT02151981|83325758|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
47054098|NCT02151981|83325759|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
46636359|NCT01514370|82810199|FG000|Overall Study|Protocol Violation|2|||
46636360|NCT01514370|82810200|FG001|Overall Study|Protocol Violation|3|||
46636361|NCT01514370|82810199|FG000|Overall Study|Lost to Follow-up|0|||
46636362|NCT01514370|82810200|FG001|Overall Study|Lost to Follow-up|2|||
46754001|NCT03265210|82971738|FG000|Overall Study|Lost to Follow-up|2|||
46754002|NCT03265210|82971739|FG001|Overall Study|Lost to Follow-up|0|||
47054099|NCT02151981|83325758|FG000|Overall Study|Study terminated|0|||
47054100|NCT02151981|83325759|FG001|Overall Study|Study terminated|1|||
47054101|NCT01981720|83325778|FG000|Overall Study|Adverse Event|1|||
47054102|NCT01981720|83325778|FG000|Overall Study|Withdrawal by Subject|3|||
46636363|NCT01514370|82810199|FG000|Overall Study|Withdrawal by Subject|2|||
46636364|NCT01514370|82810200|FG001|Overall Study|Withdrawal by Subject|1|||
46636365|NCT01514370|82810199|FG000|Overall Study|Adverse Event|1|||
46754003|NCT03265210|82971738|FG000|Overall Study|Physician Decision|2|||
46754004|NCT03265210|82971739|FG001|Overall Study|Physician Decision|0|||
46754005|NCT03265210|82971738|FG000|Overall Study|Adverse Event|1|||
46927393|NCT03978520|83161844|FG000|Overall Study|Adverse Event|2|||
46927394|NCT03978520|83161845|FG001|Overall Study|Adverse Event|5|||
46927395|NCT03978520|83161846|FG002|Overall Study|Adverse Event|3|||
46927396|NCT03978520|83161847|FG003|Overall Study|Adverse Event|5|||
46927397|NCT03978520|83161848|FG004|Overall Study|Adverse Event|6|||
46927398|NCT03978520|83161844|FG000|Overall Study|Withdrawal by Subject|10|||
47054103|NCT01981720|83325778|FG000|Overall Study|Pregnancy|1|||
46636366|NCT01514370|82810200|FG001|Overall Study|Adverse Event|3|||
46636367|NCT01514370|82810199|FG000|Overall Study|Other|6|||
46636368|NCT01514370|82810200|FG001|Overall Study|Other|7|||
46810447|NCT00617357|83029777|FG000|Overall Study|insurance concerns|2|||
46810448|NCT00617357|83029777|FG000|Overall Study|Withdrawal by Subject|1|||
46810449|NCT00617357|83029777|FG000|Overall Study|Physician Decision|1|||
46810450|NCT00420927|83029789|FG000|Period 1|Adverse Event|19|||
46810451|NCT00420927|83029790|FG001|Period 1|Adverse Event|15|||
46810452|NCT00420927|83029791|FG002|Period 1|Adverse Event|0|||
46810453|NCT00420927|83029792|FG003|Period 1|Adverse Event|0|||
46810454|NCT00420927|83029793|FG004|Period 1|Adverse Event|0|||
46810455|NCT00420927|83029794|FG005|Period 1|Adverse Event|0|||
46810456|NCT00420927|83029795|FG006|Period 1|Adverse Event|0|||
46810457|NCT00420927|83029789|FG000|Period 1|Withdrawal by Subject|7|||
46810458|NCT00420927|83029790|FG001|Period 1|Withdrawal by Subject|12|||
46810459|NCT00420927|83029791|FG002|Period 1|Withdrawal by Subject|0|||
46810460|NCT00420927|83029792|FG003|Period 1|Withdrawal by Subject|0|||
47054104|NCT01974440|83325788|FG000|Overall Study|Lost to Follow-up|8|||
47054105|NCT01974440|83325789|FG001|Overall Study|Lost to Follow-up|7|||
47054106|NCT01974440|83325788|FG000|Overall Study|Withdrawal by Subject|20|||
47054107|NCT01974440|83325789|FG001|Overall Study|Withdrawal by Subject|19|||
47054108|NCT01974440|83325788|FG000|Overall Study|Ongoing|112|||
47054109|NCT01974440|83325789|FG001|Overall Study|Ongoing|116|||
47054110|NCT01802281|83325806|FG000|Overall Study|Death|1|||
47054111|NCT01802281|83325807|FG001|Overall Study|Death|2|||
47054112|NCT01802281|83325806|FG000|Overall Study|Withdrawal by Subject|2|||
47054113|NCT01802281|83325807|FG001|Overall Study|Withdrawal by Subject|1|||
46754006|NCT03265210|82971739|FG001|Overall Study|Adverse Event|0|||
46754007|NCT00543985|82971745|FG000|Overall Study|Withdrawal by Subject|4|||
46754008|NCT00582556|82971760|FG000|Overall Study|Withdrawal by Subject|0|||
46754009|NCT00582556|82971761|FG001|Overall Study|Withdrawal by Subject|1|||
46754010|NCT00582556|82971762|FG002|Overall Study|Withdrawal by Subject|1|||
46754011|NCT00582556|82971760|FG000|Overall Study|Physician Decision|0|||
46754012|NCT00582556|82971761|FG001|Overall Study|Physician Decision|0|||
46754013|NCT00582556|82971762|FG002|Overall Study|Physician Decision|1|||
46754014|NCT00542269|82971774|FG000|Overall Study|Adverse Event|10|||
46754015|NCT00542269|82971775|FG001|Overall Study|Adverse Event|4|||
46754016|NCT00542269|82971776|FG002|Overall Study|Adverse Event|5|||
46754017|NCT00542269|82971774|FG000|Overall Study|Protocol Violation|1|||
46754018|NCT00542269|82971775|FG001|Overall Study|Protocol Violation|1|||
46754019|NCT00542269|82971776|FG002|Overall Study|Protocol Violation|0|||
46754020|NCT00542269|82971774|FG000|Overall Study|Withdrawal by Subject|1|||
46754021|NCT00542269|82971775|FG001|Overall Study|Withdrawal by Subject|0|||
46754022|NCT00542269|82971776|FG002|Overall Study|Withdrawal by Subject|0|||
46754023|NCT00542269|82971774|FG000|Overall Study|Administrative problems|1|||
46754024|NCT00542269|82971775|FG001|Overall Study|Administrative problems|1|||
46754025|NCT00542269|82971776|FG002|Overall Study|Administrative problems|1|||
46754026|NCT00866697|82971788|FG000|Overall Study|Study closed/terminated|156|||
46754027|NCT00866697|82971789|FG001|Overall Study|Study closed/terminated|138|||
46754028|NCT00866697|82971788|FG000|Overall Study|Lost to Follow-up|22|||
46754029|NCT00866697|82971789|FG001|Overall Study|Lost to Follow-up|28|||
46754030|NCT00866697|82971788|FG000|Overall Study|Physician Decision|3|||
46754031|NCT00866697|82971789|FG001|Overall Study|Physician Decision|5|||
46754032|NCT00866697|82971788|FG000|Overall Study|Withdrawal by Subject|33|||
46754033|NCT00866697|82971789|FG001|Overall Study|Withdrawal by Subject|57|||
46754034|NCT00542191|82971795|FG000|Overall Study|Death|3|||
46754035|NCT00600938|82971801|FG000|Core Study|Abnormal test procedure result(s)|3|||
46754036|NCT00600938|82971802|FG001|Core Study|Abnormal test procedure result(s)|2|||
46754037|NCT00600938|82971803|FG002|Core Study|Abnormal test procedure result(s)|0|||
46754038|NCT00600938|82971804|FG003|Core Study|Abnormal test procedure result(s)|0|||
46754039|NCT00600938|82971801|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
46754040|NCT00600938|82971802|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
46754041|NCT00600938|82971803|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
46754042|NCT00600938|82971804|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
46754043|NCT00600938|82971801|FG000|Core Study|Patient withdrew consent|7|||
46754044|NCT00600938|82971802|FG001|Core Study|Patient withdrew consent|12|||
46754045|NCT00600938|82971803|FG002|Core Study|Patient withdrew consent|0|||
46754046|NCT00600938|82971804|FG003|Core Study|Patient withdrew consent|0|||
46754047|NCT00600938|82971801|FG000|Core Study|Lost to Follow-up|3|||
46810461|NCT00420927|83029793|FG004|Period 1|Withdrawal by Subject|0|||
46810462|NCT00420927|83029794|FG005|Period 1|Withdrawal by Subject|0|||
46810463|NCT00420927|83029795|FG006|Period 1|Withdrawal by Subject|0|||
47054114|NCT01802281|83325806|FG000|Overall Study|Ineligible|5|||
46636369|NCT01519674|82810210|FG000|Overall Study|Adverse Event|3|||
46754048|NCT00600938|82971802|FG001|Core Study|Lost to Follow-up|2|||
46810464|NCT00420927|83029789|FG000|Period 1|Lost to Follow-up|8|||
46810465|NCT00420927|83029790|FG001|Period 1|Lost to Follow-up|6|||
47054115|NCT01802281|83325807|FG001|Overall Study|Ineligible|3|||
47054116|NCT01678898|83325830|FG000|PB-102-F01|Adverse Event|0|||
46810466|NCT00420927|83029791|FG002|Period 1|Lost to Follow-up|0|||
46927399|NCT03978520|83161845|FG001|Overall Study|Withdrawal by Subject|4|||
46927400|NCT03978520|83161846|FG002|Overall Study|Withdrawal by Subject|5|||
47054117|NCT01678898|83325831|FG001|PB-102-F01|Adverse Event|1|||
47054118|NCT01678898|83325832|FG002|PB-102-F01|Adverse Event|0|||
47054119|NCT01678898|83325830|FG000|PB-102-F01|Physician Decision|0|||
47054120|NCT01678898|83325831|FG001|PB-102-F01|Physician Decision|1|||
47054121|NCT01678898|83325832|FG002|PB-102-F01|Physician Decision|0|||
47054122|NCT01485861|83325859|FG000|Phase Ib|Death|1|||
46810467|NCT00420927|83029792|FG003|Period 1|Lost to Follow-up|0|||
46810468|NCT00420927|83029793|FG004|Period 1|Lost to Follow-up|0|||
46810469|NCT00420927|83029794|FG005|Period 1|Lost to Follow-up|0|||
46810470|NCT00420927|83029795|FG006|Period 1|Lost to Follow-up|0|||
46810471|NCT00420927|83029789|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
46810472|NCT00420927|83029790|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
46810473|NCT00420927|83029791|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
46810474|NCT00420927|83029792|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
46810475|NCT00420927|83029793|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
46810476|NCT00420927|83029794|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
46810477|NCT00420927|83029795|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
46810478|NCT00420927|83029789|FG000|Period 1|Death|2|||
46810479|NCT00420927|83029790|FG001|Period 1|Death|0|||
46810480|NCT00420927|83029791|FG002|Period 1|Death|0|||
46810481|NCT00420927|83029792|FG003|Period 1|Death|0|||
46810482|NCT00420927|83029793|FG004|Period 1|Death|0|||
46810483|NCT00420927|83029794|FG005|Period 1|Death|0|||
46810484|NCT00420927|83029795|FG006|Period 1|Death|0|||
46810485|NCT00420927|83029789|FG000|Period 1|Subject moved/relocated|0|||
46810486|NCT00420927|83029790|FG001|Period 1|Subject moved/relocated|2|||
46810487|NCT00420927|83029791|FG002|Period 1|Subject moved/relocated|0|||
46810488|NCT00420927|83029792|FG003|Period 1|Subject moved/relocated|0|||
46810489|NCT00420927|83029793|FG004|Period 1|Subject moved/relocated|0|||
46810490|NCT00420927|83029794|FG005|Period 1|Subject moved/relocated|0|||
46810491|NCT00420927|83029795|FG006|Period 1|Subject moved/relocated|0|||
46810492|NCT00420927|83029789|FG000|Period 1|Noncompliant with study drug|1|||
46810493|NCT00420927|83029790|FG001|Period 1|Noncompliant with study drug|1|||
46810494|NCT00420927|83029791|FG002|Period 1|Noncompliant with study drug|0|||
47054123|NCT01485861|83325860|FG001|Phase Ib|Death|0|||
47054124|NCT01485861|83325861|FG002|Phase Ib|Death|0|||
46810495|NCT00420927|83029792|FG003|Period 1|Noncompliant with study drug|0|||
46810496|NCT00420927|83029793|FG004|Period 1|Noncompliant with study drug|0|||
46810497|NCT00420927|83029794|FG005|Period 1|Noncompliant with study drug|0|||
46810498|NCT00420927|83029795|FG006|Period 1|Noncompliant with study drug|0|||
46810499|NCT00420927|83029789|FG000|Period 1|Randomization error|1|||
46810500|NCT00420927|83029790|FG001|Period 1|Randomization error|0|||
46810501|NCT00420927|83029791|FG002|Period 1|Randomization error|0|||
46810502|NCT00420927|83029792|FG003|Period 1|Randomization error|0|||
46810503|NCT00420927|83029793|FG004|Period 1|Randomization error|0|||
46810504|NCT00420927|83029794|FG005|Period 1|Randomization error|0|||
46810505|NCT00420927|83029795|FG006|Period 1|Randomization error|0|||
46810506|NCT00420927|83029789|FG000|Period 1|Suspected tuberculosis/positive test|1|||
47054125|NCT01485861|83325862|FG003|Phase Ib|Death|0|||
47054126|NCT01485861|83325863|FG004|Phase Ib|Death|0|||
46810507|NCT00420927|83029790|FG001|Period 1|Suspected tuberculosis/positive test|1|||
46810508|NCT00420927|83029791|FG002|Period 1|Suspected tuberculosis/positive test|0|||
46810509|NCT00420927|83029792|FG003|Period 1|Suspected tuberculosis/positive test|0|||
46810510|NCT00420927|83029793|FG004|Period 1|Suspected tuberculosis/positive test|0|||
46810511|NCT00420927|83029794|FG005|Period 1|Suspected tuberculosis/positive test|0|||
47054127|NCT01485861|83325864|FG005|Phase Ib|Death|0|||
47054128|NCT01485861|83325859|FG000|Phase Ib|Physician Decision|1|||
47054129|NCT01485861|83325860|FG001|Phase Ib|Physician Decision|1|||
47054130|NCT01485861|83325861|FG002|Phase Ib|Physician Decision|0|||
46754049|NCT00600938|82971803|FG002|Core Study|Lost to Follow-up|0|||
46754050|NCT00600938|82971804|FG003|Core Study|Lost to Follow-up|0|||
46754051|NCT00600938|82971801|FG000|Core Study|Death|1|||
46754052|NCT00600938|82971802|FG001|Core Study|Death|1|||
46754053|NCT00600938|82971803|FG002|Core Study|Death|0|||
46754054|NCT00600938|82971804|FG003|Core Study|Death|0|||
46754055|NCT00600938|82971801|FG000|Core Study|Protocol Violation|1|||
46754056|NCT00600938|82971802|FG001|Core Study|Protocol Violation|2|||
46754057|NCT00600938|82971803|FG002|Core Study|Protocol Violation|0|||
46754058|NCT00600938|82971804|FG003|Core Study|Protocol Violation|0|||
46754059|NCT00600938|82971801|FG000|Extension Study|Adverse Event|1|||
46810512|NCT00420927|83029795|FG006|Period 1|Suspected tuberculosis/positive test|0|||
46810513|NCT00420927|83029789|FG000|Period 1|Study site closure|0|||
46810514|NCT00420927|83029790|FG001|Period 1|Study site closure|1|||
46927401|NCT03978520|83161847|FG003|Overall Study|Withdrawal by Subject|6|||
47054131|NCT01485861|83325862|FG003|Phase Ib|Physician Decision|0|||
47054132|NCT01485861|83325863|FG004|Phase Ib|Physician Decision|0|||
47054133|NCT01485861|83325864|FG005|Phase Ib|Physician Decision|0|||
47054134|NCT01485861|83325859|FG000|Phase Ib|Adverse Event|0|||
47054135|NCT01485861|83325860|FG001|Phase Ib|Adverse Event|4|||
47054136|NCT01485861|83325861|FG002|Phase Ib|Adverse Event|0|||
47054137|NCT01485861|83325862|FG003|Phase Ib|Adverse Event|0|||
47054138|NCT01485861|83325863|FG004|Phase Ib|Adverse Event|0|||
47054139|NCT01485861|83325864|FG005|Phase Ib|Adverse Event|0|||
47054140|NCT01485861|83325859|FG000|Phase Ib|Progression of disease|5|||
47054141|NCT01485861|83325860|FG001|Phase Ib|Progression of disease|0|||
47054142|NCT01485861|83325861|FG002|Phase Ib|Progression of disease|0|||
47054143|NCT01485861|83325862|FG003|Phase Ib|Progression of disease|0|||
47054144|NCT01485861|83325863|FG004|Phase Ib|Progression of disease|0|||
47054145|NCT01485861|83325864|FG005|Phase Ib|Progression of disease|0|||
46810515|NCT00420927|83029791|FG002|Period 1|Study site closure|0|||
46810516|NCT00420927|83029792|FG003|Period 1|Study site closure|0|||
46810517|NCT00420927|83029793|FG004|Period 1|Study site closure|0|||
47054146|NCT01485861|83325859|FG000|Phase Ib|Other|3|||
47054147|NCT01485861|83325860|FG001|Phase Ib|Other|0|||
47054148|NCT01485861|83325861|FG002|Phase Ib|Other|0|||
47054149|NCT01485861|83325862|FG003|Phase Ib|Other|0|||
47054150|NCT01485861|83325863|FG004|Phase Ib|Other|0|||
47054151|NCT01485861|83325864|FG005|Phase Ib|Other|0|||
47054152|NCT01485861|83325859|FG000|Phase Ib|Withdrawal by Subject|4|||
47054153|NCT01485861|83325860|FG001|Phase Ib|Withdrawal by Subject|1|||
47054154|NCT01485861|83325861|FG002|Phase Ib|Withdrawal by Subject|0|||
47054155|NCT01485861|83325862|FG003|Phase Ib|Withdrawal by Subject|0|||
47054156|NCT01485861|83325863|FG004|Phase Ib|Withdrawal by Subject|0|||
46754060|NCT00600938|82971802|FG001|Extension Study|Adverse Event|0|||
46754061|NCT00600938|82971803|FG002|Extension Study|Adverse Event|2|||
46754062|NCT00600938|82971804|FG003|Extension Study|Adverse Event|0|||
46810518|NCT00420927|83029794|FG005|Period 1|Study site closure|0|||
46810519|NCT00420927|83029795|FG006|Period 1|Study site closure|0|||
46810520|NCT00420927|83029789|FG000|Period 1|Subject received new diagnosis|0|||
46810521|NCT00420927|83029790|FG001|Period 1|Subject received new diagnosis|2|||
46810522|NCT00420927|83029791|FG002|Period 1|Subject received new diagnosis|0|||
46810523|NCT00420927|83029792|FG003|Period 1|Subject received new diagnosis|0|||
46810524|NCT00420927|83029793|FG004|Period 1|Subject received new diagnosis|0|||
46810525|NCT00420927|83029794|FG005|Period 1|Subject received new diagnosis|0|||
46754063|NCT00600938|82971801|FG000|Extension Study|Abnormal test procedure results|0|||
46754064|NCT00600938|82971802|FG001|Extension Study|Abnormal test procedure results|1|||
46754065|NCT00600938|82971803|FG002|Extension Study|Abnormal test procedure results|1|||
46810526|NCT00420927|83029795|FG006|Period 1|Subject received new diagnosis|0|||
46810527|NCT00420927|83029789|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
46810528|NCT00420927|83029790|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
46810529|NCT00420927|83029791|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
46810530|NCT00420927|83029792|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
46810531|NCT00420927|83029793|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
46810532|NCT00420927|83029794|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
46810533|NCT00420927|83029795|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
46810534|NCT00420927|83029789|FG000|Period 1|Failed to meet entry criteria|8|||
46810535|NCT00420927|83029790|FG001|Period 1|Failed to meet entry criteria|7|||
46810536|NCT00420927|83029791|FG002|Period 1|Failed to meet entry criteria|0|||
46810537|NCT00420927|83029792|FG003|Period 1|Failed to meet entry criteria|0|||
46810538|NCT00420927|83029793|FG004|Period 1|Failed to meet entry criteria|0|||
46754066|NCT00600938|82971804|FG003|Extension Study|Abnormal test procedure results|1|||
46754067|NCT00600938|82971801|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
46754068|NCT00600938|82971802|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
46754069|NCT00600938|82971803|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
46810539|NCT00420927|83029794|FG005|Period 1|Failed to meet entry criteria|0|||
46810540|NCT00420927|83029795|FG006|Period 1|Failed to meet entry criteria|0|||
46810541|NCT00420927|83029789|FG000|Period 1|Took prohibited medication|1|||
46810542|NCT00420927|83029790|FG001|Period 1|Took prohibited medication|3|||
46810543|NCT00420927|83029791|FG002|Period 1|Took prohibited medication|0|||
46810544|NCT00420927|83029792|FG003|Period 1|Took prohibited medication|0|||
46810545|NCT00420927|83029793|FG004|Period 1|Took prohibited medication|0|||
46810546|NCT00420927|83029794|FG005|Period 1|Took prohibited medication|0|||
46810547|NCT00420927|83029795|FG006|Period 1|Took prohibited medication|0|||
46810548|NCT00420927|83029789|FG000|Period 2|Adverse Event|0|||
46810549|NCT00420927|83029790|FG001|Period 2|Adverse Event|0|||
46810550|NCT00420927|83029791|FG002|Period 2|Adverse Event|7|||
47054157|NCT01485861|83325864|FG005|Phase Ib|Withdrawal by Subject|0|||
47054158|NCT01485861|83325859|FG000|Phase II|Death|0|||
47054159|NCT01485861|83325860|FG001|Phase II|Death|0|||
47054160|NCT01485861|83325861|FG002|Phase II|Death|67|||
47054161|NCT01485861|83325862|FG003|Phase II|Death|71|||
47054162|NCT01485861|83325863|FG004|Phase II|Death|68|||
46810551|NCT00420927|83029792|FG003|Period 2|Adverse Event|3|||
46810552|NCT00420927|83029793|FG004|Period 2|Adverse Event|17|||
47054163|NCT01485861|83325864|FG005|Phase II|Death|0|||
47054164|NCT01485861|83325859|FG000|Phase II|Progression of Disease|0|||
47054165|NCT01485861|83325860|FG001|Phase II|Progression of Disease|0|||
47054166|NCT01485861|83325861|FG002|Phase II|Progression of Disease|1|||
46810553|NCT00420927|83029794|FG005|Period 2|Adverse Event|6|||
47054167|NCT01485861|83325862|FG003|Phase II|Progression of Disease|0|||
46810554|NCT00420927|83029795|FG006|Period 2|Adverse Event|20|||
46810555|NCT00420927|83029789|FG000|Period 2|Withdrawal by Subject|0|||
46810556|NCT00420927|83029790|FG001|Period 2|Withdrawal by Subject|0|||
46810557|NCT00420927|83029791|FG002|Period 2|Withdrawal by Subject|1|||
46810558|NCT00420927|83029792|FG003|Period 2|Withdrawal by Subject|3|||
46810559|NCT00420927|83029793|FG004|Period 2|Withdrawal by Subject|11|||
47054168|NCT01485861|83325863|FG004|Phase II|Progression of Disease|0|||
47054169|NCT01485861|83325864|FG005|Phase II|Progression of Disease|0|||
46810560|NCT00420927|83029794|FG005|Period 2|Withdrawal by Subject|2|||
46810561|NCT00420927|83029795|FG006|Period 2|Withdrawal by Subject|12|||
46810562|NCT00420927|83029789|FG000|Period 2|Lost to Follow-up|0|||
46810563|NCT00420927|83029790|FG001|Period 2|Lost to Follow-up|0|||
46810564|NCT00420927|83029791|FG002|Period 2|Lost to Follow-up|2|||
46810565|NCT00420927|83029792|FG003|Period 2|Lost to Follow-up|2|||
46810566|NCT00420927|83029793|FG004|Period 2|Lost to Follow-up|6|||
46810567|NCT00420927|83029794|FG005|Period 2|Lost to Follow-up|3|||
46810568|NCT00420927|83029795|FG006|Period 2|Lost to Follow-up|9|||
46810569|NCT00420927|83029789|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
46810570|NCT00420927|83029790|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
46810571|NCT00420927|83029791|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
46810572|NCT00420927|83029792|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
46810573|NCT00420927|83029793|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
46810574|NCT00420927|83029794|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
46810575|NCT00420927|83029795|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
46810576|NCT00420927|83029789|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
46810577|NCT00420927|83029790|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
46810578|NCT00420927|83029791|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
47054170|NCT01485861|83325859|FG000|Phase II|Other|0|||
47054171|NCT01485861|83325860|FG001|Phase II|Other|0|||
47054172|NCT01485861|83325861|FG002|Phase II|Other|0|||
47054173|NCT01485861|83325862|FG003|Phase II|Other|1|||
47054174|NCT01485861|83325863|FG004|Phase II|Other|0|||
46810579|NCT00420927|83029792|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
46810580|NCT00420927|83029793|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
46810581|NCT00420927|83029794|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
46810582|NCT00420927|83029795|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
46810583|NCT00420927|83029789|FG000|Period 2|Subject unable to find transportation|0|||
46810584|NCT00420927|83029790|FG001|Period 2|Subject unable to find transportation|0|||
46810585|NCT00420927|83029791|FG002|Period 2|Subject unable to find transportation|0|||
47054175|NCT01485861|83325864|FG005|Phase II|Other|0|||
47054176|NCT01485861|83325859|FG000|Phase II|Withdrawal by Subject|0|||
46810586|NCT00420927|83029792|FG003|Period 2|Subject unable to find transportation|0|||
46810587|NCT00420927|83029793|FG004|Period 2|Subject unable to find transportation|0|||
46810588|NCT00420927|83029794|FG005|Period 2|Subject unable to find transportation|0|||
46810589|NCT00420927|83029795|FG006|Period 2|Subject unable to find transportation|1|||
47054177|NCT01485861|83325860|FG001|Phase II|Withdrawal by Subject|0|||
47054178|NCT01485861|83325861|FG002|Phase II|Withdrawal by Subject|6|||
47054179|NCT01485861|83325862|FG003|Phase II|Withdrawal by Subject|3|||
47054180|NCT01485861|83325863|FG004|Phase II|Withdrawal by Subject|4|||
47054181|NCT01485861|83325864|FG005|Phase II|Withdrawal by Subject|0|||
47054182|NCT01485861|83325859|FG000|Phase II|Lost to Follow-up|0|||
47054183|NCT01485861|83325860|FG001|Phase II|Lost to Follow-up|0|||
47054184|NCT01485861|83325861|FG002|Phase II|Lost to Follow-up|2|||
46754070|NCT00600938|82971804|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
46754071|NCT00600938|82971801|FG000|Extension Study|Withdrawal by Subject|2|||
46754072|NCT00600938|82971802|FG001|Extension Study|Withdrawal by Subject|2|||
46754073|NCT00600938|82971803|FG002|Extension Study|Withdrawal by Subject|3|||
46754074|NCT00600938|82971804|FG003|Extension Study|Withdrawal by Subject|0|||
46754075|NCT00600938|82971801|FG000|Extension Study|Lost to Follow-up|1|||
46754076|NCT00600938|82971802|FG001|Extension Study|Lost to Follow-up|1|||
46754077|NCT00600938|82971803|FG002|Extension Study|Lost to Follow-up|2|||
46810590|NCT00420927|83029789|FG000|Period 2|Physician Decision|0|||
46810591|NCT00420927|83029790|FG001|Period 2|Physician Decision|0|||
46810592|NCT00420927|83029791|FG002|Period 2|Physician Decision|0|||
46810593|NCT00420927|83029792|FG003|Period 2|Physician Decision|0|||
46810594|NCT00420927|83029793|FG004|Period 2|Physician Decision|1|||
46810595|NCT00420927|83029794|FG005|Period 2|Physician Decision|1|||
47054185|NCT01485861|83325862|FG003|Phase II|Lost to Follow-up|3|||
47054186|NCT01485861|83325863|FG004|Phase II|Lost to Follow-up|5|||
47054187|NCT01485861|83325864|FG005|Phase II|Lost to Follow-up|0|||
46754078|NCT00600938|82971804|FG003|Extension Study|Lost to Follow-up|0|||
46754079|NCT00600938|82971801|FG000|Extension Study|Death|1|||
46810596|NCT00420927|83029795|FG006|Period 2|Physician Decision|0|||
46810597|NCT00420927|83029789|FG000|Period 2|Sponsor decision|0|||
46810598|NCT00420927|83029790|FG001|Period 2|Sponsor decision|0|||
47054188|NCT01485861|83325859|FG000|Phase II|Study Ended|0|||
47054189|NCT01485861|83325860|FG001|Phase II|Study Ended|0|||
46810599|NCT00420927|83029791|FG002|Period 2|Sponsor decision|1|||
46810600|NCT00420927|83029792|FG003|Period 2|Sponsor decision|0|||
46810601|NCT00420927|83029793|FG004|Period 2|Sponsor decision|0|||
46810602|NCT00420927|83029794|FG005|Period 2|Sponsor decision|0|||
46810603|NCT00420927|83029795|FG006|Period 2|Sponsor decision|1|||
46810604|NCT00420927|83029789|FG000|Period 2|Randomization error|0|||
46810605|NCT00420927|83029790|FG001|Period 2|Randomization error|0|||
46810606|NCT00420927|83029791|FG002|Period 2|Randomization error|0|||
47054190|NCT01485861|83325861|FG002|Phase II|Study Ended|7|||
47054191|NCT01485861|83325862|FG003|Phase II|Study Ended|8|||
47054192|NCT01485861|83325863|FG004|Phase II|Study Ended|6|||
47054193|NCT01485861|83325864|FG005|Phase II|Study Ended|0|||
46810607|NCT00420927|83029792|FG003|Period 2|Randomization error|0|||
46810608|NCT00420927|83029793|FG004|Period 2|Randomization error|1|||
46810609|NCT00420927|83029794|FG005|Period 2|Randomization error|1|||
46810610|NCT00420927|83029795|FG006|Period 2|Randomization error|0|||
46810611|NCT00420927|83029789|FG000|Period 2|Noncompliant with study drug|0|||
46810612|NCT00420927|83029790|FG001|Period 2|Noncompliant with study drug|0|||
46810613|NCT00420927|83029791|FG002|Period 2|Noncompliant with study drug|0|||
46810614|NCT00420927|83029792|FG003|Period 2|Noncompliant with study drug|1|||
46810615|NCT00420927|83029793|FG004|Period 2|Noncompliant with study drug|0|||
47054194|NCT01485861|83325859|FG000|Safety Phase|Death|0|||
47054195|NCT01485861|83325860|FG001|Safety Phase|Death|0|||
47054196|NCT01485861|83325861|FG002|Safety Phase|Death|0|||
47054197|NCT01485861|83325862|FG003|Safety Phase|Death|0|||
47054198|NCT01485861|83325863|FG004|Safety Phase|Death|0|||
47054199|NCT01485861|83325864|FG005|Safety Phase|Death|2|||
47054200|NCT01485861|83325859|FG000|Safety Phase|Adverse Event|0|||
47054201|NCT01485861|83325860|FG001|Safety Phase|Adverse Event|0|||
47054202|NCT01485861|83325861|FG002|Safety Phase|Adverse Event|0|||
47054203|NCT01485861|83325862|FG003|Safety Phase|Adverse Event|0|||
46754080|NCT00600938|82971802|FG001|Extension Study|Death|0|||
46754081|NCT00600938|82971803|FG002|Extension Study|Death|0|||
46754082|NCT00600938|82971804|FG003|Extension Study|Death|0|||
46754083|NCT00543439|82971845|FG000|Period 1|Adverse Event|0|||
46754084|NCT00543439|82971846|FG001|Period 1|Adverse Event|2|||
46754085|NCT00543439|82971847|FG002|Period 1|Adverse Event|1|||
46754086|NCT00543439|82971845|FG000|Period 1|Withdrawal by Subject|1|||
46754087|NCT00543439|82971846|FG001|Period 1|Withdrawal by Subject|1|||
46754088|NCT00543439|82971847|FG002|Period 1|Withdrawal by Subject|0|||
46754089|NCT00543439|82971845|FG000|Period 1|Physician Decision|0|||
46754090|NCT00543439|82971846|FG001|Period 1|Physician Decision|0|||
46754091|NCT00543439|82971847|FG002|Period 1|Physician Decision|1|||
46754092|NCT00543439|82971845|FG000|Period 2|Protocol Violation|1|||
46754093|NCT00543439|82971846|FG001|Period 2|Protocol Violation|0|||
46754094|NCT00543439|82971847|FG002|Period 2|Protocol Violation|1|||
46754095|NCT00543439|82971845|FG000|Period 2|Adverse Event|0|||
46754096|NCT00543439|82971846|FG001|Period 2|Adverse Event|1|||
46754097|NCT00543439|82971847|FG002|Period 2|Adverse Event|1|||
46754098|NCT00582166|82971864|FG000|Overall Study|Death|1|||
46754099|NCT00582166|82971864|FG000|Overall Study|Ineligible pathology|1|||
46754100|NCT00601172|82971870|FG000|Overall Study|Adverse Event|43|||
46754101|NCT00601172|82971871|FG001|Overall Study|Adverse Event|32|||
46754102|NCT00601172|82971870|FG000|Overall Study|Lack of Efficacy|11|||
46754103|NCT00601172|82971871|FG001|Overall Study|Lack of Efficacy|12|||
46754104|NCT00601172|82971870|FG000|Overall Study|Protocol Violation|2|||
46754105|NCT00601172|82971871|FG001|Overall Study|Protocol Violation|5|||
46810616|NCT00420927|83029794|FG005|Period 2|Noncompliant with study drug|0|||
46927402|NCT03978520|83161848|FG004|Overall Study|Withdrawal by Subject|5|||
46927403|NCT03978520|83161844|FG000|Overall Study|Lost to Follow-up|2|||
46927404|NCT03978520|83161845|FG001|Overall Study|Lost to Follow-up|2|||
46927405|NCT03978520|83161846|FG002|Overall Study|Lost to Follow-up|2|||
47054204|NCT01485861|83325863|FG004|Safety Phase|Adverse Event|0|||
47054205|NCT01485861|83325864|FG005|Safety Phase|Adverse Event|1|||
46754106|NCT00601172|82971870|FG000|Overall Study|Lost to Follow-up|4|||
46754107|NCT00601172|82971871|FG001|Overall Study|Lost to Follow-up|3|||
46754108|NCT00601172|82971870|FG000|Overall Study|Physician Decision|27|||
46754109|NCT00601172|82971871|FG001|Overall Study|Physician Decision|28|||
46754110|NCT00601172|82971870|FG000|Overall Study|Withdrawal by Subject|35|||
46754111|NCT00601172|82971871|FG001|Overall Study|Withdrawal by Subject|27|||
46810617|NCT00420927|83029795|FG006|Period 2|Noncompliant with study drug|2|||
46810618|NCT00420927|83029789|FG000|Period 2|Methotrexate intolerance|0|||
46810619|NCT00420927|83029790|FG001|Period 2|Methotrexate intolerance|0|||
46754112|NCT00601172|82971870|FG000|Overall Study|Did not meet continuation criteria|19|||
46810620|NCT00420927|83029791|FG002|Period 2|Methotrexate intolerance|0|||
46927406|NCT03978520|83161847|FG003|Overall Study|Lost to Follow-up|0|||
47054206|NCT01485861|83325859|FG000|Safety Phase|Other|0|||
46810621|NCT00420927|83029792|FG003|Period 2|Methotrexate intolerance|0|||
46810622|NCT00420927|83029793|FG004|Period 2|Methotrexate intolerance|0|||
46810623|NCT00420927|83029794|FG005|Period 2|Methotrexate intolerance|0|||
47054207|NCT01485861|83325860|FG001|Safety Phase|Other|0|||
47054208|NCT01485861|83325861|FG002|Safety Phase|Other|0|||
47054209|NCT01485861|83325862|FG003|Safety Phase|Other|0|||
47054210|NCT01485861|83325863|FG004|Safety Phase|Other|0|||
47054211|NCT01485861|83325864|FG005|Safety Phase|Other|5|||
47054212|NCT01485861|83325859|FG000|Safety Phase|Progression of Disease|0|||
47054213|NCT01485861|83325860|FG001|Safety Phase|Progression of Disease|0|||
47054214|NCT01485861|83325861|FG002|Safety Phase|Progression of Disease|0|||
47054215|NCT01485861|83325862|FG003|Safety Phase|Progression of Disease|0|||
46810624|NCT00420927|83029795|FG006|Period 2|Methotrexate intolerance|1|||
46927407|NCT03978520|83161848|FG004|Overall Study|Lost to Follow-up|1|||
46927408|NCT03978520|83161844|FG000|Overall Study|COVID-19 infection|0|||
46927409|NCT03978520|83161845|FG001|Overall Study|COVID-19 infection|1|||
46927410|NCT03978520|83161846|FG002|Overall Study|COVID-19 infection|0|||
46927411|NCT03978520|83161847|FG003|Overall Study|COVID-19 infection|0|||
46927412|NCT03978520|83161848|FG004|Overall Study|COVID-19 infection|0|||
46927413|NCT03978520|83161844|FG000|Overall Study|Other, not specified|9|||
46927414|NCT03978520|83161845|FG001|Overall Study|Other, not specified|4|||
47054216|NCT01485861|83325863|FG004|Safety Phase|Progression of Disease|0|||
47054217|NCT01485861|83325864|FG005|Safety Phase|Progression of Disease|9|||
47054218|NCT01485861|83325859|FG000|Safety Phase|Withdrawal by Subject|0|||
47054219|NCT01485861|83325860|FG001|Safety Phase|Withdrawal by Subject|0|||
47054220|NCT01485861|83325861|FG002|Safety Phase|Withdrawal by Subject|0|||
47054221|NCT01485861|83325862|FG003|Safety Phase|Withdrawal by Subject|0|||
47054222|NCT01485861|83325863|FG004|Safety Phase|Withdrawal by Subject|0|||
47054223|NCT01485861|83325864|FG005|Safety Phase|Withdrawal by Subject|6|||
47054224|NCT01485861|83325859|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
47054225|NCT01485861|83325860|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
47054226|NCT01485861|83325861|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
47054227|NCT01485861|83325862|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
47054228|NCT01485861|83325863|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
47054229|NCT01485861|83325864|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
47054230|NCT01101438|83325898|FG000|Overall Study|Withdrawal by Subject|8|||
46927415|NCT03978520|83161846|FG002|Overall Study|Other, not specified|1|||
47054231|NCT01101438|83325899|FG001|Overall Study|Withdrawal by Subject|9|||
46754113|NCT00601172|82971871|FG001|Overall Study|Did not meet continuation criteria|20|||
46754114|NCT00582010|82971880|FG000|Overall Study|Death|0|||
46754115|NCT00582010|82971881|FG001|Overall Study|Death|1|||
46927416|NCT03978520|83161847|FG003|Overall Study|Other, not specified|1|||
47054232|NCT00966979|83325909|FG000|Overall Study|Death|1|||
47054233|NCT00966979|83325909|FG000|Overall Study|Lost to Follow-up|6|||
47054234|NCT00966979|83325909|FG000|Overall Study|Withdrawal by Subject|14|||
47054235|NCT00966979|83325909|FG000|Overall Study|Adverse Event|5|||
47054236|NCT00966979|83325909|FG000|Overall Study|Sponsor terminated early|49|||
47054237|NCT00966979|83325909|FG000|Overall Study|Censored because surgery not done|2|||
47054238|NCT00966979|83325909|FG000|Overall Study|Censored because study device was not implanted|14|||
47054239|NCT00966979|83325909|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
47054240|NCT00931606|83325927|FG000|Overall Study|Death|1|||
47054241|NCT00931606|83325928|FG001|Overall Study|Death|3|||
47054242|NCT00931606|83325929|FG002|Overall Study|Death|2|||
46754116|NCT02771795|82971889|FG000|Overall Study|Withdrawal by Subject|47|||
46754117|NCT02771795|82971890|FG001|Overall Study|Withdrawal by Subject|37|||
46754118|NCT02771795|82971889|FG000|Overall Study|Termination by premature discontinuation of study|168|||
46754119|NCT02771795|82971890|FG001|Overall Study|Termination by premature discontinuation of study|185|||
46754120|NCT00580840|82971896|FG000|Run-in|Adverse Event|17|||
46754121|NCT00580840|82971897|FG001|Run-in|Adverse Event|0|||
46754122|NCT00580840|82971898|FG002|Run-in|Adverse Event|0|||
46754123|NCT00580840|82971899|FG003|Run-in|Adverse Event|0|||
46754124|NCT00580840|82971896|FG000|Run-in|Lack of Efficacy|93|||
46754125|NCT00580840|82971897|FG001|Run-in|Lack of Efficacy|0|||
46754126|NCT00580840|82971898|FG002|Run-in|Lack of Efficacy|0|||
46754127|NCT00580840|82971899|FG003|Run-in|Lack of Efficacy|0|||
46754128|NCT00580840|82971896|FG000|Run-in|Loss of Efficacy|1|||
46754129|NCT00580840|82971897|FG001|Run-in|Loss of Efficacy|0|||
46754130|NCT00580840|82971898|FG002|Run-in|Loss of Efficacy|0|||
46754131|NCT00580840|82971899|FG003|Run-in|Loss of Efficacy|0|||
46754132|NCT00580840|82971896|FG000|Run-in|Lost to Follow-up|4|||
46754133|NCT00580840|82971897|FG001|Run-in|Lost to Follow-up|0|||
46754134|NCT00580840|82971898|FG002|Run-in|Lost to Follow-up|0|||
46754135|NCT00580840|82971899|FG003|Run-in|Lost to Follow-up|0|||
46810625|NCT00420927|83029789|FG000|Period 2|Took prohibited medication|0|||
46810626|NCT00420927|83029790|FG001|Period 2|Took prohibited medication|0|||
46927417|NCT03978520|83161848|FG004|Overall Study|Other, not specified|2|||
46927418|NCT03978520|83161844|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
47054243|NCT00931606|83325930|FG003|Overall Study|Death|0|||
47054244|NCT00931606|83325927|FG000|Overall Study|Lost to Follow-up|0|||
47054245|NCT00931606|83325928|FG001|Overall Study|Lost to Follow-up|1|||
47054246|NCT00931606|83325929|FG002|Overall Study|Lost to Follow-up|0|||
47054247|NCT00931606|83325930|FG003|Overall Study|Lost to Follow-up|0|||
47054248|NCT00931606|83325927|FG000|Overall Study|Physician Decision|0|||
47054249|NCT00931606|83325928|FG001|Overall Study|Physician Decision|0|||
47054250|NCT00931606|83325929|FG002|Overall Study|Physician Decision|3|||
47054251|NCT00931606|83325930|FG003|Overall Study|Physician Decision|0|||
47054252|NCT00931606|83325927|FG000|Overall Study|Sponsor Decision|1|||
46810627|NCT00420927|83029791|FG002|Period 2|Took prohibited medication|0|||
46810628|NCT00420927|83029792|FG003|Period 2|Took prohibited medication|0|||
46810629|NCT00420927|83029793|FG004|Period 2|Took prohibited medication|1|||
46810630|NCT00420927|83029794|FG005|Period 2|Took prohibited medication|0|||
46810631|NCT00420927|83029795|FG006|Period 2|Took prohibited medication|0|||
47054253|NCT00931606|83325928|FG001|Overall Study|Sponsor Decision|4|||
47054254|NCT00931606|83325929|FG002|Overall Study|Sponsor Decision|0|||
47054255|NCT00931606|83325930|FG003|Overall Study|Sponsor Decision|2|||
47054256|NCT00931606|83325927|FG000|Overall Study|Withdrawal by Subject|3|||
47054257|NCT00931606|83325928|FG001|Overall Study|Withdrawal by Subject|1|||
47054258|NCT00931606|83325929|FG002|Overall Study|Withdrawal by Subject|1|||
46636370|NCT01519674|82810211|FG001|Overall Study|Adverse Event|3|||
46636371|NCT01519674|82810212|FG002|Overall Study|Adverse Event|0|||
46636372|NCT01519674|82810210|FG000|Overall Study|Lack of Efficacy|1|||
46636373|NCT01519674|82810211|FG001|Overall Study|Lack of Efficacy|1|||
46754136|NCT00580840|82971896|FG000|Run-in|Withdrawal by Subject|5|||
46754137|NCT00580840|82971897|FG001|Run-in|Withdrawal by Subject|0|||
46754138|NCT00580840|82971898|FG002|Run-in|Withdrawal by Subject|0|||
46754139|NCT00580840|82971899|FG003|Run-in|Withdrawal by Subject|0|||
46754140|NCT00580840|82971896|FG000|Run-in|Other: Per Sponsor Request|2|||
46754141|NCT00580840|82971897|FG001|Run-in|Other: Per Sponsor Request|0|||
46754142|NCT00580840|82971898|FG002|Run-in|Other: Per Sponsor Request|0|||
46754143|NCT00580840|82971899|FG003|Run-in|Other: Per Sponsor Request|0|||
46754144|NCT00580840|82971896|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
46754145|NCT00580840|82971897|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
46754146|NCT00580840|82971898|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
46754147|NCT00580840|82971899|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
46754148|NCT00580840|82971896|FG000|Run-in|Other: Exclusionary Lab Value|1|||
46754149|NCT00580840|82971897|FG001|Run-in|Other: Exclusionary Lab Value|0|||
46636374|NCT01519674|82810212|FG002|Overall Study|Lack of Efficacy|1|||
46636375|NCT01519674|82810210|FG000|Overall Study|Protocol Violation|0|||
46636376|NCT01519674|82810211|FG001|Overall Study|Protocol Violation|3|||
46636377|NCT01519674|82810212|FG002|Overall Study|Protocol Violation|1|||
46636378|NCT01519674|82810210|FG000|Overall Study|Withdrawal Criteria|7|||
46636379|NCT01519674|82810211|FG001|Overall Study|Withdrawal Criteria|2|||
46636380|NCT01519674|82810212|FG002|Overall Study|Withdrawal Criteria|7|||
46636381|NCT01519674|82810210|FG000|Overall Study|Unsclassified|10|||
46636382|NCT01519674|82810211|FG001|Overall Study|Unsclassified|4|||
46636383|NCT01519674|82810212|FG002|Overall Study|Unsclassified|3|||
46636384|NCT01519518|82810222|FG000|Overall Study|Consent not available|7|||
46754150|NCT00580840|82971898|FG002|Run-in|Other: Exclusionary Lab Value|0|||
46754151|NCT00580840|82971899|FG003|Run-in|Other: Exclusionary Lab Value|0|||
46754152|NCT00580840|82971896|FG000|Double-Blind|Adverse Event|0|||
46754153|NCT00580840|82971897|FG001|Double-Blind|Adverse Event|3|||
46754154|NCT00580840|82971898|FG002|Double-Blind|Adverse Event|4|||
46754155|NCT00580840|82971899|FG003|Double-Blind|Adverse Event|1|||
46754156|NCT00580840|82971896|FG000|Double-Blind|Loss of Efficacy|0|||
46754157|NCT00580840|82971897|FG001|Double-Blind|Loss of Efficacy|1|||
46754158|NCT00580840|82971898|FG002|Double-Blind|Loss of Efficacy|2|||
46754159|NCT00580840|82971899|FG003|Double-Blind|Loss of Efficacy|10|||
46810632|NCT00573443|83029812|FG000|Double-Blind Phase|Lost to Follow-up|1|||
46810633|NCT00573443|83029813|FG001|Double-Blind Phase|Lost to Follow-up|3|||
47054259|NCT00931606|83325930|FG003|Overall Study|Withdrawal by Subject|1|||
47054260|NCT00706914|83326001|FG000|Overall Study|Lack of Efficacy|0|||
46754160|NCT00580840|82971896|FG000|Double-Blind|Lost to Follow-up|0|||
46754161|NCT00580840|82971897|FG001|Double-Blind|Lost to Follow-up|1|||
46754162|NCT00580840|82971898|FG002|Double-Blind|Lost to Follow-up|0|||
46636385|NCT01519518|82810223|FG001|Overall Study|Consent not available|10|||
46754163|NCT00580840|82971899|FG003|Double-Blind|Lost to Follow-up|2|||
46754164|NCT00580840|82971896|FG000|Double-Blind|Withdrawal by Subject|0|||
46810634|NCT00573443|83029814|FG002|Double-Blind Phase|Lost to Follow-up|2|||
47054261|NCT00706914|83326002|FG001|Overall Study|Lack of Efficacy|1|||
47054262|NCT00706914|83326003|FG002|Overall Study|Lack of Efficacy|0|||
47054263|NCT00706914|83326001|FG000|Overall Study|Lost to Follow-up|1|||
46636386|NCT01519206|82810229|FG000|Overall Study|Lost to Follow-up|3|||
47054264|NCT00706914|83326002|FG001|Overall Study|Lost to Follow-up|0|||
47054265|NCT00706914|83326003|FG002|Overall Study|Lost to Follow-up|0|||
47054266|NCT00706914|83326001|FG000|Overall Study|Adverse Event|2|||
47054267|NCT00706914|83326002|FG001|Overall Study|Adverse Event|2|||
47054268|NCT00706914|83326003|FG002|Overall Study|Adverse Event|0|||
47054269|NCT00706914|83326001|FG000|Overall Study|Protocol Violation|3|||
47054270|NCT00706914|83326002|FG001|Overall Study|Protocol Violation|1|||
47054271|NCT00706914|83326003|FG002|Overall Study|Protocol Violation|1|||
47054272|NCT01808651|83326110|FG000|Study Period 1|Lost to Follow-up|1|||
47054273|NCT01808651|83326111|FG001|Study Period 1|Lost to Follow-up|3|||
47054274|NCT01808651|83326112|FG002|Study Period 1|Lost to Follow-up|0|||
47054275|NCT01808651|83326110|FG000|Study Period 1|Protocol Violation|1|||
47054276|NCT01808651|83326111|FG001|Study Period 1|Protocol Violation|0|||
47054277|NCT01808651|83326112|FG002|Study Period 1|Protocol Violation|1|||
47054278|NCT01808651|83326110|FG000|Study Period 1|Physician Decision|3|||
47054279|NCT01808651|83326111|FG001|Study Period 1|Physician Decision|2|||
47054280|NCT01808651|83326112|FG002|Study Period 1|Physician Decision|0|||
47054281|NCT01808651|83326110|FG000|Study Period 1|Lack of Efficacy|2|||
47054282|NCT01808651|83326111|FG001|Study Period 1|Lack of Efficacy|1|||
47054283|NCT01808651|83326112|FG002|Study Period 1|Lack of Efficacy|0|||
47054284|NCT01808651|83326110|FG000|Study Period 1|Adverse Event|10|||
47054285|NCT01808651|83326111|FG001|Study Period 1|Adverse Event|4|||
47054286|NCT01808651|83326112|FG002|Study Period 1|Adverse Event|1|||
47054287|NCT01808651|83326110|FG000|Study Period 1|Participant Decision|9|||
47054288|NCT01808651|83326111|FG001|Study Period 1|Participant Decision|7|||
47054289|NCT01808651|83326112|FG002|Study Period 1|Participant Decision|3|||
47054290|NCT00706134|83326177|FG000|Overall Study|Adverse Event|8|||
47054291|NCT00706134|83326178|FG001|Overall Study|Adverse Event|7|||
47054292|NCT00706134|83326179|FG002|Overall Study|Adverse Event|2|||
47054293|NCT00706134|83326180|FG003|Overall Study|Adverse Event|3|||
47054294|NCT00706134|83326177|FG000|Overall Study|Lost to Follow-up|0|||
47054295|NCT00706134|83326178|FG001|Overall Study|Lost to Follow-up|1|||
47054296|NCT00706134|83326179|FG002|Overall Study|Lost to Follow-up|0|||
47054297|NCT00706134|83326180|FG003|Overall Study|Lost to Follow-up|0|||
47054298|NCT00706134|83326177|FG000|Overall Study|Protocol Violation|0|||
47054299|NCT00706134|83326178|FG001|Overall Study|Protocol Violation|6|||
47054300|NCT00706134|83326179|FG002|Overall Study|Protocol Violation|0|||
47054301|NCT00706134|83326180|FG003|Overall Study|Protocol Violation|3|||
47054302|NCT00706134|83326177|FG000|Overall Study|Withdrawal by Subject|1|||
47054303|NCT00706134|83326178|FG001|Overall Study|Withdrawal by Subject|2|||
47054304|NCT00706134|83326179|FG002|Overall Study|Withdrawal by Subject|1|||
47054305|NCT00706134|83326180|FG003|Overall Study|Withdrawal by Subject|0|||
47054306|NCT00706134|83326177|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
47054307|NCT00706134|83326178|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
47054308|NCT00706134|83326179|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
47054309|NCT00706134|83326180|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
47054310|NCT00706134|83326177|FG000|Overall Study|Did not meet study criteria|2|||
47054311|NCT00706134|83326178|FG001|Overall Study|Did not meet study criteria|0|||
47054312|NCT00706134|83326179|FG002|Overall Study|Did not meet study criteria|0|||
47054313|NCT00706134|83326180|FG003|Overall Study|Did not meet study criteria|0|||
47054314|NCT01808573|83326192|FG000|Overall Study|Death|212|||
46754165|NCT00580840|82971897|FG001|Double-Blind|Withdrawal by Subject|1|||
46754166|NCT00580840|82971898|FG002|Double-Blind|Withdrawal by Subject|2|||
46754167|NCT00580840|82971899|FG003|Double-Blind|Withdrawal by Subject|2|||
46754168|NCT00580840|82971896|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
46754169|NCT00580840|82971897|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
46754170|NCT00580840|82971898|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
46754171|NCT00580840|82971899|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
46754172|NCT00580840|82971896|FG000|Double-Blind|Other: Forbidden Medication|0|||
46754173|NCT00580840|82971897|FG001|Double-Blind|Other: Forbidden Medication|0|||
46754174|NCT00580840|82971898|FG002|Double-Blind|Other: Forbidden Medication|1|||
46754175|NCT00580840|82971899|FG003|Double-Blind|Other: Forbidden Medication|0|||
47054315|NCT01808573|83326193|FG001|Overall Study|Death|240|||
47054316|NCT01808573|83326192|FG000|Overall Study|Withdrawal by Subject|12|||
47054317|NCT01808573|83326193|FG001|Overall Study|Withdrawal by Subject|10|||
47054318|NCT01808573|83326192|FG000|Overall Study|Lost to Follow-up|3|||
47054319|NCT01808573|83326193|FG001|Overall Study|Lost to Follow-up|0|||
47054320|NCT01808573|83326192|FG000|Overall Study|Discontinuation of study by sponsor|79|||
47054321|NCT01808573|83326193|FG001|Overall Study|Discontinuation of study by sponsor|64|||
46636387|NCT01519206|82810229|FG000|Overall Study|Missed Visit|2|||
47054322|NCT01808573|83326192|FG000|Overall Study|Randomized in Error|1|||
47054323|NCT01808573|83326193|FG001|Overall Study|Randomized in Error|0|||
47054324|NCT02246530|83326220|FG000|Overall Study|Lost to Follow-up|4|||
47054325|NCT02246530|83326221|FG001|Overall Study|Lost to Follow-up|0|||
47054326|NCT01808339|83326227|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054327|NCT01808339|83326228|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054328|NCT01808339|83326229|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054329|NCT01808339|83326230|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
47054330|NCT01808339|83326231|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
47054331|NCT01808339|83326232|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
47054332|NCT01808339|83326227|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
46927419|NCT03978520|83161845|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
47054333|NCT01808339|83326228|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
47054334|NCT01808339|83326229|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47054335|NCT01808339|83326230|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
47054336|NCT01808339|83326231|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47054337|NCT01808339|83326232|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
47054338|NCT01808339|83326227|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054339|NCT01808339|83326228|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054340|NCT01808339|83326229|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
46927420|NCT03978520|83161846|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
46927421|NCT03978520|83161847|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
46927422|NCT03978520|83161848|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
47054341|NCT01808339|83326230|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054342|NCT01808339|83326231|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054343|NCT01808339|83326232|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
47054344|NCT02727660|83326282|FG000|Overall Study|Lack of Efficacy|40|||
47054345|NCT02727660|83326283|FG001|Overall Study|Lack of Efficacy|40|||
47054346|NCT02727660|83326284|FG002|Overall Study|Lack of Efficacy|70|||
47054347|NCT02727660|83326282|FG000|Overall Study|Adverse Event|28|||
47054348|NCT02727660|83326283|FG001|Overall Study|Adverse Event|21|||
47054349|NCT02727660|83326284|FG002|Overall Study|Adverse Event|32|||
47054350|NCT02727660|83326282|FG000|Overall Study|Withdrawal by Subject|26|||
46754176|NCT00879684|82971909|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
46754177|NCT00879684|82971910|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
46754178|NCT00879684|82971911|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
46754179|NCT00879684|82971912|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
46754180|NCT00879684|82971913|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
46754181|NCT00879684|82971914|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
46754182|NCT00879684|82971915|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
46754183|NCT00879684|82971909|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
46754184|NCT00879684|82971910|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
46754185|NCT00879684|82971911|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
46754186|NCT00879684|82971912|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
46754187|NCT00879684|82971913|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
46754188|NCT00879684|82971914|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
46927423|NCT03929393|83161860|FG000|Overall Study|Death|1|||
46927424|NCT03929393|83161861|FG001|Overall Study|Death|0|||
46927425|NCT03929393|83161860|FG000|Overall Study|Time Commitment|2|||
46927426|NCT03929393|83161861|FG001|Overall Study|Time Commitment|5|||
46927427|NCT03929393|83161860|FG000|Overall Study|Motor Vehicle Accident|0|||
46927428|NCT03929393|83161861|FG001|Overall Study|Motor Vehicle Accident|1|||
46927429|NCT03929393|83161860|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
46927430|NCT03929393|83161861|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
46927431|NCT03929393|83161860|FG000|Overall Study|Other|1|||
46927432|NCT03929393|83161861|FG001|Overall Study|Other|3|||
46927433|NCT03874715|83161869|FG000|Overall Study|Adverse Event|2|||
46927434|NCT03874715|83161870|FG001|Overall Study|Adverse Event|0|||
46927435|NCT03874715|83161869|FG000|Overall Study|Poor compliance to protocol|5|||
46927436|NCT03874715|83161870|FG001|Overall Study|Poor compliance to protocol|1|||
46927437|NCT03874715|83161869|FG000|Overall Study|Withdrawal by Subject|1|||
47054351|NCT02727660|83326283|FG001|Overall Study|Withdrawal by Subject|25|||
46754189|NCT00879684|82971915|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
46754190|NCT00879684|82971909|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
46754191|NCT00879684|82971910|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
46927438|NCT03874715|83161870|FG001|Overall Study|Withdrawal by Subject|0|||
46927439|NCT03874715|83161869|FG000|Overall Study|Other-unspecified|1|||
46636388|NCT01518972|82810242|FG000|Overall Study|Lost to Follow-up|2|||
46636389|NCT01518972|82810243|FG001|Overall Study|Lost to Follow-up|1|||
46927440|NCT03874715|83161870|FG001|Overall Study|Other-unspecified|0|||
46927441|NCT03502200|83161882|FG000|Overall Study|Adverse Event|1|||
46927442|NCT03502200|83161883|FG001|Overall Study|Adverse Event|0|||
46927443|NCT03502200|83161882|FG000|Overall Study|Lost to Follow-up|36|||
46754192|NCT00879684|82971911|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
46927444|NCT03502200|83161883|FG001|Overall Study|Lost to Follow-up|38|||
46927445|NCT03502200|83161882|FG000|Overall Study|Study Team Decision|1|||
46927446|NCT03502200|83161883|FG001|Overall Study|Study Team Decision|1|||
46810635|NCT00573443|83029812|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
46810636|NCT00573443|83029813|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
46810637|NCT00573443|83029814|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
46810638|NCT00573443|83029812|FG000|Double-Blind Phase|Adverse Event|1|||
46810639|NCT00573443|83029813|FG001|Double-Blind Phase|Adverse Event|5|||
46810640|NCT00573443|83029814|FG002|Double-Blind Phase|Adverse Event|0|||
46810641|NCT00573443|83029812|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
46810642|NCT00573443|83029813|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
46810643|NCT00573443|83029814|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
46810644|NCT00573443|83029812|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
46810645|NCT00573443|83029813|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
46810646|NCT00573443|83029814|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
46810647|NCT00573443|83029812|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
46810648|NCT00573443|83029813|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
46810649|NCT00573443|83029814|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
46810650|NCT00573443|83029812|FG000|Double-Blind Phase|Protocol Violation|0|||
46810651|NCT00573443|83029813|FG001|Double-Blind Phase|Protocol Violation|2|||
46810652|NCT00573443|83029814|FG002|Double-Blind Phase|Protocol Violation|1|||
46810653|NCT00573443|83029812|FG000|Double-Blind Phase|Other|0|||
46810654|NCT00573443|83029813|FG001|Double-Blind Phase|Other|2|||
46810655|NCT00573443|83029814|FG002|Double-Blind Phase|Other|3|||
46810656|NCT00573443|83029812|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
46810657|NCT00573443|83029813|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
46810658|NCT00573443|83029814|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
46810659|NCT00573443|83029812|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
46810660|NCT00573443|83029813|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
46810661|NCT00573443|83029814|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
46810662|NCT00573443|83029812|FG000|Open-Label Extension Phase|Adverse Event|3|||
46810663|NCT00573443|83029813|FG001|Open-Label Extension Phase|Adverse Event|0|||
46810664|NCT00573443|83029814|FG002|Open-Label Extension Phase|Adverse Event|0|||
46810665|NCT00573443|83029812|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
46810666|NCT00573443|83029813|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
46810667|NCT00573443|83029814|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
46810668|NCT00573443|83029812|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
46810669|NCT00573443|83029813|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
46810670|NCT00573443|83029814|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
46810671|NCT00573443|83029812|FG000|Open-Label Extension Phase|Protocol Violation|2|||
46810672|NCT00573443|83029813|FG001|Open-Label Extension Phase|Protocol Violation|0|||
46810673|NCT00573443|83029814|FG002|Open-Label Extension Phase|Protocol Violation|0|||
46810674|NCT00573443|83029812|FG000|Open-Label Extension Phase|Other|2|||
46927447|NCT03502200|83161882|FG000|Overall Study|Withdrawal by Subject|5|||
46927448|NCT03502200|83161883|FG001|Overall Study|Withdrawal by Subject|7|||
46636390|NCT01518972|82810242|FG000|Overall Study|Withdrawal by Subject|1|||
46636391|NCT01518972|82810243|FG001|Overall Study|Withdrawal by Subject|0|||
46636392|NCT01518972|82810242|FG000|Overall Study|Moved from area|1|||
46636393|NCT01518972|82810243|FG001|Overall Study|Moved from area|0|||
46636394|NCT01518972|82810242|FG000|Overall Study|Transportation problems|1|||
46636395|NCT01518972|82810243|FG001|Overall Study|Transportation problems|0|||
46636396|NCT01518972|82810242|FG000|Overall Study|Exclusionary medical condition|1|||
46636397|NCT01518972|82810243|FG001|Overall Study|Exclusionary medical condition|0|||
46754193|NCT00879684|82971912|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
46754194|NCT00879684|82971913|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
46754195|NCT00879684|82971914|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
46754196|NCT00879684|82971915|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
46754197|NCT00879684|82971909|FG000|Stage 1: Dose Escalation|Death|0|||
46754198|NCT00879684|82971910|FG001|Stage 1: Dose Escalation|Death|0|||
46754199|NCT00879684|82971911|FG002|Stage 1: Dose Escalation|Death|1|||
46754200|NCT00879684|82971912|FG003|Stage 1: Dose Escalation|Death|0|||
46754201|NCT00879684|82971913|FG004|Stage 1: Dose Escalation|Death|0|||
46754202|NCT00879684|82971914|FG005|Stage 1: Dose Escalation|Death|0|||
46754203|NCT00879684|82971915|FG006|Stage 1: Dose Escalation|Death|0|||
46810675|NCT00573443|83029813|FG001|Open-Label Extension Phase|Other|0|||
46810676|NCT00573443|83029814|FG002|Open-Label Extension Phase|Other|0|||
46810677|NCT00420849|83029823|FG000|Overall Study|Lack of Efficacy|154|||
46810678|NCT00420849|83029823|FG000|Overall Study|Adverse Event|107|||
46927449|NCT03502200|83161882|FG000|Overall Study|Death|0|||
46636398|NCT01518972|82810242|FG000|Overall Study|Missed safety visits|0|||
46754204|NCT00879684|82971909|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
46810679|NCT00420849|83029823|FG000|Overall Study|Withdrawal by Subject|28|||
46810680|NCT00420849|83029823|FG000|Overall Study|Death|18|||
46636399|NCT01518972|82810243|FG001|Overall Study|Missed safety visits|1|||
46927450|NCT03502200|83161883|FG001|Overall Study|Death|2|||
46927451|NCT03336242|83161891|FG000|Overall Study|Adverse Event|0|||
46927452|NCT03336242|83161892|FG001|Overall Study|Adverse Event|1|||
46927453|NCT03334435|83161903|FG000|Overall Study|Ongoing as of Week 52|70|||
46927454|NCT03334435|83161904|FG001|Overall Study|Ongoing as of Week 52|32|||
46927455|NCT03334435|83161905|FG002|Overall Study|Ongoing as of Week 52|379|||
46636400|NCT01518972|82810242|FG000|Overall Study|Exclusionary medication|0|||
46636401|NCT01518972|82810243|FG001|Overall Study|Exclusionary medication|1|||
46636402|NCT01518972|82810242|FG000|Overall Study|Declined medication starting on day 12|0|||
46636403|NCT01518972|82810243|FG001|Overall Study|Declined medication starting on day 12|1|||
46636404|NCT01514136|82810251|FG000|Test Period 1; Test A|Protocol Violation|1|||
46636405|NCT01514136|82810252|FG001|Test Period 1; Test A|Protocol Violation|0|||
46636406|NCT01514136|82810253|FG002|Test Period 1; Test A|Protocol Violation|0|||
46636407|NCT01514136|82810254|FG003|Test Period 1; Test A|Protocol Violation|0|||
46636408|NCT01514136|82810255|FG004|Test Period 1; Test A|Protocol Violation|0|||
46636409|NCT01514136|82810256|FG005|Test Period 1; Test A|Protocol Violation|0|||
46636410|NCT01514136|82810257|FG006|Test Period 1; Test A|Protocol Violation|0|||
46636411|NCT01514136|82810258|FG007|Test Period 1; Test A|Protocol Violation|0|||
46927456|NCT03334435|83161906|FG003|Overall Study|Ongoing as of Week 52|519|||
46927457|NCT03334435|83161907|FG004|Overall Study|Ongoing as of Week 52|146|||
47054352|NCT02727660|83326284|FG002|Overall Study|Withdrawal by Subject|30|||
46754205|NCT00879684|82971910|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
46754206|NCT00879684|82971911|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
46754207|NCT00879684|82971912|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
46754208|NCT00879684|82971913|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
46754209|NCT00879684|82971914|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
46754210|NCT00879684|82971915|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
47054353|NCT02727660|83326282|FG000|Overall Study|Physician Decision|3|||
47054354|NCT02727660|83326283|FG001|Overall Study|Physician Decision|8|||
47054355|NCT02727660|83326284|FG002|Overall Study|Physician Decision|14|||
47054356|NCT02727660|83326282|FG000|Overall Study|Lost to Follow-up|5|||
47054357|NCT02727660|83326283|FG001|Overall Study|Lost to Follow-up|9|||
47054358|NCT02727660|83326284|FG002|Overall Study|Lost to Follow-up|8|||
47054359|NCT02727660|83326282|FG000|Overall Study|Protocol Violation|7|||
47054360|NCT02727660|83326283|FG001|Overall Study|Protocol Violation|5|||
46754211|NCT00879684|82971909|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
46754212|NCT00879684|82971910|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
46754213|NCT00879684|82971911|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
46754214|NCT00879684|82971912|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
46754215|NCT00879684|82971913|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
46754216|NCT00879684|82971914|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
46636412|NCT01514136|82810251|FG000|Test Period 1; Test A|Break from study holiday|2|||
46754217|NCT00879684|82971915|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
46754218|NCT00879684|82971909|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
46754219|NCT00879684|82971910|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
46754220|NCT00879684|82971911|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
46754221|NCT00879684|82971912|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
46754222|NCT00879684|82971913|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
46754223|NCT00879684|82971914|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
46754224|NCT00879684|82971915|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
46754225|NCT00581776|82971934|FG000|Overall Study|Disease progression or no response|3|||
46754226|NCT00883740|82971938|FG000|First Intervention|Lost to Follow-up|1|||
46754227|NCT00883740|82971939|FG001|First Intervention|Lost to Follow-up|0|||
46754228|NCT00883740|82971938|FG000|First Intervention|No longer willing to participate|2|||
46754229|NCT00883740|82971939|FG001|First Intervention|No longer willing to participate|0|||
46754230|NCT00883740|82971938|FG000|First Intervention|Protocol Violation|3|||
46754231|NCT00883740|82971939|FG001|First Intervention|Protocol Violation|6|||
46754232|NCT00883740|82971938|FG000|First Intervention|Adverse Event|1|||
46754233|NCT00883740|82971939|FG001|First Intervention|Adverse Event|2|||
46754234|NCT00883740|82971938|FG000|Second Intervention|Protocol Violation|1|||
46754235|NCT00883740|82971939|FG001|Second Intervention|Protocol Violation|0|||
46754236|NCT00883740|82971938|FG000|Second Intervention|No longer willing to participate|0|||
46754237|NCT00883740|82971939|FG001|Second Intervention|No longer willing to participate|1|||
46754238|NCT00597012|82971947|FG000|Overall Study|Death|1|||
46754239|NCT00597012|82971948|FG001|Overall Study|Death|1|||
46810681|NCT00420849|83029823|FG000|Overall Study|Other|14|||
46927458|NCT03334435|83161903|FG000|Overall Study|Lack of Efficacy|3|||
47054361|NCT02727660|83326284|FG002|Overall Study|Protocol Violation|5|||
47054362|NCT02727660|83326282|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
46810682|NCT00420849|83029823|FG000|Overall Study|Transplant|8|||
46810683|NCT00420849|83029823|FG000|Overall Study|Protocol Violation|1|||
46810684|NCT00420849|83029823|FG000|Overall Study|Lost to Follow-up|1|||
46810685|NCT00617279|83029832|FG000|Overall Study|Study terminated by Sponsor|10|||
46810686|NCT00617279|83029833|FG001|Overall Study|Study terminated by Sponsor|15|||
46810687|NCT00617279|83029832|FG000|Overall Study|Graft abandonment|2|||
46810688|NCT00617279|83029833|FG001|Overall Study|Graft abandonment|0|||
46810689|NCT00617279|83029832|FG000|Overall Study|Lost to Follow-up|1|||
46810690|NCT00617279|83029833|FG001|Overall Study|Lost to Follow-up|0|||
46810691|NCT00617279|83029832|FG000|Overall Study|Death|1|||
46810692|NCT00617279|83029833|FG001|Overall Study|Death|2|||
46810693|NCT00420381|83029839|FG000|Overall Study|Protocol Violation|1|||
46810694|NCT00617201|83029845|FG000|Overall Study|Lost to Follow-up|9|||
46810695|NCT00617201|83029846|FG001|Overall Study|Lost to Follow-up|13|||
46810696|NCT00420303|83029856|FG000|Overall Study|Serious Adverse Event|1|||
46810697|NCT00420303|83029857|FG001|Overall Study|Serious Adverse Event|0|||
46810698|NCT00420303|83029856|FG000|Overall Study|Lack of Efficacy|0|||
46810699|NCT00420303|83029857|FG001|Overall Study|Lack of Efficacy|3|||
46810700|NCT00420303|83029856|FG000|Overall Study|Physician Decision|0|||
46810701|NCT00420303|83029857|FG001|Overall Study|Physician Decision|1|||
46810702|NCT00617123|83029865|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
46810703|NCT00617123|83029866|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
46927459|NCT03334435|83161904|FG001|Overall Study|Lack of Efficacy|5|||
46927460|NCT03334435|83161905|FG002|Overall Study|Lack of Efficacy|76|||
46927461|NCT03334435|83161906|FG003|Overall Study|Lack of Efficacy|140|||
46927462|NCT03334435|83161907|FG004|Overall Study|Lack of Efficacy|61|||
46927463|NCT03334435|83161903|FG000|Overall Study|Adverse Event|2|||
46927464|NCT03334435|83161904|FG001|Overall Study|Adverse Event|1|||
46927465|NCT03334435|83161905|FG002|Overall Study|Adverse Event|9|||
46927466|NCT03334435|83161906|FG003|Overall Study|Adverse Event|23|||
46927467|NCT03334435|83161907|FG004|Overall Study|Adverse Event|13|||
46927468|NCT03334435|83161903|FG000|Overall Study|Withdrawal by Subject|11|||
46927469|NCT03334435|83161904|FG001|Overall Study|Withdrawal by Subject|4|||
46927470|NCT03334435|83161905|FG002|Overall Study|Withdrawal by Subject|38|||
46810704|NCT00617123|83029865|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
46810705|NCT00617123|83029866|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
46927471|NCT03334435|83161906|FG003|Overall Study|Withdrawal by Subject|42|||
46754240|NCT00597012|82971947|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
46810706|NCT00617123|83029865|FG000|Referral Screening Period|Adverse Event|0|||
46810707|NCT00617123|83029866|FG001|Referral Screening Period|Adverse Event|1|||
46810708|NCT00617123|83029865|FG000|Study Treatment Period|Withdrawal by Subject|8|||
46810709|NCT00617123|83029866|FG001|Study Treatment Period|Withdrawal by Subject|12|||
46810710|NCT00617123|83029865|FG000|Study Treatment Period|Adverse Event|7|||
46810711|NCT00617123|83029866|FG001|Study Treatment Period|Adverse Event|3|||
46810712|NCT00617123|83029865|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
46810713|NCT00617123|83029866|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
46810714|NCT00617123|83029865|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
46810715|NCT00617123|83029866|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
46810716|NCT00419757|83029874|FG000|Overall Study|Adverse Event|1|||
46810717|NCT00419757|83029875|FG001|Overall Study|Adverse Event|4|||
46810718|NCT00419757|83029874|FG000|Overall Study|Lost to Follow-up|1|||
46810719|NCT00419757|83029875|FG001|Overall Study|Lost to Follow-up|4|||
46810720|NCT00419757|83029874|FG000|Overall Study|Withdrawal by Subject|7|||
46810721|NCT00419757|83029875|FG001|Overall Study|Withdrawal by Subject|1|||
46810722|NCT00419757|83029874|FG000|Overall Study|Protocol Violation|2|||
46810723|NCT00419757|83029875|FG001|Overall Study|Protocol Violation|3|||
46810724|NCT00419757|83029874|FG000|Overall Study|Study specific discontinuation criteria|4|||
46754241|NCT00597012|82971948|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
46754242|NCT00597012|82971947|FG000|Overall Study|Withdrawal by Subject|7|||
46754243|NCT00597012|82971948|FG001|Overall Study|Withdrawal by Subject|4|||
46754244|NCT00597012|82971947|FG000|Overall Study|Ineligible|2|||
46754245|NCT00597012|82971948|FG001|Overall Study|Ineligible|0|||
46754246|NCT00597012|82971947|FG000|Overall Study|Lost to Follow-up|0|||
46754247|NCT00597012|82971948|FG001|Overall Study|Lost to Follow-up|2|||
46754248|NCT00542815|82971959|FG000|Overall Study|Adverse Event|19|||
46927472|NCT03334435|83161907|FG004|Overall Study|Withdrawal by Subject|20|||
46927473|NCT03334435|83161903|FG000|Overall Study|Lost to Follow-up|3|||
46810725|NCT00419757|83029875|FG001|Overall Study|Study specific discontinuation criteria|8|||
46810726|NCT00419757|83029874|FG000|Overall Study|Multiple reasons|3|||
46927474|NCT03334435|83161904|FG001|Overall Study|Lost to Follow-up|0|||
46810727|NCT00419757|83029875|FG001|Overall Study|Multiple reasons|1|||
46810728|NCT00434109|83029883|FG000|Overall Study|Physician Decision|9|||
46810729|NCT00434109|83029883|FG000|Overall Study|Adverse Event|5|||
46810730|NCT00434109|83029883|FG000|Overall Study|Protocol Violation|1|||
46810731|NCT00434109|83029883|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
46927475|NCT03334435|83161905|FG002|Overall Study|Lost to Follow-up|2|||
46927476|NCT03334435|83161906|FG003|Overall Study|Lost to Follow-up|1|||
46810732|NCT00433329|83029887|FG000|Overall Study|Adverse Event|9|||
46810733|NCT00433329|83029887|FG000|Overall Study|Death|4|||
46810734|NCT00433329|83029887|FG000|Overall Study|Withdrew consent|3|||
46810735|NCT00433329|83029887|FG000|Overall Study|Discontinued sildenafil|2|||
46810736|NCT00433329|83029887|FG000|Overall Study|Moved out of state|1|||
46810737|NCT00433329|83029887|FG000|Overall Study|Lost to Follow-up|1|||
46810738|NCT00433329|83029887|FG000|Overall Study|Physician Decision|1|||
46810739|NCT00616421|83029894|FG000|Overall Study|Withdrawal by Subject|9|||
46810740|NCT00616421|83029895|FG001|Overall Study|Withdrawal by Subject|11|||
46810741|NCT00616421|83029896|FG002|Overall Study|Withdrawal by Subject|8|||
46810742|NCT00616421|83029894|FG000|Overall Study|Lost to Follow-up|12|||
46810743|NCT00616421|83029895|FG001|Overall Study|Lost to Follow-up|26|||
46810744|NCT00616421|83029896|FG002|Overall Study|Lost to Follow-up|30|||
46810745|NCT00616421|83029894|FG000|Overall Study|Inappropriate enrollment|3|||
46810746|NCT00616421|83029895|FG001|Overall Study|Inappropriate enrollment|0|||
46810747|NCT00616421|83029896|FG002|Overall Study|Inappropriate enrollment|1|||
46810748|NCT00616421|83029894|FG000|Overall Study|Administrative reason|1|||
46810749|NCT00616421|83029895|FG001|Overall Study|Administrative reason|0|||
46810750|NCT00616421|83029896|FG002|Overall Study|Administrative reason|0|||
46810751|NCT00616421|83029894|FG000|Overall Study|Protocol Violation|0|||
46810752|NCT00616421|83029895|FG001|Overall Study|Protocol Violation|1|||
46810753|NCT00616421|83029896|FG002|Overall Study|Protocol Violation|2|||
46810754|NCT00616421|83029894|FG000|Overall Study|Unable to classify|1|||
46810755|NCT00616421|83029895|FG001|Overall Study|Unable to classify|0|||
46810756|NCT00616421|83029896|FG002|Overall Study|Unable to classify|0|||
46810757|NCT00433017|83029920|FG000|Overall Study|Adverse Event|5|||
46810758|NCT00433017|83029921|FG001|Overall Study|Adverse Event|3|||
46810759|NCT00433017|83029920|FG000|Overall Study|Withdrawal by Subject|4|||
46810760|NCT00433017|83029921|FG001|Overall Study|Withdrawal by Subject|5|||
46810761|NCT00433017|83029920|FG000|Overall Study|Lost to Follow-up|3|||
46810762|NCT00433017|83029921|FG001|Overall Study|Lost to Follow-up|4|||
46810763|NCT00433017|83029920|FG000|Overall Study|Administrative problems|80|||
46810764|NCT00433017|83029921|FG001|Overall Study|Administrative problems|86|||
46810765|NCT00433017|83029920|FG000|Overall Study|Protocol Violation|1|||
46810766|NCT00433017|83029921|FG001|Overall Study|Protocol Violation|0|||
46810767|NCT00433017|83029920|FG000|Overall Study|Death|2|||
46810768|NCT00433017|83029921|FG001|Overall Study|Death|2|||
46810769|NCT00433017|83029920|FG000|Overall Study|Subject no longer requires study drug|1|||
46810770|NCT00433017|83029921|FG001|Overall Study|Subject no longer requires study drug|1|||
46810771|NCT00615719|83029953|FG000|Overall Study|Physician Decision|5|||
46810772|NCT00418665|83029960|FG000|Treatment Period|Ineligibility determined|1|||
46810773|NCT00418665|83029961|FG001|Treatment Period|Ineligibility determined|1|||
46810774|NCT00418665|83029962|FG002|Treatment Period|Ineligibility determined|0|||
46810775|NCT00418665|83029960|FG000|Treatment Period|Adverse Event|2|||
46810776|NCT00418665|83029961|FG001|Treatment Period|Adverse Event|2|||
46810777|NCT00418665|83029962|FG002|Treatment Period|Adverse Event|0|||
46810778|NCT00418665|83029960|FG000|Treatment Period|Withdrawal by Subject|0|||
46810779|NCT00418665|83029961|FG001|Treatment Period|Withdrawal by Subject|3|||
46810780|NCT00418665|83029962|FG002|Treatment Period|Withdrawal by Subject|1|||
46754249|NCT00542815|82971960|FG001|Overall Study|Adverse Event|6|||
46754250|NCT00542815|82971961|FG002|Overall Study|Adverse Event|9|||
46754251|NCT00542815|82971959|FG000|Overall Study|Death|10|||
46754252|NCT00542815|82971960|FG001|Overall Study|Death|7|||
46754253|NCT00542815|82971961|FG002|Overall Study|Death|3|||
46754254|NCT00542815|82971959|FG000|Overall Study|Lack of Efficacy|9|||
46754255|NCT00542815|82971960|FG001|Overall Study|Lack of Efficacy|2|||
46754256|NCT00542815|82971961|FG002|Overall Study|Lack of Efficacy|0|||
46754257|NCT00542815|82971959|FG000|Overall Study|Physician Decision|2|||
46754258|NCT00542815|82971960|FG001|Overall Study|Physician Decision|1|||
46754259|NCT00542815|82971961|FG002|Overall Study|Physician Decision|0|||
46754260|NCT00542815|82971959|FG000|Overall Study|Protocol Violation|1|||
46754261|NCT00542815|82971960|FG001|Overall Study|Protocol Violation|1|||
46754262|NCT00542815|82971961|FG002|Overall Study|Protocol Violation|2|||
46754263|NCT00542815|82971959|FG000|Overall Study|Withdrawal by Subject|41|||
46810781|NCT00418665|83029960|FG000|Treatment Period|Requirement for alternative therapy|1|||
46810782|NCT00418665|83029961|FG001|Treatment Period|Requirement for alternative therapy|0|||
46754264|NCT00542815|82971960|FG001|Overall Study|Withdrawal by Subject|5|||
46754265|NCT00542815|82971961|FG002|Overall Study|Withdrawal by Subject|8|||
46810783|NCT00418665|83029962|FG002|Treatment Period|Requirement for alternative therapy|0|||
46810784|NCT00418665|83029960|FG000|Treatment Period|Physician Decision|1|||
46810785|NCT00418665|83029961|FG001|Treatment Period|Physician Decision|0|||
46810786|NCT00418665|83029962|FG002|Treatment Period|Physician Decision|3|||
46810787|NCT00418665|83029960|FG000|Treatment Extension|Adverse Event|1|||
46754266|NCT00542815|82971959|FG000|Overall Study|Other reasons|24|||
46754267|NCT00542815|82971960|FG001|Overall Study|Other reasons|10|||
46754268|NCT00542815|82971961|FG002|Overall Study|Other reasons|10|||
46810788|NCT00418665|83029961|FG001|Treatment Extension|Adverse Event|0|||
46810789|NCT00418665|83029962|FG002|Treatment Extension|Adverse Event|0|||
46810790|NCT00418665|83029960|FG000|Treatment Extension|Withdrawal by Subject|1|||
46810791|NCT00418665|83029961|FG001|Treatment Extension|Withdrawal by Subject|0|||
46810792|NCT00418665|83029962|FG002|Treatment Extension|Withdrawal by Subject|0|||
46810793|NCT00418665|83029960|FG000|Treatment Extension|Requirement for alternative therapy|2|||
46810794|NCT00418665|83029961|FG001|Treatment Extension|Requirement for alternative therapy|2|||
46810795|NCT00418665|83029962|FG002|Treatment Extension|Requirement for alternative therapy|0|||
46810796|NCT00418665|83029960|FG000|Treatment Extension|Physician Decision|2|||
46810797|NCT00418665|83029961|FG001|Treatment Extension|Physician Decision|2|||
46810798|NCT00418665|83029962|FG002|Treatment Extension|Physician Decision|1|||
46810799|NCT00418665|83029960|FG000|Treatment Extension|Death|0|||
46810800|NCT00418665|83029961|FG001|Treatment Extension|Death|0|||
46810801|NCT00418665|83029962|FG002|Treatment Extension|Death|1|||
46810802|NCT00432237|83029974|FG000|Overall Study|Adverse Event|0|||
46810803|NCT00432237|83029975|FG001|Overall Study|Adverse Event|0|||
46810804|NCT00432237|83029976|FG002|Overall Study|Adverse Event|0|||
46810805|NCT00432237|83029977|FG003|Overall Study|Adverse Event|1|||
46810806|NCT00432237|83029974|FG000|Overall Study|Lack of Efficacy|0|||
46810807|NCT00432237|83029975|FG001|Overall Study|Lack of Efficacy|0|||
46810808|NCT00432237|83029976|FG002|Overall Study|Lack of Efficacy|0|||
46810809|NCT00432237|83029977|FG003|Overall Study|Lack of Efficacy|1|||
46810810|NCT00432237|83029974|FG000|Overall Study|Lost to Follow-up|10|||
46810811|NCT00432237|83029975|FG001|Overall Study|Lost to Follow-up|10|||
46810812|NCT00432237|83029976|FG002|Overall Study|Lost to Follow-up|18|||
46810813|NCT00432237|83029977|FG003|Overall Study|Lost to Follow-up|18|||
46810814|NCT00432237|83029974|FG000|Overall Study|Physician Decision|1|||
46810815|NCT00432237|83029975|FG001|Overall Study|Physician Decision|3|||
46810816|NCT00432237|83029976|FG002|Overall Study|Physician Decision|2|||
46810817|NCT00432237|83029977|FG003|Overall Study|Physician Decision|1|||
46810818|NCT00432237|83029974|FG000|Overall Study|Pregnancy|0|||
46810819|NCT00432237|83029975|FG001|Overall Study|Pregnancy|1|||
46810820|NCT00432237|83029976|FG002|Overall Study|Pregnancy|0|||
46810821|NCT00432237|83029977|FG003|Overall Study|Pregnancy|0|||
46810822|NCT00432237|83029974|FG000|Overall Study|Protocol Violation|13|||
46810823|NCT00432237|83029975|FG001|Overall Study|Protocol Violation|10|||
46810824|NCT00432237|83029976|FG002|Overall Study|Protocol Violation|11|||
46810825|NCT00432237|83029977|FG003|Overall Study|Protocol Violation|8|||
46810826|NCT00432237|83029974|FG000|Overall Study|Withdrawal by Subject|5|||
46810827|NCT00432237|83029975|FG001|Overall Study|Withdrawal by Subject|6|||
46810828|NCT00432237|83029976|FG002|Overall Study|Withdrawal by Subject|9|||
46810829|NCT00432237|83029977|FG003|Overall Study|Withdrawal by Subject|11|||
46810830|NCT00432237|83029974|FG000|Overall Study|Lack of Qualifying Event|38|||
46810831|NCT00432237|83029975|FG001|Overall Study|Lack of Qualifying Event|71|||
46810832|NCT00432237|83029976|FG002|Overall Study|Lack of Qualifying Event|69|||
46636413|NCT01514136|82810252|FG001|Test Period 1; Test A|Break from study holiday|0|||
46636414|NCT01514136|82810253|FG002|Test Period 1; Test A|Break from study holiday|0|||
46636415|NCT01514136|82810254|FG003|Test Period 1; Test A|Break from study holiday|0|||
46636416|NCT01514136|82810255|FG004|Test Period 1; Test A|Break from study holiday|0|||
46636417|NCT01514136|82810256|FG005|Test Period 1; Test A|Break from study holiday|0|||
46754269|NCT00542425|82971974|FG000|Initial 24 Weeks|Administrative reasons|0|||
46754270|NCT00542425|82971975|FG001|Initial 24 Weeks|Administrative reasons|0|||
46754271|NCT00542425|82971976|FG002|Initial 24 Weeks|Administrative reasons|1|||
46754272|NCT00542425|82971977|FG003|Initial 24 Weeks|Administrative reasons|1|||
46754273|NCT00542425|82971978|FG004|Initial 24 Weeks|Administrative reasons|0|||
46754274|NCT00542425|82971974|FG000|Initial 24 Weeks|Adverse Event|0|||
46754275|NCT00542425|82971975|FG001|Initial 24 Weeks|Adverse Event|1|||
46754276|NCT00542425|82971976|FG002|Initial 24 Weeks|Adverse Event|1|||
46754277|NCT00542425|82971977|FG003|Initial 24 Weeks|Adverse Event|3|||
46754278|NCT00542425|82971978|FG004|Initial 24 Weeks|Adverse Event|2|||
46754279|NCT00542425|82971974|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
46810833|NCT00432237|83029977|FG003|Overall Study|Lack of Qualifying Event|84|||
46810834|NCT00531284|83030004|FG000|Overall Study|Progressive Disease|1|||
46810835|NCT00531284|83030005|FG001|Overall Study|Progressive Disease|3|||
46810836|NCT00531284|83030006|FG002|Overall Study|Progressive Disease|5|||
46810837|NCT00531284|83030007|FG003|Overall Study|Progressive Disease|42|||
46810838|NCT00531284|83030008|FG004|Overall Study|Progressive Disease|4|||
46636418|NCT01514136|82810257|FG006|Test Period 1; Test A|Break from study holiday|0|||
46754280|NCT00542425|82971975|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
46810839|NCT00531284|83030009|FG005|Overall Study|Progressive Disease|4|||
46810840|NCT00531284|83030010|FG006|Overall Study|Progressive Disease|3|||
46754281|NCT00542425|82971976|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
46754282|NCT00542425|82971977|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
46810841|NCT00531284|83030011|FG007|Overall Study|Progressive Disease|8|||
46810842|NCT00531284|83030012|FG008|Overall Study|Progressive Disease|6|||
46810843|NCT00531284|83030013|FG009|Overall Study|Progressive Disease|3|||
46810844|NCT00531284|83030014|FG010|Overall Study|Progressive Disease|3|||
46810845|NCT00531284|83030015|FG011|Overall Study|Progressive Disease|14|||
46810846|NCT00531284|83030016|FG012|Overall Study|Progressive Disease|2|||
46810847|NCT00531284|83030017|FG013|Overall Study|Progressive Disease|1|||
46810848|NCT00531284|83030018|FG014|Overall Study|Progressive Disease|2|||
46810849|NCT00531284|83030019|FG015|Overall Study|Progressive Disease|11|||
46810850|NCT00531284|83030020|FG016|Overall Study|Progressive Disease|5|||
46810851|NCT00531284|83030004|FG000|Overall Study|Adverse Event|0|||
46810852|NCT00531284|83030005|FG001|Overall Study|Adverse Event|1|||
46810853|NCT00531284|83030006|FG002|Overall Study|Adverse Event|1|||
46810854|NCT00531284|83030007|FG003|Overall Study|Adverse Event|7|||
46810855|NCT00531284|83030008|FG004|Overall Study|Adverse Event|0|||
46810856|NCT00531284|83030009|FG005|Overall Study|Adverse Event|2|||
46810857|NCT00531284|83030010|FG006|Overall Study|Adverse Event|3|||
46810858|NCT00531284|83030011|FG007|Overall Study|Adverse Event|2|||
46810859|NCT00531284|83030012|FG008|Overall Study|Adverse Event|3|||
46810860|NCT00531284|83030013|FG009|Overall Study|Adverse Event|0|||
46810861|NCT00531284|83030014|FG010|Overall Study|Adverse Event|0|||
46810862|NCT00531284|83030015|FG011|Overall Study|Adverse Event|5|||
46810863|NCT00531284|83030016|FG012|Overall Study|Adverse Event|0|||
46810864|NCT00531284|83030017|FG013|Overall Study|Adverse Event|1|||
46810865|NCT00531284|83030018|FG014|Overall Study|Adverse Event|1|||
46810866|NCT00531284|83030019|FG015|Overall Study|Adverse Event|0|||
46810867|NCT00531284|83030020|FG016|Overall Study|Adverse Event|2|||
46810868|NCT00531284|83030004|FG000|Overall Study|Withdrawal by Subject|1|||
46810869|NCT00531284|83030005|FG001|Overall Study|Withdrawal by Subject|0|||
46810870|NCT00531284|83030006|FG002|Overall Study|Withdrawal by Subject|0|||
46810871|NCT00531284|83030007|FG003|Overall Study|Withdrawal by Subject|4|||
46810872|NCT00531284|83030008|FG004|Overall Study|Withdrawal by Subject|0|||
46810873|NCT00531284|83030009|FG005|Overall Study|Withdrawal by Subject|0|||
46810874|NCT00531284|83030010|FG006|Overall Study|Withdrawal by Subject|0|||
46927477|NCT03334435|83161907|FG004|Overall Study|Lost to Follow-up|1|||
46927478|NCT03334435|83161903|FG000|Overall Study|Death|0|||
46927479|NCT03334435|83161904|FG001|Overall Study|Death|0|||
46927480|NCT03334435|83161905|FG002|Overall Study|Death|0|||
46927481|NCT03334435|83161906|FG003|Overall Study|Death|1|||
46927482|NCT03334435|83161907|FG004|Overall Study|Death|0|||
46927483|NCT03334435|83161903|FG000|Overall Study|Other|0|||
46927484|NCT03334435|83161904|FG001|Overall Study|Other|1|||
46927485|NCT03334435|83161905|FG002|Overall Study|Other|3|||
46927486|NCT03334435|83161906|FG003|Overall Study|Other|2|||
46927487|NCT03334435|83161907|FG004|Overall Study|Other|1|||
46927488|NCT02919449|83161980|FG000|Overall Study|Withdrawal by Subject|1|||
46927489|NCT02919449|83161980|FG000|Overall Study|Investigator decision|1|||
46927490|NCT02769832|83161984|FG000|Overall Study|Death|30|||
46927491|NCT02530970|83161989|FG000|Overall Study|Adverse Event|8|||
46927492|NCT02530970|83161989|FG000|Overall Study|Lost to Follow-up|88|||
46927493|NCT02530970|83161989|FG000|Overall Study|Physician Decision|5|||
46927494|NCT02530970|83161989|FG000|Overall Study|Withdrawal by Subject|14|||
46927495|NCT02530970|83161989|FG000|Overall Study|Death|6|||
46927496|NCT02530970|83161989|FG000|Overall Study|Hospitalization|1|||
46927497|NCT02530970|83161989|FG000|Overall Study|Insurance|2|||
46927498|NCT02530970|83161989|FG000|Overall Study|Explant|2|||
46927499|NCT02530970|83161989|FG000|Overall Study|Change in Provider|5|||
46927500|NCT02530970|83161989|FG000|Overall Study|Relocation|3|||
46927501|NCT02418156|83161993|FG000|Overall Study|Lost to Follow-up|12|||
46754283|NCT00542425|82971978|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
46754284|NCT00542425|82971974|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
46754285|NCT00542425|82971975|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
46754286|NCT00542425|82971976|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
46754287|NCT00542425|82971977|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
46754288|NCT00542425|82971978|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
46754289|NCT00542425|82971974|FG000|Initial 24 Weeks|Non-compliance|0|||
46754290|NCT00542425|82971975|FG001|Initial 24 Weeks|Non-compliance|0|||
46754291|NCT00542425|82971976|FG002|Initial 24 Weeks|Non-compliance|0|||
46754292|NCT00542425|82971977|FG003|Initial 24 Weeks|Non-compliance|1|||
46754293|NCT00542425|82971978|FG004|Initial 24 Weeks|Non-compliance|1|||
46810875|NCT00531284|83030011|FG007|Overall Study|Withdrawal by Subject|0|||
46810876|NCT00531284|83030012|FG008|Overall Study|Withdrawal by Subject|0|||
46810877|NCT00531284|83030013|FG009|Overall Study|Withdrawal by Subject|0|||
46927502|NCT02418156|83161993|FG000|Overall Study|Death|2|||
46927503|NCT02418156|83161993|FG000|Overall Study|Physician Decision|1|||
46927504|NCT02418156|83161993|FG000|Overall Study|Withdrawal by Subject|1|||
46927505|NCT02418156|83161993|FG000|Overall Study|Subject refused to return|1|||
46754294|NCT00542425|82971974|FG000|Initial 24 Weeks|Protocol Violation|0|||
46754295|NCT00542425|82971975|FG001|Initial 24 Weeks|Protocol Violation|0|||
46810878|NCT00531284|83030014|FG010|Overall Study|Withdrawal by Subject|0|||
46810879|NCT00531284|83030015|FG011|Overall Study|Withdrawal by Subject|3|||
46810880|NCT00531284|83030016|FG012|Overall Study|Withdrawal by Subject|0|||
46927506|NCT01850524|83162033|FG000|Overall Study|Lost to Follow-up|5|||
46927507|NCT01850524|83162034|FG001|Overall Study|Lost to Follow-up|10|||
46927508|NCT01850524|83162033|FG000|Overall Study|Withdrawal by Subject|24|||
46927509|NCT01850524|83162034|FG001|Overall Study|Withdrawal by Subject|22|||
46754296|NCT00542425|82971976|FG002|Initial 24 Weeks|Protocol Violation|0|||
46754297|NCT00542425|82971977|FG003|Initial 24 Weeks|Protocol Violation|1|||
46754298|NCT00542425|82971978|FG004|Initial 24 Weeks|Protocol Violation|0|||
46754299|NCT00542425|82971974|FG000|Initial 24 Weeks|Refusal of treatment|2|||
46754300|NCT00542425|82971975|FG001|Initial 24 Weeks|Refusal of treatment|2|||
46754301|NCT00542425|82971976|FG002|Initial 24 Weeks|Refusal of treatment|1|||
46754302|NCT00542425|82971977|FG003|Initial 24 Weeks|Refusal of treatment|4|||
46754303|NCT00542425|82971978|FG004|Initial 24 Weeks|Refusal of treatment|1|||
46754304|NCT00542425|82971974|FG000|Initial 24 Weeks|Other|0|||
46754305|NCT00542425|82971975|FG001|Initial 24 Weeks|Other|2|||
46754306|NCT00542425|82971976|FG002|Initial 24 Weeks|Other|1|||
46754307|NCT00542425|82971977|FG003|Initial 24 Weeks|Other|0|||
46754308|NCT00542425|82971978|FG004|Initial 24 Weeks|Other|0|||
46754309|NCT00542425|82971974|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
46754310|NCT00542425|82971975|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
46754311|NCT00542425|82971976|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
46754312|NCT00542425|82971977|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
46754313|NCT00542425|82971978|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
46754314|NCT00542425|82971974|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
46754315|NCT00542425|82971975|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
46754316|NCT00542425|82971976|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
46754317|NCT00542425|82971977|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
46754318|NCT00542425|82971978|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
46754319|NCT00542425|82971974|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
46754320|NCT00542425|82971975|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
46754321|NCT00542425|82971976|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
46754322|NCT00542425|82971977|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
46754323|NCT00542425|82971978|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
46754324|NCT00542425|82971974|FG000|Extended 24 Weeks of Treatment|Other|1|||
46754325|NCT00542425|82971975|FG001|Extended 24 Weeks of Treatment|Other|1|||
46754326|NCT00542425|82971976|FG002|Extended 24 Weeks of Treatment|Other|0|||
46754327|NCT00542425|82971977|FG003|Extended 24 Weeks of Treatment|Other|0|||
46754328|NCT00542425|82971978|FG004|Extended 24 Weeks of Treatment|Other|1|||
46754329|NCT00541099|82971990|FG000|Overall Study|Ineligible|3|||
46754330|NCT00580606|82971996|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
46754331|NCT00580606|82971997|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
46754332|NCT00580606|82971996|FG000|Open Label (OL)|Withdrawal by Subject|4|||
46754333|NCT00580606|82971997|FG001|Open Label (OL)|Withdrawal by Subject|6|||
46754334|NCT00580606|82971996|FG000|Open Label (OL)|Dosing Symptoms|0|||
46754335|NCT00580606|82971997|FG001|Open Label (OL)|Dosing Symptoms|1|||
46754336|NCT00580606|82971996|FG000|Open Label (OL)|Lost to Follow-up|0|||
46754337|NCT00580606|82971997|FG001|Open Label (OL)|Lost to Follow-up|1|||
46754338|NCT00580606|82971996|FG000|Open Label (OL)|Pregnancy|0|||
46754339|NCT00580606|82971997|FG001|Open Label (OL)|Pregnancy|1|||
46754340|NCT00580606|82971996|FG000|Open Label (OL)|Non-compliance|2|||
46754341|NCT00580606|82971997|FG001|Open Label (OL)|Non-compliance|0|||
46754342|NCT00580606|82971996|FG000|Open Label (OL)|Physician Decision|1|||
46754343|NCT00580606|82971997|FG001|Open Label (OL)|Physician Decision|1|||
46754344|NCT00580606|82971996|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
46754345|NCT00580606|82971997|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
46754346|NCT00579982|82972011|FG000|Overall Study|Adverse Event|4|||
46754347|NCT00579982|82972011|FG000|Overall Study|Protocol Violation|4|||
46754348|NCT00596466|82972015|FG000|Overall Study|Lack of Efficacy|5|||
46754349|NCT00596466|82972015|FG000|Overall Study|Adverse Event|4|||
46754350|NCT00596466|82972015|FG000|Overall Study|Withdrawal by Subject|2|||
46754351|NCT00596466|82972015|FG000|Overall Study|Protocol Violation|2|||
46754352|NCT00596466|82972015|FG000|Overall Study|Unpecified|2|||
46754353|NCT00596466|82972015|FG000|Overall Study|Enrolled, not treated|2|||
46754354|NCT00596934|82972019|FG000|Overall Study|Protocol Violation|1|||
46754355|NCT00596934|82972019|FG000|Overall Study|Withdrawal by Subject|1|||
46754356|NCT03911401|82972028|FG000|Overall Study|Adverse Event|1|||
46754357|NCT03911401|82972029|FG001|Overall Study|Adverse Event|2|||
46754358|NCT03911401|82972030|FG002|Overall Study|Adverse Event|5|||
46754359|NCT03911401|82972028|FG000|Overall Study|Lack of Efficacy|1|||
46754360|NCT03911401|82972029|FG001|Overall Study|Lack of Efficacy|1|||
46754361|NCT03911401|82972030|FG002|Overall Study|Lack of Efficacy|8|||
46754362|NCT03911401|82972028|FG000|Overall Study|Physician Decision|0|||
46754363|NCT03911401|82972029|FG001|Overall Study|Physician Decision|0|||
46754364|NCT03911401|82972030|FG002|Overall Study|Physician Decision|1|||
46754365|NCT03911401|82972028|FG000|Overall Study|Withdrawal by Subject|1|||
46754366|NCT03911401|82972029|FG001|Overall Study|Withdrawal by Subject|2|||
46754367|NCT03911401|82972030|FG002|Overall Study|Withdrawal by Subject|0|||
46754368|NCT03911401|82972028|FG000|Overall Study|Withdrawal by parent/guardian|4|||
46754369|NCT03911401|82972029|FG001|Overall Study|Withdrawal by parent/guardian|4|||
46754370|NCT03911401|82972030|FG002|Overall Study|Withdrawal by parent/guardian|11|||
46810881|NCT00531284|83030017|FG013|Overall Study|Withdrawal by Subject|1|||
46810882|NCT00531284|83030018|FG014|Overall Study|Withdrawal by Subject|0|||
46810883|NCT00531284|83030019|FG015|Overall Study|Withdrawal by Subject|1|||
46810884|NCT00531284|83030020|FG016|Overall Study|Withdrawal by Subject|1|||
46810885|NCT00531284|83030004|FG000|Overall Study|Other|1|||
46810886|NCT00531284|83030005|FG001|Overall Study|Other|0|||
46810887|NCT00531284|83030006|FG002|Overall Study|Other|0|||
46810888|NCT00531284|83030007|FG003|Overall Study|Other|10|||
46810889|NCT00531284|83030008|FG004|Overall Study|Other|2|||
46810890|NCT00531284|83030009|FG005|Overall Study|Other|1|||
46810891|NCT00531284|83030010|FG006|Overall Study|Other|0|||
46810892|NCT00531284|83030011|FG007|Overall Study|Other|0|||
46810893|NCT00531284|83030012|FG008|Overall Study|Other|2|||
46810894|NCT00531284|83030013|FG009|Overall Study|Other|1|||
46810895|NCT00531284|83030014|FG010|Overall Study|Other|0|||
46810896|NCT00531284|83030015|FG011|Overall Study|Other|2|||
46810897|NCT00531284|83030016|FG012|Overall Study|Other|0|||
46810898|NCT00531284|83030017|FG013|Overall Study|Other|0|||
46810899|NCT00531284|83030018|FG014|Overall Study|Other|1|||
46810900|NCT00531284|83030019|FG015|Overall Study|Other|0|||
46810901|NCT00531284|83030020|FG016|Overall Study|Other|0|||
46810902|NCT00531206|83030076|FG000|Overall Study|Adverse Event related|5|||
46810903|NCT00531206|83030076|FG000|Overall Study|Lack of Efficacy|2|||
46810904|NCT00531206|83030076|FG000|Overall Study|Lost to Follow-up|5|||
46810905|NCT00531206|83030076|FG000|Overall Study|including non-related adverse events|8|||
46810906|NCT00530816|83030083|FG000|Overall Study|Progressive Disease|16|||
46810907|NCT00530816|83030084|FG001|Overall Study|Progressive Disease|24|||
46810908|NCT00530816|83030085|FG002|Overall Study|Progressive Disease|24|||
46810909|NCT00530816|83030083|FG000|Overall Study|Adverse Event|6|||
46810910|NCT00530816|83030084|FG001|Overall Study|Adverse Event|13|||
46810911|NCT00530816|83030085|FG002|Overall Study|Adverse Event|7|||
46810912|NCT00530816|83030083|FG000|Overall Study|Other|3|||
46810913|NCT00530816|83030084|FG001|Overall Study|Other|3|||
46810914|NCT00530816|83030085|FG002|Overall Study|Other|4|||
46810915|NCT00530816|83030083|FG000|Overall Study|Withdrawal by Subject|1|||
46810916|NCT00530816|83030084|FG001|Overall Study|Withdrawal by Subject|2|||
46810917|NCT00530816|83030085|FG002|Overall Study|Withdrawal by Subject|6|||
46810918|NCT00615017|83030099|FG000|Overall Study|Adverse Event|0|||
46810919|NCT00615017|83030100|FG001|Overall Study|Adverse Event|1|||
46810920|NCT00615017|83030101|FG002|Overall Study|Adverse Event|2|||
46810921|NCT00615017|83030102|FG003|Overall Study|Adverse Event|0|||
46810922|NCT00615017|83030103|FG004|Overall Study|Adverse Event|0|||
46810923|NCT00615017|83030104|FG005|Overall Study|Adverse Event|1|||
46810924|NCT00615017|83030099|FG000|Overall Study|Death|0|||
46810925|NCT00615017|83030100|FG001|Overall Study|Death|0|||
46810926|NCT00615017|83030101|FG002|Overall Study|Death|2|||
46927510|NCT01850524|83162033|FG000|Overall Study|Reason not Specified|142|||
46927511|NCT01850524|83162034|FG001|Overall Study|Reason not Specified|141|||
47054363|NCT02727660|83326283|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
47054364|NCT02727660|83326284|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
47054365|NCT02727660|83326282|FG000|Overall Study|Administrative Reasons|2|||
47054366|NCT02727660|83326283|FG001|Overall Study|Administrative Reasons|3|||
47054367|NCT02727660|83326284|FG002|Overall Study|Administrative Reasons|4|||
47054368|NCT01784861|83326298|FG000|Overall Study|Adverse Event|0|||
46754371|NCT00579670|82972043|FG000|Overall Study|Death|1|||
46754372|NCT00579670|82972044|FG001|Overall Study|Death|0|||
46754373|NCT00579670|82972045|FG002|Overall Study|Death|0|||
46754374|NCT00579670|82972046|FG003|Overall Study|Death|0|||
46754375|NCT00579670|82972047|FG004|Overall Study|Death|0|||
46754376|NCT00579670|82972043|FG000|Overall Study|Adverse Event|1|||
46754377|NCT00579670|82972044|FG001|Overall Study|Adverse Event|0|||
46754378|NCT00579670|82972045|FG002|Overall Study|Adverse Event|1|||
46754379|NCT00579670|82972046|FG003|Overall Study|Adverse Event|2|||
46754380|NCT00579670|82972047|FG004|Overall Study|Adverse Event|0|||
46754381|NCT00579670|82972043|FG000|Overall Study|Lack of Efficacy|0|||
46810927|NCT00615017|83030102|FG003|Overall Study|Death|0|||
46810928|NCT00615017|83030103|FG004|Overall Study|Death|1|||
46810929|NCT00615017|83030104|FG005|Overall Study|Death|1|||
46810930|NCT00615017|83030099|FG000|Overall Study|Sepsis resolved|0|||
46810931|NCT00615017|83030100|FG001|Overall Study|Sepsis resolved|0|||
46810932|NCT00615017|83030101|FG002|Overall Study|Sepsis resolved|1|||
46810933|NCT00615017|83030102|FG003|Overall Study|Sepsis resolved|0|||
46927512|NCT01609842|83162051|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
46810934|NCT00615017|83030103|FG004|Overall Study|Sepsis resolved|0|||
47054369|NCT01784861|83326299|FG001|Overall Study|Adverse Event|0|||
47054370|NCT01784861|83326300|FG002|Overall Study|Adverse Event|1|||
46754382|NCT00579670|82972044|FG001|Overall Study|Lack of Efficacy|0|||
46754383|NCT00579670|82972045|FG002|Overall Study|Lack of Efficacy|1|||
46810935|NCT00615017|83030104|FG005|Overall Study|Sepsis resolved|0|||
46810936|NCT00615017|83030099|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
46810937|NCT00615017|83030100|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
46810938|NCT00615017|83030101|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
46810939|NCT00615017|83030102|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
46810940|NCT00615017|83030103|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
46810941|NCT00615017|83030104|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
46810942|NCT00615017|83030099|FG000|Overall Study|Physician discontinued drug|0|||
46810943|NCT00615017|83030100|FG001|Overall Study|Physician discontinued drug|0|||
46810944|NCT00615017|83030101|FG002|Overall Study|Physician discontinued drug|0|||
46810945|NCT00615017|83030102|FG003|Overall Study|Physician discontinued drug|0|||
46810946|NCT00615017|83030103|FG004|Overall Study|Physician discontinued drug|0|||
46810947|NCT00615017|83030104|FG005|Overall Study|Physician discontinued drug|1|||
46810948|NCT00614939|83030120|FG000|Overall Study|Withdrawal by Subject|10|||
46810949|NCT00614939|83030121|FG001|Overall Study|Withdrawal by Subject|17|||
46810950|NCT00614939|83030120|FG000|Overall Study|Study specific discontinuation criteris|13|||
46810951|NCT00614939|83030121|FG001|Overall Study|Study specific discontinuation criteris|16|||
46810952|NCT00614939|83030120|FG000|Overall Study|Adverse Event|2|||
46810953|NCT00614939|83030121|FG001|Overall Study|Adverse Event|5|||
46810954|NCT00614939|83030120|FG000|Overall Study|Incorrect enrollment|1|||
46810955|NCT00614939|83030121|FG001|Overall Study|Incorrect enrollment|2|||
46810956|NCT00614939|83030120|FG000|Overall Study|Death|4|||
46810957|NCT00614939|83030121|FG001|Overall Study|Death|3|||
46810958|NCT00614939|83030120|FG000|Overall Study|Poor/non-compliance|4|||
46810959|NCT00614939|83030121|FG001|Overall Study|Poor/non-compliance|0|||
46810960|NCT00614939|83030120|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
46810961|NCT00614939|83030121|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
46810962|NCT00530504|83030127|FG000|Overall Study|Death|54|||
46810963|NCT00530504|83030127|FG000|Overall Study|Lost to Follow-up|26|||
46810964|NCT00530504|83030127|FG000|Overall Study|Withdrawal by Subject|39|||
46810965|NCT00530504|83030127|FG000|Overall Study|Exited study due to other reasons|33|||
46927513|NCT01609842|83162052|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
46927514|NCT01569594|83162062|FG000|Overall Study|Physician Decision|4|||
46810966|NCT04720664|83030157|FG000|Overall Study|Adverse Event|2|||
46810967|NCT04720664|83030157|FG000|Overall Study|Lack of Efficacy|9|||
46810968|NCT04371198|83030170|FG000|Overall Study|inadequate sample|4|||
46810969|NCT04288154|83030176|FG000|Overall Study|Withdrawal by Subject|9|||
46810970|NCT04288154|83030177|FG001|Overall Study|Withdrawal by Subject|9|||
46810971|NCT04258579|83030183|FG000|Overall Study|Withdrawal by Subject|7|||
46810972|NCT04258579|83030183|FG000|Overall Study|Lost to Follow-up|3|||
46810973|NCT04258579|83030183|FG000|Overall Study|Protocol Violation|2|||
46810974|NCT04258579|83030183|FG000|Overall Study|Adverse Event|1|||
46810975|NCT03945214|83030191|FG000|Overall Study|Lost to Follow-up|3|||
46810976|NCT03945214|83030192|FG001|Overall Study|Lost to Follow-up|4|||
46810977|NCT03945214|83030193|FG002|Overall Study|Lost to Follow-up|7|||
46810978|NCT03945214|83030194|FG003|Overall Study|Lost to Follow-up|4|||
46810979|NCT03829683|83030206|FG000|Overall Study|Lost to Follow-up|1|||
46810980|NCT03829683|83030207|FG001|Overall Study|Lost to Follow-up|0|||
46810981|NCT03829683|83030206|FG000|Overall Study|Physician Decision|3|||
46927515|NCT01569594|83162062|FG000|Overall Study|Death|13|||
46927516|NCT01569594|83162062|FG000|Overall Study|Lost to Follow-up|22|||
46927517|NCT01569594|83162062|FG000|Overall Study|Adverse Event|2|||
46636419|NCT01514136|82810258|FG007|Test Period 1; Test A|Break from study holiday|0|||
46810982|NCT03829683|83030207|FG001|Overall Study|Physician Decision|1|||
46810983|NCT03829683|83030206|FG000|Overall Study|Withdrawal by Subject|0|||
46810984|NCT03829683|83030207|FG001|Overall Study|Withdrawal by Subject|1|||
46810985|NCT03829683|83030206|FG000|Overall Study|Discharge from hospital|1|||
46810986|NCT03829683|83030207|FG001|Overall Study|Discharge from hospital|0|||
46810987|NCT03810456|83030216|FG000|Treatment|Urgent Family Matters|3|||
46810988|NCT03810456|83030217|FG001|Treatment|Urgent Family Matters|0|||
46810989|NCT03810456|83030218|FG002|Treatment|Urgent Family Matters|0|||
46810990|NCT03810456|83030216|FG000|Treatment|Scheduling Conflicts|0|||
46810991|NCT03810456|83030217|FG001|Treatment|Scheduling Conflicts|11|||
46810992|NCT03810456|83030218|FG002|Treatment|Scheduling Conflicts|0|||
46927518|NCT01569594|83162062|FG000|Overall Study|Withdrawal by Subject|13|||
46927519|NCT01569594|83162062|FG000|Overall Study|Other|4|||
46810993|NCT03810456|83030216|FG000|Treatment|No Longer Interested|0|||
46810994|NCT03810456|83030217|FG001|Treatment|No Longer Interested|12|||
46810995|NCT03810456|83030218|FG002|Treatment|No Longer Interested|0|||
46810996|NCT03810456|83030216|FG000|Treatment|Transportation Issues|0|||
46810997|NCT03810456|83030217|FG001|Treatment|Transportation Issues|1|||
46810998|NCT03810456|83030218|FG002|Treatment|Transportation Issues|0|||
46927520|NCT01569594|83162062|FG000|Overall Study|No ECM used|9|||
46636420|NCT01514136|82810251|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
46810999|NCT03810456|83030216|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
46811000|NCT03810456|83030217|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
46811001|NCT03810456|83030218|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
46927521|NCT00593840|83162066|FG000|Overall Study|Withdrawal by Subject|1|||
46811002|NCT03810456|83030216|FG000|1 Month Follow-Up|Relocated to Different State|1|||
46811003|NCT03810456|83030217|FG001|1 Month Follow-Up|Relocated to Different State|0|||
46811004|NCT03810456|83030218|FG002|1 Month Follow-Up|Relocated to Different State|1|||
46811005|NCT03810456|83030216|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
46811006|NCT03810456|83030217|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
46811007|NCT03810456|83030218|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
46811008|NCT03810456|83030216|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
46811009|NCT03810456|83030217|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
46811010|NCT03810456|83030218|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
46811011|NCT03810456|83030216|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
46811012|NCT03810456|83030217|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
46811013|NCT03810456|83030218|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
46811014|NCT03810456|83030216|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
46811015|NCT03810456|83030217|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
46811016|NCT03810456|83030218|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
46811017|NCT03810456|83030216|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
46811018|NCT03810456|83030217|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
46811019|NCT03810456|83030218|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
47054371|NCT01784861|83326301|FG003|Overall Study|Adverse Event|2|||
47054372|NCT01784861|83326302|FG004|Overall Study|Adverse Event|1|||
47054373|NCT01784861|83326303|FG005|Overall Study|Adverse Event|0|||
46811023|NCT03353415|83030243|FG000|Masked CGM Wear|Lost to Follow-up|2|||
46811024|NCT03353415|83030243|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
46811025|NCT02658890|83030276|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811026|NCT02658890|83030277|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811027|NCT02658890|83030278|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46927522|NCT01329900|83162099|FG000|Overall Study|Elevated creatinine/renal function|1|||
46927523|NCT02825043|83162103|FG000|Overall Study|Lost to Follow-up|4|||
46927524|NCT02750592|83162118|FG000|Overall Study|Adverse Event|3|||
46927525|NCT02750592|83162118|FG000|Overall Study|Lack of Efficacy|2|||
46927526|NCT02624986|83162130|FG000|Overall Study|Death|0|||
46927527|NCT02624986|83162131|FG001|Overall Study|Death|1|||
46927528|NCT02624986|83162132|FG002|Overall Study|Death|2|||
46927529|NCT02624986|83162133|FG003|Overall Study|Death|2|||
46927530|NCT02624986|83162134|FG004|Overall Study|Death|2|||
46927531|NCT02624986|83162135|FG005|Overall Study|Death|0|||
47054374|NCT01784861|83326298|FG000|Overall Study|Withdrawal by Subject|0|||
47054375|NCT01784861|83326299|FG001|Overall Study|Withdrawal by Subject|0|||
47054376|NCT01784861|83326300|FG002|Overall Study|Withdrawal by Subject|0|||
47054377|NCT01784861|83326301|FG003|Overall Study|Withdrawal by Subject|1|||
47054378|NCT01784861|83326302|FG004|Overall Study|Withdrawal by Subject|0|||
47054379|NCT01784861|83326303|FG005|Overall Study|Withdrawal by Subject|0|||
47054380|NCT01784861|83326298|FG000|Overall Study|Physician Decision|0|||
47054381|NCT01784861|83326299|FG001|Overall Study|Physician Decision|0|||
47054382|NCT01784861|83326300|FG002|Overall Study|Physician Decision|0|||
47054383|NCT01784861|83326301|FG003|Overall Study|Physician Decision|2|||
47054384|NCT01784861|83326302|FG004|Overall Study|Physician Decision|0|||
47054385|NCT01784861|83326303|FG005|Overall Study|Physician Decision|1|||
47054386|NCT02727192|83326377|FG000|Overall Study|Lost to Follow-up|1|||
47054387|NCT02727192|83326378|FG001|Overall Study|Lost to Follow-up|0|||
47054388|NCT02727192|83326379|FG002|Overall Study|Lost to Follow-up|0|||
47054389|NCT00705666|83326399|FG000|Overall Study|No post-treatment questionnaire|279|||
47054390|NCT00705666|83326399|FG000|Overall Study|Withdrawal by Subject|21|||
47054391|NCT00705666|83326399|FG000|Overall Study|Physician Decision|7|||
47054392|NCT00705666|83326399|FG000|Overall Study|Lost to Follow-up|5|||
47054393|NCT00705666|83326399|FG000|Overall Study|Death|1|||
47054394|NCT00705666|83326399|FG000|Overall Study|Adverse Event|4|||
47054395|NCT00705666|83326399|FG000|Overall Study|Other|12|||
47054396|NCT00705666|83326399|FG000|Overall Study|Other|2|||
47054397|NCT00705666|83326399|FG000|Overall Study|Lack of data|3|||
46811028|NCT02658890|83030279|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811029|NCT02658890|83030280|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
47054398|NCT00705666|83326399|FG000|Overall Study|Untreated|5|||
47054399|NCT02725866|83326558|FG000|Overall Study|Failure to return|6|||
47054400|NCT02725866|83326558|FG000|Overall Study|Withdrew consent|3|||
46754384|NCT00579670|82972046|FG003|Overall Study|Lack of Efficacy|14|||
46811030|NCT02658890|83030281|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811031|NCT02658890|83030282|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811032|NCT02658890|83030283|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811033|NCT02658890|83030284|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
46811034|NCT02658890|83030285|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46927532|NCT02624986|83162136|FG006|Overall Study|Death|0|||
46927533|NCT02624986|83162137|FG007|Overall Study|Death|1|||
46927534|NCT02624986|83162130|FG000|Overall Study|Study Terminated by Sponsor|1|||
46927535|NCT02624986|83162131|FG001|Overall Study|Study Terminated by Sponsor|1|||
47054401|NCT02725866|83326558|FG000|Overall Study|Insufficient virological response|1|||
47054402|NCT02725866|83326558|FG000|Overall Study|Other, not specified|4|||
47054403|NCT02726022|83326594|FG000|Overall Study|Adverse Event|14|||
47054404|NCT02726022|83326594|FG000|Overall Study|Treatment Failure|8|||
47054405|NCT02726022|83326594|FG000|Overall Study|Poor Compliance|13|||
47054406|NCT02726022|83326594|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
47054407|NCT02725788|83326609|FG000|Overall Study|Lost to Follow-up|1|||
47054408|NCT02725788|83326610|FG001|Overall Study|Lost to Follow-up|1|||
46811035|NCT02658890|83030286|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811036|NCT02658890|83030287|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811037|NCT02658890|83030288|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46754385|NCT00579670|82972047|FG004|Overall Study|Lack of Efficacy|0|||
46754386|NCT00579670|82972043|FG000|Overall Study|Lost to Follow-up|0|||
46754387|NCT00579670|82972044|FG001|Overall Study|Lost to Follow-up|1|||
46754388|NCT00579670|82972045|FG002|Overall Study|Lost to Follow-up|0|||
46754389|NCT00579670|82972046|FG003|Overall Study|Lost to Follow-up|4|||
46754390|NCT00579670|82972047|FG004|Overall Study|Lost to Follow-up|0|||
46754391|NCT00579670|82972043|FG000|Overall Study|Other|0|||
46754392|NCT00579670|82972044|FG001|Overall Study|Other|0|||
46754393|NCT00579670|82972045|FG002|Overall Study|Other|1|||
46811038|NCT02658890|83030289|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811039|NCT02658890|83030290|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811040|NCT02658890|83030291|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811041|NCT02658890|83030292|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811042|NCT02658890|83030293|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811043|NCT02658890|83030294|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811044|NCT02658890|83030295|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811045|NCT02658890|83030296|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811046|NCT02658890|83030297|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811047|NCT02658890|83030298|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811048|NCT02658890|83030299|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811049|NCT02658890|83030300|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811050|NCT02658890|83030301|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46636421|NCT01514136|82810252|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
46636422|NCT01514136|82810253|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
46636423|NCT01514136|82810254|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
46636424|NCT01514136|82810255|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
46636425|NCT01514136|82810256|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
47054409|NCT02725788|83326609|FG000|Overall Study|Protocol Violation|0|||
47054410|NCT02725788|83326610|FG001|Overall Study|Protocol Violation|1|||
46636426|NCT01514136|82810257|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
46636427|NCT01514136|82810258|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
46636428|NCT01514136|82810251|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
46811051|NCT02658890|83030302|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811052|NCT02658890|83030276|FG000|Treatment Phase|Adverse Event|0|||
46811053|NCT02658890|83030277|FG001|Treatment Phase|Adverse Event|1|||
46811054|NCT02658890|83030278|FG002|Treatment Phase|Adverse Event|2|||
46811055|NCT02658890|83030279|FG003|Treatment Phase|Adverse Event|2|||
46811056|NCT02658890|83030280|FG004|Treatment Phase|Adverse Event|1|||
46811057|NCT02658890|83030281|FG005|Treatment Phase|Adverse Event|0|||
46811058|NCT02658890|83030282|FG006|Treatment Phase|Adverse Event|0|||
46811059|NCT02658890|83030283|FG007|Treatment Phase|Adverse Event|2|||
46811060|NCT02658890|83030284|FG008|Treatment Phase|Adverse Event|1|||
46811061|NCT02658890|83030285|FG009|Treatment Phase|Adverse Event|2|||
46811062|NCT02658890|83030286|FG010|Treatment Phase|Adverse Event|3|||
46811063|NCT02658890|83030287|FG011|Treatment Phase|Adverse Event|0|||
46811064|NCT02658890|83030288|FG012|Treatment Phase|Adverse Event|1|||
46811065|NCT02658890|83030289|FG013|Treatment Phase|Adverse Event|4|||
46811066|NCT02658890|83030290|FG014|Treatment Phase|Adverse Event|0|||
46811067|NCT02658890|83030291|FG015|Treatment Phase|Adverse Event|0|||
46811068|NCT02658890|83030292|FG016|Treatment Phase|Adverse Event|0|||
46811069|NCT02658890|83030293|FG017|Treatment Phase|Adverse Event|0|||
47054411|NCT02725710|83326749|FG000|Overall Study|Lost to Follow-up|1|||
47054412|NCT02725710|83326750|FG001|Overall Study|Lost to Follow-up|0|||
47054413|NCT02724462|83326781|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
47054414|NCT02724462|83326782|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
47054415|NCT02724462|83326781|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
47054416|NCT02724462|83326782|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
46811070|NCT02658890|83030294|FG018|Treatment Phase|Adverse Event|5|||
46811071|NCT02658890|83030295|FG019|Treatment Phase|Adverse Event|1|||
46811072|NCT02658890|83030296|FG020|Treatment Phase|Adverse Event|3|||
46811073|NCT02658890|83030297|FG021|Treatment Phase|Adverse Event|0|||
47054417|NCT02724462|83326781|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
46636429|NCT01514136|82810252|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
46754394|NCT00579670|82972046|FG003|Overall Study|Other|2|||
46754395|NCT00579670|82972047|FG004|Overall Study|Other|0|||
46811074|NCT02658890|83030298|FG022|Treatment Phase|Adverse Event|5|||
46811075|NCT02658890|83030299|FG023|Treatment Phase|Adverse Event|0|||
46811076|NCT02658890|83030300|FG024|Treatment Phase|Adverse Event|0|||
46811077|NCT02658890|83030301|FG025|Treatment Phase|Adverse Event|2|||
46811078|NCT02658890|83030302|FG026|Treatment Phase|Adverse Event|1|||
46811079|NCT02658890|83030276|FG000|Treatment Phase|Death|0|||
47054418|NCT02724462|83326782|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
47054419|NCT02724462|83326781|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
47054420|NCT02724462|83326782|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
47054421|NCT02724462|83326781|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
47054422|NCT02724462|83326782|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
47054423|NCT02724462|83326781|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
47054424|NCT02724462|83326782|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
47054425|NCT02725476|83326839|FG000|Overall Study|Physician Decision|2|||
47054426|NCT02725476|83326840|FG001|Overall Study|Physician Decision|0|||
47054427|NCT02725476|83326839|FG000|Overall Study|Adverse Event|1|||
47054428|NCT02725476|83326840|FG001|Overall Study|Adverse Event|1|||
47054429|NCT02725008|83326941|FG000|Overall Study|Lost to Follow-up|7|||
46811080|NCT02658890|83030277|FG001|Treatment Phase|Death|0|||
46811081|NCT02658890|83030278|FG002|Treatment Phase|Death|0|||
46811082|NCT02658890|83030279|FG003|Treatment Phase|Death|0|||
46811083|NCT02658890|83030280|FG004|Treatment Phase|Death|0|||
46811084|NCT02658890|83030281|FG005|Treatment Phase|Death|0|||
46811085|NCT02658890|83030282|FG006|Treatment Phase|Death|0|||
46811086|NCT02658890|83030283|FG007|Treatment Phase|Death|0|||
46811087|NCT02658890|83030284|FG008|Treatment Phase|Death|0|||
46811088|NCT02658890|83030285|FG009|Treatment Phase|Death|0|||
46811089|NCT02658890|83030286|FG010|Treatment Phase|Death|0|||
46811090|NCT02658890|83030287|FG011|Treatment Phase|Death|0|||
46811091|NCT02658890|83030288|FG012|Treatment Phase|Death|0|||
46811092|NCT02658890|83030289|FG013|Treatment Phase|Death|0|||
47054430|NCT02725008|83326942|FG001|Overall Study|Lost to Follow-up|9|||
47054431|NCT02725008|83326941|FG000|Overall Study|Withdrawal by Subject|2|||
47054432|NCT02725008|83326942|FG001|Overall Study|Withdrawal by Subject|2|||
46811093|NCT02658890|83030290|FG014|Treatment Phase|Death|0|||
46811094|NCT02658890|83030291|FG015|Treatment Phase|Death|0|||
46811095|NCT02658890|83030292|FG016|Treatment Phase|Death|0|||
46811096|NCT02658890|83030293|FG017|Treatment Phase|Death|0|||
46811097|NCT02658890|83030294|FG018|Treatment Phase|Death|1|||
46811098|NCT02658890|83030295|FG019|Treatment Phase|Death|0|||
47054433|NCT02725008|83326941|FG000|Overall Study|Admitted to hospital|0|||
47054434|NCT02725008|83326942|FG001|Overall Study|Admitted to hospital|1|||
47054435|NCT01807949|83327203|FG000|Overall Study|Adverse Event|1|||
47054436|NCT01807949|83327204|FG001|Overall Study|Adverse Event|2|||
47054437|NCT01807949|83327205|FG002|Overall Study|Adverse Event|2|||
47054438|NCT01807949|83327203|FG000|Overall Study|Withdrawal by Subject|1|||
47054439|NCT01807949|83327204|FG001|Overall Study|Withdrawal by Subject|2|||
47054440|NCT01807949|83327205|FG002|Overall Study|Withdrawal by Subject|2|||
47054441|NCT01807949|83327203|FG000|Overall Study|Non-Compliance|0|||
47054442|NCT01807949|83327204|FG001|Overall Study|Non-Compliance|0|||
47054443|NCT01807949|83327205|FG002|Overall Study|Non-Compliance|1|||
46754396|NCT00579670|82972043|FG000|Overall Study|Withdrawal by Subject|0|||
46754397|NCT00579670|82972044|FG001|Overall Study|Withdrawal by Subject|0|||
46754398|NCT00579670|82972045|FG002|Overall Study|Withdrawal by Subject|1|||
46754399|NCT00579670|82972046|FG003|Overall Study|Withdrawal by Subject|0|||
46754400|NCT00579670|82972047|FG004|Overall Study|Withdrawal by Subject|0|||
46754401|NCT03909295|82972071|FG000|Overall Study|Adverse Event|2|||
46754402|NCT03909295|82972071|FG000|Overall Study|Study terminated by sponsor|50|||
46754403|NCT00599924|82972082|FG000|Overall Study|Lack of Efficacy|3|||
46754404|NCT00599924|82972083|FG001|Overall Study|Lack of Efficacy|5|||
46754405|NCT00599924|82972084|FG002|Overall Study|Lack of Efficacy|1|||
46754406|NCT00599924|82972085|FG003|Overall Study|Lack of Efficacy|2|||
46754407|NCT00599924|82972086|FG004|Overall Study|Lack of Efficacy|3|||
46754408|NCT00599924|82972087|FG005|Overall Study|Lack of Efficacy|2|||
46754409|NCT00599924|82972088|FG006|Overall Study|Lack of Efficacy|0|||
47054444|NCT01807949|83327203|FG000|Overall Study|Undefined|0|||
46636430|NCT01514136|82810253|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
46754410|NCT00599924|82972082|FG000|Overall Study|Adverse Event|0|||
46811099|NCT02658890|83030296|FG020|Treatment Phase|Death|0|||
46811100|NCT02658890|83030297|FG021|Treatment Phase|Death|0|||
46811101|NCT02658890|83030298|FG022|Treatment Phase|Death|0|||
46811102|NCT02658890|83030299|FG023|Treatment Phase|Death|0|||
46811103|NCT02658890|83030300|FG024|Treatment Phase|Death|0|||
46754411|NCT00599924|82972083|FG001|Overall Study|Adverse Event|0|||
46754412|NCT00599924|82972084|FG002|Overall Study|Adverse Event|0|||
46811104|NCT02658890|83030301|FG025|Treatment Phase|Death|0|||
46811105|NCT02658890|83030302|FG026|Treatment Phase|Death|0|||
46811106|NCT02658890|83030276|FG000|Treatment Phase|Lost to Follow-up|0|||
46811107|NCT02658890|83030277|FG001|Treatment Phase|Lost to Follow-up|0|||
46811108|NCT02658890|83030278|FG002|Treatment Phase|Lost to Follow-up|0|||
46811109|NCT02658890|83030279|FG003|Treatment Phase|Lost to Follow-up|0|||
46811110|NCT02658890|83030280|FG004|Treatment Phase|Lost to Follow-up|0|||
46811111|NCT02658890|83030281|FG005|Treatment Phase|Lost to Follow-up|0|||
46811112|NCT02658890|83030282|FG006|Treatment Phase|Lost to Follow-up|1|||
46811113|NCT02658890|83030283|FG007|Treatment Phase|Lost to Follow-up|0|||
47054445|NCT01807949|83327204|FG001|Overall Study|Undefined|1|||
47054446|NCT01807949|83327205|FG002|Overall Study|Undefined|2|||
47054447|NCT01807949|83327203|FG000|Overall Study|Randomized But Not Treated|0|||
46811114|NCT02658890|83030284|FG008|Treatment Phase|Lost to Follow-up|0|||
46811115|NCT02658890|83030285|FG009|Treatment Phase|Lost to Follow-up|0|||
46811116|NCT02658890|83030286|FG010|Treatment Phase|Lost to Follow-up|0|||
46811117|NCT02658890|83030287|FG011|Treatment Phase|Lost to Follow-up|0|||
46811118|NCT02658890|83030288|FG012|Treatment Phase|Lost to Follow-up|0|||
46811119|NCT02658890|83030289|FG013|Treatment Phase|Lost to Follow-up|0|||
46811120|NCT02658890|83030290|FG014|Treatment Phase|Lost to Follow-up|0|||
46811121|NCT02658890|83030291|FG015|Treatment Phase|Lost to Follow-up|0|||
46811122|NCT02658890|83030292|FG016|Treatment Phase|Lost to Follow-up|0|||
46811123|NCT02658890|83030293|FG017|Treatment Phase|Lost to Follow-up|0|||
46811124|NCT02658890|83030294|FG018|Treatment Phase|Lost to Follow-up|0|||
46811125|NCT02658890|83030295|FG019|Treatment Phase|Lost to Follow-up|0|||
46811126|NCT02658890|83030296|FG020|Treatment Phase|Lost to Follow-up|0|||
46811127|NCT02658890|83030297|FG021|Treatment Phase|Lost to Follow-up|0|||
46811128|NCT02658890|83030298|FG022|Treatment Phase|Lost to Follow-up|0|||
46811129|NCT02658890|83030299|FG023|Treatment Phase|Lost to Follow-up|0|||
46811130|NCT02658890|83030300|FG024|Treatment Phase|Lost to Follow-up|0|||
46811131|NCT02658890|83030301|FG025|Treatment Phase|Lost to Follow-up|0|||
46811132|NCT02658890|83030302|FG026|Treatment Phase|Lost to Follow-up|0|||
46811133|NCT02658890|83030276|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
46811134|NCT02658890|83030277|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
46811135|NCT02658890|83030278|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
46811136|NCT02658890|83030279|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
46811137|NCT02658890|83030280|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
46811138|NCT02658890|83030281|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
46811139|NCT02658890|83030282|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
46811140|NCT02658890|83030283|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
46811141|NCT02658890|83030284|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
46811142|NCT02658890|83030285|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
46811143|NCT02658890|83030286|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
46811144|NCT02658890|83030287|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
46811145|NCT02658890|83030288|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
46811146|NCT02658890|83030289|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
46811147|NCT02658890|83030290|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
46811148|NCT02658890|83030291|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
46811149|NCT02658890|83030292|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
46811150|NCT02658890|83030293|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
46811151|NCT02658890|83030294|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
46811152|NCT02658890|83030295|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
46811153|NCT02658890|83030296|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
46811154|NCT02658890|83030297|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
46811155|NCT02658890|83030298|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
46811156|NCT02658890|83030299|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
46811157|NCT02658890|83030300|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
46811158|NCT02658890|83030301|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
46811159|NCT02658890|83030302|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
46811160|NCT02658890|83030276|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
46811161|NCT02658890|83030277|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
46811162|NCT02658890|83030278|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
46811163|NCT02658890|83030279|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
46811164|NCT02658890|83030280|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
46811165|NCT02658890|83030281|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
46811166|NCT02658890|83030282|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
46811167|NCT02658890|83030283|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
46811168|NCT02658890|83030284|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
46811169|NCT02658890|83030285|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
47054448|NCT01807949|83327204|FG001|Overall Study|Randomized But Not Treated|2|||
47054449|NCT01807949|83327205|FG002|Overall Study|Randomized But Not Treated|2|||
47054450|NCT01806779|83327217|FG000|Overall Study|Physician Decision|2|||
47054451|NCT01806779|83327218|FG001|Overall Study|Physician Decision|0|||
47054452|NCT01806779|83327219|FG002|Overall Study|Physician Decision|1|||
46811170|NCT02658890|83030286|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
46811171|NCT02658890|83030287|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
46811172|NCT02658890|83030288|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
46811173|NCT02658890|83030289|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
46811174|NCT02658890|83030290|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
46811175|NCT02658890|83030291|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
46927536|NCT02624986|83162132|FG002|Overall Study|Study Terminated by Sponsor|0|||
46927537|NCT02624986|83162133|FG003|Overall Study|Study Terminated by Sponsor|1|||
46927538|NCT02624986|83162134|FG004|Overall Study|Study Terminated by Sponsor|2|||
46927539|NCT02624986|83162135|FG005|Overall Study|Study Terminated by Sponsor|2|||
46927540|NCT02624986|83162136|FG006|Overall Study|Study Terminated by Sponsor|4|||
46927541|NCT02624986|83162137|FG007|Overall Study|Study Terminated by Sponsor|3|||
46927542|NCT02624986|83162130|FG000|Overall Study|Progressive Disease|0|||
46927543|NCT02624986|83162131|FG001|Overall Study|Progressive Disease|1|||
46927544|NCT02624986|83162132|FG002|Overall Study|Progressive Disease|0|||
46927545|NCT02624986|83162133|FG003|Overall Study|Progressive Disease|0|||
46927546|NCT02624986|83162134|FG004|Overall Study|Progressive Disease|0|||
46927547|NCT02624986|83162135|FG005|Overall Study|Progressive Disease|0|||
46927548|NCT02624986|83162136|FG006|Overall Study|Progressive Disease|0|||
46927549|NCT02624986|83162137|FG007|Overall Study|Progressive Disease|0|||
46927550|NCT02624986|83162130|FG000|Overall Study|Protocol Violation|1|||
46927551|NCT02624986|83162131|FG001|Overall Study|Protocol Violation|0|||
46927552|NCT02624986|83162132|FG002|Overall Study|Protocol Violation|0|||
46927553|NCT02624986|83162133|FG003|Overall Study|Protocol Violation|0|||
46927554|NCT02624986|83162134|FG004|Overall Study|Protocol Violation|0|||
46927555|NCT02624986|83162135|FG005|Overall Study|Protocol Violation|0|||
46927556|NCT02624986|83162136|FG006|Overall Study|Protocol Violation|0|||
46927557|NCT02624986|83162137|FG007|Overall Study|Protocol Violation|0|||
46927558|NCT02624986|83162130|FG000|Overall Study|Withdrawal by Subject|0|||
46927559|NCT02624986|83162131|FG001|Overall Study|Withdrawal by Subject|0|||
46927560|NCT02624986|83162132|FG002|Overall Study|Withdrawal by Subject|0|||
46927561|NCT02624986|83162133|FG003|Overall Study|Withdrawal by Subject|0|||
46927562|NCT02624986|83162134|FG004|Overall Study|Withdrawal by Subject|0|||
46927563|NCT02624986|83162135|FG005|Overall Study|Withdrawal by Subject|0|||
46927564|NCT02624986|83162136|FG006|Overall Study|Withdrawal by Subject|0|||
46927565|NCT02624986|83162137|FG007|Overall Study|Withdrawal by Subject|1|||
46927566|NCT02587598|83162170|FG000|Overall Study|Death|4|||
46927567|NCT02587598|83162171|FG001|Overall Study|Death|8|||
46927568|NCT02587598|83162172|FG002|Overall Study|Death|4|||
46927569|NCT02587598|83162173|FG003|Overall Study|Death|16|||
46927570|NCT02587598|83162174|FG004|Overall Study|Death|9|||
46927571|NCT02587598|83162175|FG005|Overall Study|Death|4|||
46927572|NCT02587598|83162176|FG006|Overall Study|Death|6|||
46927573|NCT02587598|83162177|FG007|Overall Study|Death|7|||
46927574|NCT02587598|83162178|FG008|Overall Study|Death|9|||
47054453|NCT01806779|83327217|FG000|Overall Study|Lack of Efficacy|1|||
47054454|NCT01806779|83327218|FG001|Overall Study|Lack of Efficacy|1|||
47054455|NCT01806779|83327219|FG002|Overall Study|Lack of Efficacy|0|||
47054456|NCT01806779|83327217|FG000|Overall Study|Lost to Follow-up|19|||
47054457|NCT01806779|83327218|FG001|Overall Study|Lost to Follow-up|20|||
47054458|NCT01806779|83327219|FG002|Overall Study|Lost to Follow-up|0|||
47054459|NCT01806779|83327217|FG000|Overall Study|Withdrawal by Subject|20|||
47054460|NCT01806779|83327218|FG001|Overall Study|Withdrawal by Subject|23|||
46811176|NCT02658890|83030292|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
47054461|NCT01806779|83327219|FG002|Overall Study|Withdrawal by Subject|22|||
46811177|NCT02658890|83030293|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
46811178|NCT02658890|83030294|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
46811179|NCT02658890|83030295|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
46811180|NCT02658890|83030296|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
46811181|NCT02658890|83030297|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
46811182|NCT02658890|83030298|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
46811183|NCT02658890|83030299|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
46811184|NCT02658890|83030300|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
46811185|NCT02658890|83030301|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
46811186|NCT02658890|83030302|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
46811187|NCT02658890|83030276|FG000|Treatment Phase|Other Reasons|0|||
47054462|NCT01607957|83327293|FG000|Overall Study|Not treated|1|||
47054463|NCT01607957|83327294|FG001|Overall Study|Not treated|1|||
47054464|NCT01607957|83327293|FG000|Overall Study|Death|367|||
46927575|NCT02587598|83162179|FG009|Overall Study|Death|1|||
46927576|NCT02587598|83162180|FG010|Overall Study|Death|3|||
46927577|NCT02587598|83162170|FG000|Overall Study|Study Terminated by the Sponsor|0|||
46927578|NCT02587598|83162171|FG001|Overall Study|Study Terminated by the Sponsor|1|||
46927579|NCT02587598|83162172|FG002|Overall Study|Study Terminated by the Sponsor|0|||
46927580|NCT02587598|83162173|FG003|Overall Study|Study Terminated by the Sponsor|3|||
46927581|NCT02587598|83162174|FG004|Overall Study|Study Terminated by the Sponsor|0|||
46927582|NCT02587598|83162175|FG005|Overall Study|Study Terminated by the Sponsor|1|||
46927583|NCT02587598|83162176|FG006|Overall Study|Study Terminated by the Sponsor|0|||
46927584|NCT02587598|83162177|FG007|Overall Study|Study Terminated by the Sponsor|0|||
46927585|NCT02587598|83162178|FG008|Overall Study|Study Terminated by the Sponsor|0|||
46811188|NCT02658890|83030277|FG001|Treatment Phase|Other Reasons|0|||
46811189|NCT02658890|83030278|FG002|Treatment Phase|Other Reasons|0|||
47054465|NCT01607957|83327294|FG001|Overall Study|Death|211|||
47054466|NCT01607957|83327293|FG000|Overall Study|Lost to Follow-up|3|||
46811190|NCT02658890|83030279|FG003|Treatment Phase|Other Reasons|0|||
46811191|NCT02658890|83030280|FG004|Treatment Phase|Other Reasons|0|||
46811192|NCT02658890|83030281|FG005|Treatment Phase|Other Reasons|0|||
46811193|NCT02658890|83030282|FG006|Treatment Phase|Other Reasons|1|||
46811194|NCT02658890|83030283|FG007|Treatment Phase|Other Reasons|0|||
46811195|NCT02658890|83030284|FG008|Treatment Phase|Other Reasons|1|||
46811196|NCT02658890|83030285|FG009|Treatment Phase|Other Reasons|0|||
46811197|NCT02658890|83030286|FG010|Treatment Phase|Other Reasons|0|||
46811198|NCT02658890|83030287|FG011|Treatment Phase|Other Reasons|0|||
46811199|NCT02658890|83030288|FG012|Treatment Phase|Other Reasons|0|||
46811200|NCT02658890|83030289|FG013|Treatment Phase|Other Reasons|2|||
46811201|NCT02658890|83030290|FG014|Treatment Phase|Other Reasons|0|||
46811202|NCT02658890|83030291|FG015|Treatment Phase|Other Reasons|0|||
46811203|NCT02658890|83030292|FG016|Treatment Phase|Other Reasons|0|||
46811204|NCT02658890|83030293|FG017|Treatment Phase|Other Reasons|0|||
46811205|NCT02658890|83030294|FG018|Treatment Phase|Other Reasons|1|||
46811206|NCT02658890|83030295|FG019|Treatment Phase|Other Reasons|0|||
46811207|NCT02658890|83030296|FG020|Treatment Phase|Other Reasons|0|||
46811208|NCT02658890|83030297|FG021|Treatment Phase|Other Reasons|0|||
46811209|NCT02658890|83030298|FG022|Treatment Phase|Other Reasons|0|||
46811210|NCT02658890|83030299|FG023|Treatment Phase|Other Reasons|0|||
46811211|NCT02658890|83030300|FG024|Treatment Phase|Other Reasons|1|||
46811212|NCT02658890|83030301|FG025|Treatment Phase|Other Reasons|0|||
46811213|NCT02658890|83030302|FG026|Treatment Phase|Other Reasons|1|||
46811214|NCT02658890|83030276|FG000|Treatment Phase|Progressive Disease|6|||
46811215|NCT02658890|83030277|FG001|Treatment Phase|Progressive Disease|7|||
46811216|NCT02658890|83030278|FG002|Treatment Phase|Progressive Disease|6|||
46811217|NCT02658890|83030279|FG003|Treatment Phase|Progressive Disease|12|||
46811218|NCT02658890|83030280|FG004|Treatment Phase|Progressive Disease|6|||
46811219|NCT02658890|83030281|FG005|Treatment Phase|Progressive Disease|18|||
46811220|NCT02658890|83030282|FG006|Treatment Phase|Progressive Disease|12|||
46811221|NCT02658890|83030283|FG007|Treatment Phase|Progressive Disease|19|||
46811222|NCT02658890|83030284|FG008|Treatment Phase|Progressive Disease|26|||
46811223|NCT02658890|83030285|FG009|Treatment Phase|Progressive Disease|8|||
46811224|NCT02658890|83030286|FG010|Treatment Phase|Progressive Disease|7|||
46811225|NCT02658890|83030287|FG011|Treatment Phase|Progressive Disease|9|||
46811226|NCT02658890|83030288|FG012|Treatment Phase|Progressive Disease|8|||
46811227|NCT02658890|83030289|FG013|Treatment Phase|Progressive Disease|29|||
46811228|NCT02658890|83030290|FG014|Treatment Phase|Progressive Disease|6|||
46811229|NCT02658890|83030291|FG015|Treatment Phase|Progressive Disease|2|||
46811230|NCT02658890|83030292|FG016|Treatment Phase|Progressive Disease|32|||
46811231|NCT02658890|83030293|FG017|Treatment Phase|Progressive Disease|14|||
46811232|NCT02658890|83030294|FG018|Treatment Phase|Progressive Disease|40|||
46811233|NCT02658890|83030295|FG019|Treatment Phase|Progressive Disease|32|||
46811234|NCT02658890|83030296|FG020|Treatment Phase|Progressive Disease|19|||
46811235|NCT02658890|83030297|FG021|Treatment Phase|Progressive Disease|30|||
46754413|NCT00599924|82972085|FG003|Overall Study|Adverse Event|2|||
46754414|NCT00599924|82972086|FG004|Overall Study|Adverse Event|0|||
46754415|NCT00599924|82972087|FG005|Overall Study|Adverse Event|0|||
46754416|NCT00599924|82972088|FG006|Overall Study|Adverse Event|2|||
46754417|NCT00599924|82972082|FG000|Overall Study|Death|0|||
46754418|NCT00599924|82972083|FG001|Overall Study|Death|0|||
46754419|NCT00599924|82972084|FG002|Overall Study|Death|0|||
46754420|NCT00599924|82972085|FG003|Overall Study|Death|2|||
46754421|NCT00599924|82972086|FG004|Overall Study|Death|0|||
46754422|NCT00599924|82972087|FG005|Overall Study|Death|2|||
46754423|NCT00599924|82972088|FG006|Overall Study|Death|1|||
46754424|NCT00599924|82972082|FG000|Overall Study|Protocol Violation|0|||
46754425|NCT00599924|82972083|FG001|Overall Study|Protocol Violation|0|||
46754426|NCT00599924|82972084|FG002|Overall Study|Protocol Violation|0|||
46754427|NCT00599924|82972085|FG003|Overall Study|Protocol Violation|1|||
46754428|NCT00599924|82972086|FG004|Overall Study|Protocol Violation|0|||
46811236|NCT02658890|83030298|FG022|Treatment Phase|Progressive Disease|15|||
46811237|NCT02658890|83030299|FG023|Treatment Phase|Progressive Disease|0|||
46811238|NCT02658890|83030300|FG024|Treatment Phase|Progressive Disease|0|||
46811239|NCT02658890|83030301|FG025|Treatment Phase|Progressive Disease|14|||
47054467|NCT01607957|83327294|FG001|Overall Study|Lost to Follow-up|3|||
46754429|NCT00599924|82972087|FG005|Overall Study|Protocol Violation|0|||
46811240|NCT02658890|83030302|FG026|Treatment Phase|Progressive Disease|11|||
46811241|NCT02658890|83030276|FG000|Treatment Phase|Study Drug Toxicity|0|||
46754430|NCT00599924|82972088|FG006|Overall Study|Protocol Violation|0|||
46754431|NCT00599924|82972082|FG000|Overall Study|Withdrawal by Subject|0|||
46754432|NCT00599924|82972083|FG001|Overall Study|Withdrawal by Subject|0|||
46754433|NCT00599924|82972084|FG002|Overall Study|Withdrawal by Subject|1|||
46811242|NCT02658890|83030277|FG001|Treatment Phase|Study Drug Toxicity|0|||
46811243|NCT02658890|83030278|FG002|Treatment Phase|Study Drug Toxicity|2|||
46811244|NCT02658890|83030279|FG003|Treatment Phase|Study Drug Toxicity|0|||
46811245|NCT02658890|83030280|FG004|Treatment Phase|Study Drug Toxicity|0|||
46811246|NCT02658890|83030281|FG005|Treatment Phase|Study Drug Toxicity|0|||
46811247|NCT02658890|83030282|FG006|Treatment Phase|Study Drug Toxicity|0|||
46811248|NCT02658890|83030283|FG007|Treatment Phase|Study Drug Toxicity|0|||
46811249|NCT02658890|83030284|FG008|Treatment Phase|Study Drug Toxicity|3|||
46811250|NCT02658890|83030285|FG009|Treatment Phase|Study Drug Toxicity|0|||
46811251|NCT02658890|83030286|FG010|Treatment Phase|Study Drug Toxicity|1|||
46811252|NCT02658890|83030287|FG011|Treatment Phase|Study Drug Toxicity|1|||
46811253|NCT02658890|83030288|FG012|Treatment Phase|Study Drug Toxicity|2|||
46811254|NCT02658890|83030289|FG013|Treatment Phase|Study Drug Toxicity|9|||
46811255|NCT02658890|83030290|FG014|Treatment Phase|Study Drug Toxicity|0|||
46811256|NCT02658890|83030291|FG015|Treatment Phase|Study Drug Toxicity|1|||
46811257|NCT02658890|83030292|FG016|Treatment Phase|Study Drug Toxicity|1|||
46811258|NCT02658890|83030293|FG017|Treatment Phase|Study Drug Toxicity|0|||
46811259|NCT02658890|83030294|FG018|Treatment Phase|Study Drug Toxicity|8|||
46811260|NCT02658890|83030295|FG019|Treatment Phase|Study Drug Toxicity|3|||
46811261|NCT02658890|83030296|FG020|Treatment Phase|Study Drug Toxicity|2|||
46811262|NCT02658890|83030297|FG021|Treatment Phase|Study Drug Toxicity|0|||
46811263|NCT02658890|83030298|FG022|Treatment Phase|Study Drug Toxicity|8|||
46811264|NCT02658890|83030299|FG023|Treatment Phase|Study Drug Toxicity|0|||
46811265|NCT02658890|83030300|FG024|Treatment Phase|Study Drug Toxicity|0|||
46811266|NCT02658890|83030301|FG025|Treatment Phase|Study Drug Toxicity|2|||
46811267|NCT02658890|83030302|FG026|Treatment Phase|Study Drug Toxicity|0|||
46811268|NCT02658890|83030276|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811269|NCT02658890|83030277|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811270|NCT02658890|83030278|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811271|NCT02658890|83030279|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
46811272|NCT02658890|83030280|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811273|NCT02658890|83030281|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811274|NCT02658890|83030282|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811275|NCT02658890|83030283|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811276|NCT02658890|83030284|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811277|NCT02658890|83030285|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
46811278|NCT02658890|83030286|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811279|NCT02658890|83030287|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811280|NCT02658890|83030288|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811281|NCT02658890|83030289|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46927586|NCT02587598|83162179|FG009|Overall Study|Study Terminated by the Sponsor|1|||
46927587|NCT02587598|83162180|FG010|Overall Study|Study Terminated by the Sponsor|6|||
46927588|NCT02587598|83162170|FG000|Overall Study|Reason for study withdrawal not specified|0|||
46927589|NCT02587598|83162171|FG001|Overall Study|Reason for study withdrawal not specified|1|||
46927590|NCT02587598|83162172|FG002|Overall Study|Reason for study withdrawal not specified|0|||
46927591|NCT02587598|83162173|FG003|Overall Study|Reason for study withdrawal not specified|0|||
46927592|NCT02587598|83162174|FG004|Overall Study|Reason for study withdrawal not specified|0|||
46927593|NCT02587598|83162175|FG005|Overall Study|Reason for study withdrawal not specified|0|||
46927594|NCT02587598|83162176|FG006|Overall Study|Reason for study withdrawal not specified|0|||
46927595|NCT02587598|83162177|FG007|Overall Study|Reason for study withdrawal not specified|0|||
46927596|NCT02587598|83162178|FG008|Overall Study|Reason for study withdrawal not specified|0|||
46927597|NCT02587598|83162179|FG009|Overall Study|Reason for study withdrawal not specified|0|||
46927598|NCT02587598|83162180|FG010|Overall Study|Reason for study withdrawal not specified|0|||
46927599|NCT02587598|83162170|FG000|Overall Study|Withdrawal by Subject|0|||
46927600|NCT02587598|83162171|FG001|Overall Study|Withdrawal by Subject|1|||
46927601|NCT02587598|83162172|FG002|Overall Study|Withdrawal by Subject|0|||
46927602|NCT02587598|83162173|FG003|Overall Study|Withdrawal by Subject|2|||
46927603|NCT02587598|83162174|FG004|Overall Study|Withdrawal by Subject|3|||
46927604|NCT02587598|83162175|FG005|Overall Study|Withdrawal by Subject|1|||
47054468|NCT01607957|83327293|FG000|Overall Study|Participant refusal|1|||
47054469|NCT01607957|83327294|FG001|Overall Study|Participant refusal|0|||
47054470|NCT01806623|83327314|FG000|Overall Study|Withdrawal by Subject|1|||
47054471|NCT01806623|83327314|FG000|Overall Study|Adverse Event|1|||
46927605|NCT02587598|83162176|FG006|Overall Study|Withdrawal by Subject|0|||
46927606|NCT02587598|83162177|FG007|Overall Study|Withdrawal by Subject|0|||
47054472|NCT01806623|83327314|FG000|Overall Study|Did not meet the inclusion criteria|56|||
47054473|NCT01806545|83327320|FG000|Overall Study|Adverse Event|2|||
47054474|NCT01806545|83327321|FG001|Overall Study|Adverse Event|3|||
47054475|NCT01806545|83327320|FG000|Overall Study|Lost to Follow-up|1|||
47054476|NCT01806545|83327321|FG001|Overall Study|Lost to Follow-up|0|||
47054477|NCT01806545|83327320|FG000|Overall Study|Withdrawal by Subject|3|||
47054478|NCT01806545|83327321|FG001|Overall Study|Withdrawal by Subject|2|||
47054479|NCT01806389|83327327|FG000|Overall Study|Withdrawal by Subject|4|||
47054480|NCT01781975|83327596|FG000|Overall Study|Death|1|||
47054481|NCT01781975|83327597|FG001|Overall Study|Death|0|||
47054482|NCT01781975|83327596|FG000|Overall Study|Withdrawal by Subject|1|||
46927607|NCT02587598|83162178|FG008|Overall Study|Withdrawal by Subject|0|||
46927608|NCT02587598|83162179|FG009|Overall Study|Withdrawal by Subject|1|||
46927609|NCT02587598|83162180|FG010|Overall Study|Withdrawal by Subject|2|||
46927610|NCT02587598|83162170|FG000|Overall Study|Physician Decision|0|||
46927611|NCT02587598|83162171|FG001|Overall Study|Physician Decision|0|||
47054483|NCT01781975|83327597|FG001|Overall Study|Withdrawal by Subject|1|||
47054484|NCT01804673|83327618|FG000|Overall Study|Adverse Event|4|||
46811282|NCT02658890|83030290|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811283|NCT02658890|83030291|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811284|NCT02658890|83030292|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811285|NCT02658890|83030293|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811286|NCT02658890|83030294|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
46811287|NCT02658890|83030295|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811288|NCT02658890|83030296|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811289|NCT02658890|83030297|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46927612|NCT02587598|83162172|FG002|Overall Study|Physician Decision|0|||
46927613|NCT02587598|83162173|FG003|Overall Study|Physician Decision|0|||
46927614|NCT02587598|83162174|FG004|Overall Study|Physician Decision|0|||
46927615|NCT02587598|83162175|FG005|Overall Study|Physician Decision|0|||
46927616|NCT02587598|83162176|FG006|Overall Study|Physician Decision|0|||
47054485|NCT01804673|83327618|FG000|Overall Study|Withdrawal by Subject|1|||
47054486|NCT01804673|83327618|FG000|Overall Study|Lack of Efficacy|9|||
47054487|NCT01804673|83327618|FG000|Overall Study|Change to Oral Therapy|37|||
47054488|NCT01804673|83327618|FG000|Overall Study|No Further Therapy Required|84|||
47054489|NCT01804673|83327618|FG000|Overall Study|Use of Prohibited Medication|1|||
47054490|NCT01804673|83327618|FG000|Overall Study|Other|4|||
47054491|NCT01774097|83327628|FG000|Overall Study|Withdrawal by Subject|1|||
47054492|NCT01774097|83327629|FG001|Overall Study|Withdrawal by Subject|1|||
47054493|NCT01774097|83327628|FG000|Overall Study|Adverse Event|1|||
47054494|NCT01774097|83327629|FG001|Overall Study|Adverse Event|1|||
47054495|NCT02859558|83327703|FG000|Step 1|Not Eligible|0|||
47054496|NCT02859558|83327704|FG001|Step 1|Not Eligible|0|||
47054497|NCT02859558|83327705|FG002|Step 1|Not Eligible|0|||
47054498|NCT02859558|83327706|FG003|Step 1|Not Eligible|0|||
47054499|NCT02859558|83327707|FG004|Step 1|Not Eligible|3|||
47054500|NCT02859558|83327703|FG000|Step 1|Lost to Follow-up|1|||
46754434|NCT00599924|82972085|FG003|Overall Study|Withdrawal by Subject|0|||
46754435|NCT00599924|82972086|FG004|Overall Study|Withdrawal by Subject|1|||
46754436|NCT00599924|82972087|FG005|Overall Study|Withdrawal by Subject|0|||
46754437|NCT00599924|82972088|FG006|Overall Study|Withdrawal by Subject|0|||
46754438|NCT00599924|82972082|FG000|Overall Study|Other|0|||
46754439|NCT00599924|82972083|FG001|Overall Study|Other|0|||
46754440|NCT00599924|82972084|FG002|Overall Study|Other|0|||
46754441|NCT00599924|82972085|FG003|Overall Study|Other|1|||
46754442|NCT00599924|82972086|FG004|Overall Study|Other|2|||
46754443|NCT00599924|82972087|FG005|Overall Study|Other|0|||
46754444|NCT00599924|82972088|FG006|Overall Study|Other|2|||
46754445|NCT00581542|82972111|FG000|Overall Study|they met an exclusion criteria|2|||
46754446|NCT00581542|82972112|FG001|Overall Study|they met an exclusion criteria|2|||
46754447|NCT00581542|82972111|FG000|Overall Study|Lost to Follow-up|9|||
46754448|NCT00581542|82972112|FG001|Overall Study|Lost to Follow-up|21|||
46754449|NCT03912337|82972122|FG000|Overall Study|Withdrawal of Consent From Study|1|||
46754450|NCT03912337|82972123|FG001|Overall Study|Withdrawal of Consent From Study|0|||
46754451|NCT03912337|82972122|FG000|Overall Study|Lost to Follow-up|1|||
46754452|NCT03912337|82972123|FG001|Overall Study|Lost to Follow-up|1|||
46754453|NCT02121652|82972131|FG000|Overall Study|Lost to Follow-up|2|||
46754454|NCT02121652|82972132|FG001|Overall Study|Lost to Follow-up|1|||
46754455|NCT02121652|82972131|FG000|Overall Study|Death|1|||
46754456|NCT02121652|82972132|FG001|Overall Study|Death|0|||
46754457|NCT02121652|82972131|FG000|Overall Study|Withdrawal by Subject|3|||
46754458|NCT02121652|82972132|FG001|Overall Study|Withdrawal by Subject|3|||
46754459|NCT00595920|82972138|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
46754460|NCT00595764|82972144|FG000|Overall Study|Protocol Violation|24|||
46754461|NCT00595764|82972145|FG001|Overall Study|Protocol Violation|19|||
46754462|NCT00595764|82972144|FG000|Overall Study|Missed Medication >1 week|10|||
46927617|NCT02587598|83162177|FG007|Overall Study|Physician Decision|0|||
46927618|NCT02587598|83162178|FG008|Overall Study|Physician Decision|0|||
47054501|NCT02859558|83327704|FG001|Step 1|Lost to Follow-up|3|||
47054502|NCT02859558|83327705|FG002|Step 1|Lost to Follow-up|3|||
47054503|NCT02859558|83327706|FG003|Step 1|Lost to Follow-up|0|||
46754463|NCT00595764|82972145|FG001|Overall Study|Missed Medication >1 week|17|||
46754464|NCT00595764|82972144|FG000|Overall Study|Missed 3 PM visits|1|||
46754465|NCT00595764|82972145|FG001|Overall Study|Missed 3 PM visits|7|||
46754466|NCT00595764|82972144|FG000|Overall Study|Withdrawal by Subject|4|||
46754467|NCT00595764|82972145|FG001|Overall Study|Withdrawal by Subject|0|||
46927619|NCT02587598|83162179|FG009|Overall Study|Physician Decision|0|||
47054504|NCT02859558|83327707|FG004|Step 1|Lost to Follow-up|0|||
46754468|NCT00581308|82972165|FG000|Pre Discharge|Lost to Follow-up|1|||
46636431|NCT01514136|82810254|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
46636432|NCT01514136|82810255|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
46754469|NCT00581308|82972165|FG000|Pre Discharge|Device Removed|1|||
46811290|NCT02658890|83030298|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
46811291|NCT02658890|83030299|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811292|NCT02658890|83030300|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811293|NCT02658890|83030301|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811294|NCT02658890|83030302|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
46811295|NCT02658890|83030276|FG000|Treatment Phase|Withdrawal by Subject|0|||
47054505|NCT02859558|83327703|FG000|Step 1|Did Not Return to Clinic|2|||
47054506|NCT02859558|83327704|FG001|Step 1|Did Not Return to Clinic|3|||
47054507|NCT02859558|83327705|FG002|Step 1|Did Not Return to Clinic|4|||
47054508|NCT02859558|83327706|FG003|Step 1|Did Not Return to Clinic|0|||
47054509|NCT02859558|83327707|FG004|Step 1|Did Not Return to Clinic|0|||
47054510|NCT02859558|83327703|FG000|Step 1|Moved|0|||
47054511|NCT02859558|83327704|FG001|Step 1|Moved|1|||
47054512|NCT02859558|83327705|FG002|Step 1|Moved|1|||
47054513|NCT02859558|83327706|FG003|Step 1|Moved|0|||
47054514|NCT02859558|83327707|FG004|Step 1|Moved|0|||
47054515|NCT02859558|83327703|FG000|Step 1|Withdrawal By Participant|1|||
47054516|NCT02859558|83327704|FG001|Step 1|Withdrawal By Participant|2|||
47054517|NCT02859558|83327705|FG002|Step 1|Withdrawal By Participant|1|||
47054518|NCT02859558|83327706|FG003|Step 1|Withdrawal By Participant|0|||
47054519|NCT02859558|83327707|FG004|Step 1|Withdrawal By Participant|0|||
47054520|NCT02859558|83327703|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
47054521|NCT02859558|83327704|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
46754470|NCT00581308|82972165|FG000|Month 1|Lost to Follow-up|3|||
46754471|NCT00581308|82972165|FG000|Month 1|Withdrawal by Subject|2|||
46754472|NCT00581308|82972165|FG000|Month 1|Device Removed|2|||
46754473|NCT00581308|82972165|FG000|Month 1|Uknown|1|||
46754474|NCT00581308|82972165|FG000|Month 6|Lost to Follow-up|1|||
46754475|NCT00581308|82972165|FG000|Month 6|Withdrawal by Subject|2|||
46754476|NCT00581308|82972165|FG000|Month 12|Death|1|||
46754477|NCT00581308|82972165|FG000|Month 12|Lost to Follow-up|14|||
46754478|NCT00581308|82972165|FG000|Month 12|Withdrawal by Subject|3|||
46754479|NCT00581308|82972165|FG000|Month 12|Device Removed|1|||
46754480|NCT00581308|82972165|FG000|Month 12|Other|1|||
46811296|NCT02658890|83030277|FG001|Treatment Phase|Withdrawal by Subject|1|||
46811297|NCT02658890|83030278|FG002|Treatment Phase|Withdrawal by Subject|0|||
46811298|NCT02658890|83030279|FG003|Treatment Phase|Withdrawal by Subject|0|||
46927620|NCT02587598|83162180|FG010|Overall Study|Physician Decision|3|||
46754481|NCT00877890|82972174|FG000|Overall Study|Adverse Event|6|||
46754482|NCT00877890|82972175|FG001|Overall Study|Adverse Event|6|||
46927621|NCT02485574|83162216|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
46927622|NCT02624284|83162228|FG000|Overall Study|Withdrawal by Subject|3|||
47054522|NCT02859558|83327705|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
46754483|NCT00877890|82972174|FG000|Overall Study|Lost to Follow-up|5|||
46754484|NCT00877890|82972175|FG001|Overall Study|Lost to Follow-up|5|||
46754485|NCT00877890|82972174|FG000|Overall Study|Protocol Violation|0|||
46811299|NCT02658890|83030280|FG004|Treatment Phase|Withdrawal by Subject|0|||
46811300|NCT02658890|83030281|FG005|Treatment Phase|Withdrawal by Subject|0|||
46811301|NCT02658890|83030282|FG006|Treatment Phase|Withdrawal by Subject|1|||
46811302|NCT02658890|83030283|FG007|Treatment Phase|Withdrawal by Subject|0|||
46811303|NCT02658890|83030284|FG008|Treatment Phase|Withdrawal by Subject|0|||
46811304|NCT02658890|83030285|FG009|Treatment Phase|Withdrawal by Subject|1|||
46811305|NCT02658890|83030286|FG010|Treatment Phase|Withdrawal by Subject|0|||
46811306|NCT02658890|83030287|FG011|Treatment Phase|Withdrawal by Subject|0|||
46811307|NCT02658890|83030288|FG012|Treatment Phase|Withdrawal by Subject|1|||
46811308|NCT02658890|83030289|FG013|Treatment Phase|Withdrawal by Subject|3|||
46811309|NCT02658890|83030290|FG014|Treatment Phase|Withdrawal by Subject|0|||
46811310|NCT02658890|83030291|FG015|Treatment Phase|Withdrawal by Subject|0|||
46811311|NCT02658890|83030292|FG016|Treatment Phase|Withdrawal by Subject|1|||
46811312|NCT02658890|83030293|FG017|Treatment Phase|Withdrawal by Subject|0|||
46811313|NCT02658890|83030294|FG018|Treatment Phase|Withdrawal by Subject|4|||
46811314|NCT02658890|83030295|FG019|Treatment Phase|Withdrawal by Subject|3|||
46811315|NCT02658890|83030296|FG020|Treatment Phase|Withdrawal by Subject|0|||
46811316|NCT02658890|83030297|FG021|Treatment Phase|Withdrawal by Subject|4|||
46811317|NCT02658890|83030298|FG022|Treatment Phase|Withdrawal by Subject|1|||
46927623|NCT02624284|83162229|FG001|Overall Study|Withdrawal by Subject|6|||
46927624|NCT02624284|83162230|FG002|Overall Study|Withdrawal by Subject|3|||
46927625|NCT02624284|83162228|FG000|Overall Study|Protocol Violation|9|||
46927626|NCT02624284|83162229|FG001|Overall Study|Protocol Violation|10|||
46927627|NCT02624284|83162230|FG002|Overall Study|Protocol Violation|7|||
46927628|NCT02624284|83162228|FG000|Overall Study|Revealed exclusionary condition|2|||
46927629|NCT02624284|83162229|FG001|Overall Study|Revealed exclusionary condition|2|||
46927630|NCT02624284|83162230|FG002|Overall Study|Revealed exclusionary condition|0|||
46927631|NCT02624284|83162228|FG000|Overall Study|Adverse Event|0|||
46927632|NCT02624284|83162229|FG001|Overall Study|Adverse Event|0|||
46927633|NCT02624284|83162230|FG002|Overall Study|Adverse Event|1|||
46927634|NCT02738450|83162242|FG000|Overall Study|Withdrawal by Subject|0|||
47054523|NCT02859558|83327706|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
47054524|NCT02859558|83327707|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
47054525|NCT02859558|83327703|FG000|Step 1|Incarceration|0|||
47054526|NCT02859558|83327704|FG001|Step 1|Incarceration|1|||
47054527|NCT02859558|83327705|FG002|Step 1|Incarceration|0|||
47054528|NCT02859558|83327706|FG003|Step 1|Incarceration|0|||
46754486|NCT00877890|82972175|FG001|Overall Study|Protocol Violation|1|||
46754487|NCT00877890|82972174|FG000|Overall Study|Withdrawal of Consent|6|||
46754488|NCT00877890|82972175|FG001|Overall Study|Withdrawal of Consent|12|||
46927635|NCT02738450|83162243|FG001|Overall Study|Withdrawal by Subject|2|||
46927636|NCT02738450|83162244|FG002|Overall Study|Withdrawal by Subject|0|||
46927637|NCT02624050|83162255|FG000|Overall Study|Physician Decision|4|||
46927638|NCT02624050|83162256|FG001|Overall Study|Physician Decision|0|||
46927639|NCT02624050|83162255|FG000|Overall Study|Protocol Violation|2|||
46927640|NCT02624050|83162256|FG001|Overall Study|Protocol Violation|0|||
47054529|NCT02859558|83327707|FG004|Step 1|Incarceration|0|||
47054530|NCT02859558|83327703|FG000|Step 1|Non-Adherence to Study Drug|2|||
47054531|NCT02859558|83327704|FG001|Step 1|Non-Adherence to Study Drug|0|||
46754489|NCT00877890|82972174|FG000|Overall Study|Investigator Decision|0|||
46754490|NCT00877890|82972175|FG001|Overall Study|Investigator Decision|2|||
46754491|NCT00877890|82972174|FG000|Overall Study|Loss of Glucose Control|3|||
46754492|NCT00877890|82972175|FG001|Overall Study|Loss of Glucose Control|4|||
46754493|NCT03474679|82972185|FG000|Overall Study|Death|7|||
46754494|NCT03474679|82972185|FG000|Overall Study|Withdrawal by Subject|1|||
46754495|NCT04639219|82972251|FG000|Overall Study|Withdrawal by Subject|8|||
46754496|NCT04639219|82972251|FG000|Overall Study|Lost to Follow-up|6|||
46754497|NCT04639219|82972251|FG000|Overall Study|Death|55|||
46754498|NCT04638153|82972258|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46754499|NCT04638153|82972259|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46754500|NCT04638153|82972260|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46754501|NCT04638153|82972258|FG000|Overall Study|Study terminated by sponsor|4|||
46754502|NCT04638153|82972259|FG001|Overall Study|Study terminated by sponsor|2|||
46754503|NCT04638153|82972260|FG002|Overall Study|Study terminated by sponsor|14|||
46811318|NCT02658890|83030299|FG023|Treatment Phase|Withdrawal by Subject|1|||
46811319|NCT02658890|83030300|FG024|Treatment Phase|Withdrawal by Subject|0|||
46927641|NCT01338987|83162281|FG000|Overall Study|enrolled on new protocol|0|||
46927642|NCT01338987|83162282|FG001|Overall Study|enrolled on new protocol|0|||
46754504|NCT04428333|82972270|FG000|Overall Study|Physician Decision|2|||
46811320|NCT02658890|83030301|FG025|Treatment Phase|Withdrawal by Subject|0|||
46927643|NCT01338987|83162283|FG002|Overall Study|enrolled on new protocol|1|||
46754505|NCT04428333|82972271|FG001|Overall Study|Physician Decision|0|||
46754506|NCT04428333|82972270|FG000|Overall Study|Withdrawal by Subject|0|||
46811321|NCT02658890|83030302|FG026|Treatment Phase|Withdrawal by Subject|0|||
46927644|NCT01338987|83162284|FG003|Overall Study|enrolled on new protocol|0|||
46927645|NCT01338987|83162285|FG004|Overall Study|enrolled on new protocol|0|||
46811322|NCT02597062|83030394|FG000|Overall Study|Ineligible|1|||
46811323|NCT05159362|83030444|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
46811324|NCT05159362|83030445|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
46811325|NCT05159362|83030446|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
46811326|NCT04975191|83030461|FG000|Overall Study|Protocol Violation|1|||
46811327|NCT04975191|83030462|FG001|Overall Study|Protocol Violation|2|||
46811328|NCT04975191|83030463|FG002|Overall Study|Protocol Violation|2|||
46927646|NCT01338987|83162281|FG000|Overall Study|Disease progression on study|2|||
46927647|NCT01338987|83162282|FG001|Overall Study|Disease progression on study|1|||
46927648|NCT01338987|83162283|FG002|Overall Study|Disease progression on study|1|||
47054532|NCT02859558|83327705|FG002|Step 1|Non-Adherence to Study Drug|1|||
46811329|NCT04975191|83030464|FG003|Overall Study|Protocol Violation|2|||
46811330|NCT04975191|83030461|FG000|Overall Study|Lost to Follow-up|13|||
46811331|NCT04975191|83030462|FG001|Overall Study|Lost to Follow-up|3|||
46811332|NCT04975191|83030463|FG002|Overall Study|Lost to Follow-up|8|||
46811333|NCT04975191|83030464|FG003|Overall Study|Lost to Follow-up|8|||
46811334|NCT04492020|83030490|FG000|Overall Study|Adverse Event|1|||
46811335|NCT04492020|83030491|FG001|Overall Study|Adverse Event|3|||
46811336|NCT04492020|83030490|FG000|Overall Study|Withdrawal by Subject|4|||
47054533|NCT02859558|83327706|FG003|Step 1|Non-Adherence to Study Drug|0|||
47054534|NCT02859558|83327707|FG004|Step 1|Non-Adherence to Study Drug|0|||
47054535|NCT02859558|83327703|FG000|Step 1|Non-Adherence to Study Requirements|3|||
47054536|NCT02859558|83327704|FG001|Step 1|Non-Adherence to Study Requirements|1|||
47054537|NCT02859558|83327705|FG002|Step 1|Non-Adherence to Study Requirements|0|||
47054538|NCT02859558|83327706|FG003|Step 1|Non-Adherence to Study Requirements|0|||
46636433|NCT01514136|82810256|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
46811337|NCT04492020|83030491|FG001|Overall Study|Withdrawal by Subject|3|||
46811338|NCT04492020|83030490|FG000|Overall Study|Lost to Follow-up|4|||
46811339|NCT04492020|83030491|FG001|Overall Study|Lost to Follow-up|3|||
46811340|NCT04492020|83030490|FG000|Overall Study|Protocol Violation|5|||
46811341|NCT04492020|83030491|FG001|Overall Study|Protocol Violation|2|||
46811342|NCT04492020|83030490|FG000|Overall Study|Lack of Qualifying Event|25|||
46811343|NCT04492020|83030491|FG001|Overall Study|Lack of Qualifying Event|27|||
46811344|NCT04492020|83030490|FG000|Overall Study|Non-compliance with Study Drug|2|||
46811345|NCT04492020|83030491|FG001|Overall Study|Non-compliance with Study Drug|1|||
46811346|NCT04382911|83030497|FG000|Overall Study|unable to be imaged prior to surgery|2|||
46811347|NCT04072575|83030505|FG000|Overall Study|Physician Decision|1|||
46811348|NCT04072575|83030505|FG000|Overall Study|Adverse Event|7|||
46811349|NCT04072575|83030505|FG000|Overall Study|Withdrawal by Subject|14|||
46811350|NCT04072575|83030505|FG000|Overall Study|Other|2|||
46811351|NCT03911869|83030511|FG000|Safety Lead-in Phase|Death|7|||
46811352|NCT03911869|83030512|FG001|Safety Lead-in Phase|Death|0|||
46811353|NCT03911869|83030513|FG002|Safety Lead-in Phase|Death|0|||
46811354|NCT03911869|83030511|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
46811355|NCT03911869|83030512|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
46811356|NCT03911869|83030513|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
46811357|NCT03911869|83030511|FG000|Safety Lead-in Phase|Other|1|||
46811358|NCT03911869|83030512|FG001|Safety Lead-in Phase|Other|0|||
46811359|NCT03911869|83030513|FG002|Safety Lead-in Phase|Other|0|||
46811360|NCT03911869|83030511|FG000|Phase 2|Death|0|||
46811361|NCT03911869|83030512|FG001|Phase 2|Death|3|||
46811362|NCT03911869|83030513|FG002|Phase 2|Death|0|||
46811363|NCT03897088|83030522|FG000|Overall Study|Withdrawal by Subject|12|||
46811364|NCT03897088|83030523|FG001|Overall Study|Withdrawal by Subject|12|||
46811365|NCT03897088|83030522|FG000|Overall Study|Lost to Follow-up|7|||
46811366|NCT03897088|83030523|FG001|Overall Study|Lost to Follow-up|15|||
46811367|NCT03897088|83030522|FG000|Overall Study|Sponsor Decision|1|||
46927649|NCT01338987|83162284|FG003|Overall Study|Disease progression on study|0|||
46927650|NCT01338987|83162285|FG004|Overall Study|Disease progression on study|0|||
46927651|NCT03706430|83162299|FG000|Overall Study|No A-Line placed|5|||
47054539|NCT02859558|83327707|FG004|Step 1|Non-Adherence to Study Requirements|0|||
47054540|NCT02859558|83327703|FG000|Step 1|Virologic Failure|2|||
46636434|NCT01514136|82810257|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
46811368|NCT03897088|83030523|FG001|Overall Study|Sponsor Decision|2|||
46811369|NCT03897088|83030522|FG000|Overall Study|COVID-19|2|||
46811370|NCT03897088|83030523|FG001|Overall Study|COVID-19|0|||
47054541|NCT02859558|83327704|FG001|Step 1|Virologic Failure|1|||
46811371|NCT03897088|83030522|FG000|Overall Study|Other|3|||
46811372|NCT03897088|83030523|FG001|Overall Study|Other|0|||
47054542|NCT02859558|83327705|FG002|Step 1|Virologic Failure|1|||
46811373|NCT03897088|83030522|FG000|Overall Study|Non-compliance with Study Drug|1|||
46811374|NCT03897088|83030523|FG001|Overall Study|Non-compliance with Study Drug|1|||
46811375|NCT03897088|83030522|FG000|Overall Study|Pregnancy|0|||
46811376|NCT03897088|83030523|FG001|Overall Study|Pregnancy|1|||
46811377|NCT03700684|83030551|FG000|Overall Study|COVID-19|0|||
46927652|NCT03706430|83162299|FG000|Overall Study|Subject had gel nail polish|1|||
46927653|NCT03706430|83162299|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
46927654|NCT03706430|83162299|FG000|Overall Study|Cancelled Case|6|||
46811378|NCT03700684|83030552|FG001|Overall Study|COVID-19|0|||
46811379|NCT03700684|83030553|FG002|Overall Study|COVID-19|2|||
46927655|NCT03706430|83162299|FG000|Overall Study|Physician Decision|2|||
46927656|NCT02738138|83162321|FG000|Overall Study|Adverse Event|0|||
46927657|NCT02738138|83162322|FG001|Overall Study|Adverse Event|1|||
46927658|NCT02738138|83162321|FG000|Overall Study|Lost to Follow-up|2|||
46927659|NCT02738138|83162322|FG001|Overall Study|Lost to Follow-up|0|||
46927660|NCT02738138|83162321|FG000|Overall Study|Other - not further specified|1|||
46927661|NCT02738138|83162322|FG001|Overall Study|Other - not further specified|0|||
46927662|NCT01355289|83162331|FG000|Core Study|Adverse Event, Non-Fatal|1|||
46927663|NCT01355289|83162332|FG001|Core Study|Adverse Event, Non-Fatal|0|||
46811380|NCT03659136|83030563|FG000|Overall Study|Not treated|2|||
46811381|NCT03659136|83030564|FG001|Overall Study|Not treated|0|||
46811382|NCT03659136|83030563|FG000|Overall Study|Covid-19 related|1|||
46811383|NCT03659136|83030564|FG001|Overall Study|Covid-19 related|1|||
46811384|NCT03659136|83030563|FG000|Overall Study|Withdrawal by Subject|1|||
46811385|NCT03659136|83030564|FG001|Overall Study|Withdrawal by Subject|6|||
46811386|NCT03659136|83030563|FG000|Overall Study|Adverse Event|4|||
46811387|NCT03659136|83030564|FG001|Overall Study|Adverse Event|6|||
46811388|NCT03659136|83030563|FG000|Overall Study|Progressive disease|37|||
46811389|NCT03659136|83030564|FG001|Overall Study|Progressive disease|31|||
46811390|NCT03659136|83030563|FG000|Overall Study|Study closure|2|||
46811391|NCT03659136|83030564|FG001|Overall Study|Study closure|2|||
46811392|NCT03659136|83030563|FG000|Overall Study|Sponsor decision/recommendation|3|||
46811393|NCT03659136|83030564|FG001|Overall Study|Sponsor decision/recommendation|2|||
46811394|NCT03659136|83030563|FG000|Overall Study|Switched to other drug/therapy|2|||
46811395|NCT03659136|83030564|FG001|Overall Study|Switched to other drug/therapy|2|||
46811396|NCT03659136|83030563|FG000|Overall Study|Lack of clinical benefit|0|||
46811397|NCT03659136|83030564|FG001|Overall Study|Lack of clinical benefit|1|||
46811398|NCT03390036|83030599|FG000|Overall Study|Lost to Follow-up|1|||
46811399|NCT03390036|83030600|FG001|Overall Study|Lost to Follow-up|0|||
46811400|NCT03390036|83030601|FG002|Overall Study|Lost to Follow-up|0|||
46811401|NCT03390036|83030599|FG000|Overall Study|Lack of Efficacy|1|||
46811402|NCT03390036|83030600|FG001|Overall Study|Lack of Efficacy|0|||
46811403|NCT03390036|83030601|FG002|Overall Study|Lack of Efficacy|0|||
46927664|NCT01355289|83162333|FG002|Core Study|Adverse Event, Non-Fatal|0|||
46927665|NCT01355289|83162334|FG003|Core Study|Adverse Event, Non-Fatal|0|||
46927666|NCT01355289|83162335|FG004|Core Study|Adverse Event, Non-Fatal|0|||
46927667|NCT01355289|83162331|FG000|Core Study|Inadequate Therapeutic Effect|0|||
46927668|NCT01355289|83162332|FG001|Core Study|Inadequate Therapeutic Effect|0|||
46927669|NCT01355289|83162333|FG002|Core Study|Inadequate Therapeutic Effect|0|||
46927670|NCT01355289|83162334|FG003|Core Study|Inadequate Therapeutic Effect|1|||
46927671|NCT01355289|83162335|FG004|Core Study|Inadequate Therapeutic Effect|0|||
46927672|NCT01355289|83162331|FG000|Core Study|Other|0|||
46927673|NCT01355289|83162332|FG001|Core Study|Other|0|||
46927674|NCT01355289|83162333|FG002|Core Study|Other|0|||
46927675|NCT01355289|83162334|FG003|Core Study|Other|1|||
46754507|NCT04428333|82972271|FG001|Overall Study|Withdrawal by Subject|1|||
46754508|NCT04428333|82972270|FG000|Overall Study|In Follow-Up|5|||
46754509|NCT04428333|82972271|FG001|Overall Study|In Follow-Up|10|||
46754510|NCT04428333|82972270|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
46754511|NCT04428333|82972271|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
46754512|NCT04389866|82972279|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
46754513|NCT04389866|82972280|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
46754514|NCT04276415|82972292|FG000|Overall Study|Adverse Event|0|||
46811404|NCT03341936|83030626|FG000|Overall Study|Ineligible|1|||
46811405|NCT03341936|83030626|FG000|Overall Study|Disease Progression|2|||
46811406|NCT03341936|83030626|FG000|Overall Study|Withdrew Consent|4|||
46927676|NCT01355289|83162335|FG004|Core Study|Other|0|||
46927677|NCT01355289|83162331|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
46927678|NCT01355289|83162332|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
46927679|NCT01355289|83162333|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
46927680|NCT01355289|83162334|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
46927681|NCT01355289|83162335|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
46927682|NCT01355289|83162331|FG000|Open Label Extension|Lost to Follow-up|0|||
46927683|NCT01355289|83162332|FG001|Open Label Extension|Lost to Follow-up|0|||
46811407|NCT03341936|83030626|FG000|Overall Study|Non-Compliance|1|||
46811408|NCT03341936|83030626|FG000|Overall Study|Physician Decision|1|||
46811409|NCT03341936|83030626|FG000|Overall Study|Withdrawal by Subject|1|||
46811410|NCT03341936|83030626|FG000|Overall Study|Other|1|||
46811411|NCT03284203|83030630|FG000|Overall Study|Lost to Follow-up|3|||
46927684|NCT01355289|83162333|FG002|Open Label Extension|Lost to Follow-up|0|||
46927685|NCT01355289|83162334|FG003|Open Label Extension|Lost to Follow-up|0|||
46927686|NCT01355289|83162335|FG004|Open Label Extension|Lost to Follow-up|1|||
46811412|NCT03233724|83030639|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
46811413|NCT03233724|83030640|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
46811414|NCT03233724|83030641|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
46811415|NCT03233724|83030642|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
46811416|NCT03233724|83030643|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
46811417|NCT03233724|83030639|FG000|Phase I Dose Escalation|Best interest of participant|1|||
46811418|NCT03233724|83030640|FG001|Phase I Dose Escalation|Best interest of participant|1|||
46811419|NCT03233724|83030641|FG002|Phase I Dose Escalation|Best interest of participant|1|||
46811420|NCT03233724|83030642|FG003|Phase I Dose Escalation|Best interest of participant|0|||
46811421|NCT03233724|83030643|FG004|Phase I Dose Escalation|Best interest of participant|0|||
46811422|NCT03233724|83030639|FG000|Phase I Dose Escalation|Physician Decision|0|||
46811423|NCT03233724|83030640|FG001|Phase I Dose Escalation|Physician Decision|0|||
46811424|NCT03233724|83030641|FG002|Phase I Dose Escalation|Physician Decision|1|||
46811425|NCT03233724|83030642|FG003|Phase I Dose Escalation|Physician Decision|0|||
46811426|NCT03233724|83030643|FG004|Phase I Dose Escalation|Physician Decision|0|||
46811427|NCT03233724|83030639|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
46811428|NCT03233724|83030640|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
46811429|NCT03233724|83030641|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
46811430|NCT03233724|83030642|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
46811431|NCT03233724|83030643|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
46811432|NCT03026283|83030657|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
46811433|NCT03026283|83030658|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
46811434|NCT03026283|83030659|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
46811435|NCT03026283|83030660|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
46811436|NCT03026283|83030661|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
46811437|NCT03026283|83030662|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
46811438|NCT03026283|83030663|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
46811439|NCT03026283|83030664|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
46811440|NCT03026283|83030657|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
46811441|NCT03026283|83030658|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
46811442|NCT03026283|83030659|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
46811443|NCT03026283|83030660|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
46811444|NCT03026283|83030661|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
46811445|NCT03026283|83030662|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
46811446|NCT03026283|83030663|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
46811447|NCT03026283|83030664|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
46811448|NCT03026283|83030657|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
46811449|NCT03026283|83030658|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
46811450|NCT03026283|83030659|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
46811451|NCT03026283|83030660|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
46927687|NCT01355289|83162331|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
46927688|NCT01355289|83162332|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
46927689|NCT01355289|83162333|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
46927690|NCT01355289|83162334|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
46927691|NCT01355289|83162335|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
46927692|NCT01355289|83162331|FG000|Open Label Extension|Other|0|||
46927693|NCT01355289|83162332|FG001|Open Label Extension|Other|0|||
46927694|NCT01355289|83162333|FG002|Open Label Extension|Other|0|||
46927695|NCT01355289|83162334|FG003|Open Label Extension|Other|0|||
46927696|NCT01355289|83162335|FG004|Open Label Extension|Other|3|||
46927697|NCT02737592|83162348|FG000|Overall Study|Withdrawal by Subject|1|||
47054543|NCT02859558|83327706|FG003|Step 1|Virologic Failure|0|||
47054544|NCT02859558|83327707|FG004|Step 1|Virologic Failure|0|||
47054545|NCT02859558|83327703|FG000|Step 2|Active On Study|23|||
47054546|NCT02859558|83327704|FG001|Step 2|Active On Study|38|||
47054547|NCT02859558|83327705|FG002|Step 2|Active On Study|20|||
47054548|NCT02859558|83327706|FG003|Step 2|Active On Study|0|||
47054549|NCT02859558|83327707|FG004|Step 2|Active On Study|0|||
47054550|NCT02859558|83327703|FG000|Step 2|Did Not Return to Clinic|2|||
47054551|NCT02859558|83327704|FG001|Step 2|Did Not Return to Clinic|0|||
47054552|NCT02859558|83327705|FG002|Step 2|Did Not Return to Clinic|0|||
47054553|NCT02859558|83327706|FG003|Step 2|Did Not Return to Clinic|0|||
47054554|NCT02859558|83327707|FG004|Step 2|Did Not Return to Clinic|0|||
47054555|NCT02859558|83327703|FG000|Step 2|Unexpected Closure of Site|0|||
47054556|NCT02859558|83327704|FG001|Step 2|Unexpected Closure of Site|1|||
47054557|NCT02859558|83327705|FG002|Step 2|Unexpected Closure of Site|1|||
47054558|NCT02859558|83327706|FG003|Step 2|Unexpected Closure of Site|0|||
47054559|NCT02859558|83327707|FG004|Step 2|Unexpected Closure of Site|0|||
47054560|NCT00705432|83327758|FG000|Treatment Period|Adverse Event|45|||
47054561|NCT00705432|83327759|FG001|Treatment Period|Adverse Event|37|||
47054562|NCT00705432|83327760|FG002|Treatment Period|Adverse Event|51|||
47054563|NCT00705432|83327761|FG003|Treatment Period|Adverse Event|12|||
47054564|NCT00705432|83327762|FG004|Treatment Period|Adverse Event|8|||
47054565|NCT00705432|83327763|FG005|Treatment Period|Adverse Event|9|||
47054566|NCT00705432|83327758|FG000|Treatment Period|Treatment failure|92|||
46927698|NCT02737358|83162375|FG000|Overall Study|Withdrawal by Subject|7|||
47054567|NCT00705432|83327759|FG001|Treatment Period|Treatment failure|42|||
47054568|NCT00705432|83327760|FG002|Treatment Period|Treatment failure|33|||
46811452|NCT03026283|83030661|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
46811453|NCT03026283|83030662|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
46811454|NCT03026283|83030663|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
46811455|NCT03026283|83030664|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
46811456|NCT03026283|83030657|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
46811457|NCT03026283|83030658|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
46811458|NCT03026283|83030659|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
46811459|NCT03026283|83030660|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
46811460|NCT03026283|83030661|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
46811461|NCT03026283|83030662|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
46811462|NCT03026283|83030663|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
46811463|NCT03026283|83030664|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
46811464|NCT03026283|83030657|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
46811465|NCT03026283|83030658|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
46811466|NCT03026283|83030659|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
46811467|NCT03026283|83030660|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
46811468|NCT03026283|83030661|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
46811469|NCT03026283|83030662|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
46811470|NCT03026283|83030663|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
46811471|NCT03026283|83030664|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
46811472|NCT03026283|83030657|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
46811473|NCT03026283|83030658|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
46811474|NCT03026283|83030659|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
46811475|NCT03026283|83030660|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
46811476|NCT03026283|83030661|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
46811477|NCT03026283|83030662|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
46811478|NCT03026283|83030663|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
46811479|NCT03026283|83030664|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
46811480|NCT03026283|83030657|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
46811481|NCT03026283|83030658|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
46811482|NCT03026283|83030659|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
46811483|NCT03026283|83030660|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
46811484|NCT03026283|83030661|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
46811485|NCT03026283|83030662|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
46811486|NCT03026283|83030663|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
46811487|NCT03026283|83030664|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
46811488|NCT03026283|83030657|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
46811489|NCT03026283|83030658|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
46811490|NCT03026283|83030659|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
46811491|NCT03026283|83030660|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
46811492|NCT03026283|83030661|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
46811493|NCT03026283|83030662|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
46811494|NCT03026283|83030663|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
46811495|NCT03026283|83030664|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
46811496|NCT03026283|83030657|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
46811497|NCT03026283|83030658|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
46811498|NCT03026283|83030659|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
46811499|NCT03026283|83030660|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
46927699|NCT02737358|83162376|FG001|Overall Study|Withdrawal by Subject|12|||
46927700|NCT02737358|83162375|FG000|Overall Study|Lost to Follow-up|2|||
46927701|NCT02737358|83162376|FG001|Overall Study|Lost to Follow-up|3|||
46927702|NCT01354431|83162385|FG000|Pre-Treatment Period|Not reported|1|||
46927703|NCT01354431|83162386|FG001|Pre-Treatment Period|Not reported|0|||
46927704|NCT01354431|83162387|FG002|Pre-Treatment Period|Not reported|0|||
46927705|NCT01354431|83162385|FG000|Treatment Period|Disease Progression|50|||
47054569|NCT00705432|83327761|FG003|Treatment Period|Treatment failure|25|||
47054570|NCT00705432|83327762|FG004|Treatment Period|Treatment failure|13|||
47054571|NCT00705432|83327763|FG005|Treatment Period|Treatment failure|14|||
46811500|NCT03026283|83030661|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
46811501|NCT03026283|83030662|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
46811502|NCT03026283|83030663|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
46811503|NCT03026283|83030664|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
46811504|NCT01994954|83030731|FG000|Overall Study|Death|1|||
46811505|NCT01994954|83030732|FG001|Overall Study|Death|0|||
46811506|NCT01994954|83030731|FG000|Overall Study|Withdrawal by Subject|9|||
46811507|NCT01994954|83030732|FG001|Overall Study|Withdrawal by Subject|14|||
46811508|NCT01994954|83030731|FG000|Overall Study|Physician Decision|2|||
46811509|NCT01994954|83030732|FG001|Overall Study|Physician Decision|2|||
46811510|NCT01994954|83030731|FG000|Overall Study|Lost to Follow-up|8|||
46811511|NCT01994954|83030732|FG001|Overall Study|Lost to Follow-up|10|||
46811512|NCT01994954|83030731|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
46811513|NCT01994954|83030732|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
46811514|NCT00380367|83030809|FG000|Overall Study|Lost to Follow-up|1|||
46811515|NCT00380367|83030809|FG000|Overall Study|Withdrawal by Subject|1|||
46811516|NCT00531050|83030819|FG000|Part 1: Period 1|Adverse Event|0|||
46811517|NCT00531050|83030820|FG001|Part 1: Period 1|Adverse Event|1|||
46811518|NCT00531050|83030821|FG002|Part 1: Period 1|Adverse Event|0|||
46811519|NCT00531050|83030822|FG003|Part 1: Period 1|Adverse Event|0|||
46811520|NCT00531050|83030823|FG004|Part 1: Period 1|Adverse Event|0|||
46811521|NCT00531050|83030824|FG005|Part 1: Period 1|Adverse Event|0|||
46811522|NCT00531050|83030819|FG000|Part 1: Period 1|Protocol Deviation|0|||
46811523|NCT00531050|83030820|FG001|Part 1: Period 1|Protocol Deviation|0|||
46811524|NCT00531050|83030821|FG002|Part 1: Period 1|Protocol Deviation|0|||
46811525|NCT00531050|83030822|FG003|Part 1: Period 1|Protocol Deviation|1|||
46811526|NCT00531050|83030823|FG004|Part 1: Period 1|Protocol Deviation|0|||
46811527|NCT00531050|83030824|FG005|Part 1: Period 1|Protocol Deviation|0|||
46927706|NCT01354431|83162386|FG001|Treatment Period|Disease Progression|40|||
46927707|NCT01354431|83162387|FG002|Treatment Period|Disease Progression|44|||
46811528|NCT00531050|83030819|FG000|Part 1: Period 3|Adverse Event|1|||
46811529|NCT00531050|83030820|FG001|Part 1: Period 3|Adverse Event|0|||
46811530|NCT00531050|83030821|FG002|Part 1: Period 3|Adverse Event|0|||
46811531|NCT00531050|83030822|FG003|Part 1: Period 3|Adverse Event|0|||
46927708|NCT01354431|83162385|FG000|Treatment Period|Study Drug Toxicity|5|||
46927709|NCT01354431|83162386|FG001|Treatment Period|Study Drug Toxicity|8|||
46927710|NCT01354431|83162387|FG002|Treatment Period|Study Drug Toxicity|4|||
46927711|NCT01354431|83162385|FG000|Treatment Period|Death|0|||
46927712|NCT01354431|83162386|FG001|Treatment Period|Death|1|||
46927713|NCT01354431|83162387|FG002|Treatment Period|Death|0|||
46927714|NCT01354431|83162385|FG000|Treatment Period|AE unrelated to study drug|1|||
46927715|NCT01354431|83162386|FG001|Treatment Period|AE unrelated to study drug|2|||
46927716|NCT01354431|83162387|FG002|Treatment Period|AE unrelated to study drug|5|||
46927717|NCT01354431|83162385|FG000|Treatment Period|Participant request to discontinue|2|||
46927718|NCT01354431|83162386|FG001|Treatment Period|Participant request to discontinue|2|||
46927719|NCT01354431|83162387|FG002|Treatment Period|Participant request to discontinue|1|||
46927720|NCT01354431|83162385|FG000|Treatment Period|Participant withdrew consent|0|||
46927721|NCT01354431|83162386|FG001|Treatment Period|Participant withdrew consent|1|||
46927722|NCT01354431|83162387|FG002|Treatment Period|Participant withdrew consent|0|||
46927723|NCT01354431|83162385|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
46927724|NCT01354431|83162386|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
46927725|NCT01354431|83162387|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
46927726|NCT02736578|83162397|FG000|Overall Study|Adverse Event|1|||
46927727|NCT02736578|83162398|FG001|Overall Study|Adverse Event|0|||
46811532|NCT00531050|83030823|FG004|Part 1: Period 3|Adverse Event|0|||
46927728|NCT02622724|83162410|FG000|Overall Study|Death|51|||
46927729|NCT02622724|83162411|FG001|Overall Study|Death|53|||
46811533|NCT00531050|83030824|FG005|Part 1: Period 3|Adverse Event|0|||
46811534|NCT00531050|83030819|FG000|Part 2: Period 1|Adverse Event|0|||
46811535|NCT00531050|83030820|FG001|Part 2: Period 1|Adverse Event|0|||
46811536|NCT00531050|83030821|FG002|Part 2: Period 1|Adverse Event|0|||
46811537|NCT00531050|83030822|FG003|Part 2: Period 1|Adverse Event|0|||
46811538|NCT00531050|83030823|FG004|Part 2: Period 1|Adverse Event|0|||
46811539|NCT00531050|83030824|FG005|Part 2: Period 1|Adverse Event|1|||
46927730|NCT02622724|83162410|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
46927731|NCT02622724|83162411|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
46927732|NCT02622724|83162410|FG000|Overall Study|Early termination of study|38|||
46811540|NCT00531050|83030819|FG000|Part 2: Period 3|Abnormal test procedure|1|||
46811541|NCT00531050|83030820|FG001|Part 2: Period 3|Abnormal test procedure|0|||
47054572|NCT00705432|83327758|FG000|Treatment Period|Non medical reason|26|||
47054573|NCT00705432|83327759|FG001|Treatment Period|Non medical reason|32|||
47054574|NCT00705432|83327760|FG002|Treatment Period|Non medical reason|37|||
46811542|NCT00531050|83030821|FG002|Part 2: Period 3|Abnormal test procedure|0|||
46811543|NCT00531050|83030822|FG003|Part 2: Period 3|Abnormal test procedure|0|||
46811544|NCT00531050|83030823|FG004|Part 2: Period 3|Abnormal test procedure|0|||
46811545|NCT00531050|83030824|FG005|Part 2: Period 3|Abnormal test procedure|1|||
46811546|NCT00530348|83030843|FG000|Overall Study|Adverse Event|5|||
46811547|NCT00530348|83030844|FG001|Overall Study|Adverse Event|1|||
46927733|NCT02622724|83162411|FG001|Overall Study|Early termination of study|43|||
46927734|NCT01354353|83162429|FG000|Overall Study|Adverse Event|1|||
46927735|NCT01354353|83162430|FG001|Overall Study|Adverse Event|0|||
46927736|NCT01354353|83162431|FG002|Overall Study|Adverse Event|0|||
46927737|NCT01354353|83162432|FG003|Overall Study|Adverse Event|4|||
46927738|NCT01354353|83162433|FG004|Overall Study|Adverse Event|0|||
46927739|NCT01354353|83162434|FG005|Overall Study|Adverse Event|5|||
46927740|NCT01354353|83162429|FG000|Overall Study|Entry Criteria Not Met|0|||
46927741|NCT01354353|83162430|FG001|Overall Study|Entry Criteria Not Met|0|||
46927742|NCT01354353|83162431|FG002|Overall Study|Entry Criteria Not Met|0|||
46927743|NCT01354353|83162432|FG003|Overall Study|Entry Criteria Not Met|1|||
46927744|NCT01354353|83162433|FG004|Overall Study|Entry Criteria Not Met|1|||
46927745|NCT01354353|83162434|FG005|Overall Study|Entry Criteria Not Met|0|||
46927746|NCT01354353|83162429|FG000|Overall Study|Physician Decision|0|||
46927747|NCT01354353|83162430|FG001|Overall Study|Physician Decision|1|||
46927748|NCT01354353|83162431|FG002|Overall Study|Physician Decision|1|||
46927749|NCT01354353|83162432|FG003|Overall Study|Physician Decision|0|||
46927750|NCT01354353|83162433|FG004|Overall Study|Physician Decision|0|||
46754515|NCT04276415|82972293|FG001|Overall Study|Adverse Event|0|||
46754516|NCT04276415|82972294|FG002|Overall Study|Adverse Event|0|||
46754517|NCT04276415|82972295|FG003|Overall Study|Adverse Event|3|||
46754518|NCT04276415|82972296|FG004|Overall Study|Adverse Event|0|||
46754519|NCT04276415|82972297|FG005|Overall Study|Adverse Event|0|||
46754520|NCT04276415|82972292|FG000|Overall Study|Clinical progression|1|||
46754521|NCT04276415|82972293|FG001|Overall Study|Clinical progression|1|||
46754522|NCT04276415|82972294|FG002|Overall Study|Clinical progression|0|||
46754523|NCT04276415|82972295|FG003|Overall Study|Clinical progression|0|||
46754524|NCT04276415|82972296|FG004|Overall Study|Clinical progression|1|||
46754525|NCT04276415|82972297|FG005|Overall Study|Clinical progression|0|||
46754526|NCT04276415|82972292|FG000|Overall Study|Other|0|||
46754527|NCT04276415|82972293|FG001|Overall Study|Other|0|||
46754528|NCT04276415|82972294|FG002|Overall Study|Other|0|||
46754529|NCT04276415|82972295|FG003|Overall Study|Other|1|||
46754530|NCT04276415|82972296|FG004|Overall Study|Other|0|||
46754531|NCT04276415|82972297|FG005|Overall Study|Other|0|||
46754532|NCT04276415|82972292|FG000|Overall Study|Physician Decision|0|||
46754533|NCT04276415|82972293|FG001|Overall Study|Physician Decision|0|||
46754534|NCT04276415|82972294|FG002|Overall Study|Physician Decision|1|||
46754535|NCT04276415|82972295|FG003|Overall Study|Physician Decision|3|||
46754536|NCT04276415|82972296|FG004|Overall Study|Physician Decision|2|||
46754537|NCT04276415|82972297|FG005|Overall Study|Physician Decision|0|||
46754538|NCT04276415|82972292|FG000|Overall Study|Progressive disease|3|||
46754539|NCT04276415|82972293|FG001|Overall Study|Progressive disease|3|||
46754540|NCT04276415|82972294|FG002|Overall Study|Progressive disease|4|||
46754541|NCT04276415|82972295|FG003|Overall Study|Progressive disease|5|||
46754542|NCT04276415|82972296|FG004|Overall Study|Progressive disease|1|||
46754543|NCT04276415|82972297|FG005|Overall Study|Progressive disease|2|||
46754544|NCT04276415|82972292|FG000|Overall Study|Withdrawal by patient|0|||
46754545|NCT04276415|82972293|FG001|Overall Study|Withdrawal by patient|0|||
46754546|NCT04276415|82972294|FG002|Overall Study|Withdrawal by patient|0|||
46754547|NCT04276415|82972295|FG003|Overall Study|Withdrawal by patient|1|||
46754548|NCT04276415|82972296|FG004|Overall Study|Withdrawal by patient|2|||
46754549|NCT04276415|82972297|FG005|Overall Study|Withdrawal by patient|0|||
46754550|NCT04146909|82972329|FG000|Overall Study|Withdrawal by Subject|3|||
46754551|NCT04146909|82972329|FG000|Overall Study|Did not qualify after consented|1|||
46754552|NCT04082884|82972335|FG000|Overall Study|Withdrawal by Subject|1|||
46754553|NCT03943550|82972355|FG000|Overall Study|Adverse Event|0|||
46754554|NCT03943550|82972356|FG001|Overall Study|Adverse Event|0|||
46754555|NCT03943550|82972357|FG002|Overall Study|Adverse Event|1|||
46754556|NCT03943550|82972355|FG000|Overall Study|Lost to Follow-up|0|||
46754557|NCT03943550|82972356|FG001|Overall Study|Lost to Follow-up|0|||
46811548|NCT00530348|83030843|FG000|Overall Study|Death|0|||
46811549|NCT00530348|83030844|FG001|Overall Study|Death|1|||
46754558|NCT03943550|82972357|FG002|Overall Study|Lost to Follow-up|1|||
46754559|NCT03943550|82972355|FG000|Overall Study|Progressive Disease|0|||
46754560|NCT03943550|82972356|FG001|Overall Study|Progressive Disease|0|||
46754561|NCT03943550|82972357|FG002|Overall Study|Progressive Disease|2|||
46754562|NCT03943550|82972355|FG000|Overall Study|Participant Moved Out of the Country|0|||
46754563|NCT03943550|82972356|FG001|Overall Study|Participant Moved Out of the Country|1|||
46754564|NCT03943550|82972357|FG002|Overall Study|Participant Moved Out of the Country|0|||
46927751|NCT01354353|83162434|FG005|Overall Study|Physician Decision|0|||
46927752|NCT01354353|83162429|FG000|Overall Study|Withdrawal by Subject|2|||
46927753|NCT01354353|83162430|FG001|Overall Study|Withdrawal by Subject|0|||
46927754|NCT01354353|83162431|FG002|Overall Study|Withdrawal by Subject|1|||
46927755|NCT01354353|83162432|FG003|Overall Study|Withdrawal by Subject|0|||
46811550|NCT00530348|83030843|FG000|Overall Study|Lack of Efficacy|2|||
46811551|NCT00530348|83030844|FG001|Overall Study|Lack of Efficacy|0|||
46811552|NCT00530348|83030843|FG000|Overall Study|Lost to Follow-up|0|||
47054575|NCT00705432|83327761|FG003|Treatment Period|Non medical reason|4|||
47054576|NCT00705432|83327762|FG004|Treatment Period|Non medical reason|7|||
47054577|NCT00705432|83327763|FG005|Treatment Period|Non medical reason|7|||
46811553|NCT00530348|83030844|FG001|Overall Study|Lost to Follow-up|2|||
46811554|NCT00530348|83030843|FG000|Overall Study|Physician Decision|1|||
46811555|NCT00530348|83030844|FG001|Overall Study|Physician Decision|2|||
46811556|NCT00530348|83030843|FG000|Overall Study|Pregnancy|1|||
46811557|NCT00530348|83030844|FG001|Overall Study|Pregnancy|0|||
46811558|NCT00530348|83030843|FG000|Overall Study|Withdrawal by Subject|12|||
46811559|NCT00530348|83030844|FG001|Overall Study|Withdrawal by Subject|12|||
46811560|NCT00530348|83030843|FG000|Overall Study|Randomised in error|1|||
46811561|NCT00530348|83030844|FG001|Overall Study|Randomised in error|0|||
46811562|NCT00530348|83030843|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
46811563|NCT00530348|83030844|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
46811564|NCT03886220|83030852|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
46811565|NCT03886220|83030853|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
46811566|NCT03886220|83030852|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
46811567|NCT03886220|83030853|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
46811568|NCT03886220|83030852|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
46811569|NCT03886220|83030853|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
46811570|NCT00530270|83030861|FG000|Overall Study|Protocol Violation|1|||
46811571|NCT00530270|83030862|FG001|Overall Study|Protocol Violation|0|||
46811572|NCT03885596|83030872|FG000|Overall Study|Withdrawal by Subject|2|||
46811573|NCT03885596|83030873|FG001|Overall Study|Withdrawal by Subject|1|||
46811574|NCT03885596|83030874|FG002|Overall Study|Withdrawal by Subject|0|||
46811575|NCT03885596|83030875|FG003|Overall Study|Withdrawal by Subject|0|||
46811576|NCT00529100|83030891|FG000|Overall Study|Adverse Event|0|||
46811577|NCT00529100|83030892|FG001|Overall Study|Adverse Event|5|||
46811578|NCT00529100|83030891|FG000|Overall Study|Protocol Violation|0|||
46811579|NCT00529100|83030892|FG001|Overall Study|Protocol Violation|1|||
46811580|NCT00529100|83030891|FG000|Overall Study|Progressive Disease|0|||
46811581|NCT00529100|83030892|FG001|Overall Study|Progressive Disease|1|||
46811582|NCT00529100|83030891|FG000|Overall Study|Withdrawal by Subject|0|||
46811583|NCT00529100|83030892|FG001|Overall Study|Withdrawal by Subject|1|||
46811584|NCT00529100|83030891|FG000|Overall Study|Participant Ineligibility|0|||
46811585|NCT00529100|83030892|FG001|Overall Study|Participant Ineligibility|1|||
46811586|NCT03878108|83030904|FG000|Overall Study|Adverse Event|1|||
46811587|NCT03878108|83030905|FG001|Overall Study|Adverse Event|0|||
46811588|NCT00529958|83030914|FG000|2-Year Follow-up|Lost to Follow-up|1|||
46811589|NCT00529958|83030915|FG001|2-Year Follow-up|Lost to Follow-up|2|||
46811590|NCT00529958|83030916|FG002|2-Year Follow-up|Lost to Follow-up|2|||
46811591|NCT00529958|83030914|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
47054578|NCT00705432|83327758|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
46754565|NCT03724396|82972389|FG000|Overall Study|Lost to Follow-up|1|||
46754566|NCT03724396|82972390|FG001|Overall Study|Lost to Follow-up|1|||
46754567|NCT03724396|82972389|FG000|Overall Study|Withdrawal by Subject|1|||
46754568|NCT03724396|82972390|FG001|Overall Study|Withdrawal by Subject|0|||
46754569|NCT03713034|82972398|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
46754570|NCT03713034|82972399|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
46754571|NCT03698019|82972409|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
46754572|NCT03698019|82972410|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
46754573|NCT03698019|82972409|FG000|Step 1: Registration|Withdrawal by Subject|7|||
46754574|NCT03698019|82972410|FG001|Step 1: Registration|Withdrawal by Subject|2|||
46754575|NCT03698019|82972409|FG000|Step 1: Registration|Toxicity|0|||
46754576|NCT03698019|82972410|FG001|Step 1: Registration|Toxicity|1|||
46754577|NCT03698019|82972409|FG000|Step 1: Registration|Disease Progression|0|||
46754578|NCT03698019|82972410|FG001|Step 1: Registration|Disease Progression|12|||
46754579|NCT03698019|82972409|FG000|Step 1: Registration|Co-morbidities|0|||
46754580|NCT03698019|82972410|FG001|Step 1: Registration|Co-morbidities|1|||
46754581|NCT03698019|82972409|FG000|Step 1: Registration|Scheduling Issues|1|||
46811592|NCT00529958|83030915|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
46811593|NCT00529958|83030916|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
46811594|NCT00529958|83030914|FG000|5-Year Follow-up|Lost to Follow-up|2|||
46811595|NCT00529958|83030915|FG001|5-Year Follow-up|Lost to Follow-up|3|||
46754582|NCT03698019|82972410|FG001|Step 1: Registration|Scheduling Issues|0|||
46754583|NCT03698019|82972409|FG000|Step 1: Registration|Participant Refusal|0|||
46811596|NCT00529958|83030916|FG002|5-Year Follow-up|Lost to Follow-up|1|||
46811597|NCT00529958|83030914|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
46811598|NCT00529958|83030915|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
46811599|NCT00529958|83030916|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
46811600|NCT00529802|83030924|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
46811601|NCT00529802|83030924|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
46811602|NCT00529802|83030924|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
46811603|NCT00529802|83030924|FG000|Evaluable for Primary Endpoint|Death|1|||
46811604|NCT00529802|83030924|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
46811605|NCT00529802|83030924|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
46811606|NCT00529802|83030924|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
46927756|NCT01354353|83162433|FG004|Overall Study|Withdrawal by Subject|0|||
46927757|NCT01354353|83162434|FG005|Overall Study|Withdrawal by Subject|1|||
46927758|NCT02622568|83162457|FG000|Overall Study|Lost to Follow-up|5|||
46927759|NCT02622568|83162458|FG001|Overall Study|Lost to Follow-up|5|||
46927760|NCT01354899|83162464|FG000|Overall Study|discharge from the hospital|2|||
46927761|NCT01354899|83162464|FG000|Overall Study|Protocol Violation|1|||
46927762|NCT01353963|83162468|FG000|Overall Study|Adverse Event|2|||
46927763|NCT02820597|83162477|FG000|Overall Study|Lost to Follow-up|12|||
46927764|NCT02822235|83162483|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
46927765|NCT02822235|83162484|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
47054579|NCT00705432|83327759|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
46636435|NCT01514136|82810258|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
46811607|NCT00528866|83030930|FG000|Overall Study|Protocol Violation|6|||
46811608|NCT00614393|83030940|FG000|Overall Study|Adverse Event|20|||
46811609|NCT00614393|83030941|FG001|Overall Study|Adverse Event|2|||
46811610|NCT00614393|83030942|FG002|Overall Study|Adverse Event|3|||
46811611|NCT00614393|83030943|FG003|Overall Study|Adverse Event|13|||
46811612|NCT00614393|83030944|FG004|Overall Study|Adverse Event|21|||
46811613|NCT00614393|83030940|FG000|Overall Study|Lost to Follow-up|0|||
46811614|NCT00614393|83030941|FG001|Overall Study|Lost to Follow-up|0|||
46811615|NCT00614393|83030942|FG002|Overall Study|Lost to Follow-up|0|||
46811616|NCT00614393|83030943|FG003|Overall Study|Lost to Follow-up|1|||
46811617|NCT00614393|83030944|FG004|Overall Study|Lost to Follow-up|2|||
46811618|NCT00614393|83030940|FG000|Overall Study|Physician Decision|17|||
46811619|NCT00614393|83030941|FG001|Overall Study|Physician Decision|0|||
46811620|NCT00614393|83030942|FG002|Overall Study|Physician Decision|1|||
46811621|NCT00614393|83030943|FG003|Overall Study|Physician Decision|8|||
46811622|NCT00614393|83030944|FG004|Overall Study|Physician Decision|9|||
46811623|NCT00614393|83030940|FG000|Overall Study|Progressive Disease|118|||
46811624|NCT00614393|83030941|FG001|Overall Study|Progressive Disease|5|||
46811625|NCT00614393|83030942|FG002|Overall Study|Progressive Disease|5|||
46811626|NCT00614393|83030943|FG003|Overall Study|Progressive Disease|138|||
46811627|NCT00614393|83030944|FG004|Overall Study|Progressive Disease|130|||
46811628|NCT00614393|83030940|FG000|Overall Study|Protocol Violation|1|||
46811629|NCT00614393|83030941|FG001|Overall Study|Protocol Violation|0|||
46811630|NCT00614393|83030942|FG002|Overall Study|Protocol Violation|0|||
46811631|NCT00614393|83030943|FG003|Overall Study|Protocol Violation|0|||
46811632|NCT00614393|83030944|FG004|Overall Study|Protocol Violation|0|||
46811633|NCT00614393|83030940|FG000|Overall Study|Terminated by Sponsor|0|||
46811634|NCT00614393|83030941|FG001|Overall Study|Terminated by Sponsor|0|||
46811635|NCT00614393|83030942|FG002|Overall Study|Terminated by Sponsor|0|||
46811636|NCT00614393|83030943|FG003|Overall Study|Terminated by Sponsor|0|||
46811637|NCT00614393|83030944|FG004|Overall Study|Terminated by Sponsor|1|||
46811638|NCT00614393|83030940|FG000|Overall Study|Withdrawal by Subject|20|||
46811639|NCT00614393|83030941|FG001|Overall Study|Withdrawal by Subject|1|||
46811640|NCT00614393|83030942|FG002|Overall Study|Withdrawal by Subject|1|||
46811641|NCT00614393|83030943|FG003|Overall Study|Withdrawal by Subject|16|||
46811642|NCT00614393|83030944|FG004|Overall Study|Withdrawal by Subject|13|||
46811643|NCT00614393|83030940|FG000|Overall Study|Other|4|||
46811644|NCT00614393|83030941|FG001|Overall Study|Other|0|||
46811645|NCT00614393|83030942|FG002|Overall Study|Other|0|||
46811646|NCT00614393|83030943|FG003|Overall Study|Other|4|||
46811647|NCT00614393|83030944|FG004|Overall Study|Other|2|||
46811648|NCT00614393|83030940|FG000|Overall Study|Not Treated|0|||
46811649|NCT00614393|83030941|FG001|Overall Study|Not Treated|0|||
46811650|NCT00614393|83030942|FG002|Overall Study|Not Treated|0|||
46811651|NCT00614393|83030943|FG003|Overall Study|Not Treated|0|||
46811652|NCT00614393|83030944|FG004|Overall Study|Not Treated|2|||
46811653|NCT00612677|83030956|FG000|Overall Study|study closed before treatment started|1|||
46811654|NCT00613925|83030962|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
46811655|NCT00613925|83030963|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
46811656|NCT00613301|83030969|FG000|Overall Study|Adverse Event|49|||
46811657|NCT00613301|83030969|FG000|Overall Study|Lost to Follow-up|88|||
46811658|NCT00613301|83030969|FG000|Overall Study|Withdrawal by Subject|5|||
46811659|NCT00613301|83030969|FG000|Overall Study|Death|6|||
46811660|NCT00613301|83030969|FG000|Overall Study|Lack of Efficacy|13|||
46811661|NCT00613301|83030969|FG000|Overall Study|Physician Decision|2|||
46811662|NCT00613301|83030969|FG000|Overall Study|No data was collected|53|||
46811663|NCT00613301|83030969|FG000|Overall Study|Irregularly enrolled patients|12|||
46927766|NCT02822235|83162483|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
46927767|NCT02822235|83162484|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
46811664|NCT00609947|83030974|FG000|Overall Study|Death|1|||
46811665|NCT00609869|83030979|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
46811666|NCT00609869|83030979|FG000|Overall Study|Severe hematologic toxicity|1|||
46811667|NCT00609869|83030979|FG000|Overall Study|Withdrawal by Subject|1|||
46811668|NCT00609869|83030979|FG000|Overall Study|Seizures|1|||
46811669|NCT00609869|83030979|FG000|Overall Study|Severe tumor flare reaction|1|||
46811670|NCT00609869|83030979|FG000|Overall Study|Hepatitis B infection|1|||
46811671|NCT00609869|83030979|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
46811672|NCT00609869|83030979|FG000|Overall Study|Mantle cell: not evaluable|4|||
46811673|NCT00529568|83030985|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
46811674|NCT00529568|83030986|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
46811675|NCT00529568|83030987|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
46811676|NCT00529568|83030985|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
46811677|NCT00529568|83030986|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
46811678|NCT00529568|83030987|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
46811679|NCT00529568|83030985|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
46811680|NCT00529568|83030986|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
46811681|NCT00529568|83030987|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
46811682|NCT00529568|83030985|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
46811683|NCT00529568|83030986|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
46811684|NCT00529568|83030987|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
46811685|NCT00529568|83030985|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
46811686|NCT00529568|83030986|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
46811687|NCT00529568|83030987|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
46811688|NCT00529568|83030985|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
46811689|NCT00529568|83030986|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
46811690|NCT00529568|83030987|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
46811691|NCT00529568|83030985|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
46811692|NCT00529568|83030986|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
46811693|NCT00529568|83030987|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
46811694|NCT00529568|83030985|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
46811695|NCT00529568|83030986|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
46811696|NCT00529568|83030987|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
46811697|NCT00529568|83030985|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
46811698|NCT00529568|83030986|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
46811699|NCT00529568|83030987|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
46811700|NCT00529568|83030985|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
46811701|NCT00529568|83030986|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
46811702|NCT00529568|83030987|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
46811703|NCT00529568|83030985|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
46811704|NCT00529568|83030986|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
46811705|NCT00529568|83030987|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
46811706|NCT00611975|83030998|FG000|Overall Study|Withdrawal by Subject|3|||
46811707|NCT00611975|83030999|FG001|Overall Study|Withdrawal by Subject|7|||
46811708|NCT00611975|83030998|FG000|Overall Study|Pregnancy|2|||
46811709|NCT00611975|83030999|FG001|Overall Study|Pregnancy|1|||
46811710|NCT00573131|83031007|FG000|Overall Study|Withdrawal by Subject|10|||
46811711|NCT00573131|83031008|FG001|Overall Study|Withdrawal by Subject|8|||
46811712|NCT00521144|83031019|FG000|Overall Study|Not Treated|0|||
46811713|NCT00521144|83031020|FG001|Overall Study|Not Treated|0|||
46811714|NCT00521144|83031021|FG002|Overall Study|Not Treated|0|||
46811715|NCT00521144|83031022|FG003|Overall Study|Not Treated|1|||
46811716|NCT00521144|83031023|FG004|Overall Study|Not Treated|0|||
46811717|NCT00521144|83031019|FG000|Overall Study|Adverse Event|0|||
46811718|NCT00521144|83031020|FG001|Overall Study|Adverse Event|1|||
46811719|NCT00521144|83031021|FG002|Overall Study|Adverse Event|0|||
46811720|NCT00521144|83031022|FG003|Overall Study|Adverse Event|0|||
46811721|NCT00521144|83031023|FG004|Overall Study|Adverse Event|1|||
46811722|NCT00521144|83031019|FG000|Overall Study|Progressive Disease|4|||
46811723|NCT00521144|83031020|FG001|Overall Study|Progressive Disease|2|||
46811724|NCT00521144|83031021|FG002|Overall Study|Progressive Disease|2|||
46927768|NCT02822235|83162483|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
46811725|NCT00521144|83031022|FG003|Overall Study|Progressive Disease|0|||
46811726|NCT00521144|83031023|FG004|Overall Study|Progressive Disease|6|||
46811727|NCT00520676|83031037|FG000|Overall Study|Death|84|||
46811728|NCT00520676|83031038|FG001|Overall Study|Death|81|||
46811729|NCT00520676|83031037|FG000|Overall Study|Lost to Follow-up|6|||
46811730|NCT00520676|83031038|FG001|Overall Study|Lost to Follow-up|10|||
46811731|NCT00520676|83031037|FG000|Overall Study|Physician Decision|4|||
46811732|NCT00520676|83031038|FG001|Overall Study|Physician Decision|1|||
46811733|NCT00520676|83031037|FG000|Overall Study|Withdrawal by Subject|7|||
46811734|NCT00520676|83031038|FG001|Overall Study|Withdrawal by Subject|11|||
46811735|NCT00610649|83031055|FG000|Overall Study|Adverse Event|1|||
46811736|NCT00610649|83031056|FG001|Overall Study|Adverse Event|0|||
46811737|NCT00610649|83031057|FG002|Overall Study|Adverse Event|0|||
46811738|NCT00610649|83031058|FG003|Overall Study|Adverse Event|0|||
46754584|NCT03698019|82972410|FG001|Step 1: Registration|Participant Refusal|1|||
46811739|NCT00610649|83031059|FG004|Overall Study|Adverse Event|0|||
46811740|NCT00610649|83031060|FG005|Overall Study|Adverse Event|0|||
46811741|NCT00610649|83031061|FG006|Overall Study|Adverse Event|0|||
46811742|NCT00610649|83031062|FG007|Overall Study|Adverse Event|0|||
46811743|NCT00610649|83031063|FG008|Overall Study|Adverse Event|0|||
46811744|NCT00610649|83031064|FG009|Overall Study|Adverse Event|0|||
46811745|NCT00610649|83031065|FG010|Overall Study|Adverse Event|1|||
46811746|NCT00610649|83031055|FG000|Overall Study|Family Emergency|0|||
46811747|NCT00610649|83031056|FG001|Overall Study|Family Emergency|1|||
46811748|NCT00610649|83031057|FG002|Overall Study|Family Emergency|0|||
46811749|NCT00610649|83031058|FG003|Overall Study|Family Emergency|0|||
46811750|NCT00610649|83031059|FG004|Overall Study|Family Emergency|0|||
46811751|NCT00610649|83031060|FG005|Overall Study|Family Emergency|0|||
46811752|NCT00610649|83031061|FG006|Overall Study|Family Emergency|0|||
46811753|NCT00610649|83031062|FG007|Overall Study|Family Emergency|0|||
46811754|NCT00610649|83031063|FG008|Overall Study|Family Emergency|0|||
46811755|NCT00610649|83031064|FG009|Overall Study|Family Emergency|0|||
46811756|NCT00610649|83031065|FG010|Overall Study|Family Emergency|0|||
46811757|NCT00610649|83031055|FG000|Overall Study|Withdrawal by Subject|0|||
46811758|NCT00610649|83031056|FG001|Overall Study|Withdrawal by Subject|0|||
46811759|NCT00610649|83031057|FG002|Overall Study|Withdrawal by Subject|0|||
46811760|NCT00610649|83031058|FG003|Overall Study|Withdrawal by Subject|0|||
46811761|NCT00610649|83031059|FG004|Overall Study|Withdrawal by Subject|0|||
46811762|NCT00610649|83031060|FG005|Overall Study|Withdrawal by Subject|0|||
46811763|NCT00610649|83031061|FG006|Overall Study|Withdrawal by Subject|0|||
46811764|NCT00610649|83031062|FG007|Overall Study|Withdrawal by Subject|0|||
46811765|NCT00610649|83031063|FG008|Overall Study|Withdrawal by Subject|0|||
46811766|NCT00610649|83031064|FG009|Overall Study|Withdrawal by Subject|1|||
46811767|NCT00610649|83031065|FG010|Overall Study|Withdrawal by Subject|0|||
46811768|NCT00608543|83031089|FG000|Overall Study|Adverse Event|4|||
46811769|NCT00520130|83031096|FG000|Overall Study|Disease progression on study|4|||
46811770|NCT00520130|83031097|FG001|Overall Study|Disease progression on study|0|||
46811771|NCT00520130|83031096|FG000|Overall Study|Physician Decision|1|||
46811772|NCT00520130|83031097|FG001|Overall Study|Physician Decision|1|||
46811773|NCT00519896|83031107|FG000|Overall Study|Protocol Violation|1|||
46811774|NCT00519896|83031107|FG000|Overall Study|Adverse Event|1|||
46811775|NCT00527618|83031120|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
46811776|NCT00527618|83031121|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
46811777|NCT00527618|83031120|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
46811778|NCT00527618|83031121|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
46811779|NCT00527618|83031120|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
46811780|NCT00527618|83031121|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
46811781|NCT00527618|83031120|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
46811782|NCT00527618|83031121|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
46811783|NCT00527618|83031120|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
46811784|NCT00527618|83031121|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
46811785|NCT00527618|83031120|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
46811786|NCT00527618|83031121|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
46811787|NCT00527072|83031128|FG000|Overall Study|Adverse Event|13|||
46811788|NCT00527072|83031128|FG000|Overall Study|Lack of Efficacy|11|||
46754585|NCT03698019|82972409|FG000|Step 2: Surgery|Participant Refusal|2|||
46754586|NCT03698019|82972410|FG001|Step 2: Surgery|Participant Refusal|1|||
46754587|NCT03698019|82972409|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
46754588|NCT03698019|82972410|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
46754589|NCT03698019|82972409|FG000|Step 2: Surgery|Metastatic Disease|16|||
46754590|NCT03698019|82972410|FG001|Step 2: Surgery|Metastatic Disease|9|||
46754591|NCT03698019|82972409|FG000|Step 2: Surgery|Residual Disease|2|||
46754592|NCT03698019|82972410|FG001|Step 2: Surgery|Residual Disease|1|||
46754593|NCT03698019|82972409|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
46754594|NCT03698019|82972410|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
46811789|NCT00527072|83031128|FG000|Overall Study|Lost to Follow-up|3|||
46811790|NCT00527072|83031128|FG000|Overall Study|Protocol Violation|2|||
46811791|NCT00527072|83031128|FG000|Overall Study|Withdrawal by Subject|7|||
46811792|NCT00526994|83031136|FG000|Overall Study|Lost to Follow-up|98|||
46811793|NCT00526994|83031137|FG001|Overall Study|Lost to Follow-up|108|||
46811794|NCT00526994|83031138|FG002|Overall Study|Lost to Follow-up|96|||
46811795|NCT00526994|83031136|FG000|Overall Study|Death|4|||
46811796|NCT00526994|83031137|FG001|Overall Study|Death|3|||
46811797|NCT00526994|83031138|FG002|Overall Study|Death|3|||
46811798|NCT00526994|83031136|FG000|Overall Study|Withdrawal by Subject|2|||
46811799|NCT00526994|83031137|FG001|Overall Study|Withdrawal by Subject|7|||
46811800|NCT00526994|83031138|FG002|Overall Study|Withdrawal by Subject|5|||
46811801|NCT00526994|83031136|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
46811802|NCT00526994|83031137|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
46811803|NCT00526994|83031138|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
46811804|NCT00519428|83031149|FG000|Overall Study|Adverse Event|5|||
46811805|NCT00519428|83031150|FG001|Overall Study|Adverse Event|2|||
46811806|NCT00519428|83031151|FG002|Overall Study|Adverse Event|10|||
46811807|NCT00519428|83031149|FG000|Overall Study|Lost to Follow-up|7|||
46811808|NCT00519428|83031150|FG001|Overall Study|Lost to Follow-up|7|||
46811809|NCT00519428|83031151|FG002|Overall Study|Lost to Follow-up|6|||
46811810|NCT00519428|83031149|FG000|Overall Study|Withdrawal by Subject|8|||
46811811|NCT00519428|83031150|FG001|Overall Study|Withdrawal by Subject|3|||
47054580|NCT00705432|83327760|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
47054581|NCT00705432|83327761|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
47054582|NCT00705432|83327762|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
47054583|NCT00705432|83327763|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
47054584|NCT00705432|83327758|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
47054585|NCT00705432|83327759|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
47054586|NCT00705432|83327760|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
47054587|NCT00705432|83327761|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
47054588|NCT00705432|83327762|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
47054589|NCT00705432|83327763|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
47054590|NCT00704964|83327774|FG000|Overall Study|Not completed on time|328|||
47054591|NCT00704808|83327790|FG000|Overall Study|Discontinued prior to starting treatment|14|||
47054592|NCT00704808|83327790|FG000|Overall Study|Death|7|||
47054593|NCT00704808|83327790|FG000|Overall Study|Tumor progression|80|||
47054594|NCT00704808|83327790|FG000|Overall Study|Patient's decision|11|||
47054595|NCT00704808|83327790|FG000|Overall Study|Early therapy discontinuation|16|||
47054596|NCT00704808|83327790|FG000|Overall Study|Adverse Event|1|||
47054597|NCT00704808|83327790|FG000|Overall Study|Lost to Follow-up|1|||
46754595|NCT03698019|82972409|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
46754596|NCT03698019|82972410|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
46754597|NCT03698019|82972409|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
46754598|NCT03698019|82972410|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
46754599|NCT03698019|82972409|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
46754600|NCT03698019|82972410|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
46754601|NCT03698019|82972409|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
46754602|NCT03698019|82972410|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
46754603|NCT03698019|82972409|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
46754604|NCT03698019|82972410|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
46754605|NCT03698019|82972409|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
46754606|NCT03698019|82972410|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
46754607|NCT03698019|82972409|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
46754608|NCT03698019|82972410|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
46754609|NCT03691428|82972420|FG000|Overall Study|Withdrawal by Subject|6|||
46754610|NCT03691428|82972421|FG001|Overall Study|Withdrawal by Subject|8|||
46754611|NCT03623386|82972430|FG000|Overall Study|Protocol Violation|3|||
46754612|NCT03623386|82972431|FG001|Overall Study|Protocol Violation|2|||
46754613|NCT03623386|82972432|FG002|Overall Study|Protocol Violation|0|||
46754614|NCT03623386|82972430|FG000|Overall Study|Physician Decision|1|||
46754615|NCT03623386|82972431|FG001|Overall Study|Physician Decision|1|||
46754616|NCT03623386|82972432|FG002|Overall Study|Physician Decision|0|||
46754617|NCT03623386|82972430|FG000|Overall Study|Lost to Follow-up|0|||
46754618|NCT03623386|82972431|FG001|Overall Study|Lost to Follow-up|2|||
46754619|NCT03623386|82972432|FG002|Overall Study|Lost to Follow-up|0|||
46754620|NCT03623386|82972430|FG000|Overall Study|COVID-19|0|||
46754621|NCT03623386|82972431|FG001|Overall Study|COVID-19|1|||
46754622|NCT03623386|82972432|FG002|Overall Study|COVID-19|0|||
46754623|NCT03476798|82972448|FG000|Overall Study|Death|1|||
47054598|NCT00704808|83327790|FG000|Overall Study|Treatment change|1|||
47054599|NCT01375608|83327825|FG000|Overall Study|Withdrawal by Subject|2|||
47054600|NCT00704418|83327840|FG000|Overall Study|Withdrawal by Subject|2|||
47054601|NCT00704418|83327841|FG001|Overall Study|Withdrawal by Subject|0|||
47054602|NCT00704418|83327840|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
46754624|NCT03476798|82972448|FG000|Overall Study|Withdrawal by Subject|2|||
46754625|NCT03476798|82972448|FG000|Overall Study|Protocol Violation|2|||
46811812|NCT00519428|83031151|FG002|Overall Study|Withdrawal by Subject|7|||
46927769|NCT02822235|83162484|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
47054603|NCT00704418|83327841|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
47054604|NCT00704340|83327910|FG000|Overall Study|Lost to Follow-up|2|||
46811813|NCT00519428|83031149|FG000|Overall Study|unstated|1|||
46811814|NCT00519428|83031150|FG001|Overall Study|unstated|3|||
46811815|NCT00519428|83031151|FG002|Overall Study|unstated|2|||
46811816|NCT00432159|83031167|FG000|Overall Study|Death|0|||
46811817|NCT00432159|83031168|FG001|Overall Study|Death|1|||
46811818|NCT00432159|83031169|FG002|Overall Study|Death|0|||
46811819|NCT00432159|83031170|FG003|Overall Study|Death|0|||
46811820|NCT00432159|83031171|FG004|Overall Study|Death|0|||
46811821|NCT00432159|83031167|FG000|Overall Study|Failure|9|||
46811822|NCT00432159|83031168|FG001|Overall Study|Failure|5|||
46811823|NCT00432159|83031169|FG002|Overall Study|Failure|3|||
46811824|NCT00432159|83031170|FG003|Overall Study|Failure|2|||
46811825|NCT00432159|83031171|FG004|Overall Study|Failure|3|||
46811826|NCT00432159|83031167|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
46811827|NCT00432159|83031168|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
46811828|NCT00432159|83031169|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
46811829|NCT00432159|83031170|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
46811830|NCT00432159|83031171|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
47054605|NCT00704340|83327911|FG001|Overall Study|Lost to Follow-up|1|||
47054606|NCT00704340|83327910|FG000|Overall Study|Death|0|||
46811831|NCT00519194|83031183|FG000|Overall Study|Withdrawal by Subject|9|||
46811832|NCT00519194|83031183|FG000|Overall Study|Death|9|||
46811833|NCT00519194|83031183|FG000|Overall Study|Lost to Follow-up|3|||
46811834|NCT00431847|83031191|FG000|Overall Study|completion of less than two study visits|6|||
46811835|NCT00431847|83031192|FG001|Overall Study|completion of less than two study visits|3|||
46811836|NCT00431847|83031193|FG002|Overall Study|completion of less than two study visits|4|||
46811837|NCT00431847|83031194|FG003|Overall Study|completion of less than two study visits|14|||
46811838|NCT00431847|83031195|FG004|Overall Study|completion of less than two study visits|0|||
46811839|NCT00431847|83031191|FG000|Overall Study|Protocol Violation|0|||
46811840|NCT00431847|83031192|FG001|Overall Study|Protocol Violation|0|||
46811841|NCT00431847|83031193|FG002|Overall Study|Protocol Violation|0|||
46811842|NCT00431847|83031194|FG003|Overall Study|Protocol Violation|0|||
46811843|NCT00431847|83031195|FG004|Overall Study|Protocol Violation|1|||
46811844|NCT00431067|83031205|FG000|Overall Study|Other Adverse Event|9|||
46811845|NCT00431067|83031205|FG000|Overall Study|Progressive disease|30|||
47054607|NCT00704340|83327911|FG001|Overall Study|Death|1|||
47054608|NCT00552058|83327919|FG000|Overall Study|Adverse Event|8|||
46754626|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
46754627|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
46754628|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
46754629|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
46754630|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
46811846|NCT00431067|83031205|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
46811847|NCT00430989|83031211|FG000|Overall Study|Lost to Follow-up|2|||
46811848|NCT00430989|83031212|FG001|Overall Study|Lost to Follow-up|3|||
46811849|NCT00430989|83031211|FG000|Overall Study|Withdrawal by Subject|15|||
46811850|NCT00430989|83031212|FG001|Overall Study|Withdrawal by Subject|14|||
46811851|NCT00430989|83031211|FG000|Overall Study|Protocol Violation|30|||
46811852|NCT00430989|83031212|FG001|Overall Study|Protocol Violation|37|||
46811853|NCT00430989|83031211|FG000|Overall Study|Not eligible|13|||
46811854|NCT00430989|83031212|FG001|Overall Study|Not eligible|6|||
46811855|NCT00430755|83031220|FG000|Overall Study|Withdrawal by Subject|53|||
46927770|NCT02822235|83162483|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
46754631|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
46754632|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
46754633|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
46754634|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
46754635|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
46754636|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
46754637|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
46754638|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
46754639|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
46754640|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
46754641|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
46754642|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
46811856|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
46811857|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
47054609|NCT00552058|83327920|FG001|Overall Study|Adverse Event|7|||
46811858|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
47054610|NCT00552058|83327919|FG000|Overall Study|Lack of Efficacy|1|||
46811859|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
46811860|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
46811861|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
46811862|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
46811863|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
46754643|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
46754644|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
46754645|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
46754646|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
46754647|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
46754648|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
46754649|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
46754650|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
46754651|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
46754652|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
46754653|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
46754654|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
46754655|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
46754656|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
46754657|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
46754658|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
46754659|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
46754660|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
46754661|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
46754662|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
46811864|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
46811865|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
46811866|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Subject decision|1|||
46811867|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Subject decision|1|||
46811868|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
46754663|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
46811869|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
46811870|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
46811871|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
46811872|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
46811873|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
46811874|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
46811875|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
46811876|NCT00518882|83031226|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
46811877|NCT00518882|83031227|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
46811878|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
46811879|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
46811880|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
46811881|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
46811882|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
46811883|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
46811884|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
46811885|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
46811886|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
46811887|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
46811888|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
46811889|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
46811890|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
46811891|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
46811892|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
46811893|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
46811894|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
46811895|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
47054611|NCT00552058|83327920|FG001|Overall Study|Lack of Efficacy|5|||
46811896|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
46811897|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
46811898|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
46811899|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
46811900|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
46811901|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
46811902|NCT00518882|83031226|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
46811903|NCT00518882|83031227|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
46811904|NCT00518336|83031235|FG000|Year 7|Lost to Follow-up|2|||
47054612|NCT00552058|83327919|FG000|Overall Study|Lost to Follow-up|1|||
47054613|NCT00552058|83327920|FG001|Overall Study|Lost to Follow-up|0|||
47054614|NCT00552058|83327919|FG000|Overall Study|Withdrawal by Subject|4|||
46811905|NCT00518336|83031236|FG001|Year 7|Lost to Follow-up|0|||
46811906|NCT00518336|83031235|FG000|Year 7|Could not attend in time|0|||
46811907|NCT00518336|83031236|FG001|Year 7|Could not attend in time|3|||
46811908|NCT00518336|83031235|FG000|Year 8|Lost to Follow-up|1|||
46811909|NCT00518336|83031236|FG001|Year 8|Lost to Follow-up|1|||
46811910|NCT00518336|83031235|FG000|Year 8|Could not attend in time|0|||
46811911|NCT00518336|83031236|FG001|Year 8|Could not attend in time|1|||
46811912|NCT00518336|83031235|FG000|Year 9|Migrated/moved from study area|1|||
46811913|NCT00518336|83031236|FG001|Year 9|Migrated/moved from study area|1|||
46811914|NCT00518336|83031235|FG000|Year 9|Lost to Follow-up|3|||
46811915|NCT00518336|83031236|FG001|Year 9|Lost to Follow-up|0|||
46811916|NCT00518336|83031235|FG000|Year 9|Personal reasons|1|||
46811917|NCT00518336|83031236|FG001|Year 9|Personal reasons|0|||
46811918|NCT00518180|83031245|FG000|Overall Study|Withdrawal by Subject|29|||
46811919|NCT00518180|83031246|FG001|Overall Study|Withdrawal by Subject|30|||
46811920|NCT00518180|83031247|FG002|Overall Study|Withdrawal by Subject|42|||
46811921|NCT00518180|83031245|FG000|Overall Study|Lost to Follow-up|30|||
46811922|NCT00518180|83031246|FG001|Overall Study|Lost to Follow-up|28|||
46811923|NCT00518180|83031247|FG002|Overall Study|Lost to Follow-up|34|||
46811924|NCT00518180|83031245|FG000|Overall Study|Administrative reason|0|||
46811925|NCT00518180|83031246|FG001|Overall Study|Administrative reason|2|||
46811926|NCT00518180|83031247|FG002|Overall Study|Administrative reason|2|||
46811927|NCT00518180|83031245|FG000|Overall Study|Protocol Violation|5|||
46811928|NCT00518180|83031246|FG001|Overall Study|Protocol Violation|7|||
46811929|NCT00518180|83031247|FG002|Overall Study|Protocol Violation|4|||
46811930|NCT00518180|83031245|FG000|Overall Study|Unable to classify|0|||
46811931|NCT00518180|83031246|FG001|Overall Study|Unable to classify|2|||
46811932|NCT00518180|83031247|FG002|Overall Study|Unable to classify|0|||
46811933|NCT00518180|83031245|FG000|Overall Study|Adverse Event|1|||
46811934|NCT00518180|83031246|FG001|Overall Study|Adverse Event|0|||
46811935|NCT00518180|83031247|FG002|Overall Study|Adverse Event|0|||
46811936|NCT00525902|83031264|FG000|Overall Study|Lack of Efficacy|1|||
46927771|NCT02822235|83162484|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
46927772|NCT02822235|83162483|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
46927773|NCT02822235|83162484|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
46927774|NCT02822235|83162483|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
46927775|NCT02822235|83162484|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
46927776|NCT02817555|83162499|FG000|Overall Study|Death|1|||
46811937|NCT00525824|83031272|FG000|Overall Study|Adverse Event|7|||
46927777|NCT02817555|83162500|FG001|Overall Study|Death|3|||
46927778|NCT02817555|83162499|FG000|Overall Study|moved away|1|||
46927779|NCT02817555|83162500|FG001|Overall Study|moved away|0|||
46927780|NCT02817555|83162499|FG000|Overall Study|transplant|1|||
46754664|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
46754665|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
46754666|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
46754667|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
46754668|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
46754669|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
46754670|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
46754671|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
46754672|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
46754673|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
46754674|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
46754675|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
46754676|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
46754677|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
46754678|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
46754679|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
46754680|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
46811938|NCT00525824|83031273|FG001|Overall Study|Adverse Event|11|||
46811939|NCT00525824|83031274|FG002|Overall Study|Adverse Event|6|||
46811940|NCT00525824|83031275|FG003|Overall Study|Adverse Event|7|||
46811941|NCT00525824|83031272|FG000|Overall Study|Withdrawal by Subject|5|||
47054615|NCT00552058|83327920|FG001|Overall Study|Withdrawal by Subject|4|||
47054616|NCT00552058|83327919|FG000|Overall Study|Other: Protocol Violation|0|||
47054617|NCT00552058|83327920|FG001|Overall Study|Other: Protocol Violation|1|||
46811942|NCT00525824|83031273|FG001|Overall Study|Withdrawal by Subject|9|||
46811943|NCT00525824|83031274|FG002|Overall Study|Withdrawal by Subject|3|||
46811944|NCT00525824|83031275|FG003|Overall Study|Withdrawal by Subject|4|||
46927781|NCT02817555|83162500|FG001|Overall Study|transplant|1|||
46927782|NCT02817555|83162499|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
46927783|NCT02817555|83162500|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
46927784|NCT02817087|83162508|FG000|Overall Study|Withdrawal by Subject|2|||
46927785|NCT02817087|83162509|FG001|Overall Study|Withdrawal by Subject|0|||
46927786|NCT02813577|83162515|FG000|Overall Study|Study terminated|4|||
46927787|NCT02815293|83162522|FG000|Overall Study|Study termination by sponsor|10|||
46927788|NCT02815293|83162523|FG001|Overall Study|Study termination by sponsor|7|||
46927789|NCT02815293|83162524|FG002|Overall Study|Study termination by sponsor|0|||
46927790|NCT02815293|83162522|FG000|Overall Study|Participants not randomized|0|||
46927791|NCT02815293|83162523|FG001|Overall Study|Participants not randomized|0|||
46927792|NCT02815293|83162524|FG002|Overall Study|Participants not randomized|18|||
46927793|NCT02815293|83162522|FG000|Overall Study|Adverse Event|0|||
46927794|NCT02815293|83162523|FG001|Overall Study|Adverse Event|1|||
46927795|NCT02815293|83162524|FG002|Overall Study|Adverse Event|0|||
46927796|NCT02813421|83162532|FG000|Overall Study|Withdrawal by Subject|1|||
46927797|NCT02813421|83162533|FG001|Overall Study|Withdrawal by Subject|2|||
46927798|NCT02813421|83162532|FG000|Overall Study|Lost to Follow-up|1|||
46927799|NCT02813421|83162533|FG001|Overall Study|Lost to Follow-up|1|||
46927800|NCT03672188|83162554|FG000|Overall Study|Withdrawal by Subject|0|||
46927801|NCT03672188|83162555|FG001|Overall Study|Withdrawal by Subject|0|||
46927802|NCT03672188|83162556|FG002|Overall Study|Withdrawal by Subject|0|||
46927803|NCT03672188|83162557|FG003|Overall Study|Withdrawal by Subject|3|||
46927804|NCT03672188|83162558|FG004|Overall Study|Withdrawal by Subject|0|||
46927805|NCT03672188|83162559|FG005|Overall Study|Withdrawal by Subject|0|||
46927806|NCT03672188|83162560|FG006|Overall Study|Withdrawal by Subject|0|||
46927807|NCT03672188|83162561|FG007|Overall Study|Withdrawal by Subject|0|||
46927808|NCT03672188|83162562|FG008|Overall Study|Withdrawal by Subject|0|||
46927809|NCT03672188|83162563|FG009|Overall Study|Withdrawal by Subject|0|||
46927810|NCT03672188|83162564|FG010|Overall Study|Withdrawal by Subject|0|||
46927811|NCT03672188|83162565|FG011|Overall Study|Withdrawal by Subject|0|||
46927812|NCT03672188|83162566|FG012|Overall Study|Withdrawal by Subject|0|||
46927813|NCT03672188|83162567|FG013|Overall Study|Withdrawal by Subject|0|||
46927814|NCT03672188|83162568|FG014|Overall Study|Withdrawal by Subject|0|||
46927815|NCT03672188|83162554|FG000|Overall Study|Death|0|||
46927816|NCT03672188|83162555|FG001|Overall Study|Death|0|||
46927817|NCT03672188|83162556|FG002|Overall Study|Death|0|||
46927818|NCT03672188|83162557|FG003|Overall Study|Death|0|||
46927819|NCT03672188|83162558|FG004|Overall Study|Death|0|||
46927820|NCT03672188|83162559|FG005|Overall Study|Death|0|||
46927821|NCT03672188|83162560|FG006|Overall Study|Death|0|||
46927822|NCT03672188|83162561|FG007|Overall Study|Death|0|||
46927823|NCT03672188|83162562|FG008|Overall Study|Death|0|||
46927824|NCT03672188|83162563|FG009|Overall Study|Death|0|||
46927825|NCT03672188|83162564|FG010|Overall Study|Death|0|||
46927826|NCT03672188|83162565|FG011|Overall Study|Death|0|||
46927827|NCT03672188|83162566|FG012|Overall Study|Death|1|||
46927828|NCT03672188|83162567|FG013|Overall Study|Death|0|||
46927829|NCT03672188|83162568|FG014|Overall Study|Death|0|||
46927830|NCT03672188|83162554|FG000|Overall Study|Lost to Follow-up|0|||
46927831|NCT03672188|83162555|FG001|Overall Study|Lost to Follow-up|0|||
46927832|NCT03672188|83162556|FG002|Overall Study|Lost to Follow-up|1|||
46927833|NCT03672188|83162557|FG003|Overall Study|Lost to Follow-up|0|||
46927834|NCT03672188|83162558|FG004|Overall Study|Lost to Follow-up|0|||
46927835|NCT03672188|83162559|FG005|Overall Study|Lost to Follow-up|0|||
46927836|NCT03672188|83162560|FG006|Overall Study|Lost to Follow-up|0|||
46927837|NCT03672188|83162561|FG007|Overall Study|Lost to Follow-up|0|||
46927838|NCT03672188|83162562|FG008|Overall Study|Lost to Follow-up|0|||
46927839|NCT03672188|83162563|FG009|Overall Study|Lost to Follow-up|0|||
46927840|NCT03672188|83162564|FG010|Overall Study|Lost to Follow-up|0|||
46927841|NCT03672188|83162565|FG011|Overall Study|Lost to Follow-up|0|||
46927842|NCT03672188|83162566|FG012|Overall Study|Lost to Follow-up|0|||
46927843|NCT03672188|83162567|FG013|Overall Study|Lost to Follow-up|0|||
46927844|NCT03672188|83162568|FG014|Overall Study|Lost to Follow-up|0|||
46927845|NCT02620384|83162636|FG000|Overall Study|Adverse Event|2|||
46927846|NCT02620384|83162637|FG001|Overall Study|Adverse Event|1|||
46927847|NCT02620384|83162636|FG000|Overall Study|Discharged prior to 2nd dose|2|||
46927848|NCT02620384|83162637|FG001|Overall Study|Discharged prior to 2nd dose|5|||
46927849|NCT02620384|83162636|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
46927850|NCT02620384|83162637|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
46927851|NCT03915860|83162643|FG000|Overall Study|Adverse Event|3|||
47054618|NCT00552058|83327919|FG000|Overall Study|Other: Non Compliance|1|||
47054619|NCT00552058|83327920|FG001|Overall Study|Other: Non Compliance|2|||
46754681|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
46927852|NCT03915860|83162643|FG000|Overall Study|Withdrawal by Subject|6|||
46927853|NCT03915860|83162643|FG000|Overall Study|Lost to Follow-up|2|||
46927854|NCT03915860|83162643|FG000|Overall Study|Other than specified|3|||
46927855|NCT05047211|83162658|FG000|Overall Study|Lost to Follow-up|8|||
46927856|NCT05047211|83162659|FG001|Overall Study|Lost to Follow-up|5|||
46927857|NCT04958642|83162668|FG000|Overall Study|Transferred to OLEX program|3|||
46927858|NCT04958642|83162669|FG001|Overall Study|Transferred to OLEX program|0|||
46927859|NCT04958642|83162670|FG002|Overall Study|Transferred to OLEX program|5|||
46927860|NCT04958642|83162668|FG000|Overall Study|Death|0|||
46927861|NCT04958642|83162669|FG001|Overall Study|Death|0|||
46927862|NCT04958642|83162670|FG002|Overall Study|Death|1|||
46927863|NCT04958642|83162668|FG000|Overall Study|Withdrawal by Subject|4|||
46927864|NCT04958642|83162669|FG001|Overall Study|Withdrawal by Subject|9|||
46927865|NCT04958642|83162670|FG002|Overall Study|Withdrawal by Subject|13|||
46811945|NCT00525824|83031272|FG000|Overall Study|Lost to Follow-up|4|||
46811946|NCT00525824|83031273|FG001|Overall Study|Lost to Follow-up|2|||
46811947|NCT00525824|83031274|FG002|Overall Study|Lost to Follow-up|4|||
46811948|NCT00525824|83031275|FG003|Overall Study|Lost to Follow-up|0|||
46811949|NCT00525824|83031272|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
46811950|NCT00525824|83031273|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
46811951|NCT00525824|83031274|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
46811952|NCT00525824|83031275|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
46811953|NCT00525824|83031272|FG000|Overall Study|Severe non-compliance|0|||
46811954|NCT00525824|83031273|FG001|Overall Study|Severe non-compliance|1|||
46754682|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
46754683|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
46754684|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
46754685|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
46754686|NCT03395197|82972458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
46754687|NCT03395197|82972459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
46754688|NCT03395197|82972460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
46754689|NCT03395197|82972461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
46754690|NCT03395197|82972462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
46754691|NCT03395197|82972463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
46754692|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Death|0|||
46811955|NCT00525824|83031274|FG002|Overall Study|Severe non-compliance|1|||
46811956|NCT00525824|83031275|FG003|Overall Study|Severe non-compliance|1|||
46811957|NCT00525824|83031272|FG000|Overall Study|Safety reasons|1|||
46811958|NCT00525824|83031273|FG001|Overall Study|Safety reasons|0|||
46811959|NCT00525824|83031274|FG002|Overall Study|Safety reasons|1|||
46811960|NCT00525824|83031275|FG003|Overall Study|Safety reasons|0|||
46811961|NCT00525824|83031272|FG000|Overall Study|Other|1|||
46811962|NCT00525824|83031273|FG001|Overall Study|Other|3|||
46811963|NCT00525824|83031274|FG002|Overall Study|Other|3|||
46811964|NCT00525824|83031275|FG003|Overall Study|Other|1|||
46811965|NCT00525590|83031289|FG000|Overall Study|Adverse Event|3|||
46811966|NCT00525590|83031289|FG000|Overall Study|Physician Decision|3|||
46811967|NCT00525590|83031289|FG000|Overall Study|Withdrawal by Subject|16|||
46811968|NCT00525590|83031289|FG000|Overall Study|Lost to Follow-up|1|||
46811969|NCT00525590|83031289|FG000|Overall Study|Death|9|||
46811970|NCT00525590|83031289|FG000|Overall Study|Other|13|||
46811971|NCT00430677|83031296|FG000|Short-term Period|Death|1|||
46811972|NCT00430677|83031297|FG001|Short-term Period|Death|1|||
46811973|NCT00430677|83031298|FG002|Short-term Period|Death|5|||
46811974|NCT00430677|83031296|FG000|Short-term Period|Adverse Event|15|||
46811975|NCT00430677|83031297|FG001|Short-term Period|Adverse Event|13|||
46811976|NCT00430677|83031298|FG002|Short-term Period|Adverse Event|9|||
46811977|NCT00430677|83031296|FG000|Short-term Period|Lack of Efficacy|5|||
46811978|NCT00430677|83031297|FG001|Short-term Period|Lack of Efficacy|6|||
46811979|NCT00430677|83031298|FG002|Short-term Period|Lack of Efficacy|4|||
46811980|NCT00430677|83031296|FG000|Short-term Period|Withdrawal by Subject|1|||
46811981|NCT00430677|83031297|FG001|Short-term Period|Withdrawal by Subject|1|||
46811982|NCT00430677|83031298|FG002|Short-term Period|Withdrawal by Subject|2|||
46811983|NCT00430677|83031296|FG000|Short-term Period|Participant no longer met study criteria|1|||
46811984|NCT00430677|83031297|FG001|Short-term Period|Participant no longer met study criteria|1|||
46811985|NCT00430677|83031298|FG002|Short-term Period|Participant no longer met study criteria|2|||
46811986|NCT00430677|83031296|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
46811987|NCT00430677|83031297|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
46811988|NCT00430677|83031298|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
46811989|NCT00430677|83031296|FG000|Short-term Period|Pregnancy|0|||
46927866|NCT04958642|83162668|FG000|Overall Study|Investigator's Decision|0|||
46927867|NCT04958642|83162669|FG001|Overall Study|Investigator's Decision|0|||
46927868|NCT04958642|83162670|FG002|Overall Study|Investigator's Decision|1|||
46927869|NCT04958642|83162668|FG000|Overall Study|Adverse Event|1|||
46927870|NCT04958642|83162669|FG001|Overall Study|Adverse Event|0|||
46754693|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Death|0|||
46811990|NCT00430677|83031297|FG001|Short-term Period|Pregnancy|2|||
46811991|NCT00430677|83031298|FG002|Short-term Period|Pregnancy|0|||
46811992|NCT00430677|83031296|FG000|Long-term Extension Period|Death|1|||
46927871|NCT04958642|83162670|FG002|Overall Study|Adverse Event|1|||
46754694|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Death|0|||
46811993|NCT00430677|83031297|FG001|Long-term Extension Period|Death|0|||
46811994|NCT00430677|83031298|FG002|Long-term Extension Period|Death|0|||
46927872|NCT04958642|83162668|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
46811995|NCT00430677|83031296|FG000|Long-term Extension Period|Adverse Event|3|||
46811996|NCT00430677|83031297|FG001|Long-term Extension Period|Adverse Event|2|||
46636436|NCT01514136|82810251|FG000|Test Period 2; Test A*|Adverse Event|0|||
46754695|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Death|0|||
46754696|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Death|1|||
46754697|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Death|4|||
46754698|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
46754699|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
46754700|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
46754701|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
46754702|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
46754703|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
46754704|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
46754705|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
46754706|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
46754707|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
46754708|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
46754709|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
46754710|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
46754711|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
46754712|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
46754713|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
46754714|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
46754715|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
46754716|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
46754717|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
46754718|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
46754719|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
46754720|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
46754721|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
46754722|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
46754723|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
46754724|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
46754725|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
46754726|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
46754727|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
46754728|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
46754729|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
46754730|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
46754731|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
46754732|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
46754733|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
46754734|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Other|0|||
46754735|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Other|0|||
46754736|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Other|0|||
46754737|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Other|0|||
46811997|NCT00430677|83031298|FG002|Long-term Extension Period|Adverse Event|5|||
46811998|NCT00430677|83031296|FG000|Long-term Extension Period|Lack of Efficacy|5|||
46811999|NCT00430677|83031297|FG001|Long-term Extension Period|Lack of Efficacy|3|||
46812000|NCT00430677|83031298|FG002|Long-term Extension Period|Lack of Efficacy|8|||
46927873|NCT04958642|83162669|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
46636437|NCT01514136|82810252|FG001|Test Period 2; Test A*|Adverse Event|0|||
46636438|NCT01514136|82810253|FG002|Test Period 2; Test A*|Adverse Event|0|||
46636439|NCT01514136|82810254|FG003|Test Period 2; Test A*|Adverse Event|0|||
46636440|NCT01514136|82810255|FG004|Test Period 2; Test A*|Adverse Event|1|||
46636441|NCT01514136|82810256|FG005|Test Period 2; Test A*|Adverse Event|0|||
46636442|NCT01514136|82810257|FG006|Test Period 2; Test A*|Adverse Event|0|||
46636443|NCT01514136|82810258|FG007|Test Period 2; Test A*|Adverse Event|0|||
46636444|NCT01514136|82810251|FG000|Test Period 2; Test A*|Holiday|0|||
46636445|NCT01514136|82810252|FG001|Test Period 2; Test A*|Holiday|0|||
46636446|NCT01514136|82810253|FG002|Test Period 2; Test A*|Holiday|0|||
46636447|NCT01514136|82810254|FG003|Test Period 2; Test A*|Holiday|0|||
46636448|NCT01514136|82810255|FG004|Test Period 2; Test A*|Holiday|1|||
46636449|NCT01514136|82810256|FG005|Test Period 2; Test A*|Holiday|0|||
46636450|NCT01514136|82810257|FG006|Test Period 2; Test A*|Holiday|0|||
46812001|NCT00430677|83031296|FG000|Long-term Extension Period|Lost to Follow-up|1|||
46812002|NCT00430677|83031297|FG001|Long-term Extension Period|Lost to Follow-up|1|||
46812003|NCT00430677|83031298|FG002|Long-term Extension Period|Lost to Follow-up|1|||
46927874|NCT04958642|83162670|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
46927875|NCT04958642|83162668|FG000|Overall Study|Lost to Follow-up|1|||
46812004|NCT00430677|83031296|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
46812005|NCT00430677|83031297|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
46812006|NCT00430677|83031298|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
46812007|NCT00430677|83031296|FG000|Long-term Extension Period|Pregnancy|1|||
46812008|NCT00430677|83031297|FG001|Long-term Extension Period|Pregnancy|1|||
46812009|NCT00430677|83031298|FG002|Long-term Extension Period|Pregnancy|0|||
46812010|NCT00430677|83031296|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
46812011|NCT00430677|83031297|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
46812012|NCT00430677|83031298|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
46812013|NCT00430677|83031296|FG000|Long-term Extension Period|Other|2|||
46812014|NCT00430677|83031297|FG001|Long-term Extension Period|Other|1|||
46812015|NCT00430677|83031298|FG002|Long-term Extension Period|Other|1|||
46812016|NCT00430677|83031296|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
46812017|NCT00430677|83031297|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
46812018|NCT00430677|83031298|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
46812019|NCT00525512|83031326|FG000|Double-Blind Phase|Adverse Event|48|||
46812020|NCT00525512|83031327|FG001|Double-Blind Phase|Adverse Event|28|||
46927876|NCT04958642|83162669|FG001|Overall Study|Lost to Follow-up|0|||
46927877|NCT04958642|83162670|FG002|Overall Study|Lost to Follow-up|0|||
46927878|NCT04958642|83162668|FG000|Overall Study|Transferred to EAP following study termination|0|||
46927879|NCT04958642|83162669|FG001|Overall Study|Transferred to EAP following study termination|0|||
46927880|NCT04958642|83162670|FG002|Overall Study|Transferred to EAP following study termination|1|||
46927881|NCT04958642|83162668|FG000|Overall Study|Transferred to Expanded Access Program|1|||
46812021|NCT00525512|83031328|FG002|Double-Blind Phase|Adverse Event|0|||
46812022|NCT00525512|83031329|FG003|Double-Blind Phase|Adverse Event|0|||
46812023|NCT00525512|83031326|FG000|Double-Blind Phase|Protocol Violation|3|||
46812024|NCT00525512|83031327|FG001|Double-Blind Phase|Protocol Violation|1|||
46812025|NCT00525512|83031328|FG002|Double-Blind Phase|Protocol Violation|0|||
46927882|NCT04958642|83162669|FG001|Overall Study|Transferred to Expanded Access Program|0|||
46927883|NCT04958642|83162670|FG002|Overall Study|Transferred to Expanded Access Program|0|||
46927884|NCT04321343|83162686|FG000|Overall Study|Adverse Event|0|||
46927885|NCT04321343|83162687|FG001|Overall Study|Adverse Event|0|||
46636451|NCT01514136|82810258|FG007|Test Period 2; Test A*|Holiday|0|||
46636452|NCT01514136|82810251|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
46636453|NCT01514136|82810252|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
46636454|NCT01514136|82810253|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
46636455|NCT01514136|82810254|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
46636456|NCT01514136|82810255|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
46927886|NCT04321343|83162688|FG002|Overall Study|Adverse Event|1|||
46927887|NCT04321343|83162689|FG003|Overall Study|Adverse Event|0|||
46636457|NCT01514136|82810256|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
46754738|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Other|3|||
46754739|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Other|3|||
46754740|NCT03395197|82972458|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
46754741|NCT03395197|82972459|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
46754742|NCT03395197|82972460|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
46754743|NCT03395197|82972461|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
46754744|NCT03395197|82972462|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
46754745|NCT03395197|82972463|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
46754746|NCT03307967|82972490|FG000|Overall Study|Lost to Follow-up|4|||
46754747|NCT03290300|82972494|FG000|Overall Study|Lost to Follow-up|3|||
46754748|NCT03239470|82972505|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
46754749|NCT03239470|82972506|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
46754750|NCT02938520|82972513|FG000|Overall Study|On-going at the time of analysis|258|||
46754751|NCT02938520|82972514|FG001|Overall Study|On-going at the time of analysis|261|||
46754752|NCT02938520|82972513|FG000|Overall Study|Physician Decision|2|||
46754753|NCT02938520|82972514|FG001|Overall Study|Physician Decision|5|||
46754754|NCT02938520|82972513|FG000|Overall Study|Lost to Follow-up|2|||
46812026|NCT00525512|83031329|FG003|Double-Blind Phase|Protocol Violation|0|||
46812027|NCT00525512|83031326|FG000|Double-Blind Phase|Lost to Follow-up|3|||
46927888|NCT04321343|83162686|FG000|Overall Study|Death|0|||
46927889|NCT04321343|83162687|FG001|Overall Study|Death|0|||
46927890|NCT04321343|83162688|FG002|Overall Study|Death|0|||
46927891|NCT04321343|83162689|FG003|Overall Study|Death|1|||
46927892|NCT04321343|83162686|FG000|Overall Study|Pregnancy|1|||
46754755|NCT02938520|82972514|FG001|Overall Study|Lost to Follow-up|2|||
46754756|NCT02938520|82972513|FG000|Overall Study|Withdrawal by Subject|7|||
46754757|NCT02938520|82972514|FG001|Overall Study|Withdrawal by Subject|7|||
46754758|NCT02938520|82972513|FG000|Overall Study|Protocol Violation|0|||
46754759|NCT02938520|82972514|FG001|Overall Study|Protocol Violation|1|||
46754760|NCT02938520|82972513|FG000|Overall Study|Lack of Efficacy|5|||
46754761|NCT02938520|82972514|FG001|Overall Study|Lack of Efficacy|3|||
46812028|NCT00525512|83031327|FG001|Double-Blind Phase|Lost to Follow-up|7|||
46812029|NCT00525512|83031328|FG002|Double-Blind Phase|Lost to Follow-up|0|||
46812030|NCT00525512|83031329|FG003|Double-Blind Phase|Lost to Follow-up|0|||
46812031|NCT00525512|83031326|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
46754762|NCT02938520|82972513|FG000|Overall Study|Adverse Event|9|||
46754763|NCT02938520|82972514|FG001|Overall Study|Adverse Event|4|||
46754764|NCT02918162|82972523|FG000|Overall Study|Withdrawal by Subject|1|||
46754765|NCT02918162|82972523|FG000|Overall Study|Omental Disease|1|||
46754766|NCT02779855|82972530|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
46754767|NCT02779855|82972531|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
46754768|NCT02779855|82972532|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
46754769|NCT02504372|82972552|FG000|Overall Study|Death|136|||
46754770|NCT02504372|82972553|FG001|Overall Study|Death|154|||
46754771|NCT02504372|82972552|FG000|Overall Study|Lost to Follow-up|0|||
46812032|NCT00525512|83031327|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
46812033|NCT00525512|83031328|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
46812034|NCT00525512|83031329|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
46812035|NCT00525512|83031326|FG000|Double-Blind Phase|Lack of Efficacy|13|||
46812036|NCT00525512|83031327|FG001|Double-Blind Phase|Lack of Efficacy|5|||
46812037|NCT00525512|83031328|FG002|Double-Blind Phase|Lack of Efficacy|0|||
46812038|NCT00525512|83031329|FG003|Double-Blind Phase|Lack of Efficacy|0|||
46812039|NCT00525512|83031326|FG000|Double-Blind Phase|Other reason (not specified)|12|||
46812040|NCT00525512|83031327|FG001|Double-Blind Phase|Other reason (not specified)|13|||
46812041|NCT00525512|83031328|FG002|Double-Blind Phase|Other reason (not specified)|0|||
46812042|NCT00525512|83031329|FG003|Double-Blind Phase|Other reason (not specified)|0|||
46812043|NCT00525512|83031326|FG000|Open-Label Phase|Adverse Event|0|||
46812044|NCT00525512|83031327|FG001|Open-Label Phase|Adverse Event|0|||
46812045|NCT00525512|83031328|FG002|Open-Label Phase|Adverse Event|1|||
46812046|NCT00525512|83031329|FG003|Open-Label Phase|Adverse Event|0|||
46812047|NCT00525512|83031326|FG000|Open-Label Phase|Lost to Follow-up|0|||
46812048|NCT00525512|83031327|FG001|Open-Label Phase|Lost to Follow-up|0|||
46812049|NCT00525512|83031328|FG002|Open-Label Phase|Lost to Follow-up|1|||
46812050|NCT00525512|83031329|FG003|Open-Label Phase|Lost to Follow-up|0|||
47054620|NCT00552058|83327919|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
47054621|NCT00552058|83327920|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
47054622|NCT00552058|83327919|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
47054623|NCT00552058|83327920|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
47054624|NCT00552058|83327919|FG000|Overall Study|Other: Positive Stool Result|0|||
47054625|NCT00552058|83327920|FG001|Overall Study|Other: Positive Stool Result|1|||
47054626|NCT00552058|83327919|FG000|Overall Study|Other: Randomized in error|0|||
47054627|NCT00552058|83327920|FG001|Overall Study|Other: Randomized in error|1|||
47054628|NCT00552058|83327919|FG000|Overall Study|Other: Sponsors Decision|0|||
47054629|NCT00552058|83327920|FG001|Overall Study|Other: Sponsors Decision|1|||
47054630|NCT00552058|83327919|FG000|Overall Study|Other: Early Roll Over|1|||
47054631|NCT00552058|83327920|FG001|Overall Study|Other: Early Roll Over|0|||
47054632|NCT00550732|83327949|FG000|Overall Study|Death|4|||
47054633|NCT00550732|83327949|FG000|Overall Study|Withdrawal by Subject|2|||
47054634|NCT00550732|83327949|FG000|Overall Study|Physician Decision|2|||
47054635|NCT00550732|83327949|FG000|Overall Study|Lost to Follow-up|1|||
46754772|NCT02504372|82972553|FG001|Overall Study|Lost to Follow-up|2|||
46812051|NCT00525512|83031326|FG000|Open-Label Phase|Other reason (not specified)|0|||
46927893|NCT04321343|83162687|FG001|Overall Study|Pregnancy|0|||
47054636|NCT00550732|83327949|FG000|Overall Study|Palliative care|1|||
46754773|NCT02504372|82972552|FG000|Overall Study|Withdrawal of consent|25|||
46754774|NCT02504372|82972553|FG001|Overall Study|Withdrawal of consent|16|||
46754775|NCT02504372|82972552|FG000|Overall Study|Participants ongoing|429|||
46812052|NCT00525512|83031327|FG001|Open-Label Phase|Other reason (not specified)|0|||
46927894|NCT04321343|83162688|FG002|Overall Study|Pregnancy|0|||
47054637|NCT00550732|83327949|FG000|Overall Study|Adverse Event|1|||
47054638|NCT00550420|83327963|FG000|Overall Study|Adverse Event|28|||
47054639|NCT00550420|83327963|FG000|Overall Study|Lost to Follow-up|8|||
47054640|NCT00550420|83327963|FG000|Overall Study|Protocol Violation|11|||
47054641|NCT00550420|83327963|FG000|Overall Study|Withdrawal by Subject|30|||
47054642|NCT00550420|83327963|FG000|Overall Study|Still in study at termination|206|||
47054643|NCT00550420|83327963|FG000|Overall Study|Missing|2|||
47054644|NCT00550420|83327963|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
47054645|NCT00550420|83327963|FG000|Overall Study|Investigators opinion|1|||
47054646|NCT00550420|83327963|FG000|Overall Study|Lack of curative effect|1|||
47054647|NCT00550420|83327963|FG000|Overall Study|Unethical stop of enrollment|2|||
47054648|NCT00550420|83327963|FG000|Overall Study|Caregiver's decision to withdraw|1|||
47054649|NCT00550420|83327963|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
47054650|NCT00550420|83327963|FG000|Overall Study|Exclusion criteria|1|||
47054651|NCT00550420|83327963|FG000|Overall Study|Prohibited medicine|1|||
47054652|NCT00558064|83327975|FG000|Overall Study|Adverse Event|3|||
46754776|NCT02504372|82972553|FG001|Overall Study|Participants ongoing|415|||
46812053|NCT00525512|83031328|FG002|Open-Label Phase|Other reason (not specified)|4|||
46754777|NCT02227199|82972562|FG000|Overall Study|Physician Decision|0|||
46754778|NCT02227199|82972563|FG001|Overall Study|Physician Decision|0|||
46754779|NCT02227199|82972564|FG002|Overall Study|Physician Decision|1|||
46754780|NCT02227199|82972562|FG000|Overall Study|Adverse Event|0|||
46754781|NCT02227199|82972563|FG001|Overall Study|Adverse Event|0|||
46812054|NCT00525512|83031329|FG003|Open-Label Phase|Other reason (not specified)|5|||
46812055|NCT00517634|83031341|FG000|Second Treatment Period|Withdrawal by Subject|0|||
46812056|NCT00517634|83031342|FG001|Second Treatment Period|Withdrawal by Subject|0|||
46812057|NCT00517634|83031343|FG002|Second Treatment Period|Withdrawal by Subject|0|||
46812058|NCT00517634|83031344|FG003|Second Treatment Period|Withdrawal by Subject|0|||
46812059|NCT00517634|83031345|FG004|Second Treatment Period|Withdrawal by Subject|1|||
46812060|NCT00517634|83031346|FG005|Second Treatment Period|Withdrawal by Subject|0|||
46812061|NCT03683576|83031358|FG000|Overall Study|Withdrawal by Subject|2|||
46812062|NCT03683576|83031359|FG001|Overall Study|Withdrawal by Subject|0|||
46812063|NCT03683576|83031360|FG002|Overall Study|Withdrawal by Subject|8|||
46812064|NCT03683576|83031361|FG003|Overall Study|Withdrawal by Subject|3|||
46812065|NCT03683576|83031358|FG000|Overall Study|Adverse Event|3|||
46812066|NCT03683576|83031359|FG001|Overall Study|Adverse Event|0|||
46812067|NCT03683576|83031360|FG002|Overall Study|Adverse Event|0|||
46812068|NCT03683576|83031361|FG003|Overall Study|Adverse Event|4|||
46812069|NCT03683576|83031358|FG000|Overall Study|Lack of Efficacy|1|||
46812070|NCT03683576|83031359|FG001|Overall Study|Lack of Efficacy|0|||
46812071|NCT03683576|83031360|FG002|Overall Study|Lack of Efficacy|1|||
46812072|NCT03683576|83031361|FG003|Overall Study|Lack of Efficacy|1|||
46812073|NCT03683576|83031358|FG000|Overall Study|Lost to Follow-up|0|||
46812074|NCT03683576|83031359|FG001|Overall Study|Lost to Follow-up|1|||
46812075|NCT03683576|83031360|FG002|Overall Study|Lost to Follow-up|2|||
46812076|NCT03683576|83031361|FG003|Overall Study|Lost to Follow-up|0|||
46812077|NCT03683576|83031358|FG000|Overall Study|Other, Not Specified|0|||
46812078|NCT03683576|83031359|FG001|Overall Study|Other, Not Specified|2|||
46812079|NCT03683576|83031360|FG002|Overall Study|Other, Not Specified|0|||
46812080|NCT03683576|83031361|FG003|Overall Study|Other, Not Specified|0|||
46812081|NCT03683576|83031358|FG000|Overall Study|Protocol Violation|0|||
46812082|NCT03683576|83031359|FG001|Overall Study|Protocol Violation|1|||
46812083|NCT03683576|83031360|FG002|Overall Study|Protocol Violation|1|||
46812084|NCT03683576|83031361|FG003|Overall Study|Protocol Violation|0|||
46812085|NCT03863834|83031371|FG000|Overall Study|Lost to Follow-up|3|||
47054653|NCT00558064|83327976|FG001|Overall Study|Adverse Event|2|||
47054654|NCT00558064|83327975|FG000|Overall Study|Lack of Efficacy|0|||
47054655|NCT00558064|83327976|FG001|Overall Study|Lack of Efficacy|1|||
46754782|NCT02227199|82972564|FG002|Overall Study|Adverse Event|3|||
47054656|NCT00558064|83327975|FG000|Overall Study|Protocol Violation|1|||
46754783|NCT02180867|82972583|FG000|Overall Study|Adverse Event|3|||
46754784|NCT02180867|82972584|FG001|Overall Study|Adverse Event|4|||
46754785|NCT02180867|82972585|FG002|Overall Study|Adverse Event|1|||
46754786|NCT02180867|82972586|FG003|Overall Study|Adverse Event|5|||
46754787|NCT02180867|82972587|FG004|Overall Study|Adverse Event|0|||
46754788|NCT02180867|82972588|FG005|Overall Study|Adverse Event|0|||
46754789|NCT02180867|82972589|FG006|Overall Study|Adverse Event|0|||
46754790|NCT02180867|82972583|FG000|Overall Study|Death|0|||
46754791|NCT02180867|82972584|FG001|Overall Study|Death|0|||
47054657|NCT00558064|83327976|FG001|Overall Study|Protocol Violation|0|||
46754792|NCT02180867|82972585|FG002|Overall Study|Death|0|||
47054658|NCT00558064|83327975|FG000|Overall Study|Lost to Follow-up|0|||
47054659|NCT00558064|83327976|FG001|Overall Study|Lost to Follow-up|1|||
46754793|NCT02180867|82972586|FG003|Overall Study|Death|0|||
46754794|NCT02180867|82972587|FG004|Overall Study|Death|1|||
46754795|NCT02180867|82972588|FG005|Overall Study|Death|0|||
46754796|NCT02180867|82972589|FG006|Overall Study|Death|0|||
46812086|NCT00430521|83031383|FG000|Overall Study|Adverse Event|0|||
47054660|NCT00558064|83327975|FG000|Overall Study|Withdrawal by Subject|0|||
46812087|NCT00430521|83031384|FG001|Overall Study|Adverse Event|0|||
46812088|NCT00430521|83031385|FG002|Overall Study|Adverse Event|0|||
46812089|NCT00430521|83031386|FG003|Overall Study|Adverse Event|0|||
46812090|NCT00430521|83031387|FG004|Overall Study|Adverse Event|0|||
46812091|NCT00430521|83031388|FG005|Overall Study|Adverse Event|2|||
46812092|NCT00430521|83031389|FG006|Overall Study|Adverse Event|1|||
46812093|NCT00430521|83031390|FG007|Overall Study|Adverse Event|0|||
46812094|NCT00430521|83031383|FG000|Overall Study|Lost to Follow-up|7|||
46812095|NCT00430521|83031384|FG001|Overall Study|Lost to Follow-up|8|||
46812096|NCT00430521|83031385|FG002|Overall Study|Lost to Follow-up|3|||
46812097|NCT00430521|83031386|FG003|Overall Study|Lost to Follow-up|5|||
46812098|NCT00430521|83031387|FG004|Overall Study|Lost to Follow-up|5|||
46812099|NCT00430521|83031388|FG005|Overall Study|Lost to Follow-up|2|||
46812100|NCT00430521|83031389|FG006|Overall Study|Lost to Follow-up|8|||
46812101|NCT00430521|83031390|FG007|Overall Study|Lost to Follow-up|10|||
46812102|NCT00430521|83031383|FG000|Overall Study|Pregnancy|0|||
46812103|NCT00430521|83031384|FG001|Overall Study|Pregnancy|0|||
46812104|NCT00430521|83031385|FG002|Overall Study|Pregnancy|0|||
46812105|NCT00430521|83031386|FG003|Overall Study|Pregnancy|0|||
46812106|NCT00430521|83031387|FG004|Overall Study|Pregnancy|0|||
46812107|NCT00430521|83031388|FG005|Overall Study|Pregnancy|0|||
46812108|NCT00430521|83031389|FG006|Overall Study|Pregnancy|1|||
46812109|NCT00430521|83031390|FG007|Overall Study|Pregnancy|0|||
46812110|NCT00430521|83031383|FG000|Overall Study|Vaccine Expired|0|||
46812111|NCT00430521|83031384|FG001|Overall Study|Vaccine Expired|0|||
46812112|NCT00430521|83031385|FG002|Overall Study|Vaccine Expired|0|||
46812113|NCT00430521|83031386|FG003|Overall Study|Vaccine Expired|0|||
46812114|NCT00430521|83031387|FG004|Overall Study|Vaccine Expired|0|||
46812115|NCT00430521|83031388|FG005|Overall Study|Vaccine Expired|1|||
46812116|NCT00430521|83031389|FG006|Overall Study|Vaccine Expired|0|||
46812117|NCT00430521|83031390|FG007|Overall Study|Vaccine Expired|0|||
46812118|NCT00430521|83031383|FG000|Overall Study|Protocol Violation|1|||
46812119|NCT00430521|83031384|FG001|Overall Study|Protocol Violation|0|||
46812120|NCT00430521|83031385|FG002|Overall Study|Protocol Violation|0|||
46812121|NCT00430521|83031386|FG003|Overall Study|Protocol Violation|0|||
46812122|NCT00430521|83031387|FG004|Overall Study|Protocol Violation|0|||
46812123|NCT00430521|83031388|FG005|Overall Study|Protocol Violation|0|||
46812124|NCT00430521|83031389|FG006|Overall Study|Protocol Violation|0|||
46812125|NCT00430521|83031390|FG007|Overall Study|Protocol Violation|0|||
46812126|NCT00430521|83031383|FG000|Overall Study|Withdrawal by Subject|3|||
46812127|NCT00430521|83031384|FG001|Overall Study|Withdrawal by Subject|1|||
46812128|NCT00430521|83031385|FG002|Overall Study|Withdrawal by Subject|0|||
46754797|NCT02180867|82972583|FG000|Overall Study|Lack of Efficacy|0|||
46754798|NCT02180867|82972584|FG001|Overall Study|Lack of Efficacy|2|||
46754799|NCT02180867|82972585|FG002|Overall Study|Lack of Efficacy|0|||
46754800|NCT02180867|82972586|FG003|Overall Study|Lack of Efficacy|1|||
46754801|NCT02180867|82972587|FG004|Overall Study|Lack of Efficacy|6|||
46754802|NCT02180867|82972588|FG005|Overall Study|Lack of Efficacy|0|||
46754803|NCT02180867|82972589|FG006|Overall Study|Lack of Efficacy|1|||
46754804|NCT02180867|82972583|FG000|Overall Study|Physician Decision|1|||
46754805|NCT02180867|82972584|FG001|Overall Study|Physician Decision|3|||
46754806|NCT02180867|82972585|FG002|Overall Study|Physician Decision|1|||
46754807|NCT02180867|82972586|FG003|Overall Study|Physician Decision|10|||
46754808|NCT02180867|82972587|FG004|Overall Study|Physician Decision|9|||
46754809|NCT02180867|82972588|FG005|Overall Study|Physician Decision|3|||
46754810|NCT02180867|82972589|FG006|Overall Study|Physician Decision|4|||
46754811|NCT02180867|82972583|FG000|Overall Study|Withdrawal by Subject|0|||
46754812|NCT02180867|82972584|FG001|Overall Study|Withdrawal by Subject|0|||
46754813|NCT02180867|82972585|FG002|Overall Study|Withdrawal by Subject|0|||
46754814|NCT02180867|82972586|FG003|Overall Study|Withdrawal by Subject|1|||
46754815|NCT02180867|82972587|FG004|Overall Study|Withdrawal by Subject|1|||
46754816|NCT02180867|82972588|FG005|Overall Study|Withdrawal by Subject|0|||
46812129|NCT00430521|83031386|FG003|Overall Study|Withdrawal by Subject|3|||
46812130|NCT00430521|83031387|FG004|Overall Study|Withdrawal by Subject|0|||
47054661|NCT00558064|83327976|FG001|Overall Study|Withdrawal by Subject|1|||
47054662|NCT00558064|83327975|FG000|Overall Study|No visit within allowance period|1|||
46754817|NCT02180867|82972589|FG006|Overall Study|Withdrawal by Subject|0|||
46754818|NCT02180867|82972583|FG000|Overall Study|Ineligible|1|||
46754819|NCT02180867|82972584|FG001|Overall Study|Ineligible|2|||
46754820|NCT02180867|82972585|FG002|Overall Study|Ineligible|0|||
46754821|NCT02180867|82972586|FG003|Overall Study|Ineligible|3|||
46754822|NCT02180867|82972587|FG004|Overall Study|Ineligible|5|||
46812131|NCT00430521|83031388|FG005|Overall Study|Withdrawal by Subject|0|||
46812132|NCT00430521|83031389|FG006|Overall Study|Withdrawal by Subject|0|||
46812133|NCT00430521|83031390|FG007|Overall Study|Withdrawal by Subject|2|||
46812134|NCT00429663|83031423|FG000|Overall Study|Lost to Follow-up|24|||
46812135|NCT00429663|83031424|FG001|Overall Study|Lost to Follow-up|31|||
46812136|NCT00429663|83031423|FG000|Overall Study|Physician Decision|6|||
46812137|NCT00429663|83031424|FG001|Overall Study|Physician Decision|3|||
46812138|NCT00429663|83031423|FG000|Overall Study|Withdrawal by Subject|2|||
46812139|NCT00429663|83031424|FG001|Overall Study|Withdrawal by Subject|5|||
46812140|NCT00429663|83031423|FG000|Overall Study|Death|4|||
46812141|NCT00429663|83031424|FG001|Overall Study|Death|0|||
46812142|NCT00429585|83031432|FG000|Overall Study|Death|1|||
46812143|NCT00429585|83031433|FG001|Overall Study|Death|0|||
46812144|NCT00429585|83031432|FG000|Overall Study|Lost to Follow-up|27|||
46812145|NCT00429585|83031433|FG001|Overall Study|Lost to Follow-up|20|||
46812146|NCT00429585|83031432|FG000|Overall Study|Physician Decision|2|||
46812147|NCT00429585|83031433|FG001|Overall Study|Physician Decision|0|||
46812148|NCT05822921|83031441|FG000|Overall Study|Lost to Follow-up|1|||
46812149|NCT05822921|83031442|FG001|Overall Study|Lost to Follow-up|1|||
46812150|NCT05094154|83031454|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
46812151|NCT05094154|83031455|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
46812152|NCT05094154|83031454|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
46812153|NCT05094154|83031455|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
46812154|NCT04530448|83031484|FG000|Overall Study|Physician Decision|3|||
46812155|NCT04530448|83031485|FG001|Overall Study|Physician Decision|0|||
46812156|NCT04476030|83031493|FG000|Overall Study|Withdrawal by Subject|20|||
46812157|NCT04476030|83031494|FG001|Overall Study|Withdrawal by Subject|16|||
46812158|NCT04476030|83031493|FG000|Overall Study|Adverse Event|10|||
46812159|NCT04476030|83031494|FG001|Overall Study|Adverse Event|11|||
46812160|NCT04476030|83031493|FG000|Overall Study|Lost to Follow-up|7|||
46812161|NCT04476030|83031494|FG001|Overall Study|Lost to Follow-up|4|||
46812162|NCT04476030|83031493|FG000|Overall Study|Physician Decision|1|||
46812163|NCT04476030|83031494|FG001|Overall Study|Physician Decision|1|||
46812164|NCT04476030|83031493|FG000|Overall Study|Protocol Deviation|2|||
46812165|NCT04476030|83031494|FG001|Overall Study|Protocol Deviation|0|||
46812166|NCT04476030|83031493|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
46812167|NCT04476030|83031494|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
46812168|NCT04476030|83031493|FG000|Overall Study|Randomized but not Dosed|2|||
46812169|NCT04476030|83031494|FG001|Overall Study|Randomized but not Dosed|8|||
46812170|NCT04382612|83031515|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
46812171|NCT04158687|83031527|FG000|Overall Study|Adverse Event|2|||
46812172|NCT04158687|83031528|FG001|Overall Study|Adverse Event|3|||
46812173|NCT04158687|83031529|FG002|Overall Study|Adverse Event|0|||
46812174|NCT04158687|83031530|FG003|Overall Study|Adverse Event|3|||
46812175|NCT04158687|83031527|FG000|Overall Study|Lost to Follow-up|5|||
46812176|NCT04158687|83031528|FG001|Overall Study|Lost to Follow-up|12|||
46812177|NCT04158687|83031529|FG002|Overall Study|Lost to Follow-up|4|||
46812178|NCT04158687|83031530|FG003|Overall Study|Lost to Follow-up|5|||
46754823|NCT02180867|82972588|FG005|Overall Study|Ineligible|0|||
46754824|NCT02180867|82972589|FG006|Overall Study|Ineligible|0|||
46754825|NCT02180867|82972583|FG000|Overall Study|Repeat Eligibility Studies|0|||
46754826|NCT02180867|82972584|FG001|Overall Study|Repeat Eligibility Studies|0|||
46754827|NCT02180867|82972585|FG002|Overall Study|Repeat Eligibility Studies|0|||
46754828|NCT02180867|82972586|FG003|Overall Study|Repeat Eligibility Studies|0|||
46812179|NCT04158687|83031527|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
46812180|NCT04158687|83031528|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
46812181|NCT04158687|83031529|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
46812182|NCT04158687|83031530|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
46812183|NCT04158687|83031527|FG000|Overall Study|Non-Compliance with Study Medication|2|||
46812184|NCT04158687|83031528|FG001|Overall Study|Non-Compliance with Study Medication|2|||
47054663|NCT00558064|83327976|FG001|Overall Study|No visit within allowance period|0|||
47054664|NCT00557830|83327985|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
47054665|NCT00557830|83327986|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
47054666|NCT00557830|83327987|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
47054667|NCT00557830|83327985|FG000|Screening Treatment Phase|Adverse Event|2|||
46754829|NCT02180867|82972587|FG004|Overall Study|Repeat Eligibility Studies|1|||
46754830|NCT02180867|82972588|FG005|Overall Study|Repeat Eligibility Studies|0|||
46754831|NCT02180867|82972589|FG006|Overall Study|Repeat Eligibility Studies|0|||
46754832|NCT02180867|82972583|FG000|Overall Study|Refusal of further protocol therapy|1|||
46812185|NCT04158687|83031529|FG002|Overall Study|Non-Compliance with Study Medication|3|||
46812186|NCT04158687|83031530|FG003|Overall Study|Non-Compliance with Study Medication|0|||
46812187|NCT04158687|83031527|FG000|Overall Study|Investigator Decision|0|||
46812188|NCT04158687|83031528|FG001|Overall Study|Investigator Decision|0|||
46812189|NCT04158687|83031529|FG002|Overall Study|Investigator Decision|2|||
46812190|NCT04158687|83031530|FG003|Overall Study|Investigator Decision|0|||
46812191|NCT04158687|83031527|FG000|Overall Study|Protocol Violation|0|||
46754833|NCT02180867|82972584|FG001|Overall Study|Refusal of further protocol therapy|0|||
46754834|NCT02180867|82972585|FG002|Overall Study|Refusal of further protocol therapy|2|||
46812192|NCT04158687|83031528|FG001|Overall Study|Protocol Violation|2|||
46812193|NCT04158687|83031529|FG002|Overall Study|Protocol Violation|1|||
47054668|NCT00557830|83327986|FG001|Screening Treatment Phase|Adverse Event|0|||
46754835|NCT02180867|82972586|FG003|Overall Study|Refusal of further protocol therapy|6|||
46812194|NCT04158687|83031530|FG003|Overall Study|Protocol Violation|0|||
46812195|NCT04158687|83031527|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
46812196|NCT04158687|83031528|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
46812197|NCT04158687|83031529|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
46812198|NCT04158687|83031530|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
46812199|NCT04158687|83031527|FG000|Overall Study|Reason not Specified|3|||
46812200|NCT04158687|83031528|FG001|Overall Study|Reason not Specified|2|||
46812201|NCT04158687|83031529|FG002|Overall Study|Reason not Specified|4|||
46812202|NCT04158687|83031530|FG003|Overall Study|Reason not Specified|4|||
46754836|NCT02180867|82972587|FG004|Overall Study|Refusal of further protocol therapy|4|||
46754837|NCT02180867|82972588|FG005|Overall Study|Refusal of further protocol therapy|0|||
46754838|NCT02180867|82972589|FG006|Overall Study|Refusal of further protocol therapy|0|||
46754839|NCT02143414|82972619|FG000|Induction|Adverse Event|1|||
46754840|NCT02143414|82972620|FG001|Induction|Adverse Event|2|||
46754841|NCT02143414|82972619|FG000|Induction|Death|1|||
46754842|NCT02143414|82972620|FG001|Induction|Death|2|||
46754843|NCT02143414|82972619|FG000|Induction|Patient refusal|1|||
46754844|NCT02143414|82972620|FG001|Induction|Patient refusal|1|||
46754845|NCT02143414|82972619|FG000|Induction|Refractory|1|||
46754846|NCT02143414|82972620|FG001|Induction|Refractory|0|||
46754847|NCT02143414|82972619|FG000|Induction|Began alternative treatment|1|||
46812203|NCT04090749|83031543|FG000|Open Label Pilot|Lost to Follow-up|1|||
46812204|NCT04090749|83031544|FG001|Open Label Pilot|Lost to Follow-up|0|||
46812205|NCT04090749|83031545|FG002|Open Label Pilot|Lost to Follow-up|0|||
46812206|NCT04090749|83031543|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
46927895|NCT04321343|83162689|FG003|Overall Study|Pregnancy|0|||
46927896|NCT04321343|83162686|FG000|Overall Study|Protocol Violation|1|||
46927897|NCT04321343|83162687|FG001|Overall Study|Protocol Violation|1|||
46927898|NCT04321343|83162688|FG002|Overall Study|Protocol Violation|1|||
46812207|NCT04090749|83031544|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
46812208|NCT04090749|83031545|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
46812209|NCT04090749|83031543|FG000|Pilot Trial|Lost to Follow-up|0|||
46812210|NCT04090749|83031544|FG001|Pilot Trial|Lost to Follow-up|1|||
46812211|NCT04090749|83031545|FG002|Pilot Trial|Lost to Follow-up|1|||
46812212|NCT04076059|83031555|FG000|Double Blind Phase|Progressive disease|22|||
46812213|NCT04076059|83031556|FG001|Double Blind Phase|Progressive disease|26|||
46812214|NCT04076059|83031557|FG002|Double Blind Phase|Progressive disease|0|||
46812215|NCT04076059|83031555|FG000|Double Blind Phase|Withdrawal by Subject|4|||
46812216|NCT04076059|83031556|FG001|Double Blind Phase|Withdrawal by Subject|11|||
46812217|NCT04076059|83031557|FG002|Double Blind Phase|Withdrawal by Subject|0|||
46812218|NCT04076059|83031555|FG000|Double Blind Phase|Death|1|||
46812219|NCT04076059|83031556|FG001|Double Blind Phase|Death|1|||
46812220|NCT04076059|83031557|FG002|Double Blind Phase|Death|0|||
46812221|NCT04076059|83031555|FG000|Double Blind Phase|Lost to Follow-up|1|||
46812222|NCT04076059|83031556|FG001|Double Blind Phase|Lost to Follow-up|0|||
46812223|NCT04076059|83031557|FG002|Double Blind Phase|Lost to Follow-up|0|||
46812224|NCT04076059|83031555|FG000|Double Blind Phase|Adverse Event|5|||
46812225|NCT04076059|83031556|FG001|Double Blind Phase|Adverse Event|1|||
46812226|NCT04076059|83031557|FG002|Double Blind Phase|Adverse Event|0|||
46812227|NCT04076059|83031555|FG000|Double Blind Phase|Ongoing Participants|82|||
46812228|NCT04076059|83031556|FG001|Double Blind Phase|Ongoing Participants|18|||
46812229|NCT04076059|83031557|FG002|Double Blind Phase|Ongoing Participants|0|||
46812230|NCT04076059|83031555|FG000|Double Blind Phase|Miscellaneous|3|||
46812231|NCT04076059|83031556|FG001|Double Blind Phase|Miscellaneous|1|||
46812232|NCT04076059|83031557|FG002|Double Blind Phase|Miscellaneous|0|||
46812233|NCT04076059|83031555|FG000|Double Blind Phase|Protocol Deviation|1|||
46812234|NCT04076059|83031556|FG001|Double Blind Phase|Protocol Deviation|1|||
46812235|NCT04076059|83031557|FG002|Double Blind Phase|Protocol Deviation|0|||
46812236|NCT04076059|83031555|FG000|Double Blind Phase|Did not take study drug|1|||
46812237|NCT04076059|83031556|FG001|Double Blind Phase|Did not take study drug|1|||
46927899|NCT04321343|83162689|FG003|Overall Study|Protocol Violation|1|||
46927900|NCT04321343|83162686|FG000|Overall Study|Withdrawal by Subject|0|||
46927901|NCT04321343|83162687|FG001|Overall Study|Withdrawal by Subject|6|||
46927902|NCT04321343|83162688|FG002|Overall Study|Withdrawal by Subject|0|||
46927903|NCT04321343|83162689|FG003|Overall Study|Withdrawal by Subject|2|||
46812238|NCT04076059|83031557|FG002|Double Blind Phase|Did not take study drug|0|||
46812239|NCT04076059|83031555|FG000|Open Label Phase|Progressive disease|0|||
46812240|NCT04076059|83031556|FG001|Open Label Phase|Progressive disease|0|||
46812241|NCT04076059|83031557|FG002|Open Label Phase|Progressive disease|7|||
46812242|NCT04076059|83031555|FG000|Open Label Phase|Withdrawal by Subject|0|||
46927904|NCT04321343|83162686|FG000|Overall Study|Lost to Follow-up|2|||
46754848|NCT02143414|82972620|FG001|Induction|Began alternative treatment|0|||
46812243|NCT04076059|83031556|FG001|Open Label Phase|Withdrawal by Subject|0|||
46812244|NCT04076059|83031557|FG002|Open Label Phase|Withdrawal by Subject|3|||
46812245|NCT04076059|83031555|FG000|Open Label Phase|Death|0|||
46812246|NCT04076059|83031556|FG001|Open Label Phase|Death|0|||
46927905|NCT04321343|83162687|FG001|Overall Study|Lost to Follow-up|2|||
46927906|NCT04321343|83162688|FG002|Overall Study|Lost to Follow-up|1|||
46927907|NCT04321343|83162689|FG003|Overall Study|Lost to Follow-up|3|||
46812247|NCT04076059|83031557|FG002|Open Label Phase|Death|2|||
46812248|NCT04076059|83031555|FG000|Open Label Phase|Ongoing Participants|0|||
46812249|NCT04076059|83031556|FG001|Open Label Phase|Ongoing Participants|0|||
46812250|NCT04076059|83031557|FG002|Open Label Phase|Ongoing Participants|11|||
46812251|NCT04047420|83031564|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
46812252|NCT04047420|83031564|FG000|Washout Period|Refused Participation|2|||
46812253|NCT03958045|83031571|FG000|Overall Study|Withdrawal by Subject|1|||
46812254|NCT03806179|83031577|FG000|Overall Study|Progressive disease|0|||
46812255|NCT03806179|83031578|FG001|Overall Study|Progressive disease|2|||
46812256|NCT03759587|83031584|FG000|Overall Study|Adverse Event|5|||
46812257|NCT03759587|83031584|FG000|Overall Study|Progressive Disease|10|||
46812258|NCT03759587|83031584|FG000|Overall Study|Site Terminated by Sponsor|3|||
46812259|NCT03759587|83031584|FG000|Overall Study|Withdrawal by Subject|1|||
46812260|NCT03730194|83031603|FG000|First Stage Treatment|Withdrawal by Subject|1|||
46812261|NCT03730194|83031604|FG001|First Stage Treatment|Withdrawal by Subject|1|||
46927908|NCT04238754|83162703|FG000|Washout - 1 Week|Lost to Follow-up|1|||
46927909|NCT04238754|83162704|FG001|Washout - 1 Week|Lost to Follow-up|0|||
46927910|NCT04150068|83162726|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
46927911|NCT04150068|83162727|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
46927912|NCT04150068|83162728|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
46927913|NCT04150068|83162726|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
46927914|NCT04150068|83162727|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
46927915|NCT04150068|83162728|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
46927916|NCT03920293|83162737|FG000|Overall Study|Withdrawal by Subject|2|||
46927917|NCT03920293|83162738|FG001|Overall Study|Withdrawal by Subject|1|||
46927918|NCT03920293|83162737|FG000|Overall Study|Physician Decision|1|||
46927919|NCT03920293|83162738|FG001|Overall Study|Physician Decision|2|||
46927920|NCT03920293|83162737|FG000|Overall Study|Adverse Event|0|||
46927921|NCT03920293|83162738|FG001|Overall Study|Adverse Event|2|||
46927922|NCT03920293|83162737|FG000|Overall Study|Sponsor Decision|0|||
46927923|NCT03920293|83162738|FG001|Overall Study|Sponsor Decision|1|||
46927924|NCT03920293|83162737|FG000|Overall Study|Death|2|||
46927925|NCT03920293|83162738|FG001|Overall Study|Death|0|||
46927926|NCT03920293|83162737|FG000|Overall Study|Protocol Violation|1|||
46927927|NCT03920293|83162738|FG001|Overall Study|Protocol Violation|0|||
46927928|NCT03920293|83162737|FG000|Overall Study|Noncompliance|1|||
47054669|NCT00557830|83327987|FG002|Screening Treatment Phase|Adverse Event|0|||
47054670|NCT00557830|83327985|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
47054671|NCT00557830|83327986|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
47054672|NCT00557830|83327987|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
47054673|NCT00557440|83327998|FG000|Treatment Period 1|Adverse Event|0|||
47054674|NCT00557440|83327999|FG001|Treatment Period 1|Adverse Event|0|||
47054675|NCT00557440|83328000|FG002|Treatment Period 1|Adverse Event|1|||
47054676|NCT00556894|83328011|FG000|Overall Study|Adverse Event|2|||
47054677|NCT00556894|83328012|FG001|Overall Study|Adverse Event|3|||
47054678|NCT00556894|83328013|FG002|Overall Study|Adverse Event|3|||
47054679|NCT00556894|83328011|FG000|Overall Study|Death|1|||
47054680|NCT00556894|83328012|FG001|Overall Study|Death|0|||
47054681|NCT00556894|83328013|FG002|Overall Study|Death|0|||
46754849|NCT02143414|82972619|FG000|Induction|Ineligible for postremission|5|||
46754850|NCT02143414|82972620|FG001|Induction|Ineligible for postremission|1|||
46754851|NCT02143414|82972619|FG000|Post-remission|Adverse Event|0|||
46754852|NCT02143414|82972620|FG001|Post-remission|Adverse Event|2|||
46754853|NCT02143414|82972619|FG000|Post-remission|Disease progression/relapse|5|||
46754854|NCT02143414|82972620|FG001|Post-remission|Disease progression/relapse|0|||
46754855|NCT02143414|82972619|FG000|Maintenance|Adverse Event|4|||
46754856|NCT02143414|82972620|FG001|Maintenance|Adverse Event|6|||
46754857|NCT02143414|82972619|FG000|Maintenance|Disease progression/relapse|3|||
46754858|NCT02143414|82972620|FG001|Maintenance|Disease progression/relapse|2|||
46927929|NCT03920293|83162738|FG001|Overall Study|Noncompliance|0|||
47054682|NCT00556894|83328011|FG000|Overall Study|regulatory decision in Bulgaria|10|||
46754859|NCT02143414|82972619|FG000|Maintenance|Patient refusal|2|||
46754860|NCT02143414|82972620|FG001|Maintenance|Patient refusal|1|||
46812262|NCT03730194|83031605|FG002|First Stage Treatment|Withdrawal by Subject|0|||
46812263|NCT03730194|83031606|FG003|First Stage Treatment|Withdrawal by Subject|0|||
46812264|NCT03730194|83031607|FG004|First Stage Treatment|Withdrawal by Subject|0|||
46812265|NCT03730194|83031608|FG005|First Stage Treatment|Withdrawal by Subject|0|||
46927930|NCT03317496|83162761|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
46927931|NCT03317496|83162762|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
47054683|NCT00556894|83328012|FG001|Overall Study|regulatory decision in Bulgaria|14|||
46754861|NCT02143414|82972619|FG000|Maintenance|Physician Decision|1|||
47054684|NCT00556894|83328013|FG002|Overall Study|regulatory decision in Bulgaria|13|||
47054685|NCT00556894|83328011|FG000|Overall Study|Change in therapy|2|||
46754862|NCT02143414|82972620|FG001|Maintenance|Physician Decision|0|||
46812266|NCT03730194|83031603|FG000|First Stage Treatment|Protocol Violation|3|||
46927932|NCT03317496|83162763|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
46927933|NCT03317496|83162764|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
46927934|NCT03317496|83162765|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
46927935|NCT03317496|83162761|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
46812267|NCT03730194|83031604|FG001|First Stage Treatment|Protocol Violation|3|||
46812268|NCT03730194|83031605|FG002|First Stage Treatment|Protocol Violation|0|||
46812269|NCT03730194|83031606|FG003|First Stage Treatment|Protocol Violation|0|||
46812270|NCT03730194|83031607|FG004|First Stage Treatment|Protocol Violation|0|||
46812271|NCT03730194|83031608|FG005|First Stage Treatment|Protocol Violation|0|||
46812272|NCT03559400|83031617|FG000|Overall Study|Lost to Follow-up|9|||
46812273|NCT03559400|83031618|FG001|Overall Study|Lost to Follow-up|7|||
47054686|NCT00556894|83328012|FG001|Overall Study|Change in therapy|1|||
47054687|NCT00556894|83328013|FG002|Overall Study|Change in therapy|2|||
46812274|NCT03559400|83031617|FG000|Overall Study|Death|0|||
47054688|NCT00556894|83328011|FG000|Overall Study|Withdrawal by Subject|1|||
47054689|NCT00556894|83328012|FG001|Overall Study|Withdrawal by Subject|1|||
46754863|NCT02143414|82972619|FG000|Maintenance|Death|0|||
46754864|NCT02143414|82972620|FG001|Maintenance|Death|1|||
46812275|NCT03559400|83031618|FG001|Overall Study|Death|2|||
46812276|NCT03483012|83031625|FG000|Overall Study|Lack of Efficacy|6|||
46812277|NCT03231709|83031635|FG000|Treatment Period 1|Reason not Specified|0|||
46812278|NCT03231709|83031636|FG001|Treatment Period 1|Reason not Specified|1|||
46812279|NCT03231709|83031635|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
46812280|NCT03231709|83031636|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
46812281|NCT03014479|83031648|FG000|Overall Study|Adverse Event|0|||
46812282|NCT03014479|83031649|FG001|Overall Study|Adverse Event|1|||
46812283|NCT03014479|83031648|FG000|Overall Study|Voluntary Withdrawal|0|||
46812284|NCT03014479|83031649|FG001|Overall Study|Voluntary Withdrawal|2|||
46927936|NCT03317496|83162762|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
46754865|NCT02143414|82972619|FG000|Maintenance|On protocol treatment|0|||
46812285|NCT03014479|83031648|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
46812286|NCT03014479|83031649|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
46812287|NCT02937818|83031659|FG000|Overall Study|Participants decision|1|||
46812288|NCT02937818|83031660|FG001|Overall Study|Participants decision|0|||
46812289|NCT02937818|83031661|FG002|Overall Study|Participants decision|1|||
46812290|NCT02937818|83031662|FG003|Overall Study|Participants decision|1|||
46812291|NCT02937818|83031659|FG000|Overall Study|Adverse Event|2|||
46812292|NCT02937818|83031660|FG001|Overall Study|Adverse Event|4|||
46812293|NCT02937818|83031661|FG002|Overall Study|Adverse Event|1|||
46812294|NCT02937818|83031662|FG003|Overall Study|Adverse Event|1|||
46812295|NCT02937818|83031659|FG000|Overall Study|Disease progression|17|||
46927937|NCT03317496|83162763|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
46927938|NCT03317496|83162764|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
47054690|NCT00556894|83328013|FG002|Overall Study|Withdrawal by Subject|1|||
46754866|NCT02143414|82972620|FG001|Maintenance|On protocol treatment|6|||
46754867|NCT01856192|82972639|FG000|Overall Study|Adverse Event|12|||
46754868|NCT01856192|82972640|FG001|Overall Study|Adverse Event|4|||
46754869|NCT01856192|82972639|FG000|Overall Study|Alternative therapy|0|||
46754870|NCT01856192|82972640|FG001|Overall Study|Alternative therapy|3|||
46754871|NCT01856192|82972639|FG000|Overall Study|Death|3|||
46754872|NCT01856192|82972640|FG001|Overall Study|Death|5|||
46754873|NCT01856192|82972639|FG000|Overall Study|Lack of Efficacy|0|||
46754874|NCT01856192|82972640|FG001|Overall Study|Lack of Efficacy|5|||
46754875|NCT01856192|82972639|FG000|Overall Study|Withdrawal by Subject|1|||
46754876|NCT01856192|82972640|FG001|Overall Study|Withdrawal by Subject|1|||
46754877|NCT01856192|82972639|FG000|Overall Study|Other diseases|1|||
46754878|NCT01856192|82972640|FG001|Overall Study|Other diseases|0|||
46754879|NCT01856192|82972639|FG000|Overall Study|Never started treatment|7|||
46754880|NCT01856192|82972640|FG001|Overall Study|Never started treatment|5|||
46754881|NCT01856192|82972639|FG000|Overall Study|Path ineligible|20|||
46754882|NCT01856192|82972640|FG001|Overall Study|Path ineligible|34|||
47054691|NCT02722044|83328021|FG000|Overall Study|Adverse Event|2|||
47054692|NCT02722044|83328021|FG000|Overall Study|Physician Decision|1|||
46754883|NCT01856192|82972639|FG000|Overall Study|Non-path ineligible|2|||
46754884|NCT01856192|82972640|FG001|Overall Study|Non-path ineligible|2|||
46754885|NCT01856192|82972639|FG000|Overall Study|Physician Decision|1|||
46812296|NCT02937818|83031660|FG001|Overall Study|Disease progression|14|||
46812297|NCT02937818|83031661|FG002|Overall Study|Disease progression|7|||
46812298|NCT02937818|83031662|FG003|Overall Study|Disease progression|18|||
46812299|NCT02937818|83031659|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
46927939|NCT03317496|83162765|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
46927940|NCT03317496|83162761|FG000|Phase 1b Lead-in: Treatment|Death|0|||
47054693|NCT02722044|83328021|FG000|Overall Study|Withdrawal by Subject|1|||
46754886|NCT01856192|82972640|FG001|Overall Study|Physician Decision|1|||
46812300|NCT02937818|83031660|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
46754887|NCT01856192|82972639|FG000|Overall Study|Suspicion of progressive disease|1|||
46636458|NCT01514136|82810257|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
46636459|NCT01514136|82810258|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
46636460|NCT01514136|82810251|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
46636461|NCT01514136|82810252|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
46754888|NCT01856192|82972640|FG001|Overall Study|Suspicion of progressive disease|0|||
46754889|NCT01856192|82972639|FG000|Overall Study|Non-compliance|1|||
47054694|NCT02722044|83328021|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
47054695|NCT00556426|83328026|FG000|Overall Study|Withdrawal by Subject|3|||
47054696|NCT00556426|83328026|FG000|Overall Study|Death|6|||
47054697|NCT00555568|83328034|FG000|Overall Study|Lost to Follow-up|26|||
47054698|NCT00555568|83328035|FG001|Overall Study|Lost to Follow-up|16|||
47054699|NCT00555568|83328036|FG002|Overall Study|Lost to Follow-up|16|||
47054700|NCT00702702|83328047|FG000|Overall Study|Study prematurely terminated|56|||
47054701|NCT02721966|83328058|FG000|Overall Study|Protocol Violation|1|||
46754890|NCT01856192|82972640|FG001|Overall Study|Non-compliance|0|||
46754891|NCT01812252|82972658|FG000|Overall Study|Persistent Disease|1|||
46812301|NCT02937818|83031661|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
46812302|NCT02937818|83031662|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
46812303|NCT02937818|83031659|FG000|Overall Study|Condition under investigation worsened|0|||
46812304|NCT02937818|83031660|FG001|Overall Study|Condition under investigation worsened|0|||
46812305|NCT02937818|83031661|FG002|Overall Study|Condition under investigation worsened|1|||
46812306|NCT02937818|83031662|FG003|Overall Study|Condition under investigation worsened|0|||
46927941|NCT03317496|83162762|FG001|Phase 1b Lead-in: Treatment|Death|0|||
46927942|NCT03317496|83162763|FG002|Phase 1b Lead-in: Treatment|Death|1|||
46927943|NCT03317496|83162764|FG003|Phase 1b Lead-in: Treatment|Death|0|||
46927944|NCT03317496|83162765|FG004|Phase 1b Lead-in: Treatment|Death|0|||
46927945|NCT03317496|83162761|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
46927946|NCT03317496|83162762|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
46754892|NCT01812252|82972659|FG001|Overall Study|Persistent Disease|0|||
46754893|NCT01812252|82972658|FG000|Overall Study|Not transplanted|11|||
46812307|NCT02937818|83031659|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
46812308|NCT02937818|83031660|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
46812309|NCT02937818|83031661|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
46812310|NCT02937818|83031662|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
46812311|NCT02864394|83031686|FG000|Overall Study|Death|184|||
46812312|NCT02864394|83031687|FG001|Overall Study|Death|189|||
46812313|NCT02864394|83031686|FG000|Overall Study|Lost to Follow-up|0|||
46812314|NCT02864394|83031687|FG001|Overall Study|Lost to Follow-up|2|||
46812315|NCT02864394|83031686|FG000|Overall Study|Sponsor Decision|26|||
46812316|NCT02864394|83031687|FG001|Overall Study|Sponsor Decision|11|||
46812317|NCT02864394|83031686|FG000|Overall Study|Withdrawal by Subject|3|||
46812318|NCT02864394|83031687|FG001|Overall Study|Withdrawal by Subject|10|||
46812319|NCT02773849|83031700|FG000|Overall Study|Adverse Event|3|||
46812320|NCT02773849|83031700|FG000|Overall Study|Lack of Efficacy|89|||
46812321|NCT02773849|83031700|FG000|Overall Study|Withdrawal by Subject|1|||
46812322|NCT02773849|83031700|FG000|Overall Study|Withdrawal of Consent|1|||
46754894|NCT01812252|82972659|FG001|Overall Study|Not transplanted|11|||
46754895|NCT01812252|82972658|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
46754896|NCT01812252|82972659|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
46754897|NCT01812252|82972658|FG000|Overall Study|Withdrawal by Subject|1|||
46754898|NCT01812252|82972659|FG001|Overall Study|Withdrawal by Subject|1|||
46754899|NCT01812252|82972658|FG000|Overall Study|Screen Failure|1|||
46754900|NCT01812252|82972659|FG001|Overall Study|Screen Failure|0|||
46754901|NCT01708954|82972670|FG000|Step 1|Disease progression|26|||
46754902|NCT01708954|82972671|FG001|Step 1|Disease progression|17|||
46754903|NCT01708954|82972672|FG002|Step 1|Disease progression|14|||
46754904|NCT01708954|82972670|FG000|Step 1|Adverse Event|3|||
46754905|NCT01708954|82972671|FG001|Step 1|Adverse Event|11|||
46754906|NCT01708954|82972672|FG002|Step 1|Adverse Event|13|||
47054702|NCT02721966|83328059|FG001|Overall Study|Protocol Violation|0|||
47054703|NCT02721966|83328060|FG002|Overall Study|Protocol Violation|0|||
46927947|NCT03317496|83162763|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
47054704|NCT02721966|83328061|FG003|Overall Study|Protocol Violation|0|||
47054705|NCT02721966|83328062|FG004|Overall Study|Protocol Violation|0|||
46636462|NCT01514136|82810253|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
46754907|NCT01708954|82972670|FG000|Step 1|Death|3|||
47054706|NCT02721966|83328058|FG000|Overall Study|Withdrawal by Subject|9|||
47054707|NCT02721966|83328059|FG001|Overall Study|Withdrawal by Subject|2|||
47054708|NCT02721966|83328060|FG002|Overall Study|Withdrawal by Subject|3|||
46927948|NCT03317496|83162764|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
46927949|NCT03317496|83162765|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
47054709|NCT02721966|83328061|FG003|Overall Study|Withdrawal by Subject|7|||
46754908|NCT01708954|82972671|FG001|Step 1|Death|2|||
46754909|NCT01708954|82972672|FG002|Step 1|Death|3|||
47054710|NCT02721966|83328062|FG004|Overall Study|Withdrawal by Subject|0|||
47054711|NCT02721966|83328058|FG000|Overall Study|Adverse Event|4|||
47054712|NCT02721966|83328059|FG001|Overall Study|Adverse Event|4|||
47054713|NCT02721966|83328060|FG002|Overall Study|Adverse Event|3|||
47054714|NCT02721966|83328061|FG003|Overall Study|Adverse Event|0|||
47054715|NCT02721966|83328062|FG004|Overall Study|Adverse Event|0|||
47054716|NCT02721966|83328058|FG000|Overall Study|Death|1|||
46812335|NCT02162810|83031752|FG000|Overall Study|Protocol Violation|1|||
46812336|NCT02162810|83031753|FG001|Overall Study|Protocol Violation|0|||
46812337|NCT02162810|83031752|FG000|Overall Study|patients did not report compliance|4|||
46812338|NCT02162810|83031753|FG001|Overall Study|patients did not report compliance|1|||
46812339|NCT01709435|83031765|FG000|Overall Study|Adverse Event|1|||
46812340|NCT01709435|83031766|FG001|Overall Study|Adverse Event|1|||
46812341|NCT01709435|83031767|FG002|Overall Study|Adverse Event|1|||
46812342|NCT01709435|83031768|FG003|Overall Study|Adverse Event|0|||
46812343|NCT01709435|83031769|FG004|Overall Study|Adverse Event|0|||
46812344|NCT01709435|83031770|FG005|Overall Study|Adverse Event|1|||
46812345|NCT01709435|83031765|FG000|Overall Study|Lack of Efficacy|5|||
46812346|NCT01709435|83031766|FG001|Overall Study|Lack of Efficacy|7|||
46812347|NCT01709435|83031767|FG002|Overall Study|Lack of Efficacy|2|||
46812348|NCT01709435|83031768|FG003|Overall Study|Lack of Efficacy|2|||
46812349|NCT01709435|83031769|FG004|Overall Study|Lack of Efficacy|6|||
46812350|NCT01709435|83031770|FG005|Overall Study|Lack of Efficacy|3|||
46812351|NCT01709435|83031765|FG000|Overall Study|Physician Decision|0|||
46812352|NCT01709435|83031766|FG001|Overall Study|Physician Decision|1|||
46812353|NCT01709435|83031767|FG002|Overall Study|Physician Decision|0|||
46812354|NCT01709435|83031768|FG003|Overall Study|Physician Decision|1|||
46812355|NCT01709435|83031769|FG004|Overall Study|Physician Decision|2|||
46812356|NCT01709435|83031770|FG005|Overall Study|Physician Decision|0|||
46812357|NCT01709435|83031765|FG000|Overall Study|Withdrawal by Subject|0|||
46812358|NCT01709435|83031766|FG001|Overall Study|Withdrawal by Subject|0|||
46812359|NCT01709435|83031767|FG002|Overall Study|Withdrawal by Subject|3|||
46812360|NCT01709435|83031768|FG003|Overall Study|Withdrawal by Subject|0|||
46812361|NCT01709435|83031769|FG004|Overall Study|Withdrawal by Subject|2|||
46812362|NCT01709435|83031770|FG005|Overall Study|Withdrawal by Subject|2|||
46812363|NCT01358877|83031788|FG000|Overall Study|Death|80|||
46812364|NCT01358877|83031789|FG001|Overall Study|Death|89|||
46812365|NCT01358877|83031788|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
46812366|NCT01358877|83031789|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
46812367|NCT01358877|83031788|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
46812368|NCT01358877|83031789|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
46812369|NCT01358877|83031788|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
46812370|NCT01358877|83031789|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
46812371|NCT01358877|83031788|FG000|Overall Study|Other|142|||
46812372|NCT01358877|83031789|FG001|Overall Study|Other|129|||
46812373|NCT00643279|83031821|FG000|Overall Study|Death|13|||
46812374|NCT00643279|83031822|FG001|Overall Study|Death|11|||
46812375|NCT00643279|83031821|FG000|Overall Study|Withdrawal by Subject|3|||
46812376|NCT00643279|83031822|FG001|Overall Study|Withdrawal by Subject|0|||
46927950|NCT03317496|83162761|FG000|Phase 1b Lead-in: Treatment|Other|2|||
46927951|NCT03317496|83162762|FG001|Phase 1b Lead-in: Treatment|Other|1|||
47054717|NCT02721966|83328059|FG001|Overall Study|Death|0|||
47054718|NCT02721966|83328060|FG002|Overall Study|Death|0|||
47054719|NCT02721966|83328061|FG003|Overall Study|Death|0|||
46636463|NCT01514136|82810254|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
46636464|NCT01514136|82810255|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
46754910|NCT01708954|82972670|FG000|Step 1|Withdrawal by Subject|2|||
46754911|NCT01708954|82972671|FG001|Step 1|Withdrawal by Subject|5|||
46754912|NCT01708954|82972672|FG002|Step 1|Withdrawal by Subject|3|||
46754913|NCT01708954|82972670|FG000|Step 1|Other complicating disease|0|||
46754914|NCT01708954|82972671|FG001|Step 1|Other complicating disease|2|||
46754915|NCT01708954|82972672|FG002|Step 1|Other complicating disease|0|||
46754916|NCT01708954|82972670|FG000|Step 1|Crossed over to Step 2|2|||
46754917|NCT01708954|82972671|FG001|Step 1|Crossed over to Step 2|0|||
46754918|NCT01708954|82972672|FG002|Step 1|Crossed over to Step 2|0|||
46754919|NCT01708954|82972670|FG000|Step 1|Symptomatic deterioration|1|||
46754920|NCT01708954|82972671|FG001|Step 1|Symptomatic deterioration|0|||
46754921|NCT01708954|82972672|FG002|Step 1|Symptomatic deterioration|1|||
46812377|NCT00643279|83031821|FG000|Overall Study|Lost to Follow-up|0|||
46812378|NCT00643279|83031822|FG001|Overall Study|Lost to Follow-up|1|||
46812379|NCT00643279|83031821|FG000|Overall Study|Physician Decision|0|||
46812380|NCT00643279|83031822|FG001|Overall Study|Physician Decision|1|||
46812381|NCT05607043|83031842|FG000|Overall Study|Lost to Follow-up|2|||
46812382|NCT04550221|83031869|FG000|Overall Study|Lost to Follow-up|0|||
46812383|NCT04550221|83031870|FG001|Overall Study|Lost to Follow-up|4|||
46812384|NCT04550221|83031869|FG000|Overall Study|Withdrawn|3|||
47054720|NCT02721966|83328062|FG004|Overall Study|Death|0|||
46754922|NCT01708954|82972670|FG000|Step 1|Off-treatment reason not submitted|1|||
46754923|NCT01708954|82972671|FG001|Step 1|Off-treatment reason not submitted|1|||
46812385|NCT04550221|83031870|FG001|Overall Study|Withdrawn|0|||
46812386|NCT04550221|83031869|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
46812387|NCT04550221|83031870|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
46812388|NCT04193176|83031891|FG000|Overall Study|Withdrawal by Subject|6|||
46812389|NCT04193176|83031892|FG001|Overall Study|Withdrawal by Subject|10|||
46812390|NCT05384834|83031898|FG000|Overall Study|Lost to Follow-up|43|||
46812391|NCT05384834|83031898|FG000|Overall Study|Withdrawal by Subject|5|||
46812392|NCT05101486|83031905|FG000|Overall Study|Death|1|||
46812393|NCT05101486|83031906|FG001|Overall Study|Death|0|||
46812394|NCT05101486|83031907|FG002|Overall Study|Death|1|||
46927952|NCT03317496|83162763|FG002|Phase 1b Lead-in: Treatment|Other|0|||
46927953|NCT03317496|83162764|FG003|Phase 1b Lead-in: Treatment|Other|0|||
46927954|NCT03317496|83162765|FG004|Phase 1b Lead-in: Treatment|Other|0|||
46927955|NCT03317496|83162761|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
46927956|NCT03317496|83162762|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
46927957|NCT03317496|83162763|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
46812395|NCT05101486|83031905|FG000|Overall Study|Lost to Follow-up|12|||
46812396|NCT05101486|83031906|FG001|Overall Study|Lost to Follow-up|8|||
46812397|NCT05101486|83031907|FG002|Overall Study|Lost to Follow-up|17|||
46812398|NCT05101486|83031905|FG000|Overall Study|Physician Decision|1|||
46812399|NCT05101486|83031906|FG001|Overall Study|Physician Decision|0|||
46812400|NCT05101486|83031907|FG002|Overall Study|Physician Decision|0|||
46812401|NCT05101486|83031905|FG000|Overall Study|Protocol Violation|0|||
46812402|NCT05101486|83031906|FG001|Overall Study|Protocol Violation|0|||
46812403|NCT05101486|83031907|FG002|Overall Study|Protocol Violation|1|||
46812404|NCT05101486|83031905|FG000|Overall Study|Withdrawal by Subject|5|||
46812405|NCT05101486|83031906|FG001|Overall Study|Withdrawal by Subject|2|||
46812406|NCT05101486|83031907|FG002|Overall Study|Withdrawal by Subject|4|||
46812407|NCT05101486|83031905|FG000|Overall Study|Randomized but not vaccinated|1|||
46812408|NCT05101486|83031906|FG001|Overall Study|Randomized but not vaccinated|1|||
46812409|NCT05101486|83031907|FG002|Overall Study|Randomized but not vaccinated|1|||
46812410|NCT05083585|83031917|FG000|Overall Study|Death|1|||
46812411|NCT05083585|83031918|FG001|Overall Study|Death|1|||
46812412|NCT05083585|83031917|FG000|Overall Study|Lost to Follow-up|1|||
46812413|NCT05083585|83031918|FG001|Overall Study|Lost to Follow-up|1|||
46812414|NCT05083585|83031917|FG000|Overall Study|Withdrawal by Subject|2|||
46812415|NCT05083585|83031918|FG001|Overall Study|Withdrawal by Subject|0|||
46812416|NCT05083585|83031917|FG000|Overall Study|Randomized but not vaccinated|2|||
46812417|NCT05083585|83031918|FG001|Overall Study|Randomized but not vaccinated|0|||
46812418|NCT05071313|83031926|FG000|Overall Study|Lost to Follow-up|17|||
46812419|NCT05071313|83031927|FG001|Overall Study|Lost to Follow-up|10|||
46927958|NCT03317496|83162764|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
46927959|NCT03317496|83162765|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
46754924|NCT01708954|82972672|FG002|Step 1|Off-treatment reason not submitted|1|||
46812420|NCT05071313|83031926|FG000|Overall Study|Physician Decision|1|||
46812421|NCT05071313|83031927|FG001|Overall Study|Physician Decision|6|||
46812422|NCT05071313|83031926|FG000|Overall Study|Death|1|||
46812423|NCT05071313|83031927|FG001|Overall Study|Death|0|||
46812424|NCT05071313|83031926|FG000|Overall Study|Withdrawal by Subject|10|||
46754925|NCT01708954|82972670|FG000|Step 1|Ineligible or never received treatment|4|||
46754926|NCT01708954|82972671|FG001|Step 1|Ineligible or never received treatment|2|||
46754927|NCT01708954|82972672|FG002|Step 1|Ineligible or never received treatment|8|||
46754928|NCT01708954|82972670|FG000|Step 2|Disease progression|9|||
46754929|NCT01708954|82972671|FG001|Step 2|Disease progression|4|||
46754930|NCT01708954|82972672|FG002|Step 2|Disease progression|0|||
46754931|NCT01708954|82972670|FG000|Step 2|Adverse Event|3|||
46754932|NCT01708954|82972671|FG001|Step 2|Adverse Event|2|||
46812425|NCT05071313|83031927|FG001|Overall Study|Withdrawal by Subject|15|||
46812426|NCT05071313|83031926|FG000|Overall Study|Other|1|||
46812427|NCT05071313|83031927|FG001|Overall Study|Other|0|||
46812428|NCT05071313|83031926|FG000|Overall Study|Randomized but not vaccinated|4|||
46812429|NCT05071313|83031927|FG001|Overall Study|Randomized but not vaccinated|2|||
46812430|NCT05019729|83031955|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
46812431|NCT05019729|83031956|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
46812432|NCT05019729|83031957|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
46812433|NCT05019729|83031958|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
46812434|NCT05019729|83031959|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
46846469|NCT00131664|83063148|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
46927960|NCT03317496|83162761|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
46754933|NCT01708954|82972672|FG002|Step 2|Adverse Event|0|||
46812435|NCT05019729|83031960|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
46812436|NCT04544475|83032008|FG000|Overall Study|Withdrawal by Subject|1|||
46812437|NCT04544475|83032009|FG001|Overall Study|Withdrawal by Subject|3|||
46812438|NCT04045613|83032040|FG000|Overall Study|Adverse Event|2|||
46812439|NCT04045613|83032041|FG001|Overall Study|Adverse Event|2|||
46812440|NCT04045613|83032042|FG002|Overall Study|Adverse Event|1|||
46812441|NCT04045613|83032043|FG003|Overall Study|Adverse Event|1|||
46812442|NCT04045613|83032044|FG004|Overall Study|Adverse Event|0|||
46812443|NCT04045613|83032045|FG005|Overall Study|Adverse Event|0|||
46812444|NCT04045613|83032046|FG006|Overall Study|Adverse Event|1|||
46812445|NCT04045613|83032040|FG000|Overall Study|Withdrawal by Subject|0|||
46812446|NCT04045613|83032041|FG001|Overall Study|Withdrawal by Subject|5|||
46812447|NCT04045613|83032042|FG002|Overall Study|Withdrawal by Subject|0|||
46812448|NCT04045613|83032043|FG003|Overall Study|Withdrawal by Subject|0|||
46812449|NCT04045613|83032044|FG004|Overall Study|Withdrawal by Subject|0|||
46812450|NCT04045613|83032045|FG005|Overall Study|Withdrawal by Subject|1|||
46812451|NCT04045613|83032046|FG006|Overall Study|Withdrawal by Subject|0|||
46812452|NCT04045613|83032040|FG000|Overall Study|Physician Decision|2|||
46812453|NCT04045613|83032041|FG001|Overall Study|Physician Decision|0|||
46812454|NCT04045613|83032042|FG002|Overall Study|Physician Decision|0|||
46812455|NCT04045613|83032043|FG003|Overall Study|Physician Decision|0|||
46812456|NCT04045613|83032044|FG004|Overall Study|Physician Decision|1|||
46812457|NCT04045613|83032045|FG005|Overall Study|Physician Decision|0|||
46812458|NCT04045613|83032046|FG006|Overall Study|Physician Decision|0|||
46812459|NCT04045613|83032040|FG000|Overall Study|Death|3|||
46812460|NCT04045613|83032041|FG001|Overall Study|Death|0|||
46812461|NCT04045613|83032042|FG002|Overall Study|Death|0|||
46812462|NCT04045613|83032043|FG003|Overall Study|Death|0|||
46812463|NCT04045613|83032044|FG004|Overall Study|Death|0|||
46812464|NCT04045613|83032045|FG005|Overall Study|Death|0|||
46812465|NCT04045613|83032046|FG006|Overall Study|Death|1|||
46812466|NCT04045613|83032040|FG000|Overall Study|Other reasons|0|||
46927961|NCT03317496|83162762|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
46927962|NCT03317496|83162763|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
46812467|NCT04045613|83032041|FG001|Overall Study|Other reasons|1|||
46812468|NCT04045613|83032042|FG002|Overall Study|Other reasons|0|||
46812469|NCT04045613|83032043|FG003|Overall Study|Other reasons|0|||
46812470|NCT04045613|83032044|FG004|Overall Study|Other reasons|0|||
46812471|NCT04045613|83032045|FG005|Overall Study|Other reasons|0|||
46812472|NCT04045613|83032046|FG006|Overall Study|Other reasons|1|||
46812473|NCT04045613|83032040|FG000|Overall Study|Progressive disease: Clinical progression|1|||
46812474|NCT04045613|83032041|FG001|Overall Study|Progressive disease: Clinical progression|0|||
46812475|NCT04045613|83032042|FG002|Overall Study|Progressive disease: Clinical progression|3|||
46812476|NCT04045613|83032043|FG003|Overall Study|Progressive disease: Clinical progression|1|||
46812477|NCT04045613|83032044|FG004|Overall Study|Progressive disease: Clinical progression|1|||
46812478|NCT04045613|83032045|FG005|Overall Study|Progressive disease: Clinical progression|3|||
46812479|NCT04045613|83032046|FG006|Overall Study|Progressive disease: Clinical progression|3|||
46812480|NCT04045613|83032040|FG000|Overall Study|Progressive disease: Radiological progression|24|||
46812481|NCT04045613|83032041|FG001|Overall Study|Progressive disease: Radiological progression|6|||
46812482|NCT04045613|83032042|FG002|Overall Study|Progressive disease: Radiological progression|8|||
46812483|NCT04045613|83032043|FG003|Overall Study|Progressive disease: Radiological progression|0|||
46812484|NCT04045613|83032044|FG004|Overall Study|Progressive disease: Radiological progression|6|||
46812485|NCT04045613|83032045|FG005|Overall Study|Progressive disease: Radiological progression|6|||
46927963|NCT03317496|83162764|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
46927964|NCT03317496|83162765|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
46927965|NCT03317496|83162761|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
46927966|NCT03317496|83162762|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
46927967|NCT03317496|83162763|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
46927968|NCT03317496|83162764|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
46927969|NCT03317496|83162765|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
46927970|NCT03317496|83162761|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
46812486|NCT04045613|83032046|FG006|Overall Study|Progressive disease: Radiological progression|11|||
46812487|NCT03964207|83032076|FG000|First Treatment|Withdrawal by Subject|1|||
46812488|NCT03964207|83032077|FG001|First Treatment|Withdrawal by Subject|2|||
46927971|NCT03317496|83162762|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
46927972|NCT03317496|83162763|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
46812489|NCT03964207|83032076|FG000|First Treatment|Protocol Violation|1|||
46812490|NCT03964207|83032077|FG001|First Treatment|Protocol Violation|0|||
46812491|NCT03964207|83032076|FG000|First Treatment|Lost to Follow-up|1|||
46812492|NCT03964207|83032077|FG001|First Treatment|Lost to Follow-up|0|||
46812493|NCT03964207|83032076|FG000|Second Treatment|Lost to Follow-up|0|||
46812494|NCT03964207|83032077|FG001|Second Treatment|Lost to Follow-up|1|||
46927973|NCT03317496|83162764|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
46927974|NCT03317496|83162765|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
46927975|NCT03317496|83162761|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
46927976|NCT03317496|83162762|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
46927977|NCT03317496|83162763|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
46927978|NCT03317496|83162764|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
46927979|NCT03317496|83162765|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
46927980|NCT03317496|83162761|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
46927981|NCT03317496|83162762|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
46927982|NCT03317496|83162763|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
46927983|NCT03317496|83162764|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
46927984|NCT03317496|83162765|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
46927985|NCT03317496|83162761|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
46927986|NCT03317496|83162762|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
46927987|NCT03317496|83162763|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
46927988|NCT03317496|83162764|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
46927989|NCT03317496|83162765|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
46927990|NCT03317496|83162761|FG000|Phase 2: Treatment|Adverse Event|0|||
46927991|NCT03317496|83162762|FG001|Phase 2: Treatment|Adverse Event|0|||
46927992|NCT03317496|83162763|FG002|Phase 2: Treatment|Adverse Event|0|||
46927993|NCT03317496|83162764|FG003|Phase 2: Treatment|Adverse Event|0|||
46927994|NCT03317496|83162765|FG004|Phase 2: Treatment|Adverse Event|6|||
46927995|NCT03317496|83162761|FG000|Phase 2: Treatment|Progressive disease|0|||
46927996|NCT03317496|83162762|FG001|Phase 2: Treatment|Progressive disease|0|||
46927997|NCT03317496|83162763|FG002|Phase 2: Treatment|Progressive disease|0|||
46927998|NCT03317496|83162764|FG003|Phase 2: Treatment|Progressive disease|0|||
46927999|NCT03317496|83162765|FG004|Phase 2: Treatment|Progressive disease|22|||
46928000|NCT03317496|83162761|FG000|Phase 2: Treatment|Other|0|||
46928001|NCT03317496|83162762|FG001|Phase 2: Treatment|Other|0|||
46928002|NCT03317496|83162763|FG002|Phase 2: Treatment|Other|0|||
46928003|NCT03317496|83162764|FG003|Phase 2: Treatment|Other|0|||
46928004|NCT03317496|83162765|FG004|Phase 2: Treatment|Other|4|||
46928005|NCT03317496|83162761|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
46928006|NCT03317496|83162762|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
46928007|NCT03317496|83162763|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
46928008|NCT03317496|83162764|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
46928009|NCT03317496|83162765|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
46928010|NCT03317496|83162761|FG000|Phase 2: Treatment|Physician Decision|0|||
47054721|NCT02721966|83328058|FG000|Overall Study|Lack of Efficacy|7|||
47054722|NCT02721966|83328059|FG001|Overall Study|Lack of Efficacy|4|||
47054723|NCT02721966|83328060|FG002|Overall Study|Lack of Efficacy|0|||
47054724|NCT02721966|83328061|FG003|Overall Study|Lack of Efficacy|0|||
47054725|NCT02721966|83328062|FG004|Overall Study|Lack of Efficacy|0|||
47054726|NCT02721966|83328058|FG000|Overall Study|Lost to Follow-up|0|||
47054727|NCT02721966|83328059|FG001|Overall Study|Lost to Follow-up|0|||
47054728|NCT02721966|83328060|FG002|Overall Study|Lost to Follow-up|3|||
47054729|NCT02721966|83328061|FG003|Overall Study|Lost to Follow-up|0|||
47054730|NCT02721966|83328062|FG004|Overall Study|Lost to Follow-up|0|||
47054731|NCT02721966|83328058|FG000|Overall Study|Physician Decision|1|||
46754934|NCT01708954|82972670|FG000|Step 2|Withdrawal by Subject|1|||
46754935|NCT01708954|82972671|FG001|Step 2|Withdrawal by Subject|1|||
46754936|NCT01708954|82972672|FG002|Step 2|Withdrawal by Subject|0|||
46754937|NCT01386385|82972690|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
46754938|NCT01386385|82972691|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
46754939|NCT01386385|82972692|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
46636465|NCT01514136|82810256|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
46636466|NCT01514136|82810257|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
46636467|NCT01514136|82810258|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
46754940|NCT01386385|82972693|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
46754941|NCT01386385|82972694|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
46754942|NCT01386385|82972695|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
46812495|NCT03964207|83032076|FG000|Second Treatment|Adverse Event|1|||
46812496|NCT03964207|83032077|FG001|Second Treatment|Adverse Event|2|||
46812497|NCT03947255|83032086|FG000|Overall Study|Study Closure by Sponsor|2|||
46812498|NCT03947255|83032087|FG001|Overall Study|Study Closure by Sponsor|2|||
46812499|NCT03947255|83032086|FG000|Overall Study|Withdrawal by Subject|2|||
46812500|NCT03947255|83032087|FG001|Overall Study|Withdrawal by Subject|2|||
46812501|NCT03947255|83032086|FG000|Overall Study|Lost to Follow-up|2|||
46812502|NCT03947255|83032087|FG001|Overall Study|Lost to Follow-up|0|||
46812503|NCT03947255|83032086|FG000|Overall Study|Death|0|||
46812504|NCT03947255|83032087|FG001|Overall Study|Death|2|||
46812505|NCT03929757|83032095|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
46812506|NCT03929757|83032096|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
46812507|NCT03929757|83032097|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
47054732|NCT02721966|83328059|FG001|Overall Study|Physician Decision|1|||
46812508|NCT03929757|83032095|FG000|Main Study: Up to Day 365|Other|1|||
46812509|NCT03929757|83032096|FG001|Main Study: Up to Day 365|Other|0|||
46812510|NCT03929757|83032097|FG002|Main Study: Up to Day 365|Other|0|||
46812511|NCT03929757|83032095|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
46812512|NCT03929757|83032096|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
46812513|NCT03929757|83032097|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
46812514|NCT03748823|83032106|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
46812515|NCT03748823|83032107|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
46928011|NCT03317496|83162762|FG001|Phase 2: Treatment|Physician Decision|0|||
46928012|NCT03317496|83162763|FG002|Phase 2: Treatment|Physician Decision|0|||
46928013|NCT03317496|83162764|FG003|Phase 2: Treatment|Physician Decision|0|||
46928014|NCT03317496|83162765|FG004|Phase 2: Treatment|Physician Decision|1|||
46928015|NCT03317496|83162761|FG000|Phase 2: Treatment|Death|0|||
46928016|NCT03317496|83162762|FG001|Phase 2: Treatment|Death|0|||
46928017|NCT03317496|83162763|FG002|Phase 2: Treatment|Death|0|||
46928018|NCT03317496|83162764|FG003|Phase 2: Treatment|Death|0|||
46928019|NCT03317496|83162765|FG004|Phase 2: Treatment|Death|1|||
46928020|NCT03317496|83162761|FG000|Phase 2: Follow-up|Death|0|||
46928021|NCT03317496|83162762|FG001|Phase 2: Follow-up|Death|0|||
46928022|NCT03317496|83162763|FG002|Phase 2: Follow-up|Death|0|||
46812516|NCT03748823|83032106|FG000|Extension Period|Withdrawal by Subject|1|||
46812517|NCT03748823|83032107|FG001|Extension Period|Withdrawal by Subject|2|||
46812518|NCT03748823|83032106|FG000|Extension Period|Death|0|||
46812519|NCT03748823|83032107|FG001|Extension Period|Death|1|||
46812520|NCT03748823|83032106|FG000|Extension Period|Protocol Violation|1|||
46812521|NCT03748823|83032107|FG001|Extension Period|Protocol Violation|0|||
46812522|NCT03748823|83032106|FG000|Extension Period|Ongoing in the Extension Period|41|||
46812523|NCT03748823|83032107|FG001|Extension Period|Ongoing in the Extension Period|84|||
46812524|NCT03548558|83032130|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
46812525|NCT03548558|83032131|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
46812526|NCT03548558|83032132|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
46812527|NCT03548558|83032133|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
46812528|NCT03548558|83032134|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
46812529|NCT03548558|83032135|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
46812530|NCT03548558|83032136|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
46812531|NCT03548558|83032130|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
46812532|NCT03548558|83032131|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
46812533|NCT03548558|83032132|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
46812534|NCT03548558|83032133|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
46812535|NCT03548558|83032134|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
46812536|NCT03548558|83032135|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
46812537|NCT03548558|83032136|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
46928023|NCT03317496|83162764|FG003|Phase 2: Follow-up|Death|0|||
46928024|NCT03317496|83162765|FG004|Phase 2: Follow-up|Death|24|||
46928025|NCT03317496|83162761|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
46928026|NCT03317496|83162762|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
46928027|NCT03317496|83162763|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
46928028|NCT03317496|83162764|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
47054733|NCT02721966|83328060|FG002|Overall Study|Physician Decision|0|||
47054734|NCT02721966|83328061|FG003|Overall Study|Physician Decision|0|||
47054735|NCT02721966|83328062|FG004|Overall Study|Physician Decision|0|||
47054736|NCT02721966|83328058|FG000|Overall Study|Pregnancy|1|||
47054737|NCT02721966|83328059|FG001|Overall Study|Pregnancy|0|||
47054738|NCT02721966|83328060|FG002|Overall Study|Pregnancy|0|||
47054739|NCT02721966|83328061|FG003|Overall Study|Pregnancy|0|||
47054740|NCT02721966|83328062|FG004|Overall Study|Pregnancy|0|||
47054741|NCT02721966|83328058|FG000|Overall Study|Did not continue to period 2|5|||
47054742|NCT02721966|83328059|FG001|Overall Study|Did not continue to period 2|12|||
47054743|NCT02721966|83328060|FG002|Overall Study|Did not continue to period 2|0|||
47054744|NCT02721966|83328061|FG003|Overall Study|Did not continue to period 2|0|||
47054745|NCT02721966|83328062|FG004|Overall Study|Did not continue to period 2|5|||
47054746|NCT00553462|83328070|FG000|Overall Study|Adverse Event|4|||
47054747|NCT00553462|83328070|FG000|Overall Study|Progression|4|||
47054748|NCT00553462|83328070|FG000|Overall Study|Withdrawal by Subject|5|||
47054749|NCT00553462|83328070|FG000|Overall Study|Physician Decision|1|||
46812538|NCT03548558|83032130|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
46928029|NCT03317496|83162765|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
46928030|NCT03317496|83162761|FG000|Phase 2: Follow-up|Other|0|||
46928031|NCT03317496|83162762|FG001|Phase 2: Follow-up|Other|0|||
46928032|NCT03317496|83162763|FG002|Phase 2: Follow-up|Other|0|||
46928033|NCT03317496|83162764|FG003|Phase 2: Follow-up|Other|0|||
47054750|NCT00553150|83328076|FG000|Overall Study|Withdrawal by Subject|0|||
46812539|NCT03548558|83032131|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
46812540|NCT03548558|83032132|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
46928034|NCT03317496|83162765|FG004|Phase 2: Follow-up|Other|1|||
47054751|NCT00553150|83328077|FG001|Overall Study|Withdrawal by Subject|0|||
46812541|NCT03548558|83032133|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
46812542|NCT03548558|83032134|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
46812543|NCT03548558|83032135|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
46812544|NCT03548558|83032136|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
46812545|NCT03548558|83032130|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
46812546|NCT03548558|83032131|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
46812547|NCT03548558|83032132|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
46812548|NCT03548558|83032133|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
46812549|NCT03548558|83032134|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
46812550|NCT03548558|83032135|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
46812551|NCT03548558|83032136|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
46812552|NCT03548558|83032130|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
46812553|NCT03548558|83032131|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
46812554|NCT03548558|83032132|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
46812555|NCT03548558|83032133|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
46812556|NCT03548558|83032134|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
46812557|NCT03548558|83032135|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
46812558|NCT03548558|83032136|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
46812559|NCT03548558|83032130|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
46812560|NCT03548558|83032131|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
46812561|NCT03548558|83032132|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
46812562|NCT03548558|83032133|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
46812563|NCT03548558|83032134|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
46812564|NCT03548558|83032135|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
46812565|NCT03548558|83032136|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
46812566|NCT03364673|83032198|FG000|Overall Study|Withdrawal by Subject|2|||
46928035|NCT03317496|83162761|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
46928036|NCT03317496|83162762|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
46928037|NCT03317496|83162763|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
46928038|NCT03317496|83162764|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
46928039|NCT03317496|83162765|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
46928040|NCT02836249|83162787|FG000|Overall Study|Randomized but Never Treated|0|||
46928041|NCT02836249|83162788|FG001|Overall Study|Randomized but Never Treated|1|||
46928042|NCT02836249|83162787|FG000|Overall Study|Pregnancy|2|||
47054752|NCT00553150|83328078|FG002|Overall Study|Withdrawal by Subject|0|||
46812567|NCT03364673|83032198|FG000|Overall Study|Injury unrelated to study|3|||
46812568|NCT03330405|83032213|FG000|Overall Study|Other|1|||
46812569|NCT03330405|83032214|FG001|Overall Study|Other|3|||
46812570|NCT03330405|83032215|FG002|Overall Study|Other|1|||
46812571|NCT03330405|83032216|FG003|Overall Study|Other|0|||
46812572|NCT03330405|83032217|FG004|Overall Study|Other|2|||
46812573|NCT03330405|83032218|FG005|Overall Study|Other|0|||
46812574|NCT03330405|83032219|FG006|Overall Study|Other|1|||
46812575|NCT03330405|83032220|FG007|Overall Study|Other|0|||
46812576|NCT03330405|83032221|FG008|Overall Study|Other|0|||
46812577|NCT03330405|83032222|FG009|Overall Study|Other|0|||
46812578|NCT03330405|83032223|FG010|Overall Study|Other|0|||
46812579|NCT03330405|83032213|FG000|Overall Study|Progressive disease|8|||
46812580|NCT03330405|83032214|FG001|Overall Study|Progressive disease|27|||
46812581|NCT03330405|83032215|FG002|Overall Study|Progressive disease|4|||
46812582|NCT03330405|83032216|FG003|Overall Study|Progressive disease|18|||
46812583|NCT03330405|83032217|FG004|Overall Study|Progressive disease|16|||
46812584|NCT03330405|83032218|FG005|Overall Study|Progressive disease|14|||
46812585|NCT03330405|83032219|FG006|Overall Study|Progressive disease|7|||
46812586|NCT03330405|83032220|FG007|Overall Study|Progressive disease|29|||
46812587|NCT03330405|83032221|FG008|Overall Study|Progressive disease|9|||
46812588|NCT03330405|83032222|FG009|Overall Study|Progressive disease|11|||
46812589|NCT03330405|83032223|FG010|Overall Study|Progressive disease|5|||
46812590|NCT03330405|83032213|FG000|Overall Study|Withdrawal by Subject|1|||
46812591|NCT03330405|83032214|FG001|Overall Study|Withdrawal by Subject|4|||
47054753|NCT00553150|83328079|FG003|Overall Study|Withdrawal by Subject|2|||
47054754|NCT00553150|83328076|FG000|Overall Study|Protocol Violation|0|||
47054755|NCT00553150|83328077|FG001|Overall Study|Protocol Violation|0|||
47054756|NCT00553150|83328078|FG002|Overall Study|Protocol Violation|0|||
47054757|NCT00553150|83328079|FG003|Overall Study|Protocol Violation|1|||
47054758|NCT00553150|83328076|FG000|Overall Study|Ineligible|0|||
46812592|NCT03330405|83032215|FG002|Overall Study|Withdrawal by Subject|0|||
46812593|NCT03330405|83032216|FG003|Overall Study|Withdrawal by Subject|1|||
46812594|NCT03330405|83032217|FG004|Overall Study|Withdrawal by Subject|1|||
46812595|NCT03330405|83032218|FG005|Overall Study|Withdrawal by Subject|1|||
47054759|NCT00553150|83328077|FG001|Overall Study|Ineligible|0|||
47054760|NCT00553150|83328078|FG002|Overall Study|Ineligible|0|||
46812596|NCT03330405|83032219|FG006|Overall Study|Withdrawal by Subject|0|||
46812597|NCT03330405|83032220|FG007|Overall Study|Withdrawal by Subject|2|||
46812598|NCT03330405|83032221|FG008|Overall Study|Withdrawal by Subject|2|||
46812599|NCT03330405|83032222|FG009|Overall Study|Withdrawal by Subject|1|||
46812600|NCT03330405|83032223|FG010|Overall Study|Withdrawal by Subject|1|||
46812601|NCT03330405|83032213|FG000|Overall Study|Global deterioration of health status|2|||
46812602|NCT03330405|83032214|FG001|Overall Study|Global deterioration of health status|3|||
46812603|NCT03330405|83032215|FG002|Overall Study|Global deterioration of health status|0|||
46812604|NCT03330405|83032216|FG003|Overall Study|Global deterioration of health status|2|||
46812605|NCT03330405|83032217|FG004|Overall Study|Global deterioration of health status|3|||
46812606|NCT03330405|83032218|FG005|Overall Study|Global deterioration of health status|3|||
46812607|NCT03330405|83032219|FG006|Overall Study|Global deterioration of health status|0|||
46812608|NCT03330405|83032220|FG007|Overall Study|Global deterioration of health status|2|||
46812609|NCT03330405|83032221|FG008|Overall Study|Global deterioration of health status|8|||
46812610|NCT03330405|83032222|FG009|Overall Study|Global deterioration of health status|4|||
46812611|NCT03330405|83032223|FG010|Overall Study|Global deterioration of health status|1|||
46812612|NCT03330405|83032213|FG000|Overall Study|Adverse Event|0|||
46812613|NCT03330405|83032214|FG001|Overall Study|Adverse Event|1|||
46812614|NCT03330405|83032215|FG002|Overall Study|Adverse Event|0|||
46812615|NCT03330405|83032216|FG003|Overall Study|Adverse Event|1|||
46812616|NCT03330405|83032217|FG004|Overall Study|Adverse Event|1|||
46812617|NCT03330405|83032218|FG005|Overall Study|Adverse Event|1|||
46812618|NCT03330405|83032219|FG006|Overall Study|Adverse Event|3|||
46812619|NCT03330405|83032220|FG007|Overall Study|Adverse Event|4|||
46812620|NCT03330405|83032221|FG008|Overall Study|Adverse Event|2|||
46812621|NCT03330405|83032222|FG009|Overall Study|Adverse Event|2|||
46812622|NCT03330405|83032223|FG010|Overall Study|Adverse Event|2|||
46812623|NCT03330405|83032213|FG000|Overall Study|Death|0|||
46812624|NCT03330405|83032214|FG001|Overall Study|Death|4|||
46812625|NCT03330405|83032215|FG002|Overall Study|Death|0|||
46812626|NCT03330405|83032216|FG003|Overall Study|Death|0|||
46812627|NCT03330405|83032217|FG004|Overall Study|Death|0|||
46812628|NCT03330405|83032218|FG005|Overall Study|Death|1|||
46812629|NCT03330405|83032219|FG006|Overall Study|Death|0|||
46812630|NCT03330405|83032220|FG007|Overall Study|Death|2|||
46812631|NCT03330405|83032221|FG008|Overall Study|Death|0|||
46812632|NCT03330405|83032222|FG009|Overall Study|Death|0|||
46812633|NCT03330405|83032223|FG010|Overall Study|Death|0|||
46812634|NCT03330405|83032213|FG000|Overall Study|Physician Decision|0|||
46812635|NCT03330405|83032214|FG001|Overall Study|Physician Decision|0|||
46812636|NCT03330405|83032215|FG002|Overall Study|Physician Decision|0|||
46812637|NCT03330405|83032216|FG003|Overall Study|Physician Decision|0|||
46812638|NCT03330405|83032217|FG004|Overall Study|Physician Decision|0|||
46812639|NCT03330405|83032218|FG005|Overall Study|Physician Decision|0|||
46812640|NCT03330405|83032219|FG006|Overall Study|Physician Decision|0|||
46812641|NCT03330405|83032220|FG007|Overall Study|Physician Decision|1|||
46812642|NCT03330405|83032221|FG008|Overall Study|Physician Decision|0|||
46812643|NCT03330405|83032222|FG009|Overall Study|Physician Decision|0|||
46812644|NCT03330405|83032223|FG010|Overall Study|Physician Decision|0|||
46812645|NCT02683239|83032364|FG000|Overall Study|Protocol Violation|35|||
46812646|NCT02683239|83032365|FG001|Overall Study|Protocol Violation|23|||
46812647|NCT02683239|83032366|FG002|Overall Study|Protocol Violation|26|||
46812648|NCT02683239|83032367|FG003|Overall Study|Protocol Violation|4|||
46812649|NCT02683239|83032368|FG004|Overall Study|Protocol Violation|35|||
46812650|NCT02683239|83032369|FG005|Overall Study|Protocol Violation|4|||
46812651|NCT02683239|83032370|FG006|Overall Study|Protocol Violation|5|||
46812652|NCT02683239|83032364|FG000|Overall Study|Adverse Event|64|||
46812653|NCT02683239|83032365|FG001|Overall Study|Adverse Event|39|||
46812654|NCT02683239|83032366|FG002|Overall Study|Adverse Event|42|||
46812655|NCT02683239|83032367|FG003|Overall Study|Adverse Event|16|||
46812656|NCT02683239|83032368|FG004|Overall Study|Adverse Event|189|||
46812657|NCT02683239|83032369|FG005|Overall Study|Adverse Event|9|||
46812658|NCT02683239|83032370|FG006|Overall Study|Adverse Event|9|||
46812659|NCT02683239|83032364|FG000|Overall Study|Physician Decision|38|||
46812660|NCT02683239|83032365|FG001|Overall Study|Physician Decision|19|||
46636468|NCT01514136|82810251|FG000|Test Period 2; Test C*|holiday|0|||
46812661|NCT02683239|83032366|FG002|Overall Study|Physician Decision|14|||
46812662|NCT02683239|83032367|FG003|Overall Study|Physician Decision|73|||
46812663|NCT02683239|83032368|FG004|Overall Study|Physician Decision|143|||
46812664|NCT02683239|83032369|FG005|Overall Study|Physician Decision|14|||
46812665|NCT02683239|83032370|FG006|Overall Study|Physician Decision|15|||
46812666|NCT02683239|83032364|FG000|Overall Study|Withdrawal by Subject|187|||
46812667|NCT02683239|83032365|FG001|Overall Study|Withdrawal by Subject|99|||
46812668|NCT02683239|83032366|FG002|Overall Study|Withdrawal by Subject|91|||
46812669|NCT02683239|83032367|FG003|Overall Study|Withdrawal by Subject|18|||
46812670|NCT02683239|83032368|FG004|Overall Study|Withdrawal by Subject|248|||
46812671|NCT02683239|83032369|FG005|Overall Study|Withdrawal by Subject|22|||
46812672|NCT02683239|83032370|FG006|Overall Study|Withdrawal by Subject|28|||
46812673|NCT02683239|83032364|FG000|Overall Study|Lost to Follow-up|77|||
46812674|NCT02683239|83032365|FG001|Overall Study|Lost to Follow-up|24|||
46812675|NCT02683239|83032366|FG002|Overall Study|Lost to Follow-up|25|||
46812676|NCT02683239|83032367|FG003|Overall Study|Lost to Follow-up|7|||
46812677|NCT02683239|83032368|FG004|Overall Study|Lost to Follow-up|88|||
46812678|NCT02683239|83032369|FG005|Overall Study|Lost to Follow-up|8|||
46812679|NCT02683239|83032370|FG006|Overall Study|Lost to Follow-up|11|||
46812680|NCT02683239|83032364|FG000|Overall Study|Death|9|||
46812681|NCT02683239|83032365|FG001|Overall Study|Death|5|||
46812682|NCT02683239|83032366|FG002|Overall Study|Death|8|||
46812683|NCT02683239|83032367|FG003|Overall Study|Death|0|||
46812684|NCT02683239|83032368|FG004|Overall Study|Death|12|||
46812685|NCT02683239|83032369|FG005|Overall Study|Death|1|||
46812686|NCT02683239|83032370|FG006|Overall Study|Death|0|||
46812687|NCT02683239|83032364|FG000|Overall Study|Lack of Efficacy|50|||
46812688|NCT02683239|83032365|FG001|Overall Study|Lack of Efficacy|23|||
46812689|NCT02683239|83032366|FG002|Overall Study|Lack of Efficacy|12|||
46812690|NCT02683239|83032367|FG003|Overall Study|Lack of Efficacy|2|||
46812691|NCT02683239|83032368|FG004|Overall Study|Lack of Efficacy|29|||
46812692|NCT02683239|83032369|FG005|Overall Study|Lack of Efficacy|2|||
46812693|NCT02683239|83032370|FG006|Overall Study|Lack of Efficacy|3|||
46812694|NCT02683239|83032364|FG000|Overall Study|Missing data|0|||
46812695|NCT02683239|83032365|FG001|Overall Study|Missing data|1|||
46812696|NCT02683239|83032366|FG002|Overall Study|Missing data|1|||
46812697|NCT02683239|83032367|FG003|Overall Study|Missing data|0|||
46812698|NCT02683239|83032368|FG004|Overall Study|Missing data|1|||
46812699|NCT02683239|83032369|FG005|Overall Study|Missing data|0|||
46928043|NCT02836249|83162788|FG001|Overall Study|Pregnancy|0|||
46928044|NCT02836249|83162787|FG000|Overall Study|Withdrew Consent|0|||
46928045|NCT02836249|83162788|FG001|Overall Study|Withdrew Consent|1|||
46928046|NCT02836249|83162787|FG000|Overall Study|Lost to Follow-up|0|||
46928047|NCT02836249|83162788|FG001|Overall Study|Lost to Follow-up|1|||
46928048|NCT02836249|83162787|FG000|Overall Study|Still on Study|121|||
46928049|NCT02836249|83162788|FG001|Overall Study|Still on Study|55|||
46928050|NCT01849562|83162801|FG000|Overall Study|Lost to Follow-up|1|||
46812700|NCT02683239|83032370|FG006|Overall Study|Missing data|0|||
46812701|NCT02097134|83032386|FG000|Overall Study|Physician Decision|4|||
46812702|NCT02097134|83032386|FG000|Overall Study|Non-Protocol Therapy|1|||
46812703|NCT02097134|83032386|FG000|Overall Study|Progressive Disease|3|||
46928051|NCT01849562|83162802|FG001|Overall Study|Lost to Follow-up|0|||
46812704|NCT02097134|83032386|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
46812705|NCT01859130|83032391|FG000|Overall Study|Death|4|||
46812706|NCT01859130|83032391|FG000|Overall Study|Lost to Follow-up|16|||
46812707|NCT01859130|83032391|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
46812708|NCT01859130|83032391|FG000|Overall Study|Physician Decision|6|||
46812709|NCT01859130|83032391|FG000|Overall Study|Withdrawal by Subject|17|||
46812710|NCT01859130|83032391|FG000|Overall Study|Adverse Event|11|||
46812711|NCT01174043|83032408|FG000|Overall Study|Disease progression|5|||
46812712|NCT01174043|83032408|FG000|Overall Study|Adverse Event|3|||
46812713|NCT01174043|83032408|FG000|Overall Study|Death|1|||
46928052|NCT01849562|83162803|FG002|Overall Study|Lost to Follow-up|0|||
46928053|NCT01849562|83162801|FG000|Overall Study|Non-compliance with Study Drug|1|||
46928054|NCT01849562|83162802|FG001|Overall Study|Non-compliance with Study Drug|0|||
46928055|NCT01849562|83162803|FG002|Overall Study|Non-compliance with Study Drug|0|||
46928056|NCT01700179|83162812|FG000|Overall Study|Physician Decision|2|||
46928057|NCT00665223|83162828|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
46928058|NCT00665223|83162829|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
46754943|NCT01386385|82972696|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
46754944|NCT01386385|82972697|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
46754945|NCT01386385|82972690|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
46754946|NCT01386385|82972691|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
46754947|NCT01386385|82972692|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
46754948|NCT01386385|82972693|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
46754949|NCT01386385|82972694|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
46754950|NCT01386385|82972695|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
46812714|NCT01174043|83032408|FG000|Overall Study|Withdrawal by Subject|2|||
46754951|NCT01386385|82972696|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
46812715|NCT04050982|83032414|FG000|Overall Study|Did not meet eligibility criteria|0|||
46812716|NCT04050982|83032415|FG001|Overall Study|Did not meet eligibility criteria|1|||
46812717|NCT04050982|83032416|FG002|Overall Study|Did not meet eligibility criteria|0|||
46812718|NCT04050982|83032414|FG000|Overall Study|Withdrawal by Subject|1|||
46812719|NCT04050982|83032415|FG001|Overall Study|Withdrawal by Subject|0|||
46812720|NCT04050982|83032416|FG002|Overall Study|Withdrawal by Subject|0|||
46928059|NCT00665223|83162830|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
46928060|NCT00665223|83162828|FG000|Randomized Phase (26 Weeks)|Death|0|||
46928061|NCT00665223|83162829|FG001|Randomized Phase (26 Weeks)|Death|0|||
46928062|NCT00665223|83162830|FG002|Randomized Phase (26 Weeks)|Death|1|||
46812721|NCT04050982|83032414|FG000|Overall Study|Unable to enroll on platform|1|||
46928063|NCT00665223|83162828|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
46812722|NCT04050982|83032415|FG001|Overall Study|Unable to enroll on platform|0|||
46928064|NCT00665223|83162829|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
46928065|NCT00665223|83162830|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
46812723|NCT04050982|83032416|FG002|Overall Study|Unable to enroll on platform|0|||
46812724|NCT03905265|83032426|FG000|Overall Study|Withdrawal by Subject|1|||
46812725|NCT03905265|83032427|FG001|Overall Study|Withdrawal by Subject|1|||
46812726|NCT03905265|83032428|FG002|Overall Study|Withdrawal by Subject|0|||
46812727|NCT03905265|83032429|FG003|Overall Study|Withdrawal by Subject|0|||
46812728|NCT03848845|83032442|FG000|Overall Study|Lost to Follow-up|0|||
46812729|NCT03848845|83032443|FG001|Overall Study|Lost to Follow-up|1|||
46812730|NCT03848845|83032444|FG002|Overall Study|Lost to Follow-up|0|||
46812731|NCT03848845|83032442|FG000|Overall Study|Withdrawal by Subject|3|||
46812732|NCT03848845|83032443|FG001|Overall Study|Withdrawal by Subject|2|||
46812733|NCT03848845|83032444|FG002|Overall Study|Withdrawal by Subject|6|||
46928066|NCT00665223|83162828|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
46928067|NCT00665223|83162829|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
46928068|NCT00665223|83162830|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
46928069|NCT00665223|83162828|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
46928070|NCT00665223|83162829|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
46928071|NCT00665223|83162830|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
46928072|NCT00665223|83162828|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
46928073|NCT00665223|83162829|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
46928074|NCT00665223|83162830|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
46928075|NCT00665223|83162828|FG000|Open-Label Period (26 Weeks)|Death|0|||
46928076|NCT00665223|83162829|FG001|Open-Label Period (26 Weeks)|Death|1|||
47054761|NCT00553150|83328079|FG003|Overall Study|Ineligible|1|||
47054762|NCT03301350|83328087|FG000|Overall Study|Withdrawal by Subject|4|||
47054763|NCT03301350|83328087|FG000|Overall Study|Adverse Event|1|||
47054764|NCT03301350|83328087|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
47054765|NCT03301350|83328087|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
47054766|NCT03301350|83328087|FG000|Overall Study|no detail provided|1|||
47054767|NCT04735432|83328094|FG000|Overall Study|Other - due to personal reason|1|||
47054768|NCT04735432|83328095|FG001|Overall Study|Other - due to personal reason|0|||
47054769|NCT04735432|83328094|FG000|Overall Study|Adverse Event|2|||
47054770|NCT04735432|83328095|FG001|Overall Study|Adverse Event|0|||
47054771|NCT02722278|83328104|FG000|Overall Study|Withdrawal by Subject|5|||
47054772|NCT02722278|83328105|FG001|Overall Study|Withdrawal by Subject|3|||
47054773|NCT02722278|83328104|FG000|Overall Study|Adverse Event|4|||
47054774|NCT02722278|83328105|FG001|Overall Study|Adverse Event|1|||
47054775|NCT02722278|83328104|FG000|Overall Study|Lost to Follow-up|2|||
46636469|NCT01514136|82810252|FG001|Test Period 2; Test C*|holiday|0|||
46754952|NCT01386385|82972697|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
46754953|NCT01386385|82972690|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
46754954|NCT01386385|82972691|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
46754955|NCT01386385|82972692|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
46754956|NCT01386385|82972693|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
46754957|NCT01386385|82972694|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
46754958|NCT01386385|82972695|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
46754959|NCT01386385|82972696|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
46812734|NCT03848845|83032442|FG000|Overall Study|In Follow-up|0|||
46812735|NCT03848845|83032443|FG001|Overall Study|In Follow-up|1|||
46812736|NCT03848845|83032444|FG002|Overall Study|In Follow-up|12|||
46812737|NCT03848845|83032442|FG000|Overall Study|On Study Treatment|0|||
46812738|NCT03848845|83032443|FG001|Overall Study|On Study Treatment|0|||
46812739|NCT03848845|83032444|FG002|Overall Study|On Study Treatment|4|||
46812740|NCT03848845|83032442|FG000|Overall Study|Physician Decision|0|||
46812741|NCT03848845|83032443|FG001|Overall Study|Physician Decision|0|||
46812742|NCT03848845|83032444|FG002|Overall Study|Physician Decision|1|||
46812743|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
46812744|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
46812745|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
46812746|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
46812747|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
46928077|NCT00665223|83162830|FG002|Open-Label Period (26 Weeks)|Death|0|||
46928078|NCT00665223|83162828|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
46754960|NCT01386385|82972697|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
46754961|NCT01386385|82972690|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
46754962|NCT01386385|82972691|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
46812748|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
46812749|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
47054776|NCT02722278|83328105|FG001|Overall Study|Lost to Follow-up|0|||
47054777|NCT02722278|83328104|FG000|Overall Study|Protocol Violation|1|||
46812750|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
46812751|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
46812752|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
46812753|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
46812754|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
46812755|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
46812756|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
46812757|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
46812758|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
46812759|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
46928079|NCT00665223|83162829|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
46928080|NCT00665223|83162830|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
46928081|NCT00665223|83162828|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
46928082|NCT00665223|83162829|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
46928083|NCT00665223|83162830|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
46928084|NCT00665223|83162828|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
46928085|NCT00665223|83162829|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
46928086|NCT00665223|83162830|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
46928087|NCT00665223|83162828|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
46928088|NCT00665223|83162829|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
46928089|NCT00665223|83162830|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
46928090|NCT03786380|83162851|FG000|Overall Study|Adverse Event|1|||
46928091|NCT03786380|83162852|FG001|Overall Study|Adverse Event|0|||
46928092|NCT03786380|83162853|FG002|Overall Study|Adverse Event|0|||
46928093|NCT03786380|83162854|FG003|Overall Study|Adverse Event|3|||
46928094|NCT03786380|83162855|FG004|Overall Study|Adverse Event|1|||
46812760|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
46928095|NCT03786380|83162851|FG000|Overall Study|Lack of Efficacy|0|||
46928096|NCT03786380|83162852|FG001|Overall Study|Lack of Efficacy|0|||
46928097|NCT03786380|83162853|FG002|Overall Study|Lack of Efficacy|0|||
46928098|NCT03786380|83162854|FG003|Overall Study|Lack of Efficacy|0|||
46928099|NCT03786380|83162855|FG004|Overall Study|Lack of Efficacy|1|||
46928100|NCT03786380|83162851|FG000|Overall Study|Withdrawal by Subject|1|||
46928101|NCT03786380|83162852|FG001|Overall Study|Withdrawal by Subject|2|||
46928102|NCT03786380|83162853|FG002|Overall Study|Withdrawal by Subject|2|||
46928103|NCT03786380|83162854|FG003|Overall Study|Withdrawal by Subject|1|||
46928104|NCT03786380|83162855|FG004|Overall Study|Withdrawal by Subject|2|||
46928105|NCT03786380|83162851|FG000|Overall Study|Lost to Follow-up|3|||
46928106|NCT03786380|83162852|FG001|Overall Study|Lost to Follow-up|0|||
46928107|NCT03786380|83162853|FG002|Overall Study|Lost to Follow-up|1|||
46928108|NCT03786380|83162854|FG003|Overall Study|Lost to Follow-up|2|||
46928109|NCT03786380|83162855|FG004|Overall Study|Lost to Follow-up|0|||
46928110|NCT03786380|83162851|FG000|Overall Study|Physician Decision|0|||
46928111|NCT03786380|83162852|FG001|Overall Study|Physician Decision|0|||
46928112|NCT03786380|83162853|FG002|Overall Study|Physician Decision|1|||
46928113|NCT03786380|83162854|FG003|Overall Study|Physician Decision|0|||
46928114|NCT03786380|83162855|FG004|Overall Study|Physician Decision|0|||
46928115|NCT03786380|83162851|FG000|Overall Study|Study Terminated by the Sponsor|30|||
46928116|NCT03786380|83162852|FG001|Overall Study|Study Terminated by the Sponsor|20|||
46812761|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
46812762|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
46812763|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
46812764|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
46812765|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
46928117|NCT03786380|83162853|FG002|Overall Study|Study Terminated by the Sponsor|50|||
46928118|NCT03786380|83162854|FG003|Overall Study|Study Terminated by the Sponsor|57|||
46928119|NCT03786380|83162855|FG004|Overall Study|Study Terminated by the Sponsor|23|||
46928120|NCT03786380|83162851|FG000|Overall Study|Reason Not Specified|0|||
46928121|NCT03786380|83162852|FG001|Overall Study|Reason Not Specified|0|||
46928122|NCT03786380|83162853|FG002|Overall Study|Reason Not Specified|0|||
46928123|NCT03786380|83162854|FG003|Overall Study|Reason Not Specified|0|||
46636470|NCT01514136|82810253|FG002|Test Period 2; Test C*|holiday|0|||
46636471|NCT01514136|82810254|FG003|Test Period 2; Test C*|holiday|0|||
46754963|NCT01386385|82972692|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
46754964|NCT01386385|82972693|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
46754965|NCT01386385|82972694|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
46754966|NCT01386385|82972695|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
46754967|NCT01386385|82972696|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
46754968|NCT01386385|82972697|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
46754969|NCT01386385|82972690|FG000|Phase II Concurrent CRT|Adverse Event|0|||
46754970|NCT01386385|82972691|FG001|Phase II Concurrent CRT|Adverse Event|0|||
46636472|NCT01514136|82810255|FG004|Test Period 2; Test C*|holiday|0|||
46754971|NCT01386385|82972692|FG002|Phase II Concurrent CRT|Adverse Event|0|||
46754972|NCT01386385|82972693|FG003|Phase II Concurrent CRT|Adverse Event|0|||
46928124|NCT03786380|83162855|FG004|Overall Study|Reason Not Specified|1|||
46928125|NCT02626000|83162867|FG000|Overall Study|Decision by Sponsor|1|||
46928126|NCT02626000|83162867|FG000|Overall Study|Death|29|||
46928127|NCT02736890|83162883|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
46928128|NCT02736890|83162884|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
46928129|NCT02736890|83162883|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
46928130|NCT02736890|83162884|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
46928131|NCT02779556|83162892|FG000|Baseline|Partial baseline interview completed|1|||
46928132|NCT02779556|83162893|FG001|Baseline|Partial baseline interview completed|0|||
46928133|NCT02779556|83162892|FG000|3 Months|Lost to Follow-up|40|||
46928134|NCT02779556|83162893|FG001|3 Months|Lost to Follow-up|29|||
46928135|NCT02779556|83162892|FG000|3 Months|Missed 3 month clinic visit|27|||
46928136|NCT02779556|83162893|FG001|3 Months|Missed 3 month clinic visit|19|||
46928137|NCT02779556|83162892|FG000|6 Month|Lost to Follow-up|33|||
46928138|NCT02779556|83162893|FG001|6 Month|Lost to Follow-up|39|||
46928139|NCT02779556|83162892|FG000|6 Month HbA1c|No value collected during window|69|||
46928140|NCT02779556|83162893|FG001|6 Month HbA1c|No value collected during window|50|||
46928141|NCT02779556|83162892|FG000|12 Month HbA1c|No value collected during window|138|||
46928142|NCT02779556|83162893|FG001|12 Month HbA1c|No value collected during window|102|||
46928143|NCT01669798|83162899|FG000|Overall Study|Physician Decision|5|||
46928144|NCT02334722|83162905|FG000|Overall Study|Lost to Follow-up|4|||
46928145|NCT02334722|83162906|FG001|Overall Study|Lost to Follow-up|0|||
46928146|NCT02334722|83162905|FG000|Overall Study|6 week questionnaire not completed|2|||
46928147|NCT02334722|83162906|FG001|Overall Study|6 week questionnaire not completed|0|||
46928148|NCT02334722|83162905|FG000|Overall Study|Unable to obtain medication|1|||
46928149|NCT02334722|83162906|FG001|Overall Study|Unable to obtain medication|1|||
46928150|NCT02334722|83162905|FG000|Overall Study|Withdrawal by Subject|0|||
46928151|NCT02334722|83162906|FG001|Overall Study|Withdrawal by Subject|3|||
46928152|NCT02334722|83162905|FG000|Overall Study|Adverse Event|0|||
46928153|NCT02334722|83162906|FG001|Overall Study|Adverse Event|2|||
46928154|NCT02334722|83162905|FG000|Overall Study|Physician Decision|0|||
46928155|NCT02334722|83162906|FG001|Overall Study|Physician Decision|1|||
46928156|NCT00812708|83162921|FG000|Overall Study|Device could not be implanted|2|||
46928157|NCT00812708|83162921|FG000|Overall Study|Lack of medical insurance|1|||
46928158|NCT00812708|83162921|FG000|Overall Study|Switched to another study|1|||
47054778|NCT02722278|83328105|FG001|Overall Study|Protocol Violation|0|||
47054779|NCT02722278|83328104|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
47054780|NCT02722278|83328105|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
47054781|NCT02722278|83328104|FG000|Overall Study|Subject declined after tx assignment|0|||
47054782|NCT02722278|83328105|FG001|Overall Study|Subject declined after tx assignment|1|||
47054783|NCT02722278|83328104|FG000|Overall Study|Site closure not study related|0|||
47054784|NCT02722278|83328105|FG001|Overall Study|Site closure not study related|1|||
47054785|NCT00703092|83328113|FG000|Overall Study|Withdrawal by Subject|2|||
47054786|NCT02720484|83328117|FG000|Treatment on Study|Adverse Event|1|||
47054787|NCT02720484|83328117|FG000|Treatment on Study|Withdrawal by Subject|1|||
47054788|NCT02720484|83328117|FG000|Treatment on Study|Progressive Disease|4|||
47054789|NCT02720484|83328117|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
47054790|NCT02720484|83328117|FG000|Follow Up for 2 Years|Death|3|||
47054791|NCT02720484|83328117|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
47054792|NCT02715804|83328123|FG000|Overall Study|Death|222|||
47054793|NCT02715804|83328124|FG001|Overall Study|Death|106|||
47054794|NCT02715804|83328123|FG000|Overall Study|Withdrawal by Subject|5|||
47054795|NCT02715804|83328124|FG001|Overall Study|Withdrawal by Subject|4|||
47054796|NCT02715804|83328123|FG000|Overall Study|Other than specified|2|||
47054797|NCT02715804|83328124|FG001|Overall Study|Other than specified|3|||
47054798|NCT02717832|83328130|FG000|Overall Study|Inability to place IV|3|||
47054799|NCT02717754|83328141|FG000|Overall Study|Incorrect Infusion Duration|0|||
47054800|NCT02717754|83328142|FG001|Overall Study|Incorrect Infusion Duration|0|||
46754973|NCT01386385|82972694|FG004|Phase II Concurrent CRT|Adverse Event|0|||
46754974|NCT01386385|82972695|FG005|Phase II Concurrent CRT|Adverse Event|0|||
46754975|NCT01386385|82972696|FG006|Phase II Concurrent CRT|Adverse Event|3|||
46754976|NCT01386385|82972697|FG007|Phase II Concurrent CRT|Adverse Event|3|||
46754977|NCT01386385|82972690|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
46754978|NCT01386385|82972691|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
46928159|NCT00812708|83162921|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
46754979|NCT01386385|82972692|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
46928160|NCT00812708|83162921|FG000|Overall Study|Signed consent but later withdrew|3|||
46928161|NCT03761810|83162937|FG000|Overall Study|Adverse Event|12|||
46928162|NCT03761810|83162938|FG001|Overall Study|Adverse Event|0|||
46928163|NCT03761810|83162937|FG000|Overall Study|Lost to Follow-up|15|||
46928164|NCT03761810|83162938|FG001|Overall Study|Lost to Follow-up|7|||
46928165|NCT03761810|83162937|FG000|Overall Study|Pregnancy|1|||
46928166|NCT03761810|83162938|FG001|Overall Study|Pregnancy|0|||
46928167|NCT03761810|83162937|FG000|Overall Study|Withdrawal by Subject|14|||
47054801|NCT02717754|83328143|FG002|Overall Study|Incorrect Infusion Duration|0|||
47054802|NCT02717754|83328144|FG003|Overall Study|Incorrect Infusion Duration|10|||
46928168|NCT03761810|83162938|FG001|Overall Study|Withdrawal by Subject|5|||
46928169|NCT03761810|83162937|FG000|Overall Study|Physician Decision|1|||
46928170|NCT03761810|83162938|FG001|Overall Study|Physician Decision|0|||
46928171|NCT03761810|83162937|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
46928172|NCT03761810|83162938|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46928173|NCT03761810|83162937|FG000|Overall Study|Other Than Specified|1|||
46928174|NCT03761810|83162938|FG001|Overall Study|Other Than Specified|0|||
46928175|NCT02811159|83162949|FG000|Treatment Course 1|Lost to Follow-up|1|||
46928176|NCT01889186|83162955|FG000|Overall Study|Adverse event- not related to progression|18|||
46928177|NCT01889186|83162956|FG001|Overall Study|Adverse event- not related to progression|5|||
46928178|NCT01889186|83162955|FG000|Overall Study|Adverse event- related to progression|7|||
46928179|NCT01889186|83162956|FG001|Overall Study|Adverse event- related to progression|2|||
46928180|NCT01889186|83162955|FG000|Overall Study|COVID-19 logistical restrictions|1|||
46928181|NCT01889186|83162956|FG001|Overall Study|COVID-19 logistical restrictions|0|||
46928182|NCT01889186|83162955|FG000|Overall Study|Investigator request|1|||
46928183|NCT01889186|83162956|FG001|Overall Study|Investigator request|1|||
46928184|NCT01889186|83162955|FG000|Overall Study|Progressive disease- Richter's|12|||
46928185|NCT01889186|83162956|FG001|Overall Study|Progressive disease- Richter's|7|||
46928186|NCT01889186|83162955|FG000|Overall Study|Progressive disease per protocol|46|||
46928187|NCT01889186|83162956|FG001|Overall Study|Progressive disease per protocol|17|||
46928188|NCT01889186|83162955|FG000|Overall Study|Stem cell transplant|2|||
46928189|NCT01889186|83162956|FG001|Overall Study|Stem cell transplant|1|||
46928190|NCT01889186|83162955|FG000|Overall Study|Withdrew consent|2|||
46928191|NCT01889186|83162956|FG001|Overall Study|Withdrew consent|3|||
46928192|NCT01889186|83162955|FG000|Overall Study|Other, not specified|18|||
46928193|NCT01889186|83162956|FG001|Overall Study|Other, not specified|15|||
46928194|NCT01510184|83162966|FG000|Overall Study|Sponsor discretion|28|||
46928195|NCT01510184|83162967|FG001|Overall Study|Sponsor discretion|28|||
46928196|NCT01510184|83162966|FG000|Overall Study|Death|1|||
46928197|NCT01510184|83162967|FG001|Overall Study|Death|2|||
46928198|NCT01510184|83162966|FG000|Overall Study|Withdrawal by Subject|1|||
46928199|NCT01510184|83162967|FG001|Overall Study|Withdrawal by Subject|4|||
46928200|NCT01510184|83162966|FG000|Overall Study|Other|0|||
46928201|NCT01510184|83162967|FG001|Overall Study|Other|1|||
47054803|NCT02717754|83328145|FG004|Overall Study|Incorrect Infusion Duration|20|||
47054804|NCT02717754|83328146|FG005|Overall Study|Incorrect Infusion Duration|20|||
47054805|NCT02717130|83328156|FG000|Overall Study|Withdrawal by Subject|1|||
47054806|NCT02717130|83328156|FG000|Overall Study|Adverse Event|1|||
47054807|NCT02717130|83328156|FG000|Overall Study|Physician Decision|1|||
47054808|NCT02717130|83328156|FG000|Overall Study|Study Closure|4|||
47054809|NCT02192502|83328176|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
47054810|NCT02192502|83328177|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
47054811|NCT02192502|83328176|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
46754980|NCT01386385|82972693|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
46754981|NCT01386385|82972694|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
46754982|NCT01386385|82972695|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
46754983|NCT01386385|82972696|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
46754984|NCT01386385|82972697|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
46754985|NCT01386385|82972690|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
46754986|NCT01386385|82972691|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
46754987|NCT01386385|82972692|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
46754988|NCT01386385|82972693|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
46754989|NCT01386385|82972694|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
46754990|NCT01386385|82972695|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
46754991|NCT01386385|82972696|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
46754992|NCT01386385|82972697|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
46754993|NCT01386385|82972690|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
46928202|NCT02809833|83162992|FG000|Overall Study|Death|3|||
46928203|NCT02809833|83162992|FG000|Overall Study|Intolerance|54|||
46636473|NCT01514136|82810256|FG005|Test Period 2; Test C*|holiday|0|||
46928204|NCT02809833|83162992|FG000|Overall Study|Lack of Efficacy|89|||
46928205|NCT02809833|83162992|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
46928206|NCT02809833|83162992|FG000|Overall Study|Noncompliance|1|||
47054812|NCT02192502|83328177|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
47054813|NCT02192502|83328176|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
46928207|NCT02809833|83162992|FG000|Overall Study|Withdrawal by Subject|34|||
46928208|NCT02809833|83162992|FG000|Overall Study|Lost to Follow-up|35|||
46928209|NCT02809833|83162992|FG000|Overall Study|Adverse Event (AE)|24|||
46928210|NCT02809833|83162992|FG000|Overall Study|Other|5|||
46928211|NCT02809833|83162992|FG000|Overall Study|Missing Information|52|||
46928212|NCT02797262|83162998|FG000|Overall Study|Withdrawal by Subject|5|||
46928213|NCT02797262|83162999|FG001|Overall Study|Withdrawal by Subject|1|||
46928214|NCT02797262|83162998|FG000|Overall Study|Lost to Follow-up|10|||
46636474|NCT01514136|82810257|FG006|Test Period 2; Test C*|holiday|1|||
46754994|NCT01386385|82972691|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
46928215|NCT02797262|83162999|FG001|Overall Study|Lost to Follow-up|7|||
46928216|NCT02797262|83162998|FG000|Overall Study|Death|1|||
46928217|NCT02797262|83162999|FG001|Overall Study|Death|2|||
46928218|NCT02797262|83162998|FG000|Overall Study|Adverse Event|1|||
46928219|NCT02797262|83162999|FG001|Overall Study|Adverse Event|0|||
46754995|NCT01386385|82972692|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
46754996|NCT01386385|82972693|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
46754997|NCT01386385|82972694|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
46754998|NCT01386385|82972695|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
46754999|NCT01386385|82972696|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
46755000|NCT01386385|82972697|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
46755001|NCT01386385|82972690|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
46755002|NCT01386385|82972691|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
46755003|NCT01386385|82972692|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
46755004|NCT01386385|82972693|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
46755005|NCT01386385|82972694|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
46755006|NCT01386385|82972695|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
46755007|NCT01386385|82972696|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
46755008|NCT01386385|82972697|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
46755009|NCT01275677|82972720|FG000|Overall Study|Not at risk for recurrence.|1|||
46755010|NCT01275677|82972721|FG001|Overall Study|Not at risk for recurrence.|1|||
46755011|NCT01275677|82972720|FG000|Overall Study|No follow-up|26|||
46755012|NCT01275677|82972721|FG001|Overall Study|No follow-up|37|||
46755013|NCT01275677|82972720|FG000|Overall Study|No clinical follow up.|1|||
46755014|NCT01275677|82972721|FG001|Overall Study|No clinical follow up.|4|||
46755015|NCT01251861|82972729|FG000|Overall Study|Disease progression|6|||
46755016|NCT01251861|82972730|FG001|Overall Study|Disease progression|6|||
46755017|NCT01251861|82972729|FG000|Overall Study|Adverse Event|2|||
46755018|NCT01251861|82972730|FG001|Overall Study|Adverse Event|17|||
46755019|NCT01251861|82972729|FG000|Overall Study|Withdrawal by Subject|2|||
46755020|NCT01251861|82972730|FG001|Overall Study|Withdrawal by Subject|2|||
46755021|NCT01251861|82972729|FG000|Overall Study|Alternative therapy|1|||
46755022|NCT01251861|82972730|FG001|Overall Study|Alternative therapy|0|||
46755023|NCT01251861|82972729|FG000|Overall Study|Other complicating disease|0|||
46755024|NCT01251861|82972730|FG001|Overall Study|Other complicating disease|1|||
46755025|NCT01251861|82972729|FG000|Overall Study|Physician Decision|1|||
46755026|NCT01251861|82972730|FG001|Overall Study|Physician Decision|0|||
46755027|NCT01251861|82972729|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
46755028|NCT01251861|82972730|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
46755029|NCT01251861|82972729|FG000|Overall Study|Other|1|||
46755030|NCT01251861|82972730|FG001|Overall Study|Other|0|||
46755031|NCT01251861|82972729|FG000|Overall Study|Never started therapy|4|||
46755032|NCT01251861|82972730|FG001|Overall Study|Never started therapy|1|||
46755033|NCT01251861|82972729|FG000|Overall Study|Potential interaction of drugs|0|||
46755034|NCT01251861|82972730|FG001|Overall Study|Potential interaction of drugs|1|||
46755035|NCT01142388|82972738|FG000|Overall Study|Lack of Efficacy|21|||
46755036|NCT01142388|82972739|FG001|Overall Study|Lack of Efficacy|31|||
46755037|NCT01142388|82972738|FG000|Overall Study|Adverse Event|9|||
46755038|NCT01142388|82972739|FG001|Overall Study|Adverse Event|5|||
46755039|NCT01142388|82972738|FG000|Overall Study|Death|3|||
46755040|NCT01142388|82972739|FG001|Overall Study|Death|2|||
46755041|NCT01142388|82972738|FG000|Overall Study|Withdrawal by Subject|5|||
46755042|NCT01142388|82972739|FG001|Overall Study|Withdrawal by Subject|3|||
46755043|NCT01142388|82972738|FG000|Overall Study|Alternative therapy|1|||
46755044|NCT01142388|82972739|FG001|Overall Study|Alternative therapy|0|||
46755045|NCT01142388|82972738|FG000|Overall Study|Other complications|0|||
46755046|NCT01142388|82972739|FG001|Overall Study|Other complications|2|||
46755047|NCT01142388|82972738|FG000|Overall Study|Other|1|||
46755048|NCT01142388|82972739|FG001|Overall Study|Other|1|||
46928220|NCT02797262|83162998|FG000|Overall Study|COVID-19|2|||
46755049|NCT01142388|82972738|FG000|Overall Study|Never started therapy|7|||
46755050|NCT01142388|82972739|FG001|Overall Study|Never started therapy|3|||
46755051|NCT01134614|82972747|FG000|Overall Study|Still on treatment as of March 2013|21|||
46928221|NCT02797262|83162999|FG001|Overall Study|COVID-19|1|||
46928222|NCT02797262|83162998|FG000|Overall Study|Out-of-country|1|||
46755052|NCT01134614|82972748|FG001|Overall Study|Still on treatment as of March 2013|13|||
46755053|NCT01134614|82972747|FG000|Overall Study|Progressive disease|60|||
46755054|NCT01134614|82972748|FG001|Overall Study|Progressive disease|54|||
46755055|NCT01134614|82972747|FG000|Overall Study|Adverse Event|26|||
46755056|NCT01134614|82972748|FG001|Overall Study|Adverse Event|39|||
46755057|NCT01134614|82972747|FG000|Overall Study|Death|5|||
46755058|NCT01134614|82972748|FG001|Overall Study|Death|8|||
46755059|NCT01134614|82972747|FG000|Overall Study|Withdrawal by Subject|3|||
46755060|NCT01134614|82972748|FG001|Overall Study|Withdrawal by Subject|2|||
46755061|NCT01134614|82972747|FG000|Overall Study|Alternative therapy|2|||
46812766|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
46812767|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
46812768|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
46812769|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
46812770|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
46812771|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
46812772|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
46812773|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
46812774|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
46812775|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
46812776|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
46812777|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
46812778|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
46812779|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
46812780|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
46812781|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
46812782|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
46812783|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
46812784|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
46812785|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
46812786|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
46812787|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
46928223|NCT02797262|83162999|FG001|Overall Study|Out-of-country|0|||
46928224|NCT02809053|83163007|FG000|Overall Study|Death|0|||
46812788|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
46812789|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
46812790|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
46812791|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
46928225|NCT02809053|83163008|FG001|Overall Study|Death|1|||
46928226|NCT02809053|83163007|FG000|Overall Study|Lost to Follow-up|3|||
46928227|NCT02809053|83163008|FG001|Overall Study|Lost to Follow-up|1|||
46928228|NCT02809053|83163007|FG000|Overall Study|Withdrawal by Subject|2|||
46928229|NCT02809053|83163008|FG001|Overall Study|Withdrawal by Subject|3|||
46928230|NCT02809053|83163007|FG000|Overall Study|Disease Progression|2|||
46928231|NCT02809053|83163008|FG001|Overall Study|Disease Progression|1|||
46928232|NCT02808975|83163016|FG000|Overall Study|Adverse Event|3|||
46928233|NCT02808975|83163017|FG001|Overall Study|Adverse Event|4|||
46928234|NCT02808975|83163016|FG000|Overall Study|Withdrew consent|9|||
46928235|NCT02808975|83163017|FG001|Overall Study|Withdrew consent|8|||
46928236|NCT02808975|83163016|FG000|Overall Study|Lost to Follow-up|4|||
46928237|NCT02808975|83163017|FG001|Overall Study|Lost to Follow-up|6|||
46928238|NCT02808975|83163016|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
46928239|NCT02808975|83163017|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
46928240|NCT02808975|83163016|FG000|Overall Study|Other, not specified|5|||
46928241|NCT02808975|83163017|FG001|Overall Study|Other, not specified|1|||
46928242|NCT02976038|83163023|FG000|Overall Study|Physician Decision|22|||
46928243|NCT02976038|83163023|FG000|Overall Study|Withdrawal by Subject|3|||
46928244|NCT02976038|83163023|FG000|Overall Study|Lost to Follow-up|2|||
46928245|NCT02976038|83163023|FG000|Overall Study|Adverse Event|1|||
46928246|NCT02808819|83163048|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
46928247|NCT02808819|83163049|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
46928248|NCT02808819|83163048|FG000|Overall Study|Withdrawal by Subject|10|||
46928249|NCT02808819|83163049|FG001|Overall Study|Withdrawal by Subject|13|||
46928250|NCT02808819|83163048|FG000|Overall Study|Site terminated by sponsor|2|||
46928251|NCT02808819|83163049|FG001|Overall Study|Site terminated by sponsor|0|||
46928252|NCT02808819|83163048|FG000|Overall Study|Pregnancy|1|||
46928253|NCT02808819|83163049|FG001|Overall Study|Pregnancy|0|||
46928254|NCT02808819|83163048|FG000|Overall Study|Lost to Follow-up|1|||
46928255|NCT02808819|83163049|FG001|Overall Study|Lost to Follow-up|6|||
46928256|NCT02808819|83163048|FG000|Overall Study|Protocol Violation|0|||
46812792|NCT03742037|83032457|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
46812793|NCT03742037|83032458|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
46812794|NCT03742037|83032459|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
46928257|NCT02808819|83163049|FG001|Overall Study|Protocol Violation|1|||
46928258|NCT02808819|83163048|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
46928259|NCT02808819|83163049|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
46928260|NCT02808819|83163048|FG000|Overall Study|Death|1|||
46928261|NCT02808819|83163049|FG001|Overall Study|Death|0|||
46928262|NCT02808819|83163048|FG000|Overall Study|Adverse Event|3|||
46928263|NCT02808819|83163049|FG001|Overall Study|Adverse Event|4|||
46928264|NCT02808429|83163059|FG000|Overall Study|Lost to Follow-up|1|||
46928265|NCT02808429|83163060|FG001|Overall Study|Lost to Follow-up|0|||
46928266|NCT02808429|83163061|FG002|Overall Study|Lost to Follow-up|0|||
46928267|NCT02808429|83163059|FG000|Overall Study|Protocol Violation|0|||
46928268|NCT02808429|83163060|FG001|Overall Study|Protocol Violation|1|||
46928269|NCT02808429|83163061|FG002|Overall Study|Protocol Violation|0|||
46928270|NCT02808429|83163059|FG000|Overall Study|Premature study termination by sponsor|2|||
46928271|NCT02808429|83163060|FG001|Overall Study|Premature study termination by sponsor|0|||
46812795|NCT03742037|83032460|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
46812796|NCT03742037|83032461|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
46812797|NCT03742037|83032462|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
46812798|NCT03742037|83032463|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
46812799|NCT03742037|83032457|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
46812800|NCT03742037|83032458|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
46812801|NCT03742037|83032459|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
46812802|NCT03742037|83032460|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
46812803|NCT03742037|83032461|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
46812804|NCT03742037|83032462|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
46812805|NCT03742037|83032463|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
46812806|NCT03742037|83032457|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
46812807|NCT03742037|83032458|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
46812808|NCT03742037|83032459|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
46812809|NCT03742037|83032460|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
46812810|NCT03742037|83032461|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
46812811|NCT03742037|83032462|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
46812812|NCT03742037|83032463|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
46812813|NCT03742037|83032457|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
46812814|NCT03742037|83032458|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
46812815|NCT03742037|83032459|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
46812816|NCT03742037|83032460|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
46812817|NCT03742037|83032461|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
46812818|NCT03742037|83032462|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
46928272|NCT02808429|83163061|FG002|Overall Study|Premature study termination by sponsor|1|||
46928273|NCT02808429|83163059|FG000|Overall Study|Relocation|0|||
46928274|NCT02808429|83163060|FG001|Overall Study|Relocation|0|||
46928275|NCT02808429|83163061|FG002|Overall Study|Relocation|1|||
46636475|NCT01514136|82810258|FG007|Test Period 2; Test C*|holiday|0|||
46636476|NCT01514136|82810251|FG000|Test Period 2; Test C*|Protocol Violation|0|||
46812819|NCT03742037|83032463|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
46812820|NCT03742037|83032457|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
46812821|NCT03742037|83032458|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
46812822|NCT03742037|83032459|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
46812823|NCT03742037|83032460|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
46812824|NCT03742037|83032461|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
46812825|NCT03742037|83032462|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
46812826|NCT03742037|83032463|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
46812827|NCT03742037|83032457|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
46812828|NCT03742037|83032458|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
46812829|NCT03742037|83032459|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
46812830|NCT03742037|83032460|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
46812831|NCT03742037|83032461|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
46812832|NCT03742037|83032462|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
46812833|NCT03742037|83032463|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
46812834|NCT03742037|83032457|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
46812835|NCT03742037|83032458|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
46812836|NCT03742037|83032459|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
46812837|NCT03742037|83032460|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
46812838|NCT03742037|83032461|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
46928276|NCT01594762|83163071|FG000|Overall Study|Withdrawal by Subject|1|||
46928277|NCT01594762|83163072|FG001|Overall Study|Withdrawal by Subject|0|||
46928278|NCT01594762|83163071|FG000|Overall Study|Lost to Follow-up|10|||
46636477|NCT01514136|82810252|FG001|Test Period 2; Test C*|Protocol Violation|0|||
46636478|NCT01514136|82810253|FG002|Test Period 2; Test C*|Protocol Violation|0|||
46928279|NCT01594762|83163072|FG001|Overall Study|Lost to Follow-up|10|||
46928280|NCT02615470|83163080|FG000|Overall Study|Lost to Follow-up|21|||
46928281|NCT02615470|83163081|FG001|Overall Study|Lost to Follow-up|32|||
46928282|NCT02806947|83163089|FG000|Overall Study|Withdrawal by Subject|5|||
46636479|NCT01514136|82810254|FG003|Test Period 2; Test C*|Protocol Violation|0|||
46812839|NCT03742037|83032462|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
46812840|NCT03742037|83032463|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
46812841|NCT03742037|83032457|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
46812842|NCT03742037|83032458|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
46812843|NCT03742037|83032459|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
46812844|NCT03742037|83032460|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
46812845|NCT03742037|83032461|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
46755062|NCT01134614|82972748|FG001|Overall Study|Alternative therapy|0|||
46755063|NCT01134614|82972747|FG000|Overall Study|Complicating disease|2|||
46755064|NCT01134614|82972748|FG001|Overall Study|Complicating disease|1|||
46812846|NCT03742037|83032462|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
46812847|NCT03742037|83032463|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
46812848|NCT03714815|83032480|FG000|Overall Study|Physician Decision|2|||
46812849|NCT03714815|83032480|FG000|Overall Study|Withdrawal by Subject|2|||
46812850|NCT03714815|83032480|FG000|Overall Study|Death|11|||
46812851|NCT03640312|83032490|FG000|Overall Study|Lost to Follow-up|3|||
46812852|NCT03640312|83032491|FG001|Overall Study|Lost to Follow-up|6|||
46812853|NCT02254278|83032503|FG000|Overall Study|Protocol Violation|1|||
46812854|NCT02254278|83032504|FG001|Overall Study|Protocol Violation|1|||
46812855|NCT01998841|83032516|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
46812856|NCT01998841|83032517|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
46812857|NCT01998841|83032518|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
46812858|NCT01998841|83032519|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
46812859|NCT01998841|83032520|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
46812860|NCT01998841|83032516|FG000|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
46812861|NCT01998841|83032517|FG001|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
46812862|NCT01998841|83032518|FG002|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
46755065|NCT01134614|82972747|FG000|Overall Study|Physician's decision|0|||
46755066|NCT01134614|82972748|FG001|Overall Study|Physician's decision|1|||
46755067|NCT01134614|82972747|FG000|Overall Study|Never started treatment|4|||
46755068|NCT01134614|82972748|FG001|Overall Study|Never started treatment|1|||
46755069|NCT01134614|82972747|FG000|Overall Study|Pt received tx not allowed on study|0|||
46755070|NCT01134614|82972748|FG001|Overall Study|Pt received tx not allowed on study|1|||
46812863|NCT01998841|83032519|FG003|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|147|||
46812864|NCT01998841|83032520|FG004|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|72|||
46812865|NCT01607879|83032530|FG000|Overall Study|Death|1|||
46812866|NCT01607879|83032531|FG001|Overall Study|Death|0|||
46812867|NCT00352027|83032542|FG000|Overall Study|Progressive disease|3|||
46812868|NCT00440271|83032584|FG000|Overall Study|Protocol Violation|1|||
46812869|NCT00440271|83032585|FG001|Overall Study|Protocol Violation|1|||
46812870|NCT00440271|83032584|FG000|Overall Study|Adverse Event|0|||
46812871|NCT00440271|83032585|FG001|Overall Study|Adverse Event|1|||
46812872|NCT00440271|83032584|FG000|Overall Study|Lost to Follow-up|1|||
46812873|NCT00440271|83032585|FG001|Overall Study|Lost to Follow-up|0|||
46812874|NCT00440271|83032584|FG000|Overall Study|Withdrawal by Subject|0|||
46812875|NCT00440271|83032585|FG001|Overall Study|Withdrawal by Subject|2|||
46812876|NCT00440271|83032584|FG000|Overall Study|Lack of Efficacy|0|||
46812877|NCT00440271|83032585|FG001|Overall Study|Lack of Efficacy|1|||
46812878|NCT00440271|83032584|FG000|Overall Study|Due to closure of trial|8|||
46812879|NCT00440271|83032585|FG001|Overall Study|Due to closure of trial|10|||
46812880|NCT00440271|83032584|FG000|Overall Study|Other|2|||
46812881|NCT00440271|83032585|FG001|Overall Study|Other|0|||
46812882|NCT00346216|83032594|FG000|Overall Study|Other|181|||
46812883|NCT00346216|83032595|FG001|Overall Study|Other|231|||
46812884|NCT00346216|83032596|FG002|Overall Study|Other|205|||
46812885|NCT00346216|83032594|FG000|Overall Study|No longer willing to participate|600|||
46812886|NCT00346216|83032595|FG001|Overall Study|No longer willing to participate|606|||
46812887|NCT00346216|83032596|FG002|Overall Study|No longer willing to participate|585|||
46812888|NCT00346216|83032594|FG000|Overall Study|Withdrawal by Subject|661|||
46812889|NCT00346216|83032595|FG001|Overall Study|Withdrawal by Subject|692|||
46812890|NCT00346216|83032596|FG002|Overall Study|Withdrawal by Subject|651|||
46812891|NCT00346216|83032594|FG000|Overall Study|Lost to Follow-up|611|||
46812892|NCT00346216|83032595|FG001|Overall Study|Lost to Follow-up|588|||
46812893|NCT00346216|83032596|FG002|Overall Study|Lost to Follow-up|542|||
46812894|NCT00346216|83032594|FG000|Overall Study|Physician Decision|80|||
47073132|NCT01045161|83361494|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
46755071|NCT01134614|82972747|FG000|Overall Study|Symptomatic deterioration|0|||
46755072|NCT01134614|82972748|FG001|Overall Study|Symptomatic deterioration|1|||
46755073|NCT01134614|82972747|FG000|Overall Study|Patient in hospice care|0|||
46928283|NCT02806947|83163090|FG001|Overall Study|Withdrawal by Subject|1|||
46928284|NCT02806713|83163098|FG000|Overall Study|Urethral injury during procedure|1|||
46928285|NCT02806713|83163099|FG001|Overall Study|Urethral injury during procedure|0|||
47054814|NCT02192502|83328177|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
47054815|NCT01781429|83328198|FG000|Overall Study|Death|0|||
47054816|NCT01781429|83328199|FG001|Overall Study|Death|0|||
46812895|NCT00346216|83032595|FG001|Overall Study|Physician Decision|76|||
46812896|NCT00346216|83032596|FG002|Overall Study|Physician Decision|59|||
46812897|NCT00346216|83032594|FG000|Overall Study|Does not meet entrance criteria|13|||
46812898|NCT00346216|83032595|FG001|Overall Study|Does not meet entrance criteria|10|||
46755074|NCT01134614|82972748|FG001|Overall Study|Patient in hospice care|1|||
46755075|NCT00601900|82972756|FG000|Overall Study|Withdrawal by Subject|0|||
46755076|NCT00601900|82972757|FG001|Overall Study|Withdrawal by Subject|3|||
46755077|NCT03905863|82972765|FG000|Overall Study|Adverse Event|2|||
46755078|NCT03905863|82972766|FG001|Overall Study|Adverse Event|4|||
46755079|NCT03905863|82972765|FG000|Overall Study|Withdrawal by Subject|2|||
46755080|NCT03905863|82972766|FG001|Overall Study|Withdrawal by Subject|2|||
46755081|NCT03905863|82972765|FG000|Overall Study|Physician Decision|0|||
46755082|NCT03905863|82972766|FG001|Overall Study|Physician Decision|3|||
46755083|NCT03905863|82972765|FG000|Overall Study|Lost to Follow-up|1|||
46755084|NCT03905863|82972766|FG001|Overall Study|Lost to Follow-up|0|||
46755085|NCT03905863|82972765|FG000|Overall Study|Protocol Violation|0|||
46755086|NCT03905863|82972766|FG001|Overall Study|Protocol Violation|2|||
46755087|NCT03905863|82972765|FG000|Overall Study|Death|0|||
46755088|NCT03905863|82972766|FG001|Overall Study|Death|1|||
46755089|NCT00539305|82972787|FG000|Overall Study|Adverse Event|1|||
46755090|NCT00539305|82972788|FG001|Overall Study|Adverse Event|0|||
46755091|NCT00539305|82972787|FG000|Overall Study|Substance Use|0|||
46755092|NCT00539305|82972788|FG001|Overall Study|Substance Use|1|||
46755093|NCT00539305|82972787|FG000|Overall Study|Withdrawal by Subject|0|||
46755094|NCT00539305|82972788|FG001|Overall Study|Withdrawal by Subject|1|||
46755095|NCT00877032|82972820|FG000|Overall Study|Did not meet entrance criteria|0|||
46812899|NCT00346216|83032596|FG002|Overall Study|Does not meet entrance criteria|8|||
46812900|NCT00346216|83032594|FG000|Overall Study|Death|189|||
46812901|NCT00346216|83032595|FG001|Overall Study|Death|192|||
46812902|NCT00346216|83032596|FG002|Overall Study|Death|228|||
46812903|NCT00346216|83032594|FG000|Overall Study|Study terminated by sponsor|11|||
46812904|NCT00346216|83032595|FG001|Overall Study|Study terminated by sponsor|4|||
46812905|NCT00346216|83032596|FG002|Overall Study|Study terminated by sponsor|8|||
46928286|NCT02806713|83163098|FG000|Overall Study|cancelled surgery|1|||
46928287|NCT02806713|83163099|FG001|Overall Study|cancelled surgery|2|||
47054817|NCT01781429|83328200|FG002|Overall Study|Death|0|||
47054818|NCT01781429|83328201|FG003|Overall Study|Death|0|||
47054819|NCT01781429|83328202|FG004|Overall Study|Death|0|||
47054820|NCT01781429|83328203|FG005|Overall Study|Death|0|||
47054821|NCT01781429|83328204|FG006|Overall Study|Death|0|||
47054822|NCT01781429|83328205|FG007|Overall Study|Death|0|||
47054823|NCT01781429|83328206|FG008|Overall Study|Death|0|||
47054824|NCT01781429|83328207|FG009|Overall Study|Death|1|||
47054825|NCT01781429|83328208|FG010|Overall Study|Death|0|||
47054826|NCT01781429|83328209|FG011|Overall Study|Death|0|||
47054827|NCT01781429|83328210|FG012|Overall Study|Death|1|||
47054828|NCT01781429|83328211|FG013|Overall Study|Death|0|||
47054829|NCT01781429|83328212|FG014|Overall Study|Death|1|||
47054830|NCT01781429|83328213|FG015|Overall Study|Death|0|||
47054831|NCT01781429|83328198|FG000|Overall Study|Withdrawal by Subject|0|||
47054832|NCT01781429|83328199|FG001|Overall Study|Withdrawal by Subject|0|||
47054833|NCT01781429|83328200|FG002|Overall Study|Withdrawal by Subject|0|||
47054834|NCT01781429|83328201|FG003|Overall Study|Withdrawal by Subject|0|||
47054835|NCT01781429|83328202|FG004|Overall Study|Withdrawal by Subject|0|||
47054836|NCT01781429|83328203|FG005|Overall Study|Withdrawal by Subject|0|||
47054837|NCT01781429|83328204|FG006|Overall Study|Withdrawal by Subject|0|||
47054838|NCT01781429|83328205|FG007|Overall Study|Withdrawal by Subject|0|||
47054839|NCT01781429|83328206|FG008|Overall Study|Withdrawal by Subject|1|||
46755096|NCT00877032|82972821|FG001|Overall Study|Did not meet entrance criteria|0|||
47054840|NCT01781429|83328207|FG009|Overall Study|Withdrawal by Subject|3|||
47054841|NCT01781429|83328208|FG010|Overall Study|Withdrawal by Subject|1|||
46755097|NCT00877032|82972822|FG002|Overall Study|Did not meet entrance criteria|0|||
46755098|NCT00877032|82972823|FG003|Overall Study|Did not meet entrance criteria|1|||
46755099|NCT00877032|82972824|FG004|Overall Study|Did not meet entrance criteria|0|||
46755100|NCT00877032|82972825|FG005|Overall Study|Did not meet entrance criteria|0|||
46755101|NCT00877032|82972826|FG006|Overall Study|Did not meet entrance criteria|2|||
46812906|NCT00346216|83032594|FG000|Overall Study|Missing Subject Summary Status|62|||
47054842|NCT01781429|83328209|FG011|Overall Study|Withdrawal by Subject|1|||
47054843|NCT01781429|83328210|FG012|Overall Study|Withdrawal by Subject|5|||
47054844|NCT01781429|83328211|FG013|Overall Study|Withdrawal by Subject|2|||
47054845|NCT01781429|83328212|FG014|Overall Study|Withdrawal by Subject|3|||
47054846|NCT01781429|83328213|FG015|Overall Study|Withdrawal by Subject|0|||
47054847|NCT01781429|83328198|FG000|Overall Study|Disease Progression|1|||
46755102|NCT00538681|82972865|FG000|Overall Study|Progressive Disease|7|||
46755103|NCT00538681|82972866|FG001|Overall Study|Progressive Disease|0|||
46755104|NCT00538681|82972867|FG002|Overall Study|Progressive Disease|1|||
46755105|NCT00538681|82972868|FG003|Overall Study|Progressive Disease|0|||
46755106|NCT00538681|82972865|FG000|Overall Study|Sponsor Decision|1|||
46755107|NCT00538681|82972866|FG001|Overall Study|Sponsor Decision|3|||
46755108|NCT00538681|82972867|FG002|Overall Study|Sponsor Decision|8|||
46755109|NCT00538681|82972868|FG003|Overall Study|Sponsor Decision|9|||
46755110|NCT00538681|82972865|FG000|Overall Study|Adverse Event|1|||
46755111|NCT00538681|82972866|FG001|Overall Study|Adverse Event|1|||
46755112|NCT00538681|82972867|FG002|Overall Study|Adverse Event|1|||
46755113|NCT00538681|82972868|FG003|Overall Study|Adverse Event|0|||
46755114|NCT00538681|82972865|FG000|Overall Study|Death|0|||
46755115|NCT00538681|82972866|FG001|Overall Study|Death|0|||
46755116|NCT00538681|82972867|FG002|Overall Study|Death|1|||
46755117|NCT00538681|82972868|FG003|Overall Study|Death|1|||
46755118|NCT00538681|82972865|FG000|Overall Study|Investigator Decision|0|||
46755119|NCT00538681|82972866|FG001|Overall Study|Investigator Decision|0|||
46755120|NCT00538681|82972867|FG002|Overall Study|Investigator Decision|0|||
46755121|NCT00538681|82972868|FG003|Overall Study|Investigator Decision|1|||
46812907|NCT00346216|83032595|FG001|Overall Study|Missing Subject Summary Status|61|||
46812908|NCT00346216|83032596|FG002|Overall Study|Missing Subject Summary Status|62|||
46812909|NCT00417963|83032604|FG000|Overall Study|Lost to Follow-up|3|||
46812910|NCT00417963|83032604|FG000|Overall Study|Withdrawal by Subject|18|||
46812911|NCT00417963|83032604|FG000|Overall Study|Death|17|||
46812912|NCT00417963|83032604|FG000|Overall Study|Study device could not be deployed|3|||
46812913|NCT00429273|83032616|FG000|Overall Study|Lost to Follow-up|1|||
46812914|NCT00429273|83032617|FG001|Overall Study|Lost to Follow-up|2|||
46812915|NCT00429273|83032618|FG002|Overall Study|Lost to Follow-up|2|||
46812916|NCT00429273|83032616|FG000|Overall Study|Physician Decision|6|||
46812917|NCT00429273|83032617|FG001|Overall Study|Physician Decision|5|||
46812918|NCT00429273|83032618|FG002|Overall Study|Physician Decision|5|||
46812919|NCT00429273|83032616|FG000|Overall Study|Adverse Event|1|||
46812920|NCT00429273|83032617|FG001|Overall Study|Adverse Event|1|||
46812921|NCT00429273|83032618|FG002|Overall Study|Adverse Event|2|||
46812922|NCT00359632|83032628|FG000|Overall Study|Death|2|||
46812923|NCT00359632|83032629|FG001|Overall Study|Death|0|||
46812924|NCT00359632|83032628|FG000|Overall Study|Adverse Event|1|||
46812925|NCT00359632|83032629|FG001|Overall Study|Adverse Event|0|||
46812926|NCT00359632|83032628|FG000|Overall Study|Non-compliance with visit schedule|1|||
46812927|NCT00359632|83032629|FG001|Overall Study|Non-compliance with visit schedule|0|||
46812928|NCT00417885|83032635|FG000|Overall Study|Adverse Event|1|||
46812929|NCT00417885|83032635|FG000|Overall Study|Objective Progression or Relapse|3|||
46812930|NCT00417885|83032635|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
46812931|NCT04488770|83032652|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812932|NCT04488770|83032653|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812933|NCT04488770|83032654|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812934|NCT04488770|83032655|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
46812935|NCT04488770|83032656|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812936|NCT04488770|83032657|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812937|NCT04488770|83032658|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812938|NCT04488770|83032659|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46928288|NCT02807493|83163107|FG000|Overall Study|Adverse Event|5|||
47054848|NCT01781429|83328199|FG001|Overall Study|Disease Progression|0|||
47054849|NCT01781429|83328200|FG002|Overall Study|Disease Progression|1|||
47054850|NCT01781429|83328201|FG003|Overall Study|Disease Progression|1|||
46636480|NCT01514136|82810255|FG004|Test Period 2; Test C*|Protocol Violation|0|||
46636481|NCT01514136|82810256|FG005|Test Period 2; Test C*|Protocol Violation|0|||
46636482|NCT01514136|82810257|FG006|Test Period 2; Test C*|Protocol Violation|1|||
46636483|NCT01514136|82810258|FG007|Test Period 2; Test C*|Protocol Violation|0|||
46636484|NCT01513590|82810286|FG000|Overall Study|Adverse Event|2|||
46812939|NCT04488770|83032660|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
47054851|NCT01781429|83328202|FG004|Overall Study|Disease Progression|1|||
46636485|NCT01513590|82810287|FG001|Overall Study|Adverse Event|3|||
46636486|NCT01513590|82810286|FG000|Overall Study|Withdrawal Criteria|3|||
46755122|NCT00876018|82972882|FG000|Overall Study|Lost to Follow-up|0|||
46755123|NCT00876018|82972883|FG001|Overall Study|Lost to Follow-up|1|||
46755124|NCT00876018|82972884|FG002|Overall Study|Lost to Follow-up|1|||
46812940|NCT04488770|83032661|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812941|NCT04488770|83032662|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812942|NCT04488770|83032663|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46755125|NCT00876018|82972882|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
46928289|NCT02807493|83163108|FG001|Overall Study|Adverse Event|2|||
47054852|NCT01781429|83328203|FG005|Overall Study|Disease Progression|4|||
46928290|NCT02807493|83163107|FG000|Overall Study|Lost to Follow-up|6|||
47054853|NCT01781429|83328204|FG006|Overall Study|Disease Progression|7|||
46928291|NCT02807493|83163108|FG001|Overall Study|Lost to Follow-up|0|||
46928292|NCT02807493|83163107|FG000|Overall Study|Physician Decision|4|||
46928293|NCT02807493|83163108|FG001|Overall Study|Physician Decision|1|||
46928294|NCT02807493|83163107|FG000|Overall Study|Protocol Violation|7|||
46928295|NCT02807493|83163108|FG001|Overall Study|Protocol Violation|0|||
46928296|NCT02807493|83163107|FG000|Overall Study|Withdrawal by Subject|17|||
47054854|NCT01781429|83328205|FG007|Overall Study|Disease Progression|4|||
46755126|NCT00876018|82972883|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
46755127|NCT00876018|82972884|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
46755128|NCT03885934|82972909|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
46755129|NCT03885934|82972910|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
46755130|NCT03885934|82972911|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
46755131|NCT03885934|82972912|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
46755132|NCT03885934|82972913|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
46755133|NCT03885934|82972914|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
46755134|NCT04417894|82972930|FG000|Overall Study|Lost to Follow-up|3|||
46755135|NCT04417894|82972931|FG001|Overall Study|Lost to Follow-up|0|||
46755136|NCT04417894|82972930|FG000|Overall Study|Withdrawal by Subject|7|||
46755137|NCT04417894|82972931|FG001|Overall Study|Withdrawal by Subject|6|||
46755138|NCT04417894|82972930|FG000|Overall Study|Lack of Efficacy|3|||
46755139|NCT04417894|82972931|FG001|Overall Study|Lack of Efficacy|1|||
46755140|NCT00875706|82972944|FG000|Overall Study|Withdrawal by Subject|1|||
46755141|NCT00875706|82972945|FG001|Overall Study|Withdrawal by Subject|0|||
46755142|NCT00875706|82972946|FG002|Overall Study|Withdrawal by Subject|0|||
46755143|NCT04399889|82972957|FG000|Overall Study|Death|5|||
46755144|NCT04399889|82972958|FG001|Overall Study|Death|1|||
46755145|NCT04399889|82972959|FG002|Overall Study|Death|1|||
46755146|NCT00837265|82972974|FG000|Pilot Phase|Withdrawal by Subject|0|||
46755147|NCT00837265|82972975|FG001|Pilot Phase|Withdrawal by Subject|2|||
46755148|NCT00837265|82972976|FG002|Pilot Phase|Withdrawal by Subject|3|||
46755149|NCT00837265|82972977|FG003|Pilot Phase|Withdrawal by Subject|2|||
46755150|NCT00837265|82972978|FG004|Pilot Phase|Withdrawal by Subject|0|||
46755151|NCT00837265|82972979|FG005|Pilot Phase|Withdrawal by Subject|0|||
46755152|NCT00837265|82972980|FG006|Pilot Phase|Withdrawal by Subject|0|||
46755153|NCT00837265|82972974|FG000|Pilot Phase|Decision of the investigator|2|||
46755154|NCT00837265|82972975|FG001|Pilot Phase|Decision of the investigator|1|||
46755155|NCT00837265|82972976|FG002|Pilot Phase|Decision of the investigator|0|||
46755156|NCT00837265|82972977|FG003|Pilot Phase|Decision of the investigator|0|||
46755157|NCT00837265|82972978|FG004|Pilot Phase|Decision of the investigator|0|||
46755158|NCT00837265|82972979|FG005|Pilot Phase|Decision of the investigator|0|||
46755159|NCT00837265|82972980|FG006|Pilot Phase|Decision of the investigator|0|||
46755160|NCT00837265|82972974|FG000|Pilot Phase|Adverse Event|1|||
46755161|NCT00837265|82972975|FG001|Pilot Phase|Adverse Event|0|||
46755162|NCT00837265|82972976|FG002|Pilot Phase|Adverse Event|0|||
46755163|NCT00837265|82972977|FG003|Pilot Phase|Adverse Event|0|||
46755164|NCT00837265|82972978|FG004|Pilot Phase|Adverse Event|0|||
46755165|NCT00837265|82972979|FG005|Pilot Phase|Adverse Event|0|||
46755166|NCT00837265|82972980|FG006|Pilot Phase|Adverse Event|0|||
46755167|NCT00837265|82972974|FG000|Pilot Phase|Disease progression|0|||
46755168|NCT00837265|82972975|FG001|Pilot Phase|Disease progression|0|||
46755169|NCT00837265|82972976|FG002|Pilot Phase|Disease progression|0|||
46755170|NCT00837265|82972977|FG003|Pilot Phase|Disease progression|1|||
46755171|NCT00837265|82972978|FG004|Pilot Phase|Disease progression|0|||
46755172|NCT00837265|82972979|FG005|Pilot Phase|Disease progression|0|||
46755173|NCT00837265|82972980|FG006|Pilot Phase|Disease progression|0|||
46755174|NCT00837265|82972974|FG000|Pilot Phase|Participant left the city|0|||
46755175|NCT00837265|82972975|FG001|Pilot Phase|Participant left the city|0|||
46755176|NCT00837265|82972976|FG002|Pilot Phase|Participant left the city|0|||
46755177|NCT00837265|82972977|FG003|Pilot Phase|Participant left the city|1|||
46755178|NCT00837265|82972978|FG004|Pilot Phase|Participant left the city|0|||
46755179|NCT00837265|82972979|FG005|Pilot Phase|Participant left the city|0|||
46755180|NCT00837265|82972980|FG006|Pilot Phase|Participant left the city|0|||
46755181|NCT00837265|82972974|FG000|Main Phase|Withdrawal by Subject|0|||
46755182|NCT00837265|82972975|FG001|Main Phase|Withdrawal by Subject|0|||
46755183|NCT00837265|82972976|FG002|Main Phase|Withdrawal by Subject|0|||
46755184|NCT00837265|82972977|FG003|Main Phase|Withdrawal by Subject|0|||
46755185|NCT00837265|82972978|FG004|Main Phase|Withdrawal by Subject|4|||
46755186|NCT00837265|82972979|FG005|Main Phase|Withdrawal by Subject|2|||
46755187|NCT00837265|82972980|FG006|Main Phase|Withdrawal by Subject|1|||
46755188|NCT00837265|82972974|FG000|Main Phase|Decision of the investigator|0|||
46755189|NCT00837265|82972975|FG001|Main Phase|Decision of the investigator|0|||
46755190|NCT00837265|82972976|FG002|Main Phase|Decision of the investigator|0|||
46928297|NCT02807493|83163108|FG001|Overall Study|Withdrawal by Subject|10|||
46755191|NCT00837265|82972977|FG003|Main Phase|Decision of the investigator|0|||
46755192|NCT00837265|82972978|FG004|Main Phase|Decision of the investigator|0|||
46755193|NCT00837265|82972979|FG005|Main Phase|Decision of the investigator|2|||
46755194|NCT00837265|82972980|FG006|Main Phase|Decision of the investigator|1|||
46755195|NCT00837265|82972974|FG000|Main Phase|Adverse Event|0|||
46812943|NCT04488770|83032664|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
46812944|NCT04488770|83032652|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
46812945|NCT04488770|83032653|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812946|NCT04488770|83032654|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812947|NCT04488770|83032655|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812948|NCT04488770|83032656|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812949|NCT04488770|83032657|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812950|NCT04488770|83032658|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812951|NCT04488770|83032659|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812952|NCT04488770|83032660|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812953|NCT04488770|83032661|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812954|NCT04488770|83032662|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812955|NCT04488770|83032663|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812956|NCT04488770|83032664|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
46812957|NCT04488770|83032652|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812958|NCT04488770|83032653|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812959|NCT04488770|83032654|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812960|NCT04488770|83032655|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812961|NCT04488770|83032656|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812962|NCT04488770|83032657|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
46812963|NCT04488770|83032658|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
46812964|NCT04488770|83032659|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812965|NCT04488770|83032660|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812966|NCT04488770|83032661|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812967|NCT04488770|83032662|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812968|NCT04488770|83032663|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812969|NCT04488770|83032664|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
46812970|NCT04488770|83032652|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812971|NCT04488770|83032653|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812972|NCT04488770|83032654|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812973|NCT04488770|83032655|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812974|NCT04488770|83032656|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
46812975|NCT04488770|83032657|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812976|NCT04488770|83032658|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812977|NCT04488770|83032659|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812978|NCT04488770|83032660|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46636487|NCT01513590|82810287|FG001|Overall Study|Withdrawal Criteria|0|||
46755196|NCT00837265|82972975|FG001|Main Phase|Adverse Event|0|||
46755197|NCT00837265|82972976|FG002|Main Phase|Adverse Event|0|||
46755198|NCT00837265|82972977|FG003|Main Phase|Adverse Event|0|||
46755199|NCT00837265|82972978|FG004|Main Phase|Adverse Event|0|||
46755200|NCT00837265|82972979|FG005|Main Phase|Adverse Event|1|||
46755201|NCT00837265|82972980|FG006|Main Phase|Adverse Event|0|||
46755202|NCT00837265|82972974|FG000|Main Phase|Death|0|||
46755203|NCT00837265|82972975|FG001|Main Phase|Death|0|||
46755204|NCT00837265|82972976|FG002|Main Phase|Death|0|||
46755205|NCT00837265|82972977|FG003|Main Phase|Death|0|||
46755206|NCT00837265|82972978|FG004|Main Phase|Death|2|||
46755207|NCT00837265|82972979|FG005|Main Phase|Death|0|||
46755208|NCT00837265|82972980|FG006|Main Phase|Death|1|||
46755209|NCT00837265|82972974|FG000|Main Phase|Lost to Follow-up|0|||
46755210|NCT00837265|82972975|FG001|Main Phase|Lost to Follow-up|0|||
46755211|NCT00837265|82972976|FG002|Main Phase|Lost to Follow-up|0|||
46755212|NCT00837265|82972977|FG003|Main Phase|Lost to Follow-up|0|||
46755213|NCT00837265|82972978|FG004|Main Phase|Lost to Follow-up|1|||
46755214|NCT00837265|82972979|FG005|Main Phase|Lost to Follow-up|0|||
46755215|NCT00837265|82972980|FG006|Main Phase|Lost to Follow-up|0|||
46755216|NCT00837265|82972974|FG000|Main Phase|Principal investigator resignation|0|||
46755217|NCT00837265|82972975|FG001|Main Phase|Principal investigator resignation|0|||
46755218|NCT00837265|82972976|FG002|Main Phase|Principal investigator resignation|0|||
46755219|NCT00837265|82972977|FG003|Main Phase|Principal investigator resignation|0|||
46755220|NCT00837265|82972978|FG004|Main Phase|Principal investigator resignation|2|||
46755221|NCT00837265|82972979|FG005|Main Phase|Principal investigator resignation|0|||
46755222|NCT00837265|82972980|FG006|Main Phase|Principal investigator resignation|0|||
46755223|NCT00837265|82972974|FG000|Main Phase|Participant's personal reason|0|||
46755224|NCT00837265|82972975|FG001|Main Phase|Participant's personal reason|0|||
46755225|NCT00837265|82972976|FG002|Main Phase|Participant's personal reason|0|||
46812979|NCT04488770|83032661|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46928298|NCT02807493|83163107|FG000|Overall Study|Other withdrawal|17|||
46928299|NCT02807493|83163108|FG001|Overall Study|Other withdrawal|0|||
46928300|NCT02807493|83163107|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
46812980|NCT04488770|83032662|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812981|NCT04488770|83032663|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812982|NCT04488770|83032664|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
46812983|NCT00525044|83032710|FG000|Overall Study|Lost to Follow-up|0|||
46812984|NCT00525044|83032711|FG001|Overall Study|Lost to Follow-up|1|||
46812985|NCT00355342|83032719|FG000|Overall Study|Adverse Event|13|||
46812986|NCT00355342|83032720|FG001|Overall Study|Adverse Event|15|||
46812987|NCT00355342|83032719|FG000|Overall Study|Lost to Follow-up|4|||
46812988|NCT00355342|83032720|FG001|Overall Study|Lost to Follow-up|2|||
46812989|NCT00355342|83032719|FG000|Overall Study|Withdrawal by Subject|14|||
46812990|NCT00355342|83032720|FG001|Overall Study|Withdrawal by Subject|11|||
46812991|NCT00355342|83032719|FG000|Overall Study|Sponsor terminated study|2|||
46812992|NCT00355342|83032720|FG001|Overall Study|Sponsor terminated study|2|||
46812993|NCT00355342|83032719|FG000|Overall Study|Overcompliant-PI discretion|1|||
46812994|NCT00355342|83032720|FG001|Overall Study|Overcompliant-PI discretion|0|||
46812995|NCT00355342|83032719|FG000|Overall Study|Use of prohibited medication|1|||
46812996|NCT00355342|83032720|FG001|Overall Study|Use of prohibited medication|0|||
46812997|NCT00355342|83032719|FG000|Overall Study|COPD exacerbation|1|||
46812998|NCT00355342|83032720|FG001|Overall Study|COPD exacerbation|1|||
46812999|NCT00355342|83032719|FG000|Overall Study|Dispensed wrong study drug kit|1|||
46813000|NCT00355342|83032720|FG001|Overall Study|Dispensed wrong study drug kit|0|||
46928301|NCT02807493|83163108|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
46928302|NCT02807259|83163116|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
46928303|NCT02807259|83163117|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
46928304|NCT02807259|83163116|FG000|Midline (3 Months)|migration, refusal, not available|30|||
46928305|NCT02807259|83163117|FG001|Midline (3 Months)|migration, refusal, not available|34|||
46928306|NCT02807259|83163116|FG000|Endline (3 Months)|migration, refusal, not available|35|||
47054855|NCT01781429|83328206|FG008|Overall Study|Disease Progression|6|||
46755226|NCT00837265|82972977|FG003|Main Phase|Participant's personal reason|0|||
46755227|NCT00837265|82972978|FG004|Main Phase|Participant's personal reason|1|||
46755228|NCT00837265|82972979|FG005|Main Phase|Participant's personal reason|0|||
46755229|NCT00837265|82972980|FG006|Main Phase|Participant's personal reason|0|||
46755230|NCT00594516|82972993|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
46755231|NCT00594516|82972994|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
46755232|NCT00594516|82972995|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
46755233|NCT00594516|82972993|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
46755234|NCT00594516|82972994|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
46755235|NCT00594516|82972995|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
46755236|NCT00594516|82972993|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
46755237|NCT00594516|82972994|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
46755238|NCT00594516|82972995|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
46755239|NCT00594516|82972993|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
46755240|NCT00594516|82972994|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
46755241|NCT00594516|82972995|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
46755242|NCT00594516|82972993|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
46755243|NCT00594516|82972994|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
46755244|NCT00594516|82972995|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
46755245|NCT00594516|82972993|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
46755246|NCT00594516|82972994|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
46755247|NCT00594516|82972995|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
46755248|NCT00594516|82972993|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
46755249|NCT00594516|82972994|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
46755250|NCT00594516|82972995|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
46755251|NCT00594516|82972993|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
46755252|NCT00594516|82972994|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
46755253|NCT00594516|82972995|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
46755254|NCT00594516|82972993|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
46755255|NCT00594516|82972994|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
46755256|NCT00594516|82972995|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
46813001|NCT00355342|83032719|FG000|Overall Study|Non-compliance with Dexa scans|1|||
46813002|NCT00355342|83032720|FG001|Overall Study|Non-compliance with Dexa scans|0|||
46813003|NCT00355342|83032719|FG000|Overall Study|Withdrawal by participant and physician|1|||
46813004|NCT00355342|83032720|FG001|Overall Study|Withdrawal by participant and physician|0|||
47054856|NCT01781429|83328207|FG009|Overall Study|Disease Progression|15|||
47054857|NCT01781429|83328208|FG010|Overall Study|Disease Progression|15|||
47054858|NCT01781429|83328209|FG011|Overall Study|Disease Progression|15|||
46928307|NCT02807259|83163117|FG001|Endline (3 Months)|migration, refusal, not available|87|||
46928308|NCT02802345|83163127|FG000|Overall Study|Not Treated|0|||
46928309|NCT02802345|83163128|FG001|Overall Study|Not Treated|1|||
46928310|NCT02802345|83163127|FG000|Overall Study|Adverse Event|28|||
46928311|NCT02802345|83163128|FG001|Overall Study|Adverse Event|20|||
46928312|NCT02802345|83163127|FG000|Overall Study|Withdrawal by Subject|3|||
46928313|NCT02802345|83163128|FG001|Overall Study|Withdrawal by Subject|3|||
46928314|NCT02802345|83163127|FG000|Overall Study|Protocol Violation|0|||
46813005|NCT00355342|83032719|FG000|Overall Study|Participant relocated|0|||
46813006|NCT00355342|83032720|FG001|Overall Study|Participant relocated|1|||
46813007|NCT00355342|83032719|FG000|Overall Study|Participant discontinued study drug|0|||
46813008|NCT00355342|83032720|FG001|Overall Study|Participant discontinued study drug|1|||
46813009|NCT00355342|83032719|FG000|Overall Study|Study management|0|||
46813010|NCT00355342|83032720|FG001|Overall Study|Study management|1|||
46813011|NCT00355342|83032719|FG000|Overall Study|Protocol Violation|0|||
46813012|NCT00355342|83032720|FG001|Overall Study|Protocol Violation|1|||
46813013|NCT00355342|83032719|FG000|Overall Study|Use of protocol excluded medication|0|||
46813014|NCT00355342|83032720|FG001|Overall Study|Use of protocol excluded medication|1|||
46813015|NCT01573754|83032728|FG000|Overall Study|Noncompliance or remission not achieved|3|||
46813016|NCT01573754|83032729|FG001|Overall Study|Noncompliance or remission not achieved|15|||
46813017|NCT00355264|83032735|FG000|Extension (Variable Duration)|Adverse Event|1|||
46813018|NCT00355264|83032735|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
46813019|NCT00355030|83032746|FG000|Study Period 1 Treatment|Adverse Event|1|||
46813020|NCT00355030|83032747|FG001|Study Period 1 Treatment|Adverse Event|1|||
46813021|NCT00355030|83032746|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
46813022|NCT00355030|83032747|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
46813023|NCT00355030|83032746|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
46813024|NCT00355030|83032747|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
46813025|NCT00355030|83032746|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
46813026|NCT00355030|83032747|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
46813027|NCT00355030|83032746|FG000|Study Period 1 Treatment|Physician Decision|0|||
46813028|NCT00355030|83032747|FG001|Study Period 1 Treatment|Physician Decision|1|||
46928315|NCT02802345|83163128|FG001|Overall Study|Protocol Violation|1|||
46928316|NCT02802345|83163127|FG000|Overall Study|Other than listed|1|||
46813029|NCT00355030|83032746|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
46813030|NCT00355030|83032747|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
46813031|NCT00355030|83032746|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
46928317|NCT02802345|83163128|FG001|Overall Study|Other than listed|5|||
46928318|NCT02801877|83163138|FG000|Overall Study|Lost to Follow-up|1|||
46928319|NCT02801877|83163139|FG001|Overall Study|Lost to Follow-up|1|||
46928320|NCT02801877|83163140|FG002|Overall Study|Lost to Follow-up|2|||
46928321|NCT02801877|83163141|FG003|Overall Study|Lost to Follow-up|0|||
46928322|NCT02801877|83163138|FG000|Overall Study|Never Started Treatment|2|||
46813032|NCT00355030|83032747|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
46813033|NCT00355030|83032746|FG000|Study Period 1 Treatment|Other|2|||
46813034|NCT00355030|83032747|FG001|Study Period 1 Treatment|Other|6|||
46813035|NCT00355030|83032746|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
46928323|NCT02801877|83163139|FG001|Overall Study|Never Started Treatment|0|||
46928324|NCT02801877|83163140|FG002|Overall Study|Never Started Treatment|4|||
46928325|NCT02801877|83163141|FG003|Overall Study|Never Started Treatment|0|||
46928326|NCT02805309|83163154|FG000|Overall Study|Lost to Follow-up|2|||
46928327|NCT02805309|83163155|FG001|Overall Study|Lost to Follow-up|2|||
46928328|NCT02805309|83163156|FG002|Overall Study|Lost to Follow-up|2|||
46928329|NCT02805309|83163154|FG000|Overall Study|Post-Randomization Exclusion|0|||
46928330|NCT02805309|83163155|FG001|Overall Study|Post-Randomization Exclusion|2|||
46928331|NCT02805309|83163156|FG002|Overall Study|Post-Randomization Exclusion|1|||
46928332|NCT02804763|83163168|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
46928333|NCT02804763|83163169|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
46928334|NCT02804763|83163170|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
46928335|NCT02804763|83163171|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
46928336|NCT02804763|83163168|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
46928337|NCT02804763|83163169|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
46813036|NCT00355030|83032747|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
46813037|NCT00355030|83032746|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
46813038|NCT00355030|83032747|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
47054859|NCT01781429|83328210|FG012|Overall Study|Disease Progression|15|||
46636488|NCT01513590|82810286|FG000|Overall Study|Unclassified|5|||
46813039|NCT00354172|83032753|FG000|Overall Study|Did not receive transplant|1|||
46813040|NCT00345592|83032759|FG000|Overall Study|Death|14|||
46813041|NCT00345592|83032760|FG001|Overall Study|Death|16|||
46813042|NCT00345592|83032759|FG000|Overall Study|Withdrawal by Subject|11|||
46813043|NCT00345592|83032760|FG001|Overall Study|Withdrawal by Subject|8|||
46813044|NCT00353704|83032768|FG000|Overall Study|Protocol Violation|3|||
46813045|NCT00353704|83032769|FG001|Overall Study|Protocol Violation|1|||
46813046|NCT00512252|83032778|FG000|Overall Study|Lost to Follow-up|0|||
46928338|NCT02804763|83163170|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
46928339|NCT02804763|83163171|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
46813047|NCT00512252|83032779|FG001|Overall Study|Lost to Follow-up|0|||
46928340|NCT02804763|83163168|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
46813048|NCT00512252|83032780|FG002|Overall Study|Lost to Follow-up|1|||
46813049|NCT00512252|83032778|FG000|Overall Study|Protocol Violation|0|||
46813050|NCT00512252|83032779|FG001|Overall Study|Protocol Violation|0|||
46813051|NCT00512252|83032780|FG002|Overall Study|Protocol Violation|1|||
46813052|NCT00512252|83032778|FG000|Overall Study|Death|0|||
46813053|NCT00512252|83032779|FG001|Overall Study|Death|0|||
46813054|NCT00512252|83032780|FG002|Overall Study|Death|1|||
46813055|NCT00516386|83032795|FG000|Overall Study|not interested in the study|4|||
46813056|NCT00516386|83032795|FG000|Overall Study|Lost to Follow-up|2|||
46813057|NCT00524420|83032801|FG000|Overall Study|Lack of Efficacy|1|||
46813058|NCT00524420|83032802|FG001|Overall Study|Lack of Efficacy|0|||
46813059|NCT00512096|83032810|FG000|Overall Study|Adverse Event|2|||
46813060|NCT00512096|83032810|FG000|Overall Study|Withdrawal by Subject|2|||
46813061|NCT00512096|83032810|FG000|Overall Study|Lack of Efficacy|3|||
46813062|NCT00524030|83032816|FG000|Overall Study|Lack of Efficacy|10|||
46813063|NCT00524030|83032817|FG001|Overall Study|Lack of Efficacy|24|||
46813064|NCT00524030|83032816|FG000|Overall Study|Lost to Follow-up|0|||
46813065|NCT00524030|83032817|FG001|Overall Study|Lost to Follow-up|2|||
46813066|NCT00524030|83032816|FG000|Overall Study|Withdrawal by Subject|3|||
46813067|NCT00524030|83032817|FG001|Overall Study|Withdrawal by Subject|8|||
46813068|NCT00524030|83032816|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
46813069|NCT00524030|83032817|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
46813070|NCT00524030|83032816|FG000|Overall Study|Protocol Violation|0|||
46813071|NCT00524030|83032817|FG001|Overall Study|Protocol Violation|1|||
46813072|NCT00524030|83032816|FG000|Overall Study|Pregnancy|1|||
46813073|NCT00524030|83032817|FG001|Overall Study|Pregnancy|0|||
46813074|NCT00524030|83032816|FG000|Overall Study|Adverse Event|3|||
46813075|NCT00524030|83032817|FG001|Overall Study|Adverse Event|21|||
46813076|NCT00524030|83032816|FG000|Overall Study|Death|0|||
46813077|NCT00524030|83032817|FG001|Overall Study|Death|1|||
46928341|NCT02804763|83163169|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
46928342|NCT02804763|83163170|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
46928343|NCT02804763|83163171|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
46928344|NCT02804763|83163168|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
46928345|NCT02804763|83163169|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
46928346|NCT02804763|83163170|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
47054860|NCT01781429|83328211|FG013|Overall Study|Disease Progression|4|||
47054861|NCT01781429|83328212|FG014|Overall Study|Disease Progression|11|||
47054862|NCT01781429|83328213|FG015|Overall Study|Disease Progression|0|||
46755257|NCT00538291|82972999|FG000|Overall Study|Adverse Event|2|||
46755258|NCT00538291|82972999|FG000|Overall Study|Withdrawal by Subject|1|||
46755259|NCT00594906|82973005|FG000|Overall Study|Physician Decision|1|||
46755260|NCT00594906|82973006|FG001|Overall Study|Physician Decision|0|||
46755261|NCT00594906|82973005|FG000|Overall Study|Physician Decision|0|||
46755262|NCT00594906|82973006|FG001|Overall Study|Physician Decision|1|||
46755263|NCT00594906|82973005|FG000|Overall Study|Death|0|||
46755264|NCT00594906|82973006|FG001|Overall Study|Death|1|||
46755265|NCT00537979|82973014|FG000|Overall Study|Adverse Event|2|||
46755266|NCT00537979|82973015|FG001|Overall Study|Adverse Event|2|||
46755267|NCT00537979|82973014|FG000|Overall Study|Withdrawal by Subject|1|||
46755268|NCT00537979|82973015|FG001|Overall Study|Withdrawal by Subject|4|||
46813078|NCT00523718|83032826|FG000|Overall Study|Withdrawal by Subject|1|||
46813079|NCT00523718|83032827|FG001|Overall Study|Withdrawal by Subject|0|||
46813080|NCT00523718|83032826|FG000|Overall Study|Protocol Violation|2|||
46813081|NCT00523718|83032827|FG001|Overall Study|Protocol Violation|0|||
46813082|NCT00523640|83032833|FG000|Overall Study|Death|1|||
46813083|NCT00345358|83032841|FG000|Primary Vaccination Phase|Other|0|||
46813084|NCT00345358|83032842|FG001|Primary Vaccination Phase|Other|1|||
46813085|NCT00345358|83032843|FG002|Primary Vaccination Phase|Other|1|||
46813086|NCT00345358|83032844|FG003|Primary Vaccination Phase|Other|0|||
46813087|NCT00345358|83032841|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
46755269|NCT00537979|82973014|FG000|Overall Study|Lost to Follow-up|1|||
46755270|NCT00537979|82973015|FG001|Overall Study|Lost to Follow-up|4|||
46813088|NCT00345358|83032842|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
46813089|NCT00345358|83032843|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
46813090|NCT00345358|83032844|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
46813091|NCT00345358|83032841|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
46813092|NCT00345358|83032842|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
46813093|NCT00345358|83032843|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
46813094|NCT00345358|83032844|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
46813095|NCT00345358|83032841|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
46813096|NCT00345358|83032842|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
46813097|NCT00345358|83032843|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
46813098|NCT00345358|83032844|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
46813099|NCT00345358|83032841|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
46813100|NCT00345358|83032842|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
46813101|NCT00345358|83032843|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
46813102|NCT00345358|83032844|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
46813103|NCT00345358|83032841|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
46813104|NCT00345358|83032842|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
46813105|NCT00345358|83032843|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
46813106|NCT00345358|83032844|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
46813107|NCT03869684|83032857|FG000|Overall Study|Adverse Event|0|||
46813108|NCT03869684|83032858|FG001|Overall Study|Adverse Event|3|||
46813109|NCT03869684|83032859|FG002|Overall Study|Adverse Event|1|||
46813110|NCT03869684|83032857|FG000|Overall Study|Withdrawal by Subject|1|||
46813111|NCT03869684|83032858|FG001|Overall Study|Withdrawal by Subject|0|||
46813112|NCT03869684|83032859|FG002|Overall Study|Withdrawal by Subject|0|||
46813113|NCT03869684|83032857|FG000|Overall Study|Lost to Follow-up|1|||
46813114|NCT03869684|83032858|FG001|Overall Study|Lost to Follow-up|0|||
46813115|NCT03869684|83032859|FG002|Overall Study|Lost to Follow-up|0|||
46813116|NCT03869684|83032857|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
46813117|NCT03869684|83032858|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
46813118|NCT03869684|83032859|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
46813119|NCT00516074|83032869|FG000|Overall Study|Adverse Event|0|||
46813120|NCT00516074|83032870|FG001|Overall Study|Adverse Event|1|||
46813121|NCT00516074|83032869|FG000|Overall Study|Subject Decision|4|||
46813122|NCT00516074|83032870|FG001|Overall Study|Subject Decision|2|||
46813123|NCT00516074|83032869|FG000|Overall Study|Loss of Glucose Control|2|||
46813124|NCT00516074|83032870|FG001|Overall Study|Loss of Glucose Control|0|||
46813125|NCT00515294|83032880|FG000|Overall Study|Lost to Follow-up|3|||
46813126|NCT00515294|83032881|FG001|Overall Study|Lost to Follow-up|2|||
46813127|NCT00515294|83032882|FG002|Overall Study|Lost to Follow-up|3|||
46813128|NCT00515294|83032883|FG003|Overall Study|Lost to Follow-up|1|||
46813129|NCT00515294|83032880|FG000|Overall Study|Driver simulator problems|1|||
46813130|NCT00515294|83032881|FG001|Overall Study|Driver simulator problems|1|||
46813131|NCT00515294|83032882|FG002|Overall Study|Driver simulator problems|1|||
47054863|NCT01781429|83328198|FG000|Overall Study|Unacceptable Toxicity|0|||
47054864|NCT01781429|83328199|FG001|Overall Study|Unacceptable Toxicity|0|||
46755271|NCT00537979|82973014|FG000|Overall Study|Lack of Efficacy|0|||
46755272|NCT00537979|82973015|FG001|Overall Study|Lack of Efficacy|1|||
46755273|NCT00537979|82973014|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
46755274|NCT00537979|82973015|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
46755275|NCT00537979|82973014|FG000|Overall Study|Death|0|||
46755276|NCT00537979|82973015|FG001|Overall Study|Death|3|||
46755277|NCT00537979|82973014|FG000|Overall Study|Kidney transplant|0|||
46755278|NCT00537979|82973015|FG001|Overall Study|Kidney transplant|3|||
46755279|NCT00537979|82973014|FG000|Overall Study|Heart failure|0|||
46755280|NCT00537979|82973015|FG001|Overall Study|Heart failure|1|||
46755281|NCT00537823|82973024|FG000|Overall Study|Adverse Event|2|||
46755282|NCT00537823|82973025|FG001|Overall Study|Adverse Event|0|||
46755283|NCT00537277|82973032|FG000|Overall Study|Adverse Event|1|||
46755284|NCT00537277|82973032|FG000|Overall Study|Lack of Efficacy|2|||
46755285|NCT00537277|82973032|FG000|Overall Study|Lost to Follow-up|12|||
46755286|NCT00537277|82973032|FG000|Overall Study|Protocol Violation|11|||
46755287|NCT00537277|82973032|FG000|Overall Study|Unclassified|4|||
46755288|NCT00537277|82973032|FG000|Overall Study|Inability to tolerate trial medication|4|||
46813132|NCT00515294|83032883|FG003|Overall Study|Driver simulator problems|3|||
46813133|NCT00515294|83032880|FG000|Overall Study|Caffeine amount inaccurate|5|||
46813134|NCT00515294|83032881|FG001|Overall Study|Caffeine amount inaccurate|0|||
46813135|NCT00515294|83032882|FG002|Overall Study|Caffeine amount inaccurate|7|||
46813136|NCT00515294|83032883|FG003|Overall Study|Caffeine amount inaccurate|0|||
46813137|NCT00345046|83032896|FG000|Overall Study|Protocol Violation|1|||
46755289|NCT00537277|82973032|FG000|Overall Study|Non-compliance with trial procedures|15|||
46813138|NCT00345046|83032897|FG001|Overall Study|Protocol Violation|1|||
47054865|NCT01781429|83328200|FG002|Overall Study|Unacceptable Toxicity|0|||
46755290|NCT00537199|82973036|FG000|Overall Study|Study Terminated|1|||
46755291|NCT03898063|82973042|FG000|Overall Study|Withdrawal by Subject|10|||
47054866|NCT01781429|83328201|FG003|Overall Study|Unacceptable Toxicity|0|||
46755292|NCT03898063|82973043|FG001|Overall Study|Withdrawal by Subject|8|||
46928347|NCT02804763|83163171|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
46928348|NCT02804763|83163168|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
46928349|NCT02804763|83163169|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
46928350|NCT02804763|83163170|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
46813139|NCT00345046|83032898|FG002|Overall Study|Protocol Violation|2|||
46813140|NCT00515216|83032906|FG000|Overall Study|Withdrawal by Subject|1|||
46813141|NCT00522626|83032911|FG000|Overall Study|Lost to Follow-up|7|||
46813142|NCT00440193|83032917|FG000|Treatment Period|Adverse Event|74|||
46813143|NCT00440193|83032918|FG001|Treatment Period|Adverse Event|67|||
46813144|NCT00440193|83032917|FG000|Treatment Period|Death|19|||
46813145|NCT00440193|83032918|FG001|Treatment Period|Death|22|||
46813146|NCT00440193|83032917|FG000|Treatment Period|Lack of Efficacy|0|||
46813147|NCT00440193|83032918|FG001|Treatment Period|Lack of Efficacy|1|||
46813148|NCT00440193|83032917|FG000|Treatment Period|Lost to Follow-up|12|||
46813149|NCT00440193|83032918|FG001|Treatment Period|Lost to Follow-up|18|||
46813150|NCT00440193|83032917|FG000|Treatment Period|Physician Decision|3|||
46813151|NCT00440193|83032918|FG001|Treatment Period|Physician Decision|6|||
46813152|NCT00440193|83032917|FG000|Treatment Period|Protocol Violation|16|||
46813153|NCT00440193|83032918|FG001|Treatment Period|Protocol Violation|19|||
46813154|NCT00440193|83032917|FG000|Treatment Period|Withdrawal by Subject|36|||
46813155|NCT00440193|83032918|FG001|Treatment Period|Withdrawal by Subject|77|||
46813156|NCT00440193|83032917|FG000|Treatment Period|Clinical endpoint reached|28|||
46813157|NCT00440193|83032918|FG001|Treatment Period|Clinical endpoint reached|25|||
46813158|NCT00440193|83032917|FG000|Treatment Period|Study terminated by sponsor|102|||
46813159|NCT00440193|83032918|FG001|Treatment Period|Study terminated by sponsor|94|||
46813160|NCT00440193|83032917|FG000|Treatment Period|Protocol driven decision point|2|||
46813161|NCT00440193|83032918|FG001|Treatment Period|Protocol driven decision point|2|||
46813162|NCT00440193|83032917|FG000|Treatment Period|Switch to commercial drug|0|||
46813163|NCT00440193|83032918|FG001|Treatment Period|Switch to commercial drug|2|||
46813164|NCT00440193|83032917|FG000|Treatment Period|Technical problems|1|||
46813165|NCT00440193|83032918|FG001|Treatment Period|Technical problems|1|||
46813166|NCT00440193|83032917|FG000|Treatment Period|Participant convenience|5|||
46813167|NCT00440193|83032918|FG001|Treatment Period|Participant convenience|2|||
46813168|NCT00440193|83032917|FG000|Treatment Period|Participant did not receive treatment|7|||
46813169|NCT00440193|83032918|FG001|Treatment Period|Participant did not receive treatment|13|||
46813170|NCT00440193|83032917|FG000|Treatment Period|Site closed by investigator|0|||
46813171|NCT00440193|83032918|FG001|Treatment Period|Site closed by investigator|2|||
46813172|NCT00440193|83032917|FG000|Observational Period|Adverse Event|2|||
46813173|NCT00440193|83032918|FG001|Observational Period|Adverse Event|2|||
46813174|NCT00440193|83032917|FG000|Observational Period|Death|15|||
46813175|NCT00440193|83032918|FG001|Observational Period|Death|20|||
46813176|NCT00440193|83032917|FG000|Observational Period|Lost to Follow-up|12|||
46928351|NCT02804763|83163171|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
46928352|NCT02804763|83163168|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
46928353|NCT02804763|83163169|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
46928354|NCT02804763|83163170|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
46928355|NCT02804763|83163171|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
46928356|NCT02748057|83163187|FG000|Overall Study|Adverse Event|1|||
46928357|NCT02748057|83163188|FG001|Overall Study|Adverse Event|0|||
46928358|NCT02748057|83163187|FG000|Overall Study|Physician Decision|0|||
46928359|NCT02748057|83163188|FG001|Overall Study|Physician Decision|1|||
46928360|NCT02748057|83163187|FG000|Overall Study|Protocol Violation|2|||
46755293|NCT00873912|82973051|FG000|Overall Study|Withdrawal by Subject|1|||
46755294|NCT00873912|82973052|FG001|Overall Study|Withdrawal by Subject|0|||
46755295|NCT00873912|82973051|FG000|Overall Study|Lost to Follow-up|2|||
46755296|NCT00873912|82973052|FG001|Overall Study|Lost to Follow-up|0|||
46755297|NCT03823300|82973064|FG000|Overall Study|Withdrawal by Subject|16|||
46755298|NCT03823300|82973065|FG001|Overall Study|Withdrawal by Subject|22|||
46755299|NCT03823300|82973064|FG000|Overall Study|Death|10|||
46755300|NCT03823300|82973065|FG001|Overall Study|Death|14|||
46755301|NCT03823300|82973064|FG000|Overall Study|Adverse Event|3|||
46755302|NCT03823300|82973065|FG001|Overall Study|Adverse Event|5|||
46755303|NCT03823300|82973064|FG000|Overall Study|Physician Decision|1|||
46813177|NCT00440193|83032918|FG001|Observational Period|Lost to Follow-up|8|||
46813178|NCT00440193|83032917|FG000|Observational Period|Protocol Violation|1|||
46813179|NCT00440193|83032918|FG001|Observational Period|Protocol Violation|0|||
46813180|NCT00440193|83032917|FG000|Observational Period|Withdrawal by Subject|11|||
46813181|NCT00440193|83032918|FG001|Observational Period|Withdrawal by Subject|8|||
46813182|NCT00440193|83032917|FG000|Observational Period|Physician Decision|1|||
46813183|NCT00440193|83032918|FG001|Observational Period|Physician Decision|0|||
46813184|NCT00440193|83032917|FG000|Observational Period|Clinical endpoint reached|1|||
46813185|NCT00440193|83032918|FG001|Observational Period|Clinical endpoint reached|0|||
46928361|NCT02748057|83163188|FG001|Overall Study|Protocol Violation|1|||
46928362|NCT02748057|83163187|FG000|Overall Study|Participant Moved|1|||
46928363|NCT02748057|83163188|FG001|Overall Study|Participant Moved|0|||
46928364|NCT02748057|83163187|FG000|Overall Study|Withdrawal by Subject|1|||
46928365|NCT02748057|83163188|FG001|Overall Study|Withdrawal by Subject|0|||
46928366|NCT02748213|83163196|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
46928367|NCT02748213|83163197|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
46928368|NCT02748213|83163196|FG000|Overall Study|Abnormal Laboratory Test|1|||
46928369|NCT02748213|83163197|FG001|Overall Study|Abnormal Laboratory Test|0|||
46813186|NCT00440193|83032917|FG000|Observational Period|Participant convenience|2|||
46813187|NCT00440193|83032918|FG001|Observational Period|Participant convenience|0|||
46813188|NCT00511472|83032926|FG000|Overall Study|Clinical Adverse Event|1|||
46813189|NCT00511472|83032927|FG001|Overall Study|Clinical Adverse Event|2|||
46813190|NCT00511472|83032926|FG000|Overall Study|Laboratory Adverse Event|0|||
46813191|NCT00511472|83032927|FG001|Overall Study|Laboratory Adverse Event|2|||
46813192|NCT00511472|83032926|FG000|Overall Study|Not reported|2|||
46813193|NCT00511472|83032927|FG001|Overall Study|Not reported|2|||
46813194|NCT00514904|83032944|FG000|Overall Study|Withdrawal by Subject|3|||
46813195|NCT00514904|83032945|FG001|Overall Study|Withdrawal by Subject|2|||
46813196|NCT00514904|83032944|FG000|Overall Study|Lost to Follow-up|21|||
46813197|NCT00514904|83032945|FG001|Overall Study|Lost to Follow-up|3|||
46813198|NCT00440115|83032954|FG000|Overall Study|Death|7|||
46813199|NCT00440115|83032955|FG001|Overall Study|Death|9|||
46813200|NCT00440115|83032956|FG002|Overall Study|Death|5|||
46813201|NCT00440115|83032954|FG000|Overall Study|Incarceration|0|||
46813202|NCT00440115|83032955|FG001|Overall Study|Incarceration|2|||
46813203|NCT00440115|83032956|FG002|Overall Study|Incarceration|1|||
46813204|NCT00440037|83032964|FG000|Overall Study|Withdrawal by Subject|6|||
46813205|NCT00440037|83032964|FG000|Overall Study|Administrative decision|3|||
46813206|NCT00417027|83032971|FG000|Overall Study|Protocol Violation|0|||
46813207|NCT00417027|83032972|FG001|Overall Study|Protocol Violation|5|||
46813208|NCT00417027|83032973|FG002|Overall Study|Protocol Violation|5|||
46813209|NCT00416949|83032981|FG000|Overall Study|Patients refused to participate|5|||
46813210|NCT00416715|83032985|FG000|Overall Study|Not evaluable for joint aches|7|||
46813211|NCT00416715|83032985|FG000|Overall Study|Vitamin D levels not evaluable|8|||
46813212|NCT00406029|83032997|FG000|Overall Study|Adverse Event|12|||
46813213|NCT00406029|83032998|FG001|Overall Study|Adverse Event|2|||
46813214|NCT00406029|83032999|FG002|Overall Study|Adverse Event|5|||
46813215|NCT00406029|83033000|FG003|Overall Study|Adverse Event|10|||
46928370|NCT02748213|83163196|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
46755304|NCT03823300|82973065|FG001|Overall Study|Physician Decision|7|||
46755305|NCT03823300|82973064|FG000|Overall Study|Lost to Follow-up|1|||
46813216|NCT00406029|83033001|FG004|Overall Study|Adverse Event|7|||
46813217|NCT00406029|83032997|FG000|Overall Study|Withdrawal by Subject|3|||
46813218|NCT00406029|83032998|FG001|Overall Study|Withdrawal by Subject|4|||
46813219|NCT00406029|83032999|FG002|Overall Study|Withdrawal by Subject|2|||
46813220|NCT00406029|83033000|FG003|Overall Study|Withdrawal by Subject|2|||
46813221|NCT00406029|83033001|FG004|Overall Study|Withdrawal by Subject|0|||
46813222|NCT00406029|83032997|FG000|Overall Study|Protocol Violation|1|||
46813223|NCT00406029|83032998|FG001|Overall Study|Protocol Violation|2|||
46813224|NCT00406029|83032999|FG002|Overall Study|Protocol Violation|0|||
46813225|NCT00406029|83033000|FG003|Overall Study|Protocol Violation|2|||
46813226|NCT00406029|83033001|FG004|Overall Study|Protocol Violation|0|||
46813227|NCT00406029|83032997|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
46928371|NCT02748213|83163197|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
46928372|NCT02748213|83163196|FG000|Overall Study|Death|5|||
46928373|NCT02748213|83163197|FG001|Overall Study|Death|3|||
46755306|NCT03823300|82973065|FG001|Overall Study|Lost to Follow-up|3|||
46755307|NCT03823300|82973064|FG000|Overall Study|Protocol Violation|1|||
46755308|NCT03823300|82973065|FG001|Overall Study|Protocol Violation|1|||
46755309|NCT03823300|82973064|FG000|Overall Study|Lack of Efficacy|1|||
46755310|NCT03823300|82973065|FG001|Overall Study|Lack of Efficacy|1|||
46755311|NCT03823300|82973064|FG000|Overall Study|Not Eligible|0|||
46755312|NCT03823300|82973065|FG001|Overall Study|Not Eligible|1|||
46755313|NCT03823300|82973064|FG000|Overall Study|Other|1|||
46813228|NCT00406029|83032998|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
46813229|NCT00406029|83032999|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
46813230|NCT00406029|83033000|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
46813231|NCT00406029|83033001|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
47054867|NCT01781429|83328202|FG004|Overall Study|Unacceptable Toxicity|0|||
47054868|NCT01781429|83328203|FG005|Overall Study|Unacceptable Toxicity|0|||
46755314|NCT03823300|82973065|FG001|Overall Study|Other|0|||
46813232|NCT00406029|83032997|FG000|Overall Study|Randomized in Error|0|||
46813233|NCT00406029|83032998|FG001|Overall Study|Randomized in Error|0|||
46928374|NCT02748213|83163196|FG000|Overall Study|Insufficient Therapeutic Response|56|||
46636489|NCT01513590|82810287|FG001|Overall Study|Unclassified|10|||
46755315|NCT00537745|82973071|FG000|Overall Study|Did not meet eligibility criteria|2|||
46813234|NCT00406029|83032999|FG002|Overall Study|Randomized in Error|2|||
46813235|NCT00406029|83033000|FG003|Overall Study|Randomized in Error|3|||
46928375|NCT02748213|83163197|FG001|Overall Study|Insufficient Therapeutic Response|57|||
46928376|NCT02748213|83163196|FG000|Overall Study|Violation of Selection Criteria|2|||
46928377|NCT02748213|83163197|FG001|Overall Study|Violation of Selection Criteria|0|||
46928378|NCT02748213|83163196|FG000|Overall Study|Protocol Violation|6|||
46928379|NCT02748213|83163197|FG001|Overall Study|Protocol Violation|4|||
46928380|NCT02748213|83163196|FG000|Overall Study|Refused Treatment*|6|||
46755316|NCT00537745|82973071|FG000|Overall Study|Withdrawal by Subject|2|||
46755317|NCT00537745|82973071|FG000|Overall Study|Subject unable to provide Interlock info|1|||
46755318|NCT00874848|82973078|FG000|Overall Study|Adverse Event|13|||
46755319|NCT00874848|82973079|FG001|Overall Study|Adverse Event|2|||
46755320|NCT00874848|82973078|FG000|Overall Study|Progressive neoplastic disease|38|||
46755321|NCT00874848|82973079|FG001|Overall Study|Progressive neoplastic disease|18|||
46755322|NCT00874848|82973078|FG000|Overall Study|Withdrawal by Subject|7|||
46755323|NCT00874848|82973079|FG001|Overall Study|Withdrawal by Subject|4|||
46755324|NCT00874848|82973078|FG000|Overall Study|Noncompliance|1|||
46755325|NCT00874848|82973079|FG001|Overall Study|Noncompliance|1|||
46755326|NCT00874848|82973078|FG000|Overall Study|Failure to comply with protocol|0|||
46755327|NCT00874848|82973079|FG001|Overall Study|Failure to comply with protocol|1|||
46755328|NCT00874848|82973078|FG000|Overall Study|Physician Decision|0|||
46755329|NCT00874848|82973079|FG001|Overall Study|Physician Decision|2|||
46755330|NCT00578812|82973087|FG000|Overall Study|Not treated|6|||
46755331|NCT00578812|82973088|FG001|Overall Study|Not treated|7|||
46755332|NCT04043806|82973095|FG000|Overall Study|Commercial drug is available for participants|13|||
46755333|NCT04043806|82973095|FG000|Overall Study|Physician Decision|2|||
46755334|NCT04043806|82973095|FG000|Overall Study|Other|12|||
46755335|NCT04043806|82973095|FG000|Overall Study|Adverse Event|2|||
46755336|NCT04043806|82973095|FG000|Overall Study|Lost to Follow-up|6|||
46755337|NCT04043806|82973095|FG000|Overall Study|Other non-compliance|2|||
46755338|NCT04043806|82973095|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
46755339|NCT04043806|82973095|FG000|Overall Study|Never Dosed|1|||
46755340|NCT00536809|82973100|FG000|Phase II|Adverse Event|1|||
46755341|NCT00536809|82973100|FG000|Phase II|Referred for surgical resection|1|||
46755342|NCT00536731|82973111|FG000|Overall Study|Adverse Event|3|||
46755343|NCT00536731|82973112|FG001|Overall Study|Adverse Event|2|||
46755344|NCT00536731|82973113|FG002|Overall Study|Adverse Event|3|||
46755345|NCT00536731|82973111|FG000|Overall Study|Withdrawal by Subject|0|||
46755346|NCT00536731|82973112|FG001|Overall Study|Withdrawal by Subject|2|||
46755347|NCT00536731|82973113|FG002|Overall Study|Withdrawal by Subject|0|||
46755348|NCT00536731|82973111|FG000|Overall Study|Intake of prohibited conc. medication|0|||
46755349|NCT00536731|82973112|FG001|Overall Study|Intake of prohibited conc. medication|0|||
46755350|NCT00536731|82973113|FG002|Overall Study|Intake of prohibited conc. medication|1|||
46755351|NCT00536731|82973111|FG000|Overall Study|Safety reasons|0|||
46755352|NCT00536731|82973112|FG001|Overall Study|Safety reasons|0|||
46755353|NCT00536731|82973113|FG002|Overall Study|Safety reasons|1|||
46755354|NCT00536731|82973111|FG000|Overall Study|Other|1|||
46755355|NCT00536731|82973112|FG001|Overall Study|Other|1|||
46755356|NCT00536731|82973113|FG002|Overall Study|Other|0|||
46755357|NCT00536575|82973121|FG000|Overall Study|Withdrawal by Subject|1|||
46755358|NCT00536575|82973121|FG000|Overall Study|Death|1|||
46755359|NCT03214250|82973132|FG000|Overall Study|Death|5|||
46755360|NCT03214250|82973133|FG001|Overall Study|Death|5|||
46755361|NCT03214250|82973134|FG002|Overall Study|Death|7|||
46755362|NCT03214250|82973135|FG003|Overall Study|Death|4|||
46755363|NCT03214250|82973136|FG004|Overall Study|Death|23|||
46755364|NCT03214250|82973137|FG005|Overall Study|Death|23|||
46755365|NCT03214250|82973138|FG006|Overall Study|Death|24|||
46755366|NCT03214250|82973132|FG000|Overall Study|Lost to Follow-up|0|||
46755367|NCT03214250|82973133|FG001|Overall Study|Lost to Follow-up|0|||
46755368|NCT03214250|82973134|FG002|Overall Study|Lost to Follow-up|0|||
46755369|NCT03214250|82973135|FG003|Overall Study|Lost to Follow-up|1|||
46755370|NCT03214250|82973136|FG004|Overall Study|Lost to Follow-up|1|||
46755371|NCT03214250|82973137|FG005|Overall Study|Lost to Follow-up|2|||
46755372|NCT03214250|82973138|FG006|Overall Study|Lost to Follow-up|0|||
46755373|NCT03214250|82973132|FG000|Overall Study|Other|0|||
46755374|NCT03214250|82973133|FG001|Overall Study|Other|0|||
46755375|NCT03214250|82973134|FG002|Overall Study|Other|0|||
46755376|NCT03214250|82973135|FG003|Overall Study|Other|0|||
46755377|NCT03214250|82973136|FG004|Overall Study|Other|1|||
46755378|NCT03214250|82973137|FG005|Overall Study|Other|1|||
46755379|NCT03214250|82973138|FG006|Overall Study|Other|2|||
46755380|NCT03214250|82973132|FG000|Overall Study|Remains on Study|2|||
46755381|NCT03214250|82973133|FG001|Overall Study|Remains on Study|2|||
46755382|NCT03214250|82973134|FG002|Overall Study|Remains on Study|0|||
46755383|NCT03214250|82973135|FG003|Overall Study|Remains on Study|1|||
46755384|NCT03214250|82973136|FG004|Overall Study|Remains on Study|7|||
46755385|NCT03214250|82973137|FG005|Overall Study|Remains on Study|5|||
46755386|NCT03214250|82973138|FG006|Overall Study|Remains on Study|3|||
46755387|NCT03214250|82973132|FG000|Overall Study|Withdrawal by Subject|0|||
46755388|NCT03214250|82973133|FG001|Overall Study|Withdrawal by Subject|0|||
46813236|NCT00406029|83033001|FG004|Overall Study|Randomized in Error|1|||
46813237|NCT00514514|83033016|FG000|Pre-phase|Death|10|||
46813238|NCT00514514|83033017|FG001|Pre-phase|Death|0|||
46813239|NCT00514514|83033018|FG002|Pre-phase|Death|0|||
46813240|NCT00514514|83033016|FG000|Pre-phase|administrative problems|2|||
46813241|NCT00514514|83033017|FG001|Pre-phase|administrative problems|0|||
46813242|NCT00514514|83033018|FG002|Pre-phase|administrative problems|0|||
46813243|NCT00514514|83033016|FG000|Pre-phase|Protocol Violation|6|||
46813244|NCT00514514|83033017|FG001|Pre-phase|Protocol Violation|0|||
46813245|NCT00514514|83033018|FG002|Pre-phase|Protocol Violation|0|||
46813246|NCT00514514|83033016|FG000|Pre-phase|condition no longer requires study drug|7|||
46813247|NCT00514514|83033017|FG001|Pre-phase|condition no longer requires study drug|0|||
46813248|NCT00514514|83033018|FG002|Pre-phase|condition no longer requires study drug|0|||
46813249|NCT00514514|83033016|FG000|Pre-phase|abnormal test procedure results|15|||
46813250|NCT00514514|83033017|FG001|Pre-phase|abnormal test procedure results|0|||
46813251|NCT00514514|83033018|FG002|Pre-phase|abnormal test procedure results|0|||
46813252|NCT00514514|83033016|FG000|Pre-phase|Lost to Follow-up|2|||
46813253|NCT00514514|83033017|FG001|Pre-phase|Lost to Follow-up|0|||
46813254|NCT00514514|83033018|FG002|Pre-phase|Lost to Follow-up|0|||
46813255|NCT00514514|83033016|FG000|Pre-phase|abnormal lab values|23|||
46813256|NCT00514514|83033017|FG001|Pre-phase|abnormal lab values|0|||
46813257|NCT00514514|83033018|FG002|Pre-phase|abnormal lab values|0|||
46813258|NCT00514514|83033016|FG000|Pre-phase|Lack of Efficacy|35|||
46813259|NCT00514514|83033017|FG001|Pre-phase|Lack of Efficacy|0|||
46813260|NCT00514514|83033018|FG002|Pre-phase|Lack of Efficacy|0|||
46813261|NCT00514514|83033016|FG000|Pre-phase|Adverse Event|137|||
46813262|NCT00514514|83033017|FG001|Pre-phase|Adverse Event|0|||
46813263|NCT00514514|83033018|FG002|Pre-phase|Adverse Event|0|||
46813264|NCT00514514|83033016|FG000|Pre-phase|Withdrawal by Subject|66|||
46813265|NCT00514514|83033017|FG001|Pre-phase|Withdrawal by Subject|0|||
46813266|NCT00514514|83033018|FG002|Pre-phase|Withdrawal by Subject|0|||
46813267|NCT00514514|83033016|FG000|Randomized - 9 Month|Death|3|||
46813268|NCT00514514|83033017|FG001|Randomized - 9 Month|Death|2|||
46813269|NCT00514514|83033018|FG002|Randomized - 9 Month|Death|2|||
46813270|NCT00514514|83033016|FG000|Randomized - 9 Month|Administrative problems|1|||
46813271|NCT00514514|83033017|FG001|Randomized - 9 Month|Administrative problems|1|||
46813272|NCT00514514|83033018|FG002|Randomized - 9 Month|Administrative problems|2|||
46813273|NCT00514514|83033016|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
46813274|NCT00514514|83033017|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
46813275|NCT00514514|83033018|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
46813276|NCT00514514|83033016|FG000|Randomized - 9 Month|Protocol Violation|1|||
46813277|NCT00514514|83033017|FG001|Randomized - 9 Month|Protocol Violation|1|||
46813278|NCT00514514|83033018|FG002|Randomized - 9 Month|Protocol Violation|0|||
46928381|NCT02748213|83163197|FG001|Overall Study|Refused Treatment*|6|||
46928382|NCT02748213|83163196|FG000|Overall Study|Failure to Return|1|||
47054869|NCT01781429|83328204|FG006|Overall Study|Unacceptable Toxicity|0|||
46755389|NCT03214250|82973134|FG002|Overall Study|Withdrawal by Subject|1|||
46755390|NCT03214250|82973135|FG003|Overall Study|Withdrawal by Subject|2|||
46755391|NCT03214250|82973136|FG004|Overall Study|Withdrawal by Subject|5|||
46755392|NCT03214250|82973137|FG005|Overall Study|Withdrawal by Subject|0|||
46755393|NCT03214250|82973138|FG006|Overall Study|Withdrawal by Subject|2|||
46755394|NCT00874770|82973162|FG000|Overall Study|Lack of Efficacy|2|||
46755395|NCT00874770|82973163|FG001|Overall Study|Lack of Efficacy|0|||
46755396|NCT00874770|82973164|FG002|Overall Study|Lack of Efficacy|0|||
46755397|NCT00874770|82973165|FG003|Overall Study|Lack of Efficacy|2|||
46813279|NCT00514514|83033016|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
46813280|NCT00514514|83033017|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
46813281|NCT00514514|83033018|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
46813282|NCT00514514|83033016|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
46813283|NCT00514514|83033017|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
46813284|NCT00514514|83033018|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
46813285|NCT00514514|83033016|FG000|Randomized - 9 Month|Adverse Event|25|||
46813286|NCT00514514|83033017|FG001|Randomized - 9 Month|Adverse Event|44|||
46813287|NCT00514514|83033018|FG002|Randomized - 9 Month|Adverse Event|27|||
46928383|NCT02748213|83163197|FG001|Overall Study|Failure to Return|0|||
46755398|NCT00874770|82973162|FG000|Overall Study|Adverse Event|1|||
46813288|NCT00514514|83033016|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
46813289|NCT00514514|83033017|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
46813290|NCT00514514|83033018|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
46813291|NCT00514514|83033016|FG000|Extension - 4 Years|Lost to Follow-up|12|||
46813292|NCT00514514|83033017|FG001|Extension - 4 Years|Lost to Follow-up|10|||
46813293|NCT00514514|83033018|FG002|Extension - 4 Years|Lost to Follow-up|9|||
46813294|NCT00514514|83033016|FG000|Extension - 4 Years|Administrative problems|3|||
46928384|NCT02748213|83163196|FG000|Overall Study|Other|30|||
47054870|NCT01781429|83328205|FG007|Overall Study|Unacceptable Toxicity|0|||
46755399|NCT00874770|82973163|FG001|Overall Study|Adverse Event|1|||
46755400|NCT00874770|82973164|FG002|Overall Study|Adverse Event|4|||
46755401|NCT00874770|82973165|FG003|Overall Study|Adverse Event|2|||
46813295|NCT00514514|83033017|FG001|Extension - 4 Years|Administrative problems|1|||
46813296|NCT00514514|83033018|FG002|Extension - 4 Years|Administrative problems|1|||
46813297|NCT00514514|83033016|FG000|Extension - 4 Years|Death|8|||
46813298|NCT00514514|83033017|FG001|Extension - 4 Years|Death|3|||
46813299|NCT00514514|83033018|FG002|Extension - 4 Years|Death|6|||
46813300|NCT00514514|83033016|FG000|Extension - 4 Years|Adverse Event|9|||
46813301|NCT00514514|83033017|FG001|Extension - 4 Years|Adverse Event|6|||
46813302|NCT00514514|83033018|FG002|Extension - 4 Years|Adverse Event|3|||
46813303|NCT00405639|83033028|FG000|Overall Study|Withdrawal by Subject|1|||
46813304|NCT00405639|83033029|FG001|Overall Study|Withdrawal by Subject|0|||
46813305|NCT00405639|83033028|FG000|Overall Study|Adverse Event|1|||
46813306|NCT00405639|83033029|FG001|Overall Study|Adverse Event|0|||
46813307|NCT00405639|83033028|FG000|Overall Study|Seizure prior to receiving BNP|1|||
46813308|NCT00405639|83033029|FG001|Overall Study|Seizure prior to receiving BNP|0|||
46813309|NCT00439725|83033037|FG000|Treatment Period|Withdrawal by Subject|22|||
46813310|NCT00439725|83033038|FG001|Treatment Period|Withdrawal by Subject|19|||
46813311|NCT00439725|83033037|FG000|Treatment Period|Study terminated by sponsor|156|||
46813312|NCT00439725|83033038|FG001|Treatment Period|Study terminated by sponsor|148|||
46813313|NCT00439725|83033037|FG000|Treatment Period|Site closed by investigator|1|||
46813314|NCT00439725|83033038|FG001|Treatment Period|Site closed by investigator|2|||
46813315|NCT00439725|83033037|FG000|Treatment Period|Adverse Event|39|||
46813316|NCT00439725|83033038|FG001|Treatment Period|Adverse Event|18|||
46813317|NCT00439725|83033037|FG000|Treatment Period|Physician Decision|1|||
46813318|NCT00439725|83033038|FG001|Treatment Period|Physician Decision|1|||
46813319|NCT00439725|83033037|FG000|Treatment Period|Protocol Violation|2|||
46813320|NCT00439725|83033038|FG001|Treatment Period|Protocol Violation|1|||
46813321|NCT00439725|83033037|FG000|Treatment Period|Clinical endpoint reached|6|||
46928385|NCT02748213|83163197|FG001|Overall Study|Other|29|||
47054871|NCT01781429|83328206|FG008|Overall Study|Unacceptable Toxicity|0|||
47054872|NCT01781429|83328207|FG009|Overall Study|Unacceptable Toxicity|0|||
47054873|NCT01781429|83328208|FG010|Overall Study|Unacceptable Toxicity|0|||
47054874|NCT01781429|83328209|FG011|Overall Study|Unacceptable Toxicity|2|||
46636490|NCT01512264|82810297|FG000|Overall Study|Lost to Follow-up|0|||
46636491|NCT01512264|82810298|FG001|Overall Study|Lost to Follow-up|0|||
46636492|NCT01512264|82810299|FG002|Overall Study|Lost to Follow-up|0|||
46636493|NCT01512264|82810300|FG003|Overall Study|Lost to Follow-up|1|||
46636494|NCT01512108|82810312|FG000|Overall Study|Adverse Event|9|||
46636495|NCT01512108|82810313|FG001|Overall Study|Adverse Event|4|||
46636496|NCT01512108|82810312|FG000|Overall Study|Protocol Violation|1|||
46636497|NCT01512108|82810313|FG001|Overall Study|Protocol Violation|2|||
46636498|NCT01512108|82810312|FG000|Overall Study|Withdrawal Criteria|1|||
46636499|NCT01512108|82810313|FG001|Overall Study|Withdrawal Criteria|0|||
46636500|NCT01512108|82810312|FG000|Overall Study|Unclassified|11|||
46636501|NCT01512108|82810313|FG001|Overall Study|Unclassified|3|||
46636502|NCT01486758|82810321|FG000|Overall Study|Lost to Follow-up|0|||
46636503|NCT01486758|82810322|FG001|Overall Study|Lost to Follow-up|1|||
46636504|NCT01463982|82810333|FG000|Overall Study|Withdrawal by Subject|0|||
46636505|NCT01463982|82810334|FG001|Overall Study|Withdrawal by Subject|1|||
46636506|NCT01463982|82810335|FG002|Overall Study|Withdrawal by Subject|1|||
46636507|NCT01463982|82810336|FG003|Overall Study|Withdrawal by Subject|0|||
46755402|NCT00874770|82973162|FG000|Overall Study|Lost to Follow-up|1|||
46755403|NCT00874770|82973163|FG001|Overall Study|Lost to Follow-up|0|||
46755404|NCT00874770|82973164|FG002|Overall Study|Lost to Follow-up|0|||
46755405|NCT00874770|82973165|FG003|Overall Study|Lost to Follow-up|1|||
46755406|NCT00874770|82973162|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
46755407|NCT00874770|82973163|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
46755408|NCT00874770|82973164|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
46813322|NCT00439725|83033038|FG001|Treatment Period|Clinical endpoint reached|50|||
46813323|NCT00439725|83033037|FG000|Treatment Period|Technical problems|1|||
46813324|NCT00439725|83033038|FG001|Treatment Period|Technical problems|0|||
46813325|NCT00439725|83033037|FG000|Treatment Period|Lost to Follow-up|1|||
46813326|NCT00439725|83033038|FG001|Treatment Period|Lost to Follow-up|1|||
46813327|NCT00439725|83033037|FG000|Treatment Period|Participant convenience|1|||
46813328|NCT00439725|83033038|FG001|Treatment Period|Participant convenience|0|||
47054875|NCT01781429|83328210|FG012|Overall Study|Unacceptable Toxicity|0|||
46636508|NCT01463982|82810333|FG000|Overall Study|Treatment delay over 5 week|0|||
46636509|NCT01463982|82810334|FG001|Overall Study|Treatment delay over 5 week|0|||
46636510|NCT01463982|82810335|FG002|Overall Study|Treatment delay over 5 week|1|||
46755409|NCT00874770|82973165|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
46755410|NCT00536263|82973188|FG000|Overall Study|Adverse Event|5|||
46755411|NCT00536263|82973189|FG001|Overall Study|Adverse Event|5|||
46755412|NCT00536263|82973190|FG002|Overall Study|Adverse Event|7|||
46813329|NCT00439725|83033037|FG000|Treatment Period|Protocol driven decision point|1|||
46928386|NCT02613910|83163203|FG000|Overall Study|Termination of study|1|||
46636511|NCT01463982|82810336|FG003|Overall Study|Treatment delay over 5 week|0|||
46636512|NCT01486446|82810348|FG000|Overall Study|Adverse Event|1|||
46636513|NCT01486446|82810349|FG001|Overall Study|Adverse Event|0|||
46636514|NCT01485354|82810355|FG000|Overall Study|Withdrawal by Subject|5|||
46636515|NCT01510158|82810362|FG000|Overall Study|Adverse Event|7|||
46636516|NCT01510158|82810363|FG001|Overall Study|Adverse Event|8|||
46636517|NCT01510158|82810364|FG002|Overall Study|Adverse Event|5|||
46636518|NCT01510158|82810362|FG000|Overall Study|Gout flare|1|||
46636519|NCT01510158|82810363|FG001|Overall Study|Gout flare|0|||
46636520|NCT01510158|82810364|FG002|Overall Study|Gout flare|0|||
46755413|NCT00536263|82973188|FG000|Overall Study|Lost to Follow-up|3|||
46755414|NCT00536263|82973189|FG001|Overall Study|Lost to Follow-up|4|||
46755415|NCT00536263|82973190|FG002|Overall Study|Lost to Follow-up|4|||
46755416|NCT00536263|82973188|FG000|Overall Study|Subject withdrew - not treatment related|2|||
47054876|NCT01781429|83328211|FG013|Overall Study|Unacceptable Toxicity|0|||
46755417|NCT00536263|82973189|FG001|Overall Study|Subject withdrew - not treatment related|0|||
46755418|NCT00536263|82973190|FG002|Overall Study|Subject withdrew - not treatment related|5|||
46755419|NCT00536263|82973188|FG000|Overall Study|Subject withdrew - treatment related|0|||
46755420|NCT00536263|82973189|FG001|Overall Study|Subject withdrew - treatment related|3|||
46755421|NCT00536263|82973190|FG002|Overall Study|Subject withdrew - treatment related|2|||
46755422|NCT00536263|82973188|FG000|Overall Study|Noncompliance with protocol|0|||
46755423|NCT00536263|82973189|FG001|Overall Study|Noncompliance with protocol|0|||
46755424|NCT00536263|82973190|FG002|Overall Study|Noncompliance with protocol|1|||
46755425|NCT00536263|82973188|FG000|Overall Study|Did not meet protocol eligibility|1|||
46755426|NCT00536263|82973189|FG001|Overall Study|Did not meet protocol eligibility|2|||
46755427|NCT00536263|82973190|FG002|Overall Study|Did not meet protocol eligibility|2|||
46755428|NCT00578344|82973198|FG000|Overall Study|Insurance problems|1|||
46755429|NCT00578344|82973198|FG000|Overall Study|Graft failure|1|||
46755430|NCT00873366|82973202|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
46755431|NCT00873366|82973202|FG000|Overall Study|Off tamoxifen due to side effects|2|||
46755432|NCT00873366|82973202|FG000|Overall Study|Refused to continue DM-BT testing|3|||
46755433|NCT00536107|82973208|FG000|Overall Study|Death|5|||
46755434|NCT00536107|82973209|FG001|Overall Study|Death|1|||
46636521|NCT01510158|82810362|FG000|Overall Study|Protocol Violation|17|||
46636522|NCT01510158|82810363|FG001|Overall Study|Protocol Violation|16|||
46755435|NCT00536107|82973208|FG000|Overall Study|Incorrect enrolment|1|||
46755436|NCT00536107|82973209|FG001|Overall Study|Incorrect enrolment|0|||
46755437|NCT00536107|82973208|FG000|Overall Study|Withdrawal by Subject|0|||
46755438|NCT00536107|82973209|FG001|Overall Study|Withdrawal by Subject|1|||
46755439|NCT00536107|82973208|FG000|Overall Study|Study Termination|2|||
46755440|NCT00536107|82973209|FG001|Overall Study|Study Termination|4|||
46755441|NCT00885482|82973229|FG000|Overall Study|Pregnancy|1|||
46755442|NCT00885482|82973229|FG000|Overall Study|Lack of Efficacy|1|||
46755443|NCT00885482|82973229|FG000|Overall Study|Death|1|||
46755444|NCT00885482|82973229|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
46755445|NCT00885170|82973253|FG000|Overall Study|Adverse Event|12|||
46755446|NCT00885170|82973254|FG001|Overall Study|Adverse Event|4|||
46755447|NCT00885170|82973253|FG000|Overall Study|Excessive bone loss|6|||
46755448|NCT00885170|82973254|FG001|Overall Study|Excessive bone loss|3|||
46755449|NCT00885170|82973253|FG000|Overall Study|Lost to Follow-up|2|||
46755450|NCT00885170|82973254|FG001|Overall Study|Lost to Follow-up|1|||
46755451|NCT00885170|82973253|FG000|Overall Study|Physician Decision|2|||
46755452|NCT00885170|82973254|FG001|Overall Study|Physician Decision|1|||
46755453|NCT00885170|82973253|FG000|Overall Study|Protocol Violation|3|||
46755454|NCT00885170|82973254|FG001|Overall Study|Protocol Violation|1|||
46755455|NCT00885170|82973253|FG000|Overall Study|Withdrawal by Subject|13|||
46755456|NCT00885170|82973254|FG001|Overall Study|Withdrawal by Subject|13|||
46755457|NCT00866619|82973281|FG000|Overall Study|Adverse Event|112|||
46755458|NCT00866619|82973282|FG001|Overall Study|Adverse Event|106|||
46755459|NCT00866619|82973283|FG002|Overall Study|Adverse Event|47|||
46755460|NCT00866619|82973284|FG003|Overall Study|Adverse Event|44|||
46755461|NCT00866619|82973281|FG000|Overall Study|Protocol Violation|2|||
46755462|NCT00866619|82973282|FG001|Overall Study|Protocol Violation|39|||
46755463|NCT00866619|82973283|FG002|Overall Study|Protocol Violation|2|||
46755464|NCT00866619|82973284|FG003|Overall Study|Protocol Violation|17|||
46755465|NCT00866619|82973281|FG000|Overall Study|Withdrawal by Subject|587|||
46755466|NCT00866619|82973282|FG001|Overall Study|Withdrawal by Subject|295|||
46755467|NCT00866619|82973283|FG002|Overall Study|Withdrawal by Subject|272|||
46755468|NCT00866619|82973284|FG003|Overall Study|Withdrawal by Subject|144|||
46755469|NCT00866619|82973281|FG000|Overall Study|Lost to Follow-up|1145|||
46755470|NCT00866619|82973282|FG001|Overall Study|Lost to Follow-up|830|||
46755471|NCT00866619|82973283|FG002|Overall Study|Lost to Follow-up|568|||
46755472|NCT00866619|82973284|FG003|Overall Study|Lost to Follow-up|425|||
46755473|NCT00884390|82973331|FG000|Overall Study|Adverse Event|0|||
46755474|NCT00884390|82973332|FG001|Overall Study|Adverse Event|1|||
46755475|NCT00884390|82973331|FG000|Overall Study|Lost to Follow-up|0|||
46755476|NCT00884390|82973332|FG001|Overall Study|Lost to Follow-up|1|||
46755477|NCT00884390|82973331|FG000|Overall Study|Physician Decision|2|||
46755478|NCT00884390|82973332|FG001|Overall Study|Physician Decision|1|||
46755479|NCT00884390|82973331|FG000|Overall Study|Protocol Violation|4|||
46813330|NCT00439725|83033038|FG001|Treatment Period|Protocol driven decision point|1|||
46813331|NCT00439725|83033037|FG000|Treatment Period|Death|1|||
46813332|NCT00439725|83033038|FG001|Treatment Period|Death|1|||
46813333|NCT00439725|83033037|FG000|Treatment Period|Participant did not receive treatment|4|||
46813334|NCT00439725|83033038|FG001|Treatment Period|Participant did not receive treatment|4|||
46813335|NCT00439725|83033037|FG000|Observational Period|Withdrawal by Subject|2|||
46813336|NCT00439725|83033038|FG001|Observational Period|Withdrawal by Subject|2|||
46813337|NCT00439725|83033037|FG000|Observational Period|Lost to Follow-up|0|||
46813338|NCT00439725|83033038|FG001|Observational Period|Lost to Follow-up|1|||
46813339|NCT00439725|83033037|FG000|Observational Period|Death|0|||
46813340|NCT00439725|83033038|FG001|Observational Period|Death|2|||
46813341|NCT00439725|83033037|FG000|Observational Period|Study termination by sponsor|1|||
46813342|NCT00439725|83033038|FG001|Observational Period|Study termination by sponsor|1|||
46813343|NCT00439725|83033037|FG000|Observational Period|Clinical endpoint reached|3|||
46813344|NCT00439725|83033038|FG001|Observational Period|Clinical endpoint reached|1|||
46813345|NCT00439725|83033037|FG000|Observational Period|Technical problems|1|||
46813346|NCT00439725|83033038|FG001|Observational Period|Technical problems|0|||
46813347|NCT00439725|83033037|FG000|Observational Period|Participant convenience|1|||
46813348|NCT00439725|83033038|FG001|Observational Period|Participant convenience|0|||
46813349|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Subject request|8|||
46813350|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Subject request|11|||
46813351|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
46813352|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
46813353|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
46813354|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
46813355|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
46813356|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
46813357|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
46813358|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
46813359|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
46813360|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
46813361|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Death|1|||
46813362|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Death|0|||
46813363|NCT00521586|83033046|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
46813364|NCT00521586|83033047|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
46813365|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
46813366|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
46813367|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
46813368|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
46813369|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
46813370|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
46813371|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
46813372|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
46813373|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
46813374|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
46813375|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
46813376|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
46755480|NCT00884390|82973332|FG001|Overall Study|Protocol Violation|1|||
46755481|NCT00884390|82973331|FG000|Overall Study|Withdrawal by Subject|4|||
46755482|NCT00884390|82973332|FG001|Overall Study|Withdrawal by Subject|1|||
46755483|NCT00884390|82973331|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
46755484|NCT00884390|82973332|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
46755485|NCT00884390|82973331|FG000|Overall Study|Other|11|||
46755486|NCT00884390|82973332|FG001|Overall Study|Other|1|||
46755487|NCT00872898|82973369|FG000|Part Two - Double Blind|Adverse Event|4|||
46755488|NCT00872898|82973370|FG001|Part Two - Double Blind|Adverse Event|3|||
46755489|NCT00872898|82973369|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
46813377|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
46813378|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
46813379|NCT00521586|83033046|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
46813380|NCT00521586|83033047|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
46813381|NCT00521586|83033046|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
46813382|NCT00521586|83033047|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
46813383|NCT00521586|83033046|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
46813384|NCT00521586|83033047|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
46813385|NCT00521586|83033046|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
46813386|NCT00521586|83033047|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
46755490|NCT00872898|82973370|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
46755491|NCT00872898|82973369|FG000|Part Two - Double Blind|Protocol Violation|1|||
46755492|NCT00872898|82973370|FG001|Part Two - Double Blind|Protocol Violation|0|||
46813387|NCT00515502|83033065|FG000|Treatment Period 1|Adverse Event|0|||
46755493|NCT00872898|82973369|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
46755494|NCT00872898|82973370|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
46813388|NCT00515502|83033066|FG001|Treatment Period 1|Adverse Event|0|||
46813389|NCT00515502|83033067|FG002|Treatment Period 1|Adverse Event|0|||
46813390|NCT00515502|83033068|FG003|Treatment Period 1|Adverse Event|0|||
46813391|NCT00515502|83033069|FG004|Treatment Period 1|Adverse Event|0|||
46813392|NCT00515502|83033070|FG005|Treatment Period 1|Adverse Event|0|||
46813393|NCT00515502|83033071|FG006|Treatment Period 1|Adverse Event|1|||
46813394|NCT00515502|83033072|FG007|Treatment Period 1|Adverse Event|0|||
46813395|NCT00515502|83033073|FG008|Treatment Period 1|Adverse Event|1|||
46813396|NCT00515502|83033074|FG009|Treatment Period 1|Adverse Event|0|||
46813397|NCT00515502|83033075|FG010|Treatment Period 1|Adverse Event|0|||
46813398|NCT00515502|83033076|FG011|Treatment Period 1|Adverse Event|1|||
46813399|NCT00515502|83033065|FG000|Treatment Period 2|Adverse Event|0|||
46928387|NCT02802735|83163210|FG000|Overall Study|Withdrawal by Subject|0|||
46928388|NCT02802735|83163211|FG001|Overall Study|Withdrawal by Subject|1|||
46928389|NCT02802735|83163212|FG002|Overall Study|Withdrawal by Subject|0|||
46928390|NCT02802735|83163213|FG003|Overall Study|Withdrawal by Subject|0|||
46928391|NCT02802735|83163214|FG004|Overall Study|Withdrawal by Subject|0|||
46928392|NCT02799381|83163231|FG000|Overall Study|Withdrew consent|3|||
46928393|NCT02799381|83163232|FG001|Overall Study|Withdrew consent|2|||
46928394|NCT02799381|83163231|FG000|Overall Study|Adverse Event|0|||
46928395|NCT02799381|83163232|FG001|Overall Study|Adverse Event|1|||
46928396|NCT02799381|83163231|FG000|Overall Study|Participant did not take any study drug|1|||
46928397|NCT02799381|83163232|FG001|Overall Study|Participant did not take any study drug|0|||
46928398|NCT01333059|83163240|FG000|Overall Study|Physician Decision|3|||
46928399|NCT01333059|83163241|FG001|Overall Study|Physician Decision|3|||
46928400|NCT01333059|83163240|FG000|Overall Study|Protocol Violation|3|||
46928401|NCT01333059|83163241|FG001|Overall Study|Protocol Violation|0|||
46928402|NCT01370733|83163251|FG000|Overall Study|Withdrawal by Subject|8|||
46928403|NCT01370733|83163252|FG001|Overall Study|Withdrawal by Subject|8|||
46928404|NCT01370733|83163251|FG000|Overall Study|Lost to Follow-up|3|||
46928405|NCT01370733|83163252|FG001|Overall Study|Lost to Follow-up|0|||
46928406|NCT01370733|83163251|FG000|Overall Study|Adverse Event|2|||
46928407|NCT01370733|83163252|FG001|Overall Study|Adverse Event|4|||
46928408|NCT01370733|83163251|FG000|Overall Study|Lack of Efficacy|3|||
46928409|NCT01370733|83163252|FG001|Overall Study|Lack of Efficacy|5|||
46928410|NCT01370733|83163251|FG000|Overall Study|Physician Decision|0|||
46928411|NCT01370733|83163252|FG001|Overall Study|Physician Decision|2|||
46928412|NCT01370733|83163251|FG000|Overall Study|Protocol Violation|1|||
46928413|NCT01370733|83163252|FG001|Overall Study|Protocol Violation|3|||
46928414|NCT02613364|83163261|FG000|Overall Study|Other|19|||
46928415|NCT02613364|83163262|FG001|Overall Study|Other|29|||
46928416|NCT02613364|83163263|FG002|Overall Study|Other|17|||
46755495|NCT00872898|82973369|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
46755496|NCT00872898|82973370|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
46755497|NCT00872898|82973369|FG000|Part Two - Double Blind|Other reasons|2|||
46755498|NCT00872898|82973370|FG001|Part Two - Double Blind|Other reasons|0|||
46755499|NCT00884312|82973381|FG000|Overall Study|Non-fatal Progressive Disease|0|||
46755500|NCT00884312|82973382|FG001|Overall Study|Non-fatal Progressive Disease|8|||
46755501|NCT00884312|82973381|FG000|Overall Study|Fatal Progressive Disease|0|||
46755502|NCT00884312|82973382|FG001|Overall Study|Fatal Progressive Disease|1|||
46813400|NCT00515502|83033066|FG001|Treatment Period 2|Adverse Event|1|||
46813401|NCT00515502|83033067|FG002|Treatment Period 2|Adverse Event|0|||
46813402|NCT00515502|83033068|FG003|Treatment Period 2|Adverse Event|0|||
46813403|NCT00515502|83033069|FG004|Treatment Period 2|Adverse Event|0|||
46813404|NCT00515502|83033070|FG005|Treatment Period 2|Adverse Event|0|||
46813405|NCT00515502|83033071|FG006|Treatment Period 2|Adverse Event|0|||
46813406|NCT00515502|83033072|FG007|Treatment Period 2|Adverse Event|0|||
46813407|NCT00515502|83033073|FG008|Treatment Period 2|Adverse Event|0|||
46813408|NCT00515502|83033074|FG009|Treatment Period 2|Adverse Event|0|||
46813409|NCT00515502|83033075|FG010|Treatment Period 2|Adverse Event|0|||
46813410|NCT00515502|83033076|FG011|Treatment Period 2|Adverse Event|0|||
46928417|NCT02613364|83163261|FG000|Overall Study|Too time consuming|21|||
46755503|NCT00884312|82973381|FG000|Overall Study|Non-fatal Adverse Event|1|||
46813411|NCT00439647|83033095|FG000|Overall Study|Withdrawal by Subject|25|||
46813412|NCT00439647|83033096|FG001|Overall Study|Withdrawal by Subject|22|||
46813413|NCT00439647|83033095|FG000|Overall Study|Death|15|||
46813414|NCT00439647|83033096|FG001|Overall Study|Death|18|||
46928418|NCT02613364|83163262|FG001|Overall Study|Too time consuming|26|||
46928419|NCT02613364|83163263|FG002|Overall Study|Too time consuming|26|||
46755504|NCT00884312|82973382|FG001|Overall Study|Non-fatal Adverse Event|0|||
46755505|NCT00884312|82973381|FG000|Overall Study|Fatal Adverse Event|1|||
46813415|NCT00439647|83033095|FG000|Overall Study|Adverse Event|11|||
46813416|NCT00439647|83033096|FG001|Overall Study|Adverse Event|11|||
46813417|NCT00439647|83033095|FG000|Overall Study|Lost to Follow-up|4|||
46928420|NCT02613364|83163261|FG000|Overall Study|Withdrawal by Subject|13|||
46928421|NCT02613364|83163262|FG001|Overall Study|Withdrawal by Subject|18|||
46928422|NCT02613364|83163263|FG002|Overall Study|Withdrawal by Subject|17|||
46928423|NCT02613364|83163261|FG000|Overall Study|Medical|12|||
46813418|NCT00439647|83033096|FG001|Overall Study|Lost to Follow-up|12|||
46813419|NCT00439647|83033095|FG000|Overall Study|Protocol Violation|3|||
46813420|NCT00439647|83033096|FG001|Overall Study|Protocol Violation|4|||
46813421|NCT00439647|83033095|FG000|Overall Study|Lack of Efficacy|0|||
46813422|NCT00439647|83033096|FG001|Overall Study|Lack of Efficacy|4|||
46813423|NCT00515112|83033104|FG000|Overall Study|Death|0|||
46813424|NCT00515112|83033105|FG001|Overall Study|Death|1|||
46813425|NCT00515112|83033104|FG000|Overall Study|The study was terminated|3|||
46813426|NCT00515112|83033105|FG001|Overall Study|The study was terminated|2|||
46813427|NCT00404547|83033113|FG000|Overall Study|Adverse Event|39|||
46813428|NCT00404547|83033114|FG001|Overall Study|Adverse Event|6|||
46813429|NCT00404547|83033113|FG000|Overall Study|Withdrawal by Subject|19|||
46813430|NCT00404547|83033114|FG001|Overall Study|Withdrawal by Subject|2|||
46813431|NCT00404547|83033113|FG000|Overall Study|Protocol Violation|0|||
46813432|NCT00404547|83033114|FG001|Overall Study|Protocol Violation|1|||
46813433|NCT00404547|83033113|FG000|Overall Study|Lost to Follow-up|20|||
46813434|NCT00404547|83033114|FG001|Overall Study|Lost to Follow-up|9|||
46813435|NCT00404547|83033113|FG000|Overall Study|Lack of compliance|5|||
46813436|NCT00404547|83033114|FG001|Overall Study|Lack of compliance|1|||
46813437|NCT00404547|83033113|FG000|Overall Study|Other|4|||
46813438|NCT00404547|83033114|FG001|Overall Study|Other|0|||
46813439|NCT00404547|83033113|FG000|Overall Study|Reason not stated|3|||
46813440|NCT00404547|83033114|FG001|Overall Study|Reason not stated|6|||
46813441|NCT00515034|83033124|FG000|Overall Study|Adverse Event|2|||
46813442|NCT00515034|83033125|FG001|Overall Study|Adverse Event|0|||
46928424|NCT02613364|83163262|FG001|Overall Study|Medical|13|||
46813443|NCT00515034|83033126|FG002|Overall Study|Adverse Event|1|||
46813444|NCT00515034|83033127|FG003|Overall Study|Adverse Event|0|||
46813445|NCT00515034|83033124|FG000|Overall Study|Death|4|||
46813446|NCT00515034|83033125|FG001|Overall Study|Death|2|||
46813447|NCT00515034|83033126|FG002|Overall Study|Death|1|||
46813448|NCT00515034|83033127|FG003|Overall Study|Death|3|||
46813449|NCT00515034|83033124|FG000|Overall Study|Withdrawal by Subject|1|||
46813450|NCT00515034|83033125|FG001|Overall Study|Withdrawal by Subject|0|||
46813451|NCT00515034|83033126|FG002|Overall Study|Withdrawal by Subject|3|||
46813452|NCT00515034|83033127|FG003|Overall Study|Withdrawal by Subject|0|||
46813453|NCT00515034|83033124|FG000|Overall Study|Physician Decision|0|||
46813454|NCT00515034|83033125|FG001|Overall Study|Physician Decision|0|||
46813455|NCT00515034|83033126|FG002|Overall Study|Physician Decision|1|||
46813456|NCT00515034|83033127|FG003|Overall Study|Physician Decision|1|||
46813457|NCT00515034|83033124|FG000|Overall Study|Other|1|||
46636523|NCT01510158|82810364|FG002|Overall Study|Protocol Violation|24|||
46636524|NCT01510158|82810362|FG000|Overall Study|Sponsor terminated study.|2|||
46636525|NCT01510158|82810363|FG001|Overall Study|Sponsor terminated study.|0|||
46636526|NCT01510158|82810364|FG002|Overall Study|Sponsor terminated study.|2|||
46813458|NCT00515034|83033125|FG001|Overall Study|Other|0|||
46813459|NCT00515034|83033126|FG002|Overall Study|Other|2|||
46813460|NCT00515034|83033127|FG003|Overall Study|Other|1|||
46813461|NCT00404235|83033139|FG000|Overall Study|Withdrawal by Subject|1|||
46813462|NCT00404235|83033140|FG001|Overall Study|Withdrawal by Subject|2|||
46813463|NCT00404079|83033148|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
46813464|NCT00404079|83033149|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
46813465|NCT00403845|83033155|FG000|Treatment Period 1|Subject withdrew consent|1|||
46813466|NCT00403845|83033156|FG001|Treatment Period 1|Subject withdrew consent|0|||
46813467|NCT00403845|83033157|FG002|Treatment Period 1|Subject withdrew consent|0|||
46813468|NCT00403845|83033158|FG003|Treatment Period 1|Subject withdrew consent|0|||
46928425|NCT02613364|83163263|FG002|Overall Study|Medical|9|||
46636527|NCT01510158|82810362|FG000|Overall Study|Lost to Follow-up|13|||
46813469|NCT00403845|83033155|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
46813470|NCT00403845|83033156|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
46813471|NCT00403845|83033157|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
46813472|NCT00403845|83033158|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
46813473|NCT00403845|83033155|FG000|Treatment Period 2|Subject withdrew consent|1|||
46813474|NCT00403845|83033156|FG001|Treatment Period 2|Subject withdrew consent|0|||
46813475|NCT00403845|83033157|FG002|Treatment Period 2|Subject withdrew consent|0|||
46813476|NCT00403845|83033158|FG003|Treatment Period 2|Subject withdrew consent|0|||
46813477|NCT00403845|83033155|FG000|Treatment Period 3|Subject withdrew consent|0|||
46813478|NCT00403845|83033156|FG001|Treatment Period 3|Subject withdrew consent|0|||
46813479|NCT00403845|83033157|FG002|Treatment Period 3|Subject withdrew consent|0|||
46813480|NCT00403845|83033158|FG003|Treatment Period 3|Subject withdrew consent|1|||
46813481|NCT00403845|83033155|FG000|Treatment Period 3|Adverse Event|0|||
46928426|NCT02613364|83163261|FG000|Overall Study|Disliked Study Procedure|1|||
46928427|NCT02613364|83163262|FG001|Overall Study|Disliked Study Procedure|1|||
46928428|NCT02613364|83163263|FG002|Overall Study|Disliked Study Procedure|4|||
46813482|NCT00403845|83033156|FG001|Treatment Period 3|Adverse Event|0|||
46928429|NCT02613364|83163261|FG000|Overall Study|Disliked Intervention|0|||
46813483|NCT00403845|83033157|FG002|Treatment Period 3|Adverse Event|0|||
46813484|NCT00403845|83033158|FG003|Treatment Period 3|Adverse Event|1|||
46813485|NCT00509262|83033170|FG000|Overall Study|Adverse Event|16|||
46813486|NCT00509262|83033171|FG001|Overall Study|Adverse Event|18|||
46813487|NCT00509262|83033170|FG000|Overall Study|Other|2|||
46813488|NCT00509262|83033171|FG001|Overall Study|Other|2|||
46813489|NCT00509262|83033170|FG000|Overall Study|Lack of Efficacy|1|||
46813490|NCT00509262|83033171|FG001|Overall Study|Lack of Efficacy|0|||
46813491|NCT00509262|83033170|FG000|Overall Study|Lost to Follow-up|1|||
46813492|NCT00509262|83033171|FG001|Overall Study|Lost to Follow-up|6|||
46813493|NCT00509262|83033170|FG000|Overall Study|Physician Decision|1|||
46813494|NCT00509262|83033171|FG001|Overall Study|Physician Decision|3|||
46813495|NCT00509262|83033170|FG000|Overall Study|Protocol Violation|2|||
46813496|NCT00509262|83033171|FG001|Overall Study|Protocol Violation|2|||
46813497|NCT00509262|83033170|FG000|Overall Study|Withdrawal by Subject|24|||
46813498|NCT00509262|83033171|FG001|Overall Study|Withdrawal by Subject|11|||
46813499|NCT00607997|83033181|FG000|Overall Study|Lack of Efficacy|6|||
46813500|NCT00607997|83033182|FG001|Overall Study|Lack of Efficacy|20|||
46813501|NCT00607997|83033183|FG002|Overall Study|Lack of Efficacy|14|||
46813502|NCT00607997|83033184|FG003|Overall Study|Lack of Efficacy|10|||
46813503|NCT00607997|83033181|FG000|Overall Study|Death|8|||
46813504|NCT00607997|83033182|FG001|Overall Study|Death|5|||
46755506|NCT00884312|82973382|FG001|Overall Study|Fatal Adverse Event|4|||
46755507|NCT00884312|82973381|FG000|Overall Study|Withdrawal by Subject|0|||
46755508|NCT00884312|82973382|FG001|Overall Study|Withdrawal by Subject|6|||
46755509|NCT00884312|82973381|FG000|Overall Study|Physician Decision|0|||
46755510|NCT00884312|82973382|FG001|Overall Study|Physician Decision|1|||
46755511|NCT00884312|82973381|FG000|Overall Study|Other|0|||
46755512|NCT00884312|82973382|FG001|Overall Study|Other|4|||
46755513|NCT00884312|82973381|FG000|Overall Study|Did Not Receive Study Drug|0|||
46755514|NCT00884312|82973382|FG001|Overall Study|Did Not Receive Study Drug|1|||
46755515|NCT00534313|82973392|FG000|Short-term Period|Adverse Event|1|||
46813505|NCT00607997|83033183|FG002|Overall Study|Death|2|||
46813506|NCT00607997|83033184|FG003|Overall Study|Death|5|||
46813507|NCT00607997|83033181|FG000|Overall Study|Adverse Event|3|||
46813508|NCT00607997|83033182|FG001|Overall Study|Adverse Event|1|||
46813509|NCT00607997|83033183|FG002|Overall Study|Adverse Event|2|||
46928430|NCT02613364|83163262|FG001|Overall Study|Disliked Intervention|3|||
46928431|NCT02613364|83163263|FG002|Overall Study|Disliked Intervention|3|||
46928432|NCT01370655|83163283|FG000|Period 1|Adverse Event|2|||
46928433|NCT01370655|83163284|FG001|Period 1|Adverse Event|0|||
46928434|NCT01370655|83163285|FG002|Period 1|Adverse Event|0|||
46928435|NCT01370655|83163286|FG003|Period 1|Adverse Event|0|||
46928436|NCT01370655|83163287|FG004|Period 1|Adverse Event|0|||
46928437|NCT01370655|83163288|FG005|Period 1|Adverse Event|0|||
46928438|NCT01370655|83163289|FG006|Period 1|Adverse Event|1|||
46755516|NCT00534313|82973393|FG001|Short-term Period|Adverse Event|2|||
46755517|NCT00534313|82973394|FG002|Short-term Period|Adverse Event|1|||
46755518|NCT00534313|82973395|FG003|Short-term Period|Adverse Event|3|||
46755519|NCT00534313|82973392|FG000|Short-term Period|Lack of Efficacy|3|||
46755520|NCT00534313|82973393|FG001|Short-term Period|Lack of Efficacy|4|||
46755521|NCT00534313|82973394|FG002|Short-term Period|Lack of Efficacy|0|||
46755522|NCT00534313|82973395|FG003|Short-term Period|Lack of Efficacy|3|||
46928439|NCT01370655|83163290|FG007|Period 1|Adverse Event|0|||
46928440|NCT01370655|83163291|FG008|Period 1|Adverse Event|0|||
46928441|NCT01370655|83163292|FG009|Period 1|Adverse Event|0|||
46928442|NCT01370655|83163293|FG010|Period 1|Adverse Event|0|||
46928443|NCT01370655|83163294|FG011|Period 1|Adverse Event|0|||
46928444|NCT01370655|83163283|FG000|Period 2|Adverse Event|0|||
46928445|NCT01370655|83163284|FG001|Period 2|Adverse Event|0|||
46928446|NCT01370655|83163285|FG002|Period 2|Adverse Event|1|||
46928447|NCT01370655|83163286|FG003|Period 2|Adverse Event|0|||
46928448|NCT01370655|83163287|FG004|Period 2|Adverse Event|1|||
46755523|NCT00534313|82973392|FG000|Short-term Period|Participant not meeting study criteria|0|||
46928449|NCT01370655|83163288|FG005|Period 2|Adverse Event|0|||
46928450|NCT01370655|83163289|FG006|Period 2|Adverse Event|0|||
46928451|NCT01370655|83163290|FG007|Period 2|Adverse Event|1|||
46813510|NCT00607997|83033184|FG003|Overall Study|Adverse Event|0|||
46813511|NCT00607997|83033181|FG000|Overall Study|Physician Decision|4|||
46813512|NCT00607997|83033182|FG001|Overall Study|Physician Decision|1|||
46813513|NCT00607997|83033183|FG002|Overall Study|Physician Decision|0|||
46813514|NCT00607997|83033184|FG003|Overall Study|Physician Decision|0|||
46813515|NCT00607997|83033181|FG000|Overall Study|Relapse, recurrent illness|4|||
46636528|NCT01510158|82810363|FG001|Overall Study|Lost to Follow-up|16|||
46755524|NCT00534313|82973393|FG001|Short-term Period|Participant not meeting study criteria|0|||
46755525|NCT00534313|82973394|FG002|Short-term Period|Participant not meeting study criteria|0|||
46755526|NCT00534313|82973395|FG003|Short-term Period|Participant not meeting study criteria|1|||
46755527|NCT00534313|82973392|FG000|Short-term Period|Participant withdrew consent|2|||
46813516|NCT00607997|83033182|FG001|Overall Study|Relapse, recurrent illness|0|||
46928452|NCT01370655|83163291|FG008|Period 2|Adverse Event|0|||
46928453|NCT01370655|83163292|FG009|Period 2|Adverse Event|0|||
46928454|NCT01370655|83163293|FG010|Period 2|Adverse Event|0|||
46928455|NCT01370655|83163294|FG011|Period 2|Adverse Event|0|||
46928456|NCT01370655|83163283|FG000|Period 2|met protocol specified stopping criteria|0|||
46928457|NCT01370655|83163284|FG001|Period 2|met protocol specified stopping criteria|0|||
46928458|NCT01370655|83163285|FG002|Period 2|met protocol specified stopping criteria|1|||
46928459|NCT01370655|83163286|FG003|Period 2|met protocol specified stopping criteria|0|||
46755528|NCT00534313|82973393|FG001|Short-term Period|Participant withdrew consent|0|||
46755529|NCT00534313|82973394|FG002|Short-term Period|Participant withdrew consent|0|||
46636529|NCT01510158|82810364|FG002|Overall Study|Lost to Follow-up|9|||
46636530|NCT01510158|82810362|FG000|Overall Study|Withdrawal by Subject|10|||
46636531|NCT01510158|82810363|FG001|Overall Study|Withdrawal by Subject|13|||
46636532|NCT01510158|82810364|FG002|Overall Study|Withdrawal by Subject|10|||
46636533|NCT01510158|82810362|FG000|Overall Study|Death|1|||
46636534|NCT01510158|82810363|FG001|Overall Study|Death|0|||
46636535|NCT01510158|82810364|FG002|Overall Study|Death|0|||
46636536|NCT01485120|82810381|FG000|Overall Study|Withdrawal by Subject|2|||
46755530|NCT00534313|82973395|FG003|Short-term Period|Participant withdrew consent|2|||
46755531|NCT00534313|82973392|FG000|Short-term Period|Pregnancy|0|||
46755532|NCT00534313|82973393|FG001|Short-term Period|Pregnancy|0|||
46755533|NCT00534313|82973394|FG002|Short-term Period|Pregnancy|1|||
46755534|NCT00534313|82973395|FG003|Short-term Period|Pregnancy|0|||
46755535|NCT00534313|82973392|FG000|Long-term Period|Adverse Event|2|||
46755536|NCT00534313|82973393|FG001|Long-term Period|Adverse Event|1|||
46755537|NCT00534313|82973394|FG002|Long-term Period|Adverse Event|0|||
46755538|NCT00534313|82973395|FG003|Long-term Period|Adverse Event|1|||
46755539|NCT00534313|82973392|FG000|Long-term Period|Lack of Efficacy|14|||
46755540|NCT00534313|82973393|FG001|Long-term Period|Lack of Efficacy|10|||
46755541|NCT00534313|82973394|FG002|Long-term Period|Lack of Efficacy|14|||
46755542|NCT00534313|82973395|FG003|Long-term Period|Lack of Efficacy|12|||
46755543|NCT00534313|82973392|FG000|Long-term Period|Lost to Follow-up|1|||
46755544|NCT00534313|82973393|FG001|Long-term Period|Lost to Follow-up|2|||
46755545|NCT00534313|82973394|FG002|Long-term Period|Lost to Follow-up|0|||
46755546|NCT00534313|82973395|FG003|Long-term Period|Lost to Follow-up|0|||
46755547|NCT00534313|82973392|FG000|Long-term Period|Withdrawal by Subject|2|||
46755548|NCT00534313|82973393|FG001|Long-term Period|Withdrawal by Subject|2|||
46755549|NCT00534313|82973394|FG002|Long-term Period|Withdrawal by Subject|0|||
46755550|NCT00534313|82973395|FG003|Long-term Period|Withdrawal by Subject|0|||
46755551|NCT00534313|82973392|FG000|Long-term Period|No longer meets study criteria|0|||
46755552|NCT00534313|82973393|FG001|Long-term Period|No longer meets study criteria|1|||
46755553|NCT00534313|82973394|FG002|Long-term Period|No longer meets study criteria|0|||
46755554|NCT00534313|82973395|FG003|Long-term Period|No longer meets study criteria|0|||
46755555|NCT00534313|82973392|FG000|Long-term Period|Poor compliance/noncompliance|0|||
46755556|NCT00534313|82973393|FG001|Long-term Period|Poor compliance/noncompliance|1|||
46755557|NCT00534313|82973394|FG002|Long-term Period|Poor compliance/noncompliance|1|||
46755558|NCT00534313|82973395|FG003|Long-term Period|Poor compliance/noncompliance|0|||
46755559|NCT00534313|82973392|FG000|Long-term Period|Administrative reason by sponsor|17|||
46755560|NCT00534313|82973393|FG001|Long-term Period|Administrative reason by sponsor|15|||
46755561|NCT00534313|82973394|FG002|Long-term Period|Administrative reason by sponsor|26|||
46755562|NCT00534313|82973395|FG003|Long-term Period|Administrative reason by sponsor|18|||
46755563|NCT00534313|82973392|FG000|Long-term Period|Other|1|||
46755564|NCT00534313|82973393|FG001|Long-term Period|Other|2|||
46755565|NCT00534313|82973394|FG002|Long-term Period|Other|2|||
46755566|NCT00534313|82973395|FG003|Long-term Period|Other|2|||
46755567|NCT03888391|82973440|FG000|Overall Study|Lost to Follow-up|15|||
46755568|NCT00594204|82973446|FG000|Overall Study|Adverse Event|15|||
46755569|NCT00594204|82973447|FG001|Overall Study|Adverse Event|3|||
46755570|NCT00594204|82973446|FG000|Overall Study|Lost to Follow-up|9|||
46755571|NCT00594204|82973447|FG001|Overall Study|Lost to Follow-up|5|||
46813517|NCT00607997|83033183|FG002|Overall Study|Relapse, recurrent illness|2|||
46928460|NCT01370655|83163287|FG004|Period 2|met protocol specified stopping criteria|0|||
46928461|NCT01370655|83163288|FG005|Period 2|met protocol specified stopping criteria|0|||
47054877|NCT01781429|83328212|FG014|Overall Study|Unacceptable Toxicity|0|||
47054878|NCT01781429|83328213|FG015|Overall Study|Unacceptable Toxicity|0|||
46636537|NCT01484496|82810388|FG000|Period 1|Protocol Violation|3|||
46636538|NCT01484496|82810389|FG001|Period 1|Protocol Violation|4|||
46636539|NCT01484496|82810390|FG002|Period 1|Protocol Violation|0|||
46755572|NCT00594204|82973446|FG000|Overall Study|Withdrawal by Subject|23|||
46755573|NCT00594204|82973447|FG001|Overall Study|Withdrawal by Subject|29|||
46755574|NCT00594204|82973446|FG000|Overall Study|Other|4|||
46755575|NCT00594204|82973447|FG001|Overall Study|Other|3|||
47054879|NCT01781429|83328198|FG000|Overall Study|Patient Condition Changed|0|||
46636540|NCT01484496|82810391|FG003|Period 1|Protocol Violation|0|||
46755576|NCT00594204|82973446|FG000|Overall Study|Lack of Efficacy|3|||
46755577|NCT00594204|82973447|FG001|Overall Study|Lack of Efficacy|4|||
47054880|NCT01781429|83328199|FG001|Overall Study|Patient Condition Changed|0|||
46755578|NCT00594204|82973446|FG000|Overall Study|Randomized but not treated|4|||
46755579|NCT00594204|82973447|FG001|Overall Study|Randomized but not treated|1|||
46813518|NCT00607997|83033184|FG003|Overall Study|Relapse, recurrent illness|0|||
46813519|NCT00607997|83033181|FG000|Overall Study|Other without explanation|2|||
46813520|NCT00607997|83033182|FG001|Overall Study|Other without explanation|0|||
46813521|NCT00607997|83033183|FG002|Overall Study|Other without explanation|4|||
46813522|NCT00607997|83033184|FG003|Overall Study|Other without explanation|1|||
46813523|NCT00509106|83033201|FG000|Overall Study|Adverse Event|3|||
46813524|NCT00509106|83033202|FG001|Overall Study|Adverse Event|2|||
46813525|NCT00509106|83033201|FG000|Overall Study|Noncompliance|0|||
46813526|NCT00509106|83033202|FG001|Overall Study|Noncompliance|1|||
46813527|NCT00509106|83033201|FG000|Overall Study|At the request of sponsor/investigator|1|||
46813528|NCT00509106|83033202|FG001|Overall Study|At the request of sponsor/investigator|2|||
46813529|NCT00509106|83033201|FG000|Overall Study|Withdrew consent|4|||
46813530|NCT00509106|83033202|FG001|Overall Study|Withdrew consent|8|||
46813531|NCT00509106|83033201|FG000|Overall Study|Lost to Follow-up|16|||
46813532|NCT00509106|83033202|FG001|Overall Study|Lost to Follow-up|10|||
46813533|NCT00509106|83033201|FG000|Overall Study|Other|1|||
46813534|NCT00509106|83033202|FG001|Overall Study|Other|0|||
46813535|NCT00509106|83033201|FG000|Overall Study|Death|6|||
46813536|NCT00509106|83033202|FG001|Overall Study|Death|6|||
46813537|NCT00607919|83033210|FG000|Acute Phase|Adverse Event|9|||
46813538|NCT00607919|83033211|FG001|Acute Phase|Adverse Event|2|||
46813539|NCT00607919|83033210|FG000|Acute Phase|Entry Criteria Not Met|1|||
46813540|NCT00607919|83033211|FG001|Acute Phase|Entry Criteria Not Met|1|||
46813541|NCT00607919|83033210|FG000|Acute Phase|Lack of Efficacy|1|||
46813542|NCT00607919|83033211|FG001|Acute Phase|Lack of Efficacy|2|||
46813543|NCT00607919|83033210|FG000|Acute Phase|Lost to Follow-up|9|||
46813544|NCT00607919|83033211|FG001|Acute Phase|Lost to Follow-up|3|||
46813545|NCT00607919|83033210|FG000|Acute Phase|Parent/Caregiver Decision|6|||
46813546|NCT00607919|83033211|FG001|Acute Phase|Parent/Caregiver Decision|4|||
46813547|NCT00607919|83033210|FG000|Acute Phase|Protocol Violation|5|||
46813548|NCT00607919|83033211|FG001|Acute Phase|Protocol Violation|1|||
46813549|NCT00607919|83033210|FG000|Acute Phase|Withdrawal by Subject|3|||
46813550|NCT00607919|83033211|FG001|Acute Phase|Withdrawal by Subject|3|||
46813551|NCT00607919|83033210|FG000|Open-Label Phase|Adverse Event|1|||
46813552|NCT00607919|83033211|FG001|Open-Label Phase|Adverse Event|5|||
46813553|NCT00607919|83033210|FG000|Open-Label Phase|Lost to Follow-up|4|||
46813554|NCT00607919|83033211|FG001|Open-Label Phase|Lost to Follow-up|1|||
46813555|NCT00607919|83033210|FG000|Open-Label Phase|Protocol Violation|2|||
46813556|NCT00607919|83033211|FG001|Open-Label Phase|Protocol Violation|2|||
46813557|NCT00607919|83033210|FG000|Open-Label Phase|Withdrawal by Subject|2|||
46813558|NCT00607919|83033211|FG001|Open-Label Phase|Withdrawal by Subject|2|||
46813559|NCT00607919|83033210|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
46813560|NCT00607919|83033211|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
46813561|NCT00344968|83033222|FG000|Overall Study|Adverse Event|5|||
46813562|NCT00344968|83033223|FG001|Overall Study|Adverse Event|4|||
46813563|NCT00344968|83033224|FG002|Overall Study|Adverse Event|15|||
46928462|NCT01370655|83163289|FG006|Period 2|met protocol specified stopping criteria|1|||
46928463|NCT01370655|83163290|FG007|Period 2|met protocol specified stopping criteria|0|||
46636541|NCT01484496|82810388|FG000|Period 1|Physician Decision|5|||
46636542|NCT01484496|82810389|FG001|Period 1|Physician Decision|1|||
46755580|NCT03888235|82973465|FG000|Overall Study|Lost to Follow-up|1|||
46755581|NCT03888235|82973466|FG001|Overall Study|Lost to Follow-up|1|||
46755582|NCT03888235|82973467|FG002|Overall Study|Lost to Follow-up|0|||
46755583|NCT00866307|82973498|FG000|Induction|Adverse Event|5|||
46755584|NCT00866307|82973499|FG001|Induction|Adverse Event|0|||
46755585|NCT00866307|82973500|FG002|Induction|Adverse Event|0|||
46755586|NCT00866307|82973498|FG000|Induction|Death|2|||
46755587|NCT00866307|82973499|FG001|Induction|Death|0|||
46755588|NCT00866307|82973500|FG002|Induction|Death|0|||
46755589|NCT00866307|82973498|FG000|Induction|Physician Decision|5|||
46813564|NCT00344968|83033222|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
46813565|NCT00344968|83033223|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46813566|NCT00344968|83033224|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
46813567|NCT00344968|83033222|FG000|Overall Study|Protocol Violation|2|||
46813568|NCT00344968|83033223|FG001|Overall Study|Protocol Violation|2|||
46813569|NCT00344968|83033224|FG002|Overall Study|Protocol Violation|5|||
46813570|NCT00344968|83033222|FG000|Overall Study|Withdrawal by Subject|14|||
46813571|NCT00344968|83033223|FG001|Overall Study|Withdrawal by Subject|31|||
46813572|NCT00344968|83033224|FG002|Overall Study|Withdrawal by Subject|27|||
46813573|NCT00344968|83033222|FG000|Overall Study|Lost to Follow-up|24|||
46813574|NCT00344968|83033223|FG001|Overall Study|Lost to Follow-up|37|||
46813575|NCT00344968|83033224|FG002|Overall Study|Lost to Follow-up|37|||
46636543|NCT01484496|82810390|FG002|Period 1|Physician Decision|0|||
46813576|NCT00344968|83033222|FG000|Overall Study|Death|11|||
46813577|NCT00344968|83033223|FG001|Overall Study|Death|27|||
46755590|NCT00866307|82973499|FG001|Induction|Physician Decision|0|||
46755591|NCT00866307|82973500|FG002|Induction|Physician Decision|0|||
46755592|NCT00866307|82973498|FG000|Induction|Progressive Disease|1|||
46813578|NCT00344968|83033224|FG002|Overall Study|Death|31|||
46813579|NCT00344968|83033222|FG000|Overall Study|Other|0|||
46813580|NCT00344968|83033223|FG001|Overall Study|Other|1|||
46813581|NCT00344968|83033224|FG002|Overall Study|Other|0|||
46813582|NCT00509028|83033235|FG000|Overall Study|Adverse Event|2|||
46813583|NCT00509028|83033236|FG001|Overall Study|Adverse Event|0|||
46813584|NCT00509028|83033235|FG000|Overall Study|Withdrawal by Subject|4|||
46813585|NCT00509028|83033236|FG001|Overall Study|Withdrawal by Subject|3|||
46813586|NCT00509028|83033235|FG000|Overall Study|Lost to Follow-up|0|||
46813587|NCT00509028|83033236|FG001|Overall Study|Lost to Follow-up|1|||
46813588|NCT00509028|83033235|FG000|Overall Study|Protocol Violation|4|||
46813589|NCT00509028|83033236|FG001|Overall Study|Protocol Violation|2|||
46813590|NCT00509028|83033235|FG000|Overall Study|Non-compliance|2|||
46813591|NCT00509028|83033236|FG001|Overall Study|Non-compliance|1|||
46813592|NCT00352846|83033244|FG000|Overall Study|Disease progression|0|||
46813593|NCT00352846|83033245|FG001|Overall Study|Disease progression|2|||
46813594|NCT00352846|83033244|FG000|Overall Study|Withdrawal by Subject|3|||
46813595|NCT00352846|83033245|FG001|Overall Study|Withdrawal by Subject|8|||
46813596|NCT00352846|83033244|FG000|Overall Study|Ineligible|3|||
46813597|NCT00352846|83033245|FG001|Overall Study|Ineligible|2|||
46813598|NCT00352846|83033244|FG000|Overall Study|Non-compliance|2|||
47054881|NCT01781429|83328200|FG002|Overall Study|Patient Condition Changed|0|||
47054882|NCT01781429|83328201|FG003|Overall Study|Patient Condition Changed|0|||
47054883|NCT01781429|83328202|FG004|Overall Study|Patient Condition Changed|0|||
47054884|NCT01781429|83328203|FG005|Overall Study|Patient Condition Changed|0|||
47054885|NCT01781429|83328204|FG006|Overall Study|Patient Condition Changed|0|||
47054886|NCT01781429|83328205|FG007|Overall Study|Patient Condition Changed|0|||
47054887|NCT01781429|83328206|FG008|Overall Study|Patient Condition Changed|0|||
47054888|NCT01781429|83328207|FG009|Overall Study|Patient Condition Changed|4|||
47054889|NCT01781429|83328208|FG010|Overall Study|Patient Condition Changed|0|||
47054890|NCT01781429|83328209|FG011|Overall Study|Patient Condition Changed|1|||
47054891|NCT01781429|83328210|FG012|Overall Study|Patient Condition Changed|0|||
47054892|NCT01781429|83328211|FG013|Overall Study|Patient Condition Changed|1|||
47054893|NCT01781429|83328212|FG014|Overall Study|Patient Condition Changed|0|||
47054894|NCT01781429|83328213|FG015|Overall Study|Patient Condition Changed|0|||
47054895|NCT01781429|83328198|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
47054896|NCT01781429|83328199|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
47054897|NCT01781429|83328200|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
47054898|NCT01781429|83328201|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
47054899|NCT01781429|83328202|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
47054900|NCT01781429|83328203|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
47054901|NCT01781429|83328204|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
47054902|NCT01781429|83328205|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
47054903|NCT01781429|83328206|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
47054904|NCT01781429|83328207|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
47054905|NCT01781429|83328208|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
47054906|NCT01781429|83328209|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
47054907|NCT01781429|83328210|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
47054908|NCT01781429|83328211|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
47054909|NCT01781429|83328212|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
46813599|NCT00352846|83033245|FG001|Overall Study|Non-compliance|0|||
46813600|NCT00352846|83033244|FG000|Overall Study|Death|0|||
46813601|NCT00352846|83033245|FG001|Overall Study|Death|1|||
47054910|NCT01781429|83328213|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
47054911|NCT01781429|83328198|FG000|Overall Study|Enrolled, but not treated|0|||
47054912|NCT01781429|83328199|FG001|Overall Study|Enrolled, but not treated|0|||
47054913|NCT01781429|83328200|FG002|Overall Study|Enrolled, but not treated|0|||
46755593|NCT00866307|82973499|FG001|Induction|Progressive Disease|0|||
46755594|NCT00866307|82973500|FG002|Induction|Progressive Disease|0|||
46755595|NCT00866307|82973498|FG000|Induction|Identification of Patients with Day 29 M|3|||
46755596|NCT00866307|82973499|FG001|Induction|Identification of Patients with Day 29 M|0|||
46755597|NCT00866307|82973500|FG002|Induction|Identification of Patients with Day 29 M|0|||
46755598|NCT00866307|82973498|FG000|Induction|Inadequate cytognetic samples th|1|||
46755599|NCT00866307|82973499|FG001|Induction|Inadequate cytognetic samples th|0|||
46755600|NCT00866307|82973500|FG002|Induction|Inadequate cytognetic samples th|0|||
46755601|NCT00866307|82973498|FG000|Induction|Improper post-induction consent|2|||
46755602|NCT00866307|82973499|FG001|Induction|Improper post-induction consent|0|||
46755603|NCT00866307|82973500|FG002|Induction|Improper post-induction consent|0|||
46755604|NCT00866307|82973498|FG000|Induction|Study was closed at the time|1|||
46813602|NCT00508872|83033251|FG000|Overall Study|Lost to Follow-up|1|||
46813603|NCT00508872|83033251|FG000|Overall Study|Physician Decision|1|||
47054914|NCT01781429|83328201|FG003|Overall Study|Enrolled, but not treated|0|||
47054915|NCT01781429|83328202|FG004|Overall Study|Enrolled, but not treated|0|||
47054916|NCT01781429|83328203|FG005|Overall Study|Enrolled, but not treated|0|||
47054917|NCT01781429|83328204|FG006|Overall Study|Enrolled, but not treated|0|||
46755605|NCT00866307|82973499|FG001|Induction|Study was closed at the time|0|||
46813604|NCT00508482|83033258|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
47054918|NCT01781429|83328205|FG007|Overall Study|Enrolled, but not treated|0|||
47054919|NCT01781429|83328206|FG008|Overall Study|Enrolled, but not treated|0|||
47054920|NCT01781429|83328207|FG009|Overall Study|Enrolled, but not treated|0|||
46813605|NCT00508482|83033259|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
46813606|NCT00508482|83033260|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
46813607|NCT00508482|83033258|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
46813608|NCT00508482|83033259|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
46813609|NCT00508482|83033260|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
46813610|NCT00508482|83033258|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
46813611|NCT00508482|83033259|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
46813612|NCT00508482|83033260|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
46813613|NCT00344500|83033271|FG000|Overall Study|Adverse Event|6|||
46813614|NCT00344500|83033272|FG001|Overall Study|Adverse Event|2|||
46813615|NCT00344500|83033273|FG002|Overall Study|Adverse Event|0|||
46813616|NCT00344500|83033271|FG000|Overall Study|Lost to Follow-up|5|||
46813617|NCT00344500|83033272|FG001|Overall Study|Lost to Follow-up|13|||
46813618|NCT00344500|83033273|FG002|Overall Study|Lost to Follow-up|1|||
46813619|NCT00344500|83033271|FG000|Overall Study|Withdrawal by Subject|7|||
46813620|NCT00344500|83033272|FG001|Overall Study|Withdrawal by Subject|10|||
46813621|NCT00344500|83033273|FG002|Overall Study|Withdrawal by Subject|0|||
46813622|NCT00344500|83033271|FG000|Overall Study|Protocol Violation|4|||
46813623|NCT00344500|83033272|FG001|Overall Study|Protocol Violation|7|||
46813624|NCT00344500|83033273|FG002|Overall Study|Protocol Violation|1|||
46813625|NCT00344500|83033271|FG000|Overall Study|Not Noted|1|||
46813626|NCT00344500|83033272|FG001|Overall Study|Not Noted|3|||
46813627|NCT00344500|83033273|FG002|Overall Study|Not Noted|0|||
46813628|NCT00344032|83033282|FG000|Overall Study|Adverse Event|0|||
46813629|NCT00344032|83033283|FG001|Overall Study|Adverse Event|1|||
46813630|NCT00344032|83033282|FG000|Overall Study|Withdrawal by Subject|6|||
46813631|NCT00344032|83033283|FG001|Overall Study|Withdrawal by Subject|2|||
46813632|NCT00344032|83033282|FG000|Overall Study|Lost to Follow-up|4|||
46813633|NCT00344032|83033283|FG001|Overall Study|Lost to Follow-up|6|||
46813634|NCT00344032|83033282|FG000|Overall Study|Physician Decision|4|||
46813635|NCT00344032|83033283|FG001|Overall Study|Physician Decision|1|||
46813636|NCT00607373|83033291|FG000|Treatment Period|Adverse Event|0|||
46813637|NCT00607373|83033292|FG001|Treatment Period|Adverse Event|4|||
46813638|NCT00607373|83033291|FG000|Treatment Period|Physician Decision|0|||
46813639|NCT00607373|83033292|FG001|Treatment Period|Physician Decision|1|||
46813640|NCT00607373|83033291|FG000|Treatment Period|Withdrawal by Subject|0|||
46813641|NCT00607373|83033292|FG001|Treatment Period|Withdrawal by Subject|1|||
46813642|NCT00607373|83033291|FG000|Follow-up Period|Other|0|||
46813643|NCT00607373|83033292|FG001|Follow-up Period|Other|1|||
46813644|NCT00607373|83033291|FG000|Follow-up Period|Protocol Violation|0|||
46813645|NCT00607373|83033292|FG001|Follow-up Period|Protocol Violation|1|||
46813646|NCT00607373|83033291|FG000|Follow-up Period|Withdrawal by Subject|1|||
46813647|NCT00607373|83033292|FG001|Follow-up Period|Withdrawal by Subject|3|||
46813648|NCT00508404|83033298|FG000|Overall Study|Ongoing at Data Cut-off|12|||
46813649|NCT00508404|83033298|FG000|Overall Study|Adverse Event|2|||
46813650|NCT00508404|83033298|FG000|Overall Study|Death|16|||
46813651|NCT00508404|83033298|FG000|Overall Study|Physician Decision|2|||
46813652|NCT00508404|83033298|FG000|Overall Study|Withdrawal by Subject|3|||
46813653|NCT00508404|83033298|FG000|Overall Study|Protocol-specified Criteria|2|||
46928464|NCT01370655|83163291|FG008|Period 2|met protocol specified stopping criteria|1|||
46928465|NCT01370655|83163292|FG009|Period 2|met protocol specified stopping criteria|0|||
46928466|NCT01370655|83163293|FG010|Period 2|met protocol specified stopping criteria|1|||
46928467|NCT01370655|83163294|FG011|Period 2|met protocol specified stopping criteria|0|||
46928468|NCT01370655|83163283|FG000|Period 2|Withdrawal by Subject|0|||
47054921|NCT01781429|83328208|FG010|Overall Study|Enrolled, but not treated|1|||
47054922|NCT01781429|83328209|FG011|Overall Study|Enrolled, but not treated|0|||
47054923|NCT01781429|83328210|FG012|Overall Study|Enrolled, but not treated|0|||
47054924|NCT01781429|83328211|FG013|Overall Study|Enrolled, but not treated|0|||
47054925|NCT01781429|83328212|FG014|Overall Study|Enrolled, but not treated|0|||
46813654|NCT00508404|83033298|FG000|Overall Study|Lost to Follow-up|2|||
46813655|NCT00508404|83033298|FG000|Overall Study|Other - Not Specified|3|||
46813656|NCT00352690|83033305|FG000|Overall Study|Determined to be ineligible|2|||
46813657|NCT00352690|83033306|FG001|Overall Study|Determined to be ineligible|0|||
46813658|NCT00609245|83033312|FG000|Overall Study|Adverse Event|1|||
46813659|NCT00343642|83033321|FG000|Overall Study|Lost to Follow-up|0|||
46813660|NCT00343642|83033322|FG001|Overall Study|Lost to Follow-up|1|||
46813661|NCT00343642|83033323|FG002|Overall Study|Lost to Follow-up|0|||
46813662|NCT00343642|83033321|FG000|Overall Study|Pregnancy|1|||
46813663|NCT00343642|83033322|FG001|Overall Study|Pregnancy|0|||
46813664|NCT00343642|83033323|FG002|Overall Study|Pregnancy|2|||
46813665|NCT00343642|83033321|FG000|Overall Study|Withdrawal by Subject|2|||
46813666|NCT00343642|83033322|FG001|Overall Study|Withdrawal by Subject|3|||
47054926|NCT01781429|83328213|FG015|Overall Study|Enrolled, but not treated|0|||
46928469|NCT01370655|83163284|FG001|Period 2|Withdrawal by Subject|0|||
46928470|NCT01370655|83163285|FG002|Period 2|Withdrawal by Subject|0|||
46928471|NCT01370655|83163286|FG003|Period 2|Withdrawal by Subject|0|||
46928472|NCT01370655|83163287|FG004|Period 2|Withdrawal by Subject|0|||
46928473|NCT01370655|83163288|FG005|Period 2|Withdrawal by Subject|0|||
46928474|NCT01370655|83163289|FG006|Period 2|Withdrawal by Subject|0|||
46928475|NCT01370655|83163290|FG007|Period 2|Withdrawal by Subject|0|||
46928476|NCT01370655|83163291|FG008|Period 2|Withdrawal by Subject|1|||
46928477|NCT01370655|83163292|FG009|Period 2|Withdrawal by Subject|0|||
47054927|NCT01773473|83328248|FG000|Overall Study|Adverse Event|3|||
47054928|NCT01773473|83328249|FG001|Overall Study|Adverse Event|2|||
47054929|NCT01773473|83328248|FG000|Overall Study|Protocol Violation|0|||
47054930|NCT01773473|83328249|FG001|Overall Study|Protocol Violation|4|||
47054931|NCT01773473|83328248|FG000|Overall Study|Physician Decision|3|||
47054932|NCT01773473|83328249|FG001|Overall Study|Physician Decision|5|||
47054933|NCT01773473|83328248|FG000|Overall Study|Sponsor Decision|2|||
47054934|NCT01773473|83328249|FG001|Overall Study|Sponsor Decision|0|||
47054935|NCT01773473|83328248|FG000|Overall Study|Lack of Efficacy|0|||
47054936|NCT01773473|83328249|FG001|Overall Study|Lack of Efficacy|1|||
47054937|NCT01773473|83328248|FG000|Overall Study|Non-Compliance with study drug|1|||
47054938|NCT01773473|83328249|FG001|Overall Study|Non-Compliance with study drug|4|||
47054939|NCT01773473|83328248|FG000|Overall Study|Withdrawal by Subject|5|||
47054940|NCT01773473|83328249|FG001|Overall Study|Withdrawal by Subject|3|||
47054941|NCT01773473|83328248|FG000|Overall Study|Lost to Follow-up|2|||
47054942|NCT01773473|83328249|FG001|Overall Study|Lost to Follow-up|0|||
47054943|NCT01772693|83328257|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
47054944|NCT01772693|83328258|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
47054945|NCT01772693|83328257|FG000|Overall Study|Withdrawal by Subject|2|||
47054946|NCT01772693|83328258|FG001|Overall Study|Withdrawal by Subject|0|||
46636544|NCT01484496|82810391|FG003|Period 1|Physician Decision|0|||
46636545|NCT01484496|82810388|FG000|Period 1|Lack of Efficacy|10|||
46636546|NCT01484496|82810389|FG001|Period 1|Lack of Efficacy|15|||
46636547|NCT01484496|82810390|FG002|Period 1|Lack of Efficacy|0|||
46755606|NCT00866307|82973500|FG002|Induction|Study was closed at the time|0|||
46755607|NCT00866307|82973498|FG000|Consolidation/Maintenance|Adverse Event|0|||
46755608|NCT00866307|82973499|FG001|Consolidation/Maintenance|Adverse Event|0|||
46755609|NCT00866307|82973500|FG002|Consolidation/Maintenance|Adverse Event|8|||
46755610|NCT00866307|82973498|FG000|Consolidation/Maintenance|Death|0|||
46755611|NCT00866307|82973499|FG001|Consolidation/Maintenance|Death|0|||
46755612|NCT00866307|82973500|FG002|Consolidation/Maintenance|Death|1|||
46755613|NCT00866307|82973498|FG000|Consolidation/Maintenance|Physician Decision|0|||
46755614|NCT00866307|82973499|FG001|Consolidation/Maintenance|Physician Decision|3|||
46755615|NCT00866307|82973500|FG002|Consolidation/Maintenance|Physician Decision|2|||
46755616|NCT00866307|82973498|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
46755617|NCT00866307|82973499|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
46755618|NCT00866307|82973500|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
46755619|NCT00866307|82973498|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
46755620|NCT00866307|82973499|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
46755621|NCT00866307|82973500|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
46755622|NCT00866307|82973498|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
46755623|NCT00866307|82973499|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
46755624|NCT00866307|82973500|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
46755625|NCT00866307|82973498|FG000|Consolidation/Maintenance|Therapy error|0|||
46755626|NCT00866307|82973499|FG001|Consolidation/Maintenance|Therapy error|1|||
46755627|NCT00866307|82973500|FG002|Consolidation/Maintenance|Therapy error|0|||
46755628|NCT00866307|82973498|FG000|Consolidation/Maintenance|Non-compliance|0|||
46755629|NCT00866307|82973499|FG001|Consolidation/Maintenance|Non-compliance|0|||
46755630|NCT00866307|82973500|FG002|Consolidation/Maintenance|Non-compliance|1|||
46755631|NCT00866307|82973498|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
46755632|NCT00866307|82973499|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
46755633|NCT00866307|82973500|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
46755634|NCT00531427|82973508|FG000|Overall Study|Withdrawal by Subject|7|||
46755635|NCT00531427|82973509|FG001|Overall Study|Withdrawal by Subject|13|||
46755636|NCT00531427|82973508|FG000|Overall Study|Adverse Event|44|||
46928478|NCT01370655|83163293|FG010|Period 2|Withdrawal by Subject|0|||
46755637|NCT00531427|82973509|FG001|Overall Study|Adverse Event|30|||
47054947|NCT01772693|83328257|FG000|Overall Study|Alternative Treatment|2|||
47054948|NCT01772693|83328258|FG001|Overall Study|Alternative Treatment|0|||
47054949|NCT01779869|83328264|FG000|Overall Study|Physician Decision|2|||
47054950|NCT01772537|83328271|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
47054951|NCT01772537|83328272|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
46636548|NCT01484496|82810391|FG003|Period 1|Lack of Efficacy|0|||
46755638|NCT00531427|82973508|FG000|Overall Study|Lost to Follow-up|4|||
46755639|NCT00531427|82973509|FG001|Overall Study|Lost to Follow-up|3|||
46928479|NCT01370655|83163294|FG011|Period 2|Withdrawal by Subject|0|||
46928480|NCT02612194|83163307|FG000|Overall Study|Death|5|||
46928481|NCT02612194|83163308|FG001|Overall Study|Death|0|||
46928482|NCT02612194|83163309|FG002|Overall Study|Death|2|||
46928483|NCT02612194|83163307|FG000|Overall Study|Early Study Termination|1|||
46928484|NCT02612194|83163308|FG001|Overall Study|Early Study Termination|0|||
46928485|NCT02612194|83163309|FG002|Overall Study|Early Study Termination|0|||
46928486|NCT02798211|83163319|FG000|Period 1|Adverse Event|1|||
46928487|NCT02798211|83163320|FG001|Period 1|Adverse Event|1|||
46928488|NCT02798211|83163321|FG002|Period 1|Adverse Event|0|||
46928489|NCT02798211|83163322|FG003|Period 1|Adverse Event|0|||
46928490|NCT02798211|83163323|FG004|Period 1|Adverse Event|0|||
46928491|NCT02798211|83163324|FG005|Period 1|Adverse Event|0|||
46928492|NCT02798211|83163319|FG000|Period 1|Lost to Follow-up|2|||
46928493|NCT02798211|83163320|FG001|Period 1|Lost to Follow-up|1|||
46928494|NCT02798211|83163321|FG002|Period 1|Lost to Follow-up|0|||
46928495|NCT02798211|83163322|FG003|Period 1|Lost to Follow-up|0|||
46928496|NCT02798211|83163323|FG004|Period 1|Lost to Follow-up|0|||
46928497|NCT02798211|83163324|FG005|Period 1|Lost to Follow-up|0|||
46928498|NCT02798211|83163319|FG000|Period 1|Protocol Violation|0|||
46928499|NCT02798211|83163320|FG001|Period 1|Protocol Violation|0|||
46755640|NCT00531427|82973508|FG000|Overall Study|Lack of Efficacy|14|||
46755641|NCT00531427|82973509|FG001|Overall Study|Lack of Efficacy|39|||
46755642|NCT00531427|82973508|FG000|Overall Study|Administrative|4|||
46755643|NCT00531427|82973509|FG001|Overall Study|Administrative|9|||
46755644|NCT00871728|82973516|FG000|Overall Study|Adverse Event|1|||
46755645|NCT00871728|82973516|FG000|Overall Study|Protocol Violation|7|||
46755646|NCT00871728|82973516|FG000|Overall Study|Lost to Follow-up|2|||
46755647|NCT00871728|82973516|FG000|Overall Study|Failed to Visit Hospital|4|||
46755648|NCT00871728|82973516|FG000|Overall Study|Participant Non-compliance|1|||
46755649|NCT00871728|82973516|FG000|Overall Study|Withdrawal of Informed Consent|5|||
46755650|NCT00868998|82973520|FG000|Overall Study|Screen Failure|1|||
46755651|NCT00868998|82973520|FG000|Overall Study|Withdrawal by Subject|1|||
46755652|NCT00868998|82973520|FG000|Overall Study|Progression of disease|2|||
46755653|NCT00868998|82973520|FG000|Overall Study|Death|1|||
46755654|NCT00533845|82973535|FG000|Overall Study|Physician Decision|1|||
46755655|NCT00533845|82973536|FG001|Overall Study|Physician Decision|0|||
46755656|NCT00857649|82973544|FG000|Overall Study|Adverse Event|15|||
46755657|NCT00857649|82973545|FG001|Overall Study|Adverse Event|10|||
46755658|NCT00857649|82973544|FG000|Overall Study|Non-compliance|1|||
46755659|NCT00857649|82973545|FG001|Overall Study|Non-compliance|1|||
46755660|NCT00857649|82973544|FG000|Overall Study|Protocol Violation|2|||
46755661|NCT00857649|82973545|FG001|Overall Study|Protocol Violation|2|||
46755662|NCT00857649|82973544|FG000|Overall Study|Withdrawal of Consent|10|||
46755663|NCT00857649|82973545|FG001|Overall Study|Withdrawal of Consent|7|||
46755664|NCT00857649|82973544|FG000|Overall Study|Nursing Home Placement|2|||
46755665|NCT00857649|82973545|FG001|Overall Study|Nursing Home Placement|9|||
46755666|NCT00857649|82973544|FG000|Overall Study|Other Reasons|1|||
46755667|NCT00857649|82973545|FG001|Overall Study|Other Reasons|3|||
46755668|NCT00857415|82973553|FG000|Overall Study|Image acquisition failure|2|||
46755669|NCT00857415|82973554|FG001|Overall Study|Image acquisition failure|0|||
46755670|NCT00857415|82973553|FG000|Overall Study|Invalid image or not imaged|3|||
46755671|NCT00857415|82973554|FG001|Overall Study|Invalid image or not imaged|0|||
46755672|NCT00857415|82973553|FG000|Overall Study|Subject still living at end of study|110|||
46755673|NCT00857415|82973554|FG001|Overall Study|Subject still living at end of study|0|||
46755674|NCT00857415|82973553|FG000|Overall Study|Deceased with no autopsy|2|||
46755675|NCT00857415|82973554|FG001|Overall Study|Deceased with no autopsy|0|||
46755676|NCT00532441|82973560|FG000|Overall Study|Death|1|||
46755677|NCT00532441|82973561|FG001|Overall Study|Death|0|||
46755678|NCT00857259|82973582|FG000|Overall Study|Protocol Violation|1|||
46755679|NCT00857259|82973583|FG001|Overall Study|Protocol Violation|0|||
46755680|NCT00857259|82973584|FG002|Overall Study|Protocol Violation|1|||
46755681|NCT00868608|82973597|FG000|Overall Study|Withdrawal by Subject|3|||
46755682|NCT00868608|82973598|FG001|Overall Study|Withdrawal by Subject|1|||
46755683|NCT00868608|82973599|FG002|Overall Study|Withdrawal by Subject|0|||
46755684|NCT00868608|82973597|FG000|Overall Study|Lost to Follow-up|3|||
46755685|NCT00868608|82973598|FG001|Overall Study|Lost to Follow-up|0|||
46755686|NCT00868608|82973599|FG002|Overall Study|Lost to Follow-up|1|||
46755687|NCT00868608|82973597|FG000|Overall Study|Death|16|||
46755688|NCT00868608|82973598|FG001|Overall Study|Death|2|||
46755689|NCT00868608|82973599|FG002|Overall Study|Death|4|||
46755690|NCT00868608|82973597|FG000|Overall Study|Other - Unspecified|1|||
46755691|NCT00868608|82973598|FG001|Overall Study|Other - Unspecified|0|||
46755692|NCT00868608|82973599|FG002|Overall Study|Other - Unspecified|0|||
46755693|NCT00856635|82973609|FG000|Overall Study|Lost to Follow-up|2|||
46755694|NCT00856635|82973610|FG001|Overall Study|Lost to Follow-up|5|||
46755695|NCT00856635|82973609|FG000|Overall Study|Pregnancy|1|||
46755696|NCT00856635|82973610|FG001|Overall Study|Pregnancy|0|||
46755697|NCT00856635|82973609|FG000|Overall Study|Withdrawal by Subject|3|||
46928500|NCT02798211|83163321|FG002|Period 1|Protocol Violation|2|||
46928501|NCT02798211|83163322|FG003|Period 1|Protocol Violation|0|||
46813667|NCT00343642|83033323|FG002|Overall Study|Withdrawal by Subject|4|||
46813668|NCT00343642|83033321|FG000|Overall Study|Adverse Event|0|||
46813669|NCT00343642|83033322|FG001|Overall Study|Adverse Event|0|||
46813670|NCT00343642|83033323|FG002|Overall Study|Adverse Event|1|||
46813671|NCT00343642|83033321|FG000|Overall Study|Flare up|6|||
46813672|NCT00343642|83033322|FG001|Overall Study|Flare up|4|||
46813673|NCT00343642|83033323|FG002|Overall Study|Flare up|0|||
46813674|NCT00609167|83033336|FG000|Overall Study|Withdrawal by Subject|1|||
46813675|NCT00609167|83033337|FG001|Overall Study|Withdrawal by Subject|0|||
46813676|NCT00609167|83033336|FG000|Overall Study|Lack of Efficacy|1|||
46813677|NCT00609167|83033337|FG001|Overall Study|Lack of Efficacy|0|||
46813678|NCT00609167|83033336|FG000|Overall Study|Adverse Event|5|||
46813679|NCT00609167|83033337|FG001|Overall Study|Adverse Event|1|||
46813680|NCT00609167|83033336|FG000|Overall Study|Disease Progression|1|||
46813681|NCT00609167|83033337|FG001|Overall Study|Disease Progression|0|||
46813682|NCT00609167|83033336|FG000|Overall Study|Stem Cell Transplant|0|||
46813683|NCT00609167|83033337|FG001|Overall Study|Stem Cell Transplant|6|||
46813684|NCT00606281|83033345|FG000|Overall Study|Adverse Event|11|||
46813685|NCT00606281|83033346|FG001|Overall Study|Adverse Event|12|||
46813686|NCT00606281|83033345|FG000|Overall Study|Death|1|||
46813687|NCT00606281|83033346|FG001|Overall Study|Death|0|||
46813688|NCT00606281|83033345|FG000|Overall Study|Lack of Efficacy|28|||
46813689|NCT00606281|83033346|FG001|Overall Study|Lack of Efficacy|35|||
46813690|NCT00606281|83033345|FG000|Overall Study|Physician Decision|0|||
46813691|NCT00606281|83033346|FG001|Overall Study|Physician Decision|1|||
46813692|NCT00606281|83033345|FG000|Overall Study|Protocol Violation|3|||
46813693|NCT00606281|83033346|FG001|Overall Study|Protocol Violation|3|||
46813694|NCT00606281|83033345|FG000|Overall Study|Withdrawal by Subject|11|||
46813695|NCT00606281|83033346|FG001|Overall Study|Withdrawal by Subject|13|||
46813696|NCT00606281|83033345|FG000|Overall Study|Progression to depressive phase|1|||
46813697|NCT00606281|83033346|FG001|Overall Study|Progression to depressive phase|1|||
46813698|NCT00606281|83033345|FG000|Overall Study|Change of residence or other commitments|1|||
46813699|NCT00606281|83033346|FG001|Overall Study|Change of residence or other commitments|1|||
46813700|NCT00506142|83033354|FG000|Overall Study|Adverse Event|8|||
46813701|NCT00506142|83033355|FG001|Overall Study|Adverse Event|7|||
46813702|NCT00506142|83033354|FG000|Overall Study|Lack of Efficacy|21|||
46813703|NCT00506142|83033355|FG001|Overall Study|Lack of Efficacy|7|||
46813704|NCT00506142|83033354|FG000|Overall Study|Withdrawal by Subject|4|||
46813705|NCT00506142|83033355|FG001|Overall Study|Withdrawal by Subject|5|||
46813706|NCT00506142|83033354|FG000|Overall Study|Physician Decision|1|||
46813707|NCT00506142|83033355|FG001|Overall Study|Physician Decision|0|||
46813708|NCT00506142|83033354|FG000|Overall Study|New health condition|1|||
46813709|NCT00506142|83033355|FG001|Overall Study|New health condition|0|||
46813710|NCT00514020|83033361|FG000|Overall Study|Adverse Event|6|||
46813711|NCT00514020|83033361|FG000|Overall Study|Withdrawal by Subject|3|||
46813712|NCT00514020|83033361|FG000|Overall Study|Physician Decision|1|||
46813713|NCT00514020|83033361|FG000|Overall Study|disease progression|9|||
46813714|NCT00514020|83033361|FG000|Overall Study|other complicating disease|2|||
46813715|NCT00514020|83033361|FG000|Overall Study|patient went to radiation treatment|1|||
46813716|NCT00514020|83033361|FG000|Overall Study|"patients moved to the no tx group"|6|||
46813717|NCT00513708|83033368|FG000|Overall Study|Lost to Follow-up|4|||
46813718|NCT00513708|83033369|FG001|Overall Study|Lost to Follow-up|4|||
46813719|NCT00513708|83033370|FG002|Overall Study|Lost to Follow-up|4|||
46813720|NCT00513474|83033380|FG000|Overall Study|Death|6|||
47054952|NCT01772537|83328273|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
47054953|NCT01772147|83328286|FG000|Overall Study|Adverse Event|13|||
47054954|NCT01772147|83328287|FG001|Overall Study|Adverse Event|10|||
47054955|NCT01772147|83328288|FG002|Overall Study|Adverse Event|6|||
47054956|NCT01772147|83328286|FG000|Overall Study|Withdrew Consent|7|||
46813721|NCT00513474|83033381|FG001|Overall Study|Death|9|||
46813722|NCT00513474|83033380|FG000|Overall Study|Participant Withdrew Consent|1|||
46813723|NCT00513474|83033381|FG001|Overall Study|Participant Withdrew Consent|0|||
46813724|NCT00505752|83033391|FG000|Overall Study|Adverse Event|1|||
46813725|NCT00505752|83033392|FG001|Overall Study|Adverse Event|0|||
46813726|NCT00505752|83033393|FG002|Overall Study|Adverse Event|1|||
46813727|NCT00505752|83033394|FG003|Overall Study|Adverse Event|0|||
46813728|NCT00505752|83033391|FG000|Overall Study|Lost to Follow-up|1|||
46813729|NCT00505752|83033392|FG001|Overall Study|Lost to Follow-up|0|||
46813730|NCT00505752|83033393|FG002|Overall Study|Lost to Follow-up|0|||
46813731|NCT00505752|83033394|FG003|Overall Study|Lost to Follow-up|0|||
46813732|NCT00505752|83033391|FG000|Overall Study|Lack of ovarian response|1|||
46813733|NCT00505752|83033392|FG001|Overall Study|Lack of ovarian response|3|||
46813734|NCT00505752|83033393|FG002|Overall Study|Lack of ovarian response|0|||
46813735|NCT00505752|83033394|FG003|Overall Study|Lack of ovarian response|0|||
46813736|NCT00505752|83033391|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
46813737|NCT00505752|83033392|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
46813738|NCT00505752|83033393|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
47054957|NCT01772147|83328287|FG001|Overall Study|Withdrew Consent|8|||
46928502|NCT02798211|83163323|FG004|Period 1|Protocol Violation|0|||
46928503|NCT02798211|83163324|FG005|Period 1|Protocol Violation|0|||
47054958|NCT01772147|83328288|FG002|Overall Study|Withdrew Consent|4|||
47054959|NCT01772147|83328286|FG000|Overall Study|Lost to Follow-up|1|||
47054960|NCT01772147|83328287|FG001|Overall Study|Lost to Follow-up|0|||
47054961|NCT01772147|83328288|FG002|Overall Study|Lost to Follow-up|1|||
47054962|NCT01772147|83328286|FG000|Overall Study|Protocol Deviation|2|||
46755698|NCT00856635|82973610|FG001|Overall Study|Withdrawal by Subject|1|||
46755699|NCT00856635|82973609|FG000|Overall Study|Serious Adverse Event|1|||
46755700|NCT00856635|82973610|FG001|Overall Study|Serious Adverse Event|0|||
46755701|NCT00856635|82973609|FG000|Overall Study|Other|1|||
46755702|NCT00856635|82973610|FG001|Overall Study|Other|0|||
46755703|NCT00856635|82973609|FG000|Overall Study|Discontinued at Randomization|2|||
46755704|NCT00856635|82973610|FG001|Overall Study|Discontinued at Randomization|2|||
46755705|NCT00856557|82973620|FG000|Overall Study|No patients with contextual flags|12|||
46755706|NCT00856557|82973621|FG001|Overall Study|No patients with contextual flags|16|||
46755707|NCT00856323|82973627|FG000|Overall Study|Withdrawal by Subject|2|||
46755708|NCT00856245|82973635|FG000|Overall Study|Was not transplanted|5|||
46755709|NCT00855933|82973641|FG000|Overall Study|Withdrawal by Subject|0|||
46755710|NCT00855933|82973642|FG001|Overall Study|Withdrawal by Subject|1|||
46755711|NCT00871572|82973652|FG000|Overall Study|Adverse Event|0|||
46755712|NCT00871572|82973653|FG001|Overall Study|Adverse Event|2|||
46755713|NCT00871572|82973654|FG002|Overall Study|Adverse Event|0|||
46755714|NCT00871572|82973655|FG003|Overall Study|Adverse Event|3|||
46755715|NCT00871572|82973652|FG000|Overall Study|Investigator Decision|0|||
46755716|NCT00871572|82973653|FG001|Overall Study|Investigator Decision|1|||
46755717|NCT00871572|82973654|FG002|Overall Study|Investigator Decision|0|||
46755718|NCT00871572|82973655|FG003|Overall Study|Investigator Decision|1|||
46755719|NCT00871572|82973652|FG000|Overall Study|Lost to Follow-up|0|||
46755720|NCT00871572|82973653|FG001|Overall Study|Lost to Follow-up|1|||
46755721|NCT00871572|82973654|FG002|Overall Study|Lost to Follow-up|0|||
46755722|NCT00871572|82973655|FG003|Overall Study|Lost to Follow-up|1|||
46755723|NCT00871572|82973652|FG000|Overall Study|Protocol Violation|0|||
46755724|NCT00871572|82973653|FG001|Overall Study|Protocol Violation|0|||
46755725|NCT00871572|82973654|FG002|Overall Study|Protocol Violation|1|||
46755726|NCT00871572|82973655|FG003|Overall Study|Protocol Violation|1|||
46755727|NCT00871572|82973652|FG000|Overall Study|Sponsor Decision|1|||
46755728|NCT00871572|82973653|FG001|Overall Study|Sponsor Decision|0|||
46755729|NCT00871572|82973654|FG002|Overall Study|Sponsor Decision|0|||
46755730|NCT00871572|82973655|FG003|Overall Study|Sponsor Decision|0|||
46755731|NCT00871572|82973652|FG000|Overall Study|Withdrawal by Subject|1|||
46755732|NCT00871572|82973653|FG001|Overall Study|Withdrawal by Subject|2|||
46755733|NCT00871572|82973654|FG002|Overall Study|Withdrawal by Subject|3|||
46755734|NCT00871572|82973655|FG003|Overall Study|Withdrawal by Subject|1|||
46755735|NCT03885661|82973667|FG000|Overall Study|Withdrawal by Subject|0|||
46755736|NCT03885661|82973668|FG001|Overall Study|Withdrawal by Subject|1|||
46755737|NCT03885661|82973667|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
46755738|NCT03885661|82973668|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
46755739|NCT00868530|82973674|FG000|Overall Study|Adverse Event|3|||
46755740|NCT00868530|82973674|FG000|Overall Study|Lost to Follow-up|1|||
46755741|NCT00598442|82973681|FG000|Overall Study|Adverse Event|3|||
46755742|NCT00598442|82973682|FG001|Overall Study|Adverse Event|0|||
46755743|NCT00598442|82973683|FG002|Overall Study|Adverse Event|0|||
46755744|NCT00598442|82973681|FG000|Overall Study|Death|19|||
46755745|NCT00598442|82973682|FG001|Overall Study|Death|11|||
46755746|NCT00598442|82973683|FG002|Overall Study|Death|11|||
46755747|NCT00598442|82973681|FG000|Overall Study|Lost to Follow-up|4|||
46755748|NCT00598442|82973682|FG001|Overall Study|Lost to Follow-up|3|||
46755749|NCT00598442|82973683|FG002|Overall Study|Lost to Follow-up|3|||
46755750|NCT00598442|82973681|FG000|Overall Study|Physician Decision|2|||
46755751|NCT00598442|82973682|FG001|Overall Study|Physician Decision|1|||
46755752|NCT00598442|82973683|FG002|Overall Study|Physician Decision|1|||
46755753|NCT00598442|82973681|FG000|Overall Study|Withdrawal by Subject|8|||
46755754|NCT00598442|82973682|FG001|Overall Study|Withdrawal by Subject|16|||
46755755|NCT00598442|82973683|FG002|Overall Study|Withdrawal by Subject|6|||
46755756|NCT00598442|82973681|FG000|Overall Study|Noncompliance|0|||
46755757|NCT00598442|82973682|FG001|Overall Study|Noncompliance|2|||
46755758|NCT00598442|82973683|FG002|Overall Study|Noncompliance|1|||
46755759|NCT00598442|82973681|FG000|Overall Study|Relocation|1|||
46755760|NCT00598442|82973682|FG001|Overall Study|Relocation|4|||
46755761|NCT00598442|82973683|FG002|Overall Study|Relocation|0|||
46755762|NCT00598442|82973681|FG000|Overall Study|Renal transplant|0|||
46755763|NCT00598442|82973682|FG001|Overall Study|Renal transplant|0|||
46755764|NCT00598442|82973683|FG002|Overall Study|Renal transplant|1|||
46755765|NCT00598442|82973681|FG000|Overall Study|Site closed by sponsor|5|||
46755766|NCT00598442|82973682|FG001|Overall Study|Site closed by sponsor|2|||
46755767|NCT00598442|82973683|FG002|Overall Study|Site closed by sponsor|1|||
46755768|NCT00598442|82973681|FG000|Overall Study|Started dialysis|1|||
47054963|NCT01772147|83328287|FG001|Overall Study|Protocol Deviation|1|||
46813739|NCT00505752|83033394|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
46813740|NCT00505752|83033391|FG000|Overall Study|No oocytes retrieved|0|||
46813741|NCT00505752|83033392|FG001|Overall Study|No oocytes retrieved|2|||
46813742|NCT00505752|83033393|FG002|Overall Study|No oocytes retrieved|0|||
46813743|NCT00505752|83033394|FG003|Overall Study|No oocytes retrieved|1|||
46813744|NCT00505752|83033391|FG000|Overall Study|No Fertilization|1|||
46813745|NCT00505752|83033392|FG001|Overall Study|No Fertilization|1|||
46813746|NCT00505752|83033393|FG002|Overall Study|No Fertilization|2|||
46813747|NCT00505752|83033394|FG003|Overall Study|No Fertilization|1|||
46813748|NCT00505752|83033391|FG000|Overall Study|All embryos/blastocysts discarded|0|||
46813749|NCT00505752|83033392|FG001|Overall Study|All embryos/blastocysts discarded|0|||
46813750|NCT00505752|83033393|FG002|Overall Study|All embryos/blastocysts discarded|1|||
46813751|NCT00505752|83033394|FG003|Overall Study|All embryos/blastocysts discarded|1|||
46813752|NCT00505752|83033391|FG000|Overall Study|Other|1|||
46813753|NCT00505752|83033392|FG001|Overall Study|Other|2|||
46813754|NCT00505752|83033393|FG002|Overall Study|Other|1|||
46813755|NCT00505752|83033394|FG003|Overall Study|Other|2|||
46813756|NCT03601637|83033406|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
46813757|NCT03601637|83033407|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
46813758|NCT03601637|83033406|FG000|Overall Study|Adverse Event|1|||
46813759|NCT03601637|83033407|FG001|Overall Study|Adverse Event|1|||
46813760|NCT03601637|83033406|FG000|Overall Study|Other|0|||
46813761|NCT03601637|83033407|FG001|Overall Study|Other|1|||
46813762|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
46813763|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
46813764|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Death|0|||
46813765|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Death|2|||
46813766|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
46813767|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
46813768|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
46813769|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
46813770|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
46928504|NCT02798211|83163319|FG000|Period 1|Withdrawal by Subject|1|||
46928505|NCT02798211|83163320|FG001|Period 1|Withdrawal by Subject|1|||
46928506|NCT02798211|83163321|FG002|Period 1|Withdrawal by Subject|0|||
46928507|NCT02798211|83163322|FG003|Period 1|Withdrawal by Subject|0|||
46928508|NCT02798211|83163323|FG004|Period 1|Withdrawal by Subject|0|||
46928509|NCT02798211|83163324|FG005|Period 1|Withdrawal by Subject|0|||
46928510|NCT02798211|83163319|FG000|Period 1|Death|0|||
46928511|NCT02798211|83163320|FG001|Period 1|Death|0|||
46928512|NCT02798211|83163321|FG002|Period 1|Death|1|||
46928513|NCT02798211|83163322|FG003|Period 1|Death|0|||
46928514|NCT02798211|83163323|FG004|Period 1|Death|0|||
46928515|NCT02798211|83163324|FG005|Period 1|Death|0|||
46928516|NCT02798211|83163319|FG000|Period 1|Withdrawal of Informed Consent|2|||
46928517|NCT02798211|83163320|FG001|Period 1|Withdrawal of Informed Consent|7|||
46928518|NCT02798211|83163321|FG002|Period 1|Withdrawal of Informed Consent|3|||
46928519|NCT02798211|83163322|FG003|Period 1|Withdrawal of Informed Consent|0|||
46928520|NCT02798211|83163323|FG004|Period 1|Withdrawal of Informed Consent|0|||
46928521|NCT02798211|83163324|FG005|Period 1|Withdrawal of Informed Consent|0|||
46928522|NCT02798211|83163319|FG000|Period 2|Withdrawal by Subject|2|||
46928523|NCT02798211|83163320|FG001|Period 2|Withdrawal by Subject|0|||
46928524|NCT02798211|83163321|FG002|Period 2|Withdrawal by Subject|0|||
46928525|NCT02798211|83163322|FG003|Period 2|Withdrawal by Subject|0|||
46928526|NCT02798211|83163323|FG004|Period 2|Withdrawal by Subject|2|||
46928527|NCT02798211|83163324|FG005|Period 2|Withdrawal by Subject|2|||
46928528|NCT02798211|83163319|FG000|Period 2|Adverse Event|5|||
46755769|NCT00598442|82973682|FG001|Overall Study|Started dialysis|0|||
46755770|NCT00598442|82973683|FG002|Overall Study|Started dialysis|0|||
46755771|NCT00593814|82973693|FG000|Overall Study|Death|7|||
46755772|NCT00593814|82973694|FG001|Overall Study|Death|0|||
46755773|NCT00593814|82973693|FG000|Overall Study|Withdrawal by Subject|7|||
46755774|NCT00593814|82973694|FG001|Overall Study|Withdrawal by Subject|0|||
46755775|NCT00593814|82973693|FG000|Overall Study|Lost to Follow-up|7|||
46755776|NCT00593814|82973694|FG001|Overall Study|Lost to Follow-up|0|||
46755777|NCT00593814|82973693|FG000|Overall Study|Physician Decision|3|||
46755778|NCT00593814|82973694|FG001|Overall Study|Physician Decision|0|||
46755779|NCT00855309|82973702|FG000|Overall Study|patient never recieved drug|1|||
46755780|NCT00855309|82973703|FG001|Overall Study|patient never recieved drug|0|||
46755781|NCT00532129|82973709|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
46755782|NCT00532129|82973709|FG000|Treatment Period|Physician Decision|15|||
46813771|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
46813772|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
46928529|NCT02798211|83163320|FG001|Period 2|Adverse Event|0|||
46928530|NCT02798211|83163321|FG002|Period 2|Adverse Event|0|||
46928531|NCT02798211|83163322|FG003|Period 2|Adverse Event|0|||
46928532|NCT02798211|83163323|FG004|Period 2|Adverse Event|1|||
46928533|NCT02798211|83163324|FG005|Period 2|Adverse Event|0|||
46813773|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
46813774|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
46813775|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
46813776|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
46813777|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
46813778|NCT00343252|83033422|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
46813779|NCT00343252|83033423|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
46813780|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
46813781|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
46813782|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Death|3|||
46813783|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Death|3|||
46813784|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
46813785|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
46813786|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
46813787|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
46813788|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
46813789|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
46813790|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
46813791|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
46813792|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
46813793|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
46813794|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
46813795|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
46813796|NCT00343252|83033422|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
46813797|NCT00343252|83033423|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
46813798|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
46813799|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
46813800|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Death|4|||
46813801|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Death|5|||
46813802|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
46813803|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
46813804|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
46813805|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
46813806|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
46813807|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
46813808|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
46813809|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
46813810|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
46813811|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
46813812|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
46813813|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
46813814|NCT00343252|83033422|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
46813815|NCT00343252|83033423|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
46813816|NCT00342628|83033432|FG000|Overall Study|Withdrawal by Subject|19|||
46813817|NCT00342628|83033433|FG001|Overall Study|Withdrawal by Subject|19|||
46813818|NCT00342628|83033434|FG002|Overall Study|Withdrawal by Subject|18|||
46813819|NCT00342628|83033432|FG000|Overall Study|Death|1|||
46928534|NCT02798211|83163319|FG000|Period 2|Lack of Efficacy|1|||
46755783|NCT00532129|82973709|FG000|Treatment Period|Disease progression|3|||
46755784|NCT00532129|82973709|FG000|Treatment Period|Protocol Violation|1|||
46755785|NCT00532129|82973709|FG000|Treatment Period|Other|5|||
46755786|NCT00532129|82973709|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
46755787|NCT00532129|82973709|FG000|Follow-up Period|Disease progression|57|||
46755788|NCT00532129|82973709|FG000|Follow-up Period|Lost to Follow-up|1|||
46755789|NCT00532129|82973709|FG000|Follow-up Period|Other|6|||
46755790|NCT00854607|82973713|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
46755791|NCT00854373|82973726|FG000|Overall Study|Withdrawal by Subject|1|||
46755792|NCT00854373|82973727|FG001|Overall Study|Withdrawal by Subject|3|||
46755793|NCT00854373|82973726|FG000|Overall Study|Forgot to take study drug|1|||
46755794|NCT00854373|82973727|FG001|Overall Study|Forgot to take study drug|1|||
46755795|NCT00853905|82973735|FG000|Overall Study|Lost to Follow-up|1|||
46755796|NCT00853905|82973736|FG001|Overall Study|Lost to Follow-up|3|||
46928535|NCT02798211|83163320|FG001|Period 2|Lack of Efficacy|0|||
46928536|NCT02798211|83163321|FG002|Period 2|Lack of Efficacy|0|||
46928537|NCT02798211|83163322|FG003|Period 2|Lack of Efficacy|1|||
46755797|NCT00853905|82973735|FG000|Overall Study|Withdrawal by Subject|0|||
46755798|NCT00853905|82973736|FG001|Overall Study|Withdrawal by Subject|1|||
46755799|NCT00853905|82973735|FG000|Overall Study|never had surgery|1|||
46755800|NCT00853905|82973736|FG001|Overall Study|never had surgery|0|||
46755801|NCT00868296|82973747|FG000|Overall Study|Adverse Event|0|||
46755802|NCT00868296|82973748|FG001|Overall Study|Adverse Event|2|||
46755803|NCT00868296|82973747|FG000|Overall Study|Withdrawal by Subject|0|||
46755804|NCT00868296|82973748|FG001|Overall Study|Withdrawal by Subject|1|||
46755805|NCT00867360|82973756|FG000|Overall Study|Withdrawal by Subject|1|||
46755806|NCT00867360|82973757|FG001|Overall Study|Withdrawal by Subject|0|||
46755807|NCT00867360|82973756|FG000|Overall Study|Physician Decision|0|||
46755808|NCT00867360|82973757|FG001|Overall Study|Physician Decision|1|||
46755809|NCT00593736|82973768|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
46755810|NCT00593736|82973769|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
46755811|NCT00593736|82973770|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
46755812|NCT00593736|82973771|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
46755813|NCT00593736|82973768|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
46755814|NCT00593736|82973769|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
46755815|NCT00593736|82973770|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
46755816|NCT00593736|82973771|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
46755817|NCT00593736|82973768|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
46755818|NCT00593736|82973769|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
46755819|NCT00593736|82973770|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
46755820|NCT00593736|82973771|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
46755821|NCT00593736|82973768|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
46755822|NCT00593736|82973769|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
46755823|NCT00593736|82973770|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
46755824|NCT00593736|82973771|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
46755825|NCT00593736|82973768|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
46755826|NCT00593736|82973769|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
46755827|NCT00593736|82973770|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
46755828|NCT00593736|82973771|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
46755829|NCT00593736|82973768|FG000|Screening Period and Placebo Run-in|Various|0|||
46755830|NCT00593736|82973769|FG001|Screening Period and Placebo Run-in|Various|0|||
46755831|NCT00593736|82973770|FG002|Screening Period and Placebo Run-in|Various|0|||
46755832|NCT00593736|82973771|FG003|Screening Period and Placebo Run-in|Various|25|||
46755833|NCT00593736|82973768|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
46755834|NCT00593736|82973769|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
46755835|NCT00593736|82973770|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
46755836|NCT00593736|82973771|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
46755837|NCT00593736|82973768|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
46755838|NCT00593736|82973769|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
46755839|NCT00593736|82973770|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
46755840|NCT00593736|82973771|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
46755841|NCT00593736|82973768|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
46755842|NCT00593736|82973769|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
46755843|NCT00593736|82973770|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
46755844|NCT00593736|82973771|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
46755845|NCT00593736|82973768|FG000|Treatment Period and Placebo Run-out|Various|1|||
46755846|NCT00593736|82973769|FG001|Treatment Period and Placebo Run-out|Various|1|||
46755847|NCT00593736|82973770|FG002|Treatment Period and Placebo Run-out|Various|1|||
46755848|NCT00593736|82973771|FG003|Treatment Period and Placebo Run-out|Various|0|||
46755849|NCT00883688|82973781|FG000|Overall Study|Ineligible|2|||
46755850|NCT03883477|82973787|FG000|Overall Study|Death|1|||
46755851|NCT03883477|82973788|FG001|Overall Study|Death|0|||
46755852|NCT03883477|82973787|FG000|Overall Study|Protocol Violation|0|||
46755853|NCT03883477|82973788|FG001|Overall Study|Protocol Violation|1|||
46755854|NCT00853827|82973796|FG000|Single Blind Period (1 Week)|Other|4|||
46755855|NCT00853827|82973797|FG001|Single Blind Period (1 Week)|Other|0|||
46755856|NCT00853827|82973796|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
46755857|NCT00853827|82973797|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
46755858|NCT00853827|82973796|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
46755859|NCT00853827|82973797|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
46755860|NCT00853827|82973796|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
46755861|NCT00853827|82973797|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
46755862|NCT00853827|82973796|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
46755863|NCT00853827|82973797|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
46755864|NCT00853827|82973796|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
46755865|NCT00853827|82973797|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
46755866|NCT00853827|82973796|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
46755867|NCT00853827|82973797|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
46755868|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
46755869|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
46755870|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
46755871|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
46755872|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
46755873|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
46755874|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
46755875|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
46755876|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
46755877|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
46755878|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
46755879|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
46755880|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
46755881|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
46755882|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
46755883|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
46755884|NCT00853827|82973796|FG000|Double Blind Period (103 Weeks)|Death|1|||
46755885|NCT00853827|82973797|FG001|Double Blind Period (103 Weeks)|Death|6|||
46755886|NCT00853749|82973805|FG000|Overall Study|Lost to Follow-up|0|||
46755887|NCT00853749|82973806|FG001|Overall Study|Lost to Follow-up|1|||
46755888|NCT00592839|82973815|FG000|Overall Study|Withdrawal by Subject|1|||
46755889|NCT00592839|82973816|FG001|Overall Study|Withdrawal by Subject|1|||
46755890|NCT00592839|82973817|FG002|Overall Study|Withdrawal by Subject|3|||
46755891|NCT00592839|82973815|FG000|Overall Study|Protocol Violation|1|||
46755892|NCT00592839|82973816|FG001|Overall Study|Protocol Violation|1|||
46755893|NCT00592839|82973817|FG002|Overall Study|Protocol Violation|2|||
46755894|NCT00592839|82973815|FG000|Overall Study|Adverse Event|0|||
46755895|NCT00592839|82973816|FG001|Overall Study|Adverse Event|1|||
46755896|NCT00592839|82973817|FG002|Overall Study|Adverse Event|0|||
46755897|NCT00592839|82973815|FG000|Overall Study|Lost to Follow-up|0|||
46755898|NCT00592839|82973816|FG001|Overall Study|Lost to Follow-up|1|||
46755899|NCT00592839|82973817|FG002|Overall Study|Lost to Follow-up|1|||
46755900|NCT00598832|82973827|FG000|Overall Study|Lack of Efficacy|3|||
46755901|NCT00598832|82973828|FG001|Overall Study|Lack of Efficacy|7|||
46755902|NCT00598832|82973827|FG000|Overall Study|Adverse Event|6|||
46755903|NCT00598832|82973828|FG001|Overall Study|Adverse Event|2|||
46755904|NCT00598832|82973827|FG000|Overall Study|Withdrawal by Subject|25|||
46755905|NCT00598832|82973828|FG001|Overall Study|Withdrawal by Subject|36|||
46755906|NCT00598832|82973827|FG000|Overall Study|Protocol Violation|0|||
46755907|NCT00598832|82973828|FG001|Overall Study|Protocol Violation|2|||
46755908|NCT00598832|82973827|FG000|Overall Study|Lost to Follow-up|24|||
46755909|NCT00598832|82973828|FG001|Overall Study|Lost to Follow-up|29|||
46755910|NCT00598832|82973827|FG000|Overall Study|Pregnancy|2|||
46755911|NCT00598832|82973828|FG001|Overall Study|Pregnancy|2|||
46755912|NCT00598832|82973827|FG000|Overall Study|Physician Decision|1|||
46755913|NCT00598832|82973828|FG001|Overall Study|Physician Decision|4|||
46755914|NCT00598832|82973827|FG000|Overall Study|Non compliance|1|||
46755915|NCT00598832|82973828|FG001|Overall Study|Non compliance|0|||
46755916|NCT00853593|82973834|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
46755917|NCT00853593|82973834|FG000|Overall Study|Model 4396 lead not attempted|29|||
46755918|NCT00853593|82973834|FG000|Overall Study|Implant not attempted|4|||
46755919|NCT00853125|82973855|FG000|Overall Study|Study participant's donor was CMV +|1|||
46755920|NCT00530023|82973862|FG000|Overall Study|Withdrawal by Subject|0|||
46755921|NCT00530023|82973863|FG001|Overall Study|Withdrawal by Subject|1|||
46755922|NCT00529087|82973872|FG000|Overall Study|Adverse Event|10|||
46755923|NCT00529087|82973873|FG001|Overall Study|Adverse Event|13|||
46755924|NCT00529087|82973874|FG002|Overall Study|Adverse Event|4|||
46755925|NCT00529087|82973872|FG000|Overall Study|Lost to Follow-up|6|||
46755926|NCT00529087|82973873|FG001|Overall Study|Lost to Follow-up|4|||
46755927|NCT00529087|82973874|FG002|Overall Study|Lost to Follow-up|1|||
46755928|NCT00529087|82973872|FG000|Overall Study|Protocol Violation|8|||
46755929|NCT00529087|82973873|FG001|Overall Study|Protocol Violation|7|||
46755930|NCT00529087|82973874|FG002|Overall Study|Protocol Violation|6|||
46755931|NCT00529087|82973872|FG000|Overall Study|Withdrawal by Subject|3|||
46755932|NCT00529087|82973873|FG001|Overall Study|Withdrawal by Subject|3|||
46755933|NCT00529087|82973874|FG002|Overall Study|Withdrawal by Subject|3|||
46755934|NCT00529087|82973872|FG000|Overall Study|Protocol deviation|1|||
46755935|NCT00529087|82973873|FG001|Overall Study|Protocol deviation|1|||
46755936|NCT00529087|82973874|FG002|Overall Study|Protocol deviation|2|||
46755937|NCT00870870|82973909|FG000|Overall Study|Withdrawal by Subject|0|||
46755938|NCT00870870|82973910|FG001|Overall Study|Withdrawal by Subject|1|||
46755939|NCT00870870|82973911|FG002|Overall Study|Withdrawal by Subject|1|||
46755940|NCT00870870|82973912|FG003|Overall Study|Withdrawal by Subject|3|||
46755941|NCT00870870|82973909|FG000|Overall Study|Adverse Event|0|||
46755942|NCT00870870|82973910|FG001|Overall Study|Adverse Event|0|||
46755943|NCT00870870|82973911|FG002|Overall Study|Adverse Event|2|||
46755944|NCT00870870|82973912|FG003|Overall Study|Adverse Event|2|||
46755945|NCT03877237|82973929|FG000|Overall Study|Adverse Event|1|||
46813820|NCT00342628|83033433|FG001|Overall Study|Death|1|||
46813821|NCT00342628|83033434|FG002|Overall Study|Death|0|||
46813822|NCT00342628|83033432|FG000|Overall Study|moved residence|0|||
46813823|NCT00342628|83033433|FG001|Overall Study|moved residence|1|||
46813824|NCT00342628|83033434|FG002|Overall Study|moved residence|1|||
46813825|NCT00505284|83033447|FG000|Overall Study|Adverse Event|3|||
46813826|NCT00505284|83033448|FG001|Overall Study|Adverse Event|7|||
46928538|NCT02798211|83163323|FG004|Period 2|Lack of Efficacy|0|||
46928539|NCT02798211|83163324|FG005|Period 2|Lack of Efficacy|1|||
46928540|NCT02798211|83163319|FG000|Period 2|Lost to Follow-up|3|||
46928541|NCT02798211|83163320|FG001|Period 2|Lost to Follow-up|0|||
46928542|NCT02798211|83163321|FG002|Period 2|Lost to Follow-up|0|||
46928543|NCT02798211|83163322|FG003|Period 2|Lost to Follow-up|0|||
46928544|NCT02798211|83163323|FG004|Period 2|Lost to Follow-up|2|||
46928545|NCT02798211|83163324|FG005|Period 2|Lost to Follow-up|0|||
46928546|NCT02798211|83163319|FG000|Period 2|Physician Decision|1|||
46928547|NCT02798211|83163320|FG001|Period 2|Physician Decision|0|||
46928548|NCT02798211|83163321|FG002|Period 2|Physician Decision|0|||
46928549|NCT02798211|83163322|FG003|Period 2|Physician Decision|1|||
46928550|NCT02798211|83163323|FG004|Period 2|Physician Decision|1|||
46928551|NCT02798211|83163324|FG005|Period 2|Physician Decision|0|||
46928552|NCT02798211|83163319|FG000|Period 2|Pregnancy|0|||
46928553|NCT02798211|83163320|FG001|Period 2|Pregnancy|0|||
46928554|NCT02798211|83163321|FG002|Period 2|Pregnancy|0|||
46928555|NCT02798211|83163322|FG003|Period 2|Pregnancy|2|||
46928556|NCT02798211|83163323|FG004|Period 2|Pregnancy|0|||
46928557|NCT02798211|83163324|FG005|Period 2|Pregnancy|0|||
46813827|NCT00505284|83033449|FG002|Overall Study|Adverse Event|9|||
46813828|NCT00505284|83033450|FG003|Overall Study|Adverse Event|14|||
47054964|NCT01772147|83328288|FG002|Overall Study|Protocol Deviation|1|||
46755946|NCT03877237|82973930|FG001|Overall Study|Adverse Event|2|||
46755947|NCT03877237|82973929|FG000|Overall Study|Death|3|||
46755948|NCT03877237|82973930|FG001|Overall Study|Death|2|||
46755949|NCT03877237|82973929|FG000|Overall Study|Physician Decision|1|||
46755950|NCT03877237|82973930|FG001|Overall Study|Physician Decision|0|||
46755951|NCT03877237|82973929|FG000|Overall Study|Withdrawal by Subject|0|||
46813829|NCT00505284|83033451|FG004|Overall Study|Adverse Event|22|||
46813830|NCT00505284|83033447|FG000|Overall Study|Protocol Violation|0|||
46813831|NCT00505284|83033448|FG001|Overall Study|Protocol Violation|1|||
46813832|NCT00505284|83033449|FG002|Overall Study|Protocol Violation|1|||
46813833|NCT00505284|83033450|FG003|Overall Study|Protocol Violation|0|||
46813834|NCT00505284|83033451|FG004|Overall Study|Protocol Violation|0|||
46813835|NCT00505284|83033447|FG000|Overall Study|Withdrawal by Subject|2|||
46813836|NCT00505284|83033448|FG001|Overall Study|Withdrawal by Subject|6|||
46813837|NCT00505284|83033449|FG002|Overall Study|Withdrawal by Subject|1|||
46813838|NCT00505284|83033450|FG003|Overall Study|Withdrawal by Subject|0|||
46813839|NCT00505284|83033451|FG004|Overall Study|Withdrawal by Subject|6|||
46813840|NCT00505284|83033447|FG000|Overall Study|Lack of Efficacy|0|||
46813841|NCT00505284|83033448|FG001|Overall Study|Lack of Efficacy|1|||
46813842|NCT00505284|83033449|FG002|Overall Study|Lack of Efficacy|1|||
46813843|NCT00505284|83033450|FG003|Overall Study|Lack of Efficacy|1|||
46813844|NCT00505284|83033451|FG004|Overall Study|Lack of Efficacy|1|||
46813845|NCT00505284|83033447|FG000|Overall Study|Physician Decision|0|||
46813846|NCT00505284|83033448|FG001|Overall Study|Physician Decision|1|||
46813847|NCT00505284|83033449|FG002|Overall Study|Physician Decision|0|||
46813848|NCT00505284|83033450|FG003|Overall Study|Physician Decision|0|||
46813849|NCT00505284|83033451|FG004|Overall Study|Physician Decision|0|||
46813850|NCT00505284|83033447|FG000|Overall Study|Other|5|||
46928558|NCT02798211|83163319|FG000|Period 2|Technical problems|1|||
46928559|NCT02798211|83163320|FG001|Period 2|Technical problems|0|||
46928560|NCT02798211|83163321|FG002|Period 2|Technical problems|0|||
46928561|NCT02798211|83163322|FG003|Period 2|Technical problems|1|||
46928562|NCT02798211|83163323|FG004|Period 2|Technical problems|0|||
46928563|NCT02798211|83163324|FG005|Period 2|Technical problems|0|||
46928564|NCT02798211|83163319|FG000|Period 2|Withdrawal of Informed Consent|1|||
46928565|NCT02798211|83163320|FG001|Period 2|Withdrawal of Informed Consent|0|||
47054965|NCT01772147|83328286|FG000|Overall Study|Lack of Efficacy|8|||
46755952|NCT03877237|82973930|FG001|Overall Study|Withdrawal by Subject|2|||
46755953|NCT00528931|82973936|FG000|Overall Study|Lost to Follow-up|1|||
46813851|NCT00505284|83033448|FG001|Overall Study|Other|0|||
46813852|NCT00505284|83033449|FG002|Overall Study|Other|0|||
46813853|NCT00505284|83033450|FG003|Overall Study|Other|4|||
46755954|NCT00866814|82973941|FG000|Overall Study|Lost to Follow-up|12|||
46813854|NCT00505284|83033451|FG004|Overall Study|Other|4|||
46813855|NCT00337168|83033463|FG000|Overall Study|Death|5|||
46813856|NCT00337168|83033463|FG000|Overall Study|Not protocol specified|2|||
46813857|NCT00337168|83033463|FG000|Overall Study|Did not start therapy|1|||
46813858|NCT00606905|83033470|FG000|Overall Study|No Pregnancy|9|||
46813859|NCT00606905|83033471|FG001|Overall Study|No Pregnancy|6|||
46928566|NCT02798211|83163321|FG002|Period 2|Withdrawal of Informed Consent|0|||
46928567|NCT02798211|83163322|FG003|Period 2|Withdrawal of Informed Consent|2|||
47054966|NCT01772147|83328287|FG001|Overall Study|Lack of Efficacy|6|||
46813860|NCT00606905|83033470|FG000|Overall Study|Non-Index Pregnancy|1|||
46813861|NCT00606905|83033471|FG001|Overall Study|Non-Index Pregnancy|4|||
46813862|NCT00606905|83033470|FG000|Overall Study|Withdrew|5|||
46813863|NCT00606905|83033471|FG001|Overall Study|Withdrew|5|||
46813864|NCT00606593|83033477|FG000|Overall Study|Adverse Event|0|||
46813865|NCT00606593|83033478|FG001|Overall Study|Adverse Event|0|||
47054967|NCT01772147|83328288|FG002|Overall Study|Lack of Efficacy|6|||
47054968|NCT01771913|83328298|FG000|Overall Study|Withdrawal by Subject|1|||
47054969|NCT01771913|83328299|FG001|Overall Study|Withdrawal by Subject|0|||
47054970|NCT01606787|83328307|FG000|Overall Study|Withdrawal by Subject|4|||
47054971|NCT01606787|83328308|FG001|Overall Study|Withdrawal by Subject|5|||
47054972|NCT01606787|83328307|FG000|Overall Study|Surgery canceled|0|||
47054973|NCT01606787|83328308|FG001|Overall Study|Surgery canceled|2|||
47054974|NCT01778855|83328316|FG000|Overall Study|Death|0|||
47054975|NCT01778855|83328317|FG001|Overall Study|Death|1|||
47054976|NCT01777997|83328323|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
47054977|NCT01777997|83328323|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
47054978|NCT01777997|83328323|FG000|Weeks 48 to 72/96 on ART|Death|1|||
47054979|NCT01777997|83328323|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
47054980|NCT01770509|83328329|FG000|Overall Study|Injury|0|||
47054981|NCT01770509|83328330|FG001|Overall Study|Injury|1|||
47054982|NCT01770509|83328329|FG000|Overall Study|Lost to Follow-up|1|||
47054983|NCT01770509|83328330|FG001|Overall Study|Lost to Follow-up|2|||
47054984|NCT01770353|83328338|FG000|Overall Study|Progressive disease|2|||
47054985|NCT01770353|83328339|FG001|Overall Study|Progressive disease|1|||
47054986|NCT01770353|83328338|FG000|Overall Study|Adverse Event|0|||
47054987|NCT01770353|83328339|FG001|Overall Study|Adverse Event|1|||
47054988|NCT01770353|83328338|FG000|Overall Study|Protocol Violation|1|||
47054989|NCT01770353|83328339|FG001|Overall Study|Protocol Violation|0|||
47054990|NCT01770353|83328338|FG000|Overall Study|Physician Decision|0|||
47054991|NCT01770353|83328339|FG001|Overall Study|Physician Decision|3|||
47054992|NCT01770353|83328338|FG000|Overall Study|Clinical deterioration|3|||
46813866|NCT00606593|83033479|FG002|Overall Study|Adverse Event|0|||
46813867|NCT00606593|83033480|FG003|Overall Study|Adverse Event|1|||
46813868|NCT00606593|83033481|FG004|Overall Study|Adverse Event|1|||
46813869|NCT00606593|83033482|FG005|Overall Study|Adverse Event|0|||
46813870|NCT00606593|83033483|FG006|Overall Study|Adverse Event|1|||
46813871|NCT00606593|83033484|FG007|Overall Study|Adverse Event|2|||
46813872|NCT00606593|83033485|FG008|Overall Study|Adverse Event|1|||
46928568|NCT02798211|83163323|FG004|Period 2|Withdrawal of Informed Consent|2|||
46928569|NCT02798211|83163324|FG005|Period 2|Withdrawal of Informed Consent|3|||
46928570|NCT02799069|83163339|FG000|Overall Study|Adverse Event|0|||
46928571|NCT02799069|83163340|FG001|Overall Study|Adverse Event|2|||
46928572|NCT02799069|83163341|FG002|Overall Study|Adverse Event|2|||
46928573|NCT02799069|83163339|FG000|Overall Study|Lack of Efficacy|2|||
46813873|NCT00606593|83033486|FG009|Overall Study|Adverse Event|0|||
46813874|NCT00606593|83033477|FG000|Overall Study|Withdrawal of consent|1|||
46813875|NCT00606593|83033478|FG001|Overall Study|Withdrawal of consent|0|||
46813876|NCT00606593|83033479|FG002|Overall Study|Withdrawal of consent|1|||
46813877|NCT00606593|83033480|FG003|Overall Study|Withdrawal of consent|0|||
46813878|NCT00606593|83033481|FG004|Overall Study|Withdrawal of consent|0|||
46813879|NCT00606593|83033482|FG005|Overall Study|Withdrawal of consent|0|||
46813880|NCT00606593|83033483|FG006|Overall Study|Withdrawal of consent|0|||
46813881|NCT00606593|83033484|FG007|Overall Study|Withdrawal of consent|0|||
46813882|NCT00606593|83033485|FG008|Overall Study|Withdrawal of consent|0|||
46813883|NCT00606593|83033486|FG009|Overall Study|Withdrawal of consent|0|||
46813884|NCT00606593|83033477|FG000|Overall Study|Administrative/Other|0|||
46813885|NCT00606593|83033478|FG001|Overall Study|Administrative/Other|0|||
46813886|NCT00606593|83033479|FG002|Overall Study|Administrative/Other|1|||
46813887|NCT00606593|83033480|FG003|Overall Study|Administrative/Other|0|||
46928574|NCT02799069|83163340|FG001|Overall Study|Lack of Efficacy|0|||
46928575|NCT02799069|83163341|FG002|Overall Study|Lack of Efficacy|0|||
46813888|NCT00606593|83033481|FG004|Overall Study|Administrative/Other|0|||
46813889|NCT00606593|83033482|FG005|Overall Study|Administrative/Other|0|||
46813890|NCT00606593|83033483|FG006|Overall Study|Administrative/Other|0|||
47054993|NCT01770353|83328339|FG001|Overall Study|Clinical deterioration|6|||
47054994|NCT01770353|83328338|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
47054995|NCT01770353|83328339|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
47054996|NCT01777763|83328355|FG000|Overall Study|Adverse Event|2|||
47054997|NCT01777763|83328356|FG001|Overall Study|Adverse Event|32|||
47054998|NCT01777763|83328355|FG000|Overall Study|Protocol Violation|1|||
47054999|NCT01777763|83328356|FG001|Overall Study|Protocol Violation|7|||
46928576|NCT02799069|83163339|FG000|Overall Study|Lost to Follow-up|1|||
46928577|NCT02799069|83163340|FG001|Overall Study|Lost to Follow-up|1|||
46928578|NCT02799069|83163341|FG002|Overall Study|Lost to Follow-up|0|||
46928579|NCT02799069|83163339|FG000|Overall Study|Withdrawal by Subject|4|||
46928580|NCT02799069|83163340|FG001|Overall Study|Withdrawal by Subject|4|||
46928581|NCT02799069|83163341|FG002|Overall Study|Withdrawal by Subject|3|||
46928582|NCT02799069|83163339|FG000|Overall Study|Protocol Violation|1|||
46928583|NCT02799069|83163340|FG001|Overall Study|Protocol Violation|0|||
46928584|NCT02799069|83163341|FG002|Overall Study|Protocol Violation|2|||
46928585|NCT01669174|83163351|FG000|Overall Study|Subject withdrew consent|2|||
46928586|NCT01669174|83163352|FG001|Overall Study|Subject withdrew consent|2|||
46928587|NCT01669174|83163351|FG000|Overall Study|Lost to Follow-up|1|||
46928588|NCT01669174|83163352|FG001|Overall Study|Lost to Follow-up|0|||
46928589|NCT01669174|83163351|FG000|Overall Study|Adverse Event|2|||
46928590|NCT01669174|83163352|FG001|Overall Study|Adverse Event|2|||
46928591|NCT01669174|83163351|FG000|Overall Study|Administrative problems|1|||
46928592|NCT01669174|83163352|FG001|Overall Study|Administrative problems|2|||
46928593|NCT02798835|83163361|FG000|Overall Study|Protocol Violation|0|||
47055000|NCT01777763|83328355|FG000|Overall Study|Withdrawal by Subject|0|||
47055001|NCT01777763|83328356|FG001|Overall Study|Withdrawal by Subject|2|||
47055002|NCT01777763|83328355|FG000|Overall Study|Treatment Failure|1|||
47055003|NCT01777763|83328356|FG001|Overall Study|Treatment Failure|6|||
47055004|NCT01769339|83328362|FG000|Overall Study|Lost to Follow-up|42|||
47055005|NCT01769339|83328362|FG000|Overall Study|Adverse Event|1|||
47055006|NCT01769105|83328368|FG000|First Intervention|Protocol Violation|2|||
47055007|NCT01769105|83328369|FG001|First Intervention|Protocol Violation|2|||
46928594|NCT02798835|83163362|FG001|Overall Study|Protocol Violation|0|||
46928595|NCT02798835|83163363|FG002|Overall Study|Protocol Violation|3|||
46928596|NCT02611882|83163374|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
46928597|NCT02611882|83163375|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
46928598|NCT02611882|83163376|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
46928599|NCT02796963|83163387|FG000|Overall Study|Lost to Follow-up|89|||
46928600|NCT02796963|83163388|FG001|Overall Study|Lost to Follow-up|76|||
46928601|NCT02796963|83163389|FG002|Overall Study|Lost to Follow-up|69|||
46928602|NCT02796963|83163390|FG003|Overall Study|Lost to Follow-up|72|||
46928603|NCT02796651|83163400|FG000|Overall Study|Adverse Event|6|||
46928604|NCT02796651|83163400|FG000|Overall Study|Lost to Follow-up|1|||
46928605|NCT02796651|83163400|FG000|Overall Study|Withdrawal by Subject|4|||
46928606|NCT02796651|83163400|FG000|Overall Study|Protocol Violation|4|||
46928607|NCT02796651|83163400|FG000|Overall Study|Lack of Efficacy|1|||
46928608|NCT02796651|83163400|FG000|Overall Study|Other|10|||
46928609|NCT02613208|83163415|FG000|Overall Study|Withdrawal by Subject|1|||
46928610|NCT02613208|83163415|FG000|Overall Study|Change of address|2|||
46928611|NCT02613208|83163415|FG000|Overall Study|Physician Decision|2|||
46928612|NCT02613208|83163415|FG000|Overall Study|Lost to Follow-up|5|||
46928613|NCT02613208|83163415|FG000|Overall Study|Death|37|||
46928614|NCT01668784|83163421|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
46928615|NCT01668784|83163422|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
46928616|NCT01668784|83163421|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
46928617|NCT01668784|83163422|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
46928618|NCT01668784|83163421|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
46928619|NCT01668784|83163422|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
46928620|NCT01668784|83163421|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
46928621|NCT01668784|83163422|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
46928622|NCT01668784|83163421|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
46928623|NCT01668784|83163422|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
46928624|NCT01668784|83163421|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
46928625|NCT01668784|83163422|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
46928626|NCT01668784|83163421|FG000|Treatment Period|Disease Progression|316|||
46928627|NCT01668784|83163422|FG001|Treatment Period|Disease Progression|293|||
46928628|NCT01668784|83163421|FG000|Treatment Period|Study Drug Toxicity|46|||
46928629|NCT01668784|83163422|FG001|Treatment Period|Study Drug Toxicity|53|||
46928630|NCT01668784|83163421|FG000|Treatment Period|Death|1|||
46928631|NCT01668784|83163422|FG001|Treatment Period|Death|1|||
46928632|NCT01668784|83163421|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
46928633|NCT01668784|83163422|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
47055008|NCT01769105|83328368|FG000|Cross-over|Lost to Follow-up|5|||
46928634|NCT01668784|83163421|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
46928635|NCT01668784|83163422|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
46928636|NCT01668784|83163421|FG000|Treatment Period|Withdrawal by Subject|5|||
46928637|NCT01668784|83163422|FG001|Treatment Period|Withdrawal by Subject|3|||
47055009|NCT01769105|83328369|FG001|Cross-over|Lost to Follow-up|0|||
47055010|NCT01777139|83328377|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
46928638|NCT01668784|83163421|FG000|Treatment Period|Maximal Clinical Benefit|3|||
46928639|NCT01668784|83163422|FG001|Treatment Period|Maximal Clinical Benefit|3|||
46928640|NCT01668784|83163421|FG000|Treatment Period|Other|2|||
46928641|NCT01668784|83163422|FG001|Treatment Period|Other|8|||
46928642|NCT01668784|83163421|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
46928643|NCT01668784|83163422|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
46928644|NCT02750514|83163433|FG000|Track 1|Disease progression|20|||
46928645|NCT02750514|83163434|FG001|Track 1|Disease progression|1|||
46928646|NCT02750514|83163435|FG002|Track 1|Disease progression|0|||
46928647|NCT02750514|83163436|FG003|Track 1|Disease progression|1|||
46928648|NCT02750514|83163437|FG004|Track 1|Disease progression|0|||
46928649|NCT02750514|83163433|FG000|Track 1|Adverse event unrelated to study drug|1|||
46928650|NCT02750514|83163434|FG001|Track 1|Adverse event unrelated to study drug|0|||
46928651|NCT02750514|83163435|FG002|Track 1|Adverse event unrelated to study drug|0|||
46928652|NCT02750514|83163436|FG003|Track 1|Adverse event unrelated to study drug|0|||
46928653|NCT02750514|83163437|FG004|Track 1|Adverse event unrelated to study drug|0|||
46928654|NCT02750514|83163433|FG000|Track 1|Study drug toxicity|4|||
46928655|NCT02750514|83163434|FG001|Track 1|Study drug toxicity|1|||
46928656|NCT02750514|83163435|FG002|Track 1|Study drug toxicity|0|||
46928657|NCT02750514|83163436|FG003|Track 1|Study drug toxicity|1|||
46928658|NCT02750514|83163437|FG004|Track 1|Study drug toxicity|0|||
46928659|NCT02750514|83163433|FG000|Track 1|Participant request to discontinue|1|||
46928660|NCT02750514|83163434|FG001|Track 1|Participant request to discontinue|0|||
46928661|NCT02750514|83163435|FG002|Track 1|Participant request to discontinue|0|||
46928662|NCT02750514|83163436|FG003|Track 1|Participant request to discontinue|0|||
46928663|NCT02750514|83163437|FG004|Track 1|Participant request to discontinue|0|||
46928664|NCT02750514|83163433|FG000|Track 1|Other reasons|1|||
46928665|NCT02750514|83163434|FG001|Track 1|Other reasons|0|||
46928666|NCT02750514|83163435|FG002|Track 1|Other reasons|0|||
46928667|NCT02750514|83163436|FG003|Track 1|Other reasons|0|||
46928668|NCT02750514|83163437|FG004|Track 1|Other reasons|0|||
46928669|NCT02750514|83163433|FG000|Track 2|Disease progression|4|||
46928670|NCT02750514|83163434|FG001|Track 2|Disease progression|5|||
46928671|NCT02750514|83163435|FG002|Track 2|Disease progression|2|||
46928672|NCT02750514|83163436|FG003|Track 2|Disease progression|5|||
46928673|NCT02750514|83163437|FG004|Track 2|Disease progression|0|||
46928674|NCT02750514|83163433|FG000|Track 2|Adverse event unrelated to study drug|1|||
46928675|NCT02750514|83163434|FG001|Track 2|Adverse event unrelated to study drug|0|||
46928676|NCT02750514|83163435|FG002|Track 2|Adverse event unrelated to study drug|0|||
46928677|NCT02750514|83163436|FG003|Track 2|Adverse event unrelated to study drug|0|||
46928678|NCT02750514|83163437|FG004|Track 2|Adverse event unrelated to study drug|0|||
46928679|NCT02750514|83163433|FG000|Track 2|Study drug toxicity|1|||
46928680|NCT02750514|83163434|FG001|Track 2|Study drug toxicity|2|||
46928681|NCT02750514|83163435|FG002|Track 2|Study drug toxicity|0|||
46928682|NCT02750514|83163436|FG003|Track 2|Study drug toxicity|2|||
46928683|NCT02750514|83163437|FG004|Track 2|Study drug toxicity|0|||
46928684|NCT02750514|83163433|FG000|Track 2|Participant withdrew consent|0|||
46928685|NCT02750514|83163434|FG001|Track 2|Participant withdrew consent|1|||
46928686|NCT02750514|83163435|FG002|Track 2|Participant withdrew consent|0|||
46928687|NCT02750514|83163436|FG003|Track 2|Participant withdrew consent|0|||
46928688|NCT02750514|83163437|FG004|Track 2|Participant withdrew consent|0|||
46928689|NCT02750514|83163433|FG000|Track 3|Disease progression|0|||
46928690|NCT02750514|83163434|FG001|Track 3|Disease progression|24|||
46928691|NCT02750514|83163435|FG002|Track 3|Disease progression|13|||
46928692|NCT02750514|83163436|FG003|Track 3|Disease progression|14|||
46928693|NCT02750514|83163437|FG004|Track 3|Disease progression|0|||
46928694|NCT02750514|83163433|FG000|Track 3|Adverse event unrelated to study drug|0|||
46928695|NCT02750514|83163434|FG001|Track 3|Adverse event unrelated to study drug|1|||
46928696|NCT02750514|83163435|FG002|Track 3|Adverse event unrelated to study drug|1|||
46928697|NCT02750514|83163436|FG003|Track 3|Adverse event unrelated to study drug|1|||
46928698|NCT02750514|83163437|FG004|Track 3|Adverse event unrelated to study drug|0|||
46928699|NCT02750514|83163433|FG000|Track 3|Study drug toxicity|0|||
46636549|NCT01484496|82810388|FG000|Period 1|Adverse Event|25|||
46755955|NCT00866814|82973941|FG000|Overall Study|Adverse Event|2|||
46755956|NCT00866814|82973941|FG000|Overall Study|Physician Decision|1|||
46928700|NCT02750514|83163434|FG001|Track 3|Study drug toxicity|3|||
46928701|NCT02750514|83163435|FG002|Track 3|Study drug toxicity|0|||
46928702|NCT02750514|83163436|FG003|Track 3|Study drug toxicity|1|||
46755957|NCT00866814|82973941|FG000|Overall Study|Death|1|||
46928703|NCT02750514|83163437|FG004|Track 3|Study drug toxicity|0|||
46928704|NCT02750514|83163433|FG000|Track 3|Participant request to discontinue|0|||
46928705|NCT02750514|83163434|FG001|Track 3|Participant request to discontinue|2|||
46928706|NCT02750514|83163435|FG002|Track 3|Participant request to discontinue|0|||
46928707|NCT02750514|83163436|FG003|Track 3|Participant request to discontinue|0|||
46928708|NCT02750514|83163437|FG004|Track 3|Participant request to discontinue|0|||
46928709|NCT02750514|83163433|FG000|Track 3|Participant withdrew consent|0|||
46636550|NCT01484496|82810389|FG001|Period 1|Adverse Event|40|||
46928710|NCT02750514|83163434|FG001|Track 3|Participant withdrew consent|3|||
46928711|NCT02750514|83163435|FG002|Track 3|Participant withdrew consent|1|||
46928712|NCT02750514|83163436|FG003|Track 3|Participant withdrew consent|0|||
46928713|NCT02750514|83163437|FG004|Track 3|Participant withdrew consent|0|||
46928714|NCT02750514|83163433|FG000|Track 3|Other reasons|0|||
46928715|NCT02750514|83163434|FG001|Track 3|Other reasons|3|||
46928716|NCT02750514|83163435|FG002|Track 3|Other reasons|0|||
46928717|NCT02750514|83163436|FG003|Track 3|Other reasons|0|||
46928718|NCT02750514|83163437|FG004|Track 3|Other reasons|0|||
46928719|NCT02750514|83163433|FG000|Track 4|Study drug toxicity|0|||
46928720|NCT02750514|83163434|FG001|Track 4|Study drug toxicity|6|||
46813891|NCT00606593|83033484|FG007|Overall Study|Administrative/Other|0|||
46813892|NCT00606593|83033485|FG008|Overall Study|Administrative/Other|0|||
46813893|NCT00606593|83033486|FG009|Overall Study|Administrative/Other|0|||
46813894|NCT00605267|83033501|FG000|Overall Study|Adverse Event|0|||
46813895|NCT00605267|83033502|FG001|Overall Study|Adverse Event|1|||
46813896|NCT00605267|83033501|FG000|Overall Study|Lack of Efficacy|1|||
46813897|NCT00605267|83033502|FG001|Overall Study|Lack of Efficacy|5|||
46813898|NCT00605267|83033501|FG000|Overall Study|Withdrawal by Subject|2|||
46813899|NCT00605267|83033502|FG001|Overall Study|Withdrawal by Subject|3|||
46813900|NCT00605813|83033508|FG000|Overall Study|Protocol Violation|25|||
46813901|NCT00604721|83033521|FG000|Overall Study|Physician Decision|1|||
46813902|NCT00604721|83033521|FG000|Overall Study|Withdrawal by Subject|1|||
46813903|NCT00605657|83033526|FG000|Overall Study|Adverse Event|1|||
46813904|NCT00605657|83033526|FG000|Overall Study|Protocol Violation|1|||
46813905|NCT00604565|83033532|FG000|Overall Study|Study terminated|0|||
46813906|NCT00604565|83033533|FG001|Overall Study|Study terminated|3|||
46813907|NCT00605345|83033541|FG000|Overall Study|Withdrawal by Subject|1|||
46813908|NCT00605345|83033542|FG001|Overall Study|Withdrawal by Subject|0|||
46813909|NCT00605345|83033541|FG000|Overall Study|Adverse Event|0|||
46813910|NCT00605345|83033542|FG001|Overall Study|Adverse Event|1|||
46813911|NCT00605345|83033541|FG000|Overall Study|Protocol Violation|0|||
46813912|NCT00605345|83033542|FG001|Overall Study|Protocol Violation|2|||
46813913|NCT00604175|83033551|FG000|Entry Through Week 28|Death|2|||
46813914|NCT00604175|83033552|FG001|Entry Through Week 28|Death|0|||
46813915|NCT00604175|83033553|FG002|Entry Through Week 28|Death|0|||
46813916|NCT00604175|83033551|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
46813917|NCT00604175|83033552|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
46813918|NCT00604175|83033553|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
46813919|NCT00604175|83033551|FG000|Entry Through Week 28|Lost to Follow-up|4|||
46928721|NCT02750514|83163435|FG002|Track 4|Study drug toxicity|0|||
46928722|NCT02750514|83163436|FG003|Track 4|Study drug toxicity|5|||
46928723|NCT02750514|83163437|FG004|Track 4|Study drug toxicity|0|||
46928724|NCT02750514|83163433|FG000|Track 4|Participant request to discontinue|0|||
46928725|NCT02750514|83163434|FG001|Track 4|Participant request to discontinue|1|||
46928726|NCT02750514|83163435|FG002|Track 4|Participant request to discontinue|0|||
46928727|NCT02750514|83163436|FG003|Track 4|Participant request to discontinue|1|||
46928728|NCT02750514|83163437|FG004|Track 4|Participant request to discontinue|0|||
46928729|NCT02750514|83163433|FG000|Track 4|Participant withdrew consent|0|||
46928730|NCT02750514|83163434|FG001|Track 4|Participant withdrew consent|1|||
46928731|NCT02750514|83163435|FG002|Track 4|Participant withdrew consent|0|||
46928732|NCT02750514|83163436|FG003|Track 4|Participant withdrew consent|0|||
46928733|NCT02750514|83163437|FG004|Track 4|Participant withdrew consent|0|||
46928734|NCT02750514|83163433|FG000|Track 4|Other reasons|0|||
46928735|NCT02750514|83163434|FG001|Track 4|Other reasons|5|||
46928736|NCT02750514|83163435|FG002|Track 4|Other reasons|0|||
46928737|NCT02750514|83163436|FG003|Track 4|Other reasons|3|||
46928738|NCT02750514|83163437|FG004|Track 4|Other reasons|0|||
46928739|NCT02750514|83163433|FG000|Track 4|Disease progression|0|||
46928740|NCT02750514|83163434|FG001|Track 4|Disease progression|33|||
46928741|NCT02750514|83163435|FG002|Track 4|Disease progression|0|||
46928742|NCT02750514|83163436|FG003|Track 4|Disease progression|32|||
46928743|NCT02750514|83163437|FG004|Track 4|Disease progression|0|||
46928744|NCT02750514|83163433|FG000|Track 4|Adverse event unrelated to study drug|0|||
46636551|NCT01484496|82810390|FG002|Period 1|Adverse Event|0|||
46928745|NCT02750514|83163434|FG001|Track 4|Adverse event unrelated to study drug|5|||
46928746|NCT02750514|83163435|FG002|Track 4|Adverse event unrelated to study drug|0|||
46928747|NCT02750514|83163436|FG003|Track 4|Adverse event unrelated to study drug|0|||
46928748|NCT02750514|83163437|FG004|Track 4|Adverse event unrelated to study drug|0|||
46928749|NCT02750514|83163433|FG000|Track 4|Death|0|||
46928750|NCT02750514|83163434|FG001|Track 4|Death|0|||
46928751|NCT02750514|83163435|FG002|Track 4|Death|0|||
46928752|NCT02750514|83163436|FG003|Track 4|Death|1|||
46928753|NCT02750514|83163437|FG004|Track 4|Death|0|||
46928754|NCT02750514|83163433|FG000|Track 5|Disease progression|0|||
46928755|NCT02750514|83163434|FG001|Track 5|Disease progression|0|||
46928756|NCT02750514|83163435|FG002|Track 5|Disease progression|0|||
46928757|NCT02750514|83163436|FG003|Track 5|Disease progression|0|||
46928758|NCT02750514|83163437|FG004|Track 5|Disease progression|34|||
46928759|NCT02750514|83163433|FG000|Track 5|Adverse event unrelated to study drug|0|||
46928760|NCT02750514|83163434|FG001|Track 5|Adverse event unrelated to study drug|0|||
46928761|NCT02750514|83163435|FG002|Track 5|Adverse event unrelated to study drug|0|||
46928762|NCT02750514|83163436|FG003|Track 5|Adverse event unrelated to study drug|0|||
46928763|NCT02750514|83163437|FG004|Track 5|Adverse event unrelated to study drug|2|||
46928764|NCT02750514|83163433|FG000|Track 5|Study drug toxicity|0|||
46928765|NCT02750514|83163434|FG001|Track 5|Study drug toxicity|0|||
46928766|NCT02750514|83163435|FG002|Track 5|Study drug toxicity|0|||
46928767|NCT02750514|83163436|FG003|Track 5|Study drug toxicity|0|||
46928768|NCT02750514|83163437|FG004|Track 5|Study drug toxicity|2|||
46928769|NCT02750514|83163433|FG000|Track 5|Participant request to discontinue|0|||
46928770|NCT02750514|83163434|FG001|Track 5|Participant request to discontinue|0|||
46928771|NCT02750514|83163435|FG002|Track 5|Participant request to discontinue|0|||
46928772|NCT02750514|83163436|FG003|Track 5|Participant request to discontinue|0|||
46928773|NCT02750514|83163437|FG004|Track 5|Participant request to discontinue|3|||
46928774|NCT02750514|83163433|FG000|Track 5|Other reasons|0|||
46928775|NCT02750514|83163434|FG001|Track 5|Other reasons|0|||
46928776|NCT02750514|83163435|FG002|Track 5|Other reasons|0|||
46928777|NCT02750514|83163436|FG003|Track 5|Other reasons|0|||
46928778|NCT02750514|83163437|FG004|Track 5|Other reasons|2|||
46928779|NCT03340974|83163461|FG000|Completion of Study -Long Term Follow up|Death|8|||
46928780|NCT03340974|83163462|FG001|Completion of Study -Long Term Follow up|Death|5|||
46928781|NCT03340974|83163463|FG002|Completion of Study -Long Term Follow up|Death|5|||
46928782|NCT03340974|83163464|FG003|Completion of Study -Long Term Follow up|Death|7|||
46928783|NCT03340974|83163461|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
46928784|NCT03340974|83163462|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
46928785|NCT03340974|83163463|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
46928786|NCT03340974|83163464|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
46928787|NCT03340974|83163461|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
46928788|NCT03340974|83163462|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
46928789|NCT03340974|83163463|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
46928790|NCT03340974|83163464|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
46928791|NCT03340974|83163461|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
46928792|NCT03340974|83163462|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
46928793|NCT03340974|83163463|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
46928794|NCT03340974|83163464|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
46928795|NCT02612428|83163480|FG000|VTL-308|Death|14|||
46928796|NCT02612428|83163481|FG001|VTL-308|Death|16|||
46928797|NCT02612428|83163480|FG000|VTL-308|Withdrawal by Subject|0|||
46928798|NCT02612428|83163481|FG001|VTL-308|Withdrawal by Subject|1|||
46928799|NCT02612428|83163480|FG000|VTL-308E|Death|9|||
46928800|NCT02612428|83163481|FG001|VTL-308E|Death|7|||
46928801|NCT02612428|83163480|FG000|VTL-308E|Lost to Follow-up|2|||
47055011|NCT01777139|83328378|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
47055012|NCT01777139|83328377|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
47055013|NCT01777139|83328378|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
47055014|NCT01777139|83328377|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
47055015|NCT01777139|83328378|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
47055016|NCT01777139|83328377|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
47055017|NCT01777139|83328378|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
47055018|NCT01777139|83328377|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
47055019|NCT01777139|83328378|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
47055020|NCT01777139|83328377|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
47055021|NCT01777139|83328378|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
47055022|NCT01777139|83328377|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
47055023|NCT01777139|83328378|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
47055024|NCT01777139|83328377|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
47055025|NCT01777139|83328378|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
47055026|NCT01768637|83328387|FG000|Overall Study|Lost to Follow-up|2|||
47055027|NCT01768637|83328388|FG001|Overall Study|Lost to Follow-up|7|||
47055028|NCT01768637|83328387|FG000|Overall Study|Difficult blood draw|1|||
47055029|NCT01768637|83328388|FG001|Overall Study|Difficult blood draw|0|||
47055030|NCT01768559|83328397|FG000|Overall Study|Randomized but not treated|0|||
47055031|NCT01768559|83328398|FG001|Overall Study|Randomized but not treated|0|||
46928802|NCT02612428|83163481|FG001|VTL-308E|Lost to Follow-up|0|||
46928803|NCT03679884|83163492|FG000|Overall Study|Other|12|||
46928804|NCT03679884|83163493|FG001|Overall Study|Other|12|||
46928805|NCT03679884|83163494|FG002|Overall Study|Other|12|||
46928806|NCT03679884|83163495|FG003|Overall Study|Other|7|||
47055032|NCT01768559|83328399|FG002|Overall Study|Randomized but not treated|1|||
46755958|NCT00866814|82973941|FG000|Overall Study|No longer wished to participate|1|||
46755959|NCT00866814|82973941|FG000|Overall Study|Unable to meet follow-up requirements|2|||
46928807|NCT03679884|83163496|FG004|Overall Study|Other|8|||
46928808|NCT03679884|83163492|FG000|Overall Study|Lack of Efficacy|15|||
46928809|NCT03679884|83163493|FG001|Overall Study|Lack of Efficacy|29|||
46928810|NCT03679884|83163494|FG002|Overall Study|Lack of Efficacy|13|||
46928811|NCT03679884|83163495|FG003|Overall Study|Lack of Efficacy|29|||
46928812|NCT03679884|83163496|FG004|Overall Study|Lack of Efficacy|10|||
46928813|NCT03679884|83163492|FG000|Overall Study|Death|1|||
46928814|NCT03679884|83163493|FG001|Overall Study|Death|0|||
46928815|NCT03679884|83163494|FG002|Overall Study|Death|0|||
46928816|NCT03679884|83163495|FG003|Overall Study|Death|0|||
46928817|NCT03679884|83163496|FG004|Overall Study|Death|0|||
46928818|NCT03679884|83163492|FG000|Overall Study|Adverse Event|2|||
46928819|NCT03679884|83163493|FG001|Overall Study|Adverse Event|10|||
46928820|NCT03679884|83163494|FG002|Overall Study|Adverse Event|9|||
46928821|NCT03679884|83163495|FG003|Overall Study|Adverse Event|6|||
46928822|NCT03679884|83163496|FG004|Overall Study|Adverse Event|6|||
46928823|NCT03679884|83163492|FG000|Overall Study|Withdrawal by Subject|12|||
46928824|NCT03679884|83163493|FG001|Overall Study|Withdrawal by Subject|23|||
46928825|NCT03679884|83163494|FG002|Overall Study|Withdrawal by Subject|8|||
46928826|NCT03679884|83163495|FG003|Overall Study|Withdrawal by Subject|8|||
46928827|NCT03679884|83163496|FG004|Overall Study|Withdrawal by Subject|9|||
46928828|NCT03679884|83163492|FG000|Overall Study|Lost to Follow-up|1|||
46928829|NCT03679884|83163493|FG001|Overall Study|Lost to Follow-up|4|||
46928830|NCT03679884|83163494|FG002|Overall Study|Lost to Follow-up|2|||
46928831|NCT03679884|83163495|FG003|Overall Study|Lost to Follow-up|0|||
46928832|NCT03679884|83163496|FG004|Overall Study|Lost to Follow-up|3|||
46928833|NCT01329978|83163511|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
46928834|NCT01329978|83163512|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
46928835|NCT01329978|83163513|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
46928836|NCT01329978|83163514|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
46928837|NCT01329978|83163515|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
46928838|NCT01329978|83163511|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
46928839|NCT01329978|83163512|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
46928840|NCT01329978|83163513|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
46928841|NCT01329978|83163514|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
46928842|NCT01329978|83163515|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
46928843|NCT01329978|83163511|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
46928844|NCT01329978|83163512|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
46928845|NCT01329978|83163513|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
46928846|NCT01329978|83163514|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
46928847|NCT01329978|83163515|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
46928848|NCT01329978|83163511|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
46928849|NCT01329978|83163512|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
46928850|NCT01329978|83163513|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
46928851|NCT01329978|83163514|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
46928852|NCT01329978|83163515|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
46928853|NCT01329978|83163511|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
46928854|NCT01329978|83163512|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
46928855|NCT01329978|83163513|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
46928856|NCT01329978|83163514|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
46928857|NCT01329978|83163515|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
46928858|NCT01329978|83163511|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
47055033|NCT01768559|83328397|FG000|Overall Study|Adverse Event|15|||
46636552|NCT01484496|82810391|FG003|Period 1|Adverse Event|0|||
46755960|NCT00866814|82973941|FG000|Overall Study|Moved to area without study site|1|||
46755961|NCT00871494|82973945|FG000|Overall Study|Protocol Violation|5|||
46755962|NCT00871494|82973945|FG000|Overall Study|Lack of Efficacy|4|||
46755963|NCT00871494|82973945|FG000|Overall Study|Adverse Event|4|||
46755964|NCT00871494|82973945|FG000|Overall Study|Lost to Follow-up|1|||
46755965|NCT00529789|82973949|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
46755966|NCT00529789|82973949|FG000|Study Period II/III|Adverse Event|3|||
46755967|NCT00529789|82973949|FG000|Study Period II/III|Lack of Efficacy|2|||
46813920|NCT00604175|83033552|FG001|Entry Through Week 28|Lost to Follow-up|3|||
46928859|NCT01329978|83163512|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
46928860|NCT01329978|83163513|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
46928861|NCT01329978|83163514|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
46928862|NCT01329978|83163515|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
46928863|NCT01329978|83163511|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
46755968|NCT00529789|82973949|FG000|Study Period II/III|Withdrawal by Subject|1|||
46755969|NCT00529789|82973949|FG000|Study Period II/III|Protocol Violation|3|||
46755970|NCT00529789|82973949|FG000|Study Period II/III|Physician Decision|3|||
46755971|NCT00529789|82973949|FG000|Study Period II/III|Lost to Follow-up|3|||
46755972|NCT00529789|82973949|FG000|Study Period IV|Parent/Caregiver Decision|1|||
46755973|NCT00529789|82973949|FG000|Study Period IV|Adverse Event|1|||
46755974|NCT00529789|82973949|FG000|Study Period IV|Lack of Efficacy|1|||
46755975|NCT00529789|82973949|FG000|Study Period IV|Lost to Follow-up|3|||
46755976|NCT00577642|82973959|FG000|Overall Study|Clinical Disease Progression|1|||
46755977|NCT00866658|82973965|FG000|Overall Study|Adverse Event|5|||
46755978|NCT00866658|82973966|FG001|Overall Study|Adverse Event|14|||
46755979|NCT00866658|82973965|FG000|Overall Study|Lack of Efficacy|2|||
46755980|NCT00866658|82973966|FG001|Overall Study|Lack of Efficacy|1|||
46755981|NCT00866658|82973965|FG000|Overall Study|Withdrawal by Subject|1|||
46755982|NCT00866658|82973966|FG001|Overall Study|Withdrawal by Subject|0|||
46755983|NCT00866658|82973965|FG000|Overall Study|Protocol Violation|1|||
46755984|NCT00866658|82973966|FG001|Overall Study|Protocol Violation|1|||
46755985|NCT00866658|82973965|FG000|Overall Study|Familial and Personal Reasons|4|||
46813921|NCT00604175|83033553|FG002|Entry Through Week 28|Lost to Follow-up|0|||
46813922|NCT00604175|83033551|FG000|Entry Through Week 28|Ineligible|1|||
46928864|NCT01329978|83163512|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
46928865|NCT01329978|83163513|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
46928866|NCT01329978|83163514|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
46928867|NCT01329978|83163515|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
46928868|NCT01338012|83163527|FG000|Overall Study|Death|4|||
46928869|NCT01338012|83163527|FG000|Overall Study|Study terminated|4|||
46928870|NCT04905498|83163533|FG000|Overall Study|Lost to Follow-up|0|||
46928871|NCT04905498|83163534|FG001|Overall Study|Lost to Follow-up|2|||
46928872|NCT04905498|83163533|FG000|Overall Study|COVID lockdown|1|||
46928873|NCT04905498|83163534|FG001|Overall Study|COVID lockdown|0|||
46928874|NCT02607280|83163542|FG000|Overall Study|Adverse Event|4|||
46928875|NCT02607280|83163543|FG001|Overall Study|Adverse Event|0|||
46928876|NCT02607280|83163542|FG000|Overall Study|Decrease in CrCl <15|0|||
46928877|NCT02607280|83163543|FG001|Overall Study|Decrease in CrCl <15|1|||
46928878|NCT02202434|83163553|FG000|Overall Study|Death|70|||
46928879|NCT02202434|83163554|FG001|Overall Study|Death|39|||
46928880|NCT02202434|83163555|FG002|Overall Study|Death|13|||
46928881|NCT02202434|83163556|FG003|Overall Study|Death|27|||
46928882|NCT02202434|83163553|FG000|Overall Study|Lost to Follow-up|1|||
46928883|NCT02202434|83163554|FG001|Overall Study|Lost to Follow-up|1|||
46928884|NCT02202434|83163555|FG002|Overall Study|Lost to Follow-up|1|||
46928885|NCT02202434|83163556|FG003|Overall Study|Lost to Follow-up|0|||
46928886|NCT02202434|83163553|FG000|Overall Study|Physician Decision|2|||
46928887|NCT02202434|83163554|FG001|Overall Study|Physician Decision|3|||
46928888|NCT02202434|83163555|FG002|Overall Study|Physician Decision|0|||
46928889|NCT02202434|83163556|FG003|Overall Study|Physician Decision|0|||
46928890|NCT02202434|83163553|FG000|Overall Study|Withdrawal by Subject|13|||
46928891|NCT02202434|83163554|FG001|Overall Study|Withdrawal by Subject|14|||
46928892|NCT02202434|83163555|FG002|Overall Study|Withdrawal by Subject|1|||
46928893|NCT02202434|83163556|FG003|Overall Study|Withdrawal by Subject|4|||
46928894|NCT02202434|83163553|FG000|Overall Study|Completed Study|1|||
46928895|NCT02202434|83163554|FG001|Overall Study|Completed Study|0|||
46928896|NCT02202434|83163555|FG002|Overall Study|Completed Study|0|||
46928897|NCT02202434|83163556|FG003|Overall Study|Completed Study|0|||
46928898|NCT02202434|83163553|FG000|Overall Study|Visit Missed|21|||
46928899|NCT02202434|83163554|FG001|Overall Study|Visit Missed|12|||
46928900|NCT02202434|83163555|FG002|Overall Study|Visit Missed|0|||
46928901|NCT02202434|83163556|FG003|Overall Study|Visit Missed|5|||
46928902|NCT02202434|83163553|FG000|Overall Study|Other|1|||
46928903|NCT02202434|83163554|FG001|Overall Study|Other|0|||
46928904|NCT02202434|83163555|FG002|Overall Study|Other|0|||
46928905|NCT02202434|83163556|FG003|Overall Study|Other|1|||
46928906|NCT02784288|83163566|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
46755986|NCT00866658|82973966|FG001|Overall Study|Familial and Personal Reasons|5|||
46755987|NCT00597584|82973974|FG000|Overall Study|Adverse Event|4|||
46928907|NCT01230242|83163571|FG000|Overall Study|Physician Decision|2|||
46928908|NCT01230242|83163571|FG000|Overall Study|Withdrawal by Subject|1|||
46928909|NCT02608450|83163577|FG000|Overall Study|Lost to Follow-up|39|||
46928910|NCT02608450|83163578|FG001|Overall Study|Lost to Follow-up|32|||
46928911|NCT02608450|83163577|FG000|Overall Study|Withdrawal by Subject|21|||
46928912|NCT02608450|83163578|FG001|Overall Study|Withdrawal by Subject|15|||
46928913|NCT02608450|83163577|FG000|Overall Study|Adverse Event|3|||
46928914|NCT02608450|83163578|FG001|Overall Study|Adverse Event|6|||
46928915|NCT02608450|83163577|FG000|Overall Study|Withdrawal by parent|2|||
46755988|NCT00597584|82973975|FG001|Overall Study|Adverse Event|2|||
46755989|NCT00597584|82973974|FG000|Overall Study|Death|53|||
46813923|NCT00604175|83033552|FG001|Entry Through Week 28|Ineligible|0|||
46813924|NCT00604175|83033553|FG002|Entry Through Week 28|Ineligible|0|||
46928916|NCT02608450|83163578|FG001|Overall Study|Withdrawal by parent|3|||
46755990|NCT00597584|82973975|FG001|Overall Study|Death|30|||
46755991|NCT00597584|82973974|FG000|Overall Study|Lack of Efficacy|1|||
46928917|NCT02608450|83163577|FG000|Overall Study|Lack of Efficacy|0|||
46928918|NCT02608450|83163578|FG001|Overall Study|Lack of Efficacy|3|||
46928919|NCT02608450|83163577|FG000|Overall Study|Noncompliance with study drug|0|||
46928920|NCT02608450|83163578|FG001|Overall Study|Noncompliance with study drug|2|||
46928921|NCT02608450|83163577|FG000|Overall Study|Physician Decision|0|||
46928922|NCT02608450|83163578|FG001|Overall Study|Physician Decision|1|||
46928923|NCT02608450|83163577|FG000|Overall Study|Pregnancy|0|||
46928924|NCT02608450|83163578|FG001|Overall Study|Pregnancy|1|||
46928925|NCT02608450|83163577|FG000|Overall Study|Progressive disease|1|||
46928926|NCT02608450|83163578|FG001|Overall Study|Progressive disease|0|||
46928927|NCT02608450|83163577|FG000|Overall Study|Multiple reasons|0|||
46928928|NCT02608450|83163578|FG001|Overall Study|Multiple reasons|2|||
46928929|NCT04918784|83163586|FG000|Overall Study|Amputation - no longer eligible|1|||
46928930|NCT04918784|83163587|FG001|Overall Study|Amputation - no longer eligible|2|||
46928931|NCT04918784|83163586|FG000|Overall Study|Death|1|||
46928932|NCT04918784|83163587|FG001|Overall Study|Death|0|||
46928933|NCT04918784|83163586|FG000|Overall Study|patient non-compliance|3|||
46928934|NCT04918784|83163587|FG001|Overall Study|patient non-compliance|1|||
46928935|NCT04918784|83163586|FG000|Overall Study|Adverse Event|1|||
46928936|NCT04918784|83163587|FG001|Overall Study|Adverse Event|0|||
46928937|NCT04786444|83163620|FG000|Overall Study|Withdrawal by Subject|4|||
46928938|NCT04786444|83163621|FG001|Overall Study|Withdrawal by Subject|7|||
46928939|NCT04786444|83163622|FG002|Overall Study|Withdrawal by Subject|2|||
46928940|NCT04786444|83163620|FG000|Overall Study|Lost to Follow-up|11|||
46928941|NCT04786444|83163621|FG001|Overall Study|Lost to Follow-up|9|||
46928942|NCT04786444|83163622|FG002|Overall Study|Lost to Follow-up|10|||
46928943|NCT04786444|83163620|FG000|Overall Study|Subject would like to become pregnant|0|||
46928944|NCT04786444|83163621|FG001|Overall Study|Subject would like to become pregnant|1|||
46928945|NCT04786444|83163622|FG002|Overall Study|Subject would like to become pregnant|0|||
46928946|NCT04692155|83163639|FG000|Overall Study|Death|1|||
46928947|NCT04499963|83163645|FG000|Overall Study|Adverse Event|3|||
46928948|NCT04499963|83163646|FG001|Overall Study|Adverse Event|0|||
46928949|NCT04499963|83163645|FG000|Overall Study|Death|3|||
46928950|NCT04499963|83163646|FG001|Overall Study|Death|0|||
46928951|NCT04499963|83163645|FG000|Overall Study|Lack of Efficacy|7|||
46928952|NCT04499963|83163646|FG001|Overall Study|Lack of Efficacy|0|||
46928953|NCT04499963|83163645|FG000|Overall Study|Lost to Follow-up|2|||
46928954|NCT04499963|83163646|FG001|Overall Study|Lost to Follow-up|0|||
46928955|NCT04330482|83163663|FG000|Overall Study|Lost to Follow-up|2|||
46928956|NCT04330482|83163664|FG001|Overall Study|Lost to Follow-up|1|||
46928957|NCT04330482|83163663|FG000|Overall Study|Withdrawal by Subject|0|||
46928958|NCT04330482|83163664|FG001|Overall Study|Withdrawal by Subject|3|||
46928959|NCT04325503|83163670|FG000|Overall Study|Withdrawal by Subject|1|||
46928960|NCT04325503|83163670|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
46928961|NCT04109222|83163681|FG000|Overall Study|Adverse Event|1|||
46928962|NCT04109222|83163682|FG001|Overall Study|Adverse Event|0|||
46928963|NCT04109222|83163683|FG002|Overall Study|Adverse Event|0|||
46928964|NCT03573297|83163722|FG000|Open Label Treatment Period|Adverse Event|67|||
46928965|NCT03573297|83163723|FG001|Open Label Treatment Period|Adverse Event|0|||
46928966|NCT03573297|83163724|FG002|Open Label Treatment Period|Adverse Event|0|||
46928967|NCT03573297|83163725|FG003|Open Label Treatment Period|Adverse Event|0|||
46928968|NCT03573297|83163722|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
46928969|NCT03573297|83163723|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
46928970|NCT03573297|83163724|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
46928971|NCT03573297|83163725|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
46928972|NCT03573297|83163722|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
46928973|NCT03573297|83163723|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
46928974|NCT03573297|83163724|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
46928975|NCT03573297|83163725|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
46928976|NCT03573297|83163722|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
46928977|NCT03573297|83163723|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
46928978|NCT03573297|83163724|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
46928979|NCT03573297|83163725|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
47055034|NCT01768559|83328398|FG001|Overall Study|Adverse Event|2|||
46813925|NCT00604175|83033551|FG000|Entry Through Week 28|Did not start intervention|2|||
46813926|NCT00604175|83033552|FG001|Entry Through Week 28|Did not start intervention|0|||
46928980|NCT03573297|83163722|FG000|Open Label Treatment Period|Pregnancy|1|||
46928981|NCT03573297|83163723|FG001|Open Label Treatment Period|Pregnancy|0|||
46928982|NCT03573297|83163724|FG002|Open Label Treatment Period|Pregnancy|0|||
46928983|NCT03573297|83163725|FG003|Open Label Treatment Period|Pregnancy|0|||
46928984|NCT03573297|83163722|FG000|Open Label Treatment Period|Protocol Violation|17|||
46928985|NCT03573297|83163723|FG001|Open Label Treatment Period|Protocol Violation|0|||
46928986|NCT03573297|83163724|FG002|Open Label Treatment Period|Protocol Violation|0|||
46928987|NCT03573297|83163725|FG003|Open Label Treatment Period|Protocol Violation|0|||
46928988|NCT03573297|83163722|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
46928989|NCT03573297|83163723|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
46928990|NCT03573297|83163724|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
46928991|NCT03573297|83163725|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
46928992|NCT03573297|83163722|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
46928993|NCT03573297|83163723|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
46928994|NCT03573297|83163724|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
46928995|NCT03573297|83163725|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
46928996|NCT03573297|83163722|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
46928997|NCT03573297|83163723|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
46928998|NCT03573297|83163724|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
46928999|NCT03573297|83163725|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
46929000|NCT03573297|83163722|FG000|Open Label Treatment Period|Other, Not Specified|7|||
46929001|NCT03573297|83163723|FG001|Open Label Treatment Period|Other, Not Specified|0|||
46929002|NCT03573297|83163724|FG002|Open Label Treatment Period|Other, Not Specified|0|||
46929003|NCT03573297|83163725|FG003|Open Label Treatment Period|Other, Not Specified|0|||
46929004|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
46929005|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
46929006|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
46929007|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
46929008|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46929009|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Adverse Event|1|||
46929010|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Adverse Event|5|||
46929011|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Adverse Event|1|||
46929012|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
46929013|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
46929014|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
46929015|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
46929016|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46929017|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
46929018|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
46929019|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
46929020|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46929021|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
46929022|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
46929023|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
46929024|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
46929025|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
46929026|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
46929027|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
46929028|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
46929029|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
46929030|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
46929031|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
46929032|NCT03573297|83163722|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
46929033|NCT03573297|83163723|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
46929034|NCT03573297|83163724|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
46929035|NCT03573297|83163725|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
46929036|NCT03536884|83163736|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
46929037|NCT03536884|83163737|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
46929038|NCT03536884|83163738|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
47055035|NCT01768559|83328399|FG002|Overall Study|Adverse Event|5|||
47055036|NCT01768559|83328397|FG000|Overall Study|Lack of Efficacy|6|||
47055037|NCT01768559|83328398|FG001|Overall Study|Lack of Efficacy|4|||
47055038|NCT01768559|83328399|FG002|Overall Study|Lack of Efficacy|0|||
46813927|NCT00604175|83033553|FG002|Entry Through Week 28|Did not start intervention|1|||
46813928|NCT00604175|83033551|FG000|Week 29 Through Week 72|Death|0|||
46813929|NCT00604175|83033552|FG001|Week 29 Through Week 72|Death|0|||
46813930|NCT00604175|83033553|FG002|Week 29 Through Week 72|Death|1|||
46813931|NCT00604175|83033551|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
46813932|NCT00604175|83033552|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
46813933|NCT00604175|83033553|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
46929039|NCT03536884|83163739|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
46929040|NCT03536884|83163740|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
47055039|NCT01768559|83328397|FG000|Overall Study|Poor compliance to protocol|0|||
47055040|NCT01768559|83328398|FG001|Overall Study|Poor compliance to protocol|3|||
46813934|NCT00604175|83033551|FG000|Week 29 Through Week 72|Site closure|0|||
46813935|NCT00604175|83033552|FG001|Week 29 Through Week 72|Site closure|1|||
46929041|NCT03536884|83163736|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
46929042|NCT03536884|83163737|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
46929043|NCT03536884|83163738|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
46929044|NCT03536884|83163739|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
46929045|NCT03536884|83163740|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
46929046|NCT03536884|83163736|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
46929047|NCT03536884|83163737|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
46929048|NCT03536884|83163738|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
46929049|NCT03536884|83163739|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
46929050|NCT03536884|83163740|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
46929051|NCT03536884|83163736|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
46929052|NCT03536884|83163737|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
46929053|NCT03536884|83163738|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
46929054|NCT03536884|83163739|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
46929055|NCT03536884|83163740|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
46929056|NCT03536884|83163736|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
46929057|NCT03536884|83163737|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
46929058|NCT03536884|83163738|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
46929059|NCT03536884|83163739|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
46929060|NCT03536884|83163740|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
46929061|NCT03536884|83163736|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
46929062|NCT03536884|83163737|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
46929063|NCT03536884|83163738|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
46929064|NCT03536884|83163739|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
46929065|NCT03536884|83163740|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
46929066|NCT03536884|83163736|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
46929067|NCT03536884|83163737|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
46929068|NCT03536884|83163738|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
46929069|NCT03536884|83163739|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
46929070|NCT03536884|83163740|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
46929071|NCT03536884|83163736|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
46929072|NCT03536884|83163737|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
46929073|NCT03536884|83163738|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
46929074|NCT03536884|83163739|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
46929075|NCT03536884|83163740|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
46929076|NCT03536884|83163736|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
46929077|NCT03536884|83163737|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
46929078|NCT03536884|83163738|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
46929079|NCT03536884|83163739|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
46929080|NCT03536884|83163740|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
46929081|NCT03536884|83163736|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
46929082|NCT03536884|83163737|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
46929083|NCT03536884|83163738|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
46929084|NCT03536884|83163739|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
46929085|NCT03536884|83163740|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
46929086|NCT03536884|83163736|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
46929087|NCT03536884|83163737|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
46929088|NCT03536884|83163738|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
46636553|NCT01484496|82810388|FG000|Period 1|Withdrawal by Subject|15|||
46636554|NCT01484496|82810389|FG001|Period 1|Withdrawal by Subject|12|||
46636555|NCT01484496|82810390|FG002|Period 1|Withdrawal by Subject|0|||
46636556|NCT01484496|82810391|FG003|Period 1|Withdrawal by Subject|0|||
46636557|NCT01484496|82810388|FG000|Period 1|Lost to Follow-up|2|||
46636558|NCT01484496|82810389|FG001|Period 1|Lost to Follow-up|6|||
46929089|NCT03536884|83163739|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
46929090|NCT03536884|83163740|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
46929091|NCT03536884|83163736|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
46929092|NCT03536884|83163737|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
46929093|NCT03536884|83163738|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
46929094|NCT03536884|83163739|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
46967670|NCT02157376|83210226|FG000|Overall Study|Investigator's misjudgement|1|||
46636559|NCT01484496|82810390|FG002|Period 1|Lost to Follow-up|0|||
46755992|NCT00597584|82973975|FG001|Overall Study|Lack of Efficacy|0|||
46636560|NCT01484496|82810391|FG003|Period 1|Lost to Follow-up|0|||
47055041|NCT01768559|83328399|FG002|Overall Study|Poor compliance to protocol|2|||
47055042|NCT01768559|83328397|FG000|Overall Study|Other than specified|9|||
47055043|NCT01768559|83328398|FG001|Overall Study|Other than specified|8|||
47055044|NCT01768559|83328399|FG002|Overall Study|Other than specified|5|||
47055045|NCT00983619|83328423|FG000|Overall Study|Lost to Follow-up|0|||
47055046|NCT00983619|83328424|FG001|Overall Study|Lost to Follow-up|1|||
47055047|NCT00983619|83328425|FG002|Overall Study|Lost to Follow-up|0|||
46929095|NCT03536884|83163740|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
46929096|NCT03225287|83163776|FG000|Overall Study|Adverse Event|0|||
46929097|NCT03225287|83163777|FG001|Overall Study|Adverse Event|0|||
46636561|NCT01484496|82810388|FG000|Period 1|Positive Pregnancy|1|||
46929098|NCT03225287|83163778|FG002|Overall Study|Adverse Event|1|||
46929099|NCT03225287|83163776|FG000|Overall Study|Protocol non-compliance|0|||
46636562|NCT01484496|82810389|FG001|Period 1|Positive Pregnancy|6|||
46813936|NCT00604175|83033553|FG002|Week 29 Through Week 72|Site closure|0|||
46813937|NCT00604175|83033551|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
47055048|NCT00983619|83328426|FG003|Overall Study|Lost to Follow-up|0|||
47055049|NCT00983619|83328427|FG004|Overall Study|Lost to Follow-up|0|||
46929100|NCT03225287|83163777|FG001|Overall Study|Protocol non-compliance|0|||
46929101|NCT03225287|83163778|FG002|Overall Study|Protocol non-compliance|1|||
46929102|NCT03225287|83163776|FG000|Overall Study|Subject withdraws consent|3|||
46929103|NCT03225287|83163777|FG001|Overall Study|Subject withdraws consent|0|||
46929104|NCT03225287|83163778|FG002|Overall Study|Subject withdraws consent|0|||
46929105|NCT03225287|83163776|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
46929106|NCT03225287|83163777|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
46929107|NCT03225287|83163778|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
46929108|NCT03225287|83163776|FG000|Overall Study|Trial drug not effective|0|||
46929109|NCT03225287|83163777|FG001|Overall Study|Trial drug not effective|1|||
46929110|NCT03225287|83163778|FG002|Overall Study|Trial drug not effective|0|||
46929111|NCT03225287|83163776|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
46929112|NCT03225287|83163777|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
46929113|NCT03225287|83163778|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
46929114|NCT03225287|83163776|FG000|Overall Study|Stem cell transplantation|0|||
46929115|NCT03225287|83163777|FG001|Overall Study|Stem cell transplantation|1|||
46929116|NCT03225287|83163778|FG002|Overall Study|Stem cell transplantation|0|||
46929117|NCT03140670|83163786|FG000|Overall Study|Withdrawal by Subject|2|||
46929118|NCT03140670|83163786|FG000|Overall Study|Lost to Follow-up|1|||
46929119|NCT03140670|83163786|FG000|Overall Study|Physician Decision|1|||
46929120|NCT02682927|83163796|FG000|Overall Study|Adverse Event|0|||
46929121|NCT02682927|83163797|FG001|Overall Study|Adverse Event|0|||
46929122|NCT02682927|83163798|FG002|Overall Study|Adverse Event|5|||
46929123|NCT02682927|83163799|FG003|Overall Study|Adverse Event|1|||
46929124|NCT02682927|83163800|FG004|Overall Study|Adverse Event|0|||
46929125|NCT02682927|83163801|FG005|Overall Study|Adverse Event|2|||
46929126|NCT02682927|83163796|FG000|Overall Study|Death|0|||
46929127|NCT02682927|83163797|FG001|Overall Study|Death|0|||
46929128|NCT02682927|83163798|FG002|Overall Study|Death|0|||
46929129|NCT02682927|83163799|FG003|Overall Study|Death|1|||
46929130|NCT02682927|83163800|FG004|Overall Study|Death|0|||
47055050|NCT00983619|83328428|FG005|Overall Study|Lost to Follow-up|2|||
46929131|NCT02682927|83163801|FG005|Overall Study|Death|0|||
46929132|NCT02682927|83163796|FG000|Overall Study|Lack of Efficacy|1|||
46929133|NCT02682927|83163797|FG001|Overall Study|Lack of Efficacy|0|||
46929134|NCT02682927|83163798|FG002|Overall Study|Lack of Efficacy|0|||
46929135|NCT02682927|83163799|FG003|Overall Study|Lack of Efficacy|1|||
46929136|NCT02682927|83163800|FG004|Overall Study|Lack of Efficacy|0|||
46929137|NCT02682927|83163801|FG005|Overall Study|Lack of Efficacy|0|||
46929138|NCT02682927|83163796|FG000|Overall Study|Other|0|||
46929139|NCT02682927|83163797|FG001|Overall Study|Other|0|||
46929140|NCT02682927|83163798|FG002|Overall Study|Other|0|||
47055051|NCT00983619|83328429|FG006|Overall Study|Lost to Follow-up|0|||
47055052|NCT00983619|83328430|FG007|Overall Study|Lost to Follow-up|0|||
46929141|NCT02682927|83163799|FG003|Overall Study|Other|2|||
46929142|NCT02682927|83163800|FG004|Overall Study|Other|0|||
46929143|NCT02682927|83163801|FG005|Overall Study|Other|0|||
46929144|NCT02682927|83163796|FG000|Overall Study|Withdrawal by Subject|2|||
46929145|NCT02682927|83163797|FG001|Overall Study|Withdrawal by Subject|0|||
46929146|NCT02682927|83163798|FG002|Overall Study|Withdrawal by Subject|1|||
46929147|NCT02682927|83163799|FG003|Overall Study|Withdrawal by Subject|0|||
46929148|NCT02682927|83163800|FG004|Overall Study|Withdrawal by Subject|1|||
46929149|NCT02682927|83163801|FG005|Overall Study|Withdrawal by Subject|1|||
47055053|NCT00983619|83328431|FG008|Overall Study|Lost to Follow-up|0|||
47055054|NCT00983619|83328432|FG009|Overall Study|Lost to Follow-up|0|||
47055055|NCT00983619|83328433|FG010|Overall Study|Lost to Follow-up|0|||
46636563|NCT01484496|82810390|FG002|Period 1|Positive Pregnancy|0|||
46929150|NCT02566850|83163856|FG000|Overall Study|Protocol Violation|1|||
46929151|NCT02408120|83163875|FG000|Overall Study|Withdrawal by Subject|0|||
46929152|NCT02408120|83163876|FG001|Overall Study|Withdrawal by Subject|1|||
46929153|NCT02408120|83163875|FG000|Overall Study|Treatment Refusal|1|||
46929154|NCT02408120|83163876|FG001|Overall Study|Treatment Refusal|0|||
46929155|NCT02408120|83163875|FG000|Overall Study|Received Steroids|1|||
46929156|NCT02408120|83163876|FG001|Overall Study|Received Steroids|1|||
46929157|NCT02408120|83163875|FG000|Overall Study|Discharged same day|1|||
46929158|NCT02408120|83163876|FG001|Overall Study|Discharged same day|1|||
46929159|NCT02408120|83163875|FG000|Overall Study|Did not receive insulin|1|||
46929160|NCT02408120|83163876|FG001|Overall Study|Did not receive insulin|2|||
46929161|NCT02391545|83163884|FG000|Overall Study|Death|0|||
46929162|NCT02391545|83163885|FG001|Overall Study|Death|2|||
46929163|NCT02391545|83163884|FG000|Overall Study|Lost to Follow-up|0|||
46929164|NCT02391545|83163885|FG001|Overall Study|Lost to Follow-up|1|||
46929165|NCT02391545|83163884|FG000|Overall Study|Termination of study by sponsor|20|||
46929166|NCT02391545|83163885|FG001|Overall Study|Termination of study by sponsor|20|||
46929167|NCT02391545|83163884|FG000|Overall Study|Withdrawal by Subject|0|||
46929168|NCT02391545|83163885|FG001|Overall Study|Withdrawal by Subject|1|||
46929169|NCT02391545|83163884|FG000|Overall Study|Other Reasons|6|||
46929170|NCT02391545|83163885|FG001|Overall Study|Other Reasons|4|||
46929171|NCT01920932|83163892|FG000|Overall Study|Death|1|||
46929172|NCT01920932|83163892|FG000|Overall Study|Withdrawal of consent|1|||
46929173|NCT01774253|83163913|FG000|Overall Study|Lack of Efficacy|4|||
46929174|NCT01774253|83163913|FG000|Overall Study|Physician Decision|2|||
46929175|NCT01774253|83163913|FG000|Overall Study|Withdrawal by Subject|2|||
46929176|NCT01774253|83163913|FG000|Overall Study|Death|1|||
46929177|NCT01505608|83163919|FG000|Phase I|Lack of Efficacy|0|||
46929178|NCT01505608|83163920|FG001|Phase I|Lack of Efficacy|4|||
46929179|NCT01505608|83163919|FG000|Phase I|Adverse Event|0|||
46929180|NCT01505608|83163920|FG001|Phase I|Adverse Event|1|||
46929181|NCT01505608|83163919|FG000|Phase I|Withdrawal by Subject|0|||
46929182|NCT01505608|83163920|FG001|Phase I|Withdrawal by Subject|1|||
46929183|NCT01505608|83163919|FG000|Phase II|Lack of Efficacy|2|||
46929184|NCT01505608|83163920|FG001|Phase II|Lack of Efficacy|1|||
46929185|NCT01505608|83163919|FG000|Phase II|Protocol Violation|0|||
46929186|NCT01505608|83163920|FG001|Phase II|Protocol Violation|1|||
46929187|NCT01483820|83163954|FG000|Overall Study|Lack of Efficacy|6|||
46929188|NCT01483820|83163954|FG000|Overall Study|Adverse Event|1|||
46929189|NCT01483820|83163954|FG000|Overall Study|Death|1|||
46929190|NCT01106898|83163969|FG000|Overall Study|Adverse Event|6|||
46929191|NCT01059071|83163973|FG000|Overall Study|Lack of Efficacy|1|||
46929192|NCT01059071|83163974|FG001|Overall Study|Lack of Efficacy|4|||
46929193|NCT01059071|83163975|FG002|Overall Study|Lack of Efficacy|2|||
46929194|NCT01059071|83163976|FG003|Overall Study|Lack of Efficacy|3|||
46929195|NCT01059071|83163973|FG000|Overall Study|Withdrawal by Subject|1|||
46929196|NCT01059071|83163974|FG001|Overall Study|Withdrawal by Subject|0|||
46929197|NCT01059071|83163975|FG002|Overall Study|Withdrawal by Subject|0|||
46929198|NCT01059071|83163976|FG003|Overall Study|Withdrawal by Subject|2|||
46929199|NCT01059071|83163973|FG000|Overall Study|Physician Decision|0|||
46929200|NCT01059071|83163974|FG001|Overall Study|Physician Decision|0|||
46929201|NCT01059071|83163975|FG002|Overall Study|Physician Decision|0|||
46929202|NCT01059071|83163976|FG003|Overall Study|Physician Decision|1|||
46929203|NCT00923702|83163989|FG000|Overall Study|Ongoing enrollment|0|||
46929204|NCT00923702|83163990|FG001|Overall Study|Ongoing enrollment|0|||
46929205|NCT00923702|83163991|FG002|Overall Study|Ongoing enrollment|0|||
46929206|NCT00923702|83163992|FG003|Overall Study|Ongoing enrollment|0|||
46929207|NCT00923702|83163993|FG004|Overall Study|Ongoing enrollment|354|||
46929208|NCT00867568|83164005|FG000|Overall Study|Lack of Efficacy|10|||
46929209|NCT00867568|83164005|FG000|Overall Study|Adverse Event|4|||
46929210|NCT00867568|83164005|FG000|Overall Study|Withdrawal by Subject|1|||
46929211|NCT00737698|83164012|FG000|Overall Study|Withdrawal by Subject|6|||
46929212|NCT00737698|83164013|FG001|Overall Study|Withdrawal by Subject|5|||
46929213|NCT00737698|83164014|FG002|Overall Study|Withdrawal by Subject|3|||
46929214|NCT00737698|83164012|FG000|Overall Study|Death|0|||
46929215|NCT00737698|83164013|FG001|Overall Study|Death|0|||
46929216|NCT00737698|83164014|FG002|Overall Study|Death|1|||
46929217|NCT01668004|83164049|FG000|Overall Study|Adverse Event|7|||
46929218|NCT01668004|83164049|FG000|Overall Study|Withdrawal by Subject|2|||
46929219|NCT01668004|83164049|FG000|Overall Study|Lost to Follow-up|5|||
46929220|NCT01668004|83164049|FG000|Overall Study|Lack of Efficacy|9|||
46929221|NCT01668004|83164049|FG000|Overall Study|Non-compliance with treatment|2|||
46929222|NCT01667926|83164057|FG000|Overall Study|Withdrawal by Subject|1|||
46929223|NCT01667926|83164058|FG001|Overall Study|Withdrawal by Subject|2|||
46929224|NCT01667926|83164059|FG002|Overall Study|Withdrawal by Subject|2|||
46929225|NCT01667926|83164057|FG000|Overall Study|Physician Decision|0|||
46929226|NCT01667926|83164058|FG001|Overall Study|Physician Decision|0|||
46929227|NCT01667926|83164059|FG002|Overall Study|Physician Decision|1|||
46929228|NCT01667926|83164057|FG000|Overall Study|Time committment|0|||
46929229|NCT01667926|83164058|FG001|Overall Study|Time committment|0|||
46929230|NCT01667926|83164059|FG002|Overall Study|Time committment|2|||
46929231|NCT01667926|83164057|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
46929232|NCT01667926|83164058|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
47055056|NCT00983619|83328434|FG011|Overall Study|Lost to Follow-up|2|||
47055057|NCT00983619|83328423|FG000|Overall Study|Withdrawal by Subject|2|||
47055058|NCT00983619|83328424|FG001|Overall Study|Withdrawal by Subject|1|||
47055059|NCT00983619|83328425|FG002|Overall Study|Withdrawal by Subject|1|||
47055060|NCT00983619|83328426|FG003|Overall Study|Withdrawal by Subject|3|||
47055061|NCT00983619|83328427|FG004|Overall Study|Withdrawal by Subject|1|||
47055062|NCT00983619|83328428|FG005|Overall Study|Withdrawal by Subject|23|||
47055063|NCT00983619|83328429|FG006|Overall Study|Withdrawal by Subject|0|||
47055064|NCT00983619|83328430|FG007|Overall Study|Withdrawal by Subject|0|||
47055065|NCT00983619|83328431|FG008|Overall Study|Withdrawal by Subject|0|||
46813938|NCT00604175|83033552|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
46813939|NCT00604175|83033553|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
46813940|NCT00605189|83033588|FG000|Overall Study|Adverse Event|1|||
46813941|NCT00605189|83033589|FG001|Overall Study|Adverse Event|0|||
46813942|NCT00605189|83033590|FG002|Overall Study|Adverse Event|0|||
46813943|NCT00605189|83033588|FG000|Overall Study|Other|2|||
46813944|NCT00605189|83033589|FG001|Overall Study|Other|2|||
46813945|NCT00605189|83033590|FG002|Overall Study|Other|0|||
46813946|NCT00340834|83033603|FG000|Core Phase of Study|Adverse Event|26|||
46813947|NCT00340834|83033604|FG001|Core Phase of Study|Adverse Event|9|||
46813948|NCT00340834|83033605|FG002|Core Phase of Study|Adverse Event|9|||
46813949|NCT00340834|83033606|FG003|Core Phase of Study|Adverse Event|0|||
46813950|NCT00340834|83033607|FG004|Core Phase of Study|Adverse Event|0|||
46813951|NCT00340834|83033603|FG000|Core Phase of Study|Withdrawal by Subject|11|||
46813952|NCT00340834|83033604|FG001|Core Phase of Study|Withdrawal by Subject|9|||
46813953|NCT00340834|83033605|FG002|Core Phase of Study|Withdrawal by Subject|16|||
46813954|NCT00340834|83033606|FG003|Core Phase of Study|Withdrawal by Subject|0|||
46813955|NCT00340834|83033607|FG004|Core Phase of Study|Withdrawal by Subject|0|||
46813956|NCT00340834|83033603|FG000|Core Phase of Study|Administrative Problems|6|||
46813957|NCT00340834|83033604|FG001|Core Phase of Study|Administrative Problems|2|||
46813958|NCT00340834|83033605|FG002|Core Phase of Study|Administrative Problems|7|||
46813959|NCT00340834|83033606|FG003|Core Phase of Study|Administrative Problems|0|||
46813960|NCT00340834|83033607|FG004|Core Phase of Study|Administrative Problems|0|||
46813961|NCT00340834|83033603|FG000|Core Phase of Study|Lack of Efficacy|3|||
46813962|NCT00340834|83033604|FG001|Core Phase of Study|Lack of Efficacy|3|||
46813963|NCT00340834|83033605|FG002|Core Phase of Study|Lack of Efficacy|7|||
46813964|NCT00340834|83033606|FG003|Core Phase of Study|Lack of Efficacy|0|||
46813965|NCT00340834|83033607|FG004|Core Phase of Study|Lack of Efficacy|0|||
46813966|NCT00340834|83033603|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
46813967|NCT00340834|83033604|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
46813968|NCT00340834|83033605|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
46813969|NCT00340834|83033606|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
46813970|NCT00340834|83033607|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
46813971|NCT00340834|83033603|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
46813972|NCT00340834|83033604|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
46813973|NCT00340834|83033605|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
46813974|NCT00340834|83033606|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
46813975|NCT00340834|83033607|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
46813976|NCT00340834|83033603|FG000|Core Phase of Study|Lost to Follow-up|1|||
46813977|NCT00340834|83033604|FG001|Core Phase of Study|Lost to Follow-up|1|||
46813978|NCT00340834|83033605|FG002|Core Phase of Study|Lost to Follow-up|4|||
46813979|NCT00340834|83033606|FG003|Core Phase of Study|Lost to Follow-up|0|||
46813980|NCT00340834|83033607|FG004|Core Phase of Study|Lost to Follow-up|0|||
46755993|NCT00597584|82973974|FG000|Overall Study|Lost to Follow-up|2|||
46755994|NCT00597584|82973975|FG001|Overall Study|Lost to Follow-up|4|||
46755995|NCT00597584|82973974|FG000|Overall Study|Physician Decision|3|||
46755996|NCT00597584|82973975|FG001|Overall Study|Physician Decision|0|||
46755997|NCT00597584|82973974|FG000|Overall Study|Pregnancy|2|||
46755998|NCT00597584|82973975|FG001|Overall Study|Pregnancy|0|||
46755999|NCT00597584|82973974|FG000|Overall Study|Withdrawal by Subject|44|||
46756000|NCT00597584|82973975|FG001|Overall Study|Withdrawal by Subject|12|||
46756001|NCT00597584|82973974|FG000|Overall Study|Discontinued Dialysis|0|||
46756002|NCT00597584|82973975|FG001|Overall Study|Discontinued Dialysis|1|||
47055066|NCT00983619|83328432|FG009|Overall Study|Withdrawal by Subject|0|||
46813981|NCT00340834|83033603|FG000|Core Phase of Study|Death|2|||
46813982|NCT00340834|83033604|FG001|Core Phase of Study|Death|0|||
46813983|NCT00340834|83033605|FG002|Core Phase of Study|Death|0|||
46813984|NCT00340834|83033606|FG003|Core Phase of Study|Death|0|||
46813985|NCT00340834|83033607|FG004|Core Phase of Study|Death|0|||
46813986|NCT00340834|83033603|FG000|Core Phase of Study|Protocol Violation|0|||
46813987|NCT00340834|83033604|FG001|Core Phase of Study|Protocol Violation|0|||
46813988|NCT00340834|83033605|FG002|Core Phase of Study|Protocol Violation|2|||
47055067|NCT00983619|83328433|FG010|Overall Study|Withdrawal by Subject|1|||
47055068|NCT00983619|83328434|FG011|Overall Study|Withdrawal by Subject|1|||
46756003|NCT00597584|82973974|FG000|Overall Study|Lost ability to consent|1|||
46756004|NCT00597584|82973975|FG001|Overall Study|Lost ability to consent|1|||
46813989|NCT00340834|83033606|FG003|Core Phase of Study|Protocol Violation|0|||
46813990|NCT00340834|83033607|FG004|Core Phase of Study|Protocol Violation|0|||
46813991|NCT00340834|83033603|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
46813992|NCT00340834|83033604|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
46813993|NCT00340834|83033605|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
46813994|NCT00340834|83033606|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
46813995|NCT00340834|83033607|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
46813996|NCT00340834|83033603|FG000|Extension Phase of Study|Subject withdrew consent|26|||
46813997|NCT00340834|83033604|FG001|Extension Phase of Study|Subject withdrew consent|31|||
46813998|NCT00340834|83033605|FG002|Extension Phase of Study|Subject withdrew consent|0|||
46813999|NCT00340834|83033606|FG003|Extension Phase of Study|Subject withdrew consent|12|||
46929233|NCT01667926|83164059|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
46929234|NCT01667926|83164057|FG000|Overall Study|Lost to Follow-up|1|||
46929235|NCT01667926|83164058|FG001|Overall Study|Lost to Follow-up|2|||
46929236|NCT01667926|83164059|FG002|Overall Study|Lost to Follow-up|1|||
46929237|NCT01667926|83164057|FG000|Overall Study|Side effects|3|||
46929238|NCT01667926|83164058|FG001|Overall Study|Side effects|0|||
46929239|NCT01667926|83164059|FG002|Overall Study|Side effects|0|||
46929240|NCT02604160|83164067|FG000|Overall Study|Protocol Violation|0|||
46929241|NCT02604160|83164068|FG001|Overall Study|Protocol Violation|1|||
46929242|NCT02604160|83164067|FG000|Overall Study|Physician Decision|0|||
46929243|NCT02604160|83164068|FG001|Overall Study|Physician Decision|1|||
46929244|NCT01359904|83164078|FG000|Overall Study|Withdrawal by Subject|1|||
46929245|NCT01359904|83164079|FG001|Overall Study|Withdrawal by Subject|0|||
46929246|NCT05044234|83164156|FG000|Overall Study|Lost to Follow-up|2|||
46929247|NCT05044234|83164157|FG001|Overall Study|Lost to Follow-up|1|||
46929248|NCT05044234|83164158|FG002|Overall Study|Lost to Follow-up|1|||
47055069|NCT00983619|83328423|FG000|Overall Study|Death|0|||
47055070|NCT00983619|83328424|FG001|Overall Study|Death|2|||
47055071|NCT00983619|83328425|FG002|Overall Study|Death|2|||
46814000|NCT00340834|83033607|FG004|Extension Phase of Study|Subject withdrew consent|15|||
46814001|NCT00340834|83033603|FG000|Extension Phase of Study|Adverse Event|21|||
46814002|NCT00340834|83033604|FG001|Extension Phase of Study|Adverse Event|22|||
46814003|NCT00340834|83033605|FG002|Extension Phase of Study|Adverse Event|0|||
46814004|NCT00340834|83033606|FG003|Extension Phase of Study|Adverse Event|19|||
46814005|NCT00340834|83033607|FG004|Extension Phase of Study|Adverse Event|7|||
46814006|NCT00340834|83033603|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
46814007|NCT00340834|83033604|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
46814008|NCT00340834|83033605|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
46814009|NCT00340834|83033606|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
46814010|NCT00340834|83033607|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
46814011|NCT00340834|83033603|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
46814012|NCT00340834|83033604|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
46814013|NCT00340834|83033605|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
46814014|NCT00340834|83033606|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
46814015|NCT00340834|83033607|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
46814016|NCT00340834|83033603|FG000|Extension Phase of Study|Lost to Follow-up|1|||
46814017|NCT00340834|83033604|FG001|Extension Phase of Study|Lost to Follow-up|1|||
46814018|NCT00340834|83033605|FG002|Extension Phase of Study|Lost to Follow-up|0|||
46814019|NCT00340834|83033606|FG003|Extension Phase of Study|Lost to Follow-up|2|||
46814020|NCT00340834|83033607|FG004|Extension Phase of Study|Lost to Follow-up|3|||
46814021|NCT00340834|83033603|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
46814022|NCT00340834|83033604|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
46814023|NCT00340834|83033605|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
46814024|NCT00340834|83033606|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
46814025|NCT00340834|83033607|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
46814026|NCT00340834|83033603|FG000|Extension Phase of Study|Administrative problems|3|||
46814027|NCT00340834|83033604|FG001|Extension Phase of Study|Administrative problems|0|||
46814028|NCT00340834|83033605|FG002|Extension Phase of Study|Administrative problems|0|||
46814029|NCT00340834|83033606|FG003|Extension Phase of Study|Administrative problems|1|||
46814030|NCT00340834|83033607|FG004|Extension Phase of Study|Administrative problems|1|||
47055072|NCT00983619|83328426|FG003|Overall Study|Death|1|||
47055073|NCT00983619|83328427|FG004|Overall Study|Death|2|||
47055074|NCT00983619|83328428|FG005|Overall Study|Death|30|||
46814031|NCT00340834|83033603|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
46929249|NCT05044234|83164159|FG003|Overall Study|Lost to Follow-up|2|||
46929250|NCT05044234|83164156|FG000|Overall Study|Withdrawal by Subject|6|||
46929251|NCT05044234|83164157|FG001|Overall Study|Withdrawal by Subject|4|||
46929252|NCT05044234|83164158|FG002|Overall Study|Withdrawal by Subject|5|||
46929253|NCT05044234|83164159|FG003|Overall Study|Withdrawal by Subject|8|||
47055075|NCT00983619|83328429|FG006|Overall Study|Death|1|||
47055076|NCT00983619|83328430|FG007|Overall Study|Death|0|||
46814032|NCT00340834|83033604|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
46814033|NCT00340834|83033605|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
46814034|NCT00340834|83033606|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
46814035|NCT00340834|83033607|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
46814036|NCT00340834|83033603|FG000|Extension Phase of Study|Protocol Violation|3|||
46814037|NCT00340834|83033604|FG001|Extension Phase of Study|Protocol Violation|0|||
46814038|NCT00340834|83033605|FG002|Extension Phase of Study|Protocol Violation|0|||
46814039|NCT00340834|83033606|FG003|Extension Phase of Study|Protocol Violation|0|||
46814040|NCT00340834|83033607|FG004|Extension Phase of Study|Protocol Violation|0|||
46814041|NCT00340834|83033603|FG000|Extension Phase of Study|Death|0|||
46814042|NCT00340834|83033604|FG001|Extension Phase of Study|Death|0|||
46814043|NCT00340834|83033605|FG002|Extension Phase of Study|Death|0|||
46814044|NCT00340834|83033606|FG003|Extension Phase of Study|Death|0|||
46814045|NCT00340834|83033607|FG004|Extension Phase of Study|Death|1|||
46814046|NCT00603941|83033620|FG000|Overall Study|Disease progression|6|||
46814047|NCT00603941|83033621|FG001|Overall Study|Disease progression|7|||
46814048|NCT00603941|83033622|FG002|Overall Study|Disease progression|1|||
46814049|NCT00603941|83033620|FG000|Overall Study|Adverse Event|1|||
46814050|NCT00603941|83033621|FG001|Overall Study|Adverse Event|0|||
46814051|NCT00603941|83033622|FG002|Overall Study|Adverse Event|1|||
46814052|NCT00603941|83033620|FG000|Overall Study|Physician Decision|0|||
46814053|NCT00603941|83033621|FG001|Overall Study|Physician Decision|1|||
46814054|NCT00603941|83033622|FG002|Overall Study|Physician Decision|0|||
46814055|NCT00603941|83033620|FG000|Overall Study|Withdrawal by Subject|0|||
46814056|NCT00603941|83033621|FG001|Overall Study|Withdrawal by Subject|2|||
47055077|NCT00983619|83328431|FG008|Overall Study|Death|1|||
47055078|NCT00983619|83328432|FG009|Overall Study|Death|2|||
47055079|NCT00983619|83328433|FG010|Overall Study|Death|9|||
47055080|NCT00983619|83328434|FG011|Overall Study|Death|8|||
47055081|NCT00983619|83328423|FG000|Overall Study|Other|1|||
47055082|NCT00983619|83328424|FG001|Overall Study|Other|0|||
47055083|NCT00983619|83328425|FG002|Overall Study|Other|0|||
47055084|NCT00983619|83328426|FG003|Overall Study|Other|1|||
47055085|NCT00983619|83328427|FG004|Overall Study|Other|0|||
47055086|NCT00983619|83328428|FG005|Overall Study|Other|12|||
47055087|NCT00983619|83328429|FG006|Overall Study|Other|2|||
47055088|NCT00983619|83328430|FG007|Overall Study|Other|2|||
47055089|NCT00983619|83328431|FG008|Overall Study|Other|0|||
47055090|NCT00983619|83328432|FG009|Overall Study|Other|1|||
47055091|NCT00983619|83328433|FG010|Overall Study|Other|1|||
47055092|NCT00983619|83328434|FG011|Overall Study|Other|0|||
47055093|NCT01767857|83328482|FG000|Overall Study|Adverse Event|27|||
47055094|NCT01767857|83328483|FG001|Overall Study|Adverse Event|7|||
47055095|NCT01767857|83328482|FG000|Overall Study|Death|28|||
47055096|NCT01767857|83328483|FG001|Overall Study|Death|13|||
46814057|NCT00603941|83033622|FG002|Overall Study|Withdrawal by Subject|0|||
47055097|NCT01767857|83328482|FG000|Overall Study|Lack of Efficacy|299|||
46756005|NCT00597584|82973974|FG000|Overall Study|Never dosed|1|||
46756006|NCT00597584|82973975|FG001|Overall Study|Never dosed|0|||
46756007|NCT00597584|82973974|FG000|Overall Study|Relocation|8|||
46756008|NCT00597584|82973975|FG001|Overall Study|Relocation|6|||
46756009|NCT00597584|82973974|FG000|Overall Study|Renal transplant|9|||
46756010|NCT00597584|82973975|FG001|Overall Study|Renal transplant|7|||
46756011|NCT00529633|82973983|FG000|Overall Study|Withdrawal by Subject|1|||
46756012|NCT00529633|82973984|FG001|Overall Study|Withdrawal by Subject|1|||
46756013|NCT00530335|82973990|FG000|Overall Study|Adverse Event|3|||
46756014|NCT00530335|82973990|FG000|Overall Study|Protocol Violation|1|||
46756015|NCT00530335|82973990|FG000|Overall Study|Withdrawal by Subject|1|||
46756016|NCT00530335|82973990|FG000|Overall Study|Physician Decision|1|||
46756017|NCT00712270|82973997|FG000|Overall Study|Withdrawal by Subject|11|||
46756018|NCT00712270|82973997|FG000|Overall Study|Screen Failure|3|||
46756019|NCT00530257|82974023|FG000|Overall Study|Lost to Follow-up|1|||
46756020|NCT00869778|82974033|FG000|Overall Study|Adverse Event|2|||
46814058|NCT00340678|83033635|FG000|Overall Study|Lost to Follow-up|1|||
46814059|NCT00340678|83033636|FG001|Overall Study|Lost to Follow-up|0|||
46814060|NCT00340678|83033637|FG002|Overall Study|Lost to Follow-up|0|||
46814061|NCT00340678|83033638|FG003|Overall Study|Lost to Follow-up|0|||
46814062|NCT00336544|83033648|FG000|Overall Study|Lack of Efficacy|8|||
46814063|NCT00336544|83033649|FG001|Overall Study|Lack of Efficacy|5|||
47055098|NCT01767857|83328483|FG001|Overall Study|Lack of Efficacy|151|||
47055099|NCT01767857|83328482|FG000|Overall Study|Lost to Follow-up|1|||
47055100|NCT01767857|83328483|FG001|Overall Study|Lost to Follow-up|1|||
47055101|NCT01767857|83328482|FG000|Overall Study|Withdrawal by Subject|38|||
47055102|NCT01767857|83328483|FG001|Overall Study|Withdrawal by Subject|18|||
46756021|NCT00869778|82974034|FG001|Overall Study|Adverse Event|0|||
46756022|NCT00869778|82974035|FG002|Overall Study|Adverse Event|0|||
46756023|NCT00869778|82974033|FG000|Overall Study|Withdrawal by Subject|3|||
47055103|NCT01767857|83328482|FG000|Overall Study|Physician Decision|17|||
47055104|NCT01767857|83328483|FG001|Overall Study|Physician Decision|10|||
47055105|NCT01767857|83328482|FG000|Overall Study|Protocol Terminated|1|||
47055106|NCT01767857|83328483|FG001|Overall Study|Protocol Terminated|0|||
47055107|NCT01767857|83328482|FG000|Overall Study|Randomized But Never Treated|19|||
46814064|NCT00336544|83033648|FG000|Overall Study|Adverse Event|4|||
46814065|NCT00336544|83033649|FG001|Overall Study|Adverse Event|9|||
46814066|NCT00336544|83033648|FG000|Overall Study|Withdrawal by Subject|4|||
46814067|NCT00336544|83033649|FG001|Overall Study|Withdrawal by Subject|3|||
46814068|NCT00336544|83033648|FG000|Overall Study|Other|3|||
46814069|NCT00336544|83033649|FG001|Overall Study|Other|5|||
46814070|NCT00605033|83033657|FG000|Overall Study|Adverse Event|2|||
46814071|NCT00605033|83033658|FG001|Overall Study|Adverse Event|2|||
46814072|NCT00605033|83033657|FG000|Overall Study|Lost to Follow-up|1|||
46814073|NCT00605033|83033658|FG001|Overall Study|Lost to Follow-up|1|||
46814074|NCT00605033|83033657|FG000|Overall Study|Withdrawal by Subject|3|||
46814075|NCT00605033|83033658|FG001|Overall Study|Withdrawal by Subject|4|||
46814076|NCT00605033|83033657|FG000|Overall Study|Protocol Violation|1|||
46814077|NCT00605033|83033658|FG001|Overall Study|Protocol Violation|1|||
46814078|NCT00339040|83033666|FG000|Stage I|Not able to attend clinic|1|||
47055108|NCT01767857|83328483|FG001|Overall Study|Randomized But Never Treated|13|||
47055109|NCT01775501|83328490|FG000|Overall Study|Discontinued prior to treatment|1|||
46814079|NCT00339040|83033667|FG001|Stage I|Not able to attend clinic|0|||
46814080|NCT00339040|83033666|FG000|Stage I|Protocol Violation|1|||
47055110|NCT01775189|83328519|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47055111|NCT01775189|83328520|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
47055112|NCT01775189|83328521|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47055113|NCT01775189|83328522|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47055114|NCT01775189|83328523|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47055115|NCT01775189|83328524|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
46814081|NCT00339040|83033667|FG001|Stage I|Protocol Violation|1|||
46814082|NCT00339040|83033666|FG000|Stage II|Lost to Follow-up|3|||
46814083|NCT00339040|83033667|FG001|Stage II|Lost to Follow-up|0|||
46814084|NCT00339040|83033666|FG000|Stage II|Withdrawal by Subject|1|||
46814085|NCT00339040|83033667|FG001|Stage II|Withdrawal by Subject|2|||
46814086|NCT00339040|83033666|FG000|Stage II|Protocol Violation|3|||
46814087|NCT00339040|83033667|FG001|Stage II|Protocol Violation|0|||
46814088|NCT00339040|83033666|FG000|Stage II|Not able to attend clinic|1|||
46814089|NCT00339040|83033667|FG001|Stage II|Not able to attend clinic|0|||
46814090|NCT00339040|83033666|FG000|Stage II|Site closing|2|||
46814091|NCT00339040|83033667|FG001|Stage II|Site closing|0|||
46814092|NCT00338962|83033677|FG000|Overall Study|Lost to Follow-up|3|||
46814093|NCT00338962|83033678|FG001|Overall Study|Lost to Follow-up|3|||
46814094|NCT00338962|83033679|FG002|Overall Study|Lost to Follow-up|2|||
46814095|NCT00338962|83033680|FG003|Overall Study|Lost to Follow-up|3|||
46814096|NCT00338962|83033677|FG000|Overall Study|Withdrawal by Subject|1|||
46814097|NCT00338962|83033678|FG001|Overall Study|Withdrawal by Subject|0|||
46814098|NCT00338962|83033679|FG002|Overall Study|Withdrawal by Subject|0|||
46814099|NCT00338962|83033680|FG003|Overall Study|Withdrawal by Subject|0|||
46814100|NCT00338962|83033677|FG000|Overall Study|No Transportation|2|||
46814101|NCT00338962|83033678|FG001|Overall Study|No Transportation|0|||
46814102|NCT00338962|83033679|FG002|Overall Study|No Transportation|0|||
46814103|NCT00338962|83033680|FG003|Overall Study|No Transportation|0|||
46929254|NCT05044234|83164156|FG000|Overall Study|Study terminated by Sponsor|21|||
46929255|NCT05044234|83164157|FG001|Overall Study|Study terminated by Sponsor|21|||
47055116|NCT01775189|83328525|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
47055117|NCT01775189|83328519|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47055118|NCT01775189|83328520|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
47055119|NCT01775189|83328521|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
46756024|NCT00869778|82974034|FG001|Overall Study|Withdrawal by Subject|4|||
46756025|NCT00869778|82974035|FG002|Overall Study|Withdrawal by Subject|5|||
46756026|NCT00869778|82974033|FG000|Overall Study|Pregnancy|1|||
46756027|NCT00869778|82974034|FG001|Overall Study|Pregnancy|0|||
46756028|NCT00869778|82974035|FG002|Overall Study|Pregnancy|0|||
46756029|NCT00869778|82974033|FG000|Overall Study|Protocol Violation|5|||
46756030|NCT00869778|82974034|FG001|Overall Study|Protocol Violation|3|||
46756031|NCT00869778|82974035|FG002|Overall Study|Protocol Violation|5|||
46814104|NCT00338962|83033677|FG000|Overall Study|Time Constraint|2|||
46814105|NCT00338962|83033678|FG001|Overall Study|Time Constraint|0|||
46814106|NCT00338962|83033679|FG002|Overall Study|Time Constraint|0|||
46814107|NCT00338962|83033680|FG003|Overall Study|Time Constraint|0|||
46814108|NCT00338962|83033677|FG000|Overall Study|Moved|0|||
46814109|NCT00338962|83033678|FG001|Overall Study|Moved|1|||
46814110|NCT00338962|83033679|FG002|Overall Study|Moved|0|||
46814111|NCT00338962|83033680|FG003|Overall Study|Moved|0|||
46814112|NCT00338962|83033677|FG000|Overall Study|Adverse Event|0|||
47055120|NCT01775189|83328522|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
46756032|NCT00869778|82974033|FG000|Overall Study|Unblinding|1|||
46756033|NCT00869778|82974034|FG001|Overall Study|Unblinding|0|||
46814113|NCT00338962|83033678|FG001|Overall Study|Adverse Event|0|||
46814114|NCT00338962|83033679|FG002|Overall Study|Adverse Event|2|||
46814115|NCT00338962|83033680|FG003|Overall Study|Adverse Event|0|||
46814116|NCT00338962|83033677|FG000|Overall Study|Poor Compliance|0|||
46814117|NCT00338962|83033678|FG001|Overall Study|Poor Compliance|0|||
46814118|NCT00338962|83033679|FG002|Overall Study|Poor Compliance|2|||
46814119|NCT00338962|83033680|FG003|Overall Study|Poor Compliance|0|||
46814120|NCT00568061|83033692|FG000|Overall Study|Inclusion / exclusion criteria|5|||
46814121|NCT00568061|83033693|FG001|Overall Study|Inclusion / exclusion criteria|1|||
46814122|NCT00568061|83033692|FG000|Overall Study|Adverse Event|0|||
46814123|NCT00568061|83033693|FG001|Overall Study|Adverse Event|1|||
46814124|NCT00338884|83033700|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
46814125|NCT00338884|83033700|FG000|Overall Study|Adverse Event|14|||
46814126|NCT00338884|83033700|FG000|Overall Study|Death|8|||
46814127|NCT00338884|83033700|FG000|Overall Study|Other|4|||
46814128|NCT00338884|83033700|FG000|Overall Study|Global Deterioration of Health Status|3|||
46814129|NCT00338884|83033700|FG000|Overall Study|Withdrawal by Subject|3|||
46814130|NCT00338884|83033700|FG000|Overall Study|Lost to Follow-up|1|||
46814131|NCT00338884|83033700|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
46814132|NCT00338806|83033706|FG000|Acute Phase|Withdrawal by Subject|0|||
46814133|NCT00338806|83033707|FG001|Acute Phase|Withdrawal by Subject|1|||
46814134|NCT00338806|83033706|FG000|Follow-up|Lost to Follow-up|1|||
46814135|NCT00338806|83033707|FG001|Follow-up|Lost to Follow-up|3|||
46814136|NCT03038100|83033717|FG000|Overall Study|Death|289|||
46814137|NCT03038100|83033718|FG001|Overall Study|Death|272|||
46814138|NCT03038100|83033717|FG000|Overall Study|Lost to Follow-up|9|||
46814139|NCT03038100|83033718|FG001|Overall Study|Lost to Follow-up|10|||
46814140|NCT03038100|83033717|FG000|Overall Study|Protocol Deviation|1|||
46814141|NCT03038100|83033718|FG001|Overall Study|Protocol Deviation|4|||
46814142|NCT03038100|83033717|FG000|Overall Study|Withdrawal by Subject|45|||
46814143|NCT03038100|83033718|FG001|Overall Study|Withdrawal by Subject|51|||
46814144|NCT03038100|83033717|FG000|Overall Study|Study Terminated By Sponsor|305|||
46814145|NCT03038100|83033718|FG001|Overall Study|Study Terminated By Sponsor|311|||
46814146|NCT03038100|83033717|FG000|Overall Study|Physician Decision|1|||
46814147|NCT03038100|83033718|FG001|Overall Study|Physician Decision|3|||
46814148|NCT00338728|83033725|FG000|Overall Study|Screen Failure|14|||
46814149|NCT00336856|83033729|FG000|Overall Study|Withdrawal by Subject|3|||
46814150|NCT00336856|83033729|FG000|Overall Study|Found ineligible at time of analysis|1|||
46814151|NCT00566501|83033735|FG000|Overall Study|Adverse Event|68|||
46814152|NCT00566501|83033736|FG001|Overall Study|Adverse Event|59|||
46814153|NCT00566501|83033735|FG000|Overall Study|Medication Non-compliance|5|||
46814154|NCT00566501|83033736|FG001|Overall Study|Medication Non-compliance|0|||
46814155|NCT00566501|83033735|FG000|Overall Study|Protocol Violation|2|||
46814156|NCT00566501|83033736|FG001|Overall Study|Protocol Violation|2|||
46814157|NCT00566501|83033735|FG000|Overall Study|Request of Investigator or Sponsor|6|||
46814158|NCT00566501|83033736|FG001|Overall Study|Request of Investigator or Sponsor|7|||
46814159|NCT00566501|83033735|FG000|Overall Study|Withdrawal by Subject|33|||
46814160|NCT00566501|83033736|FG001|Overall Study|Withdrawal by Subject|30|||
46814161|NCT00566501|83033735|FG000|Overall Study|Lack of Efficacy|8|||
46814162|NCT00566501|83033736|FG001|Overall Study|Lack of Efficacy|3|||
46814163|NCT00566501|83033735|FG000|Overall Study|Other|25|||
46814164|NCT00566501|83033736|FG001|Overall Study|Other|21|||
46814165|NCT00504894|83033745|FG000|Overall Study|fMRI technical problems|1|||
46814166|NCT00504894|83033746|FG001|Overall Study|fMRI technical problems|1|||
46814167|NCT00504894|83033747|FG002|Overall Study|fMRI technical problems|0|||
46814168|NCT00504894|83033745|FG000|Overall Study|Withdrawal by Subject|0|||
46814169|NCT00504894|83033746|FG001|Overall Study|Withdrawal by Subject|1|||
46814170|NCT00504894|83033747|FG002|Overall Study|Withdrawal by Subject|0|||
46814171|NCT00504894|83033745|FG000|Overall Study|Infusion technical problems|0|||
46814172|NCT00504894|83033746|FG001|Overall Study|Infusion technical problems|1|||
46814173|NCT00504894|83033747|FG002|Overall Study|Infusion technical problems|0|||
46814174|NCT00504894|83033745|FG000|Overall Study|poor subject data|2|||
47055121|NCT01775189|83328523|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
46814175|NCT00504894|83033746|FG001|Overall Study|poor subject data|0|||
46814176|NCT00504894|83033747|FG002|Overall Study|poor subject data|0|||
46814177|NCT00513240|83033757|FG000|Overall Study|Did not have intended surgery|3|||
46814178|NCT00513240|83033758|FG001|Overall Study|Did not have intended surgery|0|||
46929256|NCT05044234|83164158|FG002|Overall Study|Study terminated by Sponsor|20|||
47055122|NCT01775189|83328524|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
47055123|NCT01775189|83328525|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
46814179|NCT00513240|83033757|FG000|Overall Study|Death|3|||
46814180|NCT00513240|83033758|FG001|Overall Study|Death|3|||
46814181|NCT00513240|83033757|FG000|Overall Study|Withdrawal by Subject|7|||
46814182|NCT00513240|83033758|FG001|Overall Study|Withdrawal by Subject|4|||
46814183|NCT00504426|83033771|FG000|Overall Study|Adverse Event|0|||
46814184|NCT00504426|83033772|FG001|Overall Study|Adverse Event|0|||
46814185|NCT00504426|83033773|FG002|Overall Study|Adverse Event|2|||
46814186|NCT00504426|83033774|FG003|Overall Study|Adverse Event|0|||
46814187|NCT00504426|83033771|FG000|Overall Study|Protocol Violation|1|||
46814188|NCT00504426|83033772|FG001|Overall Study|Protocol Violation|1|||
46929257|NCT05044234|83164159|FG003|Overall Study|Study terminated by Sponsor|14|||
46929258|NCT05044234|83164156|FG000|Overall Study|Other, not specified|0|||
46929259|NCT05044234|83164157|FG001|Overall Study|Other, not specified|0|||
46929260|NCT05044234|83164158|FG002|Overall Study|Other, not specified|1|||
46929261|NCT05044234|83164159|FG003|Overall Study|Other, not specified|2|||
46929262|NCT05044234|83164156|FG000|Overall Study|Delayed data entry|0|||
46929263|NCT05044234|83164157|FG001|Overall Study|Delayed data entry|0|||
46929264|NCT05044234|83164158|FG002|Overall Study|Delayed data entry|0|||
46929265|NCT05044234|83164159|FG003|Overall Study|Delayed data entry|1|||
46929266|NCT04725812|83164173|FG000|Overall Study|Withdrawal by Subject|1|||
46929267|NCT04147247|83164204|FG000|Overall Study|Progressive disease|3|||
46929268|NCT04147247|83164205|FG001|Overall Study|Progressive disease|3|||
46929269|NCT04147247|83164206|FG002|Overall Study|Progressive disease|4|||
46929270|NCT04147247|83164207|FG003|Overall Study|Progressive disease|4|||
46929271|NCT04147247|83164208|FG004|Overall Study|Progressive disease|3|||
46929272|NCT04147247|83164204|FG000|Overall Study|Physician Decision|0|||
46929273|NCT04147247|83164205|FG001|Overall Study|Physician Decision|1|||
46929274|NCT04147247|83164206|FG002|Overall Study|Physician Decision|0|||
46929275|NCT04147247|83164207|FG003|Overall Study|Physician Decision|0|||
46929276|NCT04147247|83164208|FG004|Overall Study|Physician Decision|0|||
46929277|NCT04147247|83164204|FG000|Overall Study|Clinical Disease Progression|0|||
46929278|NCT04147247|83164205|FG001|Overall Study|Clinical Disease Progression|0|||
46929279|NCT04147247|83164206|FG002|Overall Study|Clinical Disease Progression|0|||
46929280|NCT04147247|83164207|FG003|Overall Study|Clinical Disease Progression|0|||
46929281|NCT04147247|83164208|FG004|Overall Study|Clinical Disease Progression|1|||
46929282|NCT04147247|83164204|FG000|Overall Study|Adverse Event|0|||
46929283|NCT04147247|83164205|FG001|Overall Study|Adverse Event|0|||
46929284|NCT04147247|83164206|FG002|Overall Study|Adverse Event|1|||
46929285|NCT04147247|83164207|FG003|Overall Study|Adverse Event|0|||
46929286|NCT04147247|83164208|FG004|Overall Study|Adverse Event|1|||
46929287|NCT04080167|83164223|FG000|Overall Study|Lost to Follow-up-Patients|7|||
46929288|NCT04080167|83164224|FG001|Overall Study|Lost to Follow-up-Patients|14|||
46929289|NCT04080167|83164225|FG002|Overall Study|Lost to Follow-up-Patients|0|||
46929290|NCT04080167|83164223|FG000|Overall Study|Lost to Follow-up-Providers|2|||
46929291|NCT04080167|83164224|FG001|Overall Study|Lost to Follow-up-Providers|2|||
46929292|NCT04080167|83164225|FG002|Overall Study|Lost to Follow-up-Providers|0|||
46929293|NCT04080167|83164223|FG000|Overall Study|Withdrawal by Subject|1|||
46929294|NCT04080167|83164224|FG001|Overall Study|Withdrawal by Subject|2|||
46929295|NCT04080167|83164225|FG002|Overall Study|Withdrawal by Subject|0|||
46929296|NCT04080167|83164223|FG000|Overall Study|Withdrawal by Provider|0|||
46929297|NCT04080167|83164224|FG001|Overall Study|Withdrawal by Provider|0|||
46929298|NCT04080167|83164225|FG002|Overall Study|Withdrawal by Provider|4|||
46929299|NCT04080167|83164223|FG000|Overall Study|Death-Patient|2|||
47055124|NCT01775189|83328519|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
46929300|NCT04080167|83164224|FG001|Overall Study|Death-Patient|1|||
46929301|NCT04080167|83164225|FG002|Overall Study|Death-Patient|0|||
46929302|NCT04080167|83164223|FG000|Overall Study|Hydroxyurea New Starts|0|||
46929303|NCT04080167|83164224|FG001|Overall Study|Hydroxyurea New Starts|0|||
46929304|NCT04080167|83164225|FG002|Overall Study|Hydroxyurea New Starts|1|||
46929305|NCT04080167|83164223|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
46929306|NCT04080167|83164224|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
46929307|NCT04080167|83164225|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
46929308|NCT04070378|83164232|FG000|Overall Study|Withdrawal by Subject|2|||
46929309|NCT04070378|83164232|FG000|Overall Study|Screen Failure|6|||
46929310|NCT04070378|83164232|FG000|Overall Study|Physician Decision|1|||
46756034|NCT00869778|82974035|FG002|Overall Study|Unblinding|0|||
46756035|NCT00711958|82974066|FG000|Overall Study|Withdrawal by Subject|6|||
46756036|NCT00711958|82974067|FG001|Overall Study|Withdrawal by Subject|8|||
46929311|NCT04070378|83164232|FG000|Overall Study|Adverse Event|1|||
46929312|NCT04007367|83164236|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
46929313|NCT04007367|83164237|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
47055125|NCT01775189|83328520|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
47055126|NCT01775189|83328521|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
46756037|NCT00711958|82974066|FG000|Overall Study|Lack of Efficacy|3|||
46756038|NCT00711958|82974067|FG001|Overall Study|Lack of Efficacy|1|||
46756039|NCT00711958|82974066|FG000|Overall Study|Clinical deterioration|1|||
46756040|NCT00711958|82974067|FG001|Overall Study|Clinical deterioration|0|||
46929314|NCT04007367|83164238|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
46929315|NCT04007367|83164236|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
47055127|NCT01775189|83328522|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
46756041|NCT00711958|82974066|FG000|Overall Study|Adverse Event|9|||
46756042|NCT00711958|82974067|FG001|Overall Study|Adverse Event|7|||
46929316|NCT04007367|83164237|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
46929317|NCT04007367|83164238|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
46929318|NCT04007367|83164236|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
46929319|NCT04007367|83164237|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
46929320|NCT04007367|83164238|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
46929321|NCT04007367|83164236|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
46929322|NCT04007367|83164237|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
46929323|NCT04007367|83164238|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
46929324|NCT04007367|83164236|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
46929325|NCT04007367|83164237|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
46929326|NCT04007367|83164238|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
46929327|NCT03900650|83164265|FG000|Overall Study|Withdrawal by Subject|1|||
46929328|NCT03900650|83164266|FG001|Overall Study|Withdrawal by Subject|1|||
46929329|NCT03900650|83164267|FG002|Overall Study|Withdrawal by Subject|0|||
46929330|NCT03900650|83164268|FG003|Overall Study|Withdrawal by Subject|0|||
46929331|NCT03900650|83164265|FG000|Overall Study|Withdrawn by staff|1|||
46929332|NCT03900650|83164266|FG001|Overall Study|Withdrawn by staff|0|||
46929333|NCT03900650|83164267|FG002|Overall Study|Withdrawn by staff|0|||
46929334|NCT03900650|83164268|FG003|Overall Study|Withdrawn by staff|0|||
46929335|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
46929336|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
46929337|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
46929338|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
46814189|NCT00504426|83033773|FG002|Overall Study|Protocol Violation|2|||
46814190|NCT00504426|83033774|FG003|Overall Study|Protocol Violation|0|||
46814191|NCT00504426|83033771|FG000|Overall Study|Withdrawal by Subject|2|||
46814192|NCT00504426|83033772|FG001|Overall Study|Withdrawal by Subject|0|||
46814193|NCT00504426|83033773|FG002|Overall Study|Withdrawal by Subject|0|||
46814194|NCT00504426|83033774|FG003|Overall Study|Withdrawal by Subject|0|||
46814195|NCT00504348|83033787|FG000|Overall Study|Adverse Event|3|||
46814196|NCT00504348|83033787|FG000|Overall Study|Lack of Efficacy|4|||
46814197|NCT00504348|83033787|FG000|Overall Study|Physician Decision|1|||
46814198|NCT00507546|83033793|FG000|Overall Study|Withdrawal by Subject|1|||
46814199|NCT00507546|83033794|FG001|Overall Study|Withdrawal by Subject|0|||
46814200|NCT00507546|83033793|FG000|Overall Study|Protocol Violation|1|||
46756043|NCT00711958|82974066|FG000|Overall Study|Protocol Violation|1|||
46756044|NCT00711958|82974067|FG001|Overall Study|Protocol Violation|0|||
46756045|NCT00711958|82974066|FG000|Overall Study|Lost to Follow-up|2|||
46756046|NCT00711958|82974067|FG001|Overall Study|Lost to Follow-up|2|||
46756047|NCT00711958|82974066|FG000|Overall Study|Death|10|||
46756048|NCT00711958|82974067|FG001|Overall Study|Death|5|||
46756049|NCT00711958|82974066|FG000|Overall Study|Progression of disease|1|||
46756050|NCT00711958|82974067|FG001|Overall Study|Progression of disease|0|||
46814201|NCT00507546|83033794|FG001|Overall Study|Protocol Violation|0|||
46814202|NCT00507546|83033793|FG000|Overall Study|Physician Decision|0|||
46814203|NCT00507546|83033794|FG001|Overall Study|Physician Decision|1|||
46814204|NCT00567593|83033802|FG000|Overall Study|Adverse Event|1|||
46814205|NCT00567593|83033802|FG000|Overall Study|Physician Decision|1|||
46814206|NCT00335764|83033811|FG000|Overall Study|wrong histology|1|||
46814207|NCT00335764|83033812|FG001|Overall Study|wrong histology|0|||
46814208|NCT00335764|83033813|FG002|Overall Study|wrong histology|0|||
46814209|NCT00335764|83033814|FG003|Overall Study|wrong histology|0|||
46814210|NCT00335764|83033815|FG004|Overall Study|wrong histology|1|||
46814211|NCT00567359|83033851|FG000|Overall Study|Withdrawal by Subject|1|||
46814212|NCT00492726|83033857|FG000|Overall Study|Adverse Event|10|||
46814213|NCT00492726|83033858|FG001|Overall Study|Adverse Event|6|||
46814214|NCT00492726|83033857|FG000|Overall Study|Death|7|||
46814215|NCT00492726|83033858|FG001|Overall Study|Death|2|||
46814216|NCT00492726|83033857|FG000|Overall Study|Lack of Efficacy|0|||
46929339|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
46756051|NCT00711880|82974075|FG000|Overall Study|Adverse Event|11|||
46756052|NCT00711880|82974076|FG001|Overall Study|Adverse Event|2|||
46756053|NCT00711880|82974075|FG000|Overall Study|Patient non-compliance|1|||
46756054|NCT00711880|82974076|FG001|Overall Study|Patient non-compliance|0|||
46756055|NCT00711880|82974075|FG000|Overall Study|Lack of Efficacy|1|||
46756056|NCT00711880|82974076|FG001|Overall Study|Lack of Efficacy|5|||
46756057|NCT00528775|82974082|FG000|Overall Study|Other not specified|1|||
46756058|NCT00529399|82974089|FG000|Overall Study|Lost to Follow-up|1|||
46756059|NCT00529399|82974090|FG001|Overall Study|Lost to Follow-up|0|||
46756060|NCT00529399|82974091|FG002|Overall Study|Lost to Follow-up|1|||
46756061|NCT00529399|82974089|FG000|Overall Study|Withdrawal by Subject|1|||
46756062|NCT00529399|82974090|FG001|Overall Study|Withdrawal by Subject|0|||
46814217|NCT00492726|83033858|FG001|Overall Study|Lack of Efficacy|2|||
46929340|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
46756063|NCT00529399|82974091|FG002|Overall Study|Withdrawal by Subject|1|||
46756064|NCT00529399|82974089|FG000|Overall Study|Non-compliant|0|||
46814218|NCT00492726|83033857|FG000|Overall Study|Lost to Follow-up|27|||
46814219|NCT00492726|83033858|FG001|Overall Study|Lost to Follow-up|19|||
46814220|NCT00492726|83033857|FG000|Overall Study|Physician Decision|0|||
46814221|NCT00492726|83033858|FG001|Overall Study|Physician Decision|1|||
46814222|NCT00492726|83033857|FG000|Overall Study|Withdrawal by Subject|6|||
46814223|NCT00492726|83033858|FG001|Overall Study|Withdrawal by Subject|3|||
46814224|NCT00492726|83033857|FG000|Overall Study|Non compliant with study medication|0|||
46814225|NCT00492726|83033858|FG001|Overall Study|Non compliant with study medication|3|||
46814226|NCT00309946|83033864|FG000|Overall Study|Withdrawal by Subject|1|||
46814227|NCT00492648|83033870|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
46814228|NCT00492648|83033871|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
46814229|NCT00506922|83033882|FG000|Overall Study|Physician Decision|0|||
46814230|NCT00506922|83033883|FG001|Overall Study|Physician Decision|0|||
46814231|NCT00506922|83033884|FG002|Overall Study|Physician Decision|0|||
46814232|NCT00506922|83033885|FG003|Overall Study|Physician Decision|2|||
46814233|NCT00506922|83033886|FG004|Overall Study|Physician Decision|0|||
46814234|NCT00506922|83033882|FG000|Overall Study|Withdrawal by Subject|0|||
46814235|NCT00506922|83033883|FG001|Overall Study|Withdrawal by Subject|0|||
46814236|NCT00506922|83033884|FG002|Overall Study|Withdrawal by Subject|0|||
46814237|NCT00506922|83033885|FG003|Overall Study|Withdrawal by Subject|0|||
46814238|NCT00506922|83033886|FG004|Overall Study|Withdrawal by Subject|1|||
46814239|NCT00492024|83033896|FG000|Treatment|Adverse Event|3|||
46814240|NCT00492024|83033897|FG001|Treatment|Adverse Event|1|||
46814241|NCT00492024|83033896|FG000|Treatment|Lack of Efficacy|21|||
46814242|NCT00492024|83033897|FG001|Treatment|Lack of Efficacy|20|||
46814243|NCT00492024|83033896|FG000|Treatment|Lost to Follow-up|3|||
46814244|NCT00492024|83033897|FG001|Treatment|Lost to Follow-up|1|||
46814245|NCT00492024|83033896|FG000|Treatment|Withdrawal by Subject|2|||
46814246|NCT00492024|83033897|FG001|Treatment|Withdrawal by Subject|0|||
46814247|NCT00492024|83033896|FG000|Follow up|Lack of Efficacy|0|||
46814248|NCT00492024|83033897|FG001|Follow up|Lack of Efficacy|1|||
46814249|NCT00492024|83033896|FG000|Follow up|Lost to Follow-up|1|||
46814250|NCT00492024|83033897|FG001|Follow up|Lost to Follow-up|1|||
46814251|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
46814252|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
46814253|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
46814254|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
46814255|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
46814256|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
46814257|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
46814258|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
46814259|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
46814260|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
46814261|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
46814262|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
46814263|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
46814264|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
46814265|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
46814266|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
46814267|NCT00491556|83033905|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
46814268|NCT00491556|83033906|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
46814269|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
46814270|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
46814271|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
46814272|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
46814273|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
46814274|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
46814275|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
46814276|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
46814277|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
46814278|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
46814279|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
46814280|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
46814281|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
46814282|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
46814283|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
46814284|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
46814285|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
46814286|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
46814287|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
46814288|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
46814289|NCT00491556|83033905|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
46814290|NCT00491556|83033906|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
46814291|NCT00506454|83033914|FG000|Overall Study|Withdrawal by Subject|1|||
46814292|NCT00506454|83033915|FG001|Overall Study|Withdrawal by Subject|1|||
46814293|NCT00485472|83033923|FG000|Overall Study|Adverse Event|8|||
46814294|NCT00485472|83033924|FG001|Overall Study|Adverse Event|5|||
46814295|NCT00485472|83033923|FG000|Overall Study|Lack of Efficacy|5|||
46814296|NCT00485472|83033924|FG001|Overall Study|Lack of Efficacy|4|||
46814297|NCT00485472|83033923|FG000|Overall Study|Withdrawal by Subject|1|||
46814298|NCT00485472|83033924|FG001|Overall Study|Withdrawal by Subject|0|||
46814299|NCT00485472|83033923|FG000|Overall Study|Protocol Violation|0|||
46814300|NCT00485472|83033924|FG001|Overall Study|Protocol Violation|1|||
46814301|NCT00485472|83033923|FG000|Overall Study|Other|2|||
46814302|NCT00485472|83033924|FG001|Overall Study|Other|1|||
46814303|NCT00485472|83033923|FG000|Overall Study|Lost to Follow-up|0|||
46814304|NCT00485472|83033924|FG001|Overall Study|Lost to Follow-up|1|||
46814305|NCT00491400|83033932|FG000|Overall Study|Withdrawal by Subject|5|||
46814306|NCT00491400|83033933|FG001|Overall Study|Withdrawal by Subject|4|||
46814307|NCT00491322|83033943|FG000|Overall Study|Protocol Violation|1|||
46814308|NCT00491322|83033944|FG001|Overall Study|Protocol Violation|0|||
46814309|NCT00491322|83033943|FG000|Overall Study|Pregnancy|0|||
46814310|NCT00491322|83033944|FG001|Overall Study|Pregnancy|1|||
46814311|NCT00502320|83033952|FG000|Overall Study|Lost to Follow-up|1|||
46814312|NCT00502320|83033953|FG001|Overall Study|Lost to Follow-up|1|||
46814313|NCT00502320|83033952|FG000|Overall Study|Withdrew Consent|1|||
46814314|NCT00502320|83033953|FG001|Overall Study|Withdrew Consent|0|||
46814315|NCT00502320|83033952|FG000|Overall Study|No longer met criteria|1|||
46814316|NCT00502320|83033953|FG001|Overall Study|No longer met criteria|0|||
47055128|NCT01775189|83328523|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
46814317|NCT00502320|83033952|FG000|Overall Study|Screen Failure|0|||
46814318|NCT00502320|83033953|FG001|Overall Study|Screen Failure|1|||
46814319|NCT00502320|83033952|FG000|Overall Study|Adverse Event|3|||
46814320|NCT00502320|83033953|FG001|Overall Study|Adverse Event|5|||
46814321|NCT02567825|83033961|FG000|Overall Study|No follow-up post-randomization|5|||
46814322|NCT02567825|83033962|FG001|Overall Study|No follow-up post-randomization|1|||
47055129|NCT01775189|83328524|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
47055130|NCT01775189|83328525|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
47055131|NCT01775189|83328519|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
47055132|NCT01775189|83328520|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
47055133|NCT01775189|83328521|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
46756065|NCT00529399|82974090|FG001|Overall Study|Non-compliant|1|||
46756066|NCT00529399|82974091|FG002|Overall Study|Non-compliant|0|||
46756067|NCT00852969|82974101|FG000|Overall Study|Adverse Event|0|||
46756068|NCT00852969|82974102|FG001|Overall Study|Adverse Event|1|||
46756069|NCT00852969|82974101|FG000|Overall Study|Lost to Follow-up|0|||
46756070|NCT00852969|82974102|FG001|Overall Study|Lost to Follow-up|1|||
46756071|NCT03870997|82974114|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
46756072|NCT03870997|82974115|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
46756073|NCT03870997|82974116|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
46756074|NCT03870997|82974117|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
46756075|NCT03870997|82974118|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
46756076|NCT03870997|82974119|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
46756077|NCT00521365|82974128|FG000|Overall Study|Adverse Event|3|||
46756078|NCT00521365|82974128|FG000|Overall Study|Lost to Follow-up|6|||
46756079|NCT00521365|82974128|FG000|Overall Study|Protocol deviation|2|||
46756080|NCT00521365|82974128|FG000|Overall Study|Drug compliance|3|||
46756081|NCT00521365|82974128|FG000|Overall Study|Usage of not allowed drugs|6|||
46756082|NCT00711802|82974140|FG000|Overall Study|Not treated (no further detail)|2|||
46756083|NCT00711802|82974141|FG001|Overall Study|Not treated (no further detail)|1|||
46756084|NCT00711802|82974142|FG002|Overall Study|Not treated (no further detail)|2|||
46756085|NCT00711802|82974143|FG003|Overall Study|Not treated (no further detail)|0|||
46756086|NCT00711802|82974144|FG004|Overall Study|Not treated (no further detail)|2|||
46756087|NCT00711802|82974145|FG005|Overall Study|Not treated (no further detail)|0|||
46756088|NCT00711802|82974146|FG006|Overall Study|Not treated (no further detail)|0|||
46756089|NCT00711802|82974147|FG007|Overall Study|Not treated (no further detail)|0|||
46814323|NCT02567825|83033961|FG000|Overall Study|Follow-up less than 23 months|16|||
46756090|NCT00711802|82974140|FG000|Overall Study|Adverse Event|0|||
46756091|NCT00711802|82974141|FG001|Overall Study|Adverse Event|0|||
46814324|NCT02567825|83033962|FG001|Overall Study|Follow-up less than 23 months|20|||
46814325|NCT00490776|83033968|FG000|Overall Study|Withdrawal by Subject|1|||
46814326|NCT00490776|83033968|FG000|Overall Study|Administrative Problems|1|||
46756092|NCT00711802|82974142|FG002|Overall Study|Adverse Event|0|||
46756093|NCT00711802|82974143|FG003|Overall Study|Adverse Event|0|||
46756094|NCT00711802|82974144|FG004|Overall Study|Adverse Event|1|||
46814327|NCT00490776|83033968|FG000|Overall Study|Death|1|||
46814328|NCT00490776|83033968|FG000|Overall Study|New Cancer Therapy|1|||
46814329|NCT00490776|83033968|FG000|Overall Study|Disease Progression|5|||
46814330|NCT00566735|83033974|FG000|Overall Study|Withdrawal by Subject|0|||
46814331|NCT00566735|83033975|FG001|Overall Study|Withdrawal by Subject|1|||
46814332|NCT00566735|83033974|FG000|Overall Study|Refused neuropsychological testing|2|||
46814333|NCT00566735|83033975|FG001|Overall Study|Refused neuropsychological testing|5|||
46814334|NCT00566735|83033974|FG000|Overall Study|Switched into a manic episode|0|||
46814335|NCT00566735|83033975|FG001|Overall Study|Switched into a manic episode|1|||
46814336|NCT00566111|83033983|FG000|Overall Study|Adverse Event|0|||
46814337|NCT00566111|83033984|FG001|Overall Study|Adverse Event|2|||
46814338|NCT00514046|83033999|FG000|Overall Study|transferred to another protocol|2|||
46814339|NCT00514046|83034000|FG001|Overall Study|transferred to another protocol|1|||
46814340|NCT00514046|83034001|FG002|Overall Study|transferred to another protocol|3|||
46814341|NCT00514046|83034002|FG003|Overall Study|transferred to another protocol|0|||
46814342|NCT00514046|83034003|FG004|Overall Study|transferred to another protocol|1|||
46814343|NCT00514046|83034004|FG005|Overall Study|transferred to another protocol|0|||
46814344|NCT00514046|83034005|FG006|Overall Study|transferred to another protocol|0|||
46814345|NCT00514046|83034006|FG007|Overall Study|transferred to another protocol|0|||
46814346|NCT00514046|83034007|FG008|Overall Study|transferred to another protocol|0|||
46814347|NCT00514046|83033999|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
46814348|NCT00514046|83034000|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
46814349|NCT00514046|83034001|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
46814350|NCT00514046|83034002|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
46814351|NCT00514046|83034003|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
46929341|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
46814352|NCT00514046|83034004|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
46814353|NCT00514046|83034005|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
46814354|NCT00514046|83034006|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
46814355|NCT00514046|83034007|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
46814356|NCT00514046|83033999|FG000|Overall Study|Disease progression on study|0|||
46814357|NCT00514046|83034000|FG001|Overall Study|Disease progression on study|0|||
46814358|NCT00514046|83034001|FG002|Overall Study|Disease progression on study|2|||
46814359|NCT00514046|83034002|FG003|Overall Study|Disease progression on study|0|||
46814360|NCT00514046|83034003|FG004|Overall Study|Disease progression on study|0|||
46814361|NCT00514046|83034004|FG005|Overall Study|Disease progression on study|1|||
46814362|NCT00514046|83034005|FG006|Overall Study|Disease progression on study|0|||
46814363|NCT00514046|83034006|FG007|Overall Study|Disease progression on study|0|||
46814364|NCT00514046|83034007|FG008|Overall Study|Disease progression on study|0|||
46814365|NCT00564629|83034031|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
46814366|NCT00564629|83034032|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
46814367|NCT00564395|83034038|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
46814368|NCT00564395|83034039|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
46814369|NCT00564395|83034038|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
46814370|NCT00564395|83034039|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
46929342|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
46929343|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
46929344|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
46929345|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
46929346|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
46929347|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
46929348|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
46814371|NCT00502242|83034047|FG000|Overall Study|Lack of Efficacy|1|||
46814372|NCT00502242|83034048|FG001|Overall Study|Lack of Efficacy|11|||
46814373|NCT00502242|83034047|FG000|Overall Study|Adverse Event|31|||
46814374|NCT00502242|83034048|FG001|Overall Study|Adverse Event|20|||
46814375|NCT00502242|83034047|FG000|Overall Study|Physician Decision|2|||
46814376|NCT00502242|83034048|FG001|Overall Study|Physician Decision|3|||
46814377|NCT00502242|83034047|FG000|Overall Study|Other - Unspecified|8|||
46814378|NCT00502242|83034048|FG001|Overall Study|Other - Unspecified|14|||
46814379|NCT00502242|83034047|FG000|Overall Study|Protocol Violation|3|||
46814380|NCT00502242|83034048|FG001|Overall Study|Protocol Violation|1|||
46814381|NCT00502242|83034047|FG000|Overall Study|Withdrawal by Subject|6|||
46929349|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
46756095|NCT00711802|82974145|FG005|Overall Study|Adverse Event|1|||
46756096|NCT00711802|82974146|FG006|Overall Study|Adverse Event|0|||
46756097|NCT00711802|82974147|FG007|Overall Study|Adverse Event|0|||
46756098|NCT00711802|82974140|FG000|Overall Study|Microbiological failure|0|||
46756099|NCT00711802|82974141|FG001|Overall Study|Microbiological failure|1|||
46756100|NCT00711802|82974142|FG002|Overall Study|Microbiological failure|0|||
46756101|NCT00711802|82974143|FG003|Overall Study|Microbiological failure|0|||
46756102|NCT00711802|82974144|FG004|Overall Study|Microbiological failure|0|||
46756103|NCT00711802|82974145|FG005|Overall Study|Microbiological failure|1|||
46814382|NCT00502242|83034048|FG001|Overall Study|Withdrawal by Subject|7|||
46814383|NCT03972137|83034058|FG000|Overall Study|Lost to Follow-up|2|||
46814384|NCT03972137|83034058|FG000|Overall Study|Withdrawal by Subject|4|||
46814385|NCT00490698|83034074|FG000|Overall Study|Withdrawal by Subject|1|||
46814386|NCT00490698|83034074|FG000|Overall Study|Disease Progression|7|||
46814387|NCT00490698|83034074|FG000|Overall Study|Physician Decision|2|||
46814388|NCT03855228|83034082|FG000|Overall Study|Adverse Event|2|||
46814389|NCT03855228|83034083|FG001|Overall Study|Adverse Event|4|||
46814390|NCT03855228|83034084|FG002|Overall Study|Adverse Event|4|||
46814391|NCT03855228|83034085|FG003|Overall Study|Adverse Event|8|||
46814392|NCT03855228|83034082|FG000|Overall Study|Treatment Failure|1|||
46814393|NCT03855228|83034083|FG001|Overall Study|Treatment Failure|2|||
46814394|NCT03855228|83034084|FG002|Overall Study|Treatment Failure|1|||
46814395|NCT03855228|83034085|FG003|Overall Study|Treatment Failure|8|||
46814396|NCT03855228|83034082|FG000|Overall Study|Lost to Follow-up|0|||
46814397|NCT03855228|83034083|FG001|Overall Study|Lost to Follow-up|0|||
46814398|NCT03855228|83034084|FG002|Overall Study|Lost to Follow-up|0|||
46814399|NCT03855228|83034085|FG003|Overall Study|Lost to Follow-up|1|||
46814400|NCT03855228|83034082|FG000|Overall Study|Protocol Violation|0|||
46814401|NCT03855228|83034083|FG001|Overall Study|Protocol Violation|1|||
46814402|NCT03855228|83034084|FG002|Overall Study|Protocol Violation|2|||
46814403|NCT03855228|83034085|FG003|Overall Study|Protocol Violation|1|||
46814404|NCT03855228|83034082|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
46814405|NCT03855228|83034083|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
46814406|NCT03855228|83034084|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
46814407|NCT03855228|83034085|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
46814408|NCT00511238|83034097|FG000|Overall Study|Adverse Event|13|||
46814409|NCT00511238|83034098|FG001|Overall Study|Adverse Event|33|||
46814410|NCT00511238|83034097|FG000|Overall Study|Withdrawal by Subject|2|||
46814411|NCT00511238|83034098|FG001|Overall Study|Withdrawal by Subject|22|||
46814412|NCT00511238|83034097|FG000|Overall Study|Progressive Disease|23|||
46814413|NCT00511238|83034098|FG001|Overall Study|Progressive Disease|157|||
46814414|NCT00511238|83034097|FG000|Overall Study|various reasons|4|||
46814415|NCT00511238|83034098|FG001|Overall Study|various reasons|14|||
46814416|NCT00513500|83034116|FG000|Overall Study|Lost to Follow-up|35|||
46814417|NCT00513500|83034117|FG001|Overall Study|Lost to Follow-up|39|||
47055134|NCT01775189|83328522|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
47055135|NCT01775189|83328523|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
46814418|NCT00513500|83034116|FG000|Overall Study|Death|2|||
46814419|NCT00513500|83034117|FG001|Overall Study|Death|1|||
46814420|NCT00513500|83034116|FG000|Overall Study|Hospitalized|4|||
46814421|NCT00513500|83034117|FG001|Overall Study|Hospitalized|14|||
46814422|NCT03969719|83034126|FG000|Overall Study|Other reasons not specified|1|||
46814423|NCT03969719|83034127|FG001|Overall Study|Other reasons not specified|1|||
46814424|NCT03969719|83034128|FG002|Overall Study|Other reasons not specified|3|||
46814425|NCT03969719|83034126|FG000|Overall Study|Withdrawal by Subject|2|||
46814426|NCT03969719|83034127|FG001|Overall Study|Withdrawal by Subject|3|||
46814427|NCT03969719|83034128|FG002|Overall Study|Withdrawal by Subject|2|||
46814428|NCT03969719|83034126|FG000|Overall Study|Protocol Violation|1|||
46814429|NCT03969719|83034127|FG001|Overall Study|Protocol Violation|2|||
46814430|NCT03969719|83034128|FG002|Overall Study|Protocol Violation|0|||
46814431|NCT03969719|83034126|FG000|Overall Study|Adverse Event|0|||
47055136|NCT01775189|83328524|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
47055137|NCT01775189|83328525|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
47055138|NCT01775189|83328519|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
47055139|NCT01775189|83328520|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
47055140|NCT01775189|83328521|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
47055141|NCT01775189|83328522|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
47055142|NCT01775189|83328523|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
47055143|NCT01775189|83328524|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
47055144|NCT01775189|83328525|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
47055145|NCT01775189|83328519|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
47055146|NCT01775189|83328520|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
47055147|NCT01775189|83328521|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
47055148|NCT01775189|83328522|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
46814432|NCT03969719|83034127|FG001|Overall Study|Adverse Event|2|||
46814433|NCT03969719|83034128|FG002|Overall Study|Adverse Event|0|||
46814434|NCT03969719|83034126|FG000|Overall Study|Lost to Follow-up|0|||
46814435|NCT03969719|83034127|FG001|Overall Study|Lost to Follow-up|1|||
46814436|NCT03969719|83034128|FG002|Overall Study|Lost to Follow-up|0|||
46814437|NCT00511004|83034139|FG000|Overall Study|Lost to Follow-up|0|||
46814438|NCT00511004|83034140|FG001|Overall Study|Lost to Follow-up|0|||
46814439|NCT00511004|83034141|FG002|Overall Study|Lost to Follow-up|4|||
46814440|NCT02877134|83034168|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814441|NCT02877134|83034169|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
46814442|NCT02877134|83034170|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
47055149|NCT01775189|83328523|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
46814443|NCT02877134|83034171|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
46929350|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
46929351|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
46929352|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
46929353|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
46929354|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
46929355|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
46929356|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
46929357|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
46756104|NCT00711802|82974146|FG006|Overall Study|Microbiological failure|0|||
46756105|NCT00711802|82974147|FG007|Overall Study|Microbiological failure|0|||
46756106|NCT00711802|82974140|FG000|Overall Study|Protocol Violation|0|||
46756107|NCT00711802|82974141|FG001|Overall Study|Protocol Violation|0|||
46756108|NCT00711802|82974142|FG002|Overall Study|Protocol Violation|0|||
46756109|NCT00711802|82974143|FG003|Overall Study|Protocol Violation|1|||
46756110|NCT00711802|82974144|FG004|Overall Study|Protocol Violation|0|||
46756111|NCT00711802|82974145|FG005|Overall Study|Protocol Violation|0|||
46756112|NCT00711802|82974146|FG006|Overall Study|Protocol Violation|0|||
46756113|NCT00711802|82974147|FG007|Overall Study|Protocol Violation|0|||
46756114|NCT00711802|82974140|FG000|Overall Study|Physician Decision|0|||
46756115|NCT00711802|82974141|FG001|Overall Study|Physician Decision|2|||
46756116|NCT00711802|82974142|FG002|Overall Study|Physician Decision|0|||
46756117|NCT00711802|82974143|FG003|Overall Study|Physician Decision|0|||
46756118|NCT00711802|82974144|FG004|Overall Study|Physician Decision|0|||
46756119|NCT00711802|82974145|FG005|Overall Study|Physician Decision|0|||
46756120|NCT00711802|82974146|FG006|Overall Study|Physician Decision|0|||
46756121|NCT00711802|82974147|FG007|Overall Study|Physician Decision|0|||
46756122|NCT00711802|82974140|FG000|Overall Study|Withdrawal by Subject|0|||
46756123|NCT00711802|82974141|FG001|Overall Study|Withdrawal by Subject|1|||
46756124|NCT00711802|82974142|FG002|Overall Study|Withdrawal by Subject|0|||
46756125|NCT00711802|82974143|FG003|Overall Study|Withdrawal by Subject|1|||
46756126|NCT00711802|82974144|FG004|Overall Study|Withdrawal by Subject|0|||
46756127|NCT00711802|82974145|FG005|Overall Study|Withdrawal by Subject|0|||
46756128|NCT00711802|82974146|FG006|Overall Study|Withdrawal by Subject|0|||
46756129|NCT00711802|82974147|FG007|Overall Study|Withdrawal by Subject|0|||
46756130|NCT00711802|82974140|FG000|Overall Study|Lost to Follow-up|0|||
46756131|NCT00711802|82974141|FG001|Overall Study|Lost to Follow-up|0|||
46756132|NCT00711802|82974142|FG002|Overall Study|Lost to Follow-up|3|||
46756133|NCT00711802|82974143|FG003|Overall Study|Lost to Follow-up|1|||
46756134|NCT00711802|82974144|FG004|Overall Study|Lost to Follow-up|10|||
46756135|NCT00711802|82974145|FG005|Overall Study|Lost to Follow-up|6|||
46756136|NCT00711802|82974146|FG006|Overall Study|Lost to Follow-up|4|||
46756137|NCT00711802|82974147|FG007|Overall Study|Lost to Follow-up|2|||
46756138|NCT00711802|82974140|FG000|Overall Study|Reason not reported|0|||
46756139|NCT00711802|82974141|FG001|Overall Study|Reason not reported|1|||
46756140|NCT00711802|82974142|FG002|Overall Study|Reason not reported|1|||
46756141|NCT00711802|82974143|FG003|Overall Study|Reason not reported|0|||
46756142|NCT00711802|82974144|FG004|Overall Study|Reason not reported|1|||
46756143|NCT00711802|82974145|FG005|Overall Study|Reason not reported|0|||
46756144|NCT00711802|82974146|FG006|Overall Study|Reason not reported|1|||
46756145|NCT00711802|82974147|FG007|Overall Study|Reason not reported|0|||
46756146|NCT00851877|82974168|FG000|Phase I-1|Death|1|||
46756147|NCT00851877|82974169|FG001|Phase I-1|Death|0|||
46756148|NCT00851877|82974170|FG002|Phase I-1|Death|0|||
46756149|NCT00851877|82974168|FG000|Phase II|Withdrawal by Subject|0|||
46756150|NCT00851877|82974169|FG001|Phase II|Withdrawal by Subject|0|||
46756151|NCT00851877|82974170|FG002|Phase II|Withdrawal by Subject|3|||
46756152|NCT00882908|82974181|FG000|Overall Study|Adverse Event|0|||
46756153|NCT00882908|82974182|FG001|Overall Study|Adverse Event|0|||
46756154|NCT00882908|82974183|FG002|Overall Study|Adverse Event|1|||
46756155|NCT00882908|82974184|FG003|Overall Study|Adverse Event|0|||
46756156|NCT00882908|82974185|FG004|Overall Study|Adverse Event|1|||
46756157|NCT00882908|82974181|FG000|Overall Study|Lost to Follow-up|3|||
46756158|NCT00882908|82974182|FG001|Overall Study|Lost to Follow-up|5|||
46756159|NCT00882908|82974183|FG002|Overall Study|Lost to Follow-up|3|||
46756160|NCT00882908|82974184|FG003|Overall Study|Lost to Follow-up|1|||
46756161|NCT00882908|82974185|FG004|Overall Study|Lost to Follow-up|2|||
46756162|NCT00882908|82974181|FG000|Overall Study|Protocol Violation|0|||
46756163|NCT00882908|82974182|FG001|Overall Study|Protocol Violation|1|||
46756164|NCT00882908|82974183|FG002|Overall Study|Protocol Violation|0|||
46756165|NCT00882908|82974184|FG003|Overall Study|Protocol Violation|0|||
46756166|NCT00882908|82974185|FG004|Overall Study|Protocol Violation|0|||
46756167|NCT00882908|82974181|FG000|Overall Study|Withdrawal by Subject|0|||
46756168|NCT00882908|82974182|FG001|Overall Study|Withdrawal by Subject|0|||
46756169|NCT00882908|82974183|FG002|Overall Study|Withdrawal by Subject|3|||
46756170|NCT00882908|82974184|FG003|Overall Study|Withdrawal by Subject|5|||
46756171|NCT00882908|82974185|FG004|Overall Study|Withdrawal by Subject|2|||
46929358|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
46929359|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
47055150|NCT01775189|83328524|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
47055151|NCT01775189|83328525|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
47055152|NCT01767467|83328670|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
47055153|NCT01767467|83328671|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
47055154|NCT01767467|83328670|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
47055155|NCT01767467|83328671|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
47055156|NCT01767467|83328670|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
47055157|NCT01767467|83328671|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
47055158|NCT01767467|83328670|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
47055159|NCT01767467|83328671|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
47055160|NCT01767467|83328670|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
47055161|NCT01767467|83328671|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
47055162|NCT01767467|83328670|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
47055163|NCT01767467|83328671|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
47055164|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
47055165|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
47055166|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
47055167|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
47055168|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
47055169|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
47055170|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
47055171|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
47055172|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
47055173|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
47055174|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
47055175|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
47055176|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
47055177|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
47055178|NCT01767467|83328670|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
47055179|NCT01767467|83328671|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
47055180|NCT04126083|83328744|FG000|Overall Study|Withdrawal by Subject|1|||
47055181|NCT01766921|83328784|FG000|Overall Study|Administrative Reason|5|||
47055182|NCT01766921|83328785|FG001|Overall Study|Administrative Reason|5|||
47055183|NCT01766921|83328784|FG000|Overall Study|Death|1|||
47055184|NCT01766921|83328785|FG001|Overall Study|Death|1|||
47055185|NCT01766921|83328784|FG000|Overall Study|Lost to Follow-up|1|||
47055186|NCT01766921|83328785|FG001|Overall Study|Lost to Follow-up|3|||
47055187|NCT01766921|83328784|FG000|Overall Study|Unclassified|2|||
47055188|NCT01766921|83328785|FG001|Overall Study|Unclassified|2|||
47055189|NCT01766921|83328784|FG000|Overall Study|Protocol Violation|1|||
47055190|NCT01766921|83328785|FG001|Overall Study|Protocol Violation|1|||
46814444|NCT02877134|83034172|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814445|NCT02877134|83034173|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
46814446|NCT02877134|83034174|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814447|NCT02877134|83034175|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814448|NCT02877134|83034176|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814449|NCT02877134|83034177|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814450|NCT02877134|83034178|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814451|NCT02877134|83034179|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
46814452|NCT02877134|83034168|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814453|NCT02877134|83034169|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
46814454|NCT02877134|83034170|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814455|NCT02877134|83034171|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
46814456|NCT02877134|83034172|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814457|NCT02877134|83034173|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814458|NCT02877134|83034174|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
46814459|NCT02877134|83034175|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814460|NCT02877134|83034176|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814461|NCT02877134|83034177|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814462|NCT02877134|83034178|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814463|NCT02877134|83034179|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
46814464|NCT02877134|83034168|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
46814465|NCT02877134|83034169|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
46814466|NCT02877134|83034170|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
46814467|NCT02877134|83034171|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
46814468|NCT02877134|83034172|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
46814469|NCT02877134|83034173|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
46814470|NCT02877134|83034174|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
46814471|NCT02877134|83034175|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
46814472|NCT02877134|83034176|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
46814473|NCT02877134|83034177|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
46814474|NCT02877134|83034178|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
46814475|NCT02877134|83034179|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
46814476|NCT02877134|83034168|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
46814477|NCT02877134|83034169|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
46814478|NCT02877134|83034170|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
46814479|NCT02877134|83034171|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
46814480|NCT02877134|83034172|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
46814481|NCT02877134|83034173|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
46814482|NCT02877134|83034174|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
46814483|NCT02877134|83034175|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
46814484|NCT02877134|83034176|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
46929360|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
47055191|NCT01766921|83328784|FG000|Overall Study|Withdrawal by Subject|14|||
47055192|NCT01766921|83328785|FG001|Overall Study|Withdrawal by Subject|5|||
47055193|NCT01774799|83328803|FG000|Overall Study|Lost to Follow-up|1|||
46756172|NCT00882908|82974181|FG000|Overall Study|Subject reached a virologic endpoint|0|||
46756173|NCT00882908|82974182|FG001|Overall Study|Subject reached a virologic endpoint|0|||
46756174|NCT00882908|82974183|FG002|Overall Study|Subject reached a virologic endpoint|0|||
46756175|NCT00882908|82974184|FG003|Overall Study|Subject reached a virologic endpoint|0|||
46756176|NCT00882908|82974185|FG004|Overall Study|Subject reached a virologic endpoint|1|||
46756177|NCT00882908|82974181|FG000|Overall Study|Study terminated in error|0|||
46756178|NCT00882908|82974182|FG001|Overall Study|Study terminated in error|0|||
46756179|NCT00882908|82974183|FG002|Overall Study|Study terminated in error|0|||
46756180|NCT00882908|82974184|FG003|Overall Study|Study terminated in error|1|||
46756181|NCT00882908|82974185|FG004|Overall Study|Study terminated in error|0|||
46756182|NCT00851799|82974201|FG000|Overall Study|Death|1|||
46756183|NCT00851799|82974202|FG001|Overall Study|Death|0|||
46756184|NCT00851799|82974203|FG002|Overall Study|Death|1|||
46756185|NCT00851799|82974201|FG000|Overall Study|Lost to Follow-up|5|||
46756186|NCT00851799|82974202|FG001|Overall Study|Lost to Follow-up|3|||
46756187|NCT00851799|82974203|FG002|Overall Study|Lost to Follow-up|10|||
46756188|NCT00851799|82974201|FG000|Overall Study|Not able to get to clinic|8|||
46756189|NCT00851799|82974202|FG001|Overall Study|Not able to get to clinic|5|||
46756190|NCT00851799|82974203|FG002|Overall Study|Not able to get to clinic|9|||
46756191|NCT00851799|82974201|FG000|Overall Study|Not willing to adhere to requirements|1|||
46756192|NCT00851799|82974202|FG001|Overall Study|Not willing to adhere to requirements|2|||
46756193|NCT00851799|82974203|FG002|Overall Study|Not willing to adhere to requirements|2|||
46756194|NCT00851799|82974201|FG000|Overall Study|Withdrew consent prior study completion|1|||
46756195|NCT00851799|82974202|FG001|Overall Study|Withdrew consent prior study completion|2|||
46756196|NCT00851799|82974203|FG002|Overall Study|Withdrew consent prior study completion|1|||
46756197|NCT00851799|82974201|FG000|Overall Study|Severe Debilitation|0|||
46756198|NCT00851799|82974202|FG001|Overall Study|Severe Debilitation|1|||
46756199|NCT00851799|82974203|FG002|Overall Study|Severe Debilitation|0|||
46756200|NCT00851799|82974201|FG000|Overall Study|Completed protocol due to pregnancy|0|||
46756201|NCT00851799|82974202|FG001|Overall Study|Completed protocol due to pregnancy|0|||
46756202|NCT00851799|82974203|FG002|Overall Study|Completed protocol due to pregnancy|1|||
46756203|NCT00521053|82974211|FG000|Observation Phase|Disease Progression|55|||
46756204|NCT00521053|82974211|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
46756205|NCT00521053|82974211|FG000|Observation Phase|Death|2|||
46756206|NCT00521053|82974211|FG000|Observation Phase|Adverse Event|1|||
46756207|NCT00521053|82974211|FG000|Observation Phase|Other non-study melanoma treatment|1|||
46814485|NCT02877134|83034177|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
46814486|NCT02877134|83034178|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
46814487|NCT02877134|83034179|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
46814488|NCT02877134|83034168|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814489|NCT02877134|83034169|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814490|NCT02877134|83034170|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814491|NCT02877134|83034171|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814492|NCT02877134|83034172|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814493|NCT02877134|83034173|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814494|NCT02877134|83034174|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814495|NCT02877134|83034175|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814496|NCT02877134|83034176|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
46814497|NCT02877134|83034177|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814498|NCT02877134|83034178|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814499|NCT02877134|83034179|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
46814500|NCT02877134|83034168|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
46814501|NCT02877134|83034169|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
46814502|NCT02877134|83034170|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
46814503|NCT02877134|83034171|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
46814504|NCT02877134|83034172|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
46814505|NCT02877134|83034173|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
46814506|NCT02877134|83034174|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
46814507|NCT02877134|83034175|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
46814508|NCT02877134|83034176|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
46756208|NCT00521053|82974211|FG000|Observation Phase|Physician Decision|1|||
46756209|NCT00853047|82974223|FG000|Core Phase|Participant Request|0|||
46756210|NCT00853047|82974224|FG001|Core Phase|Participant Request|0|||
46756211|NCT00853047|82974225|FG002|Core Phase|Participant Request|0|||
46756212|NCT00853047|82974226|FG003|Core Phase|Participant Request|1|||
46756213|NCT00853047|82974227|FG004|Core Phase|Participant Request|0|||
46756214|NCT00853047|82974228|FG005|Core Phase|Participant Request|0|||
46756215|NCT00853047|82974223|FG000|Open-Label Extension Phase|Participant Request|0|||
46756216|NCT00853047|82974224|FG001|Open-Label Extension Phase|Participant Request|0|||
46756217|NCT00853047|82974225|FG002|Open-Label Extension Phase|Participant Request|0|||
46756218|NCT00853047|82974226|FG003|Open-Label Extension Phase|Participant Request|0|||
46756219|NCT00853047|82974227|FG004|Open-Label Extension Phase|Participant Request|0|||
46756220|NCT00853047|82974228|FG005|Open-Label Extension Phase|Participant Request|7|||
46756221|NCT00853047|82974223|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
46756222|NCT00853047|82974224|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
46756223|NCT00853047|82974225|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
46756224|NCT00853047|82974226|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
46814509|NCT02877134|83034177|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
46814510|NCT02877134|83034178|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
46814511|NCT02877134|83034179|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
46814512|NCT02877134|83034168|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814513|NCT02877134|83034169|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814514|NCT02877134|83034170|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814515|NCT02877134|83034171|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814516|NCT02877134|83034172|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814517|NCT02877134|83034173|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814518|NCT02877134|83034174|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814519|NCT02877134|83034175|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
46814520|NCT02877134|83034176|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
46814521|NCT02877134|83034177|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
46814522|NCT02877134|83034178|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814523|NCT02877134|83034179|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
46814524|NCT02877134|83034168|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
46814525|NCT02877134|83034169|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
46814526|NCT02877134|83034170|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
46814527|NCT02877134|83034171|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
46814528|NCT02877134|83034172|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
46814529|NCT02877134|83034173|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
46756225|NCT00853047|82974227|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
46814530|NCT02877134|83034174|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
46814531|NCT02877134|83034175|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
46756226|NCT00853047|82974228|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
46929361|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
46929362|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
46929363|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
46929364|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
46929365|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
46929366|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
47055194|NCT01774799|83328804|FG001|Overall Study|Lost to Follow-up|1|||
47055195|NCT01774799|83328805|FG002|Overall Study|Lost to Follow-up|0|||
47055196|NCT01774799|83328806|FG003|Overall Study|Lost to Follow-up|0|||
47055197|NCT01765751|83328848|FG000|Overall Study|Lost to Follow-up|0|||
47055198|NCT01765751|83328849|FG001|Overall Study|Lost to Follow-up|2|||
47055199|NCT01765751|83328850|FG002|Overall Study|Lost to Follow-up|1|||
47055200|NCT01736657|83328870|FG000|Overall Study|insufficient vascular access|1|||
47055201|NCT01736579|83328885|FG000|Overall Study|Termination of Study by Sponsor|2|||
47055202|NCT01736579|83328886|FG001|Overall Study|Termination of Study by Sponsor|2|||
47055203|NCT01765673|83328917|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
47055204|NCT01764659|83328924|FG000|Overall Study|Death|1|||
47055205|NCT01764659|83328924|FG000|Overall Study|Physician Decision|1|||
47055206|NCT01736189|83328930|FG000|Overall Study|Violation of registration criteria|41|||
47055207|NCT01736189|83328930|FG000|Overall Study|Protocol Violation|4|||
47055208|NCT01736189|83328930|FG000|Overall Study|Criteria and protocol violations|1|||
47055209|NCT01735175|83328962|FG000|Overall Study|Withdrawal by Subject|9|||
47055210|NCT01735175|83328963|FG001|Overall Study|Withdrawal by Subject|2|||
47055211|NCT01735175|83328962|FG000|Overall Study|Lost to Follow-up|4|||
47055212|NCT01735175|83328963|FG001|Overall Study|Lost to Follow-up|2|||
46756227|NCT00853047|82974223|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
46756228|NCT00853047|82974224|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
46756229|NCT00853047|82974225|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
46756230|NCT00853047|82974226|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
46756231|NCT00853047|82974227|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
46756232|NCT00853047|82974228|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
46756233|NCT00853047|82974223|FG000|Open-Label Extension Phase|Investigator Decision|0|||
46756234|NCT00853047|82974224|FG001|Open-Label Extension Phase|Investigator Decision|0|||
46756235|NCT00853047|82974225|FG002|Open-Label Extension Phase|Investigator Decision|0|||
46756236|NCT00853047|82974226|FG003|Open-Label Extension Phase|Investigator Decision|0|||
46756237|NCT00853047|82974227|FG004|Open-Label Extension Phase|Investigator Decision|0|||
46756238|NCT00853047|82974228|FG005|Open-Label Extension Phase|Investigator Decision|1|||
46756239|NCT00853047|82974223|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
46756240|NCT00853047|82974224|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
46756241|NCT00853047|82974225|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
46756242|NCT00853047|82974226|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
46756243|NCT00853047|82974227|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
46756244|NCT00853047|82974228|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
46756245|NCT00520975|82974245|FG000|Overall Study|Disease progression|31|||
46756246|NCT00520975|82974246|FG001|Overall Study|Disease progression|23|||
46756247|NCT00520975|82974245|FG000|Overall Study|Adverse Event|7|||
46756248|NCT00520975|82974246|FG001|Overall Study|Adverse Event|10|||
46756249|NCT00520975|82974245|FG000|Overall Study|Death|0|||
46756250|NCT00520975|82974246|FG001|Overall Study|Death|2|||
46756251|NCT00520975|82974245|FG000|Overall Study|Withdrawal by Subject|3|||
46756252|NCT00520975|82974246|FG001|Overall Study|Withdrawal by Subject|5|||
46756253|NCT00520975|82974245|FG000|Overall Study|Other therapy|2|||
46756254|NCT00520975|82974246|FG001|Overall Study|Other therapy|4|||
46756255|NCT00520975|82974245|FG000|Overall Study|Other reasons|4|||
46756256|NCT00520975|82974246|FG001|Overall Study|Other reasons|2|||
46756257|NCT00520975|82974245|FG000|Overall Study|Not start protocol therapy|1|||
46756258|NCT00520975|82974246|FG001|Overall Study|Not start protocol therapy|2|||
46756259|NCT00851721|82974254|FG000|Overall Study|planned surgery|1|||
46756260|NCT00851721|82974255|FG001|Overall Study|planned surgery|0|||
46756261|NCT00851721|82974254|FG000|Overall Study|Death|1|||
46756262|NCT00851721|82974255|FG001|Overall Study|Death|0|||
46756263|NCT00851721|82974254|FG000|Overall Study|Adverse Event|0|||
46756264|NCT00851721|82974255|FG001|Overall Study|Adverse Event|1|||
46756265|NCT00520741|82974269|FG000|Overall Study|Adverse Event|16|||
46756266|NCT00520741|82974270|FG001|Overall Study|Adverse Event|56|||
46929367|NCT03890120|83164280|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
46756267|NCT00520741|82974269|FG000|Overall Study|Lack of Efficacy|11|||
46756268|NCT00520741|82974270|FG001|Overall Study|Lack of Efficacy|30|||
46814532|NCT02877134|83034176|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
46814533|NCT02877134|83034177|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
47055213|NCT01735175|83328962|FG000|Overall Study|Death|3|||
47055214|NCT01735175|83328963|FG001|Overall Study|Death|2|||
47055215|NCT01735175|83328962|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
47055216|NCT01735175|83328963|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
47055217|NCT01762943|83328975|FG000|Overall Study|Physician Decision|1|||
46814534|NCT02877134|83034178|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
47055218|NCT01762943|83328976|FG001|Overall Study|Physician Decision|1|||
47055219|NCT01762943|83328975|FG000|Overall Study|Protocol Violation|1|||
47055220|NCT01762943|83328976|FG001|Overall Study|Protocol Violation|0|||
47055221|NCT01762943|83328975|FG000|Overall Study|Withdrawal by Subject|2|||
47055222|NCT01762943|83328976|FG001|Overall Study|Withdrawal by Subject|1|||
47055223|NCT01734785|83329039|FG000|Open-Label Period|Adverse Event|0|||
47055224|NCT01734785|83329040|FG001|Open-Label Period|Adverse Event|0|||
47055225|NCT01734785|83329041|FG002|Open-Label Period|Adverse Event|0|||
47055226|NCT01734785|83329042|FG003|Open-Label Period|Adverse Event|9|||
47055227|NCT01734785|83329039|FG000|Open-Label Period|Lack of Efficacy|0|||
47055228|NCT01734785|83329040|FG001|Open-Label Period|Lack of Efficacy|0|||
47055229|NCT01734785|83329041|FG002|Open-Label Period|Lack of Efficacy|0|||
47055230|NCT01734785|83329042|FG003|Open-Label Period|Lack of Efficacy|1|||
47055231|NCT01734785|83329039|FG000|Open-Label Period|Protocol Violation|0|||
47055232|NCT01734785|83329040|FG001|Open-Label Period|Protocol Violation|0|||
47055233|NCT01734785|83329041|FG002|Open-Label Period|Protocol Violation|0|||
47055234|NCT01734785|83329042|FG003|Open-Label Period|Protocol Violation|13|||
47055235|NCT01734785|83329039|FG000|Open-Label Period|Lost to Follow-up|0|||
47055236|NCT01734785|83329040|FG001|Open-Label Period|Lost to Follow-up|0|||
47055237|NCT01734785|83329041|FG002|Open-Label Period|Lost to Follow-up|0|||
47055238|NCT01734785|83329042|FG003|Open-Label Period|Lost to Follow-up|14|||
47055239|NCT01734785|83329039|FG000|Open-Label Period|Withdrawal by Subject|0|||
47055240|NCT01734785|83329040|FG001|Open-Label Period|Withdrawal by Subject|0|||
47055241|NCT01734785|83329041|FG002|Open-Label Period|Withdrawal by Subject|0|||
47055242|NCT01734785|83329042|FG003|Open-Label Period|Withdrawal by Subject|12|||
47055243|NCT01734785|83329039|FG000|Open-Label Period|Other Reasons|0|||
47055244|NCT01734785|83329040|FG001|Open-Label Period|Other Reasons|0|||
47055245|NCT01734785|83329041|FG002|Open-Label Period|Other Reasons|0|||
47055246|NCT01734785|83329042|FG003|Open-Label Period|Other Reasons|224|||
47055247|NCT01734785|83329039|FG000|Double-Blind Period|Adverse Event|0|||
46756269|NCT00520741|82974269|FG000|Overall Study|Withdrawal by Subject|0|||
46814535|NCT02877134|83034179|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
46814536|NCT00563381|83034205|FG000|Overall Study|Adverse Event|264|||
46814537|NCT00563381|83034206|FG001|Overall Study|Adverse Event|292|||
46814538|NCT00563381|83034205|FG000|Overall Study|Protocol Violation|66|||
46814539|NCT00563381|83034206|FG001|Overall Study|Protocol Violation|74|||
46814540|NCT00563381|83034205|FG000|Overall Study|Lost to Follow-up|7|||
46814541|NCT00563381|83034206|FG001|Overall Study|Lost to Follow-up|15|||
46814542|NCT00563381|83034205|FG000|Overall Study|Withdrawal by Subject|192|||
46814543|NCT00563381|83034206|FG001|Overall Study|Withdrawal by Subject|209|||
46814544|NCT00563381|83034205|FG000|Overall Study|Lack of Efficacy|32|||
46814545|NCT00563381|83034206|FG001|Overall Study|Lack of Efficacy|24|||
46814546|NCT00563381|83034205|FG000|Overall Study|Individual different reasons|24|||
46756270|NCT00520741|82974270|FG001|Overall Study|Withdrawal by Subject|11|||
46756271|NCT00520741|82974269|FG000|Overall Study|Protocol Violation|2|||
46756272|NCT00520741|82974270|FG001|Overall Study|Protocol Violation|15|||
46756273|NCT00520741|82974269|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
46756274|NCT00520741|82974270|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
46756275|NCT00520741|82974269|FG000|Overall Study|Lost to Follow-up|4|||
46756276|NCT00520741|82974270|FG001|Overall Study|Lost to Follow-up|4|||
46756277|NCT00520741|82974269|FG000|Overall Study|Other reasons for premature termination|0|||
46756278|NCT00520741|82974270|FG001|Overall Study|Other reasons for premature termination|6|||
46756279|NCT00882518|82974280|FG000|Overall Study|Adverse Event|9|||
46814547|NCT00563381|83034206|FG001|Overall Study|Individual different reasons|34|||
46814548|NCT00512798|83034214|FG000|Overall Study|Death|0|||
46929368|NCT03890120|83164281|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
46756280|NCT00882518|82974281|FG001|Overall Study|Adverse Event|18|||
46756281|NCT00882518|82974280|FG000|Overall Study|Withdrawal by Subject|9|||
46814549|NCT00512798|83034215|FG001|Overall Study|Death|3|||
47055248|NCT01734785|83329040|FG001|Double-Blind Period|Adverse Event|3|||
47055249|NCT01734785|83329041|FG002|Double-Blind Period|Adverse Event|2|||
47055250|NCT01734785|83329042|FG003|Double-Blind Period|Adverse Event|0|||
47055251|NCT01734785|83329039|FG000|Double-Blind Period|Lack of Efficacy|0|||
47055252|NCT01734785|83329040|FG001|Double-Blind Period|Lack of Efficacy|1|||
46814550|NCT00512798|83034214|FG000|Overall Study|Adverse Event|2|||
46814551|NCT00512798|83034215|FG001|Overall Study|Adverse Event|4|||
46814552|NCT00512798|83034214|FG000|Overall Study|Progression of disease|14|||
46814553|NCT00512798|83034215|FG001|Overall Study|Progression of disease|20|||
46814554|NCT00512798|83034214|FG000|Overall Study|Withdrawal by Subject|3|||
46814555|NCT00512798|83034215|FG001|Overall Study|Withdrawal by Subject|0|||
46814556|NCT00565721|83034222|FG000|Overall Study|Screen Failure|2|||
46814557|NCT00565721|83034222|FG000|Overall Study|Lost to Follow-up|6|||
46814558|NCT00565721|83034222|FG000|Overall Study|Technical Problems|1|||
46814559|NCT00565721|83034222|FG000|Overall Study|Physician Decision|2|||
46814560|NCT00565721|83034222|FG000|Overall Study|Other reasons|6|||
46814561|NCT00561977|83034252|FG000|Overall Study|Withdrawal by Subject|0|||
46814562|NCT00561977|83034253|FG001|Overall Study|Withdrawal by Subject|2|||
46814563|NCT00561977|83034254|FG002|Overall Study|Withdrawal by Subject|1|||
46814564|NCT00561977|83034252|FG000|Overall Study|Pregnancy|0|||
46814565|NCT00561977|83034253|FG001|Overall Study|Pregnancy|1|||
46814566|NCT00561977|83034254|FG002|Overall Study|Pregnancy|1|||
46814567|NCT00561821|83034266|FG000|Overall Study|Not treated|0|||
46814568|NCT00561821|83034267|FG001|Overall Study|Not treated|0|||
46814569|NCT00561821|83034268|FG002|Overall Study|Not treated|1|||
46814570|NCT00561821|83034269|FG003|Overall Study|Not treated|0|||
46814571|NCT00561821|83034266|FG000|Overall Study|Withdrawal by Subject|0|||
46814572|NCT00561821|83034267|FG001|Overall Study|Withdrawal by Subject|1|||
46814573|NCT00561821|83034268|FG002|Overall Study|Withdrawal by Subject|0|||
46814574|NCT00561821|83034269|FG003|Overall Study|Withdrawal by Subject|2|||
46814575|NCT00561821|83034266|FG000|Overall Study|Reasons not related to trial|2|||
46929369|NCT03890120|83164282|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
46929370|NCT03890120|83164283|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
46929371|NCT03890120|83164280|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
46929372|NCT03890120|83164281|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
46929373|NCT03890120|83164282|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
46929374|NCT03890120|83164283|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
46814576|NCT00561821|83034267|FG001|Overall Study|Reasons not related to trial|1|||
46814577|NCT00561821|83034268|FG002|Overall Study|Reasons not related to trial|0|||
46814578|NCT00561821|83034269|FG003|Overall Study|Reasons not related to trial|0|||
46814579|NCT00561821|83034266|FG000|Overall Study|Other (reason not specified)|1|||
46929375|NCT03890120|83164280|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
46929376|NCT03890120|83164281|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
46929377|NCT03890120|83164282|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
46929378|NCT03890120|83164283|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
46929379|NCT03890120|83164280|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
46929380|NCT03890120|83164281|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
46929381|NCT03890120|83164282|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
46756282|NCT00882518|82974281|FG001|Overall Study|Withdrawal by Subject|13|||
46756283|NCT00882518|82974280|FG000|Overall Study|Lack of Efficacy|12|||
46756284|NCT00882518|82974281|FG001|Overall Study|Lack of Efficacy|9|||
46756285|NCT00882518|82974280|FG000|Overall Study|Severe non-compliance to protocol|3|||
46756286|NCT00882518|82974281|FG001|Overall Study|Severe non-compliance to protocol|1|||
46756287|NCT00882518|82974280|FG000|Overall Study|Incorrect enrolment|4|||
46756288|NCT00882518|82974281|FG001|Overall Study|Incorrect enrolment|2|||
46756289|NCT00882518|82974280|FG000|Overall Study|Central lab closure for National day|1|||
46756290|NCT00882518|82974281|FG001|Overall Study|Central lab closure for National day|0|||
46756291|NCT00882518|82974280|FG000|Overall Study|Allocating random number by mistake|0|||
46756292|NCT00882518|82974281|FG001|Overall Study|Allocating random number by mistake|1|||
46756293|NCT00882362|82974298|FG000|Overall Study|Adverse Event|13|||
46756294|NCT00882362|82974299|FG001|Overall Study|Adverse Event|10|||
46756295|NCT00882362|82974298|FG000|Overall Study|Withdrawal by Subject|13|||
46756296|NCT00882362|82974299|FG001|Overall Study|Withdrawal by Subject|10|||
46756297|NCT00882362|82974298|FG000|Overall Study|Lack of Efficacy|3|||
46756298|NCT00882362|82974299|FG001|Overall Study|Lack of Efficacy|0|||
46756299|NCT00882362|82974298|FG000|Overall Study|Protocol Violation|7|||
46756300|NCT00882362|82974299|FG001|Overall Study|Protocol Violation|2|||
46756301|NCT00882362|82974298|FG000|Overall Study|Pregnancy|1|||
46756302|NCT00882362|82974299|FG001|Overall Study|Pregnancy|0|||
46756303|NCT00882362|82974298|FG000|Overall Study|Physician Decision|5|||
46756304|NCT00882362|82974299|FG001|Overall Study|Physician Decision|1|||
46814580|NCT00561821|83034267|FG001|Overall Study|Other (reason not specified)|1|||
46814581|NCT00561821|83034268|FG002|Overall Study|Other (reason not specified)|0|||
46814582|NCT00561821|83034269|FG003|Overall Study|Other (reason not specified)|0|||
46814583|NCT00561821|83034266|FG000|Overall Study|Adverse Event|2|||
46814584|NCT00561821|83034267|FG001|Overall Study|Adverse Event|3|||
46814585|NCT00561821|83034268|FG002|Overall Study|Adverse Event|1|||
46814586|NCT00561821|83034269|FG003|Overall Study|Adverse Event|1|||
46756305|NCT00882362|82974298|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
46814587|NCT00558701|83034281|FG000|Overall Study|Protocol Deviations|1|||
46814588|NCT00558701|83034282|FG001|Overall Study|Protocol Deviations|4|||
46814589|NCT03684044|83034290|FG000|Overall Study|Adverse Event|3|||
46814590|NCT03684044|83034291|FG001|Overall Study|Adverse Event|0|||
46814591|NCT03684044|83034290|FG000|Overall Study|Death|4|||
46814592|NCT03684044|83034291|FG001|Overall Study|Death|7|||
46814593|NCT03684044|83034290|FG000|Overall Study|Lost to Follow-up|3|||
46814594|NCT03684044|83034291|FG001|Overall Study|Lost to Follow-up|2|||
46814595|NCT03684044|83034290|FG000|Overall Study|Patient Not Available|0|||
46814596|NCT03684044|83034291|FG001|Overall Study|Patient Not Available|2|||
46814597|NCT03684044|83034290|FG000|Overall Study|Physician Decision|1|||
46814598|NCT03684044|83034291|FG001|Overall Study|Physician Decision|0|||
46814599|NCT03684044|83034290|FG000|Overall Study|Withdrawal by Subject|11|||
46814600|NCT03684044|83034291|FG001|Overall Study|Withdrawal by Subject|9|||
46814601|NCT00510692|83034299|FG000|Overall Study|Adverse Event|1|||
46814602|NCT00510692|83034300|FG001|Overall Study|Adverse Event|3|||
46814603|NCT00510692|83034299|FG000|Overall Study|Withdrawal by Subject|1|||
46814604|NCT00510692|83034300|FG001|Overall Study|Withdrawal by Subject|0|||
46814605|NCT00335452|83034312|FG000|Overall Study|Death|156|||
46814606|NCT00335452|83034313|FG001|Overall Study|Death|144|||
46814607|NCT00335452|83034314|FG002|Overall Study|Death|158|||
46814608|NCT00335452|83034315|FG003|Overall Study|Death|129|||
46814609|NCT00335452|83034312|FG000|Overall Study|Lost to Follow-up|2|||
46814610|NCT00335452|83034313|FG001|Overall Study|Lost to Follow-up|3|||
46814611|NCT00335452|83034314|FG002|Overall Study|Lost to Follow-up|1|||
46814612|NCT00335452|83034315|FG003|Overall Study|Lost to Follow-up|2|||
46814613|NCT00522548|83034332|FG000|Overall Study|Adverse Event|2|||
46814614|NCT00522548|83034333|FG001|Overall Study|Adverse Event|2|||
46814615|NCT00522548|83034332|FG000|Overall Study|Withdrawal by Subject|0|||
46814616|NCT00522548|83034333|FG001|Overall Study|Withdrawal by Subject|2|||
46929382|NCT03890120|83164283|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
46929383|NCT03890120|83164280|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
46929384|NCT03890120|83164281|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
46929385|NCT03890120|83164282|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
46929386|NCT03890120|83164283|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
46929387|NCT03783689|83164301|FG000|Overall Study|Adverse Event|2|||
46929388|NCT03783689|83164302|FG001|Overall Study|Adverse Event|0|||
46929389|NCT03783689|83164301|FG000|Overall Study|Lost to Follow-up|2|||
46929390|NCT03783689|83164302|FG001|Overall Study|Lost to Follow-up|1|||
46929391|NCT03783689|83164301|FG000|Overall Study|Physician Decision|2|||
46929392|NCT03783689|83164302|FG001|Overall Study|Physician Decision|1|||
46929393|NCT03783689|83164301|FG000|Overall Study|Withdrawal by Subject|3|||
46929394|NCT03783689|83164302|FG001|Overall Study|Withdrawal by Subject|3|||
46929395|NCT03771664|83164311|FG000|Overall Study|Adverse Event|1|||
46929396|NCT03771664|83164312|FG001|Overall Study|Adverse Event|0|||
46929397|NCT03771664|83164311|FG000|Overall Study|Lost to Follow-up|1|||
46929398|NCT03771664|83164312|FG001|Overall Study|Lost to Follow-up|0|||
47055253|NCT01734785|83329041|FG002|Double-Blind Period|Lack of Efficacy|0|||
47055254|NCT01734785|83329042|FG003|Double-Blind Period|Lack of Efficacy|0|||
46756306|NCT00882362|82974299|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
46756307|NCT00882362|82974298|FG000|Overall Study|change of residence or other commitments|5|||
46756308|NCT00882362|82974299|FG001|Overall Study|change of residence or other commitments|0|||
46756309|NCT00851643|82974311|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
46756310|NCT00851643|82974312|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
46814617|NCT00522392|83034341|FG000|Overall Study|Disease progression|0|||
46814618|NCT00522392|83034342|FG001|Overall Study|Disease progression|3|||
46814619|NCT00522392|83034341|FG000|Overall Study|Adverse Event|7|||
47055255|NCT01734785|83329039|FG000|Double-Blind Period|Protocol Violation|0|||
47055256|NCT01734785|83329040|FG001|Double-Blind Period|Protocol Violation|1|||
47055257|NCT01734785|83329041|FG002|Double-Blind Period|Protocol Violation|1|||
46756311|NCT00851643|82974313|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
46756312|NCT00851643|82974314|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
46756313|NCT00851643|82974315|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
47055258|NCT01734785|83329042|FG003|Double-Blind Period|Protocol Violation|0|||
46756314|NCT00851643|82974316|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
46814620|NCT00522392|83034342|FG001|Overall Study|Adverse Event|7|||
46814621|NCT00522392|83034341|FG000|Overall Study|Withdrawal by Subject|1|||
46814622|NCT00522392|83034342|FG001|Overall Study|Withdrawal by Subject|1|||
46814623|NCT00522392|83034341|FG000|Overall Study|Physician Decision|0|||
46814624|NCT00522392|83034342|FG001|Overall Study|Physician Decision|1|||
46814625|NCT00522392|83034341|FG000|Overall Study|Non-compliance|0|||
46814626|NCT00522392|83034342|FG001|Overall Study|Non-compliance|1|||
46814627|NCT00309244|83034350|FG000|Overall Study|Adverse Event|29|||
46814628|NCT00309244|83034351|FG001|Overall Study|Adverse Event|12|||
46929399|NCT03771664|83164311|FG000|Overall Study|Withdrawal by Participant|1|||
46929400|NCT03771664|83164312|FG001|Overall Study|Withdrawal by Participant|4|||
46929401|NCT03771664|83164311|FG000|Overall Study|Randomized but not Treated|0|||
46814629|NCT00309244|83034350|FG000|Overall Study|Lost to Follow-up|6|||
46814630|NCT00309244|83034351|FG001|Overall Study|Lost to Follow-up|22|||
46814631|NCT00309244|83034350|FG000|Overall Study|Physician Decision|5|||
46814632|NCT00309244|83034351|FG001|Overall Study|Physician Decision|8|||
46814633|NCT00309244|83034350|FG000|Overall Study|Protocol Violation|6|||
46814634|NCT00309244|83034351|FG001|Overall Study|Protocol Violation|3|||
46814635|NCT00309244|83034350|FG000|Overall Study|Withdrawal by Subject|50|||
46814636|NCT00309244|83034351|FG001|Overall Study|Withdrawal by Subject|32|||
46814637|NCT00309244|83034350|FG000|Overall Study|Various|7|||
46814638|NCT00309244|83034351|FG001|Overall Study|Various|7|||
46814639|NCT00309244|83034350|FG000|Overall Study|Randomized but not dosed|11|||
46814640|NCT00309244|83034351|FG001|Overall Study|Randomized but not dosed|12|||
46814641|NCT00309244|83034350|FG000|Overall Study|Death|4|||
46814642|NCT00309244|83034351|FG001|Overall Study|Death|1|||
46814643|NCT00483756|83034360|FG000|Overall Study|Death|2|||
46814644|NCT00483756|83034361|FG001|Overall Study|Death|0|||
46814645|NCT00483756|83034362|FG002|Overall Study|Death|1|||
46814646|NCT00483756|83034360|FG000|Overall Study|Adverse Event|19|||
46814647|NCT00483756|83034361|FG001|Overall Study|Adverse Event|38|||
46814648|NCT00483756|83034362|FG002|Overall Study|Adverse Event|40|||
46814649|NCT00483756|83034360|FG000|Overall Study|Lack of Efficacy|1|||
46814650|NCT00483756|83034361|FG001|Overall Study|Lack of Efficacy|0|||
46814651|NCT00483756|83034362|FG002|Overall Study|Lack of Efficacy|0|||
46756315|NCT00851643|82974311|FG000|Base Study (Up to 12 Months)|Other|0|||
46756316|NCT00851643|82974312|FG001|Base Study (Up to 12 Months)|Other|0|||
46756317|NCT00851643|82974313|FG002|Base Study (Up to 12 Months)|Other|0|||
46756318|NCT00851643|82974314|FG003|Base Study (Up to 12 Months)|Other|0|||
46756319|NCT00851643|82974315|FG004|Base Study (Up to 12 Months)|Other|0|||
46756320|NCT00851643|82974316|FG005|Base Study (Up to 12 Months)|Other|1|||
46756321|NCT00851643|82974311|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
46756322|NCT00851643|82974312|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
46756323|NCT00851643|82974313|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
46756324|NCT00851643|82974314|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
46756325|NCT00851643|82974315|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
46756326|NCT00851643|82974316|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
46756327|NCT00851643|82974311|FG000|Extension Study (Up to 36 Months)|Moved|0|||
46756328|NCT00851643|82974312|FG001|Extension Study (Up to 36 Months)|Moved|2|||
46756329|NCT00851643|82974313|FG002|Extension Study (Up to 36 Months)|Moved|1|||
46756330|NCT00851643|82974314|FG003|Extension Study (Up to 36 Months)|Moved|1|||
46756331|NCT00851643|82974315|FG004|Extension Study (Up to 36 Months)|Moved|0|||
46756332|NCT00851643|82974316|FG005|Extension Study (Up to 36 Months)|Moved|1|||
46756333|NCT00529243|82974329|FG000|Overall Study|Adverse Event|1|||
46756334|NCT00529243|82974329|FG000|Overall Study|Death|1|||
46756335|NCT00529243|82974329|FG000|Overall Study|Relocated|1|||
46756336|NCT03728309|82974335|FG000|Overall Study|Randomized but not Treated|0|||
46756337|NCT03728309|82974336|FG001|Overall Study|Randomized but not Treated|1|||
46756338|NCT03728309|82974335|FG000|Overall Study|Adverse Event|0|||
46756339|NCT03728309|82974336|FG001|Overall Study|Adverse Event|1|||
46756340|NCT03728309|82974335|FG000|Overall Study|Withdrawal by Subject|2|||
46756341|NCT03728309|82974336|FG001|Overall Study|Withdrawal by Subject|8|||
46756342|NCT03728309|82974335|FG000|Overall Study|Lost to Follow-up|9|||
46756343|NCT03728309|82974336|FG001|Overall Study|Lost to Follow-up|10|||
46756344|NCT03728309|82974335|FG000|Overall Study|Protocol Deviation|0|||
46756345|NCT03728309|82974336|FG001|Overall Study|Protocol Deviation|1|||
46756346|NCT03728309|82974335|FG000|Overall Study|Due to COVID|1|||
46756347|NCT03728309|82974336|FG001|Overall Study|Due to COVID|3|||
46756348|NCT03683719|82974353|FG000|Overall Study|Lack of Efficacy|1|||
46756349|NCT03683719|82974354|FG001|Overall Study|Lack of Efficacy|3|||
46756350|NCT03683719|82974355|FG002|Overall Study|Lack of Efficacy|4|||
46756351|NCT03683719|82974356|FG003|Overall Study|Lack of Efficacy|0|||
46756352|NCT03683719|82974357|FG004|Overall Study|Lack of Efficacy|4|||
46814652|NCT00483756|83034360|FG000|Overall Study|Lost to Follow-up|3|||
46814653|NCT00483756|83034361|FG001|Overall Study|Lost to Follow-up|1|||
46756353|NCT03683719|82974353|FG000|Overall Study|Adverse Event|6|||
46814654|NCT00483756|83034362|FG002|Overall Study|Lost to Follow-up|0|||
46929402|NCT03771664|83164312|FG001|Overall Study|Randomized but not Treated|1|||
46814655|NCT00483756|83034360|FG000|Overall Study|Withdrawal by Subject|5|||
46814656|NCT00483756|83034361|FG001|Overall Study|Withdrawal by Subject|3|||
46814657|NCT00483756|83034362|FG002|Overall Study|Withdrawal by Subject|4|||
46756354|NCT03683719|82974354|FG001|Overall Study|Adverse Event|6|||
46756355|NCT03683719|82974355|FG002|Overall Study|Adverse Event|0|||
46756356|NCT03683719|82974356|FG003|Overall Study|Adverse Event|1|||
46756357|NCT03683719|82974357|FG004|Overall Study|Adverse Event|3|||
46756358|NCT03683719|82974353|FG000|Overall Study|Withdrawal by Subject|4|||
46756359|NCT03683719|82974354|FG001|Overall Study|Withdrawal by Subject|4|||
46756360|NCT03683719|82974355|FG002|Overall Study|Withdrawal by Subject|3|||
46756361|NCT03683719|82974356|FG003|Overall Study|Withdrawal by Subject|5|||
46814658|NCT00483756|83034360|FG000|Overall Study|Other|2|||
46814659|NCT00483756|83034361|FG001|Overall Study|Other|4|||
46814660|NCT00483756|83034362|FG002|Overall Study|Other|3|||
46814661|NCT00483756|83034360|FG000|Overall Study|Randomized, Not Treated|1|||
46814662|NCT00483756|83034361|FG001|Overall Study|Randomized, Not Treated|4|||
46814663|NCT00483756|83034362|FG002|Overall Study|Randomized, Not Treated|4|||
46814664|NCT00309166|83034372|FG000|Overall Study|Adverse event, non-fatal|1|||
46814665|NCT00309166|83034373|FG001|Overall Study|Adverse event, non-fatal|0|||
46814666|NCT00309166|83034372|FG000|Overall Study|Withdrawal by Subject|4|||
46814667|NCT00309166|83034373|FG001|Overall Study|Withdrawal by Subject|3|||
46814668|NCT00501852|83034379|FG000|Overall Study|Adverse Event|3|||
46814669|NCT00501852|83034379|FG000|Overall Study|Withdrawal by Subject|2|||
46814670|NCT00482274|83034393|FG000|Overall Study|Adverse Event|1|||
46814671|NCT00490542|83034399|FG000|Overall Study|Lost to Follow-up|3|||
46814672|NCT00490542|83034400|FG001|Overall Study|Lost to Follow-up|0|||
46814673|NCT00490542|83034399|FG000|Overall Study|Adverse Event|3|||
46814674|NCT00490542|83034400|FG001|Overall Study|Adverse Event|3|||
46814675|NCT00490542|83034399|FG000|Overall Study|Lack of Efficacy|1|||
46814676|NCT00490542|83034400|FG001|Overall Study|Lack of Efficacy|1|||
46814677|NCT00501540|83034406|FG000|Overall Study|Death|5|||
46814678|NCT00322348|83034412|FG000|Overall Study|Adverse Event|0|||
46814679|NCT00322348|83034413|FG001|Overall Study|Adverse Event|1|||
46814680|NCT00322348|83034412|FG000|Overall Study|Withdrawal by Subject|1|||
46814681|NCT00322348|83034413|FG001|Overall Study|Withdrawal by Subject|4|||
46814682|NCT00322348|83034412|FG000|Overall Study|Lost to Follow-up|1|||
46814683|NCT00322348|83034413|FG001|Overall Study|Lost to Follow-up|0|||
46814684|NCT00322348|83034412|FG000|Overall Study|Death|0|||
46814685|NCT00322348|83034413|FG001|Overall Study|Death|2|||
46756362|NCT03683719|82974357|FG004|Overall Study|Withdrawal by Subject|5|||
46756363|NCT03683719|82974353|FG000|Overall Study|Lost to Follow-up|1|||
46756364|NCT03683719|82974354|FG001|Overall Study|Lost to Follow-up|0|||
46756365|NCT03683719|82974355|FG002|Overall Study|Lost to Follow-up|0|||
46756366|NCT03683719|82974356|FG003|Overall Study|Lost to Follow-up|1|||
46756367|NCT03683719|82974357|FG004|Overall Study|Lost to Follow-up|1|||
46756368|NCT03683719|82974353|FG000|Overall Study|Other personal reasons|0|||
46756369|NCT03683719|82974354|FG001|Overall Study|Other personal reasons|0|||
46756370|NCT03683719|82974355|FG002|Overall Study|Other personal reasons|1|||
46756371|NCT03683719|82974356|FG003|Overall Study|Other personal reasons|0|||
46756372|NCT03683719|82974357|FG004|Overall Study|Other personal reasons|1|||
46756373|NCT00851253|82974371|FG000|Overall Study|Disease Progression|1|||
46756374|NCT00851253|82974372|FG001|Overall Study|Disease Progression|0|||
46756375|NCT00520351|82974380|FG000|First Intervention|Withdrawal by Subject|1|||
46756376|NCT00520351|82974381|FG001|First Intervention|Withdrawal by Subject|1|||
46756377|NCT00850395|82974391|FG000|Overall Study|Death|1|||
46756378|NCT00850395|82974391|FG000|Overall Study|Adverse Event|1|||
46756379|NCT00850395|82974391|FG000|Overall Study|Insufficient clinical response|3|||
46756380|NCT00850395|82974391|FG000|Overall Study|Other|5|||
46756381|NCT00520039|82974397|FG000|Overall Study|Exclusion criteria met at first visit|7|||
46756382|NCT00520039|82974398|FG001|Overall Study|Exclusion criteria met at first visit|5|||
46756383|NCT00577720|82974410|FG000|Overall Study|Adverse Event|2|||
46756384|NCT00577720|82974411|FG001|Overall Study|Adverse Event|1|||
46756385|NCT00577720|82974412|FG002|Overall Study|Adverse Event|0|||
46756386|NCT00577720|82974413|FG003|Overall Study|Adverse Event|4|||
46756387|NCT00577720|82974410|FG000|Overall Study|Lost to Follow-up|0|||
46756388|NCT00577720|82974411|FG001|Overall Study|Lost to Follow-up|0|||
46756389|NCT00577720|82974412|FG002|Overall Study|Lost to Follow-up|1|||
46756390|NCT00577720|82974413|FG003|Overall Study|Lost to Follow-up|0|||
46756391|NCT00577720|82974410|FG000|Overall Study|Protocol Violation|0|||
46756392|NCT00577720|82974411|FG001|Overall Study|Protocol Violation|0|||
46756393|NCT00577720|82974412|FG002|Overall Study|Protocol Violation|0|||
46756394|NCT00577720|82974413|FG003|Overall Study|Protocol Violation|1|||
46756395|NCT00577720|82974410|FG000|Overall Study|Withdrawal by Subject|2|||
46756396|NCT00577720|82974411|FG001|Overall Study|Withdrawal by Subject|0|||
46756397|NCT00577720|82974412|FG002|Overall Study|Withdrawal by Subject|0|||
46756398|NCT00577720|82974413|FG003|Overall Study|Withdrawal by Subject|2|||
46814686|NCT00322348|83034412|FG000|Overall Study|Disease Progression|30|||
46814687|NCT00322348|83034413|FG001|Overall Study|Disease Progression|25|||
46814688|NCT00322348|83034412|FG000|Overall Study|Reasons not specified|5|||
46814689|NCT00322348|83034413|FG001|Overall Study|Reasons not specified|1|||
46756399|NCT00519649|82974423|FG000|Overall Study|Withdrawal by Subject|1|||
46756400|NCT00512707|82974441|FG000|Overall Study|Lost to Follow-up|5|||
46756401|NCT00512707|82974442|FG001|Overall Study|Lost to Follow-up|11|||
46756402|NCT00512707|82974441|FG000|Overall Study|Developed skin irritation|2|||
46814690|NCT00501228|83034419|FG000|Overall Study|Withdrawal by Subject|1|||
46814691|NCT00308620|83034426|FG000|Overall Study|Death|1|||
46814692|NCT00308620|83034427|FG001|Overall Study|Death|1|||
46814693|NCT00308620|83034428|FG002|Overall Study|Death|0|||
46814694|NCT00308620|83034426|FG000|Overall Study|Lost to Follow-up|0|||
46814695|NCT00308620|83034427|FG001|Overall Study|Lost to Follow-up|0|||
46756403|NCT00512707|82974442|FG001|Overall Study|Developed skin irritation|1|||
46756404|NCT00512707|82974441|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
46814696|NCT00308620|83034428|FG002|Overall Study|Lost to Follow-up|1|||
46814697|NCT00492752|83034438|FG000|Double Blind Treatment|Death|13|||
46814698|NCT00492752|83034439|FG001|Double Blind Treatment|Death|0|||
46814699|NCT00492752|83034440|FG002|Double Blind Treatment|Death|2|||
46814700|NCT00492752|83034441|FG003|Double Blind Treatment|Death|0|||
46814701|NCT00492752|83034438|FG000|Double Blind Treatment|Adverse Event|1|||
46814702|NCT00492752|83034439|FG001|Double Blind Treatment|Adverse Event|0|||
46814703|NCT00492752|83034440|FG002|Double Blind Treatment|Adverse Event|0|||
46814704|NCT00492752|83034441|FG003|Double Blind Treatment|Adverse Event|0|||
46814705|NCT00492752|83034438|FG000|Double Blind Treatment|Protocol Violation|0|||
46814706|NCT00492752|83034439|FG001|Double Blind Treatment|Protocol Violation|0|||
46814707|NCT00492752|83034440|FG002|Double Blind Treatment|Protocol Violation|1|||
46814708|NCT00492752|83034441|FG003|Double Blind Treatment|Protocol Violation|0|||
46814709|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
46814710|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
46814711|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
46814712|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
46814713|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
46814714|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
46814715|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
46814716|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
46814717|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
46814718|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
46814719|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
46814720|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
46814721|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
46814722|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
46814723|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
46814724|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
46814725|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
46814726|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
46814727|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
46814728|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
46814729|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
46814730|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
46814731|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
46814732|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
46814733|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
46814734|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
46814735|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
46814736|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
46814737|NCT00492752|83034438|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
46756405|NCT00512707|82974442|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
46756406|NCT00512707|82974441|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
46756407|NCT00512707|82974442|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
46756408|NCT03471767|82974450|FG000|Overall Study|Withdrawal by Subject|3|||
46756409|NCT03471767|82974451|FG001|Overall Study|Withdrawal by Subject|1|||
46756410|NCT03471767|82974450|FG000|Overall Study|Adverse Event|1|||
46756411|NCT03471767|82974451|FG001|Overall Study|Adverse Event|0|||
46756412|NCT03471767|82974450|FG000|Overall Study|Lost to Follow-up|1|||
46756413|NCT03471767|82974451|FG001|Overall Study|Lost to Follow-up|0|||
46756414|NCT03471767|82974450|FG000|Overall Study|PI Withdrawal|1|||
46756415|NCT03471767|82974451|FG001|Overall Study|PI Withdrawal|3|||
46756416|NCT00849693|82974461|FG000|Acute Treatment Phase|Adverse Event|12|||
46756417|NCT00849693|82974462|FG001|Acute Treatment Phase|Adverse Event|7|||
46756418|NCT00849693|82974463|FG002|Acute Treatment Phase|Adverse Event|6|||
46756419|NCT00849693|82974464|FG003|Acute Treatment Phase|Adverse Event|4|||
46756420|NCT00849693|82974461|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
46756421|NCT00849693|82974462|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
46756422|NCT00849693|82974463|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
46756423|NCT00849693|82974464|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
46814738|NCT00492752|83034439|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
46814739|NCT00492752|83034440|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
46814740|NCT00492752|83034441|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
46814741|NCT00308308|83034450|FG000|Overall Study|Adverse Event|17|||
46814742|NCT00308308|83034451|FG001|Overall Study|Adverse Event|2|||
46756424|NCT00849693|82974461|FG000|Acute Treatment Phase|Protocol Violation|1|||
46756425|NCT00849693|82974462|FG001|Acute Treatment Phase|Protocol Violation|5|||
46929403|NCT03743415|83164328|FG000|Overall Study|Death|5|||
46929404|NCT03743415|83164329|FG001|Overall Study|Death|3|||
46929405|NCT03743415|83164330|FG002|Overall Study|Death|1|||
46929406|NCT03743415|83164331|FG003|Overall Study|Death|4|||
46929407|NCT03743415|83164332|FG004|Overall Study|Death|0|||
46929408|NCT03743415|83164333|FG005|Overall Study|Death|0|||
46929409|NCT03743415|83164334|FG006|Overall Study|Death|0|||
46929410|NCT03743415|83164335|FG007|Overall Study|Death|0|||
46929411|NCT03743415|83164336|FG008|Overall Study|Death|1|||
46929412|NCT03743415|83164337|FG009|Overall Study|Death|0|||
46929413|NCT03743415|83164328|FG000|Overall Study|Withdrawal by Subject|1|||
46929414|NCT03743415|83164329|FG001|Overall Study|Withdrawal by Subject|0|||
47055259|NCT01734785|83329039|FG000|Double-Blind Period|Lost to Follow-up|2|||
47055260|NCT01734785|83329040|FG001|Double-Blind Period|Lost to Follow-up|4|||
47055261|NCT01734785|83329041|FG002|Double-Blind Period|Lost to Follow-up|2|||
47055262|NCT01734785|83329042|FG003|Double-Blind Period|Lost to Follow-up|0|||
47055263|NCT01734785|83329039|FG000|Double-Blind Period|Withdrawal by Subject|2|||
47055264|NCT01734785|83329040|FG001|Double-Blind Period|Withdrawal by Subject|0|||
47055265|NCT01734785|83329041|FG002|Double-Blind Period|Withdrawal by Subject|0|||
47055266|NCT01734785|83329042|FG003|Double-Blind Period|Withdrawal by Subject|0|||
47055267|NCT01734785|83329039|FG000|Double-Blind Period|Not treated|1|||
47055268|NCT01734785|83329040|FG001|Double-Blind Period|Not treated|0|||
47055269|NCT01734785|83329041|FG002|Double-Blind Period|Not treated|0|||
47055270|NCT01734785|83329042|FG003|Double-Blind Period|Not treated|0|||
47055271|NCT01734395|83329051|FG000|Overall Study|Other|65|||
47055272|NCT01734395|83329051|FG000|Overall Study|Lost to Follow-up|287|||
46636564|NCT01484496|82810391|FG003|Period 1|Positive Pregnancy|0|||
46756426|NCT00849693|82974463|FG002|Acute Treatment Phase|Protocol Violation|2|||
46756427|NCT00849693|82974464|FG003|Acute Treatment Phase|Protocol Violation|6|||
46756428|NCT00849693|82974461|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
46756429|NCT00849693|82974462|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
46756430|NCT00849693|82974463|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
46756431|NCT00849693|82974464|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
46756432|NCT00849693|82974461|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
46756433|NCT00849693|82974462|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
46756434|NCT00849693|82974463|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
46756435|NCT00849693|82974464|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
46636565|NCT01484496|82810388|FG000|Period 1|Treatment Failure|3|||
46636566|NCT01484496|82810389|FG001|Period 1|Treatment Failure|6|||
46756436|NCT00849693|82974461|FG000|Acute Treatment Phase|Physician Decision|2|||
46756437|NCT00849693|82974462|FG001|Acute Treatment Phase|Physician Decision|1|||
46756438|NCT00849693|82974463|FG002|Acute Treatment Phase|Physician Decision|2|||
46756439|NCT00849693|82974464|FG003|Acute Treatment Phase|Physician Decision|1|||
46756440|NCT00849693|82974461|FG000|Acute Treatment Phase|Sponsor decision|0|||
46756441|NCT00849693|82974462|FG001|Acute Treatment Phase|Sponsor decision|0|||
46756442|NCT00849693|82974463|FG002|Acute Treatment Phase|Sponsor decision|1|||
46756443|NCT00849693|82974464|FG003|Acute Treatment Phase|Sponsor decision|0|||
46756444|NCT00849693|82974461|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
46756445|NCT00849693|82974462|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
46756446|NCT00849693|82974463|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
46756447|NCT00849693|82974464|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
46929415|NCT03743415|83164330|FG002|Overall Study|Withdrawal by Subject|4|||
46929416|NCT03743415|83164331|FG003|Overall Study|Withdrawal by Subject|5|||
46636567|NCT01484496|82810390|FG002|Period 1|Treatment Failure|0|||
47055273|NCT01734395|83329051|FG000|Overall Study|Lack of Efficacy|5|||
46756448|NCT00849693|82974461|FG000|Extension Phase|Adverse Event|4|||
46756449|NCT00849693|82974462|FG001|Extension Phase|Adverse Event|6|||
46929417|NCT03743415|83164332|FG004|Overall Study|Withdrawal by Subject|5|||
46929418|NCT03743415|83164333|FG005|Overall Study|Withdrawal by Subject|2|||
46929419|NCT03743415|83164334|FG006|Overall Study|Withdrawal by Subject|2|||
46756450|NCT00849693|82974463|FG002|Extension Phase|Adverse Event|3|||
46756451|NCT00849693|82974464|FG003|Extension Phase|Adverse Event|7|||
46814743|NCT00308308|83034450|FG000|Overall Study|Lost to Follow-up|5|||
46814744|NCT00308308|83034451|FG001|Overall Study|Lost to Follow-up|5|||
46814745|NCT00308308|83034450|FG000|Overall Study|Physician Decision|15|||
46814746|NCT00308308|83034451|FG001|Overall Study|Physician Decision|7|||
46814747|NCT00308308|83034450|FG000|Overall Study|Protocol Violation|3|||
46814748|NCT00308308|83034451|FG001|Overall Study|Protocol Violation|14|||
46814749|NCT00308308|83034450|FG000|Overall Study|Withdrawal by Subject|47|||
46814750|NCT00308308|83034451|FG001|Overall Study|Withdrawal by Subject|19|||
46814751|NCT00308308|83034450|FG000|Overall Study|Various|7|||
46814752|NCT00308308|83034451|FG001|Overall Study|Various|5|||
46814753|NCT00308308|83034450|FG000|Overall Study|Randomized but not dosed|8|||
46814754|NCT00308308|83034451|FG001|Overall Study|Randomized but not dosed|16|||
46814755|NCT00308308|83034450|FG000|Overall Study|Other|1|||
46814756|NCT00308308|83034451|FG001|Overall Study|Other|0|||
46814757|NCT00505934|83034457|FG000|Overall Study|Adverse Event|1|||
46814758|NCT00505934|83034457|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
46814759|NCT00505934|83034457|FG000|Overall Study|Other: IV dose needed to be changed|1|||
46814760|NCT00505778|83034463|FG000|Overall Study|Adverse Event|2|||
46814761|NCT00505778|83034464|FG001|Overall Study|Adverse Event|7|||
46814762|NCT00505778|83034463|FG000|Overall Study|Physician Decision|8|||
46814763|NCT00505778|83034464|FG001|Overall Study|Physician Decision|14|||
46814764|NCT00505778|83034463|FG000|Overall Study|Lost to Follow-up|17|||
46814765|NCT00505778|83034464|FG001|Overall Study|Lost to Follow-up|23|||
46814766|NCT00505778|83034463|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
46814767|NCT00505778|83034464|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
46814768|NCT00505778|83034463|FG000|Overall Study|Protocol Violation|7|||
46814769|NCT00505778|83034464|FG001|Overall Study|Protocol Violation|9|||
46814770|NCT00505778|83034463|FG000|Overall Study|Withdrawal by Subject|29|||
46814771|NCT00505778|83034464|FG001|Overall Study|Withdrawal by Subject|14|||
46814772|NCT00505778|83034463|FG000|Overall Study|Relapse|65|||
46814773|NCT00505778|83034464|FG001|Overall Study|Relapse|65|||
46814774|NCT00505778|83034463|FG000|Overall Study|Took No Study Drug|2|||
46814775|NCT00505778|83034464|FG001|Overall Study|Took No Study Drug|2|||
46814776|NCT00308074|83034470|FG000|Overall Study|Withdrawal by Subject|1|||
46814777|NCT00500760|83034476|FG000|Overall Study|Death|32|||
46814778|NCT00500760|83034477|FG001|Overall Study|Death|15|||
46814779|NCT00500760|83034476|FG000|Overall Study|Withdrawal by Subject|5|||
46814780|NCT00500760|83034477|FG001|Overall Study|Withdrawal by Subject|7|||
46814781|NCT00500760|83034476|FG000|Overall Study|Administrative decision|2|||
46814782|NCT00500760|83034477|FG001|Overall Study|Administrative decision|0|||
46814783|NCT00500760|83034476|FG000|Overall Study|Lost to Follow-up|3|||
46814784|NCT00500760|83034477|FG001|Overall Study|Lost to Follow-up|0|||
47055274|NCT01734395|83329051|FG000|Overall Study|Adverse Event|40|||
47055275|NCT01734395|83329051|FG000|Overall Study|Withdrawal by Subject|10|||
47055276|NCT01734395|83329051|FG000|Overall Study|Missing the reasons for not completed|3|||
47055277|NCT01597505|83329085|FG000|Overall Study|Physician Decision|5|||
47055278|NCT01597505|83329086|FG001|Overall Study|Physician Decision|0|||
47055279|NCT01597505|83329085|FG000|Overall Study|Adverse Event|19|||
47055280|NCT01597505|83329086|FG001|Overall Study|Adverse Event|7|||
47055281|NCT01597505|83329085|FG000|Overall Study|Lost to Follow-up|4|||
47055282|NCT01597505|83329086|FG001|Overall Study|Lost to Follow-up|2|||
47055283|NCT01597505|83329085|FG000|Overall Study|Withdrawal by Subject|10|||
47055284|NCT01597505|83329086|FG001|Overall Study|Withdrawal by Subject|18|||
47055285|NCT01597505|83329085|FG000|Overall Study|Other|5|||
47055286|NCT01597505|83329086|FG001|Overall Study|Other|6|||
47055287|NCT01597505|83329085|FG000|Overall Study|Missing|1|||
46756452|NCT00849693|82974461|FG000|Extension Phase|Lost to Follow-up|7|||
46756453|NCT00849693|82974462|FG001|Extension Phase|Lost to Follow-up|5|||
46756454|NCT00849693|82974463|FG002|Extension Phase|Lost to Follow-up|6|||
46756455|NCT00849693|82974464|FG003|Extension Phase|Lost to Follow-up|6|||
46756456|NCT00849693|82974461|FG000|Extension Phase|Protocol Violation|0|||
46756457|NCT00849693|82974462|FG001|Extension Phase|Protocol Violation|3|||
46756458|NCT00849693|82974463|FG002|Extension Phase|Protocol Violation|2|||
47055288|NCT01597505|83329086|FG001|Overall Study|Missing|0|||
47055289|NCT01760447|83329125|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
46756459|NCT00849693|82974464|FG003|Extension Phase|Protocol Violation|3|||
46756460|NCT00849693|82974461|FG000|Extension Phase|Withdrawal by Subject|6|||
46756461|NCT00849693|82974462|FG001|Extension Phase|Withdrawal by Subject|9|||
46814785|NCT00500760|83034476|FG000|Overall Study|Other|1|||
46814786|NCT00500760|83034477|FG001|Overall Study|Other|2|||
46814787|NCT00505622|83034486|FG000|Overall Study|Adverse Event|5|||
46814788|NCT00505622|83034487|FG001|Overall Study|Adverse Event|6|||
46814789|NCT00505622|83034488|FG002|Overall Study|Adverse Event|4|||
46814790|NCT00505622|83034486|FG000|Overall Study|Protocol Violation|1|||
46814791|NCT00505622|83034487|FG001|Overall Study|Protocol Violation|1|||
47055290|NCT01760447|83329126|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
46814792|NCT00505622|83034488|FG002|Overall Study|Protocol Violation|0|||
46814793|NCT00505622|83034486|FG000|Overall Study|Withdrawal by Subject|0|||
46814794|NCT00505622|83034487|FG001|Overall Study|Withdrawal by Subject|3|||
46814795|NCT00505622|83034488|FG002|Overall Study|Withdrawal by Subject|2|||
46814796|NCT00505622|83034486|FG000|Overall Study|Study termination by sponsor|115|||
47055291|NCT01760447|83329127|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
47055292|NCT01760447|83329128|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
47055293|NCT01760447|83329125|FG000|Weeks 0-20|Withdrawal by Subject|2|||
47055294|NCT01760447|83329126|FG001|Weeks 0-20|Withdrawal by Subject|0|||
47055295|NCT01760447|83329127|FG002|Weeks 0-20|Withdrawal by Subject|1|||
47055296|NCT01760447|83329128|FG003|Weeks 0-20|Withdrawal by Subject|0|||
47055297|NCT01760447|83329125|FG000|Weeks 0-20|Lost to Follow-up|1|||
47055298|NCT01760447|83329126|FG001|Weeks 0-20|Lost to Follow-up|0|||
47055299|NCT01760447|83329127|FG002|Weeks 0-20|Lost to Follow-up|1|||
47055300|NCT01760447|83329128|FG003|Weeks 0-20|Lost to Follow-up|1|||
47055301|NCT01760447|83329125|FG000|Weeks 0-20|Randomized but not treated|0|||
47055302|NCT01760447|83329126|FG001|Weeks 0-20|Randomized but not treated|0|||
47055303|NCT01760447|83329127|FG002|Weeks 0-20|Randomized but not treated|2|||
47055304|NCT01760447|83329128|FG003|Weeks 0-20|Randomized but not treated|0|||
47055305|NCT01760447|83329125|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
47055306|NCT01760447|83329126|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
47055307|NCT01760447|83329127|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
47055308|NCT01760447|83329128|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
47055309|NCT01760447|83329125|FG000|Weeks 20-54|Withdrawal by Subject|2|||
47055310|NCT01760447|83329126|FG001|Weeks 20-54|Withdrawal by Subject|1|||
47055311|NCT01760447|83329127|FG002|Weeks 20-54|Withdrawal by Subject|1|||
47055312|NCT01760447|83329128|FG003|Weeks 20-54|Withdrawal by Subject|2|||
46756462|NCT00849693|82974463|FG002|Extension Phase|Withdrawal by Subject|10|||
46756463|NCT00849693|82974464|FG003|Extension Phase|Withdrawal by Subject|15|||
46756464|NCT00849693|82974461|FG000|Extension Phase|Parent or caregiver decision|9|||
46756465|NCT00849693|82974462|FG001|Extension Phase|Parent or caregiver decision|4|||
46756466|NCT00849693|82974463|FG002|Extension Phase|Parent or caregiver decision|10|||
46756467|NCT00849693|82974464|FG003|Extension Phase|Parent or caregiver decision|5|||
46756468|NCT00849693|82974461|FG000|Extension Phase|Physician Decision|1|||
46756469|NCT00849693|82974462|FG001|Extension Phase|Physician Decision|1|||
46756470|NCT00849693|82974463|FG002|Extension Phase|Physician Decision|2|||
47055313|NCT01760447|83329125|FG000|Weeks 20-54|Lost to Follow-up|0|||
47055314|NCT01760447|83329126|FG001|Weeks 20-54|Lost to Follow-up|0|||
47055315|NCT01760447|83329127|FG002|Weeks 20-54|Lost to Follow-up|1|||
47055316|NCT01760447|83329128|FG003|Weeks 20-54|Lost to Follow-up|2|||
47055317|NCT01732913|83329217|FG000|Overall Study|Study Terminated by Sponsor|105|||
47055318|NCT01732913|83329218|FG001|Overall Study|Study Terminated by Sponsor|55|||
46756471|NCT00849693|82974464|FG003|Extension Phase|Physician Decision|0|||
46756472|NCT00849693|82974461|FG000|Extension Phase|Sponsor decision|1|||
46756473|NCT00849693|82974462|FG001|Extension Phase|Sponsor decision|0|||
46756474|NCT00849693|82974463|FG002|Extension Phase|Sponsor decision|0|||
46756475|NCT00849693|82974464|FG003|Extension Phase|Sponsor decision|1|||
46756476|NCT00849693|82974461|FG000|Extension Phase|Lack of Efficacy|2|||
46756477|NCT00849693|82974462|FG001|Extension Phase|Lack of Efficacy|2|||
46756478|NCT00849693|82974463|FG002|Extension Phase|Lack of Efficacy|2|||
46756479|NCT00849693|82974464|FG003|Extension Phase|Lack of Efficacy|1|||
46756480|NCT00527605|82974488|FG000|Overall Study|Adverse Event|3|||
46756481|NCT00527605|82974489|FG001|Overall Study|Adverse Event|0|||
46756482|NCT00527605|82974488|FG000|Overall Study|Withdrawal by Subject|3|||
46756483|NCT00527605|82974489|FG001|Overall Study|Withdrawal by Subject|7|||
46756484|NCT00527605|82974488|FG000|Overall Study|Lost to Follow-up|6|||
46756485|NCT00527605|82974489|FG001|Overall Study|Lost to Follow-up|2|||
46756486|NCT00527605|82974488|FG000|Overall Study|Protocol Violation|1|||
46756487|NCT00527605|82974489|FG001|Overall Study|Protocol Violation|2|||
46756488|NCT00849381|82974495|FG000|Overall Study|Adverse Event|1|||
46756489|NCT00849381|82974495|FG000|Overall Study|Lost to Follow-up|129|||
46756490|NCT00849381|82974495|FG000|Overall Study|Protocol Violation|5|||
46636568|NCT01484496|82810391|FG003|Period 1|Treatment Failure|0|||
46756491|NCT00849381|82974495|FG000|Overall Study|Withdrawal by Subject|6|||
46756492|NCT00849381|82974495|FG000|Overall Study|Other|4|||
46756493|NCT00711412|82974499|FG000|Induction Treatment|Death|2|||
46756494|NCT00711412|82974499|FG000|Induction Treatment|Adverse Event|1|||
46756495|NCT00711412|82974499|FG000|Induction Treatment|Other|1|||
46814797|NCT00505622|83034487|FG001|Overall Study|Study termination by sponsor|98|||
46756496|NCT00711412|82974499|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
46756497|NCT00711412|82974499|FG000|Evaluated for Combination Treatment|Death|1|||
46814798|NCT00505622|83034488|FG002|Overall Study|Study termination by sponsor|90|||
47055319|NCT01732913|83329217|FG000|Overall Study|Withdrawal by Subject|27|||
47055320|NCT01732913|83329218|FG001|Overall Study|Withdrawal by Subject|4|||
47055321|NCT01732913|83329217|FG000|Overall Study|Physician Decision|14|||
46814799|NCT03851094|83034498|FG000|Overall Study|Withdrawal by Subject|0|||
46814800|NCT03851094|83034499|FG001|Overall Study|Withdrawal by Subject|1|||
46814801|NCT03851094|83034498|FG000|Overall Study|Participant lost device|0|||
46814802|NCT03851094|83034499|FG001|Overall Study|Participant lost device|1|||
46814803|NCT03851094|83034498|FG000|Overall Study|Participant returned device|0|||
46814804|NCT03851094|83034499|FG001|Overall Study|Participant returned device|2|||
46814805|NCT00505076|83034510|FG000|Overall Study|Adverse Event|1|||
46814806|NCT00505076|83034511|FG001|Overall Study|Adverse Event|0|||
46814807|NCT00505076|83034512|FG002|Overall Study|Adverse Event|1|||
46814808|NCT00505076|83034510|FG000|Overall Study|Protocol Violation|2|||
46814809|NCT00505076|83034511|FG001|Overall Study|Protocol Violation|1|||
46814810|NCT00505076|83034512|FG002|Overall Study|Protocol Violation|2|||
46814811|NCT00505076|83034510|FG000|Overall Study|Withdrawal by Subject|0|||
46814812|NCT00505076|83034511|FG001|Overall Study|Withdrawal by Subject|1|||
46814813|NCT00505076|83034512|FG002|Overall Study|Withdrawal by Subject|2|||
46814814|NCT00307684|83034520|FG000|Open Label Phase|Lack of Efficacy|0|||
46814815|NCT00307684|83034521|FG001|Open Label Phase|Lack of Efficacy|0|||
46814816|NCT00307684|83034522|FG002|Open Label Phase|Lack of Efficacy|3|||
46814817|NCT00307684|83034520|FG000|Open Label Phase|Adverse Event|0|||
46814818|NCT00307684|83034521|FG001|Open Label Phase|Adverse Event|0|||
46814819|NCT00307684|83034522|FG002|Open Label Phase|Adverse Event|16|||
46814820|NCT00307684|83034520|FG000|Open Label Phase|Withdrawal by Subject|0|||
46814821|NCT00307684|83034521|FG001|Open Label Phase|Withdrawal by Subject|0|||
46814822|NCT00307684|83034522|FG002|Open Label Phase|Withdrawal by Subject|15|||
46814823|NCT00307684|83034520|FG000|Open Label Phase|Lost to Follow-up|0|||
46814824|NCT00307684|83034521|FG001|Open Label Phase|Lost to Follow-up|0|||
46814825|NCT00307684|83034522|FG002|Open Label Phase|Lost to Follow-up|11|||
46814826|NCT00307684|83034520|FG000|Open Label Phase|non compliance|0|||
46814827|NCT00307684|83034521|FG001|Open Label Phase|non compliance|0|||
46814828|NCT00307684|83034522|FG002|Open Label Phase|non compliance|5|||
46814829|NCT00307684|83034520|FG000|Open Label Phase|other|0|||
46814830|NCT00307684|83034521|FG001|Open Label Phase|other|0|||
46814831|NCT00307684|83034522|FG002|Open Label Phase|other|6|||
46814832|NCT00307684|83034520|FG000|Double Blind Phase|Lack of Efficacy|2|||
46814833|NCT00307684|83034521|FG001|Double Blind Phase|Lack of Efficacy|5|||
46814834|NCT00307684|83034522|FG002|Double Blind Phase|Lack of Efficacy|0|||
46814835|NCT00489918|83034535|FG000|Overall Study|Withdrawal by Subject|2|||
46814836|NCT00489918|83034536|FG001|Overall Study|Withdrawal by Subject|1|||
46814837|NCT00489918|83034537|FG002|Overall Study|Withdrawal by Subject|1|||
46814838|NCT00489918|83034538|FG003|Overall Study|Withdrawal by Subject|0|||
46814839|NCT00489918|83034539|FG004|Overall Study|Withdrawal by Subject|1|||
46814840|NCT00489918|83034535|FG000|Overall Study|Adverse Event|0|||
46814841|NCT00489918|83034536|FG001|Overall Study|Adverse Event|1|||
46814842|NCT00489918|83034537|FG002|Overall Study|Adverse Event|1|||
46814843|NCT00489918|83034538|FG003|Overall Study|Adverse Event|0|||
46814844|NCT00489918|83034539|FG004|Overall Study|Adverse Event|0|||
46814845|NCT00489918|83034535|FG000|Overall Study|Lost to Follow-up|0|||
46814846|NCT00489918|83034536|FG001|Overall Study|Lost to Follow-up|0|||
46814847|NCT00489918|83034537|FG002|Overall Study|Lost to Follow-up|1|||
46814848|NCT00489918|83034538|FG003|Overall Study|Lost to Follow-up|1|||
46814849|NCT00489918|83034539|FG004|Overall Study|Lost to Follow-up|0|||
46814850|NCT00489918|83034535|FG000|Overall Study|Physician Decision|0|||
46814851|NCT00489918|83034536|FG001|Overall Study|Physician Decision|0|||
46814852|NCT00489918|83034537|FG002|Overall Study|Physician Decision|1|||
46814853|NCT00489918|83034538|FG003|Overall Study|Physician Decision|0|||
46814854|NCT00489918|83034539|FG004|Overall Study|Physician Decision|0|||
46814855|NCT00307294|83034551|FG000|Overall Study|Withdrawal by Subject|1|||
46814856|NCT03963401|83034562|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
46814857|NCT03963401|83034563|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
46814858|NCT03963401|83034564|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
46814859|NCT03963401|83034565|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
46814860|NCT03963401|83034566|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
46814861|NCT03963401|83034567|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
47055322|NCT01732913|83329218|FG001|Overall Study|Physician Decision|7|||
47055323|NCT01732913|83329217|FG000|Overall Study|Other|7|||
46814862|NCT03963401|83034562|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
46814863|NCT03963401|83034563|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
46814864|NCT03963401|83034564|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
46814865|NCT03963401|83034565|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
46814866|NCT03963401|83034566|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
46814867|NCT03963401|83034567|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
46814868|NCT03963401|83034562|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
46814869|NCT03963401|83034563|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
46814870|NCT03963401|83034564|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
46814871|NCT03963401|83034565|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
47055324|NCT01732913|83329218|FG001|Overall Study|Other|1|||
47055325|NCT01732913|83329217|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
46814872|NCT03963401|83034566|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
46756498|NCT00711412|82974499|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
46756499|NCT00711412|82974499|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
46814873|NCT03963401|83034567|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
46814874|NCT03963401|83034562|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
46814875|NCT03963401|83034563|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
46814876|NCT03963401|83034564|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
46814877|NCT03963401|83034565|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
46814878|NCT03963401|83034566|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
46814879|NCT03963401|83034567|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
46814880|NCT03963401|83034562|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
46814881|NCT03963401|83034563|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
46814882|NCT03963401|83034564|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
46929420|NCT03743415|83164335|FG007|Overall Study|Withdrawal by Subject|5|||
46929421|NCT03743415|83164336|FG008|Overall Study|Withdrawal by Subject|9|||
46929422|NCT03743415|83164337|FG009|Overall Study|Withdrawal by Subject|10|||
46929423|NCT03743415|83164328|FG000|Overall Study|Lost to Follow-up|2|||
46929424|NCT03743415|83164329|FG001|Overall Study|Lost to Follow-up|0|||
46929425|NCT03743415|83164330|FG002|Overall Study|Lost to Follow-up|2|||
46929426|NCT03743415|83164331|FG003|Overall Study|Lost to Follow-up|1|||
46929427|NCT03743415|83164332|FG004|Overall Study|Lost to Follow-up|1|||
46929428|NCT03743415|83164333|FG005|Overall Study|Lost to Follow-up|0|||
46929429|NCT03743415|83164334|FG006|Overall Study|Lost to Follow-up|1|||
47055326|NCT01732913|83329218|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
47055327|NCT01732835|83329249|FG000|6-month Primary Endpoint|Did not receive device|19|||
47055328|NCT01732835|83329249|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
47055329|NCT01732835|83329249|FG000|6-month Primary Endpoint|Adverse Event|3|||
47055330|NCT01732835|83329249|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
47055331|NCT01732835|83329249|FG000|2-year Extended Follow-up|Adverse Event|3|||
47055332|NCT01732835|83329249|FG000|2-year Extended Follow-up|Death|1|||
47055333|NCT01759511|83329303|FG000|Overall Study|Adverse Event|4|||
47055334|NCT01759511|83329303|FG000|Overall Study|Death|2|||
47055335|NCT01759511|83329303|FG000|Overall Study|Lack of Efficacy|2|||
47055336|NCT01759511|83329303|FG000|Overall Study|Physician Decision|1|||
46756500|NCT00711412|82974499|FG000|Combination Treatment|Progressive Disease|1|||
46756501|NCT00711412|82974499|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
46756502|NCT00711412|82974499|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
46756503|NCT00711412|82974499|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
46756504|NCT00711412|82974499|FG000|Evaluation for Response and Surgery|Death|1|||
46756505|NCT00711412|82974499|FG000|Survival Follow up Until Death|Other|12|||
46756506|NCT00577408|82974515|FG000|Overall Study|Stopped attending study visits|9|||
46756507|NCT00577408|82974516|FG001|Overall Study|Stopped attending study visits|11|||
46756508|NCT00577408|82974515|FG000|Overall Study|Continued opioid use|3|||
46756509|NCT00577408|82974516|FG001|Overall Study|Continued opioid use|2|||
46756510|NCT00577408|82974515|FG000|Overall Study|Non-compliance with study meds|0|||
46636569|NCT01484496|82810388|FG000|Period 1|Lack of Compliance|2|||
46756511|NCT00577408|82974516|FG001|Overall Study|Non-compliance with study meds|3|||
46756512|NCT00577408|82974515|FG000|Overall Study|Refused Oral Naltrexone|0|||
46756513|NCT00577408|82974516|FG001|Overall Study|Refused Oral Naltrexone|1|||
46756514|NCT00577408|82974515|FG000|Overall Study|Moved out of state|0|||
46756515|NCT00577408|82974516|FG001|Overall Study|Moved out of state|1|||
46814883|NCT03963401|83034565|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
46929430|NCT03743415|83164335|FG007|Overall Study|Lost to Follow-up|4|||
46929431|NCT03743415|83164336|FG008|Overall Study|Lost to Follow-up|13|||
46929432|NCT03743415|83164337|FG009|Overall Study|Lost to Follow-up|13|||
46929433|NCT03672175|83164356|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
46929434|NCT03672175|83164357|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
46756516|NCT00577408|82974515|FG000|Overall Study|Scheduling Issues|0|||
46929435|NCT03672175|83164358|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
47055337|NCT01759511|83329303|FG000|Overall Study|Progressive Disease|5|||
46814884|NCT03963401|83034566|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
46814885|NCT03963401|83034567|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
46814886|NCT03963401|83034562|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
46814887|NCT03963401|83034563|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
46814888|NCT03963401|83034564|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
46814889|NCT03963401|83034565|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
46814890|NCT03963401|83034566|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
46814891|NCT03963401|83034567|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
46814892|NCT03963401|83034562|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
46814893|NCT03963401|83034563|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
46814894|NCT03963401|83034564|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
46814895|NCT03963401|83034565|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
46814896|NCT03963401|83034566|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
46814897|NCT03963401|83034567|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
46814898|NCT03963401|83034562|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
46814899|NCT03963401|83034563|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
46814900|NCT03963401|83034564|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
46814901|NCT03963401|83034565|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
46814902|NCT03963401|83034566|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
46814903|NCT03963401|83034567|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
46814904|NCT03963401|83034562|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
46814905|NCT03963401|83034563|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
46814906|NCT03963401|83034564|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
46814907|NCT03963401|83034565|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
46814908|NCT03963401|83034566|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
46814909|NCT03963401|83034567|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
46814910|NCT03963401|83034562|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
46814911|NCT03963401|83034563|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
46814912|NCT03963401|83034564|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
46814913|NCT03963401|83034565|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
46814914|NCT03963401|83034566|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
46814915|NCT03963401|83034567|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
46814916|NCT03963401|83034562|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
46814917|NCT03963401|83034563|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
46814918|NCT03963401|83034564|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
46814919|NCT03963401|83034565|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
46814920|NCT03963401|83034566|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
46814921|NCT03963401|83034567|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
46814922|NCT00334282|83034587|FG000|Overall Study|Lost to Follow-up|11|||
46814923|NCT00334282|83034588|FG001|Overall Study|Lost to Follow-up|5|||
46814924|NCT00334282|83034587|FG000|Overall Study|Withdrawal by Subject|17|||
46814925|NCT00334282|83034588|FG001|Overall Study|Withdrawal by Subject|3|||
46814926|NCT00334282|83034587|FG000|Overall Study|Death|194|||
46814927|NCT00334282|83034588|FG001|Overall Study|Death|100|||
46814928|NCT00306670|83034600|FG000|Overall Study|patients recruited; Genentech, the st|0|||
46814929|NCT00306670|83034601|FG001|Overall Study|patients recruited; Genentech, the st|2|||
46814930|NCT00306592|83034607|FG000|Overall Study|Adverse Event|8|||
46814931|NCT00306592|83034608|FG001|Overall Study|Adverse Event|15|||
46814932|NCT00306592|83034607|FG000|Overall Study|Lost to Follow-up|1|||
46814933|NCT00306592|83034608|FG001|Overall Study|Lost to Follow-up|0|||
46814934|NCT00306592|83034607|FG000|Overall Study|Noncompliance|0|||
46814935|NCT00306592|83034608|FG001|Overall Study|Noncompliance|2|||
46814936|NCT00306592|83034607|FG000|Overall Study|Persistent Antibodies|6|||
46814937|NCT00306592|83034608|FG001|Overall Study|Persistent Antibodies|3|||
46814938|NCT00306592|83034607|FG000|Overall Study|Voluntary|10|||
46814939|NCT00306592|83034608|FG001|Overall Study|Voluntary|6|||
46814940|NCT00306592|83034607|FG000|Overall Study|Other|5|||
46814941|NCT00306592|83034608|FG001|Overall Study|Other|10|||
47055338|NCT01759511|83329303|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
47055339|NCT01759511|83329303|FG000|Overall Study|Study Terminated by Sponsor|13|||
47055340|NCT01759511|83329303|FG000|Overall Study|Withdrawal by Subject|3|||
47055341|NCT01732757|83329321|FG000|Overall Study|Lost to Follow-up|1|||
47055342|NCT01732757|83329322|FG001|Overall Study|Lost to Follow-up|0|||
47055343|NCT01732757|83329323|FG002|Overall Study|Lost to Follow-up|0|||
46814942|NCT00306592|83034607|FG000|Overall Study|Other|1|||
47055344|NCT01758731|83329331|FG000|Overall Study|Physician Decision|1|||
46814943|NCT00306592|83034608|FG001|Overall Study|Other|2|||
47055345|NCT01606319|83329341|FG000|Overall Study|Lost to Follow-up|17|||
47055346|NCT01606319|83329342|FG001|Overall Study|Lost to Follow-up|14|||
47055347|NCT01606319|83329341|FG000|Overall Study|Withdrawal by Subject|9|||
46814944|NCT00306592|83034607|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
46814945|NCT00306592|83034608|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
46814946|NCT00321646|83034612|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
46814947|NCT00321646|83034612|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
46814948|NCT00321646|83034612|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
46814949|NCT00403767|83034618|FG000|Overall Study|Adverse Event|993|||
46814950|NCT00403767|83034619|FG001|Overall Study|Adverse Event|919|||
46814951|NCT00403767|83034618|FG000|Overall Study|Non-compliant with study medication|134|||
46814952|NCT00403767|83034619|FG001|Overall Study|Non-compliant with study medication|164|||
46814953|NCT00403767|83034618|FG000|Overall Study|Consent withdrawn|671|||
46814954|NCT00403767|83034619|FG001|Overall Study|Consent withdrawn|673|||
46814955|NCT00403767|83034618|FG000|Overall Study|Investigator dec./not protocol-related|191|||
46814956|NCT00403767|83034619|FG001|Overall Study|Investigator dec./not protocol-related|178|||
46814957|NCT00403767|83034618|FG000|Overall Study|Lost to Follow-up|6|||
46814958|NCT00403767|83034619|FG001|Overall Study|Lost to Follow-up|8|||
46814959|NCT00403767|83034618|FG000|Overall Study|Protocol Violation|142|||
46814960|NCT00403767|83034619|FG001|Overall Study|Protocol Violation|124|||
46814961|NCT00403767|83034618|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
46814962|NCT00403767|83034619|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
46814963|NCT00403767|83034618|FG000|Overall Study|Study terminated by sponsor|82|||
46814964|NCT00403767|83034619|FG001|Overall Study|Study terminated by sponsor|69|||
46814965|NCT00403767|83034618|FG000|Overall Study|Missing/incomplete data|1|||
46814966|NCT00403767|83034619|FG001|Overall Study|Missing/incomplete data|1|||
46814967|NCT00492284|83034629|FG000|Overall Study|Adverse Event|0|||
46814968|NCT00492284|83034630|FG001|Overall Study|Adverse Event|1|||
46814969|NCT00492284|83034631|FG002|Overall Study|Adverse Event|1|||
46814970|NCT00492284|83034632|FG003|Overall Study|Adverse Event|2|||
47055348|NCT01606319|83329342|FG001|Overall Study|Withdrawal by Subject|12|||
46814971|NCT00492284|83034629|FG000|Overall Study|Lost to Follow-up|0|||
46814972|NCT00492284|83034630|FG001|Overall Study|Lost to Follow-up|0|||
46814973|NCT00492284|83034631|FG002|Overall Study|Lost to Follow-up|3|||
46814974|NCT00492284|83034632|FG003|Overall Study|Lost to Follow-up|1|||
46814975|NCT00492284|83034629|FG000|Overall Study|Death|0|||
46814976|NCT00492284|83034630|FG001|Overall Study|Death|3|||
46814977|NCT00492284|83034631|FG002|Overall Study|Death|2|||
46814978|NCT00492284|83034632|FG003|Overall Study|Death|5|||
46814979|NCT00492284|83034629|FG000|Overall Study|Withdrawal by Subject|1|||
46814980|NCT00492284|83034630|FG001|Overall Study|Withdrawal by Subject|0|||
46814981|NCT00492284|83034631|FG002|Overall Study|Withdrawal by Subject|0|||
46814982|NCT00492284|83034632|FG003|Overall Study|Withdrawal by Subject|2|||
46814983|NCT00510458|83034642|FG000|Overall Study|5 year not evaluable/missed|21|||
46814984|NCT00510458|83034642|FG000|Overall Study|Death|1|||
46814985|NCT00510458|83034642|FG000|Overall Study|Terminated|14|||
46814986|NCT00510458|83034642|FG000|Overall Study|Lost to Follow-up|6|||
46814987|NCT00510458|83034642|FG000|Overall Study|Withdrawal by Subject|3|||
46814988|NCT00510458|83034642|FG000|Overall Study|Revision|2|||
46814989|NCT00414765|83034649|FG000|Overall Study|Adverse Event|5|||
46814990|NCT00414765|83034650|FG001|Overall Study|Adverse Event|9|||
46814991|NCT00414765|83034649|FG000|Overall Study|Withdrawal by Subject|1|||
46814992|NCT00414765|83034650|FG001|Overall Study|Withdrawal by Subject|1|||
47055349|NCT01606319|83329341|FG000|Overall Study|Physician Decision|1|||
47055350|NCT01606319|83329342|FG001|Overall Study|Physician Decision|2|||
47055351|NCT01606319|83329341|FG000|Overall Study|Lack of Efficacy|6|||
47055352|NCT01606319|83329342|FG001|Overall Study|Lack of Efficacy|8|||
47055353|NCT01606319|83329341|FG000|Overall Study|Adverse Event|1|||
47055354|NCT01606319|83329342|FG001|Overall Study|Adverse Event|4|||
47055355|NCT01757405|83329350|FG000|Overall Study|Lost to Follow-up|1|||
47055356|NCT01757405|83329351|FG001|Overall Study|Lost to Follow-up|1|||
47055357|NCT01757405|83329350|FG000|Overall Study|Withdrawal by Subject|0|||
47055358|NCT01757405|83329351|FG001|Overall Study|Withdrawal by Subject|1|||
47055359|NCT01455597|83329357|FG000|Overall Study|Adverse Event|7|||
47055360|NCT01455597|83329358|FG001|Overall Study|Adverse Event|0|||
47055361|NCT01455597|83329359|FG002|Overall Study|Adverse Event|5|||
46814993|NCT00414765|83034649|FG000|Overall Study|Disease Progression|0|||
46814994|NCT00414765|83034650|FG001|Overall Study|Disease Progression|1|||
46814995|NCT00500682|83034658|FG000|Overall Study|Adverse Event|37|||
46814996|NCT00500682|83034659|FG001|Overall Study|Adverse Event|29|||
46814997|NCT00500682|83034658|FG000|Overall Study|Death|25|||
46814998|NCT00500682|83034659|FG001|Overall Study|Death|16|||
46814999|NCT00500682|83034658|FG000|Overall Study|Lost to Follow-up|11|||
46815000|NCT00500682|83034659|FG001|Overall Study|Lost to Follow-up|11|||
46815001|NCT00500682|83034658|FG000|Overall Study|Physician Decision|6|||
46815002|NCT00500682|83034659|FG001|Overall Study|Physician Decision|10|||
46815003|NCT00500682|83034658|FG000|Overall Study|Pregnancy|2|||
46815004|NCT00500682|83034659|FG001|Overall Study|Pregnancy|0|||
46815005|NCT00500682|83034658|FG000|Overall Study|Protocol Violation|1|||
47055362|NCT01455597|83329360|FG003|Overall Study|Adverse Event|1|||
47055363|NCT01455597|83329357|FG000|Overall Study|Lack of Efficacy|0|||
47055364|NCT01455597|83329358|FG001|Overall Study|Lack of Efficacy|1|||
47055365|NCT01455597|83329359|FG002|Overall Study|Lack of Efficacy|2|||
47055366|NCT01455597|83329360|FG003|Overall Study|Lack of Efficacy|0|||
47055367|NCT01455597|83329357|FG000|Overall Study|Lost to Follow-up|3|||
47055368|NCT01455597|83329358|FG001|Overall Study|Lost to Follow-up|0|||
47055369|NCT01455597|83329359|FG002|Overall Study|Lost to Follow-up|2|||
47055370|NCT01455597|83329360|FG003|Overall Study|Lost to Follow-up|1|||
47055371|NCT01455597|83329357|FG000|Overall Study|Withdrew Consent|6|||
47055372|NCT01455597|83329358|FG001|Overall Study|Withdrew Consent|5|||
47055373|NCT01455597|83329359|FG002|Overall Study|Withdrew Consent|8|||
47055374|NCT01455597|83329360|FG003|Overall Study|Withdrew Consent|5|||
47055375|NCT01455597|83329357|FG000|Overall Study|Reason not Specified|1|||
47055376|NCT01455597|83329358|FG001|Overall Study|Reason not Specified|2|||
47055377|NCT01455597|83329359|FG002|Overall Study|Reason not Specified|3|||
47055378|NCT01455597|83329360|FG003|Overall Study|Reason not Specified|3|||
47055379|NCT01757171|83329383|FG000|Overall Study|Adverse Event|5|||
47055380|NCT01757171|83329384|FG001|Overall Study|Adverse Event|1|||
47055381|NCT01757171|83329383|FG000|Overall Study|Disease Progression|1|||
47055382|NCT01757171|83329384|FG001|Overall Study|Disease Progression|0|||
47055383|NCT01757171|83329383|FG000|Overall Study|Hospitalization|1|||
47055384|NCT01757171|83329384|FG001|Overall Study|Hospitalization|0|||
47055385|NCT01757171|83329383|FG000|Overall Study|ECOG decline|1|||
47055386|NCT01757171|83329384|FG001|Overall Study|ECOG decline|0|||
47055387|NCT01756235|83329390|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
46756517|NCT00577408|82974516|FG001|Overall Study|Scheduling Issues|3|||
46756518|NCT00577408|82974515|FG000|Overall Study|Death|0|||
46756519|NCT00577408|82974516|FG001|Overall Study|Death|1|||
46756520|NCT00577408|82974515|FG000|Overall Study|Psychiatric hospitalization|0|||
46756521|NCT00577408|82974516|FG001|Overall Study|Psychiatric hospitalization|1|||
46756522|NCT00713596|82974525|FG000|Overall Study|Study was terminated|2|||
46756523|NCT00713596|82974526|FG001|Overall Study|Study was terminated|3|||
46756524|NCT00713596|82974527|FG002|Overall Study|Study was terminated|2|||
46756525|NCT00880568|82974544|FG000|Overall Study|Disease progression|3|||
46756526|NCT00880568|82974545|FG001|Overall Study|Disease progression|3|||
46756527|NCT00880568|82974546|FG002|Overall Study|Disease progression|3|||
46756528|NCT00880568|82974547|FG003|Overall Study|Disease progression|1|||
46756529|NCT00880568|82974548|FG004|Overall Study|Disease progression|3|||
46756530|NCT00880568|82974549|FG005|Overall Study|Disease progression|3|||
46756531|NCT00880568|82974550|FG006|Overall Study|Disease progression|5|||
46815006|NCT00500682|83034659|FG001|Overall Study|Protocol Violation|3|||
46815007|NCT00500682|83034658|FG000|Overall Study|Withdrawal by Subject|80|||
46815008|NCT00500682|83034659|FG001|Overall Study|Withdrawal by Subject|74|||
46815009|NCT00500682|83034658|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
46815010|NCT00500682|83034659|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
46815011|NCT00500370|83034667|FG000|Overall Study|Adverse Event|9|||
46815012|NCT00500370|83034668|FG001|Overall Study|Adverse Event|3|||
46815013|NCT00500370|83034667|FG000|Overall Study|Lost to Follow-up|10|||
46815014|NCT00500370|83034668|FG001|Overall Study|Lost to Follow-up|10|||
46815015|NCT00500370|83034667|FG000|Overall Study|Protocol Violation|2|||
46815016|NCT00500370|83034668|FG001|Overall Study|Protocol Violation|4|||
46815017|NCT00500370|83034667|FG000|Overall Study|Sponsor Decision|2|||
46815018|NCT00500370|83034668|FG001|Overall Study|Sponsor Decision|0|||
46815019|NCT00500370|83034667|FG000|Overall Study|Subject Decision|10|||
46815020|NCT00500370|83034668|FG001|Overall Study|Subject Decision|17|||
46815021|NCT00320788|83034679|FG000|Overall Study|Adverse Event|0|||
46815022|NCT00320788|83034680|FG001|Overall Study|Adverse Event|0|||
46815023|NCT00320788|83034681|FG002|Overall Study|Adverse Event|0|||
46756532|NCT00880568|82974551|FG007|Overall Study|Disease progression|0|||
46756533|NCT00880568|82974552|FG008|Overall Study|Disease progression|3|||
46815024|NCT00320788|83034682|FG003|Overall Study|Adverse Event|1|||
46815025|NCT00320788|83034683|FG004|Overall Study|Adverse Event|0|||
46815026|NCT00320788|83034679|FG000|Overall Study|Death|0|||
47055388|NCT01730729|83329394|FG000|Overall Study|Adverse Event|1|||
47055389|NCT01730729|83329394|FG000|Overall Study|Death|1|||
47055390|NCT01730729|83329394|FG000|Overall Study|Progressive Disease|12|||
47055391|NCT01756157|83329398|FG000|First Intervention Period|Withdrawal by Subject|1|||
46756534|NCT00880568|82974544|FG000|Overall Study|Adverse Event|0|||
46756535|NCT00880568|82974545|FG001|Overall Study|Adverse Event|0|||
46756536|NCT00880568|82974546|FG002|Overall Study|Adverse Event|0|||
46815027|NCT00320788|83034680|FG001|Overall Study|Death|0|||
46815028|NCT00320788|83034681|FG002|Overall Study|Death|1|||
46815029|NCT00320788|83034682|FG003|Overall Study|Death|0|||
46815030|NCT00320788|83034683|FG004|Overall Study|Death|1|||
46815031|NCT00320788|83034679|FG000|Overall Study|Lost to Follow-up|0|||
46815032|NCT00320788|83034680|FG001|Overall Study|Lost to Follow-up|2|||
46815033|NCT00320788|83034681|FG002|Overall Study|Lost to Follow-up|1|||
46815034|NCT00320788|83034682|FG003|Overall Study|Lost to Follow-up|0|||
46815035|NCT00320788|83034683|FG004|Overall Study|Lost to Follow-up|0|||
46815036|NCT00320788|83034679|FG000|Overall Study|Decision by the Sponsor|1|||
46815037|NCT00320788|83034680|FG001|Overall Study|Decision by the Sponsor|1|||
46815038|NCT00320788|83034681|FG002|Overall Study|Decision by the Sponsor|0|||
46815039|NCT00320788|83034682|FG003|Overall Study|Decision by the Sponsor|0|||
46815040|NCT00320788|83034683|FG004|Overall Study|Decision by the Sponsor|1|||
46815041|NCT00320788|83034679|FG000|Overall Study|Other|1|||
46815042|NCT00320788|83034680|FG001|Overall Study|Other|2|||
46815043|NCT00320788|83034681|FG002|Overall Study|Other|1|||
46815044|NCT00320788|83034682|FG003|Overall Study|Other|1|||
46815045|NCT00320788|83034683|FG004|Overall Study|Other|1|||
46815046|NCT00320788|83034679|FG000|Overall Study|Physician Decision|1|||
46815047|NCT00320788|83034680|FG001|Overall Study|Physician Decision|1|||
46815048|NCT00320788|83034681|FG002|Overall Study|Physician Decision|0|||
46815049|NCT00320788|83034682|FG003|Overall Study|Physician Decision|0|||
46815050|NCT00320788|83034683|FG004|Overall Study|Physician Decision|0|||
46815051|NCT00320788|83034679|FG000|Overall Study|Protocol Violation|0|||
46815052|NCT00320788|83034680|FG001|Overall Study|Protocol Violation|0|||
46815053|NCT00320788|83034681|FG002|Overall Study|Protocol Violation|0|||
46815054|NCT00320788|83034682|FG003|Overall Study|Protocol Violation|0|||
46815055|NCT00320788|83034683|FG004|Overall Study|Protocol Violation|1|||
46815056|NCT00320788|83034679|FG000|Overall Study|Withdrawal by Subject|3|||
46815057|NCT00320788|83034680|FG001|Overall Study|Withdrawal by Subject|0|||
46815058|NCT00320788|83034681|FG002|Overall Study|Withdrawal by Subject|0|||
46815059|NCT00320788|83034682|FG003|Overall Study|Withdrawal by Subject|3|||
46815060|NCT00320788|83034683|FG004|Overall Study|Withdrawal by Subject|1|||
46815061|NCT00503984|83034703|FG000|Overall Study|Protocol Violation|0|||
46815062|NCT00503984|83034704|FG001|Overall Study|Protocol Violation|1|||
46815063|NCT00503984|83034705|FG002|Overall Study|Protocol Violation|0|||
46815064|NCT00503984|83034706|FG003|Overall Study|Protocol Violation|0|||
46815065|NCT00503984|83034707|FG004|Overall Study|Protocol Violation|0|||
46815066|NCT00503984|83034708|FG005|Overall Study|Protocol Violation|0|||
46815067|NCT00503984|83034703|FG000|Overall Study|Adverse Event|0|||
46815068|NCT00503984|83034704|FG001|Overall Study|Adverse Event|1|||
46815069|NCT00503984|83034705|FG002|Overall Study|Adverse Event|0|||
46815070|NCT00503984|83034706|FG003|Overall Study|Adverse Event|0|||
46815071|NCT00503984|83034707|FG004|Overall Study|Adverse Event|0|||
46815072|NCT00503984|83034708|FG005|Overall Study|Adverse Event|0|||
46815073|NCT00503984|83034703|FG000|Overall Study|Death|0|||
46815074|NCT00503984|83034704|FG001|Overall Study|Death|0|||
46815075|NCT00503984|83034705|FG002|Overall Study|Death|0|||
46815076|NCT00503984|83034706|FG003|Overall Study|Death|0|||
46815077|NCT00503984|83034707|FG004|Overall Study|Death|1|||
46815078|NCT00503984|83034708|FG005|Overall Study|Death|0|||
46815079|NCT00565409|83034732|FG000|Period 1 Open Label|Adverse Event|17|||
46815080|NCT00565409|83034733|FG001|Period 1 Open Label|Adverse Event|0|||
46815081|NCT00565409|83034734|FG002|Period 1 Open Label|Adverse Event|0|||
46815082|NCT00565409|83034735|FG003|Period 1 Open Label|Adverse Event|0|||
46815083|NCT00565409|83034732|FG000|Period 1 Open Label|Death|2|||
46815084|NCT00565409|83034733|FG001|Period 1 Open Label|Death|0|||
46929436|NCT03672175|83164356|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
46756537|NCT00880568|82974547|FG003|Overall Study|Adverse Event|0|||
46756538|NCT00880568|82974548|FG004|Overall Study|Adverse Event|0|||
46756539|NCT00880568|82974549|FG005|Overall Study|Adverse Event|0|||
46756540|NCT00880568|82974550|FG006|Overall Study|Adverse Event|1|||
46756541|NCT00880568|82974551|FG007|Overall Study|Adverse Event|1|||
46756542|NCT00880568|82974552|FG008|Overall Study|Adverse Event|0|||
46756543|NCT00880568|82974544|FG000|Overall Study|Withdrawal by Subject|0|||
46756544|NCT00880568|82974545|FG001|Overall Study|Withdrawal by Subject|0|||
46756545|NCT00880568|82974546|FG002|Overall Study|Withdrawal by Subject|0|||
46756546|NCT00880568|82974547|FG003|Overall Study|Withdrawal by Subject|0|||
46815085|NCT00565409|83034734|FG002|Period 1 Open Label|Death|0|||
46815086|NCT00565409|83034735|FG003|Period 1 Open Label|Death|0|||
46815087|NCT00565409|83034732|FG000|Period 1 Open Label|Lost to Follow-up|1|||
46815088|NCT00565409|83034733|FG001|Period 1 Open Label|Lost to Follow-up|0|||
46815089|NCT00565409|83034734|FG002|Period 1 Open Label|Lost to Follow-up|0|||
46815090|NCT00565409|83034735|FG003|Period 1 Open Label|Lost to Follow-up|0|||
46815091|NCT00565409|83034732|FG000|Period 1 Open Label|Other|21|||
46815092|NCT00565409|83034733|FG001|Period 1 Open Label|Other|0|||
46815093|NCT00565409|83034734|FG002|Period 1 Open Label|Other|0|||
46815094|NCT00565409|83034735|FG003|Period 1 Open Label|Other|0|||
46815095|NCT00565409|83034732|FG000|Period 1 Open Label|Protocol Violation|14|||
46815096|NCT00565409|83034733|FG001|Period 1 Open Label|Protocol Violation|0|||
46815097|NCT00565409|83034734|FG002|Period 1 Open Label|Protocol Violation|0|||
46815098|NCT00565409|83034735|FG003|Period 1 Open Label|Protocol Violation|0|||
46929437|NCT03672175|83164357|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
46815099|NCT00565409|83034732|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
46815100|NCT00565409|83034733|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
46815101|NCT00565409|83034734|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
46815102|NCT00565409|83034735|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
46815103|NCT00565409|83034732|FG000|Period 1 Open Label|no conclusion of participation record|1|||
46815104|NCT00565409|83034733|FG001|Period 1 Open Label|no conclusion of participation record|0|||
46815105|NCT00565409|83034734|FG002|Period 1 Open Label|no conclusion of participation record|0|||
46815106|NCT00565409|83034735|FG003|Period 1 Open Label|no conclusion of participation record|0|||
46815107|NCT00565409|83034732|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
46815108|NCT00565409|83034733|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
46815109|NCT00565409|83034734|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
46815110|NCT00565409|83034735|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
46815111|NCT00565409|83034732|FG000|Period 2 Double-Blind|Adverse Event|0|||
46815112|NCT00565409|83034733|FG001|Period 2 Double-Blind|Adverse Event|7|||
46815113|NCT00565409|83034734|FG002|Period 2 Double-Blind|Adverse Event|4|||
46815114|NCT00565409|83034735|FG003|Period 2 Double-Blind|Adverse Event|5|||
46815115|NCT00565409|83034732|FG000|Period 2 Double-Blind|Death|0|||
46815116|NCT00565409|83034733|FG001|Period 2 Double-Blind|Death|2|||
46815117|NCT00565409|83034734|FG002|Period 2 Double-Blind|Death|0|||
46636570|NCT01484496|82810389|FG001|Period 1|Lack of Compliance|1|||
46636571|NCT01484496|82810390|FG002|Period 1|Lack of Compliance|0|||
46636572|NCT01484496|82810391|FG003|Period 1|Lack of Compliance|0|||
46636573|NCT01484496|82810388|FG000|Period 1|Unable to Visit Site|0|||
46636574|NCT01484496|82810389|FG001|Period 1|Unable to Visit Site|2|||
46636575|NCT01484496|82810390|FG002|Period 1|Unable to Visit Site|0|||
46815118|NCT00565409|83034735|FG003|Period 2 Double-Blind|Death|0|||
46815119|NCT00565409|83034732|FG000|Period 2 Double-Blind|Protocol Violation|0|||
46815120|NCT00565409|83034733|FG001|Period 2 Double-Blind|Protocol Violation|4|||
46815121|NCT00565409|83034734|FG002|Period 2 Double-Blind|Protocol Violation|6|||
46815122|NCT00565409|83034735|FG003|Period 2 Double-Blind|Protocol Violation|2|||
46815123|NCT00565409|83034732|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
46815124|NCT00565409|83034733|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
46815125|NCT00565409|83034734|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
46815126|NCT00565409|83034735|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
46815127|NCT00565409|83034732|FG000|Period 2 Double-Blind|Other|0|||
46815128|NCT00565409|83034733|FG001|Period 2 Double-Blind|Other|4|||
46815129|NCT00565409|83034734|FG002|Period 2 Double-Blind|Other|5|||
46815130|NCT00565409|83034735|FG003|Period 2 Double-Blind|Other|9|||
46815131|NCT00565409|83034732|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
46815132|NCT00565409|83034733|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
46815133|NCT00565409|83034734|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
46815134|NCT00565409|83034735|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
46815135|NCT00394251|83034747|FG000|Overall Study|Adverse Event|7|||
46815136|NCT00394251|83034748|FG001|Overall Study|Adverse Event|5|||
46815137|NCT00394251|83034747|FG000|Overall Study|Unacceptable Toxicity|20|||
46815138|NCT00394251|83034748|FG001|Overall Study|Unacceptable Toxicity|18|||
46815139|NCT00394251|83034747|FG000|Overall Study|Physician Decision|1|||
46815140|NCT00394251|83034748|FG001|Overall Study|Physician Decision|1|||
46929438|NCT03672175|83164358|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
46636576|NCT01484496|82810391|FG003|Period 1|Unable to Visit Site|0|||
46636577|NCT01484496|82810388|FG000|Period 2|Lack of Efficacy|0|||
46756547|NCT00880568|82974548|FG004|Overall Study|Withdrawal by Subject|0|||
46756548|NCT00880568|82974549|FG005|Overall Study|Withdrawal by Subject|0|||
46756549|NCT00880568|82974550|FG006|Overall Study|Withdrawal by Subject|0|||
46756550|NCT00880568|82974551|FG007|Overall Study|Withdrawal by Subject|1|||
46756551|NCT00880568|82974552|FG008|Overall Study|Withdrawal by Subject|0|||
46756552|NCT00881894|82974579|FG000|Overall Study|Consent withdrawn|0|||
46756553|NCT00881894|82974580|FG001|Overall Study|Consent withdrawn|1|||
46756554|NCT00881894|82974579|FG000|Overall Study|Other reasons for premature termination|1|||
46756555|NCT00881894|82974580|FG001|Overall Study|Other reasons for premature termination|2|||
46756556|NCT00711100|82974586|FG000|Overall Study|Lack of Efficacy|5|||
46756557|NCT00711100|82974586|FG000|Overall Study|Withdrawal by Subject|8|||
46756558|NCT00827931|82974604|FG000|Overall Study|Death|3|||
46756559|NCT00827931|82974605|FG001|Overall Study|Death|5|||
46636578|NCT01484496|82810389|FG001|Period 2|Lack of Efficacy|0|||
46636579|NCT01484496|82810390|FG002|Period 2|Lack of Efficacy|1|||
46756560|NCT00827931|82974604|FG000|Overall Study|Adverse Event|1|||
46756561|NCT00827931|82974605|FG001|Overall Study|Adverse Event|0|||
46815141|NCT00394251|83034747|FG000|Overall Study|Protocol Violation|0|||
46636580|NCT01484496|82810391|FG003|Period 2|Lack of Efficacy|3|||
46815142|NCT00394251|83034748|FG001|Overall Study|Protocol Violation|1|||
46815143|NCT00394251|83034747|FG000|Overall Study|Withdrawal by Subject|7|||
46815144|NCT00394251|83034748|FG001|Overall Study|Withdrawal by Subject|11|||
46815145|NCT00394251|83034747|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
46815146|NCT00394251|83034748|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
46815147|NCT00394095|83034760|FG000|Overall Study|Adverse Event|1|||
46815148|NCT00394095|83034761|FG001|Overall Study|Adverse Event|0|||
46815149|NCT00503906|83034768|FG000|Overall Study|Withdrawal by Subject|1|||
46815150|NCT00305110|83034773|FG000|Overall Study|Missing data|29|||
46815151|NCT00491894|83034777|FG000|Overall Study|Adverse Event|14|||
46815152|NCT00491894|83034777|FG000|Overall Study|Withdrawal by Subject|5|||
46815153|NCT00491894|83034777|FG000|Overall Study|Death|3|||
46815154|NCT00491894|83034777|FG000|Overall Study|Lost to Follow-up|3|||
46815155|NCT00491894|83034777|FG000|Overall Study|Lack of Efficacy|2|||
46815156|NCT00491894|83034777|FG000|Overall Study|Other-Failed to meet any criteria|2|||
46815157|NCT00491894|83034777|FG000|Overall Study|Physician Decision|2|||
46815158|NCT00491894|83034777|FG000|Overall Study|Protocol Violation|2|||
46815159|NCT00491894|83034777|FG000|Overall Study|Other-Intake of prohibited medication|1|||
46815160|NCT00491504|83034785|FG000|Overall Study|Adverse Event|0|||
46815161|NCT00491504|83034786|FG001|Overall Study|Adverse Event|1|||
46815162|NCT00491504|83034787|FG002|Overall Study|Adverse Event|0|||
46815163|NCT00491504|83034788|FG003|Overall Study|Adverse Event|0|||
46815164|NCT00491504|83034785|FG000|Overall Study|Withdrawal by Subject|0|||
46815165|NCT00491504|83034786|FG001|Overall Study|Withdrawal by Subject|0|||
46815166|NCT00491504|83034787|FG002|Overall Study|Withdrawal by Subject|1|||
46815167|NCT00491504|83034788|FG003|Overall Study|Withdrawal by Subject|2|||
46815168|NCT00491504|83034785|FG000|Overall Study|Protocol Violation|0|||
46815169|NCT00491504|83034786|FG001|Overall Study|Protocol Violation|0|||
46815170|NCT00491504|83034787|FG002|Overall Study|Protocol Violation|3|||
46815171|NCT00491504|83034788|FG003|Overall Study|Protocol Violation|2|||
46815172|NCT00500292|83034799|FG000|Overall Study|Adverse Event|3|||
46815173|NCT00500292|83034800|FG001|Overall Study|Adverse Event|6|||
46815174|NCT00500292|83034801|FG002|Overall Study|Adverse Event|4|||
46815175|NCT00500292|83034799|FG000|Overall Study|Condition under investigation worsened|21|||
46815176|NCT00500292|83034800|FG001|Overall Study|Condition under investigation worsened|23|||
46815177|NCT00500292|83034801|FG002|Overall Study|Condition under investigation worsened|19|||
46815178|NCT00500292|83034799|FG000|Overall Study|Withdrawal by Subject|0|||
46815179|NCT00500292|83034800|FG001|Overall Study|Withdrawal by Subject|1|||
46815180|NCT00500292|83034801|FG002|Overall Study|Withdrawal by Subject|0|||
46815181|NCT00500292|83034799|FG000|Overall Study|Other|1|||
46815182|NCT00500292|83034800|FG001|Overall Study|Other|1|||
46815183|NCT00500292|83034801|FG002|Overall Study|Other|4|||
46815184|NCT00499746|83034809|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
46815185|NCT00499746|83034809|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
46815186|NCT00499746|83034809|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
46815187|NCT00499746|83034809|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
46929439|NCT03672175|83164356|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
46929440|NCT03672175|83164357|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
46756562|NCT00827931|82974604|FG000|Overall Study|Lost to Follow-up|1|||
46756563|NCT00827931|82974605|FG001|Overall Study|Lost to Follow-up|0|||
46756564|NCT00827931|82974604|FG000|Overall Study|Withdrawal by Subject|0|||
46756565|NCT00827931|82974605|FG001|Overall Study|Withdrawal by Subject|1|||
46756566|NCT00827931|82974604|FG000|Overall Study|Other|1|||
46756567|NCT00827931|82974605|FG001|Overall Study|Other|0|||
46756568|NCT00526669|82974611|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
46756569|NCT00526669|82974612|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
46756570|NCT00526669|82974611|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
46756571|NCT00526669|82974612|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
46756572|NCT00526669|82974611|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
46756573|NCT00526669|82974612|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
46756574|NCT00526669|82974611|FG000|Combined Treatment Phase|Death|0|||
46756575|NCT00526669|82974612|FG001|Combined Treatment Phase|Death|2|||
46815188|NCT00489216|83034823|FG000|Overall Study|Adverse Event|1|||
46929441|NCT03672175|83164358|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
46929442|NCT03672175|83164356|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
46756576|NCT00710866|82974624|FG000|Overall Study|Protocol Violation|5|||
46756577|NCT00710866|82974625|FG001|Overall Study|Protocol Violation|4|||
46756578|NCT00710866|82974624|FG000|Overall Study|Withdrawal by Subject|2|||
46756579|NCT00710866|82974625|FG001|Overall Study|Withdrawal by Subject|1|||
46756580|NCT00710866|82974624|FG000|Overall Study|Lost to Follow-up|1|||
46815189|NCT00499590|83034830|FG000|Overall Study|Study Terminated|112|||
46815190|NCT00499590|83034831|FG001|Overall Study|Study Terminated|112|||
46815191|NCT00499590|83034832|FG002|Overall Study|Study Terminated|112|||
46815192|NCT00499590|83034830|FG000|Overall Study|Not treated|1|||
46815193|NCT00499590|83034831|FG001|Overall Study|Not treated|0|||
46815194|NCT00499590|83034832|FG002|Overall Study|Not treated|1|||
46815195|NCT00510146|83034843|FG000|Double-Blind Treatment|Adverse Event|30|||
46756581|NCT00710866|82974625|FG001|Overall Study|Lost to Follow-up|0|||
46929443|NCT03672175|83164357|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
46929444|NCT03672175|83164358|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
46929445|NCT03672175|83164356|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
46929446|NCT03672175|83164357|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
46929447|NCT03672175|83164358|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
46929448|NCT03672175|83164356|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
46929449|NCT03672175|83164357|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
46929450|NCT03672175|83164358|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
46929451|NCT03672175|83164356|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
46929452|NCT03672175|83164357|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
46929453|NCT03672175|83164358|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
46929454|NCT03672175|83164356|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
46929455|NCT03672175|83164357|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
46929456|NCT03672175|83164358|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
46929457|NCT03672175|83164356|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
46929458|NCT03672175|83164357|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
46929459|NCT03672175|83164358|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
46929460|NCT03672175|83164356|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
46929461|NCT03672175|83164357|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
46929462|NCT03672175|83164358|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
46929463|NCT03672175|83164356|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
46929464|NCT03672175|83164357|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
46929465|NCT03672175|83164358|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
46929466|NCT03672175|83164356|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
46929467|NCT03672175|83164357|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
46929468|NCT03672175|83164358|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
46929469|NCT03524118|83164399|FG000|Overall Study|Lost to Follow-up|0|||
46929470|NCT03524118|83164400|FG001|Overall Study|Lost to Follow-up|0|||
46929471|NCT03524118|83164401|FG002|Overall Study|Lost to Follow-up|0|||
46929472|NCT03524118|83164402|FG003|Overall Study|Lost to Follow-up|0|||
46929473|NCT03524118|83164403|FG004|Overall Study|Lost to Follow-up|1|||
46929474|NCT03524118|83164404|FG005|Overall Study|Lost to Follow-up|0|||
46929475|NCT03524118|83164399|FG000|Overall Study|Other|0|||
46929476|NCT03524118|83164400|FG001|Overall Study|Other|1|||
46929477|NCT03524118|83164401|FG002|Overall Study|Other|0|||
46929478|NCT03524118|83164402|FG003|Overall Study|Other|0|||
46929479|NCT03524118|83164403|FG004|Overall Study|Other|1|||
46929480|NCT03524118|83164404|FG005|Overall Study|Other|1|||
46929481|NCT03524118|83164399|FG000|Overall Study|Physician Decision|0|||
46929482|NCT03524118|83164400|FG001|Overall Study|Physician Decision|0|||
46929483|NCT03524118|83164401|FG002|Overall Study|Physician Decision|0|||
46929484|NCT03524118|83164402|FG003|Overall Study|Physician Decision|0|||
46929485|NCT03524118|83164403|FG004|Overall Study|Physician Decision|1|||
46929486|NCT03524118|83164404|FG005|Overall Study|Physician Decision|0|||
46929487|NCT03524118|83164399|FG000|Overall Study|Protocol Violation|0|||
46929488|NCT03524118|83164400|FG001|Overall Study|Protocol Violation|0|||
46929489|NCT03524118|83164401|FG002|Overall Study|Protocol Violation|1|||
46929490|NCT03524118|83164402|FG003|Overall Study|Protocol Violation|0|||
46929491|NCT03524118|83164403|FG004|Overall Study|Protocol Violation|1|||
46929492|NCT03524118|83164404|FG005|Overall Study|Protocol Violation|0|||
46929493|NCT03524118|83164399|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46929494|NCT03524118|83164400|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
46929495|NCT03524118|83164401|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
46929496|NCT03524118|83164402|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
46929497|NCT03524118|83164403|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
46929498|NCT03524118|83164404|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
46929499|NCT03437265|83164418|FG000|Overall Study|Protocol Violation|6|||
46929500|NCT03414424|83164424|FG000|Overall Study|Screened out after consent|0|||
46929501|NCT03414424|83164425|FG001|Overall Study|Screened out after consent|2|||
46929502|NCT03414424|83164424|FG000|Overall Study|Lost to Follow-up|0|||
46756582|NCT00710866|82974624|FG000|Overall Study|Failed to meet eligibility|1|||
46756583|NCT00710866|82974625|FG001|Overall Study|Failed to meet eligibility|1|||
46929503|NCT03414424|83164425|FG001|Overall Study|Lost to Follow-up|1|||
46929504|NCT03349476|83164431|FG000|Overall Study|Physician Decision|3|||
46929505|NCT03312634|83164437|FG000|Overall Study|Adverse Event|11|||
46929506|NCT03312634|83164438|FG001|Overall Study|Adverse Event|0|||
46929507|NCT03312634|83164437|FG000|Overall Study|Sponsor request|2|||
46929508|NCT03312634|83164438|FG001|Overall Study|Sponsor request|0|||
46929509|NCT03312634|83164437|FG000|Overall Study|Withdrawal by Subject|31|||
46929510|NCT03312634|83164438|FG001|Overall Study|Withdrawal by Subject|9|||
46929511|NCT03312634|83164437|FG000|Overall Study|Enrolled in an interventional study|0|||
46929512|NCT03312634|83164438|FG001|Overall Study|Enrolled in an interventional study|52|||
46929513|NCT03312634|83164437|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
46929514|NCT03312634|83164438|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
46929515|NCT03312634|83164437|FG000|Overall Study|Death|0|||
46929516|NCT03312634|83164438|FG001|Overall Study|Death|1|||
46929517|NCT03312634|83164437|FG000|Overall Study|Non-compliance|0|||
46929518|NCT03312634|83164438|FG001|Overall Study|Non-compliance|2|||
46929519|NCT03312634|83164437|FG000|Overall Study|Lost to Follow-up|0|||
46929520|NCT03312634|83164438|FG001|Overall Study|Lost to Follow-up|1|||
46929521|NCT03312634|83164437|FG000|Overall Study|Enrolled into non-interventional study|0|||
46929522|NCT03312634|83164438|FG001|Overall Study|Enrolled into non-interventional study|5|||
46929523|NCT03312634|83164437|FG000|Overall Study|Worsening clinical condition|0|||
46929524|NCT03312634|83164438|FG001|Overall Study|Worsening clinical condition|1|||
46929525|NCT03312634|83164437|FG000|Overall Study|Participant did not want to travel|0|||
46929526|NCT03312634|83164438|FG001|Overall Study|Participant did not want to travel|1|||
46929527|NCT03312634|83164437|FG000|Overall Study|Physician Decision|1|||
46929528|NCT03312634|83164438|FG001|Overall Study|Physician Decision|0|||
46929529|NCT03312634|83164437|FG000|Overall Study|Other|13|||
46929530|NCT03312634|83164438|FG001|Overall Study|Other|0|||
46929531|NCT03000569|83164447|FG000|Overall Study|Withdrawal by Subject|1|||
46929532|NCT03000569|83164448|FG001|Overall Study|Withdrawal by Subject|0|||
46929533|NCT02205359|83164486|FG000|Overall Study|Death|293|||
46929534|NCT02205359|83164487|FG001|Overall Study|Death|327|||
46929535|NCT02205359|83164486|FG000|Overall Study|Lost to Follow-up|182|||
46929536|NCT02205359|83164487|FG001|Overall Study|Lost to Follow-up|162|||
46929537|NCT02205359|83164486|FG000|Overall Study|Physician Decision|51|||
46929538|NCT02205359|83164487|FG001|Overall Study|Physician Decision|53|||
46929539|NCT02205359|83164486|FG000|Overall Study|Withdrawal by Subject|167|||
46929540|NCT02205359|83164487|FG001|Overall Study|Withdrawal by Subject|169|||
46929541|NCT01979536|83164496|FG000|Overall Study|Physician Decision|2|||
46929542|NCT01979536|83164497|FG001|Overall Study|Physician Decision|3|||
46929543|NCT01979536|83164496|FG000|Overall Study|Withdrawal by Subject|0|||
46929544|NCT01979536|83164497|FG001|Overall Study|Withdrawal by Subject|1|||
46929545|NCT01979536|83164496|FG000|Overall Study|Refusal|0|||
46929546|NCT01979536|83164497|FG001|Overall Study|Refusal|1|||
46929547|NCT01979536|83164496|FG000|Overall Study|Relapse|0|||
46929548|NCT01979536|83164497|FG001|Overall Study|Relapse|1|||
46929549|NCT01979536|83164496|FG000|Overall Study|Study terminated by Sponsor|0|||
46929550|NCT01979536|83164497|FG001|Overall Study|Study terminated by Sponsor|1|||
46929551|NCT01979536|83164496|FG000|Overall Study|Did not start treatment|0|||
46929552|NCT01979536|83164497|FG001|Overall Study|Did not start treatment|1|||
46929553|NCT01798992|83164520|FG000|Overall Study|Administrative withdrawal|0|||
46929554|NCT01798992|83164521|FG001|Overall Study|Administrative withdrawal|1|||
46929555|NCT01798992|83164522|FG002|Overall Study|Administrative withdrawal|0|||
46929556|NCT01798992|83164523|FG003|Overall Study|Administrative withdrawal|1|||
46929557|NCT01798992|83164520|FG000|Overall Study|Lost to Follow-up|0|||
47055392|NCT01756157|83329399|FG001|First Intervention Period|Withdrawal by Subject|0|||
47055393|NCT01756157|83329398|FG000|First Intervention Period|Lost to Follow-up|0|||
47055394|NCT01756157|83329399|FG001|First Intervention Period|Lost to Follow-up|2|||
47055395|NCT01756079|83329405|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
47055396|NCT01756079|83329405|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
47055397|NCT01756079|83329405|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
47055398|NCT01756079|83329405|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
47055399|NCT01756079|83329405|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
46756584|NCT00827775|82974642|FG000|Overall Study|Withdrawal by Subject|0|||
46756585|NCT00827775|82974643|FG001|Overall Study|Withdrawal by Subject|5|||
46756586|NCT00827541|82974651|FG000|Overall Study|Exitus|1|||
46756587|NCT00827541|82974652|FG001|Overall Study|Exitus|8|||
46756588|NCT00827541|82974651|FG000|Overall Study|Other|1|||
46756589|NCT00827541|82974652|FG001|Overall Study|Other|3|||
46756590|NCT00827541|82974651|FG000|Overall Study|Pathogen not susceptible|1|||
46756591|NCT00827541|82974652|FG001|Overall Study|Pathogen not susceptible|0|||
46756592|NCT00827541|82974651|FG000|Overall Study|Lack of effectiveness|1|||
46756593|NCT00827541|82974652|FG001|Overall Study|Lack of effectiveness|0|||
46756594|NCT00518323|82974662|FG000|Overall Study|Lack of Efficacy|14|||
46756595|NCT00518323|82974663|FG001|Overall Study|Lack of Efficacy|2|||
46756596|NCT00518323|82974664|FG002|Overall Study|Lack of Efficacy|4|||
46756597|NCT00518323|82974665|FG003|Overall Study|Lack of Efficacy|20|||
46929558|NCT01798992|83164521|FG001|Overall Study|Lost to Follow-up|1|||
46929559|NCT01798992|83164522|FG002|Overall Study|Lost to Follow-up|1|||
46929560|NCT01798992|83164523|FG003|Overall Study|Lost to Follow-up|0|||
46929561|NCT01798992|83164520|FG000|Overall Study|Insufficient biopsy tissue|0|||
46929562|NCT01798992|83164521|FG001|Overall Study|Insufficient biopsy tissue|0|||
46756598|NCT00518323|82974662|FG000|Overall Study|Withdrawal by Subject|1|||
46756599|NCT00518323|82974663|FG001|Overall Study|Withdrawal by Subject|2|||
46756600|NCT00518323|82974664|FG002|Overall Study|Withdrawal by Subject|4|||
46929563|NCT01798992|83164522|FG002|Overall Study|Insufficient biopsy tissue|1|||
46929564|NCT01798992|83164523|FG003|Overall Study|Insufficient biopsy tissue|0|||
46929565|NCT01570868|83164534|FG000|Overall Study|Adverse Event|8|||
46929566|NCT01570868|83164535|FG001|Overall Study|Adverse Event|1|||
46929567|NCT01570868|83164534|FG000|Overall Study|FDA Recommendation|23|||
46929568|NCT01570868|83164535|FG001|Overall Study|FDA Recommendation|3|||
46929569|NCT01570868|83164534|FG000|Overall Study|Physician Decision|10|||
46929570|NCT01570868|83164535|FG001|Overall Study|Physician Decision|4|||
46929571|NCT01570868|83164534|FG000|Overall Study|Lost to Follow-up|1|||
46929572|NCT01570868|83164535|FG001|Overall Study|Lost to Follow-up|0|||
46929573|NCT01570868|83164534|FG000|Overall Study|Withdrawal by Subject|1|||
46929574|NCT01570868|83164535|FG001|Overall Study|Withdrawal by Subject|0|||
46929575|NCT01251965|83164548|FG000|Overall Study|Participant/physician decision|1|||
46929576|NCT01251965|83164549|FG001|Overall Study|Participant/physician decision|2|||
46929577|NCT01251965|83164550|FG002|Overall Study|Participant/physician decision|0|||
46929578|NCT01251965|83164548|FG000|Overall Study|Death|0|||
46929579|NCT01251965|83164549|FG001|Overall Study|Death|0|||
46929580|NCT01251965|83164550|FG002|Overall Study|Death|11|||
46929581|NCT01190644|83164559|FG000|Overall Study|Death|2|||
46929582|NCT01190644|83164559|FG000|Overall Study|Disease progression|1|||
46929583|NCT00849290|83164564|FG000|Overall Study|Adverse Event|3|||
46929584|NCT00849290|83164564|FG000|Overall Study|Death|14|||
46929585|NCT00849290|83164564|FG000|Overall Study|Withdrawal by Subject|11|||
46929586|NCT00849290|83164564|FG000|Overall Study|Lost to Follow-up|2|||
46929587|NCT00849290|83164564|FG000|Overall Study|Protocol Violation|5|||
46929588|NCT00849290|83164564|FG000|Overall Study|Disease Progression|20|||
46929589|NCT00542451|83164572|FG000|Overall Study|Adverse Event|31|||
46929590|NCT00542451|83164572|FG000|Overall Study|Withdrawal by Subject|30|||
46929591|NCT00542451|83164572|FG000|Overall Study|Physician Decision|4|||
46929592|NCT00542451|83164572|FG000|Overall Study|Recurrent disease|1|||
46929593|NCT00542451|83164572|FG000|Overall Study|unknown reason|1|||
46929594|NCT00542451|83164572|FG000|Overall Study|Death|2|||
46929595|NCT00542451|83164572|FG000|Overall Study|Lost to Follow-up|10|||
46929596|NCT00506493|83164579|FG000|Overall Study|Death|6|||
46929597|NCT00506493|83164579|FG000|Overall Study|Withdrawal by Subject|5|||
46929598|NCT00157248|83164593|FG000|Overall Study|Adverse Event|36|||
46929599|NCT00157248|83164594|FG001|Overall Study|Adverse Event|25|||
46929600|NCT00157248|83164595|FG002|Overall Study|Adverse Event|13|||
46929601|NCT00157248|83164596|FG003|Overall Study|Adverse Event|33|||
46929602|NCT00157248|83164593|FG000|Overall Study|Protocol Violation|4|||
46929603|NCT00157248|83164594|FG001|Overall Study|Protocol Violation|0|||
46929604|NCT00157248|83164595|FG002|Overall Study|Protocol Violation|2|||
46929605|NCT00157248|83164596|FG003|Overall Study|Protocol Violation|2|||
46929606|NCT00157248|83164593|FG000|Overall Study|Lost to Follow-up|0|||
46929607|NCT00157248|83164594|FG001|Overall Study|Lost to Follow-up|1|||
46929608|NCT00157248|83164595|FG002|Overall Study|Lost to Follow-up|0|||
46929609|NCT00157248|83164596|FG003|Overall Study|Lost to Follow-up|0|||
46929610|NCT00157248|83164593|FG000|Overall Study|Withdrawal by Subject|1|||
46929611|NCT00157248|83164594|FG001|Overall Study|Withdrawal by Subject|4|||
46929612|NCT00157248|83164595|FG002|Overall Study|Withdrawal by Subject|3|||
46929613|NCT00157248|83164596|FG003|Overall Study|Withdrawal by Subject|3|||
46929614|NCT00157248|83164593|FG000|Overall Study|site closures, subject moving|7|||
46929615|NCT00157248|83164594|FG001|Overall Study|site closures, subject moving|7|||
46929616|NCT00157248|83164595|FG002|Overall Study|site closures, subject moving|3|||
46929617|NCT00157248|83164596|FG003|Overall Study|site closures, subject moving|9|||
46929618|NCT02504580|83164618|FG000|Overall Study|Other|1|||
46929619|NCT02504580|83164619|FG001|Overall Study|Other|0|||
46929620|NCT02504580|83164620|FG002|Overall Study|Other|0|||
46929621|NCT02504580|83164621|FG003|Overall Study|Other|2|||
46929622|NCT02504580|83164622|FG004|Overall Study|Other|1|||
46929623|NCT02504580|83164623|FG005|Overall Study|Other|1|||
46929624|NCT02504580|83164624|FG006|Overall Study|Other|1|||
46929625|NCT02504580|83164625|FG007|Overall Study|Other|2|||
47055400|NCT04967885|83329412|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
47055401|NCT04967885|83329413|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
47055402|NCT04967885|83329412|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
47055403|NCT04967885|83329413|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
46929626|NCT02504580|83164626|FG008|Overall Study|Other|0|||
46929627|NCT02504580|83164627|FG009|Overall Study|Other|0|||
46929628|NCT02504580|83164628|FG010|Overall Study|Other|0|||
46929629|NCT02504580|83164629|FG011|Overall Study|Other|2|||
46929630|NCT02504580|83164618|FG000|Overall Study|Subject refusal to continue|0|||
46929631|NCT02504580|83164619|FG001|Overall Study|Subject refusal to continue|1|||
46929632|NCT02504580|83164620|FG002|Overall Study|Subject refusal to continue|0|||
46929633|NCT02504580|83164621|FG003|Overall Study|Subject refusal to continue|0|||
46929634|NCT02504580|83164622|FG004|Overall Study|Subject refusal to continue|0|||
46929635|NCT02504580|83164623|FG005|Overall Study|Subject refusal to continue|0|||
46929636|NCT02504580|83164624|FG006|Overall Study|Subject refusal to continue|0|||
46929637|NCT02504580|83164625|FG007|Overall Study|Subject refusal to continue|0|||
46929638|NCT02504580|83164626|FG008|Overall Study|Subject refusal to continue|0|||
46929639|NCT02504580|83164627|FG009|Overall Study|Subject refusal to continue|0|||
46929640|NCT02504580|83164628|FG010|Overall Study|Subject refusal to continue|0|||
46929641|NCT02504580|83164629|FG011|Overall Study|Subject refusal to continue|0|||
46929642|NCT01328756|83164651|FG000|Overall Study|Protocol Violation|4|||
46929643|NCT01328756|83164651|FG000|Overall Study|Adverse Event|39|||
46929644|NCT01328756|83164651|FG000|Overall Study|Lack of Efficacy|5|||
46929645|NCT01328756|83164651|FG000|Overall Study|Withdrawal by Subject|41|||
46929646|NCT01328756|83164651|FG000|Overall Study|Lost to Follow-up|5|||
46929647|NCT01328756|83164651|FG000|Overall Study|Other|29|||
46929648|NCT03922308|83164658|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
46929649|NCT03922308|83164659|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
46929650|NCT03922308|83164660|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
46929651|NCT03922308|83164658|FG000|Overall Study|Lost to Follow-up|1|||
46929652|NCT03922308|83164659|FG001|Overall Study|Lost to Follow-up|0|||
46929653|NCT03922308|83164660|FG002|Overall Study|Lost to Follow-up|0|||
46929654|NCT03922308|83164658|FG000|Overall Study|Reason not Specified|0|||
46929655|NCT03922308|83164659|FG001|Overall Study|Reason not Specified|2|||
46929656|NCT03922308|83164660|FG002|Overall Study|Reason not Specified|1|||
46929657|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
46929658|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
46929659|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
46929660|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
46929661|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
46929662|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
46929663|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
46929664|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
46929665|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
46929666|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
46929667|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
46929668|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
46929669|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
46929670|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
46929671|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
46929672|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
46929673|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
46929674|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
46929675|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
46929676|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
46929677|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
46929678|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
46929679|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
46929680|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
46929681|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Death|2|||
46929682|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Death|1|||
47055404|NCT04967885|83329412|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
47055405|NCT04967885|83329413|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
47055406|NCT04967885|83329412|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
46756601|NCT00518323|82974665|FG003|Overall Study|Withdrawal by Subject|2|||
46756602|NCT00518323|82974662|FG000|Overall Study|Lost to Follow-up|0|||
46756603|NCT00518323|82974663|FG001|Overall Study|Lost to Follow-up|2|||
46756604|NCT00518323|82974664|FG002|Overall Study|Lost to Follow-up|1|||
46756605|NCT00518323|82974665|FG003|Overall Study|Lost to Follow-up|3|||
46756606|NCT00518323|82974662|FG000|Overall Study|Adverse Event|1|||
46756607|NCT00518323|82974663|FG001|Overall Study|Adverse Event|1|||
46756608|NCT00518323|82974664|FG002|Overall Study|Adverse Event|1|||
46756609|NCT00518323|82974665|FG003|Overall Study|Adverse Event|0|||
46756610|NCT00518323|82974662|FG000|Overall Study|Prohibited medication and others|3|||
46756611|NCT00518323|82974663|FG001|Overall Study|Prohibited medication and others|1|||
46756612|NCT00518323|82974664|FG002|Overall Study|Prohibited medication and others|1|||
46756613|NCT00518323|82974665|FG003|Overall Study|Prohibited medication and others|0|||
46756614|NCT00826449|82974677|FG000|Overall Study|Disease Progression|4|||
46756615|NCT00826449|82974677|FG000|Overall Study|Withdrawal by Subject|1|||
46756616|NCT00825825|82974682|FG000|First Medication Period (14 Days)|Adverse Event|1|||
46756617|NCT00825825|82974683|FG001|First Medication Period (14 Days)|Adverse Event|0|||
46756618|NCT00825825|82974684|FG002|First Medication Period (14 Days)|Adverse Event|0|||
46756619|NCT00825825|82974685|FG003|First Medication Period (14 Days)|Adverse Event|0|||
46929683|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Death|0|||
46929684|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Death|0|||
46929685|NCT02607930|83164673|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
46929686|NCT02607930|83164674|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
46929687|NCT02607930|83164675|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
47055407|NCT04967885|83329413|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
46756620|NCT00825825|82974686|FG004|First Medication Period (14 Days)|Adverse Event|0|||
46756621|NCT00825825|82974687|FG005|First Medication Period (14 Days)|Adverse Event|1|||
46756622|NCT00825825|82974682|FG000|First Medication Period (14 Days)|Physician Decision|2|||
46756623|NCT00825825|82974683|FG001|First Medication Period (14 Days)|Physician Decision|0|||
46756624|NCT00825825|82974684|FG002|First Medication Period (14 Days)|Physician Decision|1|||
46756625|NCT00825825|82974685|FG003|First Medication Period (14 Days)|Physician Decision|0|||
46929688|NCT02607930|83164676|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
46929689|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
46929690|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
46929691|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
46929692|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
46929693|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
46929694|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
46929695|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
46929696|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
46929697|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
46929698|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
46929699|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
46929700|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
46929701|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
46929702|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
46929703|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
46929704|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
46929705|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
46929706|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
46929707|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
46929708|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
46929709|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
46929710|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
46929711|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
46929712|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
46929713|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
46929714|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
46929715|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
46929716|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
46929717|NCT02607930|83164673|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
46929718|NCT02607930|83164674|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
46929719|NCT02607930|83164675|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
46929720|NCT02607930|83164676|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
46929721|NCT02736188|83164707|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
46929722|NCT02736188|83164707|FG000|Overall Study|Adverse Event|1|||
46929723|NCT02736188|83164707|FG000|Overall Study|Withdrawal by Subject|1|||
46929724|NCT02736188|83164707|FG000|Overall Study|Other|6|||
46929725|NCT00154284|83164715|FG000|Overall Study|Adverse Event|6|||
46929726|NCT00154284|83164716|FG001|Overall Study|Adverse Event|9|||
46929727|NCT00154284|83164715|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46929728|NCT00154284|83164716|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46929729|NCT00154284|83164715|FG000|Overall Study|Lack of Efficacy|1|||
46929730|NCT00154284|83164716|FG001|Overall Study|Lack of Efficacy|2|||
46929731|NCT00154284|83164715|FG000|Overall Study|Protocol Violation|0|||
46929732|NCT00154284|83164716|FG001|Overall Study|Protocol Violation|1|||
46929733|NCT02735096|83164724|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
46929734|NCT00905346|83164737|FG000|Period 1|Withdrawal by Subject|1|||
46929735|NCT00905346|83164738|FG001|Period 1|Withdrawal by Subject|0|||
46929736|NCT01328444|83164751|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
46929737|NCT01328444|83164752|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
46929738|NCT01328444|83164753|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
46929739|NCT01328444|83164754|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
46929740|NCT01328444|83164755|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
46929741|NCT01328444|83164756|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
46929742|NCT01328444|83164751|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
46929743|NCT01328444|83164752|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
46929744|NCT01328444|83164753|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
46929745|NCT01328444|83164754|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
47055408|NCT04967885|83329412|FG000|EMI-II Intervention|Lost to Follow-up|14|||
47055409|NCT04967885|83329413|FG001|EMI-II Intervention|Lost to Follow-up|10|||
46756626|NCT00825825|82974686|FG004|First Medication Period (14 Days)|Physician Decision|0|||
46756627|NCT00825825|82974687|FG005|First Medication Period (14 Days)|Physician Decision|1|||
46929746|NCT01328444|83164755|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
46929747|NCT01328444|83164756|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
46929748|NCT01328444|83164751|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
46929749|NCT01328444|83164752|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
46929750|NCT01328444|83164753|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
46929751|NCT01328444|83164754|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
46929752|NCT01328444|83164755|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
46929753|NCT01328444|83164756|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
46929754|NCT01328444|83164751|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
46929755|NCT01328444|83164752|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
46929756|NCT01328444|83164753|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
46929757|NCT01328444|83164754|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
46929758|NCT01328444|83164755|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
46929759|NCT01328444|83164756|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
46929760|NCT01328444|83164751|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
46929761|NCT01328444|83164752|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46929762|NCT01328444|83164753|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46929763|NCT01328444|83164754|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
46929764|NCT01328444|83164755|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46929765|NCT01328444|83164756|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
46929766|NCT01328444|83164751|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
46929767|NCT01328444|83164752|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
46929768|NCT01328444|83164753|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
46929769|NCT01328444|83164754|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
46929770|NCT01328444|83164755|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
46929771|NCT01328444|83164756|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
46929772|NCT01328444|83164751|FG000|Washout Period (14 Days)|Adverse Event|1|||
46929773|NCT01328444|83164752|FG001|Washout Period (14 Days)|Adverse Event|1|||
46929774|NCT01328444|83164753|FG002|Washout Period (14 Days)|Adverse Event|0|||
46929775|NCT01328444|83164754|FG003|Washout Period (14 Days)|Adverse Event|1|||
46929776|NCT01328444|83164755|FG004|Washout Period (14 Days)|Adverse Event|1|||
46929777|NCT01328444|83164756|FG005|Washout Period (14 Days)|Adverse Event|2|||
46929778|NCT01328444|83164751|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
46929779|NCT01328444|83164752|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
46929780|NCT01328444|83164753|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
46929781|NCT01328444|83164754|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
46929782|NCT01328444|83164755|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
46929783|NCT01328444|83164756|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
46929784|NCT01328444|83164751|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
46929785|NCT01328444|83164752|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
46929786|NCT01328444|83164753|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
46929787|NCT01328444|83164754|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
46929788|NCT01328444|83164755|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
46929789|NCT01328444|83164756|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
46929790|NCT01328444|83164751|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
46929791|NCT01328444|83164752|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
46929792|NCT01328444|83164753|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
46929793|NCT01328444|83164754|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
46929794|NCT01328444|83164755|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
46929795|NCT01328444|83164756|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
46929796|NCT01328444|83164751|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
46929797|NCT01328444|83164752|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
46929798|NCT01328444|83164753|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
46756628|NCT00825825|82974682|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
46756629|NCT00825825|82974683|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
46756630|NCT00825825|82974684|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
46756631|NCT00825825|82974685|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
46756632|NCT00825825|82974686|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
46756633|NCT00825825|82974687|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
46756634|NCT00825825|82974682|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
46636581|NCT01484496|82810388|FG000|Period 2|Adverse Event|0|||
46756635|NCT00825825|82974683|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
46929799|NCT01328444|83164754|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
46929800|NCT01328444|83164755|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
46636582|NCT01484496|82810389|FG001|Period 2|Adverse Event|0|||
46636583|NCT01484496|82810390|FG002|Period 2|Adverse Event|5|||
46756636|NCT00825825|82974684|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
46756637|NCT00825825|82974685|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
46756638|NCT00825825|82974686|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
46756639|NCT00825825|82974687|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
46756640|NCT00825825|82974682|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
46756641|NCT00825825|82974683|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
46929801|NCT01328444|83164756|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
46929802|NCT01328444|83164751|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
46929803|NCT01328444|83164752|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
46929804|NCT01328444|83164753|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
46929805|NCT01328444|83164754|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
46929806|NCT01328444|83164755|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
46929807|NCT01328444|83164756|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
46929808|NCT01328444|83164751|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
46929809|NCT01328444|83164752|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
46929810|NCT01328444|83164753|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
46929811|NCT01328444|83164754|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
46929812|NCT01328444|83164755|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
46929813|NCT01328444|83164756|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
46929814|NCT01328444|83164751|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
46929815|NCT01328444|83164752|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
47055410|NCT04571060|83329430|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
46756642|NCT00825825|82974684|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
46756643|NCT00825825|82974685|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
46756644|NCT00825825|82974686|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
46815196|NCT00510146|83034844|FG001|Double-Blind Treatment|Adverse Event|13|||
46815197|NCT00510146|83034843|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
46815198|NCT00510146|83034844|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
46815199|NCT00510146|83034843|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
46815200|NCT00510146|83034844|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
46815201|NCT00510146|83034843|FG000|Double-Blind Treatment|Physician Decision|6|||
46815202|NCT00510146|83034844|FG001|Double-Blind Treatment|Physician Decision|0|||
46815203|NCT00510146|83034843|FG000|Double-Blind Treatment|Protocol Violation|1|||
46815204|NCT00510146|83034844|FG001|Double-Blind Treatment|Protocol Violation|2|||
46815205|NCT00510146|83034843|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
46815206|NCT00510146|83034844|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
46815207|NCT00510146|83034843|FG000|Double-Blind Treatment|Clinical Relapse|0|||
46815208|NCT00510146|83034844|FG001|Double-Blind Treatment|Clinical Relapse|1|||
46815209|NCT00510146|83034843|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
46815210|NCT00510146|83034844|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
46815211|NCT00510146|83034843|FG000|Open-Label Treatment|Adverse Event|22|||
46815212|NCT00510146|83034844|FG001|Open-Label Treatment|Adverse Event|8|||
46815213|NCT00510146|83034843|FG000|Open-Label Treatment|Death|1|||
46815214|NCT00510146|83034844|FG001|Open-Label Treatment|Death|1|||
46815215|NCT00510146|83034843|FG000|Open-Label Treatment|Lack of Efficacy|4|||
46815216|NCT00510146|83034844|FG001|Open-Label Treatment|Lack of Efficacy|0|||
46815217|NCT00510146|83034843|FG000|Open-Label Treatment|Lost to Follow-up|10|||
46815218|NCT00510146|83034844|FG001|Open-Label Treatment|Lost to Follow-up|1|||
46815219|NCT00510146|83034843|FG000|Open-Label Treatment|Physician Decision|3|||
46815220|NCT00510146|83034844|FG001|Open-Label Treatment|Physician Decision|1|||
46815221|NCT00510146|83034843|FG000|Open-Label Treatment|Protocol Violation|4|||
46815222|NCT00510146|83034844|FG001|Open-Label Treatment|Protocol Violation|2|||
46815223|NCT00510146|83034843|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
46815224|NCT00510146|83034844|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
46815225|NCT00510146|83034843|FG000|Open-Label Treatment|Clinical Relapse|1|||
46929816|NCT01328444|83164753|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
47055411|NCT04571060|83329431|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
47055412|NCT04571060|83329430|FG000|Overall Study|Never treated migraine|47|||
47055413|NCT04571060|83329431|FG001|Overall Study|Never treated migraine|36|||
47055414|NCT04571060|83329430|FG000|Overall Study|Protocol Violation|4|||
47055415|NCT04571060|83329431|FG001|Overall Study|Protocol Violation|2|||
47055416|NCT04571060|83329430|FG000|Overall Study|Withdrawal by Subject|6|||
47055417|NCT04571060|83329431|FG001|Overall Study|Withdrawal by Subject|2|||
47055418|NCT04571060|83329430|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
46756645|NCT00825825|82974687|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
46815226|NCT00510146|83034844|FG001|Open-Label Treatment|Clinical Relapse|1|||
46815227|NCT00510146|83034843|FG000|Open-Label Treatment|Sponsor Decision|2|||
46815228|NCT00510146|83034844|FG001|Open-Label Treatment|Sponsor Decision|0|||
46815229|NCT00480636|83034852|FG000|Overall Study|Death|12|||
46815230|NCT00480636|83034852|FG000|Overall Study|Lost to Follow-up|4|||
46815231|NCT00480636|83034852|FG000|Overall Study|Other|2|||
46815232|NCT00480636|83034852|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
46815233|NCT00499122|83034856|FG000|Overall Study|Withdrawal by Subject|2|||
46815234|NCT00393939|83034863|FG000|Overall Study|Protocol Violation|1|||
46815235|NCT00393939|83034864|FG001|Overall Study|Protocol Violation|1|||
46815236|NCT00393939|83034863|FG000|Overall Study|Lost to Follow-up|2|||
46815237|NCT00393939|83034864|FG001|Overall Study|Lost to Follow-up|4|||
46815238|NCT00393939|83034863|FG000|Overall Study|Death|10|||
46815239|NCT00393939|83034864|FG001|Overall Study|Death|4|||
46815240|NCT00393939|83034863|FG000|Overall Study|Sponsor|5|||
46815241|NCT00393939|83034864|FG001|Overall Study|Sponsor|13|||
46815242|NCT00393939|83034863|FG000|Overall Study|Objective progression or relapse|239|||
46815243|NCT00393939|83034864|FG001|Overall Study|Objective progression or relapse|223|||
46815244|NCT00393939|83034863|FG000|Overall Study|Withdrawal by Subject|2|||
46815245|NCT00393939|83034864|FG001|Overall Study|Withdrawal by Subject|7|||
46815246|NCT00393939|83034863|FG000|Overall Study|Other|37|||
46815247|NCT00393939|83034864|FG001|Overall Study|Other|45|||
46815248|NCT00488982|83034870|FG000|Course 1|Physician Decision|0|||
46815249|NCT00488982|83034871|FG001|Course 1|Physician Decision|2|||
46815250|NCT00488982|83034872|FG002|Course 1|Physician Decision|4|||
46815251|NCT00488982|83034870|FG000|Course 1|Withdrawal by Subject|0|||
46815252|NCT00488982|83034871|FG001|Course 1|Withdrawal by Subject|8|||
46815253|NCT00488982|83034872|FG002|Course 1|Withdrawal by Subject|2|||
46815254|NCT00488982|83034870|FG000|Course 1|nonprotocol therapy|0|||
46815255|NCT00488982|83034871|FG001|Course 1|nonprotocol therapy|2|||
46815256|NCT00488982|83034872|FG002|Course 1|nonprotocol therapy|2|||
46815257|NCT00488982|83034870|FG000|Course 1|Adverse Event|0|||
46815258|NCT00488982|83034871|FG001|Course 1|Adverse Event|0|||
46815259|NCT00488982|83034872|FG002|Course 1|Adverse Event|6|||
46815260|NCT00488826|83034889|FG000|Overall Study|Withdrawal by Subject|40|||
46815261|NCT00488826|83034890|FG001|Overall Study|Withdrawal by Subject|35|||
46815262|NCT00488826|83034891|FG002|Overall Study|Withdrawal by Subject|19|||
46815263|NCT00488826|83034889|FG000|Overall Study|Protocol Violation|0|||
46815264|NCT00488826|83034890|FG001|Overall Study|Protocol Violation|0|||
46815265|NCT00488826|83034891|FG002|Overall Study|Protocol Violation|2|||
46815266|NCT00488826|83034889|FG000|Overall Study|Adverse Event|9|||
47055419|NCT04571060|83329431|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
47055420|NCT04512066|83329441|FG000|Double-blind Treatment Period|Adverse Event|6|||
47055421|NCT04512066|83329442|FG001|Double-blind Treatment Period|Adverse Event|4|||
47055422|NCT04512066|83329443|FG002|Double-blind Treatment Period|Adverse Event|5|||
47055423|NCT04512066|83329444|FG003|Double-blind Treatment Period|Adverse Event|1|||
47055424|NCT04512066|83329445|FG004|Double-blind Treatment Period|Adverse Event|0|||
47055425|NCT04512066|83329446|FG005|Double-blind Treatment Period|Adverse Event|0|||
47055426|NCT04512066|83329441|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
47055427|NCT04512066|83329442|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
47055428|NCT04512066|83329443|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
47055429|NCT04512066|83329444|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
47055430|NCT04512066|83329445|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
47055431|NCT04512066|83329446|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
47055432|NCT04512066|83329441|FG000|Double-blind Treatment Period|Physician Decision|1|||
46756646|NCT00825825|82974682|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
46756647|NCT00825825|82974683|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
46756648|NCT00825825|82974684|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
46756649|NCT00825825|82974685|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
46756650|NCT00825825|82974686|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
46756651|NCT00825825|82974687|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
46756652|NCT00825825|82974682|FG000|Third Medication Period (14 Days)|poor data quality|0|||
46756653|NCT00825825|82974683|FG001|Third Medication Period (14 Days)|poor data quality|1|||
46756654|NCT00825825|82974684|FG002|Third Medication Period (14 Days)|poor data quality|0|||
46756655|NCT00825825|82974685|FG003|Third Medication Period (14 Days)|poor data quality|0|||
46756656|NCT00825825|82974686|FG004|Third Medication Period (14 Days)|poor data quality|0|||
46756657|NCT00825825|82974687|FG005|Third Medication Period (14 Days)|poor data quality|0|||
46756658|NCT00710710|82974696|FG000|Overall Study|Consent withdrawn|2|||
47055433|NCT04512066|83329442|FG001|Double-blind Treatment Period|Physician Decision|0|||
47055434|NCT04512066|83329443|FG002|Double-blind Treatment Period|Physician Decision|1|||
46756659|NCT00710710|82974697|FG001|Overall Study|Consent withdrawn|2|||
46756660|NCT00710710|82974696|FG000|Overall Study|Protocol Violation|0|||
46756661|NCT00710710|82974697|FG001|Overall Study|Protocol Violation|1|||
46756662|NCT00710710|82974696|FG000|Overall Study|Adverse Event|3|||
46815267|NCT00488826|83034890|FG001|Overall Study|Adverse Event|15|||
46815268|NCT00488826|83034891|FG002|Overall Study|Adverse Event|4|||
46815269|NCT00488826|83034889|FG000|Overall Study|Lost to Follow-up|5|||
46815270|NCT00488826|83034890|FG001|Overall Study|Lost to Follow-up|1|||
46815271|NCT00488826|83034891|FG002|Overall Study|Lost to Follow-up|0|||
46815272|NCT00488826|83034889|FG000|Overall Study|Protocol Deviations|2|||
46815273|NCT00488826|83034890|FG001|Overall Study|Protocol Deviations|1|||
46815274|NCT00488826|83034891|FG002|Overall Study|Protocol Deviations|1|||
46815275|NCT05568797|83034907|FG000|Overall Study|Adverse Event|0|||
46815276|NCT05568797|83034908|FG001|Overall Study|Adverse Event|8|||
46815277|NCT05568797|83034907|FG000|Overall Study|Lost to Follow-up|2|||
46815278|NCT05568797|83034908|FG001|Overall Study|Lost to Follow-up|3|||
46815279|NCT05568797|83034907|FG000|Overall Study|Withdrawal by Subject|1|||
46815280|NCT05568797|83034908|FG001|Overall Study|Withdrawal by Subject|10|||
46815281|NCT05568797|83034907|FG000|Overall Study|Other|2|||
46815282|NCT05568797|83034908|FG001|Overall Study|Other|2|||
46815283|NCT05441540|83034923|FG000|Overall Study|Withdrawal by Subject|2|||
46815284|NCT05349864|83034929|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
46815285|NCT05349864|83034930|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
46815286|NCT05158140|83034964|FG000|Overall Study|Death|0|||
46815287|NCT05158140|83034965|FG001|Overall Study|Death|0|||
46815288|NCT05158140|83034966|FG002|Overall Study|Death|0|||
46815289|NCT05158140|83034967|FG003|Overall Study|Death|1|||
46815290|NCT05158140|83034964|FG000|Overall Study|Lost to Follow-up|3|||
46815291|NCT05158140|83034965|FG001|Overall Study|Lost to Follow-up|6|||
46815292|NCT05158140|83034966|FG002|Overall Study|Lost to Follow-up|4|||
46815293|NCT05158140|83034967|FG003|Overall Study|Lost to Follow-up|3|||
46815294|NCT05158140|83034964|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46815295|NCT05158140|83034965|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46815296|NCT05158140|83034966|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
46815297|NCT05158140|83034967|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
46815298|NCT05158140|83034964|FG000|Overall Study|Withdrawal by Subject|3|||
46815299|NCT05158140|83034965|FG001|Overall Study|Withdrawal by Subject|7|||
46815300|NCT05158140|83034966|FG002|Overall Study|Withdrawal by Subject|3|||
46815301|NCT05158140|83034967|FG003|Overall Study|Withdrawal by Subject|7|||
46815302|NCT05022121|83034982|FG000|Overall Study|Lack of Efficacy|1|||
46815303|NCT05022121|83034983|FG001|Overall Study|Lack of Efficacy|0|||
46815304|NCT05022121|83034982|FG000|Overall Study|Lost to Follow-up|0|||
46815305|NCT05022121|83034983|FG001|Overall Study|Lost to Follow-up|2|||
46815306|NCT04669262|83035000|FG000|Overall Study|Withdrawal by Subject|0|||
46815307|NCT04669262|83035001|FG001|Overall Study|Withdrawal by Subject|0|||
46815308|NCT04669262|83035002|FG002|Overall Study|Withdrawal by Subject|0|||
46815309|NCT04669262|83035003|FG003|Overall Study|Withdrawal by Subject|1|||
46815310|NCT04669262|83035000|FG000|Overall Study|Randomized but Not Treated|0|||
46815311|NCT04669262|83035001|FG001|Overall Study|Randomized but Not Treated|1|||
46815312|NCT04669262|83035002|FG002|Overall Study|Randomized but Not Treated|0|||
46815313|NCT04669262|83035003|FG003|Overall Study|Randomized but Not Treated|0|||
47055435|NCT04512066|83329444|FG003|Double-blind Treatment Period|Physician Decision|0|||
47055436|NCT04512066|83329445|FG004|Double-blind Treatment Period|Physician Decision|0|||
47055437|NCT04512066|83329446|FG005|Double-blind Treatment Period|Physician Decision|0|||
46756663|NCT00710710|82974697|FG001|Overall Study|Adverse Event|3|||
46756664|NCT00710710|82974696|FG000|Overall Study|Progressive disease|40|||
46756665|NCT00710710|82974697|FG001|Overall Study|Progressive disease|38|||
46756666|NCT00880334|82974705|FG000|Randomized Phase|Physician Decision|1|||
46756667|NCT00880334|82974706|FG001|Randomized Phase|Physician Decision|0|||
46756668|NCT00880334|82974705|FG000|Randomized Phase|Withdrawal by Subject|2|||
46756669|NCT00880334|82974706|FG001|Randomized Phase|Withdrawal by Subject|1|||
46756670|NCT00880334|82974705|FG000|Randomized Phase|Inadequate Labs|1|||
46756671|NCT00880334|82974706|FG001|Randomized Phase|Inadequate Labs|1|||
46756672|NCT00880334|82974705|FG000|Randomized Phase|Brain Metastasis|0|||
46756673|NCT00880334|82974706|FG001|Randomized Phase|Brain Metastasis|1|||
46756674|NCT00880334|82974705|FG000|Randomized Phase|Crossover Participants|0|||
46756675|NCT00880334|82974706|FG001|Randomized Phase|Crossover Participants|37|||
46756676|NCT00865566|82974718|FG000|Overall Study|Death|1|||
46756677|NCT00865566|82974719|FG001|Overall Study|Death|11|||
46815314|NCT04631562|83035026|FG000|Overall Study|Withdrawal by Subject|0|||
46815315|NCT04631562|83035027|FG001|Overall Study|Withdrawal by Subject|0|||
46815316|NCT04631562|83035028|FG002|Overall Study|Withdrawal by Subject|0|||
46815317|NCT04631562|83035029|FG003|Overall Study|Withdrawal by Subject|0|||
46815318|NCT04631562|83035030|FG004|Overall Study|Withdrawal by Subject|0|||
46815319|NCT04631562|83035031|FG005|Overall Study|Withdrawal by Subject|0|||
47055438|NCT04512066|83329441|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
47055439|NCT04512066|83329442|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
46756678|NCT00865566|82974718|FG000|Overall Study|Lost to Follow-up|314|||
46756679|NCT00865566|82974719|FG001|Overall Study|Lost to Follow-up|315|||
46756680|NCT00865566|82974718|FG000|Overall Study|Withdrawal by Subject|45|||
46815320|NCT04631562|83035032|FG006|Overall Study|Withdrawal by Subject|0|||
46815321|NCT04631562|83035033|FG007|Overall Study|Withdrawal by Subject|1|||
46815322|NCT04631562|83035034|FG008|Overall Study|Withdrawal by Subject|0|||
46815323|NCT04631562|83035026|FG000|Overall Study|Other|0|||
46815324|NCT04631562|83035027|FG001|Overall Study|Other|0|||
46815325|NCT04631562|83035028|FG002|Overall Study|Other|0|||
46815326|NCT04631562|83035029|FG003|Overall Study|Other|0|||
46756681|NCT00865566|82974719|FG001|Overall Study|Withdrawal by Subject|65|||
46815327|NCT04631562|83035030|FG004|Overall Study|Other|0|||
46815328|NCT04631562|83035031|FG005|Overall Study|Other|0|||
46815329|NCT04631562|83035032|FG006|Overall Study|Other|0|||
46815330|NCT04631562|83035033|FG007|Overall Study|Other|0|||
46815331|NCT04631562|83035034|FG008|Overall Study|Other|1|||
46815332|NCT04631562|83035026|FG000|Overall Study|Lost to Follow-up|0|||
46815333|NCT04631562|83035027|FG001|Overall Study|Lost to Follow-up|0|||
46815334|NCT04631562|83035028|FG002|Overall Study|Lost to Follow-up|0|||
46815335|NCT04631562|83035029|FG003|Overall Study|Lost to Follow-up|1|||
46815336|NCT04631562|83035030|FG004|Overall Study|Lost to Follow-up|0|||
46815337|NCT04631562|83035031|FG005|Overall Study|Lost to Follow-up|0|||
46815338|NCT04631562|83035032|FG006|Overall Study|Lost to Follow-up|0|||
46815339|NCT04631562|83035033|FG007|Overall Study|Lost to Follow-up|0|||
46815340|NCT04631562|83035034|FG008|Overall Study|Lost to Follow-up|0|||
46815341|NCT04631562|83035026|FG000|Overall Study|Adverse Event|0|||
46815342|NCT04631562|83035027|FG001|Overall Study|Adverse Event|0|||
46815343|NCT04631562|83035028|FG002|Overall Study|Adverse Event|0|||
46815344|NCT04631562|83035029|FG003|Overall Study|Adverse Event|0|||
46815345|NCT04631562|83035030|FG004|Overall Study|Adverse Event|0|||
46815346|NCT04631562|83035031|FG005|Overall Study|Adverse Event|0|||
46815347|NCT04631562|83035032|FG006|Overall Study|Adverse Event|1|||
46815348|NCT04631562|83035033|FG007|Overall Study|Adverse Event|0|||
46815349|NCT04631562|83035034|FG008|Overall Study|Adverse Event|0|||
46815350|NCT04498468|83035095|FG000|Overall Study|Lost to Follow-up|3|||
46815351|NCT04298229|83035103|FG000|Overall Study|Physician Decision|1|||
46815352|NCT04298229|83035104|FG001|Overall Study|Physician Decision|1|||
46929817|NCT01328444|83164754|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
46929818|NCT01328444|83164755|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
46929819|NCT01328444|83164756|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
46815353|NCT04298229|83035103|FG000|Overall Study|Withdrawal by Subject|1|||
46815354|NCT04298229|83035104|FG001|Overall Study|Withdrawal by Subject|1|||
46815355|NCT04298229|83035103|FG000|Overall Study|Did not receive IV loop diuretics|2|||
46815356|NCT04298229|83035104|FG001|Overall Study|Did not receive IV loop diuretics|0|||
46815357|NCT04062448|83035129|FG000|Overall Study|Lost to Follow-up|1|||
46815358|NCT04062448|83035129|FG000|Overall Study|Withdrawal by Subject|2|||
46815359|NCT03977584|83035136|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
46815360|NCT03977584|83035137|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
46815361|NCT03977584|83035138|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
46815362|NCT03954132|83035147|FG000|Overall Study|Adverse Event|2|||
46815363|NCT03954132|83035148|FG001|Overall Study|Adverse Event|0|||
46815364|NCT03954132|83035147|FG000|Overall Study|Patient's wish|5|||
46815365|NCT03954132|83035148|FG001|Overall Study|Patient's wish|0|||
46929820|NCT01328444|83164751|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46929821|NCT01328444|83164752|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46929822|NCT01328444|83164753|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46929823|NCT01328444|83164754|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46929824|NCT01328444|83164755|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46929825|NCT01328444|83164756|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46929826|NCT00887250|83164773|FG000|Overall Study|Adverse Event|3|||
46929827|NCT00887250|83164774|FG001|Overall Study|Adverse Event|0|||
46756682|NCT00865566|82974718|FG000|Overall Study|Physician Decision|0|||
46756683|NCT00865566|82974719|FG001|Overall Study|Physician Decision|1|||
46756684|NCT00865566|82974718|FG000|Overall Study|Participant relocated|78|||
46756685|NCT00865566|82974719|FG001|Overall Study|Participant relocated|107|||
46756686|NCT00865566|82974718|FG000|Overall Study|Participant unable to adhere|27|||
46756687|NCT00865566|82974719|FG001|Overall Study|Participant unable to adhere|42|||
46756688|NCT00865566|82974718|FG000|Overall Study|Other; N=245 due to early study closure|154|||
46756689|NCT00865566|82974719|FG001|Overall Study|Other; N=245 due to early study closure|139|||
46756690|NCT00865566|82974718|FG000|Overall Study|HIV infection|5|||
46815366|NCT03954132|83035147|FG000|Overall Study|Lost to Follow-up|10|||
46815367|NCT03954132|83035148|FG001|Overall Study|Lost to Follow-up|0|||
46815368|NCT03954132|83035147|FG000|Overall Study|Screening failure|0|||
46756691|NCT00865566|82974719|FG001|Overall Study|HIV infection|7|||
46756692|NCT03866473|82974727|FG000|Phase 1|Death|1|||
46815369|NCT03954132|83035148|FG001|Overall Study|Screening failure|1|||
46815370|NCT03954132|83035147|FG000|Overall Study|No registration after Visit 1|5|||
46815371|NCT03954132|83035148|FG001|Overall Study|No registration after Visit 1|2|||
46815372|NCT03954132|83035147|FG000|Overall Study|Other reason than listed|2|||
46815373|NCT03954132|83035148|FG001|Overall Study|Other reason than listed|2|||
46815374|NCT03954132|83035147|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
46756693|NCT03866473|82974728|FG001|Phase 1|Death|0|||
46756694|NCT03866473|82974727|FG000|Phase 2|Death|0|||
46815375|NCT03954132|83035148|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
46815376|NCT03954132|83035147|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
46815377|NCT03954132|83035148|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
46756695|NCT03866473|82974728|FG001|Phase 2|Death|2|||
46815378|NCT03896035|83035156|FG000|Overall Study|Lost to Follow-up|2|||
46815379|NCT03896035|83035157|FG001|Overall Study|Lost to Follow-up|6|||
46815380|NCT03896035|83035156|FG000|Overall Study|Withdrawal by Subject|0|||
46815381|NCT03896035|83035157|FG001|Overall Study|Withdrawal by Subject|1|||
46815382|NCT03896035|83035156|FG000|Overall Study|Health/family health issues during COVID|0|||
46815383|NCT03896035|83035157|FG001|Overall Study|Health/family health issues during COVID|4|||
46815384|NCT03876457|83035165|FG000|Overall Study|Lost to Follow-up|1|||
46815385|NCT03876457|83035166|FG001|Overall Study|Lost to Follow-up|3|||
46815386|NCT03852472|83035188|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
46815387|NCT03852472|83035189|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
46815388|NCT03852472|83035190|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
46815389|NCT03852472|83035191|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
46815390|NCT03852472|83035192|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
46815391|NCT03852472|83035188|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
46815392|NCT03852472|83035189|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
46815393|NCT03852472|83035190|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
46815394|NCT03852472|83035191|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
46815395|NCT03852472|83035192|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
46815396|NCT03852472|83035188|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
46815397|NCT03852472|83035189|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
46929828|NCT00887250|83164775|FG002|Overall Study|Adverse Event|7|||
46929829|NCT00887250|83164773|FG000|Overall Study|Lack of Efficacy|9|||
46929830|NCT00887250|83164774|FG001|Overall Study|Lack of Efficacy|6|||
46929831|NCT00887250|83164775|FG002|Overall Study|Lack of Efficacy|1|||
47055440|NCT04512066|83329443|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
47055441|NCT04512066|83329444|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
47055442|NCT04512066|83329445|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
47055443|NCT04512066|83329446|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
47055444|NCT04512066|83329441|FG000|Extension Period|Adverse Event|0|||
47055445|NCT04512066|83329442|FG001|Extension Period|Adverse Event|1|||
47055446|NCT04512066|83329443|FG002|Extension Period|Adverse Event|4|||
47055447|NCT04512066|83329444|FG003|Extension Period|Adverse Event|3|||
47055448|NCT04512066|83329445|FG004|Extension Period|Adverse Event|1|||
47055449|NCT04512066|83329446|FG005|Extension Period|Adverse Event|3|||
47055450|NCT04512066|83329441|FG000|Extension Period|Death|0|||
47055451|NCT04512066|83329442|FG001|Extension Period|Death|0|||
47055452|NCT04512066|83329443|FG002|Extension Period|Death|0|||
47055453|NCT04512066|83329444|FG003|Extension Period|Death|0|||
47055454|NCT04512066|83329445|FG004|Extension Period|Death|0|||
47055455|NCT04512066|83329446|FG005|Extension Period|Death|1|||
47055456|NCT04512066|83329441|FG000|Extension Period|Lack of Efficacy|0|||
47055457|NCT04512066|83329442|FG001|Extension Period|Lack of Efficacy|4|||
47055458|NCT04512066|83329443|FG002|Extension Period|Lack of Efficacy|4|||
47055459|NCT04512066|83329444|FG003|Extension Period|Lack of Efficacy|1|||
47055460|NCT04512066|83329445|FG004|Extension Period|Lack of Efficacy|3|||
47055461|NCT04512066|83329446|FG005|Extension Period|Lack of Efficacy|3|||
47055462|NCT04512066|83329441|FG000|Extension Period|Lost to Follow-up|0|||
47055463|NCT04512066|83329442|FG001|Extension Period|Lost to Follow-up|1|||
47055464|NCT04512066|83329443|FG002|Extension Period|Lost to Follow-up|5|||
47055465|NCT04512066|83329444|FG003|Extension Period|Lost to Follow-up|2|||
47055466|NCT04512066|83329445|FG004|Extension Period|Lost to Follow-up|3|||
47055467|NCT04512066|83329446|FG005|Extension Period|Lost to Follow-up|2|||
47055468|NCT04512066|83329441|FG000|Extension Period|Non-compliance with study drug|0|||
47055469|NCT04512066|83329442|FG001|Extension Period|Non-compliance with study drug|1|||
47055470|NCT04512066|83329443|FG002|Extension Period|Non-compliance with study drug|0|||
47055471|NCT04512066|83329444|FG003|Extension Period|Non-compliance with study drug|0|||
47055472|NCT04512066|83329445|FG004|Extension Period|Non-compliance with study drug|0|||
46636584|NCT01484496|82810391|FG003|Period 2|Adverse Event|13|||
46636585|NCT01484496|82810388|FG000|Period 2|Other|0|||
46636586|NCT01484496|82810389|FG001|Period 2|Other|0|||
46756696|NCT03866473|82974727|FG000|Phase 2|Dropped|1|||
46756697|NCT03866473|82974728|FG001|Phase 2|Dropped|1|||
46756698|NCT03866473|82974727|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
46756699|NCT03866473|82974728|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
46756700|NCT00525499|82974742|FG000|Overall Study|Lost to Follow-up|2|||
46756701|NCT00525499|82974743|FG001|Overall Study|Lost to Follow-up|4|||
46756702|NCT00525499|82974744|FG002|Overall Study|Lost to Follow-up|1|||
46756703|NCT00525499|82974745|FG003|Overall Study|Lost to Follow-up|4|||
47055473|NCT04512066|83329446|FG005|Extension Period|Non-compliance with study drug|1|||
47055474|NCT04512066|83329441|FG000|Extension Period|Other|0|||
47055475|NCT04512066|83329442|FG001|Extension Period|Other|2|||
47055476|NCT04512066|83329443|FG002|Extension Period|Other|0|||
47055477|NCT04512066|83329444|FG003|Extension Period|Other|0|||
47055478|NCT04512066|83329445|FG004|Extension Period|Other|0|||
47055479|NCT04512066|83329446|FG005|Extension Period|Other|0|||
46756704|NCT00525499|82974742|FG000|Overall Study|Adverse Event|0|||
47055480|NCT04512066|83329441|FG000|Extension Period|Physician Decision|0|||
47055481|NCT04512066|83329442|FG001|Extension Period|Physician Decision|2|||
47055482|NCT04512066|83329443|FG002|Extension Period|Physician Decision|0|||
47055483|NCT04512066|83329444|FG003|Extension Period|Physician Decision|1|||
47055484|NCT04512066|83329445|FG004|Extension Period|Physician Decision|1|||
47055485|NCT04512066|83329446|FG005|Extension Period|Physician Decision|0|||
47055486|NCT04512066|83329441|FG000|Extension Period|Withdrawal by Subject|0|||
46815398|NCT03852472|83035190|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
46815399|NCT03852472|83035191|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
46815400|NCT03852472|83035192|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
47055487|NCT04512066|83329442|FG001|Extension Period|Withdrawal by Subject|3|||
47055488|NCT04512066|83329443|FG002|Extension Period|Withdrawal by Subject|7|||
47055489|NCT04512066|83329444|FG003|Extension Period|Withdrawal by Subject|11|||
47055490|NCT04512066|83329445|FG004|Extension Period|Withdrawal by Subject|8|||
47055491|NCT04512066|83329446|FG005|Extension Period|Withdrawal by Subject|4|||
47055492|NCT04426318|83329468|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
46756705|NCT00525499|82974743|FG001|Overall Study|Adverse Event|1|||
46756706|NCT00525499|82974744|FG002|Overall Study|Adverse Event|0|||
46756707|NCT00525499|82974745|FG003|Overall Study|Adverse Event|1|||
46756708|NCT00525499|82974742|FG000|Overall Study|Withdrawal by Subject|5|||
46756709|NCT00525499|82974743|FG001|Overall Study|Withdrawal by Subject|1|||
46756710|NCT00525499|82974744|FG002|Overall Study|Withdrawal by Subject|5|||
46756711|NCT00525499|82974745|FG003|Overall Study|Withdrawal by Subject|2|||
46756712|NCT00525499|82974742|FG000|Overall Study|Protocol Violation|0|||
46756713|NCT00525499|82974743|FG001|Overall Study|Protocol Violation|1|||
46756714|NCT00525499|82974744|FG002|Overall Study|Protocol Violation|1|||
46756715|NCT00525499|82974745|FG003|Overall Study|Protocol Violation|0|||
46756716|NCT00824655|82974757|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
46756717|NCT00824655|82974758|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
46756718|NCT00824655|82974757|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
46756719|NCT00824655|82974758|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
46756720|NCT00525265|82974768|FG000|Overall Study|Protocol Violation|1|||
46756721|NCT00525265|82974769|FG001|Overall Study|Protocol Violation|0|||
46756722|NCT00880256|82974775|FG000|Overall Study|Lost to Follow-up|28|||
46756723|NCT03865381|82974784|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
46756724|NCT03865381|82974784|FG000|Overall Study|Withdrawal by Subject|2|||
46756725|NCT00865098|82974788|FG000|Overall Study|Progressive disease|1|||
46756726|NCT00880100|82974792|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
46756727|NCT00880100|82974792|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
46756728|NCT00880100|82974792|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
46756729|NCT00518011|82974798|FG000|Overall Study|Death|1|||
46756730|NCT00518011|82974799|FG001|Overall Study|Death|1|||
46756731|NCT00518011|82974798|FG000|Overall Study|Adverse Event|2|||
46756732|NCT00518011|82974799|FG001|Overall Study|Adverse Event|3|||
46756733|NCT00518011|82974798|FG000|Overall Study|Disease Progression|2|||
46756734|NCT00518011|82974799|FG001|Overall Study|Disease Progression|2|||
46756735|NCT00518011|82974798|FG000|Overall Study|Other Reasons|3|||
46756736|NCT00518011|82974799|FG001|Overall Study|Other Reasons|2|||
46756737|NCT00518011|82974798|FG000|Overall Study|Withdrawal by Subject|1|||
46756738|NCT00518011|82974799|FG001|Overall Study|Withdrawal by Subject|0|||
46756739|NCT00865020|82974808|FG000|Overall Study|Withdrawal by Subject|22|||
46756740|NCT00865020|82974809|FG001|Overall Study|Withdrawal by Subject|16|||
46756741|NCT00865020|82974808|FG000|Overall Study|Adverse Event|9|||
46756742|NCT00865020|82974809|FG001|Overall Study|Adverse Event|14|||
46756743|NCT00865020|82974808|FG000|Overall Study|Abnormal test procedure result(s)|6|||
46756744|NCT00865020|82974809|FG001|Overall Study|Abnormal test procedure result(s)|8|||
46756745|NCT00865020|82974808|FG000|Overall Study|Lost to Follow-up|6|||
46756746|NCT00865020|82974809|FG001|Overall Study|Lost to Follow-up|4|||
46756747|NCT00865020|82974808|FG000|Overall Study|Protocol deviation|4|||
46756748|NCT00865020|82974809|FG001|Overall Study|Protocol deviation|1|||
46929832|NCT00887250|83164773|FG000|Overall Study|Lost to Follow-up|2|||
47055493|NCT04426318|83329469|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
46756749|NCT00865020|82974808|FG000|Overall Study|Administrative problems|0|||
46929833|NCT00887250|83164774|FG001|Overall Study|Lost to Follow-up|3|||
47055494|NCT04356963|83329484|FG000|First Session|Withdrawal by Subject|1|||
47055495|NCT04356963|83329484|FG000|Second Session|Withdrawal by Subject|3|||
46756750|NCT00865020|82974809|FG001|Overall Study|Administrative problems|2|||
46929834|NCT00887250|83164775|FG002|Overall Study|Lost to Follow-up|1|||
47055496|NCT04356963|83329484|FG000|Second Session|Lost to Follow-up|1|||
46815401|NCT03852472|83035188|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
46815402|NCT03852472|83035189|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
46815403|NCT03852472|83035190|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
46815404|NCT03852472|83035191|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
46815405|NCT03852472|83035192|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
46815406|NCT03852472|83035188|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
46815407|NCT03852472|83035189|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
46815408|NCT03852472|83035190|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
46815409|NCT03852472|83035191|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
46815410|NCT03852472|83035192|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
46815411|NCT03852472|83035188|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
46815412|NCT03852472|83035189|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
46815413|NCT03852472|83035190|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
46815414|NCT03852472|83035191|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
46815415|NCT03852472|83035192|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
46815416|NCT03852472|83035188|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
46815417|NCT03852472|83035189|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
46815418|NCT03852472|83035190|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
46815419|NCT03852472|83035191|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
46815420|NCT03852472|83035192|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
46815421|NCT03852472|83035188|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
46815422|NCT03852472|83035189|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
46815423|NCT03852472|83035190|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
46815424|NCT03852472|83035191|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
46815425|NCT03852472|83035192|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
46815426|NCT03852472|83035188|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
46815427|NCT03852472|83035189|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
46815428|NCT03852472|83035190|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
46815429|NCT03852472|83035191|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
46815430|NCT03852472|83035192|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
46815431|NCT03852472|83035188|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
46815432|NCT03852472|83035189|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
46815433|NCT03852472|83035190|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
46815434|NCT03852472|83035191|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
46815435|NCT03852472|83035192|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
46815436|NCT03852472|83035188|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
46815437|NCT03852472|83035189|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
46815438|NCT03852472|83035190|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
46815439|NCT03852472|83035191|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
46815440|NCT03852472|83035192|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
46815441|NCT03852472|83035188|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
46815442|NCT03852472|83035189|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
46815443|NCT03852472|83035190|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
46815444|NCT03852472|83035191|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
46815445|NCT03852472|83035192|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
46815446|NCT03852472|83035188|FG000|Period 2 - Week 44|Adverse Event|0|||
47055497|NCT04356963|83329484|FG000|Third Session|Lost to Follow-up|6|||
47055498|NCT04356963|83329484|FG000|Third Session|Withdrawal by Subject|1|||
47055499|NCT03941483|83329497|FG000|Overall Study|Miscellaneous|2|||
47055500|NCT03941483|83329498|FG001|Overall Study|Miscellaneous|3|||
47055501|NCT03941483|83329499|FG002|Overall Study|Miscellaneous|0|||
47055502|NCT03941483|83329497|FG000|Overall Study|Study Terminated by Sponsor|1|||
47055503|NCT03941483|83329498|FG001|Overall Study|Study Terminated by Sponsor|0|||
47055504|NCT03941483|83329499|FG002|Overall Study|Study Terminated by Sponsor|0|||
47055505|NCT03941483|83329497|FG000|Overall Study|Withdrawal by Subject|1|||
47055506|NCT03941483|83329498|FG001|Overall Study|Withdrawal by Subject|4|||
47055507|NCT03941483|83329499|FG002|Overall Study|Withdrawal by Subject|1|||
47055508|NCT03941483|83329497|FG000|Overall Study|Lost to Follow-up|2|||
46815447|NCT03852472|83035189|FG001|Period 2 - Week 44|Adverse Event|3|||
47055509|NCT03941483|83329498|FG001|Overall Study|Lost to Follow-up|1|||
47055510|NCT03941483|83329499|FG002|Overall Study|Lost to Follow-up|8|||
47055511|NCT03941483|83329497|FG000|Overall Study|Death|3|||
46636587|NCT01484496|82810390|FG002|Period 2|Other|9|||
46815448|NCT03852472|83035190|FG002|Period 2 - Week 44|Adverse Event|1|||
46815449|NCT03852472|83035191|FG003|Period 2 - Week 44|Adverse Event|2|||
46815450|NCT03852472|83035192|FG004|Period 2 - Week 44|Adverse Event|2|||
46815451|NCT03852472|83035188|FG000|Period 2 - Week 44|COVID-19 Related|0|||
46815452|NCT03852472|83035189|FG001|Period 2 - Week 44|COVID-19 Related|0|||
46815453|NCT03852472|83035190|FG002|Period 2 - Week 44|COVID-19 Related|0|||
46815454|NCT03852472|83035191|FG003|Period 2 - Week 44|COVID-19 Related|1|||
46815455|NCT03852472|83035192|FG004|Period 2 - Week 44|COVID-19 Related|0|||
46815456|NCT03852472|83035188|FG000|Period 2 - Week 44|Reason not stated|0|||
46815457|NCT03852472|83035189|FG001|Period 2 - Week 44|Reason not stated|0|||
46815458|NCT03852472|83035190|FG002|Period 2 - Week 44|Reason not stated|0|||
46815459|NCT03852472|83035191|FG003|Period 2 - Week 44|Reason not stated|0|||
46815460|NCT03852472|83035192|FG004|Period 2 - Week 44|Reason not stated|1|||
46815461|NCT03829332|83035208|FG000|Overall Study|Death|145|||
46815462|NCT03829332|83035209|FG001|Overall Study|Death|135|||
46815463|NCT03829332|83035208|FG000|Overall Study|Withdrawal by Subject|10|||
46815464|NCT03829332|83035209|FG001|Overall Study|Withdrawal by Subject|4|||
46815465|NCT03829332|83035208|FG000|Overall Study|Ongoing in Study|154|||
46815466|NCT03829332|83035209|FG001|Overall Study|Ongoing in Study|175|||
46815467|NCT03814746|83035218|FG000|Overall Study|Participant decision|9|||
46815468|NCT03814746|83035219|FG001|Overall Study|Participant decision|6|||
46815469|NCT03814746|83035220|FG002|Overall Study|Participant decision|15|||
46815470|NCT03814746|83035218|FG000|Overall Study|Physician Decision|2|||
46815471|NCT03814746|83035219|FG001|Overall Study|Physician Decision|2|||
46815472|NCT03814746|83035220|FG002|Overall Study|Physician Decision|4|||
46815473|NCT03814746|83035218|FG000|Overall Study|Death|2|||
46815474|NCT03814746|83035219|FG001|Overall Study|Death|2|||
46815475|NCT03814746|83035220|FG002|Overall Study|Death|2|||
46815476|NCT03814746|83035218|FG000|Overall Study|Adverse Event|2|||
46815477|NCT03814746|83035219|FG001|Overall Study|Adverse Event|2|||
46815478|NCT03814746|83035220|FG002|Overall Study|Adverse Event|1|||
46815479|NCT03814746|83035218|FG000|Overall Study|Lost to Follow-up|2|||
46815480|NCT03814746|83035219|FG001|Overall Study|Lost to Follow-up|1|||
46815481|NCT03814746|83035220|FG002|Overall Study|Lost to Follow-up|2|||
46815482|NCT03814746|83035218|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46815483|NCT03814746|83035219|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46815484|NCT03814746|83035220|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
46815485|NCT03814746|83035218|FG000|Overall Study|Pregnancy|0|||
46815486|NCT03814746|83035219|FG001|Overall Study|Pregnancy|1|||
46815487|NCT03814746|83035220|FG002|Overall Study|Pregnancy|1|||
46815488|NCT03814746|83035218|FG000|Overall Study|Protocol Violation|1|||
46815489|NCT03814746|83035219|FG001|Overall Study|Protocol Violation|0|||
46815490|NCT03814746|83035220|FG002|Overall Study|Protocol Violation|0|||
46815491|NCT03807778|83035233|FG000|Overall Study|Adverse Event|0|||
46929835|NCT00887250|83164773|FG000|Overall Study|Protocol Violation|2|||
47055512|NCT03941483|83329498|FG001|Overall Study|Death|2|||
47055513|NCT03941483|83329499|FG002|Overall Study|Death|6|||
47055514|NCT03689855|83329526|FG000|Overall Study|Adverse Event|3|||
46756751|NCT00865020|82974808|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46756752|NCT00865020|82974809|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46756753|NCT00865020|82974808|FG000|Overall Study|Death|0|||
46756754|NCT00865020|82974809|FG001|Overall Study|Death|1|||
46756755|NCT00865020|82974808|FG000|Overall Study|Randomized but discontinued|2|||
46756756|NCT00865020|82974809|FG001|Overall Study|Randomized but discontinued|4|||
46756757|NCT00517933|82974817|FG000|Period 1|Death|2|||
46756758|NCT00517933|82974818|FG001|Period 1|Death|1|||
46756759|NCT00517933|82974817|FG000|Period 1|Adverse Event|4|||
46756760|NCT00517933|82974818|FG001|Period 1|Adverse Event|4|||
46756761|NCT00517933|82974817|FG000|Period 1|Lost to Follow-up|2|||
46756762|NCT00517933|82974818|FG001|Period 1|Lost to Follow-up|0|||
46815492|NCT03807778|83035234|FG001|Overall Study|Adverse Event|0|||
46815493|NCT03807778|83035235|FG002|Overall Study|Adverse Event|3|||
46815494|NCT03807778|83035236|FG003|Overall Study|Adverse Event|5|||
46815495|NCT03807778|83035233|FG000|Overall Study|Progressive Disease|4|||
46815496|NCT03807778|83035234|FG001|Overall Study|Progressive Disease|2|||
46929836|NCT00887250|83164774|FG001|Overall Study|Protocol Violation|2|||
46929837|NCT00887250|83164775|FG002|Overall Study|Protocol Violation|1|||
47055515|NCT03689855|83329526|FG000|Overall Study|Withdrawal by Subject|1|||
47055516|NCT03635996|83329530|FG000|Overall Study|Study terminated by Sponsor|94|||
46756763|NCT00517933|82974817|FG000|Period 1|Underwent lung transplant|0|||
46815497|NCT03807778|83035235|FG002|Overall Study|Progressive Disease|8|||
46815498|NCT03807778|83035236|FG003|Overall Study|Progressive Disease|15|||
46756764|NCT00517933|82974818|FG001|Period 1|Underwent lung transplant|1|||
46756765|NCT00517933|82974817|FG000|Period 2|Death|2|||
46815499|NCT03807778|83035233|FG000|Overall Study|Symptomatic Deterioration|0|||
46815500|NCT03807778|83035234|FG001|Overall Study|Symptomatic Deterioration|1|||
46815501|NCT03807778|83035235|FG002|Overall Study|Symptomatic Deterioration|0|||
46815502|NCT03807778|83035236|FG003|Overall Study|Symptomatic Deterioration|1|||
46815503|NCT03807778|83035233|FG000|Overall Study|Withdrawal by Subject|0|||
46929838|NCT00887250|83164773|FG000|Overall Study|Withdrawal by Subject|2|||
46815504|NCT03807778|83035234|FG001|Overall Study|Withdrawal by Subject|1|||
46815505|NCT03807778|83035235|FG002|Overall Study|Withdrawal by Subject|0|||
46815506|NCT03807778|83035236|FG003|Overall Study|Withdrawal by Subject|1|||
46815507|NCT03807778|83035233|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
46815508|NCT03807778|83035234|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
46815509|NCT03807778|83035235|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
46815510|NCT03807778|83035236|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
46815511|NCT03779334|83035252|FG000|Overall Study|Withdrawal by Subject|3|||
46815512|NCT03779334|83035253|FG001|Overall Study|Withdrawal by Subject|0|||
46815513|NCT03779334|83035254|FG002|Overall Study|Withdrawal by Subject|0|||
46815514|NCT03779334|83035252|FG000|Overall Study|Ongoing in Study|5|||
46815515|NCT03779334|83035253|FG001|Overall Study|Ongoing in Study|13|||
46815516|NCT03779334|83035254|FG002|Overall Study|Ongoing in Study|5|||
46815517|NCT03745144|83035284|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
46815518|NCT03745144|83035285|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
46815519|NCT03745144|83035286|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
46815520|NCT03745144|83035284|FG000|Period 1|Other|0|||
46815521|NCT03745144|83035285|FG001|Period 1|Other|0|||
46929839|NCT00887250|83164774|FG001|Overall Study|Withdrawal by Subject|1|||
46929840|NCT00887250|83164775|FG002|Overall Study|Withdrawal by Subject|2|||
46815522|NCT03745144|83035286|FG002|Period 1|Other|1|||
46815523|NCT03738397|83035312|FG000|Overall Study|Adverse Event|3|||
46815524|NCT03738397|83035313|FG001|Overall Study|Adverse Event|7|||
46815525|NCT03738397|83035312|FG000|Overall Study|Withdrawal by Subject|8|||
46815526|NCT03738397|83035313|FG001|Overall Study|Withdrawal by Subject|11|||
46815527|NCT03738397|83035312|FG000|Overall Study|Lost to Follow-up|7|||
46815528|NCT03738397|83035313|FG001|Overall Study|Lost to Follow-up|5|||
46815529|NCT03738397|83035312|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
46815530|NCT03738397|83035313|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
46815531|NCT03738397|83035312|FG000|Overall Study|Other|4|||
46815532|NCT03738397|83035313|FG001|Overall Study|Other|6|||
46815533|NCT03692052|83035319|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
46815534|NCT03692052|83035319|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
46815535|NCT03692052|83035319|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
46815536|NCT03692052|83035319|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
46815537|NCT03629886|83035325|FG000|Overall Study|Migrated / moved from the study area|0|||
46815538|NCT03629886|83035326|FG001|Overall Study|Migrated / moved from the study area|55|||
46815539|NCT03629886|83035325|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
46815540|NCT03629886|83035326|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
46815541|NCT03629886|83035325|FG000|Overall Study|Study vaccine not administrated|0|||
46815542|NCT03629886|83035326|FG001|Overall Study|Study vaccine not administrated|3|||
46815543|NCT03629886|83035325|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
46815544|NCT03629886|83035326|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
46815545|NCT03629886|83035325|FG000|Overall Study|Refused vaccination step of the study|0|||
46815546|NCT03629886|83035326|FG001|Overall Study|Refused vaccination step of the study|44|||
46815547|NCT03591575|83035352|FG000|Overall Study|Adverse Event|2|||
46815548|NCT03591575|83035353|FG001|Overall Study|Adverse Event|0|||
46815549|NCT03591575|83035352|FG000|Overall Study|Withdrawal by Subject|4|||
46815550|NCT03591575|83035353|FG001|Overall Study|Withdrawal by Subject|1|||
46815551|NCT03398200|83035374|FG000|Overall Study|Withdrawal by Subject|0|||
46815552|NCT03398200|83035375|FG001|Overall Study|Withdrawal by Subject|1|||
46815553|NCT03131219|83035387|FG000|Initial Evaluation Period|Adverse Event|2|||
46815554|NCT03131219|83035388|FG001|Initial Evaluation Period|Adverse Event|0|||
46815555|NCT03131219|83035387|FG000|Initial Evaluation Period|Protocol Violation|1|||
46815556|NCT03131219|83035388|FG001|Initial Evaluation Period|Protocol Violation|0|||
46815557|NCT03131219|83035387|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
46815558|NCT03131219|83035388|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
46815559|NCT03131219|83035387|FG000|Initial Evaluation Period|Physician Decision|1|||
46815560|NCT03131219|83035388|FG001|Initial Evaluation Period|Physician Decision|0|||
46929841|NCT00887250|83164773|FG000|Overall Study|Patient uncooperative|0|||
46929842|NCT00887250|83164774|FG001|Overall Study|Patient uncooperative|0|||
46929843|NCT00887250|83164775|FG002|Overall Study|Patient uncooperative|1|||
46929844|NCT02599402|83164780|FG000|Overall Study|Disease progression|153|||
46929845|NCT02599402|83164780|FG000|Overall Study|Study drug toxicity|201|||
46929846|NCT02599402|83164780|FG000|Overall Study|Death|26|||
46929847|NCT02599402|83164780|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
46815561|NCT03131219|83035387|FG000|Extension Period|Physician Decision|1|||
46815562|NCT03131219|83035388|FG001|Extension Period|Physician Decision|0|||
46815563|NCT03072238|83035396|FG000|Overall Study|Withdrawal by Subject|30|||
46815564|NCT03072238|83035397|FG001|Overall Study|Withdrawal by Subject|51|||
46815565|NCT03072238|83035396|FG000|Overall Study|Lost to Follow-up|7|||
46815566|NCT03072238|83035397|FG001|Overall Study|Lost to Follow-up|4|||
46815567|NCT03072238|83035396|FG000|Overall Study|Physician Decision|1|||
46815568|NCT03072238|83035397|FG001|Overall Study|Physician Decision|3|||
46815569|NCT03072238|83035396|FG000|Overall Study|Death|139|||
46815570|NCT03072238|83035397|FG001|Overall Study|Death|121|||
46815571|NCT03072238|83035396|FG000|Overall Study|Other|0|||
46815572|NCT03072238|83035397|FG001|Overall Study|Other|1|||
46815573|NCT03072238|83035396|FG000|Overall Study|Ongoing on study|377|||
46815574|NCT03072238|83035397|FG001|Overall Study|Ongoing on study|367|||
46815575|NCT02948829|83035422|FG000|Overall Study|Lost to Follow-up|2|||
46815576|NCT02948829|83035422|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
46815577|NCT02948829|83035422|FG000|Overall Study|Pregnancy|1|||
46815578|NCT02948829|83035422|FG000|Overall Study|Other: Reason not Specified|8|||
46815579|NCT02927262|83035444|FG000|Overall Study|Adverse Event|7|||
46815580|NCT02927262|83035445|FG001|Overall Study|Adverse Event|1|||
46815581|NCT02927262|83035444|FG000|Overall Study|Death|1|||
46815582|NCT02927262|83035445|FG001|Overall Study|Death|0|||
46815583|NCT02927262|83035444|FG000|Overall Study|Withdrawal by Subject|3|||
46815584|NCT02927262|83035445|FG001|Overall Study|Withdrawal by Subject|0|||
46815585|NCT02927262|83035444|FG000|Overall Study|Disease Relapse|23|||
46815586|NCT02927262|83035445|FG001|Overall Study|Disease Relapse|18|||
46815587|NCT02927262|83035444|FG000|Overall Study|Miscellaneous|5|||
46815588|NCT02927262|83035445|FG001|Overall Study|Miscellaneous|4|||
46815589|NCT02927262|83035444|FG000|Overall Study|Ongoing|4|||
46815590|NCT02927262|83035445|FG001|Overall Study|Ongoing|0|||
46815591|NCT02914314|83035455|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
46756766|NCT00517933|82974818|FG001|Period 2|Death|4|||
46756767|NCT00517933|82974817|FG000|Period 2|Adverse Event|2|||
46756768|NCT00517933|82974818|FG001|Period 2|Adverse Event|4|||
46756769|NCT00517933|82974817|FG000|Period 2|Physician Decision|1|||
46756770|NCT00517933|82974818|FG001|Period 2|Physician Decision|0|||
46756771|NCT00517933|82974817|FG000|Period 2|Withdrawal by Subject|1|||
46756772|NCT00517933|82974818|FG001|Period 2|Withdrawal by Subject|3|||
46756773|NCT00517933|82974817|FG000|Period 2|Underwent lung transplant|0|||
46756774|NCT00517933|82974818|FG001|Period 2|Underwent lung transplant|2|||
46756775|NCT00701038|82974829|FG000|Overall Study|study amended pilot group of patients|4|||
46756776|NCT00701038|82974830|FG001|Overall Study|study amended pilot group of patients|4|||
46756777|NCT00857766|82974838|FG000|Overall Study|Adverse Event|13|||
46756778|NCT00857766|82974839|FG001|Overall Study|Adverse Event|12|||
46756779|NCT00857766|82974838|FG000|Overall Study|Protocol Violation|11|||
46756780|NCT00857766|82974839|FG001|Overall Study|Protocol Violation|11|||
46756781|NCT00857766|82974838|FG000|Overall Study|Lost to Follow-up|1|||
46756782|NCT00857766|82974839|FG001|Overall Study|Lost to Follow-up|0|||
46756783|NCT00857766|82974838|FG000|Overall Study|Investigator Discretion|2|||
46756784|NCT00857766|82974839|FG001|Overall Study|Investigator Discretion|3|||
46756785|NCT00857766|82974838|FG000|Overall Study|Participant Withdrew Consent|4|||
46756786|NCT00857766|82974839|FG001|Overall Study|Participant Withdrew Consent|4|||
46756787|NCT00517699|82974845|FG000|Overall Study|Withdrawal by Subject|1|||
46756788|NCT00517699|82974845|FG000|Overall Study|Lack of Efficacy|1|||
46756789|NCT00517699|82974845|FG000|Overall Study|Administrative error|1|||
46756790|NCT00517699|82974845|FG000|Overall Study|Study terminated by Sponsor|2|||
46756791|NCT00857454|82974849|FG000|Overall Study|Withdrawal by Subject|2|||
46756792|NCT00857454|82974849|FG000|Overall Study|Lost to Follow-up|1|||
46756793|NCT00857454|82974849|FG000|Overall Study|Adverse Event|2|||
46756794|NCT00857454|82974849|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
46756795|NCT00857454|82974849|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
46756796|NCT00857454|82974849|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
46756797|NCT00525031|82974855|FG000|Overall Study|Disease Progression|1|||
46756798|NCT00525031|82974856|FG001|Overall Study|Disease Progression|1|||
46756799|NCT00524485|82974863|FG000|Overall Study|Withdrawal by Subject|5|||
46756800|NCT00857220|82974867|FG000|Overall Study|Adverse Event|35|||
46756801|NCT00857220|82974867|FG000|Overall Study|Death|1|||
46756802|NCT00857220|82974867|FG000|Overall Study|Lack of Efficacy|11|||
46756803|NCT00857220|82974867|FG000|Overall Study|Lost to Follow-up|30|||
46756804|NCT00857220|82974867|FG000|Overall Study|Physician Decision|4|||
46815592|NCT02914314|83035456|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
46756805|NCT00857220|82974867|FG000|Overall Study|Protocol Violation|16|||
46756806|NCT00857220|82974867|FG000|Overall Study|Withdrawal by Subject|67|||
46756807|NCT00857220|82974867|FG000|Overall Study|Clinical Hold|6|||
46756808|NCT00857220|82974867|FG000|Overall Study|Site Closed|5|||
46756809|NCT00857220|82974867|FG000|Overall Study|Miscellaneous|8|||
46756810|NCT00524173|82974873|FG000|Overall Study|Lost to Follow-up|0|||
46756811|NCT00524173|82974874|FG001|Overall Study|Lost to Follow-up|1|||
46756812|NCT00524173|82974873|FG000|Overall Study|Death|1|||
46756813|NCT00524173|82974874|FG001|Overall Study|Death|0|||
46756814|NCT00524173|82974873|FG000|Overall Study|Had not reached endpoint at study close|4|||
46815593|NCT02914314|83035457|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
46815594|NCT02914314|83035458|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
46815595|NCT02914314|83035455|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
46815596|NCT02914314|83035456|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
46929848|NCT02599402|83164780|FG000|Overall Study|Participant request to discontinue study treatment|13|||
46929849|NCT02599402|83164780|FG000|Overall Study|Participant withdrew consent|5|||
46929850|NCT02599402|83164780|FG000|Overall Study|Lost to Follow-up|1|||
46929851|NCT02599402|83164780|FG000|Overall Study|Maximum Clinical Benefit|7|||
46929852|NCT02599402|83164780|FG000|Overall Study|Poor/non-compliance|1|||
46929853|NCT02599402|83164780|FG000|Overall Study|Pregnancy|1|||
46756815|NCT00524173|82974874|FG001|Overall Study|Had not reached endpoint at study close|1|||
46756816|NCT00879710|82974882|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
46756817|NCT00879710|82974883|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
46756818|NCT00879710|82974884|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
46756819|NCT00879710|82974885|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
46756820|NCT00879710|82974882|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
46756821|NCT00879710|82974883|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
46756822|NCT00879710|82974884|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
46756823|NCT00879710|82974885|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
46756824|NCT00597506|82974893|FG000|Overall Study|Subject is being followed for survival|1|||
46756825|NCT00708682|82974906|FG000|Infant Series|Adverse Event|1|||
46756826|NCT00708682|82974906|FG000|Infant Series|Lost to Follow-up|4|||
46756827|NCT00708682|82974906|FG000|Infant Series|Protocol Violation|1|||
46756828|NCT00708682|82974906|FG000|Infant Series|Parent/legal guardian request|6|||
46756829|NCT00708682|82974906|FG000|Infant Series|Failed to return|2|||
46756830|NCT00708682|82974906|FG000|Infant Series|Other|19|||
46756831|NCT00708682|82974906|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
46756832|NCT00708682|82974906|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
46756833|NCT00708682|82974906|FG000|Toddler Dose|Lost to Follow-up|3|||
46756834|NCT00708682|82974906|FG000|Toddler Dose|Failed to Return|4|||
46756835|NCT00712348|82974912|FG000|Overall Study|Withdrawal by Subject|1|||
46756836|NCT00881504|82974916|FG000|Overall Study|Withdrawal by Subject|1|||
46756837|NCT01936831|82974929|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756838|NCT01936831|82974930|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756839|NCT01936831|82974931|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756840|NCT01936831|82974932|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756841|NCT01936831|82974933|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756842|NCT01936831|82974934|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
46756843|NCT01936831|82974935|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756844|NCT01936831|82974936|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756845|NCT01936831|82974937|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
46756846|NCT03863353|82974954|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
46756847|NCT03863353|82974955|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
46756848|NCT00523705|82974963|FG000|Overall Study|No time for study.|0|||
46756849|NCT00523705|82974964|FG001|Overall Study|No time for study.|1|||
46756850|NCT00523549|82974977|FG000|Overall Study|Adverse Event|6|||
46756851|NCT00523549|82974978|FG001|Overall Study|Adverse Event|3|||
46756852|NCT00523549|82974977|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46756853|NCT00523549|82974978|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46756854|NCT00523549|82974977|FG000|Overall Study|Protocol Deviation|3|||
46756855|NCT00523549|82974978|FG001|Overall Study|Protocol Deviation|1|||
46756856|NCT00523549|82974977|FG000|Overall Study|Patient withdrew consent|7|||
46756857|NCT00523549|82974978|FG001|Overall Study|Patient withdrew consent|6|||
46756858|NCT00523549|82974977|FG000|Overall Study|Lost to Follow-up|3|||
46756859|NCT00523549|82974978|FG001|Overall Study|Lost to Follow-up|5|||
46929854|NCT02599402|83164780|FG000|Overall Study|Participant no longer met study criteria|7|||
47055517|NCT03635996|83329530|FG000|Overall Study|Withdrawal by Subject|20|||
47055518|NCT03635996|83329530|FG000|Overall Study|Ablation|26|||
47055519|NCT03635996|83329530|FG000|Overall Study|Adverse Event|7|||
47055520|NCT03635996|83329530|FG000|Overall Study|Physician Decision|3|||
47055521|NCT03635996|83329530|FG000|Overall Study|Prohibited medication|5|||
47055522|NCT03635996|83329530|FG000|Overall Study|Did not meet eligibility criteria|5|||
47055523|NCT03635996|83329530|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
47055524|NCT03635996|83329530|FG000|Overall Study|Protocol Violation|1|||
47055525|NCT03635996|83329530|FG000|Overall Study|Lost to Follow-up|1|||
47055526|NCT03595878|83329537|FG000|Overall Study|Death|2|||
47055527|NCT03595878|83329538|FG001|Overall Study|Death|1|||
47055528|NCT03595878|83329539|FG002|Overall Study|Death|0|||
46636588|NCT01484496|82810391|FG003|Period 2|Other|6|||
46636589|NCT01509846|82810404|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
46636590|NCT01509846|82810405|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
46756860|NCT03504085|82974986|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
46756861|NCT03504085|82974987|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
46929855|NCT02599402|83164780|FG000|Overall Study|Other Reasons|95|||
46756862|NCT03504085|82974986|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
46756863|NCT03504085|82974987|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
46756864|NCT00700102|82974995|FG000|Overall Study|Died|394|||
47055529|NCT03595878|83329537|FG000|Overall Study|Disease progression|2|||
47055530|NCT03595878|83329538|FG001|Overall Study|Disease progression|1|||
46756865|NCT00700102|82974996|FG001|Overall Study|Died|385|||
46756866|NCT00700102|82974995|FG000|Overall Study|Lost to Follow-up|8|||
46756867|NCT00700102|82974996|FG001|Overall Study|Lost to Follow-up|10|||
46756868|NCT00595478|82975004|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
46756869|NCT00595478|82975005|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
46756870|NCT00595478|82975004|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
46756871|NCT00595478|82975005|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
46756872|NCT00516295|82975014|FG000|Overall Study|Lack of Efficacy|2|||
46756873|NCT00516295|82975015|FG001|Overall Study|Lack of Efficacy|0|||
46756874|NCT00516295|82975016|FG002|Overall Study|Lack of Efficacy|0|||
46815597|NCT02914314|83035457|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
46815598|NCT02914314|83035458|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
46815599|NCT02914314|83035455|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
46815600|NCT02914314|83035456|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
46815601|NCT02914314|83035457|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
46815602|NCT02914314|83035458|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
46815603|NCT02914314|83035455|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
46815604|NCT02914314|83035456|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
46815605|NCT02914314|83035457|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
46815606|NCT02914314|83035458|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
46815607|NCT02914314|83035455|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
46815608|NCT02914314|83035456|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
46815609|NCT02914314|83035457|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
46815610|NCT02914314|83035458|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
46815611|NCT02766088|83035488|FG000|Overall Study|Sponsor study termination|498|||
47055531|NCT03595878|83329539|FG002|Overall Study|Disease progression|2|||
47055532|NCT03168464|83329585|FG000|Overall Study|Death|9|||
47055533|NCT03168464|83329585|FG000|Overall Study|Progression of disease|6|||
47055534|NCT02818920|83329589|FG000|Overall Study|Unresectable|4|||
46756875|NCT00516295|82975014|FG000|Overall Study|Ineligible|1|||
46756876|NCT00516295|82975015|FG001|Overall Study|Ineligible|0|||
46756877|NCT00516295|82975016|FG002|Overall Study|Ineligible|0|||
46756878|NCT03861559|82975026|FG000|Overall Study|Adverse Event|0|||
46756879|NCT03861559|82975027|FG001|Overall Study|Adverse Event|2|||
46756880|NCT03861559|82975026|FG000|Overall Study|Treatment failure|0|||
46756881|NCT03861559|82975027|FG001|Overall Study|Treatment failure|2|||
46756882|NCT03861559|82975026|FG000|Overall Study|Noncompliance|1|||
46756883|NCT03861559|82975027|FG001|Overall Study|Noncompliance|1|||
46756884|NCT03861559|82975026|FG000|Overall Study|Did not meet eligibility requirements|1|||
46756885|NCT03861559|82975027|FG001|Overall Study|Did not meet eligibility requirements|0|||
46756886|NCT00516139|82975033|FG000|Overall Study|Adverse Event|27|||
46756887|NCT00516139|82975033|FG000|Overall Study|Lost to Follow-up|1|||
46756888|NCT00516139|82975033|FG000|Overall Study|Protocol Violation|1|||
46756889|NCT00516139|82975033|FG000|Overall Study|Withdrawal by Subject|8|||
46756890|NCT00516139|82975033|FG000|Overall Study|Lack of Efficacy|1|||
46756891|NCT00515827|82975043|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
46756892|NCT00515827|82975044|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
46756893|NCT00515827|82975043|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
46756894|NCT00515827|82975044|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
46756895|NCT00522457|82975052|FG000|Overall Study|Due to disease progression|16|||
46756896|NCT00522457|82975052|FG000|Overall Study|Adverse Event|2|||
46756897|NCT00856986|82975061|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
46756898|NCT00856986|82975062|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
46815612|NCT02766088|83035488|FG000|Overall Study|Migrated/moved from the study area|1|||
46815613|NCT02766088|83035488|FG000|Overall Study|Lost to Follow-up|5|||
46815614|NCT02766088|83035488|FG000|Overall Study|Other|1|||
46815615|NCT02766088|83035488|FG000|Overall Study|Death|1|||
46815616|NCT02476916|83035552|FG000|Core Period|Adverse Event|2|||
47055535|NCT02818920|83329589|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
47055536|NCT02818920|83329589|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
47055537|NCT02818920|83329589|FG000|Overall Study|Adverse Event|3|||
47055538|NCT02818920|83329589|FG000|Overall Study|Developed Other Disease|1|||
47055539|NCT02818920|83329589|FG000|Overall Study|Refused Further Treatment|1|||
47055540|NCT01454401|83329615|FG000|Overall Study|Death|1|||
47055541|NCT01454401|83329615|FG000|Overall Study|hospitalised|1|||
46756899|NCT00856986|82975063|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
46815617|NCT02476916|83035553|FG001|Core Period|Adverse Event|2|||
47055542|NCT01454401|83329615|FG000|Overall Study|osteomyelitis|2|||
47055543|NCT01454401|83329615|FG000|Overall Study|non-adherence|1|||
47055544|NCT01344018|83329621|FG000|Overall Study|Death|22|||
46636591|NCT01509846|82810406|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
46756900|NCT00856986|82975064|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
46756901|NCT00856986|82975065|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
46756902|NCT00856986|82975061|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
46756903|NCT00856986|82975062|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
46815618|NCT02476916|83035552|FG000|Core Period|Investigator decision|1|||
46815619|NCT02476916|83035553|FG001|Core Period|Investigator decision|1|||
46815620|NCT02476916|83035552|FG000|Core Period|Withdrawal by Subject|3|||
46815621|NCT02476916|83035553|FG001|Core Period|Withdrawal by Subject|0|||
46815622|NCT02476916|83035552|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
46815623|NCT02476916|83035553|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
46815624|NCT02476916|83035552|FG000|Extension Period|On Treatment|12|||
46815625|NCT02476916|83035553|FG001|Extension Period|On Treatment|17|||
46815626|NCT02009761|83035578|FG000|Overall Study|Adverse Event|4|||
46815627|NCT01135394|83035613|FG000|Screening|Lost to Follow-up|2|||
46929856|NCT02734862|83164820|FG000|Part A|Death|3|||
46929857|NCT02734862|83164821|FG001|Part A|Death|4|||
46929858|NCT02734862|83164822|FG002|Part A|Death|6|||
46929859|NCT02734862|83164820|FG000|Part A|Lost to Follow-up|2|||
47055545|NCT01344018|83329622|FG001|Overall Study|Death|25|||
46929860|NCT02734862|83164821|FG001|Part A|Lost to Follow-up|1|||
47055546|NCT01344018|83329621|FG000|Overall Study|Lost to Follow-up|4|||
47055547|NCT01344018|83329622|FG001|Overall Study|Lost to Follow-up|7|||
47055548|NCT01755767|83329655|FG000|Overall Study|Progressive Disease|8|||
47055549|NCT01755767|83329656|FG001|Overall Study|Progressive Disease|7|||
47055550|NCT01755767|83329657|FG002|Overall Study|Progressive Disease|91|||
47055551|NCT01755767|83329658|FG003|Overall Study|Progressive Disease|43|||
47055552|NCT01755767|83329655|FG000|Overall Study|Clinical Disease Progression|4|||
47055553|NCT01755767|83329656|FG001|Overall Study|Clinical Disease Progression|2|||
47055554|NCT01755767|83329657|FG002|Overall Study|Clinical Disease Progression|29|||
47055555|NCT01755767|83329658|FG003|Overall Study|Clinical Disease Progression|20|||
47055556|NCT01755767|83329655|FG000|Overall Study|Radiographic Disease Progression|9|||
46756904|NCT00856986|82975063|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
46756905|NCT00856986|82975064|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
46756906|NCT00856986|82975065|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
46756907|NCT00856986|82975061|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
46756908|NCT00856986|82975062|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
46756909|NCT00856986|82975063|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
46756910|NCT00856986|82975064|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
46756911|NCT00856986|82975065|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
46756912|NCT00856986|82975061|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
46756913|NCT00856986|82975062|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
46756914|NCT00856986|82975063|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
46756915|NCT00856986|82975064|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
46756916|NCT00856986|82975065|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
46756917|NCT00856986|82975061|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
46756918|NCT00856986|82975062|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
46756919|NCT00856986|82975063|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
46756920|NCT00856986|82975064|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
46756921|NCT00856986|82975065|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
46756922|NCT00856986|82975061|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
46756923|NCT00856986|82975062|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
46756924|NCT00856986|82975063|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
46756925|NCT00856986|82975064|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
46756926|NCT00856986|82975065|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
46756927|NCT00856986|82975061|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
46756928|NCT00856986|82975062|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
46756929|NCT00856986|82975063|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
46756930|NCT00856986|82975064|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
46756931|NCT00856986|82975065|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
46756932|NCT00856986|82975061|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
46756933|NCT00856986|82975062|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
46756934|NCT00856986|82975063|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
46756935|NCT00856986|82975064|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
46756936|NCT00856986|82975065|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
46815628|NCT01135394|83035613|FG000|Screening|Withdrawal by Subject|10|||
46815629|NCT01135394|83035613|FG000|Screening|Screening failure|16|||
47055557|NCT01755767|83329656|FG001|Overall Study|Radiographic Disease Progression|4|||
47055558|NCT01755767|83329657|FG002|Overall Study|Radiographic Disease Progression|44|||
47055559|NCT01755767|83329658|FG003|Overall Study|Radiographic Disease Progression|27|||
46756937|NCT00856986|82975061|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
46756938|NCT00856986|82975062|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
46756939|NCT00856986|82975063|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
46929861|NCT02734862|83164822|FG002|Part A|Lost to Follow-up|1|||
47055560|NCT01755767|83329655|FG000|Overall Study|Adverse Event|6|||
46756940|NCT00856986|82975064|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
46756941|NCT00856986|82975065|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
46756942|NCT00856986|82975061|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
46815630|NCT01135394|83035613|FG000|Screening|Physician Decision|5|||
46929862|NCT02734862|83164820|FG000|Part A|Withdrawal by Subject|1|||
46815631|NCT01135394|83035613|FG000|Baseline Assessment|Withdrawal by Subject|9|||
46815632|NCT01135394|83035613|FG000|Baseline Assessment|Physician Decision|3|||
46815633|NCT01135394|83035613|FG000|Baseline Assessment|Lost to Follow-up|2|||
46815634|NCT01135394|83035613|FG000|Baseline Assessment|Adverse Event|1|||
46815635|NCT01135394|83035613|FG000|Study Treatment|Withdrawal by Subject|1|||
46815636|NCT01135394|83035613|FG000|Study Treatment|Physician Decision|1|||
46815637|NCT01135394|83035613|FG000|Study Treatment|Adverse Event|2|||
46815638|NCT00295646|83035621|FG000|Overall Study|Protocol Violation|18|||
46815639|NCT00295646|83035622|FG001|Overall Study|Protocol Violation|20|||
46815640|NCT00295646|83035623|FG002|Overall Study|Protocol Violation|20|||
46815641|NCT00295646|83035624|FG003|Overall Study|Protocol Violation|18|||
46815642|NCT00295646|83035621|FG000|Overall Study|Withdrawal by Subject|8|||
46815643|NCT00295646|83035622|FG001|Overall Study|Withdrawal by Subject|9|||
46815644|NCT00295646|83035623|FG002|Overall Study|Withdrawal by Subject|11|||
46815645|NCT00295646|83035624|FG003|Overall Study|Withdrawal by Subject|14|||
46815646|NCT00295646|83035621|FG000|Overall Study|Lost to Follow-up|0|||
46815647|NCT00295646|83035622|FG001|Overall Study|Lost to Follow-up|5|||
46815648|NCT00295646|83035623|FG002|Overall Study|Lost to Follow-up|1|||
46815649|NCT00295646|83035624|FG003|Overall Study|Lost to Follow-up|5|||
46815650|NCT00295646|83035621|FG000|Overall Study|Death|9|||
46815651|NCT00295646|83035622|FG001|Overall Study|Death|7|||
46815652|NCT00295646|83035623|FG002|Overall Study|Death|18|||
46815653|NCT00295646|83035624|FG003|Overall Study|Death|8|||
46929863|NCT02734862|83164821|FG001|Part A|Withdrawal by Subject|1|||
46929864|NCT02734862|83164822|FG002|Part A|Withdrawal by Subject|2|||
46929865|NCT02734862|83164820|FG000|Part A|Physician Decision|2|||
46929866|NCT02734862|83164821|FG001|Part A|Physician Decision|0|||
46929867|NCT02734862|83164822|FG002|Part A|Physician Decision|1|||
46929868|NCT02734862|83164820|FG000|Part A|Adverse Event|2|||
46929869|NCT02734862|83164821|FG001|Part A|Adverse Event|0|||
46929870|NCT02734862|83164822|FG002|Part A|Adverse Event|1|||
46929871|NCT02734862|83164820|FG000|Part A|Noncompliance|1|||
46929872|NCT02734862|83164821|FG001|Part A|Noncompliance|1|||
46929873|NCT02734862|83164822|FG002|Part A|Noncompliance|0|||
46929874|NCT02734862|83164820|FG000|Part A|Other|1|||
46929875|NCT02734862|83164821|FG001|Part A|Other|1|||
46929876|NCT02734862|83164822|FG002|Part A|Other|3|||
46929877|NCT02734862|83164820|FG000|Part B|Death|8|||
46929878|NCT02734862|83164821|FG001|Part B|Death|3|||
46929879|NCT02734862|83164822|FG002|Part B|Death|5|||
46929880|NCT02734862|83164820|FG000|Part B|Lost to Follow-up|2|||
46929881|NCT02734862|83164821|FG001|Part B|Lost to Follow-up|2|||
46929882|NCT02734862|83164822|FG002|Part B|Lost to Follow-up|0|||
46929883|NCT02734862|83164820|FG000|Part B|Withdrawal by Subject|3|||
46929884|NCT02734862|83164821|FG001|Part B|Withdrawal by Subject|1|||
46929885|NCT02734862|83164822|FG002|Part B|Withdrawal by Subject|0|||
46929886|NCT02734862|83164820|FG000|Part B|Other|0|||
46929887|NCT02734862|83164821|FG001|Part B|Other|1|||
46929888|NCT02734862|83164822|FG002|Part B|Other|0|||
46929889|NCT00858702|83164833|FG000|Overall Study|Lack of Efficacy|1|||
46756943|NCT00856986|82975062|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
46756944|NCT00856986|82975063|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
46756945|NCT00856986|82975064|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
46756946|NCT00856986|82975065|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
46756947|NCT00856986|82975061|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
46756948|NCT00856986|82975062|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
46756949|NCT00856986|82975063|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
47055561|NCT01755767|83329656|FG001|Overall Study|Adverse Event|0|||
46636592|NCT01509846|82810407|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
46636593|NCT01509846|82810408|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
46756950|NCT00856986|82975064|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
46756951|NCT00856986|82975065|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
46756952|NCT00856986|82975061|FG000|Main Period, Weeks 0-26|Unclassified|7|||
46756953|NCT00856986|82975062|FG001|Main Period, Weeks 0-26|Unclassified|6|||
46815654|NCT00393861|83035638|FG000|Overall Study|Adverse Event|2|||
46815655|NCT00393861|83035638|FG000|Overall Study|Disease Progression|24|||
46815656|NCT00480324|83035644|FG000|Overall Study|Adverse Event|1|||
46815657|NCT00480324|83035645|FG001|Overall Study|Adverse Event|1|||
46815658|NCT00480324|83035644|FG000|Overall Study|Protocol Violation|0|||
46815659|NCT00480324|83035645|FG001|Overall Study|Protocol Violation|1|||
46756954|NCT00856986|82975063|FG002|Main Period, Weeks 0-26|Unclassified|7|||
46815660|NCT00480324|83035644|FG000|Overall Study|Withdrawal by Subject|14|||
46815661|NCT00480324|83035645|FG001|Overall Study|Withdrawal by Subject|5|||
46815662|NCT00480324|83035644|FG000|Overall Study|Lost to Follow-up|17|||
46929890|NCT00858702|83164834|FG001|Overall Study|Lack of Efficacy|0|||
46929891|NCT00858702|83164833|FG000|Overall Study|Protocol Violation|1|||
46929892|NCT00858702|83164834|FG001|Overall Study|Protocol Violation|1|||
46929893|NCT00858702|83164833|FG000|Overall Study|Other|2|||
46929894|NCT00858702|83164834|FG001|Overall Study|Other|1|||
46929895|NCT00858702|83164833|FG000|Overall Study|Withdrawal by Subject|1|||
46929896|NCT00858702|83164834|FG001|Overall Study|Withdrawal by Subject|0|||
46929897|NCT02598934|83164842|FG000|Overall Study|Adverse Event|11|||
46929898|NCT02598934|83164843|FG001|Overall Study|Adverse Event|13|||
46929899|NCT02598934|83164842|FG000|Overall Study|Failure to Return|3|||
46929900|NCT02598934|83164843|FG001|Overall Study|Failure to Return|3|||
46929901|NCT02598934|83164842|FG000|Overall Study|Withdrawal by Subject|2|||
46929902|NCT02598934|83164843|FG001|Overall Study|Withdrawal by Subject|3|||
46929903|NCT02598934|83164842|FG000|Overall Study|Administrative|2|||
46929904|NCT02598934|83164843|FG001|Overall Study|Administrative|1|||
46929905|NCT02598934|83164842|FG000|Overall Study|Protocol Violation|1|||
46929906|NCT02598934|83164843|FG001|Overall Study|Protocol Violation|2|||
46929907|NCT02598622|83164851|FG000|Overall Study|Withdrawal by Subject|3|||
46929908|NCT02598622|83164852|FG001|Overall Study|Withdrawal by Subject|0|||
46929909|NCT02598622|83164851|FG000|Overall Study|Physician Decision|3|||
46815663|NCT00480324|83035645|FG001|Overall Study|Lost to Follow-up|8|||
46815664|NCT00480324|83035644|FG000|Overall Study|Subject's mother pregnant|0|||
46815665|NCT00480324|83035645|FG001|Overall Study|Subject's mother pregnant|1|||
46815666|NCT00488592|83035651|FG000|Overall Study|Withdrawal by Subject|1|||
46815667|NCT00488592|83035651|FG000|Overall Study|Disease progression|1|||
46815668|NCT00488592|83035651|FG000|Overall Study|Enrolled but not treated|1|||
46815669|NCT00488514|83035655|FG000|Overall Study|Adverse Event|41|||
46815670|NCT00488514|83035655|FG000|Overall Study|Lost to Follow-up|44|||
46815671|NCT00488514|83035655|FG000|Overall Study|Protocol Violation|32|||
46815672|NCT00488514|83035655|FG000|Overall Study|Withdrawal by Subject|106|||
46815673|NCT00488514|83035655|FG000|Overall Study|Lack of Efficacy|28|||
46815674|NCT00488514|83035655|FG000|Overall Study|Did not meet criteria for treatment|30|||
46815675|NCT00488514|83035655|FG000|Overall Study|Postive drug screen|1|||
46815676|NCT00488514|83035655|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
46815677|NCT00488514|83035655|FG000|Overall Study|Investigator decision|1|||
46815678|NCT00488514|83035655|FG000|Overall Study|Participant had too few migraines|5|||
46815679|NCT00488514|83035655|FG000|Overall Study|Increase in number of migraines|2|||
46815680|NCT00488514|83035655|FG000|Overall Study|Increased use of concomitant medication|1|||
46815681|NCT00320710|83035679|FG000|Overall Study|Disease progression|24|||
46815682|NCT00320710|83035680|FG001|Overall Study|Disease progression|19|||
46815683|NCT00320710|83035681|FG002|Overall Study|Disease progression|2|||
46815684|NCT00320710|83035679|FG000|Overall Study|Death|10|||
46815685|NCT00320710|83035680|FG001|Overall Study|Death|7|||
46815686|NCT00320710|83035681|FG002|Overall Study|Death|1|||
46815687|NCT00320710|83035679|FG000|Overall Study|Administrative problems|1|||
46815688|NCT00320710|83035680|FG001|Overall Study|Administrative problems|2|||
46815689|NCT00320710|83035681|FG002|Overall Study|Administrative problems|0|||
46929910|NCT02598622|83164852|FG001|Overall Study|Physician Decision|0|||
47055562|NCT01755767|83329657|FG002|Overall Study|Adverse Event|28|||
47055563|NCT01755767|83329658|FG003|Overall Study|Adverse Event|11|||
47055564|NCT01755767|83329655|FG000|Overall Study|Death|1|||
47055565|NCT01755767|83329656|FG001|Overall Study|Death|2|||
46756955|NCT00856986|82975064|FG003|Main Period, Weeks 0-26|Unclassified|0|||
46756956|NCT00856986|82975065|FG004|Main Period, Weeks 0-26|Unclassified|0|||
46756957|NCT00856986|82975061|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
46756958|NCT00856986|82975062|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
46756959|NCT00856986|82975063|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
46756960|NCT00856986|82975064|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
46756961|NCT00856986|82975065|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
46756962|NCT00856986|82975061|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
46756963|NCT00856986|82975062|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
46756964|NCT00856986|82975063|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
46756965|NCT00856986|82975064|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
46756966|NCT00856986|82975065|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
46756967|NCT00856986|82975061|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
46815690|NCT00320710|83035679|FG000|Overall Study|Withdrawal by Subject|20|||
46815691|NCT00320710|83035680|FG001|Overall Study|Withdrawal by Subject|26|||
46815692|NCT00320710|83035681|FG002|Overall Study|Withdrawal by Subject|1|||
46815693|NCT00320710|83035679|FG000|Overall Study|Protocol Violation|6|||
46815694|NCT00320710|83035680|FG001|Overall Study|Protocol Violation|5|||
46815695|NCT00320710|83035681|FG002|Overall Study|Protocol Violation|0|||
46815696|NCT00320710|83035679|FG000|Overall Study|Abnormal test procedure result(s)|2|||
46815697|NCT00320710|83035680|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46815698|NCT00320710|83035681|FG002|Overall Study|Abnormal test procedure result(s)|0|||
46815699|NCT00320710|83035679|FG000|Overall Study|Abnormal laboratory value(s)|12|||
46929911|NCT00841698|83164860|FG000|First Intervention|Withdrawal by Subject|1|||
46929912|NCT00841698|83164861|FG001|First Intervention|Withdrawal by Subject|0|||
46929913|NCT00841542|83164867|FG000|Period 1|Adverse Event|1|||
46929914|NCT00841542|83164868|FG001|Period 1|Adverse Event|0|||
46929915|NCT00840216|83164890|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
46756968|NCT00856986|82975062|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
46929916|NCT00840216|83164891|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
46756969|NCT00856986|82975063|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
46929917|NCT00836706|83164901|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
46815700|NCT00320710|83035680|FG001|Overall Study|Abnormal laboratory value(s)|3|||
46815701|NCT00320710|83035681|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46815702|NCT00320710|83035679|FG000|Overall Study|Adverse Event|18|||
46815703|NCT00320710|83035680|FG001|Overall Study|Adverse Event|14|||
46815704|NCT00320710|83035681|FG002|Overall Study|Adverse Event|1|||
46815705|NCT00320710|83035679|FG000|Overall Study|Lost to Follow-up|1|||
46815706|NCT00320710|83035680|FG001|Overall Study|Lost to Follow-up|0|||
46815707|NCT00320710|83035681|FG002|Overall Study|Lost to Follow-up|0|||
46815708|NCT00320398|83035690|FG000|Overall Study|Adverse Event|1|||
46815709|NCT00320398|83035691|FG001|Overall Study|Adverse Event|4|||
46815710|NCT00320398|83035690|FG000|Overall Study|Other|1|||
46815711|NCT00320398|83035691|FG001|Overall Study|Other|0|||
46815712|NCT00498186|83035698|FG000|Overall Study|Protocol Violation|10|||
46815713|NCT00498186|83035698|FG000|Overall Study|Lack of Efficacy|31|||
46815714|NCT00498186|83035698|FG000|Overall Study|Adverse Event|89|||
46815715|NCT00498186|83035698|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
46815716|NCT00498186|83035698|FG000|Overall Study|Withdrawal by Subject|18|||
46815717|NCT00498186|83035698|FG000|Overall Study|Lost to Follow-up|3|||
46815718|NCT00498186|83035698|FG000|Overall Study|Other|10|||
46815719|NCT00333970|83035704|FG000|Overall Study|Withdrawal by Subject|13|||
46815720|NCT00333970|83035705|FG001|Overall Study|Withdrawal by Subject|7|||
46815721|NCT00477594|83035713|FG000|Year 1 and Year 2|Adverse Event|4|||
46815722|NCT00477594|83035714|FG001|Year 1 and Year 2|Adverse Event|2|||
46815723|NCT00477594|83035713|FG000|Year 1 and Year 2|Physician Decision|2|||
46815724|NCT00477594|83035714|FG001|Year 1 and Year 2|Physician Decision|1|||
47055566|NCT01755767|83329657|FG002|Overall Study|Death|15|||
47055567|NCT01755767|83329658|FG003|Overall Study|Death|4|||
47055568|NCT01755767|83329655|FG000|Overall Study|Subject Decision|0|||
47055569|NCT01755767|83329656|FG001|Overall Study|Subject Decision|0|||
47055570|NCT01755767|83329657|FG002|Overall Study|Subject Decision|10|||
47055571|NCT01755767|83329658|FG003|Overall Study|Subject Decision|3|||
47055572|NCT01755767|83329655|FG000|Overall Study|Withdrawal by Subject|0|||
47055573|NCT01755767|83329656|FG001|Overall Study|Withdrawal by Subject|0|||
47055574|NCT01755767|83329657|FG002|Overall Study|Withdrawal by Subject|2|||
47055575|NCT01755767|83329658|FG003|Overall Study|Withdrawal by Subject|1|||
46636594|NCT01509846|82810404|FG000|Received Vaccination 2|Illness|0|||
46636595|NCT01509846|82810405|FG001|Received Vaccination 2|Illness|0|||
46636596|NCT01509846|82810406|FG002|Received Vaccination 2|Illness|0|||
46756970|NCT00856986|82975064|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
46756971|NCT00856986|82975065|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
46756972|NCT00856986|82975061|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
46756973|NCT00856986|82975062|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
46756974|NCT00856986|82975063|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
46756975|NCT00856986|82975064|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
46756976|NCT00856986|82975065|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
46756977|NCT00856986|82975061|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
46756978|NCT00856986|82975062|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
46756979|NCT00856986|82975063|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
46756980|NCT00856986|82975064|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
46756981|NCT00856986|82975065|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
46756982|NCT00856986|82975061|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
46756983|NCT00856986|82975062|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
46815725|NCT00477594|83035713|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
46815726|NCT00477594|83035714|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
46815727|NCT00477594|83035713|FG000|Year 1 and Year 2|Other|1|||
46815728|NCT00477594|83035714|FG001|Year 1 and Year 2|Other|0|||
46815729|NCT00477594|83035713|FG000|Year 3|Adverse Event|1|||
46815730|NCT00477594|83035714|FG001|Year 3|Adverse Event|0|||
46815731|NCT00477594|83035713|FG000|Year 3|Withdrawal by Subject|1|||
46815732|NCT00477594|83035714|FG001|Year 3|Withdrawal by Subject|0|||
46815733|NCT00477594|83035713|FG000|Follow-up Period|Withdrawal by Subject|2|||
46815734|NCT00477594|83035714|FG001|Follow-up Period|Withdrawal by Subject|1|||
46929918|NCT00836706|83164902|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
46929919|NCT00836472|83164908|FG000|Washout|Adverse Event|1|||
47055576|NCT01755767|83329655|FG000|Overall Study|Other|0|||
47055577|NCT01755767|83329656|FG001|Overall Study|Other|0|||
46636597|NCT01509846|82810407|FG003|Received Vaccination 2|Illness|0|||
46756984|NCT00856986|82975063|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
46756985|NCT00856986|82975064|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
46815735|NCT00477594|83035713|FG000|Follow-up Period|Other|1|||
46815736|NCT00477594|83035714|FG001|Follow-up Period|Other|0|||
46815737|NCT00475722|83035722|FG000|Overall Study|Withdrawal by Subject|12|||
47055578|NCT01755767|83329657|FG002|Overall Study|Other|2|||
47055579|NCT01755767|83329658|FG003|Overall Study|Other|3|||
47055580|NCT01755767|83329655|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
47055581|NCT01755767|83329656|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
47055582|NCT01755767|83329657|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
47055583|NCT01755767|83329658|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
47055584|NCT01730339|83329754|FG000|Overall Study|Withdrawal by Subject|3|||
47055585|NCT01730339|83329755|FG001|Overall Study|Withdrawal by Subject|2|||
47055586|NCT01730339|83329754|FG000|Overall Study|Lost to Follow-up|1|||
47055587|NCT01730339|83329755|FG001|Overall Study|Lost to Follow-up|1|||
47055588|NCT01730339|83329754|FG000|Overall Study|Un-specified|1|||
47055589|NCT01730339|83329755|FG001|Overall Study|Un-specified|0|||
47055590|NCT01754753|83329812|FG000|Overall Study|Study close|43|||
47055591|NCT01754753|83329813|FG001|Overall Study|Study close|44|||
47055592|NCT01754753|83329812|FG000|Overall Study|Lost to Follow-up|9|||
47055593|NCT01754753|83329813|FG001|Overall Study|Lost to Follow-up|5|||
47055594|NCT01729871|83329821|FG000|Overall Study|Adverse Event|7|||
47055595|NCT01729871|83329822|FG001|Overall Study|Adverse Event|7|||
47055596|NCT01729871|83329821|FG000|Overall Study|Death|0|||
47055597|NCT01729871|83329822|FG001|Overall Study|Death|1|||
47055598|NCT01729871|83329821|FG000|Overall Study|Lack of Efficacy|0|||
47055599|NCT01729871|83329822|FG001|Overall Study|Lack of Efficacy|1|||
47055600|NCT01729871|83329821|FG000|Overall Study|Physician Decision|0|||
47055601|NCT01729871|83329822|FG001|Overall Study|Physician Decision|2|||
46929920|NCT00836472|83164909|FG001|Washout|Adverse Event|2|||
47055602|NCT01729871|83329821|FG000|Overall Study|Protocol Violation|1|||
47055603|NCT01729871|83329822|FG001|Overall Study|Protocol Violation|0|||
47055604|NCT01729871|83329821|FG000|Overall Study|Withdrawal by Subject|0|||
47055605|NCT01729871|83329822|FG001|Overall Study|Withdrawal by Subject|3|||
47055606|NCT01729871|83329821|FG000|Overall Study|Other|4|||
47055607|NCT01729871|83329822|FG001|Overall Study|Other|9|||
47055608|NCT02611323|83329839|FG000|Overall Study|Death|3|||
47055609|NCT02611323|83329840|FG001|Overall Study|Death|1|||
47055610|NCT02611323|83329841|FG002|Overall Study|Death|0|||
46636598|NCT01509846|82810408|FG004|Received Vaccination 2|Illness|1|||
46636599|NCT01509846|82810404|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
46636600|NCT01509846|82810405|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
46636601|NCT01509846|82810406|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
46636602|NCT01509846|82810407|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
46756986|NCT00856986|82975065|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
46756987|NCT00707746|82975079|FG000|Treatment Period|Adverse Event|2|||
46756988|NCT00707746|82975080|FG001|Treatment Period|Adverse Event|4|||
46756989|NCT00707746|82975079|FG000|Treatment Period|Ineligibility|0|||
46756990|NCT00707746|82975080|FG001|Treatment Period|Ineligibility|1|||
46756991|NCT00856908|82975088|FG000|Overall Study|Lost to Follow-up|1|||
46756992|NCT00856908|82975089|FG001|Overall Study|Lost to Follow-up|0|||
46636603|NCT01509846|82810408|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
46636604|NCT01509846|82810404|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
46756993|NCT00522379|82975100|FG000|Overall Study|Adverse Event|12|||
46929921|NCT00836472|83164908|FG000|Washout|Withdrawal by Subject|1|||
47055611|NCT02611323|83329842|FG003|Overall Study|Death|0|||
47055612|NCT02611323|83329843|FG004|Overall Study|Death|1|||
47055613|NCT02611323|83329844|FG005|Overall Study|Death|1|||
47055614|NCT02611323|83329845|FG006|Overall Study|Death|8|||
47055615|NCT02611323|83329846|FG007|Overall Study|Death|0|||
47055616|NCT02611323|83329847|FG008|Overall Study|Death|4|||
47055617|NCT02611323|83329848|FG009|Overall Study|Death|6|||
47055618|NCT02611323|83329849|FG010|Overall Study|Death|26|||
47055619|NCT02611323|83329839|FG000|Overall Study|Lost to Follow-up|1|||
47055620|NCT02611323|83329840|FG001|Overall Study|Lost to Follow-up|0|||
47055621|NCT02611323|83329841|FG002|Overall Study|Lost to Follow-up|0|||
47055622|NCT02611323|83329842|FG003|Overall Study|Lost to Follow-up|0|||
47055623|NCT02611323|83329843|FG004|Overall Study|Lost to Follow-up|0|||
47055624|NCT02611323|83329844|FG005|Overall Study|Lost to Follow-up|0|||
47055625|NCT02611323|83329845|FG006|Overall Study|Lost to Follow-up|3|||
47055626|NCT02611323|83329846|FG007|Overall Study|Lost to Follow-up|0|||
47055627|NCT02611323|83329847|FG008|Overall Study|Lost to Follow-up|0|||
47055628|NCT02611323|83329848|FG009|Overall Study|Lost to Follow-up|0|||
47055629|NCT02611323|83329849|FG010|Overall Study|Lost to Follow-up|2|||
47055630|NCT02611323|83329839|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055631|NCT02611323|83329840|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055632|NCT02611323|83329841|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055633|NCT02611323|83329842|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055634|NCT02611323|83329843|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055635|NCT02611323|83329844|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055636|NCT02611323|83329845|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
46636605|NCT01509846|82810405|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
46756994|NCT00522379|82975101|FG001|Overall Study|Adverse Event|15|||
47055637|NCT02611323|83329846|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055638|NCT02611323|83329847|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055639|NCT02611323|83329848|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
47055640|NCT02611323|83329849|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
47055641|NCT02611323|83329839|FG000|Overall Study|Progressive Disease|0|||
47055642|NCT02611323|83329840|FG001|Overall Study|Progressive Disease|0|||
47055643|NCT02611323|83329841|FG002|Overall Study|Progressive Disease|0|||
47055644|NCT02611323|83329842|FG003|Overall Study|Progressive Disease|0|||
47055645|NCT02611323|83329843|FG004|Overall Study|Progressive Disease|0|||
47055646|NCT02611323|83329844|FG005|Overall Study|Progressive Disease|0|||
47055647|NCT02611323|83329845|FG006|Overall Study|Progressive Disease|0|||
47055648|NCT02611323|83329846|FG007|Overall Study|Progressive Disease|0|||
47055649|NCT02611323|83329847|FG008|Overall Study|Progressive Disease|0|||
47055650|NCT02611323|83329848|FG009|Overall Study|Progressive Disease|0|||
46929922|NCT00836472|83164909|FG001|Washout|Withdrawal by Subject|1|||
46929923|NCT02598388|83164925|FG000|Overall Study|Lost to Follow-up|1|||
46929924|NCT02598388|83164926|FG001|Overall Study|Lost to Follow-up|0|||
46929925|NCT02598388|83164927|FG002|Overall Study|Lost to Follow-up|1|||
46929926|NCT02598388|83164928|FG003|Overall Study|Lost to Follow-up|0|||
46929927|NCT02598388|83164929|FG004|Overall Study|Lost to Follow-up|5|||
46929928|NCT02598388|83164930|FG005|Overall Study|Lost to Follow-up|1|||
46929929|NCT02598388|83164931|FG006|Overall Study|Lost to Follow-up|2|||
47055651|NCT02611323|83329849|FG010|Overall Study|Progressive Disease|1|||
47055652|NCT02611323|83329839|FG000|Overall Study|Withdrawal by Subject|1|||
47055653|NCT02611323|83329840|FG001|Overall Study|Withdrawal by Subject|0|||
47055654|NCT02611323|83329841|FG002|Overall Study|Withdrawal by Subject|0|||
47055655|NCT02611323|83329842|FG003|Overall Study|Withdrawal by Subject|0|||
47055656|NCT02611323|83329843|FG004|Overall Study|Withdrawal by Subject|0|||
47055657|NCT02611323|83329844|FG005|Overall Study|Withdrawal by Subject|0|||
47055658|NCT02611323|83329845|FG006|Overall Study|Withdrawal by Subject|0|||
47055659|NCT02611323|83329846|FG007|Overall Study|Withdrawal by Subject|1|||
47055660|NCT02611323|83329847|FG008|Overall Study|Withdrawal by Subject|0|||
47055661|NCT02611323|83329848|FG009|Overall Study|Withdrawal by Subject|1|||
47055662|NCT02611323|83329849|FG010|Overall Study|Withdrawal by Subject|0|||
47055663|NCT01729559|83329888|FG000|Overall Study|Protocol Violation|31|||
47055664|NCT01729559|83329889|FG001|Overall Study|Protocol Violation|28|||
47055665|NCT01728779|83329908|FG000|Overall Study|Withdrawal by Subject|1|||
46756995|NCT00522379|82975102|FG002|Overall Study|Adverse Event|12|||
46756996|NCT00522379|82975103|FG003|Overall Study|Adverse Event|5|||
46756997|NCT00522379|82975104|FG004|Overall Study|Adverse Event|17|||
46756998|NCT00522379|82975100|FG000|Overall Study|Lack of Efficacy|3|||
46929930|NCT02598388|83164932|FG007|Overall Study|Lost to Follow-up|1|||
46929931|NCT02598388|83164933|FG008|Overall Study|Lost to Follow-up|0|||
47055666|NCT01728623|83329919|FG000|Overall Study|Disease progression|26|||
47055667|NCT01728623|83329919|FG000|Overall Study|Adverse Event|1|||
47055668|NCT01728623|83329919|FG000|Overall Study|Withdrawal by Subject|1|||
47055669|NCT01754129|83329926|FG000|Overall Study|Death|13|||
47055670|NCT01754129|83329926|FG000|Overall Study|Duodopa discontinuation|9|||
47055671|NCT01754129|83329926|FG000|Overall Study|Lost to Follow-up|7|||
46756999|NCT00522379|82975101|FG001|Overall Study|Lack of Efficacy|0|||
47055672|NCT01754129|83329926|FG000|Overall Study|Withdrew consent|1|||
46929932|NCT02598388|83164934|FG009|Overall Study|Lost to Follow-up|0|||
47055673|NCT01754129|83329926|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
47055674|NCT01728077|83329939|FG000|Overall Study|Lack of Efficacy|3|||
47055675|NCT01728077|83329940|FG001|Overall Study|Lack of Efficacy|1|||
47055676|NCT01728077|83329939|FG000|Overall Study|Lost to Follow-up|1|||
47055677|NCT01728077|83329940|FG001|Overall Study|Lost to Follow-up|0|||
47055678|NCT01728077|83329939|FG000|Overall Study|Subject choice|2|||
47055679|NCT01728077|83329940|FG001|Overall Study|Subject choice|3|||
47055680|NCT01728077|83329939|FG000|Overall Study|Death|0|||
47055681|NCT01728077|83329940|FG001|Overall Study|Death|1|||
47055682|NCT01728077|83329939|FG000|Overall Study|Patient moving|1|||
47055683|NCT01728077|83329940|FG001|Overall Study|Patient moving|0|||
47055684|NCT01728077|83329939|FG000|Overall Study|Non compliance|1|||
47055685|NCT01728077|83329940|FG001|Overall Study|Non compliance|0|||
47055686|NCT01606007|83329959|FG000|Overall Study|Reason 'Other' in the protocol|0|||
47055687|NCT01606007|83329960|FG001|Overall Study|Reason 'Other' in the protocol|1|||
47055688|NCT01606007|83329961|FG002|Overall Study|Reason 'Other' in the protocol|1|||
47055689|NCT01606007|83329959|FG000|Overall Study|Pregnancy|0|||
47055690|NCT01606007|83329960|FG001|Overall Study|Pregnancy|1|||
47055691|NCT01606007|83329961|FG002|Overall Study|Pregnancy|1|||
47055692|NCT01606007|83329959|FG000|Overall Study|Withdrawal by Subject|8|||
47055693|NCT01606007|83329960|FG001|Overall Study|Withdrawal by Subject|6|||
47055694|NCT01606007|83329961|FG002|Overall Study|Withdrawal by Subject|1|||
47055695|NCT01606007|83329959|FG000|Overall Study|Adverse Event|0|||
47055696|NCT01606007|83329960|FG001|Overall Study|Adverse Event|1|||
47055697|NCT01606007|83329961|FG002|Overall Study|Adverse Event|1|||
47055698|NCT01606007|83329959|FG000|Overall Study|discontinue study treatment|0|||
47055699|NCT01606007|83329960|FG001|Overall Study|discontinue study treatment|2|||
47055700|NCT01606007|83329961|FG002|Overall Study|discontinue study treatment|1|||
47055701|NCT01606007|83329959|FG000|Overall Study|Lost to Follow-up|6|||
47055702|NCT01606007|83329960|FG001|Overall Study|Lost to Follow-up|8|||
46929933|NCT02598388|83164935|FG010|Overall Study|Lost to Follow-up|1|||
47055703|NCT01606007|83329961|FG002|Overall Study|Lost to Follow-up|5|||
47055704|NCT01606007|83329959|FG000|Overall Study|Poor/Non-compliance|1|||
47055705|NCT01606007|83329960|FG001|Overall Study|Poor/Non-compliance|0|||
47055706|NCT01606007|83329961|FG002|Overall Study|Poor/Non-compliance|0|||
47055707|NCT01753193|83330040|FG000|Overall Study|Withdrawal by Subject|23|||
47055708|NCT01753193|83330040|FG000|Overall Study|Lost to Follow-up|6|||
47055709|NCT01753193|83330040|FG000|Overall Study|Death|1|||
47055710|NCT01753193|83330040|FG000|Overall Study|Other|16|||
46929934|NCT02598388|83164936|FG011|Overall Study|Lost to Follow-up|0|||
46929935|NCT02598388|83164925|FG000|Overall Study|Withdrawal by Subject|0|||
47055711|NCT01727297|83330087|FG000|Overall Study|Death|13|||
47055712|NCT01727297|83330088|FG001|Overall Study|Death|0|||
47055713|NCT01727297|83330087|FG000|Overall Study|Protocol Violation|1|||
47055714|NCT01727297|83330088|FG001|Overall Study|Protocol Violation|10|||
47055715|NCT01727297|83330087|FG000|Overall Study|Adverse Event|3|||
47055716|NCT01727297|83330088|FG001|Overall Study|Adverse Event|1|||
47055717|NCT01727297|83330087|FG000|Overall Study|Lost to Follow-up|11|||
47055718|NCT01727297|83330088|FG001|Overall Study|Lost to Follow-up|0|||
47055719|NCT01727297|83330087|FG000|Overall Study|Withdrawal by Subject|26|||
47055720|NCT01727297|83330088|FG001|Overall Study|Withdrawal by Subject|27|||
47055721|NCT01727297|83330087|FG000|Overall Study|Physician Decision|19|||
47055722|NCT01727297|83330088|FG001|Overall Study|Physician Decision|5|||
47055723|NCT01727297|83330087|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
47055724|NCT01727297|83330088|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
47055725|NCT01727141|83330114|FG000|Overall Study|Physician Decision|0|||
46815738|NCT00475722|83035723|FG001|Overall Study|Withdrawal by Subject|12|||
47055726|NCT01727141|83330115|FG001|Overall Study|Physician Decision|1|||
47055727|NCT01727141|83330116|FG002|Overall Study|Physician Decision|0|||
46757000|NCT00522379|82975102|FG002|Overall Study|Lack of Efficacy|2|||
46757001|NCT00522379|82975103|FG003|Overall Study|Lack of Efficacy|2|||
46757002|NCT00522379|82975104|FG004|Overall Study|Lack of Efficacy|7|||
46757003|NCT00522379|82975100|FG000|Overall Study|Withdrawal by Subject|2|||
46757004|NCT00522379|82975101|FG001|Overall Study|Withdrawal by Subject|3|||
46757005|NCT00522379|82975102|FG002|Overall Study|Withdrawal by Subject|1|||
46757006|NCT00522379|82975103|FG003|Overall Study|Withdrawal by Subject|2|||
46757007|NCT00522379|82975104|FG004|Overall Study|Withdrawal by Subject|0|||
46757008|NCT00522379|82975100|FG000|Overall Study|Protocol Violation|1|||
46757009|NCT00522379|82975101|FG001|Overall Study|Protocol Violation|1|||
46757010|NCT00522379|82975102|FG002|Overall Study|Protocol Violation|2|||
46757011|NCT00522379|82975103|FG003|Overall Study|Protocol Violation|0|||
46757012|NCT00522379|82975104|FG004|Overall Study|Protocol Violation|0|||
46757013|NCT00522379|82975100|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
46757014|NCT00522379|82975101|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
46757015|NCT00522379|82975102|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
46757016|NCT00522379|82975103|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
46757017|NCT00522379|82975104|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
47055728|NCT01727141|83330117|FG003|Overall Study|Physician Decision|2|||
47055729|NCT01727141|83330114|FG000|Overall Study|Lost to Follow-up|0|||
47055730|NCT01727141|83330115|FG001|Overall Study|Lost to Follow-up|2|||
47055731|NCT01727141|83330116|FG002|Overall Study|Lost to Follow-up|0|||
46757018|NCT00522379|82975100|FG000|Overall Study|Lost to Follow-up|1|||
46757019|NCT00522379|82975101|FG001|Overall Study|Lost to Follow-up|0|||
46757020|NCT00522379|82975102|FG002|Overall Study|Lost to Follow-up|4|||
46757021|NCT00522379|82975103|FG003|Overall Study|Lost to Follow-up|2|||
46757022|NCT00522379|82975104|FG004|Overall Study|Lost to Follow-up|2|||
46757023|NCT00522379|82975100|FG000|Overall Study|Randomization error|0|||
46757024|NCT00522379|82975101|FG001|Overall Study|Randomization error|0|||
46757025|NCT00522379|82975102|FG002|Overall Study|Randomization error|0|||
46757026|NCT00522379|82975103|FG003|Overall Study|Randomization error|0|||
46757027|NCT00522379|82975104|FG004|Overall Study|Randomization error|1|||
46757028|NCT00522379|82975100|FG000|Overall Study|Dispensing error|1|||
46757029|NCT00522379|82975101|FG001|Overall Study|Dispensing error|0|||
46757030|NCT00522379|82975102|FG002|Overall Study|Dispensing error|0|||
46757031|NCT00522379|82975103|FG003|Overall Study|Dispensing error|1|||
46757032|NCT00522379|82975104|FG004|Overall Study|Dispensing error|0|||
46757033|NCT00522379|82975100|FG000|Overall Study|Subject Moved|1|||
46757034|NCT00522379|82975101|FG001|Overall Study|Subject Moved|1|||
46757035|NCT00522379|82975102|FG002|Overall Study|Subject Moved|0|||
46757036|NCT00522379|82975103|FG003|Overall Study|Subject Moved|0|||
46757037|NCT00522379|82975104|FG004|Overall Study|Subject Moved|0|||
46757038|NCT00522379|82975100|FG000|Overall Study|Sponsor Request|0|||
46757039|NCT00522379|82975101|FG001|Overall Study|Sponsor Request|1|||
47055732|NCT01727141|83330117|FG003|Overall Study|Lost to Follow-up|0|||
47055733|NCT01727141|83330114|FG000|Overall Study|Death|0|||
47055734|NCT01727141|83330115|FG001|Overall Study|Death|1|||
47055735|NCT01727141|83330116|FG002|Overall Study|Death|1|||
47055736|NCT01727141|83330117|FG003|Overall Study|Death|1|||
47055737|NCT01727141|83330114|FG000|Overall Study|Protocol deviation|1|||
46815739|NCT00475722|83035722|FG000|Overall Study|Protocol Violation|3|||
46815740|NCT00475722|83035723|FG001|Overall Study|Protocol Violation|0|||
46815741|NCT00304954|83035733|FG000|Overall Study|Withdrawal by Subject|0|||
46815742|NCT00304954|83035734|FG001|Overall Study|Withdrawal by Subject|0|||
46815743|NCT00304954|83035735|FG002|Overall Study|Withdrawal by Subject|1|||
46815744|NCT00304954|83035736|FG003|Overall Study|Withdrawal by Subject|0|||
46815745|NCT00304954|83035733|FG000|Overall Study|Adverse Event|1|||
46815746|NCT00304954|83035734|FG001|Overall Study|Adverse Event|0|||
46815747|NCT00304954|83035735|FG002|Overall Study|Adverse Event|0|||
46815748|NCT00304954|83035736|FG003|Overall Study|Adverse Event|0|||
46815749|NCT00475176|83035754|FG000|Overall Study|Adverse Event|2|||
46815750|NCT00475176|83035754|FG000|Overall Study|Withdrawal by Subject|1|||
46815751|NCT00475176|83035754|FG000|Overall Study|Protocol Violation|1|||
46815752|NCT00414609|83035760|FG000|Core Study|Adverse Event|9|||
46815753|NCT00414609|83035761|FG001|Core Study|Adverse Event|11|||
46815754|NCT00414609|83035762|FG002|Core Study|Adverse Event|0|||
46815755|NCT00414609|83035760|FG000|Core Study|Abnormal laboratory values|0|||
46815756|NCT00414609|83035761|FG001|Core Study|Abnormal laboratory values|1|||
46815757|NCT00414609|83035762|FG002|Core Study|Abnormal laboratory values|0|||
46815758|NCT00414609|83035760|FG000|Core Study|Abnormal test procedure results|1|||
46815759|NCT00414609|83035761|FG001|Core Study|Abnormal test procedure results|1|||
46815760|NCT00414609|83035762|FG002|Core Study|Abnormal test procedure results|0|||
46815761|NCT00414609|83035760|FG000|Core Study|Protocol deviation|0|||
46815762|NCT00414609|83035761|FG001|Core Study|Protocol deviation|1|||
46815763|NCT00414609|83035762|FG002|Core Study|Protocol deviation|0|||
46815764|NCT00414609|83035760|FG000|Core Study|Patient withdrew consent|10|||
46929936|NCT02598388|83164926|FG001|Overall Study|Withdrawal by Subject|0|||
46929937|NCT02598388|83164927|FG002|Overall Study|Withdrawal by Subject|0|||
46929938|NCT02598388|83164928|FG003|Overall Study|Withdrawal by Subject|0|||
46815765|NCT00414609|83035761|FG001|Core Study|Patient withdrew consent|11|||
46815766|NCT00414609|83035762|FG002|Core Study|Patient withdrew consent|0|||
46815767|NCT00414609|83035760|FG000|Core Study|Lost to Follow-up|7|||
46815768|NCT00414609|83035761|FG001|Core Study|Lost to Follow-up|4|||
46815769|NCT00414609|83035762|FG002|Core Study|Lost to Follow-up|0|||
46815770|NCT00414609|83035760|FG000|Core Study|Administrative problems|0|||
46815771|NCT00414609|83035761|FG001|Core Study|Administrative problems|2|||
46815772|NCT00414609|83035762|FG002|Core Study|Administrative problems|0|||
46815773|NCT00414609|83035760|FG000|Core Study|Death|7|||
46815774|NCT00414609|83035761|FG001|Core Study|Death|14|||
46929939|NCT02598388|83164929|FG004|Overall Study|Withdrawal by Subject|2|||
46929940|NCT02598388|83164930|FG005|Overall Study|Withdrawal by Subject|0|||
46929941|NCT02598388|83164931|FG006|Overall Study|Withdrawal by Subject|2|||
46757040|NCT00522379|82975102|FG002|Overall Study|Sponsor Request|0|||
46757041|NCT00522379|82975103|FG003|Overall Study|Sponsor Request|0|||
46757042|NCT00522379|82975104|FG004|Overall Study|Sponsor Request|0|||
46757043|NCT00522379|82975100|FG000|Overall Study|Family Problem|0|||
46757044|NCT00522379|82975101|FG001|Overall Study|Family Problem|0|||
46757045|NCT00522379|82975102|FG002|Overall Study|Family Problem|1|||
46757046|NCT00522379|82975103|FG003|Overall Study|Family Problem|0|||
46757047|NCT00522379|82975104|FG004|Overall Study|Family Problem|0|||
46757048|NCT00522379|82975100|FG000|Overall Study|Site Closed|0|||
46757049|NCT00522379|82975101|FG001|Overall Study|Site Closed|0|||
46757050|NCT00522379|82975102|FG002|Overall Study|Site Closed|0|||
46757051|NCT00522379|82975103|FG003|Overall Study|Site Closed|1|||
46757052|NCT00522379|82975104|FG004|Overall Study|Site Closed|0|||
46757053|NCT00522379|82975100|FG000|Overall Study|Subject Withdrawal|0|||
46757054|NCT00522379|82975101|FG001|Overall Study|Subject Withdrawal|0|||
46757055|NCT00522379|82975102|FG002|Overall Study|Subject Withdrawal|0|||
46757056|NCT00522379|82975103|FG003|Overall Study|Subject Withdrawal|1|||
46757057|NCT00522379|82975104|FG004|Overall Study|Subject Withdrawal|0|||
46757058|NCT00856830|82975120|FG000|Irinotecan & Bendamustine|Death|0|||
46757059|NCT00856830|82975121|FG001|Irinotecan & Bendamustine|Death|0|||
46757060|NCT00856830|82975122|FG002|Irinotecan & Bendamustine|Death|0|||
46815775|NCT00414609|83035762|FG002|Core Study|Death|0|||
46815776|NCT00414609|83035760|FG000|Extension Study|Adverse Event|0|||
46815777|NCT00414609|83035761|FG001|Extension Study|Adverse Event|0|||
46815778|NCT00414609|83035762|FG002|Extension Study|Adverse Event|14|||
46929942|NCT02598388|83164932|FG007|Overall Study|Withdrawal by Subject|0|||
46757061|NCT00856830|82975123|FG003|Irinotecan & Bendamustine|Death|2|||
46757062|NCT00856830|82975120|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
46757063|NCT00856830|82975121|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
46757064|NCT00856830|82975122|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
46815779|NCT00414609|83035760|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
46815780|NCT00414609|83035761|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
46815781|NCT00414609|83035762|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
46815782|NCT00414609|83035760|FG000|Extension Study|Withdrawal by Subject|0|||
46815783|NCT00414609|83035761|FG001|Extension Study|Withdrawal by Subject|0|||
46929943|NCT02598388|83164933|FG008|Overall Study|Withdrawal by Subject|0|||
46815784|NCT00414609|83035762|FG002|Extension Study|Withdrawal by Subject|13|||
46815785|NCT00414609|83035760|FG000|Extension Study|Lost to Follow-up|0|||
46815786|NCT00414609|83035761|FG001|Extension Study|Lost to Follow-up|0|||
46815787|NCT00414609|83035762|FG002|Extension Study|Lost to Follow-up|10|||
46815788|NCT00414609|83035760|FG000|Extension Study|Administrative problems|0|||
46815789|NCT00414609|83035761|FG001|Extension Study|Administrative problems|0|||
46815790|NCT00414609|83035762|FG002|Extension Study|Administrative problems|1|||
46815791|NCT00414609|83035760|FG000|Extension Study|Death|0|||
46815792|NCT00414609|83035761|FG001|Extension Study|Death|0|||
46815793|NCT00414609|83035762|FG002|Extension Study|Death|17|||
46815794|NCT00393705|83035773|FG000|Overall Study|Adverse Event|0|||
46815795|NCT00393705|83035774|FG001|Overall Study|Adverse Event|2|||
46815796|NCT00393705|83035773|FG000|Overall Study|Death|0|||
46815797|NCT00393705|83035774|FG001|Overall Study|Death|1|||
46815798|NCT00393705|83035773|FG000|Overall Study|Lost to Follow-up|2|||
46815799|NCT00393705|83035774|FG001|Overall Study|Lost to Follow-up|2|||
46815800|NCT00393705|83035773|FG000|Overall Study|Entry Criteria Not Met|10|||
46815801|NCT00393705|83035774|FG001|Overall Study|Entry Criteria Not Met|10|||
46815802|NCT00393705|83035773|FG000|Overall Study|Protocol Violation|4|||
46815803|NCT00393705|83035774|FG001|Overall Study|Protocol Violation|3|||
46815804|NCT00393705|83035773|FG000|Overall Study|Withdrawal by Subject|5|||
46815805|NCT00393705|83035774|FG001|Overall Study|Withdrawal by Subject|3|||
46815806|NCT00393705|83035773|FG000|Overall Study|Physician Decision|2|||
46815807|NCT00393705|83035774|FG001|Overall Study|Physician Decision|2|||
46815808|NCT00303628|83035782|FG000|Overall Study|Disease progression|0|||
46815809|NCT00303628|83035783|FG001|Overall Study|Disease progression|1|||
46815810|NCT00303628|83035782|FG000|Overall Study|Adverse Event|26|||
46815811|NCT00303628|83035783|FG001|Overall Study|Adverse Event|36|||
46815812|NCT00303628|83035782|FG000|Overall Study|Death|0|||
46815813|NCT00303628|83035783|FG001|Overall Study|Death|1|||
46815814|NCT00303628|83035782|FG000|Overall Study|Withdrawal by Subject|11|||
46815815|NCT00303628|83035783|FG001|Overall Study|Withdrawal by Subject|20|||
46815816|NCT00303628|83035782|FG000|Overall Study|Alternative therapy|2|||
47055738|NCT01727141|83330115|FG001|Overall Study|Protocol deviation|1|||
46815817|NCT00303628|83035783|FG001|Overall Study|Alternative therapy|0|||
46815818|NCT00303628|83035782|FG000|Overall Study|Other complicating disease|0|||
46815819|NCT00303628|83035783|FG001|Overall Study|Other complicating disease|1|||
46815820|NCT00303628|83035782|FG000|Overall Study|Not start protocol therapy|3|||
46815821|NCT00303628|83035783|FG001|Overall Study|Not start protocol therapy|5|||
46815822|NCT00303628|83035782|FG000|Overall Study|Other|8|||
46815823|NCT00303628|83035783|FG001|Overall Study|Other|9|||
46815824|NCT00414453|83035789|FG000|Overall Study|Abnormal lab work|16|||
46815825|NCT00332488|83035802|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
46815826|NCT00332488|83035803|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
46815827|NCT00332488|83035804|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
46815828|NCT00332488|83035802|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
46815829|NCT00332488|83035803|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
46815830|NCT00332488|83035804|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
46815831|NCT00332488|83035802|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
46815832|NCT00332488|83035803|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
46815833|NCT00332488|83035804|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
46815834|NCT00332488|83035802|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
46815835|NCT00332488|83035803|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
46815836|NCT00332488|83035804|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
46815837|NCT00332488|83035802|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
46815838|NCT00332488|83035803|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
46815839|NCT00332488|83035804|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
46815840|NCT00332488|83035802|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
46815841|NCT00332488|83035803|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
46815842|NCT00332488|83035804|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
46815843|NCT00332488|83035802|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
46815844|NCT00332488|83035803|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
46815845|NCT00332488|83035804|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
46815846|NCT00332488|83035802|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
47055739|NCT01727141|83330116|FG002|Overall Study|Protocol deviation|0|||
47055740|NCT01727141|83330117|FG003|Overall Study|Protocol deviation|1|||
46815847|NCT00332488|83035803|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
46815848|NCT00332488|83035804|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
46815849|NCT00332488|83035802|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
46815850|NCT00332488|83035803|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
46815851|NCT00332488|83035804|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
46929944|NCT02598388|83164934|FG009|Overall Study|Withdrawal by Subject|1|||
46929945|NCT02598388|83164935|FG010|Overall Study|Withdrawal by Subject|0|||
46815852|NCT00332488|83035802|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
46815853|NCT00332488|83035803|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
46815854|NCT00332488|83035804|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
46815855|NCT00332488|83035802|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
46815856|NCT00332488|83035803|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
46815857|NCT00332488|83035804|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
46929946|NCT02598388|83164936|FG011|Overall Study|Withdrawal by Subject|0|||
46929947|NCT02598388|83164925|FG000|Overall Study|Other|0|||
46929948|NCT02598388|83164926|FG001|Overall Study|Other|0|||
46929949|NCT02598388|83164927|FG002|Overall Study|Other|1|||
46815858|NCT00332488|83035802|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
46815859|NCT00332488|83035803|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
46815860|NCT00332488|83035804|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
46815861|NCT00332332|83035814|FG000|Overall Study|Adverse Event|13|||
46815862|NCT00332332|83035814|FG000|Overall Study|Death|1|||
46815863|NCT00332332|83035814|FG000|Overall Study|Withdrawal by Subject|8|||
46929950|NCT02598388|83164928|FG003|Overall Study|Other|0|||
46929951|NCT02598388|83164929|FG004|Overall Study|Other|3|||
46929952|NCT02598388|83164930|FG005|Overall Study|Other|0|||
46929953|NCT02598388|83164931|FG006|Overall Study|Other|1|||
46929954|NCT02598388|83164932|FG007|Overall Study|Other|0|||
46815864|NCT00332332|83035814|FG000|Overall Study|Physician Decision|1|||
46815865|NCT00332332|83035814|FG000|Overall Study|Lost to Follow-up|3|||
46815866|NCT00332332|83035814|FG000|Overall Study|Protocol deviation|4|||
46815867|NCT00332332|83035814|FG000|Overall Study|Noncompliance|2|||
46815868|NCT00332332|83035814|FG000|Overall Study|Disease progression|2|||
46815869|NCT00332332|83035814|FG000|Overall Study|Other|18|||
46815870|NCT00332332|83035814|FG000|Overall Study|Did not receive study treatment|16|||
46815871|NCT00392925|83035822|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
46815872|NCT00392925|83035823|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
46815873|NCT00392925|83035824|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
46815874|NCT00392925|83035825|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
46815875|NCT00392925|83035822|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
46815876|NCT00392925|83035823|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
46815877|NCT00392925|83035824|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
46815878|NCT00392925|83035825|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
46815879|NCT00392925|83035822|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
46815880|NCT00392925|83035823|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
46815881|NCT00392925|83035824|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
46815882|NCT00392925|83035825|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
46815883|NCT00392925|83035822|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
46815884|NCT00392925|83035823|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
46815885|NCT00392925|83035824|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
46815886|NCT00392925|83035825|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
46815887|NCT00392925|83035822|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
46815888|NCT00392925|83035823|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
46815889|NCT00392925|83035824|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
46815890|NCT00392925|83035825|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
46815891|NCT00392925|83035822|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
46815892|NCT00392925|83035823|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
46815893|NCT00392925|83035824|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
46815894|NCT00392925|83035825|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
46815895|NCT00392925|83035822|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
46815896|NCT00392925|83035823|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
46815897|NCT00392925|83035824|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
46815898|NCT00392925|83035825|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
46815899|NCT00392925|83035822|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
46815900|NCT00392925|83035823|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
46815901|NCT00392925|83035824|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
46815902|NCT00392925|83035825|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
46929955|NCT02598388|83164933|FG008|Overall Study|Other|0|||
47055741|NCT01727141|83330114|FG000|Overall Study|Withdrawal by Subject|4|||
47055742|NCT01727141|83330115|FG001|Overall Study|Withdrawal by Subject|4|||
47055743|NCT01727141|83330116|FG002|Overall Study|Withdrawal by Subject|2|||
46815903|NCT00392925|83035822|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
46815904|NCT00392925|83035823|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
46929956|NCT02598388|83164934|FG009|Overall Study|Other|0|||
46929957|NCT02598388|83164935|FG010|Overall Study|Other|0|||
47055744|NCT01727141|83330117|FG003|Overall Study|Withdrawal by Subject|11|||
46815905|NCT00392925|83035824|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
46815906|NCT00392925|83035825|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
46815907|NCT00474786|83035843|FG000|Overall Study|Not Meeting Study Criteria|0|||
46636606|NCT01509846|82810406|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
46636607|NCT01509846|82810407|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
46636608|NCT01509846|82810408|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
46815908|NCT00474786|83035844|FG001|Overall Study|Not Meeting Study Criteria|1|||
46815909|NCT00474786|83035843|FG000|Overall Study|Investigator Request|2|||
46815910|NCT00474786|83035844|FG001|Overall Study|Investigator Request|1|||
46815911|NCT00474786|83035843|FG000|Overall Study|Death|189|||
46815912|NCT00474786|83035844|FG001|Overall Study|Death|170|||
46815913|NCT00474786|83035843|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
46815914|NCT00474786|83035844|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
46815915|NCT00474786|83035843|FG000|Overall Study|Lost to Follow-up|4|||
46815916|NCT00474786|83035844|FG001|Overall Study|Lost to Follow-up|7|||
46815917|NCT00474786|83035843|FG000|Overall Study|Protocol Violation|2|||
46815918|NCT00474786|83035844|FG001|Overall Study|Protocol Violation|0|||
46815919|NCT00474786|83035843|FG000|Overall Study|Withdrawal by Subject|15|||
46815920|NCT00474786|83035844|FG001|Overall Study|Withdrawal by Subject|15|||
46815921|NCT00474786|83035843|FG000|Overall Study|Other|5|||
46815922|NCT00474786|83035844|FG001|Overall Study|Other|0|||
46815923|NCT00392769|83035850|FG000|Overall Study|Clinical Deterioration|9|||
46815924|NCT00392769|83035850|FG000|Overall Study|Adverse Event|1|||
46815925|NCT00319696|83035854|FG000|Overall Study|Adverse Event|36|||
46815926|NCT00319696|83035854|FG000|Overall Study|withdrawal of consent|14|||
46815927|NCT00319696|83035854|FG000|Overall Study|administrative|7|||
46815928|NCT00319696|83035854|FG000|Overall Study|Lost to Follow-up|3|||
46815929|NCT00474630|83035866|FG000|Overall Study|Adverse Event|98|||
46815930|NCT00474630|83035867|FG001|Overall Study|Adverse Event|26|||
46815931|NCT00474630|83035866|FG000|Overall Study|Lost to Follow-up|22|||
46815932|NCT00474630|83035867|FG001|Overall Study|Lost to Follow-up|15|||
46815933|NCT00474630|83035866|FG000|Overall Study|Withdrawal by Subject|21|||
46929958|NCT02598388|83164936|FG011|Overall Study|Other|0|||
46929959|NCT00835692|83164976|FG000|First Intervention|Withdrawal by Subject|1|||
46929960|NCT00835692|83164977|FG001|First Intervention|Withdrawal by Subject|0|||
46929961|NCT00835536|83164990|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
46929962|NCT00835536|83164991|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
46929963|NCT03865316|83164995|FG000|Overall Study|Procedure Cancelled|4|||
46929964|NCT03865316|83164995|FG000|Overall Study|Equipment failure|4|||
46929965|NCT02598076|83165001|FG000|Overall Study|Lost to Follow-up|2|||
46929966|NCT02598076|83165002|FG001|Overall Study|Lost to Follow-up|3|||
46929967|NCT02602288|83165010|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
46929968|NCT02602288|83165011|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
46929969|NCT02602288|83165010|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
46929970|NCT02602288|83165011|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
46929971|NCT02602288|83165010|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
46929972|NCT02602288|83165011|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
46929973|NCT02602288|83165010|FG000|12 Month Follow-up|Lost to Follow-up|0|||
46815934|NCT00474630|83035867|FG001|Overall Study|Withdrawal by Subject|15|||
46929974|NCT02602288|83165011|FG001|12 Month Follow-up|Lost to Follow-up|4|||
46929975|NCT02602288|83165010|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
46929976|NCT02602288|83165011|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
46929977|NCT02601820|83165017|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
46929978|NCT02601820|83165017|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
46929979|NCT02601820|83165017|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
46636609|NCT01509846|82810404|FG000|Received Vaccination 3|Pregnancy|0|||
46636610|NCT01509846|82810405|FG001|Received Vaccination 3|Pregnancy|0|||
46636611|NCT01509846|82810406|FG002|Received Vaccination 3|Pregnancy|0|||
46636612|NCT01509846|82810407|FG003|Received Vaccination 3|Pregnancy|1|||
46636613|NCT01509846|82810408|FG004|Received Vaccination 3|Pregnancy|0|||
46636614|NCT01509846|82810404|FG000|Received Vaccination 3|Lost to Follow-up|0|||
46636615|NCT01509846|82810405|FG001|Received Vaccination 3|Lost to Follow-up|0|||
46815935|NCT00474630|83035866|FG000|Overall Study|Protocol Violation|3|||
46815936|NCT00474630|83035867|FG001|Overall Study|Protocol Violation|4|||
46815937|NCT00474630|83035866|FG000|Overall Study|Lack of Efficacy|5|||
46815938|NCT00474630|83035867|FG001|Overall Study|Lack of Efficacy|6|||
46815939|NCT00474630|83035866|FG000|Overall Study|Drug noncompliance, other|11|||
46815940|NCT00474630|83035867|FG001|Overall Study|Drug noncompliance, other|4|||
46815941|NCT00392379|83035876|FG000|Overall Study|Withdrawal by Subject|17|||
46929980|NCT02601820|83165017|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
46929981|NCT02807454|83165036|FG000|Overall Study|Adverse Event|1|||
46815942|NCT00392379|83035877|FG001|Overall Study|Withdrawal by Subject|28|||
46929982|NCT02807454|83165037|FG001|Overall Study|Adverse Event|0|||
46929983|NCT02807454|83165036|FG000|Overall Study|Withdrawal by Subject|0|||
46929984|NCT02807454|83165037|FG001|Overall Study|Withdrawal by Subject|1|||
46929985|NCT02807454|83165036|FG000|Overall Study|Progressive Disease|30|||
46929986|NCT02807454|83165037|FG001|Overall Study|Progressive Disease|3|||
46929987|NCT02807454|83165036|FG000|Overall Study|Other Reasons|1|||
46929988|NCT02807454|83165037|FG001|Overall Study|Other Reasons|1|||
46929989|NCT02597920|83165052|FG000|Overall Study|Worsening of other pre-existing disease|0|||
46929990|NCT02597920|83165053|FG001|Overall Study|Worsening of other pre-existing disease|1|||
46929991|NCT02597920|83165054|FG002|Overall Study|Worsening of other pre-existing disease|0|||
46929992|NCT02597920|83165052|FG000|Overall Study|Other adverse event|20|||
46929993|NCT02597920|83165053|FG001|Overall Study|Other adverse event|30|||
46929994|NCT02597920|83165054|FG002|Overall Study|Other adverse event|0|||
46929995|NCT02597920|83165052|FG000|Overall Study|Lost to Follow-up|7|||
46929996|NCT02597920|83165053|FG001|Overall Study|Lost to Follow-up|9|||
46929997|NCT02597920|83165054|FG002|Overall Study|Lost to Follow-up|0|||
46929998|NCT02597920|83165052|FG000|Overall Study|Refuse to continue in the study|3|||
46929999|NCT02597920|83165053|FG001|Overall Study|Refuse to continue in the study|13|||
46930000|NCT02597920|83165054|FG002|Overall Study|Refuse to continue in the study|1|||
46930001|NCT02597920|83165052|FG000|Overall Study|Other than specified|10|||
46930002|NCT02597920|83165053|FG001|Overall Study|Other than specified|31|||
46930003|NCT02597920|83165054|FG002|Overall Study|Other than specified|5|||
46930004|NCT02597920|83165052|FG000|Overall Study|Other|1|||
46930005|NCT02597920|83165053|FG001|Overall Study|Other|0|||
46815943|NCT00392379|83035876|FG000|Overall Study|Lost to Follow-up|4|||
46815944|NCT00392379|83035877|FG001|Overall Study|Lost to Follow-up|9|||
46815945|NCT00392379|83035876|FG000|Overall Study|Adverse Event|1|||
46815946|NCT00392379|83035877|FG001|Overall Study|Adverse Event|1|||
46815947|NCT00497874|83035885|FG000|Overall Study|Withdrawal by Subject|48|||
46815948|NCT00497874|83035886|FG001|Overall Study|Withdrawal by Subject|17|||
46757065|NCT00856830|82975123|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
46757066|NCT00522301|82975128|FG000|Overall Study|Withdrawal by Subject|1|||
46757067|NCT00522301|82975128|FG000|Overall Study|Adverse Event|5|||
46757068|NCT00863928|82975134|FG000|Overall Study|Protocol Violation|26|||
46757069|NCT00863928|82975135|FG001|Overall Study|Protocol Violation|0|||
46757070|NCT00863928|82975134|FG000|Overall Study|Withdrawal by Subject|3|||
46757071|NCT00863928|82975135|FG001|Overall Study|Withdrawal by Subject|0|||
47055745|NCT01726517|83330141|FG000|Overall Study|Withdrawal by Subject|0|||
46815949|NCT00497874|83035885|FG000|Overall Study|Illness|8|||
46930006|NCT02597920|83165054|FG002|Overall Study|Other|0|||
46930007|NCT01235234|83165074|FG000|Overall Study|Adverse Event|2|||
46930008|NCT01235234|83165075|FG001|Overall Study|Adverse Event|2|||
46930009|NCT01235234|83165076|FG002|Overall Study|Adverse Event|1|||
46930010|NCT02597452|83165091|FG000|Overall Study|testing incomplete|30|||
46930011|NCT00834756|83165097|FG000|First Intervention|Adverse Event|1|||
46930012|NCT00834756|83165098|FG001|First Intervention|Adverse Event|0|||
46930013|NCT00834756|83165097|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
46930014|NCT00834756|83165098|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
46930015|NCT00828854|83165102|FG000|Overall Study|Disease Progression|17|||
46930016|NCT00828854|83165102|FG000|Overall Study|Adverse Event|9|||
46930017|NCT00828854|83165102|FG000|Overall Study|Reason not Specified|1|||
46930018|NCT00834522|83165108|FG000|Washout|Adverse Event|1|||
46757072|NCT00863928|82975134|FG000|Overall Study|surgery cancellation|4|||
46757073|NCT00863928|82975135|FG001|Overall Study|surgery cancellation|0|||
46757074|NCT00863928|82975134|FG000|Overall Study|medication allergy|3|||
46815950|NCT00497874|83035886|FG001|Overall Study|Illness|4|||
46815951|NCT00497874|83035885|FG000|Overall Study|Death|2|||
46930019|NCT00834522|83165109|FG001|Washout|Adverse Event|0|||
46930020|NCT00834522|83165108|FG000|Washout|Withdrawal by Subject|2|||
46930021|NCT00834522|83165109|FG001|Washout|Withdrawal by Subject|1|||
46815952|NCT00497874|83035886|FG001|Overall Study|Death|4|||
46815953|NCT00497874|83035885|FG000|Overall Study|Unable to contact|52|||
46815954|NCT00497874|83035886|FG001|Overall Study|Unable to contact|67|||
46815955|NCT00497874|83035885|FG000|Overall Study|Unable to schedule|37|||
46815956|NCT00497874|83035886|FG001|Overall Study|Unable to schedule|24|||
46930022|NCT00834444|83165115|FG000|First Intervention|Adverse Event|1|||
46930023|NCT00834444|83165116|FG001|First Intervention|Adverse Event|0|||
46930024|NCT00834444|83165115|FG000|First Intervention|Intolerance to Venopuncture|0|||
46930025|NCT00834444|83165116|FG001|First Intervention|Intolerance to Venopuncture|1|||
46930026|NCT00834444|83165115|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
46930027|NCT00834444|83165116|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
47055746|NCT01726517|83330142|FG001|Overall Study|Withdrawal by Subject|0|||
47055747|NCT01726517|83330143|FG002|Overall Study|Withdrawal by Subject|1|||
46930028|NCT00834444|83165115|FG000|Second Intervention|Adverse Event|1|||
46930029|NCT00834444|83165116|FG001|Second Intervention|Adverse Event|0|||
46930030|NCT02605954|83165136|FG000|Overall Study|Adverse Event|5|||
46930031|NCT02605954|83165137|FG001|Overall Study|Adverse Event|1|||
46815957|NCT00403455|83035894|FG000|Overall Study|Withdrawal by Subject|1|||
46930032|NCT02605954|83165136|FG000|Overall Study|Investigator's Discretion|1|||
46930033|NCT02605954|83165137|FG001|Overall Study|Investigator's Discretion|0|||
46930034|NCT02605954|83165136|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46930035|NCT02605954|83165137|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46930036|NCT02605954|83165136|FG000|Overall Study|Withdrew Consent|2|||
46930037|NCT02605954|83165137|FG001|Overall Study|Withdrew Consent|2|||
46930038|NCT02605954|83165136|FG000|Overall Study|Lost to Follow-up|3|||
46930039|NCT02605954|83165137|FG001|Overall Study|Lost to Follow-up|0|||
46930040|NCT02605954|83165136|FG000|Overall Study|Randomized but not treated|0|||
46930041|NCT02605954|83165137|FG001|Overall Study|Randomized but not treated|1|||
46930042|NCT00724698|83165146|FG000|Overall Study|Adverse Event|9|||
46930043|NCT00724698|83165146|FG000|Overall Study|Failure of Therapy|4|||
46930044|NCT00724698|83165146|FG000|Overall Study|Poor Compliance|16|||
46930045|NCT00724698|83165146|FG000|Overall Study|Lost to Follow-up|36|||
46930046|NCT00724698|83165146|FG000|Overall Study|No Info|25|||
46930047|NCT00829998|83165151|FG000|Washout|Adverse Event|0|||
46930048|NCT00829998|83165152|FG001|Washout|Adverse Event|1|||
46930049|NCT00829764|83165163|FG000|First Intervention|Adverse Event|1|||
46930050|NCT00829764|83165164|FG001|First Intervention|Adverse Event|0|||
46930051|NCT00829764|83165163|FG000|First Intervention|Withdrawal by Subject|1|||
46930052|NCT00829764|83165164|FG001|First Intervention|Withdrawal by Subject|1|||
46930053|NCT00829530|83165186|FG000|First Intervention|Adverse Event|0|||
46930054|NCT00829530|83165187|FG001|First Intervention|Adverse Event|1|||
46930055|NCT00829530|83165186|FG000|First Intervention|Intolerance to Venopuncture|0|||
46930056|NCT00829530|83165187|FG001|First Intervention|Intolerance to Venopuncture|1|||
46930057|NCT00829530|83165186|FG000|Second Intervention|Intolerance to Venopuncture|1|||
46930058|NCT00829530|83165187|FG001|Second Intervention|Intolerance to Venopuncture|0|||
46930059|NCT01377194|83165194|FG000|Overall Study|Adverse Event|3|||
46930060|NCT01377194|83165195|FG001|Overall Study|Adverse Event|12|||
46930061|NCT01377194|83165196|FG002|Overall Study|Adverse Event|19|||
46930062|NCT01377194|83165194|FG000|Overall Study|Lack of Efficacy|3|||
46930063|NCT01377194|83165195|FG001|Overall Study|Lack of Efficacy|3|||
46930064|NCT01377194|83165196|FG002|Overall Study|Lack of Efficacy|3|||
46930065|NCT01377194|83165194|FG000|Overall Study|Protocol Violation|4|||
46930066|NCT01377194|83165195|FG001|Overall Study|Protocol Violation|10|||
46930067|NCT01377194|83165196|FG002|Overall Study|Protocol Violation|6|||
46930068|NCT01377194|83165194|FG000|Overall Study|Withdrawal by Subject|8|||
46930069|NCT01377194|83165195|FG001|Overall Study|Withdrawal by Subject|10|||
46930070|NCT01377194|83165196|FG002|Overall Study|Withdrawal by Subject|7|||
46930071|NCT01377194|83165194|FG000|Overall Study|Lost to Follow-up|14|||
46930072|NCT01377194|83165195|FG001|Overall Study|Lost to Follow-up|8|||
46930073|NCT01377194|83165196|FG002|Overall Study|Lost to Follow-up|11|||
46930074|NCT00829452|83165209|FG000|First Intervention|Withdrawal by Subject|0|||
46930075|NCT00829452|83165210|FG001|First Intervention|Withdrawal by Subject|1|||
46930076|NCT00829452|83165209|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
46930077|NCT00829452|83165210|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
46930078|NCT00829452|83165209|FG000|Second Intervention|Physician Decision|0|||
46930079|NCT00829452|83165210|FG001|Second Intervention|Physician Decision|1|||
46930080|NCT04600076|83165214|FG000|Overall Study|Lost to Follow-up|3|||
46930081|NCT02064387|83165230|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930082|NCT02064387|83165231|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930083|NCT02064387|83165232|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930084|NCT02064387|83165233|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930085|NCT02064387|83165234|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930086|NCT02064387|83165235|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930087|NCT02064387|83165236|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930088|NCT02064387|83165237|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
46757075|NCT00863928|82975135|FG001|Overall Study|medication allergy|0|||
46757076|NCT00856518|82975143|FG000|Overall Study|Lost to Follow-up|4|||
46757077|NCT00856518|82975144|FG001|Overall Study|Lost to Follow-up|2|||
46757078|NCT00506389|82975155|FG000|In-treatment Period|Other|3|||
46757079|NCT00506389|82975156|FG001|In-treatment Period|Other|3|||
46757080|NCT00506389|82975157|FG002|In-treatment Period|Other|4|||
46930089|NCT02064387|83165238|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930090|NCT02064387|83165239|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
46930091|NCT02064387|83165240|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930092|NCT02064387|83165241|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
46930093|NCT02064387|83165230|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930094|NCT02064387|83165231|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930095|NCT02064387|83165232|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930096|NCT02064387|83165233|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46757081|NCT00506389|82975155|FG000|In-treatment Period|Lost to Follow-up|0|||
46757082|NCT00506389|82975156|FG001|In-treatment Period|Lost to Follow-up|0|||
46757083|NCT00506389|82975157|FG002|In-treatment Period|Lost to Follow-up|1|||
46757084|NCT00506389|82975155|FG000|In-treatment Period|Lack of compliance|1|||
46815958|NCT00318370|83035898|FG000|Period 1|Lack of Efficacy|5|||
46815959|NCT00318370|83035899|FG001|Period 1|Lack of Efficacy|0|||
46815960|NCT00318370|83035900|FG002|Period 1|Lack of Efficacy|0|||
46815961|NCT00318370|83035898|FG000|Period 1|Physician Decision|1|||
46815962|NCT00318370|83035899|FG001|Period 1|Physician Decision|0|||
46815963|NCT00318370|83035900|FG002|Period 1|Physician Decision|0|||
46815964|NCT00318370|83035898|FG000|Period 1|Withdrawal by Subject|1|||
46815965|NCT00318370|83035899|FG001|Period 1|Withdrawal by Subject|0|||
46815966|NCT00318370|83035900|FG002|Period 1|Withdrawal by Subject|0|||
46815967|NCT00318370|83035898|FG000|Period 2|Adverse Event|0|||
46815968|NCT00318370|83035899|FG001|Period 2|Adverse Event|3|||
46815969|NCT00318370|83035900|FG002|Period 2|Adverse Event|0|||
46815970|NCT00318370|83035898|FG000|Period 2|Lack of Efficacy|0|||
46815971|NCT00318370|83035899|FG001|Period 2|Lack of Efficacy|5|||
46815972|NCT00318370|83035900|FG002|Period 2|Lack of Efficacy|0|||
46815973|NCT00318370|83035898|FG000|Period 2|Physician Decision|0|||
46815974|NCT00318370|83035899|FG001|Period 2|Physician Decision|1|||
46815975|NCT00318370|83035900|FG002|Period 2|Physician Decision|0|||
46815976|NCT00318370|83035898|FG000|Period 2|Withdrawal by Subject|0|||
46815977|NCT00318370|83035899|FG001|Period 2|Withdrawal by Subject|1|||
46815978|NCT00318370|83035900|FG002|Period 2|Withdrawal by Subject|0|||
46815979|NCT00318370|83035898|FG000|Period 2|Other|0|||
46815980|NCT00318370|83035899|FG001|Period 2|Other|1|||
46815981|NCT00318370|83035900|FG002|Period 2|Other|0|||
46815982|NCT00318370|83035898|FG000|Period 3|Adverse Event|0|||
46815983|NCT00318370|83035899|FG001|Period 3|Adverse Event|0|||
46815984|NCT00318370|83035900|FG002|Period 3|Adverse Event|1|||
46815985|NCT00318370|83035898|FG000|Period 3|Lack of Efficacy|0|||
46815986|NCT00318370|83035899|FG001|Period 3|Lack of Efficacy|0|||
46815987|NCT00318370|83035900|FG002|Period 3|Lack of Efficacy|24|||
46815988|NCT00318370|83035898|FG000|Period 3|Death|0|||
46815989|NCT00318370|83035899|FG001|Period 3|Death|0|||
46815990|NCT00318370|83035900|FG002|Period 3|Death|1|||
46815991|NCT00318370|83035898|FG000|Period 3|Physician Decision|0|||
46815992|NCT00318370|83035899|FG001|Period 3|Physician Decision|0|||
46815993|NCT00318370|83035900|FG002|Period 3|Physician Decision|1|||
46815994|NCT00318370|83035898|FG000|Period 3|Withdrawal by Subject|0|||
46815995|NCT00318370|83035899|FG001|Period 3|Withdrawal by Subject|0|||
46815996|NCT00318370|83035900|FG002|Period 3|Withdrawal by Subject|3|||
46815997|NCT00318370|83035898|FG000|Period 3|Other|0|||
46815998|NCT00318370|83035899|FG001|Period 3|Other|0|||
46815999|NCT00318370|83035900|FG002|Period 3|Other|3|||
46816000|NCT00510068|83035908|FG000|Double-blind Period|Disease progression|98|||
46816001|NCT00510068|83035909|FG001|Double-blind Period|Disease progression|169|||
46816002|NCT00510068|83035908|FG000|Double-blind Period|Final primary analysis|52|||
46816003|NCT00510068|83035909|FG001|Double-blind Period|Final primary analysis|18|||
46816004|NCT00510068|83035908|FG000|Double-blind Period|Adverse Event|37|||
46816005|NCT00510068|83035909|FG001|Double-blind Period|Adverse Event|7|||
46816006|NCT00510068|83035908|FG000|Double-blind Period|Withdrawal by Subject|8|||
47055748|NCT01726517|83330144|FG003|Overall Study|Withdrawal by Subject|0|||
46757085|NCT00506389|82975156|FG001|In-treatment Period|Lack of compliance|0|||
46757086|NCT00506389|82975157|FG002|In-treatment Period|Lack of compliance|0|||
46757087|NCT00506389|82975155|FG000|In-treatment Period|Reasons not related to trial|4|||
46757088|NCT00506389|82975156|FG001|In-treatment Period|Reasons not related to trial|1|||
46757089|NCT00506389|82975157|FG002|In-treatment Period|Reasons not related to trial|0|||
46757090|NCT00506389|82975155|FG000|In-treatment Period|Withdrawal by Subject|3|||
46757091|NCT00506389|82975156|FG001|In-treatment Period|Withdrawal by Subject|3|||
46757092|NCT00506389|82975157|FG002|In-treatment Period|Withdrawal by Subject|4|||
46816007|NCT00510068|83035909|FG001|Double-blind Period|Withdrawal by Subject|6|||
46816008|NCT00510068|83035908|FG000|Double-blind Period|Death|4|||
46816009|NCT00510068|83035909|FG001|Double-blind Period|Death|3|||
46757093|NCT00506389|82975155|FG000|In-treatment Period|Lack of Efficacy|0|||
46757094|NCT00506389|82975156|FG001|In-treatment Period|Lack of Efficacy|2|||
46816010|NCT00510068|83035908|FG000|Double-blind Period|Abnormal test result (s)|1|||
46816011|NCT00510068|83035909|FG001|Double-blind Period|Abnormal test result (s)|0|||
46816012|NCT00510068|83035908|FG000|Double-blind Period|Lost to Follow-up|1|||
46816013|NCT00510068|83035909|FG001|Double-blind Period|Lost to Follow-up|0|||
46816014|NCT00510068|83035908|FG000|Double-blind Period|Protocol Violation|6|||
46816015|NCT00510068|83035909|FG001|Double-blind Period|Protocol Violation|0|||
46816016|NCT00510068|83035908|FG000|Open-label Period|Disease Progression|124|||
46816017|NCT00510068|83035909|FG001|Open-label Period|Disease Progression|0|||
46816018|NCT00510068|83035908|FG000|Open-label Period|Adverse Event|46|||
46816019|NCT00510068|83035909|FG001|Open-label Period|Adverse Event|0|||
46816020|NCT00510068|83035908|FG000|Open-label Period|Withdrawal by Subject|21|||
46816021|NCT00510068|83035909|FG001|Open-label Period|Withdrawal by Subject|0|||
46816022|NCT00510068|83035908|FG000|Open-label Period|Administrative problems|17|||
46816023|NCT00510068|83035909|FG001|Open-label Period|Administrative problems|0|||
46816024|NCT00510068|83035908|FG000|Open-label Period|Death|7|||
46930097|NCT02064387|83165234|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46816025|NCT00510068|83035909|FG001|Open-label Period|Death|0|||
46816026|NCT00510068|83035908|FG000|Open-label Period|New cancer therapy|7|||
46757095|NCT00506389|82975157|FG002|In-treatment Period|Lack of Efficacy|0|||
46930098|NCT02064387|83165235|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930099|NCT02064387|83165236|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930100|NCT02064387|83165237|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
46930101|NCT02064387|83165238|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930102|NCT02064387|83165239|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
47055749|NCT01726517|83330145|FG004|Overall Study|Withdrawal by Subject|0|||
47055750|NCT01752023|83330159|FG000|Overall Study|Physician Decision|2|||
47055751|NCT01752023|83330160|FG001|Overall Study|Physician Decision|1|||
47055752|NCT01726049|83330172|FG000|Overall Study|Death|1|||
47055753|NCT01726049|83330173|FG001|Overall Study|Death|1|||
47055754|NCT01726049|83330172|FG000|Overall Study|Adverse Event|4|||
47055755|NCT01726049|83330173|FG001|Overall Study|Adverse Event|1|||
47055756|NCT01726049|83330172|FG000|Overall Study|refused second HC|0|||
47055757|NCT01726049|83330173|FG001|Overall Study|refused second HC|2|||
47055758|NCT01605617|83330194|FG000|First Intervention|Adverse Event|0|||
47055759|NCT01605617|83330195|FG001|First Intervention|Adverse Event|1|||
47055760|NCT01605617|83330194|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
46757096|NCT00506389|82975155|FG000|In-treatment Period|Adverse Event|11|||
46757097|NCT00506389|82975156|FG001|In-treatment Period|Adverse Event|5|||
46757098|NCT00506389|82975157|FG002|In-treatment Period|Adverse Event|2|||
46757099|NCT00506389|82975155|FG000|In-treatment Period|Randomized but not treated|4|||
46757100|NCT00506389|82975156|FG001|In-treatment Period|Randomized but not treated|1|||
46757101|NCT00506389|82975157|FG002|In-treatment Period|Randomized but not treated|1|||
46757102|NCT00871338|82975170|FG000|Prior to Booster|Withdrawal by Subject|1|||
46757103|NCT00871338|82975171|FG001|Prior to Booster|Withdrawal by Subject|3|||
46757104|NCT00871338|82975170|FG000|Prior to Booster|Lost to Follow-up|1|||
46757105|NCT00871338|82975171|FG001|Prior to Booster|Lost to Follow-up|0|||
46757106|NCT00824421|82975180|FG000|Overall Study|Adverse Event|6|||
46757107|NCT00824421|82975181|FG001|Overall Study|Adverse Event|6|||
46757108|NCT00824421|82975182|FG002|Overall Study|Adverse Event|6|||
46757109|NCT00824421|82975180|FG000|Overall Study|Death|0|||
46757110|NCT00824421|82975181|FG001|Overall Study|Death|1|||
46757111|NCT00824421|82975182|FG002|Overall Study|Death|0|||
46757112|NCT00824421|82975180|FG000|Overall Study|Lack of Efficacy|5|||
46757113|NCT00824421|82975181|FG001|Overall Study|Lack of Efficacy|7|||
46757114|NCT00824421|82975182|FG002|Overall Study|Lack of Efficacy|4|||
46757115|NCT00824421|82975180|FG000|Overall Study|Lost to Follow-up|2|||
46757116|NCT00824421|82975181|FG001|Overall Study|Lost to Follow-up|3|||
46757117|NCT00824421|82975182|FG002|Overall Study|Lost to Follow-up|0|||
46757118|NCT00824421|82975180|FG000|Overall Study|Pregnancy|1|||
46757119|NCT00824421|82975181|FG001|Overall Study|Pregnancy|0|||
46757120|NCT00824421|82975182|FG002|Overall Study|Pregnancy|1|||
46757121|NCT00824421|82975180|FG000|Overall Study|Withdrawal by Subject|2|||
46757122|NCT00824421|82975181|FG001|Overall Study|Withdrawal by Subject|3|||
46757123|NCT00824421|82975182|FG002|Overall Study|Withdrawal by Subject|3|||
46757124|NCT00824421|82975180|FG000|Overall Study|Randomized but not Treated|1|||
46757125|NCT00824421|82975181|FG001|Overall Study|Randomized but not Treated|1|||
46757126|NCT00824421|82975182|FG002|Overall Study|Randomized but not Treated|0|||
46757127|NCT00824421|82975180|FG000|Overall Study|Other|0|||
46757128|NCT00824421|82975181|FG001|Overall Study|Other|1|||
46757129|NCT00824421|82975182|FG002|Overall Study|Other|0|||
46816027|NCT00510068|83035909|FG001|Open-label Period|New cancer therapy|0|||
47055761|NCT01605617|83330195|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
47055762|NCT01751867|83330212|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
46757130|NCT00514813|82975196|FG000|Overall Study|Study terminated|14|||
46757131|NCT00514813|82975197|FG001|Overall Study|Study terminated|74|||
46757132|NCT00514813|82975198|FG002|Overall Study|Study terminated|40|||
46757133|NCT00514813|82975199|FG003|Overall Study|Study terminated|2|||
46757134|NCT00514813|82975196|FG000|Overall Study|Adverse Event|0|||
46757135|NCT00514813|82975197|FG001|Overall Study|Adverse Event|2|||
46757136|NCT00514813|82975198|FG002|Overall Study|Adverse Event|2|||
46757137|NCT00514813|82975199|FG003|Overall Study|Adverse Event|0|||
46757138|NCT00514813|82975196|FG000|Overall Study|Protocol Violation|1|||
46757139|NCT00514813|82975197|FG001|Overall Study|Protocol Violation|0|||
46757140|NCT00514813|82975198|FG002|Overall Study|Protocol Violation|0|||
46757141|NCT00514813|82975199|FG003|Overall Study|Protocol Violation|0|||
46757142|NCT00514813|82975196|FG000|Overall Study|Withdrawal by Subject|0|||
46757143|NCT00514813|82975197|FG001|Overall Study|Withdrawal by Subject|1|||
46816028|NCT00510068|83035908|FG000|Open-label Period|Protocol Violation|2|||
46757144|NCT00514813|82975198|FG002|Overall Study|Withdrawal by Subject|0|||
46757145|NCT00514813|82975199|FG003|Overall Study|Withdrawal by Subject|0|||
46757146|NCT00514813|82975196|FG000|Overall Study|Lack of Efficacy|0|||
46757147|NCT00514813|82975197|FG001|Overall Study|Lack of Efficacy|1|||
46757148|NCT00514813|82975198|FG002|Overall Study|Lack of Efficacy|0|||
46757149|NCT00514813|82975199|FG003|Overall Study|Lack of Efficacy|0|||
46816029|NCT00510068|83035909|FG001|Open-label Period|Protocol Violation|0|||
46816030|NCT00510068|83035908|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
46816031|NCT00510068|83035909|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
46816032|NCT00509600|83035917|FG000|Overall Study|Adverse Event|1|||
46816033|NCT00402987|83035925|FG000|Overall Study|Lack of Efficacy|0|||
46816034|NCT00402987|83035926|FG001|Overall Study|Lack of Efficacy|0|||
46816035|NCT00402987|83035927|FG002|Overall Study|Lack of Efficacy|1|||
46816036|NCT00402987|83035928|FG003|Overall Study|Lack of Efficacy|0|||
46816037|NCT00501644|83035952|FG000|Overall Study|Adverse Event|4|||
46816038|NCT00501644|83035952|FG000|Overall Study|Withdrawal by Subject|1|||
46930103|NCT02064387|83165240|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930104|NCT02064387|83165241|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
46930105|NCT02064387|83165230|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46930106|NCT02064387|83165231|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46757150|NCT00514813|82975196|FG000|Overall Study|Kidney transplant|0|||
46757151|NCT00514813|82975197|FG001|Overall Study|Kidney transplant|6|||
46757152|NCT00514813|82975198|FG002|Overall Study|Kidney transplant|2|||
46757153|NCT00514813|82975199|FG003|Overall Study|Kidney transplant|0|||
46757154|NCT00514813|82975196|FG000|Overall Study|Death|0|||
46757155|NCT00514813|82975197|FG001|Overall Study|Death|2|||
46757156|NCT00514813|82975198|FG002|Overall Study|Death|3|||
46757157|NCT00514813|82975199|FG003|Overall Study|Death|2|||
46757158|NCT00597116|82975211|FG000|Overall Study|Adverse Event|2|||
46757159|NCT00597116|82975212|FG001|Overall Study|Adverse Event|1|||
46757160|NCT00597116|82975211|FG000|Overall Study|Withdrawal by Subject|0|||
46757161|NCT00597116|82975212|FG001|Overall Study|Withdrawal by Subject|2|||
46757162|NCT00597116|82975211|FG000|Overall Study|Physician Decision|0|||
46757163|NCT00597116|82975212|FG001|Overall Study|Physician Decision|1|||
46757164|NCT00597116|82975211|FG000|Overall Study|Death|0|||
46757165|NCT00597116|82975212|FG001|Overall Study|Death|1|||
46757166|NCT00597116|82975211|FG000|Overall Study|Lost to Follow-up|1|||
46757167|NCT00597116|82975212|FG001|Overall Study|Lost to Follow-up|0|||
46757168|NCT00597116|82975211|FG000|Overall Study|Progressive disease|11|||
46757169|NCT00597116|82975212|FG001|Overall Study|Progressive disease|6|||
46757170|NCT00514735|82975220|FG000|Overall Study|Withdrawal by Subject|13|||
46757171|NCT00514735|82975221|FG001|Overall Study|Withdrawal by Subject|5|||
46757172|NCT00514735|82975220|FG000|Overall Study|Death|1|||
46757173|NCT00514735|82975221|FG001|Overall Study|Death|0|||
46757174|NCT00514735|82975220|FG000|Overall Study|Lost to Follow-up|0|||
46757175|NCT00514735|82975221|FG001|Overall Study|Lost to Follow-up|1|||
46757176|NCT03252587|82975233|FG000|Overall Study|Adverse Event|3|||
46757177|NCT03252587|82975234|FG001|Overall Study|Adverse Event|8|||
46757178|NCT03252587|82975235|FG002|Overall Study|Adverse Event|6|||
46757179|NCT03252587|82975236|FG003|Overall Study|Adverse Event|12|||
46757180|NCT03252587|82975233|FG000|Overall Study|Lack of Efficacy|7|||
46757181|NCT03252587|82975234|FG001|Overall Study|Lack of Efficacy|2|||
46757182|NCT03252587|82975235|FG002|Overall Study|Lack of Efficacy|2|||
46757183|NCT03252587|82975236|FG003|Overall Study|Lack of Efficacy|4|||
46757184|NCT03252587|82975233|FG000|Overall Study|Lost to Follow-up|2|||
46757185|NCT03252587|82975234|FG001|Overall Study|Lost to Follow-up|0|||
46757186|NCT03252587|82975235|FG002|Overall Study|Lost to Follow-up|0|||
46757187|NCT03252587|82975236|FG003|Overall Study|Lost to Follow-up|2|||
46757188|NCT03252587|82975233|FG000|Overall Study|Pregnancy|2|||
46757189|NCT03252587|82975234|FG001|Overall Study|Pregnancy|1|||
46757190|NCT03252587|82975235|FG002|Overall Study|Pregnancy|0|||
46757191|NCT03252587|82975236|FG003|Overall Study|Pregnancy|1|||
46757192|NCT03252587|82975233|FG000|Overall Study|Withdrawal by Subject|8|||
46757193|NCT03252587|82975234|FG001|Overall Study|Withdrawal by Subject|4|||
46757194|NCT03252587|82975235|FG002|Overall Study|Withdrawal by Subject|4|||
46757195|NCT03252587|82975236|FG003|Overall Study|Withdrawal by Subject|4|||
46757196|NCT03252587|82975233|FG000|Overall Study|Other Reasons|2|||
46757197|NCT03252587|82975234|FG001|Overall Study|Other Reasons|5|||
46757198|NCT03252587|82975235|FG002|Overall Study|Other Reasons|5|||
46757199|NCT03252587|82975236|FG003|Overall Study|Other Reasons|4|||
46757200|NCT00511147|82975249|FG000|Overall Study|Withdrawal by Subject|1|||
46757201|NCT00511147|82975249|FG000|Overall Study|Disease progression|5|||
46930107|NCT02064387|83165232|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46757202|NCT00511147|82975249|FG000|Overall Study|Required platelet transfusion|1|||
46757203|NCT00510835|82975256|FG000|Overall Study|Withdrawal by Subject|6|||
46757204|NCT00510835|82975257|FG001|Overall Study|Withdrawal by Subject|2|||
46816039|NCT00497796|83035958|FG000|Overall Study|Adverse event (not related)|9|||
46816040|NCT00497796|83035959|FG001|Overall Study|Adverse event (not related)|9|||
46757205|NCT00510835|82975258|FG002|Overall Study|Withdrawal by Subject|2|||
46757206|NCT00506077|82975268|FG000|Treatment Period 1|Adverse Event|2|||
46757207|NCT00506077|82975269|FG001|Treatment Period 1|Adverse Event|1|||
46757208|NCT00506077|82975268|FG000|Treatment Period 1|Lost to Follow-up|0|||
46757209|NCT00506077|82975269|FG001|Treatment Period 1|Lost to Follow-up|2|||
46816041|NCT00497796|83035958|FG000|Overall Study|Adverse event (related)|5|||
46816042|NCT00497796|83035959|FG001|Overall Study|Adverse event (related)|4|||
46816043|NCT00497796|83035958|FG000|Overall Study|CMV infection or disease treatment|30|||
46816044|NCT00497796|83035959|FG001|Overall Study|CMV infection or disease treatment|4|||
46816045|NCT00497796|83035958|FG000|Overall Study|Consent withdrawn|10|||
46816046|NCT00497796|83035959|FG001|Overall Study|Consent withdrawn|3|||
46816047|NCT00497796|83035958|FG000|Overall Study|Investigator/sponsor discretion|31|||
46816048|NCT00497796|83035959|FG001|Overall Study|Investigator/sponsor discretion|34|||
46816049|NCT00497796|83035958|FG000|Overall Study|Lost to Follow-up|0|||
46816050|NCT00497796|83035959|FG001|Overall Study|Lost to Follow-up|1|||
46816051|NCT00497796|83035958|FG000|Overall Study|Not applicable (randomized not treated)|0|||
46816052|NCT00497796|83035959|FG001|Overall Study|Not applicable (randomized not treated)|4|||
46816053|NCT00496782|83035967|FG000|Overall Study|Protocol Violation|1|||
46816054|NCT00496782|83035968|FG001|Overall Study|Protocol Violation|2|||
46816055|NCT00402831|83035976|FG000|Overall Study|Lost to Follow-up|1|||
46930108|NCT02064387|83165233|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46930109|NCT02064387|83165234|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46930110|NCT02064387|83165235|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46930111|NCT02064387|83165236|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46816056|NCT00402831|83035977|FG001|Overall Study|Lost to Follow-up|2|||
46816057|NCT00402831|83035976|FG000|Overall Study|Non-compliance with protocol|0|||
46816058|NCT00402831|83035977|FG001|Overall Study|Non-compliance with protocol|1|||
46816059|NCT00496626|83035987|FG000|Overall Study|Lost to Follow-up|0|||
46816060|NCT00496626|83035988|FG001|Overall Study|Lost to Follow-up|1|||
46816061|NCT00496626|83035987|FG000|Overall Study|Protocol Violation|1|||
46816062|NCT00496626|83035988|FG001|Overall Study|Protocol Violation|0|||
46816063|NCT00496626|83035987|FG000|Overall Study|Withdrawal by Subject|5|||
46930112|NCT02064387|83165237|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46930113|NCT02064387|83165238|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
46930114|NCT02064387|83165239|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46930115|NCT02064387|83165240|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46757210|NCT00506077|82975268|FG000|Treatment Period 1|Withdrawal by Subject|2|||
46757211|NCT00506077|82975269|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46816064|NCT00496626|83035988|FG001|Overall Study|Withdrawal by Subject|4|||
46816065|NCT00496626|83035987|FG000|Overall Study|Relocated|0|||
46816066|NCT00496626|83035988|FG001|Overall Study|Relocated|1|||
46816067|NCT00471822|83035998|FG000|Overall Study|Protocol Violation|2|||
46816068|NCT00471276|83036002|FG000|Overall Study|Death|2|||
46816069|NCT00471276|83036002|FG000|Overall Study|Adverse Event|16|||
46816070|NCT00471276|83036002|FG000|Overall Study|Protocol Violation|1|||
46816071|NCT00471276|83036002|FG000|Overall Study|Objective progression or relapse|54|||
46816072|NCT00471276|83036002|FG000|Overall Study|Global deterioration of health status|1|||
46816073|NCT00471276|83036002|FG000|Overall Study|Other|3|||
46816074|NCT00471276|83036002|FG000|Overall Study|Refused treatment|6|||
46816075|NCT00470262|83036008|FG000|Overall Study|Withdrawal by Subject|2|||
46816076|NCT00470262|83036009|FG001|Overall Study|Withdrawal by Subject|0|||
46816077|NCT00496470|83036018|FG000|Overall Study|Adverse Event|8|||
46816078|NCT00496470|83036019|FG001|Overall Study|Adverse Event|10|||
46816079|NCT00496470|83036018|FG000|Overall Study|Withdrawal by Subject|5|||
46816080|NCT00496470|83036019|FG001|Overall Study|Withdrawal by Subject|12|||
46816081|NCT00496470|83036018|FG000|Overall Study|Incorrectly enrolled|13|||
46757212|NCT00506077|82975268|FG000|Treatment Period 2|Adverse Event|0|||
46757213|NCT00506077|82975269|FG001|Treatment Period 2|Adverse Event|1|||
46757214|NCT00506077|82975268|FG000|Treatment Period 2|Withdrawal by Subject|1|||
46757215|NCT00506077|82975269|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46757216|NCT00505921|82975275|FG000|Overall Study|Ineligible|1|||
46757217|NCT00505921|82975275|FG000|Overall Study|Failed to Mobilize|8|||
46757218|NCT00596960|82975281|FG000|Overall Study|Death|1|||
46757219|NCT00596960|82975282|FG001|Overall Study|Death|2|||
46757220|NCT00596960|82975281|FG000|Overall Study|Lost to Follow-up|6|||
46757221|NCT00596960|82975282|FG001|Overall Study|Lost to Follow-up|5|||
46816082|NCT00496470|83036019|FG001|Overall Study|Incorrectly enrolled|5|||
46816083|NCT00496470|83036018|FG000|Overall Study|Other reason|0|||
46816084|NCT00496470|83036019|FG001|Overall Study|Other reason|2|||
46816085|NCT00496080|83036025|FG000|Overall Study|Lost to Follow-up|9|||
46816086|NCT00496080|83036025|FG000|Overall Study|Surgical re-intervention|7|||
46816087|NCT00496080|83036025|FG000|Overall Study|Withdrawal by Subject|5|||
46816088|NCT00496080|83036025|FG000|Overall Study|Physician Decision|6|||
46816089|NCT00487578|83036032|FG000|Overall Study|Adverse Event|1|||
46816090|NCT00487578|83036033|FG001|Overall Study|Adverse Event|2|||
46816091|NCT00487578|83036032|FG000|Overall Study|Lack of Efficacy|0|||
46816092|NCT00487578|83036033|FG001|Overall Study|Lack of Efficacy|1|||
46816093|NCT00487578|83036032|FG000|Overall Study|Lost to Follow-up|0|||
46816094|NCT00487578|83036033|FG001|Overall Study|Lost to Follow-up|1|||
46816095|NCT00495612|83036041|FG000|Overall Study|Lost to Follow-up|1|||
46757222|NCT00596960|82975281|FG000|Overall Study|Withdrawal by Subject|1|||
46816096|NCT00495612|83036042|FG001|Overall Study|Lost to Follow-up|0|||
46816097|NCT00495612|83036041|FG000|Overall Study|Subject's Decision to Withdraw|3|||
46816098|NCT00495612|83036042|FG001|Overall Study|Subject's Decision to Withdraw|0|||
46816099|NCT00487188|83036050|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
46816100|NCT00487188|83036051|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
46816101|NCT00487188|83036052|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
46816102|NCT00487188|83036050|FG000|Induction Phase|Adverse Event|5|||
46816103|NCT00487188|83036051|FG001|Induction Phase|Adverse Event|0|||
46816104|NCT00487188|83036052|FG002|Induction Phase|Adverse Event|0|||
46816105|NCT00487188|83036050|FG000|Induction Phase|Lack of Efficacy|0|||
46816106|NCT00487188|83036051|FG001|Induction Phase|Lack of Efficacy|1|||
46816107|NCT00487188|83036052|FG002|Induction Phase|Lack of Efficacy|0|||
46816108|NCT00487188|83036050|FG000|Induction Phase|Protocol Violation|1|||
46816109|NCT00487188|83036051|FG001|Induction Phase|Protocol Violation|0|||
46816110|NCT00487188|83036052|FG002|Induction Phase|Protocol Violation|0|||
46816111|NCT00487188|83036050|FG000|Induction Phase|Refused Treatment|1|||
46816112|NCT00487188|83036051|FG001|Induction Phase|Refused Treatment|2|||
46816113|NCT00487188|83036052|FG002|Induction Phase|Refused Treatment|0|||
46930116|NCT02064387|83165241|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
46930117|NCT02064387|83165230|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
46930118|NCT02064387|83165231|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
46930119|NCT02064387|83165232|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
46930120|NCT02064387|83165233|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
46930121|NCT02064387|83165234|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
46930122|NCT02064387|83165235|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
46930123|NCT02064387|83165236|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
46930124|NCT02064387|83165237|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
46930125|NCT02064387|83165238|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
46930126|NCT02064387|83165239|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
47055763|NCT01751867|83330213|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
46816114|NCT00487188|83036050|FG000|Induction Phase|Lost to Follow-up|2|||
46816115|NCT00487188|83036051|FG001|Induction Phase|Lost to Follow-up|2|||
46816116|NCT00487188|83036052|FG002|Induction Phase|Lost to Follow-up|0|||
46816117|NCT00487188|83036050|FG000|Induction Phase|Administrative|0|||
46816118|NCT00487188|83036051|FG001|Induction Phase|Administrative|1|||
46816119|NCT00487188|83036052|FG002|Induction Phase|Administrative|0|||
46816120|NCT00487188|83036050|FG000|Maintenance Phase|Adverse Event|1|||
46816121|NCT00487188|83036051|FG001|Maintenance Phase|Adverse Event|0|||
46816122|NCT00487188|83036052|FG002|Maintenance Phase|Adverse Event|0|||
46816123|NCT00487188|83036050|FG000|Maintenance Phase|Death|1|||
46816124|NCT00487188|83036051|FG001|Maintenance Phase|Death|0|||
46816125|NCT00487188|83036052|FG002|Maintenance Phase|Death|0|||
46816126|NCT00487188|83036050|FG000|Maintenance Phase|Lost to Follow-up|1|||
46816127|NCT00487188|83036051|FG001|Maintenance Phase|Lost to Follow-up|0|||
46816128|NCT00487188|83036052|FG002|Maintenance Phase|Lost to Follow-up|0|||
46816129|NCT00487188|83036050|FG000|Maintenance Phase|Administrative|0|||
46816130|NCT00487188|83036051|FG001|Maintenance Phase|Administrative|0|||
46816131|NCT00487188|83036052|FG002|Maintenance Phase|Administrative|1|||
46816132|NCT00509366|83036073|FG000|Overall Study|Not Treated (Screen Failure)|1|||
46816133|NCT00509366|83036074|FG001|Overall Study|Not Treated (Screen Failure)|1|||
46816134|NCT00509366|83036075|FG002|Overall Study|Not Treated (Screen Failure)|1|||
46816135|NCT00509366|83036076|FG003|Overall Study|Not Treated (Screen Failure)|0|||
46816136|NCT00509366|83036077|FG004|Overall Study|Not Treated (Screen Failure)|0|||
46816137|NCT00500318|83036089|FG000|Overall Study|Adverse Event|3|||
46816138|NCT00500318|83036090|FG001|Overall Study|Adverse Event|8|||
47055764|NCT01751867|83330212|FG000|Overall Study|Diease Progression|4|||
46816139|NCT00500318|83036089|FG000|Overall Study|Protocol Violation|1|||
46816140|NCT00500318|83036090|FG001|Overall Study|Protocol Violation|3|||
46816141|NCT00500318|83036089|FG000|Overall Study|Withdrawal by Subject|1|||
46816142|NCT00500318|83036090|FG001|Overall Study|Withdrawal by Subject|2|||
46816143|NCT00500318|83036089|FG000|Overall Study|Lack of Efficacy|0|||
46816144|NCT00500318|83036090|FG001|Overall Study|Lack of Efficacy|3|||
46816145|NCT00500318|83036089|FG000|Overall Study|Other Reason|0|||
46816146|NCT00500318|83036090|FG001|Overall Study|Other Reason|1|||
46816147|NCT00508820|83036098|FG000|Overall Study|Adverse Event|6|||
46816148|NCT00508820|83036099|FG001|Overall Study|Adverse Event|10|||
46816149|NCT00508820|83036098|FG000|Overall Study|Death|6|||
46816150|NCT00508820|83036099|FG001|Overall Study|Death|8|||
46816151|NCT00508820|83036098|FG000|Overall Study|Lost to Follow-up|1|||
46816152|NCT00508820|83036099|FG001|Overall Study|Lost to Follow-up|1|||
46816153|NCT00508820|83036098|FG000|Overall Study|Physician Decision|8|||
46816154|NCT00508820|83036099|FG001|Overall Study|Physician Decision|2|||
46816155|NCT00508820|83036098|FG000|Overall Study|Pregnancy|0|||
46816156|NCT00508820|83036099|FG001|Overall Study|Pregnancy|2|||
46816157|NCT00508820|83036098|FG000|Overall Study|Protocol Violation|2|||
46816158|NCT00508820|83036099|FG001|Overall Study|Protocol Violation|0|||
46816159|NCT00508820|83036098|FG000|Overall Study|Withdrawal by Subject|10|||
46816160|NCT00508820|83036099|FG001|Overall Study|Withdrawal by Subject|12|||
46816161|NCT00508820|83036098|FG000|Overall Study|Other|11|||
46816162|NCT00508820|83036099|FG001|Overall Study|Other|2|||
46816163|NCT00508820|83036098|FG000|Overall Study|Noncompliance|1|||
46757223|NCT00596960|82975282|FG001|Overall Study|Withdrawal by Subject|0|||
46757224|NCT00596960|82975281|FG000|Overall Study|Incarcerated|2|||
46816164|NCT00508820|83036099|FG001|Overall Study|Noncompliance|0|||
46816165|NCT00508820|83036098|FG000|Overall Study|Requirement for alternative therapy|7|||
46816166|NCT00508820|83036099|FG001|Overall Study|Requirement for alternative therapy|15|||
46816167|NCT00508820|83036098|FG000|Overall Study|Protocol-specified Criteria|3|||
46816168|NCT00508820|83036099|FG001|Overall Study|Protocol-specified Criteria|12|||
46816169|NCT00499694|83036105|FG000|Overall Study|Patient never received treatment.|1|||
46816170|NCT00486954|83036114|FG000|Pilot Part|Adverse Event|4|||
46816171|NCT00486954|83036115|FG001|Pilot Part|Adverse Event|0|||
46816172|NCT00486954|83036116|FG002|Pilot Part|Adverse Event|5|||
46816173|NCT00486954|83036117|FG003|Pilot Part|Adverse Event|0|||
46816174|NCT00486954|83036118|FG004|Pilot Part|Adverse Event|0|||
46816175|NCT00486954|83036114|FG000|Pilot Part|Disease Progression|2|||
46816176|NCT00486954|83036115|FG001|Pilot Part|Disease Progression|0|||
46816177|NCT00486954|83036116|FG002|Pilot Part|Disease Progression|1|||
46816178|NCT00486954|83036117|FG003|Pilot Part|Disease Progression|0|||
46816179|NCT00486954|83036118|FG004|Pilot Part|Disease Progression|0|||
46816180|NCT00486954|83036114|FG000|Randomized Part|Lost to Follow-up|0|||
46816181|NCT00486954|83036115|FG001|Randomized Part|Lost to Follow-up|0|||
46816182|NCT00486954|83036116|FG002|Randomized Part|Lost to Follow-up|0|||
46816183|NCT00486954|83036117|FG003|Randomized Part|Lost to Follow-up|0|||
46816184|NCT00486954|83036118|FG004|Randomized Part|Lost to Follow-up|1|||
46816185|NCT00486954|83036114|FG000|Randomized Part|Withdrawal by Subject|0|||
46816186|NCT00486954|83036115|FG001|Randomized Part|Withdrawal by Subject|0|||
46816187|NCT00486954|83036116|FG002|Randomized Part|Withdrawal by Subject|0|||
46816188|NCT00486954|83036117|FG003|Randomized Part|Withdrawal by Subject|1|||
46816189|NCT00486954|83036118|FG004|Randomized Part|Withdrawal by Subject|0|||
46816190|NCT00486954|83036114|FG000|Randomized Part|Sponsor Terminated Study|0|||
46816191|NCT00486954|83036115|FG001|Randomized Part|Sponsor Terminated Study|0|||
46816192|NCT00486954|83036116|FG002|Randomized Part|Sponsor Terminated Study|0|||
46816193|NCT00486954|83036117|FG003|Randomized Part|Sponsor Terminated Study|19|||
46930127|NCT02064387|83165240|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
47055765|NCT01751867|83330213|FG001|Overall Study|Diease Progression|18|||
47055766|NCT01751867|83330212|FG000|Overall Study|Adverse Event|8|||
46816194|NCT00486954|83036118|FG004|Randomized Part|Sponsor Terminated Study|13|||
46816195|NCT00494676|83036128|FG000|Allocation|Withdrawal by Subject|2|||
46816196|NCT00494676|83036129|FG001|Allocation|Withdrawal by Subject|4|||
46816197|NCT00494676|83036128|FG000|First Intervention|Withdrawal by Subject|1|||
46816198|NCT00494676|83036129|FG001|First Intervention|Withdrawal by Subject|3|||
46816199|NCT00494676|83036128|FG000|Second Intervention|Withdrawal by Subject|1|||
46816200|NCT00494676|83036129|FG001|Second Intervention|Withdrawal by Subject|1|||
46816201|NCT00486720|83036137|FG000|Overall Study|Adverse Event|1|||
46816202|NCT00486720|83036138|FG001|Overall Study|Adverse Event|2|||
46930128|NCT02064387|83165241|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
46930129|NCT02064387|83165230|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930130|NCT02064387|83165231|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
47055767|NCT01751867|83330213|FG001|Overall Study|Adverse Event|15|||
47055768|NCT01751867|83330212|FG000|Overall Study|Poor Compliance|0|||
47055769|NCT01751867|83330213|FG001|Overall Study|Poor Compliance|5|||
47055770|NCT01751867|83330212|FG000|Overall Study|Withdrawal by Subject|3|||
47055771|NCT01751867|83330213|FG001|Overall Study|Withdrawal by Subject|1|||
47055772|NCT01751867|83330212|FG000|Overall Study|Physician Decision|4|||
46757225|NCT00596960|82975282|FG001|Overall Study|Incarcerated|0|||
46930131|NCT02064387|83165232|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930132|NCT02064387|83165233|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
47055773|NCT01751867|83330213|FG001|Overall Study|Physician Decision|7|||
47055774|NCT01751867|83330212|FG000|Overall Study|Protocol Violation|0|||
46757226|NCT00596960|82975281|FG000|Overall Study|Physician Decision|1|||
46757227|NCT00596960|82975282|FG001|Overall Study|Physician Decision|0|||
46757228|NCT00596960|82975281|FG000|Overall Study|Protocol Violation|0|||
46757229|NCT00596960|82975282|FG001|Overall Study|Protocol Violation|1|||
46816203|NCT00486720|83036137|FG000|Overall Study|Lack of Efficacy|4|||
46816204|NCT00486720|83036138|FG001|Overall Study|Lack of Efficacy|6|||
46816205|NCT00486720|83036137|FG000|Overall Study|Physician Decision|1|||
46816206|NCT00486720|83036138|FG001|Overall Study|Physician Decision|2|||
46816207|NCT00486720|83036137|FG000|Overall Study|Protocol Violation|1|||
47055775|NCT01751867|83330213|FG001|Overall Study|Protocol Violation|2|||
47055776|NCT01751867|83330212|FG000|Overall Study|Death|0|||
46816208|NCT00486720|83036138|FG001|Overall Study|Protocol Violation|0|||
47055777|NCT01751867|83330213|FG001|Overall Study|Death|5|||
46757230|NCT00596960|82975281|FG000|Overall Study|No alcohol use data|0|||
46816209|NCT00486720|83036137|FG000|Overall Study|Withdrawal by Subject|3|||
46816210|NCT00486720|83036138|FG001|Overall Study|Withdrawal by Subject|1|||
46816211|NCT00486720|83036137|FG000|Overall Study|Progressive Disease|0|||
46816212|NCT00486720|83036138|FG001|Overall Study|Progressive Disease|1|||
46816213|NCT00486330|83036144|FG000|Overall Study|Adverse Event|2|||
46816214|NCT00486252|83036148|FG000|Overall Study|Adverse Event|7|||
46816215|NCT00486252|83036148|FG000|Overall Study|Lack of Efficacy|9|||
46816216|NCT00486252|83036148|FG000|Overall Study|Lost to Follow-up|24|||
46816217|NCT00486252|83036148|FG000|Overall Study|Other|18|||
46816218|NCT00494442|83036156|FG000|Overall Study|Death|1|||
46816219|NCT00494442|83036157|FG001|Overall Study|Death|1|||
46816220|NCT00494442|83036156|FG000|Overall Study|Lack of Efficacy|16|||
46816221|NCT00494442|83036157|FG001|Overall Study|Lack of Efficacy|10|||
46816222|NCT00494442|83036156|FG000|Overall Study|Adverse Event|0|||
46816223|NCT00494442|83036157|FG001|Overall Study|Adverse Event|2|||
46816224|NCT00494442|83036156|FG000|Overall Study|Physician Decision|0|||
46816225|NCT00494442|83036157|FG001|Overall Study|Physician Decision|1|||
47055778|NCT01751867|83330212|FG000|Overall Study|Other|11|||
47055779|NCT01751867|83330213|FG001|Overall Study|Other|37|||
47055780|NCT01751867|83330212|FG000|Overall Study|Randomized but not treated.|2|||
47055781|NCT01751867|83330213|FG001|Overall Study|Randomized but not treated.|1|||
47055782|NCT01751165|83330239|FG000|Overall Study|Adverse event, serious fatal|1|||
46816226|NCT00494442|83036156|FG000|Overall Study|Non-compliance|0|||
46816227|NCT00494442|83036157|FG001|Overall Study|Non-compliance|1|||
46816228|NCT00494442|83036156|FG000|Overall Study|Intercurrent illness|0|||
46816229|NCT00494442|83036157|FG001|Overall Study|Intercurrent illness|1|||
46816230|NCT03851016|83036165|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46930133|NCT02064387|83165234|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930134|NCT02064387|83165235|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930135|NCT02064387|83165236|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930136|NCT02064387|83165237|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930137|NCT02064387|83165238|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930138|NCT02064387|83165239|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46930139|NCT02064387|83165240|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
46930140|NCT02064387|83165241|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
46816231|NCT03851016|83036166|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
46816232|NCT00493974|83036174|FG000|Overall Study|Death|1|||
46816233|NCT00493974|83036175|FG001|Overall Study|Death|2|||
46816234|NCT00493974|83036174|FG000|Overall Study|Withdrawal by Subject|8|||
46816235|NCT00493974|83036175|FG001|Overall Study|Withdrawal by Subject|6|||
46816236|NCT00493974|83036174|FG000|Overall Study|Lost to Follow-up|4|||
46816237|NCT00493974|83036175|FG001|Overall Study|Lost to Follow-up|6|||
46816238|NCT00469092|83036183|FG000|Overall Study|Adverse Event|5|||
46816239|NCT00469092|83036184|FG001|Overall Study|Adverse Event|4|||
46816240|NCT00469092|83036183|FG000|Overall Study|Lack of Efficacy|1|||
46816241|NCT00469092|83036184|FG001|Overall Study|Lack of Efficacy|0|||
46816242|NCT00469092|83036183|FG000|Overall Study|Lost to Follow-up|1|||
46816243|NCT00469092|83036184|FG001|Overall Study|Lost to Follow-up|2|||
46816244|NCT00469092|83036183|FG000|Overall Study|Protocol Violation|3|||
46816245|NCT00469092|83036184|FG001|Overall Study|Protocol Violation|3|||
46816246|NCT00469092|83036183|FG000|Overall Study|Withdrawal by Subject|4|||
46816247|NCT00469092|83036184|FG001|Overall Study|Withdrawal by Subject|4|||
46816248|NCT00469092|83036183|FG000|Overall Study|Withdrawal Criteria|3|||
46816249|NCT00469092|83036184|FG001|Overall Study|Withdrawal Criteria|4|||
46816250|NCT00469092|83036183|FG000|Overall Study|Incorrectly Randomised|4|||
46816251|NCT00469092|83036184|FG001|Overall Study|Incorrectly Randomised|3|||
46816252|NCT00469092|83036183|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
46816253|NCT00469092|83036184|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
46816254|NCT00469092|83036183|FG000|Overall Study|Use of lipid lowering drug|1|||
46816255|NCT00469092|83036184|FG001|Overall Study|Use of lipid lowering drug|0|||
46930141|NCT01328366|83165280|FG000|Overall Study|Death|1|||
46816256|NCT00469092|83036183|FG000|Overall Study|Hypoglycaemic Episodes|1|||
46816257|NCT00469092|83036184|FG001|Overall Study|Hypoglycaemic Episodes|1|||
46816258|NCT00469092|83036183|FG000|Overall Study|Abnormal lab value|1|||
46816259|NCT00469092|83036184|FG001|Overall Study|Abnormal lab value|0|||
46816260|NCT00469092|83036183|FG000|Overall Study|Use of Corticosteroid|1|||
47055783|NCT01751165|83330240|FG001|Overall Study|Adverse event, serious fatal|0|||
46816261|NCT00469092|83036184|FG001|Overall Study|Use of Corticosteroid|0|||
47055784|NCT01751165|83330241|FG002|Overall Study|Adverse event, serious fatal|1|||
47055785|NCT01751165|83330239|FG000|Overall Study|Withdrawal by Subject|0|||
46816262|NCT00499616|83036194|FG000|Overall Study|Death|1|||
46816263|NCT00499616|83036195|FG001|Overall Study|Death|5|||
46816264|NCT00499616|83036196|FG002|Overall Study|Death|3|||
46816265|NCT00499616|83036197|FG003|Overall Study|Death|1|||
46636616|NCT01509846|82810406|FG002|Received Vaccination 3|Lost to Follow-up|1|||
46816266|NCT00499616|83036194|FG000|Overall Study|Lack of Efficacy|5|||
46816267|NCT00499616|83036195|FG001|Overall Study|Lack of Efficacy|0|||
46816268|NCT00499616|83036196|FG002|Overall Study|Lack of Efficacy|19|||
46636617|NCT01509846|82810407|FG003|Received Vaccination 3|Lost to Follow-up|0|||
46636618|NCT01509846|82810408|FG004|Received Vaccination 3|Lost to Follow-up|0|||
46636619|NCT01462344|82810429|FG000|Overall Study|Withdrawal by Subject|245|||
46636620|NCT01462344|82810430|FG001|Overall Study|Withdrawal by Subject|226|||
46636621|NCT01462344|82810429|FG000|Overall Study|Adverse Event|24|||
46636622|NCT01462344|82810430|FG001|Overall Study|Adverse Event|23|||
46636623|NCT01462344|82810429|FG000|Overall Study|Asthma Exacerbation|34|||
46636624|NCT01462344|82810430|FG001|Overall Study|Asthma Exacerbation|35|||
46636625|NCT01462344|82810429|FG000|Overall Study|Lack of Efficacy|5|||
46636626|NCT01462344|82810430|FG001|Overall Study|Lack of Efficacy|6|||
46636627|NCT01462344|82810429|FG000|Overall Study|Protocol Violation|68|||
46636628|NCT01462344|82810430|FG001|Overall Study|Protocol Violation|53|||
46636629|NCT01462344|82810429|FG000|Overall Study|Lost to Follow-up|7|||
46636630|NCT01462344|82810430|FG001|Overall Study|Lost to Follow-up|7|||
46636631|NCT01484028|82810436|FG000|Period 1|Lost to Follow-up|0|||
46636632|NCT01484028|82810437|FG001|Period 1|Lost to Follow-up|1|||
46636633|NCT01484028|82810438|FG002|Period 1|Lost to Follow-up|0|||
46636634|NCT01484028|82810439|FG003|Period 1|Lost to Follow-up|0|||
46636635|NCT01484028|82810436|FG000|Period 1|Non-Compliance to Protocol|0|||
46636636|NCT01484028|82810437|FG001|Period 1|Non-Compliance to Protocol|1|||
46636637|NCT01484028|82810438|FG002|Period 1|Non-Compliance to Protocol|0|||
46636638|NCT01484028|82810439|FG003|Period 1|Non-Compliance to Protocol|1|||
46636639|NCT01484028|82810436|FG000|Period 1|Lens Discomfort|0|||
46636640|NCT01484028|82810437|FG001|Period 1|Lens Discomfort|1|||
46636641|NCT01484028|82810438|FG002|Period 1|Lens Discomfort|0|||
46636642|NCT01484028|82810439|FG003|Period 1|Lens Discomfort|0|||
46636643|NCT01462266|82810449|FG000|Overall Study|Adverse Event|7|||
46636644|NCT01462266|82810450|FG001|Overall Study|Adverse Event|6|||
46636645|NCT01462266|82810449|FG000|Overall Study|Death|2|||
46636646|NCT01462266|82810450|FG001|Overall Study|Death|1|||
46636647|NCT01462266|82810449|FG000|Overall Study|Lack of Efficacy|0|||
46636648|NCT01462266|82810450|FG001|Overall Study|Lack of Efficacy|2|||
46636649|NCT01462266|82810449|FG000|Overall Study|Lost to Follow-up|4|||
46636650|NCT01462266|82810450|FG001|Overall Study|Lost to Follow-up|3|||
46636651|NCT01462266|82810449|FG000|Overall Study|Non-compliance with study drug|3|||
46636652|NCT01462266|82810450|FG001|Overall Study|Non-compliance with study drug|0|||
46636653|NCT01462266|82810449|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
46636654|NCT01462266|82810450|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
46636655|NCT01462266|82810449|FG000|Overall Study|Physician Decision|2|||
46636656|NCT01462266|82810450|FG001|Overall Study|Physician Decision|5|||
46636657|NCT01462266|82810449|FG000|Overall Study|Protocol Violation|1|||
46636658|NCT01462266|82810450|FG001|Overall Study|Protocol Violation|3|||
46636659|NCT01462266|82810449|FG000|Overall Study|Withdrawal by Subject|7|||
46636660|NCT01462266|82810450|FG001|Overall Study|Withdrawal by Subject|2|||
46757231|NCT00596960|82975282|FG001|Overall Study|No alcohol use data|1|||
46757232|NCT00505765|82975291|FG000|Overall Study|Withdrawal by Subject|1|||
46757233|NCT00505765|82975292|FG001|Overall Study|Withdrawal by Subject|0|||
46757234|NCT00505765|82975293|FG002|Overall Study|Withdrawal by Subject|0|||
46757235|NCT00505765|82975291|FG000|Overall Study|Adverse Event|1|||
46757236|NCT00505765|82975292|FG001|Overall Study|Adverse Event|2|||
46757237|NCT00505765|82975293|FG002|Overall Study|Adverse Event|0|||
46757238|NCT00505765|82975291|FG000|Overall Study|Noncompliance|0|||
46757239|NCT00505765|82975292|FG001|Overall Study|Noncompliance|1|||
46757240|NCT00505765|82975293|FG002|Overall Study|Noncompliance|3|||
46757241|NCT00505687|82975301|FG000|Overall Study|Important protocol violation|2|||
46757242|NCT00505687|82975301|FG000|Overall Study|Lack of Efficacy|15|||
46757243|NCT00505687|82975301|FG000|Overall Study|Adverse Event|48|||
46757244|NCT00505687|82975301|FG000|Overall Study|Subject withdrew consent|15|||
46757245|NCT00505687|82975301|FG000|Overall Study|Lost to Follow-up|1|||
46757246|NCT00505687|82975301|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
46757247|NCT00505687|82975301|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
46757248|NCT00505687|82975301|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
46757249|NCT00505687|82975301|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
46757250|NCT00505687|82975301|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
46757251|NCT00505687|82975301|FG000|Overall Study|Other: Disease Progression|1|||
46757252|NCT00505687|82975301|FG000|Overall Study|Other: As Per Sponsor|8|||
46757253|NCT00505375|82975307|FG000|Overall Study|Death|1|||
46757254|NCT00505375|82975308|FG001|Overall Study|Death|0|||
46757255|NCT00505375|82975307|FG000|Overall Study|Withdrawal by Subject|2|||
46757256|NCT00505375|82975308|FG001|Overall Study|Withdrawal by Subject|2|||
46757257|NCT00505375|82975307|FG000|Overall Study|Lost to Follow-up|0|||
46757258|NCT00505375|82975308|FG001|Overall Study|Lost to Follow-up|2|||
46757259|NCT00505375|82975307|FG000|Overall Study|Pregnancy|1|||
46757260|NCT00505375|82975308|FG001|Overall Study|Pregnancy|0|||
46757261|NCT00505375|82975307|FG000|Overall Study|Travel issues|0|||
46757262|NCT00505375|82975308|FG001|Overall Study|Travel issues|1|||
46757263|NCT00594932|82975316|FG000|First 3 Months|Withdrawal by Subject|1|||
46757264|NCT00594932|82975317|FG001|First 3 Months|Withdrawal by Subject|3|||
46930142|NCT01328366|83165280|FG000|Overall Study|Withdrawal by Subject|2|||
46930143|NCT01328366|83165280|FG000|Overall Study|Lost to Follow-up|7|||
46930144|NCT01370499|83165286|FG000|Overall Study|Adverse Event|38|||
46930145|NCT01370499|83165287|FG001|Overall Study|Adverse Event|12|||
46930146|NCT01370499|83165286|FG000|Overall Study|Lack of Efficacy|4|||
46930147|NCT01370499|83165287|FG001|Overall Study|Lack of Efficacy|2|||
46930148|NCT01370499|83165286|FG000|Overall Study|Lost to Follow-up|2|||
46930149|NCT01370499|83165287|FG001|Overall Study|Lost to Follow-up|1|||
46930150|NCT01370499|83165286|FG000|Overall Study|Physician Decision|3|||
46930151|NCT01370499|83165287|FG001|Overall Study|Physician Decision|3|||
46930152|NCT01370499|83165286|FG000|Overall Study|Protocol Violation|5|||
46930153|NCT01370499|83165287|FG001|Overall Study|Protocol Violation|4|||
46930154|NCT01370499|83165286|FG000|Overall Study|Withdrawal by Subject|18|||
46930155|NCT01370499|83165287|FG001|Overall Study|Withdrawal by Subject|7|||
46930156|NCT01370499|83165286|FG000|Overall Study|Sponsor Decision|41|||
46930157|NCT01370499|83165287|FG001|Overall Study|Sponsor Decision|15|||
46930158|NCT01370265|83165295|FG000|First Intervention|Adverse Event|1|||
46930159|NCT01370265|83165296|FG001|First Intervention|Adverse Event|1|||
46930160|NCT02792829|83165334|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
46930161|NCT02792829|83165335|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
46930162|NCT02792829|83165336|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
46930163|NCT02792829|83165337|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
46930164|NCT02792829|83165338|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
46930165|NCT02792829|83165339|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
46757265|NCT00594932|82975316|FG000|Final 3 Months|Withdrawal by Subject|4|||
46757266|NCT00594932|82975317|FG001|Final 3 Months|Withdrawal by Subject|3|||
46757267|NCT00504829|82975326|FG000|Overall Study|Protocol Violation|6|||
46757268|NCT00504829|82975327|FG001|Overall Study|Protocol Violation|4|||
46757269|NCT00504829|82975328|FG002|Overall Study|Protocol Violation|10|||
46757270|NCT00504595|82975340|FG000|Overall Study|Lack of Efficacy|1|||
46757271|NCT00504595|82975341|FG001|Overall Study|Lack of Efficacy|0|||
46757272|NCT00504595|82975342|FG002|Overall Study|Lack of Efficacy|0|||
46757273|NCT00504595|82975343|FG003|Overall Study|Lack of Efficacy|0|||
46757274|NCT00504595|82975340|FG000|Overall Study|Other|0|||
46757275|NCT00504595|82975341|FG001|Overall Study|Other|0|||
46757276|NCT00504595|82975342|FG002|Overall Study|Other|2|||
46757277|NCT00504595|82975343|FG003|Overall Study|Other|0|||
46757278|NCT00513409|82975355|FG000|Overall Study|Adverse Event|0|||
46757279|NCT00513409|82975356|FG001|Overall Study|Adverse Event|1|||
46757280|NCT00513409|82975355|FG000|Overall Study|Withdrawal by Subject|0|||
46757281|NCT00513409|82975356|FG001|Overall Study|Withdrawal by Subject|2|||
46757282|NCT00513409|82975355|FG000|Overall Study|Lost to Follow-up|0|||
46757283|NCT00513409|82975356|FG001|Overall Study|Lost to Follow-up|1|||
46757284|NCT00513409|82975355|FG000|Overall Study|Physician Decision|1|||
46757285|NCT00513409|82975356|FG001|Overall Study|Physician Decision|0|||
46757286|NCT00513409|82975355|FG000|Overall Study|Visit 3 not done|1|||
46757287|NCT00513409|82975356|FG001|Overall Study|Visit 3 not done|2|||
46757288|NCT03150095|82975364|FG000|Overall Study|Death|0|||
46757289|NCT03150095|82975365|FG001|Overall Study|Death|1|||
46757290|NCT03150095|82975364|FG000|Overall Study|Lost to Follow-up|1|||
46757291|NCT03150095|82975365|FG001|Overall Study|Lost to Follow-up|1|||
46757292|NCT03150095|82975364|FG000|Overall Study|Withdrawal by Subject|4|||
46757293|NCT03150095|82975365|FG001|Overall Study|Withdrawal by Subject|0|||
46757294|NCT03150095|82975364|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
46757295|NCT03150095|82975365|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
46757296|NCT00705016|82975374|FG000|Overall Study|Adverse Event|6|||
46757297|NCT00705016|82975375|FG001|Overall Study|Adverse Event|11|||
46757298|NCT00705016|82975376|FG002|Overall Study|Adverse Event|10|||
46930166|NCT02792829|83165340|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
46930167|NCT02792829|83165341|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
46930168|NCT02792829|83165334|FG000|Treatment Period 2|Adverse Event|0|||
46930169|NCT02792829|83165335|FG001|Treatment Period 2|Adverse Event|0|||
46757299|NCT00705016|82975374|FG000|Overall Study|Death|5|||
46757300|NCT00705016|82975375|FG001|Overall Study|Death|7|||
46757301|NCT00705016|82975376|FG002|Overall Study|Death|5|||
46757302|NCT00705016|82975374|FG000|Overall Study|Protocol Violation|0|||
46930170|NCT02792829|83165336|FG002|Treatment Period 2|Adverse Event|0|||
46757303|NCT00705016|82975375|FG001|Overall Study|Protocol Violation|1|||
46757304|NCT00705016|82975376|FG002|Overall Study|Protocol Violation|1|||
46757305|NCT00705016|82975374|FG000|Overall Study|Withdrawal by Subject|4|||
46757306|NCT00705016|82975375|FG001|Overall Study|Withdrawal by Subject|3|||
46757307|NCT00705016|82975376|FG002|Overall Study|Withdrawal by Subject|2|||
46930171|NCT02792829|83165337|FG003|Treatment Period 2|Adverse Event|0|||
46757308|NCT00705016|82975374|FG000|Overall Study|Progressive Disease|33|||
46757309|NCT00705016|82975375|FG001|Overall Study|Progressive Disease|29|||
46757310|NCT00705016|82975376|FG002|Overall Study|Progressive Disease|33|||
46757311|NCT00705016|82975374|FG000|Overall Study|Symptomatic Deterioration|3|||
46757312|NCT00705016|82975375|FG001|Overall Study|Symptomatic Deterioration|1|||
46816269|NCT00499616|83036197|FG003|Overall Study|Lack of Efficacy|0|||
46816270|NCT00499616|83036194|FG000|Overall Study|Lost to Follow-up|0|||
46816271|NCT00499616|83036195|FG001|Overall Study|Lost to Follow-up|0|||
46816272|NCT00499616|83036196|FG002|Overall Study|Lost to Follow-up|1|||
46930172|NCT02792829|83165338|FG004|Treatment Period 2|Adverse Event|1|||
46930173|NCT02792829|83165339|FG005|Treatment Period 2|Adverse Event|0|||
46930174|NCT02792829|83165340|FG006|Treatment Period 2|Adverse Event|1|||
46930175|NCT02792829|83165341|FG007|Treatment Period 2|Adverse Event|1|||
46930176|NCT02792829|83165334|FG000|Treatment Period 2|Use of proscribed medications|0|||
46930177|NCT02792829|83165335|FG001|Treatment Period 2|Use of proscribed medications|0|||
46930178|NCT02792829|83165336|FG002|Treatment Period 2|Use of proscribed medications|0|||
46930179|NCT02792829|83165337|FG003|Treatment Period 2|Use of proscribed medications|0|||
46930180|NCT02792829|83165338|FG004|Treatment Period 2|Use of proscribed medications|0|||
46816273|NCT00499616|83036197|FG003|Overall Study|Lost to Follow-up|0|||
46816274|NCT00499616|83036194|FG000|Overall Study|Physician Decision|6|||
46816275|NCT00499616|83036195|FG001|Overall Study|Physician Decision|16|||
46816276|NCT00499616|83036196|FG002|Overall Study|Physician Decision|9|||
46816277|NCT00499616|83036197|FG003|Overall Study|Physician Decision|0|||
46816278|NCT00499616|83036194|FG000|Overall Study|Withdrawal by Subject|1|||
46636661|NCT01462266|82810449|FG000|Overall Study|Screen failure|1|||
46636662|NCT01462266|82810450|FG001|Overall Study|Screen failure|1|||
46636663|NCT01508910|82810459|FG000|Treatment|Death|2|||
46636664|NCT01508910|82810460|FG001|Treatment|Death|3|||
46636665|NCT01508910|82810461|FG002|Treatment|Death|2|||
46636666|NCT01508910|82810462|FG003|Treatment|Death|0|||
46636667|NCT01508910|82810459|FG000|Treatment|Lost to Follow-up|0|||
46636668|NCT01508910|82810460|FG001|Treatment|Lost to Follow-up|0|||
46636669|NCT01508910|82810461|FG002|Treatment|Lost to Follow-up|2|||
46636670|NCT01508910|82810462|FG003|Treatment|Lost to Follow-up|1|||
46636671|NCT01508910|82810459|FG000|Treatment|Withdrawal by Subject|0|||
46636672|NCT01508910|82810460|FG001|Treatment|Withdrawal by Subject|1|||
46636673|NCT01508910|82810461|FG002|Treatment|Withdrawal by Subject|6|||
46636674|NCT01508910|82810462|FG003|Treatment|Withdrawal by Subject|1|||
46636675|NCT01508910|82810459|FG000|Treatment|Sponsor Decision|0|||
46636676|NCT01508910|82810460|FG001|Treatment|Sponsor Decision|0|||
46757313|NCT00705016|82975376|FG002|Overall Study|Symptomatic Deterioration|1|||
46816279|NCT00499616|83036195|FG001|Overall Study|Withdrawal by Subject|0|||
46816280|NCT00499616|83036196|FG002|Overall Study|Withdrawal by Subject|1|||
46816281|NCT00499616|83036197|FG003|Overall Study|Withdrawal by Subject|0|||
46816282|NCT00499616|83036194|FG000|Overall Study|Ineligible|1|||
46816283|NCT00499616|83036195|FG001|Overall Study|Ineligible|2|||
46816284|NCT00499616|83036196|FG002|Overall Study|Ineligible|0|||
46816285|NCT00499616|83036197|FG003|Overall Study|Ineligible|15|||
46816286|NCT00499616|83036194|FG000|Overall Study|Not evaluable|0|||
46816287|NCT00499616|83036195|FG001|Overall Study|Not evaluable|0|||
46816288|NCT00499616|83036196|FG002|Overall Study|Not evaluable|0|||
46816289|NCT00499616|83036197|FG003|Overall Study|Not evaluable|41|||
46816290|NCT00499616|83036194|FG000|Overall Study|Patient/Parent Refusal|1|||
46816291|NCT00499616|83036195|FG001|Overall Study|Patient/Parent Refusal|5|||
46816292|NCT00499616|83036196|FG002|Overall Study|Patient/Parent Refusal|3|||
46816293|NCT00499616|83036197|FG003|Overall Study|Patient/Parent Refusal|0|||
46930181|NCT02792829|83165339|FG005|Treatment Period 2|Use of proscribed medications|0|||
46930182|NCT02792829|83165340|FG006|Treatment Period 2|Use of proscribed medications|0|||
46757314|NCT00705016|82975374|FG000|Overall Study|Other|9|||
46757315|NCT00705016|82975375|FG001|Overall Study|Other|6|||
46757316|NCT00705016|82975376|FG002|Overall Study|Other|6|||
46757317|NCT00595868|82975386|FG000|Overall Study|Lost to Follow-up|45|||
46757318|NCT00595868|82975387|FG001|Overall Study|Lost to Follow-up|50|||
46757319|NCT00856284|82975417|FG000|Overall Study|Hyperglycemic rescue|231|||
46757320|NCT00856284|82975418|FG001|Overall Study|Hyperglycemic rescue|201|||
46757321|NCT00856284|82975419|FG002|Overall Study|Hyperglycemic rescue|235|||
46757322|NCT00856284|82975417|FG000|Overall Study|Adverse Event|60|||
46757323|NCT00856284|82975418|FG001|Overall Study|Adverse Event|74|||
46757324|NCT00856284|82975419|FG002|Overall Study|Adverse Event|82|||
46816294|NCT00402597|83036215|FG000|Overall Study|Death|15|||
46636677|NCT01508910|82810461|FG002|Treatment|Sponsor Decision|0|||
46636678|NCT01508910|82810462|FG003|Treatment|Sponsor Decision|1|||
46636679|NCT01462110|82810476|FG000|Overall Study|Adverse Event|1|||
46757325|NCT00856284|82975417|FG000|Overall Study|Major protocol deviation|24|||
46636680|NCT01462110|82810477|FG001|Overall Study|Adverse Event|0|||
46636681|NCT01508676|82810485|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
46757326|NCT00856284|82975418|FG001|Overall Study|Major protocol deviation|16|||
46757327|NCT00856284|82975419|FG002|Overall Study|Major protocol deviation|15|||
46757328|NCT00856284|82975417|FG000|Overall Study|Lost to Follow-up|20|||
46757329|NCT00856284|82975418|FG001|Overall Study|Lost to Follow-up|22|||
46816295|NCT00402597|83036216|FG001|Overall Study|Death|7|||
46816296|NCT00402597|83036217|FG002|Overall Study|Death|6|||
46816297|NCT00402597|83036218|FG003|Overall Study|Death|4|||
46816298|NCT00402597|83036219|FG004|Overall Study|Death|6|||
46930183|NCT02792829|83165341|FG007|Treatment Period 2|Use of proscribed medications|1|||
46816299|NCT00402597|83036215|FG000|Overall Study|Adverse Event|81|||
46816300|NCT00402597|83036216|FG001|Overall Study|Adverse Event|18|||
46816301|NCT00402597|83036217|FG002|Overall Study|Adverse Event|106|||
46816302|NCT00402597|83036218|FG003|Overall Study|Adverse Event|39|||
46930184|NCT02867592|83165373|FG000|Overall Study|Adverse Event|3|||
46930185|NCT02867592|83165374|FG001|Overall Study|Adverse Event|0|||
46816303|NCT00402597|83036219|FG004|Overall Study|Adverse Event|71|||
46816304|NCT00402597|83036215|FG000|Overall Study|Lost to Follow-up|8|||
46816305|NCT00402597|83036216|FG001|Overall Study|Lost to Follow-up|1|||
46816306|NCT00402597|83036217|FG002|Overall Study|Lost to Follow-up|8|||
46816307|NCT00402597|83036218|FG003|Overall Study|Lost to Follow-up|2|||
46816308|NCT00402597|83036219|FG004|Overall Study|Lost to Follow-up|3|||
46816309|NCT00402597|83036215|FG000|Overall Study|Withdrawal by Subject|57|||
46816310|NCT00402597|83036216|FG001|Overall Study|Withdrawal by Subject|16|||
46816311|NCT00402597|83036217|FG002|Overall Study|Withdrawal by Subject|65|||
46816312|NCT00402597|83036218|FG003|Overall Study|Withdrawal by Subject|15|||
46816313|NCT00402597|83036219|FG004|Overall Study|Withdrawal by Subject|24|||
46816314|NCT00402597|83036215|FG000|Overall Study|reason not specified|30|||
46816315|NCT00402597|83036216|FG001|Overall Study|reason not specified|4|||
46816316|NCT00402597|83036217|FG002|Overall Study|reason not specified|27|||
46816317|NCT00402597|83036218|FG003|Overall Study|reason not specified|14|||
46816318|NCT00402597|83036219|FG004|Overall Study|reason not specified|20|||
46816319|NCT00402363|83036235|FG000|Overall Study|Adverse Event|9|||
46816320|NCT00402363|83036236|FG001|Overall Study|Adverse Event|14|||
46816321|NCT00402363|83036237|FG002|Overall Study|Adverse Event|2|||
46816322|NCT00402363|83036238|FG003|Overall Study|Adverse Event|2|||
46816323|NCT00402363|83036235|FG000|Overall Study|Withdrew Consent|10|||
46816324|NCT00402363|83036236|FG001|Overall Study|Withdrew Consent|5|||
46816325|NCT00402363|83036237|FG002|Overall Study|Withdrew Consent|2|||
46816326|NCT00402363|83036238|FG003|Overall Study|Withdrew Consent|1|||
46816327|NCT00402363|83036235|FG000|Overall Study|Protocol Violation|3|||
46816328|NCT00402363|83036236|FG001|Overall Study|Protocol Violation|5|||
46930186|NCT02867592|83165375|FG002|Overall Study|Adverse Event|2|||
46930187|NCT02867592|83165376|FG003|Overall Study|Adverse Event|1|||
46930188|NCT02867592|83165377|FG004|Overall Study|Adverse Event|1|||
46930189|NCT02867592|83165378|FG005|Overall Study|Adverse Event|5|||
46930190|NCT02867592|83165373|FG000|Overall Study|Death|0|||
46930191|NCT02867592|83165374|FG001|Overall Study|Death|0|||
46930192|NCT02867592|83165375|FG002|Overall Study|Death|0|||
46930193|NCT02867592|83165376|FG003|Overall Study|Death|1|||
46930194|NCT02867592|83165377|FG004|Overall Study|Death|0|||
46930195|NCT02867592|83165378|FG005|Overall Study|Death|1|||
46930196|NCT02867592|83165373|FG000|Overall Study|Lack of Efficacy|8|||
46930197|NCT02867592|83165374|FG001|Overall Study|Lack of Efficacy|10|||
46930198|NCT02867592|83165375|FG002|Overall Study|Lack of Efficacy|8|||
46930199|NCT02867592|83165376|FG003|Overall Study|Lack of Efficacy|8|||
46930200|NCT02867592|83165377|FG004|Overall Study|Lack of Efficacy|12|||
46930201|NCT02867592|83165378|FG005|Overall Study|Lack of Efficacy|17|||
46930202|NCT02867592|83165373|FG000|Overall Study|Physician Decision|1|||
46930203|NCT02867592|83165374|FG001|Overall Study|Physician Decision|2|||
46930204|NCT02867592|83165375|FG002|Overall Study|Physician Decision|2|||
46930205|NCT02867592|83165376|FG003|Overall Study|Physician Decision|0|||
46930206|NCT02867592|83165377|FG004|Overall Study|Physician Decision|5|||
46930207|NCT02867592|83165378|FG005|Overall Study|Physician Decision|1|||
46930208|NCT02867592|83165373|FG000|Overall Study|Protocol Violation|0|||
46930209|NCT02867592|83165374|FG001|Overall Study|Protocol Violation|0|||
46930210|NCT02867592|83165375|FG002|Overall Study|Protocol Violation|0|||
46930211|NCT02867592|83165376|FG003|Overall Study|Protocol Violation|0|||
46930212|NCT02867592|83165377|FG004|Overall Study|Protocol Violation|1|||
46930213|NCT02867592|83165378|FG005|Overall Study|Protocol Violation|1|||
46930214|NCT02867592|83165373|FG000|Overall Study|Withdrawal by Subject|0|||
46930215|NCT02867592|83165374|FG001|Overall Study|Withdrawal by Subject|1|||
46930216|NCT02867592|83165375|FG002|Overall Study|Withdrawal by Subject|0|||
46816329|NCT00402363|83036237|FG002|Overall Study|Protocol Violation|0|||
46816330|NCT00402363|83036238|FG003|Overall Study|Protocol Violation|3|||
46930217|NCT02867592|83165376|FG003|Overall Study|Withdrawal by Subject|1|||
46816331|NCT00402363|83036235|FG000|Overall Study|Lost to Follow-up|5|||
46816332|NCT00402363|83036236|FG001|Overall Study|Lost to Follow-up|4|||
46816333|NCT00402363|83036237|FG002|Overall Study|Lost to Follow-up|0|||
46816334|NCT00402363|83036238|FG003|Overall Study|Lost to Follow-up|2|||
46930218|NCT02867592|83165377|FG004|Overall Study|Withdrawal by Subject|3|||
46816335|NCT00402363|83036235|FG000|Overall Study|"Captured as Other"|6|||
46816336|NCT00402363|83036236|FG001|Overall Study|"Captured as Other"|2|||
46816337|NCT00402363|83036237|FG002|Overall Study|"Captured as Other"|2|||
46816338|NCT00402363|83036238|FG003|Overall Study|"Captured as Other"|2|||
46930219|NCT02867592|83165378|FG005|Overall Study|Withdrawal by Subject|3|||
46930220|NCT02867592|83165373|FG000|Overall Study|Ineligible|1|||
46930221|NCT02867592|83165374|FG001|Overall Study|Ineligible|1|||
46930222|NCT02867592|83165375|FG002|Overall Study|Ineligible|0|||
46930223|NCT02867592|83165376|FG003|Overall Study|Ineligible|0|||
46930224|NCT02867592|83165377|FG004|Overall Study|Ineligible|2|||
46930225|NCT02867592|83165378|FG005|Overall Study|Ineligible|0|||
46930226|NCT02867592|83165373|FG000|Overall Study|No Treatment|1|||
46930227|NCT02867592|83165374|FG001|Overall Study|No Treatment|0|||
46930228|NCT02867592|83165375|FG002|Overall Study|No Treatment|0|||
46930229|NCT02867592|83165376|FG003|Overall Study|No Treatment|0|||
46930230|NCT02867592|83165377|FG004|Overall Study|No Treatment|0|||
46930231|NCT02867592|83165378|FG005|Overall Study|No Treatment|0|||
46930232|NCT02867592|83165373|FG000|Overall Study|Still on Therapy|0|||
46930233|NCT02867592|83165374|FG001|Overall Study|Still on Therapy|0|||
46930234|NCT02867592|83165375|FG002|Overall Study|Still on Therapy|0|||
46930235|NCT02867592|83165376|FG003|Overall Study|Still on Therapy|0|||
46930236|NCT02867592|83165377|FG004|Overall Study|Still on Therapy|1|||
46930237|NCT02867592|83165378|FG005|Overall Study|Still on Therapy|0|||
46930238|NCT02867592|83165373|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
46930239|NCT02867592|83165374|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
46930240|NCT02867592|83165375|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
46930241|NCT02867592|83165376|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
46930242|NCT02867592|83165377|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
46930243|NCT02867592|83165378|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
46930244|NCT02867592|83165373|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
46930245|NCT02867592|83165374|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
46930246|NCT02867592|83165375|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
46757330|NCT00856284|82975419|FG002|Overall Study|Lost to Follow-up|28|||
46757331|NCT00856284|82975417|FG000|Overall Study|Voluntary withdrawal|48|||
46757332|NCT00856284|82975418|FG001|Overall Study|Voluntary withdrawal|52|||
46757333|NCT00856284|82975419|FG002|Overall Study|Voluntary withdrawal|62|||
46757334|NCT00856284|82975417|FG000|Overall Study|Pregnancy|1|||
46757335|NCT00856284|82975418|FG001|Overall Study|Pregnancy|2|||
46757336|NCT00856284|82975419|FG002|Overall Study|Pregnancy|0|||
46757337|NCT00856284|82975417|FG000|Overall Study|Investigator discretion|9|||
46757338|NCT00856284|82975418|FG001|Overall Study|Investigator discretion|8|||
46757339|NCT00856284|82975419|FG002|Overall Study|Investigator discretion|10|||
46757340|NCT00856284|82975417|FG000|Overall Study|Other|15|||
46757341|NCT00856284|82975418|FG001|Overall Study|Other|17|||
46757342|NCT00856284|82975419|FG002|Overall Study|Other|14|||
46757343|NCT00856284|82975417|FG000|Overall Study|Randomized in error|0|||
46757344|NCT00856284|82975418|FG001|Overall Study|Randomized in error|0|||
46757345|NCT00856284|82975419|FG002|Overall Study|Randomized in error|1|||
46757346|NCT00510289|82975427|FG000|Overall Study|Withdrawal by Subject|7|||
46757347|NCT00510289|82975427|FG000|Overall Study|Refused bone marrow biopsy|2|||
46757348|NCT00510289|82975427|FG000|Overall Study|Lost to Follow-up|1|||
46757349|NCT00510289|82975427|FG000|Overall Study|Progressed prior to starting drug|2|||
46757350|NCT00492115|82975434|FG000|Overall Study|Withdrawal by Subject|3|||
46757351|NCT00492115|82975435|FG001|Overall Study|Withdrawal by Subject|4|||
46757352|NCT00856206|82975443|FG000|Overall Study|Protocol Violation|6|||
46757353|NCT00856206|82975444|FG001|Overall Study|Protocol Violation|18|||
46757354|NCT00856206|82975443|FG000|Overall Study|Adverse Event|10|||
46757355|NCT00856206|82975444|FG001|Overall Study|Adverse Event|46|||
46757356|NCT00856206|82975443|FG000|Overall Study|Lack of Efficacy|1|||
46757357|NCT00856206|82975444|FG001|Overall Study|Lack of Efficacy|2|||
46757358|NCT00856206|82975443|FG000|Overall Study|Withdrawal by Subject|15|||
46757359|NCT00856206|82975444|FG001|Overall Study|Withdrawal by Subject|36|||
46757360|NCT00856206|82975443|FG000|Overall Study|Lost to Follow-up|13|||
46757361|NCT00856206|82975444|FG001|Overall Study|Lost to Follow-up|39|||
46757362|NCT00856206|82975443|FG000|Overall Study|Death|2|||
46757363|NCT00856206|82975444|FG001|Overall Study|Death|2|||
46757364|NCT00856206|82975443|FG000|Overall Study|Decision by the Sponsor|4|||
46757365|NCT00856206|82975444|FG001|Overall Study|Decision by the Sponsor|8|||
46757366|NCT00856206|82975443|FG000|Overall Study|Other than specified above|3|||
46757367|NCT00856206|82975444|FG001|Overall Study|Other than specified above|10|||
46757368|NCT00593112|82975452|FG000|Overall Study|Scan Anxiety|3|||
46757369|NCT00593112|82975453|FG001|Overall Study|Scan Anxiety|0|||
46757370|NCT00593112|82975452|FG000|Overall Study|Abnormal Scan|1|||
46757371|NCT00593112|82975453|FG001|Overall Study|Abnormal Scan|0|||
46757372|NCT00593112|82975452|FG000|Overall Study|Unreadable Scan|1|||
46757373|NCT00593112|82975453|FG001|Overall Study|Unreadable Scan|0|||
46757374|NCT00593112|82975452|FG000|Overall Study|Withdrawal by Subject|5|||
46757375|NCT00593112|82975453|FG001|Overall Study|Withdrawal by Subject|0|||
46757376|NCT00491179|82975461|FG000|Overall Study|Adverse Event|5|||
46757377|NCT00491179|82975462|FG001|Overall Study|Adverse Event|1|||
46757378|NCT00491179|82975461|FG000|Overall Study|Withdrawal by Subject|2|||
46757379|NCT00491179|82975462|FG001|Overall Study|Withdrawal by Subject|1|||
46757380|NCT00503581|82975471|FG000|Overall Study|Study closed|3|||
46930247|NCT02867592|83165376|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
46930248|NCT02867592|83165377|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
46930249|NCT02867592|83165378|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
46930250|NCT00676494|83165394|FG000|Overall Study|Missed Visit|8|||
46930251|NCT00676494|83165394|FG000|Overall Study|Withdrawal by Subject|6|||
46930252|NCT02605642|83165399|FG000|Overall Study|Other|11|||
46930253|NCT02605642|83165400|FG001|Overall Study|Other|1|||
46930254|NCT02605642|83165399|FG000|Overall Study|Participant non-compliance|2|||
46930255|NCT02605642|83165400|FG001|Overall Study|Participant non-compliance|4|||
46930256|NCT02605642|83165399|FG000|Overall Study|Physician Decision|10|||
46930257|NCT02605642|83165400|FG001|Overall Study|Physician Decision|0|||
46930258|NCT02605642|83165399|FG000|Overall Study|Lost to Follow-up|12|||
46930259|NCT02605642|83165400|FG001|Overall Study|Lost to Follow-up|1|||
46930260|NCT02605642|83165399|FG000|Overall Study|Adverse Event|14|||
46930261|NCT02605642|83165400|FG001|Overall Study|Adverse Event|2|||
46930262|NCT02605642|83165399|FG000|Overall Study|Withdrawal by Subject|23|||
46930263|NCT02605642|83165400|FG001|Overall Study|Withdrawal by Subject|2|||
47055786|NCT01751165|83330240|FG001|Overall Study|Withdrawal by Subject|0|||
47055787|NCT01751165|83330241|FG002|Overall Study|Withdrawal by Subject|1|||
47055788|NCT01751165|83330239|FG000|Overall Study|Serious adverse event|0|||
47055789|NCT01751165|83330240|FG001|Overall Study|Serious adverse event|2|||
46757381|NCT00503581|82975472|FG001|Overall Study|Study closed|4|||
46757382|NCT00503581|82975473|FG002|Overall Study|Study closed|2|||
46757383|NCT00703534|82975483|FG000|Overall Study|Adverse Event|14|||
46757384|NCT00703534|82975484|FG001|Overall Study|Adverse Event|3|||
46757385|NCT00703534|82975483|FG000|Overall Study|Withdrawal by Subject|8|||
46757386|NCT00703534|82975484|FG001|Overall Study|Withdrawal by Subject|7|||
46757387|NCT00703534|82975483|FG000|Overall Study|Incorrect Enrollment|6|||
46757388|NCT00703534|82975484|FG001|Overall Study|Incorrect Enrollment|6|||
46757389|NCT00703534|82975483|FG000|Overall Study|Lost to Follow-up|1|||
46757390|NCT00703534|82975484|FG001|Overall Study|Lost to Follow-up|4|||
46757391|NCT00703534|82975483|FG000|Overall Study|Severe Non Compliance|1|||
46757392|NCT00703534|82975484|FG001|Overall Study|Severe Non Compliance|5|||
46757393|NCT00503425|82975490|FG000|Overall Study|Participant files lost|6|||
46757394|NCT00503425|82975490|FG000|Overall Study|Adverse Event|5|||
46757395|NCT00503425|82975490|FG000|Overall Study|Lack of Efficacy|25|||
46757396|NCT00503425|82975490|FG000|Overall Study|Withdrawal by Subject|8|||
46757397|NCT00503425|82975490|FG000|Overall Study|Lost to Follow-up|3|||
46757398|NCT00503425|82975490|FG000|Overall Study|Death|3|||
46757399|NCT00503425|82975490|FG000|Overall Study|Missing Data/Unknown|4|||
46757400|NCT00863772|82975498|FG000|Overall Study|Adverse Event|1|||
46757401|NCT00863772|82975499|FG001|Overall Study|Adverse Event|4|||
46757402|NCT00863772|82975500|FG002|Overall Study|Adverse Event|0|||
46757403|NCT00863772|82975498|FG000|Overall Study|Lack of Efficacy|4|||
46757404|NCT00863772|82975499|FG001|Overall Study|Lack of Efficacy|2|||
46757405|NCT00863772|82975500|FG002|Overall Study|Lack of Efficacy|4|||
46757406|NCT00863772|82975498|FG000|Overall Study|Lost to Follow-up|5|||
46757407|NCT00863772|82975499|FG001|Overall Study|Lost to Follow-up|1|||
46757408|NCT00863772|82975500|FG002|Overall Study|Lost to Follow-up|1|||
46757409|NCT00863772|82975498|FG000|Overall Study|Protocol Violation|2|||
46757410|NCT00863772|82975499|FG001|Overall Study|Protocol Violation|0|||
46757411|NCT00863772|82975500|FG002|Overall Study|Protocol Violation|2|||
46757412|NCT00863772|82975498|FG000|Overall Study|Withdrawal by Subject|4|||
46757413|NCT00863772|82975499|FG001|Overall Study|Withdrawal by Subject|7|||
46757414|NCT00863772|82975500|FG002|Overall Study|Withdrawal by Subject|5|||
46757415|NCT00863772|82975498|FG000|Overall Study|Study terminated by sponsor|44|||
46757416|NCT00863772|82975499|FG001|Overall Study|Study terminated by sponsor|45|||
46757417|NCT00863772|82975500|FG002|Overall Study|Study terminated by sponsor|36|||
46757418|NCT00863772|82975498|FG000|Overall Study|Entered extension study|6|||
46757419|NCT00863772|82975499|FG001|Overall Study|Entered extension study|4|||
46757420|NCT00863772|82975500|FG002|Overall Study|Entered extension study|9|||
46757421|NCT00863772|82975498|FG000|Overall Study|Other|1|||
46757422|NCT00863772|82975499|FG001|Overall Study|Other|2|||
46757423|NCT00863772|82975500|FG002|Overall Study|Other|4|||
46757424|NCT00863772|82975498|FG000|Overall Study|Randomized but not Treated|1|||
47055790|NCT01751165|83330241|FG002|Overall Study|Serious adverse event|0|||
46757425|NCT00863772|82975499|FG001|Overall Study|Randomized but not Treated|0|||
46757426|NCT00863772|82975500|FG002|Overall Study|Randomized but not Treated|0|||
47055791|NCT01751165|83330239|FG000|Overall Study|Lost to Follow-up|1|||
47055792|NCT01751165|83330240|FG001|Overall Study|Lost to Follow-up|1|||
46757427|NCT00502801|82975508|FG000|Treatment Period|Withdrawal by Subject|3|||
46757428|NCT00502801|82975508|FG000|Treatment Period|Adverse Event|7|||
46757429|NCT00502801|82975508|FG000|Treatment Period|Death|14|||
46757430|NCT00502801|82975508|FG000|Treatment Period|OTHER|30|||
46757431|NCT00502801|82975508|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
46930264|NCT02605642|83165399|FG000|Overall Study|Lack of response|24|||
46930265|NCT02605642|83165400|FG001|Overall Study|Lack of response|11|||
46816339|NCT00469014|83036258|FG000|Initial Phase Randomization|Disease Progression|0|||
46816340|NCT00469014|83036259|FG001|Initial Phase Randomization|Disease Progression|1|||
46816341|NCT00469014|83036260|FG002|Initial Phase Randomization|Disease Progression|1|||
46816342|NCT00469014|83036261|FG003|Initial Phase Randomization|Disease Progression|0|||
46816343|NCT00469014|83036258|FG000|Initial Phase Randomization|No Response|1|||
46816344|NCT00469014|83036259|FG001|Initial Phase Randomization|No Response|0|||
46930266|NCT02253810|83165408|FG000|Overall Study|Withdrawal by Subject|2|||
46930267|NCT02253810|83165409|FG001|Overall Study|Withdrawal by Subject|1|||
47055793|NCT01751165|83330241|FG002|Overall Study|Lost to Follow-up|1|||
47055794|NCT01751087|83330266|FG000|Overall Study|Withdrawal by Subject|1|||
47055795|NCT01751087|83330267|FG001|Overall Study|Withdrawal by Subject|0|||
47055796|NCT01751087|83330268|FG002|Overall Study|Withdrawal by Subject|0|||
47055797|NCT01751087|83330266|FG000|Overall Study|Physician Decision|0|||
47055798|NCT01751087|83330267|FG001|Overall Study|Physician Decision|0|||
47055799|NCT01751087|83330268|FG002|Overall Study|Physician Decision|1|||
47055800|NCT01750697|83330276|FG000|Overall Study|Transferred Back to Local Hospital|1|||
47055801|NCT01750697|83330276|FG000|Overall Study|Physician and Family Decision|1|||
47055802|NCT01750697|83330276|FG000|Overall Study|Transferred to Adult Services|5|||
47055803|NCT01750697|83330276|FG000|Overall Study|Physician Decision|1|||
47055804|NCT01750697|83330276|FG000|Overall Study|Withdrawal by Subject|1|||
47055805|NCT01750229|83330287|FG000|Randomized Crossover Phase|Adverse Event|1|||
47055806|NCT01750229|83330287|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
47055807|NCT01750229|83330287|FG000|Long-term Follow-up Phase|Adverse Event|2|||
47055808|NCT01750229|83330287|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
47055809|NCT01724489|83330299|FG000|Overall Study|Adverse Event|8|||
47055810|NCT01724489|83330300|FG001|Overall Study|Adverse Event|3|||
47055811|NCT01724489|83330299|FG000|Overall Study|Surgery, medication|1|||
46757432|NCT00502801|82975508|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
46930268|NCT02253810|83165408|FG000|Overall Study|Unknown concomitant procedure|3|||
46930269|NCT02253810|83165409|FG001|Overall Study|Unknown concomitant procedure|2|||
46930270|NCT02732912|83165433|FG000|Overall Study|Discharged before night|2|||
46930271|NCT02732912|83165434|FG001|Overall Study|Discharged before night|6|||
46930272|NCT02732912|83165433|FG000|Overall Study|Incomplete completion of questionnaire|2|||
46930273|NCT02732912|83165434|FG001|Overall Study|Incomplete completion of questionnaire|3|||
46930274|NCT02732912|83165433|FG000|Overall Study|No outcome; discharged or refused|6|||
46930275|NCT02732912|83165434|FG001|Overall Study|No outcome; discharged or refused|9|||
46757433|NCT00502801|82975508|FG000|End of Therapy to Test of Cure|Death|3|||
46757434|NCT00502801|82975508|FG000|End of Therapy to Test of Cure|OTHER|2|||
46757435|NCT00824265|82975514|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
46757436|NCT00824265|82975515|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
46757437|NCT00824265|82975514|FG000|Treatment Phase|Protocol Violation|1|||
46757438|NCT00824265|82975515|FG001|Treatment Phase|Protocol Violation|0|||
46757439|NCT00824265|82975514|FG000|Treatment Phase|Lost to Follow-up|1|||
46757440|NCT00824265|82975515|FG001|Treatment Phase|Lost to Follow-up|1|||
46757441|NCT00824265|82975514|FG000|Treatment Phase|Physician Decision|6|||
46757442|NCT00824265|82975515|FG001|Treatment Phase|Physician Decision|12|||
46757443|NCT00824265|82975514|FG000|Treatment Phase|Withdrawal by Subject|6|||
46757444|NCT00824265|82975515|FG001|Treatment Phase|Withdrawal by Subject|15|||
46757445|NCT00824265|82975514|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
46757446|NCT00824265|82975515|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
46757447|NCT00824265|82975514|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
46757448|NCT00824265|82975515|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
46757449|NCT00855894|82975525|FG000|Overall Study|Death|31|||
46757450|NCT00855894|82975525|FG000|Overall Study|Patient's decision|1|||
46757451|NCT00855894|82975525|FG000|Overall Study|Disease progression|1|||
46757452|NCT00855816|82975531|FG000|Overall Study|Withdrawal by Subject|22|||
46757453|NCT00855816|82975532|FG001|Overall Study|Withdrawal by Subject|15|||
46757454|NCT00855816|82975531|FG000|Overall Study|Lost to Follow-up|3|||
46930276|NCT02792517|83165440|FG000|Overall Study|Withdrawal by Subject|10|||
47055812|NCT01724489|83330300|FG001|Overall Study|Surgery, medication|1|||
46757455|NCT00855816|82975532|FG001|Overall Study|Lost to Follow-up|5|||
46757456|NCT00855816|82975531|FG000|Overall Study|Death|1|||
46757457|NCT00855816|82975532|FG001|Overall Study|Death|0|||
46757458|NCT00855816|82975531|FG000|Overall Study|Became ineligible|0|||
46757459|NCT00855816|82975532|FG001|Overall Study|Became ineligible|1|||
46930277|NCT02792517|83165440|FG000|Overall Study|Decision by Sponsor|7|||
47055813|NCT01724489|83330299|FG000|Overall Study|Lost to Follow-up|1|||
47055814|NCT01724489|83330300|FG001|Overall Study|Lost to Follow-up|2|||
47055815|NCT01724489|83330299|FG000|Overall Study|Withdrawal by Subject|6|||
47055816|NCT01724489|83330300|FG001|Overall Study|Withdrawal by Subject|6|||
47055817|NCT01724177|83330315|FG000|Overall Study|Adverse Event|8|||
47055818|NCT01724177|83330315|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
47055819|NCT01724177|83330315|FG000|Overall Study|Nervous participant|1|||
46816345|NCT00469014|83036260|FG002|Initial Phase Randomization|No Response|0|||
46816346|NCT00469014|83036261|FG003|Initial Phase Randomization|No Response|1|||
46816347|NCT00469014|83036258|FG000|Adaptive Randomization|Not Evaluable|1|||
46816348|NCT00469014|83036259|FG001|Adaptive Randomization|Not Evaluable|0|||
46816349|NCT00469014|83036260|FG002|Adaptive Randomization|Not Evaluable|0|||
46816350|NCT00469014|83036261|FG003|Adaptive Randomization|Not Evaluable|1|||
46816351|NCT00469014|83036258|FG000|Adaptive Randomization|No Response|0|||
46816352|NCT00469014|83036259|FG001|Adaptive Randomization|No Response|1|||
46816353|NCT00469014|83036260|FG002|Adaptive Randomization|No Response|0|||
46816354|NCT00469014|83036261|FG003|Adaptive Randomization|No Response|0|||
46816355|NCT00469014|83036258|FG000|Adaptive Randomization|Death|0|||
46816356|NCT00469014|83036259|FG001|Adaptive Randomization|Death|0|||
46816357|NCT00469014|83036260|FG002|Adaptive Randomization|Death|1|||
46816358|NCT00469014|83036261|FG003|Adaptive Randomization|Death|0|||
46816359|NCT00493038|83036273|FG000|Treatment|Adverse Event|8|||
46816360|NCT00493038|83036274|FG001|Treatment|Adverse Event|4|||
46816361|NCT00493038|83036273|FG000|Treatment|Lost to Follow-up|5|||
46816362|NCT00493038|83036274|FG001|Treatment|Lost to Follow-up|3|||
46816363|NCT00493038|83036273|FG000|Treatment|Withdrawal by Subject|11|||
46816364|NCT00493038|83036274|FG001|Treatment|Withdrawal by Subject|12|||
46816365|NCT00493038|83036273|FG000|Treatment|Other|0|||
46816366|NCT00493038|83036274|FG001|Treatment|Other|1|||
46816367|NCT00493038|83036273|FG000|Follow-up|Lost to Follow-up|1|||
46816368|NCT00493038|83036274|FG001|Follow-up|Lost to Follow-up|0|||
46816369|NCT00392223|83036282|FG000|Overall Study|Adverse Event|5|||
46816370|NCT00392223|83036283|FG001|Overall Study|Adverse Event|4|||
46816371|NCT00392223|83036282|FG000|Overall Study|Lost to Follow-up|1|||
46816372|NCT00392223|83036283|FG001|Overall Study|Lost to Follow-up|4|||
46816373|NCT00392223|83036282|FG000|Overall Study|Protocol Violation|0|||
46816374|NCT00392223|83036283|FG001|Overall Study|Protocol Violation|3|||
46816375|NCT00392223|83036282|FG000|Overall Study|Withdrawal by Subject|3|||
46816376|NCT00392223|83036283|FG001|Overall Study|Withdrawal by Subject|2|||
46816377|NCT00402285|83036292|FG000|Overall Study|insufficient RNA quality|7|||
46816378|NCT00402285|83036293|FG001|Overall Study|insufficient RNA quality|6|||
46816379|NCT00402285|83036294|FG002|Overall Study|insufficient RNA quality|2|||
46816380|NCT00413283|83036304|FG000|Overall Study|Withdrawal by Subject|1|||
46816381|NCT00413283|83036305|FG001|Overall Study|Withdrawal by Subject|0|||
46816382|NCT00413283|83036306|FG002|Overall Study|Withdrawal by Subject|0|||
46816383|NCT00413283|83036307|FG003|Overall Study|Withdrawal by Subject|1|||
46757460|NCT00855738|82975538|FG000|Overall Study|Lost to Follow-up|2|||
46757461|NCT00855738|82975538|FG000|Overall Study|Adverse Event|1|||
46816384|NCT00413283|83036304|FG000|Overall Study|Death|0|||
46816385|NCT00413283|83036305|FG001|Overall Study|Death|0|||
46816386|NCT00413283|83036306|FG002|Overall Study|Death|1|||
46816387|NCT00413283|83036307|FG003|Overall Study|Death|1|||
46816388|NCT00413283|83036304|FG000|Overall Study|Adverse Event|0|||
46757462|NCT00855738|82975538|FG000|Overall Study|Subject Defaulted|1|||
46757463|NCT00855738|82975538|FG000|Overall Study|Death|1|||
46757464|NCT05093790|82975570|FG000|Overall Study|Failure to meet continuation criteria|0|||
46757465|NCT05093790|82975571|FG001|Overall Study|Failure to meet continuation criteria|0|||
46757466|NCT05093790|82975572|FG002|Overall Study|Failure to meet continuation criteria|1|||
46757467|NCT05093790|82975573|FG003|Overall Study|Failure to meet continuation criteria|0|||
46757468|NCT05093790|82975570|FG000|Overall Study|Adverse Event|1|||
46757469|NCT05093790|82975571|FG001|Overall Study|Adverse Event|0|||
46757470|NCT05093790|82975572|FG002|Overall Study|Adverse Event|0|||
46757471|NCT05093790|82975573|FG003|Overall Study|Adverse Event|0|||
46816389|NCT00413283|83036305|FG001|Overall Study|Adverse Event|0|||
46816390|NCT00413283|83036306|FG002|Overall Study|Adverse Event|0|||
46816391|NCT00413283|83036307|FG003|Overall Study|Adverse Event|1|||
47055820|NCT01724177|83330315|FG000|Overall Study|Serious Adverse Event Related|1|||
46757472|NCT04739306|82975614|FG000|Main Study Period|Adverse Event|6|||
46757473|NCT04739306|82975615|FG001|Main Study Period|Adverse Event|7|||
46757474|NCT04739306|82975614|FG000|Main Study Period|Lost to Follow-up|4|||
46757475|NCT04739306|82975615|FG001|Main Study Period|Lost to Follow-up|6|||
46757476|NCT04739306|82975614|FG000|Main Study Period|Physician Decision|1|||
46757477|NCT04739306|82975615|FG001|Main Study Period|Physician Decision|1|||
46757478|NCT04739306|82975614|FG000|Main Study Period|Withdrawal by Subject|8|||
46816392|NCT00413283|83036304|FG000|Overall Study|Ineligibility determined|0|||
46816393|NCT00413283|83036305|FG001|Overall Study|Ineligibility determined|0|||
46816394|NCT00413283|83036306|FG002|Overall Study|Ineligibility determined|0|||
46816395|NCT00413283|83036307|FG003|Overall Study|Ineligibility determined|1|||
46816396|NCT00413283|83036304|FG000|Overall Study|Protocol deviation|0|||
46816397|NCT00413283|83036305|FG001|Overall Study|Protocol deviation|1|||
46816398|NCT00413283|83036306|FG002|Overall Study|Protocol deviation|0|||
46816399|NCT00413283|83036307|FG003|Overall Study|Protocol deviation|0|||
46816400|NCT00413283|83036304|FG000|Overall Study|Requirement for alternative therapy|0|||
46816401|NCT00413283|83036305|FG001|Overall Study|Requirement for alternative therapy|2|||
46816402|NCT00413283|83036306|FG002|Overall Study|Requirement for alternative therapy|0|||
46930278|NCT02792517|83165440|FG000|Overall Study|Lost to Follow-up|3|||
46930279|NCT01369485|83165475|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
46930280|NCT01369485|83165476|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
46930281|NCT01369485|83165475|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
46930282|NCT01369485|83165476|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
46930283|NCT01369485|83165475|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
46930284|NCT01369485|83165476|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
46930285|NCT01369485|83165475|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
46930286|NCT01369485|83165476|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
46930287|NCT01369485|83165475|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
46930288|NCT01369485|83165476|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
46930289|NCT01369485|83165475|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
46930290|NCT01369485|83165476|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
46930291|NCT01369485|83165475|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
46930292|NCT01369485|83165476|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
46930293|NCT01369485|83165475|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
46930294|NCT01369485|83165476|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
46930295|NCT01369485|83165475|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
46930296|NCT01369485|83165476|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
46930297|NCT01369485|83165475|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
46930298|NCT01369485|83165476|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
46930299|NCT02886572|83165503|FG000|Overall Study|Death|8|||
46930300|NCT02741700|83165516|FG000|Overall Study|Lost to Follow-up|17|||
46930301|NCT02741700|83165517|FG001|Overall Study|Lost to Follow-up|8|||
46930302|NCT02741700|83165516|FG000|Overall Study|Withdrawal by Subject|2|||
46930303|NCT02741700|83165517|FG001|Overall Study|Withdrawal by Subject|5|||
46930304|NCT02741700|83165516|FG000|Overall Study|Physician Decision|3|||
46930305|NCT02741700|83165517|FG001|Overall Study|Physician Decision|0|||
46930306|NCT02741700|83165516|FG000|Overall Study|Moved out of State|0|||
46930307|NCT02741700|83165517|FG001|Overall Study|Moved out of State|1|||
46930308|NCT02741700|83165516|FG000|Overall Study|Death|4|||
46930309|NCT02741700|83165517|FG001|Overall Study|Death|5|||
46930310|NCT00430950|83165525|FG000|Overall Study|Adverse Event|7|||
46930311|NCT00430950|83165526|FG001|Overall Study|Adverse Event|6|||
46930312|NCT00430950|83165525|FG000|Overall Study|Withdrawal by Subject|1|||
46930313|NCT00430950|83165526|FG001|Overall Study|Withdrawal by Subject|0|||
46930314|NCT00430950|83165525|FG000|Overall Study|concomitant medication,etc.|5|||
46930315|NCT00430950|83165526|FG001|Overall Study|concomitant medication,etc.|7|||
46930316|NCT02081391|83165534|FG000|12-hour Treatment|Withdrawal by Subject|3|||
46930317|NCT02081391|83165535|FG001|12-hour Treatment|Withdrawal by Subject|2|||
46930318|NCT02081391|83165536|FG002|12-hour Treatment|Withdrawal by Subject|0|||
46930319|NCT02081391|83165537|FG003|12-hour Treatment|Withdrawal by Subject|0|||
46930320|NCT02081391|83165534|FG000|12-hour Treatment|Physician Decision|4|||
46930321|NCT02081391|83165535|FG001|12-hour Treatment|Physician Decision|1|||
46930322|NCT02081391|83165536|FG002|12-hour Treatment|Physician Decision|0|||
46930323|NCT02081391|83165537|FG003|12-hour Treatment|Physician Decision|0|||
46930324|NCT02081391|83165534|FG000|12-hour Treatment|Lack of Efficacy|3|||
46930325|NCT02081391|83165535|FG001|12-hour Treatment|Lack of Efficacy|0|||
46930326|NCT02081391|83165536|FG002|12-hour Treatment|Lack of Efficacy|0|||
46930327|NCT02081391|83165537|FG003|12-hour Treatment|Lack of Efficacy|0|||
46930328|NCT02081391|83165534|FG000|12-hour Treatment|Adverse Event|4|||
46930329|NCT02081391|83165535|FG001|12-hour Treatment|Adverse Event|2|||
46930330|NCT02081391|83165536|FG002|12-hour Treatment|Adverse Event|0|||
46930331|NCT02081391|83165537|FG003|12-hour Treatment|Adverse Event|0|||
46930332|NCT02081391|83165534|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
46930333|NCT02081391|83165535|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
46930334|NCT02081391|83165536|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
46930335|NCT02081391|83165537|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
46930336|NCT02081391|83165534|FG000|12-hour Treatment|Further reasons|2|||
46930337|NCT02081391|83165535|FG001|12-hour Treatment|Further reasons|1|||
46930338|NCT02081391|83165536|FG002|12-hour Treatment|Further reasons|0|||
46930339|NCT02081391|83165537|FG003|12-hour Treatment|Further reasons|0|||
46930340|NCT02081391|83165534|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
46930341|NCT02081391|83165535|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
46930342|NCT02081391|83165536|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
46930343|NCT02081391|83165537|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
46930344|NCT02081391|83165534|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
46930345|NCT02081391|83165535|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
46930346|NCT02081391|83165536|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
46930347|NCT02081391|83165537|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
46930348|NCT02081391|83165534|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
46930349|NCT02081391|83165535|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
47055821|NCT01724021|83330332|FG000|Overall Study|Adverse Event|11|||
47055822|NCT01724021|83330333|FG001|Overall Study|Adverse Event|6|||
47055823|NCT01724021|83330332|FG000|Overall Study|Death|46|||
47055824|NCT01724021|83330333|FG001|Overall Study|Death|58|||
47055825|NCT01724021|83330332|FG000|Overall Study|Participant request/ Withdrew consent|18|||
47055826|NCT01724021|83330333|FG001|Overall Study|Participant request/ Withdrew consent|14|||
47055827|NCT01724021|83330332|FG000|Overall Study|Lost to Follow-up|15|||
47055828|NCT01724021|83330333|FG001|Overall Study|Lost to Follow-up|15|||
46757479|NCT04739306|82975615|FG001|Main Study Period|Withdrawal by Subject|6|||
46757480|NCT04739306|82975614|FG000|Main Study Period|Protocol Violation|0|||
46757481|NCT04739306|82975615|FG001|Main Study Period|Protocol Violation|1|||
46757482|NCT04739306|82975614|FG000|Main Study Period|War in Ukraine|1|||
46757483|NCT04739306|82975615|FG001|Main Study Period|War in Ukraine|1|||
46757484|NCT04442490|82975628|FG000|Overall Study|Withdrawal by Subject|18|||
46757485|NCT04442490|82975629|FG001|Overall Study|Withdrawal by Subject|10|||
46757486|NCT04442490|82975628|FG000|Overall Study|Lost to Follow-up|7|||
46757487|NCT04442490|82975629|FG001|Overall Study|Lost to Follow-up|7|||
46757488|NCT04442490|82975628|FG000|Overall Study|Adverse Event|2|||
46757489|NCT04442490|82975629|FG001|Overall Study|Adverse Event|6|||
46757490|NCT04442490|82975628|FG000|Overall Study|Noncompliance|3|||
46757491|NCT04442490|82975629|FG001|Overall Study|Noncompliance|1|||
46757492|NCT04442490|82975628|FG000|Overall Study|Physician Decision|2|||
46757493|NCT04442490|82975629|FG001|Overall Study|Physician Decision|1|||
46757494|NCT04442490|82975628|FG000|Overall Study|Reason not Specified|2|||
46757495|NCT04442490|82975629|FG001|Overall Study|Reason not Specified|1|||
46757496|NCT04442490|82975628|FG000|Overall Study|Randomized but not Treated|3|||
46757497|NCT04442490|82975629|FG001|Overall Study|Randomized but not Treated|3|||
46757498|NCT04375761|82975637|FG000|Overall Study|Death|1|||
46757499|NCT04375761|82975638|FG001|Overall Study|Death|2|||
46757500|NCT04375761|82975637|FG000|Overall Study|Lost to Follow-up|203|||
46757501|NCT04375761|82975638|FG001|Overall Study|Lost to Follow-up|380|||
46757502|NCT04375761|82975637|FG000|Overall Study|Withdrawal by Subject|47|||
46757503|NCT04375761|82975638|FG001|Overall Study|Withdrawal by Subject|98|||
46757504|NCT04375761|82975637|FG000|Overall Study|Noncompliance with study procedure|121|||
46757505|NCT04375761|82975638|FG001|Overall Study|Noncompliance with study procedure|251|||
46757506|NCT04375761|82975637|FG000|Overall Study|Reimbursement not enough|1|||
46757507|NCT04375761|82975638|FG001|Overall Study|Reimbursement not enough|2|||
46757508|NCT04375761|82975637|FG000|Overall Study|Unforeseen family circumstances|1|||
46757509|NCT04375761|82975638|FG001|Overall Study|Unforeseen family circumstances|3|||
46757510|NCT04375761|82975637|FG000|Overall Study|Test too painful|1|||
46757511|NCT04375761|82975638|FG001|Overall Study|Test too painful|1|||
46757512|NCT04375761|82975637|FG000|Overall Study|Moved|0|||
46757513|NCT04375761|82975638|FG001|Overall Study|Moved|2|||
46757514|NCT04375761|82975637|FG000|Overall Study|Nonresponsive|0|||
46757515|NCT04375761|82975638|FG001|Overall Study|Nonresponsive|5|||
46757516|NCT04219189|82975647|FG000|Overall Study|Withdrawal by Subject|1|||
46757517|NCT04219189|82975648|FG001|Overall Study|Withdrawal by Subject|2|||
46757518|NCT04219189|82975647|FG000|Overall Study|Protocol Violation|0|||
46757519|NCT04219189|82975648|FG001|Overall Study|Protocol Violation|1|||
46757520|NCT04219189|82975647|FG000|Overall Study|Lost to Follow-up|0|||
46757521|NCT04219189|82975648|FG001|Overall Study|Lost to Follow-up|1|||
46757522|NCT04219189|82975647|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
46757523|NCT04219189|82975648|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
46757524|NCT04209725|82975656|FG000|Overall Study|Adverse Event|1|||
46757525|NCT04164901|82975662|FG000|Overall Study|Withdrawal by Subject|4|||
46757526|NCT04164901|82975663|FG001|Overall Study|Withdrawal by Subject|4|||
46757527|NCT03739762|82975681|FG000|Overall Study|Lost to Follow-up|1|||
46757528|NCT03739762|82975682|FG001|Overall Study|Lost to Follow-up|1|||
46757529|NCT03739762|82975681|FG000|Overall Study|Withdrawal by Subject|2|||
46757530|NCT03739762|82975682|FG001|Overall Study|Withdrawal by Subject|6|||
46757531|NCT03725605|82975688|FG000|Overall Study|Unsuccessful TIL expansion|2|||
46757532|NCT03650387|82975692|FG000|Overall Study|Withdrawal by Subject|13|||
46757533|NCT03650387|82975692|FG000|Overall Study|Lost to Follow-up|12|||
46757534|NCT03650387|82975692|FG000|Overall Study|Adverse Event (Not related)|1|||
46757535|NCT03650387|82975692|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
47055829|NCT01724021|83330332|FG000|Overall Study|Reason Not Specified|36|||
47055830|NCT01724021|83330333|FG001|Overall Study|Reason Not Specified|39|||
47055831|NCT01724021|83330332|FG000|Overall Study|Missing|1|||
46757536|NCT03536754|82975718|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
46757537|NCT03536754|82975719|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
46757538|NCT03536754|82975720|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
46757539|NCT03536754|82975721|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
46757540|NCT03536754|82975722|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
46757541|NCT03536754|82975718|FG000|Open Label Extension|Other|0|||
46757542|NCT03536754|82975719|FG001|Open Label Extension|Other|0|||
46816403|NCT00413283|83036307|FG003|Overall Study|Requirement for alternative therapy|0|||
46757543|NCT03536754|82975720|FG002|Open Label Extension|Other|0|||
47055832|NCT01724021|83330333|FG001|Overall Study|Missing|1|||
47055833|NCT01723397|83330347|FG000|Study Period 1|Protocol Violation|0|||
47055834|NCT01723397|83330348|FG001|Study Period 1|Protocol Violation|1|||
47055835|NCT01723397|83330347|FG000|Study Period 2|Protocol Violation|0|||
47055836|NCT01723397|83330348|FG001|Study Period 2|Protocol Violation|1|||
47055837|NCT01723163|83330356|FG000|Treatment Phase|Withdrawal by Subject|14|||
47055838|NCT01723163|83330357|FG001|Treatment Phase|Withdrawal by Subject|6|||
47055839|NCT01723163|83330356|FG000|Treatment Phase|Withdrawal by PI|5|||
47055840|NCT01723163|83330357|FG001|Treatment Phase|Withdrawal by PI|1|||
46816404|NCT00413283|83036304|FG000|Overall Study|Other|0|||
46816405|NCT00413283|83036305|FG001|Overall Study|Other|0|||
46816406|NCT00413283|83036306|FG002|Overall Study|Other|1|||
46816407|NCT00413283|83036307|FG003|Overall Study|Other|0|||
46816408|NCT00402051|83036319|FG000|Overall Study|Progressive Disease|13|||
46816409|NCT00402051|83036320|FG001|Overall Study|Progressive Disease|20|||
46816410|NCT00402051|83036319|FG000|Overall Study|Adverse Event|11|||
46816411|NCT00402051|83036320|FG001|Overall Study|Adverse Event|4|||
46816412|NCT00402051|83036319|FG000|Overall Study|Physician Decision|7|||
46816413|NCT00402051|83036320|FG001|Overall Study|Physician Decision|3|||
46816414|NCT00402051|83036319|FG000|Overall Study|Withdrawal by Subject|3|||
46816415|NCT00402051|83036320|FG001|Overall Study|Withdrawal by Subject|3|||
46816416|NCT00402051|83036319|FG000|Overall Study|Death - Related to Study Drug|1|||
46816417|NCT00402051|83036320|FG001|Overall Study|Death - Related to Study Drug|2|||
46816418|NCT00402051|83036319|FG000|Overall Study|Death Due to Study Disease|2|||
46816419|NCT00402051|83036320|FG001|Overall Study|Death Due to Study Disease|1|||
46816420|NCT00402051|83036319|FG000|Overall Study|Death Due to Adverse Event|0|||
46816421|NCT00402051|83036320|FG001|Overall Study|Death Due to Adverse Event|2|||
46816422|NCT00402051|83036319|FG000|Overall Study|Lost to Follow-up|1|||
46816423|NCT00402051|83036320|FG001|Overall Study|Lost to Follow-up|0|||
46816424|NCT00468858|83036329|FG000|Overall Study|Adverse Event|0|||
46816425|NCT00468858|83036330|FG001|Overall Study|Adverse Event|1|||
46816426|NCT00468858|83036331|FG002|Overall Study|Adverse Event|0|||
46816427|NCT00468858|83036329|FG000|Overall Study|Withdrawal by Subject|7|||
46816428|NCT00468858|83036330|FG001|Overall Study|Withdrawal by Subject|4|||
46816429|NCT00468858|83036331|FG002|Overall Study|Withdrawal by Subject|5|||
46816430|NCT00468858|83036329|FG000|Overall Study|Relocation|1|||
46816431|NCT00468858|83036330|FG001|Overall Study|Relocation|3|||
47055841|NCT01723163|83330356|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
46816432|NCT00468858|83036331|FG002|Overall Study|Relocation|3|||
46816433|NCT00468858|83036329|FG000|Overall Study|Lost to Follow-up|1|||
46816434|NCT00468858|83036330|FG001|Overall Study|Lost to Follow-up|2|||
46816435|NCT00468858|83036331|FG002|Overall Study|Lost to Follow-up|5|||
46930350|NCT02081391|83165536|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
46930351|NCT02081391|83165537|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
47055842|NCT01723163|83330357|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
47055843|NCT01723163|83330356|FG000|3-Month Follow-up|Unable to Contact|12|||
47055844|NCT01723163|83330357|FG001|3-Month Follow-up|Unable to Contact|19|||
47055845|NCT01723163|83330356|FG000|6-Month Follow-up|Death|1|||
47055846|NCT01723163|83330357|FG001|6-Month Follow-up|Death|0|||
47055847|NCT01723163|83330356|FG000|6-Month Follow-up|Unable to Contact|17|||
46757544|NCT03536754|82975721|FG003|Open Label Extension|Other|0|||
46757545|NCT03536754|82975722|FG004|Open Label Extension|Other|1|||
46757546|NCT03436862|82975738|FG000|Overall Study|Adverse Event|4|||
46757547|NCT03436862|82975738|FG000|Overall Study|Progressive Disease|2|||
46757548|NCT02887248|82975786|FG000|Overall Study|Withdrawal by Subject|1|||
46757549|NCT02887248|82975786|FG000|Overall Study|Adverse Event|1|||
46757550|NCT02887248|82975786|FG000|Overall Study|Progressive Disease|1|||
46757551|NCT02859064|82975790|FG000|Overall Study|Progressive Disease|3|||
46757552|NCT02859064|82975790|FG000|Overall Study|Physician Decision|1|||
46757553|NCT02859064|82975790|FG000|Overall Study|Withdrawal by Subject|1|||
46757554|NCT02859064|82975790|FG000|Overall Study|Death|1|||
46757555|NCT02843074|82975794|FG000|Overall Study|Withdrawal by Subject|5|||
46757556|NCT02843074|82975794|FG000|Overall Study|Progressive disease|1|||
46757557|NCT02843074|82975794|FG000|Overall Study|Physician Decision|1|||
46757558|NCT02843074|82975794|FG000|Overall Study|Lost to Follow-up|1|||
46757559|NCT02843074|82975794|FG000|Overall Study|Death|9|||
46757560|NCT02795156|82975802|FG000|Overall Study|Progressive Disease|22|||
46757561|NCT02795156|82975803|FG001|Overall Study|Progressive Disease|7|||
46757562|NCT02795156|82975804|FG002|Overall Study|Progressive Disease|34|||
46757563|NCT02795156|82975805|FG003|Overall Study|Progressive Disease|7|||
46757564|NCT02795156|82975802|FG000|Overall Study|Adverse Event|13|||
46757565|NCT02795156|82975803|FG001|Overall Study|Adverse Event|2|||
46757566|NCT02795156|82975804|FG002|Overall Study|Adverse Event|3|||
46757567|NCT02795156|82975805|FG003|Overall Study|Adverse Event|2|||
46757568|NCT02795156|82975802|FG000|Overall Study|Death|1|||
46757569|NCT02795156|82975803|FG001|Overall Study|Death|1|||
46816436|NCT00468858|83036329|FG000|Overall Study|Other|0|||
46816437|NCT00468858|83036330|FG001|Overall Study|Other|0|||
46930352|NCT02081391|83165534|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
46757570|NCT02795156|82975804|FG002|Overall Study|Death|1|||
46816438|NCT00468858|83036331|FG002|Overall Study|Other|1|||
46930353|NCT02081391|83165535|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
46930354|NCT02081391|83165536|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
46930355|NCT02081391|83165537|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
46930356|NCT02081391|83165534|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
46930357|NCT02081391|83165535|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
46930358|NCT02081391|83165536|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
46930359|NCT02081391|83165537|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
46930360|NCT02081391|83165534|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
46816439|NCT00401973|83036396|FG000|Overall Study|Adverse Event|2|||
46816440|NCT00401973|83036397|FG001|Overall Study|Adverse Event|8|||
46816441|NCT00401973|83036398|FG002|Overall Study|Adverse Event|4|||
46816442|NCT00401973|83036396|FG000|Overall Study|Clinical Relapse|0|||
46816443|NCT00401973|83036397|FG001|Overall Study|Clinical Relapse|1|||
46816444|NCT00401973|83036398|FG002|Overall Study|Clinical Relapse|1|||
46816445|NCT00401973|83036396|FG000|Overall Study|Lack of Efficacy|0|||
46816446|NCT00401973|83036397|FG001|Overall Study|Lack of Efficacy|0|||
46816447|NCT00401973|83036398|FG002|Overall Study|Lack of Efficacy|3|||
46816448|NCT00401973|83036396|FG000|Overall Study|Lost to Follow-up|2|||
46816449|NCT00401973|83036397|FG001|Overall Study|Lost to Follow-up|2|||
46816450|NCT00401973|83036398|FG002|Overall Study|Lost to Follow-up|2|||
46816451|NCT00401973|83036396|FG000|Overall Study|Physician Decision|2|||
46816452|NCT00401973|83036397|FG001|Overall Study|Physician Decision|0|||
46816453|NCT00401973|83036398|FG002|Overall Study|Physician Decision|1|||
46816454|NCT00401973|83036396|FG000|Overall Study|Protocol Violation|1|||
46816455|NCT00401973|83036397|FG001|Overall Study|Protocol Violation|2|||
46816456|NCT00401973|83036398|FG002|Overall Study|Protocol Violation|3|||
46816457|NCT00401973|83036396|FG000|Overall Study|Sponsor Decision|0|||
46816458|NCT00401973|83036397|FG001|Overall Study|Sponsor Decision|1|||
46816459|NCT00401973|83036398|FG002|Overall Study|Sponsor Decision|0|||
46816460|NCT00401973|83036396|FG000|Overall Study|Withdrawal by Subject|4|||
46816461|NCT00401973|83036397|FG001|Overall Study|Withdrawal by Subject|12|||
46816462|NCT00401973|83036398|FG002|Overall Study|Withdrawal by Subject|9|||
46930361|NCT02081391|83165535|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
46930362|NCT02081391|83165536|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
46930363|NCT02081391|83165537|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
46930364|NCT00430092|83165560|FG000|Overall Study|Adverse Event|0|||
46930365|NCT00430092|83165561|FG001|Overall Study|Adverse Event|0|||
46930366|NCT00430092|83165562|FG002|Overall Study|Adverse Event|1|||
46930367|NCT00430092|83165560|FG000|Overall Study|Lack of Efficacy|5|||
46930368|NCT00430092|83165561|FG001|Overall Study|Lack of Efficacy|2|||
47055848|NCT01723163|83330357|FG001|6-Month Follow-up|Unable to Contact|15|||
47055849|NCT01723163|83330356|FG000|12-Month Follow-up|Death|1|||
46757571|NCT02795156|82975805|FG003|Overall Study|Death|0|||
46757572|NCT02795156|82975802|FG000|Overall Study|Physician Decision|1|||
46757573|NCT02795156|82975803|FG001|Overall Study|Physician Decision|0|||
46757574|NCT02795156|82975804|FG002|Overall Study|Physician Decision|1|||
46930369|NCT00430092|83165562|FG002|Overall Study|Lack of Efficacy|54|||
46930370|NCT00430092|83165560|FG000|Overall Study|Lost to Follow-up|1|||
46930371|NCT00430092|83165561|FG001|Overall Study|Lost to Follow-up|0|||
46930372|NCT00430092|83165562|FG002|Overall Study|Lost to Follow-up|0|||
46930373|NCT00430092|83165560|FG000|Overall Study|Protocol Violation|0|||
46930374|NCT00430092|83165561|FG001|Overall Study|Protocol Violation|1|||
46930375|NCT00430092|83165562|FG002|Overall Study|Protocol Violation|1|||
46930376|NCT00430092|83165560|FG000|Overall Study|Withdrawal by Subject|0|||
46930377|NCT00430092|83165561|FG001|Overall Study|Withdrawal by Subject|1|||
46930378|NCT00430092|83165562|FG002|Overall Study|Withdrawal by Subject|1|||
47055850|NCT01723163|83330357|FG001|12-Month Follow-up|Death|0|||
47055851|NCT01723163|83330356|FG000|12-Month Follow-up|Unable to Contact|23|||
47055852|NCT01723163|83330357|FG001|12-Month Follow-up|Unable to Contact|28|||
46757575|NCT02795156|82975805|FG003|Overall Study|Physician Decision|0|||
46757576|NCT02795156|82975802|FG000|Overall Study|Withdrawal by Subject|2|||
46816463|NCT00401193|83036411|FG000|Overall Study|Adverse Event|1|||
46757577|NCT02795156|82975803|FG001|Overall Study|Withdrawal by Subject|0|||
46757578|NCT02795156|82975804|FG002|Overall Study|Withdrawal by Subject|3|||
46757579|NCT02795156|82975805|FG003|Overall Study|Withdrawal by Subject|0|||
46816464|NCT00401193|83036412|FG001|Overall Study|Adverse Event|3|||
46816465|NCT00401193|83036413|FG002|Overall Study|Adverse Event|1|||
46816466|NCT00401193|83036411|FG000|Overall Study|Protocol Violation|3|||
46816467|NCT00401193|83036412|FG001|Overall Study|Protocol Violation|1|||
46816468|NCT00401193|83036413|FG002|Overall Study|Protocol Violation|1|||
46930379|NCT00425100|83165567|FG000|Overall Study|Adverse Event|36|||
46930380|NCT00425100|83165567|FG000|Overall Study|Lack of Efficacy|4|||
46930381|NCT00425100|83165567|FG000|Overall Study|Lost to Follow-up|2|||
46930382|NCT00425100|83165567|FG000|Overall Study|Protocol Violation|4|||
46930383|NCT00425100|83165567|FG000|Overall Study|Withdrawal by Subject|7|||
46816469|NCT00401193|83036411|FG000|Overall Study|Lost to Follow-up|6|||
46816470|NCT00401193|83036412|FG001|Overall Study|Lost to Follow-up|5|||
46816471|NCT00401193|83036413|FG002|Overall Study|Lost to Follow-up|1|||
46816472|NCT00401193|83036411|FG000|Overall Study|Withdrawal by Subject|2|||
46816473|NCT00401193|83036412|FG001|Overall Study|Withdrawal by Subject|0|||
46816474|NCT00401193|83036413|FG002|Overall Study|Withdrawal by Subject|1|||
46816475|NCT00401193|83036411|FG000|Overall Study|Other Event|3|||
46816476|NCT00401193|83036412|FG001|Overall Study|Other Event|2|||
46816477|NCT00401193|83036413|FG002|Overall Study|Other Event|2|||
46816478|NCT00400569|83036422|FG000|Overall Study|Death|1|||
46816479|NCT00413049|83036431|FG000|Overall Study|Adverse Event|10|||
46816480|NCT00413049|83036432|FG001|Overall Study|Adverse Event|8|||
46816481|NCT00413049|83036431|FG000|Overall Study|Withdrawal by Subject|7|||
46816482|NCT00413049|83036432|FG001|Overall Study|Withdrawal by Subject|5|||
46816483|NCT00413049|83036431|FG000|Overall Study|Lost to Follow-up|2|||
46816484|NCT00413049|83036432|FG001|Overall Study|Lost to Follow-up|3|||
46816485|NCT00413049|83036431|FG000|Overall Study|Protocol Violation|3|||
46816486|NCT00413049|83036432|FG001|Overall Study|Protocol Violation|1|||
46816487|NCT00413049|83036431|FG000|Overall Study|Subject no longer requires study drug|0|||
46816488|NCT00413049|83036432|FG001|Overall Study|Subject no longer requires study drug|1|||
46816489|NCT00413049|83036431|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46816490|NCT00413049|83036432|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46816491|NCT00413049|83036431|FG000|Overall Study|Lack of Efficacy|1|||
46816492|NCT00413049|83036432|FG001|Overall Study|Lack of Efficacy|0|||
46816493|NCT00454194|83036440|FG000|Overall Study|Adverse Event|7|||
46816494|NCT00454194|83036441|FG001|Overall Study|Adverse Event|2|||
46816495|NCT00454194|83036440|FG000|Overall Study|Withdrawal by Subject|12|||
46816496|NCT00454194|83036441|FG001|Overall Study|Withdrawal by Subject|8|||
46816497|NCT00454194|83036440|FG000|Overall Study|Other Medical Problems|1|||
46930384|NCT00412932|83165572|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
46930385|NCT00412932|83165572|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
46930386|NCT00412932|83165572|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
46930387|NCT00412932|83165572|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
46930388|NCT00412932|83165572|FG000|Olmesartan (Olm) 20 mg|Other|1|||
46930389|NCT00412932|83165572|FG000|Olmesartan 40 mg|Adverse Event|4|||
46930390|NCT00412932|83165572|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
46930391|NCT00412932|83165572|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
46930392|NCT00412932|83165572|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
46930393|NCT00412932|83165572|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
46930394|NCT00412932|83165572|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
46930395|NCT00412932|83165572|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
46930396|NCT02696031|83165578|FG000|Up to Week 24|Adverse Event|2|||
46930397|NCT02696031|83165579|FG001|Up to Week 24|Adverse Event|4|||
46930398|NCT02696031|83165580|FG002|Up to Week 24|Adverse Event|2|||
46816498|NCT00454194|83036441|FG001|Overall Study|Other Medical Problems|2|||
46816499|NCT00454194|83036440|FG000|Overall Study|Other Unspecified Reason|2|||
46816500|NCT00454194|83036441|FG001|Overall Study|Other Unspecified Reason|2|||
46816501|NCT00412971|83036449|FG000|Overall Study|Lost to Follow-up|17|||
46816502|NCT00412971|83036450|FG001|Overall Study|Lost to Follow-up|9|||
46816503|NCT00412971|83036449|FG000|Overall Study|Protocol Violation|13|||
46816504|NCT00412971|83036450|FG001|Overall Study|Protocol Violation|1|||
47055853|NCT01722071|83330367|FG000|Overall Study|Protocol Violation|1|||
46757580|NCT02636582|82975834|FG000|Overall Study|Surgical Pathology|1|||
46757581|NCT02636582|82975835|FG001|Overall Study|Surgical Pathology|0|||
46757582|NCT02318784|82975909|FG000|Overall Study|Adverse Event|13|||
46757583|NCT02318784|82975909|FG000|Overall Study|Death|2|||
46757584|NCT02318784|82975909|FG000|Overall Study|Progressive Disease|37|||
46757585|NCT02318784|82975909|FG000|Overall Study|Withdrawal by Subject|10|||
46757586|NCT02195011|82975915|FG000|Overall Study|Adverse Event|4|||
46757587|NCT02195011|82975916|FG001|Overall Study|Adverse Event|0|||
46757588|NCT02195011|82975915|FG000|Overall Study|Progressive Disease|18|||
46757589|NCT02195011|82975916|FG001|Overall Study|Progressive Disease|1|||
46757590|NCT02195011|82975915|FG000|Overall Study|Withdrawal by Subject|3|||
46757591|NCT02195011|82975916|FG001|Overall Study|Withdrawal by Subject|0|||
46816505|NCT00303472|83036463|FG000|Treatment Period|Adverse Event|0|||
46816506|NCT00303472|83036464|FG001|Treatment Period|Adverse Event|0|||
46816507|NCT00303472|83036465|FG002|Treatment Period|Adverse Event|0|||
46816508|NCT00303472|83036466|FG003|Treatment Period|Adverse Event|0|||
46816509|NCT00303472|83036467|FG004|Treatment Period|Adverse Event|1|||
46816510|NCT00303472|83036468|FG005|Treatment Period|Adverse Event|0|||
46757592|NCT02087501|82975922|FG000|Overall Study|Death|7|||
46816511|NCT00303472|83036469|FG006|Treatment Period|Adverse Event|0|||
46757593|NCT02087501|82975922|FG000|Overall Study|Open repair of aneurysm|1|||
46816512|NCT00303472|83036463|FG000|Treatment Period|Death|0|||
46816513|NCT00303472|83036464|FG001|Treatment Period|Death|0|||
46930399|NCT02696031|83165581|FG003|Up to Week 24|Adverse Event|0|||
46930400|NCT02696031|83165582|FG004|Up to Week 24|Adverse Event|0|||
46930401|NCT02696031|83165583|FG005|Up to Week 24|Adverse Event|0|||
46930402|NCT02696031|83165578|FG000|Up to Week 24|Lack of Efficacy|2|||
46816514|NCT00303472|83036465|FG002|Treatment Period|Death|0|||
46816515|NCT00303472|83036466|FG003|Treatment Period|Death|1|||
46930403|NCT02696031|83165579|FG001|Up to Week 24|Lack of Efficacy|1|||
46930404|NCT02696031|83165580|FG002|Up to Week 24|Lack of Efficacy|2|||
46930405|NCT02696031|83165581|FG003|Up to Week 24|Lack of Efficacy|0|||
46930406|NCT02696031|83165582|FG004|Up to Week 24|Lack of Efficacy|0|||
46930407|NCT02696031|83165583|FG005|Up to Week 24|Lack of Efficacy|0|||
46930408|NCT02696031|83165578|FG000|Up to Week 24|Lost to Follow-up|0|||
46930409|NCT02696031|83165579|FG001|Up to Week 24|Lost to Follow-up|1|||
46930410|NCT02696031|83165580|FG002|Up to Week 24|Lost to Follow-up|1|||
46930411|NCT02696031|83165581|FG003|Up to Week 24|Lost to Follow-up|0|||
46930412|NCT02696031|83165582|FG004|Up to Week 24|Lost to Follow-up|0|||
46930413|NCT02696031|83165583|FG005|Up to Week 24|Lost to Follow-up|0|||
46930414|NCT02696031|83165578|FG000|Up to Week 24|Physician Decision|1|||
46930415|NCT02696031|83165579|FG001|Up to Week 24|Physician Decision|0|||
46930416|NCT02696031|83165580|FG002|Up to Week 24|Physician Decision|1|||
46930417|NCT02696031|83165581|FG003|Up to Week 24|Physician Decision|0|||
46930418|NCT02696031|83165582|FG004|Up to Week 24|Physician Decision|0|||
46930419|NCT02696031|83165583|FG005|Up to Week 24|Physician Decision|0|||
46930420|NCT02696031|83165578|FG000|Up to Week 24|Protocol Violation|1|||
46930421|NCT02696031|83165579|FG001|Up to Week 24|Protocol Violation|0|||
46930422|NCT02696031|83165580|FG002|Up to Week 24|Protocol Violation|0|||
46930423|NCT02696031|83165581|FG003|Up to Week 24|Protocol Violation|0|||
46930424|NCT02696031|83165582|FG004|Up to Week 24|Protocol Violation|0|||
46757594|NCT02087501|82975922|FG000|Overall Study|Lost to Follow-up|2|||
46816516|NCT00303472|83036467|FG004|Treatment Period|Death|0|||
46816517|NCT00303472|83036468|FG005|Treatment Period|Death|0|||
46816518|NCT00303472|83036469|FG006|Treatment Period|Death|1|||
46816519|NCT00303472|83036463|FG000|Treatment Period|Withdrawal by Subject|0|||
46816520|NCT00303472|83036464|FG001|Treatment Period|Withdrawal by Subject|0|||
46816521|NCT00303472|83036465|FG002|Treatment Period|Withdrawal by Subject|0|||
46816522|NCT00303472|83036466|FG003|Treatment Period|Withdrawal by Subject|1|||
46816523|NCT00303472|83036467|FG004|Treatment Period|Withdrawal by Subject|0|||
46816524|NCT00303472|83036468|FG005|Treatment Period|Withdrawal by Subject|1|||
46816525|NCT00303472|83036469|FG006|Treatment Period|Withdrawal by Subject|0|||
46816526|NCT00303472|83036463|FG000|Treatment Period|Other|0|||
46816527|NCT00303472|83036464|FG001|Treatment Period|Other|0|||
46816528|NCT00303472|83036465|FG002|Treatment Period|Other|0|||
46816529|NCT00303472|83036466|FG003|Treatment Period|Other|0|||
46816530|NCT00303472|83036467|FG004|Treatment Period|Other|1|||
46816531|NCT00303472|83036468|FG005|Treatment Period|Other|0|||
46816532|NCT00303472|83036469|FG006|Treatment Period|Other|1|||
46816533|NCT00303472|83036463|FG000|Treatment Period|Disease Progression (to AML)|0|||
46816534|NCT00303472|83036464|FG001|Treatment Period|Disease Progression (to AML)|0|||
46816535|NCT00303472|83036465|FG002|Treatment Period|Disease Progression (to AML)|0|||
46816536|NCT00303472|83036466|FG003|Treatment Period|Disease Progression (to AML)|0|||
46930425|NCT02696031|83165583|FG005|Up to Week 24|Protocol Violation|0|||
46930426|NCT02696031|83165578|FG000|Up to Week 24|Withdrawal by Subject|4|||
46757595|NCT01897454|82975928|FG000|Overall Study|Withdrawal by Subject|1|||
46757596|NCT01856023|82975934|FG000|Overall Study|Death|1|||
46757597|NCT01856023|82975935|FG001|Overall Study|Death|2|||
46757598|NCT01856023|82975934|FG000|Overall Study|Adverse Event|2|||
46757599|NCT01856023|82975935|FG001|Overall Study|Adverse Event|1|||
46757600|NCT01856023|82975934|FG000|Overall Study|Lack of Efficacy|5|||
46757601|NCT01856023|82975935|FG001|Overall Study|Lack of Efficacy|5|||
46757602|NCT01856023|82975934|FG000|Overall Study|non compliance, study closure|1|||
46757603|NCT01856023|82975935|FG001|Overall Study|non compliance, study closure|3|||
46757604|NCT01856023|82975934|FG000|Overall Study|Withdrawal by Subject|1|||
46757605|NCT01856023|82975935|FG001|Overall Study|Withdrawal by Subject|1|||
46757606|NCT01364597|82975947|FG000|Overall Study|Adverse Event|4|||
46757607|NCT01364597|82975948|FG001|Overall Study|Adverse Event|5|||
46757608|NCT01364597|82975949|FG002|Overall Study|Adverse Event|16|||
46757609|NCT01364597|82975950|FG003|Overall Study|Adverse Event|7|||
46757610|NCT01364597|82975947|FG000|Overall Study|Lack of Efficacy|4|||
46816537|NCT00303472|83036467|FG004|Treatment Period|Disease Progression (to AML)|1|||
46816538|NCT00303472|83036468|FG005|Treatment Period|Disease Progression (to AML)|0|||
46816539|NCT00303472|83036469|FG006|Treatment Period|Disease Progression (to AML)|0|||
46757611|NCT01364597|82975948|FG001|Overall Study|Lack of Efficacy|4|||
46816540|NCT00303472|83036463|FG000|Treatment Extension (Optional)|Adverse Event|1|||
46816541|NCT00303472|83036464|FG001|Treatment Extension (Optional)|Adverse Event|0|||
46816542|NCT00303472|83036465|FG002|Treatment Extension (Optional)|Adverse Event|1|||
46816543|NCT00303472|83036466|FG003|Treatment Extension (Optional)|Adverse Event|0|||
46930427|NCT02696031|83165579|FG001|Up to Week 24|Withdrawal by Subject|1|||
46930428|NCT02696031|83165580|FG002|Up to Week 24|Withdrawal by Subject|5|||
46930429|NCT02696031|83165581|FG003|Up to Week 24|Withdrawal by Subject|0|||
46930430|NCT02696031|83165582|FG004|Up to Week 24|Withdrawal by Subject|0|||
46930431|NCT02696031|83165583|FG005|Up to Week 24|Withdrawal by Subject|0|||
46757612|NCT01364597|82975949|FG002|Overall Study|Lack of Efficacy|23|||
46930432|NCT02696031|83165578|FG000|Up to Week 52|Adverse Event|4|||
46930433|NCT02696031|83165579|FG001|Up to Week 52|Adverse Event|5|||
46816544|NCT00303472|83036467|FG004|Treatment Extension (Optional)|Adverse Event|0|||
46816545|NCT00303472|83036468|FG005|Treatment Extension (Optional)|Adverse Event|0|||
46816546|NCT00303472|83036469|FG006|Treatment Extension (Optional)|Adverse Event|0|||
46816547|NCT00303472|83036463|FG000|Treatment Extension (Optional)|Death|2|||
46816548|NCT00303472|83036464|FG001|Treatment Extension (Optional)|Death|0|||
46816549|NCT00303472|83036465|FG002|Treatment Extension (Optional)|Death|1|||
46816550|NCT00303472|83036466|FG003|Treatment Extension (Optional)|Death|0|||
46816551|NCT00303472|83036467|FG004|Treatment Extension (Optional)|Death|0|||
46816552|NCT00303472|83036468|FG005|Treatment Extension (Optional)|Death|0|||
46816553|NCT00303472|83036469|FG006|Treatment Extension (Optional)|Death|0|||
46816554|NCT00303472|83036463|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
46816555|NCT00303472|83036464|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
46816556|NCT00303472|83036465|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
46816557|NCT00303472|83036466|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
46816558|NCT00303472|83036467|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
46816559|NCT00303472|83036468|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
46816560|NCT00303472|83036469|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
46816561|NCT00303472|83036463|FG000|Treatment Extension (Optional)|Physician Decision|0|||
46816562|NCT00303472|83036464|FG001|Treatment Extension (Optional)|Physician Decision|4|||
46816563|NCT00303472|83036465|FG002|Treatment Extension (Optional)|Physician Decision|2|||
46816564|NCT00303472|83036466|FG003|Treatment Extension (Optional)|Physician Decision|3|||
46816565|NCT00303472|83036467|FG004|Treatment Extension (Optional)|Physician Decision|2|||
46816566|NCT00303472|83036468|FG005|Treatment Extension (Optional)|Physician Decision|0|||
46816567|NCT00303472|83036469|FG006|Treatment Extension (Optional)|Physician Decision|0|||
46816568|NCT00303472|83036463|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
46816569|NCT00303472|83036464|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
46816570|NCT00303472|83036465|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
46816571|NCT00303472|83036466|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
46816572|NCT00303472|83036467|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
46816573|NCT00303472|83036468|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
46816574|NCT00303472|83036469|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
46816575|NCT00303472|83036463|FG000|Treatment Extension (Optional)|Other|0|||
46816576|NCT00303472|83036464|FG001|Treatment Extension (Optional)|Other|2|||
46816577|NCT00303472|83036465|FG002|Treatment Extension (Optional)|Other|4|||
46816578|NCT00303472|83036466|FG003|Treatment Extension (Optional)|Other|2|||
46816579|NCT00303472|83036467|FG004|Treatment Extension (Optional)|Other|1|||
46816580|NCT00303472|83036468|FG005|Treatment Extension (Optional)|Other|0|||
46816581|NCT00303472|83036469|FG006|Treatment Extension (Optional)|Other|0|||
46816582|NCT00303472|83036463|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
46816583|NCT00303472|83036464|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
46816584|NCT00303472|83036465|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
46816585|NCT00303472|83036466|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
46816586|NCT00303472|83036467|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
46816587|NCT00303472|83036468|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
46816588|NCT00303472|83036469|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
46816589|NCT00468546|83036487|FG000|Week 24 Analysis|Lack of Efficacy|83|||
47055854|NCT01722071|83330368|FG001|Overall Study|Protocol Violation|0|||
47055855|NCT01721759|83330374|FG000|Treatment Period|Disease Progression|85|||
46757613|NCT01364597|82975950|FG003|Overall Study|Lack of Efficacy|8|||
46757614|NCT01364597|82975947|FG000|Overall Study|Protocol Violation|0|||
46757615|NCT01364597|82975948|FG001|Overall Study|Protocol Violation|0|||
46757616|NCT01364597|82975949|FG002|Overall Study|Protocol Violation|2|||
46757617|NCT01364597|82975950|FG003|Overall Study|Protocol Violation|0|||
46757618|NCT01364597|82975947|FG000|Overall Study|Lost to Follow-up|0|||
46757619|NCT01364597|82975948|FG001|Overall Study|Lost to Follow-up|0|||
46757620|NCT01364597|82975949|FG002|Overall Study|Lost to Follow-up|5|||
46757621|NCT01364597|82975950|FG003|Overall Study|Lost to Follow-up|3|||
46757622|NCT01364597|82975947|FG000|Overall Study|Withdrawal by Subject|4|||
46757623|NCT01364597|82975948|FG001|Overall Study|Withdrawal by Subject|1|||
46757624|NCT01364597|82975949|FG002|Overall Study|Withdrawal by Subject|18|||
46757625|NCT01364597|82975950|FG003|Overall Study|Withdrawal by Subject|6|||
46757626|NCT01364597|82975947|FG000|Overall Study|Non compliance|1|||
46757627|NCT01364597|82975948|FG001|Overall Study|Non compliance|0|||
46757628|NCT01364597|82975949|FG002|Overall Study|Non compliance|1|||
47055856|NCT01721759|83330374|FG000|Treatment Period|Study drug toxicity|14|||
46757629|NCT01364597|82975950|FG003|Overall Study|Non compliance|0|||
46757630|NCT01364597|82975947|FG000|Overall Study|Lack of compliance|1|||
46757631|NCT01364597|82975948|FG001|Overall Study|Lack of compliance|0|||
46816590|NCT00468546|83036488|FG001|Week 24 Analysis|Lack of Efficacy|37|||
46816591|NCT00468546|83036487|FG000|Week 24 Analysis|Refused treatment|5|||
46816592|NCT00468546|83036488|FG001|Week 24 Analysis|Refused treatment|5|||
46816593|NCT00468546|83036487|FG000|Week 24 Analysis|Adverse Event|1|||
46816594|NCT00468546|83036488|FG001|Week 24 Analysis|Adverse Event|8|||
47055857|NCT01721759|83330374|FG000|Treatment Period|Death|1|||
47055858|NCT01721759|83330374|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
47055859|NCT01721759|83330374|FG000|Treatment Period|Participant request to withdraw|3|||
47055860|NCT01721759|83330374|FG000|Treatment Period|Other Reasons|3|||
47055861|NCT01721759|83330374|FG000|End of Study Period|Participant Withdrew Consent|5|||
47055862|NCT01721759|83330374|FG000|End of Study Period|Death|101|||
46757632|NCT01364597|82975949|FG002|Overall Study|Lack of compliance|0|||
46757633|NCT01364597|82975950|FG003|Overall Study|Lack of compliance|0|||
46757634|NCT01364597|82975947|FG000|Overall Study|End of treatment epilepsy|1|||
46757635|NCT01364597|82975948|FG001|Overall Study|End of treatment epilepsy|0|||
46757636|NCT01364597|82975949|FG002|Overall Study|End of treatment epilepsy|0|||
46757637|NCT01364597|82975950|FG003|Overall Study|End of treatment epilepsy|0|||
46757638|NCT01364597|82975947|FG000|Overall Study|No Seizures|1|||
46757639|NCT01364597|82975948|FG001|Overall Study|No Seizures|0|||
46757640|NCT01364597|82975949|FG002|Overall Study|No Seizures|0|||
46757641|NCT01364597|82975950|FG003|Overall Study|No Seizures|0|||
46757642|NCT01364597|82975947|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
46757643|NCT01364597|82975948|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
46757644|NCT01364597|82975949|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
46757645|NCT01364597|82975950|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
46757646|NCT01364597|82975947|FG000|Overall Study|Cure|1|||
46757647|NCT01364597|82975948|FG001|Overall Study|Cure|0|||
46757648|NCT01364597|82975949|FG002|Overall Study|Cure|0|||
46757649|NCT01364597|82975950|FG003|Overall Study|Cure|0|||
46757650|NCT01364597|82975947|FG000|Overall Study|Patient was moving|0|||
46757651|NCT01364597|82975948|FG001|Overall Study|Patient was moving|1|||
46757652|NCT01364597|82975949|FG002|Overall Study|Patient was moving|0|||
46757653|NCT01364597|82975950|FG003|Overall Study|Patient was moving|0|||
46757654|NCT01364597|82975947|FG000|Overall Study|Seizures resolved|0|||
46757655|NCT01364597|82975948|FG001|Overall Study|Seizures resolved|0|||
46757656|NCT01364597|82975949|FG002|Overall Study|Seizures resolved|1|||
46757657|NCT01364597|82975950|FG003|Overall Study|Seizures resolved|0|||
46757658|NCT01364597|82975947|FG000|Overall Study|Patient became seizure-free after surgery|0|||
46757659|NCT01364597|82975948|FG001|Overall Study|Patient became seizure-free after surgery|0|||
46757660|NCT01364597|82975949|FG002|Overall Study|Patient became seizure-free after surgery|1|||
46757661|NCT01364597|82975950|FG003|Overall Study|Patient became seizure-free after surgery|0|||
46757662|NCT01364597|82975947|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
46757663|NCT01364597|82975948|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
46757664|NCT01364597|82975949|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
46757665|NCT01364597|82975950|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
46757666|NCT01364597|82975947|FG000|Overall Study|Patient cured from Epilepsy|0|||
46757667|NCT01364597|82975948|FG001|Overall Study|Patient cured from Epilepsy|0|||
46757668|NCT01364597|82975949|FG002|Overall Study|Patient cured from Epilepsy|1|||
46757669|NCT01364597|82975950|FG003|Overall Study|Patient cured from Epilepsy|0|||
46757670|NCT01364597|82975947|FG000|Overall Study|Investigator decision|0|||
46757671|NCT01364597|82975948|FG001|Overall Study|Investigator decision|0|||
46757672|NCT01364597|82975949|FG002|Overall Study|Investigator decision|1|||
46757673|NCT01364597|82975950|FG003|Overall Study|Investigator decision|0|||
46757674|NCT01364597|82975947|FG000|Overall Study|Sponsor recommended discontinuation|0|||
46757675|NCT01364597|82975948|FG001|Overall Study|Sponsor recommended discontinuation|0|||
46757676|NCT01364597|82975949|FG002|Overall Study|Sponsor recommended discontinuation|0|||
46757677|NCT01364597|82975950|FG003|Overall Study|Sponsor recommended discontinuation|1|||
46757678|NCT01364597|82975947|FG000|Overall Study|Parents went abroad with the patient|0|||
46757679|NCT01364597|82975948|FG001|Overall Study|Parents went abroad with the patient|0|||
46757680|NCT01364597|82975949|FG002|Overall Study|Parents went abroad with the patient|1|||
46757681|NCT01364597|82975950|FG003|Overall Study|Parents went abroad with the patient|0|||
46757682|NCT01364597|82975947|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
46757683|NCT01364597|82975948|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
46757684|NCT01364597|82975949|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
46757685|NCT01364597|82975950|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
47055863|NCT01721759|83330374|FG000|End of Study Period|Lost to Follow-up|1|||
47055864|NCT01721759|83330374|FG000|End of Study Period|Other Reasons|10|||
47055865|NCT01721369|83330383|FG000|Overall Study|Not initial etiological diagnosis|12|||
47055866|NCT01721057|83330445|FG000|Treatment Period|Withdrawal by Subject|11|||
47055867|NCT01721057|83330446|FG001|Treatment Period|Withdrawal by Subject|5|||
46757686|NCT01364597|82975947|FG000|Overall Study|BRV administration dropout|0|||
46757687|NCT01364597|82975948|FG001|Overall Study|BRV administration dropout|0|||
46757688|NCT01364597|82975949|FG002|Overall Study|BRV administration dropout|1|||
46757689|NCT01364597|82975950|FG003|Overall Study|BRV administration dropout|0|||
46816595|NCT00468546|83036487|FG000|Week 24 Analysis|Failure to return|3|||
46816596|NCT00468546|83036488|FG001|Week 24 Analysis|Failure to return|4|||
46816597|NCT00468546|83036487|FG000|Week 24 Analysis|Rescue therapy|2|||
46816598|NCT00468546|83036488|FG001|Week 24 Analysis|Rescue therapy|0|||
46816599|NCT00468546|83036487|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
46816600|NCT00468546|83036488|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
46816601|NCT00468546|83036487|FG000|Week 24 Analysis|Due to clinical hold|1|||
46816602|NCT00468546|83036488|FG001|Week 24 Analysis|Due to clinical hold|0|||
46816603|NCT00468546|83036487|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
46816604|NCT00468546|83036488|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
46816605|NCT00468546|83036487|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
46816606|NCT00468546|83036488|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
46816607|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
46816608|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
46816609|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Death|1|||
46816610|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Death|0|||
46816611|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
46816612|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
46816613|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
46816614|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
46816615|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
46816616|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
46816617|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
46816618|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
46816619|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
46816620|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
46816621|NCT00468546|83036487|FG000|Week 24 to Week 104 Analysis|Other|17|||
46816622|NCT00468546|83036488|FG001|Week 24 to Week 104 Analysis|Other|14|||
46816623|NCT00303316|83036496|FG000|Overall Study|Protocol Violation|1|||
46816624|NCT00303316|83036497|FG001|Overall Study|Protocol Violation|0|||
46816625|NCT00303316|83036496|FG000|Overall Study|Lost to Follow-up|0|||
46816626|NCT00303316|83036497|FG001|Overall Study|Lost to Follow-up|1|||
46816627|NCT00303316|83036496|FG000|Overall Study|Withdrawal by Subject|1|||
46816628|NCT00303316|83036497|FG001|Overall Study|Withdrawal by Subject|2|||
46816629|NCT00468312|83036505|FG000|Overall Study|Adverse Event|2|||
46816630|NCT00468312|83036506|FG001|Overall Study|Adverse Event|1|||
46816631|NCT00468312|83036505|FG000|Overall Study|Lack of Efficacy|0|||
46816632|NCT00468312|83036506|FG001|Overall Study|Lack of Efficacy|1|||
46816633|NCT00468312|83036505|FG000|Overall Study|Withdrawal by Subject|0|||
46816634|NCT00468312|83036506|FG001|Overall Study|Withdrawal by Subject|1|||
46816635|NCT00468312|83036505|FG000|Overall Study|Protocol Violation|2|||
46816636|NCT00468312|83036506|FG001|Overall Study|Protocol Violation|1|||
46816637|NCT00468312|83036505|FG000|Overall Study|Did not meet protocol eligibility|0|||
46816638|NCT00468312|83036506|FG001|Overall Study|Did not meet protocol eligibility|1|||
46816639|NCT00331864|83036514|FG000|Overall Study|Adverse Event|30|||
46816640|NCT00331864|83036515|FG001|Overall Study|Adverse Event|1|||
46816641|NCT00331864|83036514|FG000|Overall Study|Lack of Efficacy|4|||
46816642|NCT00331864|83036515|FG001|Overall Study|Lack of Efficacy|0|||
46816643|NCT00331864|83036514|FG000|Overall Study|Protocol Violation|3|||
46816644|NCT00331864|83036515|FG001|Overall Study|Protocol Violation|0|||
46816645|NCT00331864|83036514|FG000|Overall Study|Withdrawal by Subject|10|||
46816646|NCT00331864|83036515|FG001|Overall Study|Withdrawal by Subject|0|||
46816647|NCT00331864|83036514|FG000|Overall Study|Lost to Follow-up|4|||
46816648|NCT00331864|83036515|FG001|Overall Study|Lost to Follow-up|3|||
46816649|NCT00331864|83036514|FG000|Overall Study|Administrative Problems|1|||
46816650|NCT00331864|83036515|FG001|Overall Study|Administrative Problems|0|||
46816651|NCT00331864|83036514|FG000|Overall Study|Death|6|||
46816652|NCT00331864|83036515|FG001|Overall Study|Death|0|||
46816653|NCT00331630|83036521|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
46816654|NCT00331630|83036521|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
46930434|NCT02696031|83165580|FG002|Up to Week 52|Adverse Event|3|||
46930435|NCT02696031|83165581|FG003|Up to Week 52|Adverse Event|0|||
46930436|NCT02696031|83165582|FG004|Up to Week 52|Adverse Event|0|||
46636682|NCT01508676|82810486|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
46636683|NCT01508676|82810485|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
46816655|NCT00331630|83036521|FG000|Follow up for 5 Years|Death|5|||
46816656|NCT00331630|83036521|FG000|Follow up for 5 Years|Data collection was stopped|24|||
46816657|NCT00331552|83036527|FG000|Period 3: Phase II|Neurological Symptoms|1|||
46816658|NCT00331552|83036528|FG001|Period 3: Phase II|Neurological Symptoms|0|||
46816659|NCT00331552|83036527|FG000|Period 3: Phase II|Severe Nausea|1|||
46816660|NCT00331552|83036528|FG001|Period 3: Phase II|Severe Nausea|0|||
46816661|NCT00317356|83036543|FG000|Overall Study|Adverse Event|0|||
46816662|NCT00317356|83036544|FG001|Overall Study|Adverse Event|0|||
46816663|NCT00317356|83036545|FG002|Overall Study|Adverse Event|1|||
46816664|NCT00317356|83036546|FG003|Overall Study|Adverse Event|0|||
46930437|NCT02696031|83165583|FG005|Up to Week 52|Adverse Event|0|||
47055868|NCT01721057|83330447|FG002|Treatment Period|Withdrawal by Subject|8|||
47055869|NCT01721057|83330448|FG003|Treatment Period|Withdrawal by Subject|0|||
47055870|NCT01721057|83330449|FG004|Treatment Period|Withdrawal by Subject|0|||
47055871|NCT01721057|83330450|FG005|Treatment Period|Withdrawal by Subject|0|||
47055872|NCT01721057|83330451|FG006|Treatment Period|Withdrawal by Subject|0|||
47055873|NCT01721057|83330445|FG000|Treatment Period|Adverse Event|7|||
47055874|NCT01721057|83330446|FG001|Treatment Period|Adverse Event|10|||
47055875|NCT01721057|83330447|FG002|Treatment Period|Adverse Event|12|||
46757690|NCT01364597|82975947|FG000|Overall Study|Dropout|0|||
46757691|NCT01364597|82975948|FG001|Overall Study|Dropout|0|||
46757692|NCT01364597|82975949|FG002|Overall Study|Dropout|3|||
46757693|NCT01364597|82975950|FG003|Overall Study|Dropout|1|||
46757694|NCT01364597|82975947|FG000|Overall Study|Unreliable subject|0|||
46757695|NCT01364597|82975948|FG001|Overall Study|Unreliable subject|0|||
46757696|NCT01364597|82975949|FG002|Overall Study|Unreliable subject|0|||
46757697|NCT01364597|82975950|FG003|Overall Study|Unreliable subject|1|||
46757698|NCT01364597|82975947|FG000|Overall Study|Other|0|||
46757699|NCT01364597|82975948|FG001|Overall Study|Other|0|||
46757700|NCT01364597|82975949|FG002|Overall Study|Other|0|||
46757701|NCT01364597|82975950|FG003|Overall Study|Other|1|||
46757702|NCT01311648|82975966|FG000|Main Study|Protocol Violation|0|||
46757703|NCT01311648|82975967|FG001|Main Study|Protocol Violation|1|||
46757704|NCT01311648|82975966|FG000|Main Study|Adverse Event|0|||
46757705|NCT01311648|82975967|FG001|Main Study|Adverse Event|1|||
46757706|NCT01311648|82975966|FG000|Main Study|Inhibitor management|0|||
46757707|NCT01311648|82975967|FG001|Main Study|Inhibitor management|17|||
47055876|NCT01721057|83330448|FG003|Treatment Period|Adverse Event|0|||
47055877|NCT01721057|83330449|FG004|Treatment Period|Adverse Event|0|||
47055878|NCT01721057|83330450|FG005|Treatment Period|Adverse Event|0|||
47055879|NCT01721057|83330451|FG006|Treatment Period|Adverse Event|0|||
47055880|NCT01721057|83330445|FG000|Treatment Period|Lack of Efficacy|7|||
47055881|NCT01721057|83330446|FG001|Treatment Period|Lack of Efficacy|3|||
46757708|NCT01311648|82975966|FG000|Main Study|Withdrawal by Subject|0|||
46757709|NCT01311648|82975967|FG001|Main Study|Withdrawal by Subject|2|||
46757710|NCT01311648|82975966|FG000|Extension Study|Physician Decision|0|||
46757711|NCT01311648|82975967|FG001|Extension Study|Physician Decision|1|||
46757712|NCT01311648|82975966|FG000|Extension Study|ITI therapy with marketed product|0|||
46757713|NCT01311648|82975967|FG001|Extension Study|ITI therapy with marketed product|1|||
46757714|NCT01311648|82975966|FG000|Extension Study|Incorrect visit planning|0|||
46757715|NCT01311648|82975967|FG001|Extension Study|Incorrect visit planning|1|||
46757716|NCT01311648|82975966|FG000|Extension Study|Family's decision|0|||
46757717|NCT01311648|82975967|FG001|Extension Study|Family's decision|1|||
46757718|NCT01311648|82975966|FG000|Extension Study|Failure of ITI therapy|0|||
46757719|NCT01311648|82975967|FG001|Extension Study|Failure of ITI therapy|3|||
46757720|NCT01311648|82975966|FG000|Extension Study|Long travel|0|||
46757721|NCT01311648|82975967|FG001|Extension Study|Long travel|1|||
46757722|NCT01311648|82975966|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
46816665|NCT00317356|83036543|FG000|Overall Study|Lack of Efficacy|1|||
46816666|NCT00317356|83036544|FG001|Overall Study|Lack of Efficacy|1|||
46930438|NCT02696031|83165578|FG000|Up to Week 52|Lack of Efficacy|10|||
46930439|NCT02696031|83165579|FG001|Up to Week 52|Lack of Efficacy|7|||
46930440|NCT02696031|83165580|FG002|Up to Week 52|Lack of Efficacy|11|||
46930441|NCT02696031|83165581|FG003|Up to Week 52|Lack of Efficacy|0|||
46930442|NCT02696031|83165582|FG004|Up to Week 52|Lack of Efficacy|0|||
46930443|NCT02696031|83165583|FG005|Up to Week 52|Lack of Efficacy|0|||
46930444|NCT02696031|83165578|FG000|Up to Week 52|Lost to Follow-up|1|||
46930445|NCT02696031|83165579|FG001|Up to Week 52|Lost to Follow-up|1|||
46930446|NCT02696031|83165580|FG002|Up to Week 52|Lost to Follow-up|1|||
46930447|NCT02696031|83165581|FG003|Up to Week 52|Lost to Follow-up|0|||
46930448|NCT02696031|83165582|FG004|Up to Week 52|Lost to Follow-up|0|||
46930449|NCT02696031|83165583|FG005|Up to Week 52|Lost to Follow-up|0|||
46930450|NCT02696031|83165578|FG000|Up to Week 52|Physician Decision|1|||
46930451|NCT02696031|83165579|FG001|Up to Week 52|Physician Decision|1|||
47055882|NCT01721057|83330447|FG002|Treatment Period|Lack of Efficacy|0|||
47055883|NCT01721057|83330448|FG003|Treatment Period|Lack of Efficacy|0|||
47055884|NCT01721057|83330449|FG004|Treatment Period|Lack of Efficacy|0|||
47055885|NCT01721057|83330450|FG005|Treatment Period|Lack of Efficacy|0|||
47055886|NCT01721057|83330451|FG006|Treatment Period|Lack of Efficacy|0|||
46757723|NCT01311648|82975967|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
46757724|NCT01311648|82975966|FG000|Extension Study|Withdrawal by Subject|0|||
46757725|NCT01311648|82975967|FG001|Extension Study|Withdrawal by Subject|1|||
46930452|NCT02696031|83165580|FG002|Up to Week 52|Physician Decision|2|||
46930453|NCT02696031|83165581|FG003|Up to Week 52|Physician Decision|0|||
46757726|NCT01311648|82975966|FG000|Extension Study|Inhibitor management|0|||
46757727|NCT01311648|82975967|FG001|Extension Study|Inhibitor management|2|||
46757728|NCT00470704|82975995|FG000|Overall Study|Withdrawal by Subject|4|||
46930454|NCT02696031|83165582|FG004|Up to Week 52|Physician Decision|0|||
47055887|NCT01721057|83330445|FG000|Treatment Period|Lost to Follow-up|1|||
47055888|NCT01721057|83330446|FG001|Treatment Period|Lost to Follow-up|0|||
47055889|NCT01721057|83330447|FG002|Treatment Period|Lost to Follow-up|0|||
47055890|NCT01721057|83330448|FG003|Treatment Period|Lost to Follow-up|0|||
47055891|NCT01721057|83330449|FG004|Treatment Period|Lost to Follow-up|0|||
47055892|NCT01721057|83330450|FG005|Treatment Period|Lost to Follow-up|0|||
47055893|NCT01721057|83330451|FG006|Treatment Period|Lost to Follow-up|0|||
47055894|NCT01721057|83330445|FG000|Treatment Period|Physician Decision|0|||
47055895|NCT01721057|83330446|FG001|Treatment Period|Physician Decision|1|||
47055896|NCT01721057|83330447|FG002|Treatment Period|Physician Decision|3|||
47055897|NCT01721057|83330448|FG003|Treatment Period|Physician Decision|0|||
47055898|NCT01721057|83330449|FG004|Treatment Period|Physician Decision|0|||
47055899|NCT01721057|83330450|FG005|Treatment Period|Physician Decision|0|||
47055900|NCT01721057|83330451|FG006|Treatment Period|Physician Decision|0|||
47055901|NCT01721057|83330445|FG000|Treatment Period|Death|2|||
47055902|NCT01721057|83330446|FG001|Treatment Period|Death|0|||
46816667|NCT00317356|83036545|FG002|Overall Study|Lack of Efficacy|0|||
46816668|NCT00317356|83036546|FG003|Overall Study|Lack of Efficacy|3|||
46816669|NCT00317356|83036543|FG000|Overall Study|Physician Decision|0|||
46816670|NCT00317356|83036544|FG001|Overall Study|Physician Decision|1|||
46816671|NCT00317356|83036545|FG002|Overall Study|Physician Decision|0|||
46816672|NCT00317356|83036546|FG003|Overall Study|Physician Decision|0|||
46816673|NCT00331006|83036556|FG000|Screening Phase|Withdrawal by Subject|1|||
46816674|NCT00331006|83036556|FG000|Screening Phase|enrollment halted|1|||
46816675|NCT00331006|83036556|FG000|Screening Phase|Lost to Follow-up|1|||
46816676|NCT00331006|83036556|FG000|Screening Phase|Ineligible for treatment phase|4|||
46816677|NCT00331006|83036556|FG000|Treatment Phase|Withdrawal by Subject|1|||
46816678|NCT00331006|83036556|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
46816679|NCT00331006|83036556|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
46816680|NCT00302458|83036560|FG000|Overall Study|Lost to Follow-up|1|||
46816681|NCT00302458|83036560|FG000|Overall Study|Ineligible after screening|1|||
46816682|NCT00302458|83036560|FG000|Overall Study|Withdrawal by Subject|1|||
46816683|NCT00391053|83036572|FG000|Overall Study|Serious Adverse Events|1|||
46816684|NCT00391053|83036573|FG001|Overall Study|Serious Adverse Events|0|||
46816685|NCT00391053|83036574|FG002|Overall Study|Serious Adverse Events|1|||
46816686|NCT00391053|83036575|FG003|Overall Study|Serious Adverse Events|4|||
46816687|NCT00391053|83036572|FG000|Overall Study|Protocol Violation|2|||
46816688|NCT00391053|83036573|FG001|Overall Study|Protocol Violation|0|||
46816689|NCT00391053|83036574|FG002|Overall Study|Protocol Violation|0|||
46816690|NCT00391053|83036575|FG003|Overall Study|Protocol Violation|0|||
46816691|NCT00391053|83036572|FG000|Overall Study|Lost to Follow-up|1|||
46816692|NCT00391053|83036573|FG001|Overall Study|Lost to Follow-up|0|||
46816693|NCT00391053|83036574|FG002|Overall Study|Lost to Follow-up|0|||
46816694|NCT00391053|83036575|FG003|Overall Study|Lost to Follow-up|5|||
46816695|NCT00391053|83036572|FG000|Overall Study|Withdrawal by Subject|5|||
46816696|NCT00391053|83036573|FG001|Overall Study|Withdrawal by Subject|1|||
46816697|NCT00391053|83036574|FG002|Overall Study|Withdrawal by Subject|1|||
46816698|NCT00391053|83036575|FG003|Overall Study|Withdrawal by Subject|1|||
46816699|NCT00317044|83036588|FG000|Overall Study|Protocol Violation|28|||
46816700|NCT00317044|83036589|FG001|Overall Study|Protocol Violation|22|||
46816701|NCT00317044|83036590|FG002|Overall Study|Protocol Violation|20|||
46757729|NCT00470704|82975996|FG001|Overall Study|Withdrawal by Subject|3|||
46757730|NCT00470704|82975995|FG000|Overall Study|Relapse/Progression|37|||
46757731|NCT00470704|82975996|FG001|Overall Study|Relapse/Progression|42|||
46757732|NCT00470704|82975995|FG000|Overall Study|toxicity|0|||
46757733|NCT00470704|82975996|FG001|Overall Study|toxicity|1|||
46757734|NCT00385697|82976007|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
46757735|NCT00385697|82976008|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
47055903|NCT01721057|83330447|FG002|Treatment Period|Death|0|||
47055904|NCT01721057|83330448|FG003|Treatment Period|Death|0|||
47055905|NCT01721057|83330449|FG004|Treatment Period|Death|0|||
47055906|NCT01721057|83330450|FG005|Treatment Period|Death|0|||
47055907|NCT01721057|83330451|FG006|Treatment Period|Death|0|||
47055908|NCT01721057|83330445|FG000|Rescue Period|Adverse Event|0|||
46757736|NCT00385697|82976009|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
46757737|NCT00385697|82976010|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
46816702|NCT00317044|83036588|FG000|Overall Study|Adverse Event|4|||
46816703|NCT00317044|83036589|FG001|Overall Study|Adverse Event|7|||
46816704|NCT00317044|83036590|FG002|Overall Study|Adverse Event|4|||
46816705|NCT00317044|83036588|FG000|Overall Study|Withdrawal by Subject|10|||
46816706|NCT00317044|83036589|FG001|Overall Study|Withdrawal by Subject|7|||
46816707|NCT00317044|83036590|FG002|Overall Study|Withdrawal by Subject|12|||
46816708|NCT00317044|83036588|FG000|Overall Study|Lost to Follow-up|0|||
46816709|NCT00317044|83036589|FG001|Overall Study|Lost to Follow-up|2|||
46816710|NCT00317044|83036590|FG002|Overall Study|Lost to Follow-up|3|||
47055909|NCT01721057|83330446|FG001|Rescue Period|Adverse Event|0|||
46816711|NCT00317044|83036588|FG000|Overall Study|Multiple Reasons|6|||
46816712|NCT00317044|83036589|FG001|Overall Study|Multiple Reasons|2|||
46816713|NCT00317044|83036590|FG002|Overall Study|Multiple Reasons|6|||
46816714|NCT00301834|83036598|FG000|Overall Study|Death|1|||
46816715|NCT00301366|83036605|FG000|Overall Study|Adverse Event|1|||
46816716|NCT00330928|83036609|FG000|Overall Study|Lost to Follow-up|6|||
46816717|NCT00330928|83036609|FG000|Overall Study|Physician Decision|9|||
46816718|NCT00330928|83036609|FG000|Overall Study|Death|1|||
46816719|NCT00330928|83036609|FG000|Overall Study|IVUS could not be performed.|1|||
46816720|NCT00330616|83036613|FG000|Overall Study|Adverse Event|13|||
46816721|NCT00330616|83036613|FG000|Overall Study|Lack of Efficacy|1|||
46816722|NCT00330616|83036613|FG000|Overall Study|Lost to Follow-up|2|||
46816723|NCT00330616|83036613|FG000|Overall Study|Withdrawal by Subject|4|||
46816724|NCT00330616|83036613|FG000|Overall Study|Other|1|||
46816725|NCT00466440|83036620|FG000|Overall Study|Adverse Event|0|||
46816726|NCT00466440|83036621|FG001|Overall Study|Adverse Event|3|||
46816727|NCT00466440|83036622|FG002|Overall Study|Adverse Event|1|||
46816728|NCT00466440|83036620|FG000|Overall Study|Death|1|||
46816729|NCT00466440|83036621|FG001|Overall Study|Death|1|||
46816730|NCT00466440|83036622|FG002|Overall Study|Death|0|||
46816731|NCT00466440|83036620|FG000|Overall Study|Progressive disease|13|||
46816732|NCT00466440|83036621|FG001|Overall Study|Progressive disease|5|||
46816733|NCT00466440|83036622|FG002|Overall Study|Progressive disease|4|||
46816734|NCT00466440|83036620|FG000|Overall Study|Lost to Follow-up|0|||
46816735|NCT00466440|83036621|FG001|Overall Study|Lost to Follow-up|1|||
46816736|NCT00466440|83036622|FG002|Overall Study|Lost to Follow-up|0|||
46816737|NCT00466440|83036620|FG000|Overall Study|Physician Decision|0|||
47055910|NCT01721057|83330447|FG002|Rescue Period|Adverse Event|0|||
47055911|NCT01721057|83330448|FG003|Rescue Period|Adverse Event|1|||
47055912|NCT01721057|83330449|FG004|Rescue Period|Adverse Event|0|||
47055913|NCT01721057|83330450|FG005|Rescue Period|Adverse Event|0|||
46757738|NCT00385697|82976011|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
46757739|NCT00385697|82976007|FG000|Open-label Segment 1|Lost to Follow-up|1|||
46757740|NCT00385697|82976008|FG001|Open-label Segment 1|Lost to Follow-up|0|||
46757741|NCT00385697|82976009|FG002|Open-label Segment 1|Lost to Follow-up|0|||
46757742|NCT00385697|82976010|FG003|Open-label Segment 1|Lost to Follow-up|0|||
46757743|NCT00385697|82976011|FG004|Open-label Segment 1|Lost to Follow-up|0|||
46757744|NCT00385697|82976007|FG000|Double-blind Segment 2|Adverse Event|0|||
46757745|NCT00385697|82976008|FG001|Double-blind Segment 2|Adverse Event|3|||
46757746|NCT00385697|82976009|FG002|Double-blind Segment 2|Adverse Event|1|||
46757747|NCT00385697|82976010|FG003|Double-blind Segment 2|Adverse Event|0|||
46757748|NCT00385697|82976011|FG004|Double-blind Segment 2|Adverse Event|0|||
46757749|NCT00385697|82976007|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
46757750|NCT00385697|82976008|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
46757751|NCT00385697|82976009|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
46757752|NCT00385697|82976010|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
46757753|NCT00385697|82976011|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
46757754|NCT00385697|82976007|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
46757755|NCT00385697|82976008|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
46757756|NCT00385697|82976009|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
46757757|NCT00385697|82976010|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
46757758|NCT00385697|82976011|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
46757759|NCT00385697|82976007|FG000|Double-blind Segment 2|Other|0|||
46757760|NCT00385697|82976008|FG001|Double-blind Segment 2|Other|2|||
46757761|NCT00385697|82976009|FG002|Double-blind Segment 2|Other|0|||
46757762|NCT00385697|82976010|FG003|Double-blind Segment 2|Other|0|||
46757763|NCT00385697|82976011|FG004|Double-blind Segment 2|Other|0|||
46757764|NCT00490945|82976029|FG000|Overall Study|Adverse Event|0|||
46757765|NCT00490945|82976030|FG001|Overall Study|Adverse Event|1|||
46757766|NCT00490945|82976031|FG002|Overall Study|Adverse Event|0|||
46816738|NCT00466440|83036621|FG001|Overall Study|Physician Decision|1|||
46816739|NCT00466440|83036622|FG002|Overall Study|Physician Decision|2|||
47055914|NCT01721057|83330451|FG006|Rescue Period|Adverse Event|0|||
47055915|NCT01721057|83330445|FG000|Rescue Period|Lack of Efficacy|0|||
46757767|NCT00490945|82976032|FG003|Overall Study|Adverse Event|0|||
46757768|NCT00490945|82976033|FG004|Overall Study|Adverse Event|0|||
46757769|NCT00879398|82976051|FG000|Overall Study|Visit Stop|399|||
46816740|NCT00466440|83036620|FG000|Overall Study|Protocol entry criteria not met|0|||
46816741|NCT00466440|83036621|FG001|Overall Study|Protocol entry criteria not met|0|||
46816742|NCT00466440|83036622|FG002|Overall Study|Protocol entry criteria not met|4|||
46816743|NCT00466440|83036620|FG000|Overall Study|Withdrawal by Subject|0|||
46816744|NCT00466440|83036621|FG001|Overall Study|Withdrawal by Subject|1|||
46816745|NCT00466440|83036622|FG002|Overall Study|Withdrawal by Subject|0|||
46816746|NCT00466440|83036620|FG000|Overall Study|Sponsor decision|0|||
46816747|NCT00466440|83036621|FG001|Overall Study|Sponsor decision|0|||
46636684|NCT01508676|82810486|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
46757770|NCT00879398|82976051|FG000|Overall Study|Lack of Efficacy|64|||
46757771|NCT00879398|82976051|FG000|Overall Study|Adverse Event|41|||
47055916|NCT01721057|83330446|FG001|Rescue Period|Lack of Efficacy|0|||
46816748|NCT00466440|83036622|FG002|Overall Study|Sponsor decision|1|||
46816749|NCT00465972|83036641|FG000|Overall Study|Withdrawal by Subject|2|||
46816750|NCT00465972|83036642|FG001|Overall Study|Withdrawal by Subject|1|||
46816751|NCT00465894|83036652|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
46816752|NCT00465894|83036653|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
46816753|NCT00465894|83036652|FG000|Treatment For 12 Weeks|Family Issues|1|||
46816754|NCT00465894|83036653|FG001|Treatment For 12 Weeks|Family Issues|1|||
46816755|NCT00465894|83036652|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
46816756|NCT00465894|83036653|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
46816757|NCT00330460|83036677|FG000|Overall Study|Physician Decision|1|||
46816758|NCT00330460|83036678|FG001|Overall Study|Physician Decision|0|||
46816759|NCT00330460|83036677|FG000|Overall Study|Adverse Event|10|||
46816760|NCT00330460|83036678|FG001|Overall Study|Adverse Event|8|||
46816761|NCT00330460|83036677|FG000|Overall Study|Withdrawal by Subject|18|||
46816762|NCT00330460|83036678|FG001|Overall Study|Withdrawal by Subject|17|||
46816763|NCT00330460|83036677|FG000|Overall Study|Death|1|||
46816764|NCT00330460|83036678|FG001|Overall Study|Death|1|||
46816765|NCT00330460|83036677|FG000|Overall Study|Ineligibility determined|1|||
46816766|NCT00330460|83036678|FG001|Overall Study|Ineligibility determined|3|||
46816767|NCT00330460|83036677|FG000|Overall Study|Lost to Follow-up|8|||
46816768|NCT00330460|83036678|FG001|Overall Study|Lost to Follow-up|3|||
46816769|NCT00330460|83036677|FG000|Overall Study|Noncompliance|2|||
46816770|NCT00330460|83036678|FG001|Overall Study|Noncompliance|1|||
46816771|NCT00330460|83036677|FG000|Overall Study|Other|1|||
46816772|NCT00330460|83036678|FG001|Overall Study|Other|0|||
46816773|NCT00454116|83036687|FG000|Overall Study|Adverse Event|5|||
46816774|NCT00454116|83036688|FG001|Overall Study|Adverse Event|11|||
46816775|NCT00454116|83036689|FG002|Overall Study|Adverse Event|9|||
46816776|NCT00454116|83036687|FG000|Overall Study|Condition under investigation worsened|17|||
46816777|NCT00454116|83036688|FG001|Overall Study|Condition under investigation worsened|13|||
46816778|NCT00454116|83036689|FG002|Overall Study|Condition under investigation worsened|18|||
46816779|NCT00454116|83036687|FG000|Overall Study|Withdrawal by Subject|3|||
46816780|NCT00454116|83036688|FG001|Overall Study|Withdrawal by Subject|3|||
46816781|NCT00454116|83036689|FG002|Overall Study|Withdrawal by Subject|1|||
46816782|NCT00454116|83036687|FG000|Overall Study|Other|2|||
46816783|NCT00454116|83036688|FG001|Overall Study|Other|2|||
46816784|NCT00454116|83036689|FG002|Overall Study|Other|0|||
46816785|NCT00465816|83036700|FG000|Overall Study|Lost to Follow-up|0|||
46816786|NCT00465816|83036701|FG001|Overall Study|Lost to Follow-up|0|||
46816787|NCT00465816|83036702|FG002|Overall Study|Lost to Follow-up|2|||
46816788|NCT00465738|83036713|FG000|Overall Study|Lost to Follow-up|2|||
46816789|NCT00465738|83036714|FG001|Overall Study|Lost to Follow-up|0|||
46816790|NCT00465738|83036713|FG000|Overall Study|Adverse Event|0|||
46816791|NCT00465738|83036714|FG001|Overall Study|Adverse Event|1|||
46816792|NCT00465738|83036713|FG000|Overall Study|Withdrawal by Subject|2|||
46816793|NCT00465738|83036714|FG001|Overall Study|Withdrawal by Subject|0|||
46816794|NCT00465738|83036713|FG000|Overall Study|Other|2|||
46816795|NCT00465738|83036714|FG001|Overall Study|Other|5|||
46816796|NCT00400179|83036722|FG000|Overall Study|Adverse Event|2|||
46816797|NCT00400179|83036723|FG001|Overall Study|Adverse Event|2|||
46816798|NCT00400179|83036722|FG000|Overall Study|Death|1|||
46816799|NCT00400179|83036723|FG001|Overall Study|Death|2|||
46816800|NCT00400179|83036722|FG000|Overall Study|Withdrew Consent|1|||
46816801|NCT00400179|83036723|FG001|Overall Study|Withdrew Consent|5|||
46816802|NCT00400179|83036722|FG000|Overall Study|Disease progression|1|||
46816803|NCT00400179|83036723|FG001|Overall Study|Disease progression|1|||
46816804|NCT00400179|83036722|FG000|Overall Study|Intercurrent illness|0|||
46816805|NCT00400179|83036723|FG001|Overall Study|Intercurrent illness|1|||
46816806|NCT00400179|83036722|FG000|Overall Study|Investigator judgment|0|||
46816807|NCT00400179|83036723|FG001|Overall Study|Investigator judgment|1|||
46816808|NCT00400179|83036722|FG000|Overall Study|Randomization error/patient ineligible|1|||
46930455|NCT02696031|83165583|FG005|Up to Week 52|Physician Decision|0|||
46930456|NCT02696031|83165578|FG000|Up to Week 52|Pregnancy|0|||
46816809|NCT00400179|83036723|FG001|Overall Study|Randomization error/patient ineligible|6|||
46816810|NCT00465270|83036731|FG000|Overall Study|Death|7|||
46816811|NCT00465270|83036732|FG001|Overall Study|Death|11|||
46816812|NCT00465270|83036731|FG000|Overall Study|Withdrawal by Subject|34|||
46816813|NCT00465270|83036732|FG001|Overall Study|Withdrawal by Subject|78|||
46816814|NCT00465270|83036731|FG000|Overall Study|Lost to Follow-up|60|||
46816815|NCT00465270|83036732|FG001|Overall Study|Lost to Follow-up|67|||
46816816|NCT00465270|83036731|FG000|Overall Study|Investigator request|3|||
46930457|NCT02696031|83165579|FG001|Up to Week 52|Pregnancy|2|||
46930458|NCT02696031|83165580|FG002|Up to Week 52|Pregnancy|0|||
46816817|NCT00465270|83036732|FG001|Overall Study|Investigator request|4|||
46816818|NCT00464568|83036738|FG000|Overall Study|Adverse Event|2|||
46816819|NCT00464490|83036757|FG000|Overall Study|Physician Decision|11|||
46816820|NCT00464490|83036758|FG001|Overall Study|Physician Decision|11|||
46816821|NCT03849300|83036768|FG000|Overall Study|move out to different area|1|||
46930459|NCT02696031|83165581|FG003|Up to Week 52|Pregnancy|0|||
47055917|NCT01721057|83330447|FG002|Rescue Period|Lack of Efficacy|0|||
47055918|NCT01721057|83330448|FG003|Rescue Period|Lack of Efficacy|2|||
47055919|NCT01721057|83330449|FG004|Rescue Period|Lack of Efficacy|0|||
47055920|NCT01721057|83330450|FG005|Rescue Period|Lack of Efficacy|0|||
46757772|NCT00879398|82976051|FG000|Overall Study|Other Reasons|171|||
46757773|NCT00696436|82976060|FG000|Overall Study|Adverse Event|7|||
46757774|NCT00696436|82976061|FG001|Overall Study|Adverse Event|9|||
46757775|NCT00696436|82976062|FG002|Overall Study|Adverse Event|8|||
46757776|NCT00696436|82976063|FG003|Overall Study|Adverse Event|6|||
46757777|NCT00696436|82976064|FG004|Overall Study|Adverse Event|4|||
46757778|NCT00696436|82976060|FG000|Overall Study|Protocol Violation|3|||
46757779|NCT00696436|82976061|FG001|Overall Study|Protocol Violation|2|||
46757780|NCT00696436|82976062|FG002|Overall Study|Protocol Violation|2|||
46757781|NCT00696436|82976063|FG003|Overall Study|Protocol Violation|0|||
46757782|NCT00696436|82976064|FG004|Overall Study|Protocol Violation|1|||
46757783|NCT00696436|82976060|FG000|Overall Study|Lost to Follow-up|1|||
46757784|NCT00696436|82976061|FG001|Overall Study|Lost to Follow-up|6|||
46757785|NCT00696436|82976062|FG002|Overall Study|Lost to Follow-up|2|||
46757786|NCT00696436|82976063|FG003|Overall Study|Lost to Follow-up|4|||
46757787|NCT00696436|82976064|FG004|Overall Study|Lost to Follow-up|3|||
46757788|NCT00696436|82976060|FG000|Overall Study|Withdrawal by Subject|4|||
46757789|NCT00696436|82976061|FG001|Overall Study|Withdrawal by Subject|11|||
46757790|NCT00696436|82976062|FG002|Overall Study|Withdrawal by Subject|5|||
46757791|NCT00696436|82976063|FG003|Overall Study|Withdrawal by Subject|7|||
46757792|NCT00696436|82976064|FG004|Overall Study|Withdrawal by Subject|1|||
46757793|NCT00696436|82976060|FG000|Overall Study|Lack of Efficacy|3|||
46757794|NCT00696436|82976061|FG001|Overall Study|Lack of Efficacy|1|||
46757795|NCT00696436|82976062|FG002|Overall Study|Lack of Efficacy|5|||
46757796|NCT00696436|82976063|FG003|Overall Study|Lack of Efficacy|2|||
46757797|NCT00696436|82976064|FG004|Overall Study|Lack of Efficacy|4|||
46757798|NCT00696436|82976060|FG000|Overall Study|Participant Unavailability|2|||
46757799|NCT00696436|82976061|FG001|Overall Study|Participant Unavailability|0|||
46757800|NCT00696436|82976062|FG002|Overall Study|Participant Unavailability|2|||
46757801|NCT00696436|82976063|FG003|Overall Study|Participant Unavailability|1|||
46757802|NCT00696436|82976064|FG004|Overall Study|Participant Unavailability|0|||
46757803|NCT00696436|82976060|FG000|Overall Study|Administrative Error|2|||
46757804|NCT00696436|82976061|FG001|Overall Study|Administrative Error|0|||
46757805|NCT00696436|82976062|FG002|Overall Study|Administrative Error|2|||
46757806|NCT00696436|82976063|FG003|Overall Study|Administrative Error|0|||
46757807|NCT00696436|82976064|FG004|Overall Study|Administrative Error|0|||
46757808|NCT00696436|82976060|FG000|Overall Study|Participant Non-compliance|0|||
46757809|NCT00696436|82976061|FG001|Overall Study|Participant Non-compliance|0|||
46757810|NCT00696436|82976062|FG002|Overall Study|Participant Non-compliance|1|||
46757811|NCT00696436|82976063|FG003|Overall Study|Participant Non-compliance|2|||
46757812|NCT00696436|82976064|FG004|Overall Study|Participant Non-compliance|0|||
46757813|NCT00696436|82976060|FG000|Overall Study|Administrative Decision|1|||
46757814|NCT00696436|82976061|FG001|Overall Study|Administrative Decision|0|||
46757815|NCT00696436|82976062|FG002|Overall Study|Administrative Decision|0|||
46757816|NCT00696436|82976063|FG003|Overall Study|Administrative Decision|0|||
46757817|NCT00696436|82976064|FG004|Overall Study|Administrative Decision|0|||
46757818|NCT00696436|82976060|FG000|Overall Study|Missing|0|||
46757819|NCT00696436|82976061|FG001|Overall Study|Missing|1|||
46757820|NCT00696436|82976062|FG002|Overall Study|Missing|1|||
46757821|NCT00696436|82976063|FG003|Overall Study|Missing|0|||
46757822|NCT00696436|82976064|FG004|Overall Study|Missing|0|||
46757823|NCT00878072|82976076|FG000|Overall Study|Withdrew consent|2|||
46757824|NCT00594854|82976104|FG000|Overall Study|Study terminated|7|||
46757825|NCT00594854|82976105|FG001|Overall Study|Study terminated|10|||
46757826|NCT00855582|82976114|FG000|Overall Study|Adverse Event|2|||
46757827|NCT00855582|82976115|FG001|Overall Study|Adverse Event|6|||
46757828|NCT00855582|82976116|FG002|Overall Study|Adverse Event|3|||
47055921|NCT01721057|83330451|FG006|Rescue Period|Lack of Efficacy|0|||
47055922|NCT04570384|83330480|FG000|Overall Study|Adverse Event|2|||
47055923|NCT04570384|83330481|FG001|Overall Study|Adverse Event|1|||
46757829|NCT00855582|82976114|FG000|Overall Study|Death|1|||
46757830|NCT00855582|82976115|FG001|Overall Study|Death|0|||
46757831|NCT00855582|82976116|FG002|Overall Study|Death|0|||
46757832|NCT00855582|82976114|FG000|Overall Study|Lack of Efficacy|1|||
46757833|NCT00855582|82976115|FG001|Overall Study|Lack of Efficacy|3|||
46757834|NCT00855582|82976116|FG002|Overall Study|Lack of Efficacy|8|||
46757835|NCT00855582|82976114|FG000|Overall Study|Lost to Follow-up|1|||
46757836|NCT00855582|82976115|FG001|Overall Study|Lost to Follow-up|3|||
46757837|NCT00855582|82976116|FG002|Overall Study|Lost to Follow-up|1|||
46757838|NCT00855582|82976114|FG000|Overall Study|Physician Decision|0|||
46757839|NCT00855582|82976115|FG001|Overall Study|Physician Decision|0|||
46757840|NCT00855582|82976116|FG002|Overall Study|Physician Decision|1|||
46757841|NCT00855582|82976114|FG000|Overall Study|Protocol Violation|6|||
46757842|NCT00855582|82976115|FG001|Overall Study|Protocol Violation|2|||
47055924|NCT04570384|83330480|FG000|Overall Study|Death|2|||
47055925|NCT04570384|83330481|FG001|Overall Study|Death|5|||
46757843|NCT00855582|82976116|FG002|Overall Study|Protocol Violation|6|||
46757844|NCT00855582|82976114|FG000|Overall Study|Entry Criteria Not Met|8|||
46757845|NCT00855582|82976115|FG001|Overall Study|Entry Criteria Not Met|6|||
46757846|NCT00855582|82976116|FG002|Overall Study|Entry Criteria Not Met|3|||
46757847|NCT00855582|82976114|FG000|Overall Study|Withdrawal by Subject|7|||
46757848|NCT00855582|82976115|FG001|Overall Study|Withdrawal by Subject|4|||
46757849|NCT00855582|82976116|FG002|Overall Study|Withdrawal by Subject|8|||
46757850|NCT00854724|82976129|FG000|First Intervention|Withdrawal by Subject|1|||
46757851|NCT00854724|82976130|FG001|First Intervention|Withdrawal by Subject|1|||
46757852|NCT00854724|82976129|FG000|Washout|Protocol Violation|1|||
46757853|NCT00854724|82976130|FG001|Washout|Protocol Violation|0|||
46757854|NCT00854724|82976129|FG000|Washout|Withdrawal by Subject|0|||
46757855|NCT00854724|82976130|FG001|Washout|Withdrawal by Subject|1|||
46757856|NCT00854724|82976129|FG000|Second Intervention|Protocol Violation|1|||
46757857|NCT00854724|82976130|FG001|Second Intervention|Protocol Violation|0|||
46757858|NCT00854724|82976129|FG000|Second Intervention|Physician Decision|0|||
46757859|NCT00854724|82976130|FG001|Second Intervention|Physician Decision|1|||
46757860|NCT00698932|82976168|FG000|Overall Study|Adverse Event|0|||
46930460|NCT02696031|83165582|FG004|Up to Week 52|Pregnancy|0|||
46930461|NCT02696031|83165583|FG005|Up to Week 52|Pregnancy|0|||
46930462|NCT02696031|83165578|FG000|Up to Week 52|Protocol Violation|1|||
46930463|NCT02696031|83165579|FG001|Up to Week 52|Protocol Violation|0|||
46930464|NCT02696031|83165580|FG002|Up to Week 52|Protocol Violation|0|||
46930465|NCT02696031|83165581|FG003|Up to Week 52|Protocol Violation|0|||
46930466|NCT02696031|83165582|FG004|Up to Week 52|Protocol Violation|0|||
46930467|NCT02696031|83165583|FG005|Up to Week 52|Protocol Violation|0|||
46930468|NCT02696031|83165578|FG000|Up to Week 52|Withdrawal by Subject|12|||
46930469|NCT02696031|83165579|FG001|Up to Week 52|Withdrawal by Subject|3|||
46930470|NCT02696031|83165580|FG002|Up to Week 52|Withdrawal by Subject|9|||
46930471|NCT02696031|83165581|FG003|Up to Week 52|Withdrawal by Subject|0|||
46930472|NCT02696031|83165582|FG004|Up to Week 52|Withdrawal by Subject|0|||
46930473|NCT02696031|83165583|FG005|Up to Week 52|Withdrawal by Subject|0|||
46930474|NCT02696031|83165578|FG000|Up to Week 104|Pregnancy|0|||
46930475|NCT02696031|83165579|FG001|Up to Week 104|Pregnancy|2|||
46930476|NCT02696031|83165580|FG002|Up to Week 104|Pregnancy|1|||
46930477|NCT02696031|83165581|FG003|Up to Week 104|Pregnancy|0|||
46930478|NCT02696031|83165582|FG004|Up to Week 104|Pregnancy|0|||
46930479|NCT02696031|83165583|FG005|Up to Week 104|Pregnancy|0|||
46930480|NCT02696031|83165578|FG000|Up to Week 104|Withdrawal by Subject|15|||
46930481|NCT02696031|83165579|FG001|Up to Week 104|Withdrawal by Subject|10|||
46930482|NCT02696031|83165580|FG002|Up to Week 104|Withdrawal by Subject|16|||
46930483|NCT02696031|83165581|FG003|Up to Week 104|Withdrawal by Subject|0|||
46757861|NCT00698932|82976169|FG001|Overall Study|Adverse Event|2|||
46757862|NCT00698932|82976168|FG000|Overall Study|Incorrect enrollment|0|||
46930484|NCT02696031|83165582|FG004|Up to Week 104|Withdrawal by Subject|0|||
46930485|NCT02696031|83165583|FG005|Up to Week 104|Withdrawal by Subject|0|||
46930486|NCT02696031|83165578|FG000|Up to Week 104|Protocol Violation|1|||
46930487|NCT02696031|83165579|FG001|Up to Week 104|Protocol Violation|0|||
46930488|NCT02696031|83165580|FG002|Up to Week 104|Protocol Violation|0|||
46757863|NCT00698932|82976169|FG001|Overall Study|Incorrect enrollment|2|||
46757864|NCT00698932|82976168|FG000|Overall Study|Study specific discontinuation criteria|3|||
46816822|NCT03849300|83036769|FG001|Overall Study|move out to different area|3|||
46816823|NCT03849300|83036770|FG002|Overall Study|move out to different area|1|||
46816824|NCT03849300|83036771|FG003|Overall Study|move out to different area|4|||
46816825|NCT03849300|83036768|FG000|Overall Study|scheduling/transportation conflict|4|||
46816826|NCT03849300|83036769|FG001|Overall Study|scheduling/transportation conflict|4|||
46757865|NCT00698932|82976169|FG001|Overall Study|Study specific discontinuation criteria|4|||
46757866|NCT00698932|82976168|FG000|Overall Study|Withdrawal by Subject|11|||
46757867|NCT00698932|82976169|FG001|Overall Study|Withdrawal by Subject|23|||
46757868|NCT00698932|82976168|FG000|Overall Study|Lost to Follow-up|6|||
46757869|NCT00698932|82976169|FG001|Overall Study|Lost to Follow-up|1|||
46816827|NCT03849300|83036770|FG002|Overall Study|scheduling/transportation conflict|3|||
46930489|NCT02696031|83165581|FG003|Up to Week 104|Protocol Violation|0|||
46930490|NCT02696031|83165582|FG004|Up to Week 104|Protocol Violation|0|||
46930491|NCT02696031|83165583|FG005|Up to Week 104|Protocol Violation|0|||
46930492|NCT02696031|83165578|FG000|Up to Week 104|Physician Decision|1|||
46930493|NCT02696031|83165579|FG001|Up to Week 104|Physician Decision|2|||
46930494|NCT02696031|83165580|FG002|Up to Week 104|Physician Decision|3|||
46930495|NCT02696031|83165581|FG003|Up to Week 104|Physician Decision|0|||
46930496|NCT02696031|83165582|FG004|Up to Week 104|Physician Decision|0|||
46930497|NCT02696031|83165583|FG005|Up to Week 104|Physician Decision|0|||
46930498|NCT02696031|83165578|FG000|Up to Week 104|Lost to Follow-up|2|||
46930499|NCT02696031|83165579|FG001|Up to Week 104|Lost to Follow-up|3|||
46757870|NCT00698932|82976168|FG000|Overall Study|Severe non-compliance to protocol|1|||
46930500|NCT02696031|83165580|FG002|Up to Week 104|Lost to Follow-up|1|||
46930501|NCT02696031|83165581|FG003|Up to Week 104|Lost to Follow-up|0|||
46930502|NCT02696031|83165582|FG004|Up to Week 104|Lost to Follow-up|0|||
46930503|NCT02696031|83165583|FG005|Up to Week 104|Lost to Follow-up|0|||
46930504|NCT02696031|83165578|FG000|Up to Week 104|Lack of Efficacy|13|||
46930505|NCT02696031|83165579|FG001|Up to Week 104|Lack of Efficacy|12|||
46930506|NCT02696031|83165580|FG002|Up to Week 104|Lack of Efficacy|11|||
46930507|NCT02696031|83165581|FG003|Up to Week 104|Lack of Efficacy|0|||
46930508|NCT02696031|83165582|FG004|Up to Week 104|Lack of Efficacy|0|||
46930509|NCT02696031|83165583|FG005|Up to Week 104|Lack of Efficacy|0|||
46930510|NCT02696031|83165578|FG000|Up to Week 104|Adverse Event|7|||
46930511|NCT02696031|83165579|FG001|Up to Week 104|Adverse Event|11|||
46930512|NCT02696031|83165580|FG002|Up to Week 104|Adverse Event|5|||
46930513|NCT02696031|83165581|FG003|Up to Week 104|Adverse Event|0|||
46930514|NCT02696031|83165582|FG004|Up to Week 104|Adverse Event|0|||
46930515|NCT02696031|83165583|FG005|Up to Week 104|Adverse Event|0|||
46930516|NCT02696031|83165578|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
46930517|NCT02696031|83165579|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
46930518|NCT02696031|83165580|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
46930519|NCT02696031|83165581|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
46930520|NCT02696031|83165582|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
46930521|NCT02696031|83165583|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
46930522|NCT02696031|83165578|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
46930523|NCT02696031|83165579|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
46930524|NCT02696031|83165580|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
46757871|NCT00698932|82976169|FG001|Overall Study|Severe non-compliance to protocol|2|||
46757872|NCT00698932|82976168|FG000|Overall Study|Safety reasons|0|||
46757873|NCT00698932|82976169|FG001|Overall Study|Safety reasons|2|||
46816828|NCT03849300|83036771|FG003|Overall Study|scheduling/transportation conflict|2|||
46816829|NCT00412893|83036785|FG000|Overall Study|Adverse Event|31|||
46757874|NCT00698932|82976168|FG000|Overall Study|Death|1|||
46757875|NCT00698932|82976169|FG001|Overall Study|Death|0|||
46757876|NCT00823719|82976177|FG000|Overall Study|Adverse Event|1|||
46757877|NCT00823719|82976178|FG001|Overall Study|Adverse Event|2|||
46757878|NCT00823719|82976177|FG000|Overall Study|Physician Decision|1|||
46757879|NCT00823719|82976178|FG001|Overall Study|Physician Decision|4|||
46816830|NCT00412893|83036786|FG001|Overall Study|Adverse Event|53|||
46816831|NCT00412893|83036785|FG000|Overall Study|Death|17|||
46816832|NCT00412893|83036786|FG001|Overall Study|Death|21|||
46816833|NCT00412893|83036785|FG000|Overall Study|Insufficient Therapeutic Response|39|||
46816834|NCT00412893|83036786|FG001|Overall Study|Insufficient Therapeutic Response|23|||
46816835|NCT00412893|83036785|FG000|Overall Study|Lost to Follow-up|2|||
46816836|NCT00412893|83036786|FG001|Overall Study|Lost to Follow-up|1|||
46816837|NCT00412893|83036785|FG000|Overall Study|Violation of Selection at Entry|17|||
46816838|NCT00412893|83036786|FG001|Overall Study|Violation of Selection at Entry|10|||
46816839|NCT00412893|83036785|FG000|Overall Study|Other Protocol Violation|10|||
46816840|NCT00412893|83036786|FG001|Overall Study|Other Protocol Violation|6|||
46816841|NCT00412893|83036785|FG000|Overall Study|Did Not Cooperate|12|||
46757880|NCT00823719|82976177|FG000|Overall Study|Withdrawal by Subject|0|||
46757881|NCT00823719|82976178|FG001|Overall Study|Withdrawal by Subject|1|||
46757882|NCT00823719|82976177|FG000|Overall Study|Disease Progression|4|||
46757883|NCT00823719|82976178|FG001|Overall Study|Disease Progression|4|||
46757884|NCT00875420|82976191|FG000|Overall Study|Adverse Event|0|||
46757885|NCT00875420|82976192|FG001|Overall Study|Adverse Event|1|||
46757886|NCT00875420|82976193|FG002|Overall Study|Adverse Event|1|||
46757887|NCT00875420|82976194|FG003|Overall Study|Adverse Event|0|||
46757888|NCT00875420|82976195|FG004|Overall Study|Adverse Event|0|||
46816842|NCT00412893|83036786|FG001|Overall Study|Did Not Cooperate|9|||
46816843|NCT00412893|83036785|FG000|Overall Study|Administrative Reason|12|||
46816844|NCT00412893|83036786|FG001|Overall Study|Administrative Reason|15|||
46816845|NCT00412893|83036785|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
46816846|NCT00412893|83036786|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
46816847|NCT00412737|83036794|FG000|Overall Study|Death|1|||
46816848|NCT00412737|83036795|FG001|Overall Study|Death|0|||
46816849|NCT00412737|83036794|FG000|Overall Study|Adverse Event|3|||
46816850|NCT00412737|83036795|FG001|Overall Study|Adverse Event|2|||
46930525|NCT02696031|83165581|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
46930526|NCT02696031|83165582|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
46930527|NCT02696031|83165583|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
46930528|NCT02696031|83165578|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
46930529|NCT02696031|83165579|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
46930530|NCT02696031|83165580|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
46930531|NCT02696031|83165581|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
46930532|NCT02696031|83165582|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
46816851|NCT00412737|83036794|FG000|Overall Study|Refused Treatment|6|||
46816852|NCT00412737|83036795|FG001|Overall Study|Refused Treatment|2|||
46816853|NCT00412737|83036794|FG000|Overall Study|Failure to Return|6|||
46816854|NCT00412737|83036795|FG001|Overall Study|Failure to Return|2|||
46816855|NCT00508742|83036803|FG000|Period 1: Infant Series|Adverse Event|5|||
46816856|NCT00508742|83036804|FG001|Period 1: Infant Series|Adverse Event|4|||
46816857|NCT00508742|83036803|FG000|Period 1: Infant Series|Protocol Violation|1|||
46816858|NCT00508742|83036804|FG001|Period 1: Infant Series|Protocol Violation|0|||
46816859|NCT00508742|83036803|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
46816860|NCT00508742|83036804|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
46816861|NCT00508742|83036803|FG000|Period 1: Infant Series|Physician Decision|1|||
46816862|NCT00508742|83036804|FG001|Period 1: Infant Series|Physician Decision|0|||
46816863|NCT00508742|83036803|FG000|Period 1: Infant Series|Other|4|||
46816864|NCT00508742|83036804|FG001|Period 1: Infant Series|Other|1|||
46816865|NCT00508742|83036803|FG000|Period 2: After Infant Series|Adverse Event|2|||
46816866|NCT00508742|83036804|FG001|Period 2: After Infant Series|Adverse Event|6|||
46816867|NCT00508742|83036803|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
46816868|NCT00508742|83036804|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
46816869|NCT00508742|83036803|FG000|Period 2: After Infant Series|Protocol Violation|1|||
46816870|NCT00508742|83036804|FG001|Period 2: After Infant Series|Protocol Violation|0|||
46816871|NCT00508742|83036803|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
46816872|NCT00508742|83036804|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
46816873|NCT00508742|83036803|FG000|Period 2: After Infant Series|Failed to Return|1|||
46816874|NCT00508742|83036804|FG001|Period 2: After Infant Series|Failed to Return|0|||
46816875|NCT00508742|83036803|FG000|Period 2: After Infant Series|Other|2|||
46816876|NCT00508742|83036804|FG001|Period 2: After Infant Series|Other|1|||
46816877|NCT00508742|83036803|FG000|Period 3: Toddler Dose|Adverse Event|1|||
46816878|NCT00508742|83036804|FG001|Period 3: Toddler Dose|Adverse Event|0|||
46816879|NCT00508742|83036803|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
46816880|NCT00508742|83036804|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
46816881|NCT00508742|83036803|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
46816882|NCT00508742|83036804|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
46816883|NCT00508742|83036803|FG000|Period 3: Toddler Dose|Other|5|||
46816884|NCT00508742|83036804|FG001|Period 3: Toddler Dose|Other|4|||
46816885|NCT00508274|83036825|FG000|Overall Study|Adverse Event|5|||
46816886|NCT00508274|83036825|FG000|Overall Study|Death|7|||
46816887|NCT00508274|83036825|FG000|Overall Study|Disease progression|32|||
46816888|NCT00508274|83036825|FG000|Overall Study|Withdrawal by Subject|1|||
46816889|NCT00508274|83036825|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
46816890|NCT00508274|83036825|FG000|Overall Study|Missing|3|||
46816891|NCT00499460|83036831|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
46816892|NCT00499460|83036832|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
46816893|NCT00499460|83036831|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
46816894|NCT00499460|83036832|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
46816895|NCT00499460|83036831|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
46816896|NCT00499460|83036832|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
46816897|NCT00412113|83036850|FG000|Overall Study|Adverse Event|11|||
46816898|NCT00412113|83036851|FG001|Overall Study|Adverse Event|15|||
46816899|NCT00412113|83036850|FG000|Overall Study|did not receive treatment|1|||
46816900|NCT00412113|83036851|FG001|Overall Study|did not receive treatment|0|||
46816901|NCT00411645|83036859|FG000|Overall Study|Consent Withdrawn|13|||
46816902|NCT00411645|83036860|FG001|Overall Study|Consent Withdrawn|22|||
46816903|NCT00411645|83036859|FG000|Overall Study|Death|56|||
46816904|NCT00411645|83036860|FG001|Overall Study|Death|135|||
46816905|NCT00411645|83036859|FG000|Overall Study|Investigator/Sponsor Decision|10|||
46816906|NCT00411645|83036860|FG001|Overall Study|Investigator/Sponsor Decision|7|||
46816907|NCT00411645|83036859|FG000|Overall Study|Lost to Follow-up|2|||
46816908|NCT00411645|83036860|FG001|Overall Study|Lost to Follow-up|0|||
46816909|NCT00490724|83036870|FG000|Period I|Physician Decision|0|||
46930533|NCT02696031|83165583|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
46930534|NCT02696031|83165578|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
46930535|NCT02696031|83165579|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
46636685|NCT01508676|82810485|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
46816910|NCT00490724|83036871|FG001|Period I|Physician Decision|0|||
46816911|NCT00490724|83036872|FG002|Period I|Physician Decision|1|||
46816912|NCT00490724|83036870|FG000|Period II|Treatment Discontinuation|3|||
46816913|NCT00490724|83036871|FG001|Period II|Treatment Discontinuation|1|||
46816914|NCT00490724|83036872|FG002|Period II|Treatment Discontinuation|3|||
46816915|NCT03835221|83036880|FG000|Methafilcon A|Withdrawal by Subject|1|||
46816916|NCT00398073|83036888|FG000|Overall Study|Withdrawal by Subject|1|||
46930536|NCT02696031|83165580|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
46816917|NCT00398073|83036889|FG001|Overall Study|Withdrawal by Subject|0|||
46816918|NCT00490646|83036897|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
46816919|NCT00490646|83036898|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
46816920|NCT00490646|83036897|FG000|Overall Study|Never Treated (had an adverse event)|1|||
46816921|NCT00490646|83036898|FG001|Overall Study|Never Treated (had an adverse event)|0|||
46816922|NCT00490646|83036897|FG000|Overall Study|Never Treated (withdrew consent)|0|||
46816923|NCT00490646|83036898|FG001|Overall Study|Never Treated (withdrew consent)|1|||
46816924|NCT00388947|83036904|FG000|Overall Study|Protocol Violation|47|||
46816925|NCT00490568|83036908|FG000|Overall Study|Adverse Event|116|||
46816926|NCT00490568|83036908|FG000|Overall Study|Lost to Follow-up|13|||
46816927|NCT00490568|83036908|FG000|Overall Study|Protocol Violation|45|||
46816928|NCT00490568|83036908|FG000|Overall Study|Withdrawal by Subject|135|||
46816929|NCT00490568|83036908|FG000|Overall Study|Still in the study at termination|974|||
46816930|NCT00490568|83036908|FG000|Overall Study|Other|1|||
46816931|NCT00490568|83036908|FG000|Overall Study|Exclusion criteria met|1|||
46816932|NCT00490568|83036908|FG000|Overall Study|Caregiver related|20|||
46816933|NCT00490568|83036908|FG000|Overall Study|Abnormal ECG|25|||
46816934|NCT00490568|83036908|FG000|Overall Study|Participant refused follow-up|9|||
46816935|NCT00490568|83036908|FG000|Overall Study|Legal representative withdrew consent|1|||
46816936|NCT00490568|83036908|FG000|Overall Study|Disease progression|4|||
46816937|NCT00490568|83036908|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
46816938|NCT00490568|83036908|FG000|Overall Study|Investigator decision|3|||
46816939|NCT00490568|83036908|FG000|Overall Study|Non-Compliance|7|||
46816940|NCT00490568|83036908|FG000|Overall Study|Efficacy related|3|||
46816941|NCT00490568|83036908|FG000|Overall Study|Participant died|1|||
46816942|NCT00490568|83036908|FG000|Overall Study|Participant withdrawal due to surgery|1|||
46816943|NCT00561353|83036923|FG000|Overall Study|Subject reached a virologic endpoint|2|||
46816944|NCT00561353|83036924|FG001|Overall Study|Subject reached a virologic endpoint|1|||
46816945|NCT00561353|83036925|FG002|Overall Study|Subject reached a virologic endpoint|1|||
46816946|NCT00561353|83036926|FG003|Overall Study|Subject reached a virologic endpoint|4|||
46816947|NCT00561353|83036927|FG004|Overall Study|Subject reached a virologic endpoint|1|||
46816948|NCT00561353|83036928|FG005|Overall Study|Subject reached a virologic endpoint|3|||
46816949|NCT00561353|83036929|FG006|Overall Study|Subject reached a virologic endpoint|4|||
46816950|NCT00561353|83036930|FG007|Overall Study|Subject reached a virologic endpoint|4|||
46816951|NCT00561353|83036931|FG008|Overall Study|Subject reached a virologic endpoint|5|||
46816952|NCT00561353|83036932|FG009|Overall Study|Subject reached a virologic endpoint|0|||
46816953|NCT00561353|83036923|FG000|Overall Study|Subject ineligible to continue the trial|0|||
46816954|NCT00561353|83036924|FG001|Overall Study|Subject ineligible to continue the trial|0|||
46816955|NCT00561353|83036925|FG002|Overall Study|Subject ineligible to continue the trial|0|||
46816956|NCT00561353|83036926|FG003|Overall Study|Subject ineligible to continue the trial|0|||
46816957|NCT00561353|83036927|FG004|Overall Study|Subject ineligible to continue the trial|0|||
46816958|NCT00561353|83036928|FG005|Overall Study|Subject ineligible to continue the trial|1|||
46816959|NCT00561353|83036929|FG006|Overall Study|Subject ineligible to continue the trial|1|||
46816960|NCT00561353|83036930|FG007|Overall Study|Subject ineligible to continue the trial|0|||
46816961|NCT00561353|83036931|FG008|Overall Study|Subject ineligible to continue the trial|2|||
46816962|NCT00561353|83036932|FG009|Overall Study|Subject ineligible to continue the trial|1|||
46816963|NCT00561353|83036923|FG000|Overall Study|Other|1|||
46816964|NCT00561353|83036924|FG001|Overall Study|Other|0|||
46816965|NCT00561353|83036925|FG002|Overall Study|Other|1|||
46816966|NCT00561353|83036926|FG003|Overall Study|Other|0|||
46930537|NCT02696031|83165581|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
46636686|NCT01508676|82810486|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
46757889|NCT00875420|82976191|FG000|Overall Study|Inability to complete study procedures|1|||
46757890|NCT00875420|82976192|FG001|Overall Study|Inability to complete study procedures|0|||
46757891|NCT00875420|82976193|FG002|Overall Study|Inability to complete study procedures|1|||
46757892|NCT00875420|82976194|FG003|Overall Study|Inability to complete study procedures|1|||
46757893|NCT00875420|82976195|FG004|Overall Study|Inability to complete study procedures|1|||
46757894|NCT00875420|82976191|FG000|Overall Study|Lost to Follow-up|1|||
46757895|NCT00875420|82976192|FG001|Overall Study|Lost to Follow-up|0|||
46757896|NCT00875420|82976193|FG002|Overall Study|Lost to Follow-up|0|||
46757897|NCT00875420|82976194|FG003|Overall Study|Lost to Follow-up|0|||
46757898|NCT00875420|82976195|FG004|Overall Study|Lost to Follow-up|0|||
46757899|NCT00875420|82976191|FG000|Overall Study|Personal reason|0|||
46757900|NCT00875420|82976192|FG001|Overall Study|Personal reason|0|||
46757901|NCT00875420|82976193|FG002|Overall Study|Personal reason|0|||
46757902|NCT00875420|82976194|FG003|Overall Study|Personal reason|0|||
46757903|NCT00875420|82976195|FG004|Overall Study|Personal reason|1|||
46757904|NCT00875420|82976191|FG000|Overall Study|Prohibited medication|0|||
46757905|NCT00875420|82976192|FG001|Overall Study|Prohibited medication|0|||
46757906|NCT00875420|82976193|FG002|Overall Study|Prohibited medication|0|||
46757907|NCT00875420|82976194|FG003|Overall Study|Prohibited medication|1|||
46757908|NCT00875420|82976195|FG004|Overall Study|Prohibited medication|0|||
46816967|NCT00561353|83036927|FG004|Overall Study|Other|0|||
46757909|NCT00875420|82976191|FG000|Overall Study|Sponsor decision|0|||
46757910|NCT00875420|82976192|FG001|Overall Study|Sponsor decision|1|||
46816968|NCT00561353|83036928|FG005|Overall Study|Other|2|||
46816969|NCT00561353|83036929|FG006|Overall Study|Other|0|||
46816970|NCT00561353|83036930|FG007|Overall Study|Other|0|||
46816971|NCT00561353|83036931|FG008|Overall Study|Other|0|||
46816972|NCT00561353|83036932|FG009|Overall Study|Other|0|||
46816973|NCT00561353|83036923|FG000|Overall Study|Adverse Event|0|||
46816974|NCT00561353|83036924|FG001|Overall Study|Adverse Event|0|||
46816975|NCT00561353|83036925|FG002|Overall Study|Adverse Event|0|||
46816976|NCT00561353|83036926|FG003|Overall Study|Adverse Event|2|||
46816977|NCT00561353|83036927|FG004|Overall Study|Adverse Event|0|||
46816978|NCT00561353|83036928|FG005|Overall Study|Adverse Event|0|||
46816979|NCT00561353|83036929|FG006|Overall Study|Adverse Event|1|||
46816980|NCT00561353|83036930|FG007|Overall Study|Adverse Event|0|||
46816981|NCT00561353|83036931|FG008|Overall Study|Adverse Event|0|||
46816982|NCT00561353|83036932|FG009|Overall Study|Adverse Event|1|||
46816983|NCT00561353|83036923|FG000|Overall Study|Lost to Follow-up|2|||
46816984|NCT00561353|83036924|FG001|Overall Study|Lost to Follow-up|0|||
46816985|NCT00561353|83036925|FG002|Overall Study|Lost to Follow-up|1|||
46816986|NCT00561353|83036926|FG003|Overall Study|Lost to Follow-up|0|||
46816987|NCT00561353|83036927|FG004|Overall Study|Lost to Follow-up|0|||
46816988|NCT00561353|83036928|FG005|Overall Study|Lost to Follow-up|0|||
46816989|NCT00561353|83036929|FG006|Overall Study|Lost to Follow-up|0|||
46816990|NCT00561353|83036930|FG007|Overall Study|Lost to Follow-up|0|||
46816991|NCT00561353|83036931|FG008|Overall Study|Lost to Follow-up|0|||
46816992|NCT00561353|83036932|FG009|Overall Study|Lost to Follow-up|0|||
46816993|NCT00561353|83036923|FG000|Overall Study|Withdrawal by Subject|0|||
46816994|NCT00561353|83036924|FG001|Overall Study|Withdrawal by Subject|2|||
46816995|NCT00561353|83036925|FG002|Overall Study|Withdrawal by Subject|0|||
46816996|NCT00561353|83036926|FG003|Overall Study|Withdrawal by Subject|0|||
46816997|NCT00561353|83036927|FG004|Overall Study|Withdrawal by Subject|0|||
46816998|NCT00561353|83036928|FG005|Overall Study|Withdrawal by Subject|0|||
46816999|NCT00561353|83036929|FG006|Overall Study|Withdrawal by Subject|0|||
46817000|NCT00561353|83036930|FG007|Overall Study|Withdrawal by Subject|0|||
46817001|NCT00561353|83036931|FG008|Overall Study|Withdrawal by Subject|0|||
46817002|NCT00561353|83036932|FG009|Overall Study|Withdrawal by Subject|0|||
46817003|NCT00560885|83036999|FG000|Overall Study|Death|7|||
46817004|NCT00560885|83036999|FG000|Overall Study|Withdrawal by Subject|1|||
46817005|NCT00397215|83037007|FG000|Month 0 (Day 0)|Adverse Event|0|||
46817006|NCT00397215|83037008|FG001|Month 0 (Day 0)|Adverse Event|1|||
46817007|NCT00397215|83037009|FG002|Month 0 (Day 0)|Adverse Event|0|||
46817008|NCT00397215|83037010|FG003|Month 0 (Day 0)|Adverse Event|0|||
46817009|NCT00397215|83037007|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
46817010|NCT00397215|83037008|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
46757911|NCT00875420|82976193|FG002|Overall Study|Sponsor decision|0|||
46817011|NCT00397215|83037009|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
46817012|NCT00397215|83037010|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
46817013|NCT00397215|83037007|FG000|Month 0 (Day 0)|Other|4|||
46817014|NCT00397215|83037008|FG001|Month 0 (Day 0)|Other|1|||
46817015|NCT00397215|83037009|FG002|Month 0 (Day 0)|Other|3|||
46817016|NCT00397215|83037010|FG003|Month 0 (Day 0)|Other|3|||
46817017|NCT00397215|83037007|FG000|Month 6 (Day 180)|Adverse Event|0|||
46757912|NCT00875420|82976194|FG003|Overall Study|Sponsor decision|0|||
46757913|NCT00875420|82976195|FG004|Overall Study|Sponsor decision|0|||
46757914|NCT00875420|82976191|FG000|Overall Study|Withdrawal by Subject|0|||
46757915|NCT00875420|82976192|FG001|Overall Study|Withdrawal by Subject|0|||
46757916|NCT00875420|82976193|FG002|Overall Study|Withdrawal by Subject|1|||
46757917|NCT00875420|82976194|FG003|Overall Study|Withdrawal by Subject|0|||
46817018|NCT00397215|83037008|FG001|Month 6 (Day 180)|Adverse Event|3|||
46817019|NCT00397215|83037009|FG002|Month 6 (Day 180)|Adverse Event|2|||
46757918|NCT00875420|82976195|FG004|Overall Study|Withdrawal by Subject|0|||
46817020|NCT00397215|83037010|FG003|Month 6 (Day 180)|Adverse Event|0|||
46817021|NCT00397215|83037007|FG000|Month 6 (Day 180)|Other|2|||
46817022|NCT00397215|83037008|FG001|Month 6 (Day 180)|Other|0|||
46817023|NCT00397215|83037009|FG002|Month 6 (Day 180)|Other|3|||
46817024|NCT00397215|83037010|FG003|Month 6 (Day 180)|Other|0|||
46817025|NCT00556439|83037027|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
46757919|NCT00822237|82976209|FG000|Dose 1 Vaccination|Not vaccinated|3|||
46817026|NCT00556439|83037028|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
46817027|NCT00556439|83037029|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
46817028|NCT00556439|83037030|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
46817029|NCT00556439|83037027|FG000|Study Entry to Week 12|Physician Decision|1|||
46817030|NCT00556439|83037028|FG001|Study Entry to Week 12|Physician Decision|0|||
46930538|NCT02696031|83165582|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
46930539|NCT02696031|83165583|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
46930540|NCT02696031|83165578|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
46930541|NCT02696031|83165579|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
46930542|NCT02696031|83165580|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
46930543|NCT02696031|83165581|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
46930544|NCT02696031|83165582|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
46930545|NCT02696031|83165583|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
46930546|NCT02696031|83165578|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
46930547|NCT02696031|83165579|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
46930548|NCT02696031|83165580|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
46930549|NCT02696031|83165581|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
46930550|NCT02696031|83165582|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
46930551|NCT02696031|83165583|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
46930552|NCT02696031|83165578|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
46930553|NCT02696031|83165579|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
46930554|NCT02696031|83165580|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
46930555|NCT02696031|83165581|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
46930556|NCT02696031|83165582|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
46930557|NCT02696031|83165583|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
46930558|NCT00397254|83165592|FG000|Overall Study|Lost to Follow-up|2|||
46930559|NCT00397254|83165593|FG001|Overall Study|Lost to Follow-up|2|||
46930560|NCT01369641|83165597|FG000|Overall Study|Withdrawal by Subject|1|||
46930561|NCT00529152|83165601|FG000|Overall Study|Adverse Event|2|||
46930562|NCT00529152|83165601|FG000|Overall Study|Withdrawal by Subject|2|||
46930563|NCT00529152|83165601|FG000|Overall Study|Lost to Follow-up|1|||
46930564|NCT02605174|83165608|FG000|Overall Study|Adverse Event|0|||
46930565|NCT02605174|83165609|FG001|Overall Study|Adverse Event|0|||
46930566|NCT02605174|83165610|FG002|Overall Study|Adverse Event|1|||
46930567|NCT02605174|83165611|FG003|Overall Study|Adverse Event|0|||
46930568|NCT02605174|83165612|FG004|Overall Study|Adverse Event|4|||
46930569|NCT02605174|83165613|FG005|Overall Study|Adverse Event|0|||
46930570|NCT02605174|83165614|FG006|Overall Study|Adverse Event|0|||
46930571|NCT02605174|83165608|FG000|Overall Study|Lost to Follow-up|20|||
46930572|NCT02605174|83165609|FG001|Overall Study|Lost to Follow-up|7|||
46930573|NCT02605174|83165610|FG002|Overall Study|Lost to Follow-up|27|||
46930574|NCT02605174|83165611|FG003|Overall Study|Lost to Follow-up|10|||
46930575|NCT02605174|83165612|FG004|Overall Study|Lost to Follow-up|20|||
46930576|NCT02605174|83165613|FG005|Overall Study|Lost to Follow-up|10|||
46930577|NCT02605174|83165614|FG006|Overall Study|Lost to Follow-up|29|||
46930578|NCT02605174|83165608|FG000|Overall Study|Protocol Violation|10|||
46930579|NCT02605174|83165609|FG001|Overall Study|Protocol Violation|4|||
46930580|NCT02605174|83165610|FG002|Overall Study|Protocol Violation|14|||
46930581|NCT02605174|83165611|FG003|Overall Study|Protocol Violation|6|||
46930582|NCT02605174|83165612|FG004|Overall Study|Protocol Violation|7|||
46930583|NCT02605174|83165613|FG005|Overall Study|Protocol Violation|7|||
46930584|NCT02605174|83165614|FG006|Overall Study|Protocol Violation|12|||
46930585|NCT02605174|83165608|FG000|Overall Study|Pregnancy|1|||
46930586|NCT02605174|83165609|FG001|Overall Study|Pregnancy|0|||
46930587|NCT02605174|83165610|FG002|Overall Study|Pregnancy|0|||
46930588|NCT02605174|83165611|FG003|Overall Study|Pregnancy|2|||
46930589|NCT02605174|83165612|FG004|Overall Study|Pregnancy|0|||
46930590|NCT02605174|83165613|FG005|Overall Study|Pregnancy|0|||
46930591|NCT02605174|83165614|FG006|Overall Study|Pregnancy|0|||
46930592|NCT02605174|83165608|FG000|Overall Study|Withdrawal by Subject|9|||
46930593|NCT02605174|83165609|FG001|Overall Study|Withdrawal by Subject|6|||
46930594|NCT02605174|83165610|FG002|Overall Study|Withdrawal by Subject|14|||
46930595|NCT02605174|83165611|FG003|Overall Study|Withdrawal by Subject|11|||
46930596|NCT02605174|83165612|FG004|Overall Study|Withdrawal by Subject|6|||
46930597|NCT02605174|83165613|FG005|Overall Study|Withdrawal by Subject|4|||
46930598|NCT02605174|83165614|FG006|Overall Study|Withdrawal by Subject|15|||
46930599|NCT02605174|83165608|FG000|Overall Study|Physician Decision|2|||
46930600|NCT02605174|83165609|FG001|Overall Study|Physician Decision|0|||
46930601|NCT02605174|83165610|FG002|Overall Study|Physician Decision|0|||
46930602|NCT02605174|83165611|FG003|Overall Study|Physician Decision|0|||
46930603|NCT02605174|83165612|FG004|Overall Study|Physician Decision|0|||
46930604|NCT02605174|83165613|FG005|Overall Study|Physician Decision|0|||
46930605|NCT02605174|83165614|FG006|Overall Study|Physician Decision|3|||
46930606|NCT02605174|83165608|FG000|Overall Study|Randomization Failure|22|||
46930607|NCT02605174|83165609|FG001|Overall Study|Randomization Failure|6|||
46930608|NCT02605174|83165610|FG002|Overall Study|Randomization Failure|20|||
46930609|NCT02605174|83165611|FG003|Overall Study|Randomization Failure|7|||
46930610|NCT02605174|83165612|FG004|Overall Study|Randomization Failure|16|||
46930611|NCT02605174|83165613|FG005|Overall Study|Randomization Failure|11|||
46930612|NCT02605174|83165614|FG006|Overall Study|Randomization Failure|30|||
46930613|NCT02604550|83165642|FG000|Overall Study|Lost to Follow-up|7|||
46930614|NCT02604550|83165643|FG001|Overall Study|Lost to Follow-up|6|||
46930615|NCT02604550|83165642|FG000|Overall Study|Withdrawal by Subject|0|||
46930616|NCT02604550|83165643|FG001|Overall Study|Withdrawal by Subject|1|||
46930617|NCT02604550|83165642|FG000|Overall Study|Incomplete data using paper journal|18|||
46930618|NCT02604550|83165643|FG001|Overall Study|Incomplete data using paper journal|19|||
46930619|NCT02591290|83165649|FG000|Overall Study|Withdrawal by Subject|2|||
46930620|NCT02791893|83165655|FG000|Blinded Phase|Lost to Follow-up|2|||
46930621|NCT02791893|83165656|FG001|Blinded Phase|Lost to Follow-up|2|||
46930622|NCT02791893|83165655|FG000|Blinded Phase|Withdrawal by Subject|1|||
46930623|NCT02791893|83165656|FG001|Blinded Phase|Withdrawal by Subject|2|||
46930624|NCT02791893|83165655|FG000|Open Label Phase|Lost to Follow-up|3|||
46930625|NCT02791893|83165656|FG001|Open Label Phase|Lost to Follow-up|0|||
46930626|NCT02791893|83165655|FG000|Open Label Phase|Withdrawal by Subject|0|||
46817031|NCT00556439|83037029|FG002|Study Entry to Week 12|Physician Decision|0|||
46817032|NCT00556439|83037030|FG003|Study Entry to Week 12|Physician Decision|0|||
46817033|NCT00556439|83037027|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
46817034|NCT00556439|83037028|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
46817035|NCT00556439|83037029|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
46817036|NCT00556439|83037030|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
46817037|NCT00556439|83037027|FG000|Study Entry to Week 12|Recurrent infection|1|||
46817038|NCT00556439|83037028|FG001|Study Entry to Week 12|Recurrent infection|0|||
46817039|NCT00556439|83037029|FG002|Study Entry to Week 12|Recurrent infection|0|||
46817040|NCT00556439|83037030|FG003|Study Entry to Week 12|Recurrent infection|0|||
46817041|NCT00556439|83037027|FG000|Study Entry to Week 12|Malignancy|0|||
46817042|NCT00556439|83037028|FG001|Study Entry to Week 12|Malignancy|0|||
46817043|NCT00556439|83037029|FG002|Study Entry to Week 12|Malignancy|1|||
46817044|NCT00556439|83037030|FG003|Study Entry to Week 12|Malignancy|0|||
46817045|NCT00556439|83037027|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
46817046|NCT00556439|83037028|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
46817047|NCT00556439|83037029|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
46817048|NCT00556439|83037030|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
46817049|NCT00556439|83037027|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
46817050|NCT00556439|83037028|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
46817051|NCT00556439|83037029|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
46817052|NCT00556439|83037030|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
46817053|NCT00556439|83037027|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
46817054|NCT00556439|83037028|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
46817055|NCT00556439|83037029|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
46817056|NCT00556439|83037030|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
46817057|NCT00556439|83037027|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
46817058|NCT00556439|83037028|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
46817059|NCT00556439|83037029|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
46817060|NCT00556439|83037030|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
46930627|NCT02791893|83165656|FG001|Open Label Phase|Withdrawal by Subject|2|||
46817061|NCT00387465|83037043|FG000|Overall Study|Withdrawal by Subject|0|||
46817062|NCT00387465|83037044|FG001|Overall Study|Withdrawal by Subject|1|||
46817063|NCT00387465|83037045|FG002|Overall Study|Withdrawal by Subject|0|||
46817064|NCT00387153|83037062|FG000|Overall Study|Adverse Event|1|||
46817065|NCT00387153|83037062|FG000|Overall Study|Disease Progression|3|||
46817066|NCT00387153|83037062|FG000|Overall Study|Lack of Response|4|||
46817067|NCT00386607|83037066|FG000|Core|Adverse Event|40|||
46817068|NCT00386607|83037067|FG001|Core|Adverse Event|0|||
46817069|NCT00386607|83037066|FG000|Core|Abnormal laboratory value(s)|3|||
46817070|NCT00386607|83037067|FG001|Core|Abnormal laboratory value(s)|0|||
46817071|NCT00386607|83037066|FG000|Core|Unsatisfactory therapeutic effect|23|||
46817072|NCT00386607|83037067|FG001|Core|Unsatisfactory therapeutic effect|0|||
46817073|NCT00386607|83037066|FG000|Core|Condition no longer requires study drug|4|||
46817074|NCT00386607|83037067|FG001|Core|Condition no longer requires study drug|0|||
46817075|NCT00386607|83037066|FG000|Core|Patient withdrew consent|15|||
46817076|NCT00386607|83037067|FG001|Core|Patient withdrew consent|0|||
46817077|NCT00386607|83037066|FG000|Core|Lost to Follow-up|23|||
46817078|NCT00386607|83037067|FG001|Core|Lost to Follow-up|0|||
46817079|NCT00386607|83037066|FG000|Core|Administrative problems|1|||
46817080|NCT00386607|83037067|FG001|Core|Administrative problems|0|||
46817081|NCT00386607|83037066|FG000|Core|Protocol Deviation|6|||
46930628|NCT00120042|83165665|FG000|Overall Study|all completed protocl|0|||
46930629|NCT00120042|83165666|FG001|Overall Study|all completed protocl|0|||
46930630|NCT00120042|83165667|FG002|Overall Study|all completed protocl|0|||
46930631|NCT02476851|83165674|FG000|Overall Study|Protocol Violation|1|||
46930632|NCT02476851|83165675|FG001|Overall Study|Protocol Violation|1|||
46930633|NCT02595970|83165681|FG000|Overall Study|Withdrawal by Subject|2|||
46930634|NCT02595970|83165681|FG000|Overall Study|Physician Decision|2|||
46817082|NCT00386607|83037067|FG001|Core|Protocol Deviation|0|||
46817083|NCT00386607|83037066|FG000|Extension|Adverse Event|0|||
46817084|NCT00386607|83037067|FG001|Extension|Adverse Event|6|||
46817085|NCT00386607|83037066|FG000|Extension|Abnormal laboratory value(s)|0|||
46817086|NCT00386607|83037067|FG001|Extension|Abnormal laboratory value(s)|1|||
46817087|NCT00386607|83037066|FG000|Extension|Administrative problems|0|||
46817088|NCT00386607|83037067|FG001|Extension|Administrative problems|1|||
46817089|NCT00386607|83037066|FG000|Extension|Lost to Follow-up|0|||
46817090|NCT00386607|83037067|FG001|Extension|Lost to Follow-up|3|||
46817091|NCT00386607|83037066|FG000|Extension|Patient withdrew consent|0|||
46817092|NCT00386607|83037067|FG001|Extension|Patient withdrew consent|5|||
46817093|NCT00386607|83037066|FG000|Extension|Unsatisfactory therapeutic effect|0|||
46817094|NCT00386607|83037067|FG001|Extension|Unsatisfactory therapeutic effect|1|||
46817095|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
46817096|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
46817097|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
46817098|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
46817099|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
46817100|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
46817101|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
46817102|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
46817103|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
46817104|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
46817105|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
46817106|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
46817107|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
46817108|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
46817109|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
46817110|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
46817111|NCT00410163|83037081|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
46930635|NCT02595970|83165681|FG000|Overall Study|Protocol Violation|4|||
46930636|NCT02595970|83165681|FG000|Overall Study|Adverse Event|5|||
46817112|NCT00410163|83037082|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
46817113|NCT00410163|83037081|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
46817114|NCT00410163|83037082|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
46817115|NCT00410163|83037081|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
46817116|NCT00410163|83037082|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
46817117|NCT00410163|83037081|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
46817118|NCT00410163|83037082|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
46817119|NCT00410163|83037081|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
46817120|NCT00410163|83037082|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
46817121|NCT00410163|83037081|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
46817122|NCT00410163|83037082|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
46817123|NCT00409617|83037118|FG000|Overall Study|Adverse Event|57|||
46817124|NCT00409617|83037118|FG000|Overall Study|Lack of Efficacy|54|||
46817125|NCT00409617|83037118|FG000|Overall Study|Lost to Follow-up|2|||
46817126|NCT00409617|83037118|FG000|Overall Study|Protocol Violation|24|||
46930637|NCT02595970|83165681|FG000|Overall Study|Lack of Efficacy|7|||
46930638|NCT01866111|83165689|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
46930639|NCT01866111|83165690|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
46930640|NCT01866111|83165691|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
46930641|NCT01866111|83165692|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
46757920|NCT00822237|82976210|FG001|Dose 1 Vaccination|Not vaccinated|0|||
46757921|NCT00822237|82976209|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
46757922|NCT00822237|82976210|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
46757923|NCT00822237|82976209|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
46757924|NCT00822237|82976210|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
46757925|NCT00822237|82976209|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
46817127|NCT00409617|83037118|FG000|Overall Study|Withdrawal by Subject|8|||
46817128|NCT00409617|83037118|FG000|Overall Study|Administrative reasons|1|||
46817129|NCT00409617|83037118|FG000|Overall Study|Not described|14|||
47055926|NCT04570384|83330480|FG000|Overall Study|Lost to Follow-up|1|||
46757926|NCT00822237|82976210|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
46817130|NCT00300274|83037125|FG000|Overall Study|Withdrawal by Subject|12|||
46817131|NCT00300274|83037126|FG001|Overall Study|Withdrawal by Subject|3|||
46817132|NCT00300274|83037127|FG002|Overall Study|Withdrawal by Subject|14|||
46817133|NCT00300274|83037125|FG000|Overall Study|Lost to Follow-up|3|||
46757927|NCT00822237|82976209|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
46817134|NCT00300274|83037126|FG001|Overall Study|Lost to Follow-up|4|||
46930642|NCT01866111|83165689|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
46817135|NCT00300274|83037127|FG002|Overall Study|Lost to Follow-up|5|||
46817136|NCT00300274|83037125|FG000|Overall Study|Death|31|||
46817137|NCT00300274|83037126|FG001|Overall Study|Death|20|||
46817138|NCT00300274|83037127|FG002|Overall Study|Death|25|||
46817139|NCT00300274|83037125|FG000|Overall Study|Re-transplant|0|||
46817140|NCT00300274|83037126|FG001|Overall Study|Re-transplant|0|||
46817141|NCT00300274|83037127|FG002|Overall Study|Re-transplant|1|||
46817142|NCT00299728|83037137|FG000|Overall Study|Lost to Follow-up|0|||
46817143|NCT00299728|83037138|FG001|Overall Study|Lost to Follow-up|1|||
46817144|NCT00299728|83037137|FG000|Overall Study|Withdrawal by Subject|0|||
46817145|NCT00299728|83037138|FG001|Overall Study|Withdrawal by Subject|1|||
46817146|NCT00299728|83037137|FG000|Overall Study|Progressive disease|0|||
46817147|NCT00299728|83037138|FG001|Overall Study|Progressive disease|1|||
46817148|NCT00396591|83037144|FG000|Overall Study|Disease Progression|13|||
46817149|NCT00396591|83037144|FG000|Overall Study|Adverse Event|2|||
46817150|NCT00396591|83037144|FG000|Overall Study|Participant request|1|||
46817151|NCT00316264|83037151|FG000|Overall Study|Lost to Follow-up|0|||
46817152|NCT00316264|83037152|FG001|Overall Study|Lost to Follow-up|1|||
46817153|NCT00316264|83037153|FG002|Overall Study|Lost to Follow-up|0|||
46817154|NCT00316264|83037151|FG000|Overall Study|Withdrawal of Consent|3|||
46930643|NCT01866111|83165690|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
46967671|NCT02157376|83210227|FG001|Overall Study|Investigator's misjudgement|2|||
46817155|NCT00316264|83037152|FG001|Overall Study|Withdrawal of Consent|5|||
46817156|NCT00316264|83037153|FG002|Overall Study|Withdrawal of Consent|6|||
46817157|NCT00316264|83037151|FG000|Overall Study|Death|2|||
46817158|NCT00316264|83037152|FG001|Overall Study|Death|0|||
46817159|NCT00316264|83037153|FG002|Overall Study|Death|0|||
46817160|NCT00316264|83037151|FG000|Overall Study|Other|1|||
46817161|NCT00316264|83037152|FG001|Overall Study|Other|1|||
46817162|NCT00316264|83037153|FG002|Overall Study|Other|0|||
46817163|NCT00385827|83037164|FG000|Part 1|Adverse Event|1|||
46817164|NCT00385827|83037165|FG001|Part 1|Adverse Event|0|||
46817165|NCT00385827|83037166|FG002|Part 1|Adverse Event|0|||
46817166|NCT00385827|83037164|FG000|Part 1|Death|2|||
46817167|NCT00385827|83037165|FG001|Part 1|Death|0|||
46817168|NCT00385827|83037166|FG002|Part 1|Death|0|||
46817169|NCT00385827|83037164|FG000|Part 1|Lack of Efficacy|5|||
46817170|NCT00385827|83037165|FG001|Part 1|Lack of Efficacy|0|||
46817171|NCT00385827|83037166|FG002|Part 1|Lack of Efficacy|0|||
46817172|NCT00385827|83037164|FG000|Part 1|Other|1|||
46817173|NCT00385827|83037165|FG001|Part 1|Other|0|||
46817174|NCT00385827|83037166|FG002|Part 1|Other|0|||
46817175|NCT00385827|83037164|FG000|Part 2|Adverse Event|0|||
46817176|NCT00385827|83037165|FG001|Part 2|Adverse Event|6|||
46817177|NCT00385827|83037166|FG002|Part 2|Adverse Event|10|||
46817178|NCT00385827|83037164|FG000|Part 2|Death|0|||
46817179|NCT00385827|83037165|FG001|Part 2|Death|0|||
46817180|NCT00385827|83037166|FG002|Part 2|Death|2|||
46817181|NCT00385827|83037164|FG000|Part 2|Lack of Efficacy|0|||
46817182|NCT00385827|83037165|FG001|Part 2|Lack of Efficacy|14|||
46967672|NCT02157298|83210235|FG000|Overall Study|Adverse Event|1|||
46757928|NCT00822237|82976210|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
46757929|NCT00577096|82976217|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
46757930|NCT00577096|82976218|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
46757931|NCT00577096|82976217|FG000|Short Term Participation|Withdrawal by Subject|3|||
46757932|NCT00577096|82976218|FG001|Short Term Participation|Withdrawal by Subject|5|||
46757933|NCT00577096|82976217|FG000|Short Term Participation|Death|1|||
46757934|NCT00577096|82976218|FG001|Short Term Participation|Death|1|||
46757935|NCT00863304|82976228|FG000|Overall Study|Adverse Event|10|||
46757936|NCT00863304|82976229|FG001|Overall Study|Adverse Event|4|||
46757937|NCT00863304|82976230|FG002|Overall Study|Adverse Event|14|||
46817183|NCT00385827|83037166|FG002|Part 2|Lack of Efficacy|13|||
46817184|NCT00385827|83037164|FG000|Part 2|Randomized but not treated|0|||
46817185|NCT00385827|83037165|FG001|Part 2|Randomized but not treated|2|||
46817186|NCT00385827|83037166|FG002|Part 2|Randomized but not treated|2|||
46817187|NCT00385827|83037164|FG000|Part 2|Other|0|||
46817188|NCT00385827|83037165|FG001|Part 2|Other|11|||
46817189|NCT00385827|83037166|FG002|Part 2|Other|21|||
46817190|NCT00498602|83037183|FG000|Overall Study|Death|0|||
46817191|NCT00498602|83037184|FG001|Overall Study|Death|0|||
46757938|NCT00863304|82976231|FG003|Overall Study|Adverse Event|16|||
46757939|NCT00863304|82976228|FG000|Overall Study|Lost to Follow-up|1|||
46817192|NCT00498602|83037185|FG002|Overall Study|Death|0|||
46817193|NCT00498602|83037186|FG003|Overall Study|Death|0|||
46817194|NCT00498602|83037187|FG004|Overall Study|Death|0|||
46817195|NCT00498602|83037188|FG005|Overall Study|Death|1|||
46817196|NCT00498602|83037189|FG006|Overall Study|Death|0|||
46817197|NCT00498602|83037183|FG000|Overall Study|Lack of Efficacy|1|||
46817198|NCT00498602|83037184|FG001|Overall Study|Lack of Efficacy|0|||
46817199|NCT00498602|83037185|FG002|Overall Study|Lack of Efficacy|0|||
46817200|NCT00498602|83037186|FG003|Overall Study|Lack of Efficacy|0|||
46817201|NCT00498602|83037187|FG004|Overall Study|Lack of Efficacy|0|||
46930644|NCT01866111|83165691|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
46930645|NCT01866111|83165692|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
46930646|NCT02595502|83165702|FG000|Period 1|Adverse Event|0|||
46930647|NCT02595502|83165703|FG001|Period 1|Adverse Event|1|||
46930648|NCT02595502|83165702|FG000|Period 1|Withdrawal by Subject|1|||
47055927|NCT04570384|83330481|FG001|Overall Study|Lost to Follow-up|0|||
46757940|NCT00863304|82976229|FG001|Overall Study|Lost to Follow-up|5|||
46757941|NCT00863304|82976230|FG002|Overall Study|Lost to Follow-up|4|||
46757942|NCT00863304|82976231|FG003|Overall Study|Lost to Follow-up|2|||
46757943|NCT00863304|82976228|FG000|Overall Study|Lack of Efficacy|57|||
46757944|NCT00863304|82976229|FG001|Overall Study|Lack of Efficacy|26|||
46757945|NCT00863304|82976230|FG002|Overall Study|Lack of Efficacy|30|||
46757946|NCT00863304|82976231|FG003|Overall Study|Lack of Efficacy|28|||
46757947|NCT00863304|82976228|FG000|Overall Study|Withdrawal by Subject|19|||
46757948|NCT00863304|82976229|FG001|Overall Study|Withdrawal by Subject|14|||
46757949|NCT00863304|82976230|FG002|Overall Study|Withdrawal by Subject|20|||
46757950|NCT00863304|82976231|FG003|Overall Study|Withdrawal by Subject|18|||
46757951|NCT00863304|82976228|FG000|Overall Study|Other|1|||
46757952|NCT00863304|82976229|FG001|Overall Study|Other|0|||
46757953|NCT00863304|82976230|FG002|Overall Study|Other|0|||
46757954|NCT00863304|82976231|FG003|Overall Study|Other|1|||
46757955|NCT00863304|82976228|FG000|Overall Study|Protocol Violation|2|||
46757956|NCT00863304|82976229|FG001|Overall Study|Protocol Violation|6|||
46757957|NCT00863304|82976230|FG002|Overall Study|Protocol Violation|2|||
46757958|NCT00863304|82976231|FG003|Overall Study|Protocol Violation|0|||
46757959|NCT00863304|82976228|FG000|Overall Study|Randomized, but not Treated|3|||
46757960|NCT00863304|82976229|FG001|Overall Study|Randomized, but not Treated|1|||
46757961|NCT00863304|82976230|FG002|Overall Study|Randomized, but not Treated|4|||
46757962|NCT00863304|82976231|FG003|Overall Study|Randomized, but not Treated|1|||
46757963|NCT00863304|82976228|FG000|Overall Study|Entered extension study|101|||
46757964|NCT00863304|82976229|FG001|Overall Study|Entered extension study|129|||
46757965|NCT00863304|82976230|FG002|Overall Study|Entered extension study|113|||
46757966|NCT00863304|82976231|FG003|Overall Study|Entered extension study|125|||
46757967|NCT00695110|82976243|FG000|Treatment Period 1|Adverse Event|1|||
46757968|NCT00695110|82976243|FG000|Treatment Period 1|Withdrawal by Subject|2|||
46757969|NCT00695110|82976243|FG000|Treatment Period 3|Withdrawal by Subject|1|||
46757970|NCT00695110|82976243|FG000|Treatment Period 4|Adverse Event|1|||
46757971|NCT00594386|82976250|FG000|Overall Study|Major protocol violation|2|||
46757972|NCT00594386|82976250|FG000|Overall Study|Lack of Efficacy|12|||
46757973|NCT00594386|82976250|FG000|Overall Study|Adverse Event|68|||
46757974|NCT00594386|82976250|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
46757975|NCT00594386|82976250|FG000|Overall Study|Subject withdrew consent|35|||
46757976|NCT00594386|82976250|FG000|Overall Study|Study ended per sponsor|115|||
46757977|NCT00594386|82976250|FG000|Overall Study|Lost to Follow-up|6|||
46757978|NCT00594386|82976250|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
46757979|NCT00594386|82976250|FG000|Overall Study|Other: Subject moved to Seattle|1|||
46757980|NCT00594386|82976250|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
46757981|NCT00594386|82976250|FG000|Overall Study|Other: Study terminated per investigator|2|||
46757982|NCT00594386|82976250|FG000|Overall Study|Other: Sponsor closure of study|1|||
46757983|NCT00594386|82976250|FG000|Overall Study|Other: Site terminated participation|1|||
46757984|NCT00594386|82976250|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
46757985|NCT00594386|82976250|FG000|Overall Study|Other: Loss of drivers license|1|||
46757986|NCT00862992|82976257|FG000|Overall Study|Adverse Event|2|||
46757987|NCT00862992|82976258|FG001|Overall Study|Adverse Event|1|||
46757988|NCT00862992|82976259|FG002|Overall Study|Adverse Event|1|||
46757989|NCT00862992|82976257|FG000|Overall Study|Physician Decision|1|||
46757990|NCT00862992|82976258|FG001|Overall Study|Physician Decision|0|||
46757991|NCT00862992|82976259|FG002|Overall Study|Physician Decision|0|||
46757992|NCT00862992|82976257|FG000|Overall Study|Withdrawal by Subject|0|||
46757993|NCT00862992|82976258|FG001|Overall Study|Withdrawal by Subject|0|||
46757994|NCT00862992|82976259|FG002|Overall Study|Withdrawal by Subject|2|||
46757995|NCT00694096|82976267|FG000|Overall Study|Withdrawal by Subject|5|||
46757996|NCT00854100|82976274|FG000|Overall Study|Inability to complete the study visits|0|||
46757997|NCT00854100|82976275|FG001|Overall Study|Inability to complete the study visits|0|||
46757998|NCT00854100|82976276|FG002|Overall Study|Inability to complete the study visits|1|||
47055928|NCT04570384|83330480|FG000|Overall Study|Other|1|||
46757999|NCT00854100|82976274|FG000|Overall Study|Lost to Follow-up|2|||
46758000|NCT00854100|82976275|FG001|Overall Study|Lost to Follow-up|0|||
46758001|NCT00854100|82976276|FG002|Overall Study|Lost to Follow-up|3|||
46758002|NCT00854100|82976274|FG000|Overall Study|Withdrawal by Subject|3|||
46758003|NCT00854100|82976275|FG001|Overall Study|Withdrawal by Subject|1|||
46758004|NCT00854100|82976276|FG002|Overall Study|Withdrawal by Subject|2|||
46758005|NCT00854100|82976274|FG000|Overall Study|Protocol Violation|2|||
46758006|NCT00854100|82976275|FG001|Overall Study|Protocol Violation|4|||
46758007|NCT00854100|82976276|FG002|Overall Study|Protocol Violation|3|||
46758008|NCT00854100|82976274|FG000|Overall Study|Adverse Event|2|||
46758009|NCT00854100|82976275|FG001|Overall Study|Adverse Event|1|||
46758010|NCT00854100|82976276|FG002|Overall Study|Adverse Event|2|||
46758011|NCT00509899|82976293|FG000|Overall Study|Progressive disease|1|||
46817202|NCT00498602|83037188|FG005|Overall Study|Lack of Efficacy|0|||
46930649|NCT02595502|83165703|FG001|Period 1|Withdrawal by Subject|0|||
46930650|NCT02595502|83165702|FG000|Period 1|Lost to Follow-up|0|||
46930651|NCT02595502|83165703|FG001|Period 1|Lost to Follow-up|1|||
46930652|NCT02595502|83165702|FG000|Period 2|Adverse Event|1|||
46930653|NCT02595502|83165703|FG001|Period 2|Adverse Event|1|||
46930654|NCT02595502|83165702|FG000|Period 2|Received incorrect lens at Period 1|0|||
46930655|NCT02595502|83165703|FG001|Period 2|Received incorrect lens at Period 1|1|||
46930656|NCT02595502|83165702|FG000|Period 3|Protocol Violation|0|||
46930657|NCT02595502|83165703|FG001|Period 3|Protocol Violation|1|||
46930658|NCT02595502|83165702|FG000|Period 3|Lost to Follow-up|1|||
46930659|NCT02595502|83165703|FG001|Period 3|Lost to Follow-up|0|||
46930660|NCT02595502|83165702|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
46930661|NCT02595502|83165703|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
46930662|NCT01369329|83165712|FG000|Overall Study|Withdrawal by Subject|8|||
46930663|NCT01369329|83165713|FG001|Overall Study|Withdrawal by Subject|6|||
46817203|NCT00498602|83037189|FG006|Overall Study|Lack of Efficacy|0|||
46817204|NCT00498602|83037183|FG000|Overall Study|Lost to Follow-up|0|||
46817205|NCT00498602|83037184|FG001|Overall Study|Lost to Follow-up|2|||
46930664|NCT01369329|83165714|FG002|Overall Study|Withdrawal by Subject|10|||
46930665|NCT01369329|83165712|FG000|Overall Study|Lost to Follow-up|2|||
46930666|NCT01369329|83165713|FG001|Overall Study|Lost to Follow-up|2|||
46930667|NCT01369329|83165714|FG002|Overall Study|Lost to Follow-up|2|||
46930668|NCT01369329|83165712|FG000|Overall Study|Other|2|||
46930669|NCT01369329|83165713|FG001|Overall Study|Other|3|||
46817206|NCT00498602|83037185|FG002|Overall Study|Lost to Follow-up|0|||
46817207|NCT00498602|83037186|FG003|Overall Study|Lost to Follow-up|2|||
46817208|NCT00498602|83037187|FG004|Overall Study|Lost to Follow-up|0|||
46817209|NCT00498602|83037188|FG005|Overall Study|Lost to Follow-up|0|||
46817210|NCT00498602|83037189|FG006|Overall Study|Lost to Follow-up|0|||
46817211|NCT00498602|83037183|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
46817212|NCT00498602|83037184|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
46817213|NCT00498602|83037185|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
46817214|NCT00498602|83037186|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
46817215|NCT00498602|83037187|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
46817216|NCT00498602|83037188|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
46817217|NCT00498602|83037189|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
46817218|NCT00498602|83037183|FG000|Overall Study|AE not related to Study Drug|1|||
46817219|NCT00498602|83037184|FG001|Overall Study|AE not related to Study Drug|3|||
46817220|NCT00498602|83037185|FG002|Overall Study|AE not related to Study Drug|0|||
46817221|NCT00498602|83037186|FG003|Overall Study|AE not related to Study Drug|0|||
46817222|NCT00498602|83037187|FG004|Overall Study|AE not related to Study Drug|2|||
46817223|NCT00498602|83037188|FG005|Overall Study|AE not related to Study Drug|2|||
46817224|NCT00498602|83037189|FG006|Overall Study|AE not related to Study Drug|1|||
46817225|NCT00498602|83037183|FG000|Overall Study|Caregiver Request|2|||
46817226|NCT00498602|83037184|FG001|Overall Study|Caregiver Request|2|||
46817227|NCT00498602|83037185|FG002|Overall Study|Caregiver Request|2|||
46817228|NCT00498602|83037186|FG003|Overall Study|Caregiver Request|0|||
46817229|NCT00498602|83037187|FG004|Overall Study|Caregiver Request|1|||
46930670|NCT01369329|83165714|FG002|Overall Study|Other|2|||
46930671|NCT02791659|83165724|FG000|Overall Study|Protocol Violation|0|||
46930672|NCT02791659|83165725|FG001|Overall Study|Protocol Violation|1|||
46930673|NCT02594098|83165733|FG000|Overall Study|Lack of Efficacy|17|||
46930674|NCT02594098|83165734|FG001|Overall Study|Lack of Efficacy|6|||
46930675|NCT02594098|83165733|FG000|Overall Study|Withdrawal by Subject|1|||
46758012|NCT00509899|82976294|FG001|Overall Study|Progressive disease|3|||
46758013|NCT00509899|82976295|FG002|Overall Study|Progressive disease|5|||
46758014|NCT00509899|82976296|FG003|Overall Study|Progressive disease|1|||
46817230|NCT00498602|83037188|FG005|Overall Study|Caregiver Request|2|||
46930676|NCT02594098|83165734|FG001|Overall Study|Withdrawal by Subject|3|||
46930677|NCT02594098|83165733|FG000|Overall Study|Terminated participation|6|||
46930678|NCT02594098|83165734|FG001|Overall Study|Terminated participation|2|||
47055929|NCT04570384|83330481|FG001|Overall Study|Other|0|||
46758015|NCT00509899|82976297|FG004|Overall Study|Progressive disease|0|||
46758016|NCT00509899|82976298|FG005|Overall Study|Progressive disease|1|||
46758017|NCT00509899|82976299|FG006|Overall Study|Progressive disease|0|||
46758018|NCT00509899|82976300|FG007|Overall Study|Progressive disease|0|||
46758019|NCT00509899|82976293|FG000|Overall Study|Unacceptable Toxicity|1|||
46817231|NCT00498602|83037189|FG006|Overall Study|Caregiver Request|0|||
46930679|NCT02594098|83165733|FG000|Overall Study|Seek alternative treatment|2|||
46817232|NCT00498602|83037183|FG000|Overall Study|Investigator Request|0|||
46930680|NCT02594098|83165734|FG001|Overall Study|Seek alternative treatment|1|||
46930681|NCT02594098|83165733|FG000|Overall Study|Other|0|||
46758020|NCT00509899|82976294|FG001|Overall Study|Unacceptable Toxicity|0|||
46930682|NCT02594098|83165734|FG001|Overall Study|Other|1|||
46930683|NCT02593864|83165742|FG000|Overall Study|Withdrawal by Subject|3|||
46930684|NCT02593864|83165742|FG000|Overall Study|Lost to Follow-up|3|||
46930685|NCT02590588|83165746|FG000|Overall Study|Adverse Event|1|||
46930686|NCT01434602|83165755|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
46930687|NCT01434602|83165756|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
46930688|NCT01434602|83165757|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
46930689|NCT01434602|83165758|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
46930690|NCT01434602|83165759|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
46930691|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
46930692|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
46930693|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
46758021|NCT00509899|82976295|FG002|Overall Study|Unacceptable Toxicity|0|||
46817233|NCT00498602|83037184|FG001|Overall Study|Investigator Request|0|||
46817234|NCT00498602|83037185|FG002|Overall Study|Investigator Request|1|||
46817235|NCT00498602|83037186|FG003|Overall Study|Investigator Request|0|||
46817236|NCT00498602|83037187|FG004|Overall Study|Investigator Request|0|||
46817237|NCT00498602|83037188|FG005|Overall Study|Investigator Request|0|||
46817238|NCT00498602|83037189|FG006|Overall Study|Investigator Request|0|||
46817239|NCT00498602|83037183|FG000|Overall Study|Subject Request|3|||
46817240|NCT00498602|83037184|FG001|Overall Study|Subject Request|0|||
46817241|NCT00498602|83037185|FG002|Overall Study|Subject Request|1|||
46817242|NCT00498602|83037186|FG003|Overall Study|Subject Request|1|||
46817243|NCT00498602|83037187|FG004|Overall Study|Subject Request|1|||
46817244|NCT00498602|83037188|FG005|Overall Study|Subject Request|4|||
46817245|NCT00498602|83037189|FG006|Overall Study|Subject Request|1|||
46817246|NCT00498602|83037183|FG000|Overall Study|Other|2|||
46817247|NCT00498602|83037184|FG001|Overall Study|Other|3|||
46817248|NCT00498602|83037185|FG002|Overall Study|Other|1|||
46817249|NCT00498602|83037186|FG003|Overall Study|Other|0|||
46817250|NCT00498602|83037187|FG004|Overall Study|Other|0|||
46817251|NCT00498602|83037188|FG005|Overall Study|Other|3|||
46817252|NCT00498602|83037189|FG006|Overall Study|Other|0|||
46817253|NCT00507728|83037208|FG000|Randomization to Month 3|Lost to Follow-up|15|||
46817254|NCT00507728|83037209|FG001|Randomization to Month 3|Lost to Follow-up|14|||
46817255|NCT00507728|83037210|FG002|Randomization to Month 3|Lost to Follow-up|20|||
46817256|NCT00507728|83037208|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
46817257|NCT00507728|83037209|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
46817258|NCT00507728|83037210|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
46817259|NCT00498368|83037226|FG000|Overall Study|Withdrawal by Subject|3|||
46817260|NCT00498368|83037227|FG001|Overall Study|Withdrawal by Subject|2|||
46817261|NCT00385671|83037236|FG000|Overall Study|Adverse Event|14|||
46817262|NCT00385671|83037237|FG001|Overall Study|Adverse Event|27|||
46817263|NCT00385671|83037238|FG002|Overall Study|Adverse Event|18|||
46817264|NCT00385671|83037236|FG000|Overall Study|Lack of Efficacy|5|||
46817265|NCT00385671|83037237|FG001|Overall Study|Lack of Efficacy|9|||
46817266|NCT00385671|83037238|FG002|Overall Study|Lack of Efficacy|5|||
46817267|NCT00385671|83037236|FG000|Overall Study|Lost to Follow-up|6|||
46817268|NCT00385671|83037237|FG001|Overall Study|Lost to Follow-up|6|||
46758022|NCT00509899|82976296|FG003|Overall Study|Unacceptable Toxicity|2|||
46758023|NCT00509899|82976297|FG004|Overall Study|Unacceptable Toxicity|0|||
46758024|NCT00509899|82976298|FG005|Overall Study|Unacceptable Toxicity|0|||
46758025|NCT00509899|82976299|FG006|Overall Study|Unacceptable Toxicity|0|||
46758026|NCT00509899|82976300|FG007|Overall Study|Unacceptable Toxicity|0|||
46758027|NCT00509899|82976293|FG000|Overall Study|Withdrawal by Subject|6|||
46758028|NCT00509899|82976294|FG001|Overall Study|Withdrawal by Subject|2|||
46758029|NCT00509899|82976295|FG002|Overall Study|Withdrawal by Subject|3|||
46758030|NCT00509899|82976296|FG003|Overall Study|Withdrawal by Subject|0|||
46758031|NCT00509899|82976297|FG004|Overall Study|Withdrawal by Subject|3|||
46758032|NCT00509899|82976298|FG005|Overall Study|Withdrawal by Subject|2|||
46817269|NCT00385671|83037238|FG002|Overall Study|Lost to Follow-up|5|||
46817270|NCT00385671|83037236|FG000|Overall Study|Physician Decision|2|||
46817271|NCT00385671|83037237|FG001|Overall Study|Physician Decision|1|||
46817272|NCT00385671|83037238|FG002|Overall Study|Physician Decision|2|||
46817273|NCT00385671|83037236|FG000|Overall Study|Protocol Violation|5|||
46817274|NCT00385671|83037237|FG001|Overall Study|Protocol Violation|2|||
46817275|NCT00385671|83037238|FG002|Overall Study|Protocol Violation|1|||
46817276|NCT00385671|83037236|FG000|Overall Study|Sponsor Decision|2|||
46817277|NCT00385671|83037237|FG001|Overall Study|Sponsor Decision|2|||
46817278|NCT00385671|83037238|FG002|Overall Study|Sponsor Decision|1|||
46817279|NCT00385671|83037236|FG000|Overall Study|Withdrawal by Subject|4|||
46817280|NCT00385671|83037237|FG001|Overall Study|Withdrawal by Subject|4|||
46758033|NCT00509899|82976299|FG006|Overall Study|Withdrawal by Subject|0|||
46817281|NCT00385671|83037238|FG002|Overall Study|Withdrawal by Subject|4|||
46817282|NCT00497198|83037250|FG000|Overall Study|Adverse Event|4|||
46817283|NCT00497198|83037251|FG001|Overall Study|Adverse Event|2|||
46817284|NCT00497198|83037250|FG000|Overall Study|Physician Decision|1|||
46817285|NCT00497198|83037251|FG001|Overall Study|Physician Decision|2|||
46817286|NCT00497198|83037250|FG000|Overall Study|Withdrawal by Subject|0|||
46817287|NCT00497198|83037251|FG001|Overall Study|Withdrawal by Subject|1|||
46817288|NCT00496964|83037259|FG000|Overall Study|Withdrawal by Subject|0|||
46817289|NCT00496964|83037260|FG001|Overall Study|Withdrawal by Subject|1|||
46817290|NCT00490490|83037268|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
46817291|NCT00490490|83037268|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
46817292|NCT00385593|83037274|FG000|Overall Study|Adverse Event|3|||
46817293|NCT00385593|83037275|FG001|Overall Study|Adverse Event|2|||
46817294|NCT00385593|83037274|FG000|Overall Study|Withdrawal by Subject|17|||
46817295|NCT00385593|83037275|FG001|Overall Study|Withdrawal by Subject|7|||
46817296|NCT00385593|83037274|FG000|Overall Study|Lost to Follow-up|12|||
46817297|NCT00385593|83037275|FG001|Overall Study|Lost to Follow-up|8|||
46817298|NCT00385593|83037274|FG000|Overall Study|Protocol Violation|7|||
46817299|NCT00385593|83037275|FG001|Overall Study|Protocol Violation|4|||
46817300|NCT00385593|83037274|FG000|Overall Study|Several reasons|17|||
46817301|NCT00385593|83037275|FG001|Overall Study|Several reasons|15|||
46817302|NCT00385593|83037274|FG000|Overall Study|Incorrect inclusion|2|||
46817303|NCT00385593|83037275|FG001|Overall Study|Incorrect inclusion|0|||
46817304|NCT00385593|83037274|FG000|Overall Study|Incorrect randomization|0|||
46817305|NCT00385593|83037275|FG001|Overall Study|Incorrect randomization|1|||
46817306|NCT00495794|83037283|FG000|Overall Study|Pharmacist did not activate patient|522|||
46817307|NCT00495794|83037284|FG001|Overall Study|Pharmacist did not activate patient|0|||
46817308|NCT00495170|83037290|FG000|Overall Study|Lost to Follow-up|9|||
46817309|NCT00495170|83037290|FG000|Overall Study|Withdrawal by Subject|3|||
46817310|NCT00495170|83037290|FG000|Overall Study|Inappropriate staging|8|||
46817311|NCT03853148|83037298|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
46817312|NCT03853148|83037299|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
46817313|NCT03853148|83037300|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
46817314|NCT03853148|83037301|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
46817315|NCT00385203|83037313|FG000|Overall Study|Adverse Event|5|||
46817316|NCT00385203|83037314|FG001|Overall Study|Adverse Event|4|||
46817317|NCT00385203|83037313|FG000|Overall Study|Death|1|||
46817318|NCT00385203|83037314|FG001|Overall Study|Death|0|||
46817319|NCT00385203|83037313|FG000|Overall Study|Condition under investigation worsened|18|||
46817320|NCT00385203|83037314|FG001|Overall Study|Condition under investigation worsened|3|||
46817321|NCT00385203|83037313|FG000|Overall Study|Incorrect enrollment|2|||
46817322|NCT00385203|83037314|FG001|Overall Study|Incorrect enrollment|0|||
46817323|NCT00408993|83037323|FG000|Overall Study|Adverse Event|15|||
46817324|NCT00408993|83037324|FG001|Overall Study|Adverse Event|4|||
46817325|NCT00408993|83037323|FG000|Overall Study|Protocol Violation|1|||
46817326|NCT00408993|83037324|FG001|Overall Study|Protocol Violation|6|||
46817327|NCT00408993|83037323|FG000|Overall Study|Lack of Efficacy|1|||
46817328|NCT00408993|83037324|FG001|Overall Study|Lack of Efficacy|4|||
46817329|NCT00408993|83037323|FG000|Overall Study|Withdrawal by Subject|2|||
46817330|NCT00408993|83037324|FG001|Overall Study|Withdrawal by Subject|3|||
46817331|NCT00395967|83037334|FG000|Treatment Period|Failed Mobilization|1|||
46817332|NCT00395967|83037334|FG000|Follow-up Period|Death|1|||
46817333|NCT00395967|83037334|FG000|Follow-up Period|Lost to Follow-up|1|||
46817334|NCT00395733|83037340|FG000|Period 2|Withdrawal by Subject|1|||
46817335|NCT00395733|83037341|FG001|Period 2|Withdrawal by Subject|2|||
46817336|NCT00395733|83037340|FG000|Period 2|Protocol Violation|0|||
46930694|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
46930695|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
46930696|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
46930697|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
46930698|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
46967673|NCT02157298|83210236|FG001|Overall Study|Adverse Event|0|||
46817337|NCT00395733|83037341|FG001|Period 2|Protocol Violation|1|||
46817338|NCT00395733|83037340|FG000|Period 2|Adverse Event|0|||
46817339|NCT00395733|83037341|FG001|Period 2|Adverse Event|2|||
46817340|NCT00395733|83037340|FG000|Period 2|Technical problems|1|||
46817341|NCT00395733|83037341|FG001|Period 2|Technical problems|0|||
46817342|NCT00395343|83037349|FG000|Overall Study|Adverse Event|13|||
46817343|NCT00395343|83037350|FG001|Overall Study|Adverse Event|5|||
46817344|NCT00395343|83037349|FG000|Overall Study|Lack of Efficacy|0|||
46930699|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
46930700|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
46930701|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
46930702|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
46817345|NCT00395343|83037350|FG001|Overall Study|Lack of Efficacy|1|||
46817346|NCT00395343|83037349|FG000|Overall Study|Lost to Follow-up|4|||
46930703|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
46930704|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
46930705|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
46930706|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
46930707|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
46930708|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
46930709|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
46930710|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
46930711|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
46930712|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
46930713|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
46930714|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
46817347|NCT00395343|83037350|FG001|Overall Study|Lost to Follow-up|4|||
46817348|NCT00395343|83037349|FG000|Overall Study|Physician Decision|2|||
46817349|NCT00395343|83037350|FG001|Overall Study|Physician Decision|4|||
46817350|NCT00395343|83037349|FG000|Overall Study|Protocol Violation|6|||
46817351|NCT00395343|83037350|FG001|Overall Study|Protocol Violation|8|||
46817352|NCT00395343|83037349|FG000|Overall Study|Withdrawal by Subject|11|||
46817353|NCT00395343|83037350|FG001|Overall Study|Withdrawal by Subject|12|||
46817354|NCT00395343|83037349|FG000|Overall Study|Other|5|||
46817355|NCT00395343|83037350|FG001|Overall Study|Other|2|||
46817356|NCT00560573|83037356|FG000|Overall Study|Death|4|||
46817357|NCT00560573|83037357|FG001|Overall Study|Death|1|||
46817358|NCT00560573|83037358|FG002|Overall Study|Death|4|||
46817359|NCT00560573|83037359|FG003|Overall Study|Death|5|||
46817360|NCT00560573|83037360|FG004|Overall Study|Death|1|||
46817361|NCT00560573|83037361|FG005|Overall Study|Death|10|||
46817362|NCT00560573|83037356|FG000|Overall Study|Lost to Follow-up|0|||
46817363|NCT00560573|83037357|FG001|Overall Study|Lost to Follow-up|0|||
46817364|NCT00560573|83037358|FG002|Overall Study|Lost to Follow-up|0|||
46817365|NCT00560573|83037359|FG003|Overall Study|Lost to Follow-up|1|||
46817366|NCT00560573|83037360|FG004|Overall Study|Lost to Follow-up|1|||
46817367|NCT00560573|83037361|FG005|Overall Study|Lost to Follow-up|0|||
46817368|NCT00560573|83037356|FG000|Overall Study|Withdrawal by Subject|0|||
46817369|NCT00560573|83037357|FG001|Overall Study|Withdrawal by Subject|0|||
46817370|NCT00560573|83037358|FG002|Overall Study|Withdrawal by Subject|0|||
46817371|NCT00560573|83037359|FG003|Overall Study|Withdrawal by Subject|1|||
46817372|NCT00560573|83037360|FG004|Overall Study|Withdrawal by Subject|1|||
46817373|NCT00560573|83037361|FG005|Overall Study|Withdrawal by Subject|0|||
46817374|NCT00560573|83037356|FG000|Overall Study|Other|2|||
46817375|NCT00560573|83037357|FG001|Overall Study|Other|2|||
46817376|NCT00560573|83037358|FG002|Overall Study|Other|2|||
46817377|NCT00560573|83037359|FG003|Overall Study|Other|3|||
46817378|NCT00560573|83037360|FG004|Overall Study|Other|3|||
46817379|NCT00560573|83037361|FG005|Overall Study|Other|3|||
46817380|NCT00560573|83037356|FG000|Overall Study|Enrolled, not treated|0|||
46817381|NCT00560573|83037357|FG001|Overall Study|Enrolled, not treated|0|||
46817382|NCT00560573|83037358|FG002|Overall Study|Enrolled, not treated|0|||
46817383|NCT00560573|83037359|FG003|Overall Study|Enrolled, not treated|0|||
46817384|NCT00560573|83037360|FG004|Overall Study|Enrolled, not treated|1|||
46817385|NCT00560573|83037361|FG005|Overall Study|Enrolled, not treated|0|||
46817386|NCT03961529|83037394|FG000|Overall Study|Adverse Event|13|||
46817387|NCT03961529|83037395|FG001|Overall Study|Adverse Event|5|||
46817388|NCT03961529|83037396|FG002|Overall Study|Adverse Event|2|||
46817389|NCT03961529|83037394|FG000|Overall Study|Withdrawal by Subject|17|||
47055930|NCT04570384|83330480|FG000|Overall Study|Protocol Violation|0|||
46817390|NCT03961529|83037395|FG001|Overall Study|Withdrawal by Subject|2|||
46817391|NCT03961529|83037396|FG002|Overall Study|Withdrawal by Subject|1|||
46817392|NCT03961529|83037394|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46817393|NCT03961529|83037395|FG001|Overall Study|Withdrawal by parent/guardian|7|||
46817394|NCT03961529|83037396|FG002|Overall Study|Withdrawal by parent/guardian|0|||
46817395|NCT03961529|83037394|FG000|Overall Study|Physician Decision|2|||
46817396|NCT03961529|83037395|FG001|Overall Study|Physician Decision|1|||
47055931|NCT04570384|83330481|FG001|Overall Study|Protocol Violation|1|||
46817397|NCT03961529|83037396|FG002|Overall Study|Physician Decision|1|||
46817398|NCT03961529|83037394|FG000|Overall Study|Lost to Follow-up|2|||
46817399|NCT03961529|83037395|FG001|Overall Study|Lost to Follow-up|1|||
46817400|NCT03961529|83037396|FG002|Overall Study|Lost to Follow-up|0|||
46817401|NCT03961529|83037394|FG000|Overall Study|Lack of Efficacy|2|||
46817402|NCT03961529|83037395|FG001|Overall Study|Lack of Efficacy|0|||
46817403|NCT03961529|83037396|FG002|Overall Study|Lack of Efficacy|1|||
46817404|NCT03961529|83037394|FG000|Overall Study|Other|6|||
46817405|NCT03961529|83037395|FG001|Overall Study|Other|1|||
46817406|NCT03961529|83037396|FG002|Overall Study|Other|0|||
46817407|NCT00494780|83037406|FG000|Overall Study|Adverse Event|1|||
46817408|NCT00494780|83037407|FG001|Overall Study|Adverse Event|0|||
46817409|NCT00494780|83037406|FG000|Overall Study|Withdrew before Dosed|0|||
46817410|NCT00494780|83037407|FG001|Overall Study|Withdrew before Dosed|1|||
46817411|NCT00494780|83037406|FG000|Overall Study|Progression of Study Disease|7|||
46817412|NCT00494780|83037407|FG001|Overall Study|Progression of Study Disease|8|||
46817413|NCT00494780|83037406|FG000|Overall Study|New Treatment|2|||
46817414|NCT00494780|83037407|FG001|Overall Study|New Treatment|2|||
46817415|NCT00494780|83037406|FG000|Overall Study|Non-compliance|1|||
46817416|NCT00494780|83037407|FG001|Overall Study|Non-compliance|0|||
46817417|NCT00494780|83037406|FG000|Overall Study|Residual Tumour Mass|0|||
46817418|NCT00494780|83037407|FG001|Overall Study|Residual Tumour Mass|1|||
46817419|NCT00494780|83037406|FG000|Overall Study|Insurance Issues|0|||
46817420|NCT00494780|83037407|FG001|Overall Study|Insurance Issues|1|||
46817421|NCT00490022|83037417|FG000|Overall Study|Adverse Event|0|||
46817422|NCT00490022|83037418|FG001|Overall Study|Adverse Event|2|||
46817423|NCT00490022|83037417|FG000|Overall Study|Withdrawal by Subject|1|||
46817424|NCT00490022|83037418|FG001|Overall Study|Withdrawal by Subject|0|||
46817425|NCT00490022|83037417|FG000|Overall Study|Subject failed to disclose concommitant|0|||
46817426|NCT00490022|83037418|FG001|Overall Study|Subject failed to disclose concommitant|1|||
46817427|NCT00493454|83037424|FG000|Overall Study|Withdrawal by Subject|1|||
46817428|NCT00493220|83037434|FG000|Third Intervention|Withdrawal by Subject|1|||
46817429|NCT00493220|83037435|FG001|Third Intervention|Withdrawal by Subject|0|||
46930715|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
46930716|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
46930717|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
46930718|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
46930719|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
46930720|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
46817430|NCT00493220|83037436|FG002|Third Intervention|Withdrawal by Subject|0|||
46817431|NCT00493220|83037437|FG003|Third Intervention|Withdrawal by Subject|0|||
46817432|NCT00493220|83037438|FG004|Third Intervention|Withdrawal by Subject|0|||
46817433|NCT00493220|83037439|FG005|Third Intervention|Withdrawal by Subject|0|||
46817434|NCT00394953|83037451|FG000|First Treatment Period|Adverse Event|1|||
46817435|NCT00394953|83037452|FG001|First Treatment Period|Adverse Event|2|||
46817436|NCT00394953|83037451|FG000|First Treatment Period|Death|6|||
46817437|NCT00394953|83037452|FG001|First Treatment Period|Death|7|||
46817438|NCT00394953|83037451|FG000|First Treatment Period|Lack of Efficacy|1|||
46817439|NCT00394953|83037452|FG001|First Treatment Period|Lack of Efficacy|1|||
46817440|NCT00394953|83037451|FG000|First Treatment Period|Withdrawal by Subject|6|||
46817441|NCT00394953|83037452|FG001|First Treatment Period|Withdrawal by Subject|3|||
46817442|NCT00394953|83037451|FG000|First Treatment Period|Lost to Follow-up|0|||
46817443|NCT00394953|83037452|FG001|First Treatment Period|Lost to Follow-up|1|||
46817444|NCT00394953|83037451|FG000|First Treatment Period|Renal transplant|11|||
46817445|NCT00394953|83037452|FG001|First Treatment Period|Renal transplant|7|||
46817446|NCT00394953|83037451|FG000|First Treatment Period|Not defined|4|||
46817447|NCT00394953|83037452|FG001|First Treatment Period|Not defined|1|||
46817448|NCT00394953|83037451|FG000|Second Treatment Period|Adverse Event|2|||
46817449|NCT00394953|83037452|FG001|Second Treatment Period|Adverse Event|5|||
46817450|NCT00394953|83037451|FG000|Second Treatment Period|Death|8|||
46817451|NCT00394953|83037452|FG001|Second Treatment Period|Death|4|||
46817452|NCT00394953|83037451|FG000|Second Treatment Period|Lack of Efficacy|9|||
46817453|NCT00394953|83037452|FG001|Second Treatment Period|Lack of Efficacy|47|||
46817454|NCT00394953|83037451|FG000|Second Treatment Period|Withdrawal by Subject|3|||
46817455|NCT00394953|83037452|FG001|Second Treatment Period|Withdrawal by Subject|3|||
46930721|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
46930722|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
47055932|NCT04570384|83330480|FG000|Overall Study|Sponsor Decision|1|||
47055933|NCT04570384|83330481|FG001|Overall Study|Sponsor Decision|0|||
46817456|NCT00394953|83037451|FG000|Second Treatment Period|Lost to Follow-up|0|||
46817457|NCT00394953|83037452|FG001|Second Treatment Period|Lost to Follow-up|1|||
46817458|NCT00394953|83037451|FG000|Second Treatment Period|Renal transplant|4|||
46817459|NCT00394953|83037452|FG001|Second Treatment Period|Renal transplant|6|||
46817460|NCT00394953|83037451|FG000|Second Treatment Period|Not defined|3|||
46817461|NCT00394953|83037452|FG001|Second Treatment Period|Not defined|8|||
46817462|NCT00485732|83037460|FG000|Overall Study|Protocol Violation|1|||
46817463|NCT00485732|83037461|FG001|Overall Study|Protocol Violation|3|||
46817464|NCT00485732|83037460|FG000|Overall Study|Withdrawal by Subject|5|||
46817465|NCT00485732|83037461|FG001|Overall Study|Withdrawal by Subject|4|||
46817466|NCT00485732|83037460|FG000|Overall Study|Lost to Follow-up|2|||
46817467|NCT00485732|83037461|FG001|Overall Study|Lost to Follow-up|2|||
46817468|NCT00489554|83037467|FG000|Overall Study|Adverse Event|2|||
46817469|NCT00489554|83037467|FG000|Overall Study|Withdrawal by Subject|1|||
46817470|NCT00489554|83037467|FG000|Overall Study|Lost to Follow-up|1|||
46817471|NCT00408681|83037471|FG000|Overall Study|Lack of Efficacy|2|||
46930723|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
46930724|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
46930725|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
46930726|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
46930727|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
46930728|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
46930729|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
46930730|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
46930731|NCT01434602|83165755|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
46817472|NCT00408681|83037471|FG000|Overall Study|Adverse Event|7|||
46817473|NCT00560417|83037478|FG000|Overall Study|Adverse Event|3|||
46817474|NCT00560417|83037479|FG001|Overall Study|Adverse Event|2|||
46817475|NCT00560417|83037478|FG000|Overall Study|Entry Criteria Not Met|1|||
46817476|NCT00560417|83037479|FG001|Overall Study|Entry Criteria Not Met|0|||
46817477|NCT00560417|83037478|FG000|Overall Study|Lost to Follow-up|0|||
46817478|NCT00560417|83037479|FG001|Overall Study|Lost to Follow-up|1|||
46817479|NCT00560417|83037478|FG000|Overall Study|Physician Decision|2|||
46817480|NCT00560417|83037479|FG001|Overall Study|Physician Decision|6|||
46817481|NCT00560417|83037478|FG000|Overall Study|Protocol Violation|6|||
46817482|NCT00560417|83037479|FG001|Overall Study|Protocol Violation|5|||
46817483|NCT00560417|83037478|FG000|Overall Study|Sponsor Decision|2|||
46817484|NCT00560417|83037479|FG001|Overall Study|Sponsor Decision|0|||
46817485|NCT00560417|83037478|FG000|Overall Study|Withdrawal by Subject|3|||
46817486|NCT00560417|83037479|FG001|Overall Study|Withdrawal by Subject|3|||
46817487|NCT03968159|83037492|FG000|Overall Study|Adverse Event|4|||
46817488|NCT03968159|83037493|FG001|Overall Study|Adverse Event|4|||
46817489|NCT03968159|83037492|FG000|Overall Study|Lost to Follow-up|1|||
46817490|NCT03968159|83037493|FG001|Overall Study|Lost to Follow-up|1|||
46817491|NCT03968159|83037492|FG000|Overall Study|Use of prohibited medication|0|||
46817492|NCT03968159|83037493|FG001|Overall Study|Use of prohibited medication|1|||
46817493|NCT03968159|83037492|FG000|Overall Study|Protocol Violation|2|||
46817494|NCT03968159|83037493|FG001|Overall Study|Protocol Violation|2|||
46817495|NCT03968159|83037492|FG000|Overall Study|Withdrawal by Subject|4|||
46817496|NCT03968159|83037493|FG001|Overall Study|Withdrawal by Subject|6|||
46817497|NCT03968159|83037492|FG000|Overall Study|Lack of Efficacy|0|||
46817498|NCT03968159|83037493|FG001|Overall Study|Lack of Efficacy|1|||
46817499|NCT03968159|83037492|FG000|Overall Study|Not further specified|2|||
46817500|NCT03968159|83037493|FG001|Overall Study|Not further specified|0|||
46817501|NCT03966911|83037501|FG000|Overall Study|Adverse Event|1|||
46817502|NCT03966911|83037502|FG001|Overall Study|Adverse Event|1|||
46817503|NCT03966911|83037501|FG000|Overall Study|Withdrawal by Subject|8|||
46817504|NCT03966911|83037502|FG001|Overall Study|Withdrawal by Subject|2|||
46817505|NCT03966911|83037501|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
46817506|NCT03966911|83037502|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
46817507|NCT03966365|83037512|FG000|Overall Study|Protocol Violation|1|||
46817508|NCT03966365|83037513|FG001|Overall Study|Protocol Violation|0|||
46817509|NCT00375219|83037522|FG000|Overall Study|Failure to achieve a response|16|||
46758034|NCT00509899|82976300|FG007|Overall Study|Withdrawal by Subject|0|||
46758035|NCT00509899|82976293|FG000|Overall Study|Physician Decision|4|||
46758036|NCT00509899|82976294|FG001|Overall Study|Physician Decision|2|||
46758037|NCT00509899|82976295|FG002|Overall Study|Physician Decision|7|||
46758038|NCT00509899|82976296|FG003|Overall Study|Physician Decision|0|||
46758039|NCT00509899|82976297|FG004|Overall Study|Physician Decision|1|||
46758040|NCT00509899|82976298|FG005|Overall Study|Physician Decision|4|||
46758041|NCT00509899|82976299|FG006|Overall Study|Physician Decision|0|||
46758042|NCT00509899|82976300|FG007|Overall Study|Physician Decision|0|||
46758043|NCT00509899|82976293|FG000|Overall Study|Intercurrent Illness|1|||
46817510|NCT00375219|83037523|FG001|Overall Study|Failure to achieve a response|2|||
46817511|NCT00375219|83037524|FG002|Overall Study|Failure to achieve a response|0|||
46758044|NCT00509899|82976294|FG001|Overall Study|Intercurrent Illness|0|||
46817512|NCT00375219|83037522|FG000|Overall Study|Adverse Event|8|||
46758045|NCT00509899|82976295|FG002|Overall Study|Intercurrent Illness|0|||
46758046|NCT00509899|82976296|FG003|Overall Study|Intercurrent Illness|1|||
46817513|NCT00375219|83037523|FG001|Overall Study|Adverse Event|2|||
46817514|NCT00375219|83037524|FG002|Overall Study|Adverse Event|1|||
46817515|NCT00375219|83037522|FG000|Overall Study|Protocol Violation|1|||
46817516|NCT00375219|83037523|FG001|Overall Study|Protocol Violation|0|||
46817517|NCT00375219|83037524|FG002|Overall Study|Protocol Violation|1|||
46817518|NCT00375219|83037522|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
46817519|NCT00375219|83037523|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
46817520|NCT00375219|83037524|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
46817521|NCT00375219|83037522|FG000|Overall Study|Lost to Follow-up|1|||
46817522|NCT00375219|83037523|FG001|Overall Study|Lost to Follow-up|1|||
46817523|NCT00375219|83037524|FG002|Overall Study|Lost to Follow-up|0|||
46817524|NCT00375219|83037522|FG000|Overall Study|Disease progression|18|||
46817525|NCT00375219|83037523|FG001|Overall Study|Disease progression|9|||
46817526|NCT00375219|83037524|FG002|Overall Study|Disease progression|12|||
46817527|NCT00375219|83037522|FG000|Overall Study|Death|4|||
46817528|NCT00375219|83037523|FG001|Overall Study|Death|3|||
46817529|NCT00375219|83037524|FG002|Overall Study|Death|7|||
46817530|NCT00375219|83037522|FG000|Overall Study|Hematologic resistance|1|||
46758047|NCT00509899|82976297|FG004|Overall Study|Intercurrent Illness|0|||
46758048|NCT00509899|82976298|FG005|Overall Study|Intercurrent Illness|1|||
46758049|NCT00509899|82976299|FG006|Overall Study|Intercurrent Illness|0|||
46817531|NCT00375219|83037523|FG001|Overall Study|Hematologic resistance|0|||
46817532|NCT00375219|83037524|FG002|Overall Study|Hematologic resistance|0|||
46817533|NCT00375219|83037522|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
46817534|NCT00375219|83037523|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
46817535|NCT00375219|83037524|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
46817536|NCT00375219|83037522|FG000|Overall Study|Allograft|2|||
46817537|NCT00375219|83037523|FG001|Overall Study|Allograft|0|||
46817538|NCT00375219|83037524|FG002|Overall Study|Allograft|0|||
46817539|NCT00375219|83037522|FG000|Overall Study|Cord blood transplantation|1|||
46817540|NCT00375219|83037523|FG001|Overall Study|Cord blood transplantation|0|||
46817541|NCT00375219|83037524|FG002|Overall Study|Cord blood transplantation|0|||
46817542|NCT00375219|83037522|FG000|Overall Study|Withdrawal by Subject|1|||
46758050|NCT00509899|82976300|FG007|Overall Study|Intercurrent Illness|0|||
46817543|NCT00375219|83037523|FG001|Overall Study|Withdrawal by Subject|0|||
46817544|NCT00375219|83037524|FG002|Overall Study|Withdrawal by Subject|0|||
46817545|NCT03965351|83037533|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
46817546|NCT03965351|83037534|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
46817547|NCT03965351|83037533|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
46817548|NCT03965351|83037534|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
46817549|NCT00554801|83037542|FG000|Overall Study|left area before completion|5|||
46817550|NCT00554801|83037543|FG001|Overall Study|left area before completion|0|||
46817551|NCT00554801|83037542|FG000|Overall Study|Withdrawal by Subject|14|||
46817552|NCT00554801|83037543|FG001|Overall Study|Withdrawal by Subject|0|||
46817553|NCT00374907|83037553|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
46817554|NCT00374907|83037554|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
46817555|NCT00374907|83037553|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
46817556|NCT00374907|83037554|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
46817557|NCT00374907|83037553|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
46817558|NCT00374907|83037554|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
46817559|NCT00374907|83037553|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
46817560|NCT00374907|83037554|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
46817561|NCT00374907|83037553|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
46817562|NCT00374907|83037554|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
46817563|NCT00374127|83037562|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
46758051|NCT00509899|82976293|FG000|Overall Study|Death|2|||
46758052|NCT00509899|82976294|FG001|Overall Study|Death|2|||
46758053|NCT00509899|82976295|FG002|Overall Study|Death|3|||
46758054|NCT00509899|82976296|FG003|Overall Study|Death|0|||
46758055|NCT00509899|82976297|FG004|Overall Study|Death|1|||
46758056|NCT00509899|82976298|FG005|Overall Study|Death|1|||
46758057|NCT00509899|82976299|FG006|Overall Study|Death|1|||
46758058|NCT00509899|82976300|FG007|Overall Study|Death|1|||
46817564|NCT00374127|83037562|FG000|Overall Study|Blood could not be drawn.|2|||
46817565|NCT00374127|83037562|FG000|Overall Study|Protocol Violation|5|||
46817566|NCT00374127|83037562|FG000|Overall Study|Pregnancy|1|||
46817567|NCT00553787|83037575|FG000|Overall Study|Adverse Event|34|||
46817568|NCT00553787|83037576|FG001|Overall Study|Adverse Event|21|||
46817569|NCT00553787|83037577|FG002|Overall Study|Adverse Event|67|||
46817570|NCT00553787|83037575|FG000|Overall Study|Lost to Follow-up|132|||
46817571|NCT00553787|83037576|FG001|Overall Study|Lost to Follow-up|44|||
46817572|NCT00553787|83037577|FG002|Overall Study|Lost to Follow-up|78|||
46817573|NCT00553787|83037575|FG000|Overall Study|Withdrawal by Subject|151|||
46758059|NCT00509899|82976293|FG000|Overall Study|Lack of Efficacy|1|||
46817574|NCT00553787|83037576|FG001|Overall Study|Withdrawal by Subject|40|||
46758060|NCT00509899|82976294|FG001|Overall Study|Lack of Efficacy|0|||
46758061|NCT00509899|82976295|FG002|Overall Study|Lack of Efficacy|2|||
46758062|NCT00509899|82976296|FG003|Overall Study|Lack of Efficacy|0|||
46817575|NCT00553787|83037577|FG002|Overall Study|Withdrawal by Subject|83|||
46817576|NCT00553787|83037575|FG000|Overall Study|Lack of Efficacy|31|||
46817577|NCT00553787|83037576|FG001|Overall Study|Lack of Efficacy|1|||
46817578|NCT00553787|83037577|FG002|Overall Study|Lack of Efficacy|3|||
46817579|NCT00553787|83037575|FG000|Overall Study|Pregnancy|0|||
46817580|NCT00553787|83037576|FG001|Overall Study|Pregnancy|1|||
46817581|NCT00553787|83037577|FG002|Overall Study|Pregnancy|2|||
46817582|NCT00553787|83037575|FG000|Overall Study|non compliance|4|||
46817583|NCT00553787|83037576|FG001|Overall Study|non compliance|0|||
46817584|NCT00553787|83037577|FG002|Overall Study|non compliance|11|||
46817585|NCT00553787|83037575|FG000|Overall Study|Requirement for restricted medication|8|||
46817586|NCT00553787|83037576|FG001|Overall Study|Requirement for restricted medication|7|||
46817587|NCT00553787|83037577|FG002|Overall Study|Requirement for restricted medication|5|||
46817588|NCT00553787|83037575|FG000|Overall Study|Other|18|||
46817589|NCT00553787|83037576|FG001|Overall Study|Other|10|||
46817590|NCT00553787|83037577|FG002|Overall Study|Other|13|||
46817591|NCT00407745|83037587|FG000|Overall Study|Lack of Efficacy|1|||
46817592|NCT00407745|83037588|FG001|Overall Study|Lack of Efficacy|2|||
46817593|NCT00407745|83037587|FG000|Overall Study|Withdrawal by Subject|3|||
46817594|NCT00407745|83037588|FG001|Overall Study|Withdrawal by Subject|3|||
46817595|NCT00407745|83037587|FG000|Overall Study|Protocol Violation|5|||
46817596|NCT00407745|83037588|FG001|Overall Study|Protocol Violation|3|||
46817597|NCT00407745|83037587|FG000|Overall Study|Adverse Event|8|||
46817598|NCT00407745|83037588|FG001|Overall Study|Adverse Event|8|||
46817599|NCT00407745|83037587|FG000|Overall Study|Other|2|||
46817600|NCT00407745|83037588|FG001|Overall Study|Other|0|||
46817601|NCT00407745|83037587|FG000|Overall Study|Randomized, unknown if treated|0|||
46930732|NCT01434602|83165756|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
46817602|NCT00407745|83037588|FG001|Overall Study|Randomized, unknown if treated|1|||
46930733|NCT01434602|83165757|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
46930734|NCT01434602|83165758|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
46817603|NCT03958955|83037594|FG000|Overall Study|Adverse Event|1|||
46817604|NCT00464334|83037611|FG000|Overall Study|Adverse Event|0|||
46817605|NCT00464334|83037612|FG001|Overall Study|Adverse Event|0|||
46817606|NCT00464334|83037613|FG002|Overall Study|Adverse Event|0|||
46817607|NCT00464334|83037614|FG003|Overall Study|Adverse Event|1|||
46817608|NCT00464334|83037615|FG004|Overall Study|Adverse Event|1|||
46817609|NCT00464334|83037616|FG005|Overall Study|Adverse Event|1|||
46817610|NCT00464334|83037617|FG006|Overall Study|Adverse Event|0|||
46817611|NCT00464334|83037618|FG007|Overall Study|Adverse Event|0|||
46817612|NCT00464334|83037619|FG008|Overall Study|Adverse Event|2|||
46817613|NCT00464334|83037620|FG009|Overall Study|Adverse Event|1|||
46817614|NCT00464334|83037621|FG010|Overall Study|Adverse Event|2|||
46817615|NCT00464334|83037611|FG000|Overall Study|Lack of Efficacy|0|||
46817616|NCT00464334|83037612|FG001|Overall Study|Lack of Efficacy|1|||
46817617|NCT00464334|83037613|FG002|Overall Study|Lack of Efficacy|0|||
46817618|NCT00464334|83037614|FG003|Overall Study|Lack of Efficacy|0|||
46817619|NCT00464334|83037615|FG004|Overall Study|Lack of Efficacy|0|||
46817620|NCT00464334|83037616|FG005|Overall Study|Lack of Efficacy|0|||
46817621|NCT00464334|83037617|FG006|Overall Study|Lack of Efficacy|0|||
46817622|NCT00464334|83037618|FG007|Overall Study|Lack of Efficacy|0|||
46817623|NCT00464334|83037619|FG008|Overall Study|Lack of Efficacy|0|||
46930735|NCT01434602|83165759|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
46930736|NCT01767129|83165781|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
46930737|NCT01767129|83165782|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
46930738|NCT02791269|83165791|FG000|Overall Study|Lost to Follow-up|0|||
46930739|NCT02791269|83165792|FG001|Overall Study|Lost to Follow-up|1|||
46930740|NCT02696564|83165802|FG000|Overall Study|Death|1|||
46930741|NCT02696564|83165803|FG001|Overall Study|Death|2|||
46930742|NCT02696564|83165802|FG000|Overall Study|Withdrawal by Subject|3|||
46930743|NCT02696564|83165803|FG001|Overall Study|Withdrawal by Subject|2|||
46930744|NCT02696564|83165802|FG000|Overall Study|Lost to Follow-up|3|||
46930745|NCT02696564|83165803|FG001|Overall Study|Lost to Follow-up|3|||
46930746|NCT02696564|83165802|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
46930747|NCT02696564|83165803|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
46930748|NCT02696564|83165802|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
46930749|NCT02696564|83165803|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
46817624|NCT00464334|83037620|FG009|Overall Study|Lack of Efficacy|0|||
46817625|NCT00464334|83037621|FG010|Overall Study|Lack of Efficacy|0|||
46930750|NCT02696564|83165802|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
46817626|NCT00464334|83037611|FG000|Overall Study|Lost to Follow-up|0|||
46817627|NCT00464334|83037612|FG001|Overall Study|Lost to Follow-up|0|||
46817628|NCT00464334|83037613|FG002|Overall Study|Lost to Follow-up|1|||
46817629|NCT00464334|83037614|FG003|Overall Study|Lost to Follow-up|0|||
46817630|NCT00464334|83037615|FG004|Overall Study|Lost to Follow-up|1|||
46817631|NCT00464334|83037616|FG005|Overall Study|Lost to Follow-up|0|||
46817632|NCT00464334|83037617|FG006|Overall Study|Lost to Follow-up|1|||
46817633|NCT00464334|83037618|FG007|Overall Study|Lost to Follow-up|0|||
46817634|NCT00464334|83037619|FG008|Overall Study|Lost to Follow-up|0|||
46817635|NCT00464334|83037620|FG009|Overall Study|Lost to Follow-up|0|||
46817636|NCT00464334|83037621|FG010|Overall Study|Lost to Follow-up|2|||
46817637|NCT00464334|83037611|FG000|Overall Study|Progressive Disease|0|||
46817638|NCT00464334|83037612|FG001|Overall Study|Progressive Disease|0|||
46817639|NCT00464334|83037613|FG002|Overall Study|Progressive Disease|0|||
46817640|NCT00464334|83037614|FG003|Overall Study|Progressive Disease|0|||
46817641|NCT00464334|83037615|FG004|Overall Study|Progressive Disease|0|||
46817642|NCT00464334|83037616|FG005|Overall Study|Progressive Disease|1|||
46817643|NCT00464334|83037617|FG006|Overall Study|Progressive Disease|0|||
46817644|NCT00464334|83037618|FG007|Overall Study|Progressive Disease|0|||
46817645|NCT00464334|83037619|FG008|Overall Study|Progressive Disease|1|||
46817646|NCT00464334|83037620|FG009|Overall Study|Progressive Disease|0|||
46817647|NCT00464334|83037621|FG010|Overall Study|Progressive Disease|0|||
46817648|NCT00464334|83037611|FG000|Overall Study|Study Terminated by Sponsor|0|||
46817649|NCT00464334|83037612|FG001|Overall Study|Study Terminated by Sponsor|0|||
46817650|NCT00464334|83037613|FG002|Overall Study|Study Terminated by Sponsor|0|||
46817651|NCT00464334|83037614|FG003|Overall Study|Study Terminated by Sponsor|1|||
46817652|NCT00464334|83037615|FG004|Overall Study|Study Terminated by Sponsor|0|||
46817653|NCT00464334|83037616|FG005|Overall Study|Study Terminated by Sponsor|0|||
46817654|NCT00464334|83037617|FG006|Overall Study|Study Terminated by Sponsor|0|||
46817655|NCT00464334|83037618|FG007|Overall Study|Study Terminated by Sponsor|0|||
46817656|NCT00464334|83037619|FG008|Overall Study|Study Terminated by Sponsor|0|||
46817657|NCT00464334|83037620|FG009|Overall Study|Study Terminated by Sponsor|0|||
46817658|NCT00464334|83037621|FG010|Overall Study|Study Terminated by Sponsor|0|||
46817659|NCT00464334|83037611|FG000|Overall Study|Withdrawal by Subject|1|||
46817660|NCT00464334|83037612|FG001|Overall Study|Withdrawal by Subject|7|||
46817661|NCT00464334|83037613|FG002|Overall Study|Withdrawal by Subject|4|||
46817662|NCT00464334|83037614|FG003|Overall Study|Withdrawal by Subject|2|||
46817663|NCT00464334|83037615|FG004|Overall Study|Withdrawal by Subject|2|||
46817664|NCT00464334|83037616|FG005|Overall Study|Withdrawal by Subject|2|||
46817665|NCT00464334|83037617|FG006|Overall Study|Withdrawal by Subject|2|||
46817666|NCT00464334|83037618|FG007|Overall Study|Withdrawal by Subject|1|||
46817667|NCT00464334|83037619|FG008|Overall Study|Withdrawal by Subject|3|||
46817668|NCT00464334|83037620|FG009|Overall Study|Withdrawal by Subject|0|||
46817669|NCT00464334|83037621|FG010|Overall Study|Withdrawal by Subject|0|||
46817670|NCT00299494|83037662|FG000|Overall Study|Withdrawal by Subject|0|||
46817671|NCT00299494|83037663|FG001|Overall Study|Withdrawal by Subject|0|||
46817672|NCT00299494|83037664|FG002|Overall Study|Withdrawal by Subject|0|||
46817673|NCT00299494|83037665|FG003|Overall Study|Withdrawal by Subject|3|||
46817674|NCT00299494|83037666|FG004|Overall Study|Withdrawal by Subject|1|||
46817675|NCT00299494|83037667|FG005|Overall Study|Withdrawal by Subject|4|||
46817676|NCT00299494|83037662|FG000|Overall Study|Physician Decision|0|||
46930751|NCT02696564|83165803|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
46930752|NCT02696564|83165802|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
46930753|NCT02696564|83165803|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
46930754|NCT02696564|83165802|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
46930755|NCT02696564|83165803|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
46930756|NCT02640950|83165809|FG000|Overall Study|Adverse Event|1|||
46930757|NCT02640950|83165809|FG000|Overall Study|Withdrawal by Subject|1|||
46930758|NCT02593786|83165817|FG000|Overall Study|Disease progression|12|||
46930759|NCT02593786|83165818|FG001|Overall Study|Disease progression|16|||
46930760|NCT02593786|83165819|FG002|Overall Study|Disease progression|10|||
46758063|NCT00509899|82976297|FG004|Overall Study|Lack of Efficacy|0|||
46758064|NCT00509899|82976298|FG005|Overall Study|Lack of Efficacy|1|||
46758065|NCT00509899|82976299|FG006|Overall Study|Lack of Efficacy|0|||
46758066|NCT00509899|82976300|FG007|Overall Study|Lack of Efficacy|0|||
46758067|NCT00862836|82976314|FG000|Overall Study|Withdrawal by Subject|1|||
46758068|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
46758069|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
46817677|NCT00299494|83037663|FG001|Overall Study|Physician Decision|0|||
46930761|NCT02593786|83165820|FG003|Overall Study|Disease progression|7|||
46930762|NCT02593786|83165817|FG000|Overall Study|Study drug toxicity|1|||
46817678|NCT00299494|83037664|FG002|Overall Study|Physician Decision|0|||
46817679|NCT00299494|83037665|FG003|Overall Study|Physician Decision|0|||
46817680|NCT00299494|83037666|FG004|Overall Study|Physician Decision|1|||
47055934|NCT04570384|83330480|FG000|Overall Study|Withdrawal by Subject|4|||
47055935|NCT04570384|83330481|FG001|Overall Study|Withdrawal by Subject|2|||
46817681|NCT00299494|83037667|FG005|Overall Study|Physician Decision|0|||
46817682|NCT00299494|83037662|FG000|Overall Study|Death|3|||
46930763|NCT02593786|83165818|FG001|Overall Study|Study drug toxicity|0|||
46758070|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
46817683|NCT00299494|83037663|FG001|Overall Study|Death|1|||
46817684|NCT00299494|83037664|FG002|Overall Study|Death|4|||
46758071|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Death|28|||
46758072|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Death|0|||
46817685|NCT00299494|83037665|FG003|Overall Study|Death|6|||
46817686|NCT00299494|83037666|FG004|Overall Study|Death|18|||
46817687|NCT00299494|83037667|FG005|Overall Study|Death|19|||
46817688|NCT00299494|83037662|FG000|Overall Study|Lost to Follow-up|0|||
46817689|NCT00299494|83037663|FG001|Overall Study|Lost to Follow-up|0|||
46817690|NCT00299494|83037664|FG002|Overall Study|Lost to Follow-up|0|||
46817691|NCT00299494|83037665|FG003|Overall Study|Lost to Follow-up|0|||
46817692|NCT00299494|83037666|FG004|Overall Study|Lost to Follow-up|3|||
46817693|NCT00299494|83037667|FG005|Overall Study|Lost to Follow-up|1|||
46817694|NCT00299494|83037662|FG000|Overall Study|Other - Unspecified|0|||
46817695|NCT00299494|83037663|FG001|Overall Study|Other - Unspecified|0|||
46817696|NCT00299494|83037664|FG002|Overall Study|Other - Unspecified|0|||
46817697|NCT00299494|83037665|FG003|Overall Study|Other - Unspecified|0|||
46817698|NCT00299494|83037666|FG004|Overall Study|Other - Unspecified|3|||
46758073|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Death|0|||
46758074|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
46758075|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
46758076|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
46817699|NCT00299494|83037667|FG005|Overall Study|Other - Unspecified|1|||
46817700|NCT00299494|83037662|FG000|Overall Study|Other - site closure|0|||
46817701|NCT00299494|83037663|FG001|Overall Study|Other - site closure|0|||
46817702|NCT00299494|83037664|FG002|Overall Study|Other - site closure|0|||
46817703|NCT00299494|83037665|FG003|Overall Study|Other - site closure|1|||
46817704|NCT00299494|83037666|FG004|Overall Study|Other - site closure|1|||
46817705|NCT00299494|83037667|FG005|Overall Study|Other - site closure|1|||
46817706|NCT00453180|83037694|FG000|Overall Study|Lost to Follow-up|2|||
46758077|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
46758078|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
46758079|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
46758080|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
46758081|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
46758082|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
46758083|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
46758084|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
46758085|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
46758086|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
46758087|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
46758088|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
46758089|NCT00820755|82976318|FG000|Period 1: Combination Therapy Phase|Other|11|||
46758090|NCT00820755|82976319|FG001|Period 1: Combination Therapy Phase|Other|0|||
46817707|NCT00453180|83037695|FG001|Overall Study|Lost to Follow-up|1|||
46817708|NCT00453180|83037694|FG000|Overall Study|Adverse Event|1|||
46817709|NCT00453180|83037695|FG001|Overall Study|Adverse Event|2|||
46817710|NCT00464178|83037701|FG000|Overall Study|Protocol Violation|1|||
46817711|NCT00464178|83037701|FG000|Overall Study|Withdrawal by Subject|1|||
46817712|NCT00560105|83037708|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
46817713|NCT00560105|83037709|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
46817714|NCT00467610|83037715|FG000|Overall Study|Withdrawal by Subject|1|||
46817715|NCT00316186|83037719|FG000|Overall Study|Adverse Event|6|||
46817716|NCT00316186|83037719|FG000|Overall Study|Disease Progression|4|||
46817717|NCT00316186|83037719|FG000|Overall Study|Lost to Follow-up|1|||
46817718|NCT00316186|83037719|FG000|Overall Study|Other|1|||
46817719|NCT00453102|83037723|FG000|Overall Study|Withdrawal by Subject|2|||
46817720|NCT00299182|83037734|FG000|Overall Study|Withdrawal by Subject|0|||
46817721|NCT00299182|83037735|FG001|Overall Study|Withdrawal by Subject|0|||
46817722|NCT00299182|83037736|FG002|Overall Study|Withdrawal by Subject|1|||
46817723|NCT00299182|83037737|FG003|Overall Study|Withdrawal by Subject|0|||
46817724|NCT00299182|83037738|FG004|Overall Study|Withdrawal by Subject|1|||
46817725|NCT00299182|83037739|FG005|Overall Study|Withdrawal by Subject|2|||
46817726|NCT00299182|83037740|FG006|Overall Study|Withdrawal by Subject|0|||
46817727|NCT00299182|83037734|FG000|Overall Study|Chemotherapy Changed|0|||
46817728|NCT00299182|83037735|FG001|Overall Study|Chemotherapy Changed|0|||
46817729|NCT00299182|83037736|FG002|Overall Study|Chemotherapy Changed|1|||
46817730|NCT00299182|83037737|FG003|Overall Study|Chemotherapy Changed|0|||
46817731|NCT00299182|83037738|FG004|Overall Study|Chemotherapy Changed|1|||
46817732|NCT00299182|83037739|FG005|Overall Study|Chemotherapy Changed|0|||
46817733|NCT00299182|83037740|FG006|Overall Study|Chemotherapy Changed|1|||
46817734|NCT00299182|83037734|FG000|Overall Study|Adverse Event|0|||
46817735|NCT00299182|83037735|FG001|Overall Study|Adverse Event|0|||
46817736|NCT00299182|83037736|FG002|Overall Study|Adverse Event|0|||
46817737|NCT00299182|83037737|FG003|Overall Study|Adverse Event|0|||
46817738|NCT00299182|83037738|FG004|Overall Study|Adverse Event|0|||
46930764|NCT02593786|83165819|FG002|Overall Study|Study drug toxicity|0|||
46930765|NCT02593786|83165820|FG003|Overall Study|Study drug toxicity|0|||
46817739|NCT00299182|83037739|FG005|Overall Study|Adverse Event|1|||
46817740|NCT00299182|83037740|FG006|Overall Study|Adverse Event|0|||
46817741|NCT00299182|83037734|FG000|Overall Study|Not Eligible|0|||
46817742|NCT00299182|83037735|FG001|Overall Study|Not Eligible|0|||
46817743|NCT00299182|83037736|FG002|Overall Study|Not Eligible|0|||
46817744|NCT00299182|83037737|FG003|Overall Study|Not Eligible|0|||
46817745|NCT00299182|83037738|FG004|Overall Study|Not Eligible|1|||
46817746|NCT00299182|83037739|FG005|Overall Study|Not Eligible|0|||
46817747|NCT00299182|83037740|FG006|Overall Study|Not Eligible|0|||
46817748|NCT00467142|83037758|FG000|Overall Study|Withdrawal by Subject|1|||
46817749|NCT00467142|83037758|FG000|Overall Study|Adverse Event|1|||
46817750|NCT00467142|83037758|FG000|Overall Study|Protocol Violation|1|||
46817751|NCT00553475|83037765|FG000|Overall Study|Adverse Event|7|||
46817752|NCT00553475|83037766|FG001|Overall Study|Adverse Event|17|||
46817753|NCT00553475|83037767|FG002|Overall Study|Adverse Event|13|||
46817754|NCT00553475|83037765|FG000|Overall Study|Lack of Efficacy|7|||
46817755|NCT00553475|83037766|FG001|Overall Study|Lack of Efficacy|1|||
46817756|NCT00553475|83037767|FG002|Overall Study|Lack of Efficacy|0|||
46817757|NCT00553475|83037765|FG000|Overall Study|Withdrawal by Subject|1|||
46817758|NCT00553475|83037766|FG001|Overall Study|Withdrawal by Subject|1|||
46817759|NCT00553475|83037767|FG002|Overall Study|Withdrawal by Subject|0|||
46817760|NCT00553475|83037765|FG000|Overall Study|Physician Decision|1|||
46817761|NCT00553475|83037766|FG001|Overall Study|Physician Decision|0|||
46817762|NCT00553475|83037767|FG002|Overall Study|Physician Decision|0|||
46817763|NCT00553475|83037765|FG000|Overall Study|Due to moving|0|||
46817764|NCT00553475|83037766|FG001|Overall Study|Due to moving|1|||
46817765|NCT00553475|83037767|FG002|Overall Study|Due to moving|0|||
46758091|NCT00820755|82976320|FG002|Period 1: Combination Therapy Phase|Other|0|||
46758092|NCT00820755|82976318|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
46758093|NCT00820755|82976319|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
46758094|NCT00820755|82976320|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
46758095|NCT00820599|82976328|FG000|Overall Study|Death|129|||
46758096|NCT00820599|82976328|FG000|Overall Study|Withdrawal by Subject|2|||
46758097|NCT00819741|82976334|FG000|Overall Study|Adverse Event|5|||
46758098|NCT00819741|82976335|FG001|Overall Study|Adverse Event|2|||
46758099|NCT00819741|82976334|FG000|Overall Study|Lack of Efficacy|0|||
46758100|NCT00819741|82976335|FG001|Overall Study|Lack of Efficacy|2|||
46758101|NCT00819741|82976334|FG000|Overall Study|Lost to Follow-up|3|||
46758102|NCT00819741|82976335|FG001|Overall Study|Lost to Follow-up|1|||
46758103|NCT00819741|82976334|FG000|Overall Study|Protocol Violation|3|||
46758104|NCT00819741|82976335|FG001|Overall Study|Protocol Violation|4|||
46758105|NCT00819741|82976334|FG000|Overall Study|Withdrawal by Subject|2|||
46758106|NCT00819741|82976335|FG001|Overall Study|Withdrawal by Subject|2|||
46758107|NCT00819741|82976334|FG000|Overall Study|Unclassified|6|||
46758108|NCT00819741|82976335|FG001|Overall Study|Unclassified|0|||
46758109|NCT00819741|82976334|FG000|Overall Study|Reasons unknown|3|||
46758110|NCT00819741|82976335|FG001|Overall Study|Reasons unknown|3|||
46817766|NCT00329602|83037779|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
46817767|NCT00329602|83037780|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
46817768|NCT00329602|83037781|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
46817769|NCT00329602|83037779|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
46817770|NCT00329602|83037780|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
46817771|NCT00329602|83037781|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
46758111|NCT00862134|82976343|FG000|Overall Study|Death|1|||
46758112|NCT00862134|82976344|FG001|Overall Study|Death|0|||
46758113|NCT00862134|82976343|FG000|Overall Study|Physician Decision|0|||
46758114|NCT00862134|82976344|FG001|Overall Study|Physician Decision|1|||
46758115|NCT00862134|82976343|FG000|Overall Study|Withdrawal by Subject|1|||
46758116|NCT00862134|82976344|FG001|Overall Study|Withdrawal by Subject|2|||
46758117|NCT00862134|82976343|FG000|Overall Study|Sponsor terminated study|5|||
46758118|NCT00862134|82976344|FG001|Overall Study|Sponsor terminated study|7|||
46758119|NCT00862134|82976343|FG000|Overall Study|Adverse Event|2|||
46758120|NCT00862134|82976344|FG001|Overall Study|Adverse Event|2|||
46817772|NCT00329602|83037779|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
46817773|NCT00329602|83037780|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
46817774|NCT00329602|83037781|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
46817775|NCT00329602|83037779|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
46817776|NCT00329602|83037780|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
46930766|NCT02593786|83165817|FG000|Overall Study|Adverse event unrelated to study drug|1|||
46758121|NCT00862134|82976343|FG000|Overall Study|Withdrew prior to dosing|2|||
46758122|NCT00862134|82976344|FG001|Overall Study|Withdrew prior to dosing|0|||
46758123|NCT00848484|82976352|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
46817777|NCT00329602|83037781|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
46817778|NCT00329602|83037779|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
46817779|NCT00329602|83037780|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
46817780|NCT00329602|83037781|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
46817781|NCT00329602|83037779|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
46817782|NCT00329602|83037780|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
46817783|NCT00329602|83037781|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
46817784|NCT00463866|83037799|FG000|Overall Study|Adverse Event|70|||
46817785|NCT00463866|83037800|FG001|Overall Study|Adverse Event|93|||
46817786|NCT00463866|83037799|FG000|Overall Study|Withdrawal by Subject|81|||
46817787|NCT00463866|83037800|FG001|Overall Study|Withdrawal by Subject|79|||
46817788|NCT00463866|83037799|FG000|Overall Study|Lost to Follow-up|46|||
46817789|NCT00463866|83037800|FG001|Overall Study|Lost to Follow-up|55|||
46817790|NCT00463866|83037799|FG000|Overall Study|Incorrect Enrolment|64|||
46817791|NCT00463866|83037800|FG001|Overall Study|Incorrect Enrolment|66|||
46817792|NCT00463866|83037799|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
46817793|NCT00463866|83037800|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
46817794|NCT00463866|83037799|FG000|Overall Study|Safety Reason|1|||
46817795|NCT00463866|83037800|FG001|Overall Study|Safety Reason|3|||
46817796|NCT00463866|83037799|FG000|Overall Study|Mis-Randomization of subject|0|||
46817797|NCT00463866|83037800|FG001|Overall Study|Mis-Randomization of subject|1|||
46817798|NCT00463866|83037799|FG000|Overall Study|Other|22|||
46817799|NCT00463866|83037800|FG001|Overall Study|Other|22|||
46817800|NCT00313846|83037808|FG000|Overall Study|Withdrawal by Subject|2|||
46817801|NCT00313846|83037809|FG001|Overall Study|Withdrawal by Subject|0|||
46817802|NCT00313846|83037808|FG000|Overall Study|Adverse Event|1|||
46817803|NCT00313846|83037809|FG001|Overall Study|Adverse Event|8|||
46817804|NCT00313846|83037808|FG000|Overall Study|Administrative|2|||
46817805|NCT00313846|83037809|FG001|Overall Study|Administrative|3|||
46817806|NCT00551135|83037820|FG000|Overall Study|Adverse Event|1|||
46817807|NCT00551135|83037821|FG001|Overall Study|Adverse Event|0|||
46817808|NCT00551135|83037822|FG002|Overall Study|Adverse Event|1|||
46817809|NCT00551135|83037823|FG003|Overall Study|Adverse Event|1|||
46817810|NCT00551135|83037820|FG000|Overall Study|Lost to Follow-up|0|||
46817811|NCT00551135|83037821|FG001|Overall Study|Lost to Follow-up|0|||
46817812|NCT00551135|83037822|FG002|Overall Study|Lost to Follow-up|0|||
46817813|NCT00551135|83037823|FG003|Overall Study|Lost to Follow-up|1|||
46817814|NCT00551135|83037820|FG000|Overall Study|Other|3|||
46817815|NCT00551135|83037821|FG001|Overall Study|Other|2|||
46817816|NCT00551135|83037822|FG002|Overall Study|Other|1|||
46817817|NCT00551135|83037823|FG003|Overall Study|Other|2|||
46758124|NCT00848484|82976353|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
46758125|NCT00848484|82976352|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
46758126|NCT00848484|82976353|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
46758127|NCT00848484|82976352|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
46758128|NCT00848484|82976353|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
46758129|NCT00848484|82976352|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
46758130|NCT00848484|82976353|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
46758131|NCT00848484|82976352|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
46758132|NCT00848484|82976353|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
46758133|NCT00509821|82976361|FG000|Study Period 1 (Induction)|Death|0|||
46758134|NCT00509821|82976362|FG001|Study Period 1 (Induction)|Death|1|||
46758135|NCT00509821|82976361|FG000|Study Period 1 (Induction)|Adverse Event|0|||
46758136|NCT00509821|82976362|FG001|Study Period 1 (Induction)|Adverse Event|2|||
46758137|NCT00509821|82976361|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
46758138|NCT00509821|82976362|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
46758139|NCT00508651|82976375|FG000|Overall Study|Lost to Follow-up|3|||
46758140|NCT00508651|82976376|FG001|Overall Study|Lost to Follow-up|1|||
46758141|NCT00508651|82976375|FG000|Overall Study|Withdrawal by Subject|1|||
46758142|NCT00508651|82976376|FG001|Overall Study|Withdrawal by Subject|1|||
46758143|NCT00490555|82976386|FG000|Overall Study|noncompliant with drug administration|0|||
46758144|NCT00490555|82976387|FG001|Overall Study|noncompliant with drug administration|0|||
46758145|NCT00490555|82976388|FG002|Overall Study|noncompliant with drug administration|2|||
46758146|NCT00490555|82976389|FG003|Overall Study|noncompliant with drug administration|0|||
46817818|NCT00551135|83037820|FG000|Overall Study|Withdrawal by Subject|1|||
46817819|NCT00551135|83037821|FG001|Overall Study|Withdrawal by Subject|0|||
46758147|NCT00501085|82976399|FG000|Overall Study|Lost to Follow-up|195|||
46817820|NCT00551135|83037822|FG002|Overall Study|Withdrawal by Subject|3|||
46817821|NCT00551135|83037823|FG003|Overall Study|Withdrawal by Subject|1|||
46817822|NCT00299104|83037836|FG000|Treatment Period|Adverse Event|14|||
46817823|NCT00299104|83037837|FG001|Treatment Period|Adverse Event|9|||
46817824|NCT00299104|83037838|FG002|Treatment Period|Adverse Event|7|||
46817825|NCT00299104|83037836|FG000|Treatment Period|Death|1|||
46817826|NCT00299104|83037837|FG001|Treatment Period|Death|1|||
46817827|NCT00299104|83037838|FG002|Treatment Period|Death|1|||
46817828|NCT00299104|83037836|FG000|Treatment Period|Insufficient therapeutic response|34|||
46817829|NCT00299104|83037837|FG001|Treatment Period|Insufficient therapeutic response|13|||
46817830|NCT00299104|83037838|FG002|Treatment Period|Insufficient therapeutic response|8|||
46817831|NCT00299104|83037836|FG000|Treatment Period|Failure to return|9|||
46817832|NCT00299104|83037837|FG001|Treatment Period|Failure to return|8|||
46817833|NCT00299104|83037838|FG002|Treatment Period|Failure to return|8|||
46817834|NCT00299104|83037836|FG000|Treatment Period|Violation of selection criteria|1|||
46817835|NCT00299104|83037837|FG001|Treatment Period|Violation of selection criteria|2|||
46817836|NCT00299104|83037838|FG002|Treatment Period|Violation of selection criteria|0|||
46817837|NCT00299104|83037836|FG000|Treatment Period|Protocol Violation|1|||
46817838|NCT00299104|83037837|FG001|Treatment Period|Protocol Violation|1|||
46817839|NCT00299104|83037838|FG002|Treatment Period|Protocol Violation|0|||
46817840|NCT00299104|83037836|FG000|Treatment Period|Refused treatment|9|||
46817841|NCT00299104|83037837|FG001|Treatment Period|Refused treatment|2|||
46817842|NCT00299104|83037838|FG002|Treatment Period|Refused treatment|2|||
46817843|NCT00299104|83037836|FG000|Treatment Period|Withdrew consent|14|||
46817844|NCT00299104|83037837|FG001|Treatment Period|Withdrew consent|19|||
46817845|NCT00299104|83037838|FG002|Treatment Period|Withdrew consent|9|||
46817846|NCT00299104|83037836|FG000|Treatment Period|Administrative reasons|106|||
46817847|NCT00299104|83037837|FG001|Treatment Period|Administrative reasons|120|||
46817848|NCT00299104|83037838|FG002|Treatment Period|Administrative reasons|137|||
46817849|NCT00299104|83037836|FG000|Safety Follow-Up (SFU) Period|Death|3|||
46817850|NCT00299104|83037837|FG001|Safety Follow-Up (SFU) Period|Death|2|||
46817851|NCT00299104|83037838|FG002|Safety Follow-Up (SFU) Period|Death|1|||
46817852|NCT00299104|83037836|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
46817853|NCT00299104|83037837|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
46817854|NCT00299104|83037838|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
46817855|NCT00299104|83037836|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
46817856|NCT00299104|83037837|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
46817857|NCT00299104|83037838|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
46817858|NCT00299104|83037836|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
46817859|NCT00299104|83037837|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
46817860|NCT00299104|83037838|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
46817861|NCT00299104|83037836|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
46817862|NCT00299104|83037837|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
46817863|NCT00299104|83037838|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
46817864|NCT00299104|83037836|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
46817865|NCT00299104|83037837|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
46817866|NCT00299104|83037838|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
46817867|NCT00299104|83037836|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
46817868|NCT00299104|83037837|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
46817869|NCT00299104|83037838|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
46817870|NCT00299104|83037836|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
46817871|NCT00299104|83037837|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
46930767|NCT02593786|83165818|FG001|Overall Study|Adverse event unrelated to study drug|1|||
46930768|NCT02593786|83165819|FG002|Overall Study|Adverse event unrelated to study drug|1|||
46758148|NCT00501085|82976399|FG000|Overall Study|Withdrawal by Subject|34|||
46758149|NCT00501085|82976399|FG000|Overall Study|Subject Decision|1|||
46758150|NCT00501085|82976399|FG000|Overall Study|Revision Surgery|7|||
46758151|NCT00501085|82976399|FG000|Overall Study|Explantation Surgery|26|||
46758152|NCT00501085|82976399|FG000|Overall Study|Adverse Event|4|||
46758153|NCT00501085|82976399|FG000|Overall Study|Non-Compliance|24|||
46758154|NCT00501085|82976399|FG000|Overall Study|Study closed by sponsor|109|||
46758155|NCT00501085|82976399|FG000|Overall Study|Other loss to follow-up|32|||
46758156|NCT00501007|82976403|FG000|Overall Study|Inclusion criteria not met.|29|||
46817872|NCT00299104|83037838|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
46817873|NCT00313612|83037848|FG000|Overall Study|Patient never received treatment|0|||
46817874|NCT00313612|83037849|FG001|Overall Study|Patient never received treatment|1|||
46817875|NCT00507416|83037858|FG000|Overall Study|Adverse Event|58|||
46817876|NCT00507416|83037859|FG001|Overall Study|Adverse Event|67|||
46817877|NCT00507416|83037860|FG002|Overall Study|Adverse Event|65|||
46930769|NCT02593786|83165820|FG003|Overall Study|Adverse event unrelated to study drug|0|||
46930770|NCT02593786|83165817|FG000|Overall Study|Participant request to discontinue study therapy|0|||
46930771|NCT02593786|83165818|FG001|Overall Study|Participant request to discontinue study therapy|2|||
46817878|NCT00507416|83037858|FG000|Overall Study|Protocol Violation|1|||
46817879|NCT00507416|83037859|FG001|Overall Study|Protocol Violation|2|||
46817880|NCT00507416|83037860|FG002|Overall Study|Protocol Violation|0|||
46817881|NCT00507416|83037858|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
46817882|NCT00507416|83037859|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
46817883|NCT00507416|83037860|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
46758157|NCT00501007|82976404|FG001|Overall Study|Inclusion criteria not met.|25|||
46817884|NCT00507416|83037858|FG000|Overall Study|Progressive Disease|20|||
46817885|NCT00507416|83037859|FG001|Overall Study|Progressive Disease|10|||
46817886|NCT00507416|83037860|FG002|Overall Study|Progressive Disease|13|||
46817887|NCT00507416|83037858|FG000|Overall Study|Patient declined further treatment|18|||
46817888|NCT00507416|83037859|FG001|Overall Study|Patient declined further treatment|14|||
46817889|NCT00507416|83037860|FG002|Overall Study|Patient declined further treatment|11|||
46930772|NCT02593786|83165819|FG002|Overall Study|Participant request to discontinue study therapy|0|||
46930773|NCT02593786|83165820|FG003|Overall Study|Participant request to discontinue study therapy|0|||
46930774|NCT02593786|83165817|FG000|Overall Study|Other reasons|1|||
46930775|NCT02593786|83165818|FG001|Overall Study|Other reasons|1|||
46930776|NCT02593786|83165819|FG002|Overall Study|Other reasons|0|||
46817890|NCT00507416|83037858|FG000|Overall Study|Other|11|||
46817891|NCT00507416|83037859|FG001|Overall Study|Other|16|||
46817892|NCT00507416|83037860|FG002|Overall Study|Other|13|||
46817893|NCT00507416|83037858|FG000|Overall Study|Did not Receive Study Treatment|3|||
46817894|NCT00507416|83037859|FG001|Overall Study|Did not Receive Study Treatment|9|||
46817895|NCT00507416|83037860|FG002|Overall Study|Did not Receive Study Treatment|4|||
46817896|NCT00489476|83037872|FG000|Overall Study|Lost to Follow-up|0|||
46817897|NCT00489476|83037873|FG001|Overall Study|Lost to Follow-up|1|||
46817898|NCT00489476|83037874|FG002|Overall Study|Lost to Follow-up|0|||
46817899|NCT00489476|83037875|FG003|Overall Study|Lost to Follow-up|0|||
46817900|NCT00550745|83037887|FG000|Overall Study|Death|20|||
46817901|NCT00550745|83037888|FG001|Overall Study|Death|16|||
46817902|NCT00550745|83037887|FG000|Overall Study|Lost to Follow-up|45|||
46817903|NCT00550745|83037888|FG001|Overall Study|Lost to Follow-up|30|||
46930777|NCT02593786|83165820|FG003|Overall Study|Other reasons|5|||
46930778|NCT04829331|83165842|FG000|Overall Study|Lost to Follow-up|1|||
46817904|NCT00550745|83037887|FG000|Overall Study|Physician Decision|0|||
46817905|NCT00550745|83037888|FG001|Overall Study|Physician Decision|2|||
46817906|NCT00550745|83037887|FG000|Overall Study|Protocol Violation|4|||
46817907|NCT00550745|83037888|FG001|Overall Study|Protocol Violation|2|||
46817908|NCT00550745|83037887|FG000|Overall Study|Withdrawal by Subject|17|||
46817909|NCT00550745|83037888|FG001|Overall Study|Withdrawal by Subject|10|||
46817910|NCT00550745|83037887|FG000|Overall Study|Screen failure|1|||
46817911|NCT00550745|83037888|FG001|Overall Study|Screen failure|0|||
46817912|NCT00452790|83037896|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
46817913|NCT00452790|83037897|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
46817914|NCT00452790|83037896|FG000|Infant Series|Parent/legal guardian request|8|||
46817915|NCT00452790|83037897|FG001|Infant Series|Parent/legal guardian request|6|||
46817916|NCT00452790|83037896|FG000|Infant Series|Failed to return|4|||
46817917|NCT00452790|83037897|FG001|Infant Series|Failed to return|1|||
46817918|NCT00452790|83037896|FG000|Infant Series|Protocol Violation|1|||
46817919|NCT00452790|83037897|FG001|Infant Series|Protocol Violation|3|||
46817920|NCT00452790|83037896|FG000|Infant Series|Lost to Follow-up|2|||
46817921|NCT00452790|83037897|FG001|Infant Series|Lost to Follow-up|2|||
46817922|NCT00452790|83037896|FG000|Infant Series|Adverse Event|1|||
46817923|NCT00452790|83037897|FG001|Infant Series|Adverse Event|2|||
46817924|NCT00452790|83037896|FG000|Infant Series|Other reasons|1|||
46817925|NCT00452790|83037897|FG001|Infant Series|Other reasons|2|||
46817926|NCT00452790|83037896|FG000|Infant Series|Investigator request|0|||
46817927|NCT00452790|83037897|FG001|Infant Series|Investigator request|1|||
46817928|NCT00452790|83037896|FG000|Infant Series|Death|0|||
46930779|NCT04829331|83165843|FG001|Overall Study|Lost to Follow-up|0|||
46930780|NCT04602546|83165858|FG000|Overall Study|Training|2|||
46930781|NCT04602546|83165859|FG001|Overall Study|Training|2|||
46930782|NCT04602546|83165860|FG002|Overall Study|Training|1|||
46930783|NCT04602546|83165861|FG003|Overall Study|Training|2|||
46930784|NCT04602546|83165862|FG004|Overall Study|Training|0|||
46930785|NCT04602546|83165858|FG000|Overall Study|Randomized with disqualified data|2|||
46930786|NCT04602546|83165859|FG001|Overall Study|Randomized with disqualified data|0|||
46930787|NCT04602546|83165860|FG002|Overall Study|Randomized with disqualified data|2|||
46930788|NCT04602546|83165861|FG003|Overall Study|Randomized with disqualified data|5|||
46930789|NCT04602546|83165862|FG004|Overall Study|Randomized with disqualified data|3|||
46930790|NCT04004988|83165922|FG000|Period 1|Physician Decision|2|||
46930791|NCT04004988|83165923|FG001|Period 1|Physician Decision|0|||
46817929|NCT00452790|83037897|FG001|Infant Series|Death|1|||
46930792|NCT04004988|83165922|FG000|Period 1|Withdrawal by Subject|0|||
46817930|NCT00452790|83037896|FG000|After Infant Series|Investigator request|10|||
46817931|NCT00452790|83037897|FG001|After Infant Series|Investigator request|10|||
46817932|NCT00452790|83037896|FG000|After Infant Series|Adverse Event|4|||
46817933|NCT00452790|83037897|FG001|After Infant Series|Adverse Event|1|||
46817934|NCT00452790|83037896|FG000|After Infant Series|Parent/legal guardian request|1|||
46817935|NCT00452790|83037897|FG001|After Infant Series|Parent/legal guardian request|3|||
46817936|NCT00452790|83037896|FG000|After Infant Series|Lost to Follow-up|4|||
46817937|NCT00452790|83037897|FG001|After Infant Series|Lost to Follow-up|0|||
46817938|NCT00452790|83037896|FG000|After Infant Series|Failed to return|1|||
46930793|NCT04004988|83165923|FG001|Period 1|Withdrawal by Subject|1|||
46930794|NCT04004988|83165922|FG000|Period 1|Adverse Event|1|||
46817939|NCT00452790|83037897|FG001|After Infant Series|Failed to return|0|||
46817940|NCT00452790|83037896|FG000|After Infant Series|Other reasons|1|||
46817941|NCT00452790|83037897|FG001|After Infant Series|Other reasons|0|||
46930795|NCT04004988|83165923|FG001|Period 1|Adverse Event|2|||
46930796|NCT03898700|83165930|FG000|Overall Study|Withdrawal by Subject|2|||
46817942|NCT00452790|83037896|FG000|Toddler Dose|Failed to return|0|||
46817943|NCT00452790|83037897|FG001|Toddler Dose|Failed to return|1|||
46817944|NCT00452790|83037896|FG000|Toddler Dose|Parent/legal guardian request|0|||
46817945|NCT00452790|83037897|FG001|Toddler Dose|Parent/legal guardian request|1|||
46817946|NCT00463788|83037909|FG000|Overall Study|Progressive Disease|86|||
46817947|NCT00463788|83037910|FG001|Overall Study|Progressive Disease|42|||
46817948|NCT00463788|83037909|FG000|Overall Study|Adverse Event|6|||
46817949|NCT00463788|83037910|FG001|Overall Study|Adverse Event|2|||
46817950|NCT00463788|83037909|FG000|Overall Study|Withdrawal by Subject|6|||
46817951|NCT00463788|83037910|FG001|Overall Study|Withdrawal by Subject|2|||
46817952|NCT00463788|83037909|FG000|Overall Study|Death|4|||
46817953|NCT00463788|83037910|FG001|Overall Study|Death|3|||
46817954|NCT00463788|83037909|FG000|Overall Study|Symptomatic Deterioration|2|||
46817955|NCT00463788|83037910|FG001|Overall Study|Symptomatic Deterioration|3|||
46817956|NCT00463788|83037909|FG000|Overall Study|Lost to Follow-up|1|||
46817957|NCT00463788|83037910|FG001|Overall Study|Lost to Follow-up|0|||
46817958|NCT00463788|83037909|FG000|Overall Study|Protocol Violation|0|||
46817959|NCT00463788|83037910|FG001|Overall Study|Protocol Violation|1|||
46817960|NCT00463788|83037909|FG000|Overall Study|Other|3|||
46817961|NCT00463788|83037910|FG001|Overall Study|Other|0|||
46817962|NCT00463788|83037909|FG000|Overall Study|Randomized but not treated|1|||
46817963|NCT00463788|83037910|FG001|Overall Study|Randomized but not treated|1|||
46817964|NCT00548249|83037922|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
46817965|NCT00548249|83037923|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
46930797|NCT03586973|83165945|FG000|Overall Study|Death|15|||
46930798|NCT03586973|83165946|FG001|Overall Study|Death|8|||
46930799|NCT03586973|83165945|FG000|Overall Study|Site Terminated by Sponsor|3|||
46930800|NCT03586973|83165946|FG001|Overall Study|Site Terminated by Sponsor|6|||
46930801|NCT03586973|83165945|FG000|Overall Study|Withdrawal by Subject|1|||
46930802|NCT03586973|83165946|FG001|Overall Study|Withdrawal by Subject|0|||
46930803|NCT03586973|83165945|FG000|Overall Study|Lost to Follow-up|1|||
46930804|NCT03586973|83165946|FG001|Overall Study|Lost to Follow-up|0|||
46930805|NCT02669212|83165954|FG000|Overall Study|Lost to Follow-up|1|||
46930806|NCT02669212|83165955|FG001|Overall Study|Lost to Follow-up|0|||
46930807|NCT02669212|83165954|FG000|Overall Study|Medical Condition|3|||
46930808|NCT02669212|83165955|FG001|Overall Study|Medical Condition|4|||
46930809|NCT02669212|83165954|FG000|Overall Study|Withdrawal by Subject|0|||
46930810|NCT02669212|83165955|FG001|Overall Study|Withdrawal by Subject|2|||
46930811|NCT02669212|83165954|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
46930812|NCT02669212|83165955|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
46930813|NCT02536664|83165977|FG000|Overall Study|Inadequate completion of documentation|2|||
46930814|NCT02536664|83165978|FG001|Overall Study|Inadequate completion of documentation|4|||
46930815|NCT02536664|83165977|FG000|Overall Study|Progression|13|||
46930816|NCT02536664|83165978|FG001|Overall Study|Progression|18|||
46930817|NCT02536664|83165977|FG000|Overall Study|Death due to lymphoma|2|||
46930818|NCT02536664|83165978|FG001|Overall Study|Death due to lymphoma|1|||
46930819|NCT02536664|83165977|FG000|Overall Study|Death due to other reason|3|||
46930820|NCT02536664|83165978|FG001|Overall Study|Death due to other reason|2|||
46930821|NCT02536664|83165977|FG000|Overall Study|Intolerability|8|||
46930822|NCT02536664|83165978|FG001|Overall Study|Intolerability|6|||
46930823|NCT02536664|83165977|FG000|Overall Study|Withdrawal by Subject|8|||
46817966|NCT00548249|83037924|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
46817967|NCT00548249|83037925|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
46817968|NCT00548249|83037926|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
46817969|NCT00548249|83037922|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
46817970|NCT00548249|83037923|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
46817971|NCT00548249|83037924|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
46817972|NCT00548249|83037925|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
46930824|NCT02536664|83165978|FG001|Overall Study|Withdrawal by Subject|5|||
46930825|NCT02536664|83165977|FG000|Overall Study|Other|18|||
46930826|NCT02536664|83165978|FG001|Overall Study|Other|24|||
46817973|NCT00548249|83037926|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
46817974|NCT00548249|83037922|FG000|Overall Study|Protocol Violation|1|||
46817975|NCT00548249|83037923|FG001|Overall Study|Protocol Violation|1|||
46817976|NCT00548249|83037924|FG002|Overall Study|Protocol Violation|4|||
46930827|NCT02536664|83165977|FG000|Overall Study|Missing|53|||
46930828|NCT02536664|83165978|FG001|Overall Study|Missing|20|||
46930829|NCT02426892|83165984|FG000|Overall Study|Adverse Event|2|||
46817977|NCT00548249|83037925|FG003|Overall Study|Protocol Violation|0|||
46817978|NCT00548249|83037926|FG004|Overall Study|Protocol Violation|3|||
46817979|NCT00548249|83037922|FG000|Overall Study|Miscellaneous|2|||
46930830|NCT02426892|83165984|FG000|Overall Study|Lack of Efficacy|17|||
46930831|NCT02426892|83165984|FG000|Overall Study|Withdrawal by Subject|1|||
46930832|NCT02312687|83165988|FG000|Overall Study|Other, Not Specified|1|||
46930833|NCT02304367|83165992|FG000|Overall Study|Lack of Response to Bruosumab|1|||
46930834|NCT02304367|83165992|FG000|Overall Study|Sponsor Decision|3|||
46930835|NCT02304367|83165992|FG000|Overall Study|Death|2|||
46930836|NCT02304367|83165992|FG000|Overall Study|Physician Decision|1|||
46758158|NCT00873860|82976414|FG000|Overall Study|Lost to Follow-up|1|||
46817980|NCT00548249|83037923|FG001|Overall Study|Miscellaneous|3|||
46817981|NCT00548249|83037924|FG002|Overall Study|Miscellaneous|2|||
46817982|NCT00548249|83037925|FG003|Overall Study|Miscellaneous|0|||
46817983|NCT00548249|83037926|FG004|Overall Study|Miscellaneous|2|||
46817984|NCT00548249|83037922|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
46817985|NCT00548249|83037923|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
46817986|NCT00548249|83037924|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
46817987|NCT00548249|83037925|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
46817988|NCT00548249|83037926|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
46817989|NCT00548249|83037922|FG000|Overall Study|Adverse Event|2|||
46817990|NCT00548249|83037923|FG001|Overall Study|Adverse Event|2|||
46817991|NCT00548249|83037924|FG002|Overall Study|Adverse Event|0|||
46817992|NCT00548249|83037925|FG003|Overall Study|Adverse Event|1|||
46817993|NCT00548249|83037926|FG004|Overall Study|Adverse Event|1|||
46817994|NCT00548249|83037922|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
46817995|NCT00548249|83037923|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
46930837|NCT02304367|83165992|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
46930838|NCT02054520|83166009|FG000|Overall Study|Adverse Event|1|||
46930839|NCT02054520|83166010|FG001|Overall Study|Adverse Event|4|||
46930840|NCT02054520|83166011|FG002|Overall Study|Adverse Event|2|||
46930841|NCT02054520|83166012|FG003|Overall Study|Adverse Event|1|||
46930842|NCT02054520|83166013|FG004|Overall Study|Adverse Event|1|||
47055936|NCT02563522|83330534|FG000|Overall Study|Adverse Event|2|||
47055937|NCT02563522|83330535|FG001|Overall Study|Adverse Event|3|||
46930843|NCT02054520|83166014|FG005|Overall Study|Adverse Event|0|||
46930844|NCT02054520|83166009|FG000|Overall Study|Lack of Efficacy|7|||
46758159|NCT00873860|82976415|FG001|Overall Study|Lost to Follow-up|0|||
46758160|NCT00873860|82976416|FG002|Overall Study|Lost to Follow-up|0|||
46758161|NCT00873860|82976417|FG003|Overall Study|Lost to Follow-up|1|||
46758162|NCT00873860|82976414|FG000|Overall Study|Withdrawal by Subject|1|||
46758163|NCT00873860|82976415|FG001|Overall Study|Withdrawal by Subject|0|||
46758164|NCT00873860|82976416|FG002|Overall Study|Withdrawal by Subject|2|||
46758165|NCT00873860|82976417|FG003|Overall Study|Withdrawal by Subject|0|||
46758166|NCT00873860|82976414|FG000|Overall Study|Death|1|||
46758167|NCT00873860|82976415|FG001|Overall Study|Death|0|||
46758168|NCT00873860|82976416|FG002|Overall Study|Death|0|||
46758169|NCT00873860|82976417|FG003|Overall Study|Death|0|||
46758170|NCT00873860|82976414|FG000|Overall Study|Other|1|||
46758171|NCT00873860|82976415|FG001|Overall Study|Other|0|||
46758172|NCT00873860|82976416|FG002|Overall Study|Other|1|||
46758173|NCT00873860|82976417|FG003|Overall Study|Other|0|||
46758174|NCT03853291|82976440|FG000|Overall Study|Lost to Follow-up|1|||
46758175|NCT03853291|82976441|FG001|Overall Study|Lost to Follow-up|2|||
46758176|NCT03853291|82976442|FG002|Overall Study|Lost to Follow-up|0|||
46758177|NCT03853291|82976443|FG003|Overall Study|Lost to Follow-up|0|||
46758178|NCT03853291|82976444|FG004|Overall Study|Lost to Follow-up|0|||
46758179|NCT03853291|82976445|FG005|Overall Study|Lost to Follow-up|0|||
46758180|NCT03853291|82976440|FG000|Overall Study|Determined to be ineligible|1|||
46758181|NCT03853291|82976441|FG001|Overall Study|Determined to be ineligible|1|||
46758182|NCT03853291|82976442|FG002|Overall Study|Determined to be ineligible|0|||
46758183|NCT03853291|82976443|FG003|Overall Study|Determined to be ineligible|0|||
46758184|NCT03853291|82976444|FG004|Overall Study|Determined to be ineligible|0|||
46758185|NCT03853291|82976445|FG005|Overall Study|Determined to be ineligible|0|||
46758186|NCT03853213|82976458|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
46758187|NCT03853213|82976459|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
46758188|NCT03853213|82976458|FG000|Overall Study|Other (e.g., too busy)|0|||
46758189|NCT03853213|82976459|FG001|Overall Study|Other (e.g., too busy)|2|||
46930845|NCT02054520|83166010|FG001|Overall Study|Lack of Efficacy|0|||
47055938|NCT02563522|83330534|FG000|Overall Study|Lost to Follow-up|1|||
47055939|NCT02563522|83330535|FG001|Overall Study|Lost to Follow-up|0|||
47055940|NCT02563522|83330534|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
46758190|NCT02666105|82976485|FG000|Overall Study|Death|1|||
46758191|NCT00819585|82976504|FG000|Core Study|Adverse Event|2|||
46930846|NCT02054520|83166011|FG002|Overall Study|Lack of Efficacy|2|||
46930847|NCT02054520|83166012|FG003|Overall Study|Lack of Efficacy|1|||
46758192|NCT00819585|82976505|FG001|Core Study|Adverse Event|1|||
46758193|NCT00819585|82976506|FG002|Core Study|Adverse Event|1|||
46758194|NCT00819585|82976507|FG003|Core Study|Adverse Event|4|||
46758195|NCT00819585|82976508|FG004|Core Study|Adverse Event|1|||
46817996|NCT00548249|83037924|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
46817997|NCT00548249|83037925|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
46817998|NCT00548249|83037926|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
46817999|NCT00548249|83037922|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
46818000|NCT00548249|83037923|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
46818001|NCT00548249|83037924|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
46818002|NCT00548249|83037925|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
46818003|NCT00548249|83037926|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
46818004|NCT00548249|83037922|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
46818005|NCT00548249|83037923|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
46818006|NCT00548249|83037924|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
46818007|NCT00548249|83037925|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
46818008|NCT00548249|83037926|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
46818009|NCT00548249|83037922|FG000|Overall Study|Prolonged hospitalization|0|||
46818010|NCT00548249|83037923|FG001|Overall Study|Prolonged hospitalization|0|||
46818011|NCT00548249|83037924|FG002|Overall Study|Prolonged hospitalization|2|||
46818012|NCT00548249|83037925|FG003|Overall Study|Prolonged hospitalization|1|||
46818013|NCT00548249|83037926|FG004|Overall Study|Prolonged hospitalization|0|||
46818014|NCT00548249|83037922|FG000|Overall Study|Withdrawal by Subject|2|||
46818015|NCT00548249|83037923|FG001|Overall Study|Withdrawal by Subject|0|||
46818016|NCT00548249|83037924|FG002|Overall Study|Withdrawal by Subject|0|||
46818017|NCT00548249|83037925|FG003|Overall Study|Withdrawal by Subject|0|||
46818018|NCT00548249|83037926|FG004|Overall Study|Withdrawal by Subject|0|||
46818019|NCT00548249|83037922|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
46818020|NCT00548249|83037923|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
46818021|NCT00548249|83037924|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
46818022|NCT00548249|83037925|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
46818023|NCT00548249|83037926|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
46818024|NCT00548249|83037922|FG000|Overall Study|Sponsor's request|0|||
46818025|NCT00548249|83037923|FG001|Overall Study|Sponsor's request|0|||
46818026|NCT00548249|83037924|FG002|Overall Study|Sponsor's request|0|||
46818027|NCT00548249|83037925|FG003|Overall Study|Sponsor's request|1|||
46818028|NCT00548249|83037926|FG004|Overall Study|Sponsor's request|0|||
46818029|NCT00463476|83037940|FG000|Overall Study|Withdrawal by Subject|1|||
46818030|NCT00463476|83037941|FG001|Overall Study|Withdrawal by Subject|2|||
46818031|NCT00463476|83037940|FG000|Overall Study|Lost to Follow-up|1|||
46818032|NCT00463476|83037941|FG001|Overall Study|Lost to Follow-up|1|||
46818033|NCT03839940|83037949|FG000|Overall Study|Withdrawal by Subject|3|||
46818034|NCT03839940|83037950|FG001|Overall Study|Withdrawal by Subject|0|||
46818035|NCT03839940|83037949|FG000|Overall Study|Protocol Violation|0|||
46818036|NCT03839940|83037950|FG001|Overall Study|Protocol Violation|1|||
46818037|NCT03839940|83037949|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
46818038|NCT03839940|83037950|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
46818039|NCT03839628|83037958|FG000|Overall Study|Withdrawal by Subject|1|||
46818040|NCT00462462|83037964|FG000|Overall Study|Physician Decision|0|||
46818041|NCT00462462|83037965|FG001|Overall Study|Physician Decision|1|||
46818042|NCT00462384|83037973|FG000|Overall Study|Adverse Event|2|||
46818043|NCT00462384|83037973|FG000|Overall Study|Death|2|||
46930848|NCT02054520|83166013|FG004|Overall Study|Lack of Efficacy|3|||
46930849|NCT02054520|83166014|FG005|Overall Study|Lack of Efficacy|2|||
46930850|NCT02054520|83166009|FG000|Overall Study|Withdrawal by Subject|1|||
46930851|NCT02054520|83166010|FG001|Overall Study|Withdrawal by Subject|0|||
47055941|NCT02563522|83330535|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
47055942|NCT03578146|83330547|FG000|Overall Study|Did Not Receive Treatment|1|||
47055943|NCT03578146|83330548|FG001|Overall Study|Did Not Receive Treatment|0|||
47055944|NCT03578146|83330549|FG002|Overall Study|Did Not Receive Treatment|0|||
47055945|NCT03578146|83330550|FG003|Overall Study|Did Not Receive Treatment|0|||
47055946|NCT03578146|83330551|FG004|Overall Study|Did Not Receive Treatment|0|||
47055947|NCT03578146|83330552|FG005|Overall Study|Did Not Receive Treatment|2|||
47055948|NCT03578146|83330547|FG000|Overall Study|Lost to Follow-up|0|||
47055949|NCT03578146|83330548|FG001|Overall Study|Lost to Follow-up|1|||
47055950|NCT03578146|83330549|FG002|Overall Study|Lost to Follow-up|1|||
47055951|NCT03578146|83330550|FG003|Overall Study|Lost to Follow-up|0|||
47055952|NCT03578146|83330551|FG004|Overall Study|Lost to Follow-up|0|||
47055953|NCT03578146|83330552|FG005|Overall Study|Lost to Follow-up|1|||
47055954|NCT02716896|83330568|FG000|Overall Study|Physician Decision|0|||
46818044|NCT00462384|83037973|FG000|Overall Study|Withdrawal by Subject|1|||
46818045|NCT00462384|83037973|FG000|Overall Study|Other|4|||
46818046|NCT00452400|83037982|FG000|Overall Study|Adverse Event|1|||
46818047|NCT00452400|83037983|FG001|Overall Study|Adverse Event|1|||
46818048|NCT00452400|83037984|FG002|Overall Study|Adverse Event|5|||
46930852|NCT02054520|83166011|FG002|Overall Study|Withdrawal by Subject|0|||
47055955|NCT02716896|83330569|FG001|Overall Study|Physician Decision|1|||
47055956|NCT02715726|83330624|FG000|Overall Study|Adverse Event|2|||
47055957|NCT02715726|83330625|FG001|Overall Study|Adverse Event|6|||
47055958|NCT02715726|83330624|FG000|Overall Study|Protocol Violation|1|||
47055959|NCT02715726|83330625|FG001|Overall Study|Protocol Violation|0|||
47055960|NCT02715726|83330624|FG000|Overall Study|Death|2|||
47055961|NCT02715726|83330625|FG001|Overall Study|Death|1|||
47055962|NCT02715726|83330624|FG000|Overall Study|Participant moved|1|||
47055963|NCT02715726|83330625|FG001|Overall Study|Participant moved|3|||
47055964|NCT02715726|83330624|FG000|Overall Study|Other than specified above|11|||
47055965|NCT02715726|83330625|FG001|Overall Study|Other than specified above|15|||
47055966|NCT02715726|83330624|FG000|Overall Study|Randomized but not treated|1|||
47055967|NCT02715726|83330625|FG001|Overall Study|Randomized but not treated|2|||
47055968|NCT04248816|83330638|FG000|Overall Study|Ineligible post-randomization|7|||
47055969|NCT04248816|83330639|FG001|Overall Study|Ineligible post-randomization|21|||
47055970|NCT04248816|83330640|FG002|Overall Study|Ineligible post-randomization|25|||
47055971|NCT02314156|83330677|FG000|Overall Study|Adverse Event|1|||
47055972|NCT02314156|83330678|FG001|Overall Study|Adverse Event|0|||
47055973|NCT02314156|83330677|FG000|Overall Study|Withdrawal by Subject|1|||
47055974|NCT02314156|83330678|FG001|Overall Study|Withdrawal by Subject|0|||
47055975|NCT02716584|83330893|FG000|Overall Study|Lost to Follow-up|8|||
47055976|NCT02716584|83330894|FG001|Overall Study|Lost to Follow-up|5|||
47055977|NCT02716194|83330975|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
47055978|NCT02716194|83330976|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
47055979|NCT02716194|83330977|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
47055980|NCT03773484|83331047|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
47055981|NCT02715258|83331230|FG000|Overall Study|Withdrawal by Subject|6|||
46818049|NCT00452400|83037985|FG003|Overall Study|Adverse Event|0|||
46818050|NCT00452400|83037986|FG004|Overall Study|Adverse Event|2|||
46818051|NCT00452400|83037982|FG000|Overall Study|Protocol Violation|0|||
46818052|NCT00452400|83037983|FG001|Overall Study|Protocol Violation|0|||
46818053|NCT00452400|83037984|FG002|Overall Study|Protocol Violation|1|||
46818054|NCT00452400|83037985|FG003|Overall Study|Protocol Violation|0|||
46818055|NCT00452400|83037986|FG004|Overall Study|Protocol Violation|0|||
46818056|NCT00452400|83037982|FG000|Overall Study|Lost to Follow-up|1|||
46818057|NCT00452400|83037983|FG001|Overall Study|Lost to Follow-up|0|||
46818058|NCT00452400|83037984|FG002|Overall Study|Lost to Follow-up|0|||
46818059|NCT00452400|83037985|FG003|Overall Study|Lost to Follow-up|0|||
46818060|NCT00452400|83037986|FG004|Overall Study|Lost to Follow-up|0|||
46818061|NCT00452400|83037982|FG000|Overall Study|Withdrawal by Subject|1|||
46818062|NCT00452400|83037983|FG001|Overall Study|Withdrawal by Subject|0|||
46818063|NCT00452400|83037984|FG002|Overall Study|Withdrawal by Subject|1|||
46818064|NCT00452400|83037985|FG003|Overall Study|Withdrawal by Subject|0|||
46818065|NCT00452400|83037986|FG004|Overall Study|Withdrawal by Subject|0|||
46818066|NCT00452400|83037982|FG000|Overall Study|Lack of Efficacy|2|||
46818067|NCT00452400|83037983|FG001|Overall Study|Lack of Efficacy|0|||
46818068|NCT00452400|83037984|FG002|Overall Study|Lack of Efficacy|0|||
46930853|NCT02054520|83166012|FG003|Overall Study|Withdrawal by Subject|2|||
46930854|NCT02054520|83166013|FG004|Overall Study|Withdrawal by Subject|1|||
46930855|NCT02054520|83166014|FG005|Overall Study|Withdrawal by Subject|0|||
46930856|NCT02054520|83166009|FG000|Overall Study|Physician Decision|0|||
46930857|NCT02054520|83166010|FG001|Overall Study|Physician Decision|1|||
46930858|NCT02054520|83166011|FG002|Overall Study|Physician Decision|0|||
46930859|NCT02054520|83166012|FG003|Overall Study|Physician Decision|1|||
46930860|NCT02054520|83166013|FG004|Overall Study|Physician Decision|0|||
46930861|NCT02054520|83166014|FG005|Overall Study|Physician Decision|1|||
46930862|NCT02054520|83166009|FG000|Overall Study|Study terminated by Sponsor|0|||
46930863|NCT02054520|83166010|FG001|Overall Study|Study terminated by Sponsor|0|||
46930864|NCT02054520|83166011|FG002|Overall Study|Study terminated by Sponsor|2|||
47055982|NCT02715258|83331231|FG001|Overall Study|Withdrawal by Subject|1|||
47055983|NCT02715258|83331230|FG000|Overall Study|Lost to Follow-up|7|||
47055984|NCT02715258|83331231|FG001|Overall Study|Lost to Follow-up|1|||
47055985|NCT02715258|83331230|FG000|Overall Study|Terminated by Sponsor|0|||
47055986|NCT02715258|83331231|FG001|Overall Study|Terminated by Sponsor|1|||
46758196|NCT00819585|82976509|FG005|Core Study|Adverse Event|0|||
46758197|NCT00819585|82976510|FG006|Core Study|Adverse Event|2|||
46758198|NCT00819585|82976511|FG007|Core Study|Adverse Event|0|||
46758199|NCT00819585|82976512|FG008|Core Study|Adverse Event|0|||
46758200|NCT00819585|82976513|FG009|Core Study|Adverse Event|0|||
46758201|NCT00819585|82976514|FG010|Core Study|Adverse Event|0|||
46758202|NCT00819585|82976504|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
46758203|NCT00819585|82976505|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
46818069|NCT00452400|83037985|FG003|Overall Study|Lack of Efficacy|0|||
46818070|NCT00452400|83037986|FG004|Overall Study|Lack of Efficacy|0|||
46818071|NCT00452400|83037982|FG000|Overall Study|Other reasons not listed above|0|||
46818072|NCT00452400|83037983|FG001|Overall Study|Other reasons not listed above|0|||
47055987|NCT02715258|83331230|FG000|Overall Study|Death|0|||
46930865|NCT02054520|83166012|FG003|Overall Study|Study terminated by Sponsor|1|||
46758204|NCT00819585|82976506|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
46758205|NCT00819585|82976507|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
46930866|NCT02054520|83166013|FG004|Overall Study|Study terminated by Sponsor|0|||
47055988|NCT02715258|83331231|FG001|Overall Study|Death|1|||
46818073|NCT00452400|83037984|FG002|Overall Study|Other reasons not listed above|0|||
46818074|NCT00452400|83037985|FG003|Overall Study|Other reasons not listed above|1|||
46818075|NCT00452400|83037986|FG004|Overall Study|Other reasons not listed above|1|||
46818076|NCT00462306|83038000|FG000|Overall Study|insufficient data|0|||
46818077|NCT00462306|83038001|FG001|Overall Study|insufficient data|13|||
46818078|NCT00461682|83038009|FG000|Overall Study|Protocol Violation|1|||
46818079|NCT00443430|83038017|FG000|Overall Study|Lack of Efficacy|3|||
46818080|NCT00443430|83038018|FG001|Overall Study|Lack of Efficacy|3|||
46818081|NCT00443430|83038017|FG000|Overall Study|Adverse Event|1|||
46818082|NCT00443430|83038018|FG001|Overall Study|Adverse Event|1|||
46818083|NCT00460746|83038024|FG000|Overall Study|Adverse Event|1|||
46818084|NCT00460746|83038024|FG000|Overall Study|Lost to Follow-up|1|||
46818085|NCT00443118|83038031|FG000|Overall Study|unknown primary outcome|3|||
46818086|NCT00443118|83038032|FG001|Overall Study|unknown primary outcome|1|||
46818087|NCT00443118|83038033|FG002|Overall Study|unknown primary outcome|0|||
46818088|NCT00443118|83038031|FG000|Overall Study|Withdrawal by Subject|1|||
46818089|NCT00443118|83038032|FG001|Overall Study|Withdrawal by Subject|0|||
46818090|NCT00443118|83038033|FG002|Overall Study|Withdrawal by Subject|0|||
46818091|NCT00460434|83038061|FG000|Overall Study|Lost to Follow-up|3|||
46818092|NCT00460434|83038062|FG001|Overall Study|Lost to Follow-up|7|||
46818093|NCT00373425|83038073|FG000|Overall Study|Relapse of NSCLC|116|||
46818094|NCT00373425|83038074|FG001|Overall Study|Relapse of NSCLC|104|||
46818095|NCT00373425|83038075|FG002|Overall Study|Relapse of NSCLC|19|||
46818096|NCT00373425|83038076|FG003|Overall Study|Relapse of NSCLC|2|||
46818097|NCT00373425|83038077|FG004|Overall Study|Relapse of NSCLC|26|||
46818098|NCT00373425|83038073|FG000|Overall Study|Adverse Event|191|||
46818099|NCT00373425|83038074|FG001|Overall Study|Adverse Event|22|||
46818100|NCT00373425|83038075|FG002|Overall Study|Adverse Event|59|||
47055989|NCT02715258|83331230|FG000|Overall Study|Subject non-compliant|1|||
46930867|NCT02054520|83166014|FG005|Overall Study|Study terminated by Sponsor|0|||
46930868|NCT01546987|83166043|FG000|Overall Study|Protocol Violation|3|||
46930869|NCT01546987|83166044|FG001|Overall Study|Protocol Violation|4|||
46818101|NCT00373425|83038076|FG003|Overall Study|Adverse Event|0|||
46818102|NCT00373425|83038077|FG004|Overall Study|Adverse Event|34|||
46818103|NCT00373425|83038073|FG000|Overall Study|Patient request|35|||
46818104|NCT00373425|83038074|FG001|Overall Study|Patient request|18|||
46818105|NCT00373425|83038075|FG002|Overall Study|Patient request|43|||
46818106|NCT00373425|83038076|FG003|Overall Study|Patient request|6|||
46818107|NCT00373425|83038077|FG004|Overall Study|Patient request|7|||
46818108|NCT00373425|83038073|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
46818109|NCT00373425|83038074|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
46818110|NCT00373425|83038075|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
46818111|NCT00373425|83038076|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
46818112|NCT00373425|83038077|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
46818113|NCT00373425|83038073|FG000|Overall Study|Death|7|||
46818114|NCT00373425|83038074|FG001|Overall Study|Death|0|||
46818115|NCT00373425|83038075|FG002|Overall Study|Death|3|||
46818116|NCT00373425|83038076|FG003|Overall Study|Death|1|||
46818117|NCT00373425|83038077|FG004|Overall Study|Death|0|||
46930870|NCT00261443|83166052|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
46930871|NCT00261443|83166053|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
46930872|NCT00261443|83166054|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
46930873|NCT00261443|83166052|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
46930874|NCT00261443|83166053|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
46930875|NCT00261443|83166054|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
46758206|NCT00819585|82976508|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
46758207|NCT00819585|82976509|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
46758208|NCT00819585|82976510|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
46758209|NCT00819585|82976511|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
46758210|NCT00819585|82976512|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
46758211|NCT00819585|82976513|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
46758212|NCT00819585|82976514|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
46758213|NCT00819585|82976504|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
46818118|NCT00459342|83038086|FG000|Overall Study|Not eligible|1|||
46818119|NCT00443040|83038093|FG000|Overall Study|Withdrawal by Subject|1|||
46818120|NCT00443040|83038094|FG001|Overall Study|Withdrawal by Subject|0|||
46818121|NCT00443040|83038095|FG002|Overall Study|Withdrawal by Subject|0|||
46818122|NCT00443040|83038093|FG000|Overall Study|Converted to an open laparotomy|3|||
47055990|NCT02715258|83331231|FG001|Overall Study|Subject non-compliant|1|||
46818123|NCT00443040|83038094|FG001|Overall Study|Converted to an open laparotomy|0|||
46818124|NCT00443040|83038095|FG002|Overall Study|Converted to an open laparotomy|1|||
46818125|NCT00442962|83038103|FG000|Overall Study|Pregnancy|1|||
47055991|NCT02715258|83331230|FG000|Overall Study|GCP violation|2|||
46758214|NCT00819585|82976505|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
46818126|NCT00442962|83038103|FG000|Overall Study|Lost to Follow-up|7|||
46818127|NCT00313300|83038112|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
46930876|NCT00261443|83166052|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
46930877|NCT00261443|83166053|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
46930878|NCT00261443|83166054|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
46930879|NCT00261443|83166052|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
46930880|NCT00261443|83166053|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
46930881|NCT00261443|83166054|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
46930882|NCT00261443|83166052|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
46930883|NCT00261443|83166053|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
46930884|NCT00261443|83166054|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
46930885|NCT00261443|83166052|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
46930886|NCT00261443|83166053|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
46758215|NCT00819585|82976506|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758216|NCT00819585|82976507|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758217|NCT00819585|82976508|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758218|NCT00819585|82976509|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758219|NCT00819585|82976510|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
46758220|NCT00819585|82976511|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758221|NCT00819585|82976512|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758222|NCT00819585|82976513|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758223|NCT00819585|82976514|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
46758224|NCT00819585|82976504|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
46758225|NCT00819585|82976505|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
46758226|NCT00819585|82976506|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
46758227|NCT00819585|82976507|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
46758228|NCT00819585|82976508|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
46758229|NCT00819585|82976509|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
46758230|NCT00819585|82976510|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
46758231|NCT00819585|82976511|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
46758232|NCT00819585|82976512|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
46758233|NCT00819585|82976513|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
46758234|NCT00819585|82976514|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
46758235|NCT00819585|82976504|FG000|Core Study|Subject Withdrew Consent|0|||
46758236|NCT00819585|82976505|FG001|Core Study|Subject Withdrew Consent|3|||
46758237|NCT00819585|82976506|FG002|Core Study|Subject Withdrew Consent|2|||
46758238|NCT00819585|82976507|FG003|Core Study|Subject Withdrew Consent|1|||
46758239|NCT00819585|82976508|FG004|Core Study|Subject Withdrew Consent|0|||
46758240|NCT00819585|82976509|FG005|Core Study|Subject Withdrew Consent|0|||
46758241|NCT00819585|82976510|FG006|Core Study|Subject Withdrew Consent|3|||
46758242|NCT00819585|82976511|FG007|Core Study|Subject Withdrew Consent|0|||
46758243|NCT00819585|82976512|FG008|Core Study|Subject Withdrew Consent|0|||
46758244|NCT00819585|82976513|FG009|Core Study|Subject Withdrew Consent|0|||
46758245|NCT00819585|82976514|FG010|Core Study|Subject Withdrew Consent|0|||
46758246|NCT00819585|82976504|FG000|Core Study|Lost to Follow-up|2|||
46758247|NCT00819585|82976505|FG001|Core Study|Lost to Follow-up|1|||
46758248|NCT00819585|82976506|FG002|Core Study|Lost to Follow-up|2|||
46758249|NCT00819585|82976507|FG003|Core Study|Lost to Follow-up|0|||
46758250|NCT00819585|82976508|FG004|Core Study|Lost to Follow-up|1|||
46758251|NCT00819585|82976509|FG005|Core Study|Lost to Follow-up|1|||
46758252|NCT00819585|82976510|FG006|Core Study|Lost to Follow-up|1|||
46758253|NCT00819585|82976511|FG007|Core Study|Lost to Follow-up|0|||
46758254|NCT00819585|82976512|FG008|Core Study|Lost to Follow-up|0|||
46758255|NCT00819585|82976513|FG009|Core Study|Lost to Follow-up|0|||
46758256|NCT00819585|82976514|FG010|Core Study|Lost to Follow-up|0|||
46758257|NCT00819585|82976504|FG000|Core Study|Administrative Problems|0|||
46758258|NCT00819585|82976505|FG001|Core Study|Administrative Problems|0|||
46758259|NCT00819585|82976506|FG002|Core Study|Administrative Problems|0|||
46758260|NCT00819585|82976507|FG003|Core Study|Administrative Problems|0|||
46758261|NCT00819585|82976508|FG004|Core Study|Administrative Problems|0|||
46758262|NCT00819585|82976509|FG005|Core Study|Administrative Problems|0|||
46758263|NCT00819585|82976510|FG006|Core Study|Administrative Problems|2|||
46758264|NCT00819585|82976511|FG007|Core Study|Administrative Problems|0|||
46758265|NCT00819585|82976512|FG008|Core Study|Administrative Problems|0|||
46758266|NCT00819585|82976513|FG009|Core Study|Administrative Problems|0|||
46758267|NCT00819585|82976514|FG010|Core Study|Administrative Problems|0|||
46758268|NCT00819585|82976504|FG000|Core Study|Death|0|||
46930887|NCT00261443|83166054|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
46930888|NCT00261443|83166052|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
46930889|NCT00261443|83166053|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
46758269|NCT00819585|82976505|FG001|Core Study|Death|0|||
46758270|NCT00819585|82976506|FG002|Core Study|Death|0|||
46758271|NCT00819585|82976507|FG003|Core Study|Death|0|||
46758272|NCT00819585|82976508|FG004|Core Study|Death|0|||
46758273|NCT00819585|82976509|FG005|Core Study|Death|0|||
46818128|NCT00313300|83038113|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
46818129|NCT00313300|83038114|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
46818130|NCT00313300|83038115|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
46818131|NCT00313300|83038116|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
46818132|NCT00313300|83038112|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
46818133|NCT00313300|83038113|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
46818134|NCT00313300|83038114|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
46818135|NCT00313300|83038115|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
46818136|NCT00313300|83038116|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
46818137|NCT00313300|83038112|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
46818138|NCT00313300|83038113|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
46818139|NCT00313300|83038114|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
46818140|NCT00313300|83038115|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
46818141|NCT00313300|83038116|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
46818142|NCT00313300|83038112|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
46818143|NCT00313300|83038113|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
46818144|NCT00313300|83038114|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
46818145|NCT00313300|83038115|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
46818146|NCT00313300|83038116|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
46818147|NCT00313300|83038112|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
46818148|NCT00313300|83038113|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
46818149|NCT00313300|83038114|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
46818150|NCT00313300|83038115|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
46818151|NCT00313300|83038116|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
46818152|NCT00313300|83038112|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
46818153|NCT00313300|83038113|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
46818154|NCT00313300|83038114|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
46818155|NCT00313300|83038115|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
46818156|NCT00313300|83038116|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
46818157|NCT00313300|83038112|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
46818158|NCT00313300|83038113|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
46818159|NCT00313300|83038114|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
46818160|NCT00313300|83038115|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
46818161|NCT00313300|83038116|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
46818162|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
46818163|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
46818164|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
46818165|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
46818166|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
46818167|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
46818168|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
46930890|NCT00261443|83166054|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
46930891|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
46930892|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
46930893|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
46930894|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
46930895|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
46930896|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
46930897|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
46930898|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
46930899|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
46930900|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
46930901|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
46930902|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
46930903|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
46930904|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
46930905|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
46930906|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
46930907|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
46930908|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
46930909|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
47055992|NCT02715258|83331231|FG001|Overall Study|GCP violation|1|||
46930910|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
46930911|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
46930912|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
46930913|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
46930914|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
46930915|NCT00261443|83166052|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
46930916|NCT00261443|83166053|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
46930917|NCT00261443|83166054|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
46930918|NCT00261443|83166052|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
46930919|NCT00261443|83166053|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
46930920|NCT00261443|83166054|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
46930921|NCT00261443|83166052|FG000|3: Assessment of Relapse|Adverse Event|0|||
46930922|NCT00261443|83166053|FG001|3: Assessment of Relapse|Adverse Event|15|||
46930923|NCT00261443|83166054|FG002|3: Assessment of Relapse|Adverse Event|19|||
46930924|NCT00261443|83166052|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
46930925|NCT00261443|83166053|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
46930926|NCT00261443|83166054|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
46930927|NCT00261443|83166052|FG000|3: Assessment of Relapse|Death|0|||
46930928|NCT00261443|83166053|FG001|3: Assessment of Relapse|Death|0|||
46930929|NCT00261443|83166054|FG002|3: Assessment of Relapse|Death|1|||
46930930|NCT00261443|83166052|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
46930931|NCT00261443|83166053|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
46930932|NCT00261443|83166054|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
46930933|NCT00261443|83166052|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
46930934|NCT00261443|83166053|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
46930935|NCT00261443|83166054|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
46930936|NCT00261443|83166052|FG000|3: Assessment of Relapse|Pregnancy|0|||
46930937|NCT00261443|83166053|FG001|3: Assessment of Relapse|Pregnancy|2|||
46930938|NCT00261443|83166054|FG002|3: Assessment of Relapse|Pregnancy|1|||
46930939|NCT00261443|83166052|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
46930940|NCT00261443|83166053|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
46930941|NCT00261443|83166054|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
46930942|NCT00261443|83166052|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
46758274|NCT00819585|82976510|FG006|Core Study|Death|1|||
46758275|NCT00819585|82976511|FG007|Core Study|Death|0|||
46758276|NCT00819585|82976512|FG008|Core Study|Death|0|||
46758277|NCT00819585|82976513|FG009|Core Study|Death|0|||
46758278|NCT00819585|82976514|FG010|Core Study|Death|0|||
46758279|NCT00819585|82976504|FG000|Core Study|Protocol Violation|0|||
46758280|NCT00819585|82976505|FG001|Core Study|Protocol Violation|0|||
46758281|NCT00819585|82976506|FG002|Core Study|Protocol Violation|1|||
46758282|NCT00819585|82976507|FG003|Core Study|Protocol Violation|0|||
46758283|NCT00819585|82976508|FG004|Core Study|Protocol Violation|0|||
46758284|NCT00819585|82976509|FG005|Core Study|Protocol Violation|1|||
46758285|NCT00819585|82976510|FG006|Core Study|Protocol Violation|3|||
46758286|NCT00819585|82976511|FG007|Core Study|Protocol Violation|0|||
46758287|NCT00819585|82976512|FG008|Core Study|Protocol Violation|0|||
46758288|NCT00819585|82976513|FG009|Core Study|Protocol Violation|0|||
46758289|NCT00819585|82976514|FG010|Core Study|Protocol Violation|0|||
46758290|NCT00819585|82976504|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
46758291|NCT00819585|82976505|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
46758292|NCT00819585|82976506|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
46758293|NCT00819585|82976507|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
46758294|NCT00819585|82976508|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
46758295|NCT00819585|82976509|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
46758296|NCT00819585|82976510|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
46758297|NCT00819585|82976511|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
46758298|NCT00819585|82976512|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
46758299|NCT00819585|82976513|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
46758300|NCT00819585|82976514|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
46758301|NCT00819585|82976504|FG000|Extension Study|Subject Withdrew Consent|0|||
46758302|NCT00819585|82976505|FG001|Extension Study|Subject Withdrew Consent|0|||
46930943|NCT00261443|83166053|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
46758303|NCT00819585|82976506|FG002|Extension Study|Subject Withdrew Consent|0|||
46758304|NCT00819585|82976507|FG003|Extension Study|Subject Withdrew Consent|0|||
46758305|NCT00819585|82976508|FG004|Extension Study|Subject Withdrew Consent|0|||
46758306|NCT00819585|82976509|FG005|Extension Study|Subject Withdrew Consent|0|||
46758307|NCT00819585|82976510|FG006|Extension Study|Subject Withdrew Consent|0|||
46758308|NCT00819585|82976511|FG007|Extension Study|Subject Withdrew Consent|0|||
46758309|NCT00819585|82976512|FG008|Extension Study|Subject Withdrew Consent|3|||
46758310|NCT00819585|82976513|FG009|Extension Study|Subject Withdrew Consent|0|||
46758311|NCT00819585|82976514|FG010|Extension Study|Subject Withdrew Consent|1|||
46758312|NCT00819585|82976504|FG000|Extension Study|Lost to Follow-up|0|||
46818169|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
46818170|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
46818171|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
46818172|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
46818173|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
46818174|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
46818175|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
46818176|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
46818177|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
46818178|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
46818179|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
46818180|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
46818181|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
46818182|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
46818183|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
46818184|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
46818185|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
46818186|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
46818187|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
46818188|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
46818189|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
46818190|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
46818191|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
46818192|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
46818193|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
46818194|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
46818195|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
46930944|NCT00261443|83166054|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
46930945|NCT00261443|83166052|FG000|3: Assessment of Relapse|Other Reasons|0|||
46930946|NCT00261443|83166053|FG001|3: Assessment of Relapse|Other Reasons|4|||
46930947|NCT00261443|83166054|FG002|3: Assessment of Relapse|Other Reasons|3|||
46930948|NCT00261443|83166052|FG000|4: Extension Phase|Adverse Event|0|||
46930949|NCT00261443|83166053|FG001|4: Extension Phase|Adverse Event|1|||
46930950|NCT00261443|83166054|FG002|4: Extension Phase|Adverse Event|0|||
46930951|NCT00261443|83166052|FG000|4: Extension Phase|Withdrawal by Subject|0|||
46930952|NCT00261443|83166053|FG001|4: Extension Phase|Withdrawal by Subject|1|||
46930953|NCT00261443|83166054|FG002|4: Extension Phase|Withdrawal by Subject|2|||
46930954|NCT00261443|83166052|FG000|4: Extension Phase|Lost to Follow-up|0|||
46930955|NCT00261443|83166053|FG001|4: Extension Phase|Lost to Follow-up|1|||
46930956|NCT00261443|83166054|FG002|4: Extension Phase|Lost to Follow-up|0|||
46930957|NCT02593318|83166071|FG000|Overall Study|Withdrawal by Subject|1|||
46758313|NCT00819585|82976505|FG001|Extension Study|Lost to Follow-up|0|||
46758314|NCT00819585|82976506|FG002|Extension Study|Lost to Follow-up|0|||
46758315|NCT00819585|82976507|FG003|Extension Study|Lost to Follow-up|0|||
46758316|NCT00819585|82976508|FG004|Extension Study|Lost to Follow-up|0|||
46758317|NCT00819585|82976509|FG005|Extension Study|Lost to Follow-up|0|||
46758318|NCT00819585|82976510|FG006|Extension Study|Lost to Follow-up|0|||
46758319|NCT00819585|82976511|FG007|Extension Study|Lost to Follow-up|0|||
46758320|NCT00819585|82976512|FG008|Extension Study|Lost to Follow-up|2|||
46758321|NCT00819585|82976513|FG009|Extension Study|Lost to Follow-up|1|||
46758322|NCT00819585|82976514|FG010|Extension Study|Lost to Follow-up|1|||
46758323|NCT00819585|82976504|FG000|Extension Study|Death|0|||
46758324|NCT00819585|82976505|FG001|Extension Study|Death|0|||
46758325|NCT00819585|82976506|FG002|Extension Study|Death|0|||
46758326|NCT00819585|82976507|FG003|Extension Study|Death|0|||
46758327|NCT00819585|82976508|FG004|Extension Study|Death|0|||
46758328|NCT00819585|82976509|FG005|Extension Study|Death|0|||
46758329|NCT00819585|82976510|FG006|Extension Study|Death|0|||
46758330|NCT00819585|82976511|FG007|Extension Study|Death|0|||
46758331|NCT00819585|82976512|FG008|Extension Study|Death|2|||
46758332|NCT00819585|82976513|FG009|Extension Study|Death|0|||
46758333|NCT00819585|82976514|FG010|Extension Study|Death|0|||
46758334|NCT00508261|82976546|FG000|Overall Study|Other|0|||
46758335|NCT00508261|82976547|FG001|Overall Study|Other|1|||
46758336|NCT00508261|82976548|FG002|Overall Study|Other|1|||
46758337|NCT00508261|82976549|FG003|Overall Study|Other|0|||
46758338|NCT00508261|82976546|FG000|Overall Study|Serious Adverse Event|0|||
46758339|NCT00508261|82976547|FG001|Overall Study|Serious Adverse Event|1|||
46818196|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
46930958|NCT02593318|83166072|FG001|Overall Study|Withdrawal by Subject|1|||
46758340|NCT00508261|82976548|FG002|Overall Study|Serious Adverse Event|0|||
46758341|NCT00508261|82976549|FG003|Overall Study|Serious Adverse Event|0|||
46758342|NCT00508261|82976546|FG000|Overall Study|Withdrawal by Subject|3|||
46758343|NCT00508261|82976547|FG001|Overall Study|Withdrawal by Subject|4|||
46930959|NCT02343302|83166086|FG000|Overall Study|Physician Decision|1|||
46930960|NCT02343302|83166087|FG001|Overall Study|Physician Decision|1|||
46930961|NCT02590432|83166095|FG000|Open-label Treatment Period|Adverse Event|97|||
46930962|NCT02590432|83166096|FG001|Open-label Treatment Period|Adverse Event|79|||
46930963|NCT02590432|83166097|FG002|Open-label Treatment Period|Adverse Event|0|||
46930964|NCT02590432|83166098|FG003|Open-label Treatment Period|Adverse Event|0|||
46930965|NCT02590432|83166099|FG004|Open-label Treatment Period|Adverse Event|0|||
46930966|NCT02590432|83166100|FG005|Open-label Treatment Period|Adverse Event|0|||
46930967|NCT02590432|83166101|FG006|Open-label Treatment Period|Adverse Event|0|||
46930968|NCT02590432|83166102|FG007|Open-label Treatment Period|Adverse Event|0|||
46930969|NCT02590432|83166103|FG008|Open-label Treatment Period|Adverse Event|0|||
46930970|NCT02590432|83166095|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
46930971|NCT02590432|83166096|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
46930972|NCT02590432|83166097|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
46930973|NCT02590432|83166098|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
46930974|NCT02590432|83166099|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
46930975|NCT02590432|83166100|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
46930976|NCT02590432|83166101|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
46930977|NCT02590432|83166102|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
46930978|NCT02590432|83166103|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
46930979|NCT02590432|83166095|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
46930980|NCT02590432|83166096|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
46930981|NCT02590432|83166097|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
46930982|NCT02590432|83166098|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
46930983|NCT02590432|83166099|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
46930984|NCT02590432|83166100|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
46930985|NCT02590432|83166101|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
46930986|NCT02590432|83166102|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
46930987|NCT02590432|83166103|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
46930988|NCT02590432|83166095|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
46930989|NCT02590432|83166096|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
46930990|NCT02590432|83166097|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
46930991|NCT02590432|83166098|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
46930992|NCT02590432|83166099|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
46930993|NCT02590432|83166100|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
46930994|NCT02590432|83166101|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
46930995|NCT02590432|83166102|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
46930996|NCT02590432|83166103|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
46930997|NCT02590432|83166095|FG000|Open-label Treatment Period|Protocol Violation|10|||
46930998|NCT02590432|83166096|FG001|Open-label Treatment Period|Protocol Violation|4|||
46930999|NCT02590432|83166097|FG002|Open-label Treatment Period|Protocol Violation|0|||
46931000|NCT02590432|83166098|FG003|Open-label Treatment Period|Protocol Violation|0|||
46931001|NCT02590432|83166099|FG004|Open-label Treatment Period|Protocol Violation|0|||
46931002|NCT02590432|83166100|FG005|Open-label Treatment Period|Protocol Violation|0|||
46931003|NCT02590432|83166101|FG006|Open-label Treatment Period|Protocol Violation|0|||
46931004|NCT02590432|83166102|FG007|Open-label Treatment Period|Protocol Violation|0|||
46931005|NCT02590432|83166103|FG008|Open-label Treatment Period|Protocol Violation|0|||
46931006|NCT02590432|83166095|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
46931007|NCT02590432|83166096|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
46931008|NCT02590432|83166097|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
46931009|NCT02590432|83166098|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
46931010|NCT02590432|83166099|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
46758344|NCT00508261|82976548|FG002|Overall Study|Withdrawal by Subject|4|||
46931011|NCT02590432|83166100|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
46931012|NCT02590432|83166101|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
46758345|NCT00508261|82976549|FG003|Overall Study|Withdrawal by Subject|0|||
46758346|NCT00508261|82976546|FG000|Overall Study|Migrated/ moved from study area|0|||
46758347|NCT00508261|82976547|FG001|Overall Study|Migrated/ moved from study area|1|||
46758348|NCT00508261|82976548|FG002|Overall Study|Migrated/ moved from study area|0|||
46758349|NCT00508261|82976549|FG003|Overall Study|Migrated/ moved from study area|0|||
46758350|NCT00508261|82976546|FG000|Overall Study|Lost to Follow-up|0|||
46758351|NCT00508261|82976547|FG001|Overall Study|Lost to Follow-up|1|||
46758352|NCT00508261|82976548|FG002|Overall Study|Lost to Follow-up|1|||
46758353|NCT00508261|82976549|FG003|Overall Study|Lost to Follow-up|1|||
46758354|NCT00819039|82976588|FG000|Overall Study|Physician Decision|1|||
46758355|NCT00819039|82976589|FG001|Overall Study|Physician Decision|0|||
46758356|NCT00819039|82976590|FG002|Overall Study|Physician Decision|1|||
46758357|NCT00819039|82976588|FG000|Overall Study|Protocol Violation|1|||
46758358|NCT00819039|82976589|FG001|Overall Study|Protocol Violation|0|||
46758359|NCT00819039|82976590|FG002|Overall Study|Protocol Violation|0|||
46818197|NCT00313300|83038112|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
46818198|NCT00313300|83038113|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
46818199|NCT00313300|83038114|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
46818200|NCT00313300|83038115|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
46818201|NCT00313300|83038116|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
46818202|NCT00313300|83038112|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
46818203|NCT00313300|83038113|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
46818204|NCT00313300|83038114|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
46818205|NCT00313300|83038115|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
46818206|NCT00313300|83038116|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
46818207|NCT00313300|83038112|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
46818208|NCT00313300|83038113|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
46818209|NCT00313300|83038114|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
46818210|NCT00313300|83038115|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
46818211|NCT00313300|83038116|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
46818212|NCT00313300|83038112|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
46818213|NCT00313300|83038113|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
46818214|NCT00313300|83038114|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
46818215|NCT00313300|83038115|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
46818216|NCT00313300|83038116|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
46818217|NCT00313300|83038112|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
46931013|NCT02590432|83166102|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
46931014|NCT02590432|83166103|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
46931015|NCT02590432|83166095|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
46931016|NCT02590432|83166096|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
46931017|NCT02590432|83166097|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
47055993|NCT02714868|83331256|FG000|Overall Study|Withdrawal by Subject|3|||
47055994|NCT02714868|83331257|FG001|Overall Study|Withdrawal by Subject|0|||
47055995|NCT02714868|83331256|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
47055996|NCT02714868|83331257|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
47055997|NCT02714868|83331256|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
46758360|NCT00500539|82976600|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
46758361|NCT00500539|82976600|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
46758362|NCT00500539|82976600|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
46758363|NCT00500539|82976600|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
46758364|NCT00500539|82976600|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
46758365|NCT00500539|82976600|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
46758366|NCT00500539|82976600|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
46758367|NCT00500539|82976600|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
46758368|NCT00500539|82976600|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
46758369|NCT00500539|82976600|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
46758370|NCT00500539|82976600|FG000|Follow-up Period (16 Weeks)|Death|1|||
46758371|NCT00500539|82976600|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
46758372|NCT00500539|82976600|FG000|Follow-up Period (16 Weeks)|Missing|3|||
46758373|NCT00818883|82976609|FG000|Overall Study|Adverse Event|28|||
46758374|NCT00818883|82976610|FG001|Overall Study|Adverse Event|19|||
46758375|NCT00818883|82976609|FG000|Overall Study|Protocol Violation|2|||
46758376|NCT00818883|82976610|FG001|Overall Study|Protocol Violation|2|||
46758377|NCT00818883|82976609|FG000|Overall Study|Lost to Follow-up|3|||
46758378|NCT00818883|82976610|FG001|Overall Study|Lost to Follow-up|2|||
46758379|NCT00818883|82976609|FG000|Overall Study|Withdrawal by Subject|16|||
46758380|NCT00818883|82976610|FG001|Overall Study|Withdrawal by Subject|14|||
46758381|NCT00818883|82976609|FG000|Overall Study|Lack of Efficacy|0|||
46758382|NCT00818883|82976610|FG001|Overall Study|Lack of Efficacy|2|||
46931018|NCT02590432|83166098|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
46931019|NCT02590432|83166099|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
46931020|NCT02590432|83166100|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
46931021|NCT02590432|83166101|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
46931022|NCT02590432|83166102|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
46931023|NCT02590432|83166103|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
46931024|NCT02590432|83166095|FG000|Double-blind Treatment Period|Adverse Event|0|||
46931025|NCT02590432|83166096|FG001|Double-blind Treatment Period|Adverse Event|0|||
46931026|NCT02590432|83166097|FG002|Double-blind Treatment Period|Adverse Event|14|||
46931027|NCT02590432|83166098|FG003|Double-blind Treatment Period|Adverse Event|12|||
46931028|NCT02590432|83166099|FG004|Double-blind Treatment Period|Adverse Event|6|||
46931029|NCT02590432|83166100|FG005|Double-blind Treatment Period|Adverse Event|22|||
46758383|NCT00818883|82976609|FG000|Overall Study|Other|2|||
46758384|NCT00818883|82976610|FG001|Overall Study|Other|7|||
46758385|NCT00508027|82976616|FG000|Dose Level 1|Lost to Follow-up|4|||
46818218|NCT00313300|83038113|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
46818219|NCT00313300|83038114|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
46818220|NCT00313300|83038115|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
46818221|NCT00313300|83038116|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
46818222|NCT00313300|83038112|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
46818223|NCT00313300|83038113|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
46818224|NCT00313300|83038114|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
46818225|NCT00313300|83038115|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
46818226|NCT00313300|83038116|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
46818227|NCT00313300|83038112|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
46818228|NCT00313300|83038113|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
46818229|NCT00313300|83038114|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
46818230|NCT00313300|83038115|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
46818231|NCT00313300|83038116|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
46818232|NCT00459186|83038134|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
46818233|NCT00459186|83038134|FG000|PET Imaging and Assessment|Adverse Event|3|||
46818234|NCT00328510|83038140|FG000|Overall Study|Gag disorder, could not use frame|4|||
46818235|NCT00328510|83038141|FG001|Overall Study|Gag disorder, could not use frame|0|||
46818236|NCT00328510|83038140|FG000|Overall Study|Dentition problems, could not use frame|1|||
46818237|NCT00328510|83038141|FG001|Overall Study|Dentition problems, could not use frame|0|||
46818238|NCT00328510|83038140|FG000|Overall Study|Withdrawal by Subject|4|||
46818239|NCT00328510|83038141|FG001|Overall Study|Withdrawal by Subject|2|||
46818240|NCT00328510|83038140|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
46818241|NCT00328510|83038141|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
46818242|NCT00328510|83038140|FG000|Overall Study|Treatment changed to a single fraction|1|||
46818243|NCT00328510|83038141|FG001|Overall Study|Treatment changed to a single fraction|1|||
46818244|NCT00313144|83038147|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
46818245|NCT00313144|83038147|FG000|Overall Study|Death|7|||
46818246|NCT00313144|83038147|FG000|Overall Study|Lost to Follow-up|5|||
46818247|NCT00313144|83038147|FG000|Overall Study|Withdrawal by Subject|4|||
46818248|NCT00313144|83038147|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
46818249|NCT00313144|83038147|FG000|Overall Study|Physician Decision|4|||
46818250|NCT00313144|83038147|FG000|Overall Study|Adverse event - transient|5|||
46818251|NCT00313144|83038147|FG000|Overall Study|Liver transplant|1|||
46818252|NCT00313144|83038147|FG000|Overall Study|Insurance (homecare provider) change|1|||
46818253|NCT00313144|83038147|FG000|Overall Study|Change to different product|1|||
46818254|NCT00313144|83038147|FG000|Overall Study|Due to termination of the study|66|||
46818255|NCT00459108|83038160|FG000|Overall Study|Withdrawal by Subject|5|||
46818256|NCT00459108|83038160|FG000|Overall Study|Adverse Event|3|||
46818257|NCT00459108|83038160|FG000|Overall Study|Death|2|||
46818258|NCT00459108|83038160|FG000|Overall Study|Progression|1|||
46818259|NCT00458484|83038172|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
46818260|NCT00458484|83038173|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
46818261|NCT00458484|83038174|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
46818262|NCT00458484|83038175|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
46818263|NCT00458484|83038176|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
46818264|NCT00458484|83038177|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
46818265|NCT00458484|83038178|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
46818266|NCT00328198|83038203|FG000|Treatment|Adverse Event|21|||
46818267|NCT00328198|83038203|FG000|Treatment|Death|1|||
46818268|NCT00328198|83038203|FG000|Treatment|Physician Decision|5|||
46818269|NCT00328198|83038203|FG000|Treatment|Withdrawal by Subject|5|||
46818270|NCT00328198|83038203|FG000|Treatment|Evidence of disease progression|2|||
46818271|NCT00328198|83038203|FG000|Treatment|Non-compliance|1|||
46818272|NCT00328198|83038203|FG000|Treatment|Confirmed complete response, MRD -|3|||
46818273|NCT00328198|83038203|FG000|Follow-up|Lost to Follow-up|4|||
46818274|NCT00328198|83038203|FG000|Follow-up|Death|31|||
46818275|NCT00450450|83038209|FG000|Overall Study|Death|1|||
46818276|NCT00450450|83038210|FG001|Overall Study|Death|3|||
46818277|NCT00450450|83038209|FG000|Overall Study|Relapse|2|||
46818278|NCT00450450|83038210|FG001|Overall Study|Relapse|0|||
46818279|NCT00450450|83038209|FG000|Overall Study|Missing Data|2|||
46818280|NCT00450450|83038210|FG001|Overall Study|Missing Data|0|||
46818281|NCT00442572|83038218|FG000|Overall Study|Relapse|8|||
46818282|NCT00442572|83038219|FG001|Overall Study|Relapse|1|||
46818283|NCT00442572|83038218|FG000|Overall Study|Lost to Follow-up|0|||
46818284|NCT00442572|83038219|FG001|Overall Study|Lost to Follow-up|1|||
46818285|NCT00442572|83038218|FG000|Overall Study|Withdrawal by Subject|0|||
46818286|NCT00442572|83038219|FG001|Overall Study|Withdrawal by Subject|1|||
46818287|NCT00442416|83038228|FG000|Overall Study|Adverse Event|4|||
46818288|NCT00442416|83038229|FG001|Overall Study|Adverse Event|1|||
46818289|NCT00442416|83038228|FG000|Overall Study|Death|1|||
46818290|NCT00442416|83038229|FG001|Overall Study|Death|0|||
46818291|NCT00442416|83038228|FG000|Overall Study|Lack of Efficacy|2|||
46818292|NCT00442416|83038229|FG001|Overall Study|Lack of Efficacy|0|||
46818293|NCT00442416|83038228|FG000|Overall Study|Protocol Violation|2|||
46818294|NCT00442416|83038229|FG001|Overall Study|Protocol Violation|3|||
46818295|NCT00442416|83038228|FG000|Overall Study|Withdrew consent|1|||
46818296|NCT00442416|83038229|FG001|Overall Study|Withdrew consent|2|||
46818297|NCT00442416|83038228|FG000|Overall Study|Administrative/Other|27|||
46818298|NCT00442416|83038229|FG001|Overall Study|Administrative/Other|33|||
46818299|NCT00441792|83038237|FG000|Overall Study|Lost to Follow-up|0|||
46818300|NCT00441792|83038238|FG001|Overall Study|Lost to Follow-up|2|||
46818301|NCT00312208|83038246|FG000|Overall Study|Adverse Event|97|||
46818302|NCT00312208|83038247|FG001|Overall Study|Adverse Event|61|||
46931030|NCT02590432|83166101|FG006|Double-blind Treatment Period|Adverse Event|20|||
46931031|NCT02590432|83166102|FG007|Double-blind Treatment Period|Adverse Event|0|||
46931032|NCT02590432|83166103|FG008|Double-blind Treatment Period|Adverse Event|0|||
46931033|NCT02590432|83166095|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
46931034|NCT02590432|83166096|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
46931035|NCT02590432|83166097|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
46931036|NCT02590432|83166098|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
46931037|NCT02590432|83166099|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
46931038|NCT02590432|83166100|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
46931039|NCT02590432|83166101|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
46931040|NCT02590432|83166102|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
46931041|NCT02590432|83166103|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
46931042|NCT02590432|83166095|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
46931043|NCT02590432|83166096|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
46931044|NCT02590432|83166097|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
46931045|NCT02590432|83166098|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
46931046|NCT02590432|83166099|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
46931047|NCT02590432|83166100|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
46931048|NCT02590432|83166101|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
46931049|NCT02590432|83166102|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
46931050|NCT02590432|83166103|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
46931051|NCT02590432|83166095|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
47055998|NCT02714868|83331257|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
47055999|NCT02713542|83331602|FG000|Overall Study|Use of prohibited medication|14|||
47056000|NCT02713542|83331603|FG001|Overall Study|Use of prohibited medication|5|||
47056001|NCT02713542|83331602|FG000|Overall Study|Withdrawal by Subject|4|||
47056002|NCT02713542|83331603|FG001|Overall Study|Withdrawal by Subject|1|||
47056003|NCT03548220|83331687|FG000|Overall Study|Lost to Follow-up|1|||
47056004|NCT03548220|83331688|FG001|Overall Study|Lost to Follow-up|0|||
47056005|NCT03548220|83331689|FG002|Overall Study|Lost to Follow-up|0|||
47056006|NCT03548220|83331690|FG003|Overall Study|Lost to Follow-up|0|||
47056007|NCT02712996|83331725|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
47056008|NCT02712996|83331726|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
47056009|NCT00701064|83331842|FG000|Overall Study|Protocol Violation|1|||
47056010|NCT00701064|83331843|FG001|Overall Study|Protocol Violation|1|||
47056011|NCT00701064|83331842|FG000|Overall Study|Withdrawal by Subject|1|||
47056012|NCT00701064|83331843|FG001|Overall Study|Withdrawal by Subject|1|||
47056013|NCT00701064|83331842|FG000|Overall Study|initiated other PTSD treatment|2|||
47056014|NCT00701064|83331843|FG001|Overall Study|initiated other PTSD treatment|2|||
46818303|NCT00312208|83038246|FG000|Overall Study|Protocol Violation|5|||
46818304|NCT00312208|83038247|FG001|Overall Study|Protocol Violation|3|||
46818305|NCT00312208|83038246|FG000|Overall Study|Death|2|||
46818306|NCT00312208|83038247|FG001|Overall Study|Death|1|||
46818307|NCT00312208|83038246|FG000|Overall Study|Lack of Efficacy|7|||
46818308|NCT00312208|83038247|FG001|Overall Study|Lack of Efficacy|4|||
46818309|NCT00312208|83038246|FG000|Overall Study|Lost to Follow-up|3|||
46818310|NCT00312208|83038247|FG001|Overall Study|Lost to Follow-up|5|||
46818311|NCT00312208|83038246|FG000|Overall Study|Withdrawal by Subject|53|||
46818312|NCT00312208|83038247|FG001|Overall Study|Withdrawal by Subject|42|||
46818313|NCT00312208|83038246|FG000|Overall Study|Other|5|||
46818314|NCT00312208|83038247|FG001|Overall Study|Other|7|||
46818315|NCT00297778|83038255|FG000|Overall Study|Adverse Event|16|||
46818316|NCT00297778|83038256|FG001|Overall Study|Adverse Event|10|||
46931052|NCT02590432|83166096|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
46931053|NCT02590432|83166097|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
46931054|NCT02590432|83166098|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
46931055|NCT02590432|83166099|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
46931056|NCT02590432|83166100|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
46931057|NCT02590432|83166101|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
47056015|NCT05779072|83331851|FG000|Overall Study|Lost to Follow-up|0|||
47056016|NCT05779072|83331852|FG001|Overall Study|Lost to Follow-up|1|||
46818317|NCT00297778|83038255|FG000|Overall Study|Withdrawal by Subject|1|||
46818318|NCT00297778|83038256|FG001|Overall Study|Withdrawal by Subject|5|||
47056017|NCT05779072|83331851|FG000|Overall Study|Withdrawal by Subject|1|||
47056018|NCT05779072|83331852|FG001|Overall Study|Withdrawal by Subject|5|||
46818319|NCT00297778|83038255|FG000|Overall Study|Lack of Efficacy|2|||
46818320|NCT00297778|83038256|FG001|Overall Study|Lack of Efficacy|1|||
46818321|NCT00297778|83038255|FG000|Overall Study|Non-compliant with trial protocol|0|||
46818322|NCT00297778|83038256|FG001|Overall Study|Non-compliant with trial protocol|3|||
47056019|NCT05089682|83331867|FG000|Overall Study|Withdrawal by Subject|2|||
46818323|NCT00297778|83038255|FG000|Overall Study|Other|0|||
46818324|NCT00297778|83038256|FG001|Overall Study|Other|1|||
46931058|NCT02590432|83166102|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
46931059|NCT02590432|83166103|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
46931060|NCT02590432|83166095|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931061|NCT02590432|83166096|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931062|NCT02590432|83166097|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931063|NCT02590432|83166098|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931064|NCT02590432|83166099|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931065|NCT02590432|83166100|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
46931066|NCT02590432|83166101|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931067|NCT02590432|83166102|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931068|NCT02590432|83166103|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
46931069|NCT02590432|83166095|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
46931070|NCT02590432|83166096|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
47056020|NCT05055128|83331876|FG000|Overall Study|Adverse Event|0|||
47056021|NCT05055128|83331877|FG001|Overall Study|Adverse Event|0|||
47056022|NCT05055128|83331878|FG002|Overall Study|Adverse Event|0|||
47056023|NCT05055128|83331879|FG003|Overall Study|Adverse Event|1|||
47056024|NCT05055128|83331880|FG004|Overall Study|Adverse Event|1|||
47056025|NCT05055128|83331876|FG000|Overall Study|Protocol Violation|0|||
47056026|NCT05055128|83331877|FG001|Overall Study|Protocol Violation|0|||
47056027|NCT05055128|83331878|FG002|Overall Study|Protocol Violation|0|||
47056028|NCT05055128|83331879|FG003|Overall Study|Protocol Violation|1|||
47056029|NCT05055128|83331880|FG004|Overall Study|Protocol Violation|0|||
47056030|NCT05055128|83331876|FG000|Overall Study|Withdrawal by Subject|5|||
47056031|NCT05055128|83331877|FG001|Overall Study|Withdrawal by Subject|2|||
47056032|NCT05055128|83331878|FG002|Overall Study|Withdrawal by Subject|2|||
47056033|NCT05055128|83331879|FG003|Overall Study|Withdrawal by Subject|4|||
47056034|NCT05055128|83331880|FG004|Overall Study|Withdrawal by Subject|2|||
47056035|NCT05055128|83331876|FG000|Overall Study|Randomized By Mistake|0|||
47056036|NCT05055128|83331877|FG001|Overall Study|Randomized By Mistake|1|||
47056037|NCT05055128|83331878|FG002|Overall Study|Randomized By Mistake|0|||
47056038|NCT05055128|83331879|FG003|Overall Study|Randomized By Mistake|0|||
47056039|NCT05055128|83331880|FG004|Overall Study|Randomized By Mistake|0|||
47056040|NCT05055128|83331876|FG000|Overall Study|Other|1|||
47056041|NCT05055128|83331877|FG001|Overall Study|Other|0|||
47056042|NCT05055128|83331878|FG002|Overall Study|Other|0|||
47056043|NCT05055128|83331879|FG003|Overall Study|Other|0|||
47056044|NCT05055128|83331880|FG004|Overall Study|Other|0|||
47056045|NCT05038020|83331896|FG000|Overall Study|Early Termination|3|||
47056046|NCT05038020|83331897|FG001|Overall Study|Early Termination|0|||
47056047|NCT04796610|83331912|FG000|Overall Study|Withdrawal by Subject|1|||
47056048|NCT04796610|83331913|FG001|Overall Study|Withdrawal by Subject|0|||
47056049|NCT04796610|83331914|FG002|Overall Study|Withdrawal by Subject|0|||
47056050|NCT04796610|83331915|FG003|Overall Study|Withdrawal by Subject|0|||
47056051|NCT04796610|83331912|FG000|Overall Study|Lost to Follow-up|2|||
47056052|NCT04796610|83331913|FG001|Overall Study|Lost to Follow-up|0|||
47056053|NCT04796610|83331914|FG002|Overall Study|Lost to Follow-up|1|||
47056054|NCT04796610|83331915|FG003|Overall Study|Lost to Follow-up|1|||
47056055|NCT04702997|83331925|FG000|Overall Study|Withdrawal by Subject|1|||
47056056|NCT04702997|83331926|FG001|Overall Study|Withdrawal by Subject|1|||
47056057|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
47056058|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
47056059|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
47056060|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
47056061|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
47056062|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
47056063|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
47056064|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
47056065|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
47056066|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
47056067|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
47056068|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
47056069|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
46818325|NCT03848832|83038265|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
46818326|NCT03848832|83038266|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
46818327|NCT03848832|83038267|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
46818328|NCT03848832|83038265|FG000|Overall Study|Withdrawal by Subject|0|||
46818329|NCT03848832|83038266|FG001|Overall Study|Withdrawal by Subject|0|||
46818330|NCT03848832|83038267|FG002|Overall Study|Withdrawal by Subject|1|||
46818331|NCT03848832|83038265|FG000|Overall Study|Withdrawal (Covid-19)|0|||
46818332|NCT03848832|83038266|FG001|Overall Study|Withdrawal (Covid-19)|2|||
46818333|NCT03848832|83038267|FG002|Overall Study|Withdrawal (Covid-19)|0|||
46818334|NCT03848832|83038265|FG000|Overall Study|Physician Decision|2|||
46818335|NCT03848832|83038266|FG001|Overall Study|Physician Decision|1|||
46818336|NCT03848832|83038267|FG002|Overall Study|Physician Decision|3|||
46818337|NCT03848832|83038265|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
46818338|NCT03848832|83038266|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
46818339|NCT03848832|83038267|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
46818340|NCT03848832|83038265|FG000|Overall Study|Adverse Event|1|||
46818341|NCT03848832|83038266|FG001|Overall Study|Adverse Event|0|||
46818342|NCT03848832|83038267|FG002|Overall Study|Adverse Event|0|||
46818343|NCT00450372|83038277|FG000|Overall Study|Physician Decision|1|||
46818344|NCT00327340|83038286|FG000|Overall Study|Withdrawal by Subject|1|||
46818345|NCT00327340|83038287|FG001|Overall Study|Withdrawal by Subject|5|||
46818346|NCT00327340|83038286|FG000|Overall Study|Physician Decision|1|||
46818347|NCT00327340|83038287|FG001|Overall Study|Physician Decision|1|||
46818348|NCT00327340|83038286|FG000|Overall Study|Disease Progression|10|||
46818349|NCT00327340|83038287|FG001|Overall Study|Disease Progression|19|||
46818350|NCT00327340|83038286|FG000|Overall Study|Symptomatic Disease|0|||
46818351|NCT00327340|83038287|FG001|Overall Study|Symptomatic Disease|2|||
46818352|NCT00327340|83038286|FG000|Overall Study|Adverse Event|3|||
46818353|NCT00327340|83038287|FG001|Overall Study|Adverse Event|3|||
46818354|NCT00548093|83038297|FG000|Overall Study|Death|33|||
46818355|NCT00548093|83038298|FG001|Overall Study|Death|13|||
46818356|NCT00548093|83038297|FG000|Overall Study|Lost to Follow-up|3|||
47056070|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
47056071|NCT04173494|83331947|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
47056072|NCT04173494|83331948|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
47056073|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
47056074|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
47056075|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
47056076|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
47056077|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
47056078|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
47056079|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
47056080|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
47056081|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
47056082|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
47056083|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
47056084|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
47056085|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
46758386|NCT00508027|82976616|FG000|Dose Level 1|Withdrawal by Subject|2|||
46758387|NCT00508027|82976616|FG000|Dose Level 1|Physician Decision|2|||
46758388|NCT00508027|82976616|FG000|Dose Level 2|Lost to Follow-up|2|||
46758389|NCT00508027|82976616|FG000|Dose Level 2|Withdrawal by Subject|2|||
46758390|NCT00500149|82976645|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
46758391|NCT00500149|82976646|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
46758392|NCT00500149|82976645|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
46758393|NCT00500149|82976646|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
46758394|NCT00500149|82976645|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
46758395|NCT00500149|82976646|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
46758396|NCT00500149|82976645|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
46758397|NCT00500149|82976646|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
46758398|NCT00500149|82976645|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
46818357|NCT00548093|83038298|FG001|Overall Study|Lost to Follow-up|1|||
46818358|NCT00548093|83038297|FG000|Overall Study|Objective progression or relapse|1|||
46818359|NCT00548093|83038298|FG001|Overall Study|Objective progression or relapse|1|||
46818360|NCT00548093|83038297|FG000|Overall Study|Other|11|||
46818361|NCT00548093|83038298|FG001|Overall Study|Other|1|||
46818362|NCT00548093|83038297|FG000|Overall Study|Withdrawal by Subject|1|||
46818363|NCT00548093|83038298|FG001|Overall Study|Withdrawal by Subject|0|||
46818364|NCT00548093|83038297|FG000|Overall Study|Completed post-treatment follow-up|1|||
46818365|NCT00548093|83038298|FG001|Overall Study|Completed post-treatment follow-up|0|||
46818366|NCT00450216|83038309|FG000|Overall Study|Adverse Event|38|||
46818367|NCT00450216|83038310|FG001|Overall Study|Adverse Event|23|||
46818368|NCT00450216|83038309|FG000|Overall Study|Withdrawal by Subject|48|||
46818369|NCT00450216|83038310|FG001|Overall Study|Withdrawal by Subject|26|||
46818370|NCT00450216|83038309|FG000|Overall Study|Lost to Follow-up|16|||
46818371|NCT00450216|83038310|FG001|Overall Study|Lost to Follow-up|9|||
46818372|NCT00450216|83038309|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
46818373|NCT00450216|83038310|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
46818374|NCT00450216|83038309|FG000|Overall Study|misc|21|||
46818375|NCT00450216|83038310|FG001|Overall Study|misc|20|||
46818376|NCT00441480|83038318|FG000|Overall Study|Protocol Violation|1|||
46818377|NCT00441480|83038319|FG001|Overall Study|Protocol Violation|1|||
46818378|NCT00441480|83038318|FG000|Overall Study|Withdrawal by Subject|2|||
46818379|NCT00441480|83038319|FG001|Overall Study|Withdrawal by Subject|3|||
46818380|NCT00547703|83038327|FG000|Overall Study|Lost to Follow-up|1|||
46818381|NCT00547703|83038328|FG001|Overall Study|Lost to Follow-up|0|||
46818382|NCT00297232|83038334|FG000|Overall Study|Lack of Efficacy|7|||
46818383|NCT00297232|83038334|FG000|Overall Study|Lost to Follow-up|10|||
46931071|NCT02590432|83166097|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
46931072|NCT02590432|83166098|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
46931073|NCT02590432|83166099|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
46931074|NCT02590432|83166100|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
46931075|NCT02590432|83166101|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
46931076|NCT02590432|83166102|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
46931077|NCT02590432|83166103|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
46931078|NCT02590432|83166095|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
47056086|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
47056087|NCT04173494|83331947|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
47056088|NCT04173494|83331948|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
47056089|NCT03920215|83331973|FG000|Overall Study|Lost to Follow-up|1|||
47056090|NCT03920215|83331974|FG001|Overall Study|Lost to Follow-up|2|||
47056091|NCT03920215|83331975|FG002|Overall Study|Lost to Follow-up|0|||
47056092|NCT03920215|83331976|FG003|Overall Study|Lost to Follow-up|0|||
47056093|NCT03920215|83331973|FG000|Overall Study|Death|0|||
47056094|NCT03920215|83331974|FG001|Overall Study|Death|0|||
47056095|NCT03920215|83331975|FG002|Overall Study|Death|0|||
47056096|NCT03920215|83331976|FG003|Overall Study|Death|1|||
47056097|NCT03878134|83331986|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
47056098|NCT03874429|83331992|FG000|Overall Study|Adverse Event|2|||
47056099|NCT03874429|83331993|FG001|Overall Study|Adverse Event|2|||
46931079|NCT02590432|83166096|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
46758399|NCT00500149|82976646|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
46758400|NCT00500149|82976645|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
46758401|NCT00500149|82976646|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
46758402|NCT00500149|82976645|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
46758403|NCT00500149|82976646|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
46758404|NCT00489853|82976652|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
46758405|NCT00489853|82976653|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
46758406|NCT00489853|82976654|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
46758407|NCT00489853|82976652|FG000|Wash-out Period 1|Adverse Event|0|||
46758408|NCT00489853|82976653|FG001|Wash-out Period 1|Adverse Event|1|||
46758409|NCT00489853|82976654|FG002|Wash-out Period 1|Adverse Event|1|||
46758410|NCT00489853|82976652|FG000|Wash-out Period 1|Protocol Violation|0|||
46758411|NCT00489853|82976653|FG001|Wash-out Period 1|Protocol Violation|1|||
46758412|NCT00489853|82976654|FG002|Wash-out Period 1|Protocol Violation|1|||
46818384|NCT00297232|83038334|FG000|Overall Study|Adverse Event|63|||
46818385|NCT00297232|83038334|FG000|Overall Study|Voluntary Withdrawal|120|||
46818386|NCT00297232|83038334|FG000|Overall Study|Subject was Noncompliant|9|||
46818387|NCT00297232|83038334|FG000|Overall Study|Death|9|||
46818388|NCT00297232|83038334|FG000|Overall Study|Anti-natalizumab Positive|8|||
46818389|NCT00297232|83038334|FG000|Overall Study|Switched to Commercial Tysabri|22|||
46818390|NCT00297232|83038334|FG000|Overall Study|Disease Progression|8|||
46818391|NCT00297232|83038334|FG000|Overall Study|Fear of PML|10|||
46818392|NCT00297232|83038334|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
46931080|NCT02590432|83166097|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
46931081|NCT02590432|83166098|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
46931082|NCT02590432|83166099|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
47056100|NCT03874429|83331992|FG000|Overall Study|Lack of Efficacy|0|||
46818393|NCT00297232|83038334|FG000|Overall Study|Miscellaneous|5|||
46818394|NCT00297232|83038334|FG000|Overall Study|Sponsor Decision|34|||
47056101|NCT03874429|83331993|FG001|Overall Study|Lack of Efficacy|1|||
47056102|NCT03874429|83331992|FG000|Overall Study|Covid-19 pandemic|4|||
46818395|NCT00297232|83038334|FG000|Overall Study|Subject Relocated|7|||
46818396|NCT00297232|83038334|FG000|Overall Study|Subject Withdrew Consent|37|||
46818397|NCT00297232|83038334|FG000|Overall Study|Persistently Positive Antibodies|11|||
46818398|NCT00297232|83038334|FG000|Overall Study|Investigator Withdrew From Program|19|||
46818399|NCT00297232|83038334|FG000|Overall Study|Did Not Enroll to Week 264|34|||
46818400|NCT00297232|83038334|FG000|Overall Study|Did Not Enroll to Week 480|17|||
46818401|NCT00297232|83038334|FG000|Overall Study|No data available after Week 264|161|||
46818402|NCT00297232|83038334|FG000|Overall Study|Other|1|||
46818403|NCT00449670|83038350|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
46818404|NCT00449670|83038351|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
46818405|NCT00449670|83038350|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
46818406|NCT00449670|83038351|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
46818407|NCT00449670|83038350|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
46818408|NCT00449670|83038351|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
46818409|NCT00449670|83038350|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
46818410|NCT00449670|83038351|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
46931083|NCT02590432|83166100|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
46931084|NCT02590432|83166101|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
46931085|NCT02590432|83166102|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
46931086|NCT02590432|83166103|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
46931087|NCT02590432|83166095|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
46931088|NCT02590432|83166096|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
46931089|NCT02590432|83166097|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
46931090|NCT02590432|83166098|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
46931091|NCT02590432|83166099|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
46931092|NCT02590432|83166100|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
46931093|NCT02590432|83166101|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
46931094|NCT02590432|83166102|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
46931095|NCT02590432|83166103|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
47056103|NCT03874429|83331993|FG001|Overall Study|Covid-19 pandemic|2|||
47056104|NCT03733730|83332023|FG000|Overall Study|Lost to Follow-up|1|||
47056105|NCT03733730|83332024|FG001|Overall Study|Lost to Follow-up|32|||
47056106|NCT03733730|83332023|FG000|Overall Study|Other|1|||
47056107|NCT03733730|83332024|FG001|Overall Study|Other|0|||
47056108|NCT03733730|83332023|FG000|Overall Study|Adverse Event|0|||
46758413|NCT00489853|82976652|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
46758414|NCT00489853|82976653|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
46758415|NCT00489853|82976654|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
46758416|NCT00489853|82976652|FG000|Wash-out Period 2|Adverse Event|1|||
46758417|NCT00489853|82976653|FG001|Wash-out Period 2|Adverse Event|1|||
46758418|NCT00489853|82976654|FG002|Wash-out Period 2|Adverse Event|0|||
46758419|NCT00489853|82976652|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
46818411|NCT00449670|83038350|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
46818412|NCT00449670|83038351|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
46818413|NCT00449670|83038350|FG000|Booster Phase (Study no.109873)|Other|0|||
47056109|NCT03733730|83332024|FG001|Overall Study|Adverse Event|4|||
47056110|NCT03733730|83332023|FG000|Overall Study|Death|0|||
47056111|NCT03733730|83332024|FG001|Overall Study|Death|5|||
46758420|NCT00489853|82976653|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
46758421|NCT00489853|82976654|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
46758422|NCT00489853|82976652|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
46758423|NCT00489853|82976653|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
46758424|NCT00489853|82976654|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
46758425|NCT03686423|82976662|FG000|Overall Study|Withdrawal by Subject|9|||
46758426|NCT03686423|82976662|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
46758427|NCT00499681|82976668|FG000|Overall Study|toxicity|0|||
46758428|NCT00499681|82976669|FG001|Overall Study|toxicity|1|||
46758429|NCT00499681|82976668|FG000|Overall Study|disease progression|0|||
46758430|NCT00499681|82976669|FG001|Overall Study|disease progression|1|||
46758431|NCT00875810|82976680|FG000|Overall Study|Withdrawal by Subject|1|||
47056112|NCT03733730|83332023|FG000|Overall Study|Withdrawal by Subject|0|||
47056113|NCT03733730|83332024|FG001|Overall Study|Withdrawal by Subject|8|||
47056114|NCT03713632|83332041|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
47056115|NCT03713632|83332042|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
46931096|NCT02590432|83166095|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
46931097|NCT02590432|83166096|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
47056116|NCT03713632|83332043|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
47056117|NCT03713632|83332044|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
46758432|NCT00875810|82976680|FG000|Overall Study|Physician Decision|3|||
46818414|NCT00449670|83038351|FG001|Booster Phase (Study no.109873)|Other|2|||
46818415|NCT00296374|83038367|FG000|Overall Study|Adverse Event|14|||
46818416|NCT00296374|83038368|FG001|Overall Study|Adverse Event|10|||
46818417|NCT00296374|83038369|FG002|Overall Study|Adverse Event|7|||
46758433|NCT00875810|82976680|FG000|Overall Study|Lost to Follow-up|39|||
46818418|NCT00296374|83038367|FG000|Overall Study|Withdrawal by Subject|3|||
46931098|NCT02590432|83166097|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
46931099|NCT02590432|83166098|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
46931100|NCT02590432|83166099|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
46931101|NCT02590432|83166100|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
46818419|NCT00296374|83038368|FG001|Overall Study|Withdrawal by Subject|5|||
46818420|NCT00296374|83038369|FG002|Overall Study|Withdrawal by Subject|11|||
46818421|NCT00296374|83038367|FG000|Overall Study|Incorrect enrollment|3|||
46818422|NCT00296374|83038368|FG001|Overall Study|Incorrect enrollment|3|||
46818423|NCT00296374|83038369|FG002|Overall Study|Incorrect enrollment|4|||
46818424|NCT00296374|83038367|FG000|Overall Study|Protocol Violation|1|||
46818425|NCT00296374|83038368|FG001|Overall Study|Protocol Violation|2|||
46931102|NCT02590432|83166101|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
46931103|NCT02590432|83166102|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
46818426|NCT00296374|83038369|FG002|Overall Study|Protocol Violation|3|||
46818427|NCT00296374|83038367|FG000|Overall Study|Lost to Follow-up|3|||
46818428|NCT00296374|83038368|FG001|Overall Study|Lost to Follow-up|1|||
46818429|NCT00296374|83038369|FG002|Overall Study|Lost to Follow-up|1|||
46818430|NCT00296374|83038367|FG000|Overall Study|Relocated to another state|1|||
46818431|NCT00296374|83038368|FG001|Overall Study|Relocated to another state|0|||
46818432|NCT00296374|83038369|FG002|Overall Study|Relocated to another state|0|||
46818433|NCT00296374|83038367|FG000|Overall Study|Stopped drug before end of study visit|0|||
46818434|NCT00296374|83038368|FG001|Overall Study|Stopped drug before end of study visit|1|||
46818435|NCT00296374|83038369|FG002|Overall Study|Stopped drug before end of study visit|0|||
46818436|NCT00296374|83038367|FG000|Overall Study|Nephrologist introduced ACE|0|||
46818437|NCT00296374|83038368|FG001|Overall Study|Nephrologist introduced ACE|1|||
46818438|NCT00296374|83038369|FG002|Overall Study|Nephrologist introduced ACE|0|||
46818439|NCT00296374|83038367|FG000|Overall Study|Pregnancy|0|||
46818440|NCT00296374|83038368|FG001|Overall Study|Pregnancy|0|||
46818441|NCT00296374|83038369|FG002|Overall Study|Pregnancy|2|||
46818442|NCT00296374|83038367|FG000|Overall Study|Other|0|||
46818443|NCT00296374|83038368|FG001|Overall Study|Other|0|||
46818444|NCT00296374|83038369|FG002|Overall Study|Other|1|||
46818445|NCT00326950|83038392|FG000|Overall Study|Progressive Disease|1|||
46818446|NCT00548717|83038398|FG000|Overall Study|Death|5|||
46818447|NCT00548717|83038399|FG001|Overall Study|Death|2|||
46818448|NCT00548717|83038398|FG000|Overall Study|Relapse|3|||
46758434|NCT00875810|82976680|FG000|Overall Study|Patient enroled but not implanted|2|||
46758435|NCT00875810|82976680|FG000|Overall Study|Device explanted|1|||
46758436|NCT00499603|82976686|FG000|Overall Study|Adverse Event|0|||
46758437|NCT00499603|82976687|FG001|Overall Study|Adverse Event|1|||
46758438|NCT00810069|82976706|FG000|Lead-in Period I|Adverse Event|43|||
46758439|NCT00810069|82976707|FG001|Lead-in Period I|Adverse Event|0|||
46758440|NCT00810069|82976708|FG002|Lead-in Period I|Adverse Event|0|||
46758441|NCT00810069|82976706|FG000|Lead-in Period I|Lack of Efficacy|1|||
46758442|NCT00810069|82976707|FG001|Lead-in Period I|Lack of Efficacy|0|||
46758443|NCT00810069|82976708|FG002|Lead-in Period I|Lack of Efficacy|0|||
46758444|NCT00810069|82976706|FG000|Lead-in Period I|Lost to Follow-up|19|||
46758445|NCT00810069|82976707|FG001|Lead-in Period I|Lost to Follow-up|0|||
46758446|NCT00810069|82976708|FG002|Lead-in Period I|Lost to Follow-up|0|||
46758447|NCT00810069|82976706|FG000|Lead-in Period I|Physician Decision|1|||
46758448|NCT00810069|82976707|FG001|Lead-in Period I|Physician Decision|0|||
46758449|NCT00810069|82976708|FG002|Lead-in Period I|Physician Decision|0|||
46758450|NCT00810069|82976706|FG000|Lead-in Period I|Protocol Violation|1|||
46758451|NCT00810069|82976707|FG001|Lead-in Period I|Protocol Violation|0|||
46758452|NCT00810069|82976708|FG002|Lead-in Period I|Protocol Violation|0|||
46758453|NCT00810069|82976706|FG000|Lead-in Period I|Withdrawal by Subject|46|||
46758454|NCT00810069|82976707|FG001|Lead-in Period I|Withdrawal by Subject|0|||
46758455|NCT00810069|82976708|FG002|Lead-in Period I|Withdrawal by Subject|0|||
46818449|NCT00548717|83038399|FG001|Overall Study|Relapse|0|||
46931104|NCT02590432|83166103|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
46818450|NCT00548717|83038398|FG000|Overall Study|Alternative treatment for GVHD|1|||
46818451|NCT00548717|83038399|FG001|Overall Study|Alternative treatment for GVHD|0|||
46931105|NCT02590432|83166095|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
46931106|NCT02590432|83166096|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
46818452|NCT00441168|83038410|FG000|Treatment Period|Death|3|||
46818453|NCT00441168|83038411|FG001|Treatment Period|Death|0|||
46758456|NCT00810069|82976706|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
46818454|NCT00441168|83038410|FG000|Treatment Period|Adverse Event|1|||
46818455|NCT00441168|83038411|FG001|Treatment Period|Adverse Event|2|||
46818456|NCT00441168|83038410|FG000|Treatment Period|Progressive Disease|0|||
46758457|NCT00810069|82976707|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
46758458|NCT00810069|82976708|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
46758459|NCT00810069|82976706|FG000|Lead-in Period I|Randomization criteria not met|158|||
46758460|NCT00810069|82976707|FG001|Lead-in Period I|Randomization criteria not met|0|||
46818457|NCT00441168|83038411|FG001|Treatment Period|Progressive Disease|2|||
46818458|NCT00441168|83038410|FG000|Treatment Period|Protocol Violation|0|||
46818459|NCT00441168|83038411|FG001|Treatment Period|Protocol Violation|1|||
46818460|NCT00441168|83038410|FG000|Treatment Period|Lost to Follow-up|0|||
46818461|NCT00441168|83038411|FG001|Treatment Period|Lost to Follow-up|1|||
46818462|NCT00441168|83038410|FG000|Treatment Period|Withdrawal by Subject|3|||
46818463|NCT00441168|83038411|FG001|Treatment Period|Withdrawal by Subject|0|||
46818464|NCT00441168|83038410|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
46818465|NCT00441168|83038411|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
46818466|NCT00441168|83038410|FG000|Treatment Period|refractory disease|1|||
47056118|NCT03713632|83332045|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
46758461|NCT00810069|82976708|FG002|Lead-in Period I|Randomization criteria not met|0|||
46758462|NCT00810069|82976706|FG000|Double-Blind Period II|Adverse Event|0|||
46758463|NCT00810069|82976707|FG001|Double-Blind Period II|Adverse Event|9|||
46758464|NCT00810069|82976708|FG002|Double-Blind Period II|Adverse Event|8|||
46758465|NCT00810069|82976706|FG000|Double-Blind Period II|Lack of Efficacy|0|||
46818467|NCT00441168|83038411|FG001|Treatment Period|refractory disease|0|||
46818468|NCT00441168|83038410|FG000|Follow-up Period|Death|3|||
46818469|NCT00441168|83038411|FG001|Follow-up Period|Death|0|||
46818470|NCT00441168|83038410|FG000|Follow-up Period|Lost to Follow-up|5|||
46818471|NCT00441168|83038411|FG001|Follow-up Period|Lost to Follow-up|6|||
46818472|NCT00441168|83038410|FG000|Follow-up Period|Withdrawal by Subject|3|||
46818473|NCT00441168|83038411|FG001|Follow-up Period|Withdrawal by Subject|0|||
46818474|NCT00441168|83038410|FG000|Follow-up Period|Other|1|||
46818475|NCT00441168|83038411|FG001|Follow-up Period|Other|3|||
46818476|NCT00296140|83038419|FG000|Overall Study|Lost to Follow-up|1|||
46818477|NCT00296140|83038420|FG001|Overall Study|Lost to Follow-up|0|||
46818478|NCT00296140|83038419|FG000|Overall Study|Withdrawal by Subject|1|||
46818479|NCT00296140|83038420|FG001|Overall Study|Withdrawal by Subject|0|||
46818480|NCT00296140|83038419|FG000|Overall Study|Discharge to Nursing Home|1|||
46818481|NCT00296140|83038420|FG001|Overall Study|Discharge to Nursing Home|0|||
46818482|NCT03958331|83038429|FG000|Overall Study|Withdrawal by Subject|3|||
46818483|NCT03958331|83038430|FG001|Overall Study|Withdrawal by Subject|1|||
46818484|NCT03958331|83038431|FG002|Overall Study|Withdrawal by Subject|5|||
46818485|NCT03958331|83038429|FG000|Overall Study|Weaned from medicine|2|||
46818486|NCT03958331|83038430|FG001|Overall Study|Weaned from medicine|0|||
46818487|NCT03958331|83038431|FG002|Overall Study|Weaned from medicine|0|||
46818488|NCT03958331|83038429|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
46818489|NCT03958331|83038430|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
46818490|NCT03958331|83038431|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
46818491|NCT03956615|83038437|FG000|Overall Study|No multiple myeloma confirmed|2|||
46818492|NCT03956615|83038437|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
46818493|NCT03956615|83038437|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
46818494|NCT03956615|83038437|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
46818495|NCT03956225|83038443|FG000|Overall Study|Lack of Efficacy|1|||
46818496|NCT03956225|83038444|FG001|Overall Study|Lack of Efficacy|1|||
46818497|NCT03956225|83038443|FG000|Overall Study|Lost to Follow-up|0|||
46818498|NCT03956225|83038444|FG001|Overall Study|Lost to Follow-up|1|||
46818499|NCT03956225|83038443|FG000|Overall Study|Withdrawal by Subject|2|||
46818500|NCT03956225|83038444|FG001|Overall Study|Withdrawal by Subject|1|||
46818501|NCT03956225|83038443|FG000|Overall Study|Other Reasons|2|||
46818502|NCT03956225|83038444|FG001|Overall Study|Other Reasons|1|||
46818503|NCT00457626|83038453|FG000|Overall Study|Adverse Event|3|||
46818504|NCT00457626|83038453|FG000|Overall Study|Administrative Problems|2|||
46818505|NCT00457626|83038453|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
46931107|NCT02590432|83166097|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
47056119|NCT03713632|83332041|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
47056120|NCT03713632|83332042|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
46758466|NCT00810069|82976707|FG001|Double-Blind Period II|Lack of Efficacy|7|||
46758467|NCT00810069|82976708|FG002|Double-Blind Period II|Lack of Efficacy|12|||
46758468|NCT00810069|82976706|FG000|Double-Blind Period II|Lost to Follow-up|0|||
46758469|NCT00810069|82976707|FG001|Double-Blind Period II|Lost to Follow-up|9|||
46758470|NCT00810069|82976708|FG002|Double-Blind Period II|Lost to Follow-up|9|||
46758471|NCT00810069|82976706|FG000|Double-Blind Period II|Physician Decision|0|||
46818506|NCT00373113|83038459|FG000|Overall Study|Death|1|||
46818507|NCT00373113|83038460|FG001|Overall Study|Death|7|||
46818508|NCT00373113|83038459|FG000|Overall Study|Adverse Event|38|||
46818509|NCT00373113|83038460|FG001|Overall Study|Adverse Event|24|||
46818510|NCT00373113|83038459|FG000|Overall Study|Study terminated by sponsor|9|||
46818511|NCT00373113|83038460|FG001|Overall Study|Study terminated by sponsor|1|||
46818512|NCT00373113|83038459|FG000|Overall Study|Global deterioration of health status|10|||
46758472|NCT00810069|82976707|FG001|Double-Blind Period II|Physician Decision|0|||
46758473|NCT00810069|82976708|FG002|Double-Blind Period II|Physician Decision|1|||
46818513|NCT00373113|83038460|FG001|Overall Study|Global deterioration of health status|7|||
46818514|NCT00373113|83038459|FG000|Overall Study|Lost to Follow-up|1|||
46818515|NCT00373113|83038460|FG001|Overall Study|Lost to Follow-up|3|||
46818516|NCT00373113|83038459|FG000|Overall Study|Objective progression or relapse|150|||
46818517|NCT00373113|83038460|FG001|Overall Study|Objective progression or relapse|169|||
46818518|NCT00373113|83038459|FG000|Overall Study|Other|14|||
46818519|NCT00373113|83038460|FG001|Overall Study|Other|17|||
46818520|NCT00373113|83038459|FG000|Overall Study|Protocol Violation|5|||
46818521|NCT00373113|83038460|FG001|Overall Study|Protocol Violation|1|||
46818522|NCT00373113|83038459|FG000|Overall Study|Withdrawal by Subject|10|||
46818523|NCT00373113|83038460|FG001|Overall Study|Withdrawal by Subject|15|||
46818524|NCT00407511|83038466|FG000|Overall Study|Adverse Event|9|||
46818525|NCT00407511|83038466|FG000|Overall Study|Lost to Follow-up|4|||
46818526|NCT00407511|83038466|FG000|Overall Study|Other|5|||
46818527|NCT00407511|83038466|FG000|Overall Study|Withdrawal by Subject|4|||
46818528|NCT00384189|83038474|FG000|Overall Study|Reason Not Specified|50|||
46818529|NCT00384189|83038475|FG001|Overall Study|Reason Not Specified|57|||
46818530|NCT00384189|83038476|FG002|Overall Study|Reason Not Specified|58|||
46818531|NCT00384189|83038477|FG003|Overall Study|Reason Not Specified|40|||
46818532|NCT00326716|83038489|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
46818533|NCT00326716|83038490|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
46818534|NCT00326716|83038491|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
46818535|NCT00326716|83038492|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
46818536|NCT00548405|83038525|FG000|Overall Study|Adverse Event|6|||
46818537|NCT00548405|83038526|FG001|Overall Study|Adverse Event|2|||
46818538|NCT00548405|83038527|FG002|Overall Study|Adverse Event|0|||
46818539|NCT00548405|83038525|FG000|Overall Study|Lack of Efficacy|6|||
46818540|NCT00548405|83038526|FG001|Overall Study|Lack of Efficacy|0|||
46818541|NCT00548405|83038527|FG002|Overall Study|Lack of Efficacy|0|||
46818542|NCT00548405|83038525|FG000|Overall Study|Physician Decision|3|||
46818543|NCT00548405|83038526|FG001|Overall Study|Physician Decision|4|||
46818544|NCT00548405|83038527|FG002|Overall Study|Physician Decision|1|||
46818545|NCT00548405|83038525|FG000|Overall Study|Pregnancy|1|||
46818546|NCT00548405|83038526|FG001|Overall Study|Pregnancy|0|||
46818547|NCT00548405|83038527|FG002|Overall Study|Pregnancy|0|||
46818548|NCT00548405|83038525|FG000|Overall Study|Protocol Violation|1|||
46818549|NCT00548405|83038526|FG001|Overall Study|Protocol Violation|0|||
46818550|NCT00548405|83038527|FG002|Overall Study|Protocol Violation|0|||
46818551|NCT00548405|83038525|FG000|Overall Study|Withdrawal by Subject|36|||
46818552|NCT00548405|83038526|FG001|Overall Study|Withdrawal by Subject|12|||
46818553|NCT00548405|83038527|FG002|Overall Study|Withdrawal by Subject|5|||
46818554|NCT00548405|83038525|FG000|Overall Study|Lost to Follow-up|1|||
46818555|NCT00548405|83038526|FG001|Overall Study|Lost to Follow-up|1|||
46931108|NCT02590432|83166098|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
46931109|NCT02590432|83166099|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
46931110|NCT02590432|83166100|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
46931111|NCT02590432|83166101|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
46931112|NCT02590432|83166102|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
46931113|NCT02590432|83166103|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
46931114|NCT02590432|83166095|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46758474|NCT00810069|82976706|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
46758475|NCT00810069|82976707|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
46758476|NCT00810069|82976708|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
46758477|NCT00810069|82976706|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
46758478|NCT00810069|82976707|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
46758479|NCT00810069|82976708|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
46758480|NCT00810069|82976706|FG000|Double-Blind Period II|Clinical relapse|0|||
46758481|NCT00810069|82976707|FG001|Double-Blind Period II|Clinical relapse|3|||
46758482|NCT00810069|82976708|FG002|Double-Blind Period II|Clinical relapse|0|||
46758483|NCT00810069|82976706|FG000|Double-Blind Period II|Protocol Violation|0|||
46758484|NCT00810069|82976707|FG001|Double-Blind Period II|Protocol Violation|7|||
46818556|NCT00548405|83038527|FG002|Overall Study|Lost to Follow-up|2|||
46758485|NCT00810069|82976708|FG002|Double-Blind Period II|Protocol Violation|6|||
46758486|NCT00489541|82976719|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
46818557|NCT00548405|83038525|FG000|Overall Study|Death|0|||
46818558|NCT00548405|83038526|FG001|Overall Study|Death|1|||
46818559|NCT00548405|83038527|FG002|Overall Study|Death|1|||
46818560|NCT00548405|83038525|FG000|Overall Study|Sponsor decision|1|||
46818561|NCT00548405|83038526|FG001|Overall Study|Sponsor decision|0|||
46818562|NCT00548405|83038527|FG002|Overall Study|Sponsor decision|0|||
46818563|NCT00548405|83038525|FG000|Overall Study|Randomized but not treated|1|||
46818564|NCT00548405|83038526|FG001|Overall Study|Randomized but not treated|0|||
46758487|NCT00489541|82976720|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
46818565|NCT00548405|83038527|FG002|Overall Study|Randomized but not treated|0|||
46818566|NCT00295750|83038539|FG000|Overall Study|Adverse Event|19|||
46818567|NCT00295750|83038540|FG001|Overall Study|Adverse Event|15|||
46818568|NCT00295750|83038541|FG002|Overall Study|Adverse Event|12|||
46818569|NCT00295750|83038539|FG000|Overall Study|Lack of Efficacy|1|||
46818570|NCT00295750|83038540|FG001|Overall Study|Lack of Efficacy|1|||
46818571|NCT00295750|83038541|FG002|Overall Study|Lack of Efficacy|0|||
46818572|NCT00295750|83038539|FG000|Overall Study|Lost to Follow-up|1|||
46818573|NCT00295750|83038540|FG001|Overall Study|Lost to Follow-up|4|||
46818574|NCT00295750|83038541|FG002|Overall Study|Lost to Follow-up|1|||
46818575|NCT00295750|83038539|FG000|Overall Study|Taking prohibited therapy|2|||
46818576|NCT00295750|83038540|FG001|Overall Study|Taking prohibited therapy|3|||
46818577|NCT00295750|83038541|FG002|Overall Study|Taking prohibited therapy|2|||
46818578|NCT00295750|83038539|FG000|Overall Study|Administrative errors|2|||
46818579|NCT00295750|83038540|FG001|Overall Study|Administrative errors|4|||
46818580|NCT00295750|83038541|FG002|Overall Study|Administrative errors|5|||
46818581|NCT00295750|83038539|FG000|Overall Study|Trial drug errors|1|||
46818582|NCT00295750|83038540|FG001|Overall Study|Trial drug errors|1|||
46818583|NCT00295750|83038541|FG002|Overall Study|Trial drug errors|0|||
46818584|NCT00295750|83038539|FG000|Overall Study|Disease progression|2|||
46818585|NCT00295750|83038540|FG001|Overall Study|Disease progression|1|||
46818586|NCT00295750|83038541|FG002|Overall Study|Disease progression|0|||
46818587|NCT00295750|83038539|FG000|Overall Study|Personal reasons|0|||
46818588|NCT00295750|83038540|FG001|Overall Study|Personal reasons|1|||
46818589|NCT00295750|83038541|FG002|Overall Study|Personal reasons|0|||
46818590|NCT00295750|83038539|FG000|Overall Study|Randomized but never received trial drug|4|||
46818591|NCT00295750|83038540|FG001|Overall Study|Randomized but never received trial drug|3|||
46818592|NCT00295750|83038541|FG002|Overall Study|Randomized but never received trial drug|3|||
46818593|NCT00295750|83038539|FG000|Overall Study|Withdrawal by Subject|9|||
46818594|NCT00295750|83038540|FG001|Overall Study|Withdrawal by Subject|4|||
46818595|NCT00295750|83038541|FG002|Overall Study|Withdrawal by Subject|7|||
46818596|NCT00295750|83038539|FG000|Overall Study|Protocol Violation|2|||
46818597|NCT00295750|83038540|FG001|Overall Study|Protocol Violation|4|||
46818598|NCT00295750|83038541|FG002|Overall Study|Protocol Violation|2|||
46818599|NCT03948581|83038551|FG000|Overall Study|Lost to Follow-up|0|||
46818600|NCT03948581|83038552|FG001|Overall Study|Lost to Follow-up|1|||
46818601|NCT00548327|83038560|FG000|Overall Study|Adverse Event|0|||
46818602|NCT00548327|83038561|FG001|Overall Study|Adverse Event|1|||
46818603|NCT03953183|83038583|FG000|Overall Study|Physician Decision|0|||
46818604|NCT03953183|83038584|FG001|Overall Study|Physician Decision|1|||
46818605|NCT03953183|83038583|FG000|Overall Study|Withdrawal by Subject|0|||
46818606|NCT03953183|83038584|FG001|Overall Study|Withdrawal by Subject|1|||
46818607|NCT00406653|83038594|FG000|Induction Period|Adverse Event|1|||
46818608|NCT00406653|83038595|FG001|Induction Period|Adverse Event|10|||
46818609|NCT00406653|83038596|FG002|Induction Period|Adverse Event|4|||
46818610|NCT00406653|83038597|FG003|Induction Period|Adverse Event|11|||
46818611|NCT00406653|83038598|FG004|Induction Period|Adverse Event|0|||
46818612|NCT00406653|83038599|FG005|Induction Period|Adverse Event|0|||
46818613|NCT00406653|83038600|FG006|Induction Period|Adverse Event|0|||
46818614|NCT00406653|83038594|FG000|Induction Period|Lack of Efficacy|11|||
46818615|NCT00406653|83038595|FG001|Induction Period|Lack of Efficacy|14|||
46818616|NCT00406653|83038596|FG002|Induction Period|Lack of Efficacy|8|||
46818617|NCT00406653|83038597|FG003|Induction Period|Lack of Efficacy|10|||
46818618|NCT00406653|83038598|FG004|Induction Period|Lack of Efficacy|0|||
46818619|NCT00406653|83038599|FG005|Induction Period|Lack of Efficacy|0|||
46818620|NCT00406653|83038600|FG006|Induction Period|Lack of Efficacy|0|||
46818621|NCT00406653|83038594|FG000|Induction Period|Lost to Follow-up|0|||
46818622|NCT00406653|83038595|FG001|Induction Period|Lost to Follow-up|2|||
46818623|NCT00406653|83038596|FG002|Induction Period|Lost to Follow-up|0|||
46818624|NCT00406653|83038597|FG003|Induction Period|Lost to Follow-up|0|||
46818625|NCT00406653|83038598|FG004|Induction Period|Lost to Follow-up|0|||
46818626|NCT00406653|83038599|FG005|Induction Period|Lost to Follow-up|0|||
46818627|NCT00406653|83038600|FG006|Induction Period|Lost to Follow-up|0|||
46818628|NCT00406653|83038594|FG000|Induction Period|Withdrawal of Consent|2|||
46818629|NCT00406653|83038595|FG001|Induction Period|Withdrawal of Consent|5|||
46818630|NCT00406653|83038596|FG002|Induction Period|Withdrawal of Consent|1|||
46818631|NCT00406653|83038597|FG003|Induction Period|Withdrawal of Consent|2|||
46818632|NCT00406653|83038598|FG004|Induction Period|Withdrawal of Consent|0|||
46818633|NCT00406653|83038599|FG005|Induction Period|Withdrawal of Consent|0|||
46818634|NCT00406653|83038600|FG006|Induction Period|Withdrawal of Consent|0|||
46818635|NCT00406653|83038594|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
46818636|NCT00406653|83038595|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
46818637|NCT00406653|83038596|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
46818638|NCT00406653|83038597|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
46818639|NCT00406653|83038598|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
46818640|NCT00406653|83038599|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
47056121|NCT03713632|83332043|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
46818641|NCT00406653|83038600|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
46818642|NCT00406653|83038594|FG000|Induction Period|Pregnancy|1|||
46818643|NCT00406653|83038595|FG001|Induction Period|Pregnancy|0|||
46818644|NCT00406653|83038596|FG002|Induction Period|Pregnancy|0|||
46818645|NCT00406653|83038597|FG003|Induction Period|Pregnancy|0|||
46818646|NCT00406653|83038598|FG004|Induction Period|Pregnancy|0|||
46818647|NCT00406653|83038599|FG005|Induction Period|Pregnancy|0|||
46818648|NCT00406653|83038600|FG006|Induction Period|Pregnancy|0|||
46818649|NCT00406653|83038594|FG000|Induction Period|Declined participation but followup done|0|||
46818650|NCT00406653|83038595|FG001|Induction Period|Declined participation but followup done|2|||
46818651|NCT00406653|83038596|FG002|Induction Period|Declined participation but followup done|1|||
46818652|NCT00406653|83038597|FG003|Induction Period|Declined participation but followup done|1|||
46818653|NCT00406653|83038598|FG004|Induction Period|Declined participation but followup done|0|||
46818654|NCT00406653|83038599|FG005|Induction Period|Declined participation but followup done|0|||
46818655|NCT00406653|83038600|FG006|Induction Period|Declined participation but followup done|0|||
46818656|NCT00406653|83038594|FG000|Induction Period|Given prohibited drug|0|||
46818657|NCT00406653|83038595|FG001|Induction Period|Given prohibited drug|1|||
46818658|NCT00406653|83038596|FG002|Induction Period|Given prohibited drug|2|||
46818659|NCT00406653|83038597|FG003|Induction Period|Given prohibited drug|0|||
46818660|NCT00406653|83038598|FG004|Induction Period|Given prohibited drug|0|||
46818661|NCT00406653|83038599|FG005|Induction Period|Given prohibited drug|0|||
46818662|NCT00406653|83038600|FG006|Induction Period|Given prohibited drug|0|||
46818663|NCT00406653|83038594|FG000|Induction Period|Incarcerated|0|||
46818664|NCT00406653|83038595|FG001|Induction Period|Incarcerated|0|||
46818665|NCT00406653|83038596|FG002|Induction Period|Incarcerated|1|||
46818666|NCT00406653|83038597|FG003|Induction Period|Incarcerated|0|||
46931115|NCT02590432|83166096|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46931116|NCT02590432|83166097|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46931117|NCT02590432|83166098|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46758488|NCT00489541|82976719|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
46758489|NCT00489541|82976720|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
46758490|NCT00489541|82976719|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
46758491|NCT00489541|82976720|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
46758492|NCT00489541|82976719|FG000|12-Month Clinical Follow-up|Death|3|||
46758493|NCT00489541|82976720|FG001|12-Month Clinical Follow-up|Death|2|||
46758494|NCT00489541|82976719|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
46758495|NCT00489541|82976720|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
46758496|NCT00489541|82976719|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
46758497|NCT00489541|82976720|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
46758498|NCT00809835|82976730|FG000|Overall Study|Lost to Follow-up|7|||
46758499|NCT00809835|82976731|FG001|Overall Study|Lost to Follow-up|6|||
46758500|NCT00809835|82976732|FG002|Overall Study|Lost to Follow-up|10|||
46758501|NCT00809835|82976733|FG003|Overall Study|Lost to Follow-up|2|||
46758502|NCT00809835|82976730|FG000|Overall Study|Withdrawal by Subject|1|||
46758503|NCT00809835|82976731|FG001|Overall Study|Withdrawal by Subject|1|||
46758504|NCT00809835|82976732|FG002|Overall Study|Withdrawal by Subject|1|||
46758505|NCT00809835|82976733|FG003|Overall Study|Withdrawal by Subject|0|||
46758506|NCT00853242|82976750|FG000|Overall Study|Adverse Event|0|||
46758507|NCT00853242|82976751|FG001|Overall Study|Adverse Event|1|||
46758508|NCT00853242|82976752|FG002|Overall Study|Adverse Event|1|||
46758509|NCT00853242|82976753|FG003|Overall Study|Adverse Event|0|||
46758510|NCT00853242|82976754|FG004|Overall Study|Adverse Event|3|||
46818667|NCT00406653|83038598|FG004|Induction Period|Incarcerated|0|||
46818668|NCT00406653|83038599|FG005|Induction Period|Incarcerated|0|||
46818669|NCT00406653|83038600|FG006|Induction Period|Incarcerated|0|||
46931118|NCT02590432|83166099|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46967674|NCT02157298|83210235|FG000|Overall Study|Subject no longer meets study criteria|1|||
46967675|NCT02157298|83210236|FG001|Overall Study|Subject no longer meets study criteria|2|||
46758511|NCT00853242|82976755|FG005|Overall Study|Adverse Event|1|||
46758512|NCT00853242|82976756|FG006|Overall Study|Adverse Event|1|||
46758513|NCT00853242|82976750|FG000|Overall Study|Noncompliant|0|||
46818670|NCT00406653|83038594|FG000|Induction Period|Patient relocated|0|||
46818671|NCT00406653|83038595|FG001|Induction Period|Patient relocated|0|||
46967676|NCT02157298|83210235|FG000|Overall Study|Poor/Non-compliance|1|||
46967677|NCT02157298|83210236|FG001|Overall Study|Poor/Non-compliance|0|||
46967678|NCT02157298|83210235|FG000|Overall Study|Withdrawal by Subject|1|||
46967679|NCT02157298|83210236|FG001|Overall Study|Withdrawal by Subject|0|||
46967680|NCT02184988|83210242|FG000|Overall Study|Pregnancy|2|||
46967681|NCT02184988|83210242|FG000|Overall Study|Adverse Event|2|||
46967682|NCT02184988|83210242|FG000|Overall Study|moving away/travelling/unable to complet|6|||
46967683|NCT02184988|83210242|FG000|Overall Study|work scheduling issues|4|||
46967684|NCT02184988|83210242|FG000|Overall Study|various other reasons|9|||
46967685|NCT02184988|83210242|FG000|Overall Study|Lost to Follow-up|32|||
46818672|NCT00406653|83038596|FG002|Induction Period|Patient relocated|1|||
46818673|NCT00406653|83038597|FG003|Induction Period|Patient relocated|0|||
46818674|NCT00406653|83038598|FG004|Induction Period|Patient relocated|0|||
46818675|NCT00406653|83038599|FG005|Induction Period|Patient relocated|0|||
46818676|NCT00406653|83038600|FG006|Induction Period|Patient relocated|0|||
46818677|NCT00406653|83038594|FG000|Maintenance Period|Adverse Event|0|||
46818678|NCT00406653|83038595|FG001|Maintenance Period|Adverse Event|0|||
46818679|NCT00406653|83038596|FG002|Maintenance Period|Adverse Event|0|||
46818680|NCT00406653|83038597|FG003|Maintenance Period|Adverse Event|0|||
46931119|NCT02590432|83166100|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46931120|NCT02590432|83166101|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46931121|NCT02590432|83166102|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
46931122|NCT02590432|83166103|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
46931123|NCT02590432|83166095|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46758514|NCT00853242|82976751|FG001|Overall Study|Noncompliant|0|||
46758515|NCT00853242|82976752|FG002|Overall Study|Noncompliant|0|||
46818681|NCT00406653|83038598|FG004|Maintenance Period|Adverse Event|1|||
46818682|NCT00406653|83038599|FG005|Maintenance Period|Adverse Event|1|||
46818683|NCT00406653|83038600|FG006|Maintenance Period|Adverse Event|0|||
46818684|NCT00406653|83038594|FG000|Maintenance Period|Lack of Efficacy|0|||
46818685|NCT00406653|83038595|FG001|Maintenance Period|Lack of Efficacy|0|||
46818686|NCT00406653|83038596|FG002|Maintenance Period|Lack of Efficacy|0|||
46818687|NCT00406653|83038597|FG003|Maintenance Period|Lack of Efficacy|0|||
46818688|NCT00406653|83038598|FG004|Maintenance Period|Lack of Efficacy|20|||
46818689|NCT00406653|83038599|FG005|Maintenance Period|Lack of Efficacy|26|||
46818690|NCT00406653|83038600|FG006|Maintenance Period|Lack of Efficacy|0|||
46818691|NCT00406653|83038594|FG000|Maintenance Period|Lost to Follow-up|0|||
46818692|NCT00406653|83038595|FG001|Maintenance Period|Lost to Follow-up|0|||
46818693|NCT00406653|83038596|FG002|Maintenance Period|Lost to Follow-up|0|||
46818694|NCT00406653|83038597|FG003|Maintenance Period|Lost to Follow-up|0|||
46818695|NCT00406653|83038598|FG004|Maintenance Period|Lost to Follow-up|2|||
46818696|NCT00406653|83038599|FG005|Maintenance Period|Lost to Follow-up|1|||
46818697|NCT00406653|83038600|FG006|Maintenance Period|Lost to Follow-up|0|||
46818698|NCT00406653|83038594|FG000|Maintenance Period|Withdrawal of Consent|0|||
46818699|NCT00406653|83038595|FG001|Maintenance Period|Withdrawal of Consent|0|||
46818700|NCT00406653|83038596|FG002|Maintenance Period|Withdrawal of Consent|0|||
46818701|NCT00406653|83038597|FG003|Maintenance Period|Withdrawal of Consent|0|||
46818702|NCT00406653|83038598|FG004|Maintenance Period|Withdrawal of Consent|2|||
46818703|NCT00406653|83038599|FG005|Maintenance Period|Withdrawal of Consent|0|||
46818704|NCT00406653|83038600|FG006|Maintenance Period|Withdrawal of Consent|0|||
46818705|NCT00406653|83038594|FG000|Maintenance Period|Pregnancy|0|||
46818706|NCT00406653|83038595|FG001|Maintenance Period|Pregnancy|0|||
46818707|NCT00406653|83038596|FG002|Maintenance Period|Pregnancy|0|||
46818708|NCT00406653|83038597|FG003|Maintenance Period|Pregnancy|0|||
46818709|NCT00406653|83038598|FG004|Maintenance Period|Pregnancy|0|||
46818710|NCT00406653|83038599|FG005|Maintenance Period|Pregnancy|1|||
46818711|NCT00406653|83038600|FG006|Maintenance Period|Pregnancy|0|||
46818712|NCT00406653|83038594|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
46818713|NCT00406653|83038595|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
46818714|NCT00406653|83038596|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
46758516|NCT00853242|82976753|FG003|Overall Study|Noncompliant|0|||
46758517|NCT00853242|82976754|FG004|Overall Study|Noncompliant|1|||
46758518|NCT00853242|82976755|FG005|Overall Study|Noncompliant|0|||
46758519|NCT00853242|82976756|FG006|Overall Study|Noncompliant|0|||
46758520|NCT00853242|82976750|FG000|Overall Study|Withdrawal by Subject|1|||
46758521|NCT00853242|82976751|FG001|Overall Study|Withdrawal by Subject|2|||
46758522|NCT00853242|82976752|FG002|Overall Study|Withdrawal by Subject|0|||
46758523|NCT00853242|82976753|FG003|Overall Study|Withdrawal by Subject|4|||
46758524|NCT00853242|82976754|FG004|Overall Study|Withdrawal by Subject|0|||
46758525|NCT00853242|82976755|FG005|Overall Study|Withdrawal by Subject|0|||
46818715|NCT00406653|83038597|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
46818716|NCT00406653|83038598|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
46931124|NCT02590432|83166096|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46931125|NCT02590432|83166097|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46818717|NCT00406653|83038599|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
46758526|NCT00853242|82976756|FG006|Overall Study|Withdrawal by Subject|2|||
46758527|NCT00853242|82976750|FG000|Overall Study|Other|2|||
46758528|NCT00853242|82976751|FG001|Overall Study|Other|0|||
46758529|NCT00853242|82976752|FG002|Overall Study|Other|2|||
46818718|NCT00406653|83038600|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
46818719|NCT00406653|83038594|FG000|Maintenance Period|Error in disease score evaluation|0|||
46818720|NCT00406653|83038595|FG001|Maintenance Period|Error in disease score evaluation|0|||
46818721|NCT00406653|83038596|FG002|Maintenance Period|Error in disease score evaluation|0|||
46931126|NCT02590432|83166098|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46931127|NCT02590432|83166099|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46931128|NCT02590432|83166100|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46931129|NCT02590432|83166101|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46931130|NCT02590432|83166102|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
46931131|NCT02590432|83166103|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
46931132|NCT02590354|83166115|FG000|Phase 1|Active hepatitis B or C infection|1|||
46931133|NCT02590354|83166115|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
46931134|NCT02590354|83166115|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
46931135|NCT02590354|83166115|FG000|Phase 1|Subject does not want to participate|20|||
47056122|NCT03713632|83332044|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
47056123|NCT03713632|83332045|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
47056124|NCT03713632|83332041|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
47056125|NCT03713632|83332042|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
47056126|NCT03713632|83332043|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
47056127|NCT03713632|83332044|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
47056128|NCT03713632|83332045|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
47056129|NCT03713632|83332041|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
47056130|NCT03713632|83332042|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
47056131|NCT03713632|83332043|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
47056132|NCT03713632|83332044|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
47056133|NCT03713632|83332045|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
47056134|NCT03713632|83332041|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
47056135|NCT03713632|83332042|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
47056136|NCT03713632|83332043|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
47056137|NCT03713632|83332044|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
47056138|NCT03713632|83332045|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
47056139|NCT03713632|83332041|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
47056140|NCT03713632|83332042|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
46758530|NCT00853242|82976753|FG003|Overall Study|Other|0|||
46758531|NCT00853242|82976754|FG004|Overall Study|Other|0|||
46758532|NCT00853242|82976755|FG005|Overall Study|Other|1|||
46758533|NCT00853242|82976756|FG006|Overall Study|Other|2|||
46758534|NCT00848250|82976780|FG000|Overall Study|surgery was completed without cardiopulm|0|||
46758535|NCT00848250|82976781|FG001|Overall Study|surgery was completed without cardiopulm|1|||
46758536|NCT00809757|82976791|FG000|Overall Study|Adverse Event|2|||
46758537|NCT00809757|82976792|FG001|Overall Study|Adverse Event|3|||
46758538|NCT00809757|82976793|FG002|Overall Study|Adverse Event|3|||
46758539|NCT00809757|82976791|FG000|Overall Study|Lost to Follow-up|0|||
46758540|NCT00809757|82976792|FG001|Overall Study|Lost to Follow-up|0|||
46758541|NCT00809757|82976793|FG002|Overall Study|Lost to Follow-up|1|||
46758542|NCT00809757|82976791|FG000|Overall Study|Protocol Violation|1|||
46758543|NCT00809757|82976792|FG001|Overall Study|Protocol Violation|1|||
46758544|NCT00809757|82976793|FG002|Overall Study|Protocol Violation|1|||
46758545|NCT00809757|82976791|FG000|Overall Study|Withdrawal by Subject|2|||
46758546|NCT00809757|82976792|FG001|Overall Study|Withdrawal by Subject|1|||
46758547|NCT00809757|82976793|FG002|Overall Study|Withdrawal by Subject|3|||
46758548|NCT00809757|82976791|FG000|Overall Study|Subject Uncooperative|1|||
46758549|NCT00809757|82976792|FG001|Overall Study|Subject Uncooperative|0|||
46758550|NCT00809757|82976793|FG002|Overall Study|Subject Uncooperative|2|||
46758551|NCT00809757|82976791|FG000|Overall Study|Noncompliance with Medication|0|||
46758552|NCT00809757|82976792|FG001|Overall Study|Noncompliance with Medication|0|||
46758553|NCT00809757|82976793|FG002|Overall Study|Noncompliance with Medication|1|||
46758554|NCT00594464|82976807|FG000|Overall Study|Withdrawal by Subject|1|||
46758555|NCT00594464|82976807|FG000|Overall Study|Delay in operation|2|||
46758556|NCT00809445|82976820|FG000|1 Month Follow-up|Lost contact|1|||
46758557|NCT00809445|82976821|FG001|1 Month Follow-up|Lost contact|2|||
46758558|NCT00809445|82976822|FG002|1 Month Follow-up|Lost contact|1|||
46758559|NCT00809445|82976820|FG000|1 Month Follow-up|Withdrew consent|1|||
46758560|NCT00809445|82976821|FG001|1 Month Follow-up|Withdrew consent|1|||
46758561|NCT00809445|82976822|FG002|1 Month Follow-up|Withdrew consent|1|||
46758562|NCT00809445|82976820|FG000|1 Month Follow-up|Death|0|||
46758563|NCT00809445|82976821|FG001|1 Month Follow-up|Death|1|||
46758564|NCT00809445|82976822|FG002|1 Month Follow-up|Death|1|||
46758565|NCT00809445|82976820|FG000|1 Month Follow-up|Incarcerated|0|||
46758566|NCT00809445|82976821|FG001|1 Month Follow-up|Incarcerated|0|||
46758567|NCT00809445|82976822|FG002|1 Month Follow-up|Incarcerated|1|||
47056141|NCT03713632|83332043|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
46758568|NCT00809445|82976820|FG000|6 Month Follow-up|Lost contact|16|||
46758569|NCT00809445|82976821|FG001|6 Month Follow-up|Lost contact|14|||
46758570|NCT00809445|82976822|FG002|6 Month Follow-up|Lost contact|14|||
46758571|NCT00809445|82976820|FG000|6 Month Follow-up|Death|2|||
46758572|NCT00809445|82976821|FG001|6 Month Follow-up|Death|1|||
46818722|NCT00406653|83038597|FG003|Maintenance Period|Error in disease score evaluation|0|||
46818723|NCT00406653|83038598|FG004|Maintenance Period|Error in disease score evaluation|1|||
46818724|NCT00406653|83038599|FG005|Maintenance Period|Error in disease score evaluation|0|||
46818725|NCT00406653|83038600|FG006|Maintenance Period|Error in disease score evaluation|0|||
46818726|NCT00406653|83038594|FG000|Open-Label Period|Death|0|||
46818727|NCT00406653|83038595|FG001|Open-Label Period|Death|0|||
46818728|NCT00406653|83038596|FG002|Open-Label Period|Death|0|||
46818729|NCT00406653|83038597|FG003|Open-Label Period|Death|0|||
46818730|NCT00406653|83038598|FG004|Open-Label Period|Death|0|||
46818731|NCT00406653|83038599|FG005|Open-Label Period|Death|0|||
46818732|NCT00406653|83038600|FG006|Open-Label Period|Death|1|||
46818733|NCT00406653|83038594|FG000|Open-Label Period|Adverse Event|0|||
46818734|NCT00406653|83038595|FG001|Open-Label Period|Adverse Event|0|||
46818735|NCT00406653|83038596|FG002|Open-Label Period|Adverse Event|0|||
46818736|NCT00406653|83038597|FG003|Open-Label Period|Adverse Event|0|||
46818737|NCT00406653|83038598|FG004|Open-Label Period|Adverse Event|0|||
46818738|NCT00406653|83038599|FG005|Open-Label Period|Adverse Event|0|||
46818739|NCT00406653|83038600|FG006|Open-Label Period|Adverse Event|18|||
46818740|NCT00406653|83038594|FG000|Open-Label Period|Lack of Efficacy|0|||
46818741|NCT00406653|83038595|FG001|Open-Label Period|Lack of Efficacy|0|||
46818742|NCT00406653|83038596|FG002|Open-Label Period|Lack of Efficacy|0|||
46818743|NCT00406653|83038597|FG003|Open-Label Period|Lack of Efficacy|0|||
46818744|NCT00406653|83038598|FG004|Open-Label Period|Lack of Efficacy|0|||
46818745|NCT00406653|83038599|FG005|Open-Label Period|Lack of Efficacy|0|||
46818746|NCT00406653|83038600|FG006|Open-Label Period|Lack of Efficacy|160|||
46818747|NCT00406653|83038594|FG000|Open-Label Period|Lost to Follow-up|0|||
46818748|NCT00406653|83038595|FG001|Open-Label Period|Lost to Follow-up|0|||
46818749|NCT00406653|83038596|FG002|Open-Label Period|Lost to Follow-up|0|||
46818750|NCT00406653|83038597|FG003|Open-Label Period|Lost to Follow-up|0|||
46818751|NCT00406653|83038598|FG004|Open-Label Period|Lost to Follow-up|0|||
46818752|NCT00406653|83038599|FG005|Open-Label Period|Lost to Follow-up|0|||
46818753|NCT00406653|83038600|FG006|Open-Label Period|Lost to Follow-up|6|||
46818754|NCT00406653|83038594|FG000|Open-Label Period|Withdrawal of Consent|0|||
46818755|NCT00406653|83038595|FG001|Open-Label Period|Withdrawal of Consent|0|||
46818756|NCT00406653|83038596|FG002|Open-Label Period|Withdrawal of Consent|0|||
46931136|NCT02590354|83166115|FG000|Phase 1|Lost to Follow-up|1|||
46758573|NCT00809445|82976822|FG002|6 Month Follow-up|Death|1|||
46758574|NCT00809445|82976820|FG000|6 Month Follow-up|Incarcerated|6|||
46758575|NCT00809445|82976821|FG001|6 Month Follow-up|Incarcerated|8|||
46758576|NCT00809445|82976822|FG002|6 Month Follow-up|Incarcerated|8|||
46758577|NCT00809445|82976820|FG000|6 Month Follow-up|Withdrew consent|0|||
46758578|NCT00809445|82976821|FG001|6 Month Follow-up|Withdrew consent|0|||
46758579|NCT00809445|82976822|FG002|6 Month Follow-up|Withdrew consent|1|||
46758580|NCT00593918|82976845|FG000|Overall Study|Withdrawal by Subject|5|||
46758581|NCT00593918|82976846|FG001|Overall Study|Withdrawal by Subject|24|||
46758582|NCT04135196|82976857|FG000|Overall Study|Lost to Follow-up|8|||
46758583|NCT04135196|82976858|FG001|Overall Study|Lost to Follow-up|7|||
46758584|NCT04135196|82976859|FG002|Overall Study|Lost to Follow-up|8|||
46758585|NCT04135196|82976860|FG003|Overall Study|Lost to Follow-up|9|||
46758586|NCT04135196|82976861|FG004|Overall Study|Lost to Follow-up|1|||
46758587|NCT04135196|82976857|FG000|Overall Study|Pregnancy|0|||
46758588|NCT04135196|82976858|FG001|Overall Study|Pregnancy|0|||
46758589|NCT04135196|82976859|FG002|Overall Study|Pregnancy|1|||
46758590|NCT04135196|82976860|FG003|Overall Study|Pregnancy|0|||
46758591|NCT04135196|82976861|FG004|Overall Study|Pregnancy|0|||
46758592|NCT04135196|82976857|FG000|Overall Study|Withdrawal by Subject|0|||
46758593|NCT04135196|82976858|FG001|Overall Study|Withdrawal by Subject|0|||
46758594|NCT04135196|82976859|FG002|Overall Study|Withdrawal by Subject|0|||
46931137|NCT02590354|83166115|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
46931138|NCT01667224|83166122|FG000|Overall Study|Withdrawal by Subject|3|||
46758595|NCT04135196|82976860|FG003|Overall Study|Withdrawal by Subject|0|||
46818757|NCT00406653|83038597|FG003|Open-Label Period|Withdrawal of Consent|0|||
46818758|NCT00406653|83038598|FG004|Open-Label Period|Withdrawal of Consent|0|||
46818759|NCT00406653|83038599|FG005|Open-Label Period|Withdrawal of Consent|0|||
46818760|NCT00406653|83038600|FG006|Open-Label Period|Withdrawal of Consent|11|||
46818761|NCT00406653|83038594|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
46818762|NCT00406653|83038595|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
46818763|NCT00406653|83038596|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
46758596|NCT04135196|82976861|FG004|Overall Study|Withdrawal by Subject|1|||
46758597|NCT00499369|82976878|FG000|Overall Study|Adverse Event|2|||
46758598|NCT00499369|82976879|FG001|Overall Study|Adverse Event|2|||
46758599|NCT00499369|82976880|FG002|Overall Study|Adverse Event|3|||
46758600|NCT00499369|82976881|FG003|Overall Study|Adverse Event|1|||
46758601|NCT00499369|82976882|FG004|Overall Study|Adverse Event|2|||
46758602|NCT00499369|82976878|FG000|Overall Study|Withdrawal by Subject|0|||
46931139|NCT01667224|83166123|FG001|Overall Study|Withdrawal by Subject|1|||
46931140|NCT01667224|83166122|FG000|Overall Study|Protocol Violation|1|||
46931141|NCT01667224|83166123|FG001|Overall Study|Protocol Violation|1|||
46931142|NCT03923738|83166131|FG000|Period 1|Adverse Event|1|||
46931143|NCT03923738|83166131|FG000|Period 1|Withdrawal by Subject|1|||
46931144|NCT02588248|83166139|FG000|Overall Study|Physician Decision|4|||
46931145|NCT02588248|83166140|FG001|Overall Study|Physician Decision|3|||
46931146|NCT01328054|83166151|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
46931147|NCT01328054|83166152|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
46931148|NCT01328054|83166151|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
46931149|NCT01328054|83166152|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
46931150|NCT01328054|83166151|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
46931151|NCT01328054|83166152|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
46931152|NCT01849250|83166175|FG000|Overall Study|Withdrawal by Subject|1|||
46931153|NCT01849250|83166176|FG001|Overall Study|Withdrawal by Subject|0|||
46818764|NCT00406653|83038597|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
46818765|NCT00406653|83038598|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
46818766|NCT00406653|83038599|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
46818767|NCT00406653|83038600|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
46818768|NCT00406653|83038594|FG000|Open-Label Period|Pregnancy|0|||
46818769|NCT00406653|83038595|FG001|Open-Label Period|Pregnancy|0|||
46818770|NCT00406653|83038596|FG002|Open-Label Period|Pregnancy|0|||
46818771|NCT00406653|83038597|FG003|Open-Label Period|Pregnancy|0|||
46818772|NCT00406653|83038598|FG004|Open-Label Period|Pregnancy|0|||
46818773|NCT00406653|83038599|FG005|Open-Label Period|Pregnancy|0|||
46931154|NCT01849250|83166175|FG000|Overall Study|Not Evaluable|5|||
46931155|NCT01849250|83166176|FG001|Overall Study|Not Evaluable|3|||
46931156|NCT01849250|83166175|FG000|Overall Study|Screen Failure|1|||
46931157|NCT01849250|83166176|FG001|Overall Study|Screen Failure|0|||
46931158|NCT02791191|83166186|FG000|Overall Study|Adverse Event|2|||
46931159|NCT02791191|83166187|FG001|Overall Study|Adverse Event|4|||
46931160|NCT02791191|83166188|FG002|Overall Study|Adverse Event|5|||
46931161|NCT02791191|83166186|FG000|Overall Study|Lack of Efficacy|0|||
46931162|NCT02791191|83166187|FG001|Overall Study|Lack of Efficacy|1|||
46931163|NCT02791191|83166188|FG002|Overall Study|Lack of Efficacy|0|||
46931164|NCT02791191|83166186|FG000|Overall Study|Study Drug Non-Compliance|0|||
46931165|NCT02791191|83166187|FG001|Overall Study|Study Drug Non-Compliance|2|||
46931166|NCT02791191|83166188|FG002|Overall Study|Study Drug Non-Compliance|0|||
46931167|NCT02791191|83166186|FG000|Overall Study|Site Closed by Sponsor|1|||
46931168|NCT02791191|83166187|FG001|Overall Study|Site Closed by Sponsor|1|||
46931169|NCT02791191|83166188|FG002|Overall Study|Site Closed by Sponsor|3|||
46931170|NCT02791191|83166186|FG000|Overall Study|Progressive Disease|1|||
46931171|NCT02791191|83166187|FG001|Overall Study|Progressive Disease|0|||
46931172|NCT02791191|83166188|FG002|Overall Study|Progressive Disease|0|||
46931173|NCT02791191|83166186|FG000|Overall Study|Study Terminated by Sponsor|29|||
47056142|NCT03713632|83332044|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
46931174|NCT02791191|83166187|FG001|Overall Study|Study Terminated by Sponsor|101|||
46931175|NCT02791191|83166188|FG002|Overall Study|Study Terminated by Sponsor|109|||
46931176|NCT02791191|83166186|FG000|Overall Study|Withdrawal by Subject|3|||
46931177|NCT02791191|83166187|FG001|Overall Study|Withdrawal by Subject|1|||
46758603|NCT00499369|82976879|FG001|Overall Study|Withdrawal by Subject|1|||
46758604|NCT00499369|82976880|FG002|Overall Study|Withdrawal by Subject|1|||
46758605|NCT00499369|82976881|FG003|Overall Study|Withdrawal by Subject|0|||
46758606|NCT00499369|82976882|FG004|Overall Study|Withdrawal by Subject|0|||
46758607|NCT00499369|82976878|FG000|Overall Study|Progression|10|||
46758608|NCT00499369|82976879|FG001|Overall Study|Progression|12|||
46758609|NCT00499369|82976880|FG002|Overall Study|Progression|9|||
46758610|NCT00499369|82976881|FG003|Overall Study|Progression|6|||
46758611|NCT00499369|82976882|FG004|Overall Study|Progression|10|||
46758612|NCT00499369|82976878|FG000|Overall Study|Death|0|||
46758613|NCT00499369|82976879|FG001|Overall Study|Death|1|||
46758614|NCT00499369|82976880|FG002|Overall Study|Death|0|||
46758615|NCT00499369|82976881|FG003|Overall Study|Death|0|||
46758616|NCT00499369|82976882|FG004|Overall Study|Death|0|||
46758617|NCT00499369|82976878|FG000|Overall Study|Not protocol specified|2|||
46931178|NCT02791191|83166188|FG002|Overall Study|Withdrawal by Subject|3|||
46931179|NCT02791191|83166186|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
46931180|NCT02791191|83166187|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
46931181|NCT02791191|83166188|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
46931182|NCT02114697|83166211|FG000|Overall Study|Study terminated|5|||
46931183|NCT02114697|83166212|FG001|Overall Study|Study terminated|4|||
46931184|NCT01330017|83166223|FG000|Overall Study|Adverse Event|0|||
46758618|NCT00499369|82976879|FG001|Overall Study|Not protocol specified|0|||
46758619|NCT00499369|82976880|FG002|Overall Study|Not protocol specified|3|||
46758620|NCT00499369|82976881|FG003|Overall Study|Not protocol specified|1|||
46758621|NCT00499369|82976882|FG004|Overall Study|Not protocol specified|0|||
46818774|NCT00406653|83038600|FG006|Open-Label Period|Pregnancy|2|||
46818775|NCT00406653|83038594|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
46818776|NCT00406653|83038595|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
46818777|NCT00406653|83038596|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
46818778|NCT00406653|83038597|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
46818779|NCT00406653|83038598|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
46818780|NCT00406653|83038599|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
46818781|NCT00406653|83038600|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
46818782|NCT00406653|83038594|FG000|Open-Label Period|Declined participation but followup done|0|||
46818783|NCT00406653|83038595|FG001|Open-Label Period|Declined participation but followup done|0|||
47056143|NCT03713632|83332045|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
46636687|NCT01508676|82810485|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
46636688|NCT01508676|82810486|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
46636689|NCT01508676|82810485|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
46636690|NCT01508676|82810486|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
46636691|NCT01508130|82810495|FG000|Overall Study|Adverse Event|81|||
46636692|NCT01508130|82810496|FG001|Overall Study|Adverse Event|28|||
46636693|NCT01508130|82810495|FG000|Overall Study|Death|3|||
46636694|NCT01508130|82810496|FG001|Overall Study|Death|1|||
46636695|NCT01508130|82810495|FG000|Overall Study|Protocol Violation|2|||
46636696|NCT01508130|82810496|FG001|Overall Study|Protocol Violation|0|||
46636697|NCT01508130|82810495|FG000|Overall Study|Lost to Follow-up|25|||
46636698|NCT01508130|82810496|FG001|Overall Study|Lost to Follow-up|2|||
46758622|NCT00499369|82976878|FG000|Overall Study|Ineligible|2|||
46758623|NCT00499369|82976879|FG001|Overall Study|Ineligible|2|||
46818784|NCT00406653|83038596|FG002|Open-Label Period|Declined participation but followup done|0|||
46818785|NCT00406653|83038597|FG003|Open-Label Period|Declined participation but followup done|0|||
46818786|NCT00406653|83038598|FG004|Open-Label Period|Declined participation but followup done|0|||
46818787|NCT00406653|83038599|FG005|Open-Label Period|Declined participation but followup done|0|||
46818788|NCT00406653|83038600|FG006|Open-Label Period|Declined participation but followup done|8|||
46818789|NCT00406653|83038594|FG000|Open-Label Period|Discontinued by Sponsor|0|||
46818790|NCT00406653|83038595|FG001|Open-Label Period|Discontinued by Sponsor|0|||
46818791|NCT00406653|83038596|FG002|Open-Label Period|Discontinued by Sponsor|0|||
46818792|NCT00406653|83038597|FG003|Open-Label Period|Discontinued by Sponsor|0|||
46818793|NCT00406653|83038598|FG004|Open-Label Period|Discontinued by Sponsor|0|||
46818794|NCT00406653|83038599|FG005|Open-Label Period|Discontinued by Sponsor|0|||
46818795|NCT00406653|83038600|FG006|Open-Label Period|Discontinued by Sponsor|1|||
46818796|NCT00406653|83038594|FG000|Open-Label Period|Refused followup|0|||
46818797|NCT00406653|83038595|FG001|Open-Label Period|Refused followup|0|||
46818798|NCT00406653|83038596|FG002|Open-Label Period|Refused followup|0|||
46818799|NCT00406653|83038597|FG003|Open-Label Period|Refused followup|0|||
46818800|NCT00406653|83038598|FG004|Open-Label Period|Refused followup|0|||
46818801|NCT00406653|83038599|FG005|Open-Label Period|Refused followup|0|||
46818802|NCT00406653|83038600|FG006|Open-Label Period|Refused followup|1|||
46818803|NCT00547157|83038622|FG000|Overall Study|Other|1|||
46818804|NCT00547157|83038623|FG001|Overall Study|Other|0|||
46818805|NCT00547157|83038622|FG000|Overall Study|Death|38|||
46818806|NCT00547157|83038623|FG001|Overall Study|Death|18|||
46818807|NCT00547157|83038622|FG000|Overall Study|Withdrawal by Subject|3|||
46818808|NCT00547157|83038623|FG001|Overall Study|Withdrawal by Subject|1|||
46818809|NCT00547157|83038622|FG000|Overall Study|Administrative decision|3|||
46818810|NCT00547157|83038623|FG001|Overall Study|Administrative decision|2|||
46818811|NCT00547157|83038622|FG000|Overall Study|Lost to Follow-up|4|||
46818812|NCT00547157|83038623|FG001|Overall Study|Lost to Follow-up|2|||
46758624|NCT00499369|82976880|FG002|Overall Study|Ineligible|1|||
46758625|NCT00499369|82976881|FG003|Overall Study|Ineligible|1|||
46758626|NCT00499369|82976882|FG004|Overall Study|Ineligible|0|||
46758627|NCT00869258|82976894|FG000|Overall Study|Physician Decision|1|||
46758628|NCT00693784|82976898|FG000|Overall Study|Lost to Follow-up|2|||
46758629|NCT00693784|82976898|FG000|Overall Study|Withdrawal by Subject|2|||
46758630|NCT00693706|82976904|FG000|Overall Study|Protocol Violation|0|||
46818813|NCT00384033|83038633|FG000|Overall Study|Adverse Event|10|||
46818814|NCT00384033|83038634|FG001|Overall Study|Adverse Event|8|||
46818815|NCT00384033|83038635|FG002|Overall Study|Adverse Event|11|||
46818816|NCT00384033|83038636|FG003|Overall Study|Adverse Event|20|||
46636699|NCT01508130|82810495|FG000|Overall Study|Withdrawal by Subject|3|||
46818817|NCT00384033|83038633|FG000|Overall Study|Failed to return|1|||
46818818|NCT00384033|83038634|FG001|Overall Study|Failed to return|3|||
46636700|NCT01508130|82810496|FG001|Overall Study|Withdrawal by Subject|3|||
46636701|NCT01508130|82810495|FG000|Overall Study|Subject's substantial non-compliance|25|||
46758631|NCT00693706|82976905|FG001|Overall Study|Protocol Violation|1|||
46758632|NCT00488683|82976914|FG000|Overall Study|Withdrawal by Subject|1|||
46758633|NCT00488683|82976915|FG001|Overall Study|Withdrawal by Subject|2|||
46758634|NCT00488683|82976916|FG002|Overall Study|Withdrawal by Subject|2|||
46758635|NCT00488683|82976914|FG000|Overall Study|Lost to Follow-up|5|||
46931185|NCT01330017|83166224|FG001|Overall Study|Adverse Event|1|||
46931186|NCT01330017|83166225|FG002|Overall Study|Adverse Event|1|||
46931187|NCT01330017|83166226|FG003|Overall Study|Adverse Event|4|||
46931188|NCT01330017|83166227|FG004|Overall Study|Adverse Event|0|||
46931189|NCT01330017|83166223|FG000|Overall Study|Withdrawal by Subject|0|||
46931190|NCT01330017|83166224|FG001|Overall Study|Withdrawal by Subject|0|||
46931191|NCT01330017|83166225|FG002|Overall Study|Withdrawal by Subject|1|||
46931192|NCT01330017|83166226|FG003|Overall Study|Withdrawal by Subject|0|||
46931193|NCT01330017|83166227|FG004|Overall Study|Withdrawal by Subject|1|||
46931194|NCT01330017|83166223|FG000|Overall Study|Lost to Follow-up|0|||
46931195|NCT01330017|83166224|FG001|Overall Study|Lost to Follow-up|0|||
46931196|NCT01330017|83166225|FG002|Overall Study|Lost to Follow-up|1|||
46931197|NCT01330017|83166226|FG003|Overall Study|Lost to Follow-up|0|||
46931198|NCT01330017|83166227|FG004|Overall Study|Lost to Follow-up|0|||
46931199|NCT01330017|83166223|FG000|Overall Study|Protocol Violation|0|||
46931200|NCT01330017|83166224|FG001|Overall Study|Protocol Violation|0|||
46931201|NCT01330017|83166225|FG002|Overall Study|Protocol Violation|0|||
46931202|NCT01330017|83166226|FG003|Overall Study|Protocol Violation|1|||
46931203|NCT01330017|83166227|FG004|Overall Study|Protocol Violation|0|||
46931204|NCT01330017|83166223|FG000|Overall Study|Unknown Reason|5|||
46931205|NCT01330017|83166224|FG001|Overall Study|Unknown Reason|3|||
46931206|NCT01330017|83166225|FG002|Overall Study|Unknown Reason|5|||
46931207|NCT01330017|83166226|FG003|Overall Study|Unknown Reason|7|||
46636702|NCT01508130|82810496|FG001|Overall Study|Subject's substantial non-compliance|9|||
46636703|NCT01508130|82810495|FG000|Overall Study|Insufficient therapeutic response|74|||
46758636|NCT00488683|82976915|FG001|Overall Study|Lost to Follow-up|3|||
46758637|NCT00488683|82976916|FG002|Overall Study|Lost to Follow-up|0|||
46758638|NCT00488683|82976914|FG000|Overall Study|Protocol Violation|5|||
46758639|NCT00488683|82976915|FG001|Overall Study|Protocol Violation|1|||
46758640|NCT00488683|82976916|FG002|Overall Study|Protocol Violation|0|||
46758641|NCT00488683|82976914|FG000|Overall Study|Unable to Classify|1|||
46758642|NCT00488683|82976915|FG001|Overall Study|Unable to Classify|0|||
46758643|NCT00488683|82976916|FG002|Overall Study|Unable to Classify|0|||
46758644|NCT00693472|82976950|FG000|Part 1|Adverse Event|1|||
46758645|NCT00693472|82976951|FG001|Part 1|Adverse Event|1|||
46758646|NCT00693472|82976952|FG002|Part 1|Adverse Event|0|||
46758647|NCT00693472|82976953|FG003|Part 1|Adverse Event|0|||
46758648|NCT00693472|82976950|FG000|Part 1|Lost to Follow-up|0|||
46758649|NCT00693472|82976951|FG001|Part 1|Lost to Follow-up|1|||
46758650|NCT00693472|82976952|FG002|Part 1|Lost to Follow-up|0|||
46758651|NCT00693472|82976953|FG003|Part 1|Lost to Follow-up|0|||
46758652|NCT00693472|82976950|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
46758653|NCT00693472|82976951|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
46758654|NCT00693472|82976952|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
46758655|NCT00693472|82976953|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
46758656|NCT00693472|82976950|FG000|Part 2|Adverse Event|0|||
46758657|NCT00693472|82976951|FG001|Part 2|Adverse Event|0|||
46758658|NCT00693472|82976952|FG002|Part 2|Adverse Event|1|||
46758659|NCT00693472|82976953|FG003|Part 2|Adverse Event|0|||
46758660|NCT00693472|82976950|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
46758661|NCT00693472|82976951|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
46758662|NCT00693472|82976952|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
46758663|NCT00693472|82976953|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
46758664|NCT00498433|82976966|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
46758665|NCT00498433|82976967|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
46758666|NCT00498433|82976968|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
46758667|NCT00498433|82976966|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
46758668|NCT00498433|82976967|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
46758669|NCT00498433|82976968|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
46758670|NCT00498433|82976966|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
46758671|NCT00498433|82976967|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
46758672|NCT00498433|82976968|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
46758673|NCT00498433|82976966|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
46758674|NCT00498433|82976967|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
46931208|NCT01330017|83166227|FG004|Overall Study|Unknown Reason|2|||
46636704|NCT01508130|82810496|FG001|Overall Study|Insufficient therapeutic response|23|||
46758675|NCT00498433|82976968|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
46758676|NCT00498355|82976985|FG000|Overall Study|Lost to Follow-up|1|||
46931209|NCT05375838|83166258|FG000|Overall Study|Other|0|||
46931210|NCT05375838|83166259|FG001|Overall Study|Other|0|||
46758677|NCT04327271|82976992|FG000|Overall Study|Death|1|||
46758678|NCT04327271|82976993|FG001|Overall Study|Death|0|||
46758679|NCT04327271|82976992|FG000|Overall Study|Withdrawal by Subject|1|||
46931211|NCT05375838|83166260|FG002|Overall Study|Other|0|||
46931212|NCT05375838|83166261|FG003|Overall Study|Other|1|||
46931213|NCT05375838|83166262|FG004|Overall Study|Other|1|||
46931214|NCT05375838|83166263|FG005|Overall Study|Other|0|||
46931215|NCT05375838|83166258|FG000|Overall Study|Withdrawal by Subject|2|||
46818819|NCT00384033|83038635|FG002|Overall Study|Failed to return|2|||
46818820|NCT00384033|83038636|FG003|Overall Study|Failed to return|2|||
46818821|NCT00384033|83038633|FG000|Overall Study|Physician Decision|1|||
46818822|NCT00384033|83038634|FG001|Overall Study|Physician Decision|0|||
46818823|NCT00384033|83038635|FG002|Overall Study|Physician Decision|0|||
46818824|NCT00384033|83038636|FG003|Overall Study|Physician Decision|0|||
46818825|NCT00384033|83038633|FG000|Overall Study|Lost to Follow-up|6|||
46818826|NCT00384033|83038634|FG001|Overall Study|Lost to Follow-up|12|||
46818827|NCT00384033|83038635|FG002|Overall Study|Lost to Follow-up|7|||
46818828|NCT00384033|83038636|FG003|Overall Study|Lost to Follow-up|7|||
46818829|NCT00384033|83038633|FG000|Overall Study|Other|2|||
46818830|NCT00384033|83038634|FG001|Overall Study|Other|0|||
46818831|NCT00384033|83038635|FG002|Overall Study|Other|0|||
46818832|NCT00384033|83038636|FG003|Overall Study|Other|0|||
46818833|NCT00384033|83038633|FG000|Overall Study|Protocol Violation|5|||
46818834|NCT00384033|83038634|FG001|Overall Study|Protocol Violation|0|||
46818835|NCT00384033|83038635|FG002|Overall Study|Protocol Violation|5|||
46931216|NCT05375838|83166259|FG001|Overall Study|Withdrawal by Subject|1|||
46931217|NCT05375838|83166260|FG002|Overall Study|Withdrawal by Subject|3|||
46931218|NCT05375838|83166261|FG003|Overall Study|Withdrawal by Subject|2|||
46758680|NCT04327271|82976993|FG001|Overall Study|Withdrawal by Subject|0|||
46758681|NCT04327271|82976992|FG000|Overall Study|randomization error (data capture)|4|||
46758682|NCT04327271|82976993|FG001|Overall Study|randomization error (data capture)|3|||
46758683|NCT00688636|82977010|FG000|Overall Study|Adverse Event|2|||
46758684|NCT00688636|82977011|FG001|Overall Study|Adverse Event|1|||
46758685|NCT00870740|82977023|FG000|Overall Study|Adverse Event|2|||
46758686|NCT00870740|82977024|FG001|Overall Study|Adverse Event|1|||
46758687|NCT00870740|82977025|FG002|Overall Study|Adverse Event|3|||
46758688|NCT00870740|82977026|FG003|Overall Study|Adverse Event|2|||
46758689|NCT00870740|82977027|FG004|Overall Study|Adverse Event|1|||
46758690|NCT00870740|82977028|FG005|Overall Study|Adverse Event|6|||
46758691|NCT00870740|82977023|FG000|Overall Study|Consent Withdrawn|6|||
46758692|NCT00870740|82977024|FG001|Overall Study|Consent Withdrawn|3|||
46818836|NCT00384033|83038636|FG003|Overall Study|Protocol Violation|6|||
46818837|NCT00384033|83038633|FG000|Overall Study|Withdrawal by Subject|6|||
46818838|NCT00384033|83038634|FG001|Overall Study|Withdrawal by Subject|2|||
46818839|NCT00384033|83038635|FG002|Overall Study|Withdrawal by Subject|5|||
46818840|NCT00384033|83038636|FG003|Overall Study|Withdrawal by Subject|2|||
46818841|NCT00384033|83038633|FG000|Overall Study|Lack of Efficacy|7|||
46818842|NCT00384033|83038634|FG001|Overall Study|Lack of Efficacy|3|||
46931219|NCT05375838|83166262|FG004|Overall Study|Withdrawal by Subject|2|||
46931220|NCT05375838|83166263|FG005|Overall Study|Withdrawal by Subject|0|||
46931221|NCT05375838|83166258|FG000|Overall Study|Protocol Violation|0|||
46931222|NCT05375838|83166259|FG001|Overall Study|Protocol Violation|0|||
46931223|NCT05375838|83166260|FG002|Overall Study|Protocol Violation|0|||
46931224|NCT05375838|83166261|FG003|Overall Study|Protocol Violation|0|||
46931225|NCT05375838|83166262|FG004|Overall Study|Protocol Violation|1|||
46931226|NCT05375838|83166263|FG005|Overall Study|Protocol Violation|0|||
46931227|NCT05375838|83166258|FG000|Overall Study|Physician Decision|0|||
46931228|NCT05375838|83166259|FG001|Overall Study|Physician Decision|1|||
46931229|NCT05375838|83166260|FG002|Overall Study|Physician Decision|0|||
46931230|NCT05375838|83166261|FG003|Overall Study|Physician Decision|0|||
46931231|NCT05375838|83166262|FG004|Overall Study|Physician Decision|0|||
46818843|NCT00384033|83038635|FG002|Overall Study|Lack of Efficacy|3|||
46818844|NCT00384033|83038636|FG003|Overall Study|Lack of Efficacy|1|||
47056144|NCT03713632|83332041|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
47056145|NCT03713632|83332042|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
46758693|NCT00870740|82977025|FG002|Overall Study|Consent Withdrawn|4|||
46758694|NCT00870740|82977026|FG003|Overall Study|Consent Withdrawn|6|||
46758695|NCT00870740|82977027|FG004|Overall Study|Consent Withdrawn|6|||
46758696|NCT00870740|82977028|FG005|Overall Study|Consent Withdrawn|5|||
46818845|NCT00384033|83038633|FG000|Overall Study|Randomized but not treated|3|||
46818846|NCT00384033|83038634|FG001|Overall Study|Randomized but not treated|7|||
46818847|NCT00384033|83038635|FG002|Overall Study|Randomized but not treated|10|||
46818848|NCT00384033|83038636|FG003|Overall Study|Randomized but not treated|2|||
46818849|NCT00546377|83038646|FG000|Overall Study|Deemed ineligible|1|||
46818850|NCT00546377|83038646|FG000|Overall Study|Adverse Event|6|||
46818851|NCT00545753|83038653|FG000|Overall Study|Withdrawal by Subject|0|||
46818852|NCT00545753|83038654|FG001|Overall Study|Withdrawal by Subject|1|||
46818853|NCT00545753|83038655|FG002|Overall Study|Withdrawal by Subject|10|||
46931232|NCT05375838|83166263|FG005|Overall Study|Physician Decision|1|||
46758697|NCT00870740|82977023|FG000|Overall Study|Investigator Decision|2|||
46818854|NCT00545753|83038653|FG000|Overall Study|Lost to Follow-up|13|||
46818855|NCT00545753|83038654|FG001|Overall Study|Lost to Follow-up|3|||
46758698|NCT00870740|82977024|FG001|Overall Study|Investigator Decision|0|||
46758699|NCT00870740|82977025|FG002|Overall Study|Investigator Decision|1|||
46818856|NCT00545753|83038655|FG002|Overall Study|Lost to Follow-up|12|||
46931233|NCT05375838|83166258|FG000|Overall Study|Lost to Follow-up|2|||
46931234|NCT05375838|83166259|FG001|Overall Study|Lost to Follow-up|7|||
46818857|NCT00545753|83038653|FG000|Overall Study|Protocol Violation|3|||
46818858|NCT00545753|83038654|FG001|Overall Study|Protocol Violation|1|||
46818859|NCT00545753|83038655|FG002|Overall Study|Protocol Violation|4|||
46818860|NCT00406419|83038667|FG000|Overall Study|Death|3|||
47056146|NCT03713632|83332043|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
47056147|NCT03713632|83332044|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
47056148|NCT03713632|83332045|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
47056149|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
46818861|NCT00406419|83038668|FG001|Overall Study|Death|1|||
46818862|NCT00406419|83038669|FG002|Overall Study|Death|4|||
46818863|NCT00406419|83038667|FG000|Overall Study|Protocol Violation|6|||
46818864|NCT00406419|83038668|FG001|Overall Study|Protocol Violation|2|||
46818865|NCT00406419|83038669|FG002|Overall Study|Protocol Violation|5|||
46818866|NCT00406419|83038667|FG000|Overall Study|Study Terminated by Sponsor|260|||
46818867|NCT00406419|83038668|FG001|Overall Study|Study Terminated by Sponsor|288|||
46818868|NCT00406419|83038669|FG002|Overall Study|Study Terminated by Sponsor|282|||
46818869|NCT00406419|83038667|FG000|Overall Study|Withdrawal by Subject|17|||
46818870|NCT00406419|83038668|FG001|Overall Study|Withdrawal by Subject|24|||
46818871|NCT00406419|83038669|FG002|Overall Study|Withdrawal by Subject|26|||
46818872|NCT00406419|83038667|FG000|Overall Study|Lack of Efficacy|12|||
46818873|NCT00406419|83038668|FG001|Overall Study|Lack of Efficacy|1|||
46818874|NCT00406419|83038669|FG002|Overall Study|Lack of Efficacy|6|||
46818875|NCT00406419|83038667|FG000|Overall Study|Non-Compliance with Study Drug|5|||
46818876|NCT00406419|83038668|FG001|Overall Study|Non-Compliance with Study Drug|6|||
46818877|NCT00406419|83038669|FG002|Overall Study|Non-Compliance with Study Drug|3|||
46818878|NCT00406419|83038667|FG000|Overall Study|Adverse Event|10|||
46818879|NCT00406419|83038668|FG001|Overall Study|Adverse Event|12|||
46818880|NCT00406419|83038669|FG002|Overall Study|Adverse Event|16|||
46818881|NCT00406419|83038667|FG000|Overall Study|Lost to Follow-up|11|||
46818882|NCT00406419|83038668|FG001|Overall Study|Lost to Follow-up|10|||
46818883|NCT00406419|83038669|FG002|Overall Study|Lost to Follow-up|5|||
46818884|NCT00325468|83038682|FG000|Overall Study|Adverse Event|1|||
46818885|NCT00325468|83038683|FG001|Overall Study|Adverse Event|1|||
46818886|NCT00325468|83038684|FG002|Overall Study|Adverse Event|0|||
46818887|NCT00325468|83038685|FG003|Overall Study|Adverse Event|5|||
46818888|NCT00325468|83038686|FG004|Overall Study|Adverse Event|1|||
47056150|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
47056151|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
47056152|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
47056153|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
47056154|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
46818889|NCT00325468|83038682|FG000|Overall Study|Death|2|||
46818890|NCT00325468|83038683|FG001|Overall Study|Death|0|||
46931235|NCT05375838|83166260|FG002|Overall Study|Lost to Follow-up|0|||
47056155|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
47056156|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
47056157|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
47056158|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
47056159|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
47056160|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
47056161|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
47056162|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
46818891|NCT00325468|83038684|FG002|Overall Study|Death|2|||
46818892|NCT00325468|83038685|FG003|Overall Study|Death|4|||
46818893|NCT00325468|83038686|FG004|Overall Study|Death|0|||
46818894|NCT00325468|83038682|FG000|Overall Study|Lost to Follow-up|0|||
46818895|NCT00325468|83038683|FG001|Overall Study|Lost to Follow-up|0|||
46818896|NCT00325468|83038684|FG002|Overall Study|Lost to Follow-up|1|||
47056163|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
46818897|NCT00325468|83038685|FG003|Overall Study|Lost to Follow-up|2|||
46818898|NCT00325468|83038686|FG004|Overall Study|Lost to Follow-up|2|||
46818899|NCT00325468|83038682|FG000|Overall Study|Physician Decision|1|||
46818900|NCT00325468|83038683|FG001|Overall Study|Physician Decision|1|||
46931236|NCT05375838|83166261|FG003|Overall Study|Lost to Follow-up|4|||
46931237|NCT05375838|83166262|FG004|Overall Study|Lost to Follow-up|2|||
46931238|NCT05375838|83166263|FG005|Overall Study|Lost to Follow-up|3|||
46818901|NCT00325468|83038684|FG002|Overall Study|Physician Decision|0|||
46818902|NCT00325468|83038685|FG003|Overall Study|Physician Decision|1|||
46818903|NCT00325468|83038686|FG004|Overall Study|Physician Decision|0|||
46818904|NCT00325468|83038682|FG000|Overall Study|Withdrawal by Subject|3|||
46931239|NCT05332392|83166282|FG000|Overall Study|Did not meet inclusion criteria|25|||
46818905|NCT00325468|83038683|FG001|Overall Study|Withdrawal by Subject|1|||
46931240|NCT05332392|83166282|FG000|Overall Study|Principal Investigator's decision|17|||
46818906|NCT00325468|83038684|FG002|Overall Study|Withdrawal by Subject|0|||
46818907|NCT00325468|83038685|FG003|Overall Study|Withdrawal by Subject|14|||
46818908|NCT00325468|83038686|FG004|Overall Study|Withdrawal by Subject|4|||
46818909|NCT00325468|83038682|FG000|Overall Study|site closure etc|4|||
46818910|NCT00325468|83038683|FG001|Overall Study|site closure etc|2|||
46818911|NCT00325468|83038684|FG002|Overall Study|site closure etc|1|||
46818912|NCT00325468|83038685|FG003|Overall Study|site closure etc|8|||
46818913|NCT00325468|83038686|FG004|Overall Study|site closure etc|1|||
46818914|NCT00311584|83038701|FG000|Overall Study|Death|1|||
46758700|NCT00870740|82977026|FG003|Overall Study|Investigator Decision|0|||
46758701|NCT00870740|82977027|FG004|Overall Study|Investigator Decision|0|||
46758702|NCT00870740|82977028|FG005|Overall Study|Investigator Decision|0|||
46758703|NCT00870740|82977023|FG000|Overall Study|Subject Non-compliance|0|||
46758704|NCT00870740|82977024|FG001|Overall Study|Subject Non-compliance|0|||
46758705|NCT00870740|82977025|FG002|Overall Study|Subject Non-compliance|0|||
46758706|NCT00870740|82977026|FG003|Overall Study|Subject Non-compliance|0|||
46758707|NCT00870740|82977027|FG004|Overall Study|Subject Non-compliance|0|||
46758708|NCT00870740|82977028|FG005|Overall Study|Subject Non-compliance|1|||
46758709|NCT00870740|82977023|FG000|Overall Study|Death|0|||
46758710|NCT00870740|82977024|FG001|Overall Study|Death|0|||
46758711|NCT00870740|82977025|FG002|Overall Study|Death|0|||
46758712|NCT00870740|82977026|FG003|Overall Study|Death|0|||
46758713|NCT00870740|82977027|FG004|Overall Study|Death|1|||
46758714|NCT00870740|82977028|FG005|Overall Study|Death|0|||
46758715|NCT00870740|82977023|FG000|Overall Study|Other|2|||
46818915|NCT00311584|83038702|FG001|Overall Study|Death|0|||
46818916|NCT00311584|83038701|FG000|Overall Study|Lack of Efficacy|12|||
46818917|NCT00311584|83038702|FG001|Overall Study|Lack of Efficacy|15|||
46818918|NCT00311584|83038701|FG000|Overall Study|Physician Decision|4|||
46818919|NCT00311584|83038702|FG001|Overall Study|Physician Decision|5|||
46818920|NCT00311584|83038701|FG000|Overall Study|Withdrawal by Subject|1|||
46818921|NCT00311584|83038702|FG001|Overall Study|Withdrawal by Subject|1|||
46818922|NCT00311584|83038701|FG000|Overall Study|ineligible|2|||
46818923|NCT00311584|83038702|FG001|Overall Study|ineligible|2|||
46818924|NCT00383331|83038710|FG000|Overall Study|Protocol Violation|0|||
46818925|NCT00383331|83038711|FG001|Overall Study|Protocol Violation|1|||
46818926|NCT03934541|83038721|FG000|Overall Study|Study Terminated by Sponsor|0|||
46818927|NCT03934541|83038722|FG001|Overall Study|Study Terminated by Sponsor|1|||
46818928|NCT03934541|83038723|FG002|Overall Study|Study Terminated by Sponsor|0|||
46818929|NCT03934541|83038724|FG003|Overall Study|Study Terminated by Sponsor|0|||
46818930|NCT00325234|83038736|FG000|Overall Study|Adverse Event|10|||
46818931|NCT00325234|83038737|FG001|Overall Study|Adverse Event|7|||
46818932|NCT00325234|83038736|FG000|Overall Study|Death due to Study Disease|1|||
46818933|NCT00325234|83038737|FG001|Overall Study|Death due to Study Disease|0|||
46818934|NCT00325234|83038736|FG000|Overall Study|Entry Criteria Not Met|1|||
46818935|NCT00325234|83038737|FG001|Overall Study|Entry Criteria Not Met|2|||
46818936|NCT00325234|83038736|FG000|Overall Study|Subject Decision|6|||
46818937|NCT00325234|83038737|FG001|Overall Study|Subject Decision|8|||
46818938|NCT00325234|83038736|FG000|Overall Study|Physician Decision|17|||
46818939|NCT00325234|83038737|FG001|Overall Study|Physician Decision|12|||
46818940|NCT00325234|83038736|FG000|Overall Study|Progressive Disease|34|||
46818941|NCT00325234|83038737|FG001|Overall Study|Progressive Disease|37|||
46818942|NCT00366249|83038747|FG000|Overall Study|Adverse Event|53|||
46818943|NCT00366249|83038748|FG001|Overall Study|Adverse Event|28|||
46818944|NCT00366249|83038747|FG000|Overall Study|Death|0|||
46818945|NCT00366249|83038748|FG001|Overall Study|Death|1|||
46818946|NCT00366249|83038747|FG000|Overall Study|Physician Decision|5|||
46818947|NCT00366249|83038748|FG001|Overall Study|Physician Decision|2|||
46818948|NCT00366249|83038747|FG000|Overall Study|Lost to Follow-up|2|||
46818949|NCT00366249|83038748|FG001|Overall Study|Lost to Follow-up|0|||
46818950|NCT00366249|83038747|FG000|Overall Study|Protocol Violation|1|||
46818951|NCT00366249|83038748|FG001|Overall Study|Protocol Violation|2|||
46818952|NCT00366249|83038747|FG000|Overall Study|Withdrawal by Subject|18|||
46818953|NCT00366249|83038748|FG001|Overall Study|Withdrawal by Subject|4|||
46818954|NCT00366249|83038747|FG000|Overall Study|Lack of Efficacy|21|||
46758716|NCT00870740|82977024|FG001|Overall Study|Other|5|||
46758717|NCT00870740|82977025|FG002|Overall Study|Other|2|||
46818955|NCT00366249|83038748|FG001|Overall Study|Lack of Efficacy|21|||
46758718|NCT00870740|82977026|FG003|Overall Study|Other|4|||
46758719|NCT00870740|82977027|FG004|Overall Study|Other|3|||
46758720|NCT00870740|82977028|FG005|Overall Study|Other|5|||
46758721|NCT00869024|82977055|FG000|Overall Study|Death|2|||
46758722|NCT00869024|82977056|FG001|Overall Study|Death|3|||
46758723|NCT00869024|82977055|FG000|Overall Study|Lost to Follow-up|0|||
46758724|NCT00869024|82977056|FG001|Overall Study|Lost to Follow-up|1|||
46818956|NCT00366249|83038747|FG000|Overall Study|Most due to osteomylitis status|31|||
46818957|NCT00366249|83038748|FG001|Overall Study|Most due to osteomylitis status|20|||
46758725|NCT00869024|82977055|FG000|Overall Study|Protocol Violation|0|||
46818958|NCT00325156|83038754|FG000|Overall Study|Protocol Violation|8|||
46818959|NCT00325156|83038754|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
46818960|NCT00325156|83038754|FG000|Overall Study|Migrated/moved from study area|12|||
46818961|NCT00325156|83038754|FG000|Overall Study|Adverse event, non-fatal|3|||
46818962|NCT00325156|83038754|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
46818963|NCT00325156|83038754|FG000|Overall Study|Other|1|||
46818964|NCT00325156|83038754|FG000|Overall Study|Withdrawal by Subject|31|||
46818965|NCT03927911|83038764|FG000|Overall Study|problems with eDiary|0|||
46818966|NCT03927911|83038765|FG001|Overall Study|problems with eDiary|1|||
46818967|NCT03927911|83038766|FG002|Overall Study|problems with eDiary|0|||
46818968|NCT03927911|83038767|FG003|Overall Study|problems with eDiary|1|||
46818969|NCT03927911|83038768|FG004|Overall Study|problems with eDiary|0|||
46818970|NCT03927911|83038769|FG005|Overall Study|problems with eDiary|4|||
46818971|NCT03927911|83038764|FG000|Overall Study|Adverse Event|0|||
46818972|NCT03927911|83038765|FG001|Overall Study|Adverse Event|0|||
46818973|NCT03927911|83038766|FG002|Overall Study|Adverse Event|0|||
46818974|NCT03927911|83038767|FG003|Overall Study|Adverse Event|0|||
46818975|NCT03927911|83038768|FG004|Overall Study|Adverse Event|0|||
46818976|NCT03927911|83038769|FG005|Overall Study|Adverse Event|1|||
46818977|NCT03927911|83038764|FG000|Overall Study|not treated -study terminated by sponsor|0|||
46818978|NCT03927911|83038765|FG001|Overall Study|not treated -study terminated by sponsor|1|||
46818979|NCT03927911|83038766|FG002|Overall Study|not treated -study terminated by sponsor|0|||
46818980|NCT03927911|83038767|FG003|Overall Study|not treated -study terminated by sponsor|0|||
46818981|NCT03927911|83038768|FG004|Overall Study|not treated -study terminated by sponsor|0|||
46818982|NCT03927911|83038769|FG005|Overall Study|not treated -study terminated by sponsor|0|||
46818983|NCT03927911|83038764|FG000|Overall Study|Surgery cancelled|0|||
46818984|NCT03927911|83038765|FG001|Overall Study|Surgery cancelled|0|||
46818985|NCT03927911|83038766|FG002|Overall Study|Surgery cancelled|0|||
46818986|NCT03927911|83038767|FG003|Overall Study|Surgery cancelled|1|||
46818987|NCT03927911|83038768|FG004|Overall Study|Surgery cancelled|0|||
46818988|NCT03927911|83038769|FG005|Overall Study|Surgery cancelled|1|||
46818989|NCT03927911|83038764|FG000|Overall Study|Protocol Violation|0|||
46818990|NCT03927911|83038765|FG001|Overall Study|Protocol Violation|0|||
46818991|NCT03927911|83038766|FG002|Overall Study|Protocol Violation|0|||
46818992|NCT03927911|83038767|FG003|Overall Study|Protocol Violation|0|||
46818993|NCT03927911|83038768|FG004|Overall Study|Protocol Violation|0|||
46818994|NCT03927911|83038769|FG005|Overall Study|Protocol Violation|1|||
46818995|NCT00383019|83038785|FG000|Overall Study|Adverse Event|5|||
46818996|NCT00383019|83038786|FG001|Overall Study|Adverse Event|1|||
46818997|NCT00383019|83038785|FG000|Overall Study|Withdrawal by Subject|0|||
46818998|NCT00383019|83038786|FG001|Overall Study|Withdrawal by Subject|1|||
46818999|NCT00310804|83038794|FG000|Overall Study|Lost to Follow-up|2|||
46819000|NCT00310804|83038795|FG001|Overall Study|Lost to Follow-up|0|||
46819001|NCT00310804|83038794|FG000|Overall Study|Withdrawal by Subject|3|||
46819002|NCT00310804|83038795|FG001|Overall Study|Withdrawal by Subject|0|||
46819003|NCT03826186|83038817|FG000|Overall Study|Protocol Violation|2|||
46819004|NCT03826186|83038818|FG001|Overall Study|Protocol Violation|0|||
46819005|NCT03826186|83038817|FG000|Overall Study|Withdrawal by Subject|1|||
46819006|NCT03826186|83038818|FG001|Overall Study|Withdrawal by Subject|0|||
46819007|NCT00382863|83038826|FG000|Overall Study|Death|9|||
46819008|NCT00382863|83038827|FG001|Overall Study|Death|9|||
46819009|NCT00382863|83038826|FG000|Overall Study|Lost to Follow-up|1|||
46819010|NCT00382863|83038827|FG001|Overall Study|Lost to Follow-up|2|||
46819011|NCT00382863|83038826|FG000|Overall Study|Withdrawal by Subject|5|||
46819012|NCT00382863|83038827|FG001|Overall Study|Withdrawal by Subject|25|||
46819013|NCT03933449|83038835|FG000|Overall Study|Adverse Event|6|||
46819014|NCT03933449|83038836|FG001|Overall Study|Adverse Event|4|||
46819015|NCT03933449|83038835|FG000|Overall Study|Death|55|||
46819016|NCT03933449|83038836|FG001|Overall Study|Death|57|||
46819017|NCT03933449|83038835|FG000|Overall Study|Sponsor Decision|1|||
46819018|NCT03933449|83038836|FG001|Overall Study|Sponsor Decision|0|||
46819019|NCT00290758|83038859|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
46819020|NCT00290758|83038860|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
46819021|NCT00290758|83038859|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
46819022|NCT00290758|83038860|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
46819023|NCT00290758|83038859|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
46819024|NCT00290758|83038860|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
46819025|NCT00290758|83038859|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
47056164|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
47056165|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
47056166|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
47056167|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
47056168|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
47056169|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
47056170|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
47056171|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
47056172|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
46819026|NCT00290758|83038860|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
46819027|NCT00290758|83038859|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
46819028|NCT00290758|83038860|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
46819029|NCT00290758|83038859|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
46819030|NCT00290758|83038860|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
46819031|NCT00290758|83038859|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
46819032|NCT00290758|83038860|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
46819033|NCT00290758|83038859|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
46819034|NCT00290758|83038860|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
46931241|NCT05332392|83166282|FG000|Overall Study|Adverse Event|1|||
46931242|NCT05332392|83166282|FG000|Overall Study|Subject's decision|1|||
46931243|NCT05315908|83166292|FG000|Overall Study|Lost to Follow-up|4477|||
46931244|NCT05315908|83166293|FG001|Overall Study|Lost to Follow-up|4606|||
46931245|NCT05490771|83166355|FG000|Overall Study|Disease progression|18|||
46931246|NCT05490771|83166355|FG000|Overall Study|Adverse Event|3|||
46931247|NCT05490771|83166355|FG000|Overall Study|Other complicating disease|1|||
46931248|NCT05490771|83166355|FG000|Overall Study|Withdrawal by Subject|3|||
46931249|NCT05490771|83166355|FG000|Overall Study|Physician Decision|1|||
46819035|NCT00372567|83038873|FG000|Phase 3 Study|Adverse Event|5|||
46819036|NCT00372567|83038874|FG001|Phase 3 Study|Adverse Event|1|||
46931250|NCT05490771|83166355|FG000|Overall Study|Still on treatment|2|||
46931251|NCT05490771|83166355|FG000|Overall Study|Never start protocol therapy|5|||
46931252|NCT05490771|83166355|FG000|Overall Study|Ineligible|2|||
46931253|NCT05466240|83166361|FG000|Overall Study|Adverse Event|1|||
46931254|NCT05466240|83166362|FG001|Overall Study|Adverse Event|0|||
46931255|NCT05466240|83166361|FG000|Overall Study|Withdrawal by Subject|1|||
46931256|NCT05466240|83166362|FG001|Overall Study|Withdrawal by Subject|0|||
46931257|NCT05223673|83166381|FG000|Overall Study|Protocol Violation|1|||
46931258|NCT05223673|83166381|FG000|Overall Study|Study termination|6|||
46931259|NCT05095311|83166388|FG000|Overall Study|Lost to Follow-up|7|||
46931260|NCT05095311|83166389|FG001|Overall Study|Lost to Follow-up|0|||
46931261|NCT05095311|83166390|FG002|Overall Study|Lost to Follow-up|0|||
46931262|NCT04654468|83166401|FG000|Overall Study|Death|1|||
46819037|NCT00372567|83038875|FG002|Phase 3 Study|Adverse Event|1|||
46819038|NCT00372567|83038873|FG000|Phase 3 Study|Death|1|||
46819039|NCT00372567|83038874|FG001|Phase 3 Study|Death|1|||
46819040|NCT00372567|83038875|FG002|Phase 3 Study|Death|0|||
46819041|NCT00372567|83038873|FG000|Phase 3 Study|Protocol Violation|0|||
46819042|NCT00372567|83038874|FG001|Phase 3 Study|Protocol Violation|0|||
46819043|NCT00372567|83038875|FG002|Phase 3 Study|Protocol Violation|1|||
46819044|NCT00372567|83038873|FG000|Phase 3 Study|Objective progression or relapse|10|||
46819045|NCT00372567|83038874|FG001|Phase 3 Study|Objective progression or relapse|13|||
46819046|NCT00372567|83038875|FG002|Phase 3 Study|Objective progression or relapse|4|||
46819047|NCT00372567|83038873|FG000|Phase 3 Study|Global deterioration of health status|0|||
46819048|NCT00372567|83038874|FG001|Phase 3 Study|Global deterioration of health status|1|||
46819049|NCT00372567|83038875|FG002|Phase 3 Study|Global deterioration of health status|0|||
46819050|NCT00372567|83038873|FG000|Phase 3 Study|Other|2|||
46819051|NCT00372567|83038874|FG001|Phase 3 Study|Other|2|||
46819052|NCT00372567|83038875|FG002|Phase 3 Study|Other|1|||
46819053|NCT00372567|83038873|FG000|Phase 3 Study|study terminated by sponsor|13|||
46819054|NCT00372567|83038874|FG001|Phase 3 Study|study terminated by sponsor|8|||
46819055|NCT00372567|83038875|FG002|Phase 3 Study|study terminated by sponsor|5|||
46819056|NCT00365547|83038883|FG000|Overall Study|Insurance did not cover Avastin|1|||
46819057|NCT00365547|83038883|FG000|Overall Study|Screen failure|1|||
46819058|NCT00365547|83038883|FG000|Overall Study|Withdrawal by Subject|1|||
46819059|NCT00545441|83038892|FG000|Overall Study|Fistula draining at 6 months|2|||
46819060|NCT00545441|83038893|FG001|Overall Study|Fistula draining at 6 months|4|||
46819061|NCT00545441|83038892|FG000|Overall Study|Lost to Follow-up|9|||
46819062|NCT00545441|83038893|FG001|Overall Study|Lost to Follow-up|5|||
46819063|NCT00545441|83038892|FG000|Overall Study|Technical failure|0|||
46819064|NCT00545441|83038893|FG001|Overall Study|Technical failure|1|||
46819065|NCT00545441|83038892|FG000|Overall Study|Withdrawal by Subject|1|||
46819066|NCT00545441|83038893|FG001|Overall Study|Withdrawal by Subject|1|||
46819067|NCT00545441|83038892|FG000|Overall Study|Persistence or recurrence of fistula|5|||
46819068|NCT00545441|83038893|FG001|Overall Study|Persistence or recurrence of fistula|2|||
46819069|NCT00545441|83038892|FG000|Overall Study|Patients were not treated|1|||
46931263|NCT04654468|83166401|FG000|Overall Study|Ongoing in the Study|50|||
46931264|NCT04649359|83166407|FG000|Overall Study|Withdrawal by Subject|7|||
46931265|NCT04649359|83166408|FG001|Overall Study|Withdrawal by Subject|7|||
46931266|NCT04649359|83166407|FG000|Overall Study|Death|41|||
46931267|NCT04649359|83166408|FG001|Overall Study|Death|26|||
46931268|NCT04649359|83166407|FG000|Overall Study|Ongoing in the study|75|||
46931269|NCT04649359|83166408|FG001|Overall Study|Ongoing in the study|31|||
46931270|NCT04625413|83166414|FG000|Overall Study|Hospice|2|||
46931271|NCT04625413|83166414|FG000|Overall Study|Distress|1|||
46931272|NCT04625413|83166414|FG000|Overall Study|Not feeling well|1|||
46819070|NCT00545441|83038893|FG001|Overall Study|Patients were not treated|3|||
46819071|NCT00294658|83038901|FG000|Overall Study|Death|0|||
46819072|NCT00294658|83038902|FG001|Overall Study|Death|1|||
46819073|NCT00294658|83038901|FG000|Overall Study|Lost to Follow-up|4|||
46819074|NCT00294658|83038902|FG001|Overall Study|Lost to Follow-up|0|||
46819075|NCT00294658|83038901|FG000|Overall Study|Physician Decision|1|||
46819076|NCT00294658|83038902|FG001|Overall Study|Physician Decision|2|||
47056173|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
47056174|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
46819077|NCT00294658|83038901|FG000|Overall Study|Pregnancy|0|||
46819078|NCT00294658|83038902|FG001|Overall Study|Pregnancy|1|||
46819079|NCT00294658|83038901|FG000|Overall Study|Withdrawal by Subject|0|||
46819080|NCT00294658|83038902|FG001|Overall Study|Withdrawal by Subject|4|||
46819081|NCT00294658|83038901|FG000|Overall Study|Found to have invasive thymoma|1|||
46819082|NCT00294658|83038902|FG001|Overall Study|Found to have invasive thymoma|0|||
46819083|NCT00294658|83038901|FG000|Overall Study|Patient and family were not satisfied|0|||
46819084|NCT00294658|83038902|FG001|Overall Study|Patient and family were not satisfied|1|||
46819085|NCT03923933|83038910|FG000|Overall Study|Lost to Follow-up|1|||
46819086|NCT03923933|83038911|FG001|Overall Study|Lost to Follow-up|0|||
46819087|NCT03923933|83038910|FG000|Overall Study|Withdrawal by Subject|0|||
47056175|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
47056176|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
47056177|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
47056178|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
47056179|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Death|0|||
46819088|NCT03923933|83038911|FG001|Overall Study|Withdrawal by Subject|1|||
46819089|NCT00372489|83038917|FG000|Overall Study|Adverse Event|18|||
46819090|NCT00372489|83038917|FG000|Overall Study|Lack of Efficacy|1|||
46819091|NCT00372489|83038917|FG000|Overall Study|Lost to Follow-up|3|||
46819092|NCT00372489|83038917|FG000|Overall Study|Physician Decision|3|||
47056180|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Death|1|||
47056181|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Death|0|||
47056182|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Death|0|||
47056183|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Death|0|||
47056184|NCT03713632|83332041|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
46758726|NCT00869024|82977056|FG001|Overall Study|Protocol Violation|1|||
46758727|NCT00506779|82977064|FG000|Overall Study|Withdrawal by Subject|1|||
46758728|NCT00506779|82977065|FG001|Overall Study|Withdrawal by Subject|0|||
46758729|NCT00506779|82977066|FG002|Overall Study|Withdrawal by Subject|1|||
46758730|NCT00506779|82977067|FG003|Overall Study|Withdrawal by Subject|0|||
46758731|NCT00506779|82977064|FG000|Overall Study|Adverse Event|0|||
46758732|NCT00506779|82977065|FG001|Overall Study|Adverse Event|1|||
46758733|NCT00506779|82977066|FG002|Overall Study|Adverse Event|1|||
46819093|NCT00372489|83038917|FG000|Overall Study|Withdrawal by Subject|5|||
46819094|NCT00372489|83038917|FG000|Overall Study|Patient Relocation|2|||
46819095|NCT00372489|83038917|FG000|Overall Study|Renal transplant|6|||
46819096|NCT00372489|83038917|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
46819097|NCT00372411|83038924|FG000|Overall Study|Withdrawal by Subject|3|||
46819098|NCT00372411|83038925|FG001|Overall Study|Withdrawal by Subject|4|||
46819099|NCT00372411|83038926|FG002|Overall Study|Withdrawal by Subject|1|||
46819100|NCT00372411|83038924|FG000|Overall Study|Death|0|||
46819101|NCT00372411|83038925|FG001|Overall Study|Death|2|||
46819102|NCT00372411|83038926|FG002|Overall Study|Death|1|||
46819103|NCT00372411|83038924|FG000|Overall Study|Lost to Follow-up|1|||
46819104|NCT00372411|83038925|FG001|Overall Study|Lost to Follow-up|1|||
46819105|NCT00372411|83038926|FG002|Overall Study|Lost to Follow-up|1|||
46819106|NCT00372411|83038924|FG000|Overall Study|Adverse Event|1|||
46819107|NCT00372411|83038925|FG001|Overall Study|Adverse Event|1|||
46819108|NCT00372411|83038926|FG002|Overall Study|Adverse Event|0|||
46819109|NCT00372255|83038936|FG000|Overall Study|Withdrawn for other reasons|2|||
46819110|NCT00372255|83038937|FG001|Overall Study|Withdrawn for other reasons|1|||
47056185|NCT03713632|83332042|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
47056186|NCT03713632|83332043|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
47056187|NCT03713632|83332044|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
47056188|NCT03713632|83332045|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
46758734|NCT00506779|82977067|FG003|Overall Study|Adverse Event|1|||
46758735|NCT00488293|82977080|FG000|Overall Study|Lost to Follow-up|28|||
46819111|NCT00274456|83038948|FG000|Overall Study|Still on treatment|2|||
46819112|NCT00274456|83038949|FG001|Overall Study|Still on treatment|3|||
46819113|NCT00274456|83038950|FG002|Overall Study|Still on treatment|5|||
46819114|NCT00274456|83038951|FG003|Overall Study|Still on treatment|1|||
46819115|NCT00274456|83038948|FG000|Overall Study|Unacceptable toxicity|10|||
47056189|NCT03517436|83332067|FG000|Overall Study|Death|3|||
47056190|NCT03517436|83332067|FG000|Overall Study|Withdrawal by Subject|4|||
46758736|NCT00488293|82977081|FG001|Overall Study|Lost to Follow-up|25|||
46819116|NCT00274456|83038949|FG001|Overall Study|Unacceptable toxicity|5|||
46819117|NCT00274456|83038950|FG002|Overall Study|Unacceptable toxicity|12|||
46819118|NCT00274456|83038951|FG003|Overall Study|Unacceptable toxicity|16|||
46819119|NCT00274456|83038948|FG000|Overall Study|Adverse Event|0|||
46819120|NCT00274456|83038949|FG001|Overall Study|Adverse Event|1|||
46819121|NCT00274456|83038950|FG002|Overall Study|Adverse Event|2|||
46819122|NCT00274456|83038951|FG003|Overall Study|Adverse Event|2|||
46819123|NCT00274456|83038948|FG000|Overall Study|Physician Decision|7|||
46931273|NCT04585789|83166422|FG000|Overall Study|Withdrawal by Subject|1|||
46931274|NCT04585789|83166423|FG001|Overall Study|Withdrawal by Subject|0|||
46931275|NCT04585789|83166422|FG000|Overall Study|Ongoing|9|||
46931276|NCT04585789|83166423|FG001|Overall Study|Ongoing|10|||
46931277|NCT04502693|83166433|FG000|Overall Study|Adverse Event|7|||
46931278|NCT04502693|83166434|FG001|Overall Study|Adverse Event|6|||
46931279|NCT04502693|83166435|FG002|Overall Study|Adverse Event|11|||
46931280|NCT04502693|83166436|FG003|Overall Study|Adverse Event|1|||
46931281|NCT04502693|83166433|FG000|Overall Study|Lost to Follow-up|32|||
46931282|NCT04502693|83166434|FG001|Overall Study|Lost to Follow-up|36|||
46636705|NCT01508130|82810495|FG000|Overall Study|Administrative|14|||
46636706|NCT01508130|82810496|FG001|Overall Study|Administrative|3|||
46758737|NCT00488293|82977080|FG000|Overall Study|Withdrawal by Subject|5|||
46758738|NCT00488293|82977081|FG001|Overall Study|Withdrawal by Subject|3|||
46758739|NCT00488293|82977080|FG000|Overall Study|Death|2|||
46758740|NCT00488293|82977081|FG001|Overall Study|Death|1|||
46758741|NCT00488293|82977080|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
46758742|NCT00488293|82977081|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
46758743|NCT00868790|82977087|FG000|Period 1|Adverse Event|1|||
46758744|NCT00868790|82977088|FG001|Period 1|Adverse Event|0|||
46758745|NCT00868790|82977089|FG002|Period 1|Adverse Event|0|||
46758746|NCT00868790|82977090|FG003|Period 1|Adverse Event|0|||
46758747|NCT00868790|82977091|FG004|Period 1|Adverse Event|0|||
46758748|NCT00868790|82977092|FG005|Period 1|Adverse Event|0|||
46758749|NCT00868790|82977093|FG006|Period 1|Adverse Event|0|||
46758750|NCT00868790|82977094|FG007|Period 1|Adverse Event|3|||
46758751|NCT00868790|82977095|FG008|Period 1|Adverse Event|1|||
46758752|NCT00868790|82977096|FG009|Period 1|Adverse Event|0|||
46758753|NCT00868790|82977097|FG010|Period 1|Adverse Event|0|||
46758754|NCT00868790|82977098|FG011|Period 1|Adverse Event|0|||
46758755|NCT00868790|82977099|FG012|Period 1|Adverse Event|0|||
46758756|NCT00868790|82977100|FG013|Period 1|Adverse Event|1|||
46758757|NCT00868790|82977087|FG000|Period 1|Protocol Violation|1|||
46758758|NCT00868790|82977088|FG001|Period 1|Protocol Violation|0|||
46758759|NCT00868790|82977089|FG002|Period 1|Protocol Violation|0|||
46758760|NCT00868790|82977090|FG003|Period 1|Protocol Violation|0|||
46758761|NCT00868790|82977091|FG004|Period 1|Protocol Violation|0|||
46758762|NCT00868790|82977092|FG005|Period 1|Protocol Violation|0|||
46758763|NCT00868790|82977093|FG006|Period 1|Protocol Violation|0|||
46758764|NCT00868790|82977094|FG007|Period 1|Protocol Violation|0|||
46758765|NCT00868790|82977095|FG008|Period 1|Protocol Violation|0|||
46758766|NCT00868790|82977096|FG009|Period 1|Protocol Violation|0|||
46758767|NCT00868790|82977097|FG010|Period 1|Protocol Violation|0|||
46758768|NCT00868790|82977098|FG011|Period 1|Protocol Violation|0|||
46758769|NCT00868790|82977099|FG012|Period 1|Protocol Violation|0|||
46758770|NCT00868790|82977100|FG013|Period 1|Protocol Violation|0|||
46758771|NCT00868790|82977087|FG000|Period 1|Withdrawal by Subject|0|||
46758772|NCT00868790|82977088|FG001|Period 1|Withdrawal by Subject|1|||
46758773|NCT00868790|82977089|FG002|Period 1|Withdrawal by Subject|0|||
46758774|NCT00868790|82977090|FG003|Period 1|Withdrawal by Subject|0|||
46758775|NCT00868790|82977091|FG004|Period 1|Withdrawal by Subject|0|||
46758776|NCT00868790|82977092|FG005|Period 1|Withdrawal by Subject|0|||
46758777|NCT00868790|82977093|FG006|Period 1|Withdrawal by Subject|0|||
46758778|NCT00868790|82977094|FG007|Period 1|Withdrawal by Subject|0|||
46819124|NCT00274456|83038949|FG001|Overall Study|Physician Decision|5|||
46819125|NCT00274456|83038950|FG002|Overall Study|Physician Decision|6|||
46758779|NCT00868790|82977095|FG008|Period 1|Withdrawal by Subject|0|||
46758780|NCT00868790|82977096|FG009|Period 1|Withdrawal by Subject|0|||
46819126|NCT00274456|83038951|FG003|Overall Study|Physician Decision|13|||
46931283|NCT04502693|83166435|FG002|Overall Study|Lost to Follow-up|69|||
46636707|NCT01482312|82810504|FG000|Period 1, 90 Minutes of Wear|Other|1|||
46758781|NCT00868790|82977097|FG010|Period 1|Withdrawal by Subject|0|||
46758782|NCT00868790|82977098|FG011|Period 1|Withdrawal by Subject|0|||
46758783|NCT00868790|82977099|FG012|Period 1|Withdrawal by Subject|0|||
46758784|NCT00868790|82977100|FG013|Period 1|Withdrawal by Subject|1|||
46758785|NCT00868790|82977087|FG000|Period 1|Abnormal Triglycerides|0|||
46758786|NCT00868790|82977088|FG001|Period 1|Abnormal Triglycerides|0|||
46758787|NCT00868790|82977089|FG002|Period 1|Abnormal Triglycerides|0|||
46819127|NCT00274456|83038948|FG000|Overall Study|Lost to Follow-up|0|||
46819128|NCT00274456|83038949|FG001|Overall Study|Lost to Follow-up|0|||
46819129|NCT00274456|83038950|FG002|Overall Study|Lost to Follow-up|1|||
46931284|NCT04502693|83166436|FG003|Overall Study|Lost to Follow-up|4|||
46931285|NCT04502693|83166433|FG000|Overall Study|Protocol Violation|8|||
46758788|NCT00868790|82977090|FG003|Period 1|Abnormal Triglycerides|0|||
46758789|NCT00868790|82977091|FG004|Period 1|Abnormal Triglycerides|1|||
46931286|NCT04502693|83166434|FG001|Overall Study|Protocol Violation|8|||
46819130|NCT00274456|83038951|FG003|Overall Study|Lost to Follow-up|0|||
46758790|NCT00868790|82977092|FG005|Period 1|Abnormal Triglycerides|0|||
46758791|NCT00868790|82977093|FG006|Period 1|Abnormal Triglycerides|0|||
46758792|NCT00868790|82977094|FG007|Period 1|Abnormal Triglycerides|0|||
46758793|NCT00868790|82977095|FG008|Period 1|Abnormal Triglycerides|0|||
46758794|NCT00868790|82977096|FG009|Period 1|Abnormal Triglycerides|0|||
46758795|NCT00868790|82977097|FG010|Period 1|Abnormal Triglycerides|0|||
46819131|NCT00274456|83038948|FG000|Overall Study|Withdrawal by Subject|18|||
46819132|NCT00274456|83038949|FG001|Overall Study|Withdrawal by Subject|13|||
46819133|NCT00274456|83038950|FG002|Overall Study|Withdrawal by Subject|9|||
46819134|NCT00274456|83038951|FG003|Overall Study|Withdrawal by Subject|13|||
46819135|NCT00364923|83038961|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
46819136|NCT00364923|83038961|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
46819137|NCT00381849|83038967|FG000|Wash Out|Withdrawal by Subject|0|||
46819138|NCT00381849|83038968|FG001|Wash Out|Withdrawal by Subject|1|||
46819139|NCT00273052|83038976|FG000|Overall Study|Withdrawal by Subject|16|||
46819140|NCT00273052|83038977|FG001|Overall Study|Withdrawal by Subject|19|||
46819141|NCT00273052|83038976|FG000|Overall Study|Adverse Event|21|||
46819142|NCT00273052|83038977|FG001|Overall Study|Adverse Event|19|||
46819143|NCT00273052|83038976|FG000|Overall Study|Protocol Violation|14|||
46819144|NCT00273052|83038977|FG001|Overall Study|Protocol Violation|18|||
46819145|NCT00273052|83038976|FG000|Overall Study|Lost to Follow-up|7|||
46819146|NCT00273052|83038977|FG001|Overall Study|Lost to Follow-up|25|||
46819147|NCT00273052|83038976|FG000|Overall Study|Lack of Efficacy|6|||
46819148|NCT00273052|83038977|FG001|Overall Study|Lack of Efficacy|4|||
46819149|NCT00273052|83038976|FG000|Overall Study|Non-Compliance|3|||
46819150|NCT00273052|83038977|FG001|Overall Study|Non-Compliance|1|||
46819151|NCT00273052|83038976|FG000|Overall Study|Other|2|||
46819152|NCT00273052|83038977|FG001|Overall Study|Other|0|||
46819153|NCT00273052|83038976|FG000|Overall Study|Worsening serum lipid levels|0|||
46819154|NCT00273052|83038977|FG001|Overall Study|Worsening serum lipid levels|2|||
46819155|NCT00290290|83038985|FG000|Overall Study|Death|3|||
46819156|NCT00290290|83038986|FG001|Overall Study|Death|4|||
46819157|NCT00290290|83038985|FG000|Overall Study|Withdrawal by Subject|2|||
46819158|NCT00290290|83038986|FG001|Overall Study|Withdrawal by Subject|2|||
46819159|NCT00290290|83038985|FG000|Overall Study|Underwent clean surgical procedure|13|||
46819160|NCT00290290|83038986|FG001|Overall Study|Underwent clean surgical procedure|12|||
46819161|NCT00272038|83038992|FG000|Overall Study|withdrew before they received 2 cycles|7|||
46819162|NCT00271024|83039001|FG000|Overall Study|Lost Interest|3|||
46819163|NCT00271024|83039002|FG001|Overall Study|Lost Interest|4|||
46819164|NCT00271024|83039003|FG002|Overall Study|Lost Interest|2|||
46819165|NCT00271024|83039004|FG003|Overall Study|Lost Interest|3|||
46758796|NCT00868790|82977098|FG011|Period 1|Abnormal Triglycerides|0|||
46819166|NCT00271024|83039001|FG000|Overall Study|Unknown/Unspecified|11|||
46819167|NCT00271024|83039002|FG001|Overall Study|Unknown/Unspecified|11|||
46758797|NCT00868790|82977099|FG012|Period 1|Abnormal Triglycerides|0|||
46758798|NCT00868790|82977100|FG013|Period 1|Abnormal Triglycerides|0|||
46758799|NCT00868790|82977087|FG000|Period 1|Lost to Follow-up|0|||
46758800|NCT00868790|82977088|FG001|Period 1|Lost to Follow-up|0|||
46758801|NCT00868790|82977089|FG002|Period 1|Lost to Follow-up|0|||
46758802|NCT00868790|82977090|FG003|Period 1|Lost to Follow-up|0|||
46758803|NCT00868790|82977091|FG004|Period 1|Lost to Follow-up|0|||
46758804|NCT00868790|82977092|FG005|Period 1|Lost to Follow-up|1|||
46758805|NCT00868790|82977093|FG006|Period 1|Lost to Follow-up|0|||
46758806|NCT00868790|82977094|FG007|Period 1|Lost to Follow-up|0|||
46758807|NCT00868790|82977095|FG008|Period 1|Lost to Follow-up|0|||
46819168|NCT00271024|83039003|FG002|Overall Study|Unknown/Unspecified|8|||
46819169|NCT00271024|83039004|FG003|Overall Study|Unknown/Unspecified|4|||
46819170|NCT00271024|83039001|FG000|Overall Study|Protocol Violation|1|||
46819171|NCT00271024|83039002|FG001|Overall Study|Protocol Violation|6|||
47056191|NCT03517436|83332067|FG000|Overall Study|Did not receive study valve.|1|||
47056192|NCT03170349|83332071|FG000|At 30 Days Follow-up|Death|1|||
47056193|NCT03170349|83332071|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
47056194|NCT03170349|83332071|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
47056195|NCT03170349|83332071|FG000|At 6 Months Follow-up|Death|3|||
46758808|NCT00868790|82977096|FG009|Period 1|Lost to Follow-up|0|||
46758809|NCT00868790|82977097|FG010|Period 1|Lost to Follow-up|0|||
47056196|NCT03170349|83332071|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
46758810|NCT00868790|82977098|FG011|Period 1|Lost to Follow-up|0|||
46819172|NCT00271024|83039003|FG002|Overall Study|Protocol Violation|5|||
46819173|NCT00271024|83039004|FG003|Overall Study|Protocol Violation|11|||
46819174|NCT00271024|83039001|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
46819175|NCT00271024|83039002|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
46819176|NCT00271024|83039003|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
46819177|NCT00271024|83039004|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
47056197|NCT03170349|83332071|FG000|At 1 Year Follow-up|Death|6|||
46758811|NCT00868790|82977099|FG012|Period 1|Lost to Follow-up|0|||
46758812|NCT00868790|82977100|FG013|Period 1|Lost to Follow-up|0|||
46819178|NCT00271024|83039001|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
46819179|NCT00271024|83039002|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
46819180|NCT00271024|83039003|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
46819181|NCT00271024|83039004|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
46819182|NCT00381693|83039014|FG000|Overall Study|Death|1|||
46819183|NCT00381693|83039014|FG000|Overall Study|Adverse Event|4|||
46636708|NCT01482312|82810505|FG001|Period 1, 90 Minutes of Wear|Other|0|||
46758813|NCT00868790|82977087|FG000|Period 2|Adverse Event|0|||
46819184|NCT00381693|83039014|FG000|Overall Study|Patient Choice|1|||
46819185|NCT00381693|83039014|FG000|Overall Study|Progression|2|||
46819186|NCT00545363|83039020|FG000|Overall Study|Adverse Event|6|||
46819187|NCT00545363|83039021|FG001|Overall Study|Adverse Event|7|||
46819188|NCT00545363|83039020|FG000|Overall Study|Withdrawal by Subject|6|||
46819189|NCT00545363|83039021|FG001|Overall Study|Withdrawal by Subject|5|||
46819190|NCT00545363|83039020|FG000|Overall Study|Non-compliance|3|||
46819191|NCT00545363|83039021|FG001|Overall Study|Non-compliance|1|||
46819192|NCT00545363|83039020|FG000|Overall Study|Did not meet entry criteria|1|||
46819193|NCT00545363|83039021|FG001|Overall Study|Did not meet entry criteria|1|||
46819194|NCT00545363|83039020|FG000|Overall Study|Lost to Follow-up|2|||
46819195|NCT00545363|83039021|FG001|Overall Study|Lost to Follow-up|0|||
46819196|NCT00545363|83039020|FG000|Overall Study|Other|1|||
46819197|NCT00545363|83039021|FG001|Overall Study|Other|1|||
46819198|NCT00457392|83039029|FG000|Overall Study|Objective Progression or Relapse|229|||
46819199|NCT00457392|83039030|FG001|Overall Study|Objective Progression or Relapse|296|||
46819200|NCT00457392|83039029|FG000|Overall Study|Death|106|||
46758814|NCT00868790|82977088|FG001|Period 2|Adverse Event|0|||
47056198|NCT03170349|83332071|FG000|At 2 Year Follow-up|Missed Visit|4|||
47056199|NCT03170349|83332071|FG000|At 2 Year Follow-up|Death|13|||
47056200|NCT03170349|83332071|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
47056201|NCT02836236|83332091|FG000|Overall Study|Randomized but Never Treated|1|||
47056202|NCT02836236|83332092|FG001|Overall Study|Randomized but Never Treated|0|||
47056203|NCT02836236|83332091|FG000|Overall Study|Withdrew Consent|2|||
46758815|NCT00868790|82977089|FG002|Period 2|Adverse Event|0|||
46819201|NCT00457392|83039030|FG001|Overall Study|Death|106|||
46819202|NCT00457392|83039029|FG000|Overall Study|Adverse Event|84|||
46819203|NCT00457392|83039030|FG001|Overall Study|Adverse Event|41|||
46819204|NCT00457392|83039029|FG000|Overall Study|Global Deterioration of Health Status|22|||
46819205|NCT00457392|83039030|FG001|Overall Study|Global Deterioration of Health Status|8|||
46819206|NCT00457392|83039029|FG000|Overall Study|Withdrawal by Subject|14|||
46819207|NCT00457392|83039030|FG001|Overall Study|Withdrawal by Subject|8|||
46819208|NCT00457392|83039029|FG000|Overall Study|Lost to Follow-up|6|||
46819209|NCT00457392|83039030|FG001|Overall Study|Lost to Follow-up|7|||
46819210|NCT00457392|83039029|FG000|Overall Study|Protocol Violation|4|||
46819211|NCT00457392|83039030|FG001|Overall Study|Protocol Violation|3|||
46819212|NCT00457392|83039029|FG000|Overall Study|Other|7|||
46819213|NCT00457392|83039030|FG001|Overall Study|Other|4|||
46819214|NCT00457392|83039029|FG000|Overall Study|Study Terminated by Sponsor|1|||
47056204|NCT02836236|83332092|FG001|Overall Study|Withdrew Consent|0|||
46758816|NCT00868790|82977090|FG003|Period 2|Adverse Event|0|||
46758817|NCT00868790|82977091|FG004|Period 2|Adverse Event|0|||
46758818|NCT00868790|82977092|FG005|Period 2|Adverse Event|0|||
46758819|NCT00868790|82977093|FG006|Period 2|Adverse Event|0|||
46758820|NCT00868790|82977094|FG007|Period 2|Adverse Event|0|||
46758821|NCT00868790|82977095|FG008|Period 2|Adverse Event|1|||
46758822|NCT00868790|82977096|FG009|Period 2|Adverse Event|0|||
46758823|NCT00868790|82977097|FG010|Period 2|Adverse Event|0|||
46758824|NCT00868790|82977098|FG011|Period 2|Adverse Event|0|||
46819215|NCT00457392|83039030|FG001|Overall Study|Study Terminated by Sponsor|4|||
46819216|NCT00457392|83039029|FG000|Overall Study|Randomized, Not Treated|7|||
47056205|NCT02836236|83332091|FG000|Overall Study|Adverse Event|0|||
47056206|NCT02836236|83332092|FG001|Overall Study|Adverse Event|1|||
47056207|NCT02836236|83332091|FG000|Overall Study|Investigator's Discretion|1|||
46758825|NCT00868790|82977099|FG012|Period 2|Adverse Event|0|||
46758826|NCT00868790|82977100|FG013|Period 2|Adverse Event|0|||
46758827|NCT00868790|82977087|FG000|Period 2|Lost to Follow-up|0|||
46819217|NCT00457392|83039030|FG001|Overall Study|Randomized, Not Treated|3|||
46819218|NCT00545051|83039038|FG000|Overall Study|Adverse Event|7|||
46819219|NCT00545051|83039039|FG001|Overall Study|Adverse Event|3|||
46758828|NCT00868790|82977088|FG001|Period 2|Lost to Follow-up|1|||
47056208|NCT02836236|83332092|FG001|Overall Study|Investigator's Discretion|0|||
46636709|NCT01482312|82810506|FG002|Period 1, 90 Minutes of Wear|Other|0|||
46819220|NCT00545051|83039038|FG000|Overall Study|Death|1|||
46819221|NCT00545051|83039039|FG001|Overall Study|Death|0|||
46819222|NCT00545051|83039038|FG000|Overall Study|Violation of inclusion/exclusion|0|||
46758829|NCT00868790|82977089|FG002|Period 2|Lost to Follow-up|0|||
46819223|NCT00545051|83039039|FG001|Overall Study|Violation of inclusion/exclusion|2|||
46819224|NCT00545051|83039038|FG000|Overall Study|Protocol Violation|1|||
46819225|NCT00545051|83039039|FG001|Overall Study|Protocol Violation|0|||
47056209|NCT02836236|83332091|FG000|Overall Study|Still on Study|101|||
47056210|NCT02836236|83332092|FG001|Overall Study|Still on Study|49|||
46931287|NCT04502693|83166435|FG002|Overall Study|Protocol Violation|16|||
46931288|NCT04502693|83166436|FG003|Overall Study|Protocol Violation|1|||
46931289|NCT04502693|83166433|FG000|Overall Study|Withdrawal by Subject|46|||
46931290|NCT04502693|83166434|FG001|Overall Study|Withdrawal by Subject|38|||
46931291|NCT04502693|83166435|FG002|Overall Study|Withdrawal by Subject|54|||
46931292|NCT04502693|83166436|FG003|Overall Study|Withdrawal by Subject|7|||
46931293|NCT04502693|83166433|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
46931294|NCT04502693|83166434|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
46931295|NCT04502693|83166435|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
46931296|NCT04502693|83166436|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46931297|NCT04502693|83166433|FG000|Overall Study|Other|1|||
46931298|NCT04502693|83166434|FG001|Overall Study|Other|0|||
46931299|NCT04502693|83166435|FG002|Overall Study|Other|1|||
46931300|NCT04502693|83166436|FG003|Overall Study|Other|1|||
46931301|NCT04343872|83166458|FG000|Overall Study|Lost to Follow-up|6|||
46931302|NCT04343872|83166459|FG001|Overall Study|Lost to Follow-up|3|||
46931303|NCT04093492|83166469|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
46931304|NCT04093492|83166470|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
46931305|NCT04093492|83166471|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
46758830|NCT00868790|82977090|FG003|Period 2|Lost to Follow-up|0|||
46758831|NCT00868790|82977091|FG004|Period 2|Lost to Follow-up|0|||
46758832|NCT00868790|82977092|FG005|Period 2|Lost to Follow-up|1|||
46758833|NCT00868790|82977093|FG006|Period 2|Lost to Follow-up|0|||
46758834|NCT00868790|82977094|FG007|Period 2|Lost to Follow-up|0|||
46758835|NCT00868790|82977095|FG008|Period 2|Lost to Follow-up|0|||
46758836|NCT00868790|82977096|FG009|Period 2|Lost to Follow-up|0|||
46758837|NCT00868790|82977097|FG010|Period 2|Lost to Follow-up|0|||
46758838|NCT00868790|82977098|FG011|Period 2|Lost to Follow-up|0|||
46758839|NCT00868790|82977099|FG012|Period 2|Lost to Follow-up|0|||
46758840|NCT00868790|82977100|FG013|Period 2|Lost to Follow-up|0|||
46758841|NCT00868790|82977087|FG000|Period 2|Withdrawal by Subject|0|||
46758842|NCT00868790|82977088|FG001|Period 2|Withdrawal by Subject|0|||
46758843|NCT00868790|82977089|FG002|Period 2|Withdrawal by Subject|0|||
46758844|NCT00868790|82977090|FG003|Period 2|Withdrawal by Subject|0|||
46758845|NCT00868790|82977091|FG004|Period 2|Withdrawal by Subject|0|||
46758846|NCT00868790|82977092|FG005|Period 2|Withdrawal by Subject|0|||
46758847|NCT00868790|82977093|FG006|Period 2|Withdrawal by Subject|0|||
46758848|NCT00868790|82977094|FG007|Period 2|Withdrawal by Subject|0|||
46758849|NCT00868790|82977095|FG008|Period 2|Withdrawal by Subject|1|||
46758850|NCT00868790|82977096|FG009|Period 2|Withdrawal by Subject|0|||
46758851|NCT00868790|82977097|FG010|Period 2|Withdrawal by Subject|0|||
46758852|NCT00868790|82977098|FG011|Period 2|Withdrawal by Subject|0|||
46758853|NCT00868790|82977099|FG012|Period 2|Withdrawal by Subject|0|||
46758854|NCT00868790|82977100|FG013|Period 2|Withdrawal by Subject|1|||
46758855|NCT00868790|82977087|FG000|Period 3|Adverse Event|0|||
46758856|NCT00868790|82977088|FG001|Period 3|Adverse Event|0|||
46758857|NCT00868790|82977089|FG002|Period 3|Adverse Event|0|||
46758858|NCT00868790|82977090|FG003|Period 3|Adverse Event|0|||
46758859|NCT00868790|82977091|FG004|Period 3|Adverse Event|0|||
46758860|NCT00868790|82977092|FG005|Period 3|Adverse Event|0|||
46758861|NCT00868790|82977093|FG006|Period 3|Adverse Event|0|||
46758862|NCT00868790|82977094|FG007|Period 3|Adverse Event|0|||
46758863|NCT00868790|82977095|FG008|Period 3|Adverse Event|0|||
46758864|NCT00868790|82977096|FG009|Period 3|Adverse Event|1|||
46758865|NCT00868790|82977097|FG010|Period 3|Adverse Event|0|||
46758866|NCT00868790|82977098|FG011|Period 3|Adverse Event|0|||
46758867|NCT00868790|82977099|FG012|Period 3|Adverse Event|0|||
46758868|NCT00868790|82977100|FG013|Period 3|Adverse Event|0|||
46758869|NCT00868790|82977087|FG000|Period 3|Protocol Violation|0|||
46758870|NCT00868790|82977088|FG001|Period 3|Protocol Violation|0|||
46758871|NCT00868790|82977089|FG002|Period 3|Protocol Violation|0|||
46758872|NCT00868790|82977090|FG003|Period 3|Protocol Violation|0|||
46758873|NCT00868790|82977091|FG004|Period 3|Protocol Violation|0|||
46758874|NCT00868790|82977092|FG005|Period 3|Protocol Violation|0|||
46758875|NCT00868790|82977093|FG006|Period 3|Protocol Violation|0|||
46758876|NCT00868790|82977094|FG007|Period 3|Protocol Violation|0|||
46819226|NCT00545051|83039038|FG000|Overall Study|Withdrawal by Subject|0|||
46931306|NCT04093492|83166472|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
46931307|NCT04093492|83166469|FG000|25 Weeks Gestational Age (GA)|No response|5|||
46931308|NCT04093492|83166470|FG001|25 Weeks Gestational Age (GA)|No response|5|||
46758877|NCT00868790|82977095|FG008|Period 3|Protocol Violation|0|||
46758878|NCT00868790|82977096|FG009|Period 3|Protocol Violation|0|||
46758879|NCT00868790|82977097|FG010|Period 3|Protocol Violation|1|||
46758880|NCT00868790|82977098|FG011|Period 3|Protocol Violation|0|||
46758881|NCT00868790|82977099|FG012|Period 3|Protocol Violation|0|||
46758882|NCT00868790|82977100|FG013|Period 3|Protocol Violation|0|||
46758883|NCT00868790|82977087|FG000|Period 3|Study Terminated by Sponsor|0|||
46758884|NCT00868790|82977088|FG001|Period 3|Study Terminated by Sponsor|0|||
46758885|NCT00868790|82977089|FG002|Period 3|Study Terminated by Sponsor|0|||
46758886|NCT00868790|82977090|FG003|Period 3|Study Terminated by Sponsor|1|||
46931309|NCT04093492|83166471|FG002|25 Weeks Gestational Age (GA)|No response|5|||
46931310|NCT04093492|83166472|FG003|25 Weeks Gestational Age (GA)|No response|2|||
46931311|NCT04093492|83166469|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
46931312|NCT04093492|83166470|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
46931313|NCT04093492|83166471|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
46931314|NCT04093492|83166472|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
47056211|NCT02670525|83332100|FG000|Overall Study|Death|94|||
46758887|NCT00868790|82977091|FG004|Period 3|Study Terminated by Sponsor|0|||
46758888|NCT00868790|82977092|FG005|Period 3|Study Terminated by Sponsor|0|||
46758889|NCT00868790|82977093|FG006|Period 3|Study Terminated by Sponsor|0|||
46758890|NCT00868790|82977094|FG007|Period 3|Study Terminated by Sponsor|0|||
46758891|NCT00868790|82977095|FG008|Period 3|Study Terminated by Sponsor|0|||
46758892|NCT00868790|82977096|FG009|Period 3|Study Terminated by Sponsor|0|||
46758893|NCT00868790|82977097|FG010|Period 3|Study Terminated by Sponsor|0|||
46758894|NCT00868790|82977098|FG011|Period 3|Study Terminated by Sponsor|0|||
46758895|NCT00868790|82977099|FG012|Period 3|Study Terminated by Sponsor|0|||
46758896|NCT00868790|82977100|FG013|Period 3|Study Terminated by Sponsor|0|||
46758897|NCT00868790|82977087|FG000|Period 4|Adverse Event|0|||
46758898|NCT00868790|82977088|FG001|Period 4|Adverse Event|0|||
46758899|NCT00868790|82977089|FG002|Period 4|Adverse Event|0|||
46758900|NCT00868790|82977090|FG003|Period 4|Adverse Event|0|||
46758901|NCT00868790|82977091|FG004|Period 4|Adverse Event|0|||
46758902|NCT00868790|82977092|FG005|Period 4|Adverse Event|0|||
46758903|NCT00868790|82977093|FG006|Period 4|Adverse Event|0|||
46758904|NCT00868790|82977094|FG007|Period 4|Adverse Event|1|||
46758905|NCT00868790|82977095|FG008|Period 4|Adverse Event|0|||
46758906|NCT00868790|82977096|FG009|Period 4|Adverse Event|0|||
46758907|NCT00868790|82977097|FG010|Period 4|Adverse Event|1|||
46758908|NCT00868790|82977098|FG011|Period 4|Adverse Event|0|||
46758909|NCT00868790|82977099|FG012|Period 4|Adverse Event|1|||
46758910|NCT00868790|82977100|FG013|Period 4|Adverse Event|0|||
46758911|NCT00868790|82977087|FG000|Period 4|Lost to Follow-up|0|||
46758912|NCT00868790|82977088|FG001|Period 4|Lost to Follow-up|0|||
46758913|NCT00868790|82977089|FG002|Period 4|Lost to Follow-up|0|||
46758914|NCT00868790|82977090|FG003|Period 4|Lost to Follow-up|0|||
46758915|NCT00868790|82977091|FG004|Period 4|Lost to Follow-up|0|||
46758916|NCT00868790|82977092|FG005|Period 4|Lost to Follow-up|0|||
46758917|NCT00868790|82977093|FG006|Period 4|Lost to Follow-up|0|||
46758918|NCT00868790|82977094|FG007|Period 4|Lost to Follow-up|1|||
46758919|NCT00868790|82977095|FG008|Period 4|Lost to Follow-up|0|||
46758920|NCT00868790|82977096|FG009|Period 4|Lost to Follow-up|0|||
46758921|NCT00868790|82977097|FG010|Period 4|Lost to Follow-up|0|||
46758922|NCT00868790|82977098|FG011|Period 4|Lost to Follow-up|0|||
46758923|NCT00868790|82977099|FG012|Period 4|Lost to Follow-up|0|||
46758924|NCT00868790|82977100|FG013|Period 4|Lost to Follow-up|0|||
46758925|NCT00868790|82977087|FG000|Period 4|Study Terminated by Sponsor|2|||
46758926|NCT00868790|82977088|FG001|Period 4|Study Terminated by Sponsor|0|||
46758927|NCT00868790|82977089|FG002|Period 4|Study Terminated by Sponsor|0|||
46758928|NCT00868790|82977090|FG003|Period 4|Study Terminated by Sponsor|0|||
46758929|NCT00868790|82977091|FG004|Period 4|Study Terminated by Sponsor|0|||
46758930|NCT00868790|82977092|FG005|Period 4|Study Terminated by Sponsor|0|||
46758931|NCT00868790|82977093|FG006|Period 4|Study Terminated by Sponsor|0|||
46758932|NCT00868790|82977094|FG007|Period 4|Study Terminated by Sponsor|1|||
46758933|NCT00868790|82977095|FG008|Period 4|Study Terminated by Sponsor|2|||
46758934|NCT00868790|82977096|FG009|Period 4|Study Terminated by Sponsor|0|||
46758935|NCT00868790|82977097|FG010|Period 4|Study Terminated by Sponsor|2|||
46758936|NCT00868790|82977098|FG011|Period 4|Study Terminated by Sponsor|1|||
46758937|NCT00868790|82977099|FG012|Period 4|Study Terminated by Sponsor|0|||
46758938|NCT00868790|82977100|FG013|Period 4|Study Terminated by Sponsor|1|||
46758939|NCT00868790|82977087|FG000|Period 4|Abnormal ALT/AST|0|||
46758940|NCT00868790|82977088|FG001|Period 4|Abnormal ALT/AST|0|||
46758941|NCT00868790|82977089|FG002|Period 4|Abnormal ALT/AST|1|||
46758942|NCT00868790|82977090|FG003|Period 4|Abnormal ALT/AST|0|||
46931315|NCT04093492|83166469|FG000|30 Weeks GA|Delivered before assessment|1|||
46758943|NCT00868790|82977091|FG004|Period 4|Abnormal ALT/AST|0|||
46758944|NCT00868790|82977092|FG005|Period 4|Abnormal ALT/AST|0|||
46758945|NCT00868790|82977093|FG006|Period 4|Abnormal ALT/AST|0|||
46758946|NCT00868790|82977094|FG007|Period 4|Abnormal ALT/AST|0|||
46758947|NCT00868790|82977095|FG008|Period 4|Abnormal ALT/AST|0|||
46758948|NCT00868790|82977096|FG009|Period 4|Abnormal ALT/AST|0|||
46758949|NCT00868790|82977097|FG010|Period 4|Abnormal ALT/AST|0|||
46758950|NCT00868790|82977098|FG011|Period 4|Abnormal ALT/AST|0|||
46758951|NCT00868790|82977099|FG012|Period 4|Abnormal ALT/AST|0|||
46758952|NCT00868790|82977100|FG013|Period 4|Abnormal ALT/AST|0|||
46758953|NCT00868790|82977087|FG000|Post-study|Withdrawal by Subject|0|||
46758954|NCT00868790|82977088|FG001|Post-study|Withdrawal by Subject|0|||
46758955|NCT00868790|82977089|FG002|Post-study|Withdrawal by Subject|0|||
46758956|NCT00868790|82977090|FG003|Post-study|Withdrawal by Subject|0|||
46758957|NCT00868790|82977091|FG004|Post-study|Withdrawal by Subject|1|||
46758958|NCT00868790|82977092|FG005|Post-study|Withdrawal by Subject|0|||
46819227|NCT00545051|83039039|FG001|Overall Study|Withdrawal by Subject|1|||
46819228|NCT00545051|83039038|FG000|Overall Study|Administrative reasons|0|||
46819229|NCT00545051|83039039|FG001|Overall Study|Administrative reasons|1|||
46819230|NCT00381615|83039049|FG000|Overall Study|Withdrawal by Subject|1|||
46819231|NCT00381615|83039050|FG001|Overall Study|Withdrawal by Subject|3|||
46819232|NCT00381615|83039051|FG002|Overall Study|Withdrawal by Subject|0|||
46819233|NCT00381615|83039052|FG003|Overall Study|Withdrawal by Subject|1|||
46819234|NCT00381615|83039049|FG000|Overall Study|Lost to Follow-up|3|||
46819235|NCT00381615|83039050|FG001|Overall Study|Lost to Follow-up|2|||
46819236|NCT00381615|83039051|FG002|Overall Study|Lost to Follow-up|0|||
46819237|NCT00381615|83039052|FG003|Overall Study|Lost to Follow-up|1|||
46819238|NCT00381615|83039049|FG000|Overall Study|Protocol Violation|0|||
46819239|NCT00381615|83039050|FG001|Overall Study|Protocol Violation|0|||
46819240|NCT00381615|83039051|FG002|Overall Study|Protocol Violation|1|||
46819241|NCT00381615|83039052|FG003|Overall Study|Protocol Violation|0|||
46819242|NCT00371865|83039066|FG000|Overall Study|Lack of Efficacy|0|||
46819243|NCT00371865|83039067|FG001|Overall Study|Lack of Efficacy|2|||
46819244|NCT00371865|83039066|FG000|Overall Study|Protocol Violation|3|||
46819245|NCT00371865|83039067|FG001|Overall Study|Protocol Violation|2|||
46819246|NCT00371865|83039066|FG000|Overall Study|Withdrawal by Subject|12|||
46819247|NCT00371865|83039067|FG001|Overall Study|Withdrawal by Subject|10|||
46819248|NCT00364845|83039075|FG000|Overall Study|Adverse Event|1|||
46819249|NCT00364845|83039076|FG001|Overall Study|Adverse Event|0|||
46819250|NCT00364845|83039075|FG000|Overall Study|Withdrawal by Subject|2|||
46819251|NCT00364845|83039076|FG001|Overall Study|Withdrawal by Subject|1|||
46819252|NCT00364845|83039075|FG000|Overall Study|Physician Decision|8|||
46819253|NCT00364845|83039076|FG001|Overall Study|Physician Decision|8|||
46819254|NCT00364845|83039075|FG000|Overall Study|Lost to Follow-up|0|||
46819255|NCT00364845|83039076|FG001|Overall Study|Lost to Follow-up|1|||
46819256|NCT00364845|83039075|FG000|Overall Study|Death|0|||
46819257|NCT00364845|83039076|FG001|Overall Study|Death|1|||
46819258|NCT00293722|83039082|FG000|Overall Study|Other|427|||
46819259|NCT00381303|83039088|FG000|Overall Study|Lost to Follow-up|25|||
46819260|NCT00381303|83039089|FG001|Overall Study|Lost to Follow-up|9|||
46758959|NCT00868790|82977093|FG006|Post-study|Withdrawal by Subject|0|||
46758960|NCT00868790|82977094|FG007|Post-study|Withdrawal by Subject|0|||
46758961|NCT00868790|82977095|FG008|Post-study|Withdrawal by Subject|0|||
46819261|NCT00381303|83039088|FG000|Overall Study|AE/HIV-related event|22|||
46819262|NCT00381303|83039089|FG001|Overall Study|AE/HIV-related event|6|||
46819263|NCT00381303|83039088|FG000|Overall Study|Non-Adherence|13|||
46819264|NCT00381303|83039089|FG001|Overall Study|Non-Adherence|6|||
46819265|NCT00381303|83039088|FG000|Overall Study|Withdrawal by Subject|13|||
46819266|NCT00381303|83039089|FG001|Overall Study|Withdrawal by Subject|6|||
46819267|NCT00381303|83039088|FG000|Overall Study|Virologic failure|6|||
46819268|NCT00381303|83039089|FG001|Overall Study|Virologic failure|4|||
46819269|NCT00381303|83039088|FG000|Overall Study|Ineligible to continue the trial|2|||
46819270|NCT00381303|83039089|FG001|Overall Study|Ineligible to continue the trial|1|||
46819271|NCT00381303|83039088|FG000|Overall Study|Pregnancy|2|||
46819272|NCT00381303|83039089|FG001|Overall Study|Pregnancy|0|||
46758962|NCT00868790|82977096|FG009|Post-study|Withdrawal by Subject|0|||
46819273|NCT00381303|83039088|FG000|Overall Study|Physician Decision|1|||
46819274|NCT00381303|83039089|FG001|Overall Study|Physician Decision|0|||
46758963|NCT00868790|82977097|FG010|Post-study|Withdrawal by Subject|0|||
46758964|NCT00868790|82977098|FG011|Post-study|Withdrawal by Subject|0|||
46758965|NCT00868790|82977099|FG012|Post-study|Withdrawal by Subject|0|||
46758966|NCT00868790|82977100|FG013|Post-study|Withdrawal by Subject|0|||
46819275|NCT00381303|83039088|FG000|Overall Study|Physician's decision to close the site|3|||
46819276|NCT00381303|83039089|FG001|Overall Study|Physician's decision to close the site|1|||
46819277|NCT00381303|83039088|FG000|Overall Study|Subject moved out of state|2|||
46819278|NCT00381303|83039089|FG001|Overall Study|Subject moved out of state|0|||
46758967|NCT00868790|82977087|FG000|Post-study|Excluded Medication|0|||
46758968|NCT00868790|82977088|FG001|Post-study|Excluded Medication|0|||
46819279|NCT00381303|83039088|FG000|Overall Study|Subject taking too many different meds|1|||
46819280|NCT00381303|83039089|FG001|Overall Study|Subject taking too many different meds|0|||
46819281|NCT00381303|83039088|FG000|Overall Study|No virologic response by week 12|1|||
46967686|NCT02121262|83210248|FG000|Overall Study|Adverse Event|6|||
46758969|NCT00868790|82977089|FG002|Post-study|Excluded Medication|0|||
46758970|NCT00868790|82977090|FG003|Post-study|Excluded Medication|0|||
46819282|NCT00381303|83039089|FG001|Overall Study|No virologic response by week 12|0|||
46819283|NCT00381303|83039088|FG000|Overall Study|Subject was too busy for appointments|1|||
46819284|NCT00381303|83039089|FG001|Overall Study|Subject was too busy for appointments|0|||
46819285|NCT00381303|83039088|FG000|Overall Study|Subject did not continue visits|1|||
46819286|NCT00381303|83039089|FG001|Overall Study|Subject did not continue visits|0|||
46967687|NCT02121262|83210249|FG001|Overall Study|Adverse Event|3|||
46967688|NCT02121262|83210248|FG000|Overall Study|Lack of Efficacy|3|||
46967689|NCT02121262|83210249|FG001|Overall Study|Lack of Efficacy|0|||
46967690|NCT02121262|83210248|FG000|Overall Study|Personal Reasons|19|||
46967691|NCT02121262|83210249|FG001|Overall Study|Personal Reasons|5|||
46819287|NCT00381303|83039088|FG000|Overall Study|Subject primary physician's decision|1|||
46819288|NCT00381303|83039089|FG001|Overall Study|Subject primary physician's decision|0|||
46819289|NCT00448812|83039109|FG000|Year 2|Missed visit but remained in study|4|||
46819290|NCT00448812|83039110|FG001|Year 2|Missed visit but remained in study|1|||
46819291|NCT00448812|83039109|FG000|Year 3|Withdrawal by Subject|1|||
46819292|NCT00448812|83039110|FG001|Year 3|Withdrawal by Subject|3|||
46819293|NCT00448812|83039109|FG000|Year 3|Lost to Follow-up|1|||
46819294|NCT00448812|83039110|FG001|Year 3|Lost to Follow-up|0|||
46819295|NCT00448812|83039109|FG000|Year 3|Missed visit but remained in study|2|||
46931316|NCT04093492|83166470|FG001|30 Weeks GA|Delivered before assessment|2|||
46931317|NCT04093492|83166471|FG002|30 Weeks GA|Delivered before assessment|0|||
46931318|NCT04093492|83166472|FG003|30 Weeks GA|Delivered before assessment|0|||
46931319|NCT04093492|83166469|FG000|30 Weeks GA|No response|7|||
46931320|NCT04093492|83166470|FG001|30 Weeks GA|No response|5|||
46931321|NCT04093492|83166471|FG002|30 Weeks GA|No response|5|||
46931322|NCT04093492|83166472|FG003|30 Weeks GA|No response|2|||
46931323|NCT04093492|83166469|FG000|30 Weeks GA|Lost to Follow-up|0|||
46931324|NCT04093492|83166470|FG001|30 Weeks GA|Lost to Follow-up|1|||
46931325|NCT04093492|83166471|FG002|30 Weeks GA|Lost to Follow-up|0|||
46931326|NCT04093492|83166472|FG003|30 Weeks GA|Lost to Follow-up|0|||
46931327|NCT04093492|83166469|FG000|34 Weeks GA|Delivered before assessment|6|||
47056212|NCT02670525|83332101|FG001|Overall Study|Death|14|||
47056213|NCT02670525|83332100|FG000|Overall Study|Lost to Follow-up|4|||
46636710|NCT01482312|82810504|FG000|Period 2, 90 Minutes of Wear|Other|1|||
46636711|NCT01482312|82810505|FG001|Period 2, 90 Minutes of Wear|Other|0|||
46819296|NCT00448812|83039110|FG001|Year 3|Missed visit but remained in study|0|||
46819297|NCT00448812|83039109|FG000|Year 5|Missed visit but remained in study|1|||
46819298|NCT00448812|83039110|FG001|Year 5|Missed visit but remained in study|0|||
46819299|NCT00364689|83039131|FG000|Overall Study|Lost to Follow-up|1|||
46819300|NCT00545129|83039139|FG000|Overall Study|Lack of Efficacy|2|||
46819301|NCT00545129|83039140|FG001|Overall Study|Lack of Efficacy|5|||
46819302|NCT00545129|83039139|FG000|Overall Study|Death|2|||
46819303|NCT00545129|83039140|FG001|Overall Study|Death|1|||
46819304|NCT00545129|83039139|FG000|Overall Study|Adverse Event|1|||
46819305|NCT00545129|83039140|FG001|Overall Study|Adverse Event|1|||
46819306|NCT00545129|83039139|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
46819307|NCT00545129|83039140|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
46819308|NCT00545129|83039139|FG000|Overall Study|Other|3|||
46819309|NCT00545129|83039140|FG001|Overall Study|Other|3|||
46819310|NCT00364611|83039148|FG000|Overall Study|Did not receive study medication|0|||
46819311|NCT00364611|83039149|FG001|Overall Study|Did not receive study medication|1|||
46819312|NCT00364611|83039148|FG000|Overall Study|Adverse Event|7|||
46819313|NCT00364611|83039149|FG001|Overall Study|Adverse Event|4|||
46819314|NCT00364611|83039148|FG000|Overall Study|Participant's Request|3|||
46819315|NCT00364611|83039149|FG001|Overall Study|Participant's Request|4|||
46819316|NCT00364611|83039148|FG000|Overall Study|Disease Progression|38|||
46819317|NCT00364611|83039149|FG001|Overall Study|Disease Progression|8|||
46819318|NCT00364611|83039148|FG000|Overall Study|Investigator decision|2|||
46819319|NCT00364611|83039149|FG001|Overall Study|Investigator decision|2|||
46636712|NCT01482312|82810506|FG002|Period 2, 90 Minutes of Wear|Other|0|||
46636713|NCT01461096|82810516|FG000|Overall Study|Death|3|||
46636714|NCT01461096|82810517|FG001|Overall Study|Death|6|||
46636715|NCT01461096|82810516|FG000|Overall Study|Severe debilitation, unable to continue|1|||
46636716|NCT01461096|82810517|FG001|Overall Study|Severe debilitation, unable to continue|1|||
46636717|NCT01461096|82810516|FG000|Overall Study|Subj not able to get to clinic|15|||
46636718|NCT01461096|82810517|FG001|Overall Study|Subj not able to get to clinic|13|||
46636719|NCT01461096|82810516|FG000|Overall Study|Site is closing|27|||
46819320|NCT00364611|83039148|FG000|Overall Study|Found Ineligible|1|||
46819321|NCT00364611|83039149|FG001|Overall Study|Found Ineligible|0|||
46819322|NCT00364611|83039148|FG000|Overall Study|Presumed CR on Study|0|||
46819323|NCT00364611|83039149|FG001|Overall Study|Presumed CR on Study|1|||
46819324|NCT00364611|83039148|FG000|Overall Study|Receiving Liver Ablation|0|||
46931328|NCT04093492|83166470|FG001|34 Weeks GA|Delivered before assessment|3|||
46931329|NCT04093492|83166471|FG002|34 Weeks GA|Delivered before assessment|0|||
46931330|NCT04093492|83166472|FG003|34 Weeks GA|Delivered before assessment|0|||
46931331|NCT04093492|83166469|FG000|34 Weeks GA|No response|0|||
46636720|NCT01461096|82810517|FG001|Overall Study|Site is closing|30|||
46931332|NCT04093492|83166470|FG001|34 Weeks GA|No response|7|||
46636721|NCT01461096|82810516|FG000|Overall Study|Withdrawal by Subject|5|||
47056214|NCT02670525|83332101|FG001|Overall Study|Lost to Follow-up|1|||
47056215|NCT02670525|83332100|FG000|Overall Study|Subject withdrew consent|1|||
47056216|NCT02670525|83332101|FG001|Overall Study|Subject withdrew consent|0|||
46819325|NCT00364611|83039149|FG001|Overall Study|Receiving Liver Ablation|1|||
46819326|NCT00364533|83039160|FG000|Overall Study|Adverse Event|8|||
46819327|NCT00364533|83039161|FG001|Overall Study|Adverse Event|7|||
46819328|NCT00364533|83039162|FG002|Overall Study|Adverse Event|15|||
46819329|NCT00364533|83039163|FG003|Overall Study|Adverse Event|5|||
46819330|NCT00364533|83039164|FG004|Overall Study|Adverse Event|2|||
47056217|NCT02670525|83332100|FG000|Overall Study|Unknown, data entry delayed|123|||
47056218|NCT02670525|83332101|FG001|Overall Study|Unknown, data entry delayed|78|||
47056219|NCT02394795|83332109|FG000|Overall Study|Adverse Event|92|||
47056220|NCT02394795|83332110|FG001|Overall Study|Adverse Event|70|||
47056221|NCT02394795|83332109|FG000|Overall Study|Lost to Follow-up|0|||
47056222|NCT02394795|83332110|FG001|Overall Study|Lost to Follow-up|1|||
46931333|NCT04093492|83166471|FG002|34 Weeks GA|No response|5|||
46931334|NCT04093492|83166472|FG003|34 Weeks GA|No response|3|||
46931335|NCT04093492|83166469|FG000|34 Weeks GA|Lost to Follow-up|0|||
46931336|NCT04093492|83166470|FG001|34 Weeks GA|Lost to Follow-up|1|||
46931337|NCT04093492|83166471|FG002|34 Weeks GA|Lost to Follow-up|0|||
46931338|NCT04093492|83166472|FG003|34 Weeks GA|Lost to Follow-up|0|||
46931339|NCT04057937|83166493|FG000|Placebo-controlled Phase|Adverse Event|3|||
46931340|NCT04057937|83166494|FG001|Placebo-controlled Phase|Adverse Event|0|||
46931341|NCT04057937|83166493|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
46931342|NCT04057937|83166494|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
46931343|NCT04057937|83166493|FG000|Active-treatment Phase|Pregnancy|0|||
47056223|NCT02394795|83332109|FG000|Overall Study|Withdrawal by Subject|17|||
47056224|NCT02394795|83332110|FG001|Overall Study|Withdrawal by Subject|26|||
46931344|NCT04057937|83166494|FG001|Active-treatment Phase|Pregnancy|1|||
46931345|NCT04057937|83166493|FG000|Active-treatment Phase|Physician Decision|0|||
46931346|NCT04057937|83166494|FG001|Active-treatment Phase|Physician Decision|1|||
46931347|NCT04003636|83166503|FG000|Overall Study|Death|409|||
46931348|NCT04003636|83166504|FG001|Overall Study|Death|443|||
46931349|NCT04003636|83166503|FG000|Overall Study|Lost to Follow-up|0|||
46931350|NCT04003636|83166504|FG001|Overall Study|Lost to Follow-up|1|||
46931351|NCT04003636|83166503|FG000|Overall Study|Withdrawal by Subject|5|||
46931352|NCT04003636|83166504|FG001|Overall Study|Withdrawal by Subject|2|||
46931353|NCT04003636|83166503|FG000|Overall Study|Participant On-going|119|||
46931354|NCT04003636|83166504|FG001|Overall Study|Participant On-going|90|||
46931355|NCT03777436|83166513|FG000|Placebo-controlled Phase|Adverse Event|8|||
46931356|NCT03777436|83166514|FG001|Placebo-controlled Phase|Adverse Event|10|||
46931357|NCT03777436|83166515|FG002|Placebo-controlled Phase|Adverse Event|0|||
46931358|NCT03777436|83166513|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
47056225|NCT02394795|83332109|FG000|Overall Study|Lack of Efficacy|181|||
47056226|NCT02394795|83332110|FG001|Overall Study|Lack of Efficacy|211|||
46931359|NCT03777436|83166514|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
46931360|NCT03777436|83166515|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
46931361|NCT03777436|83166513|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
46931362|NCT03777436|83166514|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
46931363|NCT03777436|83166515|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
46931364|NCT03777436|83166513|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
46931365|NCT03777436|83166514|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
46931366|NCT03777436|83166515|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
46931367|NCT03777436|83166513|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
47056227|NCT02394795|83332109|FG000|Overall Study|Death|4|||
47056228|NCT02394795|83332110|FG001|Overall Study|Death|5|||
47056229|NCT02394795|83332109|FG000|Overall Study|Physician Decision|109|||
47056230|NCT02394795|83332110|FG001|Overall Study|Physician Decision|93|||
47056231|NCT02255422|83332123|FG000|Overall Study|Withdrawal by Subject|0|||
47056232|NCT02255422|83332124|FG001|Overall Study|Withdrawal by Subject|0|||
47056233|NCT02255422|83332125|FG002|Overall Study|Withdrawal by Subject|0|||
47056234|NCT02255422|83332126|FG003|Overall Study|Withdrawal by Subject|0|||
47056235|NCT02255422|83332127|FG004|Overall Study|Withdrawal by Subject|0|||
47056236|NCT02255422|83332128|FG005|Overall Study|Withdrawal by Subject|0|||
47056237|NCT02255422|83332129|FG006|Overall Study|Withdrawal by Subject|2|||
46758971|NCT00868790|82977091|FG004|Post-study|Excluded Medication|0|||
46758972|NCT00868790|82977092|FG005|Post-study|Excluded Medication|0|||
46758973|NCT00868790|82977093|FG006|Post-study|Excluded Medication|0|||
46758974|NCT00868790|82977094|FG007|Post-study|Excluded Medication|2|||
46758975|NCT00868790|82977095|FG008|Post-study|Excluded Medication|0|||
46758976|NCT00868790|82977096|FG009|Post-study|Excluded Medication|1|||
46758977|NCT00868790|82977097|FG010|Post-study|Excluded Medication|0|||
46758978|NCT00868790|82977098|FG011|Post-study|Excluded Medication|0|||
46758979|NCT00868790|82977099|FG012|Post-study|Excluded Medication|0|||
46758980|NCT00868790|82977100|FG013|Post-study|Excluded Medication|0|||
46758981|NCT00496483|82977116|FG000|Overall Study|Not dosed|9|||
46931368|NCT03777436|83166514|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
46931369|NCT03777436|83166515|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
47056238|NCT02255422|83332123|FG000|Overall Study|Lost to Follow-up|0|||
47056239|NCT02255422|83332124|FG001|Overall Study|Lost to Follow-up|0|||
46758982|NCT00496483|82977116|FG000|Overall Study|Adverse Event|2|||
46758983|NCT00496483|82977116|FG000|Overall Study|Lack of Efficacy|1|||
46758984|NCT03528551|82977126|FG000|Overall Study|Lost to Follow-up|0|||
46758985|NCT03528551|82977127|FG001|Overall Study|Lost to Follow-up|1|||
47056240|NCT02255422|83332125|FG002|Overall Study|Lost to Follow-up|1|||
47056241|NCT02255422|83332126|FG003|Overall Study|Lost to Follow-up|0|||
47056242|NCT02255422|83332127|FG004|Overall Study|Lost to Follow-up|0|||
46758986|NCT03528551|82977128|FG002|Overall Study|Lost to Follow-up|0|||
46931370|NCT03777436|83166513|FG000|Placebo-controlled Phase|Physician Decision|0|||
46931371|NCT03777436|83166514|FG001|Placebo-controlled Phase|Physician Decision|1|||
46931372|NCT03777436|83166515|FG002|Placebo-controlled Phase|Physician Decision|0|||
46931373|NCT03777436|83166513|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
46931374|NCT03777436|83166514|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
46931375|NCT03777436|83166515|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
46931376|NCT03777436|83166513|FG000|Apremilast Extension Phase|Adverse Event|0|||
46931377|NCT03777436|83166514|FG001|Apremilast Extension Phase|Adverse Event|0|||
46931378|NCT03777436|83166515|FG002|Apremilast Extension Phase|Adverse Event|6|||
46931379|NCT03777436|83166513|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
46931380|NCT03777436|83166514|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
46931381|NCT03777436|83166515|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
46931382|NCT03777436|83166513|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
46931383|NCT03777436|83166514|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
46931384|NCT03777436|83166515|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
46931385|NCT03777436|83166513|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
46931386|NCT03777436|83166514|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
46931387|NCT03777436|83166515|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
46931388|NCT03777436|83166513|FG000|Apremilast Extension Phase|Miscellaneous|0|||
46931389|NCT03777436|83166514|FG001|Apremilast Extension Phase|Miscellaneous|0|||
46931390|NCT03777436|83166515|FG002|Apremilast Extension Phase|Miscellaneous|1|||
46931391|NCT03721172|83166524|FG000|Placebo-controlled Phase|Adverse Event|7|||
46758987|NCT03528551|82977126|FG000|Overall Study|Transferred to other arm/group|2|||
46758988|NCT03528551|82977127|FG001|Overall Study|Transferred to other arm/group|3|||
46758989|NCT03528551|82977128|FG002|Overall Study|Transferred to other arm/group|0|||
46758990|NCT03528551|82977126|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46931392|NCT03721172|83166525|FG001|Placebo-controlled Phase|Adverse Event|7|||
46931393|NCT03721172|83166526|FG002|Placebo-controlled Phase|Adverse Event|0|||
46931394|NCT03721172|83166524|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
46931395|NCT03721172|83166525|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
46931396|NCT03721172|83166526|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
47056243|NCT02255422|83332128|FG005|Overall Study|Lost to Follow-up|0|||
47056244|NCT02255422|83332129|FG006|Overall Study|Lost to Follow-up|0|||
47056245|NCT02142959|83332148|FG000|Overall Study|Adverse Event|1|||
47056246|NCT02142959|83332149|FG001|Overall Study|Adverse Event|0|||
47056247|NCT02142959|83332150|FG002|Overall Study|Adverse Event|0|||
47056248|NCT02142959|83332148|FG000|Overall Study|Death|0|||
47056249|NCT02142959|83332149|FG001|Overall Study|Death|1|||
47056250|NCT02142959|83332150|FG002|Overall Study|Death|0|||
47056251|NCT02142959|83332148|FG000|Overall Study|Withdrawal by Subject|3|||
47056252|NCT02142959|83332149|FG001|Overall Study|Withdrawal by Subject|1|||
47056253|NCT02142959|83332150|FG002|Overall Study|Withdrawal by Subject|3|||
47056254|NCT02142959|83332148|FG000|Overall Study|Administrative Reasons|1|||
46758991|NCT03528551|82977127|FG001|Overall Study|Withdrawal by parent/guardian|5|||
46758992|NCT03528551|82977128|FG002|Overall Study|Withdrawal by parent/guardian|0|||
46758993|NCT03528551|82977126|FG000|Overall Study|Protocol Violation|0|||
46758994|NCT03528551|82977127|FG001|Overall Study|Protocol Violation|3|||
46758995|NCT03528551|82977128|FG002|Overall Study|Protocol Violation|0|||
46758996|NCT03528551|82977126|FG000|Overall Study|Withdrawal by Subject|0|||
46758997|NCT03528551|82977127|FG001|Overall Study|Withdrawal by Subject|7|||
46758998|NCT03528551|82977128|FG002|Overall Study|Withdrawal by Subject|0|||
46758999|NCT00487981|82977137|FG000|Overall Study|Hypothyroidism diagnosis|1|||
47056255|NCT02142959|83332149|FG001|Overall Study|Administrative Reasons|0|||
47056256|NCT02142959|83332150|FG002|Overall Study|Administrative Reasons|1|||
46759000|NCT00861744|82977145|FG000|Overall Study|Adverse Event|0|||
46759001|NCT00861744|82977146|FG001|Overall Study|Adverse Event|0|||
47056257|NCT02142959|83332148|FG000|Overall Study|Missing|0|||
46819331|NCT00364533|83039160|FG000|Overall Study|Withdrawal by Subject|4|||
46819332|NCT00364533|83039161|FG001|Overall Study|Withdrawal by Subject|8|||
46819333|NCT00364533|83039162|FG002|Overall Study|Withdrawal by Subject|6|||
46819334|NCT00364533|83039163|FG003|Overall Study|Withdrawal by Subject|6|||
46819335|NCT00364533|83039164|FG004|Overall Study|Withdrawal by Subject|6|||
46819336|NCT00364533|83039160|FG000|Overall Study|Lack of Efficacy|22|||
46819337|NCT00364533|83039161|FG001|Overall Study|Lack of Efficacy|22|||
46819338|NCT00364533|83039162|FG002|Overall Study|Lack of Efficacy|21|||
46819339|NCT00364533|83039163|FG003|Overall Study|Lack of Efficacy|17|||
46819340|NCT00364533|83039164|FG004|Overall Study|Lack of Efficacy|42|||
46819341|NCT00364533|83039160|FG000|Overall Study|Subject discharged from hospital|4|||
46819342|NCT00364533|83039161|FG001|Overall Study|Subject discharged from hospital|1|||
46819343|NCT00364533|83039162|FG002|Overall Study|Subject discharged from hospital|2|||
46819344|NCT00364533|83039163|FG003|Overall Study|Subject discharged from hospital|3|||
46819345|NCT00364533|83039164|FG004|Overall Study|Subject discharged from hospital|1|||
46819346|NCT00364533|83039160|FG000|Overall Study|Variations in drug compliance|2|||
46819347|NCT00364533|83039161|FG001|Overall Study|Variations in drug compliance|1|||
46819348|NCT00364533|83039162|FG002|Overall Study|Variations in drug compliance|1|||
46819349|NCT00364533|83039163|FG003|Overall Study|Variations in drug compliance|0|||
46819350|NCT00364533|83039164|FG004|Overall Study|Variations in drug compliance|0|||
46819351|NCT00364533|83039160|FG000|Overall Study|Non-compliance|1|||
46819352|NCT00364533|83039161|FG001|Overall Study|Non-compliance|0|||
46819353|NCT00364533|83039162|FG002|Overall Study|Non-compliance|0|||
46819354|NCT00364533|83039163|FG003|Overall Study|Non-compliance|0|||
46819355|NCT00364533|83039164|FG004|Overall Study|Non-compliance|0|||
46819356|NCT00364533|83039160|FG000|Overall Study|Protocol Violation|1|||
46819357|NCT00364533|83039161|FG001|Overall Study|Protocol Violation|1|||
46819358|NCT00364533|83039162|FG002|Overall Study|Protocol Violation|0|||
46819359|NCT00364533|83039163|FG003|Overall Study|Protocol Violation|0|||
46819360|NCT00364533|83039164|FG004|Overall Study|Protocol Violation|0|||
46819361|NCT04006847|83039176|FG000|Overall Study|Product issue|1|||
47056258|NCT02142959|83332149|FG001|Overall Study|Missing|1|||
47056259|NCT02142959|83332150|FG002|Overall Study|Missing|0|||
47056260|NCT02142959|83332148|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
46759002|NCT00861744|82977147|FG002|Overall Study|Adverse Event|0|||
46759003|NCT00861744|82977148|FG003|Overall Study|Adverse Event|1|||
46759004|NCT00861744|82977145|FG000|Overall Study|Lost to Follow-up|7|||
46759005|NCT00861744|82977146|FG001|Overall Study|Lost to Follow-up|19|||
46759006|NCT00861744|82977147|FG002|Overall Study|Lost to Follow-up|17|||
46759007|NCT00861744|82977148|FG003|Overall Study|Lost to Follow-up|12|||
46759008|NCT00861744|82977145|FG000|Overall Study|Withdrawal by Subject|10|||
46759009|NCT00861744|82977146|FG001|Overall Study|Withdrawal by Subject|6|||
46759010|NCT00861744|82977147|FG002|Overall Study|Withdrawal by Subject|6|||
46759011|NCT00861744|82977148|FG003|Overall Study|Withdrawal by Subject|19|||
46759012|NCT00861744|82977145|FG000|Overall Study|Protocol Violation|0|||
46759013|NCT00861744|82977146|FG001|Overall Study|Protocol Violation|1|||
46759014|NCT00861744|82977147|FG002|Overall Study|Protocol Violation|0|||
46759015|NCT00861744|82977148|FG003|Overall Study|Protocol Violation|0|||
46759016|NCT00861744|82977145|FG000|Overall Study|Migration from study area|0|||
46759017|NCT00861744|82977146|FG001|Overall Study|Migration from study area|3|||
46759018|NCT00861744|82977147|FG002|Overall Study|Migration from study area|1|||
46759019|NCT00861744|82977148|FG003|Overall Study|Migration from study area|0|||
46759020|NCT00861744|82977145|FG000|Overall Study|Blood draws|0|||
46759021|NCT00861744|82977146|FG001|Overall Study|Blood draws|0|||
46759022|NCT00861744|82977147|FG002|Overall Study|Blood draws|0|||
46759023|NCT00861744|82977148|FG003|Overall Study|Blood draws|1|||
46759024|NCT00603239|82977160|FG000|Overall Study|Adverse Event|4|||
46759025|NCT00603239|82977161|FG001|Overall Study|Adverse Event|1|||
47056261|NCT02142959|83332149|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
47056262|NCT02142959|83332150|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
47056263|NCT02142959|83332148|FG000|Overall Study|Patient didn't complete end of study visit|0|||
46636722|NCT01461096|82810517|FG001|Overall Study|Withdrawal by Subject|3|||
46819362|NCT00544817|83039180|FG000|Combined Modality|Lack of Efficacy|2|||
46819363|NCT00544817|83039180|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
46636723|NCT01461096|82810516|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
46759026|NCT00603239|82977160|FG000|Overall Study|Entry criteria not met|0|||
46759027|NCT00603239|82977161|FG001|Overall Study|Entry criteria not met|1|||
46819364|NCT00544817|83039180|FG000|Combined Modality|Adverse Event|2|||
46819365|NCT00544817|83039180|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
47056264|NCT02142959|83332149|FG001|Overall Study|Patient didn't complete end of study visit|0|||
46759028|NCT00603239|82977160|FG000|Overall Study|Loss of glucose control|3|||
46759029|NCT00603239|82977161|FG001|Overall Study|Loss of glucose control|0|||
46759030|NCT00603239|82977160|FG000|Overall Study|Lost to Follow-up|2|||
46759031|NCT00603239|82977161|FG001|Overall Study|Lost to Follow-up|1|||
46759032|NCT00603239|82977160|FG000|Overall Study|Physician Decision|2|||
46819366|NCT00544817|83039180|FG000|No Treatment Interval|Lack of Efficacy|8|||
46819367|NCT00544817|83039180|FG000|No Treatment Interval|Physician Decision|3|||
46819368|NCT00544817|83039180|FG000|No Treatment Interval|Adverse Event|1|||
46819369|NCT00544817|83039180|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
46819370|NCT00544817|83039180|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
46819371|NCT00544817|83039180|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
46819372|NCT00289978|83039187|FG000|Overall Study|Withdrawal by Subject|31|||
46819373|NCT00289978|83039188|FG001|Overall Study|Withdrawal by Subject|17|||
46819374|NCT00289978|83039189|FG002|Overall Study|Withdrawal by Subject|28|||
46819375|NCT00289978|83039187|FG000|Overall Study|Adverse Event|22|||
46819376|NCT00289978|83039188|FG001|Overall Study|Adverse Event|13|||
46819377|NCT00289978|83039189|FG002|Overall Study|Adverse Event|18|||
46819378|NCT00289978|83039187|FG000|Overall Study|Lack of Efficacy|13|||
46819379|NCT00289978|83039188|FG001|Overall Study|Lack of Efficacy|6|||
46819380|NCT00289978|83039189|FG002|Overall Study|Lack of Efficacy|25|||
46819381|NCT00289978|83039187|FG000|Overall Study|Abnormal laboratory value(s)|20|||
46819382|NCT00289978|83039188|FG001|Overall Study|Abnormal laboratory value(s)|9|||
46819383|NCT00289978|83039189|FG002|Overall Study|Abnormal laboratory value(s)|1|||
46819384|NCT00289978|83039187|FG000|Overall Study|Lost to Follow-up|3|||
46819385|NCT00289978|83039188|FG001|Overall Study|Lost to Follow-up|5|||
46819386|NCT00289978|83039189|FG002|Overall Study|Lost to Follow-up|7|||
46819387|NCT00289978|83039187|FG000|Overall Study|Protocol Violation|5|||
46819388|NCT00289978|83039188|FG001|Overall Study|Protocol Violation|5|||
46819389|NCT00289978|83039189|FG002|Overall Study|Protocol Violation|4|||
46931397|NCT03721172|83166524|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
46759033|NCT00603239|82977161|FG001|Overall Study|Physician Decision|0|||
46759034|NCT00603239|82977160|FG000|Overall Study|Protocol Violation|2|||
46759035|NCT00603239|82977161|FG001|Overall Study|Protocol Violation|0|||
46819390|NCT00289978|83039187|FG000|Overall Study|Abnormal test procedure result(s)|2|||
46819391|NCT00289978|83039188|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46819392|NCT00289978|83039189|FG002|Overall Study|Abnormal test procedure result(s)|1|||
46819393|NCT00289978|83039187|FG000|Overall Study|Death|1|||
46819394|NCT00289978|83039188|FG001|Overall Study|Death|0|||
46819395|NCT00289978|83039189|FG002|Overall Study|Death|2|||
46819396|NCT00543803|83039197|FG000|Overall Study|Adverse Event|14|||
46819397|NCT00543803|83039197|FG000|Overall Study|Lack of Efficacy|22|||
46819398|NCT00543803|83039197|FG000|Overall Study|Lost to Follow-up|20|||
46819399|NCT00543803|83039197|FG000|Overall Study|Other|86|||
46819400|NCT00542321|83039205|FG000|Overall Study|Death|0|||
46819401|NCT00542321|83039206|FG001|Overall Study|Death|1|||
46819402|NCT00289900|83039218|FG000|Overall Study|Adverse Event|28|||
46819403|NCT00289900|83039219|FG001|Overall Study|Adverse Event|40|||
46819404|NCT00289900|83039220|FG002|Overall Study|Adverse Event|13|||
46819405|NCT00289900|83039221|FG003|Overall Study|Adverse Event|19|||
46819406|NCT00289900|83039222|FG004|Overall Study|Adverse Event|20|||
46819407|NCT00289900|83039223|FG005|Overall Study|Adverse Event|33|||
46819408|NCT00289900|83039218|FG000|Overall Study|Lost to Follow-up|7|||
46819409|NCT00289900|83039219|FG001|Overall Study|Lost to Follow-up|7|||
46759036|NCT00603239|82977160|FG000|Overall Study|Subject decision|2|||
46759037|NCT00603239|82977161|FG001|Overall Study|Subject decision|1|||
46759038|NCT00852930|82977170|FG000|Overall Study|Withdrawal by Subject|1|||
46759039|NCT00852930|82977171|FG001|Overall Study|Withdrawal by Subject|1|||
46759040|NCT00852930|82977172|FG002|Overall Study|Withdrawal by Subject|1|||
46759041|NCT00852930|82977170|FG000|Overall Study|Physician Decision|0|||
46759042|NCT00852930|82977171|FG001|Overall Study|Physician Decision|0|||
46759043|NCT00852930|82977172|FG002|Overall Study|Physician Decision|1|||
46759044|NCT00852540|82977183|FG000|Overall Study|Adverse Event|10|||
46759045|NCT00852540|82977184|FG001|Overall Study|Adverse Event|3|||
46759046|NCT00852540|82977183|FG000|Overall Study|Lack of Efficacy|15|||
46759047|NCT00852540|82977184|FG001|Overall Study|Lack of Efficacy|3|||
46759048|NCT00852540|82977183|FG000|Overall Study|Protocol Violation|1|||
46759049|NCT00852540|82977184|FG001|Overall Study|Protocol Violation|2|||
46819410|NCT00289900|83039220|FG002|Overall Study|Lost to Follow-up|8|||
46819411|NCT00289900|83039221|FG003|Overall Study|Lost to Follow-up|8|||
46819412|NCT00289900|83039222|FG004|Overall Study|Lost to Follow-up|4|||
46819413|NCT00289900|83039223|FG005|Overall Study|Lost to Follow-up|8|||
46819414|NCT00289900|83039218|FG000|Overall Study|Participant had flushing|18|||
46931398|NCT03721172|83166525|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
47056265|NCT02142959|83332150|FG002|Overall Study|Patient didn't complete end of study visit|1|||
46759050|NCT00852540|82977183|FG000|Overall Study|Lost to Follow-up|2|||
46759051|NCT00852540|82977184|FG001|Overall Study|Lost to Follow-up|3|||
46759052|NCT00852540|82977183|FG000|Overall Study|Investigator Discretion|2|||
46759053|NCT00852540|82977184|FG001|Overall Study|Investigator Discretion|3|||
46759054|NCT00852540|82977183|FG000|Overall Study|Withdrawal by Subject|3|||
46931399|NCT03721172|83166526|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
46819415|NCT00289900|83039219|FG001|Overall Study|Participant had flushing|42|||
46819416|NCT00289900|83039220|FG002|Overall Study|Participant had flushing|1|||
46819417|NCT00289900|83039221|FG003|Overall Study|Participant had flushing|2|||
46819418|NCT00289900|83039222|FG004|Overall Study|Participant had flushing|0|||
46819419|NCT00289900|83039223|FG005|Overall Study|Participant had flushing|4|||
46819420|NCT00289900|83039218|FG000|Overall Study|Other|0|||
46819421|NCT00289900|83039219|FG001|Overall Study|Other|0|||
46819422|NCT00289900|83039220|FG002|Overall Study|Other|0|||
46819423|NCT00289900|83039221|FG003|Overall Study|Other|5|||
46819424|NCT00289900|83039222|FG004|Overall Study|Other|1|||
46819425|NCT00289900|83039223|FG005|Overall Study|Other|0|||
46819426|NCT00289900|83039218|FG000|Overall Study|Participant moved|1|||
46819427|NCT00289900|83039219|FG001|Overall Study|Participant moved|0|||
46819428|NCT00289900|83039220|FG002|Overall Study|Participant moved|0|||
46819429|NCT00289900|83039221|FG003|Overall Study|Participant moved|1|||
46819430|NCT00289900|83039222|FG004|Overall Study|Participant moved|1|||
46819431|NCT00289900|83039223|FG005|Overall Study|Participant moved|1|||
46819432|NCT00289900|83039218|FG000|Overall Study|Withdrawal by Subject|10|||
46819433|NCT00289900|83039219|FG001|Overall Study|Withdrawal by Subject|21|||
46819434|NCT00289900|83039220|FG002|Overall Study|Withdrawal by Subject|8|||
46931400|NCT03721172|83166524|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
46931401|NCT03721172|83166525|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
46931402|NCT03721172|83166526|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
46931403|NCT03721172|83166524|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
46759055|NCT00852540|82977184|FG001|Overall Study|Withdrawal by Subject|1|||
46759056|NCT00852540|82977183|FG000|Overall Study|Did Not Receive Study Drug|3|||
46759057|NCT00852540|82977184|FG001|Overall Study|Did Not Receive Study Drug|3|||
46759058|NCT00861198|82977191|FG000|Overall Study|SpyGlass Failed|5|||
46759059|NCT00847704|82977195|FG000|Overall Study|Withdrawal by Subject|1|||
46759060|NCT00860574|82977199|FG000|Overall Study|Death|2|||
46759061|NCT00860574|82977199|FG000|Overall Study|Relapse|1|||
46759062|NCT00496015|82977208|FG000|Overall Study|Other|1|||
46759063|NCT00496015|82977209|FG001|Overall Study|Other|0|||
46759064|NCT00496015|82977210|FG002|Overall Study|Other|0|||
46759065|NCT00496015|82977211|FG003|Overall Study|Other|1|||
46759066|NCT00496015|82977212|FG004|Overall Study|Other|0|||
46759067|NCT00487825|82977234|FG000|Overall Study|Adverse Event|2|||
46759068|NCT00487825|82977235|FG001|Overall Study|Adverse Event|2|||
46759069|NCT00487825|82977234|FG000|Overall Study|Lack of Efficacy|1|||
46759070|NCT00487825|82977235|FG001|Overall Study|Lack of Efficacy|1|||
46759071|NCT00487825|82977234|FG000|Overall Study|Other|3|||
46759072|NCT00487825|82977235|FG001|Overall Study|Other|2|||
46759073|NCT00487747|82977241|FG000|Overall Study|Adverse Event|1|||
46759074|NCT00487747|82977241|FG000|Overall Study|Lost to Follow-up|9|||
46759075|NCT00487747|82977241|FG000|Overall Study|Lack of Efficacy|1|||
46759076|NCT00487435|82977245|FG000|Overall Study|Adverse Event|146|||
46759077|NCT00487435|82977245|FG000|Overall Study|Death|2|||
46759078|NCT00487435|82977245|FG000|Overall Study|Lack of Efficacy|33|||
46759079|NCT00487435|82977245|FG000|Overall Study|Lost to Follow-up|54|||
46759080|NCT00487435|82977245|FG000|Overall Study|Pregnancy|2|||
46759081|NCT00487435|82977245|FG000|Overall Study|Withdrawal by Subject|132|||
46759082|NCT00487435|82977245|FG000|Overall Study|Resolution Of Pain|1|||
46759083|NCT00487435|82977245|FG000|Overall Study|Study Medication Non-Compliant|32|||
46759084|NCT00487435|82977245|FG000|Overall Study|Other|83|||
46759085|NCT00487279|82977251|FG000|Overall Study|Death|1|||
46759086|NCT00487279|82977252|FG001|Overall Study|Death|0|||
46759087|NCT00487279|82977251|FG000|Overall Study|Withdrawal by Subject|0|||
46759088|NCT00487279|82977252|FG001|Overall Study|Withdrawal by Subject|2|||
46759089|NCT00495625|82977258|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
46759090|NCT00847626|82977273|FG000|Overall Study|Adverse Event|10|||
46759091|NCT00847626|82977274|FG001|Overall Study|Adverse Event|10|||
46759092|NCT00847626|82977275|FG002|Overall Study|Adverse Event|6|||
46819435|NCT00289900|83039221|FG003|Overall Study|Withdrawal by Subject|18|||
46819436|NCT00289900|83039222|FG004|Overall Study|Withdrawal by Subject|12|||
46819437|NCT00289900|83039223|FG005|Overall Study|Withdrawal by Subject|11|||
46931404|NCT03721172|83166525|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
46931405|NCT03721172|83166526|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
47056266|NCT02128113|83332161|FG000|Overall Study|Withdrawal by Subject|3|||
46759093|NCT00847626|82977276|FG003|Overall Study|Adverse Event|19|||
46759094|NCT00847626|82977277|FG004|Overall Study|Adverse Event|11|||
46759095|NCT00847626|82977278|FG005|Overall Study|Adverse Event|22|||
46759096|NCT00847626|82977279|FG006|Overall Study|Adverse Event|4|||
46759097|NCT00847626|82977280|FG007|Overall Study|Adverse Event|6|||
46759098|NCT00847626|82977281|FG008|Overall Study|Adverse Event|3|||
46759099|NCT00847626|82977282|FG009|Overall Study|Adverse Event|6|||
46759100|NCT00847626|82977283|FG010|Overall Study|Adverse Event|6|||
46759101|NCT00847626|82977273|FG000|Overall Study|Protocol Violation|2|||
46759102|NCT00847626|82977274|FG001|Overall Study|Protocol Violation|1|||
46759103|NCT00847626|82977275|FG002|Overall Study|Protocol Violation|2|||
46759104|NCT00847626|82977276|FG003|Overall Study|Protocol Violation|1|||
46819438|NCT00289900|83039218|FG000|Overall Study|Protocol Violation|3|||
46819439|NCT00289900|83039219|FG001|Overall Study|Protocol Violation|9|||
46819440|NCT00289900|83039220|FG002|Overall Study|Protocol Violation|2|||
46819441|NCT00289900|83039221|FG003|Overall Study|Protocol Violation|6|||
46819442|NCT00289900|83039222|FG004|Overall Study|Protocol Violation|7|||
46819443|NCT00289900|83039223|FG005|Overall Study|Protocol Violation|4|||
46819444|NCT00289900|83039218|FG000|Overall Study|site terminated|1|||
46819445|NCT00289900|83039219|FG001|Overall Study|site terminated|0|||
46819446|NCT00289900|83039220|FG002|Overall Study|site terminated|1|||
46819447|NCT00289900|83039221|FG003|Overall Study|site terminated|0|||
46819448|NCT00289900|83039222|FG004|Overall Study|site terminated|0|||
46819449|NCT00289900|83039223|FG005|Overall Study|site terminated|0|||
46819450|NCT00289900|83039218|FG000|Overall Study|Not treated|0|||
46819451|NCT00289900|83039219|FG001|Overall Study|Not treated|1|||
46819452|NCT00289900|83039220|FG002|Overall Study|Not treated|0|||
46819453|NCT00289900|83039221|FG003|Overall Study|Not treated|0|||
46819454|NCT00289900|83039222|FG004|Overall Study|Not treated|0|||
46636724|NCT01461096|82810517|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
46636725|NCT01461096|82810516|FG000|Overall Study|Lost to Follow-up|8|||
46636726|NCT01461096|82810517|FG001|Overall Study|Lost to Follow-up|4|||
46759105|NCT00847626|82977277|FG004|Overall Study|Protocol Violation|1|||
46759106|NCT00847626|82977278|FG005|Overall Study|Protocol Violation|1|||
46759107|NCT00847626|82977279|FG006|Overall Study|Protocol Violation|1|||
46759108|NCT00847626|82977280|FG007|Overall Study|Protocol Violation|1|||
46759109|NCT00847626|82977281|FG008|Overall Study|Protocol Violation|0|||
46759110|NCT00847626|82977282|FG009|Overall Study|Protocol Violation|1|||
46759111|NCT00847626|82977283|FG010|Overall Study|Protocol Violation|1|||
46759112|NCT00847626|82977273|FG000|Overall Study|Lost to Follow-up|0|||
46759113|NCT00847626|82977274|FG001|Overall Study|Lost to Follow-up|1|||
46759114|NCT00847626|82977275|FG002|Overall Study|Lost to Follow-up|1|||
46759115|NCT00847626|82977276|FG003|Overall Study|Lost to Follow-up|1|||
46759116|NCT00847626|82977277|FG004|Overall Study|Lost to Follow-up|0|||
46759117|NCT00847626|82977278|FG005|Overall Study|Lost to Follow-up|3|||
46759118|NCT00847626|82977279|FG006|Overall Study|Lost to Follow-up|1|||
46759119|NCT00847626|82977280|FG007|Overall Study|Lost to Follow-up|3|||
46759120|NCT00847626|82977281|FG008|Overall Study|Lost to Follow-up|1|||
46759121|NCT00847626|82977282|FG009|Overall Study|Lost to Follow-up|0|||
46759122|NCT00847626|82977283|FG010|Overall Study|Lost to Follow-up|1|||
46819455|NCT00289900|83039223|FG005|Overall Study|Not treated|0|||
46819456|NCT00543725|83039242|FG000|Overall Study|Adverse Event|18|||
46759123|NCT00847626|82977273|FG000|Overall Study|Withdrawal by Subject|5|||
46759124|NCT00847626|82977274|FG001|Overall Study|Withdrawal by Subject|5|||
46759125|NCT00847626|82977275|FG002|Overall Study|Withdrawal by Subject|3|||
46759126|NCT00847626|82977276|FG003|Overall Study|Withdrawal by Subject|8|||
46759127|NCT00847626|82977277|FG004|Overall Study|Withdrawal by Subject|12|||
46759128|NCT00847626|82977278|FG005|Overall Study|Withdrawal by Subject|9|||
46819457|NCT00543725|83039243|FG001|Overall Study|Adverse Event|27|||
46819458|NCT00543725|83039242|FG000|Overall Study|Sponsor's Decision|0|||
46819459|NCT00543725|83039243|FG001|Overall Study|Sponsor's Decision|1|||
46819460|NCT00543725|83039242|FG000|Overall Study|Subject Non-Compliant|4|||
47056267|NCT02128113|83332162|FG001|Overall Study|Withdrawal by Subject|1|||
46819461|NCT00543725|83039243|FG001|Overall Study|Subject Non-Compliant|4|||
46819462|NCT00543725|83039242|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
46819463|NCT00543725|83039243|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
46819464|NCT00543725|83039242|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
46819465|NCT00543725|83039243|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
46819466|NCT00543725|83039242|FG000|Overall Study|Protocol Violation|0|||
46819467|NCT00543725|83039243|FG001|Overall Study|Protocol Violation|1|||
46819468|NCT00543725|83039242|FG000|Overall Study|Withdrawal by Subject|4|||
46819469|NCT00543725|83039243|FG001|Overall Study|Withdrawal by Subject|13|||
46819470|NCT00543725|83039242|FG000|Overall Study|Lost to Follow-up|15|||
46819471|NCT00543725|83039243|FG001|Overall Study|Lost to Follow-up|11|||
46819472|NCT00543725|83039242|FG000|Overall Study|Other|3|||
46819473|NCT00543725|83039243|FG001|Overall Study|Other|3|||
46819474|NCT00269152|83039251|FG000|Overall Study|Adverse Event|9|||
46819475|NCT00269152|83039252|FG001|Overall Study|Adverse Event|3|||
46819476|NCT00269152|83039251|FG000|Overall Study|Withdrawal by Subject|7|||
46819477|NCT00269152|83039252|FG001|Overall Study|Withdrawal by Subject|3|||
46819478|NCT00269152|83039251|FG000|Overall Study|Physician Decision|2|||
46819479|NCT00269152|83039252|FG001|Overall Study|Physician Decision|3|||
46819480|NCT00269152|83039251|FG000|Overall Study|Protocol Violation|0|||
46819481|NCT00269152|83039252|FG001|Overall Study|Protocol Violation|1|||
46819482|NCT00379899|83039260|FG000|Overall Study|Adverse Event|7|||
46819483|NCT00379899|83039261|FG001|Overall Study|Adverse Event|3|||
46819484|NCT00379899|83039260|FG000|Overall Study|Death|10|||
46819485|NCT00379899|83039261|FG001|Overall Study|Death|10|||
46819486|NCT00379899|83039260|FG000|Overall Study|Lost to Follow-up|2|||
46819487|NCT00379899|83039261|FG001|Overall Study|Lost to Follow-up|4|||
46819488|NCT00379899|83039260|FG000|Overall Study|Physician Decision|3|||
46819489|NCT00379899|83039261|FG001|Overall Study|Physician Decision|4|||
46819490|NCT00379899|83039260|FG000|Overall Study|Withdrawal by Subject|5|||
46819491|NCT00379899|83039261|FG001|Overall Study|Withdrawal by Subject|5|||
46819492|NCT00379899|83039260|FG000|Overall Study|Ineligibility determined|0|||
46819493|NCT00379899|83039261|FG001|Overall Study|Ineligibility determined|1|||
46819494|NCT00379899|83039260|FG000|Overall Study|Noncompliance|1|||
46819495|NCT00379899|83039261|FG001|Overall Study|Noncompliance|1|||
46819496|NCT00379899|83039260|FG000|Overall Study|Parathyroidectomy|0|||
46819497|NCT00379899|83039261|FG001|Overall Study|Parathyroidectomy|2|||
46819498|NCT00379899|83039260|FG000|Overall Study|Renal transplantation|5|||
47056268|NCT02128113|83332163|FG002|Overall Study|Withdrawal by Subject|0|||
47056269|NCT02128113|83332161|FG000|Overall Study|Protocol Violation|0|||
47056270|NCT02128113|83332162|FG001|Overall Study|Protocol Violation|1|||
47056271|NCT02128113|83332163|FG002|Overall Study|Protocol Violation|0|||
47056272|NCT02128113|83332161|FG000|Overall Study|Surgery cancelled|0|||
46931406|NCT03721172|83166524|FG000|Placebo-controlled Phase|Other|3|||
46931407|NCT03721172|83166525|FG001|Placebo-controlled Phase|Other|0|||
46931408|NCT03721172|83166526|FG002|Placebo-controlled Phase|Other|0|||
46931409|NCT03721172|83166524|FG000|Apremilast Extension Phase|Adverse Event|0|||
46931410|NCT03721172|83166525|FG001|Apremilast Extension Phase|Adverse Event|0|||
46931411|NCT03721172|83166526|FG002|Apremilast Extension Phase|Adverse Event|10|||
46931412|NCT03721172|83166524|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
46931413|NCT03721172|83166525|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
46931414|NCT03721172|83166526|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
46931415|NCT03721172|83166524|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
46931416|NCT03721172|83166525|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
46931417|NCT03721172|83166526|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
46819499|NCT00379899|83039261|FG001|Overall Study|Renal transplantation|4|||
46819500|NCT00379899|83039260|FG000|Overall Study|Coronary artery bypass graft|1|||
46931418|NCT03721172|83166524|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
46931419|NCT03721172|83166525|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
46931420|NCT03721172|83166526|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
46931421|NCT03721172|83166524|FG000|Apremilast Extension Phase|Protocol Violation|0|||
47056273|NCT02128113|83332162|FG001|Overall Study|Surgery cancelled|1|||
47056274|NCT02128113|83332163|FG002|Overall Study|Surgery cancelled|0|||
47056275|NCT02128113|83332161|FG000|Overall Study|Adverse Event|0|||
47056276|NCT02128113|83332162|FG001|Overall Study|Adverse Event|0|||
47056277|NCT02128113|83332163|FG002|Overall Study|Adverse Event|1|||
46819501|NCT00379899|83039261|FG001|Overall Study|Coronary artery bypass graft|1|||
46931422|NCT03721172|83166525|FG001|Apremilast Extension Phase|Protocol Violation|0|||
46931423|NCT03721172|83166526|FG002|Apremilast Extension Phase|Protocol Violation|1|||
46819502|NCT00379899|83039260|FG000|Overall Study|Other protocol-specified criteria|3|||
46819503|NCT00379899|83039261|FG001|Overall Study|Other protocol-specified criteria|4|||
46819504|NCT00379899|83039260|FG000|Overall Study|Other|3|||
47056278|NCT02036970|83332200|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
47056279|NCT02036970|83332201|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
46819505|NCT00379899|83039261|FG001|Overall Study|Other|1|||
46819506|NCT00371787|83039269|FG000|Overall Study|Withdrawal by Subject|3|||
46819507|NCT00371787|83039270|FG001|Overall Study|Withdrawal by Subject|1|||
46819508|NCT00363129|83039278|FG000|Overall Study|Withdrawal by Subject|11|||
46931424|NCT03721172|83166524|FG000|Apremilast Extension Phase|Physician Decision|0|||
46819509|NCT00363129|83039279|FG001|Overall Study|Withdrawal by Subject|18|||
46819510|NCT00363129|83039278|FG000|Overall Study|Adverse Event|8|||
46819511|NCT00363129|83039279|FG001|Overall Study|Adverse Event|3|||
46819512|NCT00363129|83039278|FG000|Overall Study|Alternate Treatment|2|||
46819513|NCT00363129|83039279|FG001|Overall Study|Alternate Treatment|4|||
46819514|NCT00363129|83039278|FG000|Overall Study|Other Medical Problems|2|||
46819515|NCT00363129|83039279|FG001|Overall Study|Other Medical Problems|4|||
46819516|NCT00363129|83039278|FG000|Overall Study|Death|0|||
46819517|NCT00363129|83039279|FG001|Overall Study|Death|1|||
46819518|NCT00363129|83039278|FG000|Overall Study|Other Reasons|6|||
46819519|NCT00363129|83039279|FG001|Overall Study|Other Reasons|3|||
46819520|NCT00268996|83039287|FG000|Overall Study|Adverse Event|11|||
46819521|NCT00268996|83039288|FG001|Overall Study|Adverse Event|7|||
46819522|NCT00268996|83039287|FG000|Overall Study|Lost to Follow-up|3|||
46819523|NCT00268996|83039288|FG001|Overall Study|Lost to Follow-up|1|||
46819524|NCT00268996|83039287|FG000|Overall Study|Withdrawal by Subject|5|||
46819525|NCT00268996|83039288|FG001|Overall Study|Withdrawal by Subject|11|||
46819526|NCT00268996|83039287|FG000|Overall Study|Non-compliance|1|||
46819527|NCT00268996|83039288|FG001|Overall Study|Non-compliance|0|||
46819528|NCT00268996|83039287|FG000|Overall Study|Other|1|||
46819529|NCT00268996|83039288|FG001|Overall Study|Other|1|||
46819530|NCT00371397|83039296|FG000|Session 1|Withdrawal by Subject|1|||
46819531|NCT00371397|83039297|FG001|Session 1|Withdrawal by Subject|0|||
46931425|NCT03721172|83166525|FG001|Apremilast Extension Phase|Physician Decision|0|||
46819532|NCT00371397|83039298|FG002|Session 1|Withdrawal by Subject|0|||
46819533|NCT00371397|83039299|FG003|Session 1|Withdrawal by Subject|0|||
46819534|NCT00371397|83039300|FG004|Session 1|Withdrawal by Subject|0|||
46819535|NCT00371397|83039301|FG005|Session 1|Withdrawal by Subject|0|||
46819536|NCT00371397|83039302|FG006|Session 1|Withdrawal by Subject|0|||
46819537|NCT00371397|83039303|FG007|Session 1|Withdrawal by Subject|1|||
46819538|NCT00371397|83039304|FG008|Session 1|Withdrawal by Subject|0|||
46931426|NCT03721172|83166526|FG002|Apremilast Extension Phase|Physician Decision|1|||
46931427|NCT03721172|83166524|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
46931428|NCT03721172|83166525|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
46931429|NCT03721172|83166526|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
46931430|NCT03721172|83166524|FG000|Apremilast Extension Phase|Other|0|||
46931431|NCT03721172|83166525|FG001|Apremilast Extension Phase|Other|0|||
46931432|NCT03721172|83166526|FG002|Apremilast Extension Phase|Other|3|||
46931433|NCT03721172|83166524|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
46931434|NCT03721172|83166525|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
46931435|NCT03721172|83166526|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
46931436|NCT03607422|83166540|FG000|Overall Study|Adverse Event|7|||
46931437|NCT03607422|83166541|FG001|Overall Study|Adverse Event|3|||
46931438|NCT03607422|83166542|FG002|Overall Study|Adverse Event|2|||
46931439|NCT03607422|83166543|FG003|Overall Study|Adverse Event|0|||
46759129|NCT00847626|82977279|FG006|Overall Study|Withdrawal by Subject|8|||
46759130|NCT00847626|82977280|FG007|Overall Study|Withdrawal by Subject|4|||
46759131|NCT00847626|82977281|FG008|Overall Study|Withdrawal by Subject|4|||
46759132|NCT00847626|82977282|FG009|Overall Study|Withdrawal by Subject|5|||
46759133|NCT00847626|82977283|FG010|Overall Study|Withdrawal by Subject|2|||
46759134|NCT00847626|82977273|FG000|Overall Study|Lack of Efficacy|3|||
46759135|NCT00847626|82977274|FG001|Overall Study|Lack of Efficacy|1|||
46759136|NCT00847626|82977275|FG002|Overall Study|Lack of Efficacy|0|||
46759137|NCT00847626|82977276|FG003|Overall Study|Lack of Efficacy|1|||
46759138|NCT00847626|82977277|FG004|Overall Study|Lack of Efficacy|2|||
46759139|NCT00847626|82977278|FG005|Overall Study|Lack of Efficacy|0|||
46759140|NCT00847626|82977279|FG006|Overall Study|Lack of Efficacy|6|||
46759141|NCT00847626|82977280|FG007|Overall Study|Lack of Efficacy|2|||
46819539|NCT00371397|83039305|FG009|Session 1|Withdrawal by Subject|0|||
46819540|NCT00371397|83039306|FG010|Session 1|Withdrawal by Subject|0|||
46819541|NCT00371397|83039307|FG011|Session 1|Withdrawal by Subject|0|||
46819542|NCT00379587|83039313|FG000|Overall Study|Lost to Follow-up|2|||
46819543|NCT00289276|83039319|FG000|Second Part of FAST Study (Expansion)|Death|0|||
46819544|NCT00289276|83039320|FG001|Second Part of FAST Study (Expansion)|Death|2|||
46819545|NCT00289276|83039319|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
46819546|NCT00289276|83039320|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
46819547|NCT00289198|83039328|FG000|Overall Study|Adverse Event|0|||
46819548|NCT00289198|83039329|FG001|Overall Study|Adverse Event|2|||
46819549|NCT00289198|83039328|FG000|Overall Study|Protocol Violation|2|||
46819550|NCT00289198|83039329|FG001|Overall Study|Protocol Violation|1|||
46931440|NCT03607422|83166544|FG004|Overall Study|Adverse Event|2|||
46931441|NCT03607422|83166545|FG005|Overall Study|Adverse Event|0|||
46931442|NCT03607422|83166540|FG000|Overall Study|Withdrawal by Subject|11|||
46931443|NCT03607422|83166541|FG001|Overall Study|Withdrawal by Subject|3|||
46931444|NCT03607422|83166542|FG002|Overall Study|Withdrawal by Subject|6|||
46931445|NCT03607422|83166543|FG003|Overall Study|Withdrawal by Subject|2|||
46931446|NCT03607422|83166544|FG004|Overall Study|Withdrawal by Subject|0|||
46931447|NCT03607422|83166545|FG005|Overall Study|Withdrawal by Subject|0|||
46931448|NCT03607422|83166540|FG000|Overall Study|Lost to Follow-up|0|||
46931449|NCT03607422|83166541|FG001|Overall Study|Lost to Follow-up|0|||
46931450|NCT03607422|83166542|FG002|Overall Study|Lost to Follow-up|1|||
46931451|NCT03607422|83166543|FG003|Overall Study|Lost to Follow-up|0|||
46931452|NCT03607422|83166544|FG004|Overall Study|Lost to Follow-up|0|||
46931453|NCT03607422|83166545|FG005|Overall Study|Lost to Follow-up|0|||
46759142|NCT00847626|82977281|FG008|Overall Study|Lack of Efficacy|5|||
46759143|NCT00847626|82977282|FG009|Overall Study|Lack of Efficacy|1|||
46759144|NCT00847626|82977283|FG010|Overall Study|Lack of Efficacy|7|||
46759145|NCT00847626|82977273|FG000|Overall Study|Other|1|||
46759146|NCT00847626|82977274|FG001|Overall Study|Other|5|||
46819551|NCT00289198|83039328|FG000|Overall Study|Withdrawal by Subject|4|||
46819552|NCT00289198|83039329|FG001|Overall Study|Withdrawal by Subject|1|||
46819553|NCT00289198|83039328|FG000|Overall Study|Lack of Efficacy|2|||
46819554|NCT00289198|83039329|FG001|Overall Study|Lack of Efficacy|0|||
46819555|NCT00289198|83039328|FG000|Overall Study|Other: Low compliance|0|||
46819556|NCT00289198|83039329|FG001|Overall Study|Other: Low compliance|1|||
46819557|NCT00289198|83039328|FG000|Overall Study|Other: Physician's decision|0|||
46819558|NCT00289198|83039329|FG001|Overall Study|Other: Physician's decision|1|||
46819559|NCT00289198|83039328|FG000|Overall Study|Other: Unable to attend on schedule|2|||
46819560|NCT00289198|83039329|FG001|Overall Study|Other: Unable to attend on schedule|1|||
46759147|NCT00847626|82977275|FG002|Overall Study|Other|4|||
46759148|NCT00847626|82977276|FG003|Overall Study|Other|1|||
46759149|NCT00847626|82977277|FG004|Overall Study|Other|2|||
46819561|NCT00289198|83039328|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
46819562|NCT00289198|83039329|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
46819563|NCT00289198|83039328|FG000|Overall Study|Other: Impossible to come on visit|0|||
46819564|NCT00289198|83039329|FG001|Overall Study|Other: Impossible to come on visit|1|||
46819565|NCT00363051|83039338|FG000|Overall Study|Adminstrative problems|1|||
46819566|NCT00363051|83039339|FG001|Overall Study|Adminstrative problems|1|||
46819567|NCT00363051|83039338|FG000|Overall Study|Adverse Event|21|||
46819568|NCT00363051|83039339|FG001|Overall Study|Adverse Event|12|||
46819569|NCT00363051|83039338|FG000|Overall Study|New Cancer Therapy|2|||
46819570|NCT00363051|83039339|FG001|Overall Study|New Cancer Therapy|1|||
46819571|NCT00363051|83039338|FG000|Overall Study|Withdrawal by Subject|11|||
46819572|NCT00363051|83039339|FG001|Overall Study|Withdrawal by Subject|3|||
46819573|NCT00363051|83039338|FG000|Overall Study|Lost to Follow-up|0|||
46819574|NCT00363051|83039339|FG001|Overall Study|Lost to Follow-up|1|||
46819575|NCT00363051|83039338|FG000|Overall Study|Protocol Violation|0|||
46819576|NCT00363051|83039339|FG001|Overall Study|Protocol Violation|2|||
46931454|NCT03607422|83166540|FG000|Overall Study|Other|12|||
46931455|NCT03607422|83166541|FG001|Overall Study|Other|4|||
46931456|NCT03607422|83166542|FG002|Overall Study|Other|1|||
46759150|NCT00847626|82977278|FG005|Overall Study|Other|2|||
46759151|NCT00847626|82977279|FG006|Overall Study|Other|2|||
46759152|NCT00847626|82977280|FG007|Overall Study|Other|3|||
46759153|NCT00847626|82977281|FG008|Overall Study|Other|1|||
46759154|NCT00847626|82977282|FG009|Overall Study|Other|1|||
46759155|NCT00847626|82977283|FG010|Overall Study|Other|3|||
46759156|NCT00851682|82977312|FG000|Overall Study|screen failure|5|||
46759157|NCT00851682|82977313|FG001|Overall Study|screen failure|0|||
46759158|NCT00860262|82977322|FG000|Overall Study|Adverse Event|9|||
46759159|NCT00860262|82977323|FG001|Overall Study|Adverse Event|6|||
46759160|NCT00860262|82977324|FG002|Overall Study|Adverse Event|7|||
46759161|NCT00860262|82977322|FG000|Overall Study|Protocol Violation|0|||
46759162|NCT00860262|82977323|FG001|Overall Study|Protocol Violation|1|||
46759163|NCT00860262|82977324|FG002|Overall Study|Protocol Violation|0|||
46759164|NCT00860262|82977322|FG000|Overall Study|Lost to Follow-up|2|||
46759165|NCT00860262|82977323|FG001|Overall Study|Lost to Follow-up|0|||
46759166|NCT00860262|82977324|FG002|Overall Study|Lost to Follow-up|1|||
46759167|NCT00860262|82977322|FG000|Overall Study|Withdrawal by Subject|4|||
46759168|NCT00860262|82977323|FG001|Overall Study|Withdrawal by Subject|8|||
46819577|NCT00363051|83039338|FG000|Overall Study|Death|3|||
46819578|NCT00363051|83039339|FG001|Overall Study|Death|2|||
46819579|NCT00379353|83039349|FG000|Overall Study|Hospitalization|3|||
46819580|NCT00379353|83039350|FG001|Overall Study|Hospitalization|3|||
46819581|NCT00379353|83039349|FG000|Overall Study|Withdrawal by Subject|5|||
46931457|NCT03607422|83166543|FG003|Overall Study|Other|2|||
46931458|NCT03607422|83166544|FG004|Overall Study|Other|0|||
46931459|NCT03607422|83166545|FG005|Overall Study|Other|2|||
46931460|NCT03607422|83166540|FG000|Overall Study|Ongoing at Time of Analysis|8|||
46819582|NCT00379353|83039350|FG001|Overall Study|Withdrawal by Subject|2|||
46819583|NCT00379353|83039349|FG000|Overall Study|Death|1|||
46819584|NCT00379353|83039350|FG001|Overall Study|Death|0|||
46819585|NCT00379353|83039349|FG000|Overall Study|Cardiac Tamponade|1|||
46819586|NCT00379353|83039350|FG001|Overall Study|Cardiac Tamponade|0|||
46819587|NCT00379353|83039349|FG000|Overall Study|Non-compliance|1|||
46819588|NCT00379353|83039350|FG001|Overall Study|Non-compliance|0|||
46819589|NCT00379353|83039349|FG000|Overall Study|Conflicting drug treatment|0|||
46819590|NCT00379353|83039350|FG001|Overall Study|Conflicting drug treatment|1|||
46819591|NCT00378573|83039366|FG000|Treatment Period|Adverse Event|9|||
46931461|NCT03607422|83166541|FG001|Overall Study|Ongoing at Time of Analysis|0|||
46931462|NCT03607422|83166542|FG002|Overall Study|Ongoing at Time of Analysis|2|||
46931463|NCT03607422|83166543|FG003|Overall Study|Ongoing at Time of Analysis|1|||
46931464|NCT03607422|83166544|FG004|Overall Study|Ongoing at Time of Analysis|1|||
46931465|NCT03607422|83166545|FG005|Overall Study|Ongoing at Time of Analysis|1|||
46931466|NCT03569293|83166565|FG000|Overall Study|Adverse Event|4|||
46931467|NCT03569293|83166566|FG001|Overall Study|Adverse Event|1|||
46931468|NCT03569293|83166567|FG002|Overall Study|Adverse Event|5|||
46931469|NCT03569293|83166568|FG003|Overall Study|Adverse Event|1|||
46931470|NCT03569293|83166569|FG004|Overall Study|Adverse Event|0|||
46931471|NCT03569293|83166570|FG005|Overall Study|Adverse Event|0|||
46931472|NCT03569293|83166565|FG000|Overall Study|Withdrawal by Subject|16|||
46931473|NCT03569293|83166566|FG001|Overall Study|Withdrawal by Subject|2|||
46931474|NCT03569293|83166567|FG002|Overall Study|Withdrawal by Subject|4|||
46931475|NCT03569293|83166568|FG003|Overall Study|Withdrawal by Subject|1|||
46931476|NCT03569293|83166569|FG004|Overall Study|Withdrawal by Subject|0|||
46931477|NCT03569293|83166570|FG005|Overall Study|Withdrawal by Subject|0|||
46931478|NCT03569293|83166565|FG000|Overall Study|Lost to Follow-up|1|||
46931479|NCT03569293|83166566|FG001|Overall Study|Lost to Follow-up|3|||
46931480|NCT03569293|83166567|FG002|Overall Study|Lost to Follow-up|1|||
46931481|NCT03569293|83166568|FG003|Overall Study|Lost to Follow-up|1|||
46931482|NCT03569293|83166569|FG004|Overall Study|Lost to Follow-up|0|||
46931483|NCT03569293|83166570|FG005|Overall Study|Lost to Follow-up|0|||
46931484|NCT03569293|83166565|FG000|Overall Study|Other|8|||
46931485|NCT03569293|83166566|FG001|Overall Study|Other|2|||
46931486|NCT03569293|83166567|FG002|Overall Study|Other|1|||
46931487|NCT03569293|83166568|FG003|Overall Study|Other|1|||
46931488|NCT03569293|83166569|FG004|Overall Study|Other|0|||
46759169|NCT00860262|82977324|FG002|Overall Study|Withdrawal by Subject|6|||
46759170|NCT00860262|82977322|FG000|Overall Study|Lack of Efficacy|0|||
46759171|NCT00860262|82977323|FG001|Overall Study|Lack of Efficacy|4|||
46759172|NCT00860262|82977324|FG002|Overall Study|Lack of Efficacy|3|||
46759173|NCT00860262|82977322|FG000|Overall Study|Other|5|||
46759174|NCT00860262|82977323|FG001|Overall Study|Other|3|||
46759175|NCT00860262|82977324|FG002|Overall Study|Other|1|||
46759176|NCT00860028|82977336|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
46759177|NCT00860028|82977337|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
46759178|NCT00859638|82977347|FG000|Overall Study|Lost to Follow-up|6|||
46759179|NCT00859638|82977348|FG001|Overall Study|Lost to Follow-up|1|||
46759180|NCT00859638|82977347|FG000|Overall Study|Withdrawal by Subject|3|||
46759181|NCT00859638|82977348|FG001|Overall Study|Withdrawal by Subject|2|||
46759182|NCT00859638|82977347|FG000|Overall Study|Ill health|1|||
46759183|NCT00859638|82977348|FG001|Overall Study|Ill health|1|||
46759184|NCT00846846|82977354|FG000|Overall Study|Death|56|||
46759185|NCT00846846|82977354|FG000|Overall Study|Withdrawal by Subject|19|||
46759186|NCT00846768|82977358|FG000|Overall Study|Adverse Event|0|||
46759187|NCT00846768|82977359|FG001|Overall Study|Adverse Event|1|||
46759188|NCT00846768|82977360|FG002|Overall Study|Adverse Event|0|||
46759189|NCT00846768|82977361|FG003|Overall Study|Adverse Event|0|||
46759190|NCT00863798|82977374|FG000|Overall Study|Adverse Event|5|||
46759191|NCT00863798|82977375|FG001|Overall Study|Adverse Event|2|||
46931489|NCT03569293|83166570|FG005|Overall Study|Other|0|||
46931490|NCT03569293|83166565|FG000|Overall Study|Ongoing at Time of Analysis|8|||
46931491|NCT03569293|83166566|FG001|Overall Study|Ongoing at Time of Analysis|1|||
46819592|NCT00378573|83039366|FG000|Treatment Period|Physician Decision|1|||
46931492|NCT03569293|83166567|FG002|Overall Study|Ongoing at Time of Analysis|3|||
46931493|NCT03569293|83166568|FG003|Overall Study|Ongoing at Time of Analysis|0|||
46931494|NCT03569293|83166569|FG004|Overall Study|Ongoing at Time of Analysis|0|||
46931495|NCT03569293|83166570|FG005|Overall Study|Ongoing at Time of Analysis|0|||
46759192|NCT00863798|82977376|FG002|Overall Study|Adverse Event|4|||
46759193|NCT00863798|82977374|FG000|Overall Study|Participant failed to return|2|||
46759194|NCT00863798|82977375|FG001|Overall Study|Participant failed to return|1|||
46759195|NCT00863798|82977376|FG002|Overall Study|Participant failed to return|0|||
46819593|NCT00378573|83039366|FG000|Treatment Period|Withdrawal by Subject|2|||
46819594|NCT00378573|83039366|FG000|Treatment Period|Disease Progression|4|||
46819595|NCT00378573|83039366|FG000|Treatment Period|Sponsor decision to close study|1|||
46819596|NCT00378573|83039366|FG000|Follow-up|Death|12|||
46931496|NCT03496610|83166586|FG000|Overall Study|Lost to Follow-up|3|||
46931497|NCT03496610|83166587|FG001|Overall Study|Lost to Follow-up|2|||
46931498|NCT03496610|83166586|FG000|Overall Study|Physician Decision|1|||
46931499|NCT03496610|83166587|FG001|Overall Study|Physician Decision|0|||
46931500|NCT03496610|83166586|FG000|Overall Study|Withdrawal by Subject|1|||
46931501|NCT03496610|83166587|FG001|Overall Study|Withdrawal by Subject|0|||
46931502|NCT03484819|83166593|FG000|Overall Study|Death|2|||
46931503|NCT03484819|83166593|FG000|Overall Study|Adverse Event|2|||
46931504|NCT03484819|83166593|FG000|Overall Study|Physician Decision|1|||
46931505|NCT03484819|83166593|FG000|Overall Study|Withdrawal by Subject|2|||
46931506|NCT03484819|83166593|FG000|Overall Study|Disease Progression|4|||
46931507|NCT03484819|83166593|FG000|Overall Study|Complicating Condition|1|||
46931508|NCT03338790|83166628|FG000|Overall Study|Disease Progression|65|||
46931509|NCT03338790|83166629|FG001|Overall Study|Disease Progression|43|||
46931510|NCT03338790|83166630|FG002|Overall Study|Disease Progression|50|||
46931511|NCT03338790|83166631|FG003|Overall Study|Disease Progression|37|||
46931512|NCT03338790|83166628|FG000|Overall Study|Study Drug Toxicity|9|||
46931513|NCT03338790|83166629|FG001|Overall Study|Study Drug Toxicity|8|||
46931514|NCT03338790|83166630|FG002|Overall Study|Study Drug Toxicity|15|||
46931515|NCT03338790|83166631|FG003|Overall Study|Study Drug Toxicity|0|||
46931516|NCT03338790|83166628|FG000|Overall Study|Death|1|||
46931517|NCT03338790|83166629|FG001|Overall Study|Death|1|||
46931518|NCT03338790|83166630|FG002|Overall Study|Death|1|||
46931519|NCT03338790|83166631|FG003|Overall Study|Death|0|||
46931520|NCT03338790|83166628|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
46931521|NCT03338790|83166629|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
46931522|NCT03338790|83166630|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
46931523|NCT03338790|83166631|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
46931524|NCT03338790|83166628|FG000|Overall Study|Participant request to discontinue study treatment|3|||
46931525|NCT03338790|83166629|FG001|Overall Study|Participant request to discontinue study treatment|3|||
46931526|NCT03338790|83166630|FG002|Overall Study|Participant request to discontinue study treatment|2|||
46931527|NCT03338790|83166631|FG003|Overall Study|Participant request to discontinue study treatment|1|||
46931528|NCT03338790|83166628|FG000|Overall Study|Poor/non-compliance|0|||
46931529|NCT03338790|83166629|FG001|Overall Study|Poor/non-compliance|1|||
46931530|NCT03338790|83166630|FG002|Overall Study|Poor/non-compliance|0|||
46931531|NCT03338790|83166631|FG003|Overall Study|Poor/non-compliance|0|||
46931532|NCT03338790|83166628|FG000|Overall Study|Participant withdrew consent|1|||
46931533|NCT03338790|83166629|FG001|Overall Study|Participant withdrew consent|0|||
46931534|NCT03338790|83166630|FG002|Overall Study|Participant withdrew consent|1|||
46931535|NCT03338790|83166631|FG003|Overall Study|Participant withdrew consent|1|||
46931536|NCT03338790|83166628|FG000|Overall Study|Other reasons|0|||
46931537|NCT03338790|83166629|FG001|Overall Study|Other reasons|5|||
46931538|NCT03338790|83166630|FG002|Overall Study|Other reasons|0|||
46931539|NCT03338790|83166631|FG003|Overall Study|Other reasons|2|||
46931540|NCT03338790|83166628|FG000|Overall Study|Not reported|0|||
46931541|NCT03338790|83166629|FG001|Overall Study|Not reported|0|||
46931542|NCT03338790|83166630|FG002|Overall Study|Not reported|1|||
46931543|NCT03338790|83166631|FG003|Overall Study|Not reported|0|||
46931544|NCT03338790|83166628|FG000|Overall Study|Completed treatment period|1|||
46759196|NCT00863798|82977374|FG000|Overall Study|Investigator request|1|||
46759197|NCT00863798|82977375|FG001|Overall Study|Investigator request|2|||
46759198|NCT00863798|82977376|FG002|Overall Study|Investigator request|1|||
46759199|NCT00863798|82977374|FG000|Overall Study|Lack of Efficacy|4|||
46759200|NCT00863798|82977375|FG001|Overall Study|Lack of Efficacy|3|||
46759201|NCT00863798|82977376|FG002|Overall Study|Lack of Efficacy|6|||
46759202|NCT00863798|82977374|FG000|Overall Study|Lost to Follow-up|6|||
46759203|NCT00863798|82977375|FG001|Overall Study|Lost to Follow-up|9|||
46759204|NCT00863798|82977376|FG002|Overall Study|Lost to Follow-up|5|||
46759205|NCT00863798|82977374|FG000|Overall Study|Other|2|||
46759206|NCT00863798|82977375|FG001|Overall Study|Other|3|||
46759207|NCT00863798|82977376|FG002|Overall Study|Other|1|||
46759208|NCT00863798|82977374|FG000|Overall Study|Protocol Violation|0|||
46931545|NCT03338790|83166629|FG001|Overall Study|Completed treatment period|2|||
46931546|NCT03338790|83166630|FG002|Overall Study|Completed treatment period|0|||
46759209|NCT00863798|82977375|FG001|Overall Study|Protocol Violation|1|||
46931547|NCT03338790|83166631|FG003|Overall Study|Completed treatment period|0|||
46931548|NCT03228537|83166641|FG000|Neoadjuvant|Adverse Event|2|||
46931549|NCT03228537|83166641|FG000|Neoadjuvant|Progression/Relapse|4|||
46931550|NCT03228537|83166641|FG000|Neoadjuvant|Death|1|||
46931551|NCT03228537|83166641|FG000|Surgery|Death|1|||
46931552|NCT03228537|83166641|FG000|Surgery|Other - Not Protocol Specified|2|||
46931553|NCT03228537|83166641|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
46931554|NCT03228537|83166641|FG000|Maintenance|Progression/Relapse|10|||
46931555|NCT03173248|83166649|FG000|Overall Study|Death|28|||
46759210|NCT00863798|82977376|FG002|Overall Study|Protocol Violation|1|||
46759211|NCT00863798|82977374|FG000|Overall Study|Withdrawal by Subject|8|||
46759212|NCT00863798|82977375|FG001|Overall Study|Withdrawal by Subject|7|||
46759213|NCT00863798|82977376|FG002|Overall Study|Withdrawal by Subject|4|||
46931556|NCT03173248|83166650|FG001|Overall Study|Death|46|||
46931557|NCT03173248|83166649|FG000|Overall Study|Lost to Follow-up|0|||
46931558|NCT03173248|83166650|FG001|Overall Study|Lost to Follow-up|1|||
46931559|NCT03173248|83166649|FG000|Overall Study|Withdrawal by Subject|6|||
46819597|NCT00378573|83039366|FG000|Follow-up|Lost to Follow-up|1|||
46819598|NCT00378573|83039366|FG000|Follow-up|Withdrawal by Subject|1|||
46819599|NCT03831945|83039372|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
46819600|NCT03831945|83039373|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
46819601|NCT03831945|83039372|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
46819602|NCT03831945|83039373|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
46819603|NCT03831945|83039372|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
46819604|NCT03831945|83039373|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
46819605|NCT00457002|83039381|FG000|Overall Study|Death|40|||
46819606|NCT00457002|83039382|FG001|Overall Study|Death|47|||
46819607|NCT00457002|83039381|FG000|Overall Study|Adverse Event|284|||
46819608|NCT00457002|83039382|FG001|Overall Study|Adverse Event|260|||
46819609|NCT00457002|83039381|FG000|Overall Study|Withdrawal by Subject|299|||
46819610|NCT00457002|83039382|FG001|Overall Study|Withdrawal by Subject|271|||
46819611|NCT00457002|83039381|FG000|Overall Study|Lost to Follow-up|72|||
46819612|NCT00457002|83039382|FG001|Overall Study|Lost to Follow-up|71|||
46819613|NCT00457002|83039381|FG000|Overall Study|Poor/Non-compliance|46|||
46819614|NCT00457002|83039382|FG001|Overall Study|Poor/Non-compliance|33|||
46819615|NCT00457002|83039381|FG000|Overall Study|No longer met criteria|41|||
46819616|NCT00457002|83039382|FG001|Overall Study|No longer met criteria|37|||
46819617|NCT00457002|83039381|FG000|Overall Study|Administrative reason by Sponsor|1|||
46819618|NCT00457002|83039382|FG001|Overall Study|Administrative reason by Sponsor|0|||
46819619|NCT00457002|83039381|FG000|Overall Study|non-specified|29|||
46819620|NCT00457002|83039382|FG001|Overall Study|non-specified|38|||
46819621|NCT00457002|83039381|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
46819622|NCT00457002|83039382|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
46819623|NCT00362115|83039395|FG000|Overall Study|Adverse Event|0|||
46819624|NCT00362115|83039396|FG001|Overall Study|Adverse Event|1|||
46819625|NCT00362115|83039397|FG002|Overall Study|Adverse Event|1|||
46819626|NCT00362115|83039398|FG003|Overall Study|Adverse Event|1|||
46819627|NCT00362115|83039399|FG004|Overall Study|Adverse Event|2|||
46819628|NCT00362115|83039400|FG005|Overall Study|Adverse Event|2|||
46819629|NCT00362115|83039401|FG006|Overall Study|Adverse Event|1|||
46819630|NCT00362115|83039395|FG000|Overall Study|Protocol Violation|0|||
46819631|NCT00362115|83039396|FG001|Overall Study|Protocol Violation|0|||
46819632|NCT00362115|83039397|FG002|Overall Study|Protocol Violation|0|||
46931560|NCT03173248|83166650|FG001|Overall Study|Withdrawal by Subject|4|||
46931561|NCT03173248|83166649|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
46931562|NCT03173248|83166650|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
46931563|NCT03164616|83166659|FG000|Overall Study|Death|250|||
46931564|NCT03164616|83166660|FG001|Overall Study|Death|264|||
46931565|NCT03164616|83166661|FG002|Overall Study|Death|279|||
46931566|NCT03164616|83166659|FG000|Overall Study|Lost to Follow-up|2|||
46931567|NCT03164616|83166660|FG001|Overall Study|Lost to Follow-up|2|||
46931568|NCT03164616|83166661|FG002|Overall Study|Lost to Follow-up|2|||
46931569|NCT03164616|83166659|FG000|Overall Study|Withdrawal by Subject|6|||
46931570|NCT03164616|83166660|FG001|Overall Study|Withdrawal by Subject|7|||
46931571|NCT03164616|83166661|FG002|Overall Study|Withdrawal by Subject|16|||
46931572|NCT03158688|83166673|FG000|Overall Study|Withdrawal by Subject|14|||
46931573|NCT03158688|83166674|FG001|Overall Study|Withdrawal by Subject|28|||
46931574|NCT03158688|83166673|FG000|Overall Study|Decision by sponsor|13|||
46931575|NCT03158688|83166674|FG001|Overall Study|Decision by sponsor|37|||
46931576|NCT03158688|83166673|FG000|Overall Study|Lost to Follow-up|4|||
46759214|NCT00863798|82977374|FG000|Overall Study|Randomized not treated|4|||
46759215|NCT00863798|82977375|FG001|Overall Study|Randomized not treated|2|||
46759216|NCT00863798|82977376|FG002|Overall Study|Randomized not treated|3|||
46759217|NCT00859014|82977384|FG000|Overall Study|Death|4|||
46759218|NCT00859014|82977384|FG000|Overall Study|Lost to Follow-up|1|||
46759219|NCT00593606|82977388|FG000|Overall Study|Adverse Event|13|||
46759220|NCT00593606|82977388|FG000|Overall Study|Withdrawal by Subject|1|||
46759221|NCT00593606|82977388|FG000|Overall Study|Protocol Violation|3|||
46759222|NCT00593606|82977388|FG000|Overall Study|Lost to Follow-up|2|||
46759223|NCT00593606|82977388|FG000|Overall Study|Run-In Failure|5|||
46759224|NCT00593606|82977388|FG000|Overall Study|Screen Failure|3|||
46931577|NCT03158688|83166674|FG001|Overall Study|Lost to Follow-up|3|||
46931578|NCT03158688|83166673|FG000|Overall Study|Death|74|||
46931579|NCT03158688|83166674|FG001|Overall Study|Death|142|||
46931580|NCT03156023|83166685|FG000|Overall Study|Withdrawal by Subject|1|||
46931581|NCT03156023|83166686|FG001|Overall Study|Withdrawal by Subject|0|||
46759225|NCT00870584|82977394|FG000|Overall Study|Adverse Event|3|||
46759226|NCT00870584|82977395|FG001|Overall Study|Adverse Event|3|||
46759227|NCT00870584|82977394|FG000|Overall Study|Withdrawal by Subject|6|||
46931582|NCT03156023|83166687|FG002|Overall Study|Withdrawal by Subject|2|||
46931583|NCT03156023|83166688|FG003|Overall Study|Withdrawal by Subject|1|||
46931584|NCT03156023|83166689|FG004|Overall Study|Withdrawal by Subject|1|||
46931585|NCT03156023|83166685|FG000|Overall Study|Lost to Follow-up|0|||
46931586|NCT03156023|83166686|FG001|Overall Study|Lost to Follow-up|0|||
47056280|NCT02036970|83332202|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
47056281|NCT02036970|83332203|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
46636727|NCT01507896|82810524|FG000|Overall Study|Withdrawal by Subject|1|||
46636728|NCT01507896|82810524|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
46636729|NCT01507662|82810539|FG000|Overall Study|Death|26|||
46759228|NCT00870584|82977395|FG001|Overall Study|Withdrawal by Subject|7|||
46759229|NCT00870584|82977394|FG000|Overall Study|Lost to Follow-up|5|||
46819633|NCT00362115|83039398|FG003|Overall Study|Protocol Violation|0|||
46819634|NCT00362115|83039399|FG004|Overall Study|Protocol Violation|0|||
46819635|NCT00362115|83039400|FG005|Overall Study|Protocol Violation|1|||
46819636|NCT00362115|83039401|FG006|Overall Study|Protocol Violation|0|||
46819637|NCT00362115|83039395|FG000|Overall Study|Lost to Follow-up|0|||
46819638|NCT00362115|83039396|FG001|Overall Study|Lost to Follow-up|1|||
46819639|NCT00362115|83039397|FG002|Overall Study|Lost to Follow-up|0|||
46819640|NCT00362115|83039398|FG003|Overall Study|Lost to Follow-up|0|||
46819641|NCT00362115|83039399|FG004|Overall Study|Lost to Follow-up|2|||
46819642|NCT00362115|83039400|FG005|Overall Study|Lost to Follow-up|0|||
46819643|NCT00362115|83039401|FG006|Overall Study|Lost to Follow-up|1|||
46819644|NCT00362115|83039395|FG000|Overall Study|Withdrawal by Subject|1|||
46819645|NCT00362115|83039396|FG001|Overall Study|Withdrawal by Subject|3|||
46819646|NCT00362115|83039397|FG002|Overall Study|Withdrawal by Subject|1|||
46819647|NCT00362115|83039398|FG003|Overall Study|Withdrawal by Subject|0|||
46819648|NCT00362115|83039399|FG004|Overall Study|Withdrawal by Subject|1|||
46819649|NCT00362115|83039400|FG005|Overall Study|Withdrawal by Subject|3|||
46819650|NCT00362115|83039401|FG006|Overall Study|Withdrawal by Subject|4|||
46819651|NCT00362115|83039395|FG000|Overall Study|Lack of Efficacy|1|||
46819652|NCT00362115|83039396|FG001|Overall Study|Lack of Efficacy|0|||
46819653|NCT00362115|83039397|FG002|Overall Study|Lack of Efficacy|5|||
46819654|NCT00362115|83039398|FG003|Overall Study|Lack of Efficacy|2|||
46819655|NCT00362115|83039399|FG004|Overall Study|Lack of Efficacy|2|||
46819656|NCT00362115|83039400|FG005|Overall Study|Lack of Efficacy|0|||
46819657|NCT00362115|83039401|FG006|Overall Study|Lack of Efficacy|3|||
46819658|NCT00362115|83039395|FG000|Overall Study|Physician Decision|0|||
46819659|NCT00362115|83039396|FG001|Overall Study|Physician Decision|0|||
46819660|NCT00362115|83039397|FG002|Overall Study|Physician Decision|0|||
46819661|NCT00362115|83039398|FG003|Overall Study|Physician Decision|0|||
46819662|NCT00362115|83039399|FG004|Overall Study|Physician Decision|0|||
46819663|NCT00362115|83039400|FG005|Overall Study|Physician Decision|0|||
46819664|NCT00362115|83039401|FG006|Overall Study|Physician Decision|3|||
46819665|NCT00362115|83039395|FG000|Overall Study|Other|0|||
46819666|NCT00362115|83039396|FG001|Overall Study|Other|1|||
46819667|NCT00362115|83039397|FG002|Overall Study|Other|0|||
46819668|NCT00362115|83039398|FG003|Overall Study|Other|1|||
46819669|NCT00362115|83039399|FG004|Overall Study|Other|0|||
46819670|NCT00362115|83039400|FG005|Overall Study|Other|1|||
46819671|NCT00362115|83039401|FG006|Overall Study|Other|0|||
46819672|NCT00485264|83039423|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
46819673|NCT00485264|83039424|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
46819674|NCT00485264|83039425|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
46819675|NCT00485264|83039426|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
46819676|NCT00485264|83039427|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
46759230|NCT00870584|82977395|FG001|Overall Study|Lost to Follow-up|1|||
46759231|NCT00870584|82977394|FG000|Overall Study|Protocol Deviation|2|||
46759232|NCT00870584|82977395|FG001|Overall Study|Protocol Deviation|2|||
46759233|NCT00870194|82977403|FG000|Overall Study|Adverse Event|10|||
46759234|NCT00870194|82977404|FG001|Overall Study|Adverse Event|5|||
46759235|NCT00870194|82977403|FG000|Overall Study|Lack of Efficacy|0|||
46759236|NCT00870194|82977404|FG001|Overall Study|Lack of Efficacy|1|||
46819677|NCT00485264|83039428|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
46819678|NCT00485264|83039423|FG000|Overall Study|Death|1|||
46819679|NCT00485264|83039424|FG001|Overall Study|Death|0|||
46636730|NCT01507662|82810540|FG001|Overall Study|Death|18|||
46819680|NCT00485264|83039425|FG002|Overall Study|Death|0|||
46819681|NCT00485264|83039426|FG003|Overall Study|Death|0|||
46819682|NCT00485264|83039427|FG004|Overall Study|Death|1|||
46819683|NCT00485264|83039428|FG005|Overall Study|Death|0|||
46819684|NCT00485264|83039423|FG000|Overall Study|Adverse Event|1|||
46931587|NCT03156023|83166687|FG002|Overall Study|Lost to Follow-up|0|||
47056282|NCT02036970|83332204|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
46759237|NCT00870194|82977403|FG000|Overall Study|Lost to Follow-up|2|||
47056283|NCT02036970|83332205|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
46759238|NCT00870194|82977404|FG001|Overall Study|Lost to Follow-up|0|||
46819685|NCT00485264|83039424|FG001|Overall Study|Adverse Event|0|||
46819686|NCT00485264|83039425|FG002|Overall Study|Adverse Event|2|||
46819687|NCT00485264|83039426|FG003|Overall Study|Adverse Event|3|||
47056284|NCT02036970|83332206|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
46931588|NCT03156023|83166688|FG003|Overall Study|Lost to Follow-up|0|||
46931589|NCT03156023|83166689|FG004|Overall Study|Lost to Follow-up|1|||
46931590|NCT03151707|83166705|FG000|Overall Study|Lost to Follow-up|6|||
46931591|NCT03111147|83166711|FG000|Overall Study|Lost to Follow-up|2|||
46931592|NCT03111147|83166712|FG001|Overall Study|Lost to Follow-up|5|||
46931593|NCT03111147|83166711|FG000|Overall Study|Withdrawal by Subject|4|||
46759239|NCT00870194|82977403|FG000|Overall Study|Physician Decision|3|||
46759240|NCT00870194|82977404|FG001|Overall Study|Physician Decision|1|||
46759241|NCT00870194|82977403|FG000|Overall Study|Protocol Violation|3|||
46759242|NCT00870194|82977404|FG001|Overall Study|Protocol Violation|3|||
46759243|NCT00870194|82977403|FG000|Overall Study|Entry Criteria Not Met|1|||
46759244|NCT00870194|82977404|FG001|Overall Study|Entry Criteria Not Met|2|||
46759245|NCT00870194|82977403|FG000|Overall Study|Subject Decision|7|||
46759246|NCT00870194|82977404|FG001|Overall Study|Subject Decision|2|||
46759247|NCT00690430|82977412|FG000|Core Phase|Abnormal Laboratory value|0|||
46759248|NCT00690430|82977413|FG001|Core Phase|Abnormal Laboratory value|1|||
46759249|NCT00690430|82977414|FG002|Core Phase|Abnormal Laboratory value|0|||
46759250|NCT00690430|82977412|FG000|Core Phase|Adverse Event|5|||
46759251|NCT00690430|82977413|FG001|Core Phase|Adverse Event|1|||
46759252|NCT00690430|82977414|FG002|Core Phase|Adverse Event|0|||
46759253|NCT00690430|82977412|FG000|Core Phase|Death|0|||
46759254|NCT00690430|82977413|FG001|Core Phase|Death|2|||
46759255|NCT00690430|82977414|FG002|Core Phase|Death|0|||
46759256|NCT00690430|82977412|FG000|Core Phase|Protocol Violation|1|||
46759257|NCT00690430|82977413|FG001|Core Phase|Protocol Violation|0|||
46759258|NCT00690430|82977414|FG002|Core Phase|Protocol Violation|0|||
46759259|NCT00690430|82977412|FG000|Core Phase|Withdrawal by Subject|3|||
46759260|NCT00690430|82977413|FG001|Core Phase|Withdrawal by Subject|3|||
46759261|NCT00690430|82977414|FG002|Core Phase|Withdrawal by Subject|0|||
46759262|NCT00690430|82977412|FG000|Core Phase|Subject no longer requires study drug|1|||
46759263|NCT00690430|82977413|FG001|Core Phase|Subject no longer requires study drug|0|||
46759264|NCT00690430|82977414|FG002|Core Phase|Subject no longer requires study drug|0|||
46759265|NCT00690430|82977412|FG000|Core Phase|Lack of Efficacy|8|||
46759266|NCT00690430|82977413|FG001|Core Phase|Lack of Efficacy|10|||
46759267|NCT00690430|82977414|FG002|Core Phase|Lack of Efficacy|0|||
46759268|NCT00690430|82977412|FG000|Core Phase|Administrative Problems|0|||
46759269|NCT00690430|82977413|FG001|Core Phase|Administrative Problems|1|||
46759270|NCT00690430|82977414|FG002|Core Phase|Administrative Problems|0|||
46759271|NCT00690430|82977412|FG000|Core Phase|Early Termination|0|||
46759272|NCT00690430|82977413|FG001|Core Phase|Early Termination|5|||
46759273|NCT00690430|82977414|FG002|Core Phase|Early Termination|0|||
46759274|NCT00690430|82977412|FG000|Extension Phase|Lack of Efficacy|3|||
46759275|NCT00690430|82977413|FG001|Extension Phase|Lack of Efficacy|1|||
46759276|NCT00690430|82977414|FG002|Extension Phase|Lack of Efficacy|4|||
46759277|NCT00690430|82977412|FG000|Extension Phase|Abnormal Lab Values|1|||
46759278|NCT00690430|82977413|FG001|Extension Phase|Abnormal Lab Values|0|||
46759279|NCT00690430|82977414|FG002|Extension Phase|Abnormal Lab Values|0|||
46759280|NCT00690430|82977412|FG000|Extension Phase|Abnormal test procedure results|1|||
46759281|NCT00690430|82977413|FG001|Extension Phase|Abnormal test procedure results|0|||
46759282|NCT00690430|82977414|FG002|Extension Phase|Abnormal test procedure results|0|||
46759283|NCT00690430|82977412|FG000|Extension Phase|Administrative Problems|0|||
46759284|NCT00690430|82977413|FG001|Extension Phase|Administrative Problems|1|||
46759285|NCT00690430|82977414|FG002|Extension Phase|Administrative Problems|1|||
46759286|NCT00690430|82977412|FG000|Extension Phase|Adverse Event|2|||
46759287|NCT00690430|82977413|FG001|Extension Phase|Adverse Event|1|||
46759288|NCT00690430|82977414|FG002|Extension Phase|Adverse Event|2|||
46759289|NCT00690430|82977412|FG000|Extension Phase|Death|1|||
46759290|NCT00690430|82977413|FG001|Extension Phase|Death|1|||
46759291|NCT00690430|82977414|FG002|Extension Phase|Death|1|||
46759292|NCT00690430|82977412|FG000|Extension Phase|Withdrawal by Subject|0|||
46759293|NCT00690430|82977413|FG001|Extension Phase|Withdrawal by Subject|0|||
46759294|NCT00690430|82977414|FG002|Extension Phase|Withdrawal by Subject|2|||
46759295|NCT00690430|82977412|FG000|Extension Phase|Early Termination|10|||
46759296|NCT00690430|82977413|FG001|Extension Phase|Early Termination|1|||
46759297|NCT00690430|82977414|FG002|Extension Phase|Early Termination|3|||
46759298|NCT00863330|82977423|FG000|Overall Study|study terminated early due to administra|6|||
46759299|NCT00688324|82977427|FG000|Overall Study|Withdrawal by Subject|2|||
46759300|NCT00688324|82977427|FG000|Overall Study|Physician Decision|5|||
46931594|NCT03111147|83166712|FG001|Overall Study|Withdrawal by Subject|3|||
46759301|NCT00688324|82977427|FG000|Overall Study|Lost to Follow-up|1|||
46759302|NCT00862940|82977434|FG000|Overall Study|Adverse Event|15|||
46759303|NCT00862940|82977435|FG001|Overall Study|Adverse Event|12|||
46759304|NCT00862940|82977434|FG000|Overall Study|Lack of Efficacy|1|||
46759305|NCT00862940|82977435|FG001|Overall Study|Lack of Efficacy|3|||
46759306|NCT00862940|82977434|FG000|Overall Study|Protocol Violation|2|||
46759307|NCT00862940|82977435|FG001|Overall Study|Protocol Violation|5|||
46759308|NCT00862940|82977434|FG000|Overall Study|Withdrawal by Subject|4|||
46759309|NCT00862940|82977435|FG001|Overall Study|Withdrawal by Subject|6|||
46819688|NCT00485264|83039427|FG004|Overall Study|Adverse Event|1|||
46819689|NCT00485264|83039428|FG005|Overall Study|Adverse Event|3|||
46819690|NCT00485264|83039423|FG000|Overall Study|Pregnancy|4|||
46819691|NCT00485264|83039424|FG001|Overall Study|Pregnancy|0|||
46819692|NCT00485264|83039425|FG002|Overall Study|Pregnancy|0|||
46819693|NCT00485264|83039426|FG003|Overall Study|Pregnancy|0|||
46819694|NCT00485264|83039427|FG004|Overall Study|Pregnancy|0|||
46819695|NCT00485264|83039428|FG005|Overall Study|Pregnancy|0|||
46819696|NCT00485264|83039423|FG000|Overall Study|Disallowed Medication|0|||
46819697|NCT00485264|83039424|FG001|Overall Study|Disallowed Medication|0|||
46819698|NCT00485264|83039425|FG002|Overall Study|Disallowed Medication|0|||
46819699|NCT00485264|83039426|FG003|Overall Study|Disallowed Medication|0|||
46819700|NCT00485264|83039427|FG004|Overall Study|Disallowed Medication|0|||
46819701|NCT00485264|83039428|FG005|Overall Study|Disallowed Medication|1|||
46819702|NCT00485264|83039423|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
46819703|NCT00485264|83039424|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
46819704|NCT00485264|83039425|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
46819705|NCT00485264|83039426|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
46819706|NCT00485264|83039427|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
46819707|NCT00485264|83039428|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
46819708|NCT00485264|83039423|FG000|Overall Study|Lack of Efficacy|0|||
46819709|NCT00485264|83039424|FG001|Overall Study|Lack of Efficacy|1|||
46819710|NCT00485264|83039425|FG002|Overall Study|Lack of Efficacy|0|||
46819711|NCT00485264|83039426|FG003|Overall Study|Lack of Efficacy|0|||
46819712|NCT00485264|83039427|FG004|Overall Study|Lack of Efficacy|0|||
46819713|NCT00485264|83039428|FG005|Overall Study|Lack of Efficacy|0|||
46819714|NCT00485264|83039423|FG000|Overall Study|Guardian Consent Withdrawn|1|||
46819715|NCT00485264|83039424|FG001|Overall Study|Guardian Consent Withdrawn|0|||
46819716|NCT00485264|83039425|FG002|Overall Study|Guardian Consent Withdrawn|0|||
46819717|NCT00485264|83039426|FG003|Overall Study|Guardian Consent Withdrawn|0|||
46819718|NCT00485264|83039427|FG004|Overall Study|Guardian Consent Withdrawn|1|||
46819719|NCT00485264|83039428|FG005|Overall Study|Guardian Consent Withdrawn|0|||
46819720|NCT00485264|83039423|FG000|Overall Study|Physician Decision|0|||
46819721|NCT00485264|83039424|FG001|Overall Study|Physician Decision|2|||
46931595|NCT03111147|83166711|FG000|Overall Study|Protocol Violation|2|||
46931596|NCT03111147|83166712|FG001|Overall Study|Protocol Violation|1|||
46931597|NCT03111147|83166711|FG000|Overall Study|Death|1|||
46759310|NCT00862940|82977434|FG000|Overall Study|Non-compliance|4|||
46759311|NCT00862940|82977435|FG001|Overall Study|Non-compliance|0|||
46759312|NCT00862940|82977434|FG000|Overall Study|Lost to Follow-up|0|||
46759313|NCT00862940|82977435|FG001|Overall Study|Lost to Follow-up|1|||
46759314|NCT00862940|82977434|FG000|Overall Study|Administrative or other reason(s)|4|||
46759315|NCT00862940|82977435|FG001|Overall Study|Administrative or other reason(s)|3|||
46759316|NCT00868166|82977443|FG000|Overall Study|Death|58|||
46759317|NCT00868166|82977444|FG001|Overall Study|Death|65|||
46759318|NCT00868166|82977443|FG000|Overall Study|Withdrawal by Subject|33|||
46759319|NCT00868166|82977444|FG001|Overall Study|Withdrawal by Subject|25|||
46759320|NCT00868166|82977443|FG000|Overall Study|Protocol Violation|1|||
46759321|NCT00868166|82977444|FG001|Overall Study|Protocol Violation|0|||
46759322|NCT00868166|82977443|FG000|Overall Study|Lost to Follow-up|1|||
46759323|NCT00868166|82977444|FG001|Overall Study|Lost to Follow-up|3|||
46759324|NCT00868166|82977443|FG000|Overall Study|Adverse Event|9|||
46759325|NCT00868166|82977444|FG001|Overall Study|Adverse Event|10|||
46759326|NCT00868166|82977443|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
46759327|NCT00868166|82977444|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
46759328|NCT00868166|82977443|FG000|Overall Study|Non-compliance with IMP|1|||
46759329|NCT00868166|82977444|FG001|Overall Study|Non-compliance with IMP|1|||
46759330|NCT00858780|82977450|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
46759331|NCT00858780|82977451|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
46759332|NCT00858780|82977452|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
46759333|NCT00858780|82977453|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
46759334|NCT00858780|82977454|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
46759335|NCT00858780|82977450|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
46759336|NCT00858780|82977451|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
46759337|NCT00858780|82977452|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
46819722|NCT00485264|83039425|FG002|Overall Study|Physician Decision|0|||
46819723|NCT00485264|83039426|FG003|Overall Study|Physician Decision|0|||
46931598|NCT03111147|83166712|FG001|Overall Study|Death|1|||
46819724|NCT00485264|83039427|FG004|Overall Study|Physician Decision|0|||
46819725|NCT00485264|83039428|FG005|Overall Study|Physician Decision|0|||
46819726|NCT00485264|83039423|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
46819727|NCT00485264|83039424|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
46759338|NCT00858780|82977453|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
46759339|NCT00858780|82977454|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
46759340|NCT00858780|82977450|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
46931599|NCT02974621|83166720|FG000|Overall Study|Didn't receive study treatment|1|||
46931600|NCT02974621|83166721|FG001|Overall Study|Didn't receive study treatment|10|||
46931601|NCT02968849|83166729|FG000|Overall Study|Death|8|||
46931602|NCT02968849|83166730|FG001|Overall Study|Death|10|||
46931603|NCT02968849|83166729|FG000|Overall Study|Lost to Follow-up|31|||
46931604|NCT02968849|83166730|FG001|Overall Study|Lost to Follow-up|29|||
46931605|NCT02968849|83166729|FG000|Overall Study|Withdrawal by Subject|73|||
46931606|NCT02968849|83166730|FG001|Overall Study|Withdrawal by Subject|64|||
46931607|NCT02968849|83166729|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
46931608|NCT02968849|83166730|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
46636731|NCT01507662|82810539|FG000|Overall Study|Withdrawal by Subject|290|||
46636732|NCT01507662|82810540|FG001|Overall Study|Withdrawal by Subject|287|||
46759341|NCT00858780|82977451|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
46819728|NCT00485264|83039425|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
46819729|NCT00485264|83039426|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
46819730|NCT00485264|83039427|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
46819731|NCT00485264|83039428|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
46819732|NCT00485264|83039423|FG000|Overall Study|Not Able to Attend Clinic|5|||
46819733|NCT00485264|83039424|FG001|Overall Study|Not Able to Attend Clinic|0|||
46819734|NCT00485264|83039425|FG002|Overall Study|Not Able to Attend Clinic|0|||
46819735|NCT00485264|83039426|FG003|Overall Study|Not Able to Attend Clinic|1|||
46759342|NCT00858780|82977452|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
46759343|NCT00858780|82977453|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
46819736|NCT00485264|83039427|FG004|Overall Study|Not Able to Attend Clinic|1|||
46819737|NCT00485264|83039428|FG005|Overall Study|Not Able to Attend Clinic|2|||
46819738|NCT00485264|83039423|FG000|Overall Study|Non-Compliant|17|||
46819739|NCT00485264|83039424|FG001|Overall Study|Non-Compliant|2|||
46819740|NCT00485264|83039425|FG002|Overall Study|Non-Compliant|1|||
46819741|NCT00485264|83039426|FG003|Overall Study|Non-Compliant|0|||
46819742|NCT00485264|83039427|FG004|Overall Study|Non-Compliant|1|||
46819743|NCT00485264|83039428|FG005|Overall Study|Non-Compliant|0|||
46819744|NCT00485264|83039423|FG000|Overall Study|Lost to Follow-up|2|||
46819745|NCT00485264|83039424|FG001|Overall Study|Lost to Follow-up|1|||
46819746|NCT00485264|83039425|FG002|Overall Study|Lost to Follow-up|1|||
46819747|NCT00485264|83039426|FG003|Overall Study|Lost to Follow-up|0|||
46819748|NCT00485264|83039427|FG004|Overall Study|Lost to Follow-up|0|||
46819749|NCT00485264|83039428|FG005|Overall Study|Lost to Follow-up|1|||
46819750|NCT00485264|83039423|FG000|Overall Study|Other Reason|3|||
46819751|NCT00485264|83039424|FG001|Overall Study|Other Reason|0|||
46931609|NCT02968849|83166729|FG000|Overall Study|Physician Decision|6|||
46759344|NCT00858780|82977454|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
46759345|NCT00858780|82977450|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
46759346|NCT00858780|82977451|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
46759347|NCT00858780|82977452|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
46759348|NCT00858780|82977453|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
46759349|NCT00858780|82977454|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
46759350|NCT00858780|82977450|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
46759351|NCT00858780|82977451|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
46759352|NCT00858780|82977452|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
46759353|NCT00858780|82977453|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
46759354|NCT00858780|82977454|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
46759355|NCT00858780|82977450|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
46759356|NCT00858780|82977451|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
46759357|NCT00858780|82977452|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
46759358|NCT00858780|82977453|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
46759359|NCT00858780|82977454|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
46759360|NCT00850200|82977464|FG000|Overall Study|Physician Decision|2|||
46759361|NCT00850200|82977464|FG000|Overall Study|Did not recieve treatment|2|||
46759362|NCT00850200|82977464|FG000|Overall Study|Withdrawal by Subject|1|||
46759363|NCT00858234|82977471|FG000|Overall Study|Adverse Event|6|||
46931610|NCT02968849|83166730|FG001|Overall Study|Physician Decision|9|||
46931611|NCT02968849|83166729|FG000|Overall Study|Other|16|||
46931612|NCT02968849|83166730|FG001|Overall Study|Other|10|||
46931613|NCT02923180|83166736|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
46931614|NCT02923180|83166736|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
46759364|NCT00858234|82977471|FG000|Overall Study|Progressive disease|2|||
46759365|NCT00858234|82977471|FG000|Overall Study|Status unknown|1|||
46819752|NCT00485264|83039425|FG002|Overall Study|Other Reason|0|||
46819753|NCT00485264|83039426|FG003|Overall Study|Other Reason|0|||
46759366|NCT00862082|82977477|FG000|Overall Study|Sponsor decision to terminate the study|5|||
46819754|NCT00485264|83039427|FG004|Overall Study|Other Reason|0|||
46819755|NCT00485264|83039428|FG005|Overall Study|Other Reason|0|||
46819756|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
46819757|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
46636733|NCT01507662|82810539|FG000|Overall Study|Lost to Follow-up|498|||
46636734|NCT01507662|82810540|FG001|Overall Study|Lost to Follow-up|523|||
46636735|NCT01507662|82810539|FG000|Overall Study|Proxy interview done|2|||
46636736|NCT01507662|82810540|FG001|Overall Study|Proxy interview done|3|||
46636737|NCT01506960|82810546|FG000|Overall Study|Did not meet angiographic criteria|47|||
46636738|NCT01480674|82810552|FG000|Overall Study|Death|23|||
46636739|NCT01480674|82810552|FG000|Overall Study|Lost to Follow-up|2|||
46636740|NCT01480674|82810552|FG000|Overall Study|visit not done|10|||
46636741|NCT01506882|82810558|FG000|Overall Study|Lack of Efficacy|4|||
46636742|NCT01506882|82810559|FG001|Overall Study|Lack of Efficacy|3|||
46636743|NCT01506882|82810558|FG000|Overall Study|Lost to Follow-up|1|||
46636744|NCT01506882|82810559|FG001|Overall Study|Lost to Follow-up|0|||
46636745|NCT01506882|82810558|FG000|Overall Study|Withdrawal by Subject|9|||
46636746|NCT01506882|82810559|FG001|Overall Study|Withdrawal by Subject|3|||
46636747|NCT01506882|82810558|FG000|Overall Study|SAE, non-fatal|2|||
46636748|NCT01506882|82810559|FG001|Overall Study|SAE, non-fatal|0|||
46759367|NCT00862082|82977478|FG001|Overall Study|Sponsor decision to terminate the study|0|||
46759368|NCT00862082|82977477|FG000|Overall Study|Withdrawal by Subject|0|||
46759369|NCT00862082|82977478|FG001|Overall Study|Withdrawal by Subject|1|||
46759370|NCT00692770|82977493|FG000|Overall Study|Protocol Violation|2|||
46931615|NCT02723006|83166749|FG000|Overall Study|Withdrawal by Subject|0|||
46931616|NCT02723006|83166750|FG001|Overall Study|Withdrawal by Subject|1|||
46759371|NCT00692770|82977494|FG001|Overall Study|Protocol Violation|7|||
46759372|NCT00692770|82977493|FG000|Overall Study|Withdrawal by Subject|97|||
46819758|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
46819759|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
46819760|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
46819761|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
46819762|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
46819763|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
46819764|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
46819765|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
46759373|NCT00692770|82977494|FG001|Overall Study|Withdrawal by Subject|36|||
46759374|NCT00692770|82977493|FG000|Overall Study|Adverse Event|136|||
46759375|NCT00692770|82977494|FG001|Overall Study|Adverse Event|41|||
46759376|NCT00692770|82977493|FG000|Overall Study|Death|10|||
46759377|NCT00692770|82977494|FG001|Overall Study|Death|5|||
46759378|NCT00692770|82977493|FG000|Overall Study|Lost to Follow-up|7|||
46759379|NCT00692770|82977494|FG001|Overall Study|Lost to Follow-up|3|||
46759380|NCT00692770|82977493|FG000|Overall Study|Non-compliant with study medication|11|||
46759381|NCT00692770|82977494|FG001|Overall Study|Non-compliant with study medication|5|||
46759382|NCT00692770|82977493|FG000|Overall Study|Progression by clinical judgment|2|||
46759383|NCT00692770|82977494|FG001|Overall Study|Progression by clinical judgment|3|||
46759384|NCT00692770|82977493|FG000|Overall Study|Physician decision not protocol driven|10|||
46759385|NCT00692770|82977494|FG001|Overall Study|Physician decision not protocol driven|14|||
46759386|NCT00692770|82977493|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
46759387|NCT00692770|82977494|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
46759388|NCT00692770|82977493|FG000|Overall Study|Protocol driven decision point|3|||
46759389|NCT00692770|82977494|FG001|Overall Study|Protocol driven decision point|7|||
46759390|NCT00692770|82977493|FG000|Overall Study|Completed all planned assessments|79|||
46759391|NCT00692770|82977494|FG001|Overall Study|Completed all planned assessments|101|||
46759392|NCT00692770|82977493|FG000|Overall Study|Radiological and clinical progression|8|||
46759393|NCT00692770|82977494|FG001|Overall Study|Radiological and clinical progression|8|||
46759394|NCT00692770|82977493|FG000|Overall Study|Clinical endpoint reached|16|||
46759395|NCT00692770|82977494|FG001|Overall Study|Clinical endpoint reached|43|||
46759396|NCT00692770|82977493|FG000|Overall Study|Study terminated by sponsor|2|||
46759397|NCT00692770|82977494|FG001|Overall Study|Study terminated by sponsor|2|||
46819766|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
46931617|NCT02723006|83166751|FG002|Overall Study|Withdrawal by Subject|1|||
46931618|NCT02723006|83166749|FG000|Overall Study|Study Terminated by Sponsor|1|||
46931619|NCT02723006|83166750|FG001|Overall Study|Study Terminated by Sponsor|6|||
47056285|NCT02036970|83332207|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
46636749|NCT01506882|82810558|FG000|Overall Study|AE, non-serious non-fatal|3|||
46636750|NCT01506882|82810559|FG001|Overall Study|AE, non-serious non-fatal|1|||
46759398|NCT00692770|82977493|FG000|Overall Study|Randomized but not treated|3|||
46759399|NCT00692770|82977494|FG001|Overall Study|Randomized but not treated|4|||
46759400|NCT00849108|82977509|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
46759401|NCT00849108|82977510|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
46759402|NCT00849108|82977509|FG000|Cohort 2 Efficacy|Adverse Event|0|||
46759403|NCT00849108|82977510|FG001|Cohort 2 Efficacy|Adverse Event|1|||
46759404|NCT00849108|82977509|FG000|Cohort 2 Efficacy|Other|0|||
46759405|NCT00849108|82977510|FG001|Cohort 2 Efficacy|Other|9|||
46759406|NCT00867308|82977520|FG000|Overall Study|Death|1|||
46759407|NCT00867308|82977521|FG001|Overall Study|Death|0|||
46819767|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
46819768|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
46819769|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
46819770|NCT00293254|83039449|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
46819771|NCT00293254|83039450|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
46819772|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
46819773|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
46819774|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Death|4|||
46819775|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Death|1|||
46819776|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
46819777|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
46819778|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
46819779|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
46819780|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
46819781|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
46819782|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
46819783|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
46819784|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
46819785|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
46819786|NCT00293254|83039449|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
46819787|NCT00293254|83039450|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
46819788|NCT00293254|83039449|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
46819789|NCT00293254|83039450|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
46819790|NCT00293254|83039449|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
46819791|NCT00293254|83039450|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
46819792|NCT00293254|83039449|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
46819793|NCT00293254|83039450|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
46819794|NCT00293254|83039449|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
46819795|NCT00293254|83039450|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
46819796|NCT00293254|83039449|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
46819797|NCT00293254|83039450|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
46819798|NCT00293254|83039449|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
46819799|NCT00293254|83039450|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
46819800|NCT00293254|83039449|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
46931620|NCT02723006|83166751|FG002|Overall Study|Study Terminated by Sponsor|6|||
46931621|NCT02632344|83166759|FG000|Overall Study|Adverse Event|3|||
46931622|NCT02632344|83166759|FG000|Overall Study|Lack of Efficacy|3|||
46819801|NCT00293254|83039450|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
46931623|NCT02632344|83166759|FG000|Overall Study|Withdrawal by Subject|2|||
46931624|NCT02618967|83166771|FG000|Overall Study|Lost to Follow-up|0|||
46931625|NCT02618967|83166772|FG001|Overall Study|Lost to Follow-up|0|||
46931626|NCT02618967|83166773|FG002|Overall Study|Lost to Follow-up|1|||
46931627|NCT02618967|83166774|FG003|Overall Study|Lost to Follow-up|0|||
46931628|NCT02618967|83166775|FG004|Overall Study|Lost to Follow-up|2|||
46759408|NCT00867308|82977520|FG000|Overall Study|Adverse Event|1|||
46931629|NCT02618967|83166776|FG005|Overall Study|Lost to Follow-up|0|||
46931630|NCT02618967|83166777|FG006|Overall Study|Lost to Follow-up|0|||
46931631|NCT02618967|83166778|FG007|Overall Study|Lost to Follow-up|0|||
46931632|NCT02618967|83166771|FG000|Overall Study|Withdrawal by Subject|1|||
46931633|NCT02618967|83166772|FG001|Overall Study|Withdrawal by Subject|0|||
46931634|NCT02618967|83166773|FG002|Overall Study|Withdrawal by Subject|0|||
46931635|NCT02618967|83166774|FG003|Overall Study|Withdrawal by Subject|0|||
46759409|NCT00867308|82977521|FG001|Overall Study|Adverse Event|4|||
46759410|NCT00867308|82977520|FG000|Overall Study|Lack of Efficacy|6|||
46759411|NCT00867308|82977521|FG001|Overall Study|Lack of Efficacy|12|||
46759412|NCT00867308|82977520|FG000|Overall Study|Withdrawal by Subject|1|||
46759413|NCT00867308|82977521|FG001|Overall Study|Withdrawal by Subject|2|||
46759414|NCT00849186|82977527|FG000|Overall Study|Adverse Event|2|||
46759415|NCT00849186|82977527|FG000|Overall Study|Withdrawal by Subject|1|||
46759416|NCT00849186|82977527|FG000|Overall Study|not treated|6|||
46759417|NCT00849186|82977527|FG000|Overall Study|Other|1|||
46931636|NCT02618967|83166775|FG004|Overall Study|Withdrawal by Subject|0|||
46931637|NCT02618967|83166776|FG005|Overall Study|Withdrawal by Subject|0|||
46931638|NCT02618967|83166777|FG006|Overall Study|Withdrawal by Subject|0|||
46759418|NCT00866918|82977534|FG000|Overall Study|Death|1|||
46759419|NCT00866918|82977535|FG001|Overall Study|Death|5|||
46931639|NCT02618967|83166778|FG007|Overall Study|Withdrawal by Subject|0|||
46931640|NCT02562235|83166796|FG000|Overall Study|Adverse Event|3|||
46931641|NCT02487095|83166819|FG000|Dose Expansion|Unable to scan/restage participant|0|||
46759420|NCT00866918|82977534|FG000|Overall Study|Lack of Efficacy|1|||
46759421|NCT00866918|82977535|FG001|Overall Study|Lack of Efficacy|1|||
46819802|NCT00293254|83039449|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
46819803|NCT00293254|83039450|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
46819804|NCT00293254|83039449|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
46819805|NCT00293254|83039450|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
46819806|NCT00293254|83039449|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
46819807|NCT00293254|83039450|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
46819808|NCT00293254|83039449|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
46819809|NCT00293254|83039450|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
46819810|NCT00456846|83039464|FG000|Overall Study|Adverse Event|2|||
46819811|NCT00456846|83039465|FG001|Overall Study|Adverse Event|15|||
46819812|NCT00456846|83039464|FG000|Overall Study|Physician Decision|11|||
46819813|NCT00456846|83039465|FG001|Overall Study|Physician Decision|6|||
46819814|NCT00456846|83039464|FG000|Overall Study|Protocol Deviation|2|||
46819815|NCT00456846|83039465|FG001|Overall Study|Protocol Deviation|0|||
46819816|NCT00456846|83039464|FG000|Overall Study|Participant Discretion|1|||
46819817|NCT00456846|83039465|FG001|Overall Study|Participant Discretion|5|||
46819818|NCT00456846|83039464|FG000|Overall Study|Other|0|||
46819819|NCT00456846|83039465|FG001|Overall Study|Other|2|||
46819820|NCT00448344|83039473|FG000|Overall Study|Lost to Follow-up|20|||
46819821|NCT00448344|83039474|FG001|Overall Study|Lost to Follow-up|22|||
46819822|NCT00448344|83039473|FG000|Overall Study|Withdrawal by Subject|6|||
46819823|NCT00448344|83039474|FG001|Overall Study|Withdrawal by Subject|8|||
46819824|NCT00448344|83039473|FG000|Overall Study|Death|3|||
46819825|NCT00448344|83039474|FG001|Overall Study|Death|4|||
46819826|NCT00448344|83039473|FG000|Overall Study|Physician Decision|1|||
46819827|NCT00448344|83039474|FG001|Overall Study|Physician Decision|2|||
47056286|NCT02036970|83332208|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
47056287|NCT02036970|83332209|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
47056288|NCT02036970|83332200|FG000|Part 1: Day 1 Through Week 16|Death|0|||
47056289|NCT02036970|83332201|FG001|Part 1: Day 1 Through Week 16|Death|0|||
47056290|NCT02036970|83332202|FG002|Part 1: Day 1 Through Week 16|Death|0|||
47056291|NCT02036970|83332203|FG003|Part 1: Day 1 Through Week 16|Death|0|||
46819828|NCT00484094|83039480|FG000|Overall Study|Discontinued|39|||
46819829|NCT00484094|83039480|FG000|Overall Study|Other|3|||
46819830|NCT00447876|83039486|FG000|Overall Study|Withdrawal by Subject|1|||
46819831|NCT00447876|83039487|FG001|Overall Study|Withdrawal by Subject|4|||
46819832|NCT00447876|83039486|FG000|Overall Study|Lost to Follow-up|1|||
46819833|NCT00447876|83039487|FG001|Overall Study|Lost to Follow-up|0|||
46819834|NCT00447876|83039486|FG000|Overall Study|Deterioration of symptomology|1|||
46819835|NCT00447876|83039487|FG001|Overall Study|Deterioration of symptomology|0|||
46819836|NCT00456612|83039493|FG000|Overall Study|Withdrawal by Subject|3|||
46819837|NCT00456300|83039498|FG000|Overall Study|Adverse Event|1|||
46819838|NCT00456300|83039499|FG001|Overall Study|Adverse Event|0|||
46819839|NCT00267748|83039510|FG000|Non-randomized Period|Progressive disease|10|||
46819840|NCT00267748|83039511|FG001|Non-randomized Period|Progressive disease|0|||
46819841|NCT00267748|83039512|FG002|Non-randomized Period|Progressive disease|0|||
46819842|NCT00267748|83039510|FG000|Non-randomized Period|Adverse Event|8|||
46819843|NCT00267748|83039511|FG001|Non-randomized Period|Adverse Event|0|||
46819844|NCT00267748|83039512|FG002|Non-randomized Period|Adverse Event|0|||
46931642|NCT02487095|83166820|FG001|Dose Expansion|Unable to scan/restage participant|0|||
46931643|NCT02487095|83166821|FG002|Dose Expansion|Unable to scan/restage participant|0|||
46931644|NCT02487095|83166822|FG003|Dose Expansion|Unable to scan/restage participant|0|||
46931645|NCT02487095|83166823|FG004|Dose Expansion|Unable to scan/restage participant|1|||
46819845|NCT00267748|83039510|FG000|Non-randomized Period|Death|1|||
46819846|NCT00267748|83039511|FG001|Non-randomized Period|Death|0|||
46819847|NCT00267748|83039512|FG002|Non-randomized Period|Death|0|||
46819848|NCT00267748|83039510|FG000|Non-randomized Period|Participant not willing to participate|1|||
46819849|NCT00267748|83039511|FG001|Non-randomized Period|Participant not willing to participate|0|||
46819850|NCT00267748|83039512|FG002|Non-randomized Period|Participant not willing to participate|0|||
46819851|NCT00267748|83039510|FG000|Non-randomized Period|Other|3|||
46819852|NCT00267748|83039511|FG001|Non-randomized Period|Other|0|||
46819853|NCT00267748|83039512|FG002|Non-randomized Period|Other|0|||
46819854|NCT00267748|83039510|FG000|Randomized Period|Death|0|||
46819855|NCT00267748|83039511|FG001|Randomized Period|Death|2|||
46819856|NCT00267748|83039512|FG002|Randomized Period|Death|3|||
47056292|NCT02036970|83332204|FG004|Part 1: Day 1 Through Week 16|Death|0|||
46819857|NCT00267748|83039510|FG000|Randomized Period|Adverse Event|0|||
46819858|NCT00267748|83039511|FG001|Randomized Period|Adverse Event|23|||
46819859|NCT00267748|83039512|FG002|Randomized Period|Adverse Event|25|||
47056293|NCT02036970|83332205|FG005|Part 1: Day 1 Through Week 16|Death|0|||
46819860|NCT00267748|83039510|FG000|Randomized Period|Global deterioration of health status|0|||
46819861|NCT00267748|83039511|FG001|Randomized Period|Global deterioration of health status|6|||
46819862|NCT00267748|83039512|FG002|Randomized Period|Global deterioration of health status|7|||
46931646|NCT02446600|83166847|FG000|Overall Study|Never treated|20|||
46931647|NCT02446600|83166848|FG001|Overall Study|Never treated|2|||
46819863|NCT00267748|83039510|FG000|Randomized Period|Lost to Follow-up|0|||
46819864|NCT00267748|83039511|FG001|Randomized Period|Lost to Follow-up|1|||
46819865|NCT00267748|83039512|FG002|Randomized Period|Lost to Follow-up|0|||
46819866|NCT00267748|83039510|FG000|Randomized Period|Objective progression or relapse|0|||
46819867|NCT00267748|83039511|FG001|Randomized Period|Objective progression or relapse|77|||
46819868|NCT00267748|83039512|FG002|Randomized Period|Objective progression or relapse|86|||
46819869|NCT00267748|83039510|FG000|Randomized Period|Withdrawal by Subject|0|||
46819870|NCT00267748|83039511|FG001|Randomized Period|Withdrawal by Subject|9|||
46819871|NCT00267748|83039512|FG002|Randomized Period|Withdrawal by Subject|2|||
46819872|NCT00267748|83039510|FG000|Randomized Period|Other|0|||
46819873|NCT00267748|83039511|FG001|Randomized Period|Other|9|||
46819874|NCT00267748|83039512|FG002|Randomized Period|Other|6|||
46819875|NCT00267748|83039510|FG000|Randomized Period|randomized but not treated|0|||
46819876|NCT00267748|83039511|FG001|Randomized Period|randomized but not treated|0|||
46819877|NCT00267748|83039512|FG002|Randomized Period|randomized but not treated|3|||
46819878|NCT00267202|83039521|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
46819879|NCT00267202|83039522|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
46819880|NCT00267202|83039521|FG000|Overall Study|Withdrawal by Subject|12|||
46819881|NCT00267202|83039522|FG001|Overall Study|Withdrawal by Subject|15|||
46819882|NCT00267202|83039521|FG000|Overall Study|Adverse Event|13|||
46819883|NCT00267202|83039522|FG001|Overall Study|Adverse Event|7|||
46819884|NCT00267202|83039521|FG000|Overall Study|Protocol Violation|2|||
46819885|NCT00267202|83039522|FG001|Overall Study|Protocol Violation|3|||
46819886|NCT00267202|83039521|FG000|Overall Study|Administrative problems|2|||
46819887|NCT00267202|83039522|FG001|Overall Study|Administrative problems|1|||
46819888|NCT00267202|83039521|FG000|Overall Study|Lost to Follow-up|3|||
46819889|NCT00267202|83039522|FG001|Overall Study|Lost to Follow-up|0|||
46819890|NCT00267046|83039531|FG000|Overall Study|Disease progression|4|||
46819891|NCT00267046|83039532|FG001|Overall Study|Disease progression|2|||
46819892|NCT00267046|83039531|FG000|Overall Study|Chemotoxicity|2|||
46819893|NCT00267046|83039532|FG001|Overall Study|Chemotoxicity|0|||
46819894|NCT00267046|83039531|FG000|Overall Study|Open-label palifermin|2|||
46819895|NCT00267046|83039532|FG001|Overall Study|Open-label palifermin|7|||
46819896|NCT00267046|83039531|FG000|Overall Study|Surgery|3|||
46819897|NCT00267046|83039532|FG001|Overall Study|Surgery|1|||
46819898|NCT00267046|83039531|FG000|Overall Study|Withdrawal by Subject|1|||
46931648|NCT02446600|83166849|FG002|Overall Study|Never treated|6|||
46931649|NCT02446600|83166850|FG003|Overall Study|Never treated|0|||
46931650|NCT02446600|83166847|FG000|Overall Study|Withdrawal by Subject|19|||
46931651|NCT02446600|83166848|FG001|Overall Study|Withdrawal by Subject|5|||
46931652|NCT02446600|83166849|FG002|Overall Study|Withdrawal by Subject|17|||
46931653|NCT02446600|83166850|FG003|Overall Study|Withdrawal by Subject|0|||
46931654|NCT02446600|83166847|FG000|Overall Study|Ineligible|1|||
46931655|NCT02446600|83166848|FG001|Overall Study|Ineligible|4|||
46819899|NCT00267046|83039532|FG001|Overall Study|Withdrawal by Subject|0|||
46819900|NCT00267046|83039531|FG000|Overall Study|Radiation|0|||
46931656|NCT02446600|83166849|FG002|Overall Study|Ineligible|4|||
46931657|NCT02446600|83166850|FG003|Overall Study|Ineligible|1|||
46931658|NCT02446600|83166847|FG000|Overall Study|Duplicate Enrollment|0|||
46931659|NCT02446600|83166848|FG001|Overall Study|Duplicate Enrollment|1|||
46931660|NCT02446600|83166849|FG002|Overall Study|Duplicate Enrollment|0|||
46931661|NCT02446600|83166850|FG003|Overall Study|Duplicate Enrollment|0|||
46931662|NCT02281955|83166880|FG000|Overall Study|Death|1|||
46931663|NCT02261883|83166886|FG000|Overall Study|Death|3|||
46931664|NCT02261883|83166887|FG001|Overall Study|Death|2|||
46931665|NCT02261883|83166886|FG000|Overall Study|Physician Decision|1|||
46931666|NCT02261883|83166887|FG001|Overall Study|Physician Decision|0|||
46636751|NCT01506882|82810558|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
46636752|NCT01506882|82810559|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
46819901|NCT00267046|83039532|FG001|Overall Study|Radiation|1|||
46819902|NCT00441090|83039543|FG000|Overall Study|Adverse Event|0|||
46819903|NCT00441090|83039544|FG001|Overall Study|Adverse Event|1|||
46819904|NCT00441090|83039545|FG002|Overall Study|Adverse Event|1|||
46819905|NCT00441090|83039546|FG003|Overall Study|Adverse Event|0|||
46819906|NCT00441090|83039547|FG004|Overall Study|Adverse Event|0|||
46819907|NCT00441090|83039543|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
46819908|NCT00441090|83039544|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
46819909|NCT00441090|83039545|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
46819910|NCT00441090|83039546|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
46931667|NCT02261883|83166886|FG000|Overall Study|Protocol Violation|1|||
46931668|NCT02261883|83166887|FG001|Overall Study|Protocol Violation|0|||
46931669|NCT02261883|83166886|FG000|Overall Study|Withdrawal by Subject|0|||
46931670|NCT02261883|83166887|FG001|Overall Study|Withdrawal by Subject|1|||
46931671|NCT02261883|83166886|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
46931672|NCT02261883|83166887|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
46931673|NCT02257528|83166893|FG000|Overall Study|Never received study treatment|1|||
46931674|NCT02247349|83166903|FG000|Overall Study|Disease Progression|7|||
46819911|NCT00441090|83039547|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
46819912|NCT00441090|83039543|FG000|Overall Study|Withdrawal by Subject|1|||
46819913|NCT00441090|83039544|FG001|Overall Study|Withdrawal by Subject|0|||
46819914|NCT00441090|83039545|FG002|Overall Study|Withdrawal by Subject|1|||
46819915|NCT00441090|83039546|FG003|Overall Study|Withdrawal by Subject|0|||
46819916|NCT00441090|83039547|FG004|Overall Study|Withdrawal by Subject|0|||
46819917|NCT00441090|83039543|FG000|Overall Study|Lack of Efficacy|1|||
46819918|NCT00441090|83039544|FG001|Overall Study|Lack of Efficacy|0|||
46819919|NCT00441090|83039545|FG002|Overall Study|Lack of Efficacy|0|||
46819920|NCT00441090|83039546|FG003|Overall Study|Lack of Efficacy|0|||
46819921|NCT00441090|83039547|FG004|Overall Study|Lack of Efficacy|0|||
46819922|NCT00441012|83039561|FG000|Overall Study|Adverse Event|0|||
46819923|NCT00441012|83039562|FG001|Overall Study|Adverse Event|1|||
46819924|NCT00441012|83039561|FG000|Overall Study|Lost to Follow-up|3|||
46819925|NCT00441012|83039562|FG001|Overall Study|Lost to Follow-up|3|||
46819926|NCT00441012|83039561|FG000|Overall Study|Protocol Violation|10|||
46819927|NCT00441012|83039562|FG001|Overall Study|Protocol Violation|9|||
46819928|NCT00441012|83039561|FG000|Overall Study|Withdrawal by Subject|4|||
46819929|NCT00441012|83039562|FG001|Overall Study|Withdrawal by Subject|0|||
46819930|NCT00441012|83039561|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
46819931|NCT00441012|83039562|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
46819932|NCT00286468|83039571|FG000|Overall Study|Hyperglycemic Rescue|28|||
46819933|NCT00286468|83039572|FG001|Overall Study|Hyperglycemic Rescue|30|||
46819934|NCT00286468|83039573|FG002|Overall Study|Hyperglycemic Rescue|31|||
46819935|NCT00286468|83039571|FG000|Overall Study|Adverse Event|2|||
46819936|NCT00286468|83039572|FG001|Overall Study|Adverse Event|6|||
46931675|NCT02247349|83166904|FG001|Overall Study|Disease Progression|4|||
46931676|NCT02247349|83166905|FG002|Overall Study|Disease Progression|26|||
46931677|NCT02247349|83166906|FG003|Overall Study|Disease Progression|31|||
46931678|NCT02247349|83166907|FG004|Overall Study|Disease Progression|16|||
46931679|NCT02247349|83166908|FG005|Overall Study|Disease Progression|6|||
46931680|NCT02247349|83166903|FG000|Overall Study|Study drug toxicity|0|||
46931681|NCT02247349|83166904|FG001|Overall Study|Study drug toxicity|1|||
46931682|NCT02247349|83166905|FG002|Overall Study|Study drug toxicity|1|||
46931683|NCT02247349|83166906|FG003|Overall Study|Study drug toxicity|1|||
46931684|NCT02247349|83166907|FG004|Overall Study|Study drug toxicity|2|||
46931685|NCT02247349|83166908|FG005|Overall Study|Study drug toxicity|2|||
46931686|NCT02247349|83166903|FG000|Overall Study|Death|0|||
46931687|NCT02247349|83166904|FG001|Overall Study|Death|0|||
46931688|NCT02247349|83166905|FG002|Overall Study|Death|0|||
46931689|NCT02247349|83166906|FG003|Overall Study|Death|1|||
46931690|NCT02247349|83166907|FG004|Overall Study|Death|0|||
46931691|NCT02247349|83166908|FG005|Overall Study|Death|0|||
46931692|NCT02247349|83166903|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
46931693|NCT02247349|83166904|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
46931694|NCT02247349|83166905|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
46931695|NCT02247349|83166906|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
46931696|NCT02247349|83166907|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
46931697|NCT02247349|83166908|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
46819937|NCT00286468|83039573|FG002|Overall Study|Adverse Event|4|||
46931698|NCT02247349|83166903|FG000|Overall Study|Participant request to discontinue study treatment|0|||
46931699|NCT02247349|83166904|FG001|Overall Study|Participant request to discontinue study treatment|0|||
46931700|NCT02247349|83166905|FG002|Overall Study|Participant request to discontinue study treatment|1|||
46931701|NCT02247349|83166906|FG003|Overall Study|Participant request to discontinue study treatment|2|||
47056294|NCT02036970|83332206|FG006|Part 1: Day 1 Through Week 16|Death|0|||
47056295|NCT02036970|83332207|FG007|Part 1: Day 1 Through Week 16|Death|0|||
47056296|NCT02036970|83332208|FG008|Part 1: Day 1 Through Week 16|Death|1|||
47056297|NCT02036970|83332209|FG009|Part 1: Day 1 Through Week 16|Death|0|||
46819938|NCT00286468|83039571|FG000|Overall Study|Protocol Violation|0|||
46819939|NCT00286468|83039572|FG001|Overall Study|Protocol Violation|3|||
46819940|NCT00286468|83039573|FG002|Overall Study|Protocol Violation|1|||
46819941|NCT00286468|83039571|FG000|Overall Study|Lost to Follow-up|1|||
46819942|NCT00286468|83039572|FG001|Overall Study|Lost to Follow-up|1|||
46819943|NCT00286468|83039573|FG002|Overall Study|Lost to Follow-up|2|||
46819944|NCT00286468|83039571|FG000|Overall Study|Withdrawal by Subject|3|||
46819945|NCT00286468|83039572|FG001|Overall Study|Withdrawal by Subject|8|||
46819946|NCT00286468|83039573|FG002|Overall Study|Withdrawal by Subject|11|||
46819947|NCT00286468|83039571|FG000|Overall Study|Physician Decision|3|||
46819948|NCT00286468|83039572|FG001|Overall Study|Physician Decision|2|||
46819949|NCT00286468|83039573|FG002|Overall Study|Physician Decision|1|||
46819950|NCT00507026|83039584|FG000|Overall Study|Lack of Efficacy|6|||
46819951|NCT00507026|83039585|FG001|Overall Study|Lack of Efficacy|4|||
46819952|NCT00507026|83039586|FG002|Overall Study|Lack of Efficacy|21|||
46931702|NCT02247349|83166907|FG004|Overall Study|Participant request to discontinue study treatment|1|||
47056298|NCT02036970|83332200|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
46819953|NCT00507026|83039584|FG000|Overall Study|Withdrawal by Subject|2|||
46819954|NCT00507026|83039585|FG001|Overall Study|Withdrawal by Subject|0|||
46819955|NCT00507026|83039586|FG002|Overall Study|Withdrawal by Subject|0|||
46819956|NCT00507026|83039584|FG000|Overall Study|Investigator Decision|1|||
46819957|NCT00507026|83039585|FG001|Overall Study|Investigator Decision|0|||
46819958|NCT00507026|83039586|FG002|Overall Study|Investigator Decision|0|||
46819959|NCT00507026|83039584|FG000|Overall Study|Adverse Event|2|||
46819960|NCT00507026|83039585|FG001|Overall Study|Adverse Event|0|||
46819961|NCT00507026|83039586|FG002|Overall Study|Adverse Event|0|||
46819962|NCT00507026|83039584|FG000|Overall Study|Protocol Violation|1|||
46819963|NCT00507026|83039585|FG001|Overall Study|Protocol Violation|0|||
46819964|NCT00507026|83039586|FG002|Overall Study|Protocol Violation|0|||
46819965|NCT00507026|83039584|FG000|Overall Study|Other|1|||
46819966|NCT00507026|83039585|FG001|Overall Study|Other|0|||
46819967|NCT00507026|83039586|FG002|Overall Study|Other|0|||
46819968|NCT00446550|83039596|FG000|Overall Study|Adverse Event|1|||
46819969|NCT00446550|83039597|FG001|Overall Study|Adverse Event|0|||
46819970|NCT03847974|83039604|FG000|Overall Study|relocated out of region|3|||
46819971|NCT03847974|83039604|FG000|Overall Study|Withdrawal by Subject|2|||
46819972|NCT03847974|83039604|FG000|Overall Study|Adverse Event|1|||
46819973|NCT03976102|83039610|FG000|Overall Study|Withdrawal by Subject|4|||
46819974|NCT03976102|83039611|FG001|Overall Study|Withdrawal by Subject|4|||
46931703|NCT02247349|83166908|FG005|Overall Study|Participant request to discontinue study treatment|0|||
46819975|NCT03976102|83039610|FG000|Overall Study|Adverse Event|2|||
46819976|NCT03976102|83039611|FG001|Overall Study|Adverse Event|4|||
46819977|NCT03976102|83039610|FG000|Overall Study|Not related to Covid-19|9|||
46819978|NCT03976102|83039611|FG001|Overall Study|Not related to Covid-19|13|||
46931704|NCT02247349|83166903|FG000|Overall Study|Withdrawal by Subject|0|||
46819979|NCT03976102|83039610|FG000|Overall Study|Lost to Follow-up|0|||
46819980|NCT03976102|83039611|FG001|Overall Study|Lost to Follow-up|2|||
46819981|NCT03976102|83039610|FG000|Overall Study|Death|3|||
46819982|NCT03976102|83039611|FG001|Overall Study|Death|2|||
46819983|NCT03976102|83039610|FG000|Overall Study|Physician Decision|1|||
46819984|NCT03976102|83039611|FG001|Overall Study|Physician Decision|1|||
46819985|NCT00506948|83039620|FG000|Overall Study|Death|4|||
46819986|NCT00506948|83039620|FG000|Overall Study|Adverse Event|5|||
46819987|NCT00506948|83039620|FG000|Overall Study|Physician Decision|1|||
46819988|NCT00286234|83039628|FG000|Overall Study|Protocol Violation|1|||
46931705|NCT02247349|83166904|FG001|Overall Study|Withdrawal by Subject|1|||
46931706|NCT02247349|83166905|FG002|Overall Study|Withdrawal by Subject|0|||
46931707|NCT02247349|83166906|FG003|Overall Study|Withdrawal by Subject|0|||
46931708|NCT02247349|83166907|FG004|Overall Study|Withdrawal by Subject|0|||
46931709|NCT02247349|83166908|FG005|Overall Study|Withdrawal by Subject|0|||
46931710|NCT02247349|83166903|FG000|Overall Study|Administrative reason by sponsor|0|||
46931711|NCT02247349|83166904|FG001|Overall Study|Administrative reason by sponsor|0|||
46931712|NCT02247349|83166905|FG002|Overall Study|Administrative reason by sponsor|0|||
46759422|NCT00866918|82977534|FG000|Overall Study|Physician Decision|10|||
46759423|NCT00866918|82977535|FG001|Overall Study|Physician Decision|2|||
46759424|NCT00866918|82977534|FG000|Overall Study|Ineligible|2|||
46759425|NCT00866918|82977535|FG001|Overall Study|Ineligible|4|||
46759426|NCT00866918|82977534|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
46759427|NCT00866918|82977535|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
46759428|NCT00866918|82977534|FG000|Overall Study|Secondary malignancy|1|||
46759429|NCT00866918|82977535|FG001|Overall Study|Secondary malignancy|0|||
46759430|NCT03158285|82977544|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
46759431|NCT03158285|82977545|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
46759432|NCT03158285|82977546|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
46759433|NCT03158285|82977544|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
46759434|NCT03158285|82977545|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
46759435|NCT03158285|82977546|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
46759436|NCT03158285|82977544|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
46759437|NCT03158285|82977545|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
46759438|NCT03158285|82977546|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
46759439|NCT03158285|82977544|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
46759440|NCT03158285|82977545|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
46819989|NCT00286234|83039629|FG001|Overall Study|Protocol Violation|2|||
46931713|NCT02247349|83166906|FG003|Overall Study|Administrative reason by sponsor|0|||
46931714|NCT02247349|83166907|FG004|Overall Study|Administrative reason by sponsor|1|||
46636753|NCT01506882|82810558|FG000|Overall Study|Other Reason|2|||
46819990|NCT00286234|83039630|FG002|Overall Study|Protocol Violation|0|||
46819991|NCT00286234|83039631|FG003|Overall Study|Protocol Violation|1|||
46819992|NCT00286234|83039628|FG000|Overall Study|Physician Decision|1|||
46819993|NCT00286234|83039629|FG001|Overall Study|Physician Decision|0|||
46819994|NCT00286234|83039630|FG002|Overall Study|Physician Decision|0|||
46931715|NCT02247349|83166908|FG005|Overall Study|Administrative reason by sponsor|0|||
46819995|NCT00286234|83039631|FG003|Overall Study|Physician Decision|1|||
46819996|NCT00286234|83039628|FG000|Overall Study|Adverse Event|0|||
46819997|NCT00286234|83039629|FG001|Overall Study|Adverse Event|0|||
46931716|NCT02247349|83166903|FG000|Overall Study|Other reasons|0|||
46931717|NCT02247349|83166904|FG001|Overall Study|Other reasons|0|||
46819998|NCT00286234|83039630|FG002|Overall Study|Adverse Event|0|||
46819999|NCT00286234|83039631|FG003|Overall Study|Adverse Event|1|||
46820000|NCT00286234|83039628|FG000|Overall Study|Adverse Event|0|||
46820001|NCT00286234|83039629|FG001|Overall Study|Adverse Event|0|||
46820002|NCT00286234|83039630|FG002|Overall Study|Adverse Event|0|||
46820003|NCT00286234|83039631|FG003|Overall Study|Adverse Event|1|||
46820004|NCT00445848|83039641|FG000|Overall Study|Adverse Event|14|||
46820005|NCT00445848|83039641|FG000|Overall Study|Withdrawal by Subject|4|||
46820006|NCT00445848|83039641|FG000|Overall Study|Progression|62|||
46820007|NCT00445848|83039641|FG000|Overall Study|Other-Not protocol specified|5|||
46820008|NCT00286156|83039648|FG000|Overall Study|Missed 12 month visit|0|||
46820009|NCT00286156|83039649|FG001|Overall Study|Missed 12 month visit|0|||
46820010|NCT00286156|83039650|FG002|Overall Study|Missed 12 month visit|1|||
46820011|NCT00286156|83039648|FG000|Overall Study|AE: pulmonary embolus|0|||
46820012|NCT00286156|83039649|FG001|Overall Study|AE: pulmonary embolus|1|||
46820013|NCT00286156|83039650|FG002|Overall Study|AE: pulmonary embolus|0|||
46820014|NCT00286156|83039648|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
46820015|NCT00286156|83039649|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
46820016|NCT00286156|83039650|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
46820017|NCT00286156|83039648|FG000|Overall Study|AE: pneumonia|1|||
46820018|NCT00286156|83039649|FG001|Overall Study|AE: pneumonia|0|||
46820019|NCT00286156|83039650|FG002|Overall Study|AE: pneumonia|0|||
46820020|NCT00455520|83039660|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
46820021|NCT00455520|83039661|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
46820022|NCT00455520|83039660|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
46820023|NCT00455520|83039661|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
46820024|NCT00455520|83039660|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
46820025|NCT00455520|83039661|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
46820026|NCT00455520|83039660|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
46820027|NCT00455520|83039661|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
46636754|NCT01506882|82810559|FG001|Overall Study|Other Reason|0|||
46820028|NCT00455520|83039660|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
46820029|NCT00455520|83039661|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
46820030|NCT00455520|83039660|FG000|Open Label Tapentadol Extended Release|All other|33|||
46820031|NCT00455520|83039661|FG001|Open Label Tapentadol Extended Release|All other|0|||
46820032|NCT00455520|83039660|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
46820033|NCT00455520|83039661|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
46820034|NCT00455520|83039660|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
46820035|NCT00455520|83039661|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
46820036|NCT00455520|83039660|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
46820037|NCT00455520|83039661|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
46820038|NCT00455520|83039660|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
46820039|NCT00455520|83039661|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
46820040|NCT00455520|83039660|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
46820041|NCT00455520|83039661|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
46820042|NCT00455520|83039660|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
46820043|NCT00455520|83039661|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
46820044|NCT00440700|83039670|FG000|Overall Study|Withdrawal by Subject|8|||
46820045|NCT00440700|83039671|FG001|Overall Study|Withdrawal by Subject|8|||
46820046|NCT00440700|83039672|FG002|Overall Study|Withdrawal by Subject|4|||
46820047|NCT00284050|83039683|FG000|Overall Study|Adverse Event|1|||
46820048|NCT00284050|83039684|FG001|Overall Study|Adverse Event|1|||
46820049|NCT00284050|83039685|FG002|Overall Study|Adverse Event|1|||
46820050|NCT00284050|83039683|FG000|Overall Study|Lack of Efficacy|0|||
46820051|NCT00284050|83039684|FG001|Overall Study|Lack of Efficacy|1|||
46820052|NCT00284050|83039685|FG002|Overall Study|Lack of Efficacy|3|||
46931718|NCT02247349|83166905|FG002|Overall Study|Other reasons|1|||
46931719|NCT02247349|83166906|FG003|Overall Study|Other reasons|0|||
46820053|NCT00284050|83039683|FG000|Overall Study|Protocol Violation|0|||
46820054|NCT00284050|83039684|FG001|Overall Study|Protocol Violation|1|||
46820055|NCT00284050|83039685|FG002|Overall Study|Protocol Violation|2|||
46820056|NCT00284050|83039683|FG000|Overall Study|Withdrawal by Subject|2|||
46820057|NCT00284050|83039684|FG001|Overall Study|Withdrawal by Subject|2|||
46931720|NCT02247349|83166907|FG004|Overall Study|Other reasons|0|||
46931721|NCT02247349|83166908|FG005|Overall Study|Other reasons|0|||
46820058|NCT00284050|83039685|FG002|Overall Study|Withdrawal by Subject|2|||
46820059|NCT00284050|83039683|FG000|Overall Study|Lost to Follow-up|1|||
46820060|NCT00284050|83039684|FG001|Overall Study|Lost to Follow-up|0|||
46820061|NCT00284050|83039685|FG002|Overall Study|Lost to Follow-up|1|||
46931722|NCT02182687|83166936|FG000|Overall Study|Withdrawal by Subject|4|||
46820062|NCT00284050|83039683|FG000|Overall Study|Death|1|||
46820063|NCT00284050|83039684|FG001|Overall Study|Death|0|||
46820064|NCT00284050|83039685|FG002|Overall Study|Death|0|||
46820065|NCT00293020|83039693|FG000|Overall Study|Withdrawal by Subject|34|||
46820066|NCT00293020|83039693|FG000|Overall Study|Adverse Event|30|||
46820067|NCT00293020|83039693|FG000|Overall Study|Death|32|||
46820068|NCT00293020|83039693|FG000|Overall Study|Lack of Efficacy|12|||
46820069|NCT00293020|83039693|FG000|Overall Study|Lost to Follow-up|4|||
46820070|NCT00293020|83039693|FG000|Overall Study|Protocol Violation|6|||
46820071|NCT00293020|83039693|FG000|Overall Study|Physician Decision|21|||
46820072|NCT00293020|83039693|FG000|Overall Study|Other Reason|22|||
46931723|NCT02182687|83166937|FG001|Overall Study|Withdrawal by Subject|0|||
46931724|NCT02182687|83166936|FG000|Overall Study|Adverse Event|1|||
46931725|NCT02182687|83166937|FG001|Overall Study|Adverse Event|0|||
46931726|NCT02182687|83166936|FG000|Overall Study|Lost to Follow-up|0|||
46931727|NCT02182687|83166937|FG001|Overall Study|Lost to Follow-up|1|||
46931728|NCT02159066|83166951|FG000|Part I|Adverse Event|7|||
46931729|NCT02159066|83166952|FG001|Part I|Adverse Event|5|||
46931730|NCT02159066|83166953|FG002|Part I|Adverse Event|0|||
46931731|NCT02159066|83166954|FG003|Part I|Adverse Event|0|||
46931732|NCT02159066|83166955|FG004|Part I|Adverse Event|0|||
46931733|NCT02159066|83166956|FG005|Part I|Adverse Event|0|||
46759441|NCT03158285|82977546|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
46759442|NCT03158285|82977544|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
47056299|NCT02036970|83332201|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
46759443|NCT03158285|82977545|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
46759444|NCT03158285|82977546|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
46759445|NCT03158285|82977544|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
46759446|NCT03158285|82977545|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
46759447|NCT03158285|82977546|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
46759448|NCT03158285|82977544|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
46759449|NCT03158285|82977545|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
46759450|NCT03158285|82977546|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
46759451|NCT03158285|82977544|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
46759452|NCT03158285|82977545|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
46759453|NCT03158285|82977546|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
46759454|NCT03158285|82977544|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
46759455|NCT03158285|82977545|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
46759456|NCT03158285|82977546|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
46759457|NCT03158285|82977544|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
46759458|NCT03158285|82977545|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
46759459|NCT03158285|82977546|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
46931734|NCT02159066|83166951|FG000|Part I|Death|11|||
46931735|NCT02159066|83166952|FG001|Part I|Death|9|||
46931736|NCT02159066|83166953|FG002|Part I|Death|0|||
46931737|NCT02159066|83166954|FG003|Part I|Death|0|||
46931738|NCT02159066|83166955|FG004|Part I|Death|0|||
46931739|NCT02159066|83166956|FG005|Part I|Death|0|||
46931740|NCT02159066|83166951|FG000|Part I|Progressive Disease|37|||
46931741|NCT02159066|83166952|FG001|Part I|Progressive Disease|46|||
46931742|NCT02159066|83166953|FG002|Part I|Progressive Disease|0|||
46931743|NCT02159066|83166954|FG003|Part I|Progressive Disease|0|||
46759460|NCT03158285|82977544|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
46759461|NCT03158285|82977545|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
46759462|NCT03158285|82977546|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
46759463|NCT03158285|82977544|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
46820073|NCT00293020|83039693|FG000|Overall Study|No dose taken|1|||
46820074|NCT00377637|83039701|FG000|Induction Phase|Adverse Event|12|||
46931744|NCT02159066|83166955|FG004|Part I|Progressive Disease|0|||
46931745|NCT02159066|83166956|FG005|Part I|Progressive Disease|0|||
46931746|NCT02159066|83166951|FG000|Part I|New Therapy for Study Indication|5|||
46931747|NCT02159066|83166952|FG001|Part I|New Therapy for Study Indication|4|||
46759464|NCT03158285|82977545|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
47056300|NCT02036970|83332202|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
46759465|NCT03158285|82977546|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
46759466|NCT03158285|82977544|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
46820075|NCT00377637|83039702|FG001|Induction Phase|Adverse Event|21|||
46820076|NCT00377637|83039703|FG002|Induction Phase|Adverse Event|0|||
46820077|NCT00377637|83039704|FG003|Induction Phase|Adverse Event|0|||
46931748|NCT02159066|83166953|FG002|Part I|New Therapy for Study Indication|0|||
46931749|NCT02159066|83166954|FG003|Part I|New Therapy for Study Indication|0|||
46931750|NCT02159066|83166955|FG004|Part I|New Therapy for Study Indication|0|||
46931751|NCT02159066|83166956|FG005|Part I|New Therapy for Study Indication|0|||
46931752|NCT02159066|83166951|FG000|Part I|Termination of participants from the study|3|||
46931753|NCT02159066|83166952|FG001|Part I|Termination of participants from the study|3|||
46931754|NCT02159066|83166953|FG002|Part I|Termination of participants from the study|0|||
46931755|NCT02159066|83166954|FG003|Part I|Termination of participants from the study|0|||
46931756|NCT02159066|83166955|FG004|Part I|Termination of participants from the study|0|||
46931757|NCT02159066|83166956|FG005|Part I|Termination of participants from the study|0|||
46931758|NCT02159066|83166951|FG000|Part I|Physician Decision|2|||
46931759|NCT02159066|83166952|FG001|Part I|Physician Decision|9|||
46931760|NCT02159066|83166953|FG002|Part I|Physician Decision|0|||
46931761|NCT02159066|83166954|FG003|Part I|Physician Decision|0|||
46931762|NCT02159066|83166955|FG004|Part I|Physician Decision|0|||
46931763|NCT02159066|83166956|FG005|Part I|Physician Decision|0|||
46931764|NCT02159066|83166951|FG000|Part I|Participant/Guardian Decision|9|||
46931765|NCT02159066|83166952|FG001|Part I|Participant/Guardian Decision|3|||
46931766|NCT02159066|83166953|FG002|Part I|Participant/Guardian Decision|0|||
46931767|NCT02159066|83166954|FG003|Part I|Participant/Guardian Decision|0|||
46931768|NCT02159066|83166955|FG004|Part I|Participant/Guardian Decision|0|||
46820078|NCT00377637|83039701|FG000|Induction Phase|Deterioration/serum creatinine|2|||
46820079|NCT00377637|83039702|FG001|Induction Phase|Deterioration/serum creatinine|0|||
46820080|NCT00377637|83039703|FG002|Induction Phase|Deterioration/serum creatinine|0|||
46820081|NCT00377637|83039704|FG003|Induction Phase|Deterioration/serum creatinine|0|||
46820082|NCT00377637|83039701|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
46820083|NCT00377637|83039702|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
46820084|NCT00377637|83039703|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
46820085|NCT00377637|83039704|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
46820086|NCT00377637|83039701|FG000|Induction Phase|Lost to Follow-up|2|||
46820087|NCT00377637|83039702|FG001|Induction Phase|Lost to Follow-up|1|||
46820088|NCT00377637|83039703|FG002|Induction Phase|Lost to Follow-up|0|||
46820089|NCT00377637|83039704|FG003|Induction Phase|Lost to Follow-up|0|||
46820090|NCT00377637|83039701|FG000|Induction Phase|Death|1|||
46820091|NCT00377637|83039702|FG001|Induction Phase|Death|3|||
46820092|NCT00377637|83039703|FG002|Induction Phase|Death|0|||
46820093|NCT00377637|83039704|FG003|Induction Phase|Death|0|||
46820094|NCT00377637|83039701|FG000|Induction Phase|Withdrawal by Subject|5|||
46820095|NCT00377637|83039702|FG001|Induction Phase|Withdrawal by Subject|6|||
46820096|NCT00377637|83039703|FG002|Induction Phase|Withdrawal by Subject|0|||
46820097|NCT00377637|83039704|FG003|Induction Phase|Withdrawal by Subject|0|||
46820098|NCT00377637|83039701|FG000|Induction Phase|Physician Decision|3|||
46820099|NCT00377637|83039702|FG001|Induction Phase|Physician Decision|1|||
46820100|NCT00377637|83039703|FG002|Induction Phase|Physician Decision|0|||
46820101|NCT00377637|83039704|FG003|Induction Phase|Physician Decision|0|||
46820102|NCT00377637|83039701|FG000|Induction Phase|Sponsor decision|1|||
46820103|NCT00377637|83039702|FG001|Induction Phase|Sponsor decision|2|||
46820104|NCT00377637|83039703|FG002|Induction Phase|Sponsor decision|0|||
46820105|NCT00377637|83039704|FG003|Induction Phase|Sponsor decision|0|||
46820106|NCT00377637|83039701|FG000|Induction Phase|Non-Compliance|1|||
46820107|NCT00377637|83039702|FG001|Induction Phase|Non-Compliance|0|||
46820108|NCT00377637|83039703|FG002|Induction Phase|Non-Compliance|0|||
46820109|NCT00377637|83039704|FG003|Induction Phase|Non-Compliance|0|||
46820110|NCT00377637|83039701|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
46820111|NCT00377637|83039702|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
46820112|NCT00377637|83039703|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
46820113|NCT00377637|83039704|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
46820114|NCT00377637|83039701|FG000|Maintenance Phase|Adverse Event|0|||
46820115|NCT00377637|83039702|FG001|Maintenance Phase|Adverse Event|0|||
46820116|NCT00377637|83039703|FG002|Maintenance Phase|Adverse Event|29|||
46820117|NCT00377637|83039704|FG003|Maintenance Phase|Adverse Event|43|||
46820118|NCT00377637|83039701|FG000|Maintenance Phase|Physician Decision|0|||
46820119|NCT00377637|83039702|FG001|Maintenance Phase|Physician Decision|0|||
46820120|NCT00377637|83039703|FG002|Maintenance Phase|Physician Decision|5|||
46820121|NCT00377637|83039704|FG003|Maintenance Phase|Physician Decision|4|||
46820122|NCT00377637|83039701|FG000|Maintenance Phase|Lost to Follow-up|0|||
46820123|NCT00377637|83039702|FG001|Maintenance Phase|Lost to Follow-up|0|||
46820124|NCT00377637|83039703|FG002|Maintenance Phase|Lost to Follow-up|3|||
46820125|NCT00377637|83039704|FG003|Maintenance Phase|Lost to Follow-up|1|||
46931769|NCT02159066|83166956|FG005|Part I|Participant/Guardian Decision|0|||
46931770|NCT02159066|83166951|FG000|Part I|Missing Data|1|||
46931771|NCT02159066|83166952|FG001|Part I|Missing Data|0|||
46931772|NCT02159066|83166953|FG002|Part I|Missing Data|0|||
46931773|NCT02159066|83166954|FG003|Part I|Missing Data|0|||
46931774|NCT02159066|83166955|FG004|Part I|Missing Data|0|||
46931775|NCT02159066|83166956|FG005|Part I|Missing Data|0|||
46820126|NCT00377637|83039701|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46820127|NCT00377637|83039702|FG001|Maintenance Phase|Withdrawal by Subject|0|||
46820128|NCT00377637|83039703|FG002|Maintenance Phase|Withdrawal by Subject|3|||
46931776|NCT02159066|83166951|FG000|Part II|Adverse Event|0|||
46931777|NCT02159066|83166952|FG001|Part II|Adverse Event|0|||
46931778|NCT02159066|83166953|FG002|Part II|Adverse Event|1|||
46931779|NCT02159066|83166954|FG003|Part II|Adverse Event|0|||
46931780|NCT02159066|83166955|FG004|Part II|Adverse Event|1|||
46820129|NCT00377637|83039704|FG003|Maintenance Phase|Withdrawal by Subject|3|||
46820130|NCT00377637|83039701|FG000|Maintenance Phase|Sponsor decision|0|||
46820131|NCT00377637|83039702|FG001|Maintenance Phase|Sponsor decision|0|||
46820132|NCT00377637|83039703|FG002|Maintenance Phase|Sponsor decision|2|||
46820133|NCT00377637|83039704|FG003|Maintenance Phase|Sponsor decision|3|||
46820134|NCT00377637|83039701|FG000|Maintenance Phase|Non-compliance|0|||
46820135|NCT00377637|83039702|FG001|Maintenance Phase|Non-compliance|0|||
46820136|NCT00377637|83039703|FG002|Maintenance Phase|Non-compliance|1|||
46820137|NCT00377637|83039704|FG003|Maintenance Phase|Non-compliance|1|||
46820138|NCT00377637|83039701|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
46820139|NCT00377637|83039702|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
46820140|NCT00377637|83039703|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
46820141|NCT00377637|83039704|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
46820142|NCT00377637|83039701|FG000|Maintenance Phase|Death|0|||
46820143|NCT00377637|83039702|FG001|Maintenance Phase|Death|0|||
46820144|NCT00377637|83039703|FG002|Maintenance Phase|Death|0|||
46820145|NCT00377637|83039704|FG003|Maintenance Phase|Death|1|||
46820146|NCT00377403|83039720|FG000|Overall Study|Unable to contact for telephone intervie|4|||
46820147|NCT00377403|83039721|FG001|Overall Study|Unable to contact for telephone intervie|7|||
46820148|NCT00370149|83039729|FG000|Overall Study|Physician Decision|16|||
46820149|NCT00370149|83039730|FG001|Overall Study|Physician Decision|16|||
46820150|NCT00370149|83039729|FG000|Overall Study|Protocol Violation|1|||
46820151|NCT00370149|83039730|FG001|Overall Study|Protocol Violation|0|||
46820152|NCT00370149|83039729|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
46820153|NCT00370149|83039730|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
46820154|NCT00370149|83039729|FG000|Overall Study|Pre-existing infection|0|||
46820155|NCT00370149|83039730|FG001|Overall Study|Pre-existing infection|1|||
46820156|NCT00370149|83039729|FG000|Overall Study|Antibiotic coated dressing placed|0|||
46820157|NCT00370149|83039730|FG001|Overall Study|Antibiotic coated dressing placed|1|||
46820158|NCT00292942|83039743|FG000|Overall Study|Withdrawal by Subject|0|||
46820159|NCT00292942|83039744|FG001|Overall Study|Withdrawal by Subject|0|||
46820160|NCT00292942|83039745|FG002|Overall Study|Withdrawal by Subject|1|||
46820161|NCT00292942|83039746|FG003|Overall Study|Withdrawal by Subject|0|||
46820162|NCT00292942|83039743|FG000|Overall Study|Adverse Event|0|||
46820163|NCT00292942|83039744|FG001|Overall Study|Adverse Event|0|||
46820164|NCT00292942|83039745|FG002|Overall Study|Adverse Event|0|||
46820165|NCT00292942|83039746|FG003|Overall Study|Adverse Event|1|||
46820166|NCT00483938|83039766|FG000|Overall Study|Protocol Violation|0|||
46820167|NCT00483938|83039767|FG001|Overall Study|Protocol Violation|0|||
46820168|NCT00483938|83039768|FG002|Overall Study|Protocol Violation|0|||
46820169|NCT00483938|83039769|FG003|Overall Study|Protocol Violation|0|||
46820170|NCT00483938|83039770|FG004|Overall Study|Protocol Violation|0|||
46820171|NCT00483938|83039771|FG005|Overall Study|Protocol Violation|0|||
46820172|NCT00483938|83039772|FG006|Overall Study|Protocol Violation|3|||
46820173|NCT00483938|83039766|FG000|Overall Study|Withdrawal by Subject|1|||
46820174|NCT00483938|83039767|FG001|Overall Study|Withdrawal by Subject|6|||
46820175|NCT00483938|83039768|FG002|Overall Study|Withdrawal by Subject|0|||
46820176|NCT00483938|83039769|FG003|Overall Study|Withdrawal by Subject|0|||
46820177|NCT00483938|83039770|FG004|Overall Study|Withdrawal by Subject|1|||
46820178|NCT00483938|83039771|FG005|Overall Study|Withdrawal by Subject|3|||
46820179|NCT00483938|83039772|FG006|Overall Study|Withdrawal by Subject|2|||
46820180|NCT00483938|83039766|FG000|Overall Study|Lost to Follow-up|1|||
46820181|NCT00483938|83039767|FG001|Overall Study|Lost to Follow-up|2|||
46759467|NCT03158285|82977545|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
46759468|NCT03158285|82977546|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
46759469|NCT03158285|82977544|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
46759470|NCT03158285|82977545|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
46759471|NCT03158285|82977546|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
46759472|NCT03158285|82977544|FG000|Active Treatment Period: Week 52-100|Death|1|||
46759473|NCT03158285|82977545|FG001|Active Treatment Period: Week 52-100|Death|0|||
46759474|NCT03158285|82977546|FG002|Active Treatment Period: Week 52-100|Death|0|||
46759475|NCT03158285|82977544|FG000|Active Treatment Period: Week 52-100|Other|4|||
46759476|NCT03158285|82977545|FG001|Active Treatment Period: Week 52-100|Other|1|||
46759477|NCT03158285|82977546|FG002|Active Treatment Period: Week 52-100|Other|0|||
46820182|NCT00483938|83039768|FG002|Overall Study|Lost to Follow-up|0|||
47056301|NCT02036970|83332203|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
46820183|NCT00483938|83039769|FG003|Overall Study|Lost to Follow-up|2|||
46820184|NCT00483938|83039770|FG004|Overall Study|Lost to Follow-up|1|||
46820185|NCT00483938|83039771|FG005|Overall Study|Lost to Follow-up|1|||
47056302|NCT02036970|83332204|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
46759478|NCT00861692|82977559|FG000|Overall Study|Death|6|||
46820186|NCT00483938|83039772|FG006|Overall Study|Lost to Follow-up|3|||
46820187|NCT00483938|83039766|FG000|Overall Study|Death|0|||
46820188|NCT00483938|83039767|FG001|Overall Study|Death|2|||
46820189|NCT00483938|83039768|FG002|Overall Study|Death|0|||
46820190|NCT00483938|83039769|FG003|Overall Study|Death|0|||
46820191|NCT00483938|83039770|FG004|Overall Study|Death|0|||
46820192|NCT00483938|83039771|FG005|Overall Study|Death|0|||
46820193|NCT00483938|83039772|FG006|Overall Study|Death|0|||
46931781|NCT02159066|83166956|FG005|Part II|Adverse Event|1|||
46931782|NCT02159066|83166951|FG000|Part II|Death|0|||
46931783|NCT02159066|83166952|FG001|Part II|Death|0|||
46931784|NCT02159066|83166953|FG002|Part II|Death|1|||
46931785|NCT02159066|83166954|FG003|Part II|Death|0|||
46931786|NCT02159066|83166955|FG004|Part II|Death|2|||
46931787|NCT02159066|83166956|FG005|Part II|Death|1|||
46931788|NCT02159066|83166951|FG000|Part II|Progressive Disease|0|||
46931789|NCT02159066|83166952|FG001|Part II|Progressive Disease|0|||
46931790|NCT02159066|83166953|FG002|Part II|Progressive Disease|35|||
46931791|NCT02159066|83166954|FG003|Part II|Progressive Disease|1|||
46931792|NCT02159066|83166955|FG004|Part II|Progressive Disease|7|||
46931793|NCT02159066|83166956|FG005|Part II|Progressive Disease|4|||
46931794|NCT02159066|83166951|FG000|Part II|New Therapy for Study Indication|0|||
46931795|NCT02159066|83166952|FG001|Part II|New Therapy for Study Indication|0|||
46931796|NCT02159066|83166953|FG002|Part II|New Therapy for Study Indication|0|||
46931797|NCT02159066|83166954|FG003|Part II|New Therapy for Study Indication|0|||
46931798|NCT02159066|83166955|FG004|Part II|New Therapy for Study Indication|1|||
46931799|NCT02159066|83166956|FG005|Part II|New Therapy for Study Indication|0|||
46931800|NCT02159066|83166951|FG000|Part II|Physician Decision|0|||
46931801|NCT02159066|83166952|FG001|Part II|Physician Decision|0|||
46931802|NCT02159066|83166953|FG002|Part II|Physician Decision|1|||
46931803|NCT02159066|83166954|FG003|Part II|Physician Decision|0|||
47056303|NCT02036970|83332205|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
47056304|NCT02036970|83332206|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
47056305|NCT02036970|83332207|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
47056306|NCT02036970|83332208|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
47056307|NCT02036970|83332209|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
47056308|NCT02036970|83332200|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
47056309|NCT02036970|83332201|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
47056310|NCT02036970|83332202|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
47056311|NCT02036970|83332203|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
47056312|NCT02036970|83332204|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
47056313|NCT02036970|83332205|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
47056314|NCT02036970|83332206|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
47056315|NCT02036970|83332207|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
47056316|NCT02036970|83332208|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
47056317|NCT02036970|83332209|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
47056318|NCT02036970|83332200|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
47056319|NCT02036970|83332201|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
47056320|NCT02036970|83332202|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
47056321|NCT02036970|83332203|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
47056322|NCT02036970|83332204|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
47056323|NCT02036970|83332205|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
47056324|NCT02036970|83332206|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
46636755|NCT01506726|82810569|FG000|Overall Study|Adverse Event|1|||
46759479|NCT00602927|82977565|FG000|Period 1: 13 Days|Protocol Violation|2|||
46759480|NCT00602927|82977566|FG001|Period 1: 13 Days|Protocol Violation|4|||
46759481|NCT00602927|82977565|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
46759482|NCT00602927|82977566|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
46759483|NCT00602927|82977565|FG000|Period 1: 13 Days|Time|1|||
46759484|NCT00602927|82977566|FG001|Period 1: 13 Days|Time|0|||
46759485|NCT00602927|82977565|FG000|Period 1: 13 Days|Claustrophobia|0|||
46759486|NCT00602927|82977566|FG001|Period 1: 13 Days|Claustrophobia|1|||
46759487|NCT00602927|82977565|FG000|Period 2: 14 Days|Protocol Violation|0|||
46759488|NCT00602927|82977566|FG001|Period 2: 14 Days|Protocol Violation|2|||
46759489|NCT00602927|82977565|FG000|Period 3: 13 Days|Protocol Violation|0|||
46759490|NCT00602927|82977566|FG001|Period 3: 13 Days|Protocol Violation|1|||
46759491|NCT00602927|82977565|FG000|Period 3: 13 Days|MRI data quality|2|||
46759492|NCT00602927|82977566|FG001|Period 3: 13 Days|MRI data quality|2|||
46759493|NCT00602537|82977574|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
46759494|NCT00602537|82977575|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
46820194|NCT00483938|83039766|FG000|Overall Study|Other|3|||
46820195|NCT00483938|83039767|FG001|Overall Study|Other|9|||
46931804|NCT02159066|83166955|FG004|Part II|Physician Decision|0|||
46931805|NCT02159066|83166956|FG005|Part II|Physician Decision|0|||
46931806|NCT02159066|83166951|FG000|Part II|Participant/Guardian Decision|0|||
46931807|NCT02159066|83166952|FG001|Part II|Participant/Guardian Decision|0|||
46931808|NCT02159066|83166953|FG002|Part II|Participant/Guardian Decision|0|||
46931809|NCT02159066|83166954|FG003|Part II|Participant/Guardian Decision|0|||
46931810|NCT02159066|83166955|FG004|Part II|Participant/Guardian Decision|2|||
46931811|NCT02159066|83166956|FG005|Part II|Participant/Guardian Decision|0|||
46931812|NCT02152995|83167010|FG000|Overall Study|Withdrawal by Subject|1|||
47056325|NCT02036970|83332207|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
47056326|NCT02036970|83332208|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
46820196|NCT00483938|83039768|FG002|Overall Study|Other|0|||
46820197|NCT00483938|83039769|FG003|Overall Study|Other|4|||
46820198|NCT00483938|83039770|FG004|Overall Study|Other|0|||
46820199|NCT00483938|83039771|FG005|Overall Study|Other|4|||
46820200|NCT00483938|83039772|FG006|Overall Study|Other|32|||
46820201|NCT00370071|83039791|FG000|Overall Study|Withdrawal by Subject|2|||
46820202|NCT00369915|83039797|FG000|Overall Study|expected side effects|2|||
46820203|NCT00369915|83039798|FG001|Overall Study|expected side effects|1|||
46820204|NCT00369915|83039797|FG000|Overall Study|Withdrawal by Subject|4|||
46820205|NCT00369915|83039798|FG001|Overall Study|Withdrawal by Subject|1|||
46820206|NCT00369915|83039797|FG000|Overall Study|W/drawl by investigators|0|||
46820207|NCT00369915|83039798|FG001|Overall Study|W/drawl by investigators|1|||
46820208|NCT00369681|83039804|FG000|Overall Study|Death|1|||
46820209|NCT00266812|83039810|FG000|Overall Study|Disease Progression|9|||
46820210|NCT00266812|83039811|FG001|Overall Study|Disease Progression|3|||
46759495|NCT00602537|82977574|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
46820211|NCT00266812|83039810|FG000|Overall Study|Death|5|||
46820212|NCT00266812|83039811|FG001|Overall Study|Death|4|||
46931813|NCT02152995|83167011|FG001|Overall Study|Withdrawal by Subject|0|||
46931814|NCT02025010|83167018|FG000|Overall Study|Symptomatic or radiographic progression|36|||
46931815|NCT02025010|83167018|FG000|Overall Study|Adverse Event|6|||
46931816|NCT02025010|83167018|FG000|Overall Study|Physician Decision|7|||
46931817|NCT02025010|83167018|FG000|Overall Study|Withdrawal by Subject|3|||
46931818|NCT02025010|83167018|FG000|Overall Study|Intercurrent illness|3|||
46820213|NCT00266812|83039810|FG000|Overall Study|Adverse Event|3|||
46820214|NCT00266812|83039811|FG001|Overall Study|Adverse Event|1|||
46820215|NCT00266812|83039810|FG000|Overall Study|Protocol Violation|0|||
46820216|NCT00266812|83039811|FG001|Overall Study|Protocol Violation|1|||
46820217|NCT00266812|83039810|FG000|Overall Study|Withdrawal by Subject|0|||
46931819|NCT02025010|83167018|FG000|Overall Study|Patients still on treatment|3|||
46931820|NCT02025010|83167018|FG000|Overall Study|Never initiate the treatment|2|||
46931821|NCT02000427|83167024|FG000|Overall Study|Death|22|||
46931822|NCT01909453|83167033|FG000|Overall Study|Ongoing|118|||
46931823|NCT01909453|83167034|FG001|Overall Study|Ongoing|103|||
46931824|NCT01909453|83167035|FG002|Overall Study|Ongoing|83|||
46931825|NCT01909453|83167036|FG003|Overall Study|Ongoing|164|||
47056327|NCT02036970|83332209|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
46759496|NCT00602537|82977575|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
46759497|NCT00602537|82977574|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
46820218|NCT00266812|83039811|FG001|Overall Study|Withdrawal by Subject|2|||
46820219|NCT00266812|83039810|FG000|Overall Study|Discontinued before starting study drug|4|||
47056328|NCT02036970|83332200|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
47056329|NCT02036970|83332201|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
46759498|NCT00602537|82977575|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
46759499|NCT00602537|82977574|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
47056330|NCT02036970|83332202|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
46759500|NCT00602537|82977575|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
46759501|NCT00602537|82977574|FG000|Follow Up Study Comparison|Adverse Event|1|||
46759502|NCT00602537|82977575|FG001|Follow Up Study Comparison|Adverse Event|0|||
46759503|NCT00602537|82977574|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
46759504|NCT00602537|82977575|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
46759505|NCT00602537|82977574|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
46759506|NCT00602537|82977575|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
46759507|NCT00861614|82977583|FG000|Overall Study|Disease Progression|182|||
46759508|NCT00861614|82977584|FG001|Overall Study|Disease Progression|263|||
46759509|NCT00861614|82977583|FG000|Overall Study|Study Drug Toxicity|79|||
46759510|NCT00861614|82977584|FG001|Overall Study|Study Drug Toxicity|6|||
46759511|NCT00861614|82977583|FG000|Overall Study|Death|32|||
46759512|NCT00861614|82977584|FG001|Overall Study|Death|19|||
46759513|NCT00861614|82977583|FG000|Overall Study|Adverse Event|27|||
46820220|NCT00266812|83039811|FG001|Overall Study|Discontinued before starting study drug|0|||
46820221|NCT00488774|83039821|FG000|Overall Study|Withdrawal of consent|2|||
46820222|NCT00488774|83039822|FG001|Overall Study|Withdrawal of consent|2|||
46820223|NCT00488774|83039823|FG002|Overall Study|Withdrawal of consent|2|||
46820224|NCT00488774|83039824|FG003|Overall Study|Withdrawal of consent|0|||
46931826|NCT01909453|83167037|FG004|Overall Study|Ongoing|50|||
47056331|NCT02036970|83332203|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
47056332|NCT02036970|83332204|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
46931827|NCT01909453|83167033|FG000|Overall Study|Death|69|||
46931828|NCT01909453|83167034|FG001|Overall Study|Death|74|||
46931829|NCT01909453|83167035|FG002|Overall Study|Death|88|||
46931830|NCT01909453|83167036|FG003|Overall Study|Death|86|||
47056333|NCT02036970|83332205|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
46759514|NCT00861614|82977584|FG001|Overall Study|Adverse Event|23|||
46820225|NCT00488774|83039821|FG000|Overall Study|Other|6|||
46820226|NCT00488774|83039822|FG001|Overall Study|Other|3|||
46759515|NCT00861614|82977583|FG000|Overall Study|Withdrawal by Subject|34|||
46759516|NCT00861614|82977584|FG001|Overall Study|Withdrawal by Subject|35|||
46759517|NCT00861614|82977583|FG000|Overall Study|Other|17|||
46759518|NCT00861614|82977584|FG001|Overall Study|Other|22|||
46759519|NCT00485173|82977592|FG000|Overall Study|Death|4|||
46759520|NCT00485173|82977593|FG001|Overall Study|Death|3|||
46759521|NCT00485173|82977592|FG000|Overall Study|Lost to Follow-up|32|||
46759522|NCT00485173|82977593|FG001|Overall Study|Lost to Follow-up|61|||
46759523|NCT00495469|82977606|FG000|Overall Study|Adverse Event|0|||
46759524|NCT00495469|82977607|FG001|Overall Study|Adverse Event|1|||
46759525|NCT00495469|82977608|FG002|Overall Study|Adverse Event|3|||
46759526|NCT00495469|82977609|FG003|Overall Study|Adverse Event|0|||
46759527|NCT00495469|82977610|FG004|Overall Study|Adverse Event|1|||
46759528|NCT00495469|82977611|FG005|Overall Study|Adverse Event|1|||
46759529|NCT00495469|82977612|FG006|Overall Study|Adverse Event|1|||
46759530|NCT00495469|82977606|FG000|Overall Study|Lost to Follow-up|1|||
46759531|NCT00495469|82977607|FG001|Overall Study|Lost to Follow-up|1|||
46759532|NCT00495469|82977608|FG002|Overall Study|Lost to Follow-up|3|||
46759533|NCT00495469|82977609|FG003|Overall Study|Lost to Follow-up|1|||
46759534|NCT00495469|82977610|FG004|Overall Study|Lost to Follow-up|0|||
46759535|NCT00495469|82977611|FG005|Overall Study|Lost to Follow-up|0|||
46759536|NCT00495469|82977612|FG006|Overall Study|Lost to Follow-up|0|||
46759537|NCT00495469|82977606|FG000|Overall Study|Protocol Violation|0|||
46759538|NCT00495469|82977607|FG001|Overall Study|Protocol Violation|0|||
46759539|NCT00495469|82977608|FG002|Overall Study|Protocol Violation|0|||
46759540|NCT00495469|82977609|FG003|Overall Study|Protocol Violation|0|||
46759541|NCT00495469|82977610|FG004|Overall Study|Protocol Violation|1|||
46759542|NCT00495469|82977611|FG005|Overall Study|Protocol Violation|2|||
46759543|NCT00495469|82977612|FG006|Overall Study|Protocol Violation|0|||
46759544|NCT00495469|82977606|FG000|Overall Study|Withdrawal by Subject|5|||
46759545|NCT00495469|82977607|FG001|Overall Study|Withdrawal by Subject|3|||
46759546|NCT00495469|82977608|FG002|Overall Study|Withdrawal by Subject|1|||
46759547|NCT00495469|82977609|FG003|Overall Study|Withdrawal by Subject|3|||
46759548|NCT00495469|82977610|FG004|Overall Study|Withdrawal by Subject|3|||
46759549|NCT00495469|82977611|FG005|Overall Study|Withdrawal by Subject|2|||
46759550|NCT00495469|82977612|FG006|Overall Study|Withdrawal by Subject|3|||
46759551|NCT00495469|82977606|FG000|Overall Study|Lack of Efficacy|0|||
46759552|NCT00495469|82977607|FG001|Overall Study|Lack of Efficacy|0|||
46759553|NCT00495469|82977608|FG002|Overall Study|Lack of Efficacy|0|||
46759554|NCT00495469|82977609|FG003|Overall Study|Lack of Efficacy|0|||
46759555|NCT00495469|82977610|FG004|Overall Study|Lack of Efficacy|0|||
46759556|NCT00495469|82977611|FG005|Overall Study|Lack of Efficacy|0|||
46759557|NCT00495469|82977612|FG006|Overall Study|Lack of Efficacy|1|||
46759558|NCT00495469|82977606|FG000|Overall Study|Liver function test abnormality|0|||
46759559|NCT00495469|82977607|FG001|Overall Study|Liver function test abnormality|1|||
46759560|NCT00495469|82977608|FG002|Overall Study|Liver function test abnormality|0|||
46759561|NCT00495469|82977609|FG003|Overall Study|Liver function test abnormality|0|||
46759562|NCT00495469|82977610|FG004|Overall Study|Liver function test abnormality|0|||
46759563|NCT00495469|82977611|FG005|Overall Study|Liver function test abnormality|0|||
46759564|NCT00495469|82977612|FG006|Overall Study|Liver function test abnormality|0|||
46759565|NCT00495469|82977606|FG000|Overall Study|ST depression at randomisation in ECG|0|||
46759566|NCT00495469|82977607|FG001|Overall Study|ST depression at randomisation in ECG|1|||
46759567|NCT00495469|82977608|FG002|Overall Study|ST depression at randomisation in ECG|0|||
46759568|NCT00495469|82977609|FG003|Overall Study|ST depression at randomisation in ECG|0|||
46759569|NCT00495469|82977610|FG004|Overall Study|ST depression at randomisation in ECG|0|||
46759570|NCT00495469|82977611|FG005|Overall Study|ST depression at randomisation in ECG|0|||
46759571|NCT00495469|82977612|FG006|Overall Study|ST depression at randomisation in ECG|0|||
46759572|NCT00861380|82977642|FG000|Overall Study|Withdrawal Information not recorded|8427|||
46759573|NCT00861380|82977643|FG001|Overall Study|Withdrawal Information not recorded|9112|||
46759574|NCT00861380|82977644|FG002|Overall Study|Withdrawal Information not recorded|8872|||
46759575|NCT00861380|82977645|FG003|Overall Study|Withdrawal Information not recorded|3689|||
47056334|NCT02036970|83332206|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
46759576|NCT00861380|82977646|FG004|Overall Study|Withdrawal Information not recorded|1812|||
46759577|NCT00861380|82977647|FG005|Overall Study|Withdrawal Information not recorded|6249|||
46759578|NCT00861380|82977648|FG006|Overall Study|Withdrawal Information not recorded|3020|||
46759579|NCT00495391|82977683|FG000|Overall Study|Lack of Efficacy|34|||
46759580|NCT00495391|82977684|FG001|Overall Study|Lack of Efficacy|18|||
46820227|NCT00488774|83039823|FG002|Overall Study|Other|2|||
46820228|NCT00488774|83039824|FG003|Overall Study|Other|2|||
47056335|NCT02036970|83332207|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
46759581|NCT00495391|82977683|FG000|Overall Study|Withdrawal by Subject|2|||
46759582|NCT00495391|82977684|FG001|Overall Study|Withdrawal by Subject|3|||
46759583|NCT00869960|82977690|FG000|Overall Study|Lost to Follow-up|2|||
46759584|NCT00494299|82977696|FG000|Overall Study|Adverse Event|93|||
46759585|NCT00494299|82977697|FG001|Overall Study|Adverse Event|13|||
46759586|NCT00494299|82977696|FG000|Overall Study|Lost to Follow-up|1|||
46820229|NCT00488774|83039821|FG000|Overall Study|Lost to Follow-up|0|||
46820230|NCT00488774|83039822|FG001|Overall Study|Lost to Follow-up|0|||
46820231|NCT00488774|83039823|FG002|Overall Study|Lost to Follow-up|1|||
46820232|NCT00488774|83039824|FG003|Overall Study|Lost to Follow-up|1|||
46820233|NCT00361569|83039839|FG000|Overall Study|Protocol Violation|3|||
46820234|NCT00361569|83039840|FG001|Overall Study|Protocol Violation|2|||
46820235|NCT00361569|83039841|FG002|Overall Study|Protocol Violation|4|||
46820236|NCT00361569|83039842|FG003|Overall Study|Protocol Violation|2|||
46820237|NCT00361569|83039839|FG000|Overall Study|Withdrawal by Subject|2|||
46820238|NCT00361569|83039840|FG001|Overall Study|Withdrawal by Subject|1|||
46820239|NCT00361569|83039841|FG002|Overall Study|Withdrawal by Subject|9|||
46820240|NCT00361569|83039842|FG003|Overall Study|Withdrawal by Subject|14|||
46820241|NCT00361569|83039839|FG000|Overall Study|Adverse Event|3|||
46820242|NCT00361569|83039840|FG001|Overall Study|Adverse Event|5|||
46820243|NCT00361569|83039841|FG002|Overall Study|Adverse Event|2|||
46820244|NCT00361569|83039842|FG003|Overall Study|Adverse Event|2|||
46820245|NCT00361569|83039839|FG000|Overall Study|Lost to Follow-up|2|||
46931831|NCT01909453|83167037|FG004|Overall Study|Death|29|||
46931832|NCT01909453|83167033|FG000|Overall Study|Lost to Follow-up|3|||
46820246|NCT00361569|83039840|FG001|Overall Study|Lost to Follow-up|3|||
46820247|NCT00361569|83039841|FG002|Overall Study|Lost to Follow-up|3|||
46820248|NCT00361569|83039842|FG003|Overall Study|Lost to Follow-up|2|||
46820249|NCT00361569|83039839|FG000|Overall Study|Not specified by investigator|2|||
46636756|NCT01506726|82810570|FG001|Overall Study|Adverse Event|2|||
46636757|NCT01505868|82810581|FG000|Overall Study|Withdrawal by Subject|1|||
46636758|NCT01505868|82810582|FG001|Overall Study|Withdrawal by Subject|0|||
46636759|NCT01505868|82810583|FG002|Overall Study|Withdrawal by Subject|0|||
46636760|NCT01505868|82810584|FG003|Overall Study|Withdrawal by Subject|0|||
46636761|NCT01505868|82810585|FG004|Overall Study|Withdrawal by Subject|0|||
46820250|NCT00361569|83039840|FG001|Overall Study|Not specified by investigator|0|||
46820251|NCT00361569|83039841|FG002|Overall Study|Not specified by investigator|0|||
46820252|NCT00361569|83039842|FG003|Overall Study|Not specified by investigator|1|||
46820253|NCT00488618|83039854|FG000|Overall Study|Adverse Event|13|||
46820254|NCT00488618|83039855|FG001|Overall Study|Adverse Event|17|||
46820255|NCT00488618|83039854|FG000|Overall Study|Insufficient Therapeutic Response|18|||
46820256|NCT00488618|83039855|FG001|Overall Study|Insufficient Therapeutic Response|11|||
46820257|NCT00488618|83039854|FG000|Overall Study|Protocol Violation|0|||
46820258|NCT00488618|83039855|FG001|Overall Study|Protocol Violation|2|||
46820259|NCT00488618|83039854|FG000|Overall Study|Withdrawal of Consent|15|||
46820260|NCT00488618|83039855|FG001|Overall Study|Withdrawal of Consent|13|||
46820261|NCT00488618|83039854|FG000|Overall Study|Lost to Follow-up|1|||
46820262|NCT00488618|83039855|FG001|Overall Study|Lost to Follow-up|0|||
46820263|NCT00266656|83039863|FG000|Overall Study|Death|1|||
46820264|NCT00266656|83039864|FG001|Overall Study|Death|0|||
46820265|NCT00266656|83039863|FG000|Overall Study|Lost to Follow-up|4|||
46820266|NCT00266656|83039864|FG001|Overall Study|Lost to Follow-up|1|||
46820267|NCT00266656|83039863|FG000|Overall Study|Withdrawal by Subject|4|||
46820268|NCT00266656|83039864|FG001|Overall Study|Withdrawal by Subject|2|||
46820269|NCT00266656|83039863|FG000|Overall Study|Did Not Reach Final Height|4|||
46820270|NCT00266656|83039864|FG001|Overall Study|Did Not Reach Final Height|8|||
46820271|NCT00266656|83039863|FG000|Overall Study|Parent/Caregiver Decision|1|||
46820272|NCT00266656|83039864|FG001|Overall Study|Parent/Caregiver Decision|2|||
46820273|NCT00483704|83039873|FG000|Randomization|Withdrawal by Subject|19|||
46820274|NCT00483704|83039874|FG001|Randomization|Withdrawal by Subject|28|||
46820275|NCT00483704|83039875|FG002|Randomization|Withdrawal by Subject|18|||
46820276|NCT00483704|83039873|FG000|Randomization|Protocol Violation|14|||
46820277|NCT00483704|83039874|FG001|Randomization|Protocol Violation|25|||
46820278|NCT00483704|83039875|FG002|Randomization|Protocol Violation|22|||
46820279|NCT00483704|83039873|FG000|Randomization|Lost to Follow-up|14|||
46820280|NCT00483704|83039874|FG001|Randomization|Lost to Follow-up|14|||
46820281|NCT00483704|83039875|FG002|Randomization|Lost to Follow-up|19|||
46820282|NCT00483704|83039873|FG000|Randomization|Pregnancy|1|||
46820283|NCT00483704|83039874|FG001|Randomization|Pregnancy|0|||
46820284|NCT00483704|83039875|FG002|Randomization|Pregnancy|0|||
46820285|NCT00483704|83039873|FG000|Randomization|Physician Decision|2|||
46820286|NCT00483704|83039874|FG001|Randomization|Physician Decision|4|||
46931833|NCT01909453|83167034|FG001|Overall Study|Lost to Follow-up|4|||
46931834|NCT01909453|83167035|FG002|Overall Study|Lost to Follow-up|4|||
46931835|NCT01909453|83167036|FG003|Overall Study|Lost to Follow-up|3|||
46931836|NCT01909453|83167037|FG004|Overall Study|Lost to Follow-up|3|||
46636762|NCT01505634|82810600|FG000|Overall Study|Withdrawal by Subject|2|||
46820287|NCT00483704|83039875|FG002|Randomization|Physician Decision|0|||
46820288|NCT00483704|83039873|FG000|Randomization|Progressive disease|0|||
46931837|NCT01909453|83167033|FG000|Overall Study|Withdrawal by Subject|2|||
46820289|NCT00483704|83039874|FG001|Randomization|Progressive disease|0|||
46820290|NCT00483704|83039875|FG002|Randomization|Progressive disease|1|||
46820291|NCT00483704|83039873|FG000|Randomization|Lack of qualifying migraines|21|||
46820292|NCT00483704|83039874|FG001|Randomization|Lack of qualifying migraines|25|||
46820293|NCT00483704|83039875|FG002|Randomization|Lack of qualifying migraines|31|||
46820294|NCT00483704|83039873|FG000|Treatment|Lack of qualifying migraines|101|||
46820295|NCT00483704|83039874|FG001|Treatment|Lack of qualifying migraines|99|||
46820296|NCT00483704|83039875|FG002|Treatment|Lack of qualifying migraines|116|||
46820297|NCT00483704|83039873|FG000|Treatment|Adverse Event|3|||
46820298|NCT00483704|83039874|FG001|Treatment|Adverse Event|5|||
46820299|NCT00483704|83039875|FG002|Treatment|Adverse Event|4|||
46820300|NCT00483704|83039873|FG000|Treatment|Withdrawal by Subject|16|||
46820301|NCT00483704|83039874|FG001|Treatment|Withdrawal by Subject|12|||
46820302|NCT00483704|83039875|FG002|Treatment|Withdrawal by Subject|21|||
46820303|NCT00483704|83039873|FG000|Treatment|Protocol Violation|6|||
46820304|NCT00483704|83039874|FG001|Treatment|Protocol Violation|3|||
46820305|NCT00483704|83039875|FG002|Treatment|Protocol Violation|5|||
46931838|NCT01909453|83167034|FG001|Overall Study|Withdrawal by Subject|13|||
46931839|NCT01909453|83167035|FG002|Overall Study|Withdrawal by Subject|16|||
46931840|NCT01909453|83167036|FG003|Overall Study|Withdrawal by Subject|5|||
46759587|NCT00494299|82977697|FG001|Overall Study|Lost to Follow-up|0|||
46759588|NCT00494299|82977696|FG000|Overall Study|Physician Decision|0|||
46759589|NCT00494299|82977697|FG001|Overall Study|Physician Decision|2|||
46759590|NCT00494299|82977696|FG000|Overall Study|Protocol Violation|1|||
46759591|NCT00494299|82977697|FG001|Overall Study|Protocol Violation|2|||
46759592|NCT00494299|82977696|FG000|Overall Study|Withdrawal by Subject|8|||
46759593|NCT00494299|82977697|FG001|Overall Study|Withdrawal by Subject|3|||
46759594|NCT00494299|82977696|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
46759595|NCT00494299|82977697|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
46759596|NCT00494299|82977696|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
46759597|NCT00494299|82977697|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
46759598|NCT00494299|82977696|FG000|Overall Study|Site Closed by Sponsor|6|||
46931841|NCT01909453|83167037|FG004|Overall Study|Withdrawal by Subject|4|||
46931842|NCT01466036|83167066|FG000|Overall Study|Death|1|||
46759599|NCT00494299|82977697|FG001|Overall Study|Site Closed by Sponsor|0|||
46759600|NCT00494299|82977696|FG000|Overall Study|Protocol Driven Decision Point|11|||
46759601|NCT00494299|82977697|FG001|Overall Study|Protocol Driven Decision Point|22|||
46759602|NCT00593684|82977705|FG000|Overall Study|Death|2|||
46759603|NCT00593684|82977706|FG001|Overall Study|Death|1|||
46820306|NCT00483704|83039873|FG000|Treatment|Lost to Follow-up|2|||
46820307|NCT00483704|83039874|FG001|Treatment|Lost to Follow-up|7|||
46931843|NCT01466036|83167067|FG001|Overall Study|Death|1|||
46931844|NCT01466036|83167066|FG000|Overall Study|Physician Decision|0|||
46931845|NCT01466036|83167067|FG001|Overall Study|Physician Decision|4|||
47056336|NCT02036970|83332208|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
47056337|NCT02036970|83332209|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
47056338|NCT02036970|83332200|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
47056339|NCT02036970|83332201|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
47056340|NCT02036970|83332202|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
47056341|NCT02036970|83332203|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
47056342|NCT02036970|83332204|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
47056343|NCT02036970|83332205|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
46636763|NCT01505634|82810601|FG001|Overall Study|Withdrawal by Subject|5|||
46759604|NCT02963831|82977716|FG000|Overall Study|Progressive Disease|3|||
46759605|NCT02963831|82977717|FG001|Overall Study|Progressive Disease|3|||
46759606|NCT02963831|82977718|FG002|Overall Study|Progressive Disease|16|||
46820308|NCT00483704|83039875|FG002|Treatment|Lost to Follow-up|5|||
46820309|NCT00483704|83039873|FG000|Treatment|Lack of Efficacy|1|||
46820310|NCT00483704|83039874|FG001|Treatment|Lack of Efficacy|1|||
46820311|NCT00483704|83039875|FG002|Treatment|Lack of Efficacy|1|||
46820312|NCT00483704|83039873|FG000|Treatment|Pregnancy|0|||
46820313|NCT00483704|83039874|FG001|Treatment|Pregnancy|1|||
46820314|NCT00483704|83039875|FG002|Treatment|Pregnancy|0|||
46820315|NCT00483704|83039873|FG000|Treatment|Physician Decision|0|||
46820316|NCT00483704|83039874|FG001|Treatment|Physician Decision|1|||
46820317|NCT00483704|83039875|FG002|Treatment|Physician Decision|4|||
46820318|NCT00483548|83039888|FG000|Overall Study|Randomized; not treated with study drug|1|||
46820319|NCT00483548|83039889|FG001|Overall Study|Randomized; not treated with study drug|3|||
46820320|NCT00483548|83039888|FG000|Overall Study|Adverse Event|25|||
46820321|NCT00483548|83039889|FG001|Overall Study|Adverse Event|14|||
46820322|NCT00483548|83039888|FG000|Overall Study|Laboratory abnormality|1|||
46820323|NCT00483548|83039889|FG001|Overall Study|Laboratory abnormality|2|||
46820324|NCT00483548|83039888|FG000|Overall Study|Lack of Efficacy|4|||
46820325|NCT00483548|83039889|FG001|Overall Study|Lack of Efficacy|8|||
46820326|NCT00483548|83039888|FG000|Overall Study|Protocol Violation|11|||
46820327|NCT00483548|83039889|FG001|Overall Study|Protocol Violation|7|||
46931846|NCT01466036|83167066|FG000|Overall Study|Adverse Event|2|||
46931847|NCT01466036|83167067|FG001|Overall Study|Adverse Event|6|||
46931848|NCT01466036|83167066|FG000|Overall Study|Withdrawal by Subject|2|||
46931849|NCT01466036|83167067|FG001|Overall Study|Withdrawal by Subject|8|||
47056344|NCT02036970|83332206|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
46759607|NCT02963831|82977719|FG003|Overall Study|Progressive Disease|27|||
46820328|NCT00483548|83039888|FG000|Overall Study|Pregnancy|1|||
46759608|NCT02963831|82977716|FG000|Overall Study|Withdrawal by Subject|1|||
46759609|NCT02963831|82977717|FG001|Overall Study|Withdrawal by Subject|0|||
46759610|NCT02963831|82977718|FG002|Overall Study|Withdrawal by Subject|2|||
46759611|NCT02963831|82977719|FG003|Overall Study|Withdrawal by Subject|4|||
46759612|NCT02963831|82977716|FG000|Overall Study|Adverse Event|0|||
46759613|NCT02963831|82977717|FG001|Overall Study|Adverse Event|1|||
46759614|NCT02963831|82977718|FG002|Overall Study|Adverse Event|1|||
46759615|NCT02963831|82977719|FG003|Overall Study|Adverse Event|2|||
46759616|NCT02963831|82977716|FG000|Overall Study|Death|0|||
46759617|NCT02963831|82977717|FG001|Overall Study|Death|0|||
46759618|NCT02963831|82977718|FG002|Overall Study|Death|0|||
46759619|NCT02963831|82977719|FG003|Overall Study|Death|2|||
46931850|NCT01466036|83167066|FG000|Overall Study|progression/relapse|14|||
46931851|NCT01466036|83167067|FG001|Overall Study|progression/relapse|21|||
46931852|NCT01466036|83167066|FG000|Overall Study|prolonged treatment delay|1|||
46931853|NCT01466036|83167067|FG001|Overall Study|prolonged treatment delay|1|||
46931854|NCT01012817|83167088|FG000|Overall Study|Withdrawal by Subject|0|||
46931855|NCT01012817|83167089|FG001|Overall Study|Withdrawal by Subject|0|||
46931856|NCT01012817|83167090|FG002|Overall Study|Withdrawal by Subject|0|||
46931857|NCT01012817|83167091|FG003|Overall Study|Withdrawal by Subject|1|||
46931858|NCT01012817|83167092|FG004|Overall Study|Withdrawal by Subject|0|||
47056345|NCT02036970|83332207|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
47056346|NCT02036970|83332208|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
47056347|NCT02036970|83332209|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
47056348|NCT02036970|83332200|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
46759620|NCT00859898|82977734|FG000|Overall Study|Lack of Efficacy|0|||
46759621|NCT00859898|82977735|FG001|Overall Study|Lack of Efficacy|1|||
46759622|NCT00859898|82977736|FG002|Overall Study|Lack of Efficacy|1|||
46759623|NCT00859898|82977734|FG000|Overall Study|Adverse Event|4|||
46759624|NCT00859898|82977735|FG001|Overall Study|Adverse Event|9|||
46759625|NCT00859898|82977736|FG002|Overall Study|Adverse Event|8|||
46759626|NCT00859898|82977734|FG000|Overall Study|Withdrawal by Subject|11|||
46759627|NCT00859898|82977735|FG001|Overall Study|Withdrawal by Subject|8|||
46759628|NCT00859898|82977736|FG002|Overall Study|Withdrawal by Subject|11|||
46759629|NCT00859898|82977734|FG000|Overall Study|Death|0|||
46759630|NCT00859898|82977735|FG001|Overall Study|Death|0|||
46759631|NCT00859898|82977736|FG002|Overall Study|Death|1|||
46759632|NCT00859898|82977734|FG000|Overall Study|Lost to Follow-up|10|||
46759633|NCT00859898|82977735|FG001|Overall Study|Lost to Follow-up|11|||
46759634|NCT00859898|82977736|FG002|Overall Study|Lost to Follow-up|5|||
46759635|NCT00859898|82977734|FG000|Overall Study|poor/non-compliance|2|||
46759636|NCT00859898|82977735|FG001|Overall Study|poor/non-compliance|0|||
46759637|NCT00859898|82977736|FG002|Overall Study|poor/non-compliance|0|||
46759638|NCT00859898|82977734|FG000|Overall Study|No longer meets criteria|0|||
46759639|NCT00859898|82977735|FG001|Overall Study|No longer meets criteria|1|||
46759640|NCT00859898|82977736|FG002|Overall Study|No longer meets criteria|0|||
47056349|NCT02036970|83332201|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
47056350|NCT02036970|83332202|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
47056351|NCT02036970|83332203|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
47056352|NCT02036970|83332204|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
47056353|NCT02036970|83332205|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
47056354|NCT02036970|83332206|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
47056355|NCT02036970|83332207|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
47056356|NCT02036970|83332208|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
46759641|NCT00859898|82977734|FG000|Overall Study|non-specified|1|||
46759642|NCT00859898|82977735|FG001|Overall Study|non-specified|1|||
46759643|NCT00859898|82977736|FG002|Overall Study|non-specified|1|||
46759644|NCT00859586|82977745|FG000|Overall Study|Donors|4|||
46759645|NCT00494221|82977752|FG000|Overall Study|Death|15|||
46759646|NCT00494221|82977753|FG001|Overall Study|Death|9|||
46759647|NCT00494221|82977754|FG002|Overall Study|Death|14|||
46931859|NCT01012817|83167093|FG005|Overall Study|Withdrawal by Subject|0|||
46759648|NCT00494221|82977752|FG000|Overall Study|Withdrawal by Subject|1|||
46759649|NCT00494221|82977753|FG001|Overall Study|Withdrawal by Subject|2|||
46759650|NCT00494221|82977754|FG002|Overall Study|Withdrawal by Subject|0|||
46759651|NCT00857948|82977766|FG000|Overall Study|Withdrawal by Subject|2|||
46759652|NCT00857948|82977767|FG001|Overall Study|Withdrawal by Subject|0|||
46759653|NCT00857948|82977768|FG002|Overall Study|Withdrawal by Subject|0|||
46759654|NCT00857948|82977769|FG003|Overall Study|Withdrawal by Subject|0|||
46759655|NCT00857948|82977766|FG000|Overall Study|Protocol Violation|1|||
46931860|NCT01012817|83167094|FG006|Overall Study|Withdrawal by Subject|0|||
46931861|NCT01012817|83167095|FG007|Overall Study|Withdrawal by Subject|1|||
46759656|NCT00857948|82977767|FG001|Overall Study|Protocol Violation|0|||
46759657|NCT00857948|82977768|FG002|Overall Study|Protocol Violation|1|||
46759658|NCT00857948|82977769|FG003|Overall Study|Protocol Violation|0|||
46931862|NCT01012817|83167096|FG008|Overall Study|Withdrawal by Subject|0|||
46759659|NCT00866606|82977779|FG000|Overall Study|Lost to Follow-up|3|||
46759660|NCT00866606|82977779|FG000|Overall Study|Adverse Event|1|||
46759661|NCT00857792|82977783|FG000|Overall Study|inadequate image quality for analysis|12|||
46759662|NCT00601835|82977789|FG000|Overall Study|Withdrawal by Subject|9|||
46759663|NCT00601835|82977790|FG001|Overall Study|Withdrawal by Subject|6|||
46759664|NCT00601835|82977789|FG000|Overall Study|Physician Decision|1|||
46759665|NCT00601835|82977790|FG001|Overall Study|Physician Decision|0|||
46759666|NCT00601835|82977789|FG000|Overall Study|Lost to Follow-up|37|||
46759667|NCT00601835|82977790|FG001|Overall Study|Lost to Follow-up|5|||
46759668|NCT00601835|82977789|FG000|Overall Study|Adverse Event|1|||
46759669|NCT00601835|82977790|FG001|Overall Study|Adverse Event|1|||
46759670|NCT00601835|82977789|FG000|Overall Study|Relocate|12|||
46759671|NCT00601835|82977790|FG001|Overall Study|Relocate|2|||
46759672|NCT00857246|82977796|FG000|Induction Regimen|Adverse Event|1|||
46759673|NCT00857246|82977796|FG000|Induction Regimen|disease-related complications|1|||
46759674|NCT00857246|82977796|FG000|Induction Regimen|Withdrawal by Subject|1|||
46759675|NCT00857246|82977796|FG000|Surgery (Curative)|disease progression|6|||
46759676|NCT00857246|82977796|FG000|ChemoRT|Withdrawal by Subject|1|||
46759677|NCT00857246|82977796|FG000|ChemoRT|Adverse Event|2|||
46759678|NCT00856856|82977803|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
46759679|NCT00856856|82977803|FG000|4-year Clinical Follow-up|Missed visit|1|||
46759680|NCT00493285|82977818|FG000|Overall Study|Lost to Follow-up|0|||
46759681|NCT00493285|82977819|FG001|Overall Study|Lost to Follow-up|0|||
46759682|NCT00493285|82977820|FG002|Overall Study|Lost to Follow-up|0|||
46759683|NCT00493285|82977821|FG003|Overall Study|Lost to Follow-up|0|||
46759684|NCT00493285|82977822|FG004|Overall Study|Lost to Follow-up|1|||
46759685|NCT00493285|82977823|FG005|Overall Study|Lost to Follow-up|0|||
46759686|NCT00856778|82977837|FG000|Overall Study|Adverse Event|7|||
46759687|NCT00856778|82977837|FG000|Overall Study|Withdrawal by Subject|10|||
46759688|NCT00856778|82977837|FG000|Overall Study|Study deviation|2|||
46759689|NCT00856778|82977837|FG000|Overall Study|Lost to Follow-up|5|||
46759690|NCT00603473|82977841|FG000|Overall Study|Adverse Event|4|||
46931863|NCT01012817|83167097|FG009|Overall Study|Withdrawal by Subject|0|||
46931864|NCT01012817|83167098|FG010|Overall Study|Withdrawal by Subject|1|||
46931865|NCT01012817|83167099|FG011|Overall Study|Withdrawal by Subject|1|||
46759691|NCT00603473|82977841|FG000|Overall Study|Lack of Efficacy|4|||
46759692|NCT00603473|82977841|FG000|Overall Study|Protocol Violation|1|||
46931866|NCT01012817|83167100|FG012|Overall Study|Withdrawal by Subject|0|||
46931867|NCT01012817|83167101|FG013|Overall Study|Withdrawal by Subject|1|||
46759693|NCT00486889|82977845|FG000|Overall Study|Death|3|||
46759694|NCT00486889|82977845|FG000|Overall Study|Non-compliant|2|||
46759695|NCT00486889|82977845|FG000|Overall Study|Withdrawal by Subject|6|||
46759696|NCT00486811|82977852|FG000|Overall Study|Adverse Event|28|||
46759697|NCT00486811|82977853|FG001|Overall Study|Adverse Event|60|||
46759698|NCT00486811|82977854|FG002|Overall Study|Adverse Event|135|||
46759699|NCT00486811|82977852|FG000|Overall Study|Lack of Efficacy|34|||
46759700|NCT00486811|82977853|FG001|Overall Study|Lack of Efficacy|14|||
46759701|NCT00486811|82977854|FG002|Overall Study|Lack of Efficacy|7|||
46759702|NCT00486811|82977852|FG000|Overall Study|Lost to Follow-up|4|||
46759703|NCT00486811|82977853|FG001|Overall Study|Lost to Follow-up|6|||
46759704|NCT00486811|82977854|FG002|Overall Study|Lost to Follow-up|4|||
46931868|NCT01012817|83167088|FG000|Overall Study|Adverse Event|0|||
46931869|NCT01012817|83167089|FG001|Overall Study|Adverse Event|0|||
46931870|NCT01012817|83167090|FG002|Overall Study|Adverse Event|0|||
46931871|NCT01012817|83167091|FG003|Overall Study|Adverse Event|0|||
46931872|NCT01012817|83167092|FG004|Overall Study|Adverse Event|0|||
46931873|NCT01012817|83167093|FG005|Overall Study|Adverse Event|1|||
46931874|NCT01012817|83167094|FG006|Overall Study|Adverse Event|0|||
47056357|NCT02036970|83332209|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
46759705|NCT00486811|82977852|FG000|Overall Study|Withdrawal by Subject|33|||
47056358|NCT02036970|83332200|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
46759706|NCT00486811|82977853|FG001|Overall Study|Withdrawal by Subject|44|||
46759707|NCT00486811|82977854|FG002|Overall Study|Withdrawal by Subject|58|||
46759708|NCT00486811|82977852|FG000|Overall Study|Study drug non-compliant|5|||
46759709|NCT00486811|82977853|FG001|Overall Study|Study drug non-compliant|6|||
47056359|NCT02036970|83332201|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
47056360|NCT02036970|83332202|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
47056361|NCT02036970|83332203|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
46759710|NCT00486811|82977854|FG002|Overall Study|Study drug non-compliant|3|||
46759711|NCT00486811|82977852|FG000|Overall Study|All other|18|||
46759712|NCT00486811|82977853|FG001|Overall Study|All other|11|||
46759713|NCT00486811|82977854|FG002|Overall Study|All other|7|||
46931875|NCT01012817|83167095|FG007|Overall Study|Adverse Event|0|||
46931876|NCT01012817|83167096|FG008|Overall Study|Adverse Event|0|||
46931877|NCT01012817|83167097|FG009|Overall Study|Adverse Event|0|||
46759714|NCT00486265|82977862|FG000|Overall Study|Adverse Event|1|||
46759715|NCT00486265|82977862|FG000|Overall Study|Lack of Efficacy|8|||
46759716|NCT02151604|82977866|FG000|Overall Study|Lost to Follow-up|3|||
46759717|NCT02151604|82977866|FG000|Overall Study|Withdrawal by Subject|2|||
46759718|NCT02151604|82977866|FG000|Overall Study|Physician Decision|3|||
46759719|NCT02151604|82977866|FG000|Overall Study|Death|1|||
46759720|NCT00466921|82977871|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
46759721|NCT00466921|82977871|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
46759722|NCT00466921|82977871|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
46759723|NCT00466921|82977871|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
46759724|NCT00466921|82977871|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
46759725|NCT00466921|82977871|FG000|Follow up for a Minimum of 1 Year|Death|6|||
46759726|NCT00601523|82977877|FG000|Overall Study|Adverse Event|42|||
46759727|NCT00601523|82977878|FG001|Overall Study|Adverse Event|14|||
46759728|NCT00601523|82977877|FG000|Overall Study|Lack of Efficacy|3|||
46759729|NCT00601523|82977878|FG001|Overall Study|Lack of Efficacy|0|||
46759730|NCT00601523|82977877|FG000|Overall Study|Protocol Violation|5|||
46759731|NCT00601523|82977878|FG001|Overall Study|Protocol Violation|1|||
46759732|NCT00601523|82977877|FG000|Overall Study|Lost to Follow-up|0|||
46759733|NCT00601523|82977878|FG001|Overall Study|Lost to Follow-up|1|||
46759734|NCT00601523|82977877|FG000|Overall Study|Withdrawal by Subject|18|||
46759735|NCT00601523|82977878|FG001|Overall Study|Withdrawal by Subject|9|||
46759736|NCT00601523|82977877|FG000|Overall Study|Other|9|||
46759737|NCT00601523|82977878|FG001|Overall Study|Other|1|||
46759738|NCT00466687|82977884|FG000|Overall Study|Adverse Event|1|||
46759739|NCT00466687|82977884|FG000|Overall Study|Other complicating illness|3|||
46931878|NCT01012817|83167098|FG010|Overall Study|Adverse Event|1|||
46931879|NCT01012817|83167099|FG011|Overall Study|Adverse Event|0|||
46931880|NCT01012817|83167100|FG012|Overall Study|Adverse Event|0|||
46931881|NCT01012817|83167101|FG013|Overall Study|Adverse Event|1|||
46931882|NCT00278915|83167131|FG000|Overall Study|Disease progression|1|||
46931883|NCT05005273|83167137|FG000|Overall Study|Study Terminated|1|||
46931884|NCT05005273|83167138|FG001|Overall Study|Study Terminated|0|||
46931885|NCT04907227|83167146|FG000|Overall Study|Death|10|||
46931886|NCT04907227|83167147|FG001|Overall Study|Death|7|||
46931887|NCT04907227|83167146|FG000|Overall Study|Withdrawal by Subject|1|||
46931888|NCT04907227|83167147|FG001|Overall Study|Withdrawal by Subject|0|||
46931889|NCT04907227|83167146|FG000|Overall Study|Participants ongoing in the study|30|||
46931890|NCT04907227|83167147|FG001|Overall Study|Participants ongoing in the study|33|||
46931891|NCT04846569|83167155|FG000|Overall Study|Withdrawal by Subject|3|||
46931892|NCT04846569|83167156|FG001|Overall Study|Withdrawal by Subject|1|||
46931893|NCT04741802|83167162|FG000|Overall Study|Death|1|||
46931894|NCT04741802|83167162|FG000|Overall Study|Lost to Follow-up|11|||
46931895|NCT04623086|83167168|FG000|Overall Study|Withdrawal by Subject|0|||
46931896|NCT04623086|83167169|FG001|Overall Study|Withdrawal by Subject|0|||
47056362|NCT02036970|83332204|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
47056363|NCT02036970|83332205|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
47056364|NCT02036970|83332206|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
47056365|NCT02036970|83332207|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
46759740|NCT00466687|82977884|FG000|Overall Study|Withdrawal by Subject|1|||
46759741|NCT00466687|82977884|FG000|Overall Study|Disease progression|29|||
46759742|NCT00465985|82977906|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
46759743|NCT00465985|82977907|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
46759744|NCT00465985|82977906|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
46759745|NCT00465985|82977907|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
46759746|NCT00465985|82977906|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
46759747|NCT00465985|82977907|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
46759748|NCT00465985|82977906|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
46759749|NCT00465985|82977907|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
46759750|NCT00454051|82977918|FG000|Overall Study|Adverse Event|1|||
46759751|NCT00454051|82977919|FG001|Overall Study|Adverse Event|2|||
46759752|NCT00454051|82977918|FG000|Overall Study|Withdrawal by Subject|1|||
46759753|NCT00454051|82977919|FG001|Overall Study|Withdrawal by Subject|0|||
46759754|NCT00454051|82977918|FG000|Overall Study|Protocol Violation|1|||
46759755|NCT00454051|82977919|FG001|Overall Study|Protocol Violation|1|||
46759756|NCT00484939|82977927|FG000|Overall Study|Death|9|||
46759757|NCT00484939|82977928|FG001|Overall Study|Death|13|||
46759758|NCT00484939|82977927|FG000|Overall Study|Adverse Event|22|||
46759759|NCT00484939|82977928|FG001|Overall Study|Adverse Event|12|||
46759760|NCT00484939|82977927|FG000|Overall Study|Patient Withdrew Consent|19|||
46759761|NCT00484939|82977928|FG001|Overall Study|Patient Withdrew Consent|10|||
46759762|NCT00484939|82977927|FG000|Overall Study|Protocol Violation|3|||
46759763|NCT00484939|82977928|FG001|Overall Study|Protocol Violation|3|||
46759764|NCT00484939|82977927|FG000|Overall Study|Lost to Follow-up|0|||
46931897|NCT04623086|83167170|FG002|Overall Study|Withdrawal by Subject|10|||
46931898|NCT04587193|83167179|FG000|Overall Study|Screen failure after consent|3|||
46931899|NCT04587193|83167180|FG001|Overall Study|Screen failure after consent|0|||
46931900|NCT04587193|83167179|FG000|Overall Study|Device broke during study|3|||
46931901|NCT04587193|83167180|FG001|Overall Study|Device broke during study|2|||
46759765|NCT00484939|82977928|FG001|Overall Study|Lost to Follow-up|3|||
46759766|NCT00484939|82977927|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
46759767|NCT00484939|82977928|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
46759768|NCT00484939|82977927|FG000|Overall Study|Disease progression|67|||
46759769|NCT00484939|82977928|FG001|Overall Study|Disease progression|88|||
46759770|NCT00484939|82977927|FG000|Overall Study|Screen Failure|2|||
46759771|NCT00484939|82977928|FG001|Overall Study|Screen Failure|2|||
46759772|NCT00484939|82977927|FG000|Overall Study|Reason Not Specified|11|||
46759773|NCT00484939|82977928|FG001|Overall Study|Reason Not Specified|6|||
46759774|NCT00453973|82977936|FG000|Overall Study|Adverse Event|4|||
46759775|NCT00453973|82977937|FG001|Overall Study|Adverse Event|9|||
46759776|NCT00453973|82977936|FG000|Overall Study|Withdrawal by Subject|7|||
46759777|NCT00453973|82977937|FG001|Overall Study|Withdrawal by Subject|6|||
46759778|NCT00453973|82977936|FG000|Overall Study|PI Decision|0|||
46759779|NCT00453973|82977937|FG001|Overall Study|PI Decision|2|||
46759780|NCT00453973|82977936|FG000|Overall Study|Relocation|1|||
46759781|NCT00453973|82977937|FG001|Overall Study|Relocation|0|||
46759782|NCT00453973|82977936|FG000|Overall Study|Renal transplant|1|||
46759783|NCT00453973|82977937|FG001|Overall Study|Renal transplant|1|||
46759784|NCT00453973|82977936|FG000|Overall Study|Site closed by sponsor|3|||
46759785|NCT00453973|82977937|FG001|Overall Study|Site closed by sponsor|0|||
46759786|NCT00453973|82977936|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
46759787|NCT00453973|82977937|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
47056366|NCT02036970|83332208|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
47056367|NCT02036970|83332209|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
46759788|NCT00465361|82977943|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
46759789|NCT00464815|82977949|FG000|Overall Study|Withdrawal by Subject|6|||
46759790|NCT00464815|82977950|FG001|Overall Study|Withdrawal by Subject|3|||
46759791|NCT00464737|82977959|FG000|Overall Study|Adverse Event|12|||
46759792|NCT00464737|82977960|FG001|Overall Study|Adverse Event|17|||
46759793|NCT00464737|82977961|FG002|Overall Study|Adverse Event|33|||
46759794|NCT00464737|82977959|FG000|Overall Study|Lack of Efficacy|7|||
46759795|NCT00464737|82977960|FG001|Overall Study|Lack of Efficacy|7|||
46759796|NCT00464737|82977961|FG002|Overall Study|Lack of Efficacy|4|||
46759797|NCT00464737|82977959|FG000|Overall Study|Withdrawal by Subject|5|||
47056368|NCT01748825|83332399|FG000|Dose Escalation|Refused further treatment|2|||
47056369|NCT01748825|83332400|FG001|Dose Escalation|Refused further treatment|2|||
47056370|NCT01748825|83332401|FG002|Dose Escalation|Refused further treatment|0|||
47056371|NCT01748825|83332402|FG003|Dose Escalation|Refused further treatment|0|||
47056372|NCT01748825|83332403|FG004|Dose Escalation|Refused further treatment|1|||
47056373|NCT01748825|83332404|FG005|Dose Escalation|Refused further treatment|2|||
47056374|NCT01748825|83332405|FG006|Dose Escalation|Refused further treatment|0|||
47056375|NCT01748825|83332406|FG007|Dose Escalation|Refused further treatment|0|||
47056376|NCT01748825|83332407|FG008|Dose Escalation|Refused further treatment|0|||
46759798|NCT00464737|82977960|FG001|Overall Study|Withdrawal by Subject|3|||
46759799|NCT00464737|82977961|FG002|Overall Study|Withdrawal by Subject|5|||
46759800|NCT00464737|82977959|FG000|Overall Study|Protocol Violation|1|||
46759801|NCT00464737|82977960|FG001|Overall Study|Protocol Violation|1|||
46759802|NCT00464737|82977961|FG002|Overall Study|Protocol Violation|5|||
46759803|NCT00464737|82977959|FG000|Overall Study|Non-compliance|0|||
46759804|NCT00464737|82977960|FG001|Overall Study|Non-compliance|1|||
46759805|NCT00464737|82977961|FG002|Overall Study|Non-compliance|1|||
46759806|NCT00464737|82977959|FG000|Overall Study|Lost to Follow-up|5|||
46759807|NCT00464737|82977960|FG001|Overall Study|Lost to Follow-up|2|||
46759808|NCT00464737|82977961|FG002|Overall Study|Lost to Follow-up|5|||
46759809|NCT00464737|82977959|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
46759810|NCT00464737|82977960|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
46759811|NCT00464737|82977961|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
46759812|NCT00464737|82977959|FG000|Overall Study|Other: Subject left town; family illness|1|||
46759813|NCT00464737|82977960|FG001|Overall Study|Other: Subject left town; family illness|0|||
47056377|NCT01748825|83332408|FG009|Dose Escalation|Refused further treatment|0|||
46759814|NCT00464737|82977961|FG002|Overall Study|Other: Subject left town; family illness|0|||
46759815|NCT00464737|82977959|FG000|Overall Study|Other: Study demands too great|0|||
46759816|NCT00464737|82977960|FG001|Overall Study|Other: Study demands too great|1|||
46759817|NCT00464737|82977961|FG002|Overall Study|Other: Study demands too great|0|||
46759818|NCT00464737|82977959|FG000|Overall Study|Other: Personal family reasons|0|||
46759819|NCT00464737|82977960|FG001|Overall Study|Other: Personal family reasons|0|||
47056378|NCT01748825|83332399|FG000|Dose Escalation|Switched to alternative treatment|0|||
46759820|NCT00464737|82977961|FG002|Overall Study|Other: Personal family reasons|1|||
46759821|NCT00464737|82977959|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
46759822|NCT00464737|82977960|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
47056379|NCT01748825|83332400|FG001|Dose Escalation|Switched to alternative treatment|0|||
46759823|NCT00464737|82977961|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
46759824|NCT00453349|82977971|FG000|Randomized|Adverse Event|12|||
46759825|NCT00453349|82977972|FG001|Randomized|Adverse Event|11|||
46759826|NCT00453349|82977971|FG000|Randomized|Lack of Efficacy|2|||
46931902|NCT04576455|83167188|FG000|Overall Study|Ongoing in the Study|122|||
46931903|NCT04576455|83167189|FG001|Overall Study|Ongoing in the Study|135|||
46931904|NCT04576455|83167188|FG000|Overall Study|Death|18|||
46931905|NCT04576455|83167189|FG001|Overall Study|Death|12|||
46931906|NCT04576455|83167188|FG000|Overall Study|Lost to Follow-up|1|||
46931907|NCT04576455|83167189|FG001|Overall Study|Lost to Follow-up|0|||
46931908|NCT04576455|83167188|FG000|Overall Study|Withdrawal by Subject|10|||
46931909|NCT04576455|83167189|FG001|Overall Study|Withdrawal by Subject|5|||
46931910|NCT04305327|83167235|FG000|Overall Study|Study early termination|2|||
46931911|NCT04305327|83167236|FG001|Overall Study|Study early termination|5|||
46931912|NCT04305327|83167237|FG002|Overall Study|Study early termination|2|||
46931913|NCT04305327|83167238|FG003|Overall Study|Study early termination|2|||
46931914|NCT04305327|83167235|FG000|Overall Study|Withdrawal by Subject|0|||
46931915|NCT04305327|83167236|FG001|Overall Study|Withdrawal by Subject|1|||
46931916|NCT04305327|83167237|FG002|Overall Study|Withdrawal by Subject|0|||
46931917|NCT04305327|83167238|FG003|Overall Study|Withdrawal by Subject|0|||
46931918|NCT04281030|83167250|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
47056380|NCT01748825|83332401|FG002|Dose Escalation|Switched to alternative treatment|0|||
47056381|NCT01748825|83332402|FG003|Dose Escalation|Switched to alternative treatment|1|||
47056382|NCT01748825|83332403|FG004|Dose Escalation|Switched to alternative treatment|0|||
46759827|NCT00453349|82977972|FG001|Randomized|Lack of Efficacy|1|||
46759828|NCT00453349|82977971|FG000|Randomized|Lost to Follow-up|7|||
46759829|NCT00453349|82977972|FG001|Randomized|Lost to Follow-up|5|||
46931919|NCT04281030|83167251|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
46931920|NCT04281030|83167250|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
46931921|NCT04281030|83167251|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
46931922|NCT04129242|83167263|FG000|Overall Study|Physician Decision|1|||
46931923|NCT04129242|83167264|FG001|Overall Study|Physician Decision|1|||
46931924|NCT04129242|83167263|FG000|Overall Study|Protocol Violation|0|||
46931925|NCT04129242|83167264|FG001|Overall Study|Protocol Violation|1|||
46931926|NCT04122443|83167272|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
46931927|NCT04122443|83167273|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
46931928|NCT04122443|83167274|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
46931929|NCT04122443|83167272|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
46931930|NCT04122443|83167273|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
46931931|NCT04122443|83167274|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
46931932|NCT04075396|83167283|FG000|Overall Study|Death|11|||
46931933|NCT04075396|83167284|FG001|Overall Study|Death|9|||
46931934|NCT04075396|83167283|FG000|Overall Study|Withdrawal by Subject|1|||
46931935|NCT04075396|83167284|FG001|Overall Study|Withdrawal by Subject|2|||
46931936|NCT04075396|83167283|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
46931937|NCT04075396|83167284|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
46931938|NCT04075396|83167283|FG000|Overall Study|Enrolled but not-treated|0|||
46931939|NCT04075396|83167284|FG001|Overall Study|Enrolled but not-treated|1|||
46931940|NCT03979313|83167292|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
46931941|NCT03979313|83167293|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
46931942|NCT03979313|83167292|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
46931943|NCT03979313|83167293|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
46931944|NCT03979313|83167292|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
46931945|NCT03979313|83167293|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
46931946|NCT03979313|83167292|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
46931947|NCT03979313|83167293|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
46759830|NCT00453349|82977971|FG000|Randomized|Protocol Violation|1|||
46759831|NCT00453349|82977972|FG001|Randomized|Protocol Violation|1|||
46759832|NCT00453349|82977971|FG000|Randomized|Withdrawal by Subject|3|||
46759833|NCT00453349|82977972|FG001|Randomized|Withdrawal by Subject|5|||
46759834|NCT00453349|82977971|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
46759835|NCT00453349|82977972|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
46931948|NCT03979313|83167292|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
46931949|NCT03979313|83167293|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
46931950|NCT03979313|83167292|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
46931951|NCT03979313|83167293|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
46931952|NCT03979313|83167292|FG000|All Subjects|Any Other Reason|16|||
46931953|NCT03979313|83167293|FG001|All Subjects|Any Other Reason|23|||
46931954|NCT03979313|83167292|FG000|All Subjects|Covid-19|1|||
46931955|NCT03979313|83167293|FG001|All Subjects|Covid-19|3|||
46931956|NCT03979313|83167292|FG000|All Subjects|Withdrawal by Subject|35|||
47056383|NCT01748825|83332404|FG005|Dose Escalation|Switched to alternative treatment|0|||
47056384|NCT01748825|83332405|FG006|Dose Escalation|Switched to alternative treatment|0|||
46931957|NCT03979313|83167293|FG001|All Subjects|Withdrawal by Subject|44|||
46931958|NCT03979313|83167292|FG000|All Subjects|Death|0|||
46931959|NCT03979313|83167293|FG001|All Subjects|Death|5|||
46931960|NCT03979313|83167292|FG000|All Subjects|Lost to Follow-up|28|||
46931961|NCT03979313|83167293|FG001|All Subjects|Lost to Follow-up|61|||
46931962|NCT03930732|83167308|FG000|Overall Study|Adverse Event|9|||
46931963|NCT03930732|83167309|FG001|Overall Study|Adverse Event|7|||
46931964|NCT03930732|83167308|FG000|Overall Study|Poor compliance to protocol|0|||
46931965|NCT03930732|83167309|FG001|Overall Study|Poor compliance to protocol|1|||
46931966|NCT03930732|83167308|FG000|Overall Study|Withdrawal by Subject|23|||
47056385|NCT01748825|83332406|FG007|Dose Escalation|Switched to alternative treatment|0|||
47056386|NCT01748825|83332407|FG008|Dose Escalation|Switched to alternative treatment|0|||
47056387|NCT01748825|83332408|FG009|Dose Escalation|Switched to alternative treatment|0|||
47056388|NCT01748825|83332399|FG000|Dose Escalation|Adverse Event|0|||
47056389|NCT01748825|83332400|FG001|Dose Escalation|Adverse Event|0|||
46759836|NCT00453349|82977971|FG000|Completed Study|Adverse Event|12|||
46759837|NCT00453349|82977972|FG001|Completed Study|Adverse Event|11|||
46759838|NCT00453349|82977971|FG000|Completed Study|Lack of Efficacy|2|||
46759839|NCT00453349|82977972|FG001|Completed Study|Lack of Efficacy|1|||
46759840|NCT00453349|82977971|FG000|Completed Study|Lost to Follow-up|7|||
46759841|NCT00453349|82977972|FG001|Completed Study|Lost to Follow-up|5|||
46759842|NCT00453349|82977971|FG000|Completed Study|Protocol Violation|1|||
46759843|NCT00453349|82977972|FG001|Completed Study|Protocol Violation|1|||
46759844|NCT00453349|82977971|FG000|Completed Study|Withdrawal by Subject|3|||
46759845|NCT00453349|82977972|FG001|Completed Study|Withdrawal by Subject|5|||
46759846|NCT00453349|82977971|FG000|Completed Study|Lost to follow up after study treatment|2|||
46759847|NCT00453349|82977972|FG001|Completed Study|Lost to follow up after study treatment|11|||
46759848|NCT00464269|82977982|FG000|Overall Study|Lack of Efficacy|1|||
46759849|NCT00464269|82977983|FG001|Overall Study|Lack of Efficacy|0|||
46759850|NCT00464269|82977984|FG002|Overall Study|Lack of Efficacy|0|||
46759851|NCT00464269|82977985|FG003|Overall Study|Lack of Efficacy|0|||
46759852|NCT00464269|82977982|FG000|Overall Study|Lost to Follow-up|0|||
46759853|NCT00464269|82977983|FG001|Overall Study|Lost to Follow-up|4|||
46759854|NCT00464269|82977984|FG002|Overall Study|Lost to Follow-up|0|||
46759855|NCT00464269|82977985|FG003|Overall Study|Lost to Follow-up|1|||
46759856|NCT00464269|82977982|FG000|Overall Study|Withdrawal by Subject|0|||
46759857|NCT00464269|82977983|FG001|Overall Study|Withdrawal by Subject|2|||
46759858|NCT00464269|82977984|FG002|Overall Study|Withdrawal by Subject|1|||
46759859|NCT00464269|82977985|FG003|Overall Study|Withdrawal by Subject|1|||
46759860|NCT00464269|82977982|FG000|Overall Study|Other reason|3|||
46759861|NCT00464269|82977983|FG001|Overall Study|Other reason|3|||
46759862|NCT00464269|82977984|FG002|Overall Study|Other reason|1|||
46931967|NCT03930732|83167309|FG001|Overall Study|Withdrawal by Subject|11|||
46931968|NCT03930732|83167308|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
47056390|NCT01748825|83332401|FG002|Dose Escalation|Adverse Event|0|||
47056391|NCT01748825|83332402|FG003|Dose Escalation|Adverse Event|0|||
47056392|NCT01748825|83332403|FG004|Dose Escalation|Adverse Event|0|||
47056393|NCT01748825|83332404|FG005|Dose Escalation|Adverse Event|0|||
47056394|NCT01748825|83332405|FG006|Dose Escalation|Adverse Event|1|||
47056395|NCT01748825|83332406|FG007|Dose Escalation|Adverse Event|0|||
47056396|NCT01748825|83332407|FG008|Dose Escalation|Adverse Event|0|||
47056397|NCT01748825|83332408|FG009|Dose Escalation|Adverse Event|0|||
47056398|NCT01748825|83332399|FG000|Dose Expansion|Refused further treatment|0|||
47056399|NCT01748825|83332400|FG001|Dose Expansion|Refused further treatment|0|||
47056400|NCT01748825|83332401|FG002|Dose Expansion|Refused further treatment|0|||
47056401|NCT01748825|83332402|FG003|Dose Expansion|Refused further treatment|0|||
47056402|NCT01748825|83332403|FG004|Dose Expansion|Refused further treatment|0|||
47056403|NCT01748825|83332404|FG005|Dose Expansion|Refused further treatment|0|||
47056404|NCT01748825|83332405|FG006|Dose Expansion|Refused further treatment|0|||
47056405|NCT01748825|83332406|FG007|Dose Expansion|Refused further treatment|0|||
47056406|NCT01748825|83332407|FG008|Dose Expansion|Refused further treatment|1|||
47056407|NCT01748825|83332408|FG009|Dose Expansion|Refused further treatment|1|||
47056408|NCT01748825|83332399|FG000|Dose Expansion|Switched to alternative treatment|0|||
47056409|NCT01748825|83332400|FG001|Dose Expansion|Switched to alternative treatment|0|||
47056410|NCT01748825|83332401|FG002|Dose Expansion|Switched to alternative treatment|0|||
47056411|NCT01748825|83332402|FG003|Dose Expansion|Switched to alternative treatment|0|||
46759863|NCT00464269|82977985|FG003|Overall Study|Other reason|1|||
46931969|NCT03930732|83167309|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
46931970|NCT03930732|83167308|FG000|Overall Study|Other reason not related to COVID-19|5|||
46931971|NCT03930732|83167309|FG001|Overall Study|Other reason not related to COVID-19|8|||
47056412|NCT01748825|83332403|FG004|Dose Expansion|Switched to alternative treatment|0|||
47056413|NCT01748825|83332404|FG005|Dose Expansion|Switched to alternative treatment|0|||
47056414|NCT01748825|83332405|FG006|Dose Expansion|Switched to alternative treatment|0|||
47056415|NCT01748825|83332406|FG007|Dose Expansion|Switched to alternative treatment|0|||
46759864|NCT00464269|82977982|FG000|Overall Study|AE, serious fatal|0|||
46931972|NCT03783078|83167326|FG000|Overall Study|Participants Ongoing|29|||
47056416|NCT01748825|83332407|FG008|Dose Expansion|Switched to alternative treatment|0|||
47056417|NCT01748825|83332408|FG009|Dose Expansion|Switched to alternative treatment|1|||
47056418|NCT01748825|83332399|FG000|Dose Expansion|Adverse Event|0|||
47056419|NCT01748825|83332400|FG001|Dose Expansion|Adverse Event|0|||
47056420|NCT01748825|83332401|FG002|Dose Expansion|Adverse Event|0|||
47056421|NCT01748825|83332402|FG003|Dose Expansion|Adverse Event|0|||
47056422|NCT01748825|83332403|FG004|Dose Expansion|Adverse Event|0|||
47056423|NCT01748825|83332404|FG005|Dose Expansion|Adverse Event|0|||
46636764|NCT01505634|82810602|FG002|Overall Study|Withdrawal by Subject|1|||
46759865|NCT00464269|82977983|FG001|Overall Study|AE, serious fatal|0|||
46759866|NCT00464269|82977984|FG002|Overall Study|AE, serious fatal|1|||
46759867|NCT00464269|82977985|FG003|Overall Study|AE, serious fatal|1|||
46759868|NCT00464269|82977982|FG000|Overall Study|SAE, non-fatal|0|||
46759869|NCT00464269|82977983|FG001|Overall Study|SAE, non-fatal|0|||
46759870|NCT00464269|82977984|FG002|Overall Study|SAE, non-fatal|0|||
46759871|NCT00464269|82977985|FG003|Overall Study|SAE, non-fatal|1|||
46759872|NCT00464269|82977982|FG000|Overall Study|AE, non-serious non-fatal|2|||
46759873|NCT00464269|82977983|FG001|Overall Study|AE, non-serious non-fatal|8|||
46759874|NCT00464269|82977984|FG002|Overall Study|AE, non-serious non-fatal|3|||
46931973|NCT03783078|83167326|FG000|Overall Study|Death|26|||
46931974|NCT03732820|83167332|FG000|Overall Study|Death|168|||
46931975|NCT03732820|83167333|FG001|Overall Study|Death|203|||
46931976|NCT03732820|83167332|FG000|Overall Study|Other|2|||
46931977|NCT03732820|83167333|FG001|Overall Study|Other|2|||
46636765|NCT01505634|82810600|FG000|Overall Study|Physician Decision|1|||
46636766|NCT01505634|82810601|FG001|Overall Study|Physician Decision|1|||
46636767|NCT01505634|82810602|FG002|Overall Study|Physician Decision|0|||
46636768|NCT01505634|82810600|FG000|Overall Study|Adverse Event|1|||
46636769|NCT01505634|82810601|FG001|Overall Study|Adverse Event|0|||
46636770|NCT01505634|82810602|FG002|Overall Study|Adverse Event|0|||
46636771|NCT01505634|82810600|FG000|Overall Study|Insufficient supply of drug at site|1|||
46636772|NCT01505634|82810601|FG001|Overall Study|Insufficient supply of drug at site|0|||
46636773|NCT01505634|82810602|FG002|Overall Study|Insufficient supply of drug at site|0|||
46636774|NCT01505634|82810600|FG000|Overall Study|Protocol Violation|2|||
46636775|NCT01505634|82810601|FG001|Overall Study|Protocol Violation|0|||
46636776|NCT01505634|82810602|FG002|Overall Study|Protocol Violation|0|||
46636777|NCT01505634|82810600|FG000|Overall Study|Lost to Follow-up|1|||
46636778|NCT01505634|82810601|FG001|Overall Study|Lost to Follow-up|4|||
46931978|NCT03732820|83167332|FG000|Overall Study|Failure to meet randomisation criteria|1|||
46931979|NCT03732820|83167333|FG001|Overall Study|Failure to meet randomisation criteria|1|||
46931980|NCT03732820|83167332|FG000|Overall Study|Patient decision|14|||
46931981|NCT03732820|83167333|FG001|Overall Study|Patient decision|10|||
46931982|NCT03732820|83167332|FG000|Overall Study|Screen failure|0|||
46931983|NCT03732820|83167333|FG001|Overall Study|Screen failure|1|||
46931984|NCT03732820|83167332|FG000|Overall Study|Patients ongoing study at data cut off|210|||
46931985|NCT03732820|83167333|FG001|Overall Study|Patients ongoing study at data cut off|178|||
46931986|NCT03732820|83167332|FG000|Overall Study|Lost to Follow-up|4|||
46931987|NCT03732820|83167333|FG001|Overall Study|Lost to Follow-up|2|||
46931988|NCT03704051|83167339|FG000|Overall Study|Withdrawal by Subject|4|||
46931989|NCT03704051|83167340|FG001|Overall Study|Withdrawal by Subject|0|||
46931990|NCT03694522|83167350|FG000|Overall Study|Withdrawal by Subject|8|||
46931991|NCT03694522|83167351|FG001|Overall Study|Withdrawal by Subject|10|||
46931992|NCT03694522|83167350|FG000|Overall Study|Physician Decision|53|||
46931993|NCT03694522|83167351|FG001|Overall Study|Physician Decision|54|||
46636779|NCT01505634|82810602|FG002|Overall Study|Lost to Follow-up|4|||
46636780|NCT01505634|82810600|FG000|Overall Study|Death|1|||
46636781|NCT01505634|82810601|FG001|Overall Study|Death|0|||
46636782|NCT01505634|82810602|FG002|Overall Study|Death|0|||
46636783|NCT01505634|82810600|FG000|Overall Study|In a conflict zone|0|||
46636784|NCT01505634|82810601|FG001|Overall Study|In a conflict zone|0|||
46636785|NCT01505634|82810602|FG002|Overall Study|In a conflict zone|1|||
46636786|NCT01460628|82810610|FG000|Overall Study|Adverse Event|3|||
46636787|NCT01460628|82810610|FG000|Overall Study|Withdrawal by Subject|2|||
46636788|NCT01480596|82810616|FG000|Overall Study|Adverse Event|3|||
46636789|NCT01480596|82810617|FG001|Overall Study|Adverse Event|0|||
46820329|NCT00483548|83039889|FG001|Overall Study|Pregnancy|0|||
46636790|NCT01480596|82810616|FG000|Overall Study|MG exacerbation or change in medication|2|||
46636791|NCT01480596|82810617|FG001|Overall Study|MG exacerbation or change in medication|2|||
46759875|NCT00464269|82977985|FG003|Overall Study|AE, non-serious non-fatal|4|||
46931994|NCT03694522|83167350|FG000|Overall Study|Other|1|||
46931995|NCT03694522|83167351|FG001|Overall Study|Other|1|||
46931996|NCT03694522|83167350|FG000|Overall Study|Lost to Follow-up|0|||
46636792|NCT01480284|82810625|FG000|Overall Study|Withdrawal by Subject|2|||
46820330|NCT00483548|83039888|FG000|Overall Study|Protocol required discontinuation|6|||
46931997|NCT03694522|83167351|FG001|Overall Study|Lost to Follow-up|1|||
46931998|NCT03664960|83167359|FG000|Overall Study|Adverse Event|0|||
46931999|NCT03664960|83167360|FG001|Overall Study|Adverse Event|3|||
46932000|NCT03664960|83167359|FG000|Overall Study|Lost to Follow-up|3|||
47056424|NCT01748825|83332405|FG006|Dose Expansion|Adverse Event|0|||
46932001|NCT03664960|83167360|FG001|Overall Study|Lost to Follow-up|2|||
46932002|NCT03664960|83167359|FG000|Overall Study|Physician Decision|1|||
47056425|NCT01748825|83332406|FG007|Dose Expansion|Adverse Event|0|||
47056426|NCT01748825|83332407|FG008|Dose Expansion|Adverse Event|0|||
47056427|NCT01748825|83332408|FG009|Dose Expansion|Adverse Event|3|||
46636793|NCT01480284|82810626|FG001|Overall Study|Withdrawal by Subject|0|||
46636794|NCT01480284|82810625|FG000|Overall Study|Adverse Event|1|||
46636795|NCT01480284|82810626|FG001|Overall Study|Adverse Event|0|||
46636796|NCT01480284|82810625|FG000|Overall Study|Study closed/terminated|3|||
46636797|NCT01480284|82810626|FG001|Overall Study|Study closed/terminated|0|||
46636798|NCT01480284|82810625|FG000|Overall Study|Lost to Follow-up|1|||
46636799|NCT01480284|82810626|FG001|Overall Study|Lost to Follow-up|0|||
46636800|NCT01480284|82810625|FG000|Overall Study|Physician Decision|1|||
46636801|NCT01480284|82810626|FG001|Overall Study|Physician Decision|0|||
46636802|NCT01459614|82810634|FG000|Overall Study|Adverse Event|1|||
46636803|NCT01459614|82810635|FG001|Overall Study|Adverse Event|0|||
46636804|NCT01458522|82810643|FG000|Overall Study|Withdrawal by Subject|2|||
46636805|NCT01458522|82810644|FG001|Overall Study|Withdrawal by Subject|2|||
46636806|NCT01458522|82810643|FG000|Overall Study|Physician Decision|1|||
46636807|NCT01458522|82810644|FG001|Overall Study|Physician Decision|9|||
46636808|NCT01505010|82810658|FG000|Overall Study|Protocol Violation|0|||
46636809|NCT01505010|82810659|FG001|Overall Study|Protocol Violation|1|||
46636810|NCT01505010|82810658|FG000|Overall Study|Lost to Follow-up|0|||
46636811|NCT01505010|82810659|FG001|Overall Study|Lost to Follow-up|1|||
46636812|NCT01458210|82810665|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
46636813|NCT01458210|82810665|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
46636814|NCT01458210|82810665|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
46636815|NCT01458210|82810665|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
46636816|NCT01478958|82810675|FG000|Overall Study|Withdrawal by Subject|1|||
46636817|NCT01478958|82810676|FG001|Overall Study|Withdrawal by Subject|1|||
46636818|NCT01478958|82810677|FG002|Overall Study|Withdrawal by Subject|1|||
46636819|NCT01478958|82810675|FG000|Overall Study|Weight loss|1|||
46636820|NCT01478958|82810676|FG001|Overall Study|Weight loss|0|||
46636821|NCT01478958|82810677|FG002|Overall Study|Weight loss|0|||
46636822|NCT01478958|82810675|FG000|Overall Study|Re-located|0|||
46636823|NCT01478958|82810676|FG001|Overall Study|Re-located|1|||
46636824|NCT01478958|82810677|FG002|Overall Study|Re-located|0|||
46636825|NCT01478958|82810675|FG000|Overall Study|Unable to comply|0|||
46636826|NCT01478958|82810676|FG001|Overall Study|Unable to comply|0|||
46636827|NCT01478958|82810677|FG002|Overall Study|Unable to comply|2|||
46636828|NCT01458132|82810687|FG000|Overall Study|Other|15|||
46636829|NCT01458132|82810688|FG001|Overall Study|Other|3|||
46636830|NCT05220254|82810698|FG000|Overall Study|Withdrawal by Subject|4|||
47056428|NCT01748825|83332399|FG000|Dose Expansion|Physician Decision|0|||
47056429|NCT01748825|83332400|FG001|Dose Expansion|Physician Decision|0|||
47056430|NCT01748825|83332401|FG002|Dose Expansion|Physician Decision|0|||
46636831|NCT05220254|82810698|FG000|Overall Study|Removed due to ineligibility|1|||
46636832|NCT05220254|82810698|FG000|Overall Study|Lost to Follow-up|7|||
46636833|NCT05178121|82810702|FG000|Overall Study|Other|4|||
46636834|NCT05178121|82810702|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
46636835|NCT05110690|82810707|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
46636836|NCT05110690|82810707|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
46636837|NCT05110690|82810707|FG000|Completion of Intervention|Lost to Follow-up|1|||
46636838|NCT05110690|82810707|FG000|Completion of Intervention|Death|1|||
46636839|NCT05110690|82810707|FG000|Completion of Intervention|Withdrawal by Subject|2|||
46636840|NCT04842604|82810722|FG000|Overall Study|Death|1|||
46636841|NCT04842604|82810723|FG001|Overall Study|Death|0|||
46636842|NCT04842604|82810722|FG000|Overall Study|Other|4|||
46636843|NCT04842604|82810723|FG001|Overall Study|Other|4|||
47056431|NCT01748825|83332402|FG003|Dose Expansion|Physician Decision|0|||
47056432|NCT01748825|83332403|FG004|Dose Expansion|Physician Decision|0|||
46636844|NCT04842604|82810722|FG000|Overall Study|Randomized but not treated|1|||
47056433|NCT01748825|83332404|FG005|Dose Expansion|Physician Decision|0|||
46636845|NCT04842604|82810723|FG001|Overall Study|Randomized but not treated|0|||
46636846|NCT04508621|82810740|FG000|Overall Study|Adverse Event|39|||
46636847|NCT04508621|82810741|FG001|Overall Study|Adverse Event|16|||
46636848|NCT04508621|82810740|FG000|Overall Study|Lack of Efficacy|2|||
46636849|NCT04508621|82810741|FG001|Overall Study|Lack of Efficacy|8|||
46932003|NCT03664960|83167360|FG001|Overall Study|Physician Decision|0|||
46932004|NCT03664960|83167359|FG000|Overall Study|Withdrawal by Subject|3|||
47056434|NCT01748825|83332405|FG006|Dose Expansion|Physician Decision|0|||
47056435|NCT01748825|83332406|FG007|Dose Expansion|Physician Decision|0|||
47056436|NCT01748825|83332407|FG008|Dose Expansion|Physician Decision|1|||
46636850|NCT04508621|82810740|FG000|Overall Study|Physician Decision|0|||
46636851|NCT04508621|82810741|FG001|Overall Study|Physician Decision|1|||
46636852|NCT04508621|82810740|FG000|Overall Study|Withdrawal by Subject|10|||
46636853|NCT04508621|82810741|FG001|Overall Study|Withdrawal by Subject|14|||
46636854|NCT04508621|82810740|FG000|Overall Study|Lost to Follow-up|12|||
46636855|NCT04508621|82810741|FG001|Overall Study|Lost to Follow-up|9|||
46636856|NCT04508621|82810740|FG000|Overall Study|COVID-19 related crisis|3|||
46636857|NCT04508621|82810741|FG001|Overall Study|COVID-19 related crisis|0|||
46636858|NCT04508621|82810740|FG000|Overall Study|Subject non-compliance|1|||
46636859|NCT04508621|82810741|FG001|Overall Study|Subject non-compliance|0|||
46636860|NCT04107935|82810749|FG000|Overall Study|Death|1|||
46636861|NCT04107935|82810750|FG001|Overall Study|Death|0|||
46636862|NCT03923491|82810777|FG000|Overall Study|Lost to Follow-up|5|||
46636863|NCT03923491|82810778|FG001|Overall Study|Lost to Follow-up|8|||
46636864|NCT03923491|82810777|FG000|Overall Study|Withdrawal by Subject|4|||
46636865|NCT03923491|82810778|FG001|Overall Study|Withdrawal by Subject|6|||
46636866|NCT03923426|82810784|FG000|Overall Study|Other|19|||
46636867|NCT03923426|82810784|FG000|Overall Study|Lost to Follow-up|16|||
46636868|NCT03923426|82810784|FG000|Overall Study|Death|107|||
46636869|NCT03923426|82810784|FG000|Overall Study|Incomplete response to question|13|||
46636870|NCT03896152|82810790|FG000|Overall Study|Patient/guardian decision|1|||
46636871|NCT03896152|82810791|FG001|Overall Study|Patient/guardian decision|1|||
46636872|NCT03896152|82810790|FG000|Overall Study|Adverse Event|0|||
46636873|NCT03896152|82810791|FG001|Overall Study|Adverse Event|1|||
46636874|NCT03896152|82810790|FG000|Overall Study|Physician Decision|1|||
46636875|NCT03896152|82810791|FG001|Overall Study|Physician Decision|0|||
46636876|NCT03896152|82810790|FG000|Overall Study|Technical problems|1|||
46820331|NCT00483548|83039889|FG001|Overall Study|Protocol required discontinuation|6|||
46820332|NCT00483548|83039888|FG000|Overall Study|Unable to comply with protocol schedule|1|||
46820333|NCT00483548|83039889|FG001|Overall Study|Unable to comply with protocol schedule|0|||
46820334|NCT00483548|83039888|FG000|Overall Study|Non-compliance with medication|2|||
46820335|NCT00483548|83039889|FG001|Overall Study|Non-compliance with medication|0|||
46820336|NCT00483548|83039888|FG000|Overall Study|Lost to Follow-up|3|||
46820337|NCT00483548|83039889|FG001|Overall Study|Lost to Follow-up|4|||
46820338|NCT00483548|83039888|FG000|Overall Study|Withdrawal by Subject|5|||
46820339|NCT00483548|83039889|FG001|Overall Study|Withdrawal by Subject|2|||
46820340|NCT00445770|83039898|FG000|Overall Study|Adverse Event|9|||
46820341|NCT00445770|83039899|FG001|Overall Study|Adverse Event|15|||
46820342|NCT00445770|83039900|FG002|Overall Study|Adverse Event|19|||
46820343|NCT00445770|83039898|FG000|Overall Study|Lack of Efficacy|38|||
46820344|NCT00445770|83039899|FG001|Overall Study|Lack of Efficacy|13|||
46820345|NCT00445770|83039900|FG002|Overall Study|Lack of Efficacy|6|||
46820346|NCT00445770|83039898|FG000|Overall Study|Lost to Follow-up|0|||
46820347|NCT00445770|83039899|FG001|Overall Study|Lost to Follow-up|2|||
46820348|NCT00445770|83039900|FG002|Overall Study|Lost to Follow-up|0|||
46820349|NCT00445770|83039898|FG000|Overall Study|Other|6|||
46636877|NCT03896152|82810791|FG001|Overall Study|Technical problems|0|||
46636878|NCT03794583|82810836|FG000|Overall Study|Death|8|||
46636879|NCT03794583|82810836|FG000|Overall Study|Study Terminated by Sponsor|24|||
46636880|NCT03794583|82810836|FG000|Overall Study|Withdrawal by Subject|9|||
46636881|NCT03759366|82810840|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
46636882|NCT03759366|82810840|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
46759876|NCT00464269|82977982|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
46759877|NCT00464269|82977983|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
46759878|NCT00464269|82977984|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
46759879|NCT00464269|82977985|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
46759880|NCT00484315|82977999|FG000|12-Month Clinical Follow-up|Death|6|||
46759881|NCT00484315|82978000|FG001|12-Month Clinical Follow-up|Death|2|||
46759882|NCT00484315|82977999|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
46759883|NCT00484315|82978000|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
46759884|NCT00484315|82977999|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
46759885|NCT00484315|82978000|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
46759886|NCT00484315|82977999|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
46759887|NCT00484315|82978000|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
46759888|NCT00484315|82977999|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
46759889|NCT00484315|82978000|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
46759890|NCT00484315|82977999|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
46967692|NCT02121262|83210248|FG000|Overall Study|Protocol Violation|1|||
46820350|NCT00445770|83039899|FG001|Overall Study|Other|5|||
46636883|NCT03695237|82810855|FG000|Overall Study|Discontinued to Restart Puberty|1|||
46636884|NCT03695237|82810856|FG001|Overall Study|Discontinued to Restart Puberty|0|||
46636885|NCT03584373|82810865|FG000|Overall Study|Lost to Follow-up|7|||
46636886|NCT03584373|82810866|FG001|Overall Study|Lost to Follow-up|8|||
46820351|NCT00445770|83039900|FG002|Overall Study|Other|6|||
46820352|NCT00266032|83039913|FG000|Treatment|Adverse Event|42|||
46967693|NCT02121262|83210249|FG001|Overall Study|Protocol Violation|1|||
46967694|NCT02121262|83210248|FG000|Overall Study|Participant Dropped-out|0|||
46636887|NCT03386929|82810879|FG000|Overall Study|Death|0|||
46967695|NCT02121262|83210249|FG001|Overall Study|Participant Dropped-out|1|||
46967696|NCT02121262|83210248|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
46967697|NCT02121262|83210249|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
46820353|NCT00266032|83039914|FG001|Treatment|Adverse Event|26|||
46820354|NCT00266032|83039915|FG002|Treatment|Adverse Event|10|||
46820355|NCT00266032|83039913|FG000|Treatment|Lost to Follow-up|19|||
46820356|NCT00266032|83039914|FG001|Treatment|Lost to Follow-up|4|||
46636888|NCT03386929|82810880|FG001|Overall Study|Death|0|||
46636889|NCT03386929|82810881|FG002|Overall Study|Death|1|||
46636890|NCT03386929|82810879|FG000|Overall Study|Withdrawal by Subject|0|||
46636891|NCT03386929|82810880|FG001|Overall Study|Withdrawal by Subject|1|||
46636892|NCT03386929|82810881|FG002|Overall Study|Withdrawal by Subject|0|||
46636893|NCT03386929|82810879|FG000|Overall Study|Physician Decision|0|||
46636894|NCT03386929|82810880|FG001|Overall Study|Physician Decision|0|||
46636895|NCT03386929|82810881|FG002|Overall Study|Physician Decision|1|||
46636896|NCT03386929|82810879|FG000|Overall Study|Progression|4|||
46820357|NCT00266032|83039915|FG002|Treatment|Lost to Follow-up|2|||
46820358|NCT00266032|83039913|FG000|Treatment|Pregnancy|3|||
46636897|NCT03386929|82810880|FG001|Overall Study|Progression|4|||
46636898|NCT03386929|82810881|FG002|Overall Study|Progression|0|||
46759891|NCT00484315|82978000|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
46820359|NCT00266032|83039914|FG001|Treatment|Pregnancy|2|||
46820360|NCT00266032|83039915|FG002|Treatment|Pregnancy|2|||
46820361|NCT00266032|83039913|FG000|Treatment|Protocol Violation|6|||
46820362|NCT00266032|83039914|FG001|Treatment|Protocol Violation|14|||
46820363|NCT00266032|83039915|FG002|Treatment|Protocol Violation|13|||
46820364|NCT00266032|83039913|FG000|Treatment|Withdrawal by Subject|28|||
46820365|NCT00266032|83039914|FG001|Treatment|Withdrawal by Subject|13|||
46820366|NCT00266032|83039915|FG002|Treatment|Withdrawal by Subject|12|||
46820367|NCT00266032|83039913|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
46820368|NCT00266032|83039914|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
46820369|NCT00266032|83039915|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
46820370|NCT00266032|83039913|FG000|Open-label Safety Extension|Adverse Event|5|||
46820371|NCT00266032|83039914|FG001|Open-label Safety Extension|Adverse Event|0|||
46820372|NCT00266032|83039915|FG002|Open-label Safety Extension|Adverse Event|4|||
46820373|NCT00266032|83039913|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
46820374|NCT00266032|83039914|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
46820375|NCT00266032|83039915|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
46820376|NCT00266032|83039913|FG000|Open-label Safety Extension|Pregnancy|4|||
46820377|NCT00266032|83039914|FG001|Open-label Safety Extension|Pregnancy|1|||
46820378|NCT00266032|83039915|FG002|Open-label Safety Extension|Pregnancy|2|||
46967698|NCT02121262|83210248|FG000|Overall Study|Consent Withdrawn|1|||
46636899|NCT03386929|82810879|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
46759892|NCT00484315|82977999|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
46759893|NCT00484315|82978000|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
46759894|NCT00463801|82978006|FG000|Overall Study|Protocol Violation|1|||
46759895|NCT00463801|82978006|FG000|Overall Study|Lack of Efficacy|2|||
46759896|NCT00463801|82978006|FG000|Overall Study|Adverse Event|4|||
46759897|NCT00463801|82978006|FG000|Overall Study|Lost to Follow-up|5|||
46759898|NCT00463801|82978006|FG000|Overall Study|No longer require therapy|1|||
46759899|NCT00463567|82978017|FG000|Overall Study|Adverse Event|29|||
46759900|NCT00463567|82978018|FG001|Overall Study|Adverse Event|26|||
46759901|NCT00463567|82978019|FG002|Overall Study|Adverse Event|17|||
46759902|NCT00463567|82978020|FG003|Overall Study|Adverse Event|46|||
46759903|NCT00463567|82978021|FG004|Overall Study|Adverse Event|10|||
46759904|NCT00463567|82978022|FG005|Overall Study|Adverse Event|10|||
46759905|NCT00463567|82978023|FG006|Overall Study|Adverse Event|4|||
46759906|NCT00463567|82978017|FG000|Overall Study|Withdrawal by Subject|29|||
46759907|NCT00463567|82978018|FG001|Overall Study|Withdrawal by Subject|22|||
46759908|NCT00463567|82978019|FG002|Overall Study|Withdrawal by Subject|20|||
46759909|NCT00463567|82978020|FG003|Overall Study|Withdrawal by Subject|37|||
46759910|NCT00463567|82978021|FG004|Overall Study|Withdrawal by Subject|6|||
46759911|NCT00463567|82978022|FG005|Overall Study|Withdrawal by Subject|5|||
46759912|NCT00463567|82978023|FG006|Overall Study|Withdrawal by Subject|1|||
46759913|NCT00463567|82978017|FG000|Overall Study|Protocol Deviation|13|||
46759914|NCT00463567|82978018|FG001|Overall Study|Protocol Deviation|9|||
46759915|NCT00463567|82978019|FG002|Overall Study|Protocol Deviation|14|||
46759916|NCT00463567|82978020|FG003|Overall Study|Protocol Deviation|11|||
46759917|NCT00463567|82978021|FG004|Overall Study|Protocol Deviation|1|||
46759918|NCT00463567|82978022|FG005|Overall Study|Protocol Deviation|1|||
46759919|NCT00463567|82978023|FG006|Overall Study|Protocol Deviation|2|||
46759920|NCT00463567|82978017|FG000|Overall Study|Lost to Follow-up|12|||
46759921|NCT00463567|82978018|FG001|Overall Study|Lost to Follow-up|6|||
46759922|NCT00463567|82978019|FG002|Overall Study|Lost to Follow-up|13|||
46759923|NCT00463567|82978020|FG003|Overall Study|Lost to Follow-up|8|||
46759924|NCT00463567|82978021|FG004|Overall Study|Lost to Follow-up|1|||
46820379|NCT00266032|83039913|FG000|Open-label Safety Extension|Protocol Violation|1|||
46820380|NCT00266032|83039914|FG001|Open-label Safety Extension|Protocol Violation|3|||
46759925|NCT00463567|82978022|FG005|Overall Study|Lost to Follow-up|1|||
46759926|NCT00463567|82978023|FG006|Overall Study|Lost to Follow-up|1|||
46759927|NCT00463567|82978017|FG000|Overall Study|Administrative problems|5|||
46820381|NCT00266032|83039915|FG002|Open-label Safety Extension|Protocol Violation|2|||
46820382|NCT00266032|83039913|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
46820383|NCT00266032|83039914|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
46820384|NCT00266032|83039915|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
46820385|NCT00266032|83039913|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
46820386|NCT00266032|83039914|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
46820387|NCT00266032|83039915|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
46820388|NCT00483002|83039923|FG000|Overall Study|Adverse Event|68|||
46820389|NCT00483002|83039923|FG000|Overall Study|Lack of Efficacy|555|||
46820390|NCT00483002|83039923|FG000|Overall Study|Lost to Follow-up|962|||
46820391|NCT00483002|83039923|FG000|Overall Study|Other|2|||
46820392|NCT00483002|83039923|FG000|Overall Study|Other|967|||
46820393|NCT00482612|83039931|FG000|In-treatment Period|No study medication administered|0|||
46820394|NCT00482612|83039932|FG001|In-treatment Period|No study medication administered|0|||
46820395|NCT00482612|83039933|FG002|In-treatment Period|No study medication administered|1|||
46820396|NCT00482612|83039934|FG003|In-treatment Period|No study medication administered|0|||
46820397|NCT00482612|83039931|FG000|Follow-up Period|Other|4|||
46820398|NCT00482612|83039932|FG001|Follow-up Period|Other|2|||
46820399|NCT00482612|83039933|FG002|Follow-up Period|Other|1|||
46820400|NCT00482612|83039934|FG003|Follow-up Period|Other|2|||
46820401|NCT00482612|83039931|FG000|Follow-up Period|Lack of compliance|0|||
46820402|NCT00482612|83039932|FG001|Follow-up Period|Lack of compliance|0|||
46820403|NCT00482612|83039933|FG002|Follow-up Period|Lack of compliance|1|||
46820404|NCT00482612|83039934|FG003|Follow-up Period|Lack of compliance|0|||
46820405|NCT00482612|83039931|FG000|Follow-up Period|Lost to Follow-up|0|||
46820406|NCT00482612|83039932|FG001|Follow-up Period|Lost to Follow-up|4|||
46820407|NCT00482612|83039933|FG002|Follow-up Period|Lost to Follow-up|2|||
46820408|NCT00482612|83039934|FG003|Follow-up Period|Lost to Follow-up|1|||
46820409|NCT00482612|83039931|FG000|Follow-up Period|Adverse Event|4|||
46820410|NCT00482612|83039932|FG001|Follow-up Period|Adverse Event|7|||
46820411|NCT00482612|83039933|FG002|Follow-up Period|Adverse Event|9|||
46820412|NCT00482612|83039934|FG003|Follow-up Period|Adverse Event|0|||
46820413|NCT00482612|83039931|FG000|Follow-up Period|Lack of Efficacy|2|||
46820414|NCT00482612|83039932|FG001|Follow-up Period|Lack of Efficacy|0|||
46820415|NCT00482612|83039933|FG002|Follow-up Period|Lack of Efficacy|1|||
46820416|NCT00482612|83039934|FG003|Follow-up Period|Lack of Efficacy|0|||
46820417|NCT00482612|83039931|FG000|Follow-up Period|Withdrawal by Subject|3|||
46820418|NCT00482612|83039932|FG001|Follow-up Period|Withdrawal by Subject|5|||
46820419|NCT00482612|83039933|FG002|Follow-up Period|Withdrawal by Subject|7|||
46820420|NCT00482612|83039934|FG003|Follow-up Period|Withdrawal by Subject|2|||
46820421|NCT00482612|83039931|FG000|Follow-up Period|Reasons not related to trial|1|||
46820422|NCT00482612|83039932|FG001|Follow-up Period|Reasons not related to trial|0|||
46820423|NCT00482612|83039933|FG002|Follow-up Period|Reasons not related to trial|1|||
46820424|NCT00482612|83039934|FG003|Follow-up Period|Reasons not related to trial|3|||
46820425|NCT00282568|83039948|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
46820426|NCT00282568|83039948|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
46820427|NCT00282568|83039948|FG000|Extended Treatment Period|Adverse Event|17|||
46820428|NCT00282568|83039948|FG000|Extended Treatment Period|Non-compliance|4|||
46820429|NCT00282568|83039948|FG000|Extended Treatment Period|Physician Decision|1|||
46820430|NCT00282568|83039948|FG000|Extended Treatment Period|Lost to Follow-up|2|||
46820431|NCT00265564|83039954|FG000|Overall Study|Lost to Follow-up|5|||
46820432|NCT00265564|83039955|FG001|Overall Study|Lost to Follow-up|7|||
46820433|NCT00265564|83039954|FG000|Overall Study|met exclusion criteria|5|||
46759928|NCT00463567|82978018|FG001|Overall Study|Administrative problems|3|||
46759929|NCT00463567|82978019|FG002|Overall Study|Administrative problems|6|||
46759930|NCT00463567|82978020|FG003|Overall Study|Administrative problems|9|||
46759931|NCT00463567|82978021|FG004|Overall Study|Administrative problems|3|||
46759932|NCT00463567|82978022|FG005|Overall Study|Administrative problems|2|||
46759933|NCT00463567|82978023|FG006|Overall Study|Administrative problems|2|||
46759934|NCT00463567|82978017|FG000|Overall Study|Lack of Efficacy|4|||
46759935|NCT00463567|82978018|FG001|Overall Study|Lack of Efficacy|9|||
46820434|NCT00265564|83039955|FG001|Overall Study|met exclusion criteria|2|||
46820435|NCT00376623|83039964|FG000|Overall Study|Progressive disease|35|||
46759936|NCT00463567|82978019|FG002|Overall Study|Lack of Efficacy|9|||
46759937|NCT00463567|82978020|FG003|Overall Study|Lack of Efficacy|17|||
46820436|NCT00376623|83039965|FG001|Overall Study|Progressive disease|22|||
46820437|NCT00376623|83039966|FG002|Overall Study|Progressive disease|17|||
46820438|NCT00376623|83039964|FG000|Overall Study|Lost to Follow-up|0|||
46820439|NCT00376623|83039965|FG001|Overall Study|Lost to Follow-up|1|||
46820440|NCT00376623|83039966|FG002|Overall Study|Lost to Follow-up|0|||
46820441|NCT00376623|83039964|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
46820442|NCT00376623|83039965|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
46967699|NCT02121262|83210249|FG001|Overall Study|Consent Withdrawn|0|||
46759938|NCT00463567|82978021|FG004|Overall Study|Lack of Efficacy|1|||
46759939|NCT00463567|82978022|FG005|Overall Study|Lack of Efficacy|0|||
46820443|NCT00376623|83039966|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
46820444|NCT00376623|83039964|FG000|Overall Study|Not treated with BI 2536|1|||
46820445|NCT00376623|83039965|FG001|Overall Study|Not treated with BI 2536|0|||
46820446|NCT00376623|83039966|FG002|Overall Study|Not treated with BI 2536|0|||
46820447|NCT00376623|83039964|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
46820448|NCT00376623|83039965|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
46820449|NCT00376623|83039966|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
46820450|NCT00376623|83039964|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
46820451|NCT00376623|83039965|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
46820452|NCT00376623|83039966|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
46820453|NCT00376623|83039964|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
46820454|NCT00376623|83039965|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
46820455|NCT00376623|83039966|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
46820456|NCT00376623|83039964|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
46820457|NCT00376623|83039965|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
46820458|NCT00376623|83039966|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
46820459|NCT00376623|83039964|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
46820460|NCT00376623|83039965|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
46820461|NCT00376623|83039966|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
46820462|NCT00376623|83039964|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
46820463|NCT00376623|83039965|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
46820464|NCT00376623|83039966|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
46820465|NCT00376623|83039964|FG000|Overall Study|Increase of tumour markers|0|||
46820466|NCT00376623|83039965|FG001|Overall Study|Increase of tumour markers|1|||
46820467|NCT00376623|83039966|FG002|Overall Study|Increase of tumour markers|0|||
46820468|NCT00376623|83039964|FG000|Overall Study|Bone metastasis|1|||
46820469|NCT00376623|83039965|FG001|Overall Study|Bone metastasis|0|||
46820470|NCT00376623|83039966|FG002|Overall Study|Bone metastasis|0|||
46820471|NCT00445692|83039980|FG000|Overall Study|Adverse Event|11|||
46820472|NCT00445692|83039980|FG000|Overall Study|Lack of Efficacy|5|||
46820473|NCT03824236|83039989|FG000|Overall Study|Lost to Follow-up|0|||
46820474|NCT03824236|83039990|FG001|Overall Study|Lost to Follow-up|0|||
46820475|NCT03824236|83039991|FG002|Overall Study|Lost to Follow-up|1|||
46820476|NCT00282412|83039999|FG000|Overall Study|Death|2|||
46820477|NCT00282334|83040005|FG000|Overall Study|Withdrawal by Subject|8|||
46820478|NCT00282334|83040006|FG001|Overall Study|Withdrawal by Subject|5|||
46820479|NCT00282256|83040012|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
46820480|NCT00282256|83040012|FG000|Extension Treatment Period|Adverse Event|2|||
46820481|NCT00265330|83040016|FG000|Overall Study|Adverse Event|41|||
46820482|NCT00265330|83040016|FG000|Overall Study|Lost to Follow-up|8|||
46820483|NCT00265330|83040016|FG000|Overall Study|Withdrawal by Subject|34|||
46820484|NCT00265330|83040016|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
46820485|NCT00265330|83040016|FG000|Overall Study|Lack of Efficacy|4|||
46820486|NCT00265330|83040016|FG000|Overall Study|Family Scheduling Conflicts|1|||
46820487|NCT00265330|83040016|FG000|Overall Study|Began Taking Formulary Geodon|1|||
46820488|NCT00265330|83040016|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
46820489|NCT00265330|83040016|FG000|Overall Study|Site Closed by Sponsor|1|||
46820490|NCT00265330|83040016|FG000|Overall Study|Principal Investigators Request|1|||
46820491|NCT00265330|83040016|FG000|Overall Study|Withdrew Consent|1|||
46820492|NCT00265330|83040016|FG000|Overall Study|Protocol Violation|1|||
46820493|NCT00292318|83040022|FG000|Overall Study|Study terminated by officials|2|||
46820494|NCT00292318|83040023|FG001|Overall Study|Study terminated by officials|1|||
46820495|NCT00281632|83040029|FG000|Overall Study|Adverse Event|7|||
46820496|NCT00281632|83040029|FG000|Overall Study|Withdrawal by Subject|2|||
46820497|NCT00281632|83040029|FG000|Overall Study|Disease Progression|22|||
46820498|NCT00281632|83040029|FG000|Overall Study|Death|1|||
46820499|NCT00281632|83040029|FG000|Overall Study|Physician Decision|1|||
46820500|NCT00281632|83040029|FG000|Overall Study|Ongoing|3|||
46967700|NCT02120950|83210257|FG000|Overall Study|Adverse Event|5|||
46820501|NCT00543569|83040045|FG000|Overall Study|Death|2|||
46820502|NCT00543569|83040046|FG001|Overall Study|Death|2|||
46820503|NCT00543569|83040047|FG002|Overall Study|Death|3|||
46967701|NCT02120950|83210258|FG001|Overall Study|Adverse Event|4|||
46967702|NCT02120950|83210259|FG002|Overall Study|Adverse Event|3|||
46967703|NCT02120950|83210257|FG000|Overall Study|Death|3|||
46967704|NCT02120950|83210258|FG001|Overall Study|Death|0|||
46967705|NCT02120950|83210259|FG002|Overall Study|Death|1|||
46967706|NCT02120950|83210257|FG000|Overall Study|Withdrawal by Subject|6|||
46967707|NCT02120950|83210258|FG001|Overall Study|Withdrawal by Subject|3|||
46932005|NCT03664960|83167360|FG001|Overall Study|Withdrawal by Subject|14|||
46820504|NCT00543569|83040048|FG003|Overall Study|Death|1|||
46820505|NCT00543569|83040045|FG000|Overall Study|Lost to Follow-up|0|||
46820506|NCT00543569|83040046|FG001|Overall Study|Lost to Follow-up|0|||
46820507|NCT00543569|83040047|FG002|Overall Study|Lost to Follow-up|1|||
46820508|NCT00543569|83040048|FG003|Overall Study|Lost to Follow-up|1|||
46820509|NCT00543569|83040045|FG000|Overall Study|Miscellaneous Reasons|7|||
46820510|NCT00543569|83040046|FG001|Overall Study|Miscellaneous Reasons|3|||
46820511|NCT00543569|83040047|FG002|Overall Study|Miscellaneous Reasons|11|||
46820512|NCT00543569|83040048|FG003|Overall Study|Miscellaneous Reasons|4|||
46820513|NCT00543569|83040045|FG000|Overall Study|Randomized but never received study drug|3|||
46820514|NCT00543569|83040046|FG001|Overall Study|Randomized but never received study drug|3|||
46820515|NCT00543569|83040047|FG002|Overall Study|Randomized but never received study drug|5|||
46820516|NCT00543569|83040048|FG003|Overall Study|Randomized but never received study drug|3|||
46820517|NCT00445458|83040062|FG000|Overall Study|Disease Progression|3|||
46820518|NCT00445458|83040063|FG001|Overall Study|Disease Progression|4|||
46820519|NCT00445458|83040064|FG002|Overall Study|Disease Progression|54|||
46820520|NCT00445458|83040065|FG003|Overall Study|Disease Progression|27|||
46820521|NCT00445458|83040062|FG000|Overall Study|Withdrawal by Subject|0|||
46820522|NCT00445458|83040063|FG001|Overall Study|Withdrawal by Subject|0|||
46820523|NCT00445458|83040064|FG002|Overall Study|Withdrawal by Subject|7|||
46820524|NCT00445458|83040065|FG003|Overall Study|Withdrawal by Subject|0|||
46820525|NCT00445458|83040062|FG000|Overall Study|Adverse Event|0|||
46820526|NCT00445458|83040063|FG001|Overall Study|Adverse Event|0|||
46932006|NCT03664960|83167359|FG000|Overall Study|Sponsor Decision|1|||
46932007|NCT03664960|83167360|FG001|Overall Study|Sponsor Decision|1|||
46932008|NCT03664960|83167359|FG000|Overall Study|Other|1|||
46636900|NCT03386929|82810880|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
46636901|NCT03386929|82810881|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
46820527|NCT00445458|83040064|FG002|Overall Study|Adverse Event|3|||
46820528|NCT00445458|83040065|FG003|Overall Study|Adverse Event|0|||
46820529|NCT00445458|83040062|FG000|Overall Study|Death|0|||
46820530|NCT00445458|83040063|FG001|Overall Study|Death|1|||
46820531|NCT00445458|83040064|FG002|Overall Study|Death|2|||
46820532|NCT00445458|83040065|FG003|Overall Study|Death|0|||
46820533|NCT00445458|83040062|FG000|Overall Study|Physician Decision|0|||
46820534|NCT00445458|83040063|FG001|Overall Study|Physician Decision|0|||
46820535|NCT00445458|83040064|FG002|Overall Study|Physician Decision|1|||
46820536|NCT00445458|83040065|FG003|Overall Study|Physician Decision|1|||
46820537|NCT00445458|83040062|FG000|Overall Study|Surgery|0|||
46820538|NCT00445458|83040063|FG001|Overall Study|Surgery|0|||
46820539|NCT00445458|83040064|FG002|Overall Study|Surgery|1|||
46820540|NCT00445458|83040065|FG003|Overall Study|Surgery|0|||
46820541|NCT03914417|83040078|FG000|Overall Study|Withdrawal by Subject|2|||
46820542|NCT00541385|83040084|FG000|Overall Study|Adverse Event|6|||
46820543|NCT00541385|83040085|FG001|Overall Study|Adverse Event|3|||
46820544|NCT00541385|83040084|FG000|Overall Study|Withdrawal by Subject|2|||
46820545|NCT00541385|83040085|FG001|Overall Study|Withdrawal by Subject|2|||
46820546|NCT00541385|83040084|FG000|Overall Study|Lost to Follow-up|6|||
46820547|NCT00541385|83040085|FG001|Overall Study|Lost to Follow-up|1|||
46820548|NCT00541385|83040084|FG000|Overall Study|Parasite reappearance/malaria|67|||
46820549|NCT00541385|83040085|FG001|Overall Study|Parasite reappearance/malaria|32|||
46820550|NCT00265096|83040094|FG000|Overall Study|Adverse Event|14|||
46820551|NCT00265096|83040095|FG001|Overall Study|Adverse Event|18|||
46820552|NCT00265096|83040096|FG002|Overall Study|Adverse Event|18|||
46820553|NCT00265096|83040094|FG000|Overall Study|Lost to Follow-up|2|||
46820554|NCT00265096|83040095|FG001|Overall Study|Lost to Follow-up|5|||
46636902|NCT03386929|82810879|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
46759940|NCT00463567|82978023|FG006|Overall Study|Lack of Efficacy|1|||
46759941|NCT00463567|82978017|FG000|Overall Study|Abnormal lab value(s)|1|||
46820555|NCT00265096|83040096|FG002|Overall Study|Lost to Follow-up|3|||
46820556|NCT00265096|83040094|FG000|Overall Study|Death|0|||
47056437|NCT01748825|83332408|FG009|Dose Expansion|Physician Decision|0|||
47056438|NCT01720667|83332470|FG000|Overall Study|Adverse Event|1|||
46820557|NCT00265096|83040095|FG001|Overall Study|Death|1|||
46820558|NCT00265096|83040096|FG002|Overall Study|Death|2|||
46932009|NCT03664960|83167360|FG001|Overall Study|Other|2|||
47056439|NCT01720667|83332471|FG001|Overall Study|Adverse Event|1|||
46759942|NCT00463567|82978018|FG001|Overall Study|Abnormal lab value(s)|1|||
46759943|NCT00463567|82978019|FG002|Overall Study|Abnormal lab value(s)|2|||
46759944|NCT00463567|82978020|FG003|Overall Study|Abnormal lab value(s)|1|||
46759945|NCT00463567|82978021|FG004|Overall Study|Abnormal lab value(s)|1|||
46759946|NCT00463567|82978022|FG005|Overall Study|Abnormal lab value(s)|0|||
46759947|NCT00463567|82978023|FG006|Overall Study|Abnormal lab value(s)|0|||
46759948|NCT00463567|82978017|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46820559|NCT00265096|83040094|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
46820560|NCT00265096|83040095|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
46932010|NCT03652051|83167382|FG000|Stage 1|Adverse Event|0|||
46820561|NCT00265096|83040096|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
46820562|NCT00265096|83040094|FG000|Overall Study|Other|11|||
46820563|NCT00265096|83040095|FG001|Overall Study|Other|19|||
46820564|NCT00265096|83040096|FG002|Overall Study|Other|10|||
46820565|NCT00281320|83040108|FG000|Overall Study|Adverse Event|12|||
46820566|NCT00281320|83040109|FG001|Overall Study|Adverse Event|9|||
46820567|NCT00281320|83040108|FG000|Overall Study|Lack of Efficacy|4|||
46820568|NCT00281320|83040109|FG001|Overall Study|Lack of Efficacy|3|||
46820569|NCT00281320|83040108|FG000|Overall Study|Withdrawal by Subject|5|||
46820570|NCT00281320|83040109|FG001|Overall Study|Withdrawal by Subject|6|||
47056440|NCT01720667|83332470|FG000|Overall Study|Withdrawal by Subject|3|||
47056441|NCT01720667|83332471|FG001|Overall Study|Withdrawal by Subject|0|||
47056442|NCT01720043|83332479|FG000|Overall Study|Withdrawal by Subject|1|||
47056443|NCT00700752|83332483|FG000|First Intervention|Withdrawal by Subject|0|||
47056444|NCT00700752|83332484|FG001|First Intervention|Withdrawal by Subject|2|||
47056445|NCT01747811|83332501|FG000|Overall Study|Lack of Efficacy|2|||
47056446|NCT01747811|83332502|FG001|Overall Study|Lack of Efficacy|4|||
47056447|NCT01747655|83332510|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
47056448|NCT01747655|83332511|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
47056449|NCT01747655|83332510|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
47056450|NCT01747655|83332511|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
47056451|NCT01747655|83332510|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
47056452|NCT01747655|83332511|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
46759949|NCT00463567|82978018|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46759950|NCT00463567|82978019|FG002|Overall Study|Abnormal test procedure result(s)|6|||
47056453|NCT01718483|83332519|FG000|Overall Study|Withdrawal by Subject|14|||
47056454|NCT01718483|83332520|FG001|Overall Study|Withdrawal by Subject|12|||
47056455|NCT01718483|83332519|FG000|Overall Study|Adverse Event|5|||
47056456|NCT01718483|83332520|FG001|Overall Study|Adverse Event|12|||
47056457|NCT01718483|83332519|FG000|Overall Study|Lost to Follow-up|8|||
47056458|NCT01718483|83332520|FG001|Overall Study|Lost to Follow-up|3|||
46759951|NCT00463567|82978020|FG003|Overall Study|Abnormal test procedure result(s)|2|||
46759952|NCT00463567|82978021|FG004|Overall Study|Abnormal test procedure result(s)|0|||
46759953|NCT00463567|82978022|FG005|Overall Study|Abnormal test procedure result(s)|2|||
46759954|NCT00463567|82978023|FG006|Overall Study|Abnormal test procedure result(s)|0|||
46759955|NCT00463567|82978017|FG000|Overall Study|Death|1|||
46759956|NCT00463567|82978018|FG001|Overall Study|Death|0|||
46759957|NCT00463567|82978019|FG002|Overall Study|Death|2|||
46759958|NCT00463567|82978020|FG003|Overall Study|Death|0|||
46759959|NCT00463567|82978021|FG004|Overall Study|Death|0|||
46759960|NCT00463567|82978022|FG005|Overall Study|Death|0|||
46759961|NCT00463567|82978023|FG006|Overall Study|Death|0|||
46759962|NCT00484159|82978048|FG000|Overall Study|Lost to Follow-up|1|||
46759963|NCT00484159|82978049|FG001|Overall Study|Lost to Follow-up|1|||
46759964|NCT00484159|82978050|FG002|Overall Study|Lost to Follow-up|0|||
46759965|NCT00462865|82978058|FG000|Overall Study|Adverse Event|1|||
46759966|NCT03839641|82978064|FG000|Overall Study|Withdrawal by Subject|1|||
46759967|NCT03839641|82978065|FG001|Overall Study|Withdrawal by Subject|1|||
46759968|NCT00462709|82978073|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
46759969|NCT00462709|82978073|FG000|Overall Study|Lost to Follow-up|10|||
46759970|NCT00462709|82978073|FG000|Overall Study|Withdrawal by Subject|8|||
46759971|NCT00462709|82978073|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
46759972|NCT00462709|82978073|FG000|Overall Study|Death|2|||
46759973|NCT00462709|82978073|FG000|Overall Study|Logistical reasons|2|||
46759974|NCT00462709|82978073|FG000|Overall Study|Physician Decision|1|||
46759975|NCT00462709|82978073|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
46759976|NCT00461305|82978079|FG000|Treatment|Adverse Event|26|||
46759977|NCT00461305|82978080|FG001|Treatment|Adverse Event|3|||
46759978|NCT00461305|82978079|FG000|Treatment|Lost to Follow-up|4|||
46759979|NCT00461305|82978080|FG001|Treatment|Lost to Follow-up|2|||
46759980|NCT00461305|82978079|FG000|Treatment|Protocol Violation|13|||
46759981|NCT00461305|82978080|FG001|Treatment|Protocol Violation|2|||
46759982|NCT00461305|82978079|FG000|Treatment|Withdrawal by Subject|48|||
46759983|NCT00461305|82978080|FG001|Treatment|Withdrawal by Subject|2|||
46759984|NCT00461305|82978079|FG000|Treatment|Never dispensed|5|||
46820571|NCT00281320|83040108|FG000|Overall Study|Lost to Follow-up|1|||
46820572|NCT00281320|83040109|FG001|Overall Study|Lost to Follow-up|2|||
47056459|NCT01718483|83332519|FG000|Overall Study|Protocol Violation|4|||
47056460|NCT01718483|83332520|FG001|Overall Study|Protocol Violation|2|||
47056461|NCT01718483|83332519|FG000|Overall Study|Other|1|||
46759985|NCT00461305|82978080|FG001|Treatment|Never dispensed|0|||
46759986|NCT00461305|82978079|FG000|Treatment|Study drug not taken|1|||
46759987|NCT00461305|82978080|FG001|Treatment|Study drug not taken|0|||
46759988|NCT00461305|82978079|FG000|Treatment|Partially missing diary|2|||
46759989|NCT00461305|82978080|FG001|Treatment|Partially missing diary|0|||
46820573|NCT00281320|83040108|FG000|Overall Study|Other|3|||
46820574|NCT00281320|83040109|FG001|Overall Study|Other|1|||
46820575|NCT00541307|83040121|FG000|Overall Study|Death|5|||
46820576|NCT00541307|83040121|FG000|Overall Study|Physician Decision|3|||
46820577|NCT00541307|83040121|FG000|Overall Study|Withdrawal by Subject|6|||
46820578|NCT00541307|83040121|FG000|Overall Study|Lost to Follow-up|4|||
46820579|NCT00541307|83040121|FG000|Overall Study|Subject returned early (outside window)|1|||
46820580|NCT00541307|83040121|FG000|Overall Study|Surgical Bypass|5|||
46820581|NCT00541229|83040131|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
47056462|NCT01718483|83332520|FG001|Overall Study|Other|4|||
47056463|NCT01718483|83332519|FG000|Overall Study|Pregnancy|1|||
46820582|NCT00541229|83040132|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
46820583|NCT00541229|83040133|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
46820584|NCT00541229|83040134|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
46820585|NCT00541229|83040135|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
46820586|NCT00541229|83040136|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
46820587|NCT00541229|83040131|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
46820588|NCT00541229|83040132|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
46820589|NCT00541229|83040133|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
46820590|NCT00541229|83040134|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
46820591|NCT00541229|83040135|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
46820592|NCT00541229|83040136|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
46820593|NCT00541229|83040131|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
46820594|NCT00541229|83040132|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
46820595|NCT00541229|83040133|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
46820596|NCT00541229|83040134|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
46820597|NCT00541229|83040135|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
46820598|NCT00541229|83040136|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
46820599|NCT00541229|83040131|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
46820600|NCT00541229|83040132|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
46820601|NCT00541229|83040133|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
46820602|NCT00541229|83040134|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
46820603|NCT00541229|83040135|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
46820604|NCT00541229|83040136|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
46820605|NCT00541229|83040131|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
46820606|NCT00541229|83040132|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
46820607|NCT00541229|83040133|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
46820608|NCT00541229|83040134|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
46820609|NCT00541229|83040135|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
46820610|NCT00541229|83040136|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
46820611|NCT00541229|83040131|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
46820612|NCT00541229|83040132|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
46820613|NCT00541229|83040133|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
46820614|NCT00541229|83040134|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
46820615|NCT00541229|83040135|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
46820616|NCT00541229|83040136|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
46820617|NCT00541229|83040131|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
46820618|NCT00541229|83040132|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
46820619|NCT00541229|83040133|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
46820620|NCT00541229|83040134|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
46820621|NCT00541229|83040135|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
46820622|NCT00541229|83040136|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
46820623|NCT00541229|83040131|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
46820624|NCT00541229|83040132|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
46820625|NCT00541229|83040133|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
46820626|NCT00541229|83040134|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
46820627|NCT00541229|83040135|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
46820628|NCT00541229|83040136|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
46820629|NCT00541229|83040131|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
46820630|NCT00541229|83040132|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
46820631|NCT00541229|83040133|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
46820632|NCT00541229|83040134|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
46932011|NCT03652051|83167383|FG001|Stage 1|Adverse Event|5|||
47056464|NCT01718483|83332520|FG001|Overall Study|Pregnancy|1|||
47056465|NCT01718483|83332519|FG000|Overall Study|Lack of Efficacy|1|||
47056466|NCT01718483|83332520|FG001|Overall Study|Lack of Efficacy|0|||
47056467|NCT01717859|83332526|FG000|Overall Study|Adverse Event|5|||
46820633|NCT00541229|83040135|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
46820634|NCT00541229|83040136|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
46820635|NCT00541229|83040131|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
46820636|NCT00541229|83040132|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
46820637|NCT00541229|83040133|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
46820638|NCT00541229|83040134|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
46932012|NCT03652051|83167384|FG002|Stage 1|Adverse Event|7|||
46932013|NCT03652051|83167385|FG003|Stage 1|Adverse Event|1|||
46932014|NCT03652051|83167382|FG000|Stage 1|Withdrawal by Subject|0|||
46932015|NCT03652051|83167383|FG001|Stage 1|Withdrawal by Subject|0|||
46932016|NCT03652051|83167384|FG002|Stage 1|Withdrawal by Subject|1|||
46932017|NCT03652051|83167385|FG003|Stage 1|Withdrawal by Subject|0|||
46932018|NCT03652051|83167382|FG000|Stage 2|Adverse Event|0|||
46932019|NCT03652051|83167383|FG001|Stage 2|Adverse Event|2|||
46932020|NCT03652051|83167384|FG002|Stage 2|Adverse Event|1|||
46932021|NCT03652051|83167385|FG003|Stage 2|Adverse Event|0|||
46932022|NCT03652051|83167382|FG000|Stage 2|Protocol Violation|0|||
46932023|NCT03652051|83167383|FG001|Stage 2|Protocol Violation|1|||
46932024|NCT03652051|83167384|FG002|Stage 2|Protocol Violation|6|||
46932025|NCT03652051|83167385|FG003|Stage 2|Protocol Violation|0|||
46932026|NCT03652051|83167382|FG000|Stage 2|Lost to Follow-up|0|||
46932027|NCT03652051|83167383|FG001|Stage 2|Lost to Follow-up|2|||
46932028|NCT03652051|83167384|FG002|Stage 2|Lost to Follow-up|0|||
46932029|NCT03652051|83167385|FG003|Stage 2|Lost to Follow-up|3|||
46932030|NCT03652051|83167382|FG000|Stage 2|Withdrawal by Subject|0|||
46932031|NCT03652051|83167383|FG001|Stage 2|Withdrawal by Subject|11|||
46932032|NCT03652051|83167384|FG002|Stage 2|Withdrawal by Subject|9|||
46932033|NCT03652051|83167385|FG003|Stage 2|Withdrawal by Subject|3|||
46932034|NCT03610737|83167403|FG000|Overall Study|Withdrawal by Subject|1|||
46932035|NCT03610737|83167404|FG001|Overall Study|Withdrawal by Subject|5|||
46932036|NCT03610737|83167403|FG000|Overall Study|Death|1|||
46932037|NCT03610737|83167404|FG001|Overall Study|Death|0|||
46932038|NCT03610737|83167403|FG000|Overall Study|Not treated|5|||
46932039|NCT03610737|83167404|FG001|Overall Study|Not treated|2|||
46932040|NCT03610737|83167403|FG000|Overall Study|Missed Visit|1|||
46932041|NCT03610737|83167404|FG001|Overall Study|Missed Visit|2|||
46932042|NCT03554018|83167412|FG000|Overall Study|Lost to Follow-up|3|||
46932043|NCT03554018|83167413|FG001|Overall Study|Lost to Follow-up|7|||
46932044|NCT03520036|83167422|FG000|Overall Study|Adverse Event|1|||
46932045|NCT03520036|83167423|FG001|Overall Study|Adverse Event|2|||
46932046|NCT03520036|83167424|FG002|Overall Study|Adverse Event|0|||
46932047|NCT03520036|83167422|FG000|Overall Study|Protocol Violation|1|||
46932048|NCT03520036|83167423|FG001|Overall Study|Protocol Violation|0|||
46932049|NCT03520036|83167424|FG002|Overall Study|Protocol Violation|0|||
46932050|NCT03520036|83167422|FG000|Overall Study|Withdrawal by Subject|0|||
46932051|NCT03520036|83167423|FG001|Overall Study|Withdrawal by Subject|1|||
46932052|NCT03520036|83167424|FG002|Overall Study|Withdrawal by Subject|4|||
46932053|NCT03520036|83167422|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
46932054|NCT03520036|83167423|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
46932055|NCT03520036|83167424|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
46932056|NCT03396822|83167460|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
46932057|NCT03396822|83167460|FG000|Overall Study|Physician Decision|1|||
46932058|NCT03382639|83167468|FG000|Overall Study|Adverse Event|2|||
46932059|NCT03382639|83167469|FG001|Overall Study|Adverse Event|0|||
46932060|NCT03382639|83167470|FG002|Overall Study|Adverse Event|1|||
46932061|NCT03382639|83167471|FG003|Overall Study|Adverse Event|1|||
46932062|NCT03382639|83167468|FG000|Overall Study|Lost to Follow-up|1|||
46932063|NCT03382639|83167469|FG001|Overall Study|Lost to Follow-up|0|||
46932064|NCT03382639|83167470|FG002|Overall Study|Lost to Follow-up|0|||
46932065|NCT03382639|83167471|FG003|Overall Study|Lost to Follow-up|0|||
46932066|NCT03382639|83167468|FG000|Overall Study|Withdrawal by Subject|4|||
46932067|NCT03382639|83167469|FG001|Overall Study|Withdrawal by Subject|3|||
46932068|NCT03382639|83167470|FG002|Overall Study|Withdrawal by Subject|2|||
46932069|NCT03382639|83167471|FG003|Overall Study|Withdrawal by Subject|3|||
46932070|NCT03382639|83167468|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
46932071|NCT03382639|83167469|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
46932072|NCT03382639|83167470|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
46636903|NCT03386929|82810880|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
46759990|NCT00461305|82978079|FG000|Treatment|Other (missing drug etc)|2|||
46932073|NCT03382639|83167471|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
46932074|NCT03382639|83167468|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
46932075|NCT03382639|83167469|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
46932076|NCT03382639|83167470|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
46932077|NCT03382639|83167471|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
46932078|NCT03382639|83167468|FG000|Overall Study|Other|2|||
46932079|NCT03382639|83167469|FG001|Overall Study|Other|0|||
46932080|NCT03382639|83167470|FG002|Overall Study|Other|0|||
46932081|NCT03382639|83167471|FG003|Overall Study|Other|3|||
46932082|NCT03359785|83167488|FG000|Overall Study|Protocol Violation|0|||
46932083|NCT03359785|83167489|FG001|Overall Study|Protocol Violation|1|||
46932084|NCT03359785|83167490|FG002|Overall Study|Protocol Violation|0|||
46932085|NCT03359785|83167491|FG003|Overall Study|Protocol Violation|0|||
46932086|NCT03359785|83167488|FG000|Overall Study|Early study termination due to study pause|0|||
46932087|NCT03359785|83167489|FG001|Overall Study|Early study termination due to study pause|0|||
46932088|NCT03359785|83167490|FG002|Overall Study|Early study termination due to study pause|2|||
46932089|NCT03359785|83167491|FG003|Overall Study|Early study termination due to study pause|0|||
46932090|NCT03359785|83167488|FG000|Overall Study|Withdrawal by Subject|2|||
46932091|NCT03359785|83167489|FG001|Overall Study|Withdrawal by Subject|2|||
46932092|NCT03359785|83167490|FG002|Overall Study|Withdrawal by Subject|0|||
46932093|NCT03359785|83167491|FG003|Overall Study|Withdrawal by Subject|0|||
46932094|NCT03343535|83167501|FG000|Overall Study|Lost to Follow-up|1|||
46932095|NCT03343535|83167501|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
46932096|NCT03343535|83167501|FG000|Overall Study|Death|12|||
46932097|NCT03343301|83167507|FG000|Overall Study|Withdrawal by Subject|1|||
46932098|NCT03343301|83167508|FG001|Overall Study|Withdrawal by Subject|1|||
46932099|NCT03343301|83167507|FG000|Overall Study|Death|0|||
46932100|NCT03343301|83167508|FG001|Overall Study|Death|2|||
46932101|NCT03343301|83167507|FG000|Overall Study|Other|0|||
46932102|NCT03343301|83167508|FG001|Overall Study|Other|6|||
46932103|NCT03343301|83167507|FG000|Overall Study|Missing|2|||
46932104|NCT03343301|83167508|FG001|Overall Study|Missing|0|||
46932105|NCT02823652|83167546|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
46932106|NCT02823652|83167547|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
46932107|NCT02823652|83167548|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
46932108|NCT02823652|83167546|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
46932109|NCT02823652|83167547|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
46932110|NCT02823652|83167548|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
46932111|NCT02823652|83167546|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
46932112|NCT02823652|83167547|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
46932113|NCT02823652|83167548|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
46932114|NCT02823652|83167546|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
46932115|NCT02823652|83167547|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
46932116|NCT02823652|83167548|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
46932117|NCT02656823|83167567|FG000|Overall Study|Adverse Event|3|||
46932118|NCT02656823|83167567|FG000|Overall Study|Lost to Follow-up|2|||
46932119|NCT02652949|83167571|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
46932120|NCT02652949|83167571|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
46932121|NCT02652949|83167571|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
46932122|NCT02652949|83167571|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
46932123|NCT02652949|83167571|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
46932124|NCT02652949|83167571|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
46932125|NCT02652949|83167571|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
46932126|NCT02652949|83167571|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
46932127|NCT02652949|83167571|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
46932128|NCT02652949|83167571|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
46932129|NCT02652949|83167571|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
46932130|NCT02652949|83167571|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
46932131|NCT02652949|83167571|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
46932132|NCT02652949|83167571|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
46932133|NCT02652949|83167571|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
46932134|NCT02652949|83167571|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
46932135|NCT02652949|83167571|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
46932136|NCT02625324|83167583|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
46932137|NCT02625324|83167583|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
46932138|NCT02625324|83167583|FG000|6-Month Follow-up Subject Accountability|Death|5|||
46932139|NCT02625324|83167583|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
46932140|NCT02625324|83167583|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
46932141|NCT02625324|83167583|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
46932142|NCT02625324|83167583|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
46932143|NCT02625324|83167583|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
46932144|NCT02625324|83167583|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
46932145|NCT02625324|83167583|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
46932146|NCT02625324|83167583|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
46759991|NCT00461305|82978080|FG001|Treatment|Other (missing drug etc)|0|||
46759992|NCT00461305|82978079|FG000|Continued Treatment|Adverse Event|26|||
46759993|NCT00461305|82978080|FG001|Continued Treatment|Adverse Event|0|||
46932147|NCT02625324|83167583|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
46932148|NCT02625324|83167583|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
46932149|NCT02625324|83167583|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
46932150|NCT02625324|83167583|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
46932151|NCT02625324|83167583|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
46759994|NCT00461305|82978079|FG000|Continued Treatment|Lost to Follow-up|4|||
46759995|NCT00461305|82978080|FG001|Continued Treatment|Lost to Follow-up|0|||
46932152|NCT02625324|83167583|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
46932153|NCT02567227|83167598|FG000|9 Weeks|Adverse Event|5|||
46932154|NCT02567227|83167599|FG001|9 Weeks|Adverse Event|5|||
46932155|NCT02567227|83167598|FG000|9 Weeks|Withdrawal by Subject|18|||
46932156|NCT02567227|83167599|FG001|9 Weeks|Withdrawal by Subject|8|||
46932157|NCT02567227|83167598|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
46932158|NCT02567227|83167599|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
46932159|NCT02567227|83167598|FG000|6 Month|Death|2|||
46932160|NCT02567227|83167599|FG001|6 Month|Death|0|||
46932161|NCT02567227|83167598|FG000|6 Month|Lost to Follow-up|43|||
46932162|NCT02567227|83167599|FG001|6 Month|Lost to Follow-up|40|||
46932163|NCT02567227|83167598|FG000|12 Months|Lost to Follow-up|31|||
46932164|NCT02567227|83167599|FG001|12 Months|Lost to Follow-up|32|||
46932165|NCT02567227|83167598|FG000|12 Months|Death|0|||
46932166|NCT02567227|83167599|FG001|12 Months|Death|2|||
46932167|NCT02362464|83167618|FG000|Overall Study|Switched to alternative therapy|1|||
46932168|NCT02362464|83167618|FG000|Overall Study|Refused further treatment|1|||
46932169|NCT02362464|83167618|FG000|Overall Study|Physician Decision|4|||
46932170|NCT02326974|83167622|FG000|Overall Study|Withdrawal by Subject|2|||
46932171|NCT02326974|83167622|FG000|Overall Study|failed heterogenity evaluation|5|||
46932172|NCT02281084|83167634|FG000|Overall Study|Adverse Event|1|||
46932173|NCT02281084|83167635|FG001|Overall Study|Adverse Event|0|||
46932174|NCT02281084|83167636|FG002|Overall Study|Adverse Event|0|||
46932175|NCT02281084|83167637|FG003|Overall Study|Adverse Event|0|||
46932176|NCT02281084|83167634|FG000|Overall Study|Withdrawal by Subject|1|||
46932177|NCT02281084|83167635|FG001|Overall Study|Withdrawal by Subject|2|||
46932178|NCT02281084|83167636|FG002|Overall Study|Withdrawal by Subject|0|||
46932179|NCT02281084|83167637|FG003|Overall Study|Withdrawal by Subject|0|||
46932180|NCT02281084|83167634|FG000|Overall Study|Death|20|||
46932181|NCT02281084|83167635|FG001|Overall Study|Death|16|||
46932182|NCT02281084|83167636|FG002|Overall Study|Death|3|||
46932183|NCT02281084|83167637|FG003|Overall Study|Death|5|||
46932184|NCT02281084|83167634|FG000|Overall Study|Physician Decision|0|||
46932185|NCT02281084|83167635|FG001|Overall Study|Physician Decision|0|||
46932186|NCT02281084|83167636|FG002|Overall Study|Physician Decision|1|||
46932187|NCT02281084|83167637|FG003|Overall Study|Physician Decision|0|||
46932188|NCT02126579|83167654|FG000|Overall Study|disease progression|0|||
46932189|NCT02126579|83167655|FG001|Overall Study|disease progression|0|||
46932190|NCT02126579|83167656|FG002|Overall Study|disease progression|0|||
46932191|NCT02126579|83167657|FG003|Overall Study|disease progression|1|||
46932192|NCT02126579|83167658|FG004|Overall Study|disease progression|0|||
46932193|NCT02126579|83167659|FG005|Overall Study|disease progression|0|||
46932194|NCT02126579|83167660|FG006|Overall Study|disease progression|1|||
46932195|NCT01886872|83167698|FG000|Overall Study|Ineligible|7|||
46932196|NCT01886872|83167699|FG001|Overall Study|Ineligible|4|||
46932197|NCT01886872|83167700|FG002|Overall Study|Ineligible|12|||
46932198|NCT01854775|83167721|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
46932199|NCT01854775|83167722|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
46932200|NCT01854775|83167723|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
46932201|NCT01854775|83167721|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
46932202|NCT01854775|83167722|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
46932203|NCT01854775|83167723|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
46932204|NCT01854775|83167721|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
46932205|NCT01854775|83167722|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
46932206|NCT01854775|83167723|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
46932207|NCT01854775|83167721|FG000|Extension Phase|Pregnancy|3|||
46932208|NCT01854775|83167722|FG001|Extension Phase|Pregnancy|0|||
46932209|NCT01854775|83167723|FG002|Extension Phase|Pregnancy|0|||
47056468|NCT01717859|83332526|FG000|Overall Study|Moved out of state|1|||
47056469|NCT01717859|83332526|FG000|Overall Study|Patient concerned about mental health|1|||
47056470|NCT01717859|83332526|FG000|Overall Study|Lost to Follow-up|1|||
46932210|NCT01854775|83167721|FG000|Extension Phase|Investigator's Discretion|1|||
46932211|NCT01854775|83167722|FG001|Extension Phase|Investigator's Discretion|0|||
46932212|NCT01854775|83167723|FG002|Extension Phase|Investigator's Discretion|0|||
46932213|NCT01854775|83167721|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
46932214|NCT01854775|83167722|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
46759996|NCT00461305|82978079|FG000|Continued Treatment|Protocol Violation|13|||
46759997|NCT00461305|82978080|FG001|Continued Treatment|Protocol Violation|0|||
46932215|NCT01854775|83167723|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
46932216|NCT01854775|83167721|FG000|Extension Phase|Lost to Follow-up|2|||
46932217|NCT01854775|83167722|FG001|Extension Phase|Lost to Follow-up|0|||
46932218|NCT01854775|83167723|FG002|Extension Phase|Lost to Follow-up|0|||
46932219|NCT01854775|83167721|FG000|Extension Phase|Still on Study|32|||
46932220|NCT01854775|83167722|FG001|Extension Phase|Still on Study|47|||
46932221|NCT01854775|83167723|FG002|Extension Phase|Still on Study|18|||
46932222|NCT01764633|83167733|FG000|Overall Study|Withdrawal by Subject|105|||
46932223|NCT01764633|83167734|FG001|Overall Study|Withdrawal by Subject|88|||
46932224|NCT01764633|83167733|FG000|Overall Study|Lost to Follow-up|13|||
46932225|NCT01764633|83167734|FG001|Overall Study|Lost to Follow-up|5|||
46932226|NCT01116648|83167802|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
46932227|NCT01116648|83167803|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
46932228|NCT01116648|83167804|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
46932229|NCT01116648|83167805|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
46932230|NCT01116648|83167806|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
46932231|NCT01116648|83167807|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
46932232|NCT01116648|83167808|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
46932233|NCT01116648|83167809|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
46932234|NCT01116648|83167810|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
46932235|NCT01116648|83167811|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
46932236|NCT01116648|83167812|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
46932237|NCT01116648|83167813|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
46932238|NCT01116648|83167814|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
46932239|NCT01116648|83167815|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
46932240|NCT01116648|83167816|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
46932241|NCT01001910|83167841|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
46932242|NCT00609154|83167858|FG000|Overall Study|Protocol Violation|1|||
46932243|NCT00609154|83167859|FG001|Overall Study|Protocol Violation|2|||
46932244|NCT00609154|83167858|FG000|Overall Study|Unable to establish IV access|0|||
46932245|NCT00609154|83167859|FG001|Overall Study|Unable to establish IV access|4|||
46932246|NCT00609154|83167858|FG000|Overall Study|Adverse Event|0|||
46932247|NCT00609154|83167859|FG001|Overall Study|Adverse Event|2|||
46932248|NCT00304070|83167868|FG000|Overall Study|Death|0|||
46932249|NCT00304070|83167869|FG001|Overall Study|Death|0|||
46932250|NCT00304070|83167870|FG002|Overall Study|Death|3|||
46932251|NCT00304070|83167868|FG000|Overall Study|Lost to Follow-up|0|||
46932252|NCT00304070|83167869|FG001|Overall Study|Lost to Follow-up|0|||
46932253|NCT00304070|83167870|FG002|Overall Study|Lost to Follow-up|1|||
46932254|NCT00304070|83167868|FG000|Overall Study|Physician Decision|0|||
46932255|NCT00304070|83167869|FG001|Overall Study|Physician Decision|0|||
46932256|NCT00304070|83167870|FG002|Overall Study|Physician Decision|3|||
46932257|NCT00304070|83167868|FG000|Overall Study|Withdrawal by Subject|0|||
46932258|NCT00304070|83167869|FG001|Overall Study|Withdrawal by Subject|0|||
46932259|NCT00304070|83167870|FG002|Overall Study|Withdrawal by Subject|1|||
46932260|NCT00304070|83167868|FG000|Overall Study|Progressive Disease|3|||
46932261|NCT00304070|83167869|FG001|Overall Study|Progressive Disease|7|||
46932262|NCT00304070|83167870|FG002|Overall Study|Progressive Disease|4|||
46932263|NCT00150462|83167893|FG000|Overall Study|Disease Progression or Relapse|3|||
46932264|NCT00150462|83167894|FG001|Overall Study|Disease Progression or Relapse|1|||
46932265|NCT00150462|83167895|FG002|Overall Study|Disease Progression or Relapse|2|||
46932266|NCT00150462|83167896|FG003|Overall Study|Disease Progression or Relapse|1|||
46932267|NCT00150462|83167897|FG004|Overall Study|Disease Progression or Relapse|2|||
46932268|NCT00150462|83167898|FG005|Overall Study|Disease Progression or Relapse|2|||
46932269|NCT00150462|83167899|FG006|Overall Study|Disease Progression or Relapse|3|||
46932270|NCT00150462|83167900|FG007|Overall Study|Disease Progression or Relapse|5|||
46932271|NCT00150462|83167901|FG008|Overall Study|Disease Progression or Relapse|5|||
46932272|NCT00150462|83167902|FG009|Overall Study|Disease Progression or Relapse|3|||
46932273|NCT00150462|83167903|FG010|Overall Study|Disease Progression or Relapse|2|||
46932274|NCT00150462|83167893|FG000|Overall Study|Withdrawal by Subject|0|||
46932275|NCT00150462|83167894|FG001|Overall Study|Withdrawal by Subject|1|||
46932276|NCT00150462|83167895|FG002|Overall Study|Withdrawal by Subject|1|||
46932277|NCT00150462|83167896|FG003|Overall Study|Withdrawal by Subject|0|||
46932278|NCT00150462|83167897|FG004|Overall Study|Withdrawal by Subject|1|||
46932279|NCT00150462|83167898|FG005|Overall Study|Withdrawal by Subject|2|||
46932280|NCT00150462|83167899|FG006|Overall Study|Withdrawal by Subject|0|||
46932281|NCT00150462|83167900|FG007|Overall Study|Withdrawal by Subject|1|||
47056471|NCT01717859|83332526|FG000|Overall Study|Withdrawal by Subject|2|||
47056472|NCT01747499|83332810|FG000|Overall Study|Steroid refractory aGvHD|1|||
47056473|NCT01747499|83332811|FG001|Overall Study|Steroid refractory aGvHD|0|||
46932282|NCT00150462|83167901|FG008|Overall Study|Withdrawal by Subject|0|||
46932283|NCT00150462|83167902|FG009|Overall Study|Withdrawal by Subject|1|||
47056474|NCT01747499|83332812|FG002|Overall Study|Steroid refractory aGvHD|0|||
47056475|NCT01747499|83332813|FG003|Overall Study|Steroid refractory aGvHD|1|||
46932284|NCT00150462|83167903|FG010|Overall Study|Withdrawal by Subject|0|||
46932285|NCT00150462|83167893|FG000|Overall Study|Death|0|||
46932286|NCT00150462|83167894|FG001|Overall Study|Death|1|||
46932287|NCT00150462|83167895|FG002|Overall Study|Death|0|||
46932288|NCT00150462|83167896|FG003|Overall Study|Death|0|||
47056476|NCT01747499|83332814|FG004|Overall Study|Steroid refractory aGvHD|4|||
47056477|NCT01747499|83332810|FG000|Overall Study|Physician Decision|0|||
46932289|NCT00150462|83167897|FG004|Overall Study|Death|0|||
46932290|NCT00150462|83167898|FG005|Overall Study|Death|0|||
46932291|NCT00150462|83167899|FG006|Overall Study|Death|0|||
46932292|NCT00150462|83167900|FG007|Overall Study|Death|0|||
46932293|NCT00150462|83167901|FG008|Overall Study|Death|1|||
46932294|NCT00150462|83167902|FG009|Overall Study|Death|0|||
46932295|NCT00150462|83167903|FG010|Overall Study|Death|0|||
46932296|NCT00150462|83167893|FG000|Overall Study|Adverse Event|0|||
46932297|NCT00150462|83167894|FG001|Overall Study|Adverse Event|0|||
46932298|NCT00150462|83167895|FG002|Overall Study|Adverse Event|0|||
46932299|NCT00150462|83167896|FG003|Overall Study|Adverse Event|1|||
46932300|NCT00150462|83167897|FG004|Overall Study|Adverse Event|0|||
46932301|NCT00150462|83167898|FG005|Overall Study|Adverse Event|0|||
46932302|NCT00150462|83167899|FG006|Overall Study|Adverse Event|0|||
46932303|NCT00150462|83167900|FG007|Overall Study|Adverse Event|2|||
46932304|NCT00150462|83167901|FG008|Overall Study|Adverse Event|0|||
46932305|NCT00150462|83167902|FG009|Overall Study|Adverse Event|1|||
46932306|NCT00150462|83167903|FG010|Overall Study|Adverse Event|0|||
46932307|NCT00150462|83167893|FG000|Overall Study|Physician Decision|0|||
46932308|NCT00150462|83167894|FG001|Overall Study|Physician Decision|0|||
46932309|NCT00150462|83167895|FG002|Overall Study|Physician Decision|1|||
46932310|NCT00150462|83167896|FG003|Overall Study|Physician Decision|1|||
46932311|NCT00150462|83167897|FG004|Overall Study|Physician Decision|0|||
46932312|NCT00150462|83167898|FG005|Overall Study|Physician Decision|0|||
46932313|NCT00150462|83167899|FG006|Overall Study|Physician Decision|0|||
46932314|NCT00150462|83167900|FG007|Overall Study|Physician Decision|0|||
46932315|NCT00150462|83167901|FG008|Overall Study|Physician Decision|0|||
46932316|NCT00150462|83167902|FG009|Overall Study|Physician Decision|0|||
46932317|NCT00150462|83167903|FG010|Overall Study|Physician Decision|0|||
46932318|NCT00150462|83167893|FG000|Overall Study|Other|0|||
46932319|NCT00150462|83167894|FG001|Overall Study|Other|0|||
46932320|NCT00150462|83167895|FG002|Overall Study|Other|0|||
46932321|NCT00150462|83167896|FG003|Overall Study|Other|0|||
46932322|NCT00150462|83167897|FG004|Overall Study|Other|0|||
46932323|NCT00150462|83167898|FG005|Overall Study|Other|0|||
46932324|NCT00150462|83167899|FG006|Overall Study|Other|0|||
46932325|NCT00150462|83167900|FG007|Overall Study|Other|0|||
46932326|NCT00150462|83167901|FG008|Overall Study|Other|0|||
46932327|NCT00150462|83167902|FG009|Overall Study|Other|1|||
46932328|NCT00150462|83167903|FG010|Overall Study|Other|1|||
46932329|NCT01368081|83167943|FG000|Overall Study|Adverse Event|4|||
46932330|NCT01368081|83167944|FG001|Overall Study|Adverse Event|4|||
46932331|NCT01368081|83167945|FG002|Overall Study|Adverse Event|3|||
46820639|NCT00541229|83040135|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
46820640|NCT00541229|83040136|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
46820641|NCT00541229|83040131|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
46820642|NCT00541229|83040132|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
46820643|NCT00541229|83040133|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
46820644|NCT00541229|83040134|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
46932332|NCT01368081|83167946|FG003|Overall Study|Adverse Event|2|||
46932333|NCT01368081|83167947|FG004|Overall Study|Adverse Event|2|||
47056478|NCT01747499|83332811|FG001|Overall Study|Physician Decision|1|||
47056479|NCT01747499|83332812|FG002|Overall Study|Physician Decision|0|||
47056480|NCT01747499|83332813|FG003|Overall Study|Physician Decision|0|||
47056481|NCT01747499|83332814|FG004|Overall Study|Physician Decision|2|||
46820645|NCT00541229|83040135|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
46820646|NCT00541229|83040136|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
46820647|NCT00541229|83040131|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
46820648|NCT00541229|83040132|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
46820649|NCT00541229|83040133|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
46820650|NCT00541229|83040134|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
46820651|NCT00541229|83040135|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
46820652|NCT00541229|83040136|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
46820653|NCT00541229|83040131|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
46820654|NCT00541229|83040132|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
46820655|NCT00541229|83040133|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
46932334|NCT01368081|83167948|FG005|Overall Study|Adverse Event|5|||
46932335|NCT01368081|83167949|FG006|Overall Study|Adverse Event|6|||
46932336|NCT01368081|83167950|FG007|Overall Study|Adverse Event|2|||
46932337|NCT01368081|83167951|FG008|Overall Study|Adverse Event|3|||
46932338|NCT01368081|83167952|FG009|Overall Study|Adverse Event|5|||
47056482|NCT01747499|83332810|FG000|Overall Study|Death|0|||
47056483|NCT01747499|83332811|FG001|Overall Study|Death|0|||
47056484|NCT01747499|83332812|FG002|Overall Study|Death|0|||
46932339|NCT01368081|83167953|FG010|Overall Study|Adverse Event|6|||
46932340|NCT01368081|83167954|FG011|Overall Study|Adverse Event|1|||
46932341|NCT01368081|83167955|FG012|Overall Study|Adverse Event|3|||
46932342|NCT01368081|83167943|FG000|Overall Study|Lack of Efficacy|0|||
46932343|NCT01368081|83167944|FG001|Overall Study|Lack of Efficacy|1|||
46932344|NCT01368081|83167945|FG002|Overall Study|Lack of Efficacy|0|||
46932345|NCT01368081|83167946|FG003|Overall Study|Lack of Efficacy|1|||
46932346|NCT01368081|83167947|FG004|Overall Study|Lack of Efficacy|0|||
47056485|NCT01747499|83332813|FG003|Overall Study|Death|1|||
47056486|NCT01747499|83332814|FG004|Overall Study|Death|1|||
46759998|NCT00461305|82978079|FG000|Continued Treatment|Withdrawal by Subject|48|||
46759999|NCT00461305|82978080|FG001|Continued Treatment|Withdrawal by Subject|0|||
46760000|NCT00461305|82978079|FG000|Continued Treatment|Partially missing diary|2|||
46760001|NCT00461305|82978080|FG001|Continued Treatment|Partially missing diary|0|||
46760002|NCT00461305|82978079|FG000|Continued Treatment|Other (missing drug etc)|2|||
46760003|NCT00461305|82978080|FG001|Continued Treatment|Other (missing drug etc)|0|||
46932347|NCT01368081|83167948|FG005|Overall Study|Lack of Efficacy|0|||
46932348|NCT01368081|83167949|FG006|Overall Study|Lack of Efficacy|0|||
46932349|NCT01368081|83167950|FG007|Overall Study|Lack of Efficacy|2|||
46932350|NCT01368081|83167951|FG008|Overall Study|Lack of Efficacy|0|||
46932351|NCT01368081|83167952|FG009|Overall Study|Lack of Efficacy|0|||
47056487|NCT01747499|83332810|FG000|Overall Study|Withdrawal by Subject|0|||
47056488|NCT01747499|83332811|FG001|Overall Study|Withdrawal by Subject|0|||
47056489|NCT01747499|83332812|FG002|Overall Study|Withdrawal by Subject|0|||
47056490|NCT01747499|83332813|FG003|Overall Study|Withdrawal by Subject|0|||
47056491|NCT01747499|83332814|FG004|Overall Study|Withdrawal by Subject|6|||
47056492|NCT01747499|83332810|FG000|Overall Study|Developed AML and death|0|||
47056493|NCT01747499|83332811|FG001|Overall Study|Developed AML and death|0|||
47056494|NCT01747499|83332812|FG002|Overall Study|Developed AML and death|0|||
47056495|NCT01747499|83332813|FG003|Overall Study|Developed AML and death|0|||
47056496|NCT01747499|83332814|FG004|Overall Study|Developed AML and death|1|||
47056497|NCT01747499|83332810|FG000|Overall Study|Determined not to be eligible|0|||
47056498|NCT01747499|83332811|FG001|Overall Study|Determined not to be eligible|0|||
46760004|NCT00856544|82978091|FG000|Overall Study|Randomized but not treated|3|||
46932352|NCT01368081|83167953|FG010|Overall Study|Lack of Efficacy|0|||
47056499|NCT01747499|83332812|FG002|Overall Study|Determined not to be eligible|0|||
46932353|NCT01368081|83167954|FG011|Overall Study|Lack of Efficacy|0|||
46932354|NCT01368081|83167955|FG012|Overall Study|Lack of Efficacy|0|||
46932355|NCT01368081|83167943|FG000|Overall Study|Protocol Violation|0|||
46932356|NCT01368081|83167944|FG001|Overall Study|Protocol Violation|0|||
46932357|NCT01368081|83167945|FG002|Overall Study|Protocol Violation|0|||
46932358|NCT01368081|83167946|FG003|Overall Study|Protocol Violation|0|||
46932359|NCT01368081|83167947|FG004|Overall Study|Protocol Violation|0|||
46932360|NCT01368081|83167948|FG005|Overall Study|Protocol Violation|1|||
46932361|NCT01368081|83167949|FG006|Overall Study|Protocol Violation|0|||
46932362|NCT01368081|83167950|FG007|Overall Study|Protocol Violation|1|||
46932363|NCT01368081|83167951|FG008|Overall Study|Protocol Violation|0|||
46932364|NCT01368081|83167952|FG009|Overall Study|Protocol Violation|0|||
46932365|NCT01368081|83167953|FG010|Overall Study|Protocol Violation|0|||
46932366|NCT01368081|83167954|FG011|Overall Study|Protocol Violation|0|||
46932367|NCT01368081|83167955|FG012|Overall Study|Protocol Violation|0|||
46932368|NCT01368081|83167943|FG000|Overall Study|Lost to Follow-up|0|||
47056500|NCT01747499|83332813|FG003|Overall Study|Determined not to be eligible|0|||
46820656|NCT00541229|83040134|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
46820657|NCT00541229|83040135|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
46820658|NCT00541229|83040136|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
46820659|NCT00541229|83040131|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
46820660|NCT00541229|83040132|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
46820661|NCT00541229|83040133|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
46820662|NCT00541229|83040134|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
46820663|NCT00541229|83040135|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
46820664|NCT00541229|83040136|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
46820665|NCT00541229|83040131|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
47056501|NCT01747499|83332814|FG004|Overall Study|Determined not to be eligible|1|||
46820666|NCT00541229|83040132|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
46820667|NCT00541229|83040133|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
46820668|NCT00541229|83040134|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
46820669|NCT00541229|83040135|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
46820670|NCT00541229|83040136|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
46820671|NCT00541229|83040131|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
46820672|NCT00541229|83040132|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
46820673|NCT00541229|83040133|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
46820674|NCT00541229|83040134|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
46820675|NCT00541229|83040135|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
46820676|NCT00541229|83040136|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
46820677|NCT00481988|83040146|FG000|Overall Study|Withdrawal by Subject|1|||
46820678|NCT00481988|83040147|FG001|Overall Study|Withdrawal by Subject|1|||
46820679|NCT00481832|83040164|FG000|Enrollment|Physician Decision|8|||
46820680|NCT00481832|83040164|FG000|Enrollment|Unable to collect enough stem cells|2|||
46820681|NCT00481832|83040164|FG000|Inter-transplant Period|Adverse Event|4|||
46820682|NCT00481832|83040164|FG000|Inter-transplant Period|Death|3|||
46820683|NCT00481832|83040164|FG000|Inter-transplant Period|Physician Decision|4|||
46820684|NCT00481832|83040164|FG000|Inter-transplant Period|Disease relapse|11|||
46820685|NCT00481832|83040164|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
46820686|NCT00481676|83040170|FG000|Overall Study|Adverse Event|0|||
46820687|NCT00481676|83040171|FG001|Overall Study|Adverse Event|1|||
46820688|NCT00481676|83040170|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46820689|NCT00481676|83040171|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
46820690|NCT00481676|83040170|FG000|Overall Study|Administrative problem|1|||
47056502|NCT01717391|83332846|FG000|Overall Study|Withdrawal by Subject|5|||
47056503|NCT01717391|83332846|FG000|Overall Study|Physician Decision|1|||
47056504|NCT01717391|83332846|FG000|Overall Study|FLT technical failure|3|||
47056505|NCT01746017|83332989|FG000|Period 1|Withdrawal by Subject|0|||
47056506|NCT01746017|83332990|FG001|Period 1|Withdrawal by Subject|0|||
47056507|NCT01746017|83332991|FG002|Period 1|Withdrawal by Subject|0|||
47056508|NCT01746017|83332992|FG003|Period 1|Withdrawal by Subject|0|||
47056509|NCT01746017|83332993|FG004|Period 1|Withdrawal by Subject|0|||
47056510|NCT01746017|83332994|FG005|Period 1|Withdrawal by Subject|0|||
47056511|NCT01746017|83332995|FG006|Period 1|Withdrawal by Subject|1|||
47056512|NCT01746017|83332996|FG007|Period 1|Withdrawal by Subject|0|||
47056513|NCT01746017|83332997|FG008|Period 1|Withdrawal by Subject|0|||
46932369|NCT01368081|83167944|FG001|Overall Study|Lost to Follow-up|0|||
46932370|NCT01368081|83167945|FG002|Overall Study|Lost to Follow-up|0|||
46932371|NCT01368081|83167946|FG003|Overall Study|Lost to Follow-up|0|||
46932372|NCT01368081|83167947|FG004|Overall Study|Lost to Follow-up|0|||
46932373|NCT01368081|83167948|FG005|Overall Study|Lost to Follow-up|0|||
47056514|NCT01746017|83332998|FG009|Period 1|Withdrawal by Subject|0|||
47056515|NCT01746017|83332999|FG010|Period 1|Withdrawal by Subject|0|||
47056516|NCT01746017|83332989|FG000|Period 3|Withdrawal by Subject|0|||
46932374|NCT01368081|83167949|FG006|Overall Study|Lost to Follow-up|0|||
46932375|NCT01368081|83167950|FG007|Overall Study|Lost to Follow-up|0|||
46932376|NCT01368081|83167951|FG008|Overall Study|Lost to Follow-up|0|||
46932377|NCT01368081|83167952|FG009|Overall Study|Lost to Follow-up|0|||
46932378|NCT01368081|83167953|FG010|Overall Study|Lost to Follow-up|0|||
46932379|NCT01368081|83167954|FG011|Overall Study|Lost to Follow-up|0|||
46932380|NCT01368081|83167955|FG012|Overall Study|Lost to Follow-up|1|||
46932381|NCT01368081|83167943|FG000|Overall Study|Withdrawal by Subject|4|||
46932382|NCT01368081|83167944|FG001|Overall Study|Withdrawal by Subject|4|||
46932383|NCT01368081|83167945|FG002|Overall Study|Withdrawal by Subject|1|||
46932384|NCT01368081|83167946|FG003|Overall Study|Withdrawal by Subject|1|||
46932385|NCT01368081|83167947|FG004|Overall Study|Withdrawal by Subject|0|||
46932386|NCT01368081|83167948|FG005|Overall Study|Withdrawal by Subject|3|||
46932387|NCT01368081|83167949|FG006|Overall Study|Withdrawal by Subject|4|||
46932388|NCT01368081|83167950|FG007|Overall Study|Withdrawal by Subject|2|||
46932389|NCT01368081|83167951|FG008|Overall Study|Withdrawal by Subject|5|||
46932390|NCT01368081|83167952|FG009|Overall Study|Withdrawal by Subject|4|||
46932391|NCT01368081|83167953|FG010|Overall Study|Withdrawal by Subject|3|||
46932392|NCT01368081|83167954|FG011|Overall Study|Withdrawal by Subject|2|||
46932393|NCT01368081|83167955|FG012|Overall Study|Withdrawal by Subject|0|||
46932394|NCT01368081|83167943|FG000|Overall Study|Other reason not defined above|2|||
46932395|NCT01368081|83167944|FG001|Overall Study|Other reason not defined above|0|||
46932396|NCT01368081|83167945|FG002|Overall Study|Other reason not defined above|0|||
46932397|NCT01368081|83167946|FG003|Overall Study|Other reason not defined above|1|||
46932398|NCT01368081|83167947|FG004|Overall Study|Other reason not defined above|0|||
46932399|NCT01368081|83167948|FG005|Overall Study|Other reason not defined above|1|||
46932400|NCT01368081|83167949|FG006|Overall Study|Other reason not defined above|2|||
46932401|NCT01368081|83167950|FG007|Overall Study|Other reason not defined above|0|||
46932402|NCT01368081|83167951|FG008|Overall Study|Other reason not defined above|0|||
46932403|NCT01368081|83167952|FG009|Overall Study|Other reason not defined above|1|||
46932404|NCT01368081|83167953|FG010|Overall Study|Other reason not defined above|0|||
46932405|NCT01368081|83167954|FG011|Overall Study|Other reason not defined above|0|||
46932406|NCT01368081|83167955|FG012|Overall Study|Other reason not defined above|3|||
46932407|NCT00303498|83167985|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
46932408|NCT00303498|83167986|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
46932409|NCT00303498|83167985|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
46932410|NCT00303498|83167986|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
46932411|NCT00303498|83167985|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
46932412|NCT00303498|83167986|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
46932413|NCT00303498|83167985|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
46932414|NCT00303498|83167986|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
46932415|NCT00303498|83167985|FG000|Run-In-Phase (10 Weeks)|Other|4|||
46932416|NCT00303498|83167986|FG001|Run-In-Phase (10 Weeks)|Other|1|||
46932417|NCT00303498|83167985|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
46932418|NCT00303498|83167986|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
46932419|NCT00303498|83167985|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
46932420|NCT00303498|83167986|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
46932421|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
46932422|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
46932423|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Death|1|||
46932424|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Death|0|||
46932425|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
46932426|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
46932427|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
46932428|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
46760005|NCT00856544|82978092|FG001|Overall Study|Randomized but not treated|0|||
46760006|NCT00856544|82978093|FG002|Overall Study|Randomized but not treated|0|||
46760007|NCT00856544|82978094|FG003|Overall Study|Randomized but not treated|0|||
46760008|NCT00856544|82978091|FG000|Overall Study|Death|0|||
46760009|NCT00856544|82978092|FG001|Overall Study|Death|2|||
46760010|NCT00856544|82978093|FG002|Overall Study|Death|0|||
46760011|NCT00856544|82978094|FG003|Overall Study|Death|0|||
46932429|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
46932430|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
46932431|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
46932432|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
46932433|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Other|1|||
46932434|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Other|0|||
46932435|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
46967708|NCT02120950|83210259|FG002|Overall Study|Withdrawal by Subject|2|||
46967709|NCT02120950|83210257|FG000|Overall Study|Protocol Violation|1|||
46760012|NCT00856544|82978091|FG000|Overall Study|Adverse Event|20|||
46760013|NCT00856544|82978092|FG001|Overall Study|Adverse Event|29|||
46820691|NCT00481676|83040171|FG001|Overall Study|Administrative problem|0|||
46820692|NCT00542789|83040179|FG000|Overall Study|Adverse Event|18|||
46820693|NCT00542789|83040180|FG001|Overall Study|Adverse Event|17|||
46820694|NCT00542789|83040179|FG000|Overall Study|Withdrawal by Subject|7|||
46820695|NCT00542789|83040180|FG001|Overall Study|Withdrawal by Subject|3|||
46820696|NCT00542789|83040179|FG000|Overall Study|Protocol Violation|8|||
46820697|NCT00542789|83040180|FG001|Overall Study|Protocol Violation|1|||
46820698|NCT00542789|83040179|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
46820699|NCT00542789|83040180|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
46820700|NCT00464672|83040188|FG000|Overall Study|withdrawal of consent|0|||
46820701|NCT00464672|83040189|FG001|Overall Study|withdrawal of consent|0|||
46820702|NCT00464672|83040190|FG002|Overall Study|withdrawal of consent|0|||
46820703|NCT00464672|83040191|FG003|Overall Study|withdrawal of consent|1|||
46820704|NCT00464672|83040192|FG004|Overall Study|withdrawal of consent|9|||
46820705|NCT00464672|83040193|FG005|Overall Study|withdrawal of consent|4|||
46820706|NCT00464672|83040188|FG000|Overall Study|Lost to Follow-up|25|||
46820707|NCT00464672|83040189|FG001|Overall Study|Lost to Follow-up|10|||
46820708|NCT00464672|83040190|FG002|Overall Study|Lost to Follow-up|0|||
46820709|NCT00464672|83040191|FG003|Overall Study|Lost to Follow-up|0|||
46820710|NCT00464672|83040192|FG004|Overall Study|Lost to Follow-up|1|||
46820711|NCT00464672|83040193|FG005|Overall Study|Lost to Follow-up|0|||
46820712|NCT00473876|83040223|FG000|Overall Study|Lost to Follow-up|3|||
46820713|NCT00473876|83040224|FG001|Overall Study|Lost to Follow-up|1|||
46820714|NCT00463580|83040234|FG000|Overall Study|Lost to Follow-up|1|||
46820715|NCT00463580|83040235|FG001|Overall Study|Lost to Follow-up|0|||
46820716|NCT00463580|83040234|FG000|Overall Study|Schedule conflict|2|||
46820717|NCT00463580|83040235|FG001|Overall Study|Schedule conflict|0|||
46820718|NCT00463580|83040234|FG000|Overall Study|Medical/psychiatric complications|0|||
46820719|NCT00463580|83040235|FG001|Overall Study|Medical/psychiatric complications|2|||
46820720|NCT00540449|83040249|FG000|Overall Study|Adverse Event|12|||
46820721|NCT00540449|83040250|FG001|Overall Study|Adverse Event|32|||
46820722|NCT00540449|83040249|FG000|Overall Study|Sponsor's Decision|1|||
46820723|NCT00540449|83040250|FG001|Overall Study|Sponsor's Decision|1|||
46820724|NCT00540449|83040249|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
46820725|NCT00540449|83040250|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
46820726|NCT00540449|83040249|FG000|Overall Study|Lost to Follow-up|19|||
46820727|NCT00540449|83040250|FG001|Overall Study|Lost to Follow-up|17|||
46820728|NCT00540449|83040249|FG000|Overall Study|Subject Non-Compliant|7|||
46820729|NCT00540449|83040250|FG001|Overall Study|Subject Non-Compliant|5|||
46820730|NCT00540449|83040249|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
46820731|NCT00540449|83040250|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
46820732|NCT00540449|83040249|FG000|Overall Study|Withdrawal by Subject|10|||
46820733|NCT00540449|83040250|FG001|Overall Study|Withdrawal by Subject|10|||
46820734|NCT00540449|83040249|FG000|Overall Study|Other|1|||
46820735|NCT00540449|83040250|FG001|Overall Study|Other|4|||
46820736|NCT03911843|83040258|FG000|Overall Study|Adverse Event|2|||
46820737|NCT03911843|83040259|FG001|Overall Study|Adverse Event|0|||
46820738|NCT03911843|83040258|FG000|Overall Study|Protocol Violation|2|||
46820739|NCT03911843|83040259|FG001|Overall Study|Protocol Violation|0|||
46820740|NCT03911843|83040258|FG000|Overall Study|Lost to Follow-up|0|||
46820741|NCT03911843|83040259|FG001|Overall Study|Lost to Follow-up|1|||
46820742|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Adverse Event|9|||
46820743|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Adverse Event|4|||
46760014|NCT00856544|82978093|FG002|Overall Study|Adverse Event|2|||
46760015|NCT00856544|82978094|FG003|Overall Study|Adverse Event|3|||
46760016|NCT00856544|82978091|FG000|Overall Study|Lack of Efficacy|16|||
46760017|NCT00856544|82978092|FG001|Overall Study|Lack of Efficacy|12|||
46760018|NCT00856544|82978093|FG002|Overall Study|Lack of Efficacy|3|||
46760019|NCT00856544|82978094|FG003|Overall Study|Lack of Efficacy|3|||
46760020|NCT00856544|82978091|FG000|Overall Study|Other|9|||
46760021|NCT00856544|82978092|FG001|Overall Study|Other|16|||
46760022|NCT00856544|82978093|FG002|Overall Study|Other|1|||
46760023|NCT00856544|82978094|FG003|Overall Study|Other|6|||
46760024|NCT00856544|82978091|FG000|Overall Study|Lost to Follow-up|1|||
46760025|NCT00856544|82978092|FG001|Overall Study|Lost to Follow-up|2|||
46760026|NCT00856544|82978093|FG002|Overall Study|Lost to Follow-up|2|||
46760027|NCT00856544|82978094|FG003|Overall Study|Lost to Follow-up|0|||
46820744|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Adverse Event|5|||
46820745|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Adverse Event|9|||
46820746|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Adverse Event|8|||
46820747|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Adverse Event|0|||
46820748|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Adverse Event|0|||
46760028|NCT00856544|82978091|FG000|Overall Study|Withdrawal by Subject|8|||
46760029|NCT00856544|82978092|FG001|Overall Study|Withdrawal by Subject|5|||
46760030|NCT00856544|82978093|FG002|Overall Study|Withdrawal by Subject|0|||
46820749|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
46760031|NCT00856544|82978094|FG003|Overall Study|Withdrawal by Subject|1|||
46820750|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
46820751|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
46820752|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
46820753|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
46760032|NCT00856388|82978116|FG000|Overall Study|Other|1|||
46760033|NCT00848354|82978123|FG000|Phase 1|Adverse Event|5|||
46760034|NCT00848354|82978124|FG001|Phase 1|Adverse Event|4|||
46820754|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
46820755|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
46820756|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Death|1|||
46820757|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Death|1|||
46820758|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Death|1|||
46820759|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Death|1|||
46820760|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Death|0|||
46820761|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Death|0|||
46820762|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Death|0|||
46820763|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
46820764|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
46820765|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
46820766|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
46820767|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
46820768|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
46820769|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
46820770|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
46820771|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
46820772|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
46820773|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
46820774|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
46820775|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
46820776|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
46820777|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
46820778|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
46820779|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
46820780|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
46820781|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
46820782|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
46820783|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
46820784|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Other|2|||
46820785|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Other|9|||
46820786|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Other|9|||
46820787|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Other|3|||
46820788|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Other|2|||
46820789|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Other|0|||
46820790|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Other|0|||
46820791|NCT00361335|83040270|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
46820792|NCT00361335|83040271|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
46820793|NCT00361335|83040272|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
46820794|NCT00361335|83040273|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
46820795|NCT00361335|83040274|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
46820796|NCT00361335|83040275|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
46820797|NCT00361335|83040276|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
46820798|NCT00361335|83040270|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
46820799|NCT00361335|83040271|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
46820800|NCT00361335|83040272|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
46760035|NCT00848354|82978123|FG000|Phase 1|Discontinuation of study by sponsor|2|||
46760036|NCT00848354|82978124|FG001|Phase 1|Discontinuation of study by sponsor|1|||
46760037|NCT00848354|82978123|FG000|Phase 1|Failed to return|0|||
46760038|NCT00848354|82978124|FG001|Phase 1|Failed to return|1|||
46760039|NCT00848354|82978123|FG000|Phase 1|Lost to Follow-up|1|||
46760040|NCT00848354|82978124|FG001|Phase 1|Lost to Follow-up|1|||
46760041|NCT00848354|82978123|FG000|Phase 1|Unspecified Reason|1|||
46760042|NCT00848354|82978124|FG001|Phase 1|Unspecified Reason|1|||
46760043|NCT00848354|82978123|FG000|Phase 1|Protocol Violation|1|||
46760044|NCT00848354|82978124|FG001|Phase 1|Protocol Violation|1|||
46760045|NCT00848354|82978123|FG000|Phase 1|Withdrawal by Subject|2|||
46820801|NCT00361335|83040273|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
46760046|NCT00848354|82978124|FG001|Phase 1|Withdrawal by Subject|4|||
46760047|NCT00848354|82978123|FG000|Phase 1|Lack of Efficacy|0|||
46760048|NCT00848354|82978124|FG001|Phase 1|Lack of Efficacy|1|||
46760049|NCT00848354|82978123|FG000|Phase 2 Year 1|Adverse Event|7|||
46760050|NCT00848354|82978124|FG001|Phase 2 Year 1|Adverse Event|2|||
46820802|NCT00361335|83040274|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
46820803|NCT00361335|83040275|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
46820804|NCT00361335|83040276|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
46820805|NCT00361335|83040270|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
46820806|NCT00361335|83040271|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
46820807|NCT00361335|83040272|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
46820808|NCT00361335|83040273|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
46820809|NCT00361335|83040274|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
46820810|NCT00361335|83040275|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
46820811|NCT00361335|83040276|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
46820812|NCT00361335|83040270|FG000|SC Period: Week E0 to Week E24|Death|0|||
46820813|NCT00361335|83040271|FG001|SC Period: Week E0 to Week E24|Death|0|||
46820814|NCT00361335|83040272|FG002|SC Period: Week E0 to Week E24|Death|0|||
46820815|NCT00361335|83040273|FG003|SC Period: Week E0 to Week E24|Death|0|||
46820816|NCT00361335|83040274|FG004|SC Period: Week E0 to Week E24|Death|0|||
46820817|NCT00361335|83040275|FG005|SC Period: Week E0 to Week E24|Death|0|||
46932436|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
46932437|NCT00303498|83167985|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
46932438|NCT00303498|83167986|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
46932439|NCT02588092|83168002|FG000|Overall Study|Death|4|||
46932440|NCT02588092|83168003|FG001|Overall Study|Death|3|||
46932441|NCT02588092|83168004|FG002|Overall Study|Death|3|||
46932442|NCT02588092|83168005|FG003|Overall Study|Death|3|||
46932443|NCT02588092|83168006|FG004|Overall Study|Death|2|||
46932444|NCT02588092|83168007|FG005|Overall Study|Death|2|||
46932445|NCT02588092|83168008|FG006|Overall Study|Death|2|||
46932446|NCT02588092|83168009|FG007|Overall Study|Death|1|||
46932447|NCT02588092|83168010|FG008|Overall Study|Death|5|||
46932448|NCT02588092|83168011|FG009|Overall Study|Death|2|||
46932449|NCT02588092|83168002|FG000|Overall Study|Withdrawal by Subject|0|||
46932450|NCT02588092|83168003|FG001|Overall Study|Withdrawal by Subject|0|||
46932451|NCT02588092|83168004|FG002|Overall Study|Withdrawal by Subject|0|||
46932452|NCT02588092|83168005|FG003|Overall Study|Withdrawal by Subject|0|||
46932453|NCT02588092|83168006|FG004|Overall Study|Withdrawal by Subject|0|||
46932454|NCT02588092|83168007|FG005|Overall Study|Withdrawal by Subject|1|||
46932455|NCT02588092|83168008|FG006|Overall Study|Withdrawal by Subject|1|||
46932456|NCT02588092|83168009|FG007|Overall Study|Withdrawal by Subject|2|||
46932457|NCT02588092|83168010|FG008|Overall Study|Withdrawal by Subject|0|||
46932458|NCT02588092|83168011|FG009|Overall Study|Withdrawal by Subject|0|||
46932459|NCT02588092|83168002|FG000|Overall Study|Started Another Treatment|0|||
46932460|NCT02588092|83168003|FG001|Overall Study|Started Another Treatment|0|||
46932461|NCT02588092|83168004|FG002|Overall Study|Started Another Treatment|0|||
46932462|NCT02588092|83168005|FG003|Overall Study|Started Another Treatment|0|||
46932463|NCT02588092|83168006|FG004|Overall Study|Started Another Treatment|1|||
46932464|NCT02588092|83168007|FG005|Overall Study|Started Another Treatment|0|||
46932465|NCT02588092|83168008|FG006|Overall Study|Started Another Treatment|0|||
46932466|NCT02588092|83168009|FG007|Overall Study|Started Another Treatment|1|||
46932467|NCT02588092|83168010|FG008|Overall Study|Started Another Treatment|0|||
46760051|NCT00848354|82978123|FG000|Phase 2 Year 1|Death|1|||
46760052|NCT00848354|82978124|FG001|Phase 2 Year 1|Death|0|||
46760053|NCT00848354|82978123|FG000|Phase 2 Year 1|Failed to Return|1|||
46760054|NCT00848354|82978124|FG001|Phase 2 Year 1|Failed to Return|1|||
46760055|NCT00848354|82978123|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
46760056|NCT00848354|82978124|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
46760057|NCT00848354|82978123|FG000|Phase 2 Year 1|Unspecified Reason|3|||
46760058|NCT00848354|82978124|FG001|Phase 2 Year 1|Unspecified Reason|0|||
46760059|NCT00848354|82978123|FG000|Phase 2 Year 1|Protocol Violation|4|||
46760060|NCT00848354|82978124|FG001|Phase 2 Year 1|Protocol Violation|1|||
46760061|NCT00848354|82978123|FG000|Phase 2 Year 1|Subject Request|1|||
46760062|NCT00848354|82978124|FG001|Phase 2 Year 1|Subject Request|2|||
46760063|NCT00848354|82978123|FG000|Phase 2 Year 2|Adverse Event|12|||
46760064|NCT00848354|82978124|FG001|Phase 2 Year 2|Adverse Event|2|||
46760065|NCT00848354|82978123|FG000|Phase 2 Year 2|Death|2|||
46820818|NCT00361335|83040276|FG006|SC Period: Week E0 to Week E24|Death|1|||
46932468|NCT02588092|83168011|FG009|Overall Study|Started Another Treatment|0|||
46932469|NCT02588092|83168002|FG000|Overall Study|Sponsor Decision|0|||
46932470|NCT02588092|83168003|FG001|Overall Study|Sponsor Decision|0|||
46932471|NCT02588092|83168004|FG002|Overall Study|Sponsor Decision|0|||
46932472|NCT02588092|83168005|FG003|Overall Study|Sponsor Decision|0|||
46932473|NCT02588092|83168006|FG004|Overall Study|Sponsor Decision|0|||
46932474|NCT02588092|83168007|FG005|Overall Study|Sponsor Decision|0|||
46820819|NCT00361335|83040270|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
46820820|NCT00361335|83040271|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
46932475|NCT02588092|83168008|FG006|Overall Study|Sponsor Decision|0|||
46932476|NCT02588092|83168009|FG007|Overall Study|Sponsor Decision|0|||
46932477|NCT02588092|83168010|FG008|Overall Study|Sponsor Decision|1|||
46932478|NCT02588092|83168011|FG009|Overall Study|Sponsor Decision|1|||
46932479|NCT01367847|83168039|FG000|Overall Study|Withdrawal by Subject|2|||
46932480|NCT01367847|83168040|FG001|Overall Study|Withdrawal by Subject|2|||
46932481|NCT00150618|83168052|FG000|Overall Study|Adverse Event|2|||
46760066|NCT00848354|82978124|FG001|Phase 2 Year 2|Death|0|||
46932482|NCT00150618|83168053|FG001|Overall Study|Adverse Event|2|||
46932483|NCT00150618|83168054|FG002|Overall Study|Adverse Event|6|||
46932484|NCT00150618|83168055|FG003|Overall Study|Adverse Event|9|||
46932485|NCT00150618|83168056|FG004|Overall Study|Adverse Event|5|||
46932486|NCT00150618|83168052|FG000|Overall Study|Withdrawal by Subject|6|||
46932487|NCT00150618|83168053|FG001|Overall Study|Withdrawal by Subject|8|||
46932488|NCT00150618|83168054|FG002|Overall Study|Withdrawal by Subject|8|||
46932489|NCT00150618|83168055|FG003|Overall Study|Withdrawal by Subject|4|||
47056517|NCT01746017|83332990|FG001|Period 3|Withdrawal by Subject|0|||
46932490|NCT00150618|83168056|FG004|Overall Study|Withdrawal by Subject|5|||
46932491|NCT00150618|83168052|FG000|Overall Study|Lost to Follow-up|4|||
46932492|NCT00150618|83168053|FG001|Overall Study|Lost to Follow-up|1|||
46932493|NCT00150618|83168054|FG002|Overall Study|Lost to Follow-up|5|||
46932494|NCT00150618|83168055|FG003|Overall Study|Lost to Follow-up|8|||
46932495|NCT00150618|83168056|FG004|Overall Study|Lost to Follow-up|4|||
46932496|NCT00150618|83168052|FG000|Overall Study|Protocol Violation|1|||
46932497|NCT00150618|83168053|FG001|Overall Study|Protocol Violation|0|||
46932498|NCT00150618|83168054|FG002|Overall Study|Protocol Violation|0|||
46932499|NCT00150618|83168055|FG003|Overall Study|Protocol Violation|0|||
47056518|NCT01746017|83332991|FG002|Period 3|Withdrawal by Subject|0|||
46932500|NCT00150618|83168056|FG004|Overall Study|Protocol Violation|1|||
46932501|NCT00150618|83168052|FG000|Overall Study|Lack of Efficacy|1|||
46932502|NCT00150618|83168053|FG001|Overall Study|Lack of Efficacy|4|||
46932503|NCT00150618|83168054|FG002|Overall Study|Lack of Efficacy|7|||
46932504|NCT00150618|83168055|FG003|Overall Study|Lack of Efficacy|4|||
46932505|NCT00150618|83168056|FG004|Overall Study|Lack of Efficacy|6|||
47056519|NCT01746017|83332992|FG003|Period 3|Withdrawal by Subject|0|||
46932506|NCT00150618|83168052|FG000|Overall Study|No study meds|0|||
46932507|NCT00150618|83168053|FG001|Overall Study|No study meds|0|||
46932508|NCT00150618|83168054|FG002|Overall Study|No study meds|0|||
46932509|NCT00150618|83168055|FG003|Overall Study|No study meds|0|||
46932510|NCT00150618|83168056|FG004|Overall Study|No study meds|2|||
46932511|NCT00150618|83168052|FG000|Overall Study|Physician Decision|0|||
46932512|NCT00150618|83168053|FG001|Overall Study|Physician Decision|2|||
46932513|NCT00150618|83168054|FG002|Overall Study|Physician Decision|0|||
47056520|NCT01746017|83332993|FG004|Period 3|Withdrawal by Subject|0|||
47056521|NCT01746017|83332994|FG005|Period 3|Withdrawal by Subject|1|||
47056522|NCT01746017|83332995|FG006|Period 3|Withdrawal by Subject|0|||
47056523|NCT01746017|83332996|FG007|Period 3|Withdrawal by Subject|0|||
47056524|NCT01746017|83332997|FG008|Period 3|Withdrawal by Subject|0|||
47056525|NCT01746017|83332998|FG009|Period 3|Withdrawal by Subject|0|||
47056526|NCT01746017|83332999|FG010|Period 3|Withdrawal by Subject|0|||
47056527|NCT01717313|83333061|FG000|Phase A (Weeks 0 to 24)|Death|0|||
47056528|NCT01717313|83333062|FG001|Phase A (Weeks 0 to 24)|Death|1|||
47056529|NCT01717313|83333061|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
47056530|NCT01717313|83333062|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
47056531|NCT01717313|83333061|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
47056532|NCT01717313|83333062|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
47056533|NCT01717313|83333061|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
47056534|NCT01717313|83333062|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
47056535|NCT01717313|83333061|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
47056536|NCT01717313|83333062|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
47056537|NCT01717313|83333061|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
46760067|NCT00848354|82978123|FG000|Phase 2 Year 2|Failed to return|3|||
46760068|NCT00848354|82978124|FG001|Phase 2 Year 2|Failed to return|0|||
46760069|NCT00848354|82978123|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
46760070|NCT00848354|82978124|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
46760071|NCT00848354|82978123|FG000|Phase 2 Year 2|Unspecified Reason|1|||
46760072|NCT00848354|82978124|FG001|Phase 2 Year 2|Unspecified Reason|0|||
46760073|NCT00848354|82978123|FG000|Phase 2 Year 2|Protocol Violation|1|||
46760074|NCT00848354|82978124|FG001|Phase 2 Year 2|Protocol Violation|1|||
46760075|NCT00848354|82978123|FG000|Phase 2 Year 2|Subject Request|1|||
46760076|NCT00848354|82978124|FG001|Phase 2 Year 2|Subject Request|1|||
46760077|NCT00848354|82978123|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
46760078|NCT00848354|82978124|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
46932514|NCT00150618|83168055|FG003|Overall Study|Physician Decision|0|||
46760079|NCT00848198|82978134|FG000|Overall Study|Incomplete Case Report Forms|15|||
46760080|NCT00848120|82978142|FG000|Overall Study|Adverse Event|1|||
46760081|NCT00600821|82978148|FG000|Overall Study|Death|45|||
46932515|NCT00150618|83168056|FG004|Overall Study|Physician Decision|1|||
46932516|NCT00150618|83168052|FG000|Overall Study|Lack of compliance|2|||
46932517|NCT00150618|83168053|FG001|Overall Study|Lack of compliance|1|||
46932518|NCT00150618|83168054|FG002|Overall Study|Lack of compliance|1|||
46932519|NCT00150618|83168055|FG003|Overall Study|Lack of compliance|0|||
46932520|NCT00150618|83168056|FG004|Overall Study|Lack of compliance|1|||
47056538|NCT01717313|83333062|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
47056539|NCT01717313|83333061|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
47056540|NCT01717313|83333062|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
47056541|NCT01717313|83333061|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
47056542|NCT01717313|83333062|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
47056543|NCT01717313|83333061|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
47056544|NCT01717313|83333062|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
47056545|NCT01745393|83333074|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
47056546|NCT01745393|83333075|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
47056547|NCT01745393|83333074|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
47056548|NCT01745393|83333075|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
47056549|NCT01745393|83333074|FG000|12-month Follow-up|Lost to Follow-up|6|||
47056550|NCT01745393|83333075|FG001|12-month Follow-up|Lost to Follow-up|5|||
47056551|NCT01744691|83333106|FG000|Overall Study|Progressive Disease|18|||
47056552|NCT01744691|83333106|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
47056553|NCT01744691|83333106|FG000|Overall Study|Withdrawal of consent for treatment|3|||
46820821|NCT00361335|83040272|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
46820822|NCT00361335|83040273|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
46820823|NCT00361335|83040274|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
46820824|NCT00361335|83040275|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
46820825|NCT00361335|83040276|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
46820826|NCT00361335|83040270|FG000|SC Period: Week E0 to Week E24|Other|1|||
46820827|NCT00361335|83040271|FG001|SC Period: Week E0 to Week E24|Other|0|||
46820828|NCT00361335|83040272|FG002|SC Period: Week E0 to Week E24|Other|0|||
46820829|NCT00361335|83040273|FG003|SC Period: Week E0 to Week E24|Other|1|||
46820830|NCT00361335|83040274|FG004|SC Period: Week E0 to Week E24|Other|0|||
46820831|NCT00361335|83040275|FG005|SC Period: Week E0 to Week E24|Other|1|||
46820832|NCT00361335|83040276|FG006|SC Period: Week E0 to Week E24|Other|2|||
46820833|NCT00361335|83040270|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
46820834|NCT00361335|83040271|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
46820835|NCT00361335|83040272|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
46820836|NCT00361335|83040273|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
46820837|NCT00361335|83040274|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
46820838|NCT00361335|83040275|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
46820839|NCT00361335|83040276|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
46820840|NCT00264550|83040296|FG000|Overall Study|Death|0|||
46820841|NCT00264550|83040297|FG001|Overall Study|Death|3|||
46820842|NCT00264550|83040298|FG002|Overall Study|Death|0|||
46820843|NCT00264550|83040299|FG003|Overall Study|Death|0|||
46820844|NCT00264550|83040296|FG000|Overall Study|Lost to Follow-up|3|||
46820845|NCT00264550|83040297|FG001|Overall Study|Lost to Follow-up|1|||
46820846|NCT00264550|83040298|FG002|Overall Study|Lost to Follow-up|1|||
46820847|NCT00264550|83040299|FG003|Overall Study|Lost to Follow-up|1|||
46820848|NCT00264550|83040296|FG000|Overall Study|Adverse Event|23|||
46820849|NCT00264550|83040297|FG001|Overall Study|Adverse Event|18|||
46820850|NCT00264550|83040298|FG002|Overall Study|Adverse Event|9|||
46820851|NCT00264550|83040299|FG003|Overall Study|Adverse Event|14|||
47056554|NCT01744691|83333106|FG000|Overall Study|Physician Decision|4|||
47056555|NCT01716533|83333141|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
47056556|NCT01716533|83333142|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
47056557|NCT01716533|83333143|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
47056558|NCT01716533|83333144|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
46760082|NCT00600821|82978149|FG001|Overall Study|Death|46|||
46760083|NCT00600821|82978148|FG000|Overall Study|Lost to Follow-up|2|||
46760084|NCT00600821|82978149|FG001|Overall Study|Lost to Follow-up|2|||
46760085|NCT00600821|82978148|FG000|Overall Study|Withdrawal by Subject|1|||
46760086|NCT00600821|82978149|FG001|Overall Study|Withdrawal by Subject|1|||
46760087|NCT00600821|82978148|FG000|Overall Study|Terminated by sponsor|8|||
46760088|NCT00600821|82978149|FG001|Overall Study|Terminated by sponsor|6|||
46760089|NCT00600821|82978148|FG000|Overall Study|Objective progression or relapse|0|||
46760090|NCT00600821|82978149|FG001|Overall Study|Objective progression or relapse|1|||
46760091|NCT00600821|82978148|FG000|Overall Study|Randomized but not treated|0|||
46760092|NCT00600821|82978149|FG001|Overall Study|Randomized but not treated|1|||
46760093|NCT00600821|82978148|FG000|Overall Study|Other|2|||
46760094|NCT00600821|82978149|FG001|Overall Study|Other|3|||
46760095|NCT00592904|82978161|FG000|Overall Study|Adverse Event|15|||
46760096|NCT00592904|82978162|FG001|Overall Study|Adverse Event|25|||
46760097|NCT00592904|82978163|FG002|Overall Study|Adverse Event|13|||
46760098|NCT00592904|82978164|FG003|Overall Study|Adverse Event|5|||
46820852|NCT00264550|83040296|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
46760099|NCT00592904|82978161|FG000|Overall Study|Protocol Violation|1|||
46760100|NCT00592904|82978162|FG001|Overall Study|Protocol Violation|1|||
46820853|NCT00264550|83040297|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
46820854|NCT00264550|83040298|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
46820855|NCT00264550|83040299|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
47056559|NCT01716533|83333141|FG000|Overall Study|Withdrawal by Subject|0|||
46760101|NCT00592904|82978163|FG002|Overall Study|Protocol Violation|0|||
46820856|NCT00264550|83040296|FG000|Overall Study|Discontinued oral study agent|0|||
46820857|NCT00264550|83040297|FG001|Overall Study|Discontinued oral study agent|1|||
46820858|NCT00264550|83040298|FG002|Overall Study|Discontinued oral study agent|0|||
46820859|NCT00264550|83040299|FG003|Overall Study|Discontinued oral study agent|0|||
46820860|NCT00264550|83040296|FG000|Overall Study|Other|13|||
46820861|NCT00264550|83040297|FG001|Overall Study|Other|7|||
47056560|NCT01716533|83333142|FG001|Overall Study|Withdrawal by Subject|0|||
46820862|NCT00264550|83040298|FG002|Overall Study|Other|3|||
46820863|NCT00264550|83040299|FG003|Overall Study|Other|9|||
46820864|NCT00541931|83040311|FG000|Overall Study|Adverse Event|1|||
46820865|NCT00541931|83040312|FG001|Overall Study|Adverse Event|0|||
46820866|NCT00541931|83040311|FG000|Overall Study|Lost to Follow-up|3|||
46820867|NCT00541931|83040312|FG001|Overall Study|Lost to Follow-up|3|||
46820868|NCT00541931|83040311|FG000|Overall Study|Withdrawal by Subject|1|||
46820869|NCT00541931|83040312|FG001|Overall Study|Withdrawal by Subject|0|||
46820870|NCT00541931|83040311|FG000|Overall Study|Transportation Issue|0|||
46820871|NCT00541931|83040312|FG001|Overall Study|Transportation Issue|1|||
46820872|NCT00368979|83040322|FG000|Overall Study|Adverse Event|9|||
46820873|NCT00368979|83040323|FG001|Overall Study|Adverse Event|16|||
46820874|NCT00368979|83040322|FG000|Overall Study|Lack of Efficacy|5|||
46820875|NCT00368979|83040323|FG001|Overall Study|Lack of Efficacy|3|||
46820876|NCT00368979|83040322|FG000|Overall Study|Other|3|||
46820877|NCT00368979|83040323|FG001|Overall Study|Other|1|||
46820878|NCT00368979|83040322|FG000|Overall Study|Lost to Follow-up|1|||
46820879|NCT00368979|83040323|FG001|Overall Study|Lost to Follow-up|0|||
46820880|NCT00368979|83040322|FG000|Overall Study|Protocol Violation|2|||
46820881|NCT00368979|83040323|FG001|Overall Study|Protocol Violation|1|||
46820882|NCT00368979|83040322|FG000|Overall Study|Withdrawal by Subject|5|||
46820883|NCT00368979|83040323|FG001|Overall Study|Withdrawal by Subject|9|||
46820884|NCT00264238|83040329|FG000|Overall Study|Protocol Violation|1|||
46820885|NCT00540293|83040335|FG000|Overall Study|Adverse event related to study drug|10|||
46820886|NCT00540293|83040335|FG000|Overall Study|Adverse event not related to study drug|7|||
47056561|NCT01716533|83333143|FG002|Overall Study|Withdrawal by Subject|0|||
47056562|NCT01716533|83333144|FG003|Overall Study|Withdrawal by Subject|5|||
46820887|NCT00540293|83040335|FG000|Overall Study|Withdrawal by Subject|6|||
46820888|NCT00540293|83040335|FG000|Overall Study|Protocol violation, & subject schedule|12|||
46820889|NCT00359073|83040376|FG000|Overall Study|Withdrawal by Subject|1|||
46820890|NCT00359073|83040377|FG001|Overall Study|Withdrawal by Subject|1|||
46820891|NCT00359073|83040376|FG000|Overall Study|Eligibility criteria no longer met|3|||
47056563|NCT01716533|83333141|FG000|Overall Study|Death|0|||
47056564|NCT01716533|83333142|FG001|Overall Study|Death|0|||
47056565|NCT01716533|83333143|FG002|Overall Study|Death|0|||
47056566|NCT01716533|83333144|FG003|Overall Study|Death|2|||
46760102|NCT00592904|82978164|FG003|Overall Study|Protocol Violation|1|||
46760103|NCT00592904|82978161|FG000|Overall Study|Withdrawal by Subject|4|||
46820892|NCT00359073|83040377|FG001|Overall Study|Eligibility criteria no longer met|0|||
46820893|NCT00359073|83040376|FG000|Overall Study|developed RV16 antibody|0|||
46820894|NCT00359073|83040377|FG001|Overall Study|developed RV16 antibody|1|||
46820895|NCT03918239|83040387|FG000|Overall Study|Lost to Follow-up|3|||
46820896|NCT03918239|83040388|FG001|Overall Study|Lost to Follow-up|1|||
46820897|NCT03918239|83040387|FG000|Overall Study|Pregnancy|0|||
47056567|NCT01716533|83333141|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
47056568|NCT01716533|83333142|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
46760104|NCT00592904|82978162|FG001|Overall Study|Withdrawal by Subject|16|||
46760105|NCT00592904|82978163|FG002|Overall Study|Withdrawal by Subject|1|||
46760106|NCT00592904|82978164|FG003|Overall Study|Withdrawal by Subject|2|||
46760107|NCT00592904|82978161|FG000|Overall Study|Lack of Efficacy|2|||
46760108|NCT00592904|82978162|FG001|Overall Study|Lack of Efficacy|7|||
46760109|NCT00592904|82978163|FG002|Overall Study|Lack of Efficacy|2|||
46760110|NCT00592904|82978164|FG003|Overall Study|Lack of Efficacy|3|||
46760111|NCT00592904|82978161|FG000|Overall Study|Physician Decision|0|||
46760112|NCT00592904|82978162|FG001|Overall Study|Physician Decision|3|||
46820898|NCT03918239|83040388|FG001|Overall Study|Pregnancy|2|||
46820899|NCT03918239|83040387|FG000|Overall Study|Withdrawal by Subject|3|||
46820900|NCT03918239|83040388|FG001|Overall Study|Withdrawal by Subject|3|||
46932521|NCT00150618|83168052|FG000|Overall Study|Abnormal ECG|1|||
46932522|NCT00150618|83168053|FG001|Overall Study|Abnormal ECG|0|||
46932523|NCT00150618|83168054|FG002|Overall Study|Abnormal ECG|0|||
47056569|NCT01716533|83333143|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
47056570|NCT01716533|83333144|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
46760113|NCT00592904|82978163|FG002|Overall Study|Physician Decision|1|||
46760114|NCT00592904|82978164|FG003|Overall Study|Physician Decision|0|||
46760115|NCT00592904|82978161|FG000|Overall Study|Other|3|||
46820901|NCT03918239|83040387|FG000|Overall Study|positive urine drug screening results|4|||
46820902|NCT03918239|83040388|FG001|Overall Study|positive urine drug screening results|1|||
46820903|NCT00368745|83040396|FG000|Double-blind Treatment Period|Adverse Event|6|||
47056571|NCT01375374|83333158|FG000|Overall Study|Adverse Event|1|||
47056572|NCT01743989|83333756|FG000|Treatment Phase|Unstable MR4.0|0|||
47056573|NCT01743989|83333757|FG001|Treatment Phase|Unstable MR4.0|6|||
47056574|NCT01743989|83333758|FG002|Treatment Phase|Unstable MR4.0|263|||
47056575|NCT01743989|83333756|FG000|Treatment Phase|Adverse Event|0|||
47056576|NCT01743989|83333757|FG001|Treatment Phase|Adverse Event|4|||
47056577|NCT01743989|83333758|FG002|Treatment Phase|Adverse Event|67|||
47056578|NCT01743989|83333756|FG000|Treatment Phase|Withdrawal by Subject|1|||
47056579|NCT01743989|83333757|FG001|Treatment Phase|Withdrawal by Subject|3|||
47056580|NCT01743989|83333758|FG002|Treatment Phase|Withdrawal by Subject|28|||
47056581|NCT01743989|83333756|FG000|Treatment Phase|Death|0|||
47056582|NCT01743989|83333757|FG001|Treatment Phase|Death|1|||
46760116|NCT00592904|82978162|FG001|Overall Study|Other|3|||
46760117|NCT00592904|82978163|FG002|Overall Study|Other|0|||
46760118|NCT00592904|82978164|FG003|Overall Study|Other|0|||
46760119|NCT00855920|82978177|FG000|Overall Study|Protocol Violation|0|||
46760120|NCT00855920|82978178|FG001|Overall Study|Protocol Violation|0|||
46760121|NCT00855920|82978179|FG002|Overall Study|Protocol Violation|2|||
46760122|NCT00855920|82978177|FG000|Overall Study|Adverse Event|2|||
46760123|NCT00855920|82978178|FG001|Overall Study|Adverse Event|1|||
46760124|NCT00855920|82978179|FG002|Overall Study|Adverse Event|1|||
46760125|NCT00855920|82978177|FG000|Overall Study|Lack of Efficacy|2|||
46760126|NCT00855920|82978178|FG001|Overall Study|Lack of Efficacy|2|||
46760127|NCT00855920|82978179|FG002|Overall Study|Lack of Efficacy|2|||
46760128|NCT00855920|82978177|FG000|Overall Study|Withdrawal by Subject|2|||
46760129|NCT00855920|82978178|FG001|Overall Study|Withdrawal by Subject|3|||
46760130|NCT00855920|82978179|FG002|Overall Study|Withdrawal by Subject|2|||
46760131|NCT00855920|82978177|FG000|Overall Study|Lost to Follow-up|1|||
46760132|NCT00855920|82978178|FG001|Overall Study|Lost to Follow-up|0|||
46760133|NCT00855920|82978179|FG002|Overall Study|Lost to Follow-up|2|||
46760134|NCT00855920|82978177|FG000|Overall Study|Death|0|||
46760135|NCT00855920|82978178|FG001|Overall Study|Death|1|||
46760136|NCT00855920|82978179|FG002|Overall Study|Death|0|||
46760137|NCT00855920|82978177|FG000|Overall Study|Decision by the sponsor|0|||
46760138|NCT00855920|82978178|FG001|Overall Study|Decision by the sponsor|1|||
46760139|NCT00855920|82978179|FG002|Overall Study|Decision by the sponsor|1|||
46760140|NCT00855920|82978177|FG000|Overall Study|Other than specified above|1|||
46760141|NCT00855920|82978178|FG001|Overall Study|Other than specified above|1|||
46760142|NCT00855920|82978179|FG002|Overall Study|Other than specified above|1|||
46760143|NCT00848042|82978190|FG000|Overall Study|Death|1|||
46760144|NCT00848042|82978191|FG001|Overall Study|Death|2|||
46760145|NCT00848042|82978192|FG002|Overall Study|Death|0|||
46760146|NCT00848042|82978190|FG000|Overall Study|Other Therapy|3|||
46760147|NCT00848042|82978191|FG001|Overall Study|Other Therapy|0|||
46760148|NCT00848042|82978192|FG002|Overall Study|Other Therapy|0|||
46760149|NCT00847886|82978202|FG000|Overall Study|Adverse Event|0|||
46760150|NCT00847886|82978203|FG001|Overall Study|Adverse Event|1|||
46760151|NCT00847808|82978209|FG000|Overall Study|Adverse Event|7|||
46760152|NCT00847808|82978209|FG000|Overall Study|Protocol Violation|1|||
46760153|NCT00847808|82978209|FG000|Overall Study|Lost to Follow-up|1|||
46760154|NCT00847808|82978209|FG000|Overall Study|Withdrawal by Subject|4|||
46760155|NCT00847808|82978209|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
46760156|NCT00847808|82978209|FG000|Overall Study|Participant Took Excluded Medication|1|||
46760157|NCT00600353|82978215|FG000|Overall Study|history of malignancy within 5 years|1|||
46760158|NCT00600353|82978216|FG001|Overall Study|history of malignancy within 5 years|0|||
46760159|NCT00600353|82978215|FG000|Overall Study|History of prepartive regimen|0|||
46760160|NCT00600353|82978216|FG001|Overall Study|History of prepartive regimen|1|||
46760161|NCT00691210|82978230|FG000|Overall Study|Progression of Disease|0|||
46760162|NCT00691210|82978231|FG001|Overall Study|Progression of Disease|0|||
47056583|NCT01743989|83333758|FG002|Treatment Phase|Death|3|||
46760163|NCT00691210|82978232|FG002|Overall Study|Progression of Disease|0|||
46760164|NCT00691210|82978233|FG003|Overall Study|Progression of Disease|2|||
46760165|NCT00691210|82978234|FG004|Overall Study|Progression of Disease|0|||
46760166|NCT00691210|82978235|FG005|Overall Study|Progression of Disease|0|||
47056584|NCT01743989|83333756|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
46760167|NCT00691210|82978236|FG006|Overall Study|Progression of Disease|0|||
46760168|NCT00691210|82978237|FG007|Overall Study|Progression of Disease|0|||
46760169|NCT00691210|82978230|FG000|Overall Study|Lack of Efficacy|0|||
46932524|NCT00150618|83168055|FG003|Overall Study|Abnormal ECG|0|||
47056585|NCT01743989|83333757|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
46760170|NCT00691210|82978231|FG001|Overall Study|Lack of Efficacy|0|||
46760171|NCT00691210|82978232|FG002|Overall Study|Lack of Efficacy|0|||
46760172|NCT00691210|82978233|FG003|Overall Study|Lack of Efficacy|1|||
46760173|NCT00691210|82978234|FG004|Overall Study|Lack of Efficacy|0|||
46760174|NCT00691210|82978235|FG005|Overall Study|Lack of Efficacy|1|||
46760175|NCT00691210|82978236|FG006|Overall Study|Lack of Efficacy|0|||
46760176|NCT00691210|82978237|FG007|Overall Study|Lack of Efficacy|0|||
46760177|NCT00691132|82978257|FG000|Overall Study|Adverse Event|2|||
47056586|NCT01743989|83333758|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
47056587|NCT01743989|83333756|FG000|Treatment Phase|Protocol deviation|0|||
47056588|NCT01743989|83333757|FG001|Treatment Phase|Protocol deviation|0|||
47056589|NCT01743989|83333758|FG002|Treatment Phase|Protocol deviation|3|||
47056590|NCT01743989|83333756|FG000|Treatment Phase|Pregnancy|0|||
47056591|NCT01743989|83333757|FG001|Treatment Phase|Pregnancy|0|||
47056592|NCT01743989|83333758|FG002|Treatment Phase|Pregnancy|2|||
46820904|NCT00368745|83040397|FG001|Double-blind Treatment Period|Adverse Event|6|||
46820905|NCT00368745|83040396|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
46820906|NCT00368745|83040397|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
46820907|NCT00368745|83040396|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
46820908|NCT00368745|83040397|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
46820909|NCT00368745|83040396|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
46820910|NCT00368745|83040397|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
46820911|NCT00368745|83040396|FG000|Double-blind Treatment Period|Other|7|||
46820912|NCT00368745|83040397|FG001|Double-blind Treatment Period|Other|6|||
46820913|NCT00454818|83040411|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
46820914|NCT00454818|83040412|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
46820915|NCT00454818|83040413|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
46820916|NCT00454818|83040414|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
46820917|NCT00454818|83040415|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
46820918|NCT00454818|83040411|FG000|Phase I: Open-label Dose-escalation|Death|0|||
46820919|NCT00454818|83040412|FG001|Phase I: Open-label Dose-escalation|Death|1|||
46820920|NCT00454818|83040413|FG002|Phase I: Open-label Dose-escalation|Death|0|||
46932525|NCT00150618|83168056|FG004|Overall Study|Abnormal ECG|0|||
46932526|NCT00150618|83168052|FG000|Overall Study|Sponsor's decision|0|||
46932527|NCT00150618|83168053|FG001|Overall Study|Sponsor's decision|0|||
46932528|NCT00150618|83168054|FG002|Overall Study|Sponsor's decision|0|||
46932529|NCT00150618|83168055|FG003|Overall Study|Sponsor's decision|1|||
46932530|NCT00150618|83168056|FG004|Overall Study|Sponsor's decision|0|||
46932531|NCT01359046|83168070|FG000|Overall Study|Did not receive allocated intervention|6|||
46932532|NCT01359046|83168071|FG001|Overall Study|Did not receive allocated intervention|6|||
46932533|NCT01359046|83168070|FG000|Overall Study|Physician Decision|1|||
46932534|NCT01359046|83168071|FG001|Overall Study|Physician Decision|11|||
46932535|NCT02741310|83168079|FG000|Overall Study|Sponsor Decision|2|||
46932536|NCT02741310|83168080|FG001|Overall Study|Sponsor Decision|2|||
46932537|NCT01367457|83168097|FG000|Overall Study|Death|2|||
46932538|NCT01367457|83168098|FG001|Overall Study|Death|0|||
46820921|NCT00454818|83040414|FG003|Phase I: Open-label Dose-escalation|Death|0|||
46820922|NCT00454818|83040415|FG004|Phase I: Open-label Dose-escalation|Death|0|||
46820923|NCT00454818|83040411|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
46820924|NCT00454818|83040412|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
46820925|NCT00454818|83040413|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
46820926|NCT00454818|83040414|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
46820927|NCT00454818|83040415|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
46820928|NCT00454818|83040411|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
46820929|NCT00454818|83040412|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
46820930|NCT00454818|83040413|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
46820931|NCT00454818|83040414|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
46820932|NCT00454818|83040415|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
46820933|NCT00454818|83040411|FG000|Phase 2: Randomized Double-blind|Death|0|||
46820934|NCT00454818|83040412|FG001|Phase 2: Randomized Double-blind|Death|1|||
46820935|NCT00454818|83040413|FG002|Phase 2: Randomized Double-blind|Death|0|||
46820936|NCT00454818|83040414|FG003|Phase 2: Randomized Double-blind|Death|0|||
46820937|NCT00454818|83040415|FG004|Phase 2: Randomized Double-blind|Death|1|||
46820938|NCT00454818|83040411|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
46932539|NCT01367457|83168099|FG002|Overall Study|Death|0|||
46932540|NCT01367457|83168097|FG000|Overall Study|Investigator's decision|2|||
46932541|NCT01367457|83168098|FG001|Overall Study|Investigator's decision|0|||
46932542|NCT01367457|83168099|FG002|Overall Study|Investigator's decision|0|||
46932543|NCT01367457|83168097|FG000|Overall Study|Clinical decline (CD)|2|||
46932544|NCT01367457|83168098|FG001|Overall Study|Clinical decline (CD)|0|||
47056593|NCT01743989|83333756|FG000|Treatment Phase|Lost to Follow-up|0|||
46820939|NCT00454818|83040412|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
46820940|NCT00454818|83040413|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
46820941|NCT00454818|83040414|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
47056594|NCT01743989|83333757|FG001|Treatment Phase|Lost to Follow-up|0|||
46932545|NCT01367457|83168099|FG002|Overall Study|Clinical decline (CD)|0|||
47056595|NCT01743989|83333758|FG002|Treatment Phase|Lost to Follow-up|2|||
46932546|NCT01367457|83168097|FG000|Overall Study|Progression and death|8|||
46932547|NCT01367457|83168098|FG001|Overall Study|Progression and death|0|||
47056596|NCT01743989|83333756|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
47056597|NCT01743989|83333757|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
46820942|NCT00454818|83040415|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
46820943|NCT00454818|83040411|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
46932548|NCT01367457|83168099|FG002|Overall Study|Progression and death|0|||
46932549|NCT01367457|83168097|FG000|Overall Study|Toxicity|16|||
46932550|NCT01367457|83168098|FG001|Overall Study|Toxicity|0|||
46932551|NCT01367457|83168099|FG002|Overall Study|Toxicity|0|||
46932552|NCT01367457|83168097|FG000|Overall Study|Progression|137|||
46932553|NCT01367457|83168098|FG001|Overall Study|Progression|0|||
46932554|NCT01367457|83168099|FG002|Overall Study|Progression|0|||
46932555|NCT01367457|83168097|FG000|Overall Study|Patient asks for rest + slow progression|1|||
46932556|NCT01367457|83168098|FG001|Overall Study|Patient asks for rest + slow progression|0|||
46932557|NCT01367457|83168099|FG002|Overall Study|Patient asks for rest + slow progression|0|||
46820944|NCT00454818|83040412|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
46820945|NCT00454818|83040413|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
46820946|NCT00454818|83040414|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
46820947|NCT00454818|83040415|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
46820948|NCT00445224|83040434|FG000|Specific Exercises|Withdrawal by Subject|3|||
46820949|NCT00445224|83040435|FG001|Specific Exercises|Withdrawal by Subject|3|||
46820950|NCT00445224|83040434|FG000|Specific Exercises|Withdrawal by Subject|1|||
46820951|NCT00445224|83040435|FG001|Specific Exercises|Withdrawal by Subject|0|||
46820952|NCT00358917|83040452|FG000|Overall Study|Adverse Event|14|||
46820953|NCT00358917|83040453|FG001|Overall Study|Adverse Event|21|||
46820954|NCT00358917|83040452|FG000|Overall Study|Withdrawal by Subject|5|||
46820955|NCT00358917|83040453|FG001|Overall Study|Withdrawal by Subject|7|||
46820956|NCT00358917|83040452|FG000|Overall Study|Lost to Follow-up|20|||
46820957|NCT00358917|83040453|FG001|Overall Study|Lost to Follow-up|17|||
46820958|NCT00358917|83040452|FG000|Overall Study|Noncompliance|12|||
46820959|NCT00358917|83040453|FG001|Overall Study|Noncompliance|11|||
46932558|NCT01367457|83168097|FG000|Overall Study|Investigator's opinion, stable disease|1|||
46820960|NCT00358917|83040452|FG000|Overall Study|Death|2|||
46820961|NCT00358917|83040453|FG001|Overall Study|Death|3|||
46820962|NCT00358917|83040452|FG000|Overall Study|Virologic failure|11|||
46820963|NCT00358917|83040453|FG001|Overall Study|Virologic failure|8|||
46820964|NCT00358917|83040452|FG000|Overall Study|Unable to Continue Participation|2|||
46820965|NCT00358917|83040453|FG001|Overall Study|Unable to Continue Participation|2|||
46820966|NCT00264004|83040465|FG000|Overall Study|Adverse Event|2|||
46932559|NCT01367457|83168098|FG001|Overall Study|Investigator's opinion, stable disease|0|||
46932560|NCT01367457|83168099|FG002|Overall Study|Investigator's opinion, stable disease|0|||
46932561|NCT01367457|83168097|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
46932562|NCT01367457|83168098|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
46932563|NCT01367457|83168099|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
46760178|NCT00691132|82978258|FG001|Overall Study|Adverse Event|3|||
46760179|NCT00691132|82978257|FG000|Overall Study|Withdrawal by Subject|10|||
46760180|NCT00691132|82978258|FG001|Overall Study|Withdrawal by Subject|10|||
46760181|NCT00855218|82978280|FG000|Overall Study|Adverse Event|43|||
46932564|NCT01367457|83168097|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
46932565|NCT01367457|83168098|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
46932566|NCT01367457|83168099|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
46932567|NCT01367457|83168097|FG000|Overall Study|low grade toxicities + stable disease|1|||
46932568|NCT01367457|83168098|FG001|Overall Study|low grade toxicities + stable disease|0|||
46932569|NCT01367457|83168099|FG002|Overall Study|low grade toxicities + stable disease|0|||
46932570|NCT01367457|83168097|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
46932571|NCT01367457|83168098|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
46932572|NCT01367457|83168099|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
47056598|NCT01743989|83333758|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
46760182|NCT00855218|82978281|FG001|Overall Study|Adverse Event|27|||
46760183|NCT00855218|82978280|FG000|Overall Study|Withdrawal by Subject|10|||
46760184|NCT00855218|82978281|FG001|Overall Study|Withdrawal by Subject|6|||
46760185|NCT00855218|82978280|FG000|Overall Study|Physician Decision|18|||
46760186|NCT00855218|82978281|FG001|Overall Study|Physician Decision|11|||
46760187|NCT00855218|82978280|FG000|Overall Study|Lost to Follow-up|0|||
46760188|NCT00855218|82978281|FG001|Overall Study|Lost to Follow-up|1|||
46932573|NCT01367457|83168097|FG000|Overall Study|Withdrawal by Subject|1|||
46932574|NCT01367457|83168098|FG001|Overall Study|Withdrawal by Subject|0|||
46932575|NCT01367457|83168099|FG002|Overall Study|Withdrawal by Subject|0|||
46932576|NCT01367457|83168097|FG000|Overall Study|CD, associated leukaemia|1|||
46932577|NCT01367457|83168098|FG001|Overall Study|CD, associated leukaemia|0|||
46932578|NCT01367457|83168099|FG002|Overall Study|CD, associated leukaemia|0|||
46932579|NCT01367457|83168097|FG000|Overall Study|Uncontrolled pain|1|||
46760189|NCT00855218|82978280|FG000|Overall Study|Protocol Violation|5|||
46760190|NCT00855218|82978281|FG001|Overall Study|Protocol Violation|9|||
46820967|NCT00264004|83040466|FG001|Overall Study|Adverse Event|3|||
46820968|NCT00264004|83040467|FG002|Overall Study|Adverse Event|6|||
46932580|NCT01367457|83168098|FG001|Overall Study|Uncontrolled pain|0|||
46932581|NCT01367457|83168099|FG002|Overall Study|Uncontrolled pain|0|||
46932582|NCT01367457|83168097|FG000|Overall Study|Overall status worsens to grade 4|1|||
46932583|NCT01367457|83168098|FG001|Overall Study|Overall status worsens to grade 4|0|||
46932584|NCT01367457|83168099|FG002|Overall Study|Overall status worsens to grade 4|0|||
46932585|NCT01367457|83168097|FG000|Overall Study|Stabilisation + frequent infections|1|||
46932586|NCT01367457|83168098|FG001|Overall Study|Stabilisation + frequent infections|0|||
46760191|NCT00855218|82978280|FG000|Overall Study|non-compliant with study drug|3|||
46760192|NCT00855218|82978281|FG001|Overall Study|non-compliant with study drug|1|||
46760193|NCT00855218|82978280|FG000|Overall Study|patient convenience|2|||
46760194|NCT00855218|82978281|FG001|Overall Study|patient convenience|0|||
46760195|NCT00855218|82978280|FG000|Overall Study|technical problems|2|||
46760196|NCT00855218|82978281|FG001|Overall Study|technical problems|1|||
46760197|NCT00855218|82978280|FG000|Overall Study|Still treated with study medication|0|||
46820969|NCT00264004|83040468|FG003|Overall Study|Adverse Event|4|||
46820970|NCT00264004|83040465|FG000|Overall Study|Withdrawal by Subject|0|||
46820971|NCT00264004|83040466|FG001|Overall Study|Withdrawal by Subject|1|||
46820972|NCT00264004|83040467|FG002|Overall Study|Withdrawal by Subject|2|||
46820973|NCT00264004|83040468|FG003|Overall Study|Withdrawal by Subject|2|||
46820974|NCT00264004|83040465|FG000|Overall Study|Other|2|||
46820975|NCT00264004|83040466|FG001|Overall Study|Other|2|||
46820976|NCT00264004|83040467|FG002|Overall Study|Other|0|||
46820977|NCT00264004|83040468|FG003|Overall Study|Other|3|||
46820978|NCT00264004|83040465|FG000|Overall Study|Development study specific disc. crit.|1|||
46820979|NCT00264004|83040466|FG001|Overall Study|Development study specific disc. crit.|0|||
46820980|NCT00264004|83040467|FG002|Overall Study|Development study specific disc. crit.|1|||
46820981|NCT00264004|83040468|FG003|Overall Study|Development study specific disc. crit.|0|||
46820982|NCT00264004|83040465|FG000|Overall Study|Cond. under inv. worsened|9|||
46820983|NCT00264004|83040466|FG001|Overall Study|Cond. under inv. worsened|5|||
46820984|NCT00264004|83040467|FG002|Overall Study|Cond. under inv. worsened|3|||
46820985|NCT00264004|83040468|FG003|Overall Study|Cond. under inv. worsened|4|||
46820986|NCT00264004|83040465|FG000|Overall Study|Not treated|3|||
46820987|NCT00264004|83040466|FG001|Overall Study|Not treated|0|||
46820988|NCT00264004|83040467|FG002|Overall Study|Not treated|2|||
46820989|NCT00264004|83040468|FG003|Overall Study|Not treated|2|||
46820990|NCT00368355|83040480|FG000|Overall Study|Adverse Event|1|||
46820991|NCT00368355|83040481|FG001|Overall Study|Adverse Event|0|||
46820992|NCT00368355|83040480|FG000|Overall Study|Death|2|||
46820993|NCT00368355|83040481|FG001|Overall Study|Death|4|||
46820994|NCT00368355|83040480|FG000|Overall Study|Relapse|6|||
46820995|NCT00368355|83040481|FG001|Overall Study|Relapse|10|||
46820996|NCT00368355|83040480|FG000|Overall Study|Subsequent transplant|0|||
46820997|NCT00368355|83040481|FG001|Overall Study|Subsequent transplant|3|||
46820998|NCT00368355|83040480|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
46820999|NCT00368355|83040481|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
46821000|NCT00445146|83040487|FG000|Overall Study|Withdrew Consent|29|||
46821001|NCT00445146|83040487|FG000|Overall Study|Lack of Efficacy|28|||
46821002|NCT00445146|83040487|FG000|Overall Study|Investigator's Discretion|22|||
46821003|NCT00445146|83040487|FG000|Overall Study|Adverse Event|13|||
46821004|NCT00445146|83040487|FG000|Overall Study|Lost to Follow-up|13|||
46821005|NCT00445146|83040487|FG000|Overall Study|Death|9|||
46821006|NCT00445146|83040487|FG000|Overall Study|Protocol Violation|4|||
46821007|NCT00445146|83040487|FG000|Overall Study|Pregnancy|1|||
46821008|NCT00368277|83040493|FG000|Overall Study|Adverse Event|33|||
46821009|NCT00368277|83040494|FG001|Overall Study|Adverse Event|49|||
46821010|NCT00368277|83040493|FG000|Overall Study|Death|2|||
46821011|NCT00368277|83040494|FG001|Overall Study|Death|1|||
46821012|NCT00368277|83040493|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
46821013|NCT00368277|83040494|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
46821014|NCT00368277|83040493|FG000|Overall Study|Protocol deviation|7|||
46821015|NCT00368277|83040494|FG001|Overall Study|Protocol deviation|0|||
46821016|NCT00368277|83040493|FG000|Overall Study|Patient withdrew consent|32|||
46932587|NCT01367457|83168099|FG002|Overall Study|Stabilisation + frequent infections|0|||
46932588|NCT01367457|83168097|FG000|Overall Study|No clinical benefit|1|||
46932589|NCT01367457|83168098|FG001|Overall Study|No clinical benefit|0|||
46932590|NCT01367457|83168099|FG002|Overall Study|No clinical benefit|0|||
46967710|NCT02120950|83210258|FG001|Overall Study|Protocol Violation|1|||
46760198|NCT00855218|82978281|FG001|Overall Study|Still treated with study medication|1|||
46760199|NCT00855218|82978280|FG000|Overall Study|Untreatable disease progression|54|||
46821017|NCT00368277|83040494|FG001|Overall Study|Patient withdrew consent|28|||
46821018|NCT00368277|83040493|FG000|Overall Study|Lost to Follow-up|8|||
46821019|NCT00368277|83040494|FG001|Overall Study|Lost to Follow-up|6|||
46821020|NCT00280150|83040504|FG000|Overall Study|Adverse Event|0|||
46821021|NCT00280150|83040505|FG001|Overall Study|Adverse Event|1|||
46821022|NCT00280150|83040506|FG002|Overall Study|Adverse Event|2|||
46967711|NCT02120950|83210259|FG002|Overall Study|Protocol Violation|7|||
46967712|NCT02120950|83210257|FG000|Overall Study|Other reasons|5|||
46967713|NCT02120950|83210258|FG001|Overall Study|Other reasons|4|||
46967714|NCT02120950|83210259|FG002|Overall Study|Other reasons|1|||
46821023|NCT00280150|83040507|FG003|Overall Study|Adverse Event|3|||
46821024|NCT00280150|83040504|FG000|Overall Study|Lack of Efficacy|0|||
46821025|NCT00280150|83040505|FG001|Overall Study|Lack of Efficacy|0|||
46821026|NCT00280150|83040506|FG002|Overall Study|Lack of Efficacy|0|||
46821027|NCT00280150|83040507|FG003|Overall Study|Lack of Efficacy|3|||
46821028|NCT00280150|83040504|FG000|Overall Study|Physician Decision|0|||
46821029|NCT00280150|83040505|FG001|Overall Study|Physician Decision|0|||
46821030|NCT00280150|83040506|FG002|Overall Study|Physician Decision|0|||
46821031|NCT00280150|83040507|FG003|Overall Study|Physician Decision|1|||
46821032|NCT00280150|83040504|FG000|Overall Study|Protocol Violation|0|||
46821033|NCT00280150|83040505|FG001|Overall Study|Protocol Violation|0|||
46821034|NCT00280150|83040506|FG002|Overall Study|Protocol Violation|0|||
46821035|NCT00280150|83040507|FG003|Overall Study|Protocol Violation|1|||
46821036|NCT00280150|83040504|FG000|Overall Study|Withdrawal by Subject|0|||
46821037|NCT00280150|83040505|FG001|Overall Study|Withdrawal by Subject|0|||
46821038|NCT00280150|83040506|FG002|Overall Study|Withdrawal by Subject|0|||
46821039|NCT00280150|83040507|FG003|Overall Study|Withdrawal by Subject|1|||
46821040|NCT00280150|83040504|FG000|Overall Study|Did not get consolidation therapy|3|||
46821041|NCT00280150|83040505|FG001|Overall Study|Did not get consolidation therapy|0|||
46821042|NCT00280150|83040506|FG002|Overall Study|Did not get consolidation therapy|3|||
46821043|NCT00280150|83040507|FG003|Overall Study|Did not get consolidation therapy|0|||
46821044|NCT00280150|83040504|FG000|Overall Study|Declining Performance Status|0|||
46821045|NCT00280150|83040505|FG001|Overall Study|Declining Performance Status|0|||
46821046|NCT00280150|83040506|FG002|Overall Study|Declining Performance Status|0|||
46821047|NCT00280150|83040507|FG003|Overall Study|Declining Performance Status|1|||
46821048|NCT00279916|83040520|FG000|Overall Study|Withdrawal by Subject|4|||
46821049|NCT00279916|83040521|FG001|Overall Study|Withdrawal by Subject|3|||
46821050|NCT00279916|83040520|FG000|Overall Study|Lost to Follow-up|3|||
46821051|NCT00279916|83040521|FG001|Overall Study|Lost to Follow-up|2|||
46821052|NCT00358527|83040529|FG000|Overall Study|Adverse Event|4|||
46821053|NCT00358527|83040530|FG001|Overall Study|Adverse Event|0|||
46821054|NCT00358527|83040529|FG000|Overall Study|Withdrawal by Subject|1|||
46821055|NCT00358527|83040530|FG001|Overall Study|Withdrawal by Subject|1|||
46821056|NCT00358527|83040529|FG000|Overall Study|Non-compliance with protocol|6|||
46821057|NCT00358527|83040530|FG001|Overall Study|Non-compliance with protocol|1|||
46932591|NCT01367457|83168097|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
46932592|NCT01367457|83168098|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
46932593|NCT01367457|83168099|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
46932594|NCT01367457|83168097|FG000|Overall Study|Overall decline|1|||
46932595|NCT01367457|83168098|FG001|Overall Study|Overall decline|0|||
46932596|NCT01367457|83168099|FG002|Overall Study|Overall decline|0|||
46932597|NCT01367457|83168097|FG000|Overall Study|Rejection of treatment|1|||
46932598|NCT01367457|83168098|FG001|Overall Study|Rejection of treatment|0|||
46932599|NCT01367457|83168099|FG002|Overall Study|Rejection of treatment|0|||
46932600|NCT01367457|83168097|FG000|Overall Study|Lost to Follow-up|1|||
46932601|NCT01367457|83168098|FG001|Overall Study|Lost to Follow-up|0|||
46932602|NCT01367457|83168099|FG002|Overall Study|Lost to Follow-up|0|||
46932603|NCT01367457|83168097|FG000|Overall Study|Death from septic shock|1|||
46821058|NCT00358527|83040529|FG000|Overall Study|Administrative|2|||
46821059|NCT00358527|83040530|FG001|Overall Study|Administrative|1|||
46821060|NCT00251758|83040539|FG000|Overall Study|Adverse Event|7|||
46821061|NCT00251758|83040540|FG001|Overall Study|Adverse Event|9|||
46932604|NCT01367457|83168098|FG001|Overall Study|Death from septic shock|0|||
46932605|NCT01367457|83168099|FG002|Overall Study|Death from septic shock|0|||
46932606|NCT01367457|83168097|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
47056599|NCT01743989|83333756|FG000|Treatment Phase|Administrative problems|0|||
46760200|NCT00855218|82978281|FG001|Overall Study|Untreatable disease progression|67|||
46760201|NCT00855218|82978280|FG000|Overall Study|Second malignancy|0|||
46760202|NCT00855218|82978281|FG001|Overall Study|Second malignancy|1|||
46760203|NCT00855218|82978280|FG000|Overall Study|Progression measurement proven|7|||
46760204|NCT00855218|82978281|FG001|Overall Study|Progression measurement proven|15|||
46760205|NCT00855218|82978280|FG000|Overall Study|Clinical endpoint reached|10|||
46760206|NCT00855218|82978281|FG001|Overall Study|Clinical endpoint reached|13|||
46760207|NCT01063348|82978289|FG000|Overall Study|Lost to Follow-up|3|||
46760208|NCT01063348|82978290|FG001|Overall Study|Lost to Follow-up|10|||
46760209|NCT00855062|82978298|FG000|Step1|Early Study Closure|5|||
46760210|NCT00855062|82978299|FG001|Step1|Early Study Closure|7|||
46821062|NCT00251758|83040541|FG002|Overall Study|Adverse Event|11|||
46821063|NCT00251758|83040539|FG000|Overall Study|Lost to Follow-up|4|||
46821064|NCT00251758|83040540|FG001|Overall Study|Lost to Follow-up|2|||
46821065|NCT00251758|83040541|FG002|Overall Study|Lost to Follow-up|5|||
46821066|NCT00251758|83040539|FG000|Overall Study|Withdrawal by Subject|13|||
46821067|NCT00251758|83040540|FG001|Overall Study|Withdrawal by Subject|7|||
46821068|NCT00251758|83040541|FG002|Overall Study|Withdrawal by Subject|3|||
46821069|NCT00251758|83040539|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
46932607|NCT01367457|83168098|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
46821070|NCT00251758|83040540|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
46821071|NCT00251758|83040541|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
46821072|NCT00251758|83040539|FG000|Overall Study|Lack of Efficacy|3|||
46821073|NCT00251758|83040540|FG001|Overall Study|Lack of Efficacy|0|||
46821074|NCT00251758|83040541|FG002|Overall Study|Lack of Efficacy|0|||
46821075|NCT00251758|83040539|FG000|Overall Study|Noncompliant|0|||
46821076|NCT00251758|83040540|FG001|Overall Study|Noncompliant|2|||
46821077|NCT00251758|83040541|FG002|Overall Study|Noncompliant|2|||
46821078|NCT00251758|83040539|FG000|Overall Study|Pregnancy|0|||
46821079|NCT00251758|83040540|FG001|Overall Study|Pregnancy|1|||
46821080|NCT00251758|83040541|FG002|Overall Study|Pregnancy|0|||
46821081|NCT00251758|83040539|FG000|Overall Study|Per Subject Request|0|||
46821082|NCT00251758|83040540|FG001|Overall Study|Per Subject Request|0|||
46821083|NCT00251758|83040541|FG002|Overall Study|Per Subject Request|1|||
46821084|NCT00251758|83040539|FG000|Overall Study|Per Investigator Request|1|||
46821085|NCT00251758|83040540|FG001|Overall Study|Per Investigator Request|0|||
46821086|NCT00251758|83040541|FG002|Overall Study|Per Investigator Request|0|||
46932608|NCT01367457|83168099|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
46932609|NCT01367457|83168097|FG000|Overall Study|Patient's Wish|1|||
46932610|NCT01367457|83168098|FG001|Overall Study|Patient's Wish|0|||
46932611|NCT01367457|83168099|FG002|Overall Study|Patient's Wish|0|||
46932612|NCT01367457|83168097|FG000|Overall Study|Palliative. Overall decline|1|||
46932613|NCT01367457|83168098|FG001|Overall Study|Palliative. Overall decline|0|||
46932614|NCT01367457|83168099|FG002|Overall Study|Palliative. Overall decline|0|||
46932615|NCT01367457|83168097|FG000|Overall Study|Suspected DP/suspected active infection|1|||
46932616|NCT01367457|83168098|FG001|Overall Study|Suspected DP/suspected active infection|0|||
46932617|NCT01367457|83168099|FG002|Overall Study|Suspected DP/suspected active infection|0|||
46932618|NCT00235326|83168109|FG000|Overall Study|Lost to Follow-up|746|||
46932619|NCT00235326|83168110|FG001|Overall Study|Lost to Follow-up|1400|||
46932620|NCT00162942|83168120|FG000|Overall Study|Adverse Event|10|||
47056600|NCT01743989|83333757|FG001|Treatment Phase|Administrative problems|0|||
47056601|NCT01743989|83333758|FG002|Treatment Phase|Administrative problems|1|||
47056602|NCT01743989|83333756|FG000|Treatment Phase|New cancer (CML) therapy|0|||
47056603|NCT01743989|83333757|FG001|Treatment Phase|New cancer (CML) therapy|1|||
47056604|NCT01743989|83333758|FG002|Treatment Phase|New cancer (CML) therapy|0|||
47056605|NCT01743989|83333756|FG000|Treatment Phase|Physician Decision|0|||
47056606|NCT01743989|83333757|FG001|Treatment Phase|Physician Decision|0|||
47056607|NCT01743989|83333758|FG002|Treatment Phase|Physician Decision|3|||
47056608|NCT01743989|83333756|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
47056609|NCT01743989|83333757|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
47056610|NCT01743989|83333758|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
46760211|NCT00855062|82978298|FG000|Step1|Adverse Event|1|||
46760212|NCT00855062|82978299|FG001|Step1|Adverse Event|1|||
46760213|NCT00855062|82978298|FG000|Step1|Protocol Violation|1|||
46760214|NCT00855062|82978299|FG001|Step1|Protocol Violation|0|||
46760215|NCT00855062|82978298|FG000|Step1|Pregnancy|1|||
46760216|NCT00855062|82978299|FG001|Step1|Pregnancy|0|||
46760217|NCT00855062|82978298|FG000|Step1|Withdrawal by Subject|2|||
46760218|NCT00855062|82978299|FG001|Step1|Withdrawal by Subject|3|||
46760219|NCT00855062|82978298|FG000|Step2|Early Study Closure|6|||
46760220|NCT00855062|82978299|FG001|Step2|Early Study Closure|2|||
46760221|NCT00855062|82978298|FG000|Step2|Adverse Event|0|||
46760222|NCT00855062|82978299|FG001|Step2|Adverse Event|3|||
46760223|NCT00855062|82978298|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
46760224|NCT00855062|82978299|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
46760225|NCT00854906|82978305|FG000|Overall Study|One person had no ocular history|1|||
46760226|NCT00854828|82978316|FG000|Overall Study|Death|1|||
46760227|NCT00854828|82978317|FG001|Overall Study|Death|0|||
46760228|NCT00854828|82978318|FG002|Overall Study|Death|0|||
46760229|NCT00854828|82978319|FG003|Overall Study|Death|0|||
46760230|NCT00854828|82978316|FG000|Overall Study|Withdrawal by Subject|1|||
46760231|NCT00854828|82978317|FG001|Overall Study|Withdrawal by Subject|1|||
46760232|NCT00854828|82978318|FG002|Overall Study|Withdrawal by Subject|0|||
46760233|NCT00854828|82978319|FG003|Overall Study|Withdrawal by Subject|9|||
46760234|NCT00854828|82978316|FG000|Overall Study|Missed 24mo visit|1|||
46760235|NCT00854828|82978317|FG001|Overall Study|Missed 24mo visit|1|||
46821087|NCT00279214|83040551|FG000|Overall Study|Physician Decision|3|||
46821088|NCT00279214|83040552|FG001|Overall Study|Physician Decision|2|||
46821089|NCT00262834|83040560|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
46821090|NCT00262834|83040561|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
46821091|NCT00541775|83040570|FG000|Overall Study|Adverse Event|3|||
46821092|NCT00541775|83040571|FG001|Overall Study|Adverse Event|2|||
46932621|NCT00162942|83168121|FG001|Overall Study|Adverse Event|6|||
46932622|NCT00162942|83168120|FG000|Overall Study|Death|1|||
46932623|NCT00162942|83168121|FG001|Overall Study|Death|0|||
46821093|NCT00541775|83040572|FG002|Overall Study|Adverse Event|1|||
46821094|NCT00541775|83040570|FG000|Overall Study|Lack of Efficacy|0|||
46821095|NCT00541775|83040571|FG001|Overall Study|Lack of Efficacy|0|||
46821096|NCT00541775|83040572|FG002|Overall Study|Lack of Efficacy|3|||
46821097|NCT00541775|83040570|FG000|Overall Study|Lost to Follow-up|0|||
46821098|NCT00541775|83040571|FG001|Overall Study|Lost to Follow-up|0|||
46821099|NCT00541775|83040572|FG002|Overall Study|Lost to Follow-up|2|||
46821100|NCT00541775|83040570|FG000|Overall Study|Protocol Violation|1|||
46821101|NCT00541775|83040571|FG001|Overall Study|Protocol Violation|0|||
46821102|NCT00541775|83040572|FG002|Overall Study|Protocol Violation|0|||
46821103|NCT00541775|83040570|FG000|Overall Study|Withdrawal by Subject and Other|5|||
46821104|NCT00541775|83040571|FG001|Overall Study|Withdrawal by Subject and Other|0|||
46821105|NCT00541775|83040572|FG002|Overall Study|Withdrawal by Subject and Other|2|||
46821106|NCT00539513|83040582|FG000|Overall Study|Withdrawal by Subject|2|||
46821107|NCT00539513|83040583|FG001|Overall Study|Withdrawal by Subject|1|||
46932624|NCT00162942|83168120|FG000|Overall Study|Withdrawal by Subject|3|||
46932625|NCT00162942|83168121|FG001|Overall Study|Withdrawal by Subject|6|||
46932626|NCT00162942|83168120|FG000|Overall Study|Physician Decision|1|||
46932627|NCT00162942|83168121|FG001|Overall Study|Physician Decision|0|||
46932628|NCT00162942|83168120|FG000|Overall Study|Enter Open-Label Study|76|||
46932629|NCT00162942|83168121|FG001|Overall Study|Enter Open-Label Study|35|||
46932630|NCT00162942|83168120|FG000|Overall Study|Alternate Therapy|6|||
46932631|NCT00162942|83168121|FG001|Overall Study|Alternate Therapy|2|||
46932632|NCT00162942|83168120|FG000|Overall Study|Lack of Efficacy|1|||
46932633|NCT00162942|83168121|FG001|Overall Study|Lack of Efficacy|0|||
46932634|NCT00162942|83168120|FG000|Overall Study|Flare During Active Treatment|7|||
46760236|NCT00854828|82978318|FG002|Overall Study|Missed 24mo visit|8|||
46760237|NCT00854828|82978319|FG003|Overall Study|Missed 24mo visit|8|||
46760238|NCT00847730|82978329|FG000|Overall Study|Multiple interruptions in therapy|8|||
46760239|NCT00600119|82978339|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
46821108|NCT00539513|83040582|FG000|Overall Study|Lost to Follow-up|0|||
46821109|NCT00539513|83040583|FG001|Overall Study|Lost to Follow-up|1|||
46821110|NCT00454584|83040592|FG000|Controlled Period|Adverse Event|5|||
46821111|NCT00454584|83040593|FG001|Controlled Period|Adverse Event|2|||
46821112|NCT00454584|83040594|FG002|Controlled Period|Adverse Event|1|||
46821113|NCT00454584|83040595|FG003|Controlled Period|Adverse Event|0|||
46821114|NCT00454584|83040596|FG004|Controlled Period|Adverse Event|0|||
46821115|NCT00454584|83040597|FG005|Controlled Period|Adverse Event|0|||
46821116|NCT00454584|83040592|FG000|Controlled Period|Lost to Follow-up|1|||
46932635|NCT00162942|83168121|FG001|Overall Study|Flare During Active Treatment|3|||
46760240|NCT00600119|82978340|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
46760241|NCT00600119|82978341|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
46760242|NCT00600119|82978342|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
46760243|NCT00600119|82978343|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
46760244|NCT00600119|82978344|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
46760245|NCT00600119|82978339|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46760246|NCT00600119|82978340|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
46760247|NCT00600119|82978341|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
46760248|NCT00600119|82978342|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46760249|NCT00600119|82978343|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46760250|NCT00600119|82978344|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46760251|NCT00600119|82978339|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
46760252|NCT00600119|82978340|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
46760253|NCT00600119|82978341|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
46760254|NCT00600119|82978342|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
46760255|NCT00600119|82978343|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
46760256|NCT00600119|82978344|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
46760257|NCT00600119|82978339|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
46760258|NCT00600119|82978340|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
46821117|NCT00454584|83040593|FG001|Controlled Period|Lost to Follow-up|2|||
46932636|NCT00162942|83168120|FG000|Overall Study|2 or more consecutive treatments missed|1|||
46821118|NCT00454584|83040594|FG002|Controlled Period|Lost to Follow-up|2|||
46821119|NCT00454584|83040595|FG003|Controlled Period|Lost to Follow-up|0|||
46760259|NCT00600119|82978341|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
46760260|NCT00600119|82978342|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
46760261|NCT00600119|82978343|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
46821120|NCT00454584|83040596|FG004|Controlled Period|Lost to Follow-up|0|||
46821121|NCT00454584|83040597|FG005|Controlled Period|Lost to Follow-up|0|||
46821122|NCT00454584|83040592|FG000|Controlled Period|Other|5|||
46821123|NCT00454584|83040593|FG001|Controlled Period|Other|4|||
46932637|NCT00162942|83168121|FG001|Overall Study|2 or more consecutive treatments missed|0|||
46821124|NCT00454584|83040594|FG002|Controlled Period|Other|2|||
46821125|NCT00454584|83040595|FG003|Controlled Period|Other|0|||
46821126|NCT00454584|83040596|FG004|Controlled Period|Other|0|||
46821127|NCT00454584|83040597|FG005|Controlled Period|Other|0|||
46821128|NCT00454584|83040592|FG000|After Controlled Period|Adverse Event|0|||
46821129|NCT00454584|83040593|FG001|After Controlled Period|Adverse Event|0|||
46821130|NCT00454584|83040594|FG002|After Controlled Period|Adverse Event|0|||
46821131|NCT00454584|83040595|FG003|After Controlled Period|Adverse Event|9|||
46821132|NCT00454584|83040596|FG004|After Controlled Period|Adverse Event|3|||
46821133|NCT00454584|83040597|FG005|After Controlled Period|Adverse Event|9|||
46821134|NCT00454584|83040592|FG000|After Controlled Period|Lack of Efficacy|0|||
46821135|NCT00454584|83040593|FG001|After Controlled Period|Lack of Efficacy|0|||
46821136|NCT00454584|83040594|FG002|After Controlled Period|Lack of Efficacy|0|||
46821137|NCT00454584|83040595|FG003|After Controlled Period|Lack of Efficacy|1|||
46821138|NCT00454584|83040596|FG004|After Controlled Period|Lack of Efficacy|0|||
46821139|NCT00454584|83040597|FG005|After Controlled Period|Lack of Efficacy|0|||
46821140|NCT00454584|83040592|FG000|After Controlled Period|Lost to Follow-up|0|||
46821141|NCT00454584|83040593|FG001|After Controlled Period|Lost to Follow-up|0|||
46821142|NCT00454584|83040594|FG002|After Controlled Period|Lost to Follow-up|0|||
46932638|NCT02786901|83168151|FG000|Overall Study|Adverse Event|1|||
46932639|NCT02786901|83168152|FG001|Overall Study|Adverse Event|1|||
46932640|NCT02786901|83168153|FG002|Overall Study|Adverse Event|2|||
46932641|NCT02786901|83168151|FG000|Overall Study|Physician Decision|1|||
46932642|NCT02786901|83168152|FG001|Overall Study|Physician Decision|0|||
46932643|NCT02786901|83168153|FG002|Overall Study|Physician Decision|0|||
46932644|NCT02786901|83168151|FG000|Overall Study|Rescue Therapy Use|71|||
46932645|NCT02786901|83168152|FG001|Overall Study|Rescue Therapy Use|49|||
46821143|NCT00454584|83040595|FG003|After Controlled Period|Lost to Follow-up|2|||
46821144|NCT00454584|83040596|FG004|After Controlled Period|Lost to Follow-up|4|||
46821145|NCT00454584|83040597|FG005|After Controlled Period|Lost to Follow-up|6|||
46821146|NCT00454584|83040592|FG000|After Controlled Period|Other|0|||
46821147|NCT00454584|83040593|FG001|After Controlled Period|Other|0|||
46821148|NCT00454584|83040594|FG002|After Controlled Period|Other|0|||
46821149|NCT00454584|83040595|FG003|After Controlled Period|Other|1|||
46821150|NCT00454584|83040596|FG004|After Controlled Period|Other|0|||
46821151|NCT00454584|83040597|FG005|After Controlled Period|Other|0|||
46821152|NCT00454584|83040592|FG000|After Controlled Period|Other|0|||
46821153|NCT00454584|83040593|FG001|After Controlled Period|Other|0|||
46821154|NCT00454584|83040594|FG002|After Controlled Period|Other|0|||
46821155|NCT00454584|83040595|FG003|After Controlled Period|Other|13|||
46821156|NCT00454584|83040596|FG004|After Controlled Period|Other|5|||
46821157|NCT00454584|83040597|FG005|After Controlled Period|Other|17|||
46821158|NCT00445068|83040611|FG000|Overall Study|Disease progression|26|||
46821159|NCT00445068|83040611|FG000|Overall Study|Adverse Event|5|||
46821160|NCT00445068|83040611|FG000|Overall Study|Abnormal laboratory value|2|||
46821161|NCT00445068|83040611|FG000|Overall Study|Withdrawal by Subject|2|||
46821162|NCT00445068|83040611|FG000|Overall Study|Death|1|||
46932646|NCT02786901|83168153|FG002|Overall Study|Rescue Therapy Use|33|||
46932647|NCT02786901|83168151|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
46932648|NCT02786901|83168152|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
46932649|NCT02786901|83168153|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
46932650|NCT02786901|83168151|FG000|Overall Study|Disallowed medication|1|||
46932651|NCT02786901|83168152|FG001|Overall Study|Disallowed medication|1|||
46932652|NCT02786901|83168153|FG002|Overall Study|Disallowed medication|0|||
46932653|NCT02786901|83168151|FG000|Overall Study|Randomized in error|2|||
46932654|NCT02786901|83168152|FG001|Overall Study|Randomized in error|0|||
46932655|NCT02786901|83168153|FG002|Overall Study|Randomized in error|1|||
46932656|NCT02137239|83168163|FG000|Overall Study|Discontinued Study Treatment|0|||
47056611|NCT01743989|83333756|FG000|Treatment Phase|Not randomized by mistake|0|||
47056612|NCT01743989|83333757|FG001|Treatment Phase|Not randomized by mistake|0|||
47056613|NCT01743989|83333758|FG002|Treatment Phase|Not randomized by mistake|1|||
46821163|NCT00539279|83040617|FG000|Treatment|Withdrawal by Subject|10|||
46821164|NCT00539279|83040618|FG001|Treatment|Withdrawal by Subject|8|||
46821165|NCT00539279|83040617|FG000|Treatment|Death|1|||
46821166|NCT00539279|83040618|FG001|Treatment|Death|0|||
46821167|NCT00539279|83040617|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
46821168|NCT00539279|83040618|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
46821169|NCT00539279|83040617|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
46821170|NCT00539279|83040618|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
46821171|NCT00444912|83040626|FG000|Overall Study|Death|1|||
46821172|NCT00444912|83040627|FG001|Overall Study|Death|2|||
46821173|NCT00444912|83040626|FG000|Overall Study|Lost to Follow-up|1|||
46821174|NCT00444912|83040627|FG001|Overall Study|Lost to Follow-up|0|||
46821175|NCT00444912|83040626|FG000|Overall Study|Participant Failed Mobilization|1|||
46932657|NCT02137239|83168164|FG001|Overall Study|Discontinued Study Treatment|3|||
46932658|NCT02137239|83168163|FG000|Overall Study|Withdrew Consent|1|||
46932659|NCT02137239|83168164|FG001|Overall Study|Withdrew Consent|1|||
47056614|NCT01743989|83333756|FG000|Treatment Phase|Included by mistake|0|||
46821176|NCT00444912|83040627|FG001|Overall Study|Participant Failed Mobilization|0|||
46821177|NCT00538733|83040633|FG000|Overall Study|Adverse Event|8|||
46821178|NCT00538733|83040633|FG000|Overall Study|Death|1|||
46821179|NCT00538733|83040633|FG000|Overall Study|declined to participate|2|||
46821180|NCT00538733|83040633|FG000|Overall Study|still on therapy|1|||
46821181|NCT00444678|83040640|FG000|Overall Study|Toxicity|11|||
46821182|NCT00444678|83040640|FG000|Overall Study|Disease Progression|12|||
46821183|NCT00444678|83040640|FG000|Overall Study|Death|3|||
46821184|NCT00444678|83040640|FG000|Overall Study|Physician Decision|3|||
46821185|NCT00444678|83040640|FG000|Overall Study|Withdrawal by Subject|2|||
46821186|NCT00358449|83040647|FG000|Overall Study|Adverse Event|1|||
46821187|NCT00358449|83040648|FG001|Overall Study|Adverse Event|0|||
46821188|NCT00358449|83040649|FG002|Overall Study|Adverse Event|1|||
46821189|NCT00358449|83040647|FG000|Overall Study|Lost to Follow-up|1|||
46821190|NCT00358449|83040648|FG001|Overall Study|Lost to Follow-up|0|||
46821191|NCT00358449|83040649|FG002|Overall Study|Lost to Follow-up|0|||
46932660|NCT02137239|83168163|FG000|Overall Study|Adverse Event|2|||
46932661|NCT02137239|83168164|FG001|Overall Study|Adverse Event|2|||
46932662|NCT02741076|83168183|FG000|Overall Study|Adverse Event|0|||
46932663|NCT02741076|83168184|FG001|Overall Study|Adverse Event|1|||
46932664|NCT02741076|83168185|FG002|Overall Study|Adverse Event|1|||
46932665|NCT02741076|83168186|FG003|Overall Study|Adverse Event|0|||
46932666|NCT02741076|83168183|FG000|Overall Study|Lack of Efficacy|1|||
46932667|NCT02741076|83168184|FG001|Overall Study|Lack of Efficacy|0|||
46821192|NCT00358449|83040647|FG000|Overall Study|Withdrawal by Subject|2|||
46821193|NCT00358449|83040648|FG001|Overall Study|Withdrawal by Subject|0|||
46821194|NCT00358449|83040649|FG002|Overall Study|Withdrawal by Subject|0|||
46821195|NCT00358449|83040647|FG000|Overall Study|Lack of Efficacy|0|||
46821196|NCT00358449|83040648|FG001|Overall Study|Lack of Efficacy|1|||
46821197|NCT00358449|83040649|FG002|Overall Study|Lack of Efficacy|0|||
46821198|NCT00358449|83040647|FG000|Overall Study|Steriod Inhaler was Increased|0|||
46821199|NCT00358449|83040648|FG001|Overall Study|Steriod Inhaler was Increased|0|||
46821200|NCT00358449|83040649|FG002|Overall Study|Steriod Inhaler was Increased|1|||
46821201|NCT00539981|83040661|FG000|Overall Study|Adverse events (AE)|3|||
46821202|NCT00539981|83040662|FG001|Overall Study|Adverse events (AE)|3|||
46932668|NCT02741076|83168185|FG002|Overall Study|Lack of Efficacy|0|||
46932669|NCT02741076|83168186|FG003|Overall Study|Lack of Efficacy|0|||
46932670|NCT02741076|83168183|FG000|Overall Study|Withdrawal by Subject|0|||
46932671|NCT02741076|83168184|FG001|Overall Study|Withdrawal by Subject|1|||
46932672|NCT02741076|83168185|FG002|Overall Study|Withdrawal by Subject|0|||
47056615|NCT01743989|83333757|FG001|Treatment Phase|Included by mistake|0|||
47056616|NCT01743989|83333758|FG002|Treatment Phase|Included by mistake|1|||
47056617|NCT01743989|83333756|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
47056618|NCT01743989|83333757|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
47056619|NCT01743989|83333758|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
47056620|NCT01743989|83333756|FG000|TFR Phase|Adverse Event|0|||
47056621|NCT01743989|83333757|FG001|TFR Phase|Adverse Event|1|||
47056622|NCT01743989|83333758|FG002|TFR Phase|Adverse Event|0|||
47056623|NCT01743989|83333756|FG000|TFR Phase|Lost to Follow-up|0|||
46760262|NCT00600119|82978344|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
46760263|NCT00600119|82978339|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
46760264|NCT00600119|82978340|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
46760265|NCT00600119|82978341|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
46760266|NCT00600119|82978342|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
46760267|NCT00600119|82978343|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
46760268|NCT00600119|82978344|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
46760269|NCT00600119|82978339|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
46760270|NCT00600119|82978340|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
46760271|NCT00600119|82978341|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
46760272|NCT00600119|82978342|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
46760273|NCT00600119|82978343|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
47056624|NCT01743989|83333757|FG001|TFR Phase|Lost to Follow-up|2|||
47056625|NCT01743989|83333758|FG002|TFR Phase|Lost to Follow-up|0|||
47056626|NCT01743989|83333756|FG000|TFR Phase|Physician Decision|0|||
46760274|NCT00600119|82978344|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
46760275|NCT00600119|82978339|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
46821203|NCT00539981|83040661|FG000|Overall Study|Lost to Follow-up|260|||
46821204|NCT00539981|83040662|FG001|Overall Study|Lost to Follow-up|251|||
46821205|NCT00539981|83040661|FG000|Overall Study|Withdrew consent|22|||
46821206|NCT00539981|83040662|FG001|Overall Study|Withdrew consent|14|||
46821207|NCT00539981|83040661|FG000|Overall Study|Death|1|||
46821208|NCT00539981|83040662|FG001|Overall Study|Death|1|||
46932673|NCT02741076|83168186|FG003|Overall Study|Withdrawal by Subject|0|||
46932674|NCT02741076|83168183|FG000|Overall Study|Sponsor Request|2|||
46932675|NCT02741076|83168184|FG001|Overall Study|Sponsor Request|3|||
47056627|NCT01743989|83333757|FG001|TFR Phase|Physician Decision|1|||
47056628|NCT01743989|83333758|FG002|TFR Phase|Physician Decision|0|||
46821209|NCT00539981|83040661|FG000|Overall Study|Other reason-unspecified|9|||
46821210|NCT00539981|83040662|FG001|Overall Study|Other reason-unspecified|13|||
46821211|NCT00367341|83040673|FG000|Overall Study|Physician Decision|1|||
46821212|NCT00367341|83040674|FG001|Overall Study|Physician Decision|0|||
46821213|NCT00367341|83040673|FG000|Overall Study|Protocol Violation|1|||
46821214|NCT00367341|83040674|FG001|Overall Study|Protocol Violation|0|||
46821215|NCT00440466|83040683|FG000|Overall Study|Death|3|||
46821216|NCT00440466|83040684|FG001|Overall Study|Death|2|||
46821217|NCT00440466|83040685|FG002|Overall Study|Death|9|||
46821218|NCT00440466|83040683|FG000|Overall Study|Adverse Event|3|||
46821219|NCT00440466|83040684|FG001|Overall Study|Adverse Event|4|||
46821220|NCT00440466|83040685|FG002|Overall Study|Adverse Event|11|||
46821221|NCT00440466|83040683|FG000|Overall Study|Lost to Follow-up|1|||
46821222|NCT00440466|83040684|FG001|Overall Study|Lost to Follow-up|0|||
46821223|NCT00440466|83040685|FG002|Overall Study|Lost to Follow-up|2|||
46821224|NCT00440466|83040683|FG000|Overall Study|Physician Decision|2|||
46821225|NCT00440466|83040684|FG001|Overall Study|Physician Decision|0|||
46821226|NCT00440466|83040685|FG002|Overall Study|Physician Decision|1|||
46821227|NCT00440466|83040683|FG000|Overall Study|Protocol Violation|2|||
46821228|NCT00440466|83040684|FG001|Overall Study|Protocol Violation|0|||
46821229|NCT00440466|83040685|FG002|Overall Study|Protocol Violation|4|||
46821230|NCT00440466|83040683|FG000|Overall Study|Withdrawal by Subject|2|||
46821231|NCT00440466|83040684|FG001|Overall Study|Withdrawal by Subject|5|||
46821232|NCT00440466|83040685|FG002|Overall Study|Withdrawal by Subject|9|||
46821233|NCT00440466|83040683|FG000|Overall Study|Began Dialysis|0|||
46821234|NCT00440466|83040684|FG001|Overall Study|Began Dialysis|0|||
46821235|NCT00440466|83040685|FG002|Overall Study|Began Dialysis|1|||
46932676|NCT02741076|83168185|FG002|Overall Study|Sponsor Request|0|||
46932677|NCT02741076|83168186|FG003|Overall Study|Sponsor Request|1|||
46932678|NCT02741076|83168183|FG000|Overall Study|No additional information available|0|||
46932679|NCT02741076|83168184|FG001|Overall Study|No additional information available|0|||
46932680|NCT02741076|83168185|FG002|Overall Study|No additional information available|1|||
46932681|NCT02741076|83168186|FG003|Overall Study|No additional information available|1|||
46760276|NCT00600119|82978340|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
46760277|NCT00600119|82978341|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46760278|NCT00600119|82978342|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
46760279|NCT00600119|82978343|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
46760280|NCT00600119|82978344|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
46760281|NCT00600119|82978339|FG000|Double-blind Treatment Period|Other|0|||
46760282|NCT00600119|82978340|FG001|Double-blind Treatment Period|Other|0|||
46760283|NCT00600119|82978341|FG002|Double-blind Treatment Period|Other|0|||
46760284|NCT00600119|82978342|FG003|Double-blind Treatment Period|Other|0|||
46760285|NCT00600119|82978343|FG004|Double-blind Treatment Period|Other|2|||
46760286|NCT00600119|82978344|FG005|Double-blind Treatment Period|Other|1|||
46760287|NCT00600119|82978339|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
46760288|NCT00600119|82978340|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
46760289|NCT00600119|82978341|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
46760290|NCT00600119|82978342|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
46760291|NCT00600119|82978343|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
46760292|NCT00600119|82978344|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
46760293|NCT00600119|82978339|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
46760294|NCT00600119|82978340|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
46760295|NCT00600119|82978341|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
46760296|NCT00600119|82978342|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
46760297|NCT00600119|82978343|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
46760298|NCT00600119|82978344|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
46760299|NCT00600119|82978339|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
46760300|NCT00600119|82978340|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
46821236|NCT00440466|83040683|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
46821237|NCT00440466|83040684|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
46821238|NCT00440466|83040685|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
46821239|NCT00537485|83040695|FG000|Overall Study|Adverse Event|10|||
47056629|NCT01743989|83333756|FG000|TFR Phase|Logistical problems|0|||
47056630|NCT01743989|83333757|FG001|TFR Phase|Logistical problems|2|||
46760301|NCT00600119|82978341|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
46821240|NCT00537485|83040696|FG001|Overall Study|Adverse Event|5|||
46932682|NCT01666444|83168199|FG000|Overall Study|Did not initiate treatment|2|||
46932683|NCT01666444|83168200|FG001|Overall Study|Did not initiate treatment|1|||
46760302|NCT00600119|82978342|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
46821241|NCT00537485|83040695|FG000|Overall Study|Withdrawal by Subject|3|||
46821242|NCT00537485|83040696|FG001|Overall Study|Withdrawal by Subject|2|||
46821243|NCT00537485|83040695|FG000|Overall Study|Withdrawal by Subject|1|||
46821244|NCT00537485|83040696|FG001|Overall Study|Withdrawal by Subject|3|||
46821245|NCT00537485|83040695|FG000|Overall Study|Physician Decision|1|||
46821246|NCT00537485|83040696|FG001|Overall Study|Physician Decision|0|||
46821247|NCT00537329|83040702|FG000|Overall Study|Death|10|||
46821248|NCT00537329|83040702|FG000|Overall Study|Adverse Event|3|||
46821249|NCT00537329|83040702|FG000|Overall Study|Lack of Efficacy|2|||
46821250|NCT00537329|83040702|FG000|Overall Study|Lost to Follow-up|6|||
46821251|NCT00537329|83040702|FG000|Overall Study|Withdrawal by Subject|4|||
46821252|NCT00537329|83040702|FG000|Overall Study|Other|1|||
46821253|NCT03897179|83040706|FG000|Overall Study|Withdrawal by Subject|1|||
46821254|NCT03905135|83040712|FG000|Dose Escalation|Adverse Event|1|||
46821255|NCT03905135|83040713|FG001|Dose Escalation|Adverse Event|1|||
46821256|NCT03905135|83040712|FG000|Dose Escalation|Progressive disease|3|||
46821257|NCT03905135|83040713|FG001|Dose Escalation|Progressive disease|1|||
46821258|NCT03905135|83040712|FG000|Dose Escalation|Intercurrent illness|1|||
46821259|NCT03905135|83040713|FG001|Dose Escalation|Intercurrent illness|0|||
46821260|NCT00357903|83040723|FG000|Overall Study|Adverse Event|87|||
46821261|NCT00357903|83040724|FG001|Overall Study|Adverse Event|4|||
46821262|NCT00357903|83040723|FG000|Overall Study|Death|33|||
46821263|NCT00357903|83040724|FG001|Overall Study|Death|0|||
46821264|NCT00357903|83040723|FG000|Overall Study|Lost to Follow-up|23|||
46821265|NCT00357903|83040724|FG001|Overall Study|Lost to Follow-up|4|||
46821266|NCT00357903|83040723|FG000|Overall Study|Physician Decision|39|||
46821267|NCT00357903|83040724|FG001|Overall Study|Physician Decision|5|||
46821268|NCT00357903|83040723|FG000|Overall Study|Withdrawal by Subject|57|||
46821269|NCT00357903|83040724|FG001|Overall Study|Withdrawal by Subject|7|||
46821270|NCT00357903|83040723|FG000|Overall Study|Completed month 12 only|0|||
46821271|NCT00357903|83040724|FG001|Overall Study|Completed month 12 only|1|||
46821272|NCT00357903|83040723|FG000|Overall Study|Protocol issues|14|||
46821273|NCT00357903|83040724|FG001|Overall Study|Protocol issues|3|||
46821274|NCT00357903|83040723|FG000|Overall Study|Response status|61|||
46821275|NCT00357903|83040724|FG001|Overall Study|Response status|9|||
46932684|NCT05159622|83168208|FG000|Overall Study|Lost to Follow-up|4|||
46932685|NCT05159622|83168209|FG001|Overall Study|Lost to Follow-up|5|||
46821276|NCT00357903|83040723|FG000|Overall Study|Other|49|||
46821277|NCT00357903|83040724|FG001|Overall Study|Other|10|||
46821278|NCT00348933|83040731|FG000|Overall Study|Withdrawal by Subject|10|||
46821279|NCT00348933|83040731|FG000|Overall Study|Lost to Follow-up|6|||
46821280|NCT00348933|83040731|FG000|Overall Study|Protocol Violation|2|||
46932686|NCT01665430|83168221|FG000|Overall Study|Adverse Event|1|||
46932687|NCT01665430|83168221|FG000|Overall Study|Withdrawal by Subject|6|||
46932688|NCT01665430|83168221|FG000|Overall Study|Other Unspecified|2|||
46932689|NCT02739594|83168227|FG000|Overall Study|Undesired Event|3|||
46932690|NCT02739594|83168228|FG001|Overall Study|Undesired Event|4|||
46932691|NCT02739594|83168227|FG000|Overall Study|Violation of Eligibility Criteria|1|||
46932692|NCT02739594|83168228|FG001|Overall Study|Violation of Eligibility Criteria|2|||
46932693|NCT02739594|83168227|FG000|Overall Study|Protocol Violation|5|||
46932694|NCT02739594|83168228|FG001|Overall Study|Protocol Violation|6|||
46932695|NCT02739594|83168227|FG000|Overall Study|Death|4|||
46932696|NCT02739594|83168228|FG001|Overall Study|Death|2|||
46932697|NCT02739594|83168227|FG000|Overall Study|Renal Insufficiency|4|||
46932698|NCT02739594|83168228|FG001|Overall Study|Renal Insufficiency|6|||
46760303|NCT00600119|82978343|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
46760304|NCT00600119|82978344|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
47056631|NCT01743989|83333758|FG002|TFR Phase|Logistical problems|0|||
47056632|NCT01743989|83333756|FG000|TFR Phase|Protocol deviation|0|||
46760305|NCT00600119|82978339|FG000|Double-blind Treatment Period|Physician Decision|2|||
46760306|NCT00600119|82978340|FG001|Double-blind Treatment Period|Physician Decision|0|||
46760307|NCT00600119|82978341|FG002|Double-blind Treatment Period|Physician Decision|0|||
46760308|NCT00600119|82978342|FG003|Double-blind Treatment Period|Physician Decision|0|||
46760309|NCT00600119|82978343|FG004|Double-blind Treatment Period|Physician Decision|0|||
46760310|NCT00600119|82978344|FG005|Double-blind Treatment Period|Physician Decision|0|||
46760311|NCT00600119|82978339|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
46760312|NCT00600119|82978340|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
46821281|NCT00348933|83040731|FG000|Overall Study|Adverse Event|7|||
46821282|NCT03896477|83040739|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
46821283|NCT03896477|83040740|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
46932699|NCT02739594|83168227|FG000|Overall Study|Administrative Reasons|1|||
46760313|NCT00600119|82978341|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
46821284|NCT03896477|83040741|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
46821285|NCT03896477|83040739|FG000|Overall Study|Parent Requested Withdrawal|8|||
46932700|NCT02739594|83168228|FG001|Overall Study|Administrative Reasons|3|||
46932701|NCT02739594|83168227|FG000|Overall Study|Withdrawal by Subject|1|||
46932702|NCT02739594|83168228|FG001|Overall Study|Withdrawal by Subject|1|||
47056633|NCT01743989|83333757|FG001|TFR Phase|Protocol deviation|1|||
46821286|NCT03896477|83040740|FG001|Overall Study|Parent Requested Withdrawal|12|||
46821287|NCT03896477|83040741|FG002|Overall Study|Parent Requested Withdrawal|9|||
46821288|NCT03896477|83040739|FG000|Overall Study|Adverse Event|0|||
46821289|NCT03896477|83040740|FG001|Overall Study|Adverse Event|0|||
46821290|NCT03896477|83040741|FG002|Overall Study|Adverse Event|1|||
46821291|NCT03896477|83040739|FG000|Overall Study|Death|1|||
46821292|NCT03896477|83040740|FG001|Overall Study|Death|0|||
46821293|NCT03896477|83040741|FG002|Overall Study|Death|0|||
46821294|NCT03896477|83040739|FG000|Overall Study|Other|5|||
46932703|NCT02739594|83168227|FG000|Overall Study|Lost to Follow-up|0|||
46932704|NCT02739594|83168228|FG001|Overall Study|Lost to Follow-up|1|||
46932705|NCT02739594|83168227|FG000|Overall Study|Elevated Serum Creatinine|0|||
46932706|NCT02739594|83168228|FG001|Overall Study|Elevated Serum Creatinine|1|||
46932707|NCT02739594|83168227|FG000|Overall Study|Other|6|||
46932708|NCT02739594|83168228|FG001|Overall Study|Other|2|||
47056634|NCT01743989|83333758|FG002|TFR Phase|Protocol deviation|0|||
47056635|NCT01743989|83333756|FG000|TFR Phase|Withdrawal by Subject|0|||
47056636|NCT01743989|83333757|FG001|TFR Phase|Withdrawal by Subject|2|||
47056637|NCT01743989|83333758|FG002|TFR Phase|Withdrawal by Subject|0|||
47056638|NCT01743989|83333756|FG000|Re-treatment Phase|Adverse Event|8|||
47056639|NCT01743989|83333757|FG001|Re-treatment Phase|Adverse Event|4|||
47056640|NCT01743989|83333758|FG002|Re-treatment Phase|Adverse Event|0|||
47056641|NCT01743989|83333756|FG000|Re-treatment Phase|Death|1|||
47056642|NCT01743989|83333757|FG001|Re-treatment Phase|Death|1|||
47056643|NCT01743989|83333758|FG002|Re-treatment Phase|Death|0|||
47056644|NCT01743989|83333756|FG000|Re-treatment Phase|Administrative problems|1|||
47056645|NCT01743989|83333757|FG001|Re-treatment Phase|Administrative problems|1|||
46821295|NCT03896477|83040740|FG001|Overall Study|Other|6|||
46821296|NCT03896477|83040741|FG002|Overall Study|Other|7|||
46821297|NCT03896477|83040739|FG000|Overall Study|Lost to Follow-up|2|||
46821298|NCT03896477|83040740|FG001|Overall Study|Lost to Follow-up|1|||
46821299|NCT03896477|83040741|FG002|Overall Study|Lost to Follow-up|1|||
46821300|NCT00444600|83040756|FG000|Overall Study|Death|7|||
46821301|NCT00444600|83040757|FG001|Overall Study|Death|5|||
46821302|NCT00444600|83040758|FG002|Overall Study|Death|3|||
46821303|NCT00444600|83040759|FG003|Overall Study|Death|2|||
46821304|NCT00444600|83040756|FG000|Overall Study|Dropped|11|||
46821305|NCT00444600|83040757|FG001|Overall Study|Dropped|11|||
46821306|NCT00444600|83040758|FG002|Overall Study|Dropped|7|||
46821307|NCT00444600|83040759|FG003|Overall Study|Dropped|7|||
46821308|NCT00444600|83040756|FG000|Overall Study|Missed visit|1|||
46821309|NCT00444600|83040757|FG001|Overall Study|Missed visit|0|||
46821310|NCT00444600|83040758|FG002|Overall Study|Missed visit|0|||
46821311|NCT00444600|83040759|FG003|Overall Study|Missed visit|1|||
46821312|NCT00537095|83040777|FG000|Overall Study|surgery|1|||
46821313|NCT00537095|83040778|FG001|Overall Study|surgery|0|||
46821314|NCT00537095|83040777|FG000|Overall Study|Adverse Event|24|||
46821315|NCT00537095|83040778|FG001|Overall Study|Adverse Event|4|||
46821316|NCT00537095|83040777|FG000|Overall Study|disease progression|21|||
46821317|NCT00537095|83040778|FG001|Overall Study|disease progression|48|||
46821318|NCT00537095|83040777|FG000|Overall Study|Death|3|||
46821319|NCT00537095|83040778|FG001|Overall Study|Death|1|||
46821320|NCT00537095|83040777|FG000|Overall Study|Withdrawal by Subject|2|||
46821321|NCT00537095|83040778|FG001|Overall Study|Withdrawal by Subject|2|||
46821322|NCT00537095|83040777|FG000|Overall Study|subjective disease progression|0|||
46821323|NCT00537095|83040778|FG001|Overall Study|subjective disease progression|1|||
46821324|NCT00537095|83040777|FG000|Overall Study|Incorrect enrolment|0|||
46821325|NCT00537095|83040778|FG001|Overall Study|Incorrect enrolment|1|||
46821326|NCT00443898|83040788|FG000|Overall Study|Adverse Event|0|||
46821327|NCT00443898|83040789|FG001|Overall Study|Adverse Event|0|||
46821328|NCT00443898|83040790|FG002|Overall Study|Adverse Event|1|||
46821329|NCT00443898|83040791|FG003|Overall Study|Adverse Event|1|||
46821330|NCT00443898|83040788|FG000|Overall Study|Lack of Efficacy|2|||
46821331|NCT00443898|83040789|FG001|Overall Study|Lack of Efficacy|3|||
46821332|NCT00443898|83040790|FG002|Overall Study|Lack of Efficacy|3|||
46821333|NCT00443898|83040791|FG003|Overall Study|Lack of Efficacy|1|||
46821334|NCT00443898|83040788|FG000|Overall Study|Protocol Violation|1|||
46821335|NCT00443898|83040789|FG001|Overall Study|Protocol Violation|1|||
46821336|NCT00443898|83040790|FG002|Overall Study|Protocol Violation|1|||
46821337|NCT00443898|83040791|FG003|Overall Study|Protocol Violation|0|||
46821338|NCT00443898|83040788|FG000|Overall Study|Withdrawal by Subject|11|||
46821339|NCT00443898|83040789|FG001|Overall Study|Withdrawal by Subject|10|||
46821340|NCT00443898|83040790|FG002|Overall Study|Withdrawal by Subject|10|||
46821341|NCT00443898|83040791|FG003|Overall Study|Withdrawal by Subject|6|||
46821342|NCT00443898|83040788|FG000|Overall Study|Lost to Follow-up|10|||
46932709|NCT03989232|83168237|FG000|Overall Study|Lost to Follow-up|3|||
47056646|NCT01743989|83333758|FG002|Re-treatment Phase|Administrative problems|0|||
46821343|NCT00443898|83040789|FG001|Overall Study|Lost to Follow-up|10|||
46821344|NCT00443898|83040790|FG002|Overall Study|Lost to Follow-up|14|||
46821345|NCT00443898|83040791|FG003|Overall Study|Lost to Follow-up|10|||
46821346|NCT00443898|83040788|FG000|Overall Study|Death|0|||
46821347|NCT00443898|83040789|FG001|Overall Study|Death|1|||
46821348|NCT00443898|83040790|FG002|Overall Study|Death|0|||
46821349|NCT00443898|83040791|FG003|Overall Study|Death|0|||
46821350|NCT00537017|83040801|FG000|Treatment Phase|Adverse Event|19|||
47056647|NCT01743989|83333756|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
46821351|NCT00537017|83040801|FG000|Treatment Phase|Withdrawal by Subject|13|||
46821352|NCT00537017|83040801|FG000|Treatment Phase|Protocol Violation|2|||
46821353|NCT00537017|83040801|FG000|Follow-up Phase|Withdrawal by Subject|9|||
46821354|NCT00348309|83040808|FG000|Overall Study|Adverse Event|56|||
46821355|NCT00348309|83040809|FG001|Overall Study|Adverse Event|28|||
46821356|NCT00348309|83040810|FG002|Overall Study|Adverse Event|63|||
46821357|NCT00348309|83040808|FG000|Overall Study|Lost to Follow-up|6|||
46760314|NCT00600119|82978342|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
46821358|NCT00348309|83040809|FG001|Overall Study|Lost to Follow-up|7|||
46821359|NCT00348309|83040810|FG002|Overall Study|Lost to Follow-up|4|||
47056648|NCT01743989|83333757|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
47056649|NCT01743989|83333758|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
47056650|NCT01743989|83333756|FG000|Re-treatment Phase|Unstable MR|1|||
46821360|NCT00348309|83040808|FG000|Overall Study|Protocol Violation|7|||
47056651|NCT01743989|83333757|FG001|Re-treatment Phase|Unstable MR|0|||
47056652|NCT01743989|83333758|FG002|Re-treatment Phase|Unstable MR|0|||
47056653|NCT01743989|83333756|FG000|Re-treatment Phase|Physician Decision|0|||
47056654|NCT01743989|83333757|FG001|Re-treatment Phase|Physician Decision|1|||
47056655|NCT01743989|83333758|FG002|Re-treatment Phase|Physician Decision|0|||
47056656|NCT01743989|83333756|FG000|Re-treatment Phase|Lost to Follow-up|0|||
47056657|NCT01743989|83333757|FG001|Re-treatment Phase|Lost to Follow-up|1|||
47056658|NCT01743989|83333758|FG002|Re-treatment Phase|Lost to Follow-up|0|||
47056659|NCT01605461|83333791|FG000|Overall Study|Lost to Follow-up|3|||
47056660|NCT01605461|83333791|FG000|Overall Study|Withdrawal by Subject|1|||
47056661|NCT01742897|83333795|FG000|Overall Study|Adverse Event|3|||
47056662|NCT01742897|83333795|FG000|Overall Study|Withdrawal by Subject|1|||
47056663|NCT01742897|83333795|FG000|Overall Study|Other|1|||
47056664|NCT01715831|83333799|FG000|Overall Study|Adverse Event|1|||
47056665|NCT01741259|83333805|FG000|Overall Study|Protocol Violation|6|||
47056666|NCT01741259|83333806|FG001|Overall Study|Protocol Violation|4|||
46760315|NCT00600119|82978343|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
46760316|NCT00600119|82978344|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
46821361|NCT00348309|83040809|FG001|Overall Study|Protocol Violation|12|||
46821362|NCT00348309|83040810|FG002|Overall Study|Protocol Violation|7|||
46821363|NCT00348309|83040808|FG000|Overall Study|Withdrawal by Subject|33|||
46821364|NCT00348309|83040809|FG001|Overall Study|Withdrawal by Subject|37|||
46821365|NCT00348309|83040810|FG002|Overall Study|Withdrawal by Subject|40|||
46821366|NCT00348309|83040808|FG000|Overall Study|Non-compliance|8|||
46821367|NCT00348309|83040809|FG001|Overall Study|Non-compliance|6|||
46821368|NCT00348309|83040810|FG002|Overall Study|Non-compliance|8|||
46760317|NCT00600119|82978339|FG000|Double-blind Treatment Period|Adverse Event|1|||
46760318|NCT00600119|82978340|FG001|Double-blind Treatment Period|Adverse Event|1|||
46760319|NCT00600119|82978341|FG002|Double-blind Treatment Period|Adverse Event|0|||
46760320|NCT00600119|82978342|FG003|Double-blind Treatment Period|Adverse Event|1|||
46760321|NCT00600119|82978343|FG004|Double-blind Treatment Period|Adverse Event|2|||
46760322|NCT00600119|82978344|FG005|Double-blind Treatment Period|Adverse Event|10|||
46760323|NCT00600119|82978339|FG000|Follow-up Period|Adverse Event|0|||
46760324|NCT00600119|82978340|FG001|Follow-up Period|Adverse Event|0|||
46760325|NCT00600119|82978341|FG002|Follow-up Period|Adverse Event|0|||
46760326|NCT00600119|82978342|FG003|Follow-up Period|Adverse Event|0|||
46760327|NCT00600119|82978343|FG004|Follow-up Period|Adverse Event|0|||
46760328|NCT00600119|82978344|FG005|Follow-up Period|Adverse Event|1|||
46760329|NCT00600119|82978339|FG000|Follow-up Period|Other|1|||
46760330|NCT00600119|82978340|FG001|Follow-up Period|Other|0|||
46760331|NCT00600119|82978341|FG002|Follow-up Period|Other|0|||
46821369|NCT00348309|83040808|FG000|Overall Study|Death of caregiver|1|||
46821370|NCT00348309|83040809|FG001|Overall Study|Death of caregiver|0|||
47056667|NCT01741259|83333805|FG000|Overall Study|Withdrawal by Subject|0|||
47056668|NCT01741259|83333806|FG001|Overall Study|Withdrawal by Subject|2|||
47056669|NCT01715129|83333812|FG000|Overall Study|Adverse Event, fatal|1|||
47056670|NCT01715129|83333812|FG000|Overall Study|Lack of Efficacy|3|||
47056671|NCT01715129|83333812|FG000|Overall Study|Protocol Violation|1|||
46760332|NCT00600119|82978342|FG003|Follow-up Period|Other|0|||
46760333|NCT00600119|82978343|FG004|Follow-up Period|Other|0|||
46760334|NCT00600119|82978344|FG005|Follow-up Period|Other|0|||
47056672|NCT01715129|83333812|FG000|Overall Study|Consent Withdrawn|2|||
46760335|NCT00866294|82978361|FG000|Overall Study|Adverse Event|12|||
46821371|NCT00348309|83040810|FG002|Overall Study|Death of caregiver|1|||
46821372|NCT00348309|83040808|FG000|Overall Study|Lack of insight, dementia|1|||
46821373|NCT00348309|83040809|FG001|Overall Study|Lack of insight, dementia|0|||
46821374|NCT00348309|83040810|FG002|Overall Study|Lack of insight, dementia|0|||
46821375|NCT00348309|83040808|FG000|Overall Study|Wrong bottle allocated|1|||
46821376|NCT00348309|83040809|FG001|Overall Study|Wrong bottle allocated|0|||
47056673|NCT01715129|83333812|FG000|Overall Study|Lost to Follow-up|1|||
47056674|NCT01715129|83333812|FG000|Overall Study|Other|1|||
47056675|NCT01740791|83333905|FG000|Overall Study|Randomized but never treated|5|||
46821377|NCT00348309|83040810|FG002|Overall Study|Wrong bottle allocated|0|||
46821378|NCT00348309|83040808|FG000|Overall Study|Caregiver sick|1|||
46821379|NCT00348309|83040809|FG001|Overall Study|Caregiver sick|0|||
46821380|NCT00348309|83040810|FG002|Overall Study|Caregiver sick|0|||
46821381|NCT00348309|83040808|FG000|Overall Study|Use of prohibited medication|5|||
46821382|NCT00348309|83040809|FG001|Overall Study|Use of prohibited medication|2|||
46821383|NCT00348309|83040810|FG002|Overall Study|Use of prohibited medication|2|||
46821384|NCT00348309|83040808|FG000|Overall Study|Caregiver withdrawal|3|||
46821385|NCT00348309|83040809|FG001|Overall Study|Caregiver withdrawal|0|||
46821386|NCT00348309|83040810|FG002|Overall Study|Caregiver withdrawal|7|||
46821387|NCT00348309|83040808|FG000|Overall Study|Unable to complete ET visit|1|||
46821388|NCT00348309|83040809|FG001|Overall Study|Unable to complete ET visit|0|||
46821389|NCT00348309|83040810|FG002|Overall Study|Unable to complete ET visit|0|||
46821390|NCT00348309|83040808|FG000|Overall Study|PI closing medical practice|1|||
46821391|NCT00348309|83040809|FG001|Overall Study|PI closing medical practice|0|||
46821392|NCT00348309|83040810|FG002|Overall Study|PI closing medical practice|0|||
46821393|NCT00348309|83040808|FG000|Overall Study|Principal investigator's decision|1|||
46821394|NCT00348309|83040809|FG001|Overall Study|Principal investigator's decision|0|||
46821395|NCT00348309|83040810|FG002|Overall Study|Principal investigator's decision|0|||
46821396|NCT00348309|83040808|FG000|Overall Study|No disponibility of medication|1|||
46821397|NCT00348309|83040809|FG001|Overall Study|No disponibility of medication|0|||
46821398|NCT00348309|83040810|FG002|Overall Study|No disponibility of medication|0|||
46821399|NCT00348309|83040808|FG000|Overall Study|Worsened neurodegenerative disease|1|||
46821400|NCT00348309|83040809|FG001|Overall Study|Worsened neurodegenerative disease|0|||
46821401|NCT00348309|83040810|FG002|Overall Study|Worsened neurodegenerative disease|0|||
46821402|NCT00348309|83040808|FG000|Overall Study|Cognitive and behaviour worsening|2|||
46821403|NCT00348309|83040809|FG001|Overall Study|Cognitive and behaviour worsening|0|||
46821404|NCT00348309|83040810|FG002|Overall Study|Cognitive and behaviour worsening|0|||
46821405|NCT00348309|83040808|FG000|Overall Study|Worsening of alzheimer|1|||
46821406|NCT00348309|83040809|FG001|Overall Study|Worsening of alzheimer|0|||
47056676|NCT01740791|83333906|FG001|Overall Study|Randomized but never treated|3|||
47056677|NCT01740791|83333907|FG002|Overall Study|Randomized but never treated|2|||
47056678|NCT01740791|83333908|FG003|Overall Study|Randomized but never treated|2|||
47056679|NCT01740791|83333909|FG004|Overall Study|Randomized but never treated|1|||
47056680|NCT01740791|83333910|FG005|Overall Study|Randomized but never treated|3|||
47056681|NCT01740791|83333905|FG000|Overall Study|Lost to Follow-up|2|||
46760336|NCT00866294|82978362|FG001|Overall Study|Adverse Event|13|||
46821407|NCT00348309|83040810|FG002|Overall Study|Worsening of alzheimer|1|||
46932710|NCT03989232|83168238|FG001|Overall Study|Lost to Follow-up|10|||
46932711|NCT03989232|83168237|FG000|Overall Study|Withdrawal by Subject|6|||
46932712|NCT03989232|83168238|FG001|Overall Study|Withdrawal by Subject|6|||
46932713|NCT03989232|83168237|FG000|Overall Study|Death|1|||
46932714|NCT03989232|83168238|FG001|Overall Study|Death|2|||
46932715|NCT02585830|83168244|FG000|Overall Study|Withdrawal by Subject|3|||
46932716|NCT02584504|83168251|FG000|Double-blind Treatment|Participant withdrew consent|0|||
46760337|NCT00866294|82978363|FG002|Overall Study|Adverse Event|9|||
46760338|NCT00866294|82978361|FG000|Overall Study|Lack of Efficacy|7|||
46760339|NCT00866294|82978362|FG001|Overall Study|Lack of Efficacy|1|||
46760340|NCT00866294|82978363|FG002|Overall Study|Lack of Efficacy|0|||
46760341|NCT00866294|82978361|FG000|Overall Study|Protocol Violation|2|||
46760342|NCT00866294|82978362|FG001|Overall Study|Protocol Violation|0|||
46760343|NCT00866294|82978363|FG002|Overall Study|Protocol Violation|0|||
46760344|NCT00866294|82978361|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
46760345|NCT00866294|82978362|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
46821408|NCT00348309|83040808|FG000|Overall Study|Did not appear in time for Visit 3|1|||
46821409|NCT00348309|83040809|FG001|Overall Study|Did not appear in time for Visit 3|0|||
46932717|NCT02584504|83168252|FG001|Double-blind Treatment|Participant withdrew consent|0|||
46932718|NCT02584504|83168253|FG002|Double-blind Treatment|Participant withdrew consent|1|||
47056682|NCT01740791|83333906|FG001|Overall Study|Lost to Follow-up|0|||
46760346|NCT00866294|82978363|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
46821410|NCT00348309|83040810|FG002|Overall Study|Did not appear in time for Visit 3|0|||
46821411|NCT00348309|83040808|FG000|Overall Study|Participant died|2|||
46821412|NCT00348309|83040809|FG001|Overall Study|Participant died|1|||
46821413|NCT00348309|83040810|FG002|Overall Study|Participant died|1|||
46760347|NCT00866294|82978361|FG000|Overall Study|Lost to Follow-up|1|||
46821414|NCT00348309|83040808|FG000|Overall Study|Decision of sponsor|1|||
46932719|NCT02584504|83168251|FG000|Double-blind Treatment|Adverse Event|0|||
46760348|NCT00866294|82978362|FG001|Overall Study|Lost to Follow-up|3|||
46821415|NCT00348309|83040809|FG001|Overall Study|Decision of sponsor|0|||
47056683|NCT01740791|83333907|FG002|Overall Study|Lost to Follow-up|2|||
46760349|NCT00866294|82978363|FG002|Overall Study|Lost to Follow-up|0|||
46821416|NCT00348309|83040810|FG002|Overall Study|Decision of sponsor|0|||
47056684|NCT01740791|83333908|FG003|Overall Study|Lost to Follow-up|3|||
47056685|NCT01740791|83333909|FG004|Overall Study|Lost to Follow-up|2|||
46821417|NCT00348309|83040808|FG000|Overall Study|Ineffectiveness of treatment|0|||
46821418|NCT00348309|83040809|FG001|Overall Study|Ineffectiveness of treatment|1|||
46821419|NCT00348309|83040810|FG002|Overall Study|Ineffectiveness of treatment|0|||
47056686|NCT01740791|83333910|FG005|Overall Study|Lost to Follow-up|3|||
47056687|NCT01740791|83333905|FG000|Overall Study|Withdrew Consent|4|||
47056688|NCT01740791|83333906|FG001|Overall Study|Withdrew Consent|0|||
47056689|NCT01740791|83333907|FG002|Overall Study|Withdrew Consent|1|||
47056690|NCT01740791|83333908|FG003|Overall Study|Withdrew Consent|2|||
47056691|NCT01740791|83333909|FG004|Overall Study|Withdrew Consent|0|||
47056692|NCT01740791|83333910|FG005|Overall Study|Withdrew Consent|3|||
47056693|NCT01740791|83333905|FG000|Overall Study|Investigator's discretion|1|||
47056694|NCT01740791|83333906|FG001|Overall Study|Investigator's discretion|0|||
47056695|NCT01740791|83333907|FG002|Overall Study|Investigator's discretion|1|||
47056696|NCT01740791|83333908|FG003|Overall Study|Investigator's discretion|0|||
47056697|NCT01740791|83333909|FG004|Overall Study|Investigator's discretion|0|||
47056698|NCT01740791|83333910|FG005|Overall Study|Investigator's discretion|1|||
47056699|NCT01740791|83333905|FG000|Overall Study|Adverse Event|0|||
47056700|NCT01740791|83333906|FG001|Overall Study|Adverse Event|0|||
47056701|NCT01740791|83333907|FG002|Overall Study|Adverse Event|0|||
47056702|NCT01740791|83333908|FG003|Overall Study|Adverse Event|0|||
47056703|NCT01740791|83333909|FG004|Overall Study|Adverse Event|0|||
47056704|NCT01740791|83333910|FG005|Overall Study|Adverse Event|1|||
47056705|NCT01740323|83333967|FG000|Overall Study|Adverse Event|1|||
47056706|NCT01740323|83333968|FG001|Overall Study|Adverse Event|0|||
47056707|NCT01740323|83333967|FG000|Overall Study|Randomized but did not take study drug|1|||
47056708|NCT01740323|83333968|FG001|Overall Study|Randomized but did not take study drug|0|||
47056709|NCT01740089|83333986|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
47056710|NCT01740089|83333987|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
47056711|NCT01740089|83333988|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
47056712|NCT01740089|83333986|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
47056713|NCT01740089|83333987|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
47056714|NCT01740089|83333988|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
47056715|NCT01740089|83333986|FG000|After 12 Weeks|Lack of Efficacy|3|||
47056716|NCT01740089|83333987|FG001|After 12 Weeks|Lack of Efficacy|1|||
47056717|NCT01740089|83333988|FG002|After 12 Weeks|Lack of Efficacy|4|||
47056718|NCT01740089|83333986|FG000|After 12 Weeks|Adverse Event|2|||
47056719|NCT01740089|83333987|FG001|After 12 Weeks|Adverse Event|0|||
47056720|NCT01740089|83333988|FG002|After 12 Weeks|Adverse Event|5|||
47056721|NCT01740089|83333986|FG000|After 12 Weeks|Protocol Violation|1|||
47056722|NCT01740089|83333987|FG001|After 12 Weeks|Protocol Violation|1|||
47056723|NCT01740089|83333988|FG002|After 12 Weeks|Protocol Violation|1|||
47056724|NCT01740089|83333986|FG000|After 12 Weeks|Withdrawal by Subject|1|||
47056725|NCT01740089|83333987|FG001|After 12 Weeks|Withdrawal by Subject|1|||
46821420|NCT00348309|83040808|FG000|Overall Study|A foul of exclusion criteria|0|||
46821421|NCT00348309|83040809|FG001|Overall Study|A foul of exclusion criteria|1|||
47056726|NCT01740089|83333988|FG002|After 12 Weeks|Withdrawal by Subject|1|||
47056727|NCT01739933|83333999|FG000|Overall Study|Death|89|||
46760350|NCT00866294|82978361|FG000|Overall Study|Physician Decision|6|||
46760351|NCT00866294|82978362|FG001|Overall Study|Physician Decision|2|||
46760352|NCT00866294|82978363|FG002|Overall Study|Physician Decision|1|||
46760353|NCT00854360|82978383|FG000|Overall Study|Adverse Event|0|||
46760354|NCT00854360|82978384|FG001|Overall Study|Adverse Event|1|||
46760355|NCT00854360|82978385|FG002|Overall Study|Adverse Event|2|||
46760356|NCT00854360|82978386|FG003|Overall Study|Adverse Event|6|||
46760357|NCT00854360|82978383|FG000|Overall Study|Withdrawal by Subject|0|||
46760358|NCT00854360|82978384|FG001|Overall Study|Withdrawal by Subject|0|||
46760359|NCT00854360|82978385|FG002|Overall Study|Withdrawal by Subject|0|||
46760360|NCT00854360|82978386|FG003|Overall Study|Withdrawal by Subject|1|||
46821422|NCT00348309|83040810|FG002|Overall Study|A foul of exclusion criteria|0|||
47056728|NCT01739933|83334000|FG001|Overall Study|Death|86|||
47056729|NCT01739933|83333999|FG000|Overall Study|Withdrawal by Subject|10|||
47056730|NCT01739933|83334000|FG001|Overall Study|Withdrawal by Subject|8|||
46760361|NCT00854360|82978383|FG000|Overall Study|Pregnancy|0|||
46821423|NCT00348309|83040808|FG000|Overall Study|Participant was hospitalized|0|||
46932720|NCT02584504|83168252|FG001|Double-blind Treatment|Adverse Event|1|||
46932721|NCT02584504|83168253|FG002|Double-blind Treatment|Adverse Event|0|||
47056731|NCT01739933|83333999|FG000|Overall Study|Lost to Follow-up|3|||
47056732|NCT01739933|83334000|FG001|Overall Study|Lost to Follow-up|10|||
47056733|NCT01739933|83333999|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
47056734|NCT01739933|83334000|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
47056735|NCT01738919|83334017|FG000|Overall Study|Lost to Follow-up|1|||
47056736|NCT01738919|83334018|FG001|Overall Study|Lost to Follow-up|0|||
46760362|NCT00854360|82978384|FG001|Overall Study|Pregnancy|1|||
46760363|NCT00854360|82978385|FG002|Overall Study|Pregnancy|0|||
46821424|NCT00348309|83040809|FG001|Overall Study|Participant was hospitalized|1|||
46821425|NCT00348309|83040810|FG002|Overall Study|Participant was hospitalized|0|||
46821426|NCT00348309|83040808|FG000|Overall Study|Sponsor refuseal|0|||
46821427|NCT00348309|83040809|FG001|Overall Study|Sponsor refuseal|1|||
46821428|NCT00348309|83040810|FG002|Overall Study|Sponsor refuseal|1|||
46821429|NCT00348309|83040808|FG000|Overall Study|Forgot often medication|0|||
46821430|NCT00348309|83040809|FG001|Overall Study|Forgot often medication|1|||
46821431|NCT00348309|83040810|FG002|Overall Study|Forgot often medication|0|||
46821432|NCT00348309|83040808|FG000|Overall Study|Medical Monitor decision|0|||
46821433|NCT00348309|83040809|FG001|Overall Study|Medical Monitor decision|0|||
46821434|NCT00348309|83040810|FG002|Overall Study|Medical Monitor decision|1|||
46821435|NCT00348309|83040808|FG000|Overall Study|Increased dose of Aricept|0|||
46821436|NCT00348309|83040809|FG001|Overall Study|Increased dose of Aricept|0|||
46821437|NCT00348309|83040810|FG002|Overall Study|Increased dose of Aricept|1|||
46821438|NCT00348309|83040808|FG000|Overall Study|Site closure|0|||
46821439|NCT00348309|83040809|FG001|Overall Study|Site closure|0|||
46821440|NCT00348309|83040810|FG002|Overall Study|Site closure|1|||
46821441|NCT00348309|83040808|FG000|Overall Study|Adverse event not attended|0|||
46821442|NCT00348309|83040809|FG001|Overall Study|Adverse event not attended|0|||
46821443|NCT00348309|83040810|FG002|Overall Study|Adverse event not attended|1|||
47056737|NCT01738919|83334017|FG000|Overall Study|Immigrated|0|||
47056738|NCT01738919|83334018|FG001|Overall Study|Immigrated|1|||
47056739|NCT01738919|83334017|FG000|Overall Study|Withdrawal by Subject|0|||
46932722|NCT02584504|83168251|FG000|Double-blind Treatment|Family Matter|0|||
46932723|NCT02584504|83168252|FG001|Double-blind Treatment|Family Matter|1|||
46932724|NCT02584504|83168253|FG002|Double-blind Treatment|Family Matter|0|||
46932725|NCT02584504|83168251|FG000|Open-label Treatment|Participant withdrew consent|0|||
46932726|NCT02584504|83168252|FG001|Open-label Treatment|Participant withdrew consent|0|||
46932727|NCT02584504|83168253|FG002|Open-label Treatment|Participant withdrew consent|4|||
46932728|NCT02584504|83168251|FG000|Open-label Treatment|Adverse Event|2|||
46932729|NCT02584504|83168252|FG001|Open-label Treatment|Adverse Event|2|||
46932730|NCT02584504|83168253|FG002|Open-label Treatment|Adverse Event|3|||
46932731|NCT02584504|83168251|FG000|Open-label Treatment|Physician Decision|0|||
47056740|NCT01738919|83334018|FG001|Overall Study|Withdrawal by Subject|1|||
47056741|NCT01738919|83334017|FG000|Overall Study|Not treated in accordance to guidelines|0|||
47056742|NCT01738919|83334018|FG001|Overall Study|Not treated in accordance to guidelines|1|||
47056743|NCT01712399|83334039|FG000|Overall Study|Lost to Follow-up|1|||
47056744|NCT01712399|83334039|FG000|Overall Study|Withdrawal by Subject|39|||
47056745|NCT01712399|83334039|FG000|Overall Study|Death|1|||
47056746|NCT01712399|83334039|FG000|Overall Study|Adverse Event|11|||
47056747|NCT01712399|83334039|FG000|Overall Study|Study closure|345|||
47056748|NCT03225846|83334146|FG000|Overall Study|Adverse Event|0|||
47056749|NCT03225846|83334147|FG001|Overall Study|Adverse Event|0|||
47056750|NCT03225846|83334148|FG002|Overall Study|Adverse Event|0|||
47056751|NCT03225846|83334149|FG003|Overall Study|Adverse Event|0|||
47056752|NCT03225846|83334150|FG004|Overall Study|Adverse Event|0|||
47056753|NCT03225846|83334151|FG005|Overall Study|Adverse Event|0|||
46821444|NCT00348309|83040808|FG000|Overall Study|ECG abnormal|0|||
46821445|NCT00348309|83040809|FG001|Overall Study|ECG abnormal|0|||
46821446|NCT00348309|83040810|FG002|Overall Study|ECG abnormal|2|||
46821447|NCT00348309|83040808|FG000|Overall Study|Cardiologist recommendations|0|||
46821448|NCT00348309|83040809|FG001|Overall Study|Cardiologist recommendations|0|||
46821449|NCT00348309|83040810|FG002|Overall Study|Cardiologist recommendations|1|||
46821450|NCT00348309|83040808|FG000|Overall Study|HCV career|0|||
46821451|NCT00348309|83040809|FG001|Overall Study|HCV career|0|||
46821452|NCT00348309|83040810|FG002|Overall Study|HCV career|1|||
46821453|NCT00440310|83040821|FG000|Overall Study|Lost to Follow-up|4|||
46821454|NCT00440310|83040822|FG001|Overall Study|Lost to Follow-up|5|||
46821455|NCT00440310|83040821|FG000|Overall Study|Protocol Violation|0|||
46821456|NCT00440310|83040822|FG001|Overall Study|Protocol Violation|1|||
46821457|NCT00440310|83040821|FG000|Overall Study|Withdrawal by Subject|15|||
46821458|NCT00440310|83040822|FG001|Overall Study|Withdrawal by Subject|14|||
46821459|NCT00440310|83040821|FG000|Overall Study|No Reply at EOS|7|||
46821460|NCT00440310|83040822|FG001|Overall Study|No Reply at EOS|7|||
46821461|NCT00440310|83040821|FG000|Overall Study|Other|1|||
46821462|NCT00440310|83040822|FG001|Overall Study|Other|0|||
46821463|NCT00440310|83040821|FG000|Overall Study|Status Unknown|1|||
46821464|NCT00440310|83040822|FG001|Overall Study|Status Unknown|3|||
46821465|NCT00440232|83040830|FG000|Overall Study|Lost to Follow-up|1|||
46821466|NCT00440232|83040831|FG001|Overall Study|Lost to Follow-up|1|||
46821467|NCT00440232|83040830|FG000|Overall Study|Unable to treat within allowed time|0|||
46821468|NCT00440232|83040831|FG001|Overall Study|Unable to treat within allowed time|1|||
46821469|NCT00440232|83040830|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
46821470|NCT00440232|83040831|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
46821471|NCT00356889|83040837|FG000|Overall Study|Protocol Violation|2|||
46932732|NCT02584504|83168252|FG001|Open-label Treatment|Physician Decision|1|||
47056754|NCT03225846|83334152|FG006|Overall Study|Adverse Event|6|||
46821472|NCT00356889|83040837|FG000|Overall Study|Adverse Event|1|||
46821473|NCT00356811|83040842|FG000|Overall Study|Death|35|||
46821474|NCT00356811|83040842|FG000|Overall Study|Lost to Follow-up|2|||
46821475|NCT00356811|83040842|FG000|Overall Study|Withdrawal by Subject|6|||
46821476|NCT00356811|83040842|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
46821477|NCT00356811|83040842|FG000|Overall Study|Study Is Terminating|3|||
46821478|NCT00356811|83040842|FG000|Overall Study|Site Closed during Follow-up|2|||
46821479|NCT00439218|83040847|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
46821480|NCT00535223|83040866|FG000|Overall Study|Withdrawal by Subject|4|||
46821481|NCT00535223|83040867|FG001|Overall Study|Withdrawal by Subject|1|||
46821482|NCT00536939|83040873|FG000|Overall Study|Withdrawal by Subject|1|||
46821483|NCT00536939|83040874|FG001|Overall Study|Withdrawal by Subject|0|||
46821484|NCT00536939|83040873|FG000|Overall Study|Other Complicating Disease|1|||
46821485|NCT00536939|83040874|FG001|Overall Study|Other Complicating Disease|0|||
46821486|NCT00347919|83040882|FG000|Overall Study|Lost to Follow-up|11|||
46821487|NCT00347919|83040883|FG001|Overall Study|Lost to Follow-up|13|||
46821488|NCT00347919|83040884|FG002|Overall Study|Lost to Follow-up|0|||
46821489|NCT00347919|83040882|FG000|Overall Study|Withdrawal by Subject|6|||
46821490|NCT00347919|83040883|FG001|Overall Study|Withdrawal by Subject|8|||
46821491|NCT00347919|83040884|FG002|Overall Study|Withdrawal by Subject|0|||
46821492|NCT00347919|83040882|FG000|Overall Study|Physician Decision|1|||
46821493|NCT00347919|83040883|FG001|Overall Study|Physician Decision|1|||
46821494|NCT00347919|83040884|FG002|Overall Study|Physician Decision|0|||
46821495|NCT00347919|83040882|FG000|Overall Study|Sponsor terminated study|15|||
46821496|NCT00347919|83040883|FG001|Overall Study|Sponsor terminated study|10|||
46821497|NCT00347919|83040884|FG002|Overall Study|Sponsor terminated study|16|||
46821498|NCT00347919|83040882|FG000|Overall Study|Death|35|||
46821499|NCT00347919|83040883|FG001|Overall Study|Death|42|||
46821500|NCT00347919|83040884|FG002|Overall Study|Death|19|||
46821501|NCT00347919|83040882|FG000|Overall Study|Par. Started Other Treatment|1|||
46821502|NCT00347919|83040883|FG001|Overall Study|Par. Started Other Treatment|1|||
46821503|NCT00347919|83040884|FG002|Overall Study|Par. Started Other Treatment|1|||
46821504|NCT00347919|83040882|FG000|Overall Study|Missing|2|||
46821505|NCT00347919|83040883|FG001|Overall Study|Missing|1|||
46821506|NCT00347919|83040884|FG002|Overall Study|Missing|2|||
46821507|NCT00439140|83040897|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
46821508|NCT00439140|83040898|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
46821509|NCT00439140|83040899|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
46932733|NCT02584504|83168253|FG002|Open-label Treatment|Physician Decision|0|||
46760364|NCT00854360|82978386|FG003|Overall Study|Pregnancy|0|||
46760365|NCT00854360|82978383|FG000|Overall Study|Lack of Efficacy|2|||
46760366|NCT00854360|82978384|FG001|Overall Study|Lack of Efficacy|1|||
46760367|NCT00854360|82978385|FG002|Overall Study|Lack of Efficacy|0|||
46760368|NCT00854360|82978386|FG003|Overall Study|Lack of Efficacy|0|||
46760369|NCT00854360|82978383|FG000|Overall Study|Other|0|||
46760370|NCT00854360|82978384|FG001|Overall Study|Other|0|||
46760371|NCT00854360|82978385|FG002|Overall Study|Other|0|||
46760372|NCT00854360|82978386|FG003|Overall Study|Other|3|||
46760373|NCT00853970|82978398|FG000|Overall Study|Withdrawal by Subject|2|||
46760374|NCT00853970|82978399|FG001|Overall Study|Withdrawal by Subject|1|||
46760375|NCT00853970|82978398|FG000|Overall Study|Cancelled surgery|4|||
46760376|NCT00853970|82978399|FG001|Overall Study|Cancelled surgery|2|||
46760377|NCT00865904|82978427|FG000|Overall Study|Randomized but not Treated|2|||
46760378|NCT00865904|82978428|FG001|Overall Study|Randomized but not Treated|0|||
46760379|NCT00865904|82978429|FG002|Overall Study|Randomized but not Treated|0|||
46760380|NCT00865904|82978430|FG003|Overall Study|Randomized but not Treated|1|||
46760381|NCT00865904|82978431|FG004|Overall Study|Randomized but not Treated|1|||
46760382|NCT00599339|82978447|FG000|Overall Study|Adverse Event|79|||
46821510|NCT00439140|83040897|FG000|Treatment Cycle 1|Personal reasons|0|||
46821511|NCT00439140|83040898|FG001|Treatment Cycle 1|Personal reasons|2|||
46821512|NCT00439140|83040899|FG002|Treatment Cycle 1|Personal reasons|0|||
46821513|NCT00439140|83040897|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
46821514|NCT00439140|83040898|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
46821515|NCT00439140|83040899|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
46821516|NCT00439140|83040897|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
46821517|NCT00439140|83040898|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
46821518|NCT00439140|83040899|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
46821519|NCT00439140|83040897|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
46821520|NCT00439140|83040898|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
46821521|NCT00439140|83040899|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
46821522|NCT00356421|83040909|FG000|Overall Study|Lack of Efficacy|3|||
46760383|NCT00599339|82978447|FG000|Overall Study|Withdrawal by Subject|137|||
46821523|NCT00356421|83040910|FG001|Overall Study|Lack of Efficacy|0|||
46760384|NCT00599339|82978447|FG000|Overall Study|Other Reason|179|||
46967715|NCT02120950|83210257|FG000|Overall Study|Lost to Follow-up|0|||
46760385|NCT00599339|82978447|FG000|Overall Study|Lost to Follow-up|221|||
46760386|NCT00599339|82978447|FG000|Overall Study|No valid data consent|36|||
46967716|NCT02120950|83210258|FG001|Overall Study|Lost to Follow-up|2|||
46821524|NCT00356421|83040909|FG000|Overall Study|Withdrawal by Subject|9|||
46821525|NCT00356421|83040910|FG001|Overall Study|Withdrawal by Subject|2|||
46821526|NCT00356421|83040909|FG000|Overall Study|Related to study drug|15|||
46821527|NCT00356421|83040910|FG001|Overall Study|Related to study drug|12|||
46932734|NCT02584504|83168251|FG000|Open-label Treatment|Entered but not treated|0|||
46932735|NCT02584504|83168252|FG001|Open-label Treatment|Entered but not treated|1|||
46821528|NCT00356421|83040909|FG000|Overall Study|Not related to study drug|5|||
46821529|NCT00356421|83040910|FG001|Overall Study|Not related to study drug|3|||
46821530|NCT00443820|83040920|FG000|Overall Study|Adverse Event|1|||
46821531|NCT00443820|83040921|FG001|Overall Study|Adverse Event|1|||
46821532|NCT00443820|83040922|FG002|Overall Study|Adverse Event|0|||
46821533|NCT00443820|83040923|FG003|Overall Study|Adverse Event|0|||
46821534|NCT00443820|83040920|FG000|Overall Study|Lack of Efficacy|3|||
46821535|NCT00443820|83040921|FG001|Overall Study|Lack of Efficacy|2|||
46821536|NCT00443820|83040922|FG002|Overall Study|Lack of Efficacy|1|||
46821537|NCT00443820|83040923|FG003|Overall Study|Lack of Efficacy|1|||
46821538|NCT00443820|83040920|FG000|Overall Study|Protocol Violation|2|||
46821539|NCT00443820|83040921|FG001|Overall Study|Protocol Violation|1|||
46821540|NCT00443820|83040922|FG002|Overall Study|Protocol Violation|2|||
46821541|NCT00443820|83040923|FG003|Overall Study|Protocol Violation|1|||
46821542|NCT00443820|83040920|FG000|Overall Study|Withdrawal by Subject|6|||
46821543|NCT00443820|83040921|FG001|Overall Study|Withdrawal by Subject|7|||
46821544|NCT00443820|83040922|FG002|Overall Study|Withdrawal by Subject|8|||
46821545|NCT00443820|83040923|FG003|Overall Study|Withdrawal by Subject|9|||
46821546|NCT00443820|83040920|FG000|Overall Study|Lost to Follow-up|9|||
46821547|NCT00443820|83040921|FG001|Overall Study|Lost to Follow-up|8|||
46821548|NCT00443820|83040922|FG002|Overall Study|Lost to Follow-up|6|||
46821549|NCT00443820|83040923|FG003|Overall Study|Lost to Follow-up|5|||
46821550|NCT00443820|83040920|FG000|Overall Study|Administrative problems|0|||
46821551|NCT00443820|83040921|FG001|Overall Study|Administrative problems|0|||
46821552|NCT00443820|83040922|FG002|Overall Study|Administrative problems|0|||
46821553|NCT00443820|83040923|FG003|Overall Study|Administrative problems|1|||
46821554|NCT00443820|83040920|FG000|Overall Study|Death|0|||
46821555|NCT00443820|83040921|FG001|Overall Study|Death|0|||
46821556|NCT00443820|83040922|FG002|Overall Study|Death|1|||
46821557|NCT00443820|83040923|FG003|Overall Study|Death|0|||
46821558|NCT00438672|83040935|FG000|Overall Study|Lost to Follow-up|7|||
46821559|NCT00438672|83040936|FG001|Overall Study|Lost to Follow-up|9|||
46821560|NCT00438360|83040944|FG000|Overall Study|Adverse Event|6|||
46821561|NCT00438360|83040945|FG001|Overall Study|Adverse Event|1|||
46821562|NCT00438360|83040944|FG000|Overall Study|Lack of Efficacy|42|||
46821563|NCT00438360|83040945|FG001|Overall Study|Lack of Efficacy|27|||
46821564|NCT00438360|83040944|FG000|Overall Study|Other|24|||
46821565|NCT00438360|83040945|FG001|Overall Study|Other|15|||
46932736|NCT02584504|83168253|FG002|Open-label Treatment|Entered but not treated|1|||
46932737|NCT04354155|83168278|FG000|Overall Study|Withdrawal by Subject|1|||
46821566|NCT00536471|83040955|FG000|Overall Study|Lost to Follow-up|48|||
46821567|NCT00536471|83040956|FG001|Overall Study|Lost to Follow-up|23|||
46821568|NCT00536471|83040957|FG002|Overall Study|Lost to Follow-up|48|||
46821569|NCT00536471|83040958|FG003|Overall Study|Lost to Follow-up|22|||
46821570|NCT00536471|83040955|FG000|Overall Study|Adverse Event|32|||
46821571|NCT00536471|83040956|FG001|Overall Study|Adverse Event|16|||
46821572|NCT00536471|83040957|FG002|Overall Study|Adverse Event|28|||
46821573|NCT00536471|83040958|FG003|Overall Study|Adverse Event|13|||
46821574|NCT00536471|83040955|FG000|Overall Study|Withdrawal by Subject|40|||
46760387|NCT00599339|82978447|FG000|Overall Study|Study Termination Status Unknown|12|||
46760388|NCT00599027|82978471|FG000|Overall Study|Withdrawal by Subject|1|||
46760389|NCT00599027|82978472|FG001|Overall Study|Withdrawal by Subject|1|||
46760390|NCT00599027|82978471|FG000|Overall Study|Adverse Event|0|||
46760391|NCT00599027|82978472|FG001|Overall Study|Adverse Event|1|||
46760392|NCT00599027|82978471|FG000|Overall Study|Treatment Failure|0|||
46760393|NCT00599027|82978472|FG001|Overall Study|Treatment Failure|1|||
46760394|NCT02881151|82978487|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
46821575|NCT00536471|83040956|FG001|Overall Study|Withdrawal by Subject|24|||
46821576|NCT00536471|83040957|FG002|Overall Study|Withdrawal by Subject|43|||
46821577|NCT00536471|83040958|FG003|Overall Study|Withdrawal by Subject|21|||
46821578|NCT00536471|83040955|FG000|Overall Study|Lack of Efficacy|17|||
46821579|NCT00536471|83040956|FG001|Overall Study|Lack of Efficacy|18|||
46760395|NCT00689728|82978495|FG000|Double-Blind Treatment|Adverse Event|1|||
46932738|NCT04354155|83168278|FG000|Overall Study|Did not meet criteria for study intervention|1|||
46760396|NCT00689728|82978496|FG001|Double-Blind Treatment|Adverse Event|0|||
46821580|NCT00536471|83040957|FG002|Overall Study|Lack of Efficacy|11|||
46932739|NCT02586064|83168284|FG000|Overall Study|Other Obligations|6|||
46932740|NCT02586064|83168285|FG001|Overall Study|Other Obligations|6|||
46821581|NCT00536471|83040958|FG003|Overall Study|Lack of Efficacy|9|||
46821582|NCT00536471|83040955|FG000|Overall Study|Protocol Violation|8|||
46821583|NCT00536471|83040956|FG001|Overall Study|Protocol Violation|1|||
46821584|NCT00536471|83040957|FG002|Overall Study|Protocol Violation|2|||
46821585|NCT00536471|83040958|FG003|Overall Study|Protocol Violation|3|||
46821586|NCT00536471|83040955|FG000|Overall Study|Physician Decision|11|||
46821587|NCT00536471|83040956|FG001|Overall Study|Physician Decision|1|||
46821588|NCT00536471|83040957|FG002|Overall Study|Physician Decision|3|||
46821589|NCT00536471|83040958|FG003|Overall Study|Physician Decision|2|||
46636904|NCT03386929|82810881|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
46932741|NCT02586064|83168284|FG000|Overall Study|Other|3|||
46932742|NCT02586064|83168285|FG001|Overall Study|Other|7|||
46932743|NCT02586064|83168284|FG000|Overall Study|Never Started|3|||
46932744|NCT02586064|83168285|FG001|Overall Study|Never Started|3|||
46932745|NCT02586064|83168284|FG000|Overall Study|Lost Interest|1|||
46932746|NCT02586064|83168285|FG001|Overall Study|Lost Interest|4|||
46932747|NCT02586064|83168284|FG000|Overall Study|Miscellaneous Life Issues|0|||
46932748|NCT02586064|83168285|FG001|Overall Study|Miscellaneous Life Issues|5|||
46760397|NCT00689728|82978497|FG002|Double-Blind Treatment|Adverse Event|0|||
46760398|NCT00689728|82978495|FG000|Double-Blind Treatment|Protocol Violation|0|||
46760399|NCT00689728|82978496|FG001|Double-Blind Treatment|Protocol Violation|0|||
46760400|NCT00689728|82978497|FG002|Double-Blind Treatment|Protocol Violation|1|||
46760401|NCT00689728|82978495|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
46760402|NCT00689728|82978496|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
46760403|NCT00689728|82978497|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
46760404|NCT00689728|82978495|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
46760405|NCT00689728|82978496|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
46760406|NCT00689728|82978497|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
46760407|NCT00689728|82978495|FG000|Rescue|Adverse Event|0|||
46821590|NCT00536471|83040955|FG000|Overall Study|Death|0|||
46821591|NCT00536471|83040956|FG001|Overall Study|Death|0|||
46821592|NCT00536471|83040957|FG002|Overall Study|Death|1|||
46821593|NCT00536471|83040958|FG003|Overall Study|Death|2|||
46821594|NCT00536471|83040955|FG000|Overall Study|Sponsor Decision|0|||
46821595|NCT00536471|83040956|FG001|Overall Study|Sponsor Decision|1|||
46821596|NCT00536471|83040957|FG002|Overall Study|Sponsor Decision|3|||
46821597|NCT00536471|83040958|FG003|Overall Study|Sponsor Decision|2|||
46932749|NCT02586064|83168284|FG000|Overall Study|Infrequent Attendance|2|||
46932750|NCT02586064|83168285|FG001|Overall Study|Infrequent Attendance|1|||
46932751|NCT02586064|83168284|FG000|Overall Study|Timed Out|2|||
46932752|NCT02586064|83168285|FG001|Overall Study|Timed Out|0|||
47056755|NCT03225846|83334146|FG000|Overall Study|Withdrawal by Subject|0|||
47056756|NCT03225846|83334147|FG001|Overall Study|Withdrawal by Subject|1|||
47056757|NCT03225846|83334148|FG002|Overall Study|Withdrawal by Subject|0|||
47056758|NCT03225846|83334149|FG003|Overall Study|Withdrawal by Subject|0|||
47056759|NCT03225846|83334150|FG004|Overall Study|Withdrawal by Subject|0|||
47056760|NCT03225846|83334151|FG005|Overall Study|Withdrawal by Subject|0|||
47056761|NCT03225846|83334152|FG006|Overall Study|Withdrawal by Subject|0|||
47056762|NCT03225846|83334146|FG000|Overall Study|Death|0|||
47056763|NCT03225846|83334147|FG001|Overall Study|Death|1|||
47056764|NCT03225846|83334148|FG002|Overall Study|Death|0|||
47056765|NCT03225846|83334149|FG003|Overall Study|Death|0|||
47056766|NCT03225846|83334150|FG004|Overall Study|Death|0|||
47056767|NCT03225846|83334151|FG005|Overall Study|Death|0|||
47056768|NCT03225846|83334152|FG006|Overall Study|Death|0|||
47056769|NCT03225846|83334146|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
46636905|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
46821598|NCT00359619|83040982|FG000|Overall Study|Adverse Event|0|||
46821599|NCT00359619|83040983|FG001|Overall Study|Adverse Event|0|||
46821600|NCT00359619|83040984|FG002|Overall Study|Adverse Event|1|||
46932753|NCT02586064|83168284|FG000|Overall Study|AUD relapse|0|||
47056770|NCT03225846|83334147|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
47056771|NCT03225846|83334148|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
46760408|NCT00689728|82978496|FG001|Rescue|Adverse Event|1|||
46760409|NCT00689728|82978497|FG002|Rescue|Adverse Event|0|||
46760410|NCT00689728|82978495|FG000|Rescue|Withdrawal by Subject|1|||
46821601|NCT00359619|83040985|FG003|Overall Study|Adverse Event|0|||
46932754|NCT02586064|83168285|FG001|Overall Study|AUD relapse|2|||
46932755|NCT02586064|83168284|FG000|Overall Study|Legal Issue|1|||
46932756|NCT02586064|83168285|FG001|Overall Study|Legal Issue|0|||
46932757|NCT03810495|83168294|FG000|Overall Study|Lost to Follow-up|2|||
46932758|NCT03810495|83168294|FG000|Overall Study|Withdrawal by Subject|1|||
46932759|NCT02782923|83168298|FG000|Overall Study|Lost to Follow-up|15|||
46932760|NCT03760458|83168307|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
47056772|NCT03225846|83334149|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
46636906|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
46636907|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
46636908|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
46636909|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
46760411|NCT00689728|82978496|FG001|Rescue|Withdrawal by Subject|1|||
46760412|NCT00689728|82978497|FG002|Rescue|Withdrawal by Subject|1|||
46760413|NCT00689728|82978495|FG000|Optional Follow-Up|Adverse Event|1|||
46760414|NCT00689728|82978496|FG001|Optional Follow-Up|Adverse Event|0|||
46760415|NCT00689728|82978497|FG002|Optional Follow-Up|Adverse Event|0|||
46760416|NCT00689728|82978495|FG000|Optional Follow-Up|Lack of Efficacy|0|||
46760417|NCT00689728|82978496|FG001|Optional Follow-Up|Lack of Efficacy|1|||
46760418|NCT00689728|82978497|FG002|Optional Follow-Up|Lack of Efficacy|1|||
46760419|NCT00689728|82978495|FG000|Optional Follow-Up|Lost to Follow-up|0|||
46760420|NCT00689728|82978496|FG001|Optional Follow-Up|Lost to Follow-up|1|||
46760421|NCT00689728|82978497|FG002|Optional Follow-Up|Lost to Follow-up|1|||
46760422|NCT00689728|82978495|FG000|Optional Follow-Up|Protocol Violation|0|||
46760423|NCT00689728|82978496|FG001|Optional Follow-Up|Protocol Violation|0|||
46760424|NCT00689728|82978497|FG002|Optional Follow-Up|Protocol Violation|1|||
46760425|NCT00689728|82978495|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
46760426|NCT00689728|82978496|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
46760427|NCT00689728|82978497|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
46760428|NCT00691054|82978526|FG000|Overall Study|Withdrawal by Subject|1|||
46760429|NCT00598871|82978534|FG000|Overall Study|Adverse Event|0|||
46760430|NCT00598871|82978535|FG001|Overall Study|Adverse Event|1|||
46760431|NCT00690820|82978543|FG000|Period 1|Withdrawal by Subject|0|||
46760432|NCT00690820|82978544|FG001|Period 1|Withdrawal by Subject|1|||
46760433|NCT00689338|82978550|FG000|Overall Study|Death|65|||
46760434|NCT00689338|82978550|FG000|Overall Study|Adverse Event|13|||
46760435|NCT00689338|82978550|FG000|Overall Study|Insufficient Clinical Response|1|||
46760436|NCT00689338|82978550|FG000|Overall Study|Lack of Efficacy|6|||
46760437|NCT00689338|82978550|FG000|Overall Study|Other|8|||
46760438|NCT00689338|82978550|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
46760439|NCT00689338|82978550|FG000|Overall Study|Lost to Follow-up|5|||
46760440|NCT00689338|82978550|FG000|Overall Study|Withdrawal by Subject|3|||
46760441|NCT00689338|82978550|FG000|Overall Study|Protocol Violation|15|||
46760442|NCT00686998|82978557|FG000|Overall Study|Adverse Event|3|||
46760443|NCT00686998|82978558|FG001|Overall Study|Adverse Event|2|||
46760444|NCT00686998|82978559|FG002|Overall Study|Adverse Event|1|||
46760445|NCT00686998|82978557|FG000|Overall Study|Withdrawal by Subject|2|||
46760446|NCT00686998|82978558|FG001|Overall Study|Withdrawal by Subject|1|||
46760447|NCT00686998|82978559|FG002|Overall Study|Withdrawal by Subject|2|||
46760448|NCT00686998|82978557|FG000|Overall Study|Lack of Efficacy|7|||
46760449|NCT00686998|82978558|FG001|Overall Study|Lack of Efficacy|5|||
46760450|NCT00686998|82978559|FG002|Overall Study|Lack of Efficacy|0|||
46760451|NCT00686998|82978557|FG000|Overall Study|Other|0|||
46760452|NCT00686998|82978558|FG001|Overall Study|Other|0|||
46760453|NCT00686998|82978559|FG002|Overall Study|Other|1|||
46760454|NCT00686998|82978557|FG000|Overall Study|Safety Reasons|1|||
46760455|NCT00686998|82978558|FG001|Overall Study|Safety Reasons|0|||
46760456|NCT00686998|82978559|FG002|Overall Study|Safety Reasons|0|||
46760457|NCT00848718|82978580|FG000|Overall Study|Adverse Event|2|||
46760458|NCT00848718|82978581|FG001|Overall Study|Adverse Event|2|||
46760459|NCT00848718|82978582|FG002|Overall Study|Adverse Event|1|||
46760460|NCT00848718|82978583|FG003|Overall Study|Adverse Event|1|||
46760461|NCT00848718|82978584|FG004|Overall Study|Adverse Event|1|||
46760462|NCT00848718|82978585|FG005|Overall Study|Adverse Event|0|||
46760463|NCT00848718|82978586|FG006|Overall Study|Adverse Event|0|||
46760464|NCT00848718|82978587|FG007|Overall Study|Adverse Event|1|||
46760465|NCT00848718|82978588|FG008|Overall Study|Adverse Event|1|||
46760466|NCT00848718|82978589|FG009|Overall Study|Adverse Event|0|||
46760467|NCT00848718|82978590|FG010|Overall Study|Adverse Event|0|||
46760468|NCT00848718|82978591|FG011|Overall Study|Adverse Event|0|||
47056773|NCT03225846|83334150|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
46760469|NCT00848718|82978592|FG012|Overall Study|Adverse Event|2|||
46760470|NCT00848718|82978580|FG000|Overall Study|Lack of Efficacy|0|||
46760471|NCT00848718|82978581|FG001|Overall Study|Lack of Efficacy|0|||
46760472|NCT00848718|82978582|FG002|Overall Study|Lack of Efficacy|1|||
46760473|NCT00848718|82978583|FG003|Overall Study|Lack of Efficacy|0|||
46760474|NCT00848718|82978584|FG004|Overall Study|Lack of Efficacy|0|||
46760475|NCT00848718|82978585|FG005|Overall Study|Lack of Efficacy|0|||
46760476|NCT00848718|82978586|FG006|Overall Study|Lack of Efficacy|1|||
46932761|NCT03760458|83168308|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
46821602|NCT00359619|83040986|FG004|Overall Study|Adverse Event|0|||
46821603|NCT00359619|83040987|FG005|Overall Study|Adverse Event|0|||
46821604|NCT00359619|83040988|FG006|Overall Study|Adverse Event|1|||
46821605|NCT00359619|83040982|FG000|Overall Study|Withdrawal by Subject|3|||
46821606|NCT00359619|83040983|FG001|Overall Study|Withdrawal by Subject|1|||
46821607|NCT00359619|83040984|FG002|Overall Study|Withdrawal by Subject|4|||
46821608|NCT00359619|83040985|FG003|Overall Study|Withdrawal by Subject|2|||
46821609|NCT00359619|83040986|FG004|Overall Study|Withdrawal by Subject|2|||
46821610|NCT00359619|83040987|FG005|Overall Study|Withdrawal by Subject|0|||
46821611|NCT00359619|83040988|FG006|Overall Study|Withdrawal by Subject|3|||
46821612|NCT00359619|83040982|FG000|Overall Study|Other|1|||
46821613|NCT00359619|83040983|FG001|Overall Study|Other|0|||
46821614|NCT00359619|83040984|FG002|Overall Study|Other|0|||
46821615|NCT00359619|83040985|FG003|Overall Study|Other|0|||
46821616|NCT00359619|83040986|FG004|Overall Study|Other|0|||
46821617|NCT00359619|83040987|FG005|Overall Study|Other|0|||
46821618|NCT00359619|83040988|FG006|Overall Study|Other|0|||
46821619|NCT00359619|83040982|FG000|Overall Study|Lost to Follow-up|4|||
46821620|NCT00359619|83040983|FG001|Overall Study|Lost to Follow-up|4|||
46821621|NCT00359619|83040984|FG002|Overall Study|Lost to Follow-up|2|||
46821622|NCT00359619|83040985|FG003|Overall Study|Lost to Follow-up|1|||
46821623|NCT00359619|83040986|FG004|Overall Study|Lost to Follow-up|1|||
46821624|NCT00359619|83040987|FG005|Overall Study|Lost to Follow-up|5|||
46821625|NCT00359619|83040988|FG006|Overall Study|Lost to Follow-up|0|||
46821626|NCT00437658|83041007|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
46821627|NCT00437658|83041008|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
46821628|NCT00437658|83041009|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
46821629|NCT00437658|83041007|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
46821630|NCT00437658|83041008|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
46821631|NCT00437658|83041009|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
46821632|NCT00437658|83041007|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
46821633|NCT00437658|83041008|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
46821634|NCT00437658|83041009|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
46821635|NCT00437658|83041007|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
46821636|NCT00437658|83041008|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
46821637|NCT00437658|83041009|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
46821638|NCT00437658|83041007|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
46821639|NCT00437658|83041008|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
46821640|NCT00437658|83041009|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
46821641|NCT00437658|83041007|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
46821642|NCT00437658|83041008|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
46821643|NCT00437658|83041009|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
46821644|NCT00437658|83041007|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
46821645|NCT00437658|83041008|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
46821646|NCT00437658|83041009|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
46821647|NCT00437658|83041007|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
46821648|NCT00437658|83041008|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
46821649|NCT00437658|83041009|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
46821650|NCT00437658|83041007|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
46821651|NCT00437658|83041008|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
46821652|NCT00437658|83041009|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
46821653|NCT00437658|83041007|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
46821654|NCT00437658|83041008|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
46821655|NCT00437658|83041009|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
46821656|NCT00437658|83041007|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
46821657|NCT00437658|83041008|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
46932762|NCT03760458|83168309|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
46932763|NCT03760458|83168310|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
46821658|NCT00437658|83041009|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
46821659|NCT00437658|83041007|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
46821660|NCT00437658|83041008|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
46821661|NCT00437658|83041009|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
46821662|NCT00356265|83041020|FG000|Overall Study|Withdrawal by Subject|0|||
46821663|NCT00356265|83041021|FG001|Overall Study|Withdrawal by Subject|0|||
46821664|NCT00356265|83041022|FG002|Overall Study|Withdrawal by Subject|1|||
46821665|NCT00535145|83041031|FG000|Phase I|Adverse Event|3|||
46932764|NCT03760458|83168311|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
46932765|NCT02066415|83168326|FG000|Overall Study|Decision by Sponsor|5|||
46821666|NCT00535145|83041031|FG000|Phase I|Lost to Follow-up|7|||
46821667|NCT00535145|83041031|FG000|Phase I|Withdrawal by Subject|6|||
47056774|NCT03225846|83334151|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
47056775|NCT03225846|83334152|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
46821668|NCT00535145|83041031|FG000|Phase I|(eligibility)|8|||
46821669|NCT00535145|83041031|FG000|Phase I|(protocol violation)|1|||
46821670|NCT00535145|83041031|FG000|Phase I|(PI decision)|1|||
46821671|NCT00535145|83041031|FG000|Phase I|(diagnosis)|3|||
46821672|NCT00535145|83041031|FG000|Phase II|Adverse Event|2|||
46821673|NCT00535145|83041031|FG000|Phase II|Lack of Efficacy|1|||
46821674|NCT00535145|83041031|FG000|Phase II|Lost to Follow-up|5|||
46821675|NCT00535145|83041031|FG000|Phase II|Withdrawal by Subject|5|||
46821676|NCT00535145|83041031|FG000|Phase II|Subject non-compliance|2|||
46821677|NCT00437268|83041041|FG000|Overall Study|Adverse Event|1|||
46821678|NCT00437268|83041042|FG001|Overall Study|Adverse Event|1|||
46821679|NCT00437268|83041041|FG000|Overall Study|Withdrawal by Subject|2|||
46821680|NCT00437268|83041042|FG001|Overall Study|Withdrawal by Subject|2|||
46821681|NCT00437268|83041041|FG000|Overall Study|Progressive disease|9|||
46821682|NCT00437268|83041042|FG001|Overall Study|Progressive disease|9|||
46821683|NCT00437268|83041041|FG000|Overall Study|Physician Decision|1|||
46821684|NCT00437268|83041042|FG001|Overall Study|Physician Decision|0|||
46821685|NCT00437268|83041041|FG000|Overall Study|Death|0|||
46821686|NCT00437268|83041042|FG001|Overall Study|Death|1|||
46821687|NCT00437034|83041050|FG000|Overall Study|Adverse Event|1|||
46821688|NCT00437034|83041050|FG000|Overall Study|Disease progression during treatment|5|||
46821689|NCT00337467|83041054|FG000|Overall Study|Adverse Event|3|||
46821690|NCT00337467|83041054|FG000|Overall Study|Subject Withdrew Consent|2|||
46821691|NCT00337467|83041054|FG000|Overall Study|Pregnancy|1|||
46821692|NCT00337467|83041054|FG000|Overall Study|Lost to Follow-up|2|||
46821693|NCT00337467|83041054|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
46821694|NCT00337077|83041064|FG000|Overall Study|Progressive disease|25|||
46821695|NCT00337077|83041065|FG001|Overall Study|Progressive disease|37|||
46821696|NCT00337077|83041066|FG002|Overall Study|Progressive disease|19|||
46821697|NCT00337077|83041064|FG000|Overall Study|Adverse Event|7|||
46821698|NCT00337077|83041065|FG001|Overall Study|Adverse Event|7|||
46821699|NCT00337077|83041066|FG002|Overall Study|Adverse Event|1|||
46821700|NCT00337077|83041064|FG000|Overall Study|Death|0|||
46821701|NCT00337077|83041065|FG001|Overall Study|Death|1|||
46821702|NCT00337077|83041066|FG002|Overall Study|Death|0|||
46821703|NCT00337077|83041064|FG000|Overall Study|Withdrawal by Subject|7|||
46821704|NCT00337077|83041065|FG001|Overall Study|Withdrawal by Subject|2|||
46821705|NCT00337077|83041066|FG002|Overall Study|Withdrawal by Subject|2|||
46821706|NCT00337077|83041064|FG000|Overall Study|Alternative therapy|1|||
46760477|NCT00848718|82978587|FG007|Overall Study|Lack of Efficacy|0|||
46760478|NCT00848718|82978588|FG008|Overall Study|Lack of Efficacy|0|||
46760479|NCT00848718|82978589|FG009|Overall Study|Lack of Efficacy|0|||
46760480|NCT00848718|82978590|FG010|Overall Study|Lack of Efficacy|0|||
46760481|NCT00848718|82978591|FG011|Overall Study|Lack of Efficacy|0|||
46932766|NCT02066415|83168327|FG001|Overall Study|Decision by Sponsor|4|||
46932767|NCT02066415|83168328|FG002|Overall Study|Decision by Sponsor|2|||
46932768|NCT02066415|83168326|FG000|Overall Study|Withdrawal by Subject|9|||
46932769|NCT02066415|83168327|FG001|Overall Study|Withdrawal by Subject|1|||
46760482|NCT00848718|82978592|FG012|Overall Study|Lack of Efficacy|0|||
46760483|NCT00848718|82978580|FG000|Overall Study|Physician Decision|0|||
46821707|NCT00337077|83041065|FG001|Overall Study|Alternative therapy|0|||
46821708|NCT00337077|83041066|FG002|Overall Study|Alternative therapy|0|||
46821709|NCT00337077|83041064|FG000|Overall Study|Physician Decision|1|||
46932770|NCT02066415|83168328|FG002|Overall Study|Withdrawal by Subject|4|||
46932771|NCT02066415|83168326|FG000|Overall Study|Lost to Follow-up|7|||
47056776|NCT03225846|83334146|FG000|Overall Study|Patient decision|0|||
46760484|NCT00848718|82978581|FG001|Overall Study|Physician Decision|1|||
46760485|NCT00848718|82978582|FG002|Overall Study|Physician Decision|0|||
46760486|NCT00848718|82978583|FG003|Overall Study|Physician Decision|0|||
46760487|NCT00848718|82978584|FG004|Overall Study|Physician Decision|1|||
46760488|NCT00848718|82978585|FG005|Overall Study|Physician Decision|1|||
46760489|NCT00848718|82978586|FG006|Overall Study|Physician Decision|0|||
46760490|NCT00848718|82978587|FG007|Overall Study|Physician Decision|0|||
46821710|NCT00337077|83041065|FG001|Overall Study|Physician Decision|4|||
46821711|NCT00337077|83041066|FG002|Overall Study|Physician Decision|2|||
46821712|NCT00337077|83041064|FG000|Overall Study|Never started treatment|1|||
46821713|NCT00337077|83041065|FG001|Overall Study|Never started treatment|1|||
46821714|NCT00337077|83041066|FG002|Overall Study|Never started treatment|0|||
46760491|NCT00848718|82978588|FG008|Overall Study|Physician Decision|1|||
46760492|NCT00848718|82978589|FG009|Overall Study|Physician Decision|2|||
46821715|NCT00337077|83041064|FG000|Overall Study|Ineligible|1|||
46821716|NCT00337077|83041065|FG001|Overall Study|Ineligible|1|||
46821717|NCT00337077|83041066|FG002|Overall Study|Ineligible|1|||
46821718|NCT00428220|83041072|FG000|Overall Study|Participant died|8|||
46760493|NCT00848718|82978590|FG010|Overall Study|Physician Decision|0|||
46760494|NCT00848718|82978591|FG011|Overall Study|Physician Decision|0|||
46821719|NCT00428220|83041072|FG000|Overall Study|Global deterioration of health status|7|||
46821720|NCT00428220|83041072|FG000|Overall Study|Lost to Follow-up|4|||
46821721|NCT00428220|83041072|FG000|Overall Study|Objective progression or relapse|123|||
46932772|NCT02066415|83168327|FG001|Overall Study|Lost to Follow-up|2|||
46821722|NCT00428220|83041072|FG000|Overall Study|Participant refused continued treatment|7|||
46821723|NCT00428220|83041072|FG000|Overall Study|Adverse Event|51|||
46821724|NCT00428220|83041072|FG000|Overall Study|Other|23|||
46821725|NCT00345579|83041102|FG000|Overall Study|Adverse Event|9|||
46821726|NCT00345579|83041103|FG001|Overall Study|Adverse Event|6|||
46821727|NCT00345579|83041102|FG000|Overall Study|Protocol Violation|14|||
46821728|NCT00345579|83041103|FG001|Overall Study|Protocol Violation|5|||
46821729|NCT00345579|83041102|FG000|Overall Study|Withdrawal by Subject|50|||
46821730|NCT00345579|83041103|FG001|Overall Study|Withdrawal by Subject|17|||
46821731|NCT00345579|83041102|FG000|Overall Study|Lost to Follow-up|82|||
46932773|NCT02066415|83168328|FG002|Overall Study|Lost to Follow-up|2|||
46932774|NCT02583256|83168340|FG000|Overall Study|Withdrawal by Subject|0|||
46932775|NCT02583256|83168341|FG001|Overall Study|Withdrawal by Subject|1|||
46821732|NCT00345579|83041103|FG001|Overall Study|Lost to Follow-up|36|||
46821733|NCT00345579|83041102|FG000|Overall Study|Other|9|||
46821734|NCT00345579|83041103|FG001|Overall Study|Other|1|||
46821735|NCT00335829|83041110|FG000|Overall Study|Withdrawal by Subject|1|||
46821736|NCT00335829|83041110|FG000|Overall Study|Lost to Follow-up|1|||
46821737|NCT00335829|83041110|FG000|Overall Study|Adverse Event|1|||
46821738|NCT00344019|83041117|FG000|Overall Study|did not meet final inclusion criteria|0|||
46821739|NCT00344019|83041118|FG001|Overall Study|did not meet final inclusion criteria|0|||
46821740|NCT00344019|83041119|FG002|Overall Study|did not meet final inclusion criteria|74|||
46821741|NCT00535847|83041133|FG000|Overall Study|Adverse Event|5|||
46821742|NCT00535847|83041134|FG001|Overall Study|Adverse Event|3|||
46821743|NCT00535847|83041135|FG002|Overall Study|Adverse Event|2|||
46821744|NCT00535847|83041133|FG000|Overall Study|Non compliance|1|||
46821745|NCT00535847|83041134|FG001|Overall Study|Non compliance|1|||
46821746|NCT00535847|83041135|FG002|Overall Study|Non compliance|0|||
46821747|NCT00535847|83041133|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
46821748|NCT00535847|83041134|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
46821749|NCT00535847|83041135|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
46821750|NCT00334893|83041149|FG000|Overall Study|Not Treated|1|||
46821751|NCT00334893|83041150|FG001|Overall Study|Not Treated|0|||
46821752|NCT00334737|83041161|FG000|Hospital Phase|Death|1|||
46821753|NCT00334737|83041162|FG001|Hospital Phase|Death|2|||
46821754|NCT00334737|83041163|FG002|Hospital Phase|Death|3|||
46821755|NCT00334737|83041161|FG000|Hospital Phase|Withdrawal by Subject|0|||
46821756|NCT00334737|83041162|FG001|Hospital Phase|Withdrawal by Subject|0|||
46821757|NCT00334737|83041163|FG002|Hospital Phase|Withdrawal by Subject|1|||
46821758|NCT00334737|83041161|FG000|Hospital Phase|Did not receive study drug|1|||
46821759|NCT00334737|83041162|FG001|Hospital Phase|Did not receive study drug|0|||
46821760|NCT00334737|83041163|FG002|Hospital Phase|Did not receive study drug|0|||
46821761|NCT00334737|83041161|FG000|Follow up Phase|Lost to Follow-up|5|||
46821762|NCT00334737|83041162|FG001|Follow up Phase|Lost to Follow-up|3|||
46821763|NCT00334737|83041163|FG002|Follow up Phase|Lost to Follow-up|6|||
46821764|NCT00427908|83041175|FG000|Primary Phase|Lost to Follow-up|4|||
46821765|NCT00427908|83041176|FG001|Primary Phase|Lost to Follow-up|0|||
46932776|NCT02583256|83168342|FG002|Overall Study|Withdrawal by Subject|1|||
46932777|NCT02583256|83168343|FG003|Overall Study|Withdrawal by Subject|0|||
46760495|NCT00848718|82978592|FG012|Overall Study|Physician Decision|1|||
46932778|NCT02583256|83168340|FG000|Overall Study|Lost to Follow-up|1|||
46760496|NCT00848718|82978580|FG000|Overall Study|Progressive disease before treatment|1|||
46760497|NCT00848718|82978581|FG001|Overall Study|Progressive disease before treatment|5|||
46760498|NCT00848718|82978582|FG002|Overall Study|Progressive disease before treatment|1|||
46760499|NCT00848718|82978583|FG003|Overall Study|Progressive disease before treatment|3|||
46760500|NCT00848718|82978584|FG004|Overall Study|Progressive disease before treatment|4|||
46760501|NCT00848718|82978585|FG005|Overall Study|Progressive disease before treatment|4|||
46760502|NCT00848718|82978586|FG006|Overall Study|Progressive disease before treatment|2|||
46760503|NCT00848718|82978587|FG007|Overall Study|Progressive disease before treatment|1|||
46760504|NCT00848718|82978588|FG008|Overall Study|Progressive disease before treatment|2|||
46760505|NCT00848718|82978589|FG009|Overall Study|Progressive disease before treatment|7|||
46821766|NCT00427908|83041177|FG002|Primary Phase|Lost to Follow-up|2|||
46821767|NCT00427908|83041178|FG003|Primary Phase|Lost to Follow-up|0|||
46821768|NCT00427908|83041175|FG000|Primary Phase|Withdrawal by Subject|1|||
46821769|NCT00427908|83041176|FG001|Primary Phase|Withdrawal by Subject|2|||
46821770|NCT00427908|83041177|FG002|Primary Phase|Withdrawal by Subject|1|||
46821771|NCT00427908|83041178|FG003|Primary Phase|Withdrawal by Subject|0|||
46821772|NCT00427908|83041175|FG000|Primary Phase|Adverse Event|0|||
46821773|NCT00427908|83041176|FG001|Primary Phase|Adverse Event|1|||
46821774|NCT00427908|83041177|FG002|Primary Phase|Adverse Event|0|||
46821775|NCT00427908|83041178|FG003|Primary Phase|Adverse Event|0|||
46821776|NCT00334113|83041215|FG000|Overall Study|Lost to Follow-up|2|||
46932779|NCT02583256|83168341|FG001|Overall Study|Lost to Follow-up|1|||
46821777|NCT00334113|83041216|FG001|Overall Study|Lost to Follow-up|2|||
46821778|NCT00334113|83041215|FG000|Overall Study|Withdrawal by Subject|0|||
46932780|NCT02583256|83168342|FG002|Overall Study|Lost to Follow-up|0|||
46821779|NCT00334113|83041216|FG001|Overall Study|Withdrawal by Subject|1|||
46821780|NCT00416598|83041222|FG000|Induction & Intensification|Adverse Event|38|||
46821781|NCT00416598|83041222|FG000|Induction & Intensification|Death|32|||
46821782|NCT00416598|83041222|FG000|Induction & Intensification|Withdrawal by Subject|46|||
46821783|NCT00416598|83041222|FG000|Induction & Intensification|Alternative Treatment|135|||
46821784|NCT00416598|83041222|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
46821785|NCT00416598|83041222|FG000|Induction & Intensification|Relapse/progression|29|||
46821786|NCT00416598|83041222|FG000|Induction & Intensification|Failed induction|87|||
46821787|NCT00416598|83041222|FG000|Decitabine Maintenance|Adverse Event|5|||
46821788|NCT00416598|83041222|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
46821789|NCT00416598|83041222|FG000|Decitabine Maintenance|Progression/relapse|38|||
46821790|NCT00416598|83041222|FG000|Decitabine Maintenance|Alternative treatment|2|||
46821791|NCT00416598|83041222|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
46760506|NCT00848718|82978590|FG010|Overall Study|Progressive disease before treatment|3|||
46821792|NCT00534599|83041228|FG000|Overall Study|Adverse Event|25|||
46821793|NCT00534599|83041229|FG001|Overall Study|Adverse Event|4|||
46821794|NCT00534599|83041228|FG000|Overall Study|Incorrect enrollment|2|||
46821795|NCT00534599|83041229|FG001|Overall Study|Incorrect enrollment|1|||
46821796|NCT00534599|83041228|FG000|Overall Study|Mis-randomization|2|||
46821797|NCT00534599|83041229|FG001|Overall Study|Mis-randomization|2|||
46821798|NCT00534599|83041228|FG000|Overall Study|Developed study-specific d/c criteria|5|||
46821799|NCT00534599|83041229|FG001|Overall Study|Developed study-specific d/c criteria|0|||
46821800|NCT00534599|83041228|FG000|Overall Study|Lack of Efficacy|0|||
46821801|NCT00534599|83041229|FG001|Overall Study|Lack of Efficacy|1|||
46821802|NCT00534599|83041228|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
46821803|NCT00534599|83041229|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
46821804|NCT00534599|83041228|FG000|Overall Study|Protocol Violation|1|||
46821805|NCT00534599|83041229|FG001|Overall Study|Protocol Violation|3|||
46821806|NCT00534599|83041228|FG000|Overall Study|Lost to Follow-up|11|||
46821807|NCT00534599|83041229|FG001|Overall Study|Lost to Follow-up|14|||
46821808|NCT00534599|83041228|FG000|Overall Study|Withdrawal by Subject|4|||
46821809|NCT00534599|83041229|FG001|Overall Study|Withdrawal by Subject|6|||
46821810|NCT00534599|83041228|FG000|Overall Study|Other|7|||
46821811|NCT00534599|83041229|FG001|Overall Study|Other|0|||
46821812|NCT03892889|83041252|FG000|Overall Study|Adverse Event|17|||
46821813|NCT03892889|83041252|FG000|Overall Study|Lack of Efficacy|1|||
46821814|NCT03892889|83041252|FG000|Overall Study|Lost to Follow-up|46|||
46821815|NCT03892889|83041252|FG000|Overall Study|Non-compliance with study drug|22|||
46821816|NCT03892889|83041252|FG000|Overall Study|Pregnancy|1|||
46760507|NCT00848718|82978591|FG011|Overall Study|Progressive disease before treatment|6|||
46760508|NCT00848718|82978592|FG012|Overall Study|Progressive disease before treatment|2|||
46760509|NCT00848718|82978580|FG000|Overall Study|Protocol Violation|0|||
46760510|NCT00848718|82978581|FG001|Overall Study|Protocol Violation|1|||
46760511|NCT00848718|82978582|FG002|Overall Study|Protocol Violation|0|||
46760512|NCT00848718|82978583|FG003|Overall Study|Protocol Violation|0|||
46760513|NCT00848718|82978584|FG004|Overall Study|Protocol Violation|0|||
46760514|NCT00848718|82978585|FG005|Overall Study|Protocol Violation|0|||
46760515|NCT00848718|82978586|FG006|Overall Study|Protocol Violation|0|||
46760516|NCT00848718|82978587|FG007|Overall Study|Protocol Violation|1|||
46760517|NCT00848718|82978588|FG008|Overall Study|Protocol Violation|0|||
46760518|NCT00848718|82978589|FG009|Overall Study|Protocol Violation|0|||
46932781|NCT02583256|83168343|FG003|Overall Study|Lost to Follow-up|1|||
46932782|NCT02583256|83168340|FG000|Overall Study|Administrative/Other|2|||
46932783|NCT02583256|83168341|FG001|Overall Study|Administrative/Other|0|||
46932784|NCT02583256|83168342|FG002|Overall Study|Administrative/Other|1|||
46932785|NCT02583256|83168343|FG003|Overall Study|Administrative/Other|2|||
46932786|NCT02584660|83168366|FG000|Overall Study|Adverse Event|4|||
46932787|NCT02584660|83168367|FG001|Overall Study|Adverse Event|0|||
46932788|NCT02584660|83168366|FG000|Overall Study|Lost to Follow-up|3|||
46932789|NCT02584660|83168367|FG001|Overall Study|Lost to Follow-up|4|||
46760519|NCT00848718|82978590|FG010|Overall Study|Protocol Violation|0|||
46760520|NCT00848718|82978591|FG011|Overall Study|Protocol Violation|0|||
46760521|NCT00848718|82978592|FG012|Overall Study|Protocol Violation|1|||
46821817|NCT03892889|83041252|FG000|Overall Study|Protocol Deviation|3|||
46821818|NCT03892889|83041252|FG000|Overall Study|Withdrawal by Subject|50|||
46821819|NCT03892889|83041252|FG000|Overall Study|Withdrawal by Caregiver|1|||
46821820|NCT03892889|83041252|FG000|Overall Study|Study Terminated by Sponsor|50|||
46821821|NCT03892889|83041252|FG000|Overall Study|Physician Decision|8|||
46821822|NCT03892889|83041252|FG000|Overall Study|Reason not Specified|5|||
46932790|NCT02584660|83168366|FG000|Overall Study|Protocol Violation|0|||
46821823|NCT00473330|83041259|FG000|Core Study|Adverse Event|4|||
46932791|NCT02584660|83168367|FG001|Overall Study|Protocol Violation|1|||
46932792|NCT02584660|83168366|FG000|Overall Study|Withdrawal by Subject|0|||
46760522|NCT00848718|82978580|FG000|Overall Study|Withdrawal by Subject|1|||
46760523|NCT00848718|82978581|FG001|Overall Study|Withdrawal by Subject|0|||
46760524|NCT00848718|82978582|FG002|Overall Study|Withdrawal by Subject|0|||
46821824|NCT00473330|83041260|FG001|Core Study|Adverse Event|4|||
46821825|NCT00473330|83041261|FG002|Core Study|Adverse Event|1|||
46821826|NCT00473330|83041259|FG000|Core Study|Death|6|||
46821827|NCT00473330|83041260|FG001|Core Study|Death|4|||
46821828|NCT00473330|83041261|FG002|Core Study|Death|4|||
46821829|NCT00473330|83041259|FG000|Core Study|Lost to Follow-up|5|||
46821830|NCT00473330|83041260|FG001|Core Study|Lost to Follow-up|5|||
46821831|NCT00473330|83041261|FG002|Core Study|Lost to Follow-up|10|||
46821832|NCT00473330|83041259|FG000|Core Study|Physician Decision|2|||
46821833|NCT00473330|83041260|FG001|Core Study|Physician Decision|1|||
46821834|NCT00473330|83041261|FG002|Core Study|Physician Decision|3|||
46821835|NCT00473330|83041259|FG000|Core Study|Subject Non-compliance|1|||
46821836|NCT00473330|83041260|FG001|Core Study|Subject Non-compliance|2|||
46821837|NCT00473330|83041261|FG002|Core Study|Subject Non-compliance|1|||
46821838|NCT00473330|83041259|FG000|Core Study|Subject Required Other Therapy|0|||
46821839|NCT00473330|83041260|FG001|Core Study|Subject Required Other Therapy|1|||
46821840|NCT00473330|83041261|FG002|Core Study|Subject Required Other Therapy|3|||
46821841|NCT00473330|83041259|FG000|Core Study|Subject's Decision|9|||
46821842|NCT00473330|83041260|FG001|Core Study|Subject's Decision|8|||
46821843|NCT00473330|83041261|FG002|Core Study|Subject's Decision|19|||
46821844|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
46821845|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
46821846|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
46821847|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Death|2|||
46821848|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Death|0|||
46821849|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Death|0|||
46821850|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
46821851|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
46821852|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
46821853|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
46821854|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
46821855|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
46821856|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
46821857|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
46821858|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
46821859|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
46821860|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
46821861|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
46821862|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
46821863|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
46821864|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
46821865|NCT00473330|83041259|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
46821866|NCT00473330|83041260|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
46821867|NCT00473330|83041261|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
46821868|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
46821869|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
46821870|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
46821871|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Death|2|||
46821872|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Death|2|||
46821873|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Death|1|||
46821874|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
46821875|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
46821876|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
46821877|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
46821878|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
46821879|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
46821880|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
46821881|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
46821882|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
46821883|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
46821884|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
46821885|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
46821886|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
46821887|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
46821888|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
46821889|NCT00473330|83041259|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
46932793|NCT02584660|83168367|FG001|Overall Study|Withdrawal by Subject|2|||
46932794|NCT02584660|83168366|FG000|Overall Study|Other|0|||
46932795|NCT02584660|83168367|FG001|Overall Study|Other|1|||
46932796|NCT02582632|83168389|FG000|Overall Study|Other|1|||
47056777|NCT03225846|83334147|FG001|Overall Study|Patient decision|0|||
46821890|NCT00473330|83041260|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
46821891|NCT00473330|83041261|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
46821892|NCT00416520|83041291|FG000|Open-label Period|Adverse Event|28|||
46821893|NCT00416520|83041292|FG001|Open-label Period|Adverse Event|10|||
46821894|NCT00416520|83041293|FG002|Open-label Period|Adverse Event|0|||
47056778|NCT03225846|83334148|FG002|Overall Study|Patient decision|0|||
47056779|NCT03225846|83334149|FG003|Overall Study|Patient decision|0|||
47056780|NCT03225846|83334150|FG004|Overall Study|Patient decision|0|||
46821895|NCT00416520|83041294|FG003|Open-label Period|Adverse Event|0|||
46821896|NCT00416520|83041291|FG000|Open-label Period|Death|2|||
46821897|NCT00416520|83041292|FG001|Open-label Period|Death|1|||
46821898|NCT00416520|83041293|FG002|Open-label Period|Death|0|||
46821899|NCT00416520|83041294|FG003|Open-label Period|Death|0|||
46821900|NCT00416520|83041291|FG000|Open-label Period|Lack of Efficacy|8|||
46821901|NCT00416520|83041292|FG001|Open-label Period|Lack of Efficacy|1|||
46932797|NCT02178722|83168398|FG000|Overall Study|Withdrawal by Subject|0|||
46932798|NCT02178722|83168399|FG001|Overall Study|Withdrawal by Subject|0|||
47056781|NCT03225846|83334151|FG005|Overall Study|Patient decision|0|||
47056782|NCT03225846|83334152|FG006|Overall Study|Patient decision|1|||
46760525|NCT00848718|82978583|FG003|Overall Study|Withdrawal by Subject|1|||
46760526|NCT00848718|82978584|FG004|Overall Study|Withdrawal by Subject|0|||
46760527|NCT00848718|82978585|FG005|Overall Study|Withdrawal by Subject|0|||
46760528|NCT00848718|82978586|FG006|Overall Study|Withdrawal by Subject|0|||
46760529|NCT00848718|82978587|FG007|Overall Study|Withdrawal by Subject|0|||
46760530|NCT00848718|82978588|FG008|Overall Study|Withdrawal by Subject|0|||
46760531|NCT00848718|82978589|FG009|Overall Study|Withdrawal by Subject|0|||
46760532|NCT00848718|82978590|FG010|Overall Study|Withdrawal by Subject|1|||
46760533|NCT00848718|82978591|FG011|Overall Study|Withdrawal by Subject|0|||
46760534|NCT00848718|82978592|FG012|Overall Study|Withdrawal by Subject|0|||
47056783|NCT01712009|83334217|FG000|Overall Study|Withdrawal by Subject|24|||
47056784|NCT01712009|83334218|FG001|Overall Study|Withdrawal by Subject|15|||
47056785|NCT01712009|83334219|FG002|Overall Study|Withdrawal by Subject|8|||
47056786|NCT01712009|83334217|FG000|Overall Study|Lost to Follow-up|2|||
46760535|NCT00848718|82978580|FG000|Overall Study|Progressive disease during treatment|3|||
46760536|NCT00848718|82978581|FG001|Overall Study|Progressive disease during treatment|0|||
46760537|NCT00848718|82978582|FG002|Overall Study|Progressive disease during treatment|3|||
46760538|NCT00848718|82978583|FG003|Overall Study|Progressive disease during treatment|0|||
46760539|NCT00848718|82978584|FG004|Overall Study|Progressive disease during treatment|0|||
46760540|NCT00848718|82978585|FG005|Overall Study|Progressive disease during treatment|0|||
46760541|NCT00848718|82978586|FG006|Overall Study|Progressive disease during treatment|0|||
46760542|NCT00848718|82978587|FG007|Overall Study|Progressive disease during treatment|2|||
46760543|NCT00848718|82978588|FG008|Overall Study|Progressive disease during treatment|0|||
46760544|NCT00848718|82978589|FG009|Overall Study|Progressive disease during treatment|0|||
46760545|NCT00848718|82978590|FG010|Overall Study|Progressive disease during treatment|0|||
46760546|NCT00848718|82978591|FG011|Overall Study|Progressive disease during treatment|0|||
46760547|NCT00848718|82978592|FG012|Overall Study|Progressive disease during treatment|2|||
46760548|NCT00883337|82978629|FG000|Core Treatment Period|Adverse Event|9|||
46760549|NCT00883337|82978630|FG001|Core Treatment Period|Adverse Event|12|||
46760550|NCT00883337|82978631|FG002|Core Treatment Period|Adverse Event|22|||
46760551|NCT00883337|82978629|FG000|Core Treatment Period|Lack of Efficacy|7|||
46760552|NCT00883337|82978630|FG001|Core Treatment Period|Lack of Efficacy|4|||
46760553|NCT00883337|82978631|FG002|Core Treatment Period|Lack of Efficacy|2|||
46760554|NCT00883337|82978629|FG000|Core Treatment Period|Lost to Follow-up|1|||
46760555|NCT00883337|82978630|FG001|Core Treatment Period|Lost to Follow-up|1|||
46760556|NCT00883337|82978631|FG002|Core Treatment Period|Lost to Follow-up|0|||
46760557|NCT00883337|82978629|FG000|Core Treatment Period|Withdrawal by Subject|2|||
46821902|NCT00416520|83041293|FG002|Open-label Period|Lack of Efficacy|0|||
46821903|NCT00416520|83041294|FG003|Open-label Period|Lack of Efficacy|0|||
46821904|NCT00416520|83041291|FG000|Open-label Period|Protocol Violation|3|||
46821905|NCT00416520|83041292|FG001|Open-label Period|Protocol Violation|3|||
46821906|NCT00416520|83041293|FG002|Open-label Period|Protocol Violation|0|||
46967717|NCT02120950|83210259|FG002|Overall Study|Lost to Follow-up|1|||
46967718|NCT02120794|83210266|FG000|Overall Study|Withdrawal by Subject|43|||
46967719|NCT02120794|83210266|FG000|Overall Study|Adverse Event|10|||
46967720|NCT02120794|83210266|FG000|Overall Study|Physician Decision|4|||
46967721|NCT02120794|83210266|FG000|Overall Study|Due to insurance coverage|1|||
46967722|NCT02184442|83210272|FG000|Overall Study|Death|61|||
46967723|NCT02184442|83210273|FG001|Overall Study|Death|65|||
46967724|NCT02184442|83210272|FG000|Overall Study|Withdrawal by Subject|3|||
46967725|NCT02184442|83210273|FG001|Overall Study|Withdrawal by Subject|11|||
46967726|NCT02155738|83210283|FG000|Overall Study|Missing critical information|1|||
46932799|NCT02178722|83168400|FG002|Overall Study|Withdrawal by Subject|0|||
46932800|NCT02178722|83168401|FG003|Overall Study|Withdrawal by Subject|2|||
46932801|NCT02178722|83168402|FG004|Overall Study|Withdrawal by Subject|33|||
46932802|NCT02178722|83168398|FG000|Overall Study|Death|2|||
46932803|NCT02178722|83168399|FG001|Overall Study|Death|13|||
46932804|NCT02178722|83168400|FG002|Overall Study|Death|12|||
46932805|NCT02178722|83168401|FG003|Overall Study|Death|12|||
46932806|NCT02178722|83168402|FG004|Overall Study|Death|205|||
46932807|NCT02178722|83168398|FG000|Overall Study|Lost to Follow-up|0|||
46932808|NCT02178722|83168399|FG001|Overall Study|Lost to Follow-up|0|||
46932809|NCT02178722|83168400|FG002|Overall Study|Lost to Follow-up|0|||
46932810|NCT02178722|83168401|FG003|Overall Study|Lost to Follow-up|2|||
46932811|NCT02178722|83168402|FG004|Overall Study|Lost to Follow-up|11|||
46932812|NCT02178722|83168398|FG000|Overall Study|Study terminated by Sponsor|2|||
46932813|NCT02178722|83168399|FG001|Overall Study|Study terminated by Sponsor|7|||
46932814|NCT02178722|83168400|FG002|Overall Study|Study terminated by Sponsor|6|||
46932815|NCT02178722|83168401|FG003|Overall Study|Study terminated by Sponsor|4|||
46932816|NCT02178722|83168402|FG004|Overall Study|Study terminated by Sponsor|128|||
46932817|NCT02178722|83168398|FG000|Overall Study|Physician Decision|0|||
46932818|NCT02178722|83168399|FG001|Overall Study|Physician Decision|0|||
46932819|NCT02178722|83168400|FG002|Overall Study|Physician Decision|0|||
46932820|NCT02178722|83168401|FG003|Overall Study|Physician Decision|0|||
46932821|NCT02178722|83168402|FG004|Overall Study|Physician Decision|3|||
46932822|NCT02178722|83168398|FG000|Overall Study|Other|0|||
46932823|NCT02178722|83168399|FG001|Overall Study|Other|0|||
46932824|NCT02178722|83168400|FG002|Overall Study|Other|0|||
46932825|NCT02178722|83168401|FG003|Overall Study|Other|0|||
46932826|NCT02178722|83168402|FG004|Overall Study|Other|2|||
46932827|NCT00972309|83168419|FG000|Overall Study|Switched to alternative treatment|0|||
46932828|NCT00972309|83168420|FG001|Overall Study|Switched to alternative treatment|2|||
47056787|NCT01712009|83334218|FG001|Overall Study|Lost to Follow-up|0|||
47056788|NCT01712009|83334219|FG002|Overall Study|Lost to Follow-up|1|||
47056789|NCT01712009|83334217|FG000|Overall Study|Decision by Sponsor|12|||
47056790|NCT01712009|83334218|FG001|Overall Study|Decision by Sponsor|14|||
46932829|NCT00972309|83168419|FG000|Overall Study|Refused further treatment|0|||
46932830|NCT00972309|83168420|FG001|Overall Study|Refused further treatment|1|||
46932831|NCT00972309|83168419|FG000|Overall Study|Late determination of ineligibility|0|||
46932832|NCT00972309|83168420|FG001|Overall Study|Late determination of ineligibility|1|||
46932833|NCT00972309|83168419|FG000|Overall Study|Second malignancy|1|||
46932834|NCT00972309|83168420|FG001|Overall Study|Second malignancy|1|||
46932835|NCT00972309|83168419|FG000|Overall Study|Visa issues|0|||
46932836|NCT00972309|83168420|FG001|Overall Study|Visa issues|1|||
46932837|NCT00972309|83168419|FG000|Overall Study|Secondary cancer (SCC)|0|||
46932838|NCT00972309|83168420|FG001|Overall Study|Secondary cancer (SCC)|1|||
46932839|NCT00972309|83168419|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
46932840|NCT00972309|83168420|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
46932841|NCT00972309|83168419|FG000|Overall Study|Lost to Follow-up|1|||
46932842|NCT00972309|83168420|FG001|Overall Study|Lost to Follow-up|1|||
46932843|NCT00972309|83168419|FG000|Overall Study|Disease progression on study|10|||
46932844|NCT00972309|83168420|FG001|Overall Study|Disease progression on study|4|||
46932845|NCT02582242|83168439|FG000|Overall Study|Adverse Event|4|||
46932846|NCT02582242|83168440|FG001|Overall Study|Adverse Event|3|||
47056791|NCT01712009|83334219|FG002|Overall Study|Decision by Sponsor|12|||
47056792|NCT01711853|83334248|FG000|Overall Study|Not treated|3|||
47056793|NCT01708187|83334254|FG000|Overall Study|Lost to Follow-up|0|||
47056794|NCT01708187|83334255|FG001|Overall Study|Lost to Follow-up|1|||
47056795|NCT01740401|83334331|FG000|Overall Study|Progression of disease|6|||
47056796|NCT01740401|83334331|FG000|Overall Study|Adverse Event|2|||
47056797|NCT01740401|83334331|FG000|Overall Study|Did not reach primary endpoint|2|||
47056798|NCT01711619|83334352|FG000|Overall Study|Early study termination|10|||
46636910|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
47056799|NCT01711619|83334353|FG001|Overall Study|Early study termination|14|||
47056800|NCT01711619|83334352|FG000|Overall Study|Withdrawal by Subject|3|||
46760558|NCT00883337|82978630|FG001|Core Treatment Period|Withdrawal by Subject|2|||
46932847|NCT02582242|83168439|FG000|Overall Study|Protocol Violation|3|||
46932848|NCT02582242|83168440|FG001|Overall Study|Protocol Violation|1|||
46932849|NCT02582242|83168439|FG000|Overall Study|Lost to Follow-up|0|||
46932850|NCT02582242|83168440|FG001|Overall Study|Lost to Follow-up|1|||
46932851|NCT02582242|83168439|FG000|Overall Study|Withdrawal by Subject|11|||
47056801|NCT01711619|83334353|FG001|Overall Study|Withdrawal by Subject|7|||
46932852|NCT02582242|83168440|FG001|Overall Study|Withdrawal by Subject|11|||
46932853|NCT02582242|83168439|FG000|Overall Study|Unclassified|2|||
46932854|NCT02582242|83168440|FG001|Overall Study|Unclassified|1|||
46932855|NCT00663351|83168448|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
46760559|NCT00883337|82978631|FG002|Core Treatment Period|Withdrawal by Subject|6|||
46760560|NCT00883337|82978629|FG000|Core Treatment Period|Wish to be pregnant|1|||
46760561|NCT00883337|82978630|FG001|Core Treatment Period|Wish to be pregnant|2|||
46760562|NCT00883337|82978631|FG002|Core Treatment Period|Wish to be pregnant|1|||
46760563|NCT00883337|82978629|FG000|Core Treatment Period|Poor compliance to protocol|0|||
46760564|NCT00883337|82978630|FG001|Core Treatment Period|Poor compliance to protocol|0|||
46760565|NCT00883337|82978631|FG002|Core Treatment Period|Poor compliance to protocol|1|||
46821907|NCT00416520|83041294|FG003|Open-label Period|Protocol Violation|0|||
46821908|NCT00416520|83041291|FG000|Open-label Period|Withdrawal by Subject|16|||
46821909|NCT00416520|83041292|FG001|Open-label Period|Withdrawal by Subject|5|||
46821910|NCT00416520|83041293|FG002|Open-label Period|Withdrawal by Subject|0|||
46821911|NCT00416520|83041294|FG003|Open-label Period|Withdrawal by Subject|0|||
46821912|NCT00416520|83041291|FG000|Open-label Period|Other Reasons|3|||
46821913|NCT00416520|83041292|FG001|Open-label Period|Other Reasons|12|||
46821914|NCT00416520|83041293|FG002|Open-label Period|Other Reasons|0|||
47056802|NCT01711619|83334352|FG000|Overall Study|Protocol Violation|2|||
47056803|NCT01711619|83334353|FG001|Overall Study|Protocol Violation|3|||
47056804|NCT01711619|83334352|FG000|Overall Study|Adverse Event|2|||
47056805|NCT01711619|83334353|FG001|Overall Study|Adverse Event|0|||
46821915|NCT00416520|83041294|FG003|Open-label Period|Other Reasons|0|||
46821916|NCT00416520|83041291|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
46821917|NCT00416520|83041292|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
46821918|NCT00416520|83041293|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
46821919|NCT00416520|83041294|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
46821920|NCT00416520|83041291|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
46932856|NCT00663351|83168449|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
47056806|NCT01711619|83334352|FG000|Overall Study|Lost to Follow-up|1|||
47056807|NCT01711619|83334353|FG001|Overall Study|Lost to Follow-up|0|||
47056808|NCT01710527|83334368|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
46760566|NCT00883337|82978629|FG000|Core Treatment Period|Other than above|0|||
46760567|NCT00883337|82978630|FG001|Core Treatment Period|Other than above|1|||
46760568|NCT00883337|82978631|FG002|Core Treatment Period|Other than above|1|||
46760569|NCT00883337|82978629|FG000|Extension Treatment Period|Adverse Event|8|||
46760570|NCT00883337|82978630|FG001|Extension Treatment Period|Adverse Event|5|||
46760571|NCT00883337|82978631|FG002|Extension Treatment Period|Adverse Event|5|||
46760572|NCT00883337|82978629|FG000|Extension Treatment Period|Lack of Efficacy|8|||
46760573|NCT00883337|82978630|FG001|Extension Treatment Period|Lack of Efficacy|8|||
46932857|NCT00663351|83168448|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
47056809|NCT01710527|83334369|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
47056810|NCT01706939|83334377|FG000|Pre Randomization|Screen Failure|1|||
47056811|NCT01706939|83334378|FG001|Pre Randomization|Screen Failure|0|||
47056812|NCT01706939|83334379|FG002|Pre Randomization|Screen Failure|0|||
47056813|NCT01706939|83334377|FG000|Pre Randomization|Ineligible for Randomization|1|||
46760574|NCT00883337|82978631|FG002|Extension Treatment Period|Lack of Efficacy|8|||
46760575|NCT00883337|82978629|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
46821921|NCT00416520|83041292|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
46821922|NCT00416520|83041293|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
46821923|NCT00416520|83041294|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
46821924|NCT00416520|83041291|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
46821925|NCT00416520|83041292|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
46821926|NCT00416520|83041293|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
46821927|NCT00416520|83041294|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
46821928|NCT00533429|83041306|FG000|Overall Study|Adverse Event|3|||
46821929|NCT00533429|83041307|FG001|Overall Study|Adverse Event|1|||
46821930|NCT00533429|83041306|FG000|Overall Study|Death|1|||
46821931|NCT00533429|83041307|FG001|Overall Study|Death|0|||
46821932|NCT00533429|83041306|FG000|Overall Study|Withdrawal by Subject|2|||
46821933|NCT00533429|83041307|FG001|Overall Study|Withdrawal by Subject|0|||
46821934|NCT00533429|83041306|FG000|Overall Study|Progressive Disease|12|||
46821935|NCT00533429|83041307|FG001|Overall Study|Progressive Disease|13|||
46821936|NCT00533429|83041306|FG000|Overall Study|Symptomatic deterioration|1|||
46821937|NCT00533429|83041307|FG001|Overall Study|Symptomatic deterioration|2|||
46821938|NCT00533273|83041317|FG000|Double-blind|Withdrew consent|0|||
46821939|NCT00533273|83041318|FG001|Double-blind|Withdrew consent|2|||
46821940|NCT00533273|83041317|FG000|Open-label|Withdrawal by Subject|6|||
46821941|NCT00533273|83041318|FG001|Open-label|Withdrawal by Subject|0|||
46821942|NCT03891641|83041326|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
46821943|NCT03891641|83041327|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
46821944|NCT00339183|83041335|FG000|Overall Study|Adverse Event|5|||
46821945|NCT00339183|83041336|FG001|Overall Study|Adverse Event|3|||
46821946|NCT00339183|83041335|FG000|Overall Study|Withdrawal by Subject|16|||
46821947|NCT00339183|83041336|FG001|Overall Study|Withdrawal by Subject|19|||
46821948|NCT00339183|83041335|FG000|Overall Study|Physician Decision|2|||
46821949|NCT00339183|83041336|FG001|Overall Study|Physician Decision|4|||
46821950|NCT00339183|83041335|FG000|Overall Study|Lost to Follow-up|17|||
46821951|NCT00339183|83041336|FG001|Overall Study|Lost to Follow-up|17|||
46821952|NCT00339183|83041335|FG000|Overall Study|Protocol-specified criteria|12|||
46821953|NCT00339183|83041336|FG001|Overall Study|Protocol-specified criteria|8|||
46821954|NCT00339183|83041335|FG000|Overall Study|Missing reason|3|||
46821955|NCT00339183|83041336|FG001|Overall Study|Missing reason|1|||
46821956|NCT00339183|83041335|FG000|Overall Study|Other|46|||
46821957|NCT00339183|83041336|FG001|Overall Study|Other|40|||
46821958|NCT00339183|83041335|FG000|Overall Study|Ongoing|20|||
46821959|NCT00339183|83041336|FG001|Overall Study|Ongoing|13|||
46821960|NCT00532883|83041350|FG000|Overall Study|Adverse Event|1|||
46821961|NCT00532883|83041351|FG001|Overall Study|Adverse Event|0|||
46821962|NCT00532883|83041352|FG002|Overall Study|Adverse Event|0|||
46821963|NCT00532883|83041353|FG003|Overall Study|Adverse Event|1|||
46821964|NCT00532883|83041350|FG000|Overall Study|Lost to Follow-up|1|||
46821965|NCT00532883|83041351|FG001|Overall Study|Lost to Follow-up|1|||
46821966|NCT00532883|83041352|FG002|Overall Study|Lost to Follow-up|1|||
46821967|NCT00532883|83041353|FG003|Overall Study|Lost to Follow-up|0|||
46821968|NCT00532883|83041350|FG000|Overall Study|Withdrawal by Subject|0|||
46821969|NCT00532883|83041351|FG001|Overall Study|Withdrawal by Subject|1|||
46821970|NCT00532883|83041352|FG002|Overall Study|Withdrawal by Subject|1|||
46821971|NCT00532883|83041353|FG003|Overall Study|Withdrawal by Subject|0|||
46821972|NCT00532883|83041350|FG000|Overall Study|Subject was Nonadherent|0|||
46821973|NCT00532883|83041351|FG001|Overall Study|Subject was Nonadherent|1|||
46821974|NCT00532883|83041352|FG002|Overall Study|Subject was Nonadherent|1|||
46821975|NCT00532883|83041353|FG003|Overall Study|Subject was Nonadherent|0|||
46821976|NCT00532883|83041350|FG000|Overall Study|Early Study Termination|4|||
46821977|NCT00532883|83041351|FG001|Overall Study|Early Study Termination|4|||
46821978|NCT00532883|83041352|FG002|Overall Study|Early Study Termination|1|||
46821979|NCT00532883|83041353|FG003|Overall Study|Early Study Termination|4|||
46821980|NCT00354159|83041365|FG000|Randomized Study Period|Withdrawal by Subject|5|||
46821981|NCT00354159|83041366|FG001|Randomized Study Period|Withdrawal by Subject|3|||
46821982|NCT00354159|83041365|FG000|Randomized Study Period|Physician Decision|6|||
46821983|NCT00354159|83041366|FG001|Randomized Study Period|Physician Decision|10|||
46821984|NCT00354159|83041365|FG000|Randomized Study Period|Lost to Follow-up|4|||
46821985|NCT00354159|83041366|FG001|Randomized Study Period|Lost to Follow-up|0|||
46821986|NCT00354159|83041365|FG000|Randomized Study Period|Death|7|||
46821987|NCT00354159|83041366|FG001|Randomized Study Period|Death|9|||
46932858|NCT00663351|83168449|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
46821988|NCT00354159|83041365|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
46821989|NCT00354159|83041366|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
46821990|NCT00354159|83041365|FG000|Long-term Follow-up|Physician Decision|127|||
46821991|NCT00354159|83041366|FG001|Long-term Follow-up|Physician Decision|122|||
46821992|NCT00354159|83041365|FG000|Long-term Follow-up|Lost to Follow-up|1|||
46821993|NCT00354159|83041366|FG001|Long-term Follow-up|Lost to Follow-up|0|||
46821994|NCT00354159|83041365|FG000|Long-term Follow-up|Death|14|||
46821995|NCT00354159|83041366|FG001|Long-term Follow-up|Death|11|||
46821996|NCT00354159|83041365|FG000|Long-term Follow-up|Study Closed|29|||
46821997|NCT00354159|83041366|FG001|Long-term Follow-up|Study Closed|34|||
46821998|NCT00338949|83041381|FG000|Subject Screening|Screen failures|11|||
46821999|NCT00338949|83041382|FG001|Subject Screening|Screen failures|11|||
46822000|NCT00338949|83041381|FG000|Randomization|Withdrawal by Subject|1|||
46822001|NCT00338949|83041382|FG001|Randomization|Withdrawal by Subject|0|||
46822002|NCT00338949|83041381|FG000|Randomization|Adverse Event|0|||
46822003|NCT00338949|83041382|FG001|Randomization|Adverse Event|5|||
46822004|NCT00332709|83041390|FG000|Overall Study|Adverse Event|11|||
46822005|NCT00332709|83041391|FG001|Overall Study|Adverse Event|14|||
46822006|NCT00332709|83041390|FG000|Overall Study|Withdrawal by Subject|2|||
46822007|NCT00332709|83041391|FG001|Overall Study|Withdrawal by Subject|3|||
46822008|NCT00332709|83041390|FG000|Overall Study|Lost to Follow-up|2|||
46822009|NCT00332709|83041391|FG001|Overall Study|Lost to Follow-up|0|||
46822010|NCT00332709|83041390|FG000|Overall Study|Administrative Problems|0|||
46822011|NCT00332709|83041391|FG001|Overall Study|Administrative Problems|3|||
46822012|NCT00332709|83041390|FG000|Overall Study|Abnormal test procedure result|1|||
46822013|NCT00332709|83041391|FG001|Overall Study|Abnormal test procedure result|0|||
46822014|NCT00332241|83041399|FG000|Overall Study|Lack of Efficacy|6|||
46822015|NCT00332241|83041400|FG001|Overall Study|Lack of Efficacy|1|||
46822016|NCT00332241|83041399|FG000|Overall Study|Adverse Event|3|||
46822017|NCT00332241|83041400|FG001|Overall Study|Adverse Event|5|||
46822018|NCT00332241|83041399|FG000|Overall Study|Withdrawal by Subject|2|||
46822019|NCT00332241|83041400|FG001|Overall Study|Withdrawal by Subject|1|||
46822020|NCT00332241|83041399|FG000|Overall Study|Lost to Follow-up|4|||
46822021|NCT00332241|83041400|FG001|Overall Study|Lost to Follow-up|1|||
46822022|NCT00337935|83041408|FG000|Overall Study|Adverse Event|2|||
46822023|NCT00337935|83041409|FG001|Overall Study|Adverse Event|5|||
46822024|NCT00337935|83041408|FG000|Overall Study|Death|2|||
46822025|NCT00337935|83041409|FG001|Overall Study|Death|8|||
46822026|NCT00337935|83041408|FG000|Overall Study|Physician Decision|1|||
46822027|NCT00337935|83041409|FG001|Overall Study|Physician Decision|1|||
46822028|NCT00337935|83041408|FG000|Overall Study|Lost to Follow-up|0|||
46822029|NCT00337935|83041409|FG001|Overall Study|Lost to Follow-up|1|||
46822030|NCT00337935|83041408|FG000|Overall Study|Protocol Violation|4|||
46822031|NCT00337935|83041409|FG001|Overall Study|Protocol Violation|3|||
46822032|NCT00337935|83041408|FG000|Overall Study|Withdrawal by Subject|1|||
46822033|NCT00337935|83041409|FG001|Overall Study|Withdrawal by Subject|7|||
46822034|NCT00337935|83041408|FG000|Overall Study|Other|0|||
46822035|NCT00337935|83041409|FG001|Overall Study|Other|1|||
46822036|NCT00337935|83041408|FG000|Overall Study|Lack of Efficacy|0|||
46822037|NCT00337935|83041409|FG001|Overall Study|Lack of Efficacy|1|||
46822038|NCT00337779|83041418|FG000|Overall Study|Withdrawal by Subject|10|||
46822039|NCT00337779|83041419|FG001|Overall Study|Withdrawal by Subject|12|||
46822040|NCT00337779|83041418|FG000|Overall Study|Sponsor decision|1|||
46822041|NCT00337779|83041419|FG001|Overall Study|Sponsor decision|1|||
46822042|NCT00337779|83041418|FG000|Overall Study|Physician Decision|3|||
46822043|NCT00337779|83041419|FG001|Overall Study|Physician Decision|6|||
46822044|NCT00337779|83041418|FG000|Overall Study|Protocol Violation|1|||
46822045|NCT00337779|83041419|FG001|Overall Study|Protocol Violation|1|||
46822046|NCT00337779|83041418|FG000|Overall Study|Lost to Follow-up|6|||
46822047|NCT00337779|83041419|FG001|Overall Study|Lost to Follow-up|5|||
46822048|NCT00337779|83041418|FG000|Overall Study|Adverse Event|28|||
46822049|NCT00337779|83041419|FG001|Overall Study|Adverse Event|51|||
46822050|NCT00337779|83041418|FG000|Overall Study|Pregnancy|3|||
46822051|NCT00337779|83041419|FG001|Overall Study|Pregnancy|2|||
47056814|NCT01706939|83334378|FG001|Pre Randomization|Ineligible for Randomization|0|||
47056815|NCT01706939|83334379|FG002|Pre Randomization|Ineligible for Randomization|0|||
47056816|NCT01706939|83334377|FG000|Pre Randomization|Withdrawal by Subject|1|||
47056817|NCT01706939|83334378|FG001|Pre Randomization|Withdrawal by Subject|0|||
47056818|NCT01706939|83334379|FG002|Pre Randomization|Withdrawal by Subject|0|||
46636911|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
46760576|NCT00883337|82978630|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
46760577|NCT00883337|82978631|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
46760578|NCT00883337|82978629|FG000|Extension Treatment Period|Lost to Follow-up|1|||
46760579|NCT00883337|82978630|FG001|Extension Treatment Period|Lost to Follow-up|0|||
46760580|NCT00883337|82978631|FG002|Extension Treatment Period|Lost to Follow-up|0|||
46760581|NCT00883337|82978629|FG000|Extension Treatment Period|Other than above|10|||
46760582|NCT00883337|82978630|FG001|Extension Treatment Period|Other than above|9|||
46822052|NCT00337779|83041418|FG000|Overall Study|Death|0|||
46822053|NCT00337779|83041419|FG001|Overall Study|Death|1|||
46822054|NCT00352755|83041425|FG000|Overall Study|Physician Decision|1|||
46822055|NCT00352755|83041425|FG000|Overall Study|Adverse Event|1|||
46822056|NCT00533897|83041432|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
47056819|NCT01706939|83334377|FG000|Randomization|Insufficient QoL survey compliance|0|||
46822057|NCT00533897|83041433|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
46822058|NCT00533897|83041434|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
47056820|NCT01706939|83334378|FG001|Randomization|Insufficient QoL survey compliance|1|||
46760583|NCT00883337|82978631|FG002|Extension Treatment Period|Other than above|5|||
46822059|NCT00533897|83041435|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
46822060|NCT00533897|83041436|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
46822061|NCT00533897|83041437|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
46822062|NCT00533897|83041438|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
46822063|NCT00533897|83041439|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
46822064|NCT00533897|83041432|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
46822065|NCT00533897|83041433|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
46822066|NCT00533897|83041434|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
46822067|NCT00533897|83041435|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
46822068|NCT00533897|83041436|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
46822069|NCT00533897|83041437|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
46822070|NCT00533897|83041438|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
46822071|NCT00533897|83041439|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
46822072|NCT00533897|83041432|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
46822073|NCT00533897|83041433|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
46822074|NCT00533897|83041434|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
46822075|NCT00533897|83041435|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
46822076|NCT00533897|83041436|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
46822077|NCT00533897|83041437|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
46932859|NCT00663351|83168448|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
46932860|NCT00663351|83168449|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
46932861|NCT00663351|83168448|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
47056821|NCT01706939|83334379|FG002|Randomization|Insufficient QoL survey compliance|1|||
47056822|NCT01706939|83334377|FG000|Randomization|Progression of disease|0|||
47056823|NCT01706939|83334378|FG001|Randomization|Progression of disease|2|||
47056824|NCT01706939|83334379|FG002|Randomization|Progression of disease|1|||
47056825|NCT01709903|83334388|FG000|Overall Study|administrative problems|2|||
47056826|NCT01709903|83334389|FG001|Overall Study|administrative problems|6|||
47056827|NCT01709903|83334388|FG000|Overall Study|Abnormal test procedure results|1|||
47056828|NCT01709903|83334389|FG001|Overall Study|Abnormal test procedure results|0|||
47056829|NCT01709903|83334388|FG000|Overall Study|In ability to use device|1|||
47056830|NCT01709903|83334389|FG001|Overall Study|In ability to use device|1|||
47056831|NCT01709903|83334388|FG000|Overall Study|no longer needed study drug|0|||
47056832|NCT01709903|83334389|FG001|Overall Study|no longer needed study drug|1|||
47056833|NCT01709903|83334388|FG000|Overall Study|Lost to Follow-up|0|||
47056834|NCT01709903|83334389|FG001|Overall Study|Lost to Follow-up|2|||
47056835|NCT01709903|83334388|FG000|Overall Study|Death|2|||
47056836|NCT01709903|83334389|FG001|Overall Study|Death|0|||
47056837|NCT01709903|83334388|FG000|Overall Study|Protocol Violation|3|||
47056838|NCT01709903|83334389|FG001|Overall Study|Protocol Violation|2|||
47056839|NCT01709903|83334388|FG000|Overall Study|Lack of Efficacy|3|||
47056840|NCT01709903|83334389|FG001|Overall Study|Lack of Efficacy|3|||
47056841|NCT01709903|83334388|FG000|Overall Study|Withdrawal by Subject|6|||
47056842|NCT01709903|83334389|FG001|Overall Study|Withdrawal by Subject|6|||
47056843|NCT01709903|83334388|FG000|Overall Study|Adverse Event|11|||
47056844|NCT01709903|83334389|FG001|Overall Study|Adverse Event|18|||
47056845|NCT04492618|83334395|FG000|Overall Study|Withdrawal by Subject|1|||
47056846|NCT04978090|83334399|FG000|Overall Study|unable to adequately fit device|2|||
47056847|NCT04677504|83334405|FG000|Overall Study|Death|31|||
47056848|NCT04677504|83334406|FG001|Overall Study|Death|24|||
47056849|NCT04677504|83334405|FG000|Overall Study|Progressive Disease|1|||
47056850|NCT04677504|83334406|FG001|Overall Study|Progressive Disease|0|||
47056851|NCT04677504|83334405|FG000|Overall Study|Symptomatic Deterioration|1|||
46760584|NCT00838110|82978647|FG000|Overall Study|Death|0|||
46760585|NCT00838110|82978648|FG001|Overall Study|Death|0|||
46760586|NCT00838110|82978649|FG002|Overall Study|Death|1|||
46760587|NCT00838110|82978650|FG003|Overall Study|Death|2|||
46760588|NCT00838110|82978647|FG000|Overall Study|Adverse Event|11|||
46760589|NCT00838110|82978648|FG001|Overall Study|Adverse Event|10|||
47056852|NCT04677504|83334406|FG001|Overall Study|Symptomatic Deterioration|0|||
47056853|NCT04677504|83334405|FG000|Overall Study|Withdrawal by Subject|2|||
47056854|NCT04677504|83334406|FG001|Overall Study|Withdrawal by Subject|5|||
47056855|NCT04677504|83334405|FG000|Overall Study|Ongoing in study|48|||
47056856|NCT04677504|83334406|FG001|Overall Study|Ongoing in study|50|||
47056857|NCT04635631|83334414|FG000|Overall Study|Adverse Event|1|||
46760590|NCT00838110|82978649|FG002|Overall Study|Adverse Event|8|||
46760591|NCT00838110|82978650|FG003|Overall Study|Adverse Event|7|||
46760592|NCT00838110|82978647|FG000|Overall Study|Withdrawal by Subject|5|||
46760593|NCT00838110|82978648|FG001|Overall Study|Withdrawal by Subject|6|||
46760594|NCT00838110|82978649|FG002|Overall Study|Withdrawal by Subject|3|||
46760595|NCT00838110|82978650|FG003|Overall Study|Withdrawal by Subject|4|||
46932862|NCT00663351|83168449|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
46932863|NCT00663351|83168448|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
46932864|NCT00663351|83168449|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
46932865|NCT00663351|83168448|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
46932866|NCT00663351|83168449|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
46932867|NCT00616941|83168458|FG000|Overall Study|Progressive Disease|1|||
47056858|NCT04635631|83334414|FG000|Overall Study|Progressive disease|13|||
47056859|NCT04635631|83334414|FG000|Overall Study|Withdrawal by Subject|1|||
46822078|NCT00533897|83041438|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
46822079|NCT00533897|83041439|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
46822080|NCT00533897|83041432|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
46822081|NCT00533897|83041433|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
46822082|NCT00533897|83041434|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
46822083|NCT00533897|83041435|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
46822084|NCT00533897|83041436|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
46822085|NCT00533897|83041437|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
46822086|NCT00533897|83041438|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
46822087|NCT00533897|83041439|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
46822088|NCT00533897|83041432|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
46822089|NCT00533897|83041433|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
46822090|NCT00533897|83041434|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
46822091|NCT00533897|83041435|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
46822092|NCT00533897|83041436|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
46822093|NCT00533897|83041437|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
46822094|NCT00533897|83041438|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
46822095|NCT00533897|83041439|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
46822096|NCT00533897|83041432|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
46822097|NCT00533897|83041433|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
46822098|NCT00533897|83041434|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
46822099|NCT00533897|83041435|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
46822100|NCT00533897|83041436|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
46822101|NCT00533897|83041437|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
46822102|NCT00533897|83041438|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
46822103|NCT00533897|83041439|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
46822104|NCT00533897|83041432|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
46822105|NCT00533897|83041433|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
47056860|NCT04269395|83334431|FG000|Overall Study|Lost to Follow-up|1|||
47056861|NCT04269395|83334432|FG001|Overall Study|Lost to Follow-up|0|||
46636912|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
46636913|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
46760596|NCT00838110|82978647|FG000|Overall Study|Other|3|||
46760597|NCT00838110|82978648|FG001|Overall Study|Other|3|||
46760598|NCT00838110|82978649|FG002|Overall Study|Other|3|||
46760599|NCT00838110|82978650|FG003|Overall Study|Other|2|||
46760600|NCT00838110|82978647|FG000|Overall Study|Protocol Violation|0|||
46760601|NCT00838110|82978648|FG001|Overall Study|Protocol Violation|2|||
46760602|NCT00838110|82978649|FG002|Overall Study|Protocol Violation|1|||
46760603|NCT00838110|82978650|FG003|Overall Study|Protocol Violation|1|||
46760604|NCT00838110|82978647|FG000|Overall Study|Lost to Follow-up|3|||
46760605|NCT00838110|82978648|FG001|Overall Study|Lost to Follow-up|0|||
46760606|NCT00838110|82978649|FG002|Overall Study|Lost to Follow-up|0|||
46760607|NCT00838110|82978650|FG003|Overall Study|Lost to Follow-up|0|||
46760608|NCT00838110|82978647|FG000|Overall Study|Did not meet eligibility criteria|0|||
46760609|NCT00838110|82978648|FG001|Overall Study|Did not meet eligibility criteria|0|||
46760610|NCT00838110|82978649|FG002|Overall Study|Did not meet eligibility criteria|1|||
46760611|NCT00838110|82978650|FG003|Overall Study|Did not meet eligibility criteria|2|||
46760612|NCT00838110|82978647|FG000|Overall Study|Randomized but not treated|0|||
46760613|NCT00838110|82978648|FG001|Overall Study|Randomized but not treated|1|||
46760614|NCT00838110|82978649|FG002|Overall Study|Randomized but not treated|0|||
46760615|NCT00838110|82978650|FG003|Overall Study|Randomized but not treated|0|||
46760616|NCT00837876|82978660|FG000|Overall Study|Death|2|||
46760617|NCT00837876|82978660|FG000|Overall Study|Adverse Event|7|||
46760618|NCT00837876|82978660|FG000|Overall Study|Physician Decision|1|||
46760619|NCT00837876|82978660|FG000|Overall Study|Withdrawal by Subject|3|||
46760620|NCT00837876|82978660|FG000|Overall Study|disease progression|24|||
46760621|NCT00686920|82978666|FG000|Overall Study|Death|45|||
46932868|NCT00616941|83168459|FG001|Overall Study|Progressive Disease|2|||
46932869|NCT00616941|83168460|FG002|Overall Study|Progressive Disease|1|||
47056862|NCT04269395|83334431|FG000|Overall Study|Study terminated by Sponsor|13|||
46760622|NCT00686920|82978667|FG001|Overall Study|Death|14|||
46760623|NCT00686920|82978666|FG000|Overall Study|Liver Transplant|23|||
46760624|NCT00686920|82978667|FG001|Overall Study|Liver Transplant|8|||
46760625|NCT00686920|82978666|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
46822106|NCT00533897|83041434|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
46822107|NCT00533897|83041435|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
46822108|NCT00533897|83041436|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
46822109|NCT00533897|83041437|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
46822110|NCT00533897|83041438|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
46822111|NCT00533897|83041439|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
46822112|NCT00533897|83041432|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
46822113|NCT00533897|83041433|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
46822114|NCT00533897|83041434|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
46822115|NCT00533897|83041435|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
46822116|NCT00533897|83041436|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
46822117|NCT00533897|83041437|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
46822118|NCT00533897|83041438|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
46822119|NCT00533897|83041439|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
46822120|NCT00533897|83041432|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
46822121|NCT00533897|83041433|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
46822122|NCT00533897|83041434|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
46822123|NCT00533897|83041435|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
46822124|NCT00533897|83041436|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
46822125|NCT00533897|83041437|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
46822126|NCT00533897|83041438|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
46822127|NCT00533897|83041439|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
46822128|NCT00533897|83041432|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
46822129|NCT00533897|83041433|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
46822130|NCT00533897|83041434|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
46822131|NCT00533897|83041435|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
46822132|NCT00533897|83041436|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
46822133|NCT00533897|83041437|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
46822134|NCT00533897|83041438|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
46822135|NCT00533897|83041439|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
46822136|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
46822137|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
46822138|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
46822139|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
46822140|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
46822141|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
46822142|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
46822143|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
46822144|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Death|0|||
46822145|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Death|0|||
46822146|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Death|0|||
46822147|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Death|0|||
46822148|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Death|0|||
46822149|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Death|0|||
46822150|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Death|1|||
46822151|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Death|3|||
46822152|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
46822153|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
46822154|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
46822155|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
46822156|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
46822157|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
46822158|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
46822159|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
46822160|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
46822161|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
46822162|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
47056863|NCT04269395|83334432|FG001|Overall Study|Study terminated by Sponsor|10|||
47056864|NCT04143594|83334442|FG000|Overall Study|Still on study|48|||
46822163|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
46822164|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
46822165|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
46822166|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
46822167|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
47056865|NCT04143594|83334443|FG001|Overall Study|Still on study|42|||
47056866|NCT04143594|83334444|FG002|Overall Study|Still on study|48|||
46636914|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
46822168|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Adverse Event|0|||
46822169|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Adverse Event|0|||
46822170|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Adverse Event|0|||
46822171|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Adverse Event|0|||
46822172|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Adverse Event|0|||
46822173|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Adverse Event|0|||
46822174|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Adverse Event|2|||
46822175|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Adverse Event|5|||
46822176|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Pregnancy|0|||
46822177|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Pregnancy|0|||
46822178|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Pregnancy|0|||
46822179|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Pregnancy|0|||
46822180|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Pregnancy|0|||
46822181|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Pregnancy|0|||
46822182|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Pregnancy|0|||
46822183|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Pregnancy|2|||
46822184|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
46822185|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
46822186|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
46822187|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
46822188|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
46822189|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
46822190|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
46822191|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
46822192|NCT00533897|83041432|FG000|Long Term Extension (LTE)|Other|0|||
46822193|NCT00533897|83041433|FG001|Long Term Extension (LTE)|Other|0|||
46822194|NCT00533897|83041434|FG002|Long Term Extension (LTE)|Other|0|||
46822195|NCT00533897|83041435|FG003|Long Term Extension (LTE)|Other|0|||
46822196|NCT00533897|83041436|FG004|Long Term Extension (LTE)|Other|0|||
46822197|NCT00533897|83041437|FG005|Long Term Extension (LTE)|Other|0|||
46822198|NCT00533897|83041438|FG006|Long Term Extension (LTE)|Other|1|||
46822199|NCT00533897|83041439|FG007|Long Term Extension (LTE)|Other|6|||
46822200|NCT00426660|83041470|FG000|Overall Study|Death|14|||
46822201|NCT00426660|83041470|FG000|Overall Study|Adverse Event|23|||
46822202|NCT00426660|83041470|FG000|Overall Study|Insufficient Clinical Response|22|||
46822203|NCT00426660|83041470|FG000|Overall Study|Lost to Follow-up|15|||
46822204|NCT00426660|83041470|FG000|Overall Study|Other|23|||
46822205|NCT00426660|83041470|FG000|Overall Study|Withdrawal by Subject|18|||
46822206|NCT00426660|83041470|FG000|Overall Study|Protocol Violation|1|||
46822207|NCT00426660|83041470|FG000|Overall Study|Enrolled Not Treated|15|||
46822208|NCT00426270|83041474|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
46822209|NCT00426270|83041474|FG000|Overall Study|Adverse Event|5|||
46822210|NCT00330681|83041480|FG000|Overall Study|Adverse Event|3|||
46822211|NCT00330681|83041481|FG001|Overall Study|Adverse Event|6|||
46822212|NCT00330681|83041480|FG000|Overall Study|Protocol Violation|0|||
46822213|NCT00330681|83041481|FG001|Overall Study|Protocol Violation|1|||
46822214|NCT00330681|83041480|FG000|Overall Study|Withdrawal by Subject|5|||
46822215|NCT00330681|83041481|FG001|Overall Study|Withdrawal by Subject|5|||
46822216|NCT00330681|83041480|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
46822217|NCT00330681|83041481|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
46822218|NCT00329901|83041490|FG000|Overall Study|Withdrawal by Subject|4|||
46822219|NCT00329901|83041491|FG001|Overall Study|Withdrawal by Subject|3|||
46822220|NCT00329901|83041492|FG002|Overall Study|Withdrawal by Subject|2|||
46822221|NCT00329901|83041490|FG000|Overall Study|Lost to Follow-up|2|||
46822222|NCT00329901|83041491|FG001|Overall Study|Lost to Follow-up|0|||
46822223|NCT00329901|83041492|FG002|Overall Study|Lost to Follow-up|1|||
46822224|NCT00329901|83041490|FG000|Overall Study|Protocol Violation|1|||
46822225|NCT00329901|83041491|FG001|Overall Study|Protocol Violation|0|||
46822226|NCT00329901|83041492|FG002|Overall Study|Protocol Violation|1|||
46822227|NCT00329901|83041490|FG000|Overall Study|Unable to classify|2|||
46822228|NCT00329901|83041491|FG001|Overall Study|Unable to classify|2|||
46822229|NCT00329901|83041492|FG002|Overall Study|Unable to classify|0|||
46822230|NCT00436956|83041504|FG000|Overall Study|Not evaluable|1|||
46822231|NCT00436956|83041505|FG001|Overall Study|Not evaluable|0|||
46822232|NCT00329745|83041514|FG000|Overall Study|Protocol Violation|1|||
46822233|NCT00329745|83041515|FG001|Overall Study|Protocol Violation|0|||
46822234|NCT00329745|83041514|FG000|Overall Study|Withdrawal by Subject|0|||
46822235|NCT00329745|83041515|FG001|Overall Study|Withdrawal by Subject|1|||
46822236|NCT00329745|83041514|FG000|Overall Study|Lost to Follow-up|86|||
46822237|NCT00329745|83041515|FG001|Overall Study|Lost to Follow-up|101|||
46822238|NCT00436644|83041521|FG000|Overall Study|Adverse Event|2|||
46822239|NCT00436644|83041521|FG000|Overall Study|Death|1|||
46822240|NCT00324987|83041527|FG000|Overall Study|Adverse Event|2|||
46822241|NCT00324987|83041528|FG001|Overall Study|Adverse Event|1|||
46822242|NCT00324987|83041527|FG000|Overall Study|Withdrawal by Subject|1|||
46822243|NCT00324987|83041528|FG001|Overall Study|Withdrawal by Subject|1|||
46822244|NCT00324987|83041527|FG000|Overall Study|Progression|1|||
46822245|NCT00324987|83041528|FG001|Overall Study|Progression|1|||
46932870|NCT00616941|83168458|FG000|Overall Study|Adverse Event|0|||
46932871|NCT00616941|83168459|FG001|Overall Study|Adverse Event|1|||
46932872|NCT00616941|83168460|FG002|Overall Study|Adverse Event|1|||
46932873|NCT00616941|83168458|FG000|Overall Study|Subject Non-compliance|0|||
46932874|NCT00616941|83168459|FG001|Overall Study|Subject Non-compliance|0|||
46932875|NCT00616941|83168460|FG002|Overall Study|Subject Non-compliance|1|||
46932876|NCT00616941|83168458|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
46932877|NCT00616941|83168459|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
46932878|NCT00616941|83168460|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
46932879|NCT00616941|83168458|FG000|Overall Study|Vaccination Suspended|0|||
46932880|NCT00616941|83168459|FG001|Overall Study|Vaccination Suspended|0|||
46932881|NCT00616941|83168460|FG002|Overall Study|Vaccination Suspended|3|||
46932882|NCT00105560|83168468|FG000|Overall Study|Lost to Follow-up|1|||
46932883|NCT02577718|83168481|FG000|Overall Study|Death|6|||
46932884|NCT02577718|83168481|FG000|Overall Study|Withdrawal by Subject|2|||
46932885|NCT00520533|83168487|FG000|Overall Study|Death|1|||
46932886|NCT00520533|83168487|FG000|Overall Study|Suspension of the study for safety reasons|1|||
46932887|NCT00520533|83168487|FG000|Overall Study|Withdrawal by Subject|1|||
46932888|NCT00520533|83168487|FG000|Overall Study|Physician Decision|1|||
46932889|NCT01664104|83168496|FG000|Overall Study|Adverse Event|6|||
46932890|NCT01664104|83168496|FG000|Overall Study|Lack of Efficacy|2|||
46932891|NCT01664104|83168496|FG000|Overall Study|Withdrawal by Subject|1|||
46932892|NCT01664104|83168496|FG000|Overall Study|Lost to Follow-up|4|||
46932893|NCT01664104|83168496|FG000|Overall Study|Other|1|||
46932894|NCT01664104|83168496|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
46932895|NCT02739984|83168504|FG000|Overall Study|Sponsor Decision|1|||
46932896|NCT02739984|83168505|FG001|Overall Study|Sponsor Decision|0|||
46932897|NCT02739984|83168504|FG000|Overall Study|Withdrawal by Subject|1|||
46932898|NCT02739984|83168505|FG001|Overall Study|Withdrawal by Subject|1|||
46932899|NCT02739984|83168504|FG000|Overall Study|Death|0|||
46932900|NCT02739984|83168505|FG001|Overall Study|Death|1|||
46932901|NCT02739984|83168504|FG000|Overall Study|Lost to Follow-up|3|||
47056867|NCT04143594|83334445|FG003|Overall Study|Still on study|18|||
47056868|NCT04143594|83334442|FG000|Overall Study|Withdrew consent|0|||
47056869|NCT04143594|83334443|FG001|Overall Study|Withdrew consent|6|||
46636915|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
46636916|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
46636917|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
46636918|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
46636919|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
46760626|NCT00686920|82978667|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
46760627|NCT00686920|82978666|FG000|Overall Study|Withdrawal by Subject|23|||
46760628|NCT00686920|82978667|FG001|Overall Study|Withdrawal by Subject|5|||
46760629|NCT00686920|82978666|FG000|Overall Study|Protocol Violation|2|||
46636920|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
46636921|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
46760630|NCT00686920|82978667|FG001|Overall Study|Protocol Violation|1|||
46760631|NCT00686920|82978666|FG000|Overall Study|Adverse Event|10|||
46760632|NCT00686920|82978667|FG001|Overall Study|Adverse Event|2|||
46760633|NCT00686920|82978666|FG000|Overall Study|Personal Reason|0|||
46760634|NCT00686920|82978667|FG001|Overall Study|Personal Reason|1|||
46760635|NCT00686920|82978666|FG000|Overall Study|Lost to Follow-up|15|||
46760636|NCT00686920|82978667|FG001|Overall Study|Lost to Follow-up|3|||
46760637|NCT00686920|82978666|FG000|Overall Study|Moved to Another State|1|||
46760638|NCT00686920|82978667|FG001|Overall Study|Moved to Another State|0|||
46760639|NCT00686920|82978666|FG000|Overall Study|Transferred to Nursing Home|1|||
46760640|NCT00686920|82978667|FG001|Overall Study|Transferred to Nursing Home|0|||
46760641|NCT00686920|82978666|FG000|Overall Study|Noncompliance|9|||
46760642|NCT00686920|82978667|FG001|Overall Study|Noncompliance|0|||
46932902|NCT02739984|83168505|FG001|Overall Study|Lost to Follow-up|0|||
46932903|NCT00496730|83168513|FG000|Overall Study|Lost to Follow-up|4|||
46932904|NCT00496730|83168514|FG001|Overall Study|Lost to Follow-up|3|||
46932905|NCT00496730|83168513|FG000|Overall Study|Withdrawal by Subject|2|||
46932906|NCT00496730|83168514|FG001|Overall Study|Withdrawal by Subject|2|||
46932907|NCT02739828|83168520|FG000|Overall Study|Adverse Event|1|||
46932908|NCT02739828|83168520|FG000|Overall Study|Lost to Follow-up|4|||
46932909|NCT04435808|83168535|FG000|Overall Study|Study stopped by DSMB|0|||
47056870|NCT04143594|83334444|FG002|Overall Study|Withdrew consent|1|||
46932910|NCT04435808|83168536|FG001|Overall Study|Study stopped by DSMB|1|||
46932911|NCT01664494|83168559|FG000|Overall Study|Withdrawal by Subject|27|||
46932912|NCT01664494|83168559|FG000|Overall Study|Death|18|||
46932913|NCT01664494|83168559|FG000|Overall Study|Other|49|||
46636922|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
46760643|NCT00686920|82978666|FG000|Overall Study|Principal Investigator Decision|2|||
46760644|NCT00686920|82978667|FG001|Overall Study|Principal Investigator Decision|0|||
46760645|NCT00845832|82978676|FG000|Treatment Period|Adverse Event|0|||
46932914|NCT01664494|83168559|FG000|Overall Study|Lost to Follow-up|99|||
46932915|NCT02577016|83168565|FG000|Overall Study|Adverse Event|2|||
46932916|NCT02577016|83168566|FG001|Overall Study|Adverse Event|1|||
46932917|NCT02577016|83168565|FG000|Overall Study|Physician Decision|0|||
46932918|NCT02577016|83168566|FG001|Overall Study|Physician Decision|1|||
46760646|NCT00845832|82978677|FG001|Treatment Period|Adverse Event|2|||
46760647|NCT00845832|82978678|FG002|Treatment Period|Adverse Event|0|||
46760648|NCT00845832|82978676|FG000|Treatment Period|Protocol Violation|1|||
46760649|NCT00845832|82978677|FG001|Treatment Period|Protocol Violation|1|||
46932919|NCT05101252|83168574|FG000|Overall Study|Unsatisfactory Test Article|1|||
46932920|NCT05101252|83168575|FG001|Overall Study|Unsatisfactory Test Article|0|||
46932921|NCT05101252|83168574|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
46932922|NCT05101252|83168575|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
46932923|NCT05101252|83168574|FG000|Overall Study|Withdrew Consent during study|0|||
46932924|NCT05101252|83168575|FG001|Overall Study|Withdrew Consent during study|1|||
46932925|NCT05101252|83168574|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
46822246|NCT00324987|83041527|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
46822247|NCT00324987|83041528|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
46822248|NCT00324675|83041536|FG000|Overall Study|Adverse Event|1|||
46822249|NCT00324675|83041537|FG001|Overall Study|Adverse Event|0|||
46822250|NCT00436566|83041543|FG000|Overall Study|Withdrawal by Subject|2|||
46822251|NCT00436566|83041543|FG000|Overall Study|Protocol Violation|1|||
46822252|NCT00352365|83041547|FG000|Induction Therapy|Adverse Event|7|||
46822253|NCT00352365|83041547|FG000|Induction Therapy|Progression/Relapse|8|||
46822254|NCT00352365|83041547|FG000|Induction Therapy|Death|7|||
46822255|NCT00352365|83041547|FG000|Induction Therapy|Not protocol specified|1|||
46822256|NCT00352365|83041547|FG000|Induction Therapy|Not eligible|3|||
46822257|NCT00352365|83041547|FG000|Induction Therapy|Death before starting protocol therapy|1|||
46822258|NCT00352365|83041547|FG000|Maintenance Therapy|Progression/Relapse|3|||
46932926|NCT05101252|83168575|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
46932927|NCT03316586|83168581|FG000|Overall Study|Adverse Event|2|||
46932928|NCT03316586|83168581|FG000|Overall Study|Physician Decision|3|||
46932929|NCT03316586|83168581|FG000|Overall Study|Lack of Efficacy|10|||
46932930|NCT03316586|83168581|FG000|Overall Study|still on treatment|1|||
46932931|NCT03316586|83168581|FG000|Overall Study|Patient needed radiation therapy|1|||
46932932|NCT03316586|83168581|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
46932933|NCT00107991|83168585|FG000|Eligibility Assessment|Disease not severe enough|7|||
46932934|NCT00107991|83168585|FG000|Eligibility Assessment|Unwilling to participate|7|||
46932935|NCT00107991|83168585|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
46932936|NCT00107991|83168585|FG000|Eligibility Assessment|Abnormal labs|2|||
46932937|NCT00107991|83168585|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
46932938|NCT00107991|83168585|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
46932939|NCT00107991|83168585|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
46932940|NCT00107991|83168585|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
46932941|NCT00107991|83168585|FG000|12 Week Treatment Period|Adverse Event|1|||
46932942|NCT00107991|83168585|FG000|12 Week Treatment Period|Protocol Violation|1|||
46932943|NCT00107991|83168585|FG000|12 Week Treatment Period|Incarcerated|1|||
46932944|NCT00107991|83168585|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
46932945|NCT00492856|83168589|FG000|Induction|Adverse Event|2|||
46932946|NCT00492856|83168590|FG001|Induction|Adverse Event|0|||
46932947|NCT00492856|83168591|FG002|Induction|Adverse Event|0|||
46932948|NCT00492856|83168592|FG003|Induction|Adverse Event|0|||
46932949|NCT00492856|83168589|FG000|Induction|Withdrawal by Subject|1|||
46932950|NCT00492856|83168590|FG001|Induction|Withdrawal by Subject|0|||
46932951|NCT00492856|83168591|FG002|Induction|Withdrawal by Subject|0|||
46636923|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
46636924|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
46760650|NCT00845832|82978678|FG002|Treatment Period|Protocol Violation|0|||
46760651|NCT00845832|82978676|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
46760652|NCT00845832|82978677|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
46760653|NCT00845832|82978678|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
46760654|NCT00845832|82978676|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
46822259|NCT00352365|83041547|FG000|Maintenance Therapy|Death|2|||
46822260|NCT00352365|83041547|FG000|Maintenance Therapy|Not protocol specified|3|||
46822261|NCT00352365|83041547|FG000|Maintenance Therapy|Not eligible|4|||
46932952|NCT00492856|83168592|FG003|Induction|Withdrawal by Subject|0|||
46932953|NCT00492856|83168589|FG000|Induction|Death|3|||
46932954|NCT00492856|83168590|FG001|Induction|Death|0|||
46932955|NCT00492856|83168591|FG002|Induction|Death|0|||
46760655|NCT00845832|82978677|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
46822262|NCT00532493|83041557|FG000|Overall Study|Death|1|||
46822263|NCT00532493|83041558|FG001|Overall Study|Death|1|||
46932956|NCT00492856|83168592|FG003|Induction|Death|0|||
46932957|NCT00492856|83168589|FG000|Consolidation|Adverse Event|6|||
46932958|NCT00492856|83168590|FG001|Consolidation|Adverse Event|0|||
46932959|NCT00492856|83168591|FG002|Consolidation|Adverse Event|0|||
46822264|NCT00532493|83041557|FG000|Overall Study|Lost to Follow-up|10|||
46822265|NCT00532493|83041558|FG001|Overall Study|Lost to Follow-up|7|||
46822266|NCT00532493|83041557|FG000|Overall Study|Withdrawal by Subject|7|||
46822267|NCT00532493|83041558|FG001|Overall Study|Withdrawal by Subject|9|||
46822268|NCT00532493|83041557|FG000|Overall Study|Physician Decision|1|||
46822269|NCT00532493|83041558|FG001|Overall Study|Physician Decision|6|||
46822270|NCT00532493|83041557|FG000|Overall Study|Adverse Event|6|||
46822271|NCT00532493|83041558|FG001|Overall Study|Adverse Event|5|||
46822272|NCT00532493|83041557|FG000|Overall Study|Protocol Deviation|1|||
46822273|NCT00532493|83041558|FG001|Overall Study|Protocol Deviation|0|||
46822274|NCT00532493|83041557|FG000|Overall Study|Subject Moved Away|3|||
46822275|NCT00532493|83041558|FG001|Overall Study|Subject Moved Away|1|||
46822276|NCT00532493|83041557|FG000|Overall Study|Contraindicative Medication|1|||
46822277|NCT00532493|83041558|FG001|Overall Study|Contraindicative Medication|0|||
46822278|NCT00533507|83041566|FG000|Overall Study|Withdrawal by Subject|1|||
46822279|NCT03886493|83041570|FG000|Overall Study|Adverse Event|1|||
46822280|NCT00352053|83041576|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
46822281|NCT00352053|83041577|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
46822282|NCT00352053|83041576|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
46822283|NCT00352053|83041577|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
46822284|NCT00352053|83041576|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
46822285|NCT00352053|83041577|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
46822286|NCT00352053|83041576|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
46822287|NCT00352053|83041577|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
46822288|NCT00352053|83041576|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
46822289|NCT00352053|83041577|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
46822290|NCT00352053|83041576|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
46822291|NCT00352053|83041577|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
46822292|NCT00352053|83041576|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
46822293|NCT00352053|83041577|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
46822294|NCT00352053|83041576|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
46822295|NCT00352053|83041577|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
46822296|NCT00352053|83041576|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
46932960|NCT00492856|83168592|FG003|Consolidation|Adverse Event|0|||
46932961|NCT00492856|83168589|FG000|Consolidation|Not protocol specified|2|||
46932962|NCT00492856|83168590|FG001|Consolidation|Not protocol specified|0|||
46932963|NCT00492856|83168591|FG002|Consolidation|Not protocol specified|0|||
46932964|NCT00492856|83168592|FG003|Consolidation|Not protocol specified|0|||
46932965|NCT00492856|83168589|FG000|Consolidation|Lost to Follow-up|1|||
46932966|NCT00492856|83168590|FG001|Consolidation|Lost to Follow-up|0|||
47056871|NCT04143594|83334445|FG003|Overall Study|Withdrew consent|1|||
47056872|NCT04143594|83334442|FG000|Overall Study|Lost to Follow-up|2|||
47056873|NCT04143594|83334443|FG001|Overall Study|Lost to Follow-up|2|||
47056874|NCT04143594|83334444|FG002|Overall Study|Lost to Follow-up|3|||
47056875|NCT04143594|83334445|FG003|Overall Study|Lost to Follow-up|0|||
47056876|NCT04143594|83334442|FG000|Overall Study|Investigator's discretion|1|||
47056877|NCT04143594|83334443|FG001|Overall Study|Investigator's discretion|2|||
47056878|NCT04143594|83334444|FG002|Overall Study|Investigator's discretion|0|||
47056879|NCT04143594|83334445|FG003|Overall Study|Investigator's discretion|0|||
47056880|NCT04143594|83334442|FG000|Overall Study|Lack of Efficacy|0|||
47056881|NCT04143594|83334443|FG001|Overall Study|Lack of Efficacy|1|||
47056882|NCT04143594|83334444|FG002|Overall Study|Lack of Efficacy|0|||
47056883|NCT04143594|83334445|FG003|Overall Study|Lack of Efficacy|0|||
47056884|NCT04143594|83334442|FG000|Overall Study|Protocol Violation|0|||
47056885|NCT04143594|83334443|FG001|Overall Study|Protocol Violation|0|||
47056886|NCT04143594|83334444|FG002|Overall Study|Protocol Violation|0|||
47056887|NCT04143594|83334445|FG003|Overall Study|Protocol Violation|1|||
47056888|NCT04046549|83334462|FG000|Overall Study|Adverse Event|1|||
47056889|NCT04046549|83334462|FG000|Overall Study|Physician Decision|1|||
47056890|NCT04046549|83334462|FG000|Overall Study|Withdrawal by Subject|3|||
47056891|NCT04046549|83334462|FG000|Overall Study|Other, Not Specified|5|||
47056892|NCT03403205|83334471|FG000|Overall Study|Randomized but not treated|1|||
47056893|NCT03403205|83334472|FG001|Overall Study|Randomized but not treated|0|||
47056894|NCT03403205|83334473|FG002|Overall Study|Randomized but not treated|4|||
47056895|NCT03403205|83334474|FG003|Overall Study|Randomized but not treated|2|||
47056896|NCT03403205|83334471|FG000|Overall Study|Withdrawal by Subject|4|||
47056897|NCT03403205|83334472|FG001|Overall Study|Withdrawal by Subject|2|||
47056898|NCT03403205|83334473|FG002|Overall Study|Withdrawal by Subject|2|||
47056899|NCT03403205|83334474|FG003|Overall Study|Withdrawal by Subject|1|||
46822297|NCT00352053|83041577|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
46822298|NCT00352053|83041576|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
46822299|NCT00352053|83041577|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
46822300|NCT00352053|83041576|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
47056900|NCT03403205|83334471|FG000|Overall Study|Adverse Event|4|||
47056901|NCT03403205|83334472|FG001|Overall Study|Adverse Event|0|||
47056902|NCT03403205|83334473|FG002|Overall Study|Adverse Event|1|||
47056903|NCT03403205|83334474|FG003|Overall Study|Adverse Event|0|||
47056904|NCT03403205|83334471|FG000|Overall Study|Death|1|||
47056905|NCT03403205|83334472|FG001|Overall Study|Death|0|||
47056906|NCT03403205|83334473|FG002|Overall Study|Death|1|||
47056907|NCT03403205|83334474|FG003|Overall Study|Death|0|||
47056908|NCT03403205|83334471|FG000|Overall Study|Lost to Follow-up|1|||
47056909|NCT03403205|83334472|FG001|Overall Study|Lost to Follow-up|1|||
47056910|NCT03403205|83334473|FG002|Overall Study|Lost to Follow-up|0|||
47056911|NCT03403205|83334474|FG003|Overall Study|Lost to Follow-up|0|||
47056912|NCT03403205|83334471|FG000|Overall Study|Pregnancy|1|||
47056913|NCT03403205|83334472|FG001|Overall Study|Pregnancy|0|||
47056914|NCT03403205|83334473|FG002|Overall Study|Pregnancy|0|||
47056915|NCT03403205|83334474|FG003|Overall Study|Pregnancy|0|||
47056916|NCT03403205|83334471|FG000|Overall Study|Protocol Deviation|0|||
47056917|NCT03403205|83334472|FG001|Overall Study|Protocol Deviation|1|||
47056918|NCT03403205|83334473|FG002|Overall Study|Protocol Deviation|0|||
47056919|NCT03403205|83334474|FG003|Overall Study|Protocol Deviation|0|||
47056920|NCT03375112|83334486|FG000|Overall Study|Withdrawal by Subject|3|||
47056921|NCT03375112|83334487|FG001|Overall Study|Withdrawal by Subject|0|||
47056922|NCT03122106|83334493|FG000|Overall Study|Not enough tissue|1|||
47056923|NCT03122106|83334493|FG000|Overall Study|Disease progression during screening|2|||
47056924|NCT03122106|83334493|FG000|Overall Study|Poor RNA quality for vaccine|1|||
47056925|NCT02920892|83334499|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
47056926|NCT02920892|83334500|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
47056927|NCT02920892|83334501|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
47056928|NCT02920892|83334499|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
47056929|NCT02920892|83334500|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
47056930|NCT02920892|83334501|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
47056931|NCT02920892|83334499|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
47056932|NCT02920892|83334500|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
47056933|NCT02920892|83334501|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
47056934|NCT02920892|83334499|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
47056935|NCT02920892|83334500|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
47056936|NCT02920892|83334501|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
47056937|NCT02920892|83334499|FG000|Placebo-Controlled Period|Physician Decision|0|||
47056938|NCT02920892|83334500|FG001|Placebo-Controlled Period|Physician Decision|0|||
47056939|NCT02920892|83334501|FG002|Placebo-Controlled Period|Physician Decision|1|||
47056940|NCT02920892|83334499|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
47056941|NCT02920892|83334500|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
47056942|NCT02920892|83334501|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
47056943|NCT02920892|83334499|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
47056944|NCT02920892|83334500|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
47056945|NCT02920892|83334501|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
47056946|NCT02920892|83334499|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
46932967|NCT00492856|83168591|FG002|Consolidation|Lost to Follow-up|0|||
46932968|NCT00492856|83168592|FG003|Consolidation|Lost to Follow-up|0|||
46932969|NCT00492856|83168589|FG000|Post-consolidation|Adverse Event|0|||
46932970|NCT00492856|83168590|FG001|Post-consolidation|Adverse Event|4|||
46932971|NCT00492856|83168591|FG002|Post-consolidation|Adverse Event|0|||
46932972|NCT00492856|83168592|FG003|Post-consolidation|Adverse Event|1|||
46932973|NCT00492856|83168589|FG000|Post-consolidation|Withdrawal by Subject|0|||
46932974|NCT00492856|83168590|FG001|Post-consolidation|Withdrawal by Subject|4|||
46932975|NCT00492856|83168591|FG002|Post-consolidation|Withdrawal by Subject|0|||
47056947|NCT02920892|83334500|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
47056948|NCT02920892|83334501|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
47056949|NCT02509052|83334512|FG000|Overall Study|Non compliance|0|||
47056950|NCT02509052|83334513|FG001|Overall Study|Non compliance|0|||
47056951|NCT02509052|83334514|FG002|Overall Study|Non compliance|1|||
47056952|NCT02365597|83334527|FG000|Overall Study|Lost to Follow-up|0|||
47056953|NCT02365597|83334528|FG001|Overall Study|Lost to Follow-up|1|||
47056954|NCT02365597|83334529|FG002|Overall Study|Lost to Follow-up|0|||
47056955|NCT02365597|83334530|FG003|Overall Study|Lost to Follow-up|1|||
47056956|NCT02365597|83334527|FG000|Overall Study|Withdrawal by Subject|1|||
47056957|NCT02365597|83334528|FG001|Overall Study|Withdrawal by Subject|8|||
47056958|NCT02365597|83334529|FG002|Overall Study|Withdrawal by Subject|5|||
47056959|NCT02365597|83334530|FG003|Overall Study|Withdrawal by Subject|1|||
47056960|NCT02365597|83334527|FG000|Overall Study|Sponsor's decision|1|||
47056961|NCT02365597|83334528|FG001|Overall Study|Sponsor's decision|3|||
47056962|NCT02365597|83334529|FG002|Overall Study|Sponsor's decision|13|||
47056963|NCT02365597|83334530|FG003|Overall Study|Sponsor's decision|0|||
47056964|NCT02365597|83334527|FG000|Overall Study|Other|0|||
47056965|NCT02365597|83334528|FG001|Overall Study|Other|4|||
47056966|NCT02365597|83334529|FG002|Overall Study|Other|0|||
46932976|NCT00492856|83168592|FG003|Post-consolidation|Withdrawal by Subject|0|||
47056967|NCT02365597|83334530|FG003|Overall Study|Other|0|||
47056968|NCT02365597|83334527|FG000|Overall Study|Enrolled but not treated|0|||
47056969|NCT02365597|83334528|FG001|Overall Study|Enrolled but not treated|1|||
47056970|NCT02365597|83334529|FG002|Overall Study|Enrolled but not treated|1|||
47056971|NCT02365597|83334530|FG003|Overall Study|Enrolled but not treated|0|||
47056972|NCT02365597|83334527|FG000|Overall Study|Ongoing|0|||
47056973|NCT02365597|83334528|FG001|Overall Study|Ongoing|0|||
47056974|NCT02365597|83334529|FG002|Overall Study|Ongoing|0|||
47056975|NCT02365597|83334530|FG003|Overall Study|Ongoing|17|||
47056976|NCT02220894|83334547|FG000|Overall Study|Adverse Event|127|||
47056977|NCT02220894|83334548|FG001|Overall Study|Adverse Event|74|||
47056978|NCT02220894|83334547|FG000|Overall Study|Death|418|||
47056979|NCT02220894|83334548|FG001|Overall Study|Death|508|||
47056980|NCT02220894|83334547|FG000|Overall Study|Lost to Follow-up|0|||
47056981|NCT02220894|83334548|FG001|Overall Study|Lost to Follow-up|4|||
47056982|NCT02220894|83334547|FG000|Overall Study|Site Terminated by Sponsor|2|||
47056983|NCT02220894|83334548|FG001|Overall Study|Site Terminated by Sponsor|0|||
47056984|NCT02220894|83334547|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
47056985|NCT02220894|83334548|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
47056986|NCT02220894|83334547|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46932977|NCT00492856|83168589|FG000|Post-consolidation|Death|0|||
46932978|NCT00492856|83168590|FG001|Post-consolidation|Death|1|||
46932979|NCT00492856|83168591|FG002|Post-consolidation|Death|0|||
46932980|NCT00492856|83168592|FG003|Post-consolidation|Death|0|||
46932981|NCT00492856|83168589|FG000|Post-consolidation|Not protocol specified|0|||
46932982|NCT00492856|83168590|FG001|Post-consolidation|Not protocol specified|1|||
46932983|NCT00492856|83168591|FG002|Post-consolidation|Not protocol specified|0|||
46932984|NCT00492856|83168592|FG003|Post-consolidation|Not protocol specified|0|||
46932985|NCT00492856|83168589|FG000|Post-consolidation|Lost to Follow-up|0|||
46932986|NCT00492856|83168590|FG001|Post-consolidation|Lost to Follow-up|2|||
46932987|NCT00492856|83168591|FG002|Post-consolidation|Lost to Follow-up|0|||
46932988|NCT00492856|83168592|FG003|Post-consolidation|Lost to Follow-up|0|||
46932989|NCT00492856|83168589|FG000|Post-consolidation|Observation Arm|0|||
46932990|NCT00492856|83168590|FG001|Post-consolidation|Observation Arm|0|||
46932991|NCT00492856|83168591|FG002|Post-consolidation|Observation Arm|27|||
46932992|NCT00492856|83168592|FG003|Post-consolidation|Observation Arm|0|||
46932993|NCT02782377|83168604|FG000|Overall Study|Physician Decision|5|||
46932994|NCT02410629|83168611|FG000|Overall Study|Family cannot commit to the study|2|||
46932995|NCT02410629|83168612|FG001|Overall Study|Family cannot commit to the study|1|||
47056987|NCT02220894|83334548|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
47056988|NCT02220894|83334547|FG000|Overall Study|Withdrawal by Subject|10|||
46822301|NCT00352053|83041577|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
46822302|NCT00352053|83041576|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
46822303|NCT00352053|83041577|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
46822304|NCT00352053|83041576|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
46822305|NCT00352053|83041577|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
46822306|NCT00351819|83041593|FG000|Overall Study|Lost to Follow-up|4|||
46822307|NCT00351819|83041594|FG001|Overall Study|Lost to Follow-up|4|||
46822308|NCT00351819|83041593|FG000|Overall Study|Withdrawal by Subject|0|||
46822309|NCT00351819|83041594|FG001|Overall Study|Withdrawal by Subject|4|||
46822310|NCT00351819|83041593|FG000|Overall Study|Elevated PSA|1|||
46932996|NCT02410629|83168611|FG000|Overall Study|Subject returned to work|1|||
46932997|NCT02410629|83168612|FG001|Overall Study|Subject returned to work|0|||
46932998|NCT02410629|83168611|FG000|Overall Study|Subject moved back to home country|0|||
46932999|NCT02410629|83168612|FG001|Overall Study|Subject moved back to home country|1|||
47056989|NCT02220894|83334548|FG001|Overall Study|Withdrawal by Subject|9|||
47056990|NCT02068092|83334555|FG000|Overall Study|Physician Decision|2|||
47056991|NCT02068092|83334555|FG000|Overall Study|Adverse Event|2|||
46822311|NCT00351819|83041594|FG001|Overall Study|Elevated PSA|1|||
46822312|NCT00351819|83041593|FG000|Overall Study|Traumatic ankle fracture|1|||
46822313|NCT00351819|83041594|FG001|Overall Study|Traumatic ankle fracture|0|||
46822314|NCT00351819|83041593|FG000|Overall Study|Unprofessional behavior|1|||
46822315|NCT00351819|83041594|FG001|Overall Study|Unprofessional behavior|0|||
47056992|NCT02068092|83334555|FG000|Overall Study|Lost to Follow-up|4|||
47056993|NCT02068092|83334555|FG000|Overall Study|Withdrawal by Subject|2|||
47056994|NCT01959672|83334559|FG000|Overall Study|Death|1|||
47056995|NCT00071760|83334587|FG000|Overall Study|Adverse Event|2|||
47056996|NCT00071760|83334588|FG001|Overall Study|Adverse Event|1|||
47056997|NCT00071760|83334587|FG000|Overall Study|Lost to Follow-up|0|||
47056998|NCT00071760|83334588|FG001|Overall Study|Lost to Follow-up|3|||
46822316|NCT00351819|83041593|FG000|Overall Study|Non-compliance|0|||
46822317|NCT00351819|83041594|FG001|Overall Study|Non-compliance|1|||
46822318|NCT00351819|83041593|FG000|Overall Study|Incarcerated|0|||
46933000|NCT02410629|83168611|FG000|Overall Study|Subject underwent heart surgery|0|||
46933001|NCT02410629|83168612|FG001|Overall Study|Subject underwent heart surgery|1|||
46933002|NCT02252211|83168620|FG000|Overall Study|Adverse Event|0|||
47056999|NCT00071760|83334587|FG000|Overall Study|Protocol Violation|1|||
46822319|NCT00351819|83041594|FG001|Overall Study|Incarcerated|1|||
46822320|NCT00351819|83041593|FG000|Overall Study|Enrolled in another trial|0|||
46822321|NCT00351819|83041594|FG001|Overall Study|Enrolled in another trial|1|||
46822322|NCT00351351|83041602|FG000|Overall Study|surgical access pbs; device issues|9|||
46822323|NCT00351351|83041603|FG001|Overall Study|surgical access pbs; device issues|4|||
46822324|NCT00323115|83041609|FG000|Vaccine Administration|Adverse Event|1|||
46822325|NCT00323115|83041609|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
46822326|NCT00322881|83041618|FG000|Overall Study|Death|2|||
46822327|NCT00322881|83041618|FG000|Overall Study|Adverse Event|1|||
46822328|NCT00322881|83041618|FG000|Overall Study|Disease Progression|2|||
46822329|NCT00415194|83041624|FG000|Overall Study|Adverse Event|37|||
46822330|NCT00415194|83041625|FG001|Overall Study|Adverse Event|32|||
46822331|NCT00415194|83041624|FG000|Overall Study|Entry Criteria Not Met|4|||
46822332|NCT00415194|83041625|FG001|Overall Study|Entry Criteria Not Met|8|||
46822333|NCT00415194|83041624|FG000|Overall Study|Lost to Follow-up|1|||
46822334|NCT00415194|83041625|FG001|Overall Study|Lost to Follow-up|0|||
46822335|NCT00415194|83041624|FG000|Overall Study|Physician Decision|10|||
46822336|NCT00415194|83041625|FG001|Overall Study|Physician Decision|16|||
46822337|NCT00415194|83041624|FG000|Overall Study|Progressive Disease|180|||
46822338|NCT00415194|83041625|FG001|Overall Study|Progressive Disease|217|||
46822339|NCT00415194|83041624|FG000|Overall Study|Protocol Violation|4|||
46822340|NCT00415194|83041625|FG001|Overall Study|Protocol Violation|2|||
46822341|NCT00415194|83041624|FG000|Overall Study|Withdrawal by Subject|28|||
46822342|NCT00415194|83041625|FG001|Overall Study|Withdrawal by Subject|21|||
46822343|NCT00415194|83041624|FG000|Overall Study|Death Due to Study Disease|26|||
46822344|NCT00415194|83041625|FG001|Overall Study|Death Due to Study Disease|29|||
46822345|NCT00415194|83041624|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
46822346|NCT00415194|83041625|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
46822347|NCT00415194|83041624|FG000|Overall Study|Death Due to Procedural Related AE|0|||
46822348|NCT00415194|83041625|FG001|Overall Study|Death Due to Procedural Related AE|1|||
46822349|NCT00415194|83041624|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
46822350|NCT00415194|83041625|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
46822351|NCT00436332|83041631|FG000|Overall Study|Adverse Event|9|||
46822352|NCT00436332|83041631|FG000|Overall Study|Withdrawal by Subject|2|||
46822353|NCT00436332|83041631|FG000|Overall Study|Progression|59|||
46822354|NCT00436332|83041631|FG000|Overall Study|Death|2|||
46822355|NCT00436332|83041631|FG000|Overall Study|Not Protocol Specified|6|||
46822356|NCT00436332|83041631|FG000|Overall Study|Ineligible|2|||
46822357|NCT00436332|83041631|FG000|Overall Study|Never Received Treatment|3|||
46822358|NCT00532259|83041635|FG000|Overall Study|Withdrawal by Subject|2|||
46822359|NCT00532259|83041635|FG000|Overall Study|Adverse Event|1|||
46822360|NCT00532259|83041635|FG000|Overall Study|Death|1|||
46822361|NCT00532259|83041635|FG000|Overall Study|Lack of Efficacy|21|||
46822362|NCT00532259|83041635|FG000|Overall Study|Lost to Follow-up|3|||
46822363|NCT00532259|83041635|FG000|Overall Study|Physician Decision|3|||
46822364|NCT00532259|83041635|FG000|Overall Study|Protocol Violation|1|||
46822365|NCT00322491|83041642|FG000|Overall Study|Adverse Event|1|||
46822366|NCT00322491|83041643|FG001|Overall Study|Adverse Event|0|||
46822367|NCT00322491|83041642|FG000|Overall Study|Death|1|||
46822368|NCT00322491|83041643|FG001|Overall Study|Death|2|||
46822369|NCT00322023|83041653|FG000|Overall Study|various|0|||
46822370|NCT00322023|83041654|FG001|Overall Study|various|2|||
46822371|NCT00322023|83041655|FG002|Overall Study|various|6|||
46822372|NCT00414960|83041665|FG000|Overall Study|Adverse Event|4|||
46822373|NCT00414960|83041666|FG001|Overall Study|Adverse Event|0|||
46822374|NCT00414960|83041665|FG000|Overall Study|Withdrawal by Subject|3|||
46822375|NCT00414960|83041666|FG001|Overall Study|Withdrawal by Subject|0|||
46822376|NCT00414960|83041665|FG000|Overall Study|Physician Decision|0|||
46822377|NCT00414960|83041666|FG001|Overall Study|Physician Decision|1|||
46822378|NCT00321789|83041674|FG000|Overall Study|Lost to Follow-up|4|||
46822379|NCT00321789|83041675|FG001|Overall Study|Lost to Follow-up|7|||
46822380|NCT00321789|83041674|FG000|Overall Study|Withdrawal by Subject|6|||
46822381|NCT00321789|83041675|FG001|Overall Study|Withdrawal by Subject|6|||
46822382|NCT00321789|83041674|FG000|Overall Study|Protocol Violation|5|||
46822383|NCT00321789|83041675|FG001|Overall Study|Protocol Violation|3|||
46822384|NCT00414726|83041683|FG000|Overall Study|Withdrawal by Subject|0|||
46822385|NCT00414726|83041684|FG001|Overall Study|Withdrawal by Subject|1|||
46822386|NCT00531947|83041692|FG000|Overall Study|Adverse Event|5|||
46822387|NCT00531947|83041693|FG001|Overall Study|Adverse Event|10|||
46822388|NCT00531947|83041692|FG000|Overall Study|Lost to Follow-up|12|||
46822389|NCT00531947|83041693|FG001|Overall Study|Lost to Follow-up|9|||
46822390|NCT00531947|83041692|FG000|Overall Study|Withdrawal by Subject|14|||
46822391|NCT00531947|83041693|FG001|Overall Study|Withdrawal by Subject|19|||
46822392|NCT00531947|83041692|FG000|Overall Study|Protocol Violation|2|||
46822393|NCT00531947|83041693|FG001|Overall Study|Protocol Violation|1|||
47057000|NCT00071760|83334588|FG001|Overall Study|Protocol Violation|0|||
46822394|NCT00531947|83041692|FG000|Overall Study|Non-Compliance|4|||
46822395|NCT00531947|83041693|FG001|Overall Study|Non-Compliance|7|||
46822396|NCT00531947|83041692|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
46822397|NCT00531947|83041693|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
46822398|NCT00530855|83041699|FG000|Overall Study|Lack of Efficacy|20|||
46822399|NCT00530855|83041699|FG000|Overall Study|Withdrawal by Subject|30|||
46822400|NCT00530855|83041699|FG000|Overall Study|Fatal Serious AE|3|||
46822401|NCT00530855|83041699|FG000|Overall Study|Non Fatal Serious AE|7|||
46822402|NCT00530855|83041699|FG000|Overall Study|Non Fatal Non Serious AE|12|||
46822403|NCT00530855|83041699|FG000|Overall Study|Protocol Violation|3|||
46822404|NCT00530855|83041699|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
46822405|NCT00530855|83041699|FG000|Overall Study|Lost to Follow-up|9|||
46822406|NCT00530855|83041699|FG000|Overall Study|Other reason for premature termination|17|||
46822407|NCT00530777|83041705|FG000|Overall Study|Lost to Follow-up|0|||
46822408|NCT00530777|83041706|FG001|Overall Study|Lost to Follow-up|1|||
46822409|NCT00530777|83041705|FG000|Overall Study|Death|1|||
46822410|NCT00530777|83041706|FG001|Overall Study|Death|2|||
46822411|NCT00530777|83041705|FG000|Overall Study|Physician Decision|1|||
46822412|NCT00530777|83041706|FG001|Overall Study|Physician Decision|0|||
46822413|NCT00530777|83041705|FG000|Overall Study|Withdrawal by Subject|0|||
46822414|NCT00530777|83041706|FG001|Overall Study|Withdrawal by Subject|1|||
46822415|NCT00530777|83041705|FG000|Overall Study|Unable to adhere to visit schedule|5|||
46822416|NCT00530777|83041706|FG001|Overall Study|Unable to adhere to visit schedule|1|||
46822417|NCT03882047|83041715|FG000|Overall Study|Adverse Event|0|||
46822418|NCT03882047|83041716|FG001|Overall Study|Adverse Event|2|||
46822419|NCT03882047|83041717|FG002|Overall Study|Adverse Event|2|||
46822420|NCT03882047|83041715|FG000|Overall Study|Treatment Failure|3|||
46822421|NCT03882047|83041716|FG001|Overall Study|Treatment Failure|3|||
46822422|NCT03882047|83041717|FG002|Overall Study|Treatment Failure|12|||
46822423|NCT03882047|83041715|FG000|Overall Study|Lost to Follow-up|0|||
46822424|NCT03882047|83041716|FG001|Overall Study|Lost to Follow-up|1|||
46822425|NCT03882047|83041717|FG002|Overall Study|Lost to Follow-up|0|||
46822426|NCT03882047|83041715|FG000|Overall Study|Did Not Wish to Continue|1|||
46822427|NCT03882047|83041716|FG001|Overall Study|Did Not Wish to Continue|4|||
46822428|NCT03882047|83041717|FG002|Overall Study|Did Not Wish to Continue|1|||
46822429|NCT03882047|83041715|FG000|Overall Study|Noncompliance With Protocol|2|||
46822430|NCT03882047|83041716|FG001|Overall Study|Noncompliance With Protocol|0|||
46822431|NCT03882047|83041717|FG002|Overall Study|Noncompliance With Protocol|0|||
46822432|NCT03882047|83041715|FG000|Overall Study|Did Not Meet Eligibility|0|||
46822433|NCT03882047|83041716|FG001|Overall Study|Did Not Meet Eligibility|0|||
46822434|NCT03882047|83041717|FG002|Overall Study|Did Not Meet Eligibility|1|||
46822435|NCT00530621|83041727|FG000|Overall Study|Adverse Event|11|||
46822436|NCT00530621|83041728|FG001|Overall Study|Adverse Event|8|||
46822437|NCT00530621|83041727|FG000|Overall Study|Physician Decision|2|||
46822438|NCT00530621|83041728|FG001|Overall Study|Physician Decision|4|||
46822439|NCT00530621|83041727|FG000|Overall Study|Progressive Disease (PD)|47|||
46822440|NCT00530621|83041728|FG001|Overall Study|Progressive Disease (PD)|40|||
46822441|NCT00530621|83041727|FG000|Overall Study|Sponsor Decision|12|||
46822442|NCT00530621|83041728|FG001|Overall Study|Sponsor Decision|15|||
46822443|NCT00530621|83041727|FG000|Overall Study|Subject Decision|4|||
46822444|NCT00530621|83041728|FG001|Overall Study|Subject Decision|7|||
46822445|NCT00530621|83041727|FG000|Overall Study|Death|3|||
46822446|NCT00530621|83041728|FG001|Overall Study|Death|6|||
46822447|NCT00530621|83041727|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
46822448|NCT00530621|83041728|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
46822449|NCT00531479|83041740|FG000|Overall Study|Death|68|||
46822450|NCT00531479|83041741|FG001|Overall Study|Death|71|||
46822451|NCT00531479|83041740|FG000|Overall Study|Lost to Follow-up|0|||
46822452|NCT00531479|83041741|FG001|Overall Study|Lost to Follow-up|2|||
46822453|NCT00531479|83041740|FG000|Overall Study|Other|0|||
46822454|NCT00531479|83041741|FG001|Overall Study|Other|1|||
46822455|NCT00531479|83041740|FG000|Overall Study|Withdrawal by Subject|6|||
46822456|NCT00531479|83041741|FG001|Overall Study|Withdrawal by Subject|6|||
46822457|NCT00531479|83041740|FG000|Overall Study|Did not receive treatment|2|||
46822458|NCT00531479|83041741|FG001|Overall Study|Did not receive treatment|3|||
46822459|NCT00530075|83041747|FG000|Overall Study|Adverse Event|1|||
46822460|NCT00530075|83041747|FG000|Overall Study|Death|1|||
46822461|NCT00530075|83041747|FG000|Overall Study|Lack of Efficacy|3|||
46822462|NCT00530075|83041747|FG000|Overall Study|Protocol Violation|1|||
46822463|NCT00530075|83041747|FG000|Overall Study|Withdrawal by Subject|1|||
46822464|NCT00531011|83041753|FG000|Overall Study|Withdrawal by Subject|2|||
46822465|NCT00531011|83041754|FG001|Overall Study|Withdrawal by Subject|4|||
46822466|NCT00531011|83041753|FG000|Overall Study|Death|1|||
46822467|NCT00531011|83041754|FG001|Overall Study|Death|0|||
46822468|NCT00531011|83041753|FG000|Overall Study|Lost to Follow-up|1|||
46822469|NCT00531011|83041754|FG001|Overall Study|Lost to Follow-up|0|||
46822470|NCT00531011|83041753|FG000|Overall Study|Physician Decision|0|||
46822471|NCT00531011|83041754|FG001|Overall Study|Physician Decision|3|||
46822472|NCT00529217|83041760|FG000|Overall Study|Lack of Efficacy|2|||
46822473|NCT00529217|83041760|FG000|Overall Study|Unable to adhere to study schedule|2|||
46822474|NCT00471146|83041767|FG000|Overall Study|Adverse Event|32|||
46822475|NCT00471146|83041768|FG001|Overall Study|Adverse Event|33|||
46822476|NCT00471146|83041767|FG000|Overall Study|Withdrawal by Subject|14|||
46822477|NCT00471146|83041768|FG001|Overall Study|Withdrawal by Subject|11|||
46822478|NCT00471146|83041767|FG000|Overall Study|Death|11|||
46822479|NCT00471146|83041768|FG001|Overall Study|Death|12|||
46822480|NCT00471146|83041767|FG000|Overall Study|Lost to Follow-up|4|||
46822481|NCT00471146|83041768|FG001|Overall Study|Lost to Follow-up|2|||
46822482|NCT00471146|83041767|FG000|Overall Study|Protocol Violation|2|||
46822483|NCT00471146|83041768|FG001|Overall Study|Protocol Violation|2|||
46822484|NCT00471146|83041767|FG000|Overall Study|Objective progression or relapse|84|||
46822485|NCT00471146|83041768|FG001|Overall Study|Objective progression or relapse|87|||
46822486|NCT00471146|83041767|FG000|Overall Study|Global deterioration of health status|12|||
46822487|NCT00471146|83041768|FG001|Overall Study|Global deterioration of health status|14|||
46822488|NCT00471146|83041767|FG000|Overall Study|Randomized but not treated|9|||
46822489|NCT00471146|83041768|FG001|Overall Study|Randomized but not treated|8|||
46822490|NCT00471146|83041767|FG000|Overall Study|Other|4|||
46822491|NCT00471146|83041768|FG001|Overall Study|Other|5|||
46822492|NCT00469898|83041774|FG000|Overall Study|Adverse Event|7|||
46822493|NCT00469898|83041774|FG000|Overall Study|Withdrawal by Subject|4|||
46822494|NCT00469898|83041774|FG000|Overall Study|Death|4|||
46822495|NCT00469898|83041774|FG000|Overall Study|Disease progression|9|||
46822496|NCT00469898|83041774|FG000|Overall Study|Decreased performance status|1|||
46822497|NCT00529763|83041781|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
46822498|NCT00529763|83041782|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
46822499|NCT00529763|83041783|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
46822500|NCT00529763|83041781|FG000|Overall Study|Death|1|||
46822501|NCT00529763|83041782|FG001|Overall Study|Death|1|||
46822502|NCT00529763|83041783|FG002|Overall Study|Death|1|||
46822503|NCT00529763|83041781|FG000|Overall Study|Disease Progression|10|||
46822504|NCT00529763|83041782|FG001|Overall Study|Disease Progression|16|||
46822505|NCT00529763|83041783|FG002|Overall Study|Disease Progression|11|||
46822506|NCT00529763|83041781|FG000|Overall Study|Lost to Follow-up|1|||
46822507|NCT00529763|83041782|FG001|Overall Study|Lost to Follow-up|2|||
46933003|NCT02252211|83168621|FG001|Overall Study|Adverse Event|1|||
46933004|NCT02252211|83168622|FG002|Overall Study|Adverse Event|0|||
46933005|NCT02252211|83168620|FG000|Overall Study|Progressive disease|3|||
46933006|NCT02252211|83168621|FG001|Overall Study|Progressive disease|2|||
46933007|NCT02252211|83168622|FG002|Overall Study|Progressive disease|0|||
46933008|NCT02252211|83168620|FG000|Overall Study|Withdrawal by Subject|1|||
46933009|NCT02252211|83168621|FG001|Overall Study|Withdrawal by Subject|0|||
46933010|NCT02252211|83168622|FG002|Overall Study|Withdrawal by Subject|0|||
46933011|NCT02252211|83168620|FG000|Overall Study|Serious Adverse Event During Screening|1|||
46933012|NCT02252211|83168621|FG001|Overall Study|Serious Adverse Event During Screening|0|||
46933013|NCT02252211|83168622|FG002|Overall Study|Serious Adverse Event During Screening|1|||
46933014|NCT02776683|83168629|FG000|Pre-switch Period|Protocol Violation|1|||
46933015|NCT02776683|83168630|FG001|Pre-switch Period|Protocol Violation|0|||
46933016|NCT02776683|83168629|FG000|Pre-switch Period|Adverse Event|21|||
46933017|NCT02776683|83168630|FG001|Pre-switch Period|Adverse Event|0|||
46933018|NCT02776683|83168629|FG000|Pre-switch Period|Withdrawal by Subject|9|||
46933019|NCT02776683|83168630|FG001|Pre-switch Period|Withdrawal by Subject|0|||
46933020|NCT02776683|83168629|FG000|Pre-switch Period|Physician Decision|7|||
46933021|NCT02776683|83168630|FG001|Pre-switch Period|Physician Decision|0|||
46933022|NCT02776683|83168629|FG000|Pre-switch Period|Progressive disease|39|||
46933023|NCT02776683|83168630|FG001|Pre-switch Period|Progressive disease|0|||
46933024|NCT02776683|83168629|FG000|Pre-switch Period|Other than listed|3|||
46933025|NCT02776683|83168630|FG001|Pre-switch Period|Other than listed|0|||
46933026|NCT02776683|83168629|FG000|Post-switch Period|Adverse Event|0|||
46933027|NCT02776683|83168630|FG001|Post-switch Period|Adverse Event|3|||
46933028|NCT02776683|83168629|FG000|Post-switch Period|Withdrawal by Subject|0|||
46933029|NCT02776683|83168630|FG001|Post-switch Period|Withdrawal by Subject|2|||
46933030|NCT02776683|83168629|FG000|Post-switch Period|Physician Decision|0|||
46933031|NCT02776683|83168630|FG001|Post-switch Period|Physician Decision|3|||
46822508|NCT00529763|83041783|FG002|Overall Study|Lost to Follow-up|3|||
46822509|NCT00529763|83041781|FG000|Overall Study|Stem Cell Transplant|0|||
46822510|NCT00529763|83041782|FG001|Overall Study|Stem Cell Transplant|3|||
46822511|NCT00529763|83041783|FG002|Overall Study|Stem Cell Transplant|1|||
46933032|NCT02776683|83168629|FG000|Post-switch Period|Progressive disease|0|||
46933033|NCT02776683|83168630|FG001|Post-switch Period|Progressive disease|20|||
46933034|NCT02776683|83168629|FG000|Post-switch Period|Other than listed|0|||
46933035|NCT02776683|83168630|FG001|Post-switch Period|Other than listed|15|||
46933036|NCT02731742|83168638|FG000|Overall Study|Death|1|||
46933037|NCT02731742|83168639|FG001|Overall Study|Death|2|||
46822512|NCT00529763|83041781|FG000|Overall Study|Study Drug Toxicity|3|||
46822513|NCT00529763|83041782|FG001|Overall Study|Study Drug Toxicity|6|||
46822514|NCT00529763|83041783|FG002|Overall Study|Study Drug Toxicity|4|||
46822515|NCT00529763|83041781|FG000|Overall Study|Participant Withdrew Consent|2|||
46933038|NCT02731742|83168640|FG002|Overall Study|Death|5|||
46933039|NCT02731742|83168641|FG003|Overall Study|Death|0|||
46933040|NCT02731742|83168638|FG000|Overall Study|Physician Decision|0|||
46933041|NCT02731742|83168639|FG001|Overall Study|Physician Decision|0|||
46933042|NCT02731742|83168640|FG002|Overall Study|Physician Decision|0|||
46822516|NCT00529763|83041782|FG001|Overall Study|Participant Withdrew Consent|3|||
46822517|NCT00529763|83041783|FG002|Overall Study|Participant Withdrew Consent|4|||
46822518|NCT00529763|83041781|FG000|Overall Study|Other reasons|2|||
46822519|NCT00529763|83041782|FG001|Overall Study|Other reasons|0|||
46822520|NCT00529763|83041783|FG002|Overall Study|Other reasons|2|||
46822521|NCT00529763|83041781|FG000|Overall Study|Participant request to discontinue treatment|1|||
46822522|NCT00529763|83041782|FG001|Overall Study|Participant request to discontinue treatment|1|||
46822523|NCT00529763|83041783|FG002|Overall Study|Participant request to discontinue treatment|3|||
46822524|NCT00486902|83041798|FG000|Overall Study|Withdrawal by Subject|1|||
46822525|NCT00486902|83041799|FG001|Overall Study|Withdrawal by Subject|2|||
46822526|NCT00486902|83041798|FG000|Overall Study|decision for postpartum tubal ligation|3|||
46822527|NCT00486902|83041799|FG001|Overall Study|decision for postpartum tubal ligation|1|||
46822528|NCT00486902|83041798|FG000|Overall Study|spinal anesthetic protocal violation|1|||
46822529|NCT00486902|83041799|FG001|Overall Study|spinal anesthetic protocal violation|1|||
46822530|NCT00486902|83041798|FG000|Overall Study|Did not meet inclusion criteria|1|||
46822531|NCT00486902|83041799|FG001|Overall Study|Did not meet inclusion criteria|0|||
46822532|NCT00486902|83041798|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
46822533|NCT00486902|83041799|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
46822534|NCT03687827|83041805|FG000|Treatment Period 1|Death|0|||
46822535|NCT03687827|83041806|FG001|Treatment Period 1|Death|1|||
46822536|NCT03687827|83041805|FG000|Treatment Period 1|Lost to Follow-up|2|||
46822537|NCT03687827|83041806|FG001|Treatment Period 1|Lost to Follow-up|2|||
46822538|NCT03687827|83041805|FG000|Treatment Period 1|Physician Decision|5|||
46822539|NCT03687827|83041806|FG001|Treatment Period 1|Physician Decision|2|||
46822540|NCT03687827|83041805|FG000|Treatment Period 1|Withdrawal by Subject|7|||
46822541|NCT03687827|83041806|FG001|Treatment Period 1|Withdrawal by Subject|3|||
46822542|NCT03687827|83041805|FG000|Treatment Period 2|Physician Decision|4|||
46822543|NCT03687827|83041806|FG001|Treatment Period 2|Physician Decision|1|||
46822544|NCT03687827|83041805|FG000|Treatment Period 2|Withdrawal by Subject|1|||
46822545|NCT03687827|83041806|FG001|Treatment Period 2|Withdrawal by Subject|2|||
46822546|NCT00529529|83041815|FG000|Overall Study|Adverse Event|12|||
46822547|NCT00529529|83041816|FG001|Overall Study|Adverse Event|17|||
46822548|NCT00529529|83041817|FG002|Overall Study|Adverse Event|8|||
46822549|NCT00529529|83041815|FG000|Overall Study|Subject withdrew consent|12|||
46822550|NCT00529529|83041816|FG001|Overall Study|Subject withdrew consent|9|||
46822551|NCT00529529|83041817|FG002|Overall Study|Subject withdrew consent|12|||
46822552|NCT00529529|83041815|FG000|Overall Study|Protocol deviation|8|||
46822553|NCT00529529|83041816|FG001|Overall Study|Protocol deviation|12|||
46822554|NCT00529529|83041817|FG002|Overall Study|Protocol deviation|5|||
46822555|NCT00529529|83041815|FG000|Overall Study|Lost to Follow-up|5|||
46822556|NCT00529529|83041816|FG001|Overall Study|Lost to Follow-up|3|||
46933043|NCT02731742|83168641|FG003|Overall Study|Physician Decision|1|||
46933044|NCT02731742|83168638|FG000|Overall Study|Study Terminated by Sponsor|2|||
46933045|NCT02731742|83168639|FG001|Overall Study|Study Terminated by Sponsor|1|||
46933046|NCT02731742|83168640|FG002|Overall Study|Study Terminated by Sponsor|1|||
46933047|NCT02731742|83168641|FG003|Overall Study|Study Terminated by Sponsor|1|||
46933048|NCT00104871|83168664|FG000|Overall Study|Not evaluable|1|||
46933049|NCT03487796|83168672|FG000|Overall Study|Lost to Follow-up|18|||
46933050|NCT03487796|83168673|FG001|Overall Study|Lost to Follow-up|6|||
46760656|NCT00845832|82978678|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
46760657|NCT00591864|82978686|FG000|Overall Study|Incomplete Imaging|5|||
46760658|NCT00885755|82978694|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
46760659|NCT00885755|82978695|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
46760660|NCT00885755|82978696|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
46760661|NCT00885755|82978694|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
46760662|NCT00885755|82978695|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
46760663|NCT00885755|82978696|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
46822557|NCT00529529|83041817|FG002|Overall Study|Lost to Follow-up|1|||
46822558|NCT00529529|83041815|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46822559|NCT00529529|83041816|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46822560|NCT00529529|83041817|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
46933051|NCT02148705|83168688|FG000|Overall Study|Death|2|||
46760664|NCT00885755|82978694|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
46933052|NCT02148705|83168689|FG001|Overall Study|Death|0|||
46933053|NCT02148705|83168690|FG002|Overall Study|Death|0|||
46933054|NCT02148705|83168688|FG000|Overall Study|Lost to Follow-up|13|||
46822561|NCT00529529|83041815|FG000|Overall Study|Death|2|||
46822562|NCT00529529|83041816|FG001|Overall Study|Death|0|||
46822563|NCT00529529|83041817|FG002|Overall Study|Death|0|||
46822564|NCT00529529|83041815|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46822565|NCT00529529|83041816|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46822566|NCT00529529|83041817|FG002|Overall Study|Abnormal test procedure result(s)|0|||
46822567|NCT00529529|83041815|FG000|Overall Study|Administrative problems|1|||
46822568|NCT00529529|83041816|FG001|Overall Study|Administrative problems|0|||
46822569|NCT00529529|83041817|FG002|Overall Study|Administrative problems|3|||
46822570|NCT05655377|83041825|FG000|Overall Study|Withdrawal by Subject|2|||
46822571|NCT00486434|83041831|FG000|Overall Study|Withdrawal by Subject|34|||
46822572|NCT00486434|83041832|FG001|Overall Study|Withdrawal by Subject|39|||
46822573|NCT00486434|83041831|FG000|Overall Study|Adverse Event|118|||
46822574|NCT00486434|83041832|FG001|Overall Study|Adverse Event|44|||
46822575|NCT00486434|83041831|FG000|Overall Study|Protocol Violation|22|||
46822576|NCT00486434|83041832|FG001|Overall Study|Protocol Violation|21|||
46822577|NCT00486434|83041831|FG000|Overall Study|Lack of Efficacy|12|||
46822578|NCT00486434|83041832|FG001|Overall Study|Lack of Efficacy|19|||
46822579|NCT00486434|83041831|FG000|Overall Study|Lost to Follow-up|2|||
46822580|NCT00486434|83041832|FG001|Overall Study|Lost to Follow-up|3|||
46822581|NCT00486434|83041831|FG000|Overall Study|Death|1|||
46933055|NCT02148705|83168689|FG001|Overall Study|Lost to Follow-up|4|||
46933056|NCT02148705|83168690|FG002|Overall Study|Lost to Follow-up|10|||
46933057|NCT02148705|83168688|FG000|Overall Study|Withdrawal by Subject|3|||
46933058|NCT02148705|83168689|FG001|Overall Study|Withdrawal by Subject|0|||
46933059|NCT02148705|83168690|FG002|Overall Study|Withdrawal by Subject|2|||
46933060|NCT02148705|83168688|FG000|Overall Study|Not Treated|0|||
46822582|NCT00486434|83041832|FG001|Overall Study|Death|2|||
46822583|NCT00486434|83041831|FG000|Overall Study|Personal reasons|5|||
46822584|NCT00486434|83041832|FG001|Overall Study|Personal reasons|6|||
46822585|NCT00424632|83041841|FG000|Overall Study|Death|0|||
46822586|NCT00424632|83041842|FG001|Overall Study|Death|0|||
46822587|NCT00424632|83041843|FG002|Overall Study|Death|0|||
46822588|NCT00424632|83041844|FG003|Overall Study|Death|0|||
46822589|NCT00424632|83041845|FG004|Overall Study|Death|0|||
46822590|NCT00424632|83041846|FG005|Overall Study|Death|2|||
46822591|NCT00424632|83041847|FG006|Overall Study|Death|0|||
46822592|NCT00424632|83041848|FG007|Overall Study|Death|0|||
46822593|NCT00424632|83041849|FG008|Overall Study|Death|0|||
46822594|NCT00424632|83041850|FG009|Overall Study|Death|0|||
46822595|NCT00424632|83041841|FG000|Overall Study|Adverse Event|0|||
46933061|NCT02148705|83168689|FG001|Overall Study|Not Treated|1|||
46933062|NCT02148705|83168690|FG002|Overall Study|Not Treated|5|||
46933063|NCT02730728|83168701|FG000|Overall Study|Withdrawal by Subject|0|||
46933064|NCT02730728|83168702|FG001|Overall Study|Withdrawal by Subject|1|||
46933065|NCT02730728|83168703|FG002|Overall Study|Withdrawal by Subject|0|||
46933066|NCT02730728|83168701|FG000|Overall Study|Lack of Efficacy|0|||
46933067|NCT02730728|83168702|FG001|Overall Study|Lack of Efficacy|1|||
46933068|NCT02730728|83168703|FG002|Overall Study|Lack of Efficacy|1|||
46933069|NCT00104637|83168711|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
46933070|NCT00104637|83168712|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
46933071|NCT02768103|83168721|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
46933072|NCT02767323|83168730|FG000|Overall Study|Withdrawal by Subject|17|||
46933073|NCT02767323|83168731|FG001|Overall Study|Withdrawal by Subject|5|||
46933074|NCT02767323|83168732|FG002|Overall Study|Withdrawal by Subject|13|||
46933075|NCT02767323|83168733|FG003|Overall Study|Withdrawal by Subject|0|||
46933076|NCT02767323|83168730|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
46933077|NCT02767323|83168731|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
46933078|NCT02767323|83168732|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
46933079|NCT02767323|83168733|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
46822596|NCT00424632|83041842|FG001|Overall Study|Adverse Event|0|||
46933080|NCT04304950|83168748|FG000|Overall Study|Lost to Follow-up|1|||
46933081|NCT04304950|83168749|FG001|Overall Study|Lost to Follow-up|1|||
46933082|NCT02780115|83168763|FG000|Overall Study|Withdrawal by Subject|0|||
47057001|NCT00071760|83334587|FG000|Overall Study|Withdrawal by Subject|0|||
46822597|NCT00424632|83041843|FG002|Overall Study|Adverse Event|0|||
46822598|NCT00424632|83041844|FG003|Overall Study|Adverse Event|0|||
46822599|NCT00424632|83041845|FG004|Overall Study|Adverse Event|0|||
46933083|NCT02780115|83168764|FG001|Overall Study|Withdrawal by Subject|1|||
46933084|NCT02780115|83168765|FG002|Overall Study|Withdrawal by Subject|1|||
46933085|NCT02780115|83168766|FG003|Overall Study|Withdrawal by Subject|0|||
46933086|NCT02780115|83168767|FG004|Overall Study|Withdrawal by Subject|0|||
47057002|NCT00071760|83334588|FG001|Overall Study|Withdrawal by Subject|1|||
46822600|NCT00424632|83041846|FG005|Overall Study|Adverse Event|0|||
46822601|NCT00424632|83041847|FG006|Overall Study|Adverse Event|0|||
46822602|NCT00424632|83041848|FG007|Overall Study|Adverse Event|0|||
46822603|NCT00424632|83041849|FG008|Overall Study|Adverse Event|3|||
46933087|NCT02780115|83168763|FG000|Overall Study|Adverse Event|0|||
46822604|NCT00424632|83041850|FG009|Overall Study|Adverse Event|2|||
46822605|NCT00424632|83041841|FG000|Overall Study|Global deterioration of health status|0|||
46822606|NCT00424632|83041842|FG001|Overall Study|Global deterioration of health status|0|||
46822607|NCT00424632|83041843|FG002|Overall Study|Global deterioration of health status|0|||
46822608|NCT00424632|83041844|FG003|Overall Study|Global deterioration of health status|1|||
46822609|NCT00424632|83041845|FG004|Overall Study|Global deterioration of health status|1|||
46822610|NCT00424632|83041846|FG005|Overall Study|Global deterioration of health status|0|||
46822611|NCT00424632|83041847|FG006|Overall Study|Global deterioration of health status|0|||
46822612|NCT00424632|83041848|FG007|Overall Study|Global deterioration of health status|0|||
46822613|NCT00424632|83041849|FG008|Overall Study|Global deterioration of health status|0|||
46822614|NCT00424632|83041850|FG009|Overall Study|Global deterioration of health status|0|||
46822615|NCT00424632|83041841|FG000|Overall Study|Objective progression or relapse|1|||
46822616|NCT00424632|83041842|FG001|Overall Study|Objective progression or relapse|1|||
46822617|NCT00424632|83041843|FG002|Overall Study|Objective progression or relapse|1|||
46822618|NCT00424632|83041844|FG003|Overall Study|Objective progression or relapse|2|||
46822619|NCT00424632|83041845|FG004|Overall Study|Objective progression or relapse|2|||
46822620|NCT00424632|83041846|FG005|Overall Study|Objective progression or relapse|13|||
46822621|NCT00424632|83041847|FG006|Overall Study|Objective progression or relapse|7|||
46822622|NCT00424632|83041848|FG007|Overall Study|Objective progression or relapse|3|||
46822623|NCT00424632|83041849|FG008|Overall Study|Objective progression or relapse|12|||
46822624|NCT00424632|83041850|FG009|Overall Study|Objective progression or relapse|4|||
46822625|NCT00424632|83041841|FG000|Overall Study|Other|0|||
46822626|NCT00424632|83041842|FG001|Overall Study|Other|0|||
46822627|NCT00424632|83041843|FG002|Overall Study|Other|0|||
46822628|NCT00424632|83041844|FG003|Overall Study|Other|1|||
46822629|NCT00424632|83041845|FG004|Overall Study|Other|0|||
46822630|NCT00424632|83041846|FG005|Overall Study|Other|0|||
46822631|NCT00424632|83041847|FG006|Overall Study|Other|0|||
46822632|NCT00424632|83041848|FG007|Overall Study|Other|0|||
46822633|NCT00424632|83041849|FG008|Overall Study|Other|1|||
46822634|NCT00424632|83041850|FG009|Overall Study|Other|0|||
46822635|NCT00529451|83041885|FG000|Overall Study|Subject withdrew consent|16|||
46822636|NCT00529451|83041886|FG001|Overall Study|Subject withdrew consent|21|||
46822637|NCT00529451|83041887|FG002|Overall Study|Subject withdrew consent|13|||
46822638|NCT00529451|83041888|FG003|Overall Study|Subject withdrew consent|12|||
46822639|NCT00529451|83041885|FG000|Overall Study|Adverse Event|9|||
46822640|NCT00529451|83041886|FG001|Overall Study|Adverse Event|16|||
46822641|NCT00529451|83041887|FG002|Overall Study|Adverse Event|14|||
46822642|NCT00529451|83041888|FG003|Overall Study|Adverse Event|8|||
46822643|NCT00529451|83041885|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
46822644|NCT00529451|83041886|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
46822645|NCT00529451|83041887|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
46822646|NCT00529451|83041888|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
46822647|NCT00529451|83041885|FG000|Overall Study|Lost to Follow-up|4|||
46822648|NCT00529451|83041886|FG001|Overall Study|Lost to Follow-up|7|||
46822649|NCT00529451|83041887|FG002|Overall Study|Lost to Follow-up|4|||
46822650|NCT00529451|83041888|FG003|Overall Study|Lost to Follow-up|4|||
46822651|NCT00529451|83041885|FG000|Overall Study|Protocol deviation|1|||
46822652|NCT00529451|83041886|FG001|Overall Study|Protocol deviation|1|||
46822653|NCT00529451|83041887|FG002|Overall Study|Protocol deviation|4|||
46822654|NCT00529451|83041888|FG003|Overall Study|Protocol deviation|1|||
46822655|NCT00529451|83041885|FG000|Overall Study|Administrative problems|1|||
46822656|NCT00529451|83041886|FG001|Overall Study|Administrative problems|1|||
46822657|NCT00529451|83041887|FG002|Overall Study|Administrative problems|0|||
46822658|NCT00529451|83041888|FG003|Overall Study|Administrative problems|2|||
46822659|NCT03876743|83041905|FG000|Overall Study|Lost to Follow-up|6|||
46822660|NCT03876743|83041906|FG001|Overall Study|Lost to Follow-up|4|||
46822661|NCT03876743|83041907|FG002|Overall Study|Lost to Follow-up|4|||
46822662|NCT03876743|83041908|FG003|Overall Study|Lost to Follow-up|7|||
46822663|NCT00486278|83041922|FG000|Overall Study|Adverse Event|5|||
46822664|NCT00486278|83041922|FG000|Overall Study|Withdrawal by Subject|2|||
46822665|NCT00486278|83041922|FG000|Overall Study|Physician Decision|2|||
46822666|NCT00321711|83041941|FG000|Part A|Adverse Event|3|||
46822667|NCT00321711|83041942|FG001|Part A|Adverse Event|3|||
46822668|NCT00321711|83041943|FG002|Part A|Adverse Event|2|||
46822669|NCT00321711|83041944|FG003|Part A|Adverse Event|0|||
46822670|NCT00321711|83041945|FG004|Part A|Adverse Event|0|||
46822671|NCT00321711|83041941|FG000|Part A|Withdrawal by Subject|1|||
46822672|NCT00321711|83041942|FG001|Part A|Withdrawal by Subject|1|||
46822673|NCT00321711|83041943|FG002|Part A|Withdrawal by Subject|1|||
46822674|NCT00321711|83041944|FG003|Part A|Withdrawal by Subject|0|||
46822675|NCT00321711|83041945|FG004|Part A|Withdrawal by Subject|0|||
46822676|NCT00321711|83041941|FG000|Part A|Disease progression|0|||
46822677|NCT00321711|83041942|FG001|Part A|Disease progression|1|||
46822678|NCT00321711|83041943|FG002|Part A|Disease progression|0|||
46822679|NCT00321711|83041944|FG003|Part A|Disease progression|0|||
46822680|NCT00321711|83041945|FG004|Part A|Disease progression|0|||
46933088|NCT02780115|83168764|FG001|Overall Study|Adverse Event|0|||
46933089|NCT02780115|83168765|FG002|Overall Study|Adverse Event|0|||
46933090|NCT02780115|83168766|FG003|Overall Study|Adverse Event|1|||
46933091|NCT02780115|83168767|FG004|Overall Study|Adverse Event|1|||
46933092|NCT02766777|83168779|FG000|Overall Study|Adverse Event|12|||
46933093|NCT02766777|83168779|FG000|Overall Study|Lost to Follow-up|16|||
46933094|NCT02766777|83168779|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46933095|NCT02766777|83168779|FG000|Overall Study|Protocol Violation|1|||
46933096|NCT02766777|83168779|FG000|Overall Study|Withdrawal by Subject|4|||
46933097|NCT00157014|83168787|FG000|Overall Study|Death|4|||
46933098|NCT00157014|83168788|FG001|Overall Study|Death|2|||
46933099|NCT00157014|83168789|FG002|Overall Study|Death|1|||
46933100|NCT00157014|83168790|FG003|Overall Study|Death|1|||
46933101|NCT00157014|83168787|FG000|Overall Study|Physician Decision|0|||
46933102|NCT00157014|83168788|FG001|Overall Study|Physician Decision|1|||
46933103|NCT00157014|83168789|FG002|Overall Study|Physician Decision|0|||
46933104|NCT00157014|83168790|FG003|Overall Study|Physician Decision|0|||
46933105|NCT00157014|83168787|FG000|Overall Study|Medications withdrawn on family request|0|||
46933106|NCT00157014|83168788|FG001|Overall Study|Medications withdrawn on family request|1|||
46933107|NCT00157014|83168789|FG002|Overall Study|Medications withdrawn on family request|0|||
46933108|NCT00157014|83168790|FG003|Overall Study|Medications withdrawn on family request|0|||
46933109|NCT00157014|83168787|FG000|Overall Study|Patient withdrawn by investigator|1|||
46933110|NCT00157014|83168788|FG001|Overall Study|Patient withdrawn by investigator|0|||
46822681|NCT00321711|83041941|FG000|Part A|Requirement for alternative therapy|0|||
46933111|NCT00157014|83168789|FG002|Overall Study|Patient withdrawn by investigator|0|||
46933112|NCT00157014|83168790|FG003|Overall Study|Patient withdrawn by investigator|0|||
46933113|NCT00157014|83168787|FG000|Overall Study|Patient unable to return in nursing home|1|||
46933114|NCT00157014|83168788|FG001|Overall Study|Patient unable to return in nursing home|0|||
46933115|NCT00157014|83168789|FG002|Overall Study|Patient unable to return in nursing home|0|||
46933116|NCT00157014|83168790|FG003|Overall Study|Patient unable to return in nursing home|0|||
46933117|NCT00157014|83168787|FG000|Overall Study|Patient would not receive transplant|0|||
46933118|NCT00157014|83168788|FG001|Overall Study|Patient would not receive transplant|1|||
46933119|NCT00157014|83168789|FG002|Overall Study|Patient would not receive transplant|0|||
46933120|NCT00157014|83168790|FG003|Overall Study|Patient would not receive transplant|0|||
46933121|NCT00157014|83168787|FG000|Overall Study|Withdrawal by Subject|1|||
46933122|NCT00157014|83168788|FG001|Overall Study|Withdrawal by Subject|0|||
46933123|NCT00157014|83168789|FG002|Overall Study|Withdrawal by Subject|0|||
46933124|NCT00157014|83168790|FG003|Overall Study|Withdrawal by Subject|0|||
46933125|NCT02778867|83168802|FG000|Phase 1|Withdrawal by Subject|2|||
46933126|NCT02778867|83168803|FG001|Phase 1|Withdrawal by Subject|3|||
46933127|NCT02778867|83168804|FG002|Phase 1|Withdrawal by Subject|0|||
46933128|NCT02778867|83168805|FG003|Phase 1|Withdrawal by Subject|0|||
46933129|NCT02778867|83168802|FG000|Phase 2|Withdrawal by Subject|0|||
46933130|NCT02778867|83168803|FG001|Phase 2|Withdrawal by Subject|0|||
46933131|NCT02778867|83168804|FG002|Phase 2|Withdrawal by Subject|1|||
46933132|NCT02778867|83168805|FG003|Phase 2|Withdrawal by Subject|0|||
46933133|NCT02778867|83168802|FG000|Phase 2|Physician Decision|0|||
46933134|NCT02778867|83168803|FG001|Phase 2|Physician Decision|0|||
46933135|NCT02778867|83168804|FG002|Phase 2|Physician Decision|0|||
46933136|NCT02778867|83168805|FG003|Phase 2|Physician Decision|1|||
46933137|NCT02778867|83168802|FG000|Phase 2|Adverse Event|0|||
46933138|NCT02778867|83168803|FG001|Phase 2|Adverse Event|0|||
46933139|NCT02778867|83168804|FG002|Phase 2|Adverse Event|0|||
46933140|NCT02778867|83168805|FG003|Phase 2|Adverse Event|1|||
46933141|NCT02778555|83168818|FG000|Overall Study|Withdrawal by Subject|55|||
46933142|NCT02778555|83168819|FG001|Overall Study|Withdrawal by Subject|32|||
46933143|NCT02778555|83168820|FG002|Overall Study|Withdrawal by Subject|107|||
46933144|NCT02778399|83168834|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
46933145|NCT02778399|83168835|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
46933146|NCT02778399|83168836|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
46933147|NCT02778399|83168837|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
46933148|NCT02778399|83168838|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
46933149|NCT02778399|83168839|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
46933150|NCT02778399|83168834|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
46933151|NCT02778399|83168835|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
46933152|NCT02778399|83168836|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
46933153|NCT02778399|83168837|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
46933154|NCT02778399|83168838|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
46933155|NCT02778399|83168839|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
46933156|NCT02778399|83168834|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
46933157|NCT02778399|83168835|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
46933158|NCT02778399|83168836|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
47057003|NCT00071760|83334587|FG000|Overall Study|Insufficient Viral Load Response|1|||
46933159|NCT02778399|83168837|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
47057004|NCT00071760|83334588|FG001|Overall Study|Insufficient Viral Load Response|1|||
47057005|NCT00071760|83334587|FG000|Overall Study|Lack of availability of RTV|1|||
47057006|NCT00071760|83334588|FG001|Overall Study|Lack of availability of RTV|0|||
47057007|NCT00071760|83334587|FG000|Overall Study|Physician Decision|2|||
47057008|NCT00071760|83334588|FG001|Overall Study|Physician Decision|1|||
47057009|NCT00071760|83334587|FG000|Overall Study|Relocation|0|||
47057010|NCT00071760|83334588|FG001|Overall Study|Relocation|1|||
46822682|NCT00321711|83041942|FG001|Part A|Requirement for alternative therapy|2|||
46822683|NCT00321711|83041943|FG002|Part A|Requirement for alternative therapy|1|||
46822684|NCT00321711|83041944|FG003|Part A|Requirement for alternative therapy|0|||
46822685|NCT00321711|83041945|FG004|Part A|Requirement for alternative therapy|0|||
46822686|NCT00321711|83041941|FG000|Part A|Physician Decision|0|||
46822687|NCT00321711|83041942|FG001|Part A|Physician Decision|1|||
46822688|NCT00321711|83041943|FG002|Part A|Physician Decision|3|||
46822689|NCT00321711|83041944|FG003|Part A|Physician Decision|0|||
46822690|NCT00321711|83041945|FG004|Part A|Physician Decision|0|||
46822691|NCT00321711|83041941|FG000|Part A|Other|1|||
46822692|NCT00321711|83041942|FG001|Part A|Other|2|||
46822693|NCT00321711|83041943|FG002|Part A|Other|3|||
46822694|NCT00321711|83041944|FG003|Part A|Other|0|||
46822695|NCT00321711|83041945|FG004|Part A|Other|0|||
46822696|NCT00321711|83041941|FG000|Part A|Protocol deviation|0|||
46822697|NCT00321711|83041942|FG001|Part A|Protocol deviation|0|||
46822698|NCT00321711|83041943|FG002|Part A|Protocol deviation|1|||
46822699|NCT00321711|83041944|FG003|Part A|Protocol deviation|0|||
46822700|NCT00321711|83041945|FG004|Part A|Protocol deviation|0|||
46822701|NCT00321711|83041941|FG000|Part B|Noncompliance|0|||
46822702|NCT00321711|83041942|FG001|Part B|Noncompliance|0|||
46822703|NCT00321711|83041943|FG002|Part B|Noncompliance|0|||
46822704|NCT00321711|83041944|FG003|Part B|Noncompliance|0|||
46822705|NCT00321711|83041945|FG004|Part B|Noncompliance|1|||
46822706|NCT00321711|83041941|FG000|Part B|Adverse Event|0|||
46822707|NCT00321711|83041942|FG001|Part B|Adverse Event|0|||
46822708|NCT00321711|83041943|FG002|Part B|Adverse Event|0|||
46822709|NCT00321711|83041944|FG003|Part B|Adverse Event|2|||
46822710|NCT00321711|83041945|FG004|Part B|Adverse Event|1|||
46822711|NCT00321711|83041941|FG000|Part B|Disease progression|0|||
46822712|NCT00321711|83041942|FG001|Part B|Disease progression|0|||
46822713|NCT00321711|83041943|FG002|Part B|Disease progression|0|||
46822714|NCT00321711|83041944|FG003|Part B|Disease progression|1|||
46822715|NCT00321711|83041945|FG004|Part B|Disease progression|0|||
46822716|NCT00321711|83041941|FG000|Part B|Physician Decision|0|||
46822717|NCT00321711|83041942|FG001|Part B|Physician Decision|0|||
46822718|NCT00321711|83041943|FG002|Part B|Physician Decision|0|||
46822719|NCT00321711|83041944|FG003|Part B|Physician Decision|1|||
46822720|NCT00321711|83041945|FG004|Part B|Physician Decision|2|||
46822721|NCT00321711|83041941|FG000|Part B|Death|0|||
46822722|NCT00321711|83041942|FG001|Part B|Death|0|||
46933160|NCT02778399|83168838|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
47057011|NCT05327816|83334633|FG000|Overall Study|Lost to Follow-up|1|||
46760665|NCT00885755|82978695|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
46760666|NCT00885755|82978696|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
46760667|NCT00885755|82978694|FG000|Part I: Trastuzumab+Taxane|Death|0|||
46760668|NCT00885755|82978695|FG001|Part I: Trastuzumab+Taxane|Death|0|||
46760669|NCT00885755|82978696|FG002|Part I: Trastuzumab+Taxane|Death|1|||
46760670|NCT00885755|82978694|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
46760671|NCT00885755|82978695|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
46760672|NCT00885755|82978696|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
46760673|NCT00837486|82978706|FG000|Blinded-treatment Phase|Physician Decision|1|||
46760674|NCT00837486|82978707|FG001|Blinded-treatment Phase|Physician Decision|0|||
46760675|NCT00837486|82978706|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
46760676|NCT00837486|82978707|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
46760677|NCT00837486|82978706|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
46760678|NCT00837486|82978707|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
46760679|NCT00837486|82978706|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
46760680|NCT00837486|82978707|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
46760681|NCT00845676|82978715|FG000|Overall Study|Virologic breakthrough at week 20|1|||
46760682|NCT00845676|82978715|FG000|Overall Study|Adverse Event|1|||
46760683|NCT00883181|82978720|FG000|Overall Study|Hematological Adverse Event|26|||
46760684|NCT00883181|82978720|FG000|Overall Study|Non-hematological Adverse Event|55|||
46760685|NCT00883181|82978720|FG000|Overall Study|Disease Progression|94|||
46760686|NCT00883181|82978720|FG000|Overall Study|Administrative Reason|24|||
46822723|NCT00321711|83041943|FG002|Part B|Death|0|||
46933161|NCT02778399|83168839|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
47057012|NCT05327816|83334634|FG001|Overall Study|Lost to Follow-up|0|||
46822724|NCT00321711|83041944|FG003|Part B|Death|2|||
46822725|NCT00321711|83041945|FG004|Part B|Death|1|||
46822726|NCT00486044|83041959|FG000|Overall Study|Withdrawal by Subject|2|||
46822727|NCT00486044|83041960|FG001|Overall Study|Withdrawal by Subject|1|||
47057013|NCT05327816|83334635|FG002|Overall Study|Lost to Follow-up|0|||
46760687|NCT00883181|82978720|FG000|Overall Study|Withdrawal by Subject|4|||
46760688|NCT00883181|82978720|FG000|Overall Study|Death|31|||
46760689|NCT00883181|82978720|FG000|Overall Study|Other|38|||
46760690|NCT00883181|82978720|FG000|Overall Study|Protocol Deviation|3|||
46760691|NCT00883181|82978720|FG000|Overall Study|Noncompliance|3|||
46760692|NCT00845520|82978740|FG000|Overall Study|Death|1|||
46760693|NCT00845520|82978741|FG001|Overall Study|Death|2|||
46760694|NCT00845520|82978742|FG002|Overall Study|Death|0|||
46760695|NCT00845520|82978740|FG000|Overall Study|Lost to Follow-up|1|||
46760696|NCT00845520|82978741|FG001|Overall Study|Lost to Follow-up|0|||
46760697|NCT00845520|82978742|FG002|Overall Study|Lost to Follow-up|0|||
46760698|NCT00845520|82978740|FG000|Overall Study|Adverse Event|0|||
46760699|NCT00845520|82978741|FG001|Overall Study|Adverse Event|0|||
46760700|NCT00845520|82978742|FG002|Overall Study|Adverse Event|1|||
46760701|NCT00844896|82978758|FG000|Overall Study|Lost to Follow-up|12|||
46760702|NCT00844896|82978759|FG001|Overall Study|Lost to Follow-up|16|||
46760703|NCT00844896|82978758|FG000|Overall Study|Parents did not have time to complete|0|||
46760704|NCT00844896|82978759|FG001|Overall Study|Parents did not have time to complete|1|||
46760705|NCT00827502|82978766|FG000|Overall Study|randomized but not treated|11|||
46760706|NCT00827502|82978766|FG000|Overall Study|Adverse Event|1|||
46760707|NCT00827502|82978766|FG000|Overall Study|Lost to Follow-up|4|||
46760708|NCT00827502|82978766|FG000|Overall Study|Withdrawal by Subject|5|||
46760709|NCT00837330|82978772|FG000|Overall Study|Lost to Follow-up|1|||
46760710|NCT00837330|82978773|FG001|Overall Study|Lost to Follow-up|3|||
46760711|NCT00837096|82978781|FG000|Overall Study|Physician Decision|1|||
46760712|NCT00837096|82978782|FG001|Overall Study|Physician Decision|1|||
46760713|NCT00837096|82978781|FG000|Overall Study|Not reported|9|||
46760714|NCT00837096|82978782|FG001|Overall Study|Not reported|8|||
46760715|NCT00885677|82978790|FG000|Overall Study|Death|40|||
46760716|NCT00885677|82978791|FG001|Overall Study|Death|34|||
46760717|NCT00885677|82978790|FG000|Overall Study|Lost to Follow-up|15|||
46760718|NCT00885677|82978791|FG001|Overall Study|Lost to Follow-up|13|||
46760719|NCT00885677|82978790|FG000|Overall Study|Protocol Violation|54|||
46760720|NCT00885677|82978791|FG001|Overall Study|Protocol Violation|54|||
46760721|NCT00885677|82978790|FG000|Overall Study|premature study closure|41|||
46760722|NCT00885677|82978791|FG001|Overall Study|premature study closure|44|||
46760723|NCT00885677|82978790|FG000|Overall Study|device/lead revision or replacement|7|||
46760724|NCT00885677|82978791|FG001|Overall Study|device/lead revision or replacement|6|||
46760725|NCT00885677|82978790|FG000|Overall Study|Heart transplantation|1|||
46760726|NCT00885677|82978791|FG001|Overall Study|Heart transplantation|0|||
46760727|NCT00885677|82978790|FG000|Overall Study|Inclusion/exclusion not met|25|||
46760728|NCT00885677|82978791|FG001|Overall Study|Inclusion/exclusion not met|27|||
46760729|NCT00885365|82978799|FG000|4 Weeks ON Treatment|Adverse Event|2|||
46760730|NCT00885365|82978800|FG001|4 Weeks ON Treatment|Adverse Event|4|||
46760731|NCT00885365|82978799|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
46760732|NCT00885365|82978800|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
46760733|NCT00885365|82978799|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
46760734|NCT00885365|82978800|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
46760735|NCT00827112|82978808|FG000|Overall Study|Adverse Event|2|||
46760736|NCT00827112|82978809|FG001|Overall Study|Adverse Event|0|||
46760737|NCT00827112|82978808|FG000|Overall Study|Lack of Efficacy|2|||
46760738|NCT00827112|82978809|FG001|Overall Study|Lack of Efficacy|0|||
46760739|NCT00827112|82978808|FG000|Overall Study|Lost to Follow-up|3|||
46760740|NCT00827112|82978809|FG001|Overall Study|Lost to Follow-up|2|||
46760741|NCT00827112|82978808|FG000|Overall Study|Pregnancy|0|||
46760742|NCT00827112|82978809|FG001|Overall Study|Pregnancy|1|||
46760743|NCT00827112|82978808|FG000|Overall Study|Protocol Violation|0|||
46760744|NCT00827112|82978809|FG001|Overall Study|Protocol Violation|2|||
46760745|NCT00827112|82978808|FG000|Overall Study|Withdrawal by Subject|2|||
46760746|NCT00827112|82978809|FG001|Overall Study|Withdrawal by Subject|1|||
46760747|NCT00827112|82978808|FG000|Overall Study|Randomized but not treated|5|||
46760748|NCT00827112|82978809|FG001|Overall Study|Randomized but not treated|3|||
46760749|NCT00827112|82978808|FG000|Overall Study|Other|1|||
46760750|NCT00827112|82978809|FG001|Overall Study|Other|3|||
46760751|NCT00689104|82978819|FG000|Overall Study|Eligibility criterion not met|5|||
46760752|NCT00689104|82978820|FG001|Overall Study|Eligibility criterion not met|8|||
46760753|NCT00689104|82978821|FG002|Overall Study|Eligibility criterion not met|0|||
46760754|NCT00689104|82978822|FG003|Overall Study|Eligibility criterion not met|4|||
46760755|NCT00689104|82978819|FG000|Overall Study|Adverse Event|13|||
46760756|NCT00689104|82978820|FG001|Overall Study|Adverse Event|25|||
46760757|NCT00689104|82978821|FG002|Overall Study|Adverse Event|16|||
46760758|NCT00689104|82978822|FG003|Overall Study|Adverse Event|24|||
46760759|NCT00689104|82978819|FG000|Overall Study|Lack of Efficacy|5|||
46760760|NCT00689104|82978820|FG001|Overall Study|Lack of Efficacy|6|||
46760761|NCT00689104|82978821|FG002|Overall Study|Lack of Efficacy|2|||
46760762|NCT00689104|82978822|FG003|Overall Study|Lack of Efficacy|3|||
46760763|NCT00689104|82978819|FG000|Overall Study|Withdrawal by Subject|12|||
46760764|NCT00689104|82978820|FG001|Overall Study|Withdrawal by Subject|11|||
46760765|NCT00689104|82978821|FG002|Overall Study|Withdrawal by Subject|18|||
46822728|NCT00486044|83041959|FG000|Overall Study|Adverse Event|0|||
46822729|NCT00486044|83041960|FG001|Overall Study|Adverse Event|1|||
46822730|NCT00486044|83041959|FG000|Overall Study|Lost to Follow-up|0|||
46822731|NCT00486044|83041960|FG001|Overall Study|Lost to Follow-up|1|||
46933162|NCT02778399|83168834|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
46933163|NCT02778399|83168835|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
46933164|NCT02778399|83168836|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
46933165|NCT02778399|83168837|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
46822732|NCT00351273|83041969|FG000|Overall Study|Lost to Follow-up|1|||
46822733|NCT00351273|83041970|FG001|Overall Study|Lost to Follow-up|2|||
46822734|NCT00351273|83041971|FG002|Overall Study|Lost to Follow-up|5|||
46822735|NCT00327717|83041986|FG000|Overall Study|Adverse Event|6|||
46822736|NCT00327717|83041987|FG001|Overall Study|Adverse Event|6|||
46822737|NCT00327717|83041986|FG000|Overall Study|Lack of Efficacy|0|||
46822738|NCT00327717|83041987|FG001|Overall Study|Lack of Efficacy|1|||
46822739|NCT00327717|83041986|FG000|Overall Study|Withdrawal by Subject|3|||
46822740|NCT00327717|83041987|FG001|Overall Study|Withdrawal by Subject|7|||
46822741|NCT00463346|83041995|FG000|Overall Study|Withdrawal by Subject|3|||
46822742|NCT00463346|83041996|FG001|Overall Study|Withdrawal by Subject|3|||
46822743|NCT00462488|83042006|FG000|Overall Study|Protocol Violation|1|||
46822744|NCT00462488|83042007|FG001|Overall Study|Protocol Violation|0|||
46822745|NCT00462488|83042006|FG000|Overall Study|Lack of Efficacy|19|||
46822746|NCT00462488|83042007|FG001|Overall Study|Lack of Efficacy|17|||
46822747|NCT00454142|83042013|FG000|Overall Study|Withdrawal by Subject|1|||
46822748|NCT00424476|83042022|FG000|Overall Study|Withdrawal by Subject|7|||
46822749|NCT00424476|83042023|FG001|Overall Study|Withdrawal by Subject|6|||
46822750|NCT00424476|83042024|FG002|Overall Study|Withdrawal by Subject|3|||
46822751|NCT00424476|83042022|FG000|Overall Study|Adverse Event|19|||
46822752|NCT00424476|83042023|FG001|Overall Study|Adverse Event|16|||
46822753|NCT00424476|83042024|FG002|Overall Study|Adverse Event|15|||
46822754|NCT00424476|83042022|FG000|Overall Study|Lack of Efficacy|16|||
46822755|NCT00424476|83042023|FG001|Overall Study|Lack of Efficacy|12|||
46822756|NCT00424476|83042024|FG002|Overall Study|Lack of Efficacy|12|||
46933166|NCT02778399|83168838|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
46822757|NCT00424476|83042022|FG000|Overall Study|Lack of Compliance|1|||
46822758|NCT00424476|83042023|FG001|Overall Study|Lack of Compliance|1|||
46822759|NCT00424476|83042024|FG002|Overall Study|Lack of Compliance|1|||
46822760|NCT00424476|83042022|FG000|Overall Study|Lost to Follow-up|4|||
46822761|NCT00424476|83042023|FG001|Overall Study|Lost to Follow-up|6|||
46822762|NCT00424476|83042024|FG002|Overall Study|Lost to Follow-up|3|||
46822763|NCT00424476|83042022|FG000|Overall Study|Protocol Violation|7|||
46822764|NCT00424476|83042023|FG001|Overall Study|Protocol Violation|2|||
46933167|NCT02778399|83168839|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
46933168|NCT02778399|83168834|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
46933169|NCT02778399|83168835|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
46933170|NCT02778399|83168836|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
46933171|NCT02778399|83168837|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
46933172|NCT02778399|83168838|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
46933173|NCT02778399|83168839|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
46933174|NCT02778399|83168834|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
46933175|NCT02778399|83168835|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
46933176|NCT02778399|83168836|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
46933177|NCT02778399|83168837|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
46933178|NCT02778399|83168838|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
46933179|NCT02778399|83168839|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
46933180|NCT02778399|83168834|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
46933181|NCT02778399|83168835|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
46933182|NCT02778399|83168836|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
46933183|NCT02778399|83168837|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
46760766|NCT00689104|82978822|FG003|Overall Study|Withdrawal by Subject|11|||
46760767|NCT00689104|82978819|FG000|Overall Study|Lost to Follow-up|4|||
46760768|NCT00689104|82978820|FG001|Overall Study|Lost to Follow-up|3|||
46760769|NCT00689104|82978821|FG002|Overall Study|Lost to Follow-up|2|||
46760770|NCT00689104|82978822|FG003|Overall Study|Lost to Follow-up|5|||
46760771|NCT00689104|82978819|FG000|Overall Study|Protocol Violation|2|||
46760772|NCT00689104|82978820|FG001|Overall Study|Protocol Violation|3|||
46760773|NCT00689104|82978821|FG002|Overall Study|Protocol Violation|5|||
46760774|NCT00689104|82978822|FG003|Overall Study|Protocol Violation|3|||
46760775|NCT00689104|82978819|FG000|Overall Study|Randomized but never received study drug|2|||
46822765|NCT00424476|83042024|FG002|Overall Study|Protocol Violation|3|||
46822766|NCT00424476|83042022|FG000|Overall Study|Physician Decision|3|||
46822767|NCT00424476|83042023|FG001|Overall Study|Physician Decision|2|||
46822768|NCT00424476|83042024|FG002|Overall Study|Physician Decision|3|||
46822769|NCT00424476|83042022|FG000|Overall Study|Other|4|||
46760776|NCT00689104|82978820|FG001|Overall Study|Randomized but never received study drug|1|||
46822770|NCT00424476|83042023|FG001|Overall Study|Other|3|||
46822771|NCT00424476|83042024|FG002|Overall Study|Other|9|||
46822772|NCT00453986|83042037|FG000|Overall Study|Lost to Follow-up|6|||
46822773|NCT00453986|83042038|FG001|Overall Study|Lost to Follow-up|5|||
46822774|NCT00453986|83042039|FG002|Overall Study|Lost to Follow-up|6|||
46822775|NCT00453986|83042040|FG003|Overall Study|Lost to Follow-up|2|||
46822776|NCT00453986|83042041|FG004|Overall Study|Lost to Follow-up|0|||
46822777|NCT00435942|83042059|FG000|Overall Study|Death|17|||
46822778|NCT00435942|83042060|FG001|Overall Study|Death|10|||
46822779|NCT00435942|83042059|FG000|Overall Study|Withdrawal by Subject|2|||
46822780|NCT00435942|83042060|FG001|Overall Study|Withdrawal by Subject|0|||
46822781|NCT00435942|83042059|FG000|Overall Study|Lost to Follow-up|0|||
46822782|NCT00435942|83042060|FG001|Overall Study|Lost to Follow-up|16|||
46822783|NCT00435942|83042059|FG000|Overall Study|Conversion to Open Repair|1|||
46822784|NCT00435942|83042060|FG001|Overall Study|Conversion to Open Repair|0|||
46822785|NCT00435942|83042059|FG000|Overall Study|Technical Failure|3|||
46822786|NCT00435942|83042060|FG001|Overall Study|Technical Failure|0|||
46822787|NCT00435942|83042059|FG000|Overall Study|Other|0|||
46822788|NCT00435942|83042060|FG001|Overall Study|Other|1|||
46822789|NCT00453362|83042066|FG000|Overall Study|Adverse Event|5|||
46822790|NCT00453362|83042066|FG000|Overall Study|Death|7|||
46822791|NCT00453362|83042066|FG000|Overall Study|Physician Decision|2|||
46822792|NCT00453362|83042066|FG000|Overall Study|Withdrawal by Subject|3|||
46822793|NCT00453362|83042066|FG000|Overall Study|Progression of disease|56|||
46822794|NCT00453362|83042066|FG000|Overall Study|Screening Failure|14|||
46933184|NCT02778399|83168838|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
46933185|NCT02778399|83168839|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
46933186|NCT02778399|83168834|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
46933187|NCT02778399|83168835|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
46933188|NCT02778399|83168836|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
46933189|NCT02778399|83168837|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
46933190|NCT02778399|83168838|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
46933191|NCT02778399|83168839|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
46933192|NCT02778399|83168834|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
46933193|NCT02778399|83168835|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
46933194|NCT02778399|83168836|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
46933195|NCT02778399|83168837|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
46933196|NCT02778399|83168838|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
46933197|NCT02778399|83168839|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
46933198|NCT02778399|83168834|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
46933199|NCT02778399|83168835|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
46933200|NCT02778399|83168836|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
46933201|NCT02778399|83168837|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
46933202|NCT02778399|83168838|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
46933203|NCT02778399|83168839|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
46933204|NCT02778399|83168834|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
46933205|NCT02778399|83168835|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
46933206|NCT02778399|83168836|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
46933207|NCT02778399|83168837|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
46933208|NCT02778399|83168838|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
46933209|NCT02778399|83168839|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
46933210|NCT03656744|83168888|FG000|Overall Study|Adverse Event|1|||
46933211|NCT03656744|83168889|FG001|Overall Study|Adverse Event|4|||
46760777|NCT00689104|82978821|FG002|Overall Study|Randomized but never received study drug|1|||
46760778|NCT00689104|82978822|FG003|Overall Study|Randomized but never received study drug|0|||
46760779|NCT00689104|82978819|FG000|Overall Study|Physician Decision|1|||
46760780|NCT00689104|82978820|FG001|Overall Study|Physician Decision|0|||
46760781|NCT00689104|82978821|FG002|Overall Study|Physician Decision|0|||
46760782|NCT00689104|82978822|FG003|Overall Study|Physician Decision|0|||
46760783|NCT00689104|82978819|FG000|Overall Study|Non-compliance with study procedures|0|||
46760784|NCT00689104|82978820|FG001|Overall Study|Non-compliance with study procedures|0|||
46760785|NCT00689104|82978821|FG002|Overall Study|Non-compliance with study procedures|1|||
46760786|NCT00689104|82978822|FG003|Overall Study|Non-compliance with study procedures|0|||
46760787|NCT00689026|82978834|FG000|Overall Study|Withdrawal by Subject|13|||
46760788|NCT00689026|82978835|FG001|Overall Study|Withdrawal by Subject|6|||
46760789|NCT00598559|82978844|FG000|Overall Study|Adverse Event|11|||
46822795|NCT00424398|83042085|FG000|Overall Study|Withdrawal by Subject|2|||
46822796|NCT00424398|83042086|FG001|Overall Study|Withdrawal by Subject|1|||
46822797|NCT00424398|83042087|FG002|Overall Study|Withdrawal by Subject|0|||
46822798|NCT00424398|83042085|FG000|Overall Study|Subject met exclusion criteria|1|||
46822799|NCT00424398|83042086|FG001|Overall Study|Subject met exclusion criteria|0|||
46760790|NCT00598559|82978845|FG001|Overall Study|Adverse Event|7|||
46822800|NCT00424398|83042087|FG002|Overall Study|Subject met exclusion criteria|0|||
46933212|NCT03656744|83168890|FG002|Overall Study|Adverse Event|1|||
46822801|NCT00461786|83042095|FG000|Overall Study|Entry Criteria Not Met|2|||
46822802|NCT00461786|83042095|FG000|Overall Study|Inevaluable (Never Treated)|1|||
46822803|NCT00435162|83042102|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
46822804|NCT00435162|83042103|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
46822805|NCT00435162|83042104|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
46822806|NCT00435162|83042105|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
46822807|NCT00435162|83042106|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
46822808|NCT00435162|83042107|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
46822809|NCT03836664|83042122|FG000|Overall Study|Didn't complete forms and lost drug|3|||
46822810|NCT03836664|83042123|FG001|Overall Study|Didn't complete forms and lost drug|3|||
46822811|NCT00350727|83042136|FG000|Phase I: Dose Escalation|Adverse Event|4|||
46822812|NCT00350727|83042137|FG001|Phase I: Dose Escalation|Adverse Event|0|||
46822813|NCT00350727|83042138|FG002|Phase I: Dose Escalation|Adverse Event|0|||
46822814|NCT00350727|83042136|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
46933213|NCT03656744|83168888|FG000|Overall Study|Protocol Violation|1|||
46933214|NCT03656744|83168889|FG001|Overall Study|Protocol Violation|0|||
46933215|NCT03656744|83168890|FG002|Overall Study|Protocol Violation|0|||
46933216|NCT03656744|83168888|FG000|Overall Study|Lost to Follow-up|2|||
46933217|NCT03656744|83168889|FG001|Overall Study|Lost to Follow-up|2|||
46933218|NCT03656744|83168890|FG002|Overall Study|Lost to Follow-up|0|||
46933219|NCT03656744|83168888|FG000|Overall Study|Withdrawal by Subject|0|||
46933220|NCT03656744|83168889|FG001|Overall Study|Withdrawal by Subject|1|||
46933221|NCT03656744|83168890|FG002|Overall Study|Withdrawal by Subject|0|||
46933222|NCT03656744|83168888|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
46933223|NCT03656744|83168889|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
46933224|NCT03656744|83168890|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
46933225|NCT02739360|83168898|FG000|Overall Study|Adverse Event|1|||
46933226|NCT02739360|83168898|FG000|Overall Study|Study terminated by Sponsor|2|||
46636925|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
46636926|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
46636927|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
46636928|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
46636929|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
46636930|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
46636931|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
46636932|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
46636933|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
46636934|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
46636935|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
46636936|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
46636937|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
46636938|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
46636939|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
46636940|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
46636941|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
46636942|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
46636943|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
46636944|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
46636945|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
46636946|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
46636947|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
46636948|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
46760791|NCT00598559|82978846|FG002|Overall Study|Adverse Event|0|||
46760792|NCT00598559|82978844|FG000|Overall Study|Withdrawal by Subject|2|||
46760793|NCT00598559|82978845|FG001|Overall Study|Withdrawal by Subject|2|||
46760794|NCT00598559|82978846|FG002|Overall Study|Withdrawal by Subject|0|||
46760795|NCT00598559|82978844|FG000|Overall Study|Protocol Non-compliance|1|||
46760796|NCT00598559|82978845|FG001|Overall Study|Protocol Non-compliance|0|||
46760797|NCT00598559|82978846|FG002|Overall Study|Protocol Non-compliance|0|||
46760798|NCT00598559|82978844|FG000|Overall Study|Early discharge from hospital|9|||
46760799|NCT00598559|82978845|FG001|Overall Study|Early discharge from hospital|12|||
46760800|NCT00598559|82978846|FG002|Overall Study|Early discharge from hospital|3|||
46760801|NCT00598559|82978844|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
46760802|NCT00598559|82978845|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
46760803|NCT00598559|82978846|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
46760804|NCT00686686|82978854|FG000|Overall Study|Non-compliance|1|||
46760805|NCT00686686|82978854|FG000|Overall Study|Adverse Event|2|||
46822815|NCT00350727|83042137|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
46822816|NCT00350727|83042138|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
46933227|NCT01822522|83168908|FG000|Overall Study|Adverse Event|1|||
46636949|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636950|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636951|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
46636952|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636953|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636954|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
46636955|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636956|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636957|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636958|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636959|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
46636960|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
46636961|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636962|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636963|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636964|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636965|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636966|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636967|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636968|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636969|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46636970|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
46760806|NCT00686686|82978854|FG000|Overall Study|Lost to Follow-up|3|||
46760807|NCT04160195|82978860|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
46760808|NCT04160195|82978861|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
46760809|NCT00686374|82978869|FG000|Overall Study|Lack of Efficacy|10|||
47057014|NCT05327816|83334636|FG003|Overall Study|Lost to Follow-up|0|||
47057015|NCT05327816|83334637|FG004|Overall Study|Lost to Follow-up|0|||
47057016|NCT05327816|83334638|FG005|Overall Study|Lost to Follow-up|0|||
47057017|NCT05327816|83334639|FG006|Overall Study|Lost to Follow-up|0|||
47057018|NCT05327816|83334640|FG007|Overall Study|Lost to Follow-up|0|||
47057019|NCT05327816|83334641|FG008|Overall Study|Lost to Follow-up|0|||
47057020|NCT05327816|83334642|FG009|Overall Study|Lost to Follow-up|1|||
47057021|NCT05327816|83334643|FG010|Overall Study|Lost to Follow-up|0|||
47057022|NCT05327816|83334633|FG000|Overall Study|Withdrawal by Subject|0|||
47057023|NCT05327816|83334634|FG001|Overall Study|Withdrawal by Subject|0|||
47057024|NCT05327816|83334635|FG002|Overall Study|Withdrawal by Subject|0|||
47057025|NCT05327816|83334636|FG003|Overall Study|Withdrawal by Subject|0|||
47057026|NCT05327816|83334637|FG004|Overall Study|Withdrawal by Subject|1|||
47057027|NCT05327816|83334638|FG005|Overall Study|Withdrawal by Subject|1|||
47057028|NCT05327816|83334639|FG006|Overall Study|Withdrawal by Subject|0|||
47057029|NCT05327816|83334640|FG007|Overall Study|Withdrawal by Subject|0|||
47057030|NCT05327816|83334641|FG008|Overall Study|Withdrawal by Subject|0|||
47057031|NCT05327816|83334642|FG009|Overall Study|Withdrawal by Subject|0|||
47057032|NCT05327816|83334643|FG010|Overall Study|Withdrawal by Subject|0|||
47057033|NCT05327816|83334633|FG000|Overall Study|Study Terminated by Sponsor|11|||
47057034|NCT05327816|83334634|FG001|Overall Study|Study Terminated by Sponsor|12|||
47057035|NCT05327816|83334635|FG002|Overall Study|Study Terminated by Sponsor|12|||
47057036|NCT05327816|83334636|FG003|Overall Study|Study Terminated by Sponsor|12|||
47057037|NCT05327816|83334637|FG004|Overall Study|Study Terminated by Sponsor|11|||
47057038|NCT05327816|83334638|FG005|Overall Study|Study Terminated by Sponsor|11|||
47057039|NCT05327816|83334639|FG006|Overall Study|Study Terminated by Sponsor|11|||
47057040|NCT05327816|83334640|FG007|Overall Study|Study Terminated by Sponsor|11|||
47057041|NCT05327816|83334641|FG008|Overall Study|Study Terminated by Sponsor|11|||
47057042|NCT05327816|83334642|FG009|Overall Study|Study Terminated by Sponsor|11|||
47057043|NCT05327816|83334643|FG010|Overall Study|Study Terminated by Sponsor|12|||
47057044|NCT05327816|83334633|FG000|Overall Study|Randomized but not treated|0|||
47057045|NCT05327816|83334634|FG001|Overall Study|Randomized but not treated|0|||
47057046|NCT05327816|83334635|FG002|Overall Study|Randomized but not treated|0|||
46636971|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46636972|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46760810|NCT00686374|82978869|FG000|Overall Study|Adverse Event|8|||
46760811|NCT00686374|82978869|FG000|Overall Study|Withdrew consent|5|||
46760812|NCT00686374|82978869|FG000|Overall Study|Lost to Follow-up|1|||
47057047|NCT05327816|83334636|FG003|Overall Study|Randomized but not treated|0|||
47057048|NCT05327816|83334637|FG004|Overall Study|Randomized but not treated|0|||
47057049|NCT05327816|83334638|FG005|Overall Study|Randomized but not treated|0|||
47057050|NCT05327816|83334639|FG006|Overall Study|Randomized but not treated|1|||
47057051|NCT05327816|83334640|FG007|Overall Study|Randomized but not treated|1|||
47057052|NCT05327816|83334641|FG008|Overall Study|Randomized but not treated|1|||
47057053|NCT05327816|83334642|FG009|Overall Study|Randomized but not treated|0|||
47057054|NCT05327816|83334643|FG010|Overall Study|Randomized but not treated|0|||
47057055|NCT05265247|83334683|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
47057056|NCT05265247|83334684|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
47057057|NCT05265247|83334683|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
46822817|NCT00350727|83042136|FG000|Phase I: Dose Escalation|Death|1|||
46822818|NCT00350727|83042137|FG001|Phase I: Dose Escalation|Death|0|||
46822819|NCT00350727|83042138|FG002|Phase I: Dose Escalation|Death|0|||
46822820|NCT00350727|83042136|FG000|Phase I: Dose Escalation|Physician Decision|1|||
46822821|NCT00350727|83042137|FG001|Phase I: Dose Escalation|Physician Decision|0|||
46822822|NCT00350727|83042138|FG002|Phase I: Dose Escalation|Physician Decision|0|||
46822823|NCT00350727|83042136|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
46822824|NCT00350727|83042137|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
46822825|NCT00350727|83042138|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
46822826|NCT00350727|83042136|FG000|Phase II|Disease Progression|0|||
46822827|NCT00350727|83042137|FG001|Phase II|Disease Progression|15|||
46822828|NCT00350727|83042138|FG002|Phase II|Disease Progression|16|||
46933228|NCT01822522|83168909|FG001|Overall Study|Adverse Event|1|||
46933229|NCT01822522|83168910|FG002|Overall Study|Adverse Event|1|||
46933230|NCT01822522|83168911|FG003|Overall Study|Adverse Event|0|||
46933231|NCT01822522|83168912|FG004|Overall Study|Adverse Event|0|||
46933232|NCT01822522|83168913|FG005|Overall Study|Adverse Event|1|||
46933233|NCT01822522|83168908|FG000|Overall Study|Death|3|||
46933234|NCT01822522|83168909|FG001|Overall Study|Death|0|||
46933235|NCT01822522|83168910|FG002|Overall Study|Death|2|||
46933236|NCT01822522|83168911|FG003|Overall Study|Death|0|||
46933237|NCT01822522|83168912|FG004|Overall Study|Death|0|||
46822829|NCT00350727|83042136|FG000|Phase II|Clinical Deterioration|0|||
46822830|NCT00350727|83042137|FG001|Phase II|Clinical Deterioration|1|||
46933238|NCT01822522|83168913|FG005|Overall Study|Death|0|||
46933239|NCT01822522|83168908|FG000|Overall Study|Lost to Follow-up|0|||
46933240|NCT01822522|83168909|FG001|Overall Study|Lost to Follow-up|0|||
46933241|NCT01822522|83168910|FG002|Overall Study|Lost to Follow-up|1|||
46933242|NCT01822522|83168911|FG003|Overall Study|Lost to Follow-up|1|||
46933243|NCT01822522|83168912|FG004|Overall Study|Lost to Follow-up|0|||
46933244|NCT01822522|83168913|FG005|Overall Study|Lost to Follow-up|1|||
46933245|NCT01822522|83168908|FG000|Overall Study|Withdrawal by Subject|0|||
46933246|NCT01822522|83168909|FG001|Overall Study|Withdrawal by Subject|0|||
46933247|NCT01822522|83168910|FG002|Overall Study|Withdrawal by Subject|0|||
46933248|NCT01822522|83168911|FG003|Overall Study|Withdrawal by Subject|1|||
46933249|NCT01822522|83168912|FG004|Overall Study|Withdrawal by Subject|0|||
46933250|NCT01822522|83168913|FG005|Overall Study|Withdrawal by Subject|0|||
46933251|NCT01822522|83168908|FG000|Overall Study|Lack of Efficacy|0|||
46933252|NCT01822522|83168909|FG001|Overall Study|Lack of Efficacy|0|||
46933253|NCT01822522|83168910|FG002|Overall Study|Lack of Efficacy|0|||
46933254|NCT01822522|83168911|FG003|Overall Study|Lack of Efficacy|0|||
46933255|NCT01822522|83168912|FG004|Overall Study|Lack of Efficacy|0|||
46933256|NCT01822522|83168913|FG005|Overall Study|Lack of Efficacy|2|||
46933257|NCT00102687|83168957|FG000|Initial Period|Withdrawal by Subject|6|||
46933258|NCT00102687|83168958|FG001|Initial Period|Withdrawal by Subject|3|||
46933259|NCT00102687|83168959|FG002|Initial Period|Withdrawal by Subject|5|||
46933260|NCT00102687|83168960|FG003|Initial Period|Withdrawal by Subject|0|||
46933261|NCT00102687|83168961|FG004|Initial Period|Withdrawal by Subject|0|||
46822831|NCT00350727|83042138|FG002|Phase II|Clinical Deterioration|0|||
46933262|NCT00102687|83168957|FG000|Initial Period|Adverse Event|4|||
46933263|NCT00102687|83168958|FG001|Initial Period|Adverse Event|7|||
46933264|NCT00102687|83168959|FG002|Initial Period|Adverse Event|9|||
46933265|NCT00102687|83168960|FG003|Initial Period|Adverse Event|0|||
46933266|NCT00102687|83168961|FG004|Initial Period|Adverse Event|0|||
46933267|NCT00102687|83168957|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
46933268|NCT00102687|83168958|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
46933269|NCT00102687|83168959|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
46933270|NCT00102687|83168960|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
46933271|NCT00102687|83168961|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
46933272|NCT00102687|83168957|FG000|Initial Period|Protocol Violation|0|||
47057058|NCT05265247|83334684|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
47057059|NCT05265247|83334683|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
46760813|NCT00686374|82978869|FG000|Overall Study|Missing reason|33|||
46822832|NCT00350727|83042136|FG000|Phase II|Withdrawal by Subject|0|||
46822833|NCT00350727|83042137|FG001|Phase II|Withdrawal by Subject|2|||
46933273|NCT00102687|83168958|FG001|Initial Period|Protocol Violation|0|||
46933274|NCT00102687|83168959|FG002|Initial Period|Protocol Violation|2|||
46933275|NCT00102687|83168960|FG003|Initial Period|Protocol Violation|0|||
46933276|NCT00102687|83168961|FG004|Initial Period|Protocol Violation|0|||
46933277|NCT00102687|83168957|FG000|Initial Period|Physician Decision|2|||
46933278|NCT00102687|83168958|FG001|Initial Period|Physician Decision|9|||
46933279|NCT00102687|83168959|FG002|Initial Period|Physician Decision|6|||
46933280|NCT00102687|83168960|FG003|Initial Period|Physician Decision|0|||
46822834|NCT00350727|83042138|FG002|Phase II|Withdrawal by Subject|1|||
46822835|NCT00350727|83042136|FG000|Phase II|Adverse Event|0|||
46822836|NCT00350727|83042137|FG001|Phase II|Adverse Event|1|||
46822837|NCT00350727|83042138|FG002|Phase II|Adverse Event|1|||
46822838|NCT00350727|83042136|FG000|Phase II|Death|0|||
46822839|NCT00350727|83042137|FG001|Phase II|Death|0|||
46822840|NCT00350727|83042138|FG002|Phase II|Death|2|||
46822841|NCT00350727|83042136|FG000|Phase II|Sponsor Terminated Study|0|||
46822842|NCT00350727|83042137|FG001|Phase II|Sponsor Terminated Study|0|||
46822843|NCT00350727|83042138|FG002|Phase II|Sponsor Terminated Study|1|||
46822844|NCT00350727|83042136|FG000|Phase II|Enrolled in Rollover Study|0|||
46822845|NCT00350727|83042137|FG001|Phase II|Enrolled in Rollover Study|0|||
46822846|NCT00350727|83042138|FG002|Phase II|Enrolled in Rollover Study|1|||
46822847|NCT00434304|83042157|FG000|Overall Study|Adverse Event|14|||
46822848|NCT00434304|83042157|FG000|Overall Study|Lack of Efficacy|2|||
46822849|NCT00434304|83042157|FG000|Overall Study|Withdrawal by Subject|4|||
46822850|NCT00424008|83042164|FG000|Overall Study|Adverse Event|8|||
46822851|NCT00424008|83042165|FG001|Overall Study|Adverse Event|6|||
46822852|NCT00424008|83042164|FG000|Overall Study|Lack of Efficacy|40|||
46822853|NCT00424008|83042165|FG001|Overall Study|Lack of Efficacy|34|||
46822854|NCT00424008|83042164|FG000|Overall Study|Lost to Follow-up|1|||
46822855|NCT00424008|83042165|FG001|Overall Study|Lost to Follow-up|2|||
46822856|NCT00424008|83042164|FG000|Overall Study|Withdrawal by Subject|5|||
46822857|NCT00424008|83042165|FG001|Overall Study|Withdrawal by Subject|8|||
46822858|NCT00424008|83042164|FG000|Overall Study|Noncompliance with protocol|13|||
47057060|NCT05265247|83334684|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
47057061|NCT05033743|83334694|FG000|Overall Study|Lost to Follow-up|1|||
47057062|NCT05033743|83334694|FG000|Overall Study|Protocol Violation|2|||
47057063|NCT05033743|83334694|FG000|Overall Study|Withdrawal by Subject|1|||
47057064|NCT04984278|83334700|FG000|Period 1|Withdrawal by Subject|1|||
47057065|NCT04984278|83334701|FG001|Period 1|Withdrawal by Subject|0|||
47057066|NCT04984278|83334700|FG000|Period 1|Other|0|||
47057067|NCT04984278|83334701|FG001|Period 1|Other|1|||
47057068|NCT04984278|83334700|FG000|Period 2|Adverse Event|1|||
47057069|NCT04984278|83334701|FG001|Period 2|Adverse Event|0|||
47057070|NCT04984278|83334700|FG000|Period 2|Other|0|||
47057071|NCT04984278|83334701|FG001|Period 2|Other|1|||
47057072|NCT04596995|83334707|FG000|Overall Study|Lack of Efficacy|8|||
47057073|NCT04596995|83334707|FG000|Overall Study|Lost to Follow-up|3|||
47057074|NCT04596995|83334707|FG000|Overall Study|Withdrawal by Subject|12|||
47057075|NCT04596995|83334707|FG000|Overall Study|Sponsor decision|3|||
47057076|NCT04596995|83334707|FG000|Overall Study|Enrolled in managed access program|3|||
47057077|NCT04559529|83334715|FG000|First Intervention (1 Day)|Adverse Event|0|||
47057078|NCT04559529|83334716|FG001|First Intervention (1 Day)|Adverse Event|0|||
47057079|NCT04559529|83334717|FG002|First Intervention (1 Day)|Adverse Event|0|||
47057080|NCT04559529|83334718|FG003|First Intervention (1 Day)|Adverse Event|1|||
47057081|NCT04559529|83334715|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
47057082|NCT04559529|83334716|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
47057083|NCT04559529|83334717|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
47057084|NCT04559529|83334718|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
47057085|NCT04559529|83334715|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
46822859|NCT00424008|83042165|FG001|Overall Study|Noncompliance with protocol|7|||
46822860|NCT00424008|83042164|FG000|Overall Study|Did not meet protocol eligibility|16|||
46822861|NCT00424008|83042165|FG001|Overall Study|Did not meet protocol eligibility|21|||
46822862|NCT00424008|83042164|FG000|Overall Study|Administrative|266|||
46822863|NCT00424008|83042165|FG001|Overall Study|Administrative|257|||
46822864|NCT00423930|83042172|FG000|Overall Study|Withdrawal by Subject|2|||
46822865|NCT00423852|83042176|FG000|Overall Study|Removed pior to the high-dose portion|3|||
46822866|NCT00461708|83042182|FG000|Overall Study|Adverse Event|17|||
46822867|NCT00461708|83042183|FG001|Overall Study|Adverse Event|7|||
46933281|NCT00102687|83168961|FG004|Initial Period|Physician Decision|0|||
47057086|NCT04559529|83334716|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
47057087|NCT04559529|83334717|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
47057088|NCT04559529|83334718|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
47057089|NCT04516746|83334730|FG000|Overall Study|Randomized but not Treated|51|||
47057090|NCT04516746|83334731|FG001|Overall Study|Randomized but not Treated|19|||
47057091|NCT04516746|83334730|FG000|Overall Study|Adverse Event|0|||
46822868|NCT00461708|83042182|FG000|Overall Study|Lack of Efficacy|68|||
46933282|NCT00102687|83168957|FG000|Initial Period|Sponsor's decision|0|||
46933283|NCT00102687|83168958|FG001|Initial Period|Sponsor's decision|1|||
47057092|NCT04516746|83334731|FG001|Overall Study|Adverse Event|1|||
47057093|NCT04516746|83334730|FG000|Overall Study|Death|62|||
46822869|NCT00461708|83042183|FG001|Overall Study|Lack of Efficacy|20|||
46822870|NCT00461708|83042182|FG000|Overall Study|Physician Decision|10|||
46822871|NCT00461708|83042183|FG001|Overall Study|Physician Decision|4|||
46822872|NCT00461708|83042182|FG000|Overall Study|Withdrawal by Subject|8|||
46822873|NCT00461708|83042183|FG001|Overall Study|Withdrawal by Subject|2|||
46822874|NCT00461708|83042182|FG000|Overall Study|Other|4|||
46822875|NCT00461708|83042183|FG001|Overall Study|Other|4|||
46822876|NCT00461708|83042182|FG000|Overall Study|Death|8|||
46822877|NCT00461708|83042183|FG001|Overall Study|Death|1|||
46822878|NCT00327171|83042194|FG000|Overall Study|Did not receive study medication|3|||
46822879|NCT00327171|83042195|FG001|Overall Study|Did not receive study medication|0|||
46822880|NCT00327171|83042194|FG000|Overall Study|Adverse Event|23|||
46933284|NCT00102687|83168959|FG002|Initial Period|Sponsor's decision|1|||
46933285|NCT00102687|83168960|FG003|Initial Period|Sponsor's decision|0|||
46933286|NCT00102687|83168961|FG004|Initial Period|Sponsor's decision|0|||
46933287|NCT00102687|83168957|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
46822881|NCT00327171|83042195|FG001|Overall Study|Adverse Event|23|||
46822882|NCT00327171|83042194|FG000|Overall Study|Disease progression/lack of efficacy|68|||
46822883|NCT00327171|83042195|FG001|Overall Study|Disease progression/lack of efficacy|69|||
46822884|NCT00327171|83042194|FG000|Overall Study|Investigator/participant request|1|||
46822885|NCT00327171|83042195|FG001|Overall Study|Investigator/participant request|8|||
46822886|NCT00327171|83042194|FG000|Overall Study|Clinical progression|12|||
46822887|NCT00327171|83042195|FG001|Overall Study|Clinical progression|8|||
46822888|NCT00327171|83042194|FG000|Overall Study|Undisclosed history of ischemia|0|||
46822889|NCT00327171|83042195|FG001|Overall Study|Undisclosed history of ischemia|1|||
46822890|NCT00327171|83042194|FG000|Overall Study|Other|1|||
46822891|NCT00327171|83042195|FG001|Overall Study|Other|0|||
46822892|NCT00461630|83042203|FG000|Overall Study|Death|798|||
47057094|NCT04516746|83334731|FG001|Overall Study|Death|32|||
47057095|NCT04516746|83334730|FG000|Overall Study|Lost to Follow-up|3431|||
47057096|NCT04516746|83334731|FG001|Overall Study|Lost to Follow-up|1831|||
47057097|NCT04516746|83334730|FG000|Overall Study|Withdrawal by Subject|1946|||
47057098|NCT04516746|83334731|FG001|Overall Study|Withdrawal by Subject|1696|||
47057099|NCT04516746|83334730|FG000|Overall Study|Physician Decision|10|||
47057100|NCT04516746|83334731|FG001|Overall Study|Physician Decision|8|||
47057101|NCT04516746|83334730|FG000|Overall Study|Other|35|||
47057102|NCT04516746|83334731|FG001|Overall Study|Other|16|||
47057103|NCT04423718|83334755|FG000|Overall Study|Adverse Event|6|||
47057104|NCT04423718|83334756|FG001|Overall Study|Adverse Event|2|||
47057105|NCT04423718|83334757|FG002|Overall Study|Adverse Event|5|||
47057106|NCT04423718|83334755|FG000|Overall Study|Physician Decision|1|||
47057107|NCT04423718|83334756|FG001|Overall Study|Physician Decision|4|||
47057108|NCT04423718|83334757|FG002|Overall Study|Physician Decision|1|||
47057109|NCT04423718|83334755|FG000|Overall Study|Protocol Violation|0|||
47057110|NCT04423718|83334756|FG001|Overall Study|Protocol Violation|1|||
47057111|NCT04423718|83334757|FG002|Overall Study|Protocol Violation|1|||
47057112|NCT04423718|83334755|FG000|Overall Study|Lost to Follow-up|1|||
46933288|NCT00102687|83168958|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
46933289|NCT00102687|83168959|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
46933290|NCT00102687|83168960|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
46933291|NCT00102687|83168961|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
46933292|NCT00102687|83168957|FG000|Initial Period|Death|1|||
46933293|NCT00102687|83168958|FG001|Initial Period|Death|1|||
46933294|NCT00102687|83168959|FG002|Initial Period|Death|1|||
46933295|NCT00102687|83168960|FG003|Initial Period|Death|0|||
47057113|NCT04423718|83334756|FG001|Overall Study|Lost to Follow-up|1|||
47057114|NCT04423718|83334757|FG002|Overall Study|Lost to Follow-up|2|||
47057115|NCT04423718|83334755|FG000|Overall Study|Lack of Efficacy|2|||
47057116|NCT04423718|83334756|FG001|Overall Study|Lack of Efficacy|0|||
47057117|NCT04423718|83334757|FG002|Overall Study|Lack of Efficacy|0|||
46933296|NCT00102687|83168961|FG004|Initial Period|Death|0|||
46933297|NCT00102687|83168957|FG000|Maintenance Period|Withdrawal by Subject|4|||
46933298|NCT00102687|83168958|FG001|Maintenance Period|Withdrawal by Subject|0|||
46933299|NCT00102687|83168959|FG002|Maintenance Period|Withdrawal by Subject|2|||
46933300|NCT00102687|83168960|FG003|Maintenance Period|Withdrawal by Subject|3|||
47057118|NCT04423718|83334755|FG000|Overall Study|Withdrawal by Subject|6|||
47057119|NCT04423718|83334756|FG001|Overall Study|Withdrawal by Subject|8|||
47057120|NCT04423718|83334757|FG002|Overall Study|Withdrawal by Subject|14|||
47057121|NCT04423718|83334755|FG000|Overall Study|Death|5|||
47057122|NCT04423718|83334756|FG001|Overall Study|Death|3|||
47057123|NCT04423718|83334757|FG002|Overall Study|Death|2|||
47057124|NCT04423718|83334755|FG000|Overall Study|COVID-19 pandemic|2|||
47057125|NCT04423718|83334756|FG001|Overall Study|COVID-19 pandemic|2|||
47057126|NCT04423718|83334757|FG002|Overall Study|COVID-19 pandemic|2|||
47057127|NCT04423718|83334755|FG000|Overall Study|Other|6|||
47057128|NCT04423718|83334756|FG001|Overall Study|Other|2|||
47057129|NCT04423718|83334757|FG002|Overall Study|Other|2|||
47057130|NCT04423718|83334755|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
46933301|NCT00102687|83168961|FG004|Maintenance Period|Withdrawal by Subject|1|||
46933302|NCT00102687|83168957|FG000|Maintenance Period|Adverse Event|1|||
46933303|NCT00102687|83168958|FG001|Maintenance Period|Adverse Event|0|||
46933304|NCT00102687|83168959|FG002|Maintenance Period|Adverse Event|0|||
46933305|NCT00102687|83168960|FG003|Maintenance Period|Adverse Event|1|||
47057131|NCT04423718|83334756|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
46822893|NCT00461630|83042204|FG001|Overall Study|Death|732|||
47057132|NCT04423718|83334757|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
47057133|NCT04305587|83334778|FG000|Overall Study|Withdrawal by Subject|0|||
47057134|NCT04305587|83334779|FG001|Overall Study|Withdrawal by Subject|0|||
47057135|NCT04305587|83334780|FG002|Overall Study|Withdrawal by Subject|0|||
47057136|NCT04305587|83334781|FG003|Overall Study|Withdrawal by Subject|1|||
47057137|NCT04305587|83334782|FG004|Overall Study|Withdrawal by Subject|0|||
47057138|NCT04305587|83334783|FG005|Overall Study|Withdrawal by Subject|0|||
47057139|NCT04305587|83334784|FG006|Overall Study|Withdrawal by Subject|0|||
47057140|NCT04305587|83334785|FG007|Overall Study|Withdrawal by Subject|0|||
47057141|NCT04305587|83334786|FG008|Overall Study|Withdrawal by Subject|0|||
47057142|NCT04137224|83334815|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
47057143|NCT04137224|83334816|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
46822894|NCT00461630|83042203|FG000|Overall Study|Lost to Follow-up|108|||
46822895|NCT00461630|83042204|FG001|Overall Study|Lost to Follow-up|95|||
47057144|NCT04137224|83334815|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
46822896|NCT00461552|83042212|FG000|Overall Study|Drug Dispensing error|0|||
46822897|NCT00461552|83042213|FG001|Overall Study|Drug Dispensing error|2|||
46822898|NCT00453206|83042219|FG000|Overall Study|Death|1|||
46822899|NCT03850496|83042226|FG000|Overall Study|Withdrawal by Subject|1|||
46822900|NCT03850496|83042227|FG001|Overall Study|Withdrawal by Subject|0|||
46822901|NCT03850496|83042228|FG002|Overall Study|Withdrawal by Subject|0|||
47057145|NCT04137224|83334816|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
47057146|NCT04137224|83334815|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
47057147|NCT04137224|83334816|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
47057148|NCT03872128|83334843|FG000|Overall Study|Dropped out before treatment|1|||
47057149|NCT03872128|83334844|FG001|Overall Study|Dropped out before treatment|0|||
47057150|NCT03872128|83334845|FG002|Overall Study|Dropped out before treatment|4|||
47057151|NCT03872128|83334843|FG000|Overall Study|Lost to Follow-up|2|||
47057152|NCT03872128|83334844|FG001|Overall Study|Lost to Follow-up|5|||
47057153|NCT03872128|83334845|FG002|Overall Study|Lost to Follow-up|8|||
47057154|NCT03740698|83334867|FG000|Overall Study|Physician Decision|0|||
47057155|NCT03740698|83334868|FG001|Overall Study|Physician Decision|1|||
47057156|NCT03740698|83334869|FG002|Overall Study|Physician Decision|1|||
47057157|NCT03541642|83334879|FG000|Overall Study|Withdrawal by Subject|1|||
47057158|NCT03541642|83334880|FG001|Overall Study|Withdrawal by Subject|2|||
47057159|NCT03541642|83334879|FG000|Overall Study|Lost to Follow-up|16|||
47057160|NCT03541642|83334880|FG001|Overall Study|Lost to Follow-up|12|||
47057161|NCT03541642|83334879|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
47057162|NCT03541642|83334880|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
47057163|NCT03534284|83334889|FG000|Overall Study|Death|2|||
47057164|NCT03534284|83334890|FG001|Overall Study|Death|3|||
47057165|NCT03534284|83334891|FG002|Overall Study|Death|3|||
47057166|NCT03534284|83334889|FG000|Overall Study|Withdrawal by Subject|5|||
47057167|NCT03534284|83334890|FG001|Overall Study|Withdrawal by Subject|0|||
47057168|NCT03534284|83334891|FG002|Overall Study|Withdrawal by Subject|0|||
47057169|NCT03375463|83334930|FG000|Period 1|Lost to Follow-up|0|||
47057170|NCT03375463|83334931|FG001|Period 1|Lost to Follow-up|0|||
47057171|NCT03375463|83334932|FG002|Period 1|Lost to Follow-up|1|||
47057172|NCT03375463|83334933|FG003|Period 1|Lost to Follow-up|0|||
47057173|NCT03375463|83334934|FG004|Period 1|Lost to Follow-up|0|||
47057174|NCT03375463|83334935|FG005|Period 1|Lost to Follow-up|0|||
46822902|NCT03850496|83042226|FG000|Overall Study|Lost to Follow-up|0|||
46822903|NCT03850496|83042227|FG001|Overall Study|Lost to Follow-up|1|||
46822904|NCT03850496|83042228|FG002|Overall Study|Lost to Follow-up|4|||
46822905|NCT00327015|83042240|FG000|Overall Study|Lack of Efficacy|18|||
46822906|NCT00327015|83042241|FG001|Overall Study|Lack of Efficacy|18|||
46822907|NCT00327015|83042242|FG002|Overall Study|Lack of Efficacy|35|||
46822908|NCT00327015|83042243|FG003|Overall Study|Lack of Efficacy|29|||
47057175|NCT03375463|83334930|FG000|Period 1|Adverse Event|0|||
47057176|NCT03375463|83334931|FG001|Period 1|Adverse Event|0|||
47057177|NCT03375463|83334932|FG002|Period 1|Adverse Event|0|||
47057178|NCT03375463|83334933|FG003|Period 1|Adverse Event|0|||
47057179|NCT03375463|83334934|FG004|Period 1|Adverse Event|1|||
47057180|NCT03375463|83334935|FG005|Period 1|Adverse Event|0|||
47057181|NCT03375463|83334930|FG000|Period 2|Lost to Follow-up|1|||
47057182|NCT03375463|83334931|FG001|Period 2|Lost to Follow-up|1|||
47057183|NCT03375463|83334932|FG002|Period 2|Lost to Follow-up|0|||
46822909|NCT00327015|83042240|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
46822910|NCT00327015|83042241|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
46822911|NCT00327015|83042242|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
46822912|NCT00327015|83042243|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
46822913|NCT00327015|83042240|FG000|Overall Study|Lost to Follow-up|22|||
46822914|NCT00327015|83042241|FG001|Overall Study|Lost to Follow-up|23|||
47057184|NCT03375463|83334933|FG003|Period 2|Lost to Follow-up|0|||
47057185|NCT03375463|83334934|FG004|Period 2|Lost to Follow-up|0|||
46822915|NCT00327015|83042242|FG002|Overall Study|Lost to Follow-up|29|||
46933306|NCT00102687|83168961|FG004|Maintenance Period|Adverse Event|3|||
46933307|NCT00102687|83168957|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
46933308|NCT00102687|83168958|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
46933309|NCT00102687|83168959|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
46933310|NCT00102687|83168960|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
46933311|NCT00102687|83168961|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
46933312|NCT00102687|83168957|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
46933313|NCT00102687|83168958|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
46933314|NCT00102687|83168959|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
46933315|NCT00102687|83168960|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
46933316|NCT00102687|83168961|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
46933317|NCT00102687|83168957|FG000|Maintenance Period|Death|0|||
47057186|NCT03375463|83334935|FG005|Period 2|Lost to Follow-up|0|||
47057187|NCT03366337|83334958|FG000|Overall Study|Lost to Follow-up|1|||
46760814|NCT00686374|82978869|FG000|Overall Study|Other, not specified|4|||
46760815|NCT00571948|82978875|FG000|Overall Study|Lost to Follow-up|2|||
46760816|NCT00571948|82978876|FG001|Overall Study|Lost to Follow-up|0|||
46760817|NCT00571948|82978875|FG000|Overall Study|Withdrawal by Subject|1|||
46760818|NCT00571948|82978876|FG001|Overall Study|Withdrawal by Subject|2|||
46760819|NCT00571948|82978875|FG000|Overall Study|Protocol Violation|3|||
46760820|NCT00571948|82978876|FG001|Overall Study|Protocol Violation|3|||
46760821|NCT00571948|82978875|FG000|Overall Study|infant refused study meal|3|||
46760822|NCT00571948|82978876|FG001|Overall Study|infant refused study meal|4|||
46760823|NCT00571948|82978875|FG000|Overall Study|Parent were afraid of blood colection|2|||
46760824|NCT00571948|82978876|FG001|Overall Study|Parent were afraid of blood colection|5|||
46760825|NCT00684424|82978882|FG000|Overall Study|Adverse Event|1|||
46760826|NCT00684424|82978882|FG000|Overall Study|Lost to Follow-up|2|||
46760827|NCT00684424|82978882|FG000|Overall Study|Other|2|||
46760828|NCT00685750|82978894|FG000|Overall Study|Tumor sampling failure|0|||
46760829|NCT00685750|82978895|FG001|Overall Study|Tumor sampling failure|0|||
46760830|NCT00685750|82978896|FG002|Overall Study|Tumor sampling failure|1|||
46760831|NCT00685750|82978897|FG003|Overall Study|Tumor sampling failure|0|||
46760832|NCT00685750|82978898|FG004|Overall Study|Tumor sampling failure|0|||
46760833|NCT00685750|82978899|FG005|Overall Study|Tumor sampling failure|0|||
46760834|NCT00685750|82978900|FG006|Overall Study|Tumor sampling failure|0|||
46760835|NCT00685750|82978894|FG000|Overall Study|Patient didn't receive the treatment|0|||
46760836|NCT00685750|82978895|FG001|Overall Study|Patient didn't receive the treatment|0|||
46760837|NCT00685750|82978896|FG002|Overall Study|Patient didn't receive the treatment|0|||
46760838|NCT00685750|82978897|FG003|Overall Study|Patient didn't receive the treatment|0|||
46760839|NCT00685750|82978898|FG004|Overall Study|Patient didn't receive the treatment|0|||
46760840|NCT00685750|82978899|FG005|Overall Study|Patient didn't receive the treatment|0|||
46760841|NCT00685750|82978900|FG006|Overall Study|Patient didn't receive the treatment|1|||
46760842|NCT00685750|82978894|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46760843|NCT00685750|82978895|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46760844|NCT00685750|82978896|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
46760845|NCT00685750|82978897|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
46760846|NCT00685750|82978898|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
46760847|NCT00685750|82978899|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
46760848|NCT00685750|82978900|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
46760849|NCT00576628|82978920|FG000|Overall Study|Adverse Event|11|||
46760850|NCT00576628|82978920|FG000|Overall Study|Death|2|||
46760851|NCT00576628|82978920|FG000|Overall Study|Failure to return|1|||
46760852|NCT00576628|82978920|FG000|Overall Study|Refused Treatment|8|||
46760853|NCT00576628|82978920|FG000|Overall Study|Pregnancy|1|||
46760854|NCT00576628|82978920|FG000|Overall Study|RBC transfusion|1|||
46760855|NCT00576628|82978920|FG000|Overall Study|Progression of Kidney Disease|1|||
46760856|NCT00576628|82978920|FG000|Overall Study|Progression of Renal Failure|1|||
46760857|NCT00576628|82978920|FG000|Overall Study|The patient move into other town|1|||
46760858|NCT00576628|82978920|FG000|Overall Study|Transplantation|1|||
46760859|NCT00576628|82978920|FG000|Overall Study|Dialysis|15|||
46760860|NCT00683878|82978928|FG000|Overall Study|Lack of Efficacy|3|||
46760861|NCT00683878|82978929|FG001|Overall Study|Lack of Efficacy|0|||
46760862|NCT00683878|82978930|FG002|Overall Study|Lack of Efficacy|1|||
46760863|NCT00683878|82978928|FG000|Overall Study|Adverse Event|4|||
46760864|NCT00683878|82978929|FG001|Overall Study|Adverse Event|3|||
46760865|NCT00683878|82978930|FG002|Overall Study|Adverse Event|3|||
46760866|NCT00683878|82978928|FG000|Overall Study|Withdrawal by Subject|9|||
46760867|NCT00683878|82978929|FG001|Overall Study|Withdrawal by Subject|8|||
46760868|NCT00683878|82978930|FG002|Overall Study|Withdrawal by Subject|6|||
46933318|NCT00102687|83168958|FG001|Maintenance Period|Death|0|||
46760869|NCT00683878|82978928|FG000|Overall Study|Death|0|||
46760870|NCT00683878|82978929|FG001|Overall Study|Death|1|||
46760871|NCT00683878|82978930|FG002|Overall Study|Death|0|||
46760872|NCT00683878|82978928|FG000|Overall Study|Lost to Follow-up|4|||
46822916|NCT00327015|83042243|FG003|Overall Study|Lost to Follow-up|22|||
46822917|NCT00327015|83042240|FG000|Overall Study|Adverse Event|14|||
46822918|NCT00327015|83042241|FG001|Overall Study|Adverse Event|10|||
46933319|NCT00102687|83168959|FG002|Maintenance Period|Death|0|||
46933320|NCT00102687|83168960|FG003|Maintenance Period|Death|1|||
46933321|NCT00102687|83168961|FG004|Maintenance Period|Death|1|||
46933322|NCT00102687|83168957|FG000|Maintenance Period|Physician Decision|1|||
46933323|NCT00102687|83168958|FG001|Maintenance Period|Physician Decision|2|||
46933324|NCT00102687|83168959|FG002|Maintenance Period|Physician Decision|3|||
46933325|NCT00102687|83168960|FG003|Maintenance Period|Physician Decision|0|||
46933326|NCT00102687|83168961|FG004|Maintenance Period|Physician Decision|4|||
46933327|NCT00102531|83168979|FG000|Overall Study|Adverse Event|0|||
46933328|NCT00102531|83168980|FG001|Overall Study|Adverse Event|1|||
46933329|NCT00102531|83168979|FG000|Overall Study|Disease Progression|5|||
46933330|NCT00102531|83168980|FG001|Overall Study|Disease Progression|9|||
46933331|NCT00102531|83168979|FG000|Overall Study|Physician Decision|0|||
46933332|NCT00102531|83168980|FG001|Overall Study|Physician Decision|1|||
46933333|NCT02771145|83168986|FG000|Overall Study|Adverse Event|3|||
46933334|NCT02771145|83168986|FG000|Overall Study|Lost to Follow-up|1|||
46933335|NCT02578186|83169006|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
46933336|NCT02578186|83169007|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
46933337|NCT02578186|83169006|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
46933338|NCT02578186|83169007|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
46933339|NCT00103311|83169015|FG000|Overall Study|Lost to Follow-up|1|||
46933340|NCT00103311|83169016|FG001|Overall Study|Lost to Follow-up|0|||
46933341|NCT00103311|83169015|FG000|Overall Study|Withdrawal by Subject|2|||
46933342|NCT00103311|83169016|FG001|Overall Study|Withdrawal by Subject|1|||
46933343|NCT00103311|83169015|FG000|Overall Study|Adverse Event|1|||
47057188|NCT03366337|83334959|FG001|Overall Study|Lost to Follow-up|0|||
47057189|NCT03366337|83334960|FG002|Overall Study|Lost to Follow-up|1|||
47057190|NCT03366337|83334961|FG003|Overall Study|Lost to Follow-up|0|||
47057191|NCT03366337|83334958|FG000|Overall Study|Withdrawal by Subject|2|||
47057192|NCT03366337|83334959|FG001|Overall Study|Withdrawal by Subject|0|||
47057193|NCT03366337|83334960|FG002|Overall Study|Withdrawal by Subject|1|||
46760873|NCT00683878|82978929|FG001|Overall Study|Lost to Follow-up|2|||
46760874|NCT00683878|82978930|FG002|Overall Study|Lost to Follow-up|4|||
46760875|NCT00683878|82978928|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
46760876|NCT00683878|82978929|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
46760877|NCT00683878|82978930|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
46760878|NCT00884741|82978941|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
46760879|NCT00884741|82978942|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
46760880|NCT00884741|82978943|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
46760881|NCT00884741|82978944|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
46760882|NCT00884741|82978941|FG000|Step 1 Registration: Tissue Screening|Death|3|||
46760883|NCT00884741|82978942|FG001|Step 1 Registration: Tissue Screening|Death|0|||
46760884|NCT00884741|82978943|FG002|Step 1 Registration: Tissue Screening|Death|0|||
46760885|NCT00884741|82978944|FG003|Step 1 Registration: Tissue Screening|Death|0|||
46760886|NCT00884741|82978941|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
46760887|NCT00884741|82978942|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
46760888|NCT00884741|82978943|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
46760889|NCT00884741|82978944|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
46760890|NCT00884741|82978941|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
46760891|NCT00884741|82978942|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
46760892|NCT00884741|82978943|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
46760893|NCT00884741|82978944|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
46760894|NCT00884741|82978941|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
46760895|NCT00884741|82978942|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
46760896|NCT00884741|82978943|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
46760897|NCT00884741|82978944|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
46760898|NCT00884741|82978941|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
46760899|NCT00884741|82978942|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
46760900|NCT00884741|82978943|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
46760901|NCT00884741|82978944|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
46760902|NCT00884741|82978941|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
46822919|NCT00327015|83042242|FG002|Overall Study|Adverse Event|14|||
46933344|NCT00103311|83169016|FG001|Overall Study|Adverse Event|0|||
46933345|NCT02576938|83169029|FG000|Overall Study|Adverse Event|5|||
46933346|NCT02576938|83169030|FG001|Overall Study|Adverse Event|3|||
46933347|NCT02576938|83169031|FG002|Overall Study|Adverse Event|6|||
46933348|NCT02576938|83169029|FG000|Overall Study|Protocol Violation|1|||
46933349|NCT02576938|83169030|FG001|Overall Study|Protocol Violation|1|||
46933350|NCT02576938|83169031|FG002|Overall Study|Protocol Violation|1|||
47057194|NCT03366337|83334961|FG003|Overall Study|Withdrawal by Subject|1|||
46822920|NCT00327015|83042243|FG003|Overall Study|Adverse Event|14|||
46822921|NCT00327015|83042240|FG000|Overall Study|Subject no longer meets study criteria|4|||
46822922|NCT00327015|83042241|FG001|Overall Study|Subject no longer meets study criteria|2|||
46822923|NCT00327015|83042242|FG002|Overall Study|Subject no longer meets study criteria|8|||
46822924|NCT00327015|83042243|FG003|Overall Study|Subject no longer meets study criteria|7|||
46822925|NCT00327015|83042240|FG000|Overall Study|Poor/Noncompliance|11|||
46822926|NCT00327015|83042241|FG001|Overall Study|Poor/Noncompliance|8|||
46822927|NCT00327015|83042242|FG002|Overall Study|Poor/Noncompliance|4|||
46822928|NCT00327015|83042243|FG003|Overall Study|Poor/Noncompliance|5|||
46822929|NCT00327015|83042240|FG000|Overall Study|Physician Decision|0|||
46822930|NCT00327015|83042241|FG001|Overall Study|Physician Decision|1|||
46822931|NCT00327015|83042242|FG002|Overall Study|Physician Decision|3|||
46822932|NCT00327015|83042243|FG003|Overall Study|Physician Decision|2|||
46822933|NCT00327015|83042240|FG000|Overall Study|Death|1|||
46822934|NCT00327015|83042241|FG001|Overall Study|Death|2|||
46822935|NCT00327015|83042242|FG002|Overall Study|Death|2|||
46822936|NCT00327015|83042243|FG003|Overall Study|Death|3|||
46822937|NCT00327015|83042240|FG000|Overall Study|Pregnancy|0|||
46822938|NCT00327015|83042241|FG001|Overall Study|Pregnancy|2|||
46822939|NCT00327015|83042242|FG002|Overall Study|Pregnancy|1|||
46822940|NCT00327015|83042243|FG003|Overall Study|Pregnancy|1|||
46822941|NCT00327015|83042240|FG000|Overall Study|Administrative Reason by Sponsor|1|||
46822942|NCT00327015|83042241|FG001|Overall Study|Administrative Reason by Sponsor|2|||
46822943|NCT00327015|83042242|FG002|Overall Study|Administrative Reason by Sponsor|2|||
46822944|NCT00327015|83042243|FG003|Overall Study|Administrative Reason by Sponsor|1|||
46822945|NCT00434148|83042255|FG000|Overall Study|Adverse Event|18|||
46822946|NCT00434148|83042256|FG001|Overall Study|Adverse Event|18|||
46822947|NCT00434148|83042255|FG000|Overall Study|Lack of Efficacy|25|||
46822948|NCT00434148|83042256|FG001|Overall Study|Lack of Efficacy|28|||
46822949|NCT00434148|83042255|FG000|Overall Study|Withdrawal by Subject|15|||
46822950|NCT00434148|83042256|FG001|Overall Study|Withdrawal by Subject|15|||
46822951|NCT00434148|83042255|FG000|Overall Study|Protocol Violation|4|||
46822952|NCT00434148|83042256|FG001|Overall Study|Protocol Violation|0|||
46822953|NCT00434148|83042255|FG000|Overall Study|Administrative problems|6|||
46822954|NCT00434148|83042256|FG001|Overall Study|Administrative problems|10|||
46822955|NCT00434148|83042255|FG000|Overall Study|Lost to Follow-up|0|||
46822956|NCT00434148|83042256|FG001|Overall Study|Lost to Follow-up|1|||
46933351|NCT02576938|83169029|FG000|Overall Study|Withdrawal by Subject|3|||
46933352|NCT02576938|83169030|FG001|Overall Study|Withdrawal by Subject|2|||
46822957|NCT00434148|83042255|FG000|Overall Study|Condition no longer requires study drug|1|||
46822958|NCT00434148|83042256|FG001|Overall Study|Condition no longer requires study drug|0|||
46822959|NCT00434148|83042255|FG000|Overall Study|Abnormal test procedure result|0|||
46822960|NCT00434148|83042256|FG001|Overall Study|Abnormal test procedure result|1|||
46822961|NCT00468728|83042264|FG000|Treatment|criteria for mITT population|4|||
47057195|NCT03144674|83334975|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
46933353|NCT02576938|83169031|FG002|Overall Study|Withdrawal by Subject|4|||
46760903|NCT00884741|82978942|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
46760904|NCT00884741|82978943|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
46822962|NCT00468728|83042265|FG001|Treatment|criteria for mITT population|11|||
46822963|NCT00468728|83042264|FG000|Follow-up|mITT failure|34|||
46822964|NCT00468728|83042265|FG001|Follow-up|mITT failure|31|||
46822965|NCT00433914|83042275|FG000|Overall Study|Withdrawal by Subject|0|||
46822966|NCT00433914|83042276|FG001|Overall Study|Withdrawal by Subject|2|||
46822967|NCT00433914|83042275|FG000|Overall Study|Lost to Follow-up|0|||
46822968|NCT00433914|83042276|FG001|Overall Study|Lost to Follow-up|1|||
46933354|NCT02576938|83169029|FG000|Overall Study|Lack of Efficacy|9|||
46933355|NCT02576938|83169030|FG001|Overall Study|Lack of Efficacy|4|||
47057196|NCT03144674|83334976|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
46760905|NCT00884741|82978944|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
46760906|NCT00884741|82978941|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
46760907|NCT00884741|82978942|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
46760908|NCT00884741|82978943|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
46760909|NCT00884741|82978944|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
46760910|NCT00884741|82978941|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
46822969|NCT00468650|83042282|FG000|Overall Study|Lost to Follow-up|4|||
46760911|NCT00884741|82978942|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
46822970|NCT00468650|83042282|FG000|Overall Study|Withdrawal by Subject|2|||
46933356|NCT02576938|83169031|FG002|Overall Study|Lack of Efficacy|0|||
46933357|NCT02576938|83169029|FG000|Overall Study|Lost to Follow-up|2|||
46636973|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
46822971|NCT00468650|83042282|FG000|Overall Study|Protocol Violation|1|||
46822972|NCT00423150|83042287|FG000|Overall Study|Adverse Event|11|||
46822973|NCT00423150|83042287|FG000|Overall Study|Progression of disease being studied|69|||
46822974|NCT00423150|83042287|FG000|Overall Study|Withdrawal by Subject|1|||
46822975|NCT00423150|83042287|FG000|Overall Study|Non-compliance with protocol|1|||
46822976|NCT00423150|83042287|FG000|Overall Study|Administrative|4|||
46822977|NCT00433836|83042293|FG000|Overall Study|Adverse Event|7|||
46933358|NCT02576938|83169030|FG001|Overall Study|Lost to Follow-up|0|||
46933359|NCT02576938|83169031|FG002|Overall Study|Lost to Follow-up|1|||
46933360|NCT02576938|83169029|FG000|Overall Study|Physician Decision|0|||
46933361|NCT02576938|83169030|FG001|Overall Study|Physician Decision|1|||
46760912|NCT00884741|82978943|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
46760913|NCT00884741|82978944|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
46760914|NCT00884741|82978941|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
46760915|NCT00884741|82978942|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
46760916|NCT00884741|82978943|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
46760917|NCT00884741|82978944|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
46760918|NCT00884741|82978941|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
46760919|NCT00884741|82978942|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
46760920|NCT00884741|82978943|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
46760921|NCT00884741|82978944|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
46760922|NCT00884741|82978941|FG000|Randomization|Protocol Violation|0|||
46760923|NCT00884741|82978942|FG001|Randomization|Protocol Violation|0|||
46760924|NCT00884741|82978943|FG002|Randomization|Protocol Violation|8|||
46760925|NCT00884741|82978944|FG003|Randomization|Protocol Violation|8|||
46760926|NCT00880763|82978955|FG000|Extension Period (Part 2)|Adverse Event|0|||
46760927|NCT00880763|82978956|FG001|Extension Period (Part 2)|Adverse Event|0|||
46760928|NCT00880763|82978957|FG002|Extension Period (Part 2)|Adverse Event|1|||
46760929|NCT00880763|82978958|FG003|Extension Period (Part 2)|Adverse Event|1|||
46760930|NCT00880763|82978955|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
46760931|NCT00880763|82978956|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
46760932|NCT00880763|82978957|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
46760933|NCT00880763|82978958|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
46760934|NCT00880763|82978955|FG000|Extension Period (Part 2)|Physician Decision|0|||
46760935|NCT00880763|82978956|FG001|Extension Period (Part 2)|Physician Decision|1|||
46760936|NCT00880763|82978957|FG002|Extension Period (Part 2)|Physician Decision|1|||
46760937|NCT00880763|82978958|FG003|Extension Period (Part 2)|Physician Decision|0|||
46760938|NCT00880763|82978955|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
46760939|NCT00880763|82978956|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
46760940|NCT00880763|82978957|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
46760941|NCT00880763|82978958|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
46760942|NCT00884273|82978970|FG000|Overall Study|Adverse Event|0|||
46760943|NCT00884273|82978971|FG001|Overall Study|Adverse Event|2|||
46760944|NCT00884273|82978970|FG000|Overall Study|Protocol Violation|1|||
46760945|NCT00884273|82978971|FG001|Overall Study|Protocol Violation|3|||
46760946|NCT00884273|82978970|FG000|Overall Study|Practical reasons|1|||
46760947|NCT00884273|82978971|FG001|Overall Study|Practical reasons|0|||
46760948|NCT00884117|82978977|FG000|Overall Study|Adverse Event|2|||
46760949|NCT00884117|82978977|FG000|Overall Study|Withdrawal by Subject|89|||
46760950|NCT00884117|82978977|FG000|Overall Study|Death|3|||
46760951|NCT00884117|82978977|FG000|Overall Study|Lost to Follow-up|143|||
46760952|NCT00884117|82978977|FG000|Overall Study|Other|12|||
46760953|NCT00884039|82978996|FG000|Overall Study|Withdrawal by Subject|0|||
46760954|NCT00884039|82978997|FG001|Overall Study|Withdrawal by Subject|1|||
46760955|NCT00884039|82978996|FG000|Overall Study|Lack of Efficacy|2|||
46760956|NCT00884039|82978997|FG001|Overall Study|Lack of Efficacy|0|||
46760957|NCT00835770|82979005|FG000|Overall Study|MS Relapse|17|||
46760958|NCT00835770|82979006|FG001|Overall Study|MS Relapse|23|||
46760959|NCT00835770|82979005|FG000|Overall Study|MS Progression|14|||
46760960|NCT00835770|82979006|FG001|Overall Study|MS Progression|9|||
46760961|NCT00835770|82979005|FG000|Overall Study|Adverse Event|113|||
46760962|NCT00835770|82979006|FG001|Overall Study|Adverse Event|124|||
46760963|NCT00835770|82979005|FG000|Overall Study|Lost to Follow-up|22|||
46760964|NCT00835770|82979006|FG001|Overall Study|Lost to Follow-up|19|||
46760965|NCT00835770|82979005|FG000|Overall Study|Consent Withdrawn|144|||
46760966|NCT00835770|82979006|FG001|Overall Study|Consent Withdrawn|156|||
46760967|NCT00835770|82979005|FG000|Overall Study|Investigator Decision|42|||
46822978|NCT00433836|83042294|FG001|Overall Study|Adverse Event|0|||
46933362|NCT02576938|83169031|FG002|Overall Study|Physician Decision|0|||
46760968|NCT00835770|82979006|FG001|Overall Study|Investigator Decision|42|||
46760969|NCT00835770|82979005|FG000|Overall Study|Participant Non-Compliance|11|||
46760970|NCT00835770|82979006|FG001|Overall Study|Participant Non-Compliance|9|||
46760971|NCT00835770|82979005|FG000|Overall Study|Death|4|||
46760972|NCT00835770|82979006|FG001|Overall Study|Death|6|||
46760973|NCT00835770|82979005|FG000|Overall Study|Other|115|||
46760974|NCT00835770|82979006|FG001|Overall Study|Other|104|||
46933363|NCT02576938|83169029|FG000|Overall Study|Met Exclusion Criteria|0|||
46760975|NCT00835770|82979005|FG000|Overall Study|Other|2|||
46760976|NCT00835770|82979006|FG001|Overall Study|Other|1|||
46760977|NCT00880685|82979018|FG000|Memantine 10mg|Lost to Follow-up|2|||
46933364|NCT02576938|83169030|FG001|Overall Study|Met Exclusion Criteria|1|||
46822979|NCT00433836|83042293|FG000|Overall Study|Lost to Follow-up|3|||
46822980|NCT00433836|83042294|FG001|Overall Study|Lost to Follow-up|0|||
46822981|NCT00433836|83042293|FG000|Overall Study|Withdrawal by Subject|2|||
46822982|NCT00433836|83042294|FG001|Overall Study|Withdrawal by Subject|1|||
46822983|NCT00433836|83042293|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46822984|NCT00433836|83042294|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46822985|NCT00433836|83042293|FG000|Overall Study|Protocol Violation|0|||
46822986|NCT00433836|83042294|FG001|Overall Study|Protocol Violation|2|||
46822987|NCT00433836|83042293|FG000|Overall Study|Condition no longer requires study drug|0|||
46822988|NCT00433836|83042294|FG001|Overall Study|Condition no longer requires study drug|1|||
46822989|NCT00433836|83042293|FG000|Overall Study|Abnormal laboratory values|0|||
46822990|NCT00433836|83042294|FG001|Overall Study|Abnormal laboratory values|1|||
46822991|NCT00433446|83042300|FG000|Overall Study|Adverse Event|4|||
46822992|NCT00433446|83042300|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
46822993|NCT00433446|83042300|FG000|Overall Study|Progression|44|||
46822994|NCT00433446|83042300|FG000|Overall Study|Other - Not Protocol specified|3|||
46822995|NCT00433446|83042300|FG000|Overall Study|Ineligible|9|||
46822996|NCT00468104|83042304|FG000|First Intervention|Protocol Violation|2|||
46822997|NCT00468104|83042305|FG001|First Intervention|Protocol Violation|1|||
46822998|NCT00468104|83042304|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
46822999|NCT00468104|83042305|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
46823000|NCT00468104|83042304|FG000|First Intervention|died within 3 weeks|1|||
46823001|NCT00468104|83042305|FG001|First Intervention|died within 3 weeks|0|||
46823002|NCT00468104|83042304|FG000|First Intervention|malposition/blocked chest tube tube|2|||
46823003|NCT00468104|83042305|FG001|First Intervention|malposition/blocked chest tube tube|0|||
46823004|NCT00468104|83042304|FG000|First Intervention|large lung mass with minimal effusion|1|||
46823005|NCT00468104|83042305|FG001|First Intervention|large lung mass with minimal effusion|0|||
46823006|NCT00468104|83042304|FG000|First Intervention|associated prolonged pneumothorax|1|||
46823007|NCT00468104|83042305|FG001|First Intervention|associated prolonged pneumothorax|0|||
46823008|NCT00468104|83042304|FG000|First Intervention|trapped lung|1|||
46823009|NCT00468104|83042305|FG001|First Intervention|trapped lung|0|||
46823010|NCT00468104|83042304|FG000|Second Intervention|Withdrawal by Subject|5|||
46823011|NCT00468104|83042305|FG001|Second Intervention|Withdrawal by Subject|2|||
46823012|NCT00468104|83042304|FG000|Second Intervention|discarded for malposition of chest tube|0|||
46823013|NCT00468104|83042305|FG001|Second Intervention|discarded for malposition of chest tube|2|||
46823014|NCT00326625|83042316|FG000|Overall Study|Adverse Event|20|||
46823015|NCT00326625|83042317|FG001|Overall Study|Adverse Event|9|||
46823016|NCT00326625|83042316|FG000|Overall Study|Withdrawal by Subject|15|||
46823017|NCT00326625|83042317|FG001|Overall Study|Withdrawal by Subject|12|||
46823018|NCT00326625|83042316|FG000|Overall Study|Death|18|||
46823019|NCT00326625|83042317|FG001|Overall Study|Death|16|||
46823020|NCT00326625|83042316|FG000|Overall Study|Lost to Follow-up|1|||
46823021|NCT00326625|83042317|FG001|Overall Study|Lost to Follow-up|0|||
46823022|NCT00326625|83042316|FG000|Overall Study|prescheduled medical intervention|0|||
46823023|NCT00326625|83042317|FG001|Overall Study|prescheduled medical intervention|1|||
46823024|NCT00433290|83042325|FG000|Overall Study|Adverse Event|24|||
46823025|NCT00433290|83042326|FG001|Overall Study|Adverse Event|7|||
46823026|NCT00433290|83042325|FG000|Overall Study|Lack of Efficacy|1|||
46823027|NCT00433290|83042326|FG001|Overall Study|Lack of Efficacy|5|||
46823028|NCT00433290|83042325|FG000|Overall Study|Withdrawal by Subject|4|||
46823029|NCT00433290|83042326|FG001|Overall Study|Withdrawal by Subject|2|||
46823030|NCT00433290|83042325|FG000|Overall Study|Protocol Violation|3|||
46823031|NCT00433290|83042326|FG001|Overall Study|Protocol Violation|2|||
46823032|NCT00433290|83042325|FG000|Overall Study|Physician Decision|2|||
46823033|NCT00433290|83042326|FG001|Overall Study|Physician Decision|0|||
46823034|NCT00433290|83042325|FG000|Overall Study|Entry Criteria Not Met|0|||
46823035|NCT00433290|83042326|FG001|Overall Study|Entry Criteria Not Met|1|||
46823036|NCT00433290|83042325|FG000|Overall Study|Lost to Follow-up|1|||
46823037|NCT00433290|83042326|FG001|Overall Study|Lost to Follow-up|0|||
46823038|NCT00467870|83042338|FG000|Overall Study|Adverse Event|13|||
46823039|NCT00467870|83042339|FG001|Overall Study|Adverse Event|9|||
46760978|NCT00880685|82979018|FG000|Memantine 20mg|Withdrawal by Subject|1|||
46760979|NCT00835380|82979025|FG000|Overall Study|Withdrawal by Subject|2|||
46760980|NCT00880607|82979031|FG000|Overall Study|Physician Decision|2|||
46760981|NCT00880607|82979032|FG001|Overall Study|Physician Decision|2|||
46760982|NCT00880607|82979031|FG000|Overall Study|Protocol Violation|2|||
46760983|NCT00880607|82979032|FG001|Overall Study|Protocol Violation|1|||
46760984|NCT00880607|82979031|FG000|Overall Study|surgery did not extend past L1 level|3|||
46760985|NCT00880607|82979032|FG001|Overall Study|surgery did not extend past L1 level|0|||
46760986|NCT00835068|82979042|FG000|Overall Study|Death|1|||
46823040|NCT00467870|83042340|FG002|Overall Study|Adverse Event|1|||
46823041|NCT00467870|83042341|FG003|Overall Study|Adverse Event|15|||
46760987|NCT00835068|82979043|FG001|Overall Study|Death|0|||
46823042|NCT00467870|83042342|FG004|Overall Study|Adverse Event|15|||
46823043|NCT00467870|83042343|FG005|Overall Study|Adverse Event|1|||
46823044|NCT00467870|83042338|FG000|Overall Study|Protocol Violation|2|||
46823045|NCT00467870|83042339|FG001|Overall Study|Protocol Violation|1|||
46823046|NCT00467870|83042340|FG002|Overall Study|Protocol Violation|1|||
46823047|NCT00467870|83042341|FG003|Overall Study|Protocol Violation|2|||
46823048|NCT00467870|83042342|FG004|Overall Study|Protocol Violation|0|||
46823049|NCT00467870|83042343|FG005|Overall Study|Protocol Violation|0|||
46823050|NCT00467870|83042338|FG000|Overall Study|Withdrawal by Subject|14|||
46823051|NCT00467870|83042339|FG001|Overall Study|Withdrawal by Subject|21|||
46823052|NCT00467870|83042340|FG002|Overall Study|Withdrawal by Subject|0|||
46823053|NCT00467870|83042341|FG003|Overall Study|Withdrawal by Subject|9|||
46823054|NCT00467870|83042342|FG004|Overall Study|Withdrawal by Subject|10|||
46823055|NCT00467870|83042343|FG005|Overall Study|Withdrawal by Subject|1|||
46823056|NCT00467870|83042338|FG000|Overall Study|Lost to Follow-up|5|||
46823057|NCT00467870|83042339|FG001|Overall Study|Lost to Follow-up|3|||
46823058|NCT00467870|83042340|FG002|Overall Study|Lost to Follow-up|1|||
46823059|NCT00467870|83042341|FG003|Overall Study|Lost to Follow-up|1|||
46823060|NCT00467870|83042342|FG004|Overall Study|Lost to Follow-up|3|||
46823061|NCT00467870|83042343|FG005|Overall Study|Lost to Follow-up|0|||
46823062|NCT00467870|83042338|FG000|Overall Study|Subject Non-compliance|3|||
46823063|NCT00467870|83042339|FG001|Overall Study|Subject Non-compliance|4|||
46823064|NCT00467870|83042340|FG002|Overall Study|Subject Non-compliance|0|||
46823065|NCT00467870|83042341|FG003|Overall Study|Subject Non-compliance|1|||
46823066|NCT00467870|83042342|FG004|Overall Study|Subject Non-compliance|5|||
46823067|NCT00467870|83042343|FG005|Overall Study|Subject Non-compliance|0|||
46823068|NCT00467870|83042338|FG000|Overall Study|Other/Unknown|8|||
46823069|NCT00467870|83042339|FG001|Overall Study|Other/Unknown|5|||
46760988|NCT00835068|82979042|FG000|Overall Study|Adverse Event|0|||
46760989|NCT00835068|82979043|FG001|Overall Study|Adverse Event|1|||
46760990|NCT00835068|82979042|FG000|Overall Study|Other|8|||
46760991|NCT00835068|82979043|FG001|Overall Study|Other|0|||
46760992|NCT00835068|82979042|FG000|Overall Study|Withdrawal by Subject|1|||
46760993|NCT00835068|82979043|FG001|Overall Study|Withdrawal by Subject|0|||
46760994|NCT00834912|82979055|FG000|Treatment Period 1|Adverse Event|0|||
46760995|NCT00834912|82979056|FG001|Treatment Period 1|Adverse Event|1|||
46760996|NCT00834912|82979057|FG002|Treatment Period 1|Adverse Event|0|||
46760997|NCT00834912|82979058|FG003|Treatment Period 1|Adverse Event|1|||
46760998|NCT00834912|82979059|FG004|Treatment Period 1|Adverse Event|0|||
46760999|NCT00834912|82979060|FG005|Treatment Period 1|Adverse Event|0|||
46761000|NCT00834912|82979055|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46761001|NCT00834912|82979056|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46761002|NCT00834912|82979057|FG002|Treatment Period 2|Withdrawal by Subject|1|||
46761003|NCT00834912|82979058|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46761004|NCT00834912|82979059|FG004|Treatment Period 2|Withdrawal by Subject|1|||
46761005|NCT00834912|82979060|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46823070|NCT00467870|83042340|FG002|Overall Study|Other/Unknown|1|||
46823071|NCT00467870|83042341|FG003|Overall Study|Other/Unknown|5|||
46823072|NCT00467870|83042342|FG004|Overall Study|Other/Unknown|4|||
46823073|NCT00467870|83042343|FG005|Overall Study|Other/Unknown|0|||
47057197|NCT03144674|83334977|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
47057198|NCT03144674|83334978|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
47057199|NCT03144674|83334975|FG000|Overall Study|Death|3|||
47057200|NCT03144674|83334976|FG001|Overall Study|Death|1|||
47057201|NCT03144674|83334977|FG002|Overall Study|Death|1|||
47057202|NCT03144674|83334978|FG003|Overall Study|Death|10|||
47057203|NCT03144674|83334975|FG000|Overall Study|Lost to Follow-up|0|||
47057204|NCT03144674|83334976|FG001|Overall Study|Lost to Follow-up|1|||
47057205|NCT03144674|83334977|FG002|Overall Study|Lost to Follow-up|1|||
47057206|NCT03144674|83334978|FG003|Overall Study|Lost to Follow-up|1|||
47057207|NCT03144674|83334975|FG000|Overall Study|Withdrawal by Participant|0|||
46761006|NCT00883493|82979070|FG000|Overall Study|Adverse Event|11|||
46823074|NCT00467558|83042355|FG000|Overall Study|Lost to Follow-up|2|||
46823075|NCT00467558|83042356|FG001|Overall Study|Lost to Follow-up|0|||
46823076|NCT00422292|83042366|FG000|Overall Study|Serious adverse events|1|||
46823077|NCT00422292|83042367|FG001|Overall Study|Serious adverse events|4|||
46823078|NCT00422292|83042368|FG002|Overall Study|Serious adverse events|0|||
46823079|NCT00422292|83042369|FG003|Overall Study|Serious adverse events|0|||
46823080|NCT00422292|83042366|FG000|Overall Study|Adverse Event|1|||
46823081|NCT00422292|83042367|FG001|Overall Study|Adverse Event|0|||
46823082|NCT00422292|83042368|FG002|Overall Study|Adverse Event|1|||
46823083|NCT00422292|83042369|FG003|Overall Study|Adverse Event|0|||
46823084|NCT00422292|83042366|FG000|Overall Study|Protocol Violation|4|||
46823085|NCT00422292|83042367|FG001|Overall Study|Protocol Violation|25|||
46823086|NCT00422292|83042368|FG002|Overall Study|Protocol Violation|8|||
46823087|NCT00422292|83042369|FG003|Overall Study|Protocol Violation|5|||
46823088|NCT00422292|83042366|FG000|Overall Study|Lost to Follow-up|6|||
46823089|NCT00422292|83042367|FG001|Overall Study|Lost to Follow-up|12|||
46823090|NCT00422292|83042368|FG002|Overall Study|Lost to Follow-up|6|||
46823091|NCT00422292|83042369|FG003|Overall Study|Lost to Follow-up|6|||
46823092|NCT00422292|83042366|FG000|Overall Study|Withdrawal by Subject|6|||
46823093|NCT00422292|83042367|FG001|Overall Study|Withdrawal by Subject|25|||
46823094|NCT00422292|83042368|FG002|Overall Study|Withdrawal by Subject|7|||
46823095|NCT00422292|83042369|FG003|Overall Study|Withdrawal by Subject|13|||
46823096|NCT00452348|83042381|FG000|Overall Study|Adverse Event|6|||
46823097|NCT00452348|83042382|FG001|Overall Study|Adverse Event|9|||
46823098|NCT00452348|83042381|FG000|Overall Study|Lack of Efficacy|10|||
46823099|NCT00452348|83042382|FG001|Overall Study|Lack of Efficacy|9|||
46823100|NCT00452348|83042381|FG000|Overall Study|Lost to Follow-up|14|||
46823101|NCT00452348|83042382|FG001|Overall Study|Lost to Follow-up|8|||
46823102|NCT00452348|83042381|FG000|Overall Study|Protocol Violation|22|||
46823103|NCT00452348|83042382|FG001|Overall Study|Protocol Violation|28|||
46823104|NCT00452348|83042381|FG000|Overall Study|Withdrawal by Subject|18|||
46823105|NCT00452348|83042382|FG001|Overall Study|Withdrawal by Subject|21|||
46823106|NCT00452348|83042381|FG000|Overall Study|Other|9|||
46823107|NCT00452348|83042382|FG001|Overall Study|Other|9|||
46823108|NCT00452114|83042390|FG000|Overall Study|Physician Decision|3|||
46823109|NCT00452114|83042391|FG001|Overall Study|Physician Decision|3|||
46823110|NCT00320541|83042399|FG000|Overall Study|Adverse Event|21|||
46823111|NCT00320541|83042400|FG001|Overall Study|Adverse Event|19|||
46823112|NCT00320541|83042399|FG000|Overall Study|Protocol Violation|0|||
46823113|NCT00320541|83042400|FG001|Overall Study|Protocol Violation|1|||
46823114|NCT00320541|83042399|FG000|Overall Study|Withdrawal by Subject|12|||
46823115|NCT00320541|83042400|FG001|Overall Study|Withdrawal by Subject|16|||
46823116|NCT00320541|83042399|FG000|Overall Study|Physician Decision|9|||
46823117|NCT00320541|83042400|FG001|Overall Study|Physician Decision|13|||
46823118|NCT00320541|83042399|FG000|Overall Study|Other|3|||
46823119|NCT00320541|83042400|FG001|Overall Study|Other|4|||
46823120|NCT00320541|83042399|FG000|Overall Study|Sponsor Decision|2|||
46823121|NCT00320541|83042400|FG001|Overall Study|Sponsor Decision|1|||
46823122|NCT00320541|83042399|FG000|Overall Study|Death due to Study Disease|1|||
46823123|NCT00320541|83042400|FG001|Overall Study|Death due to Study Disease|3|||
46823124|NCT00320541|83042399|FG000|Overall Study|Death due to Adverse Event(s)|1|||
46823125|NCT00320541|83042400|FG001|Overall Study|Death due to Adverse Event(s)|0|||
46823126|NCT00320541|83042399|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
46823127|NCT00320541|83042400|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
46823128|NCT00320385|83042408|FG000|Overall Study|Lost to Follow-up|7|||
46823129|NCT00320385|83042409|FG001|Overall Study|Lost to Follow-up|10|||
46823130|NCT00320385|83042408|FG000|Overall Study|Withdrawal by Subject|6|||
46823131|NCT00320385|83042409|FG001|Overall Study|Withdrawal by Subject|7|||
46823132|NCT00320385|83042408|FG000|Overall Study|Sponsor Terminated Study|2|||
46823133|NCT00320385|83042409|FG001|Overall Study|Sponsor Terminated Study|1|||
46823134|NCT00320385|83042408|FG000|Overall Study|Investigator Decision|0|||
46823135|NCT00320385|83042409|FG001|Overall Study|Investigator Decision|1|||
46823136|NCT00320385|83042408|FG000|Overall Study|Death|1|||
46823137|NCT00320385|83042409|FG001|Overall Study|Death|2|||
46933365|NCT02576938|83169031|FG002|Overall Study|Met Exclusion Criteria|0|||
46933366|NCT02576860|83169043|FG000|Overall Study|Adverse Event|6|||
46823138|NCT00320385|83042408|FG000|Overall Study|Serious Adverse Event|1|||
46823139|NCT00320385|83042409|FG001|Overall Study|Serious Adverse Event|0|||
46823140|NCT00320385|83042408|FG000|Overall Study|Withdrew Consent|1|||
46823141|NCT00320385|83042409|FG001|Overall Study|Withdrew Consent|0|||
46823142|NCT00320385|83042408|FG000|Overall Study|Adverse Event|0|||
46823143|NCT00320385|83042409|FG001|Overall Study|Adverse Event|1|||
46823144|NCT00326001|83042417|FG000|Overall Study|Adverse Event|4|||
46823145|NCT00326001|83042418|FG001|Overall Study|Adverse Event|5|||
46823146|NCT00326001|83042417|FG000|Overall Study|Physician Decision|3|||
46823147|NCT00326001|83042418|FG001|Overall Study|Physician Decision|3|||
46823148|NCT00309777|83042428|FG000|Overall Study|Adverse Event|13|||
46823149|NCT00309777|83042429|FG001|Overall Study|Adverse Event|2|||
46823150|NCT00309777|83042430|FG002|Overall Study|Adverse Event|8|||
46823151|NCT00309777|83042431|FG003|Overall Study|Adverse Event|1|||
46823152|NCT00309777|83042428|FG000|Overall Study|Protocol Violation|4|||
46823153|NCT00309777|83042429|FG001|Overall Study|Protocol Violation|1|||
46761007|NCT00883493|82979071|FG001|Overall Study|Adverse Event|12|||
46761008|NCT00883493|82979070|FG000|Overall Study|Lack of Efficacy|4|||
46761009|NCT00883493|82979071|FG001|Overall Study|Lack of Efficacy|3|||
46761010|NCT00883493|82979070|FG000|Overall Study|Lost to Follow-up|7|||
46761011|NCT00883493|82979071|FG001|Overall Study|Lost to Follow-up|6|||
46761012|NCT00883493|82979070|FG000|Overall Study|Withdrawal by Subject|11|||
46761013|NCT00883493|82979071|FG001|Overall Study|Withdrawal by Subject|20|||
46761014|NCT00883493|82979070|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
46761015|NCT00883493|82979071|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
46761016|NCT00883493|82979070|FG000|Overall Study|Study specific disc. criteria|2|||
46761017|NCT00883493|82979071|FG001|Overall Study|Study specific disc. criteria|0|||
46761018|NCT00883493|82979070|FG000|Overall Study|Other|5|||
46761019|NCT00883493|82979071|FG001|Overall Study|Other|3|||
46761020|NCT04887922|82979086|FG000|1st Randomization|Decided not to have surgery|0|||
46761021|NCT04887922|82979087|FG001|1st Randomization|Decided not to have surgery|1|||
46761022|NCT04887922|82979088|FG002|1st Randomization|Decided not to have surgery|0|||
46761023|NCT04887922|82979089|FG003|1st Randomization|Decided not to have surgery|0|||
46761024|NCT04887922|82979090|FG004|1st Randomization|Decided not to have surgery|0|||
46761025|NCT04771403|82979113|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
46761026|NCT04771403|82979114|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
46761027|NCT04771403|82979113|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
46761028|NCT04771403|82979114|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
46761029|NCT04771403|82979113|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
46761030|NCT04771403|82979114|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
46761031|NCT04771403|82979113|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
46761032|NCT04771403|82979114|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
46761033|NCT04771403|82979113|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
46761034|NCT04771403|82979114|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
46761035|NCT04771403|82979113|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
46761036|NCT04771403|82979114|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
46761037|NCT04771403|82979113|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
46761038|NCT04771403|82979114|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
46761039|NCT04771403|82979113|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
46761040|NCT04771403|82979114|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
46761041|NCT04698525|82979123|FG000|Overall Study|Lost to Follow-up|1|||
46761042|NCT04698525|82979124|FG001|Overall Study|Lost to Follow-up|2|||
46761043|NCT04698525|82979123|FG000|Overall Study|Three suffered of Covid-19|2|||
46761044|NCT04698525|82979124|FG001|Overall Study|Three suffered of Covid-19|1|||
46761045|NCT04510675|82979138|FG000|Overall Study|Withdrawal by Subject|5|||
46761046|NCT04228783|82979160|FG000|Overall Study|Adverse Event|1|||
46761047|NCT04228783|82979161|FG001|Overall Study|Adverse Event|0|||
46761048|NCT04228783|82979162|FG002|Overall Study|Adverse Event|2|||
46761049|NCT04228783|82979163|FG003|Overall Study|Adverse Event|0|||
46761050|NCT04228783|82979164|FG004|Overall Study|Adverse Event|0|||
46761051|NCT04228783|82979165|FG005|Overall Study|Adverse Event|1|||
46761052|NCT04228783|82979160|FG000|Overall Study|Death|0|||
46761053|NCT04228783|82979161|FG001|Overall Study|Death|0|||
46761054|NCT04228783|82979162|FG002|Overall Study|Death|0|||
46761055|NCT04228783|82979163|FG003|Overall Study|Death|0|||
46761056|NCT04228783|82979164|FG004|Overall Study|Death|1|||
46761057|NCT04228783|82979165|FG005|Overall Study|Death|0|||
46823154|NCT00309777|83042430|FG002|Overall Study|Protocol Violation|3|||
46823155|NCT00309777|83042431|FG003|Overall Study|Protocol Violation|1|||
46823156|NCT00309777|83042428|FG000|Overall Study|Withdrawal by Subject|6|||
46933367|NCT02576860|83169044|FG001|Overall Study|Adverse Event|6|||
47057208|NCT03144674|83334976|FG001|Overall Study|Withdrawal by Participant|0|||
47057209|NCT03144674|83334977|FG002|Overall Study|Withdrawal by Participant|0|||
47057210|NCT03144674|83334978|FG003|Overall Study|Withdrawal by Participant|3|||
47057211|NCT03144674|83334975|FG000|Overall Study|Reason not Specified|0|||
47057212|NCT03144674|83334976|FG001|Overall Study|Reason not Specified|0|||
47057213|NCT03144674|83334977|FG002|Overall Study|Reason not Specified|2|||
47057214|NCT03144674|83334978|FG003|Overall Study|Reason not Specified|4|||
47057215|NCT02887859|83334993|FG000|Overall Study|Ongoing|6|||
47057216|NCT02887859|83334993|FG000|Overall Study|Adverse Event|7|||
47057217|NCT02887859|83334993|FG000|Overall Study|Death|1|||
47057218|NCT02887859|83334993|FG000|Overall Study|Physician Decision|1|||
46823157|NCT00309777|83042429|FG001|Overall Study|Withdrawal by Subject|5|||
46823158|NCT00309777|83042430|FG002|Overall Study|Withdrawal by Subject|7|||
46823159|NCT00309777|83042431|FG003|Overall Study|Withdrawal by Subject|2|||
46823160|NCT00309777|83042428|FG000|Overall Study|Lost to Follow-up|0|||
46823161|NCT00309777|83042429|FG001|Overall Study|Lost to Follow-up|0|||
46823162|NCT00309777|83042430|FG002|Overall Study|Lost to Follow-up|1|||
46823163|NCT00309777|83042431|FG003|Overall Study|Lost to Follow-up|0|||
46823164|NCT00309777|83042428|FG000|Overall Study|Death|0|||
46823165|NCT00309777|83042429|FG001|Overall Study|Death|1|||
46823166|NCT00309777|83042430|FG002|Overall Study|Death|0|||
46823167|NCT00309777|83042431|FG003|Overall Study|Death|0|||
46823168|NCT00309387|83042443|FG000|Overall Study|Death|72|||
46823169|NCT00309387|83042444|FG001|Overall Study|Death|73|||
46823170|NCT00309387|83042443|FG000|Overall Study|Lost to Follow-up|70|||
46823171|NCT00309387|83042444|FG001|Overall Study|Lost to Follow-up|86|||
46823172|NCT00325143|83042451|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
46823173|NCT00325143|83042451|FG000|Overall Study|Migrated/moved from study area|1|||
46823174|NCT00325143|83042451|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
46823175|NCT00325143|83042451|FG000|Overall Study|Withdrawal by Subject|8|||
46823176|NCT00319839|83042455|FG000|Overall Study|Adverse Event|5|||
47057219|NCT02789345|83335000|FG000|Overall Study|Adverse Event|0|||
47057220|NCT02789345|83335001|FG001|Overall Study|Adverse Event|0|||
46761058|NCT04228783|82979160|FG000|Overall Study|Lost to Follow-up|36|||
46761059|NCT04228783|82979161|FG001|Overall Study|Lost to Follow-up|36|||
46761060|NCT04228783|82979162|FG002|Overall Study|Lost to Follow-up|28|||
46761061|NCT04228783|82979163|FG003|Overall Study|Lost to Follow-up|6|||
46761062|NCT04228783|82979164|FG004|Overall Study|Lost to Follow-up|14|||
46761063|NCT04228783|82979165|FG005|Overall Study|Lost to Follow-up|3|||
46761064|NCT04228783|82979160|FG000|Overall Study|Physician Decision|1|||
46761065|NCT04228783|82979161|FG001|Overall Study|Physician Decision|2|||
46761066|NCT04228783|82979162|FG002|Overall Study|Physician Decision|0|||
46761067|NCT04228783|82979163|FG003|Overall Study|Physician Decision|0|||
46761068|NCT04228783|82979164|FG004|Overall Study|Physician Decision|0|||
46761069|NCT04228783|82979165|FG005|Overall Study|Physician Decision|0|||
46761070|NCT04228783|82979160|FG000|Overall Study|Protocol Violation|0|||
46761071|NCT04228783|82979161|FG001|Overall Study|Protocol Violation|0|||
46761072|NCT04228783|82979162|FG002|Overall Study|Protocol Violation|0|||
46761073|NCT04228783|82979163|FG003|Overall Study|Protocol Violation|1|||
46761074|NCT04228783|82979164|FG004|Overall Study|Protocol Violation|0|||
46761075|NCT04228783|82979165|FG005|Overall Study|Protocol Violation|0|||
46761076|NCT04228783|82979160|FG000|Overall Study|Withdrawal by Subject|6|||
46761077|NCT04228783|82979161|FG001|Overall Study|Withdrawal by Subject|10|||
46636974|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46636975|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46636976|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46636977|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46636978|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46636979|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46761078|NCT04228783|82979162|FG002|Overall Study|Withdrawal by Subject|19|||
46823177|NCT00319839|83042455|FG000|Overall Study|Withdrawal by Subject|1|||
46823178|NCT00319449|83042461|FG000|Overall Study|Subject did not wish to continue|1|||
46823179|NCT00319449|83042462|FG001|Overall Study|Subject did not wish to continue|0|||
46823180|NCT00319449|83042461|FG000|Overall Study|Noncompliance with the protocol|1|||
46823181|NCT00319449|83042462|FG001|Overall Study|Noncompliance with the protocol|0|||
46823182|NCT00308997|83042470|FG000|Overall Study|Subject feigned clinical data|0|||
46823183|NCT00308997|83042471|FG001|Overall Study|Subject feigned clinical data|1|||
46823184|NCT00308997|83042470|FG000|Overall Study|Unable to tolerate intervention|1|||
46823185|NCT00308997|83042471|FG001|Overall Study|Unable to tolerate intervention|0|||
46823186|NCT00308685|83042479|FG000|Overall Study|Lost to Follow-up|1|||
46823187|NCT00308685|83042480|FG001|Overall Study|Lost to Follow-up|0|||
46823188|NCT00308685|83042479|FG000|Overall Study|Need to administer prohibited medication|1|||
46761079|NCT04228783|82979163|FG003|Overall Study|Withdrawal by Subject|1|||
46761080|NCT04228783|82979164|FG004|Overall Study|Withdrawal by Subject|2|||
46823189|NCT00308685|83042480|FG001|Overall Study|Need to administer prohibited medication|2|||
46823190|NCT00308685|83042479|FG000|Overall Study|Other than specified|1|||
46823191|NCT00308685|83042480|FG001|Overall Study|Other than specified|3|||
47057221|NCT02789345|83335002|FG002|Overall Study|Adverse Event|1|||
46761081|NCT04228783|82979165|FG005|Overall Study|Withdrawal by Subject|0|||
46761082|NCT04228783|82979160|FG000|Overall Study|Other|4|||
46823192|NCT00317109|83042488|FG000|Overall Study|Withdrawal by Subject|2|||
46823193|NCT00317109|83042489|FG001|Overall Study|Withdrawal by Subject|0|||
46823194|NCT00317109|83042488|FG000|Overall Study|Migated/moved from study area|1|||
46761083|NCT04228783|82979161|FG001|Overall Study|Other|3|||
46761084|NCT04228783|82979162|FG002|Overall Study|Other|2|||
46761085|NCT04228783|82979163|FG003|Overall Study|Other|1|||
46823195|NCT00317109|83042489|FG001|Overall Study|Migated/moved from study area|0|||
46823196|NCT00316719|83042497|FG000|Overall Study|Adverse Event|0|||
46823197|NCT00316719|83042498|FG001|Overall Study|Adverse Event|6|||
46823198|NCT00316719|83042497|FG000|Overall Study|Consent withdrawn|2|||
46823199|NCT00316719|83042498|FG001|Overall Study|Consent withdrawn|0|||
46823200|NCT00422058|83042510|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
46823201|NCT00422058|83042511|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
46823202|NCT00422058|83042512|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
46823203|NCT00422058|83042513|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
46823204|NCT00422058|83042514|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
46823205|NCT00422058|83042515|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
46823206|NCT00422058|83042510|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
46823207|NCT00422058|83042511|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
46823208|NCT00422058|83042512|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
46823209|NCT00422058|83042513|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
46823210|NCT00422058|83042514|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
46823211|NCT00422058|83042515|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
46823212|NCT00422058|83042510|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
46823213|NCT00422058|83042511|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
46823214|NCT00422058|83042512|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
46823215|NCT00422058|83042513|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
46823216|NCT00422058|83042514|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
46823217|NCT00422058|83042515|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
46823218|NCT00422058|83042510|FG000|Double-Blind, Week 0-20|Other|11|||
46823219|NCT00422058|83042511|FG001|Double-Blind, Week 0-20|Other|3|||
46823220|NCT00422058|83042512|FG002|Double-Blind, Week 0-20|Other|8|||
46823221|NCT00422058|83042513|FG003|Double-Blind, Week 0-20|Other|8|||
46823222|NCT00422058|83042514|FG004|Double-Blind, Week 0-20|Other|4|||
46823223|NCT00422058|83042515|FG005|Double-Blind, Week 0-20|Other|10|||
46823224|NCT00422058|83042510|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
46823225|NCT00422058|83042511|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
46823226|NCT00422058|83042512|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
46823227|NCT00422058|83042513|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
46823228|NCT00422058|83042514|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
46823229|NCT00422058|83042515|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
46823230|NCT00422058|83042510|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
47057222|NCT02789345|83335000|FG000|Overall Study|Death|0|||
47057223|NCT02789345|83335001|FG001|Overall Study|Death|0|||
47057224|NCT02789345|83335002|FG002|Overall Study|Death|1|||
47057225|NCT02789345|83335000|FG000|Overall Study|Physician Decision|2|||
47057226|NCT02789345|83335001|FG001|Overall Study|Physician Decision|0|||
47057227|NCT02789345|83335002|FG002|Overall Study|Physician Decision|1|||
47057228|NCT02789345|83335000|FG000|Overall Study|Progressive Disease|1|||
47057229|NCT02789345|83335001|FG001|Overall Study|Progressive Disease|3|||
46761086|NCT04228783|82979164|FG004|Overall Study|Other|0|||
46761087|NCT04228783|82979165|FG005|Overall Study|Other|0|||
46761088|NCT03950674|82979181|FG000|Overall Study|Death|3|||
46761089|NCT03950674|82979182|FG001|Overall Study|Death|7|||
46761090|NCT03950674|82979181|FG000|Overall Study|Ongoing in Study|22|||
46761091|NCT03950674|82979182|FG001|Overall Study|Ongoing in Study|8|||
46761092|NCT03702621|82979191|FG000|Overall Study|Physician Decision|6|||
46761093|NCT03702621|82979192|FG001|Overall Study|Physician Decision|6|||
46761094|NCT03577990|82979200|FG000|Overall Study|Lost to Follow-up|4|||
46761095|NCT03577990|82979201|FG001|Overall Study|Lost to Follow-up|6|||
46761096|NCT03577990|82979200|FG000|Overall Study|Withdrawal by Subject|4|||
46761097|NCT03577990|82979201|FG001|Overall Study|Withdrawal by Subject|7|||
46761098|NCT03565497|82979211|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
46761099|NCT03565497|82979212|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
46761100|NCT03565497|82979213|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
46761101|NCT03565497|82979211|FG000|Overall Study|Lost to Follow-up|1|||
46761102|NCT03565497|82979212|FG001|Overall Study|Lost to Follow-up|1|||
46761103|NCT03565497|82979213|FG002|Overall Study|Lost to Follow-up|2|||
46761104|NCT03565497|82979211|FG000|Overall Study|Withdrawal by Subject|1|||
46761105|NCT03565497|82979212|FG001|Overall Study|Withdrawal by Subject|1|||
46761106|NCT03565497|82979213|FG002|Overall Study|Withdrawal by Subject|1|||
46761107|NCT03362931|82979221|FG000|Overall Study|Adverse Event|1|||
46761108|NCT03362931|82979221|FG000|Overall Study|Death|2|||
46761109|NCT03360019|82979228|FG000|Overall Study|Withdrawal by Subject|2|||
46761110|NCT03360019|82979229|FG001|Overall Study|Withdrawal by Subject|0|||
46761111|NCT03360019|82979230|FG002|Overall Study|Withdrawal by Subject|0|||
46823231|NCT00422058|83042511|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
46823232|NCT00422058|83042512|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
46823233|NCT00422058|83042513|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
46761112|NCT03360019|82979228|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
46761113|NCT03360019|82979229|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
46933368|NCT02576860|83169043|FG000|Overall Study|Lost to Follow-up|5|||
47057230|NCT02789345|83335002|FG002|Overall Study|Progressive Disease|14|||
46823234|NCT00422058|83042514|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
46823235|NCT00422058|83042515|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
46823236|NCT00422058|83042510|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
46823237|NCT00422058|83042511|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
46823238|NCT00422058|83042512|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
46823239|NCT00422058|83042513|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
46823240|NCT00422058|83042514|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
46823241|NCT00422058|83042515|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
46823242|NCT00422058|83042510|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
46823243|NCT00422058|83042511|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
46823244|NCT00422058|83042512|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
46823245|NCT00422058|83042513|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
46823246|NCT00422058|83042514|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
46823247|NCT00422058|83042515|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
46823248|NCT00422058|83042510|FG000|Open-Label Extension, Week 20-104|Other|13|||
46823249|NCT00422058|83042511|FG001|Open-Label Extension, Week 20-104|Other|14|||
46933369|NCT02576860|83169044|FG001|Overall Study|Lost to Follow-up|7|||
46933370|NCT02576860|83169043|FG000|Overall Study|Physician Decision|0|||
46933371|NCT02576860|83169044|FG001|Overall Study|Physician Decision|1|||
47057231|NCT02747927|83335013|FG000|Overall Study|Adverse Event|5|||
47057232|NCT02747927|83335014|FG001|Overall Study|Adverse Event|14|||
46761114|NCT03360019|82979230|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
46761115|NCT03245008|82979247|FG000|Overall Study|Adverse Event|15|||
46761116|NCT03245008|82979248|FG001|Overall Study|Adverse Event|18|||
46761117|NCT03245008|82979249|FG002|Overall Study|Adverse Event|15|||
46761118|NCT03245008|82979250|FG003|Overall Study|Adverse Event|0|||
46761119|NCT03245008|82979251|FG004|Overall Study|Adverse Event|1|||
46761120|NCT03245008|82979247|FG000|Overall Study|Lack of Efficacy|0|||
46761121|NCT03245008|82979248|FG001|Overall Study|Lack of Efficacy|1|||
46761122|NCT03245008|82979249|FG002|Overall Study|Lack of Efficacy|0|||
46761123|NCT03245008|82979250|FG003|Overall Study|Lack of Efficacy|0|||
46761124|NCT03245008|82979251|FG004|Overall Study|Lack of Efficacy|0|||
46761125|NCT03245008|82979247|FG000|Overall Study|Lost to Follow-up|4|||
46761126|NCT03245008|82979248|FG001|Overall Study|Lost to Follow-up|1|||
46761127|NCT03245008|82979249|FG002|Overall Study|Lost to Follow-up|0|||
46761128|NCT03245008|82979250|FG003|Overall Study|Lost to Follow-up|0|||
46761129|NCT03245008|82979251|FG004|Overall Study|Lost to Follow-up|1|||
46761130|NCT03245008|82979247|FG000|Overall Study|Physician Decision|1|||
46761131|NCT03245008|82979248|FG001|Overall Study|Physician Decision|3|||
46761132|NCT03245008|82979249|FG002|Overall Study|Physician Decision|4|||
46761133|NCT03245008|82979250|FG003|Overall Study|Physician Decision|0|||
46761134|NCT03245008|82979251|FG004|Overall Study|Physician Decision|0|||
46761135|NCT03245008|82979247|FG000|Overall Study|Protocol Violation|0|||
46761136|NCT03245008|82979248|FG001|Overall Study|Protocol Violation|1|||
46761137|NCT03245008|82979249|FG002|Overall Study|Protocol Violation|0|||
46761138|NCT03245008|82979250|FG003|Overall Study|Protocol Violation|0|||
46761139|NCT03245008|82979251|FG004|Overall Study|Protocol Violation|0|||
46761140|NCT03245008|82979247|FG000|Overall Study|Withdrawal by Subject|20|||
46761141|NCT03245008|82979248|FG001|Overall Study|Withdrawal by Subject|19|||
46761142|NCT03245008|82979249|FG002|Overall Study|Withdrawal by Subject|11|||
46761143|NCT03245008|82979250|FG003|Overall Study|Withdrawal by Subject|0|||
46761144|NCT03245008|82979251|FG004|Overall Study|Withdrawal by Subject|0|||
46761145|NCT03245008|82979247|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
46761146|NCT03245008|82979248|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
46761147|NCT03245008|82979249|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
46761148|NCT03245008|82979250|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
46761149|NCT03245008|82979251|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
46761150|NCT03245008|82979247|FG000|Overall Study|Failure to meet randomization criteria|0|||
46761151|NCT03245008|82979248|FG001|Overall Study|Failure to meet randomization criteria|1|||
46761152|NCT03245008|82979249|FG002|Overall Study|Failure to meet randomization criteria|0|||
46761153|NCT03245008|82979250|FG003|Overall Study|Failure to meet randomization criteria|1|||
46761154|NCT03245008|82979251|FG004|Overall Study|Failure to meet randomization criteria|0|||
46761155|NCT03203473|82979273|FG000|Induction Phase|Never started primary treatment|2|||
46761156|NCT03203473|82979274|FG001|Induction Phase|Never started primary treatment|0|||
46761157|NCT03203473|82979275|FG002|Induction Phase|Never started primary treatment|0|||
46761158|NCT03203473|82979273|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
46761159|NCT03203473|82979274|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
46761160|NCT03203473|82979275|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
46761161|NCT03203473|82979273|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
46823250|NCT00422058|83042512|FG002|Open-Label Extension, Week 20-104|Other|6|||
46823251|NCT00422058|83042513|FG003|Open-Label Extension, Week 20-104|Other|13|||
46761162|NCT03203473|82979274|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
46761163|NCT03203473|82979275|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
46761164|NCT03203473|82979273|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
46823252|NCT00422058|83042514|FG004|Open-Label Extension, Week 20-104|Other|16|||
46823253|NCT00422058|83042515|FG005|Open-Label Extension, Week 20-104|Other|18|||
46823254|NCT00413244|83042539|FG000|Overall Study|Withdrawal by Subject|10|||
46823255|NCT00413244|83042540|FG001|Overall Study|Withdrawal by Subject|1|||
46823256|NCT00420420|83042568|FG000|Overall Study|Adverse Event|5|||
46933372|NCT02576860|83169043|FG000|Overall Study|Protocol Violation|0|||
46933373|NCT02576860|83169044|FG001|Overall Study|Protocol Violation|2|||
46933374|NCT02576860|83169043|FG000|Overall Study|Withdrawal by Subject|13|||
46933375|NCT02576860|83169044|FG001|Overall Study|Withdrawal by Subject|8|||
46933376|NCT02576860|83169043|FG000|Overall Study|Disallowed medication|1|||
46933377|NCT02576860|83169044|FG001|Overall Study|Disallowed medication|0|||
46933378|NCT02572570|83169051|FG000|Overall Study|Study Terminated|27|||
46933379|NCT00709202|83169060|FG000|Overall Study|Withdrawal by Subject|6|||
46933380|NCT00709202|83169061|FG001|Overall Study|Withdrawal by Subject|6|||
46933381|NCT00709124|83169070|FG000|Overall Study|Death|3|||
46933382|NCT00709124|83169071|FG001|Overall Study|Death|1|||
47057233|NCT02747927|83335013|FG000|Overall Study|Lost to Follow-up|22|||
46761165|NCT03203473|82979274|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
46761166|NCT03203473|82979275|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
46761167|NCT03203473|82979273|FG000|Arm Allocation Phase|started salvage therapy|0|||
46761168|NCT03203473|82979274|FG001|Arm Allocation Phase|started salvage therapy|5|||
46761169|NCT03203473|82979275|FG002|Arm Allocation Phase|started salvage therapy|0|||
46761170|NCT03203473|82979273|FG000|Arm Allocation Phase|Disease progression|0|||
46761171|NCT03203473|82979274|FG001|Arm Allocation Phase|Disease progression|0|||
46761172|NCT03203473|82979275|FG002|Arm Allocation Phase|Disease progression|37|||
46761173|NCT03203473|82979273|FG000|Arm Allocation Phase|Adverse Event|0|||
46761174|NCT03203473|82979274|FG001|Arm Allocation Phase|Adverse Event|0|||
46761175|NCT03203473|82979275|FG002|Arm Allocation Phase|Adverse Event|11|||
46761176|NCT03203473|82979273|FG000|Arm Allocation Phase|Physician Decision|0|||
46823257|NCT00420420|83042569|FG001|Overall Study|Adverse Event|3|||
46761177|NCT03203473|82979274|FG001|Arm Allocation Phase|Physician Decision|0|||
46823258|NCT00420420|83042568|FG000|Overall Study|Protocol Violation|1|||
46823259|NCT00420420|83042569|FG001|Overall Study|Protocol Violation|1|||
46823260|NCT00420420|83042568|FG000|Overall Study|Withdrawal by Subject|1|||
46761178|NCT03203473|82979275|FG002|Arm Allocation Phase|Physician Decision|3|||
46761179|NCT03203473|82979273|FG000|Arm Allocation Phase|Death|0|||
46761180|NCT03203473|82979274|FG001|Arm Allocation Phase|Death|0|||
46761181|NCT03203473|82979275|FG002|Arm Allocation Phase|Death|1|||
46933383|NCT00709124|83169070|FG000|Overall Study|encephalopathy; can't do assessment|1|||
46933384|NCT00709124|83169071|FG001|Overall Study|encephalopathy; can't do assessment|0|||
46933385|NCT02738580|83169083|FG000|Overall Study|Adverse Event|1|||
46933386|NCT02738580|83169084|FG001|Overall Study|Adverse Event|0|||
46933387|NCT02738580|83169083|FG000|Overall Study|Lack of Efficacy|3|||
46823261|NCT00420420|83042569|FG001|Overall Study|Withdrawal by Subject|0|||
46823262|NCT00420420|83042568|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
46933388|NCT02738580|83169084|FG001|Overall Study|Lack of Efficacy|2|||
46933389|NCT02738580|83169083|FG000|Overall Study|Withdrawal by Subject|0|||
46933390|NCT02738580|83169084|FG001|Overall Study|Withdrawal by Subject|1|||
46933391|NCT02738580|83169083|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
46933392|NCT02738580|83169084|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
46933393|NCT02571244|83169092|FG000|Overall Study|Lost to Follow-up|0|||
47057234|NCT02747927|83335014|FG001|Overall Study|Lost to Follow-up|43|||
47057235|NCT02747927|83335013|FG000|Overall Study|Pregnancy|34|||
46823263|NCT00420420|83042569|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
46823264|NCT00420342|83042578|FG000|Overall Study|Lost to Follow-up|1|||
46823265|NCT00420342|83042579|FG001|Overall Study|Lost to Follow-up|0|||
46823266|NCT00420342|83042580|FG002|Overall Study|Lost to Follow-up|1|||
46823267|NCT00420342|83042578|FG000|Overall Study|Withdrawal by Subject|0|||
46823268|NCT00420342|83042579|FG001|Overall Study|Withdrawal by Subject|2|||
46823269|NCT00420342|83042580|FG002|Overall Study|Withdrawal by Subject|0|||
46823270|NCT00432744|83042590|FG000|Months 0-6|Withdrawal by Subject|4|||
46823271|NCT00432744|83042591|FG001|Months 0-6|Withdrawal by Subject|4|||
46823272|NCT00432744|83042590|FG000|Months 0-6|Too disabled to score|1|||
46933394|NCT02571244|83169093|FG001|Overall Study|Lost to Follow-up|1|||
46933395|NCT02571244|83169092|FG000|Overall Study|Unable to reach out post discharge|3|||
46933396|NCT02571244|83169093|FG001|Overall Study|Unable to reach out post discharge|0|||
47057236|NCT02747927|83335014|FG001|Overall Study|Pregnancy|66|||
46823273|NCT00432744|83042591|FG001|Months 0-6|Too disabled to score|0|||
46823274|NCT00432744|83042590|FG000|Months 7 - 12|Withdrawal by Subject|1|||
46823275|NCT00432744|83042591|FG001|Months 7 - 12|Withdrawal by Subject|0|||
46823276|NCT00432744|83042590|FG000|Months 7 - 12|Too disabled to score|0|||
46933397|NCT02573350|83169104|FG000|Overall Study|Lost to Follow-up|2|||
46933398|NCT02573350|83169105|FG001|Overall Study|Lost to Follow-up|1|||
46933399|NCT02573350|83169104|FG000|Overall Study|Adverse Event|3|||
47057237|NCT02747927|83335013|FG000|Overall Study|Protocol Violation|2|||
46823277|NCT00432744|83042591|FG001|Months 7 - 12|Too disabled to score|1|||
46823278|NCT00432666|83042599|FG000|Main Period|Adverse Event|1|||
46823279|NCT00432666|83042600|FG001|Main Period|Adverse Event|1|||
46933400|NCT02573350|83169105|FG001|Overall Study|Adverse Event|4|||
46823280|NCT00432666|83042599|FG000|Main Period|Consent Withdrawn|1|||
46823281|NCT00432666|83042600|FG001|Main Period|Consent Withdrawn|0|||
46823282|NCT00432666|83042599|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
46823283|NCT00432666|83042600|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
46823284|NCT00432666|83042599|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
46823285|NCT00432666|83042600|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
46823286|NCT00432666|83042599|FG000|Open-Label Extension Period|Adverse Event|5|||
46823287|NCT00432666|83042600|FG001|Open-Label Extension Period|Adverse Event|0|||
46823288|NCT00432666|83042599|FG000|Open-Label Extension Period|Consent withdrawn|10|||
46823289|NCT00432666|83042600|FG001|Open-Label Extension Period|Consent withdrawn|0|||
46823290|NCT00432666|83042599|FG000|Open-Label Extension Period|Physician Decision|3|||
46823291|NCT00432666|83042600|FG001|Open-Label Extension Period|Physician Decision|0|||
46823292|NCT00451958|83042610|FG000|CS21A (NCT00451958)|Adverse Event|21|||
46823293|NCT00451958|83042611|FG001|CS21A (NCT00451958)|Adverse Event|34|||
46823294|NCT00451958|83042612|FG002|CS21A (NCT00451958)|Adverse Event|14|||
46823295|NCT00451958|83042613|FG003|CS21A (NCT00451958)|Adverse Event|17|||
46823296|NCT00451958|83042614|FG004|CS21A (NCT00451958)|Adverse Event|0|||
46823297|NCT00451958|83042610|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
46823298|NCT00451958|83042611|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
46823299|NCT00451958|83042612|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
46823300|NCT00451958|83042613|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
46823301|NCT00451958|83042614|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
46823302|NCT00451958|83042610|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
46823303|NCT00451958|83042611|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
46823304|NCT00451958|83042612|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
46823305|NCT00451958|83042613|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
46823306|NCT00451958|83042614|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
46823307|NCT00451958|83042610|FG000|CS21A (NCT00451958)|Physician Decision|2|||
46823308|NCT00451958|83042611|FG001|CS21A (NCT00451958)|Physician Decision|4|||
46823309|NCT00451958|83042612|FG002|CS21A (NCT00451958)|Physician Decision|4|||
46823310|NCT00451958|83042613|FG003|CS21A (NCT00451958)|Physician Decision|4|||
46823311|NCT00451958|83042614|FG004|CS21A (NCT00451958)|Physician Decision|0|||
46823312|NCT00451958|83042610|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
46823313|NCT00451958|83042611|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
46823314|NCT00451958|83042612|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
46933401|NCT02573350|83169104|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
46933402|NCT02573350|83169105|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
46967727|NCT02155738|83210284|FG001|Overall Study|Missing critical information|0|||
46761182|NCT03203473|82979273|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
46761183|NCT03203473|82979274|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
46761184|NCT03203473|82979275|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
46761185|NCT03203473|82979273|FG000|Arm Allocation Phase|Intercurrent illness|0|||
46761186|NCT03203473|82979274|FG001|Arm Allocation Phase|Intercurrent illness|0|||
46761187|NCT03203473|82979275|FG002|Arm Allocation Phase|Intercurrent illness|1|||
46761188|NCT03203473|82979273|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
46761189|NCT03203473|82979274|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
46761190|NCT03203473|82979275|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
46761191|NCT03158051|82979288|FG000|Overall Study|Lost to Follow-up|41|||
46761192|NCT03158051|82979289|FG001|Overall Study|Lost to Follow-up|47|||
46761193|NCT03158051|82979288|FG000|Overall Study|Physician Decision|6|||
46761194|NCT03158051|82979289|FG001|Overall Study|Physician Decision|7|||
46761195|NCT03158051|82979288|FG000|Overall Study|Withdrawal by Subject|24|||
46761196|NCT03158051|82979289|FG001|Overall Study|Withdrawal by Subject|15|||
46761197|NCT03158051|82979288|FG000|Overall Study|Death|0|||
46761198|NCT03158051|82979289|FG001|Overall Study|Death|1|||
46761199|NCT02600507|82979307|FG000|Overall Study|Adverse Event|3|||
46761200|NCT02600507|82979308|FG001|Overall Study|Adverse Event|15|||
46761201|NCT02600507|82979309|FG002|Overall Study|Adverse Event|5|||
46761202|NCT02600507|82979307|FG000|Overall Study|Lack of Efficacy|3|||
46823315|NCT00451958|83042613|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
46823316|NCT00451958|83042614|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
46761203|NCT02600507|82979308|FG001|Overall Study|Lack of Efficacy|8|||
46823317|NCT00451958|83042610|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
46823318|NCT00451958|83042611|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
46823319|NCT00451958|83042612|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
46823320|NCT00451958|83042613|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
46823321|NCT00451958|83042614|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
46823322|NCT00432276|83042630|FG000|Overall Study|Hyperglycemic Rescue|44|||
46761204|NCT02600507|82979309|FG002|Overall Study|Lack of Efficacy|5|||
46823323|NCT00432276|83042631|FG001|Overall Study|Hyperglycemic Rescue|87|||
46967728|NCT02155738|83210285|FG002|Overall Study|Missing critical information|0|||
46967729|NCT02155738|83210286|FG003|Overall Study|Missing critical information|1|||
46823324|NCT00432276|83042630|FG000|Overall Study|Adverse Event|13|||
46823325|NCT00432276|83042631|FG001|Overall Study|Adverse Event|16|||
46823326|NCT00432276|83042630|FG000|Overall Study|Protocol Violation|25|||
46823327|NCT00432276|83042631|FG001|Overall Study|Protocol Violation|20|||
46823328|NCT00432276|83042630|FG000|Overall Study|Lost to Follow-up|6|||
46823329|NCT00432276|83042631|FG001|Overall Study|Lost to Follow-up|2|||
46823330|NCT00432276|83042630|FG000|Overall Study|Withdrawal by Subject|25|||
46823331|NCT00432276|83042631|FG001|Overall Study|Withdrawal by Subject|20|||
46823332|NCT00432276|83042630|FG000|Overall Study|Physician Decision|6|||
46823333|NCT00432276|83042631|FG001|Overall Study|Physician Decision|8|||
46823334|NCT00432276|83042630|FG000|Overall Study|Other|2|||
46823335|NCT00432276|83042631|FG001|Overall Study|Other|3|||
46823336|NCT00413010|83042639|FG000|Overall Study|Adverse Event|8|||
46823337|NCT00413010|83042640|FG001|Overall Study|Adverse Event|4|||
46823338|NCT00413010|83042639|FG000|Overall Study|Laboratory abnormality|0|||
46823339|NCT00413010|83042640|FG001|Overall Study|Laboratory abnormality|2|||
46823340|NCT00413010|83042639|FG000|Overall Study|Lack of Efficacy|0|||
46823341|NCT00413010|83042640|FG001|Overall Study|Lack of Efficacy|3|||
46823342|NCT00413010|83042639|FG000|Overall Study|Lost to Follow-up|3|||
46823343|NCT00413010|83042640|FG001|Overall Study|Lost to Follow-up|0|||
46823344|NCT00413010|83042639|FG000|Overall Study|Withdrawal by Subject|7|||
46823345|NCT00413010|83042640|FG001|Overall Study|Withdrawal by Subject|2|||
46823346|NCT00413010|83042639|FG000|Overall Study|Due to termination of the study|54|||
46823347|NCT00413010|83042640|FG001|Overall Study|Due to termination of the study|52|||
46823348|NCT00459290|83042646|FG000|Overall Study|Adverse Event|3|||
46823349|NCT00459290|83042646|FG000|Overall Study|Ineligible|2|||
46823350|NCT00443534|83042657|FG000|Overall Study|Lack of Efficacy|67|||
46823351|NCT00443534|83042657|FG000|Overall Study|Adverse Event|16|||
46823352|NCT00443534|83042657|FG000|Overall Study|Death|9|||
46823353|NCT00443534|83042657|FG000|Overall Study|Withdrawal by Subject|8|||
46823354|NCT00443534|83042657|FG000|Overall Study|Study Terminated by Sponsor|12|||
46823355|NCT00443534|83042657|FG000|Overall Study|Other|10|||
46823356|NCT00443534|83042657|FG000|Overall Study|Enrolled, Not Treated|1|||
46823357|NCT00419952|83042663|FG000|Overall Study|Adverse Event|8|||
46823358|NCT00419952|83042664|FG001|Overall Study|Adverse Event|10|||
46823359|NCT00419952|83042663|FG000|Overall Study|Withdrawal by Subject|44|||
46823360|NCT00419952|83042664|FG001|Overall Study|Withdrawal by Subject|43|||
46823361|NCT00419952|83042663|FG000|Overall Study|Lost to Follow-up|43|||
46823362|NCT00419952|83042664|FG001|Overall Study|Lost to Follow-up|34|||
46823363|NCT00419952|83042663|FG000|Overall Study|Protocol Violation|32|||
46823364|NCT00419952|83042664|FG001|Overall Study|Protocol Violation|24|||
46823365|NCT00419952|83042663|FG000|Overall Study|Pregnancy|4|||
46823366|NCT00419952|83042664|FG001|Overall Study|Pregnancy|2|||
46823367|NCT00419952|83042663|FG000|Overall Study|Physician Decision|1|||
46823368|NCT00419952|83042664|FG001|Overall Study|Physician Decision|3|||
46823369|NCT00419952|83042663|FG000|Overall Study|Incorrectly enrolled|10|||
46823370|NCT00419952|83042664|FG001|Overall Study|Incorrectly enrolled|3|||
46823371|NCT00419952|83042663|FG000|Overall Study|Intake of prohibited medication|2|||
46761205|NCT02600507|82979307|FG000|Overall Study|Lost to Follow-up|3|||
46761206|NCT02600507|82979308|FG001|Overall Study|Lost to Follow-up|5|||
46761207|NCT02600507|82979309|FG002|Overall Study|Lost to Follow-up|2|||
46761208|NCT02600507|82979307|FG000|Overall Study|Protocol Violation|12|||
46761209|NCT02600507|82979308|FG001|Overall Study|Protocol Violation|4|||
46761210|NCT02600507|82979309|FG002|Overall Study|Protocol Violation|4|||
46761211|NCT02600507|82979307|FG000|Overall Study|Physician Decision|1|||
46761212|NCT02600507|82979308|FG001|Overall Study|Physician Decision|0|||
46761213|NCT02600507|82979309|FG002|Overall Study|Physician Decision|1|||
46761214|NCT02600507|82979307|FG000|Overall Study|Withdrawal by Subject|7|||
46761215|NCT02600507|82979308|FG001|Overall Study|Withdrawal by Subject|11|||
46761216|NCT02600507|82979309|FG002|Overall Study|Withdrawal by Subject|7|||
46761217|NCT02600507|82979307|FG000|Overall Study|Other|0|||
46761218|NCT02600507|82979308|FG001|Overall Study|Other|1|||
46823372|NCT00419952|83042664|FG001|Overall Study|Intake of prohibited medication|2|||
46823373|NCT00419952|83042663|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
47057238|NCT02747927|83335014|FG001|Overall Study|Protocol Violation|4|||
47057239|NCT02747927|83335013|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
46761219|NCT02600507|82979309|FG002|Overall Study|Other|1|||
46761220|NCT02578680|82979319|FG000|Overall Study|Death|124|||
46761221|NCT02578680|82979320|FG001|Overall Study|Death|104|||
46823374|NCT00419952|83042664|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
46823375|NCT00419952|83042663|FG000|Overall Study|Diary or medication non-compliance|2|||
46823376|NCT00419952|83042664|FG001|Overall Study|Diary or medication non-compliance|4|||
46823377|NCT00419952|83042663|FG000|Overall Study|Abnormal ECG|1|||
46823378|NCT00419952|83042664|FG001|Overall Study|Abnormal ECG|0|||
46823379|NCT00443456|83042670|FG000|Overall Study|Adverse Event|16|||
46823380|NCT00443456|83042670|FG000|Overall Study|Move|1|||
46823381|NCT00443456|83042670|FG000|Overall Study|Withdrawal by Subject|1|||
46823382|NCT00419562|83042680|FG000|Overall Study|Lost to Follow-up|12|||
46761222|NCT02578680|82979319|FG000|Overall Study|Protocol Violation|1|||
46823383|NCT00419562|83042681|FG001|Overall Study|Lost to Follow-up|13|||
46823384|NCT00419562|83042680|FG000|Overall Study|Withdrawal by Subject|20|||
46823385|NCT00419562|83042681|FG001|Overall Study|Withdrawal by Subject|18|||
46823386|NCT00419562|83042680|FG000|Overall Study|Participant Institutionalized|1|||
46823387|NCT00419562|83042681|FG001|Overall Study|Participant Institutionalized|0|||
46823388|NCT00432042|83042690|FG000|Overall Study|Protocol Violation|2|||
46823389|NCT00432042|83042691|FG001|Overall Study|Protocol Violation|0|||
46823390|NCT00432042|83042692|FG002|Overall Study|Protocol Violation|0|||
46823391|NCT00432042|83042690|FG000|Overall Study|Withdrawal by Subject|0|||
46823392|NCT00432042|83042691|FG001|Overall Study|Withdrawal by Subject|0|||
46823393|NCT00432042|83042692|FG002|Overall Study|Withdrawal by Subject|2|||
46823394|NCT00432042|83042690|FG000|Overall Study|Lost to Follow-up|5|||
46823395|NCT00432042|83042691|FG001|Overall Study|Lost to Follow-up|1|||
46823396|NCT00432042|83042692|FG002|Overall Study|Lost to Follow-up|0|||
46823397|NCT00308139|83042702|FG000|Overall Study|Adverse Event|20|||
46823398|NCT00308139|83042703|FG001|Overall Study|Adverse Event|14|||
46823399|NCT00308139|83042702|FG000|Overall Study|Lost to Follow-up|13|||
46823400|NCT00308139|83042703|FG001|Overall Study|Lost to Follow-up|8|||
46823401|NCT00308139|83042702|FG000|Overall Study|Protocol Violation|3|||
46823402|NCT00308139|83042703|FG001|Overall Study|Protocol Violation|2|||
46823403|NCT00308139|83042702|FG000|Overall Study|Withdrawal of Consent|40|||
46933403|NCT02573350|83169104|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
46823404|NCT00308139|83042703|FG001|Overall Study|Withdrawal of Consent|42|||
46823405|NCT00308139|83042702|FG000|Overall Study|Investigator Decision|11|||
46823406|NCT00308139|83042703|FG001|Overall Study|Investigator Decision|10|||
46823407|NCT00308139|83042702|FG000|Overall Study|Loss of Glucose Control|5|||
46933404|NCT02573350|83169105|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
46933405|NCT02573350|83169104|FG000|Overall Study|Subject withdrew consent to participate|6|||
46933406|NCT02573350|83169105|FG001|Overall Study|Subject withdrew consent to participate|1|||
46933407|NCT02573350|83169104|FG000|Overall Study|Protocol Deviation|1|||
46933408|NCT02573350|83169105|FG001|Overall Study|Protocol Deviation|1|||
46933409|NCT01376804|83169114|FG000|Treatment Period|Withdrawal by Subject|1|||
46933410|NCT01376804|83169114|FG000|Treatment Period|Adverse Event|6|||
46933411|NCT01376804|83169114|FG000|Treatment Period|Patient did not receive study drug|1|||
46933412|NCT02574520|83169122|FG000|Overall Study|Not dosed|2|||
46933413|NCT02574520|83169123|FG001|Overall Study|Not dosed|0|||
46933414|NCT02574520|83169124|FG002|Overall Study|Not dosed|5|||
46933415|NCT02574520|83169125|FG003|Overall Study|Not dosed|4|||
46933416|NCT02574520|83169122|FG000|Overall Study|Adverse Event|0|||
46933417|NCT02574520|83169123|FG001|Overall Study|Adverse Event|0|||
46933418|NCT02574520|83169124|FG002|Overall Study|Adverse Event|0|||
46823408|NCT00308139|83042703|FG001|Overall Study|Loss of Glucose Control|7|||
46823409|NCT00308139|83042702|FG000|Overall Study|Administrative|1|||
46823410|NCT00308139|83042703|FG001|Overall Study|Administrative|4|||
46823411|NCT00308139|83042702|FG000|Overall Study|Other|1|||
46823412|NCT00308139|83042703|FG001|Overall Study|Other|0|||
46823413|NCT00459134|83042731|FG000|Overall Study|Physician Decision|1|||
46823414|NCT00459134|83042732|FG001|Overall Study|Physician Decision|1|||
46823415|NCT00459134|83042731|FG000|Overall Study|Withdrawal by Subject|8|||
46823416|NCT00459134|83042732|FG001|Overall Study|Withdrawal by Subject|7|||
46823417|NCT00459134|83042731|FG000|Overall Study|Lost to Follow-up|6|||
46823418|NCT00459134|83042732|FG001|Overall Study|Lost to Follow-up|7|||
46823419|NCT00459134|83042731|FG000|Overall Study|Surgery|1|||
46823420|NCT00459134|83042732|FG001|Overall Study|Surgery|2|||
46823421|NCT00459134|83042731|FG000|Overall Study|Toxicity|4|||
46823422|NCT00459134|83042732|FG001|Overall Study|Toxicity|5|||
46823423|NCT00459134|83042731|FG000|Overall Study|Progression|1|||
46823424|NCT00459134|83042732|FG001|Overall Study|Progression|0|||
46933419|NCT02574520|83169125|FG003|Overall Study|Adverse Event|1|||
47057240|NCT02747927|83335014|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
47057241|NCT02747927|83335013|FG000|Overall Study|Reason not Specified|11|||
46823425|NCT00459134|83042731|FG000|Overall Study|Multiple Reasons|2|||
46933420|NCT02574520|83169122|FG000|Overall Study|Withdrawal by Subject|0|||
46933421|NCT02574520|83169123|FG001|Overall Study|Withdrawal by Subject|0|||
46933422|NCT02574520|83169124|FG002|Overall Study|Withdrawal by Subject|0|||
47057242|NCT02747927|83335014|FG001|Overall Study|Reason not Specified|27|||
46823426|NCT00459134|83042732|FG001|Overall Study|Multiple Reasons|3|||
46823427|NCT00459056|83042740|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
46823428|NCT00459056|83042741|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
46823429|NCT00431964|83042749|FG000|Overall Study|Adverse Event|1|||
46823430|NCT00431964|83042750|FG001|Overall Study|Adverse Event|0|||
46823431|NCT00431964|83042749|FG000|Overall Study|Lost to Follow-up|1|||
46823432|NCT00431964|83042750|FG001|Overall Study|Lost to Follow-up|2|||
46823433|NCT00431964|83042749|FG000|Overall Study|Physician Decision|2|||
46823434|NCT00431964|83042750|FG001|Overall Study|Physician Decision|2|||
46823435|NCT00431964|83042749|FG000|Overall Study|Withdrawal by Subject|2|||
46823436|NCT00431964|83042750|FG001|Overall Study|Withdrawal by Subject|1|||
46823437|NCT00431964|83042749|FG000|Overall Study|Parental Consent Withdrawn|0|||
46823438|NCT00431964|83042750|FG001|Overall Study|Parental Consent Withdrawn|2|||
46823439|NCT00431964|83042749|FG000|Overall Study|Due to Unstable Health|0|||
46823440|NCT00431964|83042750|FG001|Overall Study|Due to Unstable Health|1|||
46823441|NCT00412854|83042758|FG000|Overall Study|Withdrawn due to adverse events|1|||
46823442|NCT00412854|83042759|FG001|Overall Study|Withdrawn due to adverse events|5|||
46823443|NCT00412854|83042758|FG000|Overall Study|Withdrawn for other reasons|13|||
46823444|NCT00412854|83042759|FG001|Overall Study|Withdrawn for other reasons|11|||
46823445|NCT00431496|83042765|FG000|Overall Study|Adverse Event|3|||
46823446|NCT00431496|83042765|FG000|Overall Study|Lost to Follow-up|1|||
46823447|NCT00431496|83042765|FG000|Overall Study|Withdrawal by Subject|2|||
46823448|NCT00431496|83042765|FG000|Overall Study|Protocol-specified criteria|5|||
46823449|NCT00316173|83042771|FG000|Run-in Phase|Adverse Event|1|||
46823450|NCT00316173|83042772|FG001|Run-in Phase|Adverse Event|0|||
46823451|NCT00316173|83042771|FG000|Run-in Phase|Protocol Violation|1|||
46823452|NCT00316173|83042772|FG001|Run-in Phase|Protocol Violation|0|||
46823453|NCT00316173|83042771|FG000|Run-in Phase|Study Follow-up Stopped|5|||
46823454|NCT00316173|83042772|FG001|Run-in Phase|Study Follow-up Stopped|0|||
46823455|NCT00316173|83042771|FG000|Treatment Phase|Adverse Event|0|||
46823456|NCT00316173|83042772|FG001|Treatment Phase|Adverse Event|1|||
46823457|NCT00316173|83042771|FG000|Treatment Phase|Lack of Efficacy|0|||
46823458|NCT00316173|83042772|FG001|Treatment Phase|Lack of Efficacy|3|||
46823459|NCT00316173|83042771|FG000|Treatment Phase|Lost to Follow-up|0|||
46823460|NCT00316173|83042772|FG001|Treatment Phase|Lost to Follow-up|3|||
46823461|NCT00316173|83042771|FG000|Treatment Phase|Withdrawal by Subject|0|||
46823462|NCT00316173|83042772|FG001|Treatment Phase|Withdrawal by Subject|1|||
46823463|NCT00316173|83042771|FG000|Treatment Phase|Study Follow-up Stopped|0|||
46823464|NCT00316173|83042772|FG001|Treatment Phase|Study Follow-up Stopped|34|||
46823465|NCT00412542|83042779|FG000|Overall Study|Withdrawal by Subject|0|||
46823466|NCT00412542|83042780|FG001|Overall Study|Withdrawal by Subject|2|||
46823467|NCT00412542|83042779|FG000|Overall Study|Not Eligible|0|||
46933423|NCT02574520|83169125|FG003|Overall Study|Withdrawal by Subject|1|||
46636980|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46761223|NCT02578680|82979320|FG001|Overall Study|Protocol Violation|1|||
46761224|NCT02578680|82979319|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
46761225|NCT02578680|82979320|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46761226|NCT02578680|82979319|FG000|Overall Study|Withdrawal by Subject|8|||
46761227|NCT02578680|82979320|FG001|Overall Study|Withdrawal by Subject|5|||
46761228|NCT02578680|82979319|FG000|Overall Study|Ongoing in Study|276|||
46761229|NCT02578680|82979320|FG001|Overall Study|Ongoing in Study|96|||
46761230|NCT02385266|82979328|FG000|Overall Study|Withdrawal by Subject|1|||
46761231|NCT02385266|82979329|FG001|Overall Study|Withdrawal by Subject|3|||
46761232|NCT02379988|82979335|FG000|Overall Study|Not eligible|1|||
46761233|NCT02006069|82979350|FG000|Overall Study|MPP other programming|239|||
46761234|NCT02006069|82979351|FG001|Overall Study|MPP other programming|0|||
46761235|NCT02006069|82979350|FG000|Overall Study|RV only pacing|0|||
46761236|NCT02006069|82979351|FG001|Overall Study|RV only pacing|3|||
46761237|NCT01985867|82979359|FG000|Overall Study|Lost to Follow-up|3|||
46761238|NCT01985867|82979360|FG001|Overall Study|Lost to Follow-up|4|||
46761239|NCT01985867|82979359|FG000|Overall Study|Adverse Event|3|||
46761240|NCT01985867|82979360|FG001|Overall Study|Adverse Event|2|||
46761241|NCT01985867|82979359|FG000|Overall Study|Lack of Efficacy|1|||
46761242|NCT01985867|82979360|FG001|Overall Study|Lack of Efficacy|0|||
46761243|NCT01367002|82979368|FG000|Overall Study|Withdrawal by Subject|1|||
46761244|NCT01367002|82979369|FG001|Overall Study|Withdrawal by Subject|0|||
46761245|NCT01367002|82979368|FG000|Overall Study|Physician Decision|0|||
46761246|NCT01367002|82979369|FG001|Overall Study|Physician Decision|2|||
46761247|NCT00858273|82979377|FG000|Overall Study|Protocol Violation|3|||
46761248|NCT00858273|82979378|FG001|Overall Study|Protocol Violation|5|||
46761249|NCT00844428|82979409|FG000|Screening Period|Screen Failure|3|||
46761250|NCT00844428|82979409|FG000|Extension Treatment Period|Death|1|||
46761251|NCT00844428|82979409|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
46761252|NCT00834834|82979415|FG000|Overall Study|Withdrawal by Subject|4|||
46761253|NCT00834834|82979416|FG001|Overall Study|Withdrawal by Subject|3|||
46761254|NCT00834366|82979424|FG000|Treatment Period 1|Adverse Event|1|||
46761255|NCT00834366|82979425|FG001|Treatment Period 1|Adverse Event|1|||
46761256|NCT00844194|82979433|FG000|Overall Study|Adverse Event|17|||
46823468|NCT00412542|83042780|FG001|Overall Study|Not Eligible|1|||
46823469|NCT00316017|83042787|FG000|Overall Study|Protocol Violation|11|||
46823470|NCT00316017|83042788|FG001|Overall Study|Protocol Violation|13|||
46823471|NCT00316017|83042789|FG002|Overall Study|Protocol Violation|19|||
46823472|NCT00451178|83042799|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
46933424|NCT02574520|83169122|FG000|Overall Study|Other|0|||
46761257|NCT00844194|82979434|FG001|Overall Study|Adverse Event|5|||
46761258|NCT00844194|82979433|FG000|Overall Study|Protocol Violation|1|||
46761259|NCT00844194|82979434|FG001|Overall Study|Protocol Violation|1|||
46823473|NCT00451178|83042800|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
46933425|NCT02574520|83169123|FG001|Overall Study|Other|0|||
46823474|NCT00451178|83042799|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
46823475|NCT00451178|83042800|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
46823476|NCT00451178|83042799|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
46823477|NCT00451178|83042800|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
46823478|NCT00451178|83042799|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
46823479|NCT00451178|83042800|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
46823480|NCT00451178|83042799|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
46823481|NCT00451178|83042800|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
46823482|NCT00451178|83042799|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
46823483|NCT00451178|83042800|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
46823484|NCT00451178|83042799|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
46823485|NCT00451178|83042800|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
46823486|NCT00451178|83042799|FG000|Prior to Maintenance Therapy|PD|2|||
46823487|NCT00451178|83042800|FG001|Prior to Maintenance Therapy|PD|0|||
46823488|NCT00451178|83042799|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
46823489|NCT00451178|83042800|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
46823490|NCT00451178|83042799|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
46823491|NCT00451178|83042800|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
46823492|NCT00451178|83042799|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
46823493|NCT00451178|83042800|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
46823494|NCT00451178|83042799|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
46823495|NCT00451178|83042800|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
46823496|NCT00451178|83042799|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
46823497|NCT00451178|83042800|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
46823498|NCT00451178|83042799|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
46823499|NCT00451178|83042800|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
46823500|NCT00451178|83042799|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
46823501|NCT00451178|83042800|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
46823502|NCT00450866|83042810|FG000|Overall Study|Adverse Event|0|||
46823503|NCT00450866|83042811|FG001|Overall Study|Adverse Event|1|||
46823504|NCT00450866|83042810|FG000|Overall Study|Withdrawal by Subject|5|||
46823505|NCT00450866|83042811|FG001|Overall Study|Withdrawal by Subject|2|||
46823506|NCT00450866|83042810|FG000|Overall Study|Death|1|||
46823507|NCT00450866|83042811|FG001|Overall Study|Death|0|||
46823508|NCT00450866|83042810|FG000|Overall Study|Physician Decision|1|||
46823509|NCT00450866|83042811|FG001|Overall Study|Physician Decision|0|||
46823510|NCT00442598|83042820|FG000|Overall Study|Adverse Event|1|||
46823511|NCT00442598|83042821|FG001|Overall Study|Adverse Event|0|||
46823512|NCT00442598|83042822|FG002|Overall Study|Adverse Event|0|||
46823513|NCT00442598|83042820|FG000|Overall Study|Tumor progression|3|||
46823514|NCT00442598|83042821|FG001|Overall Study|Tumor progression|4|||
46823515|NCT00442598|83042822|FG002|Overall Study|Tumor progression|0|||
46823516|NCT00442598|83042820|FG000|Overall Study|Clinical deterioration|1|||
46823517|NCT00442598|83042821|FG001|Overall Study|Clinical deterioration|2|||
46823518|NCT00442598|83042822|FG002|Overall Study|Clinical deterioration|0|||
46823519|NCT00442598|83042820|FG000|Overall Study|CA125 progression|0|||
46823520|NCT00442598|83042821|FG001|Overall Study|CA125 progression|1|||
46823521|NCT00442598|83042822|FG002|Overall Study|CA125 progression|0|||
46823522|NCT00442598|83042820|FG000|Overall Study|Reduced creatinine clearance|1|||
46823523|NCT00442598|83042821|FG001|Overall Study|Reduced creatinine clearance|0|||
46823524|NCT00442598|83042822|FG002|Overall Study|Reduced creatinine clearance|0|||
46823525|NCT00442598|83042820|FG000|Overall Study|Death|0|||
46823526|NCT00442598|83042821|FG001|Overall Study|Death|1|||
46823527|NCT00442598|83042822|FG002|Overall Study|Death|0|||
46823528|NCT00442286|83042832|FG000|Overall Study|Death|2|||
46823529|NCT00442286|83042833|FG001|Overall Study|Death|2|||
47057243|NCT02557295|83335025|FG000|Overall Study|Withdrawal by Subject|9|||
47057244|NCT02557295|83335026|FG001|Overall Study|Withdrawal by Subject|2|||
47057245|NCT02557295|83335027|FG002|Overall Study|Withdrawal by Subject|4|||
47057246|NCT02557295|83335028|FG003|Overall Study|Withdrawal by Subject|0|||
47057247|NCT02557295|83335029|FG004|Overall Study|Withdrawal by Subject|0|||
47057248|NCT02557295|83335030|FG005|Overall Study|Withdrawal by Subject|0|||
47057249|NCT02557295|83335031|FG006|Overall Study|Withdrawal by Subject|15|||
46823530|NCT00442286|83042832|FG000|Overall Study|Lost to Follow-up|1|||
46823531|NCT00442286|83042833|FG001|Overall Study|Lost to Follow-up|0|||
46823532|NCT00442286|83042832|FG000|Overall Study|Withdrawal by Subject|2|||
46823533|NCT00442286|83042833|FG001|Overall Study|Withdrawal by Subject|0|||
46823534|NCT00442286|83042832|FG000|Overall Study|System explanted|1|||
46823535|NCT00442286|83042833|FG001|Overall Study|System explanted|0|||
46823536|NCT00442286|83042832|FG000|Overall Study|Patient Injury|1|||
46823537|NCT00442286|83042833|FG001|Overall Study|Patient Injury|0|||
46823538|NCT00441974|83042841|FG000|Overall Study|Adverse Event|6|||
46823539|NCT00441974|83042841|FG000|Overall Study|Consent Withdrawn|35|||
46823540|NCT00441974|83042841|FG000|Overall Study|Lost to Follow-up|80|||
46823541|NCT00441974|83042841|FG000|Overall Study|Protocol Violation|7|||
46823542|NCT00441584|83042848|FG000|Overall Study|Lack of Efficacy|79|||
46823543|NCT00441584|83042848|FG000|Overall Study|Withdrawal by Subject|8|||
46933426|NCT02574520|83169124|FG002|Overall Study|Other|0|||
46823544|NCT00441584|83042848|FG000|Overall Study|Adverse Event|6|||
46823545|NCT00441584|83042848|FG000|Overall Study|Protocol Violation|5|||
46823546|NCT00441584|83042848|FG000|Overall Study|Lost to Follow-up|4|||
46823547|NCT00441584|83042848|FG000|Overall Study|Failure to meet eligibility criteria|3|||
46823548|NCT00430716|83042855|FG000|Double Blind Phase|Death|1|||
46823549|NCT00430716|83042856|FG001|Double Blind Phase|Death|0|||
46823550|NCT00430716|83042857|FG002|Double Blind Phase|Death|0|||
46823551|NCT00430716|83042855|FG000|Double Blind Phase|No longer willing to participate|2|||
46823552|NCT00430716|83042856|FG001|Double Blind Phase|No longer willing to participate|1|||
46823553|NCT00430716|83042857|FG002|Double Blind Phase|No longer willing to participate|1|||
46823554|NCT00430716|83042855|FG000|Double Blind Phase|Other|0|||
46823555|NCT00430716|83042856|FG001|Double Blind Phase|Other|2|||
46823556|NCT00430716|83042857|FG002|Double Blind Phase|Other|0|||
46823557|NCT00430716|83042855|FG000|Double Blind Phase|Study terminated by sponsor|1|||
46823558|NCT00430716|83042856|FG001|Double Blind Phase|Study terminated by sponsor|1|||
46823559|NCT00430716|83042857|FG002|Double Blind Phase|Study terminated by sponsor|2|||
46823560|NCT00430716|83042855|FG000|Double Blind Phase|Adverse Event|1|||
46823561|NCT00430716|83042856|FG001|Double Blind Phase|Adverse Event|1|||
46823562|NCT00430716|83042857|FG002|Double Blind Phase|Adverse Event|3|||
46823563|NCT00430716|83042855|FG000|Double Blind Phase|Not treated|1|||
46823564|NCT00430716|83042856|FG001|Double Blind Phase|Not treated|0|||
46823565|NCT00430716|83042857|FG002|Double Blind Phase|Not treated|0|||
46823566|NCT00430716|83042855|FG000|Open Label Phase|Lost to Follow-up|1|||
46823567|NCT00430716|83042856|FG001|Open Label Phase|Lost to Follow-up|0|||
46823568|NCT00430716|83042857|FG002|Open Label Phase|Lost to Follow-up|1|||
46823569|NCT00430716|83042855|FG000|Open Label Phase|No longer willing to participate|0|||
46823570|NCT00430716|83042856|FG001|Open Label Phase|No longer willing to participate|1|||
46823571|NCT00430716|83042857|FG002|Open Label Phase|No longer willing to participate|1|||
46823572|NCT00430716|83042855|FG000|Open Label Phase|Other|3|||
46823573|NCT00430716|83042856|FG001|Open Label Phase|Other|1|||
46823574|NCT00430716|83042857|FG002|Open Label Phase|Other|1|||
46823575|NCT00430716|83042855|FG000|Open Label Phase|Protocol Violation|1|||
46823576|NCT00430716|83042856|FG001|Open Label Phase|Protocol Violation|0|||
46823577|NCT00430716|83042857|FG002|Open Label Phase|Protocol Violation|0|||
46823578|NCT00430716|83042855|FG000|Open Label Phase|Study terminated by sponsor|4|||
46823579|NCT00430716|83042856|FG001|Open Label Phase|Study terminated by sponsor|5|||
46823580|NCT00430716|83042857|FG002|Open Label Phase|Study terminated by sponsor|4|||
46823581|NCT00441272|83042867|FG000|Overall Study|Study terminated prior to enrollment|25|||
46823582|NCT00441272|83042868|FG001|Overall Study|Study terminated prior to enrollment|25|||
46823583|NCT00430638|83042876|FG000|Overall Study|Adverse Event|15|||
46823584|NCT00430638|83042877|FG001|Overall Study|Adverse Event|15|||
46823585|NCT00430638|83042876|FG000|Overall Study|Uncontrolled blood pressure|48|||
46823586|NCT00430638|83042877|FG001|Overall Study|Uncontrolled blood pressure|13|||
46823587|NCT00430638|83042876|FG000|Overall Study|Lost to Follow-up|1|||
46823588|NCT00430638|83042877|FG001|Overall Study|Lost to Follow-up|7|||
46823589|NCT00430638|83042876|FG000|Overall Study|Protocol Violation|6|||
46823590|NCT00430638|83042877|FG001|Overall Study|Protocol Violation|4|||
46823591|NCT00430638|83042876|FG000|Overall Study|Withdrawal by Subject|4|||
46823592|NCT00430638|83042877|FG001|Overall Study|Withdrawal by Subject|6|||
46823593|NCT00430638|83042876|FG000|Overall Study|Non-compliant|2|||
46823594|NCT00430638|83042877|FG001|Overall Study|Non-compliant|1|||
46823595|NCT00430638|83042876|FG000|Overall Study|Other|2|||
46823596|NCT00430638|83042877|FG001|Overall Study|Other|2|||
46823597|NCT00430482|83042889|FG000|Completed Treatment|Insufficient Treatment|7|||
46823598|NCT00430482|83042890|FG001|Completed Treatment|Insufficient Treatment|11|||
46823599|NCT00449930|83042898|FG000|Overall Study|Adverse Event|9|||
46823600|NCT00449930|83042899|FG001|Overall Study|Adverse Event|19|||
46823601|NCT00449930|83042898|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
46823602|NCT00449930|83042899|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
46823603|NCT00449930|83042898|FG000|Overall Study|Lack of Efficacy|10|||
46823604|NCT00449930|83042899|FG001|Overall Study|Lack of Efficacy|1|||
46823605|NCT00449930|83042898|FG000|Overall Study|Lost to Follow-up|9|||
46823606|NCT00449930|83042899|FG001|Overall Study|Lost to Follow-up|14|||
46823607|NCT00449930|83042898|FG000|Overall Study|Physician Decision|1|||
46823608|NCT00449930|83042899|FG001|Overall Study|Physician Decision|2|||
46823609|NCT00449930|83042898|FG000|Overall Study|Protocol Violation|14|||
46823610|NCT00449930|83042899|FG001|Overall Study|Protocol Violation|15|||
46823611|NCT00449930|83042898|FG000|Overall Study|Withdrawal by Subject|16|||
46823612|NCT00449930|83042899|FG001|Overall Study|Withdrawal by Subject|23|||
46823613|NCT00449930|83042898|FG000|Overall Study|Glycemic discontinuation criteria|1|||
46933427|NCT02574520|83169125|FG003|Overall Study|Other|2|||
46823614|NCT00449930|83042899|FG001|Overall Study|Glycemic discontinuation criteria|1|||
46823615|NCT00449696|83042907|FG000|Overall Study|Other Treatment Required|6|||
46823616|NCT00449696|83042908|FG001|Overall Study|Other Treatment Required|1|||
46823617|NCT00449696|83042907|FG000|Overall Study|Withdrawal by Subject|5|||
46823618|NCT00449696|83042908|FG001|Overall Study|Withdrawal by Subject|5|||
46823619|NCT00449696|83042907|FG000|Overall Study|Lost to Follow-up|2|||
46823620|NCT00449696|83042908|FG001|Overall Study|Lost to Follow-up|3|||
46823621|NCT00449696|83042907|FG000|Overall Study|Others|7|||
46823622|NCT00449696|83042908|FG001|Overall Study|Others|0|||
46823623|NCT00441116|83042916|FG000|Overall Study|Adverse Event|1|||
46823624|NCT00441116|83042917|FG001|Overall Study|Adverse Event|1|||
46823625|NCT00441116|83042916|FG000|Overall Study|Withdrawal by Subject|1|||
46823626|NCT00441116|83042917|FG001|Overall Study|Withdrawal by Subject|0|||
46823627|NCT00441116|83042916|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
46823628|NCT00441116|83042917|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
46823629|NCT00430248|83042926|FG000|Overall Study|Adverse Event|49|||
46823630|NCT00430248|83042927|FG001|Overall Study|Adverse Event|61|||
46823631|NCT00430248|83042928|FG002|Overall Study|Adverse Event|64|||
46823632|NCT00430248|83042926|FG000|Overall Study|Protocol Violation|10|||
46823633|NCT00430248|83042927|FG001|Overall Study|Protocol Violation|2|||
46823634|NCT00430248|83042928|FG002|Overall Study|Protocol Violation|4|||
46823635|NCT00430248|83042926|FG000|Overall Study|Personal Reasons|12|||
46823636|NCT00430248|83042927|FG001|Overall Study|Personal Reasons|24|||
46823637|NCT00430248|83042928|FG002|Overall Study|Personal Reasons|9|||
46823638|NCT00430248|83042926|FG000|Overall Study|Lost to Follow-up|28|||
46823639|NCT00430248|83042927|FG001|Overall Study|Lost to Follow-up|33|||
46823640|NCT00430248|83042928|FG002|Overall Study|Lost to Follow-up|28|||
46823641|NCT00430248|83042926|FG000|Overall Study|Therapeutic Failure|1|||
46823642|NCT00430248|83042927|FG001|Overall Study|Therapeutic Failure|1|||
46823643|NCT00430248|83042928|FG002|Overall Study|Therapeutic Failure|1|||
46823644|NCT00430248|83042926|FG000|Overall Study|Withdrawal by Subject|14|||
46823645|NCT00430248|83042927|FG001|Overall Study|Withdrawal by Subject|20|||
46823646|NCT00430248|83042928|FG002|Overall Study|Withdrawal by Subject|16|||
46823647|NCT00430248|83042926|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46823648|NCT00430248|83042927|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
46823649|NCT00430248|83042928|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46823650|NCT00430248|83042926|FG000|Overall Study|Gout Flare|3|||
46823651|NCT00430248|83042927|FG001|Overall Study|Gout Flare|7|||
46823652|NCT00430248|83042928|FG002|Overall Study|Gout Flare|2|||
46823653|NCT00430248|83042926|FG000|Overall Study|Reason Not Specified|8|||
46823654|NCT00430248|83042927|FG001|Overall Study|Reason Not Specified|8|||
46823655|NCT00430248|83042928|FG002|Overall Study|Reason Not Specified|11|||
46823656|NCT00449540|83042938|FG000|Pretreatment Phase|No migraine experienced|66|||
46823657|NCT00449540|83042939|FG001|Pretreatment Phase|No migraine experienced|0|||
46823658|NCT00449540|83042940|FG002|Pretreatment Phase|No migraine experienced|0|||
46823659|NCT00449540|83042938|FG000|Treatment Phase|did not experience or treat migraine|0|||
46823660|NCT00449540|83042939|FG001|Treatment Phase|did not experience or treat migraine|20|||
46823661|NCT00449540|83042940|FG002|Treatment Phase|did not experience or treat migraine|17|||
46823662|NCT00411762|83042948|FG000|Overall Study|Withdrawal by Subject|5|||
46823663|NCT00429858|83042952|FG000|Overall Study|Withdrawal by Subject|1|||
46823664|NCT00429858|83042952|FG000|Overall Study|Study Termination|1|||
46823665|NCT00449150|83042960|FG000|Overall Study|Adverse Event|11|||
46823666|NCT00449150|83042961|FG001|Overall Study|Adverse Event|18|||
46823667|NCT00449150|83042962|FG002|Overall Study|Adverse Event|9|||
47057250|NCT02557295|83335032|FG007|Overall Study|Withdrawal by Subject|1|||
47057251|NCT02557295|83335033|FG008|Overall Study|Withdrawal by Subject|3|||
47057252|NCT02557295|83335025|FG000|Overall Study|Disease Progression|0|||
47057253|NCT02557295|83335026|FG001|Overall Study|Disease Progression|0|||
47057254|NCT02557295|83335027|FG002|Overall Study|Disease Progression|0|||
46761260|NCT00844194|82979433|FG000|Overall Study|Lost to Follow-up|1|||
46761261|NCT00844194|82979434|FG001|Overall Study|Lost to Follow-up|1|||
46761262|NCT00844194|82979433|FG000|Overall Study|Withdrawal by Subject|2|||
46761263|NCT00844194|82979434|FG001|Overall Study|Withdrawal by Subject|1|||
46761264|NCT00844194|82979433|FG000|Overall Study|Lack of Efficacy|3|||
46761265|NCT00844194|82979434|FG001|Overall Study|Lack of Efficacy|0|||
46761266|NCT00844194|82979433|FG000|Overall Study|Other reason (not specified)|1|||
46761267|NCT00844194|82979434|FG001|Overall Study|Other reason (not specified)|0|||
46761268|NCT00826176|82979446|FG000|Overall Study|Lost to Follow-up|1|||
46761269|NCT00826176|82979447|FG001|Overall Study|Lost to Follow-up|0|||
46823668|NCT00449150|83042960|FG000|Overall Study|Lack of Efficacy|1|||
46933428|NCT00709592|83169137|FG000|Overall Study|Unable to proceed to transplant|0|||
47057255|NCT02557295|83335028|FG003|Overall Study|Disease Progression|0|||
47057256|NCT02557295|83335029|FG004|Overall Study|Disease Progression|0|||
46761270|NCT00826176|82979446|FG000|Overall Study|Subject Withdrew Consent|3|||
46823669|NCT00449150|83042961|FG001|Overall Study|Lack of Efficacy|2|||
46823670|NCT00449150|83042962|FG002|Overall Study|Lack of Efficacy|2|||
46823671|NCT00449150|83042960|FG000|Overall Study|Other|16|||
46823672|NCT00449150|83042961|FG001|Overall Study|Other|13|||
46823673|NCT00449150|83042962|FG002|Overall Study|Other|14|||
46823674|NCT00449150|83042960|FG000|Overall Study|Withdrawal by Subject|17|||
47057257|NCT02557295|83335030|FG005|Overall Study|Disease Progression|0|||
47057258|NCT02557295|83335031|FG006|Overall Study|Disease Progression|1|||
47057259|NCT02557295|83335032|FG007|Overall Study|Disease Progression|0|||
47057260|NCT02557295|83335033|FG008|Overall Study|Disease Progression|0|||
47057261|NCT02557295|83335025|FG000|Overall Study|Lack of Efficacy|24|||
47057262|NCT02557295|83335026|FG001|Overall Study|Lack of Efficacy|1|||
46636981|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
46636982|NCT02914561|82810923|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
46761271|NCT00826176|82979447|FG001|Overall Study|Subject Withdrew Consent|0|||
46761272|NCT00826176|82979446|FG000|Overall Study|Administrative|9|||
46761273|NCT00826176|82979447|FG001|Overall Study|Administrative|0|||
47057263|NCT02557295|83335027|FG002|Overall Study|Lack of Efficacy|3|||
47057264|NCT02557295|83335028|FG003|Overall Study|Lack of Efficacy|0|||
47057265|NCT02557295|83335029|FG004|Overall Study|Lack of Efficacy|0|||
47057266|NCT02557295|83335030|FG005|Overall Study|Lack of Efficacy|0|||
47057267|NCT02557295|83335031|FG006|Overall Study|Lack of Efficacy|12|||
47057268|NCT02557295|83335032|FG007|Overall Study|Lack of Efficacy|1|||
47057269|NCT02557295|83335033|FG008|Overall Study|Lack of Efficacy|0|||
47057270|NCT02557295|83335025|FG000|Overall Study|Adverse Event|16|||
47057271|NCT02557295|83335026|FG001|Overall Study|Adverse Event|2|||
46761274|NCT00878969|82979456|FG000|Overall Study|Physician Decision|5|||
46761275|NCT00878969|82979457|FG001|Overall Study|Physician Decision|3|||
46761276|NCT00878969|82979458|FG002|Overall Study|Physician Decision|2|||
46761277|NCT00878969|82979456|FG000|Overall Study|Withdrawal by Subject|1|||
46761278|NCT00878969|82979457|FG001|Overall Study|Withdrawal by Subject|6|||
46761279|NCT00878969|82979458|FG002|Overall Study|Withdrawal by Subject|3|||
46761280|NCT00878969|82979456|FG000|Overall Study|kidney transplant|2|||
46761281|NCT00878969|82979457|FG001|Overall Study|kidney transplant|3|||
46933429|NCT00709592|83169138|FG001|Overall Study|Unable to proceed to transplant|1|||
46933430|NCT02570152|83169144|FG000|Overall Study|Protocol Violation|2|||
46761282|NCT00878969|82979458|FG002|Overall Study|kidney transplant|2|||
46761283|NCT00878969|82979456|FG000|Overall Study|Adverse Event|3|||
46761284|NCT00878969|82979457|FG001|Overall Study|Adverse Event|1|||
46761285|NCT00878969|82979458|FG002|Overall Study|Adverse Event|2|||
46761286|NCT00878969|82979456|FG000|Overall Study|Lost to Follow-up|2|||
46761287|NCT00878969|82979457|FG001|Overall Study|Lost to Follow-up|1|||
46761288|NCT00878969|82979458|FG002|Overall Study|Lost to Follow-up|0|||
46761289|NCT00878969|82979456|FG000|Overall Study|Protocol Violation|2|||
46761290|NCT00878969|82979457|FG001|Overall Study|Protocol Violation|0|||
46761291|NCT00878969|82979458|FG002|Overall Study|Protocol Violation|0|||
46761292|NCT00878969|82979456|FG000|Overall Study|Death|0|||
46761293|NCT00878969|82979457|FG001|Overall Study|Death|0|||
46761294|NCT00878969|82979458|FG002|Overall Study|Death|2|||
46761295|NCT00878969|82979456|FG000|Overall Study|Pregnancy|0|||
46761296|NCT00878969|82979457|FG001|Overall Study|Pregnancy|1|||
46823675|NCT00449150|83042961|FG001|Overall Study|Withdrawal by Subject|18|||
46761297|NCT00878969|82979458|FG002|Overall Study|Pregnancy|0|||
46761298|NCT00843726|82979472|FG000|Overall Study|Death|1|||
46761299|NCT00843726|82979473|FG001|Overall Study|Death|0|||
46933431|NCT02570152|83169144|FG000|Overall Study|Migrated/moved from study area|13|||
46967730|NCT02181790|83210298|FG000|Overall Study|study terminated|2|||
46967731|NCT02181790|83210299|FG001|Overall Study|study terminated|0|||
46967732|NCT02616783|83210318|FG000|Overall Study|Randomized but Not Treated|1|||
46967733|NCT02616783|83210319|FG001|Overall Study|Randomized but Not Treated|0|||
46967734|NCT02616783|83210318|FG000|Overall Study|Adverse Event|1|||
46967735|NCT02616783|83210319|FG001|Overall Study|Adverse Event|0|||
46967736|NCT02616783|83210318|FG000|Overall Study|Death|1|||
46967737|NCT02616783|83210319|FG001|Overall Study|Death|0|||
46967738|NCT02616783|83210318|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46967739|NCT02616783|83210319|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46967740|NCT02616783|83210318|FG000|Overall Study|Protocol Violation|1|||
46967741|NCT02616783|83210319|FG001|Overall Study|Protocol Violation|1|||
46967742|NCT02616783|83210318|FG000|Overall Study|Withdrew Consent|1|||
46967743|NCT02616783|83210319|FG001|Overall Study|Withdrew Consent|1|||
46967744|NCT02616393|83210328|FG000|Overall Study|Death|5|||
46967745|NCT02616393|83210329|FG001|Overall Study|Death|12|||
46967746|NCT02616393|83210330|FG002|Overall Study|Death|1|||
46967747|NCT02616393|83210328|FG000|Overall Study|Termination by Sponsor|4|||
46967748|NCT02616393|83210329|FG001|Overall Study|Termination by Sponsor|5|||
46967749|NCT02616393|83210330|FG002|Overall Study|Termination by Sponsor|2|||
46967750|NCT02616393|83210328|FG000|Overall Study|Other|3|||
46967751|NCT02616393|83210329|FG001|Overall Study|Other|0|||
46967752|NCT02616393|83210330|FG002|Overall Study|Other|0|||
46967753|NCT02616393|83210328|FG000|Overall Study|Withdrawal by Subject|1|||
46967754|NCT02616393|83210329|FG001|Overall Study|Withdrawal by Subject|1|||
46967755|NCT02616393|83210330|FG002|Overall Study|Withdrawal by Subject|0|||
46967756|NCT02616393|83210328|FG000|Overall Study|Lost to Follow-up|0|||
46967757|NCT02616393|83210329|FG001|Overall Study|Lost to Follow-up|2|||
46967758|NCT02616393|83210330|FG002|Overall Study|Lost to Follow-up|0|||
46967759|NCT02155660|83210358|FG000|Overall Study|Other Reason|8|||
46823676|NCT00449150|83042962|FG002|Overall Study|Withdrawal by Subject|21|||
46823677|NCT00449150|83042960|FG000|Overall Study|Protocol Violation|1|||
46823678|NCT00449150|83042961|FG001|Overall Study|Protocol Violation|2|||
46823679|NCT00449150|83042962|FG002|Overall Study|Protocol Violation|1|||
46823680|NCT00428844|83042976|FG000|Completed Study Drug Treatment|Adverse Event|2|||
46823681|NCT00428844|83042977|FG001|Completed Study Drug Treatment|Adverse Event|4|||
46823682|NCT00428844|83042978|FG002|Completed Study Drug Treatment|Adverse Event|4|||
46823683|NCT00428844|83042976|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
46823684|NCT00428844|83042977|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
46823685|NCT00428844|83042978|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
46823686|NCT00428844|83042976|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
46823687|NCT00428844|83042977|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
46823688|NCT00428844|83042978|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
46823689|NCT00428844|83042976|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
46823690|NCT00428844|83042977|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
46823691|NCT00428844|83042978|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
46823692|NCT00428844|83042976|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
46823693|NCT00428844|83042977|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
46823694|NCT00428844|83042978|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
46823695|NCT00428844|83042976|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
46823696|NCT00428844|83042977|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
46823697|NCT00428844|83042978|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
46823698|NCT00428844|83042976|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
46823699|NCT00428844|83042977|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
46823700|NCT00428844|83042978|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
46823701|NCT00428844|83042976|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
46823702|NCT00428844|83042977|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
46823703|NCT00428844|83042978|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
46823704|NCT00428844|83042976|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
46823705|NCT00428844|83042977|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
46823706|NCT00428844|83042978|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
46823707|NCT00457418|83042986|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
46823708|NCT00457418|83042986|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
46823709|NCT00457418|83042986|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
46823710|NCT00457418|83042986|FG000|Post PK Maintenance|Adverse Event|10|||
46823711|NCT00457418|83042986|FG000|Post PK Maintenance|Progression of Disease|6|||
46823712|NCT00457418|83042986|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
46823713|NCT00457418|83042986|FG000|Post PK Maintenance|Lost to Follow-up|1|||
46823714|NCT00449072|83042992|FG000|Overall Study|Adverse Event|3|||
46823715|NCT00449072|83042993|FG001|Overall Study|Adverse Event|1|||
46823716|NCT00449072|83042992|FG000|Overall Study|Protocol Violation|14|||
46823717|NCT00449072|83042993|FG001|Overall Study|Protocol Violation|12|||
46823718|NCT00449072|83042992|FG000|Overall Study|Lost to Follow-up|5|||
46823719|NCT00449072|83042993|FG001|Overall Study|Lost to Follow-up|7|||
46823720|NCT00449072|83042992|FG000|Overall Study|Withdrawal by Subject|11|||
46823721|NCT00449072|83042993|FG001|Overall Study|Withdrawal by Subject|8|||
46823722|NCT00449072|83042992|FG000|Overall Study|Lack of Efficacy|1|||
46823723|NCT00449072|83042993|FG001|Overall Study|Lack of Efficacy|1|||
46823724|NCT00449072|83042992|FG000|Overall Study|Physician Decision|1|||
46761300|NCT00843726|82979472|FG000|Overall Study|Withdrawal by Subject|0|||
46761301|NCT00843726|82979473|FG001|Overall Study|Withdrawal by Subject|1|||
46823725|NCT00449072|83042993|FG001|Overall Study|Physician Decision|0|||
46823726|NCT00449072|83042992|FG000|Overall Study|Not treated|0|||
46823727|NCT00449072|83042993|FG001|Overall Study|Not treated|1|||
46823728|NCT00449072|83042992|FG000|Overall Study|Excluded medication|0|||
46823729|NCT00449072|83042993|FG001|Overall Study|Excluded medication|2|||
46823730|NCT00449072|83042992|FG000|Overall Study|Non-compliance|2|||
46823731|NCT00449072|83042993|FG001|Overall Study|Non-compliance|5|||
46761302|NCT00843492|82979482|FG000|Overall Study|Adverse Event|0|||
46761303|NCT00843492|82979483|FG001|Overall Study|Adverse Event|3|||
46761304|NCT00843492|82979482|FG000|Overall Study|Lost to Follow-up|4|||
46761305|NCT00843492|82979483|FG001|Overall Study|Lost to Follow-up|4|||
46823732|NCT00449072|83042992|FG000|Overall Study|Sponsor decision|1|||
46823733|NCT00449072|83042993|FG001|Overall Study|Sponsor decision|3|||
46823734|NCT00449072|83042992|FG000|Overall Study|Relocation|3|||
46761306|NCT00843492|82979482|FG000|Overall Study|Withdrawal by Subject|0|||
46823735|NCT00449072|83042993|FG001|Overall Study|Relocation|2|||
46823736|NCT00428610|83043002|FG000|Overall Study|Death Due to Adverse Event|3|||
46823737|NCT00428610|83043003|FG001|Overall Study|Death Due to Adverse Event|0|||
46823738|NCT00428610|83043004|FG002|Overall Study|Death Due to Adverse Event|5|||
46823739|NCT00428610|83043002|FG000|Overall Study|Death Due to Progressive Disease|0|||
46761307|NCT00843492|82979483|FG001|Overall Study|Withdrawal by Subject|4|||
46761308|NCT00843492|82979482|FG000|Overall Study|Immobilization Stopped|1|||
46823740|NCT00428610|83043003|FG001|Overall Study|Death Due to Progressive Disease|0|||
46823741|NCT00428610|83043004|FG002|Overall Study|Death Due to Progressive Disease|2|||
46823742|NCT00428610|83043002|FG000|Overall Study|Adverse Event|2|||
46823743|NCT00428610|83043003|FG001|Overall Study|Adverse Event|3|||
46823744|NCT00428610|83043004|FG002|Overall Study|Adverse Event|2|||
46823745|NCT00428610|83043002|FG000|Overall Study|Investigator Decision|2|||
46823746|NCT00428610|83043003|FG001|Overall Study|Investigator Decision|1|||
46823747|NCT00428610|83043004|FG002|Overall Study|Investigator Decision|1|||
46823748|NCT00428610|83043002|FG000|Overall Study|Progressive Disease|42|||
46823749|NCT00428610|83043003|FG001|Overall Study|Progressive Disease|14|||
46823750|NCT00428610|83043004|FG002|Overall Study|Progressive Disease|22|||
46823751|NCT00428610|83043002|FG000|Overall Study|Withdrawal by Subject|4|||
46823752|NCT00428610|83043003|FG001|Overall Study|Withdrawal by Subject|0|||
46823753|NCT00428610|83043004|FG002|Overall Study|Withdrawal by Subject|0|||
46823754|NCT00419094|83043014|FG000|Overall Study|Adverse Event|3|||
46933432|NCT02570074|83169150|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
46933433|NCT02570074|83169151|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
46933434|NCT02569996|83169169|FG000|Overall Study|Adverse Event|6|||
46933435|NCT02569996|83169169|FG000|Overall Study|Physician Decision|3|||
46933436|NCT02569996|83169169|FG000|Overall Study|Progression of the disease|18|||
46933437|NCT02569996|83169169|FG000|Overall Study|New anti-lymphoma treatment|1|||
46761309|NCT00843492|82979483|FG001|Overall Study|Immobilization Stopped|0|||
46823755|NCT00419094|83043015|FG001|Overall Study|Adverse Event|7|||
46823756|NCT00419094|83043014|FG000|Overall Study|Lack of Efficacy|1|||
46823757|NCT00419094|83043015|FG001|Overall Study|Lack of Efficacy|0|||
46823758|NCT00419094|83043014|FG000|Overall Study|Lost to Follow-up|0|||
46823759|NCT00419094|83043015|FG001|Overall Study|Lost to Follow-up|2|||
46823760|NCT00419094|83043014|FG000|Overall Study|Protocol Violation|1|||
46823761|NCT00419094|83043015|FG001|Overall Study|Protocol Violation|14|||
46823762|NCT00419094|83043014|FG000|Overall Study|Withdrawal of consent|1|||
46823763|NCT00419094|83043015|FG001|Overall Study|Withdrawal of consent|5|||
46823764|NCT00419094|83043014|FG000|Overall Study|Other: Error determining exit criteria|1|||
46823765|NCT00419094|83043015|FG001|Overall Study|Other: Error determining exit criteria|0|||
46823766|NCT00419094|83043014|FG000|Overall Study|Other: Patient non-compliant|0|||
46823767|NCT00419094|83043015|FG001|Overall Study|Other: Patient non-compliant|1|||
46823768|NCT00419094|83043014|FG000|Overall Study|Other: No contact for extended period|0|||
46823769|NCT00419094|83043015|FG001|Overall Study|Other: No contact for extended period|1|||
46823770|NCT00448916|83043025|FG000|Overall Study|Adverse Event|2|||
46823771|NCT00448916|83043026|FG001|Overall Study|Adverse Event|2|||
46823772|NCT00448916|83043027|FG002|Overall Study|Adverse Event|3|||
46933438|NCT02569996|83169169|FG000|Overall Study|Non-compliance|9|||
46933439|NCT02569996|83169169|FG000|Overall Study|Withdrawal by Subject|5|||
46761310|NCT00843492|82979482|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
46761311|NCT00843492|82979483|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
46761312|NCT00843492|82979482|FG000|Overall Study|Orthopedic Surgery|0|||
46761313|NCT00843492|82979483|FG001|Overall Study|Orthopedic Surgery|2|||
46761314|NCT00843492|82979482|FG000|Overall Study|Visit Not Performed|1|||
46761315|NCT00843492|82979483|FG001|Overall Study|Visit Not Performed|0|||
46761316|NCT00843492|82979482|FG000|Overall Study|Deep-vein Thrombosis|1|||
46761317|NCT00843492|82979483|FG001|Overall Study|Deep-vein Thrombosis|0|||
46761318|NCT00833976|82979489|FG000|Overall Study|Withdrawal by Subject|5|||
46761319|NCT00833976|82979489|FG000|Overall Study|Lost to Follow-up|4|||
46761320|NCT00833976|82979489|FG000|Overall Study|Did not meet eligibility criteria|41|||
46761321|NCT00833976|82979489|FG000|Overall Study|Physician Decision|1|||
46761322|NCT00833898|82979495|FG000|Overall Study|Withdrawal by Subject|33|||
46761323|NCT00833898|82979496|FG001|Overall Study|Withdrawal by Subject|27|||
46761324|NCT00833898|82979495|FG000|Overall Study|Lost to Follow-up|7|||
46761325|NCT00833898|82979496|FG001|Overall Study|Lost to Follow-up|7|||
46761326|NCT00833898|82979495|FG000|Overall Study|Patient did not receive transplant|0|||
46761327|NCT00833898|82979496|FG001|Overall Study|Patient did not receive transplant|2|||
46761328|NCT00825162|82979505|FG000|Overall Study|Withdrawal by Subject|11|||
46761329|NCT00825162|82979506|FG001|Overall Study|Withdrawal by Subject|13|||
46761330|NCT00825162|82979507|FG002|Overall Study|Withdrawal by Subject|3|||
46823773|NCT00448916|83043028|FG003|Overall Study|Adverse Event|2|||
46823774|NCT00448916|83043025|FG000|Overall Study|Lack of Efficacy|1|||
46823775|NCT00448916|83043026|FG001|Overall Study|Lack of Efficacy|0|||
46761331|NCT00825162|82979505|FG000|Overall Study|Lost to Follow-up|9|||
46761332|NCT00825162|82979506|FG001|Overall Study|Lost to Follow-up|6|||
46823776|NCT00448916|83043027|FG002|Overall Study|Lack of Efficacy|2|||
46823777|NCT00448916|83043028|FG003|Overall Study|Lack of Efficacy|1|||
46933440|NCT02569996|83169169|FG000|Overall Study|Lost to Follow-up|5|||
46761333|NCT00825162|82979507|FG002|Overall Study|Lost to Follow-up|3|||
46761334|NCT00825162|82979505|FG000|Overall Study|Physician Decision|2|||
46761335|NCT00825162|82979506|FG001|Overall Study|Physician Decision|0|||
46761336|NCT00825162|82979507|FG002|Overall Study|Physician Decision|0|||
46823778|NCT00448916|83043025|FG000|Overall Study|Withdrawal by Subject|3|||
46823779|NCT00448916|83043026|FG001|Overall Study|Withdrawal by Subject|3|||
46933441|NCT02569996|83169169|FG000|Overall Study|Complete remission|7|||
46933442|NCT02569996|83169169|FG000|Overall Study|Unknown reason|1|||
46933443|NCT02572882|83169173|FG000|Overall Study|Withdrawal by Subject|1|||
46933444|NCT02572882|83169173|FG000|Overall Study|Participant received kidney transplant|1|||
46933445|NCT00708500|83169203|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
46933446|NCT00708500|83169204|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
46933447|NCT00708500|83169205|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
46933448|NCT00708500|83169203|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
46933449|NCT00708500|83169204|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
46933450|NCT00708500|83169205|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
46933451|NCT00708500|83169203|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
46933452|NCT00708500|83169204|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
46933453|NCT00708500|83169205|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
46933454|NCT00708500|83169203|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
46933455|NCT00708500|83169204|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
46933456|NCT00708500|83169205|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
46933457|NCT00708500|83169203|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
46933458|NCT00708500|83169204|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
46933459|NCT00708500|83169205|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
46933460|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
46933461|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
46933462|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
46933463|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
46933464|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
46933465|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
46933466|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
46933467|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
46933468|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
46933469|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
46933470|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
46933471|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
46933472|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
46933473|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
46933474|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
46933475|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
46933476|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
46761337|NCT00825162|82979505|FG000|Overall Study|Move away from the study area|1|||
46761338|NCT00825162|82979506|FG001|Overall Study|Move away from the study area|0|||
46933477|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
46933478|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
46933479|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
46933480|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
46933481|NCT00708500|83169203|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
46933482|NCT00708500|83169204|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
46933483|NCT00708500|83169205|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
46933484|NCT00708500|83169203|FG000|FOLLOWUP|Adverse Event|0|||
46933485|NCT00708500|83169204|FG001|FOLLOWUP|Adverse Event|1|||
46933486|NCT00708500|83169205|FG002|FOLLOWUP|Adverse Event|0|||
46933487|NCT00708500|83169203|FG000|FOLLOWUP|Lost to Follow-up|1|||
46933488|NCT00708500|83169204|FG001|FOLLOWUP|Lost to Follow-up|6|||
46761339|NCT00825162|82979507|FG002|Overall Study|Move away from the study area|0|||
46761340|NCT00825162|82979505|FG000|Overall Study|Unable to attend the study visit|5|||
46761341|NCT00825162|82979506|FG001|Overall Study|Unable to attend the study visit|2|||
46761342|NCT00825162|82979507|FG002|Overall Study|Unable to attend the study visit|0|||
46933489|NCT00708500|83169205|FG002|FOLLOWUP|Lost to Follow-up|4|||
46933490|NCT00708500|83169203|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
46933491|NCT00708500|83169204|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
46933492|NCT00708500|83169205|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
46933493|NCT00708500|83169203|FG000|FOLLOWUP|Subject withdrew consent|31|||
46933494|NCT00708500|83169204|FG001|FOLLOWUP|Subject withdrew consent|4|||
46933495|NCT00708500|83169205|FG002|FOLLOWUP|Subject withdrew consent|5|||
46761343|NCT00824850|82979522|FG000|Overall Study|Withdrawal by Subject|0|||
46761344|NCT00824850|82979523|FG001|Overall Study|Withdrawal by Subject|1|||
46761345|NCT00596687|82979537|FG000|Overall Study|< 24 hours of insulin treatment|8|||
46761346|NCT00596687|82979538|FG001|Overall Study|< 24 hours of insulin treatment|6|||
46761347|NCT00596687|82979537|FG000|Overall Study|continuous insulin infusion during TPN|2|||
47057272|NCT02557295|83335027|FG002|Overall Study|Adverse Event|3|||
47057273|NCT02557295|83335028|FG003|Overall Study|Adverse Event|0|||
47057274|NCT02557295|83335029|FG004|Overall Study|Adverse Event|0|||
47057275|NCT02557295|83335030|FG005|Overall Study|Adverse Event|0|||
47057276|NCT02557295|83335031|FG006|Overall Study|Adverse Event|2|||
47057277|NCT02557295|83335032|FG007|Overall Study|Adverse Event|1|||
47057278|NCT02557295|83335033|FG008|Overall Study|Adverse Event|1|||
47057279|NCT02557295|83335025|FG000|Overall Study|Lost to Follow-up|4|||
47057280|NCT02557295|83335026|FG001|Overall Study|Lost to Follow-up|0|||
47057281|NCT02557295|83335027|FG002|Overall Study|Lost to Follow-up|0|||
47057282|NCT02557295|83335028|FG003|Overall Study|Lost to Follow-up|0|||
47057283|NCT02557295|83335029|FG004|Overall Study|Lost to Follow-up|0|||
46933496|NCT00708500|83169203|FG000|FOLLOWUP|Non-compliance with protocol|5|||
46933497|NCT00708500|83169204|FG001|FOLLOWUP|Non-compliance with protocol|0|||
46933498|NCT00708500|83169205|FG002|FOLLOWUP|Non-compliance with protocol|1|||
46933499|NCT00708734|83169222|FG000|Overall Study|scheduling conflict|2|||
46933500|NCT00708734|83169222|FG000|Overall Study|moved|1|||
46823780|NCT00448916|83043027|FG002|Overall Study|Withdrawal by Subject|1|||
46823781|NCT00448916|83043028|FG003|Overall Study|Withdrawal by Subject|1|||
46823782|NCT00448916|83043025|FG000|Overall Study|Other|1|||
46823783|NCT00448916|83043026|FG001|Overall Study|Other|0|||
46823784|NCT00448916|83043027|FG002|Overall Study|Other|0|||
46823785|NCT00448916|83043028|FG003|Overall Study|Other|0|||
46823786|NCT00448916|83043025|FG000|Overall Study|Lost to Follow-up|0|||
46823787|NCT00448916|83043026|FG001|Overall Study|Lost to Follow-up|1|||
46823788|NCT00448916|83043027|FG002|Overall Study|Lost to Follow-up|0|||
46823789|NCT00448916|83043028|FG003|Overall Study|Lost to Follow-up|1|||
46823790|NCT00448916|83043025|FG000|Overall Study|Protocol Violation|0|||
46823791|NCT00448916|83043026|FG001|Overall Study|Protocol Violation|0|||
46823792|NCT00448916|83043027|FG002|Overall Study|Protocol Violation|0|||
46823793|NCT00448916|83043028|FG003|Overall Study|Protocol Violation|1|||
46823794|NCT00418938|83043042|FG000|Overall Study|Reimbursement|1|||
46823795|NCT00418938|83043043|FG001|Overall Study|Reimbursement|0|||
46823796|NCT00418938|83043042|FG000|Overall Study|Administrative decision|3|||
46823797|NCT00418938|83043043|FG001|Overall Study|Administrative decision|3|||
46823798|NCT00418938|83043042|FG000|Overall Study|Withdrawal by Subject|16|||
46823799|NCT00418938|83043043|FG001|Overall Study|Withdrawal by Subject|15|||
46823800|NCT00418938|83043042|FG000|Overall Study|Lost to Follow-up|1|||
46823801|NCT00418938|83043043|FG001|Overall Study|Lost to Follow-up|3|||
46823802|NCT00418938|83043042|FG000|Overall Study|Adverse Event|1|||
46823803|NCT00418938|83043043|FG001|Overall Study|Adverse Event|1|||
46823804|NCT00418938|83043042|FG000|Overall Study|On-going|1|||
46823805|NCT00418938|83043043|FG001|Overall Study|On-going|1|||
46823806|NCT00418938|83043042|FG000|Overall Study|Ineligibility Determined|1|||
46823807|NCT00418938|83043043|FG001|Overall Study|Ineligibility Determined|0|||
46823808|NCT00448760|83043049|FG000|Overall Study|Death|3|||
46823809|NCT00418314|83043055|FG000|Overall Study|Withdrawal by Subject|1|||
46823810|NCT00418314|83043056|FG001|Overall Study|Withdrawal by Subject|2|||
46823811|NCT00448448|83043064|FG000|Overall Study|Withdrawal by Subject|13|||
46933501|NCT00708734|83169222|FG000|Overall Study|leg injury|1|||
46933502|NCT00708734|83169222|FG000|Overall Study|knee replacement|1|||
47057284|NCT02557295|83335030|FG005|Overall Study|Lost to Follow-up|0|||
46933503|NCT00708734|83169222|FG000|Overall Study|vertigo|1|||
46933504|NCT00708734|83169222|FG000|Overall Study|leg fracture|1|||
46933505|NCT04834362|83169228|FG000|Overall Study|Death|1|||
46933506|NCT04834362|83169229|FG001|Overall Study|Death|2|||
46933507|NCT00101907|83169241|FG000|Overall Study|Adverse Event|1|||
46933508|NCT00101907|83169242|FG001|Overall Study|Adverse Event|0|||
46933509|NCT00101907|83169243|FG002|Overall Study|Adverse Event|0|||
46933510|NCT00101907|83169244|FG003|Overall Study|Adverse Event|0|||
46933511|NCT00101907|83169245|FG004|Overall Study|Adverse Event|0|||
46933512|NCT00101907|83169246|FG005|Overall Study|Adverse Event|0|||
46933513|NCT00101907|83169241|FG000|Overall Study|Death|0|||
46933514|NCT00101907|83169242|FG001|Overall Study|Death|1|||
46933515|NCT00101907|83169243|FG002|Overall Study|Death|0|||
46933516|NCT00101907|83169244|FG003|Overall Study|Death|0|||
46933517|NCT00101907|83169245|FG004|Overall Study|Death|3|||
47057285|NCT02557295|83335031|FG006|Overall Study|Lost to Follow-up|9|||
46823812|NCT00448448|83043065|FG001|Overall Study|Withdrawal by Subject|2|||
46823813|NCT00448448|83043064|FG000|Overall Study|On protocol when study ended|83|||
46933518|NCT00101907|83169246|FG005|Overall Study|Death|0|||
47057286|NCT02557295|83335032|FG007|Overall Study|Lost to Follow-up|0|||
47057287|NCT02557295|83335033|FG008|Overall Study|Lost to Follow-up|0|||
46823814|NCT00448448|83043065|FG001|Overall Study|On protocol when study ended|36|||
46823815|NCT00448448|83043064|FG000|Overall Study|Lost to Follow-up|2|||
46823816|NCT00448448|83043065|FG001|Overall Study|Lost to Follow-up|1|||
46823817|NCT00448448|83043064|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
47057288|NCT02557295|83335025|FG000|Overall Study|Study Close|54|||
46823818|NCT00448448|83043065|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
46933519|NCT00101907|83169241|FG000|Overall Study|Physician Decision|0|||
46933520|NCT00101907|83169242|FG001|Overall Study|Physician Decision|0|||
47057289|NCT02557295|83335026|FG001|Overall Study|Study Close|3|||
46823819|NCT00448448|83043064|FG000|Overall Study|Signed consent lost|0|||
46823820|NCT00448448|83043065|FG001|Overall Study|Signed consent lost|1|||
46823821|NCT00405912|83043074|FG000|Overall Study|Withdrawal by Subject|12|||
46823822|NCT00405912|83043075|FG001|Overall Study|Withdrawal by Subject|11|||
46823823|NCT00405912|83043076|FG002|Overall Study|Withdrawal by Subject|12|||
46823824|NCT00405912|83043074|FG000|Overall Study|Lost to Follow-up|4|||
46823825|NCT00405912|83043075|FG001|Overall Study|Lost to Follow-up|8|||
46823826|NCT00405912|83043076|FG002|Overall Study|Lost to Follow-up|4|||
47057290|NCT02557295|83335027|FG002|Overall Study|Study Close|5|||
47057291|NCT02557295|83335028|FG003|Overall Study|Study Close|3|||
47057292|NCT02557295|83335029|FG004|Overall Study|Study Close|0|||
47057293|NCT02557295|83335030|FG005|Overall Study|Study Close|0|||
47057294|NCT02557295|83335031|FG006|Overall Study|Study Close|37|||
47057295|NCT02557295|83335032|FG007|Overall Study|Study Close|3|||
47057296|NCT02557295|83335033|FG008|Overall Study|Study Close|19|||
47057297|NCT02557295|83335025|FG000|Overall Study|except for study close|4|||
47057298|NCT02557295|83335026|FG001|Overall Study|except for study close|0|||
47057299|NCT02557295|83335027|FG002|Overall Study|except for study close|0|||
47057300|NCT02557295|83335028|FG003|Overall Study|except for study close|0|||
47057301|NCT02557295|83335029|FG004|Overall Study|except for study close|0|||
47057302|NCT02557295|83335030|FG005|Overall Study|except for study close|0|||
47057303|NCT02557295|83335031|FG006|Overall Study|except for study close|5|||
47057304|NCT02557295|83335032|FG007|Overall Study|except for study close|1|||
46823827|NCT00448136|83043086|FG000|Overall Study|Death|3|||
46823828|NCT00448136|83043087|FG001|Overall Study|Death|8|||
46823829|NCT00448136|83043086|FG000|Overall Study|Investigator's decision (progression)|1|||
46636983|NCT02914561|82810924|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
47057305|NCT02557295|83335033|FG008|Overall Study|except for study close|0|||
47057306|NCT02425046|83335047|FG000|Overall Study|Lost to Follow-up|52|||
47057307|NCT02425046|83335048|FG001|Overall Study|Lost to Follow-up|50|||
47057308|NCT02425046|83335049|FG002|Overall Study|Lost to Follow-up|56|||
47057309|NCT02425046|83335047|FG000|Overall Study|Withdrawal by Subject|16|||
47057310|NCT02425046|83335048|FG001|Overall Study|Withdrawal by Subject|12|||
47057311|NCT02425046|83335049|FG002|Overall Study|Withdrawal by Subject|0|||
47057312|NCT02255435|83335083|FG000|Overall Study|Patient's Limited Time Availability|0|||
47057313|NCT02255435|83335084|FG001|Overall Study|Patient's Limited Time Availability|0|||
47057314|NCT02255435|83335085|FG002|Overall Study|Patient's Limited Time Availability|0|||
47057315|NCT02255435|83335086|FG003|Overall Study|Patient's Limited Time Availability|0|||
47057316|NCT02255435|83335087|FG004|Overall Study|Patient's Limited Time Availability|0|||
47057317|NCT02255435|83335088|FG005|Overall Study|Patient's Limited Time Availability|0|||
47057318|NCT02255435|83335089|FG006|Overall Study|Patient's Limited Time Availability|0|||
47057319|NCT02255435|83335090|FG007|Overall Study|Patient's Limited Time Availability|1|||
47057320|NCT02255435|83335091|FG008|Overall Study|Patient's Limited Time Availability|0|||
47057321|NCT02255435|83335092|FG009|Overall Study|Patient's Limited Time Availability|0|||
47057322|NCT02255435|83335083|FG000|Overall Study|Withdrawal by Subject|0|||
47057323|NCT02255435|83335084|FG001|Overall Study|Withdrawal by Subject|0|||
47057324|NCT02255435|83335085|FG002|Overall Study|Withdrawal by Subject|0|||
47057325|NCT02255435|83335086|FG003|Overall Study|Withdrawal by Subject|0|||
47057326|NCT02255435|83335087|FG004|Overall Study|Withdrawal by Subject|0|||
47057327|NCT02255435|83335088|FG005|Overall Study|Withdrawal by Subject|0|||
46636984|NCT02914561|82810925|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
46761348|NCT00596687|82979538|FG001|Overall Study|continuous insulin infusion during TPN|1|||
46761349|NCT00596687|82979537|FG000|Overall Study|Withdrawal by Subject|3|||
46761350|NCT00596687|82979538|FG001|Overall Study|Withdrawal by Subject|1|||
46761351|NCT00596687|82979537|FG000|Overall Study|cancelled surgery|1|||
46761352|NCT00596687|82979538|FG001|Overall Study|cancelled surgery|1|||
46761353|NCT00824772|82979544|FG000|Overall Study|Withdrawal by Subject|8|||
46761354|NCT00824616|82979550|FG000|Overall Study|Adverse Event|2|||
46761355|NCT00824616|82979551|FG001|Overall Study|Adverse Event|1|||
46761356|NCT00824616|82979550|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
46823830|NCT00448136|83043087|FG001|Overall Study|Investigator's decision (progression)|0|||
46823831|NCT00447902|83043095|FG000|Overall Study|Adverse Event|0|||
46823832|NCT00447902|83043096|FG001|Overall Study|Adverse Event|3|||
46823833|NCT00447902|83043095|FG000|Overall Study|Protocol Violation|1|||
47057328|NCT02255435|83335089|FG006|Overall Study|Withdrawal by Subject|0|||
46761357|NCT00824616|82979551|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
47057329|NCT02255435|83335090|FG007|Overall Study|Withdrawal by Subject|0|||
47057330|NCT02255435|83335091|FG008|Overall Study|Withdrawal by Subject|1|||
47057331|NCT02255435|83335092|FG009|Overall Study|Withdrawal by Subject|4|||
47057332|NCT02255435|83335083|FG000|Overall Study|Administrative reasons|0|||
46761358|NCT00824616|82979550|FG000|Overall Study|Hyperglycemia|1|||
46761359|NCT00824616|82979551|FG001|Overall Study|Hyperglycemia|1|||
47057333|NCT02255435|83335084|FG001|Overall Study|Administrative reasons|0|||
46823834|NCT00447902|83043096|FG001|Overall Study|Protocol Violation|0|||
46823835|NCT00447902|83043095|FG000|Overall Study|Withdrawal by Subject|0|||
46823836|NCT00447902|83043096|FG001|Overall Study|Withdrawal by Subject|1|||
46823837|NCT00447902|83043095|FG000|Overall Study|included patients who discontinued|1|||
46823838|NCT00447902|83043096|FG001|Overall Study|included patients who discontinued|1|||
46823839|NCT00447902|83043095|FG000|Overall Study|Lack of Efficacy|2|||
46933521|NCT00101907|83169243|FG002|Overall Study|Physician Decision|0|||
46933522|NCT00101907|83169244|FG003|Overall Study|Physician Decision|1|||
46933523|NCT00101907|83169245|FG004|Overall Study|Physician Decision|1|||
46933524|NCT00101907|83169246|FG005|Overall Study|Physician Decision|0|||
46933525|NCT00101907|83169241|FG000|Overall Study|Withdrawal by Subject|1|||
46933526|NCT00101907|83169242|FG001|Overall Study|Withdrawal by Subject|0|||
46933527|NCT00101907|83169243|FG002|Overall Study|Withdrawal by Subject|1|||
46933528|NCT00101907|83169244|FG003|Overall Study|Withdrawal by Subject|0|||
46933529|NCT00101907|83169245|FG004|Overall Study|Withdrawal by Subject|1|||
46933530|NCT00101907|83169246|FG005|Overall Study|Withdrawal by Subject|0|||
46933531|NCT02565784|83169267|FG000|First Treatment|Adverse Event|1|||
46933532|NCT02565784|83169267|FG000|First Treatment|Withdrawal by Subject|1|||
46636985|NCT02914561|82810926|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
46636986|NCT02914561|82810927|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
46823840|NCT00447902|83043096|FG001|Overall Study|Lack of Efficacy|1|||
46823841|NCT00307437|83043105|FG000|Controlled Period|Adverse Event|7|||
46823842|NCT00307437|83043106|FG001|Controlled Period|Adverse Event|2|||
46823843|NCT00307437|83043107|FG002|Controlled Period|Adverse Event|5|||
46823844|NCT00307437|83043108|FG003|Controlled Period|Adverse Event|0|||
46823845|NCT00307437|83043109|FG004|Controlled Period|Adverse Event|0|||
46823846|NCT00307437|83043110|FG005|Controlled Period|Adverse Event|0|||
46823847|NCT00307437|83043111|FG006|Controlled Period|Adverse Event|0|||
46823848|NCT00307437|83043105|FG000|Controlled Period|Death|0|||
46823849|NCT00307437|83043106|FG001|Controlled Period|Death|0|||
46823850|NCT00307437|83043107|FG002|Controlled Period|Death|1|||
46823851|NCT00307437|83043108|FG003|Controlled Period|Death|0|||
46823852|NCT00307437|83043109|FG004|Controlled Period|Death|0|||
46823853|NCT00307437|83043110|FG005|Controlled Period|Death|0|||
46823854|NCT00307437|83043111|FG006|Controlled Period|Death|0|||
46823855|NCT00307437|83043105|FG000|Controlled Period|Lack of Efficacy|2|||
46823856|NCT00307437|83043106|FG001|Controlled Period|Lack of Efficacy|0|||
46823857|NCT00307437|83043107|FG002|Controlled Period|Lack of Efficacy|0|||
46823858|NCT00307437|83043108|FG003|Controlled Period|Lack of Efficacy|0|||
46933533|NCT02565784|83169267|FG000|Second Treatment|Withdrawal by Subject|2|||
46933534|NCT04650204|83169314|FG000|Overall Study|Study was Terminated|2|||
46636987|NCT02914561|82810928|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
46636988|NCT02914561|82810929|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
46636989|NCT02914561|82810930|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
46636990|NCT02914561|82810931|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
46761360|NCT00824616|82979550|FG000|Overall Study|Lack of Efficacy|2|||
46761361|NCT00824616|82979551|FG001|Overall Study|Lack of Efficacy|1|||
46761362|NCT00824616|82979550|FG000|Overall Study|Lost to Follow-up|0|||
46761363|NCT00824616|82979551|FG001|Overall Study|Lost to Follow-up|1|||
46761364|NCT00824616|82979550|FG000|Overall Study|Withdrawal by Subject|1|||
46761365|NCT00824616|82979551|FG001|Overall Study|Withdrawal by Subject|1|||
46761366|NCT00824382|82979561|FG000|Overall Study|Adverse Event|4|||
46761367|NCT00824382|82979562|FG001|Overall Study|Adverse Event|1|||
46761368|NCT00824382|82979563|FG002|Overall Study|Adverse Event|1|||
46761369|NCT00824382|82979564|FG003|Overall Study|Adverse Event|4|||
46761370|NCT00824382|82979561|FG000|Overall Study|Protocol Violation|1|||
46761371|NCT00824382|82979562|FG001|Overall Study|Protocol Violation|0|||
46761372|NCT00824382|82979563|FG002|Overall Study|Protocol Violation|0|||
46761373|NCT00824382|82979564|FG003|Overall Study|Protocol Violation|1|||
46761374|NCT00824382|82979561|FG000|Overall Study|Investigator's decision|0|||
46761375|NCT00824382|82979562|FG001|Overall Study|Investigator's decision|1|||
46761376|NCT00824382|82979563|FG002|Overall Study|Investigator's decision|2|||
46761377|NCT00824382|82979564|FG003|Overall Study|Investigator's decision|0|||
46761378|NCT00833040|82979576|FG000|Overall Study|Adverse Event|0|||
46761379|NCT00833040|82979577|FG001|Overall Study|Adverse Event|0|||
46761380|NCT00833040|82979578|FG002|Overall Study|Adverse Event|0|||
46761381|NCT00833040|82979579|FG003|Overall Study|Adverse Event|0|||
46761382|NCT00833040|82979580|FG004|Overall Study|Adverse Event|0|||
46761383|NCT00833040|82979581|FG005|Overall Study|Adverse Event|1|||
46761384|NCT00843024|82979590|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
46823859|NCT00307437|83043109|FG004|Controlled Period|Lack of Efficacy|0|||
46823860|NCT00307437|83043110|FG005|Controlled Period|Lack of Efficacy|0|||
46823861|NCT00307437|83043111|FG006|Controlled Period|Lack of Efficacy|0|||
46823862|NCT00307437|83043105|FG000|Controlled Period|Lost to Follow-up|2|||
46823863|NCT00307437|83043106|FG001|Controlled Period|Lost to Follow-up|3|||
46823864|NCT00307437|83043107|FG002|Controlled Period|Lost to Follow-up|0|||
46823865|NCT00307437|83043108|FG003|Controlled Period|Lost to Follow-up|0|||
46823866|NCT00307437|83043109|FG004|Controlled Period|Lost to Follow-up|0|||
46823867|NCT00307437|83043110|FG005|Controlled Period|Lost to Follow-up|0|||
46823868|NCT00307437|83043111|FG006|Controlled Period|Lost to Follow-up|0|||
46823869|NCT00307437|83043105|FG000|Controlled Period|Other|5|||
46823870|NCT00307437|83043106|FG001|Controlled Period|Other|1|||
46823871|NCT00307437|83043107|FG002|Controlled Period|Other|3|||
46823872|NCT00307437|83043108|FG003|Controlled Period|Other|0|||
46823873|NCT00307437|83043109|FG004|Controlled Period|Other|0|||
46823874|NCT00307437|83043110|FG005|Controlled Period|Other|0|||
46823875|NCT00307437|83043111|FG006|Controlled Period|Other|0|||
46823876|NCT00307437|83043105|FG000|After Controlled Period|Adverse Event|0|||
46823877|NCT00307437|83043106|FG001|After Controlled Period|Adverse Event|0|||
46823878|NCT00307437|83043107|FG002|After Controlled Period|Adverse Event|0|||
46823879|NCT00307437|83043108|FG003|After Controlled Period|Adverse Event|18|||
46636991|NCT02914561|82810932|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
46636992|NCT02914561|82810933|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
46823880|NCT00307437|83043109|FG004|After Controlled Period|Adverse Event|16|||
46933535|NCT04650204|83169315|FG001|Overall Study|Study was Terminated|1|||
47057334|NCT02255435|83335085|FG002|Overall Study|Administrative reasons|0|||
47057335|NCT02255435|83335086|FG003|Overall Study|Administrative reasons|0|||
47057336|NCT02255435|83335087|FG004|Overall Study|Administrative reasons|0|||
47057337|NCT02255435|83335088|FG005|Overall Study|Administrative reasons|0|||
47057338|NCT02255435|83335089|FG006|Overall Study|Administrative reasons|0|||
47057339|NCT02255435|83335090|FG007|Overall Study|Administrative reasons|0|||
47057340|NCT02255435|83335091|FG008|Overall Study|Administrative reasons|0|||
47057341|NCT02255435|83335092|FG009|Overall Study|Administrative reasons|2|||
46636993|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
46636994|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
46636995|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
46636996|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
46636997|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
46636998|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
46636999|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
46637000|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
46637001|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
46637002|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
46637003|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
46637004|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
46637005|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
46637006|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
46637007|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
46637008|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
46637009|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
46637010|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
46637011|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
46637012|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
46637013|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
46637014|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
46761385|NCT00843024|82979591|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
46761386|NCT00843024|82979592|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
46761387|NCT00843024|82979593|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
46761388|NCT00843024|82979594|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
46761389|NCT00843024|82979595|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
46761390|NCT00843024|82979590|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
46761391|NCT00843024|82979591|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
46761392|NCT00843024|82979592|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
46761393|NCT00843024|82979593|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
47057342|NCT01721798|83335118|FG000|Overall Study|Death|0|||
47057343|NCT01721798|83335119|FG001|Overall Study|Death|0|||
47057344|NCT01721798|83335120|FG002|Overall Study|Death|1|||
47057345|NCT01721798|83335121|FG003|Overall Study|Death|1|||
46761394|NCT00843024|82979594|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
46761395|NCT00843024|82979595|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
46761396|NCT00843024|82979590|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
46761397|NCT00843024|82979591|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
46761398|NCT00843024|82979592|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
46761399|NCT00843024|82979593|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
46823881|NCT00307437|83043110|FG005|After Controlled Period|Adverse Event|31|||
46823882|NCT00307437|83043111|FG006|After Controlled Period|Adverse Event|40|||
46933536|NCT02761629|83169323|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
47057346|NCT01721798|83335118|FG000|Overall Study|Lost to Follow-up|2|||
46933537|NCT02761629|83169324|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
46933538|NCT02761629|83169323|FG000|Overall Study|Insufficient Therapeutic Response|2|||
46933539|NCT02761629|83169324|FG001|Overall Study|Insufficient Therapeutic Response|7|||
46933540|NCT02761629|83169323|FG000|Overall Study|Failure to Return|2|||
46933541|NCT02761629|83169324|FG001|Overall Study|Failure to Return|4|||
46933542|NCT02761629|83169323|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
46933543|NCT02761629|83169324|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
46933544|NCT02761629|83169323|FG000|Overall Study|Protocol Violation|2|||
46933545|NCT02761629|83169324|FG001|Overall Study|Protocol Violation|2|||
46761400|NCT00843024|82979594|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
46761401|NCT00843024|82979595|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
46761402|NCT00843024|82979590|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
46637015|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
46637016|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
47057347|NCT01721798|83335119|FG001|Overall Study|Lost to Follow-up|2|||
47057348|NCT01721798|83335120|FG002|Overall Study|Lost to Follow-up|9|||
47057349|NCT01721798|83335121|FG003|Overall Study|Lost to Follow-up|9|||
47057350|NCT01721798|83335118|FG000|Overall Study|Pregnancy|0|||
47057351|NCT01721798|83335119|FG001|Overall Study|Pregnancy|0|||
47057352|NCT01721798|83335120|FG002|Overall Study|Pregnancy|1|||
46637017|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
46823883|NCT00307437|83043105|FG000|After Controlled Period|Death|0|||
46823884|NCT00307437|83043106|FG001|After Controlled Period|Death|0|||
46823885|NCT00307437|83043107|FG002|After Controlled Period|Death|0|||
46761403|NCT00843024|82979591|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
46761404|NCT00843024|82979592|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
46761405|NCT00843024|82979593|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
46761406|NCT00843024|82979594|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
46823886|NCT00307437|83043108|FG003|After Controlled Period|Death|3|||
46823887|NCT00307437|83043109|FG004|After Controlled Period|Death|1|||
46823888|NCT00307437|83043110|FG005|After Controlled Period|Death|1|||
46823889|NCT00307437|83043111|FG006|After Controlled Period|Death|3|||
46823890|NCT00307437|83043105|FG000|After Controlled Period|Lack of Efficacy|0|||
46933546|NCT02761629|83169323|FG000|Overall Study|Withdrawal by Subject|0|||
46933547|NCT02761629|83169324|FG001|Overall Study|Withdrawal by Subject|3|||
46933548|NCT02761629|83169323|FG000|Overall Study|Other|0|||
46933549|NCT02761629|83169324|FG001|Overall Study|Other|2|||
46823891|NCT00307437|83043106|FG001|After Controlled Period|Lack of Efficacy|0|||
46933550|NCT02761629|83169323|FG000|Overall Study|Lost to Follow-up|4|||
46933551|NCT02761629|83169324|FG001|Overall Study|Lost to Follow-up|1|||
46933552|NCT02761629|83169323|FG000|Overall Study|Randomized But Not Treated|8|||
46933553|NCT02761629|83169324|FG001|Overall Study|Randomized But Not Treated|4|||
46933554|NCT02760927|83169330|FG000|Overall Study|Tube Slippage from Device|1|||
46933555|NCT00101439|83169336|FG000|Period 2|Withdrawal by Subject|0|||
46933556|NCT00101439|83169337|FG001|Period 2|Withdrawal by Subject|2|||
46933557|NCT04033068|83169347|FG000|Overall Study|Withdrawal by Subject|0|||
46933558|NCT04033068|83169348|FG001|Overall Study|Withdrawal by Subject|0|||
46933559|NCT04033068|83169349|FG002|Overall Study|Withdrawal by Subject|1|||
46933560|NCT04033068|83169350|FG003|Overall Study|Withdrawal by Subject|0|||
46933561|NCT04033068|83169347|FG000|Overall Study|Lost to Follow-up|0|||
46823892|NCT00307437|83043107|FG002|After Controlled Period|Lack of Efficacy|0|||
46933562|NCT04033068|83169348|FG001|Overall Study|Lost to Follow-up|1|||
46933563|NCT04033068|83169349|FG002|Overall Study|Lost to Follow-up|0|||
46823893|NCT00307437|83043108|FG003|After Controlled Period|Lack of Efficacy|15|||
46823894|NCT00307437|83043109|FG004|After Controlled Period|Lack of Efficacy|17|||
46823895|NCT00307437|83043110|FG005|After Controlled Period|Lack of Efficacy|37|||
46823896|NCT00307437|83043111|FG006|After Controlled Period|Lack of Efficacy|24|||
46823897|NCT00307437|83043105|FG000|After Controlled Period|Lost to Follow-up|0|||
46823898|NCT00307437|83043106|FG001|After Controlled Period|Lost to Follow-up|0|||
46933564|NCT04033068|83169350|FG003|Overall Study|Lost to Follow-up|0|||
46933565|NCT04033068|83169347|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
46933566|NCT04033068|83169348|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
46637018|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
46933567|NCT04033068|83169349|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
46933568|NCT04033068|83169350|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
46933569|NCT02762565|83169360|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
46933570|NCT02757963|83169373|FG000|Overall Study|Adverse Event|3|||
46933571|NCT02757963|83169373|FG000|Overall Study|Reached Stopping Criteria|1054|||
46637019|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
46637020|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
46933572|NCT02757963|83169373|FG000|Overall Study|Lost to Follow-up|5|||
47057353|NCT01721798|83335121|FG003|Overall Study|Pregnancy|1|||
47057354|NCT01721798|83335118|FG000|Overall Study|Withdrawal by Subject|1|||
46637021|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
46933573|NCT02757963|83169373|FG000|Overall Study|Physician Decision|1|||
46933574|NCT02757963|83169373|FG000|Overall Study|Withdrawal by Subject|34|||
46933575|NCT03111732|83169388|FG000|Overall Study|Enrolled in different study|1|||
46933576|NCT03111732|83169388|FG000|Overall Study|Progressive disease|3|||
46933577|NCT03111732|83169388|FG000|Overall Study|Withdrawal by Subject|1|||
47057355|NCT01721798|83335119|FG001|Overall Study|Withdrawal by Subject|0|||
47057356|NCT01721798|83335120|FG002|Overall Study|Withdrawal by Subject|2|||
46933578|NCT01663714|83169397|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
46761407|NCT00843024|82979595|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
47057357|NCT01721798|83335121|FG003|Overall Study|Withdrawal by Subject|1|||
47057358|NCT01721798|83335118|FG000|Overall Study|Not eligible for 24 month visit|1|||
47057359|NCT01721798|83335119|FG001|Overall Study|Not eligible for 24 month visit|0|||
47057360|NCT01721798|83335120|FG002|Overall Study|Not eligible for 24 month visit|8|||
47057361|NCT01721798|83335121|FG003|Overall Study|Not eligible for 24 month visit|7|||
47057362|NCT01038778|83335145|FG000|Overall Study|Withdrawal by Subject|0|||
47057363|NCT01038778|83335146|FG001|Overall Study|Withdrawal by Subject|2|||
47057364|NCT01038778|83335147|FG002|Overall Study|Withdrawal by Subject|3|||
47057365|NCT00704288|83335156|FG000|Overall Treatment Period|Adverse Event|11|||
47057366|NCT00704288|83335157|FG001|Overall Treatment Period|Adverse Event|8|||
47057367|NCT00704288|83335158|FG002|Overall Treatment Period|Adverse Event|22|||
47057368|NCT00704288|83335156|FG000|Overall Treatment Period|Death|0|||
47057369|NCT00704288|83335157|FG001|Overall Treatment Period|Death|0|||
47057370|NCT00704288|83335158|FG002|Overall Treatment Period|Death|1|||
47057371|NCT00704288|83335156|FG000|Overall Treatment Period|Physician Decision|0|||
47057372|NCT00704288|83335157|FG001|Overall Treatment Period|Physician Decision|2|||
47057373|NCT00704288|83335158|FG002|Overall Treatment Period|Physician Decision|0|||
47057374|NCT00704288|83335156|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
47057375|NCT00704288|83335157|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
47057376|NCT00704288|83335158|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
47057377|NCT00704288|83335156|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
47057378|NCT00704288|83335157|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
47057379|NCT00704288|83335158|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
47057380|NCT00704288|83335156|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
47057381|NCT00704288|83335157|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
47057382|NCT00704288|83335158|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
47057383|NCT00704288|83335156|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
47057384|NCT00704288|83335157|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
47057385|NCT00704288|83335158|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
47057386|NCT00704288|83335156|FG000|Overall Treatment Period|Roll-over to another study|1|||
47057387|NCT00704288|83335157|FG001|Overall Treatment Period|Roll-over to another study|0|||
47057388|NCT00704288|83335158|FG002|Overall Treatment Period|Roll-over to another study|4|||
47057389|NCT00704288|83335156|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
47057390|NCT00704288|83335157|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
47057391|NCT00704288|83335158|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
47057392|NCT00704288|83335156|FG000|Extended Post Treatment Follow Up Period|Death|41|||
47057393|NCT00704288|83335157|FG001|Extended Post Treatment Follow Up Period|Death|50|||
47057394|NCT00704288|83335158|FG002|Extended Post Treatment Follow Up Period|Death|93|||
47057395|NCT00704288|83335156|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
47057396|NCT00704288|83335157|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
46933579|NCT01663714|83169397|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
46933580|NCT01663714|83169397|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
46933581|NCT01663714|83169397|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
46933582|NCT01663714|83169397|FG000|Long-Term Follow-Up|Death|4|||
46933583|NCT01663714|83169397|FG000|Long-Term Follow-Up|Non-compliance|1|||
46933584|NCT01663636|83169419|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
46933585|NCT01663636|83169420|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
46933586|NCT03065244|83169428|FG000|Overall Study|Lost to Follow-up|1|||
46933587|NCT03065244|83169429|FG001|Overall Study|Lost to Follow-up|1|||
46933588|NCT03065244|83169428|FG000|Overall Study|Diagnosed with a different disease|1|||
46933589|NCT03065244|83169429|FG001|Overall Study|Diagnosed with a different disease|1|||
46933590|NCT03065244|83169428|FG000|Overall Study|Protocol Violation|0|||
46761408|NCT00843024|82979590|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
46761409|NCT00843024|82979591|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
47057397|NCT00704288|83335158|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
47057398|NCT00704288|83335156|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
47057399|NCT00704288|83335157|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
47057400|NCT00704288|83335158|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
47057401|NCT00704288|83335156|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
46823899|NCT00307437|83043107|FG002|After Controlled Period|Lost to Follow-up|0|||
47057402|NCT00704288|83335157|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
47057403|NCT00704288|83335158|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
47057404|NCT00322712|83335175|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
47057405|NCT01605227|83335181|FG000|Overall Study|Did not receive study treatment|2|||
47057406|NCT01605227|83335182|FG001|Overall Study|Did not receive study treatment|3|||
47057407|NCT01605227|83335181|FG000|Overall Study|Adverse Event|228|||
46637022|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
46637023|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
47057408|NCT01605227|83335182|FG001|Overall Study|Adverse Event|42|||
47057409|NCT01605227|83335181|FG000|Overall Study|Progressive Disease|132|||
47057410|NCT01605227|83335182|FG001|Overall Study|Progressive Disease|128|||
47057411|NCT01605227|83335181|FG000|Overall Study|Clinical Deterioration|227|||
47057412|NCT01605227|83335182|FG001|Overall Study|Clinical Deterioration|133|||
47057413|NCT01605227|83335181|FG000|Overall Study|Lost to Follow-up|1|||
47057414|NCT01605227|83335182|FG001|Overall Study|Lost to Follow-up|0|||
47057415|NCT01605227|83335181|FG000|Overall Study|Protocol Violation|1|||
47057416|NCT01605227|83335182|FG001|Overall Study|Protocol Violation|0|||
47057417|NCT01605227|83335181|FG000|Overall Study|Physician Decision|9|||
47057418|NCT01605227|83335182|FG001|Overall Study|Physician Decision|7|||
46823900|NCT00307437|83043108|FG003|After Controlled Period|Lost to Follow-up|7|||
46823901|NCT00307437|83043109|FG004|After Controlled Period|Lost to Follow-up|12|||
46933591|NCT03065244|83169429|FG001|Overall Study|Protocol Violation|1|||
46933592|NCT03065244|83169428|FG000|Overall Study|Withdrawal by Subject|1|||
46933593|NCT03065244|83169429|FG001|Overall Study|Withdrawal by Subject|1|||
46933594|NCT00100815|83169435|FG000|Overall Study|Progression|24|||
46933595|NCT00100815|83169435|FG000|Overall Study|Adverse Event|18|||
46933596|NCT00100815|83169435|FG000|Overall Study|Death|4|||
46933597|NCT00100815|83169435|FG000|Overall Study|Other|3|||
46933598|NCT00708422|83169441|FG000|Overall Study|Adverse Event|3|||
46933599|NCT00708422|83169442|FG001|Overall Study|Adverse Event|1|||
46933600|NCT00708422|83169441|FG000|Overall Study|Withdrawal by Subject|1|||
47057419|NCT01605227|83335181|FG000|Overall Study|Withdrawal by Subject|18|||
47057420|NCT01605227|83335182|FG001|Overall Study|Withdrawal by Subject|14|||
47057421|NCT01605227|83335181|FG000|Overall Study|Sponsor Decision|2|||
47057422|NCT01605227|83335182|FG001|Overall Study|Sponsor Decision|0|||
47057423|NCT01605227|83335181|FG000|Overall Study|Started New Therapy|1|||
47057424|NCT01605227|83335182|FG001|Overall Study|Started New Therapy|0|||
47057425|NCT01605227|83335181|FG000|Overall Study|Subject Decision|0|||
47057426|NCT01605227|83335182|FG001|Overall Study|Subject Decision|1|||
47057427|NCT01605227|83335181|FG000|Overall Study|Dose Held >6 weeks|0|||
47057428|NCT01605227|83335182|FG001|Overall Study|Dose Held >6 weeks|1|||
47057429|NCT01709513|83335191|FG000|Overall Study|Randomized but not treated|0|||
47057430|NCT01709513|83335192|FG001|Overall Study|Randomized but not treated|1|||
47057431|NCT01709513|83335193|FG002|Overall Study|Randomized but not treated|0|||
46933601|NCT00708422|83169442|FG001|Overall Study|Withdrawal by Subject|0|||
47057432|NCT01709513|83335191|FG000|Overall Study|Adverse Event|16|||
46637024|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
47057433|NCT01709513|83335192|FG001|Overall Study|Adverse Event|31|||
47057434|NCT01709513|83335193|FG002|Overall Study|Adverse Event|23|||
47057435|NCT01709513|83335191|FG000|Overall Study|Poor compliance to protocol|2|||
46637025|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
46637026|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
46637027|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
46637028|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
46933602|NCT02760069|83169451|FG000|Overall Study|Withdrawal by Subject|0|||
46933603|NCT02760069|83169452|FG001|Overall Study|Withdrawal by Subject|1|||
46933604|NCT02760069|83169453|FG002|Overall Study|Withdrawal by Subject|1|||
46933605|NCT00707486|83169461|FG000|Overall Study|Withdrawal by Subject|1|||
47057436|NCT01709513|83335192|FG001|Overall Study|Poor compliance to protocol|0|||
47057437|NCT01709513|83335193|FG002|Overall Study|Poor compliance to protocol|0|||
47057438|NCT01709513|83335191|FG000|Overall Study|Other|3|||
47057439|NCT01709513|83335192|FG001|Overall Study|Other|11|||
47057440|NCT01709513|83335193|FG002|Overall Study|Other|7|||
47057441|NCT01605071|83335206|FG000|Overall Study|Withdrawal by Subject|3|||
47057442|NCT01605071|83335207|FG001|Overall Study|Withdrawal by Subject|2|||
47057443|NCT02710422|83335217|FG000|Overall Study|Termination of study|9|||
47057444|NCT02710422|83335218|FG001|Overall Study|Termination of study|9|||
47057445|NCT01706159|83335228|FG000|Overall Study|Withdrawal Criteria|2|||
47057446|NCT01706159|83335229|FG001|Overall Study|Withdrawal Criteria|1|||
47057447|NCT01706159|83335228|FG000|Overall Study|Unclassified|6|||
47057448|NCT01706159|83335229|FG001|Overall Study|Unclassified|1|||
47057449|NCT01706003|83335237|FG000|Overall Study|Withdrawal by Subject|2|||
47057450|NCT01706003|83335238|FG001|Overall Study|Withdrawal by Subject|0|||
47057451|NCT01706003|83335237|FG000|Overall Study|Not scheduled|3|||
47057452|NCT01706003|83335238|FG001|Overall Study|Not scheduled|0|||
47057453|NCT01706003|83335237|FG000|Overall Study|Lost to Follow-up|6|||
47057454|NCT01706003|83335238|FG001|Overall Study|Lost to Follow-up|4|||
47057455|NCT01705691|83335246|FG000|Overall Study|Death|1|||
47057456|NCT01705691|83335247|FG001|Overall Study|Death|2|||
47057457|NCT01705691|83335246|FG000|Overall Study|Withdrawal by Subject|1|||
47057458|NCT01705691|83335247|FG001|Overall Study|Withdrawal by Subject|2|||
47057459|NCT01705691|83335246|FG000|Overall Study|Lost to Follow-up|1|||
47057460|NCT01705691|83335247|FG001|Overall Study|Lost to Follow-up|1|||
47057461|NCT01705691|83335246|FG000|Overall Study|Other|0|||
47057462|NCT01705691|83335247|FG001|Overall Study|Other|1|||
47057463|NCT03766906|83335253|FG000|Overall Study|Withdrawal by Subject|6|||
47057464|NCT01705145|83335257|FG000|Part B|Adverse Event|1|||
47057465|NCT01704755|83335275|FG000|Overall Study|Adverse Event|4|||
47057466|NCT01704755|83335276|FG001|Overall Study|Adverse Event|1|||
47057467|NCT01704755|83335275|FG000|Overall Study|Lost to Follow-up|3|||
47057468|NCT01704755|83335276|FG001|Overall Study|Lost to Follow-up|4|||
47057469|NCT01704755|83335275|FG000|Overall Study|Withdrew consent|1|||
47057470|NCT01704755|83335276|FG001|Overall Study|Withdrew consent|1|||
47057471|NCT01704755|83335275|FG000|Overall Study|Other (not specified)|3|||
47057472|NCT01704755|83335276|FG001|Overall Study|Other (not specified)|1|||
47057473|NCT01704755|83335275|FG000|Overall Study|Withdrew consent and personal issues|1|||
47057474|NCT01704755|83335276|FG001|Overall Study|Withdrew consent and personal issues|0|||
47057475|NCT01704599|83335282|FG000|Overall Study|Adverse Event|1|||
47057476|NCT03599518|83335314|FG000|Overall Study|Clinical progression|0|||
47057477|NCT03599518|83335315|FG001|Overall Study|Clinical progression|0|||
47057478|NCT03599518|83335316|FG002|Overall Study|Clinical progression|0|||
47057479|NCT03599518|83335317|FG003|Overall Study|Clinical progression|0|||
47057480|NCT03599518|83335318|FG004|Overall Study|Clinical progression|1|||
47057481|NCT03599518|83335314|FG000|Overall Study|Adverse Event|0|||
47057482|NCT03599518|83335315|FG001|Overall Study|Adverse Event|0|||
47057483|NCT03599518|83335316|FG002|Overall Study|Adverse Event|0|||
47057484|NCT03599518|83335317|FG003|Overall Study|Adverse Event|0|||
47057485|NCT03599518|83335318|FG004|Overall Study|Adverse Event|1|||
47057486|NCT03599518|83335314|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
47057487|NCT03599518|83335315|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
47057488|NCT03599518|83335316|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
47057489|NCT03599518|83335317|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
47057490|NCT03599518|83335318|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
47057491|NCT03599518|83335314|FG000|Overall Study|Participant withdrawal from study treatment|0|||
47057492|NCT03599518|83335315|FG001|Overall Study|Participant withdrawal from study treatment|0|||
47057493|NCT03599518|83335316|FG002|Overall Study|Participant withdrawal from study treatment|1|||
47057494|NCT03599518|83335317|FG003|Overall Study|Participant withdrawal from study treatment|0|||
47057495|NCT03599518|83335318|FG004|Overall Study|Participant withdrawal from study treatment|0|||
47057496|NCT02709486|83335395|FG000|Overall Study|Adverse Event|2|||
47057497|NCT02709486|83335396|FG001|Overall Study|Adverse Event|5|||
47057498|NCT02709486|83335397|FG002|Overall Study|Adverse Event|3|||
47057499|NCT02709486|83335395|FG000|Overall Study|Death|0|||
47057500|NCT02709486|83335396|FG001|Overall Study|Death|0|||
47057501|NCT02709486|83335397|FG002|Overall Study|Death|2|||
47057502|NCT02709486|83335395|FG000|Overall Study|Insufficient clinical response|7|||
47057503|NCT02709486|83335396|FG001|Overall Study|Insufficient clinical response|3|||
47057504|NCT02709486|83335397|FG002|Overall Study|Insufficient clinical response|3|||
47057505|NCT02709486|83335395|FG000|Overall Study|Lost to Follow-up|3|||
47057506|NCT02709486|83335396|FG001|Overall Study|Lost to Follow-up|2|||
47057507|NCT02709486|83335397|FG002|Overall Study|Lost to Follow-up|2|||
47057508|NCT02709486|83335395|FG000|Overall Study|Other|0|||
47057509|NCT02709486|83335396|FG001|Overall Study|Other|2|||
47057510|NCT02709486|83335397|FG002|Overall Study|Other|3|||
47057511|NCT02709486|83335395|FG000|Overall Study|Withdrawal by Subject|32|||
47057512|NCT02709486|83335396|FG001|Overall Study|Withdrawal by Subject|22|||
47057513|NCT02709486|83335397|FG002|Overall Study|Withdrawal by Subject|32|||
47057514|NCT00703326|83335601|FG000|Overall Study|Lost to Follow-up|47|||
47057515|NCT00703326|83335602|FG001|Overall Study|Lost to Follow-up|18|||
47057516|NCT00703326|83335601|FG000|Overall Study|Withdrawal by Subject|54|||
47057517|NCT00703326|83335602|FG001|Overall Study|Withdrawal by Subject|20|||
47057518|NCT00703326|83335601|FG000|Overall Study|Adverse Event|1|||
46761410|NCT00843024|82979592|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
46761411|NCT00843024|82979593|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
46761412|NCT00843024|82979594|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
46761413|NCT00843024|82979595|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
46761414|NCT00843024|82979590|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
46761415|NCT00843024|82979591|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
46761416|NCT00843024|82979592|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
46933606|NCT02759055|83169469|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
46967760|NCT02155660|83210359|FG001|Overall Study|Other Reason|6|||
46761417|NCT00843024|82979593|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
46761418|NCT00843024|82979594|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
46761419|NCT00843024|82979595|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
46761420|NCT00843024|82979590|FG000|Single-blind Placebo Run-In Phase|Other|0|||
46761421|NCT00843024|82979591|FG001|Single-blind Placebo Run-In Phase|Other|1|||
46761422|NCT00843024|82979592|FG002|Single-blind Placebo Run-In Phase|Other|0|||
46761423|NCT00843024|82979593|FG003|Single-blind Placebo Run-In Phase|Other|0|||
46761424|NCT00843024|82979594|FG004|Single-blind Placebo Run-In Phase|Other|0|||
46761425|NCT00843024|82979595|FG005|Single-blind Placebo Run-In Phase|Other|0|||
46761426|NCT00843024|82979590|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
46823902|NCT00307437|83043110|FG005|After Controlled Period|Lost to Follow-up|13|||
46823903|NCT00307437|83043111|FG006|After Controlled Period|Lost to Follow-up|18|||
46823904|NCT00307437|83043105|FG000|After Controlled Period|Other|0|||
46823905|NCT00307437|83043106|FG001|After Controlled Period|Other|0|||
46823906|NCT00307437|83043107|FG002|After Controlled Period|Other|0|||
46823907|NCT00307437|83043108|FG003|After Controlled Period|Other|15|||
46761427|NCT00843024|82979591|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
46761428|NCT00843024|82979592|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
46823908|NCT00307437|83043109|FG004|After Controlled Period|Other|9|||
46823909|NCT00307437|83043110|FG005|After Controlled Period|Other|40|||
46823910|NCT00307437|83043111|FG006|After Controlled Period|Other|28|||
46823911|NCT00440726|83043136|FG000|Phase 1|Dose-Limiting Toxicity|0|||
46823912|NCT00440726|83043137|FG001|Phase 1|Dose-Limiting Toxicity|1|||
46823913|NCT00440726|83043138|FG002|Phase 1|Dose-Limiting Toxicity|0|||
46823914|NCT00440726|83043136|FG000|Phase 1|Physician Decision|1|||
46823915|NCT00440726|83043137|FG001|Phase 1|Physician Decision|0|||
46823916|NCT00440726|83043138|FG002|Phase 1|Physician Decision|0|||
46823917|NCT00440726|83043136|FG000|Phase 2|Death|0|||
46823918|NCT00440726|83043137|FG001|Phase 2|Death|0|||
46823919|NCT00440726|83043138|FG002|Phase 2|Death|1|||
46823920|NCT00440726|83043136|FG000|Phase 2|Adverse Event|0|||
46823921|NCT00440726|83043137|FG001|Phase 2|Adverse Event|0|||
46967761|NCT02155660|83210360|FG002|Overall Study|Other Reason|10|||
46967762|NCT02155660|83210361|FG003|Overall Study|Other Reason|10|||
46967763|NCT02155660|83210358|FG000|Overall Study|Study-specific withdrawal criteria|0|||
46967764|NCT02155660|83210359|FG001|Overall Study|Study-specific withdrawal criteria|1|||
46967765|NCT02155660|83210360|FG002|Overall Study|Study-specific withdrawal criteria|1|||
46967766|NCT02155660|83210361|FG003|Overall Study|Study-specific withdrawal criteria|1|||
46967767|NCT02155660|83210358|FG000|Overall Study|Severe non-compliance|0|||
46967768|NCT02155660|83210359|FG001|Overall Study|Severe non-compliance|4|||
46967769|NCT02155660|83210360|FG002|Overall Study|Severe non-compliance|0|||
46967770|NCT02155660|83210361|FG003|Overall Study|Severe non-compliance|1|||
46967771|NCT02155660|83210358|FG000|Overall Study|Adverse Event|2|||
46967772|NCT02155660|83210359|FG001|Overall Study|Adverse Event|6|||
46967773|NCT02155660|83210360|FG002|Overall Study|Adverse Event|3|||
46967774|NCT02155660|83210361|FG003|Overall Study|Adverse Event|1|||
46967775|NCT02155660|83210358|FG000|Overall Study|Lost to Follow-up|3|||
46967776|NCT02155660|83210359|FG001|Overall Study|Lost to Follow-up|6|||
46967777|NCT02155660|83210360|FG002|Overall Study|Lost to Follow-up|5|||
46967778|NCT02155660|83210361|FG003|Overall Study|Lost to Follow-up|8|||
46967779|NCT02155660|83210358|FG000|Overall Study|Death|17|||
46967780|NCT02155660|83210359|FG001|Overall Study|Death|19|||
46967781|NCT02155660|83210360|FG002|Overall Study|Death|17|||
46967782|NCT02155660|83210361|FG003|Overall Study|Death|19|||
46967783|NCT02155660|83210358|FG000|Overall Study|Withdrawal by Subject|28|||
46967784|NCT02155660|83210359|FG001|Overall Study|Withdrawal by Subject|31|||
46967785|NCT02155660|83210360|FG002|Overall Study|Withdrawal by Subject|24|||
46967786|NCT02155660|83210361|FG003|Overall Study|Withdrawal by Subject|21|||
46967787|NCT02119936|83210371|FG000|Overall Study|Lost to Follow-up|10|||
46967788|NCT02181634|83210375|FG000|Overall Study|Lack of Efficacy|33|||
46967789|NCT02181634|83210375|FG000|Overall Study|Adverse Event|17|||
46967790|NCT02181634|83210375|FG000|Overall Study|Physician Decision|8|||
46967791|NCT02181634|83210375|FG000|Overall Study|Withdrawal by Subject|5|||
46967792|NCT02181634|83210375|FG000|Overall Study|Death|2|||
46967793|NCT02181634|83210375|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
46967794|NCT02181634|83210375|FG000|Overall Study|Ineligible|1|||
46933607|NCT02759055|83169470|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
46933608|NCT00708032|83169478|FG000|Overall Study|Adverse Event|0|||
46933609|NCT00708032|83169479|FG001|Overall Study|Adverse Event|2|||
46933610|NCT00708032|83169478|FG000|Overall Study|Lost to Follow-up|1|||
46933611|NCT00708032|83169479|FG001|Overall Study|Lost to Follow-up|2|||
46933612|NCT00708032|83169478|FG000|Overall Study|Pregnancy|0|||
46933613|NCT00708032|83169479|FG001|Overall Study|Pregnancy|1|||
46933614|NCT00708032|83169478|FG000|Overall Study|Poor vision|0|||
46933615|NCT00708032|83169479|FG001|Overall Study|Poor vision|6|||
46933616|NCT00708032|83169478|FG000|Overall Study|Visit out of range at month 12|4|||
46933617|NCT00708032|83169479|FG001|Overall Study|Visit out of range at month 12|1|||
46933618|NCT00708032|83169478|FG000|Overall Study|Did not meet protocol criteria|1|||
46933619|NCT00708032|83169479|FG001|Overall Study|Did not meet protocol criteria|2|||
46933620|NCT00708032|83169478|FG000|Overall Study|Protocol Violation|4|||
46933621|NCT00708032|83169479|FG001|Overall Study|Protocol Violation|1|||
46933622|NCT00708032|83169478|FG000|Overall Study|Withdrawal by Subject|0|||
46933623|NCT00708032|83169479|FG001|Overall Study|Withdrawal by Subject|1|||
46933624|NCT00707174|83169487|FG000|Overall Study|Adverse Event|1|||
46933625|NCT00707174|83169488|FG001|Overall Study|Adverse Event|6|||
46933626|NCT00707174|83169487|FG000|Overall Study|Withdrawal by Subject|4|||
46933627|NCT00707174|83169488|FG001|Overall Study|Withdrawal by Subject|1|||
46933628|NCT02756403|83169498|FG000|Overall Study|Unable to swallow medication|0|||
46933629|NCT02756403|83169499|FG001|Overall Study|Unable to swallow medication|1|||
46933630|NCT02756403|83169500|FG002|Overall Study|Unable to swallow medication|1|||
46933631|NCT02756403|83169501|FG003|Overall Study|Unable to swallow medication|1|||
46933632|NCT02756403|83169498|FG000|Overall Study|Did not complete Procedure|0|||
46933633|NCT02756403|83169499|FG001|Overall Study|Did not complete Procedure|1|||
46933634|NCT02756403|83169500|FG002|Overall Study|Did not complete Procedure|0|||
46933635|NCT02756403|83169501|FG003|Overall Study|Did not complete Procedure|0|||
46933636|NCT02756403|83169498|FG000|Overall Study|Changed Mind About Procedure|0|||
46933637|NCT02756403|83169499|FG001|Overall Study|Changed Mind About Procedure|0|||
46933638|NCT02756403|83169500|FG002|Overall Study|Changed Mind About Procedure|1|||
46933639|NCT02756403|83169501|FG003|Overall Study|Changed Mind About Procedure|0|||
46933640|NCT02756403|83169498|FG000|Overall Study|Protocol Violation|0|||
46933641|NCT02756403|83169499|FG001|Overall Study|Protocol Violation|1|||
46933642|NCT02756403|83169500|FG002|Overall Study|Protocol Violation|0|||
46933643|NCT02756403|83169501|FG003|Overall Study|Protocol Violation|1|||
46933644|NCT02753595|83169513|FG000|Overall Study|Sponsor termination|2|||
46933645|NCT02753595|83169514|FG001|Overall Study|Sponsor termination|2|||
46933646|NCT00707954|83169524|FG000|Overall Study|Physician Decision|0|||
46933647|NCT00707954|83169525|FG001|Overall Study|Physician Decision|0|||
46933648|NCT00707954|83169526|FG002|Overall Study|Physician Decision|0|||
46933649|NCT00707954|83169527|FG003|Overall Study|Physician Decision|0|||
46933650|NCT00707954|83169528|FG004|Overall Study|Physician Decision|1|||
46933651|NCT02565706|83169544|FG000|Overall Study|Withdrawal by Subject|5|||
46933652|NCT02565706|83169545|FG001|Overall Study|Withdrawal by Subject|7|||
46933653|NCT02565706|83169546|FG002|Overall Study|Withdrawal by Subject|7|||
46933654|NCT02565706|83169547|FG003|Overall Study|Withdrawal by Subject|11|||
46933655|NCT02565706|83169544|FG000|Overall Study|Lost to Follow-up|72|||
46933656|NCT02565706|83169545|FG001|Overall Study|Lost to Follow-up|75|||
46933657|NCT02565706|83169546|FG002|Overall Study|Lost to Follow-up|82|||
46933658|NCT02565706|83169547|FG003|Overall Study|Lost to Follow-up|74|||
46933659|NCT00706628|83169566|FG000|Overall Study|Other Adverse Event|16|||
46933660|NCT00706628|83169567|FG001|Overall Study|Other Adverse Event|5|||
46933661|NCT00706628|83169568|FG002|Overall Study|Other Adverse Event|5|||
46933662|NCT00706628|83169569|FG003|Overall Study|Other Adverse Event|2|||
46933663|NCT00706628|83169566|FG000|Overall Study|Non compliant with protocol|0|||
46933664|NCT00706628|83169567|FG001|Overall Study|Non compliant with protocol|1|||
46933665|NCT00706628|83169568|FG002|Overall Study|Non compliant with protocol|0|||
46933666|NCT00706628|83169569|FG003|Overall Study|Non compliant with protocol|0|||
46933667|NCT00706628|83169566|FG000|Overall Study|Consent withdrawn|6|||
46933668|NCT00706628|83169567|FG001|Overall Study|Consent withdrawn|1|||
46933669|NCT00706628|83169568|FG002|Overall Study|Consent withdrawn|3|||
46933670|NCT00706628|83169569|FG003|Overall Study|Consent withdrawn|0|||
46933671|NCT00706628|83169566|FG000|Overall Study|Progressive disease|20|||
46933672|NCT00706628|83169567|FG001|Overall Study|Progressive disease|13|||
46933673|NCT00706628|83169568|FG002|Overall Study|Progressive disease|8|||
46933674|NCT00706628|83169569|FG003|Overall Study|Progressive disease|1|||
46933675|NCT00706628|83169566|FG000|Overall Study|Other than those stated above|4|||
46933676|NCT00706628|83169567|FG001|Overall Study|Other than those stated above|0|||
46933677|NCT00706628|83169568|FG002|Overall Study|Other than those stated above|0|||
46933678|NCT00706628|83169569|FG003|Overall Study|Other than those stated above|0|||
46933679|NCT00706628|83169566|FG000|Overall Study|Not treated|1|||
46933680|NCT00706628|83169567|FG001|Overall Study|Not treated|1|||
46933681|NCT00706628|83169568|FG002|Overall Study|Not treated|0|||
46933682|NCT00706628|83169569|FG003|Overall Study|Not treated|0|||
46933683|NCT02561806|83169584|FG000|Induction Period|Adverse Event|0|||
46933684|NCT02561806|83169585|FG001|Induction Period|Adverse Event|2|||
46933685|NCT02561806|83169584|FG000|Induction Period|Lack of Efficacy|1|||
47057519|NCT00703326|83335602|FG001|Overall Study|Adverse Event|0|||
47057520|NCT04868500|83335655|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
46933686|NCT02561806|83169585|FG001|Induction Period|Lack of Efficacy|0|||
47057521|NCT04868500|83335656|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
47057522|NCT04868500|83335655|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
47057523|NCT04868500|83335656|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
47057524|NCT04372186|83335664|FG000|Overall Study|Death|24|||
47057525|NCT04372186|83335665|FG001|Overall Study|Death|11|||
47057526|NCT04372186|83335664|FG000|Overall Study|Transferred to a different facility for care|0|||
47057527|NCT04372186|83335665|FG001|Overall Study|Transferred to a different facility for care|2|||
47057528|NCT04317040|83335695|FG000|Overall Study|Lost to Follow-up|2|||
46933687|NCT02561806|83169584|FG000|Induction Period|Withdrawal by Subject|0|||
46933688|NCT02561806|83169585|FG001|Induction Period|Withdrawal by Subject|2|||
46933689|NCT02561806|83169584|FG000|Induction Period|Site staff became unblinded|1|||
46933690|NCT02561806|83169585|FG001|Induction Period|Site staff became unblinded|0|||
46933691|NCT02561806|83169584|FG000|Induction Period|Randomized but not treated|0|||
46933692|NCT02561806|83169585|FG001|Induction Period|Randomized but not treated|1|||
46933693|NCT02561806|83169584|FG000|Maintenance Period|Adverse Event|2|||
46933694|NCT02561806|83169585|FG001|Maintenance Period|Adverse Event|1|||
46933695|NCT02561806|83169584|FG000|Maintenance Period|Lack of Efficacy|3|||
46933696|NCT02561806|83169585|FG001|Maintenance Period|Lack of Efficacy|1|||
46933697|NCT02561806|83169584|FG000|Maintenance Period|Lost to Follow-up|2|||
46933698|NCT02561806|83169585|FG001|Maintenance Period|Lost to Follow-up|2|||
46933699|NCT02561806|83169584|FG000|Maintenance Period|Protocol Violation|1|||
46933700|NCT02561806|83169585|FG001|Maintenance Period|Protocol Violation|0|||
46933701|NCT02561806|83169584|FG000|Maintenance Period|Withdrawal by Subject|5|||
46933702|NCT02561806|83169585|FG001|Maintenance Period|Withdrawal by Subject|3|||
46933703|NCT02561806|83169584|FG000|Maintenance Period|Site staff became unblinded|0|||
46933704|NCT02561806|83169585|FG001|Maintenance Period|Site staff became unblinded|1|||
46933705|NCT02561806|83169584|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
46933706|NCT02561806|83169585|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
46933707|NCT02561806|83169584|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
46933708|NCT02561806|83169585|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
46933709|NCT02561572|83169608|FG000|Overall Study|Inadequate time before surgery|2|||
46933710|NCT02561572|83169609|FG001|Overall Study|Inadequate time before surgery|1|||
46933711|NCT02561572|83169608|FG000|Overall Study|Protocol Violation|0|||
46933712|NCT02561572|83169609|FG001|Overall Study|Protocol Violation|1|||
46933713|NCT02180217|83169618|FG000|Overall Study|Adverse Event|3|||
46933714|NCT02180217|83169619|FG001|Overall Study|Adverse Event|2|||
46933715|NCT02180217|83169620|FG002|Overall Study|Adverse Event|22|||
47057529|NCT04317040|83335696|FG001|Overall Study|Lost to Follow-up|0|||
47057530|NCT04317040|83335695|FG000|Overall Study|Death|16|||
47057531|NCT04317040|83335696|FG001|Overall Study|Death|18|||
47057532|NCT04317040|83335695|FG000|Overall Study|Withdrawal by Subject|0|||
47057533|NCT04317040|83335696|FG001|Overall Study|Withdrawal by Subject|1|||
47057534|NCT04317040|83335695|FG000|Overall Study|Incomplete assessments|0|||
47057535|NCT04317040|83335696|FG001|Overall Study|Incomplete assessments|1|||
47057536|NCT00703014|83335776|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
47057537|NCT00703014|83335777|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
47057538|NCT00703014|83335778|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
47057539|NCT00703014|83335779|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
47057540|NCT00703014|83335776|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
47057541|NCT00703014|83335777|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
47057542|NCT00703014|83335778|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
47057543|NCT00703014|83335779|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
47057544|NCT03915496|83335827|FG000|Overall Study|Adverse Event|2|||
47057545|NCT03915496|83335828|FG001|Overall Study|Adverse Event|1|||
47057546|NCT03915496|83335829|FG002|Overall Study|Adverse Event|2|||
47057547|NCT02709330|83335846|FG000|Overall Study|Death|5|||
47057548|NCT02709330|83335847|FG001|Overall Study|Death|0|||
47057549|NCT02709330|83335846|FG000|Overall Study|Lost to Follow-up|2|||
47057550|NCT02709330|83335847|FG001|Overall Study|Lost to Follow-up|0|||
47057551|NCT02709330|83335846|FG000|Overall Study|Physician Decision|2|||
47057552|NCT02709330|83335847|FG001|Overall Study|Physician Decision|0|||
46637029|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
46933716|NCT02180217|83169618|FG000|Overall Study|Death|1|||
46933717|NCT02180217|83169619|FG001|Overall Study|Death|1|||
46933718|NCT02180217|83169620|FG002|Overall Study|Death|0|||
46933719|NCT02180217|83169618|FG000|Overall Study|Withdrawal by Subject|1|||
47057553|NCT02709330|83335846|FG000|Overall Study|Withdrawal by Subject|4|||
47057554|NCT02709330|83335847|FG001|Overall Study|Withdrawal by Subject|0|||
47057555|NCT02709096|83335855|FG000|Overall Study|non-compliance|1|||
47057556|NCT02709096|83335856|FG001|Overall Study|non-compliance|1|||
47057557|NCT01372410|83335862|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
46933720|NCT02180217|83169619|FG001|Overall Study|Withdrawal by Subject|1|||
46933721|NCT02180217|83169620|FG002|Overall Study|Withdrawal by Subject|4|||
47057558|NCT01372410|83335863|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
47057559|NCT01372410|83335864|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
47057560|NCT01372410|83335865|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
47057561|NCT01372410|83335866|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
47057562|NCT01372410|83335867|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
47057563|NCT01372410|83335868|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
47057564|NCT01372410|83335869|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
47057565|NCT01372410|83335862|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
47057566|NCT01372410|83335863|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
47057567|NCT01372410|83335864|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
47057568|NCT01372410|83335865|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
47057569|NCT01372410|83335866|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
47057570|NCT01372410|83335867|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
47057571|NCT01372410|83335868|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
46933722|NCT02180217|83169618|FG000|Overall Study|Subject/Guardian decision|5|||
46933723|NCT02180217|83169619|FG001|Overall Study|Subject/Guardian decision|3|||
46933724|NCT02180217|83169620|FG002|Overall Study|Subject/Guardian decision|6|||
46933725|NCT02180217|83169618|FG000|Overall Study|Physician Decision|1|||
47057572|NCT01372410|83335869|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
46637030|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
47057573|NCT01372410|83335862|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47057574|NCT01372410|83335863|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
46933726|NCT02180217|83169619|FG001|Overall Study|Physician Decision|1|||
46933727|NCT02180217|83169620|FG002|Overall Study|Physician Decision|6|||
46933728|NCT02180217|83169618|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46933729|NCT02180217|83169619|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46933730|NCT02180217|83169620|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
46933731|NCT02560558|83169637|FG000|Overall Study|Adverse Event|1|||
46933732|NCT02560558|83169638|FG001|Overall Study|Adverse Event|0|||
46933733|NCT02560558|83169637|FG000|Overall Study|Death|0|||
46933734|NCT02560558|83169638|FG001|Overall Study|Death|2|||
46933735|NCT02560558|83169637|FG000|Overall Study|Lost to Follow-up|0|||
46933736|NCT02560558|83169638|FG001|Overall Study|Lost to Follow-up|4|||
46933737|NCT02560558|83169637|FG000|Overall Study|Protocol Violation|3|||
46761429|NCT00843024|82979593|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
46933738|NCT02560558|83169638|FG001|Overall Study|Protocol Violation|0|||
46933739|NCT02560558|83169637|FG000|Overall Study|Withdrawal by Subject|3|||
47057575|NCT01372410|83335864|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
46761430|NCT00843024|82979594|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
46761431|NCT00843024|82979595|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
46761432|NCT00843024|82979590|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
46761433|NCT00843024|82979591|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
46761434|NCT00843024|82979592|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
46761435|NCT00843024|82979593|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
46761436|NCT00843024|82979594|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
46761437|NCT00843024|82979595|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
46761438|NCT00843024|82979590|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46761439|NCT00843024|82979591|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46933740|NCT02560558|83169638|FG001|Overall Study|Withdrawal by Subject|0|||
47057576|NCT01372410|83335865|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47057577|NCT01372410|83335866|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
47057578|NCT01372410|83335867|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47057579|NCT01372410|83335868|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47057580|NCT01372410|83335869|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
47057581|NCT01372410|83335862|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
47057582|NCT01372410|83335863|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
47057583|NCT01372410|83335864|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
47057584|NCT01372410|83335865|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
47057585|NCT01372410|83335866|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
47057586|NCT01372410|83335867|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
47057587|NCT01372410|83335868|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
47057588|NCT01372410|83335869|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
47057589|NCT01372410|83335862|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
47057590|NCT01372410|83335863|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
47057591|NCT01372410|83335864|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
46933741|NCT02568046|83169646|FG000|Overall Study|Adverse Event|0|||
46933742|NCT02568046|83169647|FG001|Overall Study|Adverse Event|1|||
46933743|NCT02568046|83169646|FG000|Overall Study|Death|2|||
46933744|NCT02568046|83169647|FG001|Overall Study|Death|0|||
46933745|NCT02568046|83169646|FG000|Overall Study|Progressive Disease|1|||
46933746|NCT02568046|83169647|FG001|Overall Study|Progressive Disease|0|||
46933747|NCT02568046|83169646|FG000|Overall Study|Withdrawal by Subject|2|||
46933748|NCT02568046|83169647|FG001|Overall Study|Withdrawal by Subject|1|||
46933749|NCT02568046|83169646|FG000|Overall Study|Other Events|0|||
46933750|NCT02568046|83169647|FG001|Overall Study|Other Events|1|||
46823922|NCT00440726|83043138|FG002|Phase 2|Adverse Event|1|||
46823923|NCT00447590|83043149|FG000|Overall Study|Withdrawal by Subject|26|||
46823924|NCT00447590|83043149|FG000|Overall Study|Lost to Follow-up|24|||
46823925|NCT00447590|83043149|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
46823926|NCT00447278|83043155|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
46823927|NCT00447278|83043156|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
46823928|NCT00447278|83043155|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
46823929|NCT00447278|83043156|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
46823930|NCT00447278|83043155|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
46823931|NCT00447278|83043156|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
46823932|NCT00447278|83043155|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
46823933|NCT00447278|83043156|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
46823934|NCT00447278|83043155|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
46823935|NCT00447278|83043156|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
46823936|NCT00447278|83043155|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
46823937|NCT00447278|83043156|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
46933751|NCT02567656|83169659|FG000|Overall Study|Premature discontinuation due to PD|1|||
46823938|NCT00447278|83043155|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
46823939|NCT00447278|83043156|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
46823940|NCT00447278|83043155|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
46823941|NCT00447278|83043156|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
46823942|NCT00447278|83043155|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
46823943|NCT00447278|83043156|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
46823944|NCT00447278|83043155|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
46823945|NCT00447278|83043156|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
46823946|NCT00447278|83043155|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
46823947|NCT00447278|83043156|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
46823948|NCT00447278|83043155|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
46823949|NCT00447278|83043156|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
46823950|NCT00447278|83043155|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
46823951|NCT00447278|83043156|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
46823952|NCT00447278|83043155|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
46823953|NCT00447278|83043156|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
46823954|NCT00446966|83043165|FG000|Overall Study|Lost to Follow-up|10|||
46823955|NCT00446966|83043166|FG001|Overall Study|Lost to Follow-up|7|||
46823956|NCT00446654|83043174|FG000|Overall Study|Withdrawal by Subject|1|||
46823957|NCT00446654|83043175|FG001|Overall Study|Withdrawal by Subject|0|||
46823958|NCT00446654|83043174|FG000|Overall Study|Adverse Event|1|||
46823959|NCT00446654|83043175|FG001|Overall Study|Adverse Event|0|||
46823960|NCT00405756|83043184|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
46823961|NCT00405756|83043185|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
46823962|NCT00405756|83043186|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
46823963|NCT00405756|83043184|FG000|Double-blind Treatment|Adverse Event|31|||
46823964|NCT00405756|83043185|FG001|Double-blind Treatment|Adverse Event|27|||
46823965|NCT00405756|83043186|FG002|Double-blind Treatment|Adverse Event|12|||
46823966|NCT00405756|83043184|FG000|Double-blind Treatment|Disease Progression|47|||
46823967|NCT00405756|83043185|FG001|Double-blind Treatment|Disease Progression|81|||
46823968|NCT00405756|83043186|FG002|Double-blind Treatment|Disease Progression|102|||
46823969|NCT00405756|83043184|FG000|Double-blind Treatment|Lack of Efficacy|1|||
46823970|NCT00405756|83043185|FG001|Double-blind Treatment|Lack of Efficacy|4|||
46823971|NCT00405756|83043186|FG002|Double-blind Treatment|Lack of Efficacy|2|||
46823972|NCT00405756|83043184|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
46823973|NCT00405756|83043185|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
46933752|NCT02567656|83169660|FG001|Overall Study|Premature discontinuation due to PD|1|||
46933753|NCT02567656|83169661|FG002|Overall Study|Premature discontinuation due to PD|2|||
46933754|NCT02567656|83169662|FG003|Overall Study|Premature discontinuation due to PD|0|||
46933755|NCT02567656|83169663|FG004|Overall Study|Premature discontinuation due to PD|0|||
46823974|NCT00405756|83043186|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
46823975|NCT00405756|83043184|FG000|Double-blind Treatment|Lost to Follow-up|1|||
46823976|NCT00405756|83043185|FG001|Double-blind Treatment|Lost to Follow-up|0|||
46823977|NCT00405756|83043186|FG002|Double-blind Treatment|Lost to Follow-up|0|||
46933756|NCT02567656|83169664|FG005|Overall Study|Premature discontinuation due to PD|0|||
46933757|NCT02560012|83169678|FG000|Overall Study|Study Terminated|2|||
46933758|NCT02567266|83169685|FG000|Overall Study|Withdrawal by Subject|10|||
46933759|NCT02567266|83169686|FG001|Overall Study|Withdrawal by Subject|7|||
46933760|NCT02567266|83169687|FG002|Overall Study|Withdrawal by Subject|6|||
46933761|NCT02567266|83169685|FG000|Overall Study|Lost to Follow-up|13|||
46933762|NCT02567266|83169686|FG001|Overall Study|Lost to Follow-up|8|||
46933763|NCT02567266|83169687|FG002|Overall Study|Lost to Follow-up|10|||
46933764|NCT02567188|83169695|FG000|Overall Study|Death|10|||
46933765|NCT02567188|83169695|FG000|Overall Study|Terminated Mircera Treatment|9|||
46933766|NCT02567188|83169695|FG000|Overall Study|Lost to Follow-up|5|||
46933767|NCT02567188|83169695|FG000|Overall Study|Adverse Event|1|||
47057592|NCT01372410|83335865|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
46761440|NCT00843024|82979592|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46761441|NCT00843024|82979593|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
46761442|NCT00843024|82979594|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46761443|NCT00843024|82979595|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
46761444|NCT00843024|82979590|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
46761445|NCT00843024|82979591|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
46761446|NCT00843024|82979592|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
46761447|NCT00843024|82979593|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
46761448|NCT00843024|82979594|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
46761449|NCT00843024|82979595|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
46761450|NCT00843024|82979590|FG000|Double-blind Treatment Phase|Physician Decision|0|||
46761451|NCT00843024|82979591|FG001|Double-blind Treatment Phase|Physician Decision|0|||
46761452|NCT00843024|82979592|FG002|Double-blind Treatment Phase|Physician Decision|0|||
46761453|NCT00843024|82979593|FG003|Double-blind Treatment Phase|Physician Decision|3|||
46761454|NCT00843024|82979594|FG004|Double-blind Treatment Phase|Physician Decision|1|||
46761455|NCT00843024|82979595|FG005|Double-blind Treatment Phase|Physician Decision|1|||
46761456|NCT00843024|82979590|FG000|Double-blind Treatment Phase|Adverse Event|0|||
46761457|NCT00843024|82979591|FG001|Double-blind Treatment Phase|Adverse Event|0|||
46761458|NCT00843024|82979592|FG002|Double-blind Treatment Phase|Adverse Event|0|||
46761459|NCT00843024|82979593|FG003|Double-blind Treatment Phase|Adverse Event|0|||
46761460|NCT00843024|82979594|FG004|Double-blind Treatment Phase|Adverse Event|1|||
46761461|NCT00843024|82979595|FG005|Double-blind Treatment Phase|Adverse Event|1|||
46761462|NCT00843024|82979590|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
46761463|NCT00843024|82979591|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
46761464|NCT00843024|82979592|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
46761465|NCT00843024|82979593|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
46761466|NCT00843024|82979594|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
46761467|NCT00843024|82979595|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
46761468|NCT00832650|82979611|FG000|Overall Study|Randomized but not treated|0|||
46761469|NCT00832650|82979612|FG001|Overall Study|Randomized but not treated|0|||
46761470|NCT00832650|82979613|FG002|Overall Study|Randomized but not treated|1|||
46761471|NCT00595517|82979621|FG000|Overall Study|Adverse Event|6|||
46761472|NCT00595517|82979621|FG000|Overall Study|Withdrawal by Subject|4|||
46761473|NCT00595517|82979621|FG000|Overall Study|Protocol Violation|2|||
46761474|NCT00595517|82979621|FG000|Overall Study|Recurrence of ulcer|5|||
46761475|NCT00595517|82979621|FG000|Overall Study|usage of prohibited treatment|1|||
46761476|NCT00595517|82979621|FG000|Overall Study|No intention to attend regularly|1|||
47057593|NCT01372410|83335866|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
47057594|NCT01372410|83335867|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
47057595|NCT01372410|83335868|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
47057596|NCT01372410|83335869|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
47057597|NCT01372410|83335862|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
47057598|NCT01372410|83335863|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
47057599|NCT01372410|83335864|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
47057600|NCT01372410|83335865|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
47057601|NCT01372410|83335866|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
46933768|NCT02567188|83169695|FG000|Overall Study|Withdrawal by Subject|1|||
46933769|NCT02567188|83169695|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
46933770|NCT02567188|83169695|FG000|Overall Study|Moved and Changed Clinic|1|||
46933771|NCT02567188|83169695|FG000|Overall Study|Started Hemodialysis|2|||
46933772|NCT02567188|83169695|FG000|Overall Study|Protocol Violation|5|||
47057602|NCT01372410|83335867|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
47057603|NCT01372410|83335868|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
47057604|NCT01372410|83335869|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
47057605|NCT01372410|83335862|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
47057606|NCT01372410|83335863|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
47057607|NCT01372410|83335864|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
47057608|NCT01372410|83335865|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
47057609|NCT01372410|83335866|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
47057610|NCT01372410|83335867|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
47057611|NCT01372410|83335868|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
47057612|NCT01372410|83335869|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
46761477|NCT00823836|82979627|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
46761478|NCT00823836|82979628|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
46761479|NCT00823836|82979627|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
46761480|NCT00823836|82979628|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
46761481|NCT00823836|82979627|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
46761482|NCT00823836|82979628|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
46761483|NCT00823836|82979627|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
46761484|NCT00823836|82979628|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
46761485|NCT00823836|82979627|FG000|Long-term Phase|Adverse Event|3|||
46761486|NCT00823836|82979628|FG001|Long-term Phase|Adverse Event|2|||
46761487|NCT00823836|82979627|FG000|Long-term Phase|Physician Decision|1|||
46761488|NCT00823836|82979628|FG001|Long-term Phase|Physician Decision|2|||
46761489|NCT00823836|82979627|FG000|Long-term Phase|Withdrawal by Subject|1|||
46761490|NCT00823836|82979628|FG001|Long-term Phase|Withdrawal by Subject|1|||
46761491|NCT00879437|82979637|FG000|Overall Study|Protocol Violation|0|||
46761492|NCT00879437|82979638|FG001|Overall Study|Protocol Violation|1|||
46761493|NCT00879437|82979637|FG000|Overall Study|Death|1|||
46761494|NCT00879437|82979638|FG001|Overall Study|Death|0|||
46761495|NCT00877799|82979651|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
46761496|NCT00877799|82979652|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
46761497|NCT00877799|82979653|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
46761498|NCT00877799|82979654|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
46761499|NCT00877799|82979655|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
46761500|NCT00877799|82979651|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
46761501|NCT00877799|82979652|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
46761502|NCT00877799|82979653|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
46761503|NCT00877799|82979654|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
46761504|NCT00877799|82979655|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
46761505|NCT00877799|82979651|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
46761506|NCT00877799|82979652|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
46761507|NCT00877799|82979653|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
46761508|NCT00877799|82979654|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
46761509|NCT00877799|82979655|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
46761510|NCT00877799|82979651|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
46761511|NCT00877799|82979652|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
46761512|NCT00877799|82979653|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
46761513|NCT00877799|82979654|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
46761514|NCT00877799|82979655|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
46761515|NCT00877799|82979651|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
46761516|NCT00877799|82979652|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
46761517|NCT00877799|82979653|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
46761518|NCT00877799|82979654|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
46761519|NCT00877799|82979655|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
46761520|NCT00595127|82979666|FG000|Overall Study|Death|6|||
46761521|NCT00595127|82979666|FG000|Overall Study|Relapsed|3|||
46761522|NCT00595127|82979666|FG000|Overall Study|joined another trial|1|||
46761523|NCT00877487|82979670|FG000|Open-label Treatment Phase|Adverse Event|1|||
46761524|NCT00877487|82979671|FG001|Open-label Treatment Phase|Adverse Event|0|||
46761525|NCT00877487|82979670|FG000|Open-label Treatment Phase|Protocol Violation|3|||
46761526|NCT00877487|82979671|FG001|Open-label Treatment Phase|Protocol Violation|0|||
46761527|NCT00877487|82979670|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
46761528|NCT00877487|82979671|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
46761529|NCT00877487|82979670|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
46933773|NCT00706238|83169700|FG000|Overall Study|Disease progression|4|||
47057613|NCT01372410|83335862|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
46823978|NCT00405756|83043184|FG000|Double-blind Treatment|Death|4|||
46823979|NCT00405756|83043185|FG001|Double-blind Treatment|Death|4|||
46823980|NCT00405756|83043186|FG002|Double-blind Treatment|Death|4|||
46823981|NCT00405756|83043184|FG000|Double-blind Treatment|Protocol Violation|1|||
46823982|NCT00405756|83043185|FG001|Double-blind Treatment|Protocol Violation|0|||
46823983|NCT00405756|83043186|FG002|Double-blind Treatment|Protocol Violation|2|||
46823984|NCT00405756|83043184|FG000|Double-blind Treatment|Other|7|||
46823985|NCT00405756|83043185|FG001|Double-blind Treatment|Other|4|||
46823986|NCT00405756|83043186|FG002|Double-blind Treatment|Other|4|||
46823987|NCT00405756|83043184|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
46823988|NCT00405756|83043185|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
46823989|NCT00405756|83043186|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
46823990|NCT00405756|83043184|FG000|Open-label Extension|Adverse Event|1|||
46823991|NCT00405756|83043185|FG001|Open-label Extension|Adverse Event|3|||
46823992|NCT00405756|83043186|FG002|Open-label Extension|Adverse Event|7|||
46823993|NCT00405756|83043184|FG000|Open-label Extension|Disease Progression|8|||
46823994|NCT00405756|83043185|FG001|Open-label Extension|Disease Progression|23|||
46823995|NCT00405756|83043186|FG002|Open-label Extension|Disease Progression|26|||
46823996|NCT00405756|83043184|FG000|Open-label Extension|Withdrawal by Subject|2|||
46823997|NCT00405756|83043185|FG001|Open-label Extension|Withdrawal by Subject|3|||
46823998|NCT00405756|83043186|FG002|Open-label Extension|Withdrawal by Subject|3|||
46823999|NCT00405756|83043184|FG000|Open-label Extension|Death|1|||
46933774|NCT00706238|83169700|FG000|Overall Study|Other|1|||
46933775|NCT03321968|83169707|FG000|Overall Study|Withdrawal by Subject|1|||
46933776|NCT03321968|83169708|FG001|Overall Study|Withdrawal by Subject|2|||
46933777|NCT03321968|83169709|FG002|Overall Study|Withdrawal by Subject|1|||
46933778|NCT03321968|83169707|FG000|Overall Study|Lost to Follow-up|2|||
46933779|NCT03321968|83169708|FG001|Overall Study|Lost to Follow-up|0|||
46933780|NCT03321968|83169709|FG002|Overall Study|Lost to Follow-up|1|||
46933781|NCT03321968|83169707|FG000|Overall Study|Other than specified|0|||
46933782|NCT03321968|83169708|FG001|Overall Study|Other than specified|0|||
46933783|NCT03321968|83169709|FG002|Overall Study|Other than specified|1|||
46933784|NCT05338333|83169723|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
46824000|NCT00405756|83043185|FG001|Open-label Extension|Death|2|||
46824001|NCT00405756|83043186|FG002|Open-label Extension|Death|4|||
46824002|NCT00405756|83043184|FG000|Open-label Extension|Other|0|||
46824003|NCT00405756|83043185|FG001|Open-label Extension|Other|1|||
46824004|NCT00405756|83043186|FG002|Open-label Extension|Other|7|||
46824005|NCT00405756|83043184|FG000|Follow-up|Ongoing in Follow-up Period|52|||
46824006|NCT00405756|83043185|FG001|Follow-up|Ongoing in Follow-up Period|51|||
46824007|NCT00405756|83043186|FG002|Follow-up|Ongoing in Follow-up Period|60|||
46824008|NCT00405756|83043184|FG000|Follow-up|Death|21|||
46824009|NCT00405756|83043185|FG001|Follow-up|Death|31|||
46824010|NCT00405756|83043186|FG002|Follow-up|Death|24|||
46824011|NCT00405756|83043184|FG000|Follow-up|Lost to Follow-up|2|||
46824012|NCT00405756|83043185|FG001|Follow-up|Lost to Follow-up|8|||
46824013|NCT00405756|83043186|FG002|Follow-up|Lost to Follow-up|4|||
46824014|NCT00456092|83043197|FG000|Extension Phase|Grade 2 or Greater AE|2|||
46824015|NCT00456092|83043198|FG001|Extension Phase|Grade 2 or Greater AE|2|||
46824016|NCT00456092|83043199|FG002|Extension Phase|Grade 2 or Greater AE|0|||
46824017|NCT00456092|83043200|FG003|Extension Phase|Grade 2 or Greater AE|0|||
46824018|NCT00456092|83043201|FG004|Extension Phase|Grade 2 or Greater AE|2|||
46824019|NCT00456092|83043197|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
46824020|NCT00456092|83043198|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
46824021|NCT00456092|83043199|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
46824022|NCT00456092|83043200|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
46824023|NCT00456092|83043201|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
46824024|NCT00456092|83043197|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
46824025|NCT00456092|83043198|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
46933785|NCT05338333|83169724|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
46933786|NCT05051579|83169740|FG000|Overall Study|Withdrawal by Subject|3|||
46933787|NCT05051579|83169741|FG001|Overall Study|Withdrawal by Subject|5|||
46933788|NCT05051579|83169742|FG002|Overall Study|Withdrawal by Subject|2|||
46824026|NCT00456092|83043199|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
46824027|NCT00456092|83043200|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
46933789|NCT05051579|83169743|FG003|Overall Study|Withdrawal by Subject|1|||
47057614|NCT01372410|83335863|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
46824028|NCT00456092|83043201|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
46824029|NCT00456092|83043197|FG000|Extension Phase|Withdrew Consent|2|||
46824030|NCT00456092|83043198|FG001|Extension Phase|Withdrew Consent|0|||
46824031|NCT00456092|83043199|FG002|Extension Phase|Withdrew Consent|0|||
46824032|NCT00456092|83043200|FG003|Extension Phase|Withdrew Consent|0|||
46824033|NCT00456092|83043201|FG004|Extension Phase|Withdrew Consent|0|||
46933790|NCT05051579|83169744|FG004|Overall Study|Withdrawal by Subject|4|||
46933791|NCT05051579|83169745|FG005|Overall Study|Withdrawal by Subject|0|||
46824034|NCT00456092|83043197|FG000|Extension Phase|Lost to Follow-up|1|||
46824035|NCT00456092|83043198|FG001|Extension Phase|Lost to Follow-up|1|||
46824036|NCT00456092|83043199|FG002|Extension Phase|Lost to Follow-up|0|||
46824037|NCT00456092|83043200|FG003|Extension Phase|Lost to Follow-up|0|||
46824038|NCT00456092|83043201|FG004|Extension Phase|Lost to Follow-up|1|||
46824039|NCT00456092|83043197|FG000|Extension Phase|Other|2|||
46824040|NCT00456092|83043198|FG001|Extension Phase|Other|0|||
46761530|NCT00877487|82979671|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
46824041|NCT00456092|83043199|FG002|Extension Phase|Other|0|||
46824042|NCT00456092|83043200|FG003|Extension Phase|Other|1|||
46824043|NCT00456092|83043201|FG004|Extension Phase|Other|1|||
46824044|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
46824045|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
46824046|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
46824047|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
46824048|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
46824049|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
46824050|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
46824051|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
46824052|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
46824053|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
46824054|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
46933792|NCT05051579|83169746|FG006|Overall Study|Withdrawal by Subject|4|||
47057615|NCT01372410|83335864|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
46637031|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
46761531|NCT00877487|82979670|FG000|Open-label Treatment Phase|Out of country for business|1|||
46761532|NCT00877487|82979671|FG001|Open-label Treatment Phase|Out of country for business|0|||
46761533|NCT00877487|82979670|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
46761534|NCT00877487|82979671|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
46761535|NCT00877487|82979670|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
46761536|NCT00877487|82979671|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
46761537|NCT00877487|82979670|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
46761538|NCT00877487|82979671|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
46761539|NCT00877487|82979670|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
46761540|NCT00877487|82979671|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
46761541|NCT00878501|82979680|FG000|Overall Study|Adverse Event|11|||
46761542|NCT00878501|82979681|FG001|Overall Study|Adverse Event|3|||
46761543|NCT00878501|82979682|FG002|Overall Study|Adverse Event|3|||
46761544|NCT00878501|82979680|FG000|Overall Study|Lack of Efficacy|2|||
46761545|NCT00878501|82979681|FG001|Overall Study|Lack of Efficacy|1|||
46761546|NCT00878501|82979682|FG002|Overall Study|Lack of Efficacy|0|||
46761547|NCT00878501|82979680|FG000|Overall Study|Withdrawal by Subject|2|||
46761548|NCT00878501|82979681|FG001|Overall Study|Withdrawal by Subject|1|||
46761549|NCT00878501|82979682|FG002|Overall Study|Withdrawal by Subject|2|||
46761550|NCT00878501|82979680|FG000|Overall Study|Protocol Violation|0|||
46761551|NCT00878501|82979681|FG001|Overall Study|Protocol Violation|0|||
46761552|NCT00878501|82979682|FG002|Overall Study|Protocol Violation|1|||
46761553|NCT00878501|82979680|FG000|Overall Study|Incorrect enrolment|1|||
46761554|NCT00878501|82979681|FG001|Overall Study|Incorrect enrolment|2|||
46761555|NCT00878501|82979682|FG002|Overall Study|Incorrect enrolment|0|||
46761556|NCT00878501|82979680|FG000|Overall Study|Intake of prohibited concom. medication|0|||
46761557|NCT00878501|82979681|FG001|Overall Study|Intake of prohibited concom. medication|0|||
46761558|NCT00878501|82979682|FG002|Overall Study|Intake of prohibited concom. medication|1|||
46761559|NCT00878501|82979680|FG000|Overall Study|Mis-randomisation of patient|1|||
46761560|NCT00878501|82979681|FG001|Overall Study|Mis-randomisation of patient|0|||
46761561|NCT00878501|82979682|FG002|Overall Study|Mis-randomisation of patient|0|||
46761562|NCT00878501|82979680|FG000|Overall Study|Administrative|0|||
46761563|NCT00878501|82979681|FG001|Overall Study|Administrative|0|||
46933793|NCT05051579|83169740|FG000|Overall Study|Lost to Follow-up|1|||
46637032|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
46637033|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
46637034|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
46637035|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
46637036|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
46761564|NCT00878501|82979682|FG002|Overall Study|Administrative|1|||
46761565|NCT00882713|82979690|FG000|Overall Study|Adverse Event|2|||
46761566|NCT00882713|82979690|FG000|Overall Study|Death|3|||
46761567|NCT00882713|82979690|FG000|Overall Study|Administrative reasons|4|||
46761568|NCT00882713|82979690|FG000|Overall Study|refused treatment/withdrew consent|4|||
46761569|NCT00882713|82979690|FG000|Overall Study|Blood transfusion|2|||
46933794|NCT05051579|83169741|FG001|Overall Study|Lost to Follow-up|0|||
46933795|NCT05051579|83169742|FG002|Overall Study|Lost to Follow-up|0|||
46824055|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
46824056|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
46824057|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
46933796|NCT05051579|83169743|FG003|Overall Study|Lost to Follow-up|0|||
46933797|NCT05051579|83169744|FG004|Overall Study|Lost to Follow-up|1|||
46933798|NCT05051579|83169745|FG005|Overall Study|Lost to Follow-up|0|||
46933799|NCT05051579|83169746|FG006|Overall Study|Lost to Follow-up|1|||
46933800|NCT05051579|83169740|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
46933801|NCT05051579|83169741|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
46933802|NCT05051579|83169742|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
46933803|NCT05051579|83169743|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
46933804|NCT05051579|83169744|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
46933805|NCT05051579|83169745|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
47057616|NCT01372410|83335865|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
47057617|NCT01372410|83335866|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
46824058|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
46824059|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
46824060|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
46824061|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
46824062|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
46824063|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
46824064|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
46824065|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
46824066|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
46824067|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
46824068|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
46824069|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
46824070|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
46824071|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
46824072|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
46933806|NCT05051579|83169746|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
46761570|NCT00882713|82979690|FG000|Overall Study|Insufficient therapeutic response|3|||
46761571|NCT00882713|82979690|FG000|Overall Study|Failure to return|2|||
46761572|NCT00882713|82979690|FG000|Overall Study|Other - Reasons|2|||
46761573|NCT00809133|82979709|FG000|Overall Study|Progressive disease|2|||
46933807|NCT05051579|83169740|FG000|Overall Study|Adverse Event|2|||
47057618|NCT01372410|83335867|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
47057619|NCT01372410|83335868|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
47057620|NCT01372410|83335869|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
46761574|NCT00809133|82979710|FG001|Overall Study|Progressive disease|5|||
46761575|NCT00809133|82979711|FG002|Overall Study|Progressive disease|5|||
46761576|NCT00809133|82979712|FG003|Overall Study|Progressive disease|3|||
46761577|NCT00809133|82979713|FG004|Overall Study|Progressive disease|4|||
46761578|NCT00809133|82979714|FG005|Overall Study|Progressive disease|1|||
46761579|NCT00809133|82979715|FG006|Overall Study|Progressive disease|3|||
46761580|NCT00809133|82979716|FG007|Overall Study|Progressive disease|3|||
46761581|NCT00809133|82979717|FG008|Overall Study|Progressive disease|3|||
46761582|NCT00809133|82979718|FG009|Overall Study|Progressive disease|9|||
46761583|NCT00809133|82979719|FG010|Overall Study|Progressive disease|5|||
46761584|NCT00809133|82979720|FG011|Overall Study|Progressive disease|7|||
46761585|NCT00809133|82979721|FG012|Overall Study|Progressive disease|5|||
46761586|NCT00809133|82979722|FG013|Overall Study|Progressive disease|4|||
46761587|NCT00809133|82979709|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761588|NCT00809133|82979710|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761589|NCT00809133|82979711|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761590|NCT00809133|82979712|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761591|NCT00809133|82979713|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761592|NCT00809133|82979714|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
46761593|NCT00809133|82979715|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
46761594|NCT00809133|82979716|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
46824073|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
46824074|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
46824075|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
46824076|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
47057621|NCT01372410|83335862|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
47057622|NCT01372410|83335863|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
47057623|NCT01372410|83335864|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
47057624|NCT01372410|83335865|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
47057625|NCT01372410|83335866|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
47057626|NCT01372410|83335867|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
47057627|NCT01372410|83335868|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
47057628|NCT01372410|83335869|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
47057629|NCT01372410|83335862|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
47057630|NCT01372410|83335863|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
47057631|NCT01372410|83335864|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
47057632|NCT01372410|83335865|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
47057633|NCT01372410|83335866|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
47057634|NCT01372410|83335867|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
47057635|NCT01372410|83335868|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
47057636|NCT01372410|83335869|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
47057637|NCT01704287|83335907|FG000|Initial Treatment Period|Death|139|||
47057638|NCT01704287|83335908|FG001|Initial Treatment Period|Death|129|||
47057639|NCT01704287|83335909|FG002|Initial Treatment Period|Death|71|||
47057640|NCT01704287|83335910|FG003|Initial Treatment Period|Death|0|||
47057641|NCT01704287|83335911|FG004|Initial Treatment Period|Death|0|||
47057642|NCT01704287|83335907|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
47057643|NCT01704287|83335908|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
47057644|NCT01704287|83335909|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
47057645|NCT01704287|83335910|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
47057646|NCT01704287|83335911|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
47057647|NCT01704287|83335907|FG000|Initial Treatment Period|Lost to Follow-up|5|||
47057648|NCT01704287|83335908|FG001|Initial Treatment Period|Lost to Follow-up|3|||
47057649|NCT01704287|83335909|FG002|Initial Treatment Period|Lost to Follow-up|0|||
47057650|NCT01704287|83335910|FG003|Initial Treatment Period|Lost to Follow-up|0|||
47057651|NCT01704287|83335911|FG004|Initial Treatment Period|Lost to Follow-up|0|||
47057652|NCT01704287|83335907|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
47057653|NCT01704287|83335908|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
47057654|NCT01704287|83335909|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
47057655|NCT01704287|83335910|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
47057656|NCT01704287|83335911|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
47057657|NCT01704287|83335907|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
47057658|NCT01704287|83335908|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
47057659|NCT01704287|83335909|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
46761595|NCT00809133|82979717|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761596|NCT00809133|82979718|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761597|NCT00809133|82979719|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761598|NCT00809133|82979720|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761599|NCT00809133|82979721|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46761600|NCT00809133|82979722|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
46761601|NCT00809133|82979709|FG000|Overall Study|Other adverse event|1|||
46761602|NCT00809133|82979710|FG001|Overall Study|Other adverse event|1|||
46761603|NCT00809133|82979711|FG002|Overall Study|Other adverse event|1|||
46761604|NCT00809133|82979712|FG003|Overall Study|Other adverse event|0|||
46761605|NCT00809133|82979713|FG004|Overall Study|Other adverse event|0|||
46761606|NCT00809133|82979714|FG005|Overall Study|Other adverse event|3|||
46761607|NCT00809133|82979715|FG006|Overall Study|Other adverse event|2|||
46761608|NCT00809133|82979716|FG007|Overall Study|Other adverse event|4|||
46761609|NCT00809133|82979717|FG008|Overall Study|Other adverse event|0|||
46761610|NCT00809133|82979718|FG009|Overall Study|Other adverse event|0|||
46761611|NCT00809133|82979719|FG010|Overall Study|Other adverse event|1|||
46761612|NCT00809133|82979720|FG011|Overall Study|Other adverse event|1|||
46761613|NCT00809133|82979721|FG012|Overall Study|Other adverse event|0|||
46761614|NCT00809133|82979722|FG013|Overall Study|Other adverse event|1|||
46761615|NCT00809133|82979709|FG000|Overall Study|Lost to Follow-up|0|||
46761616|NCT00809133|82979710|FG001|Overall Study|Lost to Follow-up|0|||
46761617|NCT00809133|82979711|FG002|Overall Study|Lost to Follow-up|0|||
46761618|NCT00809133|82979712|FG003|Overall Study|Lost to Follow-up|0|||
46761619|NCT00809133|82979713|FG004|Overall Study|Lost to Follow-up|0|||
46761620|NCT00809133|82979714|FG005|Overall Study|Lost to Follow-up|1|||
46824077|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
47057660|NCT01704287|83335910|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
46761621|NCT00809133|82979715|FG006|Overall Study|Lost to Follow-up|0|||
47057661|NCT01704287|83335911|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
47057662|NCT01704287|83335907|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
47057663|NCT01704287|83335908|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
47057664|NCT01704287|83335909|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
46761622|NCT00809133|82979716|FG007|Overall Study|Lost to Follow-up|0|||
46761623|NCT00809133|82979717|FG008|Overall Study|Lost to Follow-up|0|||
46824078|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
46761624|NCT00809133|82979718|FG009|Overall Study|Lost to Follow-up|0|||
46761625|NCT00809133|82979719|FG010|Overall Study|Lost to Follow-up|0|||
46761626|NCT00809133|82979720|FG011|Overall Study|Lost to Follow-up|0|||
46761627|NCT00809133|82979721|FG012|Overall Study|Lost to Follow-up|0|||
46824079|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
47057665|NCT01704287|83335910|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
47057666|NCT01704287|83335911|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
47057667|NCT01704287|83335907|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
47057668|NCT01704287|83335908|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
46824080|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
46824081|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
46824082|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
46824083|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
46824084|NCT00456092|83043197|FG000|Treatment Phase (12 Weeks)|Other|1|||
46824085|NCT00456092|83043198|FG001|Treatment Phase (12 Weeks)|Other|0|||
46824086|NCT00456092|83043199|FG002|Treatment Phase (12 Weeks)|Other|1|||
46824087|NCT00456092|83043200|FG003|Treatment Phase (12 Weeks)|Other|0|||
46824088|NCT00456092|83043201|FG004|Treatment Phase (12 Weeks)|Other|0|||
46824089|NCT00411450|83043215|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
46824090|NCT00404820|83043223|FG000|Overall Study|Adverse Event|4|||
46824091|NCT00404820|83043224|FG001|Overall Study|Adverse Event|16|||
46824092|NCT00404820|83043223|FG000|Overall Study|Withdrawal by Subject|5|||
46824093|NCT00404820|83043224|FG001|Overall Study|Withdrawal by Subject|3|||
46933808|NCT05051579|83169741|FG001|Overall Study|Adverse Event|1|||
46933809|NCT05051579|83169742|FG002|Overall Study|Adverse Event|0|||
46933810|NCT05051579|83169743|FG003|Overall Study|Adverse Event|4|||
46637037|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
46637038|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
46637039|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
46637040|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
46637041|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
46637042|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
47057669|NCT01704287|83335909|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
47057670|NCT01704287|83335910|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
47057671|NCT01704287|83335911|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
47057672|NCT01682837|83335939|FG000|Baseline|Withdrawal by Subject|5|||
47057673|NCT01703819|83335976|FG000|Overall Study|Adverse Event|0|||
47057674|NCT01703819|83335977|FG001|Overall Study|Adverse Event|1|||
47057675|NCT01703819|83335976|FG000|Overall Study|Withdrawal by Subject|0|||
47057676|NCT01703819|83335977|FG001|Overall Study|Withdrawal by Subject|1|||
47057677|NCT01682759|83335989|FG000|Overall Study|Death|2|||
47057678|NCT01682759|83335990|FG001|Overall Study|Death|1|||
47057679|NCT01682759|83335989|FG000|Overall Study|Lost to Follow-up|10|||
47057680|NCT01682759|83335990|FG001|Overall Study|Lost to Follow-up|13|||
47057681|NCT01682759|83335989|FG000|Overall Study|Physician Decision|1|||
47057682|NCT01682759|83335990|FG001|Overall Study|Physician Decision|1|||
47057683|NCT01682759|83335989|FG000|Overall Study|Withdrawal by Subject|56|||
46637043|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
46637044|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
46637045|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
46637046|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
46933811|NCT05051579|83169744|FG004|Overall Study|Adverse Event|1|||
46933812|NCT05051579|83169745|FG005|Overall Study|Adverse Event|2|||
46933813|NCT05051579|83169746|FG006|Overall Study|Adverse Event|0|||
46637047|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
46761628|NCT00809133|82979722|FG013|Overall Study|Lost to Follow-up|0|||
46933814|NCT05051579|83169740|FG000|Overall Study|Inadvertent Enrollment|0|||
46933815|NCT05051579|83169741|FG001|Overall Study|Inadvertent Enrollment|0|||
47057684|NCT01682759|83335990|FG001|Overall Study|Withdrawal by Subject|55|||
46761629|NCT00809133|82979709|FG000|Overall Study|Consent withdrawn|0|||
46761630|NCT00809133|82979710|FG001|Overall Study|Consent withdrawn|0|||
47057685|NCT01682681|83336000|FG000|Overall Study|Lack of Efficacy|62|||
47057686|NCT01682681|83336000|FG000|Overall Study|Withdrawal by Subject|1|||
47057687|NCT01682681|83336000|FG000|Overall Study|Moved to other hospital|10|||
46761631|NCT00809133|82979711|FG002|Overall Study|Consent withdrawn|0|||
46761632|NCT00809133|82979712|FG003|Overall Study|Consent withdrawn|0|||
46761633|NCT00809133|82979713|FG004|Overall Study|Consent withdrawn|1|||
46761634|NCT00809133|82979714|FG005|Overall Study|Consent withdrawn|0|||
46761635|NCT00809133|82979715|FG006|Overall Study|Consent withdrawn|0|||
46761636|NCT00809133|82979716|FG007|Overall Study|Consent withdrawn|0|||
46761637|NCT00809133|82979717|FG008|Overall Study|Consent withdrawn|0|||
46637048|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46637049|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46637050|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46637051|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46637052|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46637053|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46637054|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
46637055|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46824094|NCT00404820|83043223|FG000|Overall Study|Lost to Follow-up|7|||
46824095|NCT00404820|83043224|FG001|Overall Study|Lost to Follow-up|3|||
46824096|NCT00404820|83043223|FG000|Overall Study|Administrative problems|2|||
46824097|NCT00404820|83043224|FG001|Overall Study|Administrative problems|0|||
46824098|NCT00404820|83043223|FG000|Overall Study|Death|1|||
46824099|NCT00404820|83043224|FG001|Overall Study|Death|0|||
46824100|NCT00404820|83043223|FG000|Overall Study|Other|0|||
46933816|NCT05051579|83169742|FG002|Overall Study|Inadvertent Enrollment|0|||
47057688|NCT01682681|83336000|FG000|Overall Study|Lost to Follow-up|174|||
46824101|NCT00404820|83043224|FG001|Overall Study|Other|2|||
46824102|NCT00417612|83043232|FG000|Overall Study|Errant diagnosis|0|||
46824103|NCT00417612|83043233|FG001|Overall Study|Errant diagnosis|1|||
46824104|NCT00417612|83043232|FG000|Overall Study|Adverse Event|2|||
46824105|NCT00417612|83043233|FG001|Overall Study|Adverse Event|0|||
46824106|NCT00417612|83043232|FG000|Overall Study|Protocol Violation|0|||
46824107|NCT00417612|83043233|FG001|Overall Study|Protocol Violation|2|||
46824108|NCT00417612|83043232|FG000|Overall Study|Lost to Follow-up|1|||
46824109|NCT00417612|83043233|FG001|Overall Study|Lost to Follow-up|0|||
46824110|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
46824111|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
46824112|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
46824113|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
46824114|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
46824115|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
46824116|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
46824117|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
46824118|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
46824119|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
46824120|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
46824121|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
46824122|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
46824123|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
46824124|NCT00446030|83043243|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
46824125|NCT00446030|83043244|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
46824126|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
47057689|NCT01682681|83336000|FG000|Overall Study|Adverse Event|46|||
47057690|NCT01682681|83336000|FG000|Overall Study|tapering of topiramate|5|||
47057691|NCT01682681|83336000|FG000|Overall Study|Other|21|||
46824127|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
46824128|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
46824129|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
46824130|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
46824131|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
46824132|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
46933817|NCT05051579|83169743|FG003|Overall Study|Inadvertent Enrollment|0|||
46933818|NCT05051579|83169744|FG004|Overall Study|Inadvertent Enrollment|0|||
46933819|NCT05051579|83169745|FG005|Overall Study|Inadvertent Enrollment|0|||
46933820|NCT05051579|83169746|FG006|Overall Study|Inadvertent Enrollment|1|||
46824133|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
46824134|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
46824135|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
46824136|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
47057692|NCT01682681|83336000|FG000|Overall Study|Low compliance|13|||
47057693|NCT01682603|83336004|FG000|Overall Study|Lost to Follow-up|3|||
47057694|NCT01682213|83336020|FG000|Overall Study|Withdrawal by Subject|2|||
46637056|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
46824137|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
46824138|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
46824139|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
46824140|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
46824141|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
46824142|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
46824143|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
47057695|NCT01703741|83336029|FG000|Overall Study|Withdrawal by Subject|6|||
47057696|NCT01703741|83336029|FG000|Overall Study|Adverse Event|2|||
47057697|NCT01703741|83336029|FG000|Overall Study|Physician Decision|2|||
47057698|NCT01703741|83336029|FG000|Overall Study|Protocol Violation|1|||
47057699|NCT01703741|83336029|FG000|Overall Study|Lost to Follow-up|3|||
46824144|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
46824145|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
46933821|NCT05051579|83169740|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
46933822|NCT05051579|83169741|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
46933823|NCT05051579|83169742|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
46933824|NCT05051579|83169743|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
46933825|NCT05051579|83169744|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
46933826|NCT05051579|83169745|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
46933827|NCT05051579|83169746|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
46933828|NCT05051579|83169740|FG000|Overall Study|Sponsor Decision|0|||
46933829|NCT05051579|83169741|FG001|Overall Study|Sponsor Decision|0|||
46933830|NCT05051579|83169742|FG002|Overall Study|Sponsor Decision|0|||
46933831|NCT05051579|83169743|FG003|Overall Study|Sponsor Decision|0|||
46824146|NCT00446030|83043243|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
46824147|NCT00446030|83043244|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
46824148|NCT00411216|83043252|FG000|Overall Study|Ten participants were entered into the c|0|||
46824149|NCT00411216|83043253|FG001|Overall Study|Ten participants were entered into the c|2|||
46824150|NCT00410514|83043262|FG000|Overall Study|Adverse Event|2|||
46824151|NCT00410514|83043263|FG001|Overall Study|Adverse Event|2|||
46824152|NCT00410514|83043264|FG002|Overall Study|Adverse Event|2|||
46824153|NCT00410514|83043262|FG000|Overall Study|Protocol Violation|0|||
46824154|NCT00410514|83043263|FG001|Overall Study|Protocol Violation|1|||
46824155|NCT00410514|83043264|FG002|Overall Study|Protocol Violation|1|||
46824156|NCT00410514|83043262|FG000|Overall Study|Lost to Follow-up|0|||
46824157|NCT00410514|83043263|FG001|Overall Study|Lost to Follow-up|0|||
46824158|NCT00410514|83043264|FG002|Overall Study|Lost to Follow-up|2|||
46824159|NCT00410514|83043262|FG000|Overall Study|Non-compliant with study procedures|0|||
46824160|NCT00410514|83043263|FG001|Overall Study|Non-compliant with study procedures|0|||
46824161|NCT00410514|83043264|FG002|Overall Study|Non-compliant with study procedures|2|||
46933832|NCT05051579|83169744|FG004|Overall Study|Sponsor Decision|1|||
46933833|NCT05051579|83169745|FG005|Overall Study|Sponsor Decision|0|||
46824162|NCT03843632|83043276|FG000|Overall Study|Withdrawal by Subject|1|||
46824163|NCT03843632|83043277|FG001|Overall Study|Withdrawal by Subject|0|||
46824164|NCT03843632|83043278|FG002|Overall Study|Withdrawal by Subject|0|||
46824165|NCT03843632|83043279|FG003|Overall Study|Withdrawal by Subject|0|||
46824166|NCT00439556|83043292|FG000|Overall Study|Patient was taken off study for non-comp|0|||
46933834|NCT05051579|83169746|FG006|Overall Study|Sponsor Decision|0|||
46933835|NCT05051579|83169740|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
47057700|NCT01703741|83336029|FG000|Overall Study|Subject did not want to continue|2|||
47057701|NCT01703741|83336029|FG000|Overall Study|Subject cannot comply with study visits|1|||
46761638|NCT00809133|82979718|FG009|Overall Study|Consent withdrawn|0|||
46761639|NCT00809133|82979719|FG010|Overall Study|Consent withdrawn|0|||
46761640|NCT00809133|82979720|FG011|Overall Study|Consent withdrawn|0|||
46761641|NCT00809133|82979721|FG012|Overall Study|Consent withdrawn|0|||
46761642|NCT00809133|82979722|FG013|Overall Study|Consent withdrawn|0|||
46761643|NCT00809133|82979709|FG000|Overall Study|Other not mentioned above|0|||
46761644|NCT00809133|82979710|FG001|Overall Study|Other not mentioned above|1|||
46761645|NCT00809133|82979711|FG002|Overall Study|Other not mentioned above|0|||
46761646|NCT00809133|82979712|FG003|Overall Study|Other not mentioned above|0|||
46761647|NCT00809133|82979713|FG004|Overall Study|Other not mentioned above|0|||
46761648|NCT00809133|82979714|FG005|Overall Study|Other not mentioned above|1|||
46761649|NCT00809133|82979715|FG006|Overall Study|Other not mentioned above|0|||
46761650|NCT00809133|82979716|FG007|Overall Study|Other not mentioned above|0|||
46761651|NCT00809133|82979717|FG008|Overall Study|Other not mentioned above|0|||
46761652|NCT00809133|82979718|FG009|Overall Study|Other not mentioned above|0|||
46761653|NCT00809133|82979719|FG010|Overall Study|Other not mentioned above|0|||
47057702|NCT01703741|83336029|FG000|Overall Study|Subject started testosterone injections|1|||
46761654|NCT00809133|82979720|FG011|Overall Study|Other not mentioned above|0|||
46761655|NCT00809133|82979721|FG012|Overall Study|Other not mentioned above|0|||
46824167|NCT00439556|83043293|FG001|Overall Study|Patient was taken off study for non-comp|1|||
46824168|NCT00439556|83043294|FG002|Overall Study|Patient was taken off study for non-comp|0|||
46824169|NCT00410202|83043306|FG000|On-Treatment|Continuing treatment|69|||
46824170|NCT00410202|83043307|FG001|On-Treatment|Continuing treatment|71|||
46824171|NCT00410202|83043308|FG002|On-Treatment|Continuing treatment|66|||
46824172|NCT00410202|83043306|FG000|On-Treatment|Adverse Event|1|||
46761656|NCT00809133|82979722|FG013|Overall Study|Other not mentioned above|0|||
46761657|NCT00882557|82979767|FG000|Overall Study|Withdrawal by Subject|1|||
46824173|NCT00410202|83043307|FG001|On-Treatment|Adverse Event|3|||
46824174|NCT00410202|83043308|FG002|On-Treatment|Adverse Event|2|||
46824175|NCT00410202|83043306|FG000|On-Treatment|Death|1|||
46824176|NCT00410202|83043307|FG001|On-Treatment|Death|0|||
46824177|NCT00410202|83043308|FG002|On-Treatment|Death|0|||
46824178|NCT00410202|83043306|FG000|On-Treatment|Lost to Follow-up|1|||
46824179|NCT00410202|83043307|FG001|On-Treatment|Lost to Follow-up|0|||
46824180|NCT00410202|83043308|FG002|On-Treatment|Lost to Follow-up|1|||
46824181|NCT00410202|83043306|FG000|On-Treatment|Lack of Efficacy|1|||
46824182|NCT00410202|83043307|FG001|On-Treatment|Lack of Efficacy|4|||
46824183|NCT00410202|83043308|FG002|On-Treatment|Lack of Efficacy|0|||
46824184|NCT00410202|83043306|FG000|On-Treatment|Withdrawal by Subject|2|||
46824185|NCT00410202|83043307|FG001|On-Treatment|Withdrawal by Subject|1|||
46824186|NCT00410202|83043308|FG002|On-Treatment|Withdrawal by Subject|1|||
46824187|NCT00410202|83043306|FG000|On-Treatment|Other Reason|0|||
46824188|NCT00410202|83043307|FG001|On-Treatment|Other Reason|0|||
46824189|NCT00410202|83043308|FG002|On-Treatment|Other Reason|1|||
46824190|NCT00410202|83043306|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
46824191|NCT00410202|83043307|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
46824192|NCT00410202|83043308|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
47057703|NCT01681511|83336035|FG000|Overall Study|No Treatment Received|1|||
47057704|NCT01681511|83336036|FG001|Overall Study|No Treatment Received|3|||
47057705|NCT01681511|83336035|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
47057706|NCT01681511|83336036|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
47057707|NCT01681511|83336035|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
47057708|NCT01681511|83336036|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
47057709|NCT01681511|83336035|FG000|Overall Study|No Daily Urine Sample Collected|0|||
47057710|NCT01681511|83336036|FG001|Overall Study|No Daily Urine Sample Collected|1|||
47057711|NCT01681511|83336035|FG000|Overall Study|No post-catheter sample collected|11|||
47057712|NCT01681511|83336036|FG001|Overall Study|No post-catheter sample collected|4|||
47057713|NCT01681433|83336044|FG000|Overall Study|Lack of Efficacy|23|||
47057714|NCT01681433|83336045|FG001|Overall Study|Lack of Efficacy|23|||
46824193|NCT00410202|83043306|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
46824194|NCT00410202|83043307|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
46824195|NCT00410202|83043308|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
46824196|NCT00410202|83043306|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
46824197|NCT00410202|83043307|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
47057715|NCT01681433|83336044|FG000|Overall Study|Withdrawal by Subject|5|||
47057716|NCT01681433|83336045|FG001|Overall Study|Withdrawal by Subject|5|||
47057717|NCT01681433|83336044|FG000|Overall Study|Protocol Violation|2|||
46824198|NCT00410202|83043308|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
46824199|NCT00445328|83043319|FG000|Overall Study|Death|0|||
46824200|NCT00445328|83043320|FG001|Overall Study|Death|1|||
46824201|NCT00445328|83043319|FG000|Overall Study|Adverse Event|0|||
47057718|NCT01681433|83336045|FG001|Overall Study|Protocol Violation|0|||
47057719|NCT01681433|83336044|FG000|Overall Study|Adverse Event|2|||
47057720|NCT01681433|83336045|FG001|Overall Study|Adverse Event|4|||
47057721|NCT01681433|83336044|FG000|Overall Study|Lost to Follow-up|0|||
47057722|NCT01681433|83336045|FG001|Overall Study|Lost to Follow-up|1|||
47057723|NCT01681277|83336056|FG000|Overall Study|Adverse Event|1|||
47057724|NCT01681277|83336057|FG001|Overall Study|Adverse Event|0|||
47057725|NCT01681277|83336058|FG002|Overall Study|Adverse Event|0|||
47057726|NCT01681277|83336059|FG003|Overall Study|Adverse Event|0|||
46824202|NCT00445328|83043320|FG001|Overall Study|Adverse Event|3|||
46824203|NCT00445328|83043319|FG000|Overall Study|Other|0|||
46824204|NCT00445328|83043320|FG001|Overall Study|Other|2|||
46824205|NCT00445328|83043319|FG000|Overall Study|Withdrawal by Subject|2|||
46824206|NCT00445328|83043320|FG001|Overall Study|Withdrawal by Subject|0|||
47057727|NCT01681277|83336060|FG004|Overall Study|Adverse Event|0|||
47057728|NCT01703117|83336078|FG000|Overall Study|Adverse Event|4|||
47057729|NCT01703117|83336079|FG001|Overall Study|Adverse Event|3|||
47057730|NCT01703117|83336078|FG000|Overall Study|Withdrawal by Subject|0|||
47057731|NCT01703117|83336079|FG001|Overall Study|Withdrawal by Subject|1|||
46824207|NCT00445328|83043319|FG000|Overall Study|Protocol Violation|1|||
46824208|NCT00445328|83043320|FG001|Overall Study|Protocol Violation|0|||
46824209|NCT00455312|83043328|FG000|Overall Study|Death|0|||
46824210|NCT00455312|83043329|FG001|Overall Study|Death|1|||
46824211|NCT00444626|83043335|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
46824212|NCT00444626|83043335|FG000|Initial Treatment Period|Adverse Event|1|||
46824213|NCT00444626|83043335|FG000|Initial Treatment Period|Lost to Follow-up|9|||
46824214|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
46824215|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
47057732|NCT01702961|83336087|FG000|Overall Study|Additional treatment|3|||
47057733|NCT01702961|83336087|FG000|Overall Study|Progressive disease|5|||
47057734|NCT01702961|83336087|FG000|Overall Study|Relapse|20|||
47057735|NCT01702961|83336087|FG000|Overall Study|Death|6|||
47057736|NCT01702961|83336087|FG000|Overall Study|Lost to Follow-up|2|||
47057737|NCT01702961|83336087|FG000|Overall Study|Ongoing|11|||
47057738|NCT01593917|83336091|FG000|Overall Study|Death|67|||
47057739|NCT01593917|83336091|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
47057740|NCT01593917|83336091|FG000|Overall Study|Withdrawal by Subject|23|||
47057741|NCT01593917|83336091|FG000|Overall Study|Lost to Follow-up|12|||
47057742|NCT01593917|83336091|FG000|Overall Study|Protocol Violation|5|||
47057743|NCT01593917|83336091|FG000|Overall Study|Physician Decision|3|||
47057744|NCT01593761|83336095|FG000|Overall Study|Lost to Follow-up|1|||
47057745|NCT01593761|83336095|FG000|Overall Study|culture negative for MRSA at baseline|5|||
47057746|NCT01593761|83336095|FG000|Overall Study|positive for hepatitis C virus|1|||
47057747|NCT01593761|83336095|FG000|Overall Study|secondary cellulitis|1|||
47057748|NCT02706834|83336116|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
47057749|NCT02706834|83336117|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
47057750|NCT02706834|83336118|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
47057751|NCT02706834|83336119|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
47057752|NCT02706834|83336120|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
47057753|NCT02706834|83336121|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
47057754|NCT02706834|83336122|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
47057755|NCT02706834|83336123|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
46824216|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
46824217|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
46824218|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
46824219|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
46824220|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
46761658|NCT00882557|82979768|FG001|Overall Study|Withdrawal by Subject|0|||
46761659|NCT00882557|82979767|FG000|Overall Study|Trouble with Vein Access|1|||
46761660|NCT00882557|82979768|FG001|Overall Study|Trouble with Vein Access|0|||
46761661|NCT00882557|82979767|FG000|Overall Study|Randomized Not Treated|0|||
46761662|NCT00882557|82979768|FG001|Overall Study|Randomized Not Treated|1|||
46761663|NCT00808899|82979774|FG000|Overall Study|Death|1|||
46761664|NCT00808899|82979774|FG000|Overall Study|Physician Decision|3|||
46761665|NCT00808665|82979780|FG000|Overall Study|Withdrawal by Subject|1|||
46761666|NCT00808665|82979781|FG001|Overall Study|Withdrawal by Subject|0|||
46761667|NCT00808665|82979780|FG000|Overall Study|only required minimally invasive surgery|1|||
46761668|NCT00808665|82979781|FG001|Overall Study|only required minimally invasive surgery|0|||
46761669|NCT00808665|82979780|FG000|Overall Study|surgery cancelled|1|||
46761670|NCT00808665|82979781|FG001|Overall Study|surgery cancelled|0|||
46761671|NCT00808665|82979780|FG000|Overall Study|required an additional procedure|0|||
46761672|NCT00808665|82979781|FG001|Overall Study|required an additional procedure|1|||
46761673|NCT00808665|82979780|FG000|Overall Study|Physician Decision|3|||
46761674|NCT00808665|82979781|FG001|Overall Study|Physician Decision|1|||
46761675|NCT00808665|82979780|FG000|Overall Study|Medication stopped by resident|0|||
46761676|NCT00808665|82979781|FG001|Overall Study|Medication stopped by resident|1|||
46761677|NCT00808509|82979789|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
46761678|NCT00808509|82979790|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
46761679|NCT00808509|82979789|FG000|Randomized Phase|Reduced methotrexate dose|1|||
46761680|NCT00808509|82979790|FG001|Randomized Phase|Reduced methotrexate dose|2|||
46761681|NCT00808509|82979789|FG000|Randomized Phase|Patient refused rescue therapy|0|||
46761682|NCT00808509|82979790|FG001|Randomized Phase|Patient refused rescue therapy|3|||
46761683|NCT00807885|82979807|FG000|Overall Study|Lost to Follow-up|0|||
46761684|NCT00807885|82979808|FG001|Overall Study|Lost to Follow-up|0|||
46761685|NCT00807885|82979809|FG002|Overall Study|Lost to Follow-up|0|||
46761686|NCT00807885|82979810|FG003|Overall Study|Lost to Follow-up|0|||
46761687|NCT00807885|82979811|FG004|Overall Study|Lost to Follow-up|0|||
46761688|NCT00807885|82979812|FG005|Overall Study|Lost to Follow-up|1|||
46761689|NCT00807885|82979813|FG006|Overall Study|Lost to Follow-up|0|||
46761690|NCT00807885|82979814|FG007|Overall Study|Lost to Follow-up|0|||
46761691|NCT00807885|82979815|FG008|Overall Study|Lost to Follow-up|0|||
46761692|NCT00807573|82979835|FG000|Overall Study|Withdrawal by Subject|1|||
46761693|NCT00807573|82979835|FG000|Overall Study|Adverse Event|1|||
46761694|NCT00842712|82979846|FG000|Safety Run-in Part|Adverse Event|0|||
46824221|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
46761695|NCT00842712|82979847|FG001|Safety Run-in Part|Adverse Event|1|||
46761696|NCT00842712|82979848|FG002|Safety Run-in Part|Adverse Event|0|||
46761697|NCT00842712|82979849|FG003|Safety Run-in Part|Adverse Event|0|||
46761698|NCT00842712|82979850|FG004|Safety Run-in Part|Adverse Event|0|||
46761699|NCT00842712|82979851|FG005|Safety Run-in Part|Adverse Event|0|||
46824222|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
47057756|NCT02706834|83336124|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
47057757|NCT02706834|83336125|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
47057758|NCT02706834|83336126|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
47057759|NCT02706834|83336116|FG000|Overall Study|Lost to Follow-up|0|||
47057760|NCT02706834|83336117|FG001|Overall Study|Lost to Follow-up|0|||
47057761|NCT02706834|83336118|FG002|Overall Study|Lost to Follow-up|1|||
47057762|NCT02706834|83336119|FG003|Overall Study|Lost to Follow-up|0|||
47057763|NCT02706834|83336120|FG004|Overall Study|Lost to Follow-up|0|||
47057764|NCT02706834|83336121|FG005|Overall Study|Lost to Follow-up|0|||
47057765|NCT02706834|83336122|FG006|Overall Study|Lost to Follow-up|0|||
47057766|NCT02706834|83336123|FG007|Overall Study|Lost to Follow-up|0|||
47057767|NCT02706834|83336124|FG008|Overall Study|Lost to Follow-up|0|||
47057768|NCT02706834|83336125|FG009|Overall Study|Lost to Follow-up|0|||
47057769|NCT02706834|83336126|FG010|Overall Study|Lost to Follow-up|0|||
47057770|NCT02706834|83336116|FG000|Overall Study|Voluntary Withdrawal|1|||
47057771|NCT02706834|83336117|FG001|Overall Study|Voluntary Withdrawal|0|||
47057772|NCT02706834|83336118|FG002|Overall Study|Voluntary Withdrawal|0|||
47057773|NCT02706834|83336119|FG003|Overall Study|Voluntary Withdrawal|0|||
47057774|NCT02706834|83336120|FG004|Overall Study|Voluntary Withdrawal|0|||
47057775|NCT02706834|83336121|FG005|Overall Study|Voluntary Withdrawal|0|||
47057776|NCT02706834|83336122|FG006|Overall Study|Voluntary Withdrawal|0|||
47057777|NCT02706834|83336123|FG007|Overall Study|Voluntary Withdrawal|0|||
47057778|NCT02706834|83336124|FG008|Overall Study|Voluntary Withdrawal|0|||
47057779|NCT02706834|83336125|FG009|Overall Study|Voluntary Withdrawal|1|||
47057780|NCT02706834|83336126|FG010|Overall Study|Voluntary Withdrawal|0|||
47057781|NCT02706834|83336116|FG000|Overall Study|Other Reason Not Specified|1|||
47057782|NCT02706834|83336117|FG001|Overall Study|Other Reason Not Specified|0|||
47057783|NCT02706834|83336118|FG002|Overall Study|Other Reason Not Specified|0|||
47057784|NCT02706834|83336119|FG003|Overall Study|Other Reason Not Specified|0|||
46761700|NCT00842712|82979852|FG006|Safety Run-in Part|Adverse Event|0|||
46761701|NCT00842712|82979846|FG000|Safety Run-in Part|Progressive disease|3|||
46761702|NCT00842712|82979847|FG001|Safety Run-in Part|Progressive disease|1|||
46761703|NCT00842712|82979848|FG002|Safety Run-in Part|Progressive disease|0|||
46761704|NCT00842712|82979849|FG003|Safety Run-in Part|Progressive disease|1|||
46761705|NCT00842712|82979850|FG004|Safety Run-in Part|Progressive disease|0|||
46761706|NCT00842712|82979851|FG005|Safety Run-in Part|Progressive disease|0|||
46761707|NCT00842712|82979852|FG006|Safety Run-in Part|Progressive disease|0|||
46761708|NCT00842712|82979846|FG000|Randomized Part|Randomized but not treated|0|||
46761709|NCT00842712|82979847|FG001|Randomized Part|Randomized but not treated|0|||
46761710|NCT00842712|82979848|FG002|Randomized Part|Randomized but not treated|0|||
46761711|NCT00842712|82979849|FG003|Randomized Part|Randomized but not treated|0|||
46761712|NCT00842712|82979850|FG004|Randomized Part|Randomized but not treated|0|||
46824223|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
46824224|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
46824225|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
46824226|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
46824227|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
46824228|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
46824229|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
46824230|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
46824231|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
47057785|NCT02706834|83336120|FG004|Overall Study|Other Reason Not Specified|1|||
46761713|NCT00842712|82979851|FG005|Randomized Part|Randomized but not treated|1|||
46761714|NCT00842712|82979852|FG006|Randomized Part|Randomized but not treated|4|||
46761715|NCT00842712|82979846|FG000|Randomized Part|Ongoing at cut-off date|0|||
46824232|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Death|0|||
47057786|NCT02706834|83336121|FG005|Overall Study|Other Reason Not Specified|0|||
47057787|NCT02706834|83336122|FG006|Overall Study|Other Reason Not Specified|0|||
47057788|NCT02706834|83336123|FG007|Overall Study|Other Reason Not Specified|0|||
47057789|NCT02706834|83336124|FG008|Overall Study|Other Reason Not Specified|0|||
47057790|NCT02706834|83336125|FG009|Overall Study|Other Reason Not Specified|0|||
47057791|NCT02706834|83336126|FG010|Overall Study|Other Reason Not Specified|0|||
46761716|NCT00842712|82979847|FG001|Randomized Part|Ongoing at cut-off date|0|||
46761717|NCT00842712|82979848|FG002|Randomized Part|Ongoing at cut-off date|0|||
46761718|NCT00842712|82979849|FG003|Randomized Part|Ongoing at cut-off date|0|||
46761719|NCT00842712|82979850|FG004|Randomized Part|Ongoing at cut-off date|0|||
46824233|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Death|0|||
46824234|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Death|1|||
46824235|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Death|0|||
46824236|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Death|0|||
46824237|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Death|0|||
47057792|NCT01702025|83336175|FG000|Overall Study|Equipment failure|1|||
47057793|NCT01702025|83336176|FG001|Overall Study|Equipment failure|0|||
47057794|NCT01702025|83336177|FG002|Overall Study|Equipment failure|0|||
47057795|NCT01702025|83336178|FG003|Overall Study|Equipment failure|0|||
47057796|NCT01702025|83336175|FG000|Overall Study|Adverse Event|1|||
47057797|NCT01702025|83336176|FG001|Overall Study|Adverse Event|1|||
47057798|NCT01702025|83336177|FG002|Overall Study|Adverse Event|1|||
47057799|NCT01702025|83336178|FG003|Overall Study|Adverse Event|0|||
47057800|NCT01592747|83336195|FG000|Overall Study|Loss of Therapeutic Response|107|||
47057801|NCT01592747|83336196|FG001|Overall Study|Loss of Therapeutic Response|108|||
47057802|NCT01592747|83336197|FG002|Overall Study|Loss of Therapeutic Response|100|||
47057803|NCT01592747|83336195|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
47057804|NCT01592747|83336196|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
47057805|NCT01592747|83336197|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
47057806|NCT01592747|83336195|FG000|Overall Study|Adverse Event|1|||
47057807|NCT01592747|83336196|FG001|Overall Study|Adverse Event|0|||
47057808|NCT01592747|83336197|FG002|Overall Study|Adverse Event|0|||
47057809|NCT01592747|83336195|FG000|Overall Study|Protocol Violation|4|||
47057810|NCT01592747|83336196|FG001|Overall Study|Protocol Violation|0|||
47057811|NCT01592747|83336197|FG002|Overall Study|Protocol Violation|4|||
47057812|NCT01592747|83336195|FG000|Overall Study|Lack of Efficacy|0|||
47057813|NCT01592747|83336196|FG001|Overall Study|Lack of Efficacy|1|||
47057814|NCT01592747|83336197|FG002|Overall Study|Lack of Efficacy|0|||
47057815|NCT01592747|83336195|FG000|Overall Study|Withdrawal by Subject|2|||
47057816|NCT01592747|83336196|FG001|Overall Study|Withdrawal by Subject|0|||
47057817|NCT01592747|83336197|FG002|Overall Study|Withdrawal by Subject|2|||
47057818|NCT01592747|83336195|FG000|Overall Study|Lost to Follow-up|1|||
47057819|NCT01592747|83336196|FG001|Overall Study|Lost to Follow-up|0|||
47057820|NCT01592747|83336197|FG002|Overall Study|Lost to Follow-up|1|||
47057821|NCT01592747|83336195|FG000|Overall Study|Other Reasons|1|||
47057822|NCT01592747|83336196|FG001|Overall Study|Other Reasons|1|||
47057823|NCT01592747|83336197|FG002|Overall Study|Other Reasons|0|||
47057824|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Death|3|||
47057825|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Death|3|||
47057826|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Death|0|||
47057827|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Death|0|||
47057828|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
46761720|NCT00842712|82979851|FG005|Randomized Part|Ongoing at cut-off date|0|||
46761721|NCT00842712|82979852|FG006|Randomized Part|Ongoing at cut-off date|2|||
46761722|NCT00842244|82979868|FG000|Overall Study|Death|3|||
46761723|NCT00842244|82979868|FG000|Overall Study|Withdrawal by Subject|1|||
46761724|NCT00842244|82979868|FG000|Overall Study|Other|17|||
46933836|NCT05051579|83169741|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
46933837|NCT05051579|83169742|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
46933838|NCT05051579|83169743|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
46933839|NCT05051579|83169744|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
47057829|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
46637057|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46761725|NCT00832416|82979879|FG000|Overall Study|Lack of Efficacy|17|||
46761726|NCT00832416|82979880|FG001|Overall Study|Lack of Efficacy|15|||
46761727|NCT00832416|82979881|FG002|Overall Study|Lack of Efficacy|13|||
46761728|NCT00832416|82979882|FG003|Overall Study|Lack of Efficacy|52|||
46761729|NCT00832416|82979879|FG000|Overall Study|Withdrawal by Subject|5|||
46761730|NCT00832416|82979880|FG001|Overall Study|Withdrawal by Subject|7|||
46761731|NCT00832416|82979881|FG002|Overall Study|Withdrawal by Subject|2|||
46761732|NCT00832416|82979882|FG003|Overall Study|Withdrawal by Subject|10|||
46761733|NCT00832416|82979879|FG000|Overall Study|Physician Decision|2|||
46761734|NCT00832416|82979880|FG001|Overall Study|Physician Decision|12|||
46761735|NCT00832416|82979881|FG002|Overall Study|Physician Decision|5|||
46761736|NCT00832416|82979882|FG003|Overall Study|Physician Decision|10|||
46761737|NCT00832416|82979879|FG000|Overall Study|Administrative|0|||
46761738|NCT00832416|82979880|FG001|Overall Study|Administrative|0|||
46761739|NCT00832416|82979881|FG002|Overall Study|Administrative|0|||
46761740|NCT00832416|82979882|FG003|Overall Study|Administrative|1|||
46761741|NCT00832416|82979879|FG000|Overall Study|Adverse Event|21|||
46761742|NCT00832416|82979880|FG001|Overall Study|Adverse Event|19|||
46761743|NCT00832416|82979881|FG002|Overall Study|Adverse Event|41|||
46761744|NCT00832416|82979882|FG003|Overall Study|Adverse Event|10|||
46761745|NCT00832416|82979879|FG000|Overall Study|Death|1|||
46761746|NCT00832416|82979880|FG001|Overall Study|Death|0|||
46761747|NCT00832416|82979881|FG002|Overall Study|Death|0|||
46761748|NCT00832416|82979882|FG003|Overall Study|Death|0|||
46824238|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Death|0|||
47057830|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
46761749|NCT00841776|82979894|FG000|Overall Study|Lack of Efficacy|0|||
46761750|NCT00841776|82979895|FG001|Overall Study|Lack of Efficacy|1|||
46761751|NCT00841776|82979894|FG000|Overall Study|Lost to Follow-up|2|||
46761752|NCT00841776|82979895|FG001|Overall Study|Lost to Follow-up|1|||
46824239|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Death|0|||
47057831|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
47057832|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
47057833|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
46824240|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Death|0|||
46824241|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
46824242|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
46824243|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
46824244|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
46824245|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
46824246|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
46824247|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
46824248|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
46824249|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
46824250|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
46824251|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
46824252|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
46824253|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
46824254|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
46824255|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
47057834|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
47057835|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
47057836|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
47057837|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
47057838|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
47057839|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
47057840|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
47057841|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
47057842|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
47057843|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
47057844|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
47057845|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
47057846|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
47057847|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
47057848|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
47057849|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
46824256|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
46824257|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
46824258|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
46824259|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
46824260|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
46824261|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
46933840|NCT05051579|83169745|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
46933841|NCT05051579|83169746|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
46933842|NCT04964128|83169770|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
46933843|NCT04964128|83169770|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
46933844|NCT04881760|83169785|FG000|Overall Study|Adverse Event|0|||
46933845|NCT04881760|83169786|FG001|Overall Study|Adverse Event|1|||
46933846|NCT04881760|83169787|FG002|Overall Study|Adverse Event|1|||
47057850|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
46637058|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
46637059|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637060|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46761753|NCT00841776|82979894|FG000|Overall Study|Withdrawal by Subject|0|||
46761754|NCT00841776|82979895|FG001|Overall Study|Withdrawal by Subject|1|||
46761755|NCT00683800|82979903|FG000|Overall Study|Adverse Event|195|||
46761756|NCT00683800|82979904|FG001|Overall Study|Adverse Event|102|||
46761757|NCT00683800|82979903|FG000|Overall Study|Death|0|||
46761758|NCT00683800|82979904|FG001|Overall Study|Death|1|||
46761759|NCT00683800|82979903|FG000|Overall Study|Lost to Follow-up|57|||
46761760|NCT00683800|82979904|FG001|Overall Study|Lost to Follow-up|44|||
46761761|NCT00683800|82979903|FG000|Overall Study|Other|5|||
46761762|NCT00683800|82979904|FG001|Overall Study|Other|2|||
46761763|NCT00683800|82979903|FG000|Overall Study|Protocol Violation|13|||
46761764|NCT00683800|82979904|FG001|Overall Study|Protocol Violation|16|||
46761765|NCT00683800|82979903|FG000|Overall Study|Withdrawal by Subject|66|||
46761766|NCT00683800|82979904|FG001|Overall Study|Withdrawal by Subject|64|||
46761767|NCT00683800|82979903|FG000|Overall Study|Lack of Efficacy|61|||
46761768|NCT00683800|82979904|FG001|Overall Study|Lack of Efficacy|104|||
46824262|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
46824263|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
47057851|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
46933847|NCT04881760|83169788|FG003|Overall Study|Adverse Event|0|||
46933848|NCT04881760|83169789|FG004|Overall Study|Adverse Event|1|||
46933849|NCT04881760|83169790|FG005|Overall Study|Adverse Event|1|||
46933850|NCT04881760|83169791|FG006|Overall Study|Adverse Event|2|||
46933851|NCT04881760|83169785|FG000|Overall Study|Death|0|||
46933852|NCT04881760|83169786|FG001|Overall Study|Death|0|||
46933853|NCT04881760|83169787|FG002|Overall Study|Death|0|||
46933854|NCT04881760|83169788|FG003|Overall Study|Death|1|||
46933855|NCT04881760|83169789|FG004|Overall Study|Death|0|||
46933856|NCT04881760|83169790|FG005|Overall Study|Death|0|||
46933857|NCT04881760|83169791|FG006|Overall Study|Death|0|||
46933858|NCT04881760|83169785|FG000|Overall Study|Lost to Follow-up|5|||
46933859|NCT04881760|83169786|FG001|Overall Study|Lost to Follow-up|7|||
46933860|NCT04881760|83169787|FG002|Overall Study|Lost to Follow-up|5|||
46933861|NCT04881760|83169788|FG003|Overall Study|Lost to Follow-up|1|||
46933862|NCT04881760|83169789|FG004|Overall Study|Lost to Follow-up|2|||
46933863|NCT04881760|83169790|FG005|Overall Study|Lost to Follow-up|4|||
46933864|NCT04881760|83169791|FG006|Overall Study|Lost to Follow-up|4|||
46933865|NCT04881760|83169785|FG000|Overall Study|Withdrawal by Subject|13|||
46933866|NCT04881760|83169786|FG001|Overall Study|Withdrawal by Subject|1|||
46933867|NCT04881760|83169787|FG002|Overall Study|Withdrawal by Subject|1|||
46933868|NCT04881760|83169788|FG003|Overall Study|Withdrawal by Subject|4|||
46933869|NCT04881760|83169789|FG004|Overall Study|Withdrawal by Subject|2|||
46933870|NCT04881760|83169790|FG005|Overall Study|Withdrawal by Subject|1|||
46933871|NCT04881760|83169791|FG006|Overall Study|Withdrawal by Subject|2|||
46933872|NCT04881760|83169785|FG000|Overall Study|Randomized but Never Treated|0|||
46933873|NCT04881760|83169786|FG001|Overall Study|Randomized but Never Treated|0|||
46933874|NCT04881760|83169787|FG002|Overall Study|Randomized but Never Treated|0|||
46933875|NCT04881760|83169788|FG003|Overall Study|Randomized but Never Treated|1|||
46933876|NCT04881760|83169789|FG004|Overall Study|Randomized but Never Treated|0|||
46933877|NCT04881760|83169790|FG005|Overall Study|Randomized but Never Treated|0|||
46824264|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
46933878|NCT04881760|83169791|FG006|Overall Study|Randomized but Never Treated|0|||
46933879|NCT04881760|83169785|FG000|Overall Study|Inadvertent Enrollment|2|||
46933880|NCT04881760|83169786|FG001|Overall Study|Inadvertent Enrollment|0|||
46933881|NCT04881760|83169787|FG002|Overall Study|Inadvertent Enrollment|0|||
46933882|NCT04881760|83169788|FG003|Overall Study|Inadvertent Enrollment|0|||
46933883|NCT04881760|83169789|FG004|Overall Study|Inadvertent Enrollment|0|||
46933884|NCT04881760|83169790|FG005|Overall Study|Inadvertent Enrollment|0|||
46933885|NCT04881760|83169791|FG006|Overall Study|Inadvertent Enrollment|0|||
46933886|NCT04881760|83169785|FG000|Overall Study|Site Closure|0|||
46933887|NCT04881760|83169786|FG001|Overall Study|Site Closure|0|||
46933888|NCT04881760|83169787|FG002|Overall Study|Site Closure|0|||
46933889|NCT04881760|83169788|FG003|Overall Study|Site Closure|1|||
46933890|NCT04881760|83169789|FG004|Overall Study|Site Closure|0|||
46824265|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
46824266|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
46824267|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
46824268|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
46824269|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
46824270|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
46824271|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
46824272|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
46824273|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
46824274|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
46824275|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
46824276|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
46824277|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
46824278|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
46824279|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
46824280|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
46824281|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
46824282|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
46824283|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
46824284|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
46824285|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
46824286|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46933891|NCT04881760|83169790|FG005|Overall Study|Site Closure|0|||
46933892|NCT04881760|83169791|FG006|Overall Study|Site Closure|0|||
46933893|NCT04749797|83169810|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
46933894|NCT04749797|83169811|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
46933895|NCT04749797|83169812|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
46933896|NCT04747275|83169822|FG000|Overall Study|Study terminated|0|||
46933897|NCT04747275|83169823|FG001|Overall Study|Study terminated|1|||
46933898|NCT04556552|83169831|FG000|Overall Study|Lost to Follow-up|1|||
46933899|NCT04556552|83169832|FG001|Overall Study|Lost to Follow-up|0|||
46933900|NCT04556552|83169831|FG000|Overall Study|Claustrophobia|0|||
46933901|NCT04556552|83169832|FG001|Overall Study|Claustrophobia|1|||
46933902|NCT04556552|83169831|FG000|Overall Study|Inability to continue|0|||
46933903|NCT04556552|83169832|FG001|Overall Study|Inability to continue|1|||
46933904|NCT04496167|83169840|FG000|Overall Study|Adverse Event|6|||
46933905|NCT04496167|83169841|FG001|Overall Study|Adverse Event|2|||
46933906|NCT04496167|83169840|FG000|Overall Study|Withdrawal by Subject|7|||
46933907|NCT04496167|83169841|FG001|Overall Study|Withdrawal by Subject|6|||
46933908|NCT04496167|83169840|FG000|Overall Study|Lost to Follow-up|3|||
46933909|NCT04496167|83169841|FG001|Overall Study|Lost to Follow-up|5|||
46933910|NCT04496167|83169840|FG000|Overall Study|Not Treated|1|||
46933911|NCT04496167|83169841|FG001|Overall Study|Not Treated|2|||
46933912|NCT04496167|83169840|FG000|Overall Study|Other Than Specified|1|||
46933913|NCT04496167|83169841|FG001|Overall Study|Other Than Specified|1|||
46933914|NCT04238481|83169884|FG000|Overall Study|Miscellaneous|0|||
46933915|NCT04238481|83169885|FG001|Overall Study|Miscellaneous|1|||
46933916|NCT04238481|83169886|FG002|Overall Study|Miscellaneous|0|||
46933917|NCT04238481|83169887|FG003|Overall Study|Miscellaneous|0|||
46933918|NCT04145700|83169899|FG000|Overall Study|Withdrawal by Subject|8|||
46933919|NCT04145700|83169900|FG001|Overall Study|Withdrawal by Subject|3|||
46933920|NCT04079738|83169906|FG000|Study Treatment|Death|1|||
46933921|NCT04079738|83169907|FG001|Study Treatment|Death|0|||
46933922|NCT04079738|83169908|FG002|Study Treatment|Death|0|||
46933923|NCT04079738|83169909|FG003|Study Treatment|Death|0|||
46933924|NCT04079738|83169906|FG000|Study Treatment|Adverse Event|2|||
46933925|NCT04079738|83169907|FG001|Study Treatment|Adverse Event|0|||
46933926|NCT04079738|83169908|FG002|Study Treatment|Adverse Event|0|||
47057852|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Other|6|||
47057853|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Other|3|||
47057854|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Other|0|||
46761769|NCT00683800|82979903|FG000|Overall Study|Randomized, not treated|35|||
46761770|NCT00683800|82979904|FG001|Overall Study|Randomized, not treated|33|||
46761771|NCT00683644|82979912|FG000|Overall Study|Withdrawal by Subject|4|||
46761772|NCT00683644|82979913|FG001|Overall Study|Withdrawal by Subject|2|||
46761773|NCT00683644|82979912|FG000|Overall Study|Lost to Follow-up|1|||
46761774|NCT00683644|82979913|FG001|Overall Study|Lost to Follow-up|4|||
46761775|NCT00683644|82979912|FG000|Overall Study|Adverse Event|1|||
46761776|NCT00683644|82979913|FG001|Overall Study|Adverse Event|2|||
46761777|NCT00683644|82979912|FG000|Overall Study|Low copper, other health problems,|7|||
46761778|NCT00683644|82979913|FG001|Overall Study|Low copper, other health problems,|6|||
46761779|NCT00685360|82979926|FG000|Overall Study|Lost to Follow-up|0|||
46761780|NCT00685360|82979927|FG001|Overall Study|Lost to Follow-up|1|||
46761781|NCT00685360|82979928|FG002|Overall Study|Lost to Follow-up|2|||
46761782|NCT00685360|82979926|FG000|Overall Study|Adverse Event|4|||
46761783|NCT00685360|82979927|FG001|Overall Study|Adverse Event|6|||
46761784|NCT00685360|82979928|FG002|Overall Study|Adverse Event|4|||
46761785|NCT00685360|82979926|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
46761786|NCT00685360|82979927|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
46761787|NCT00685360|82979928|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
46761788|NCT00685360|82979926|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
46761789|NCT00685360|82979927|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
46761790|NCT00685360|82979928|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
46761791|NCT00685360|82979926|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
46761792|NCT00685360|82979927|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
46761793|NCT00685360|82979928|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
46761794|NCT00685360|82979926|FG000|Overall Study|Protocol Deviation|0|||
46824287|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
47057855|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Other|0|||
47057856|NCT02051608|83336210|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
46761795|NCT00685360|82979927|FG001|Overall Study|Protocol Deviation|1|||
46761796|NCT00685360|82979928|FG002|Overall Study|Protocol Deviation|1|||
46761797|NCT00684814|82979936|FG000|Washout Period of 7 Days|Adverse Event|1|||
46761798|NCT00684814|82979937|FG001|Washout Period of 7 Days|Adverse Event|2|||
46761799|NCT00684814|82979936|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
46933927|NCT04079738|83169909|FG003|Study Treatment|Adverse Event|0|||
46933928|NCT04079738|83169906|FG000|Study Treatment|withdrawal before treatment|1|||
46933929|NCT04079738|83169907|FG001|Study Treatment|withdrawal before treatment|0|||
46933930|NCT04079738|83169908|FG002|Study Treatment|withdrawal before treatment|0|||
46933931|NCT04079738|83169909|FG003|Study Treatment|withdrawal before treatment|0|||
46933932|NCT04079738|83169906|FG000|Study Treatment|symptomatic deterioration|2|||
46933933|NCT04079738|83169907|FG001|Study Treatment|symptomatic deterioration|0|||
46933934|NCT04079738|83169908|FG002|Study Treatment|symptomatic deterioration|0|||
47057857|NCT02051608|83336211|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
46637061|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637062|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637063|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637064|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637065|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637066|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637067|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
46637068|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637069|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
46637070|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637071|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637072|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637073|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637074|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637075|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637076|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
46637077|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637078|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637079|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637080|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
46637081|NCT02914561|82810923|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46637082|NCT02914561|82810924|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46637083|NCT02914561|82810925|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46637084|NCT02914561|82810926|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46637085|NCT02914561|82810927|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46637086|NCT02914561|82810928|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46637087|NCT02914561|82810929|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46824288|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46824289|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46824290|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46824291|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46824292|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46824293|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46824294|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
46824295|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
46824296|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
46933935|NCT04079738|83169909|FG003|Study Treatment|symptomatic deterioration|0|||
46933936|NCT04079738|83169906|FG000|Study Treatment|Disease Progression|1|||
46933937|NCT04079738|83169907|FG001|Study Treatment|Disease Progression|0|||
46933938|NCT04079738|83169908|FG002|Study Treatment|Disease Progression|0|||
46933939|NCT04079738|83169909|FG003|Study Treatment|Disease Progression|0|||
46824297|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
46824298|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
46824299|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
46824300|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
46824301|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
46824302|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
46824303|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
46824304|NCT00404352|83043362|FG000|Double Blind (up to 24 Month)|Other|0|||
46824305|NCT00404352|83043363|FG001|Double Blind (up to 24 Month)|Other|1|||
46824306|NCT00404352|83043364|FG002|Double Blind (up to 24 Month)|Other|0|||
46824307|NCT00404352|83043365|FG003|Double Blind (up to 24 Month)|Other|0|||
46824308|NCT00404352|83043366|FG004|Double Blind (up to 24 Month)|Other|0|||
46824309|NCT00404352|83043367|FG005|Double Blind (up to 24 Month)|Other|0|||
46824310|NCT00404352|83043368|FG006|Double Blind (up to 24 Month)|Other|0|||
46824311|NCT00404352|83043369|FG007|Double Blind (up to 24 Month)|Other|0|||
46824312|NCT00404352|83043370|FG008|Double Blind (up to 24 Month)|Other|0|||
46824313|NCT00404352|83043362|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
46933940|NCT04079738|83169906|FG000|Study Treatment|withdrawal after treatment|1|||
46933941|NCT04079738|83169907|FG001|Study Treatment|withdrawal after treatment|0|||
46933942|NCT04079738|83169908|FG002|Study Treatment|withdrawal after treatment|0|||
46933943|NCT04079738|83169909|FG003|Study Treatment|withdrawal after treatment|0|||
46637088|NCT02914561|82810930|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
46637089|NCT02914561|82810931|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
46637090|NCT02914561|82810932|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
46824314|NCT00404352|83043363|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
46933944|NCT04079738|83169906|FG000|Follow up|Withdrawal by Subject|3|||
46933945|NCT04079738|83169907|FG001|Follow up|Withdrawal by Subject|0|||
46824315|NCT00404352|83043364|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
46824316|NCT00404352|83043365|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
46824317|NCT00404352|83043366|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
46824318|NCT00404352|83043367|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
46824319|NCT00404352|83043368|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
46824320|NCT00404352|83043369|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
46824321|NCT00404352|83043370|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
46824322|NCT00404352|83043362|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
46824323|NCT00404352|83043363|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
46824324|NCT00404352|83043364|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
46824325|NCT00404352|83043365|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
46824326|NCT00404352|83043366|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
46824327|NCT00404352|83043367|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
46824328|NCT00404352|83043368|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
46824329|NCT00404352|83043369|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
46824330|NCT00404352|83043370|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
46824331|NCT00404352|83043362|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46824332|NCT00404352|83043363|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46824333|NCT00404352|83043364|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46824334|NCT00404352|83043365|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46824335|NCT00404352|83043366|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
46824336|NCT00404352|83043367|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46824337|NCT00404352|83043368|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46824338|NCT00404352|83043369|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46824339|NCT00404352|83043370|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
46933946|NCT04079738|83169908|FG002|Follow up|Withdrawal by Subject|0|||
46933947|NCT04079738|83169909|FG003|Follow up|Withdrawal by Subject|0|||
46933948|NCT04079738|83169906|FG000|Follow up|Death|5|||
46933949|NCT04079738|83169907|FG001|Follow up|Death|0|||
46933950|NCT04079738|83169908|FG002|Follow up|Death|0|||
46933951|NCT04079738|83169909|FG003|Follow up|Death|0|||
46933952|NCT04054635|83169918|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
46933953|NCT04054635|83169919|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
46933954|NCT04054635|83169920|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
46933955|NCT04054635|83169918|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
47057858|NCT02051608|83336212|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
47057859|NCT02051608|83336213|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
47057860|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Adverse Event|0|||
46824340|NCT00404352|83043362|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824341|NCT00404352|83043363|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824342|NCT00404352|83043364|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824343|NCT00404352|83043365|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824344|NCT00404352|83043366|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824345|NCT00404352|83043367|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
46824346|NCT00404352|83043368|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824347|NCT00404352|83043369|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824348|NCT00404352|83043370|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
46824349|NCT00404352|83043362|FG000|Open Label (up to 24 Month)|Disease progression|0|||
46824350|NCT00404352|83043363|FG001|Open Label (up to 24 Month)|Disease progression|0|||
46824351|NCT00404352|83043364|FG002|Open Label (up to 24 Month)|Disease progression|0|||
46824352|NCT00404352|83043365|FG003|Open Label (up to 24 Month)|Disease progression|1|||
46824353|NCT00404352|83043366|FG004|Open Label (up to 24 Month)|Disease progression|0|||
46824354|NCT00404352|83043367|FG005|Open Label (up to 24 Month)|Disease progression|0|||
46824355|NCT00404352|83043368|FG006|Open Label (up to 24 Month)|Disease progression|0|||
46824356|NCT00404352|83043369|FG007|Open Label (up to 24 Month)|Disease progression|0|||
46824357|NCT00404352|83043370|FG008|Open Label (up to 24 Month)|Disease progression|0|||
47057861|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Adverse Event|0|||
47057862|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Adverse Event|6|||
46824358|NCT00404352|83043362|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
46824359|NCT00404352|83043363|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
46824360|NCT00404352|83043364|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
46824361|NCT00404352|83043365|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
46824362|NCT00404352|83043366|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
47057863|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Adverse Event|8|||
47057864|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Death|0|||
47057865|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Death|0|||
46824363|NCT00404352|83043367|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
46824364|NCT00404352|83043368|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
46933956|NCT04054635|83169919|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
46933957|NCT04054635|83169920|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
46933958|NCT03820726|83169928|FG000|Overall Study|Other than listed|23|||
46933959|NCT03820726|83169928|FG000|Overall Study|Withdrawal by Subject|37|||
46824365|NCT00404352|83043369|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
46824366|NCT00404352|83043370|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
46824367|NCT00404352|83043362|FG000|Open Label Extension (up to 36 Months)|Other|0|||
46824368|NCT00404352|83043363|FG001|Open Label Extension (up to 36 Months)|Other|0|||
46824369|NCT00404352|83043364|FG002|Open Label Extension (up to 36 Months)|Other|0|||
46824370|NCT00404352|83043365|FG003|Open Label Extension (up to 36 Months)|Other|0|||
46824371|NCT00404352|83043366|FG004|Open Label Extension (up to 36 Months)|Other|0|||
46824372|NCT00404352|83043367|FG005|Open Label Extension (up to 36 Months)|Other|0|||
46824373|NCT00404352|83043368|FG006|Open Label Extension (up to 36 Months)|Other|0|||
46824374|NCT00404352|83043369|FG007|Open Label Extension (up to 36 Months)|Other|0|||
46824375|NCT00404352|83043370|FG008|Open Label Extension (up to 36 Months)|Other|2|||
46824376|NCT00439244|83043390|FG000|Overall Study|Adverse Event|5|||
46824377|NCT00439244|83043391|FG001|Overall Study|Adverse Event|2|||
46824378|NCT00439244|83043392|FG002|Overall Study|Adverse Event|3|||
46824379|NCT00439244|83043390|FG000|Overall Study|Withdrawal by Subject|3|||
46824380|NCT00439244|83043391|FG001|Overall Study|Withdrawal by Subject|1|||
46824381|NCT00439244|83043392|FG002|Overall Study|Withdrawal by Subject|2|||
46824382|NCT00439244|83043390|FG000|Overall Study|Lost to Follow-up|2|||
46824383|NCT00439244|83043391|FG001|Overall Study|Lost to Follow-up|1|||
47057866|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Death|7|||
47057867|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Death|4|||
47057868|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
47057869|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
47057870|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
47057871|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
47057872|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
47057873|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
46761800|NCT00684814|82979937|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
46761801|NCT00684814|82979936|FG000|Second Intervention|Adverse Event|1|||
46761802|NCT00684814|82979937|FG001|Second Intervention|Adverse Event|0|||
46761803|NCT00576472|82979958|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761804|NCT00576472|82979959|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761805|NCT00576472|82979960|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761806|NCT00576472|82979961|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
46824384|NCT00439244|83043392|FG002|Overall Study|Lost to Follow-up|2|||
46824385|NCT00439244|83043390|FG000|Overall Study|Death|0|||
46824386|NCT00439244|83043391|FG001|Overall Study|Death|1|||
46824387|NCT00439244|83043392|FG002|Overall Study|Death|0|||
46824388|NCT00439244|83043390|FG000|Overall Study|Protocol Violation|0|||
46824389|NCT00439244|83043391|FG001|Overall Study|Protocol Violation|1|||
46824390|NCT00439244|83043392|FG002|Overall Study|Protocol Violation|0|||
46824391|NCT00439244|83043390|FG000|Overall Study|Administrative problems|1|||
46824392|NCT00439244|83043391|FG001|Overall Study|Administrative problems|0|||
46824393|NCT00439244|83043392|FG002|Overall Study|Administrative problems|0|||
46824394|NCT04844762|83043400|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824395|NCT04844762|83043401|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824396|NCT04844762|83043402|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
46824397|NCT04844762|83043403|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824398|NCT04844762|83043404|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824399|NCT04844762|83043405|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
47057874|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
47057875|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
47057876|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
46761807|NCT00576472|82979962|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761808|NCT00576472|82979963|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761809|NCT00576472|82979964|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761810|NCT00576472|82979965|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761811|NCT00576472|82979966|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761812|NCT00576472|82979967|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761813|NCT00576472|82979968|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761814|NCT00576472|82979969|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761815|NCT00576472|82979970|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
47057877|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
47057878|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
46761816|NCT00576472|82979971|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
46761817|NCT00576472|82979972|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
46824400|NCT04844762|83043400|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
47057879|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
46761818|NCT00576472|82979958|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
47057880|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
47057881|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
46824401|NCT04844762|83043401|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
46824402|NCT04844762|83043402|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
46824403|NCT04844762|83043403|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
46824404|NCT04844762|83043404|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
46824405|NCT04844762|83043405|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
46824406|NCT04844762|83043400|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824407|NCT04844762|83043401|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824408|NCT04844762|83043402|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
46824409|NCT04844762|83043403|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
46824410|NCT04844762|83043404|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824411|NCT04844762|83043405|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
46824412|NCT04844762|83043400|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824413|NCT04844762|83043401|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824414|NCT04844762|83043402|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
46824415|NCT04844762|83043403|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
46824416|NCT04844762|83043404|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
46824417|NCT04844762|83043405|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824418|NCT04844762|83043400|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
46824419|NCT04844762|83043401|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
46824420|NCT04844762|83043402|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824421|NCT04844762|83043403|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824422|NCT04844762|83043404|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824423|NCT04844762|83043405|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824424|NCT04844762|83043400|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
46824425|NCT04844762|83043401|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824426|NCT04844762|83043402|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824427|NCT04844762|83043403|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824428|NCT04844762|83043404|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824429|NCT04844762|83043405|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824430|NCT04844762|83043400|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824431|NCT04844762|83043401|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824432|NCT04844762|83043402|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824433|NCT04844762|83043403|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824434|NCT04844762|83043404|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
46824435|NCT04844762|83043405|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
46824436|NCT04844762|83043400|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
46824437|NCT04844762|83043401|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824438|NCT04844762|83043402|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824439|NCT04844762|83043403|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824440|NCT04844762|83043404|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824441|NCT04844762|83043405|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
46824442|NCT04844762|83043400|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
46824443|NCT04844762|83043401|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46761819|NCT00576472|82979959|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
46761820|NCT00576472|82979960|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
46761821|NCT00576472|82979961|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
46761822|NCT00576472|82979962|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
46761823|NCT00576472|82979963|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
46761824|NCT00576472|82979964|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
46761825|NCT00576472|82979965|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
46761826|NCT00576472|82979966|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
46761827|NCT00576472|82979967|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
46761828|NCT00576472|82979968|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
46824444|NCT04844762|83043402|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824445|NCT04844762|83043403|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824446|NCT04844762|83043404|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
46824447|NCT04844762|83043405|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
46824448|NCT04844762|83043400|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
46824449|NCT04844762|83043401|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
46824450|NCT04844762|83043402|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
46824451|NCT04844762|83043403|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
46824452|NCT04844762|83043404|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
47057882|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
46761829|NCT00576472|82979969|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
46761830|NCT00576472|82979970|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
46761831|NCT00576472|82979971|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
46824453|NCT04844762|83043405|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
46824454|NCT04844762|83043400|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
46824455|NCT04844762|83043401|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
46824456|NCT04844762|83043402|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
46824457|NCT04844762|83043403|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
46824458|NCT04844762|83043404|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
46824459|NCT04844762|83043405|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
46824460|NCT00438464|83043429|FG000|Overall Study|Terminated Early|14|||
46824461|NCT00438464|83043430|FG001|Overall Study|Terminated Early|5|||
46824462|NCT00438464|83043429|FG000|Overall Study|Incomplete data submission|0|||
46824463|NCT00438464|83043430|FG001|Overall Study|Incomplete data submission|2|||
46824464|NCT00437294|83043450|FG000|Overall Study|Adverse Event|5|||
46824465|NCT00437294|83043451|FG001|Overall Study|Adverse Event|4|||
46824466|NCT00437294|83043450|FG000|Overall Study|Death|5|||
46933960|NCT03820726|83169928|FG000|Overall Study|Lost to Follow-up|3|||
46933961|NCT03820726|83169928|FG000|Overall Study|Protocol deviation|1|||
46933962|NCT03820726|83169928|FG000|Overall Study|Adverse Event|146|||
46933963|NCT03820726|83169928|FG000|Overall Study|Not treated|1|||
46933964|NCT03744312|83169934|FG000|Overall Study|Withdrawal by Subject|0|||
46933965|NCT03744312|83169935|FG001|Overall Study|Withdrawal by Subject|1|||
46933966|NCT03744312|83169934|FG000|Overall Study|Screen fail|0|||
46933967|NCT03744312|83169935|FG001|Overall Study|Screen fail|1|||
46933968|NCT03737123|83169943|FG000|Study Treatment|Adverse Event|2|||
46933969|NCT03737123|83169944|FG001|Study Treatment|Adverse Event|0|||
46933970|NCT03737123|83169943|FG000|Study Treatment|Disease Progression|2|||
46933971|NCT03737123|83169944|FG001|Study Treatment|Disease Progression|0|||
46933972|NCT03737123|83169943|FG000|Study Treatment|Withdrawal by Subject|2|||
47057883|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
47057884|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Physician Decision|0|||
47057885|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Physician Decision|0|||
47057886|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Physician Decision|8|||
47057887|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Physician Decision|5|||
47057888|NCT02051608|83336210|FG000|Part 2: Open-label Extension|Other|0|||
47057889|NCT02051608|83336211|FG001|Part 2: Open-label Extension|Other|0|||
47057890|NCT02051608|83336212|FG002|Part 2: Open-label Extension|Other|9|||
47057891|NCT02051608|83336213|FG003|Part 2: Open-label Extension|Other|9|||
47057892|NCT02705586|83336226|FG000|Overall Study|Health Issues|2|||
47057893|NCT02705586|83336226|FG000|Overall Study|Transportation Difficulties|5|||
47057894|NCT02705586|83336226|FG000|Overall Study|Vacation/Planned Absence|1|||
47057895|NCT01592045|83336232|FG000|Overall Study|Disease Progression|1|||
46933973|NCT03737123|83169944|FG001|Study Treatment|Withdrawal by Subject|0|||
46933974|NCT03737123|83169943|FG000|Follow up|Death|1|||
46933975|NCT03737123|83169944|FG001|Follow up|Death|0|||
46933976|NCT03737123|83169943|FG000|Follow up|Withdrawal by Subject|1|||
47057896|NCT01592045|83336233|FG001|Overall Study|Disease Progression|1|||
47057897|NCT01592045|83336232|FG000|Overall Study|Adverse Event|1|||
47057898|NCT01592045|83336233|FG001|Overall Study|Adverse Event|1|||
46761832|NCT00576472|82979972|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
46761833|NCT00576472|82979958|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761834|NCT00576472|82979959|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761835|NCT00576472|82979960|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761836|NCT00576472|82979961|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
46761837|NCT00576472|82979962|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761838|NCT00576472|82979963|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761839|NCT00576472|82979964|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761840|NCT00576472|82979965|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761841|NCT00576472|82979966|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761842|NCT00576472|82979967|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761843|NCT00576472|82979968|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761844|NCT00576472|82979969|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761845|NCT00576472|82979970|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761846|NCT00576472|82979971|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761847|NCT00576472|82979972|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
46761848|NCT00576472|82979958|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
46761849|NCT00576472|82979959|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
46761850|NCT00576472|82979960|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
46933977|NCT03737123|83169944|FG001|Follow up|Withdrawal by Subject|0|||
46824467|NCT00437294|83043451|FG001|Overall Study|Death|2|||
46824468|NCT00437294|83043450|FG000|Overall Study|Physician Decision|0|||
46933978|NCT03737123|83169943|FG000|Follow up|Termination of study|4|||
46933979|NCT03737123|83169944|FG001|Follow up|Termination of study|0|||
46933980|NCT03502707|83169967|FG000|Overall Study|Adverse Event|0|||
47057899|NCT01592045|83336232|FG000|Overall Study|Withdrawal by Subject|1|||
47057900|NCT01592045|83336233|FG001|Overall Study|Withdrawal by Subject|0|||
46933981|NCT03502707|83169968|FG001|Overall Study|Adverse Event|0|||
46933982|NCT03502707|83169969|FG002|Overall Study|Adverse Event|0|||
46933983|NCT03502707|83169970|FG003|Overall Study|Adverse Event|0|||
46933984|NCT03502707|83169971|FG004|Overall Study|Adverse Event|0|||
46933985|NCT03502707|83169972|FG005|Overall Study|Adverse Event|0|||
46933986|NCT03502707|83169973|FG006|Overall Study|Adverse Event|0|||
47057901|NCT01592045|83336232|FG000|Overall Study|Moved out of country|2|||
47057902|NCT01592045|83336233|FG001|Overall Study|Moved out of country|0|||
47057903|NCT01591499|83336241|FG000|Baseline Visit|Withdrawal by Subject|0|||
47057904|NCT01591499|83336242|FG001|Baseline Visit|Withdrawal by Subject|2|||
47057905|NCT01591499|83336243|FG002|Baseline Visit|Withdrawal by Subject|0|||
47057906|NCT01591499|83336244|FG003|Baseline Visit|Withdrawal by Subject|2|||
47057907|NCT01591499|83336241|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
47057908|NCT01591499|83336242|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
46824469|NCT00437294|83043451|FG001|Overall Study|Physician Decision|3|||
46824470|NCT00437294|83043450|FG000|Overall Study|Withdrawal by Subject|5|||
46824471|NCT00437294|83043451|FG001|Overall Study|Withdrawal by Subject|0|||
46824472|NCT00437294|83043450|FG000|Overall Study|Progressive Disease|19|||
46824473|NCT00437294|83043451|FG001|Overall Study|Progressive Disease|23|||
46824474|NCT00437294|83043450|FG000|Overall Study|Sponsor Decision|8|||
46824475|NCT00437294|83043451|FG001|Overall Study|Sponsor Decision|9|||
46824476|NCT00437294|83043450|FG000|Overall Study|Protocol Violation|0|||
46824477|NCT00437294|83043451|FG001|Overall Study|Protocol Violation|1|||
46824478|NCT00437294|83043450|FG000|Overall Study|Entry criteria not met|1|||
46824479|NCT00437294|83043451|FG001|Overall Study|Entry criteria not met|1|||
46824480|NCT00443846|83043465|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
46824481|NCT00443846|83043466|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
46824482|NCT00443846|83043465|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
46824483|NCT00443846|83043466|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
47057909|NCT01591499|83336243|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
46761851|NCT00576472|82979961|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
46761852|NCT00576472|82979962|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
46761853|NCT00576472|82979963|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
46761854|NCT00576472|82979964|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
46761855|NCT00576472|82979965|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
46761856|NCT00576472|82979966|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
46761857|NCT00576472|82979967|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
46761858|NCT00576472|82979968|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
46761859|NCT00576472|82979969|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
46824484|NCT00443846|83043465|FG000|Overall Study|Adverse Event|0|||
46824485|NCT00443846|83043466|FG001|Overall Study|Adverse Event|1|||
46824486|NCT00443846|83043465|FG000|Overall Study|Personal reason|8|||
46824487|NCT00443846|83043466|FG001|Overall Study|Personal reason|3|||
46824488|NCT00443846|83043465|FG000|Overall Study|Lost to Follow-up|1|||
46824489|NCT00443846|83043466|FG001|Overall Study|Lost to Follow-up|2|||
46824490|NCT00436826|83043474|FG000|Double Blind Period (DBP)|Adverse Event|2|||
46824491|NCT00436826|83043475|FG001|Double Blind Period (DBP)|Adverse Event|0|||
46824492|NCT00436826|83043476|FG002|Double Blind Period (DBP)|Adverse Event|0|||
46824493|NCT00436826|83043477|FG003|Double Blind Period (DBP)|Adverse Event|0|||
46824494|NCT00436826|83043478|FG004|Double Blind Period (DBP)|Adverse Event|0|||
46824495|NCT00436826|83043479|FG005|Double Blind Period (DBP)|Adverse Event|0|||
46824496|NCT00436826|83043474|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
46824497|NCT00436826|83043475|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
46824498|NCT00436826|83043476|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
46824499|NCT00436826|83043477|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
46824500|NCT00436826|83043478|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
46824501|NCT00436826|83043479|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
46824502|NCT00436826|83043474|FG000|Double Blind Period (DBP)|Other|10|||
46824503|NCT00436826|83043475|FG001|Double Blind Period (DBP)|Other|11|||
46824504|NCT00436826|83043476|FG002|Double Blind Period (DBP)|Other|0|||
46824505|NCT00436826|83043477|FG003|Double Blind Period (DBP)|Other|0|||
46824506|NCT00436826|83043478|FG004|Double Blind Period (DBP)|Other|0|||
46824507|NCT00436826|83043479|FG005|Double Blind Period (DBP)|Other|0|||
46824508|NCT00436826|83043474|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
46824509|NCT00436826|83043475|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
46824510|NCT00436826|83043476|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
46824511|NCT00436826|83043477|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
46824512|NCT00436826|83043478|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
46933987|NCT03502707|83169974|FG007|Overall Study|Adverse Event|0|||
46933988|NCT03502707|83169975|FG008|Overall Study|Adverse Event|0|||
46933989|NCT03502707|83169976|FG009|Overall Study|Adverse Event|0|||
46933990|NCT03502707|83169977|FG010|Overall Study|Adverse Event|0|||
47057910|NCT01591499|83336244|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
46637091|NCT02914561|82810933|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
47057911|NCT01591499|83336241|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
47057912|NCT01591499|83336242|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
47057913|NCT01591499|83336243|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
47057914|NCT01591499|83336244|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
47057915|NCT01590797|83336270|FG000|Overall Study|Adverse Event|4|||
47057916|NCT01590797|83336271|FG001|Overall Study|Adverse Event|3|||
47057917|NCT01590797|83336270|FG000|Overall Study|Lack of Efficacy|0|||
47057918|NCT01590797|83336271|FG001|Overall Study|Lack of Efficacy|2|||
47057919|NCT01590797|83336270|FG000|Overall Study|Lost to Follow-up|0|||
47057920|NCT01590797|83336271|FG001|Overall Study|Lost to Follow-up|1|||
47057921|NCT01590797|83336270|FG000|Overall Study|Protocol Violation|4|||
47057922|NCT01590797|83336271|FG001|Overall Study|Protocol Violation|1|||
47057923|NCT01590797|83336270|FG000|Overall Study|Withdrawal by Subject|7|||
47057924|NCT01590797|83336271|FG001|Overall Study|Withdrawal by Subject|5|||
47057925|NCT01590797|83336270|FG000|Overall Study|Other Protocol Specified Criteria|2|||
47057926|NCT01590797|83336271|FG001|Overall Study|Other Protocol Specified Criteria|4|||
47057927|NCT01590563|83336277|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
47057928|NCT01701401|83336286|FG000|Overall Study|Randomized But Not Treated|3|||
47057929|NCT01701401|83336287|FG001|Overall Study|Randomized But Not Treated|1|||
47057930|NCT01701401|83336288|FG002|Overall Study|Randomized But Not Treated|0|||
47057931|NCT01701401|83336289|FG003|Overall Study|Randomized But Not Treated|1|||
47057932|NCT01701401|83336286|FG000|Overall Study|Lost to Follow-up|5|||
47057933|NCT01701401|83336287|FG001|Overall Study|Lost to Follow-up|5|||
47057934|NCT01701401|83336288|FG002|Overall Study|Lost to Follow-up|1|||
47057935|NCT01701401|83336289|FG003|Overall Study|Lost to Follow-up|3|||
47057936|NCT01701401|83336286|FG000|Overall Study|Withdrew Consent|0|||
47057937|NCT01701401|83336287|FG001|Overall Study|Withdrew Consent|3|||
47057938|NCT01701401|83336288|FG002|Overall Study|Withdrew Consent|1|||
47057939|NCT01701401|83336289|FG003|Overall Study|Withdrew Consent|2|||
46761860|NCT00576472|82979970|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
46761861|NCT00576472|82979971|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
46761862|NCT00576472|82979972|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
46824513|NCT00436826|83043479|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
46824514|NCT00436826|83043474|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
46824515|NCT00436826|83043475|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
46824516|NCT00436826|83043476|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
46824517|NCT00436826|83043477|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
46824518|NCT00436826|83043478|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
46824519|NCT00436826|83043479|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
46824520|NCT00436826|83043474|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
46761863|NCT00576472|82979958|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761864|NCT00576472|82979959|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761865|NCT00576472|82979960|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761866|NCT00576472|82979961|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
46761867|NCT00576472|82979962|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761868|NCT00576472|82979963|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761869|NCT00576472|82979964|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761870|NCT00576472|82979965|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761871|NCT00576472|82979966|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761872|NCT00576472|82979967|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761873|NCT00576472|82979968|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761874|NCT00576472|82979969|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761875|NCT00576472|82979970|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761876|NCT00576472|82979971|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761877|NCT00576472|82979972|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
46761878|NCT00576472|82979958|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761879|NCT00576472|82979959|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761880|NCT00576472|82979960|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761881|NCT00576472|82979961|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
46824521|NCT00436826|83043475|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
46824522|NCT00436826|83043476|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
46824523|NCT00436826|83043477|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
47057940|NCT01701401|83336286|FG000|Overall Study|Lack of Efficacy|1|||
47057941|NCT01701401|83336287|FG001|Overall Study|Lack of Efficacy|0|||
47057942|NCT01701401|83336288|FG002|Overall Study|Lack of Efficacy|2|||
47057943|NCT01701401|83336289|FG003|Overall Study|Lack of Efficacy|0|||
47057944|NCT01701401|83336286|FG000|Overall Study|Adverse Event|1|||
47057945|NCT01701401|83336287|FG001|Overall Study|Adverse Event|0|||
47057946|NCT01701401|83336288|FG002|Overall Study|Adverse Event|0|||
46637092|NCT02840799|82810963|FG000|Phase 1|Physician Decision|1|||
47057947|NCT01701401|83336289|FG003|Overall Study|Adverse Event|0|||
47057948|NCT01701401|83336286|FG000|Overall Study|Protocol Violation|0|||
47057949|NCT01701401|83336287|FG001|Overall Study|Protocol Violation|0|||
47057950|NCT01701401|83336288|FG002|Overall Study|Protocol Violation|1|||
47057951|NCT01701401|83336289|FG003|Overall Study|Protocol Violation|0|||
47057952|NCT01701245|83336301|FG000|Overall Study|Protocol Violation|1|||
47057953|NCT01701245|83336302|FG001|Overall Study|Protocol Violation|3|||
47057954|NCT01701245|83336301|FG000|Overall Study|Did not complete the open label period|11|||
47057955|NCT01701245|83336302|FG001|Overall Study|Did not complete the open label period|12|||
47057956|NCT01590017|83336308|FG000|Overall Study|Adverse Event|1|||
47057957|NCT01590017|83336308|FG000|Overall Study|Withdrawal by Subject|1|||
47057958|NCT01590017|83336308|FG000|Overall Study|Lack of Efficacy|1|||
47057959|NCT01590017|83336308|FG000|Overall Study|Physician Decision|1|||
47057960|NCT01700621|83336314|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
46637093|NCT02840799|82810964|FG001|Phase 1|Physician Decision|3|||
46637094|NCT02840799|82810963|FG000|Phase 1|Withdrawal by Subject|4|||
46761882|NCT00576472|82979962|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761883|NCT00576472|82979963|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761884|NCT00576472|82979964|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
46761885|NCT00576472|82979965|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761886|NCT00576472|82979966|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761887|NCT00576472|82979967|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761888|NCT00576472|82979968|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761889|NCT00576472|82979969|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761890|NCT00576472|82979970|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761891|NCT00576472|82979971|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761892|NCT00576472|82979972|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
46761893|NCT00576472|82979958|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
46761894|NCT00576472|82979959|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
46761895|NCT00576472|82979960|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
46761896|NCT00576472|82979961|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
46761897|NCT00576472|82979962|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
46824524|NCT00436826|83043478|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
46824525|NCT00436826|83043479|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
46824526|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
46824527|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
46824528|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
46824529|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
46824530|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
46824531|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
46824532|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
46824533|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
46824534|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
46824535|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
46824536|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
46824537|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
46824538|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Death|7|||
46824539|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Death|4|||
46824540|NCT00410124|83043497|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
46824541|NCT00410124|83043498|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
46824542|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
46824543|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
46824544|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
46824545|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
46824546|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
46824547|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
46824548|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
46824549|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
46761898|NCT00576472|82979963|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
46824550|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
47057961|NCT01700621|83336315|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
47057962|NCT01700621|83336314|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
47057963|NCT01700621|83336315|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
46824551|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
46824552|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
46824553|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
46824554|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
46824555|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
46824556|NCT00410124|83043497|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
46824557|NCT00410124|83043498|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
46933991|NCT03502707|83169978|FG011|Overall Study|Adverse Event|0|||
46824558|NCT00410046|83043508|FG000|Overall Study|Adverse Event|3|||
46824559|NCT00410046|83043508|FG000|Overall Study|Withdrawal by Subject|1|||
46824560|NCT00410046|83043508|FG000|Overall Study|Lost to Follow-up|1|||
46824561|NCT00416624|83043517|FG000|Overall Study|Withdrawal by Subject|1|||
46824562|NCT00416624|83043518|FG001|Overall Study|Withdrawal by Subject|6|||
46824563|NCT00416624|83043519|FG002|Overall Study|Withdrawal by Subject|4|||
46824564|NCT00416624|83043520|FG003|Overall Study|Withdrawal by Subject|9|||
46824565|NCT00416624|83043517|FG000|Overall Study|Death|4|||
46824566|NCT00416624|83043518|FG001|Overall Study|Death|7|||
46824567|NCT00416624|83043519|FG002|Overall Study|Death|7|||
46824568|NCT00416624|83043520|FG003|Overall Study|Death|1|||
46824569|NCT00416624|83043517|FG000|Overall Study|Adverse Event|8|||
46824570|NCT00416624|83043518|FG001|Overall Study|Adverse Event|3|||
46824571|NCT00416624|83043519|FG002|Overall Study|Adverse Event|2|||
46824572|NCT00416624|83043520|FG003|Overall Study|Adverse Event|2|||
46824573|NCT00416624|83043517|FG000|Overall Study|Other|8|||
46824574|NCT00416624|83043518|FG001|Overall Study|Other|11|||
46824575|NCT00416624|83043519|FG002|Overall Study|Other|5|||
46824576|NCT00416624|83043520|FG003|Overall Study|Other|5|||
46824577|NCT00416624|83043517|FG000|Overall Study|Cancel|1|||
46824578|NCT00416624|83043518|FG001|Overall Study|Cancel|0|||
46824579|NCT00416624|83043519|FG002|Overall Study|Cancel|0|||
46824580|NCT00416624|83043520|FG003|Overall Study|Cancel|0|||
46824581|NCT00262600|83043533|FG000|Overall Study|Lost to Follow-up|17|||
46824582|NCT00262600|83043534|FG001|Overall Study|Lost to Follow-up|31|||
46824583|NCT00262600|83043535|FG002|Overall Study|Lost to Follow-up|41|||
46824584|NCT00262600|83043533|FG000|Overall Study|Withdrawal by Subject|128|||
46824585|NCT00262600|83043534|FG001|Overall Study|Withdrawal by Subject|145|||
46824586|NCT00262600|83043535|FG002|Overall Study|Withdrawal by Subject|139|||
46824587|NCT00262600|83043533|FG000|Overall Study|Not Treated|32|||
46824588|NCT00262600|83043534|FG001|Overall Study|Not Treated|17|||
46824589|NCT00262600|83043535|FG002|Overall Study|Not Treated|24|||
46824590|NCT00262600|83043533|FG000|Overall Study|Other|58|||
46824591|NCT00262600|83043534|FG001|Overall Study|Other|59|||
46824592|NCT00262600|83043535|FG002|Overall Study|Other|62|||
46824593|NCT00409578|83043547|FG000|Overall Study|Adverse Event|27|||
46824594|NCT00409578|83043548|FG001|Overall Study|Adverse Event|37|||
46824595|NCT00409578|83043549|FG002|Overall Study|Adverse Event|25|||
46824596|NCT00409578|83043550|FG003|Overall Study|Adverse Event|33|||
46824597|NCT00409578|83043547|FG000|Overall Study|Abnormal laboratory value(s)|2|||
46824598|NCT00409578|83043548|FG001|Overall Study|Abnormal laboratory value(s)|2|||
46824599|NCT00409578|83043549|FG002|Overall Study|Abnormal laboratory value(s)|2|||
46824600|NCT00409578|83043550|FG003|Overall Study|Abnormal laboratory value(s)|4|||
46824601|NCT00409578|83043547|FG000|Overall Study|Lack of Efficacy|0|||
46824602|NCT00409578|83043548|FG001|Overall Study|Lack of Efficacy|0|||
46761899|NCT00576472|82979964|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
46761900|NCT00576472|82979965|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
46761901|NCT00576472|82979966|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
46761902|NCT00576472|82979967|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
46761903|NCT00576472|82979968|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
46761904|NCT00576472|82979969|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
46761905|NCT00576472|82979970|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
46761906|NCT00576472|82979971|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
46761907|NCT00576472|82979972|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
46761908|NCT00576472|82979958|FG000|MPH Cross Over Phase|Physician Decision|0|||
46761909|NCT00576472|82979959|FG001|MPH Cross Over Phase|Physician Decision|0|||
46761910|NCT00576472|82979960|FG002|MPH Cross Over Phase|Physician Decision|0|||
46761911|NCT00576472|82979961|FG003|MPH Cross Over Phase|Physician Decision|0|||
46761912|NCT00576472|82979962|FG004|MPH Cross Over Phase|Physician Decision|0|||
46761913|NCT00576472|82979963|FG005|MPH Cross Over Phase|Physician Decision|0|||
46824603|NCT00409578|83043549|FG002|Overall Study|Lack of Efficacy|0|||
46824604|NCT00409578|83043550|FG003|Overall Study|Lack of Efficacy|2|||
46933992|NCT03502707|83169979|FG012|Overall Study|Adverse Event|0|||
46824605|NCT00409578|83043547|FG000|Overall Study|Subject no longer requires study drug|0|||
46824606|NCT00409578|83043548|FG001|Overall Study|Subject no longer requires study drug|0|||
46824607|NCT00409578|83043549|FG002|Overall Study|Subject no longer requires study drug|0|||
46824608|NCT00409578|83043550|FG003|Overall Study|Subject no longer requires study drug|1|||
46824609|NCT00409578|83043547|FG000|Overall Study|Withdrawal by Subject|8|||
46824610|NCT00409578|83043548|FG001|Overall Study|Withdrawal by Subject|15|||
46824611|NCT00409578|83043549|FG002|Overall Study|Withdrawal by Subject|16|||
46824612|NCT00409578|83043550|FG003|Overall Study|Withdrawal by Subject|17|||
46824613|NCT00409578|83043547|FG000|Overall Study|Lost to Follow-up|2|||
46824614|NCT00409578|83043548|FG001|Overall Study|Lost to Follow-up|0|||
46933993|NCT03502707|83169980|FG013|Overall Study|Adverse Event|0|||
46933994|NCT03502707|83169981|FG014|Overall Study|Adverse Event|0|||
46933995|NCT03502707|83169982|FG015|Overall Study|Adverse Event|1|||
46933996|NCT03502707|83169983|FG016|Overall Study|Adverse Event|5|||
46824615|NCT00409578|83043549|FG002|Overall Study|Lost to Follow-up|2|||
46824616|NCT00409578|83043550|FG003|Overall Study|Lost to Follow-up|2|||
46824617|NCT00409578|83043547|FG000|Overall Study|Administrative problems|8|||
46824618|NCT00409578|83043548|FG001|Overall Study|Administrative problems|9|||
46824619|NCT00409578|83043549|FG002|Overall Study|Administrative problems|2|||
46824620|NCT00409578|83043550|FG003|Overall Study|Administrative problems|4|||
46824621|NCT00409578|83043547|FG000|Overall Study|Death|2|||
46824622|NCT00409578|83043548|FG001|Overall Study|Death|4|||
46824623|NCT00409578|83043549|FG002|Overall Study|Death|4|||
46824624|NCT00409578|83043550|FG003|Overall Study|Death|2|||
46824625|NCT00409578|83043547|FG000|Overall Study|Protocol Violation|3|||
46824626|NCT00409578|83043548|FG001|Overall Study|Protocol Violation|2|||
46824627|NCT00409578|83043549|FG002|Overall Study|Protocol Violation|3|||
46824628|NCT00409578|83043550|FG003|Overall Study|Protocol Violation|1|||
46824629|NCT00409578|83043547|FG000|Overall Study|Missing|0|||
46824630|NCT00409578|83043548|FG001|Overall Study|Missing|1|||
46824631|NCT00409578|83043549|FG002|Overall Study|Missing|0|||
46824632|NCT00409578|83043550|FG003|Overall Study|Missing|1|||
46824633|NCT00428090|83043564|FG000|Overall Study|Adverse Event|10|||
46824634|NCT00428090|83043565|FG001|Overall Study|Adverse Event|8|||
46824635|NCT00428090|83043566|FG002|Overall Study|Adverse Event|10|||
46824636|NCT00428090|83043567|FG003|Overall Study|Adverse Event|11|||
46824637|NCT00428090|83043564|FG000|Overall Study|Lost to Follow-up|3|||
46824638|NCT00428090|83043565|FG001|Overall Study|Lost to Follow-up|6|||
46824639|NCT00428090|83043566|FG002|Overall Study|Lost to Follow-up|1|||
46824640|NCT00428090|83043567|FG003|Overall Study|Lost to Follow-up|4|||
46824641|NCT00428090|83043564|FG000|Overall Study|Protocol Violation|3|||
46824642|NCT00428090|83043565|FG001|Overall Study|Protocol Violation|1|||
46824643|NCT00428090|83043566|FG002|Overall Study|Protocol Violation|3|||
46824644|NCT00428090|83043567|FG003|Overall Study|Protocol Violation|3|||
46824645|NCT00428090|83043564|FG000|Overall Study|Withdrawal by Subject|10|||
46824646|NCT00428090|83043565|FG001|Overall Study|Withdrawal by Subject|12|||
46824647|NCT00428090|83043566|FG002|Overall Study|Withdrawal by Subject|15|||
46824648|NCT00428090|83043567|FG003|Overall Study|Withdrawal by Subject|5|||
46824649|NCT00428090|83043564|FG000|Overall Study|Sponsor terminated study|0|||
46824650|NCT00428090|83043565|FG001|Overall Study|Sponsor terminated study|1|||
46824651|NCT00428090|83043566|FG002|Overall Study|Sponsor terminated study|0|||
46824652|NCT00428090|83043567|FG003|Overall Study|Sponsor terminated study|0|||
46824653|NCT00428090|83043564|FG000|Overall Study|Non-compliance|4|||
46824654|NCT00428090|83043565|FG001|Overall Study|Non-compliance|0|||
46933997|NCT03502707|83169984|FG017|Overall Study|Adverse Event|0|||
46933998|NCT03502707|83169967|FG000|Overall Study|Death|0|||
46933999|NCT03502707|83169968|FG001|Overall Study|Death|0|||
46761914|NCT00576472|82979964|FG006|MPH Cross Over Phase|Physician Decision|4|||
46761915|NCT00576472|82979965|FG007|MPH Cross Over Phase|Physician Decision|0|||
46761916|NCT00576472|82979966|FG008|MPH Cross Over Phase|Physician Decision|0|||
46761917|NCT00576472|82979967|FG009|MPH Cross Over Phase|Physician Decision|0|||
46761918|NCT00576472|82979968|FG010|MPH Cross Over Phase|Physician Decision|0|||
46761919|NCT00576472|82979969|FG011|MPH Cross Over Phase|Physician Decision|0|||
46761920|NCT00576472|82979970|FG012|MPH Cross Over Phase|Physician Decision|0|||
46761921|NCT00576472|82979971|FG013|MPH Cross Over Phase|Physician Decision|0|||
46761922|NCT00576472|82979972|FG014|MPH Cross Over Phase|Physician Decision|0|||
46761923|NCT00576472|82979958|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761924|NCT00576472|82979959|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761925|NCT00576472|82979960|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761926|NCT00576472|82979961|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761927|NCT00576472|82979962|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
46934000|NCT03502707|83169969|FG002|Overall Study|Death|0|||
46761928|NCT00576472|82979963|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
46824655|NCT00428090|83043566|FG002|Overall Study|Non-compliance|1|||
46824656|NCT00428090|83043567|FG003|Overall Study|Non-compliance|3|||
46934001|NCT03502707|83169970|FG003|Overall Study|Death|1|||
46637095|NCT02840799|82810964|FG001|Phase 1|Withdrawal by Subject|0|||
46824657|NCT00428090|83043564|FG000|Overall Study|Par. did not returned to visit|1|||
46824658|NCT00428090|83043565|FG001|Overall Study|Par. did not returned to visit|0|||
46824659|NCT00428090|83043566|FG002|Overall Study|Par. did not returned to visit|0|||
46824660|NCT00428090|83043567|FG003|Overall Study|Par. did not returned to visit|1|||
46824661|NCT00428090|83043564|FG000|Overall Study|Follow-Up visit not possible|1|||
46934002|NCT03502707|83169971|FG004|Overall Study|Death|0|||
46934003|NCT03502707|83169972|FG005|Overall Study|Death|0|||
46934004|NCT03502707|83169973|FG006|Overall Study|Death|0|||
46934005|NCT03502707|83169974|FG007|Overall Study|Death|0|||
46934006|NCT03502707|83169975|FG008|Overall Study|Death|1|||
46934007|NCT03502707|83169976|FG009|Overall Study|Death|1|||
46934008|NCT03502707|83169977|FG010|Overall Study|Death|0|||
46934009|NCT03502707|83169978|FG011|Overall Study|Death|0|||
46934010|NCT03502707|83169979|FG012|Overall Study|Death|1|||
47057964|NCT01700621|83336314|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
47057965|NCT01700621|83336315|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
47057966|NCT01589237|83336326|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
47057967|NCT01589237|83336327|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
47057968|NCT01589237|83336328|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
47057969|NCT01589237|83336329|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
47057970|NCT01589237|83336326|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
47057971|NCT01589237|83336327|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
47057972|NCT01589237|83336328|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
47057973|NCT01589237|83336329|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
46934011|NCT03502707|83169980|FG013|Overall Study|Death|0|||
46934012|NCT03502707|83169981|FG014|Overall Study|Death|0|||
46934013|NCT03502707|83169982|FG015|Overall Study|Death|1|||
46934014|NCT03502707|83169983|FG016|Overall Study|Death|0|||
46934015|NCT03502707|83169984|FG017|Overall Study|Death|0|||
46934016|NCT03502707|83169967|FG000|Overall Study|Lost to Follow-up|0|||
46934017|NCT03502707|83169968|FG001|Overall Study|Lost to Follow-up|0|||
46934018|NCT03502707|83169969|FG002|Overall Study|Lost to Follow-up|0|||
46934019|NCT03502707|83169970|FG003|Overall Study|Lost to Follow-up|0|||
46934020|NCT03502707|83169971|FG004|Overall Study|Lost to Follow-up|0|||
46934021|NCT03502707|83169972|FG005|Overall Study|Lost to Follow-up|0|||
46934022|NCT03502707|83169973|FG006|Overall Study|Lost to Follow-up|0|||
46824662|NCT00428090|83043565|FG001|Overall Study|Follow-Up visit not possible|0|||
46934023|NCT03502707|83169974|FG007|Overall Study|Lost to Follow-up|5|||
46934024|NCT03502707|83169975|FG008|Overall Study|Lost to Follow-up|0|||
46934025|NCT03502707|83169976|FG009|Overall Study|Lost to Follow-up|2|||
46934026|NCT03502707|83169977|FG010|Overall Study|Lost to Follow-up|1|||
46934027|NCT03502707|83169978|FG011|Overall Study|Lost to Follow-up|2|||
46934028|NCT03502707|83169979|FG012|Overall Study|Lost to Follow-up|1|||
46934029|NCT03502707|83169980|FG013|Overall Study|Lost to Follow-up|1|||
46934030|NCT03502707|83169981|FG014|Overall Study|Lost to Follow-up|0|||
46934031|NCT03502707|83169982|FG015|Overall Study|Lost to Follow-up|4|||
46934032|NCT03502707|83169983|FG016|Overall Study|Lost to Follow-up|9|||
46934033|NCT03502707|83169984|FG017|Overall Study|Lost to Follow-up|2|||
46934034|NCT03502707|83169967|FG000|Overall Study|Physician Decision|0|||
46934035|NCT03502707|83169968|FG001|Overall Study|Physician Decision|0|||
46934036|NCT03502707|83169969|FG002|Overall Study|Physician Decision|0|||
46934037|NCT03502707|83169970|FG003|Overall Study|Physician Decision|0|||
46934038|NCT03502707|83169971|FG004|Overall Study|Physician Decision|0|||
46934039|NCT03502707|83169972|FG005|Overall Study|Physician Decision|0|||
47057974|NCT01589237|83336326|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
47057975|NCT01589237|83336327|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
46637096|NCT02840799|82810963|FG000|Phase 2 (Crossover)|Adverse Event|0|||
46761929|NCT00576472|82979964|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761930|NCT00576472|82979965|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761931|NCT00576472|82979966|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
46761932|NCT00576472|82979967|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761933|NCT00576472|82979968|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
46761934|NCT00576472|82979969|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
46761935|NCT00576472|82979970|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
46824663|NCT00428090|83043566|FG002|Overall Study|Follow-Up visit not possible|0|||
46824664|NCT00428090|83043567|FG003|Overall Study|Follow-Up visit not possible|0|||
46934040|NCT03502707|83169973|FG006|Overall Study|Physician Decision|0|||
46934041|NCT03502707|83169974|FG007|Overall Study|Physician Decision|0|||
46934042|NCT03502707|83169975|FG008|Overall Study|Physician Decision|2|||
46934043|NCT03502707|83169976|FG009|Overall Study|Physician Decision|1|||
46934044|NCT03502707|83169977|FG010|Overall Study|Physician Decision|0|||
46934045|NCT03502707|83169978|FG011|Overall Study|Physician Decision|0|||
46934046|NCT03502707|83169979|FG012|Overall Study|Physician Decision|0|||
46934047|NCT03502707|83169980|FG013|Overall Study|Physician Decision|0|||
46934048|NCT03502707|83169981|FG014|Overall Study|Physician Decision|1|||
46934049|NCT03502707|83169982|FG015|Overall Study|Physician Decision|3|||
46934050|NCT03502707|83169983|FG016|Overall Study|Physician Decision|0|||
46934051|NCT03502707|83169984|FG017|Overall Study|Physician Decision|0|||
46934052|NCT03502707|83169967|FG000|Overall Study|Protocol Violation|0|||
46934053|NCT03502707|83169968|FG001|Overall Study|Protocol Violation|0|||
46934054|NCT03502707|83169969|FG002|Overall Study|Protocol Violation|0|||
46824665|NCT00428090|83043564|FG000|Overall Study|Prohibited medication used for SAE|1|||
46824666|NCT00428090|83043565|FG001|Overall Study|Prohibited medication used for SAE|0|||
46824667|NCT00428090|83043566|FG002|Overall Study|Prohibited medication used for SAE|0|||
46934055|NCT03502707|83169970|FG003|Overall Study|Protocol Violation|0|||
46934056|NCT03502707|83169971|FG004|Overall Study|Protocol Violation|0|||
46934057|NCT03502707|83169972|FG005|Overall Study|Protocol Violation|0|||
46934058|NCT03502707|83169973|FG006|Overall Study|Protocol Violation|0|||
46934059|NCT03502707|83169974|FG007|Overall Study|Protocol Violation|0|||
46934060|NCT03502707|83169975|FG008|Overall Study|Protocol Violation|0|||
46934061|NCT03502707|83169976|FG009|Overall Study|Protocol Violation|0|||
46934062|NCT03502707|83169977|FG010|Overall Study|Protocol Violation|0|||
46934063|NCT03502707|83169978|FG011|Overall Study|Protocol Violation|0|||
46934064|NCT03502707|83169979|FG012|Overall Study|Protocol Violation|0|||
46934065|NCT03502707|83169980|FG013|Overall Study|Protocol Violation|0|||
46934066|NCT03502707|83169981|FG014|Overall Study|Protocol Violation|0|||
46934067|NCT03502707|83169982|FG015|Overall Study|Protocol Violation|1|||
46934068|NCT03502707|83169983|FG016|Overall Study|Protocol Violation|0|||
46934069|NCT03502707|83169984|FG017|Overall Study|Protocol Violation|0|||
46934070|NCT03502707|83169967|FG000|Overall Study|Withdrawal by Subject|1|||
46934071|NCT03502707|83169968|FG001|Overall Study|Withdrawal by Subject|1|||
46934072|NCT03502707|83169969|FG002|Overall Study|Withdrawal by Subject|0|||
46934073|NCT03502707|83169970|FG003|Overall Study|Withdrawal by Subject|0|||
46934074|NCT03502707|83169971|FG004|Overall Study|Withdrawal by Subject|0|||
46934075|NCT03502707|83169972|FG005|Overall Study|Withdrawal by Subject|2|||
46934076|NCT03502707|83169973|FG006|Overall Study|Withdrawal by Subject|0|||
46934077|NCT03502707|83169974|FG007|Overall Study|Withdrawal by Subject|3|||
46934078|NCT03502707|83169975|FG008|Overall Study|Withdrawal by Subject|1|||
46934079|NCT03502707|83169976|FG009|Overall Study|Withdrawal by Subject|2|||
46934080|NCT03502707|83169977|FG010|Overall Study|Withdrawal by Subject|12|||
46934081|NCT03502707|83169978|FG011|Overall Study|Withdrawal by Subject|23|||
46934082|NCT03502707|83169979|FG012|Overall Study|Withdrawal by Subject|5|||
46934083|NCT03502707|83169980|FG013|Overall Study|Withdrawal by Subject|3|||
46934084|NCT03502707|83169981|FG014|Overall Study|Withdrawal by Subject|3|||
46934085|NCT03502707|83169982|FG015|Overall Study|Withdrawal by Subject|43|||
46934086|NCT03502707|83169983|FG016|Overall Study|Withdrawal by Subject|44|||
46934087|NCT03502707|83169984|FG017|Overall Study|Withdrawal by Subject|18|||
46934088|NCT03502707|83169967|FG000|Overall Study|Sponsor's Decision|1|||
46934089|NCT03502707|83169968|FG001|Overall Study|Sponsor's Decision|0|||
46934090|NCT03502707|83169969|FG002|Overall Study|Sponsor's Decision|0|||
46934091|NCT03502707|83169970|FG003|Overall Study|Sponsor's Decision|0|||
46934092|NCT03502707|83169971|FG004|Overall Study|Sponsor's Decision|0|||
46934093|NCT03502707|83169972|FG005|Overall Study|Sponsor's Decision|0|||
46934094|NCT03502707|83169973|FG006|Overall Study|Sponsor's Decision|0|||
46934095|NCT03502707|83169974|FG007|Overall Study|Sponsor's Decision|0|||
46934096|NCT03502707|83169975|FG008|Overall Study|Sponsor's Decision|0|||
46934097|NCT03502707|83169976|FG009|Overall Study|Sponsor's Decision|1|||
46934098|NCT03502707|83169977|FG010|Overall Study|Sponsor's Decision|0|||
46934099|NCT03502707|83169978|FG011|Overall Study|Sponsor's Decision|0|||
46934100|NCT03502707|83169979|FG012|Overall Study|Sponsor's Decision|0|||
46934101|NCT03502707|83169980|FG013|Overall Study|Sponsor's Decision|0|||
46934102|NCT03502707|83169981|FG014|Overall Study|Sponsor's Decision|0|||
46934103|NCT03502707|83169982|FG015|Overall Study|Sponsor's Decision|2|||
46824668|NCT00428090|83043567|FG003|Overall Study|Prohibited medication used for SAE|0|||
46824669|NCT00428090|83043564|FG000|Overall Study|Death of par.|1|||
46824670|NCT00428090|83043565|FG001|Overall Study|Death of par.|0|||
46824671|NCT00428090|83043566|FG002|Overall Study|Death of par.|1|||
46824672|NCT00428090|83043567|FG003|Overall Study|Death of par.|0|||
46824673|NCT00428090|83043564|FG000|Overall Study|Visit 7 exceed the visit window|0|||
46824674|NCT00428090|83043565|FG001|Overall Study|Visit 7 exceed the visit window|1|||
46824675|NCT00428090|83043566|FG002|Overall Study|Visit 7 exceed the visit window|0|||
46824676|NCT00428090|83043567|FG003|Overall Study|Visit 7 exceed the visit window|0|||
46824677|NCT00428090|83043564|FG000|Overall Study|Medical monitor terminated par.|0|||
46934104|NCT03502707|83169983|FG016|Overall Study|Sponsor's Decision|1|||
46934105|NCT03502707|83169984|FG017|Overall Study|Sponsor's Decision|0|||
46934106|NCT03502707|83169967|FG000|Overall Study|Initiated Prohibited Medication|0|||
46934107|NCT03502707|83169968|FG001|Overall Study|Initiated Prohibited Medication|0|||
46934108|NCT03502707|83169969|FG002|Overall Study|Initiated Prohibited Medication|0|||
46934109|NCT03502707|83169970|FG003|Overall Study|Initiated Prohibited Medication|0|||
46824678|NCT00428090|83043565|FG001|Overall Study|Medical monitor terminated par.|1|||
46824679|NCT00428090|83043566|FG002|Overall Study|Medical monitor terminated par.|0|||
46824680|NCT00428090|83043567|FG003|Overall Study|Medical monitor terminated par.|0|||
46934110|NCT03502707|83169971|FG004|Overall Study|Initiated Prohibited Medication|0|||
46934111|NCT03502707|83169972|FG005|Overall Study|Initiated Prohibited Medication|0|||
46934112|NCT03502707|83169973|FG006|Overall Study|Initiated Prohibited Medication|0|||
46934113|NCT03502707|83169974|FG007|Overall Study|Initiated Prohibited Medication|0|||
46934114|NCT03502707|83169975|FG008|Overall Study|Initiated Prohibited Medication|0|||
46824681|NCT00428090|83043564|FG000|Overall Study|Mental status of par. was|0|||
46824682|NCT00428090|83043565|FG001|Overall Study|Mental status of par. was|1|||
46824683|NCT00428090|83043566|FG002|Overall Study|Mental status of par. was|0|||
46824684|NCT00428090|83043567|FG003|Overall Study|Mental status of par. was|0|||
46824685|NCT00428090|83043564|FG000|Overall Study|Worsening of AD|0|||
46824686|NCT00428090|83043565|FG001|Overall Study|Worsening of AD|0|||
46824687|NCT00428090|83043566|FG002|Overall Study|Worsening of AD|1|||
46824688|NCT00428090|83043567|FG003|Overall Study|Worsening of AD|0|||
46824689|NCT00428090|83043564|FG000|Overall Study|Excluded for concerning QTc value|0|||
46824690|NCT00428090|83043565|FG001|Overall Study|Excluded for concerning QTc value|0|||
46824691|NCT00428090|83043566|FG002|Overall Study|Excluded for concerning QTc value|1|||
46824692|NCT00428090|83043567|FG003|Overall Study|Excluded for concerning QTc value|0|||
46824693|NCT00428090|83043564|FG000|Overall Study|Insufficient AD documentation|0|||
46824694|NCT00428090|83043565|FG001|Overall Study|Insufficient AD documentation|0|||
46824695|NCT00428090|83043566|FG002|Overall Study|Insufficient AD documentation|1|||
46824696|NCT00428090|83043567|FG003|Overall Study|Insufficient AD documentation|0|||
46761936|NCT00576472|82979971|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761937|NCT00576472|82979972|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
46761938|NCT00576472|82979958|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761939|NCT00576472|82979959|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761940|NCT00576472|82979960|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761941|NCT00576472|82979961|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761942|NCT00576472|82979962|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761943|NCT00576472|82979963|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761944|NCT00576472|82979964|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761945|NCT00576472|82979965|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761946|NCT00576472|82979966|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761947|NCT00576472|82979967|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761948|NCT00576472|82979968|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761949|NCT00576472|82979969|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761950|NCT00576472|82979970|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761951|NCT00576472|82979971|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
46761952|NCT00576472|82979972|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
46761953|NCT00576472|82979958|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
46761954|NCT00576472|82979959|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
46761955|NCT00576472|82979960|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
46761956|NCT00576472|82979961|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
46761957|NCT00576472|82979962|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
46761958|NCT00576472|82979963|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
46761959|NCT00576472|82979964|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
46761960|NCT00576472|82979965|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
46761961|NCT00576472|82979966|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
46761962|NCT00576472|82979967|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
46761963|NCT00576472|82979968|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
46761964|NCT00576472|82979969|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
46761965|NCT00576472|82979970|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
46761966|NCT00576472|82979971|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
46761967|NCT00576472|82979972|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
46761968|NCT00576472|82979958|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
46761969|NCT00576472|82979959|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
46761970|NCT00576472|82979960|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
46761971|NCT00576472|82979961|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
46761972|NCT00576472|82979962|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
46761973|NCT00576472|82979963|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
46761974|NCT00576472|82979964|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
46761975|NCT00576472|82979965|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
46761976|NCT00576472|82979966|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
46761977|NCT00576472|82979967|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
46761978|NCT00576472|82979968|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
46761979|NCT00576472|82979969|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
46761980|NCT00576472|82979970|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
46761981|NCT00576472|82979971|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
46761982|NCT00576472|82979972|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
46824697|NCT00428090|83043564|FG000|Overall Study|High MMSE scores|0|||
46824698|NCT00428090|83043565|FG001|Overall Study|High MMSE scores|0|||
46934115|NCT03502707|83169976|FG009|Overall Study|Initiated Prohibited Medication|0|||
46934116|NCT03502707|83169977|FG010|Overall Study|Initiated Prohibited Medication|0|||
46761983|NCT00576472|82979958|FG000|MPH Home Maintenance Phase|Side effects|0|||
46934117|NCT03502707|83169978|FG011|Overall Study|Initiated Prohibited Medication|0|||
46824699|NCT00428090|83043566|FG002|Overall Study|High MMSE scores|1|||
46824700|NCT00428090|83043567|FG003|Overall Study|High MMSE scores|0|||
46824701|NCT00428090|83043564|FG000|Overall Study|Deterioration of cognitive status|0|||
46824702|NCT00428090|83043565|FG001|Overall Study|Deterioration of cognitive status|0|||
46824703|NCT00428090|83043566|FG002|Overall Study|Deterioration of cognitive status|1|||
46761984|NCT00576472|82979959|FG001|MPH Home Maintenance Phase|Side effects|0|||
46761985|NCT00576472|82979960|FG002|MPH Home Maintenance Phase|Side effects|0|||
46761986|NCT00576472|82979961|FG003|MPH Home Maintenance Phase|Side effects|0|||
46761987|NCT00576472|82979962|FG004|MPH Home Maintenance Phase|Side effects|0|||
46761988|NCT00576472|82979963|FG005|MPH Home Maintenance Phase|Side effects|0|||
46761989|NCT00576472|82979964|FG006|MPH Home Maintenance Phase|Side effects|0|||
46824704|NCT00428090|83043567|FG003|Overall Study|Deterioration of cognitive status|0|||
46824705|NCT00428090|83043564|FG000|Overall Study|Serious adverse event|0|||
46824706|NCT00428090|83043565|FG001|Overall Study|Serious adverse event|0|||
46824707|NCT00428090|83043566|FG002|Overall Study|Serious adverse event|1|||
46824708|NCT00428090|83043567|FG003|Overall Study|Serious adverse event|0|||
46824709|NCT00428090|83043564|FG000|Overall Study|Excluded for heart insufficiency|0|||
46824710|NCT00428090|83043565|FG001|Overall Study|Excluded for heart insufficiency|0|||
46824711|NCT00428090|83043566|FG002|Overall Study|Excluded for heart insufficiency|1|||
47057976|NCT01589237|83336328|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
47057977|NCT01589237|83336329|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
47057978|NCT01589237|83336326|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
47057979|NCT01589237|83336327|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
47057980|NCT01589237|83336328|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
47057981|NCT01589237|83336329|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
47057982|NCT01700387|83336345|FG000|Overall Study|Withdrawal by Subject|1|||
47057983|NCT01700387|83336346|FG001|Overall Study|Withdrawal by Subject|2|||
47057984|NCT01700387|83336345|FG000|Overall Study|Adverse Event|1|||
47057985|NCT01700387|83336346|FG001|Overall Study|Adverse Event|1|||
47057986|NCT01700387|83336345|FG000|Overall Study|Lost to Follow-up|2|||
47057987|NCT01700387|83336346|FG001|Overall Study|Lost to Follow-up|1|||
47057988|NCT01699685|83336358|FG000|Period 1|Adverse Event|1|||
47057989|NCT01699685|83336359|FG001|Period 1|Adverse Event|1|||
47057990|NCT01699685|83336358|FG000|Period 1|Medical or ethical, noncompliance|2|||
47057991|NCT01699685|83336359|FG001|Period 1|Medical or ethical, noncompliance|0|||
47057992|NCT01699685|83336358|FG000|Period 1|Other|0|||
47057993|NCT01699685|83336359|FG001|Period 1|Other|1|||
47057994|NCT01699685|83336358|FG000|Period 1|Patient request|0|||
47057995|NCT01699685|83336359|FG001|Period 1|Patient request|1|||
47057996|NCT01699685|83336358|FG000|Period 2|Lost to Follow-up|1|||
47057997|NCT01699685|83336359|FG001|Period 2|Lost to Follow-up|0|||
47057998|NCT01587989|83336367|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
47057999|NCT01587989|83336368|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
47058000|NCT01587989|83336369|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
47058001|NCT01587989|83336367|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
47058002|NCT01587989|83336368|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
47058003|NCT01587989|83336369|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
47058004|NCT01587989|83336367|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
47058005|NCT01587989|83336368|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
47058006|NCT01587989|83336369|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
47058007|NCT01587989|83336367|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
47058008|NCT01587989|83336368|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
47058009|NCT01587989|83336369|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
47058010|NCT01587989|83336367|FG000|Randomized Study Treatment|Screening failure|0|||
46761990|NCT00576472|82979965|FG007|MPH Home Maintenance Phase|Side effects|0|||
46761991|NCT00576472|82979966|FG008|MPH Home Maintenance Phase|Side effects|0|||
46761992|NCT00576472|82979967|FG009|MPH Home Maintenance Phase|Side effects|0|||
46761993|NCT00576472|82979968|FG010|MPH Home Maintenance Phase|Side effects|0|||
46761994|NCT00576472|82979969|FG011|MPH Home Maintenance Phase|Side effects|0|||
46824712|NCT00428090|83043567|FG003|Overall Study|Excluded for heart insufficiency|0|||
46824713|NCT00428090|83043564|FG000|Overall Study|Raised Creatinine Value|0|||
47058011|NCT01587989|83336368|FG001|Randomized Study Treatment|Screening failure|1|||
47058012|NCT01587989|83336369|FG002|Randomized Study Treatment|Screening failure|0|||
47058013|NCT01587989|83336367|FG000|Randomized Study Treatment|Physician Decision|0|||
47058014|NCT01587989|83336368|FG001|Randomized Study Treatment|Physician Decision|0|||
47058015|NCT01587989|83336369|FG002|Randomized Study Treatment|Physician Decision|1|||
47058016|NCT01697969|83336375|FG000|Overall Study|Did not meet inc/exc criteria|3|||
46824714|NCT00428090|83043565|FG001|Overall Study|Raised Creatinine Value|0|||
46824715|NCT00428090|83043566|FG002|Overall Study|Raised Creatinine Value|0|||
46824716|NCT00428090|83043567|FG003|Overall Study|Raised Creatinine Value|1|||
47058017|NCT01586819|83336382|FG000|Overall Study|Withdrawal by Subject|1|||
47058018|NCT01586819|83336383|FG001|Overall Study|Withdrawal by Subject|0|||
47058019|NCT01697579|83336394|FG000|Base Study-Cycle 1|Adverse Event|1|||
46934118|NCT03502707|83169979|FG012|Overall Study|Initiated Prohibited Medication|0|||
46934119|NCT03502707|83169980|FG013|Overall Study|Initiated Prohibited Medication|0|||
46934120|NCT03502707|83169981|FG014|Overall Study|Initiated Prohibited Medication|0|||
46934121|NCT03502707|83169982|FG015|Overall Study|Initiated Prohibited Medication|0|||
46934122|NCT03502707|83169983|FG016|Overall Study|Initiated Prohibited Medication|1|||
46934123|NCT03502707|83169984|FG017|Overall Study|Initiated Prohibited Medication|0|||
46934124|NCT03502707|83169967|FG000|Overall Study|Other|0|||
46934125|NCT03502707|83169968|FG001|Overall Study|Other|0|||
46934126|NCT03502707|83169969|FG002|Overall Study|Other|0|||
46934127|NCT03502707|83169970|FG003|Overall Study|Other|0|||
46934128|NCT03502707|83169971|FG004|Overall Study|Other|0|||
46934129|NCT03502707|83169972|FG005|Overall Study|Other|0|||
46934130|NCT03502707|83169973|FG006|Overall Study|Other|0|||
46934131|NCT03502707|83169974|FG007|Overall Study|Other|0|||
46934132|NCT03502707|83169975|FG008|Overall Study|Other|1|||
46934133|NCT03502707|83169976|FG009|Overall Study|Other|1|||
46934134|NCT03502707|83169977|FG010|Overall Study|Other|2|||
46934135|NCT03502707|83169978|FG011|Overall Study|Other|0|||
46934136|NCT03502707|83169979|FG012|Overall Study|Other|0|||
46761995|NCT00576472|82979970|FG012|MPH Home Maintenance Phase|Side effects|0|||
46761996|NCT00576472|82979971|FG013|MPH Home Maintenance Phase|Side effects|0|||
46824717|NCT00416312|83043585|FG000|Overall Study|tumors not visible on imaging|2|||
46824718|NCT00436436|83043589|FG000|Overall Study|Progression|4|||
46824719|NCT00436436|83043589|FG000|Overall Study|Adverse Event|2|||
46824720|NCT00436436|83043589|FG000|Overall Study|Death|6|||
46824721|NCT00262522|83043597|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
46824722|NCT00262522|83043598|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
46824723|NCT00262522|83043599|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
46824724|NCT00262522|83043600|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
46824725|NCT00262522|83043597|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
46824726|NCT00262522|83043598|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
46824727|NCT00262522|83043599|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
46824728|NCT00262522|83043600|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
46824729|NCT00262522|83043597|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
46824730|NCT00262522|83043598|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
46824731|NCT00262522|83043599|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
46824732|NCT00262522|83043600|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
46824733|NCT00262522|83043597|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
46824734|NCT00262522|83043598|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
46824735|NCT00262522|83043599|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
46824736|NCT00262522|83043600|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
46824737|NCT00262522|83043597|FG000|Study Start Through 8 Weeks|Death|1|||
46824738|NCT00262522|83043598|FG001|Study Start Through 8 Weeks|Death|0|||
46824739|NCT00262522|83043599|FG002|Study Start Through 8 Weeks|Death|0|||
46824740|NCT00262522|83043600|FG003|Study Start Through 8 Weeks|Death|0|||
46824741|NCT00262522|83043597|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
46934137|NCT03502707|83169980|FG013|Overall Study|Other|0|||
46934138|NCT03502707|83169981|FG014|Overall Study|Other|0|||
46934139|NCT03502707|83169982|FG015|Overall Study|Other|4|||
46934140|NCT03502707|83169983|FG016|Overall Study|Other|1|||
46934141|NCT03502707|83169984|FG017|Overall Study|Other|0|||
46934142|NCT03502707|83169967|FG000|Overall Study|Randomized but not vaccinated|0|||
46934143|NCT03502707|83169968|FG001|Overall Study|Randomized but not vaccinated|0|||
46761997|NCT00576472|82979972|FG014|MPH Home Maintenance Phase|Side effects|8|||
46761998|NCT00576472|82979958|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46761999|NCT00576472|82979959|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762000|NCT00576472|82979960|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762001|NCT00576472|82979961|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762002|NCT00576472|82979962|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46934144|NCT03502707|83169969|FG002|Overall Study|Randomized but not vaccinated|0|||
46934145|NCT03502707|83169970|FG003|Overall Study|Randomized but not vaccinated|0|||
46934146|NCT03502707|83169971|FG004|Overall Study|Randomized but not vaccinated|0|||
46934147|NCT03502707|83169972|FG005|Overall Study|Randomized but not vaccinated|0|||
47058020|NCT01697579|83336395|FG001|Base Study-Cycle 1|Adverse Event|0|||
47058021|NCT01697579|83336396|FG002|Base Study-Cycle 1|Adverse Event|0|||
46637097|NCT02840799|82810964|FG001|Phase 2 (Crossover)|Adverse Event|1|||
46762003|NCT00576472|82979963|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46824742|NCT00262522|83043598|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
46824743|NCT00262522|83043599|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
46824744|NCT00262522|83043600|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
46824745|NCT00262522|83043597|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
46824746|NCT00262522|83043598|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
46824747|NCT00262522|83043599|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
46824748|NCT00262522|83043600|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
46934148|NCT03502707|83169973|FG006|Overall Study|Randomized but not vaccinated|0|||
47058022|NCT01697579|83336397|FG003|Base Study-Cycle 1|Adverse Event|0|||
47058023|NCT01697579|83336398|FG004|Base Study-Cycle 1|Adverse Event|0|||
47058024|NCT01697579|83336399|FG005|Base Study-Cycle 1|Adverse Event|0|||
47058025|NCT01697579|83336400|FG006|Base Study-Cycle 1|Adverse Event|0|||
47058026|NCT01697579|83336394|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
47058027|NCT01697579|83336395|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
47058028|NCT01697579|83336396|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
47058029|NCT01697579|83336397|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
47058030|NCT01697579|83336398|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
47058031|NCT01697579|83336399|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
47058032|NCT01697579|83336400|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
47058033|NCT01697579|83336394|FG000|Base Study-Cycle 1|Protocol Violation|0|||
47058034|NCT01697579|83336395|FG001|Base Study-Cycle 1|Protocol Violation|0|||
47058035|NCT01697579|83336396|FG002|Base Study-Cycle 1|Protocol Violation|0|||
47058036|NCT01697579|83336397|FG003|Base Study-Cycle 1|Protocol Violation|0|||
47058037|NCT01697579|83336398|FG004|Base Study-Cycle 1|Protocol Violation|3|||
47058038|NCT01697579|83336399|FG005|Base Study-Cycle 1|Protocol Violation|0|||
47058039|NCT01697579|83336400|FG006|Base Study-Cycle 1|Protocol Violation|0|||
46824749|NCT00262522|83043597|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
46824750|NCT00262522|83043598|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
46824751|NCT00262522|83043599|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
46824752|NCT00262522|83043600|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
46824753|NCT00262522|83043597|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
46824754|NCT00262522|83043598|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
46824755|NCT00262522|83043599|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
46824756|NCT00262522|83043600|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
46934149|NCT03502707|83169974|FG007|Overall Study|Randomized but not vaccinated|0|||
46934150|NCT03502707|83169975|FG008|Overall Study|Randomized but not vaccinated|0|||
46934151|NCT03502707|83169976|FG009|Overall Study|Randomized but not vaccinated|0|||
46934152|NCT03502707|83169977|FG010|Overall Study|Randomized but not vaccinated|0|||
46934153|NCT03502707|83169978|FG011|Overall Study|Randomized but not vaccinated|1|||
46934154|NCT03502707|83169979|FG012|Overall Study|Randomized but not vaccinated|0|||
46934155|NCT03502707|83169980|FG013|Overall Study|Randomized but not vaccinated|0|||
46934156|NCT03502707|83169981|FG014|Overall Study|Randomized but not vaccinated|0|||
46934157|NCT03502707|83169982|FG015|Overall Study|Randomized but not vaccinated|0|||
46934158|NCT03502707|83169983|FG016|Overall Study|Randomized but not vaccinated|0|||
46934159|NCT03502707|83169984|FG017|Overall Study|Randomized but not vaccinated|1|||
46762004|NCT00576472|82979964|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762005|NCT00576472|82979965|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762006|NCT00576472|82979966|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762007|NCT00576472|82979967|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762008|NCT00576472|82979968|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762009|NCT00576472|82979969|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762010|NCT00576472|82979970|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762011|NCT00576472|82979971|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
46762012|NCT00576472|82979972|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
46762013|NCT00576472|82979958|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
46762014|NCT00576472|82979959|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
46762015|NCT00576472|82979960|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
46762016|NCT00576472|82979961|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
46762017|NCT00576472|82979962|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
46762018|NCT00576472|82979963|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
46762019|NCT00576472|82979964|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
46762020|NCT00576472|82979965|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
46762021|NCT00576472|82979966|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
46762022|NCT00576472|82979967|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
46762023|NCT00576472|82979968|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
46762024|NCT00576472|82979969|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
46762025|NCT00576472|82979970|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
46824757|NCT00262522|83043597|FG000|Study Start Through 48 Weeks|Death|2|||
46824758|NCT00262522|83043598|FG001|Study Start Through 48 Weeks|Death|0|||
46934160|NCT03425006|83170034|FG000|Overall Study|Withdrawal by Subject|1|||
46934161|NCT03425006|83170034|FG000|Overall Study|Physician Decision|1|||
47058040|NCT01697579|83336394|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
47058041|NCT01697579|83336395|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
46762026|NCT00576472|82979971|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
46762027|NCT00576472|82979972|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
46934162|NCT03425006|83170034|FG000|Overall Study|Death|1|||
46824759|NCT00262522|83043599|FG002|Study Start Through 48 Weeks|Death|1|||
46824760|NCT00262522|83043600|FG003|Study Start Through 48 Weeks|Death|0|||
46934163|NCT03401073|83170040|FG000|Overall Study|Lost to Follow-up|1|||
46934164|NCT03401073|83170041|FG001|Overall Study|Lost to Follow-up|2|||
46934165|NCT02915263|83170066|FG000|Overall Study|Covid|3|||
46934166|NCT02915263|83170067|FG001|Overall Study|Covid|2|||
46934167|NCT02343952|83170073|FG000|Study Treatment|Disease Progression|23|||
46824761|NCT00262522|83043597|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
46824762|NCT00262522|83043598|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
47058042|NCT01697579|83336396|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
47058043|NCT01697579|83336397|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
47058044|NCT01697579|83336398|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
47058045|NCT01697579|83336399|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
47058046|NCT01697579|83336400|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
47058047|NCT01697579|83336394|FG000|Base Study-Cycle 1|Technical Problems|0|||
47058048|NCT01697579|83336395|FG001|Base Study-Cycle 1|Technical Problems|0|||
47058049|NCT01697579|83336396|FG002|Base Study-Cycle 1|Technical Problems|1|||
47058050|NCT01697579|83336397|FG003|Base Study-Cycle 1|Technical Problems|1|||
47058051|NCT01697579|83336398|FG004|Base Study-Cycle 1|Technical Problems|0|||
47058052|NCT01697579|83336399|FG005|Base Study-Cycle 1|Technical Problems|0|||
47058053|NCT01697579|83336400|FG006|Base Study-Cycle 1|Technical Problems|0|||
47058054|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Death|0|||
47058055|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Death|0|||
47058056|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Death|0|||
47058057|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Death|0|||
46824763|NCT00262522|83043599|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
46824764|NCT00262522|83043600|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
46824765|NCT00262522|83043597|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
46824766|NCT00262522|83043598|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
46824767|NCT00262522|83043599|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
46824768|NCT00262522|83043600|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
46824769|NCT00262522|83043597|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
46824770|NCT00262522|83043598|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
46824771|NCT00262522|83043599|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
46824772|NCT00262522|83043600|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
46824773|NCT00262522|83043597|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
46824774|NCT00262522|83043598|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
46824775|NCT00262522|83043599|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
46824776|NCT00262522|83043600|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
46824777|NCT00262522|83043597|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
46824778|NCT00262522|83043598|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
46824779|NCT00262522|83043599|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
46824780|NCT00262522|83043600|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
46824781|NCT00262522|83043597|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
46824782|NCT00262522|83043598|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
46824783|NCT00262522|83043599|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
46824784|NCT00262522|83043600|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
46824785|NCT00262522|83043597|FG000|Study Start Through 96 Weeks|Death|2|||
46824786|NCT00262522|83043598|FG001|Study Start Through 96 Weeks|Death|0|||
46824787|NCT00262522|83043599|FG002|Study Start Through 96 Weeks|Death|2|||
46824788|NCT00262522|83043600|FG003|Study Start Through 96 Weeks|Death|0|||
46824789|NCT00262522|83043597|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
46934168|NCT02343952|83170073|FG000|Study Treatment|Death|3|||
47058058|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Death|0|||
47058059|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Death|0|||
46762028|NCT00576472|82979958|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762029|NCT00576472|82979959|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762030|NCT00576472|82979960|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762031|NCT00576472|82979961|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762032|NCT00576472|82979962|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762033|NCT00576472|82979963|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762034|NCT00576472|82979964|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762035|NCT00576472|82979965|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
47058060|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Death|2|||
47058061|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
47058062|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
47058063|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
46762036|NCT00576472|82979966|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46824790|NCT00262522|83043598|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
46934169|NCT02343952|83170073|FG000|Study Treatment|Adverse Event|19|||
46824791|NCT00262522|83043599|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
46824792|NCT00262522|83043600|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
46824793|NCT00262522|83043597|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
46824794|NCT00262522|83043598|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
46824795|NCT00262522|83043599|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
46824796|NCT00262522|83043600|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
46824797|NCT00436280|83043608|FG000|Period 1: Induction|Adverse Event|8|||
46762037|NCT00576472|82979967|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762038|NCT00576472|82979968|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762039|NCT00576472|82979969|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762040|NCT00576472|82979970|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762041|NCT00576472|82979971|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
46762042|NCT00576472|82979972|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
46762043|NCT00823212|82980005|FG000|Overall Study|Death|8|||
46762044|NCT00823212|82980006|FG001|Overall Study|Death|10|||
46762045|NCT00823212|82980005|FG000|Overall Study|Withdrawal by Subject|6|||
46762046|NCT00823212|82980006|FG001|Overall Study|Withdrawal by Subject|1|||
46762047|NCT00823212|82980005|FG000|Overall Study|Incarcerated|0|||
46762048|NCT00823212|82980006|FG001|Overall Study|Incarcerated|1|||
46762049|NCT00823212|82980005|FG000|Overall Study|Missed 12-month visit|21|||
46762050|NCT00823212|82980006|FG001|Overall Study|Missed 12-month visit|21|||
46762051|NCT00807495|82980019|FG000|Overall Study|Adverse Event|6|||
46762052|NCT00807495|82980020|FG001|Overall Study|Adverse Event|3|||
46762053|NCT00807495|82980021|FG002|Overall Study|Adverse Event|1|||
46762054|NCT00807495|82980022|FG003|Overall Study|Adverse Event|1|||
46762055|NCT00807495|82980023|FG004|Overall Study|Adverse Event|2|||
46762056|NCT00807495|82980019|FG000|Overall Study|Withdrawal by Patient|2|||
46762057|NCT00807495|82980020|FG001|Overall Study|Withdrawal by Patient|0|||
46762058|NCT00807495|82980021|FG002|Overall Study|Withdrawal by Patient|1|||
46762059|NCT00807495|82980022|FG003|Overall Study|Withdrawal by Patient|0|||
46762060|NCT00807495|82980023|FG004|Overall Study|Withdrawal by Patient|0|||
46762061|NCT00807495|82980019|FG000|Overall Study|Reason Not Specified|0|||
46762062|NCT00807495|82980020|FG001|Overall Study|Reason Not Specified|3|||
46762063|NCT00807495|82980021|FG002|Overall Study|Reason Not Specified|2|||
46762064|NCT00807495|82980022|FG003|Overall Study|Reason Not Specified|0|||
46762065|NCT00807495|82980023|FG004|Overall Study|Reason Not Specified|3|||
46762066|NCT05074433|82980039|FG000|Overall Study|Adverse Event|0|||
46762067|NCT05074433|82980040|FG001|Overall Study|Adverse Event|2|||
46762068|NCT05074433|82980041|FG002|Overall Study|Adverse Event|0|||
46762069|NCT05074433|82980042|FG003|Overall Study|Adverse Event|1|||
46762070|NCT05074433|82980039|FG000|Overall Study|Sponsor Request|0|||
46762071|NCT05074433|82980040|FG001|Overall Study|Sponsor Request|1|||
46762072|NCT05074433|82980041|FG002|Overall Study|Sponsor Request|1|||
46762073|NCT05074433|82980042|FG003|Overall Study|Sponsor Request|0|||
46762074|NCT05074433|82980039|FG000|Overall Study|Death|1|||
46762075|NCT05074433|82980040|FG001|Overall Study|Death|0|||
46762076|NCT05074433|82980041|FG002|Overall Study|Death|0|||
46762077|NCT05074433|82980042|FG003|Overall Study|Death|0|||
46762078|NCT05074433|82980039|FG000|Overall Study|Lost to Follow-up|0|||
46762079|NCT05074433|82980040|FG001|Overall Study|Lost to Follow-up|0|||
46762080|NCT05074433|82980041|FG002|Overall Study|Lost to Follow-up|2|||
46762081|NCT05074433|82980042|FG003|Overall Study|Lost to Follow-up|0|||
46762082|NCT05074433|82980039|FG000|Overall Study|Subject Decision|8|||
46762083|NCT05074433|82980040|FG001|Overall Study|Subject Decision|6|||
46762084|NCT05074433|82980041|FG002|Overall Study|Subject Decision|4|||
46762085|NCT05074433|82980042|FG003|Overall Study|Subject Decision|5|||
46762086|NCT04922021|82980066|FG000|Overall Study|Withdrawal by Subject|4|||
46824798|NCT00436280|83043608|FG000|Period 1: Induction|Progressive Disease|12|||
46824799|NCT00436280|83043608|FG000|Period 1: Induction|Stable Disease|6|||
46824800|NCT00436280|83043608|FG000|Period 1: Induction|Withdrawal by Subject|1|||
46824801|NCT00436280|83043608|FG000|Period 1: Induction|Death|1|||
46824802|NCT00436280|83043608|FG000|Period 2: Consolidation|Adverse Event|1|||
46824803|NCT00436280|83043608|FG000|Period 2: Consolidation|Progressive Disease|10|||
46824804|NCT00436280|83043608|FG000|Period 2: Consolidation|Stable Disease|1|||
46824805|NCT00436280|83043608|FG000|Period 2: Consolidation|Physician Decision|2|||
46762087|NCT04922021|82980067|FG001|Overall Study|Withdrawal by Subject|10|||
46762088|NCT04922021|82980066|FG000|Overall Study|Adverse Event|2|||
46762089|NCT04922021|82980067|FG001|Overall Study|Adverse Event|2|||
46762090|NCT04922021|82980066|FG000|Overall Study|Lack of Efficacy|0|||
46762091|NCT04922021|82980067|FG001|Overall Study|Lack of Efficacy|1|||
46762092|NCT04922021|82980066|FG000|Overall Study|Multiple reasons|1|||
46934170|NCT02343952|83170073|FG000|Study Treatment|Withdrawal by Subject|7|||
46934171|NCT02343952|83170073|FG000|Study Treatment|other complicating Diseases|1|||
46762093|NCT04922021|82980067|FG001|Overall Study|Multiple reasons|0|||
46762094|NCT04233580|82980118|FG000|Overall Study|Adverse Event|3|||
46762095|NCT04233580|82980119|FG001|Overall Study|Adverse Event|3|||
46762096|NCT04233580|82980118|FG000|Overall Study|Withdrawal by Subject|2|||
46824806|NCT00436280|83043608|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
46824807|NCT00436280|83043608|FG000|Period 2: Consolidation|Death|1|||
46824808|NCT00436280|83043608|FG000|Period 3: Maintenance|Adverse Event|6|||
46824809|NCT00436280|83043608|FG000|Period 3: Maintenance|Progressive Disease|12|||
46824810|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
46824811|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
46824812|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
46824813|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
46824814|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
46824815|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
46824816|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
46934172|NCT02343952|83170073|FG000|Follow up|Withdrawal by Subject|3|||
46934173|NCT02343952|83170073|FG000|Follow up|Death|33|||
46934174|NCT02343952|83170073|FG000|Follow up|Patient does not meet eligibility for study.|1|||
46934175|NCT02343952|83170073|FG000|Follow up|Research department closed by the practice.|5|||
46934176|NCT02343952|83170073|FG000|Follow up|Patient went home to Russia|1|||
46934177|NCT02343952|83170073|FG000|Follow up|Disease Progression|1|||
46934178|NCT02343952|83170073|FG000|Follow up|study terminated|1|||
46934179|NCT01592370|83170084|FG000|Overall Study|Disease Progression|62|||
46934180|NCT01592370|83170085|FG001|Overall Study|Disease Progression|16|||
47058064|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
47058065|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
46824817|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
46824818|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Death|0|||
46824819|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Death|1|||
46824820|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
46824821|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
46824822|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
46824823|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
46824824|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
47058066|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
47058067|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
47058068|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
47058069|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
47058070|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
47058071|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
47058072|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
47058073|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
47058074|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
47058075|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
47058076|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
47058077|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
47058078|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
47058079|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
47058080|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
47058081|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
47058082|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
47058083|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
47058084|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
47058085|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
47058086|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
47058087|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
47058088|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
47058089|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
47058090|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
47058091|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
47058092|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
46824825|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
46824826|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
46824827|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
46934181|NCT01592370|83170086|FG002|Overall Study|Disease Progression|52|||
47058093|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
47058094|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
47058095|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
47058096|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
47058097|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
46824828|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
46934182|NCT01592370|83170087|FG003|Overall Study|Disease Progression|3|||
46934183|NCT01592370|83170088|FG004|Overall Study|Disease Progression|3|||
46824829|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
46824830|NCT00394836|83043614|FG000|Teatment or Follow-up Phase|Non compliance|0|||
46824831|NCT00394836|83043615|FG001|Teatment or Follow-up Phase|Non compliance|1|||
46934184|NCT01592370|83170089|FG005|Overall Study|Disease Progression|31|||
46934185|NCT01592370|83170090|FG006|Overall Study|Disease Progression|14|||
46934186|NCT01592370|83170084|FG000|Overall Study|Study Drug Toxicity|14|||
46934187|NCT01592370|83170085|FG001|Overall Study|Study Drug Toxicity|3|||
46934188|NCT01592370|83170086|FG002|Overall Study|Study Drug Toxicity|0|||
46934189|NCT01592370|83170087|FG003|Overall Study|Study Drug Toxicity|0|||
46934190|NCT01592370|83170088|FG004|Overall Study|Study Drug Toxicity|0|||
46934191|NCT01592370|83170089|FG005|Overall Study|Study Drug Toxicity|0|||
46934192|NCT01592370|83170090|FG006|Overall Study|Study Drug Toxicity|1|||
46934193|NCT01592370|83170084|FG000|Overall Study|AE unrelated to study drug|4|||
46934194|NCT01592370|83170085|FG001|Overall Study|AE unrelated to study drug|3|||
46934195|NCT01592370|83170086|FG002|Overall Study|AE unrelated to study drug|0|||
46934196|NCT01592370|83170087|FG003|Overall Study|AE unrelated to study drug|0|||
46934197|NCT01592370|83170088|FG004|Overall Study|AE unrelated to study drug|0|||
46934198|NCT01592370|83170089|FG005|Overall Study|AE unrelated to study drug|0|||
46934199|NCT01592370|83170090|FG006|Overall Study|AE unrelated to study drug|1|||
46934200|NCT01592370|83170084|FG000|Overall Study|Request to discontinue study treatment|5|||
46934201|NCT01592370|83170085|FG001|Overall Study|Request to discontinue study treatment|0|||
46934202|NCT01592370|83170086|FG002|Overall Study|Request to discontinue study treatment|2|||
46934203|NCT01592370|83170087|FG003|Overall Study|Request to discontinue study treatment|0|||
46934204|NCT01592370|83170088|FG004|Overall Study|Request to discontinue study treatment|1|||
46934205|NCT01592370|83170089|FG005|Overall Study|Request to discontinue study treatment|2|||
46934206|NCT01592370|83170090|FG006|Overall Study|Request to discontinue study treatment|0|||
46934207|NCT01592370|83170084|FG000|Overall Study|Withdrew consent|1|||
46934208|NCT01592370|83170085|FG001|Overall Study|Withdrew consent|2|||
46934209|NCT01592370|83170086|FG002|Overall Study|Withdrew consent|1|||
46934210|NCT01592370|83170087|FG003|Overall Study|Withdrew consent|1|||
46934211|NCT01592370|83170088|FG004|Overall Study|Withdrew consent|0|||
46934212|NCT01592370|83170089|FG005|Overall Study|Withdrew consent|0|||
46934213|NCT01592370|83170090|FG006|Overall Study|Withdrew consent|0|||
46934214|NCT01592370|83170084|FG000|Overall Study|Maximum clinical benefit|11|||
46934215|NCT01592370|83170085|FG001|Overall Study|Maximum clinical benefit|1|||
46934216|NCT01592370|83170086|FG002|Overall Study|Maximum clinical benefit|7|||
46934217|NCT01592370|83170087|FG003|Overall Study|Maximum clinical benefit|1|||
46934218|NCT01592370|83170088|FG004|Overall Study|Maximum clinical benefit|0|||
46934219|NCT01592370|83170089|FG005|Overall Study|Maximum clinical benefit|0|||
46934220|NCT01592370|83170090|FG006|Overall Study|Maximum clinical benefit|0|||
46934221|NCT01592370|83170084|FG000|Overall Study|No longer meets study criteria|1|||
46934222|NCT01592370|83170085|FG001|Overall Study|No longer meets study criteria|0|||
46934223|NCT01592370|83170086|FG002|Overall Study|No longer meets study criteria|0|||
46934224|NCT01592370|83170087|FG003|Overall Study|No longer meets study criteria|0|||
46934225|NCT01592370|83170088|FG004|Overall Study|No longer meets study criteria|0|||
46934226|NCT01592370|83170089|FG005|Overall Study|No longer meets study criteria|0|||
46934227|NCT01592370|83170090|FG006|Overall Study|No longer meets study criteria|0|||
46934228|NCT01592370|83170084|FG000|Overall Study|Other Reasons|6|||
46934229|NCT01592370|83170085|FG001|Overall Study|Other Reasons|0|||
46762097|NCT04233580|82980119|FG001|Overall Study|Withdrawal by Subject|1|||
46762098|NCT04016805|82980139|FG000|Overall Study|Sponsor's Discretion|30|||
46762099|NCT04016805|82980140|FG001|Overall Study|Sponsor's Discretion|6|||
46762100|NCT04016805|82980141|FG002|Overall Study|Sponsor's Discretion|5|||
46762101|NCT03982199|82980151|FG000|Overall Study|Site terminated by sponsor|14|||
46762102|NCT03982199|82980152|FG001|Overall Study|Site terminated by sponsor|17|||
46762103|NCT03982199|82980151|FG000|Overall Study|Lost to Follow-up|137|||
46824832|NCT00394836|83043614|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
46934230|NCT01592370|83170086|FG002|Overall Study|Other Reasons|10|||
46934231|NCT01592370|83170087|FG003|Overall Study|Other Reasons|0|||
46934232|NCT01592370|83170088|FG004|Overall Study|Other Reasons|0|||
46934233|NCT01592370|83170089|FG005|Overall Study|Other Reasons|1|||
46934234|NCT01592370|83170090|FG006|Overall Study|Other Reasons|0|||
46934235|NCT00777036|83170118|FG000|On Treatment|Reason Not Specified|4|||
46934236|NCT00777036|83170119|FG001|On Treatment|Reason Not Specified|7|||
46934237|NCT00777036|83170120|FG002|On Treatment|Reason Not Specified|12|||
46934238|NCT00777036|83170118|FG000|On Treatment|Failure to Meet Study Criteria|0|||
46934239|NCT00777036|83170119|FG001|On Treatment|Failure to Meet Study Criteria|1|||
46934240|NCT00777036|83170120|FG002|On Treatment|Failure to Meet Study Criteria|0|||
46934241|NCT00777036|83170118|FG000|On Treatment|Non-compliance with Study Drug|1|||
46934242|NCT00777036|83170119|FG001|On Treatment|Non-compliance with Study Drug|0|||
46934243|NCT00777036|83170120|FG002|On Treatment|Non-compliance with Study Drug|0|||
46762104|NCT03982199|82980152|FG001|Overall Study|Lost to Follow-up|142|||
46934244|NCT00777036|83170118|FG000|On Treatment|Maximum Clinical Benefit|2|||
46934245|NCT00777036|83170119|FG001|On Treatment|Maximum Clinical Benefit|0|||
46762105|NCT03982199|82980151|FG000|Overall Study|Physician Decision|38|||
46824833|NCT00394836|83043615|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
46824834|NCT00394836|83043614|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
46824835|NCT00394836|83043615|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
46824836|NCT00394836|83043614|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
46824837|NCT00394836|83043615|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
46824838|NCT00394836|83043614|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
46824839|NCT00394836|83043615|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
46824840|NCT00250588|83043626|FG000|Overall Study|Withdrawal by Subject|3|||
46824841|NCT00250588|83043627|FG001|Overall Study|Withdrawal by Subject|6|||
46824842|NCT00250588|83043628|FG002|Overall Study|Withdrawal by Subject|0|||
46824843|NCT00250588|83043626|FG000|Overall Study|Lost to Follow-up|6|||
46824844|NCT00250588|83043627|FG001|Overall Study|Lost to Follow-up|13|||
46824845|NCT00250588|83043628|FG002|Overall Study|Lost to Follow-up|13|||
46824846|NCT00416078|83043638|FG000|Overall Study|Death|3|||
46824847|NCT00416078|83043639|FG001|Overall Study|Death|4|||
46824848|NCT00416078|83043638|FG000|Overall Study|Withdrawal by Subject|3|||
46824849|NCT00416078|83043639|FG001|Overall Study|Withdrawal by Subject|2|||
46824850|NCT00416078|83043638|FG000|Overall Study|Physician Decision|1|||
46824851|NCT00416078|83043639|FG001|Overall Study|Physician Decision|0|||
46824852|NCT00416078|83043638|FG000|Overall Study|Lost to Follow-up|4|||
46824853|NCT00416078|83043639|FG001|Overall Study|Lost to Follow-up|2|||
46824854|NCT00394524|83043647|FG000|Overall Study|Protocol Violation|2|||
46824855|NCT00394524|83043648|FG001|Overall Study|Protocol Violation|3|||
46824856|NCT00394524|83043647|FG000|Overall Study|Death|1|||
46824857|NCT00394524|83043648|FG001|Overall Study|Death|0|||
46824858|NCT00394524|83043647|FG000|Overall Study|Withdrawal by Subject|0|||
46824859|NCT00394524|83043648|FG001|Overall Study|Withdrawal by Subject|1|||
46824860|NCT00409344|83043658|FG000|Overall Study|no enrollment|0|||
46824861|NCT00409344|83043659|FG001|Overall Study|no enrollment|0|||
46824862|NCT00415610|83043668|FG000|Overall Study|Death|3|||
46824863|NCT00415610|83043669|FG001|Overall Study|Death|2|||
46824864|NCT00415610|83043670|FG002|Overall Study|Death|5|||
47058098|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
47058099|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
47058100|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
46824865|NCT00394212|83043680|FG000|Overall Study|Lost to Follow-up|3|||
46824866|NCT00394212|83043681|FG001|Overall Study|Lost to Follow-up|0|||
46824867|NCT00394212|83043680|FG000|Overall Study|Withdrawal by Subject|4|||
46824868|NCT00394212|83043681|FG001|Overall Study|Withdrawal by Subject|1|||
46824869|NCT00250432|83043689|FG000|Overall Study|Adverse Event|25|||
46824870|NCT00250432|83043690|FG001|Overall Study|Adverse Event|29|||
46824871|NCT00250432|83043689|FG000|Overall Study|Lack of Efficacy|2|||
46824872|NCT00250432|83043690|FG001|Overall Study|Lack of Efficacy|1|||
46824873|NCT00250432|83043689|FG000|Overall Study|Lost to Follow-up|6|||
46824874|NCT00250432|83043690|FG001|Overall Study|Lost to Follow-up|5|||
46824875|NCT00250432|83043689|FG000|Overall Study|Patient Moved|0|||
46824876|NCT00250432|83043690|FG001|Overall Study|Patient Moved|1|||
46824877|NCT00250432|83043689|FG000|Overall Study|Protocol Violation|0|||
46824878|NCT00250432|83043690|FG001|Overall Study|Protocol Violation|3|||
46824879|NCT00250432|83043689|FG000|Overall Study|Withdrawal by Subject|6|||
46824880|NCT00250432|83043690|FG001|Overall Study|Withdrawal by Subject|2|||
46824881|NCT00250432|83043689|FG000|Overall Study|Pt died out of posttherapy report period|6|||
46824882|NCT00250432|83043690|FG001|Overall Study|Pt died out of posttherapy report period|5|||
46824883|NCT00250432|83043689|FG000|Overall Study|Pt was considered untreatable|0|||
46824884|NCT00250432|83043690|FG001|Overall Study|Pt was considered untreatable|1|||
46824885|NCT00250276|83043700|FG000|Overall Study|Serious Adverse Event|0|||
46824886|NCT00250276|83043701|FG001|Overall Study|Serious Adverse Event|0|||
46824887|NCT00250276|83043702|FG002|Overall Study|Serious Adverse Event|1|||
46824888|NCT00250276|83043703|FG003|Overall Study|Serious Adverse Event|0|||
46824889|NCT00250276|83043700|FG000|Overall Study|Non-serious Adverse Event|2|||
46824890|NCT00250276|83043701|FG001|Overall Study|Non-serious Adverse Event|0|||
46824891|NCT00250276|83043702|FG002|Overall Study|Non-serious Adverse Event|0|||
46824892|NCT00250276|83043703|FG003|Overall Study|Non-serious Adverse Event|2|||
46762106|NCT03982199|82980152|FG001|Overall Study|Physician Decision|33|||
46824893|NCT00250276|83043700|FG000|Overall Study|Protocol Violation|0|||
46824894|NCT00250276|83043701|FG001|Overall Study|Protocol Violation|1|||
46762107|NCT03982199|82980151|FG000|Overall Study|Withdrawal by Subject|514|||
46762108|NCT03982199|82980152|FG001|Overall Study|Withdrawal by Subject|496|||
46762109|NCT03982199|82980151|FG000|Overall Study|Adverse Event|10|||
46762110|NCT03982199|82980152|FG001|Overall Study|Adverse Event|14|||
46762111|NCT03982199|82980151|FG000|Overall Study|Technical Problems|9|||
46762112|NCT03982199|82980152|FG001|Overall Study|Technical Problems|8|||
46762113|NCT03982199|82980151|FG000|Overall Study|Death|40|||
46762114|NCT03982199|82980152|FG001|Overall Study|Death|40|||
46824895|NCT00250276|83043702|FG002|Overall Study|Protocol Violation|0|||
46824896|NCT00250276|83043703|FG003|Overall Study|Protocol Violation|0|||
46824897|NCT00250276|83043700|FG000|Overall Study|Withdrawal by Subject|1|||
46824898|NCT00250276|83043701|FG001|Overall Study|Withdrawal by Subject|2|||
46824899|NCT00250276|83043702|FG002|Overall Study|Withdrawal by Subject|3|||
46824900|NCT00250276|83043703|FG003|Overall Study|Withdrawal by Subject|2|||
46824901|NCT00250276|83043700|FG000|Overall Study|Migrated/moved from study area|3|||
46824902|NCT00250276|83043701|FG001|Overall Study|Migrated/moved from study area|0|||
46824903|NCT00250276|83043702|FG002|Overall Study|Migrated/moved from study area|2|||
46824904|NCT00250276|83043703|FG003|Overall Study|Migrated/moved from study area|7|||
46824905|NCT00250276|83043700|FG000|Overall Study|Lost to Follow-up|11|||
46824906|NCT00250276|83043701|FG001|Overall Study|Lost to Follow-up|18|||
46824907|NCT00250276|83043702|FG002|Overall Study|Lost to Follow-up|13|||
46824908|NCT00250276|83043703|FG003|Overall Study|Lost to Follow-up|8|||
46824909|NCT00249808|83043718|FG000|Overall Study|Other|27|||
46824910|NCT00249808|83043718|FG000|Overall Study|Protocol Violation|3|||
47058101|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
47058102|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
47058103|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
47058104|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
47058105|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
47058106|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
47058107|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
47058108|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
47058109|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
47058110|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
46824911|NCT00249808|83043718|FG000|Overall Study|Lost to Follow-up|8|||
46824912|NCT00249808|83043718|FG000|Overall Study|Adverse Event|81|||
46824913|NCT00249808|83043718|FG000|Overall Study|Lack of Efficacy|52|||
46824914|NCT00249808|83043718|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
46824915|NCT00278512|83043724|FG000|Overall Study|Death|1|||
46824916|NCT00278512|83043725|FG001|Overall Study|Death|0|||
46934246|NCT00777036|83170120|FG002|On Treatment|Maximum Clinical Benefit|1|||
46824917|NCT00427934|83043735|FG000|Overall Study|Adverse Event|1|||
46824918|NCT00427934|83043736|FG001|Overall Study|Adverse Event|0|||
46824919|NCT00427934|83043737|FG002|Overall Study|Adverse Event|5|||
46934247|NCT00777036|83170118|FG000|On Treatment|Withdrawal by Subject|3|||
46934248|NCT00777036|83170119|FG001|On Treatment|Withdrawal by Subject|2|||
46934249|NCT00777036|83170120|FG002|On Treatment|Withdrawal by Subject|3|||
46934250|NCT00777036|83170118|FG000|On Treatment|Death|0|||
46934251|NCT00777036|83170119|FG001|On Treatment|Death|2|||
46934252|NCT00777036|83170120|FG002|On Treatment|Death|0|||
46934253|NCT00777036|83170118|FG000|On Treatment|Study Drug Toxicity|0|||
46934254|NCT00777036|83170119|FG001|On Treatment|Study Drug Toxicity|0|||
46934255|NCT00777036|83170120|FG002|On Treatment|Study Drug Toxicity|1|||
47058111|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
47058112|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
47058113|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
47058114|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
46762115|NCT03982199|82980151|FG000|Overall Study|Study terminated by sponsor|2|||
46762116|NCT03982199|82980152|FG001|Overall Study|Study terminated by sponsor|1|||
46762117|NCT03982199|82980151|FG000|Overall Study|Other|76|||
46762118|NCT03982199|82980152|FG001|Overall Study|Other|81|||
46762119|NCT03982199|82980151|FG000|Overall Study|Ongoing|743|||
46762120|NCT03982199|82980152|FG001|Overall Study|Ongoing|799|||
46762121|NCT03982199|82980151|FG000|Overall Study|Randomized but not vaccinated|18|||
46762122|NCT03982199|82980152|FG001|Overall Study|Randomized but not vaccinated|15|||
46762123|NCT03828448|82980158|FG000|Overall Study|Sponsor's Discretion|34|||
46824920|NCT00427934|83043738|FG003|Overall Study|Adverse Event|4|||
46824921|NCT00427934|83043735|FG000|Overall Study|Lack of Efficacy|0|||
46824922|NCT00427934|83043736|FG001|Overall Study|Lack of Efficacy|0|||
46824923|NCT00427934|83043737|FG002|Overall Study|Lack of Efficacy|5|||
46934256|NCT00777036|83170118|FG000|On Treatment|Progressive Disease|5|||
46762124|NCT03580369|82980170|FG000|Overall Study|No treatment due to mis-randomization|1|||
46762125|NCT03580369|82980171|FG001|Overall Study|No treatment due to mis-randomization|0|||
46934257|NCT00777036|83170119|FG001|On Treatment|Progressive Disease|4|||
46934258|NCT00777036|83170120|FG002|On Treatment|Progressive Disease|6|||
46762126|NCT03580369|82980172|FG002|Overall Study|No treatment due to mis-randomization|0|||
46762127|NCT03580369|82980173|FG003|Overall Study|No treatment due to mis-randomization|0|||
46824924|NCT00427934|83043738|FG003|Overall Study|Lack of Efficacy|2|||
46824925|NCT00427934|83043735|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
46824926|NCT00427934|83043736|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
46824927|NCT00427934|83043737|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
46824928|NCT00427934|83043738|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
46934259|NCT00777036|83170118|FG000|Follow-Up|Lost to Follow-up|1|||
46934260|NCT00777036|83170119|FG001|Follow-Up|Lost to Follow-up|0|||
46934261|NCT00777036|83170120|FG002|Follow-Up|Lost to Follow-up|0|||
46934262|NCT00777036|83170118|FG000|Follow-Up|Reason Not Specified|2|||
46934263|NCT00777036|83170119|FG001|Follow-Up|Reason Not Specified|0|||
46934264|NCT00777036|83170120|FG002|Follow-Up|Reason Not Specified|0|||
46934265|NCT00777036|83170118|FG000|Follow-Up|Withdrawal by Subject|1|||
46934266|NCT00777036|83170119|FG001|Follow-Up|Withdrawal by Subject|0|||
46934267|NCT00777036|83170120|FG002|Follow-Up|Withdrawal by Subject|4|||
46934268|NCT00777036|83170118|FG000|Follow-Up|Death|1|||
46934269|NCT00777036|83170119|FG001|Follow-Up|Death|8|||
46934270|NCT00777036|83170120|FG002|Follow-Up|Death|0|||
46934271|NCT00176644|83170135|FG000|Overall Study|Withdrawal by Subject|1|||
46934272|NCT04649164|83170153|FG000|Overall Study|Withdrawal by Subject|1|||
46934273|NCT04649164|83170154|FG001|Overall Study|Withdrawal by Subject|1|||
46934274|NCT04649164|83170155|FG002|Overall Study|Withdrawal by Subject|2|||
46934275|NCT04649164|83170153|FG000|Overall Study|Participant's care recipient expired|0|||
46934276|NCT04649164|83170154|FG001|Overall Study|Participant's care recipient expired|0|||
46934277|NCT04649164|83170155|FG002|Overall Study|Participant's care recipient expired|2|||
46934278|NCT00706004|83170196|FG000|Overall Study|Did not meet eligibility criteria|2|||
47058115|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
47058116|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
46824929|NCT00427934|83043735|FG000|Overall Study|Other|0|||
46824930|NCT00427934|83043736|FG001|Overall Study|Other|0|||
46824931|NCT00427934|83043737|FG002|Overall Study|Other|11|||
46824932|NCT00427934|83043738|FG003|Overall Study|Other|5|||
46934279|NCT02724644|83170203|FG000|Overall Study|Adverse Event|7|||
47058117|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
46824933|NCT00427934|83043735|FG000|Overall Study|Withdrawal by Subject|0|||
46824934|NCT00427934|83043736|FG001|Overall Study|Withdrawal by Subject|0|||
46824935|NCT00427934|83043737|FG002|Overall Study|Withdrawal by Subject|1|||
46824936|NCT00427934|83043738|FG003|Overall Study|Withdrawal by Subject|3|||
46824937|NCT00435188|83043752|FG000|Overall Study|Death|1|||
46934280|NCT02724644|83170204|FG001|Overall Study|Adverse Event|1|||
46934281|NCT02724644|83170203|FG000|Overall Study|Lost to Follow-up|6|||
46934282|NCT02724644|83170204|FG001|Overall Study|Lost to Follow-up|2|||
47058118|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
47058119|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
47058120|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
47058121|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
47058122|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
47058123|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
46637098|NCT02840799|82810963|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
46637099|NCT02840799|82810964|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
46637100|NCT02400255|82810990|FG000|Overall Study|Relapse|4|||
46637101|NCT02400255|82810991|FG001|Overall Study|Relapse|1|||
46762128|NCT03580369|82980174|FG004|Overall Study|No treatment due to mis-randomization|3|||
46762129|NCT03580369|82980175|FG005|Overall Study|No treatment due to mis-randomization|0|||
46762130|NCT03580369|82980176|FG006|Overall Study|No treatment due to mis-randomization|0|||
46762131|NCT03580369|82980177|FG007|Overall Study|No treatment due to mis-randomization|0|||
46762132|NCT03580369|82980170|FG000|Overall Study|Reason unknown|0|||
46762133|NCT03580369|82980171|FG001|Overall Study|Reason unknown|0|||
46762134|NCT03580369|82980172|FG002|Overall Study|Reason unknown|1|||
46762135|NCT03580369|82980173|FG003|Overall Study|Reason unknown|0|||
46762136|NCT03580369|82980174|FG004|Overall Study|Reason unknown|0|||
46762137|NCT03580369|82980175|FG005|Overall Study|Reason unknown|0|||
46762138|NCT03580369|82980176|FG006|Overall Study|Reason unknown|0|||
46762139|NCT03580369|82980177|FG007|Overall Study|Reason unknown|0|||
46762140|NCT03580369|82980170|FG000|Overall Study|Technical problems|0|||
46762141|NCT03580369|82980171|FG001|Overall Study|Technical problems|0|||
46762142|NCT03580369|82980172|FG002|Overall Study|Technical problems|0|||
46934283|NCT02724644|83170203|FG000|Overall Study|Withdrawal by Subject|7|||
46934284|NCT02724644|83170204|FG001|Overall Study|Withdrawal by Subject|1|||
46637102|NCT02400255|82810992|FG002|Overall Study|Relapse|1|||
46637103|NCT02400255|82810993|FG003|Overall Study|Relapse|2|||
46762143|NCT03580369|82980173|FG003|Overall Study|Technical problems|0|||
46934285|NCT02724644|83170203|FG000|Overall Study|Administrative|1|||
46934286|NCT02724644|83170204|FG001|Overall Study|Administrative|0|||
47058124|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
46637104|NCT02400255|82810990|FG000|Overall Study|Adverse Event|6|||
46762144|NCT03580369|82980174|FG004|Overall Study|Technical problems|1|||
46637105|NCT02400255|82810991|FG001|Overall Study|Adverse Event|3|||
46824938|NCT00435188|83043753|FG001|Overall Study|Death|6|||
46824939|NCT00435188|83043752|FG000|Overall Study|Withdrawal by Subject|16|||
46824940|NCT00435188|83043753|FG001|Overall Study|Withdrawal by Subject|11|||
46934287|NCT02725268|83170214|FG000|Overall Study|Death|58|||
46637106|NCT02400255|82810992|FG002|Overall Study|Adverse Event|0|||
46637107|NCT02400255|82810993|FG003|Overall Study|Adverse Event|0|||
46637108|NCT02400255|82810990|FG000|Overall Study|Physician Decision|6|||
46637109|NCT02400255|82810991|FG001|Overall Study|Physician Decision|0|||
46637110|NCT02400255|82810992|FG002|Overall Study|Physician Decision|0|||
46637111|NCT02400255|82810993|FG003|Overall Study|Physician Decision|0|||
46637112|NCT02400255|82810990|FG000|Overall Study|Loss of insurance|1|||
46637113|NCT02400255|82810991|FG001|Overall Study|Loss of insurance|0|||
46637114|NCT02400255|82810992|FG002|Overall Study|Loss of insurance|0|||
46637115|NCT02400255|82810993|FG003|Overall Study|Loss of insurance|0|||
46637116|NCT01868438|82811001|FG000|First Intervention|Withdrawal by Subject|5|||
46637117|NCT01868438|82811002|FG001|First Intervention|Withdrawal by Subject|1|||
46637118|NCT01868438|82811001|FG000|First Intervention|Lost to Follow-up|2|||
46637119|NCT01868438|82811002|FG001|First Intervention|Lost to Follow-up|3|||
46762145|NCT03580369|82980175|FG005|Overall Study|Technical problems|0|||
46762146|NCT03580369|82980176|FG006|Overall Study|Technical problems|2|||
46762147|NCT03580369|82980177|FG007|Overall Study|Technical problems|0|||
46762148|NCT03580369|82980170|FG000|Overall Study|Pregnancy|2|||
46762149|NCT03580369|82980171|FG001|Overall Study|Pregnancy|0|||
46762150|NCT03580369|82980172|FG002|Overall Study|Pregnancy|3|||
46762151|NCT03580369|82980173|FG003|Overall Study|Pregnancy|0|||
46762152|NCT03580369|82980174|FG004|Overall Study|Pregnancy|2|||
46762153|NCT03580369|82980175|FG005|Overall Study|Pregnancy|0|||
46762154|NCT03580369|82980176|FG006|Overall Study|Pregnancy|0|||
46762155|NCT03580369|82980177|FG007|Overall Study|Pregnancy|0|||
46762156|NCT03580369|82980170|FG000|Overall Study|Lost to Follow-up|2|||
46762157|NCT03580369|82980171|FG001|Overall Study|Lost to Follow-up|0|||
46762158|NCT03580369|82980172|FG002|Overall Study|Lost to Follow-up|2|||
46762159|NCT03580369|82980173|FG003|Overall Study|Lost to Follow-up|0|||
46762160|NCT03580369|82980174|FG004|Overall Study|Lost to Follow-up|3|||
46762161|NCT03580369|82980175|FG005|Overall Study|Lost to Follow-up|0|||
46762162|NCT03580369|82980176|FG006|Overall Study|Lost to Follow-up|1|||
46762163|NCT03580369|82980177|FG007|Overall Study|Lost to Follow-up|0|||
46762164|NCT03580369|82980170|FG000|Overall Study|Physician Decision|4|||
46762165|NCT03580369|82980171|FG001|Overall Study|Physician Decision|0|||
46762166|NCT03580369|82980172|FG002|Overall Study|Physician Decision|4|||
46762167|NCT03580369|82980173|FG003|Overall Study|Physician Decision|1|||
46934288|NCT02725268|83170215|FG001|Overall Study|Death|59|||
46934289|NCT02725268|83170216|FG002|Overall Study|Death|30|||
46934290|NCT02725268|83170217|FG003|Overall Study|Death|16|||
46934291|NCT02725268|83170214|FG000|Overall Study|Lost to Follow-up|4|||
46934292|NCT02725268|83170215|FG001|Overall Study|Lost to Follow-up|3|||
46934293|NCT02725268|83170216|FG002|Overall Study|Lost to Follow-up|0|||
46934294|NCT02725268|83170217|FG003|Overall Study|Lost to Follow-up|1|||
46934295|NCT02725268|83170214|FG000|Overall Study|Site Terminated by Sponsor|0|||
46934296|NCT02725268|83170215|FG001|Overall Study|Site Terminated by Sponsor|1|||
46934297|NCT02725268|83170216|FG002|Overall Study|Site Terminated by Sponsor|0|||
46934298|NCT02725268|83170217|FG003|Overall Study|Site Terminated by Sponsor|0|||
46934299|NCT02725268|83170214|FG000|Overall Study|Withdrawal by Subject|8|||
46934300|NCT02725268|83170215|FG001|Overall Study|Withdrawal by Subject|6|||
46934301|NCT02725268|83170216|FG002|Overall Study|Withdrawal by Subject|8|||
46934302|NCT02725268|83170217|FG003|Overall Study|Withdrawal by Subject|1|||
46934303|NCT02725268|83170214|FG000|Overall Study|Reason not Specified|2|||
46934304|NCT02725268|83170215|FG001|Overall Study|Reason not Specified|1|||
46934305|NCT02725268|83170216|FG002|Overall Study|Reason not Specified|0|||
46934306|NCT02725268|83170217|FG003|Overall Study|Reason not Specified|0|||
46934307|NCT02724956|83170229|FG000|Overall Study|Physician Decision|1|||
47058125|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
47058126|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
47058127|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
46637120|NCT01868438|82811001|FG000|First Intervention|Meeting the non-redosing criteria|0|||
46637121|NCT01868438|82811002|FG001|First Intervention|Meeting the non-redosing criteria|1|||
46637122|NCT01868438|82811001|FG000|Second Intervention|Adverse Event|3|||
46637123|NCT01868438|82811002|FG001|Second Intervention|Adverse Event|3|||
46637124|NCT01208662|82811011|FG000|Induction and Consolidation|Disease Progression|23|||
46637125|NCT01208662|82811012|FG001|Induction and Consolidation|Disease Progression|13|||
46637126|NCT01208662|82811013|FG002|Induction and Consolidation|Disease Progression|0|||
46762168|NCT03580369|82980174|FG004|Overall Study|Physician Decision|1|||
46762169|NCT03580369|82980175|FG005|Overall Study|Physician Decision|0|||
46934308|NCT02724956|83170230|FG001|Overall Study|Physician Decision|0|||
47058128|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
47058129|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
46762170|NCT03580369|82980176|FG006|Overall Study|Physician Decision|0|||
46762171|NCT03580369|82980177|FG007|Overall Study|Physician Decision|0|||
46762172|NCT03580369|82980170|FG000|Overall Study|Lack of Efficacy|3|||
46762173|NCT03580369|82980171|FG001|Overall Study|Lack of Efficacy|0|||
46762174|NCT03580369|82980172|FG002|Overall Study|Lack of Efficacy|7|||
46934309|NCT02724956|83170229|FG000|Overall Study|Lack of Efficacy|0|||
46934310|NCT02724956|83170230|FG001|Overall Study|Lack of Efficacy|1|||
46934311|NCT02724956|83170229|FG000|Overall Study|Withdrawal by Subject|0|||
46934312|NCT02724956|83170230|FG001|Overall Study|Withdrawal by Subject|1|||
46934313|NCT00705536|83170238|FG000|Start Period 1|Withdrawal by Subject|0|||
46934314|NCT00705536|83170239|FG001|Start Period 1|Withdrawal by Subject|0|||
46934315|NCT00705536|83170240|FG002|Start Period 1|Withdrawal by Subject|0|||
46934316|NCT00705536|83170241|FG003|Start Period 1|Withdrawal by Subject|1|||
46934317|NCT02724020|83170263|FG000|Overall Study|Death|16|||
46934318|NCT02724020|83170264|FG001|Overall Study|Death|18|||
46934319|NCT02724020|83170265|FG002|Overall Study|Death|19|||
46934320|NCT02724020|83170263|FG000|Overall Study|Lost to Follow-up|0|||
46934321|NCT02724020|83170264|FG001|Overall Study|Lost to Follow-up|3|||
46934322|NCT02724020|83170265|FG002|Overall Study|Lost to Follow-up|0|||
46934323|NCT02724020|83170263|FG000|Overall Study|Site Terminated by Sponsor|15|||
46934324|NCT02724020|83170264|FG001|Overall Study|Site Terminated by Sponsor|8|||
46934325|NCT02724020|83170265|FG002|Overall Study|Site Terminated by Sponsor|8|||
46934326|NCT02724020|83170263|FG000|Overall Study|Withdrawal by Subject|1|||
46934327|NCT02724020|83170264|FG001|Overall Study|Withdrawal by Subject|3|||
46934328|NCT02724020|83170265|FG002|Overall Study|Withdrawal by Subject|5|||
46934329|NCT02660034|83170287|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
46934330|NCT02660034|83170288|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
46934331|NCT02660034|83170289|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
46934332|NCT02660034|83170290|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
46934333|NCT02660034|83170291|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
46934334|NCT02660034|83170292|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
46934335|NCT02660034|83170293|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
46934336|NCT02660034|83170294|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
46934337|NCT02660034|83170295|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
46934338|NCT02660034|83170296|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
47058130|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
46762175|NCT03580369|82980173|FG003|Overall Study|Lack of Efficacy|0|||
46762176|NCT03580369|82980174|FG004|Overall Study|Lack of Efficacy|2|||
46824941|NCT00435188|83043752|FG000|Overall Study|Lost to Follow-up|5|||
46824942|NCT00435188|83043753|FG001|Overall Study|Lost to Follow-up|6|||
46824943|NCT00427778|83043761|FG000|First Intervention (4 Weeks)|no longer interested|1|||
46824944|NCT00427778|83043762|FG001|First Intervention (4 Weeks)|no longer interested|0|||
46824945|NCT00427778|83043761|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
46824946|NCT00427778|83043762|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
46824947|NCT00427778|83043761|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
46824948|NCT00427778|83043762|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
46824949|NCT00427778|83043761|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
46824950|NCT00427778|83043762|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
46824951|NCT00427700|83043783|FG000|Overall Study|Lost to Follow-up|2|||
46824952|NCT00427700|83043784|FG001|Overall Study|Lost to Follow-up|5|||
46824953|NCT00427700|83043783|FG000|Overall Study|no induction of menses|1|||
46824954|NCT00427700|83043784|FG001|Overall Study|no induction of menses|4|||
47058131|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
47058132|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
47058133|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
46762177|NCT03580369|82980175|FG005|Overall Study|Lack of Efficacy|0|||
46762178|NCT03580369|82980176|FG006|Overall Study|Lack of Efficacy|3|||
46762179|NCT03580369|82980177|FG007|Overall Study|Lack of Efficacy|0|||
46762180|NCT03580369|82980170|FG000|Overall Study|Protocol Violation|6|||
46762181|NCT03580369|82980171|FG001|Overall Study|Protocol Violation|0|||
46762182|NCT03580369|82980172|FG002|Overall Study|Protocol Violation|6|||
46762183|NCT03580369|82980173|FG003|Overall Study|Protocol Violation|1|||
46824955|NCT00427700|83043783|FG000|Overall Study|Pregnancy|0|||
46824956|NCT00427700|83043784|FG001|Overall Study|Pregnancy|2|||
47058134|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
47058135|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
47058136|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
46934339|NCT02660034|83170297|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
46934340|NCT02660034|83170298|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
46934341|NCT02660034|83170299|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
46934342|NCT02660034|83170300|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
46934343|NCT02660034|83170287|FG000|Overall Study|Progressive Disease (Clinical)|7|||
46762184|NCT03580369|82980174|FG004|Overall Study|Protocol Violation|8|||
46762185|NCT03580369|82980175|FG005|Overall Study|Protocol Violation|2|||
46824957|NCT00409188|83043793|FG000|Overall Study|Ongoing at data cut-off|383|||
46824958|NCT00409188|83043794|FG001|Overall Study|Ongoing at data cut-off|175|||
46824959|NCT00434954|83043802|FG000|Overall Study|Adverse Event|17|||
46824960|NCT00434954|83043803|FG001|Overall Study|Adverse Event|2|||
46824961|NCT00434954|83043802|FG000|Overall Study|Entry criteria not met|14|||
46824962|NCT00434954|83043803|FG001|Overall Study|Entry criteria not met|16|||
46824963|NCT00434954|83043802|FG000|Overall Study|Lost to Follow-up|0|||
46824964|NCT00434954|83043803|FG001|Overall Study|Lost to Follow-up|1|||
46824965|NCT00434954|83043802|FG000|Overall Study|Physician Decision|6|||
46824966|NCT00434954|83043803|FG001|Overall Study|Physician Decision|3|||
46824967|NCT00434954|83043802|FG000|Overall Study|Protocol Violation|36|||
46824968|NCT00434954|83043803|FG001|Overall Study|Protocol Violation|27|||
46824969|NCT00434954|83043802|FG000|Overall Study|Sponsor decision|1|||
46824970|NCT00434954|83043803|FG001|Overall Study|Sponsor decision|0|||
46824971|NCT00434954|83043802|FG000|Overall Study|Subject decision|8|||
46824972|NCT00434954|83043803|FG001|Overall Study|Subject decision|22|||
46824973|NCT00276484|83043811|FG000|Overall Study|Adverse Event|4|||
46824974|NCT00276484|83043812|FG001|Overall Study|Adverse Event|7|||
46824975|NCT00276484|83043811|FG000|Overall Study|Lost to Follow-up|1|||
46824976|NCT00276484|83043812|FG001|Overall Study|Lost to Follow-up|1|||
46824977|NCT00276484|83043811|FG000|Overall Study|Protocol Violation|0|||
46824978|NCT00276484|83043812|FG001|Overall Study|Protocol Violation|1|||
46824979|NCT00276484|83043811|FG000|Overall Study|Withdrawal by Subject|4|||
46824980|NCT00276484|83043812|FG001|Overall Study|Withdrawal by Subject|3|||
46824981|NCT00276484|83043811|FG000|Overall Study|Could not take time off work|0|||
46824982|NCT00276484|83043812|FG001|Overall Study|Could not take time off work|1|||
46824983|NCT00426842|83043818|FG000|Overall Study|Lost to Follow-up|1|||
46824984|NCT00434876|83043826|FG000|Overall Study|Lost to Follow-up|1|||
46824985|NCT00434876|83043827|FG001|Overall Study|Lost to Follow-up|1|||
46934344|NCT02660034|83170288|FG001|Overall Study|Progressive Disease (Clinical)|8|||
46934345|NCT02660034|83170289|FG002|Overall Study|Progressive Disease (Clinical)|3|||
46934346|NCT02660034|83170290|FG003|Overall Study|Progressive Disease (Clinical)|9|||
47058137|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
46637127|NCT01208662|82811011|FG000|Induction and Consolidation|Adverse Event|16|||
46637128|NCT01208662|82811012|FG001|Induction and Consolidation|Adverse Event|18|||
46637129|NCT01208662|82811013|FG002|Induction and Consolidation|Adverse Event|2|||
46762186|NCT03580369|82980176|FG006|Overall Study|Protocol Violation|1|||
46762187|NCT03580369|82980177|FG007|Overall Study|Protocol Violation|0|||
46762188|NCT03580369|82980170|FG000|Overall Study|Adverse Event|7|||
46762189|NCT03580369|82980171|FG001|Overall Study|Adverse Event|0|||
46762190|NCT03580369|82980172|FG002|Overall Study|Adverse Event|14|||
46762191|NCT03580369|82980173|FG003|Overall Study|Adverse Event|1|||
46762192|NCT03580369|82980174|FG004|Overall Study|Adverse Event|6|||
46762193|NCT03580369|82980175|FG005|Overall Study|Adverse Event|0|||
46762194|NCT03580369|82980176|FG006|Overall Study|Adverse Event|1|||
46762195|NCT03580369|82980177|FG007|Overall Study|Adverse Event|0|||
46762196|NCT03580369|82980170|FG000|Overall Study|Withdrawal by Subject|19|||
46762197|NCT03580369|82980171|FG001|Overall Study|Withdrawal by Subject|0|||
46762198|NCT03580369|82980172|FG002|Overall Study|Withdrawal by Subject|17|||
46762199|NCT03580369|82980173|FG003|Overall Study|Withdrawal by Subject|0|||
46762200|NCT03580369|82980174|FG004|Overall Study|Withdrawal by Subject|16|||
46762201|NCT03580369|82980175|FG005|Overall Study|Withdrawal by Subject|1|||
46762202|NCT03580369|82980176|FG006|Overall Study|Withdrawal by Subject|7|||
46762203|NCT03580369|82980177|FG007|Overall Study|Withdrawal by Subject|0|||
46762204|NCT03215810|82980214|FG000|Overall Study|Still responding to nivolumab|1|||
46762205|NCT03215810|82980214|FG000|Overall Study|Insufficient TIL growth|1|||
46762206|NCT03215810|82980214|FG000|Overall Study|Decline in performance status|1|||
46762207|NCT03215810|82980214|FG000|Overall Study|Withdrawal by Subject|1|||
46762208|NCT02634710|82980249|FG000|Overall Study|Death|4|||
46762209|NCT02540993|82980264|FG000|Overall Study|Lost to Follow-up|5|||
46762210|NCT02540993|82980265|FG001|Overall Study|Lost to Follow-up|3|||
46762211|NCT02540993|82980264|FG000|Overall Study|Withdrawal by Subject|4|||
46824986|NCT00276094|83043836|FG000|Overall Study|Adverse Event|15|||
46824987|NCT00276094|83043837|FG001|Overall Study|Adverse Event|13|||
46824988|NCT00276094|83043838|FG002|Overall Study|Adverse Event|11|||
46762212|NCT02540993|82980265|FG001|Overall Study|Withdrawal by Subject|6|||
46824989|NCT00276094|83043836|FG000|Overall Study|Withdrawal by Subject|14|||
46824990|NCT00276094|83043837|FG001|Overall Study|Withdrawal by Subject|14|||
46824991|NCT00276094|83043838|FG002|Overall Study|Withdrawal by Subject|12|||
46824992|NCT00276094|83043836|FG000|Overall Study|Protocol Violation|16|||
46824993|NCT00276094|83043837|FG001|Overall Study|Protocol Violation|7|||
46824994|NCT00276094|83043838|FG002|Overall Study|Protocol Violation|10|||
46824995|NCT00276094|83043836|FG000|Overall Study|Lost to Follow-up|8|||
47058138|NCT01697579|83336394|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
46762213|NCT02540993|82980264|FG000|Overall Study|GCP violations|33|||
46762214|NCT02540993|82980265|FG001|Overall Study|GCP violations|27|||
46762215|NCT02449239|82980300|FG000|Induction Phase|Lack of Efficacy|64|||
46762216|NCT02449239|82980300|FG000|Induction Phase|Adverse Event|1|||
46762217|NCT02449239|82980300|FG000|Induction Phase|Lost to Follow-up|1|||
46762218|NCT02449239|82980300|FG000|Induction Phase|Protocol Violation|1|||
46824996|NCT00276094|83043837|FG001|Overall Study|Lost to Follow-up|6|||
46824997|NCT00276094|83043838|FG002|Overall Study|Lost to Follow-up|4|||
46637130|NCT01208662|82811011|FG000|Induction and Consolidation|MD or Participant Decision|16|||
46637131|NCT01208662|82811012|FG001|Induction and Consolidation|MD or Participant Decision|34|||
46637132|NCT01208662|82811013|FG002|Induction and Consolidation|MD or Participant Decision|4|||
46637133|NCT01208662|82811011|FG000|Induction and Consolidation|Death|1|||
46637134|NCT01208662|82811012|FG001|Induction and Consolidation|Death|3|||
46637135|NCT01208662|82811013|FG002|Induction and Consolidation|Death|1|||
46637136|NCT01208662|82811011|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
46637137|NCT01208662|82811012|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
46637138|NCT01208662|82811013|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
46637139|NCT01208662|82811011|FG000|Maintenance|Disease Progression|156|||
46637140|NCT01208662|82811012|FG001|Maintenance|Disease Progression|102|||
46637141|NCT01208662|82811013|FG002|Maintenance|Disease Progression|0|||
46637142|NCT01208662|82811011|FG000|Maintenance|Adverse Event|12|||
46637143|NCT01208662|82811012|FG001|Maintenance|Adverse Event|28|||
46637144|NCT01208662|82811013|FG002|Maintenance|Adverse Event|0|||
46637145|NCT01208662|82811011|FG000|Maintenance|MD or Participant Decision|24|||
46637146|NCT01208662|82811012|FG001|Maintenance|MD or Participant Decision|36|||
46637147|NCT01208662|82811013|FG002|Maintenance|MD or Participant Decision|0|||
46637148|NCT01208662|82811011|FG000|Maintenance|Death|0|||
46637149|NCT01208662|82811012|FG001|Maintenance|Death|3|||
46637150|NCT01208662|82811013|FG002|Maintenance|Death|0|||
46637151|NCT01208662|82811011|FG000|Maintenance|Discontinued for other reasons|21|||
46637152|NCT01208662|82811012|FG001|Maintenance|Discontinued for other reasons|31|||
46637153|NCT01208662|82811013|FG002|Maintenance|Discontinued for other reasons|0|||
46637154|NCT01208662|82811011|FG000|Maintenance|Still on Treatment|78|||
46637155|NCT01208662|82811012|FG001|Maintenance|Still on Treatment|89|||
46637156|NCT01208662|82811013|FG002|Maintenance|Still on Treatment|0|||
46637157|NCT01457352|82811022|FG000|Period 1|Adverse Event|2|||
46637158|NCT01457352|82811023|FG001|Period 1|Adverse Event|0|||
46637159|NCT01457352|82811022|FG000|Period 1|Withdrawal by Subject|2|||
46637160|NCT01457352|82811023|FG001|Period 1|Withdrawal by Subject|0|||
46637161|NCT01457352|82811022|FG000|Period 1|Physician Decision|2|||
46637162|NCT01457352|82811023|FG001|Period 1|Physician Decision|0|||
46637163|NCT01457352|82811022|FG000|Period 1|MS related disease progression|1|||
46637164|NCT01457352|82811023|FG001|Period 1|MS related disease progression|0|||
46637165|NCT01457352|82811022|FG000|Period 1|Withdrawn|1|||
46637166|NCT01457352|82811023|FG001|Period 1|Withdrawn|0|||
46637167|NCT01457352|82811022|FG000|Period 1|withdrew per sponsor|1|||
46637168|NCT01457352|82811023|FG001|Period 1|withdrew per sponsor|0|||
46637169|NCT01457352|82811022|FG000|Period 1|Protocol Violation|4|||
46637170|NCT01457352|82811023|FG001|Period 1|Protocol Violation|0|||
46637171|NCT01457352|82811022|FG000|Period 1|Did not meet eligibility criteria|3|||
46637172|NCT01457352|82811023|FG001|Period 1|Did not meet eligibility criteria|0|||
46637173|NCT01457352|82811022|FG000|Period 2|Withdrawal by Subject|23|||
46637174|NCT01457352|82811023|FG001|Period 2|Withdrawal by Subject|0|||
46637175|NCT01457352|82811022|FG000|Period 2|Adverse Event|22|||
46637176|NCT01457352|82811023|FG001|Period 2|Adverse Event|0|||
46637177|NCT01457352|82811022|FG000|Period 2|no analysis|10|||
46637178|NCT01457352|82811023|FG001|Period 2|no analysis|0|||
46637179|NCT01457352|82811022|FG000|Period 2|Lack of Efficacy|8|||
46637180|NCT01457352|82811023|FG001|Period 2|Lack of Efficacy|0|||
46637181|NCT01457352|82811022|FG000|Period 2|Protocol Violation|4|||
46762219|NCT02449239|82980300|FG000|Induction Phase|Physician Decision|1|||
46637182|NCT01457352|82811023|FG001|Period 2|Protocol Violation|0|||
46762220|NCT02449239|82980300|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
46824998|NCT00276094|83043836|FG000|Overall Study|Other-Subject moved out of country|1|||
47058139|NCT01697579|83336395|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
47058140|NCT01697579|83336396|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
47058141|NCT01697579|83336397|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
47058142|NCT01697579|83336398|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
47058143|NCT01697579|83336399|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
47058144|NCT01697579|83336400|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
47058145|NCT01586195|83336428|FG000|Overall Study|Death|11|||
47058146|NCT01586195|83336428|FG000|Overall Study|Withdrawal of Consent|5|||
47058147|NCT01586195|83336428|FG000|Overall Study|Started new anti-melanoma therapy|1|||
47058148|NCT01586195|83336428|FG000|Overall Study|Reason not specified|9|||
47058149|NCT01585961|83336432|FG000|Overall Study|Death|6|||
47058150|NCT01585961|83336432|FG000|Overall Study|Physician Decision|1|||
47058151|NCT01585961|83336432|FG000|Overall Study|Decision to use non-study catheter|1|||
47058152|NCT01585961|83336432|FG000|Overall Study|Withdrawal by Subject|1|||
46637183|NCT01457352|82811022|FG000|Period 2|Sponsor's withdrawal|7|||
46637184|NCT01457352|82811023|FG001|Period 2|Sponsor's withdrawal|0|||
46637185|NCT01457352|82811022|FG000|Period 2|Lost to Follow-up|1|||
46637186|NCT01457352|82811023|FG001|Period 2|Lost to Follow-up|0|||
46637187|NCT01457352|82811022|FG000|Period 2|dose change|1|||
46637188|NCT01457352|82811023|FG001|Period 2|dose change|0|||
46637189|NCT01457352|82811022|FG000|Period 2|Physician Decision|1|||
46637190|NCT01457352|82811023|FG001|Period 2|Physician Decision|0|||
46824999|NCT00276094|83043837|FG001|Overall Study|Other-Subject moved out of country|0|||
46825000|NCT00276094|83043838|FG002|Overall Study|Other-Subject moved out of country|0|||
46825001|NCT00276094|83043836|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
46825002|NCT00276094|83043837|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
46825003|NCT00276094|83043838|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
46825004|NCT00276094|83043836|FG000|Overall Study|Other-Lack of efficacy|1|||
46825005|NCT00276094|83043837|FG001|Overall Study|Other-Lack of efficacy|0|||
46825006|NCT00276094|83043838|FG002|Overall Study|Other-Lack of efficacy|0|||
46825007|NCT00276094|83043836|FG000|Overall Study|Other-Refused follow-up visit|1|||
46825008|NCT00276094|83043837|FG001|Overall Study|Other-Refused follow-up visit|0|||
46825009|NCT00276094|83043838|FG002|Overall Study|Other-Refused follow-up visit|0|||
46825010|NCT00276094|83043836|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
46825011|NCT00276094|83043837|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
46637191|NCT01457352|82811022|FG000|Period 2|Did not meet eligibility criteria|3|||
46637192|NCT01457352|82811023|FG001|Period 2|Did not meet eligibility criteria|0|||
46637193|NCT01457352|82811022|FG000|Period 3|Adverse Event|1|||
46637194|NCT01457352|82811023|FG001|Period 3|Adverse Event|1|||
46825012|NCT00276094|83043838|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
46825013|NCT00276094|83043836|FG000|Overall Study|Other-Relocation|0|||
46825014|NCT00276094|83043837|FG001|Overall Study|Other-Relocation|1|||
46825015|NCT00276094|83043838|FG002|Overall Study|Other-Relocation|0|||
46825016|NCT00276094|83043836|FG000|Overall Study|Other-Study medication lost|0|||
46637195|NCT01457352|82811022|FG000|Period 3|Withdrawal by Subject|0|||
46637196|NCT01457352|82811023|FG001|Period 3|Withdrawal by Subject|2|||
46637197|NCT01457352|82811022|FG000|Period 3|incorrect treatment|0|||
46637198|NCT01457352|82811023|FG001|Period 3|incorrect treatment|1|||
46825017|NCT00276094|83043837|FG001|Overall Study|Other-Study medication lost|0|||
46825018|NCT00276094|83043838|FG002|Overall Study|Other-Study medication lost|1|||
46637199|NCT01457352|82811022|FG000|Period 3|Sponsor's withdrawal|0|||
46637200|NCT01457352|82811023|FG001|Period 3|Sponsor's withdrawal|1|||
46762221|NCT02449239|82980300|FG000|Induction Phase|Withdrawal by Subject|1|||
46762222|NCT02449239|82980300|FG000|Maintenance Month 3|Lack of Efficacy|14|||
46762223|NCT02449239|82980300|FG000|Maintenance Month 6|Lack of Efficacy|10|||
46762224|NCT02449239|82980300|FG000|Maintenance Month 6|Adverse Event|2|||
46762225|NCT02449239|82980300|FG000|Maintenance Month 6|Physician Decision|1|||
46825019|NCT00276016|83043852|FG000|Intervention 1|Withdrawal by Subject|0|||
46825020|NCT00276016|83043853|FG001|Intervention 1|Withdrawal by Subject|1|||
46762226|NCT02449239|82980300|FG000|Maintenance Month 9|Lack of Efficacy|2|||
46762227|NCT02449239|82980300|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
46762228|NCT02449239|82980300|FG000|Maintenance Month 12|Lack of Efficacy|5|||
46762229|NCT02449239|82980300|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
46762230|NCT02449239|82980300|FG000|Maintenance Month 12|Subject moved from area|1|||
46762231|NCT02449239|82980300|FG000|Maintenance Month 15|Lack of Efficacy|1|||
46762232|NCT02449239|82980300|FG000|Maintenance Month 21|Lack of Efficacy|1|||
46762233|NCT02449239|82980300|FG000|Maintenance Month 21|Sponsor decision|1|||
46762234|NCT01292928|82980304|FG000|Overall Study|Death|8|||
46762235|NCT01292928|82980304|FG000|Overall Study|Withdrawal by Subject|8|||
46762236|NCT01292928|82980304|FG000|Overall Study|Lost to Follow-up|6|||
46762237|NCT01292928|82980304|FG000|Overall Study|Physician Decision|2|||
46762238|NCT00581828|82980323|FG000|Overall Study|Protocol Violation|1|||
46762239|NCT00220337|82980372|FG000|Overall Study|Adverse Event|70|||
46762240|NCT00220337|82980372|FG000|Overall Study|Lack of Efficacy|17|||
46762241|NCT00220337|82980372|FG000|Overall Study|Withdrawal by Subject|68|||
46762242|NCT00220337|82980372|FG000|Overall Study|Protocol Violation|2|||
46762243|NCT00220337|82980372|FG000|Overall Study|Lost to Follow-up|5|||
46762244|NCT00220337|82980372|FG000|Overall Study|Other|12|||
46825021|NCT00276016|83043854|FG002|Intervention 1|Withdrawal by Subject|0|||
46825022|NCT00276016|83043855|FG003|Intervention 1|Withdrawal by Subject|0|||
46825023|NCT00276016|83043856|FG004|Intervention 1|Withdrawal by Subject|0|||
46825024|NCT00276016|83043857|FG005|Intervention 1|Withdrawal by Subject|0|||
46825025|NCT00434642|83043868|FG000|Blinded Treatment Phase|Adverse Event|12|||
46825026|NCT00434642|83043869|FG001|Blinded Treatment Phase|Adverse Event|58|||
46825027|NCT00434642|83043868|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
46825028|NCT00434642|83043869|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
46825029|NCT00434642|83043868|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
46825030|NCT00434642|83043869|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
46762245|NCT00220337|82980372|FG000|Overall Study|Unsatisfactory compliance|5|||
46762246|NCT00576316|82980376|FG000|Overall Study|Adverse Event|9|||
46762247|NCT00576316|82980376|FG000|Overall Study|Withdrawal by Subject|2|||
46762248|NCT00576316|82980376|FG000|Overall Study|Protocol Violation|9|||
46825031|NCT00434642|83043868|FG000|Blinded Treatment Phase|Physician Decision|19|||
46825032|NCT00434642|83043869|FG001|Blinded Treatment Phase|Physician Decision|27|||
46637201|NCT01457118|82811037|FG000|Overall Study|Adverse Event|1|||
46762249|NCT00823134|82980380|FG000|Overall Study|Invalid measurement|1|||
46762250|NCT00831792|82980385|FG000|Overall Study|Not Eligible|3|||
46825033|NCT00434642|83043868|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
46825034|NCT00434642|83043869|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
46825035|NCT00434642|83043868|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
46825036|NCT00434642|83043869|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
46825037|NCT00434642|83043868|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
46825038|NCT00434642|83043869|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
46825039|NCT00434642|83043868|FG000|Open-label Treatment Phase|Adverse Event|0|||
46825040|NCT00434642|83043869|FG001|Open-label Treatment Phase|Adverse Event|5|||
46825041|NCT00434642|83043868|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
46825042|NCT00434642|83043869|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
46825043|NCT00434330|83043881|FG000|Overall Study|Adverse Event|0|||
46825044|NCT00434330|83043882|FG001|Overall Study|Adverse Event|0|||
46825045|NCT00434330|83043883|FG002|Overall Study|Adverse Event|1|||
46825046|NCT00434330|83043884|FG003|Overall Study|Adverse Event|0|||
46825047|NCT00434330|83043885|FG004|Overall Study|Adverse Event|0|||
46825048|NCT00434330|83043886|FG005|Overall Study|Adverse Event|0|||
46825049|NCT00434330|83043881|FG000|Overall Study|Death|1|||
46825050|NCT00434330|83043882|FG001|Overall Study|Death|0|||
46825051|NCT00434330|83043883|FG002|Overall Study|Death|0|||
46825052|NCT00434330|83043884|FG003|Overall Study|Death|0|||
46825053|NCT00434330|83043885|FG004|Overall Study|Death|1|||
46825054|NCT00434330|83043886|FG005|Overall Study|Death|1|||
46825055|NCT00434330|83043881|FG000|Overall Study|Withdrawal by Subject|0|||
46825056|NCT00434330|83043882|FG001|Overall Study|Withdrawal by Subject|0|||
46825057|NCT00434330|83043883|FG002|Overall Study|Withdrawal by Subject|1|||
46825058|NCT00434330|83043884|FG003|Overall Study|Withdrawal by Subject|1|||
47058153|NCT01585961|83336432|FG000|Overall Study|Lost to Follow-up|23|||
46637202|NCT01457118|82811038|FG001|Overall Study|Adverse Event|0|||
46637203|NCT01457118|82811039|FG002|Overall Study|Adverse Event|0|||
46637204|NCT01457118|82811040|FG003|Overall Study|Adverse Event|1|||
46637205|NCT01457118|82811037|FG000|Overall Study|Clinical Progression|0|||
46637206|NCT01457118|82811038|FG001|Overall Study|Clinical Progression|1|||
46637207|NCT01457118|82811039|FG002|Overall Study|Clinical Progression|0|||
46637208|NCT01457118|82811040|FG003|Overall Study|Clinical Progression|1|||
46637209|NCT01457118|82811037|FG000|Overall Study|Physician Decision|2|||
46637210|NCT01457118|82811038|FG001|Overall Study|Physician Decision|0|||
46637211|NCT01457118|82811039|FG002|Overall Study|Physician Decision|0|||
46637212|NCT01457118|82811040|FG003|Overall Study|Physician Decision|0|||
46637213|NCT01457118|82811037|FG000|Overall Study|Progressive Disease by RECIST|12|||
46825059|NCT00434330|83043885|FG004|Overall Study|Withdrawal by Subject|0|||
46825060|NCT00434330|83043886|FG005|Overall Study|Withdrawal by Subject|0|||
46637214|NCT01457118|82811038|FG001|Overall Study|Progressive Disease by RECIST|3|||
46762251|NCT00831792|82980385|FG000|Overall Study|Adverse Event|1|||
46762252|NCT00831792|82980385|FG000|Overall Study|Death|1|||
46762253|NCT00831792|82980385|FG000|Overall Study|Lack of Efficacy|1|||
46762254|NCT00575380|82980391|FG000|Overall Study|Withdrawal by Subject|1|||
46762255|NCT00575380|82980392|FG001|Overall Study|Withdrawal by Subject|0|||
46762256|NCT00575380|82980391|FG000|Overall Study|Adverse Event|0|||
46762257|NCT00575380|82980392|FG001|Overall Study|Adverse Event|1|||
46762258|NCT00575380|82980391|FG000|Overall Study|Various|0|||
46762259|NCT00575380|82980392|FG001|Overall Study|Various|2|||
46762260|NCT00840996|82980400|FG000|Overall Study|Withdrawal by Subject|1|||
46762261|NCT00840996|82980401|FG001|Overall Study|Withdrawal by Subject|0|||
46762262|NCT00680914|82980409|FG000|Overall Study|Consent withdrawal|6|||
46762263|NCT00680914|82980410|FG001|Overall Study|Consent withdrawal|3|||
46762264|NCT00680914|82980409|FG000|Overall Study|Lost to Follow-up|4|||
46825061|NCT00434330|83043881|FG000|Overall Study|Renal transplant|0|||
46825062|NCT00434330|83043882|FG001|Overall Study|Renal transplant|0|||
46825063|NCT00434330|83043883|FG002|Overall Study|Renal transplant|0|||
46825064|NCT00434330|83043884|FG003|Overall Study|Renal transplant|1|||
46825065|NCT00434330|83043885|FG004|Overall Study|Renal transplant|0|||
46825066|NCT00434330|83043886|FG005|Overall Study|Renal transplant|0|||
46825067|NCT00434330|83043881|FG000|Overall Study|Subject Not Compliant With Study|0|||
46825068|NCT00434330|83043882|FG001|Overall Study|Subject Not Compliant With Study|0|||
46825069|NCT00434330|83043883|FG002|Overall Study|Subject Not Compliant With Study|1|||
46825070|NCT00434330|83043884|FG003|Overall Study|Subject Not Compliant With Study|0|||
46825071|NCT00434330|83043885|FG004|Overall Study|Subject Not Compliant With Study|0|||
46825072|NCT00434330|83043886|FG005|Overall Study|Subject Not Compliant With Study|0|||
46825073|NCT00426764|83043900|FG000|Overall Study|Protocol Violation|1|||
46762265|NCT00680914|82980410|FG001|Overall Study|Lost to Follow-up|0|||
46762266|NCT00680914|82980409|FG000|Overall Study|serious adverse event (SAE)|0|||
46762267|NCT00680914|82980410|FG001|Overall Study|serious adverse event (SAE)|1|||
46825074|NCT00426764|83043900|FG000|Overall Study|Withdrawal by Subject|4|||
46762268|NCT00680836|82980418|FG000|Overall Study|Withdrawal by Subject|3|||
46762269|NCT00680836|82980419|FG001|Overall Study|Withdrawal by Subject|0|||
46762270|NCT00680836|82980418|FG000|Overall Study|Lost to Follow-up|3|||
46762271|NCT00680836|82980419|FG001|Overall Study|Lost to Follow-up|1|||
46825075|NCT00426764|83043900|FG000|Overall Study|Physician Decision|6|||
46825076|NCT00426764|83043900|FG000|Overall Study|Compassionate Use|1|||
46825077|NCT00426764|83043900|FG000|Overall Study|Progressive Disease|83|||
46825078|NCT00426764|83043900|FG000|Overall Study|Adverse Event|24|||
46825079|NCT00426764|83043900|FG000|Overall Study|Other|1|||
46825080|NCT00426764|83043900|FG000|Overall Study|Death|1|||
46825081|NCT00426764|83043900|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
46825082|NCT00434252|83043912|FG000|Overall Study|Lack of Efficacy|50|||
46825083|NCT00434252|83043913|FG001|Overall Study|Lack of Efficacy|100|||
46825084|NCT00434252|83043912|FG000|Overall Study|Adverse Event|6|||
46825085|NCT00434252|83043913|FG001|Overall Study|Adverse Event|13|||
46825086|NCT00434252|83043912|FG000|Overall Study|Death|1|||
46825087|NCT00434252|83043913|FG001|Overall Study|Death|2|||
46825088|NCT00434252|83043912|FG000|Overall Study|Lost to Follow-up|0|||
46825089|NCT00434252|83043913|FG001|Overall Study|Lost to Follow-up|1|||
46825090|NCT00434252|83043912|FG000|Overall Study|Physician Decision|4|||
46825091|NCT00434252|83043913|FG001|Overall Study|Physician Decision|8|||
46825092|NCT00434252|83043912|FG000|Overall Study|Withdrawal by Subject|3|||
46825093|NCT00434252|83043913|FG001|Overall Study|Withdrawal by Subject|7|||
46825094|NCT00425750|83043919|FG000|Overall Study|Death|1|||
46825095|NCT00425750|83043919|FG000|Overall Study|Withdrawal by Subject|3|||
46825096|NCT00425750|83043919|FG000|Overall Study|Adverse Event|3|||
46825097|NCT00425750|83043919|FG000|Overall Study|Progression of disease|18|||
46825098|NCT00414908|83043925|FG000|Overall Study|Protocol Violation|1|||
46825099|NCT00414908|83043926|FG001|Overall Study|Protocol Violation|1|||
46825100|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Adverse Event|30|||
46825101|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Adverse Event|25|||
46825102|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Adverse Event|23|||
46825103|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Adverse Event|14|||
46825104|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Death|0|||
46825105|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Death|0|||
46825106|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Death|1|||
46825107|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Death|0|||
46825108|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Physician Decision|0|||
46825109|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Physician Decision|1|||
46825110|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Physician Decision|0|||
46825111|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Physician Decision|1|||
47058154|NCT01585961|83336432|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
47058155|NCT01697501|83336436|FG000|Overall Study|Protocol Violation|2|||
47058156|NCT01697345|83336449|FG000|Overall Study|Withdrawal by Subject|1|||
47058157|NCT01697267|83336518|FG000|Overall Study|Death|3|||
47058158|NCT01697267|83336519|FG001|Overall Study|Death|1|||
47058159|NCT01697267|83336518|FG000|Overall Study|Withdrawal by Subject|5|||
47058160|NCT01697267|83336519|FG001|Overall Study|Withdrawal by Subject|5|||
47058161|NCT01697267|83336518|FG000|Overall Study|Adverse Event|2|||
47058162|NCT01697267|83336519|FG001|Overall Study|Adverse Event|1|||
47058163|NCT01697267|83336518|FG000|Overall Study|Lost to Follow-up|2|||
47058164|NCT01697267|83336519|FG001|Overall Study|Lost to Follow-up|4|||
47058165|NCT01697267|83336518|FG000|Overall Study|Physician Decision|2|||
47058166|NCT01697267|83336519|FG001|Overall Study|Physician Decision|4|||
47058167|NCT01696955|83336581|FG000|Main Study|Protocol Violation|1|||
47058168|NCT01696955|83336582|FG001|Main Study|Protocol Violation|0|||
47058169|NCT01696955|83336581|FG000|Main Study|Withdrawal by Subject|1|||
47058170|NCT01696955|83336582|FG001|Main Study|Withdrawal by Subject|1|||
47058171|NCT02702388|83336606|FG000|Overall Study|Disease Progression|18|||
47058172|NCT02702388|83336607|FG001|Overall Study|Disease Progression|25|||
47058173|NCT02702388|83336606|FG000|Overall Study|Withdrawal by Subject|9|||
47058174|NCT02702388|83336607|FG001|Overall Study|Withdrawal by Subject|7|||
46825112|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
46825113|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
46825114|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
46825115|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
46825116|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Other|6|||
47058175|NCT02702388|83336606|FG000|Overall Study|Adverse Event|11|||
47058176|NCT02702388|83336607|FG001|Overall Study|Adverse Event|15|||
47058177|NCT02702388|83336606|FG000|Overall Study|Other|2|||
47058178|NCT02702388|83336607|FG001|Overall Study|Other|4|||
47058179|NCT01696877|83336633|FG000|Overall Study|Adverse Event|0|||
46825117|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Other|1|||
46825118|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Other|0|||
46825119|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Other|2|||
47058180|NCT01696877|83336634|FG001|Overall Study|Adverse Event|1|||
47058181|NCT02703636|83336821|FG000|Overall Study|Adverse Event|14|||
46825120|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
46825121|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
46825122|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
46825123|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
47058182|NCT02703636|83336821|FG000|Overall Study|Study stopped by sponsor|1|||
46825124|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
46825125|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
46825126|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
46825127|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
46825128|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
46825129|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
46825130|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
46825131|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
46825132|NCT00242710|83043938|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
46825133|NCT00242710|83043939|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
46825134|NCT00242710|83043940|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
46825135|NCT00242710|83043941|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
46825136|NCT00242710|83043938|FG000|Period Between Core Study and Extension|Adverse Event|2|||
46825137|NCT00242710|83043939|FG001|Period Between Core Study and Extension|Adverse Event|3|||
46825138|NCT00242710|83043940|FG002|Period Between Core Study and Extension|Adverse Event|5|||
46825139|NCT00242710|83043941|FG003|Period Between Core Study and Extension|Adverse Event|2|||
46825140|NCT00242710|83043938|FG000|Period Between Core Study and Extension|Physician Decision|1|||
46825141|NCT00242710|83043939|FG001|Period Between Core Study and Extension|Physician Decision|1|||
46825142|NCT00242710|83043940|FG002|Period Between Core Study and Extension|Physician Decision|0|||
46825143|NCT00242710|83043941|FG003|Period Between Core Study and Extension|Physician Decision|0|||
46825144|NCT00242710|83043938|FG000|Period Between Core Study and Extension|Other|24|||
46825145|NCT00242710|83043939|FG001|Period Between Core Study and Extension|Other|24|||
46825146|NCT00242710|83043940|FG002|Period Between Core Study and Extension|Other|9|||
46825147|NCT00242710|83043941|FG003|Period Between Core Study and Extension|Other|11|||
46825148|NCT00242710|83043938|FG000|Period Between Core Study and Extension|Extension not Available|17|||
46825149|NCT00242710|83043939|FG001|Period Between Core Study and Extension|Extension not Available|21|||
46825150|NCT00242710|83043940|FG002|Period Between Core Study and Extension|Extension not Available|8|||
46825151|NCT00242710|83043941|FG003|Period Between Core Study and Extension|Extension not Available|7|||
46825152|NCT00242710|83043938|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
46825153|NCT00242710|83043939|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
46825154|NCT00242710|83043940|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
46825155|NCT00242710|83043941|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
46825156|NCT00242710|83043938|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
46825157|NCT00242710|83043939|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
46825158|NCT00242710|83043940|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
46825159|NCT00242710|83043941|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
46825160|NCT00242710|83043938|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
46825161|NCT00242710|83043939|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
47058183|NCT02703636|83336821|FG000|Overall Study|Withdrawal by Subject|1|||
47058184|NCT02703324|83337049|FG000|Period Two|Withdrawal by Subject|0|||
46825162|NCT00242710|83043940|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
46825163|NCT00242710|83043941|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
46825164|NCT00242710|83043938|FG000|Study Extension (up to Year 2)|Death|0|||
47058185|NCT02703324|83337050|FG001|Period Two|Withdrawal by Subject|0|||
47058186|NCT02703324|83337051|FG002|Period Two|Withdrawal by Subject|1|||
47058187|NCT02703324|83337052|FG003|Period Two|Withdrawal by Subject|0|||
47058188|NCT02703324|83337053|FG004|Period Two|Withdrawal by Subject|0|||
47058189|NCT02703324|83337054|FG005|Period Two|Withdrawal by Subject|0|||
47058190|NCT02701764|83337065|FG000|Overall Study|Lost to Follow-up|0|||
47058191|NCT02701764|83337066|FG001|Overall Study|Lost to Follow-up|1|||
47058192|NCT01696643|83337247|FG000|Overall Study|Adverse Event|15|||
47058193|NCT01696643|83337248|FG001|Overall Study|Adverse Event|7|||
47058194|NCT01696643|83337247|FG000|Overall Study|Death|1|||
47058195|NCT01696643|83337248|FG001|Overall Study|Death|2|||
47058196|NCT01696643|83337247|FG000|Overall Study|Lack of Efficacy|3|||
47058197|NCT01696643|83337248|FG001|Overall Study|Lack of Efficacy|0|||
47058198|NCT01696643|83337247|FG000|Overall Study|Lost to Follow-up|67|||
46762272|NCT00680836|82980418|FG000|Overall Study|Physician Decision|2|||
46762273|NCT00680836|82980419|FG001|Overall Study|Physician Decision|1|||
46762274|NCT00679432|82980430|FG000|Overall Study|Adverse Event|5|||
46762275|NCT00679432|82980431|FG001|Overall Study|Adverse Event|6|||
46762276|NCT00679432|82980432|FG002|Overall Study|Adverse Event|10|||
46762277|NCT00679432|82980433|FG003|Overall Study|Adverse Event|7|||
46762278|NCT00679432|82980430|FG000|Overall Study|Protocol Violation|1|||
46762279|NCT00679432|82980431|FG001|Overall Study|Protocol Violation|1|||
46762280|NCT00679432|82980432|FG002|Overall Study|Protocol Violation|2|||
46762281|NCT00679432|82980433|FG003|Overall Study|Protocol Violation|1|||
46762282|NCT00679432|82980430|FG000|Overall Study|Withdrawal by Subject|8|||
46762283|NCT00679432|82980431|FG001|Overall Study|Withdrawal by Subject|11|||
46762284|NCT00679432|82980432|FG002|Overall Study|Withdrawal by Subject|10|||
46762285|NCT00679432|82980433|FG003|Overall Study|Withdrawal by Subject|9|||
46825165|NCT00242710|83043939|FG001|Study Extension (up to Year 2)|Death|0|||
46825166|NCT00242710|83043940|FG002|Study Extension (up to Year 2)|Death|0|||
46825167|NCT00242710|83043941|FG003|Study Extension (up to Year 2)|Death|1|||
46825168|NCT00242710|83043938|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
46825169|NCT00242710|83043939|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
46934347|NCT02660034|83170291|FG004|Overall Study|Progressive Disease (Clinical)|3|||
46934348|NCT02660034|83170292|FG005|Overall Study|Progressive Disease (Clinical)|0|||
46934349|NCT02660034|83170293|FG006|Overall Study|Progressive Disease (Clinical)|0|||
46934350|NCT02660034|83170294|FG007|Overall Study|Progressive Disease (Clinical)|0|||
46934351|NCT02660034|83170295|FG008|Overall Study|Progressive Disease (Clinical)|0|||
46934352|NCT02660034|83170296|FG009|Overall Study|Progressive Disease (Clinical)|0|||
46934353|NCT02660034|83170297|FG010|Overall Study|Progressive Disease (Clinical)|0|||
46934354|NCT02660034|83170298|FG011|Overall Study|Progressive Disease (Clinical)|0|||
46934355|NCT02660034|83170299|FG012|Overall Study|Progressive Disease (Clinical)|0|||
46934356|NCT02660034|83170300|FG013|Overall Study|Progressive Disease (Clinical)|0|||
46934357|NCT02660034|83170287|FG000|Overall Study|Lost to Follow-up|0|||
46934358|NCT02660034|83170288|FG001|Overall Study|Lost to Follow-up|0|||
46934359|NCT02660034|83170289|FG002|Overall Study|Lost to Follow-up|1|||
46934360|NCT02660034|83170290|FG003|Overall Study|Lost to Follow-up|1|||
47058199|NCT01696643|83337248|FG001|Overall Study|Lost to Follow-up|67|||
46637215|NCT01457118|82811039|FG002|Overall Study|Progressive Disease by RECIST|1|||
46637216|NCT01457118|82811040|FG003|Overall Study|Progressive Disease by RECIST|0|||
46637217|NCT01457118|82811037|FG000|Overall Study|Withdrawal by Subject|5|||
46637218|NCT01457118|82811038|FG001|Overall Study|Withdrawal by Subject|0|||
46637219|NCT01457118|82811039|FG002|Overall Study|Withdrawal by Subject|0|||
46637220|NCT01457118|82811040|FG003|Overall Study|Withdrawal by Subject|0|||
46637221|NCT01456962|82811052|FG000|Overall Study|Lost to Follow-up|2|||
46762286|NCT00679432|82980430|FG000|Overall Study|Lost to Follow-up|1|||
46762287|NCT00679432|82980431|FG001|Overall Study|Lost to Follow-up|5|||
46762288|NCT00679432|82980432|FG002|Overall Study|Lost to Follow-up|4|||
46762289|NCT00679432|82980433|FG003|Overall Study|Lost to Follow-up|2|||
46762290|NCT00679432|82980430|FG000|Overall Study|Physician Decision|3|||
46762291|NCT00679432|82980431|FG001|Overall Study|Physician Decision|2|||
46762292|NCT00679432|82980432|FG002|Overall Study|Physician Decision|2|||
46762293|NCT00679432|82980433|FG003|Overall Study|Physician Decision|2|||
46762294|NCT00679432|82980430|FG000|Overall Study|Sponsor decision|1|||
46762295|NCT00679432|82980431|FG001|Overall Study|Sponsor decision|0|||
46762296|NCT00679432|82980432|FG002|Overall Study|Sponsor decision|0|||
46762297|NCT00679432|82980433|FG003|Overall Study|Sponsor decision|0|||
46762298|NCT00679432|82980430|FG000|Overall Study|Lack of Efficacy|13|||
46762299|NCT00679432|82980431|FG001|Overall Study|Lack of Efficacy|9|||
46762300|NCT00679432|82980432|FG002|Overall Study|Lack of Efficacy|14|||
46762301|NCT00679432|82980433|FG003|Overall Study|Lack of Efficacy|8|||
46762302|NCT00679432|82980430|FG000|Overall Study|Infectious colitis, normal histology|5|||
46762303|NCT00679432|82980431|FG001|Overall Study|Infectious colitis, normal histology|4|||
46762304|NCT00679432|82980432|FG002|Overall Study|Infectious colitis, normal histology|8|||
46762305|NCT00679432|82980433|FG003|Overall Study|Infectious colitis, normal histology|3|||
46762306|NCT00679432|82980430|FG000|Overall Study|Randomization error, return to prior Rx|0|||
46762307|NCT00679432|82980431|FG001|Overall Study|Randomization error, return to prior Rx|0|||
46762308|NCT00679432|82980432|FG002|Overall Study|Randomization error, return to prior Rx|3|||
46762309|NCT00679432|82980433|FG003|Overall Study|Randomization error, return to prior Rx|0|||
46762310|NCT00679354|82980443|FG000|Overall Study|Death|3|||
46762311|NCT00679354|82980443|FG000|Overall Study|Lack of Efficacy|22|||
46762312|NCT00679354|82980443|FG000|Overall Study|Physician Decision|4|||
46762313|NCT00679354|82980443|FG000|Overall Study|Ineligible|1|||
46762314|NCT00822900|82980450|FG000|Overall Study|Withdrawal by Subject|14|||
46762315|NCT00822900|82980451|FG001|Overall Study|Withdrawal by Subject|14|||
46762316|NCT00822900|82980450|FG000|Overall Study|Lost to Follow-up|9|||
46762317|NCT00822900|82980451|FG001|Overall Study|Lost to Follow-up|9|||
46762318|NCT00822900|82980450|FG000|Overall Study|Death|83|||
46762319|NCT00822900|82980451|FG001|Overall Study|Death|69|||
46762320|NCT00822900|82980450|FG000|Overall Study|Became a ward of the state|2|||
46762321|NCT00822900|82980451|FG001|Overall Study|Became a ward of the state|1|||
46637222|NCT01456962|82811053|FG001|Overall Study|Lost to Follow-up|1|||
46762322|NCT00682786|82980459|FG000|Overall Study|Withdrawal by Subject|2|||
46934361|NCT02660034|83170291|FG004|Overall Study|Lost to Follow-up|0|||
46934362|NCT02660034|83170292|FG005|Overall Study|Lost to Follow-up|0|||
46934363|NCT02660034|83170293|FG006|Overall Study|Lost to Follow-up|0|||
47058200|NCT01696643|83337247|FG000|Overall Study|Physician Decision|3|||
46762323|NCT00682786|82980460|FG001|Overall Study|Withdrawal by Subject|2|||
46762324|NCT00682786|82980459|FG000|Overall Study|Did not receive irinotecan|0|||
46762325|NCT00682786|82980460|FG001|Overall Study|Did not receive irinotecan|1|||
46762326|NCT00840450|82980472|FG000|Overall Study|Adverse Event|1|||
46934364|NCT02660034|83170294|FG007|Overall Study|Lost to Follow-up|0|||
46762327|NCT00840450|82980472|FG000|Overall Study|Lack of Efficacy|2|||
46762328|NCT00840294|82980478|FG000|Overall Study|Withdrawal by Subject|2|||
46637223|NCT01501110|82811061|FG000|Overall Study|Death|0|||
46637224|NCT01501110|82811062|FG001|Overall Study|Death|1|||
46637225|NCT01500720|82811070|FG000|Overall Study|Randomized But Not Treated|1|||
46637226|NCT01500720|82811071|FG001|Overall Study|Randomized But Not Treated|1|||
46637227|NCT01500720|82811070|FG000|Overall Study|Other|4|||
46637228|NCT01500720|82811071|FG001|Overall Study|Other|8|||
46637229|NCT01500252|82811079|FG000|Overall Study|Death|4|||
46637230|NCT01500252|82811080|FG001|Overall Study|Death|2|||
46637231|NCT01500252|82811079|FG000|Overall Study|Lost to Follow-up|5|||
46637232|NCT01500252|82811080|FG001|Overall Study|Lost to Follow-up|4|||
46637233|NCT01476696|82811087|FG000|Overall Study|Sponsor decision|2|||
46637234|NCT01476696|82811088|FG001|Overall Study|Sponsor decision|1|||
46637235|NCT01476696|82811089|FG002|Overall Study|Sponsor decision|0|||
46637236|NCT01476696|82811087|FG000|Overall Study|Withdrawal by Subject|1|||
46637237|NCT01476696|82811088|FG001|Overall Study|Withdrawal by Subject|0|||
46762329|NCT00840294|82980479|FG001|Overall Study|Withdrawal by Subject|1|||
46762330|NCT00840294|82980478|FG000|Overall Study|Protocol Violation|1|||
46762331|NCT00840294|82980479|FG001|Overall Study|Protocol Violation|3|||
46762332|NCT00840294|82980478|FG000|Overall Study|Illness|0|||
46762333|NCT00840294|82980479|FG001|Overall Study|Illness|1|||
46825170|NCT00242710|83043940|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
46825171|NCT00242710|83043941|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
46825172|NCT00242710|83043938|FG000|Study Extension (up to Year 2)|Other|3|||
46825173|NCT00242710|83043939|FG001|Study Extension (up to Year 2)|Other|5|||
46825174|NCT00242710|83043940|FG002|Study Extension (up to Year 2)|Other|4|||
46825175|NCT00242710|83043941|FG003|Study Extension (up to Year 2)|Other|3|||
46825176|NCT00242710|83043938|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
46825177|NCT00242710|83043939|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
46825178|NCT00242710|83043940|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
46825179|NCT00242710|83043941|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
46825180|NCT00242710|83043938|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
46825181|NCT00242710|83043939|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
46825182|NCT00242710|83043940|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
46637238|NCT01476696|82811089|FG002|Overall Study|Withdrawal by Subject|0|||
46762334|NCT00680368|82980485|FG000|Overall Study|not supervised, not eligible|15|||
46762335|NCT00680056|82980493|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
46762336|NCT00680056|82980494|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
46762337|NCT00680056|82980493|FG000|Second Intervention|Protocol Violation|3|||
46762338|NCT00680056|82980494|FG001|Second Intervention|Protocol Violation|1|||
46762339|NCT00680992|82980504|FG000|Overall Study|Complete Resection (as per protocol)|25|||
46762340|NCT00680992|82980505|FG001|Overall Study|Complete Resection (as per protocol)|121|||
46762341|NCT00680992|82980506|FG002|Overall Study|Complete Resection (as per protocol)|0|||
46762342|NCT00680992|82980504|FG000|Overall Study|Administrative Decision|83|||
46762343|NCT00680992|82980505|FG001|Overall Study|Administrative Decision|42|||
46762344|NCT00680992|82980506|FG002|Overall Study|Administrative Decision|5|||
46762345|NCT00680992|82980504|FG000|Overall Study|End of Trial|32|||
46762346|NCT00680992|82980505|FG001|Overall Study|End of Trial|12|||
46762347|NCT00680992|82980506|FG002|Overall Study|End of Trial|3|||
46762348|NCT00680992|82980504|FG000|Overall Study|Withdrawal by Subject|33|||
46762349|NCT00680992|82980505|FG001|Overall Study|Withdrawal by Subject|11|||
46762350|NCT00680992|82980506|FG002|Overall Study|Withdrawal by Subject|1|||
46762351|NCT00680992|82980504|FG000|Overall Study|Adverse Event|21|||
46762352|NCT00680992|82980505|FG001|Overall Study|Adverse Event|19|||
46762353|NCT00680992|82980506|FG002|Overall Study|Adverse Event|1|||
46762354|NCT00680992|82980504|FG000|Overall Study|Other|19|||
46762355|NCT00680992|82980505|FG001|Overall Study|Other|14|||
46762356|NCT00680992|82980506|FG002|Overall Study|Other|1|||
46762357|NCT00680992|82980504|FG000|Overall Study|Disease Progression|21|||
46762358|NCT00680992|82980505|FG001|Overall Study|Disease Progression|9|||
46762359|NCT00680992|82980506|FG002|Overall Study|Disease Progression|0|||
46762360|NCT00680992|82980504|FG000|Overall Study|Lost to Follow-up|12|||
46762361|NCT00680992|82980505|FG001|Overall Study|Lost to Follow-up|14|||
46825183|NCT00242710|83043941|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
46762362|NCT00680992|82980506|FG002|Overall Study|Lost to Follow-up|0|||
46825184|NCT00408876|83043955|FG000|Overall Study|Adverse Event|9|||
46637239|NCT01500096|82811106|FG000|Overall Study|Lost to Follow-up|1|||
46762363|NCT00680992|82980504|FG000|Overall Study|Noncompliance|4|||
46825185|NCT00408876|83043956|FG001|Overall Study|Adverse Event|17|||
46637240|NCT01500096|82811107|FG001|Overall Study|Lost to Follow-up|0|||
46637241|NCT01500096|82811108|FG002|Overall Study|Lost to Follow-up|0|||
46637242|NCT01500096|82811109|FG003|Overall Study|Lost to Follow-up|2|||
46637243|NCT01455012|82811121|FG000|Overall Study|Adverse Event|0|||
46762364|NCT00680992|82980505|FG001|Overall Study|Noncompliance|6|||
46762365|NCT00680992|82980506|FG002|Overall Study|Noncompliance|0|||
46762366|NCT00680992|82980504|FG000|Overall Study|Requirement for Alternative Therapy|8|||
46762367|NCT00680992|82980505|FG001|Overall Study|Requirement for Alternative Therapy|2|||
46825186|NCT00408876|83043957|FG002|Overall Study|Adverse Event|27|||
46825187|NCT00408876|83043958|FG003|Overall Study|Adverse Event|10|||
46825188|NCT00408876|83043955|FG000|Overall Study|Withdrawal by Subject|3|||
46825189|NCT00408876|83043956|FG001|Overall Study|Withdrawal by Subject|6|||
46825190|NCT00408876|83043957|FG002|Overall Study|Withdrawal by Subject|6|||
46825191|NCT00408876|83043958|FG003|Overall Study|Withdrawal by Subject|14|||
46825192|NCT00408876|83043955|FG000|Overall Study|Lack of Efficacy|2|||
46825193|NCT00408876|83043956|FG001|Overall Study|Lack of Efficacy|4|||
46825194|NCT00408876|83043957|FG002|Overall Study|Lack of Efficacy|5|||
46825195|NCT00408876|83043958|FG003|Overall Study|Lack of Efficacy|6|||
46825196|NCT00408876|83043955|FG000|Overall Study|Lost to Follow-up|1|||
46825197|NCT00408876|83043956|FG001|Overall Study|Lost to Follow-up|6|||
46825198|NCT00408876|83043957|FG002|Overall Study|Lost to Follow-up|5|||
46825199|NCT00408876|83043958|FG003|Overall Study|Lost to Follow-up|2|||
46825200|NCT00408876|83043955|FG000|Overall Study|Protocol Violation|0|||
46825201|NCT00408876|83043956|FG001|Overall Study|Protocol Violation|3|||
46825202|NCT00408876|83043957|FG002|Overall Study|Protocol Violation|4|||
46825203|NCT00408876|83043958|FG003|Overall Study|Protocol Violation|3|||
46825204|NCT00408876|83043955|FG000|Overall Study|Physician Decision|1|||
46825205|NCT00408876|83043956|FG001|Overall Study|Physician Decision|0|||
46825206|NCT00408876|83043957|FG002|Overall Study|Physician Decision|3|||
46825207|NCT00408876|83043958|FG003|Overall Study|Physician Decision|0|||
46934365|NCT02660034|83170295|FG008|Overall Study|Lost to Follow-up|0|||
46846470|NCT00131664|83063149|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
46846471|NCT00131664|83063150|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
46846472|NCT00131664|83063151|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
46846473|NCT00131664|83063152|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
46846474|NCT00131664|83063153|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
46846475|NCT00131664|83063148|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
46846476|NCT00131664|83063149|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
46846477|NCT00131664|83063150|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
46846478|NCT00131664|83063151|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
46846479|NCT00131664|83063152|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
46846480|NCT00131664|83063153|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
46934366|NCT02660034|83170296|FG009|Overall Study|Lost to Follow-up|1|||
46934367|NCT02660034|83170297|FG010|Overall Study|Lost to Follow-up|1|||
46934368|NCT02660034|83170298|FG011|Overall Study|Lost to Follow-up|1|||
46934369|NCT02660034|83170299|FG012|Overall Study|Lost to Follow-up|0|||
46934370|NCT02660034|83170300|FG013|Overall Study|Lost to Follow-up|0|||
46934371|NCT02660034|83170287|FG000|Overall Study|Participant moved into special access scheme|1|||
46934372|NCT02660034|83170288|FG001|Overall Study|Participant moved into special access scheme|2|||
46934373|NCT02660034|83170289|FG002|Overall Study|Participant moved into special access scheme|0|||
46934374|NCT02660034|83170290|FG003|Overall Study|Participant moved into special access scheme|0|||
46934375|NCT02660034|83170291|FG004|Overall Study|Participant moved into special access scheme|0|||
46934376|NCT02660034|83170292|FG005|Overall Study|Participant moved into special access scheme|0|||
46934377|NCT02660034|83170293|FG006|Overall Study|Participant moved into special access scheme|0|||
46934378|NCT02660034|83170294|FG007|Overall Study|Participant moved into special access scheme|0|||
46934379|NCT02660034|83170295|FG008|Overall Study|Participant moved into special access scheme|0|||
46934380|NCT02660034|83170296|FG009|Overall Study|Participant moved into special access scheme|0|||
47058201|NCT01696643|83337248|FG001|Overall Study|Physician Decision|2|||
47058202|NCT01696643|83337247|FG000|Overall Study|Pregnancy|0|||
46637244|NCT01455012|82811122|FG001|Overall Study|Adverse Event|2|||
46762368|NCT00680992|82980506|FG002|Overall Study|Requirement for Alternative Therapy|0|||
46762369|NCT00680992|82980504|FG000|Overall Study|Pregnancy|5|||
46762370|NCT00680992|82980505|FG001|Overall Study|Pregnancy|0|||
46762371|NCT00680992|82980506|FG002|Overall Study|Pregnancy|1|||
46762372|NCT00680992|82980504|FG000|Overall Study|Death|5|||
46762373|NCT00680992|82980505|FG001|Overall Study|Death|1|||
46762374|NCT00680992|82980506|FG002|Overall Study|Death|0|||
46762375|NCT00680992|82980504|FG000|Overall Study|Ineligibility Determined|0|||
46762376|NCT00680992|82980505|FG001|Overall Study|Ineligibility Determined|1|||
46762377|NCT00680992|82980506|FG002|Overall Study|Ineligibility Determined|0|||
46762378|NCT00805389|82980520|FG000|Overall Study|Adverse Event|0|||
46846481|NCT00131664|83063148|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
46846482|NCT00131664|83063149|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
46846483|NCT00131664|83063150|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
46846484|NCT00131664|83063151|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
46846485|NCT00131664|83063152|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
46846486|NCT00131664|83063153|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
46846487|NCT00131664|83063148|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
47058203|NCT01696643|83337248|FG001|Overall Study|Pregnancy|1|||
46762379|NCT00805389|82980521|FG001|Overall Study|Adverse Event|0|||
46762380|NCT00805389|82980522|FG002|Overall Study|Adverse Event|1|||
46825208|NCT00240994|83043968|FG000|Overall Study|Lost to Follow-up|1|||
46825209|NCT00240994|83043968|FG000|Overall Study|Protocol Violation|1|||
46825210|NCT00240994|83043968|FG000|Overall Study|Graft failure|1|||
46825211|NCT00239590|83043972|FG000|Randomized|Lost to Follow-up|0|||
46825212|NCT00239590|83043973|FG001|Randomized|Lost to Follow-up|1|||
46825213|NCT00239590|83043972|FG000|Randomized|Withdrawal by Subject|0|||
46825214|NCT00239590|83043973|FG001|Randomized|Withdrawal by Subject|1|||
46825215|NCT00239590|83043972|FG000|Completed Study Protocol|Adverse Event|1|||
46825216|NCT00239590|83043973|FG001|Completed Study Protocol|Adverse Event|1|||
46825217|NCT00239590|83043972|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
46825218|NCT00239590|83043973|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
46825219|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
46825220|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
46637245|NCT01455012|82811121|FG000|Overall Study|Lack of Efficacy|6|||
46637246|NCT01455012|82811122|FG001|Overall Study|Lack of Efficacy|1|||
46637247|NCT01455012|82811121|FG000|Overall Study|Withdrawal by Subject|3|||
46637248|NCT01455012|82811122|FG001|Overall Study|Withdrawal by Subject|1|||
46637249|NCT01455012|82811121|FG000|Overall Study|Unknown reason|2|||
46637250|NCT01455012|82811122|FG001|Overall Study|Unknown reason|0|||
46637251|NCT01454778|82811128|FG000|Overall Study|Lost to Follow-up|2|||
46637252|NCT01454778|82811128|FG000|Overall Study|Death|1|||
46637253|NCT01454076|82811137|FG000|Overall Study|Other|2|||
46637254|NCT01454076|82811138|FG001|Overall Study|Other|0|||
46637255|NCT01454076|82811139|FG002|Overall Study|Other|0|||
46637256|NCT01454076|82811140|FG003|Overall Study|Other|1|||
46637257|NCT01454076|82811141|FG004|Overall Study|Other|2|||
46637258|NCT01454076|82811137|FG000|Overall Study|Withdrawal by Subject|3|||
46637259|NCT01454076|82811138|FG001|Overall Study|Withdrawal by Subject|4|||
46637260|NCT01454076|82811139|FG002|Overall Study|Withdrawal by Subject|2|||
46637261|NCT01454076|82811140|FG003|Overall Study|Withdrawal by Subject|1|||
46637262|NCT01454076|82811141|FG004|Overall Study|Withdrawal by Subject|2|||
46637263|NCT01454076|82811137|FG000|Overall Study|Adverse Event|8|||
46637264|NCT01454076|82811138|FG001|Overall Study|Adverse Event|2|||
46637265|NCT01454076|82811139|FG002|Overall Study|Adverse Event|7|||
46637266|NCT01454076|82811140|FG003|Overall Study|Adverse Event|0|||
46825221|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Death|0|||
46825222|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Death|0|||
46825223|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
46825224|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
46637267|NCT01454076|82811141|FG004|Overall Study|Adverse Event|2|||
46637268|NCT01453998|82811165|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
46637269|NCT01453998|82811166|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
46637270|NCT01453998|82811167|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
46637271|NCT01453374|82811178|FG000|Overall Study|Adverse Event|7|||
46637272|NCT01453374|82811178|FG000|Overall Study|Lack of Efficacy|1|||
46637273|NCT01453374|82811178|FG000|Overall Study|Lost to Follow-up|3|||
46637274|NCT01453374|82811178|FG000|Overall Study|Withdrawal by Subject|5|||
46762381|NCT00805389|82980523|FG003|Overall Study|Adverse Event|2|||
46762382|NCT00805389|82980524|FG004|Overall Study|Adverse Event|0|||
46762383|NCT00805389|82980520|FG000|Overall Study|Lost to Follow-up|4|||
46762384|NCT00805389|82980521|FG001|Overall Study|Lost to Follow-up|3|||
46762385|NCT00805389|82980522|FG002|Overall Study|Lost to Follow-up|6|||
46762386|NCT00805389|82980523|FG003|Overall Study|Lost to Follow-up|10|||
46762387|NCT00805389|82980524|FG004|Overall Study|Lost to Follow-up|9|||
46762388|NCT00805389|82980520|FG000|Overall Study|Protocol Violation|0|||
46762389|NCT00805389|82980521|FG001|Overall Study|Protocol Violation|0|||
46762390|NCT00805389|82980522|FG002|Overall Study|Protocol Violation|1|||
46762391|NCT00805389|82980523|FG003|Overall Study|Protocol Violation|0|||
46762392|NCT00805389|82980524|FG004|Overall Study|Protocol Violation|0|||
46934381|NCT02660034|83170297|FG010|Overall Study|Participant moved into special access scheme|0|||
47058204|NCT01696643|83337247|FG000|Overall Study|Protocol Violation|7|||
46637275|NCT01453374|82811178|FG000|Overall Study|Incarcerated|2|||
46762393|NCT00805389|82980520|FG000|Overall Study|Withdrawal by Subject|3|||
46825225|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
46825226|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
47058205|NCT01696643|83337248|FG001|Overall Study|Protocol Violation|7|||
47058206|NCT01696643|83337247|FG000|Overall Study|Study Terminated by Sponsor|286|||
46637276|NCT01453296|82811184|FG000|Treatment Period 1|Adverse Event|0|||
46637277|NCT01453296|82811185|FG001|Treatment Period 1|Adverse Event|1|||
46637278|NCT01453296|82811184|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
46637279|NCT01453296|82811185|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
46637280|NCT01453296|82811184|FG000|Treatment Period 2|Adverse Event|1|||
46637281|NCT01453296|82811185|FG001|Treatment Period 2|Adverse Event|0|||
46637282|NCT01453296|82811184|FG000|Treatment Period 2|Withdrawal by Subject|1|||
46637283|NCT01453296|82811185|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46762394|NCT00805389|82980521|FG001|Overall Study|Withdrawal by Subject|2|||
46762395|NCT00805389|82980522|FG002|Overall Study|Withdrawal by Subject|4|||
46637284|NCT01453140|82811191|FG000|Overall Study|Adverse Event|3|||
46637285|NCT01499940|82811199|FG000|Overall Study|Study was withdrawn before completion.|9|||
46637286|NCT01499160|82811203|FG000|Overall Study|Adverse Event|1|||
46825227|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
46825228|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
46825229|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
46825230|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
46825231|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
46825232|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
46825233|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
46825234|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
46825235|NCT00433160|83043983|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
46825236|NCT00433160|83043984|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
46825237|NCT00433160|83043983|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
46825238|NCT00433160|83043984|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
46825239|NCT00433160|83043983|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
46825240|NCT00433160|83043984|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
46637287|NCT01499160|82811203|FG000|Overall Study|Withdrawal by Subject|1|||
46762396|NCT00805389|82980523|FG003|Overall Study|Withdrawal by Subject|5|||
46825241|NCT00433160|83043983|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
46825242|NCT00433160|83043984|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
46825243|NCT00433160|83043983|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
46825244|NCT00433160|83043984|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
46825245|NCT00433160|83043983|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
46825246|NCT00433160|83043984|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
46825247|NCT00433160|83043983|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
46825248|NCT00433160|83043984|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
46825249|NCT00433160|83043983|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
46825250|NCT00433160|83043984|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
46825251|NCT00239356|83043996|FG000|Overall Study|Lack of Efficacy|1|||
46825252|NCT00239356|83043997|FG001|Overall Study|Lack of Efficacy|0|||
46825253|NCT00239356|83043996|FG000|Overall Study|Adverse Event|6|||
46825254|NCT00239356|83043997|FG001|Overall Study|Adverse Event|0|||
46762397|NCT00805389|82980524|FG004|Overall Study|Withdrawal by Subject|4|||
46762398|NCT00678886|82980548|FG000|Overall Study|Withdrawal by Subject|0|||
46762399|NCT00678886|82980549|FG001|Overall Study|Withdrawal by Subject|0|||
46762400|NCT00678886|82980550|FG002|Overall Study|Withdrawal by Subject|4|||
46762401|NCT00678886|82980551|FG003|Overall Study|Withdrawal by Subject|6|||
46762402|NCT00678886|82980548|FG000|Overall Study|Physician Decision|0|||
46762403|NCT00678886|82980549|FG001|Overall Study|Physician Decision|0|||
46762404|NCT00678886|82980550|FG002|Overall Study|Physician Decision|1|||
47058207|NCT01696643|83337248|FG001|Overall Study|Study Terminated by Sponsor|294|||
47058208|NCT01696643|83337247|FG000|Overall Study|Withdrawal by Subject|142|||
47058209|NCT01696643|83337248|FG001|Overall Study|Withdrawal by Subject|149|||
47058210|NCT01696643|83337247|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
47058211|NCT01696643|83337248|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
47058212|NCT01696643|83337247|FG000|Overall Study|Site Error|2|||
46762405|NCT00678886|82980551|FG003|Overall Study|Physician Decision|1|||
46762406|NCT00678886|82980548|FG000|Overall Study|Lost to Follow-up|0|||
46762407|NCT00678886|82980549|FG001|Overall Study|Lost to Follow-up|0|||
46762408|NCT00678886|82980550|FG002|Overall Study|Lost to Follow-up|3|||
46762409|NCT00678886|82980551|FG003|Overall Study|Lost to Follow-up|2|||
46762410|NCT00678886|82980548|FG000|Overall Study|Other|0|||
46762411|NCT00678886|82980549|FG001|Overall Study|Other|0|||
46762412|NCT00678886|82980550|FG002|Overall Study|Other|1|||
46762413|NCT00678886|82980551|FG003|Overall Study|Other|0|||
46762414|NCT00804843|82980562|FG000|Overall Study|Protocol Violation|1|||
46762415|NCT00804843|82980563|FG001|Overall Study|Protocol Violation|0|||
46762416|NCT00804843|82980562|FG000|Overall Study|Adverse Event|8|||
46825255|NCT00239356|83043996|FG000|Overall Study|Withdrawal by Subject|15|||
46825256|NCT00239356|83043997|FG001|Overall Study|Withdrawal by Subject|6|||
46825257|NCT00239356|83043996|FG000|Overall Study|Lost to Follow-up|3|||
46825258|NCT00239356|83043997|FG001|Overall Study|Lost to Follow-up|0|||
46825259|NCT00239356|83043996|FG000|Overall Study|poor/non-compliance|2|||
47058213|NCT01696643|83337248|FG001|Overall Study|Site Error|1|||
47058214|NCT01696643|83337247|FG000|Overall Study|Participant Incarcerated|0|||
47058215|NCT01696643|83337248|FG001|Overall Study|Participant Incarcerated|1|||
46637288|NCT01498692|82811208|FG000|Overall Study|Death|4|||
46762417|NCT00804843|82980563|FG001|Overall Study|Adverse Event|5|||
46762418|NCT00804843|82980562|FG000|Overall Study|Withdrawal by Subject|1|||
46762419|NCT00804843|82980563|FG001|Overall Study|Withdrawal by Subject|2|||
46762420|NCT00822120|82980572|FG000|Initial Registration|Adverse Event|1|||
46762421|NCT00822120|82980573|FG001|Initial Registration|Adverse Event|0|||
46762422|NCT00822120|82980574|FG002|Initial Registration|Adverse Event|0|||
46825260|NCT00239356|83043997|FG001|Overall Study|poor/non-compliance|0|||
46825261|NCT00239356|83043996|FG000|Overall Study|Pregnancy|1|||
46825262|NCT00239356|83043997|FG001|Overall Study|Pregnancy|0|||
46825263|NCT00239356|83043996|FG000|Overall Study|Administrative reason|0|||
46825264|NCT00239356|83043997|FG001|Overall Study|Administrative reason|1|||
46825265|NCT00239356|83043996|FG000|Overall Study|Drug available on market|11|||
46825266|NCT00239356|83043997|FG001|Overall Study|Drug available on market|2|||
46825267|NCT00393510|83044005|FG000|Overall Study|Physician Decision|3|||
46825268|NCT00393510|83044006|FG001|Overall Study|Physician Decision|9|||
46825269|NCT00425438|83044014|FG000|Overall Study|Termination by Sponsor|25|||
46825270|NCT00425438|83044015|FG001|Overall Study|Termination by Sponsor|27|||
46825271|NCT00275002|83044023|FG000|Overall Study|Death|1|||
46825272|NCT00275002|83044024|FG001|Overall Study|Death|0|||
46825273|NCT00275002|83044023|FG000|Overall Study|Disease progression|21|||
46825274|NCT00275002|83044024|FG001|Overall Study|Disease progression|15|||
46825275|NCT00275002|83044023|FG000|Overall Study|Adverse Event|0|||
46825276|NCT00275002|83044024|FG001|Overall Study|Adverse Event|1|||
46825277|NCT00433004|83044032|FG000|Overall Study|Lost to Follow-up|5|||
46825278|NCT00433004|83044033|FG001|Overall Study|Lost to Follow-up|7|||
46825279|NCT00238264|83044039|FG000|Overall Study|Death|7|||
46825280|NCT00238264|83044039|FG000|Overall Study|Lost to Follow-up|18|||
46825281|NCT00238264|83044039|FG000|Overall Study|Withdrawal by Subject|4|||
46825282|NCT00238264|83044039|FG000|Overall Study|Ineligible|7|||
46825283|NCT00414596|83044043|FG000|Overall Study|Protocol Violation|2|||
46825284|NCT00393042|83044047|FG000|First Intervention|Withdrawal by Subject|1|||
46825285|NCT00393042|83044048|FG001|First Intervention|Withdrawal by Subject|2|||
46825286|NCT00393042|83044047|FG000|First Intervention|Lost to Follow-up|3|||
46825287|NCT00393042|83044048|FG001|First Intervention|Lost to Follow-up|3|||
46825288|NCT00393042|83044047|FG000|First Intervention|Protocol Violation|1|||
46825289|NCT00393042|83044048|FG001|First Intervention|Protocol Violation|0|||
46825290|NCT00393042|83044047|FG000|First Intervention|Adverse Event|0|||
46825291|NCT00393042|83044048|FG001|First Intervention|Adverse Event|1|||
46825292|NCT00393042|83044047|FG000|Second Intervetion|Adverse Event|0|||
46825293|NCT00393042|83044048|FG001|Second Intervetion|Adverse Event|3|||
46825294|NCT00393042|83044047|FG000|Second Intervetion|Withdrawal by Subject|0|||
46825295|NCT00393042|83044048|FG001|Second Intervetion|Withdrawal by Subject|2|||
46825296|NCT00393042|83044047|FG000|Second Intervetion|Lack of Efficacy|1|||
46825297|NCT00393042|83044048|FG001|Second Intervetion|Lack of Efficacy|0|||
46825298|NCT00393042|83044047|FG000|Second Intervetion|Lost to Follow-up|0|||
46825299|NCT00393042|83044048|FG001|Second Intervetion|Lost to Follow-up|2|||
46825300|NCT00393042|83044047|FG000|Second Intervetion|Protocol Violation|1|||
46825301|NCT00393042|83044048|FG001|Second Intervetion|Protocol Violation|1|||
46934382|NCT02660034|83170298|FG011|Overall Study|Participant moved into special access scheme|0|||
46934383|NCT02660034|83170299|FG012|Overall Study|Participant moved into special access scheme|0|||
46934384|NCT02660034|83170300|FG013|Overall Study|Participant moved into special access scheme|0|||
46934385|NCT02660034|83170287|FG000|Overall Study|Adverse Event|1|||
46934386|NCT02660034|83170288|FG001|Overall Study|Adverse Event|0|||
46934387|NCT02660034|83170289|FG002|Overall Study|Adverse Event|0|||
47058216|NCT01696643|83337247|FG000|Overall Study|Medical Monitor Decision|0|||
46762423|NCT00822120|82980575|FG003|Initial Registration|Adverse Event|0|||
46762424|NCT00822120|82980576|FG004|Initial Registration|Adverse Event|0|||
46762425|NCT00822120|82980577|FG005|Initial Registration|Adverse Event|0|||
46762426|NCT00822120|82980572|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
46762427|NCT00822120|82980573|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
46762428|NCT00822120|82980574|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
46762429|NCT00822120|82980575|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
46762430|NCT00822120|82980576|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
46762431|NCT00822120|82980577|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
46762432|NCT00822120|82980572|FG000|Initial Registration|Reasons not Protocol Specified|2|||
46762433|NCT00822120|82980573|FG001|Initial Registration|Reasons not Protocol Specified|0|||
46762434|NCT00822120|82980574|FG002|Initial Registration|Reasons not Protocol Specified|0|||
46762435|NCT00822120|82980575|FG003|Initial Registration|Reasons not Protocol Specified|0|||
46762436|NCT00822120|82980576|FG004|Initial Registration|Reasons not Protocol Specified|0|||
46762437|NCT00822120|82980577|FG005|Initial Registration|Reasons not Protocol Specified|0|||
46762438|NCT00822120|82980572|FG000|Initial Registration|Ineligible|22|||
46825302|NCT00392808|83044106|FG000|Overall Study|Lost to Follow-up|3|||
46825303|NCT00392808|83044107|FG001|Overall Study|Lost to Follow-up|2|||
46825304|NCT00392808|83044108|FG002|Overall Study|Lost to Follow-up|1|||
46934388|NCT02660034|83170290|FG003|Overall Study|Adverse Event|0|||
46934389|NCT02660034|83170291|FG004|Overall Study|Adverse Event|0|||
47058217|NCT01696643|83337248|FG001|Overall Study|Medical Monitor Decision|2|||
46825305|NCT00392808|83044109|FG003|Overall Study|Lost to Follow-up|2|||
46825306|NCT00392808|83044106|FG000|Overall Study|Unable to withdraw blood|3|||
46762439|NCT00822120|82980573|FG001|Initial Registration|Ineligible|1|||
46762440|NCT00822120|82980574|FG002|Initial Registration|Ineligible|0|||
46762441|NCT00822120|82980575|FG003|Initial Registration|Ineligible|0|||
46825307|NCT00392808|83044107|FG001|Overall Study|Unable to withdraw blood|1|||
46825308|NCT00392808|83044108|FG002|Overall Study|Unable to withdraw blood|1|||
46825309|NCT00392808|83044109|FG003|Overall Study|Unable to withdraw blood|2|||
46825310|NCT00274846|83044128|FG000|Overall Study|Did not receive adequate NK cells|1|||
46934390|NCT02660034|83170292|FG005|Overall Study|Adverse Event|0|||
46934391|NCT02660034|83170293|FG006|Overall Study|Adverse Event|0|||
46934392|NCT02660034|83170294|FG007|Overall Study|Adverse Event|0|||
46934393|NCT02660034|83170295|FG008|Overall Study|Adverse Event|0|||
46934394|NCT02660034|83170296|FG009|Overall Study|Adverse Event|0|||
46934395|NCT02660034|83170297|FG010|Overall Study|Adverse Event|0|||
46934396|NCT02660034|83170298|FG011|Overall Study|Adverse Event|0|||
46934397|NCT02660034|83170299|FG012|Overall Study|Adverse Event|0|||
46934398|NCT02660034|83170300|FG013|Overall Study|Adverse Event|0|||
46934399|NCT02660034|83170287|FG000|Overall Study|Sponsor Decision|0|||
46934400|NCT02660034|83170288|FG001|Overall Study|Sponsor Decision|1|||
46934401|NCT02660034|83170289|FG002|Overall Study|Sponsor Decision|2|||
46934402|NCT02660034|83170290|FG003|Overall Study|Sponsor Decision|2|||
46825311|NCT00237796|83044135|FG000|Overall Study|Baseline and one other ILSS required|10|||
46825312|NCT00237796|83044136|FG001|Overall Study|Baseline and one other ILSS required|5|||
46825313|NCT00414440|83044145|FG000|Core Period|Withdrawal by Subject|70|||
46825314|NCT00414440|83044146|FG001|Core Period|Withdrawal by Subject|32|||
46825315|NCT00414440|83044145|FG000|Extension Period|Lost to Follow-up|44|||
46825316|NCT00414440|83044146|FG001|Extension Period|Lost to Follow-up|52|||
46825317|NCT00414440|83044145|FG000|Extension Period|Did not consent to continue follow up|61|||
46825318|NCT00414440|83044146|FG001|Extension Period|Did not consent to continue follow up|54|||
46825319|NCT00414440|83044145|FG000|Extension Period|Other|1|||
46825320|NCT00414440|83044146|FG001|Extension Period|Other|1|||
46825321|NCT00414440|83044145|FG000|Extension Period|Administrative|16|||
46825322|NCT00414440|83044146|FG001|Extension Period|Administrative|16|||
46825323|NCT00414440|83044145|FG000|Extension Period|Death|1|||
46825324|NCT00414440|83044146|FG001|Extension Period|Death|2|||
46825325|NCT00414440|83044145|FG000|Extension Period|Withdrawal by Subject|9|||
46825326|NCT00414440|83044146|FG001|Extension Period|Withdrawal by Subject|7|||
46825327|NCT00414440|83044145|FG000|Extension Period|Not included in follow up period|18|||
46825328|NCT00414440|83044146|FG001|Extension Period|Not included in follow up period|8|||
46825329|NCT00209560|83044154|FG000|Overall Study|Lack of Efficacy|1|||
46825330|NCT00209560|83044155|FG001|Overall Study|Lack of Efficacy|0|||
46825331|NCT00236080|83044166|FG000|Overall Study|Adverse Event|0|||
46825332|NCT00236080|83044167|FG001|Overall Study|Adverse Event|0|||
46825333|NCT00236080|83044168|FG002|Overall Study|Adverse Event|3|||
46825334|NCT00236080|83044169|FG003|Overall Study|Adverse Event|1|||
46934403|NCT02660034|83170291|FG004|Overall Study|Sponsor Decision|3|||
47058218|NCT01696643|83337247|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
47058219|NCT01696643|83337248|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
47058220|NCT01695317|83337260|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
46762442|NCT00822120|82980576|FG004|Initial Registration|Ineligible|0|||
46762443|NCT00822120|82980577|FG005|Initial Registration|Ineligible|0|||
46762444|NCT00822120|82980572|FG000|PET-directed Therapy|Adverse Event|0|||
46762445|NCT00822120|82980573|FG001|PET-directed Therapy|Adverse Event|0|||
46762446|NCT00822120|82980574|FG002|PET-directed Therapy|Adverse Event|0|||
46762447|NCT00822120|82980575|FG003|PET-directed Therapy|Adverse Event|1|||
46762448|NCT00822120|82980576|FG004|PET-directed Therapy|Adverse Event|0|||
46762449|NCT00822120|82980577|FG005|PET-directed Therapy|Adverse Event|0|||
46762450|NCT00822120|82980572|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
46762451|NCT00822120|82980573|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
46762452|NCT00822120|82980574|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
46762453|NCT00822120|82980575|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
46762454|NCT00822120|82980576|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
46762455|NCT00822120|82980577|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
46762456|NCT00822120|82980572|FG000|PET-directed Therapy|Death|0|||
46825335|NCT00236080|83044170|FG004|Overall Study|Adverse Event|0|||
46825336|NCT00236080|83044166|FG000|Overall Study|Lost to Follow-up|0|||
47058221|NCT01695317|83337261|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
46825337|NCT00236080|83044167|FG001|Overall Study|Lost to Follow-up|1|||
46825338|NCT00236080|83044168|FG002|Overall Study|Lost to Follow-up|0|||
46825339|NCT00236080|83044169|FG003|Overall Study|Lost to Follow-up|0|||
46934404|NCT02660034|83170292|FG005|Overall Study|Sponsor Decision|0|||
46934405|NCT02660034|83170293|FG006|Overall Study|Sponsor Decision|0|||
46934406|NCT02660034|83170294|FG007|Overall Study|Sponsor Decision|0|||
46762457|NCT00822120|82980573|FG001|PET-directed Therapy|Death|0|||
46825340|NCT00236080|83044170|FG004|Overall Study|Lost to Follow-up|0|||
46825341|NCT00236080|83044166|FG000|Overall Study|Physician Decision|1|||
46825342|NCT00236080|83044167|FG001|Overall Study|Physician Decision|0|||
46762458|NCT00822120|82980574|FG002|PET-directed Therapy|Death|0|||
46762459|NCT00822120|82980575|FG003|PET-directed Therapy|Death|2|||
46825343|NCT00236080|83044168|FG002|Overall Study|Physician Decision|1|||
46934407|NCT02660034|83170295|FG008|Overall Study|Sponsor Decision|0|||
46825344|NCT00236080|83044169|FG003|Overall Study|Physician Decision|1|||
46825345|NCT00236080|83044170|FG004|Overall Study|Physician Decision|1|||
46825346|NCT00236080|83044166|FG000|Overall Study|Withdrawal by Subject|1|||
46934408|NCT02660034|83170296|FG009|Overall Study|Sponsor Decision|0|||
46934409|NCT02660034|83170297|FG010|Overall Study|Sponsor Decision|0|||
46934410|NCT02660034|83170298|FG011|Overall Study|Sponsor Decision|0|||
46934411|NCT02660034|83170299|FG012|Overall Study|Sponsor Decision|0|||
46934412|NCT02660034|83170300|FG013|Overall Study|Sponsor Decision|1|||
46934413|NCT02660034|83170287|FG000|Overall Study|Withdrawal by Subject|0|||
46934414|NCT02660034|83170288|FG001|Overall Study|Withdrawal by Subject|0|||
46934415|NCT02660034|83170289|FG002|Overall Study|Withdrawal by Subject|0|||
46934416|NCT02660034|83170290|FG003|Overall Study|Withdrawal by Subject|0|||
46934417|NCT02660034|83170291|FG004|Overall Study|Withdrawal by Subject|0|||
46934418|NCT02660034|83170292|FG005|Overall Study|Withdrawal by Subject|0|||
46934419|NCT02660034|83170293|FG006|Overall Study|Withdrawal by Subject|1|||
46934420|NCT02660034|83170294|FG007|Overall Study|Withdrawal by Subject|1|||
46934421|NCT02660034|83170295|FG008|Overall Study|Withdrawal by Subject|1|||
46934422|NCT02660034|83170296|FG009|Overall Study|Withdrawal by Subject|0|||
46934423|NCT02660034|83170297|FG010|Overall Study|Withdrawal by Subject|0|||
46934424|NCT02660034|83170298|FG011|Overall Study|Withdrawal by Subject|1|||
46934425|NCT02660034|83170299|FG012|Overall Study|Withdrawal by Subject|2|||
46934426|NCT02660034|83170300|FG013|Overall Study|Withdrawal by Subject|0|||
46934427|NCT02660034|83170287|FG000|Overall Study|Death|0|||
46934428|NCT02660034|83170288|FG001|Overall Study|Death|0|||
46934429|NCT02660034|83170289|FG002|Overall Study|Death|0|||
46934430|NCT02660034|83170290|FG003|Overall Study|Death|0|||
46934431|NCT02660034|83170291|FG004|Overall Study|Death|0|||
46934432|NCT02660034|83170292|FG005|Overall Study|Death|13|||
46934433|NCT02660034|83170293|FG006|Overall Study|Death|14|||
46934434|NCT02660034|83170294|FG007|Overall Study|Death|10|||
46934435|NCT02660034|83170295|FG008|Overall Study|Death|9|||
46934436|NCT02660034|83170296|FG009|Overall Study|Death|21|||
46934437|NCT02660034|83170297|FG010|Overall Study|Death|17|||
46934438|NCT02660034|83170298|FG011|Overall Study|Death|15|||
46934439|NCT02660034|83170299|FG012|Overall Study|Death|18|||
46934440|NCT02660034|83170300|FG013|Overall Study|Death|7|||
46934441|NCT02660034|83170287|FG000|Overall Study|Physician Decision|0|||
46934442|NCT02660034|83170288|FG001|Overall Study|Physician Decision|0|||
46934443|NCT02660034|83170289|FG002|Overall Study|Physician Decision|0|||
46934444|NCT02660034|83170290|FG003|Overall Study|Physician Decision|0|||
46934445|NCT02660034|83170291|FG004|Overall Study|Physician Decision|0|||
46934446|NCT02660034|83170292|FG005|Overall Study|Physician Decision|0|||
46934447|NCT02660034|83170293|FG006|Overall Study|Physician Decision|0|||
46934448|NCT02660034|83170294|FG007|Overall Study|Physician Decision|0|||
46934449|NCT02660034|83170295|FG008|Overall Study|Physician Decision|0|||
46934450|NCT02660034|83170296|FG009|Overall Study|Physician Decision|0|||
46934451|NCT02660034|83170297|FG010|Overall Study|Physician Decision|0|||
46934452|NCT02660034|83170298|FG011|Overall Study|Physician Decision|0|||
46934453|NCT02660034|83170299|FG012|Overall Study|Physician Decision|0|||
46934454|NCT02660034|83170300|FG013|Overall Study|Physician Decision|1|||
46934455|NCT02660034|83170287|FG000|Overall Study|Participants transferred to LTE|0|||
46934456|NCT02660034|83170288|FG001|Overall Study|Participants transferred to LTE|0|||
46934457|NCT02660034|83170289|FG002|Overall Study|Participants transferred to LTE|0|||
46825347|NCT00236080|83044167|FG001|Overall Study|Withdrawal by Subject|0|||
46825348|NCT00236080|83044168|FG002|Overall Study|Withdrawal by Subject|0|||
46825349|NCT00236080|83044169|FG003|Overall Study|Withdrawal by Subject|0|||
46825350|NCT00236080|83044170|FG004|Overall Study|Withdrawal by Subject|0|||
46825351|NCT00236080|83044166|FG000|Overall Study|Miscellaneous|0|||
46825352|NCT00236080|83044167|FG001|Overall Study|Miscellaneous|0|||
46825353|NCT00236080|83044168|FG002|Overall Study|Miscellaneous|1|||
46825354|NCT00236080|83044169|FG003|Overall Study|Miscellaneous|0|||
46934458|NCT02660034|83170290|FG003|Overall Study|Participants transferred to LTE|0|||
46934459|NCT02660034|83170291|FG004|Overall Study|Participants transferred to LTE|0|||
46934460|NCT02660034|83170292|FG005|Overall Study|Participants transferred to LTE|10|||
46934461|NCT02660034|83170293|FG006|Overall Study|Participants transferred to LTE|8|||
46934462|NCT02660034|83170294|FG007|Overall Study|Participants transferred to LTE|8|||
46934463|NCT02660034|83170295|FG008|Overall Study|Participants transferred to LTE|10|||
46934464|NCT02660034|83170296|FG009|Overall Study|Participants transferred to LTE|1|||
46934465|NCT02660034|83170297|FG010|Overall Study|Participants transferred to LTE|2|||
46934466|NCT02660034|83170298|FG011|Overall Study|Participants transferred to LTE|4|||
46934467|NCT02660034|83170299|FG012|Overall Study|Participants transferred to LTE|1|||
46934468|NCT02660034|83170300|FG013|Overall Study|Participants transferred to LTE|1|||
46934469|NCT02193867|83170343|FG000|Overall Study|Death|2|||
46934470|NCT02193867|83170343|FG000|Overall Study|Sponsor Study Termination|2|||
46825355|NCT00236080|83044170|FG004|Overall Study|Miscellaneous|0|||
46825356|NCT00432380|83044185|FG000|Overall Study|Migrated/moved from study area|3|||
46825357|NCT00432380|83044186|FG001|Overall Study|Migrated/moved from study area|4|||
46825358|NCT00432380|83044187|FG002|Overall Study|Migrated/moved from study area|1|||
46825359|NCT00432380|83044185|FG000|Overall Study|Adverse Event|1|||
46825360|NCT00432380|83044186|FG001|Overall Study|Adverse Event|0|||
46825361|NCT00432380|83044187|FG002|Overall Study|Adverse Event|0|||
46825362|NCT00234052|83044196|FG000|Treatment|Withdrawal by Subject|3|||
46825363|NCT00234052|83044196|FG000|Treatment|Adverse Event|5|||
46825364|NCT00234052|83044196|FG000|Treatment|Death|2|||
46825365|NCT00234052|83044196|FG000|Treatment|Progressive Disease|11|||
46825366|NCT00234052|83044196|FG000|Follow-up for 5 Years|Death|41|||
46825367|NCT00234052|83044196|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
46825368|NCT00234052|83044196|FG000|Follow-up for 5 Years|Other|7|||
46825369|NCT00408408|83044206|FG000|Overall Study|No follow up data|2|||
46825370|NCT00408408|83044207|FG001|Overall Study|No follow up data|3|||
46825371|NCT00408408|83044208|FG002|Overall Study|No follow up data|0|||
46825372|NCT00408408|83044209|FG003|Overall Study|No follow up data|7|||
46825373|NCT00408408|83044210|FG004|Overall Study|No follow up data|5|||
46825374|NCT00408408|83044211|FG005|Overall Study|No follow up data|3|||
46825375|NCT00414050|83044229|FG000|Overall Study|Adverse Event|1|||
46825376|NCT00414050|83044230|FG001|Overall Study|Adverse Event|1|||
46825377|NCT00414050|83044231|FG002|Overall Study|Adverse Event|1|||
46825378|NCT00414050|83044232|FG003|Overall Study|Adverse Event|1|||
46825379|NCT00414050|83044229|FG000|Overall Study|Lost to Follow-up|2|||
46825380|NCT00414050|83044230|FG001|Overall Study|Lost to Follow-up|2|||
46825381|NCT00414050|83044231|FG002|Overall Study|Lost to Follow-up|1|||
46825382|NCT00414050|83044232|FG003|Overall Study|Lost to Follow-up|1|||
46825383|NCT00414050|83044229|FG000|Overall Study|Withdrawal by Subject|5|||
46825384|NCT00414050|83044230|FG001|Overall Study|Withdrawal by Subject|3|||
46825385|NCT00414050|83044231|FG002|Overall Study|Withdrawal by Subject|2|||
46825386|NCT00414050|83044232|FG003|Overall Study|Withdrawal by Subject|4|||
46825387|NCT00414050|83044229|FG000|Overall Study|Subject discontinued for other reason|1|||
46825388|NCT00414050|83044230|FG001|Overall Study|Subject discontinued for other reason|2|||
46825389|NCT00414050|83044231|FG002|Overall Study|Subject discontinued for other reason|2|||
46825390|NCT00414050|83044232|FG003|Overall Study|Subject discontinued for other reason|1|||
46825391|NCT00414050|83044229|FG000|Overall Study|Subject Moved|0|||
46825392|NCT00414050|83044230|FG001|Overall Study|Subject Moved|0|||
46825393|NCT00414050|83044231|FG002|Overall Study|Subject Moved|0|||
46934471|NCT02200770|83170371|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
46934472|NCT02200770|83170372|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
46934473|NCT02200770|83170371|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
46934474|NCT02200770|83170372|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
46934475|NCT02200770|83170371|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
46934476|NCT02200770|83170372|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
46934477|NCT02200770|83170371|FG000|Randomized-controlled Period (RCP)|Other|1|||
46934478|NCT02200770|83170372|FG001|Randomized-controlled Period (RCP)|Other|2|||
46637289|NCT01498692|82811208|FG000|Overall Study|Withdrawal by Subject|1|||
46637290|NCT01498692|82811208|FG000|Overall Study|Missed 12-month visit|3|||
46637291|NCT01498068|82811214|FG000|Overall Study|Withdrawal by Subject|1|||
46637292|NCT01498068|82811215|FG001|Overall Study|Withdrawal by Subject|1|||
46762460|NCT00822120|82980576|FG004|PET-directed Therapy|Death|0|||
46762461|NCT00822120|82980577|FG005|PET-directed Therapy|Death|0|||
46762462|NCT00822120|82980572|FG000|PET-directed Therapy|Protocol Violation|0|||
46762463|NCT00822120|82980573|FG001|PET-directed Therapy|Protocol Violation|0|||
46762464|NCT00822120|82980574|FG002|PET-directed Therapy|Protocol Violation|0|||
46762465|NCT00822120|82980575|FG003|PET-directed Therapy|Protocol Violation|6|||
46762466|NCT00822120|82980576|FG004|PET-directed Therapy|Protocol Violation|0|||
46762467|NCT00822120|82980577|FG005|PET-directed Therapy|Protocol Violation|0|||
46762468|NCT00804687|82980598|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
46762469|NCT00804687|82980599|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
46762470|NCT00804687|82980600|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
46762471|NCT00804687|82980601|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
46762472|NCT00804687|82980602|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
46762473|NCT00804687|82980603|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
46762474|NCT00804687|82980598|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
46762475|NCT00804687|82980599|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
46762476|NCT00804687|82980600|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
46762477|NCT00804687|82980601|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
46762478|NCT00804687|82980602|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
46762479|NCT00804687|82980603|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
46762480|NCT00804687|82980598|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
46762481|NCT00804687|82980599|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
46762482|NCT00804687|82980600|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
46762483|NCT00804687|82980601|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
46762484|NCT00804687|82980602|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
46825394|NCT00414050|83044232|FG003|Overall Study|Subject Moved|1|||
46825395|NCT00413972|83044246|FG000|Overall Study|Adverse Event|2|||
46637293|NCT01497366|82811223|FG000|Overall Study|Virologic failure|2|||
46637294|NCT01497366|82811224|FG001|Overall Study|Virologic failure|50|||
46637295|NCT01497366|82811223|FG000|Overall Study|Lost to Follow-up|11|||
46637296|NCT01497366|82811224|FG001|Overall Study|Lost to Follow-up|10|||
46637297|NCT01497366|82811223|FG000|Overall Study|Withdrawal by Subject|6|||
46637298|NCT01497366|82811224|FG001|Overall Study|Withdrawal by Subject|6|||
46637299|NCT01497366|82811223|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
46762485|NCT00804687|82980603|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
46825396|NCT00413972|83044247|FG001|Overall Study|Adverse Event|1|||
46825397|NCT00413972|83044248|FG002|Overall Study|Adverse Event|0|||
46825398|NCT00413972|83044249|FG003|Overall Study|Adverse Event|0|||
46825399|NCT00413972|83044246|FG000|Overall Study|Lost to Follow-up|1|||
46825400|NCT00413972|83044247|FG001|Overall Study|Lost to Follow-up|2|||
46825401|NCT00413972|83044248|FG002|Overall Study|Lost to Follow-up|1|||
46825402|NCT00413972|83044249|FG003|Overall Study|Lost to Follow-up|0|||
46825403|NCT00413972|83044246|FG000|Overall Study|Withdrawal by Subject|4|||
46825404|NCT00413972|83044247|FG001|Overall Study|Withdrawal by Subject|5|||
46825405|NCT00413972|83044248|FG002|Overall Study|Withdrawal by Subject|7|||
46825406|NCT00413972|83044249|FG003|Overall Study|Withdrawal by Subject|2|||
46825407|NCT00413972|83044246|FG000|Overall Study|Protocol Violation|0|||
46825408|NCT00413972|83044247|FG001|Overall Study|Protocol Violation|0|||
46825409|NCT00413972|83044248|FG002|Overall Study|Protocol Violation|2|||
46825410|NCT00413972|83044249|FG003|Overall Study|Protocol Violation|0|||
46825411|NCT00413972|83044246|FG000|Overall Study|Other|0|||
46825412|NCT00413972|83044247|FG001|Overall Study|Other|0|||
46825413|NCT00413972|83044248|FG002|Overall Study|Other|0|||
46825414|NCT00413972|83044249|FG003|Overall Study|Other|1|||
46825415|NCT00259012|83044261|FG000|Overall Study|Adverse Event|0|||
46825416|NCT00259012|83044262|FG001|Overall Study|Adverse Event|1|||
46825417|NCT00259012|83044261|FG000|Overall Study|Withdrawal by Subject|1|||
46825418|NCT00259012|83044262|FG001|Overall Study|Withdrawal by Subject|0|||
46825419|NCT00259012|83044261|FG000|Overall Study|Physician Decision|0|||
46825420|NCT00259012|83044262|FG001|Overall Study|Physician Decision|1|||
46825421|NCT00259012|83044261|FG000|Overall Study|Lost to Follow-up|0|||
46825422|NCT00259012|83044262|FG001|Overall Study|Lost to Follow-up|1|||
46825423|NCT00259012|83044261|FG000|Overall Study|Protocol Violation|1|||
46825424|NCT00259012|83044262|FG001|Overall Study|Protocol Violation|1|||
46637300|NCT01497366|82811224|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
46762486|NCT00804687|82980598|FG000|Period 5: Treatment Period|Positive drug test|1|||
46762487|NCT00804687|82980599|FG001|Period 5: Treatment Period|Positive drug test|0|||
46762488|NCT00804687|82980600|FG002|Period 5: Treatment Period|Positive drug test|0|||
46762489|NCT00804687|82980601|FG003|Period 5: Treatment Period|Positive drug test|0|||
46762490|NCT00804687|82980602|FG004|Period 5: Treatment Period|Positive drug test|0|||
46762491|NCT00804687|82980603|FG005|Period 5: Treatment Period|Positive drug test|0|||
46762492|NCT00678652|82980615|FG000|Overall Study|Protocol Violation|2|||
46762493|NCT00678652|82980616|FG001|Overall Study|Protocol Violation|0|||
46762494|NCT00678652|82980617|FG002|Overall Study|Protocol Violation|0|||
46762495|NCT00678652|82980618|FG003|Overall Study|Protocol Violation|0|||
46762496|NCT00678652|82980615|FG000|Overall Study|Pregnancy|0|||
46762497|NCT00678652|82980616|FG001|Overall Study|Pregnancy|0|||
46762498|NCT00678652|82980617|FG002|Overall Study|Pregnancy|1|||
46762499|NCT00678652|82980618|FG003|Overall Study|Pregnancy|0|||
46762500|NCT00678652|82980615|FG000|Overall Study|Relocation|1|||
46762501|NCT00678652|82980616|FG001|Overall Study|Relocation|0|||
46825425|NCT00209170|83044270|FG000|Overall Study|Adverse Event|0|||
46825426|NCT00209170|83044271|FG001|Overall Study|Adverse Event|1|||
46825427|NCT00209170|83044270|FG000|Overall Study|Withdrawal by Subject|2|||
46825428|NCT00209170|83044271|FG001|Overall Study|Withdrawal by Subject|1|||
46825429|NCT00209170|83044270|FG000|Overall Study|Lack of Efficacy|0|||
46825430|NCT00209170|83044271|FG001|Overall Study|Lack of Efficacy|1|||
46637301|NCT01497366|82811223|FG000|Overall Study|Other|5|||
46825431|NCT00413894|83044277|FG000|Overall Study|Withdrawal by Subject|10|||
46934479|NCT02200770|83170371|FG000|Open-label Period (OLP)|Adverse Event|1|||
46934480|NCT02200770|83170372|FG001|Open-label Period (OLP)|Adverse Event|2|||
46934481|NCT02200770|83170371|FG000|Open-label Period (OLP)|Death|1|||
46934482|NCT02200770|83170372|FG001|Open-label Period (OLP)|Death|2|||
46934483|NCT02200770|83170371|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
46934484|NCT02200770|83170372|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
46934485|NCT02200770|83170371|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
46934486|NCT02200770|83170372|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
46934487|NCT02200770|83170371|FG000|Open-label Period (OLP)|Other|6|||
46934488|NCT02200770|83170372|FG001|Open-label Period (OLP)|Other|15|||
46934489|NCT01186848|83170394|FG000|Overall Study|Lost to Follow-up|4|||
46934490|NCT01186848|83170394|FG000|Overall Study|Withdrawal by Subject|2|||
46934491|NCT01186848|83170394|FG000|Overall Study|Adverse Event|2|||
46934492|NCT01024608|83170402|FG000|Overall Study|Adverse Event|1|||
46934493|NCT01024608|83170403|FG001|Overall Study|Adverse Event|0|||
46934494|NCT01024608|83170402|FG000|Overall Study|Withdrawal by Subject|1|||
46934495|NCT01024608|83170403|FG001|Overall Study|Withdrawal by Subject|0|||
47058222|NCT01695317|83337260|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
46637302|NCT01497366|82811224|FG001|Overall Study|Other|0|||
46637303|NCT01497366|82811223|FG000|Overall Study|Death|1|||
46637304|NCT01497366|82811224|FG001|Overall Study|Death|1|||
46637305|NCT01497366|82811223|FG000|Overall Study|Randomized but not treated|7|||
46637306|NCT01497366|82811224|FG001|Overall Study|Randomized but not treated|21|||
46637307|NCT01475838|82811233|FG000|Randomized Phase|Randomized but Not Treated|0|||
46637308|NCT01475838|82811234|FG001|Randomized Phase|Randomized but Not Treated|5|||
46637309|NCT01475838|82811233|FG000|Randomized Phase|Adverse Event|6|||
46637310|NCT01475838|82811234|FG001|Randomized Phase|Adverse Event|1|||
46637311|NCT01475838|82811233|FG000|Randomized Phase|Pregnancy|0|||
46637312|NCT01475838|82811234|FG001|Randomized Phase|Pregnancy|1|||
46637313|NCT01475838|82811233|FG000|Randomized Phase|Investigators Discretion|1|||
46637314|NCT01475838|82811234|FG001|Randomized Phase|Investigators Discretion|2|||
46637315|NCT01475838|82811233|FG000|Randomized Phase|Withdrew Consent|10|||
46637316|NCT01475838|82811234|FG001|Randomized Phase|Withdrew Consent|14|||
46637317|NCT01475838|82811233|FG000|Randomized Phase|Lost to Follow-up|3|||
46637318|NCT01475838|82811234|FG001|Randomized Phase|Lost to Follow-up|4|||
46637319|NCT01475838|82811233|FG000|Randomized Phase|Participant Noncompliance|1|||
46637320|NCT01475838|82811234|FG001|Randomized Phase|Participant Noncompliance|5|||
46762502|NCT00678652|82980617|FG002|Overall Study|Relocation|0|||
46762503|NCT00678652|82980618|FG003|Overall Study|Relocation|0|||
46762504|NCT00840060|82980639|FG000|Overall Study|Withdrawal by Subject|1|||
46762505|NCT00840060|82980640|FG001|Overall Study|Withdrawal by Subject|0|||
46762506|NCT00840060|82980639|FG000|Overall Study|Change in emotional/behavioral status|0|||
46762507|NCT00840060|82980640|FG001|Overall Study|Change in emotional/behavioral status|1|||
46762508|NCT00574912|82980646|FG000|Overall Study|Could not place IV lines.|3|||
46762509|NCT00574912|82980646|FG000|Overall Study|scheduling conflicts|3|||
46762510|NCT00574912|82980646|FG000|Overall Study|Physician Decision|2|||
46762511|NCT00674128|82980660|FG000|Overall Study|Withdrawal by Subject|25|||
46762512|NCT00674128|82980661|FG001|Overall Study|Withdrawal by Subject|23|||
46762513|NCT00804141|82980667|FG000|Overall Study|Adverse Event|157|||
46762514|NCT00804141|82980667|FG000|Overall Study|Death|4|||
46762515|NCT00804141|82980667|FG000|Overall Study|Failed to return|96|||
46762516|NCT00804141|82980667|FG000|Overall Study|Investigator request|8|||
46762517|NCT00804141|82980667|FG000|Overall Study|Protocol Violation|85|||
46762518|NCT00804141|82980667|FG000|Overall Study|Withdrawal by Subject|131|||
46762519|NCT00804141|82980667|FG000|Overall Study|Lack of Efficacy|46|||
46762520|NCT00804141|82980667|FG000|Overall Study|Other than specified|30|||
46762521|NCT00804141|82980667|FG000|Overall Study|Enrolled but not treated|6|||
46762522|NCT00677092|82980671|FG000|Overall Study|Adverse Event|1|||
46934496|NCT01024608|83170402|FG000|Overall Study|Lost to Follow-up|0|||
46934497|NCT01024608|83170403|FG001|Overall Study|Lost to Follow-up|1|||
46934498|NCT01024608|83170402|FG000|Overall Study|Protocol Violation|0|||
46637321|NCT01475838|82811233|FG000|Randomized Phase|Protocol Violation|9|||
46637322|NCT01475838|82811234|FG001|Randomized Phase|Protocol Violation|4|||
46762523|NCT00677092|82980671|FG000|Overall Study|Lost to Follow-up|1|||
46762524|NCT00677092|82980671|FG000|Overall Study|Withdrawal by Subject|3|||
46762525|NCT00677092|82980671|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
46762526|NCT00677014|82980679|FG000|Overall Study|Lost to Follow-up|20|||
46762527|NCT00677014|82980680|FG001|Overall Study|Lost to Follow-up|12|||
46762528|NCT00677014|82980681|FG002|Overall Study|Lost to Follow-up|24|||
46934499|NCT01024608|83170403|FG001|Overall Study|Protocol Violation|3|||
46934500|NCT01024608|83170402|FG000|Overall Study|Never received study treatment|2|||
46637323|NCT01475838|82811233|FG000|Extension Phase|Participant Noncompliance|1|||
46637324|NCT01475838|82811234|FG001|Extension Phase|Participant Noncompliance|0|||
46637325|NCT01451814|82811243|FG000|Overall Study|Withdrawal by Subject|1|||
46762529|NCT00677014|82980679|FG000|Overall Study|Death|6|||
46762530|NCT00677014|82980680|FG001|Overall Study|Death|15|||
46762531|NCT00677014|82980681|FG002|Overall Study|Death|7|||
46637326|NCT01451814|82811244|FG001|Overall Study|Withdrawal by Subject|1|||
46637327|NCT01451814|82811243|FG000|Overall Study|Lost to Follow-up|5|||
46637328|NCT01451814|82811244|FG001|Overall Study|Lost to Follow-up|4|||
46637329|NCT01475370|82811253|FG000|Overall Study|Exacerbation of primary disease|2|||
46637330|NCT01475370|82811254|FG001|Overall Study|Exacerbation of primary disease|2|||
46637331|NCT01475370|82811255|FG002|Overall Study|Exacerbation of primary disease|2|||
46637332|NCT01475370|82811253|FG000|Overall Study|Study drug administration difficult|0|||
46637333|NCT01475370|82811254|FG001|Overall Study|Study drug administration difficult|1|||
46762532|NCT00677014|82980679|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
46762533|NCT00677014|82980680|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
46762534|NCT00677014|82980681|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
46762535|NCT00839436|82980692|FG000|Overall Study|Developed exclusionary condition|1|||
46762536|NCT00839436|82980693|FG001|Overall Study|Developed exclusionary condition|0|||
46762537|NCT00839436|82980694|FG002|Overall Study|Developed exclusionary condition|0|||
46825432|NCT00413894|83044277|FG000|Overall Study|Administrative Reasons|1|||
46825433|NCT00413894|83044277|FG000|Overall Study|Hb <10 grams/deciliter|12|||
46934501|NCT01024608|83170403|FG001|Overall Study|Never received study treatment|0|||
46934502|NCT00910650|83170409|FG000|Overall Study|Death|2|||
46762538|NCT00839436|82980692|FG000|Overall Study|Withdrawal by Subject|0|||
46934503|NCT03996876|83170430|FG000|Overall Study|Incomplete Data|2|||
46762539|NCT00839436|82980693|FG001|Overall Study|Withdrawal by Subject|1|||
46762540|NCT00839436|82980694|FG002|Overall Study|Withdrawal by Subject|0|||
46762541|NCT00839436|82980692|FG000|Overall Study|Study drug no longer available|0|||
46934504|NCT03996876|83170431|FG001|Overall Study|Incomplete Data|4|||
46934505|NCT01460160|83170438|FG000|Treatment Phase|Lack of Efficacy|3|||
46934506|NCT01460160|83170438|FG000|Treatment Phase|Study Drug Toxicity|2|||
47058223|NCT01695317|83337261|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
46762542|NCT00839436|82980693|FG001|Overall Study|Study drug no longer available|0|||
46762543|NCT00839436|82980694|FG002|Overall Study|Study drug no longer available|1|||
46762544|NCT00675766|82980706|FG000|Overall Study|Lost to Follow-up|6|||
46762545|NCT00675766|82980707|FG001|Overall Study|Lost to Follow-up|5|||
46762546|NCT00675766|82980708|FG002|Overall Study|Lost to Follow-up|21|||
46762547|NCT00675766|82980709|FG003|Overall Study|Lost to Follow-up|26|||
46762548|NCT00673894|82980721|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
46762549|NCT00673894|82980722|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
46762550|NCT00673894|82980721|FG000|First Intervention 4 Weeks|Adverse Event|1|||
46762551|NCT00673894|82980722|FG001|First Intervention 4 Weeks|Adverse Event|0|||
46762552|NCT00674986|82980730|FG000|Overall Study|Adverse Event|2|||
46762553|NCT00674986|82980731|FG001|Overall Study|Adverse Event|1|||
46762554|NCT00674986|82980730|FG000|Overall Study|Subject withdrew consent|12|||
46762555|NCT00674986|82980731|FG001|Overall Study|Subject withdrew consent|19|||
46762556|NCT00674986|82980730|FG000|Overall Study|Lost to Follow-up|25|||
46762557|NCT00674986|82980731|FG001|Overall Study|Lost to Follow-up|53|||
46762558|NCT00674986|82980730|FG000|Overall Study|Other reasons|4|||
46762559|NCT00674986|82980731|FG001|Overall Study|Other reasons|8|||
46762560|NCT00673660|82980738|FG000|Overall Study|Lost to Follow-up|107|||
46762561|NCT00672958|82980749|FG000|Overall Study|Adverse Event|11|||
46762562|NCT00672958|82980750|FG001|Overall Study|Adverse Event|9|||
46762563|NCT00672958|82980749|FG000|Overall Study|Lack of Efficacy|6|||
46762564|NCT00672958|82980750|FG001|Overall Study|Lack of Efficacy|11|||
46762565|NCT00672958|82980749|FG000|Overall Study|Non-compliance with study drug|2|||
46762566|NCT00672958|82980750|FG001|Overall Study|Non-compliance with study drug|3|||
46762567|NCT00672958|82980749|FG000|Overall Study|Protocol deviations|11|||
46762568|NCT00672958|82980750|FG001|Overall Study|Protocol deviations|5|||
46762569|NCT00672958|82980749|FG000|Overall Study|Voluntary withdrawal|12|||
46762570|NCT00672958|82980750|FG001|Overall Study|Voluntary withdrawal|8|||
46762571|NCT00672958|82980749|FG000|Overall Study|Lost to Follow-up|22|||
46762572|NCT00672958|82980750|FG001|Overall Study|Lost to Follow-up|17|||
46762573|NCT00672958|82980749|FG000|Overall Study|Reason not specified|0|||
46762574|NCT00672958|82980750|FG001|Overall Study|Reason not specified|3|||
46762575|NCT00672646|82980759|FG000|Overall Study|Lost to Follow-up|0|||
46825434|NCT00413894|83044277|FG000|Overall Study|Adverse Event|28|||
46825435|NCT00413894|83044277|FG000|Overall Study|Protocol Violation|11|||
46934507|NCT01460160|83170438|FG000|Treatment Phase|Adverse Event|8|||
46934508|NCT01460160|83170438|FG000|Treatment Phase|Withdrawal by Subject|4|||
46637334|NCT01475370|82811255|FG002|Overall Study|Study drug administration difficult|1|||
46637335|NCT01475370|82811253|FG000|Overall Study|Other than specified|1|||
46762576|NCT00672646|82980760|FG001|Overall Study|Lost to Follow-up|1|||
46762577|NCT00672646|82980761|FG002|Overall Study|Lost to Follow-up|2|||
46762578|NCT00672646|82980759|FG000|Overall Study|Withdrawal by Subject|0|||
46762579|NCT00672646|82980760|FG001|Overall Study|Withdrawal by Subject|0|||
46762580|NCT00672646|82980761|FG002|Overall Study|Withdrawal by Subject|1|||
46762581|NCT00672490|82980771|FG000|Overall Study|Withdrawal by Subject|8|||
46762582|NCT00672490|82980772|FG001|Overall Study|Withdrawal by Subject|8|||
46762583|NCT00672490|82980771|FG000|Overall Study|Lack of Compliance|2|||
46762584|NCT00672490|82980772|FG001|Overall Study|Lack of Compliance|7|||
46825436|NCT00413894|83044277|FG000|Overall Study|Other|18|||
46825437|NCT00407550|83044286|FG000|Overall Study|Adverse Event|0|||
46825438|NCT00407550|83044287|FG001|Overall Study|Adverse Event|1|||
46825439|NCT00407550|83044286|FG000|Overall Study|Withdrawal by Subject|0|||
46825440|NCT00407550|83044287|FG001|Overall Study|Withdrawal by Subject|2|||
46825441|NCT00407550|83044286|FG000|Overall Study|Death|1|||
46825442|NCT00407550|83044287|FG001|Overall Study|Death|0|||
46825443|NCT00407550|83044286|FG000|Overall Study|Insurance or Other medical condition|2|||
46825444|NCT00407550|83044287|FG001|Overall Study|Insurance or Other medical condition|1|||
46825445|NCT00209092|83044295|FG000|Overall Study|Progression of disease|7|||
46825446|NCT00209092|83044296|FG001|Overall Study|Progression of disease|1|||
46825447|NCT00209092|83044295|FG000|Overall Study|Adverse Event|0|||
46825448|NCT00209092|83044296|FG001|Overall Study|Adverse Event|1|||
46825449|NCT00209092|83044295|FG000|Overall Study|Withdrawal by Subject|1|||
46825450|NCT00209092|83044296|FG001|Overall Study|Withdrawal by Subject|0|||
46825451|NCT00403494|83044304|FG000|Overall Study|Adverse Event|10|||
46825452|NCT00403494|83044305|FG001|Overall Study|Adverse Event|8|||
46825453|NCT00403494|83044304|FG000|Overall Study|Withdrew Consent|3|||
46825454|NCT00403494|83044305|FG001|Overall Study|Withdrew Consent|2|||
46825455|NCT00403494|83044304|FG000|Overall Study|Inappropriately enrolled|0|||
46825456|NCT00403494|83044305|FG001|Overall Study|Inappropriately enrolled|1|||
46825457|NCT00403494|83044304|FG000|Overall Study|Lost to Follow-up|0|||
46825458|NCT00403494|83044305|FG001|Overall Study|Lost to Follow-up|2|||
46825459|NCT00403494|83044304|FG000|Overall Study|Protocol noncompliance|0|||
46825460|NCT00403494|83044305|FG001|Overall Study|Protocol noncompliance|1|||
46825461|NCT00403494|83044304|FG000|Overall Study|Death|1|||
46825462|NCT00403494|83044305|FG001|Overall Study|Death|0|||
46825463|NCT00403494|83044304|FG000|Overall Study|Sponsor Request|1|||
46825464|NCT00403494|83044305|FG001|Overall Study|Sponsor Request|0|||
46825465|NCT00403260|83044315|FG000|Overall Study|Adverse Event|5|||
46825466|NCT00403260|83044316|FG001|Overall Study|Adverse Event|4|||
46825467|NCT00403260|83044315|FG000|Overall Study|Withdrawal by Subject|5|||
46825468|NCT00403260|83044316|FG001|Overall Study|Withdrawal by Subject|6|||
46825469|NCT00403260|83044315|FG000|Overall Study|Lost to Follow-up|49|||
46825470|NCT00403260|83044316|FG001|Overall Study|Lost to Follow-up|25|||
46825471|NCT00403260|83044315|FG000|Overall Study|Re-appearance of P. falciparum|34|||
46825472|NCT00403260|83044316|FG001|Overall Study|Re-appearance of P. falciparum|25|||
46825473|NCT00403260|83044315|FG000|Overall Study|P. vivax infection|26|||
46825474|NCT00403260|83044316|FG001|Overall Study|P. vivax infection|4|||
46825475|NCT00403260|83044315|FG000|Overall Study|Mixed infection with P. vivax|2|||
46825476|NCT00403260|83044316|FG001|Overall Study|Mixed infection with P. vivax|0|||
46825477|NCT00403260|83044315|FG000|Overall Study|Mixed infection with P. falciparum|1|||
46825478|NCT00403260|83044316|FG001|Overall Study|Mixed infection with P. falciparum|0|||
46825479|NCT00403260|83044315|FG000|Overall Study|P. vivax infection at screening|1|||
46825480|NCT00403260|83044316|FG001|Overall Study|P. vivax infection at screening|0|||
46825481|NCT00403260|83044315|FG000|Overall Study|P. ovale infection|1|||
46825482|NCT00403260|83044316|FG001|Overall Study|P. ovale infection|0|||
46825483|NCT00403260|83044315|FG000|Overall Study|Gametocyte re-appearance|1|||
46825484|NCT00403260|83044316|FG001|Overall Study|Gametocyte re-appearance|1|||
46762585|NCT00672490|82980771|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
46762586|NCT00672490|82980772|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
46825485|NCT00403260|83044315|FG000|Overall Study|Withdrawn from study accidentally|0|||
46825486|NCT00403260|83044316|FG001|Overall Study|Withdrawn from study accidentally|1|||
46825487|NCT00406848|83044324|FG000|Overall Study|Withdrawal by Subject|27|||
46825488|NCT00406848|83044325|FG001|Overall Study|Withdrawal by Subject|22|||
46825489|NCT00406848|83044324|FG000|Overall Study|Adverse Event|38|||
46825490|NCT00406848|83044325|FG001|Overall Study|Adverse Event|7|||
46825491|NCT00406848|83044324|FG000|Overall Study|Lack of Efficacy|9|||
46825492|NCT00406848|83044325|FG001|Overall Study|Lack of Efficacy|14|||
46825493|NCT00406848|83044324|FG000|Overall Study|Protocol Violation|10|||
46825494|NCT00406848|83044325|FG001|Overall Study|Protocol Violation|6|||
46762587|NCT00672490|82980771|FG000|Overall Study|Adverse Event|5|||
46762588|NCT00672490|82980772|FG001|Overall Study|Adverse Event|8|||
46762589|NCT00672490|82980771|FG000|Overall Study|Violation of Concomitant Medicine|1|||
46762590|NCT00672490|82980772|FG001|Overall Study|Violation of Concomitant Medicine|0|||
46762591|NCT00672490|82980771|FG000|Overall Study|Intolerance|0|||
46762592|NCT00672490|82980772|FG001|Overall Study|Intolerance|2|||
46825495|NCT00406848|83044324|FG000|Overall Study|Lost to Follow-up|6|||
46825496|NCT00406848|83044325|FG001|Overall Study|Lost to Follow-up|2|||
46637336|NCT01475370|82811254|FG001|Overall Study|Other than specified|0|||
46825497|NCT00406848|83044324|FG000|Overall Study|Physician Decision|2|||
46825498|NCT00406848|83044325|FG001|Overall Study|Physician Decision|2|||
46825499|NCT00406848|83044324|FG000|Overall Study|Sponsor Decision|1|||
46825500|NCT00406848|83044325|FG001|Overall Study|Sponsor Decision|1|||
46825501|NCT00406692|83044334|FG000|Overall Study|Withdrawal by Subject|4|||
46762593|NCT00672490|82980771|FG000|Overall Study|Lost to Follow-up|1|||
46762594|NCT00672490|82980772|FG001|Overall Study|Lost to Follow-up|5|||
46825502|NCT00406692|83044334|FG000|Overall Study|Physician Decision|1|||
46825503|NCT00406692|83044334|FG000|Overall Study|Adverse Event|1|||
46825504|NCT00406692|83044334|FG000|Overall Study|Lack of Efficacy|1|||
46825505|NCT00315705|83044340|FG000|Phase 1|Refused further treatment|1|||
46825506|NCT00315705|83044340|FG000|Phase 1|Failure to achieve response|8|||
46825507|NCT00315705|83044340|FG000|Phase 1|Disease relapse|4|||
46825508|NCT00315705|83044340|FG000|Phase 1|Scheduled for transplant|9|||
46825509|NCT00315705|83044340|FG000|Phase 1|Death|3|||
46825510|NCT00315705|83044340|FG000|Phase 2|Physician Decision|4|||
46825511|NCT00315705|83044340|FG000|Phase 2|Adverse Event|1|||
46762595|NCT00672490|82980771|FG000|Overall Study|No reason was provided|6|||
46762596|NCT00672490|82980772|FG001|Overall Study|No reason was provided|2|||
46825512|NCT00315705|83044340|FG000|Phase 2|Failure to achieve response|3|||
46825513|NCT00315705|83044340|FG000|Phase 2|Disease relapse|1|||
46825514|NCT00315705|83044340|FG000|Phase 2|Scheduled for transplant|8|||
46825515|NCT00315705|83044340|FG000|Phase 2|Other|1|||
46762597|NCT00670930|82980780|FG000|Overall Study|Adminstrative Problem|0|||
46762598|NCT00670930|82980781|FG001|Overall Study|Adminstrative Problem|1|||
46762599|NCT00670930|82980780|FG000|Overall Study|Lost to Follow-up|1|||
46762600|NCT00670930|82980781|FG001|Overall Study|Lost to Follow-up|0|||
46762601|NCT00670540|82980787|FG000|Overall Study|ineligible|17|||
46762602|NCT00670540|82980787|FG000|Overall Study|not living in France|348|||
46762603|NCT00670540|82980787|FG000|Overall Study|refused to participate|189|||
46762604|NCT00670540|82980787|FG000|Overall Study|controls randomised for no follow up|2770|||
46762605|NCT00670540|82980787|FG000|Overall Study|missing information inclusion criteria|1|||
46762606|NCT00591786|82980801|FG000|Overall Study|Withdrawal of Informed Consent|0|||
46762607|NCT00591786|82980802|FG001|Overall Study|Withdrawal of Informed Consent|0|||
46762608|NCT00591786|82980803|FG002|Overall Study|Withdrawal of Informed Consent|1|||
46762609|NCT00591786|82980804|FG003|Overall Study|Withdrawal of Informed Consent|0|||
46762610|NCT00591786|82980805|FG004|Overall Study|Withdrawal of Informed Consent|0|||
46762611|NCT00591786|82980806|FG005|Overall Study|Withdrawal of Informed Consent|0|||
46762612|NCT00591786|82980807|FG006|Overall Study|Withdrawal of Informed Consent|0|||
46762613|NCT00591786|82980808|FG007|Overall Study|Withdrawal of Informed Consent|0|||
46762614|NCT00591786|82980809|FG008|Overall Study|Withdrawal of Informed Consent|0|||
46762615|NCT00591786|82980810|FG009|Overall Study|Withdrawal of Informed Consent|0|||
46762616|NCT00674362|82980834|FG000|Double Blind|Adverse Event|6|||
46762617|NCT00674362|82980835|FG001|Double Blind|Adverse Event|6|||
46762618|NCT00674362|82980834|FG000|Double Blind|Lack of Efficacy|2|||
46762619|NCT00674362|82980835|FG001|Double Blind|Lack of Efficacy|6|||
46762620|NCT00674362|82980834|FG000|Double Blind|Loss of efficacy|0|||
46762621|NCT00674362|82980835|FG001|Double Blind|Loss of efficacy|1|||
46762622|NCT00674362|82980834|FG000|Double Blind|Withdrawal by Subject|4|||
46762623|NCT00674362|82980835|FG001|Double Blind|Withdrawal by Subject|3|||
46762624|NCT00674362|82980834|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
46762625|NCT00674362|82980835|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
46762626|NCT00674362|82980834|FG000|Double Blind|Other: Surgery|0|||
46762627|NCT00674362|82980835|FG001|Double Blind|Other: Surgery|1|||
46762628|NCT00674362|82980834|FG000|Open Label|Adverse Event|1|||
46762629|NCT00674362|82980835|FG001|Open Label|Adverse Event|0|||
46762630|NCT00674362|82980834|FG000|Open Label|Other: Subject moved to extension study|1|||
46762631|NCT00674362|82980835|FG001|Open Label|Other: Subject moved to extension study|0|||
46762632|NCT00820950|82980847|FG000|Overall Study|Scheduling Conflict|0|||
46762633|NCT00820950|82980848|FG001|Overall Study|Scheduling Conflict|0|||
46762634|NCT00820950|82980849|FG002|Overall Study|Scheduling Conflict|0|||
46762635|NCT00820950|82980850|FG003|Overall Study|Scheduling Conflict|0|||
46762636|NCT00820950|82980851|FG004|Overall Study|Scheduling Conflict|0|||
46762637|NCT00820950|82980852|FG005|Overall Study|Scheduling Conflict|0|||
46825516|NCT00315705|83044340|FG000|Phase 2|Death|7|||
46825517|NCT00307125|83044359|FG000|Screening Phase|Adverse Event|1|||
46825518|NCT00307125|83044360|FG001|Screening Phase|Adverse Event|0|||
46825519|NCT00307125|83044361|FG002|Screening Phase|Adverse Event|0|||
46825520|NCT00307125|83044359|FG000|Screening Phase|Protocol Violation|27|||
46825521|NCT00307125|83044360|FG001|Screening Phase|Protocol Violation|0|||
46825522|NCT00307125|83044361|FG002|Screening Phase|Protocol Violation|0|||
46825523|NCT00307125|83044359|FG000|Screening Phase|Lost to Follow-up|87|||
46825524|NCT00307125|83044360|FG001|Screening Phase|Lost to Follow-up|0|||
46825525|NCT00307125|83044361|FG002|Screening Phase|Lost to Follow-up|0|||
46762638|NCT00820950|82980853|FG006|Overall Study|Scheduling Conflict|1|||
46762639|NCT00820950|82980854|FG007|Overall Study|Scheduling Conflict|1|||
46762640|NCT00820950|82980855|FG008|Overall Study|Scheduling Conflict|0|||
46762641|NCT00820950|82980856|FG009|Overall Study|Scheduling Conflict|0|||
46762642|NCT00820950|82980847|FG000|Overall Study|Protocol Violation|1|||
46762643|NCT00820950|82980848|FG001|Overall Study|Protocol Violation|1|||
46762644|NCT00820950|82980849|FG002|Overall Study|Protocol Violation|0|||
46762645|NCT00820950|82980850|FG003|Overall Study|Protocol Violation|0|||
46762646|NCT00820950|82980851|FG004|Overall Study|Protocol Violation|0|||
46825526|NCT00307125|83044359|FG000|Screening Phase|Death|10|||
46825527|NCT00307125|83044360|FG001|Screening Phase|Death|0|||
46825528|NCT00307125|83044361|FG002|Screening Phase|Death|0|||
46637337|NCT01475370|82811255|FG002|Overall Study|Other than specified|0|||
46637338|NCT01496430|82811266|FG000|Overall Study|Adverse Event|0|||
46637339|NCT01496430|82811267|FG001|Overall Study|Adverse Event|0|||
46637340|NCT01496430|82811268|FG002|Overall Study|Adverse Event|1|||
46637341|NCT01496430|82811266|FG000|Overall Study|Major Protocol Deviation|0|||
46637342|NCT01496430|82811267|FG001|Overall Study|Major Protocol Deviation|0|||
46637343|NCT01496430|82811268|FG002|Overall Study|Major Protocol Deviation|1|||
46637344|NCT01496430|82811266|FG000|Overall Study|Lost to Follow-up|2|||
46637345|NCT01496430|82811267|FG001|Overall Study|Lost to Follow-up|3|||
46637346|NCT01496430|82811268|FG002|Overall Study|Lost to Follow-up|1|||
46637347|NCT01496430|82811266|FG000|Overall Study|Voluntary Withdrawal|2|||
46637348|NCT01496430|82811267|FG001|Overall Study|Voluntary Withdrawal|1|||
46637349|NCT01496430|82811268|FG002|Overall Study|Voluntary Withdrawal|6|||
46637350|NCT01496430|82811266|FG000|Overall Study|Principal Investigator Discretion|0|||
46637351|NCT01496430|82811267|FG001|Overall Study|Principal Investigator Discretion|1|||
46637352|NCT01496430|82811268|FG002|Overall Study|Principal Investigator Discretion|1|||
46637353|NCT01496430|82811266|FG000|Overall Study|Other|2|||
46637354|NCT01496430|82811267|FG001|Overall Study|Other|0|||
46637355|NCT01496430|82811268|FG002|Overall Study|Other|0|||
46637356|NCT01451424|82811280|FG000|Overall Study|Withdrawal by Subject|1|||
46637357|NCT01451424|82811281|FG001|Overall Study|Withdrawal by Subject|1|||
46637358|NCT01451424|82811282|FG002|Overall Study|Withdrawal by Subject|0|||
46637359|NCT01451424|82811283|FG003|Overall Study|Withdrawal by Subject|2|||
46637360|NCT01451424|82811280|FG000|Overall Study|Lost to Follow-up|0|||
46637361|NCT01451424|82811281|FG001|Overall Study|Lost to Follow-up|1|||
46637362|NCT01451424|82811282|FG002|Overall Study|Lost to Follow-up|0|||
46637363|NCT01451424|82811283|FG003|Overall Study|Lost to Follow-up|1|||
46637364|NCT01451424|82811280|FG000|Overall Study|Physician Decision|0|||
46637365|NCT01451424|82811281|FG001|Overall Study|Physician Decision|0|||
46637366|NCT01451424|82811282|FG002|Overall Study|Physician Decision|1|||
46637367|NCT01451424|82811283|FG003|Overall Study|Physician Decision|1|||
46637368|NCT01451424|82811280|FG000|Overall Study|Adverse Event|0|||
46637369|NCT01451424|82811281|FG001|Overall Study|Adverse Event|0|||
46637370|NCT01451424|82811282|FG002|Overall Study|Adverse Event|0|||
46637371|NCT01451424|82811283|FG003|Overall Study|Adverse Event|1|||
46637372|NCT01475214|82811301|FG000|Overall Study|Lost to Follow-up|1|||
46637373|NCT01475214|82811302|FG001|Overall Study|Lost to Follow-up|0|||
46637374|NCT01475214|82811303|FG002|Overall Study|Lost to Follow-up|1|||
46637375|NCT01475214|82811301|FG000|Overall Study|Physician Decision|2|||
46637376|NCT01475214|82811302|FG001|Overall Study|Physician Decision|0|||
46637377|NCT01475214|82811303|FG002|Overall Study|Physician Decision|0|||
46637378|NCT01475214|82811301|FG000|Overall Study|Withdrawal by Subject|2|||
46637379|NCT01475214|82811302|FG001|Overall Study|Withdrawal by Subject|4|||
46637380|NCT01475214|82811303|FG002|Overall Study|Withdrawal by Subject|1|||
46637381|NCT01496274|82811314|FG000|Overall Study|Protocol Violation|0|||
46637382|NCT01496274|82811315|FG001|Overall Study|Protocol Violation|1|||
46762647|NCT00820950|82980852|FG005|Overall Study|Protocol Violation|0|||
46762648|NCT00820950|82980853|FG006|Overall Study|Protocol Violation|0|||
46762649|NCT00820950|82980854|FG007|Overall Study|Protocol Violation|0|||
46762650|NCT00820950|82980855|FG008|Overall Study|Protocol Violation|0|||
46762651|NCT00820950|82980856|FG009|Overall Study|Protocol Violation|0|||
46637383|NCT01496274|82811314|FG000|Overall Study|Adverse Event|1|||
46637384|NCT01496274|82811315|FG001|Overall Study|Adverse Event|1|||
46637385|NCT01496274|82811314|FG000|Overall Study|Withdrawal by Subject|2|||
46637386|NCT01496274|82811315|FG001|Overall Study|Withdrawal by Subject|0|||
46637387|NCT01496274|82811314|FG000|Overall Study|Lost to Follow-up|0|||
46637388|NCT01496274|82811315|FG001|Overall Study|Lost to Follow-up|3|||
46637389|NCT01475136|82811340|FG000|Overall Study|Sponsor Decision|0|||
46637390|NCT01475136|82811341|FG001|Overall Study|Sponsor Decision|1|||
46637391|NCT01475136|82811342|FG002|Overall Study|Sponsor Decision|0|||
46637392|NCT01475136|82811343|FG003|Overall Study|Sponsor Decision|0|||
46637393|NCT01475136|82811340|FG000|Overall Study|Entry Criteria Not Met|0|||
46637394|NCT01475136|82811341|FG001|Overall Study|Entry Criteria Not Met|2|||
46637395|NCT01475136|82811342|FG002|Overall Study|Entry Criteria Not Met|3|||
46637396|NCT01475136|82811343|FG003|Overall Study|Entry Criteria Not Met|1|||
46637397|NCT01475136|82811340|FG000|Overall Study|Withdrawal by Subject|0|||
46637398|NCT01475136|82811341|FG001|Overall Study|Withdrawal by Subject|0|||
46637399|NCT01475136|82811342|FG002|Overall Study|Withdrawal by Subject|0|||
46637400|NCT01475136|82811343|FG003|Overall Study|Withdrawal by Subject|2|||
46637401|NCT01475136|82811340|FG000|Overall Study|Adverse Event|1|||
46637402|NCT01475136|82811341|FG001|Overall Study|Adverse Event|0|||
46637403|NCT01475136|82811342|FG002|Overall Study|Adverse Event|0|||
46637404|NCT01475136|82811343|FG003|Overall Study|Adverse Event|1|||
46637405|NCT01475136|82811340|FG000|Overall Study|Death|0|||
46637406|NCT01475136|82811341|FG001|Overall Study|Death|0|||
46762652|NCT00670306|82980896|FG000|Overall Study|Adverse Event|8|||
46762653|NCT00670306|82980896|FG000|Overall Study|Lack of Efficacy|10|||
46825529|NCT00307125|83044359|FG000|Screening Phase|Withdrawal by Subject|77|||
46637407|NCT01475136|82811342|FG002|Overall Study|Death|0|||
46637408|NCT01475136|82811343|FG003|Overall Study|Death|1|||
46637409|NCT01474746|82811355|FG000|Overall Study|Lost to Follow-up|1|||
46637410|NCT01474746|82811356|FG001|Overall Study|Lost to Follow-up|1|||
46637411|NCT01474746|82811355|FG000|Overall Study|Withdrawal by Subject|2|||
46637412|NCT01474746|82811356|FG001|Overall Study|Withdrawal by Subject|1|||
46637413|NCT01450800|82811364|FG000|Overall Study|Protocol Violation|1|||
46637414|NCT01450800|82811365|FG001|Overall Study|Protocol Violation|3|||
46637415|NCT01474512|82811376|FG000|Induction Period|Adverse Event|6|||
46637416|NCT01474512|82811377|FG001|Induction Period|Adverse Event|10|||
46637417|NCT01474512|82811378|FG002|Induction Period|Adverse Event|10|||
46762654|NCT00670306|82980896|FG000|Overall Study|Withdrawal by Subject|9|||
46762655|NCT00670306|82980896|FG000|Overall Study|Physician Decision|1|||
46762656|NCT00670306|82980896|FG000|Overall Study|Lost to Follow-up|8|||
47058224|NCT02701296|83337317|FG000|Overall Study|Incomplete Data|0|||
47058225|NCT02701296|83337318|FG001|Overall Study|Incomplete Data|2|||
47058226|NCT01582451|83337335|FG000|Overall Study|Adverse Event|1|||
47058227|NCT01582451|83337336|FG001|Overall Study|Adverse Event|3|||
47058228|NCT01582451|83337335|FG000|Overall Study|Death|3|||
47058229|NCT01582451|83337336|FG001|Overall Study|Death|3|||
47058230|NCT01582451|83337335|FG000|Overall Study|Lost to Follow-up|0|||
47058231|NCT01582451|83337336|FG001|Overall Study|Lost to Follow-up|2|||
47058232|NCT01582451|83337335|FG000|Overall Study|Protocol Violation|11|||
47058233|NCT01582451|83337336|FG001|Overall Study|Protocol Violation|3|||
47058234|NCT01582451|83337335|FG000|Overall Study|Withdrawal by Subject|13|||
46825530|NCT00307125|83044360|FG001|Screening Phase|Withdrawal by Subject|0|||
46825531|NCT00307125|83044361|FG002|Screening Phase|Withdrawal by Subject|0|||
46825532|NCT00307125|83044359|FG000|Screening Phase|Physician Decision|26|||
46825533|NCT00307125|83044360|FG001|Screening Phase|Physician Decision|0|||
46825534|NCT00307125|83044361|FG002|Screening Phase|Physician Decision|0|||
46934509|NCT01460160|83170438|FG000|Treatment Phase|Death|2|||
46934510|NCT01460160|83170438|FG000|Treatment Phase|Other reasons|9|||
46934511|NCT01460160|83170438|FG000|Follow-up Phase|Withdrawal by Subject|4|||
46934512|NCT01460160|83170438|FG000|Follow-up Phase|Death|14|||
47058235|NCT01582451|83337336|FG001|Overall Study|Withdrawal by Subject|9|||
46825535|NCT00307125|83044359|FG000|Screening Phase|Sponsor Decision|4|||
46825536|NCT00307125|83044360|FG001|Screening Phase|Sponsor Decision|0|||
46825537|NCT00307125|83044361|FG002|Screening Phase|Sponsor Decision|0|||
46825538|NCT00307125|83044359|FG000|Screening Phase|Study Terminated|17|||
46825539|NCT00307125|83044360|FG001|Screening Phase|Study Terminated|0|||
46825540|NCT00307125|83044361|FG002|Screening Phase|Study Terminated|0|||
46825541|NCT00307125|83044359|FG000|Screening Phase|Graft Loss|3|||
46825542|NCT00307125|83044360|FG001|Screening Phase|Graft Loss|0|||
47058236|NCT01582451|83337335|FG000|Overall Study|Physician Decision|3|||
47058237|NCT01582451|83337336|FG001|Overall Study|Physician Decision|0|||
46637418|NCT01474512|82811379|FG003|Induction Period|Adverse Event|0|||
46637419|NCT01474512|82811380|FG004|Induction Period|Adverse Event|0|||
46762657|NCT00670306|82980896|FG000|Overall Study|incl/excl criterias did not meet|19|||
46762658|NCT00672256|82980900|FG000|Overall Study|PI dropped, bad data|44|||
46762659|NCT00591630|82980908|FG000|Overall Study|Death|0|||
46762660|NCT00591630|82980909|FG001|Overall Study|Death|0|||
46762661|NCT00591630|82980910|FG002|Overall Study|Death|1|||
46762662|NCT00591630|82980911|FG003|Overall Study|Death|0|||
46762663|NCT00670228|82980923|FG000|Overall Study|Adverse Event|1|||
46762664|NCT00670228|82980924|FG001|Overall Study|Adverse Event|0|||
46762665|NCT00670228|82980923|FG000|Overall Study|Death or MACE|0|||
46762666|NCT00670228|82980924|FG001|Overall Study|Death or MACE|1|||
46762667|NCT00670228|82980923|FG000|Overall Study|Not treated|2|||
46762668|NCT00670228|82980924|FG001|Overall Study|Not treated|2|||
46762669|NCT00670228|82980923|FG000|Overall Study|Not meeting the selection criteria|2|||
46762670|NCT00670228|82980924|FG001|Overall Study|Not meeting the selection criteria|0|||
46825543|NCT00307125|83044361|FG002|Screening Phase|Graft Loss|0|||
47058238|NCT01582451|83337335|FG000|Overall Study|Sponsor Decision|1|||
47058239|NCT01582451|83337336|FG001|Overall Study|Sponsor Decision|0|||
46637420|NCT01474512|82811381|FG005|Induction Period|Adverse Event|0|||
46637421|NCT01474512|82811382|FG006|Induction Period|Adverse Event|0|||
47058240|NCT02700984|83337420|FG000|Overall Study|Death|2|||
46637422|NCT01474512|82811383|FG007|Induction Period|Adverse Event|0|||
46762671|NCT00570778|82980930|FG000|Overall Study|Protocol deviation|2|||
46762672|NCT00570778|82980931|FG001|Overall Study|Protocol deviation|1|||
46762673|NCT00570778|82980932|FG002|Overall Study|Protocol deviation|2|||
46825544|NCT00307125|83044359|FG000|Screening Phase|Graft Failure|8|||
46825545|NCT00307125|83044360|FG001|Screening Phase|Graft Failure|0|||
46825546|NCT00307125|83044361|FG002|Screening Phase|Graft Failure|0|||
46762674|NCT00570778|82980933|FG003|Overall Study|Protocol deviation|2|||
46762675|NCT00570778|82980930|FG000|Overall Study|Adverse Event|0|||
46637423|NCT01474512|82811384|FG008|Induction Period|Adverse Event|0|||
46762676|NCT00570778|82980931|FG001|Overall Study|Adverse Event|1|||
46934513|NCT01460160|83170438|FG000|Follow-up Phase|Lost to Follow-up|7|||
47058241|NCT02700984|83337421|FG001|Overall Study|Death|1|||
47058242|NCT02700984|83337420|FG000|Overall Study|Lost to Follow-up|2|||
46825547|NCT00307125|83044359|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
46825548|NCT00307125|83044360|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
46825549|NCT00307125|83044361|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
46825550|NCT00307125|83044359|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
46825551|NCT00307125|83044360|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
46825552|NCT00307125|83044361|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
46825553|NCT00307125|83044359|FG000|Screening Phase|Moved or transferred facilities|34|||
46825554|NCT00307125|83044360|FG001|Screening Phase|Moved or transferred facilities|0|||
46825555|NCT00307125|83044361|FG002|Screening Phase|Moved or transferred facilities|0|||
46825556|NCT00307125|83044359|FG000|Screening Phase|Received Pancreas Transplant|8|||
46825557|NCT00307125|83044360|FG001|Screening Phase|Received Pancreas Transplant|0|||
46825558|NCT00307125|83044361|FG002|Screening Phase|Received Pancreas Transplant|0|||
46825559|NCT00307125|83044359|FG000|Screening Phase|Ineligible for pilot|4|||
46825560|NCT00307125|83044360|FG001|Screening Phase|Ineligible for pilot|0|||
46825561|NCT00307125|83044361|FG002|Screening Phase|Ineligible for pilot|0|||
46825562|NCT00307125|83044359|FG000|Screening Phase|Try to get pregnant|1|||
46825563|NCT00307125|83044360|FG001|Screening Phase|Try to get pregnant|0|||
46825564|NCT00307125|83044361|FG002|Screening Phase|Try to get pregnant|0|||
46825565|NCT00307125|83044359|FG000|Screening Phase|Developed acute leukemia|1|||
46825566|NCT00307125|83044360|FG001|Screening Phase|Developed acute leukemia|0|||
46825567|NCT00307125|83044361|FG002|Screening Phase|Developed acute leukemia|0|||
46934514|NCT01460160|83170438|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
46934515|NCT01460160|83170438|FG000|Follow-up Phase|Other and not reported reasons|5|||
46934516|NCT01170702|83170446|FG000|Overall Study|Exclusion criteria met after consent|1|||
46934517|NCT01170702|83170447|FG001|Overall Study|Exclusion criteria met after consent|2|||
46825568|NCT00307125|83044359|FG000|Screening Phase|Metastatic colon cancer|1|||
46825569|NCT00307125|83044360|FG001|Screening Phase|Metastatic colon cancer|0|||
46825570|NCT00307125|83044361|FG002|Screening Phase|Metastatic colon cancer|0|||
46825571|NCT00307125|83044359|FG000|Screening Phase|Malignancy|1|||
46825572|NCT00307125|83044360|FG001|Screening Phase|Malignancy|0|||
46825573|NCT00307125|83044361|FG002|Screening Phase|Malignancy|0|||
46825574|NCT00307125|83044359|FG000|Screening Phase|PAK|1|||
46825575|NCT00307125|83044360|FG001|Screening Phase|PAK|0|||
46825576|NCT00307125|83044361|FG002|Screening Phase|PAK|0|||
46825577|NCT00307125|83044359|FG000|Screening Phase|Ineligible|1|||
46825578|NCT00307125|83044360|FG001|Screening Phase|Ineligible|0|||
46825579|NCT00307125|83044361|FG002|Screening Phase|Ineligible|0|||
46825580|NCT00307125|83044359|FG000|Screening Phase|Screen Error|1|||
46825581|NCT00307125|83044360|FG001|Screening Phase|Screen Error|0|||
46825582|NCT00307125|83044361|FG002|Screening Phase|Screen Error|0|||
46825583|NCT00307125|83044359|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
46825584|NCT00307125|83044360|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
46825585|NCT00307125|83044361|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
46825586|NCT00307125|83044359|FG000|Screening Phase|AMR and treated with rituximab|1|||
46825587|NCT00307125|83044360|FG001|Screening Phase|AMR and treated with rituximab|0|||
46825588|NCT00307125|83044361|FG002|Screening Phase|AMR and treated with rituximab|0|||
46825589|NCT00307125|83044359|FG000|Screening Phase|Coronary artery bypass|1|||
46825590|NCT00307125|83044360|FG001|Screening Phase|Coronary artery bypass|0|||
46825591|NCT00307125|83044361|FG002|Screening Phase|Coronary artery bypass|0|||
46825592|NCT00307125|83044359|FG000|Pilot Phase|Lost to Follow-up|0|||
46825593|NCT00307125|83044360|FG001|Pilot Phase|Lost to Follow-up|1|||
46825594|NCT00307125|83044361|FG002|Pilot Phase|Lost to Follow-up|0|||
46825595|NCT00307125|83044359|FG000|Pilot Phase|Withdrawal by Subject|0|||
46825596|NCT00307125|83044360|FG001|Pilot Phase|Withdrawal by Subject|1|||
46825597|NCT00307125|83044361|FG002|Pilot Phase|Withdrawal by Subject|1|||
46825598|NCT00307047|83044373|FG000|Overall Study|Lost to Follow-up|35|||
46825599|NCT00307047|83044374|FG001|Overall Study|Lost to Follow-up|24|||
46825600|NCT00307047|83044373|FG000|Overall Study|Withdrawal by Subject|6|||
46934518|NCT01170702|83170448|FG002|Overall Study|Exclusion criteria met after consent|0|||
46934519|NCT01170702|83170449|FG003|Overall Study|Exclusion criteria met after consent|2|||
47058243|NCT02700984|83337421|FG001|Overall Study|Lost to Follow-up|1|||
46825601|NCT00307047|83044374|FG001|Overall Study|Withdrawal by Subject|6|||
46825602|NCT00307047|83044373|FG000|Overall Study|Physician Decision|1|||
46825603|NCT00307047|83044374|FG001|Overall Study|Physician Decision|2|||
46825604|NCT00307047|83044373|FG000|Overall Study|Lost to follow-up for other reasons|0|||
47058244|NCT02700984|83337420|FG000|Overall Study|Physician Decision|0|||
46825605|NCT00307047|83044374|FG001|Overall Study|Lost to follow-up for other reasons|1|||
46825606|NCT00307047|83044373|FG000|Overall Study|All death, all MI, all Revascularization|27|||
46934520|NCT02723864|83170488|FG000|Overall Study|Refused further treatment|1|||
46934521|NCT02723864|83170489|FG001|Overall Study|Refused further treatment|0|||
46825607|NCT00307047|83044374|FG001|Overall Study|All death, all MI, all Revascularization|16|||
46934522|NCT02723864|83170490|FG002|Overall Study|Refused further treatment|0|||
46825608|NCT00306891|83044384|FG000|Part A|Withdrawal by Subject|1|||
46825609|NCT00306891|83044385|FG001|Part A|Withdrawal by Subject|1|||
46825610|NCT00306891|83044386|FG002|Part A|Withdrawal by Subject|0|||
46825611|NCT00306891|83044387|FG003|Part A|Withdrawal by Subject|0|||
46825612|NCT00306891|83044384|FG000|Part A|Condition under investigation worsened|2|||
46825613|NCT00306891|83044385|FG001|Part A|Condition under investigation worsened|2|||
46825614|NCT00306891|83044386|FG002|Part A|Condition under investigation worsened|0|||
46825615|NCT00306891|83044387|FG003|Part A|Condition under investigation worsened|0|||
46825616|NCT00306891|83044384|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
46825617|NCT00306891|83044385|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
46825618|NCT00306891|83044386|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
46825619|NCT00306891|83044387|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
46825620|NCT00306891|83044384|FG000|Part A|Partial bowel obstruction|1|||
46825621|NCT00306891|83044385|FG001|Part A|Partial bowel obstruction|0|||
46825622|NCT00306891|83044386|FG002|Part A|Partial bowel obstruction|0|||
46825623|NCT00306891|83044387|FG003|Part A|Partial bowel obstruction|0|||
46825624|NCT00306891|83044384|FG000|Part A|Reaccumul. of ascites following drainage|0|||
46825625|NCT00306891|83044385|FG001|Part A|Reaccumul. of ascites following drainage|1|||
46825626|NCT00306891|83044386|FG002|Part A|Reaccumul. of ascites following drainage|0|||
46825627|NCT00306891|83044387|FG003|Part A|Reaccumul. of ascites following drainage|0|||
46825628|NCT00306891|83044384|FG000|Part A|Suspicion of second malignancy|0|||
46825629|NCT00306891|83044385|FG001|Part A|Suspicion of second malignancy|1|||
46825630|NCT00306891|83044386|FG002|Part A|Suspicion of second malignancy|0|||
46825631|NCT00306891|83044387|FG003|Part A|Suspicion of second malignancy|0|||
46825632|NCT00306891|83044384|FG000|Part A|QTC interval outwith elig. criteria|1|||
46825633|NCT00306891|83044385|FG001|Part A|QTC interval outwith elig. criteria|0|||
46825634|NCT00306891|83044386|FG002|Part A|QTC interval outwith elig. criteria|0|||
46825635|NCT00306891|83044387|FG003|Part A|QTC interval outwith elig. criteria|0|||
46825636|NCT00306891|83044384|FG000|Part B|Death|0|||
46825637|NCT00306891|83044385|FG001|Part B|Death|0|||
46825638|NCT00306891|83044386|FG002|Part B|Death|1|||
46825639|NCT00306891|83044387|FG003|Part B|Death|2|||
46825640|NCT00306891|83044384|FG000|Part B|Adverse Event|0|||
46825641|NCT00306891|83044385|FG001|Part B|Adverse Event|0|||
46825642|NCT00306891|83044386|FG002|Part B|Adverse Event|5|||
46825643|NCT00306891|83044387|FG003|Part B|Adverse Event|5|||
46825644|NCT00306891|83044384|FG000|Part B|Withdrawal by Subject|0|||
46825645|NCT00306891|83044385|FG001|Part B|Withdrawal by Subject|0|||
46825646|NCT00306891|83044386|FG002|Part B|Withdrawal by Subject|3|||
46825647|NCT00306891|83044387|FG003|Part B|Withdrawal by Subject|1|||
46825648|NCT00306891|83044384|FG000|Part B|Condition under investigation worsened|0|||
46825649|NCT00306891|83044385|FG001|Part B|Condition under investigation worsened|0|||
46934523|NCT02723864|83170491|FG003|Overall Study|Refused further treatment|0|||
46934524|NCT02723864|83170492|FG004|Overall Study|Refused further treatment|1|||
46934525|NCT02723864|83170493|FG005|Overall Study|Refused further treatment|2|||
46934526|NCT02723864|83170494|FG006|Overall Study|Refused further treatment|0|||
46934527|NCT02723864|83170488|FG000|Overall Study|Exceed treatment hold time|0|||
46934528|NCT02723864|83170489|FG001|Overall Study|Exceed treatment hold time|1|||
46934529|NCT02723864|83170490|FG002|Overall Study|Exceed treatment hold time|0|||
46934530|NCT02723864|83170491|FG003|Overall Study|Exceed treatment hold time|0|||
46934531|NCT02723864|83170492|FG004|Overall Study|Exceed treatment hold time|0|||
46934532|NCT02723864|83170493|FG005|Overall Study|Exceed treatment hold time|0|||
46825650|NCT00306891|83044386|FG002|Part B|Condition under investigation worsened|2|||
46825651|NCT00306891|83044387|FG003|Part B|Condition under investigation worsened|8|||
46825652|NCT00306891|83044384|FG000|Part B|Development of study specific disc crit.|0|||
46825653|NCT00306891|83044385|FG001|Part B|Development of study specific disc crit.|0|||
46825654|NCT00306891|83044386|FG002|Part B|Development of study specific disc crit.|0|||
46825655|NCT00306891|83044387|FG003|Part B|Development of study specific disc crit.|1|||
46825656|NCT00314145|83044400|FG000|Overall Study|Withdrawal by Subject|8|||
46934533|NCT02723864|83170494|FG006|Overall Study|Exceed treatment hold time|0|||
46934534|NCT02723864|83170488|FG000|Overall Study|Clinical progression|0|||
46934535|NCT02723864|83170489|FG001|Overall Study|Clinical progression|0|||
47058245|NCT02700984|83337421|FG001|Overall Study|Physician Decision|1|||
47058246|NCT02700984|83337420|FG000|Overall Study|Withdrawal by Subject|8|||
47058247|NCT02700984|83337421|FG001|Overall Study|Withdrawal by Subject|9|||
46762677|NCT00570778|82980932|FG002|Overall Study|Adverse Event|4|||
46762678|NCT00570778|82980933|FG003|Overall Study|Adverse Event|1|||
47058248|NCT02700984|83337420|FG000|Overall Study|Reason not specified|3|||
46762679|NCT00570778|82980930|FG000|Overall Study|Subject withdrew consent|0|||
46762680|NCT00570778|82980931|FG001|Overall Study|Subject withdrew consent|1|||
46762681|NCT00570778|82980932|FG002|Overall Study|Subject withdrew consent|0|||
46762682|NCT00570778|82980933|FG003|Overall Study|Subject withdrew consent|1|||
46762683|NCT00570778|82980930|FG000|Overall Study|Abnormal test procedure|1|||
46825657|NCT00314145|83044401|FG001|Overall Study|Withdrawal by Subject|10|||
46825658|NCT00314145|83044400|FG000|Overall Study|Lost to Follow-up|5|||
47058249|NCT02700984|83337421|FG001|Overall Study|Reason not specified|2|||
46762684|NCT00570778|82980931|FG001|Overall Study|Abnormal test procedure|0|||
46762685|NCT00570778|82980932|FG002|Overall Study|Abnormal test procedure|0|||
46825659|NCT00314145|83044401|FG001|Overall Study|Lost to Follow-up|12|||
46825660|NCT00314145|83044400|FG000|Overall Study|Physician Decision|3|||
46825661|NCT00314145|83044401|FG001|Overall Study|Physician Decision|4|||
46825662|NCT00314145|83044400|FG000|Overall Study|Adverse Event|0|||
46825663|NCT00314145|83044401|FG001|Overall Study|Adverse Event|3|||
46825664|NCT00314145|83044400|FG000|Overall Study|Protocol Violation|3|||
46825665|NCT00314145|83044401|FG001|Overall Study|Protocol Violation|0|||
46825666|NCT00314145|83044400|FG000|Overall Study|Sponsor Decision|2|||
46825667|NCT00314145|83044401|FG001|Overall Study|Sponsor Decision|0|||
46825668|NCT00313911|83044410|FG000|Overall Study|Serious adverse event|6|||
46825669|NCT00313911|83044411|FG001|Overall Study|Serious adverse event|1|||
46825670|NCT00313911|83044410|FG000|Overall Study|Adverse Event|2|||
46825671|NCT00313911|83044411|FG001|Overall Study|Adverse Event|3|||
46825672|NCT00313911|83044410|FG000|Overall Study|Protocol Violation|19|||
46825673|NCT00313911|83044411|FG001|Overall Study|Protocol Violation|10|||
46825674|NCT00313911|83044410|FG000|Overall Study|Lost to Follow-up|27|||
46825675|NCT00313911|83044411|FG001|Overall Study|Lost to Follow-up|14|||
46825676|NCT00313911|83044410|FG000|Overall Study|Withdrawal by Subject|39|||
46825677|NCT00313911|83044411|FG001|Overall Study|Withdrawal by Subject|12|||
46825678|NCT00313911|83044410|FG000|Overall Study|Did not meet age criteria|1|||
46825679|NCT00313911|83044411|FG001|Overall Study|Did not meet age criteria|1|||
46825680|NCT00391872|83044419|FG000|Overall Study|Protocol Violation|7|||
46825681|NCT00391872|83044420|FG001|Overall Study|Protocol Violation|2|||
46825682|NCT00391872|83044419|FG000|Overall Study|Withdrawal by Subject|296|||
46825683|NCT00391872|83044420|FG001|Overall Study|Withdrawal by Subject|249|||
46825684|NCT00391872|83044419|FG000|Overall Study|Reason unknown|2|||
46825685|NCT00391872|83044420|FG001|Overall Study|Reason unknown|4|||
46825686|NCT00391872|83044419|FG000|Overall Study|Lost to Follow-up|2|||
46825687|NCT00391872|83044420|FG001|Overall Study|Lost to Follow-up|0|||
46825688|NCT00391170|83044428|FG000|Overall Study|Withdrawal by Subject|1|||
46825689|NCT00391170|83044429|FG001|Overall Study|Withdrawal by Subject|0|||
46825690|NCT00391170|83044428|FG000|Overall Study|Adverse Event|3|||
46825691|NCT00391170|83044429|FG001|Overall Study|Adverse Event|2|||
46825692|NCT00391170|83044428|FG000|Overall Study|Physician Decision|2|||
46825693|NCT00391170|83044429|FG001|Overall Study|Physician Decision|2|||
46825694|NCT00402324|83044437|FG000|Overall Study|Lost to Follow-up|11|||
46825695|NCT00402324|83044438|FG001|Overall Study|Lost to Follow-up|11|||
46825696|NCT00402324|83044437|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
46825697|NCT00402324|83044438|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
46825698|NCT00402324|83044437|FG000|Overall Study|Protocol Violation|8|||
46825699|NCT00402324|83044438|FG001|Overall Study|Protocol Violation|7|||
46825700|NCT00402324|83044437|FG000|Overall Study|Withdrawal by Subject|5|||
46825701|NCT00402324|83044438|FG001|Overall Study|Withdrawal by Subject|2|||
46825702|NCT00402324|83044437|FG000|Overall Study|Physician Decision|2|||
46825703|NCT00402324|83044438|FG001|Overall Study|Physician Decision|4|||
46825704|NCT00402324|83044437|FG000|Overall Study|Sponsor Decision|4|||
46825705|NCT00402324|83044438|FG001|Overall Study|Sponsor Decision|5|||
46825706|NCT00402324|83044437|FG000|Overall Study|Lack of Efficacy|1|||
46934536|NCT02723864|83170490|FG002|Overall Study|Clinical progression|1|||
46934537|NCT02723864|83170491|FG003|Overall Study|Clinical progression|0|||
46825707|NCT00402324|83044438|FG001|Overall Study|Lack of Efficacy|4|||
46825708|NCT00402324|83044437|FG000|Overall Study|Adverse Event|6|||
46825709|NCT00402324|83044438|FG001|Overall Study|Adverse Event|4|||
46825710|NCT00402324|83044437|FG000|Overall Study|Death|1|||
46825711|NCT00402324|83044438|FG001|Overall Study|Death|0|||
46825712|NCT00294723|83044447|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
46825713|NCT00294723|83044448|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
46825714|NCT00294723|83044449|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
46825715|NCT00294723|83044447|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
46825716|NCT00294723|83044448|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
46934538|NCT02723864|83170492|FG004|Overall Study|Clinical progression|0|||
46825717|NCT00294723|83044449|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
46825718|NCT00294723|83044447|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
46825719|NCT00294723|83044448|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
46825720|NCT00294723|83044449|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
46825721|NCT00294723|83044447|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
46934539|NCT02723864|83170493|FG005|Overall Study|Clinical progression|3|||
46825722|NCT00294723|83044448|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
46934540|NCT02723864|83170494|FG006|Overall Study|Clinical progression|1|||
46825723|NCT00294723|83044449|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
46825724|NCT00294723|83044447|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
46825725|NCT00294723|83044448|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
46825726|NCT00294723|83044449|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
46825727|NCT00294723|83044447|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
46825728|NCT00294723|83044448|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
46825729|NCT00294723|83044449|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
46825730|NCT00294723|83044447|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
46825731|NCT00294723|83044448|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
46825732|NCT00294723|83044449|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
46825733|NCT00294723|83044447|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
46825734|NCT00294723|83044448|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
46825735|NCT00294723|83044449|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
46825736|NCT00294723|83044447|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
46825737|NCT00294723|83044448|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
46825738|NCT00294723|83044449|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
46825739|NCT00294723|83044447|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
46825740|NCT00294723|83044448|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
46825741|NCT00294723|83044449|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
46825742|NCT00294723|83044447|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
46825743|NCT00294723|83044448|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
46825744|NCT00294723|83044449|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
46825745|NCT00294723|83044447|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
46825746|NCT00294723|83044448|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
46825747|NCT00294723|83044449|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
46825748|NCT00402246|83044462|FG000|Overall Study|Death|62|||
46825749|NCT00402246|83044463|FG001|Overall Study|Death|58|||
46825750|NCT00402246|83044462|FG000|Overall Study|Lost to Follow-up|20|||
46825751|NCT00402246|83044463|FG001|Overall Study|Lost to Follow-up|28|||
46825752|NCT00402246|83044462|FG000|Overall Study|Withdrawal by Subject|72|||
46825753|NCT00402246|83044463|FG001|Overall Study|Withdrawal by Subject|87|||
46825754|NCT00402246|83044462|FG000|Overall Study|Physician Decision|24|||
46825755|NCT00402246|83044463|FG001|Overall Study|Physician Decision|26|||
46825756|NCT00402246|83044462|FG000|Overall Study|Protocol Violation|25|||
46825757|NCT00402246|83044463|FG001|Overall Study|Protocol Violation|24|||
46825758|NCT00402246|83044462|FG000|Overall Study|Missed Final Visit|1|||
46825759|NCT00402246|83044463|FG001|Overall Study|Missed Final Visit|2|||
46825760|NCT00402246|83044462|FG000|Overall Study|Insurance Issues|2|||
46825761|NCT00402246|83044463|FG001|Overall Study|Insurance Issues|1|||
46825762|NCT00402246|83044462|FG000|Overall Study|Heart Transplant|0|||
46825763|NCT00402246|83044463|FG001|Overall Study|Heart Transplant|1|||
46825764|NCT00402246|83044462|FG000|Overall Study|Patient's device explanted|6|||
46825765|NCT00402246|83044463|FG001|Overall Study|Patient's device explanted|2|||
46825766|NCT00402246|83044462|FG000|Overall Study|Center Closure|5|||
46825767|NCT00402246|83044463|FG001|Overall Study|Center Closure|3|||
46825768|NCT00402246|83044462|FG000|Overall Study|Deterioriating Condition|3|||
46825769|NCT00402246|83044463|FG001|Overall Study|Deterioriating Condition|2|||
46825770|NCT00375492|83044473|FG000|Overall Study|Adverse Event|4|||
46825771|NCT00375492|83044474|FG001|Overall Study|Adverse Event|5|||
46825772|NCT00375492|83044473|FG000|Overall Study|Entry Criteria Not Met|0|||
46825773|NCT00375492|83044474|FG001|Overall Study|Entry Criteria Not Met|1|||
46825774|NCT00375492|83044473|FG000|Overall Study|Loss of Glucose Control|0|||
46825775|NCT00375492|83044474|FG001|Overall Study|Loss of Glucose Control|1|||
46825776|NCT00375492|83044473|FG000|Overall Study|Lost to Follow-up|10|||
46825777|NCT00375492|83044474|FG001|Overall Study|Lost to Follow-up|5|||
46825778|NCT00375492|83044473|FG000|Overall Study|Physician Decision|0|||
46825779|NCT00375492|83044474|FG001|Overall Study|Physician Decision|4|||
46825780|NCT00375492|83044473|FG000|Overall Study|Protocol Violation|6|||
46825781|NCT00375492|83044474|FG001|Overall Study|Protocol Violation|3|||
46825782|NCT00375492|83044473|FG000|Overall Study|Sponsor Decision|0|||
46825783|NCT00375492|83044474|FG001|Overall Study|Sponsor Decision|1|||
46825784|NCT00375492|83044473|FG000|Overall Study|Withdrawal by Subject|6|||
46825785|NCT00375492|83044474|FG001|Overall Study|Withdrawal by Subject|6|||
46825786|NCT00306189|83044484|FG000|Overall Study|Physician Decision|0|||
46825787|NCT00306189|83044485|FG001|Overall Study|Physician Decision|0|||
46825788|NCT00306189|83044486|FG002|Overall Study|Physician Decision|0|||
46825789|NCT00306189|83044487|FG003|Overall Study|Physician Decision|1|||
46825790|NCT00306189|83044484|FG000|Overall Study|Adverse Event|3|||
46825791|NCT00306189|83044485|FG001|Overall Study|Adverse Event|3|||
46825792|NCT00306189|83044486|FG002|Overall Study|Adverse Event|2|||
47058250|NCT02696850|83337495|FG000|Overall Study|Withdrawal by Subject|3|||
47058251|NCT02696850|83337496|FG001|Overall Study|Withdrawal by Subject|3|||
46825793|NCT00306189|83044487|FG003|Overall Study|Adverse Event|2|||
46934541|NCT02723864|83170488|FG000|Overall Study|Physician Decision|0|||
47058252|NCT02696850|83337495|FG000|Overall Study|Lost to Follow-up|8|||
46825794|NCT00306189|83044484|FG000|Overall Study|Withdrawal by Subject|4|||
46825795|NCT00306189|83044485|FG001|Overall Study|Withdrawal by Subject|2|||
46825796|NCT00306189|83044486|FG002|Overall Study|Withdrawal by Subject|8|||
46825797|NCT00306189|83044487|FG003|Overall Study|Withdrawal by Subject|1|||
46825798|NCT00306189|83044484|FG000|Overall Study|Ineligibility determined|1|||
46825799|NCT00306189|83044485|FG001|Overall Study|Ineligibility determined|1|||
47058253|NCT02696850|83337496|FG001|Overall Study|Lost to Follow-up|5|||
46825800|NCT00306189|83044486|FG002|Overall Study|Ineligibility determined|1|||
46825801|NCT00306189|83044487|FG003|Overall Study|Ineligibility determined|1|||
46825802|NCT00306189|83044484|FG000|Overall Study|Other|1|||
46825803|NCT00306189|83044485|FG001|Overall Study|Other|0|||
46825804|NCT00306189|83044486|FG002|Overall Study|Other|0|||
46825805|NCT00306189|83044487|FG003|Overall Study|Other|0|||
47058254|NCT02698410|83337650|FG000|Overall Study|Adverse Event|2|||
47058255|NCT02698410|83337650|FG000|Overall Study|Withdrawal by Subject|1|||
47058256|NCT02698410|83337650|FG000|Overall Study|Other|1|||
46825806|NCT00312897|83044499|FG000|Overall Study|Adverse Event|1|||
46825807|NCT00312897|83044500|FG001|Overall Study|Adverse Event|0|||
46825808|NCT00312897|83044499|FG000|Overall Study|Lost to Follow-up|2|||
46825809|NCT00312897|83044500|FG001|Overall Study|Lost to Follow-up|0|||
46825810|NCT00312897|83044499|FG000|Overall Study|Physician Decision|1|||
46825811|NCT00312897|83044500|FG001|Overall Study|Physician Decision|0|||
46825812|NCT00312897|83044499|FG000|Overall Study|Withdrawal by Subject|1|||
47058257|NCT02699892|83337654|FG000|Overall Study|Other|36|||
47058258|NCT02698176|83337661|FG000|Overall Study|Progressive disease|4|||
46825813|NCT00312897|83044500|FG001|Overall Study|Withdrawal by Subject|3|||
46825814|NCT00312897|83044499|FG000|Overall Study|Pregnancy|1|||
46825815|NCT00312897|83044500|FG001|Overall Study|Pregnancy|0|||
46825816|NCT00312897|83044499|FG000|Overall Study|discontinued prior to getting treatment|0|||
46825817|NCT00312897|83044500|FG001|Overall Study|discontinued prior to getting treatment|3|||
46825818|NCT00312663|83044509|FG000|Immunization Phase|Adverse Event|0|||
46825819|NCT00312663|83044510|FG001|Immunization Phase|Adverse Event|1|||
46825820|NCT00312663|83044511|FG002|Immunization Phase|Adverse Event|0|||
46825821|NCT00294645|83044522|FG000|Overall Study|Death|10|||
47058259|NCT02698176|83337662|FG001|Overall Study|Progressive disease|3|||
47058260|NCT02698176|83337663|FG002|Overall Study|Progressive disease|1|||
47058261|NCT02698176|83337664|FG003|Overall Study|Progressive disease|0|||
47058262|NCT02698176|83337661|FG000|Overall Study|Adverse Event|2|||
47058263|NCT02698176|83337662|FG001|Overall Study|Adverse Event|0|||
47058264|NCT02698176|83337663|FG002|Overall Study|Adverse Event|0|||
47058265|NCT02698176|83337664|FG003|Overall Study|Adverse Event|0|||
46825822|NCT00294645|83044523|FG001|Overall Study|Death|18|||
46825823|NCT00294645|83044522|FG000|Overall Study|Lost to Follow-up|1|||
46825824|NCT00294645|83044523|FG001|Overall Study|Lost to Follow-up|10|||
46825825|NCT00294645|83044522|FG000|Overall Study|Withdrawal by Subject|18|||
46825826|NCT00294645|83044523|FG001|Overall Study|Withdrawal by Subject|34|||
46825827|NCT00294645|83044522|FG000|Overall Study|Physician Decision|15|||
46825828|NCT00294645|83044523|FG001|Overall Study|Physician Decision|20|||
46825829|NCT00294645|83044522|FG000|Overall Study|Other|4|||
46825830|NCT00294645|83044523|FG001|Overall Study|Other|10|||
46825831|NCT00305877|83044531|FG000|Overall Study|Lack of Efficacy|6|||
46825832|NCT00305877|83044532|FG001|Overall Study|Lack of Efficacy|9|||
47058266|NCT02698176|83337661|FG000|Overall Study|Clinical progression|3|||
47058267|NCT02698176|83337662|FG001|Overall Study|Clinical progression|0|||
47058268|NCT02698176|83337663|FG002|Overall Study|Clinical progression|0|||
46825833|NCT00305877|83044531|FG000|Overall Study|Adverse Event|9|||
46825834|NCT00305877|83044532|FG001|Overall Study|Adverse Event|14|||
46825835|NCT00305877|83044531|FG000|Overall Study|Death|0|||
46825836|NCT00305877|83044532|FG001|Overall Study|Death|1|||
46825837|NCT00305877|83044531|FG000|Overall Study|Withdrawal by Subject|4|||
46825838|NCT00305877|83044532|FG001|Overall Study|Withdrawal by Subject|2|||
46825839|NCT00305877|83044531|FG000|Overall Study|Physician Decision|1|||
46825840|NCT00305877|83044532|FG001|Overall Study|Physician Decision|1|||
46825841|NCT00305877|83044531|FG000|Overall Study|Never start treatment|2|||
46825842|NCT00305877|83044532|FG001|Overall Study|Never start treatment|5|||
46825843|NCT00305877|83044531|FG000|Overall Study|Ineligible|2|||
47058269|NCT02698176|83337664|FG003|Overall Study|Clinical progression|0|||
47058270|NCT02693418|83337680|FG000|Overall Study|Lost to Follow-up|1|||
46825844|NCT00305877|83044532|FG001|Overall Study|Ineligible|1|||
46825845|NCT00305877|83044531|FG000|Overall Study|Transportation issue with daily RT|0|||
46825846|NCT00305877|83044532|FG001|Overall Study|Transportation issue with daily RT|1|||
46825847|NCT00312195|83044540|FG000|Overall Study|Adverse Event|4|||
46825848|NCT00312195|83044541|FG001|Overall Study|Adverse Event|6|||
46825849|NCT00312195|83044540|FG000|Overall Study|Lost to Follow-up|1|||
46825850|NCT00312195|83044541|FG001|Overall Study|Lost to Follow-up|0|||
46825851|NCT00312195|83044540|FG000|Overall Study|Protocol Violation|1|||
46825852|NCT00312195|83044541|FG001|Overall Study|Protocol Violation|0|||
46934542|NCT02723864|83170489|FG001|Overall Study|Physician Decision|0|||
47058271|NCT02693418|83337681|FG001|Overall Study|Lost to Follow-up|2|||
47058272|NCT02693418|83337682|FG002|Overall Study|Lost to Follow-up|0|||
47058273|NCT02693418|83337683|FG003|Overall Study|Lost to Follow-up|0|||
47058274|NCT02693418|83337684|FG004|Overall Study|Lost to Follow-up|0|||
47058275|NCT02693418|83337680|FG000|Overall Study|Menses during study period|0|||
47058276|NCT02693418|83337681|FG001|Overall Study|Menses during study period|0|||
47058277|NCT02693418|83337682|FG002|Overall Study|Menses during study period|2|||
47058278|NCT02693418|83337683|FG003|Overall Study|Menses during study period|0|||
47058279|NCT02693418|83337684|FG004|Overall Study|Menses during study period|0|||
47058280|NCT02693106|83337717|FG000|Overall Study|No time|3|||
47058281|NCT02546986|83337729|FG000|Treatment Period|Progressive Disease|20|||
47058282|NCT02546986|83337730|FG001|Treatment Period|Progressive Disease|22|||
47058283|NCT02546986|83337729|FG000|Treatment Period|Adverse Event|14|||
46762686|NCT00570778|82980933|FG003|Overall Study|Abnormal test procedure|0|||
46762687|NCT00570778|82980930|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46825853|NCT00305253|83044551|FG000|Overall Study|Withdrawal by Subject|0|||
46825854|NCT00305253|83044552|FG001|Overall Study|Withdrawal by Subject|1|||
46825855|NCT00293709|83044558|FG000|Overall Study|Other|47|||
46825856|NCT00311181|83044562|FG000|Overall Study|Final DFTs were not obtained|96|||
46825857|NCT00293397|83044566|FG000|Overall Study|Death|2|||
46825858|NCT00290745|83044571|FG000|Overall Study|Withdrawal by Subject|4|||
46825859|NCT00290745|83044571|FG000|Overall Study|Physician Decision|2|||
46825860|NCT00290745|83044571|FG000|Overall Study|Surgery after 3 months for progression|3|||
46825861|NCT00290745|83044571|FG000|Overall Study|Baseline MRI not available|3|||
46825862|NCT00402168|83044577|FG000|Randomized|Lost to Follow-up|1|||
46825863|NCT00402168|83044578|FG001|Randomized|Lost to Follow-up|0|||
46825864|NCT00402168|83044577|FG000|Randomized|Withdrawal by Subject|0|||
46825865|NCT00402168|83044578|FG001|Randomized|Withdrawal by Subject|1|||
46825866|NCT00402168|83044577|FG000|Treatment (up to 12 Months)|Death|0|||
46825867|NCT00402168|83044578|FG001|Treatment (up to 12 Months)|Death|1|||
46825868|NCT00402168|83044577|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
46825869|NCT00402168|83044578|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
46825870|NCT00402168|83044577|FG000|Treatment (up to 12 Months)|non-specified|0|||
46825871|NCT00402168|83044578|FG001|Treatment (up to 12 Months)|non-specified|1|||
46825872|NCT00402168|83044577|FG000|Long Term (LT)|Adverse Event|1|||
46934543|NCT02723864|83170490|FG002|Overall Study|Physician Decision|0|||
46934544|NCT02723864|83170491|FG003|Overall Study|Physician Decision|0|||
46934545|NCT02723864|83170492|FG004|Overall Study|Physician Decision|0|||
46934546|NCT02723864|83170493|FG005|Overall Study|Physician Decision|0|||
46934547|NCT02723864|83170494|FG006|Overall Study|Physician Decision|1|||
46934548|NCT02723864|83170488|FG000|Overall Study|Changes in patient condition|0|||
46825873|NCT00402168|83044578|FG001|Long Term (LT)|Adverse Event|5|||
46825874|NCT00402168|83044577|FG000|Long Term (LT)|Withdrawal by Subject|4|||
46825875|NCT00402168|83044578|FG001|Long Term (LT)|Withdrawal by Subject|7|||
46825876|NCT00402168|83044577|FG000|Long Term (LT)|Pregnancy|0|||
46825877|NCT00402168|83044578|FG001|Long Term (LT)|Pregnancy|1|||
46825878|NCT00402168|83044577|FG000|Long Term (LT)|Lost to Follow-up|1|||
46825879|NCT00402168|83044578|FG001|Long Term (LT)|Lost to Follow-up|0|||
46825880|NCT00402168|83044577|FG000|Long Term (LT)|Death|4|||
46825881|NCT00402168|83044578|FG001|Long Term (LT)|Death|0|||
46825882|NCT00402168|83044577|FG000|Long Term (LT)|Lack of Efficacy|0|||
46825883|NCT00402168|83044578|FG001|Long Term (LT)|Lack of Efficacy|2|||
46825884|NCT00402168|83044577|FG000|Long Term (LT)|non-specified|1|||
46825885|NCT00402168|83044578|FG001|Long Term (LT)|non-specified|2|||
46762688|NCT00570778|82980931|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46934549|NCT02723864|83170489|FG001|Overall Study|Changes in patient condition|0|||
47058284|NCT02546986|83337730|FG001|Treatment Period|Adverse Event|6|||
46762689|NCT00570778|82980932|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
46762690|NCT00570778|82980933|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
46762691|NCT00570778|82980930|FG000|Overall Study|Lost to Follow-up|0|||
46762692|NCT00570778|82980931|FG001|Overall Study|Lost to Follow-up|0|||
46762693|NCT00570778|82980932|FG002|Overall Study|Lost to Follow-up|1|||
46762694|NCT00570778|82980933|FG003|Overall Study|Lost to Follow-up|0|||
46762695|NCT00570778|82980930|FG000|Overall Study|Subject no longer requires study drug|0|||
46762696|NCT00570778|82980931|FG001|Overall Study|Subject no longer requires study drug|1|||
46825886|NCT00402168|83044577|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
46825887|NCT00402168|83044578|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
46934550|NCT02723864|83170490|FG002|Overall Study|Changes in patient condition|0|||
46934551|NCT02723864|83170491|FG003|Overall Study|Changes in patient condition|0|||
46934552|NCT02723864|83170492|FG004|Overall Study|Changes in patient condition|0|||
46934553|NCT02723864|83170493|FG005|Overall Study|Changes in patient condition|1|||
46934554|NCT02723864|83170494|FG006|Overall Study|Changes in patient condition|0|||
46825888|NCT00402168|83044577|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
46825889|NCT00402168|83044578|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
46825890|NCT00290589|83044594|FG000|Overall Study|Lost to Follow-up|2|||
46934555|NCT02723864|83170488|FG000|Overall Study|Patient choice|0|||
47058285|NCT02546986|83337729|FG000|Treatment Period|Symptomatic Deterioration|4|||
47058286|NCT02546986|83337730|FG001|Treatment Period|Symptomatic Deterioration|3|||
47058287|NCT02546986|83337729|FG000|Treatment Period|Death|3|||
46825891|NCT00290589|83044595|FG001|Overall Study|Lost to Follow-up|2|||
46825892|NCT00290511|83044601|FG000|Overall Study|Adverse Event|1|||
46825893|NCT00290511|83044601|FG000|Overall Study|Death|1|||
46825894|NCT00290511|83044601|FG000|Overall Study|Physician Decision|1|||
46825895|NCT00290511|83044601|FG000|Overall Study|Withdrawal by Subject|1|||
46825896|NCT00290433|83044605|FG000|Overall Study|Disease Progression|13|||
47058288|NCT02546986|83337730|FG001|Treatment Period|Death|4|||
46825897|NCT00290433|83044605|FG000|Overall Study|Adverse Event|14|||
46825898|NCT00290433|83044605|FG000|Overall Study|Withdrawal by Subject|1|||
46825899|NCT00290433|83044605|FG000|Overall Study|Non-Compliance|1|||
46825900|NCT00290433|83044605|FG000|Overall Study|Congestive Heart Failure|1|||
46825901|NCT00290433|83044605|FG000|Overall Study|Transplant in CR|5|||
46825902|NCT00290433|83044605|FG000|Overall Study|Unrelated Infection/Death|1|||
46825903|NCT00304083|83044611|FG000|Overall Study|Withdrawal by Subject|4|||
46825904|NCT00304083|83044612|FG001|Overall Study|Withdrawal by Subject|2|||
46825905|NCT00304083|83044611|FG000|Overall Study|Physician Decision|8|||
46825906|NCT00304083|83044612|FG001|Overall Study|Physician Decision|3|||
47058289|NCT02546986|83337729|FG000|Treatment Period|Physician Decision|1|||
46825907|NCT00304083|83044611|FG000|Overall Study|Disease Progression|5|||
47058290|NCT02546986|83337730|FG001|Treatment Period|Physician Decision|2|||
47058291|NCT02546986|83337729|FG000|Treatment Period|Protocol Violation|1|||
47058292|NCT02546986|83337730|FG001|Treatment Period|Protocol Violation|0|||
46825908|NCT00304083|83044612|FG001|Overall Study|Disease Progression|1|||
46825909|NCT00304083|83044611|FG000|Overall Study|Other|5|||
46825910|NCT00304083|83044612|FG001|Overall Study|Other|2|||
46825911|NCT00293241|83044620|FG000|Overall Study|Lost to Follow-up|9|||
46825912|NCT00293241|83044621|FG001|Overall Study|Lost to Follow-up|16|||
46825913|NCT00293241|83044620|FG000|Overall Study|Physician Decision|23|||
47058293|NCT02546986|83337729|FG000|Treatment Period|Withdrawal by Subject|1|||
47058294|NCT02546986|83337730|FG001|Treatment Period|Withdrawal by Subject|1|||
47058295|NCT02546986|83337729|FG000|Treatment Period|Non-compliance with Study Drug|0|||
47058296|NCT02546986|83337730|FG001|Treatment Period|Non-compliance with Study Drug|1|||
47058297|NCT02546986|83337729|FG000|Treatment Period|Study Terminated by Sponsor|0|||
47058298|NCT02546986|83337730|FG001|Treatment Period|Study Terminated by Sponsor|1|||
47058299|NCT02546986|83337729|FG000|Treatment Period|Miscellaneous|7|||
47058300|NCT02546986|83337730|FG001|Treatment Period|Miscellaneous|9|||
47058301|NCT02546986|83337729|FG000|Survival Follow-Up Phase|Missing Status|3|||
47058302|NCT02546986|83337730|FG001|Survival Follow-Up Phase|Missing Status|5|||
47058303|NCT02546986|83337729|FG000|Survival Follow-Up Phase|Death|18|||
47058304|NCT02546986|83337730|FG001|Survival Follow-Up Phase|Death|12|||
47058305|NCT02546986|83337729|FG000|Survival Follow-Up Phase|Alive|13|||
47058306|NCT02546986|83337730|FG001|Survival Follow-Up Phase|Alive|16|||
47058307|NCT02546986|83337729|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
47058308|NCT02546986|83337730|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
47058309|NCT02689206|83337741|FG000|Overall Study|Adverse Event|0|||
47058310|NCT02689206|83337742|FG001|Overall Study|Adverse Event|0|||
47058311|NCT02689206|83337743|FG002|Overall Study|Adverse Event|1|||
47058312|NCT02689206|83337744|FG003|Overall Study|Adverse Event|0|||
47058313|NCT02689206|83337745|FG004|Overall Study|Adverse Event|2|||
47058314|NCT02689206|83337741|FG000|Overall Study|Protocol Violation|1|||
47058315|NCT02689206|83337742|FG001|Overall Study|Protocol Violation|0|||
47058316|NCT02689206|83337743|FG002|Overall Study|Protocol Violation|0|||
47058317|NCT02689206|83337744|FG003|Overall Study|Protocol Violation|1|||
47058318|NCT02689206|83337745|FG004|Overall Study|Protocol Violation|2|||
47058319|NCT02689206|83337741|FG000|Overall Study|Other: Reached stopping criteria|0|||
47058320|NCT02689206|83337742|FG001|Overall Study|Other: Reached stopping criteria|1|||
46637424|NCT01474512|82811385|FG009|Induction Period|Adverse Event|0|||
46762697|NCT00570778|82980932|FG002|Overall Study|Subject no longer requires study drug|0|||
46762698|NCT00570778|82980933|FG003|Overall Study|Subject no longer requires study drug|0|||
46762699|NCT00668746|82980945|FG000|Overall Study|Lost to Follow-up|2|||
46762700|NCT00668746|82980946|FG001|Overall Study|Lost to Follow-up|1|||
46762701|NCT00878189|82980964|FG000|Overall Study|Death|0|||
46762702|NCT00878189|82980965|FG001|Overall Study|Death|1|||
46762703|NCT00878189|82980966|FG002|Overall Study|Death|0|||
47058321|NCT02689206|83337743|FG002|Overall Study|Other: Reached stopping criteria|2|||
47058322|NCT02689206|83337744|FG003|Overall Study|Other: Reached stopping criteria|3|||
47058323|NCT02689206|83337745|FG004|Overall Study|Other: Reached stopping criteria|4|||
47058324|NCT02689206|83337741|FG000|Overall Study|Physician Decision|1|||
46762704|NCT00878189|82980967|FG003|Overall Study|Death|1|||
46762705|NCT00878189|82980968|FG004|Overall Study|Death|0|||
46762706|NCT00878189|82980969|FG005|Overall Study|Death|0|||
46762707|NCT00878189|82980970|FG006|Overall Study|Death|0|||
46762708|NCT00878189|82980971|FG007|Overall Study|Death|0|||
46762709|NCT00878189|82980972|FG008|Overall Study|Death|1|||
46762710|NCT00878189|82980964|FG000|Overall Study|Participant Refused to Follow-up|0|||
46762711|NCT00878189|82980965|FG001|Overall Study|Participant Refused to Follow-up|0|||
46762712|NCT00878189|82980966|FG002|Overall Study|Participant Refused to Follow-up|0|||
46762713|NCT00878189|82980967|FG003|Overall Study|Participant Refused to Follow-up|0|||
47058325|NCT02689206|83337742|FG001|Overall Study|Physician Decision|0|||
47058326|NCT02689206|83337743|FG002|Overall Study|Physician Decision|0|||
47058327|NCT02689206|83337744|FG003|Overall Study|Physician Decision|0|||
47058328|NCT02689206|83337745|FG004|Overall Study|Physician Decision|0|||
47058329|NCT02689206|83337741|FG000|Overall Study|Withdrawal by Subject|1|||
46762714|NCT00878189|82980968|FG004|Overall Study|Participant Refused to Follow-up|0|||
46825914|NCT00293241|83044621|FG001|Overall Study|Physician Decision|17|||
46825915|NCT00293241|83044620|FG000|Overall Study|Withdrawal by Subject|4|||
46825916|NCT00293241|83044621|FG001|Overall Study|Withdrawal by Subject|8|||
46825917|NCT00391092|83044632|FG000|Overall Study|Death|78|||
46825918|NCT00391092|83044633|FG001|Overall Study|Death|81|||
46762715|NCT00878189|82980969|FG005|Overall Study|Participant Refused to Follow-up|4|||
46762716|NCT00878189|82980970|FG006|Overall Study|Participant Refused to Follow-up|0|||
46825919|NCT00391092|83044632|FG000|Overall Study|Lost to Follow-up|13|||
46825920|NCT00391092|83044633|FG001|Overall Study|Lost to Follow-up|18|||
46762717|NCT00878189|82980971|FG007|Overall Study|Participant Refused to Follow-up|0|||
46762718|NCT00878189|82980972|FG008|Overall Study|Participant Refused to Follow-up|0|||
46762719|NCT00878189|82980964|FG000|Overall Study|Other|3|||
46762720|NCT00878189|82980965|FG001|Overall Study|Other|2|||
46762721|NCT00878189|82980966|FG002|Overall Study|Other|4|||
46825921|NCT00391092|83044632|FG000|Overall Study|Alive on treatment|29|||
46825922|NCT00391092|83044633|FG001|Overall Study|Alive on treatment|33|||
46825923|NCT00391092|83044632|FG000|Overall Study|Alive in follow-up|88|||
46825924|NCT00391092|83044633|FG001|Overall Study|Alive in follow-up|84|||
46825925|NCT00374868|83044639|FG000|Overall Study|Adverse Event|12|||
46825926|NCT00374868|83044639|FG000|Overall Study|Progressive Disease|7|||
46825927|NCT00374868|83044639|FG000|Overall Study|Physician Decision|13|||
46825928|NCT00374868|83044639|FG000|Overall Study|Lost to Follow-up|1|||
46825929|NCT00374868|83044639|FG000|Overall Study|Death|2|||
46825930|NCT00374868|83044639|FG000|Overall Study|Other - Not Specified|1|||
46762722|NCT00878189|82980967|FG003|Overall Study|Other|7|||
46762723|NCT00878189|82980968|FG004|Overall Study|Other|4|||
46762724|NCT00878189|82980969|FG005|Overall Study|Other|18|||
46762725|NCT00878189|82980970|FG006|Overall Study|Other|15|||
46762726|NCT00878189|82980971|FG007|Overall Study|Other|3|||
46762727|NCT00878189|82980972|FG008|Overall Study|Other|4|||
46762728|NCT00878189|82980964|FG000|Overall Study|Lost to Follow-up|0|||
46762729|NCT00878189|82980965|FG001|Overall Study|Lost to Follow-up|0|||
46762730|NCT00878189|82980966|FG002|Overall Study|Lost to Follow-up|0|||
46762731|NCT00878189|82980967|FG003|Overall Study|Lost to Follow-up|0|||
46762732|NCT00878189|82980968|FG004|Overall Study|Lost to Follow-up|0|||
46762733|NCT00878189|82980969|FG005|Overall Study|Lost to Follow-up|1|||
46762734|NCT00878189|82980970|FG006|Overall Study|Lost to Follow-up|1|||
46762735|NCT00878189|82980971|FG007|Overall Study|Lost to Follow-up|0|||
46762736|NCT00878189|82980972|FG008|Overall Study|Lost to Follow-up|0|||
46762737|NCT00878189|82980964|FG000|Overall Study|Objection Progression or Relapse|0|||
46762738|NCT00878189|82980965|FG001|Overall Study|Objection Progression or Relapse|0|||
46762739|NCT00878189|82980966|FG002|Overall Study|Objection Progression or Relapse|0|||
46825931|NCT00374556|83044645|FG000|Overall Study|Lost to Follow-up|1|||
46825932|NCT00374556|83044646|FG001|Overall Study|Lost to Follow-up|0|||
46934556|NCT02723864|83170489|FG001|Overall Study|Patient choice|0|||
46934557|NCT02723864|83170490|FG002|Overall Study|Patient choice|0|||
46934558|NCT02723864|83170491|FG003|Overall Study|Patient choice|0|||
46934559|NCT02723864|83170492|FG004|Overall Study|Patient choice|0|||
46934560|NCT02723864|83170493|FG005|Overall Study|Patient choice|1|||
46934561|NCT02723864|83170494|FG006|Overall Study|Patient choice|0|||
46934562|NCT02723864|83170488|FG000|Overall Study|Adverse Event|0|||
46934563|NCT02723864|83170489|FG001|Overall Study|Adverse Event|0|||
46934564|NCT02723864|83170490|FG002|Overall Study|Adverse Event|0|||
47058330|NCT02689206|83337742|FG001|Overall Study|Withdrawal by Subject|0|||
47058331|NCT02689206|83337743|FG002|Overall Study|Withdrawal by Subject|1|||
46762740|NCT00878189|82980967|FG003|Overall Study|Objection Progression or Relapse|0|||
46762741|NCT00878189|82980968|FG004|Overall Study|Objection Progression or Relapse|0|||
46762742|NCT00878189|82980969|FG005|Overall Study|Objection Progression or Relapse|0|||
46762743|NCT00878189|82980970|FG006|Overall Study|Objection Progression or Relapse|0|||
46762744|NCT00878189|82980971|FG007|Overall Study|Objection Progression or Relapse|0|||
46762745|NCT00878189|82980972|FG008|Overall Study|Objection Progression or Relapse|3|||
46762746|NCT00668200|82981006|FG000|Overall Study|Withdrawal by Subject|2|||
46762747|NCT00668200|82981006|FG000|Overall Study|Lost to Follow-up|1|||
46762748|NCT00838578|82981010|FG000|Overall Study|Protocol Violation|2|||
46762749|NCT00829296|82981020|FG000|Overall Study|Adverse Event|5|||
46762750|NCT00829296|82981021|FG001|Overall Study|Adverse Event|4|||
46762751|NCT00881621|82981027|FG000|Overall Study|Physician Decision|34|||
46762752|NCT00818766|82981033|FG000|Overall Study|Could not be Contacted on Day 28|11|||
46825933|NCT00374556|83044645|FG000|Overall Study|Removed at baseline due to medical cond|0|||
46934565|NCT02723864|83170491|FG003|Overall Study|Adverse Event|0|||
47058332|NCT02689206|83337744|FG003|Overall Study|Withdrawal by Subject|0|||
46825934|NCT00374556|83044646|FG001|Overall Study|Removed at baseline due to medical cond|1|||
46934566|NCT02723864|83170492|FG004|Overall Study|Adverse Event|0|||
46934567|NCT02723864|83170493|FG005|Overall Study|Adverse Event|1|||
46934568|NCT02723864|83170494|FG006|Overall Study|Adverse Event|0|||
46825935|NCT00290355|83044654|FG000|Overall Study|Serious adverse event|7|||
46825936|NCT00290355|83044655|FG001|Overall Study|Serious adverse event|4|||
46825937|NCT00290355|83044654|FG000|Overall Study|Study product reactogenicity|1|||
46825938|NCT00290355|83044655|FG001|Overall Study|Study product reactogenicity|0|||
46825939|NCT00290355|83044654|FG000|Overall Study|Protocol Violation|1|||
46825940|NCT00290355|83044655|FG001|Overall Study|Protocol Violation|0|||
46825941|NCT00290355|83044654|FG000|Overall Study|Withdrawal by Subject|2|||
46825942|NCT00290355|83044655|FG001|Overall Study|Withdrawal by Subject|0|||
46825943|NCT00290355|83044654|FG000|Overall Study|Migrated / moved from the study area|1|||
46825944|NCT00290355|83044655|FG001|Overall Study|Migrated / moved from the study area|0|||
46934569|NCT02723864|83170488|FG000|Overall Study|Started new treatment|0|||
46825945|NCT00290355|83044654|FG000|Overall Study|Lost to Follow-up|3|||
46825946|NCT00290355|83044655|FG001|Overall Study|Lost to Follow-up|1|||
46825947|NCT00290355|83044654|FG000|Overall Study|Other|2|||
46825948|NCT00290355|83044655|FG001|Overall Study|Other|0|||
46825949|NCT00374322|83044663|FG000|Overall Study|Lost to Follow-up|92|||
46825950|NCT00374322|83044664|FG001|Overall Study|Lost to Follow-up|90|||
46825951|NCT00374322|83044663|FG000|Overall Study|Protocol Violation|8|||
46825952|NCT00374322|83044664|FG001|Overall Study|Protocol Violation|3|||
46825953|NCT00374322|83044663|FG000|Overall Study|Withdrawal by Subject|235|||
46825954|NCT00374322|83044664|FG001|Overall Study|Withdrawal by Subject|167|||
46825955|NCT00374322|83044663|FG000|Overall Study|Sponsor Terminated Study|866|||
46825956|NCT00374322|83044664|FG001|Overall Study|Sponsor Terminated Study|990|||
46934570|NCT02723864|83170489|FG001|Overall Study|Started new treatment|0|||
46637425|NCT01474512|82811386|FG010|Induction Period|Adverse Event|0|||
46637426|NCT01474512|82811387|FG011|Induction Period|Adverse Event|0|||
46762753|NCT00818766|82981034|FG001|Overall Study|Could not be Contacted on Day 28|10|||
46762754|NCT00818766|82981033|FG000|Overall Study|Death|1|||
46825957|NCT00374322|83044663|FG000|Overall Study|Physician Decision|36|||
46825958|NCT00374322|83044664|FG001|Overall Study|Physician Decision|32|||
46825959|NCT00374322|83044663|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
46934571|NCT02723864|83170490|FG002|Overall Study|Started new treatment|0|||
46637427|NCT01474512|82811388|FG012|Induction Period|Adverse Event|0|||
46637428|NCT01474512|82811389|FG013|Induction Period|Adverse Event|0|||
46637429|NCT01474512|82811390|FG014|Induction Period|Adverse Event|0|||
46637430|NCT01474512|82811391|FG015|Induction Period|Adverse Event|0|||
46762755|NCT00818766|82981034|FG001|Overall Study|Death|0|||
46762756|NCT00818766|82981033|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
46762757|NCT00818766|82981034|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
46762758|NCT00667888|82981042|FG000|Overall Study|Death|1|||
46762759|NCT00667888|82981043|FG001|Overall Study|Death|1|||
46762760|NCT00667888|82981042|FG000|Overall Study|Withdrawal by Subject|6|||
46762761|NCT00667888|82981043|FG001|Overall Study|Withdrawal by Subject|3|||
46762762|NCT00667888|82981042|FG000|Overall Study|Proceed with other treatment|3|||
46762763|NCT00667888|82981043|FG001|Overall Study|Proceed with other treatment|3|||
46762764|NCT00667888|82981042|FG000|Overall Study|Ineligible after SIM|0|||
46762765|NCT00667888|82981043|FG001|Overall Study|Ineligible after SIM|2|||
46762766|NCT00594815|82981049|FG000|Overall Study|Never Treated|3|||
46762767|NCT00594815|82981049|FG000|Overall Study|Withdrawal by Subject|2|||
46762768|NCT00594815|82981049|FG000|Overall Study|Toxicity|4|||
46762769|NCT00820170|82981058|FG000|Overall Study|Adverse Event|0|||
46762770|NCT00820170|82981059|FG001|Overall Study|Adverse Event|0|||
46762771|NCT00820170|82981060|FG002|Overall Study|Adverse Event|0|||
46762772|NCT00820170|82981061|FG003|Overall Study|Adverse Event|0|||
46762773|NCT00820170|82981062|FG004|Overall Study|Adverse Event|2|||
46762774|NCT00820170|82981058|FG000|Overall Study|Progressive Disease|0|||
46762775|NCT00820170|82981059|FG001|Overall Study|Progressive Disease|0|||
46762776|NCT00820170|82981060|FG002|Overall Study|Progressive Disease|0|||
46762777|NCT00820170|82981061|FG003|Overall Study|Progressive Disease|0|||
46762778|NCT00820170|82981062|FG004|Overall Study|Progressive Disease|2|||
46762779|NCT00818454|82981079|FG000|Treatment Period 1|Adverse Event|0|||
46762780|NCT00818454|82981080|FG001|Treatment Period 1|Adverse Event|1|||
46762781|NCT00818454|82981081|FG002|Treatment Period 1|Adverse Event|0|||
46762782|NCT00818454|82981082|FG003|Treatment Period 1|Adverse Event|0|||
46762783|NCT00818454|82981079|FG000|Treatment Period 1|Other|3|||
46762784|NCT00818454|82981080|FG001|Treatment Period 1|Other|0|||
46825960|NCT00374322|83044664|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
46825961|NCT00374322|83044663|FG000|Overall Study|Sponsor Decision|2|||
46825962|NCT00374322|83044664|FG001|Overall Study|Sponsor Decision|3|||
46825963|NCT00374322|83044663|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
46934572|NCT02723864|83170491|FG003|Overall Study|Started new treatment|0|||
46934573|NCT02723864|83170492|FG004|Overall Study|Started new treatment|0|||
46762785|NCT00818454|82981081|FG002|Treatment Period 1|Other|0|||
46762786|NCT00818454|82981082|FG003|Treatment Period 1|Other|0|||
46637431|NCT01474512|82811392|FG016|Induction Period|Adverse Event|0|||
46762787|NCT00818454|82981079|FG000|Washout Period of 1 Week|Adverse Event|1|||
46825964|NCT00374322|83044664|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
46825965|NCT00374322|83044663|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
46825966|NCT00374322|83044664|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
46825967|NCT00374322|83044663|FG000|Overall Study|Severe Toxicity|1|||
46825968|NCT00374322|83044664|FG001|Overall Study|Severe Toxicity|0|||
46825969|NCT00374322|83044663|FG000|Overall Study|Site Closed|2|||
46825970|NCT00374322|83044664|FG001|Overall Study|Site Closed|2|||
46934574|NCT02723864|83170493|FG005|Overall Study|Started new treatment|1|||
46934575|NCT02723864|83170494|FG006|Overall Study|Started new treatment|0|||
46934576|NCT02723864|83170488|FG000|Overall Study|Switched to alternative treatment|0|||
46934577|NCT02723864|83170489|FG001|Overall Study|Switched to alternative treatment|0|||
46934578|NCT02723864|83170490|FG002|Overall Study|Switched to alternative treatment|0|||
46934579|NCT02723864|83170491|FG003|Overall Study|Switched to alternative treatment|0|||
46934580|NCT02723864|83170492|FG004|Overall Study|Switched to alternative treatment|0|||
46934581|NCT02723864|83170493|FG005|Overall Study|Switched to alternative treatment|1|||
46934582|NCT02723864|83170494|FG006|Overall Study|Switched to alternative treatment|0|||
46934583|NCT02723864|83170488|FG000|Overall Study|Late determination of ineligibility|0|||
46934584|NCT02723864|83170489|FG001|Overall Study|Late determination of ineligibility|0|||
46934585|NCT02723864|83170490|FG002|Overall Study|Late determination of ineligibility|0|||
46934586|NCT02723864|83170491|FG003|Overall Study|Late determination of ineligibility|0|||
46934587|NCT02723864|83170492|FG004|Overall Study|Late determination of ineligibility|0|||
46934588|NCT02723864|83170493|FG005|Overall Study|Late determination of ineligibility|1|||
46934589|NCT02723864|83170494|FG006|Overall Study|Late determination of ineligibility|0|||
46934590|NCT00705146|83170533|FG000|Overall Study|Lost to Follow-up|1|||
46934591|NCT00705146|83170534|FG001|Overall Study|Lost to Follow-up|1|||
46934592|NCT03203642|83170542|FG000|Overall Study|Adverse Event|3|||
46934593|NCT03203642|83170543|FG001|Overall Study|Adverse Event|1|||
46934594|NCT03203642|83170542|FG000|Overall Study|Withdrawal by Subject|6|||
46934595|NCT03203642|83170543|FG001|Overall Study|Withdrawal by Subject|6|||
46934596|NCT03203642|83170542|FG000|Overall Study|Lost to Follow-up|2|||
46934597|NCT03203642|83170543|FG001|Overall Study|Lost to Follow-up|1|||
46934598|NCT03203642|83170542|FG000|Overall Study|Termination of the study by sponsor|1|||
46934599|NCT03203642|83170543|FG001|Overall Study|Termination of the study by sponsor|1|||
46934600|NCT03203642|83170542|FG000|Overall Study|Participant moved|0|||
46934601|NCT03203642|83170543|FG001|Overall Study|Participant moved|1|||
46934602|NCT03203642|83170542|FG000|Overall Study|Investigator's decision|3|||
46934603|NCT03203642|83170543|FG001|Overall Study|Investigator's decision|0|||
46934604|NCT03203642|83170542|FG000|Overall Study|Other than above specified|0|||
46934605|NCT03203642|83170543|FG001|Overall Study|Other than above specified|1|||
46934606|NCT02737722|83170553|FG000|Overall Study|Physician Decision|0|||
46934607|NCT02737722|83170554|FG001|Overall Study|Physician Decision|0|||
47058333|NCT02689206|83337745|FG004|Overall Study|Withdrawal by Subject|0|||
47058334|NCT01695239|83337765|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
47058335|NCT01695239|83337766|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
47058336|NCT01695239|83337767|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
46637432|NCT01474512|82811393|FG017|Induction Period|Adverse Event|0|||
46637433|NCT01474512|82811376|FG000|Induction Period|Lack of Efficacy|7|||
46637434|NCT01474512|82811377|FG001|Induction Period|Lack of Efficacy|1|||
46637435|NCT01474512|82811378|FG002|Induction Period|Lack of Efficacy|0|||
46637436|NCT01474512|82811379|FG003|Induction Period|Lack of Efficacy|0|||
46825971|NCT00374322|83044663|FG000|Overall Study|Participant Changed Physician|1|||
46825972|NCT00374322|83044664|FG001|Overall Study|Participant Changed Physician|0|||
46825973|NCT00374322|83044663|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
46825974|NCT00374322|83044664|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
46825975|NCT00374322|83044663|FG000|Overall Study|Noncompliance with Study Requirements|0|||
46825976|NCT00374322|83044664|FG001|Overall Study|Noncompliance with Study Requirements|1|||
46825977|NCT00374322|83044663|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
46825978|NCT00374322|83044664|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
46825979|NCT00374322|83044663|FG000|Overall Study|Did Not Receive Study Medication|8|||
46825980|NCT00374322|83044664|FG001|Overall Study|Did Not Receive Study Medication|6|||
46825981|NCT00303459|83044673|FG000|Overall Study|Death|33|||
46825982|NCT00303459|83044674|FG001|Overall Study|Death|44|||
46825983|NCT00303459|83044673|FG000|Overall Study|Withdrawal of consent|32|||
46825984|NCT00303459|83044674|FG001|Overall Study|Withdrawal of consent|26|||
46934608|NCT02737722|83170555|FG002|Overall Study|Physician Decision|1|||
46934609|NCT02737722|83170556|FG003|Overall Study|Physician Decision|0|||
46934610|NCT03792750|83170566|FG000|Overall Study|Death|3|||
46934611|NCT02750709|83170571|FG000|Treatment Period 1|Adverse Event|0|||
46934612|NCT02750709|83170572|FG001|Treatment Period 1|Adverse Event|0|||
46934613|NCT02750709|83170573|FG002|Treatment Period 1|Adverse Event|0|||
46934614|NCT02750709|83170574|FG003|Treatment Period 1|Adverse Event|0|||
46934615|NCT02750709|83170575|FG004|Treatment Period 1|Adverse Event|0|||
46637437|NCT01474512|82811380|FG004|Induction Period|Lack of Efficacy|0|||
46934616|NCT02750709|83170576|FG005|Treatment Period 1|Adverse Event|1|||
46762788|NCT00818454|82981080|FG001|Washout Period of 1 Week|Adverse Event|1|||
47058337|NCT01695239|83337768|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
46762789|NCT00818454|82981081|FG002|Washout Period of 1 Week|Adverse Event|0|||
47058338|NCT01695239|83337769|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058339|NCT01695239|83337770|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058340|NCT01695239|83337771|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058341|NCT01695239|83337772|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058342|NCT01695239|83337773|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058343|NCT01695239|83337774|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058344|NCT01695239|83337775|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058345|NCT01695239|83337776|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058346|NCT01695239|83337777|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
47058347|NCT01695239|83337778|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
46825985|NCT00303459|83044673|FG000|Overall Study|Lost to Follow-up|5|||
46825986|NCT00303459|83044674|FG001|Overall Study|Lost to Follow-up|4|||
46825987|NCT00303459|83044673|FG000|Overall Study|Administrative reason|7|||
46825988|NCT00303459|83044674|FG001|Overall Study|Administrative reason|7|||
46825989|NCT00303459|83044673|FG000|Overall Study|Decision by the investigator|5|||
46825990|NCT00303459|83044674|FG001|Overall Study|Decision by the investigator|7|||
46825991|NCT00303459|83044673|FG000|Overall Study|Lung transplantation|1|||
46825992|NCT00303459|83044674|FG001|Overall Study|Lung transplantation|1|||
46825993|NCT00289887|83044683|FG000|Overall Study|Adverse Event|3|||
46825994|NCT00289887|83044684|FG001|Overall Study|Adverse Event|3|||
46825995|NCT00289887|83044683|FG000|Overall Study|Lack of Efficacy|3|||
46825996|NCT00289887|83044684|FG001|Overall Study|Lack of Efficacy|11|||
46825997|NCT00289887|83044683|FG000|Overall Study|Lost to Follow-up|3|||
46825998|NCT00289887|83044684|FG001|Overall Study|Lost to Follow-up|3|||
47058348|NCT01695239|83337765|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
47058349|NCT01695239|83337766|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
47058350|NCT01695239|83337767|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
47058351|NCT01695239|83337768|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
47058352|NCT01695239|83337769|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058353|NCT01695239|83337770|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
46762790|NCT00818454|82981082|FG003|Washout Period of 1 Week|Adverse Event|0|||
46762791|NCT00818454|82981079|FG000|Washout Period of 1 Week|Protocol Violation|2|||
46762792|NCT00818454|82981080|FG001|Washout Period of 1 Week|Protocol Violation|0|||
46762793|NCT00818454|82981081|FG002|Washout Period of 1 Week|Protocol Violation|0|||
46762794|NCT00818454|82981082|FG003|Washout Period of 1 Week|Protocol Violation|0|||
46762795|NCT00818454|82981079|FG000|Washout Period of 1 Week|Other|1|||
46762796|NCT00818454|82981080|FG001|Washout Period of 1 Week|Other|2|||
46762797|NCT00818454|82981081|FG002|Washout Period of 1 Week|Other|0|||
46762798|NCT00818454|82981082|FG003|Washout Period of 1 Week|Other|0|||
46762799|NCT00818454|82981079|FG000|Treatment Period 2|Other|2|||
46762800|NCT00818454|82981080|FG001|Treatment Period 2|Other|1|||
46762801|NCT00818454|82981081|FG002|Treatment Period 2|Other|0|||
46762802|NCT00818454|82981082|FG003|Treatment Period 2|Other|0|||
46762803|NCT00818454|82981079|FG000|Treatment Period 3|Adverse Event|0|||
46762804|NCT00818454|82981080|FG001|Treatment Period 3|Adverse Event|0|||
46762805|NCT00818454|82981081|FG002|Treatment Period 3|Adverse Event|0|||
46762806|NCT00818454|82981082|FG003|Treatment Period 3|Adverse Event|1|||
46762807|NCT00828984|82981095|FG000|Overall Study|Adverse Event|2|||
46825999|NCT00289887|83044683|FG000|Overall Study|Protocol Violation|3|||
46826000|NCT00289887|83044684|FG001|Overall Study|Protocol Violation|1|||
46826001|NCT00289887|83044683|FG000|Overall Study|Withdrawal by Subject|3|||
46826002|NCT00289887|83044684|FG001|Overall Study|Withdrawal by Subject|8|||
46826003|NCT00289887|83044683|FG000|Overall Study|Other|7|||
46826004|NCT00289887|83044684|FG001|Overall Study|Other|3|||
46826005|NCT00303069|83044694|FG000|Overall Study|Lost to Follow-up|1|||
46826006|NCT00303069|83044695|FG001|Overall Study|Lost to Follow-up|0|||
46826007|NCT00303069|83044696|FG002|Overall Study|Lost to Follow-up|0|||
46826008|NCT00303069|83044697|FG003|Overall Study|Lost to Follow-up|2|||
46826009|NCT00303069|83044694|FG000|Overall Study|subject moved|1|||
46826010|NCT00303069|83044695|FG001|Overall Study|subject moved|0|||
46826011|NCT00303069|83044696|FG002|Overall Study|subject moved|0|||
46826012|NCT00303069|83044697|FG003|Overall Study|subject moved|0|||
47058354|NCT01695239|83337771|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
46762808|NCT00828984|82981096|FG001|Overall Study|Adverse Event|3|||
46762809|NCT00828984|82981097|FG002|Overall Study|Adverse Event|0|||
46826013|NCT00303069|83044694|FG000|Overall Study|Recruitment into Army Reserves|0|||
46826014|NCT00303069|83044695|FG001|Overall Study|Recruitment into Army Reserves|0|||
46826015|NCT00303069|83044696|FG002|Overall Study|Recruitment into Army Reserves|1|||
46762810|NCT00828984|82981095|FG000|Overall Study|Lost to Follow-up|5|||
46762811|NCT00828984|82981096|FG001|Overall Study|Lost to Follow-up|3|||
46762812|NCT00828984|82981097|FG002|Overall Study|Lost to Follow-up|1|||
47058355|NCT01695239|83337772|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058356|NCT01695239|83337773|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058357|NCT01695239|83337774|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058358|NCT01695239|83337775|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058359|NCT01695239|83337776|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058360|NCT01695239|83337777|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058361|NCT01695239|83337778|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
47058362|NCT01695239|83337765|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
47058363|NCT01695239|83337766|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058364|NCT01695239|83337767|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
47058365|NCT01695239|83337768|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
46826016|NCT00303069|83044697|FG003|Overall Study|Recruitment into Army Reserves|0|||
46826017|NCT00401544|83044711|FG000|Overall Study|Adverse Event|5|||
46826018|NCT00401544|83044712|FG001|Overall Study|Adverse Event|1|||
46826019|NCT00401544|83044713|FG002|Overall Study|Adverse Event|1|||
46826020|NCT00401544|83044714|FG003|Overall Study|Adverse Event|1|||
46826021|NCT00401544|83044711|FG000|Overall Study|Death|3|||
46826022|NCT00401544|83044712|FG001|Overall Study|Death|6|||
46826023|NCT00401544|83044713|FG002|Overall Study|Death|2|||
46826024|NCT00401544|83044714|FG003|Overall Study|Death|5|||
46826025|NCT00401544|83044711|FG000|Overall Study|Lost to Follow-up|2|||
46826026|NCT00401544|83044712|FG001|Overall Study|Lost to Follow-up|0|||
46826027|NCT00401544|83044713|FG002|Overall Study|Lost to Follow-up|1|||
46826028|NCT00401544|83044714|FG003|Overall Study|Lost to Follow-up|1|||
46826029|NCT00401544|83044711|FG000|Overall Study|Withdrawal by Subject|7|||
46826030|NCT00401544|83044712|FG001|Overall Study|Withdrawal by Subject|6|||
46826031|NCT00401544|83044713|FG002|Overall Study|Withdrawal by Subject|6|||
46826032|NCT00401544|83044714|FG003|Overall Study|Withdrawal by Subject|5|||
46826033|NCT00401544|83044711|FG000|Overall Study|Physician Decision|1|||
46826034|NCT00401544|83044712|FG001|Overall Study|Physician Decision|3|||
46826035|NCT00401544|83044713|FG002|Overall Study|Physician Decision|0|||
46826036|NCT00401544|83044714|FG003|Overall Study|Physician Decision|0|||
46826037|NCT00401544|83044711|FG000|Overall Study|Ineligibility determined|0|||
46934617|NCT02723786|83170584|FG000|Overall Study|Lost to Follow-up|1|||
47058366|NCT01695239|83337769|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058367|NCT01695239|83337770|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058368|NCT01695239|83337771|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058369|NCT01695239|83337772|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058370|NCT01695239|83337773|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058371|NCT01695239|83337774|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058372|NCT01695239|83337775|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058373|NCT01695239|83337776|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058374|NCT01695239|83337777|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058375|NCT01695239|83337778|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
47058376|NCT01695239|83337765|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
47058377|NCT01695239|83337766|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
47058378|NCT01695239|83337767|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
47058379|NCT01695239|83337768|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058380|NCT01695239|83337769|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058381|NCT01695239|83337770|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058382|NCT01695239|83337771|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058383|NCT01695239|83337772|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058384|NCT01695239|83337773|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058385|NCT01695239|83337774|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
46637438|NCT01474512|82811381|FG005|Induction Period|Lack of Efficacy|0|||
46637439|NCT01474512|82811382|FG006|Induction Period|Lack of Efficacy|0|||
46637440|NCT01474512|82811383|FG007|Induction Period|Lack of Efficacy|0|||
46637441|NCT01474512|82811384|FG008|Induction Period|Lack of Efficacy|0|||
46637442|NCT01474512|82811385|FG009|Induction Period|Lack of Efficacy|0|||
46762813|NCT00828984|82981095|FG000|Overall Study|Withdrawal by Subject|4|||
46762814|NCT00828984|82981096|FG001|Overall Study|Withdrawal by Subject|4|||
46762815|NCT00828984|82981097|FG002|Overall Study|Withdrawal by Subject|4|||
46762816|NCT00828984|82981095|FG000|Overall Study|Ineligable|1|||
46762817|NCT00828984|82981096|FG001|Overall Study|Ineligable|2|||
46762818|NCT00828984|82981097|FG002|Overall Study|Ineligable|0|||
46762819|NCT00828984|82981095|FG000|Overall Study|Medical Contraindication|0|||
46762820|NCT00828984|82981096|FG001|Overall Study|Medical Contraindication|1|||
46637443|NCT01474512|82811386|FG010|Induction Period|Lack of Efficacy|0|||
46826038|NCT00401544|83044712|FG001|Overall Study|Ineligibility determined|1|||
46826039|NCT00401544|83044713|FG002|Overall Study|Ineligibility determined|0|||
46762821|NCT00828984|82981097|FG002|Overall Study|Medical Contraindication|0|||
46762822|NCT00828984|82981095|FG000|Overall Study|Noncompliant|1|||
46826040|NCT00401544|83044714|FG003|Overall Study|Ineligibility determined|2|||
47058386|NCT01695239|83337775|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058387|NCT01695239|83337776|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058388|NCT01695239|83337777|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058389|NCT01695239|83337778|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
47058390|NCT01695239|83337765|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
47058391|NCT01695239|83337766|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
46762823|NCT00828984|82981096|FG001|Overall Study|Noncompliant|2|||
46826041|NCT00401544|83044711|FG000|Overall Study|Disease progression|0|||
46826042|NCT00401544|83044712|FG001|Overall Study|Disease progression|1|||
46826043|NCT00401544|83044713|FG002|Overall Study|Disease progression|0|||
46826044|NCT00401544|83044714|FG003|Overall Study|Disease progression|0|||
46826045|NCT00401544|83044711|FG000|Overall Study|Other|0|||
46826046|NCT00401544|83044712|FG001|Overall Study|Other|0|||
46826047|NCT00401544|83044713|FG002|Overall Study|Other|2|||
46826048|NCT00401544|83044714|FG003|Overall Study|Other|2|||
46826049|NCT00289731|83044732|FG000|Overall Study|Adverse Event|1|||
46826050|NCT00289731|83044733|FG001|Overall Study|Adverse Event|2|||
46826051|NCT00289731|83044734|FG002|Overall Study|Adverse Event|2|||
47058392|NCT01695239|83337767|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
46762824|NCT00828984|82981097|FG002|Overall Study|Noncompliant|3|||
46826052|NCT00289731|83044732|FG000|Overall Study|Other|1|||
46826053|NCT00289731|83044733|FG001|Overall Study|Other|0|||
46826054|NCT00289731|83044734|FG002|Overall Study|Other|0|||
46826055|NCT00289185|83044746|FG000|Overall Study|Withdrawal by Subject|4|||
46826056|NCT00289185|83044747|FG001|Overall Study|Withdrawal by Subject|8|||
46826057|NCT00289185|83044746|FG000|Overall Study|Lost to Follow-up|23|||
46826058|NCT00289185|83044747|FG001|Overall Study|Lost to Follow-up|17|||
46826059|NCT00289185|83044746|FG000|Overall Study|Death|1|||
46826060|NCT00289185|83044747|FG001|Overall Study|Death|1|||
46826061|NCT00292461|83044756|FG000|Overall Study|Adverse Event|4|||
46826062|NCT00292461|83044757|FG001|Overall Study|Adverse Event|2|||
46826063|NCT00292461|83044756|FG000|Overall Study|Lack of Efficacy|1|||
46826064|NCT00292461|83044757|FG001|Overall Study|Lack of Efficacy|0|||
46826065|NCT00292461|83044756|FG000|Overall Study|Withdrawal by Subject|0|||
46826066|NCT00292461|83044757|FG001|Overall Study|Withdrawal by Subject|1|||
46826067|NCT00292461|83044756|FG000|Overall Study|Protocol Violation|4|||
46826068|NCT00292461|83044757|FG001|Overall Study|Protocol Violation|3|||
46826069|NCT00292461|83044756|FG000|Overall Study|Lost to Follow-up|1|||
46826070|NCT00292461|83044757|FG001|Overall Study|Lost to Follow-up|0|||
46826071|NCT00288639|83044763|FG000|Overall Study|Adverse Event|5|||
46826072|NCT00288639|83044763|FG000|Overall Study|Lack of Efficacy|4|||
46826073|NCT00288639|83044763|FG000|Overall Study|Withdrawal by Subject|2|||
46826074|NCT00288639|83044763|FG000|Overall Study|Other|1|||
46826075|NCT00390858|83044769|FG000|Overall Study|Adverse Event|6|||
46762825|NCT00828984|82981095|FG000|Overall Study|ConMed|1|||
46762826|NCT00828984|82981096|FG001|Overall Study|ConMed|1|||
46762827|NCT00828984|82981097|FG002|Overall Study|ConMed|1|||
46762828|NCT00828750|82981105|FG000|Overall Study|Lack of Efficacy|3|||
46762829|NCT00828750|82981105|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
46762830|NCT00667810|82981114|FG000|Overall Study|Adverse Event|13|||
46762831|NCT00667810|82981115|FG001|Overall Study|Adverse Event|14|||
46762832|NCT00667810|82981116|FG002|Overall Study|Adverse Event|19|||
46762833|NCT00667810|82981117|FG003|Overall Study|Adverse Event|1|||
46762834|NCT00667810|82981114|FG000|Overall Study|Death|1|||
46762835|NCT00667810|82981115|FG001|Overall Study|Death|1|||
46762836|NCT00667810|82981116|FG002|Overall Study|Death|3|||
46762837|NCT00667810|82981117|FG003|Overall Study|Death|0|||
46826076|NCT00390858|83044770|FG001|Overall Study|Adverse Event|2|||
46826077|NCT00390858|83044769|FG000|Overall Study|Lack of Efficacy|0|||
46826078|NCT00390858|83044770|FG001|Overall Study|Lack of Efficacy|1|||
46826079|NCT00390858|83044769|FG000|Overall Study|Withdrawal by Subject|3|||
46826080|NCT00390858|83044770|FG001|Overall Study|Withdrawal by Subject|4|||
46826081|NCT00390780|83044778|FG000|Overall Study|Not completed|10|||
46762838|NCT00667810|82981114|FG000|Overall Study|Lack of Efficacy|1|||
46762839|NCT00667810|82981115|FG001|Overall Study|Lack of Efficacy|0|||
46762840|NCT00667810|82981116|FG002|Overall Study|Lack of Efficacy|2|||
46762841|NCT00667810|82981117|FG003|Overall Study|Lack of Efficacy|0|||
46762842|NCT00667810|82981114|FG000|Overall Study|Lost to Follow-up|1|||
46762843|NCT00667810|82981115|FG001|Overall Study|Lost to Follow-up|4|||
46826082|NCT00390780|83044779|FG001|Overall Study|Not completed|4|||
46826083|NCT00390780|83044778|FG000|Overall Study|Protocol Violation|6|||
46826084|NCT00390780|83044779|FG001|Overall Study|Protocol Violation|4|||
46826085|NCT00390780|83044778|FG000|Overall Study|Lost to Follow-up|3|||
46826086|NCT00390780|83044779|FG001|Overall Study|Lost to Follow-up|6|||
46826087|NCT00390780|83044778|FG000|Overall Study|Adverse Event|2|||
46826088|NCT00390780|83044779|FG001|Overall Study|Adverse Event|3|||
46826089|NCT00390780|83044778|FG000|Overall Study|Death|1|||
46826090|NCT00390780|83044779|FG001|Overall Study|Death|3|||
46826091|NCT00390780|83044778|FG000|Overall Study|Withdrawal by Subject|1|||
46826092|NCT00390780|83044779|FG001|Overall Study|Withdrawal by Subject|2|||
46826093|NCT00390780|83044778|FG000|Overall Study|Inclusion criteria not satisfied|0|||
46826094|NCT00390780|83044779|FG001|Overall Study|Inclusion criteria not satisfied|2|||
46826095|NCT00390780|83044778|FG000|Overall Study|Lost to follow up and other reasons|0|||
46826096|NCT00390780|83044779|FG001|Overall Study|Lost to follow up and other reasons|1|||
46826097|NCT00390780|83044778|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
46826098|NCT00390780|83044779|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
46826099|NCT00390780|83044778|FG000|Overall Study|SAE, death|0|||
46934618|NCT02723084|83170603|FG000|Overall Study|Withdrawal by Subject|1|||
46934619|NCT02723084|83170604|FG001|Overall Study|Withdrawal by Subject|1|||
46934620|NCT02723084|83170603|FG000|Overall Study|Lost to Follow-up|3|||
46934621|NCT02723084|83170604|FG001|Overall Study|Lost to Follow-up|0|||
46934622|NCT02750943|83170612|FG000|Overall Study|Lost to Follow-up|1|||
46934623|NCT02750943|83170613|FG001|Overall Study|Lost to Follow-up|2|||
46934624|NCT02750943|83170612|FG000|Overall Study|Withdrawal by Subject|5|||
46934625|NCT02750943|83170613|FG001|Overall Study|Withdrawal by Subject|7|||
46934626|NCT05177094|83170638|FG000|Overall Study|Adverse Event|5|||
46934627|NCT05177094|83170639|FG001|Overall Study|Adverse Event|5|||
46637444|NCT01474512|82811387|FG011|Induction Period|Lack of Efficacy|0|||
46637445|NCT01474512|82811388|FG012|Induction Period|Lack of Efficacy|0|||
46637446|NCT01474512|82811389|FG013|Induction Period|Lack of Efficacy|0|||
46637447|NCT01474512|82811390|FG014|Induction Period|Lack of Efficacy|0|||
46762844|NCT00667810|82981116|FG002|Overall Study|Lost to Follow-up|2|||
46762845|NCT00667810|82981117|FG003|Overall Study|Lost to Follow-up|0|||
46934628|NCT05177094|83170638|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
46934629|NCT05177094|83170639|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
46934630|NCT05177094|83170638|FG000|Overall Study|Protocol Deviation|3|||
47058393|NCT01695239|83337768|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058394|NCT01695239|83337769|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058395|NCT01695239|83337770|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058396|NCT01695239|83337771|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058397|NCT01695239|83337772|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
46826100|NCT00390780|83044779|FG001|Overall Study|SAE, death|1|||
46826101|NCT00390546|83044787|FG000|Overall Study|Renal impairment|1|||
47058398|NCT01695239|83337773|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058399|NCT01695239|83337774|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
46826102|NCT00390546|83044788|FG001|Overall Study|Renal impairment|0|||
46934631|NCT05177094|83170639|FG001|Overall Study|Protocol Deviation|0|||
47058400|NCT01695239|83337775|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058401|NCT01695239|83337776|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058402|NCT01695239|83337777|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058403|NCT01695239|83337778|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
47058404|NCT01695239|83337765|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
47058405|NCT01695239|83337766|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058406|NCT01695239|83337767|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
46762846|NCT00667810|82981114|FG000|Overall Study|Physician Decision|1|||
46762847|NCT00667810|82981115|FG001|Overall Study|Physician Decision|1|||
46762848|NCT00667810|82981116|FG002|Overall Study|Physician Decision|2|||
46762849|NCT00667810|82981117|FG003|Overall Study|Physician Decision|0|||
46762850|NCT00667810|82981114|FG000|Overall Study|Protocol Violation|0|||
46762851|NCT00667810|82981115|FG001|Overall Study|Protocol Violation|2|||
46762852|NCT00667810|82981116|FG002|Overall Study|Protocol Violation|0|||
46762853|NCT00667810|82981117|FG003|Overall Study|Protocol Violation|0|||
46762854|NCT00667810|82981114|FG000|Overall Study|Withdrawal by Subject|14|||
46762855|NCT00667810|82981115|FG001|Overall Study|Withdrawal by Subject|20|||
46762856|NCT00667810|82981116|FG002|Overall Study|Withdrawal by Subject|29|||
46762857|NCT00667810|82981117|FG003|Overall Study|Withdrawal by Subject|1|||
46762858|NCT00667810|82981114|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
46762859|NCT00667810|82981115|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
46762860|NCT00667810|82981116|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
46762861|NCT00667810|82981117|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
47058407|NCT01695239|83337768|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058408|NCT01695239|83337769|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
46762862|NCT00667810|82981114|FG000|Overall Study|Failed to Return|0|||
46762863|NCT00667810|82981115|FG001|Overall Study|Failed to Return|0|||
46826103|NCT00390546|83044787|FG000|Overall Study|Physician Decision|5|||
46934632|NCT05177094|83170638|FG000|Overall Study|Withdrawal by Subject|6|||
46826104|NCT00390546|83044788|FG001|Overall Study|Physician Decision|5|||
46826105|NCT00390468|83044795|FG000|Overall Study|Protocol Violation|2|||
46934633|NCT05177094|83170639|FG001|Overall Study|Withdrawal by Subject|3|||
46637448|NCT01474512|82811391|FG015|Induction Period|Lack of Efficacy|0|||
46762864|NCT00667810|82981116|FG002|Overall Study|Failed to Return|2|||
46762865|NCT00667810|82981117|FG003|Overall Study|Failed to Return|0|||
46826106|NCT00390468|83044795|FG000|Overall Study|Lack of Efficacy|1|||
46826107|NCT00400764|83044804|FG000|Phase Ib|Adverse Event|1|||
47058409|NCT01695239|83337770|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058410|NCT01695239|83337771|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058411|NCT01695239|83337772|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058412|NCT01695239|83337773|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058413|NCT01695239|83337774|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
46826108|NCT00400764|83044805|FG001|Phase Ib|Adverse Event|0|||
46826109|NCT00400764|83044806|FG002|Phase Ib|Adverse Event|0|||
46826110|NCT00400764|83044807|FG003|Phase Ib|Adverse Event|0|||
46826111|NCT00400764|83044808|FG004|Phase Ib|Adverse Event|0|||
46826112|NCT00400764|83044804|FG000|Phase Ib|Death|1|||
46826113|NCT00400764|83044805|FG001|Phase Ib|Death|0|||
46826114|NCT00400764|83044806|FG002|Phase Ib|Death|0|||
46826115|NCT00400764|83044807|FG003|Phase Ib|Death|0|||
46826116|NCT00400764|83044808|FG004|Phase Ib|Death|0|||
46826117|NCT00400764|83044804|FG000|Phase Ib|Disease Progression|4|||
46826118|NCT00400764|83044805|FG001|Phase Ib|Disease Progression|4|||
46826119|NCT00400764|83044806|FG002|Phase Ib|Disease Progression|0|||
46826120|NCT00400764|83044807|FG003|Phase Ib|Disease Progression|0|||
46826121|NCT00400764|83044808|FG004|Phase Ib|Disease Progression|0|||
46934634|NCT05177094|83170638|FG000|Overall Study|Participant could not tolerate long study visits|1|||
46934635|NCT05177094|83170639|FG001|Overall Study|Participant could not tolerate long study visits|0|||
46934636|NCT05104749|83170649|FG000|Overall Study|Lost to Follow-up|2|||
46934637|NCT05104749|83170650|FG001|Overall Study|Lost to Follow-up|3|||
47058414|NCT01695239|83337775|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058415|NCT01695239|83337776|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
46762866|NCT00667810|82981114|FG000|Overall Study|Loss of Caregiver|0|||
46762867|NCT00667810|82981115|FG001|Overall Study|Loss of Caregiver|1|||
46762868|NCT00667810|82981116|FG002|Overall Study|Loss of Caregiver|3|||
46762869|NCT00667810|82981117|FG003|Overall Study|Loss of Caregiver|0|||
46762870|NCT00667810|82981114|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
46762871|NCT00667810|82981115|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
46762872|NCT00667810|82981116|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
46762873|NCT00667810|82981117|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
46762874|NCT00667810|82981114|FG000|Overall Study|Other|6|||
46762875|NCT00667810|82981115|FG001|Overall Study|Other|6|||
46762876|NCT00667810|82981116|FG002|Overall Study|Other|5|||
46762877|NCT00667810|82981117|FG003|Overall Study|Other|0|||
46762878|NCT00819390|82981136|FG000|Overall Study|Lost to Follow-up|1|||
46762879|NCT00819390|82981137|FG001|Overall Study|Lost to Follow-up|1|||
46762880|NCT00819390|82981138|FG002|Overall Study|Lost to Follow-up|0|||
46762881|NCT00819390|82981139|FG003|Overall Study|Lost to Follow-up|0|||
46762882|NCT00819390|82981136|FG000|Overall Study|Withdrawal by Subject|2|||
46762883|NCT00819390|82981137|FG001|Overall Study|Withdrawal by Subject|0|||
46762884|NCT00819390|82981138|FG002|Overall Study|Withdrawal by Subject|0|||
46762885|NCT00819390|82981139|FG003|Overall Study|Withdrawal by Subject|0|||
46762886|NCT00819390|82981136|FG000|Overall Study|Adverse Event|0|||
46762887|NCT00819390|82981137|FG001|Overall Study|Adverse Event|0|||
46762888|NCT00819390|82981138|FG002|Overall Study|Adverse Event|1|||
46762889|NCT00819390|82981139|FG003|Overall Study|Adverse Event|0|||
46762890|NCT00876395|82981154|FG000|Overall Study|Untreated|8|||
46762891|NCT00876395|82981155|FG001|Overall Study|Untreated|1|||
46762892|NCT00876395|82981154|FG000|Overall Study|Adverse Event|63|||
46762893|NCT00876395|82981155|FG001|Overall Study|Adverse Event|11|||
46762894|NCT00876395|82981154|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46762895|NCT00876395|82981155|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46762896|NCT00876395|82981154|FG000|Overall Study|Disease progression|259|||
46762897|NCT00876395|82981155|FG001|Overall Study|Disease progression|162|||
46762898|NCT00876395|82981154|FG000|Overall Study|New cancer therapy|25|||
46762899|NCT00876395|82981155|FG001|Overall Study|New cancer therapy|7|||
46762900|NCT00876395|82981154|FG000|Overall Study|Protocol Violation|5|||
46826122|NCT00400764|83044804|FG000|Phase II|Death|0|||
46826123|NCT00400764|83044805|FG001|Phase II|Death|0|||
46934638|NCT05098041|83170656|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
46762901|NCT00876395|82981155|FG001|Overall Study|Protocol Violation|2|||
46762902|NCT00876395|82981154|FG000|Overall Study|Withdrawal by Subject|66|||
46826124|NCT00400764|83044806|FG002|Phase II|Death|1|||
46826125|NCT00400764|83044807|FG003|Phase II|Death|2|||
46826126|NCT00400764|83044808|FG004|Phase II|Death|0|||
46934639|NCT04648241|83170677|FG000|Overall Study|Lost to Follow-up|1|||
46762903|NCT00876395|82981155|FG001|Overall Study|Withdrawal by Subject|33|||
46762904|NCT00876395|82981154|FG000|Overall Study|Lost to Follow-up|2|||
46826127|NCT00400764|83044804|FG000|Phase II|Lost to Follow-up|0|||
46826128|NCT00400764|83044805|FG001|Phase II|Lost to Follow-up|0|||
46934640|NCT04648241|83170678|FG001|Overall Study|Lost to Follow-up|0|||
46762905|NCT00876395|82981155|FG001|Overall Study|Lost to Follow-up|0|||
46762906|NCT00876395|82981154|FG000|Overall Study|Administrative problems|39|||
46762907|NCT00876395|82981155|FG001|Overall Study|Administrative problems|23|||
46762908|NCT00876395|82981154|FG000|Overall Study|Death|12|||
46826129|NCT00400764|83044806|FG002|Phase II|Lost to Follow-up|1|||
46826130|NCT00400764|83044807|FG003|Phase II|Lost to Follow-up|0|||
46826131|NCT00400764|83044808|FG004|Phase II|Lost to Follow-up|0|||
46934641|NCT04124952|83170713|FG000|Overall Study|Lost to Follow-up|1|||
46934642|NCT03677596|83170754|FG000|Overall Study|Adverse Event|0|||
46934643|NCT03677596|83170755|FG001|Overall Study|Adverse Event|1|||
46934644|NCT03677596|83170754|FG000|Overall Study|Death|10|||
46934645|NCT03677596|83170755|FG001|Overall Study|Death|6|||
46934646|NCT03677596|83170754|FG000|Overall Study|Lost to Follow-up|0|||
46934647|NCT03677596|83170755|FG001|Overall Study|Lost to Follow-up|1|||
46934648|NCT03677596|83170754|FG000|Overall Study|Progressive Disease|8|||
46934649|NCT03677596|83170755|FG001|Overall Study|Progressive Disease|8|||
46934650|NCT03677596|83170754|FG000|Overall Study|Withdrawal by Subject|3|||
46934651|NCT03677596|83170755|FG001|Overall Study|Withdrawal by Subject|0|||
46934652|NCT03677596|83170754|FG000|Overall Study|Disease Relapse|2|||
46934653|NCT03677596|83170755|FG001|Overall Study|Disease Relapse|2|||
46934654|NCT03677596|83170754|FG000|Overall Study|Other|0|||
46826132|NCT00400764|83044804|FG000|Phase II|Physician Decision|0|||
46826133|NCT00400764|83044805|FG001|Phase II|Physician Decision|0|||
46826134|NCT00400764|83044806|FG002|Phase II|Physician Decision|1|||
46826135|NCT00400764|83044807|FG003|Phase II|Physician Decision|1|||
46826136|NCT00400764|83044808|FG004|Phase II|Physician Decision|0|||
46826137|NCT00400764|83044804|FG000|Phase II|Sponsor's decision to terminate|0|||
47058416|NCT01695239|83337777|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058417|NCT01695239|83337778|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
47058418|NCT01695239|83337765|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
47058419|NCT01695239|83337766|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058420|NCT01695239|83337767|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058421|NCT01695239|83337768|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058422|NCT01695239|83337769|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058423|NCT01695239|83337770|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058424|NCT01695239|83337771|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
46826138|NCT00400764|83044805|FG001|Phase II|Sponsor's decision to terminate|0|||
46826139|NCT00400764|83044806|FG002|Phase II|Sponsor's decision to terminate|18|||
46934655|NCT03677596|83170755|FG001|Overall Study|Other|1|||
46934656|NCT03422627|83170775|FG000|Overall Study|Protocol-specified Criteria|1|||
46934657|NCT03422627|83170776|FG001|Overall Study|Protocol-specified Criteria|1|||
46934658|NCT03422627|83170777|FG002|Overall Study|Protocol-specified Criteria|0|||
46762909|NCT00876395|82981155|FG001|Overall Study|Death|0|||
46762910|NCT00594659|82981169|FG000|Overall Study|Lost to Follow-up|13|||
46762911|NCT00594659|82981170|FG001|Overall Study|Lost to Follow-up|9|||
46762912|NCT00594659|82981171|FG002|Overall Study|Lost to Follow-up|7|||
46762913|NCT00667732|82981181|FG000|Run -In (8 Weeks)|Adverse Event|4|||
46762914|NCT00667732|82981182|FG001|Run -In (8 Weeks)|Adverse Event|0|||
46762915|NCT00667732|82981183|FG002|Run -In (8 Weeks)|Adverse Event|0|||
46762916|NCT00667732|82981181|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
46762917|NCT00667732|82981182|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
46762918|NCT00667732|82981183|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
46762919|NCT00667732|82981181|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
46762920|NCT00667732|82981182|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
46762921|NCT00667732|82981183|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
46762922|NCT00671788|82981193|FG000|Overall Study|Adverse Event|8|||
46762923|NCT00671788|82981193|FG000|Overall Study|Refused further treatment|3|||
46762924|NCT00671788|82981193|FG000|Overall Study|Ineligible|1|||
46762925|NCT00671788|82981193|FG000|Overall Study|MD Decision|1|||
46762926|NCT00671788|82981193|FG000|Overall Study|Other|1|||
46762927|NCT00875615|82981197|FG000|Overall Study|Withdrawal by Subject|1|||
46762928|NCT00597701|82981203|FG000|Overall Study|Withdrawal by Subject|5|||
46762929|NCT00597701|82981204|FG001|Overall Study|Withdrawal by Subject|5|||
46762930|NCT00597701|82981203|FG000|Overall Study|Death|0|||
46762931|NCT00597701|82981204|FG001|Overall Study|Death|1|||
46762932|NCT00597701|82981203|FG000|Overall Study|Physician Decision|2|||
46762933|NCT00597701|82981204|FG001|Overall Study|Physician Decision|0|||
46762934|NCT00597701|82981203|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
46762935|NCT00597701|82981204|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
46762936|NCT00671554|82981210|FG000|Overall Study|Disease progression|3|||
46826140|NCT00400764|83044807|FG003|Phase II|Sponsor's decision to terminate|22|||
47058425|NCT01695239|83337772|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
46762937|NCT00667576|82981220|FG000|Overall Study|Withdrawal by Subject|1|||
46762938|NCT00667576|82981221|FG001|Overall Study|Withdrawal by Subject|0|||
46762939|NCT00667576|82981222|FG002|Overall Study|Withdrawal by Subject|1|||
46934659|NCT03422627|83170778|FG003|Overall Study|Protocol-specified Criteria|0|||
46762940|NCT00667576|82981223|FG003|Overall Study|Withdrawal by Subject|1|||
46762941|NCT00667576|82981224|FG004|Overall Study|Withdrawal by Subject|1|||
46762942|NCT00667576|82981220|FG000|Overall Study|Adverse Event|1|||
46762943|NCT00667576|82981221|FG001|Overall Study|Adverse Event|1|||
46934660|NCT03422627|83170779|FG004|Overall Study|Protocol-specified Criteria|2|||
46934661|NCT03422627|83170775|FG000|Overall Study|Requirement for Alternative Therapy|1|||
47058426|NCT01695239|83337773|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058427|NCT01695239|83337774|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058428|NCT01695239|83337775|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058429|NCT01695239|83337776|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058430|NCT01695239|83337777|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
46826141|NCT00400764|83044808|FG004|Phase II|Sponsor's decision to terminate|11|||
46826142|NCT00400764|83044804|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
46826143|NCT00400764|83044805|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
46826144|NCT00400764|83044806|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
46826145|NCT00400764|83044807|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
46826146|NCT00400764|83044808|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
46826147|NCT00400764|83044804|FG000|Phase II|Withdrawal by Subject|0|||
46826148|NCT00400764|83044805|FG001|Phase II|Withdrawal by Subject|0|||
46826149|NCT00400764|83044806|FG002|Phase II|Withdrawal by Subject|1|||
46826150|NCT00400764|83044807|FG003|Phase II|Withdrawal by Subject|1|||
46826151|NCT00400764|83044808|FG004|Phase II|Withdrawal by Subject|0|||
46826152|NCT00302211|83044828|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
46826153|NCT00302211|83044829|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
46826154|NCT00302211|83044830|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
46826155|NCT00302211|83044831|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
46826156|NCT00302211|83044832|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
46826157|NCT00302211|83044828|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
46826158|NCT00302211|83044829|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
46826159|NCT00302211|83044830|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
46826160|NCT00302211|83044831|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
46826161|NCT00302211|83044832|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
46826162|NCT00302211|83044828|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
46826163|NCT00302211|83044829|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
46826164|NCT00302211|83044830|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
46826165|NCT00302211|83044831|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
46826166|NCT00302211|83044832|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
46826167|NCT00302211|83044828|FG000|Double Blind Period (New Patients)|Disease progression|0|||
47058431|NCT01695239|83337778|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
47058432|NCT01695239|83337765|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058433|NCT01695239|83337766|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058434|NCT01695239|83337767|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058435|NCT01695239|83337768|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058436|NCT01695239|83337769|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058437|NCT01695239|83337770|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058438|NCT01695239|83337771|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058439|NCT01695239|83337772|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
47058440|NCT01695239|83337773|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058441|NCT01695239|83337774|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058442|NCT01695239|83337775|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058443|NCT01695239|83337776|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058444|NCT01695239|83337777|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058445|NCT01695239|83337778|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
47058446|NCT01695239|83337765|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058447|NCT01695239|83337766|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058448|NCT01695239|83337767|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058449|NCT01695239|83337768|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058450|NCT01695239|83337769|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
46762944|NCT00667576|82981222|FG002|Overall Study|Adverse Event|0|||
46762945|NCT00667576|82981223|FG003|Overall Study|Adverse Event|0|||
46762946|NCT00667576|82981224|FG004|Overall Study|Adverse Event|0|||
46762947|NCT00667576|82981220|FG000|Overall Study|Lost to Follow-up|0|||
46762948|NCT00667576|82981221|FG001|Overall Study|Lost to Follow-up|0|||
46762949|NCT00667576|82981222|FG002|Overall Study|Lost to Follow-up|1|||
46762950|NCT00667576|82981223|FG003|Overall Study|Lost to Follow-up|0|||
46762951|NCT00667576|82981224|FG004|Overall Study|Lost to Follow-up|0|||
46762952|NCT00667576|82981220|FG000|Overall Study|Protocol Violation|0|||
46762953|NCT00667576|82981221|FG001|Overall Study|Protocol Violation|0|||
46762954|NCT00667576|82981222|FG002|Overall Study|Protocol Violation|0|||
46762955|NCT00667576|82981223|FG003|Overall Study|Protocol Violation|1|||
46762956|NCT00667576|82981224|FG004|Overall Study|Protocol Violation|0|||
46826168|NCT00302211|83044829|FG001|Double Blind Period (New Patients)|Disease progression|1|||
46826169|NCT00302211|83044830|FG002|Double Blind Period (New Patients)|Disease progression|1|||
46762957|NCT00667576|82981220|FG000|Overall Study|Physician Decision|0|||
46762958|NCT00667576|82981221|FG001|Overall Study|Physician Decision|0|||
46762959|NCT00667576|82981222|FG002|Overall Study|Physician Decision|0|||
46934662|NCT03422627|83170776|FG001|Overall Study|Requirement for Alternative Therapy|1|||
46934663|NCT03422627|83170777|FG002|Overall Study|Requirement for Alternative Therapy|2|||
46934664|NCT03422627|83170778|FG003|Overall Study|Requirement for Alternative Therapy|0|||
46934665|NCT03422627|83170779|FG004|Overall Study|Requirement for Alternative Therapy|0|||
46934666|NCT03422627|83170775|FG000|Overall Study|Disease Progression|1|||
46934667|NCT03422627|83170776|FG001|Overall Study|Disease Progression|0|||
46934668|NCT03422627|83170777|FG002|Overall Study|Disease Progression|1|||
46934669|NCT03422627|83170778|FG003|Overall Study|Disease Progression|2|||
46934670|NCT03422627|83170779|FG004|Overall Study|Disease Progression|0|||
46934671|NCT03422627|83170775|FG000|Overall Study|Adverse Event|2|||
47058451|NCT01695239|83337770|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058452|NCT01695239|83337771|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058453|NCT01695239|83337772|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
47058454|NCT01695239|83337773|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
46934672|NCT03422627|83170776|FG001|Overall Study|Adverse Event|1|||
46934673|NCT03422627|83170777|FG002|Overall Study|Adverse Event|0|||
46934674|NCT03422627|83170778|FG003|Overall Study|Adverse Event|0|||
46934675|NCT03422627|83170779|FG004|Overall Study|Adverse Event|2|||
46934676|NCT03422627|83170775|FG000|Overall Study|Ineligibility Determined|0|||
46934677|NCT03422627|83170776|FG001|Overall Study|Ineligibility Determined|1|||
47058455|NCT01695239|83337774|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
46934678|NCT03422627|83170777|FG002|Overall Study|Ineligibility Determined|0|||
46934679|NCT03422627|83170778|FG003|Overall Study|Ineligibility Determined|0|||
46934680|NCT03422627|83170779|FG004|Overall Study|Ineligibility Determined|0|||
46934681|NCT03422627|83170775|FG000|Overall Study|Death|0|||
46934682|NCT03422627|83170776|FG001|Overall Study|Death|1|||
46934683|NCT03422627|83170777|FG002|Overall Study|Death|1|||
46934684|NCT03422627|83170778|FG003|Overall Study|Death|0|||
46934685|NCT03422627|83170779|FG004|Overall Study|Death|0|||
46934686|NCT03422627|83170775|FG000|Overall Study|Withdrawal by Subject|0|||
46934687|NCT03422627|83170776|FG001|Overall Study|Withdrawal by Subject|0|||
46934688|NCT03422627|83170777|FG002|Overall Study|Withdrawal by Subject|0|||
46934689|NCT03422627|83170778|FG003|Overall Study|Withdrawal by Subject|1|||
46934690|NCT03422627|83170779|FG004|Overall Study|Withdrawal by Subject|0|||
46934691|NCT03403621|83170791|FG000|Overall Study|Withdrawal by Subject|2|||
46934692|NCT03403621|83170792|FG001|Overall Study|Withdrawal by Subject|2|||
46934693|NCT03225105|83170802|FG000|Overall Study|Withdrawal by Subject|1|||
46934694|NCT03225105|83170803|FG001|Overall Study|Withdrawal by Subject|0|||
46934695|NCT03225105|83170804|FG002|Overall Study|Withdrawal by Subject|0|||
46934696|NCT03225105|83170805|FG003|Overall Study|Withdrawal by Subject|0|||
46934697|NCT03225105|83170802|FG000|Overall Study|Death|0|||
46934698|NCT03225105|83170803|FG001|Overall Study|Death|4|||
46934699|NCT03225105|83170804|FG002|Overall Study|Death|2|||
46934700|NCT03225105|83170805|FG003|Overall Study|Death|0|||
46934701|NCT03225105|83170802|FG000|Overall Study|Study termination per Sponsor Decision|2|||
46934702|NCT03225105|83170803|FG001|Overall Study|Study termination per Sponsor Decision|0|||
46934703|NCT03225105|83170804|FG002|Overall Study|Study termination per Sponsor Decision|3|||
46934704|NCT03225105|83170805|FG003|Overall Study|Study termination per Sponsor Decision|3|||
46934705|NCT02900976|83170836|FG000|Overall Study|Adverse Event|0|||
46934706|NCT02900976|83170837|FG001|Overall Study|Adverse Event|1|||
46934707|NCT02900976|83170836|FG000|Overall Study|Physician Decision|0|||
47058456|NCT01695239|83337775|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
46762960|NCT00667576|82981223|FG003|Overall Study|Physician Decision|1|||
46762961|NCT00667576|82981224|FG004|Overall Study|Physician Decision|0|||
46762962|NCT00667576|82981220|FG000|Overall Study|Missed Visit|0|||
46762963|NCT00667576|82981221|FG001|Overall Study|Missed Visit|0|||
46762964|NCT00667576|82981222|FG002|Overall Study|Missed Visit|0|||
46762965|NCT00667576|82981223|FG003|Overall Study|Missed Visit|1|||
46762966|NCT00667576|82981224|FG004|Overall Study|Missed Visit|0|||
46762967|NCT00666718|82981238|FG000|Overall Study|Adverse Event|0|||
46762968|NCT00666718|82981239|FG001|Overall Study|Adverse Event|1|||
46762969|NCT00666718|82981238|FG000|Overall Study|Death|1|||
46762970|NCT00666718|82981239|FG001|Overall Study|Death|0|||
46762971|NCT00666718|82981238|FG000|Overall Study|Lost to Follow-up|1|||
46762972|NCT00666718|82981239|FG001|Overall Study|Lost to Follow-up|0|||
46762973|NCT00666718|82981238|FG000|Overall Study|Entry Criteria Not Met|2|||
46762974|NCT00666718|82981239|FG001|Overall Study|Entry Criteria Not Met|0|||
46762975|NCT00666718|82981238|FG000|Overall Study|Protocol Violation|1|||
46934708|NCT02900976|83170837|FG001|Overall Study|Physician Decision|2|||
46934709|NCT02900976|83170836|FG000|Overall Study|Progressive disease|0|||
46934710|NCT02900976|83170837|FG001|Overall Study|Progressive disease|6|||
46934711|NCT02654015|83170844|FG000|Overall Study|Death|12|||
46934712|NCT02654015|83170844|FG000|Overall Study|Lost to Follow-up|3|||
46934713|NCT02542696|83170848|FG000|Overall Study|Adverse Event|167|||
46934714|NCT02542696|83170848|FG000|Overall Study|Lack of Efficacy|26|||
46934715|NCT02542696|83170848|FG000|Overall Study|Lost to Follow-up|6|||
46934716|NCT02542696|83170848|FG000|Overall Study|Withdrawal by Subject|104|||
46934717|NCT02542696|83170848|FG000|Overall Study|Protocol Violation|5|||
46934718|NCT02542696|83170848|FG000|Overall Study|Death|8|||
46934719|NCT02542696|83170848|FG000|Overall Study|DECREASED OFF TIME|1|||
46934720|NCT02542696|83170848|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
46934721|NCT02542696|83170848|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
46934722|NCT02542696|83170848|FG000|Overall Study|MEDICAL HISTORY|1|||
46934723|NCT02542696|83170848|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
47058457|NCT01695239|83337776|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
46934724|NCT02542696|83170848|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
46934725|NCT02542696|83170848|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
46934726|NCT02542696|83170848|FG000|Overall Study|SPONSOR DECISION|3|||
46934727|NCT02542696|83170848|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
46934728|NCT02542696|83170848|FG000|Overall Study|SUBJECT DECISION|2|||
46934729|NCT02339740|83170855|FG000|Overall Study|Death|1|||
46934730|NCT02339740|83170856|FG001|Overall Study|Death|0|||
46934731|NCT02339740|83170855|FG000|Overall Study|Physician Decision|0|||
46934732|NCT02339740|83170856|FG001|Overall Study|Physician Decision|2|||
46934733|NCT02339740|83170855|FG000|Overall Study|Withdrawal by Subject|5|||
46934734|NCT02339740|83170856|FG001|Overall Study|Withdrawal by Subject|1|||
46934735|NCT02339740|83170855|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
46934736|NCT02339740|83170856|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
46934737|NCT02163395|83170862|FG000|Overall Study|Withdrawal by Subject|1|||
46826170|NCT00302211|83044831|FG003|Double Blind Period (New Patients)|Disease progression|0|||
46826171|NCT00302211|83044832|FG004|Double Blind Period (New Patients)|Disease progression|0|||
46826172|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
46826173|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
46826174|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
46826175|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
46934738|NCT02163395|83170862|FG000|Overall Study|Lost to Follow-up|3|||
47058458|NCT01695239|83337777|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058459|NCT01695239|83337778|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
47058460|NCT01695239|83337765|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058461|NCT01695239|83337766|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058462|NCT01695239|83337767|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058463|NCT01695239|83337768|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058464|NCT01695239|83337769|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058465|NCT01695239|83337770|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058466|NCT01695239|83337771|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058467|NCT01695239|83337772|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
47058468|NCT01695239|83337773|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058469|NCT01695239|83337774|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058470|NCT01695239|83337775|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058471|NCT01695239|83337776|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
47058472|NCT01695239|83337777|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
46637449|NCT01474512|82811392|FG016|Induction Period|Lack of Efficacy|0|||
46637450|NCT01474512|82811393|FG017|Induction Period|Lack of Efficacy|0|||
46637451|NCT01474512|82811376|FG000|Induction Period|Withdrawal by Subject|6|||
46934739|NCT02163395|83170862|FG000|Overall Study|Adverse Event|1|||
46934740|NCT01397552|83170872|FG000|Overall Study|Adverse Event|1|||
46934741|NCT01397552|83170873|FG001|Overall Study|Adverse Event|0|||
46934742|NCT01397552|83170872|FG000|Overall Study|Withdrawal by Subject|2|||
46934743|NCT01397552|83170873|FG001|Overall Study|Withdrawal by Subject|1|||
46934744|NCT01256710|83170879|FG000|Overall Study|Death|449|||
46934745|NCT01256710|83170879|FG000|Overall Study|System Explant|67|||
46934746|NCT01256710|83170879|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
46934747|NCT01256710|83170879|FG000|Overall Study|Lost to Follow-up|67|||
46934748|NCT01256710|83170879|FG000|Overall Study|Withdrawal by Subject|29|||
46637452|NCT01474512|82811377|FG001|Induction Period|Withdrawal by Subject|6|||
46637453|NCT01474512|82811378|FG002|Induction Period|Withdrawal by Subject|5|||
46637454|NCT01474512|82811379|FG003|Induction Period|Withdrawal by Subject|0|||
46637455|NCT01474512|82811380|FG004|Induction Period|Withdrawal by Subject|0|||
46637456|NCT01474512|82811381|FG005|Induction Period|Withdrawal by Subject|0|||
46934749|NCT01256710|83170879|FG000|Overall Study|Physician Decision|9|||
46934750|NCT01256710|83170879|FG000|Overall Study|Subject Noncompliance|2|||
46934751|NCT01256710|83170879|FG000|Overall Study|Study Terminated by Sponsor|273|||
46637457|NCT01474512|82811382|FG006|Induction Period|Withdrawal by Subject|0|||
46934752|NCT01096368|83170890|FG000|Overall Study|Death|0|||
46934753|NCT01096368|83170891|FG001|Overall Study|Death|1|||
46934754|NCT01096368|83170892|FG002|Overall Study|Death|0|||
46934755|NCT01096368|83170893|FG003|Overall Study|Death|0|||
46934756|NCT01096368|83170894|FG004|Overall Study|Death|0|||
46934757|NCT01096368|83170890|FG000|Overall Study|Physician Decision|0|||
46934758|NCT01096368|83170891|FG001|Overall Study|Physician Decision|13|||
46934759|NCT01096368|83170892|FG002|Overall Study|Physician Decision|2|||
46934760|NCT01096368|83170893|FG003|Overall Study|Physician Decision|4|||
46934761|NCT01096368|83170894|FG004|Overall Study|Physician Decision|6|||
46934762|NCT01096368|83170890|FG000|Overall Study|Withdrawal by Subject|0|||
46934763|NCT01096368|83170891|FG001|Overall Study|Withdrawal by Subject|52|||
46934764|NCT01096368|83170892|FG002|Overall Study|Withdrawal by Subject|0|||
46934765|NCT01096368|83170893|FG003|Overall Study|Withdrawal by Subject|10|||
46826176|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
46826177|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
46826178|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
46826179|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
46826180|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
46826181|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
46826182|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
46826183|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
46826184|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
46826185|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
46826186|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
46826187|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
46826188|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
46826189|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
46826190|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
46826191|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
46826192|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|Death|0|||
46826193|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|Death|0|||
46826194|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|Death|0|||
46826195|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|Death|1|||
46826196|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|Death|1|||
46826197|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
46826198|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
46826199|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
46826200|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
46826201|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
46826202|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
46826203|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
46826204|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
46826205|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
46826206|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
46826207|NCT00302211|83044828|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
46826208|NCT00302211|83044829|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
46826209|NCT00302211|83044830|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
46934766|NCT01096368|83170894|FG004|Overall Study|Withdrawal by Subject|14|||
46934767|NCT01096368|83170890|FG000|Overall Study|Ineligible|0|||
47058473|NCT01695239|83337778|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
46762976|NCT00666718|82981239|FG001|Overall Study|Protocol Violation|3|||
46762977|NCT00666718|82981238|FG000|Overall Study|Withdrawal by Subject|7|||
46762978|NCT00666718|82981239|FG001|Overall Study|Withdrawal by Subject|12|||
46762979|NCT00666718|82981238|FG000|Overall Study|Physician Decision|0|||
46762980|NCT00666718|82981239|FG001|Overall Study|Physician Decision|2|||
46762981|NCT00667420|82981245|FG000|Overall Study|Adverse Event|2|||
46762982|NCT00667420|82981245|FG000|Overall Study|Lack of Efficacy|5|||
46762983|NCT00667420|82981245|FG000|Overall Study|Physician Decision|1|||
46762984|NCT00667420|82981245|FG000|Overall Study|Withdrawal by Subject|2|||
46762985|NCT00853658|82981253|FG000|Overall Study|Death|713|||
46762986|NCT00853658|82981254|FG001|Overall Study|Death|768|||
46762987|NCT00853658|82981255|FG002|Overall Study|Death|753|||
46762988|NCT00853658|82981253|FG000|Overall Study|Lost to Follow-up|11|||
46762989|NCT00853658|82981254|FG001|Overall Study|Lost to Follow-up|6|||
46762990|NCT00853658|82981255|FG002|Overall Study|Lost to Follow-up|11|||
46762991|NCT00853658|82981253|FG000|Overall Study|H.A. Request|26|||
46762992|NCT00853658|82981254|FG001|Overall Study|H.A. Request|23|||
46762993|NCT00853658|82981255|FG002|Overall Study|H.A. Request|19|||
46762994|NCT00853658|82981253|FG000|Overall Study|IRB request|0|||
46762995|NCT00853658|82981254|FG001|Overall Study|IRB request|0|||
46762996|NCT00853658|82981255|FG002|Overall Study|IRB request|2|||
46826210|NCT00302211|83044831|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
46934768|NCT01096368|83170891|FG001|Overall Study|Ineligible|3|||
46762997|NCT00853658|82981253|FG000|Overall Study|Vital Status known (alive) at study end|2|||
46762998|NCT00853658|82981254|FG001|Overall Study|Vital Status known (alive) at study end|3|||
46934769|NCT01096368|83170892|FG002|Overall Study|Ineligible|2|||
46934770|NCT01096368|83170893|FG003|Overall Study|Ineligible|0|||
46934771|NCT01096368|83170894|FG004|Overall Study|Ineligible|25|||
46934772|NCT01096368|83170890|FG000|Overall Study|Did not start treatment|0|||
46934773|NCT01096368|83170891|FG001|Overall Study|Did not start treatment|4|||
46934774|NCT01096368|83170892|FG002|Overall Study|Did not start treatment|4|||
46934775|NCT01096368|83170893|FG003|Overall Study|Did not start treatment|0|||
46934776|NCT01096368|83170894|FG004|Overall Study|Did not start treatment|0|||
46934777|NCT01096368|83170890|FG000|Overall Study|Progressive disease|0|||
46934778|NCT01096368|83170891|FG001|Overall Study|Progressive disease|6|||
46934779|NCT01096368|83170892|FG002|Overall Study|Progressive disease|0|||
46934780|NCT01096368|83170893|FG003|Overall Study|Progressive disease|10|||
46934781|NCT01096368|83170894|FG004|Overall Study|Progressive disease|3|||
46934782|NCT01096368|83170890|FG000|Overall Study|Other|0|||
46637458|NCT01474512|82811383|FG007|Induction Period|Withdrawal by Subject|0|||
46637459|NCT01474512|82811384|FG008|Induction Period|Withdrawal by Subject|0|||
46637460|NCT01474512|82811385|FG009|Induction Period|Withdrawal by Subject|0|||
46637461|NCT01474512|82811386|FG010|Induction Period|Withdrawal by Subject|0|||
46637462|NCT01474512|82811387|FG011|Induction Period|Withdrawal by Subject|0|||
46637463|NCT01474512|82811388|FG012|Induction Period|Withdrawal by Subject|0|||
46637464|NCT01474512|82811389|FG013|Induction Period|Withdrawal by Subject|0|||
46637465|NCT01474512|82811390|FG014|Induction Period|Withdrawal by Subject|0|||
46637466|NCT01474512|82811391|FG015|Induction Period|Withdrawal by Subject|0|||
46637467|NCT01474512|82811392|FG016|Induction Period|Withdrawal by Subject|0|||
46762999|NCT00853658|82981255|FG002|Overall Study|Vital Status known (alive) at study end|3|||
46763000|NCT00853658|82981253|FG000|Overall Study|Vital Status unknown at study end|1|||
46763001|NCT00853658|82981254|FG001|Overall Study|Vital Status unknown at study end|1|||
46763002|NCT00853658|82981255|FG002|Overall Study|Vital Status unknown at study end|0|||
46763003|NCT00853658|82981253|FG000|Overall Study|Vital Status at study end N/A|8|||
46763004|NCT00853658|82981254|FG001|Overall Study|Vital Status at study end N/A|10|||
46934783|NCT01096368|83170891|FG001|Overall Study|Other|0|||
46934784|NCT01096368|83170892|FG002|Overall Study|Other|1|||
46934785|NCT01096368|83170893|FG003|Overall Study|Other|0|||
46934786|NCT01096368|83170894|FG004|Overall Study|Other|0|||
46934787|NCT01096368|83170890|FG000|Overall Study|Treated with institutional review|0|||
46934788|NCT01096368|83170891|FG001|Overall Study|Treated with institutional review|0|||
47058474|NCT01695239|83337765|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058475|NCT01695239|83337766|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058476|NCT01695239|83337767|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058477|NCT01695239|83337768|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058478|NCT01695239|83337769|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058479|NCT01695239|83337770|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058480|NCT01695239|83337771|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058481|NCT01695239|83337772|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
46934789|NCT01096368|83170892|FG002|Overall Study|Treated with institutional review|0|||
46934790|NCT01096368|83170893|FG003|Overall Study|Treated with institutional review|0|||
46934791|NCT01096368|83170894|FG004|Overall Study|Treated with institutional review|1|||
46934792|NCT00938587|83170922|FG000|Overall Study|Adverse Event|2|||
46934793|NCT00938587|83170923|FG001|Overall Study|Adverse Event|0|||
46934794|NCT00938587|83170924|FG002|Overall Study|Adverse Event|0|||
46934795|NCT00938587|83170925|FG003|Overall Study|Adverse Event|2|||
46934796|NCT00938587|83170922|FG000|Overall Study|Did not meet entrance criteria|0|||
46934797|NCT00938587|83170923|FG001|Overall Study|Did not meet entrance criteria|0|||
46934798|NCT00938587|83170924|FG002|Overall Study|Did not meet entrance criteria|1|||
46934799|NCT00938587|83170925|FG003|Overall Study|Did not meet entrance criteria|0|||
46934800|NCT00938587|83170922|FG000|Overall Study|Withdrawal by Subject|1|||
47058482|NCT01695239|83337773|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
47058483|NCT01695239|83337774|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
47058484|NCT01695239|83337775|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058485|NCT01695239|83337776|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
46763005|NCT00853658|82981255|FG002|Overall Study|Vital Status at study end N/A|10|||
46637468|NCT01474512|82811393|FG017|Induction Period|Withdrawal by Subject|0|||
46637469|NCT01474512|82811376|FG000|Induction Period|Protocol Violation|3|||
46763006|NCT00853658|82981253|FG000|Overall Study|Patient's request|21|||
46934801|NCT00938587|83170923|FG001|Overall Study|Withdrawal by Subject|1|||
46934802|NCT00938587|83170924|FG002|Overall Study|Withdrawal by Subject|0|||
46934803|NCT00938587|83170925|FG003|Overall Study|Withdrawal by Subject|0|||
46934804|NCT00937937|83170935|FG000|Overall Study|Adverse Event|6|||
46934805|NCT00937937|83170935|FG000|Overall Study|Withdrawal by Subject|2|||
46934806|NCT00937937|83170935|FG000|Overall Study|Progression/relapse|61|||
46934807|NCT00937937|83170935|FG000|Overall Study|Death|1|||
46934808|NCT00937937|83170935|FG000|Overall Study|Other|2|||
46637470|NCT01474512|82811377|FG001|Induction Period|Protocol Violation|6|||
46637471|NCT01474512|82811378|FG002|Induction Period|Protocol Violation|0|||
46934809|NCT00810693|83170943|FG000|Treatment Period|Adverse Event|8|||
46934810|NCT00810693|83170944|FG001|Treatment Period|Adverse Event|1|||
46934811|NCT00810693|83170945|FG002|Treatment Period|Adverse Event|7|||
46934812|NCT00810693|83170943|FG000|Treatment Period|Death|0|||
46934813|NCT00810693|83170944|FG001|Treatment Period|Death|1|||
46934814|NCT00810693|83170945|FG002|Treatment Period|Death|2|||
46934815|NCT00810693|83170943|FG000|Treatment Period|Lack of Efficacy|0|||
46934816|NCT00810693|83170944|FG001|Treatment Period|Lack of Efficacy|0|||
46934817|NCT00810693|83170945|FG002|Treatment Period|Lack of Efficacy|1|||
46934818|NCT00810693|83170943|FG000|Treatment Period|Lost to Follow-up|1|||
46934819|NCT00810693|83170944|FG001|Treatment Period|Lost to Follow-up|0|||
46934820|NCT00810693|83170945|FG002|Treatment Period|Lost to Follow-up|0|||
46934821|NCT00810693|83170943|FG000|Treatment Period|Non-compliance|1|||
46934822|NCT00810693|83170944|FG001|Treatment Period|Non-compliance|0|||
46934823|NCT00810693|83170945|FG002|Treatment Period|Non-compliance|0|||
46934824|NCT00810693|83170943|FG000|Treatment Period|Protocol Violation|1|||
46934825|NCT00810693|83170944|FG001|Treatment Period|Protocol Violation|2|||
46934826|NCT00810693|83170945|FG002|Treatment Period|Protocol Violation|2|||
47058486|NCT01695239|83337777|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058487|NCT01695239|83337778|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
47058488|NCT01695239|83337765|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
47058489|NCT01695239|83337766|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
47058490|NCT01695239|83337767|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
47058491|NCT01695239|83337768|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
47058492|NCT01695239|83337769|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
47058493|NCT01695239|83337770|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
47058494|NCT01695239|83337771|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
47058495|NCT01695239|83337772|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
47058496|NCT01695239|83337773|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
47058497|NCT01695239|83337774|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
47058498|NCT01695239|83337775|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
47058499|NCT01695239|83337776|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
47058500|NCT01695239|83337777|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
47058501|NCT01695239|83337778|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
47058502|NCT01695239|83337765|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058503|NCT01695239|83337766|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058504|NCT01695239|83337767|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058505|NCT01695239|83337768|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058506|NCT01695239|83337769|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058507|NCT01695239|83337770|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058508|NCT01695239|83337771|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058509|NCT01695239|83337772|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
46934827|NCT00810693|83170943|FG000|Treatment Period|Withdrawal by Subject|6|||
46934828|NCT00810693|83170944|FG001|Treatment Period|Withdrawal by Subject|2|||
46934829|NCT00810693|83170945|FG002|Treatment Period|Withdrawal by Subject|3|||
46934830|NCT00810693|83170943|FG000|Treatment Period|Not treated|0|||
46934831|NCT00810693|83170944|FG001|Treatment Period|Not treated|1|||
46934832|NCT00810693|83170945|FG002|Treatment Period|Not treated|1|||
46934833|NCT00810693|83170943|FG000|Follow-up Period (FUP)|Adverse Event|3|||
46934834|NCT00810693|83170944|FG001|Follow-up Period (FUP)|Adverse Event|1|||
46763007|NCT00853658|82981254|FG001|Overall Study|Patient's request|17|||
46763008|NCT00853658|82981255|FG002|Overall Study|Patient's request|11|||
46763009|NCT00853658|82981253|FG000|Overall Study|Missing study completion information|5|||
46763010|NCT00853658|82981254|FG001|Overall Study|Missing study completion information|4|||
46763011|NCT00853658|82981255|FG002|Overall Study|Missing study completion information|6|||
46763012|NCT00666562|82981266|FG000|Overall Study|Withdrawal by Subject|0|||
46934835|NCT00810693|83170945|FG002|Follow-up Period (FUP)|Adverse Event|1|||
46934836|NCT00810693|83170943|FG000|Follow-up Period (FUP)|Death|2|||
46934837|NCT00810693|83170944|FG001|Follow-up Period (FUP)|Death|0|||
46934838|NCT00810693|83170945|FG002|Follow-up Period (FUP)|Death|1|||
46934839|NCT00810693|83170943|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
46934840|NCT00810693|83170944|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
46934841|NCT00810693|83170945|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
46763013|NCT00666562|82981267|FG001|Overall Study|Withdrawal by Subject|1|||
46763014|NCT00666562|82981268|FG002|Overall Study|Withdrawal by Subject|0|||
46763015|NCT00666562|82981266|FG000|Overall Study|Concomitant Medication|0|||
46763016|NCT00666562|82981267|FG001|Overall Study|Concomitant Medication|1|||
46763017|NCT00666562|82981268|FG002|Overall Study|Concomitant Medication|0|||
46763018|NCT00666328|82981283|FG000|Overall Study|Death|2|||
46763019|NCT00666328|82981283|FG000|Overall Study|Lost to Follow-up|2|||
46763020|NCT00666328|82981283|FG000|Overall Study|No longer met eligibility criteria|1|||
46763021|NCT00853580|82981291|FG000|Overall Study|Lost to Follow-up|3|||
46934842|NCT00810693|83170943|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
46934843|NCT00810693|83170944|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
46934844|NCT00810693|83170945|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
46934845|NCT00810693|83170943|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
46934846|NCT00810693|83170944|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
46934847|NCT00810693|83170945|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
46934848|NCT00381641|83170955|FG000|Overall Study|Withdrawal by Subject|0|||
46934849|NCT00381641|83170956|FG001|Overall Study|Withdrawal by Subject|2|||
46826211|NCT00302211|83044832|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
46826212|NCT00288015|83044844|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
46826213|NCT00288015|83044844|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
46826214|NCT00288015|83044844|FG000|First Response Assessment|Withdrawal by Subject|1|||
46826215|NCT00288015|83044844|FG000|First Response Assessment|Death|1|||
46826216|NCT00288015|83044844|FG000|First Response Assessment|Physician Decision|2|||
46826217|NCT00288015|83044844|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
46826218|NCT00288015|83044844|FG000|Follow up for Survival x 2 Years|Death|13|||
46826219|NCT00288015|83044844|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
46826220|NCT00288015|83044844|FG000|Follow up for Survival x 2 Years|Other|9|||
46826221|NCT00389064|83044850|FG000|Overall Study|Adverse Event|11|||
46826222|NCT00389064|83044851|FG001|Overall Study|Adverse Event|3|||
46826223|NCT00389064|83044850|FG000|Overall Study|Lack of Efficacy|3|||
46826224|NCT00389064|83044851|FG001|Overall Study|Lack of Efficacy|14|||
46826225|NCT00389064|83044850|FG000|Overall Study|Withdrawal by Subject|17|||
46826226|NCT00389064|83044851|FG001|Overall Study|Withdrawal by Subject|27|||
46934850|NCT04730349|83170973|FG000|Overall Study|Participant withdrew consent|1|||
46934851|NCT04730349|83170974|FG001|Overall Study|Participant withdrew consent|0|||
46826227|NCT00389064|83044850|FG000|Overall Study|Physician Decision|2|||
46826228|NCT00389064|83044851|FG001|Overall Study|Physician Decision|2|||
46826229|NCT00389064|83044850|FG000|Overall Study|Lost to Follow-up|1|||
46826230|NCT00389064|83044851|FG001|Overall Study|Lost to Follow-up|2|||
46826231|NCT00389064|83044850|FG000|Overall Study|Protocol Violation|2|||
46826232|NCT00389064|83044851|FG001|Overall Study|Protocol Violation|0|||
46934852|NCT04730349|83170973|FG000|Overall Study|Disease progression|6|||
46934853|NCT04730349|83170974|FG001|Overall Study|Disease progression|4|||
46934854|NCT04730349|83170973|FG000|Overall Study|Study drug toxicity|0|||
46934855|NCT04730349|83170974|FG001|Overall Study|Study drug toxicity|1|||
46934856|NCT04307394|83170993|FG000|Overall Study|Lost to Follow-up|3|||
46934857|NCT04307394|83170993|FG000|Overall Study|Withdrawal by Subject|2|||
46934858|NCT03940742|83171019|FG000|Overall Study|Lost to Follow-up|0|||
46934859|NCT03940742|83171020|FG001|Overall Study|Lost to Follow-up|0|||
46934860|NCT03940742|83171021|FG002|Overall Study|Lost to Follow-up|0|||
46934861|NCT03940742|83171022|FG003|Overall Study|Lost to Follow-up|1|||
46934862|NCT03917654|83171044|FG000|Year 1|Withdrawal by Subject|1|||
46934863|NCT03917654|83171045|FG001|Year 1|Withdrawal by Subject|0|||
46934864|NCT03917654|83171046|FG002|Year 1|Withdrawal by Subject|0|||
46934865|NCT03917654|83171047|FG003|Year 1|Withdrawal by Subject|0|||
46934866|NCT03917654|83171048|FG004|Year 1|Withdrawal by Subject|0|||
46826233|NCT00389064|83044850|FG000|Overall Study|Multiple Reasons|9|||
46826234|NCT00389064|83044851|FG001|Overall Study|Multiple Reasons|11|||
46826235|NCT00388674|83044859|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
46826236|NCT00388674|83044860|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
46826237|NCT00388674|83044859|FG000|Initial Treatment|Adverse Event|22|||
46826238|NCT00388674|83044860|FG001|Initial Treatment|Adverse Event|87|||
46934867|NCT03917654|83171049|FG005|Year 1|Withdrawal by Subject|1|||
46934868|NCT03917654|83171050|FG006|Year 1|Withdrawal by Subject|6|||
46934869|NCT03917654|83171051|FG007|Year 1|Withdrawal by Subject|2|||
46934870|NCT03917654|83171052|FG008|Year 1|Withdrawal by Subject|5|||
46934871|NCT03917654|83171053|FG009|Year 1|Withdrawal by Subject|3|||
46934872|NCT03917654|83171054|FG010|Year 1|Withdrawal by Subject|1|||
46934873|NCT03917654|83171055|FG011|Year 1|Withdrawal by Subject|0|||
46934874|NCT03917654|83171044|FG000|Year 1|Travel|0|||
46934875|NCT03917654|83171045|FG001|Year 1|Travel|1|||
46934876|NCT03917654|83171046|FG002|Year 1|Travel|1|||
46934877|NCT03917654|83171047|FG003|Year 1|Travel|0|||
46826239|NCT00388674|83044859|FG000|Initial Treatment|Death|215|||
46826240|NCT00388674|83044860|FG001|Initial Treatment|Death|216|||
46826241|NCT00388674|83044859|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
46934878|NCT03917654|83171048|FG004|Year 1|Travel|4|||
46934879|NCT03917654|83171049|FG005|Year 1|Travel|4|||
46934880|NCT03917654|83171050|FG006|Year 1|Travel|10|||
46934881|NCT03917654|83171051|FG007|Year 1|Travel|8|||
46826242|NCT00388674|83044860|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
46826243|NCT00388674|83044859|FG000|Initial Treatment|HCC|12|||
46826244|NCT00388674|83044860|FG001|Initial Treatment|HCC|20|||
46826245|NCT00388674|83044859|FG000|Initial Treatment|Lost to Follow-up|526|||
46934882|NCT03917654|83171052|FG008|Year 1|Travel|2|||
46934883|NCT03917654|83171053|FG009|Year 1|Travel|5|||
46934884|NCT03917654|83171054|FG010|Year 1|Travel|3|||
46934885|NCT03917654|83171055|FG011|Year 1|Travel|3|||
46934886|NCT03917654|83171044|FG000|Year 1|Subject moved away from site|0|||
46934887|NCT03917654|83171045|FG001|Year 1|Subject moved away from site|1|||
46934888|NCT03917654|83171046|FG002|Year 1|Subject moved away from site|0|||
46934889|NCT03917654|83171047|FG003|Year 1|Subject moved away from site|0|||
46934890|NCT03917654|83171048|FG004|Year 1|Subject moved away from site|0|||
46934891|NCT03917654|83171049|FG005|Year 1|Subject moved away from site|0|||
46934892|NCT03917654|83171050|FG006|Year 1|Subject moved away from site|1|||
46934893|NCT03917654|83171051|FG007|Year 1|Subject moved away from site|2|||
46934894|NCT03917654|83171052|FG008|Year 1|Subject moved away from site|1|||
46934895|NCT03917654|83171053|FG009|Year 1|Subject moved away from site|0|||
46934896|NCT03917654|83171054|FG010|Year 1|Subject moved away from site|0|||
46934897|NCT03917654|83171055|FG011|Year 1|Subject moved away from site|3|||
46934898|NCT03917654|83171044|FG000|Year 1|Spouse/Family member request|0|||
46934899|NCT03917654|83171045|FG001|Year 1|Spouse/Family member request|0|||
46934900|NCT03917654|83171046|FG002|Year 1|Spouse/Family member request|1|||
46934901|NCT03917654|83171047|FG003|Year 1|Spouse/Family member request|0|||
46934902|NCT03917654|83171048|FG004|Year 1|Spouse/Family member request|1|||
46934903|NCT03917654|83171049|FG005|Year 1|Spouse/Family member request|0|||
46934904|NCT03917654|83171050|FG006|Year 1|Spouse/Family member request|0|||
47058510|NCT01695239|83337773|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
47058511|NCT01695239|83337774|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
47058512|NCT01695239|83337775|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058513|NCT01695239|83337776|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058514|NCT01695239|83337777|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058515|NCT01695239|83337778|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
47058516|NCT01695239|83337765|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
47058517|NCT01695239|83337766|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
47058518|NCT01695239|83337767|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
47058519|NCT01695239|83337768|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
47058520|NCT01695239|83337769|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
47058521|NCT01695239|83337770|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
47058522|NCT01695239|83337771|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
47058523|NCT01695239|83337772|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
47058524|NCT01695239|83337773|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
47058525|NCT01695239|83337774|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
47058526|NCT01695239|83337775|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
47058527|NCT01695239|83337776|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
47058528|NCT01695239|83337777|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
47058529|NCT01695239|83337778|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
47058530|NCT01695239|83337765|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
46763022|NCT00853580|82981292|FG001|Overall Study|Lost to Follow-up|5|||
46763023|NCT00853580|82981291|FG000|Overall Study|Protocol Violation|2|||
46934905|NCT03917654|83171051|FG007|Year 1|Spouse/Family member request|2|||
46934906|NCT03917654|83171052|FG008|Year 1|Spouse/Family member request|0|||
46934907|NCT03917654|83171053|FG009|Year 1|Spouse/Family member request|0|||
46934908|NCT03917654|83171054|FG010|Year 1|Spouse/Family member request|0|||
46934909|NCT03917654|83171055|FG011|Year 1|Spouse/Family member request|1|||
46934910|NCT03917654|83171044|FG000|Year 1|Death|0|||
46763024|NCT00853580|82981292|FG001|Overall Study|Protocol Violation|1|||
46763025|NCT00853580|82981291|FG000|Overall Study|Withdrawal by Subject|2|||
46763026|NCT00853580|82981292|FG001|Overall Study|Withdrawal by Subject|8|||
46763027|NCT00853580|82981291|FG000|Overall Study|Commenced contraindicated therapy|0|||
46763028|NCT00853580|82981292|FG001|Overall Study|Commenced contraindicated therapy|2|||
46763029|NCT00865514|82981298|FG000|Overall Study|Infusion cost exceeded funding|2|||
46763030|NCT00865280|82981305|FG000|Overall Study|Withdrawal by Subject|4|||
46763031|NCT00865280|82981306|FG001|Overall Study|Withdrawal by Subject|1|||
46934911|NCT03917654|83171045|FG001|Year 1|Death|0|||
46934912|NCT03917654|83171046|FG002|Year 1|Death|0|||
46934913|NCT03917654|83171047|FG003|Year 1|Death|0|||
46934914|NCT03917654|83171048|FG004|Year 1|Death|0|||
46934915|NCT03917654|83171049|FG005|Year 1|Death|0|||
46934916|NCT03917654|83171050|FG006|Year 1|Death|0|||
46934917|NCT03917654|83171051|FG007|Year 1|Death|0|||
46934918|NCT03917654|83171052|FG008|Year 1|Death|1|||
46934919|NCT03917654|83171053|FG009|Year 1|Death|1|||
46934920|NCT03917654|83171054|FG010|Year 1|Death|0|||
46934921|NCT03917654|83171055|FG011|Year 1|Death|0|||
46934922|NCT03917654|83171044|FG000|Year 1|Lost to Follow-up|0|||
46934923|NCT03917654|83171045|FG001|Year 1|Lost to Follow-up|0|||
46934924|NCT03917654|83171046|FG002|Year 1|Lost to Follow-up|0|||
46934925|NCT03917654|83171047|FG003|Year 1|Lost to Follow-up|0|||
46934926|NCT03917654|83171048|FG004|Year 1|Lost to Follow-up|0|||
46934927|NCT03917654|83171049|FG005|Year 1|Lost to Follow-up|0|||
46934928|NCT03917654|83171050|FG006|Year 1|Lost to Follow-up|2|||
46934929|NCT03917654|83171051|FG007|Year 1|Lost to Follow-up|0|||
46934930|NCT03917654|83171052|FG008|Year 1|Lost to Follow-up|0|||
46934931|NCT03917654|83171053|FG009|Year 1|Lost to Follow-up|0|||
46934932|NCT03917654|83171054|FG010|Year 1|Lost to Follow-up|0|||
46934933|NCT03917654|83171055|FG011|Year 1|Lost to Follow-up|0|||
46934934|NCT03917654|83171044|FG000|Year 1|Missed visits|0|||
46934935|NCT03917654|83171045|FG001|Year 1|Missed visits|0|||
46934936|NCT03917654|83171046|FG002|Year 1|Missed visits|0|||
46934937|NCT03917654|83171047|FG003|Year 1|Missed visits|0|||
46934938|NCT03917654|83171048|FG004|Year 1|Missed visits|0|||
46934939|NCT03917654|83171049|FG005|Year 1|Missed visits|0|||
46934940|NCT03917654|83171050|FG006|Year 1|Missed visits|0|||
46934941|NCT03917654|83171051|FG007|Year 1|Missed visits|0|||
46934942|NCT03917654|83171052|FG008|Year 1|Missed visits|0|||
46934943|NCT03917654|83171053|FG009|Year 1|Missed visits|0|||
46934944|NCT03917654|83171054|FG010|Year 1|Missed visits|1|||
46934945|NCT03917654|83171055|FG011|Year 1|Missed visits|1|||
46934946|NCT03917654|83171044|FG000|Year 1|Pregnancy|0|||
46934947|NCT03917654|83171045|FG001|Year 1|Pregnancy|0|||
46934948|NCT03917654|83171046|FG002|Year 1|Pregnancy|0|||
46934949|NCT03917654|83171047|FG003|Year 1|Pregnancy|0|||
46934950|NCT03917654|83171048|FG004|Year 1|Pregnancy|0|||
46934951|NCT03917654|83171049|FG005|Year 1|Pregnancy|0|||
46934952|NCT03917654|83171050|FG006|Year 1|Pregnancy|0|||
46934953|NCT03917654|83171051|FG007|Year 1|Pregnancy|1|||
46934954|NCT03917654|83171052|FG008|Year 1|Pregnancy|0|||
46934955|NCT03917654|83171053|FG009|Year 1|Pregnancy|1|||
46934956|NCT03917654|83171054|FG010|Year 1|Pregnancy|0|||
46934957|NCT03917654|83171055|FG011|Year 1|Pregnancy|0|||
46934958|NCT03917654|83171044|FG000|Year 2|Travel|1|||
46934959|NCT03917654|83171045|FG001|Year 2|Travel|0|||
46934960|NCT03917654|83171046|FG002|Year 2|Travel|0|||
46934961|NCT03917654|83171047|FG003|Year 2|Travel|0|||
46934962|NCT03917654|83171048|FG004|Year 2|Travel|1|||
46934963|NCT03917654|83171049|FG005|Year 2|Travel|1|||
47058531|NCT01695239|83337766|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058532|NCT01695239|83337767|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058533|NCT01695239|83337768|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058534|NCT01695239|83337769|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
46826246|NCT00388674|83044860|FG001|Initial Treatment|Lost to Follow-up|624|||
46826247|NCT00388674|83044859|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
46826248|NCT00388674|83044860|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
46826249|NCT00388674|83044859|FG000|Initial Treatment|Never Treated with Study Medication|1|||
46826250|NCT00388674|83044860|FG001|Initial Treatment|Never Treated with Study Medication|7|||
46826251|NCT00388674|83044859|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
46826252|NCT00388674|83044860|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
46826253|NCT00388674|83044859|FG000|Initial Treatment|Not Defined|125|||
46826254|NCT00388674|83044860|FG001|Initial Treatment|Not Defined|172|||
46826255|NCT00388674|83044859|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
46826256|NCT00388674|83044860|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
46826257|NCT00388674|83044859|FG000|Initial Treatment|Pregnancy|26|||
46826258|NCT00388674|83044860|FG001|Initial Treatment|Pregnancy|16|||
46826259|NCT00388674|83044859|FG000|Initial Treatment|Study Drug Toxicity|5|||
46826260|NCT00388674|83044860|FG001|Initial Treatment|Study Drug Toxicity|92|||
46826261|NCT00388674|83044859|FG000|Initial Treatment|Participant Request|501|||
46826262|NCT00388674|83044860|FG001|Initial Treatment|Participant Request|673|||
46826263|NCT00388674|83044859|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
46826264|NCT00388674|83044860|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
46826265|NCT00388674|83044859|FG000|Initial Treatment|Not Reported|10|||
46826266|NCT00388674|83044860|FG001|Initial Treatment|Not Reported|12|||
46826267|NCT00388674|83044859|FG000|End of Study|Administrative Reason By Sponsor|299|||
46826268|NCT00388674|83044860|FG001|End of Study|Administrative Reason By Sponsor|253|||
46826269|NCT00388674|83044859|FG000|End of Study|Death|239|||
46934964|NCT03917654|83171050|FG006|Year 2|Travel|2|||
46934965|NCT03917654|83171051|FG007|Year 2|Travel|1|||
46934966|NCT03917654|83171052|FG008|Year 2|Travel|0|||
46934967|NCT03917654|83171053|FG009|Year 2|Travel|1|||
46763032|NCT00865280|82981305|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
46763033|NCT00865280|82981306|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
46763034|NCT00865280|82981305|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
46763035|NCT00865280|82981306|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
46763036|NCT00865280|82981305|FG000|Overall Study|Exclusion Condition|1|||
46763037|NCT00865280|82981306|FG001|Overall Study|Exclusion Condition|0|||
46763038|NCT00865280|82981305|FG000|Overall Study|Adverse Event|0|||
46763039|NCT00865280|82981306|FG001|Overall Study|Adverse Event|1|||
46763040|NCT00865124|82981315|FG000|Overall Study|Physician Decision|2|||
46934968|NCT03917654|83171054|FG010|Year 2|Travel|0|||
46934969|NCT03917654|83171055|FG011|Year 2|Travel|1|||
46934970|NCT03917654|83171044|FG000|Year 2|Married|1|||
46934971|NCT03917654|83171045|FG001|Year 2|Married|0|||
46934972|NCT03917654|83171046|FG002|Year 2|Married|0|||
46934973|NCT03917654|83171047|FG003|Year 2|Married|0|||
46934974|NCT03917654|83171048|FG004|Year 2|Married|0|||
46934975|NCT03917654|83171049|FG005|Year 2|Married|0|||
46934976|NCT03917654|83171050|FG006|Year 2|Married|1|||
46934977|NCT03917654|83171051|FG007|Year 2|Married|1|||
46763041|NCT00865124|82981316|FG001|Overall Study|Physician Decision|1|||
46934978|NCT03917654|83171052|FG008|Year 2|Married|0|||
46934979|NCT03917654|83171053|FG009|Year 2|Married|0|||
46934980|NCT03917654|83171054|FG010|Year 2|Married|0|||
46934981|NCT03917654|83171055|FG011|Year 2|Married|0|||
46934982|NCT03917654|83171044|FG000|Year 2|Subject moved away from site|1|||
46934983|NCT03917654|83171045|FG001|Year 2|Subject moved away from site|0|||
46934984|NCT03917654|83171046|FG002|Year 2|Subject moved away from site|0|||
46934985|NCT03917654|83171047|FG003|Year 2|Subject moved away from site|0|||
46934986|NCT03917654|83171048|FG004|Year 2|Subject moved away from site|1|||
46934987|NCT03917654|83171049|FG005|Year 2|Subject moved away from site|0|||
46934988|NCT03917654|83171050|FG006|Year 2|Subject moved away from site|2|||
46934989|NCT03917654|83171051|FG007|Year 2|Subject moved away from site|3|||
46934990|NCT03917654|83171052|FG008|Year 2|Subject moved away from site|0|||
46934991|NCT03917654|83171053|FG009|Year 2|Subject moved away from site|2|||
46934992|NCT03917654|83171054|FG010|Year 2|Subject moved away from site|0|||
46934993|NCT03917654|83171055|FG011|Year 2|Subject moved away from site|1|||
46934994|NCT03917654|83171044|FG000|Year 2|Year 2 Screening failure|0|||
46934995|NCT03917654|83171045|FG001|Year 2|Year 2 Screening failure|1|||
46934996|NCT03917654|83171046|FG002|Year 2|Year 2 Screening failure|0|||
46934997|NCT03917654|83171047|FG003|Year 2|Year 2 Screening failure|0|||
46934998|NCT03917654|83171048|FG004|Year 2|Year 2 Screening failure|2|||
46934999|NCT03917654|83171049|FG005|Year 2|Year 2 Screening failure|0|||
46935000|NCT03917654|83171050|FG006|Year 2|Year 2 Screening failure|4|||
46935001|NCT03917654|83171051|FG007|Year 2|Year 2 Screening failure|3|||
46935002|NCT03917654|83171052|FG008|Year 2|Year 2 Screening failure|10|||
46935003|NCT03917654|83171053|FG009|Year 2|Year 2 Screening failure|2|||
46935004|NCT03917654|83171054|FG010|Year 2|Year 2 Screening failure|1|||
46935005|NCT03917654|83171055|FG011|Year 2|Year 2 Screening failure|1|||
46935006|NCT03917654|83171044|FG000|Year 2|Death|0|||
46935007|NCT03917654|83171045|FG001|Year 2|Death|0|||
46935008|NCT03917654|83171046|FG002|Year 2|Death|0|||
46935009|NCT03917654|83171047|FG003|Year 2|Death|0|||
46935010|NCT03917654|83171048|FG004|Year 2|Death|0|||
46935011|NCT03917654|83171049|FG005|Year 2|Death|1|||
46763042|NCT00865124|82981317|FG002|Overall Study|Physician Decision|0|||
46935012|NCT03917654|83171050|FG006|Year 2|Death|0|||
46763043|NCT00865124|82981315|FG000|Overall Study|Withdrawn consent|2|||
46763044|NCT00865124|82981316|FG001|Overall Study|Withdrawn consent|0|||
46763045|NCT00865124|82981317|FG002|Overall Study|Withdrawn consent|0|||
46763046|NCT00871715|82981328|FG000|Overall Study|Withdrawal by Subject|6|||
46763047|NCT00871715|82981329|FG001|Overall Study|Withdrawal by Subject|10|||
46763048|NCT00871715|82981330|FG002|Overall Study|Withdrawal by Subject|15|||
46763049|NCT00871715|82981328|FG000|Overall Study|Physician Decision|6|||
46763050|NCT00871715|82981329|FG001|Overall Study|Physician Decision|0|||
46763051|NCT00871715|82981330|FG002|Overall Study|Physician Decision|2|||
46763052|NCT00871715|82981328|FG000|Overall Study|Lost to Follow-up|3|||
46763053|NCT00871715|82981329|FG001|Overall Study|Lost to Follow-up|6|||
46763054|NCT00871715|82981330|FG002|Overall Study|Lost to Follow-up|9|||
46763055|NCT00819234|82981339|FG000|Overall Study|Withdrawal by Subject|8|||
46763056|NCT00819234|82981340|FG001|Overall Study|Withdrawal by Subject|13|||
46763057|NCT00819234|82981341|FG002|Overall Study|Withdrawal by Subject|6|||
46763058|NCT00819234|82981342|FG003|Overall Study|Withdrawal by Subject|3|||
46763059|NCT00819234|82981343|FG004|Overall Study|Withdrawal by Subject|0|||
46763060|NCT00819234|82981344|FG005|Overall Study|Withdrawal by Subject|4|||
46935013|NCT03917654|83171051|FG007|Year 2|Death|0|||
47058535|NCT01695239|83337770|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058536|NCT01695239|83337771|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
46637472|NCT01474512|82811379|FG003|Induction Period|Protocol Violation|0|||
46763061|NCT00819234|82981345|FG006|Overall Study|Withdrawal by Subject|4|||
46763062|NCT00819234|82981346|FG007|Overall Study|Withdrawal by Subject|8|||
46763063|NCT00819234|82981347|FG008|Overall Study|Withdrawal by Subject|5|||
46763064|NCT00819234|82981348|FG009|Overall Study|Withdrawal by Subject|3|||
46763065|NCT00819234|82981339|FG000|Overall Study|Adverse Event|0|||
46763066|NCT00819234|82981340|FG001|Overall Study|Adverse Event|0|||
46763067|NCT00819234|82981341|FG002|Overall Study|Adverse Event|1|||
46763068|NCT00819234|82981342|FG003|Overall Study|Adverse Event|0|||
46763069|NCT00819234|82981343|FG004|Overall Study|Adverse Event|0|||
46935014|NCT03917654|83171052|FG008|Year 2|Death|1|||
46935015|NCT03917654|83171053|FG009|Year 2|Death|1|||
46935016|NCT03917654|83171054|FG010|Year 2|Death|0|||
46935017|NCT03917654|83171055|FG011|Year 2|Death|0|||
46935018|NCT03917654|83171044|FG000|Year 2|Withdrawal by Subject|0|||
46935019|NCT03917654|83171045|FG001|Year 2|Withdrawal by Subject|0|||
46935020|NCT03917654|83171046|FG002|Year 2|Withdrawal by Subject|0|||
46763070|NCT00819234|82981344|FG005|Overall Study|Adverse Event|2|||
46935021|NCT03917654|83171047|FG003|Year 2|Withdrawal by Subject|0|||
46935022|NCT03917654|83171048|FG004|Year 2|Withdrawal by Subject|0|||
46935023|NCT03917654|83171049|FG005|Year 2|Withdrawal by Subject|0|||
46935024|NCT03917654|83171050|FG006|Year 2|Withdrawal by Subject|3|||
46826270|NCT00388674|83044860|FG001|End of Study|Death|262|||
46826271|NCT00388674|83044859|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
46826272|NCT00388674|83044860|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
46826273|NCT00388674|83044859|FG000|End of Study|HCC|8|||
46826274|NCT00388674|83044860|FG001|End of Study|HCC|7|||
46826275|NCT00388674|83044859|FG000|End of Study|Lost to Follow-up|587|||
46826276|NCT00388674|83044860|FG001|End of Study|Lost to Follow-up|715|||
46826277|NCT00388674|83044859|FG000|End of Study|Malignancy (Non-HCC)|1|||
46826278|NCT00388674|83044860|FG001|End of Study|Malignancy (Non-HCC)|1|||
46826279|NCT00388674|83044859|FG000|End of Study|Non-Study Related Comorbidities|3|||
46826280|NCT00388674|83044860|FG001|End of Study|Non-Study Related Comorbidities|4|||
46826281|NCT00388674|83044859|FG000|End of Study|Not Defined|135|||
46826282|NCT00388674|83044860|FG001|End of Study|Not Defined|214|||
46826283|NCT00388674|83044859|FG000|End of Study|Participant Withdrew Consent|437|||
46826284|NCT00388674|83044860|FG001|End of Study|Participant Withdrew Consent|673|||
46826285|NCT00388674|83044859|FG000|End of Study|No Off-Treatment Status Data|22|||
46826286|NCT00388674|83044860|FG001|End of Study|No Off-Treatment Status Data|30|||
46826287|NCT00388674|83044859|FG000|End of Study|Not Reported|0|||
46826288|NCT00388674|83044860|FG001|End of Study|Not Reported|1|||
46826289|NCT00388362|83044866|FG000|Enrolled|Ineligible|1|||
46826290|NCT00388362|83044866|FG000|Enrolled|Adverse Event|9|||
46826291|NCT00388362|83044866|FG000|Enrolled|Death|1|||
46826292|NCT00388362|83044866|FG000|Enrolled|Loss insurance|1|||
46826293|NCT00388362|83044866|FG000|Enrolled|Withdrawal by Subject|1|||
46826294|NCT00388362|83044866|FG000|Remained on Study Median of 514 Days|Death|2|||
46826295|NCT00387894|83044870|FG000|Overall Study|Withdrawal by Subject|1|||
46826296|NCT00387426|83044874|FG000|Overall Study|Lack of Response|7|||
46826297|NCT00387426|83044874|FG000|Overall Study|Toxicities|4|||
46826298|NCT00387426|83044874|FG000|Overall Study|Disease Progression|3|||
46826299|NCT00387348|83044881|FG000|Overall Study|Death|1|||
46826300|NCT00387348|83044882|FG001|Overall Study|Death|1|||
46826301|NCT00387348|83044883|FG002|Overall Study|Death|0|||
46826302|NCT00387348|83044881|FG000|Overall Study|Physician Decision|1|||
46826303|NCT00387348|83044882|FG001|Overall Study|Physician Decision|0|||
46826304|NCT00387348|83044883|FG002|Overall Study|Physician Decision|1|||
46826305|NCT00387348|83044881|FG000|Overall Study|Withdrawal by Subject|0|||
46826306|NCT00387348|83044882|FG001|Overall Study|Withdrawal by Subject|2|||
46826307|NCT00387348|83044883|FG002|Overall Study|Withdrawal by Subject|2|||
46826308|NCT00387348|83044881|FG000|Overall Study|Adverse Event|1|||
46826309|NCT00387348|83044882|FG001|Overall Study|Adverse Event|0|||
46826310|NCT00387348|83044883|FG002|Overall Study|Adverse Event|1|||
46826311|NCT00413660|83044903|FG000|Up To Week 12|Adverse Event|1|||
46826312|NCT00413660|83044904|FG001|Up To Week 12|Adverse Event|3|||
46826313|NCT00413660|83044905|FG002|Up To Week 12|Adverse Event|1|||
46826314|NCT00413660|83044906|FG003|Up To Week 12|Adverse Event|4|||
46935025|NCT03917654|83171051|FG007|Year 2|Withdrawal by Subject|0|||
46935026|NCT03917654|83171052|FG008|Year 2|Withdrawal by Subject|2|||
46935027|NCT03917654|83171053|FG009|Year 2|Withdrawal by Subject|5|||
46935028|NCT03917654|83171054|FG010|Year 2|Withdrawal by Subject|0|||
46935029|NCT03917654|83171055|FG011|Year 2|Withdrawal by Subject|0|||
46935030|NCT03917654|83171044|FG000|Year 2|Spouse/family member request|0|||
46935031|NCT03917654|83171045|FG001|Year 2|Spouse/family member request|0|||
46935032|NCT03917654|83171046|FG002|Year 2|Spouse/family member request|0|||
46935033|NCT03917654|83171047|FG003|Year 2|Spouse/family member request|0|||
46935034|NCT03917654|83171048|FG004|Year 2|Spouse/family member request|0|||
46935035|NCT03917654|83171049|FG005|Year 2|Spouse/family member request|0|||
46935036|NCT03917654|83171050|FG006|Year 2|Spouse/family member request|1|||
46935037|NCT03917654|83171051|FG007|Year 2|Spouse/family member request|0|||
46935038|NCT03917654|83171052|FG008|Year 2|Spouse/family member request|0|||
46935039|NCT03917654|83171053|FG009|Year 2|Spouse/family member request|0|||
46935040|NCT03917654|83171054|FG010|Year 2|Spouse/family member request|0|||
46935041|NCT03917654|83171055|FG011|Year 2|Spouse/family member request|0|||
47058537|NCT01695239|83337772|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058538|NCT01695239|83337773|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
47058539|NCT01695239|83337774|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
46826315|NCT00413660|83044907|FG004|Up To Week 12|Adverse Event|6|||
46826316|NCT00413660|83044908|FG005|Up To Week 12|Adverse Event|4|||
46826317|NCT00413660|83044909|FG006|Up To Week 12|Adverse Event|1|||
46826318|NCT00413660|83044910|FG007|Up To Week 12|Adverse Event|0|||
46826319|NCT00413660|83044911|FG008|Up To Week 12|Adverse Event|0|||
46826320|NCT00413660|83044912|FG009|Up To Week 12|Adverse Event|0|||
46935042|NCT03917654|83171044|FG000|Year 2|Lost to Follow-up|0|||
46935043|NCT03917654|83171045|FG001|Year 2|Lost to Follow-up|0|||
46935044|NCT03917654|83171046|FG002|Year 2|Lost to Follow-up|0|||
46826321|NCT00413660|83044913|FG010|Up To Week 12|Adverse Event|0|||
46826322|NCT00413660|83044903|FG000|Up To Week 12|Lack of Efficacy|2|||
46826323|NCT00413660|83044904|FG001|Up To Week 12|Lack of Efficacy|0|||
46826324|NCT00413660|83044905|FG002|Up To Week 12|Lack of Efficacy|0|||
46826325|NCT00413660|83044906|FG003|Up To Week 12|Lack of Efficacy|0|||
46935045|NCT03917654|83171047|FG003|Year 2|Lost to Follow-up|0|||
46935046|NCT03917654|83171048|FG004|Year 2|Lost to Follow-up|0|||
46935047|NCT03917654|83171049|FG005|Year 2|Lost to Follow-up|0|||
46935048|NCT03917654|83171050|FG006|Year 2|Lost to Follow-up|1|||
46935049|NCT03917654|83171051|FG007|Year 2|Lost to Follow-up|0|||
46935050|NCT03917654|83171052|FG008|Year 2|Lost to Follow-up|1|||
46935051|NCT03917654|83171053|FG009|Year 2|Lost to Follow-up|0|||
46935052|NCT03917654|83171054|FG010|Year 2|Lost to Follow-up|0|||
46826326|NCT00413660|83044907|FG004|Up To Week 12|Lack of Efficacy|0|||
46826327|NCT00413660|83044908|FG005|Up To Week 12|Lack of Efficacy|0|||
46826328|NCT00413660|83044909|FG006|Up To Week 12|Lack of Efficacy|5|||
46826329|NCT00413660|83044910|FG007|Up To Week 12|Lack of Efficacy|0|||
46826330|NCT00413660|83044911|FG008|Up To Week 12|Lack of Efficacy|0|||
46826331|NCT00413660|83044912|FG009|Up To Week 12|Lack of Efficacy|0|||
46826332|NCT00413660|83044913|FG010|Up To Week 12|Lack of Efficacy|0|||
46826333|NCT00413660|83044903|FG000|Up To Week 12|Lost to Follow-up|0|||
46826334|NCT00413660|83044904|FG001|Up To Week 12|Lost to Follow-up|1|||
46826335|NCT00413660|83044905|FG002|Up To Week 12|Lost to Follow-up|0|||
46935053|NCT03917654|83171055|FG011|Year 2|Lost to Follow-up|1|||
46935054|NCT03917654|83171044|FG000|Year 2|Adverse Event|0|||
46935055|NCT03917654|83171045|FG001|Year 2|Adverse Event|0|||
46935056|NCT03917654|83171046|FG002|Year 2|Adverse Event|0|||
46935057|NCT03917654|83171047|FG003|Year 2|Adverse Event|0|||
46935058|NCT03917654|83171048|FG004|Year 2|Adverse Event|0|||
46935059|NCT03917654|83171049|FG005|Year 2|Adverse Event|0|||
46935060|NCT03917654|83171050|FG006|Year 2|Adverse Event|0|||
46935061|NCT03917654|83171051|FG007|Year 2|Adverse Event|0|||
46935062|NCT03917654|83171052|FG008|Year 2|Adverse Event|0|||
46935063|NCT03917654|83171053|FG009|Year 2|Adverse Event|1|||
46935064|NCT03917654|83171054|FG010|Year 2|Adverse Event|0|||
46935065|NCT03917654|83171055|FG011|Year 2|Adverse Event|0|||
46935066|NCT03060577|83171092|FG000|Overall Study|Withdrawal by Subject|25|||
46826336|NCT00413660|83044906|FG003|Up To Week 12|Lost to Follow-up|0|||
46826337|NCT00413660|83044907|FG004|Up To Week 12|Lost to Follow-up|1|||
46826338|NCT00413660|83044908|FG005|Up To Week 12|Lost to Follow-up|0|||
46826339|NCT00413660|83044909|FG006|Up To Week 12|Lost to Follow-up|0|||
46826340|NCT00413660|83044910|FG007|Up To Week 12|Lost to Follow-up|0|||
46826341|NCT00413660|83044911|FG008|Up To Week 12|Lost to Follow-up|0|||
46826342|NCT00413660|83044912|FG009|Up To Week 12|Lost to Follow-up|0|||
46826343|NCT00413660|83044913|FG010|Up To Week 12|Lost to Follow-up|0|||
46826344|NCT00413660|83044903|FG000|Up To Week 12|Withdrawal by Subject|0|||
46826345|NCT00413660|83044904|FG001|Up To Week 12|Withdrawal by Subject|2|||
46826346|NCT00413660|83044905|FG002|Up To Week 12|Withdrawal by Subject|0|||
46826347|NCT00413660|83044906|FG003|Up To Week 12|Withdrawal by Subject|2|||
46935067|NCT03060577|83171093|FG001|Overall Study|Withdrawal by Subject|5|||
46935068|NCT03060577|83171092|FG000|Overall Study|Physician Decision|4|||
46935069|NCT03060577|83171093|FG001|Overall Study|Physician Decision|3|||
46935070|NCT03060577|83171092|FG000|Overall Study|Lost to Follow-up|3|||
46935071|NCT03060577|83171093|FG001|Overall Study|Lost to Follow-up|0|||
46935072|NCT03060577|83171092|FG000|Overall Study|Death|7|||
46935073|NCT03060577|83171093|FG001|Overall Study|Death|1|||
47058540|NCT01695239|83337775|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058541|NCT01695239|83337776|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058542|NCT01695239|83337777|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
47058543|NCT01695239|83337778|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
46763071|NCT00819234|82981345|FG006|Overall Study|Adverse Event|0|||
46763072|NCT00819234|82981346|FG007|Overall Study|Adverse Event|0|||
46763073|NCT00819234|82981347|FG008|Overall Study|Adverse Event|0|||
46763074|NCT00819234|82981348|FG009|Overall Study|Adverse Event|0|||
46763075|NCT00819234|82981339|FG000|Overall Study|Physician Decision|0|||
46763076|NCT00819234|82981340|FG001|Overall Study|Physician Decision|0|||
46763077|NCT00819234|82981341|FG002|Overall Study|Physician Decision|0|||
46763078|NCT00819234|82981342|FG003|Overall Study|Physician Decision|1|||
46763079|NCT00819234|82981343|FG004|Overall Study|Physician Decision|0|||
46763080|NCT00819234|82981344|FG005|Overall Study|Physician Decision|0|||
46763081|NCT00819234|82981345|FG006|Overall Study|Physician Decision|0|||
46763082|NCT00819234|82981346|FG007|Overall Study|Physician Decision|0|||
46763083|NCT00819234|82981347|FG008|Overall Study|Physician Decision|0|||
46763084|NCT00819234|82981348|FG009|Overall Study|Physician Decision|2|||
46763085|NCT00819234|82981339|FG000|Overall Study|Protocol Violation|0|||
46763086|NCT00819234|82981340|FG001|Overall Study|Protocol Violation|0|||
46935074|NCT03060577|83171092|FG000|Overall Study|Adverse Event|9|||
46935075|NCT03060577|83171093|FG001|Overall Study|Adverse Event|1|||
46763087|NCT00819234|82981341|FG002|Overall Study|Protocol Violation|1|||
46763088|NCT00819234|82981342|FG003|Overall Study|Protocol Violation|0|||
46763089|NCT00819234|82981343|FG004|Overall Study|Protocol Violation|0|||
46826348|NCT00413660|83044907|FG004|Up To Week 12|Withdrawal by Subject|0|||
46935076|NCT03060577|83171092|FG000|Overall Study|Inclusion/Exclusion|1|||
46935077|NCT03060577|83171093|FG001|Overall Study|Inclusion/Exclusion|0|||
46935078|NCT03060577|83171092|FG000|Overall Study|Other|8|||
46935079|NCT03060577|83171093|FG001|Overall Study|Other|2|||
46826349|NCT00413660|83044908|FG005|Up To Week 12|Withdrawal by Subject|2|||
46826350|NCT00413660|83044909|FG006|Up To Week 12|Withdrawal by Subject|2|||
46826351|NCT00413660|83044910|FG007|Up To Week 12|Withdrawal by Subject|0|||
46826352|NCT00413660|83044911|FG008|Up To Week 12|Withdrawal by Subject|0|||
46826353|NCT00413660|83044912|FG009|Up To Week 12|Withdrawal by Subject|0|||
46826354|NCT00413660|83044913|FG010|Up To Week 12|Withdrawal by Subject|0|||
46826355|NCT00413660|83044903|FG000|Up To Week 12|Randomized, Not Treated|1|||
46826356|NCT00413660|83044904|FG001|Up To Week 12|Randomized, Not Treated|0|||
46826357|NCT00413660|83044905|FG002|Up To Week 12|Randomized, Not Treated|0|||
46826358|NCT00413660|83044906|FG003|Up To Week 12|Randomized, Not Treated|1|||
46826359|NCT00413660|83044907|FG004|Up To Week 12|Randomized, Not Treated|0|||
46826360|NCT00413660|83044908|FG005|Up To Week 12|Randomized, Not Treated|0|||
46826361|NCT00413660|83044909|FG006|Up To Week 12|Randomized, Not Treated|0|||
46826362|NCT00413660|83044910|FG007|Up To Week 12|Randomized, Not Treated|0|||
46826363|NCT00413660|83044911|FG008|Up To Week 12|Randomized, Not Treated|0|||
46826364|NCT00413660|83044912|FG009|Up To Week 12|Randomized, Not Treated|0|||
46826365|NCT00413660|83044913|FG010|Up To Week 12|Randomized, Not Treated|0|||
46826366|NCT00413660|83044903|FG000|Up To Week 12|Other|3|||
46826367|NCT00413660|83044904|FG001|Up To Week 12|Other|1|||
46826368|NCT00413660|83044905|FG002|Up To Week 12|Other|6|||
46826369|NCT00413660|83044906|FG003|Up To Week 12|Other|1|||
46826370|NCT00413660|83044907|FG004|Up To Week 12|Other|2|||
46826371|NCT00413660|83044908|FG005|Up To Week 12|Other|4|||
46935080|NCT02872714|83171104|FG000|Overall Study|Progressive Disease|1|||
46935081|NCT02872714|83171105|FG001|Overall Study|Progressive Disease|2|||
46935082|NCT02872714|83171106|FG002|Overall Study|Progressive Disease|0|||
46935083|NCT02872714|83171107|FG003|Overall Study|Progressive Disease|0|||
46935084|NCT02872714|83171108|FG004|Overall Study|Progressive Disease|0|||
46935085|NCT02872714|83171104|FG000|Overall Study|Death|87|||
46935086|NCT02872714|83171105|FG001|Overall Study|Death|36|||
46935087|NCT02872714|83171106|FG002|Overall Study|Death|8|||
46935088|NCT02872714|83171107|FG003|Overall Study|Death|81|||
46763090|NCT00819234|82981344|FG005|Overall Study|Protocol Violation|0|||
46763091|NCT00819234|82981345|FG006|Overall Study|Protocol Violation|0|||
46826372|NCT00413660|83044909|FG006|Up To Week 12|Other|3|||
46826373|NCT00413660|83044910|FG007|Up To Week 12|Other|0|||
46826374|NCT00413660|83044911|FG008|Up To Week 12|Other|0|||
46826375|NCT00413660|83044912|FG009|Up To Week 12|Other|0|||
46826376|NCT00413660|83044913|FG010|Up To Week 12|Other|0|||
46826377|NCT00413660|83044903|FG000|Post Week 12|Adverse Event|2|||
46826378|NCT00413660|83044904|FG001|Post Week 12|Adverse Event|0|||
46826379|NCT00413660|83044905|FG002|Post Week 12|Adverse Event|2|||
46826380|NCT00413660|83044906|FG003|Post Week 12|Adverse Event|1|||
46826381|NCT00413660|83044907|FG004|Post Week 12|Adverse Event|4|||
46826382|NCT00413660|83044908|FG005|Post Week 12|Adverse Event|2|||
46826383|NCT00413660|83044909|FG006|Post Week 12|Adverse Event|2|||
46826384|NCT00413660|83044910|FG007|Post Week 12|Adverse Event|0|||
46826385|NCT00413660|83044911|FG008|Post Week 12|Adverse Event|0|||
46826386|NCT00413660|83044912|FG009|Post Week 12|Adverse Event|0|||
46826387|NCT00413660|83044913|FG010|Post Week 12|Adverse Event|0|||
46826388|NCT00413660|83044903|FG000|Post Week 12|Lack of Efficacy|0|||
46826389|NCT00413660|83044904|FG001|Post Week 12|Lack of Efficacy|0|||
46826390|NCT00413660|83044905|FG002|Post Week 12|Lack of Efficacy|1|||
46826391|NCT00413660|83044906|FG003|Post Week 12|Lack of Efficacy|0|||
46826392|NCT00413660|83044907|FG004|Post Week 12|Lack of Efficacy|0|||
46935089|NCT02872714|83171108|FG004|Overall Study|Death|2|||
46935090|NCT02872714|83171104|FG000|Overall Study|Lost to Follow-up|2|||
46935091|NCT02872714|83171105|FG001|Overall Study|Lost to Follow-up|1|||
46935092|NCT02872714|83171106|FG002|Overall Study|Lost to Follow-up|0|||
46763092|NCT00819234|82981346|FG007|Overall Study|Protocol Violation|0|||
46763093|NCT00819234|82981347|FG008|Overall Study|Protocol Violation|0|||
46763094|NCT00819234|82981348|FG009|Overall Study|Protocol Violation|0|||
46763095|NCT00819234|82981339|FG000|Overall Study|Lost to Follow-up|2|||
46763096|NCT00819234|82981340|FG001|Overall Study|Lost to Follow-up|2|||
46826393|NCT00413660|83044908|FG005|Post Week 12|Lack of Efficacy|0|||
47058544|NCT01695239|83337765|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
46763097|NCT00819234|82981341|FG002|Overall Study|Lost to Follow-up|0|||
46763098|NCT00819234|82981342|FG003|Overall Study|Lost to Follow-up|2|||
46826394|NCT00413660|83044909|FG006|Post Week 12|Lack of Efficacy|0|||
46826395|NCT00413660|83044910|FG007|Post Week 12|Lack of Efficacy|0|||
46935093|NCT02872714|83171107|FG003|Overall Study|Lost to Follow-up|3|||
46935094|NCT02872714|83171108|FG004|Overall Study|Lost to Follow-up|0|||
46935095|NCT02872714|83171104|FG000|Overall Study|Physician Decision|0|||
46763099|NCT00819234|82981343|FG004|Overall Study|Lost to Follow-up|1|||
46826396|NCT00413660|83044911|FG008|Post Week 12|Lack of Efficacy|0|||
46826397|NCT00413660|83044912|FG009|Post Week 12|Lack of Efficacy|1|||
46826398|NCT00413660|83044913|FG010|Post Week 12|Lack of Efficacy|0|||
46826399|NCT00413660|83044903|FG000|Post Week 12|Lost to Follow-up|0|||
46826400|NCT00413660|83044904|FG001|Post Week 12|Lost to Follow-up|1|||
46826401|NCT00413660|83044905|FG002|Post Week 12|Lost to Follow-up|1|||
46935096|NCT02872714|83171105|FG001|Overall Study|Physician Decision|0|||
46826402|NCT00413660|83044906|FG003|Post Week 12|Lost to Follow-up|0|||
46826403|NCT00413660|83044907|FG004|Post Week 12|Lost to Follow-up|0|||
46826404|NCT00413660|83044908|FG005|Post Week 12|Lost to Follow-up|0|||
46826405|NCT00413660|83044909|FG006|Post Week 12|Lost to Follow-up|0|||
46826406|NCT00413660|83044910|FG007|Post Week 12|Lost to Follow-up|0|||
46826407|NCT00413660|83044911|FG008|Post Week 12|Lost to Follow-up|0|||
46826408|NCT00413660|83044912|FG009|Post Week 12|Lost to Follow-up|0|||
46826409|NCT00413660|83044913|FG010|Post Week 12|Lost to Follow-up|0|||
46826410|NCT00413660|83044903|FG000|Post Week 12|Withdrawal by Subject|0|||
46826411|NCT00413660|83044904|FG001|Post Week 12|Withdrawal by Subject|1|||
46826412|NCT00413660|83044905|FG002|Post Week 12|Withdrawal by Subject|1|||
46826413|NCT00413660|83044906|FG003|Post Week 12|Withdrawal by Subject|0|||
46826414|NCT00413660|83044907|FG004|Post Week 12|Withdrawal by Subject|1|||
46826415|NCT00413660|83044908|FG005|Post Week 12|Withdrawal by Subject|0|||
46826416|NCT00413660|83044909|FG006|Post Week 12|Withdrawal by Subject|0|||
46826417|NCT00413660|83044910|FG007|Post Week 12|Withdrawal by Subject|0|||
47058545|NCT01695239|83337766|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058546|NCT01695239|83337767|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058547|NCT01695239|83337768|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058548|NCT01695239|83337769|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
46826418|NCT00413660|83044911|FG008|Post Week 12|Withdrawal by Subject|0|||
46826419|NCT00413660|83044912|FG009|Post Week 12|Withdrawal by Subject|0|||
46826420|NCT00413660|83044913|FG010|Post Week 12|Withdrawal by Subject|1|||
46826421|NCT00413660|83044903|FG000|Post Week 12|Other|1|||
46826422|NCT00413660|83044904|FG001|Post Week 12|Other|2|||
46826423|NCT00413660|83044905|FG002|Post Week 12|Other|3|||
46826424|NCT00413660|83044906|FG003|Post Week 12|Other|0|||
46826425|NCT00413660|83044907|FG004|Post Week 12|Other|1|||
46826426|NCT00413660|83044908|FG005|Post Week 12|Other|1|||
46826427|NCT00413660|83044909|FG006|Post Week 12|Other|1|||
46826428|NCT00413660|83044910|FG007|Post Week 12|Other|0|||
46826429|NCT00413660|83044911|FG008|Post Week 12|Other|0|||
46826430|NCT00413660|83044912|FG009|Post Week 12|Other|0|||
46826431|NCT00413660|83044913|FG010|Post Week 12|Other|0|||
46826432|NCT00431834|83044947|FG000|Overall Study|Withdrawal by Subject|7|||
46826433|NCT00431834|83044947|FG000|Overall Study|Death|3|||
46826434|NCT00431834|83044947|FG000|Overall Study|Missed Endpoint Visit|2|||
46826435|NCT00431834|83044947|FG000|Overall Study|Lost to Follow-up|1|||
46826436|NCT00431444|83044956|FG000|Overall Study|Protocol Violation|1|||
46826437|NCT00431444|83044957|FG001|Overall Study|Protocol Violation|4|||
46826438|NCT00431444|83044956|FG000|Overall Study|Adverse Event|2|||
46826439|NCT00431444|83044957|FG001|Overall Study|Adverse Event|1|||
46826440|NCT00431444|83044956|FG000|Overall Study|Withdrawal by Subject|1|||
46826441|NCT00431444|83044957|FG001|Overall Study|Withdrawal by Subject|1|||
46826442|NCT00431444|83044956|FG000|Overall Study|Lost to Follow-up|1|||
46826443|NCT00431444|83044957|FG001|Overall Study|Lost to Follow-up|0|||
46826444|NCT00431444|83044956|FG000|Overall Study|Administrative Problems|0|||
46826445|NCT00431444|83044957|FG001|Overall Study|Administrative Problems|1|||
46826446|NCT00430352|83044963|FG000|Overall Study|Disease progression|58|||
46826447|NCT00430352|83044963|FG000|Overall Study|Withdrawal by Subject|11|||
46826448|NCT00430352|83044963|FG000|Overall Study|Adverse Event|16|||
46826449|NCT00430352|83044963|FG000|Overall Study|Death|5|||
46826450|NCT00430352|83044963|FG000|Overall Study|Other|48|||
46826451|NCT00287469|83044969|FG000|Overall Study|serious adverse event|1|||
46826452|NCT00287469|83044970|FG001|Overall Study|serious adverse event|6|||
46826453|NCT00287469|83044969|FG000|Overall Study|Adverse Event|1|||
46826454|NCT00287469|83044970|FG001|Overall Study|Adverse Event|1|||
47058549|NCT01695239|83337770|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058550|NCT01695239|83337771|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058551|NCT01695239|83337772|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058552|NCT01695239|83337773|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
46763100|NCT00819234|82981344|FG005|Overall Study|Lost to Follow-up|1|||
46763101|NCT00819234|82981345|FG006|Overall Study|Lost to Follow-up|1|||
46763102|NCT00819234|82981346|FG007|Overall Study|Lost to Follow-up|1|||
46763103|NCT00819234|82981347|FG008|Overall Study|Lost to Follow-up|1|||
46763104|NCT00819234|82981348|FG009|Overall Study|Lost to Follow-up|2|||
46763105|NCT00871403|82981406|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
46763106|NCT00871403|82981407|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
46763107|NCT00871403|82981408|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
46763108|NCT00871403|82981406|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
46826455|NCT00287469|83044969|FG000|Overall Study|moved from area|144|||
46826456|NCT00287469|83044970|FG001|Overall Study|moved from area|138|||
46826457|NCT00287469|83044969|FG000|Overall Study|Lost to Follow-up|74|||
46826458|NCT00287469|83044970|FG001|Overall Study|Lost to Follow-up|69|||
46826459|NCT00429572|83044978|FG000|Overall Study|Disease progression|1|||
46826460|NCT00287079|83044984|FG000|Overall Study|Qualifying relapse|12|||
46826461|NCT00287079|83044985|FG001|Overall Study|Qualifying relapse|1|||
46826462|NCT00287079|83044984|FG000|Overall Study|Non-qualifying relapse|1|||
46826463|NCT00287079|83044985|FG001|Overall Study|Non-qualifying relapse|0|||
46826464|NCT00287079|83044984|FG000|Overall Study|Adverse Event|5|||
46826465|NCT00287079|83044985|FG001|Overall Study|Adverse Event|0|||
46826466|NCT00287079|83044984|FG000|Overall Study|Protocol Violation|1|||
46826467|NCT00287079|83044985|FG001|Overall Study|Protocol Violation|0|||
46826468|NCT00287079|83044984|FG000|Overall Study|Other|3|||
46826469|NCT00287079|83044985|FG001|Overall Study|Other|0|||
46826470|NCT00429494|83044991|FG000|Overall Study|Withdrawal by Subject|9|||
46826471|NCT00429494|83044991|FG000|Overall Study|Death|6|||
46826472|NCT00429416|83044995|FG000|Overall Study|Death|1|||
46826473|NCT00429182|83044999|FG000|Overall Study|Not evaluable, Disease Progression|2|||
46826474|NCT00429182|83044999|FG000|Overall Study|Not eligible|5|||
46826475|NCT00429104|83045003|FG000|Overall Study|Protocol Violation|1|||
46826476|NCT00429026|83045007|FG000|Overall Study|Inevaluable for response.|40|||
46826477|NCT00301821|83045011|FG000|Overall Study|Ineligible|25|||
46826478|NCT00301821|83045011|FG000|Overall Study|Cancel|1|||
46826479|NCT00372996|83045017|FG000|Overall Study|Death|11|||
46826480|NCT00372996|83045018|FG001|Overall Study|Death|4|||
46826481|NCT00372996|83045019|FG002|Overall Study|Death|8|||
46826482|NCT00372996|83045020|FG003|Overall Study|Death|7|||
46826483|NCT00372996|83045017|FG000|Overall Study|Lost to Follow-up|0|||
46826484|NCT00372996|83045018|FG001|Overall Study|Lost to Follow-up|2|||
46826485|NCT00372996|83045019|FG002|Overall Study|Lost to Follow-up|0|||
46826486|NCT00372996|83045020|FG003|Overall Study|Lost to Follow-up|1|||
46826487|NCT00372996|83045017|FG000|Overall Study|Withdrawal by Subject|12|||
46826488|NCT00372996|83045018|FG001|Overall Study|Withdrawal by Subject|6|||
46826489|NCT00372996|83045019|FG002|Overall Study|Withdrawal by Subject|9|||
46826490|NCT00372996|83045020|FG003|Overall Study|Withdrawal by Subject|5|||
46826491|NCT00372996|83045017|FG000|Overall Study|Study Terminated by Sponsor|4|||
46826492|NCT00372996|83045018|FG001|Overall Study|Study Terminated by Sponsor|0|||
46826493|NCT00372996|83045019|FG002|Overall Study|Study Terminated by Sponsor|4|||
46826494|NCT00372996|83045020|FG003|Overall Study|Study Terminated by Sponsor|0|||
46826495|NCT00372996|83045017|FG000|Overall Study|Other|10|||
46826496|NCT00372996|83045018|FG001|Overall Study|Other|2|||
46826497|NCT00372996|83045019|FG002|Overall Study|Other|7|||
46826498|NCT00372996|83045020|FG003|Overall Study|Other|7|||
46826499|NCT00399516|83045030|FG000|Overall Study|Lost to Follow-up|2|||
47058553|NCT01695239|83337774|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
47058554|NCT01695239|83337775|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058555|NCT01695239|83337776|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058556|NCT01695239|83337777|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
47058557|NCT01695239|83337778|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
46763109|NCT00871403|82981407|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
46763110|NCT00871403|82981408|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
46763111|NCT00871403|82981406|FG000|Combination Treatment Phase|Adverse Event|0|||
46763112|NCT00871403|82981407|FG001|Combination Treatment Phase|Adverse Event|17|||
46763113|NCT00871403|82981408|FG002|Combination Treatment Phase|Adverse Event|2|||
46763114|NCT00871403|82981406|FG000|Combination Treatment Phase|Disease Progression|0|||
46763115|NCT00871403|82981407|FG001|Combination Treatment Phase|Disease Progression|8|||
46763116|NCT00871403|82981408|FG002|Combination Treatment Phase|Disease Progression|5|||
46763117|NCT00871403|82981406|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
46763118|NCT00871403|82981407|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
46763119|NCT00871403|82981408|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
46763120|NCT00871403|82981406|FG000|Combination Treatment Phase|Physician Decision|0|||
46763121|NCT00871403|82981407|FG001|Combination Treatment Phase|Physician Decision|1|||
46763122|NCT00871403|82981408|FG002|Combination Treatment Phase|Physician Decision|3|||
46763123|NCT00871403|82981406|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
46763124|NCT00871403|82981407|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
46763125|NCT00871403|82981408|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
46763126|NCT00871403|82981406|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
46763127|NCT00871403|82981407|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
46763128|NCT00871403|82981408|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
46763129|NCT00853112|82981422|FG000|Overall Study|Randomized but not treated|0|||
46763130|NCT00853112|82981423|FG001|Overall Study|Randomized but not treated|1|||
46763131|NCT00853112|82981424|FG002|Overall Study|Randomized but not treated|0|||
46763132|NCT00853112|82981425|FG003|Overall Study|Randomized but not treated|2|||
46763133|NCT00853112|82981426|FG004|Overall Study|Randomized but not treated|0|||
46826500|NCT00399360|83045038|FG000|Overall Study|Lost to Follow-up|2|||
46826501|NCT00399360|83045039|FG001|Overall Study|Lost to Follow-up|1|||
46826502|NCT00399360|83045040|FG002|Overall Study|Lost to Follow-up|2|||
46826503|NCT00399360|83045041|FG003|Overall Study|Lost to Follow-up|4|||
46826504|NCT00399360|83045038|FG000|Overall Study|Adverse Event|0|||
46826505|NCT00399360|83045039|FG001|Overall Study|Adverse Event|0|||
46826506|NCT00399360|83045040|FG002|Overall Study|Adverse Event|1|||
46826507|NCT00399360|83045041|FG003|Overall Study|Adverse Event|0|||
46826508|NCT00399360|83045038|FG000|Overall Study|Withdrawal by Subject|0|||
46826509|NCT00399360|83045039|FG001|Overall Study|Withdrawal by Subject|2|||
46826510|NCT00399360|83045040|FG002|Overall Study|Withdrawal by Subject|0|||
46826511|NCT00399360|83045041|FG003|Overall Study|Withdrawal by Subject|2|||
46826512|NCT00428948|83045058|FG000|Overall Study|Lost to Follow-up|15|||
46826513|NCT00428948|83045059|FG001|Overall Study|Lost to Follow-up|8|||
46826514|NCT00428948|83045058|FG000|Overall Study|Adverse Event|148|||
46826515|NCT00428948|83045059|FG001|Overall Study|Adverse Event|24|||
46826516|NCT00428948|83045058|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
46826517|NCT00428948|83045059|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
46826518|NCT00428948|83045058|FG000|Overall Study|Investigator Withdrew Subject|3|||
46826519|NCT00428948|83045059|FG001|Overall Study|Investigator Withdrew Subject|4|||
46826520|NCT00428948|83045058|FG000|Overall Study|Subject Withdrew Consent|50|||
46826521|NCT00428948|83045059|FG001|Overall Study|Subject Withdrew Consent|30|||
46826522|NCT00428948|83045058|FG000|Overall Study|Protocol Deviation|1|||
46826523|NCT00428948|83045059|FG001|Overall Study|Protocol Deviation|1|||
46826524|NCT00428792|83045067|FG000|Overall Study|Lack of Efficacy|1|||
46826525|NCT00428792|83045068|FG001|Overall Study|Lack of Efficacy|3|||
46826526|NCT00428792|83045067|FG000|Overall Study|Lost to Follow-up|0|||
46826527|NCT00428792|83045068|FG001|Overall Study|Lost to Follow-up|1|||
46826528|NCT00300885|83045076|FG000|Treatment|Adverse Event|134|||
46826529|NCT00300885|83045077|FG001|Treatment|Adverse Event|82|||
46826530|NCT00300885|83045076|FG000|Treatment|Death|20|||
46826531|NCT00300885|83045077|FG001|Treatment|Death|7|||
46826532|NCT00300885|83045076|FG000|Treatment|Lack of Efficacy|1|||
46826533|NCT00300885|83045077|FG001|Treatment|Lack of Efficacy|1|||
46826534|NCT00300885|83045076|FG000|Treatment|Lost to Follow-up|3|||
46826535|NCT00300885|83045077|FG001|Treatment|Lost to Follow-up|2|||
46826536|NCT00300885|83045076|FG000|Treatment|Physician Decision|4|||
46826537|NCT00300885|83045077|FG001|Treatment|Physician Decision|5|||
46826538|NCT00300885|83045076|FG000|Treatment|Protocol Violation|11|||
46826539|NCT00300885|83045077|FG001|Treatment|Protocol Violation|11|||
46826540|NCT00300885|83045076|FG000|Treatment|Withdrawal by Subject|26|||
46826541|NCT00300885|83045077|FG001|Treatment|Withdrawal by Subject|23|||
46826542|NCT00300885|83045076|FG000|Treatment|Disease progression|171|||
46826543|NCT00300885|83045077|FG001|Treatment|Disease progression|238|||
46826544|NCT00300885|83045076|FG000|Treatment|Random code broken (subject died)|0|||
46826545|NCT00300885|83045077|FG001|Treatment|Random code broken (subject died)|1|||
46826546|NCT00300885|83045076|FG000|Treatment|Non-compliant with study medication|3|||
46826547|NCT00300885|83045077|FG001|Treatment|Non-compliant with study medication|4|||
46826548|NCT00300885|83045076|FG000|Follow-up|Death|141|||
46826549|NCT00300885|83045077|FG001|Follow-up|Death|163|||
46826550|NCT00300885|83045076|FG000|Follow-up|Lost to Follow-up|11|||
46826551|NCT00300885|83045077|FG001|Follow-up|Lost to Follow-up|7|||
46826552|NCT00300885|83045076|FG000|Follow-up|Withdrawal by Subject|26|||
46826553|NCT00300885|83045077|FG001|Follow-up|Withdrawal by Subject|25|||
46826554|NCT00386334|83045085|FG000|Double Blind Period|Adverse Event|9|||
46826555|NCT00386334|83045086|FG001|Double Blind Period|Adverse Event|14|||
46826556|NCT00386334|83045085|FG000|Double Blind Period|Protocol Violation|1|||
46826557|NCT00386334|83045086|FG001|Double Blind Period|Protocol Violation|1|||
46826558|NCT00386334|83045085|FG000|Double Blind Period|Withdrawal by Subject|9|||
46826559|NCT00386334|83045086|FG001|Double Blind Period|Withdrawal by Subject|13|||
46935097|NCT02872714|83171106|FG002|Overall Study|Physician Decision|0|||
46935098|NCT02872714|83171107|FG003|Overall Study|Physician Decision|1|||
46935099|NCT02872714|83171108|FG004|Overall Study|Physician Decision|0|||
46935100|NCT02872714|83171104|FG000|Overall Study|Withdrawal by Subject|1|||
46935101|NCT02872714|83171105|FG001|Overall Study|Withdrawal by Subject|3|||
46935102|NCT02872714|83171106|FG002|Overall Study|Withdrawal by Subject|0|||
46935103|NCT02872714|83171107|FG003|Overall Study|Withdrawal by Subject|2|||
47058558|NCT01695239|83337765|FG000|Extension Long-Term Extension Periods|Death|0|||
47058559|NCT01695239|83337766|FG001|Extension Long-Term Extension Periods|Death|0|||
47058560|NCT01695239|83337767|FG002|Extension Long-Term Extension Periods|Death|0|||
46826560|NCT00386334|83045085|FG000|Double Blind Period|Lack of Efficacy|20|||
46826561|NCT00386334|83045086|FG001|Double Blind Period|Lack of Efficacy|11|||
46826562|NCT00386334|83045085|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
46935104|NCT02872714|83171108|FG004|Overall Study|Withdrawal by Subject|0|||
47058561|NCT01695239|83337768|FG003|Extension Long-Term Extension Periods|Death|0|||
46826563|NCT00386334|83045086|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
46826564|NCT00386334|83045085|FG000|Double Blind Period|Other|3|||
46826565|NCT00386334|83045086|FG001|Double Blind Period|Other|3|||
46826566|NCT00386334|83045085|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
46826567|NCT00386334|83045086|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
46826568|NCT00428714|83045103|FG000|Overall Study|Progressive Disease|28|||
46826569|NCT00428714|83045104|FG001|Overall Study|Progressive Disease|36|||
46826570|NCT00428714|83045103|FG000|Overall Study|Withdrawal by Subject|0|||
46935105|NCT02872714|83171104|FG000|Overall Study|Captured as Other|2|||
46826571|NCT00428714|83045104|FG001|Overall Study|Withdrawal by Subject|3|||
46826572|NCT00428714|83045103|FG000|Overall Study|Adverse Event|0|||
46826573|NCT00428714|83045104|FG001|Overall Study|Adverse Event|2|||
46826574|NCT00428714|83045103|FG000|Overall Study|Physician Decision|1|||
46826575|NCT00428714|83045104|FG001|Overall Study|Physician Decision|1|||
46826576|NCT00428714|83045103|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
46826577|NCT00428714|83045104|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
46826578|NCT00428714|83045103|FG000|Overall Study|Death due to other then PD|1|||
46826579|NCT00428714|83045104|FG001|Overall Study|Death due to other then PD|0|||
46826580|NCT00292227|83045113|FG000|Patch Period|Adverse Event|1|||
46826581|NCT00292227|83045114|FG001|Patch Period|Adverse Event|0|||
46826582|NCT00292227|83045115|FG002|Patch Period|Adverse Event|2|||
46826583|NCT00292227|83045113|FG000|Patch Period|Withdrawal by Subject|0|||
46826584|NCT00292227|83045114|FG001|Patch Period|Withdrawal by Subject|0|||
46826585|NCT00292227|83045115|FG002|Patch Period|Withdrawal by Subject|1|||
46826586|NCT00386100|83045125|FG000|Overall Study|Did not receive study medication|6|||
46826587|NCT00386100|83045126|FG001|Overall Study|Did not receive study medication|4|||
46826588|NCT00386100|83045125|FG000|Overall Study|Adverse Event|15|||
46826589|NCT00386100|83045126|FG001|Overall Study|Adverse Event|25|||
46826590|NCT00386100|83045125|FG000|Overall Study|Death|0|||
46935106|NCT02872714|83171105|FG001|Overall Study|Captured as Other|0|||
47058562|NCT01695239|83337769|FG004|Extension Long-Term Extension Periods|Death|0|||
47058563|NCT01695239|83337770|FG005|Extension Long-Term Extension Periods|Death|0|||
47058564|NCT01695239|83337771|FG006|Extension Long-Term Extension Periods|Death|0|||
47058565|NCT01695239|83337772|FG007|Extension Long-Term Extension Periods|Death|0|||
47058566|NCT01695239|83337773|FG008|Extension Long-Term Extension Periods|Death|1|||
47058567|NCT01695239|83337774|FG009|Extension Long-Term Extension Periods|Death|0|||
47058568|NCT01695239|83337775|FG010|Extension Long-Term Extension Periods|Death|0|||
46826591|NCT00386100|83045126|FG001|Overall Study|Death|1|||
47058569|NCT01695239|83337776|FG011|Extension Long-Term Extension Periods|Death|0|||
47058570|NCT01695239|83337777|FG012|Extension Long-Term Extension Periods|Death|0|||
47058571|NCT01695239|83337778|FG013|Extension Long-Term Extension Periods|Death|0|||
47058572|NCT01695239|83337765|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058573|NCT01695239|83337766|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058574|NCT01695239|83337767|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058575|NCT01695239|83337768|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058576|NCT01695239|83337769|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058577|NCT01695239|83337770|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058578|NCT01695239|83337771|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058579|NCT01695239|83337772|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058580|NCT01695239|83337773|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058581|NCT01695239|83337774|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058582|NCT01695239|83337775|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
47058583|NCT01695239|83337776|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
47058584|NCT01695239|83337777|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
47058585|NCT01695239|83337778|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
47058586|NCT01695239|83337765|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058587|NCT01695239|83337766|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058588|NCT01695239|83337767|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058589|NCT01695239|83337768|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058590|NCT01695239|83337769|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058591|NCT01695239|83337770|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058592|NCT01695239|83337771|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058593|NCT01695239|83337772|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058594|NCT01695239|83337773|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058595|NCT01695239|83337774|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058596|NCT01695239|83337775|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47058597|NCT01695239|83337776|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
46826592|NCT00386100|83045125|FG000|Overall Study|Insufficient therapeutic effect|30|||
46826593|NCT00386100|83045126|FG001|Overall Study|Insufficient therapeutic effect|6|||
46826594|NCT00386100|83045125|FG000|Overall Study|Lost to Follow-up|29|||
46826595|NCT00386100|83045126|FG001|Overall Study|Lost to Follow-up|29|||
46826596|NCT00386100|83045125|FG000|Overall Study|Non-compliance|18|||
47058598|NCT01695239|83337777|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
47058599|NCT01695239|83337778|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
46826597|NCT00386100|83045126|FG001|Overall Study|Non-compliance|19|||
47058600|NCT01695239|83337765|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058601|NCT01695239|83337766|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
46826598|NCT00386100|83045125|FG000|Overall Study|Protocol Violation|5|||
46826599|NCT00386100|83045126|FG001|Overall Study|Protocol Violation|3|||
46826600|NCT00386100|83045125|FG000|Overall Study|Withdrawal by Subject|32|||
46826601|NCT00386100|83045126|FG001|Overall Study|Withdrawal by Subject|31|||
46935107|NCT02872714|83171106|FG002|Overall Study|Captured as Other|0|||
46826602|NCT00386100|83045125|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
46826603|NCT00386100|83045126|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
46935108|NCT02872714|83171107|FG003|Overall Study|Captured as Other|1|||
46935109|NCT02872714|83171108|FG004|Overall Study|Captured as Other|0|||
46935110|NCT02787005|83171128|FG000|Overall Study|Adverse Event|24|||
46935111|NCT02787005|83171129|FG001|Overall Study|Adverse Event|9|||
46935112|NCT02787005|83171130|FG002|Overall Study|Adverse Event|9|||
46935113|NCT02787005|83171131|FG003|Overall Study|Adverse Event|7|||
46935114|NCT02787005|83171132|FG004|Overall Study|Adverse Event|2|||
46935115|NCT02787005|83171128|FG000|Overall Study|Death|100|||
46935116|NCT02787005|83171129|FG001|Overall Study|Death|53|||
46935117|NCT02787005|83171130|FG002|Overall Study|Death|48|||
46935118|NCT02787005|83171131|FG003|Overall Study|Death|69|||
46935119|NCT02787005|83171132|FG004|Overall Study|Death|38|||
46935120|NCT02787005|83171128|FG000|Overall Study|Sponsor Decision|7|||
46935121|NCT02787005|83171129|FG001|Overall Study|Sponsor Decision|4|||
46935122|NCT02787005|83171130|FG002|Overall Study|Sponsor Decision|0|||
46935123|NCT02787005|83171131|FG003|Overall Study|Sponsor Decision|4|||
46935124|NCT02787005|83171132|FG004|Overall Study|Sponsor Decision|5|||
46935125|NCT02787005|83171128|FG000|Overall Study|Withdrawal by Subject|2|||
46935126|NCT02787005|83171129|FG001|Overall Study|Withdrawal by Subject|1|||
46935127|NCT02787005|83171130|FG002|Overall Study|Withdrawal by Subject|1|||
46935128|NCT02787005|83171131|FG003|Overall Study|Withdrawal by Subject|0|||
46935129|NCT02787005|83171132|FG004|Overall Study|Withdrawal by Subject|1|||
47058602|NCT01695239|83337767|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058603|NCT01695239|83337768|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058604|NCT01695239|83337769|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058605|NCT01695239|83337770|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058606|NCT01695239|83337771|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058607|NCT01695239|83337772|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058608|NCT01695239|83337773|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058609|NCT01695239|83337774|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058610|NCT01695239|83337775|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
46935130|NCT02787005|83171128|FG000|Overall Study|Screen Failure|0|||
46935131|NCT02787005|83171129|FG001|Overall Study|Screen Failure|2|||
46935132|NCT02787005|83171130|FG002|Overall Study|Screen Failure|0|||
46935133|NCT02787005|83171131|FG003|Overall Study|Screen Failure|0|||
46935134|NCT02787005|83171132|FG004|Overall Study|Screen Failure|1|||
46935135|NCT02787005|83171128|FG000|Overall Study|Lost to Follow-up|0|||
46935136|NCT02787005|83171129|FG001|Overall Study|Lost to Follow-up|0|||
46935137|NCT02787005|83171130|FG002|Overall Study|Lost to Follow-up|0|||
46935138|NCT02787005|83171131|FG003|Overall Study|Lost to Follow-up|1|||
46935139|NCT02787005|83171132|FG004|Overall Study|Lost to Follow-up|0|||
46935140|NCT02514083|83171159|FG000|Overall Study|Adverse Event|1|||
46935141|NCT02395848|83171163|FG000|Overall Study|Lost to Follow-up|2|||
46935142|NCT02061761|83171180|FG000|Overall Study|Disease progression|2|||
46935143|NCT02061761|83171181|FG001|Overall Study|Disease progression|8|||
46935144|NCT02061761|83171182|FG002|Overall Study|Disease progression|4|||
46935145|NCT02061761|83171183|FG003|Overall Study|Disease progression|5|||
46935146|NCT02061761|83171184|FG004|Overall Study|Disease progression|9|||
46935147|NCT02061761|83171185|FG005|Overall Study|Disease progression|3|||
46763134|NCT00853112|82981427|FG005|Overall Study|Randomized but not treated|0|||
46763135|NCT00853112|82981428|FG006|Overall Study|Randomized but not treated|1|||
46763136|NCT00460603|82981456|FG000|Phase 1|Death|1|||
46763137|NCT00460603|82981457|FG001|Phase 1|Death|0|||
46763138|NCT00460603|82981458|FG002|Phase 1|Death|0|||
46763139|NCT00460603|82981459|FG003|Phase 1|Death|2|||
46763140|NCT00460603|82981460|FG004|Phase 1|Death|0|||
46763141|NCT00460603|82981461|FG005|Phase 1|Death|0|||
46763142|NCT00460603|82981462|FG006|Phase 1|Death|0|||
46763143|NCT00460603|82981463|FG007|Phase 1|Death|0|||
46763144|NCT00460603|82981464|FG008|Phase 1|Death|1|||
46935148|NCT02061761|83171186|FG006|Overall Study|Disease progression|1|||
47058611|NCT01695239|83337776|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
46763145|NCT00460603|82981465|FG009|Phase 1|Death|0|||
46763146|NCT00460603|82981466|FG010|Phase 1|Death|0|||
46763147|NCT00460603|82981467|FG011|Phase 1|Death|0|||
46763148|NCT00460603|82981456|FG000|Phase 1|Adverse Event|3|||
46935149|NCT02061761|83171187|FG007|Overall Study|Disease progression|2|||
46935150|NCT02061761|83171188|FG008|Overall Study|Disease progression|28|||
46935151|NCT02061761|83171180|FG000|Overall Study|Study Drug toxicity|0|||
46935152|NCT02061761|83171181|FG001|Overall Study|Study Drug toxicity|0|||
46935153|NCT02061761|83171182|FG002|Overall Study|Study Drug toxicity|0|||
46935154|NCT02061761|83171183|FG003|Overall Study|Study Drug toxicity|0|||
46935155|NCT02061761|83171184|FG004|Overall Study|Study Drug toxicity|0|||
46763149|NCT00460603|82981457|FG001|Phase 1|Adverse Event|1|||
46935156|NCT02061761|83171185|FG005|Overall Study|Study Drug toxicity|1|||
46935157|NCT02061761|83171186|FG006|Overall Study|Study Drug toxicity|0|||
46763150|NCT00460603|82981458|FG002|Phase 1|Adverse Event|1|||
46763151|NCT00460603|82981459|FG003|Phase 1|Adverse Event|2|||
46935158|NCT02061761|83171187|FG007|Overall Study|Study Drug toxicity|2|||
46935159|NCT02061761|83171188|FG008|Overall Study|Study Drug toxicity|6|||
46935160|NCT02061761|83171180|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
46826604|NCT00386100|83045125|FG000|Overall Study|BMD <2.5|1|||
46826605|NCT00386100|83045126|FG001|Overall Study|BMD <2.5|0|||
46826606|NCT00386100|83045125|FG000|Overall Study|Consecutive elevated Hba1C|1|||
46826607|NCT00386100|83045126|FG001|Overall Study|Consecutive elevated Hba1C|0|||
46826608|NCT00386100|83045125|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
46826609|NCT00386100|83045126|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
46826610|NCT00386100|83045125|FG000|Overall Study|Laboratory findings|1|||
46826611|NCT00386100|83045126|FG001|Overall Study|Laboratory findings|0|||
46826612|NCT00386100|83045125|FG000|Overall Study|Participant's concern due to CPK levels|1|||
46826613|NCT00386100|83045126|FG001|Overall Study|Participant's concern due to CPK levels|0|||
46826614|NCT00386100|83045125|FG000|Overall Study|Participant moving out of state|2|||
46826615|NCT00386100|83045126|FG001|Overall Study|Participant moving out of state|0|||
46826616|NCT00386100|83045125|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
46826617|NCT00386100|83045126|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
46826618|NCT00386100|83045125|FG000|Overall Study|Didn't meet entry criteria|1|||
46826619|NCT00386100|83045126|FG001|Overall Study|Didn't meet entry criteria|1|||
46826620|NCT00386100|83045125|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
46826621|NCT00386100|83045126|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
46826622|NCT00386100|83045125|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
46826623|NCT00386100|83045126|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
46826624|NCT00386100|83045125|FG000|Overall Study|Bad metabolic control & patient security|1|||
46935161|NCT02061761|83171181|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
46935162|NCT02061761|83171182|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
46935163|NCT02061761|83171183|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
46935164|NCT02061761|83171184|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
46763152|NCT00460603|82981460|FG004|Phase 1|Adverse Event|0|||
46763153|NCT00460603|82981461|FG005|Phase 1|Adverse Event|0|||
46763154|NCT00460603|82981462|FG006|Phase 1|Adverse Event|3|||
46763155|NCT00460603|82981463|FG007|Phase 1|Adverse Event|0|||
46763156|NCT00460603|82981464|FG008|Phase 1|Adverse Event|4|||
46763157|NCT00460603|82981465|FG009|Phase 1|Adverse Event|0|||
46763158|NCT00460603|82981466|FG010|Phase 1|Adverse Event|0|||
46763159|NCT00460603|82981467|FG011|Phase 1|Adverse Event|0|||
46935165|NCT02061761|83171185|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
46935166|NCT02061761|83171186|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
46935167|NCT02061761|83171187|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
46935168|NCT02061761|83171188|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
46935169|NCT02061761|83171180|FG000|Overall Study|Participant request to discontinue study treatment|0|||
46935170|NCT02061761|83171181|FG001|Overall Study|Participant request to discontinue study treatment|0|||
46935171|NCT02061761|83171182|FG002|Overall Study|Participant request to discontinue study treatment|2|||
47058612|NCT01695239|83337777|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
46763160|NCT00460603|82981456|FG000|Phase 1|Lack of Efficacy|1|||
46826625|NCT00386100|83045126|FG001|Overall Study|Bad metabolic control & patient security|0|||
46826626|NCT00386100|83045125|FG000|Overall Study|Bone loss by DXA bone scan|1|||
46826627|NCT00386100|83045126|FG001|Overall Study|Bone loss by DXA bone scan|0|||
46826628|NCT00386100|83045125|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
46826629|NCT00386100|83045126|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
46826630|NCT00386100|83045125|FG000|Overall Study|7.6% bone loss|1|||
46826631|NCT00386100|83045126|FG001|Overall Study|7.6% bone loss|0|||
46826632|NCT00386100|83045125|FG000|Overall Study|Osteoporosis|0|||
46826633|NCT00386100|83045126|FG001|Overall Study|Osteoporosis|1|||
46826634|NCT00386100|83045125|FG000|Overall Study|Positive pregnancy test|1|||
46826635|NCT00386100|83045126|FG001|Overall Study|Positive pregnancy test|3|||
46826636|NCT00386100|83045125|FG000|Overall Study|Out of country for 5 months|1|||
46826637|NCT00386100|83045126|FG001|Overall Study|Out of country for 5 months|0|||
46826638|NCT00386100|83045125|FG000|Overall Study|Hb1Ac >8%|0|||
46826639|NCT00386100|83045126|FG001|Overall Study|Hb1Ac >8%|1|||
46826640|NCT00386100|83045125|FG000|Overall Study|Participant randomized in error|1|||
46826641|NCT00386100|83045126|FG001|Overall Study|Participant randomized in error|0|||
46826642|NCT00300495|83045134|FG000|Overall Study|Protocol Violation|4|||
46935172|NCT02061761|83171183|FG003|Overall Study|Participant request to discontinue study treatment|2|||
46935173|NCT02061761|83171184|FG004|Overall Study|Participant request to discontinue study treatment|0|||
46935174|NCT02061761|83171185|FG005|Overall Study|Participant request to discontinue study treatment|1|||
46935175|NCT02061761|83171186|FG006|Overall Study|Participant request to discontinue study treatment|0|||
46763161|NCT00460603|82981457|FG001|Phase 1|Lack of Efficacy|0|||
46763162|NCT00460603|82981458|FG002|Phase 1|Lack of Efficacy|1|||
46763163|NCT00460603|82981459|FG003|Phase 1|Lack of Efficacy|2|||
46763164|NCT00460603|82981460|FG004|Phase 1|Lack of Efficacy|2|||
46763165|NCT00460603|82981461|FG005|Phase 1|Lack of Efficacy|2|||
46763166|NCT00460603|82981462|FG006|Phase 1|Lack of Efficacy|2|||
46763167|NCT00460603|82981463|FG007|Phase 1|Lack of Efficacy|2|||
46826643|NCT00300495|83045135|FG001|Overall Study|Protocol Violation|1|||
46826644|NCT00386022|83045143|FG000|Plus Estrogen|Lost to Follow-up|2|||
46826645|NCT00386022|83045144|FG001|Plus Estrogen|Lost to Follow-up|0|||
46826646|NCT00386022|83045143|FG000|Plus Estrogen|Adverse Event|0|||
46826647|NCT00386022|83045144|FG001|Plus Estrogen|Adverse Event|1|||
46826648|NCT00286455|83045155|FG000|Overall Study|Hyperglycemia rescue|19|||
46826649|NCT00286455|83045156|FG001|Overall Study|Hyperglycemia rescue|13|||
46826650|NCT00286455|83045157|FG002|Overall Study|Hyperglycemia rescue|10|||
46826651|NCT00286455|83045155|FG000|Overall Study|Adverse Event|1|||
46826652|NCT00286455|83045156|FG001|Overall Study|Adverse Event|3|||
46826653|NCT00286455|83045157|FG002|Overall Study|Adverse Event|2|||
46826654|NCT00286455|83045155|FG000|Overall Study|Lost to Follow-up|0|||
46826655|NCT00286455|83045156|FG001|Overall Study|Lost to Follow-up|3|||
46826656|NCT00286455|83045157|FG002|Overall Study|Lost to Follow-up|3|||
46826657|NCT00286455|83045155|FG000|Overall Study|Physician Decision|3|||
46826658|NCT00286455|83045156|FG001|Overall Study|Physician Decision|0|||
46826659|NCT00286455|83045157|FG002|Overall Study|Physician Decision|2|||
46826660|NCT00286455|83045155|FG000|Overall Study|Protocol Violation|1|||
46826661|NCT00286455|83045156|FG001|Overall Study|Protocol Violation|1|||
46826662|NCT00286455|83045157|FG002|Overall Study|Protocol Violation|0|||
46826663|NCT00286455|83045155|FG000|Overall Study|Participant Non-compliance|1|||
46826664|NCT00286455|83045156|FG001|Overall Study|Participant Non-compliance|0|||
46826665|NCT00286455|83045157|FG002|Overall Study|Participant Non-compliance|0|||
46826666|NCT00286455|83045155|FG000|Overall Study|Withdrawal by Subject|0|||
46826667|NCT00286455|83045156|FG001|Overall Study|Withdrawal by Subject|8|||
46826668|NCT00286455|83045157|FG002|Overall Study|Withdrawal by Subject|7|||
46826669|NCT00385944|83045167|FG000|1st Maintenance Dose Period|Physician Decision|1|||
46826670|NCT00385944|83045168|FG001|1st Maintenance Dose Period|Physician Decision|0|||
46826671|NCT00385944|83045169|FG002|1st Maintenance Dose Period|Physician Decision|0|||
46826672|NCT00385944|83045167|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
46826673|NCT00385944|83045168|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
46826674|NCT00385944|83045169|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
46826675|NCT00385944|83045167|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
46826676|NCT00385944|83045168|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
46826677|NCT00385944|83045169|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
46826678|NCT00385944|83045167|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
46826679|NCT00385944|83045168|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
46826680|NCT00385944|83045169|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
46826681|NCT00286221|83045188|FG000|Overall Study|Protocol Violation|2|||
46826682|NCT00286221|83045189|FG001|Overall Study|Protocol Violation|1|||
46826683|NCT00286221|83045190|FG002|Overall Study|Protocol Violation|6|||
46826684|NCT00286221|83045191|FG003|Overall Study|Protocol Violation|4|||
46826685|NCT00286221|83045188|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
46826686|NCT00286221|83045189|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
46826687|NCT00286221|83045190|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
46826688|NCT00286221|83045191|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
46826689|NCT00286221|83045188|FG000|Overall Study|Inability to trigger PCA|2|||
46826690|NCT00286221|83045189|FG001|Overall Study|Inability to trigger PCA|0|||
46826691|NCT00286221|83045190|FG002|Overall Study|Inability to trigger PCA|0|||
46826692|NCT00286221|83045191|FG003|Overall Study|Inability to trigger PCA|0|||
46826693|NCT00286221|83045188|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
46826694|NCT00286221|83045189|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
46826695|NCT00286221|83045190|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
46826696|NCT00286221|83045191|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
46826697|NCT00285207|83045203|FG000|Overall Study|Lost to Follow-up|3|||
46826698|NCT00285207|83045204|FG001|Overall Study|Lost to Follow-up|2|||
46826699|NCT00285207|83045203|FG000|Overall Study|Withdrawal by Subject|5|||
46826700|NCT00285207|83045204|FG001|Overall Study|Withdrawal by Subject|2|||
46826701|NCT00285207|83045203|FG000|Overall Study|Pregnancy|1|||
46935176|NCT02061761|83171187|FG007|Overall Study|Participant request to discontinue study treatment|0|||
46935177|NCT02061761|83171188|FG008|Overall Study|Participant request to discontinue study treatment|2|||
46935178|NCT02061761|83171180|FG000|Overall Study|Withdrawal by Subject|0|||
46637473|NCT01474512|82811380|FG004|Induction Period|Protocol Violation|0|||
46826702|NCT00285207|83045204|FG001|Overall Study|Pregnancy|1|||
46826703|NCT00285207|83045203|FG000|Overall Study|non-compliance|0|||
46935179|NCT02061761|83171181|FG001|Overall Study|Withdrawal by Subject|0|||
46935180|NCT02061761|83171182|FG002|Overall Study|Withdrawal by Subject|0|||
46935181|NCT02061761|83171183|FG003|Overall Study|Withdrawal by Subject|0|||
46826704|NCT00285207|83045204|FG001|Overall Study|non-compliance|1|||
46826705|NCT00398112|83045210|FG000|Overall Study|Adverse Event|4|||
46826706|NCT00398112|83045210|FG000|Overall Study|Disease progression|9|||
46826707|NCT00398112|83045210|FG000|Overall Study|Alternative treatment|1|||
46826708|NCT00398112|83045210|FG000|Overall Study|Withdrawal by Subject|3|||
46826709|NCT00398112|83045210|FG000|Overall Study|Death|1|||
46826710|NCT00424346|83045218|FG000|Core Study|Adverse Event|5|||
46826711|NCT00424346|83045219|FG001|Core Study|Adverse Event|3|||
46826712|NCT00424346|83045220|FG002|Core Study|Adverse Event|1|||
46826713|NCT00424346|83045221|FG003|Core Study|Adverse Event|1|||
46826714|NCT00424346|83045218|FG000|Core Study|Abnormal Laboratory Values|0|||
46826715|NCT00424346|83045219|FG001|Core Study|Abnormal Laboratory Values|1|||
46826716|NCT00424346|83045220|FG002|Core Study|Abnormal Laboratory Values|0|||
46826717|NCT00424346|83045221|FG003|Core Study|Abnormal Laboratory Values|0|||
46826718|NCT00424346|83045218|FG000|Core Study|Lack of Efficacy|1|||
46826719|NCT00424346|83045219|FG001|Core Study|Lack of Efficacy|3|||
46826720|NCT00424346|83045220|FG002|Core Study|Lack of Efficacy|0|||
46826721|NCT00424346|83045221|FG003|Core Study|Lack of Efficacy|4|||
46826722|NCT00424346|83045218|FG000|Core Study|Withdrawal by Subject|1|||
46826723|NCT00424346|83045219|FG001|Core Study|Withdrawal by Subject|0|||
46826724|NCT00424346|83045220|FG002|Core Study|Withdrawal by Subject|0|||
46826725|NCT00424346|83045221|FG003|Core Study|Withdrawal by Subject|2|||
46826726|NCT00424346|83045218|FG000|Core Study|Lost to Follow-up|1|||
46826727|NCT00424346|83045219|FG001|Core Study|Lost to Follow-up|1|||
46826728|NCT00424346|83045220|FG002|Core Study|Lost to Follow-up|0|||
46826729|NCT00424346|83045221|FG003|Core Study|Lost to Follow-up|0|||
46826730|NCT00424346|83045218|FG000|Core Study|Administrative Problems|1|||
46826731|NCT00424346|83045219|FG001|Core Study|Administrative Problems|0|||
46826732|NCT00424346|83045220|FG002|Core Study|Administrative Problems|1|||
46826733|NCT00424346|83045221|FG003|Core Study|Administrative Problems|0|||
46826734|NCT00424346|83045218|FG000|Core Study|Protocol Violation|0|||
46826735|NCT00424346|83045219|FG001|Core Study|Protocol Violation|0|||
46826736|NCT00424346|83045220|FG002|Core Study|Protocol Violation|2|||
46826737|NCT00424346|83045221|FG003|Core Study|Protocol Violation|0|||
46826738|NCT00424346|83045218|FG000|Extension Phase|Adverse Event|0|||
46826739|NCT00424346|83045219|FG001|Extension Phase|Adverse Event|9|||
46826740|NCT00424346|83045220|FG002|Extension Phase|Adverse Event|5|||
46826741|NCT00424346|83045221|FG003|Extension Phase|Adverse Event|4|||
46826742|NCT00424346|83045218|FG000|Extension Phase|Lack of Efficacy|0|||
46826743|NCT00424346|83045219|FG001|Extension Phase|Lack of Efficacy|16|||
46826744|NCT00424346|83045220|FG002|Extension Phase|Lack of Efficacy|14|||
46826745|NCT00424346|83045221|FG003|Extension Phase|Lack of Efficacy|11|||
46826746|NCT00424346|83045218|FG000|Extension Phase|Withdrawal by Subject|0|||
46826747|NCT00424346|83045219|FG001|Extension Phase|Withdrawal by Subject|5|||
46826748|NCT00424346|83045220|FG002|Extension Phase|Withdrawal by Subject|3|||
46826749|NCT00424346|83045221|FG003|Extension Phase|Withdrawal by Subject|4|||
46826750|NCT00424346|83045218|FG000|Extension Phase|Lost to Follow-up|0|||
46826751|NCT00424346|83045219|FG001|Extension Phase|Lost to Follow-up|2|||
46826752|NCT00424346|83045220|FG002|Extension Phase|Lost to Follow-up|0|||
46826753|NCT00424346|83045221|FG003|Extension Phase|Lost to Follow-up|0|||
46826754|NCT00424346|83045218|FG000|Extension Phase|Administrative Problems|0|||
46826755|NCT00424346|83045219|FG001|Extension Phase|Administrative Problems|69|||
46826756|NCT00424346|83045220|FG002|Extension Phase|Administrative Problems|32|||
46826757|NCT00424346|83045221|FG003|Extension Phase|Administrative Problems|35|||
46826758|NCT00424346|83045218|FG000|Extension Phase|Death|0|||
46826759|NCT00424346|83045219|FG001|Extension Phase|Death|0|||
46826760|NCT00424346|83045220|FG002|Extension Phase|Death|0|||
46826761|NCT00424346|83045221|FG003|Extension Phase|Death|1|||
46826762|NCT00424346|83045218|FG000|Extension Phase|Protocol Violation|0|||
46826763|NCT00424346|83045219|FG001|Extension Phase|Protocol Violation|1|||
47058613|NCT01695239|83337778|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
47058614|NCT01695239|83337765|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058615|NCT01695239|83337766|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058616|NCT01695239|83337767|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058617|NCT01695239|83337768|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058618|NCT01695239|83337769|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058619|NCT01695239|83337770|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058620|NCT01695239|83337771|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058621|NCT01695239|83337772|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058622|NCT01695239|83337773|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
46763168|NCT00460603|82981464|FG008|Phase 1|Lack of Efficacy|11|||
46763169|NCT00460603|82981465|FG009|Phase 1|Lack of Efficacy|0|||
46763170|NCT00460603|82981466|FG010|Phase 1|Lack of Efficacy|0|||
46763171|NCT00460603|82981467|FG011|Phase 1|Lack of Efficacy|0|||
46763172|NCT00460603|82981456|FG000|Phase 1|Withdrawal by Subject|1|||
46763173|NCT00460603|82981457|FG001|Phase 1|Withdrawal by Subject|2|||
46763174|NCT00460603|82981458|FG002|Phase 1|Withdrawal by Subject|1|||
46763175|NCT00460603|82981459|FG003|Phase 1|Withdrawal by Subject|1|||
46763176|NCT00460603|82981460|FG004|Phase 1|Withdrawal by Subject|3|||
46763177|NCT00460603|82981461|FG005|Phase 1|Withdrawal by Subject|0|||
46763178|NCT00460603|82981462|FG006|Phase 1|Withdrawal by Subject|1|||
46763179|NCT00460603|82981463|FG007|Phase 1|Withdrawal by Subject|0|||
46826764|NCT00424346|83045220|FG002|Extension Phase|Protocol Violation|1|||
46826765|NCT00424346|83045221|FG003|Extension Phase|Protocol Violation|0|||
46826766|NCT00283959|83045234|FG000|Extension Period|Low Compliance|1|||
46763180|NCT00460603|82981464|FG008|Phase 1|Withdrawal by Subject|2|||
46826767|NCT00372528|83045238|FG000|Overall Study|Lack of Efficacy|1|||
46826768|NCT00372528|83045238|FG000|Overall Study|Adverse Event|1|||
46826769|NCT00372528|83045238|FG000|Overall Study|Study Terminated by Sponsor|18|||
46826770|NCT00372528|83045238|FG000|Overall Study|Other|1|||
46826771|NCT00283803|83045242|FG000|Overall Study|Physician Decision|9|||
47058623|NCT01695239|83337774|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058624|NCT01695239|83337775|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058625|NCT01695239|83337776|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058626|NCT01695239|83337777|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
47058627|NCT01695239|83337778|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
47058628|NCT01694849|83337828|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
47058629|NCT01694849|83337829|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
46637474|NCT01474512|82811381|FG005|Induction Period|Protocol Violation|0|||
46637475|NCT01474512|82811382|FG006|Induction Period|Protocol Violation|0|||
46637476|NCT01474512|82811383|FG007|Induction Period|Protocol Violation|0|||
46637477|NCT01474512|82811384|FG008|Induction Period|Protocol Violation|0|||
46637478|NCT01474512|82811385|FG009|Induction Period|Protocol Violation|0|||
46637479|NCT01474512|82811386|FG010|Induction Period|Protocol Violation|0|||
46637480|NCT01474512|82811387|FG011|Induction Period|Protocol Violation|0|||
46637481|NCT01474512|82811388|FG012|Induction Period|Protocol Violation|0|||
46763181|NCT00460603|82981465|FG009|Phase 1|Withdrawal by Subject|0|||
46763182|NCT00460603|82981466|FG010|Phase 1|Withdrawal by Subject|0|||
46763183|NCT00460603|82981467|FG011|Phase 1|Withdrawal by Subject|0|||
46763184|NCT00460603|82981456|FG000|Phase 1|Other|0|||
46763185|NCT00460603|82981457|FG001|Phase 1|Other|3|||
46763186|NCT00460603|82981458|FG002|Phase 1|Other|1|||
46763187|NCT00460603|82981459|FG003|Phase 1|Other|1|||
46763188|NCT00460603|82981460|FG004|Phase 1|Other|1|||
46763189|NCT00460603|82981461|FG005|Phase 1|Other|2|||
46763190|NCT00460603|82981462|FG006|Phase 1|Other|0|||
46763191|NCT00460603|82981463|FG007|Phase 1|Other|1|||
46763192|NCT00460603|82981464|FG008|Phase 1|Other|0|||
46763193|NCT00460603|82981465|FG009|Phase 1|Other|0|||
46763194|NCT00460603|82981466|FG010|Phase 1|Other|0|||
46763195|NCT00460603|82981467|FG011|Phase 1|Other|0|||
46763196|NCT00460603|82981456|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763197|NCT00460603|82981457|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763198|NCT00460603|82981458|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763199|NCT00460603|82981459|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763200|NCT00460603|82981460|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763201|NCT00460603|82981461|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763202|NCT00460603|82981462|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763203|NCT00460603|82981463|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763204|NCT00460603|82981464|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763205|NCT00460603|82981465|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
46763206|NCT00460603|82981466|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763207|NCT00460603|82981467|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
46763208|NCT00460603|82981456|FG000|Phase 2|Adverse Event|0|||
46763209|NCT00460603|82981457|FG001|Phase 2|Adverse Event|0|||
46763210|NCT00460603|82981458|FG002|Phase 2|Adverse Event|0|||
46763211|NCT00460603|82981459|FG003|Phase 2|Adverse Event|0|||
46763212|NCT00460603|82981460|FG004|Phase 2|Adverse Event|0|||
46763213|NCT00460603|82981461|FG005|Phase 2|Adverse Event|0|||
46763214|NCT00460603|82981462|FG006|Phase 2|Adverse Event|0|||
46763215|NCT00460603|82981463|FG007|Phase 2|Adverse Event|0|||
46763216|NCT00460603|82981464|FG008|Phase 2|Adverse Event|0|||
46763217|NCT00460603|82981465|FG009|Phase 2|Adverse Event|12|||
46763218|NCT00460603|82981466|FG010|Phase 2|Adverse Event|9|||
46763219|NCT00460603|82981467|FG011|Phase 2|Adverse Event|10|||
46763220|NCT00460603|82981456|FG000|Phase 2|Death|0|||
46763221|NCT00460603|82981457|FG001|Phase 2|Death|0|||
46763222|NCT00460603|82981458|FG002|Phase 2|Death|0|||
46763223|NCT00460603|82981459|FG003|Phase 2|Death|0|||
46763224|NCT00460603|82981460|FG004|Phase 2|Death|0|||
46826772|NCT00283803|83045242|FG000|Overall Study|Withdrawal by Subject|4|||
46826773|NCT00397488|83045246|FG000|Overall Study|Withdrawal by Subject|3|||
46763225|NCT00460603|82981461|FG005|Phase 2|Death|0|||
46763226|NCT00460603|82981462|FG006|Phase 2|Death|0|||
46763227|NCT00460603|82981463|FG007|Phase 2|Death|0|||
46826774|NCT00397488|83045246|FG000|Overall Study|Adverse Event|3|||
46826775|NCT00397488|83045246|FG000|Overall Study|Death|1|||
46637482|NCT01474512|82811389|FG013|Induction Period|Protocol Violation|0|||
46763228|NCT00460603|82981464|FG008|Phase 2|Death|0|||
46763229|NCT00460603|82981465|FG009|Phase 2|Death|4|||
46763230|NCT00460603|82981466|FG010|Phase 2|Death|2|||
46763231|NCT00460603|82981467|FG011|Phase 2|Death|2|||
46763232|NCT00460603|82981456|FG000|Phase 2|Protocol Violation|0|||
46763233|NCT00460603|82981457|FG001|Phase 2|Protocol Violation|0|||
46763234|NCT00460603|82981458|FG002|Phase 2|Protocol Violation|0|||
46763235|NCT00460603|82981459|FG003|Phase 2|Protocol Violation|0|||
46935182|NCT02061761|83171184|FG004|Overall Study|Withdrawal by Subject|0|||
46935183|NCT02061761|83171185|FG005|Overall Study|Withdrawal by Subject|0|||
46935184|NCT02061761|83171186|FG006|Overall Study|Withdrawal by Subject|0|||
46935185|NCT02061761|83171187|FG007|Overall Study|Withdrawal by Subject|0|||
46935186|NCT02061761|83171188|FG008|Overall Study|Withdrawal by Subject|2|||
46935187|NCT02061761|83171180|FG000|Overall Study|Maximum clinical benefit|0|||
46935188|NCT02061761|83171181|FG001|Overall Study|Maximum clinical benefit|0|||
46935189|NCT02061761|83171182|FG002|Overall Study|Maximum clinical benefit|0|||
46935190|NCT02061761|83171183|FG003|Overall Study|Maximum clinical benefit|1|||
46935191|NCT02061761|83171184|FG004|Overall Study|Maximum clinical benefit|0|||
46935192|NCT02061761|83171185|FG005|Overall Study|Maximum clinical benefit|0|||
46826776|NCT00424190|83045252|FG000|Overall Study|Withdrew consent|3|||
46826777|NCT00424190|83045253|FG001|Overall Study|Withdrew consent|4|||
46826778|NCT00424190|83045252|FG000|Overall Study|Death|3|||
46826779|NCT00424190|83045253|FG001|Overall Study|Death|0|||
46826780|NCT00424190|83045252|FG000|Overall Study|Noncompliance|1|||
46826781|NCT00424190|83045253|FG001|Overall Study|Noncompliance|2|||
46826782|NCT00424190|83045252|FG000|Overall Study|Request of sponsor or investigator|0|||
46826783|NCT00424190|83045253|FG001|Overall Study|Request of sponsor or investigator|2|||
46826784|NCT00424190|83045252|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
46826785|NCT00424190|83045253|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
46826786|NCT00424190|83045252|FG000|Overall Study|Other|15|||
46826787|NCT00424190|83045253|FG001|Overall Study|Other|21|||
46826788|NCT00428246|83045262|FG000|Overall Study|Withdrawal by Subject|0|||
46826789|NCT00428246|83045263|FG001|Overall Study|Withdrawal by Subject|0|||
46826790|NCT00428246|83045264|FG002|Overall Study|Withdrawal by Subject|1|||
46826791|NCT00428246|83045262|FG000|Overall Study|Adverse Event|1|||
46826792|NCT00428246|83045263|FG001|Overall Study|Adverse Event|0|||
46826793|NCT00428246|83045264|FG002|Overall Study|Adverse Event|0|||
46826794|NCT00274287|83045272|FG000|Overall Study|Withdrawal by Subject|1|||
46826795|NCT00274287|83045272|FG000|Overall Study|subject non-compliance|1|||
46826796|NCT00423800|83045279|FG000|Overall Study|Protocol Violation|0|||
46826797|NCT00423800|83045280|FG001|Overall Study|Protocol Violation|1|||
46826798|NCT00405548|83045289|FG000|Overall Study|Cognitive Memory problems on study day|1|||
46826799|NCT00405548|83045290|FG001|Overall Study|Cognitive Memory problems on study day|0|||
46826800|NCT00405548|83045289|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
46826801|NCT00405548|83045290|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
46826802|NCT00405548|83045289|FG000|Overall Study|Unable to self-administer shots|1|||
46826803|NCT00405548|83045290|FG001|Overall Study|Unable to self-administer shots|0|||
46826804|NCT00405548|83045289|FG000|Overall Study|Venous access failed during study day|1|||
46826805|NCT00405548|83045290|FG001|Overall Study|Venous access failed during study day|0|||
46826806|NCT00405548|83045289|FG000|Overall Study|Withdrawal by Subject|1|||
46826807|NCT00405548|83045290|FG001|Overall Study|Withdrawal by Subject|0|||
46826808|NCT00405392|83045298|FG000|Overall Study|Adverse Event|15|||
46826809|NCT00405392|83045299|FG001|Overall Study|Adverse Event|14|||
46826810|NCT00405392|83045298|FG000|Overall Study|Did not meet Eligibility criteria|7|||
46826811|NCT00405392|83045299|FG001|Overall Study|Did not meet Eligibility criteria|2|||
46826812|NCT00405392|83045298|FG000|Overall Study|Withdrawal by Subject|4|||
46826813|NCT00405392|83045299|FG001|Overall Study|Withdrawal by Subject|3|||
46826814|NCT00405392|83045298|FG000|Overall Study|Lost to Follow-up|1|||
46826815|NCT00405392|83045299|FG001|Overall Study|Lost to Follow-up|2|||
46826816|NCT00405392|83045298|FG000|Overall Study|Data missing|2|||
46826817|NCT00405392|83045299|FG001|Overall Study|Data missing|0|||
46826818|NCT00405392|83045298|FG000|Overall Study|Non-compliance|0|||
46826819|NCT00405392|83045299|FG001|Overall Study|Non-compliance|1|||
46826820|NCT00405392|83045298|FG000|Overall Study|Other|1|||
46826821|NCT00405392|83045299|FG001|Overall Study|Other|5|||
46935193|NCT02061761|83171186|FG006|Overall Study|Maximum clinical benefit|0|||
46935194|NCT02061761|83171187|FG007|Overall Study|Maximum clinical benefit|0|||
46935195|NCT02061761|83171188|FG008|Overall Study|Maximum clinical benefit|6|||
46935196|NCT02061761|83171180|FG000|Overall Study|Participant no longer meets study criteria|0|||
46935197|NCT02061761|83171181|FG001|Overall Study|Participant no longer meets study criteria|0|||
46935198|NCT02061761|83171182|FG002|Overall Study|Participant no longer meets study criteria|0|||
47058630|NCT01694849|83337830|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
46826822|NCT00282243|83045305|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
46826823|NCT00282243|83045305|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
46826824|NCT00282243|83045305|FG000|Extension Treatment Period|Adverse Event|15|||
46935199|NCT02061761|83171183|FG003|Overall Study|Participant no longer meets study criteria|0|||
46935200|NCT02061761|83171184|FG004|Overall Study|Participant no longer meets study criteria|0|||
46826825|NCT00282243|83045305|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
46826826|NCT00282243|83045305|FG000|Extension Treatment Period|Non-compliance|2|||
46826827|NCT00282243|83045305|FG000|Extension Treatment Period|Physician Decision|1|||
46826828|NCT00272961|83045314|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
46826829|NCT00272961|83045315|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
46826830|NCT00272961|83045316|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
46826831|NCT00272961|83045317|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
46826832|NCT00272961|83045318|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
46826833|NCT00272961|83045314|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
46826834|NCT00272961|83045315|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
46826835|NCT00272961|83045316|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
46826836|NCT00272961|83045317|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
46826837|NCT00272961|83045318|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
46826838|NCT00272961|83045314|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
46826839|NCT00272961|83045315|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
46826840|NCT00272961|83045316|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
46826841|NCT00272961|83045317|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
46826842|NCT00272961|83045318|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
46826843|NCT00272961|83045314|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
46826844|NCT00272961|83045315|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
46826845|NCT00272961|83045316|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
46826846|NCT00272961|83045317|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
46826847|NCT00272961|83045318|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
46826848|NCT00272961|83045314|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
46826849|NCT00272961|83045315|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
46826850|NCT00272961|83045316|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
46826851|NCT00272961|83045317|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
46826852|NCT00272961|83045318|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
46826853|NCT00272961|83045314|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
46826854|NCT00272961|83045315|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
46826855|NCT00272961|83045316|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
46826856|NCT00272961|83045317|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
46826857|NCT00272961|83045318|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
46826858|NCT00272961|83045314|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
46826859|NCT00272961|83045315|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
46826860|NCT00272961|83045316|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
46826861|NCT00272961|83045317|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
46826862|NCT00272961|83045318|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
46826863|NCT00272961|83045314|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
46826864|NCT00272961|83045315|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
46826865|NCT00272961|83045316|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
46826866|NCT00272961|83045317|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
46826867|NCT00272961|83045318|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
46826868|NCT00282087|83045330|FG000|Overall Study|Death|1|||
46826869|NCT00404924|83045337|FG000|Overall Study|Adverse Event|75|||
46826870|NCT00404924|83045338|FG001|Overall Study|Adverse Event|16|||
47058631|NCT01694849|83337828|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
47058632|NCT01694849|83337829|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
46763236|NCT00460603|82981460|FG004|Phase 2|Protocol Violation|0|||
46763237|NCT00460603|82981461|FG005|Phase 2|Protocol Violation|0|||
46763238|NCT00460603|82981462|FG006|Phase 2|Protocol Violation|0|||
46763239|NCT00460603|82981463|FG007|Phase 2|Protocol Violation|0|||
46763240|NCT00460603|82981464|FG008|Phase 2|Protocol Violation|0|||
46763241|NCT00460603|82981465|FG009|Phase 2|Protocol Violation|1|||
46763242|NCT00460603|82981466|FG010|Phase 2|Protocol Violation|1|||
46763243|NCT00460603|82981467|FG011|Phase 2|Protocol Violation|0|||
46763244|NCT00460603|82981456|FG000|Phase 2|Lost to Follow-up|0|||
46763245|NCT00460603|82981457|FG001|Phase 2|Lost to Follow-up|0|||
46763246|NCT00460603|82981458|FG002|Phase 2|Lost to Follow-up|0|||
46763247|NCT00460603|82981459|FG003|Phase 2|Lost to Follow-up|0|||
46763248|NCT00460603|82981460|FG004|Phase 2|Lost to Follow-up|0|||
46763249|NCT00460603|82981461|FG005|Phase 2|Lost to Follow-up|0|||
46763250|NCT00460603|82981462|FG006|Phase 2|Lost to Follow-up|0|||
46763251|NCT00460603|82981463|FG007|Phase 2|Lost to Follow-up|0|||
46763252|NCT00460603|82981464|FG008|Phase 2|Lost to Follow-up|0|||
46763253|NCT00460603|82981465|FG009|Phase 2|Lost to Follow-up|1|||
46763254|NCT00460603|82981466|FG010|Phase 2|Lost to Follow-up|0|||
46763255|NCT00460603|82981467|FG011|Phase 2|Lost to Follow-up|0|||
46763256|NCT00460603|82981456|FG000|Phase 2|Other|0|||
46763257|NCT00460603|82981457|FG001|Phase 2|Other|0|||
46763258|NCT00460603|82981458|FG002|Phase 2|Other|0|||
46763259|NCT00460603|82981459|FG003|Phase 2|Other|0|||
46763260|NCT00460603|82981460|FG004|Phase 2|Other|0|||
46763261|NCT00460603|82981461|FG005|Phase 2|Other|0|||
46763262|NCT00460603|82981462|FG006|Phase 2|Other|0|||
46763263|NCT00460603|82981463|FG007|Phase 2|Other|0|||
46763264|NCT00460603|82981464|FG008|Phase 2|Other|0|||
46763265|NCT00460603|82981465|FG009|Phase 2|Other|6|||
46826871|NCT00404924|83045337|FG000|Overall Study|Condition under investigation worsened|475|||
46826872|NCT00404924|83045338|FG001|Overall Study|Condition under investigation worsened|264|||
46826873|NCT00404924|83045337|FG000|Overall Study|Lost to Follow-up|1|||
46826874|NCT00404924|83045338|FG001|Overall Study|Lost to Follow-up|1|||
46826875|NCT00404924|83045337|FG000|Overall Study|Withdrawal by Subject|26|||
46826876|NCT00404924|83045338|FG001|Overall Study|Withdrawal by Subject|13|||
46826877|NCT00404924|83045337|FG000|Overall Study|Other|25|||
46826878|NCT00404924|83045338|FG001|Overall Study|Other|11|||
46826879|NCT00404924|83045337|FG000|Overall Study|Randomised but not received treatment|1|||
46826880|NCT00404924|83045338|FG001|Overall Study|Randomised but not received treatment|1|||
46826881|NCT00281697|83045346|FG000|Overall Study|> 60 days since last dose of study drug|4|||
46826882|NCT00281697|83045347|FG001|Overall Study|> 60 days since last dose of study drug|4|||
46826883|NCT00281697|83045346|FG000|Overall Study|Adverse Event|54|||
46826884|NCT00281697|83045347|FG001|Overall Study|Adverse Event|15|||
46826885|NCT00281697|83045346|FG000|Overall Study|Death|8|||
46826886|NCT00281697|83045347|FG001|Overall Study|Death|3|||
46826887|NCT00281697|83045346|FG000|Overall Study|Disease progression|279|||
46826888|NCT00281697|83045347|FG001|Overall Study|Disease progression|149|||
46826889|NCT00281697|83045346|FG000|Overall Study|Other|5|||
46826890|NCT00281697|83045347|FG001|Overall Study|Other|6|||
46826891|NCT00281697|83045346|FG000|Overall Study|Physician's decision to withdraw|15|||
46826892|NCT00281697|83045347|FG001|Overall Study|Physician's decision to withdraw|12|||
46826893|NCT00281697|83045346|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
46826894|NCT00281697|83045347|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
46826895|NCT00281697|83045346|FG000|Overall Study|Did not receive study drug|3|||
46826896|NCT00281697|83045347|FG001|Overall Study|Did not receive study drug|2|||
46826897|NCT00271947|83045353|FG000|Overall Study|Lost to Follow-up|1|||
46826898|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Death|186|||
46826899|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Death|222|||
46826900|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Death|0|||
46826901|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
46826902|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
46826903|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
46826904|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
46826905|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
46826906|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
46826907|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
46826908|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
46826909|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
46826910|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Adverse Event|83|||
46826911|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Adverse Event|100|||
46826912|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Adverse Event|0|||
46826913|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Other|70|||
46826914|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Other|75|||
46826915|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Other|0|||
46826916|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
46826917|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
46826918|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
46826919|NCT00232180|83045359|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
46826920|NCT00232180|83045360|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
46935201|NCT02061761|83171185|FG005|Overall Study|Participant no longer meets study criteria|0|||
46935202|NCT02061761|83171186|FG006|Overall Study|Participant no longer meets study criteria|0|||
46935203|NCT02061761|83171187|FG007|Overall Study|Participant no longer meets study criteria|0|||
46935204|NCT02061761|83171188|FG008|Overall Study|Participant no longer meets study criteria|1|||
46763266|NCT00460603|82981466|FG010|Phase 2|Other|16|||
46763267|NCT00460603|82981467|FG011|Phase 2|Other|7|||
46763268|NCT00460603|82981456|FG000|Phase 2|Objective Progression or Relapse|0|||
46763269|NCT00460603|82981457|FG001|Phase 2|Objective Progression or Relapse|0|||
46763270|NCT00460603|82981458|FG002|Phase 2|Objective Progression or Relapse|0|||
46763271|NCT00460603|82981459|FG003|Phase 2|Objective Progression or Relapse|0|||
46763272|NCT00460603|82981460|FG004|Phase 2|Objective Progression or Relapse|0|||
46763273|NCT00460603|82981461|FG005|Phase 2|Objective Progression or Relapse|0|||
46826921|NCT00232180|83045361|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
46826922|NCT00232180|83045359|FG000|Open Label Phase|Death|0|||
46826923|NCT00232180|83045360|FG001|Open Label Phase|Death|0|||
46826924|NCT00232180|83045361|FG002|Open Label Phase|Death|48|||
46935205|NCT02061761|83171180|FG000|Overall Study|Other reasons|0|||
46763274|NCT00460603|82981462|FG006|Phase 2|Objective Progression or Relapse|0|||
46826925|NCT00232180|83045359|FG000|Open Label Phase|Lost to Follow-up|0|||
46826926|NCT00232180|83045360|FG001|Open Label Phase|Lost to Follow-up|0|||
46763275|NCT00460603|82981463|FG007|Phase 2|Objective Progression or Relapse|0|||
46826927|NCT00232180|83045361|FG002|Open Label Phase|Lost to Follow-up|5|||
46826928|NCT00232180|83045359|FG000|Open Label Phase|Protocol Violation|0|||
46826929|NCT00232180|83045360|FG001|Open Label Phase|Protocol Violation|0|||
46826930|NCT00232180|83045361|FG002|Open Label Phase|Protocol Violation|3|||
46826931|NCT00232180|83045359|FG000|Open Label Phase|Study terminated by sponsor|0|||
46826932|NCT00232180|83045360|FG001|Open Label Phase|Study terminated by sponsor|0|||
46826933|NCT00232180|83045361|FG002|Open Label Phase|Study terminated by sponsor|3|||
46826934|NCT00232180|83045359|FG000|Open Label Phase|Withdrawal by Subject|0|||
46826935|NCT00232180|83045360|FG001|Open Label Phase|Withdrawal by Subject|0|||
46826936|NCT00232180|83045361|FG002|Open Label Phase|Withdrawal by Subject|37|||
46826937|NCT00232180|83045359|FG000|Open Label Phase|Other|0|||
46826938|NCT00232180|83045360|FG001|Open Label Phase|Other|0|||
46826939|NCT00232180|83045361|FG002|Open Label Phase|Other|16|||
46826940|NCT00232180|83045359|FG000|Open Label Phase|Adverse Event|0|||
46826941|NCT00232180|83045360|FG001|Open Label Phase|Adverse Event|0|||
46826942|NCT00232180|83045361|FG002|Open Label Phase|Adverse Event|25|||
46826943|NCT00232180|83045359|FG000|Open Label Phase|Laboratory abnormality|0|||
46826944|NCT00232180|83045360|FG001|Open Label Phase|Laboratory abnormality|0|||
46826945|NCT00232180|83045361|FG002|Open Label Phase|Laboratory abnormality|10|||
46826946|NCT00232180|83045359|FG000|Open Label Phase|Randomized but not treated|0|||
46826947|NCT00232180|83045360|FG001|Open Label Phase|Randomized but not treated|0|||
46826948|NCT00232180|83045361|FG002|Open Label Phase|Randomized but not treated|1|||
46826949|NCT00280683|83045372|FG000|Overall Study|Withdrawal by Subject|1|||
46826950|NCT00280683|83045373|FG001|Overall Study|Withdrawal by Subject|2|||
46826951|NCT00280683|83045372|FG000|Overall Study|Adverse Event|1|||
46826952|NCT00280683|83045373|FG001|Overall Study|Adverse Event|1|||
46826953|NCT00270855|83045383|FG000|Overall Study|Withdrawal by Subject|8|||
46826954|NCT00270855|83045384|FG001|Overall Study|Withdrawal by Subject|8|||
46826955|NCT00404768|83045396|FG000|Part A and B|Withdrawn due to labor progression|1|||
46826956|NCT00404768|83045397|FG001|Part A and B|Withdrawn due to labor progression|0|||
46826957|NCT00404768|83045398|FG002|Part A and B|Withdrawn due to labor progression|0|||
46826958|NCT00404768|83045399|FG003|Part A and B|Withdrawn due to labor progression|0|||
46826959|NCT00404768|83045396|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
46826960|NCT00404768|83045397|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
46826961|NCT00404768|83045398|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
46826962|NCT00404768|83045399|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
46826963|NCT00404768|83045396|FG000|Part C|Adverse Event|0|||
46826964|NCT00404768|83045397|FG001|Part C|Adverse Event|0|||
46826965|NCT00404768|83045398|FG002|Part C|Adverse Event|0|||
46826966|NCT00404768|83045399|FG003|Part C|Adverse Event|3|||
46826967|NCT00404768|83045396|FG000|Part C|Lost to Follow-up|0|||
46935206|NCT02061761|83171181|FG001|Overall Study|Other reasons|0|||
46935207|NCT02061761|83171182|FG002|Overall Study|Other reasons|0|||
46935208|NCT02061761|83171183|FG003|Overall Study|Other reasons|0|||
46826968|NCT00404768|83045397|FG001|Part C|Lost to Follow-up|0|||
46826969|NCT00404768|83045398|FG002|Part C|Lost to Follow-up|3|||
46826970|NCT00404768|83045399|FG003|Part C|Lost to Follow-up|1|||
46826971|NCT00404768|83045396|FG000|Part C|Withdrawal by Subject|0|||
46826972|NCT00404768|83045397|FG001|Part C|Withdrawal by Subject|0|||
46826973|NCT00404768|83045398|FG002|Part C|Withdrawal by Subject|2|||
46826974|NCT00404768|83045399|FG003|Part C|Withdrawal by Subject|1|||
46826975|NCT00404768|83045396|FG000|Part C|Early withdrawal from study medication|0|||
46935209|NCT02061761|83171184|FG004|Overall Study|Other reasons|2|||
46935210|NCT02061761|83171185|FG005|Overall Study|Other reasons|0|||
46935211|NCT02061761|83171186|FG006|Overall Study|Other reasons|0|||
46935212|NCT02061761|83171187|FG007|Overall Study|Other reasons|0|||
46935213|NCT02061761|83171188|FG008|Overall Study|Other reasons|6|||
46935214|NCT01927068|83171216|FG000|Overall Study|Death|37|||
46826976|NCT00404768|83045397|FG001|Part C|Early withdrawal from study medication|0|||
46826977|NCT00404768|83045398|FG002|Part C|Early withdrawal from study medication|1|||
46826978|NCT00404768|83045399|FG003|Part C|Early withdrawal from study medication|0|||
46826979|NCT00404768|83045396|FG000|Part C|Participant did not respond to therapy|0|||
46826980|NCT00404768|83045397|FG001|Part C|Participant did not respond to therapy|0|||
46826981|NCT00404768|83045398|FG002|Part C|Participant did not respond to therapy|1|||
46935215|NCT01927068|83171217|FG001|Overall Study|Death|3|||
46935216|NCT01927068|83171216|FG000|Overall Study|Withdrawal by Subject|50|||
46935217|NCT01927068|83171217|FG001|Overall Study|Withdrawal by Subject|3|||
46935218|NCT01927068|83171216|FG000|Overall Study|Lost to Follow-up|10|||
47058633|NCT01694849|83337830|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
47058634|NCT01694849|83337828|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
47058635|NCT01694849|83337829|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
46826982|NCT00404768|83045399|FG003|Part C|Participant did not respond to therapy|1|||
46826983|NCT00404768|83045396|FG000|Part C|Physician withdrew the study medication|0|||
46826984|NCT00404768|83045397|FG001|Part C|Physician withdrew the study medication|0|||
46826985|NCT00404768|83045398|FG002|Part C|Physician withdrew the study medication|1|||
46826986|NCT00404768|83045399|FG003|Part C|Physician withdrew the study medication|0|||
46826987|NCT00404768|83045396|FG000|Part C|Participant delivered baby|0|||
46826988|NCT00404768|83045397|FG001|Part C|Participant delivered baby|0|||
46935219|NCT01927068|83171217|FG001|Overall Study|Lost to Follow-up|2|||
46826989|NCT00404768|83045398|FG002|Part C|Participant delivered baby|0|||
46826990|NCT00404768|83045399|FG003|Part C|Participant delivered baby|1|||
46826991|NCT00404768|83045396|FG000|Part C|Unsatisfactory uterine response to IP|0|||
46826992|NCT00404768|83045397|FG001|Part C|Unsatisfactory uterine response to IP|0|||
46826993|NCT00404768|83045398|FG002|Part C|Unsatisfactory uterine response to IP|0|||
46826994|NCT00404768|83045399|FG003|Part C|Unsatisfactory uterine response to IP|1|||
46826995|NCT00404768|83045396|FG000|Part C|Active labor|0|||
46826996|NCT00404768|83045397|FG001|Part C|Active labor|0|||
46826997|NCT00404768|83045398|FG002|Part C|Active labor|0|||
46826998|NCT00404768|83045399|FG003|Part C|Active labor|1|||
46826999|NCT00404768|83045396|FG000|Part C|Lack of Efficacy|0|||
46827000|NCT00404768|83045397|FG001|Part C|Lack of Efficacy|0|||
46827001|NCT00404768|83045398|FG002|Part C|Lack of Efficacy|0|||
46827002|NCT00404768|83045399|FG003|Part C|Lack of Efficacy|2|||
46827003|NCT00404768|83045396|FG000|Part C|Treatment failure|0|||
46827004|NCT00404768|83045397|FG001|Part C|Treatment failure|0|||
46827005|NCT00404768|83045398|FG002|Part C|Treatment failure|0|||
46827006|NCT00404768|83045399|FG003|Part C|Treatment failure|1|||
46827007|NCT00404768|83045396|FG000|Part C|Investigator discretion|0|||
46827008|NCT00404768|83045397|FG001|Part C|Investigator discretion|0|||
46827009|NCT00404768|83045398|FG002|Part C|Investigator discretion|0|||
46827010|NCT00404768|83045399|FG003|Part C|Investigator discretion|1|||
46827011|NCT00404768|83045396|FG000|Part C|Researcher suspended study medication|0|||
46827012|NCT00404768|83045397|FG001|Part C|Researcher suspended study medication|0|||
46827013|NCT00404768|83045398|FG002|Part C|Researcher suspended study medication|0|||
46827014|NCT00404768|83045399|FG003|Part C|Researcher suspended study medication|1|||
46827015|NCT00270231|83045414|FG000|First Intervention|Lost to Follow-up|1|||
46827016|NCT00270231|83045415|FG001|First Intervention|Lost to Follow-up|1|||
46827017|NCT00270231|83045414|FG000|Washout Period|Lost to Follow-up|1|||
46827018|NCT00270231|83045415|FG001|Washout Period|Lost to Follow-up|0|||
46827019|NCT00270231|83045414|FG000|Second Intervention|Lost to Follow-up|0|||
46827020|NCT00270231|83045415|FG001|Second Intervention|Lost to Follow-up|1|||
46827021|NCT00258856|83045425|FG000|Overall Study|Lost to Follow-up|1|||
46827022|NCT00258856|83045426|FG001|Overall Study|Lost to Follow-up|0|||
46827023|NCT00258856|83045427|FG002|Overall Study|Lost to Follow-up|2|||
46827024|NCT00258856|83045428|FG003|Overall Study|Lost to Follow-up|0|||
46827025|NCT00258856|83045425|FG000|Overall Study|Non-compliance|2|||
46827026|NCT00258856|83045426|FG001|Overall Study|Non-compliance|0|||
46935220|NCT01927068|83171216|FG000|Overall Study|Physician Decision|9|||
46935221|NCT01927068|83171217|FG001|Overall Study|Physician Decision|0|||
46935222|NCT01927068|83171216|FG000|Overall Study|Missed last follow-up visit|2|||
46827027|NCT00258856|83045427|FG002|Overall Study|Non-compliance|0|||
46827028|NCT00258856|83045428|FG003|Overall Study|Non-compliance|1|||
46827029|NCT00269919|83045438|FG000|Overall Study|Other|26|||
46827030|NCT00269919|83045438|FG000|Overall Study|Started but not treated|1|||
46827031|NCT00258154|83045445|FG000|Overall Study|Adverse Event|1|||
46827032|NCT00258154|83045446|FG001|Overall Study|Adverse Event|0|||
46827033|NCT00258154|83045445|FG000|Overall Study|Lost to Follow-up|0|||
46827034|NCT00258154|83045446|FG001|Overall Study|Lost to Follow-up|1|||
46827035|NCT00258154|83045445|FG000|Overall Study|Protocol Violation|2|||
46827036|NCT00258154|83045446|FG001|Overall Study|Protocol Violation|1|||
46827037|NCT00258154|83045445|FG000|Overall Study|Withdrawal by Subject|3|||
46827038|NCT00258154|83045446|FG001|Overall Study|Withdrawal by Subject|4|||
46827039|NCT00258154|83045445|FG000|Overall Study|Patient Moved|3|||
46827040|NCT00258154|83045446|FG001|Overall Study|Patient Moved|1|||
46827041|NCT00257920|83045454|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
46935223|NCT01927068|83171217|FG001|Overall Study|Missed last follow-up visit|0|||
46935224|NCT01309230|83171226|FG000|Overall Study|Withdrawal by Subject|0|||
46935225|NCT01309230|83171227|FG001|Overall Study|Withdrawal by Subject|2|||
46935226|NCT01309230|83171226|FG000|Overall Study|Observation arm closed|0|||
46935227|NCT01309230|83171227|FG001|Overall Study|Observation arm closed|2|||
46935228|NCT00819832|83171239|FG000|Overall Study|Sponsor Termination of Study|3|||
46935229|NCT00819832|83171240|FG001|Overall Study|Sponsor Termination of Study|0|||
46935230|NCT00819832|83171241|FG002|Overall Study|Sponsor Termination of Study|0|||
47058636|NCT01694849|83337830|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
47058637|NCT01694849|83337828|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
46827042|NCT00257920|83045455|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
46827043|NCT00257920|83045454|FG000|Period: Second Intervention|Other|2|||
46827044|NCT00257920|83045455|FG001|Period: Second Intervention|Other|1|||
46827045|NCT00268983|83045464|FG000|Overall Study|Death|3|||
46827046|NCT00268983|83045465|FG001|Overall Study|Death|0|||
46827047|NCT00257608|83045473|FG000|Chemotherapy Phase|Adverse Event|138|||
46827048|NCT00257608|83045474|FG001|Chemotherapy Phase|Adverse Event|0|||
46827049|NCT00257608|83045475|FG002|Chemotherapy Phase|Adverse Event|0|||
46827050|NCT00257608|83045473|FG000|Chemotherapy Phase|Disease progression|139|||
46827051|NCT00257608|83045474|FG001|Chemotherapy Phase|Disease progression|0|||
46827052|NCT00257608|83045475|FG002|Chemotherapy Phase|Disease progression|0|||
46827053|NCT00257608|83045473|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
46827054|NCT00257608|83045474|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
46827055|NCT00257608|83045475|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
46827056|NCT00257608|83045473|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
46827057|NCT00257608|83045474|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
46827058|NCT00257608|83045475|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
46827059|NCT00257608|83045473|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
46827060|NCT00257608|83045474|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
46827061|NCT00257608|83045475|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
46827062|NCT00257608|83045473|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
46827063|NCT00257608|83045474|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
46827064|NCT00257608|83045475|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
46827065|NCT00257608|83045473|FG000|Chemotherapy Phase|Physician Decision|28|||
46827066|NCT00257608|83045474|FG001|Chemotherapy Phase|Physician Decision|0|||
46827067|NCT00257608|83045475|FG002|Chemotherapy Phase|Physician Decision|0|||
46827068|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Adverse Event|0|||
46827069|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Adverse Event|34|||
46827070|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Adverse Event|38|||
46827071|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Disease progression|0|||
46827072|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Disease progression|204|||
46827073|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Disease progression|168|||
46827074|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
46827075|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
46827076|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
46827077|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
46827078|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
46827079|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
46827080|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
46827081|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
46827082|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
46827083|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
46827084|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
46827085|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
46827086|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
46827087|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
46827088|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
46827089|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Physician Decision|0|||
46827090|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Physician Decision|8|||
46827091|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Physician Decision|11|||
46827092|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
46827093|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
46827094|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
46827095|NCT00257608|83045473|FG000|Post Chemotherapy Phase|Not treated|0|||
46827096|NCT00257608|83045474|FG001|Post Chemotherapy Phase|Not treated|4|||
46827097|NCT00257608|83045475|FG002|Post Chemotherapy Phase|Not treated|7|||
46827098|NCT00231478|83045490|FG000|Overall Study|Protocol Violation|3|||
46827099|NCT00231478|83045491|FG001|Overall Study|Protocol Violation|2|||
46827100|NCT00231478|83045490|FG000|Overall Study|Refused Treatment|1|||
46827101|NCT00231478|83045491|FG001|Overall Study|Refused Treatment|1|||
46827102|NCT00231478|83045490|FG000|Overall Study|Withdrawal by Subject|1|||
46827103|NCT00231478|83045491|FG001|Overall Study|Withdrawal by Subject|0|||
46827104|NCT00231478|83045490|FG000|Overall Study|Adverse Event|0|||
46827105|NCT00231478|83045491|FG001|Overall Study|Adverse Event|1|||
46827106|NCT00231478|83045490|FG000|Overall Study|Administrative|3|||
46827107|NCT00231478|83045491|FG001|Overall Study|Administrative|2|||
46827108|NCT00413192|83045501|FG000|Overall Study|Disease progression|26|||
46935231|NCT00819832|83171242|FG003|Overall Study|Sponsor Termination of Study|0|||
46935232|NCT00819832|83171243|FG004|Overall Study|Sponsor Termination of Study|0|||
46935233|NCT00819832|83171244|FG005|Overall Study|Sponsor Termination of Study|0|||
46935234|NCT00704522|83171260|FG000|Overall Study|Lack of Efficacy|65|||
46935235|NCT00704522|83171261|FG001|Overall Study|Lack of Efficacy|17|||
46935236|NCT00704522|83171260|FG000|Overall Study|Failure to appear again at hospital|56|||
46935237|NCT00704522|83171261|FG001|Overall Study|Failure to appear again at hospital|10|||
46827109|NCT00413192|83045502|FG001|Overall Study|Disease progression|31|||
46935238|NCT00704522|83171260|FG000|Overall Study|Withdrawal by Subject|17|||
46935239|NCT00704522|83171261|FG001|Overall Study|Withdrawal by Subject|8|||
46827110|NCT00413192|83045503|FG002|Overall Study|Disease progression|16|||
46827111|NCT00413192|83045504|FG003|Overall Study|Disease progression|25|||
46827112|NCT00413192|83045501|FG000|Overall Study|Toxicity|3|||
46827113|NCT00413192|83045502|FG001|Overall Study|Toxicity|2|||
46827114|NCT00413192|83045503|FG002|Overall Study|Toxicity|2|||
46935240|NCT00704522|83171260|FG000|Overall Study|Adverse Event|9|||
46935241|NCT00704522|83171261|FG001|Overall Study|Adverse Event|1|||
46827115|NCT00413192|83045504|FG003|Overall Study|Toxicity|2|||
46827116|NCT00413192|83045501|FG000|Overall Study|Withdrawal by Subject|3|||
46827117|NCT00413192|83045502|FG001|Overall Study|Withdrawal by Subject|5|||
46827118|NCT00413192|83045503|FG002|Overall Study|Withdrawal by Subject|0|||
46827119|NCT00413192|83045504|FG003|Overall Study|Withdrawal by Subject|1|||
46827120|NCT00413192|83045501|FG000|Overall Study|Intercurrent illness|0|||
47058638|NCT01694849|83337829|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
46827121|NCT00413192|83045502|FG001|Overall Study|Intercurrent illness|0|||
46827122|NCT00413192|83045503|FG002|Overall Study|Intercurrent illness|0|||
46827123|NCT00413192|83045504|FG003|Overall Study|Intercurrent illness|1|||
46827124|NCT00413192|83045501|FG000|Overall Study|Intercurrent death|0|||
46827125|NCT00413192|83045502|FG001|Overall Study|Intercurrent death|1|||
47058639|NCT01694849|83337830|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
46827126|NCT00413192|83045503|FG002|Overall Study|Intercurrent death|0|||
46827127|NCT00413192|83045504|FG003|Overall Study|Intercurrent death|0|||
46827128|NCT00413192|83045501|FG000|Overall Study|Other|5|||
46827129|NCT00413192|83045502|FG001|Overall Study|Other|1|||
46827130|NCT00413192|83045503|FG002|Overall Study|Other|1|||
46827131|NCT00413192|83045504|FG003|Overall Study|Other|2|||
46827132|NCT00413192|83045501|FG000|Overall Study|Not treated|0|||
46827133|NCT00413192|83045502|FG001|Overall Study|Not treated|0|||
46827134|NCT00413192|83045503|FG002|Overall Study|Not treated|0|||
46827135|NCT00413192|83045504|FG003|Overall Study|Not treated|1|||
46827136|NCT00207142|83045517|FG000|Induction Phase|Adverse Event|9|||
46827137|NCT00207142|83045518|FG001|Induction Phase|Adverse Event|0|||
46827138|NCT00207142|83045519|FG002|Induction Phase|Adverse Event|0|||
46827139|NCT00207142|83045520|FG003|Induction Phase|Adverse Event|0|||
46827140|NCT00207142|83045517|FG000|Induction Phase|Death|1|||
46827141|NCT00207142|83045518|FG001|Induction Phase|Death|0|||
46827142|NCT00207142|83045519|FG002|Induction Phase|Death|0|||
46827143|NCT00207142|83045520|FG003|Induction Phase|Death|0|||
46827144|NCT00207142|83045517|FG000|Induction Phase|Lack of Efficacy|1|||
46827145|NCT00207142|83045518|FG001|Induction Phase|Lack of Efficacy|0|||
46827146|NCT00207142|83045519|FG002|Induction Phase|Lack of Efficacy|0|||
46827147|NCT00207142|83045520|FG003|Induction Phase|Lack of Efficacy|0|||
46827148|NCT00207142|83045517|FG000|Induction Phase|Lost to Follow-up|5|||
46827149|NCT00207142|83045518|FG001|Induction Phase|Lost to Follow-up|0|||
46827150|NCT00207142|83045519|FG002|Induction Phase|Lost to Follow-up|0|||
46827151|NCT00207142|83045520|FG003|Induction Phase|Lost to Follow-up|0|||
46827152|NCT00207142|83045517|FG000|Induction Phase|Physician Decision|2|||
46827153|NCT00207142|83045518|FG001|Induction Phase|Physician Decision|0|||
46827154|NCT00207142|83045519|FG002|Induction Phase|Physician Decision|0|||
46827155|NCT00207142|83045520|FG003|Induction Phase|Physician Decision|0|||
46827156|NCT00207142|83045517|FG000|Induction Phase|Poor/noncompliance|2|||
46827157|NCT00207142|83045518|FG001|Induction Phase|Poor/noncompliance|0|||
46827158|NCT00207142|83045519|FG002|Induction Phase|Poor/noncompliance|0|||
46827159|NCT00207142|83045520|FG003|Induction Phase|Poor/noncompliance|0|||
46827160|NCT00207142|83045517|FG000|Induction Phase|Pregnancy|1|||
46827161|NCT00207142|83045518|FG001|Induction Phase|Pregnancy|0|||
46827162|NCT00207142|83045519|FG002|Induction Phase|Pregnancy|0|||
46827163|NCT00207142|83045520|FG003|Induction Phase|Pregnancy|0|||
46827164|NCT00207142|83045517|FG000|Induction Phase|Subject no longer meets study criteria|3|||
46827165|NCT00207142|83045518|FG001|Induction Phase|Subject no longer meets study criteria|0|||
46827166|NCT00207142|83045519|FG002|Induction Phase|Subject no longer meets study criteria|0|||
46827167|NCT00207142|83045520|FG003|Induction Phase|Subject no longer meets study criteria|0|||
46827168|NCT00207142|83045517|FG000|Induction Phase|Withdrawal by Subject|4|||
46827169|NCT00207142|83045518|FG001|Induction Phase|Withdrawal by Subject|0|||
46827170|NCT00207142|83045519|FG002|Induction Phase|Withdrawal by Subject|0|||
46827171|NCT00207142|83045520|FG003|Induction Phase|Withdrawal by Subject|0|||
46827172|NCT00207142|83045517|FG000|Induction Phase|Incarceration|1|||
46827173|NCT00207142|83045518|FG001|Induction Phase|Incarceration|0|||
46827174|NCT00207142|83045519|FG002|Induction Phase|Incarceration|0|||
47058640|NCT01694849|83337828|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
47058641|NCT01694849|83337829|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
46827175|NCT00207142|83045520|FG003|Induction Phase|Incarceration|0|||
46827176|NCT00207142|83045517|FG000|Induction Phase|Missing lab data|1|||
46827177|NCT00207142|83045518|FG001|Induction Phase|Missing lab data|0|||
46827178|NCT00207142|83045519|FG002|Induction Phase|Missing lab data|0|||
46827179|NCT00207142|83045520|FG003|Induction Phase|Missing lab data|0|||
46827180|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
46827181|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
46827182|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
46827183|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
46827184|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
46827185|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
46827186|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
46827187|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
46827188|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
46827189|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
46827190|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
46827191|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
46827192|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
46827193|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
46827194|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
46827195|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
46827196|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
46827197|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
46827198|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
46827199|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
46827200|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
46827201|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
46827202|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
46827203|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
46827204|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
46827205|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
46827206|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
46827207|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
46827208|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Death|0|||
46827209|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Death|0|||
46827210|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Death|0|||
46827211|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Death|1|||
46827212|NCT00207142|83045517|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
46827213|NCT00207142|83045518|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
46827214|NCT00207142|83045519|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
46827215|NCT00207142|83045520|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
46827216|NCT00268905|83045538|FG000|Overall Study|Adverse Event|3|||
46827217|NCT00268905|83045539|FG001|Overall Study|Adverse Event|0|||
46827218|NCT00268905|83045540|FG002|Overall Study|Adverse Event|4|||
46763276|NCT00460603|82981464|FG008|Phase 2|Objective Progression or Relapse|0|||
46763277|NCT00460603|82981465|FG009|Phase 2|Objective Progression or Relapse|9|||
46763278|NCT00460603|82981466|FG010|Phase 2|Objective Progression or Relapse|10|||
46827219|NCT00268905|83045538|FG000|Overall Study|Lost to Follow-up|0|||
46827220|NCT00268905|83045539|FG001|Overall Study|Lost to Follow-up|1|||
46827221|NCT00268905|83045540|FG002|Overall Study|Lost to Follow-up|0|||
46827222|NCT00268905|83045538|FG000|Overall Study|Withdrawal by Subject|0|||
46827223|NCT00268905|83045539|FG001|Overall Study|Withdrawal by Subject|0|||
46827224|NCT00268905|83045540|FG002|Overall Study|Withdrawal by Subject|3|||
46827225|NCT00268905|83045538|FG000|Overall Study|Progressive Disease|28|||
46827226|NCT00268905|83045539|FG001|Overall Study|Progressive Disease|4|||
46827227|NCT00268905|83045540|FG002|Overall Study|Progressive Disease|3|||
46827228|NCT00268905|83045538|FG000|Overall Study|Physician Decision|3|||
46827229|NCT00268905|83045539|FG001|Overall Study|Physician Decision|0|||
46827230|NCT00268905|83045540|FG002|Overall Study|Physician Decision|1|||
47058642|NCT01694849|83337830|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
47058643|NCT01694849|83337828|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
47058644|NCT01694849|83337829|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
47058645|NCT01694849|83337830|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
47058646|NCT01694849|83337828|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
47058647|NCT01694849|83337829|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
47058648|NCT01694849|83337830|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
47058649|NCT01694849|83337828|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
47058650|NCT01694849|83337829|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
47058651|NCT01694849|83337830|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
47058652|NCT01694771|83337879|FG000|Overall Study|Adverse Event|18|||
47058653|NCT01694771|83337880|FG001|Overall Study|Adverse Event|16|||
46763279|NCT00460603|82981467|FG011|Phase 2|Objective Progression or Relapse|17|||
46763280|NCT00460603|82981456|FG000|Phase 2|Global Deterioration of Health Status|0|||
46763281|NCT00460603|82981457|FG001|Phase 2|Global Deterioration of Health Status|0|||
46763282|NCT00460603|82981458|FG002|Phase 2|Global Deterioration of Health Status|0|||
46763283|NCT00460603|82981459|FG003|Phase 2|Global Deterioration of Health Status|0|||
46763284|NCT00460603|82981460|FG004|Phase 2|Global Deterioration of Health Status|0|||
46763285|NCT00460603|82981461|FG005|Phase 2|Global Deterioration of Health Status|0|||
46763286|NCT00460603|82981462|FG006|Phase 2|Global Deterioration of Health Status|0|||
46763287|NCT00460603|82981463|FG007|Phase 2|Global Deterioration of Health Status|0|||
46763288|NCT00460603|82981464|FG008|Phase 2|Global Deterioration of Health Status|0|||
46827231|NCT00268905|83045538|FG000|Overall Study|Clinical Progression|9|||
46827232|NCT00268905|83045539|FG001|Overall Study|Clinical Progression|4|||
46827233|NCT00268905|83045540|FG002|Overall Study|Clinical Progression|1|||
47058654|NCT01694771|83337879|FG000|Overall Study|Lack of Efficacy|1|||
47058655|NCT01694771|83337880|FG001|Overall Study|Lack of Efficacy|0|||
47058656|NCT01694771|83337879|FG000|Overall Study|Non compliance protocol|7|||
47058657|NCT01694771|83337880|FG001|Overall Study|Non compliance protocol|6|||
46827234|NCT00206518|83045550|FG000|Overall Study|Lack of Efficacy|6|||
46827235|NCT00206518|83045551|FG001|Overall Study|Lack of Efficacy|4|||
46827236|NCT00206518|83045550|FG000|Overall Study|Adverse Event|2|||
46827237|NCT00206518|83045551|FG001|Overall Study|Adverse Event|1|||
46827238|NCT00206518|83045550|FG000|Overall Study|Physician Decision|1|||
46827239|NCT00206518|83045551|FG001|Overall Study|Physician Decision|0|||
46827240|NCT00206518|83045550|FG000|Overall Study|Protocol Violation|1|||
46827241|NCT00206518|83045551|FG001|Overall Study|Protocol Violation|1|||
46827242|NCT00206440|83045559|FG000|Overall Study|Protocol Violation|1|||
46827243|NCT00206440|83045560|FG001|Overall Study|Protocol Violation|2|||
46827244|NCT00206440|83045559|FG000|Overall Study|Adverse Event|4|||
46827245|NCT00206440|83045560|FG001|Overall Study|Adverse Event|2|||
46827246|NCT00268437|83045566|FG000|Overall Study|Ineligible|1|||
46827247|NCT00423488|83045573|FG000|Overall Study|No evidence of study drug intake|2|||
46827248|NCT00423488|83045574|FG001|Overall Study|No evidence of study drug intake|1|||
46827249|NCT00423488|83045573|FG000|Overall Study|No post baseline data|3|||
46827250|NCT00423488|83045574|FG001|Overall Study|No post baseline data|0|||
46827251|NCT00404066|83045580|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
46827252|NCT00404066|83045580|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
46827253|NCT00423332|83045586|FG000|Overall Study|Adverse Event|6|||
46827254|NCT00423332|83045587|FG001|Overall Study|Adverse Event|2|||
46827255|NCT00423332|83045586|FG000|Overall Study|Withdrawal by Subject|1|||
46827256|NCT00423332|83045587|FG001|Overall Study|Withdrawal by Subject|0|||
46827257|NCT00423332|83045586|FG000|Overall Study|Condition under investigation worsened|1|||
46827258|NCT00423332|83045587|FG001|Overall Study|Condition under investigation worsened|1|||
46827259|NCT00423332|83045586|FG000|Overall Study|Progressive at Week 6|0|||
46827260|NCT00423332|83045587|FG001|Overall Study|Progressive at Week 6|1|||
46827261|NCT00423332|83045586|FG000|Overall Study|Unblinded before 12 weeks|1|||
46827262|NCT00423332|83045587|FG001|Overall Study|Unblinded before 12 weeks|3|||
46827263|NCT00413036|83045594|FG000|Overall Study|Adverse Event|44|||
46827264|NCT00413036|83045594|FG000|Overall Study|Lack of Efficacy|129|||
46827265|NCT00413036|83045594|FG000|Overall Study|Withdrawal by Subject|7|||
46827266|NCT00413036|83045594|FG000|Overall Study|Death|9|||
46827267|NCT00413036|83045594|FG000|Overall Study|Other|26|||
46827268|NCT00413036|83045594|FG000|Overall Study|Missing|2|||
46827269|NCT00412958|83045602|FG000|Overall Study|Withdrawal by Subject|3|||
46827270|NCT00412958|83045603|FG001|Overall Study|Withdrawal by Subject|0|||
46827271|NCT00412958|83045604|FG002|Overall Study|Withdrawal by Subject|0|||
46827272|NCT00412958|83045605|FG003|Overall Study|Withdrawal by Subject|1|||
46827273|NCT00412958|83045602|FG000|Overall Study|Adverse Event|0|||
46827274|NCT00412958|83045603|FG001|Overall Study|Adverse Event|1|||
46827275|NCT00412958|83045604|FG002|Overall Study|Adverse Event|0|||
46827276|NCT00412958|83045605|FG003|Overall Study|Adverse Event|0|||
46827277|NCT00412958|83045602|FG000|Overall Study|Lost to Follow-up|0|||
46827278|NCT00412958|83045603|FG001|Overall Study|Lost to Follow-up|1|||
46827279|NCT00412958|83045604|FG002|Overall Study|Lost to Follow-up|0|||
46827280|NCT00412958|83045605|FG003|Overall Study|Lost to Follow-up|0|||
46827281|NCT00412958|83045602|FG000|Overall Study|Death|0|||
46827282|NCT00412958|83045603|FG001|Overall Study|Death|1|||
46827283|NCT00412958|83045604|FG002|Overall Study|Death|0|||
46827284|NCT00412958|83045605|FG003|Overall Study|Death|0|||
46827285|NCT00412958|83045602|FG000|Overall Study|Transport issue|0|||
46827286|NCT00412958|83045603|FG001|Overall Study|Transport issue|1|||
47058658|NCT01694771|83337879|FG000|Overall Study|Lost to Follow-up|2|||
47058659|NCT01694771|83337880|FG001|Overall Study|Lost to Follow-up|3|||
47058660|NCT01694771|83337879|FG000|Overall Study|Consent withdrawn|7|||
47058661|NCT01694771|83337880|FG001|Overall Study|Consent withdrawn|9|||
47058662|NCT01694771|83337879|FG000|Overall Study|Other reasons|5|||
47058663|NCT01694771|83337880|FG001|Overall Study|Other reasons|6|||
47058664|NCT01582061|83337909|FG000|Overall Study|Lack of Efficacy|3|||
47058665|NCT01582061|83337910|FG001|Overall Study|Lack of Efficacy|23|||
47058666|NCT01582061|83337909|FG000|Overall Study|Adverse Event|12|||
46827287|NCT00412958|83045604|FG002|Overall Study|Transport issue|0|||
46827288|NCT00412958|83045605|FG003|Overall Study|Transport issue|0|||
46827289|NCT00423176|83045617|FG000|Overall Study|Adverse Event|4|||
46827290|NCT00423176|83045618|FG001|Overall Study|Adverse Event|6|||
46827291|NCT00423176|83045617|FG000|Overall Study|Treatment Failure|1|||
46827292|NCT00423176|83045618|FG001|Overall Study|Treatment Failure|6|||
46827293|NCT00423176|83045617|FG000|Overall Study|Lost to Follow-up|4|||
46827294|NCT00423176|83045618|FG001|Overall Study|Lost to Follow-up|7|||
46827295|NCT00423176|83045617|FG000|Overall Study|Withdrawal by Subject|4|||
46827296|NCT00423176|83045618|FG001|Overall Study|Withdrawal by Subject|3|||
46827297|NCT00423176|83045617|FG000|Overall Study|Protocol Violation|1|||
46827298|NCT00423176|83045618|FG001|Overall Study|Protocol Violation|3|||
46827299|NCT00423176|83045617|FG000|Overall Study|Did not meet protocol eligibility|2|||
46827300|NCT00423176|83045618|FG001|Overall Study|Did not meet protocol eligibility|4|||
46827301|NCT00412880|83045624|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
46827302|NCT00412880|83045624|FG000|Overall Study|Consent withdrawn|1|||
46827303|NCT00412880|83045624|FG000|Overall Study|Adverse Event|1|||
46827304|NCT00412880|83045624|FG000|Overall Study|Progressive disease|20|||
46827305|NCT00268203|83045628|FG000|Overall Study|Lost to Follow-up|92|||
46827306|NCT00268203|83045628|FG000|Overall Study|Withdrawal by Subject|9|||
46827307|NCT00268203|83045628|FG000|Overall Study|Received Other NHL Therapy|7|||
46827308|NCT00268203|83045628|FG000|Overall Study|Progressive Disease|359|||
46827309|NCT00268203|83045628|FG000|Overall Study|Death|84|||
46827310|NCT00268203|83045628|FG000|Overall Study|Reason Not Specified|34|||
46827311|NCT00268203|83045628|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
46827312|NCT00384930|83045637|FG000|Overall Study|Adverse Event|5|||
46827313|NCT00384930|83045638|FG001|Overall Study|Adverse Event|4|||
46827314|NCT00384930|83045639|FG002|Overall Study|Adverse Event|12|||
46827315|NCT00384930|83045640|FG003|Overall Study|Adverse Event|11|||
46827316|NCT00384930|83045641|FG004|Overall Study|Adverse Event|14|||
46827317|NCT00384930|83045637|FG000|Overall Study|Entry Criteria Not Met|2|||
46827318|NCT00384930|83045638|FG001|Overall Study|Entry Criteria Not Met|6|||
46827319|NCT00384930|83045639|FG002|Overall Study|Entry Criteria Not Met|7|||
46827320|NCT00384930|83045640|FG003|Overall Study|Entry Criteria Not Met|8|||
46827321|NCT00384930|83045641|FG004|Overall Study|Entry Criteria Not Met|4|||
46827322|NCT00384930|83045637|FG000|Overall Study|Lack of Efficacy|1|||
46827323|NCT00384930|83045638|FG001|Overall Study|Lack of Efficacy|1|||
46827324|NCT00384930|83045639|FG002|Overall Study|Lack of Efficacy|2|||
46827325|NCT00384930|83045640|FG003|Overall Study|Lack of Efficacy|1|||
46827326|NCT00384930|83045641|FG004|Overall Study|Lack of Efficacy|2|||
46827327|NCT00384930|83045637|FG000|Overall Study|Lost to Follow-up|5|||
46827328|NCT00384930|83045638|FG001|Overall Study|Lost to Follow-up|3|||
46827329|NCT00384930|83045639|FG002|Overall Study|Lost to Follow-up|0|||
46827330|NCT00384930|83045640|FG003|Overall Study|Lost to Follow-up|4|||
46827331|NCT00384930|83045641|FG004|Overall Study|Lost to Follow-up|6|||
46827332|NCT00384930|83045637|FG000|Overall Study|Physician Decision|0|||
46827333|NCT00384930|83045638|FG001|Overall Study|Physician Decision|1|||
46827334|NCT00384930|83045639|FG002|Overall Study|Physician Decision|1|||
46827335|NCT00384930|83045640|FG003|Overall Study|Physician Decision|0|||
46827336|NCT00384930|83045641|FG004|Overall Study|Physician Decision|1|||
46827337|NCT00384930|83045637|FG000|Overall Study|Protocol Violation|1|||
46827338|NCT00384930|83045638|FG001|Overall Study|Protocol Violation|0|||
46827339|NCT00384930|83045639|FG002|Overall Study|Protocol Violation|1|||
46827340|NCT00384930|83045640|FG003|Overall Study|Protocol Violation|6|||
46827341|NCT00384930|83045641|FG004|Overall Study|Protocol Violation|4|||
46827342|NCT00384930|83045637|FG000|Overall Study|Sponsor Decision|3|||
46827343|NCT00384930|83045638|FG001|Overall Study|Sponsor Decision|4|||
46827344|NCT00384930|83045639|FG002|Overall Study|Sponsor Decision|0|||
46827345|NCT00384930|83045640|FG003|Overall Study|Sponsor Decision|5|||
46827346|NCT00384930|83045641|FG004|Overall Study|Sponsor Decision|0|||
46827347|NCT00384930|83045637|FG000|Overall Study|Withdrawal by Subject|9|||
46827348|NCT00384930|83045638|FG001|Overall Study|Withdrawal by Subject|7|||
46827349|NCT00384930|83045639|FG002|Overall Study|Withdrawal by Subject|7|||
46827350|NCT00384930|83045640|FG003|Overall Study|Withdrawal by Subject|6|||
46827351|NCT00384930|83045641|FG004|Overall Study|Withdrawal by Subject|16|||
46827352|NCT00384930|83045637|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
46827353|NCT00384930|83045638|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
46935242|NCT00704522|83171260|FG000|Overall Study|Undefined causes|9|||
47058667|NCT01582061|83337910|FG001|Overall Study|Adverse Event|8|||
47058668|NCT01582061|83337909|FG000|Overall Study|Withdrawal by Subject|10|||
47058669|NCT01582061|83337910|FG001|Overall Study|Withdrawal by Subject|4|||
46827354|NCT00384930|83045639|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
46827355|NCT00384930|83045640|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
46827356|NCT00384930|83045641|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
46827357|NCT00423098|83045658|FG000|Overall Study|Adverse Event|1|||
46935243|NCT00704522|83171261|FG001|Overall Study|Undefined causes|7|||
46935244|NCT00704522|83171260|FG000|Overall Study|No information on therapy end|27|||
47058670|NCT01582061|83337909|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46827358|NCT00423098|83045659|FG001|Overall Study|Adverse Event|2|||
47058671|NCT01582061|83337910|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46827359|NCT00423098|83045658|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46827360|NCT00423098|83045659|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46827361|NCT00423098|83045658|FG000|Overall Study|Administrative problems|0|||
46827362|NCT00423098|83045659|FG001|Overall Study|Administrative problems|1|||
46827363|NCT00423098|83045658|FG000|Overall Study|Death|2|||
46827364|NCT00423098|83045659|FG001|Overall Study|Death|0|||
46827365|NCT00750698|83045667|FG000|Overall Study|Withdrawal by Subject|1|||
46827366|NCT00750698|83045668|FG001|Overall Study|Withdrawal by Subject|0|||
46827367|NCT00750698|83045667|FG000|Overall Study|Progressive disease|5|||
46827368|NCT00750698|83045668|FG001|Overall Study|Progressive disease|2|||
46827369|NCT00411788|83045674|FG000|Overall Study|Protocol Violation|1|||
46827370|NCT00411788|83045674|FG000|Overall Study|Adverse Event|1|||
46827371|NCT00422942|83045678|FG000|Overall Study|Study terminated by Sponsor|3|||
46827372|NCT00422162|83045684|FG000|Overall Study|Adverse Event|11|||
46827373|NCT00422162|83045685|FG001|Overall Study|Adverse Event|9|||
46827374|NCT00422162|83045684|FG000|Overall Study|Lack of Efficacy|4|||
46827375|NCT00422162|83045685|FG001|Overall Study|Lack of Efficacy|10|||
46827376|NCT00422162|83045684|FG000|Overall Study|Withdrawal by Subject|7|||
46827377|NCT00422162|83045685|FG001|Overall Study|Withdrawal by Subject|6|||
46827378|NCT00422162|83045684|FG000|Overall Study|Lost to Follow-up|1|||
46827379|NCT00422162|83045685|FG001|Overall Study|Lost to Follow-up|2|||
46827380|NCT00422162|83045684|FG000|Overall Study|Non-Compliant with Protocol|1|||
46827381|NCT00422162|83045685|FG001|Overall Study|Non-Compliant with Protocol|1|||
46827382|NCT00422162|83045684|FG000|Overall Study|Other|0|||
46827383|NCT00422162|83045685|FG001|Overall Study|Other|1|||
46827384|NCT00422162|83045684|FG000|Overall Study|Didn't Receive Treatment|0|||
46827385|NCT00422162|83045685|FG001|Overall Study|Didn't Receive Treatment|1|||
46827386|NCT00411632|83045701|FG000|Overall Study|Death|1|||
46827387|NCT00422084|83045707|FG000|Overall Study|Adverse Event|21|||
46827388|NCT00422084|83045708|FG001|Overall Study|Adverse Event|7|||
46827389|NCT00422084|83045707|FG000|Overall Study|Withdrawal by Subject|12|||
46827390|NCT00422084|83045708|FG001|Overall Study|Withdrawal by Subject|9|||
46827391|NCT00422084|83045707|FG000|Overall Study|Lost to Follow-up|14|||
46827392|NCT00422084|83045708|FG001|Overall Study|Lost to Follow-up|9|||
46827393|NCT00422084|83045707|FG000|Overall Study|Protocol Violation|4|||
46827394|NCT00422084|83045708|FG001|Overall Study|Protocol Violation|1|||
46827395|NCT00422084|83045707|FG000|Overall Study|Lack of Efficacy|40|||
46827396|NCT00422084|83045708|FG001|Overall Study|Lack of Efficacy|42|||
46827397|NCT00422084|83045707|FG000|Overall Study|P. vivax infection|3|||
46827398|NCT00422084|83045708|FG001|Overall Study|P. vivax infection|6|||
46827399|NCT00422084|83045707|FG000|Overall Study|Cyesis|1|||
46827400|NCT00422084|83045708|FG001|Overall Study|Cyesis|0|||
46827401|NCT00422084|83045707|FG000|Overall Study|Withdrawn from study accidentally|1|||
46827402|NCT00422084|83045708|FG001|Overall Study|Withdrawn from study accidentally|0|||
46827403|NCT00422084|83045707|FG000|Overall Study|Non-compliance|1|||
46827404|NCT00422084|83045708|FG001|Overall Study|Non-compliance|0|||
46827405|NCT00422084|83045707|FG000|Overall Study|Re-location|0|||
46827406|NCT00422084|83045708|FG001|Overall Study|Re-location|1|||
46827407|NCT00422084|83045707|FG000|Overall Study|Not defined|1|||
46827408|NCT00422084|83045708|FG001|Overall Study|Not defined|1|||
46827409|NCT00421928|83045717|FG000|Overall Study|Adverse Event|61|||
46827410|NCT00421928|83045718|FG001|Overall Study|Adverse Event|140|||
46827411|NCT00421928|83045719|FG002|Overall Study|Adverse Event|22|||
46827412|NCT00421928|83045717|FG000|Overall Study|Lost to Follow-up|5|||
46827413|NCT00421928|83045718|FG001|Overall Study|Lost to Follow-up|0|||
46827414|NCT00421928|83045719|FG002|Overall Study|Lost to Follow-up|3|||
46827415|NCT00421928|83045717|FG000|Overall Study|Withdrawal by Subject|50|||
46827416|NCT00421928|83045718|FG001|Overall Study|Withdrawal by Subject|48|||
46827417|NCT00421928|83045719|FG002|Overall Study|Withdrawal by Subject|43|||
46827418|NCT00421928|83045717|FG000|Overall Study|Lack of Efficacy|15|||
46827419|NCT00421928|83045718|FG001|Overall Study|Lack of Efficacy|7|||
46827420|NCT00421928|83045719|FG002|Overall Study|Lack of Efficacy|35|||
46827421|NCT00421928|83045717|FG000|Overall Study|Study drug non-compliant|6|||
47058672|NCT01582061|83337909|FG000|Overall Study|Death|0|||
47058673|NCT01582061|83337910|FG001|Overall Study|Death|1|||
47058674|NCT01582061|83337909|FG000|Overall Study|condition no longer requires study drug|1|||
46827422|NCT00421928|83045718|FG001|Overall Study|Study drug non-compliant|7|||
46827423|NCT00421928|83045719|FG002|Overall Study|Study drug non-compliant|4|||
46827424|NCT00421928|83045717|FG000|Overall Study|All other|26|||
47058675|NCT01582061|83337910|FG001|Overall Study|condition no longer requires study drug|0|||
46827425|NCT00421928|83045718|FG001|Overall Study|All other|21|||
47058676|NCT01582061|83337909|FG000|Overall Study|Lost to Follow-up|1|||
47058677|NCT01582061|83337910|FG001|Overall Study|Lost to Follow-up|0|||
46827426|NCT00421928|83045719|FG002|Overall Study|All other|27|||
46827427|NCT00421928|83045717|FG000|Overall Study|Death|0|||
46827428|NCT00421928|83045718|FG001|Overall Study|Death|1|||
46827429|NCT00421928|83045719|FG002|Overall Study|Death|0|||
46827430|NCT00383292|83045730|FG000|Overall Study|Adverse Event|4|||
46827431|NCT00383292|83045731|FG001|Overall Study|Adverse Event|1|||
46827432|NCT00383292|83045732|FG002|Overall Study|Adverse Event|2|||
46827433|NCT00383292|83045730|FG000|Overall Study|Death|3|||
46827434|NCT00383292|83045731|FG001|Overall Study|Death|3|||
46827435|NCT00383292|83045732|FG002|Overall Study|Death|3|||
46827436|NCT00383292|83045730|FG000|Overall Study|Physician Decision|4|||
46827437|NCT00383292|83045731|FG001|Overall Study|Physician Decision|0|||
46827438|NCT00383292|83045732|FG002|Overall Study|Physician Decision|1|||
46827439|NCT00383292|83045730|FG000|Overall Study|Withdrawal by Subject|3|||
46827440|NCT00383292|83045731|FG001|Overall Study|Withdrawal by Subject|2|||
46827441|NCT00383292|83045732|FG002|Overall Study|Withdrawal by Subject|2|||
46827442|NCT00383292|83045730|FG000|Overall Study|Other|1|||
46827443|NCT00383292|83045731|FG001|Overall Study|Other|0|||
46827444|NCT00383292|83045732|FG002|Overall Study|Other|0|||
46827445|NCT00372060|83045743|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
46827446|NCT00372060|83045744|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
46827447|NCT00372060|83045743|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
46827448|NCT00372060|83045744|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
46827449|NCT00372060|83045743|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
46827450|NCT00372060|83045744|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
46827451|NCT00372060|83045743|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
46827452|NCT00372060|83045744|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
46827453|NCT00372060|83045743|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
46827454|NCT00372060|83045744|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
46827455|NCT00372060|83045743|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
46827456|NCT00372060|83045744|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
46827457|NCT00421304|83045756|FG000|Overall Study|Lost to Follow-up|5|||
46827458|NCT00421304|83045757|FG001|Overall Study|Lost to Follow-up|2|||
46827459|NCT00421304|83045758|FG002|Overall Study|Lost to Follow-up|5|||
46827460|NCT00421304|83045756|FG000|Overall Study|Withdrawal by Subject|2|||
46827461|NCT00421304|83045757|FG001|Overall Study|Withdrawal by Subject|2|||
46827462|NCT00421304|83045758|FG002|Overall Study|Withdrawal by Subject|2|||
46827463|NCT00421304|83045756|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
46827464|NCT00421304|83045757|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
46827465|NCT00421304|83045758|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
46827466|NCT00421304|83045756|FG000|Overall Study|Did not attend Day 360 visit|0|||
46827467|NCT00421304|83045757|FG001|Overall Study|Did not attend Day 360 visit|0|||
46827468|NCT00421304|83045758|FG002|Overall Study|Did not attend Day 360 visit|1|||
46827469|NCT00396630|83045770|FG000|Overall Study|Lost to Follow-up|1|||
46827470|NCT00396630|83045771|FG001|Overall Study|Lost to Follow-up|1|||
46827471|NCT00396630|83045770|FG000|Overall Study|Withdrawal by Subject|1|||
46827472|NCT00396630|83045771|FG001|Overall Study|Withdrawal by Subject|1|||
46827473|NCT00396630|83045770|FG000|Overall Study|Not vaccinated at Visit 3|3|||
46827474|NCT00396630|83045771|FG001|Overall Study|Not vaccinated at Visit 3|3|||
46827475|NCT00396318|83045778|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
46827476|NCT00396162|83045784|FG000|Overall Study|Withdrawal by Subject|2|||
46827477|NCT00396162|83045785|FG001|Overall Study|Withdrawal by Subject|3|||
46827478|NCT00381888|83045795|FG000|Overall Study|Death|1|||
46827479|NCT00381888|83045795|FG000|Overall Study|Withdrawal by Subject|1|||
46827480|NCT00381888|83045795|FG000|Overall Study|Physician Decision|1|||
46827481|NCT00381888|83045795|FG000|Overall Study|Protocol Violation|9|||
46827482|NCT00381888|83045795|FG000|Overall Study|Had laparoscopic surgery|2|||
46827483|NCT00381888|83045795|FG000|Overall Study|Surgery was cancelled|2|||
46827484|NCT00381888|83045795|FG000|Overall Study|Adverse Event|1|||
46827485|NCT00267969|83045802|FG000|Controlled Period|Adverse Event|6|||
46827486|NCT00267969|83045803|FG001|Controlled Period|Adverse Event|0|||
46827487|NCT00267969|83045804|FG002|Controlled Period|Adverse Event|2|||
46827488|NCT00267969|83045805|FG003|Controlled Period|Adverse Event|0|||
46827489|NCT00267969|83045806|FG004|Controlled Period|Adverse Event|0|||
46827490|NCT00267969|83045807|FG005|Controlled Period|Adverse Event|0|||
46827491|NCT00267969|83045808|FG006|Controlled Period|Adverse Event|0|||
46827492|NCT00267969|83045802|FG000|Controlled Period|Lack of Efficacy|3|||
46827493|NCT00267969|83045803|FG001|Controlled Period|Lack of Efficacy|0|||
46827494|NCT00267969|83045804|FG002|Controlled Period|Lack of Efficacy|1|||
46827495|NCT00267969|83045805|FG003|Controlled Period|Lack of Efficacy|0|||
46827496|NCT00267969|83045806|FG004|Controlled Period|Lack of Efficacy|0|||
46827497|NCT00267969|83045807|FG005|Controlled Period|Lack of Efficacy|0|||
46827498|NCT00267969|83045808|FG006|Controlled Period|Lack of Efficacy|0|||
46827499|NCT00267969|83045802|FG000|Controlled Period|Lost to Follow-up|1|||
46827500|NCT00267969|83045803|FG001|Controlled Period|Lost to Follow-up|0|||
46827501|NCT00267969|83045804|FG002|Controlled Period|Lost to Follow-up|1|||
46935245|NCT00704522|83171261|FG001|Overall Study|No information on therapy end|2|||
46935246|NCT02723630|83171276|FG000|Intervention Period 1|Adverse Event|1|||
46935247|NCT02723630|83171277|FG001|Intervention Period 1|Adverse Event|0|||
46935248|NCT02723630|83171278|FG002|Intervention Period 1|Adverse Event|0|||
46827502|NCT00267969|83045805|FG003|Controlled Period|Lost to Follow-up|0|||
46827503|NCT00267969|83045806|FG004|Controlled Period|Lost to Follow-up|0|||
46827504|NCT00267969|83045807|FG005|Controlled Period|Lost to Follow-up|0|||
46827505|NCT00267969|83045808|FG006|Controlled Period|Lost to Follow-up|0|||
46827506|NCT00267969|83045802|FG000|Controlled Period|Randomized but not treated|0|||
46935249|NCT02723630|83171279|FG003|Intervention Period 1|Adverse Event|0|||
46827507|NCT00267969|83045803|FG001|Controlled Period|Randomized but not treated|0|||
46827508|NCT00267969|83045804|FG002|Controlled Period|Randomized but not treated|1|||
46935250|NCT02723630|83171280|FG004|Intervention Period 1|Adverse Event|0|||
46827509|NCT00267969|83045805|FG003|Controlled Period|Randomized but not treated|0|||
46935251|NCT02723630|83171281|FG005|Intervention Period 1|Adverse Event|0|||
46935252|NCT02723630|83171276|FG000|Intervention Period 3|consumption of restricted item|0|||
47058678|NCT01693523|83337929|FG000|Overall Study|Adverse Event|2|||
47058679|NCT01693523|83337930|FG001|Overall Study|Adverse Event|1|||
46935253|NCT02723630|83171277|FG001|Intervention Period 3|consumption of restricted item|1|||
46935254|NCT02723630|83171278|FG002|Intervention Period 3|consumption of restricted item|0|||
46935255|NCT02723630|83171279|FG003|Intervention Period 3|consumption of restricted item|0|||
47058680|NCT01693523|83337931|FG002|Overall Study|Adverse Event|0|||
47058681|NCT01693523|83337929|FG000|Overall Study|Death|0|||
47058682|NCT01693523|83337930|FG001|Overall Study|Death|1|||
47058683|NCT01693523|83337931|FG002|Overall Study|Death|1|||
47058684|NCT01693523|83337929|FG000|Overall Study|Lost to Follow-up|0|||
47058685|NCT01693523|83337930|FG001|Overall Study|Lost to Follow-up|0|||
47058686|NCT01693523|83337931|FG002|Overall Study|Lost to Follow-up|4|||
47058687|NCT01693523|83337929|FG000|Overall Study|Physician Decision|0|||
47058688|NCT01693523|83337930|FG001|Overall Study|Physician Decision|0|||
47058689|NCT01693523|83337931|FG002|Overall Study|Physician Decision|1|||
47058690|NCT01693523|83337929|FG000|Overall Study|Withdrawal by Subject|1|||
47058691|NCT01693523|83337930|FG001|Overall Study|Withdrawal by Subject|2|||
47058692|NCT01693523|83337931|FG002|Overall Study|Withdrawal by Subject|2|||
47058693|NCT01693523|83337929|FG000|Overall Study|Lack of compliance study medication|1|||
47058694|NCT01693523|83337930|FG001|Overall Study|Lack of compliance study medication|2|||
47058695|NCT01693523|83337931|FG002|Overall Study|Lack of compliance study medication|0|||
47058696|NCT01693523|83337929|FG000|Overall Study|Chemotherapy was held|1|||
47058697|NCT01693523|83337930|FG001|Overall Study|Chemotherapy was held|2|||
47058698|NCT01693523|83337931|FG002|Overall Study|Chemotherapy was held|0|||
47058699|NCT01581593|83337947|FG000|Overall Study|Withdrawal by Subject|1|||
47058700|NCT01581281|83337958|FG000|Overall Study|Early Study Closure|15|||
47058701|NCT01581281|83337959|FG001|Overall Study|Early Study Closure|6|||
47058702|NCT01581281|83337960|FG002|Overall Study|Early Study Closure|12|||
47058703|NCT02692716|83337971|FG000|Overall Study|Lost to Follow-up|2|||
47058704|NCT02692716|83337972|FG001|Overall Study|Lost to Follow-up|5|||
47058705|NCT02692716|83337971|FG000|Overall Study|Withdrawal by Subject|3|||
47058706|NCT02692716|83337972|FG001|Overall Study|Withdrawal by Subject|1|||
47058707|NCT01580969|83337981|FG000|Overall Study|Physician Decision|3|||
47058708|NCT01580969|83337982|FG001|Overall Study|Physician Decision|0|||
47058709|NCT01580969|83337983|FG002|Overall Study|Physician Decision|0|||
47058710|NCT01693367|83337993|FG000|Overall Study|Withdrawal by Subject|1|||
47058711|NCT01693367|83337994|FG001|Overall Study|Withdrawal by Subject|1|||
47058712|NCT01693367|83337993|FG000|Overall Study|Physician Decision|0|||
47058713|NCT01693367|83337994|FG001|Overall Study|Physician Decision|1|||
47058714|NCT02696226|83338004|FG000|Overall Study|Study terminated - lack of enrollment|1|||
47058715|NCT02696226|83338005|FG001|Overall Study|Study terminated - lack of enrollment|0|||
47058716|NCT02696226|83338006|FG002|Overall Study|Study terminated - lack of enrollment|2|||
47058717|NCT02696226|83338007|FG003|Overall Study|Study terminated - lack of enrollment|0|||
47058718|NCT01692275|83338023|FG000|Overall Study|Lost to Follow-up|57|||
47058719|NCT01692275|83338024|FG001|Overall Study|Lost to Follow-up|48|||
47058720|NCT01692275|83338023|FG000|Overall Study|Withdrawal by Subject|9|||
47058721|NCT01692275|83338024|FG001|Overall Study|Withdrawal by Subject|11|||
47058722|NCT02692560|83338044|FG000|Overall Study|Withdrawal by Subject|0|||
47058723|NCT02692560|83338045|FG001|Overall Study|Withdrawal by Subject|6|||
47058724|NCT02688192|83338053|FG000|Overall Study|Lost to Follow-up|11|||
47058725|NCT02688192|83338054|FG001|Overall Study|Lost to Follow-up|5|||
47058726|NCT02688192|83338053|FG000|Overall Study|Physician Decision|1|||
47058727|NCT02688192|83338054|FG001|Overall Study|Physician Decision|0|||
47058728|NCT01579565|83338063|FG000|Randomized|Adverse Event|1|||
47058729|NCT01579565|83338064|FG001|Randomized|Adverse Event|3|||
47058730|NCT01579565|83338063|FG000|Randomized|Withdrawal by Subject|3|||
47058731|NCT01579565|83338064|FG001|Randomized|Withdrawal by Subject|0|||
46935256|NCT02723630|83171280|FG004|Intervention Period 3|consumption of restricted item|0|||
46935257|NCT02723630|83171281|FG005|Intervention Period 3|consumption of restricted item|0|||
46935258|NCT04089735|83171324|FG000|Overall Study|Adverse Event|1|||
46935259|NCT04089735|83171325|FG001|Overall Study|Adverse Event|0|||
46935260|NCT04089735|83171326|FG002|Overall Study|Adverse Event|1|||
46935261|NCT04089735|83171327|FG003|Overall Study|Adverse Event|1|||
46935262|NCT04089735|83171328|FG004|Overall Study|Adverse Event|0|||
46935263|NCT04089735|83171329|FG005|Overall Study|Adverse Event|0|||
46935264|NCT04089735|83171324|FG000|Overall Study|Physician Decision|0|||
47058732|NCT01579565|83338063|FG000|Randomized|inadequate preoperative pupil dilation|0|||
47058733|NCT01579565|83338064|FG001|Randomized|inadequate preoperative pupil dilation|1|||
47058734|NCT01579565|83338063|FG000|Randomized|prohibited preoperative eating|1|||
47058735|NCT01579565|83338064|FG001|Randomized|prohibited preoperative eating|0|||
47058736|NCT01579565|83338063|FG000|Randomized|prohibited preoperative medication|0|||
47058737|NCT01579565|83338064|FG001|Randomized|prohibited preoperative medication|1|||
47058738|NCT01579565|83338063|FG000|Treated|Physician Decision|0|||
47058739|NCT01579565|83338064|FG001|Treated|Physician Decision|1|||
47058740|NCT01579565|83338063|FG000|Treated|Lost to Follow-up|2|||
46935265|NCT04089735|83171325|FG001|Overall Study|Physician Decision|3|||
46935266|NCT04089735|83171326|FG002|Overall Study|Physician Decision|0|||
46935267|NCT04089735|83171327|FG003|Overall Study|Physician Decision|0|||
46935268|NCT04089735|83171328|FG004|Overall Study|Physician Decision|0|||
47058741|NCT01579565|83338064|FG001|Treated|Lost to Follow-up|1|||
47058742|NCT01579565|83338063|FG000|Treated|declined to return for final visit|0|||
46935269|NCT04089735|83171329|FG005|Overall Study|Physician Decision|0|||
46935270|NCT04089735|83171324|FG000|Overall Study|Withdrawal by Subject|0|||
46935271|NCT04089735|83171325|FG001|Overall Study|Withdrawal by Subject|0|||
46935272|NCT04089735|83171326|FG002|Overall Study|Withdrawal by Subject|1|||
46935273|NCT04089735|83171327|FG003|Overall Study|Withdrawal by Subject|0|||
46935274|NCT04089735|83171328|FG004|Overall Study|Withdrawal by Subject|0|||
46935275|NCT04089735|83171329|FG005|Overall Study|Withdrawal by Subject|0|||
46935276|NCT04089735|83171324|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
46935277|NCT04089735|83171325|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
46935278|NCT04089735|83171326|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
46935279|NCT04089735|83171327|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
46935280|NCT04089735|83171328|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
46935281|NCT04089735|83171329|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
46935282|NCT01876784|83171345|FG000|Overall Study|Withdrawal by Subject|17|||
47058743|NCT01579565|83338064|FG001|Treated|declined to return for final visit|1|||
47058744|NCT01578785|83338074|FG000|Overall Study|Withdrawal by Subject|0|||
47058745|NCT01578785|83338075|FG001|Overall Study|Withdrawal by Subject|1|||
47058746|NCT01578785|83338074|FG000|Overall Study|Study terminated by sponsor|59|||
47058747|NCT01578785|83338075|FG001|Overall Study|Study terminated by sponsor|118|||
47058748|NCT02692482|83338083|FG000|Overall Study|Death|2|||
47058749|NCT02692482|83338084|FG001|Overall Study|Death|2|||
47058750|NCT02692482|83338083|FG000|Overall Study|Withdrawal by Subject|1|||
47058751|NCT02692482|83338084|FG001|Overall Study|Withdrawal by Subject|2|||
47058752|NCT01578551|83338093|FG000|Overall Study|Adverse Event|1|||
47058753|NCT01578551|83338094|FG001|Overall Study|Adverse Event|0|||
47058754|NCT01692197|83338101|FG000|Overall Study|Failed Screening|3|||
47058755|NCT01692119|83338108|FG000|Overall Study|Protocol Violation|3|||
47058756|NCT01692119|83338109|FG001|Overall Study|Protocol Violation|1|||
47058757|NCT01692119|83338108|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
47058758|NCT01692119|83338109|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
47058759|NCT01691885|83338115|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
47058760|NCT01691885|83338116|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
47058761|NCT01691885|83338115|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
47058762|NCT01691885|83338116|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
46935283|NCT01876784|83171346|FG001|Overall Study|Withdrawal by Subject|2|||
46935284|NCT01876784|83171345|FG000|Overall Study|Adverse Event|15|||
47058763|NCT01587703|83338149|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
47058764|NCT01587703|83338150|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058765|NCT01587703|83338151|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058766|NCT01587703|83338152|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
46763289|NCT00460603|82981465|FG009|Phase 2|Global Deterioration of Health Status|0|||
46763290|NCT00460603|82981466|FG010|Phase 2|Global Deterioration of Health Status|1|||
46763291|NCT00460603|82981467|FG011|Phase 2|Global Deterioration of Health Status|0|||
46763292|NCT00460603|82981456|FG000|Phase 2|Withdrawal by Subject|0|||
46763293|NCT00460603|82981457|FG001|Phase 2|Withdrawal by Subject|0|||
46763294|NCT00460603|82981458|FG002|Phase 2|Withdrawal by Subject|0|||
46763295|NCT00460603|82981459|FG003|Phase 2|Withdrawal by Subject|0|||
46763296|NCT00460603|82981460|FG004|Phase 2|Withdrawal by Subject|0|||
46763297|NCT00460603|82981461|FG005|Phase 2|Withdrawal by Subject|0|||
46763298|NCT00460603|82981462|FG006|Phase 2|Withdrawal by Subject|0|||
46763299|NCT00460603|82981463|FG007|Phase 2|Withdrawal by Subject|0|||
46763300|NCT00460603|82981464|FG008|Phase 2|Withdrawal by Subject|0|||
46763301|NCT00460603|82981465|FG009|Phase 2|Withdrawal by Subject|5|||
46763302|NCT00460603|82981466|FG010|Phase 2|Withdrawal by Subject|4|||
46763303|NCT00460603|82981467|FG011|Phase 2|Withdrawal by Subject|5|||
46763304|NCT00460603|82981456|FG000|Phase 2|Randomized, but not treated|0|||
46763305|NCT00460603|82981457|FG001|Phase 2|Randomized, but not treated|0|||
46763306|NCT00460603|82981458|FG002|Phase 2|Randomized, but not treated|0|||
46763307|NCT00460603|82981459|FG003|Phase 2|Randomized, but not treated|0|||
46763308|NCT00460603|82981460|FG004|Phase 2|Randomized, but not treated|0|||
46763309|NCT00460603|82981461|FG005|Phase 2|Randomized, but not treated|0|||
46935285|NCT01876784|83171346|FG001|Overall Study|Adverse Event|2|||
46827510|NCT00267969|83045806|FG004|Controlled Period|Randomized but not treated|0|||
46827511|NCT00267969|83045807|FG005|Controlled Period|Randomized but not treated|0|||
46827512|NCT00267969|83045808|FG006|Controlled Period|Randomized but not treated|0|||
46827513|NCT00267969|83045802|FG000|Controlled Period|Other|2|||
46827514|NCT00267969|83045803|FG001|Controlled Period|Other|1|||
46827515|NCT00267969|83045804|FG002|Controlled Period|Other|6|||
46827516|NCT00267969|83045805|FG003|Controlled Period|Other|0|||
46827517|NCT00267969|83045806|FG004|Controlled Period|Other|0|||
46827518|NCT00267969|83045807|FG005|Controlled Period|Other|0|||
46827519|NCT00267969|83045808|FG006|Controlled Period|Other|0|||
46827520|NCT00267969|83045802|FG000|After Controlled Period|Adverse Event|0|||
46827521|NCT00267969|83045803|FG001|After Controlled Period|Adverse Event|0|||
46827522|NCT00267969|83045804|FG002|After Controlled Period|Adverse Event|0|||
46827523|NCT00267969|83045805|FG003|After Controlled Period|Adverse Event|7|||
46827524|NCT00267969|83045806|FG004|After Controlled Period|Adverse Event|8|||
46827525|NCT00267969|83045807|FG005|After Controlled Period|Adverse Event|23|||
46827526|NCT00267969|83045808|FG006|After Controlled Period|Adverse Event|21|||
46827527|NCT00267969|83045802|FG000|After Controlled Period|Death|0|||
46827528|NCT00267969|83045803|FG001|After Controlled Period|Death|0|||
46827529|NCT00267969|83045804|FG002|After Controlled Period|Death|0|||
46827530|NCT00267969|83045805|FG003|After Controlled Period|Death|1|||
46827531|NCT00267969|83045806|FG004|After Controlled Period|Death|2|||
46827532|NCT00267969|83045807|FG005|After Controlled Period|Death|0|||
46827533|NCT00267969|83045808|FG006|After Controlled Period|Death|1|||
46827534|NCT00267969|83045802|FG000|After Controlled Period|Lack of Efficacy|0|||
46827535|NCT00267969|83045803|FG001|After Controlled Period|Lack of Efficacy|0|||
46827536|NCT00267969|83045804|FG002|After Controlled Period|Lack of Efficacy|0|||
46827537|NCT00267969|83045805|FG003|After Controlled Period|Lack of Efficacy|10|||
46827538|NCT00267969|83045806|FG004|After Controlled Period|Lack of Efficacy|6|||
46827539|NCT00267969|83045807|FG005|After Controlled Period|Lack of Efficacy|28|||
47058767|NCT01587703|83338153|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058768|NCT01587703|83338154|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
46827540|NCT00267969|83045808|FG006|After Controlled Period|Lack of Efficacy|15|||
46827541|NCT00267969|83045802|FG000|After Controlled Period|Lost to Follow-up|0|||
46827542|NCT00267969|83045803|FG001|After Controlled Period|Lost to Follow-up|0|||
46827543|NCT00267969|83045804|FG002|After Controlled Period|Lost to Follow-up|0|||
46827544|NCT00267969|83045805|FG003|After Controlled Period|Lost to Follow-up|5|||
46827545|NCT00267969|83045806|FG004|After Controlled Period|Lost to Follow-up|8|||
46827546|NCT00267969|83045807|FG005|After Controlled Period|Lost to Follow-up|9|||
46827547|NCT00267969|83045808|FG006|After Controlled Period|Lost to Follow-up|10|||
46827548|NCT00267969|83045802|FG000|After Controlled Period|Other|0|||
46827549|NCT00267969|83045803|FG001|After Controlled Period|Other|0|||
47058769|NCT01587703|83338155|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058770|NCT01587703|83338156|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058771|NCT01587703|83338157|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058772|NCT01587703|83338158|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058773|NCT01587703|83338159|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058774|NCT01587703|83338160|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058775|NCT01587703|83338161|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058776|NCT01587703|83338162|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058777|NCT01587703|83338163|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
46763310|NCT00460603|82981462|FG006|Phase 2|Randomized, but not treated|0|||
46763311|NCT00460603|82981463|FG007|Phase 2|Randomized, but not treated|0|||
46763312|NCT00460603|82981464|FG008|Phase 2|Randomized, but not treated|0|||
46763313|NCT00460603|82981465|FG009|Phase 2|Randomized, but not treated|3|||
46763314|NCT00460603|82981466|FG010|Phase 2|Randomized, but not treated|0|||
46763315|NCT00460603|82981467|FG011|Phase 2|Randomized, but not treated|0|||
46763316|NCT00662038|82981493|FG000|Overall Study|Reason not specified|3|||
46763317|NCT00662038|82981493|FG000|Overall Study|Withdrawn consent|22|||
46763318|NCT00662038|82981493|FG000|Overall Study|Withdrawal by Subject|83|||
46763319|NCT00662038|82981493|FG000|Overall Study|Sponsor decision|1|||
46827550|NCT00267969|83045804|FG002|After Controlled Period|Other|0|||
46827551|NCT00267969|83045805|FG003|After Controlled Period|Other|13|||
46827552|NCT00267969|83045806|FG004|After Controlled Period|Other|11|||
46827553|NCT00267969|83045807|FG005|After Controlled Period|Other|22|||
46827554|NCT00267969|83045808|FG006|After Controlled Period|Other|25|||
46827555|NCT00280293|83045828|FG000|Overall Study|Protocol Violation|3|||
46827556|NCT00280293|83045829|FG001|Overall Study|Protocol Violation|0|||
46827557|NCT00280293|83045828|FG000|Overall Study|Physician Decision|5|||
46827558|NCT00280293|83045829|FG001|Overall Study|Physician Decision|4|||
46827559|NCT00280293|83045828|FG000|Overall Study|Lost to Follow-up|14|||
46827560|NCT00280293|83045829|FG001|Overall Study|Lost to Follow-up|12|||
46827561|NCT00280293|83045828|FG000|Overall Study|Withdrawal by Subject|3|||
46827562|NCT00280293|83045829|FG001|Overall Study|Withdrawal by Subject|5|||
46763320|NCT00662038|82981493|FG000|Overall Study|Physician Decision|19|||
47058778|NCT01587703|83338164|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058779|NCT01587703|83338165|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058780|NCT01587703|83338166|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
47058781|NCT01587703|83338167|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
46827563|NCT00280293|83045828|FG000|Overall Study|Incarceration/Legal Reasons|1|||
46827564|NCT00280293|83045829|FG001|Overall Study|Incarceration/Legal Reasons|1|||
46827565|NCT00280293|83045828|FG000|Overall Study|Adverse Event|0|||
46827566|NCT00280293|83045829|FG001|Overall Study|Adverse Event|1|||
46827567|NCT00421148|83045855|FG000|Overall Study|Lost to Follow-up|0|||
46827568|NCT00421148|83045856|FG001|Overall Study|Lost to Follow-up|0|||
46827569|NCT00421148|83045857|FG002|Overall Study|Lost to Follow-up|0|||
46827570|NCT00421148|83045858|FG003|Overall Study|Lost to Follow-up|0|||
46827571|NCT00421148|83045859|FG004|Overall Study|Lost to Follow-up|0|||
46827572|NCT00421148|83045860|FG005|Overall Study|Lost to Follow-up|0|||
46827573|NCT00421148|83045861|FG006|Overall Study|Lost to Follow-up|0|||
46827574|NCT00421148|83045862|FG007|Overall Study|Lost to Follow-up|0|||
46827575|NCT00421148|83045863|FG008|Overall Study|Lost to Follow-up|0|||
46827576|NCT00421148|83045864|FG009|Overall Study|Lost to Follow-up|0|||
46827577|NCT00421148|83045865|FG010|Overall Study|Lost to Follow-up|0|||
46827578|NCT00421148|83045866|FG011|Overall Study|Lost to Follow-up|0|||
46827579|NCT00421148|83045867|FG012|Overall Study|Lost to Follow-up|0|||
47058782|NCT01587703|83338149|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
46827580|NCT00421148|83045868|FG013|Overall Study|Lost to Follow-up|0|||
46827581|NCT00421148|83045869|FG014|Overall Study|Lost to Follow-up|0|||
46827582|NCT00421148|83045870|FG015|Overall Study|Lost to Follow-up|0|||
46827583|NCT00421148|83045871|FG016|Overall Study|Lost to Follow-up|0|||
46827584|NCT00421148|83045872|FG017|Overall Study|Lost to Follow-up|1|||
46827585|NCT00421148|83045873|FG018|Overall Study|Lost to Follow-up|0|||
46827586|NCT00421148|83045874|FG019|Overall Study|Lost to Follow-up|0|||
46827587|NCT00421148|83045855|FG000|Overall Study|Withdrawal by Subject|0|||
46827588|NCT00421148|83045856|FG001|Overall Study|Withdrawal by Subject|0|||
46827589|NCT00421148|83045857|FG002|Overall Study|Withdrawal by Subject|0|||
46827590|NCT00421148|83045858|FG003|Overall Study|Withdrawal by Subject|0|||
46827591|NCT00421148|83045859|FG004|Overall Study|Withdrawal by Subject|0|||
46827592|NCT00421148|83045860|FG005|Overall Study|Withdrawal by Subject|0|||
46827593|NCT00421148|83045861|FG006|Overall Study|Withdrawal by Subject|0|||
46827594|NCT00421148|83045862|FG007|Overall Study|Withdrawal by Subject|0|||
46827595|NCT00421148|83045863|FG008|Overall Study|Withdrawal by Subject|0|||
46827596|NCT00421148|83045864|FG009|Overall Study|Withdrawal by Subject|0|||
46827597|NCT00421148|83045865|FG010|Overall Study|Withdrawal by Subject|0|||
46827598|NCT00421148|83045866|FG011|Overall Study|Withdrawal by Subject|0|||
46827599|NCT00421148|83045867|FG012|Overall Study|Withdrawal by Subject|0|||
46827600|NCT00421148|83045868|FG013|Overall Study|Withdrawal by Subject|0|||
46827601|NCT00421148|83045869|FG014|Overall Study|Withdrawal by Subject|0|||
46827602|NCT00421148|83045870|FG015|Overall Study|Withdrawal by Subject|0|||
46827603|NCT00421148|83045871|FG016|Overall Study|Withdrawal by Subject|0|||
46827604|NCT00421148|83045872|FG017|Overall Study|Withdrawal by Subject|1|||
46827605|NCT00421148|83045873|FG018|Overall Study|Withdrawal by Subject|0|||
47058783|NCT01587703|83338150|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058784|NCT01587703|83338151|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
46827606|NCT00421148|83045874|FG019|Overall Study|Withdrawal by Subject|0|||
47058785|NCT01587703|83338152|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058786|NCT01587703|83338153|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058787|NCT01587703|83338154|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
47058788|NCT01587703|83338155|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058789|NCT01587703|83338156|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
47058790|NCT01587703|83338157|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058791|NCT01587703|83338158|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058792|NCT01587703|83338159|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058793|NCT01587703|83338160|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
46827607|NCT00421148|83045855|FG000|Overall Study|Protocol Violation|0|||
46827608|NCT00421148|83045856|FG001|Overall Study|Protocol Violation|0|||
46827609|NCT00421148|83045857|FG002|Overall Study|Protocol Violation|0|||
46827610|NCT00421148|83045858|FG003|Overall Study|Protocol Violation|0|||
46827611|NCT00421148|83045859|FG004|Overall Study|Protocol Violation|0|||
46827612|NCT00421148|83045860|FG005|Overall Study|Protocol Violation|1|||
46827613|NCT00421148|83045861|FG006|Overall Study|Protocol Violation|0|||
46827614|NCT00421148|83045862|FG007|Overall Study|Protocol Violation|0|||
46827615|NCT00421148|83045863|FG008|Overall Study|Protocol Violation|0|||
46827616|NCT00421148|83045864|FG009|Overall Study|Protocol Violation|0|||
46827617|NCT00421148|83045865|FG010|Overall Study|Protocol Violation|0|||
47058794|NCT01587703|83338161|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058795|NCT01587703|83338162|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058796|NCT01587703|83338163|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058797|NCT01587703|83338164|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058798|NCT01587703|83338165|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058799|NCT01587703|83338166|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058800|NCT01587703|83338167|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
47058801|NCT01587703|83338149|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058802|NCT01587703|83338150|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058803|NCT01587703|83338151|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058804|NCT01587703|83338152|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058805|NCT01587703|83338153|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058806|NCT01587703|83338154|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058807|NCT01587703|83338155|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
47058808|NCT01587703|83338156|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058809|NCT01587703|83338157|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058810|NCT01587703|83338158|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058811|NCT01587703|83338159|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058812|NCT01587703|83338160|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058813|NCT01587703|83338161|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058814|NCT01587703|83338162|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058815|NCT01587703|83338163|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058816|NCT01587703|83338164|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058817|NCT01587703|83338165|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058818|NCT01587703|83338166|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058819|NCT01587703|83338167|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
47058820|NCT01587703|83338149|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
47058821|NCT01587703|83338150|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
47058822|NCT01587703|83338151|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
47058823|NCT01587703|83338152|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
47058824|NCT01587703|83338153|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
47058825|NCT01587703|83338154|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
47058826|NCT01587703|83338155|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
47058827|NCT01587703|83338156|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
47058828|NCT01587703|83338157|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058829|NCT01587703|83338158|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058830|NCT01587703|83338159|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058831|NCT01587703|83338160|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058832|NCT01587703|83338161|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058833|NCT01587703|83338162|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
46827618|NCT00421148|83045866|FG011|Overall Study|Protocol Violation|0|||
46827619|NCT00421148|83045867|FG012|Overall Study|Protocol Violation|0|||
46827620|NCT00421148|83045868|FG013|Overall Study|Protocol Violation|0|||
46827621|NCT00421148|83045869|FG014|Overall Study|Protocol Violation|0|||
47058834|NCT01587703|83338163|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058835|NCT01587703|83338164|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058836|NCT01587703|83338165|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058837|NCT01587703|83338166|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058838|NCT01587703|83338167|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
47058839|NCT01587703|83338149|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058840|NCT01587703|83338150|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058841|NCT01587703|83338151|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058842|NCT01587703|83338152|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058843|NCT01587703|83338153|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058844|NCT01587703|83338154|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058845|NCT01587703|83338155|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058846|NCT01587703|83338156|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058847|NCT01587703|83338157|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
46827622|NCT00421148|83045870|FG015|Overall Study|Protocol Violation|0|||
46935286|NCT01876784|83171345|FG000|Overall Study|Protocol Violation|1|||
46935287|NCT01876784|83171346|FG001|Overall Study|Protocol Violation|0|||
46935288|NCT01876784|83171345|FG000|Overall Study|Disease progression|37|||
47058848|NCT01587703|83338158|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
47058849|NCT01587703|83338159|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
46827623|NCT00421148|83045871|FG016|Overall Study|Protocol Violation|0|||
47058850|NCT01587703|83338160|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
46827624|NCT00421148|83045872|FG017|Overall Study|Protocol Violation|0|||
46827625|NCT00421148|83045873|FG018|Overall Study|Protocol Violation|1|||
46935289|NCT01876784|83171346|FG001|Overall Study|Disease progression|67|||
47058851|NCT01587703|83338161|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
46763321|NCT00662038|82981493|FG000|Overall Study|Lung transplantation|44|||
46763322|NCT00662038|82981493|FG000|Overall Study|Lost to Follow-up|1|||
46763323|NCT00662038|82981493|FG000|Overall Study|Death|95|||
46827626|NCT00421148|83045874|FG019|Overall Study|Protocol Violation|0|||
46827627|NCT00403754|83045916|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
46827628|NCT00403754|83045917|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
46827629|NCT00403754|83045918|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
46827630|NCT00403754|83045919|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
46827631|NCT00403754|83045916|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
46763324|NCT00662038|82981493|FG000|Overall Study|Adverse Event|358|||
46763325|NCT00662038|82981493|FG000|Overall Study|Continued treatment|5|||
46763326|NCT00459979|82981497|FG000|Overall Study|Withdrawal by Subject|1|||
46763327|NCT00459979|82981497|FG000|Overall Study|Protocol Violation|1|||
46763328|NCT00851786|82981503|FG000|Overall Study|Withdrawal by Subject|0|||
46763329|NCT00851786|82981504|FG001|Overall Study|Withdrawal by Subject|1|||
46763330|NCT00851786|82981503|FG000|Overall Study|Protocol Violation|0|||
46763331|NCT00851786|82981504|FG001|Overall Study|Protocol Violation|1|||
46763332|NCT00851786|82981503|FG000|Overall Study|Lost to Follow-up|1|||
46763333|NCT00851786|82981504|FG001|Overall Study|Lost to Follow-up|0|||
46763334|NCT00851786|82981503|FG000|Overall Study|Incarceration|1|||
46763335|NCT00851786|82981504|FG001|Overall Study|Incarceration|0|||
46763336|NCT00851786|82981503|FG000|Overall Study|Site Closure|1|||
46763337|NCT00851786|82981504|FG001|Overall Study|Site Closure|0|||
46827632|NCT00403754|83045917|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
46827633|NCT00403754|83045918|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
46827634|NCT00403754|83045919|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
46827635|NCT00280059|83045933|FG000|Efficacy Assessment Phase|Death|2|||
46827636|NCT00280059|83045934|FG001|Efficacy Assessment Phase|Death|0|||
46827637|NCT00280059|83045933|FG000|Efficacy Assessment Phase|Adverse Event|33|||
46935290|NCT01876784|83171345|FG000|Overall Study|Lost to Follow-up|0|||
46935291|NCT01876784|83171346|FG001|Overall Study|Lost to Follow-up|1|||
46935292|NCT01876784|83171345|FG000|Overall Study|Death|1|||
46935293|NCT01876784|83171346|FG001|Overall Study|Death|0|||
46935294|NCT01876784|83171345|FG000|Overall Study|Randomized but not treated|2|||
46827638|NCT00280059|83045934|FG001|Efficacy Assessment Phase|Adverse Event|31|||
46827639|NCT00280059|83045933|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
46827640|NCT00280059|83045934|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
46827641|NCT00280059|83045933|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
46935295|NCT01876784|83171346|FG001|Overall Study|Randomized but not treated|1|||
46827642|NCT00280059|83045934|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
46827643|NCT00280059|83045933|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
46827644|NCT00280059|83045934|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
46827645|NCT00280059|83045933|FG000|Efficacy Assessment Phase|Other|7|||
46827646|NCT00280059|83045934|FG001|Efficacy Assessment Phase|Other|8|||
46827647|NCT00280059|83045933|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
46827648|NCT00280059|83045934|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
46935296|NCT01876784|83171345|FG000|Overall Study|Other than specified above|5|||
46935297|NCT01876784|83171346|FG001|Overall Study|Other than specified above|6|||
46935298|NCT01876784|83171345|FG000|Overall Study|Ongoing|41|||
46935299|NCT01876784|83171346|FG001|Overall Study|Ongoing|40|||
46935300|NCT04205162|83171354|FG000|Overall Study|Lost to Follow-up|1|||
46935301|NCT04205162|83171355|FG001|Overall Study|Lost to Follow-up|0|||
46935302|NCT04205162|83171354|FG000|Overall Study|Withdrawal by Subject|2|||
46935303|NCT04205162|83171355|FG001|Overall Study|Withdrawal by Subject|0|||
46935304|NCT04205162|83171354|FG000|Overall Study|University closure due to COVID-19|1|||
46935305|NCT04205162|83171355|FG001|Overall Study|University closure due to COVID-19|0|||
46935306|NCT01329939|83171380|FG000|Overall Study|Lost to Follow-up|3|||
46827649|NCT00403130|83045948|FG000|2 Years From Start of Treatment|Not Eligible|3|||
46827650|NCT00403130|83045948|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
46827651|NCT00403130|83045948|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
46935307|NCT01329939|83171381|FG001|Overall Study|Lost to Follow-up|0|||
47058852|NCT01587703|83338162|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058853|NCT01587703|83338163|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
46763338|NCT00851786|82981503|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
46763339|NCT00851786|82981504|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
46763340|NCT00665626|82981512|FG000|Overall Study|Lack of Efficacy|8|||
46827652|NCT00403130|83045948|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
46763341|NCT00665626|82981513|FG001|Overall Study|Lack of Efficacy|5|||
46827653|NCT00402740|83045952|FG000|Overall Study|Withdrawal by Subject|18|||
46827654|NCT00402740|83045952|FG000|Overall Study|Death|50|||
46827655|NCT00402740|83045952|FG000|Overall Study|Lost to Follow-up|6|||
46935308|NCT01329939|83171382|FG002|Overall Study|Lost to Follow-up|1|||
46935309|NCT01329939|83171383|FG003|Overall Study|Lost to Follow-up|2|||
46935310|NCT01329939|83171380|FG000|Overall Study|Withdrawal by Subject|0|||
47058854|NCT01587703|83338164|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058855|NCT01587703|83338165|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058856|NCT01587703|83338166|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058857|NCT01587703|83338167|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
47058858|NCT01587703|83338149|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058859|NCT01587703|83338150|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058860|NCT01587703|83338151|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058861|NCT01587703|83338152|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
46827656|NCT00402740|83045952|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
46827657|NCT00402740|83045952|FG000|Overall Study|Subject disposition unknown.|1|||
46827658|NCT00420290|83045962|FG000|Overall Study|Adverse Event|3|||
46827659|NCT00420290|83045963|FG001|Overall Study|Adverse Event|1|||
46827660|NCT00420290|83045962|FG000|Overall Study|Withdrawal by Subject|0|||
46827661|NCT00420290|83045963|FG001|Overall Study|Withdrawal by Subject|2|||
46827662|NCT00420290|83045962|FG000|Overall Study|did not meet inclusion/exclusion|1|||
46827663|NCT00420290|83045963|FG001|Overall Study|did not meet inclusion/exclusion|1|||
46827664|NCT00267189|83045971|FG000|Overall Study|Patient withdrew consent|1|||
46827665|NCT00267189|83045972|FG001|Overall Study|Patient withdrew consent|1|||
46827666|NCT00267189|83045971|FG000|Overall Study|Death|1|||
46827667|NCT00267189|83045972|FG001|Overall Study|Death|0|||
46827668|NCT00267189|83045971|FG000|Overall Study|Missing|3|||
46827669|NCT00267189|83045972|FG001|Overall Study|Missing|0|||
46827670|NCT03834350|83045978|FG000|Overall Study|Withdrawal by Subject|1|||
46827671|NCT00402116|83045986|FG000|Overall Study|Jaw infection after surgery-other|1|||
46827672|NCT00402116|83045987|FG001|Overall Study|Jaw infection after surgery-other|0|||
46827673|NCT00402116|83045988|FG002|Overall Study|Jaw infection after surgery-other|0|||
46827674|NCT00402116|83045986|FG000|Overall Study|Withdrawal by Subject|1|||
46827675|NCT00402116|83045987|FG001|Overall Study|Withdrawal by Subject|0|||
46827676|NCT00402116|83045988|FG002|Overall Study|Withdrawal by Subject|5|||
46827677|NCT00402116|83045986|FG000|Overall Study|Treatment completed per protocol|1|||
46827678|NCT00402116|83045987|FG001|Overall Study|Treatment completed per protocol|1|||
46827679|NCT00402116|83045988|FG002|Overall Study|Treatment completed per protocol|2|||
46827680|NCT00402116|83045986|FG000|Overall Study|other complicating disease|0|||
46827681|NCT00402116|83045987|FG001|Overall Study|other complicating disease|0|||
46827682|NCT00402116|83045988|FG002|Overall Study|other complicating disease|2|||
46827683|NCT00402116|83045986|FG000|Overall Study|Disease Progression|0|||
46827684|NCT00402116|83045987|FG001|Overall Study|Disease Progression|4|||
47058862|NCT01587703|83338153|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058863|NCT01587703|83338154|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
46763342|NCT00665626|82981512|FG000|Overall Study|Lost to Follow-up|0|||
46763343|NCT00665626|82981513|FG001|Overall Study|Lost to Follow-up|2|||
46763344|NCT00665626|82981512|FG000|Overall Study|Withdrawal by Subject|0|||
46763345|NCT00665626|82981513|FG001|Overall Study|Withdrawal by Subject|1|||
46763346|NCT00665626|82981512|FG000|Overall Study|Protocol Violation|0|||
46763347|NCT00665626|82981513|FG001|Overall Study|Protocol Violation|2|||
46763348|NCT00665626|82981512|FG000|Overall Study|Adverse Event|1|||
46763349|NCT00665626|82981513|FG001|Overall Study|Adverse Event|9|||
46763350|NCT00665626|82981512|FG000|Overall Study|Due to exclusion criteria|0|||
46763351|NCT00665626|82981513|FG001|Overall Study|Due to exclusion criteria|1|||
46763352|NCT00665626|82981512|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
46763353|NCT00665626|82981513|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
46763354|NCT00665626|82981512|FG000|Overall Study|Unably to comply with dosing regimen|0|||
46763355|NCT00665626|82981513|FG001|Overall Study|Unably to comply with dosing regimen|1|||
46763356|NCT00665626|82981512|FG000|Overall Study|Death|1|||
46763357|NCT00665626|82981513|FG001|Overall Study|Death|0|||
46763358|NCT00828672|82981521|FG000|Study Treatment|Lost to Follow-up|1|||
46827685|NCT00402116|83045988|FG002|Overall Study|Disease Progression|38|||
46827686|NCT00402116|83045986|FG000|Overall Study|mistaken thrombocytopenia|0|||
46827687|NCT00402116|83045987|FG001|Overall Study|mistaken thrombocytopenia|0|||
47058864|NCT01587703|83338155|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
46763359|NCT00828672|82981522|FG001|Study Treatment|Lost to Follow-up|0|||
46763360|NCT00828672|82981521|FG000|Study Treatment|Adverse Event|0|||
46763361|NCT00828672|82981522|FG001|Study Treatment|Adverse Event|1|||
46763362|NCT00828672|82981521|FG000|Study Treatment|Complete response, no surgery|1|||
46827688|NCT00402116|83045988|FG002|Overall Study|mistaken thrombocytopenia|1|||
46827689|NCT00402116|83045986|FG000|Overall Study|decline related hyponatremia/tumor|0|||
46827690|NCT00402116|83045987|FG001|Overall Study|decline related hyponatremia/tumor|0|||
46763363|NCT00828672|82981522|FG001|Study Treatment|Complete response, no surgery|1|||
46827691|NCT00402116|83045988|FG002|Overall Study|decline related hyponatremia/tumor|1|||
46827692|NCT00402116|83045986|FG000|Overall Study|Adverse Event|0|||
46827693|NCT00402116|83045987|FG001|Overall Study|Adverse Event|1|||
46827694|NCT00402116|83045988|FG002|Overall Study|Adverse Event|6|||
46827695|NCT00401960|83046018|FG000|Overall Study|Lost to Follow-up|3|||
46827696|NCT00401960|83046019|FG001|Overall Study|Lost to Follow-up|0|||
47058865|NCT01587703|83338156|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058866|NCT01587703|83338157|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
47058867|NCT01587703|83338158|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058868|NCT01587703|83338159|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
47058869|NCT01587703|83338160|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058870|NCT01587703|83338161|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058871|NCT01587703|83338162|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058872|NCT01587703|83338163|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058873|NCT01587703|83338164|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058874|NCT01587703|83338165|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058875|NCT01587703|83338166|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058876|NCT01587703|83338167|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
47058877|NCT01587703|83338149|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058878|NCT01587703|83338150|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058879|NCT01587703|83338151|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058880|NCT01587703|83338152|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058881|NCT01587703|83338153|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058882|NCT01587703|83338154|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058883|NCT01587703|83338155|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058884|NCT01587703|83338156|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058885|NCT01587703|83338157|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058886|NCT01587703|83338158|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
46763364|NCT00828672|82981521|FG000|Post-surgery (<30 Days)|No central review materials|0|||
46763365|NCT00828672|82981522|FG001|Post-surgery (<30 Days)|No central review materials|1|||
46763366|NCT00873119|82981530|FG000|Overall Study|Patient request|4|||
46763367|NCT00873119|82981531|FG001|Overall Study|Patient request|2|||
46763368|NCT00873119|82981530|FG000|Overall Study|Adverse Event|8|||
46763369|NCT00873119|82981531|FG001|Overall Study|Adverse Event|0|||
46763370|NCT00873119|82981530|FG000|Overall Study|Progressive disease|26|||
46827697|NCT00401960|83046018|FG000|Overall Study|Death|2|||
46827698|NCT00401960|83046019|FG001|Overall Study|Death|0|||
46827699|NCT00401726|83046029|FG000|Overall Study|Adverse Event|34|||
46827700|NCT00401726|83046030|FG001|Overall Study|Adverse Event|45|||
46827701|NCT00401726|83046029|FG000|Overall Study|Death|0|||
46827702|NCT00401726|83046030|FG001|Overall Study|Death|3|||
46827703|NCT00401726|83046029|FG000|Overall Study|Sponsor Request|0|||
46827704|NCT00401726|83046030|FG001|Overall Study|Sponsor Request|1|||
46827705|NCT00401726|83046029|FG000|Overall Study|Physician Decision|3|||
46827706|NCT00401726|83046030|FG001|Overall Study|Physician Decision|6|||
46827707|NCT00401726|83046029|FG000|Overall Study|Lost to Follow-up|23|||
46827708|NCT00401726|83046030|FG001|Overall Study|Lost to Follow-up|20|||
46827709|NCT00401726|83046029|FG000|Overall Study|Protocol Violation|6|||
46827710|NCT00401726|83046030|FG001|Overall Study|Protocol Violation|3|||
46827711|NCT00401726|83046029|FG000|Overall Study|Withdrawal by Subject|18|||
46827712|NCT00401726|83046030|FG001|Overall Study|Withdrawal by Subject|24|||
46827713|NCT00401726|83046029|FG000|Overall Study|Lack of Efficacy|4|||
46827714|NCT00401726|83046030|FG001|Overall Study|Lack of Efficacy|6|||
46827715|NCT00401726|83046029|FG000|Overall Study|Protocol Deviation|9|||
46827716|NCT00401726|83046030|FG001|Overall Study|Protocol Deviation|4|||
46827717|NCT00371826|83046039|FG000|Core Phase (12 Months)|Adverse Event|15|||
46827718|NCT00371826|83046040|FG001|Core Phase (12 Months)|Adverse Event|4|||
46827719|NCT00371826|83046041|FG002|Core Phase (12 Months)|Adverse Event|9|||
46763371|NCT00873119|82981531|FG001|Overall Study|Progressive disease|18|||
46763372|NCT00873119|82981530|FG000|Overall Study|Death|2|||
46763373|NCT00873119|82981531|FG001|Overall Study|Death|1|||
46763374|NCT00873119|82981530|FG000|Overall Study|Other|2|||
46763375|NCT00873119|82981531|FG001|Overall Study|Other|5|||
46763376|NCT00873119|82981530|FG000|Overall Study|Not treated|2|||
46763377|NCT00873119|82981531|FG001|Overall Study|Not treated|0|||
46763378|NCT00661726|82981537|FG000|Overall Study|Adverse Event|1|||
46827720|NCT00371826|83046039|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
46827721|NCT00371826|83046040|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
46827722|NCT00371826|83046041|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
46827723|NCT00371826|83046039|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
46935311|NCT01329939|83171381|FG001|Overall Study|Withdrawal by Subject|1|||
46935312|NCT01329939|83171382|FG002|Overall Study|Withdrawal by Subject|0|||
46935313|NCT01329939|83171383|FG003|Overall Study|Withdrawal by Subject|0|||
46935314|NCT01329939|83171380|FG000|Overall Study|Adverse Event|0|||
46935315|NCT01329939|83171381|FG001|Overall Study|Adverse Event|0|||
46935316|NCT01329939|83171382|FG002|Overall Study|Adverse Event|0|||
46935317|NCT01329939|83171383|FG003|Overall Study|Adverse Event|3|||
46935318|NCT02499900|83171395|FG000|Core Study Period|Other|1|||
46935319|NCT02499900|83171396|FG001|Core Study Period|Other|4|||
46935320|NCT02499900|83171395|FG000|Core Study Period|Lost to Follow-up|1|||
46935321|NCT02499900|83171396|FG001|Core Study Period|Lost to Follow-up|2|||
46935322|NCT02499900|83171395|FG000|Core Study Period|Per sponsor request|0|||
46935323|NCT02499900|83171396|FG001|Core Study Period|Per sponsor request|1|||
46935324|NCT02499900|83171395|FG000|Core Study Period|Pregnancy|1|||
46935325|NCT02499900|83171396|FG001|Core Study Period|Pregnancy|0|||
46935326|NCT02499900|83171395|FG000|Core Study Period|Protocol Violation|3|||
46935327|NCT02499900|83171396|FG001|Core Study Period|Protocol Violation|0|||
46935328|NCT02499900|83171395|FG000|Core Study Period|Withdrawal by Subject|11|||
46935329|NCT02499900|83171396|FG001|Core Study Period|Withdrawal by Subject|10|||
46935330|NCT02499900|83171395|FG000|Core Study Period|Adverse Event|18|||
46935331|NCT02499900|83171396|FG001|Core Study Period|Adverse Event|14|||
46935332|NCT02499900|83171395|FG000|Core Study Period|Death|0|||
46935333|NCT02499900|83171396|FG001|Core Study Period|Death|1|||
46935334|NCT02499900|83171395|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
46935335|NCT02499900|83171396|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
46935336|NCT02499900|83171395|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
46935337|NCT02499900|83171396|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
46935338|NCT02499900|83171395|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
46935339|NCT02499900|83171396|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
46935340|NCT02499900|83171395|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
46935341|NCT02499900|83171396|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
46935342|NCT02499900|83171395|FG000|Extension Study Period|Adverse Event|2|||
46935343|NCT02499900|83171396|FG001|Extension Study Period|Adverse Event|4|||
46935344|NCT02499900|83171395|FG000|Extension Study Period|Withdrawal by Subject|5|||
46935345|NCT02499900|83171396|FG001|Extension Study Period|Withdrawal by Subject|2|||
46935346|NCT02499900|83171395|FG000|Extension Study Period|Physician Decision|2|||
47058887|NCT01587703|83338159|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
47058888|NCT01587703|83338160|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058889|NCT01587703|83338161|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058890|NCT01587703|83338162|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058891|NCT01587703|83338163|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058892|NCT01587703|83338164|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058893|NCT01587703|83338165|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
46763379|NCT00865046|82981544|FG000|Overall Study|Lost to Follow-up|1|||
46763380|NCT00865046|82981545|FG001|Overall Study|Lost to Follow-up|4|||
46763381|NCT00865046|82981546|FG002|Overall Study|Lost to Follow-up|0|||
46763382|NCT00865046|82981544|FG000|Overall Study|Death|0|||
46763383|NCT00865046|82981545|FG001|Overall Study|Death|1|||
46763384|NCT00865046|82981546|FG002|Overall Study|Death|1|||
46763385|NCT00865046|82981544|FG000|Overall Study|Withdrawal by Subject|5|||
46935347|NCT02499900|83171396|FG001|Extension Study Period|Physician Decision|5|||
46935348|NCT02499900|83171395|FG000|Extension Study Period|Pregnancy|1|||
46935349|NCT02499900|83171396|FG001|Extension Study Period|Pregnancy|2|||
46935350|NCT02499900|83171395|FG000|Extension Study Period|Lost to Follow-up|2|||
46935351|NCT02499900|83171396|FG001|Extension Study Period|Lost to Follow-up|5|||
46935352|NCT02499900|83171395|FG000|Extension Study Period|Other|0|||
46935353|NCT02499900|83171396|FG001|Extension Study Period|Other|2|||
46935354|NCT03505749|83171410|FG000|Overall Study|Lost to Follow-up|7|||
46935355|NCT03505749|83171411|FG001|Overall Study|Lost to Follow-up|11|||
46935356|NCT03505749|83171410|FG000|Overall Study|Withdrawal by Subject|6|||
46935357|NCT03505749|83171411|FG001|Overall Study|Withdrawal by Subject|0|||
46935358|NCT03505749|83171410|FG000|Overall Study|Discharged from treatment|3|||
46935359|NCT03505749|83171411|FG001|Overall Study|Discharged from treatment|6|||
46935360|NCT03710642|83171435|FG000|Overall Study|Adverse Event|5|||
46935361|NCT03710642|83171436|FG001|Overall Study|Adverse Event|1|||
46935362|NCT03710642|83171435|FG000|Overall Study|non-site physician recommendation|1|||
46763386|NCT00865046|82981545|FG001|Overall Study|Withdrawal by Subject|0|||
47058894|NCT01587703|83338166|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058895|NCT01587703|83338167|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
47058896|NCT01587703|83338149|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058897|NCT01587703|83338150|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058898|NCT01587703|83338151|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058899|NCT01587703|83338152|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058900|NCT01587703|83338153|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058901|NCT01587703|83338154|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058902|NCT01587703|83338155|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058903|NCT01587703|83338156|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058904|NCT01587703|83338157|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
47058905|NCT01587703|83338158|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058906|NCT01587703|83338159|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058907|NCT01587703|83338160|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058908|NCT01587703|83338161|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058909|NCT01587703|83338162|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058910|NCT01587703|83338163|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
46827724|NCT00371826|83046040|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
46827725|NCT00371826|83046041|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
46935363|NCT03710642|83171436|FG001|Overall Study|non-site physician recommendation|0|||
46935364|NCT03710642|83171435|FG000|Overall Study|Participant unwilling or unable to participate|1|||
46935365|NCT03710642|83171436|FG001|Overall Study|Participant unwilling or unable to participate|1|||
46935366|NCT03710642|83171435|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
46935367|NCT03710642|83171436|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
46935368|NCT03710642|83171435|FG000|Overall Study|NA-no code provided|1|||
46935369|NCT03710642|83171436|FG001|Overall Study|NA-no code provided|0|||
47058911|NCT01587703|83338164|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058912|NCT01587703|83338165|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058913|NCT01587703|83338166|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058914|NCT01587703|83338167|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
47058915|NCT01587703|83338149|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058916|NCT01587703|83338150|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058917|NCT01587703|83338151|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058918|NCT01587703|83338152|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058919|NCT01587703|83338153|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058920|NCT01587703|83338154|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058921|NCT01587703|83338155|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058922|NCT01587703|83338156|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058923|NCT01587703|83338157|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
46935370|NCT03710642|83171435|FG000|Overall Study|Withdrawal by Subject|1|||
46935371|NCT03710642|83171436|FG001|Overall Study|Withdrawal by Subject|0|||
46935372|NCT00705224|83171442|FG000|Overall Study|Adverse Event|1|||
46935373|NCT00705224|83171442|FG000|Overall Study|Lack of Efficacy|2|||
46935374|NCT00705224|83171442|FG000|Overall Study|Withdrawal by Subject|3|||
46935375|NCT00705224|83171442|FG000|Overall Study|Lost to Follow-up|5|||
46935376|NCT02722148|83171449|FG000|Overall Study|Lost to Follow-up|2|||
46935377|NCT02722148|83171449|FG000|Overall Study|Non compliant with treatment regimen|3|||
46935378|NCT00704132|83171455|FG000|Overall Study|Clinical Adverse Experience|1|||
46935379|NCT00704132|83171456|FG001|Overall Study|Clinical Adverse Experience|0|||
46935380|NCT00704132|83171455|FG000|Overall Study|Lack of Efficacy|0|||
46935381|NCT00704132|83171456|FG001|Overall Study|Lack of Efficacy|1|||
46935382|NCT00704132|83171455|FG000|Overall Study|Withdrawal by Subject|0|||
46935383|NCT00704132|83171456|FG001|Overall Study|Withdrawal by Subject|1|||
46935384|NCT01329549|83171471|FG000|Overall Study|Withdrawal by Subject|1|||
46935385|NCT01329549|83171471|FG000|Overall Study|Adverse Event|1|||
47058924|NCT01587703|83338158|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058925|NCT01587703|83338159|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058926|NCT01587703|83338160|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058927|NCT01587703|83338161|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058928|NCT01587703|83338162|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058929|NCT01587703|83338163|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058930|NCT01587703|83338164|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058931|NCT01587703|83338165|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058932|NCT01587703|83338166|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
47058933|NCT01587703|83338167|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
47058934|NCT01587703|83338149|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058935|NCT01587703|83338150|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058936|NCT01587703|83338151|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058937|NCT01587703|83338152|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058938|NCT01587703|83338153|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
46935386|NCT02736474|83171477|FG000|Overall Study|Lost to Follow-up|0|||
47058939|NCT01587703|83338154|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058940|NCT01587703|83338155|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058941|NCT01587703|83338156|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058942|NCT01587703|83338157|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058943|NCT01587703|83338158|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058944|NCT01587703|83338159|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
46827726|NCT00371826|83046039|FG000|Core Phase (12 Months)|Protocol Violation|1|||
46827727|NCT00371826|83046040|FG001|Core Phase (12 Months)|Protocol Violation|0|||
46827728|NCT00371826|83046041|FG002|Core Phase (12 Months)|Protocol Violation|1|||
46827729|NCT00371826|83046039|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
46827730|NCT00371826|83046040|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
46827731|NCT00371826|83046041|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
46827732|NCT00371826|83046039|FG000|Core Phase (12 Months)|Administrative problems|1|||
46827733|NCT00371826|83046040|FG001|Core Phase (12 Months)|Administrative problems|0|||
46827734|NCT00371826|83046041|FG002|Core Phase (12 Months)|Administrative problems|8|||
47058945|NCT01587703|83338160|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058946|NCT01587703|83338161|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058947|NCT01587703|83338162|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058948|NCT01587703|83338163|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058949|NCT01587703|83338164|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058950|NCT01587703|83338165|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
47058951|NCT01587703|83338166|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
47058952|NCT01587703|83338167|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
47058953|NCT01587703|83338149|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058954|NCT01587703|83338150|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058955|NCT01587703|83338151|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058956|NCT01587703|83338152|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058957|NCT01587703|83338153|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058958|NCT01587703|83338154|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058959|NCT01587703|83338155|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058960|NCT01587703|83338156|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058961|NCT01587703|83338157|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058962|NCT01587703|83338158|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058963|NCT01587703|83338159|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058964|NCT01587703|83338160|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058965|NCT01587703|83338161|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058966|NCT01587703|83338162|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058967|NCT01587703|83338163|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058968|NCT01587703|83338164|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
47058969|NCT01587703|83338165|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058970|NCT01587703|83338166|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
46827735|NCT00371826|83046039|FG000|Core Phase (12 Months)|Graft Loss|0|||
46827736|NCT00371826|83046040|FG001|Core Phase (12 Months)|Graft Loss|1|||
46827737|NCT00371826|83046041|FG002|Core Phase (12 Months)|Graft Loss|0|||
46827738|NCT00371826|83046039|FG000|Extension Phase (24 Months)|Adverse Event|4|||
46827739|NCT00371826|83046040|FG001|Extension Phase (24 Months)|Adverse Event|5|||
46827740|NCT00371826|83046041|FG002|Extension Phase (24 Months)|Adverse Event|0|||
46827741|NCT00371826|83046039|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
46827742|NCT00371826|83046040|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
46935387|NCT02736474|83171478|FG001|Overall Study|Lost to Follow-up|1|||
47058971|NCT01587703|83338167|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
47058972|NCT01587703|83338149|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058973|NCT01587703|83338150|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058974|NCT01587703|83338151|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058975|NCT01587703|83338152|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058976|NCT01587703|83338153|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058977|NCT01587703|83338154|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058978|NCT01587703|83338155|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
46827743|NCT00371826|83046041|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
46827744|NCT00371826|83046039|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
46935388|NCT00702650|83171500|FG000|Overall Study|Withdrawal by Subject|9|||
46935389|NCT00702650|83171500|FG000|Overall Study|Non-Compliance of Study Drug|3|||
46827745|NCT00371826|83046040|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
46827746|NCT00371826|83046041|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
46827747|NCT00371826|83046039|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
46827748|NCT00371826|83046040|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
46827749|NCT00371826|83046041|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
46827750|NCT00371826|83046039|FG000|Extension Phase (24 Months)|Administrative problems|0|||
46827751|NCT00371826|83046040|FG001|Extension Phase (24 Months)|Administrative problems|0|||
47058979|NCT01587703|83338156|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058980|NCT01587703|83338157|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058981|NCT01587703|83338158|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058982|NCT01587703|83338159|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058983|NCT01587703|83338160|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
47058984|NCT01587703|83338161|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058985|NCT01587703|83338162|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058986|NCT01587703|83338163|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
47058987|NCT01587703|83338164|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058988|NCT01587703|83338165|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058989|NCT01587703|83338166|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
46827752|NCT00371826|83046041|FG002|Extension Phase (24 Months)|Administrative problems|2|||
46827753|NCT00396084|83046055|FG000|Overall Study|Adverse Event|0|||
46827754|NCT00396084|83046056|FG001|Overall Study|Adverse Event|0|||
46827755|NCT00396084|83046057|FG002|Overall Study|Adverse Event|0|||
46827756|NCT00396084|83046058|FG003|Overall Study|Adverse Event|0|||
46827757|NCT00396084|83046059|FG004|Overall Study|Adverse Event|1|||
46827758|NCT00396084|83046060|FG005|Overall Study|Adverse Event|2|||
46827759|NCT00396084|83046055|FG000|Overall Study|Withdrawal by Subject|0|||
46827760|NCT00396084|83046056|FG001|Overall Study|Withdrawal by Subject|0|||
46827761|NCT00396084|83046057|FG002|Overall Study|Withdrawal by Subject|0|||
46827762|NCT00396084|83046058|FG003|Overall Study|Withdrawal by Subject|1|||
46827763|NCT00396084|83046059|FG004|Overall Study|Withdrawal by Subject|0|||
46827764|NCT00396084|83046060|FG005|Overall Study|Withdrawal by Subject|0|||
46827765|NCT00395850|83046082|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
46827766|NCT00395850|83046083|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
46827767|NCT00395850|83046084|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
46827768|NCT00395850|83046085|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
46827769|NCT00395850|83046082|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
46827770|NCT00395850|83046083|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
46827771|NCT00395850|83046084|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
46827772|NCT00395850|83046085|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
46827773|NCT00395850|83046082|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
47058990|NCT01587703|83338167|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
47058991|NCT01587703|83338149|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47058992|NCT01587703|83338150|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
46827774|NCT00395850|83046083|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
46827775|NCT00395850|83046084|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
46935390|NCT00702650|83171500|FG000|Overall Study|Lost to Follow-up|2|||
47058993|NCT01587703|83338151|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47058994|NCT01587703|83338152|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47058995|NCT01587703|83338153|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47058996|NCT01587703|83338154|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47058997|NCT01587703|83338155|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47058998|NCT01587703|83338156|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47058999|NCT01587703|83338157|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47059000|NCT01587703|83338158|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
46827776|NCT00395850|83046085|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
46827777|NCT00395850|83046082|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
46827778|NCT00395850|83046083|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
46827779|NCT00395850|83046084|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
46827780|NCT00395850|83046085|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
46827781|NCT00395850|83046082|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
47059001|NCT01587703|83338159|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47059002|NCT01587703|83338160|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
47059003|NCT01587703|83338161|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
47059004|NCT01587703|83338162|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
47059005|NCT01587703|83338163|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
47059006|NCT01587703|83338164|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
47059007|NCT01587703|83338165|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
47059008|NCT01587703|83338166|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47059009|NCT01587703|83338167|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
47059010|NCT01587703|83338149|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059011|NCT01587703|83338150|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059012|NCT01587703|83338151|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059013|NCT01587703|83338152|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059014|NCT01587703|83338153|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
46827782|NCT00395850|83046083|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
46827783|NCT00395850|83046084|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
46827784|NCT00395850|83046085|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
46827785|NCT00395850|83046082|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
46827786|NCT00395850|83046083|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
46827787|NCT00395850|83046084|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
46827788|NCT00395850|83046085|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
46827789|NCT00395850|83046082|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
46827790|NCT00395850|83046083|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
46827791|NCT00395850|83046084|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
46827792|NCT00395850|83046085|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
46827793|NCT00420212|83046098|FG000|Overall Study|Adverse Event|22|||
46827794|NCT00420212|83046099|FG001|Overall Study|Adverse Event|40|||
46827795|NCT00420212|83046100|FG002|Overall Study|Adverse Event|36|||
46827796|NCT00420212|83046098|FG000|Overall Study|Lost to Follow-up|9|||
46827797|NCT00420212|83046099|FG001|Overall Study|Lost to Follow-up|11|||
46827798|NCT00420212|83046100|FG002|Overall Study|Lost to Follow-up|11|||
46827799|NCT00420212|83046098|FG000|Overall Study|Withdrawal by Subject|31|||
46827800|NCT00420212|83046099|FG001|Overall Study|Withdrawal by Subject|22|||
46827801|NCT00420212|83046100|FG002|Overall Study|Withdrawal by Subject|19|||
46827802|NCT00420212|83046098|FG000|Overall Study|Physician Decision|4|||
46827803|NCT00420212|83046099|FG001|Overall Study|Physician Decision|4|||
46827804|NCT00420212|83046100|FG002|Overall Study|Physician Decision|3|||
46827805|NCT00420212|83046098|FG000|Overall Study|Protocol Violation|4|||
46827806|NCT00420212|83046099|FG001|Overall Study|Protocol Violation|4|||
46827807|NCT00420212|83046100|FG002|Overall Study|Protocol Violation|8|||
46827808|NCT00420212|83046098|FG000|Overall Study|Death|0|||
46827809|NCT00420212|83046099|FG001|Overall Study|Death|0|||
46827810|NCT00420212|83046100|FG002|Overall Study|Death|1|||
46827811|NCT00420212|83046098|FG000|Overall Study|Other-Unspecified|21|||
47059015|NCT01587703|83338154|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059016|NCT01587703|83338155|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059017|NCT01587703|83338156|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
46827812|NCT00420212|83046099|FG001|Overall Study|Other-Unspecified|14|||
46827813|NCT00420212|83046100|FG002|Overall Study|Other-Unspecified|18|||
46827814|NCT00401258|83046111|FG000|Overall Study|Adverse Event|7|||
46827815|NCT00380874|83046117|FG000|Overall Study|Adverse Event|7|||
46827816|NCT00380874|83046118|FG001|Overall Study|Adverse Event|7|||
46827817|NCT00380874|83046117|FG000|Overall Study|Death|1|||
47059018|NCT01587703|83338157|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059019|NCT01587703|83338158|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059020|NCT01587703|83338159|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059021|NCT01587703|83338160|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
47059022|NCT01587703|83338161|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
47059023|NCT01587703|83338162|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
47059024|NCT01587703|83338163|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
47059025|NCT01587703|83338164|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
46827818|NCT00380874|83046118|FG001|Overall Study|Death|0|||
46827819|NCT00380874|83046117|FG000|Overall Study|Withdrawal by Subject|2|||
46827820|NCT00380874|83046118|FG001|Overall Study|Withdrawal by Subject|1|||
47059026|NCT01587703|83338165|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
47059027|NCT01587703|83338166|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059028|NCT01587703|83338167|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
47059029|NCT01587703|83338149|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
46763387|NCT00865046|82981546|FG002|Overall Study|Withdrawal by Subject|0|||
46763388|NCT00828516|82981554|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
46763389|NCT00665392|82981558|FG000|Overall Study|not treated|1|||
46763390|NCT00851630|82981565|FG000|Overall Study|Death|2|||
46763391|NCT00851630|82981566|FG001|Overall Study|Death|1|||
46763392|NCT00851630|82981565|FG000|Overall Study|Clinical failure|0|||
46827821|NCT00380874|83046117|FG000|Overall Study|Not related to study drug|3|||
46763393|NCT00851630|82981566|FG001|Overall Study|Clinical failure|1|||
46763394|NCT00459667|82981575|FG000|Overall Study|Adverse Event|9|||
46763395|NCT00459667|82981576|FG001|Overall Study|Adverse Event|12|||
46763396|NCT00459667|82981577|FG002|Overall Study|Adverse Event|8|||
46763397|NCT00459667|82981575|FG000|Overall Study|Lost to Follow-up|5|||
46763398|NCT00459667|82981576|FG001|Overall Study|Lost to Follow-up|9|||
46763399|NCT00459667|82981577|FG002|Overall Study|Lost to Follow-up|3|||
46763400|NCT00459667|82981575|FG000|Overall Study|Pregnancy|1|||
46763401|NCT00459667|82981576|FG001|Overall Study|Pregnancy|1|||
46763402|NCT00459667|82981577|FG002|Overall Study|Pregnancy|1|||
46763403|NCT00459667|82981575|FG000|Overall Study|Protocol Violation|1|||
46763404|NCT00459667|82981576|FG001|Overall Study|Protocol Violation|0|||
46763405|NCT00459667|82981577|FG002|Overall Study|Protocol Violation|0|||
46763406|NCT00459667|82981575|FG000|Overall Study|Withdrawal by Subject|3|||
46763407|NCT00459667|82981576|FG001|Overall Study|Withdrawal by Subject|5|||
46763408|NCT00459667|82981577|FG002|Overall Study|Withdrawal by Subject|5|||
46763409|NCT00459667|82981575|FG000|Overall Study|Other disease modifying treatment|1|||
46763410|NCT00459667|82981576|FG001|Overall Study|Other disease modifying treatment|2|||
46763411|NCT00459667|82981577|FG002|Overall Study|Other disease modifying treatment|1|||
46763412|NCT00459667|82981575|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
46763413|NCT00459667|82981576|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
46763414|NCT00459667|82981577|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
46763415|NCT00459667|82981575|FG000|Overall Study|No treatment administered|6|||
46763416|NCT00459667|82981576|FG001|Overall Study|No treatment administered|3|||
46763417|NCT00459667|82981577|FG002|Overall Study|No treatment administered|1|||
46763418|NCT00828204|82981587|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
46763419|NCT00828204|82981588|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
46763420|NCT00828204|82981587|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
46763421|NCT00828204|82981588|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
46763422|NCT00828204|82981587|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
46763423|NCT00828204|82981588|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
46763424|NCT00828204|82981587|FG000|Main Study: After Study Restart|Adverse Event|0|||
46763425|NCT00828204|82981588|FG001|Main Study: After Study Restart|Adverse Event|2|||
46763426|NCT00828204|82981587|FG000|Main Study: After Study Restart|Noncompliance|0|||
46763427|NCT00828204|82981588|FG001|Main Study: After Study Restart|Noncompliance|1|||
46763428|NCT00828204|82981587|FG000|Extension Study|Lost to Follow-up|0|||
46763429|NCT00828204|82981588|FG001|Extension Study|Lost to Follow-up|1|||
46763430|NCT00828204|82981587|FG000|Extension Study|Physician Decision|0|||
46763431|NCT00828204|82981588|FG001|Extension Study|Physician Decision|2|||
46763432|NCT00851552|82981595|FG000|Overall Study|Death|2|||
46763433|NCT00851552|82981595|FG000|Overall Study|Adverse Event|1|||
46763434|NCT00851552|82981595|FG000|Overall Study|Disease Progression|4|||
46763435|NCT00459355|82981601|FG000|Overall Study|Subject no longer met inc criteria|20|||
46763436|NCT00459355|82981602|FG001|Overall Study|Subject no longer met inc criteria|18|||
46763437|NCT00459043|82981614|FG000|Overall Study|Withdrawal by Subject|1|||
46827822|NCT00380874|83046118|FG001|Overall Study|Not related to study drug|2|||
46827823|NCT00420056|83046124|FG000|Overall Study|Objective progression or relapse|17|||
46827824|NCT00411554|83046130|FG000|Overall Study|Adverse Event|2|||
46827825|NCT00411554|83046131|FG001|Overall Study|Adverse Event|4|||
46827826|NCT00411554|83046130|FG000|Overall Study|Lack of Efficacy|2|||
46827827|NCT00411554|83046131|FG001|Overall Study|Lack of Efficacy|5|||
46763438|NCT00459043|82981615|FG001|Overall Study|Withdrawal by Subject|0|||
46763439|NCT00817206|82981623|FG000|Overall Study|Adverse Event|10|||
46763440|NCT00817206|82981624|FG001|Overall Study|Adverse Event|3|||
46763441|NCT00817206|82981623|FG000|Overall Study|Protocol Violation|0|||
46763442|NCT00817206|82981624|FG001|Overall Study|Protocol Violation|2|||
46763443|NCT00817206|82981623|FG000|Overall Study|Lost to Follow-up|0|||
46763444|NCT00817206|82981624|FG001|Overall Study|Lost to Follow-up|1|||
46763445|NCT00817206|82981623|FG000|Overall Study|Death|2|||
46763446|NCT00817206|82981624|FG001|Overall Study|Death|0|||
46763447|NCT00817206|82981623|FG000|Overall Study|Withdrawal by Subject|7|||
46827828|NCT00411554|83046130|FG000|Overall Study|Withdrawal by Subject|3|||
46763448|NCT00817206|82981624|FG001|Overall Study|Withdrawal by Subject|3|||
46827829|NCT00411554|83046131|FG001|Overall Study|Withdrawal by Subject|0|||
47059030|NCT01587703|83338150|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059031|NCT01587703|83338151|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059032|NCT01587703|83338152|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059033|NCT01587703|83338153|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059034|NCT01587703|83338154|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059035|NCT01587703|83338155|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059036|NCT01587703|83338156|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059037|NCT01587703|83338157|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059038|NCT01587703|83338158|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059039|NCT01587703|83338159|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059040|NCT01587703|83338160|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
47059041|NCT01587703|83338161|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059042|NCT01587703|83338162|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059043|NCT01587703|83338163|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059044|NCT01587703|83338164|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059045|NCT01587703|83338165|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059046|NCT01587703|83338166|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059047|NCT01587703|83338167|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
47059048|NCT01577381|83338230|FG000|Overall Study|Discontinued|2|||
47059049|NCT01577381|83338231|FG001|Overall Study|Discontinued|1|||
47059050|NCT01577381|83338232|FG002|Overall Study|Discontinued|2|||
47059051|NCT01577381|83338233|FG003|Overall Study|Discontinued|2|||
47059052|NCT01577381|83338230|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
47059053|NCT01577381|83338231|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
47059054|NCT01577381|83338232|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
47059055|NCT01577381|83338233|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
47059056|NCT02686164|83338243|FG000|Overall Study|Adverse Event|1|||
47059057|NCT02686164|83338243|FG000|Overall Study|Withdrawal of consent|1|||
47059058|NCT02686164|83338243|FG000|Overall Study|Clinical progression|1|||
47059059|NCT01691105|83338264|FG000|1 Month Follow-up|Lost to Follow-up|41|||
47059060|NCT01691105|83338265|FG001|1 Month Follow-up|Lost to Follow-up|38|||
47059061|NCT01691105|83338264|FG000|1 Month Follow-up|Death|2|||
47059062|NCT01691105|83338265|FG001|1 Month Follow-up|Death|3|||
47059063|NCT01691105|83338264|FG000|6 Month Follow-up|Lost to Follow-up|39|||
47059064|NCT01691105|83338265|FG001|6 Month Follow-up|Lost to Follow-up|58|||
47059065|NCT01691105|83338264|FG000|6 Month Follow-up|Death|13|||
47059066|NCT01691105|83338265|FG001|6 Month Follow-up|Death|13|||
47059067|NCT01691105|83338264|FG000|12 Month Follow-up|Lost to Follow-up|50|||
47059068|NCT01691105|83338265|FG001|12 Month Follow-up|Lost to Follow-up|71|||
47059069|NCT01691105|83338264|FG000|12 Month Follow-up|Death|22|||
47059070|NCT01691105|83338265|FG001|12 Month Follow-up|Death|30|||
47059071|NCT01691105|83338264|FG000|12 Month Biochemical Verification|Death|22|||
47059072|NCT01691105|83338265|FG001|12 Month Biochemical Verification|Death|30|||
47059073|NCT01691105|83338264|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
47059074|NCT01691105|83338265|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
47059075|NCT01691105|83338264|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
47059076|NCT01691105|83338265|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
47059077|NCT02685072|83338273|FG000|Treatment Period|Lost to Follow-up|12|||
47059078|NCT02685072|83338274|FG001|Treatment Period|Lost to Follow-up|6|||
47059079|NCT02685072|83338273|FG000|Treatment Period|Withdrawal by Subject|1|||
47059080|NCT02685072|83338274|FG001|Treatment Period|Withdrawal by Subject|3|||
47059081|NCT02685072|83338273|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
47059082|NCT02685072|83338274|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
47059083|NCT02695524|83338344|FG000|Overall Study|Lost to Follow-up|3|||
47059084|NCT02695524|83338345|FG001|Overall Study|Lost to Follow-up|2|||
47059085|NCT02695524|83338344|FG000|Overall Study|Death|0|||
47059086|NCT02695524|83338345|FG001|Overall Study|Death|1|||
47059087|NCT01576367|83338351|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
47059088|NCT01576367|83338351|FG000|Overall Study|Moved to commercial use after 6 months|1|||
46763449|NCT00817206|82981623|FG000|Overall Study|Physician Decision|2|||
46763450|NCT00817206|82981624|FG001|Overall Study|Physician Decision|0|||
46763451|NCT00665002|82981630|FG000|Overall Study|Progression/relapse during treatment|11|||
47059089|NCT01689857|83338362|FG000|Overall Study|Lost to Follow-up|5|||
47059090|NCT01689857|83338363|FG001|Overall Study|Lost to Follow-up|2|||
46763452|NCT00665002|82981630|FG000|Overall Study|Cytogenetic resistance|1|||
46763453|NCT03847987|82981636|FG000|Overall Study|Lost to Follow-up|1|||
47059091|NCT01587079|83338369|FG000|Overall Study|Protocol-specified criteria|9|||
47059092|NCT01587079|83338369|FG000|Overall Study|Protocol Violation|5|||
47059093|NCT01587079|83338369|FG000|Overall Study|Lost to Follow-up|2|||
47059094|NCT01587079|83338369|FG000|Overall Study|Physician Decision|2|||
47059095|NCT01587079|83338369|FG000|Overall Study|Withdrawal by Subject|7|||
46763454|NCT03847987|82981637|FG001|Overall Study|Lost to Follow-up|0|||
47059096|NCT01587079|83338369|FG000|Overall Study|Adverse Event|14|||
47059097|NCT01587001|83338422|FG000|Overall Study|Lost to Follow-up|2|||
47059098|NCT01587001|83338423|FG001|Overall Study|Lost to Follow-up|0|||
47059099|NCT01587001|83338422|FG000|Overall Study|Insufficient samples to complete testing|4|||
47059100|NCT01587001|83338423|FG001|Overall Study|Insufficient samples to complete testing|1|||
47059101|NCT01568047|83338453|FG000|Overall Study|Ineligibility|1|||
47059102|NCT01568047|83338454|FG001|Overall Study|Ineligibility|0|||
47059103|NCT01568047|83338455|FG002|Overall Study|Ineligibility|0|||
47059104|NCT01568047|83338456|FG003|Overall Study|Ineligibility|0|||
47059105|NCT01568047|83338453|FG000|Overall Study|Withdrawal by Subject|0|||
47059106|NCT01568047|83338454|FG001|Overall Study|Withdrawal by Subject|1|||
47059107|NCT01568047|83338455|FG002|Overall Study|Withdrawal by Subject|0|||
47059108|NCT01568047|83338456|FG003|Overall Study|Withdrawal by Subject|0|||
47059109|NCT01568047|83338453|FG000|Overall Study|Adverse Event|0|||
47059110|NCT01568047|83338454|FG001|Overall Study|Adverse Event|0|||
47059111|NCT01568047|83338455|FG002|Overall Study|Adverse Event|1|||
46827830|NCT00411554|83046130|FG000|Overall Study|Patient Moved|1|||
46827831|NCT00411554|83046131|FG001|Overall Study|Patient Moved|0|||
46827832|NCT00400712|83046139|FG000|Overall Study|Death|1|||
46827833|NCT00400712|83046140|FG001|Overall Study|Death|0|||
46827834|NCT00400712|83046139|FG000|Overall Study|Withdrawal by Subject|11|||
46827835|NCT00400712|83046140|FG001|Overall Study|Withdrawal by Subject|12|||
46827836|NCT00400712|83046139|FG000|Overall Study|Physician Decision|5|||
46827837|NCT00400712|83046140|FG001|Overall Study|Physician Decision|4|||
46827838|NCT00380718|83046148|FG000|Overall Study|Adverse Event|1|||
46827839|NCT00380718|83046148|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
46827840|NCT00380250|83046154|FG000|Overall Study|Withdrawal by Subject|39|||
46827841|NCT00380250|83046155|FG001|Overall Study|Withdrawal by Subject|28|||
46827842|NCT00380250|83046154|FG000|Overall Study|Adverse Event|20|||
46827843|NCT00380250|83046155|FG001|Overall Study|Adverse Event|9|||
46827844|NCT00380250|83046154|FG000|Overall Study|Lack of Efficacy|10|||
46827845|NCT00380250|83046155|FG001|Overall Study|Lack of Efficacy|8|||
46827846|NCT00380250|83046154|FG000|Overall Study|Protocol Violation|15|||
46827847|NCT00380250|83046155|FG001|Overall Study|Protocol Violation|5|||
46827848|NCT00380250|83046154|FG000|Overall Study|Lost to Follow-up|14|||
46827849|NCT00380250|83046155|FG001|Overall Study|Lost to Follow-up|5|||
46827850|NCT00380250|83046154|FG000|Overall Study|Physician Decision|1|||
46827851|NCT00380250|83046155|FG001|Overall Study|Physician Decision|0|||
46827852|NCT00400400|83046163|FG000|Overall Study|Adverse Event|9|||
46827853|NCT00400400|83046164|FG001|Overall Study|Adverse Event|8|||
46827854|NCT00400400|83046163|FG000|Overall Study|Protocol Violation|2|||
46827855|NCT00400400|83046164|FG001|Overall Study|Protocol Violation|0|||
46827856|NCT00400400|83046163|FG000|Overall Study|Withdrawal by Subject|1|||
46827857|NCT00400400|83046164|FG001|Overall Study|Withdrawal by Subject|3|||
46827858|NCT00400400|83046163|FG000|Overall Study|Administrative Problem|1|||
46827859|NCT00400400|83046164|FG001|Overall Study|Administrative Problem|0|||
46827860|NCT00400400|83046163|FG000|Overall Study|Lost to Follow-up|0|||
46827861|NCT00400400|83046164|FG001|Overall Study|Lost to Follow-up|1|||
46827862|NCT00400400|83046163|FG000|Overall Study|Did not receive study drug|1|||
46827863|NCT00400400|83046164|FG001|Overall Study|Did not receive study drug|3|||
47059112|NCT01568047|83338456|FG003|Overall Study|Adverse Event|1|||
47059113|NCT01688999|83338469|FG000|Overall Study|Withdrawal by Subject|5|||
47059114|NCT01688999|83338470|FG001|Overall Study|Withdrawal by Subject|1|||
47059115|NCT01688999|83338471|FG002|Overall Study|Withdrawal by Subject|1|||
47059116|NCT01688999|83338469|FG000|Overall Study|Adverse Event|2|||
47059117|NCT01688999|83338470|FG001|Overall Study|Adverse Event|0|||
47059118|NCT01688999|83338471|FG002|Overall Study|Adverse Event|2|||
47059119|NCT01688999|83338469|FG000|Overall Study|Ineligible/Not treated|1|||
47059120|NCT01688999|83338470|FG001|Overall Study|Ineligible/Not treated|0|||
47059121|NCT01688999|83338471|FG002|Overall Study|Ineligible/Not treated|0|||
47059122|NCT01541917|83338495|FG000|Overall Study|Lost to Follow-up|2|||
46763455|NCT03847987|82981636|FG000|Overall Study|Adverse Event|2|||
46763456|NCT03847987|82981637|FG001|Overall Study|Adverse Event|0|||
46763457|NCT00660010|82981654|FG000|Overall Study|Withdrawal by Subject|2|||
46763458|NCT00660010|82981654|FG000|Overall Study|Lost to Follow-up|3|||
46763459|NCT00660010|82981654|FG000|Overall Study|Adverse Event|1|||
46763460|NCT00660010|82981654|FG000|Overall Study|Noncompliance with visit schedule|3|||
46763461|NCT00873041|82981661|FG000|Core Study|Adverse Event|2|||
46763462|NCT00873041|82981662|FG001|Core Study|Adverse Event|3|||
46763463|NCT00873041|82981663|FG002|Core Study|Adverse Event|1|||
46763464|NCT00873041|82981661|FG000|Core Study|Withdrawal by Subject|1|||
46763465|NCT00873041|82981662|FG001|Core Study|Withdrawal by Subject|2|||
46763466|NCT00873041|82981663|FG002|Core Study|Withdrawal by Subject|2|||
47059123|NCT01541917|83338496|FG001|Overall Study|Lost to Follow-up|2|||
47059124|NCT01541917|83338495|FG000|Overall Study|Withdrawal by Subject|13|||
46827864|NCT00395694|83046172|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
46827865|NCT00395694|83046173|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
46827866|NCT00395694|83046172|FG000|Continuation Phase|Adverse Event|1|||
46827867|NCT00395694|83046173|FG001|Continuation Phase|Adverse Event|0|||
47059125|NCT01541917|83338496|FG001|Overall Study|Withdrawal by Subject|7|||
47059126|NCT01688921|83338516|FG000|Overall Study|Lost to Follow-up|7|||
47059127|NCT01688921|83338517|FG001|Overall Study|Lost to Follow-up|13|||
47059128|NCT01688921|83338516|FG000|Overall Study|Physician Decision|6|||
47059129|NCT01688921|83338517|FG001|Overall Study|Physician Decision|1|||
47059130|NCT01688921|83338516|FG000|Overall Study|Protocol Violation|0|||
47059131|NCT01688921|83338517|FG001|Overall Study|Protocol Violation|1|||
46827868|NCT00395694|83046172|FG000|Continuation Phase|Lack of Efficacy|12|||
46827869|NCT00395694|83046173|FG001|Continuation Phase|Lack of Efficacy|11|||
46827870|NCT00395694|83046172|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
46827871|NCT00395694|83046173|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
46827872|NCT00395694|83046172|FG000|Continuation Phase|Poor Compliance|1|||
46827873|NCT00395694|83046173|FG001|Continuation Phase|Poor Compliance|0|||
46827874|NCT00395694|83046172|FG000|Continuation Phase|Withdrawal by Subject|0|||
46827875|NCT00395694|83046173|FG001|Continuation Phase|Withdrawal by Subject|2|||
46827876|NCT00419744|83046185|FG000|Overall Study|Adverse Event|39|||
46827877|NCT00419744|83046186|FG001|Overall Study|Adverse Event|40|||
46827878|NCT00419744|83046187|FG002|Overall Study|Adverse Event|50|||
46827879|NCT00419744|83046185|FG000|Overall Study|Withdrawal by Subject|45|||
46827880|NCT00419744|83046186|FG001|Overall Study|Withdrawal by Subject|49|||
46827881|NCT00419744|83046187|FG002|Overall Study|Withdrawal by Subject|52|||
46827882|NCT00419744|83046185|FG000|Overall Study|Lost to Follow-up|8|||
46827883|NCT00419744|83046186|FG001|Overall Study|Lost to Follow-up|10|||
46827884|NCT00419744|83046187|FG002|Overall Study|Lost to Follow-up|6|||
46827885|NCT00419744|83046185|FG000|Overall Study|Protocol Violation|4|||
46827886|NCT00419744|83046186|FG001|Overall Study|Protocol Violation|7|||
46827887|NCT00419744|83046187|FG002|Overall Study|Protocol Violation|8|||
46827888|NCT00419744|83046185|FG000|Overall Study|Randomized in error|9|||
46827889|NCT00419744|83046186|FG001|Overall Study|Randomized in error|6|||
46827890|NCT00419744|83046187|FG002|Overall Study|Randomized in error|7|||
46763467|NCT00873041|82981661|FG000|Core Study|Lost to Follow-up|3|||
46763468|NCT00873041|82981662|FG001|Core Study|Lost to Follow-up|1|||
46763469|NCT00873041|82981663|FG002|Core Study|Lost to Follow-up|0|||
46763470|NCT00873041|82981661|FG000|Core Study|Abnormal laboratory value|0|||
46763471|NCT00873041|82981662|FG001|Core Study|Abnormal laboratory value|0|||
46763472|NCT00873041|82981663|FG002|Core Study|Abnormal laboratory value|1|||
46763473|NCT00873041|82981661|FG000|Core Study|Protocol deviation|1|||
46763474|NCT00873041|82981662|FG001|Core Study|Protocol deviation|0|||
46763475|NCT00873041|82981663|FG002|Core Study|Protocol deviation|1|||
46763476|NCT00873041|82981661|FG000|Extension Study|Adverse Event|1|||
46763477|NCT00873041|82981662|FG001|Extension Study|Adverse Event|0|||
46763478|NCT00873041|82981663|FG002|Extension Study|Adverse Event|1|||
46827891|NCT00419744|83046185|FG000|Overall Study|Moving out of state|2|||
46827892|NCT00419744|83046186|FG001|Overall Study|Moving out of state|0|||
47059132|NCT01688921|83338516|FG000|Overall Study|informed consent|3|||
46763479|NCT00873041|82981661|FG000|Extension Study|Administrative reasons|0|||
46763480|NCT00873041|82981662|FG001|Extension Study|Administrative reasons|0|||
46827893|NCT00419744|83046187|FG002|Overall Study|Moving out of state|1|||
46827894|NCT00419744|83046185|FG000|Overall Study|Physician Decision|10|||
46827895|NCT00419744|83046186|FG001|Overall Study|Physician Decision|5|||
46827896|NCT00419744|83046187|FG002|Overall Study|Physician Decision|6|||
46827897|NCT00419744|83046185|FG000|Overall Study|Spirometry mouthpiece issues|0|||
46827898|NCT00419744|83046186|FG001|Overall Study|Spirometry mouthpiece issues|1|||
47059133|NCT01688921|83338517|FG001|Overall Study|informed consent|0|||
47059134|NCT01541371|83338539|FG000|Overall Study|Withdrawal by Subject|14|||
46763481|NCT00873041|82981663|FG002|Extension Study|Administrative reasons|1|||
46827899|NCT00419744|83046187|FG002|Overall Study|Spirometry mouthpiece issues|2|||
47059135|NCT01541371|83338539|FG000|Overall Study|Lost to Follow-up|21|||
46763482|NCT00458341|82981680|FG000|Cycle 1|Adverse Event|1|||
46763483|NCT00458341|82981681|FG001|Cycle 1|Adverse Event|0|||
46827900|NCT00419744|83046185|FG000|Overall Study|Incorrect medication kit dispensed|0|||
47059136|NCT01541371|83338539|FG000|Overall Study|Adverse Event|15|||
47059137|NCT01541371|83338539|FG000|Overall Study|Lack of Efficacy|12|||
46935391|NCT00702650|83171500|FG000|Overall Study|Non-Compliance with Site Directives|1|||
46935392|NCT00702650|83171500|FG000|Overall Study|Sponsor Request|1|||
46935393|NCT00702650|83171500|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
46935394|NCT00702650|83171500|FG000|Overall Study|Adverse Event|3|||
46935395|NCT01337115|83171506|FG000|Overall Study|Protocol Violation|2|||
46935396|NCT01337115|83171507|FG001|Overall Study|Protocol Violation|0|||
46935397|NCT03761784|83171517|FG000|Overall Study|Adverse Event|4|||
46935398|NCT03761784|83171518|FG001|Overall Study|Adverse Event|0|||
46935399|NCT03761784|83171517|FG000|Overall Study|Lost to Follow-up|10|||
46935400|NCT03761784|83171518|FG001|Overall Study|Lost to Follow-up|7|||
46935401|NCT03761784|83171517|FG000|Overall Study|Pregnancy|1|||
46935402|NCT03761784|83171518|FG001|Overall Study|Pregnancy|0|||
46935403|NCT03761784|83171517|FG000|Overall Study|Protocol Violation|2|||
46935404|NCT03761784|83171518|FG001|Overall Study|Protocol Violation|0|||
46935405|NCT03761784|83171517|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
46935406|NCT03761784|83171518|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
46935407|NCT03761784|83171517|FG000|Overall Study|Withdrawal by Subject|9|||
46935408|NCT03761784|83171518|FG001|Overall Study|Withdrawal by Subject|4|||
46935409|NCT03761784|83171517|FG000|Overall Study|Physician Decision|1|||
46935410|NCT03761784|83171518|FG001|Overall Study|Physician Decision|0|||
46935411|NCT03761784|83171517|FG000|Overall Study|Other Than Specified|1|||
46935412|NCT03761784|83171518|FG001|Overall Study|Other Than Specified|0|||
46935413|NCT03195894|83171526|FG000|Overall Study|"An example is Started other treatment."|4|||
46935414|NCT03195894|83171527|FG001|Overall Study|"An example is Started other treatment."|5|||
46935415|NCT03195894|83171526|FG000|Overall Study|Withdrawal by Subject|15|||
46935416|NCT03195894|83171527|FG001|Overall Study|Withdrawal by Subject|4|||
47059138|NCT01541371|83338539|FG000|Overall Study|Protocol Violation|6|||
47059139|NCT01541371|83338539|FG000|Overall Study|Study medication non-compliance|3|||
47059140|NCT01541371|83338539|FG000|Overall Study|Other|6|||
47059141|NCT01687673|83338572|FG000|Overall Study|Physician Decision|1|||
47059142|NCT01687595|83338652|FG000|Overall Study|Withdrawal by Subject|8|||
47059143|NCT01687595|83338653|FG001|Overall Study|Withdrawal by Subject|0|||
46763484|NCT00816036|82981689|FG000|Overall Study|Death|47|||
46763485|NCT00816036|82981690|FG001|Overall Study|Death|28|||
46763486|NCT00816036|82981689|FG000|Overall Study|Lost to Follow-up|75|||
46763487|NCT00816036|82981690|FG001|Overall Study|Lost to Follow-up|57|||
46763488|NCT00816036|82981689|FG000|Overall Study|Withdrawal by Subject|54|||
46763489|NCT00816036|82981690|FG001|Overall Study|Withdrawal by Subject|23|||
46763490|NCT00664534|82981698|FG000|Overall Study|Adverse Event|2|||
46763491|NCT00664534|82981699|FG001|Overall Study|Adverse Event|3|||
46763492|NCT00664534|82981698|FG000|Overall Study|Lost to Follow-up|6|||
46763493|NCT00664534|82981699|FG001|Overall Study|Lost to Follow-up|10|||
46763494|NCT00664534|82981698|FG000|Overall Study|Protocol Violation|10|||
46763495|NCT00664534|82981699|FG001|Overall Study|Protocol Violation|8|||
46763496|NCT00664534|82981698|FG000|Overall Study|Withdrawal by Subject|7|||
46763497|NCT00664534|82981699|FG001|Overall Study|Withdrawal by Subject|6|||
46763498|NCT00664534|82981698|FG000|Overall Study|Physician Decision|8|||
46763499|NCT00664534|82981699|FG001|Overall Study|Physician Decision|0|||
46763500|NCT00664534|82981698|FG000|Overall Study|Sponsor decision|8|||
46763501|NCT00664534|82981699|FG001|Overall Study|Sponsor decision|6|||
46763502|NCT00594035|82981707|FG000|Overall Study|Lost to Follow-up|1|||
46763503|NCT00594035|82981708|FG001|Overall Study|Lost to Follow-up|1|||
46763504|NCT00594035|82981707|FG000|Overall Study|Withdrawal by Subject|1|||
46763505|NCT00594035|82981708|FG001|Overall Study|Withdrawal by Subject|0|||
46763506|NCT00594035|82981707|FG000|Overall Study|Subject transferred to nursing home|0|||
46763507|NCT00594035|82981708|FG001|Overall Study|Subject transferred to nursing home|1|||
46763508|NCT00594035|82981707|FG000|Overall Study|Subject couldn't return due to job|0|||
46763509|NCT00594035|82981708|FG001|Overall Study|Subject couldn't return due to job|1|||
46763510|NCT00570310|82981716|FG000|Overall Study|Adverse Event|1|||
46763511|NCT00570310|82981717|FG001|Overall Study|Adverse Event|2|||
46763512|NCT00570310|82981716|FG000|Overall Study|Lack of Efficacy|1|||
46935417|NCT03195894|83171526|FG000|Overall Study|Lost to Follow-up|14|||
46935418|NCT03195894|83171527|FG001|Overall Study|Lost to Follow-up|19|||
47059144|NCT01687595|83338652|FG000|Overall Study|Lost to Follow-up|3|||
47059145|NCT01687595|83338653|FG001|Overall Study|Lost to Follow-up|1|||
46763513|NCT00570310|82981717|FG001|Overall Study|Lack of Efficacy|4|||
46763514|NCT00664066|82981723|FG000|Overall Study|Study terminated|3|||
46763515|NCT00814710|82981729|FG000|Overall Study|Adverse Event|1|||
46763516|NCT00814710|82981730|FG001|Overall Study|Adverse Event|0|||
46763517|NCT00814710|82981729|FG000|Overall Study|Lost to Follow-up|7|||
46763518|NCT00814710|82981730|FG001|Overall Study|Lost to Follow-up|3|||
46763519|NCT00871169|82981736|FG000|Overall Study|Protocol Violation|1|||
46935419|NCT01337973|83171539|FG000|Overall Study|Lost to Follow-up|2|||
46935420|NCT01337973|83171540|FG001|Overall Study|Lost to Follow-up|4|||
46935421|NCT01337973|83171541|FG002|Overall Study|Lost to Follow-up|3|||
46935422|NCT01337973|83171539|FG000|Overall Study|Death|1|||
46935423|NCT01337973|83171540|FG001|Overall Study|Death|2|||
46935424|NCT01337973|83171541|FG002|Overall Study|Death|1|||
46935425|NCT01337973|83171539|FG000|Overall Study|Withdrawal by Subject|10|||
46935426|NCT01337973|83171540|FG001|Overall Study|Withdrawal by Subject|8|||
46827901|NCT00419744|83046186|FG001|Overall Study|Incorrect medication kit dispensed|0|||
46827902|NCT00419744|83046187|FG002|Overall Study|Incorrect medication kit dispensed|1|||
46827903|NCT00395538|83046198|FG000|Overall Study|Did not re-consent to revised protocol|1|||
46827904|NCT00395538|83046199|FG001|Overall Study|Did not re-consent to revised protocol|10|||
46827905|NCT00395538|83046200|FG002|Overall Study|Did not re-consent to revised protocol|0|||
46827906|NCT00395538|83046198|FG000|Overall Study|FDA partial hold on PTH|0|||
46827907|NCT00395538|83046199|FG001|Overall Study|FDA partial hold on PTH|0|||
46827908|NCT00395538|83046200|FG002|Overall Study|FDA partial hold on PTH|11|||
46827909|NCT00395538|83046198|FG000|Overall Study|Failed screening|0|||
46827910|NCT00395538|83046199|FG001|Overall Study|Failed screening|0|||
46827911|NCT00395538|83046200|FG002|Overall Study|Failed screening|4|||
46827912|NCT00395538|83046198|FG000|Overall Study|Switch to Natpara|0|||
46827913|NCT00395538|83046199|FG001|Overall Study|Switch to Natpara|0|||
46827914|NCT00395538|83046200|FG002|Overall Study|Switch to Natpara|3|||
46935427|NCT01337973|83171541|FG002|Overall Study|Withdrawal by Subject|4|||
46935428|NCT01337973|83171539|FG000|Overall Study|missing data on primary outcome|3|||
46935429|NCT01337973|83171540|FG001|Overall Study|missing data on primary outcome|1|||
46935430|NCT01337973|83171541|FG002|Overall Study|missing data on primary outcome|3|||
46935431|NCT02929056|83171551|FG000|Overall Study|Lost to Follow-up|0|||
46935432|NCT02929056|83171552|FG001|Overall Study|Lost to Follow-up|1|||
46935433|NCT00157755|83171571|FG000|Overall Study|Death|2|||
46935434|NCT00157755|83171572|FG001|Overall Study|Death|3|||
46935435|NCT00157755|83171573|FG002|Overall Study|Death|3|||
46935436|NCT00157755|83171574|FG003|Overall Study|Death|2|||
46935437|NCT00157755|83171575|FG004|Overall Study|Death|0|||
47059146|NCT01687595|83338652|FG000|Overall Study|Investigator's decision|1|||
47059147|NCT01687595|83338653|FG001|Overall Study|Investigator's decision|0|||
47059148|NCT01687595|83338652|FG000|Overall Study|Sponsor's decision|1|||
47059149|NCT01687595|83338653|FG001|Overall Study|Sponsor's decision|0|||
47059150|NCT01687595|83338652|FG000|Overall Study|Noncompliance|1|||
46827915|NCT00395538|83046198|FG000|Overall Study|Adverse Event|1|||
46827916|NCT00395538|83046199|FG001|Overall Study|Adverse Event|0|||
46827917|NCT00395538|83046200|FG002|Overall Study|Adverse Event|2|||
46827918|NCT00395538|83046198|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
46827919|NCT00395538|83046199|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
46827920|NCT00395538|83046200|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
46827921|NCT00395538|83046198|FG000|Overall Study|Non-compliance with study protocol|0|||
46935438|NCT00157755|83171576|FG005|Overall Study|Death|0|||
46935439|NCT00157755|83171571|FG000|Overall Study|Lost to Follow-up|0|||
47059151|NCT01687595|83338653|FG001|Overall Study|Noncompliance|2|||
47059152|NCT01687595|83338652|FG000|Overall Study|Other than specified|56|||
47059153|NCT01687595|83338653|FG001|Overall Study|Other than specified|7|||
47059154|NCT01687283|83338661|FG000|Overall Study|Adverse Event|11|||
47059155|NCT01687283|83338662|FG001|Overall Study|Adverse Event|4|||
47059156|NCT01687283|83338661|FG000|Overall Study|Lack of Efficacy|3|||
47059157|NCT01687283|83338662|FG001|Overall Study|Lack of Efficacy|1|||
47059158|NCT01687283|83338661|FG000|Overall Study|Protocol Violation|1|||
47059159|NCT01687283|83338662|FG001|Overall Study|Protocol Violation|3|||
47059160|NCT01687283|83338661|FG000|Overall Study|protocol defined stopping criteria|8|||
47059161|NCT01687283|83338662|FG001|Overall Study|protocol defined stopping criteria|10|||
47059162|NCT01687283|83338661|FG000|Overall Study|Lost to Follow-up|1|||
47059163|NCT01687283|83338662|FG001|Overall Study|Lost to Follow-up|1|||
47059164|NCT01687283|83338661|FG000|Overall Study|Investigator discretion|2|||
47059165|NCT01687283|83338662|FG001|Overall Study|Investigator discretion|0|||
46763520|NCT00871169|82981736|FG000|Overall Study|Patient did not receive study treatment|2|||
46763521|NCT00814632|82981740|FG000|Overall Study|Lack of Efficacy|2|||
46763522|NCT00851318|82981748|FG000|Overall Study|Withdrawal by Subject|7|||
46763523|NCT00851318|82981749|FG001|Overall Study|Withdrawal by Subject|1|||
46763524|NCT00851318|82981750|FG002|Overall Study|Withdrawal by Subject|5|||
46763525|NCT00851318|82981751|FG003|Overall Study|Withdrawal by Subject|3|||
46763526|NCT00851318|82981748|FG000|Overall Study|Adverse Event|13|||
46763527|NCT00851318|82981749|FG001|Overall Study|Adverse Event|2|||
46763528|NCT00851318|82981750|FG002|Overall Study|Adverse Event|9|||
46827922|NCT00395538|83046199|FG001|Overall Study|Non-compliance with study protocol|1|||
47059166|NCT01687283|83338661|FG000|Overall Study|Withdrawal by Subject|9|||
47059167|NCT01687283|83338662|FG001|Overall Study|Withdrawal by Subject|8|||
46763529|NCT00851318|82981751|FG003|Overall Study|Adverse Event|12|||
46763530|NCT00851318|82981748|FG000|Overall Study|Pregnancy|0|||
46827923|NCT00395538|83046200|FG002|Overall Study|Non-compliance with study protocol|0|||
46935440|NCT00157755|83171572|FG001|Overall Study|Lost to Follow-up|0|||
46935441|NCT00157755|83171573|FG002|Overall Study|Lost to Follow-up|1|||
46935442|NCT00157755|83171574|FG003|Overall Study|Lost to Follow-up|0|||
46935443|NCT00157755|83171575|FG004|Overall Study|Lost to Follow-up|0|||
47059168|NCT02684370|83338671|FG000|Part A|Adverse Event|2|||
47059169|NCT02684370|83338672|FG001|Part A|Adverse Event|0|||
47059170|NCT02684370|83338673|FG002|Part A|Adverse Event|1|||
47059171|NCT02684370|83338674|FG003|Part A|Adverse Event|0|||
47059172|NCT02684370|83338675|FG004|Part A|Adverse Event|0|||
47059173|NCT02684370|83338676|FG005|Part A|Adverse Event|0|||
47059174|NCT02684370|83338671|FG000|Part A|Lost to Follow-up|1|||
47059175|NCT02684370|83338672|FG001|Part A|Lost to Follow-up|1|||
47059176|NCT02684370|83338673|FG002|Part A|Lost to Follow-up|0|||
47059177|NCT02684370|83338674|FG003|Part A|Lost to Follow-up|0|||
46827924|NCT00395538|83046198|FG000|Overall Study|PTH resistance|0|||
46827925|NCT00395538|83046199|FG001|Overall Study|PTH resistance|0|||
46827926|NCT00395538|83046200|FG002|Overall Study|PTH resistance|1|||
46827927|NCT00395538|83046198|FG000|Overall Study|Pregnancy|1|||
46827928|NCT00395538|83046199|FG001|Overall Study|Pregnancy|0|||
46827929|NCT00395538|83046200|FG002|Overall Study|Pregnancy|0|||
46827930|NCT00395538|83046198|FG000|Overall Study|Partial recovery of parathyroid function|0|||
46827931|NCT00395538|83046199|FG001|Overall Study|Partial recovery of parathyroid function|0|||
46935444|NCT00157755|83171576|FG005|Overall Study|Lost to Follow-up|0|||
46935445|NCT00157755|83171571|FG000|Overall Study|Withdrawal by Subject|0|||
46935446|NCT00157755|83171572|FG001|Overall Study|Withdrawal by Subject|0|||
46935447|NCT00157755|83171573|FG002|Overall Study|Withdrawal by Subject|1|||
46935448|NCT00157755|83171574|FG003|Overall Study|Withdrawal by Subject|1|||
46935449|NCT00157755|83171575|FG004|Overall Study|Withdrawal by Subject|1|||
46935450|NCT00157755|83171576|FG005|Overall Study|Withdrawal by Subject|2|||
47059178|NCT02684370|83338675|FG004|Part A|Lost to Follow-up|0|||
47059179|NCT02684370|83338676|FG005|Part A|Lost to Follow-up|0|||
47059180|NCT02684370|83338671|FG000|Part A|Subject Withdrawal|1|||
47059181|NCT02684370|83338672|FG001|Part A|Subject Withdrawal|0|||
47059182|NCT02684370|83338673|FG002|Part A|Subject Withdrawal|3|||
47059183|NCT02684370|83338674|FG003|Part A|Subject Withdrawal|0|||
47059184|NCT02684370|83338675|FG004|Part A|Subject Withdrawal|0|||
47059185|NCT02684370|83338676|FG005|Part A|Subject Withdrawal|0|||
47059186|NCT02684370|83338671|FG000|Part A|Other|0|||
47059187|NCT02684370|83338672|FG001|Part A|Other|0|||
47059188|NCT02684370|83338673|FG002|Part A|Other|1|||
47059189|NCT02684370|83338674|FG003|Part A|Other|0|||
47059190|NCT02684370|83338675|FG004|Part A|Other|0|||
47059191|NCT02684370|83338676|FG005|Part A|Other|0|||
46763531|NCT00851318|82981749|FG001|Overall Study|Pregnancy|0|||
46763532|NCT00851318|82981750|FG002|Overall Study|Pregnancy|1|||
46763533|NCT00851318|82981751|FG003|Overall Study|Pregnancy|1|||
46763534|NCT00851318|82981748|FG000|Overall Study|Lack of Efficacy|8|||
46763535|NCT00851318|82981749|FG001|Overall Study|Lack of Efficacy|2|||
46763536|NCT00851318|82981750|FG002|Overall Study|Lack of Efficacy|4|||
46763537|NCT00851318|82981751|FG003|Overall Study|Lack of Efficacy|2|||
46763538|NCT00851318|82981748|FG000|Overall Study|Non-compliance with Study Procedures|2|||
46763539|NCT00851318|82981749|FG001|Overall Study|Non-compliance with Study Procedures|0|||
46763540|NCT00851318|82981750|FG002|Overall Study|Non-compliance with Study Procedures|1|||
46763541|NCT00851318|82981751|FG003|Overall Study|Non-compliance with Study Procedures|0|||
46763542|NCT00851318|82981748|FG000|Overall Study|Physician Decision|0|||
46763543|NCT00851318|82981749|FG001|Overall Study|Physician Decision|0|||
46763544|NCT00851318|82981750|FG002|Overall Study|Physician Decision|1|||
46763545|NCT00851318|82981751|FG003|Overall Study|Physician Decision|1|||
46763546|NCT00593957|82981764|FG000|Overall Study|Physician Decision|0|||
46763547|NCT00593957|82981765|FG001|Overall Study|Physician Decision|1|||
46763548|NCT00593957|82981766|FG002|Overall Study|Physician Decision|2|||
46763549|NCT00870233|82981788|FG000|Overall Study|Withdrawal by Subject|18|||
46763550|NCT00870233|82981788|FG000|Overall Study|Did not undergo laparotomy|3|||
46935451|NCT00157755|83171571|FG000|Overall Study|Explant due to infection|0|||
46935452|NCT00157755|83171572|FG001|Overall Study|Explant due to infection|0|||
47059192|NCT02684370|83338671|FG000|Part B|Adverse Event|0|||
47059193|NCT02684370|83338672|FG001|Part B|Adverse Event|0|||
47059194|NCT02684370|83338673|FG002|Part B|Adverse Event|0|||
47059195|NCT02684370|83338674|FG003|Part B|Adverse Event|0|||
47059196|NCT02684370|83338675|FG004|Part B|Adverse Event|2|||
47059197|NCT02684370|83338676|FG005|Part B|Adverse Event|1|||
47059198|NCT02684370|83338671|FG000|Part B|Lost to Follow-up|0|||
46763551|NCT00870233|82981788|FG000|Overall Study|Incompatible internet browser|2|||
46763552|NCT00870233|82981788|FG000|Overall Study|Death|1|||
46763553|NCT00851084|82981795|FG000|Overall Study|Randomized but not treated|1|||
46763554|NCT00851084|82981796|FG001|Overall Study|Randomized but not treated|0|||
46763555|NCT00851084|82981795|FG000|Overall Study|Adverse Event|26|||
46827932|NCT00395538|83046200|FG002|Overall Study|Partial recovery of parathyroid function|1|||
47059199|NCT02684370|83338672|FG001|Part B|Lost to Follow-up|0|||
47059200|NCT02684370|83338673|FG002|Part B|Lost to Follow-up|0|||
47059201|NCT02684370|83338674|FG003|Part B|Lost to Follow-up|1|||
47059202|NCT02684370|83338675|FG004|Part B|Lost to Follow-up|2|||
47059203|NCT02684370|83338676|FG005|Part B|Lost to Follow-up|5|||
47059204|NCT02684370|83338671|FG000|Part B|Subject Withdrawal|0|||
47059205|NCT02684370|83338672|FG001|Part B|Subject Withdrawal|0|||
46827933|NCT00395538|83046198|FG000|Overall Study|Participant elected to discontinue|0|||
46827934|NCT00395538|83046199|FG001|Overall Study|Participant elected to discontinue|0|||
46827935|NCT00395538|83046200|FG002|Overall Study|Participant elected to discontinue|1|||
46827936|NCT00395460|83046210|FG000|Overall Study|Withdrawal by Subject|1|||
46827937|NCT00395460|83046211|FG001|Overall Study|Withdrawal by Subject|0|||
46827938|NCT00395304|83046217|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46827939|NCT00395304|83046218|FG001|Treatment Period 1|Withdrawal by Subject|3|||
46827940|NCT00395304|83046219|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46827941|NCT00395304|83046220|FG003|Treatment Period 1|Withdrawal by Subject|2|||
46827942|NCT00395304|83046221|FG004|Treatment Period 1|Withdrawal by Subject|1|||
46827943|NCT00395304|83046222|FG005|Treatment Period 1|Withdrawal by Subject|1|||
46935453|NCT00157755|83171573|FG002|Overall Study|Explant due to infection|1|||
46935454|NCT00157755|83171574|FG003|Overall Study|Explant due to infection|0|||
46935455|NCT00157755|83171575|FG004|Overall Study|Explant due to infection|0|||
46827944|NCT00395304|83046217|FG000|Treatment Period 1|Lost to Follow-up|1|||
46827945|NCT00395304|83046218|FG001|Treatment Period 1|Lost to Follow-up|0|||
46827946|NCT00395304|83046219|FG002|Treatment Period 1|Lost to Follow-up|0|||
47059206|NCT02684370|83338673|FG002|Part B|Subject Withdrawal|0|||
47059207|NCT02684370|83338674|FG003|Part B|Subject Withdrawal|1|||
47059208|NCT02684370|83338675|FG004|Part B|Subject Withdrawal|1|||
47059209|NCT02684370|83338676|FG005|Part B|Subject Withdrawal|2|||
47059210|NCT01686581|83338703|FG000|Overall Study|Side-effects or Health Problems|15|||
47059211|NCT01686581|83338703|FG000|Overall Study|Lack of Efficacy|90|||
47059212|NCT01686581|83338703|FG000|Overall Study|Participant Concerned about Risks|6|||
47059213|NCT01686581|83338703|FG000|Overall Study|Thinks Injections Too Painful|8|||
47059214|NCT01686581|83338703|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
47059215|NCT01686581|83338703|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
47059216|NCT01686581|83338703|FG000|Overall Study|Thinks it is Inconvenient|17|||
47059217|NCT01686581|83338703|FG000|Overall Study|Other Miscellaneous Reasons|36|||
47059218|NCT01686581|83338703|FG000|Overall Study|Reason Missing|1|||
47059219|NCT02691936|83338721|FG000|Overall Study|Withdrawal by Subject|2|||
47059220|NCT02691936|83338722|FG001|Overall Study|Withdrawal by Subject|5|||
47059221|NCT01685801|83338760|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
47059222|NCT01685801|83338761|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
47059223|NCT01685801|83338762|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
47059224|NCT01685801|83338763|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
47059225|NCT01685801|83338760|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
47059226|NCT01685801|83338761|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
47059227|NCT01685801|83338762|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
47059228|NCT01685801|83338763|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
47059229|NCT01353222|83338782|FG000|Overall Study|Death|30|||
47059230|NCT01353222|83338783|FG001|Overall Study|Death|30|||
47059231|NCT01353222|83338782|FG000|Overall Study|Withdrawal by Subject|8|||
46827947|NCT00395304|83046220|FG003|Treatment Period 1|Lost to Follow-up|1|||
46827948|NCT00395304|83046221|FG004|Treatment Period 1|Lost to Follow-up|0|||
46827949|NCT00395304|83046222|FG005|Treatment Period 1|Lost to Follow-up|1|||
46827950|NCT00395304|83046217|FG000|Treatment Period 1|Physician Decision|0|||
46827951|NCT00395304|83046218|FG001|Treatment Period 1|Physician Decision|1|||
46827952|NCT00395304|83046219|FG002|Treatment Period 1|Physician Decision|0|||
46827953|NCT00395304|83046220|FG003|Treatment Period 1|Physician Decision|0|||
46827954|NCT00395304|83046221|FG004|Treatment Period 1|Physician Decision|0|||
46827955|NCT00395304|83046222|FG005|Treatment Period 1|Physician Decision|0|||
46827956|NCT00395304|83046217|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46827957|NCT00395304|83046218|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46827958|NCT00395304|83046219|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46827959|NCT00395304|83046220|FG003|Treatment Period 2|Withdrawal by Subject|1|||
46827960|NCT00395304|83046221|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46827961|NCT00395304|83046222|FG005|Treatment Period 2|Withdrawal by Subject|2|||
46935456|NCT00157755|83171576|FG005|Overall Study|Explant due to infection|0|||
46935457|NCT00157755|83171571|FG000|Overall Study|Medical reason|0|||
46935458|NCT00157755|83171572|FG001|Overall Study|Medical reason|0|||
46935459|NCT00157755|83171573|FG002|Overall Study|Medical reason|1|||
46935460|NCT00157755|83171574|FG003|Overall Study|Medical reason|1|||
47059232|NCT01353222|83338783|FG001|Overall Study|Withdrawal by Subject|5|||
47059233|NCT01353222|83338782|FG000|Overall Study|Study Terminated|31|||
47059234|NCT01353222|83338783|FG001|Overall Study|Study Terminated|37|||
47059235|NCT01353222|83338782|FG000|Overall Study|Site closed research department|1|||
47059236|NCT01353222|83338783|FG001|Overall Study|Site closed research department|0|||
47059237|NCT01684943|83338813|FG000|Overall Study|Inadequate Venous Access|3|||
47059238|NCT01684943|83338814|FG001|Overall Study|Inadequate Venous Access|0|||
46827962|NCT00395304|83046217|FG000|Treatment Period 2|Lost to Follow-up|0|||
46827963|NCT00395304|83046218|FG001|Treatment Period 2|Lost to Follow-up|3|||
46827964|NCT00395304|83046219|FG002|Treatment Period 2|Lost to Follow-up|0|||
46935461|NCT00157755|83171575|FG004|Overall Study|Medical reason|0|||
46827965|NCT00395304|83046220|FG003|Treatment Period 2|Lost to Follow-up|0|||
46827966|NCT00395304|83046221|FG004|Treatment Period 2|Lost to Follow-up|0|||
46827967|NCT00395304|83046222|FG005|Treatment Period 2|Lost to Follow-up|0|||
46827968|NCT00395304|83046217|FG000|Treatment Period 2|Physician Decision|0|||
46827969|NCT00395304|83046218|FG001|Treatment Period 2|Physician Decision|0|||
46827970|NCT00395304|83046219|FG002|Treatment Period 2|Physician Decision|1|||
46827971|NCT00395304|83046220|FG003|Treatment Period 2|Physician Decision|0|||
46827972|NCT00395304|83046221|FG004|Treatment Period 2|Physician Decision|0|||
46827973|NCT00395304|83046222|FG005|Treatment Period 2|Physician Decision|0|||
46827974|NCT00395304|83046217|FG000|Treatment Period 2|Other|0|||
46827975|NCT00395304|83046218|FG001|Treatment Period 2|Other|1|||
46827976|NCT00395304|83046219|FG002|Treatment Period 2|Other|0|||
46827977|NCT00395304|83046220|FG003|Treatment Period 2|Other|0|||
46827978|NCT00395304|83046221|FG004|Treatment Period 2|Other|0|||
46827979|NCT00395304|83046222|FG005|Treatment Period 2|Other|0|||
46827980|NCT00395304|83046217|FG000|Treatment Period 3|Withdrawal by Subject|0|||
46827981|NCT00395304|83046218|FG001|Treatment Period 3|Withdrawal by Subject|0|||
46935462|NCT00157755|83171576|FG005|Overall Study|Medical reason|0|||
46935463|NCT00157755|83171571|FG000|Overall Study|Study site closure|0|||
46935464|NCT00157755|83171572|FG001|Overall Study|Study site closure|1|||
46935465|NCT00157755|83171573|FG002|Overall Study|Study site closure|0|||
46935466|NCT00157755|83171574|FG003|Overall Study|Study site closure|0|||
46935467|NCT00157755|83171575|FG004|Overall Study|Study site closure|0|||
46935468|NCT00157755|83171576|FG005|Overall Study|Study site closure|0|||
46935469|NCT00157755|83171571|FG000|Overall Study|Subject non-compliance|0|||
46935470|NCT00157755|83171572|FG001|Overall Study|Subject non-compliance|0|||
46935471|NCT00157755|83171573|FG002|Overall Study|Subject non-compliance|0|||
46935472|NCT00157755|83171574|FG003|Overall Study|Subject non-compliance|0|||
46935473|NCT00157755|83171575|FG004|Overall Study|Subject non-compliance|0|||
46935474|NCT00157755|83171576|FG005|Overall Study|Subject non-compliance|1|||
46935475|NCT00157755|83171571|FG000|Overall Study|Study completion|0|||
46935476|NCT00157755|83171572|FG001|Overall Study|Study completion|0|||
47059239|NCT01684943|83338815|FG002|Overall Study|Inadequate Venous Access|0|||
47059240|NCT01684943|83338813|FG000|Overall Study|Principal Investigator Determination|1|||
47059241|NCT01684943|83338814|FG001|Overall Study|Principal Investigator Determination|0|||
47059242|NCT01684943|83338815|FG002|Overall Study|Principal Investigator Determination|0|||
47059243|NCT01684943|83338813|FG000|Overall Study|Excluded from Analysis|1|||
47059244|NCT01684943|83338814|FG001|Overall Study|Excluded from Analysis|1|||
47059245|NCT01684943|83338815|FG002|Overall Study|Excluded from Analysis|1|||
47059246|NCT01684943|83338813|FG000|Overall Study|Lost to Follow-up|3|||
47059247|NCT01684943|83338814|FG001|Overall Study|Lost to Follow-up|0|||
47059248|NCT01684943|83338815|FG002|Overall Study|Lost to Follow-up|0|||
47059249|NCT01684943|83338813|FG000|Overall Study|Planning Pregnancy|1|||
47059250|NCT01684943|83338814|FG001|Overall Study|Planning Pregnancy|0|||
47059251|NCT01684943|83338815|FG002|Overall Study|Planning Pregnancy|0|||
47059252|NCT01683383|83338830|FG000|Overall Study|Infant was not transported|1|||
46763556|NCT00851084|82981796|FG001|Overall Study|Adverse Event|36|||
46763557|NCT00851084|82981795|FG000|Overall Study|Disease progression|52|||
46763558|NCT00851084|82981796|FG001|Overall Study|Disease progression|47|||
46763559|NCT00851084|82981795|FG000|Overall Study|Poor compliance to protocol|1|||
46763560|NCT00851084|82981796|FG001|Overall Study|Poor compliance to protocol|1|||
46763561|NCT00851084|82981795|FG000|Overall Study|Physician Decision|13|||
46763562|NCT00851084|82981796|FG001|Overall Study|Physician Decision|14|||
46763563|NCT00851084|82981795|FG000|Overall Study|Consent withdrawn|0|||
46763564|NCT00851084|82981796|FG001|Overall Study|Consent withdrawn|2|||
46763565|NCT00851084|82981795|FG000|Overall Study|Withdrawal by Subject|11|||
46763566|NCT00851084|82981796|FG001|Overall Study|Withdrawal by Subject|12|||
46763567|NCT00851084|82981795|FG000|Overall Study|Metastatic surgery|6|||
46827982|NCT00395304|83046219|FG002|Treatment Period 3|Withdrawal by Subject|0|||
46827983|NCT00395304|83046220|FG003|Treatment Period 3|Withdrawal by Subject|1|||
46827984|NCT00395304|83046221|FG004|Treatment Period 3|Withdrawal by Subject|0|||
46827985|NCT00395304|83046222|FG005|Treatment Period 3|Withdrawal by Subject|1|||
47059253|NCT01683383|83338831|FG001|Overall Study|Infant was not transported|0|||
47059254|NCT02694744|83338839|FG000|Overall Study|Adverse Event|2|||
47059255|NCT02694744|83338840|FG001|Overall Study|Adverse Event|1|||
47059256|NCT02694744|83338839|FG000|Overall Study|Withdrawal by Subject|2|||
47059257|NCT02694744|83338840|FG001|Overall Study|Withdrawal by Subject|1|||
47059258|NCT02694744|83338839|FG000|Overall Study|Physician Decision|1|||
46763568|NCT00851084|82981796|FG001|Overall Study|Metastatic surgery|6|||
46763569|NCT00851084|82981795|FG000|Overall Study|Other|7|||
46763570|NCT00851084|82981796|FG001|Overall Study|Other|1|||
46827986|NCT00395304|83046217|FG000|Treatment Period 3|Lost to Follow-up|1|||
46827987|NCT00395304|83046218|FG001|Treatment Period 3|Lost to Follow-up|1|||
46827988|NCT00395304|83046219|FG002|Treatment Period 3|Lost to Follow-up|0|||
46827989|NCT00395304|83046220|FG003|Treatment Period 3|Lost to Follow-up|0|||
46935477|NCT00157755|83171573|FG002|Overall Study|Study completion|0|||
46935478|NCT00157755|83171574|FG003|Overall Study|Study completion|0|||
46935479|NCT00157755|83171575|FG004|Overall Study|Study completion|1|||
47059259|NCT02694744|83338840|FG001|Overall Study|Physician Decision|2|||
47059260|NCT02694744|83338839|FG000|Overall Study|Lost to Follow-up|1|||
47059261|NCT02694744|83338840|FG001|Overall Study|Lost to Follow-up|0|||
47059262|NCT02694744|83338839|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
47059263|NCT02694744|83338840|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
47059264|NCT01683071|83338854|FG000|Part 1|Lack of Efficacy|1|||
47059265|NCT01683071|83338855|FG001|Part 1|Lack of Efficacy|0|||
47059266|NCT01683071|83338856|FG002|Part 1|Lack of Efficacy|0|||
47059267|NCT01683071|83338857|FG003|Part 1|Lack of Efficacy|3|||
47059268|NCT01683071|83338858|FG004|Part 1|Lack of Efficacy|0|||
47059269|NCT01683071|83338859|FG005|Part 1|Lack of Efficacy|0|||
47059270|NCT01683071|83338854|FG000|Part 1|Withdrawal by Subject|1|||
47059271|NCT01683071|83338855|FG001|Part 1|Withdrawal by Subject|2|||
47059272|NCT01683071|83338856|FG002|Part 1|Withdrawal by Subject|2|||
47059273|NCT01683071|83338857|FG003|Part 1|Withdrawal by Subject|1|||
47059274|NCT01683071|83338858|FG004|Part 1|Withdrawal by Subject|0|||
47059275|NCT01683071|83338859|FG005|Part 1|Withdrawal by Subject|0|||
47059276|NCT01683071|83338854|FG000|Part 1|Surgery Cancelled|1|||
47059277|NCT01683071|83338855|FG001|Part 1|Surgery Cancelled|0|||
47059278|NCT01683071|83338856|FG002|Part 1|Surgery Cancelled|0|||
47059279|NCT01683071|83338857|FG003|Part 1|Surgery Cancelled|0|||
47059280|NCT01683071|83338858|FG004|Part 1|Surgery Cancelled|0|||
47059281|NCT01683071|83338859|FG005|Part 1|Surgery Cancelled|0|||
47059282|NCT01683071|83338854|FG000|Part 1|Did not receive study drug|1|||
46763571|NCT00845858|82981807|FG000|Overall Study|Withdrawal by Subject|5|||
46763572|NCT00845858|82981808|FG001|Overall Study|Withdrawal by Subject|1|||
46763573|NCT00845858|82981809|FG002|Overall Study|Withdrawal by Subject|1|||
46763574|NCT00845858|82981807|FG000|Overall Study|Adverse Event|3|||
46763575|NCT00845858|82981808|FG001|Overall Study|Adverse Event|8|||
46763576|NCT00845858|82981809|FG002|Overall Study|Adverse Event|4|||
46763577|NCT00845858|82981807|FG000|Overall Study|Protocol Violation|0|||
46763578|NCT00845858|82981808|FG001|Overall Study|Protocol Violation|0|||
46763579|NCT00845858|82981809|FG002|Overall Study|Protocol Violation|1|||
46827990|NCT00395304|83046221|FG004|Treatment Period 3|Lost to Follow-up|0|||
47059283|NCT01683071|83338855|FG001|Part 1|Did not receive study drug|0|||
47059284|NCT01683071|83338856|FG002|Part 1|Did not receive study drug|0|||
47059285|NCT01683071|83338857|FG003|Part 1|Did not receive study drug|1|||
47059286|NCT01683071|83338858|FG004|Part 1|Did not receive study drug|0|||
47059287|NCT01683071|83338859|FG005|Part 1|Did not receive study drug|0|||
47059288|NCT01683071|83338854|FG000|Part 1|Early termination; met exclusion criteria|0|||
47059289|NCT01683071|83338855|FG001|Part 1|Early termination; met exclusion criteria|2|||
47059290|NCT01683071|83338856|FG002|Part 1|Early termination; met exclusion criteria|1|||
46763580|NCT00845858|82981807|FG000|Overall Study|not eligible|0|||
46763581|NCT00845858|82981808|FG001|Overall Study|not eligible|3|||
46763582|NCT00845858|82981809|FG002|Overall Study|not eligible|2|||
47059291|NCT01683071|83338857|FG003|Part 1|Early termination; met exclusion criteria|0|||
47059292|NCT01683071|83338858|FG004|Part 1|Early termination; met exclusion criteria|0|||
47059293|NCT01683071|83338859|FG005|Part 1|Early termination; met exclusion criteria|0|||
47059294|NCT01683071|83338854|FG000|Part 2|Lack of Efficacy|0|||
47059295|NCT01683071|83338855|FG001|Part 2|Lack of Efficacy|0|||
46935480|NCT00157755|83171576|FG005|Overall Study|Study completion|2|||
46935481|NCT00702962|83171584|FG000|Overall Study|Progressive disease|0|||
47059296|NCT01683071|83338856|FG002|Part 2|Lack of Efficacy|0|||
47059297|NCT01683071|83338857|FG003|Part 2|Lack of Efficacy|0|||
47059298|NCT01683071|83338858|FG004|Part 2|Lack of Efficacy|3|||
47059299|NCT01683071|83338859|FG005|Part 2|Lack of Efficacy|4|||
47059300|NCT01683071|83338854|FG000|Part 2|Lost to Follow-up|0|||
47059301|NCT01683071|83338855|FG001|Part 2|Lost to Follow-up|0|||
47059302|NCT01683071|83338856|FG002|Part 2|Lost to Follow-up|0|||
47059303|NCT01683071|83338857|FG003|Part 2|Lost to Follow-up|0|||
47059304|NCT01683071|83338858|FG004|Part 2|Lost to Follow-up|2|||
47059305|NCT01683071|83338859|FG005|Part 2|Lost to Follow-up|0|||
47059306|NCT01683071|83338854|FG000|Part 2|Withdrawal by Subject|0|||
47059307|NCT01683071|83338855|FG001|Part 2|Withdrawal by Subject|0|||
47059308|NCT01683071|83338856|FG002|Part 2|Withdrawal by Subject|0|||
47059309|NCT01683071|83338857|FG003|Part 2|Withdrawal by Subject|0|||
47059310|NCT01683071|83338858|FG004|Part 2|Withdrawal by Subject|3|||
47059311|NCT01683071|83338859|FG005|Part 2|Withdrawal by Subject|3|||
47059312|NCT01683071|83338854|FG000|Part 2|Surgery cancelled|0|||
47059313|NCT01683071|83338855|FG001|Part 2|Surgery cancelled|0|||
47059314|NCT01683071|83338856|FG002|Part 2|Surgery cancelled|0|||
47059315|NCT01683071|83338857|FG003|Part 2|Surgery cancelled|0|||
47059316|NCT01683071|83338858|FG004|Part 2|Surgery cancelled|4|||
47059317|NCT01683071|83338859|FG005|Part 2|Surgery cancelled|2|||
47059318|NCT01683071|83338854|FG000|Part 2|Did not receive study drug|0|||
47059319|NCT01683071|83338855|FG001|Part 2|Did not receive study drug|0|||
47059320|NCT01683071|83338856|FG002|Part 2|Did not receive study drug|0|||
47059321|NCT01683071|83338857|FG003|Part 2|Did not receive study drug|0|||
47059322|NCT01683071|83338858|FG004|Part 2|Did not receive study drug|2|||
47059323|NCT01683071|83338859|FG005|Part 2|Did not receive study drug|1|||
47059324|NCT01683071|83338854|FG000|Part 2|Met exclusion criterion|0|||
47059325|NCT01683071|83338855|FG001|Part 2|Met exclusion criterion|0|||
47059326|NCT01683071|83338856|FG002|Part 2|Met exclusion criterion|0|||
47059327|NCT01683071|83338857|FG003|Part 2|Met exclusion criterion|0|||
47059328|NCT01683071|83338858|FG004|Part 2|Met exclusion criterion|1|||
47059329|NCT01683071|83338859|FG005|Part 2|Met exclusion criterion|1|||
47059330|NCT01683071|83338854|FG000|Part 2|Protocol deviation|0|||
47059331|NCT01683071|83338855|FG001|Part 2|Protocol deviation|0|||
47059332|NCT01683071|83338856|FG002|Part 2|Protocol deviation|0|||
47059333|NCT01683071|83338857|FG003|Part 2|Protocol deviation|0|||
47059334|NCT01683071|83338858|FG004|Part 2|Protocol deviation|1|||
47059335|NCT01683071|83338859|FG005|Part 2|Protocol deviation|2|||
46763583|NCT00850538|82981820|FG000|Overall Study|unable/unwilling to complete MRI|13|||
46763584|NCT00850538|82981820|FG000|Overall Study|specimen missed due to scheduling error|14|||
46935482|NCT00702962|83171585|FG001|Overall Study|Progressive disease|1|||
46935483|NCT00702962|83171584|FG000|Overall Study|Hospitalized for other health disorder|1|||
46763585|NCT00850538|82981820|FG000|Overall Study|specimen unusable|7|||
46763586|NCT00850538|82981820|FG000|Overall Study|Withdrawal by Subject|3|||
46763587|NCT00850538|82981820|FG000|Overall Study|radiology error|2|||
46763588|NCT00850538|82981820|FG000|Overall Study|Protocol Violation|2|||
46763589|NCT00850460|82981826|FG000|Overall Study|Lost to Follow-up|4|||
46827991|NCT00395304|83046222|FG005|Treatment Period 3|Lost to Follow-up|0|||
46827992|NCT00395304|83046217|FG000|Treatment Period 3|Physician Decision|0|||
46935484|NCT00702962|83171585|FG001|Overall Study|Hospitalized for other health disorder|0|||
46935485|NCT01379508|83171597|FG000|Treatment to Week 104|Adverse Event|2|||
46935486|NCT01379508|83171598|FG001|Treatment to Week 104|Adverse Event|0|||
46935487|NCT01379508|83171599|FG002|Treatment to Week 104|Adverse Event|5|||
46935488|NCT01379508|83171600|FG003|Treatment to Week 104|Adverse Event|0|||
46935489|NCT01379508|83171597|FG000|Treatment to Week 104|Abnormal lab value|1|||
46935490|NCT01379508|83171598|FG001|Treatment to Week 104|Abnormal lab value|0|||
46935491|NCT01379508|83171599|FG002|Treatment to Week 104|Abnormal lab value|0|||
46935492|NCT01379508|83171600|FG003|Treatment to Week 104|Abnormal lab value|0|||
46935493|NCT01379508|83171597|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
46935494|NCT01379508|83171598|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
46935495|NCT01379508|83171599|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
46935496|NCT01379508|83171600|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
46935497|NCT01379508|83171597|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
47059336|NCT01683071|83338854|FG000|Part 2|Withdrawal by investigator decision|0|||
47059337|NCT01683071|83338855|FG001|Part 2|Withdrawal by investigator decision|0|||
47059338|NCT01683071|83338856|FG002|Part 2|Withdrawal by investigator decision|0|||
47059339|NCT01683071|83338857|FG003|Part 2|Withdrawal by investigator decision|0|||
46763590|NCT00850460|82981827|FG001|Overall Study|Lost to Follow-up|4|||
46763591|NCT00661492|82981835|FG000|Overall Study|Adverse Event|16|||
47059340|NCT01683071|83338858|FG004|Part 2|Withdrawal by investigator decision|1|||
47059341|NCT01683071|83338859|FG005|Part 2|Withdrawal by investigator decision|2|||
47059342|NCT01567865|83338883|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
47059343|NCT01567865|83338884|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
47059344|NCT01567865|83338885|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
47059345|NCT01567865|83338886|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
47059346|NCT01567865|83338883|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
47059347|NCT01567865|83338884|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
47059348|NCT01567865|83338885|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
47059349|NCT01567865|83338886|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
47059350|NCT01567163|83338897|FG000|Overall Study|Progressive Disease|2|||
47059351|NCT01567163|83338897|FG000|Overall Study|Lost to Follow-up|2|||
47059352|NCT01567085|83338906|FG000|Overall Study|Death|6|||
47059353|NCT01567085|83338906|FG000|Overall Study|Adverse Event|6|||
47059354|NCT01567085|83338906|FG000|Overall Study|Lost to Follow-up|3|||
47059355|NCT01567085|83338906|FG000|Overall Study|Graft loss|2|||
47059356|NCT01567085|83338906|FG000|Overall Study|Renal transplantectomy|1|||
47059357|NCT01567085|83338906|FG000|Overall Study|Returned to chronic dialysis|1|||
47059358|NCT01567085|83338906|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
47059359|NCT01566773|83338910|FG000|Overall Study|Protocol specified criteria|4|||
47059360|NCT01566773|83338910|FG000|Overall Study|Protocol Violation|4|||
47059361|NCT01566773|83338910|FG000|Overall Study|Withdrawal by Subject|9|||
47059362|NCT01566773|83338910|FG000|Overall Study|Administrative reason|1|||
47059363|NCT01566773|83338910|FG000|Overall Study|Adverse Event|10|||
47059364|NCT01566773|83338910|FG000|Overall Study|Physician Decision|2|||
47059365|NCT01566149|83338932|FG000|Overall Study|Adverse Event|0|||
47059366|NCT01566149|83338933|FG001|Overall Study|Adverse Event|1|||
47059367|NCT01566149|83338932|FG000|Overall Study|Non-compliance with study medication|2|||
47059368|NCT01566149|83338933|FG001|Overall Study|Non-compliance with study medication|0|||
47059369|NCT01566149|83338932|FG000|Overall Study|Protocol Violation|0|||
47059370|NCT01566149|83338933|FG001|Overall Study|Protocol Violation|1|||
47059371|NCT01566149|83338932|FG000|Overall Study|Withdrawal by Subject|1|||
47059372|NCT01566149|83338933|FG001|Overall Study|Withdrawal by Subject|0|||
47059373|NCT01565993|83338941|FG000|Overall Study|Physician Decision|0|||
47059374|NCT01565993|83338942|FG001|Overall Study|Physician Decision|3|||
47059375|NCT01565291|83338950|FG000|Overall Study|Withdrawal by Subject|1|||
47059376|NCT01565291|83338951|FG001|Overall Study|Withdrawal by Subject|0|||
47059377|NCT02691702|83338968|FG000|Overall Study|Adverse Event|1|||
47059378|NCT02691702|83338969|FG001|Overall Study|Adverse Event|0|||
47059379|NCT02691702|83338970|FG002|Overall Study|Adverse Event|0|||
46935498|NCT01379508|83171598|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
46935499|NCT01379508|83171599|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
46935500|NCT01379508|83171600|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
46935501|NCT01379508|83171597|FG000|Treatment to Week 104|Lost to Follow-up|5|||
46935502|NCT01379508|83171598|FG001|Treatment to Week 104|Lost to Follow-up|0|||
46935503|NCT01379508|83171599|FG002|Treatment to Week 104|Lost to Follow-up|3|||
46935504|NCT01379508|83171600|FG003|Treatment to Week 104|Lost to Follow-up|0|||
46935505|NCT01379508|83171597|FG000|Treatment to Week 104|Administrative problems|3|||
47059380|NCT02691702|83338971|FG003|Overall Study|Adverse Event|0|||
47059381|NCT02691702|83338972|FG004|Overall Study|Adverse Event|0|||
47059382|NCT02691702|83338973|FG005|Overall Study|Adverse Event|0|||
47059383|NCT02691702|83338974|FG006|Overall Study|Adverse Event|0|||
47059384|NCT02691702|83338975|FG007|Overall Study|Adverse Event|0|||
47059385|NCT02691702|83338976|FG008|Overall Study|Adverse Event|1|||
47059386|NCT02691702|83338977|FG009|Overall Study|Adverse Event|0|||
47059387|NCT02691702|83338978|FG010|Overall Study|Adverse Event|1|||
47059388|NCT02691702|83338968|FG000|Overall Study|Lost to Follow-up|0|||
47059389|NCT02691702|83338969|FG001|Overall Study|Lost to Follow-up|0|||
47059390|NCT02691702|83338970|FG002|Overall Study|Lost to Follow-up|1|||
47059391|NCT02691702|83338971|FG003|Overall Study|Lost to Follow-up|0|||
47059392|NCT02691702|83338972|FG004|Overall Study|Lost to Follow-up|0|||
47059393|NCT02691702|83338973|FG005|Overall Study|Lost to Follow-up|2|||
47059394|NCT02691702|83338974|FG006|Overall Study|Lost to Follow-up|0|||
46935506|NCT01379508|83171598|FG001|Treatment to Week 104|Administrative problems|1|||
47059395|NCT02691702|83338975|FG007|Overall Study|Lost to Follow-up|0|||
47059396|NCT02691702|83338976|FG008|Overall Study|Lost to Follow-up|0|||
47059397|NCT02691702|83338977|FG009|Overall Study|Lost to Follow-up|0|||
47059398|NCT02691702|83338978|FG010|Overall Study|Lost to Follow-up|1|||
47059399|NCT02691702|83338968|FG000|Overall Study|Withdrawal by Subject|1|||
47059400|NCT02691702|83338969|FG001|Overall Study|Withdrawal by Subject|1|||
46935507|NCT01379508|83171599|FG002|Treatment to Week 104|Administrative problems|0|||
47059401|NCT02691702|83338970|FG002|Overall Study|Withdrawal by Subject|0|||
47059402|NCT02691702|83338971|FG003|Overall Study|Withdrawal by Subject|0|||
47059403|NCT02691702|83338972|FG004|Overall Study|Withdrawal by Subject|0|||
47059404|NCT02691702|83338973|FG005|Overall Study|Withdrawal by Subject|1|||
47059405|NCT02691702|83338974|FG006|Overall Study|Withdrawal by Subject|2|||
47059406|NCT02691702|83338975|FG007|Overall Study|Withdrawal by Subject|0|||
47059407|NCT02691702|83338976|FG008|Overall Study|Withdrawal by Subject|0|||
47059408|NCT02691702|83338977|FG009|Overall Study|Withdrawal by Subject|0|||
46637483|NCT01474512|82811390|FG014|Induction Period|Protocol Violation|0|||
47059409|NCT02691702|83338978|FG010|Overall Study|Withdrawal by Subject|0|||
47059410|NCT02691702|83338968|FG000|Overall Study|Other|0|||
47059411|NCT02691702|83338969|FG001|Overall Study|Other|0|||
47059412|NCT02691702|83338970|FG002|Overall Study|Other|0|||
47059413|NCT02691702|83338971|FG003|Overall Study|Other|0|||
47059414|NCT02691702|83338972|FG004|Overall Study|Other|0|||
47059415|NCT02691702|83338973|FG005|Overall Study|Other|0|||
47059416|NCT02691702|83338974|FG006|Overall Study|Other|1|||
47059417|NCT02691702|83338975|FG007|Overall Study|Other|0|||
47059418|NCT02691702|83338976|FG008|Overall Study|Other|1|||
47059419|NCT02691702|83338977|FG009|Overall Study|Other|0|||
47059420|NCT02691702|83338978|FG010|Overall Study|Other|0|||
47059421|NCT02691702|83338968|FG000|Overall Study|Protocol Violation|0|||
47059422|NCT02691702|83338969|FG001|Overall Study|Protocol Violation|0|||
46637484|NCT01474512|82811391|FG015|Induction Period|Protocol Violation|0|||
46637485|NCT01474512|82811392|FG016|Induction Period|Protocol Violation|0|||
46637486|NCT01474512|82811393|FG017|Induction Period|Protocol Violation|0|||
46637487|NCT01474512|82811376|FG000|Induction Period|Sponsor Decision|1|||
46763592|NCT00661492|82981836|FG001|Overall Study|Adverse Event|13|||
46763593|NCT00661492|82981835|FG000|Overall Study|Disease Progression|44|||
47059423|NCT02691702|83338970|FG002|Overall Study|Protocol Violation|0|||
47059424|NCT02691702|83338971|FG003|Overall Study|Protocol Violation|0|||
46763594|NCT00661492|82981836|FG001|Overall Study|Disease Progression|14|||
46763595|NCT00661492|82981835|FG000|Overall Study|Patient Request|6|||
46763596|NCT00661492|82981836|FG001|Overall Study|Patient Request|1|||
46763597|NCT00661492|82981835|FG000|Overall Study|Investigator Request|1|||
46763598|NCT00661492|82981836|FG001|Overall Study|Investigator Request|0|||
46763599|NCT00661492|82981835|FG000|Overall Study|Lost to Follow-up|0|||
46763600|NCT00661492|82981836|FG001|Overall Study|Lost to Follow-up|1|||
46763601|NCT00661492|82981835|FG000|Overall Study|Other|1|||
46763602|NCT00661492|82981836|FG001|Overall Study|Other|0|||
46763603|NCT00850070|82981844|FG000|Overall Study|Lack of Efficacy|1|||
46827993|NCT00395304|83046218|FG001|Treatment Period 3|Physician Decision|1|||
46827994|NCT00395304|83046219|FG002|Treatment Period 3|Physician Decision|0|||
46827995|NCT00395304|83046220|FG003|Treatment Period 3|Physician Decision|0|||
46827996|NCT00395304|83046221|FG004|Treatment Period 3|Physician Decision|0|||
46827997|NCT00395304|83046222|FG005|Treatment Period 3|Physician Decision|0|||
46827998|NCT00395304|83046217|FG000|Treatment Period 3|Other|0|||
46827999|NCT00395304|83046218|FG001|Treatment Period 3|Other|0|||
47059425|NCT02691702|83338972|FG004|Overall Study|Protocol Violation|0|||
47059426|NCT02691702|83338973|FG005|Overall Study|Protocol Violation|0|||
47059427|NCT02691702|83338974|FG006|Overall Study|Protocol Violation|0|||
46637488|NCT01474512|82811377|FG001|Induction Period|Sponsor Decision|1|||
46763604|NCT00850070|82981845|FG001|Overall Study|Lack of Efficacy|1|||
46763605|NCT00850070|82981844|FG000|Overall Study|Adverse Event|2|||
46763606|NCT00850070|82981845|FG001|Overall Study|Adverse Event|0|||
46763607|NCT00592358|82981856|FG000|Overall Study|Withdrawal by Subject|2|||
46763608|NCT00592358|82981856|FG000|Overall Study|Adverse Event|1|||
46828000|NCT00395304|83046219|FG002|Treatment Period 3|Other|0|||
46828001|NCT00395304|83046220|FG003|Treatment Period 3|Other|1|||
46828002|NCT00395304|83046221|FG004|Treatment Period 3|Other|0|||
46828003|NCT00395304|83046222|FG005|Treatment Period 3|Other|0|||
46828004|NCT00395226|83046231|FG000|Overall Study|Adverse Event|4|||
46828005|NCT00395226|83046232|FG001|Overall Study|Adverse Event|3|||
46828006|NCT00395226|83046231|FG000|Overall Study|Withdrawal by Subject|0|||
46828007|NCT00395226|83046232|FG001|Overall Study|Withdrawal by Subject|1|||
46828008|NCT00395226|83046231|FG000|Overall Study|Lost to Follow-up|0|||
46828009|NCT00395226|83046232|FG001|Overall Study|Lost to Follow-up|1|||
46828010|NCT00394914|83046240|FG000|Treatment Period|Adverse Event|0|||
46828011|NCT00394914|83046241|FG001|Treatment Period|Adverse Event|3|||
46935508|NCT01379508|83171600|FG003|Treatment to Week 104|Administrative problems|0|||
46935509|NCT01379508|83171597|FG000|Treatment to Week 104|Protocol Violation|1|||
46935510|NCT01379508|83171598|FG001|Treatment to Week 104|Protocol Violation|1|||
47059428|NCT02691702|83338975|FG007|Overall Study|Protocol Violation|0|||
47059429|NCT02691702|83338976|FG008|Overall Study|Protocol Violation|0|||
47059430|NCT02691702|83338977|FG009|Overall Study|Protocol Violation|2|||
47059431|NCT02691702|83338978|FG010|Overall Study|Protocol Violation|0|||
47059432|NCT01564277|83339012|FG000|Overall Study|Protocol Violation|0|||
47059433|NCT01564277|83339013|FG001|Overall Study|Protocol Violation|1|||
47059434|NCT01564277|83339012|FG000|Overall Study|Physician Decision|1|||
46763609|NCT00592358|82981856|FG000|Overall Study|Lack of Efficacy|2|||
46763610|NCT00592358|82981856|FG000|Overall Study|Inability to swallow pills|1|||
46763611|NCT00814320|82981862|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
46763612|NCT00814320|82981863|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
46828012|NCT00394914|83046242|FG002|Treatment Period|Adverse Event|1|||
46828013|NCT00394914|83046240|FG000|Treatment Period|Lost to Follow-up|0|||
47059435|NCT01564277|83339013|FG001|Overall Study|Physician Decision|0|||
47059436|NCT02679222|83339019|FG000|Overall Study|No time for project|1|||
47059437|NCT01563185|83339031|FG000|Overall Study|Withdrawal by Subject|1|||
47059438|NCT01563185|83339031|FG000|Overall Study|Non-Compliance with study drug|1|||
47059439|NCT03305848|83339035|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
47059440|NCT03305848|83339035|FG000|Overall Study|Physician Decision|2|||
47059441|NCT01563029|83339044|FG000|Overall Study|Adverse Event|1|||
47059442|NCT01563029|83339045|FG001|Overall Study|Adverse Event|0|||
47059443|NCT01563029|83339046|FG002|Overall Study|Adverse Event|1|||
47059444|NCT01563029|83339047|FG003|Overall Study|Adverse Event|2|||
47059445|NCT01563029|83339048|FG004|Overall Study|Adverse Event|1|||
47059446|NCT01563029|83339044|FG000|Overall Study|Lack of Efficacy|42|||
47059447|NCT01563029|83339045|FG001|Overall Study|Lack of Efficacy|16|||
47059448|NCT01563029|83339046|FG002|Overall Study|Lack of Efficacy|23|||
47059449|NCT01563029|83339047|FG003|Overall Study|Lack of Efficacy|21|||
47059450|NCT01563029|83339048|FG004|Overall Study|Lack of Efficacy|19|||
47059451|NCT01563029|83339044|FG000|Overall Study|Protocol Violation|1|||
47059452|NCT01563029|83339045|FG001|Overall Study|Protocol Violation|2|||
47059453|NCT01563029|83339046|FG002|Overall Study|Protocol Violation|3|||
47059454|NCT01563029|83339047|FG003|Overall Study|Protocol Violation|1|||
47059455|NCT01563029|83339048|FG004|Overall Study|Protocol Violation|3|||
47059456|NCT01563029|83339044|FG000|Overall Study|Protocol defined stopping criteria|1|||
47059457|NCT01563029|83339045|FG001|Overall Study|Protocol defined stopping criteria|0|||
47059458|NCT01563029|83339046|FG002|Overall Study|Protocol defined stopping criteria|0|||
47059459|NCT01563029|83339047|FG003|Overall Study|Protocol defined stopping criteria|0|||
47059460|NCT01563029|83339048|FG004|Overall Study|Protocol defined stopping criteria|0|||
47059461|NCT01563029|83339044|FG000|Overall Study|Lost to Follow-up|1|||
47059462|NCT01563029|83339045|FG001|Overall Study|Lost to Follow-up|0|||
47059463|NCT01563029|83339046|FG002|Overall Study|Lost to Follow-up|1|||
47059464|NCT01563029|83339047|FG003|Overall Study|Lost to Follow-up|1|||
47059465|NCT01563029|83339048|FG004|Overall Study|Lost to Follow-up|1|||
47059466|NCT01563029|83339044|FG000|Overall Study|Physician Decision|3|||
47059467|NCT01563029|83339045|FG001|Overall Study|Physician Decision|5|||
47059468|NCT01563029|83339046|FG002|Overall Study|Physician Decision|2|||
47059469|NCT01563029|83339047|FG003|Overall Study|Physician Decision|4|||
47059470|NCT01563029|83339048|FG004|Overall Study|Physician Decision|2|||
47059471|NCT01563029|83339044|FG000|Overall Study|Withdrawal by Subject|4|||
47059472|NCT01563029|83339045|FG001|Overall Study|Withdrawal by Subject|1|||
47059473|NCT01563029|83339046|FG002|Overall Study|Withdrawal by Subject|3|||
47059474|NCT01563029|83339047|FG003|Overall Study|Withdrawal by Subject|4|||
47059475|NCT01563029|83339048|FG004|Overall Study|Withdrawal by Subject|3|||
47059476|NCT01562873|83339061|FG000|Overall Study|Disease Progression per RECIST|10|||
47059477|NCT01562873|83339062|FG001|Overall Study|Disease Progression per RECIST|0|||
47059478|NCT01562873|83339061|FG000|Overall Study|Adverse Event|1|||
47059479|NCT01562873|83339062|FG001|Overall Study|Adverse Event|0|||
47059480|NCT01562873|83339061|FG000|Overall Study|Clinical Disease Progression|9|||
47059481|NCT01562873|83339062|FG001|Overall Study|Clinical Disease Progression|0|||
47059482|NCT01562873|83339061|FG000|Overall Study|Clinical PD and adverse event|1|||
47059483|NCT01562873|83339062|FG001|Overall Study|Clinical PD and adverse event|0|||
47059484|NCT03273712|83339066|FG000|Overall Study|Death|5|||
47059485|NCT03273712|83339066|FG000|Overall Study|Adverse Event|1|||
47059486|NCT03273712|83339066|FG000|Overall Study|Disease Progression|1|||
46763613|NCT00814320|82981862|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
46828014|NCT00394914|83046241|FG001|Treatment Period|Lost to Follow-up|1|||
46828015|NCT00394914|83046242|FG002|Treatment Period|Lost to Follow-up|0|||
46763614|NCT00814320|82981863|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
46763615|NCT00814320|82981862|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
46763616|NCT00814320|82981863|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
46763617|NCT00814320|82981862|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
46763618|NCT00814320|82981863|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
46763619|NCT00814320|82981862|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
46828016|NCT00394914|83046240|FG000|Treatment Period|Withdrawal by Subject|0|||
46828017|NCT00394914|83046241|FG001|Treatment Period|Withdrawal by Subject|2|||
47059487|NCT01562327|83339071|FG000|Overall Study|Adverse Event|2|||
46763620|NCT00814320|82981863|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
46763621|NCT00814320|82981862|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
46763622|NCT00814320|82981863|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
47059488|NCT01562327|83339071|FG000|Overall Study|Lack of Efficacy|1|||
47059489|NCT01562327|83339071|FG000|Overall Study|Participant drop-out|1|||
47059490|NCT01562327|83339071|FG000|Overall Study|Infusion not received at 6 month window|4|||
46828018|NCT00394914|83046242|FG002|Treatment Period|Withdrawal by Subject|2|||
47059491|NCT01561313|83339078|FG000|Overall Study|Withdrawal by Subject|1|||
47059492|NCT01561313|83339079|FG001|Overall Study|Withdrawal by Subject|0|||
47059493|NCT01561313|83339078|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
47059494|NCT01561313|83339079|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
47059495|NCT01561079|83339085|FG000|Overall Study|Physician Decision|17|||
47059496|NCT01561079|83339085|FG000|Overall Study|Withdrawal by Subject|59|||
47059497|NCT01561079|83339085|FG000|Overall Study|Protocol Violation|2|||
47059498|NCT01559675|83339130|FG000|Overall Study|Protocol Violation|1|||
47059499|NCT01559675|83339131|FG001|Overall Study|Protocol Violation|2|||
47059500|NCT01559675|83339130|FG000|Overall Study|2nd operation on same patient excluded|14|||
47059501|NCT01559675|83339131|FG001|Overall Study|2nd operation on same patient excluded|12|||
47059502|NCT01374906|83339139|FG000|Overall Study|Abnormal laboratory value(s)|0|||
47059503|NCT01374906|83339140|FG001|Overall Study|Abnormal laboratory value(s)|3|||
47059504|NCT01374906|83339139|FG000|Overall Study|Administrative problems|2|||
47059505|NCT01374906|83339140|FG001|Overall Study|Administrative problems|2|||
47059506|NCT01374906|83339139|FG000|Overall Study|Adverse Event|10|||
47059507|NCT01374906|83339140|FG001|Overall Study|Adverse Event|11|||
47059508|NCT01374906|83339139|FG000|Overall Study|Death|0|||
47059509|NCT01374906|83339140|FG001|Overall Study|Death|2|||
47059510|NCT01374906|83339139|FG000|Overall Study|Protocol Violation|2|||
47059511|NCT01374906|83339140|FG001|Overall Study|Protocol Violation|2|||
47059512|NCT01374906|83339139|FG000|Overall Study|Withdrawal by Subject|15|||
47059513|NCT01374906|83339140|FG001|Overall Study|Withdrawal by Subject|9|||
47059514|NCT01374906|83339139|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
47059515|NCT01374906|83339140|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
47059516|NCT02683746|83339170|FG000|Overall Study|Adverse Event|3|||
47059517|NCT02683746|83339171|FG001|Overall Study|Adverse Event|2|||
47059518|NCT02683746|83339170|FG000|Overall Study|Lost to Follow-up|5|||
47059519|NCT02683746|83339171|FG001|Overall Study|Lost to Follow-up|6|||
47059520|NCT02683746|83339170|FG000|Overall Study|Withdrawal by Subject|6|||
47059521|NCT02683746|83339171|FG001|Overall Study|Withdrawal by Subject|5|||
47059522|NCT02683746|83339170|FG000|Overall Study|Physician Decision|2|||
47059523|NCT02683746|83339171|FG001|Overall Study|Physician Decision|1|||
47059524|NCT02691468|83339179|FG000|Overall Study|Bronchial blocker use|2|||
47059525|NCT02691468|83339180|FG001|Overall Study|Bronchial blocker use|1|||
47059526|NCT02691468|83339179|FG000|Overall Study|Lost to Follow-up|2|||
47059527|NCT02691468|83339180|FG001|Overall Study|Lost to Follow-up|1|||
47059528|NCT02691468|83339179|FG000|Overall Study|Failure to advance FOB|2|||
47059529|NCT02691468|83339180|FG001|Overall Study|Failure to advance FOB|0|||
47059530|NCT02678676|83339188|FG000|Overall Study|Death|619|||
47059531|NCT02678676|83339189|FG001|Overall Study|Death|649|||
47059532|NCT02678676|83339188|FG000|Overall Study|Withdrawal by Subject|13|||
47059533|NCT02678676|83339189|FG001|Overall Study|Withdrawal by Subject|5|||
47059534|NCT02678676|83339188|FG000|Overall Study|Lost to Follow-up|171|||
47059535|NCT02678676|83339189|FG001|Overall Study|Lost to Follow-up|151|||
47059536|NCT02678676|83339188|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
47059537|NCT02678676|83339189|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
47059538|NCT01558739|83339195|FG000|Overall Study|Adverse Event|7|||
47059539|NCT01558739|83339195|FG000|Overall Study|Withdrawal by Subject|2|||
47059540|NCT01558739|83339195|FG000|Overall Study|Death|3|||
47059541|NCT01558739|83339195|FG000|Overall Study|Disease Progression|4|||
47059542|NCT01558739|83339195|FG000|Overall Study|Protocol Violation|1|||
47059543|NCT02683668|83339199|FG000|Period 2|Withdrawal by Subject|0|||
47059544|NCT02683668|83339200|FG001|Period 2|Withdrawal by Subject|1|||
47059545|NCT02683668|83339201|FG002|Period 2|Withdrawal by Subject|0|||
47059546|NCT02678286|83339209|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
47059547|NCT02678286|83339210|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
47059548|NCT02678286|83339209|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
47059549|NCT02678286|83339210|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
47059550|NCT02678286|83339209|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
47059551|NCT02678286|83339210|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
47059552|NCT02678286|83339209|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
47059553|NCT02678286|83339210|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
47059554|NCT02678286|83339209|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
47059555|NCT02678286|83339210|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
47059556|NCT02682264|83339218|FG000|Overall Study|Withdrawal by Subject|56|||
46935511|NCT01379508|83171599|FG002|Treatment to Week 104|Protocol Violation|1|||
46935512|NCT01379508|83171600|FG003|Treatment to Week 104|Protocol Violation|0|||
46935513|NCT01379508|83171597|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
46935514|NCT01379508|83171598|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
47059557|NCT02682264|83339219|FG001|Overall Study|Withdrawal by Subject|45|||
47059558|NCT02682264|83339218|FG000|Overall Study|Lost to Follow-up|49|||
47059559|NCT02682264|83339219|FG001|Overall Study|Lost to Follow-up|41|||
47059560|NCT02682264|83339218|FG000|Overall Study|Lack of Efficacy|14|||
46935515|NCT01379508|83171599|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
46935516|NCT01379508|83171600|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
47059561|NCT02682264|83339219|FG001|Overall Study|Lack of Efficacy|16|||
47059562|NCT02682264|83339218|FG000|Overall Study|Withdrawal by Parent|6|||
47059563|NCT02682264|83339219|FG001|Overall Study|Withdrawal by Parent|7|||
47059564|NCT02682264|83339218|FG000|Overall Study|Adverse Event|9|||
47059565|NCT02682264|83339219|FG001|Overall Study|Adverse Event|0|||
47059566|NCT02682264|83339218|FG000|Overall Study|Noncompliance with study drug|1|||
46935517|NCT01379508|83171597|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
46935518|NCT01379508|83171598|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
46935519|NCT01379508|83171599|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
46935520|NCT01379508|83171600|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
46935521|NCT01379508|83171597|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
46935522|NCT01379508|83171598|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
46935523|NCT01379508|83171599|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
46935524|NCT01379508|83171600|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
47059567|NCT02682264|83339219|FG001|Overall Study|Noncompliance with study drug|4|||
47059568|NCT02682264|83339218|FG000|Overall Study|Pregnancy|1|||
47059569|NCT02682264|83339219|FG001|Overall Study|Pregnancy|2|||
46828019|NCT00394914|83046240|FG000|Treatment Period|Noncompliance with protocol|0|||
46828020|NCT00394914|83046241|FG001|Treatment Period|Noncompliance with protocol|3|||
46828021|NCT00394914|83046242|FG002|Treatment Period|Noncompliance with protocol|2|||
46828022|NCT00394914|83046240|FG000|Treatment Period|Did not meet protocol eligibility|0|||
46828023|NCT00394914|83046241|FG001|Treatment Period|Did not meet protocol eligibility|1|||
46828024|NCT00394914|83046242|FG002|Treatment Period|Did not meet protocol eligibility|1|||
46828025|NCT00366444|83046250|FG000|Overall Study|Withdrawal by Subject|1|||
46828026|NCT00366444|83046251|FG001|Overall Study|Withdrawal by Subject|1|||
46828027|NCT00366444|83046250|FG000|Overall Study|Lack of Efficacy|0|||
46828028|NCT00366444|83046251|FG001|Overall Study|Lack of Efficacy|1|||
46828029|NCT00365976|83046259|FG000|Overall Study|Withdrawal by Subject|1|||
46828030|NCT00365976|83046260|FG001|Overall Study|Withdrawal by Subject|5|||
46828031|NCT00379236|83046268|FG000|Double-blind|Adverse Event|11|||
46828032|NCT00379236|83046269|FG001|Double-blind|Adverse Event|6|||
46828033|NCT00379236|83046270|FG002|Double-blind|Adverse Event|0|||
46828034|NCT00379236|83046268|FG000|Double-blind|Protocol Violation|3|||
46828035|NCT00379236|83046269|FG001|Double-blind|Protocol Violation|3|||
46828036|NCT00379236|83046270|FG002|Double-blind|Protocol Violation|0|||
46828037|NCT00379236|83046268|FG000|Double-blind|Withdrawal by Subject|12|||
46828038|NCT00379236|83046269|FG001|Double-blind|Withdrawal by Subject|13|||
46828039|NCT00379236|83046270|FG002|Double-blind|Withdrawal by Subject|0|||
46828040|NCT00379236|83046268|FG000|Double-blind|Lost to Follow-up|4|||
46828041|NCT00379236|83046269|FG001|Double-blind|Lost to Follow-up|3|||
46828042|NCT00379236|83046270|FG002|Double-blind|Lost to Follow-up|0|||
46828043|NCT00379236|83046268|FG000|Double-blind|Use of exclusionary medication|1|||
46828044|NCT00379236|83046269|FG001|Double-blind|Use of exclusionary medication|2|||
46828045|NCT00379236|83046270|FG002|Double-blind|Use of exclusionary medication|0|||
47059570|NCT02682264|83339218|FG000|Overall Study|Recovery|1|||
47059571|NCT02682264|83339219|FG001|Overall Study|Recovery|2|||
47059572|NCT02682264|83339218|FG000|Overall Study|Progressive Disease|1|||
47059573|NCT02682264|83339219|FG001|Overall Study|Progressive Disease|0|||
47059574|NCT02682264|83339218|FG000|Overall Study|Technical Problems|0|||
47059575|NCT02682264|83339219|FG001|Overall Study|Technical Problems|1|||
47059576|NCT02682264|83339218|FG000|Overall Study|Moved abroad and unable to continue|0|||
47059577|NCT02682264|83339219|FG001|Overall Study|Moved abroad and unable to continue|3|||
47059578|NCT02682264|83339218|FG000|Overall Study|Stopped test article application|0|||
47059579|NCT02682264|83339219|FG001|Overall Study|Stopped test article application|1|||
47059580|NCT01566721|83339227|FG000|Treatment Period|Withdrawal by Subject|35|||
47059581|NCT01566721|83339228|FG001|Treatment Period|Withdrawal by Subject|9|||
46637489|NCT01474512|82811378|FG002|Induction Period|Sponsor Decision|1|||
46637490|NCT01474512|82811379|FG003|Induction Period|Sponsor Decision|0|||
46637491|NCT01474512|82811380|FG004|Induction Period|Sponsor Decision|0|||
46763623|NCT00814320|82981862|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
46763624|NCT00814320|82981863|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
46763625|NCT00814320|82981862|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
46763626|NCT00814320|82981863|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
46763627|NCT00814320|82981862|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
46763628|NCT00814320|82981863|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
46763629|NCT00814320|82981862|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
46763630|NCT00814320|82981863|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
46763631|NCT00869999|82981886|FG000|Overall Study|Withdrawal by Subject|1|||
46763632|NCT00869999|82981886|FG000|Overall Study|removed prior to starting therapy|1|||
46763633|NCT00570232|82981890|FG000|Overall Study|Adverse Event|10|||
46763634|NCT00570232|82981890|FG000|Overall Study|discontinued due to medical condition|3|||
46828046|NCT00379236|83046268|FG000|Double-blind|Other|3|||
46828047|NCT00379236|83046269|FG001|Double-blind|Other|7|||
47059582|NCT01566721|83339227|FG000|Treatment Period|Disease Progression/Recurrence|37|||
47059583|NCT01566721|83339228|FG001|Treatment Period|Disease Progression/Recurrence|13|||
47059584|NCT01566721|83339227|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
46828048|NCT00379236|83046270|FG002|Double-blind|Other|0|||
47059585|NCT01566721|83339228|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
47059586|NCT01566721|83339227|FG000|Treatment Period|Other|13|||
47059587|NCT01566721|83339228|FG001|Treatment Period|Other|2|||
47059588|NCT01566721|83339227|FG000|Treatment Period|Lack of Compliance|5|||
47059589|NCT01566721|83339228|FG001|Treatment Period|Lack of Compliance|1|||
47059590|NCT01566721|83339227|FG000|Treatment Period|Adverse Event|100|||
47059591|NCT01566721|83339228|FG001|Treatment Period|Adverse Event|30|||
47059592|NCT01566721|83339227|FG000|Treatment Period|Pregnancy|1|||
47059593|NCT01566721|83339228|FG001|Treatment Period|Pregnancy|0|||
47059594|NCT01566721|83339227|FG000|Safety Follow-up|Physician Decision|6|||
46763635|NCT00570232|82981890|FG000|Overall Study|discontinued due to recurrence|8|||
46763636|NCT00570232|82981890|FG000|Overall Study|discontinued due to noncompliance|2|||
46763637|NCT00809328|82981894|FG000|Overall Study|Lack of Efficacy|18|||
46763638|NCT00809328|82981894|FG000|Overall Study|Adverse Event|6|||
46763639|NCT00809328|82981894|FG000|Overall Study|Protocol Violation|3|||
46763640|NCT00809328|82981894|FG000|Overall Study|Withdrawal by Subject|2|||
46828049|NCT00379236|83046268|FG000|Double-blind|Data could not be retrieved|2|||
46828050|NCT00379236|83046269|FG001|Double-blind|Data could not be retrieved|2|||
46828051|NCT00379236|83046270|FG002|Double-blind|Data could not be retrieved|0|||
46828052|NCT00379236|83046268|FG000|Open-label Extension|Adverse Event|0|||
46828053|NCT00379236|83046269|FG001|Open-label Extension|Adverse Event|0|||
46828054|NCT00379236|83046270|FG002|Open-label Extension|Adverse Event|13|||
46828055|NCT00379236|83046268|FG000|Open-label Extension|Protocol Violation|0|||
46828056|NCT00379236|83046269|FG001|Open-label Extension|Protocol Violation|0|||
46828057|NCT00379236|83046270|FG002|Open-label Extension|Protocol Violation|7|||
46828058|NCT00379236|83046268|FG000|Open-label Extension|Withdrawal by Subject|0|||
46828059|NCT00379236|83046269|FG001|Open-label Extension|Withdrawal by Subject|0|||
46828060|NCT00379236|83046270|FG002|Open-label Extension|Withdrawal by Subject|13|||
46828061|NCT00379236|83046268|FG000|Open-label Extension|Lost to Follow-up|0|||
46828062|NCT00379236|83046269|FG001|Open-label Extension|Lost to Follow-up|0|||
46828063|NCT00379236|83046270|FG002|Open-label Extension|Lost to Follow-up|12|||
46828064|NCT00379236|83046268|FG000|Open-label Extension|Use of exclusionary medication|0|||
46828065|NCT00379236|83046269|FG001|Open-label Extension|Use of exclusionary medication|0|||
46828066|NCT00379236|83046270|FG002|Open-label Extension|Use of exclusionary medication|3|||
46828067|NCT00379236|83046268|FG000|Open-label Extension|Other|0|||
46828068|NCT00379236|83046269|FG001|Open-label Extension|Other|0|||
46828069|NCT00379236|83046270|FG002|Open-label Extension|Other|7|||
46828070|NCT00379080|83046285|FG000|Overall Study|Withdrawal by Subject|0|||
46828071|NCT00379080|83046286|FG001|Overall Study|Withdrawal by Subject|4|||
46828072|NCT00379080|83046287|FG002|Overall Study|Withdrawal by Subject|0|||
46828073|NCT00378534|83046312|FG000|Overall Study|Participants did not receive transplant|3|||
46828074|NCT00378534|83046313|FG001|Overall Study|Participants did not receive transplant|0|||
46828075|NCT00377676|83046320|FG000|Overall Study|Adverse Event|498|||
46828076|NCT00377676|83046321|FG001|Overall Study|Adverse Event|107|||
46828077|NCT00377676|83046320|FG000|Overall Study|Protocol Violation|33|||
46828078|NCT00377676|83046321|FG001|Overall Study|Protocol Violation|27|||
46935525|NCT01379508|83171597|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
46935526|NCT01379508|83171598|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
46935527|NCT01379508|83171599|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
46935528|NCT01379508|83171600|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
46637492|NCT01474512|82811381|FG005|Induction Period|Sponsor Decision|0|||
46763641|NCT00868517|82981901|FG000|Overall Study|Withdrawal by Subject|3|||
46828079|NCT00377676|83046320|FG000|Overall Study|Death|5|||
46828080|NCT00377676|83046321|FG001|Overall Study|Death|2|||
46828081|NCT00377676|83046320|FG000|Overall Study|Withdrawal by Subject|187|||
46828082|NCT00377676|83046321|FG001|Overall Study|Withdrawal by Subject|72|||
46828083|NCT00377676|83046320|FG000|Overall Study|Lost to Follow-up|120|||
46828084|NCT00377676|83046321|FG001|Overall Study|Lost to Follow-up|56|||
46828085|NCT00377676|83046320|FG000|Overall Study|Other|118|||
46828086|NCT00377676|83046321|FG001|Overall Study|Other|58|||
46828087|NCT00377520|83046327|FG000|Overall Study|Ineligible (Prior radiation)|1|||
46828088|NCT00377364|83046333|FG000|Overall Study|Lost to Follow-up|1|||
46828089|NCT00377364|83046334|FG001|Overall Study|Lost to Follow-up|0|||
46763642|NCT00868517|82981902|FG001|Overall Study|Withdrawal by Subject|3|||
46828090|NCT00377364|83046333|FG000|Overall Study|Withdrawal by Subject|1|||
46828091|NCT00377364|83046334|FG001|Overall Study|Withdrawal by Subject|0|||
46828092|NCT03831282|83046342|FG000|Overall Study|Could not place sensor|1|||
46828093|NCT00365508|83046348|FG000|Overall Study|Lost to Follow-up|139|||
46828094|NCT00365508|83046349|FG001|Overall Study|Lost to Follow-up|154|||
46935529|NCT02722928|83171616|FG000|Overall Study|Standard CT was not as required per prot|5|||
46763643|NCT00868517|82981903|FG002|Overall Study|Withdrawal by Subject|2|||
47059595|NCT01566721|83339228|FG001|Safety Follow-up|Physician Decision|4|||
46828095|NCT00365352|83046358|FG000|Overall Study|Adverse Event|6|||
46828096|NCT00365352|83046359|FG001|Overall Study|Adverse Event|7|||
46828097|NCT00365352|83046360|FG002|Overall Study|Adverse Event|8|||
47059596|NCT01566721|83339227|FG000|Safety Follow-up|Lost to Follow-up|101|||
47059597|NCT01566721|83339228|FG001|Safety Follow-up|Lost to Follow-up|48|||
46828098|NCT00365352|83046358|FG000|Overall Study|Participant Withdrew Consent|8|||
46828099|NCT00365352|83046359|FG001|Overall Study|Participant Withdrew Consent|3|||
46828100|NCT00365352|83046360|FG002|Overall Study|Participant Withdrew Consent|4|||
46828101|NCT00365352|83046358|FG000|Overall Study|Lack of Efficacy|3|||
46828102|NCT00365352|83046359|FG001|Overall Study|Lack of Efficacy|0|||
46828103|NCT00365352|83046360|FG002|Overall Study|Lack of Efficacy|0|||
47059598|NCT01566721|83339227|FG000|Safety Follow-up|Withdrawal by Subject|155|||
47059599|NCT01566721|83339228|FG001|Safety Follow-up|Withdrawal by Subject|49|||
47059600|NCT01566721|83339227|FG000|Safety Follow-up|Death|28|||
47059601|NCT01566721|83339228|FG001|Safety Follow-up|Death|4|||
47059602|NCT01566721|83339227|FG000|Safety Follow-up|Non-compliance|7|||
47059603|NCT01566721|83339228|FG001|Safety Follow-up|Non-compliance|3|||
47059604|NCT01566721|83339227|FG000|Safety Follow-up|Protocol Violation|7|||
47059605|NCT01566721|83339228|FG001|Safety Follow-up|Protocol Violation|0|||
47059606|NCT01566721|83339227|FG000|Safety Follow-up|Site closure|2|||
47059607|NCT01566721|83339228|FG001|Safety Follow-up|Site closure|3|||
47059608|NCT01566721|83339227|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
47059609|NCT01566721|83339228|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
47059610|NCT01566721|83339227|FG000|Safety Follow-up|Missing|7|||
47059611|NCT01566721|83339228|FG001|Safety Follow-up|Missing|2|||
47059612|NCT01566721|83339227|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
47059613|NCT01566721|83339228|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
46828104|NCT00365352|83046358|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
46828105|NCT00365352|83046359|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
46828106|NCT00365352|83046360|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
46828107|NCT00365352|83046358|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
46828108|NCT00365352|83046359|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
46828109|NCT00365352|83046360|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
46828110|NCT00365352|83046358|FG000|Overall Study|Lost to Follow-up|1|||
46828111|NCT00365352|83046359|FG001|Overall Study|Lost to Follow-up|1|||
46828112|NCT00365352|83046360|FG002|Overall Study|Lost to Follow-up|0|||
46828113|NCT00365352|83046358|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
46828114|NCT00365352|83046359|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
46828115|NCT00365352|83046360|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
46935530|NCT02722928|83171617|FG001|Overall Study|Standard CT was not as required per prot|13|||
46935531|NCT02722928|83171616|FG000|Overall Study|Required Intraoperative MRI|5|||
46935532|NCT02722928|83171617|FG001|Overall Study|Required Intraoperative MRI|7|||
46935533|NCT02722304|83171648|FG000|Overall Study|Study Terminated by Sponsor|1|||
46935534|NCT02722304|83171649|FG001|Overall Study|Study Terminated by Sponsor|0|||
46935535|NCT02722304|83171650|FG002|Overall Study|Study Terminated by Sponsor|2|||
46935536|NCT02722304|83171651|FG003|Overall Study|Study Terminated by Sponsor|1|||
46935537|NCT02722304|83171652|FG004|Overall Study|Study Terminated by Sponsor|1|||
47059614|NCT01566721|83339227|FG000|Safety Follow-up|Sponsor decision|1|||
47059615|NCT01566721|83339228|FG001|Safety Follow-up|Sponsor decision|0|||
47059616|NCT01566721|83339227|FG000|Safety Follow-up|Adverse Event|8|||
47059617|NCT01566721|83339228|FG001|Safety Follow-up|Adverse Event|4|||
46763644|NCT00868517|82981901|FG000|Overall Study|Protocol Violation|1|||
46763645|NCT00868517|82981902|FG001|Overall Study|Protocol Violation|1|||
46763646|NCT00868517|82981903|FG002|Overall Study|Protocol Violation|0|||
46763647|NCT00868439|82981913|FG000|Overall Study|Adverse Event|4|||
46763648|NCT00868439|82981914|FG001|Overall Study|Adverse Event|3|||
46763649|NCT00868439|82981913|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
46763650|NCT00868439|82981914|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
46763651|NCT00868439|82981913|FG000|Overall Study|Death|0|||
46763652|NCT00868439|82981914|FG001|Overall Study|Death|1|||
46828116|NCT00376506|83046373|FG000|Overall Study|Death|0|||
46828117|NCT00376506|83046374|FG001|Overall Study|Death|2|||
46828118|NCT00410384|83046386|FG000|Overall Study|Withdrawal by Subject|28|||
47059618|NCT01541215|83339243|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
47059619|NCT01541215|83339244|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
47059620|NCT01541215|83339243|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
47059621|NCT01541215|83339244|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
47059622|NCT01541215|83339243|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
46828119|NCT00410384|83046387|FG001|Overall Study|Withdrawal by Subject|17|||
46828120|NCT00410384|83046388|FG002|Overall Study|Withdrawal by Subject|20|||
47059623|NCT01541215|83339244|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
47059624|NCT01541215|83339243|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
47059625|NCT01541215|83339244|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
46828121|NCT00410384|83046386|FG000|Overall Study|Adverse Event|23|||
46828122|NCT00410384|83046387|FG001|Overall Study|Adverse Event|18|||
46935538|NCT02722304|83171648|FG000|Overall Study|Other|0|||
46763653|NCT00868439|82981913|FG000|Overall Study|Protocol Violation|1|||
46763654|NCT00868439|82981914|FG001|Overall Study|Protocol Violation|1|||
46763655|NCT00868439|82981913|FG000|Overall Study|Physician Decision|1|||
46935539|NCT02722304|83171649|FG001|Overall Study|Other|0|||
47059626|NCT01541215|83339243|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
47059627|NCT01541215|83339244|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
47059628|NCT01541215|83339243|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
47059629|NCT01541215|83339244|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
46935540|NCT02722304|83171650|FG002|Overall Study|Other|0|||
46828123|NCT00410384|83046388|FG002|Overall Study|Adverse Event|23|||
46828124|NCT00410384|83046386|FG000|Overall Study|Lack of Efficacy|20|||
46828125|NCT00410384|83046387|FG001|Overall Study|Lack of Efficacy|12|||
46828126|NCT00410384|83046388|FG002|Overall Study|Lack of Efficacy|17|||
46828127|NCT00410384|83046386|FG000|Overall Study|Lack of Compliance|2|||
46828128|NCT00410384|83046387|FG001|Overall Study|Lack of Compliance|2|||
46828129|NCT00410384|83046388|FG002|Overall Study|Lack of Compliance|2|||
46828130|NCT00410384|83046386|FG000|Overall Study|Lost to Follow-up|4|||
46828131|NCT00410384|83046387|FG001|Overall Study|Lost to Follow-up|6|||
46828132|NCT00410384|83046388|FG002|Overall Study|Lost to Follow-up|6|||
46828133|NCT00410384|83046386|FG000|Overall Study|Protocol Violation|6|||
46828134|NCT00410384|83046387|FG001|Overall Study|Protocol Violation|6|||
46828135|NCT00410384|83046388|FG002|Overall Study|Protocol Violation|6|||
46828136|NCT00410384|83046386|FG000|Overall Study|Physician Decision|3|||
46828137|NCT00410384|83046387|FG001|Overall Study|Physician Decision|3|||
46935541|NCT02722304|83171651|FG003|Overall Study|Other|1|||
46935542|NCT02722304|83171652|FG004|Overall Study|Other|1|||
46828138|NCT00410384|83046388|FG002|Overall Study|Physician Decision|4|||
46763656|NCT00868439|82981914|FG001|Overall Study|Physician Decision|0|||
46763657|NCT00868439|82981913|FG000|Overall Study|Withdrawal by Subject|0|||
46763658|NCT00868439|82981914|FG001|Overall Study|Withdrawal by Subject|1|||
46828139|NCT00410384|83046386|FG000|Overall Study|Other|3|||
46828140|NCT00410384|83046387|FG001|Overall Study|Other|8|||
46828141|NCT00410384|83046388|FG002|Overall Study|Other|4|||
46828142|NCT00370032|83046398|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
46828143|NCT00370032|83046399|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
46828144|NCT00370032|83046398|FG000|Washout Period|Withdrawal by Subject|0|||
46828145|NCT00370032|83046399|FG001|Washout Period|Withdrawal by Subject|1|||
46828146|NCT00370032|83046398|FG000|Washout Period|Lost to Follow-up|0|||
46828147|NCT00370032|83046399|FG001|Washout Period|Lost to Follow-up|1|||
46828148|NCT00370032|83046398|FG000|Washout Period|Adverse Event|1|||
46935543|NCT00709956|83171668|FG000|Overall Study|Withdrawal by Subject|1|||
46935544|NCT00709956|83171669|FG001|Overall Study|Withdrawal by Subject|1|||
46935545|NCT00709956|83171668|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
46935546|NCT00709956|83171669|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
46935547|NCT02719028|83171699|FG000|Overall Study|Adverse Event|2|||
46935548|NCT02719028|83171700|FG001|Overall Study|Adverse Event|1|||
46935549|NCT02719028|83171701|FG002|Overall Study|Adverse Event|4|||
46935550|NCT02719028|83171702|FG003|Overall Study|Adverse Event|8|||
46763659|NCT00814164|82981920|FG000|Overall Study|Progression|7|||
46763660|NCT00814164|82981920|FG000|Overall Study|not stated|7|||
46935551|NCT02719028|83171699|FG000|Overall Study|Physician Decision|0|||
46935552|NCT02719028|83171700|FG001|Overall Study|Physician Decision|1|||
47059630|NCT01540981|83339256|FG000|Overall Study|Withdrawal by Subject|1|||
46637493|NCT01474512|82811382|FG006|Induction Period|Sponsor Decision|0|||
46763661|NCT00814164|82981920|FG000|Overall Study|Death|5|||
46763662|NCT00659230|82981926|FG000|Overall Study|Lost to Follow-up|2|||
46763663|NCT00659230|82981927|FG001|Overall Study|Lost to Follow-up|5|||
46763664|NCT00659230|82981926|FG000|Overall Study|Lost source documentation|5|||
46763665|NCT00659230|82981927|FG001|Overall Study|Lost source documentation|4|||
46763666|NCT00659230|82981926|FG000|Overall Study|Did not return post-randomization|2|||
46763667|NCT00659230|82981927|FG001|Overall Study|Did not return post-randomization|3|||
46763668|NCT00809094|82981935|FG000|Overall Study|Lost to Follow-up|0|||
46763669|NCT00809094|82981936|FG001|Overall Study|Lost to Follow-up|1|||
46763670|NCT00658996|82981942|FG000|First Intervention|Positive slit lamp finding|1|||
46763671|NCT00658996|82981943|FG001|First Intervention|Positive slit lamp finding|0|||
46763672|NCT00658996|82981942|FG000|First Intervention|Lack of lenses|0|||
46828149|NCT00370032|83046399|FG001|Washout Period|Adverse Event|0|||
46828150|NCT00370032|83046398|FG000|Follow-up Period|Withdrawal by Subject|1|||
46828151|NCT00370032|83046399|FG001|Follow-up Period|Withdrawal by Subject|0|||
46828152|NCT00410072|83046416|FG000|Day 1 to Week 48|Adverse Event|1|||
46828153|NCT00410072|83046417|FG001|Day 1 to Week 48|Adverse Event|2|||
46935553|NCT02719028|83171701|FG002|Overall Study|Physician Decision|1|||
46935554|NCT02719028|83171702|FG003|Overall Study|Physician Decision|1|||
47059631|NCT01540981|83339257|FG001|Overall Study|Withdrawal by Subject|0|||
47059632|NCT01585987|83339265|FG000|Randomized|Withdrawal by Subject|0|||
47059633|NCT01585987|83339266|FG001|Randomized|Withdrawal by Subject|4|||
46763673|NCT00658996|82981943|FG001|First Intervention|Lack of lenses|1|||
46763674|NCT00658996|82981942|FG000|Crossover Period|Physician Decision|1|||
46828154|NCT00410072|83046416|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
46828155|NCT00410072|83046417|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
46828156|NCT00410072|83046416|FG000|Day 1 to Week 48|Other|0|||
46828157|NCT00410072|83046417|FG001|Day 1 to Week 48|Other|1|||
46935555|NCT02719028|83171699|FG000|Overall Study|Use of prohibited medication|0|||
46935556|NCT02719028|83171700|FG001|Overall Study|Use of prohibited medication|0|||
46935557|NCT02719028|83171701|FG002|Overall Study|Use of prohibited medication|1|||
46935558|NCT02719028|83171702|FG003|Overall Study|Use of prohibited medication|0|||
46935559|NCT02719028|83171699|FG000|Overall Study|Protocol Violation|0|||
46935560|NCT02719028|83171700|FG001|Overall Study|Protocol Violation|0|||
46935561|NCT02719028|83171701|FG002|Overall Study|Protocol Violation|0|||
46935562|NCT02719028|83171702|FG003|Overall Study|Protocol Violation|1|||
46935563|NCT02720510|83171714|FG000|Overall Study|Study Terminated by the sponsor|2|||
46935564|NCT02720510|83171715|FG001|Overall Study|Study Terminated by the sponsor|0|||
46763675|NCT00658996|82981943|FG001|Crossover Period|Physician Decision|0|||
46763676|NCT00658996|82981942|FG000|Crossover Period|Ineligible|1|||
46763677|NCT00658996|82981943|FG001|Crossover Period|Ineligible|1|||
46763678|NCT00658996|82981942|FG000|Second Intervention|Developed a stye on upper lid|1|||
46763679|NCT00658996|82981943|FG001|Second Intervention|Developed a stye on upper lid|0|||
46828158|NCT00410072|83046416|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
46828159|NCT00410072|83046417|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
46763680|NCT00658996|82981942|FG000|Second Intervention|Positive slit lamp finding|0|||
46763681|NCT00658996|82981943|FG001|Second Intervention|Positive slit lamp finding|1|||
46763682|NCT00867815|82981949|FG000|Overall Study|Lost to Follow-up|1|||
46763683|NCT00452413|82981956|FG000|Overall Study|Progressive Disease|4|||
46763684|NCT00452413|82981957|FG001|Overall Study|Progressive Disease|11|||
46763685|NCT00452413|82981958|FG002|Overall Study|Progressive Disease|30|||
46763686|NCT00452413|82981956|FG000|Overall Study|Withdrawal by Subject|0|||
46828160|NCT00410072|83046416|FG000|Day 1 to Week 48|Pregnancy|0|||
46828161|NCT00410072|83046417|FG001|Day 1 to Week 48|Pregnancy|2|||
46828162|NCT00410072|83046416|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
46828163|NCT00410072|83046417|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
46828164|NCT00410072|83046416|FG000|After Week 48 to Week 96|Adverse Event|1|||
46828165|NCT00410072|83046417|FG001|After Week 48 to Week 96|Adverse Event|2|||
46828166|NCT00410072|83046416|FG000|After Week 48 to Week 96|Death|0|||
46828167|NCT00410072|83046417|FG001|After Week 48 to Week 96|Death|1|||
46828168|NCT00410072|83046416|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
46828169|NCT00410072|83046417|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
46828170|NCT00410072|83046416|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
46828171|NCT00410072|83046417|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
46828172|NCT00410072|83046416|FG000|After Week 48 to Week 96|Other|2|||
46828173|NCT00410072|83046417|FG001|After Week 48 to Week 96|Other|0|||
46828174|NCT00410072|83046416|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
46828175|NCT00410072|83046417|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
46828176|NCT00410072|83046416|FG000|After Week 48 to Week 96|Pregnancy|0|||
46828177|NCT00410072|83046417|FG001|After Week 48 to Week 96|Pregnancy|2|||
46828178|NCT00410072|83046416|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
46828179|NCT00410072|83046417|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
46828180|NCT00409838|83046425|FG000|Short-term Period|Adverse Event|0|||
46828181|NCT00409838|83046426|FG001|Short-term Period|Adverse Event|1|||
46828182|NCT00409838|83046425|FG000|Short-term Period|Lost to Follow-up|0|||
46828183|NCT00409838|83046426|FG001|Short-term Period|Lost to Follow-up|1|||
46828184|NCT00409838|83046425|FG000|Short-term Period|Withdrawal by Subject|2|||
46828185|NCT00409838|83046426|FG001|Short-term Period|Withdrawal by Subject|3|||
46828186|NCT00409838|83046425|FG000|Short-term Period|Never Treated|1|||
46828187|NCT00409838|83046426|FG001|Short-term Period|Never Treated|0|||
46828188|NCT00409838|83046425|FG000|Long-term Extension Period|Adverse Event|10|||
46828189|NCT00409838|83046426|FG001|Long-term Extension Period|Adverse Event|0|||
46828190|NCT00409838|83046425|FG000|Long-term Extension Period|Death|1|||
46828191|NCT00409838|83046426|FG001|Long-term Extension Period|Death|0|||
46828192|NCT00409838|83046425|FG000|Long-term Extension Period|Lack of Efficacy|2|||
46828193|NCT00409838|83046426|FG001|Long-term Extension Period|Lack of Efficacy|0|||
46935565|NCT02720510|83171714|FG000|Overall Study|Adverse Event|0|||
46935566|NCT02720510|83171715|FG001|Overall Study|Adverse Event|1|||
46935567|NCT02720510|83171714|FG000|Overall Study|Physician Decision|1|||
47059634|NCT01585987|83339265|FG000|Randomized|No longer met criteria|0|||
46763687|NCT00452413|82981957|FG001|Overall Study|Withdrawal by Subject|1|||
46763688|NCT00452413|82981958|FG002|Overall Study|Withdrawal by Subject|4|||
46828194|NCT00409838|83046425|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
46828195|NCT00409838|83046426|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
46828196|NCT00409838|83046425|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
46828197|NCT00409838|83046426|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
47059635|NCT01585987|83339266|FG001|Randomized|No longer met criteria|2|||
47059636|NCT01585987|83339265|FG000|Treated|Disease Progression|39|||
47059637|NCT01585987|83339266|FG001|Treated|Disease Progression|36|||
46935568|NCT02720510|83171715|FG001|Overall Study|Physician Decision|2|||
46763689|NCT00452413|82981956|FG000|Overall Study|Adverse Event|0|||
46763690|NCT00452413|82981957|FG001|Overall Study|Adverse Event|0|||
47059638|NCT01585987|83339265|FG000|Treated|Study Drug Toxicity|9|||
47059639|NCT01585987|83339266|FG001|Treated|Study Drug Toxicity|5|||
46935569|NCT02720198|83171723|FG000|Overall Study|Withdrawal by Subject|0|||
46828198|NCT00409838|83046425|FG000|Long-term Extension Period|Pregnancy|1|||
46828199|NCT00409838|83046426|FG001|Long-term Extension Period|Pregnancy|0|||
46828200|NCT00399542|83046451|FG000|Overall Study|Adverse Event|18|||
46828201|NCT00399542|83046452|FG001|Overall Study|Adverse Event|15|||
46828202|NCT00399542|83046451|FG000|Overall Study|Protocol Violation|13|||
46828203|NCT00399542|83046452|FG001|Overall Study|Protocol Violation|3|||
46828204|NCT00399542|83046451|FG000|Overall Study|Withdrawal by Subject|28|||
46935570|NCT02720198|83171724|FG001|Overall Study|Withdrawal by Subject|1|||
46935571|NCT01359969|83171743|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
46935572|NCT00703118|83171750|FG000|Overall Study|Adverse Event|1|||
46935573|NCT00703118|83171751|FG001|Overall Study|Adverse Event|2|||
46828205|NCT00399542|83046452|FG001|Overall Study|Withdrawal by Subject|10|||
46828206|NCT00399542|83046451|FG000|Overall Study|Lack of Efficacy|18|||
46828207|NCT00399542|83046452|FG001|Overall Study|Lack of Efficacy|8|||
46828208|NCT00399542|83046451|FG000|Overall Study|Lost to Follow-up|6|||
46828209|NCT00399542|83046452|FG001|Overall Study|Lost to Follow-up|6|||
46828210|NCT00399542|83046451|FG000|Overall Study|Other|1|||
46828211|NCT00399542|83046452|FG001|Overall Study|Other|0|||
46828212|NCT00399542|83046451|FG000|Overall Study|Physician Decision|0|||
46828213|NCT00399542|83046452|FG001|Overall Study|Physician Decision|1|||
46828214|NCT00409682|83046461|FG000|Open-label Induction Period|Adverse Event|1|||
46828215|NCT00409682|83046462|FG001|Open-label Induction Period|Adverse Event|0|||
46828216|NCT00409682|83046463|FG002|Open-label Induction Period|Adverse Event|0|||
46828217|NCT00409682|83046461|FG000|Open-label Induction Period|Lack of Efficacy|1|||
46828218|NCT00409682|83046462|FG001|Open-label Induction Period|Lack of Efficacy|0|||
46828219|NCT00409682|83046463|FG002|Open-label Induction Period|Lack of Efficacy|0|||
46828220|NCT00409682|83046461|FG000|Open-label Induction Period|Protocol Violation|1|||
46828221|NCT00409682|83046462|FG001|Open-label Induction Period|Protocol Violation|0|||
46828222|NCT00409682|83046463|FG002|Open-label Induction Period|Protocol Violation|0|||
46828223|NCT00409682|83046461|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
46828224|NCT00409682|83046462|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
46828225|NCT00409682|83046463|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
46828226|NCT00409682|83046461|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
46828227|NCT00409682|83046462|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
46828228|NCT00409682|83046463|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
46828229|NCT00409682|83046461|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
46828230|NCT00409682|83046462|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
46828231|NCT00409682|83046463|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
46828232|NCT00409682|83046461|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
46828233|NCT00409682|83046462|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
46828234|NCT00409682|83046463|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
46828235|NCT00409682|83046461|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
46828236|NCT00409682|83046462|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
46828237|NCT00409682|83046463|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
46828238|NCT00409682|83046461|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
47059640|NCT01585987|83339265|FG000|Treated|Adverse Event|3|||
47059641|NCT01585987|83339266|FG001|Treated|Adverse Event|0|||
47059642|NCT01585987|83339265|FG000|Treated|Withdrawal by Subject|1|||
47059643|NCT01585987|83339266|FG001|Treated|Withdrawal by Subject|2|||
47059644|NCT01585987|83339265|FG000|Treated|Death|1|||
47059645|NCT01585987|83339266|FG001|Treated|Death|0|||
47059646|NCT01585987|83339265|FG000|Treated|Lost to Follow-up|0|||
47059647|NCT01585987|83339266|FG001|Treated|Lost to Follow-up|1|||
47059648|NCT01585987|83339265|FG000|Treated|Maximum Clinical Benefit|0|||
47059649|NCT01585987|83339266|FG001|Treated|Maximum Clinical Benefit|1|||
46935574|NCT00703118|83171752|FG002|Overall Study|Adverse Event|2|||
47059650|NCT01585987|83339265|FG000|Treated|Non-Specified|1|||
47059651|NCT01585987|83339266|FG001|Treated|Non-Specified|2|||
46828239|NCT00409682|83046462|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
46828240|NCT00409682|83046463|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
46828241|NCT00409682|83046461|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
46828242|NCT00409682|83046462|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
46828243|NCT00409682|83046463|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
46828244|NCT00398216|83046475|FG000|Overall Study|Adverse Event|4|||
47059652|NCT01585987|83339265|FG000|Treated|Subject Request|0|||
46935575|NCT00703118|83171750|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
46935576|NCT00703118|83171751|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
47059653|NCT01585987|83339266|FG001|Treated|Subject Request|1|||
47059654|NCT01585987|83339265|FG000|Treated|Poor/Non-Compliance|0|||
47059655|NCT01585987|83339266|FG001|Treated|Poor/Non-Compliance|1|||
47059656|NCT01585831|83339275|FG000|Overall Study|Physician Decision|0|||
47059657|NCT01585831|83339276|FG001|Overall Study|Physician Decision|1|||
47059658|NCT01585831|83339275|FG000|Overall Study|Withdrawal by Subject|2|||
46935577|NCT00703118|83171752|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
46935578|NCT00703118|83171750|FG000|Overall Study|Lost to Follow-up|6|||
46935579|NCT00703118|83171751|FG001|Overall Study|Lost to Follow-up|4|||
46935580|NCT00703118|83171752|FG002|Overall Study|Lost to Follow-up|4|||
46828245|NCT00398216|83046476|FG001|Overall Study|Adverse Event|2|||
46828246|NCT00398216|83046477|FG002|Overall Study|Adverse Event|5|||
46828247|NCT00398216|83046478|FG003|Overall Study|Adverse Event|7|||
46828248|NCT00398216|83046479|FG004|Overall Study|Adverse Event|2|||
46828249|NCT00398216|83046475|FG000|Overall Study|Protocol Violation|2|||
46828250|NCT00398216|83046476|FG001|Overall Study|Protocol Violation|4|||
46828251|NCT00398216|83046477|FG002|Overall Study|Protocol Violation|5|||
46828252|NCT00398216|83046478|FG003|Overall Study|Protocol Violation|7|||
46828253|NCT00398216|83046479|FG004|Overall Study|Protocol Violation|5|||
46828254|NCT00398216|83046475|FG000|Overall Study|Lost to Follow-up|1|||
46828255|NCT00398216|83046476|FG001|Overall Study|Lost to Follow-up|6|||
46828256|NCT00398216|83046477|FG002|Overall Study|Lost to Follow-up|4|||
46828257|NCT00398216|83046478|FG003|Overall Study|Lost to Follow-up|4|||
46828258|NCT00398216|83046479|FG004|Overall Study|Lost to Follow-up|1|||
46828259|NCT00398216|83046475|FG000|Overall Study|Death|0|||
46828260|NCT00398216|83046476|FG001|Overall Study|Death|3|||
46828261|NCT00398216|83046477|FG002|Overall Study|Death|0|||
46935581|NCT00703118|83171750|FG000|Overall Study|Withdrawal by Subject|8|||
46935582|NCT00703118|83171751|FG001|Overall Study|Withdrawal by Subject|7|||
46935583|NCT00703118|83171752|FG002|Overall Study|Withdrawal by Subject|13|||
46935584|NCT00703118|83171750|FG000|Overall Study|Other|0|||
46935585|NCT00703118|83171751|FG001|Overall Study|Other|0|||
46935586|NCT00703118|83171752|FG002|Overall Study|Other|1|||
47059659|NCT01585831|83339276|FG001|Overall Study|Withdrawal by Subject|1|||
47059660|NCT01565941|83339284|FG000|Overall Study|Withdrawn by parent/guardian|3|||
46828262|NCT00398216|83046478|FG003|Overall Study|Death|0|||
46828263|NCT00398216|83046479|FG004|Overall Study|Death|0|||
46828264|NCT00398216|83046475|FG000|Overall Study|Withdrawal by Subject|1|||
46828265|NCT00398216|83046476|FG001|Overall Study|Withdrawal by Subject|0|||
46828266|NCT00398216|83046477|FG002|Overall Study|Withdrawal by Subject|3|||
46828267|NCT00398216|83046478|FG003|Overall Study|Withdrawal by Subject|1|||
46828268|NCT00398216|83046479|FG004|Overall Study|Withdrawal by Subject|2|||
46828269|NCT00398216|83046475|FG000|Overall Study|administrative reasons|3|||
46828270|NCT00398216|83046476|FG001|Overall Study|administrative reasons|4|||
46828271|NCT00398216|83046477|FG002|Overall Study|administrative reasons|4|||
46828272|NCT00398216|83046478|FG003|Overall Study|administrative reasons|3|||
46828273|NCT00398216|83046479|FG004|Overall Study|administrative reasons|3|||
46828274|NCT00398216|83046475|FG000|Overall Study|entrance criteria|0|||
46828275|NCT00398216|83046476|FG001|Overall Study|entrance criteria|0|||
46828276|NCT00398216|83046477|FG002|Overall Study|entrance criteria|0|||
46828277|NCT00398216|83046478|FG003|Overall Study|entrance criteria|0|||
46828278|NCT00398216|83046479|FG004|Overall Study|entrance criteria|2|||
46828279|NCT00398138|83046491|FG000|Overall Study|Adverse Event|2|||
46828280|NCT00397982|83046495|FG000|Overall Study|Withdrawal by Subject|1|||
46828281|NCT00397982|83046495|FG000|Overall Study|Adverse Event|1|||
46828282|NCT00397982|83046495|FG000|Overall Study|noncompliance|1|||
46828283|NCT00397982|83046495|FG000|Overall Study|Unrelated health issues|1|||
46828284|NCT00408902|83046500|FG000|Overall Study|Lack of Efficacy|7|||
46828285|NCT00408902|83046500|FG000|Overall Study|Adverse Event|3|||
46828286|NCT00397514|83046505|FG000|Overall Study|Withdrawal by Subject|1|||
46828287|NCT00397514|83046505|FG000|Overall Study|Pacing wire malfunction|1|||
46828288|NCT00397514|83046505|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
46828289|NCT00397514|83046505|FG000|Overall Study|early extubation|2|||
46828290|NCT00397514|83046505|FG000|Overall Study|poor echocardiographic windows|1|||
46828291|NCT00397046|83046519|FG000|Overall Study|Disease Progression|3|||
46828292|NCT00397046|83046520|FG001|Overall Study|Disease Progression|3|||
46828293|NCT00397046|83046521|FG002|Overall Study|Disease Progression|10|||
46828294|NCT00397046|83046522|FG003|Overall Study|Disease Progression|5|||
46828295|NCT00396812|83046533|FG000|Overall Study|Physician Decision|1|||
46828296|NCT00396656|83046537|FG000|First Treatment Period|Withdrawal by Subject|0|||
46828297|NCT00396656|83046538|FG001|First Treatment Period|Withdrawal by Subject|2|||
46828298|NCT00396656|83046537|FG000|Second Treatment Period|Adverse Event|0|||
46828299|NCT00396656|83046538|FG001|Second Treatment Period|Adverse Event|1|||
46828300|NCT00408434|83046551|FG000|Overall Study|Adverse Event|0|||
46828301|NCT00408434|83046552|FG001|Overall Study|Adverse Event|0|||
46828302|NCT00408434|83046553|FG002|Overall Study|Adverse Event|1|||
46935587|NCT00909753|83171774|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
46935588|NCT00909753|83171775|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
46828303|NCT00408434|83046554|FG003|Overall Study|Adverse Event|0|||
46828304|NCT00408434|83046555|FG004|Overall Study|Adverse Event|0|||
46828305|NCT00408434|83046556|FG005|Overall Study|Adverse Event|0|||
46828306|NCT00408434|83046557|FG006|Overall Study|Adverse Event|0|||
46828307|NCT00408434|83046551|FG000|Overall Study|Progressive disease|6|||
46828308|NCT00408434|83046552|FG001|Overall Study|Progressive disease|3|||
46935589|NCT00909753|83171774|FG000|Period: Second Intervention|Protocol Violation|1|||
46935590|NCT00909753|83171775|FG001|Period: Second Intervention|Protocol Violation|0|||
46935591|NCT03715764|83171781|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
46935592|NCT03715764|83171782|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
46828309|NCT00408434|83046553|FG002|Overall Study|Progressive disease|4|||
46828310|NCT00408434|83046554|FG003|Overall Study|Progressive disease|3|||
46828311|NCT00408434|83046555|FG004|Overall Study|Progressive disease|3|||
46828312|NCT00408434|83046556|FG005|Overall Study|Progressive disease|1|||
46828313|NCT00408434|83046557|FG006|Overall Study|Progressive disease|4|||
46828314|NCT00408434|83046551|FG000|Overall Study|Other|0|||
46828315|NCT00408434|83046552|FG001|Overall Study|Other|0|||
46828316|NCT00408434|83046553|FG002|Overall Study|Other|1|||
46828317|NCT00408434|83046554|FG003|Overall Study|Other|0|||
46828318|NCT00408434|83046555|FG004|Overall Study|Other|2|||
46828319|NCT00408434|83046556|FG005|Overall Study|Other|1|||
46828320|NCT00408434|83046557|FG006|Overall Study|Other|0|||
46828321|NCT00408434|83046551|FG000|Overall Study|Terminated by Investigator|0|||
46828322|NCT00408434|83046552|FG001|Overall Study|Terminated by Investigator|0|||
46828323|NCT00408434|83046553|FG002|Overall Study|Terminated by Investigator|0|||
46828324|NCT00408434|83046554|FG003|Overall Study|Terminated by Investigator|0|||
46828325|NCT00408434|83046555|FG004|Overall Study|Terminated by Investigator|1|||
46828326|NCT00408434|83046556|FG005|Overall Study|Terminated by Investigator|1|||
46828327|NCT00408434|83046557|FG006|Overall Study|Terminated by Investigator|0|||
46828328|NCT00418184|83046576|FG000|Double-blind Phase|Withdrawal by Subject|22|||
46828329|NCT00418184|83046577|FG001|Double-blind Phase|Withdrawal by Subject|9|||
46828330|NCT00418184|83046576|FG000|Double-blind Phase|Adverse Event|2|||
46828331|NCT00418184|83046577|FG001|Double-blind Phase|Adverse Event|1|||
46828332|NCT00418184|83046576|FG000|Double-blind Phase|Poor compliance|3|||
46828333|NCT00418184|83046577|FG001|Double-blind Phase|Poor compliance|1|||
46828334|NCT00407030|83046586|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
46828335|NCT00407030|83046587|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
46828336|NCT00407030|83046588|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
46828337|NCT00407030|83046586|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
46828338|NCT00407030|83046587|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
46828339|NCT00407030|83046588|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
46828340|NCT00407030|83046586|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
46828341|NCT00407030|83046587|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
46935593|NCT03715764|83171781|FG000|3 Month Follow-up|Lost to Follow-up|2|||
46935594|NCT03715764|83171782|FG001|3 Month Follow-up|Lost to Follow-up|2|||
46935595|NCT03715764|83171781|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
47059661|NCT01565941|83339285|FG001|Overall Study|Withdrawn by parent/guardian|2|||
46828342|NCT00407030|83046588|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
46828343|NCT00407030|83046586|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
46828344|NCT00407030|83046587|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
46828345|NCT00407030|83046588|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
46828346|NCT00407030|83046586|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
46828347|NCT00407030|83046587|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
46828348|NCT00407030|83046588|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
46828349|NCT00407030|83046586|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
46828350|NCT00407030|83046587|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
47059662|NCT01565941|83339284|FG000|Overall Study|Randomized; did not receive intevention|8|||
46763691|NCT00452413|82981958|FG002|Overall Study|Adverse Event|5|||
46763692|NCT00452413|82981956|FG000|Overall Study|Physician Decision|0|||
46763693|NCT00452413|82981957|FG001|Overall Study|Physician Decision|0|||
46763694|NCT00452413|82981958|FG002|Overall Study|Physician Decision|4|||
46763695|NCT00452413|82981956|FG000|Overall Study|Death due to study disease|0|||
46763696|NCT00452413|82981957|FG001|Overall Study|Death due to study disease|0|||
46763697|NCT00452413|82981958|FG002|Overall Study|Death due to study disease|2|||
46763698|NCT00452413|82981956|FG000|Overall Study|Death due to adverse event (AE)|0|||
46763699|NCT00452413|82981957|FG001|Overall Study|Death due to adverse event (AE)|0|||
46763700|NCT00452413|82981958|FG002|Overall Study|Death due to adverse event (AE)|1|||
46763701|NCT00452413|82981956|FG000|Overall Study|On treatment|0|||
46763702|NCT00452413|82981957|FG001|Overall Study|On treatment|0|||
46763703|NCT00452413|82981958|FG002|Overall Study|On treatment|3|||
46763704|NCT00867503|82981967|FG000|Overall Study|Withdrawal by Subject|1|||
46763705|NCT00867113|82981973|FG000|Treatment Period|Adverse Event|15|||
46763706|NCT00867113|82981973|FG000|Treatment Period|Death|2|||
46763707|NCT00867113|82981973|FG000|Treatment Period|Withdrawal by Subject|19|||
46763708|NCT00867113|82981973|FG000|Treatment Period|Lost to Follow-up|3|||
46828351|NCT00407030|83046588|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
46828352|NCT00407030|83046586|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
46828353|NCT00407030|83046587|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
46935596|NCT03715764|83171782|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
46935597|NCT03715764|83171781|FG000|6 Month Follow-up|Lost to Follow-up|3|||
46935598|NCT03715764|83171782|FG001|6 Month Follow-up|Lost to Follow-up|0|||
46828354|NCT00407030|83046588|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
46828355|NCT00407030|83046586|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
46828356|NCT00407030|83046587|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
46828357|NCT00407030|83046588|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
46828358|NCT00407030|83046586|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
46828359|NCT00407030|83046587|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
46828360|NCT00407030|83046588|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
46828361|NCT00407030|83046586|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
46828362|NCT00407030|83046587|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
46828363|NCT00407030|83046588|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
47059663|NCT01565941|83339285|FG001|Overall Study|Randomized; did not receive intevention|2|||
47059664|NCT01558271|83339296|FG000|Overall Study|Adverse Event|6|||
47059665|NCT01558271|83339297|FG001|Overall Study|Adverse Event|3|||
47059666|NCT01558271|83339298|FG002|Overall Study|Adverse Event|4|||
47059667|NCT01558271|83339296|FG000|Overall Study|Lost to Follow-up|1|||
46763709|NCT00867113|82981973|FG000|Treatment Period|Administrative problems|1|||
46828364|NCT00407030|83046586|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
46828365|NCT00407030|83046587|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
46828366|NCT00407030|83046588|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
46828367|NCT00407030|83046586|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
46828368|NCT00407030|83046587|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
46828369|NCT00407030|83046588|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
46828370|NCT00407030|83046586|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
46828371|NCT00407030|83046587|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
46828372|NCT00407030|83046588|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
46828373|NCT00406718|83046601|FG000|Overall Study|Withdrawal by Subject|2|||
46828374|NCT00406718|83046602|FG001|Overall Study|Withdrawal by Subject|9|||
46828375|NCT00406718|83046603|FG002|Overall Study|Withdrawal by Subject|4|||
46828376|NCT00406718|83046601|FG000|Overall Study|Lost to Follow-up|2|||
46828377|NCT00406718|83046602|FG001|Overall Study|Lost to Follow-up|5|||
46828378|NCT00406718|83046603|FG002|Overall Study|Lost to Follow-up|4|||
46828379|NCT00394706|83046621|FG000|Overall Study|Withdrawal by Subject|2|||
46828380|NCT00394706|83046622|FG001|Overall Study|Withdrawal by Subject|0|||
46828381|NCT00394706|83046623|FG002|Overall Study|Withdrawal by Subject|1|||
46828382|NCT00394706|83046624|FG003|Overall Study|Withdrawal by Subject|0|||
46828383|NCT00394706|83046625|FG004|Overall Study|Withdrawal by Subject|0|||
46828384|NCT00394706|83046626|FG005|Overall Study|Withdrawal by Subject|2|||
46828385|NCT00394706|83046627|FG006|Overall Study|Withdrawal by Subject|1|||
46828386|NCT00394706|83046628|FG007|Overall Study|Withdrawal by Subject|0|||
46763710|NCT00867113|82981973|FG000|Treatment Period|Disease progression/relapse|1|||
46763711|NCT00867113|82981973|FG000|Treatment Period|Protocol Violation|4|||
46763712|NCT00867113|82981973|FG000|Post Treatment After Survival Follow-up|Death|1|||
46763713|NCT00867113|82981973|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
46763714|NCT00867113|82981973|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
46763715|NCT00867113|82981973|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
46763716|NCT00451555|82981980|FG000|Overall Study|Protocol Violation|2|||
46763717|NCT00451555|82981981|FG001|Overall Study|Protocol Violation|2|||
46763718|NCT00451555|82981980|FG000|Overall Study|Adverse Event|3|||
46763719|NCT00451555|82981981|FG001|Overall Study|Adverse Event|1|||
46763720|NCT00451555|82981980|FG000|Overall Study|Withdrawal by Subject|6|||
46763721|NCT00451555|82981981|FG001|Overall Study|Withdrawal by Subject|0|||
46763722|NCT00451555|82981980|FG000|Overall Study|Physician Decision|2|||
46763723|NCT00451555|82981981|FG001|Overall Study|Physician Decision|1|||
46763724|NCT00808236|82981998|FG000|Overall Study|Was not resuscitated|50|||
46763725|NCT00808236|82981999|FG001|Overall Study|Was not resuscitated|56|||
46763726|NCT00808236|82981998|FG000|Overall Study|Pre-defined exclusion|13|||
46763727|NCT00808236|82981999|FG001|Overall Study|Pre-defined exclusion|3|||
46763728|NCT00808236|82981998|FG000|Overall Study|Lost to Follow-up|1|||
46763729|NCT00808236|82981999|FG001|Overall Study|Lost to Follow-up|1|||
46763730|NCT00808236|82981998|FG000|Overall Study|Physician Decision|0|||
46763731|NCT00808236|82981999|FG001|Overall Study|Physician Decision|1|||
46763732|NCT00808236|82981998|FG000|Overall Study|Death|18|||
46763733|NCT00808236|82981999|FG001|Overall Study|Death|30|||
46763734|NCT00867035|82982007|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
46763735|NCT00867035|82982008|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
46828387|NCT00394706|83046621|FG000|Overall Study|Lost to Follow-up|2|||
46828388|NCT00394706|83046622|FG001|Overall Study|Lost to Follow-up|2|||
46828389|NCT00394706|83046623|FG002|Overall Study|Lost to Follow-up|8|||
47059668|NCT01558271|83339297|FG001|Overall Study|Lost to Follow-up|0|||
46763736|NCT00867035|82982007|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
46763737|NCT00867035|82982008|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
46763738|NCT00663208|82982021|FG000|Treatment Period|Lost to Follow-up|0|||
46763739|NCT00663208|82982022|FG001|Treatment Period|Lost to Follow-up|1|||
46763740|NCT00663208|82982023|FG002|Treatment Period|Lost to Follow-up|0|||
46828390|NCT00394706|83046624|FG003|Overall Study|Lost to Follow-up|1|||
46828391|NCT00394706|83046625|FG004|Overall Study|Lost to Follow-up|2|||
46828392|NCT00394706|83046626|FG005|Overall Study|Lost to Follow-up|5|||
46828393|NCT00394706|83046627|FG006|Overall Study|Lost to Follow-up|2|||
46828394|NCT00394706|83046628|FG007|Overall Study|Lost to Follow-up|0|||
46828395|NCT00394472|83046644|FG000|Overall Study|Protocol Violation|1|||
46828396|NCT00394472|83046645|FG001|Overall Study|Protocol Violation|3|||
46828397|NCT00394472|83046644|FG000|Overall Study|incorrect enrolment|4|||
46828398|NCT00394472|83046645|FG001|Overall Study|incorrect enrolment|2|||
46935599|NCT03715764|83171781|FG000|12 Month Follow-up|Lost to Follow-up|2|||
46935600|NCT03715764|83171782|FG001|12 Month Follow-up|Lost to Follow-up|3|||
46935601|NCT03715764|83171781|FG000|12 Month Follow-up|Pregnancy|0|||
46935602|NCT03715764|83171782|FG001|12 Month Follow-up|Pregnancy|1|||
46935603|NCT03715764|83171781|FG000|12 Month Follow-up|Surgery|2|||
46935604|NCT03715764|83171782|FG001|12 Month Follow-up|Surgery|0|||
46935605|NCT03715764|83171781|FG000|12 Month Follow-up|Wrong address|1|||
46935606|NCT03715764|83171782|FG001|12 Month Follow-up|Wrong address|0|||
46828399|NCT00394472|83046644|FG000|Overall Study|Adverse Event|4|||
46828400|NCT00394472|83046645|FG001|Overall Study|Adverse Event|2|||
46828401|NCT00394472|83046644|FG000|Overall Study|Withdrawal by Subject|0|||
46828402|NCT00394472|83046645|FG001|Overall Study|Withdrawal by Subject|2|||
46828403|NCT00394472|83046644|FG000|Overall Study|Physician Decision|0|||
46828404|NCT00394472|83046645|FG001|Overall Study|Physician Decision|1|||
46828405|NCT00394472|83046644|FG000|Overall Study|Lost to Follow-up|0|||
46637494|NCT01474512|82811383|FG007|Induction Period|Sponsor Decision|0|||
46637495|NCT01474512|82811384|FG008|Induction Period|Sponsor Decision|0|||
46763741|NCT00663208|82982024|FG003|Treatment Period|Lost to Follow-up|0|||
46828406|NCT00394472|83046645|FG001|Overall Study|Lost to Follow-up|1|||
46828407|NCT00419120|83046651|FG000|Long Term Follow up Period|study ongoing|10|||
46828408|NCT00395642|83046655|FG000|Overall Study|Death|4|||
46828409|NCT00395642|83046655|FG000|Overall Study|Lost to Follow-up|1|||
46828410|NCT00395642|83046655|FG000|Overall Study|Physician Decision|7|||
46828411|NCT00395642|83046655|FG000|Overall Study|Withdrawal by Subject|1|||
46828412|NCT00395486|83046661|FG000|Overall Study|Adverse Event|1|||
46828413|NCT00395486|83046662|FG001|Overall Study|Adverse Event|2|||
46828414|NCT00395486|83046661|FG000|Overall Study|Withdrawal by Subject|5|||
46828415|NCT00395486|83046662|FG001|Overall Study|Withdrawal by Subject|2|||
46828416|NCT00395486|83046661|FG000|Overall Study|Lost to Follow-up|0|||
46935607|NCT03715764|83171781|FG000|12 Month Follow-up|No symptoms|1|||
46935608|NCT03715764|83171782|FG001|12 Month Follow-up|No symptoms|0|||
46828417|NCT00395486|83046662|FG001|Overall Study|Lost to Follow-up|1|||
46828418|NCT00395018|83046668|FG000|On-Treatment|Death|4|||
46828419|NCT00395018|83046668|FG000|On-Treatment|Other Reason|2|||
46935609|NCT03715764|83171781|FG000|12 Month Follow-up|Changed primary care centre|0|||
46935610|NCT03715764|83171782|FG001|12 Month Follow-up|Changed primary care centre|1|||
46935611|NCT02718326|83171791|FG000|Overall Study|Adverse Event|4|||
46935612|NCT02718326|83171792|FG001|Overall Study|Adverse Event|9|||
46935613|NCT02718326|83171793|FG002|Overall Study|Adverse Event|0|||
46935614|NCT02718326|83171791|FG000|Overall Study|Death|8|||
46935615|NCT02718326|83171792|FG001|Overall Study|Death|1|||
47059669|NCT01558271|83339298|FG002|Overall Study|Lost to Follow-up|0|||
47059670|NCT01558271|83339296|FG000|Overall Study|Protocol Violation|1|||
47059671|NCT01558271|83339297|FG001|Overall Study|Protocol Violation|0|||
47059672|NCT01558271|83339298|FG002|Overall Study|Protocol Violation|0|||
47059673|NCT01558271|83339296|FG000|Overall Study|Withdrawal by Subject|10|||
47059674|NCT01558271|83339297|FG001|Overall Study|Withdrawal by Subject|6|||
47059675|NCT01558271|83339298|FG002|Overall Study|Withdrawal by Subject|12|||
47059676|NCT01558271|83339296|FG000|Overall Study|Physician Decision|0|||
47059677|NCT01558271|83339297|FG001|Overall Study|Physician Decision|2|||
47059678|NCT01558271|83339298|FG002|Overall Study|Physician Decision|1|||
46763742|NCT00663208|82982025|FG004|Treatment Period|Lost to Follow-up|0|||
46763743|NCT00663208|82982026|FG005|Treatment Period|Lost to Follow-up|0|||
46763744|NCT00663208|82982027|FG006|Treatment Period|Lost to Follow-up|0|||
46763745|NCT00663208|82982021|FG000|Follow-up Period|Lost to Follow-up|2|||
46763746|NCT00663208|82982022|FG001|Follow-up Period|Lost to Follow-up|0|||
46763747|NCT00663208|82982023|FG002|Follow-up Period|Lost to Follow-up|3|||
46763748|NCT00663208|82982024|FG003|Follow-up Period|Lost to Follow-up|2|||
46763749|NCT00663208|82982025|FG004|Follow-up Period|Lost to Follow-up|0|||
46935616|NCT02718326|83171793|FG002|Overall Study|Death|2|||
46935617|NCT02718326|83171791|FG000|Overall Study|Withdrawal by Subject|4|||
46828420|NCT00395018|83046668|FG000|On-Treatment|Poor/non-compliance|2|||
47059679|NCT01565707|83339314|FG000|Overall Study|Adverse Event|1|||
46763750|NCT00663208|82982026|FG005|Follow-up Period|Lost to Follow-up|0|||
46935618|NCT02718326|83171792|FG001|Overall Study|Withdrawal by Subject|9|||
46935619|NCT02718326|83171793|FG002|Overall Study|Withdrawal by Subject|6|||
46828421|NCT00395018|83046668|FG000|On-Treatment|Subject no longer meets study criteria|2|||
46828422|NCT00395018|83046668|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
46935620|NCT02718326|83171791|FG000|Overall Study|Lost to Follow-up|18|||
46935621|NCT02718326|83171792|FG001|Overall Study|Lost to Follow-up|5|||
46828423|NCT00395018|83046668|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
46828424|NCT00395018|83046668|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
46828425|NCT00375518|83046674|FG000|Overall Study|Withdrawal by Subject|2|||
46828426|NCT00375518|83046675|FG001|Overall Study|Withdrawal by Subject|10|||
46828427|NCT00375518|83046674|FG000|Overall Study|Patient Not Treated|6|||
46828428|NCT00375518|83046675|FG001|Overall Study|Patient Not Treated|6|||
46828429|NCT00375518|83046674|FG000|Overall Study|Death|0|||
46828430|NCT00375518|83046675|FG001|Overall Study|Death|1|||
46828431|NCT00256750|83046684|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
46828432|NCT00256750|83046685|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
46828433|NCT00256750|83046686|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
46828434|NCT00256750|83046684|FG000|Transplanted Pre-Treatment|Other|2|||
46828435|NCT00256750|83046685|FG001|Transplanted Pre-Treatment|Other|0|||
46828436|NCT00256750|83046686|FG002|Transplanted Pre-Treatment|Other|0|||
46828437|NCT00256750|83046684|FG000|Transplanted Pre-Treatment|Death|1|||
46828438|NCT00256750|83046685|FG001|Transplanted Pre-Treatment|Death|0|||
46828439|NCT00256750|83046686|FG002|Transplanted Pre-Treatment|Death|0|||
46828440|NCT00256750|83046684|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
46828441|NCT00256750|83046685|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
46828442|NCT00256750|83046686|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
46828443|NCT00256750|83046684|FG000|Post-Transplant Treated (12 Months)|Death|3|||
46828444|NCT00256750|83046685|FG001|Post-Transplant Treated (12 Months)|Death|2|||
46828445|NCT00256750|83046686|FG002|Post-Transplant Treated (12 Months)|Death|4|||
46828446|NCT00256750|83046684|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
46828447|NCT00256750|83046685|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
46828448|NCT00256750|83046686|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
46828449|NCT00256750|83046684|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
46828450|NCT00256750|83046685|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
46828451|NCT00256750|83046686|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
46828452|NCT00256750|83046684|FG000|Post-Transplant Treated (12 Months)|Other|5|||
46828453|NCT00256750|83046685|FG001|Post-Transplant Treated (12 Months)|Other|4|||
46828454|NCT00256750|83046686|FG002|Post-Transplant Treated (12 Months)|Other|2|||
46637496|NCT01474512|82811385|FG009|Induction Period|Sponsor Decision|0|||
46637497|NCT01474512|82811386|FG010|Induction Period|Sponsor Decision|0|||
47059680|NCT01565707|83339315|FG001|Overall Study|Adverse Event|6|||
47059681|NCT01565707|83339316|FG002|Overall Study|Adverse Event|2|||
47059682|NCT01565707|83339317|FG003|Overall Study|Adverse Event|1|||
47059683|NCT01565707|83339314|FG000|Overall Study|Lost to Follow-up|1|||
46637498|NCT01474512|82811387|FG011|Induction Period|Sponsor Decision|0|||
46828455|NCT00256750|83046684|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
46828456|NCT00256750|83046685|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
46828457|NCT00256750|83046686|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
46828458|NCT00256750|83046684|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
46828459|NCT00256750|83046685|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
46828460|NCT00256750|83046686|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
47059684|NCT01565707|83339315|FG001|Overall Study|Lost to Follow-up|0|||
46828461|NCT00256750|83046684|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
46828462|NCT00256750|83046685|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
46828463|NCT00256750|83046686|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
46828464|NCT00256750|83046684|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
46828465|NCT00256750|83046685|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
46828466|NCT00256750|83046686|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
46828467|NCT00256750|83046684|FG000|Post-Transplant Treated (24 Months)|Death|3|||
46828468|NCT00256750|83046685|FG001|Post-Transplant Treated (24 Months)|Death|0|||
46828469|NCT00256750|83046686|FG002|Post-Transplant Treated (24 Months)|Death|0|||
46828470|NCT00256750|83046684|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
46828471|NCT00256750|83046685|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
46828472|NCT00256750|83046686|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
46828473|NCT00256750|83046684|FG000|Post-Transplant Treated (24 Months)|Other|2|||
46828474|NCT00256750|83046685|FG001|Post-Transplant Treated (24 Months)|Other|0|||
46828475|NCT00256750|83046686|FG002|Post-Transplant Treated (24 Months)|Other|1|||
47059685|NCT01565707|83339316|FG002|Overall Study|Lost to Follow-up|0|||
46828476|NCT00256750|83046684|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
46828477|NCT00256750|83046685|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
46637499|NCT01474512|82811388|FG012|Induction Period|Sponsor Decision|0|||
46935622|NCT02718326|83171793|FG002|Overall Study|Lost to Follow-up|14|||
47059686|NCT01565707|83339317|FG003|Overall Study|Lost to Follow-up|0|||
46637500|NCT01474512|82811389|FG013|Induction Period|Sponsor Decision|0|||
46637501|NCT01474512|82811390|FG014|Induction Period|Sponsor Decision|0|||
46637502|NCT01474512|82811391|FG015|Induction Period|Sponsor Decision|0|||
47059687|NCT01565707|83339314|FG000|Overall Study|Protocol Violation|1|||
46637503|NCT01474512|82811392|FG016|Induction Period|Sponsor Decision|0|||
46637504|NCT01474512|82811393|FG017|Induction Period|Sponsor Decision|0|||
46637505|NCT01474512|82811376|FG000|Induction Period|Lost to Follow-up|1|||
46828478|NCT00256750|83046686|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
46828479|NCT00256750|83046684|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
46828480|NCT00256750|83046685|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
46828481|NCT00256750|83046686|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
46828482|NCT00256750|83046684|FG000|Post-Transplant Treated (36 Months)|Death|0|||
46828483|NCT00256750|83046685|FG001|Post-Transplant Treated (36 Months)|Death|2|||
46828484|NCT00256750|83046686|FG002|Post-Transplant Treated (36 Months)|Death|1|||
46828485|NCT00256750|83046684|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
46828486|NCT00256750|83046685|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
46828487|NCT00256750|83046686|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
46828488|NCT00256750|83046684|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
46828489|NCT00256750|83046685|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
46828490|NCT00256750|83046686|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
46828491|NCT00256750|83046684|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
46828492|NCT00256750|83046685|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
46828493|NCT00256750|83046686|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
46828494|NCT00256750|83046684|FG000|Post-Transplant Treated (36 Months)|Other|0|||
46828495|NCT00256750|83046685|FG001|Post-Transplant Treated (36 Months)|Other|1|||
46828496|NCT00256750|83046686|FG002|Post-Transplant Treated (36 Months)|Other|1|||
46828497|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
46828498|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
46828499|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
46828500|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
46828501|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
46828502|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
46828503|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
46828504|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
46935623|NCT02718326|83171791|FG000|Overall Study|Protocol Deviation|1|||
46935624|NCT02718326|83171792|FG001|Overall Study|Protocol Deviation|0|||
46935625|NCT02718326|83171793|FG002|Overall Study|Protocol Deviation|0|||
46935626|NCT02718326|83171791|FG000|Overall Study|Pregnancy|1|||
46935627|NCT02718326|83171792|FG001|Overall Study|Pregnancy|0|||
46935628|NCT02718326|83171793|FG002|Overall Study|Pregnancy|0|||
46935629|NCT03600714|83171803|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
46935630|NCT02720042|83171842|FG000|Overall Study|Death|3|||
46935631|NCT02720042|83171842|FG000|Overall Study|Lost to Follow-up|4|||
46763751|NCT00663208|82982027|FG006|Follow-up Period|Lost to Follow-up|0|||
46763752|NCT00663208|82982021|FG000|Follow-up Period|Other reason|1|||
46763753|NCT00663208|82982022|FG001|Follow-up Period|Other reason|0|||
46763754|NCT00663208|82982023|FG002|Follow-up Period|Other reason|0|||
46763755|NCT00663208|82982024|FG003|Follow-up Period|Other reason|0|||
46763756|NCT00663208|82982025|FG004|Follow-up Period|Other reason|0|||
46763757|NCT00663208|82982026|FG005|Follow-up Period|Other reason|0|||
46763758|NCT00663208|82982027|FG006|Follow-up Period|Other reason|1|||
46763759|NCT00810810|82982049|FG000|Overall Study|Withdrawal by Subject|0|||
46763760|NCT00810810|82982050|FG001|Overall Study|Withdrawal by Subject|8|||
46763761|NCT00810810|82982051|FG002|Overall Study|Withdrawal by Subject|10|||
46763762|NCT00810810|82982052|FG003|Overall Study|Withdrawal by Subject|8|||
46763763|NCT00810810|82982049|FG000|Overall Study|Physician Decision|0|||
46763764|NCT00810810|82982050|FG001|Overall Study|Physician Decision|3|||
46763765|NCT00810810|82982051|FG002|Overall Study|Physician Decision|1|||
46763766|NCT00810810|82982052|FG003|Overall Study|Physician Decision|5|||
46763767|NCT00661258|82982064|FG000|Overall Study|Death|1|||
46763768|NCT00661258|82982065|FG001|Overall Study|Death|0|||
46763769|NCT00661258|82982064|FG000|Overall Study|caught by police and in detox center|2|||
46763770|NCT00661258|82982065|FG001|Overall Study|caught by police and in detox center|1|||
46763771|NCT00871871|82982073|FG000|Part I|Adverse Event|0|||
46763772|NCT00871871|82982074|FG001|Part I|Adverse Event|2|||
46763773|NCT00871871|82982075|FG002|Part I|Adverse Event|0|||
46763774|NCT00871871|82982076|FG003|Part I|Adverse Event|0|||
46763775|NCT00871871|82982073|FG000|Part I|Withdrawal by Subject|3|||
46935632|NCT02720042|83171842|FG000|Overall Study|Withdrawal by Subject|1|||
46935633|NCT02720042|83171842|FG000|Overall Study|Physician Decision|3|||
46637506|NCT01474512|82811377|FG001|Induction Period|Lost to Follow-up|0|||
46763776|NCT00871871|82982074|FG001|Part I|Withdrawal by Subject|0|||
46763777|NCT00871871|82982075|FG002|Part I|Withdrawal by Subject|0|||
46763778|NCT00871871|82982076|FG003|Part I|Withdrawal by Subject|0|||
46763779|NCT00871871|82982073|FG000|Part I|Laboratory abnormality|0|||
46763780|NCT00871871|82982074|FG001|Part I|Laboratory abnormality|1|||
46637507|NCT01474512|82811378|FG002|Induction Period|Lost to Follow-up|2|||
46763781|NCT00871871|82982075|FG002|Part I|Laboratory abnormality|0|||
46763782|NCT00871871|82982076|FG003|Part I|Laboratory abnormality|0|||
46763783|NCT00871871|82982073|FG000|Part II|Lack of Efficacy|0|||
46763784|NCT00871871|82982074|FG001|Part II|Lack of Efficacy|0|||
46935634|NCT02720042|83171842|FG000|Overall Study|Phasix Mesh explanted|1|||
46935635|NCT02720042|83171842|FG000|Overall Study|unable due to non-study-related illness|3|||
46935636|NCT01352793|83171848|FG000|Overall Study|Lost to Follow-up|289|||
46935637|NCT01352793|83171849|FG001|Overall Study|Lost to Follow-up|125|||
46935638|NCT01352793|83171848|FG000|Overall Study|Withdrawal by Subject|120|||
46935639|NCT01352793|83171849|FG001|Overall Study|Withdrawal by Subject|55|||
46935640|NCT01352793|83171848|FG000|Overall Study|Protocol Violation|44|||
46935641|NCT01352793|83171849|FG001|Overall Study|Protocol Violation|23|||
46935642|NCT01352793|83171848|FG000|Overall Study|Adverse Event|44|||
46935643|NCT01352793|83171849|FG001|Overall Study|Adverse Event|10|||
46935644|NCT01352793|83171848|FG000|Overall Study|Physician Decision|1|||
46935645|NCT01352793|83171849|FG001|Overall Study|Physician Decision|0|||
46935646|NCT01352793|83171848|FG000|Overall Study|Pregnancy|26|||
46935647|NCT01352793|83171849|FG001|Overall Study|Pregnancy|8|||
46935648|NCT01352793|83171848|FG000|Overall Study|Other|25|||
46935649|NCT01352793|83171849|FG001|Overall Study|Other|7|||
46935650|NCT01352793|83171848|FG000|Overall Study|Medication error|2|||
46935651|NCT01352793|83171849|FG001|Overall Study|Medication error|2|||
46935652|NCT01352793|83171848|FG000|Overall Study|Death|1|||
46935653|NCT01352793|83171849|FG001|Overall Study|Death|0|||
46935654|NCT01352793|83171848|FG000|Overall Study|Randomized but not vaccinated|8|||
46935655|NCT01352793|83171849|FG001|Overall Study|Randomized but not vaccinated|0|||
46935656|NCT01352793|83171848|FG000|Overall Study|No longer meets eligibility criteria|25|||
46935657|NCT01352793|83171849|FG001|Overall Study|No longer meets eligibility criteria|15|||
46935658|NCT02717546|83171855|FG000|Overall Study|Lost to Follow-up|12|||
46935659|NCT01378962|83171859|FG000|Overall Study|Death|14|||
46935660|NCT01378962|83171859|FG000|Overall Study|Lost to Follow-up|1|||
46935661|NCT01378962|83171859|FG000|Overall Study|Other|2|||
46935662|NCT00890409|83171865|FG000|Overall Study|Lost to Follow-up|20|||
46935663|NCT00890409|83171866|FG001|Overall Study|Lost to Follow-up|21|||
46935664|NCT04495478|83171877|FG000|Overall Study|Withdrawal by Subject|0|||
46935665|NCT04495478|83171878|FG001|Overall Study|Withdrawal by Subject|0|||
46935666|NCT04495478|83171879|FG002|Overall Study|Withdrawal by Subject|0|||
46935667|NCT04495478|83171880|FG003|Overall Study|Withdrawal by Subject|1|||
46935668|NCT04495478|83171881|FG004|Overall Study|Withdrawal by Subject|0|||
46935669|NCT04495478|83171882|FG005|Overall Study|Withdrawal by Subject|0|||
46935670|NCT04495478|83171883|FG006|Overall Study|Withdrawal by Subject|0|||
46935671|NCT04495478|83171877|FG000|Overall Study|Physician Decision|0|||
46935672|NCT04495478|83171878|FG001|Overall Study|Physician Decision|1|||
46935673|NCT04495478|83171879|FG002|Overall Study|Physician Decision|0|||
46935674|NCT04495478|83171880|FG003|Overall Study|Physician Decision|0|||
46935675|NCT04495478|83171881|FG004|Overall Study|Physician Decision|1|||
46935676|NCT04495478|83171882|FG005|Overall Study|Physician Decision|0|||
46935677|NCT04495478|83171883|FG006|Overall Study|Physician Decision|0|||
46935678|NCT00152763|83171909|FG000|Overall Study|Death|4|||
46935679|NCT00152763|83171910|FG001|Overall Study|Death|1|||
46935680|NCT00152763|83171911|FG002|Overall Study|Death|2|||
46935681|NCT00152763|83171912|FG003|Overall Study|Death|1|||
46935682|NCT00152763|83171909|FG000|Overall Study|Lost to Follow-up|6|||
46935683|NCT00152763|83171910|FG001|Overall Study|Lost to Follow-up|4|||
46935684|NCT00152763|83171911|FG002|Overall Study|Lost to Follow-up|2|||
46935685|NCT00152763|83171912|FG003|Overall Study|Lost to Follow-up|13|||
47059688|NCT01565707|83339315|FG001|Overall Study|Protocol Violation|0|||
47059689|NCT01565707|83339316|FG002|Overall Study|Protocol Violation|0|||
47059690|NCT01565707|83339317|FG003|Overall Study|Protocol Violation|1|||
47059691|NCT01565707|83339314|FG000|Overall Study|Withdrawal by Subject|3|||
47059692|NCT01565707|83339315|FG001|Overall Study|Withdrawal by Subject|1|||
47059693|NCT01565707|83339316|FG002|Overall Study|Withdrawal by Subject|1|||
47059694|NCT01565707|83339317|FG003|Overall Study|Withdrawal by Subject|1|||
47059695|NCT01565707|83339314|FG000|Overall Study|Randomized but not evaluable|2|||
47059696|NCT01565707|83339315|FG001|Overall Study|Randomized but not evaluable|0|||
46637508|NCT01474512|82811379|FG003|Induction Period|Lost to Follow-up|0|||
46935686|NCT03181542|83171926|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
46935687|NCT03181542|83171927|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
46935688|NCT00806403|83171935|FG000|Overall Study|Death|4|||
46935689|NCT00806403|83171936|FG001|Overall Study|Death|3|||
46935690|NCT00701558|83171953|FG000|Overall Study|Death|7|||
46935691|NCT00701558|83171953|FG000|Overall Study|Lost to Follow-up|8|||
46935692|NCT01663402|83171976|FG000|Overall Study|Randomized but not treated|19|||
46935693|NCT01663402|83171977|FG001|Overall Study|Randomized but not treated|11|||
46935694|NCT01663402|83171976|FG000|Overall Study|Adverse Event|347|||
46935695|NCT01663402|83171977|FG001|Overall Study|Adverse Event|362|||
46935696|NCT01663402|83171976|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
46935697|NCT01663402|83171977|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
46935698|NCT01663402|83171976|FG000|Overall Study|Poor compliance to protocol|529|||
46935699|NCT01663402|83171977|FG001|Overall Study|Poor compliance to protocol|454|||
46935700|NCT01663402|83171976|FG000|Overall Study|Physician Decision|77|||
46935701|NCT01663402|83171977|FG001|Overall Study|Physician Decision|62|||
47059697|NCT01565707|83339316|FG002|Overall Study|Randomized but not evaluable|0|||
47059698|NCT01565707|83339317|FG003|Overall Study|Randomized but not evaluable|0|||
47059699|NCT01565707|83339314|FG000|Overall Study|Miscellaneous|1|||
47059700|NCT01565707|83339315|FG001|Overall Study|Miscellaneous|1|||
47059701|NCT01565707|83339316|FG002|Overall Study|Miscellaneous|0|||
47059702|NCT01565707|83339317|FG003|Overall Study|Miscellaneous|2|||
47059703|NCT01557569|83339336|FG000|Overall Study|Adverse Event|2|||
46935702|NCT01663402|83171976|FG000|Overall Study|Site terminated by sponsor|1|||
46935703|NCT01663402|83171977|FG001|Overall Study|Site terminated by sponsor|3|||
47059704|NCT01557569|83339337|FG001|Overall Study|Adverse Event|0|||
47059705|NCT01557569|83339336|FG000|Overall Study|high blood pressure|0|||
47059706|NCT01557569|83339337|FG001|Overall Study|high blood pressure|1|||
47059707|NCT01557569|83339336|FG000|Overall Study|Withdrawal by Subject|3|||
47059708|NCT01557569|83339337|FG001|Overall Study|Withdrawal by Subject|5|||
47059709|NCT01557569|83339336|FG000|Overall Study|noncompliance with rules of residential|0|||
47059710|NCT01557569|83339337|FG001|Overall Study|noncompliance with rules of residential|1|||
46828505|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
46828506|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
46828507|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
46828508|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
46828509|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
46828510|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
46828511|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
46828512|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
46828513|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
46828514|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
46828515|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
46828516|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
46828517|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
46828518|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
46828519|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
46828520|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
46828521|NCT00256750|83046684|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
46828522|NCT00256750|83046685|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
46828523|NCT00256750|83046686|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
46828524|NCT00279201|83046697|FG000|Initiation|Death|1|||
46828525|NCT00279201|83046698|FG001|Initiation|Death|5|||
46828526|NCT00279201|83046699|FG002|Initiation|Death|0|||
46828527|NCT00279201|83046700|FG003|Initiation|Death|0|||
46828528|NCT00279201|83046701|FG004|Initiation|Death|0|||
46828529|NCT00279201|83046702|FG005|Initiation|Death|0|||
46828530|NCT00279201|83046697|FG000|Initiation|Adverse Event|6|||
46828531|NCT00279201|83046698|FG001|Initiation|Adverse Event|15|||
46828532|NCT00279201|83046699|FG002|Initiation|Adverse Event|0|||
46828533|NCT00279201|83046700|FG003|Initiation|Adverse Event|0|||
46828534|NCT00279201|83046701|FG004|Initiation|Adverse Event|0|||
46828535|NCT00279201|83046702|FG005|Initiation|Adverse Event|0|||
47059711|NCT01538719|83339345|FG000|Overall Study|Lost to Follow-up|2|||
46763785|NCT00871871|82982075|FG002|Part II|Lack of Efficacy|1|||
46763786|NCT00871871|82982076|FG003|Part II|Lack of Efficacy|0|||
46763787|NCT00871871|82982073|FG000|Part II|Withdrawal by Subject|0|||
46763788|NCT00871871|82982074|FG001|Part II|Withdrawal by Subject|0|||
46763789|NCT00871871|82982075|FG002|Part II|Withdrawal by Subject|2|||
46763790|NCT00871871|82982076|FG003|Part II|Withdrawal by Subject|1|||
46763791|NCT00871871|82982073|FG000|Part II|Adverse Event|0|||
46763792|NCT00871871|82982074|FG001|Part II|Adverse Event|0|||
46763793|NCT00871871|82982075|FG002|Part II|Adverse Event|1|||
46763794|NCT00871871|82982076|FG003|Part II|Adverse Event|2|||
46763795|NCT00871871|82982073|FG000|Part II|Protocol Violation|0|||
46763796|NCT00871871|82982074|FG001|Part II|Protocol Violation|0|||
46763797|NCT00871871|82982075|FG002|Part II|Protocol Violation|0|||
46763798|NCT00871871|82982076|FG003|Part II|Protocol Violation|1|||
46763799|NCT00849680|82982094|FG000|Overall Study|Adverse Event|0|||
46828536|NCT00279201|83046697|FG000|Initiation|Lost to Follow-up|42|||
46828537|NCT00279201|83046698|FG001|Initiation|Lost to Follow-up|41|||
46935704|NCT01663402|83171976|FG000|Overall Study|Participant moved|139|||
47059712|NCT01538719|83339346|FG001|Overall Study|Lost to Follow-up|0|||
47059713|NCT01537783|83339354|FG000|Overall Study|Lost to Follow-up|11|||
47059714|NCT01537783|83339355|FG001|Overall Study|Lost to Follow-up|2|||
46763800|NCT00849680|82982095|FG001|Overall Study|Adverse Event|0|||
46763801|NCT00849680|82982096|FG002|Overall Study|Adverse Event|0|||
46763802|NCT00849680|82982097|FG003|Overall Study|Adverse Event|0|||
46828538|NCT00279201|83046699|FG002|Initiation|Lost to Follow-up|0|||
46828539|NCT00279201|83046700|FG003|Initiation|Lost to Follow-up|0|||
46828540|NCT00279201|83046701|FG004|Initiation|Lost to Follow-up|0|||
47059715|NCT01556165|83339363|FG000|Overall Study|Adverse Event|5|||
47059716|NCT01556165|83339364|FG001|Overall Study|Adverse Event|3|||
46763803|NCT00849680|82982098|FG004|Overall Study|Adverse Event|0|||
46828541|NCT00279201|83046702|FG005|Initiation|Lost to Follow-up|0|||
46828542|NCT00279201|83046697|FG000|Initiation|Entry Criteria Exclusion|7|||
46828543|NCT00279201|83046698|FG001|Initiation|Entry Criteria Exclusion|9|||
46828544|NCT00279201|83046699|FG002|Initiation|Entry Criteria Exclusion|0|||
46828545|NCT00279201|83046700|FG003|Initiation|Entry Criteria Exclusion|0|||
46828546|NCT00279201|83046701|FG004|Initiation|Entry Criteria Exclusion|0|||
46828547|NCT00279201|83046702|FG005|Initiation|Entry Criteria Exclusion|0|||
46828548|NCT00279201|83046697|FG000|Initiation|Protocol Violation|9|||
46828549|NCT00279201|83046698|FG001|Initiation|Protocol Violation|10|||
46828550|NCT00279201|83046699|FG002|Initiation|Protocol Violation|0|||
46828551|NCT00279201|83046700|FG003|Initiation|Protocol Violation|0|||
46828552|NCT00279201|83046701|FG004|Initiation|Protocol Violation|0|||
46828553|NCT00279201|83046702|FG005|Initiation|Protocol Violation|0|||
46828554|NCT00279201|83046697|FG000|Initiation|Withdrawal by Subject|35|||
46828555|NCT00279201|83046698|FG001|Initiation|Withdrawal by Subject|41|||
46935705|NCT01663402|83171977|FG001|Overall Study|Participant moved|104|||
46935706|NCT01663402|83171976|FG000|Overall Study|Withdrawal by Subject|118|||
47059717|NCT01556165|83339363|FG000|Overall Study|Protocol Violation|0|||
47059718|NCT01556165|83339364|FG001|Overall Study|Protocol Violation|3|||
46763804|NCT00849680|82982099|FG005|Overall Study|Adverse Event|0|||
46763805|NCT00849680|82982100|FG006|Overall Study|Adverse Event|2|||
46763806|NCT00849680|82982101|FG007|Overall Study|Adverse Event|0|||
46763807|NCT00849680|82982094|FG000|Overall Study|Lost to Follow-up|7|||
46763808|NCT00849680|82982095|FG001|Overall Study|Lost to Follow-up|3|||
46763809|NCT00849680|82982096|FG002|Overall Study|Lost to Follow-up|12|||
46763810|NCT00849680|82982097|FG003|Overall Study|Lost to Follow-up|11|||
46763811|NCT00849680|82982098|FG004|Overall Study|Lost to Follow-up|8|||
46763812|NCT00849680|82982099|FG005|Overall Study|Lost to Follow-up|11|||
46763813|NCT00849680|82982100|FG006|Overall Study|Lost to Follow-up|12|||
46763814|NCT00849680|82982101|FG007|Overall Study|Lost to Follow-up|5|||
46763815|NCT00849680|82982094|FG000|Overall Study|Subject moved|1|||
46763816|NCT00849680|82982095|FG001|Overall Study|Subject moved|0|||
46763817|NCT00849680|82982096|FG002|Overall Study|Subject moved|3|||
46763818|NCT00849680|82982097|FG003|Overall Study|Subject moved|1|||
46763819|NCT00849680|82982098|FG004|Overall Study|Subject moved|0|||
46763820|NCT00849680|82982099|FG005|Overall Study|Subject moved|2|||
46763821|NCT00849680|82982100|FG006|Overall Study|Subject moved|2|||
46763822|NCT00849680|82982101|FG007|Overall Study|Subject moved|2|||
46763823|NCT00849680|82982094|FG000|Overall Study|Withdrawal by Subject|2|||
46763824|NCT00849680|82982095|FG001|Overall Study|Withdrawal by Subject|0|||
46763825|NCT00849680|82982096|FG002|Overall Study|Withdrawal by Subject|0|||
46763826|NCT00849680|82982097|FG003|Overall Study|Withdrawal by Subject|2|||
46763827|NCT00849680|82982098|FG004|Overall Study|Withdrawal by Subject|2|||
46763828|NCT00849680|82982099|FG005|Overall Study|Withdrawal by Subject|2|||
46763829|NCT00849680|82982100|FG006|Overall Study|Withdrawal by Subject|1|||
46763830|NCT00849680|82982101|FG007|Overall Study|Withdrawal by Subject|1|||
46763831|NCT00849680|82982094|FG000|Overall Study|Subject unable to comply with protocol|1|||
46763832|NCT00849680|82982095|FG001|Overall Study|Subject unable to comply with protocol|0|||
46763833|NCT00849680|82982096|FG002|Overall Study|Subject unable to comply with protocol|0|||
46763834|NCT00849680|82982097|FG003|Overall Study|Subject unable to comply with protocol|0|||
46763835|NCT00849680|82982098|FG004|Overall Study|Subject unable to comply with protocol|0|||
46763836|NCT00849680|82982099|FG005|Overall Study|Subject unable to comply with protocol|0|||
46763837|NCT00849680|82982100|FG006|Overall Study|Subject unable to comply with protocol|0|||
46763838|NCT00849680|82982101|FG007|Overall Study|Subject unable to comply with protocol|0|||
46763839|NCT00810342|82982121|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
46763840|NCT00810342|82982122|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
46763841|NCT00810342|82982121|FG000|Month 1 Follow-up|Pregnancy|1|||
46763842|NCT00810342|82982122|FG001|Month 1 Follow-up|Pregnancy|0|||
46763843|NCT00810342|82982121|FG000|6-month Follow-up|Lost to Follow-up|18|||
46763844|NCT00810342|82982122|FG001|6-month Follow-up|Lost to Follow-up|6|||
46763845|NCT00810342|82982121|FG000|6-month Follow-up|Pregnancy|6|||
46763846|NCT00810342|82982122|FG001|6-month Follow-up|Pregnancy|2|||
46763847|NCT00810342|82982121|FG000|12-month Followup|Pregnancy|9|||
46763848|NCT00810342|82982122|FG001|12-month Followup|Pregnancy|10|||
46763849|NCT00810342|82982121|FG000|12-month Followup|Lost to Follow-up|3|||
46763850|NCT00810342|82982122|FG001|12-month Followup|Lost to Follow-up|1|||
46828556|NCT00279201|83046699|FG002|Initiation|Withdrawal by Subject|0|||
46828557|NCT00279201|83046700|FG003|Initiation|Withdrawal by Subject|0|||
46935707|NCT01663402|83171977|FG001|Overall Study|Withdrawal by Subject|91|||
46935708|NCT01663402|83171976|FG000|Overall Study|Related to study drug administration|96|||
46763851|NCT00849524|82982130|FG000|Overall Study|Lack of Efficacy|3|||
46763852|NCT00808080|82982134|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
46763853|NCT00866723|82982139|FG000|Overall Study|Withdrawal by Subject|1|||
46828558|NCT00279201|83046701|FG004|Initiation|Withdrawal by Subject|0|||
46828559|NCT00279201|83046702|FG005|Initiation|Withdrawal by Subject|0|||
46935709|NCT01663402|83171977|FG001|Overall Study|Related to study drug administration|105|||
47059719|NCT01556165|83339363|FG000|Overall Study|Withdrawal of Consent|7|||
46935710|NCT01663402|83171976|FG000|Overall Study|Lost to Follow-up|17|||
46935711|NCT01663402|83171977|FG001|Overall Study|Lost to Follow-up|15|||
46935712|NCT01663402|83171976|FG000|Overall Study|Other than specified above|172|||
46935713|NCT01663402|83171977|FG001|Overall Study|Other than specified above|147|||
46935714|NCT00859521|83171994|FG000|Washout|Withdrawal by Subject|0|||
46935715|NCT00859521|83171995|FG001|Washout|Withdrawal by Subject|1|||
46935716|NCT00841815|83172010|FG000|Washout|Withdrawal by Subject|0|||
46935717|NCT00841815|83172011|FG001|Washout|Withdrawal by Subject|1|||
46935718|NCT00841659|83172018|FG000|Washout: 2 Weeks|Protocol Violation|1|||
46935719|NCT00841659|83172019|FG001|Washout: 2 Weeks|Protocol Violation|0|||
46935720|NCT02716298|83172023|FG000|First Intervention (1 Month)|Lens discomfort|1|||
46935721|NCT02716298|83172024|FG001|First Intervention (1 Month)|Lens discomfort|1|||
47059720|NCT01556165|83339364|FG001|Overall Study|Withdrawal of Consent|1|||
47059721|NCT01537549|83339370|FG000|Overall Study|Lost to Follow-up|1|||
47059722|NCT01537549|83339370|FG000|Overall Study|Withdrawal by Subject|2|||
47059723|NCT01555931|83339378|FG000|Overall Study|Lost to Follow-up|2|||
47059724|NCT01555931|83339379|FG001|Overall Study|Lost to Follow-up|5|||
47059725|NCT01583179|83339387|FG000|Overall Study|Screen failure|1|||
47059726|NCT01583179|83339388|FG001|Overall Study|Screen failure|2|||
47059727|NCT01582945|83339394|FG000|Overall Study|Intolerable side-effects|1|||
47059728|NCT01582945|83339394|FG000|Overall Study|Scheduling conflicts|1|||
47059729|NCT01565083|83339400|FG000|Overall Study|Withdrawal by Subject|6|||
47059730|NCT01565083|83339401|FG001|Overall Study|Withdrawal by Subject|4|||
47059731|NCT01565083|83339400|FG000|Overall Study|Lost to Follow-up|2|||
47059732|NCT01565083|83339401|FG001|Overall Study|Lost to Follow-up|7|||
47059733|NCT01565083|83339400|FG000|Overall Study|Death|22|||
46828560|NCT00279201|83046697|FG000|Initiation|Physician Decision|15|||
46828561|NCT00279201|83046698|FG001|Initiation|Physician Decision|18|||
46828562|NCT00279201|83046699|FG002|Initiation|Physician Decision|0|||
46828563|NCT00279201|83046700|FG003|Initiation|Physician Decision|0|||
46828564|NCT00279201|83046701|FG004|Initiation|Physician Decision|0|||
46828565|NCT00279201|83046702|FG005|Initiation|Physician Decision|0|||
46828566|NCT00279201|83046697|FG000|Initiation|Sponsor Decision|13|||
46828567|NCT00279201|83046698|FG001|Initiation|Sponsor Decision|5|||
46828568|NCT00279201|83046699|FG002|Initiation|Sponsor Decision|0|||
46828569|NCT00279201|83046700|FG003|Initiation|Sponsor Decision|0|||
46828570|NCT00279201|83046701|FG004|Initiation|Sponsor Decision|0|||
46828571|NCT00279201|83046702|FG005|Initiation|Sponsor Decision|0|||
46828572|NCT00279201|83046697|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
46828573|NCT00279201|83046698|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
46828574|NCT00279201|83046699|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
46828575|NCT00279201|83046700|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
46828576|NCT00279201|83046701|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
46828577|NCT00279201|83046702|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
46828578|NCT00279201|83046697|FG000|Maintenance|Lack of Efficacy|32|||
46828579|NCT00279201|83046698|FG001|Maintenance|Lack of Efficacy|30|||
46828580|NCT00279201|83046699|FG002|Maintenance|Lack of Efficacy|0|||
46828581|NCT00279201|83046700|FG003|Maintenance|Lack of Efficacy|0|||
46828582|NCT00279201|83046701|FG004|Maintenance|Lack of Efficacy|0|||
46828583|NCT00279201|83046702|FG005|Maintenance|Lack of Efficacy|0|||
46828584|NCT00279201|83046697|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
46828585|NCT00279201|83046698|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
46828586|NCT00279201|83046699|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
46828587|NCT00279201|83046700|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
46828588|NCT00279201|83046701|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
46828589|NCT00279201|83046702|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
46828590|NCT00279201|83046697|FG000|Maintenance|Adverse Event|4|||
46935722|NCT00840879|83172037|FG000|Second Intervention|Withdrawal by Subject|1|||
46935723|NCT00840879|83172038|FG001|Second Intervention|Withdrawal by Subject|0|||
47059734|NCT01565083|83339401|FG001|Overall Study|Death|23|||
47059735|NCT01565083|83339400|FG000|Overall Study|Other|3|||
47059736|NCT01565083|83339401|FG001|Overall Study|Other|5|||
47059737|NCT01582789|83339407|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
47059738|NCT01582789|83339408|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
47059739|NCT01537393|83339418|FG000|Overall Study|Exclude prior to study|32|||
47059740|NCT01537393|83339419|FG001|Overall Study|Exclude prior to study|44|||
46828591|NCT00279201|83046698|FG001|Maintenance|Adverse Event|4|||
46828592|NCT00279201|83046699|FG002|Maintenance|Adverse Event|0|||
46828593|NCT00279201|83046700|FG003|Maintenance|Adverse Event|0|||
46828594|NCT00279201|83046701|FG004|Maintenance|Adverse Event|0|||
46828595|NCT00279201|83046702|FG005|Maintenance|Adverse Event|0|||
46828596|NCT00279201|83046697|FG000|Maintenance|Death|4|||
46828597|NCT00279201|83046698|FG001|Maintenance|Death|4|||
46828598|NCT00279201|83046699|FG002|Maintenance|Death|0|||
46935724|NCT00840411|83172053|FG000|First Intervention|Adverse Event|1|||
46935725|NCT00840411|83172054|FG001|First Intervention|Adverse Event|0|||
46935726|NCT00840411|83172053|FG000|Washout|Withdrawal by Subject|1|||
47059741|NCT01537393|83339418|FG000|Overall Study|Death|20|||
46828599|NCT00279201|83046700|FG003|Maintenance|Death|0|||
46828600|NCT00279201|83046701|FG004|Maintenance|Death|0|||
46828601|NCT00279201|83046702|FG005|Maintenance|Death|0|||
46828602|NCT00279201|83046697|FG000|Maintenance|Lost to Follow-up|17|||
47059742|NCT01537393|83339419|FG001|Overall Study|Death|32|||
46828603|NCT00279201|83046698|FG001|Maintenance|Lost to Follow-up|13|||
46828604|NCT00279201|83046699|FG002|Maintenance|Lost to Follow-up|0|||
47059743|NCT01537393|83339418|FG000|Overall Study|Withdrawal by Subject|18|||
47059744|NCT01537393|83339419|FG001|Overall Study|Withdrawal by Subject|17|||
47059745|NCT01537393|83339418|FG000|Overall Study|Lost to Follow-up|53|||
47059746|NCT01537393|83339419|FG001|Overall Study|Lost to Follow-up|48|||
46828605|NCT00279201|83046700|FG003|Maintenance|Lost to Follow-up|0|||
47059747|NCT01537393|83339418|FG000|Overall Study|Failure - Regrafted|28|||
46828606|NCT00279201|83046701|FG004|Maintenance|Lost to Follow-up|0|||
46828607|NCT00279201|83046702|FG005|Maintenance|Lost to Follow-up|0|||
46828608|NCT00279201|83046697|FG000|Maintenance|Entry Criteria Exclusion|1|||
46828609|NCT00279201|83046698|FG001|Maintenance|Entry Criteria Exclusion|4|||
46828610|NCT00279201|83046699|FG002|Maintenance|Entry Criteria Exclusion|0|||
46828611|NCT00279201|83046700|FG003|Maintenance|Entry Criteria Exclusion|0|||
46828612|NCT00279201|83046701|FG004|Maintenance|Entry Criteria Exclusion|0|||
46828613|NCT00279201|83046702|FG005|Maintenance|Entry Criteria Exclusion|0|||
47059748|NCT01537393|83339419|FG001|Overall Study|Failure - Regrafted|43|||
47059749|NCT01537393|83339418|FG000|Overall Study|Failure - Not regrafted|2|||
47059750|NCT01537393|83339419|FG001|Overall Study|Failure - Not regrafted|6|||
47059751|NCT01537393|83339418|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
47059752|NCT01537393|83339419|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
47059753|NCT01555151|83339429|FG000|Overall Study|Withdrawal by Subject|6|||
47059754|NCT01555151|83339430|FG001|Overall Study|Withdrawal by Subject|2|||
47059755|NCT01555151|83339431|FG002|Overall Study|Withdrawal by Subject|0|||
47059756|NCT01555151|83339432|FG003|Overall Study|Withdrawal by Subject|2|||
47059757|NCT01555151|83339429|FG000|Overall Study|Administrative|3|||
46828614|NCT00279201|83046697|FG000|Maintenance|Protocol Violation|16|||
46828615|NCT00279201|83046698|FG001|Maintenance|Protocol Violation|24|||
46935727|NCT00840411|83172054|FG001|Washout|Withdrawal by Subject|0|||
46935728|NCT00836901|83172067|FG000|First Intervention|Withdrawal by Subject|1|||
46935729|NCT00836901|83172068|FG001|First Intervention|Withdrawal by Subject|0|||
46935730|NCT04466384|83172072|FG000|First Phase|Protocol Violation|1|||
46935731|NCT04466384|83172073|FG001|First Phase|Protocol Violation|0|||
46935732|NCT04466384|83172072|FG000|First Phase|Missing data|1|||
46935733|NCT04466384|83172073|FG001|First Phase|Missing data|0|||
46935734|NCT04466384|83172072|FG000|Cross Over Phase|Physician Decision|1|||
46935735|NCT04466384|83172073|FG001|Cross Over Phase|Physician Decision|0|||
46935736|NCT04466384|83172072|FG000|Cross Over Phase|Withdrawal by Subject|0|||
46935737|NCT04466384|83172073|FG001|Cross Over Phase|Withdrawal by Subject|1|||
46935738|NCT03050814|83172084|FG000|Overall Study|Screen failures|0|||
46935739|NCT03050814|83172085|FG001|Overall Study|Screen failures|0|||
46935740|NCT03050814|83172086|FG002|Overall Study|Screen failures|4|||
46935741|NCT00835575|83172094|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
46935742|NCT00835575|83172095|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
46935743|NCT04601194|83172099|FG000|Overall Study|Lost to Follow-up|7|||
46935744|NCT00835263|83172112|FG000|Second Intervention|Adverse Event|1|||
46935745|NCT00835263|83172113|FG001|Second Intervention|Adverse Event|0|||
47059758|NCT01555151|83339430|FG001|Overall Study|Administrative|1|||
47059759|NCT01555151|83339431|FG002|Overall Study|Administrative|2|||
47059760|NCT01555151|83339432|FG003|Overall Study|Administrative|0|||
47059761|NCT01555151|83339429|FG000|Overall Study|Protocol Violation|3|||
46763854|NCT00866723|82982139|FG000|Overall Study|Disease Progression|4|||
46763855|NCT00849212|82982143|FG000|Overall Study|Lack of Efficacy|1|||
46763856|NCT00849212|82982143|FG000|Overall Study|Withdrawal by Subject|3|||
46763857|NCT00849212|82982143|FG000|Overall Study|Adverse Event|2|||
46763858|NCT00849212|82982143|FG000|Overall Study|Miscellaneous|1|||
46763859|NCT00810264|82982147|FG000|Overall Study|Lost to Follow-up|191|||
46763860|NCT00810264|82982147|FG000|Overall Study|Withdrawal by subject or physician|721|||
46763861|NCT00810264|82982147|FG000|Overall Study|Death|641|||
47059762|NCT01555151|83339430|FG001|Overall Study|Protocol Violation|3|||
47059763|NCT01555151|83339431|FG002|Overall Study|Protocol Violation|3|||
47059764|NCT01555151|83339432|FG003|Overall Study|Protocol Violation|5|||
47059765|NCT01555151|83339429|FG000|Overall Study|Adverse Event|1|||
47059766|NCT01555151|83339430|FG001|Overall Study|Adverse Event|2|||
46763862|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
46763863|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
46763864|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
46828616|NCT00279201|83046699|FG002|Maintenance|Protocol Violation|0|||
46828617|NCT00279201|83046700|FG003|Maintenance|Protocol Violation|0|||
46935746|NCT01963208|83172151|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
46935747|NCT01963208|83172152|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
46935748|NCT01963208|83172153|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
46935749|NCT01963208|83172154|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
46935750|NCT01963208|83172155|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
46935751|NCT01963208|83172156|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
46935752|NCT01963208|83172151|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
46935753|NCT01963208|83172152|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
46935754|NCT01963208|83172153|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
46935755|NCT01963208|83172154|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
46935756|NCT01963208|83172155|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
46935757|NCT01963208|83172156|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
46935758|NCT01963208|83172151|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
46935759|NCT01963208|83172152|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
46935760|NCT01963208|83172153|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
46935761|NCT01963208|83172154|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
46935762|NCT01963208|83172155|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
46935763|NCT01963208|83172156|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
46935764|NCT01963208|83172151|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
46935765|NCT01963208|83172152|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
46935766|NCT01963208|83172153|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
46935767|NCT01963208|83172154|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
46935768|NCT01963208|83172155|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
46935769|NCT01963208|83172156|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
46935770|NCT01963208|83172151|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
46935771|NCT01963208|83172152|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
46935772|NCT01963208|83172153|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
46935773|NCT01963208|83172154|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
46935774|NCT01963208|83172155|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
46935775|NCT01963208|83172156|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
46935776|NCT01963208|83172151|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
46935777|NCT01963208|83172152|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
46935778|NCT01963208|83172153|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
46763865|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
46828618|NCT00279201|83046701|FG004|Maintenance|Protocol Violation|0|||
46828619|NCT00279201|83046702|FG005|Maintenance|Protocol Violation|0|||
46828620|NCT00279201|83046697|FG000|Maintenance|Withdrawal by Subject|18|||
46828621|NCT00279201|83046698|FG001|Maintenance|Withdrawal by Subject|18|||
46828622|NCT00279201|83046699|FG002|Maintenance|Withdrawal by Subject|0|||
46828623|NCT00279201|83046700|FG003|Maintenance|Withdrawal by Subject|0|||
46828624|NCT00279201|83046701|FG004|Maintenance|Withdrawal by Subject|0|||
46828625|NCT00279201|83046702|FG005|Maintenance|Withdrawal by Subject|0|||
46828626|NCT00279201|83046697|FG000|Maintenance|Physician Decision|9|||
46828627|NCT00279201|83046698|FG001|Maintenance|Physician Decision|9|||
46828628|NCT00279201|83046699|FG002|Maintenance|Physician Decision|0|||
46828629|NCT00279201|83046700|FG003|Maintenance|Physician Decision|0|||
46828630|NCT00279201|83046701|FG004|Maintenance|Physician Decision|0|||
46828631|NCT00279201|83046702|FG005|Maintenance|Physician Decision|0|||
46828632|NCT00279201|83046697|FG000|Maintenance|Sponsor Decision|4|||
46828633|NCT00279201|83046698|FG001|Maintenance|Sponsor Decision|0|||
46828634|NCT00279201|83046699|FG002|Maintenance|Sponsor Decision|0|||
46763866|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
46763867|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
46763868|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
46763869|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
46763870|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
46763871|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
46763872|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
46763873|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
46763874|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
46763875|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
46828635|NCT00279201|83046700|FG003|Maintenance|Sponsor Decision|0|||
46828636|NCT00279201|83046701|FG004|Maintenance|Sponsor Decision|0|||
46828637|NCT00279201|83046702|FG005|Maintenance|Sponsor Decision|0|||
46828638|NCT00279201|83046697|FG000|Maintenance|HbA1c>7.5%|123|||
46828639|NCT00279201|83046698|FG001|Maintenance|HbA1c>7.5%|126|||
46828640|NCT00279201|83046699|FG002|Maintenance|HbA1c>7.5%|0|||
46828641|NCT00279201|83046700|FG003|Maintenance|HbA1c>7.5%|0|||
46935779|NCT01963208|83172154|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
46935780|NCT01963208|83172155|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
46935781|NCT01963208|83172156|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
46935782|NCT01963208|83172151|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
46828642|NCT00279201|83046701|FG004|Maintenance|HbA1c>7.5%|0|||
47059767|NCT01555151|83339431|FG002|Overall Study|Adverse Event|1|||
46828643|NCT00279201|83046702|FG005|Maintenance|HbA1c>7.5%|0|||
46828644|NCT00279201|83046697|FG000|Intensification Addendum|Withdrawal by Subject|0|||
46828645|NCT00279201|83046698|FG001|Intensification Addendum|Withdrawal by Subject|0|||
46828646|NCT00279201|83046699|FG002|Intensification Addendum|Withdrawal by Subject|12|||
46828647|NCT00279201|83046700|FG003|Intensification Addendum|Withdrawal by Subject|14|||
46828648|NCT00279201|83046701|FG004|Intensification Addendum|Withdrawal by Subject|9|||
46828649|NCT00279201|83046702|FG005|Intensification Addendum|Withdrawal by Subject|18|||
46828650|NCT00279201|83046697|FG000|Intensification Addendum|Lost to Follow-up|0|||
46828651|NCT00279201|83046698|FG001|Intensification Addendum|Lost to Follow-up|0|||
46828652|NCT00279201|83046699|FG002|Intensification Addendum|Lost to Follow-up|4|||
46828653|NCT00279201|83046700|FG003|Intensification Addendum|Lost to Follow-up|6|||
46828654|NCT00279201|83046701|FG004|Intensification Addendum|Lost to Follow-up|7|||
46828655|NCT00279201|83046702|FG005|Intensification Addendum|Lost to Follow-up|7|||
46828656|NCT00279201|83046697|FG000|Intensification Addendum|Protocol Violation|0|||
46828657|NCT00279201|83046698|FG001|Intensification Addendum|Protocol Violation|0|||
46828658|NCT00279201|83046699|FG002|Intensification Addendum|Protocol Violation|2|||
46828659|NCT00279201|83046700|FG003|Intensification Addendum|Protocol Violation|2|||
46828660|NCT00279201|83046701|FG004|Intensification Addendum|Protocol Violation|6|||
46828661|NCT00279201|83046702|FG005|Intensification Addendum|Protocol Violation|6|||
46828662|NCT00279201|83046697|FG000|Intensification Addendum|Adverse Event|0|||
46828663|NCT00279201|83046698|FG001|Intensification Addendum|Adverse Event|0|||
46828664|NCT00279201|83046699|FG002|Intensification Addendum|Adverse Event|0|||
46828665|NCT00279201|83046700|FG003|Intensification Addendum|Adverse Event|4|||
46828666|NCT00279201|83046701|FG004|Intensification Addendum|Adverse Event|1|||
46935783|NCT01963208|83172152|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
46935784|NCT01963208|83172153|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
47059768|NCT01555151|83339432|FG003|Overall Study|Adverse Event|2|||
47059769|NCT01555151|83339429|FG000|Overall Study|Lost to Follow-up|0|||
47059770|NCT01555151|83339430|FG001|Overall Study|Lost to Follow-up|0|||
47059771|NCT01555151|83339431|FG002|Overall Study|Lost to Follow-up|0|||
47059772|NCT01555151|83339432|FG003|Overall Study|Lost to Follow-up|1|||
46828667|NCT00279201|83046702|FG005|Intensification Addendum|Adverse Event|3|||
46828668|NCT00279201|83046697|FG000|Intensification Addendum|Physician Decision|0|||
47059773|NCT01537081|83339446|FG000|Overall Study|Adverse Event|5|||
47059774|NCT01537081|83339447|FG001|Overall Study|Adverse Event|2|||
47059775|NCT01537081|83339448|FG002|Overall Study|Adverse Event|2|||
47059776|NCT01537081|83339446|FG000|Overall Study|Lack of Efficacy|2|||
47059777|NCT01537081|83339447|FG001|Overall Study|Lack of Efficacy|1|||
47059778|NCT01537081|83339448|FG002|Overall Study|Lack of Efficacy|0|||
47059779|NCT01537081|83339446|FG000|Overall Study|Lost to Follow-up|17|||
47059780|NCT01537081|83339447|FG001|Overall Study|Lost to Follow-up|15|||
47059781|NCT01537081|83339448|FG002|Overall Study|Lost to Follow-up|9|||
47059782|NCT01537081|83339446|FG000|Overall Study|Protocol Violation|3|||
47059783|NCT01537081|83339447|FG001|Overall Study|Protocol Violation|2|||
47059784|NCT01537081|83339448|FG002|Overall Study|Protocol Violation|2|||
47059785|NCT01537081|83339446|FG000|Overall Study|Withdrawal by Subject|6|||
47059786|NCT01537081|83339447|FG001|Overall Study|Withdrawal by Subject|11|||
47059787|NCT01537081|83339448|FG002|Overall Study|Withdrawal by Subject|3|||
47059788|NCT01537081|83339446|FG000|Overall Study|Physician Decision|5|||
47059789|NCT01537081|83339447|FG001|Overall Study|Physician Decision|6|||
47059790|NCT01537081|83339448|FG002|Overall Study|Physician Decision|0|||
47059791|NCT01537081|83339446|FG000|Overall Study|Sponsor decision|0|||
47059792|NCT01537081|83339447|FG001|Overall Study|Sponsor decision|1|||
46763876|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
46763877|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
46763878|NCT00849056|82982157|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
46763879|NCT00849056|82982158|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
46763880|NCT00849056|82982157|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
46763881|NCT00849056|82982158|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
46763882|NCT00849056|82982157|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
46763883|NCT00849056|82982158|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
46763884|NCT00849056|82982157|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
46763885|NCT00849056|82982158|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
46763886|NCT00849056|82982157|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
46828669|NCT00279201|83046698|FG001|Intensification Addendum|Physician Decision|0|||
47059793|NCT01537081|83339448|FG002|Overall Study|Sponsor decision|0|||
47059794|NCT01537081|83339446|FG000|Overall Study|Assigned but never dosed|1|||
47059795|NCT01537081|83339447|FG001|Overall Study|Assigned but never dosed|0|||
47059796|NCT01537081|83339448|FG002|Overall Study|Assigned but never dosed|0|||
47059797|NCT01564459|83339460|FG000|Run-In|Adverse Event|7|||
46828670|NCT00279201|83046699|FG002|Intensification Addendum|Physician Decision|4|||
46828671|NCT00279201|83046700|FG003|Intensification Addendum|Physician Decision|1|||
46828672|NCT00279201|83046701|FG004|Intensification Addendum|Physician Decision|3|||
46935785|NCT01963208|83172154|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
47059798|NCT01564459|83339461|FG001|Run-In|Adverse Event|0|||
46763887|NCT00849056|82982158|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
47059799|NCT01564459|83339462|FG002|Run-In|Adverse Event|0|||
47059800|NCT01564459|83339460|FG000|Run-In|Lost to Follow-up|1|||
47059801|NCT01564459|83339461|FG001|Run-In|Lost to Follow-up|0|||
47059802|NCT01564459|83339462|FG002|Run-In|Lost to Follow-up|0|||
47059803|NCT01564459|83339460|FG000|Run-In|Non-compliance with study drug|2|||
47059804|NCT01564459|83339461|FG001|Run-In|Non-compliance with study drug|0|||
47059805|NCT01564459|83339462|FG002|Run-In|Non-compliance with study drug|0|||
47059806|NCT01564459|83339460|FG000|Run-In|Protocol Violation|1|||
47059807|NCT01564459|83339461|FG001|Run-In|Protocol Violation|0|||
47059808|NCT01564459|83339462|FG002|Run-In|Protocol Violation|0|||
47059809|NCT01564459|83339460|FG000|Run-In|Withdrawal by Subject|1|||
47059810|NCT01564459|83339461|FG001|Run-In|Withdrawal by Subject|0|||
47059811|NCT01564459|83339462|FG002|Run-In|Withdrawal by Subject|0|||
47059812|NCT01564459|83339460|FG000|Double-blind Treatment|Adverse Event|0|||
47059813|NCT01564459|83339461|FG001|Double-blind Treatment|Adverse Event|0|||
47059814|NCT01564459|83339462|FG002|Double-blind Treatment|Adverse Event|1|||
47059815|NCT01555073|83339477|FG000|Overall Study|Lost to Follow-up|1|||
47059816|NCT01555073|83339478|FG001|Overall Study|Lost to Follow-up|2|||
47059817|NCT01555073|83339479|FG002|Overall Study|Lost to Follow-up|0|||
47059818|NCT01555073|83339480|FG003|Overall Study|Lost to Follow-up|5|||
47059819|NCT01582243|83339490|FG000|Overall Study|Withdrawal by Subject|1|||
47059820|NCT01582243|83339490|FG000|Overall Study|Adverse Event|1|||
47059821|NCT01582243|83339490|FG000|Overall Study|Lost to Follow-up|1|||
46828673|NCT00279201|83046702|FG005|Intensification Addendum|Physician Decision|2|||
46828674|NCT00279201|83046697|FG000|Intensification Addendum|Sponsor Decision|0|||
46828675|NCT00279201|83046698|FG001|Intensification Addendum|Sponsor Decision|0|||
46828676|NCT00279201|83046699|FG002|Intensification Addendum|Sponsor Decision|0|||
46828677|NCT00279201|83046700|FG003|Intensification Addendum|Sponsor Decision|0|||
46828678|NCT00279201|83046701|FG004|Intensification Addendum|Sponsor Decision|1|||
46935786|NCT01963208|83172155|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
46935787|NCT01963208|83172156|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
46935788|NCT01963208|83172151|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
46935789|NCT01963208|83172152|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
46935790|NCT01963208|83172153|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
46935791|NCT01963208|83172154|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
46935792|NCT01963208|83172155|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
46935793|NCT01963208|83172156|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
46935794|NCT01963208|83172151|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
46935795|NCT01963208|83172152|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
47059822|NCT01536535|83339496|FG000|Overall Study|Withdrawal by Subject|10|||
47059823|NCT01536535|83339497|FG001|Overall Study|Withdrawal by Subject|5|||
47059824|NCT01536535|83339496|FG000|Overall Study|Lost to Follow-up|4|||
47059825|NCT01536535|83339497|FG001|Overall Study|Lost to Follow-up|6|||
46828679|NCT00279201|83046702|FG005|Intensification Addendum|Sponsor Decision|1|||
46828680|NCT00279201|83046697|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
46828681|NCT00279201|83046698|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
46828682|NCT00279201|83046699|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
46828683|NCT00279201|83046700|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
46828684|NCT00279201|83046701|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
46828685|NCT00279201|83046702|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
46828686|NCT00279201|83046697|FG000|Intensification Addendum|Lack of Efficacy|0|||
46828687|NCT00279201|83046698|FG001|Intensification Addendum|Lack of Efficacy|0|||
46828688|NCT00279201|83046699|FG002|Intensification Addendum|Lack of Efficacy|0|||
46828689|NCT00279201|83046700|FG003|Intensification Addendum|Lack of Efficacy|1|||
46828690|NCT00279201|83046701|FG004|Intensification Addendum|Lack of Efficacy|1|||
46828691|NCT00279201|83046702|FG005|Intensification Addendum|Lack of Efficacy|0|||
46828692|NCT00279201|83046697|FG000|Intensification Addendum|Death|0|||
46828693|NCT00279201|83046698|FG001|Intensification Addendum|Death|0|||
46935796|NCT01963208|83172153|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
46935797|NCT01963208|83172154|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
46935798|NCT01963208|83172155|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
47059826|NCT01536535|83339496|FG000|Overall Study|Physician Decision|1|||
47059827|NCT01536535|83339497|FG001|Overall Study|Physician Decision|1|||
47059828|NCT01536535|83339496|FG000|Overall Study|Participant moved|0|||
47059829|NCT01536535|83339497|FG001|Overall Study|Participant moved|1|||
47059830|NCT01554527|83339507|FG000|Overall Study|Withdrawal by Subject|1|||
47059831|NCT01554527|83339508|FG001|Overall Study|Withdrawal by Subject|0|||
47059832|NCT01554527|83339509|FG002|Overall Study|Withdrawal by Subject|3|||
46828694|NCT00279201|83046699|FG002|Intensification Addendum|Death|0|||
47059833|NCT01554527|83339507|FG000|Overall Study|Lost to Follow-up|0|||
47059834|NCT01554527|83339508|FG001|Overall Study|Lost to Follow-up|0|||
47059835|NCT01554527|83339509|FG002|Overall Study|Lost to Follow-up|4|||
47059836|NCT01554527|83339507|FG000|Overall Study|Physician Decision|0|||
47059837|NCT01554527|83339508|FG001|Overall Study|Physician Decision|0|||
47059838|NCT01554527|83339509|FG002|Overall Study|Physician Decision|1|||
47059839|NCT01563913|83339520|FG000|Overall Study|Physician Decision|1|||
46935799|NCT01963208|83172156|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
46935800|NCT01963208|83172151|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
46935801|NCT01963208|83172152|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
46935802|NCT01963208|83172153|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
46935803|NCT01963208|83172154|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
46935804|NCT01963208|83172155|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
46935805|NCT01963208|83172156|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
46935806|NCT01963208|83172151|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
46935807|NCT01963208|83172152|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
46935808|NCT01963208|83172153|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
46935809|NCT01963208|83172154|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
46935810|NCT01963208|83172155|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
46935811|NCT01963208|83172156|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
46935812|NCT01963208|83172151|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
46935813|NCT01963208|83172152|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
46935814|NCT01963208|83172153|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
46935815|NCT01963208|83172154|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
46935816|NCT01963208|83172155|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
46935817|NCT01963208|83172156|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
46935818|NCT01963208|83172151|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
47059840|NCT01563913|83339521|FG001|Overall Study|Physician Decision|0|||
47059841|NCT01563913|83339520|FG000|Overall Study|Spouse Passed Away|1|||
47059842|NCT01563913|83339521|FG001|Overall Study|Spouse Passed Away|0|||
47059843|NCT01553747|83339530|FG000|Overall Study|Protocol Violation|0|||
47059844|NCT01553747|83339531|FG001|Overall Study|Protocol Violation|2|||
47059845|NCT01553747|83339532|FG002|Overall Study|Protocol Violation|0|||
47059846|NCT01553747|83339530|FG000|Overall Study|Voluntarily withdrew|70|||
46935819|NCT01963208|83172152|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
46935820|NCT01963208|83172153|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
47059847|NCT01553747|83339531|FG001|Overall Study|Voluntarily withdrew|66|||
47059848|NCT01553747|83339532|FG002|Overall Study|Voluntarily withdrew|74|||
47059849|NCT01553747|83339530|FG000|Overall Study|Adverse event or SAE|32|||
46935821|NCT01963208|83172154|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
46935822|NCT01963208|83172155|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
47059850|NCT01553747|83339531|FG001|Overall Study|Adverse event or SAE|28|||
46935823|NCT01963208|83172156|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
46935824|NCT01963208|83172151|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
46935825|NCT01963208|83172152|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
46935826|NCT01963208|83172153|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
47059851|NCT01553747|83339532|FG002|Overall Study|Adverse event or SAE|19|||
47059852|NCT01553747|83339530|FG000|Overall Study|Physician decision: other|10|||
46935827|NCT01963208|83172154|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
46935828|NCT01963208|83172155|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
46935829|NCT01963208|83172156|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
46935830|NCT00834873|83172168|FG000|First Intervention|Adverse Event|0|||
46935831|NCT00834873|83172169|FG001|First Intervention|Adverse Event|1|||
46935832|NCT01377480|83172177|FG000|Overall Study|Protocol Violation|0|||
46935833|NCT01377480|83172178|FG001|Overall Study|Protocol Violation|0|||
46935834|NCT01377480|83172179|FG002|Overall Study|Protocol Violation|0|||
46935835|NCT01377480|83172180|FG003|Overall Study|Protocol Violation|4|||
46935836|NCT01377480|83172177|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
46935837|NCT01377480|83172178|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
46935838|NCT01377480|83172179|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
46935839|NCT01377480|83172180|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
46935840|NCT01377480|83172177|FG000|Overall Study|Withdrawal by Subject|0|||
47059853|NCT01553747|83339531|FG001|Overall Study|Physician decision: other|8|||
47059854|NCT01553747|83339532|FG002|Overall Study|Physician decision: other|7|||
47059855|NCT01553747|83339530|FG000|Overall Study|Lost to Follow-up|11|||
47059856|NCT01553747|83339531|FG001|Overall Study|Lost to Follow-up|5|||
47059857|NCT01553747|83339532|FG002|Overall Study|Lost to Follow-up|6|||
47059858|NCT01553747|83339530|FG000|Overall Study|Sponsor decision, specify|7|||
47059859|NCT01553747|83339531|FG001|Overall Study|Sponsor decision, specify|5|||
47059860|NCT01553747|83339532|FG002|Overall Study|Sponsor decision, specify|0|||
46763888|NCT00849056|82982157|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
47059861|NCT01553747|83339530|FG000|Overall Study|Physician decision: lack of efficacy|1|||
47059862|NCT01553747|83339531|FG001|Overall Study|Physician decision: lack of efficacy|5|||
46763889|NCT00849056|82982158|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
46935841|NCT01377480|83172178|FG001|Overall Study|Withdrawal by Subject|0|||
46935842|NCT01377480|83172179|FG002|Overall Study|Withdrawal by Subject|1|||
46935843|NCT01377480|83172180|FG003|Overall Study|Withdrawal by Subject|0|||
46935844|NCT01377480|83172177|FG000|Overall Study|Serious adverse event|0|||
47059863|NCT01553747|83339532|FG002|Overall Study|Physician decision: lack of efficacy|3|||
46935845|NCT01377480|83172178|FG001|Overall Study|Serious adverse event|0|||
46935846|NCT01377480|83172179|FG002|Overall Study|Serious adverse event|1|||
46935847|NCT01377480|83172180|FG003|Overall Study|Serious adverse event|1|||
46935848|NCT01377480|83172177|FG000|Overall Study|Other|0|||
46935849|NCT01377480|83172178|FG001|Overall Study|Other|0|||
46935850|NCT01377480|83172179|FG002|Overall Study|Other|7|||
46935851|NCT01377480|83172180|FG003|Overall Study|Other|6|||
46935852|NCT00834795|83172192|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
46935853|NCT00834795|83172193|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
46935854|NCT00834795|83172192|FG000|Second Intervention|Adverse Event|1|||
46935855|NCT00834795|83172193|FG001|Second Intervention|Adverse Event|0|||
46935856|NCT00834717|83172199|FG000|First Intervention|Adverse Event|1|||
46935857|NCT00834717|83172200|FG001|First Intervention|Adverse Event|0|||
46935858|NCT00834717|83172199|FG000|First Intervention|Withdrawal by Subject|0|||
46935859|NCT00834717|83172200|FG001|First Intervention|Withdrawal by Subject|1|||
46935860|NCT00834639|83172206|FG000|Second Intervention|Physician Decision|0|||
46935861|NCT00834639|83172207|FG001|Second Intervention|Physician Decision|2|||
46935862|NCT00834249|83172227|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
46935863|NCT00834249|83172228|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
46935864|NCT00834249|83172227|FG000|Second Intervention|Adverse Event|1|||
46935865|NCT00834249|83172228|FG001|Second Intervention|Adverse Event|0|||
46935866|NCT00833937|83172234|FG000|Washout|Withdrawal by Subject|1|||
46935867|NCT00833937|83172235|FG001|Washout|Withdrawal by Subject|0|||
46935868|NCT00924170|83172241|FG000|Overall Study|Refused further treatment|0|||
46828695|NCT00279201|83046700|FG003|Intensification Addendum|Death|0|||
46935869|NCT00924170|83172242|FG001|Overall Study|Refused further treatment|1|||
46935870|NCT00924170|83172241|FG000|Overall Study|Physician Decision|0|||
46935871|NCT00924170|83172242|FG001|Overall Study|Physician Decision|1|||
46935872|NCT00924170|83172241|FG000|Overall Study|Progressive disease|3|||
46935873|NCT00924170|83172242|FG001|Overall Study|Progressive disease|6|||
46935874|NCT00924170|83172241|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
46935875|NCT00924170|83172242|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
46935876|NCT00924170|83172241|FG000|Overall Study|Death|1|||
46828696|NCT00279201|83046701|FG004|Intensification Addendum|Death|1|||
46828697|NCT00279201|83046702|FG005|Intensification Addendum|Death|0|||
46828698|NCT00203476|83046738|FG000|Overall Study|Lost to Follow-up|1|||
46828699|NCT00203476|83046739|FG001|Overall Study|Lost to Follow-up|0|||
46828700|NCT00203476|83046740|FG002|Overall Study|Lost to Follow-up|0|||
46828701|NCT00203476|83046738|FG000|Overall Study|Withdrawal by Subject|0|||
46828702|NCT00203476|83046739|FG001|Overall Study|Withdrawal by Subject|1|||
46828703|NCT00203476|83046740|FG002|Overall Study|Withdrawal by Subject|0|||
46828704|NCT00203242|83046748|FG000|Overall Study|Lost to Follow-up|1|||
46828705|NCT00200356|83046754|FG000|Overall Study|Lack of Efficacy|3|||
46828706|NCT00200356|83046755|FG001|Overall Study|Lack of Efficacy|3|||
46828707|NCT00200356|83046754|FG000|Overall Study|Protocol Violation|4|||
46828708|NCT00200356|83046755|FG001|Overall Study|Protocol Violation|4|||
46828709|NCT00200356|83046754|FG000|Overall Study|Nontreatment|1|||
46828710|NCT00200356|83046755|FG001|Overall Study|Nontreatment|0|||
46828711|NCT00227344|83046763|FG000|Overall Study|study terminated early|12|||
46828712|NCT00227344|83046764|FG001|Overall Study|study terminated early|5|||
46828713|NCT00227266|83046773|FG000|Overall Study|Withdrawal by Subject|0|||
46828714|NCT00227266|83046774|FG001|Overall Study|Withdrawal by Subject|0|||
46828715|NCT00227266|83046775|FG002|Overall Study|Withdrawal by Subject|1|||
46828716|NCT00227266|83046773|FG000|Overall Study|Protocol Violation|1|||
46828717|NCT00227266|83046774|FG001|Overall Study|Protocol Violation|0|||
46828718|NCT00227266|83046775|FG002|Overall Study|Protocol Violation|1|||
46828719|NCT00227266|83046773|FG000|Overall Study|Excessive weight gain|0|||
46828720|NCT00227266|83046774|FG001|Overall Study|Excessive weight gain|0|||
46828721|NCT00227266|83046775|FG002|Overall Study|Excessive weight gain|2|||
46828722|NCT00256282|83046786|FG000|Overall Study|Disease progression, relapse during acti|12|||
46828723|NCT00256282|83046786|FG000|Overall Study|Adverse Event|3|||
46828724|NCT00256282|83046786|FG000|Overall Study|Physician Decision|1|||
46935877|NCT00924170|83172242|FG001|Overall Study|Death|0|||
46935878|NCT00828321|83172256|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
46935879|NCT00828321|83172257|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
46935880|NCT00828321|83172256|FG000|Second Intervention|Protocol Violation|0|||
46637509|NCT01474512|82811380|FG004|Induction Period|Lost to Follow-up|0|||
46935881|NCT00828321|83172257|FG001|Second Intervention|Protocol Violation|1|||
46935882|NCT01352715|83172263|FG000|Overall Study|Death|3|||
46935883|NCT01352715|83172264|FG001|Overall Study|Death|3|||
46828725|NCT00266877|83046793|FG000|Overall Study|Death|1|||
46828726|NCT00266877|83046794|FG001|Overall Study|Death|1|||
46828727|NCT00266877|83046795|FG002|Overall Study|Death|1|||
46828728|NCT00266877|83046793|FG000|Overall Study|Adverse Event|6|||
46935884|NCT01352715|83172263|FG000|Overall Study|Lost to Follow-up|5|||
46935885|NCT01352715|83172264|FG001|Overall Study|Lost to Follow-up|7|||
46637510|NCT01474512|82811381|FG005|Induction Period|Lost to Follow-up|0|||
46828729|NCT00266877|83046794|FG001|Overall Study|Adverse Event|4|||
46828730|NCT00266877|83046795|FG002|Overall Study|Adverse Event|1|||
46828731|NCT00266877|83046793|FG000|Overall Study|Physician Decision|2|||
46828732|NCT00266877|83046794|FG001|Overall Study|Physician Decision|1|||
46828733|NCT00266877|83046795|FG002|Overall Study|Physician Decision|1|||
46828734|NCT00266877|83046793|FG000|Overall Study|Withdrawal by Subject|3|||
46828735|NCT00266877|83046794|FG001|Overall Study|Withdrawal by Subject|1|||
47059864|NCT01536379|83339545|FG000|Overall Study|Adverse Event|1|||
47059865|NCT01536379|83339546|FG001|Overall Study|Adverse Event|2|||
47059866|NCT01536379|83339545|FG000|Overall Study|Withdrawal by Subject|1|||
47059867|NCT01536379|83339546|FG001|Overall Study|Withdrawal by Subject|1|||
47059868|NCT01536145|83339552|FG000|Overall Study|Progressive disease|3|||
47059869|NCT01536145|83339553|FG001|Overall Study|Progressive disease|4|||
47059870|NCT01536145|83339554|FG002|Overall Study|Progressive disease|1|||
47059871|NCT01536145|83339555|FG003|Overall Study|Progressive disease|2|||
46828736|NCT00266877|83046795|FG002|Overall Study|Withdrawal by Subject|1|||
46828737|NCT00266877|83046793|FG000|Overall Study|Disease Progression|72|||
46828738|NCT00266877|83046794|FG001|Overall Study|Disease Progression|37|||
46828739|NCT00266877|83046795|FG002|Overall Study|Disease Progression|23|||
46828740|NCT00266877|83046793|FG000|Overall Study|Symptomatic Deterioration|6|||
47059872|NCT01536145|83339556|FG004|Overall Study|Progressive disease|1|||
46828741|NCT00266877|83046794|FG001|Overall Study|Symptomatic Deterioration|3|||
46828742|NCT00266877|83046795|FG002|Overall Study|Symptomatic Deterioration|1|||
46828743|NCT00266877|83046793|FG000|Overall Study|Hospitalization|1|||
46828744|NCT00266877|83046794|FG001|Overall Study|Hospitalization|0|||
46828745|NCT00266877|83046795|FG002|Overall Study|Hospitalization|0|||
46828746|NCT00266877|83046793|FG000|Overall Study|Concomitant Radiotherapy|0|||
46828747|NCT00266877|83046794|FG001|Overall Study|Concomitant Radiotherapy|1|||
46828748|NCT00266877|83046795|FG002|Overall Study|Concomitant Radiotherapy|0|||
46828749|NCT00256204|83046807|FG000|Overall Study|Adverse Event|10|||
46935886|NCT01352715|83172263|FG000|Overall Study|Withdrawal by Subject|4|||
46935887|NCT01352715|83172264|FG001|Overall Study|Withdrawal by Subject|8|||
46935888|NCT01352715|83172263|FG000|Overall Study|site closure|16|||
46935889|NCT01352715|83172264|FG001|Overall Study|site closure|15|||
46935890|NCT01352715|83172263|FG000|Overall Study|no final visit in closeout period|15|||
46935891|NCT01352715|83172264|FG001|Overall Study|no final visit in closeout period|12|||
46935892|NCT01352715|83172263|FG000|Overall Study|major ineligibility|2|||
46935893|NCT01352715|83172264|FG001|Overall Study|major ineligibility|1|||
47059873|NCT01536145|83339557|FG005|Overall Study|Progressive disease|2|||
47059874|NCT01536145|83339558|FG006|Overall Study|Progressive disease|1|||
47059875|NCT01536145|83339559|FG007|Overall Study|Progressive disease|2|||
46763890|NCT00849056|82982157|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
46763891|NCT00849056|82982158|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
46763892|NCT00849056|82982157|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
46763893|NCT00849056|82982158|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
46763894|NCT00837434|82982166|FG000|Overall Study|Physician Decision|3|||
46763895|NCT00837434|82982167|FG001|Overall Study|Physician Decision|0|||
46763896|NCT00837434|82982166|FG000|Overall Study|Lost to Follow-up|1|||
46763897|NCT00837434|82982167|FG001|Overall Study|Lost to Follow-up|1|||
46763898|NCT00837434|82982166|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
46763899|NCT00837434|82982167|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
46763900|NCT00837434|82982166|FG000|Overall Study|Noncompliant|2|||
46763901|NCT00837434|82982167|FG001|Overall Study|Noncompliant|0|||
46763902|NCT00837434|82982166|FG000|Overall Study|Baseline assessments not done in time|1|||
46828750|NCT00256204|83046808|FG001|Overall Study|Adverse Event|14|||
46828751|NCT00256204|83046809|FG002|Overall Study|Adverse Event|16|||
46828752|NCT00256204|83046810|FG003|Overall Study|Adverse Event|14|||
46828753|NCT00256204|83046807|FG000|Overall Study|Death|0|||
46828754|NCT00256204|83046808|FG001|Overall Study|Death|1|||
46828755|NCT00256204|83046809|FG002|Overall Study|Death|0|||
46828756|NCT00256204|83046810|FG003|Overall Study|Death|0|||
47059876|NCT01536145|83339560|FG008|Overall Study|Progressive disease|1|||
47059877|NCT01536145|83339561|FG009|Overall Study|Progressive disease|3|||
47059878|NCT01536145|83339562|FG010|Overall Study|Progressive disease|3|||
46828757|NCT00256204|83046807|FG000|Overall Study|Lost to Follow-up|1|||
46828758|NCT00256204|83046808|FG001|Overall Study|Lost to Follow-up|1|||
46828759|NCT00256204|83046809|FG002|Overall Study|Lost to Follow-up|1|||
46828760|NCT00256204|83046810|FG003|Overall Study|Lost to Follow-up|2|||
46828761|NCT00256204|83046807|FG000|Overall Study|Protocol Violation|1|||
46828762|NCT00256204|83046808|FG001|Overall Study|Protocol Violation|0|||
46935894|NCT00919893|83172275|FG000|Overall Study|Protocol Violation|19|||
47059879|NCT01536145|83339552|FG000|Overall Study|Withdrawal by Subject|0|||
47059880|NCT01536145|83339553|FG001|Overall Study|Withdrawal by Subject|0|||
47059881|NCT01536145|83339554|FG002|Overall Study|Withdrawal by Subject|1|||
46828763|NCT00256204|83046809|FG002|Overall Study|Protocol Violation|2|||
47059882|NCT01536145|83339555|FG003|Overall Study|Withdrawal by Subject|0|||
46935895|NCT00919893|83172276|FG001|Overall Study|Protocol Violation|9|||
46935896|NCT02559622|83172284|FG000|Overall Study|Progressive disease|0|||
46935897|NCT02559622|83172285|FG001|Overall Study|Progressive disease|1|||
46935898|NCT02559622|83172286|FG002|Overall Study|Progressive disease|0|||
47059883|NCT01536145|83339556|FG004|Overall Study|Withdrawal by Subject|0|||
47059884|NCT01536145|83339557|FG005|Overall Study|Withdrawal by Subject|1|||
47059885|NCT01536145|83339558|FG006|Overall Study|Withdrawal by Subject|0|||
47059886|NCT01536145|83339559|FG007|Overall Study|Withdrawal by Subject|0|||
47059887|NCT01536145|83339560|FG008|Overall Study|Withdrawal by Subject|2|||
47059888|NCT01536145|83339561|FG009|Overall Study|Withdrawal by Subject|0|||
47059889|NCT01536145|83339562|FG010|Overall Study|Withdrawal by Subject|2|||
47059890|NCT01536145|83339552|FG000|Overall Study|Other|0|||
47059891|NCT01536145|83339553|FG001|Overall Study|Other|0|||
47059892|NCT01536145|83339554|FG002|Overall Study|Other|0|||
47059893|NCT01536145|83339555|FG003|Overall Study|Other|0|||
47059894|NCT01536145|83339556|FG004|Overall Study|Other|1|||
47059895|NCT01536145|83339557|FG005|Overall Study|Other|0|||
47059896|NCT01536145|83339558|FG006|Overall Study|Other|0|||
47059897|NCT01536145|83339559|FG007|Overall Study|Other|0|||
47059898|NCT01536145|83339560|FG008|Overall Study|Other|0|||
47059899|NCT01536145|83339561|FG009|Overall Study|Other|3|||
47059900|NCT01536145|83339562|FG010|Overall Study|Other|2|||
47059901|NCT01536145|83339552|FG000|Overall Study|Death|0|||
47059902|NCT01536145|83339553|FG001|Overall Study|Death|0|||
47059903|NCT01536145|83339554|FG002|Overall Study|Death|0|||
47059904|NCT01536145|83339555|FG003|Overall Study|Death|0|||
47059905|NCT01536145|83339556|FG004|Overall Study|Death|0|||
47059906|NCT01536145|83339557|FG005|Overall Study|Death|0|||
47059907|NCT01536145|83339558|FG006|Overall Study|Death|1|||
47059908|NCT01536145|83339559|FG007|Overall Study|Death|0|||
47059909|NCT01536145|83339560|FG008|Overall Study|Death|0|||
47059910|NCT01536145|83339561|FG009|Overall Study|Death|0|||
47059911|NCT01536145|83339562|FG010|Overall Study|Death|0|||
47059912|NCT01536145|83339552|FG000|Overall Study|Adverse Event|0|||
47059913|NCT01536145|83339553|FG001|Overall Study|Adverse Event|0|||
47059914|NCT01536145|83339554|FG002|Overall Study|Adverse Event|0|||
47059915|NCT01536145|83339555|FG003|Overall Study|Adverse Event|0|||
47059916|NCT01536145|83339556|FG004|Overall Study|Adverse Event|0|||
47059917|NCT01536145|83339557|FG005|Overall Study|Adverse Event|0|||
47059918|NCT01536145|83339558|FG006|Overall Study|Adverse Event|0|||
47059919|NCT01536145|83339559|FG007|Overall Study|Adverse Event|2|||
47059920|NCT01536145|83339560|FG008|Overall Study|Adverse Event|0|||
47059921|NCT01536145|83339561|FG009|Overall Study|Adverse Event|0|||
47059922|NCT01536145|83339562|FG010|Overall Study|Adverse Event|3|||
47059923|NCT01536067|83339593|FG000|Overall Study|Disease Progression|1|||
47059924|NCT01582009|83339597|FG000|Overall Study|Withdrawal by Subject|1|||
47059925|NCT01582009|83339597|FG000|Overall Study|Physician Decision|1|||
47059926|NCT01553591|83339604|FG000|Overall Study|Voluntarily withdrew|94|||
47059927|NCT01553591|83339605|FG001|Overall Study|Voluntarily withdrew|79|||
47059928|NCT01553591|83339606|FG002|Overall Study|Voluntarily withdrew|96|||
47059929|NCT01553591|83339604|FG000|Overall Study|Adverse Event|36|||
47059930|NCT01553591|83339605|FG001|Overall Study|Adverse Event|45|||
46935899|NCT02559622|83172287|FG003|Overall Study|Progressive disease|0|||
46935900|NCT02559622|83172284|FG000|Overall Study|Adverse Event|0|||
46935901|NCT02559622|83172285|FG001|Overall Study|Adverse Event|2|||
46935902|NCT02559622|83172286|FG002|Overall Study|Adverse Event|2|||
47059931|NCT01553591|83339606|FG002|Overall Study|Adverse Event|16|||
47059932|NCT01553591|83339604|FG000|Overall Study|Lost to Follow-up|25|||
47059933|NCT01553591|83339605|FG001|Overall Study|Lost to Follow-up|23|||
47059934|NCT01553591|83339606|FG002|Overall Study|Lost to Follow-up|16|||
47059935|NCT01553591|83339604|FG000|Overall Study|Physician decision: other|11|||
47059936|NCT01553591|83339605|FG001|Overall Study|Physician decision: other|14|||
47059937|NCT01553591|83339606|FG002|Overall Study|Physician decision: other|16|||
47059938|NCT01553591|83339604|FG000|Overall Study|Physician decision: lack of efficacy|2|||
47059939|NCT01553591|83339605|FG001|Overall Study|Physician decision: lack of efficacy|3|||
47059940|NCT01553591|83339606|FG002|Overall Study|Physician decision: lack of efficacy|7|||
47059941|NCT01553591|83339604|FG000|Overall Study|Protocol Violation|3|||
46763903|NCT00837434|82982167|FG001|Overall Study|Baseline assessments not done in time|0|||
46763904|NCT00837434|82982166|FG000|Overall Study|Unable to obtain study drug|1|||
46763905|NCT00837434|82982167|FG001|Overall Study|Unable to obtain study drug|0|||
46763906|NCT00827918|82982176|FG000|Overall Study|Adverse Event|4|||
46763907|NCT00827918|82982177|FG001|Overall Study|Adverse Event|0|||
47059942|NCT01553591|83339605|FG001|Overall Study|Protocol Violation|4|||
47059943|NCT01553591|83339606|FG002|Overall Study|Protocol Violation|4|||
47059944|NCT01553591|83339604|FG000|Overall Study|Sponsor decision|1|||
47059945|NCT01553591|83339605|FG001|Overall Study|Sponsor decision|0|||
46828764|NCT00256204|83046810|FG003|Overall Study|Protocol Violation|1|||
46828765|NCT00256204|83046807|FG000|Overall Study|Physician Decision|0|||
46828766|NCT00256204|83046808|FG001|Overall Study|Physician Decision|0|||
46828767|NCT00256204|83046809|FG002|Overall Study|Physician Decision|1|||
46828768|NCT00256204|83046810|FG003|Overall Study|Physician Decision|2|||
46828769|NCT00256204|83046807|FG000|Overall Study|Withdrawal by Subject|17|||
46828770|NCT00256204|83046808|FG001|Overall Study|Withdrawal by Subject|6|||
46828771|NCT00256204|83046809|FG002|Overall Study|Withdrawal by Subject|7|||
46828772|NCT00256204|83046810|FG003|Overall Study|Withdrawal by Subject|5|||
46828773|NCT00256204|83046807|FG000|Overall Study|Need for additional prohibited treatment|38|||
46935903|NCT02559622|83172287|FG003|Overall Study|Adverse Event|2|||
46935904|NCT02559622|83172284|FG000|Overall Study|Patient/guardian decision|1|||
46935905|NCT02559622|83172285|FG001|Overall Study|Patient/guardian decision|2|||
47059946|NCT01553591|83339606|FG002|Overall Study|Sponsor decision|3|||
46828774|NCT00256204|83046808|FG001|Overall Study|Need for additional prohibited treatment|28|||
46828775|NCT00256204|83046809|FG002|Overall Study|Need for additional prohibited treatment|27|||
46828776|NCT00256204|83046810|FG003|Overall Study|Need for additional prohibited treatment|25|||
46828777|NCT00256126|83046825|FG000|Overall Study|Adverse Event|1|||
46828778|NCT00256126|83046826|FG001|Overall Study|Adverse Event|0|||
46828779|NCT00256126|83046825|FG000|Overall Study|Other|1|||
46828780|NCT00256126|83046826|FG001|Overall Study|Other|2|||
46828781|NCT00278889|83046835|FG000|Overall Study|Withdrawal by Subject|0|||
46828782|NCT00278889|83046836|FG001|Overall Study|Withdrawal by Subject|5|||
46828783|NCT00278889|83046837|FG002|Overall Study|Withdrawal by Subject|3|||
46828784|NCT00278889|83046835|FG000|Overall Study|Lost to Follow-up|1|||
47059947|NCT01553591|83339604|FG000|Overall Study|Randomized and never dispensed drug|0|||
47059948|NCT01553591|83339605|FG001|Overall Study|Randomized and never dispensed drug|1|||
47059949|NCT01553591|83339606|FG002|Overall Study|Randomized and never dispensed drug|0|||
47059950|NCT01581931|83339614|FG000|Washout|Adverse Event|0|||
47059951|NCT01581931|83339615|FG001|Washout|Adverse Event|1|||
47059952|NCT01581619|83339621|FG000|Overall Study|Withdrawal by Subject|1|||
47059953|NCT01581619|83339621|FG000|Overall Study|Lost to Follow-up|1|||
47059954|NCT01581307|83339627|FG000|Overall Study|Withdrawal by Subject|1|||
47059955|NCT01580995|83339633|FG000|Overall Study|Lost to Follow-up|2|||
47059956|NCT01580995|83339634|FG001|Overall Study|Lost to Follow-up|2|||
47059957|NCT01535599|83339642|FG000|Overall Study|Adverse Event|6|||
47059958|NCT01535599|83339643|FG001|Overall Study|Adverse Event|15|||
47059959|NCT01535599|83339642|FG000|Overall Study|Lost to Follow-up|3|||
47059960|NCT01535599|83339643|FG001|Overall Study|Lost to Follow-up|4|||
47059961|NCT01535599|83339642|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
47059962|NCT01535599|83339643|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
47059963|NCT01535599|83339642|FG000|Overall Study|Treatment Failure|33|||
47059964|NCT01535599|83339643|FG001|Overall Study|Treatment Failure|66|||
47059965|NCT01535599|83339642|FG000|Overall Study|BL Culture + for Group A Strep|0|||
47059966|NCT01535599|83339643|FG001|Overall Study|BL Culture + for Group A Strep|1|||
47059967|NCT01535599|83339642|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
47059968|NCT01535599|83339643|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
47059969|NCT01535599|83339642|FG000|Overall Study|Randomized in Error|2|||
47059970|NCT01535599|83339643|FG001|Overall Study|Randomized in Error|4|||
47059971|NCT01535599|83339642|FG000|Overall Study|Did not use product|1|||
47059972|NCT01535599|83339643|FG001|Overall Study|Did not use product|0|||
47059973|NCT01535599|83339642|FG000|Overall Study|Other|1|||
47059974|NCT01535599|83339643|FG001|Overall Study|Other|0|||
47059975|NCT01535599|83339642|FG000|Overall Study|Stopped medication|0|||
47059976|NCT01535599|83339643|FG001|Overall Study|Stopped medication|1|||
47059977|NCT01535599|83339642|FG000|Overall Study|Noncompliance|0|||
47059978|NCT01535599|83339643|FG001|Overall Study|Noncompliance|1|||
47059979|NCT01553279|83339651|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
46763908|NCT00827918|82982178|FG002|Overall Study|Adverse Event|0|||
46763909|NCT00827918|82982176|FG000|Overall Study|Lack of Efficacy|16|||
46763910|NCT00827918|82982177|FG001|Overall Study|Lack of Efficacy|4|||
46763911|NCT00827918|82982178|FG002|Overall Study|Lack of Efficacy|15|||
46763912|NCT00827918|82982176|FG000|Overall Study|Physician Decision|1|||
46763913|NCT00827918|82982177|FG001|Overall Study|Physician Decision|0|||
46763914|NCT00827918|82982178|FG002|Overall Study|Physician Decision|0|||
46828785|NCT00278889|83046836|FG001|Overall Study|Lost to Follow-up|1|||
47059980|NCT01553279|83339652|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
46763915|NCT00827918|82982176|FG000|Overall Study|Pregnancy|0|||
46763916|NCT00827918|82982177|FG001|Overall Study|Pregnancy|1|||
46763917|NCT00827918|82982178|FG002|Overall Study|Pregnancy|0|||
46763918|NCT00827918|82982176|FG000|Overall Study|Progressive Disease|1|||
46828786|NCT00278889|83046837|FG002|Overall Study|Lost to Follow-up|0|||
47059981|NCT01553279|83339651|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
47059982|NCT01553279|83339652|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
47059983|NCT01553279|83339651|FG000|Interim Period|Withdrawal by Subject|2|||
47059984|NCT01553279|83339652|FG001|Interim Period|Withdrawal by Subject|2|||
47059985|NCT01553279|83339651|FG000|Interim Period|Lost to Follow-up|1|||
47059986|NCT01553279|83339652|FG001|Interim Period|Lost to Follow-up|0|||
47059987|NCT01553279|83339651|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
47059988|NCT01553279|83339652|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
47059989|NCT01553279|83339651|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
46828787|NCT00278889|83046835|FG000|Overall Study|Death|24|||
46828788|NCT00278889|83046836|FG001|Overall Study|Death|21|||
46828789|NCT00278889|83046837|FG002|Overall Study|Death|17|||
46828790|NCT00278109|83046845|FG000|Overall Study|Adverse Event|3|||
46935906|NCT02559622|83172286|FG002|Overall Study|Patient/guardian decision|0|||
46935907|NCT02559622|83172287|FG003|Overall Study|Patient/guardian decision|1|||
46935908|NCT02559310|83172303|FG000|Overall Study|Death|4|||
46935909|NCT02559310|83172304|FG001|Overall Study|Death|3|||
46935910|NCT02559310|83172303|FG000|Overall Study|Lost to Follow-up|5|||
46935911|NCT02559310|83172304|FG001|Overall Study|Lost to Follow-up|3|||
46935912|NCT02559310|83172303|FG000|Overall Study|Physician Decision|2|||
46935913|NCT02559310|83172304|FG001|Overall Study|Physician Decision|1|||
46935914|NCT02559310|83172303|FG000|Overall Study|Withdrawal by Subject|13|||
46935915|NCT02559310|83172304|FG001|Overall Study|Withdrawal by Subject|9|||
46935916|NCT02559310|83172303|FG000|Overall Study|Sponsor Decision|0|||
46935917|NCT02559310|83172304|FG001|Overall Study|Sponsor Decision|1|||
46828791|NCT00278109|83046845|FG000|Overall Study|social circumstances|1|||
46935918|NCT02559310|83172303|FG000|Overall Study|Randomized but not treated|3|||
46935919|NCT02559310|83172304|FG001|Overall Study|Randomized but not treated|2|||
46935920|NCT02555878|83172312|FG000|Overall Study|Lost to Follow-up|2|||
46935921|NCT02555878|83172313|FG001|Overall Study|Lost to Follow-up|3|||
46828792|NCT00296517|83046851|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
46828793|NCT00296517|83046852|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
46828794|NCT00296517|83046851|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
47059990|NCT01553279|83339652|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
46828795|NCT00296517|83046852|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
46828796|NCT00296517|83046851|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
46828797|NCT00296517|83046852|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
46828798|NCT00296517|83046851|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
46828799|NCT00296517|83046852|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
46828800|NCT00296517|83046851|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
46828801|NCT00296517|83046852|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
46828802|NCT00296517|83046851|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
46828803|NCT00296517|83046852|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
46828804|NCT00296517|83046851|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
46828805|NCT00296517|83046852|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
46828806|NCT00296517|83046851|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
46828807|NCT00296517|83046852|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
46828808|NCT00296517|83046851|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
46828809|NCT00296517|83046852|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
46828810|NCT00224770|83046861|FG000|Overall Study|Lost to Follow-up|4|||
46828811|NCT00224770|83046862|FG001|Overall Study|Lost to Follow-up|2|||
46828812|NCT00224770|83046863|FG002|Overall Study|Lost to Follow-up|0|||
46828813|NCT00266409|83046876|FG000|Overall Study|Lack of Efficacy|2|||
46828814|NCT00266409|83046877|FG001|Overall Study|Lack of Efficacy|6|||
46828815|NCT00266409|83046878|FG002|Overall Study|Lack of Efficacy|1|||
47059991|NCT01562743|83339659|FG000|Overall Study|Adverse Event|29|||
47059992|NCT01562743|83339659|FG000|Overall Study|Lack of Efficacy|3|||
47059993|NCT01562743|83339659|FG000|Overall Study|Withdrawal by Subject|13|||
46828816|NCT00266409|83046879|FG003|Overall Study|Lack of Efficacy|2|||
46828817|NCT00266409|83046876|FG000|Overall Study|Adverse Event|7|||
46828818|NCT00266409|83046877|FG001|Overall Study|Adverse Event|2|||
46828819|NCT00266409|83046878|FG002|Overall Study|Adverse Event|1|||
46828820|NCT00266409|83046879|FG003|Overall Study|Adverse Event|1|||
46828821|NCT00266409|83046876|FG000|Overall Study|Lost to Follow-up|18|||
46935922|NCT02555878|83172312|FG000|Overall Study|Withdrawal by Subject|48|||
46935923|NCT02555878|83172313|FG001|Overall Study|Withdrawal by Subject|48|||
47059994|NCT01562743|83339659|FG000|Overall Study|Protocol Violation|1|||
47059995|NCT01562743|83339659|FG000|Overall Study|Discontinuation criteria|2|||
47059996|NCT01562743|83339659|FG000|Overall Study|Lost to Follow-up|2|||
47059997|NCT01562743|83339659|FG000|Overall Study|Physician Decision|2|||
46828822|NCT00266409|83046877|FG001|Overall Study|Lost to Follow-up|21|||
46828823|NCT00266409|83046878|FG002|Overall Study|Lost to Follow-up|6|||
46828824|NCT00266409|83046879|FG003|Overall Study|Lost to Follow-up|8|||
46828825|NCT00266409|83046876|FG000|Overall Study|Withdrawal by Subject|6|||
46828826|NCT00266409|83046877|FG001|Overall Study|Withdrawal by Subject|10|||
46828827|NCT00266409|83046878|FG002|Overall Study|Withdrawal by Subject|3|||
46828828|NCT00266409|83046879|FG003|Overall Study|Withdrawal by Subject|9|||
46935924|NCT02555878|83172312|FG000|Overall Study|Adverse Event|12|||
46935925|NCT02555878|83172313|FG001|Overall Study|Adverse Event|8|||
46935926|NCT02555878|83172312|FG000|Overall Study|Death|74|||
46828829|NCT00266409|83046876|FG000|Overall Study|Protocol Violation|5|||
46935927|NCT02555878|83172313|FG001|Overall Study|Death|59|||
46935928|NCT02555878|83172312|FG000|Overall Study|Protocol Violation|1|||
47059998|NCT01535443|83339663|FG000|Overall Study|Physician Decision|3|||
46828830|NCT00266409|83046877|FG001|Overall Study|Protocol Violation|3|||
46828831|NCT00266409|83046878|FG002|Overall Study|Protocol Violation|4|||
46828832|NCT00266409|83046879|FG003|Overall Study|Protocol Violation|2|||
46828833|NCT00266409|83046876|FG000|Overall Study|Other|7|||
46828834|NCT00266409|83046877|FG001|Overall Study|Other|4|||
46828835|NCT00266409|83046878|FG002|Overall Study|Other|2|||
46828836|NCT00266409|83046879|FG003|Overall Study|Other|0|||
46828837|NCT00277095|83046889|FG000|Overall Study|Death|2|||
46828838|NCT00277095|83046889|FG000|Overall Study|Explanted|7|||
46828839|NCT00277095|83046889|FG000|Overall Study|Lost to Follow-up|2|||
46828840|NCT00277095|83046889|FG000|Overall Study|Missed Follow-up|9|||
46828841|NCT00277095|83046889|FG000|Overall Study|Physician Decision|1|||
46828842|NCT00265785|83046893|FG000|Overall Study|Adverse Event|4|||
46828843|NCT00265785|83046893|FG000|Overall Study|Withdrawal by Subject|3|||
46828844|NCT00265785|83046893|FG000|Overall Study|Progression/Relapse|15|||
46828845|NCT00265785|83046893|FG000|Overall Study|Not protocol specified|2|||
46828846|NCT00265785|83046893|FG000|Overall Study|Ineligible|1|||
46828847|NCT00265785|83046893|FG000|Overall Study|Did not receive protocol treatment|2|||
46828848|NCT00276159|83046897|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
46828849|NCT00265395|83046903|FG000|Overall Study|Adverse Event|3|||
46828850|NCT00265395|83046904|FG001|Overall Study|Adverse Event|6|||
46828851|NCT00265395|83046903|FG000|Overall Study|Lost to Follow-up|2|||
46828852|NCT00265395|83046904|FG001|Overall Study|Lost to Follow-up|1|||
46828853|NCT00265395|83046903|FG000|Overall Study|Withdrawal by Subject|1|||
46828854|NCT00265395|83046904|FG001|Overall Study|Withdrawal by Subject|6|||
47059999|NCT01535287|83339670|FG000|Overall Study|drug not prepared in time|5|||
47060000|NCT01535287|83339671|FG001|Overall Study|drug not prepared in time|6|||
46763919|NCT00827918|82982177|FG001|Overall Study|Progressive Disease|1|||
46763920|NCT00827918|82982178|FG002|Overall Study|Progressive Disease|0|||
46763921|NCT00827918|82982176|FG000|Overall Study|Protocol Violation|0|||
46763922|NCT00827918|82982177|FG001|Overall Study|Protocol Violation|1|||
46763923|NCT00827918|82982178|FG002|Overall Study|Protocol Violation|0|||
46763924|NCT00827918|82982176|FG000|Overall Study|Withdrawal by Subject|6|||
46763925|NCT00827918|82982177|FG001|Overall Study|Withdrawal by Subject|2|||
46763926|NCT00827918|82982178|FG002|Overall Study|Withdrawal by Subject|6|||
46763927|NCT00813150|82982188|FG000|Treatment Period|Adverse Event|16|||
46763928|NCT00813150|82982189|FG001|Treatment Period|Adverse Event|15|||
46763929|NCT00813150|82982188|FG000|Treatment Period|Death|2|||
46763930|NCT00813150|82982189|FG001|Treatment Period|Death|0|||
46763931|NCT00813150|82982188|FG000|Treatment Period|Progressive disease|1|||
46763932|NCT00813150|82982189|FG001|Treatment Period|Progressive disease|0|||
46763933|NCT00813150|82982188|FG000|Treatment Period|Complete response|0|||
46763934|NCT00813150|82982189|FG001|Treatment Period|Complete response|1|||
46763935|NCT00813150|82982188|FG000|Treatment Period|Stable disease|1|||
46763936|NCT00813150|82982189|FG001|Treatment Period|Stable disease|2|||
46763937|NCT00813150|82982188|FG000|Treatment Period|Protocol Violation|3|||
46763938|NCT00813150|82982189|FG001|Treatment Period|Protocol Violation|4|||
46763939|NCT00813150|82982188|FG000|Treatment Period|Withdrawal by Subject|5|||
46763940|NCT00813150|82982189|FG001|Treatment Period|Withdrawal by Subject|3|||
46763941|NCT00813150|82982188|FG000|Treatment Period|Non compliance|0|||
46763942|NCT00813150|82982189|FG001|Treatment Period|Non compliance|1|||
46763943|NCT00813150|82982188|FG000|Treatment Period|Reason not specified|3|||
46763944|NCT00813150|82982189|FG001|Treatment Period|Reason not specified|4|||
46763945|NCT00813150|82982188|FG000|Treatment Period|Data not available|1|||
46763946|NCT00813150|82982189|FG001|Treatment Period|Data not available|2|||
46763947|NCT00813150|82982188|FG000|Long Term Follow-up|Death|0|||
46763948|NCT00813150|82982189|FG001|Long Term Follow-up|Death|4|||
46763949|NCT00813150|82982188|FG000|Long Term Follow-up|Other|0|||
46763950|NCT00813150|82982189|FG001|Long Term Follow-up|Other|3|||
46763951|NCT00813150|82982188|FG000|Long Term Follow-up|Lost to Follow-up|2|||
46763952|NCT00813150|82982189|FG001|Long Term Follow-up|Lost to Follow-up|0|||
46763953|NCT00813150|82982188|FG000|Long Term Follow-up|Progression/Relapse|22|||
46763954|NCT00813150|82982189|FG001|Long Term Follow-up|Progression/Relapse|24|||
46763955|NCT00807846|82982197|FG000|Overall Study|Adverse Event|5|||
46763956|NCT00807846|82982198|FG001|Overall Study|Adverse Event|0|||
46763957|NCT00807846|82982197|FG000|Overall Study|Lack of Efficacy|2|||
46763958|NCT00807846|82982198|FG001|Overall Study|Lack of Efficacy|0|||
46763959|NCT00807846|82982197|FG000|Overall Study|Protocol Violation|2|||
46828855|NCT00265395|83046903|FG000|Overall Study|Protocol Violation|2|||
46828856|NCT00265395|83046904|FG001|Overall Study|Protocol Violation|2|||
46763960|NCT00807846|82982198|FG001|Overall Study|Protocol Violation|1|||
46763961|NCT00807846|82982197|FG000|Overall Study|Withdrawal by Subject|2|||
46828857|NCT00265395|83046903|FG000|Overall Study|Lack of Efficacy|0|||
46828858|NCT00265395|83046904|FG001|Overall Study|Lack of Efficacy|1|||
47060001|NCT01551173|83339679|FG000|Overall Study|Withdrawal by Subject|11|||
46763962|NCT00807846|82982198|FG001|Overall Study|Withdrawal by Subject|1|||
46763963|NCT00807846|82982197|FG000|Overall Study|Other|1|||
46763964|NCT00807846|82982198|FG001|Overall Study|Other|2|||
46763965|NCT00810108|82982206|FG000|Overall Study|Withdrawal by Subject|1|||
46828859|NCT00265395|83046903|FG000|Overall Study|Administrative|0|||
46828860|NCT00265395|83046904|FG001|Overall Study|Administrative|1|||
46828861|NCT00195442|83046909|FG000|Overall Study|Less than expected therapeutic effect|38|||
46828862|NCT00195442|83046909|FG000|Overall Study|Lost to Follow-up|27|||
46828863|NCT00195442|83046909|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
46828864|NCT00195442|83046909|FG000|Overall Study|Intermittent product shortage|21|||
46828865|NCT00195442|83046909|FG000|Overall Study|Death|7|||
46828866|NCT00195442|83046909|FG000|Overall Study|No reason specified|4|||
46828867|NCT00195442|83046909|FG000|Overall Study|Poor cooperation|2|||
46828868|NCT00195442|83046909|FG000|Overall Study|Other|14|||
46828869|NCT00275301|83046913|FG000|Overall Study|Adverse Event|5|||
46828870|NCT00251745|83046920|FG000|Overall Study|Adverse Event|7|||
46828871|NCT00251745|83046921|FG001|Overall Study|Adverse Event|9|||
46828872|NCT00251745|83046922|FG002|Overall Study|Adverse Event|11|||
46828873|NCT00251745|83046920|FG000|Overall Study|Lost to Follow-up|4|||
46828874|NCT00251745|83046921|FG001|Overall Study|Lost to Follow-up|2|||
46828875|NCT00251745|83046922|FG002|Overall Study|Lost to Follow-up|5|||
46828876|NCT00251745|83046920|FG000|Overall Study|Withdrawal by Subject|13|||
46828877|NCT00251745|83046921|FG001|Overall Study|Withdrawal by Subject|7|||
46828878|NCT00251745|83046922|FG002|Overall Study|Withdrawal by Subject|3|||
46828879|NCT00251745|83046920|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
46828880|NCT00251745|83046921|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
46828881|NCT00251745|83046922|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
46828882|NCT00251745|83046920|FG000|Overall Study|Lack of Efficacy|3|||
46828883|NCT00251745|83046921|FG001|Overall Study|Lack of Efficacy|0|||
46828884|NCT00251745|83046922|FG002|Overall Study|Lack of Efficacy|0|||
46828885|NCT00251745|83046920|FG000|Overall Study|Noncompliant|0|||
46828886|NCT00251745|83046921|FG001|Overall Study|Noncompliant|2|||
46828887|NCT00251745|83046922|FG002|Overall Study|Noncompliant|2|||
46828888|NCT00251745|83046920|FG000|Overall Study|Pregnancy|0|||
46828889|NCT00251745|83046921|FG001|Overall Study|Pregnancy|1|||
46828890|NCT00251745|83046922|FG002|Overall Study|Pregnancy|0|||
46828891|NCT00251745|83046920|FG000|Overall Study|Per Subject Request|0|||
46828892|NCT00251745|83046921|FG001|Overall Study|Per Subject Request|0|||
46828893|NCT00251745|83046922|FG002|Overall Study|Per Subject Request|1|||
46828894|NCT00251745|83046920|FG000|Overall Study|Per Investigator Request|1|||
46828895|NCT00251745|83046921|FG001|Overall Study|Per Investigator Request|0|||
46828896|NCT00251745|83046922|FG002|Overall Study|Per Investigator Request|0|||
46828897|NCT00255190|83046932|FG000|Overall Study|Adverse Event|17|||
46828898|NCT00255190|83046933|FG001|Overall Study|Adverse Event|36|||
46828899|NCT00255190|83046932|FG000|Overall Study|Protocol Violation|2|||
46828900|NCT00255190|83046933|FG001|Overall Study|Protocol Violation|2|||
46828901|NCT00255190|83046932|FG000|Overall Study|Lost to Follow-up|10|||
46828902|NCT00255190|83046933|FG001|Overall Study|Lost to Follow-up|27|||
46828903|NCT00255190|83046932|FG000|Overall Study|Withdrew Consent|17|||
46828904|NCT00255190|83046933|FG001|Overall Study|Withdrew Consent|48|||
46828905|NCT00255190|83046932|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
46828906|NCT00255190|83046933|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
46828907|NCT00255190|83046932|FG000|Overall Study|Erosive esophagitis not healed|0|||
46828908|NCT00255190|83046933|FG001|Overall Study|Erosive esophagitis not healed|20|||
46828909|NCT00255190|83046932|FG000|Overall Study|Various|4|||
46828910|NCT00255190|83046933|FG001|Overall Study|Various|23|||
46828911|NCT00359424|83046941|FG000|Overall Study|Death|99|||
46828912|NCT00359424|83046942|FG001|Overall Study|Death|58|||
46828913|NCT00359424|83046941|FG000|Overall Study|Lost to Follow-up|19|||
46828914|NCT00359424|83046942|FG001|Overall Study|Lost to Follow-up|7|||
46828915|NCT00359424|83046941|FG000|Overall Study|Withdrawal by Subject|10|||
46828916|NCT00359424|83046942|FG001|Overall Study|Withdrawal by Subject|2|||
46828917|NCT00359424|83046941|FG000|Overall Study|follow up not conducted|2|||
46828918|NCT00359424|83046942|FG001|Overall Study|follow up not conducted|0|||
46828919|NCT00255034|83046950|FG000|Overall Study|Withdrawal by Subject|15|||
46828920|NCT00255034|83046951|FG001|Overall Study|Withdrawal by Subject|38|||
46828921|NCT00254566|83046959|FG000|Overall Study|Death|1|||
46828922|NCT00254566|83046960|FG001|Overall Study|Death|0|||
46828923|NCT00254566|83046959|FG000|Overall Study|Adverse Event|5|||
46935929|NCT02555878|83172313|FG001|Overall Study|Protocol Violation|2|||
46828924|NCT00254566|83046960|FG001|Overall Study|Adverse Event|4|||
46828925|NCT00254566|83046959|FG000|Overall Study|Lack of Efficacy|12|||
46828926|NCT00254566|83046960|FG001|Overall Study|Lack of Efficacy|9|||
46828927|NCT00254566|83046959|FG000|Overall Study|Other|1|||
46828928|NCT00254566|83046960|FG001|Overall Study|Other|5|||
46828929|NCT00254566|83046959|FG000|Overall Study|Withdrawal by Subject|5|||
46828930|NCT00254566|83046960|FG001|Overall Study|Withdrawal by Subject|6|||
46828931|NCT00254566|83046959|FG000|Overall Study|Lost to Follow-up|7|||
47060002|NCT01551173|83339680|FG001|Overall Study|Withdrawal by Subject|16|||
46828932|NCT00254566|83046960|FG001|Overall Study|Lost to Follow-up|2|||
46828933|NCT00358956|83046966|FG000|Overall Study|Adverse Event|3|||
46828934|NCT00358956|83046966|FG000|Overall Study|condition under investigation worsened|4|||
46828935|NCT00358956|83046966|FG000|Overall Study|Withdrawal by Subject|1|||
46828936|NCT03830892|83046972|FG000|Overall Study|Physician Decision|2|||
46828937|NCT03830892|83046973|FG001|Overall Study|Physician Decision|3|||
46828938|NCT03830892|83046972|FG000|Overall Study|Study terminated due to COVID|4|||
46828939|NCT03830892|83046973|FG001|Overall Study|Study terminated due to COVID|0|||
46828940|NCT03830892|83046972|FG000|Overall Study|Protocol Violation|0|||
46828941|NCT03830892|83046973|FG001|Overall Study|Protocol Violation|1|||
46828942|NCT03830892|83046972|FG000|Overall Study|Withdrawal by Subject|0|||
46828943|NCT03830892|83046973|FG001|Overall Study|Withdrawal by Subject|2|||
46828944|NCT00253630|83046979|FG000|Overall Study|ineligible|2|||
46828945|NCT00358644|83046983|FG000|Overall Study|Progressive Disease|21|||
46828946|NCT00358644|83046983|FG000|Overall Study|Adverse Event|7|||
46828947|NCT00358644|83046983|FG000|Overall Study|Death|11|||
46828948|NCT00358644|83046983|FG000|Overall Study|Withdrawal by Subject|4|||
46828949|NCT00358644|83046983|FG000|Overall Study|Physician Decision|6|||
46828950|NCT00358644|83046983|FG000|Overall Study|Patient not eligible for study|1|||
46828951|NCT00364182|83046990|FG000|First Intervention|Secondary prophylaxis|1|||
46828952|NCT00364182|83046991|FG001|First Intervention|Secondary prophylaxis|0|||
46828953|NCT00364182|83046992|FG002|First Intervention|Secondary prophylaxis|0|||
46828954|NCT00364182|83046990|FG000|First Intervention|Withdrawal by Subject|2|||
46828955|NCT00364182|83046991|FG001|First Intervention|Withdrawal by Subject|0|||
46828956|NCT00364182|83046992|FG002|First Intervention|Withdrawal by Subject|0|||
46828957|NCT00364182|83046990|FG000|Second Intervention|non-compliance|0|||
46828958|NCT00364182|83046991|FG001|Second Intervention|non-compliance|1|||
46828959|NCT00364182|83046992|FG002|Second Intervention|non-compliance|1|||
46828960|NCT00364182|83046990|FG000|Second Intervention|Protocol Violation|0|||
46828961|NCT00364182|83046991|FG001|Second Intervention|Protocol Violation|1|||
46935930|NCT02555878|83172312|FG000|Overall Study|Physician Decision|12|||
46935931|NCT02555878|83172313|FG001|Overall Study|Physician Decision|13|||
46935932|NCT02555878|83172312|FG000|Overall Study|Other|17|||
46763966|NCT00810108|82982207|FG001|Overall Study|Withdrawal by Subject|0|||
46828962|NCT00364182|83046992|FG002|Second Intervention|Protocol Violation|0|||
46828963|NCT00364182|83046990|FG000|Second Intervention|Adverse Event|0|||
46828964|NCT00364182|83046991|FG001|Second Intervention|Adverse Event|0|||
46828965|NCT00364182|83046992|FG002|Second Intervention|Adverse Event|1|||
46828966|NCT00364182|83046990|FG000|Third Intervention|non-compliance|0|||
46828967|NCT00364182|83046991|FG001|Third Intervention|non-compliance|1|||
46828968|NCT00364182|83046992|FG002|Third Intervention|non-compliance|0|||
46828969|NCT00364182|83046990|FG000|Third Intervention|Lost to Follow-up|0|||
46828970|NCT00364182|83046991|FG001|Third Intervention|Lost to Follow-up|0|||
46828971|NCT00364182|83046992|FG002|Third Intervention|Lost to Follow-up|1|||
46828972|NCT00369486|83047007|FG000|4-Week Visit|Missed visit|2|||
46828973|NCT00369486|83047008|FG001|4-Week Visit|Missed visit|2|||
46828974|NCT00369486|83047009|FG002|4-Week Visit|Missed visit|0|||
46828975|NCT00369486|83047010|FG003|4-Week Visit|Missed visit|2|||
46935933|NCT02555878|83172313|FG001|Overall Study|Other|17|||
46935934|NCT02555722|83172321|FG000|Week 2|Adverse Event|0|||
47060003|NCT01551173|83339679|FG000|Overall Study|Adverse Event|7|||
47060004|NCT01551173|83339680|FG001|Overall Study|Adverse Event|6|||
47060005|NCT01551173|83339679|FG000|Overall Study|Lost to Follow-up|5|||
47060006|NCT01551173|83339680|FG001|Overall Study|Lost to Follow-up|7|||
47060007|NCT01551173|83339679|FG000|Overall Study|Other|5|||
47060008|NCT01551173|83339680|FG001|Overall Study|Other|3|||
47060009|NCT01549613|83339689|FG000|Overall Study|Lost to Follow-up|11|||
47060010|NCT01549613|83339690|FG001|Overall Study|Lost to Follow-up|11|||
47060011|NCT01548599|83339698|FG000|Overall Study|Lost to Follow-up|0|||
47060012|NCT01548599|83339699|FG001|Overall Study|Lost to Follow-up|1|||
46763967|NCT00827606|82982214|FG000|Overall Study|Protocol Violation|4|||
46763968|NCT00827606|82982215|FG001|Overall Study|Protocol Violation|3|||
46763969|NCT00827606|82982214|FG000|Overall Study|Lost to Follow-up|3|||
46763970|NCT00827606|82982215|FG001|Overall Study|Lost to Follow-up|1|||
46763971|NCT00827606|82982214|FG000|Overall Study|Withdrawal by Subject|7|||
46763972|NCT00827606|82982215|FG001|Overall Study|Withdrawal by Subject|6|||
46763973|NCT00827606|82982214|FG000|Overall Study|Pregnancy|0|||
46763974|NCT00827606|82982215|FG001|Overall Study|Pregnancy|1|||
46935935|NCT02555722|83172322|FG001|Week 2|Adverse Event|1|||
47060013|NCT01548599|83339698|FG000|Overall Study|Withdrawal by Subject|4|||
46637511|NCT01474512|82811382|FG006|Induction Period|Lost to Follow-up|0|||
46763975|NCT00827606|82982214|FG000|Overall Study|Other|5|||
46828976|NCT00369486|83047011|FG004|4-Week Visit|Missed visit|1|||
46828977|NCT00369486|83047007|FG000|4-Week Visit|Dropped|0|||
46828978|NCT00369486|83047008|FG001|4-Week Visit|Dropped|0|||
46828979|NCT00369486|83047009|FG002|4-Week Visit|Dropped|1|||
46828980|NCT00369486|83047010|FG003|4-Week Visit|Dropped|0|||
46828981|NCT00369486|83047011|FG004|4-Week Visit|Dropped|0|||
46763976|NCT00827606|82982215|FG001|Overall Study|Other|13|||
46828982|NCT00369486|83047007|FG000|8-Week Visit|Missed visit|0|||
47060014|NCT01548599|83339699|FG001|Overall Study|Withdrawal by Subject|0|||
46828983|NCT00369486|83047008|FG001|8-Week Visit|Missed visit|1|||
46828984|NCT00369486|83047009|FG002|8-Week Visit|Missed visit|0|||
46828985|NCT00369486|83047010|FG003|8-Week Visit|Missed visit|0|||
46935936|NCT02555722|83172321|FG000|Week 2|Withdrawal by Subject|1|||
47060015|NCT01548599|83339698|FG000|Overall Study|Death|2|||
47060016|NCT01548599|83339699|FG001|Overall Study|Death|1|||
47060017|NCT01548287|83339712|FG000|Screening|No reason provided|0|||
47060018|NCT01548287|83339713|FG001|Screening|No reason provided|0|||
47060019|NCT01548287|83339714|FG002|Screening|No reason provided|0|||
47060020|NCT01548287|83339715|FG003|Screening|No reason provided|0|||
47060021|NCT01548287|83339716|FG004|Screening|No reason provided|9|||
47060022|NCT01548287|83339712|FG000|Screening|Did not meet eligibility criteria|0|||
47060023|NCT01548287|83339713|FG001|Screening|Did not meet eligibility criteria|0|||
47060024|NCT01548287|83339714|FG002|Screening|Did not meet eligibility criteria|0|||
47060025|NCT01548287|83339715|FG003|Screening|Did not meet eligibility criteria|0|||
47060026|NCT01548287|83339716|FG004|Screening|Did not meet eligibility criteria|74|||
47060027|NCT01548287|83339712|FG000|Randomized Period|Did not meet inclusion criteria|0|||
47060028|NCT01548287|83339713|FG001|Randomized Period|Did not meet inclusion criteria|0|||
47060029|NCT01548287|83339714|FG002|Randomized Period|Did not meet inclusion criteria|2|||
47060030|NCT01548287|83339715|FG003|Randomized Period|Did not meet inclusion criteria|0|||
47060031|NCT01548287|83339716|FG004|Randomized Period|Did not meet inclusion criteria|0|||
47060032|NCT01548287|83339712|FG000|Randomized Period|Adverse Event|0|||
47060033|NCT01548287|83339713|FG001|Randomized Period|Adverse Event|2|||
46637512|NCT01474512|82811383|FG007|Induction Period|Lost to Follow-up|0|||
47060034|NCT01548287|83339714|FG002|Randomized Period|Adverse Event|5|||
47060035|NCT01548287|83339715|FG003|Randomized Period|Adverse Event|0|||
47060036|NCT01548287|83339716|FG004|Randomized Period|Adverse Event|0|||
47060037|NCT01546883|83339726|FG000|Overall Study|Withdrawal by Subject|3|||
47060038|NCT01546883|83339726|FG000|Overall Study|Adverse Event|4|||
47060039|NCT01546883|83339726|FG000|Overall Study|Lost to Follow-up|2|||
47060040|NCT01546883|83339726|FG000|Overall Study|early closure of study|2|||
47060041|NCT01546883|83339726|FG000|Overall Study|other unrelated illness|1|||
47060042|NCT01546649|83339732|FG000|Overall Study|Adverse Event|4|||
47060043|NCT01546649|83339733|FG001|Overall Study|Adverse Event|5|||
47060044|NCT01546649|83339732|FG000|Overall Study|Protocol Violation|1|||
46637513|NCT01474512|82811384|FG008|Induction Period|Lost to Follow-up|0|||
46637514|NCT01474512|82811385|FG009|Induction Period|Lost to Follow-up|0|||
46637515|NCT01474512|82811386|FG010|Induction Period|Lost to Follow-up|0|||
46637516|NCT01474512|82811387|FG011|Induction Period|Lost to Follow-up|0|||
46637517|NCT01474512|82811388|FG012|Induction Period|Lost to Follow-up|0|||
46637518|NCT01474512|82811389|FG013|Induction Period|Lost to Follow-up|0|||
46637519|NCT01474512|82811390|FG014|Induction Period|Lost to Follow-up|0|||
46637520|NCT01474512|82811391|FG015|Induction Period|Lost to Follow-up|0|||
46637521|NCT01474512|82811392|FG016|Induction Period|Lost to Follow-up|0|||
46637522|NCT01474512|82811393|FG017|Induction Period|Lost to Follow-up|0|||
46637523|NCT01474512|82811376|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637524|NCT01474512|82811377|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637525|NCT01474512|82811378|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637526|NCT01474512|82811379|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
46637527|NCT01474512|82811380|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
46637528|NCT01474512|82811381|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
46637529|NCT01474512|82811382|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
46637530|NCT01474512|82811383|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637531|NCT01474512|82811384|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637532|NCT01474512|82811385|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637533|NCT01474512|82811386|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637534|NCT01474512|82811387|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637535|NCT01474512|82811388|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46763977|NCT00827606|82982214|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
46763978|NCT00827606|82982215|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
47060045|NCT01546649|83339733|FG001|Overall Study|Protocol Violation|0|||
47060046|NCT01546649|83339732|FG000|Overall Study|Lack of Efficacy|1|||
47060047|NCT01546649|83339733|FG001|Overall Study|Lack of Efficacy|0|||
46763979|NCT00827606|82982214|FG000|Overall Study|Adverse Event|4|||
46763980|NCT00827606|82982215|FG001|Overall Study|Adverse Event|2|||
46763981|NCT00663052|82982229|FG000|Overall Study|Adverse Event|6|||
46763982|NCT00663052|82982230|FG001|Overall Study|Adverse Event|3|||
46763983|NCT00663052|82982229|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
46763984|NCT00663052|82982230|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
46763985|NCT00663052|82982229|FG000|Overall Study|Protocol Violation|1|||
46763986|NCT00663052|82982230|FG001|Overall Study|Protocol Violation|0|||
47060048|NCT01546649|83339732|FG000|Overall Study|Recurrence|1|||
46935937|NCT02555722|83172322|FG001|Week 2|Withdrawal by Subject|0|||
47060049|NCT01546649|83339733|FG001|Overall Study|Recurrence|1|||
47060050|NCT01546649|83339732|FG000|Overall Study|Discovery of secondary cancer|0|||
47060051|NCT01546649|83339733|FG001|Overall Study|Discovery of secondary cancer|1|||
47060052|NCT01546649|83339732|FG000|Overall Study|Withdrawal by Subject|1|||
47060053|NCT01546649|83339733|FG001|Overall Study|Withdrawal by Subject|2|||
47060054|NCT01544309|83339741|FG000|Overall Study|Withdrawal by Subject|12|||
46637536|NCT01474512|82811389|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637537|NCT01474512|82811390|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46935938|NCT02555722|83172321|FG000|Month 1|Lens Discomfort|1|||
46637538|NCT01474512|82811391|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637539|NCT01474512|82811392|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637540|NCT01474512|82811393|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
46637541|NCT01474512|82811376|FG000|Maintenance Period|Adverse Event|0|||
46637542|NCT01474512|82811377|FG001|Maintenance Period|Adverse Event|0|||
46637543|NCT01474512|82811378|FG002|Maintenance Period|Adverse Event|0|||
46637544|NCT01474512|82811379|FG003|Maintenance Period|Adverse Event|4|||
46935939|NCT02555722|83172322|FG001|Month 1|Lens Discomfort|0|||
46935940|NCT02555722|83172321|FG000|Month 2|Withdrawal by Subject|3|||
46935941|NCT02555722|83172322|FG001|Month 2|Withdrawal by Subject|0|||
46935942|NCT02555722|83172321|FG000|Month 2|Lost to Follow-up|1|||
46935943|NCT02555722|83172322|FG001|Month 2|Lost to Follow-up|0|||
46935944|NCT03287960|83172374|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
46935945|NCT03287960|83172374|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
46935946|NCT02558296|83172381|FG000|Completed the Study Through Week 24|Adverse Event|9|||
47060055|NCT01544309|83339742|FG001|Overall Study|Withdrawal by Subject|7|||
47060056|NCT01544309|83339741|FG000|Overall Study|Protocol Violation|2|||
47060057|NCT01544309|83339742|FG001|Overall Study|Protocol Violation|1|||
47060058|NCT01544309|83339741|FG000|Overall Study|Physician Decision|4|||
47060059|NCT01544309|83339742|FG001|Overall Study|Physician Decision|1|||
47060060|NCT01544309|83339741|FG000|Overall Study|Not performed pre-dose examination|1|||
47060061|NCT01544309|83339742|FG001|Overall Study|Not performed pre-dose examination|2|||
47060062|NCT01544309|83339741|FG000|Overall Study|Administered prohibit prior medication|1|||
47060063|NCT01544309|83339742|FG001|Overall Study|Administered prohibit prior medication|0|||
47060064|NCT01544153|83339754|FG000|Overall Study|Under 18|0|||
47060065|NCT01544153|83339755|FG001|Overall Study|Under 18|1|||
47060066|NCT01544153|83339756|FG002|Overall Study|Under 18|0|||
47060067|NCT01544153|83339757|FG003|Overall Study|Under 18|0|||
46935947|NCT02558296|83172382|FG001|Completed the Study Through Week 24|Adverse Event|3|||
46763987|NCT00663052|82982229|FG000|Overall Study|Withdrawal by Subject|2|||
46828986|NCT00369486|83047011|FG004|8-Week Visit|Missed visit|1|||
46828987|NCT00369486|83047007|FG000|8-Week Visit|Dropped|0|||
46828988|NCT00369486|83047008|FG001|8-Week Visit|Dropped|0|||
46828989|NCT00369486|83047009|FG002|8-Week Visit|Dropped|0|||
46935948|NCT02558296|83172381|FG000|Completed the Study Through Week 24|Death|7|||
46935949|NCT02558296|83172382|FG001|Completed the Study Through Week 24|Death|7|||
46935950|NCT02558296|83172381|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
46935951|NCT02558296|83172382|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
47060068|NCT01544153|83339754|FG000|Overall Study|Non-smoker|0|||
47060069|NCT01544153|83339755|FG001|Overall Study|Non-smoker|0|||
47060070|NCT01544153|83339756|FG002|Overall Study|Non-smoker|1|||
46935952|NCT02558296|83172381|FG000|Completed the Study Through Week 24|Physician Decision|1|||
46935953|NCT02558296|83172382|FG001|Completed the Study Through Week 24|Physician Decision|0|||
46935954|NCT02558296|83172381|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
46935955|NCT02558296|83172382|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
46935956|NCT02558296|83172381|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
46763988|NCT00663052|82982230|FG001|Overall Study|Withdrawal by Subject|5|||
46763989|NCT00663052|82982229|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
46763990|NCT00663052|82982230|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
46828990|NCT00369486|83047010|FG003|8-Week Visit|Dropped|1|||
46935957|NCT02558296|83172382|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
46763991|NCT00663052|82982229|FG000|Overall Study|Other|0|||
46763992|NCT00663052|82982230|FG001|Overall Study|Other|1|||
46763993|NCT00826748|82982239|FG000|Overall Study|Withdrawal by Subject|0|||
46763994|NCT00826748|82982240|FG001|Overall Study|Withdrawal by Subject|0|||
46763995|NCT00826748|82982241|FG002|Overall Study|Withdrawal by Subject|2|||
46763996|NCT00826748|82982239|FG000|Overall Study|Physician Decision|0|||
46763997|NCT00826748|82982240|FG001|Overall Study|Physician Decision|0|||
46763998|NCT00826748|82982241|FG002|Overall Study|Physician Decision|1|||
46763999|NCT00826748|82982239|FG000|Overall Study|Samples Did Not pass QC|0|||
46764000|NCT00826748|82982240|FG001|Overall Study|Samples Did Not pass QC|0|||
46764001|NCT00826748|82982241|FG002|Overall Study|Samples Did Not pass QC|1|||
46764002|NCT00806988|82982251|FG000|Overall Study|Death|15|||
46828991|NCT00369486|83047011|FG004|8-Week Visit|Dropped|0|||
46935958|NCT02558296|83172381|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
46935959|NCT02558296|83172382|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
47060071|NCT01544153|83339757|FG003|Overall Study|Non-smoker|0|||
46935960|NCT02558296|83172381|FG000|Completed the Study|Adverse Event|14|||
46637545|NCT01474512|82811380|FG004|Maintenance Period|Adverse Event|2|||
47060072|NCT01543685|83339772|FG000|Overall Study|Lack of Efficacy|1|||
47060073|NCT01543685|83339773|FG001|Overall Study|Lack of Efficacy|2|||
47060074|NCT01543685|83339774|FG002|Overall Study|Lack of Efficacy|2|||
46764003|NCT00806988|82982252|FG001|Overall Study|Death|16|||
46764004|NCT00806988|82982251|FG000|Overall Study|Withdrawal by Subject|8|||
46828992|NCT00369486|83047007|FG000|17-Week Visit|Missed visit|0|||
47060075|NCT01543685|83339775|FG003|Overall Study|Lack of Efficacy|0|||
46828993|NCT00369486|83047008|FG001|17-Week Visit|Missed visit|0|||
46828994|NCT00369486|83047009|FG002|17-Week Visit|Missed visit|1|||
46828995|NCT00369486|83047010|FG003|17-Week Visit|Missed visit|1|||
46828996|NCT00369486|83047011|FG004|17-Week Visit|Missed visit|1|||
46828997|NCT00369486|83047007|FG000|34-Week Visit|Dropped|0|||
46828998|NCT00369486|83047008|FG001|34-Week Visit|Dropped|1|||
46828999|NCT00369486|83047009|FG002|34-Week Visit|Dropped|1|||
46829000|NCT00369486|83047010|FG003|34-Week Visit|Dropped|3|||
46829001|NCT00369486|83047011|FG004|34-Week Visit|Dropped|3|||
46829002|NCT00363480|83047023|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
46829003|NCT00363480|83047023|FG000|Overall Study|Adverse Event|4|||
46829004|NCT00363480|83047023|FG000|Overall Study|Lost to Follow-up|5|||
46829005|NCT00363480|83047023|FG000|Overall Study|Withdrawal by Subject|5|||
46829006|NCT00363480|83047023|FG000|Overall Study|Non-compliance of subject|1|||
46829007|NCT00363480|83047023|FG000|Overall Study|Participant discontinued on its own|1|||
46829008|NCT00363246|83047027|FG000|Overall Study|Death|40|||
46829009|NCT00363246|83047027|FG000|Overall Study|Withdrawal by Subject|19|||
46829010|NCT00363246|83047027|FG000|Overall Study|Lost to Follow-up|14|||
46829011|NCT00363246|83047027|FG000|Overall Study|Bad health|6|||
46829012|NCT00363246|83047027|FG000|Overall Study|Stopped using wheelchair|11|||
46829013|NCT00363246|83047027|FG000|Overall Study|Subject expressed security concerns|2|||
46829014|NCT00363246|83047027|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
46829015|NCT00223990|83047034|FG000|Overall Study|Moved from area|2|||
46829016|NCT00223990|83047035|FG001|Overall Study|Moved from area|1|||
46829017|NCT00223990|83047034|FG000|Overall Study|Withdrawal by Subject|4|||
46829018|NCT00223990|83047035|FG001|Overall Study|Withdrawal by Subject|8|||
46829019|NCT00223990|83047034|FG000|Overall Study|Lost to Follow-up|1|||
46829020|NCT00223990|83047035|FG001|Overall Study|Lost to Follow-up|0|||
46829021|NCT00221104|83047043|FG000|Overall Study|Adverse Event|1|||
46829022|NCT00221104|83047044|FG001|Overall Study|Adverse Event|0|||
46829023|NCT00221104|83047043|FG000|Overall Study|Physician Decision|1|||
46829024|NCT00221104|83047044|FG001|Overall Study|Physician Decision|0|||
46829025|NCT00221104|83047043|FG000|Overall Study|Protocol Violation|2|||
46829026|NCT00221104|83047044|FG001|Overall Study|Protocol Violation|0|||
46829027|NCT00221104|83047043|FG000|Overall Study|Withdrawal by Subject|42|||
46829028|NCT00221104|83047044|FG001|Overall Study|Withdrawal by Subject|29|||
46829029|NCT00221104|83047043|FG000|Overall Study|Others|37|||
46829030|NCT00221104|83047044|FG001|Overall Study|Others|47|||
46829031|NCT00189202|83047052|FG000|Overall Study|Physician Decision|5|||
46829032|NCT00187486|83047056|FG000|Overall Study|Protocol Violation|1|||
46829033|NCT00220636|83047060|FG000|Overall Study|Withdrawal by Subject|4|||
46829034|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
46829035|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
46829036|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Death|1|||
46829037|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Death|3|||
46829038|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
46829039|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
46829040|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
46829041|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
46829042|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
46764005|NCT00806988|82982252|FG001|Overall Study|Withdrawal by Subject|8|||
46764006|NCT00806988|82982251|FG000|Overall Study|Lost to Follow-up|4|||
46764007|NCT00806988|82982252|FG001|Overall Study|Lost to Follow-up|19|||
46764008|NCT00807144|82982260|FG000|Overall Study|Lost to Follow-up|0|||
46764009|NCT00807144|82982261|FG001|Overall Study|Lost to Follow-up|1|||
46764010|NCT00591006|82982267|FG000|Overall Study|Withdrawal by Subject|0|||
46764011|NCT00591006|82982268|FG001|Overall Study|Withdrawal by Subject|0|||
46764012|NCT00591006|82982269|FG002|Overall Study|Withdrawal by Subject|0|||
46764013|NCT00591006|82982270|FG003|Overall Study|Withdrawal by Subject|0|||
46764014|NCT00591006|82982271|FG004|Overall Study|Withdrawal by Subject|0|||
46764015|NCT00591006|82982272|FG005|Overall Study|Withdrawal by Subject|0|||
46764016|NCT00591006|82982273|FG006|Overall Study|Withdrawal by Subject|0|||
46935961|NCT02558296|83172382|FG001|Completed the Study|Adverse Event|5|||
46829043|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
46829044|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
46829045|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
46829046|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
46829047|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
46829048|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
46935962|NCT02558296|83172381|FG000|Completed the Study|Death|39|||
47060076|NCT01543685|83339776|FG004|Overall Study|Lack of Efficacy|2|||
46764017|NCT00591006|82982274|FG007|Overall Study|Withdrawal by Subject|0|||
46764018|NCT00591006|82982275|FG008|Overall Study|Withdrawal by Subject|0|||
46829049|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
46829050|NCT00362232|83047067|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
46829051|NCT00362232|83047068|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
46829052|NCT00362232|83047067|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
46829053|NCT00362232|83047068|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
46829054|NCT00362232|83047067|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
46829055|NCT00362232|83047068|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
46829056|NCT00362232|83047067|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
46829057|NCT00362232|83047068|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
46829058|NCT00362232|83047067|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
46829059|NCT00362232|83047068|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
46829060|NCT00219544|83047074|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
46829061|NCT00219544|83047075|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
46829062|NCT00219544|83047074|FG000|Single Blind Treatment Period|Adverse Event|9|||
46829063|NCT00219544|83047075|FG001|Single Blind Treatment Period|Adverse Event|0|||
46829064|NCT00219544|83047074|FG000|Single Blind Treatment Period|Protocol Violation|4|||
47060077|NCT01543685|83339772|FG000|Overall Study|Adverse Event|2|||
47060078|NCT01543685|83339773|FG001|Overall Study|Adverse Event|1|||
47060079|NCT01543685|83339774|FG002|Overall Study|Adverse Event|0|||
47060080|NCT01543685|83339775|FG003|Overall Study|Adverse Event|0|||
47060081|NCT01543685|83339776|FG004|Overall Study|Adverse Event|2|||
47060082|NCT01541969|83339790|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
47060083|NCT01541969|83339791|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
46829065|NCT00219544|83047075|FG001|Single Blind Treatment Period|Protocol Violation|0|||
46829066|NCT00219544|83047074|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
46829067|NCT00219544|83047075|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
47060084|NCT01541969|83339790|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
47060085|NCT01541969|83339791|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
47060086|NCT01541969|83339790|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
47060087|NCT01541969|83339791|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
47060088|NCT01541969|83339790|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
46935963|NCT02558296|83172382|FG001|Completed the Study|Death|25|||
46829068|NCT00219544|83047074|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
46829069|NCT00219544|83047075|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
46829070|NCT00219544|83047074|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
46829071|NCT00219544|83047075|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
46829072|NCT00357552|83047083|FG000|Screening|Did not meet eligibility criteria|84|||
46829073|NCT00357552|83047083|FG000|Weeks 0 to 24|Death|1|||
46829074|NCT00357552|83047083|FG000|Weeks 24 to 104|Death|3|||
46829075|NCT00357552|83047083|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
46829076|NCT00187096|83047094|FG000|Overall Study|unacceptable toxicity|0|||
46829077|NCT00187096|83047095|FG001|Overall Study|unacceptable toxicity|0|||
46829078|NCT00187096|83047096|FG002|Overall Study|unacceptable toxicity|1|||
46829079|NCT00357396|83047106|FG000|Overall Study|Adverse Event|1|||
46829080|NCT00357396|83047107|FG001|Overall Study|Adverse Event|0|||
46829081|NCT00186628|83047112|FG000|Overall Study|Death|2|||
46829082|NCT00186628|83047112|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
46829083|NCT00368550|83047120|FG000|Overall Study|Adverse Event|7|||
47060089|NCT01541969|83339791|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
47060090|NCT01541969|83339790|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
47060091|NCT01541969|83339791|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
46764019|NCT00591006|82982276|FG009|Overall Study|Withdrawal by Subject|0|||
46764020|NCT00591006|82982277|FG010|Overall Study|Withdrawal by Subject|0|||
46764021|NCT00591006|82982278|FG011|Overall Study|Withdrawal by Subject|0|||
46764022|NCT00591006|82982279|FG012|Overall Study|Withdrawal by Subject|0|||
46764023|NCT00591006|82982280|FG013|Overall Study|Withdrawal by Subject|0|||
46764024|NCT00591006|82982281|FG014|Overall Study|Withdrawal by Subject|0|||
46764025|NCT00591006|82982282|FG015|Overall Study|Withdrawal by Subject|1|||
46764026|NCT00591006|82982283|FG016|Overall Study|Withdrawal by Subject|0|||
46764027|NCT00591006|82982284|FG017|Overall Study|Withdrawal by Subject|0|||
46764028|NCT00591006|82982285|FG018|Overall Study|Withdrawal by Subject|0|||
46764029|NCT00591006|82982286|FG019|Overall Study|Withdrawal by Subject|0|||
46764030|NCT00591006|82982287|FG020|Overall Study|Withdrawal by Subject|0|||
46764031|NCT00591006|82982288|FG021|Overall Study|Withdrawal by Subject|0|||
46764032|NCT00591006|82982289|FG022|Overall Study|Withdrawal by Subject|0|||
46764033|NCT00591006|82982290|FG023|Overall Study|Withdrawal by Subject|1|||
46764034|NCT00591006|82982267|FG000|Overall Study|Adverse Event|0|||
46764035|NCT00591006|82982268|FG001|Overall Study|Adverse Event|0|||
46829084|NCT00368550|83047121|FG001|Overall Study|Adverse Event|4|||
46829085|NCT00368550|83047120|FG000|Overall Study|Lack of Efficacy|4|||
47060092|NCT01541969|83339790|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
46764036|NCT00591006|82982269|FG002|Overall Study|Adverse Event|0|||
46764037|NCT00591006|82982270|FG003|Overall Study|Adverse Event|0|||
46829086|NCT00368550|83047121|FG001|Overall Study|Lack of Efficacy|9|||
46829087|NCT00368550|83047120|FG000|Overall Study|Withdrawal by Subject|17|||
46829088|NCT00368550|83047121|FG001|Overall Study|Withdrawal by Subject|10|||
46829089|NCT00368472|83047127|FG000|Overall Study|Adverse Event|22|||
46829090|NCT00368472|83047127|FG000|Overall Study|Medication non-compliance|4|||
46829091|NCT00368472|83047127|FG000|Overall Study|Protocol Violation|2|||
46829092|NCT00368472|83047127|FG000|Overall Study|Request of Investigator or Sponsor|3|||
46829093|NCT00368472|83047127|FG000|Overall Study|Withdrawal by Subject|40|||
46829094|NCT00368472|83047127|FG000|Overall Study|Diary non-compliance|1|||
46829095|NCT00368472|83047127|FG000|Overall Study|Other|32|||
46829096|NCT00368472|83047127|FG000|Overall Study|Missing Final Disposition Date|1|||
46829097|NCT00357006|83047134|FG000|Overall Study|Lost to Follow-up|1|||
46829098|NCT00357006|83047135|FG001|Overall Study|Lost to Follow-up|2|||
46829099|NCT00357006|83047136|FG002|Overall Study|Lost to Follow-up|1|||
46829100|NCT00357006|83047134|FG000|Overall Study|Withdrawal by Subject|1|||
46829101|NCT00357006|83047135|FG001|Overall Study|Withdrawal by Subject|3|||
46829102|NCT00357006|83047136|FG002|Overall Study|Withdrawal by Subject|2|||
46829103|NCT00165646|83047147|FG000|Overall Study|Adverse Event|1|||
46829104|NCT00165646|83047148|FG001|Overall Study|Adverse Event|1|||
46829105|NCT00165646|83047149|FG002|Overall Study|Adverse Event|1|||
46829106|NCT00165646|83047147|FG000|Overall Study|Lack of Efficacy|1|||
46764038|NCT00591006|82982271|FG004|Overall Study|Adverse Event|0|||
46764039|NCT00591006|82982272|FG005|Overall Study|Adverse Event|0|||
46829107|NCT00165646|83047148|FG001|Overall Study|Lack of Efficacy|2|||
46829108|NCT00165646|83047149|FG002|Overall Study|Lack of Efficacy|0|||
46829109|NCT00165646|83047147|FG000|Overall Study|Withdrawal by Subject|0|||
46829110|NCT00165646|83047148|FG001|Overall Study|Withdrawal by Subject|2|||
46829111|NCT00165646|83047149|FG002|Overall Study|Withdrawal by Subject|1|||
46829112|NCT00165646|83047147|FG000|Overall Study|Physician Decision|2|||
46829113|NCT00165646|83047148|FG001|Overall Study|Physician Decision|0|||
46829114|NCT00165646|83047149|FG002|Overall Study|Physician Decision|2|||
46829115|NCT00165646|83047147|FG000|Overall Study|Protocol Violation|1|||
46829116|NCT00165646|83047148|FG001|Overall Study|Protocol Violation|0|||
46829117|NCT00165646|83047149|FG002|Overall Study|Protocol Violation|0|||
46829118|NCT00367770|83047157|FG000|Overall Study|Adverse Event|1|||
46829119|NCT00367770|83047157|FG000|Overall Study|Withdrawal by Subject|1|||
46829120|NCT00185614|83047161|FG000|Inter-treatment Period|Physician Decision|1|||
46829121|NCT00185614|83047161|FG000|Inter-treatment Period|Relapse|2|||
46829122|NCT00185614|83047161|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
46829123|NCT00162370|83047165|FG000|Efficacy Population|Lost to Follow-up|51|||
46829124|NCT00361842|83047174|FG000|Overall Study|Withdrawal by Subject|2|||
46829125|NCT00361842|83047175|FG001|Overall Study|Withdrawal by Subject|3|||
46829126|NCT00361842|83047174|FG000|Overall Study|Death|2|||
46764040|NCT00591006|82982273|FG006|Overall Study|Adverse Event|0|||
46764041|NCT00591006|82982274|FG007|Overall Study|Adverse Event|0|||
46764042|NCT00591006|82982275|FG008|Overall Study|Adverse Event|0|||
46764043|NCT00591006|82982276|FG009|Overall Study|Adverse Event|0|||
46829127|NCT00361842|83047175|FG001|Overall Study|Death|1|||
46829128|NCT00361842|83047174|FG000|Overall Study|Disease progression|19|||
46829129|NCT00361842|83047175|FG001|Overall Study|Disease progression|20|||
46829130|NCT00361842|83047174|FG000|Overall Study|Adverse Event|2|||
46829131|NCT00361842|83047175|FG001|Overall Study|Adverse Event|3|||
46829132|NCT00361842|83047174|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
46829133|NCT00361842|83047175|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
46829134|NCT00361842|83047174|FG000|Overall Study|Other|1|||
46829135|NCT00361842|83047175|FG001|Overall Study|Other|0|||
46829136|NCT00361842|83047174|FG000|Overall Study|Other|0|||
46829137|NCT00361842|83047175|FG001|Overall Study|Other|2|||
46829138|NCT00361296|83047183|FG000|Overall Study|Physician Decision|1|||
46829139|NCT00361296|83047183|FG000|Overall Study|Lack of Efficacy|2|||
46829140|NCT00356148|83047189|FG000|Overall Study|Reoperation within 30 days|2|||
46829141|NCT00356148|83047190|FG001|Overall Study|Reoperation within 30 days|1|||
46935964|NCT02558296|83172381|FG000|Completed the Study|Lost to Follow-up|31|||
46764044|NCT00591006|82982277|FG010|Overall Study|Adverse Event|0|||
46764045|NCT00591006|82982278|FG011|Overall Study|Adverse Event|0|||
46764046|NCT00591006|82982279|FG012|Overall Study|Adverse Event|0|||
46764047|NCT00591006|82982280|FG013|Overall Study|Adverse Event|0|||
46764048|NCT00591006|82982281|FG014|Overall Study|Adverse Event|0|||
46829142|NCT00361218|83047197|FG000|Overall Study|Lost to Follow-up|11|||
46829143|NCT00361218|83047197|FG000|Overall Study|Personal Reasons|7|||
46829144|NCT00361218|83047197|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
46935965|NCT02558296|83172382|FG001|Completed the Study|Lost to Follow-up|23|||
46764049|NCT00591006|82982282|FG015|Overall Study|Adverse Event|0|||
46764050|NCT00591006|82982283|FG016|Overall Study|Adverse Event|0|||
46829145|NCT00367458|83047203|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
46829146|NCT00367458|83047204|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
46829147|NCT00162136|83047216|FG000|Overall Study|Adverse Event|1|||
46829148|NCT00162136|83047216|FG000|Overall Study|Death|1|||
46829149|NCT00162136|83047216|FG000|Overall Study|Disease Progression/Relapse|23|||
46829150|NCT00162136|83047216|FG000|Overall Study|Investigator Request|5|||
46829151|NCT00162136|83047216|FG000|Overall Study|Study Drug Toxicity|4|||
46829152|NCT00162136|83047216|FG000|Overall Study|Withdrawal by Subject|1|||
46829153|NCT00252694|83047242|FG000|Overall Study|Withdrawal by Subject|83|||
46829154|NCT00252694|83047243|FG001|Overall Study|Withdrawal by Subject|91|||
46829155|NCT00252694|83047242|FG000|Overall Study|Death|36|||
46829156|NCT00252694|83047243|FG001|Overall Study|Death|34|||
46829157|NCT00252694|83047242|FG000|Overall Study|Mostly Lost to Follow Up|8|||
46935966|NCT02558296|83172381|FG000|Completed the Study|Physician Decision|6|||
46935967|NCT02558296|83172382|FG001|Completed the Study|Physician Decision|0|||
46935968|NCT02558296|83172381|FG000|Completed the Study|Protocol Violation|2|||
46935969|NCT02558296|83172382|FG001|Completed the Study|Protocol Violation|1|||
46935970|NCT02558296|83172381|FG000|Completed the Study|Withdrawal by Subject|53|||
46935971|NCT02558296|83172382|FG001|Completed the Study|Withdrawal by Subject|31|||
46935972|NCT02558296|83172381|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
46935973|NCT02558296|83172382|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
46935974|NCT02737475|83172419|FG000|Overall Study|Other reasons|0|||
46764051|NCT00591006|82982284|FG017|Overall Study|Adverse Event|0|||
46829158|NCT00252694|83047243|FG001|Overall Study|Mostly Lost to Follow Up|13|||
46829159|NCT00252694|83047242|FG000|Overall Study|Patient Moving|17|||
46829160|NCT00252694|83047243|FG001|Overall Study|Patient Moving|16|||
46829161|NCT00185458|83047249|FG000|Contraception Phase|Adverse Event|37|||
46829162|NCT00185458|83047249|FG000|Contraception Phase|Lost to Follow-up|10|||
46829163|NCT00185458|83047249|FG000|Contraception Phase|Protocol Violation|2|||
46829164|NCT00185458|83047249|FG000|Contraception Phase|Physician Decision|2|||
46829165|NCT00185458|83047249|FG000|Contraception Phase|Withdrawal by Subject|7|||
46829166|NCT00185458|83047249|FG000|HRT Phase|Adverse Event|18|||
46829167|NCT00185458|83047249|FG000|HRT Phase|Lost to Follow-up|4|||
46829168|NCT00185458|83047249|FG000|HRT Phase|Protocol Violation|2|||
46829169|NCT00185458|83047249|FG000|HRT Phase|Withdrawal by Subject|3|||
46829170|NCT00185380|83047264|FG000|Overall Study|Adverse Event|41|||
46829171|NCT00185380|83047265|FG001|Overall Study|Adverse Event|43|||
46829172|NCT00185380|83047266|FG002|Overall Study|Adverse Event|48|||
46829173|NCT00185380|83047264|FG000|Overall Study|Lost to Follow-up|0|||
46829174|NCT00185380|83047265|FG001|Overall Study|Lost to Follow-up|4|||
46829175|NCT00185380|83047266|FG002|Overall Study|Lost to Follow-up|3|||
46829176|NCT00185380|83047264|FG000|Overall Study|Pregnancy|1|||
46829177|NCT00185380|83047265|FG001|Overall Study|Pregnancy|4|||
46829178|NCT00185380|83047266|FG002|Overall Study|Pregnancy|0|||
46829179|NCT00185380|83047264|FG000|Overall Study|Protocol Violation|2|||
46829180|NCT00185380|83047265|FG001|Overall Study|Protocol Violation|2|||
46829181|NCT00185380|83047266|FG002|Overall Study|Protocol Violation|1|||
46829182|NCT00185380|83047264|FG000|Overall Study|Withdrawal by Subject|1|||
46829183|NCT00185380|83047265|FG001|Overall Study|Withdrawal by Subject|2|||
46829184|NCT00185380|83047266|FG002|Overall Study|Withdrawal by Subject|0|||
46829185|NCT00185380|83047264|FG000|Overall Study|Failed insertion|1|||
46829186|NCT00185380|83047265|FG001|Overall Study|Failed insertion|1|||
46829187|NCT00185380|83047266|FG002|Overall Study|Failed insertion|2|||
46829188|NCT00185380|83047264|FG000|Overall Study|Planned pregnancy|9|||
46829189|NCT00185380|83047265|FG001|Overall Study|Planned pregnancy|12|||
46829190|NCT00185380|83047266|FG002|Overall Study|Planned pregnancy|12|||
46935975|NCT02737475|83172420|FG001|Overall Study|Other reasons|0|||
46764052|NCT00591006|82982285|FG018|Overall Study|Adverse Event|0|||
46764053|NCT00591006|82982286|FG019|Overall Study|Adverse Event|0|||
46764054|NCT00591006|82982287|FG020|Overall Study|Adverse Event|0|||
46764055|NCT00591006|82982288|FG021|Overall Study|Adverse Event|0|||
46764056|NCT00591006|82982289|FG022|Overall Study|Adverse Event|1|||
46764057|NCT00591006|82982290|FG023|Overall Study|Adverse Event|0|||
46764058|NCT00844844|82982307|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
46764059|NCT00844844|82982307|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
46764060|NCT00844844|82982307|FG000|Extension Treatment Period|Adverse Event|2|||
46764061|NCT00844844|82982307|FG000|Post Treatment Period|Withdrawal by Subject|1|||
46829191|NCT00185380|83047264|FG000|Overall Study|No need for contraception|3|||
46829192|NCT00185380|83047265|FG001|Overall Study|No need for contraception|3|||
46829193|NCT00185380|83047266|FG002|Overall Study|No need for contraception|3|||
46829194|NCT00185380|83047264|FG000|Overall Study|Could not attend visits|2|||
46829195|NCT00185380|83047265|FG001|Overall Study|Could not attend visits|0|||
46829196|NCT00185380|83047266|FG002|Overall Study|Could not attend visits|4|||
46829197|NCT00185380|83047264|FG000|Overall Study|personal reason|6|||
46829198|NCT00185380|83047265|FG001|Overall Study|personal reason|1|||
46829199|NCT00185380|83047266|FG002|Overall Study|personal reason|1|||
46829200|NCT00160654|83047274|FG000|Overall Study|Adverse Event|14|||
46829201|NCT00160654|83047274|FG000|Overall Study|Lack of Efficacy|4|||
46935976|NCT02737475|83172421|FG002|Overall Study|Other reasons|0|||
46935977|NCT02737475|83172422|FG003|Overall Study|Other reasons|0|||
46764062|NCT00660790|82982311|FG000|Baseline to 3 Months|Death|1|||
46764063|NCT00660790|82982311|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
46764064|NCT00660790|82982311|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
46829202|NCT00160654|83047274|FG000|Overall Study|Lost to Follow-up|2|||
46829203|NCT00160654|83047274|FG000|Overall Study|Intake of expired drug|7|||
46829204|NCT00160654|83047274|FG000|Overall Study|Psychological trauma|1|||
46829205|NCT00160654|83047274|FG000|Overall Study|Sponsor decision|1|||
46829206|NCT00160654|83047274|FG000|Overall Study|Patient met exclusion criteria|1|||
46829207|NCT00160654|83047274|FG000|Overall Study|Patient decision|1|||
46829208|NCT00160654|83047274|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
46829209|NCT00160654|83047274|FG000|Overall Study|Met exclusion criteria|1|||
46829210|NCT00366678|83047280|FG000|Infant Series|Withdrawal by Subject|8|||
46829211|NCT00366678|83047281|FG001|Infant Series|Withdrawal by Subject|6|||
46829212|NCT00366678|83047282|FG002|Infant Series|Withdrawal by Subject|0|||
46829213|NCT00366678|83047280|FG000|Infant Series|Protocol Violation|4|||
46829214|NCT00366678|83047281|FG001|Infant Series|Protocol Violation|3|||
46829215|NCT00366678|83047282|FG002|Infant Series|Protocol Violation|0|||
47060093|NCT01541969|83339791|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
47060094|NCT01541969|83339790|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
47060095|NCT01541969|83339791|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
47060096|NCT01541969|83339790|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
47060097|NCT01541969|83339791|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
47060098|NCT01541969|83339790|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
47060099|NCT01541969|83339791|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
47060100|NCT01541969|83339790|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
47060101|NCT01541969|83339791|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
47060102|NCT01540565|83339800|FG000|Overall Study|Ineligible|2|||
47060103|NCT01540487|83339806|FG000|Overall Study|Protocol Violation|1|||
47060104|NCT01540487|83339807|FG001|Overall Study|Protocol Violation|0|||
47060105|NCT01539317|83339819|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
47060106|NCT01539317|83339820|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
47060107|NCT01539239|83339831|FG000|Overall Study|Death|5|||
47060108|NCT01539239|83339832|FG001|Overall Study|Death|5|||
47060109|NCT01539239|83339831|FG000|Overall Study|Lost to Follow-up|7|||
47060110|NCT01539239|83339832|FG001|Overall Study|Lost to Follow-up|12|||
47060111|NCT01539083|83339838|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
47060112|NCT01539083|83339839|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
47060113|NCT01539083|83339840|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
46829216|NCT00366678|83047280|FG000|Infant Series|Failed to return|1|||
46829217|NCT00366678|83047281|FG001|Infant Series|Failed to return|1|||
46829218|NCT00366678|83047282|FG002|Infant Series|Failed to return|0|||
46829219|NCT00366678|83047280|FG000|Infant Series|Adverse Event|1|||
46829220|NCT00366678|83047281|FG001|Infant Series|Adverse Event|0|||
46829221|NCT00366678|83047282|FG002|Infant Series|Adverse Event|0|||
46829222|NCT00366678|83047280|FG000|After Infant|Withdrawal by Subject|8|||
46829223|NCT00366678|83047281|FG001|After Infant|Withdrawal by Subject|4|||
46829224|NCT00366678|83047282|FG002|After Infant|Withdrawal by Subject|0|||
46829225|NCT00366678|83047280|FG000|After Infant|Lost to Follow-up|2|||
46829226|NCT00366678|83047281|FG001|After Infant|Lost to Follow-up|1|||
46829227|NCT00366678|83047282|FG002|After Infant|Lost to Follow-up|0|||
46829228|NCT00366678|83047280|FG000|After Infant|Failed to return|5|||
46829229|NCT00366678|83047281|FG001|After Infant|Failed to return|5|||
46829230|NCT00366678|83047282|FG002|After Infant|Failed to return|0|||
46829231|NCT00366678|83047280|FG000|After Infant|Adverse Event|1|||
47060114|NCT01539083|83339838|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
46764065|NCT00836810|82982317|FG000|Overall Study|New diagnosis|1|||
46764066|NCT00836810|82982318|FG001|Overall Study|New diagnosis|0|||
46764067|NCT00658684|82982327|FG000|Overall Study|Adverse Event|10|||
46764068|NCT00658684|82982328|FG001|Overall Study|Adverse Event|8|||
46764069|NCT00658684|82982329|FG002|Overall Study|Adverse Event|2|||
46764070|NCT00658684|82982330|FG003|Overall Study|Adverse Event|0|||
46764071|NCT00658684|82982327|FG000|Overall Study|Withdrawal by Subject|6|||
46764072|NCT00658684|82982328|FG001|Overall Study|Withdrawal by Subject|4|||
46764073|NCT00658684|82982329|FG002|Overall Study|Withdrawal by Subject|1|||
46764074|NCT00658684|82982330|FG003|Overall Study|Withdrawal by Subject|1|||
46764075|NCT00658684|82982327|FG000|Overall Study|Lack of Efficacy|1|||
46764076|NCT00658684|82982328|FG001|Overall Study|Lack of Efficacy|1|||
46829232|NCT00366678|83047281|FG001|After Infant|Adverse Event|0|||
46829233|NCT00366678|83047282|FG002|After Infant|Adverse Event|0|||
46764077|NCT00658684|82982329|FG002|Overall Study|Lack of Efficacy|0|||
46829234|NCT00366678|83047280|FG000|After Infant|Protocol Violation|1|||
46829235|NCT00366678|83047281|FG001|After Infant|Protocol Violation|0|||
46829236|NCT00366678|83047282|FG002|After Infant|Protocol Violation|0|||
46829237|NCT00366678|83047280|FG000|Toddler Dose|Protocol Violation|2|||
46764078|NCT00658684|82982330|FG003|Overall Study|Lack of Efficacy|0|||
46829238|NCT00366678|83047281|FG001|Toddler Dose|Protocol Violation|1|||
46829239|NCT00366678|83047282|FG002|Toddler Dose|Protocol Violation|0|||
46829240|NCT00366678|83047280|FG000|Toddler Dose|Failed to return|1|||
46829241|NCT00366678|83047281|FG001|Toddler Dose|Failed to return|0|||
46829242|NCT00366678|83047282|FG002|Toddler Dose|Failed to return|0|||
46935978|NCT02737475|83172423|FG004|Overall Study|Other reasons|1|||
46935979|NCT02737475|83172424|FG005|Overall Study|Other reasons|1|||
46935980|NCT02737475|83172425|FG006|Overall Study|Other reasons|0|||
46935981|NCT02737475|83172426|FG007|Overall Study|Other reasons|0|||
46935982|NCT02737475|83172427|FG008|Overall Study|Other reasons|1|||
47060115|NCT01539083|83339839|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
47060116|NCT01539083|83339840|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
47060117|NCT01539083|83339838|FG000|Before Randomization (VCD Induction)|Death|6|||
47060118|NCT01539083|83339839|FG001|Before Randomization (VCD Induction)|Death|0|||
47060119|NCT01539083|83339840|FG002|Before Randomization (VCD Induction)|Death|0|||
47060120|NCT01539083|83339838|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
47060121|NCT01539083|83339839|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
47060122|NCT01539083|83339840|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
47060123|NCT01539083|83339838|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
47060124|NCT01539083|83339839|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
47060125|NCT01539083|83339840|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
47060126|NCT01539083|83339838|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
47060127|NCT01539083|83339839|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
46764079|NCT00658684|82982327|FG000|Overall Study|Protocol Violation|1|||
46764080|NCT00658684|82982328|FG001|Overall Study|Protocol Violation|1|||
46764081|NCT00658684|82982329|FG002|Overall Study|Protocol Violation|0|||
46764082|NCT00658684|82982330|FG003|Overall Study|Protocol Violation|0|||
46764083|NCT00658684|82982327|FG000|Overall Study|Pregnancy|1|||
46764084|NCT00658684|82982328|FG001|Overall Study|Pregnancy|1|||
46764085|NCT00658684|82982329|FG002|Overall Study|Pregnancy|0|||
46764086|NCT00658684|82982330|FG003|Overall Study|Pregnancy|0|||
46764087|NCT00660400|82982340|FG000|Overall Study|Lack of insurance approval|1|||
46764088|NCT00660400|82982340|FG000|Overall Study|Suboptimal organ function|1|||
46764089|NCT00660400|82982340|FG000|Overall Study|Intracranial hemorrhage|1|||
46764090|NCT00660400|82982340|FG000|Overall Study|Withdrawal by Subject|1|||
46764091|NCT00826514|82982346|FG000|Overall Study|Adverse Event|1|||
46764092|NCT00826514|82982347|FG001|Overall Study|Adverse Event|1|||
46764093|NCT00826514|82982346|FG000|Overall Study|Lack of Efficacy|0|||
46764094|NCT00826514|82982347|FG001|Overall Study|Lack of Efficacy|1|||
46764095|NCT00826514|82982346|FG000|Overall Study|Withdrawal by Subject|2|||
46764096|NCT00826514|82982347|FG001|Overall Study|Withdrawal by Subject|3|||
46764097|NCT00826280|82982356|FG000|Overall Study|Randomized but drug not received|1|||
46829243|NCT00366678|83047280|FG000|Toddler Dose|Withdrawal by Subject|1|||
46935983|NCT02737475|83172428|FG009|Overall Study|Other reasons|0|||
46935984|NCT02737475|83172429|FG010|Overall Study|Other reasons|1|||
46935985|NCT02737475|83172430|FG011|Overall Study|Other reasons|0|||
46935986|NCT02737475|83172431|FG012|Overall Study|Other reasons|0|||
46935987|NCT02737475|83172432|FG013|Overall Study|Other reasons|0|||
46935988|NCT02737475|83172433|FG014|Overall Study|Other reasons|0|||
46935989|NCT02737475|83172434|FG015|Overall Study|Other reasons|0|||
46935990|NCT02737475|83172435|FG016|Overall Study|Other reasons|0|||
46935991|NCT02737475|83172436|FG017|Overall Study|Other reasons|0|||
46935992|NCT02737475|83172437|FG018|Overall Study|Other reasons|0|||
46935993|NCT02737475|83172438|FG019|Overall Study|Other reasons|0|||
46935994|NCT02737475|83172439|FG020|Overall Study|Other reasons|0|||
46935995|NCT02737475|83172440|FG021|Overall Study|Other reasons|1|||
46935996|NCT02737475|83172441|FG022|Overall Study|Other reasons|0|||
46935997|NCT02737475|83172442|FG023|Overall Study|Other reasons|1|||
46935998|NCT02737475|83172443|FG024|Overall Study|Other reasons|1|||
46935999|NCT02737475|83172444|FG025|Overall Study|Other reasons|1|||
46936000|NCT02737475|83172445|FG026|Overall Study|Other reasons|0|||
46936001|NCT02737475|83172419|FG000|Overall Study|Death|1|||
46936002|NCT02737475|83172420|FG001|Overall Study|Death|0|||
46936003|NCT02737475|83172421|FG002|Overall Study|Death|0|||
46936004|NCT02737475|83172422|FG003|Overall Study|Death|1|||
46936005|NCT02737475|83172423|FG004|Overall Study|Death|0|||
46764098|NCT00826280|82982357|FG001|Overall Study|Randomized but drug not received|0|||
46829244|NCT00366678|83047281|FG001|Toddler Dose|Withdrawal by Subject|0|||
46936006|NCT02737475|83172424|FG005|Overall Study|Death|0|||
46936007|NCT02737475|83172425|FG006|Overall Study|Death|0|||
46936008|NCT02737475|83172426|FG007|Overall Study|Death|2|||
46936009|NCT02737475|83172427|FG008|Overall Study|Death|0|||
46936010|NCT02737475|83172428|FG009|Overall Study|Death|0|||
46936011|NCT02737475|83172429|FG010|Overall Study|Death|0|||
46936012|NCT02737475|83172430|FG011|Overall Study|Death|4|||
46936013|NCT02737475|83172431|FG012|Overall Study|Death|2|||
46764099|NCT00826280|82982358|FG002|Overall Study|Randomized but drug not received|1|||
46764100|NCT00826280|82982356|FG000|Overall Study|Adverse Event|1|||
46829245|NCT00366678|83047282|FG002|Toddler Dose|Withdrawal by Subject|0|||
46829246|NCT00366678|83047280|FG000|Toddler Dose|protocol deviation|1|||
46829247|NCT00366678|83047281|FG001|Toddler Dose|protocol deviation|0|||
46829248|NCT00366678|83047282|FG002|Toddler Dose|protocol deviation|0|||
46829249|NCT00355368|83047329|FG000|Overall Study|Protocol Violation|8|||
46829250|NCT00355368|83047330|FG001|Overall Study|Protocol Violation|7|||
46829251|NCT00355368|83047329|FG000|Overall Study|cardiac arrest prior to intubation|2|||
46829252|NCT00355368|83047330|FG001|Overall Study|cardiac arrest prior to intubation|2|||
46829253|NCT00360282|83047336|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
46829254|NCT00360282|83047337|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
46829255|NCT00360282|83047338|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
46829256|NCT00360282|83047339|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
46829257|NCT00360282|83047336|FG000|Second Intervention|Adverse Event|0|||
46829258|NCT00360282|83047337|FG001|Second Intervention|Adverse Event|1|||
46829259|NCT00360282|83047338|FG002|Second Intervention|Adverse Event|0|||
46829260|NCT00360282|83047339|FG003|Second Intervention|Adverse Event|0|||
46829261|NCT00373958|83047349|FG000|Infant Series|Withdrawal by Subject|13|||
46829262|NCT00373958|83047350|FG001|Infant Series|Withdrawal by Subject|15|||
46829263|NCT00373958|83047349|FG000|Infant Series|Failed to return|8|||
47060128|NCT01539083|83339840|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
47060129|NCT01539083|83339838|FG000|Before Randomization (VCD Induction)|Other|5|||
47060130|NCT01539083|83339839|FG001|Before Randomization (VCD Induction)|Other|0|||
47060131|NCT01539083|83339840|FG002|Before Randomization (VCD Induction)|Other|0|||
47060132|NCT01539083|83339838|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
47060133|NCT01539083|83339839|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
47060134|NCT01539083|83339840|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
47060135|NCT01539083|83339838|FG000|After Randomization (TP and VTP)|Other|0|||
47060136|NCT01539083|83339839|FG001|After Randomization (TP and VTP)|Other|1|||
47060137|NCT01539083|83339840|FG002|After Randomization (TP and VTP)|Other|1|||
47060138|NCT01539083|83339838|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
47060139|NCT01539083|83339839|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
47060140|NCT01539083|83339840|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
47060141|NCT01539083|83339838|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
47060142|NCT01539083|83339839|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
47060143|NCT01539083|83339840|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
47060144|NCT01539083|83339838|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
46764101|NCT00826280|82982357|FG001|Overall Study|Adverse Event|3|||
46764102|NCT00826280|82982358|FG002|Overall Study|Adverse Event|0|||
46764103|NCT00826280|82982356|FG000|Overall Study|Lost to Follow-up|0|||
46764104|NCT00826280|82982357|FG001|Overall Study|Lost to Follow-up|1|||
46764105|NCT00826280|82982358|FG002|Overall Study|Lost to Follow-up|0|||
46764106|NCT00826280|82982356|FG000|Overall Study|Sponsor discontinued subject or study|1|||
46764107|NCT00826280|82982357|FG001|Overall Study|Sponsor discontinued subject or study|0|||
46764108|NCT00826280|82982358|FG002|Overall Study|Sponsor discontinued subject or study|0|||
46764109|NCT00826280|82982356|FG000|Overall Study|Reversible ischemic defect not present|43|||
46764110|NCT00826280|82982357|FG001|Overall Study|Reversible ischemic defect not present|40|||
46764111|NCT00826280|82982358|FG002|Overall Study|Reversible ischemic defect not present|44|||
46764112|NCT00826280|82982356|FG000|Overall Study|Interpretation Failure|1|||
46764113|NCT00826280|82982357|FG001|Overall Study|Interpretation Failure|0|||
46764114|NCT00826280|82982358|FG002|Overall Study|Interpretation Failure|0|||
46764115|NCT00826280|82982356|FG000|Overall Study|Machine Failure|1|||
46829264|NCT00373958|83047350|FG001|Infant Series|Failed to return|13|||
46829265|NCT00373958|83047349|FG000|Infant Series|Lost to Follow-up|6|||
46829266|NCT00373958|83047350|FG001|Infant Series|Lost to Follow-up|5|||
46829267|NCT00373958|83047349|FG000|Infant Series|Protocol Violation|3|||
46936014|NCT02737475|83172432|FG013|Overall Study|Death|2|||
46936015|NCT02737475|83172433|FG014|Overall Study|Death|0|||
46936016|NCT02737475|83172434|FG015|Overall Study|Death|2|||
46936017|NCT02737475|83172435|FG016|Overall Study|Death|2|||
46936018|NCT02737475|83172436|FG017|Overall Study|Death|2|||
46936019|NCT02737475|83172437|FG018|Overall Study|Death|1|||
46936020|NCT02737475|83172438|FG019|Overall Study|Death|0|||
46764116|NCT00826280|82982357|FG001|Overall Study|Machine Failure|1|||
46829268|NCT00373958|83047350|FG001|Infant Series|Protocol Violation|7|||
46829269|NCT00373958|83047349|FG000|Infant Series|Lost Kaiser coverage|4|||
46829270|NCT00373958|83047350|FG001|Infant Series|Lost Kaiser coverage|0|||
46829271|NCT00373958|83047349|FG000|Infant Series|Child relocated|1|||
46829272|NCT00373958|83047350|FG001|Infant Series|Child relocated|0|||
46936021|NCT02737475|83172439|FG020|Overall Study|Death|0|||
46936022|NCT02737475|83172440|FG021|Overall Study|Death|0|||
46936023|NCT02737475|83172441|FG022|Overall Study|Death|0|||
46936024|NCT02737475|83172442|FG023|Overall Study|Death|0|||
46829273|NCT00373958|83047349|FG000|Infant Series|Consent was not received|1|||
47060145|NCT01539083|83339839|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
47060146|NCT01539083|83339840|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
47060147|NCT01539083|83339838|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
47060148|NCT01539083|83339839|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
47060149|NCT01539083|83339840|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
47060150|NCT01539083|83339838|FG000|After Randomization (TP and VTP)|Death|0|||
47060151|NCT01539083|83339839|FG001|After Randomization (TP and VTP)|Death|6|||
47060152|NCT01539083|83339840|FG002|After Randomization (TP and VTP)|Death|11|||
47060153|NCT01537211|83339849|FG000|Overall Study|Lost to Follow-up|0|||
47060154|NCT01537211|83339850|FG001|Overall Study|Lost to Follow-up|1|||
47060155|NCT01537133|83339864|FG000|Overall Study|Withdrawal by Subject|2|||
46829274|NCT00373958|83047350|FG001|Infant Series|Consent was not received|0|||
46829275|NCT00373958|83047349|FG000|Infant Series|Adverse Event|3|||
46829276|NCT00373958|83047350|FG001|Infant Series|Adverse Event|1|||
46829277|NCT00373958|83047349|FG000|Infant Series|Physician Decision|1|||
46829278|NCT00373958|83047350|FG001|Infant Series|Physician Decision|1|||
46829279|NCT00373958|83047349|FG000|Toddler Dose|Lost to Follow-up|5|||
46829280|NCT00373958|83047350|FG001|Toddler Dose|Lost to Follow-up|8|||
47060156|NCT01537133|83339865|FG001|Overall Study|Withdrawal by Subject|0|||
47060157|NCT01537133|83339866|FG002|Overall Study|Withdrawal by Subject|0|||
46764117|NCT00826280|82982358|FG002|Overall Study|Machine Failure|0|||
46764118|NCT00826280|82982356|FG000|Overall Study|One or more non-interpretable scan|0|||
46829281|NCT00373958|83047349|FG000|Toddler Dose|Withdrawal by Subject|2|||
46764119|NCT00826280|82982357|FG001|Overall Study|One or more non-interpretable scan|1|||
46764120|NCT00826280|82982358|FG002|Overall Study|One or more non-interpretable scan|1|||
46764121|NCT00864851|82982369|FG000|Overall Study|Withdrawal by Subject|0|||
46764122|NCT00864851|82982370|FG001|Overall Study|Withdrawal by Subject|1|||
46764123|NCT00864851|82982371|FG002|Overall Study|Withdrawal by Subject|0|||
46764124|NCT00864851|82982369|FG000|Overall Study|Physician Decision|1|||
46829282|NCT00373958|83047350|FG001|Toddler Dose|Withdrawal by Subject|2|||
46764125|NCT00864851|82982370|FG001|Overall Study|Physician Decision|0|||
46764126|NCT00864851|82982371|FG002|Overall Study|Physician Decision|0|||
46764127|NCT00864851|82982369|FG000|Overall Study|Death|1|||
46764128|NCT00864851|82982370|FG001|Overall Study|Death|0|||
46764129|NCT00864851|82982371|FG002|Overall Study|Death|0|||
46829283|NCT00373958|83047349|FG000|Toddler Dose|Failed to return|1|||
46829284|NCT00373958|83047350|FG001|Toddler Dose|Failed to return|2|||
46829285|NCT00373958|83047349|FG000|Toddler Dose|Protocol Violation|0|||
46829286|NCT00373958|83047350|FG001|Toddler Dose|Protocol Violation|1|||
46829287|NCT00373958|83047349|FG000|Toddler Dose|Withdrawn after infant series|22|||
46829288|NCT00373958|83047350|FG001|Toddler Dose|Withdrawn after infant series|25|||
46829289|NCT00373880|83047379|FG000|Overall Study|Physician Decision|3|||
46829290|NCT00373880|83047379|FG000|Overall Study|Arrested|1|||
46829291|NCT00373880|83047379|FG000|Overall Study|Protocol Violation|14|||
46829292|NCT00184600|83047394|FG000|Overall Study|Adverse Event|9|||
46829293|NCT00184600|83047395|FG001|Overall Study|Adverse Event|0|||
46829294|NCT00184600|83047396|FG002|Overall Study|Adverse Event|5|||
46829295|NCT00184600|83047394|FG000|Overall Study|Death|3|||
46829296|NCT00184600|83047395|FG001|Overall Study|Death|9|||
46829297|NCT00184600|83047396|FG002|Overall Study|Death|7|||
46829298|NCT00184600|83047394|FG000|Overall Study|Lack of Efficacy|3|||
46829299|NCT00184600|83047395|FG001|Overall Study|Lack of Efficacy|1|||
46829300|NCT00184600|83047396|FG002|Overall Study|Lack of Efficacy|3|||
46829301|NCT00184600|83047394|FG000|Overall Study|Lost to Follow-up|4|||
46829302|NCT00184600|83047395|FG001|Overall Study|Lost to Follow-up|6|||
46829303|NCT00184600|83047396|FG002|Overall Study|Lost to Follow-up|1|||
46829304|NCT00184600|83047394|FG000|Overall Study|Protocol Violation|2|||
46829305|NCT00184600|83047395|FG001|Overall Study|Protocol Violation|2|||
47060158|NCT01537133|83339867|FG003|Overall Study|Withdrawal by Subject|0|||
47060159|NCT01537133|83339864|FG000|Overall Study|Lost to Follow-up|1|||
47060160|NCT01537133|83339865|FG001|Overall Study|Lost to Follow-up|0|||
46829306|NCT00184600|83047396|FG002|Overall Study|Protocol Violation|3|||
46829307|NCT00184600|83047394|FG000|Overall Study|Withdrawal by Subject|20|||
47060161|NCT01537133|83339866|FG002|Overall Study|Lost to Follow-up|0|||
46764130|NCT00864851|82982369|FG000|Overall Study|Patient uncooperative|1|||
46764131|NCT00864851|82982370|FG001|Overall Study|Patient uncooperative|0|||
46764132|NCT00864851|82982371|FG002|Overall Study|Patient uncooperative|0|||
46764133|NCT00857207|82982383|FG000|Overall Study|Withdrawal by Subject|13|||
46764134|NCT00857207|82982384|FG001|Overall Study|Withdrawal by Subject|0|||
46829308|NCT00184600|83047395|FG001|Overall Study|Withdrawal by Subject|28|||
46829309|NCT00184600|83047396|FG002|Overall Study|Withdrawal by Subject|12|||
46829310|NCT00184600|83047394|FG000|Overall Study|Unclassified|4|||
46829311|NCT00184600|83047395|FG001|Overall Study|Unclassified|5|||
47060162|NCT01537133|83339867|FG003|Overall Study|Lost to Follow-up|0|||
46764135|NCT00857207|82982383|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
46829312|NCT00184600|83047396|FG002|Overall Study|Unclassified|3|||
47060163|NCT01536587|83339875|FG000|Overall Study|Adverse Event|2|||
47060164|NCT01536119|83339881|FG000|Overall Study|Lost to Follow-up|17|||
46764136|NCT00857207|82982384|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
46764137|NCT00857207|82982383|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
46764138|NCT00857207|82982384|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
46764139|NCT00836498|82982393|FG000|Overall Study|Adverse Event|1|||
46764140|NCT00836498|82982394|FG001|Overall Study|Adverse Event|0|||
46764141|NCT00836498|82982393|FG000|Overall Study|Lost to Follow-up|1|||
46764142|NCT00836498|82982394|FG001|Overall Study|Lost to Follow-up|0|||
46764143|NCT00836498|82982393|FG000|Overall Study|Withdrawal by Subject|2|||
46764144|NCT00836498|82982394|FG001|Overall Study|Withdrawal by Subject|1|||
46764145|NCT00856973|82982404|FG000|Overall Study|Adverse Event|5|||
46764146|NCT00856973|82982405|FG001|Overall Study|Adverse Event|5|||
46829313|NCT00265317|83047408|FG000|Lead-In|Objective progression or relapse|6|||
46829314|NCT00265317|83047409|FG001|Lead-In|Objective progression or relapse|11|||
46829315|NCT00265317|83047410|FG002|Lead-In|Objective progression or relapse|0|||
46829316|NCT00265317|83047411|FG003|Lead-In|Objective progression or relapse|0|||
46829317|NCT00265317|83047408|FG000|Lead-In|Adverse Event|2|||
46829318|NCT00265317|83047409|FG001|Lead-In|Adverse Event|1|||
46829319|NCT00265317|83047410|FG002|Lead-In|Adverse Event|0|||
46829320|NCT00265317|83047411|FG003|Lead-In|Adverse Event|0|||
46829321|NCT00265317|83047408|FG000|Lead-In|Death|3|||
46829322|NCT00265317|83047409|FG001|Lead-In|Death|5|||
46829323|NCT00265317|83047410|FG002|Lead-In|Death|0|||
46829324|NCT00265317|83047411|FG003|Lead-In|Death|0|||
46764147|NCT00856973|82982406|FG002|Overall Study|Adverse Event|3|||
46764148|NCT00856973|82982404|FG000|Overall Study|Lost to Follow-up|6|||
46764149|NCT00856973|82982405|FG001|Overall Study|Lost to Follow-up|3|||
46764150|NCT00856973|82982406|FG002|Overall Study|Lost to Follow-up|5|||
46764151|NCT00856973|82982404|FG000|Overall Study|Physician Decision|0|||
46764152|NCT00856973|82982405|FG001|Overall Study|Physician Decision|3|||
46764153|NCT00856973|82982406|FG002|Overall Study|Physician Decision|1|||
46764154|NCT00856973|82982404|FG000|Overall Study|Protocol Violation|1|||
46764155|NCT00856973|82982405|FG001|Overall Study|Protocol Violation|2|||
46764156|NCT00856973|82982406|FG002|Overall Study|Protocol Violation|1|||
46764157|NCT00856973|82982404|FG000|Overall Study|Withdrawal by Subject|13|||
46829325|NCT00265317|83047408|FG000|Lead-In|Withdrawal/other than adverse event|1|||
46829326|NCT00265317|83047409|FG001|Lead-In|Withdrawal/other than adverse event|0|||
46829327|NCT00265317|83047410|FG002|Lead-In|Withdrawal/other than adverse event|0|||
46829328|NCT00265317|83047411|FG003|Lead-In|Withdrawal/other than adverse event|0|||
46829329|NCT00265317|83047408|FG000|Phase 2|Objective progression or relapse|0|||
46829330|NCT00265317|83047409|FG001|Phase 2|Objective progression or relapse|0|||
46829331|NCT00265317|83047410|FG002|Phase 2|Objective progression or relapse|37|||
46829332|NCT00265317|83047411|FG003|Phase 2|Objective progression or relapse|38|||
46829333|NCT00265317|83047408|FG000|Phase 2|Global deterioration of health status|0|||
46829334|NCT00265317|83047409|FG001|Phase 2|Global deterioration of health status|0|||
46829335|NCT00265317|83047410|FG002|Phase 2|Global deterioration of health status|3|||
46829336|NCT00265317|83047411|FG003|Phase 2|Global deterioration of health status|0|||
46936025|NCT02737475|83172443|FG024|Overall Study|Death|0|||
46936026|NCT02737475|83172444|FG025|Overall Study|Death|0|||
46936027|NCT02737475|83172445|FG026|Overall Study|Death|0|||
46936028|NCT02737475|83172419|FG000|Overall Study|Participant withdrew consent|0|||
46936029|NCT02737475|83172420|FG001|Overall Study|Participant withdrew consent|0|||
46936030|NCT02737475|83172421|FG002|Overall Study|Participant withdrew consent|0|||
46936031|NCT02737475|83172422|FG003|Overall Study|Participant withdrew consent|0|||
46936032|NCT02737475|83172423|FG004|Overall Study|Participant withdrew consent|0|||
46936033|NCT02737475|83172424|FG005|Overall Study|Participant withdrew consent|2|||
46936034|NCT02737475|83172425|FG006|Overall Study|Participant withdrew consent|0|||
46936035|NCT02737475|83172426|FG007|Overall Study|Participant withdrew consent|0|||
46936036|NCT02737475|83172427|FG008|Overall Study|Participant withdrew consent|0|||
46936037|NCT02737475|83172428|FG009|Overall Study|Participant withdrew consent|0|||
46936038|NCT02737475|83172429|FG010|Overall Study|Participant withdrew consent|0|||
46936039|NCT02737475|83172430|FG011|Overall Study|Participant withdrew consent|0|||
46936040|NCT02737475|83172431|FG012|Overall Study|Participant withdrew consent|0|||
46936041|NCT02737475|83172432|FG013|Overall Study|Participant withdrew consent|0|||
46936042|NCT02737475|83172433|FG014|Overall Study|Participant withdrew consent|1|||
46936043|NCT02737475|83172434|FG015|Overall Study|Participant withdrew consent|0|||
46936044|NCT02737475|83172435|FG016|Overall Study|Participant withdrew consent|0|||
46936045|NCT02737475|83172436|FG017|Overall Study|Participant withdrew consent|2|||
46936046|NCT02737475|83172437|FG018|Overall Study|Participant withdrew consent|1|||
46764158|NCT00856973|82982405|FG001|Overall Study|Withdrawal by Subject|16|||
46829337|NCT00265317|83047408|FG000|Phase 2|Adverse Event|0|||
46936047|NCT02737475|83172438|FG019|Overall Study|Participant withdrew consent|0|||
46936048|NCT02737475|83172439|FG020|Overall Study|Participant withdrew consent|2|||
46936049|NCT02737475|83172440|FG021|Overall Study|Participant withdrew consent|0|||
46829338|NCT00265317|83047409|FG001|Phase 2|Adverse Event|0|||
46829339|NCT00265317|83047410|FG002|Phase 2|Adverse Event|7|||
46829340|NCT00265317|83047411|FG003|Phase 2|Adverse Event|5|||
46829341|NCT00265317|83047408|FG000|Phase 2|Death|0|||
46829342|NCT00265317|83047409|FG001|Phase 2|Death|0|||
46829343|NCT00265317|83047410|FG002|Phase 2|Death|12|||
46829344|NCT00265317|83047411|FG003|Phase 2|Death|15|||
46829345|NCT00265317|83047408|FG000|Phase 2|Protocol Violation|0|||
46829346|NCT00265317|83047409|FG001|Phase 2|Protocol Violation|0|||
46829347|NCT00265317|83047410|FG002|Phase 2|Protocol Violation|1|||
46829348|NCT00265317|83047411|FG003|Phase 2|Protocol Violation|4|||
46829349|NCT00265317|83047408|FG000|Phase 2|Lost to Follow-up|0|||
46829350|NCT00265317|83047409|FG001|Phase 2|Lost to Follow-up|0|||
46829351|NCT00265317|83047410|FG002|Phase 2|Lost to Follow-up|0|||
46829352|NCT00265317|83047411|FG003|Phase 2|Lost to Follow-up|1|||
46829353|NCT00265317|83047408|FG000|Phase 2|Withdrawal/other than adverse event|0|||
46829354|NCT00265317|83047409|FG001|Phase 2|Withdrawal/other than adverse event|0|||
46829355|NCT00265317|83047410|FG002|Phase 2|Withdrawal/other than adverse event|2|||
46829356|NCT00265317|83047411|FG003|Phase 2|Withdrawal/other than adverse event|1|||
46829357|NCT00265317|83047408|FG000|Phase 2|Study terminated by sponsor|0|||
46829358|NCT00265317|83047409|FG001|Phase 2|Study terminated by sponsor|0|||
46829359|NCT00265317|83047410|FG002|Phase 2|Study terminated by sponsor|1|||
46829360|NCT00265317|83047411|FG003|Phase 2|Study terminated by sponsor|0|||
47060165|NCT01536119|83339882|FG001|Overall Study|Lost to Follow-up|14|||
47060166|NCT01535729|83339888|FG000|Overall Study|Withdrawal by Subject|2|||
47060167|NCT01535729|83339888|FG000|Overall Study|Disease progression|230|||
47060168|NCT01535729|83339888|FG000|Overall Study|Discontinued treatment|25|||
47060169|NCT01535729|83339888|FG000|Overall Study|Lost to Follow-up|8|||
47060170|NCT01535729|83339888|FG000|Overall Study|Death|52|||
47060171|NCT01535729|83339888|FG000|Overall Study|Other|19|||
47060172|NCT01535729|83339888|FG000|Overall Study|Did not sign informed consent|1|||
47060173|NCT01535729|83339888|FG000|Overall Study|No previous chemotherapy|33|||
46764159|NCT00856973|82982406|FG002|Overall Study|Withdrawal by Subject|15|||
46764160|NCT00856973|82982404|FG000|Overall Study|Other|11|||
46764161|NCT00856973|82982405|FG001|Overall Study|Other|12|||
46764162|NCT00856973|82982406|FG002|Overall Study|Other|13|||
46764163|NCT00844532|82982418|FG000|Overall Study|Death|16|||
46764164|NCT00844532|82982418|FG000|Overall Study|Withdrawal by Subject|16|||
46764165|NCT00844532|82982418|FG000|Overall Study|Lost to Follow-up|7|||
46829361|NCT00265317|83047408|FG000|Phase 2|Other|0|||
46764166|NCT00805194|82982424|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
46764167|NCT00805194|82982425|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
46764168|NCT00805194|82982424|FG000|Overall Study|Worsening or AE of underlying disease|64|||
46764169|NCT00805194|82982425|FG001|Overall Study|Worsening or AE of underlying disease|70|||
46764170|NCT00805194|82982424|FG000|Overall Study|Other AE|84|||
46764171|NCT00805194|82982425|FG001|Overall Study|Other AE|73|||
46764172|NCT00805194|82982424|FG000|Overall Study|Protocol Violation|9|||
46764173|NCT00805194|82982425|FG001|Overall Study|Protocol Violation|9|||
46829362|NCT00265317|83047409|FG001|Phase 2|Other|0|||
46829363|NCT00265317|83047410|FG002|Phase 2|Other|1|||
46829364|NCT00265317|83047411|FG003|Phase 2|Other|1|||
46829365|NCT00373490|83047432|FG000|Overall Study|Adverse Event|0|||
46829366|NCT00373490|83047433|FG001|Overall Study|Adverse Event|1|||
46829367|NCT00373490|83047432|FG000|Overall Study|Lack of Efficacy|9|||
46829368|NCT00373490|83047433|FG001|Overall Study|Lack of Efficacy|4|||
46936050|NCT02737475|83172441|FG022|Overall Study|Participant withdrew consent|0|||
46936051|NCT02737475|83172442|FG023|Overall Study|Participant withdrew consent|0|||
46936052|NCT02737475|83172443|FG024|Overall Study|Participant withdrew consent|0|||
47060174|NCT01535729|83339888|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
47060175|NCT01535729|83339888|FG000|Overall Study|Protocol Violation|11|||
47060176|NCT01535729|83339888|FG000|Overall Study|Screening failure|1|||
46829369|NCT00373490|83047432|FG000|Overall Study|Withdrawal by Subject|0|||
46764174|NCT00805194|82982424|FG000|Overall Study|Lost to Follow-up|5|||
46764175|NCT00805194|82982425|FG001|Overall Study|Lost to Follow-up|5|||
46829370|NCT00373490|83047433|FG001|Overall Study|Withdrawal by Subject|1|||
46829371|NCT00251589|83047443|FG000|Overall Study|Adverse Event|5|||
46829372|NCT00251589|83047444|FG001|Overall Study|Adverse Event|1|||
46936053|NCT02737475|83172444|FG025|Overall Study|Participant withdrew consent|0|||
47060177|NCT01535729|83339888|FG000|Overall Study|Not treated|9|||
46764176|NCT00805194|82982424|FG000|Overall Study|Withdrawal by Subject|60|||
46829373|NCT00251589|83047445|FG002|Overall Study|Adverse Event|2|||
46829374|NCT00251589|83047446|FG003|Overall Study|Adverse Event|1|||
46829375|NCT00251589|83047443|FG000|Overall Study|Withdrawal by Subject|1|||
46829376|NCT00251589|83047444|FG001|Overall Study|Withdrawal by Subject|1|||
46829377|NCT00251589|83047445|FG002|Overall Study|Withdrawal by Subject|0|||
46829378|NCT00251589|83047446|FG003|Overall Study|Withdrawal by Subject|0|||
46829379|NCT00251589|83047443|FG000|Overall Study|Discontinued due to progressive disease|9|||
46829380|NCT00251589|83047444|FG001|Overall Study|Discontinued due to progressive disease|1|||
46829381|NCT00251589|83047445|FG002|Overall Study|Discontinued due to progressive disease|0|||
46829382|NCT00251589|83047446|FG003|Overall Study|Discontinued due to progressive disease|1|||
46829383|NCT00265239|83047458|FG000|Overall Study|Adverse Event|2|||
46829384|NCT00265239|83047459|FG001|Overall Study|Adverse Event|1|||
46829385|NCT00350298|83047467|FG000|Overall Study|Death|7|||
46829386|NCT00350298|83047468|FG001|Overall Study|Death|8|||
46829387|NCT00350298|83047467|FG000|Overall Study|Lost to Follow-up|1|||
46829388|NCT00350298|83047468|FG001|Overall Study|Lost to Follow-up|2|||
46829389|NCT00350298|83047467|FG000|Overall Study|Withdrawal by Subject|1|||
46829390|NCT00350298|83047468|FG001|Overall Study|Withdrawal by Subject|3|||
46829391|NCT00159874|83047481|FG000|Overall Study|Adverse Event|2|||
46829392|NCT00159874|83047482|FG001|Overall Study|Adverse Event|2|||
46829393|NCT00159874|83047483|FG002|Overall Study|Adverse Event|5|||
46829394|NCT00159874|83047484|FG003|Overall Study|Adverse Event|1|||
46829395|NCT00159874|83047485|FG004|Overall Study|Adverse Event|1|||
46829396|NCT00159874|83047486|FG005|Overall Study|Adverse Event|2|||
46829397|NCT00159874|83047487|FG006|Overall Study|Adverse Event|0|||
46829398|NCT00159874|83047481|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
46829399|NCT00159874|83047482|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
46829400|NCT00159874|83047483|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
46829401|NCT00159874|83047484|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
46829402|NCT00159874|83047485|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
46936054|NCT02737475|83172445|FG026|Overall Study|Participant withdrew consent|0|||
46936055|NCT02737475|83172419|FG000|Overall Study|Lost to Follow-up|0|||
46936056|NCT02737475|83172420|FG001|Overall Study|Lost to Follow-up|0|||
46936057|NCT02737475|83172421|FG002|Overall Study|Lost to Follow-up|0|||
47060178|NCT01535729|83339888|FG000|Overall Study|No participant record available|5|||
47060179|NCT01535261|83339892|FG000|Overall Study|Physician Decision|8|||
47060180|NCT01535261|83339892|FG000|Overall Study|Protocol Violation|3|||
47060181|NCT01535261|83339892|FG000|Overall Study|Death|5|||
47060182|NCT01535261|83339892|FG000|Overall Study|Lost to Follow-up|8|||
47060183|NCT01535261|83339892|FG000|Overall Study|Withdrawal by Subject|14|||
47060184|NCT01535261|83339892|FG000|Overall Study|Adverse Event|12|||
47060185|NCT01534637|83339896|FG000|Overall Study|Physician Decision|3|||
47060186|NCT01534637|83339896|FG000|Overall Study|Lack of Efficacy|3|||
46764177|NCT00805194|82982425|FG001|Overall Study|Withdrawal by Subject|42|||
46764178|NCT00805194|82982424|FG000|Overall Study|Not treated|3|||
46764179|NCT00805194|82982425|FG001|Overall Study|Not treated|4|||
46764180|NCT00805194|82982424|FG000|Overall Study|Reasons other than stated above|20|||
46764181|NCT00805194|82982425|FG001|Overall Study|Reasons other than stated above|16|||
46764182|NCT00836186|82982436|FG000|Overall Study|Blood could not be drawn|1|||
46764183|NCT00657046|82982444|FG000|Overall Study|Adverse Event|1|||
46764184|NCT00657046|82982445|FG001|Overall Study|Adverse Event|1|||
46764185|NCT00657046|82982446|FG002|Overall Study|Adverse Event|0|||
46764186|NCT00657046|82982444|FG000|Overall Study|Protocol Violation|2|||
46764187|NCT00657046|82982445|FG001|Overall Study|Protocol Violation|2|||
46764188|NCT00657046|82982446|FG002|Overall Study|Protocol Violation|0|||
46764189|NCT00657046|82982444|FG000|Overall Study|Withdrawal by Subject|1|||
46764190|NCT00657046|82982445|FG001|Overall Study|Withdrawal by Subject|0|||
46764191|NCT00657046|82982446|FG002|Overall Study|Withdrawal by Subject|0|||
46936058|NCT02737475|83172422|FG003|Overall Study|Lost to Follow-up|0|||
46936059|NCT02737475|83172423|FG004|Overall Study|Lost to Follow-up|0|||
46936060|NCT02737475|83172424|FG005|Overall Study|Lost to Follow-up|0|||
46936061|NCT02737475|83172425|FG006|Overall Study|Lost to Follow-up|0|||
46936062|NCT02737475|83172426|FG007|Overall Study|Lost to Follow-up|0|||
46764192|NCT00657046|82982444|FG000|Overall Study|Death|0|||
46829403|NCT00159874|83047486|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
46936063|NCT02737475|83172427|FG008|Overall Study|Lost to Follow-up|0|||
46829404|NCT00159874|83047487|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
46829405|NCT00159874|83047481|FG000|Overall Study|Lack of Efficacy|2|||
46936064|NCT02737475|83172428|FG009|Overall Study|Lost to Follow-up|0|||
46936065|NCT02737475|83172429|FG010|Overall Study|Lost to Follow-up|0|||
46936066|NCT02737475|83172430|FG011|Overall Study|Lost to Follow-up|0|||
47060187|NCT01534637|83339896|FG000|Overall Study|Withdrawal by Subject|1|||
46829406|NCT00159874|83047482|FG001|Overall Study|Lack of Efficacy|0|||
46829407|NCT00159874|83047483|FG002|Overall Study|Lack of Efficacy|1|||
46829408|NCT00159874|83047484|FG003|Overall Study|Lack of Efficacy|1|||
46829409|NCT00159874|83047485|FG004|Overall Study|Lack of Efficacy|0|||
46829410|NCT00159874|83047486|FG005|Overall Study|Lack of Efficacy|3|||
46829411|NCT00159874|83047487|FG006|Overall Study|Lack of Efficacy|0|||
46829412|NCT00159874|83047481|FG000|Overall Study|Lost to Follow-up|1|||
46829413|NCT00159874|83047482|FG001|Overall Study|Lost to Follow-up|0|||
47060188|NCT01534637|83339896|FG000|Overall Study|Adverse Event|1|||
47060189|NCT01534637|83339896|FG000|Overall Study|Liver Mets before treatment|1|||
47060190|NCT02655016|83339902|FG000|Overall Study|Disease progression|6|||
46764193|NCT00657046|82982445|FG001|Overall Study|Death|0|||
46764194|NCT00657046|82982446|FG002|Overall Study|Death|1|||
46829414|NCT00159874|83047483|FG002|Overall Study|Lost to Follow-up|3|||
46829415|NCT00159874|83047484|FG003|Overall Study|Lost to Follow-up|0|||
46936067|NCT02737475|83172431|FG012|Overall Study|Lost to Follow-up|0|||
46764195|NCT00657046|82982444|FG000|Overall Study|Surgery|0|||
46829416|NCT00159874|83047485|FG004|Overall Study|Lost to Follow-up|1|||
46829417|NCT00159874|83047486|FG005|Overall Study|Lost to Follow-up|2|||
46829418|NCT00159874|83047487|FG006|Overall Study|Lost to Follow-up|1|||
46829419|NCT00159874|83047481|FG000|Overall Study|Other|8|||
46829420|NCT00159874|83047482|FG001|Overall Study|Other|8|||
46829421|NCT00159874|83047483|FG002|Overall Study|Other|8|||
46829422|NCT00159874|83047484|FG003|Overall Study|Other|0|||
46829423|NCT00159874|83047485|FG004|Overall Study|Other|2|||
46829424|NCT00159874|83047486|FG005|Overall Study|Other|1|||
46829425|NCT00159874|83047487|FG006|Overall Study|Other|3|||
46829426|NCT00159874|83047481|FG000|Overall Study|Protocol Violation|0|||
46829427|NCT00159874|83047482|FG001|Overall Study|Protocol Violation|5|||
46829428|NCT00159874|83047483|FG002|Overall Study|Protocol Violation|2|||
46829429|NCT00159874|83047484|FG003|Overall Study|Protocol Violation|0|||
46829430|NCT00159874|83047485|FG004|Overall Study|Protocol Violation|0|||
46829431|NCT00159874|83047486|FG005|Overall Study|Protocol Violation|0|||
46829432|NCT00159874|83047487|FG006|Overall Study|Protocol Violation|0|||
46936068|NCT02737475|83172432|FG013|Overall Study|Lost to Follow-up|0|||
46936069|NCT02737475|83172433|FG014|Overall Study|Lost to Follow-up|0|||
47060191|NCT02655016|83339903|FG001|Overall Study|Disease progression|4|||
46764196|NCT00657046|82982445|FG001|Overall Study|Surgery|0|||
46764197|NCT00657046|82982446|FG002|Overall Study|Surgery|1|||
46764198|NCT00856661|82982456|FG000|Overall Study|Death|15|||
46764199|NCT00856661|82982457|FG001|Overall Study|Death|18|||
46764200|NCT00856661|82982456|FG000|Overall Study|Protocol Violation|2|||
46764201|NCT00856661|82982457|FG001|Overall Study|Protocol Violation|1|||
46764202|NCT00856661|82982456|FG000|Overall Study|Withdrawal by Subject|1|||
46764203|NCT00856661|82982457|FG001|Overall Study|Withdrawal by Subject|2|||
46764204|NCT00856661|82982456|FG000|Overall Study|Lost to Follow-up|1|||
46764205|NCT00856661|82982457|FG001|Overall Study|Lost to Follow-up|3|||
46764206|NCT00856661|82982456|FG000|Overall Study|Physician Judgement|8|||
46764207|NCT00856661|82982457|FG001|Overall Study|Physician Judgement|5|||
46764208|NCT00844376|82982463|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
46764209|NCT00844376|82982464|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
46764210|NCT00658606|82982472|FG000|Overall Study|Adverse Event|2|||
46764211|NCT00658606|82982473|FG001|Overall Study|Adverse Event|1|||
46764212|NCT00658606|82982472|FG000|Overall Study|Lack of Efficacy|6|||
46764213|NCT00658606|82982473|FG001|Overall Study|Lack of Efficacy|3|||
46764214|NCT00658606|82982472|FG000|Overall Study|Lost to Follow-up|1|||
46764215|NCT00658606|82982473|FG001|Overall Study|Lost to Follow-up|0|||
46764216|NCT00658606|82982472|FG000|Overall Study|Withdrawal by Subject|7|||
46764217|NCT00658606|82982473|FG001|Overall Study|Withdrawal by Subject|16|||
46764218|NCT00658606|82982472|FG000|Overall Study|Lack of Compliance|0|||
46764219|NCT00658606|82982473|FG001|Overall Study|Lack of Compliance|3|||
46764220|NCT00589290|82982479|FG000|Overall Study|Withdrawal by Subject|1|||
46764221|NCT00843518|82982487|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
47060192|NCT02655016|83339902|FG000|Overall Study|Site closed|0|||
46764222|NCT00843518|82982488|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
46764223|NCT00843518|82982487|FG000|Period 2 (Double-blind Treatment)|Death|0|||
46829433|NCT00159874|83047481|FG000|Overall Study|Death|3|||
46829434|NCT00159874|83047482|FG001|Overall Study|Death|8|||
46936070|NCT02737475|83172434|FG015|Overall Study|Lost to Follow-up|1|||
46764224|NCT00843518|82982488|FG001|Period 2 (Double-blind Treatment)|Death|1|||
46764225|NCT00843518|82982487|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
46829435|NCT00159874|83047483|FG002|Overall Study|Death|15|||
46829436|NCT00159874|83047484|FG003|Overall Study|Death|0|||
46829437|NCT00159874|83047485|FG004|Overall Study|Death|1|||
46829438|NCT00159874|83047486|FG005|Overall Study|Death|2|||
46829439|NCT00159874|83047487|FG006|Overall Study|Death|0|||
46829440|NCT00159874|83047481|FG000|Overall Study|Withdrawal by Subject|2|||
46829441|NCT00159874|83047482|FG001|Overall Study|Withdrawal by Subject|6|||
46829442|NCT00159874|83047483|FG002|Overall Study|Withdrawal by Subject|8|||
46936071|NCT02737475|83172435|FG016|Overall Study|Lost to Follow-up|0|||
47060193|NCT02655016|83339903|FG001|Overall Study|Site closed|1|||
46829443|NCT00159874|83047484|FG003|Overall Study|Withdrawal by Subject|4|||
46829444|NCT00159874|83047485|FG004|Overall Study|Withdrawal by Subject|3|||
46829445|NCT00159874|83047486|FG005|Overall Study|Withdrawal by Subject|2|||
46829446|NCT00159874|83047487|FG006|Overall Study|Withdrawal by Subject|1|||
46829447|NCT00159874|83047481|FG000|Overall Study|Pregnancy|1|||
46829448|NCT00159874|83047482|FG001|Overall Study|Pregnancy|1|||
46829449|NCT00159874|83047483|FG002|Overall Study|Pregnancy|0|||
46829450|NCT00159874|83047484|FG003|Overall Study|Pregnancy|0|||
47060194|NCT02655016|83339902|FG000|Overall Study|Death|30|||
46764226|NCT00843518|82982488|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
46829451|NCT00159874|83047485|FG004|Overall Study|Pregnancy|0|||
46829452|NCT00159874|83047486|FG005|Overall Study|Pregnancy|0|||
46829453|NCT00159874|83047487|FG006|Overall Study|Pregnancy|0|||
46829454|NCT00349908|83047505|FG000|Overall Study|Withdrawal by Subject|0|||
46829455|NCT00349908|83047506|FG001|Overall Study|Withdrawal by Subject|4|||
46829456|NCT00184054|83047513|FG000|Overall Study|Adverse Event|1|||
46829457|NCT00183430|83047519|FG000|Overall Study|Adverse Event|1|||
46829458|NCT00183430|83047520|FG001|Overall Study|Adverse Event|0|||
46829459|NCT00183430|83047519|FG000|Overall Study|Lost to Follow-up|3|||
46829460|NCT00183430|83047520|FG001|Overall Study|Lost to Follow-up|0|||
46829461|NCT00183430|83047519|FG000|Overall Study|did not meet inclusion criteria|1|||
46829462|NCT00183430|83047520|FG001|Overall Study|did not meet inclusion criteria|0|||
46829463|NCT00183430|83047519|FG000|Overall Study|Withdrawal by Subject|1|||
46829464|NCT00183430|83047520|FG001|Overall Study|Withdrawal by Subject|0|||
46829465|NCT00183274|83047526|FG000|Phase 1: Open-Label|Adverse Event|31|||
46829466|NCT00183274|83047527|FG001|Phase 1: Open-Label|Adverse Event|0|||
46829467|NCT00183274|83047528|FG002|Phase 1: Open-Label|Adverse Event|0|||
46829468|NCT00183274|83047529|FG003|Phase 1: Open-Label|Adverse Event|0|||
46829469|NCT00183274|83047530|FG004|Phase 1: Open-Label|Adverse Event|0|||
46829470|NCT00183274|83047531|FG005|Phase 1: Open-Label|Adverse Event|0|||
46829471|NCT00183274|83047526|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
46829472|NCT00183274|83047527|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
46829473|NCT00183274|83047528|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
46829474|NCT00183274|83047529|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
46829475|NCT00183274|83047530|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
46829476|NCT00183274|83047531|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
46829477|NCT00183274|83047526|FG000|Phase 1: Open-Label|Protocol Violation|11|||
46829478|NCT00183274|83047527|FG001|Phase 1: Open-Label|Protocol Violation|0|||
46829479|NCT00183274|83047528|FG002|Phase 1: Open-Label|Protocol Violation|0|||
46829480|NCT00183274|83047529|FG003|Phase 1: Open-Label|Protocol Violation|0|||
46829481|NCT00183274|83047530|FG004|Phase 1: Open-Label|Protocol Violation|0|||
46829482|NCT00183274|83047531|FG005|Phase 1: Open-Label|Protocol Violation|0|||
46829483|NCT00183274|83047526|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
46829484|NCT00183274|83047527|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
46829485|NCT00183274|83047528|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
46829486|NCT00183274|83047529|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
46829487|NCT00183274|83047530|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
46936072|NCT02737475|83172436|FG017|Overall Study|Lost to Follow-up|0|||
46936073|NCT02737475|83172437|FG018|Overall Study|Lost to Follow-up|0|||
46936074|NCT02737475|83172438|FG019|Overall Study|Lost to Follow-up|0|||
46936075|NCT02737475|83172439|FG020|Overall Study|Lost to Follow-up|0|||
46936076|NCT02737475|83172440|FG021|Overall Study|Lost to Follow-up|0|||
46764227|NCT00843518|82982487|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
46936077|NCT02737475|83172441|FG022|Overall Study|Lost to Follow-up|0|||
47060195|NCT02655016|83339903|FG001|Overall Study|Death|48|||
46637546|NCT01474512|82811381|FG005|Maintenance Period|Adverse Event|7|||
46764228|NCT00843518|82982488|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
46764229|NCT00843518|82982487|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
46764230|NCT00843518|82982488|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
46764231|NCT00843518|82982487|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
46764232|NCT00843518|82982488|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
46764233|NCT00843518|82982487|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
46764234|NCT00843518|82982488|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
46764235|NCT00843284|82982498|FG000|Overall Study|Adverse Event|39|||
46764236|NCT00843284|82982498|FG000|Overall Study|Lack of Efficacy|5|||
46764237|NCT00843284|82982498|FG000|Overall Study|Lost to Follow-up|11|||
46764238|NCT00843284|82982498|FG000|Overall Study|Other|10|||
46829488|NCT00183274|83047531|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
46829489|NCT00183274|83047526|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
46829490|NCT00183274|83047527|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
46829491|NCT00183274|83047528|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
46829492|NCT00183274|83047529|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
46829493|NCT00183274|83047530|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
46829494|NCT00183274|83047531|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
46829495|NCT00183274|83047526|FG000|Phase 1: Open-Label|Other|9|||
46829496|NCT00183274|83047527|FG001|Phase 1: Open-Label|Other|0|||
47060196|NCT02655016|83339902|FG000|Overall Study|Lost to Follow-up|1|||
46829497|NCT00183274|83047528|FG002|Phase 1: Open-Label|Other|0|||
46829498|NCT00183274|83047529|FG003|Phase 1: Open-Label|Other|0|||
46829499|NCT00183274|83047530|FG004|Phase 1: Open-Label|Other|0|||
46829500|NCT00183274|83047531|FG005|Phase 1: Open-Label|Other|0|||
46829501|NCT00183274|83047526|FG000|Phase 2: Double-Blind|Relapsed|0|||
46829502|NCT00183274|83047527|FG001|Phase 2: Double-Blind|Relapsed|8|||
47060197|NCT02655016|83339903|FG001|Overall Study|Lost to Follow-up|1|||
47060198|NCT02655016|83339902|FG000|Overall Study|Withdrawal by Subject|18|||
47060199|NCT02655016|83339903|FG001|Overall Study|Withdrawal by Subject|36|||
47060200|NCT01533935|83339910|FG000|Overall Study|Adverse Event|5|||
47060201|NCT01533935|83339911|FG001|Overall Study|Adverse Event|7|||
47060202|NCT01533935|83339912|FG002|Overall Study|Adverse Event|1|||
47060203|NCT01533935|83339913|FG003|Overall Study|Adverse Event|5|||
47060204|NCT01533935|83339914|FG004|Overall Study|Adverse Event|3|||
46829503|NCT00183274|83047528|FG002|Phase 2: Double-Blind|Relapsed|29|||
46829504|NCT00183274|83047529|FG003|Phase 2: Double-Blind|Relapsed|0|||
46829505|NCT00183274|83047530|FG004|Phase 2: Double-Blind|Relapsed|0|||
46829506|NCT00183274|83047531|FG005|Phase 2: Double-Blind|Relapsed|0|||
46829507|NCT00183274|83047526|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
46829508|NCT00183274|83047527|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
46829509|NCT00183274|83047528|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
46829510|NCT00183274|83047529|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
46764239|NCT00843284|82982498|FG000|Overall Study|Withdrawal by Subject|4|||
46764240|NCT00843284|82982498|FG000|Overall Study|Death|3|||
46764241|NCT00652834|82982515|FG000|Overall Study|Withdrawal by Subject|3|||
46764242|NCT00652834|82982515|FG000|Overall Study|Lost to Follow-up|2|||
46764243|NCT00825812|82982523|FG000|Overall Study|Never entered follow up|0|||
46764244|NCT00825812|82982524|FG001|Overall Study|Never entered follow up|0|||
46764245|NCT00825812|82982525|FG002|Overall Study|Never entered follow up|0|||
46764246|NCT00825812|82982526|FG003|Overall Study|Never entered follow up|1|||
46764247|NCT00825812|82982523|FG000|Overall Study|Adverse Event|0|||
46764248|NCT00825812|82982524|FG001|Overall Study|Adverse Event|0|||
46764249|NCT00825812|82982525|FG002|Overall Study|Adverse Event|0|||
46764250|NCT00825812|82982526|FG003|Overall Study|Adverse Event|1|||
46764251|NCT00825812|82982523|FG000|Overall Study|Subject withdrew consent|0|||
46764252|NCT00825812|82982524|FG001|Overall Study|Subject withdrew consent|0|||
46764253|NCT00825812|82982525|FG002|Overall Study|Subject withdrew consent|3|||
46764254|NCT00825812|82982526|FG003|Overall Study|Subject withdrew consent|2|||
46764255|NCT00825812|82982523|FG000|Overall Study|Non-compliance with protocol|0|||
46764256|NCT00825812|82982524|FG001|Overall Study|Non-compliance with protocol|0|||
46764257|NCT00825812|82982525|FG002|Overall Study|Non-compliance with protocol|0|||
46764258|NCT00825812|82982526|FG003|Overall Study|Non-compliance with protocol|1|||
46764259|NCT00825812|82982523|FG000|Overall Study|Administrative|0|||
46764260|NCT00825812|82982524|FG001|Overall Study|Administrative|1|||
46764261|NCT00825812|82982525|FG002|Overall Study|Administrative|3|||
46764262|NCT00825812|82982526|FG003|Overall Study|Administrative|5|||
46764263|NCT00824720|82982539|FG000|Overall Study|failed plug insertion|3|||
46764264|NCT00824720|82982540|FG001|Overall Study|failed plug insertion|1|||
46764265|NCT00824720|82982541|FG002|Overall Study|failed plug insertion|0|||
46764266|NCT00824720|82982539|FG000|Overall Study|Protocol Violation|0|||
46764267|NCT00824720|82982540|FG001|Overall Study|Protocol Violation|0|||
46637547|NCT01474512|82811382|FG006|Maintenance Period|Adverse Event|0|||
46764268|NCT00824720|82982541|FG002|Overall Study|Protocol Violation|1|||
46764269|NCT03704064|82982551|FG000|Overall Study|Lost to Follow-up|8|||
46764270|NCT03704064|82982552|FG001|Overall Study|Lost to Follow-up|4|||
46764271|NCT03704064|82982551|FG000|Overall Study|Withdrawal by Subject|1|||
46764272|NCT03704064|82982552|FG001|Overall Study|Withdrawal by Subject|1|||
46764273|NCT03704064|82982551|FG000|Overall Study|No longer available for study visits|0|||
46764274|NCT03704064|82982552|FG001|Overall Study|No longer available for study visits|1|||
46764275|NCT03704064|82982551|FG000|Overall Study|Censoring event|1|||
46829511|NCT00183274|83047530|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
46829512|NCT00183274|83047531|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
47060205|NCT01533935|83339910|FG000|Overall Study|Protocol Violation|0|||
47060206|NCT01533935|83339911|FG001|Overall Study|Protocol Violation|2|||
46829513|NCT00183274|83047526|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
46829514|NCT00183274|83047527|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
46829515|NCT00183274|83047528|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
46829516|NCT00183274|83047529|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
46829517|NCT00183274|83047530|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
46829518|NCT00183274|83047531|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
46829519|NCT00183274|83047526|FG000|Phase 3: Double-Blind|Relapsed|0|||
46829520|NCT00183274|83047527|FG001|Phase 3: Double-Blind|Relapsed|0|||
46829521|NCT00183274|83047528|FG002|Phase 3: Double-Blind|Relapsed|0|||
46829522|NCT00183274|83047529|FG003|Phase 3: Double-Blind|Relapsed|1|||
46829523|NCT00183274|83047530|FG004|Phase 3: Double-Blind|Relapsed|11|||
46829524|NCT00183274|83047531|FG005|Phase 3: Double-Blind|Relapsed|2|||
46829525|NCT00183196|83047549|FG000|Overall Study|Withdrawal by Subject|18|||
46829526|NCT00183196|83047550|FG001|Overall Study|Withdrawal by Subject|11|||
46829527|NCT00183196|83047551|FG002|Overall Study|Withdrawal by Subject|13|||
46829528|NCT00183196|83047549|FG000|Overall Study|Adverse Event|1|||
46829529|NCT00183196|83047550|FG001|Overall Study|Adverse Event|2|||
46829530|NCT00183196|83047551|FG002|Overall Study|Adverse Event|2|||
46829531|NCT00183196|83047549|FG000|Overall Study|Legal event|1|||
46829532|NCT00183196|83047550|FG001|Overall Study|Legal event|1|||
46829533|NCT00183196|83047551|FG002|Overall Study|Legal event|1|||
46829534|NCT00183196|83047549|FG000|Overall Study|Required more intensive care|0|||
46936078|NCT02737475|83172442|FG023|Overall Study|Lost to Follow-up|0|||
46936079|NCT02737475|83172443|FG024|Overall Study|Lost to Follow-up|0|||
46936080|NCT02737475|83172444|FG025|Overall Study|Lost to Follow-up|0|||
46936081|NCT02737475|83172445|FG026|Overall Study|Lost to Follow-up|0|||
46936082|NCT02737475|83172419|FG000|Overall Study|Disease Progression|0|||
46936083|NCT02737475|83172420|FG001|Overall Study|Disease Progression|0|||
46936084|NCT02737475|83172421|FG002|Overall Study|Disease Progression|0|||
46936085|NCT02737475|83172422|FG003|Overall Study|Disease Progression|0|||
46936086|NCT02737475|83172423|FG004|Overall Study|Disease Progression|0|||
46936087|NCT02737475|83172424|FG005|Overall Study|Disease Progression|0|||
46936088|NCT02737475|83172425|FG006|Overall Study|Disease Progression|0|||
46936089|NCT02737475|83172426|FG007|Overall Study|Disease Progression|0|||
46936090|NCT02737475|83172427|FG008|Overall Study|Disease Progression|0|||
46936091|NCT02737475|83172428|FG009|Overall Study|Disease Progression|0|||
46936092|NCT02737475|83172429|FG010|Overall Study|Disease Progression|0|||
46936093|NCT02737475|83172430|FG011|Overall Study|Disease Progression|0|||
46936094|NCT02737475|83172431|FG012|Overall Study|Disease Progression|0|||
46936095|NCT02737475|83172432|FG013|Overall Study|Disease Progression|0|||
46936096|NCT02737475|83172433|FG014|Overall Study|Disease Progression|0|||
46936097|NCT02737475|83172434|FG015|Overall Study|Disease Progression|0|||
46936098|NCT02737475|83172435|FG016|Overall Study|Disease Progression|0|||
46936099|NCT02737475|83172436|FG017|Overall Study|Disease Progression|0|||
46936100|NCT02737475|83172437|FG018|Overall Study|Disease Progression|0|||
46936101|NCT02737475|83172438|FG019|Overall Study|Disease Progression|0|||
46936102|NCT02737475|83172439|FG020|Overall Study|Disease Progression|0|||
46936103|NCT02737475|83172440|FG021|Overall Study|Disease Progression|0|||
46764276|NCT03704064|82982552|FG001|Overall Study|Censoring event|0|||
46764277|NCT00824564|82982560|FG000|Overall Study|Lost to Follow-up|5|||
46764278|NCT00824564|82982561|FG001|Overall Study|Lost to Follow-up|7|||
46764279|NCT00824564|82982560|FG000|Overall Study|Withdrawal by Subject|1|||
46764280|NCT00824564|82982561|FG001|Overall Study|Withdrawal by Subject|1|||
46764281|NCT00824564|82982560|FG000|Overall Study|Other|1|||
46764282|NCT00824564|82982561|FG001|Overall Study|Other|2|||
46764283|NCT00824564|82982560|FG000|Overall Study|Randomized, but not treated|1|||
46764284|NCT00824564|82982561|FG001|Overall Study|Randomized, but not treated|0|||
46764285|NCT00658528|82982569|FG000|Overall Study|Adverse Event|5|||
46764286|NCT00658528|82982570|FG001|Overall Study|Adverse Event|7|||
46764287|NCT00658528|82982569|FG000|Overall Study|Lost to Follow-up|14|||
46764288|NCT00658528|82982570|FG001|Overall Study|Lost to Follow-up|22|||
46764289|NCT00658528|82982569|FG000|Overall Study|Withdrawal by Subject|8|||
46936104|NCT02737475|83172441|FG022|Overall Study|Disease Progression|0|||
46936105|NCT02737475|83172442|FG023|Overall Study|Disease Progression|0|||
46936106|NCT02737475|83172443|FG024|Overall Study|Disease Progression|0|||
46936107|NCT02737475|83172444|FG025|Overall Study|Disease Progression|0|||
46764290|NCT00658528|82982570|FG001|Overall Study|Withdrawal by Subject|6|||
46764291|NCT00658528|82982569|FG000|Overall Study|Withdrawal of consent|5|||
46936108|NCT02737475|83172445|FG026|Overall Study|Disease Progression|1|||
46764292|NCT00658528|82982570|FG001|Overall Study|Withdrawal of consent|6|||
46764293|NCT00658528|82982569|FG000|Overall Study|Other|8|||
46764294|NCT00658528|82982570|FG001|Overall Study|Other|4|||
46764295|NCT00856583|82982578|FG000|Overall Study|Lack of Efficacy|389|||
46764296|NCT00856583|82982579|FG001|Overall Study|Lack of Efficacy|377|||
46829535|NCT00183196|83047550|FG001|Overall Study|Required more intensive care|1|||
46829536|NCT00183196|83047551|FG002|Overall Study|Required more intensive care|2|||
46829537|NCT00349752|83047561|FG000|Overall Study|Adverse Event|8|||
46829538|NCT00349752|83047562|FG001|Overall Study|Adverse Event|12|||
46936109|NCT02557672|83172535|FG000|Overall Study|Withdrawal by Subject|4|||
46829539|NCT00349752|83047561|FG000|Overall Study|Lack of Efficacy|37|||
46829540|NCT00349752|83047562|FG001|Overall Study|Lack of Efficacy|42|||
46829541|NCT00349752|83047561|FG000|Overall Study|Lost to Follow-up|4|||
46829542|NCT00349752|83047562|FG001|Overall Study|Lost to Follow-up|2|||
46829543|NCT00349752|83047561|FG000|Overall Study|Personal reasons|6|||
46829544|NCT00349752|83047562|FG001|Overall Study|Personal reasons|5|||
46829545|NCT00349752|83047561|FG000|Overall Study|Other: Required exclusionary medication|0|||
46829546|NCT00349752|83047562|FG001|Overall Study|Other: Required exclusionary medication|1|||
46829547|NCT00349752|83047561|FG000|Overall Study|Other: Non compliance|0|||
46829548|NCT00349752|83047562|FG001|Overall Study|Other: Non compliance|1|||
46829549|NCT00349752|83047561|FG000|Overall Study|Other: Patient stopped steroids|0|||
46829550|NCT00349752|83047562|FG001|Overall Study|Other: Patient stopped steroids|1|||
46829551|NCT00349752|83047561|FG000|Overall Study|Other: Patient's steroid use|1|||
46829552|NCT00349752|83047562|FG001|Overall Study|Other: Patient's steroid use|0|||
46829553|NCT00349752|83047561|FG000|Overall Study|Other: Ineligible|1|||
46829554|NCT00349752|83047562|FG001|Overall Study|Other: Ineligible|0|||
46829555|NCT00349752|83047561|FG000|Overall Study|Other: Inadvertently unblinded|1|||
46829556|NCT00349752|83047562|FG001|Overall Study|Other: Inadvertently unblinded|0|||
46829557|NCT00349752|83047561|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
46829558|NCT00349752|83047562|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
46829559|NCT00174460|83047570|FG000|Overall Study|Withdrawal by Subject|0|||
46829560|NCT00174460|83047571|FG001|Overall Study|Withdrawal by Subject|1|||
46829561|NCT00348816|83047578|FG000|Overall Study|Noncompliance with radiation treatment|1|||
46829562|NCT00265083|83047587|FG000|Overall Study|Adverse Event|5|||
46829563|NCT00265083|83047588|FG001|Overall Study|Adverse Event|13|||
46829564|NCT00265083|83047589|FG002|Overall Study|Adverse Event|15|||
46829565|NCT00265083|83047587|FG000|Overall Study|Lost to Follow-up|3|||
46829566|NCT00265083|83047588|FG001|Overall Study|Lost to Follow-up|4|||
46829567|NCT00265083|83047589|FG002|Overall Study|Lost to Follow-up|4|||
46829568|NCT00265083|83047587|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
46829569|NCT00265083|83047588|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
46829570|NCT00265083|83047589|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
46829571|NCT00265083|83047587|FG000|Overall Study|Other|1|||
46829572|NCT00265083|83047588|FG001|Overall Study|Other|12|||
46829573|NCT00265083|83047589|FG002|Overall Study|Other|9|||
46829574|NCT00264849|83047600|FG000|Overall Study|Adverse Event|7|||
46829575|NCT00264849|83047601|FG001|Overall Study|Adverse Event|2|||
46829576|NCT00264849|83047600|FG000|Overall Study|Withdrawal by Subject|7|||
46829577|NCT00264849|83047601|FG001|Overall Study|Withdrawal by Subject|11|||
46829578|NCT00264849|83047600|FG000|Overall Study|Protocol Violation|5|||
46829579|NCT00264849|83047601|FG001|Overall Study|Protocol Violation|3|||
46829580|NCT00264849|83047600|FG000|Overall Study|Lack of Efficacy|1|||
46829581|NCT00264849|83047601|FG001|Overall Study|Lack of Efficacy|6|||
46829582|NCT00264849|83047600|FG000|Overall Study|Lost to Follow-up|0|||
46829583|NCT00264849|83047601|FG001|Overall Study|Lost to Follow-up|2|||
46829584|NCT00264849|83047600|FG000|Overall Study|Death|0|||
46829585|NCT00264849|83047601|FG001|Overall Study|Death|1|||
46829586|NCT00264849|83047600|FG000|Overall Study|Administrative Problems|2|||
46829587|NCT00264849|83047601|FG001|Overall Study|Administrative Problems|0|||
46829588|NCT00211809|83047607|FG000|Overall Study|Lack of Efficacy|1|||
46829589|NCT00211809|83047607|FG000|Overall Study|Lost to Follow-up|2|||
46829590|NCT00211809|83047607|FG000|Overall Study|Pregnancy|1|||
46829591|NCT00211809|83047607|FG000|Overall Study|side effects|2|||
46829592|NCT00129766|83047615|FG000|Overall Study|Death|3|||
46829593|NCT00129766|83047616|FG001|Overall Study|Death|8|||
46829594|NCT00129766|83047615|FG000|Overall Study|Withdrawal of consent|31|||
46829595|NCT00129766|83047616|FG001|Overall Study|Withdrawal of consent|30|||
46829596|NCT00129766|83047615|FG000|Overall Study|Lost to Follow-up|26|||
46829597|NCT00129766|83047616|FG001|Overall Study|Lost to Follow-up|21|||
46829598|NCT00150592|83047625|FG000|Overall Study|Adverse Event|4|||
46829599|NCT00150592|83047626|FG001|Overall Study|Adverse Event|1|||
46829600|NCT00150592|83047625|FG000|Overall Study|Protocol Violation|1|||
46829601|NCT00150592|83047626|FG001|Overall Study|Protocol Violation|0|||
46829602|NCT00150592|83047625|FG000|Overall Study|Withdrawal by Subject|1|||
46829603|NCT00150592|83047626|FG001|Overall Study|Withdrawal by Subject|2|||
46829604|NCT00150592|83047625|FG000|Overall Study|Non-compliance|1|||
46829605|NCT00150592|83047626|FG001|Overall Study|Non-compliance|0|||
46829606|NCT00149890|83047634|FG000|Overall Study|Adverse Event|1|||
46829607|NCT00149890|83047635|FG001|Overall Study|Adverse Event|8|||
46829608|NCT00149890|83047634|FG000|Overall Study|Lack of Efficacy|8|||
46829609|NCT00149890|83047635|FG001|Overall Study|Lack of Efficacy|9|||
46829610|NCT00149890|83047634|FG000|Overall Study|Protocol Violation|1|||
46829611|NCT00149890|83047635|FG001|Overall Study|Protocol Violation|0|||
46829612|NCT00149890|83047634|FG000|Overall Study|Lost to Follow-up|1|||
46829613|NCT00149890|83047635|FG001|Overall Study|Lost to Follow-up|0|||
46829614|NCT00149890|83047634|FG000|Overall Study|Graft Loss|2|||
46829615|NCT00149890|83047635|FG001|Overall Study|Graft Loss|1|||
46829616|NCT00174382|83047641|FG000|Overall Study|Death|2|||
46829617|NCT00174382|83047641|FG000|Overall Study|Adverse Event|19|||
46829618|NCT00174382|83047641|FG000|Overall Study|Withdrawal by Subject|6|||
46829619|NCT00174382|83047641|FG000|Overall Study|Protocol Violation|3|||
46829620|NCT00174382|83047641|FG000|Overall Study|Arrived early for last visit in error|1|||
46829621|NCT00174382|83047641|FG000|Overall Study|Subject felt pill not effective enough|1|||
46829622|NCT00174382|83047641|FG000|Overall Study|Lost to Follow-up|1|||
46829623|NCT00355134|83047650|FG000|Core Phase|Withdrawal by Subject|35|||
46829624|NCT00355134|83047651|FG001|Core Phase|Withdrawal by Subject|24|||
46829625|NCT00355134|83047652|FG002|Core Phase|Withdrawal by Subject|35|||
46829626|NCT00355134|83047653|FG003|Core Phase|Withdrawal by Subject|0|||
46829627|NCT00355134|83047654|FG004|Core Phase|Withdrawal by Subject|0|||
46829628|NCT00355134|83047650|FG000|Core Phase|Adverse Event|28|||
46829629|NCT00355134|83047651|FG001|Core Phase|Adverse Event|22|||
46829630|NCT00355134|83047652|FG002|Core Phase|Adverse Event|16|||
46829631|NCT00355134|83047653|FG003|Core Phase|Adverse Event|0|||
46829632|NCT00355134|83047654|FG004|Core Phase|Adverse Event|0|||
46829633|NCT00355134|83047650|FG000|Core Phase|Lost to Follow-up|17|||
46829634|NCT00355134|83047651|FG001|Core Phase|Lost to Follow-up|13|||
46829635|NCT00355134|83047652|FG002|Core Phase|Lost to Follow-up|21|||
46829636|NCT00355134|83047653|FG003|Core Phase|Lost to Follow-up|0|||
46829637|NCT00355134|83047654|FG004|Core Phase|Lost to Follow-up|0|||
46829638|NCT00355134|83047650|FG000|Core Phase|Abnormal laboratory value(s)|19|||
46829639|NCT00355134|83047651|FG001|Core Phase|Abnormal laboratory value(s)|14|||
47060207|NCT01533935|83339912|FG002|Overall Study|Protocol Violation|0|||
47060208|NCT01533935|83339913|FG003|Overall Study|Protocol Violation|0|||
47060209|NCT01533935|83339914|FG004|Overall Study|Protocol Violation|0|||
46829640|NCT00355134|83047652|FG002|Core Phase|Abnormal laboratory value(s)|2|||
46829641|NCT00355134|83047653|FG003|Core Phase|Abnormal laboratory value(s)|0|||
46829642|NCT00355134|83047654|FG004|Core Phase|Abnormal laboratory value(s)|0|||
47060210|NCT01533935|83339910|FG000|Overall Study|Lost to Follow-up|0|||
47060211|NCT01533935|83339911|FG001|Overall Study|Lost to Follow-up|0|||
47060212|NCT01533935|83339912|FG002|Overall Study|Lost to Follow-up|1|||
47060213|NCT01533935|83339913|FG003|Overall Study|Lost to Follow-up|0|||
47060214|NCT01533935|83339914|FG004|Overall Study|Lost to Follow-up|0|||
47060215|NCT01533935|83339910|FG000|Overall Study|Withdrawal by Subject|0|||
47060216|NCT01533935|83339911|FG001|Overall Study|Withdrawal by Subject|4|||
47060217|NCT01533935|83339912|FG002|Overall Study|Withdrawal by Subject|5|||
47060218|NCT01533935|83339913|FG003|Overall Study|Withdrawal by Subject|2|||
47060219|NCT01533935|83339914|FG004|Overall Study|Withdrawal by Subject|4|||
47060220|NCT01533935|83339910|FG000|Overall Study|Other reason not defined above|1|||
47060221|NCT01533935|83339911|FG001|Overall Study|Other reason not defined above|0|||
47060222|NCT01533935|83339912|FG002|Overall Study|Other reason not defined above|1|||
47060223|NCT01533935|83339913|FG003|Overall Study|Other reason not defined above|0|||
46936110|NCT02557672|83172536|FG001|Overall Study|Withdrawal by Subject|2|||
47060224|NCT01533935|83339914|FG004|Overall Study|Other reason not defined above|1|||
46764297|NCT00856583|82982578|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
46764298|NCT00856583|82982579|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
46764299|NCT00856583|82982578|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
46764300|NCT00856583|82982579|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
46764301|NCT00856583|82982578|FG000|Overall Study|Non-compliance|305|||
46764302|NCT00856583|82982579|FG001|Overall Study|Non-compliance|262|||
46764303|NCT00856583|82982578|FG000|Overall Study|Withdrawal by Subject|1092|||
46764304|NCT00856583|82982579|FG001|Overall Study|Withdrawal by Subject|919|||
46764305|NCT00856583|82982578|FG000|Overall Study|Physician Decision|59|||
46764306|NCT00856583|82982579|FG001|Overall Study|Physician Decision|82|||
46764307|NCT00856583|82982578|FG000|Overall Study|Pregnancy|14|||
46764308|NCT00856583|82982579|FG001|Overall Study|Pregnancy|5|||
46764309|NCT00856583|82982578|FG000|Overall Study|Other|92|||
46764310|NCT00856583|82982579|FG001|Overall Study|Other|104|||
46764311|NCT00856583|82982578|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
47060225|NCT01532999|83339928|FG000|Overall Study|Lost to Follow-up|14|||
46764312|NCT00856583|82982579|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
46764313|NCT00856349|82982585|FG000|Overall Study|Death|418|||
46764314|NCT00856349|82982585|FG000|Overall Study|Withdrawal by Subject|116|||
46764315|NCT00856349|82982585|FG000|Overall Study|Lost to Follow-up|91|||
46764316|NCT00856349|82982585|FG000|Overall Study|Protocol Violation|38|||
46764317|NCT00856349|82982585|FG000|Overall Study|Physician Decision|13|||
46829643|NCT00355134|83047650|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
46829644|NCT00355134|83047651|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
46829645|NCT00355134|83047652|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
46829646|NCT00355134|83047653|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
46829647|NCT00355134|83047654|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
46829648|NCT00355134|83047650|FG000|Core Phase|Administrative problems|5|||
46829649|NCT00355134|83047651|FG001|Core Phase|Administrative problems|3|||
47060226|NCT01532999|83339929|FG001|Overall Study|Lost to Follow-up|8|||
47060227|NCT01532999|83339928|FG000|Overall Study|Physician Decision|1|||
47060228|NCT01532999|83339929|FG001|Overall Study|Physician Decision|2|||
46829650|NCT00355134|83047652|FG002|Core Phase|Administrative problems|5|||
46829651|NCT00355134|83047653|FG003|Core Phase|Administrative problems|0|||
46829652|NCT00355134|83047654|FG004|Core Phase|Administrative problems|0|||
46829653|NCT00355134|83047650|FG000|Core Phase|Protocol Violation|3|||
46829654|NCT00355134|83047651|FG001|Core Phase|Protocol Violation|2|||
46829655|NCT00355134|83047652|FG002|Core Phase|Protocol Violation|2|||
46829656|NCT00355134|83047653|FG003|Core Phase|Protocol Violation|0|||
46829657|NCT00355134|83047654|FG004|Core Phase|Protocol Violation|0|||
46829658|NCT00355134|83047650|FG000|Core Phase|Abnormal test procedure result(s)|1|||
47060229|NCT01532999|83339928|FG000|Overall Study|Withdrawal by Subject|5|||
47060230|NCT01532999|83339929|FG001|Overall Study|Withdrawal by Subject|0|||
47060231|NCT01532999|83339928|FG000|Overall Study|Relocated|2|||
46764318|NCT00856349|82982585|FG000|Overall Study|Subject relocation|104|||
46764319|NCT00856349|82982585|FG000|Overall Study|Device explant|33|||
46829659|NCT00355134|83047651|FG001|Core Phase|Abnormal test procedure result(s)|2|||
46829660|NCT00355134|83047652|FG002|Core Phase|Abnormal test procedure result(s)|1|||
46829661|NCT00355134|83047653|FG003|Core Phase|Abnormal test procedure result(s)|0|||
46829662|NCT00355134|83047654|FG004|Core Phase|Abnormal test procedure result(s)|0|||
46829663|NCT00355134|83047650|FG000|Core Phase|Condition no longer requires study drug|1|||
46829664|NCT00355134|83047651|FG001|Core Phase|Condition no longer requires study drug|0|||
46829665|NCT00355134|83047652|FG002|Core Phase|Condition no longer requires study drug|1|||
46829666|NCT00355134|83047653|FG003|Core Phase|Condition no longer requires study drug|0|||
46829667|NCT00355134|83047654|FG004|Core Phase|Condition no longer requires study drug|0|||
46829668|NCT00355134|83047650|FG000|Extension Phase|Withdrawal by Subject|7|||
46829669|NCT00355134|83047651|FG001|Extension Phase|Withdrawal by Subject|11|||
46829670|NCT00355134|83047652|FG002|Extension Phase|Withdrawal by Subject|0|||
46829671|NCT00355134|83047653|FG003|Extension Phase|Withdrawal by Subject|7|||
46829672|NCT00355134|83047654|FG004|Extension Phase|Withdrawal by Subject|5|||
46829673|NCT00355134|83047650|FG000|Extension Phase|Adverse Event|13|||
46829674|NCT00355134|83047651|FG001|Extension Phase|Adverse Event|9|||
46764320|NCT00856349|82982585|FG000|Overall Study|Site closure|78|||
46829675|NCT00355134|83047652|FG002|Extension Phase|Adverse Event|0|||
46829676|NCT00355134|83047653|FG003|Extension Phase|Adverse Event|3|||
46829677|NCT00355134|83047654|FG004|Extension Phase|Adverse Event|5|||
46829678|NCT00355134|83047650|FG000|Extension Phase|Lost to Follow-up|2|||
46829679|NCT00355134|83047651|FG001|Extension Phase|Lost to Follow-up|6|||
46829680|NCT00355134|83047652|FG002|Extension Phase|Lost to Follow-up|0|||
46829681|NCT00355134|83047653|FG003|Extension Phase|Lost to Follow-up|2|||
46829682|NCT00355134|83047654|FG004|Extension Phase|Lost to Follow-up|4|||
46829683|NCT00355134|83047650|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
46829684|NCT00355134|83047651|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
46829685|NCT00355134|83047652|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
46829686|NCT00355134|83047653|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
46829687|NCT00355134|83047654|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
46829688|NCT00355134|83047650|FG000|Extension Phase|Administrative problems|2|||
46829689|NCT00355134|83047651|FG001|Extension Phase|Administrative problems|4|||
46829690|NCT00355134|83047652|FG002|Extension Phase|Administrative problems|0|||
46829691|NCT00355134|83047653|FG003|Extension Phase|Administrative problems|1|||
46829692|NCT00355134|83047654|FG004|Extension Phase|Administrative problems|1|||
46829693|NCT00355134|83047650|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
46829694|NCT00355134|83047651|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
46829695|NCT00355134|83047652|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
46764321|NCT00856349|82982585|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
46764322|NCT00803244|82982593|FG000|Overall Study|Adverse Event|1|||
46764323|NCT00803244|82982594|FG001|Overall Study|Adverse Event|2|||
46764324|NCT00803244|82982593|FG000|Overall Study|Withdrawal by Subject|2|||
46764325|NCT00803244|82982594|FG001|Overall Study|Withdrawal by Subject|3|||
46764326|NCT00803244|82982593|FG000|Overall Study|Any other reason not above-mentioned|4|||
46764327|NCT00803244|82982594|FG001|Overall Study|Any other reason not above-mentioned|10|||
46764328|NCT00804570|82982602|FG000|Overall Study|Adverse Event|14|||
46764329|NCT00804570|82982603|FG001|Overall Study|Adverse Event|7|||
46764330|NCT00804570|82982602|FG000|Overall Study|Lack of Efficacy|0|||
46764331|NCT00804570|82982603|FG001|Overall Study|Lack of Efficacy|1|||
46764332|NCT00804570|82982602|FG000|Overall Study|Lost to Follow-up|18|||
46764333|NCT00804570|82982603|FG001|Overall Study|Lost to Follow-up|21|||
46829696|NCT00355134|83047653|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
46829697|NCT00355134|83047654|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
46829698|NCT00355134|83047650|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
46829699|NCT00355134|83047651|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
46764334|NCT00804570|82982602|FG000|Overall Study|Entry criteria not met|5|||
46829700|NCT00355134|83047652|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
46829701|NCT00355134|83047653|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
46829702|NCT00355134|83047654|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
46829703|NCT00355134|83047650|FG000|Extension Phase|Protocol Violation|0|||
47060232|NCT01532999|83339929|FG001|Overall Study|Relocated|0|||
46829704|NCT00355134|83047651|FG001|Extension Phase|Protocol Violation|0|||
46829705|NCT00355134|83047652|FG002|Extension Phase|Protocol Violation|0|||
46829706|NCT00355134|83047653|FG003|Extension Phase|Protocol Violation|1|||
46829707|NCT00355134|83047654|FG004|Extension Phase|Protocol Violation|0|||
46829708|NCT00171730|83047664|FG000|Overall Study|Adverse Event|3|||
46829709|NCT00171730|83047664|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
46829710|NCT00171730|83047664|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
46829711|NCT00171730|83047664|FG000|Overall Study|Withdrawal by Subject|3|||
46829712|NCT00355056|83047676|FG000|Randomization Period|Early Termination|4|||
46829713|NCT00355056|83047677|FG001|Randomization Period|Early Termination|6|||
46829714|NCT00348348|83047693|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
46829715|NCT00348348|83047694|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
46829716|NCT00348348|83047693|FG000|Overall Study|Lack of Efficacy|1|||
46829717|NCT00348348|83047694|FG001|Overall Study|Lack of Efficacy|1|||
46829718|NCT00348348|83047693|FG000|Overall Study|Lost to Follow-up|8|||
46829719|NCT00348348|83047694|FG001|Overall Study|Lost to Follow-up|10|||
46829720|NCT00348348|83047693|FG000|Overall Study|Withdrawal by Subject|4|||
46829721|NCT00348348|83047694|FG001|Overall Study|Withdrawal by Subject|1|||
46829722|NCT00348348|83047693|FG000|Overall Study|Other|7|||
46829723|NCT00348348|83047694|FG001|Overall Study|Other|4|||
46829724|NCT00348348|83047693|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
46829725|NCT00348348|83047694|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
46829726|NCT00348348|83047693|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
46829727|NCT00348348|83047694|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
46829728|NCT00348348|83047693|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
46829729|NCT00348348|83047694|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
46936111|NCT02714426|83172548|FG000|Overall Study|Withdrawal by Subject|2|||
46936112|NCT02714426|83172549|FG001|Overall Study|Withdrawal by Subject|2|||
46936113|NCT02925923|83172562|FG000|Overall Study|blood samples hemolyzed|0|||
46936114|NCT02925923|83172563|FG001|Overall Study|blood samples hemolyzed|2|||
46936115|NCT02410343|83172571|FG000|Core Period (24 Weeks)|Adverse Event|1|||
46936116|NCT02410343|83172572|FG001|Core Period (24 Weeks)|Adverse Event|0|||
46936117|NCT02410343|83172571|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
46936118|NCT02410343|83172572|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
46936119|NCT02410343|83172571|FG000|Extension Period (12 Months)|Adverse Event|1|||
46936120|NCT02410343|83172572|FG001|Extension Period (12 Months)|Adverse Event|0|||
46936121|NCT02410343|83172571|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
46936122|NCT02410343|83172572|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
46936123|NCT03064841|83172579|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
46936124|NCT03064841|83172579|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
46936125|NCT03064841|83172579|FG000|Overall Study|Screen failure|2|||
46936126|NCT02045303|83172585|FG000|Overall Study|Protocol Violation|2|||
46936127|NCT02045303|83172586|FG001|Overall Study|Protocol Violation|1|||
46829730|NCT00348348|83047693|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
46936128|NCT02045303|83172587|FG002|Overall Study|Protocol Violation|0|||
46936129|NCT02045303|83172585|FG000|Overall Study|Withdrawal by Subject|0|||
46936130|NCT02045303|83172586|FG001|Overall Study|Withdrawal by Subject|2|||
46936131|NCT02045303|83172587|FG002|Overall Study|Withdrawal by Subject|0|||
46936132|NCT03064451|83172600|FG000|Overall Study|Lost to Follow-up|1|||
46936133|NCT03064451|83172600|FG000|Overall Study|Mapping Failure|4|||
46936134|NCT03064451|83172600|FG000|Overall Study|Exited prior to procedure|8|||
46936135|NCT03064451|83172600|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
46936136|NCT03058679|83172606|FG000|Baseline to Week 6|Lost to Follow-up|3|||
46936137|NCT03058679|83172607|FG001|Baseline to Week 6|Lost to Follow-up|2|||
46936138|NCT03058679|83172606|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
46936139|NCT03058679|83172607|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
47060233|NCT01532999|83339928|FG000|Overall Study|should not have been randomized|1|||
47060234|NCT01532999|83339929|FG001|Overall Study|should not have been randomized|0|||
46936140|NCT03058679|83172606|FG000|Baseline to Week 6|Adverse Event|6|||
46936141|NCT03058679|83172607|FG001|Baseline to Week 6|Adverse Event|6|||
46936142|NCT03058679|83172606|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
46936143|NCT03058679|83172607|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
47060235|NCT01532999|83339928|FG000|Overall Study|substantial noncompliance|2|||
47060236|NCT01532999|83339929|FG001|Overall Study|substantial noncompliance|0|||
46829731|NCT00348348|83047694|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
46829732|NCT00348348|83047693|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
46829733|NCT00348348|83047694|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
46936144|NCT03058679|83172606|FG000|Baseline to Week 6|Difficulty following the diet|0|||
46936145|NCT03058679|83172607|FG001|Baseline to Week 6|Difficulty following the diet|2|||
46936146|NCT03058679|83172606|FG000|Baseline to Week 6|Physician Decision|1|||
46936147|NCT03058679|83172607|FG001|Baseline to Week 6|Physician Decision|0|||
46936148|NCT03058679|83172606|FG000|Week 6 to Week 12|Change in medication|5|||
47060237|NCT01532999|83339928|FG000|Overall Study|no show for week 9 assessments|6|||
46936149|NCT03058679|83172607|FG001|Week 6 to Week 12|Change in medication|7|||
46936150|NCT03058679|83172606|FG000|Week 6 to Week 12|Adverse Event|4|||
46936151|NCT03058679|83172607|FG001|Week 6 to Week 12|Adverse Event|3|||
47060238|NCT01532999|83339929|FG001|Overall Study|no show for week 9 assessments|4|||
46829734|NCT00348348|83047693|FG000|Overall Study|Adverse event probably related to study|1|||
46829735|NCT00348348|83047694|FG001|Overall Study|Adverse event probably related to study|0|||
46829736|NCT00347958|83047700|FG000|Overall Study|Adverse Event|1|||
46829737|NCT00347958|83047700|FG000|Overall Study|Protocol Violation|2|||
46829738|NCT00347958|83047700|FG000|Overall Study|Withdrawal by Subject|1|||
46829739|NCT00354744|83047704|FG000|Overall Study|Adverse Event|2|||
46829740|NCT00354744|83047704|FG000|Overall Study|Death|2|||
46829741|NCT00354744|83047704|FG000|Overall Study|Lack of Efficacy|11|||
47060239|NCT01532999|83339928|FG000|Overall Study|Adverse Event|0|||
47060240|NCT01532999|83339929|FG001|Overall Study|Adverse Event|1|||
46829742|NCT00354744|83047704|FG000|Overall Study|Lost to Follow-up|2|||
46829743|NCT00354744|83047704|FG000|Overall Study|Physician Decision|11|||
47060241|NCT01532999|83339928|FG000|Overall Study|incarcerated|0|||
47060242|NCT01532999|83339929|FG001|Overall Study|incarcerated|1|||
47060243|NCT01532999|83339928|FG000|Overall Study|New job|0|||
47060244|NCT01532999|83339929|FG001|Overall Study|New job|2|||
47060245|NCT01532921|83339935|FG000|Overall Study|Death|3|||
47060246|NCT01532921|83339935|FG000|Overall Study|Withdrawal by Subject|2|||
47060247|NCT01532921|83339935|FG000|Overall Study|Lost to Follow-up|3|||
47060248|NCT01532921|83339935|FG000|Overall Study|Physician Decision|7|||
47060249|NCT01532921|83339935|FG000|Overall Study|Device was explanted during procedure|1|||
47060250|NCT01532687|83339945|FG000|Overall Study|Death|2|||
47060251|NCT01532687|83339946|FG001|Overall Study|Death|0|||
47060252|NCT01532687|83339945|FG000|Overall Study|Adverse Event|6|||
47060253|NCT01532687|83339946|FG001|Overall Study|Adverse Event|1|||
47060254|NCT01532687|83339945|FG000|Overall Study|Withdrawal by Subject|1|||
47060255|NCT01532687|83339946|FG001|Overall Study|Withdrawal by Subject|0|||
47060256|NCT01532687|83339945|FG000|Overall Study|Physician Decision|2|||
47060257|NCT01532687|83339946|FG001|Overall Study|Physician Decision|1|||
47060258|NCT01532687|83339945|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
47060259|NCT01532687|83339946|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
47060260|NCT02677116|83339963|FG000|Overall Study|Adverse Event|0|||
47060261|NCT02677116|83339964|FG001|Overall Study|Adverse Event|1|||
47060262|NCT02677116|83339965|FG002|Overall Study|Adverse Event|0|||
47060263|NCT02677116|83339966|FG003|Overall Study|Adverse Event|0|||
47060264|NCT02677116|83339967|FG004|Overall Study|Adverse Event|0|||
47060265|NCT02677116|83339968|FG005|Overall Study|Adverse Event|1|||
47060266|NCT02677116|83339969|FG006|Overall Study|Adverse Event|1|||
47060267|NCT02677116|83339970|FG007|Overall Study|Adverse Event|0|||
47060268|NCT02677116|83339971|FG008|Overall Study|Adverse Event|0|||
47060269|NCT02677116|83339963|FG000|Overall Study|Physician Decision|0|||
47060270|NCT02677116|83339964|FG001|Overall Study|Physician Decision|2|||
47060271|NCT02677116|83339965|FG002|Overall Study|Physician Decision|3|||
47060272|NCT02677116|83339966|FG003|Overall Study|Physician Decision|2|||
47060273|NCT02677116|83339967|FG004|Overall Study|Physician Decision|1|||
47060274|NCT02677116|83339968|FG005|Overall Study|Physician Decision|3|||
46764335|NCT00804570|82982603|FG001|Overall Study|Entry criteria not met|5|||
46764336|NCT00804570|82982602|FG000|Overall Study|Protocol Violation|12|||
46764337|NCT00804570|82982603|FG001|Overall Study|Protocol Violation|16|||
46764338|NCT00804570|82982602|FG000|Overall Study|Physician Decision|1|||
46764339|NCT00804570|82982603|FG001|Overall Study|Physician Decision|2|||
46764340|NCT00804570|82982602|FG000|Overall Study|Sponsor decision|1|||
46764341|NCT00804570|82982603|FG001|Overall Study|Sponsor decision|4|||
46764342|NCT00804570|82982602|FG000|Overall Study|Withdrawal by Subject|21|||
46829744|NCT00354744|83047704|FG000|Overall Study|Withdrawal by Subject|14|||
46829745|NCT00373256|83047712|FG000|Overall Study|Adverse Event (AE)|1|||
46936152|NCT03058679|83172606|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
47060275|NCT02677116|83339969|FG006|Overall Study|Physician Decision|1|||
46764343|NCT00804570|82982603|FG001|Overall Study|Withdrawal by Subject|38|||
46764344|NCT00824408|82982615|FG000|Run-in Phase|Progressive disease|4|||
46764345|NCT00824408|82982616|FG001|Run-in Phase|Progressive disease|4|||
46829746|NCT00373256|83047713|FG001|Overall Study|Adverse Event (AE)|5|||
46829747|NCT00373256|83047712|FG000|Overall Study|Lost to Follow-up|2|||
47060276|NCT02677116|83339970|FG007|Overall Study|Physician Decision|1|||
47060277|NCT02677116|83339971|FG008|Overall Study|Physician Decision|2|||
46764346|NCT00824408|82982617|FG002|Run-in Phase|Progressive disease|0|||
46936153|NCT03058679|83172607|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
47060278|NCT02677116|83339963|FG000|Overall Study|Withdrawal by parent or guardian|2|||
47060279|NCT02677116|83339964|FG001|Overall Study|Withdrawal by parent or guardian|1|||
47060280|NCT02677116|83339965|FG002|Overall Study|Withdrawal by parent or guardian|0|||
47060281|NCT02677116|83339966|FG003|Overall Study|Withdrawal by parent or guardian|1|||
47060282|NCT02677116|83339967|FG004|Overall Study|Withdrawal by parent or guardian|0|||
47060283|NCT02677116|83339968|FG005|Overall Study|Withdrawal by parent or guardian|0|||
47060284|NCT02677116|83339969|FG006|Overall Study|Withdrawal by parent or guardian|2|||
47060285|NCT02677116|83339970|FG007|Overall Study|Withdrawal by parent or guardian|1|||
47060286|NCT02677116|83339971|FG008|Overall Study|Withdrawal by parent or guardian|0|||
47060287|NCT02677116|83339963|FG000|Overall Study|Withdrawal by Subject|1|||
47060288|NCT02677116|83339964|FG001|Overall Study|Withdrawal by Subject|0|||
47060289|NCT02677116|83339965|FG002|Overall Study|Withdrawal by Subject|0|||
47060290|NCT02677116|83339966|FG003|Overall Study|Withdrawal by Subject|0|||
47060291|NCT02677116|83339967|FG004|Overall Study|Withdrawal by Subject|0|||
46637548|NCT01474512|82811383|FG007|Maintenance Period|Adverse Event|19|||
46637549|NCT01474512|82811384|FG008|Maintenance Period|Adverse Event|1|||
46637550|NCT01474512|82811385|FG009|Maintenance Period|Adverse Event|3|||
46637551|NCT01474512|82811386|FG010|Maintenance Period|Adverse Event|0|||
46637552|NCT01474512|82811387|FG011|Maintenance Period|Adverse Event|0|||
46637553|NCT01474512|82811388|FG012|Maintenance Period|Adverse Event|0|||
46829748|NCT00373256|83047713|FG001|Overall Study|Lost to Follow-up|1|||
46829749|NCT00373256|83047712|FG000|Overall Study|Death|9|||
46829750|NCT00373256|83047713|FG001|Overall Study|Death|8|||
46829751|NCT00373256|83047712|FG000|Overall Study|Objective Progression or Relapse|111|||
46829752|NCT00373256|83047713|FG001|Overall Study|Objective Progression or Relapse|104|||
46829753|NCT00373256|83047712|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
46829754|NCT00373256|83047713|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
46829755|NCT00373256|83047712|FG000|Overall Study|Other|73|||
46829756|NCT00373256|83047713|FG001|Overall Study|Other|107|||
46829757|NCT00373256|83047712|FG000|Overall Study|Protocol Violation|0|||
46829758|NCT00373256|83047713|FG001|Overall Study|Protocol Violation|2|||
46829759|NCT00373256|83047712|FG000|Overall Study|Study Terminated by Sponsor|41|||
46829760|NCT00373256|83047713|FG001|Overall Study|Study Terminated by Sponsor|13|||
46829761|NCT00394082|83047719|FG000|Overall Study|Unacceptable toxicity|15|||
46829762|NCT00394082|83047719|FG000|Overall Study|Adverse Event|4|||
46829763|NCT00394082|83047719|FG000|Overall Study|Physician Decision|4|||
46829764|NCT00394082|83047719|FG000|Overall Study|Withdrawal by Subject|2|||
46829765|NCT00394082|83047719|FG000|Overall Study|Other|1|||
46936154|NCT03058679|83172606|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
46936155|NCT03058679|83172607|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
46936156|NCT03382821|83172615|FG000|Overall Study|Did not receive allocated intervention.|0|||
46936157|NCT03382821|83172616|FG001|Overall Study|Did not receive allocated intervention.|3|||
46637554|NCT01474512|82811389|FG013|Maintenance Period|Adverse Event|0|||
46637555|NCT01474512|82811390|FG014|Maintenance Period|Adverse Event|0|||
46637556|NCT01474512|82811391|FG015|Maintenance Period|Adverse Event|0|||
46637557|NCT01474512|82811392|FG016|Maintenance Period|Adverse Event|0|||
46637558|NCT01474512|82811393|FG017|Maintenance Period|Adverse Event|0|||
46637559|NCT01474512|82811376|FG000|Maintenance Period|Withdrawal by Subject|0|||
46637560|NCT01474512|82811377|FG001|Maintenance Period|Withdrawal by Subject|0|||
46637561|NCT01474512|82811378|FG002|Maintenance Period|Withdrawal by Subject|0|||
46637562|NCT01474512|82811379|FG003|Maintenance Period|Withdrawal by Subject|6|||
46637563|NCT01474512|82811380|FG004|Maintenance Period|Withdrawal by Subject|2|||
46637564|NCT01474512|82811381|FG005|Maintenance Period|Withdrawal by Subject|3|||
46637565|NCT01474512|82811382|FG006|Maintenance Period|Withdrawal by Subject|1|||
46637566|NCT01474512|82811383|FG007|Maintenance Period|Withdrawal by Subject|6|||
46637567|NCT01474512|82811384|FG008|Maintenance Period|Withdrawal by Subject|3|||
46637568|NCT01474512|82811385|FG009|Maintenance Period|Withdrawal by Subject|1|||
46637569|NCT01474512|82811386|FG010|Maintenance Period|Withdrawal by Subject|0|||
46637570|NCT01474512|82811387|FG011|Maintenance Period|Withdrawal by Subject|0|||
46764347|NCT00824408|82982618|FG003|Run-in Phase|Progressive disease|0|||
46764348|NCT00824408|82982619|FG004|Run-in Phase|Progressive disease|0|||
46764349|NCT00824408|82982615|FG000|Run-in Phase|Adverse Event|1|||
46764350|NCT00824408|82982616|FG001|Run-in Phase|Adverse Event|1|||
46764351|NCT00824408|82982617|FG002|Run-in Phase|Adverse Event|0|||
46764352|NCT00824408|82982618|FG003|Run-in Phase|Adverse Event|0|||
46764353|NCT00824408|82982619|FG004|Run-in Phase|Adverse Event|0|||
46764354|NCT00824408|82982615|FG000|Run-in Phase|Refused to continue medication|1|||
46764355|NCT00824408|82982616|FG001|Run-in Phase|Refused to continue medication|0|||
46764356|NCT00824408|82982617|FG002|Run-in Phase|Refused to continue medication|0|||
46764357|NCT00824408|82982618|FG003|Run-in Phase|Refused to continue medication|0|||
46764358|NCT00824408|82982619|FG004|Run-in Phase|Refused to continue medication|0|||
46829766|NCT00393848|83047727|FG000|Overall Study|Surgical schedule|0|||
46829767|NCT00393848|83047728|FG001|Overall Study|Surgical schedule|0|||
46936158|NCT02557516|83172627|FG000|Overall Study|Adverse Event|1|||
46936159|NCT02557516|83172628|FG001|Overall Study|Adverse Event|0|||
46936160|NCT02557516|83172629|FG002|Overall Study|Adverse Event|2|||
46936161|NCT02557516|83172630|FG003|Overall Study|Adverse Event|1|||
46936162|NCT02557516|83172627|FG000|Overall Study|Disease progression|0|||
46936163|NCT02557516|83172628|FG001|Overall Study|Disease progression|2|||
46936164|NCT02557516|83172629|FG002|Overall Study|Disease progression|0|||
46936165|NCT02557516|83172630|FG003|Overall Study|Disease progression|0|||
46936166|NCT02557516|83172627|FG000|Overall Study|Physician Decision|0|||
46936167|NCT02557516|83172628|FG001|Overall Study|Physician Decision|2|||
47060292|NCT02677116|83339968|FG005|Overall Study|Withdrawal by Subject|0|||
46829768|NCT00393848|83047729|FG002|Overall Study|Surgical schedule|0|||
46829769|NCT00393848|83047730|FG003|Overall Study|Surgical schedule|1|||
46829770|NCT00393848|83047727|FG000|Overall Study|Personal reasons|0|||
46829771|NCT00393848|83047728|FG001|Overall Study|Personal reasons|0|||
46829772|NCT00393848|83047729|FG002|Overall Study|Personal reasons|2|||
46829773|NCT00393848|83047730|FG003|Overall Study|Personal reasons|0|||
46829774|NCT00393458|83047745|FG000|Overall Study|Adverse Event|35|||
47060293|NCT02677116|83339969|FG006|Overall Study|Withdrawal by Subject|0|||
47060294|NCT02677116|83339970|FG007|Overall Study|Withdrawal by Subject|0|||
47060295|NCT02677116|83339971|FG008|Overall Study|Withdrawal by Subject|0|||
47060296|NCT02689518|83340014|FG000|Overall Study|Withdrawal by Subject|3|||
47060297|NCT02681094|83340021|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
47060298|NCT02681094|83340022|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
46637571|NCT01474512|82811388|FG012|Maintenance Period|Withdrawal by Subject|0|||
46764359|NCT00824408|82982615|FG000|Run-in Phase|Other reason not defined above|0|||
46829775|NCT00393458|83047746|FG001|Overall Study|Adverse Event|24|||
46829776|NCT00393458|83047747|FG002|Overall Study|Adverse Event|40|||
46829777|NCT00393458|83047748|FG003|Overall Study|Adverse Event|35|||
46829778|NCT00393458|83047745|FG000|Overall Study|Subject withdrew consent|27|||
46829779|NCT00393458|83047746|FG001|Overall Study|Subject withdrew consent|40|||
46829780|NCT00393458|83047747|FG002|Overall Study|Subject withdrew consent|33|||
46829781|NCT00393458|83047748|FG003|Overall Study|Subject withdrew consent|50|||
46829782|NCT00393458|83047745|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
46637572|NCT01474512|82811389|FG013|Maintenance Period|Withdrawal by Subject|0|||
46637573|NCT01474512|82811390|FG014|Maintenance Period|Withdrawal by Subject|0|||
46829783|NCT00393458|83047746|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
46829784|NCT00393458|83047747|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
46829785|NCT00393458|83047748|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
46829786|NCT00393458|83047745|FG000|Overall Study|Protocol deviation|11|||
46829787|NCT00393458|83047746|FG001|Overall Study|Protocol deviation|11|||
46829788|NCT00393458|83047747|FG002|Overall Study|Protocol deviation|11|||
46829789|NCT00393458|83047748|FG003|Overall Study|Protocol deviation|10|||
46829790|NCT00393458|83047745|FG000|Overall Study|Administrative problems|7|||
46829791|NCT00393458|83047746|FG001|Overall Study|Administrative problems|8|||
46829792|NCT00393458|83047747|FG002|Overall Study|Administrative problems|5|||
46829793|NCT00393458|83047748|FG003|Overall Study|Administrative problems|2|||
46829794|NCT00393458|83047745|FG000|Overall Study|Lost to Follow-up|5|||
46829795|NCT00393458|83047746|FG001|Overall Study|Lost to Follow-up|6|||
46829796|NCT00393458|83047747|FG002|Overall Study|Lost to Follow-up|5|||
46829797|NCT00393458|83047748|FG003|Overall Study|Lost to Follow-up|3|||
46829798|NCT00393458|83047745|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46829799|NCT00393458|83047746|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46829800|NCT00393458|83047747|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46829801|NCT00393458|83047748|FG003|Overall Study|Abnormal laboratory value(s)|0|||
46764360|NCT00824408|82982616|FG001|Run-in Phase|Other reason not defined above|1|||
46764361|NCT00824408|82982617|FG002|Run-in Phase|Other reason not defined above|0|||
46764362|NCT00824408|82982618|FG003|Run-in Phase|Other reason not defined above|0|||
46764363|NCT00824408|82982619|FG004|Run-in Phase|Other reason not defined above|0|||
46764364|NCT00824408|82982615|FG000|Randomized Phase|Not treated|0|||
46764365|NCT00824408|82982616|FG001|Randomized Phase|Not treated|0|||
46764366|NCT00824408|82982617|FG002|Randomized Phase|Not treated|1|||
46764367|NCT00824408|82982618|FG003|Randomized Phase|Not treated|1|||
46764368|NCT00824408|82982619|FG004|Randomized Phase|Not treated|1|||
46764369|NCT00824408|82982615|FG000|Randomized Phase|Progressive disease|0|||
46764370|NCT00824408|82982616|FG001|Randomized Phase|Progressive disease|0|||
46764371|NCT00824408|82982617|FG002|Randomized Phase|Progressive disease|25|||
46764372|NCT00824408|82982618|FG003|Randomized Phase|Progressive disease|36|||
46764373|NCT00824408|82982619|FG004|Randomized Phase|Progressive disease|34|||
46764374|NCT00824408|82982615|FG000|Randomized Phase|Adverse Event|0|||
46829802|NCT00393458|83047745|FG000|Overall Study|Death|1|||
46829803|NCT00393458|83047746|FG001|Overall Study|Death|1|||
46829804|NCT00393458|83047747|FG002|Overall Study|Death|5|||
46829805|NCT00393458|83047748|FG003|Overall Study|Death|5|||
46829806|NCT00393458|83047745|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46829807|NCT00393458|83047746|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46829808|NCT00393458|83047747|FG002|Overall Study|Abnormal test procedure result(s)|1|||
46829809|NCT00393458|83047748|FG003|Overall Study|Abnormal test procedure result(s)|2|||
46829810|NCT00393458|83047745|FG000|Overall Study|Subject no longer requires study drug|0|||
46829811|NCT00393458|83047746|FG001|Overall Study|Subject no longer requires study drug|1|||
46829812|NCT00393458|83047747|FG002|Overall Study|Subject no longer requires study drug|0|||
46829813|NCT00393458|83047748|FG003|Overall Study|Subject no longer requires study drug|0|||
46829814|NCT00417482|83047761|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
46829815|NCT00417482|83047762|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
46764375|NCT00824408|82982616|FG001|Randomized Phase|Adverse Event|0|||
46764376|NCT00824408|82982617|FG002|Randomized Phase|Adverse Event|4|||
46829816|NCT00417482|83047763|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
46829817|NCT00417482|83047761|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
46829818|NCT00417482|83047762|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
46829819|NCT00417482|83047763|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
46829820|NCT00417482|83047761|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
46829821|NCT00417482|83047762|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
46829822|NCT00417482|83047763|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
46829823|NCT00417482|83047761|FG000|Phase B 1st 16 Weeks|Death|1|||
46829824|NCT00417482|83047762|FG001|Phase B 1st 16 Weeks|Death|0|||
46829825|NCT00417482|83047763|FG002|Phase B 1st 16 Weeks|Death|0|||
47060299|NCT02681094|83340023|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
47060300|NCT02681094|83340021|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
47060301|NCT02681094|83340022|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
47060302|NCT02681094|83340023|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
47060303|NCT02681094|83340021|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
47060304|NCT02681094|83340022|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
46829826|NCT00417482|83047761|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
46829827|NCT00417482|83047762|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
46829828|NCT00417482|83047763|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
46829829|NCT00417482|83047761|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
46829830|NCT00417482|83047762|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
46829831|NCT00417482|83047763|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
46829832|NCT00417482|83047761|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
46829833|NCT00417482|83047762|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
46829834|NCT00417482|83047763|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
46829835|NCT00417482|83047761|FG000|Phase B 2nd 16 Weeks|Death|1|||
47060305|NCT02681094|83340023|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
47060306|NCT02681094|83340021|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
47060307|NCT02681094|83340022|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
46829836|NCT00417482|83047762|FG001|Phase B 2nd 16 Weeks|Death|1|||
46829837|NCT00417482|83047763|FG002|Phase B 2nd 16 Weeks|Death|0|||
46829838|NCT00417248|83047777|FG000|Overall Study|Study Terminated|6|||
46829839|NCT00417248|83047777|FG000|Overall Study|Death|1|||
46829840|NCT00417248|83047777|FG000|Overall Study|Lack of Efficacy|1|||
46829841|NCT00392288|83047785|FG000|Overall Study|Adverse Event|17|||
46829842|NCT00392288|83047786|FG001|Overall Study|Adverse Event|7|||
46829843|NCT00392288|83047787|FG002|Overall Study|Adverse Event|8|||
46829844|NCT00392288|83047785|FG000|Overall Study|Lack of Efficacy|8|||
46829845|NCT00392288|83047786|FG001|Overall Study|Lack of Efficacy|5|||
46829846|NCT00392288|83047787|FG002|Overall Study|Lack of Efficacy|3|||
46829847|NCT00392288|83047785|FG000|Overall Study|Protocol Violation|1|||
46829848|NCT00392288|83047786|FG001|Overall Study|Protocol Violation|3|||
46829849|NCT00392288|83047787|FG002|Overall Study|Protocol Violation|1|||
46829850|NCT00392288|83047785|FG000|Overall Study|Lost to Follow-up|1|||
46829851|NCT00392288|83047786|FG001|Overall Study|Lost to Follow-up|1|||
46829852|NCT00392288|83047787|FG002|Overall Study|Lost to Follow-up|1|||
46829853|NCT00392288|83047785|FG000|Overall Study|Withdrawal by Subject|1|||
46829854|NCT00392288|83047786|FG001|Overall Study|Withdrawal by Subject|0|||
46829855|NCT00392288|83047787|FG002|Overall Study|Withdrawal by Subject|2|||
46829856|NCT00392288|83047785|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
46829857|NCT00392288|83047786|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
46829858|NCT00392288|83047787|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
46829859|NCT00392288|83047785|FG000|Overall Study|Other|3|||
46829860|NCT00392288|83047786|FG001|Overall Study|Other|4|||
46829861|NCT00392288|83047787|FG002|Overall Study|Other|1|||
46829862|NCT00417170|83047797|FG000|Overall Study|Adverse Event|1|||
46829863|NCT00417170|83047798|FG001|Overall Study|Adverse Event|1|||
46829864|NCT00417170|83047797|FG000|Overall Study|Withdrawal by Subject|1|||
46829865|NCT00417170|83047798|FG001|Overall Study|Withdrawal by Subject|1|||
46829866|NCT00417170|83047797|FG000|Overall Study|Lost to Follow-up|0|||
46829867|NCT00417170|83047798|FG001|Overall Study|Lost to Follow-up|1|||
47060308|NCT02681094|83340023|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
47060309|NCT02681094|83340021|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
47060310|NCT02681094|83340022|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
46829868|NCT00392990|83047806|FG000|Treatment on Study|Adverse Event|3|||
46829869|NCT00392990|83047807|FG001|Treatment on Study|Adverse Event|1|||
46829870|NCT00392990|83047806|FG000|Follow up for 2 Years|Death|4|||
46829871|NCT00392990|83047807|FG001|Follow up for 2 Years|Death|0|||
46829872|NCT00249873|83047815|FG000|Overall Study|Not treated|7|||
46829873|NCT00249873|83047816|FG001|Overall Study|Not treated|8|||
46829874|NCT00249873|83047815|FG000|Overall Study|Significant thrombocytopenia|9|||
46829875|NCT00249873|83047816|FG001|Overall Study|Significant thrombocytopenia|8|||
46829876|NCT00249873|83047815|FG000|Overall Study|Severe allergic reaction|8|||
46829877|NCT00249873|83047816|FG001|Overall Study|Severe allergic reaction|1|||
46829878|NCT00249873|83047815|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
47060311|NCT02681094|83340023|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
46829879|NCT00249873|83047816|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
46829880|NCT00249873|83047815|FG000|Overall Study|Other Serious Adverse Event|86|||
46829881|NCT00249873|83047816|FG001|Overall Study|Other Serious Adverse Event|97|||
46829882|NCT00249873|83047815|FG000|Overall Study|Qualifying condition not present|20|||
46829883|NCT00249873|83047816|FG001|Overall Study|Qualifying condition not present|23|||
46829884|NCT00249873|83047815|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
46829885|NCT00249873|83047816|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
46829886|NCT00249873|83047815|FG000|Overall Study|Withdrawal by Subject|504|||
46829887|NCT00249873|83047816|FG001|Overall Study|Withdrawal by Subject|466|||
47060312|NCT02681094|83340021|FG000|1 -Modified Enrolled Participants Set|Other|6|||
47060313|NCT02681094|83340022|FG001|1 -Modified Enrolled Participants Set|Other|6|||
47060314|NCT02681094|83340023|FG002|1 -Modified Enrolled Participants Set|Other|7|||
46829888|NCT00249873|83047815|FG000|Overall Study|Lost to Follow-up|4|||
46829889|NCT00249873|83047816|FG001|Overall Study|Lost to Follow-up|7|||
46829890|NCT00249873|83047815|FG000|Overall Study|Minor bleeding|99|||
46829891|NCT00249873|83047816|FG001|Overall Study|Minor bleeding|37|||
46829892|NCT00249873|83047815|FG000|Overall Study|Non-compliance|41|||
46829893|NCT00249873|83047816|FG001|Overall Study|Non-compliance|46|||
46829894|NCT00249873|83047815|FG000|Overall Study|Other non serious Adverse Event|112|||
46829895|NCT00249873|83047816|FG001|Overall Study|Other non serious Adverse Event|108|||
46829896|NCT00249873|83047815|FG000|Overall Study|Other contraindicated medication|1|||
46829897|NCT00249873|83047816|FG001|Overall Study|Other contraindicated medication|0|||
46936168|NCT02557516|83172629|FG002|Overall Study|Physician Decision|0|||
46936169|NCT02557516|83172630|FG003|Overall Study|Physician Decision|0|||
46936170|NCT02557516|83172627|FG000|Overall Study|Sponsor decision|0|||
46936171|NCT02557516|83172628|FG001|Overall Study|Sponsor decision|1|||
46936172|NCT02557516|83172629|FG002|Overall Study|Sponsor decision|2|||
46936173|NCT02557516|83172630|FG003|Overall Study|Sponsor decision|8|||
46936174|NCT00711555|83172649|FG000|Overall Study|Adverse Event|3|||
46936175|NCT02713490|83172654|FG000|Overall Study|Withdrawal by Subject|2|||
46936176|NCT02713490|83172655|FG001|Overall Study|Withdrawal by Subject|1|||
46936177|NCT02713490|83172654|FG000|Overall Study|Did not receive study drug|1|||
46936178|NCT02713490|83172655|FG001|Overall Study|Did not receive study drug|0|||
46936179|NCT02713490|83172654|FG000|Overall Study|Met exclusion criteria|0|||
46936180|NCT02713490|83172655|FG001|Overall Study|Met exclusion criteria|1|||
46936181|NCT03772574|83172664|FG000|Overall Study|Protocol Violation|2|||
46936182|NCT03772574|83172665|FG001|Overall Study|Protocol Violation|0|||
46936183|NCT03772574|83172666|FG002|Overall Study|Protocol Violation|0|||
47060315|NCT02681094|83340021|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
47060316|NCT02681094|83340022|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
47060317|NCT02681094|83340023|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
47060318|NCT02681094|83340021|FG000|2 - Enrolled Participants Set|Participant decision|7|||
47060319|NCT02681094|83340022|FG001|2 - Enrolled Participants Set|Participant decision|10|||
46829898|NCT00249873|83047815|FG000|Overall Study|Patient not wish to continue after May08|3|||
46829899|NCT00249873|83047816|FG001|Overall Study|Patient not wish to continue after May08|4|||
46829900|NCT00249873|83047815|FG000|Overall Study|Physician withdrew consent|59|||
46829901|NCT00249873|83047816|FG001|Overall Study|Physician withdrew consent|60|||
46829902|NCT00249873|83047815|FG000|Overall Study|Open label clopidogrel required|31|||
46829903|NCT00249873|83047816|FG001|Overall Study|Open label clopidogrel required|42|||
46829904|NCT00249873|83047815|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
46829905|NCT00249873|83047816|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
46829906|NCT00249873|83047815|FG000|Overall Study|Oral anticoagulant required|159|||
46829907|NCT00249873|83047816|FG001|Overall Study|Oral anticoagulant required|157|||
46829908|NCT00249873|83047815|FG000|Overall Study|Study drug intolerance|5|||
46829909|NCT00249873|83047816|FG001|Overall Study|Study drug intolerance|0|||
46829910|NCT00249873|83047815|FG000|Overall Study|Surgery/ procedure|9|||
46829911|NCT00249873|83047816|FG001|Overall Study|Surgery/ procedure|9|||
46829912|NCT00249873|83047815|FG000|Overall Study|Event related to cardiac condition|12|||
47060320|NCT02681094|83340023|FG002|2 - Enrolled Participants Set|Participant decision|9|||
46829913|NCT00249873|83047816|FG001|Overall Study|Event related to cardiac condition|21|||
46829914|NCT00249873|83047815|FG000|Overall Study|Thromboembolic/outcome event|82|||
46829915|NCT00249873|83047816|FG001|Overall Study|Thromboembolic/outcome event|122|||
46936184|NCT03772574|83172664|FG000|Overall Study|Discomfort|0|||
46936185|NCT03772574|83172665|FG001|Overall Study|Discomfort|5|||
46936186|NCT03772574|83172666|FG002|Overall Study|Discomfort|4|||
46936187|NCT02743221|83172676|FG000|Overall Study|Progressive disease|29|||
46829916|NCT00392210|83047824|FG000|First Voiding Trial|Physician Decision|2|||
46829917|NCT00392210|83047825|FG001|First Voiding Trial|Physician Decision|2|||
46936188|NCT02743221|83172677|FG001|Overall Study|Progressive disease|38|||
46936189|NCT02743221|83172676|FG000|Overall Study|Adverse Event|17|||
47060321|NCT02681094|83340021|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
46936190|NCT02743221|83172677|FG001|Overall Study|Adverse Event|14|||
46936191|NCT02743221|83172676|FG000|Overall Study|non medical reason|8|||
46936192|NCT02743221|83172677|FG001|Overall Study|non medical reason|2|||
46936193|NCT02743221|83172676|FG000|Overall Study|Physician Decision|2|||
47060322|NCT02681094|83340022|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
47060323|NCT02681094|83340023|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
47060324|NCT02681094|83340021|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
47060325|NCT02681094|83340022|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
47060326|NCT02681094|83340023|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
47060327|NCT02681094|83340021|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
47060328|NCT02681094|83340022|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
47060329|NCT02681094|83340023|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
46764377|NCT00824408|82982618|FG003|Randomized Phase|Adverse Event|5|||
46764378|NCT00824408|82982619|FG004|Randomized Phase|Adverse Event|5|||
46764379|NCT00824408|82982615|FG000|Randomized Phase|Refused to continue medication|0|||
46764380|NCT00824408|82982616|FG001|Randomized Phase|Refused to continue medication|0|||
46936194|NCT02743221|83172677|FG001|Overall Study|Physician Decision|5|||
46936195|NCT02743221|83172676|FG000|Overall Study|Patient not eligible, not treated|0|||
46936196|NCT02743221|83172677|FG001|Overall Study|Patient not eligible, not treated|1|||
46936197|NCT03836625|83172685|FG000|Overall Study|Lost to Follow-up|9|||
46936198|NCT03836625|83172686|FG001|Overall Study|Lost to Follow-up|9|||
46936199|NCT03836625|83172685|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
46936200|NCT03836625|83172686|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
47060330|NCT02681094|83340021|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
47060331|NCT02681094|83340022|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
47060332|NCT02681094|83340023|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
47060333|NCT02681094|83340021|FG000|2 - Enrolled Participants Set|Other|6|||
47060334|NCT02681094|83340022|FG001|2 - Enrolled Participants Set|Other|6|||
46936201|NCT03836625|83172685|FG000|Overall Study|Death|0|||
47060335|NCT02681094|83340023|FG002|2 - Enrolled Participants Set|Other|7|||
46764381|NCT00824408|82982617|FG002|Randomized Phase|Refused to continue medication|2|||
46764382|NCT00824408|82982618|FG003|Randomized Phase|Refused to continue medication|2|||
46764383|NCT00824408|82982619|FG004|Randomized Phase|Refused to continue medication|2|||
46764384|NCT00824408|82982615|FG000|Randomized Phase|Other reason not defined above|0|||
46764385|NCT00824408|82982616|FG001|Randomized Phase|Other reason not defined above|0|||
46829918|NCT00391976|83047834|FG000|Overall Study|Adverse Event|0|||
46829919|NCT00391976|83047835|FG001|Overall Study|Adverse Event|0|||
46829920|NCT00391976|83047836|FG002|Overall Study|Adverse Event|1|||
46829921|NCT00391976|83047834|FG000|Overall Study|Withdrawal of consent|0|||
46829922|NCT00391976|83047835|FG001|Overall Study|Withdrawal of consent|1|||
46829923|NCT00391976|83047836|FG002|Overall Study|Withdrawal of consent|1|||
46764386|NCT00824408|82982617|FG002|Randomized Phase|Other reason not defined above|4|||
46764387|NCT00824408|82982618|FG003|Randomized Phase|Other reason not defined above|2|||
46764388|NCT00824408|82982619|FG004|Randomized Phase|Other reason not defined above|4|||
46764389|NCT00866333|82982640|FG000|Overall Study|Withdrawal of consent|0|||
46764390|NCT00866333|82982641|FG001|Overall Study|Withdrawal of consent|1|||
46764391|NCT00866333|82982642|FG002|Overall Study|Withdrawal of consent|2|||
46764392|NCT00866333|82982640|FG000|Overall Study|Reason not Specified|3|||
46764393|NCT00866333|82982641|FG001|Overall Study|Reason not Specified|1|||
46764394|NCT00866333|82982642|FG002|Overall Study|Reason not Specified|1|||
46764395|NCT00866333|82982640|FG000|Overall Study|Study Terminated by Sponsor|2|||
46764396|NCT00866333|82982641|FG001|Overall Study|Study Terminated by Sponsor|5|||
46764397|NCT00866333|82982642|FG002|Overall Study|Study Terminated by Sponsor|9|||
46764398|NCT00834080|82982650|FG000|Overall Study|Adverse Event|7|||
46829924|NCT00391976|83047834|FG000|Overall Study|Lost to Follow-up|1|||
46829925|NCT00391976|83047835|FG001|Overall Study|Lost to Follow-up|2|||
47060336|NCT02681094|83340021|FG000|2 - Enrolled Participants Set|No treatment given|0|||
46764399|NCT00834080|82982650|FG000|Overall Study|Lost to Follow-up|7|||
46764400|NCT00834080|82982650|FG000|Overall Study|Withdrawal by Subject|5|||
46764401|NCT00834080|82982650|FG000|Overall Study|Other - Pregnancy|1|||
46764402|NCT00834080|82982650|FG000|Overall Study|Other - False positive tests of the UDS|1|||
46764403|NCT00834080|82982650|FG000|Overall Study|Physician Decision|1|||
46764404|NCT00834080|82982650|FG000|Overall Study|Subject Relocated|1|||
46829926|NCT00391976|83047836|FG002|Overall Study|Lost to Follow-up|0|||
46936202|NCT03836625|83172686|FG001|Overall Study|Death|1|||
46936203|NCT03836625|83172685|FG000|Overall Study|Refused follow-up|0|||
46936204|NCT03836625|83172686|FG001|Overall Study|Refused follow-up|1|||
46764405|NCT00823472|82982656|FG000|Overall Study|Physician Decision|24|||
46829927|NCT00391976|83047834|FG000|Overall Study|Inappropriate enrollment|1|||
46829928|NCT00391976|83047835|FG001|Overall Study|Inappropriate enrollment|1|||
46936205|NCT01358968|83172692|FG000|Period 2|Adverse Event|0|||
46936206|NCT01358968|83172693|FG001|Period 2|Adverse Event|1|||
46936207|NCT01358968|83172694|FG002|Period 2|Adverse Event|0|||
47060337|NCT02681094|83340022|FG001|2 - Enrolled Participants Set|No treatment given|1|||
47060338|NCT02681094|83340023|FG002|2 - Enrolled Participants Set|No treatment given|1|||
47060339|NCT02689284|83340034|FG000|Overall Study|Adverse Event|1|||
47060340|NCT02689284|83340035|FG001|Overall Study|Adverse Event|8|||
47060341|NCT02689284|83340034|FG000|Overall Study|Death|0|||
46764406|NCT00823472|82982657|FG001|Overall Study|Physician Decision|28|||
46936208|NCT01358968|83172695|FG003|Period 2|Adverse Event|0|||
46936209|NCT01358968|83172692|FG000|Continued Access Phase|Progression of Disease|0|||
46936210|NCT01358968|83172693|FG001|Continued Access Phase|Progression of Disease|0|||
46936211|NCT01358968|83172694|FG002|Continued Access Phase|Progression of Disease|8|||
46936212|NCT01358968|83172695|FG003|Continued Access Phase|Progression of Disease|4|||
46936213|NCT01358968|83172692|FG000|Continued Access Phase|Protocol Violation|0|||
46936214|NCT01358968|83172693|FG001|Continued Access Phase|Protocol Violation|0|||
46936215|NCT01358968|83172694|FG002|Continued Access Phase|Protocol Violation|0|||
46936216|NCT01358968|83172695|FG003|Continued Access Phase|Protocol Violation|2|||
46936217|NCT01358968|83172692|FG000|Continued Access Phase|Withdrawal by Subject|0|||
46936218|NCT01358968|83172693|FG001|Continued Access Phase|Withdrawal by Subject|0|||
46936219|NCT01358968|83172694|FG002|Continued Access Phase|Withdrawal by Subject|3|||
46936220|NCT01358968|83172695|FG003|Continued Access Phase|Withdrawal by Subject|0|||
46936221|NCT01358968|83172692|FG000|Continued Access Phase|Death|0|||
46936222|NCT01358968|83172693|FG001|Continued Access Phase|Death|0|||
46936223|NCT01358968|83172694|FG002|Continued Access Phase|Death|1|||
46936224|NCT01358968|83172695|FG003|Continued Access Phase|Death|1|||
46936225|NCT00701090|83172707|FG000|Overall Study|Adverse Event|11|||
46936226|NCT00701090|83172708|FG001|Overall Study|Adverse Event|2|||
46936227|NCT00701090|83172707|FG000|Overall Study|Death|0|||
46936228|NCT00701090|83172708|FG001|Overall Study|Death|1|||
46936229|NCT00701090|83172707|FG000|Overall Study|Lack of Efficacy|5|||
46936230|NCT00701090|83172708|FG001|Overall Study|Lack of Efficacy|4|||
46936231|NCT00701090|83172707|FG000|Overall Study|Lost to Follow-up|9|||
46936232|NCT00701090|83172708|FG001|Overall Study|Lost to Follow-up|9|||
46936233|NCT00701090|83172707|FG000|Overall Study|Physician Decision|3|||
46936234|NCT00701090|83172708|FG001|Overall Study|Physician Decision|4|||
46936235|NCT00701090|83172707|FG000|Overall Study|Protocol Violation|2|||
47060342|NCT02689284|83340035|FG001|Overall Study|Death|1|||
47060343|NCT02689284|83340034|FG000|Overall Study|Physician Decision|1|||
47060344|NCT02689284|83340035|FG001|Overall Study|Physician Decision|2|||
47060345|NCT02689284|83340034|FG000|Overall Study|Withdrawal by Subject|0|||
46764407|NCT00856193|82982663|FG000|Period 2|Abnormal test procedure results|0|||
46764408|NCT00856193|82982664|FG001|Period 2|Abnormal test procedure results|1|||
46764409|NCT00856193|82982663|FG000|Period 2|Lost to Follow-up|0|||
46764410|NCT00856193|82982664|FG001|Period 2|Lost to Follow-up|1|||
46764411|NCT00652366|82982675|FG000|Overall Study|Adverse Event|8|||
46764412|NCT00652366|82982676|FG001|Overall Study|Adverse Event|4|||
46764413|NCT00652366|82982677|FG002|Overall Study|Adverse Event|7|||
46764414|NCT00652366|82982678|FG003|Overall Study|Adverse Event|17|||
46764415|NCT00652366|82982679|FG004|Overall Study|Adverse Event|13|||
46764416|NCT00652366|82982675|FG000|Overall Study|Death|5|||
46764417|NCT00652366|82982676|FG001|Overall Study|Death|4|||
46764418|NCT00652366|82982677|FG002|Overall Study|Death|1|||
46764419|NCT00652366|82982678|FG003|Overall Study|Death|8|||
46764420|NCT00652366|82982679|FG004|Overall Study|Death|5|||
46764421|NCT00652366|82982675|FG000|Overall Study|Lack of Efficacy|84|||
46764422|NCT00652366|82982676|FG001|Overall Study|Lack of Efficacy|58|||
46764423|NCT00652366|82982677|FG002|Overall Study|Lack of Efficacy|53|||
46764424|NCT00652366|82982678|FG003|Overall Study|Lack of Efficacy|133|||
46764425|NCT00652366|82982679|FG004|Overall Study|Lack of Efficacy|13|||
46764426|NCT00652366|82982675|FG000|Overall Study|Violation of Selection Criteria|0|||
46764427|NCT00652366|82982676|FG001|Overall Study|Violation of Selection Criteria|0|||
46764428|NCT00652366|82982677|FG002|Overall Study|Violation of Selection Criteria|1|||
46764429|NCT00652366|82982678|FG003|Overall Study|Violation of Selection Criteria|0|||
46764430|NCT00652366|82982679|FG004|Overall Study|Violation of Selection Criteria|0|||
46764431|NCT00652366|82982675|FG000|Overall Study|Protocol Violation|1|||
46764432|NCT00652366|82982676|FG001|Overall Study|Protocol Violation|0|||
46764433|NCT00652366|82982677|FG002|Overall Study|Protocol Violation|0|||
46936236|NCT00701090|83172708|FG001|Overall Study|Protocol Violation|3|||
46936237|NCT00701090|83172707|FG000|Overall Study|Withdrawal by Subject|11|||
46936238|NCT00701090|83172708|FG001|Overall Study|Withdrawal by Subject|16|||
46936239|NCT00701090|83172707|FG000|Overall Study|Other|7|||
46936240|NCT00701090|83172708|FG001|Overall Study|Other|12|||
47060346|NCT02689284|83340035|FG001|Overall Study|Withdrawal by Subject|1|||
46764434|NCT00652366|82982678|FG003|Overall Study|Protocol Violation|0|||
46764435|NCT00652366|82982679|FG004|Overall Study|Protocol Violation|0|||
46764436|NCT00652366|82982675|FG000|Overall Study|Refused treatment|3|||
46764437|NCT00652366|82982676|FG001|Overall Study|Refused treatment|7|||
46764438|NCT00652366|82982677|FG002|Overall Study|Refused treatment|6|||
46829929|NCT00391976|83047836|FG002|Overall Study|Inappropriate enrollment|0|||
46829930|NCT00391976|83047834|FG000|Overall Study|Protocol deviation/violation|4|||
46829931|NCT00391976|83047835|FG001|Overall Study|Protocol deviation/violation|2|||
46829932|NCT00391976|83047836|FG002|Overall Study|Protocol deviation/violation|1|||
46829933|NCT00391976|83047834|FG000|Overall Study|Recurrence/no eradication of infection|21|||
46829934|NCT00391976|83047835|FG001|Overall Study|Recurrence/no eradication of infection|19|||
46829935|NCT00391976|83047836|FG002|Overall Study|Recurrence/no eradication of infection|0|||
46829936|NCT00391976|83047834|FG000|Overall Study|Unable to classify|0|||
46829937|NCT00391976|83047835|FG001|Overall Study|Unable to classify|0|||
46829938|NCT00391976|83047836|FG002|Overall Study|Unable to classify|1|||
46829939|NCT00391976|83047834|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
46829940|NCT00391976|83047835|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
46829941|NCT00391976|83047836|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
46829942|NCT00391898|83047848|FG000|Overall Study|Adverse Event|3|||
46829943|NCT00391898|83047849|FG001|Overall Study|Adverse Event|0|||
46829944|NCT00391898|83047848|FG000|Overall Study|Other|8|||
46829945|NCT00391898|83047849|FG001|Overall Study|Other|10|||
46829946|NCT00391586|83047855|FG000|Overall Study|Progressive disease|13|||
46829947|NCT00391586|83047855|FG000|Overall Study|Adverse Event|5|||
46829948|NCT00391586|83047855|FG000|Overall Study|Physician Decision|2|||
46829949|NCT00391586|83047855|FG000|Overall Study|Death|4|||
46829950|NCT00391430|83047862|FG000|Overall Study|Withdrawal by Subject|3|||
46829951|NCT00391430|83047863|FG001|Overall Study|Withdrawal by Subject|0|||
46829952|NCT00391430|83047864|FG002|Overall Study|Withdrawal by Subject|12|||
46829953|NCT00391274|83047874|FG000|Overall Study|Death Due to Study Disease|55|||
46829954|NCT00391274|83047875|FG001|Overall Study|Death Due to Study Disease|45|||
46829955|NCT00391274|83047874|FG000|Overall Study|Lost to Follow-up|0|||
46829956|NCT00391274|83047875|FG001|Overall Study|Lost to Follow-up|3|||
46829957|NCT00391274|83047874|FG000|Overall Study|Physician Decision|4|||
46829958|NCT00391274|83047875|FG001|Overall Study|Physician Decision|2|||
46829959|NCT00391274|83047874|FG000|Overall Study|Withdrawal by Subject|0|||
46829960|NCT00391274|83047875|FG001|Overall Study|Withdrawal by Subject|3|||
46829961|NCT00391274|83047874|FG000|Overall Study|Death Due to Adverse Event|1|||
46829962|NCT00391274|83047875|FG001|Overall Study|Death Due to Adverse Event|3|||
46829963|NCT00391274|83047874|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
46829964|NCT00391274|83047875|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
46829965|NCT00391274|83047874|FG000|Overall Study|Death Not Study Related|0|||
46829966|NCT00391274|83047875|FG001|Overall Study|Death Not Study Related|1|||
46829967|NCT00391118|83047884|FG000|Overall Study|Adverse Event|3|||
46829968|NCT00391118|83047885|FG001|Overall Study|Adverse Event|10|||
46829969|NCT00391118|83047886|FG002|Overall Study|Adverse Event|7|||
46829970|NCT00391118|83047884|FG000|Overall Study|Lost to Follow-up|0|||
46829971|NCT00391118|83047885|FG001|Overall Study|Lost to Follow-up|2|||
46829972|NCT00391118|83047886|FG002|Overall Study|Lost to Follow-up|3|||
46829973|NCT00391118|83047884|FG000|Overall Study|Withdrawal by Subject|0|||
46829974|NCT00391118|83047885|FG001|Overall Study|Withdrawal by Subject|9|||
46829975|NCT00391118|83047886|FG002|Overall Study|Withdrawal by Subject|1|||
46829976|NCT00391118|83047884|FG000|Overall Study|Death|0|||
46829977|NCT00391118|83047885|FG001|Overall Study|Death|1|||
46829978|NCT00391118|83047886|FG002|Overall Study|Death|0|||
46829979|NCT00391118|83047884|FG000|Overall Study|Physician Decision|0|||
46829980|NCT00391118|83047885|FG001|Overall Study|Physician Decision|3|||
46829981|NCT00391118|83047886|FG002|Overall Study|Physician Decision|0|||
46829982|NCT00391118|83047884|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
46829983|NCT00391118|83047885|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
46829984|NCT00391118|83047886|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
46829985|NCT00391118|83047884|FG000|Overall Study|Progressive Disease|7|||
46936241|NCT03057977|83172716|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
47060347|NCT02689284|83340034|FG000|Overall Study|progression of cancer|1|||
47060348|NCT02689284|83340035|FG001|Overall Study|progression of cancer|72|||
47060349|NCT02689284|83340034|FG000|Overall Study|decreased heart function|0|||
47060350|NCT02689284|83340035|FG001|Overall Study|decreased heart function|1|||
46829986|NCT00391118|83047885|FG001|Overall Study|Progressive Disease|26|||
46829987|NCT00391118|83047886|FG002|Overall Study|Progressive Disease|43|||
46829988|NCT00391118|83047884|FG000|Overall Study|Sponsor Decision|0|||
46829989|NCT00391118|83047885|FG001|Overall Study|Sponsor Decision|1|||
46829990|NCT00391118|83047886|FG002|Overall Study|Sponsor Decision|3|||
46829991|NCT00391118|83047884|FG000|Overall Study|Protocol Violation|1|||
46829992|NCT00391118|83047885|FG001|Overall Study|Protocol Violation|0|||
46829993|NCT00391118|83047886|FG002|Overall Study|Protocol Violation|0|||
46829994|NCT00390884|83047899|FG000|Overall Study|Withdrawal by Subject|2|||
46829995|NCT00390884|83047900|FG001|Overall Study|Withdrawal by Subject|2|||
46829996|NCT00365846|83047906|FG000|Overall Study|Lost to Follow-up|1|||
46829997|NCT00264537|83047916|FG000|Overall Study|Death|0|||
46829998|NCT00264537|83047917|FG001|Overall Study|Death|3|||
46829999|NCT00264537|83047918|FG002|Overall Study|Death|3|||
46830000|NCT00264537|83047919|FG003|Overall Study|Death|2|||
46936242|NCT03057977|83172717|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
46936243|NCT03057977|83172716|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
46936244|NCT03057977|83172717|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
46936245|NCT03057977|83172716|FG000|Discontinuation From Treatment|Protocol Violation|6|||
46936246|NCT03057977|83172717|FG001|Discontinuation From Treatment|Protocol Violation|5|||
46936247|NCT03057977|83172716|FG000|Discontinuation From Treatment|Not treated|4|||
46936248|NCT03057977|83172717|FG001|Discontinuation From Treatment|Not treated|0|||
46936249|NCT03057977|83172716|FG000|Discontinuation From Treatment|Adverse Event|343|||
46936250|NCT03057977|83172717|FG001|Discontinuation From Treatment|Adverse Event|337|||
46936251|NCT03057977|83172716|FG000|Discontinuation From Treatment|Reason Unknown|0|||
46936252|NCT03057977|83172717|FG001|Discontinuation From Treatment|Reason Unknown|1|||
46936253|NCT03057977|83172716|FG000|Discontinuation From Treatment|Personal Reasons|1|||
46936254|NCT03057977|83172717|FG001|Discontinuation From Treatment|Personal Reasons|1|||
46936255|NCT03057977|83172716|FG000|Discontinuation From Treatment|Unblinded medication|1|||
46936256|NCT03057977|83172717|FG001|Discontinuation From Treatment|Unblinded medication|0|||
46936257|NCT03057977|83172716|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
46936258|NCT03057977|83172717|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
46936259|NCT03057977|83172716|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
46764439|NCT00652366|82982678|FG003|Overall Study|Refused treatment|17|||
46830001|NCT00264537|83047916|FG000|Overall Study|Lost to Follow-up|3|||
46830002|NCT00264537|83047917|FG001|Overall Study|Lost to Follow-up|4|||
46830003|NCT00264537|83047918|FG002|Overall Study|Lost to Follow-up|7|||
46830004|NCT00264537|83047919|FG003|Overall Study|Lost to Follow-up|6|||
46830005|NCT00264537|83047916|FG000|Overall Study|Adverse Event|21|||
46830006|NCT00264537|83047917|FG001|Overall Study|Adverse Event|32|||
46830007|NCT00264537|83047918|FG002|Overall Study|Adverse Event|24|||
46830008|NCT00264537|83047919|FG003|Overall Study|Adverse Event|34|||
46830009|NCT00264537|83047916|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
46830010|NCT00264537|83047917|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
46830011|NCT00264537|83047918|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
46830012|NCT00264537|83047919|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
46830013|NCT00264537|83047916|FG000|Overall Study|Other|21|||
46830014|NCT00264537|83047917|FG001|Overall Study|Other|11|||
46830015|NCT00264537|83047918|FG002|Overall Study|Other|10|||
46830016|NCT00264537|83047919|FG003|Overall Study|Other|11|||
46830017|NCT00264537|83047916|FG000|Overall Study|Not treated|0|||
46830018|NCT00264537|83047917|FG001|Overall Study|Not treated|2|||
46830019|NCT00264537|83047918|FG002|Overall Study|Not treated|1|||
46830020|NCT00264537|83047919|FG003|Overall Study|Not treated|0|||
46830021|NCT00371462|83047933|FG000|Overall Study|Withdrawal by Subject|1|||
46830022|NCT00371462|83047934|FG001|Overall Study|Withdrawal by Subject|0|||
46830023|NCT00371462|83047933|FG000|Overall Study|Other|7|||
46830024|NCT00371462|83047934|FG001|Overall Study|Other|8|||
46830025|NCT00371150|83047942|FG000|Overall Study|Lost to Follow-up|3|||
46830026|NCT00371150|83047943|FG001|Overall Study|Lost to Follow-up|2|||
46830027|NCT00264303|83047955|FG000|Overall Study|Adverse Event|4|||
46830028|NCT00264303|83047956|FG001|Overall Study|Adverse Event|3|||
46830029|NCT00264303|83047955|FG000|Overall Study|Lack of Efficacy|10|||
46830030|NCT00264303|83047956|FG001|Overall Study|Lack of Efficacy|13|||
46830031|NCT00264303|83047955|FG000|Overall Study|Lost to Follow-up|3|||
46830032|NCT00264303|83047956|FG001|Overall Study|Lost to Follow-up|3|||
46830033|NCT00264303|83047955|FG000|Overall Study|Withdrawal by Subject|2|||
46830034|NCT00264303|83047956|FG001|Overall Study|Withdrawal by Subject|3|||
46830035|NCT00264303|83047955|FG000|Overall Study|Various reasons listed in study report|6|||
46830036|NCT00264303|83047956|FG001|Overall Study|Various reasons listed in study report|7|||
46830037|NCT00370682|83047965|FG000|Overall Study|Moved from area|0|||
46830038|NCT00370682|83047966|FG001|Overall Study|Moved from area|2|||
46830039|NCT00370682|83047967|FG002|Overall Study|Moved from area|0|||
46830040|NCT00370682|83047965|FG000|Overall Study|Lost to Follow-up|0|||
46830041|NCT00370682|83047966|FG001|Overall Study|Lost to Follow-up|1|||
46936260|NCT03057977|83172717|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
47060351|NCT02689284|83340034|FG000|Overall Study|concern for anemia|0|||
46764440|NCT00652366|82982679|FG004|Overall Study|Refused treatment|5|||
46764441|NCT00652366|82982675|FG000|Overall Study|Other|5|||
46764442|NCT00652366|82982676|FG001|Overall Study|Other|2|||
46764443|NCT00652366|82982677|FG002|Overall Study|Other|3|||
46764444|NCT00652366|82982678|FG003|Overall Study|Other|4|||
46764445|NCT00652366|82982679|FG004|Overall Study|Other|0|||
46764446|NCT00841568|82982693|FG000|Overall Study|Adverse Event|1|||
46764447|NCT00841568|82982693|FG000|Overall Study|Death|1|||
46764448|NCT00841568|82982693|FG000|Overall Study|Withdrawal by Subject|2|||
46764449|NCT00841568|82982693|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
46764450|NCT00855959|82982701|FG000|Overall Study|Adverse Event|2|||
46764451|NCT00855959|82982701|FG000|Overall Study|Lost to Follow-up|2|||
46764452|NCT00855959|82982701|FG000|Overall Study|Withdrawal by Subject|3|||
46764453|NCT00855959|82982701|FG000|Overall Study|Pregnancy|1|||
46830042|NCT00370682|83047967|FG002|Overall Study|Lost to Follow-up|1|||
46830043|NCT00264147|83047984|FG000|Treatment I Period|Adverse Event|3|||
46830044|NCT00264147|83047985|FG001|Treatment I Period|Adverse Event|6|||
46830045|NCT00264147|83047986|FG002|Treatment I Period|Adverse Event|3|||
46830046|NCT00264147|83047987|FG003|Treatment I Period|Adverse Event|5|||
46830047|NCT00264147|83047988|FG004|Treatment I Period|Adverse Event|7|||
46830048|NCT00264147|83047989|FG005|Treatment I Period|Adverse Event|0|||
46830049|NCT00264147|83047984|FG000|Treatment I Period|Laboratory Adverse Event|0|||
46830050|NCT00264147|83047985|FG001|Treatment I Period|Laboratory Adverse Event|0|||
46830051|NCT00264147|83047986|FG002|Treatment I Period|Laboratory Adverse Event|0|||
46830052|NCT00264147|83047987|FG003|Treatment I Period|Laboratory Adverse Event|1|||
46830053|NCT00264147|83047988|FG004|Treatment I Period|Laboratory Adverse Event|0|||
46830054|NCT00264147|83047989|FG005|Treatment I Period|Laboratory Adverse Event|0|||
46830055|NCT00264147|83047984|FG000|Treatment I Period|Lack of Efficacy|6|||
46830056|NCT00264147|83047985|FG001|Treatment I Period|Lack of Efficacy|2|||
46830057|NCT00264147|83047986|FG002|Treatment I Period|Lack of Efficacy|8|||
46830058|NCT00264147|83047987|FG003|Treatment I Period|Lack of Efficacy|0|||
46830059|NCT00264147|83047988|FG004|Treatment I Period|Lack of Efficacy|1|||
46830060|NCT00264147|83047989|FG005|Treatment I Period|Lack of Efficacy|0|||
46830061|NCT00264147|83047984|FG000|Treatment I Period|Lost to Follow-up|1|||
46830062|NCT00264147|83047985|FG001|Treatment I Period|Lost to Follow-up|0|||
46830063|NCT00264147|83047986|FG002|Treatment I Period|Lost to Follow-up|0|||
46830064|NCT00264147|83047987|FG003|Treatment I Period|Lost to Follow-up|1|||
46830065|NCT00264147|83047988|FG004|Treatment I Period|Lost to Follow-up|1|||
46830066|NCT00264147|83047989|FG005|Treatment I Period|Lost to Follow-up|0|||
46830067|NCT00264147|83047984|FG000|Treatment I Period|Protocol Violation|2|||
46830068|NCT00264147|83047985|FG001|Treatment I Period|Protocol Violation|2|||
46830069|NCT00264147|83047986|FG002|Treatment I Period|Protocol Violation|0|||
46830070|NCT00264147|83047987|FG003|Treatment I Period|Protocol Violation|0|||
46830071|NCT00264147|83047988|FG004|Treatment I Period|Protocol Violation|0|||
46830072|NCT00264147|83047989|FG005|Treatment I Period|Protocol Violation|0|||
46830073|NCT00264147|83047984|FG000|Treatment I Period|Withdrawal by Subject|2|||
46830074|NCT00264147|83047985|FG001|Treatment I Period|Withdrawal by Subject|0|||
46830075|NCT00264147|83047986|FG002|Treatment I Period|Withdrawal by Subject|0|||
46830076|NCT00264147|83047987|FG003|Treatment I Period|Withdrawal by Subject|2|||
46830077|NCT00264147|83047988|FG004|Treatment I Period|Withdrawal by Subject|2|||
46830078|NCT00264147|83047989|FG005|Treatment I Period|Withdrawal by Subject|0|||
46830079|NCT00264147|83047984|FG000|Treatment I Period|Patient out of town for an extended time|0|||
46830080|NCT00264147|83047985|FG001|Treatment I Period|Patient out of town for an extended time|1|||
46830081|NCT00264147|83047986|FG002|Treatment I Period|Patient out of town for an extended time|0|||
46830082|NCT00264147|83047987|FG003|Treatment I Period|Patient out of town for an extended time|0|||
46830083|NCT00264147|83047988|FG004|Treatment I Period|Patient out of town for an extended time|0|||
46830084|NCT00264147|83047989|FG005|Treatment I Period|Patient out of town for an extended time|0|||
46830085|NCT00264147|83047984|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
46830086|NCT00264147|83047985|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
46830087|NCT00264147|83047986|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
46830088|NCT00264147|83047987|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
46830089|NCT00264147|83047988|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
46830090|NCT00264147|83047989|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
46830091|NCT00264147|83047984|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
46830092|NCT00264147|83047985|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
46830093|NCT00264147|83047986|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
46830094|NCT00264147|83047987|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
46830095|NCT00264147|83047988|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
46967795|NCT02181634|83210375|FG000|Overall Study|Max number of dose reduction|1|||
46764454|NCT00855959|82982701|FG000|Overall Study|Incorrect enrolment|1|||
46764455|NCT00841100|82982705|FG000|Phase 1 (28 Days)|Adverse Event|1|||
46764456|NCT00841100|82982705|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
46764457|NCT00651820|82982709|FG000|Overall Study|Lost to Follow-up|2|||
46764458|NCT00866177|82982715|FG000|Overall Study|Withdrawal by Subject|1|||
46764459|NCT00866177|82982715|FG000|Overall Study|Not Treated|151|||
46764460|NCT00833924|82982719|FG000|Overall Study|Death|21|||
46764461|NCT00833924|82982719|FG000|Overall Study|Conversion|2|||
46764462|NCT00833924|82982719|FG000|Overall Study|Lost to Follow-up|2|||
46764463|NCT00833924|82982719|FG000|Overall Study|Withdrawal by Subject|13|||
46764464|NCT00833924|82982719|FG000|Overall Study|In study follow-up|71|||
46830096|NCT00264147|83047989|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
46830097|NCT00264147|83047984|FG000|Treatment II Period|Adverse Event|0|||
46830098|NCT00264147|83047985|FG001|Treatment II Period|Adverse Event|0|||
46830099|NCT00264147|83047986|FG002|Treatment II Period|Adverse Event|0|||
46637574|NCT01474512|82811391|FG015|Maintenance Period|Withdrawal by Subject|0|||
46764465|NCT00840086|82982723|FG000|Overall Study|Adverse Event|1|||
46764466|NCT00840086|82982723|FG000|Overall Study|Protocol Violation|2|||
46637575|NCT01474512|82811392|FG016|Maintenance Period|Withdrawal by Subject|0|||
46637576|NCT01474512|82811393|FG017|Maintenance Period|Withdrawal by Subject|0|||
46764467|NCT00840086|82982723|FG000|Overall Study|Lost to Follow-up|1|||
46764468|NCT00822926|82982732|FG000|Second Injection Visit|Lost to Follow-up|1|||
46764469|NCT00822926|82982733|FG001|Second Injection Visit|Lost to Follow-up|0|||
46764470|NCT00822926|82982732|FG000|Second Injection Visit|Withdrawal by Subject|0|||
46764471|NCT00822926|82982733|FG001|Second Injection Visit|Withdrawal by Subject|1|||
46764472|NCT00822770|82982744|FG000|Overall Study|Not treated|1|||
46764473|NCT00822770|82982745|FG001|Overall Study|Not treated|0|||
46764474|NCT00822770|82982744|FG000|Overall Study|Complication/Incomplete treatment|1|||
46764475|NCT00822770|82982745|FG001|Overall Study|Complication/Incomplete treatment|0|||
46764476|NCT00822770|82982744|FG000|Overall Study|Death|1|||
46764477|NCT00822770|82982745|FG001|Overall Study|Death|1|||
46764478|NCT00822692|82982753|FG000|Overall Study|Lost to Follow-up|17|||
46764479|NCT00822692|82982754|FG001|Overall Study|Lost to Follow-up|25|||
46764480|NCT00806442|82982760|FG000|Overall Study|Lost to Follow-up|3|||
46764481|NCT00806442|82982761|FG001|Overall Study|Lost to Follow-up|2|||
46764482|NCT00806442|82982760|FG000|Overall Study|Withdrawal by Subject|1|||
46764483|NCT00806442|82982761|FG001|Overall Study|Withdrawal by Subject|5|||
46764484|NCT00821678|82982771|FG000|Overall Study|Withdrawal by Subject|8|||
46764485|NCT00821678|82982772|FG001|Overall Study|Withdrawal by Subject|0|||
46764486|NCT00821678|82982771|FG000|Overall Study|Lost to Follow-up|13|||
46764487|NCT00821678|82982772|FG001|Overall Study|Lost to Follow-up|12|||
46764488|NCT00821678|82982771|FG000|Overall Study|Death|0|||
46764489|NCT00821678|82982772|FG001|Overall Study|Death|2|||
46764490|NCT00839852|82982780|FG000|Overall Study|Adverse Event|10|||
46764491|NCT00839852|82982780|FG000|Overall Study|Insufficient Therapeutic Response|3|||
46764492|NCT00839852|82982780|FG000|Overall Study|Protocol Violation|9|||
46764493|NCT00839852|82982780|FG000|Overall Study|Withdrawal of Consent|16|||
46764494|NCT00839852|82982780|FG000|Overall Study|Lost to Follow-up|7|||
46764495|NCT00839852|82982780|FG000|Overall Study|Lack of Compliance While in Jail|1|||
46764496|NCT00839852|82982780|FG000|Overall Study|Pregnancy|1|||
46764497|NCT00833690|82982787|FG000|Overall Study|Withdrawal by Subject|1|||
46764498|NCT00833690|82982788|FG001|Overall Study|Withdrawal by Subject|0|||
46764499|NCT00833690|82982789|FG002|Overall Study|Withdrawal by Subject|0|||
46764500|NCT00833690|82982787|FG000|Overall Study|Discontinued study drug|3|||
46764501|NCT00833690|82982788|FG001|Overall Study|Discontinued study drug|2|||
46764502|NCT00833690|82982789|FG002|Overall Study|Discontinued study drug|0|||
46764503|NCT00820898|82982797|FG000|Overall Study|Inelgible - wrong primary site|1|||
46764504|NCT00865709|82982809|FG000|Treatment|Adverse Event|9|||
46764505|NCT00865709|82982810|FG001|Treatment|Adverse Event|6|||
46764506|NCT00865709|82982809|FG000|Treatment|Withdrawal by Subject|10|||
46764507|NCT00865709|82982810|FG001|Treatment|Withdrawal by Subject|7|||
46764508|NCT00865709|82982809|FG000|Treatment|Physician Decision|3|||
46764509|NCT00865709|82982810|FG001|Treatment|Physician Decision|2|||
46764510|NCT00865709|82982809|FG000|Treatment|Surgery|8|||
46764511|NCT00865709|82982810|FG001|Treatment|Surgery|3|||
46764512|NCT00839306|82982820|FG000|Overall Study|Adverse Event|3|||
46764513|NCT00839306|82982821|FG001|Overall Study|Adverse Event|5|||
46764514|NCT00839306|82982820|FG000|Overall Study|Lost to Follow-up|6|||
46764515|NCT00839306|82982821|FG001|Overall Study|Lost to Follow-up|9|||
46764516|NCT00839306|82982820|FG000|Overall Study|Withdrawal by Subject|5|||
46764517|NCT00839306|82982821|FG001|Overall Study|Withdrawal by Subject|7|||
46764518|NCT00839306|82982820|FG000|Overall Study|Lack of Efficacy|5|||
46764519|NCT00839306|82982821|FG001|Overall Study|Lack of Efficacy|4|||
46764520|NCT00839306|82982820|FG000|Overall Study|Other|6|||
46764521|NCT00839306|82982821|FG001|Overall Study|Other|18|||
46764522|NCT00839072|82982828|FG000|First Intervention Period|Withdrawal by Subject|1|||
46764523|NCT00839072|82982829|FG001|First Intervention Period|Withdrawal by Subject|0|||
46764524|NCT00839072|82982828|FG000|First Intervention Period|Adverse Event|1|||
46764525|NCT00839072|82982829|FG001|First Intervention Period|Adverse Event|1|||
46764526|NCT00839072|82982828|FG000|Second Intervention Period|Withdrawal by Subject|1|||
46764527|NCT00839072|82982829|FG001|Second Intervention Period|Withdrawal by Subject|0|||
46764528|NCT00855803|82982835|FG000|Overall Study|Death|2|||
46764529|NCT00855803|82982835|FG000|Overall Study|Lost to Follow-up|2|||
46764530|NCT00855803|82982835|FG000|Overall Study|Technical inability to undergo procedure|2|||
46764531|NCT00855803|82982835|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
46764532|NCT00855803|82982835|FG000|Overall Study|Withdrawal by Subject|3|||
46764533|NCT00855803|82982835|FG000|Overall Study|Physician Decision|3|||
46764534|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
46764535|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
46764536|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
46764537|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
46764538|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
46764539|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
46764540|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
46764541|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
46830100|NCT00264147|83047987|FG003|Treatment II Period|Adverse Event|0|||
46830101|NCT00264147|83047988|FG004|Treatment II Period|Adverse Event|9|||
46830102|NCT00264147|83047989|FG005|Treatment II Period|Adverse Event|9|||
46830103|NCT00264147|83047984|FG000|Treatment II Period|Laboratory Adverse Event|0|||
46830104|NCT00264147|83047985|FG001|Treatment II Period|Laboratory Adverse Event|0|||
46830105|NCT00264147|83047986|FG002|Treatment II Period|Laboratory Adverse Event|0|||
46830106|NCT00264147|83047987|FG003|Treatment II Period|Laboratory Adverse Event|0|||
46830107|NCT00264147|83047988|FG004|Treatment II Period|Laboratory Adverse Event|0|||
46830108|NCT00264147|83047989|FG005|Treatment II Period|Laboratory Adverse Event|1|||
46830109|NCT00264147|83047984|FG000|Treatment II Period|Lack of Efficacy|0|||
46830110|NCT00264147|83047985|FG001|Treatment II Period|Lack of Efficacy|0|||
46830111|NCT00264147|83047986|FG002|Treatment II Period|Lack of Efficacy|0|||
46830112|NCT00264147|83047987|FG003|Treatment II Period|Lack of Efficacy|0|||
46830113|NCT00264147|83047988|FG004|Treatment II Period|Lack of Efficacy|20|||
46830114|NCT00264147|83047989|FG005|Treatment II Period|Lack of Efficacy|19|||
46830115|NCT00264147|83047984|FG000|Treatment II Period|Lost to Follow-up|0|||
46830116|NCT00264147|83047985|FG001|Treatment II Period|Lost to Follow-up|0|||
46830117|NCT00264147|83047986|FG002|Treatment II Period|Lost to Follow-up|0|||
46830118|NCT00264147|83047987|FG003|Treatment II Period|Lost to Follow-up|0|||
46830119|NCT00264147|83047988|FG004|Treatment II Period|Lost to Follow-up|1|||
46830120|NCT00264147|83047989|FG005|Treatment II Period|Lost to Follow-up|1|||
46830121|NCT00264147|83047984|FG000|Treatment II Period|Withdrawal by Subject|0|||
46830122|NCT00264147|83047985|FG001|Treatment II Period|Withdrawal by Subject|0|||
46830123|NCT00264147|83047986|FG002|Treatment II Period|Withdrawal by Subject|0|||
46830124|NCT00264147|83047987|FG003|Treatment II Period|Withdrawal by Subject|0|||
46830125|NCT00264147|83047988|FG004|Treatment II Period|Withdrawal by Subject|3|||
46830126|NCT00264147|83047989|FG005|Treatment II Period|Withdrawal by Subject|2|||
46830127|NCT00264147|83047984|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
46830128|NCT00264147|83047985|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
46830129|NCT00264147|83047986|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
46830130|NCT00264147|83047987|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
46830131|NCT00264147|83047988|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
46830132|NCT00264147|83047989|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
46936261|NCT03057977|83172716|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
46936262|NCT03057977|83172717|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
46830133|NCT00263757|83048005|FG000|Overall Study|Withdrawal by Subject|5|||
46830134|NCT00263757|83048006|FG001|Overall Study|Withdrawal by Subject|4|||
46830135|NCT00263757|83048005|FG000|Overall Study|Screen failure|0|||
46830136|NCT00263757|83048006|FG001|Overall Study|Screen failure|1|||
46830137|NCT00263757|83048005|FG000|Overall Study|Adverse Event|3|||
46830138|NCT00263757|83048006|FG001|Overall Study|Adverse Event|3|||
46830139|NCT00263211|83048014|FG000|Overall Study|Death|1|||
46830140|NCT00263211|83048015|FG001|Overall Study|Death|0|||
46936263|NCT03057977|83172716|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
46936264|NCT03057977|83172717|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
46936265|NCT03057977|83172716|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
46637577|NCT01474512|82811376|FG000|Maintenance Period|Lost to Follow-up|0|||
46637578|NCT01474512|82811377|FG001|Maintenance Period|Lost to Follow-up|0|||
46637579|NCT01474512|82811378|FG002|Maintenance Period|Lost to Follow-up|0|||
46637580|NCT01474512|82811379|FG003|Maintenance Period|Lost to Follow-up|3|||
46637581|NCT01474512|82811380|FG004|Maintenance Period|Lost to Follow-up|3|||
46637582|NCT01474512|82811381|FG005|Maintenance Period|Lost to Follow-up|0|||
46637583|NCT01474512|82811382|FG006|Maintenance Period|Lost to Follow-up|0|||
46637584|NCT01474512|82811383|FG007|Maintenance Period|Lost to Follow-up|2|||
46637585|NCT01474512|82811384|FG008|Maintenance Period|Lost to Follow-up|1|||
46637586|NCT01474512|82811385|FG009|Maintenance Period|Lost to Follow-up|1|||
46637587|NCT01474512|82811386|FG010|Maintenance Period|Lost to Follow-up|0|||
46637588|NCT01474512|82811387|FG011|Maintenance Period|Lost to Follow-up|0|||
46637589|NCT01474512|82811388|FG012|Maintenance Period|Lost to Follow-up|0|||
46637590|NCT01474512|82811389|FG013|Maintenance Period|Lost to Follow-up|0|||
46764542|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
46764543|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
46764544|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
46764545|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
46764546|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
46764547|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
46764548|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
46764549|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
46764550|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Missing|3|||
46936266|NCT03057977|83172717|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
46936267|NCT03057977|83172716|FG000|Discontinuation From Treatment|Not attending study visit|3|||
46637591|NCT01474512|82811390|FG014|Maintenance Period|Lost to Follow-up|0|||
46830141|NCT00263211|83048014|FG000|Overall Study|Withdrawal by Subject|3|||
46830142|NCT00263211|83048015|FG001|Overall Study|Withdrawal by Subject|0|||
46830143|NCT00263211|83048014|FG000|Overall Study|Protocol Violation|1|||
46830144|NCT00263211|83048015|FG001|Overall Study|Protocol Violation|0|||
46830145|NCT00263211|83048014|FG000|Overall Study|Disease Progression|0|||
46830146|NCT00263211|83048015|FG001|Overall Study|Disease Progression|1|||
46830147|NCT00248625|83048026|FG000|Overall Study|Withdrawal by Subject|0|||
46830148|NCT00248625|83048027|FG001|Overall Study|Withdrawal by Subject|2|||
46830149|NCT00262821|83048035|FG000|Overall Study|Ineligible - wrong stage|0|||
46830150|NCT00262821|83048036|FG001|Overall Study|Ineligible - wrong stage|3|||
46830151|NCT00262821|83048035|FG000|Overall Study|Ineligible - wrong cell type|2|||
46830152|NCT00262821|83048036|FG001|Overall Study|Ineligible - wrong cell type|2|||
46830153|NCT00262821|83048035|FG000|Overall Study|Ineligible - wrong primary|0|||
46830154|NCT00262821|83048036|FG001|Overall Study|Ineligible - wrong primary|1|||
46830155|NCT00262821|83048035|FG000|Overall Study|Ineligible - inadequate pathology|1|||
46830156|NCT00262821|83048036|FG001|Overall Study|Ineligible - inadequate pathology|3|||
46830157|NCT00262821|83048035|FG000|Overall Study|Ineligible - elevated creatinine|0|||
46830158|NCT00262821|83048036|FG001|Overall Study|Ineligible - elevated creatinine|2|||
46830159|NCT00262821|83048035|FG000|Overall Study|Ineligible - required test not done|1|||
46830160|NCT00262821|83048036|FG001|Overall Study|Ineligible - required test not done|4|||
46830161|NCT00262821|83048035|FG000|Overall Study|Inevaluable - inadequate data|0|||
46830162|NCT00262821|83048036|FG001|Overall Study|Inevaluable - inadequate data|4|||
46830163|NCT00262743|83048044|FG000|Overall Study|Adverse Event|0|||
46830164|NCT00262743|83048045|FG001|Overall Study|Adverse Event|9|||
46830165|NCT00262743|83048044|FG000|Overall Study|Disease progression|0|||
46830166|NCT00262743|83048045|FG001|Overall Study|Disease progression|3|||
46830167|NCT00262119|83048052|FG000|Overall Study|Lost to Follow-up|38|||
46830168|NCT00262119|83048053|FG001|Overall Study|Lost to Follow-up|51|||
46830169|NCT00262119|83048054|FG002|Overall Study|Lost to Follow-up|42|||
46830170|NCT00262119|83048052|FG000|Overall Study|Death|20|||
46830171|NCT00262119|83048053|FG001|Overall Study|Death|19|||
46830172|NCT00262119|83048054|FG002|Overall Study|Death|16|||
46830173|NCT00170950|83048064|FG000|Overall Study|Death|236|||
46830174|NCT00170950|83048065|FG001|Overall Study|Death|274|||
46830175|NCT00170950|83048064|FG000|Overall Study|Withdrawal by Subject|496|||
46830176|NCT00170950|83048065|FG001|Overall Study|Withdrawal by Subject|498|||
46830177|NCT00170950|83048064|FG000|Overall Study|Lost to Follow-up|134|||
46830178|NCT00170950|83048065|FG001|Overall Study|Lost to Follow-up|115|||
46830179|NCT00170950|83048064|FG000|Overall Study|Missing|2|||
46830180|NCT00170950|83048065|FG001|Overall Study|Missing|1|||
46830181|NCT00170950|83048064|FG000|Overall Study|Termination Data Not Recorded|17|||
46830182|NCT00170950|83048065|FG001|Overall Study|Termination Data Not Recorded|22|||
46830183|NCT00239577|83048075|FG000|Primary Phase|Adverse Event|0|||
46830184|NCT00239577|83048076|FG001|Primary Phase|Adverse Event|0|||
46830185|NCT00239577|83048077|FG002|Primary Phase|Adverse Event|1|||
46830186|NCT00239577|83048078|FG003|Primary Phase|Adverse Event|0|||
46830187|NCT00239577|83048075|FG000|Primary Phase|Other|5|||
46830188|NCT00239577|83048076|FG001|Primary Phase|Other|3|||
46830189|NCT00239577|83048077|FG002|Primary Phase|Other|2|||
46830190|NCT00239577|83048078|FG003|Primary Phase|Other|0|||
46830191|NCT00262041|83048094|FG000|Overall Study|Withdrawal by Subject|0|||
46830192|NCT00262041|83048095|FG001|Overall Study|Withdrawal by Subject|3|||
46830193|NCT00262041|83048096|FG002|Overall Study|Withdrawal by Subject|1|||
46830194|NCT00262041|83048094|FG000|Overall Study|Lost to Follow-up|1|||
46637592|NCT01474512|82811391|FG015|Maintenance Period|Lost to Follow-up|0|||
46637593|NCT01474512|82811392|FG016|Maintenance Period|Lost to Follow-up|0|||
46764551|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Missing|1|||
46764552|NCT00838916|82982841|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
46764553|NCT00838916|82982842|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
46764554|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
46764555|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
46764556|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
46764557|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
46830195|NCT00262041|83048095|FG001|Overall Study|Lost to Follow-up|1|||
46830196|NCT00262041|83048096|FG002|Overall Study|Lost to Follow-up|5|||
46830197|NCT00262041|83048094|FG000|Overall Study|Unable to classify|1|||
46830198|NCT00262041|83048095|FG001|Overall Study|Unable to classify|0|||
46830199|NCT00262041|83048096|FG002|Overall Study|Unable to classify|0|||
46637594|NCT01474512|82811393|FG017|Maintenance Period|Lost to Follow-up|0|||
46764558|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
46830200|NCT00208767|83048112|FG000|Overall Study|Adverse Event|9|||
46830201|NCT00208767|83048113|FG001|Overall Study|Adverse Event|1|||
46830202|NCT00208767|83048112|FG000|Overall Study|Withdrawal by Subject|14|||
46830203|NCT00208767|83048113|FG001|Overall Study|Withdrawal by Subject|3|||
46764559|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
46830204|NCT00208767|83048112|FG000|Overall Study|Death|1|||
46830205|NCT00208767|83048113|FG001|Overall Study|Death|0|||
46830206|NCT00208767|83048112|FG000|Overall Study|Lost to Follow-up|3|||
46830207|NCT00208767|83048113|FG001|Overall Study|Lost to Follow-up|3|||
46830208|NCT00390806|83048121|FG000|Overall Study|Lost to Follow-up|7|||
46830209|NCT00390806|83048122|FG001|Overall Study|Lost to Follow-up|6|||
46830210|NCT00390806|83048121|FG000|Overall Study|Protocol Violation|2|||
46830211|NCT00390806|83048122|FG001|Overall Study|Protocol Violation|2|||
46830212|NCT00390806|83048121|FG000|Overall Study|Withdrawal by Subject|12|||
46830213|NCT00390806|83048122|FG001|Overall Study|Withdrawal by Subject|15|||
46830214|NCT00390806|83048121|FG000|Overall Study|Investigator Decision|4|||
46830215|NCT00390806|83048122|FG001|Overall Study|Investigator Decision|6|||
46830216|NCT00390806|83048121|FG000|Overall Study|Death|1|||
46830217|NCT00390806|83048122|FG001|Overall Study|Death|0|||
46830218|NCT00390806|83048121|FG000|Overall Study|Physician Decision|0|||
46830219|NCT00390806|83048122|FG001|Overall Study|Physician Decision|1|||
46830220|NCT00390806|83048121|FG000|Overall Study|Ongoing|4|||
46830221|NCT00390806|83048122|FG001|Overall Study|Ongoing|2|||
46830222|NCT00390572|83048130|FG000|Overall Study|Lost to Follow-up|8|||
46830223|NCT00390572|83048131|FG001|Overall Study|Lost to Follow-up|4|||
46830224|NCT00390572|83048130|FG000|Overall Study|health condition|0|||
46830225|NCT00390572|83048131|FG001|Overall Study|health condition|1|||
46830226|NCT00390416|83048137|FG000|Overall Study|Withdrawal by Subject|1|||
46830227|NCT00390416|83048137|FG000|Overall Study|Not treated|3|||
46830228|NCT00261495|83048143|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
46830229|NCT00261495|83048144|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
46830230|NCT00261495|83048143|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
46830231|NCT00261495|83048144|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
46830232|NCT00261495|83048143|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
46830233|NCT00261495|83048144|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
46830234|NCT00261495|83048143|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
46830235|NCT00261495|83048144|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
46830236|NCT00261495|83048143|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
46830237|NCT00261495|83048144|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
46830238|NCT00261495|83048143|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
46830239|NCT00261495|83048144|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
46830240|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
46830241|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
46830242|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
46830243|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
46830244|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
46936268|NCT03057977|83172717|FG001|Discontinuation From Treatment|Not attending study visit|10|||
46936269|NCT03057977|83172716|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
46936270|NCT03057977|83172717|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
46936271|NCT03057977|83172716|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
46637595|NCT01474512|82811376|FG000|Maintenance Period|Death|0|||
46637596|NCT01474512|82811377|FG001|Maintenance Period|Death|0|||
46637597|NCT01474512|82811378|FG002|Maintenance Period|Death|0|||
46637598|NCT01474512|82811379|FG003|Maintenance Period|Death|0|||
46637599|NCT01474512|82811380|FG004|Maintenance Period|Death|0|||
46637600|NCT01474512|82811381|FG005|Maintenance Period|Death|2|||
46637601|NCT01474512|82811382|FG006|Maintenance Period|Death|0|||
46637602|NCT01474512|82811383|FG007|Maintenance Period|Death|0|||
46764560|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
46764561|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
46764562|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
46764563|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
46764564|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
46764565|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
46764566|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
46764567|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
46637603|NCT01474512|82811384|FG008|Maintenance Period|Death|0|||
46637604|NCT01474512|82811385|FG009|Maintenance Period|Death|0|||
46637605|NCT01474512|82811386|FG010|Maintenance Period|Death|0|||
46637606|NCT01474512|82811387|FG011|Maintenance Period|Death|0|||
46637607|NCT01474512|82811388|FG012|Maintenance Period|Death|0|||
46764568|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
46764569|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
46830245|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
46830246|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
46830247|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
46830248|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
46830249|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
46830250|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
46637608|NCT01474512|82811389|FG013|Maintenance Period|Death|0|||
46637609|NCT01474512|82811390|FG014|Maintenance Period|Death|0|||
46637610|NCT01474512|82811391|FG015|Maintenance Period|Death|0|||
46637611|NCT01474512|82811392|FG016|Maintenance Period|Death|0|||
46764570|NCT00838916|82982841|FG000|Follow-up Period (8 Weeks)|Missing|3|||
46764571|NCT00838916|82982842|FG001|Follow-up Period (8 Weeks)|Missing|0|||
46764572|NCT00838682|82982850|FG000|Overall Study|Lost to Follow-up|21|||
46764573|NCT00838682|82982851|FG001|Overall Study|Lost to Follow-up|14|||
46764574|NCT00838682|82982850|FG000|Overall Study|detection of exclusion criteria|4|||
46764575|NCT00838682|82982851|FG001|Overall Study|detection of exclusion criteria|3|||
46830251|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
46830252|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
46830253|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
46830254|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
46830255|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
46830256|NCT00261495|83048143|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
46830257|NCT00261495|83048144|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
46830258|NCT00261495|83048143|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
46830259|NCT00261495|83048144|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
46936272|NCT03057977|83172717|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
46936273|NCT03057977|83172716|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
46830260|NCT00261495|83048143|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
46830261|NCT00261495|83048144|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
46830262|NCT00261495|83048143|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
46830263|NCT00261495|83048144|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
46830264|NCT00261495|83048143|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
46830265|NCT00261495|83048144|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
46830266|NCT00261495|83048143|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
46830267|NCT00261495|83048144|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
46936274|NCT03057977|83172717|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
46936275|NCT03057977|83172716|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
46936276|NCT03057977|83172717|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
46936277|NCT03057977|83172716|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
46936278|NCT03057977|83172717|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
46936279|NCT03062891|83172729|FG000|Overall Study|Withdrawal by Subject|2|||
46936280|NCT03062891|83172730|FG001|Overall Study|Withdrawal by Subject|0|||
46936281|NCT03062891|83172729|FG000|Overall Study|Lost to Follow-up|50|||
46936282|NCT03062891|83172730|FG001|Overall Study|Lost to Follow-up|38|||
46936283|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
46936284|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
46936285|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
46936286|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
46936287|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
46936288|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
46936289|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
46936290|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
46936291|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
46936292|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
46936293|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
46936294|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
46936295|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
46936296|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
46936297|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
46936298|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
46764576|NCT00838682|82982850|FG000|Overall Study|Protocol Violation|0|||
46764577|NCT00838682|82982851|FG001|Overall Study|Protocol Violation|1|||
46764578|NCT00838682|82982850|FG000|Overall Study|Withdrawal by Subject|0|||
46764579|NCT00838682|82982851|FG001|Overall Study|Withdrawal by Subject|1|||
46764580|NCT00820040|82982857|FG000|Overall Study|Death|1|||
46764581|NCT00820040|82982857|FG000|Overall Study|Sponsor terminated study|1|||
46764582|NCT00820040|82982857|FG000|Overall Study|Screen failure|1|||
46764583|NCT00803712|82982863|FG000|Overall Study|Noncompliance|3|||
46830268|NCT00261495|83048143|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
46830269|NCT00261495|83048144|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
46830270|NCT00168844|83048153|FG000|Overall Study|Adverse Event|31|||
46830271|NCT00168844|83048154|FG001|Overall Study|Adverse Event|32|||
46830272|NCT00168844|83048155|FG002|Overall Study|Adverse Event|48|||
46830273|NCT00168844|83048153|FG000|Overall Study|Lost to Follow-up|4|||
46830274|NCT00168844|83048154|FG001|Overall Study|Lost to Follow-up|5|||
46830275|NCT00168844|83048155|FG002|Overall Study|Lost to Follow-up|11|||
46830276|NCT00168844|83048153|FG000|Overall Study|Withdrawal by Subject|12|||
46936299|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
46764584|NCT00803712|82982864|FG001|Overall Study|Noncompliance|0|||
46764585|NCT00803712|82982863|FG000|Overall Study|Adverse Event|5|||
46936300|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
46936301|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
46936302|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
46936303|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
46936304|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
46936305|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
46936306|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
46936307|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
46936308|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
46936309|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
46936310|NCT02552212|83172739|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
46936311|NCT02552212|83172740|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
46936312|NCT02552212|83172741|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
46936313|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
46936314|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
46936315|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
46936316|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
46830277|NCT00168844|83048154|FG001|Overall Study|Withdrawal by Subject|9|||
46830278|NCT00168844|83048155|FG002|Overall Study|Withdrawal by Subject|19|||
46830279|NCT00168844|83048153|FG000|Overall Study|Protocol Violation|2|||
46830280|NCT00168844|83048154|FG001|Overall Study|Protocol Violation|2|||
46830281|NCT00168844|83048155|FG002|Overall Study|Protocol Violation|4|||
46830282|NCT00168844|83048153|FG000|Overall Study|Other|6|||
46830283|NCT00168844|83048154|FG001|Overall Study|Other|7|||
46830284|NCT00168844|83048155|FG002|Overall Study|Other|9|||
46830285|NCT00365456|83048163|FG000|Trial Period I (12 Months)|Adverse Event|84|||
46830286|NCT00365456|83048164|FG001|Trial Period I (12 Months)|Adverse Event|0|||
46830287|NCT00365456|83048163|FG000|Trial Period I (12 Months)|Non-compliance|3|||
46830288|NCT00365456|83048164|FG001|Trial Period I (12 Months)|Non-compliance|0|||
46830289|NCT00365456|83048163|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
46830290|NCT00365456|83048164|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
46830291|NCT00365456|83048163|FG000|Trial Period I (12 Months)|Other|11|||
46830292|NCT00365456|83048164|FG001|Trial Period I (12 Months)|Other|0|||
46830293|NCT00365456|83048163|FG000|Trial Period II (12 Months)|Adverse Event|0|||
46830294|NCT00365456|83048164|FG001|Trial Period II (12 Months)|Adverse Event|6|||
46830295|NCT00365456|83048163|FG000|Trial Period II (12 Months)|Non-compliance|0|||
46830296|NCT00365456|83048164|FG001|Trial Period II (12 Months)|Non-compliance|2|||
46830297|NCT00365456|83048163|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
46830298|NCT00365456|83048164|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
46830299|NCT00365456|83048163|FG000|Trial Period II (12 Months)|Other|0|||
46830300|NCT00365456|83048164|FG001|Trial Period II (12 Months)|Other|1|||
46830301|NCT00365456|83048163|FG000|Trial Period III (12 Months)|Adverse Event|13|||
46830302|NCT00365456|83048164|FG001|Trial Period III (12 Months)|Adverse Event|3|||
46830303|NCT00365456|83048163|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
46764586|NCT00803712|82982864|FG001|Overall Study|Adverse Event|0|||
46764587|NCT00803712|82982863|FG000|Overall Study|Death|8|||
46764588|NCT00803712|82982864|FG001|Overall Study|Death|7|||
46764589|NCT00803712|82982863|FG000|Overall Study|Lost to Follow-up|3|||
46764590|NCT00803712|82982864|FG001|Overall Study|Lost to Follow-up|1|||
46764591|NCT00803712|82982863|FG000|Overall Study|Withdrawal by Subject|2|||
46764592|NCT00803712|82982864|FG001|Overall Study|Withdrawal by Subject|4|||
46764593|NCT00803712|82982863|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
46764594|NCT00803712|82982864|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
46764595|NCT00803712|82982863|FG000|Overall Study|Protocol criteria (other)|0|||
46764596|NCT00803712|82982864|FG001|Overall Study|Protocol criteria (other)|2|||
46764597|NCT00803712|82982863|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
46764598|NCT00803712|82982864|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
46764599|NCT00803712|82982863|FG000|Overall Study|Administrative decision|2|||
46764600|NCT00803712|82982864|FG001|Overall Study|Administrative decision|3|||
46764601|NCT00803712|82982863|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
46764602|NCT00803712|82982864|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
46764603|NCT00591344|82982872|FG000|Overall Study|Transportation issues|1|||
46830304|NCT00365456|83048164|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
46830305|NCT00365456|83048163|FG000|Trial Period III (12 Months)|Other|1|||
46830306|NCT00365456|83048164|FG001|Trial Period III (12 Months)|Other|1|||
46830307|NCT00147238|83048170|FG000|Overall Study|Inevaluable|8|||
46936317|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
46830308|NCT00206427|83048174|FG000|Overall Study|Adverse Event|2|||
46830309|NCT00146848|83048181|FG000|Pre-randomization|Death|19|||
46936318|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
46936319|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
46936320|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
46764604|NCT00591344|82982873|FG001|Overall Study|Transportation issues|0|||
46936321|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
46936322|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
46936323|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
46936324|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
46936325|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
46936326|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
46936327|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
46936328|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
46936329|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
46936330|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
46936331|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
46936332|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
46936333|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
46936334|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
46936335|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
46936336|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
46936337|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
46936338|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
46936339|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
46936340|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
46936341|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
46936342|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
46936343|NCT02552212|83172739|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
46936344|NCT02552212|83172740|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
46936345|NCT02552212|83172741|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
46936346|NCT00685919|83172761|FG000|Overall Study|Withdrawal by Subject|0|||
46936347|NCT00685919|83172762|FG001|Overall Study|Withdrawal by Subject|0|||
46936348|NCT00685919|83172763|FG002|Overall Study|Withdrawal by Subject|1|||
46936349|NCT00685919|83172764|FG003|Overall Study|Withdrawal by Subject|0|||
46936350|NCT00685919|83172761|FG000|Overall Study|Physician Decision|1|||
46936351|NCT00685919|83172762|FG001|Overall Study|Physician Decision|0|||
46936352|NCT00685919|83172763|FG002|Overall Study|Physician Decision|0|||
46936353|NCT00685919|83172764|FG003|Overall Study|Physician Decision|0|||
46936354|NCT03061331|83172776|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
46936355|NCT03061331|83172777|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
46936356|NCT00700778|83172783|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
46936357|NCT02551666|83172789|FG000|Overall Study|Withdrawal by Subject|1|||
46936358|NCT02551666|83172790|FG001|Overall Study|Withdrawal by Subject|3|||
46936359|NCT03061175|83172802|FG000|Baseline|Participant was deemed ineligible|1|||
46936360|NCT03061175|83172803|FG001|Baseline|Participant was deemed ineligible|0|||
46936361|NCT03061175|83172802|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
46936362|NCT03061175|83172803|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
46936363|NCT03061175|83172802|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
46936364|NCT03061175|83172803|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
46936365|NCT03061175|83172802|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
46936366|NCT03061175|83172803|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
46936367|NCT03061097|83172820|FG000|Overall Study|Withdrawal by Subject|0|||
46936368|NCT03061097|83172821|FG001|Overall Study|Withdrawal by Subject|3|||
46936369|NCT02554318|83172829|FG000|Overall Study|Withdrawal by Subject|10|||
46936370|NCT02554318|83172830|FG001|Overall Study|Withdrawal by Subject|8|||
46936371|NCT02550106|83172836|FG000|Overall Study|Adverse Event|1|||
46936372|NCT02550106|83172836|FG000|Overall Study|Lack of Efficacy|3|||
46936373|NCT02550106|83172836|FG000|Overall Study|Protocol Violation|6|||
46936374|NCT02550106|83172836|FG000|Overall Study|Withdrawal by Subject|2|||
46936375|NCT03060551|83172842|FG000|Overall Study|Withdrawal by Subject|1|||
46936376|NCT03060551|83172842|FG000|Overall Study|Adverse Event|1|||
47060352|NCT02689284|83340035|FG001|Overall Study|concern for anemia|1|||
46637612|NCT01474512|82811393|FG017|Maintenance Period|Death|0|||
46764605|NCT00591344|82982872|FG000|Overall Study|Moved out of state|1|||
46764606|NCT00591344|82982873|FG001|Overall Study|Moved out of state|0|||
46764607|NCT00591344|82982872|FG000|Overall Study|Medical complications|1|||
46764608|NCT00591344|82982873|FG001|Overall Study|Medical complications|3|||
46764609|NCT00591344|82982872|FG000|Overall Study|Underwent DBS|2|||
46764610|NCT00591344|82982873|FG001|Overall Study|Underwent DBS|2|||
46764611|NCT00591344|82982872|FG000|Overall Study|Death|0|||
46764612|NCT00591344|82982873|FG001|Overall Study|Death|1|||
46764613|NCT00591344|82982872|FG000|Overall Study|Lost to Follow-up|0|||
46936377|NCT01662310|83172846|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
46936378|NCT01662310|83172847|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
46764614|NCT00591344|82982873|FG001|Overall Study|Lost to Follow-up|1|||
46830310|NCT00146848|83048182|FG001|Pre-randomization|Death|0|||
46830311|NCT00146848|83048183|FG002|Pre-randomization|Death|0|||
46830312|NCT00146848|83048181|FG000|Pre-randomization|Lost to Follow-up|70|||
46830313|NCT00146848|83048182|FG001|Pre-randomization|Lost to Follow-up|0|||
46830314|NCT00146848|83048183|FG002|Pre-randomization|Lost to Follow-up|0|||
46830315|NCT00146848|83048181|FG000|Pre-randomization|Physician Decision|8|||
46830316|NCT00146848|83048182|FG001|Pre-randomization|Physician Decision|0|||
46830317|NCT00146848|83048183|FG002|Pre-randomization|Physician Decision|0|||
46830318|NCT00146848|83048181|FG000|Pre-randomization|Protocol Violation|172|||
46830319|NCT00146848|83048182|FG001|Pre-randomization|Protocol Violation|0|||
46830320|NCT00146848|83048183|FG002|Pre-randomization|Protocol Violation|0|||
46830321|NCT00146848|83048181|FG000|Pre-randomization|Withdrawal by Subject|40|||
46830322|NCT00146848|83048182|FG001|Pre-randomization|Withdrawal by Subject|0|||
46830323|NCT00146848|83048183|FG002|Pre-randomization|Withdrawal by Subject|0|||
46830324|NCT00146848|83048181|FG000|Post-randomization|Lost to Follow-up|12|||
46830325|NCT00146848|83048182|FG001|Post-randomization|Lost to Follow-up|15|||
46830326|NCT00146848|83048183|FG002|Post-randomization|Lost to Follow-up|12|||
46830327|NCT00146848|83048181|FG000|Post-randomization|Withdrawn|26|||
46830328|NCT00146848|83048182|FG001|Post-randomization|Withdrawn|32|||
46830329|NCT00146848|83048183|FG002|Post-randomization|Withdrawn|27|||
46830330|NCT00205881|83048191|FG000|Overall Study|Withdrawal by Subject|16|||
46830331|NCT00365378|83048198|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
46830332|NCT00365378|83048199|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
46830333|NCT00365378|83048200|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
46830334|NCT00365378|83048198|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
46830335|NCT00365378|83048199|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
46830336|NCT00365378|83048200|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
46830337|NCT00365378|83048198|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
46830338|NCT00365378|83048199|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
46936379|NCT01662310|83172848|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
46936380|NCT01662310|83172849|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
46936381|NCT01662310|83172850|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
46936382|NCT01662310|83172846|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
46936383|NCT01662310|83172847|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
46936384|NCT01662310|83172848|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
46830339|NCT00365378|83048200|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
46830340|NCT00365378|83048198|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
46936385|NCT01662310|83172849|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
46936386|NCT01662310|83172850|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
46936387|NCT01662310|83172846|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
46830341|NCT00365378|83048199|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
46830342|NCT00365378|83048200|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
46830343|NCT00365378|83048198|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
46830344|NCT00365378|83048199|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
46830345|NCT00365378|83048200|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
46830346|NCT00365378|83048198|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
46830347|NCT00365378|83048199|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
46830348|NCT00365378|83048200|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
46830349|NCT00365378|83048198|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
46830350|NCT00365378|83048199|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
46830351|NCT00365378|83048200|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
46830352|NCT00365378|83048198|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
46830353|NCT00365378|83048199|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
46830354|NCT00365378|83048200|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
46830355|NCT00365378|83048198|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
46830356|NCT00365378|83048199|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
46830357|NCT00365378|83048200|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
46830358|NCT00365378|83048198|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
46830359|NCT00365378|83048199|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
46830360|NCT00365378|83048200|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
46830361|NCT00365378|83048198|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
46830362|NCT00365378|83048199|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
46830363|NCT00365378|83048200|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
46830364|NCT00365378|83048198|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
46830365|NCT00365378|83048199|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
46830366|NCT00365378|83048200|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
46830367|NCT00365378|83048198|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
46830368|NCT00365378|83048199|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
46830369|NCT00365378|83048200|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
46936388|NCT01662310|83172847|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
46936389|NCT01662310|83172848|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
46830370|NCT00365378|83048198|FG000|Extension|Adverse Event|0|||
46830371|NCT00365378|83048199|FG001|Extension|Adverse Event|0|||
46830372|NCT00365378|83048200|FG002|Extension|Adverse Event|1|||
46830373|NCT00365378|83048198|FG000|Extension|Moved|0|||
46830374|NCT00365378|83048199|FG001|Extension|Moved|0|||
46830375|NCT00365378|83048200|FG002|Extension|Moved|8|||
46830376|NCT00365378|83048198|FG000|Extension|Lost to Follow-up|0|||
46830377|NCT00365378|83048199|FG001|Extension|Lost to Follow-up|0|||
46830378|NCT00365378|83048200|FG002|Extension|Lost to Follow-up|57|||
46830379|NCT00365378|83048198|FG000|Extension|Protocol Violation|0|||
46830380|NCT00365378|83048199|FG001|Extension|Protocol Violation|0|||
46830381|NCT00365378|83048200|FG002|Extension|Protocol Violation|2|||
46830382|NCT00365378|83048198|FG000|Extension|Withdrawal by Subject|0|||
46830383|NCT00365378|83048199|FG001|Extension|Withdrawal by Subject|0|||
46830384|NCT00365378|83048200|FG002|Extension|Withdrawal by Subject|98|||
46830385|NCT00365378|83048198|FG000|Extension|Other|0|||
46830386|NCT00365378|83048199|FG001|Extension|Other|0|||
46830387|NCT00365378|83048200|FG002|Extension|Other|31|||
46830388|NCT00389324|83048207|FG000|Run-In Phase|Adverse Event|1|||
46830389|NCT00389324|83048207|FG000|Run-In Phase|Lost to Follow-up|1|||
46830390|NCT00389324|83048207|FG000|Run-In Phase|Withdrawal by Subject|1|||
46830391|NCT00389324|83048207|FG000|Subcutaneous Phase|Adverse Event|2|||
46830392|NCT00389324|83048207|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
46830393|NCT00389324|83048207|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
46830394|NCT00389324|83048207|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
46830395|NCT00365300|83048216|FG000|Open-label Phase|Adverse Event|4|||
46830396|NCT00365300|83048217|FG001|Open-label Phase|Adverse Event|0|||
46830397|NCT00365300|83048216|FG000|Open-label Phase|Failed to Return|1|||
46830398|NCT00365300|83048217|FG001|Open-label Phase|Failed to Return|0|||
46830399|NCT00365300|83048216|FG000|Open-label Phase|Physician Decision|1|||
46830400|NCT00365300|83048217|FG001|Open-label Phase|Physician Decision|0|||
46830401|NCT00365300|83048216|FG000|Open-label Phase|Noncompliance|9|||
46830402|NCT00365300|83048217|FG001|Open-label Phase|Noncompliance|0|||
46830403|NCT00365300|83048216|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
46830404|NCT00365300|83048217|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
46830405|NCT00365300|83048216|FG000|Open-label Phase|Protocol Violation|1|||
46936390|NCT01662310|83172849|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
46936391|NCT01662310|83172850|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
46936392|NCT01662310|83172846|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
46637613|NCT01474512|82811376|FG000|Maintenance Period|Physician Decision|0|||
46637614|NCT01474512|82811377|FG001|Maintenance Period|Physician Decision|0|||
46764615|NCT00591344|82982872|FG000|Overall Study|Did not want to come off medication|0|||
46764616|NCT00591344|82982873|FG001|Overall Study|Did not want to come off medication|1|||
46764617|NCT00803634|82982885|FG000|Overall Study|Withdrew Consent|1|||
46764618|NCT00803634|82982886|FG001|Overall Study|Withdrew Consent|0|||
46764619|NCT00803634|82982885|FG000|Overall Study|Lost to Follow-up|2|||
46764620|NCT00803634|82982886|FG001|Overall Study|Lost to Follow-up|3|||
46764621|NCT00803634|82982885|FG000|Overall Study|Death|3|||
46764622|NCT00803634|82982886|FG001|Overall Study|Death|2|||
46764623|NCT00838526|82982895|FG000|Overall Study|Adverse Event|3|||
46764624|NCT00838526|82982896|FG001|Overall Study|Adverse Event|12|||
46764625|NCT00838526|82982895|FG000|Overall Study|Lost to Follow-up|4|||
46764626|NCT00838526|82982896|FG001|Overall Study|Lost to Follow-up|12|||
46764627|NCT00838526|82982895|FG000|Overall Study|Withdrawal by Subject|4|||
46764628|NCT00838526|82982896|FG001|Overall Study|Withdrawal by Subject|5|||
46764629|NCT00838526|82982895|FG000|Overall Study|Lack of Efficacy|2|||
46764630|NCT00838526|82982896|FG001|Overall Study|Lack of Efficacy|3|||
46764631|NCT00838526|82982895|FG000|Overall Study|Other|11|||
46764632|NCT00838526|82982896|FG001|Overall Study|Other|7|||
46764633|NCT00818246|82982915|FG000|Overall Study|Impossible to match pictures|5|||
46764634|NCT00818168|82982919|FG000|Overall Study|Lack of Efficacy|18|||
46764635|NCT00818168|82982919|FG000|Overall Study|Pregnancy|2|||
46764636|NCT00818168|82982919|FG000|Overall Study|Withdrawal by Subject|16|||
46764637|NCT00818168|82982919|FG000|Overall Study|Lost to Follow-up|7|||
46764638|NCT00818168|82982919|FG000|Overall Study|Adverse Event|19|||
46764639|NCT00818168|82982919|FG000|Overall Study|Reason for Non-completion Not reported|6|||
46764640|NCT00818168|82982919|FG000|Overall Study|Participant Moved|2|||
46764641|NCT00817778|82982925|FG000|Overall Study|Adverse Event|1|||
46764642|NCT00817778|82982926|FG001|Overall Study|Adverse Event|0|||
46764643|NCT00817778|82982925|FG000|Overall Study|Withdrawal by Subject|1|||
46764644|NCT00817778|82982926|FG001|Overall Study|Withdrawal by Subject|1|||
46764645|NCT00817778|82982925|FG000|Overall Study|Protocol Violation|0|||
46764646|NCT00817778|82982926|FG001|Overall Study|Protocol Violation|1|||
46830406|NCT00365300|83048217|FG001|Open-label Phase|Protocol Violation|0|||
46830407|NCT00365300|83048216|FG000|Open-label Phase|Lack of Efficacy|1|||
46936393|NCT01662310|83172847|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
46764647|NCT00817778|82982925|FG000|Overall Study|Study-specific discontinuation criteria|0|||
46764648|NCT00817778|82982926|FG001|Overall Study|Study-specific discontinuation criteria|1|||
46764649|NCT00817778|82982925|FG000|Overall Study|Poor venous access|1|||
46830408|NCT00365300|83048217|FG001|Open-label Phase|Lack of Efficacy|0|||
46830409|NCT00365300|83048216|FG000|Open-label Phase|Patient skipped open label phase|1|||
46830410|NCT00365300|83048217|FG001|Open-label Phase|Patient skipped open label phase|0|||
46830411|NCT00365300|83048216|FG000|Double-blind Phase|Failed to return|1|||
46830412|NCT00365300|83048217|FG001|Double-blind Phase|Failed to return|0|||
46830413|NCT00365300|83048216|FG000|Double-blind Phase|Noncompliance|1|||
46830414|NCT00365300|83048217|FG001|Double-blind Phase|Noncompliance|1|||
46830415|NCT00365300|83048216|FG000|Double-blind Phase|Withdrawal by Subject|0|||
46830416|NCT00365300|83048217|FG001|Double-blind Phase|Withdrawal by Subject|1|||
46830417|NCT00365300|83048216|FG000|Double-blind Phase|Protocol Violation|3|||
46830418|NCT00365300|83048217|FG001|Double-blind Phase|Protocol Violation|1|||
46830419|NCT00365300|83048216|FG000|Double-blind Phase|Lack of Efficacy|6|||
46830420|NCT00365300|83048217|FG001|Double-blind Phase|Lack of Efficacy|6|||
46830421|NCT00370292|83048228|FG000|Overall Study|Disease Progression|4|||
46830422|NCT00370292|83048228|FG000|Overall Study|Adverse Event|7|||
46830423|NCT00370292|83048228|FG000|Overall Study|Physician Decision|2|||
46830424|NCT00369824|83048245|FG000|Overall Study|Adverse Event|0|||
46936394|NCT01662310|83172848|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
46936395|NCT01662310|83172849|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
46936396|NCT01662310|83172850|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
46936397|NCT01662310|83172846|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
46936398|NCT01662310|83172847|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
46936399|NCT01662310|83172848|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
46936400|NCT01662310|83172849|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
46936401|NCT01662310|83172850|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
46936402|NCT01662310|83172846|FG000|Run-In or Stabilization Phase|Other|1|||
46936403|NCT01662310|83172847|FG001|Run-In or Stabilization Phase|Other|0|||
46936404|NCT01662310|83172848|FG002|Run-In or Stabilization Phase|Other|0|||
47060353|NCT02689284|83340034|FG000|Overall Study|no measurable cancer for evaluation|0|||
47060354|NCT02689284|83340035|FG001|Overall Study|no measurable cancer for evaluation|1|||
47060355|NCT02676882|83340044|FG000|Overall Study|Adverse Event|1|||
47060356|NCT02676882|83340045|FG001|Overall Study|Adverse Event|0|||
47060357|NCT02676882|83340044|FG000|Overall Study|Lost to Follow-up|1|||
47060358|NCT02676882|83340045|FG001|Overall Study|Lost to Follow-up|0|||
47060359|NCT02676882|83340044|FG000|Overall Study|Withdrawal by Subject|1|||
47060360|NCT02676882|83340045|FG001|Overall Study|Withdrawal by Subject|2|||
47060361|NCT02674386|83340054|FG000|Overall Study|Lost to Follow-up|0|||
47060362|NCT02674386|83340055|FG001|Overall Study|Lost to Follow-up|1|||
47060363|NCT02674386|83340056|FG002|Overall Study|Lost to Follow-up|1|||
47060364|NCT02674386|83340054|FG000|Overall Study|Withdrawal by Subject|0|||
47060365|NCT02674386|83340055|FG001|Overall Study|Withdrawal by Subject|4|||
47060366|NCT02674386|83340056|FG002|Overall Study|Withdrawal by Subject|0|||
47060367|NCT02674386|83340054|FG000|Overall Study|Other|0|||
47060368|NCT02674386|83340055|FG001|Overall Study|Other|1|||
47060369|NCT02674386|83340056|FG002|Overall Study|Other|0|||
47060370|NCT02674386|83340054|FG000|Overall Study|Enrolled but not evaluated|0|||
47060371|NCT02674386|83340055|FG001|Overall Study|Enrolled but not evaluated|4|||
47060372|NCT02674386|83340056|FG002|Overall Study|Enrolled but not evaluated|0|||
47060373|NCT02680002|83340075|FG000|Overall Study|Lost to Follow-up|5|||
47060374|NCT02680002|83340076|FG001|Overall Study|Lost to Follow-up|1|||
47060375|NCT02680002|83340077|FG002|Overall Study|Lost to Follow-up|4|||
47060376|NCT02680002|83340078|FG003|Overall Study|Lost to Follow-up|2|||
47060377|NCT02680002|83340079|FG004|Overall Study|Lost to Follow-up|0|||
46764650|NCT00817778|82982926|FG001|Overall Study|Poor venous access|0|||
46764651|NCT00813098|82982935|FG000|Overall Study|Adverse Event|2|||
46764652|NCT00813098|82982936|FG001|Overall Study|Adverse Event|4|||
46764653|NCT00813098|82982937|FG002|Overall Study|Adverse Event|1|||
46764654|NCT00813098|82982935|FG000|Overall Study|Withdrawal by Subject|0|||
46764655|NCT00813098|82982936|FG001|Overall Study|Withdrawal by Subject|1|||
46764656|NCT00813098|82982937|FG002|Overall Study|Withdrawal by Subject|0|||
46764657|NCT00813098|82982935|FG000|Overall Study|Inability to complete study procedures|1|||
46764658|NCT00813098|82982936|FG001|Overall Study|Inability to complete study procedures|0|||
46764659|NCT00813098|82982937|FG002|Overall Study|Inability to complete study procedures|0|||
46764660|NCT00813098|82982935|FG000|Overall Study|Lost to Follow-up|0|||
46830425|NCT00369824|83048246|FG001|Overall Study|Adverse Event|2|||
46830426|NCT00369824|83048247|FG002|Overall Study|Adverse Event|0|||
46830427|NCT00369824|83048248|FG003|Overall Study|Adverse Event|0|||
46830428|NCT00369824|83048249|FG004|Overall Study|Adverse Event|1|||
47060378|NCT02680002|83340080|FG005|Overall Study|Lost to Follow-up|2|||
47060379|NCT02680002|83340075|FG000|Overall Study|Physician Decision|5|||
47060380|NCT02680002|83340076|FG001|Overall Study|Physician Decision|1|||
46830429|NCT00369824|83048250|FG005|Overall Study|Adverse Event|0|||
46936405|NCT01662310|83172849|FG003|Run-In or Stabilization Phase|Other|0|||
47060381|NCT02680002|83340077|FG002|Overall Study|Physician Decision|1|||
47060382|NCT02680002|83340078|FG003|Overall Study|Physician Decision|1|||
47060383|NCT02680002|83340079|FG004|Overall Study|Physician Decision|1|||
47060384|NCT02680002|83340080|FG005|Overall Study|Physician Decision|1|||
47060385|NCT02680002|83340075|FG000|Overall Study|Protocol Violation|1|||
47060386|NCT02680002|83340076|FG001|Overall Study|Protocol Violation|0|||
47060387|NCT02680002|83340077|FG002|Overall Study|Protocol Violation|1|||
47060388|NCT02680002|83340078|FG003|Overall Study|Protocol Violation|0|||
47060389|NCT02680002|83340079|FG004|Overall Study|Protocol Violation|1|||
47060390|NCT02680002|83340080|FG005|Overall Study|Protocol Violation|2|||
47060391|NCT02680002|83340075|FG000|Overall Study|Withdrawal by Subject|0|||
47060392|NCT02680002|83340076|FG001|Overall Study|Withdrawal by Subject|0|||
47060393|NCT02680002|83340077|FG002|Overall Study|Withdrawal by Subject|1|||
47060394|NCT02680002|83340078|FG003|Overall Study|Withdrawal by Subject|0|||
47060395|NCT02680002|83340079|FG004|Overall Study|Withdrawal by Subject|2|||
47060396|NCT02680002|83340080|FG005|Overall Study|Withdrawal by Subject|2|||
47060397|NCT02680002|83340075|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
47060398|NCT02680002|83340076|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
47060399|NCT02680002|83340077|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
47060400|NCT02680002|83340078|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
47060401|NCT02680002|83340079|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
47060402|NCT02680002|83340080|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
47060403|NCT02680002|83340075|FG000|Overall Study|Other|0|||
47060404|NCT02680002|83340076|FG001|Overall Study|Other|1|||
47060405|NCT02680002|83340077|FG002|Overall Study|Other|0|||
47060406|NCT02680002|83340078|FG003|Overall Study|Other|0|||
47060407|NCT02680002|83340079|FG004|Overall Study|Other|1|||
47060408|NCT02680002|83340080|FG005|Overall Study|Other|0|||
47060409|NCT02680002|83340075|FG000|Overall Study|Adverse Event|0|||
47060410|NCT02680002|83340076|FG001|Overall Study|Adverse Event|0|||
47060411|NCT02680002|83340077|FG002|Overall Study|Adverse Event|0|||
47060412|NCT02680002|83340078|FG003|Overall Study|Adverse Event|0|||
47060413|NCT02680002|83340079|FG004|Overall Study|Adverse Event|1|||
46830430|NCT00369824|83048245|FG000|Overall Study|Protocol Violation|0|||
46830431|NCT00369824|83048246|FG001|Overall Study|Protocol Violation|1|||
46830432|NCT00369824|83048247|FG002|Overall Study|Protocol Violation|0|||
46830433|NCT00369824|83048248|FG003|Overall Study|Protocol Violation|1|||
46830434|NCT00369824|83048249|FG004|Overall Study|Protocol Violation|1|||
46830435|NCT00369824|83048250|FG005|Overall Study|Protocol Violation|0|||
46830436|NCT00369824|83048245|FG000|Overall Study|Withdrawal by Subject|9|||
46830437|NCT00369824|83048246|FG001|Overall Study|Withdrawal by Subject|5|||
46830438|NCT00369824|83048247|FG002|Overall Study|Withdrawal by Subject|5|||
46830439|NCT00369824|83048248|FG003|Overall Study|Withdrawal by Subject|4|||
46830440|NCT00369824|83048249|FG004|Overall Study|Withdrawal by Subject|6|||
46830441|NCT00369824|83048250|FG005|Overall Study|Withdrawal by Subject|2|||
46830442|NCT00369824|83048245|FG000|Overall Study|Lost to Follow-up|6|||
46830443|NCT00369824|83048246|FG001|Overall Study|Lost to Follow-up|11|||
46830444|NCT00369824|83048247|FG002|Overall Study|Lost to Follow-up|7|||
46830445|NCT00369824|83048248|FG003|Overall Study|Lost to Follow-up|8|||
46830446|NCT00369824|83048249|FG004|Overall Study|Lost to Follow-up|9|||
46830447|NCT00369824|83048250|FG005|Overall Study|Lost to Follow-up|6|||
46830448|NCT00369824|83048245|FG000|Overall Study|Other|0|||
46830449|NCT00369824|83048246|FG001|Overall Study|Other|0|||
46830450|NCT00369824|83048247|FG002|Overall Study|Other|0|||
46830451|NCT00369824|83048248|FG003|Overall Study|Other|2|||
46830452|NCT00369824|83048249|FG004|Overall Study|Other|1|||
46830453|NCT00369824|83048250|FG005|Overall Study|Other|3|||
46830454|NCT00369668|83048267|FG000|Overall Study|Lack of Efficacy|4|||
46830455|NCT00369668|83048268|FG001|Overall Study|Lack of Efficacy|5|||
46764661|NCT00813098|82982936|FG001|Overall Study|Lost to Follow-up|1|||
46764662|NCT00813098|82982937|FG002|Overall Study|Lost to Follow-up|0|||
46764663|NCT00813098|82982935|FG000|Overall Study|Protocol Violation|0|||
46764664|NCT00813098|82982936|FG001|Overall Study|Protocol Violation|0|||
46764665|NCT00813098|82982937|FG002|Overall Study|Protocol Violation|1|||
46764666|NCT00813098|82982935|FG000|Overall Study|Principal Investigator decision|0|||
46764667|NCT00813098|82982936|FG001|Overall Study|Principal Investigator decision|1|||
46764668|NCT00813098|82982937|FG002|Overall Study|Principal Investigator decision|0|||
46764669|NCT00813098|82982935|FG000|Overall Study|Withdrew Consent|0|||
46830456|NCT00369668|83048269|FG002|Overall Study|Lack of Efficacy|7|||
46830457|NCT00388154|83048280|FG000|Overall Study|Withdrawal by Subject|1|||
46830458|NCT00387764|83048284|FG000|Overall Study|Adverse Event|12|||
46830459|NCT00387764|83048284|FG000|Overall Study|Withdrawal by Subject|8|||
46830460|NCT00387764|83048284|FG000|Overall Study|Sponsor Terminated Study|1|||
46830461|NCT00387764|83048284|FG000|Overall Study|Physician Decision|1|||
46764670|NCT00813098|82982936|FG001|Overall Study|Withdrew Consent|1|||
46830462|NCT00387764|83048284|FG000|Overall Study|Other|2|||
46830463|NCT00387764|83048284|FG000|Overall Study|Death|7|||
46830464|NCT00386360|83048290|FG000|Overall Study|Adverse Event|4|||
46830465|NCT00386360|83048291|FG001|Overall Study|Adverse Event|2|||
47060414|NCT02680002|83340080|FG005|Overall Study|Adverse Event|2|||
47060415|NCT04557384|83340097|FG000|Overall Study|Study Terminated by Sponsor|1|||
47060416|NCT04557384|83340097|FG000|Overall Study|Death|1|||
47060417|NCT02673684|83340103|FG000|Overall Study|Study not completed d/t loss of funding|9|||
47060418|NCT02673684|83340104|FG001|Overall Study|Study not completed d/t loss of funding|8|||
47060419|NCT02675634|83340112|FG000|Test Period 1|Adverse Event|0|||
47060420|NCT02675634|83340113|FG001|Test Period 1|Adverse Event|1|||
46830466|NCT00386360|83048290|FG000|Overall Study|Physician Decision|2|||
46830467|NCT00386360|83048291|FG001|Overall Study|Physician Decision|2|||
46830468|NCT00386360|83048290|FG000|Overall Study|Lost to Follow-up|0|||
46830469|NCT00386360|83048291|FG001|Overall Study|Lost to Follow-up|2|||
46830470|NCT00386360|83048290|FG000|Overall Study|Protocol Violation|0|||
46830471|NCT00386360|83048291|FG001|Overall Study|Protocol Violation|3|||
46830472|NCT00386360|83048290|FG000|Overall Study|Withdrawal by Subject|3|||
46830473|NCT00386360|83048291|FG001|Overall Study|Withdrawal by Subject|6|||
46830474|NCT00386360|83048290|FG000|Overall Study|Did not take any study medication|0|||
46830475|NCT00386360|83048291|FG001|Overall Study|Did not take any study medication|2|||
46830476|NCT00369278|83048299|FG000|Overall Study|Adverse Event|14|||
46830477|NCT00369278|83048300|FG001|Overall Study|Adverse Event|11|||
46830478|NCT00369278|83048299|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
46830479|NCT00369278|83048300|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
46830480|NCT00369278|83048299|FG000|Overall Study|Protocol Violation|2|||
46830481|NCT00369278|83048300|FG001|Overall Study|Protocol Violation|1|||
46830482|NCT00369278|83048299|FG000|Overall Study|Withdrawal by Subject|2|||
46830483|NCT00369278|83048300|FG001|Overall Study|Withdrawal by Subject|2|||
46830484|NCT00369278|83048299|FG000|Overall Study|Lost to Follow-up|1|||
46830485|NCT00369278|83048300|FG001|Overall Study|Lost to Follow-up|0|||
46830486|NCT00369278|83048299|FG000|Overall Study|Graft loss|1|||
46830487|NCT00369278|83048300|FG001|Overall Study|Graft loss|2|||
46830488|NCT00529373|83048308|FG000|Base Study|Adverse Event|525|||
46830489|NCT00529373|83048309|FG001|Base Study|Adverse Event|470|||
46830490|NCT00529373|83048308|FG000|Base Study|Lack of Efficacy|16|||
46830491|NCT00529373|83048309|FG001|Base Study|Lack of Efficacy|75|||
46830492|NCT00529373|83048308|FG000|Base Study|Lost to Follow-up|221|||
46830493|NCT00529373|83048309|FG001|Base Study|Lost to Follow-up|208|||
46830494|NCT00529373|83048308|FG000|Base Study|Other Protocol Specified Criteria|19|||
46830495|NCT00529373|83048309|FG001|Base Study|Other Protocol Specified Criteria|20|||
46830496|NCT00529373|83048308|FG000|Base Study|Physician Decision|60|||
46830497|NCT00529373|83048309|FG001|Base Study|Physician Decision|52|||
46830498|NCT00529373|83048308|FG000|Base Study|Protocol Violation|48|||
46830499|NCT00529373|83048309|FG001|Base Study|Protocol Violation|38|||
46830500|NCT00529373|83048308|FG000|Base Study|Withdrawal by Subject|1062|||
46830501|NCT00529373|83048309|FG001|Base Study|Withdrawal by Subject|967|||
46830502|NCT00529373|83048308|FG000|Base Study|Did not continue into Extension|1795|||
46830503|NCT00529373|83048309|FG001|Base Study|Did not continue into Extension|2238|||
46830504|NCT00529373|83048308|FG000|First Extension Study|Adverse Event|162|||
46830505|NCT00529373|83048309|FG001|First Extension Study|Adverse Event|142|||
46830506|NCT00529373|83048308|FG000|First Extension Study|Lack of Efficacy|65|||
46830507|NCT00529373|83048309|FG001|First Extension Study|Lack of Efficacy|427|||
46830508|NCT00529373|83048308|FG000|First Extension Study|Lost to Follow-up|41|||
46830509|NCT00529373|83048309|FG001|First Extension Study|Lost to Follow-up|37|||
46830510|NCT00529373|83048308|FG000|First Extension Study|Other|27|||
46830511|NCT00529373|83048309|FG001|First Extension Study|Other|47|||
46830512|NCT00529373|83048308|FG000|First Extension Study|Physician Decision|50|||
46830513|NCT00529373|83048309|FG001|First Extension Study|Physician Decision|45|||
46830514|NCT00529373|83048308|FG000|First Extension Study|Protocol Violation|16|||
46830515|NCT00529373|83048309|FG001|First Extension Study|Protocol Violation|13|||
46830516|NCT00529373|83048308|FG000|First Extension Study|Withdrawal by Subject|296|||
46830517|NCT00529373|83048309|FG001|First Extension Study|Withdrawal by Subject|287|||
46830518|NCT00529373|83048308|FG000|First Extension Study|Disposition record non-existing|0|||
46830519|NCT00529373|83048309|FG001|First Extension Study|Disposition record non-existing|1|||
46830520|NCT00529373|83048308|FG000|First Extension Study|Discontinued after 5 years completion|208|||
47060421|NCT02675634|83340114|FG002|Test Period 1|Adverse Event|0|||
47060422|NCT02675634|83340115|FG003|Test Period 1|Adverse Event|1|||
47060423|NCT02675634|83340116|FG004|Test Period 1|Adverse Event|0|||
47060424|NCT02675634|83340117|FG005|Test Period 1|Adverse Event|0|||
46830521|NCT00529373|83048309|FG001|First Extension Study|Discontinued after 5 years completion|346|||
46830522|NCT00529373|83048308|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
46830523|NCT00529373|83048309|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
46830524|NCT00529373|83048308|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
46830525|NCT00529373|83048309|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
46830526|NCT00529373|83048308|FG000|Second Extension Study|Adverse Event|101|||
46830527|NCT00529373|83048309|FG001|Second Extension Study|Adverse Event|51|||
46830528|NCT00529373|83048308|FG000|Second Extension Study|Lack of Efficacy|7|||
46830529|NCT00529373|83048309|FG001|Second Extension Study|Lack of Efficacy|15|||
46830530|NCT00529373|83048308|FG000|Second Extension Study|Lost to Follow-up|18|||
46830531|NCT00529373|83048309|FG001|Second Extension Study|Lost to Follow-up|12|||
46830532|NCT00529373|83048308|FG000|Second Extension Study|Other|7|||
46830533|NCT00529373|83048309|FG001|Second Extension Study|Other|12|||
46830534|NCT00529373|83048308|FG000|Second Extension Study|Physician Decision|63|||
46830535|NCT00529373|83048309|FG001|Second Extension Study|Physician Decision|26|||
47060425|NCT02675634|83340112|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
46830536|NCT00529373|83048308|FG000|Second Extension Study|Protocol Violation|2|||
46830537|NCT00529373|83048309|FG001|Second Extension Study|Protocol Violation|1|||
46830538|NCT00529373|83048308|FG000|Second Extension Study|Withdrawal by Subject|97|||
46830539|NCT00529373|83048309|FG001|Second Extension Study|Withdrawal by Subject|75|||
46830540|NCT00529373|83048308|FG000|Second Extension Study|Status Missing|5|||
46830541|NCT00529373|83048309|FG001|Second Extension Study|Status Missing|5|||
46830542|NCT00369122|83048323|FG000|Overall Study|Ineligible|10|||
46830543|NCT00369122|83048323|FG000|Overall Study|No protocol treatment|1|||
46830544|NCT03687125|83048329|FG000|Overall Study|Progressive Disease|2|||
47060426|NCT02675634|83340113|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
47060427|NCT02675634|83340114|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
47060428|NCT02675634|83340115|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
46830545|NCT03687125|83048330|FG001|Overall Study|Progressive Disease|1|||
46830546|NCT03687125|83048329|FG000|Overall Study|Protocol Violation|1|||
46830547|NCT03687125|83048330|FG001|Overall Study|Protocol Violation|0|||
46830548|NCT03872843|83048340|FG000|Overall Study|Lost to Follow-up|5|||
46830549|NCT03872843|83048341|FG001|Overall Study|Lost to Follow-up|7|||
46830550|NCT00146770|83048349|FG000|Overall Study|Adverse Event|2|||
46830551|NCT00146770|83048350|FG001|Overall Study|Adverse Event|0|||
46830552|NCT00146770|83048349|FG000|Overall Study|Pregnancy|1|||
46830553|NCT00146770|83048350|FG001|Overall Study|Pregnancy|0|||
46830554|NCT00146770|83048349|FG000|Overall Study|Withdrawal by Subject|2|||
46830555|NCT00146770|83048350|FG001|Overall Study|Withdrawal by Subject|0|||
46830556|NCT03874013|83048358|FG000|Overall Study|Adverse Event|0|||
46830557|NCT03874013|83048359|FG001|Overall Study|Adverse Event|1|||
46830558|NCT00168064|83048367|FG000|Overall Study|Adverse Event|26|||
46830559|NCT00168064|83048368|FG001|Overall Study|Adverse Event|22|||
46830560|NCT00168064|83048367|FG000|Overall Study|Withdrawal by Subject|3|||
47060429|NCT02675634|83340116|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
47060430|NCT02675634|83340117|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
47060431|NCT02675634|83340112|FG000|Test Period 2|Lack of Efficacy|1|||
47060432|NCT02675634|83340113|FG001|Test Period 2|Lack of Efficacy|0|||
47060433|NCT02675634|83340114|FG002|Test Period 2|Lack of Efficacy|0|||
47060434|NCT02675634|83340115|FG003|Test Period 2|Lack of Efficacy|0|||
47060435|NCT02675634|83340116|FG004|Test Period 2|Lack of Efficacy|0|||
47060436|NCT02675634|83340117|FG005|Test Period 2|Lack of Efficacy|0|||
47060437|NCT02675634|83340112|FG000|Test Period 2|Adverse Event|0|||
47060438|NCT02675634|83340113|FG001|Test Period 2|Adverse Event|0|||
47060439|NCT02675634|83340114|FG002|Test Period 2|Adverse Event|0|||
47060440|NCT02675634|83340115|FG003|Test Period 2|Adverse Event|0|||
47060441|NCT02675634|83340116|FG004|Test Period 2|Adverse Event|0|||
46764671|NCT00813098|82982937|FG002|Overall Study|Withdrew Consent|0|||
46764672|NCT00796653|82982949|FG000|Overall Study|Adverse Event|19|||
46764673|NCT00796653|82982950|FG001|Overall Study|Adverse Event|16|||
46764674|NCT00796653|82982951|FG002|Overall Study|Adverse Event|16|||
46764675|NCT00796653|82982952|FG003|Overall Study|Adverse Event|16|||
46764676|NCT00796653|82982949|FG000|Overall Study|Lost to Follow-up|2|||
46764677|NCT00796653|82982950|FG001|Overall Study|Lost to Follow-up|1|||
46764678|NCT00796653|82982951|FG002|Overall Study|Lost to Follow-up|2|||
46764679|NCT00796653|82982952|FG003|Overall Study|Lost to Follow-up|3|||
46764680|NCT00796653|82982949|FG000|Overall Study|Withdrawal by Subject|16|||
46764681|NCT00796653|82982950|FG001|Overall Study|Withdrawal by Subject|8|||
46764682|NCT00796653|82982951|FG002|Overall Study|Withdrawal by Subject|8|||
46764683|NCT00796653|82982952|FG003|Overall Study|Withdrawal by Subject|13|||
46764684|NCT00796653|82982949|FG000|Overall Study|Lack of Efficacy|8|||
46764685|NCT00796653|82982950|FG001|Overall Study|Lack of Efficacy|1|||
46764686|NCT00796653|82982951|FG002|Overall Study|Lack of Efficacy|3|||
46764687|NCT00796653|82982952|FG003|Overall Study|Lack of Efficacy|2|||
46830561|NCT00168064|83048368|FG001|Overall Study|Withdrawal by Subject|4|||
46830562|NCT00168064|83048367|FG000|Overall Study|Lack of Efficacy|4|||
46830563|NCT00168064|83048368|FG001|Overall Study|Lack of Efficacy|4|||
46830564|NCT00168064|83048367|FG000|Overall Study|Lost to Follow-up|4|||
46830565|NCT00168064|83048368|FG001|Overall Study|Lost to Follow-up|3|||
46764688|NCT00796653|82982949|FG000|Overall Study|Non compliance with protocol|2|||
46764689|NCT00796653|82982950|FG001|Overall Study|Non compliance with protocol|2|||
46764690|NCT00796653|82982951|FG002|Overall Study|Non compliance with protocol|0|||
46830566|NCT00168064|83048367|FG000|Overall Study|Non-compliance|2|||
46830567|NCT00168064|83048368|FG001|Overall Study|Non-compliance|3|||
46830568|NCT00168064|83048367|FG000|Overall Study|Concurrent Illness|4|||
46830569|NCT00168064|83048368|FG001|Overall Study|Concurrent Illness|3|||
46830570|NCT00168064|83048367|FG000|Overall Study|Subject's Best interest|2|||
47060442|NCT02675634|83340117|FG005|Test Period 2|Adverse Event|1|||
47060443|NCT02671500|83340125|FG000|Overall Study|Lack of Efficacy|12|||
47060444|NCT02671500|83340125|FG000|Overall Study|Lost to Follow-up|2|||
47060445|NCT02671422|83340133|FG000|Overall Study|Lost to Follow-up|1|||
47060446|NCT02671422|83340133|FG000|Overall Study|Adverse Event|68|||
47060447|NCT02671422|83340133|FG000|Overall Study|Lack of Efficacy|1|||
47060448|NCT02671422|83340133|FG000|Overall Study|Lost to Follow-up|4|||
47060449|NCT02671422|83340133|FG000|Overall Study|Withdrawal by Subject|7|||
47060450|NCT02671422|83340133|FG000|Overall Study|Progressive Disease|156|||
47060451|NCT02671422|83340133|FG000|Overall Study|Worsening of Disease|4|||
47060452|NCT02671422|83340133|FG000|Overall Study|Sponsor decision|5|||
47060453|NCT02671422|83340133|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
47060454|NCT02671422|83340133|FG000|Overall Study|Not treated with Vargatef®|3|||
47060455|NCT02671422|83340133|FG000|Overall Study|Other not defined above|3|||
47060456|NCT02671266|83340139|FG000|Overall Study|Withdrawal by Subject|1|||
47060457|NCT02671266|83340140|FG001|Overall Study|Withdrawal by Subject|1|||
47060458|NCT03320070|83340148|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
47060459|NCT03320070|83340149|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
47060460|NCT03320070|83340148|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
47060461|NCT03320070|83340149|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
46830571|NCT00168064|83048368|FG001|Overall Study|Subject's Best interest|2|||
46830572|NCT00168064|83048367|FG000|Overall Study|Various|4|||
46830573|NCT00168064|83048368|FG001|Overall Study|Various|3|||
46830574|NCT00166114|83048378|FG000|Overall Study|Protocol Violation|2|||
46830575|NCT00166114|83048379|FG001|Overall Study|Protocol Violation|1|||
46830576|NCT00166114|83048378|FG000|Overall Study|Withdrawal by Subject|10|||
46830577|NCT00166114|83048379|FG001|Overall Study|Withdrawal by Subject|4|||
46830578|NCT00166114|83048378|FG000|Overall Study|Adverse Event|2|||
46830579|NCT00166114|83048379|FG001|Overall Study|Adverse Event|1|||
46830580|NCT03686969|83048387|FG000|Overall Study|Study terminated|1|||
46830581|NCT03686969|83048388|FG001|Overall Study|Study terminated|0|||
46830582|NCT00145600|83048398|FG000|Overall Study|Death|1|||
46830583|NCT00145600|83048399|FG001|Overall Study|Death|2|||
46830584|NCT00145600|83048400|FG002|Overall Study|Death|2|||
46830585|NCT00145600|83048401|FG003|Overall Study|Death|6|||
46830586|NCT00145600|83048398|FG000|Overall Study|Ineligible|3|||
47060462|NCT03320070|83340148|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
47060463|NCT03320070|83340149|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
47060464|NCT03320070|83340148|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
47060465|NCT03320070|83340149|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
47060466|NCT03320070|83340148|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
46830587|NCT00145600|83048399|FG001|Overall Study|Ineligible|0|||
46830588|NCT00145600|83048400|FG002|Overall Study|Ineligible|1|||
46830589|NCT00145600|83048401|FG003|Overall Study|Ineligible|5|||
46764691|NCT00796653|82982952|FG003|Overall Study|Non compliance with protocol|2|||
46764692|NCT00796653|82982949|FG000|Overall Study|Other reason not described above|4|||
46764693|NCT00796653|82982950|FG001|Overall Study|Other reason not described above|9|||
46764694|NCT00796653|82982951|FG002|Overall Study|Other reason not described above|7|||
46764695|NCT00796653|82982952|FG003|Overall Study|Other reason not described above|4|||
46764696|NCT00806286|82982973|FG000|Overall Study|Adverse Event|5|||
46764697|NCT00806286|82982974|FG001|Overall Study|Adverse Event|2|||
46764698|NCT00806286|82982975|FG002|Overall Study|Adverse Event|0|||
46764699|NCT00806286|82982973|FG000|Overall Study|Disease progression|31|||
46764700|NCT00806286|82982974|FG001|Overall Study|Disease progression|38|||
46764701|NCT00806286|82982975|FG002|Overall Study|Disease progression|1|||
46764702|NCT00806286|82982973|FG000|Overall Study|Death|1|||
46764703|NCT00806286|82982974|FG001|Overall Study|Death|6|||
46764704|NCT00806286|82982975|FG002|Overall Study|Death|0|||
46764705|NCT00806286|82982973|FG000|Overall Study|Lost to Follow-up|0|||
46764706|NCT00806286|82982974|FG001|Overall Study|Lost to Follow-up|1|||
46764707|NCT00806286|82982975|FG002|Overall Study|Lost to Follow-up|0|||
46764708|NCT00806286|82982973|FG000|Overall Study|Withdrawal by Subject|8|||
46764709|NCT00806286|82982974|FG001|Overall Study|Withdrawal by Subject|3|||
46830590|NCT00145600|83048398|FG000|Overall Study|Lost to Follow-up|2|||
46830591|NCT00145600|83048399|FG001|Overall Study|Lost to Follow-up|6|||
46830592|NCT00145600|83048400|FG002|Overall Study|Lost to Follow-up|2|||
46764710|NCT00806286|82982975|FG002|Overall Study|Withdrawal by Subject|1|||
46830593|NCT00145600|83048401|FG003|Overall Study|Lost to Follow-up|4|||
46830594|NCT00145600|83048398|FG000|Overall Study|Noncompliance|1|||
47060467|NCT03320070|83340149|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
46764711|NCT00806286|82982973|FG000|Overall Study|Physician Decision|2|||
46764712|NCT00806286|82982974|FG001|Overall Study|Physician Decision|2|||
46764713|NCT00806286|82982975|FG002|Overall Study|Physician Decision|0|||
46830595|NCT00145600|83048399|FG001|Overall Study|Noncompliance|0|||
46830596|NCT00145600|83048400|FG002|Overall Study|Noncompliance|0|||
46830597|NCT00145600|83048401|FG003|Overall Study|Noncompliance|0|||
46830598|NCT00145600|83048398|FG000|Overall Study|Withdrawal by Subject|1|||
46764714|NCT00806286|82982973|FG000|Overall Study|Due to a variety of reasons|7|||
46830599|NCT00145600|83048399|FG001|Overall Study|Withdrawal by Subject|2|||
47060468|NCT03320070|83340148|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
47060469|NCT03320070|83340149|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
47060470|NCT02667912|83340160|FG000|Overall Study|Death|3|||
46830600|NCT00145600|83048400|FG002|Overall Study|Withdrawal by Subject|0|||
46830601|NCT00145600|83048401|FG003|Overall Study|Withdrawal by Subject|1|||
46830602|NCT00129376|83048425|FG000|Overall Study|Adverse Event|1|||
46830603|NCT00129376|83048425|FG000|Overall Study|Lack of Efficacy|1|||
46830604|NCT00129220|83048432|FG000|Study Period II|Adverse Event|9|||
46830605|NCT00129220|83048433|FG001|Study Period II|Adverse Event|5|||
47060471|NCT02667912|83340161|FG001|Overall Study|Death|1|||
47060472|NCT02667912|83340160|FG000|Overall Study|Withdrawal by Subject|1|||
47060473|NCT02667912|83340161|FG001|Overall Study|Withdrawal by Subject|2|||
47060474|NCT02667912|83340160|FG000|Overall Study|Withdrawal by Subject|1|||
47060475|NCT02667912|83340161|FG001|Overall Study|Withdrawal by Subject|0|||
47060476|NCT01373346|83340167|FG000|Overall Study|Death|1|||
47060477|NCT03284424|83340178|FG000|Overall Study|Death|56|||
47060478|NCT03284424|83340179|FG001|Overall Study|Death|13|||
46830606|NCT00129220|83048434|FG002|Study Period II|Adverse Event|7|||
46830607|NCT00129220|83048432|FG000|Study Period II|Lack of Efficacy|15|||
47060479|NCT03284424|83340178|FG000|Overall Study|Lost to Follow-up|1|||
47060480|NCT03284424|83340179|FG001|Overall Study|Lost to Follow-up|0|||
47060481|NCT03284424|83340178|FG000|Overall Study|Physician Decision|1|||
47060482|NCT03284424|83340179|FG001|Overall Study|Physician Decision|0|||
47060483|NCT03284424|83340178|FG000|Overall Study|Withdrawal by Subject|3|||
47060484|NCT03284424|83340179|FG001|Overall Study|Withdrawal by Subject|2|||
47060485|NCT03284424|83340178|FG000|Overall Study|Ongoing in study|44|||
47060486|NCT03284424|83340179|FG001|Overall Study|Ongoing in study|39|||
47060487|NCT02674854|83340187|FG000|Overall Study|Adverse Event|17|||
47060488|NCT02674854|83340188|FG001|Overall Study|Adverse Event|15|||
47060489|NCT02674854|83340189|FG002|Overall Study|Adverse Event|5|||
47060490|NCT02674854|83340187|FG000|Overall Study|Withdrawal by Subject|1|||
47060491|NCT02674854|83340188|FG001|Overall Study|Withdrawal by Subject|5|||
47060492|NCT02674854|83340189|FG002|Overall Study|Withdrawal by Subject|4|||
47060493|NCT02674854|83340187|FG000|Overall Study|No-compliant subject|1|||
47060494|NCT02674854|83340188|FG001|Overall Study|No-compliant subject|0|||
47060495|NCT02674854|83340189|FG002|Overall Study|No-compliant subject|1|||
47060496|NCT02674854|83340187|FG000|Overall Study|Lost to Follow-up|1|||
47060497|NCT02674854|83340188|FG001|Overall Study|Lost to Follow-up|0|||
46764715|NCT00806286|82982974|FG001|Overall Study|Due to a variety of reasons|2|||
46764716|NCT00806286|82982975|FG002|Overall Study|Due to a variety of reasons|1|||
46764717|NCT00590538|82982983|FG000|Overall Study|Study terminated before completed|2|||
46764718|NCT00796419|82982989|FG000|Overall Study|Death|0|||
46764719|NCT00796419|82982990|FG001|Overall Study|Death|1|||
46764720|NCT00796107|82982996|FG000|Overall Study|Lack of Efficacy|1|||
46764721|NCT00796107|82982996|FG000|Overall Study|Progressive Disease|5|||
46764722|NCT00795951|82983000|FG000|Overall Study|Lost to Follow-up|1|||
46764723|NCT00795951|82983000|FG000|Overall Study|Withdrawal by Subject|1|||
46764724|NCT00795717|82983007|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
46764725|NCT00795717|82983008|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
46764726|NCT00795717|82983007|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
46764727|NCT00795717|82983008|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
46764728|NCT00795717|82983007|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
46764729|NCT00795717|82983008|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
46764730|NCT00795717|82983007|FG000|Phase II|too busy|0|||
46764731|NCT00795717|82983008|FG001|Phase II|too busy|1|||
46764732|NCT00805740|82983017|FG000|Overall Study|Death|7|||
46764733|NCT00805740|82983018|FG001|Overall Study|Death|4|||
46764734|NCT00805740|82983017|FG000|Overall Study|Withdrawal by Subject|1|||
46764735|NCT00805740|82983018|FG001|Overall Study|Withdrawal by Subject|0|||
46764736|NCT00805740|82983017|FG000|Overall Study|Lost to Follow-up|1|||
46764737|NCT00805740|82983018|FG001|Overall Study|Lost to Follow-up|0|||
46764738|NCT00805740|82983017|FG000|Overall Study|Randomized, but not treated|2|||
46764739|NCT00805740|82983018|FG001|Overall Study|Randomized, but not treated|0|||
46764740|NCT00795639|82983026|FG000|Overall Study|Death|1|||
46764741|NCT00795639|82983027|FG001|Overall Study|Death|6|||
46830608|NCT00129220|83048433|FG001|Study Period II|Lack of Efficacy|1|||
46830609|NCT00129220|83048434|FG002|Study Period II|Lack of Efficacy|28|||
46830610|NCT00129220|83048432|FG000|Study Period II|Entry Criteria Not Met|2|||
46764742|NCT00795639|82983026|FG000|Overall Study|Withdrawal by Subject|1|||
46764743|NCT00795639|82983027|FG001|Overall Study|Withdrawal by Subject|3|||
46764744|NCT00795639|82983026|FG000|Overall Study|Pregnancy|1|||
46764745|NCT00795639|82983027|FG001|Overall Study|Pregnancy|0|||
46830611|NCT00129220|83048433|FG001|Study Period II|Entry Criteria Not Met|0|||
46830612|NCT00129220|83048434|FG002|Study Period II|Entry Criteria Not Met|2|||
47060498|NCT02674854|83340189|FG002|Overall Study|Lost to Follow-up|2|||
47060499|NCT02674854|83340187|FG000|Overall Study|Lack of Efficacy|0|||
47060500|NCT02674854|83340188|FG001|Overall Study|Lack of Efficacy|3|||
47060501|NCT02674854|83340189|FG002|Overall Study|Lack of Efficacy|0|||
47060502|NCT02674854|83340187|FG000|Overall Study|Disallowed Concurrent Medication|2|||
47060503|NCT02674854|83340188|FG001|Overall Study|Disallowed Concurrent Medication|2|||
47060504|NCT02674854|83340189|FG002|Overall Study|Disallowed Concurrent Medication|0|||
47060505|NCT02674854|83340187|FG000|Overall Study|Protocol Violation|1|||
47060506|NCT02674854|83340188|FG001|Overall Study|Protocol Violation|1|||
47060507|NCT02674854|83340189|FG002|Overall Study|Protocol Violation|2|||
47060508|NCT02674854|83340187|FG000|Overall Study|Death|0|||
47060509|NCT02674854|83340188|FG001|Overall Study|Death|1|||
47060510|NCT02674854|83340189|FG002|Overall Study|Death|0|||
47060511|NCT02674854|83340187|FG000|Overall Study|Subject missed V6.2|1|||
47060512|NCT02674854|83340188|FG001|Overall Study|Subject missed V6.2|0|||
47060513|NCT02674854|83340189|FG002|Overall Study|Subject missed V6.2|0|||
47060514|NCT02667288|83340197|FG000|Overall Study|Protocol Violation|5|||
47060515|NCT02667288|83340197|FG000|Overall Study|Lost to Follow-up|3|||
47060516|NCT02667288|83340197|FG000|Overall Study|Withdrawal by Subject|5|||
47060517|NCT02670330|83340203|FG000|Overall Study|Protocol Deviation|1|||
47060518|NCT02670330|83340204|FG001|Overall Study|Protocol Deviation|0|||
47060519|NCT02670330|83340203|FG000|Overall Study|Study Terminated By Sponsor|36|||
47060520|NCT02670330|83340204|FG001|Overall Study|Study Terminated By Sponsor|43|||
47060521|NCT02670330|83340203|FG000|Overall Study|Adverse Event|1|||
47060522|NCT02670330|83340204|FG001|Overall Study|Adverse Event|3|||
47060523|NCT02670330|83340203|FG000|Overall Study|Withdrawal by Subject|34|||
47060524|NCT02670330|83340204|FG001|Overall Study|Withdrawal by Subject|29|||
47060525|NCT02670330|83340203|FG000|Overall Study|Lost to Follow-up|3|||
47060526|NCT02670330|83340204|FG001|Overall Study|Lost to Follow-up|2|||
47060527|NCT02669940|83340212|FG000|Overall Study|Failure to return|0|||
47060528|NCT02669940|83340213|FG001|Overall Study|Failure to return|3|||
47060529|NCT02669940|83340212|FG000|Overall Study|Insufficient follow-up data|1|||
47060530|NCT02669940|83340213|FG001|Overall Study|Insufficient follow-up data|0|||
47060531|NCT02669862|83340229|FG000|Overall Study|Lost to Follow-up|0|||
47060532|NCT02669862|83340230|FG001|Overall Study|Lost to Follow-up|2|||
47060533|NCT02669862|83340231|FG002|Overall Study|Lost to Follow-up|1|||
47060534|NCT02669862|83340229|FG000|Overall Study|Withdrawal by Subject|2|||
47060535|NCT02669862|83340230|FG001|Overall Study|Withdrawal by Subject|2|||
47060536|NCT02669862|83340231|FG002|Overall Study|Withdrawal by Subject|3|||
47060537|NCT02669862|83340229|FG000|Overall Study|moved|0|||
47060538|NCT02669862|83340230|FG001|Overall Study|moved|1|||
47060539|NCT02669862|83340231|FG002|Overall Study|moved|0|||
47060540|NCT02669862|83340229|FG000|Overall Study|Protocol Violation|0|||
47060541|NCT02669862|83340230|FG001|Overall Study|Protocol Violation|0|||
47060542|NCT02669862|83340231|FG002|Overall Study|Protocol Violation|1|||
47060543|NCT01531673|83340255|FG000|Overall Study|Non-Compliance|0|||
47060544|NCT01531673|83340256|FG001|Overall Study|Non-Compliance|0|||
47060545|NCT01531673|83340257|FG002|Overall Study|Non-Compliance|0|||
47060546|NCT01531673|83340258|FG003|Overall Study|Non-Compliance|0|||
47060547|NCT01531673|83340259|FG004|Overall Study|Non-Compliance|0|||
47060548|NCT01531673|83340260|FG005|Overall Study|Non-Compliance|1|||
47060549|NCT01531673|83340261|FG006|Overall Study|Non-Compliance|0|||
47060550|NCT01531673|83340262|FG007|Overall Study|Non-Compliance|0|||
47060551|NCT01531673|83340263|FG008|Overall Study|Non-Compliance|0|||
47060552|NCT01531673|83340264|FG009|Overall Study|Non-Compliance|0|||
47060553|NCT01531673|83340265|FG010|Overall Study|Non-Compliance|0|||
47060554|NCT01531673|83340266|FG011|Overall Study|Non-Compliance|0|||
47060555|NCT01531673|83340267|FG012|Overall Study|Non-Compliance|0|||
47060556|NCT01531673|83340255|FG000|Overall Study|Adverse Event|0|||
47060557|NCT01531673|83340256|FG001|Overall Study|Adverse Event|1|||
47060558|NCT01531673|83340257|FG002|Overall Study|Adverse Event|0|||
47060559|NCT01531673|83340258|FG003|Overall Study|Adverse Event|0|||
47060560|NCT01531673|83340259|FG004|Overall Study|Adverse Event|0|||
47060561|NCT01531673|83340260|FG005|Overall Study|Adverse Event|0|||
47060562|NCT01531673|83340261|FG006|Overall Study|Adverse Event|0|||
47060563|NCT01531673|83340262|FG007|Overall Study|Adverse Event|0|||
47060564|NCT01531673|83340263|FG008|Overall Study|Adverse Event|0|||
47060565|NCT01531673|83340264|FG009|Overall Study|Adverse Event|0|||
46830613|NCT00129220|83048432|FG000|Study Period II|Protocol Violation|4|||
46830614|NCT00129220|83048433|FG001|Study Period II|Protocol Violation|2|||
46830615|NCT00129220|83048434|FG002|Study Period II|Protocol Violation|1|||
46830616|NCT00129220|83048432|FG000|Study Period II|Physician Decision|0|||
47060566|NCT01531673|83340265|FG010|Overall Study|Adverse Event|0|||
47060567|NCT01531673|83340266|FG011|Overall Study|Adverse Event|0|||
47060568|NCT01531673|83340267|FG012|Overall Study|Adverse Event|0|||
47060569|NCT01531673|83340255|FG000|Overall Study|Lost to Follow-up|0|||
47060570|NCT01531673|83340256|FG001|Overall Study|Lost to Follow-up|0|||
47060571|NCT01531673|83340257|FG002|Overall Study|Lost to Follow-up|0|||
47060572|NCT01531673|83340258|FG003|Overall Study|Lost to Follow-up|0|||
47060573|NCT01531673|83340259|FG004|Overall Study|Lost to Follow-up|1|||
47060574|NCT01531673|83340260|FG005|Overall Study|Lost to Follow-up|0|||
47060575|NCT01531673|83340261|FG006|Overall Study|Lost to Follow-up|0|||
47060576|NCT01531673|83340262|FG007|Overall Study|Lost to Follow-up|0|||
47060577|NCT01531673|83340263|FG008|Overall Study|Lost to Follow-up|0|||
47060578|NCT01531673|83340264|FG009|Overall Study|Lost to Follow-up|0|||
47060579|NCT01531673|83340265|FG010|Overall Study|Lost to Follow-up|0|||
47060580|NCT01531673|83340266|FG011|Overall Study|Lost to Follow-up|0|||
47060581|NCT01531673|83340267|FG012|Overall Study|Lost to Follow-up|0|||
46830617|NCT00129220|83048433|FG001|Study Period II|Physician Decision|1|||
46830618|NCT00129220|83048434|FG002|Study Period II|Physician Decision|0|||
46830619|NCT00129220|83048432|FG000|Study Period II|Withdrawal by Subject|1|||
46830620|NCT00129220|83048433|FG001|Study Period II|Withdrawal by Subject|3|||
46830621|NCT00129220|83048434|FG002|Study Period II|Withdrawal by Subject|4|||
46830622|NCT00129220|83048432|FG000|Study Period II|Reason Not Specified|2|||
46830623|NCT00129220|83048433|FG001|Study Period II|Reason Not Specified|0|||
46830624|NCT00129220|83048434|FG002|Study Period II|Reason Not Specified|5|||
46830625|NCT00129220|83048432|FG000|Study Period III|Adverse Event|1|||
46830626|NCT00129220|83048433|FG001|Study Period III|Adverse Event|0|||
46830627|NCT00129220|83048434|FG002|Study Period III|Adverse Event|3|||
46830628|NCT00129220|83048432|FG000|Study Period III|Protocol Violation|1|||
46830629|NCT00129220|83048433|FG001|Study Period III|Protocol Violation|1|||
46830630|NCT00129220|83048434|FG002|Study Period III|Protocol Violation|2|||
46830631|NCT00129220|83048432|FG000|Study Period III|Withdrawal by Subject|1|||
46830632|NCT00129220|83048433|FG001|Study Period III|Withdrawal by Subject|0|||
46830633|NCT00129220|83048434|FG002|Study Period III|Withdrawal by Subject|3|||
46830634|NCT00129220|83048432|FG000|Study Period III|Sponsor Decision|1|||
46830635|NCT00129220|83048433|FG001|Study Period III|Sponsor Decision|0|||
46830636|NCT00129220|83048434|FG002|Study Period III|Sponsor Decision|0|||
46830637|NCT00129220|83048432|FG000|Study Period III|Reason Not Specified|9|||
46830638|NCT00129220|83048433|FG001|Study Period III|Reason Not Specified|0|||
46830639|NCT00129220|83048434|FG002|Study Period III|Reason Not Specified|2|||
46830640|NCT00128830|83048454|FG000|Overall Study|Adverse Event|10|||
46830641|NCT00128830|83048454|FG000|Overall Study|Withdrawal by Subject|14|||
46830642|NCT00128830|83048454|FG000|Overall Study|Lost to Follow-up|4|||
46830643|NCT00128830|83048454|FG000|Overall Study|Reached a virologic endpoint|29|||
46830644|NCT00128830|83048454|FG000|Overall Study|Non-compliant|4|||
46830645|NCT00128830|83048454|FG000|Overall Study|Discontinued or ineligible for study|2|||
46830646|NCT00128830|83048454|FG000|Overall Study|Other|9|||
46830647|NCT03686033|83048460|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
46830648|NCT03686033|83048461|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
46830649|NCT03686033|83048462|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
46830650|NCT03686033|83048463|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
46830651|NCT03686033|83048464|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
46830652|NCT03686033|83048465|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
46830653|NCT00128206|83048481|FG000|Overall Study|Lost to Follow-up|137|||
46830654|NCT00128206|83048482|FG001|Overall Study|Lost to Follow-up|118|||
46830655|NCT00128206|83048481|FG000|Overall Study|Adverse Event|0|||
46830656|NCT00128206|83048482|FG001|Overall Study|Adverse Event|2|||
46830657|NCT03685643|83048490|FG000|Overall Study|Lost to Follow-up|14|||
46830658|NCT03685643|83048491|FG001|Overall Study|Lost to Follow-up|22|||
46830659|NCT03823378|83048503|FG000|Overall Study|Adverse Event|2|||
46830660|NCT03823378|83048504|FG001|Overall Study|Adverse Event|2|||
46764746|NCT00795639|82983026|FG000|Overall Study|Adverse Event|5|||
46764747|NCT00795639|82983027|FG001|Overall Study|Adverse Event|2|||
46764748|NCT00795639|82983026|FG000|Overall Study|Other|0|||
46764749|NCT00795639|82983027|FG001|Overall Study|Other|2|||
46764750|NCT00795639|82983026|FG000|Overall Study|Terminated by sponsor|13|||
46764751|NCT00795639|82983027|FG001|Overall Study|Terminated by sponsor|12|||
46764752|NCT00795639|82983026|FG000|Overall Study|Randomized and not treated|0|||
46764753|NCT00795639|82983027|FG001|Overall Study|Randomized and not treated|1|||
46764754|NCT00589602|82983033|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
46830661|NCT03823378|83048505|FG002|Overall Study|Adverse Event|0|||
46830662|NCT03823378|83048506|FG003|Overall Study|Adverse Event|0|||
46830663|NCT03823378|83048507|FG004|Overall Study|Adverse Event|0|||
46830664|NCT03823378|83048508|FG005|Overall Study|Adverse Event|0|||
46830665|NCT03823378|83048503|FG000|Overall Study|Lost to Follow-up|0|||
47060582|NCT01531673|83340255|FG000|Overall Study|Other|0|||
47060583|NCT01531673|83340256|FG001|Overall Study|Other|0|||
47060584|NCT01531673|83340257|FG002|Overall Study|Other|0|||
46764755|NCT00794157|82983042|FG000|Overall Study|Adverse Event|4|||
46764756|NCT00794157|82983043|FG001|Overall Study|Adverse Event|1|||
46764757|NCT00794157|82983044|FG002|Overall Study|Adverse Event|8|||
46830666|NCT03823378|83048504|FG001|Overall Study|Lost to Follow-up|1|||
46830667|NCT03823378|83048505|FG002|Overall Study|Lost to Follow-up|0|||
46830668|NCT03823378|83048506|FG003|Overall Study|Lost to Follow-up|0|||
46936406|NCT01662310|83172850|FG004|Run-In or Stabilization Phase|Other|0|||
46764758|NCT00794157|82983042|FG000|Overall Study|Subject withdrew consent|2|||
46830669|NCT03823378|83048507|FG004|Overall Study|Lost to Follow-up|1|||
46830670|NCT03823378|83048508|FG005|Overall Study|Lost to Follow-up|0|||
46830671|NCT03823378|83048503|FG000|Overall Study|Withdrawal by Subject|0|||
46830672|NCT03823378|83048504|FG001|Overall Study|Withdrawal by Subject|1|||
46830673|NCT03823378|83048505|FG002|Overall Study|Withdrawal by Subject|4|||
46936407|NCT01662310|83172846|FG000|Double-Blind Phase|Adverse Event|0|||
46830674|NCT03823378|83048506|FG003|Overall Study|Withdrawal by Subject|2|||
46830675|NCT03823378|83048507|FG004|Overall Study|Withdrawal by Subject|0|||
47060585|NCT01531673|83340258|FG003|Overall Study|Other|1|||
47060586|NCT01531673|83340259|FG004|Overall Study|Other|0|||
47060587|NCT01531673|83340260|FG005|Overall Study|Other|0|||
47060588|NCT01531673|83340261|FG006|Overall Study|Other|0|||
47060589|NCT01531673|83340262|FG007|Overall Study|Other|0|||
47060590|NCT01531673|83340263|FG008|Overall Study|Other|0|||
47060591|NCT01531673|83340264|FG009|Overall Study|Other|1|||
47060592|NCT01531673|83340265|FG010|Overall Study|Other|0|||
47060593|NCT01531673|83340266|FG011|Overall Study|Other|0|||
47060594|NCT01531673|83340267|FG012|Overall Study|Other|0|||
47060595|NCT01531205|83340319|FG000|Overall Study|Did not proceed to surgery|1|||
47060596|NCT01529645|83340335|FG000|Overall Study|Lost to Follow-up|0|||
47060597|NCT01529645|83340336|FG001|Overall Study|Lost to Follow-up|1|||
47060598|NCT01529645|83340337|FG002|Overall Study|Lost to Follow-up|1|||
47060599|NCT01529645|83340338|FG003|Overall Study|Lost to Follow-up|1|||
47060600|NCT01529645|83340339|FG004|Overall Study|Lost to Follow-up|1|||
47060601|NCT01529645|83340340|FG005|Overall Study|Lost to Follow-up|0|||
47060602|NCT01529645|83340341|FG006|Overall Study|Lost to Follow-up|2|||
47060603|NCT01529645|83340342|FG007|Overall Study|Lost to Follow-up|0|||
47060604|NCT01529645|83340343|FG008|Overall Study|Lost to Follow-up|1|||
47060605|NCT01529645|83340344|FG009|Overall Study|Lost to Follow-up|0|||
47060606|NCT01529645|83340335|FG000|Overall Study|SAE - Premature contractions|0|||
47060607|NCT01529645|83340336|FG001|Overall Study|SAE - Premature contractions|0|||
47060608|NCT01529645|83340337|FG002|Overall Study|SAE - Premature contractions|1|||
47060609|NCT01529645|83340338|FG003|Overall Study|SAE - Premature contractions|0|||
47060610|NCT01529645|83340339|FG004|Overall Study|SAE - Premature contractions|0|||
47060611|NCT01529645|83340340|FG005|Overall Study|SAE - Premature contractions|0|||
47060612|NCT01529645|83340341|FG006|Overall Study|SAE - Premature contractions|0|||
47060613|NCT01529645|83340342|FG007|Overall Study|SAE - Premature contractions|0|||
47060614|NCT01529645|83340343|FG008|Overall Study|SAE - Premature contractions|0|||
47060615|NCT01529645|83340344|FG009|Overall Study|SAE - Premature contractions|0|||
47060616|NCT01529645|83340335|FG000|Overall Study|Withdrawal by Subject|2|||
47060617|NCT01529645|83340336|FG001|Overall Study|Withdrawal by Subject|0|||
47060618|NCT01529645|83340337|FG002|Overall Study|Withdrawal by Subject|0|||
47060619|NCT01529645|83340338|FG003|Overall Study|Withdrawal by Subject|1|||
47060620|NCT01529645|83340339|FG004|Overall Study|Withdrawal by Subject|1|||
47060621|NCT01529645|83340340|FG005|Overall Study|Withdrawal by Subject|1|||
47060622|NCT01529645|83340341|FG006|Overall Study|Withdrawal by Subject|0|||
47060623|NCT01529645|83340342|FG007|Overall Study|Withdrawal by Subject|0|||
46764759|NCT00794157|82983043|FG001|Overall Study|Subject withdrew consent|0|||
46764760|NCT00794157|82983044|FG002|Overall Study|Subject withdrew consent|3|||
46764761|NCT00794157|82983042|FG000|Overall Study|Lost to Follow-up|2|||
46764762|NCT00794157|82983043|FG001|Overall Study|Lost to Follow-up|0|||
46764763|NCT00794157|82983044|FG002|Overall Study|Lost to Follow-up|1|||
46764764|NCT00794157|82983042|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46764765|NCT00794157|82983043|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46764766|NCT00794157|82983044|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
46764767|NCT00794157|82983042|FG000|Overall Study|Administrative problems|1|||
46764768|NCT00794157|82983043|FG001|Overall Study|Administrative problems|7|||
46764769|NCT00794157|82983044|FG002|Overall Study|Administrative problems|4|||
46764770|NCT00794157|82983042|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46764771|NCT00794157|82983043|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46764772|NCT00794157|82983044|FG002|Overall Study|Abnormal test procedure result(s)|0|||
46764773|NCT00794157|82983042|FG000|Overall Study|Protocol deviation|0|||
46764774|NCT00794157|82983043|FG001|Overall Study|Protocol deviation|1|||
46764775|NCT00794157|82983044|FG002|Overall Study|Protocol deviation|1|||
46764776|NCT00588237|82983052|FG000|Overall Study|Evaluable for toxicity only|3|||
46764777|NCT00588237|82983052|FG000|Overall Study|Patien not treated|1|||
46764778|NCT00790023|82983059|FG000|Overall Study|Adverse Event|2|||
46764779|NCT00790023|82983060|FG001|Overall Study|Adverse Event|1|||
46764780|NCT00790023|82983061|FG002|Overall Study|Adverse Event|4|||
46764781|NCT00790023|82983059|FG000|Overall Study|Protocol Violation|2|||
46764782|NCT00790023|82983060|FG001|Overall Study|Protocol Violation|4|||
46764783|NCT00790023|82983061|FG002|Overall Study|Protocol Violation|2|||
46764784|NCT00790023|82983059|FG000|Overall Study|Withdrawal by Subject|2|||
46764785|NCT00790023|82983060|FG001|Overall Study|Withdrawal by Subject|0|||
46764786|NCT00790023|82983061|FG002|Overall Study|Withdrawal by Subject|6|||
46764787|NCT00790023|82983059|FG000|Overall Study|Lost to Follow-up|0|||
47060624|NCT01529645|83340343|FG008|Overall Study|Withdrawal by Subject|0|||
47060625|NCT01529645|83340344|FG009|Overall Study|Withdrawal by Subject|0|||
47060626|NCT01528787|83340378|FG000|Overall Study|Withdrawal by Subject|0|||
47060627|NCT01528787|83340379|FG001|Overall Study|Withdrawal by Subject|0|||
47060628|NCT01528787|83340380|FG002|Overall Study|Withdrawal by Subject|0|||
47060629|NCT01528787|83340381|FG003|Overall Study|Withdrawal by Subject|1|||
47060630|NCT01528787|83340378|FG000|Overall Study|Family Emergency|0|||
47060631|NCT01528787|83340379|FG001|Overall Study|Family Emergency|0|||
47060632|NCT01528787|83340380|FG002|Overall Study|Family Emergency|1|||
47060633|NCT01528787|83340381|FG003|Overall Study|Family Emergency|0|||
47060634|NCT01528709|83340393|FG000|Overall Study|Death|2|||
47060635|NCT01528709|83340394|FG001|Overall Study|Death|0|||
47060636|NCT01528709|83340393|FG000|Overall Study|Withdrawal by Subject|10|||
47060637|NCT01528709|83340394|FG001|Overall Study|Withdrawal by Subject|15|||
47060638|NCT01528709|83340393|FG000|Overall Study|allergy|1|||
47060639|NCT01528709|83340394|FG001|Overall Study|allergy|0|||
47060640|NCT01527383|83340402|FG000|Overall Study|Adverse Event|5|||
47060641|NCT01527383|83340403|FG001|Overall Study|Adverse Event|0|||
47060642|NCT01527383|83340402|FG000|Overall Study|Lost to Follow-up|3|||
47060643|NCT01527383|83340403|FG001|Overall Study|Lost to Follow-up|0|||
46830676|NCT03823378|83048508|FG005|Overall Study|Withdrawal by Subject|1|||
46830677|NCT03823378|83048503|FG000|Overall Study|Other, not specified|19|||
46830678|NCT03823378|83048504|FG001|Overall Study|Other, not specified|12|||
46830679|NCT03823378|83048505|FG002|Overall Study|Other, not specified|6|||
46830680|NCT03823378|83048506|FG003|Overall Study|Other, not specified|8|||
46830681|NCT03823378|83048507|FG004|Overall Study|Other, not specified|17|||
46830682|NCT03823378|83048508|FG005|Overall Study|Other, not specified|7|||
46830683|NCT00142792|83048525|FG000|Overall Study|Death|0|||
46830684|NCT00142792|83048526|FG001|Overall Study|Death|0|||
46830685|NCT00142792|83048527|FG002|Overall Study|Death|1|||
46830686|NCT00142792|83048525|FG000|Overall Study|Withdrawal by Subject|3|||
46830687|NCT00142792|83048526|FG001|Overall Study|Withdrawal by Subject|2|||
46830688|NCT00142792|83048527|FG002|Overall Study|Withdrawal by Subject|3|||
46830689|NCT00142792|83048525|FG000|Overall Study|Lost to Follow-up|8|||
46830690|NCT00142792|83048526|FG001|Overall Study|Lost to Follow-up|11|||
46830691|NCT00142792|83048527|FG002|Overall Study|Lost to Follow-up|7|||
46830692|NCT00142792|83048525|FG000|Overall Study|No category|1|||
46830693|NCT00142792|83048526|FG001|Overall Study|No category|2|||
46830694|NCT00142792|83048527|FG002|Overall Study|No category|1|||
46830695|NCT00141778|83048538|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
46830696|NCT00141778|83048539|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
46830697|NCT00141778|83048540|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
46830698|NCT00141778|83048538|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
47060644|NCT01527383|83340402|FG000|Overall Study|Physician Decision|2|||
47060645|NCT01527383|83340403|FG001|Overall Study|Physician Decision|0|||
47060646|NCT01527383|83340402|FG000|Overall Study|Pregnancy|1|||
47060647|NCT01527383|83340403|FG001|Overall Study|Pregnancy|0|||
47060648|NCT01527383|83340402|FG000|Overall Study|Protocol Violation|1|||
47060649|NCT01527383|83340403|FG001|Overall Study|Protocol Violation|0|||
46764788|NCT00790023|82983060|FG001|Overall Study|Lost to Follow-up|0|||
46764789|NCT00790023|82983061|FG002|Overall Study|Lost to Follow-up|1|||
46764790|NCT00790023|82983059|FG000|Overall Study|Other|5|||
46764791|NCT00790023|82983060|FG001|Overall Study|Other|5|||
46764792|NCT00790023|82983061|FG002|Overall Study|Other|8|||
46764793|NCT00588822|82983070|FG000|Overall Study|progression of disease|8|||
46764794|NCT00589914|82983076|FG000|Overall Study|Adverse Event|19|||
46764795|NCT00589914|82983077|FG001|Overall Study|Adverse Event|10|||
46764796|NCT00589914|82983076|FG000|Overall Study|Death|2|||
46830699|NCT00141778|83048539|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
46830700|NCT00141778|83048540|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
46830701|NCT00141778|83048538|FG000|Started Study Medication|Withdrawal by Subject|0|||
46830702|NCT00141778|83048539|FG001|Started Study Medication|Withdrawal by Subject|2|||
46830703|NCT00141778|83048540|FG002|Started Study Medication|Withdrawal by Subject|0|||
46830704|NCT00141778|83048538|FG000|Started Study Medication|Difficulty Swallowing|0|||
46830705|NCT00141778|83048539|FG001|Started Study Medication|Difficulty Swallowing|1|||
46830706|NCT00141778|83048540|FG002|Started Study Medication|Difficulty Swallowing|0|||
46830707|NCT00141778|83048538|FG000|Started Study Medication|Chest Discomfort|0|||
46830708|NCT00141778|83048539|FG001|Started Study Medication|Chest Discomfort|0|||
46830709|NCT00141778|83048540|FG002|Started Study Medication|Chest Discomfort|1|||
46830710|NCT00127660|83048552|FG000|Overall Study|Protocol Violation|3|||
46830711|NCT00127660|83048553|FG001|Overall Study|Protocol Violation|3|||
46830712|NCT00127660|83048554|FG002|Overall Study|Protocol Violation|5|||
46830713|NCT00127660|83048555|FG003|Overall Study|Protocol Violation|0|||
46830714|NCT03817528|83048565|FG000|Overall Study|Withdrawal by Subject|1|||
46830715|NCT03817528|83048565|FG000|Overall Study|Adverse Event|2|||
46830716|NCT00115336|83048571|FG000|Overall Study|Hospital discharge before study drug|0|||
46830717|NCT00115336|83048572|FG001|Overall Study|Hospital discharge before study drug|1|||
46830718|NCT00205803|83048582|FG000|Infant Series|Lost to Follow-up|10|||
46830719|NCT00205803|83048583|FG001|Infant Series|Lost to Follow-up|4|||
46830720|NCT00205803|83048582|FG000|Infant Series|Withdrawal by Subject|2|||
46830721|NCT00205803|83048583|FG001|Infant Series|Withdrawal by Subject|5|||
46830722|NCT00205803|83048582|FG000|Infant Series|Physician Decision|3|||
46830723|NCT00205803|83048583|FG001|Infant Series|Physician Decision|1|||
46830724|NCT00205803|83048582|FG000|Infant Series|Protocol Violation|1|||
46830725|NCT00205803|83048583|FG001|Infant Series|Protocol Violation|0|||
46830726|NCT00205803|83048582|FG000|Infant Series|Lost Kaiser coverage|0|||
46830727|NCT00205803|83048583|FG001|Infant Series|Lost Kaiser coverage|1|||
46830728|NCT00205803|83048582|FG000|Infant Series|Non-compliant|1|||
46830729|NCT00205803|83048583|FG001|Infant Series|Non-compliant|0|||
46830730|NCT00205803|83048582|FG000|Infant Series|Sponsor request|1|||
46830731|NCT00205803|83048583|FG001|Infant Series|Sponsor request|0|||
46830732|NCT00205803|83048582|FG000|After Infant Series|Adverse Event|1|||
46830733|NCT00205803|83048583|FG001|After Infant Series|Adverse Event|1|||
46830734|NCT00205803|83048582|FG000|After Infant Series|Protocol Violation|1|||
46830735|NCT00205803|83048583|FG001|After Infant Series|Protocol Violation|1|||
46830736|NCT00205803|83048582|FG000|After Infant Series|Lost to Follow-up|2|||
46830737|NCT00205803|83048583|FG001|After Infant Series|Lost to Follow-up|1|||
46830738|NCT00205803|83048582|FG000|After Infant Series|Physician Decision|3|||
46830739|NCT00205803|83048583|FG001|After Infant Series|Physician Decision|2|||
46830740|NCT00205803|83048582|FG000|After Infant Series|Withdrawal by Subject|1|||
46830741|NCT00205803|83048583|FG001|After Infant Series|Withdrawal by Subject|4|||
46830742|NCT00205803|83048582|FG000|After Infant Series|Other|10|||
46830743|NCT00205803|83048583|FG001|After Infant Series|Other|4|||
46830744|NCT00205803|83048582|FG000|Toddler Dose|Lost to Follow-up|2|||
46830745|NCT00205803|83048583|FG001|Toddler Dose|Lost to Follow-up|3|||
46830746|NCT00127192|83048612|FG000|Overall Study|Adverse Event|0|||
46830747|NCT00127192|83048613|FG001|Overall Study|Adverse Event|1|||
46830748|NCT00127192|83048614|FG002|Overall Study|Adverse Event|1|||
46830749|NCT00127192|83048615|FG003|Overall Study|Adverse Event|1|||
46830750|NCT00127192|83048616|FG004|Overall Study|Adverse Event|0|||
46830751|NCT00127192|83048612|FG000|Overall Study|Lack of Efficacy|2|||
46830752|NCT00127192|83048613|FG001|Overall Study|Lack of Efficacy|0|||
47060650|NCT01527383|83340402|FG000|Overall Study|Screen failure|1|||
46764797|NCT00589914|82983077|FG001|Overall Study|Death|0|||
46764798|NCT00589914|82983076|FG000|Overall Study|Lack of Efficacy|40|||
46764799|NCT00589914|82983077|FG001|Overall Study|Lack of Efficacy|43|||
46764800|NCT00589914|82983076|FG000|Overall Study|Lost to Follow-up|11|||
46764801|NCT00589914|82983077|FG001|Overall Study|Lost to Follow-up|18|||
46764802|NCT00589914|82983076|FG000|Overall Study|Pregnancy|1|||
46764803|NCT00589914|82983077|FG001|Overall Study|Pregnancy|0|||
46764804|NCT00589914|82983076|FG000|Overall Study|Withdrawal by Subject|55|||
46764805|NCT00589914|82983077|FG001|Overall Study|Withdrawal by Subject|49|||
46764806|NCT00589914|82983076|FG000|Overall Study|Other|22|||
46764807|NCT00589914|82983077|FG001|Overall Study|Other|17|||
46764808|NCT00789555|82983086|FG000|Overall Study|Protocol Amendment|78|||
46764809|NCT00789555|82983087|FG001|Overall Study|Protocol Amendment|76|||
46764810|NCT00789555|82983088|FG002|Overall Study|Protocol Amendment|80|||
46764811|NCT00789555|82983086|FG000|Overall Study|Adverse Event|17|||
46764812|NCT00789555|82983087|FG001|Overall Study|Adverse Event|7|||
46764813|NCT00789555|82983088|FG002|Overall Study|Adverse Event|10|||
46764814|NCT00789555|82983086|FG000|Overall Study|Lost to Follow-up|9|||
46764815|NCT00789555|82983087|FG001|Overall Study|Lost to Follow-up|10|||
46764816|NCT00789555|82983088|FG002|Overall Study|Lost to Follow-up|18|||
46764817|NCT00789555|82983086|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
46764818|NCT00789555|82983087|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
46830753|NCT00127192|83048614|FG002|Overall Study|Lack of Efficacy|0|||
46830754|NCT00127192|83048615|FG003|Overall Study|Lack of Efficacy|0|||
46830755|NCT00127192|83048616|FG004|Overall Study|Lack of Efficacy|2|||
46830756|NCT00127192|83048612|FG000|Overall Study|Withdrawal by Subject|0|||
46830757|NCT00127192|83048613|FG001|Overall Study|Withdrawal by Subject|0|||
46830758|NCT00127192|83048614|FG002|Overall Study|Withdrawal by Subject|1|||
46830759|NCT00127192|83048615|FG003|Overall Study|Withdrawal by Subject|0|||
46830760|NCT00127192|83048616|FG004|Overall Study|Withdrawal by Subject|3|||
46830761|NCT00127192|83048612|FG000|Overall Study|Adverse event in pre-treatment period|1|||
46830762|NCT00127192|83048613|FG001|Overall Study|Adverse event in pre-treatment period|0|||
46830763|NCT00127192|83048614|FG002|Overall Study|Adverse event in pre-treatment period|0|||
46830764|NCT00127192|83048615|FG003|Overall Study|Adverse event in pre-treatment period|0|||
46830765|NCT00127192|83048616|FG004|Overall Study|Adverse event in pre-treatment period|0|||
46830766|NCT00205179|83048630|FG000|Overall Study|Death|0|||
46830767|NCT00205179|83048631|FG001|Overall Study|Death|2|||
46830768|NCT00205179|83048630|FG000|Overall Study|Physician Decision|1|||
46830769|NCT00205179|83048631|FG001|Overall Study|Physician Decision|1|||
46830770|NCT00205179|83048630|FG000|Overall Study|Adverse Event|1|||
46830771|NCT00205179|83048631|FG001|Overall Study|Adverse Event|1|||
46830772|NCT00127036|83048640|FG000|Overall Study|Insufficient Data for Analysis|6|||
46830773|NCT00127036|83048641|FG001|Overall Study|Insufficient Data for Analysis|11|||
46830774|NCT00127036|83048640|FG000|Overall Study|Screen Failure|2|||
46830775|NCT00127036|83048641|FG001|Overall Study|Screen Failure|0|||
46830776|NCT00259857|83048649|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
46830777|NCT00259857|83048650|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
46830778|NCT00259857|83048649|FG000|24 Months Treatment|Lost to Follow-up|0|||
46830779|NCT00259857|83048650|FG001|24 Months Treatment|Lost to Follow-up|3|||
46830780|NCT00203307|83048658|FG000|First Intervention|Adverse Event|2|||
46830781|NCT00203307|83048659|FG001|First Intervention|Adverse Event|0|||
47060651|NCT01527383|83340403|FG001|Overall Study|Screen failure|0|||
47060652|NCT01527383|83340402|FG000|Overall Study|Participant moved|0|||
47060653|NCT01527383|83340403|FG001|Overall Study|Participant moved|1|||
47060654|NCT01527383|83340402|FG000|Overall Study|Withdrawal by Subject|2|||
47060655|NCT01527383|83340403|FG001|Overall Study|Withdrawal by Subject|3|||
47060656|NCT01526057|83340412|FG000|Overall Study|Withdrawal by Subject|3|||
47060657|NCT01526057|83340413|FG001|Overall Study|Withdrawal by Subject|2|||
47060658|NCT01526057|83340414|FG002|Overall Study|Withdrawal by Subject|2|||
47060659|NCT01526057|83340412|FG000|Overall Study|Adverse Event|3|||
47060660|NCT01526057|83340413|FG001|Overall Study|Adverse Event|1|||
47060661|NCT01526057|83340414|FG002|Overall Study|Adverse Event|1|||
47060662|NCT01526057|83340412|FG000|Overall Study|Death|1|||
47060663|NCT01526057|83340413|FG001|Overall Study|Death|0|||
47060664|NCT01526057|83340414|FG002|Overall Study|Death|0|||
47060665|NCT01526057|83340412|FG000|Overall Study|Lost to Follow-up|1|||
47060666|NCT01526057|83340413|FG001|Overall Study|Lost to Follow-up|0|||
47060667|NCT01526057|83340414|FG002|Overall Study|Lost to Follow-up|1|||
47060668|NCT01526057|83340412|FG000|Overall Study|Other|1|||
47060669|NCT01526057|83340413|FG001|Overall Study|Other|0|||
47060670|NCT01526057|83340414|FG002|Overall Study|Other|1|||
47060671|NCT01526057|83340412|FG000|Overall Study|Protocol Violation|0|||
47060672|NCT01526057|83340413|FG001|Overall Study|Protocol Violation|0|||
47060673|NCT01526057|83340414|FG002|Overall Study|Protocol Violation|1|||
46764819|NCT00789555|82983088|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
46764820|NCT00789555|82983086|FG000|Overall Study|Treatment failure|11|||
46764821|NCT00789555|82983087|FG001|Overall Study|Treatment failure|8|||
46764822|NCT00789555|82983088|FG002|Overall Study|Treatment failure|12|||
46764823|NCT00789555|82983086|FG000|Overall Study|Protocol Violation|6|||
46764824|NCT00789555|82983087|FG001|Overall Study|Protocol Violation|9|||
46764825|NCT00789555|82983088|FG002|Overall Study|Protocol Violation|13|||
46764826|NCT00451321|82983104|FG000|Overall Study|Lost to Follow-up|3|||
46764827|NCT00451321|82983105|FG001|Overall Study|Lost to Follow-up|3|||
46830782|NCT00126568|83048665|FG000|Overall Study|Death|2|||
46830783|NCT00114634|83048670|FG000|Overall Study|failure to return forms|3|||
46830784|NCT00202839|83048678|FG000|Overall Study|Adverse Event|1|||
46830785|NCT00202839|83048679|FG001|Overall Study|Adverse Event|5|||
46764828|NCT00451321|82983106|FG002|Overall Study|Lost to Follow-up|1|||
46764829|NCT00451321|82983107|FG003|Overall Study|Lost to Follow-up|3|||
46830786|NCT00202839|83048678|FG000|Overall Study|Physician Decision|12|||
46830787|NCT00202839|83048679|FG001|Overall Study|Physician Decision|0|||
46830788|NCT00202839|83048678|FG000|Overall Study|Withdrawal by Subject|6|||
46830789|NCT00202839|83048679|FG001|Overall Study|Withdrawal by Subject|2|||
46830790|NCT00202839|83048678|FG000|Overall Study|Protocol Violation|2|||
46830791|NCT00202839|83048679|FG001|Overall Study|Protocol Violation|1|||
47060674|NCT01525901|83340426|FG000|Period 2: 12 Weeks|Adverse Event|0|||
47060675|NCT01525901|83340427|FG001|Period 2: 12 Weeks|Adverse Event|1|||
47060676|NCT01525901|83340428|FG002|Period 2: 12 Weeks|Adverse Event|0|||
47060677|NCT01525901|83340429|FG003|Period 2: 12 Weeks|Adverse Event|0|||
47060678|NCT01525589|83340542|FG000|Overall Study|Non-treatment-related AE|1|||
46830792|NCT00202839|83048678|FG000|Overall Study|Lost to Follow-up|3|||
46830793|NCT00202839|83048679|FG001|Overall Study|Lost to Follow-up|2|||
46830794|NCT00201201|83048687|FG000|Overall Study|Death|0|||
46830795|NCT00201201|83048688|FG001|Overall Study|Death|2|||
46830796|NCT00201201|83048687|FG000|Overall Study|Withdrawal by Subject|5|||
46830797|NCT00201201|83048688|FG001|Overall Study|Withdrawal by Subject|5|||
46830798|NCT00126490|83048694|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
46830799|NCT00346632|83048700|FG000|Overall Study|Progressive Disease|2|||
46830800|NCT00346632|83048701|FG001|Overall Study|Progressive Disease|2|||
46830801|NCT00346632|83048702|FG002|Overall Study|Progressive Disease|4|||
46830802|NCT00346632|83048703|FG003|Overall Study|Progressive Disease|3|||
46830803|NCT00346632|83048704|FG004|Overall Study|Progressive Disease|3|||
46830804|NCT00346632|83048705|FG005|Overall Study|Progressive Disease|1|||
46830805|NCT00346632|83048706|FG006|Overall Study|Progressive Disease|2|||
46830806|NCT00346632|83048707|FG007|Overall Study|Progressive Disease|2|||
46830807|NCT00346632|83048708|FG008|Overall Study|Progressive Disease|2|||
46830808|NCT00346632|83048709|FG009|Overall Study|Progressive Disease|2|||
46830809|NCT00346632|83048700|FG000|Overall Study|Adverse Event|0|||
46830810|NCT00346632|83048701|FG001|Overall Study|Adverse Event|0|||
46830811|NCT00346632|83048702|FG002|Overall Study|Adverse Event|0|||
46830812|NCT00346632|83048703|FG003|Overall Study|Adverse Event|0|||
46830813|NCT00346632|83048704|FG004|Overall Study|Adverse Event|1|||
46830814|NCT00346632|83048705|FG005|Overall Study|Adverse Event|1|||
46830815|NCT00346632|83048706|FG006|Overall Study|Adverse Event|1|||
46830816|NCT00346632|83048707|FG007|Overall Study|Adverse Event|0|||
46830817|NCT00346632|83048708|FG008|Overall Study|Adverse Event|0|||
46830818|NCT00346632|83048709|FG009|Overall Study|Adverse Event|0|||
46830819|NCT00346632|83048700|FG000|Overall Study|Death|0|||
46830820|NCT00346632|83048701|FG001|Overall Study|Death|0|||
46830821|NCT00346632|83048702|FG002|Overall Study|Death|1|||
46830822|NCT00346632|83048703|FG003|Overall Study|Death|0|||
46830823|NCT00346632|83048704|FG004|Overall Study|Death|0|||
46830824|NCT00346632|83048705|FG005|Overall Study|Death|0|||
46830825|NCT00346632|83048706|FG006|Overall Study|Death|0|||
46830826|NCT00346632|83048707|FG007|Overall Study|Death|0|||
46830827|NCT00346632|83048708|FG008|Overall Study|Death|0|||
46830828|NCT00346632|83048709|FG009|Overall Study|Death|0|||
46830829|NCT00346632|83048700|FG000|Overall Study|Protocol Violation|0|||
46830830|NCT00346632|83048701|FG001|Overall Study|Protocol Violation|0|||
46830831|NCT00346632|83048702|FG002|Overall Study|Protocol Violation|0|||
46830832|NCT00346632|83048703|FG003|Overall Study|Protocol Violation|0|||
46830833|NCT00346632|83048704|FG004|Overall Study|Protocol Violation|0|||
46830834|NCT00346632|83048705|FG005|Overall Study|Protocol Violation|0|||
46830835|NCT00346632|83048706|FG006|Overall Study|Protocol Violation|1|||
46830836|NCT00346632|83048707|FG007|Overall Study|Protocol Violation|0|||
46830837|NCT00346632|83048708|FG008|Overall Study|Protocol Violation|0|||
46830838|NCT00346632|83048709|FG009|Overall Study|Protocol Violation|0|||
46830839|NCT00346632|83048700|FG000|Overall Study|Withdrawal by Subject|0|||
46830840|NCT00346632|83048701|FG001|Overall Study|Withdrawal by Subject|0|||
46830841|NCT00346632|83048702|FG002|Overall Study|Withdrawal by Subject|0|||
46830842|NCT00346632|83048703|FG003|Overall Study|Withdrawal by Subject|0|||
46830843|NCT00346632|83048704|FG004|Overall Study|Withdrawal by Subject|0|||
46830844|NCT00346632|83048705|FG005|Overall Study|Withdrawal by Subject|0|||
46830845|NCT00346632|83048706|FG006|Overall Study|Withdrawal by Subject|1|||
46830846|NCT00346632|83048707|FG007|Overall Study|Withdrawal by Subject|0|||
46830847|NCT00346632|83048708|FG008|Overall Study|Withdrawal by Subject|0|||
47060679|NCT01525589|83340543|FG001|Overall Study|Non-treatment-related AE|0|||
47060680|NCT01525589|83340544|FG002|Overall Study|Non-treatment-related AE|0|||
46764830|NCT00451321|82983108|FG004|Overall Study|Lost to Follow-up|0|||
46764831|NCT00451321|82983109|FG005|Overall Study|Lost to Follow-up|1|||
47060681|NCT01525589|83340542|FG000|Overall Study|Progressive disease|48|||
46764832|NCT00451321|82983110|FG006|Overall Study|Lost to Follow-up|0|||
46764833|NCT00451321|82983111|FG007|Overall Study|Lost to Follow-up|0|||
46764834|NCT00451321|82983104|FG000|Overall Study|Withdrawal by Subject|3|||
46764835|NCT00451321|82983105|FG001|Overall Study|Withdrawal by Subject|1|||
46764836|NCT00451321|82983106|FG002|Overall Study|Withdrawal by Subject|0|||
46764837|NCT00451321|82983107|FG003|Overall Study|Withdrawal by Subject|4|||
46764838|NCT00451321|82983108|FG004|Overall Study|Withdrawal by Subject|0|||
46764839|NCT00451321|82983109|FG005|Overall Study|Withdrawal by Subject|0|||
46830848|NCT00346632|83048709|FG009|Overall Study|Withdrawal by Subject|0|||
46830849|NCT00346632|83048700|FG000|Overall Study|Switched to alternative treatment|0|||
46830850|NCT00346632|83048701|FG001|Overall Study|Switched to alternative treatment|0|||
46830851|NCT00346632|83048702|FG002|Overall Study|Switched to alternative treatment|1|||
46830852|NCT00346632|83048703|FG003|Overall Study|Switched to alternative treatment|0|||
46830853|NCT00346632|83048704|FG004|Overall Study|Switched to alternative treatment|0|||
46830854|NCT00346632|83048705|FG005|Overall Study|Switched to alternative treatment|0|||
46830855|NCT00346632|83048706|FG006|Overall Study|Switched to alternative treatment|0|||
46830856|NCT00346632|83048707|FG007|Overall Study|Switched to alternative treatment|0|||
46830857|NCT00346632|83048708|FG008|Overall Study|Switched to alternative treatment|0|||
46936408|NCT01662310|83172847|FG001|Double-Blind Phase|Adverse Event|0|||
46637615|NCT01474512|82811378|FG002|Maintenance Period|Physician Decision|0|||
46637616|NCT01474512|82811379|FG003|Maintenance Period|Physician Decision|0|||
46637617|NCT01474512|82811380|FG004|Maintenance Period|Physician Decision|0|||
46637618|NCT01474512|82811381|FG005|Maintenance Period|Physician Decision|1|||
46637619|NCT01474512|82811382|FG006|Maintenance Period|Physician Decision|0|||
46764840|NCT00451321|82983110|FG006|Overall Study|Withdrawal by Subject|0|||
46764841|NCT00451321|82983111|FG007|Overall Study|Withdrawal by Subject|0|||
46764842|NCT00451321|82983104|FG000|Overall Study|Study closed/terminated|1|||
46764843|NCT00451321|82983105|FG001|Overall Study|Study closed/terminated|1|||
46764844|NCT00451321|82983106|FG002|Overall Study|Study closed/terminated|17|||
46764845|NCT00451321|82983107|FG003|Overall Study|Study closed/terminated|5|||
46764846|NCT00451321|82983108|FG004|Overall Study|Study closed/terminated|7|||
46764847|NCT00451321|82983109|FG005|Overall Study|Study closed/terminated|7|||
46764848|NCT00451321|82983110|FG006|Overall Study|Study closed/terminated|5|||
46764849|NCT00451321|82983111|FG007|Overall Study|Study closed/terminated|3|||
46764850|NCT00451321|82983104|FG000|Overall Study|Sponsor decision to amend protocol|0|||
46764851|NCT00451321|82983105|FG001|Overall Study|Sponsor decision to amend protocol|0|||
46764852|NCT00451321|82983106|FG002|Overall Study|Sponsor decision to amend protocol|0|||
46764853|NCT00451321|82983107|FG003|Overall Study|Sponsor decision to amend protocol|0|||
46764854|NCT00451321|82983108|FG004|Overall Study|Sponsor decision to amend protocol|0|||
46764855|NCT00451321|82983109|FG005|Overall Study|Sponsor decision to amend protocol|1|||
46764856|NCT00451321|82983110|FG006|Overall Study|Sponsor decision to amend protocol|1|||
46764857|NCT00451321|82983111|FG007|Overall Study|Sponsor decision to amend protocol|3|||
46764858|NCT00802464|82983137|FG000|Month 0 - Month 8|Adverse Event|0|||
46764859|NCT00802464|82983138|FG001|Month 0 - Month 8|Adverse Event|1|||
46764860|NCT00802464|82983139|FG002|Month 0 - Month 8|Adverse Event|1|||
46764861|NCT00802464|82983140|FG003|Month 0 - Month 8|Adverse Event|2|||
46764862|NCT00802464|82983137|FG000|Month 0 - Month 8|Protocol Violation|0|||
46764863|NCT00802464|82983138|FG001|Month 0 - Month 8|Protocol Violation|0|||
46764864|NCT00802464|82983139|FG002|Month 0 - Month 8|Protocol Violation|1|||
46764865|NCT00802464|82983140|FG003|Month 0 - Month 8|Protocol Violation|0|||
46764866|NCT00802464|82983137|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
46764867|NCT00802464|82983138|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
46764868|NCT00802464|82983139|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
46764869|NCT00802464|82983140|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
46764870|NCT00802464|82983137|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
46764871|NCT00802464|82983138|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
46764872|NCT00802464|82983139|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
46764873|NCT00802464|82983140|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
46764874|NCT00802464|82983137|FG000|Month 0 - Month 8|Other|0|||
46764875|NCT00802464|82983138|FG001|Month 0 - Month 8|Other|0|||
46764876|NCT00802464|82983139|FG002|Month 0 - Month 8|Other|1|||
46764877|NCT00802464|82983140|FG003|Month 0 - Month 8|Other|0|||
46764878|NCT00802464|82983137|FG000|Month 8 - Month 14|Adverse Event|0|||
46764879|NCT00802464|82983138|FG001|Month 8 - Month 14|Adverse Event|1|||
46764880|NCT00802464|82983139|FG002|Month 8 - Month 14|Adverse Event|0|||
46764881|NCT00802464|82983140|FG003|Month 8 - Month 14|Adverse Event|0|||
46764882|NCT00802464|82983137|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
46764883|NCT00802464|82983138|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
46764884|NCT00802464|82983139|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
46764885|NCT00802464|82983140|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
46764886|NCT00802464|82983137|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
46764887|NCT00802464|82983138|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
46764888|NCT00802464|82983139|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
46764889|NCT00802464|82983140|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
46764890|NCT00450619|82983154|FG000|Overall Study|refused treatment after randomization|2|||
46764891|NCT00450619|82983155|FG001|Overall Study|refused treatment after randomization|0|||
46764892|NCT00450619|82983154|FG000|Overall Study|did not progress; refused further trmt|1|||
46764893|NCT00450619|82983155|FG001|Overall Study|did not progress; refused further trmt|1|||
46764894|NCT00450619|82983154|FG000|Overall Study|Adverse Event|1|||
46764895|NCT00450619|82983155|FG001|Overall Study|Adverse Event|0|||
46764896|NCT00802074|82983168|FG000|Overall Study|Adverse Event|1|||
46764897|NCT00802074|82983169|FG001|Overall Study|Adverse Event|1|||
46764898|NCT00802074|82983170|FG002|Overall Study|Adverse Event|1|||
46764899|NCT00802074|82983171|FG003|Overall Study|Adverse Event|0|||
46764900|NCT00802074|82983172|FG004|Overall Study|Adverse Event|0|||
46764901|NCT00802074|82983173|FG005|Overall Study|Adverse Event|0|||
46764902|NCT00802074|82983168|FG000|Overall Study|Withdrawal by Subject|1|||
46764903|NCT00802074|82983169|FG001|Overall Study|Withdrawal by Subject|0|||
46764904|NCT00802074|82983170|FG002|Overall Study|Withdrawal by Subject|0|||
46764905|NCT00802074|82983171|FG003|Overall Study|Withdrawal by Subject|0|||
46764906|NCT00802074|82983172|FG004|Overall Study|Withdrawal by Subject|0|||
46764907|NCT00802074|82983173|FG005|Overall Study|Withdrawal by Subject|0|||
46764908|NCT00450385|82983190|FG000|Overall Study|Death|3|||
46637620|NCT01474512|82811383|FG007|Maintenance Period|Physician Decision|2|||
46830858|NCT00346632|83048709|FG009|Overall Study|Switched to alternative treatment|0|||
46830859|NCT00346632|83048700|FG000|Overall Study|Not Stated|1|||
46830860|NCT00346632|83048701|FG001|Overall Study|Not Stated|1|||
46830861|NCT00346632|83048702|FG002|Overall Study|Not Stated|0|||
46830862|NCT00346632|83048703|FG003|Overall Study|Not Stated|0|||
46830863|NCT00346632|83048704|FG004|Overall Study|Not Stated|0|||
46830864|NCT00346632|83048705|FG005|Overall Study|Not Stated|0|||
46830865|NCT00346632|83048706|FG006|Overall Study|Not Stated|0|||
47060682|NCT01525589|83340543|FG001|Overall Study|Progressive disease|15|||
47060683|NCT01525589|83340544|FG002|Overall Study|Progressive disease|29|||
47060684|NCT01525589|83340542|FG000|Overall Study|Never treated|2|||
47060685|NCT01525589|83340543|FG001|Overall Study|Never treated|0|||
47060686|NCT01525589|83340544|FG002|Overall Study|Never treated|0|||
47060687|NCT01525589|83340542|FG000|Overall Study|Physician Decision|4|||
47060688|NCT01525589|83340543|FG001|Overall Study|Physician Decision|2|||
47060689|NCT01525589|83340544|FG002|Overall Study|Physician Decision|2|||
47060690|NCT01525589|83340542|FG000|Overall Study|Death|0|||
47060691|NCT01525589|83340543|FG001|Overall Study|Death|0|||
47060692|NCT01525589|83340544|FG002|Overall Study|Death|2|||
47060693|NCT01525589|83340542|FG000|Overall Study|Treatment-related AE|1|||
47060694|NCT01525589|83340543|FG001|Overall Study|Treatment-related AE|1|||
47060695|NCT01525589|83340544|FG002|Overall Study|Treatment-related AE|2|||
47060696|NCT01525589|83340542|FG000|Overall Study|Other reasons|0|||
47060697|NCT01525589|83340543|FG001|Overall Study|Other reasons|1|||
47060698|NCT01525589|83340544|FG002|Overall Study|Other reasons|0|||
47060699|NCT01525589|83340542|FG000|Overall Study|Withdrawal by Subject|0|||
47060700|NCT01525589|83340543|FG001|Overall Study|Withdrawal by Subject|1|||
47060701|NCT01525589|83340544|FG002|Overall Study|Withdrawal by Subject|0|||
47060702|NCT01524887|83340555|FG000|Overall Study|Withdrawal by Subject|6|||
47060703|NCT01524887|83340556|FG001|Overall Study|Withdrawal by Subject|2|||
47060704|NCT01524887|83340557|FG002|Overall Study|Withdrawal by Subject|3|||
47060705|NCT01524887|83340555|FG000|Overall Study|Adverse Event|5|||
47060706|NCT01524887|83340556|FG001|Overall Study|Adverse Event|1|||
47060707|NCT01524887|83340557|FG002|Overall Study|Adverse Event|1|||
47060708|NCT01524887|83340555|FG000|Overall Study|Protocol Violation|0|||
47060709|NCT01524887|83340556|FG001|Overall Study|Protocol Violation|0|||
47060710|NCT01524887|83340557|FG002|Overall Study|Protocol Violation|1|||
47060711|NCT01524887|83340555|FG000|Overall Study|Study termination|73|||
47060712|NCT01524887|83340556|FG001|Overall Study|Study termination|87|||
46830866|NCT00346632|83048707|FG007|Overall Study|Not Stated|2|||
46830867|NCT00346632|83048708|FG008|Overall Study|Not Stated|2|||
46830868|NCT00346632|83048709|FG009|Overall Study|Not Stated|1|||
46830869|NCT00200967|83048773|FG000|First Treatment Period|Withdrawal by Subject|5|||
46830870|NCT00200967|83048774|FG001|First Treatment Period|Withdrawal by Subject|1|||
46830871|NCT00200967|83048773|FG000|First Treatment Period|Pregnancy|1|||
46830872|NCT00200967|83048774|FG001|First Treatment Period|Pregnancy|0|||
46830873|NCT00200967|83048773|FG000|Wash-out Period|Lost to Follow-up|0|||
46830874|NCT00200967|83048774|FG001|Wash-out Period|Lost to Follow-up|1|||
46830875|NCT00200967|83048773|FG000|Second Treatment Period|Withdrawal by Subject|1|||
46830876|NCT00200967|83048774|FG001|Second Treatment Period|Withdrawal by Subject|2|||
46830877|NCT00200967|83048773|FG000|Run-out Period|Lost to Follow-up|1|||
46830878|NCT00200967|83048774|FG001|Run-out Period|Lost to Follow-up|0|||
46830879|NCT00354432|83048784|FG000|Overall Study|Adverse Event|3|||
47060713|NCT01524887|83340557|FG002|Overall Study|Study termination|79|||
47060714|NCT01524887|83340555|FG000|Overall Study|Withdrawal by Caregiver|0|||
47060715|NCT01524887|83340556|FG001|Overall Study|Withdrawal by Caregiver|0|||
46637621|NCT01474512|82811384|FG008|Maintenance Period|Physician Decision|0|||
46637622|NCT01474512|82811385|FG009|Maintenance Period|Physician Decision|0|||
46830880|NCT00354432|83048785|FG001|Overall Study|Adverse Event|1|||
46830881|NCT00354432|83048786|FG002|Overall Study|Adverse Event|5|||
47060716|NCT01524887|83340557|FG002|Overall Study|Withdrawal by Caregiver|2|||
47060717|NCT01524887|83340555|FG000|Overall Study|Use of prohibited medication|1|||
47060718|NCT01524887|83340556|FG001|Overall Study|Use of prohibited medication|0|||
46637623|NCT01474512|82811386|FG010|Maintenance Period|Physician Decision|0|||
46764909|NCT00450385|82983190|FG000|Overall Study|Protocol Violation|1|||
46764910|NCT00450385|82983190|FG000|Overall Study|Withdrawal by Subject|2|||
46764911|NCT00450385|82983190|FG000|Overall Study|Lack of Efficacy|2|||
46764912|NCT00450385|82983190|FG000|Overall Study|Adverse Event|1|||
46830882|NCT00354432|83048787|FG003|Overall Study|Adverse Event|5|||
46830883|NCT00354432|83048784|FG000|Overall Study|Off/Toxicity|3|||
46830884|NCT00354432|83048785|FG001|Overall Study|Off/Toxicity|7|||
47060719|NCT01524887|83340557|FG002|Overall Study|Use of prohibited medication|0|||
47060720|NCT01523873|83340583|FG000|Overall Study|Protocol Violation|422|||
47060721|NCT01522235|83340608|FG000|Overall Study|Physician Decision|1|||
47060722|NCT01522235|83340609|FG001|Overall Study|Physician Decision|1|||
47060723|NCT01521923|83340646|FG000|Overall Study|AE, serious fatal|1|||
47060724|NCT01521923|83340647|FG001|Overall Study|AE, serious fatal|0|||
47060725|NCT01521923|83340648|FG002|Overall Study|AE, serious fatal|0|||
47060726|NCT01521923|83340649|FG003|Overall Study|AE, serious fatal|0|||
47060727|NCT01521923|83340646|FG000|Overall Study|SAE, non-fatal|0|||
46830885|NCT00354432|83048786|FG002|Overall Study|Off/Toxicity|5|||
46830886|NCT00354432|83048787|FG003|Overall Study|Off/Toxicity|5|||
46830887|NCT00140140|83048800|FG000|Overall Study|Unacceptable toxicity|1|||
46830888|NCT00140140|83048801|FG001|Overall Study|Unacceptable toxicity|1|||
46830889|NCT00140140|83048802|FG002|Overall Study|Unacceptable toxicity|2|||
46830890|NCT00140140|83048800|FG000|Overall Study|Physician Decision|1|||
46830891|NCT00140140|83048801|FG001|Overall Study|Physician Decision|1|||
46830892|NCT00140140|83048802|FG002|Overall Study|Physician Decision|0|||
46830893|NCT00346398|83048811|FG000|Overall Study|Lost to Follow-up|3|||
46830894|NCT00346398|83048812|FG001|Overall Study|Lost to Follow-up|0|||
46830895|NCT00346398|83048811|FG000|Overall Study|Withdrawal by Subject|0|||
46830896|NCT00346398|83048812|FG001|Overall Study|Withdrawal by Subject|2|||
46830897|NCT00346164|83048822|FG000|Overall Study|Adverse Event|0|||
46830898|NCT00346164|83048823|FG001|Overall Study|Adverse Event|0|||
47060728|NCT01521923|83340647|FG001|Overall Study|SAE, non-fatal|2|||
47060729|NCT01521923|83340648|FG002|Overall Study|SAE, non-fatal|2|||
47060730|NCT01521923|83340649|FG003|Overall Study|SAE, non-fatal|0|||
47060731|NCT01521923|83340646|FG000|Overall Study|AE, non-serious, non-fatal|1|||
47060732|NCT01521923|83340647|FG001|Overall Study|AE, non-serious, non-fatal|3|||
47060733|NCT01521923|83340648|FG002|Overall Study|AE, non-serious, non-fatal|6|||
47060734|NCT01521923|83340649|FG003|Overall Study|AE, non-serious, non-fatal|2|||
47060735|NCT01521923|83340646|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
47060736|NCT01521923|83340647|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
47060737|NCT01521923|83340648|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
47060738|NCT01521923|83340649|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
47060739|NCT01521923|83340646|FG000|Overall Study|Lack of Efficacy|1|||
47060740|NCT01521923|83340647|FG001|Overall Study|Lack of Efficacy|1|||
47060741|NCT01521923|83340648|FG002|Overall Study|Lack of Efficacy|0|||
47060742|NCT01521923|83340649|FG003|Overall Study|Lack of Efficacy|0|||
47060743|NCT01521923|83340646|FG000|Overall Study|Protocol Violation|0|||
47060744|NCT01521923|83340647|FG001|Overall Study|Protocol Violation|0|||
47060745|NCT01521923|83340648|FG002|Overall Study|Protocol Violation|1|||
47060746|NCT01521923|83340649|FG003|Overall Study|Protocol Violation|0|||
47060747|NCT01521923|83340646|FG000|Overall Study|Lost to Follow-up|1|||
47060748|NCT01521923|83340647|FG001|Overall Study|Lost to Follow-up|0|||
47060749|NCT01521923|83340648|FG002|Overall Study|Lost to Follow-up|2|||
46830899|NCT00346164|83048824|FG002|Overall Study|Adverse Event|0|||
46830900|NCT00346164|83048825|FG003|Overall Study|Adverse Event|1|||
46830901|NCT00346164|83048822|FG000|Overall Study|Lack of Efficacy|0|||
46830902|NCT00346164|83048823|FG001|Overall Study|Lack of Efficacy|1|||
46830903|NCT00346164|83048824|FG002|Overall Study|Lack of Efficacy|7|||
46830904|NCT00346164|83048825|FG003|Overall Study|Lack of Efficacy|25|||
46830905|NCT00346164|83048822|FG000|Overall Study|Physician Decision|0|||
46830906|NCT00346164|83048823|FG001|Overall Study|Physician Decision|1|||
46830907|NCT00346164|83048824|FG002|Overall Study|Physician Decision|2|||
46936409|NCT01662310|83172848|FG002|Double-Blind Phase|Adverse Event|1|||
47060750|NCT01521923|83340649|FG003|Overall Study|Lost to Follow-up|1|||
47060751|NCT01521923|83340646|FG000|Overall Study|Withdrawal by Subject|1|||
47060752|NCT01521923|83340647|FG001|Overall Study|Withdrawal by Subject|1|||
47060753|NCT01521923|83340648|FG002|Overall Study|Withdrawal by Subject|1|||
47060754|NCT01521923|83340649|FG003|Overall Study|Withdrawal by Subject|2|||
47060755|NCT01521923|83340646|FG000|Overall Study|Other|2|||
47060756|NCT01521923|83340647|FG001|Overall Study|Other|1|||
47060757|NCT01521923|83340648|FG002|Overall Study|Other|3|||
47060758|NCT01521923|83340649|FG003|Overall Study|Other|6|||
47060759|NCT01521923|83340646|FG000|Overall Study|AE, captured in Period 1|0|||
47060760|NCT01521923|83340647|FG001|Overall Study|AE, captured in Period 1|1|||
46764913|NCT00450385|82983190|FG000|Overall Study|Physician Decision|1|||
46764914|NCT00450385|82983190|FG000|Overall Study|Other|3|||
46764915|NCT00588354|82983197|FG000|Baseline to 2 Weeks|Adverse Event|1|||
46764916|NCT00588354|82983198|FG001|Baseline to 2 Weeks|Adverse Event|0|||
46764917|NCT00588354|82983197|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
46764918|NCT00588354|82983198|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
46764919|NCT00588354|82983197|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
46764920|NCT00588354|82983198|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
46764921|NCT00449761|82983205|FG000|Overall Study|Disease progression|12|||
46764922|NCT00449761|82983205|FG000|Overall Study|Death|5|||
46830908|NCT00346164|83048825|FG003|Overall Study|Physician Decision|27|||
46764923|NCT00449761|82983205|FG000|Overall Study|New cancer therapy|1|||
46830909|NCT00346164|83048822|FG000|Overall Study|Protocol Violation|6|||
46830910|NCT00346164|83048823|FG001|Overall Study|Protocol Violation|2|||
46830911|NCT00346164|83048824|FG002|Overall Study|Protocol Violation|10|||
46830912|NCT00346164|83048825|FG003|Overall Study|Protocol Violation|4|||
47060761|NCT01521923|83340648|FG002|Overall Study|AE, captured in Period 1|0|||
47060762|NCT01521923|83340649|FG003|Overall Study|AE, captured in Period 1|1|||
47060763|NCT01520987|83340773|FG000|Overall Study|Withdrawal by Subject|1|||
47060764|NCT01520987|83340774|FG001|Overall Study|Withdrawal by Subject|0|||
47060765|NCT01520987|83340775|FG002|Overall Study|Withdrawal by Subject|0|||
47060766|NCT01520987|83340776|FG003|Overall Study|Withdrawal by Subject|0|||
47060767|NCT01520987|83340777|FG004|Overall Study|Withdrawal by Subject|0|||
47060768|NCT01520987|83340778|FG005|Overall Study|Withdrawal by Subject|1|||
47060769|NCT01520987|83340779|FG006|Overall Study|Withdrawal by Subject|0|||
47060770|NCT01520987|83340780|FG007|Overall Study|Withdrawal by Subject|0|||
47060771|NCT01562275|83340854|FG000|Stage 1|Adverse Event|0|||
47060772|NCT01562275|83340855|FG001|Stage 1|Adverse Event|0|||
47060773|NCT01562275|83340856|FG002|Stage 1|Adverse Event|0|||
47060774|NCT01562275|83340857|FG003|Stage 1|Adverse Event|1|||
46830913|NCT00346164|83048822|FG000|Overall Study|Withdrawal by Subject|0|||
46830914|NCT00346164|83048823|FG001|Overall Study|Withdrawal by Subject|0|||
46830915|NCT00346164|83048824|FG002|Overall Study|Withdrawal by Subject|2|||
46830916|NCT00346164|83048825|FG003|Overall Study|Withdrawal by Subject|0|||
47060775|NCT01562275|83340858|FG004|Stage 1|Adverse Event|1|||
47060776|NCT01562275|83340859|FG005|Stage 1|Adverse Event|0|||
47060777|NCT01562275|83340860|FG006|Stage 1|Adverse Event|0|||
47060778|NCT01562275|83340861|FG007|Stage 1|Adverse Event|0|||
47060779|NCT01562275|83340862|FG008|Stage 1|Adverse Event|0|||
47060780|NCT01562275|83340863|FG009|Stage 1|Adverse Event|1|||
47060781|NCT01562275|83340864|FG010|Stage 1|Adverse Event|0|||
47060782|NCT01562275|83340865|FG011|Stage 1|Adverse Event|0|||
47060783|NCT01562275|83340866|FG012|Stage 1|Adverse Event|0|||
47060784|NCT01562275|83340854|FG000|Stage 1|Death|1|||
47060785|NCT01562275|83340855|FG001|Stage 1|Death|0|||
47060786|NCT01562275|83340856|FG002|Stage 1|Death|0|||
47060787|NCT01562275|83340857|FG003|Stage 1|Death|0|||
47060788|NCT01562275|83340858|FG004|Stage 1|Death|0|||
47060789|NCT01562275|83340859|FG005|Stage 1|Death|0|||
47060790|NCT01562275|83340860|FG006|Stage 1|Death|0|||
47060791|NCT01562275|83340861|FG007|Stage 1|Death|0|||
47060792|NCT01562275|83340862|FG008|Stage 1|Death|0|||
47060793|NCT01562275|83340863|FG009|Stage 1|Death|0|||
47060794|NCT01562275|83340864|FG010|Stage 1|Death|0|||
47060795|NCT01562275|83340865|FG011|Stage 1|Death|0|||
46830917|NCT00346164|83048822|FG000|Overall Study|Ineligible|11|||
46830918|NCT00346164|83048823|FG001|Overall Study|Ineligible|2|||
46830919|NCT00346164|83048824|FG002|Overall Study|Ineligible|2|||
46830920|NCT00346164|83048825|FG003|Overall Study|Ineligible|23|||
46830921|NCT00346164|83048822|FG000|Overall Study|Refusal of further protocol therapy|0|||
46830922|NCT00346164|83048823|FG001|Overall Study|Refusal of further protocol therapy|1|||
46830923|NCT00346164|83048824|FG002|Overall Study|Refusal of further protocol therapy|3|||
46830924|NCT00346164|83048825|FG003|Overall Study|Refusal of further protocol therapy|15|||
46830925|NCT00346164|83048822|FG000|Overall Study|Inability to start week 16 tx on time|0|||
46830926|NCT00346164|83048823|FG001|Overall Study|Inability to start week 16 tx on time|0|||
46830927|NCT00346164|83048824|FG002|Overall Study|Inability to start week 16 tx on time|0|||
46830928|NCT00346164|83048825|FG003|Overall Study|Inability to start week 16 tx on time|11|||
46830929|NCT00114244|83048853|FG000|Overall Study|Adverse Event|2|||
46830930|NCT00114244|83048854|FG001|Overall Study|Adverse Event|5|||
46830931|NCT00114244|83048853|FG000|Overall Study|Withdrawal by Subject|0|||
46830932|NCT00114244|83048854|FG001|Overall Study|Withdrawal by Subject|2|||
47060796|NCT01562275|83340866|FG012|Stage 1|Death|0|||
47060797|NCT01562275|83340854|FG000|Stage 1|Non Compliance|0|||
47060798|NCT01562275|83340855|FG001|Stage 1|Non Compliance|0|||
47060799|NCT01562275|83340856|FG002|Stage 1|Non Compliance|1|||
47060800|NCT01562275|83340857|FG003|Stage 1|Non Compliance|0|||
47060801|NCT01562275|83340858|FG004|Stage 1|Non Compliance|0|||
47060802|NCT01562275|83340859|FG005|Stage 1|Non Compliance|0|||
47060803|NCT01562275|83340860|FG006|Stage 1|Non Compliance|0|||
47060804|NCT01562275|83340861|FG007|Stage 1|Non Compliance|0|||
47060805|NCT01562275|83340862|FG008|Stage 1|Non Compliance|0|||
47060806|NCT01562275|83340863|FG009|Stage 1|Non Compliance|0|||
47060807|NCT01562275|83340864|FG010|Stage 1|Non Compliance|0|||
47060808|NCT01562275|83340865|FG011|Stage 1|Non Compliance|0|||
47060809|NCT01562275|83340866|FG012|Stage 1|Non Compliance|0|||
46830933|NCT00138658|83048860|FG000|Overall Study|Adverse Event|23|||
46830934|NCT00138658|83048860|FG000|Overall Study|Death|1|||
46830935|NCT00138658|83048860|FG000|Overall Study|Disease Progression|21|||
47060810|NCT01562275|83340854|FG000|Stage 1|Physician Decision|0|||
47060811|NCT01562275|83340855|FG001|Stage 1|Physician Decision|0|||
47060812|NCT01562275|83340856|FG002|Stage 1|Physician Decision|0|||
47060813|NCT01562275|83340857|FG003|Stage 1|Physician Decision|0|||
47060814|NCT01562275|83340858|FG004|Stage 1|Physician Decision|1|||
47060815|NCT01562275|83340859|FG005|Stage 1|Physician Decision|0|||
47060816|NCT01562275|83340860|FG006|Stage 1|Physician Decision|1|||
47060817|NCT01562275|83340861|FG007|Stage 1|Physician Decision|0|||
47060818|NCT01562275|83340862|FG008|Stage 1|Physician Decision|1|||
47060819|NCT01562275|83340863|FG009|Stage 1|Physician Decision|0|||
47060820|NCT01562275|83340864|FG010|Stage 1|Physician Decision|0|||
47060821|NCT01562275|83340865|FG011|Stage 1|Physician Decision|0|||
47060822|NCT01562275|83340866|FG012|Stage 1|Physician Decision|0|||
47060823|NCT01562275|83340854|FG000|Stage 1|Progression of Disease|2|||
47060824|NCT01562275|83340855|FG001|Stage 1|Progression of Disease|6|||
47060825|NCT01562275|83340856|FG002|Stage 1|Progression of Disease|2|||
47060826|NCT01562275|83340857|FG003|Stage 1|Progression of Disease|1|||
47060827|NCT01562275|83340858|FG004|Stage 1|Progression of Disease|2|||
47060828|NCT01562275|83340859|FG005|Stage 1|Progression of Disease|4|||
47060829|NCT01562275|83340860|FG006|Stage 1|Progression of Disease|1|||
47060830|NCT01562275|83340861|FG007|Stage 1|Progression of Disease|7|||
47060831|NCT01562275|83340862|FG008|Stage 1|Progression of Disease|2|||
47060832|NCT01562275|83340863|FG009|Stage 1|Progression of Disease|5|||
47060833|NCT01562275|83340864|FG010|Stage 1|Progression of Disease|3|||
46830936|NCT00138658|83048860|FG000|Overall Study|Physician Decision|11|||
47060834|NCT01562275|83340865|FG011|Stage 1|Progression of Disease|0|||
47060835|NCT01562275|83340866|FG012|Stage 1|Progression of Disease|0|||
47060836|NCT01562275|83340854|FG000|Stage 1|Withdrawal by Subject|0|||
46830937|NCT00138658|83048860|FG000|Overall Study|Withdrawal by Subject|5|||
46830938|NCT00337662|83048869|FG000|Study Period II|Lost to Follow-up|0|||
46830939|NCT00337662|83048870|FG001|Study Period II|Lost to Follow-up|0|||
46830940|NCT00337662|83048871|FG002|Study Period II|Lost to Follow-up|0|||
46830941|NCT00337662|83048872|FG003|Study Period II|Lost to Follow-up|35|||
46830942|NCT00337662|83048869|FG000|Study Period II|Withdrawal by Subject|0|||
46830943|NCT00337662|83048870|FG001|Study Period II|Withdrawal by Subject|0|||
46830944|NCT00337662|83048871|FG002|Study Period II|Withdrawal by Subject|0|||
46830945|NCT00337662|83048872|FG003|Study Period II|Withdrawal by Subject|20|||
46830946|NCT00337662|83048869|FG000|Study Period II|Adverse Event|0|||
46830947|NCT00337662|83048870|FG001|Study Period II|Adverse Event|0|||
46830948|NCT00337662|83048871|FG002|Study Period II|Adverse Event|0|||
46830949|NCT00337662|83048872|FG003|Study Period II|Adverse Event|16|||
46830950|NCT00337662|83048869|FG000|Study Period II|Physician Decision|0|||
46830951|NCT00337662|83048870|FG001|Study Period II|Physician Decision|0|||
46830952|NCT00337662|83048871|FG002|Study Period II|Physician Decision|0|||
46830953|NCT00337662|83048872|FG003|Study Period II|Physician Decision|13|||
46830954|NCT00337662|83048869|FG000|Study Period II|Entry Criteria Not Met|0|||
46830955|NCT00337662|83048870|FG001|Study Period II|Entry Criteria Not Met|0|||
46830956|NCT00337662|83048871|FG002|Study Period II|Entry Criteria Not Met|0|||
46830957|NCT00337662|83048872|FG003|Study Period II|Entry Criteria Not Met|6|||
46830958|NCT00337662|83048869|FG000|Study Period II|Protocol Violation|0|||
46830959|NCT00337662|83048870|FG001|Study Period II|Protocol Violation|0|||
46830960|NCT00337662|83048871|FG002|Study Period II|Protocol Violation|0|||
46830961|NCT00337662|83048872|FG003|Study Period II|Protocol Violation|6|||
46830962|NCT00337662|83048869|FG000|Study Period II|Lack of Efficacy|0|||
46830963|NCT00337662|83048870|FG001|Study Period II|Lack of Efficacy|0|||
46830964|NCT00337662|83048871|FG002|Study Period II|Lack of Efficacy|0|||
46830965|NCT00337662|83048872|FG003|Study Period II|Lack of Efficacy|7|||
46830966|NCT00337662|83048869|FG000|Study Period II|Sponsor Decision|0|||
46830967|NCT00337662|83048870|FG001|Study Period II|Sponsor Decision|0|||
46830968|NCT00337662|83048871|FG002|Study Period II|Sponsor Decision|0|||
46830969|NCT00337662|83048872|FG003|Study Period II|Sponsor Decision|2|||
46830970|NCT00337662|83048869|FG000|Study Period II|Parent/Caregiver Decision|0|||
46830971|NCT00337662|83048870|FG001|Study Period II|Parent/Caregiver Decision|0|||
46830972|NCT00337662|83048871|FG002|Study Period II|Parent/Caregiver Decision|0|||
46830973|NCT00337662|83048872|FG003|Study Period II|Parent/Caregiver Decision|1|||
46830974|NCT00337662|83048869|FG000|Study Period III|Lost to Follow-up|14|||
46830975|NCT00337662|83048870|FG001|Study Period III|Lost to Follow-up|16|||
47060837|NCT01562275|83340855|FG001|Stage 1|Withdrawal by Subject|1|||
47060838|NCT01562275|83340856|FG002|Stage 1|Withdrawal by Subject|0|||
47060839|NCT01562275|83340857|FG003|Stage 1|Withdrawal by Subject|2|||
47060840|NCT01562275|83340858|FG004|Stage 1|Withdrawal by Subject|0|||
47060841|NCT01562275|83340859|FG005|Stage 1|Withdrawal by Subject|0|||
47060842|NCT01562275|83340860|FG006|Stage 1|Withdrawal by Subject|1|||
47060843|NCT01562275|83340861|FG007|Stage 1|Withdrawal by Subject|0|||
47060844|NCT01562275|83340862|FG008|Stage 1|Withdrawal by Subject|0|||
47060845|NCT01562275|83340863|FG009|Stage 1|Withdrawal by Subject|1|||
47060846|NCT01562275|83340864|FG010|Stage 1|Withdrawal by Subject|0|||
47060847|NCT01562275|83340865|FG011|Stage 1|Withdrawal by Subject|0|||
47060848|NCT01562275|83340866|FG012|Stage 1|Withdrawal by Subject|0|||
47060849|NCT01562275|83340854|FG000|Stage 2|Death|0|||
47060850|NCT01562275|83340855|FG001|Stage 2|Death|0|||
46830976|NCT00337662|83048871|FG002|Study Period III|Lost to Follow-up|14|||
46830977|NCT00337662|83048872|FG003|Study Period III|Lost to Follow-up|0|||
46830978|NCT00337662|83048869|FG000|Study Period III|Withdrawal by Subject|18|||
46830979|NCT00337662|83048870|FG001|Study Period III|Withdrawal by Subject|14|||
46830980|NCT00337662|83048871|FG002|Study Period III|Withdrawal by Subject|12|||
46830981|NCT00337662|83048872|FG003|Study Period III|Withdrawal by Subject|0|||
47060851|NCT01562275|83340856|FG002|Stage 2|Death|0|||
47060852|NCT01562275|83340857|FG003|Stage 2|Death|0|||
47060853|NCT01562275|83340858|FG004|Stage 2|Death|0|||
47060854|NCT01562275|83340859|FG005|Stage 2|Death|0|||
47060855|NCT01562275|83340860|FG006|Stage 2|Death|0|||
47060856|NCT01562275|83340861|FG007|Stage 2|Death|0|||
47060857|NCT01562275|83340862|FG008|Stage 2|Death|0|||
47060858|NCT01562275|83340863|FG009|Stage 2|Death|0|||
47060859|NCT01562275|83340864|FG010|Stage 2|Death|0|||
47060860|NCT01562275|83340865|FG011|Stage 2|Death|2|||
46830982|NCT00337662|83048869|FG000|Study Period III|Adverse Event|9|||
46830983|NCT00337662|83048870|FG001|Study Period III|Adverse Event|10|||
46830984|NCT00337662|83048871|FG002|Study Period III|Adverse Event|8|||
46830985|NCT00337662|83048872|FG003|Study Period III|Adverse Event|0|||
46830986|NCT00337662|83048869|FG000|Study Period III|Protocol Violation|3|||
46830987|NCT00337662|83048870|FG001|Study Period III|Protocol Violation|8|||
46830988|NCT00337662|83048871|FG002|Study Period III|Protocol Violation|2|||
46830989|NCT00337662|83048872|FG003|Study Period III|Protocol Violation|0|||
46830990|NCT00337662|83048869|FG000|Study Period III|Physician Decision|6|||
46830991|NCT00337662|83048870|FG001|Study Period III|Physician Decision|5|||
46830992|NCT00337662|83048871|FG002|Study Period III|Physician Decision|0|||
46830993|NCT00337662|83048872|FG003|Study Period III|Physician Decision|0|||
46830994|NCT00337662|83048869|FG000|Study Period III|Entry Criteria Not Met|4|||
46830995|NCT00337662|83048870|FG001|Study Period III|Entry Criteria Not Met|1|||
46830996|NCT00337662|83048871|FG002|Study Period III|Entry Criteria Not Met|3|||
46830997|NCT00337662|83048872|FG003|Study Period III|Entry Criteria Not Met|0|||
46830998|NCT00337662|83048869|FG000|Study Period III|Lack of Efficacy|4|||
46830999|NCT00337662|83048870|FG001|Study Period III|Lack of Efficacy|4|||
46831000|NCT00337662|83048871|FG002|Study Period III|Lack of Efficacy|2|||
46831001|NCT00337662|83048872|FG003|Study Period III|Lack of Efficacy|0|||
46831002|NCT00337662|83048869|FG000|Study Period III|Parent/Caregiver Decision|0|||
46831003|NCT00337662|83048870|FG001|Study Period III|Parent/Caregiver Decision|0|||
46831004|NCT00337662|83048871|FG002|Study Period III|Parent/Caregiver Decision|2|||
46831005|NCT00337662|83048872|FG003|Study Period III|Parent/Caregiver Decision|0|||
46831006|NCT00337662|83048869|FG000|Study Period III|Sponsor Decision|1|||
46831007|NCT00337662|83048870|FG001|Study Period III|Sponsor Decision|0|||
46831008|NCT00337662|83048871|FG002|Study Period III|Sponsor Decision|1|||
46831009|NCT00337662|83048872|FG003|Study Period III|Sponsor Decision|0|||
46831010|NCT00337662|83048869|FG000|Study Period III|Clinical Relapse|1|||
46831011|NCT00337662|83048870|FG001|Study Period III|Clinical Relapse|0|||
46831012|NCT00337662|83048871|FG002|Study Period III|Clinical Relapse|0|||
46831013|NCT00337662|83048872|FG003|Study Period III|Clinical Relapse|0|||
46831014|NCT00138424|83048887|FG000|Overall Study|Physician Decision|0|||
46831015|NCT00138424|83048888|FG001|Overall Study|Physician Decision|1|||
46831016|NCT00138424|83048889|FG002|Overall Study|Physician Decision|0|||
46831017|NCT00138424|83048890|FG003|Overall Study|Physician Decision|0|||
46831018|NCT00368966|83048904|FG000|Infant Series|Withdrawal by Subject|11|||
46831019|NCT00368966|83048905|FG001|Infant Series|Withdrawal by Subject|6|||
46831020|NCT00368966|83048904|FG000|Infant Series|Protocol Violation|2|||
46831021|NCT00368966|83048905|FG001|Infant Series|Protocol Violation|1|||
46831022|NCT00368966|83048904|FG000|Infant Series|Lost to Follow-up|2|||
46831023|NCT00368966|83048905|FG001|Infant Series|Lost to Follow-up|0|||
46831024|NCT00368966|83048904|FG000|Infant Series|Randomization error|0|||
46831025|NCT00368966|83048905|FG001|Infant Series|Randomization error|1|||
46831026|NCT00368966|83048904|FG000|Infant Series|Failed to meet eligibility criteria|0|||
46831027|NCT00368966|83048905|FG001|Infant Series|Failed to meet eligibility criteria|1|||
46831028|NCT00368966|83048904|FG000|Infant Series|Adverse Event|0|||
46831029|NCT00368966|83048905|FG001|Infant Series|Adverse Event|1|||
46831030|NCT00368966|83048904|FG000|Infant Series|Failed to return|1|||
46831031|NCT00368966|83048905|FG001|Infant Series|Failed to return|0|||
46831032|NCT00368966|83048904|FG000|After Infant|Failed to return|3|||
46831033|NCT00368966|83048905|FG001|After Infant|Failed to return|1|||
46831034|NCT00368966|83048904|FG000|After Infant|Adverse Event|1|||
46831035|NCT00368966|83048905|FG001|After Infant|Adverse Event|2|||
46831036|NCT00368966|83048904|FG000|After Infant|Withdrawal by Subject|1|||
46831037|NCT00368966|83048905|FG001|After Infant|Withdrawal by Subject|1|||
46831038|NCT00368966|83048904|FG000|After Infant|Death|1|||
47060861|NCT01562275|83340866|FG012|Stage 2|Death|1|||
47060862|NCT01562275|83340854|FG000|Stage 2|Progression of Disease|0|||
47060863|NCT01562275|83340855|FG001|Stage 2|Progression of Disease|0|||
47060864|NCT01562275|83340856|FG002|Stage 2|Progression of Disease|0|||
46831039|NCT00368966|83048905|FG001|After Infant|Death|0|||
46831040|NCT00368966|83048904|FG000|After Infant|Lost to Follow-up|0|||
46831041|NCT00368966|83048905|FG001|After Infant|Lost to Follow-up|1|||
46831042|NCT00368966|83048904|FG000|Toddler Dose|Withdrawal by Subject|1|||
46831043|NCT00368966|83048905|FG001|Toddler Dose|Withdrawal by Subject|1|||
46831044|NCT00368966|83048904|FG000|Toddler Dose|Lost to Follow-up|0|||
46831045|NCT00368966|83048905|FG001|Toddler Dose|Lost to Follow-up|2|||
46831046|NCT00114166|83048938|FG000|Overall Study|Wrong primary|0|||
47060865|NCT01562275|83340857|FG003|Stage 2|Progression of Disease|0|||
46831047|NCT00114166|83048939|FG001|Overall Study|Wrong primary|1|||
46831048|NCT00125242|83048949|FG000|Overall Study|did not qualify|7|||
46831049|NCT00125242|83048950|FG001|Overall Study|did not qualify|2|||
46831050|NCT00337428|83048957|FG000|Overall Study|Withdrawal by Subject|1|||
46831051|NCT00337428|83048958|FG001|Overall Study|Withdrawal by Subject|2|||
46831052|NCT00337428|83048957|FG000|Overall Study|Lack of Time|1|||
46831053|NCT00337428|83048958|FG001|Overall Study|Lack of Time|1|||
46831054|NCT00337428|83048957|FG000|Overall Study|Unwilling to Continue|1|||
47060866|NCT01562275|83340858|FG004|Stage 2|Progression of Disease|0|||
46831055|NCT00337428|83048958|FG001|Overall Study|Unwilling to Continue|0|||
46831056|NCT00337428|83048957|FG000|Overall Study|Anorexia|1|||
46831057|NCT00337428|83048958|FG001|Overall Study|Anorexia|0|||
46831058|NCT00235989|83048968|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
46831059|NCT00235989|83048969|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
46831060|NCT00235989|83048970|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
46831061|NCT00235989|83048971|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
46831062|NCT00235989|83048972|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
46831063|NCT00235989|83048973|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
46831064|NCT00235989|83048968|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
46831065|NCT00235989|83048969|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
46831066|NCT00235989|83048970|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
46831067|NCT00235989|83048971|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
46831068|NCT00235989|83048972|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
46831069|NCT00235989|83048973|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
46831070|NCT00235989|83048968|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
46831071|NCT00235989|83048969|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
46831072|NCT00235989|83048970|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
46831073|NCT00235989|83048971|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
46831074|NCT00235989|83048972|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
46831075|NCT00235989|83048973|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
46831076|NCT00235989|83048968|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
46831077|NCT00235989|83048969|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
46831078|NCT00235989|83048970|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
46831079|NCT00235989|83048971|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
46831080|NCT00235989|83048972|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
46831081|NCT00235989|83048973|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
46831082|NCT00235989|83048968|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
46831083|NCT00235989|83048969|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
46831084|NCT00235989|83048970|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
46831085|NCT00235989|83048971|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
46831086|NCT00235989|83048972|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
46831087|NCT00235989|83048973|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
46831088|NCT00113386|83048985|FG000|Overall Study|Withdrawal by Subject|1|||
46831089|NCT00113386|83048986|FG001|Overall Study|Withdrawal by Subject|0|||
46831090|NCT00113386|83048985|FG000|Overall Study|Physician Decision|0|||
46831091|NCT00113386|83048986|FG001|Overall Study|Physician Decision|1|||
46831092|NCT00113386|83048985|FG000|Overall Study|Toxicity|3|||
46831093|NCT00113386|83048986|FG001|Overall Study|Toxicity|0|||
46831094|NCT00113386|83048985|FG000|Overall Study|Ineligible|1|||
46831095|NCT00113386|83048986|FG001|Overall Study|Ineligible|2|||
46831096|NCT00113386|83048985|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
46831097|NCT00113386|83048986|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
46831098|NCT00353262|83048992|FG000|Overall Study|Adverse Event|8|||
46831099|NCT00353262|83048992|FG000|Overall Study|Withdrawal by Subject|2|||
47060867|NCT01562275|83340859|FG005|Stage 2|Progression of Disease|0|||
47060868|NCT01562275|83340860|FG006|Stage 2|Progression of Disease|0|||
47060869|NCT01562275|83340861|FG007|Stage 2|Progression of Disease|0|||
47060870|NCT01562275|83340862|FG008|Stage 2|Progression of Disease|0|||
47060871|NCT01562275|83340863|FG009|Stage 2|Progression of Disease|0|||
47060872|NCT01562275|83340864|FG010|Stage 2|Progression of Disease|0|||
47060873|NCT01562275|83340865|FG011|Stage 2|Progression of Disease|12|||
47060874|NCT01562275|83340866|FG012|Stage 2|Progression of Disease|4|||
47060875|NCT01535053|83340898|FG000|Overall Study|Ineligible|1|||
47060876|NCT01535053|83340899|FG001|Overall Study|Ineligible|2|||
47060877|NCT01534663|83340907|FG000|Overall Study|Lost to Follow-up|0|||
47060878|NCT01534663|83340908|FG001|Overall Study|Lost to Follow-up|2|||
47060879|NCT01534663|83340907|FG000|Overall Study|Adverse Event|2|||
47060880|NCT01534663|83340908|FG001|Overall Study|Adverse Event|1|||
47060881|NCT01520909|83340916|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
47060882|NCT01520909|83340917|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
46764924|NCT00800982|82983212|FG000|Overall Study|Lost to Follow-up|1|||
46764925|NCT00800982|82983213|FG001|Overall Study|Lost to Follow-up|2|||
46764926|NCT00800982|82983212|FG000|Overall Study|Withdrawal by Subject|0|||
46764927|NCT00800982|82983213|FG001|Overall Study|Withdrawal by Subject|1|||
46764928|NCT00800982|82983212|FG000|Overall Study|Patient moved out of state|1|||
46764929|NCT00800982|82983213|FG001|Overall Study|Patient moved out of state|0|||
46764930|NCT00830960|82983225|FG000|Overall Study|Death|5|||
46764931|NCT00830960|82983226|FG001|Overall Study|Death|4|||
46764932|NCT00830960|82983227|FG002|Overall Study|Death|3|||
46764933|NCT00830960|82983228|FG003|Overall Study|Death|2|||
46764934|NCT00830960|82983229|FG004|Overall Study|Death|6|||
46764935|NCT00830960|82983230|FG005|Overall Study|Death|1|||
46764936|NCT00830960|82983225|FG000|Overall Study|Lost to Follow-up|1|||
46764937|NCT00830960|82983226|FG001|Overall Study|Lost to Follow-up|1|||
46831100|NCT00353262|83048992|FG000|Overall Study|Insufficient Therapeutic Response|13|||
46831101|NCT00353262|83048992|FG000|Overall Study|Progression|1|||
46831102|NCT00353262|83048992|FG000|Overall Study|Surgery|4|||
46831103|NCT00353262|83048992|FG000|Overall Study|Break from Chemotherapy|1|||
46831104|NCT00337272|83048998|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
46831105|NCT00337272|83048999|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
46831106|NCT00337272|83048998|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
46831107|NCT00337272|83048999|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
46831108|NCT00337272|83048998|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
46831109|NCT00337272|83048999|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
46831110|NCT00337272|83048998|FG000|Treatment Period|Non-compliance|1|||
46831111|NCT00337272|83048999|FG001|Treatment Period|Non-compliance|1|||
46831112|NCT00337272|83048998|FG000|Treatment Period|Withdrawal by Subject|0|||
46831113|NCT00337272|83048999|FG001|Treatment Period|Withdrawal by Subject|1|||
46831114|NCT00337272|83048998|FG000|Withdrawal Period|Non-compliance|0|||
46831115|NCT00337272|83048999|FG001|Withdrawal Period|Non-compliance|1|||
46831116|NCT00125164|83049009|FG000|Overall Study|Adverse Event|0|||
46831117|NCT00125164|83049010|FG001|Overall Study|Adverse Event|0|||
46831118|NCT00125164|83049011|FG002|Overall Study|Adverse Event|2|||
46831119|NCT00125164|83049012|FG003|Overall Study|Adverse Event|4|||
46831120|NCT00125164|83049009|FG000|Overall Study|Lost to Follow-up|0|||
46831121|NCT00125164|83049010|FG001|Overall Study|Lost to Follow-up|0|||
46831122|NCT00125164|83049011|FG002|Overall Study|Lost to Follow-up|1|||
46831123|NCT00125164|83049012|FG003|Overall Study|Lost to Follow-up|1|||
46831124|NCT00125164|83049009|FG000|Overall Study|Withdrawal by Subject|2|||
46831125|NCT00125164|83049010|FG001|Overall Study|Withdrawal by Subject|0|||
46831126|NCT00125164|83049011|FG002|Overall Study|Withdrawal by Subject|1|||
46831127|NCT00125164|83049012|FG003|Overall Study|Withdrawal by Subject|1|||
46831128|NCT00136318|83049024|FG000|Overall Study|Adverse Event|5|||
46831129|NCT00136318|83049025|FG001|Overall Study|Adverse Event|5|||
46831130|NCT00136318|83049024|FG000|Overall Study|Withdrawal by Subject|2|||
46831131|NCT00136318|83049025|FG001|Overall Study|Withdrawal by Subject|2|||
47060883|NCT01520909|83340918|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
47060884|NCT01520909|83340916|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
47060885|NCT01520909|83340917|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
47060886|NCT01520909|83340918|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
47060887|NCT01520909|83340916|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
47060888|NCT01520909|83340917|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
47060889|NCT01520909|83340918|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
47060890|NCT01520909|83340916|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
47060891|NCT01520909|83340917|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
47060892|NCT01520909|83340918|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
47060893|NCT01520363|83340940|FG000|Overall Study|Withdrawal by Subject|2|||
47060894|NCT01520363|83340941|FG001|Overall Study|Withdrawal by Subject|0|||
47060895|NCT01578499|83340973|FG000|Overall Study|Reason not Specified|0|||
47060896|NCT01578499|83340974|FG001|Overall Study|Reason not Specified|1|||
47060897|NCT01578499|83340973|FG000|Overall Study|Lost to Follow-up|2|||
47060898|NCT01578499|83340974|FG001|Overall Study|Lost to Follow-up|1|||
47060899|NCT01578499|83340973|FG000|Overall Study|Withdrawal by Subject|10|||
47060900|NCT01578499|83340974|FG001|Overall Study|Withdrawal by Subject|16|||
47060901|NCT01578499|83340973|FG000|Overall Study|Death|20|||
46764938|NCT00830960|82983227|FG002|Overall Study|Lost to Follow-up|1|||
46764939|NCT00830960|82983228|FG003|Overall Study|Lost to Follow-up|0|||
46764940|NCT00830960|82983229|FG004|Overall Study|Lost to Follow-up|0|||
46764941|NCT00830960|82983230|FG005|Overall Study|Lost to Follow-up|1|||
46764942|NCT00830960|82983225|FG000|Overall Study|Withdrawal by Subject|19|||
46764943|NCT00830960|82983226|FG001|Overall Study|Withdrawal by Subject|19|||
46764944|NCT00830960|82983227|FG002|Overall Study|Withdrawal by Subject|18|||
46764945|NCT00830960|82983228|FG003|Overall Study|Withdrawal by Subject|23|||
46764946|NCT00830960|82983229|FG004|Overall Study|Withdrawal by Subject|16|||
46764947|NCT00830960|82983230|FG005|Overall Study|Withdrawal by Subject|21|||
46764948|NCT00830960|82983225|FG000|Overall Study|Sponsor Decision|1|||
46764949|NCT00830960|82983226|FG001|Overall Study|Sponsor Decision|2|||
46764950|NCT00830960|82983227|FG002|Overall Study|Sponsor Decision|3|||
46764951|NCT00830960|82983228|FG003|Overall Study|Sponsor Decision|4|||
46764952|NCT00830960|82983229|FG004|Overall Study|Sponsor Decision|5|||
46764953|NCT00830960|82983230|FG005|Overall Study|Sponsor Decision|7|||
46764954|NCT00830960|82983225|FG000|Overall Study|No study drug received|7|||
46764955|NCT00830960|82983226|FG001|Overall Study|No study drug received|2|||
46764956|NCT00830960|82983227|FG002|Overall Study|No study drug received|4|||
46764957|NCT00830960|82983228|FG003|Overall Study|No study drug received|3|||
46764958|NCT00830960|82983229|FG004|Overall Study|No study drug received|5|||
46764959|NCT00830960|82983230|FG005|Overall Study|No study drug received|7|||
46764960|NCT00830804|82983267|FG000|Overall Study|Lost to Follow-up|4|||
47060902|NCT01578499|83340974|FG001|Overall Study|Death|25|||
47060903|NCT01578499|83340973|FG000|Overall Study|Died and End of Study Page not Completed|2|||
47060904|NCT01578499|83340974|FG001|Overall Study|Died and End of Study Page not Completed|0|||
47060905|NCT01578187|83340984|FG000|Usability Phase|Withdrawal by Subject|1|||
47060906|NCT01561963|83340990|FG000|Overall Study|Adverse Event|1|||
47060907|NCT01576783|83341001|FG000|Overall Study|Change in Medical Care|1|||
47060908|NCT01576783|83341002|FG001|Overall Study|Change in Medical Care|0|||
47060909|NCT01576783|83341001|FG000|Overall Study|Lost to Follow-up|14|||
47060910|NCT01576783|83341002|FG001|Overall Study|Lost to Follow-up|16|||
47060911|NCT01576783|83341001|FG000|Overall Study|Withdrawal by Subject|5|||
47060912|NCT01576783|83341002|FG001|Overall Study|Withdrawal by Subject|1|||
47060913|NCT01534351|83341011|FG000|Overall Study|Study Terminated Early|1|||
46936410|NCT01662310|83172849|FG003|Double-Blind Phase|Adverse Event|0|||
46936411|NCT01662310|83172850|FG004|Double-Blind Phase|Adverse Event|0|||
46936412|NCT01662310|83172846|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46936413|NCT01662310|83172847|FG001|Double-Blind Phase|Lost to Follow-up|3|||
46936414|NCT01662310|83172848|FG002|Double-Blind Phase|Lost to Follow-up|0|||
46936415|NCT01662310|83172849|FG003|Double-Blind Phase|Lost to Follow-up|0|||
46936416|NCT01662310|83172850|FG004|Double-Blind Phase|Lost to Follow-up|0|||
46936417|NCT01662310|83172846|FG000|Double-Blind Phase|Pregnancy|0|||
46936418|NCT01662310|83172847|FG001|Double-Blind Phase|Pregnancy|2|||
46936419|NCT01662310|83172848|FG002|Double-Blind Phase|Pregnancy|0|||
46936420|NCT01662310|83172849|FG003|Double-Blind Phase|Pregnancy|0|||
46936421|NCT01662310|83172850|FG004|Double-Blind Phase|Pregnancy|0|||
46936422|NCT01662310|83172846|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
46936423|NCT01662310|83172847|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
46936424|NCT01662310|83172848|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
46936425|NCT01662310|83172849|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
46936426|NCT01662310|83172850|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
46936427|NCT01662310|83172846|FG000|Double-Blind Phase|Other|0|||
46936428|NCT01662310|83172847|FG001|Double-Blind Phase|Other|0|||
46936429|NCT01662310|83172848|FG002|Double-Blind Phase|Other|1|||
46936430|NCT01662310|83172849|FG003|Double-Blind Phase|Other|0|||
46936431|NCT01662310|83172850|FG004|Double-Blind Phase|Other|0|||
46936432|NCT01662310|83172846|FG000|Double-Blind Phase|Randomized but not treated|0|||
46936433|NCT01662310|83172847|FG001|Double-Blind Phase|Randomized but not treated|1|||
46936434|NCT01662310|83172848|FG002|Double-Blind Phase|Randomized but not treated|0|||
46831132|NCT00136084|83049034|FG000|Overall Study|Death|12|||
46831133|NCT00136084|83049035|FG001|Overall Study|Death|5|||
46831134|NCT00136084|83049034|FG000|Overall Study|Unacceptable toxicity|8|||
46831135|NCT00136084|83049035|FG001|Overall Study|Unacceptable toxicity|11|||
46831136|NCT00136084|83049034|FG000|Overall Study|Relapse|20|||
46831137|NCT00136084|83049035|FG001|Overall Study|Relapse|23|||
46831138|NCT00136084|83049034|FG000|Overall Study|Lost to Follow-up|2|||
46831139|NCT00136084|83049035|FG001|Overall Study|Lost to Follow-up|0|||
46831140|NCT00136084|83049034|FG000|Overall Study|No Response|1|||
46831141|NCT00136084|83049035|FG001|Overall Study|No Response|2|||
46831142|NCT00136084|83049034|FG000|Overall Study|Withdrawal by Subject|5|||
46831143|NCT00136084|83049035|FG001|Overall Study|Withdrawal by Subject|1|||
46831144|NCT00364832|83049056|FG000|Core Period|Early Withdrawals|2|||
46831145|NCT00364832|83049057|FG001|Core Period|Early Withdrawals|2|||
46831146|NCT00364832|83049058|FG002|Core Period|Early Withdrawals|1|||
46831147|NCT00364832|83049059|FG003|Core Period|Early Withdrawals|1|||
46831148|NCT00364832|83049060|FG004|Core Period|Early Withdrawals|0|||
46831149|NCT00364832|83049061|FG005|Core Period|Early Withdrawals|0|||
46831150|NCT00364832|83049062|FG006|Core Period|Early Withdrawals|4|||
46831151|NCT00364832|83049063|FG007|Core Period|Early Withdrawals|1|||
46831152|NCT00364832|83049064|FG008|Core Period|Early Withdrawals|0|||
46831153|NCT00364832|83049065|FG009|Core Period|Early Withdrawals|0|||
46831154|NCT00364832|83049066|FG010|Core Period|Early Withdrawals|0|||
46936435|NCT01662310|83172849|FG003|Double-Blind Phase|Randomized but not treated|0|||
46936436|NCT01662310|83172850|FG004|Double-Blind Phase|Randomized but not treated|0|||
46936437|NCT01662310|83172846|FG000|Open-Label Extension Phase|Adverse Event|0|||
46936438|NCT01662310|83172847|FG001|Open-Label Extension Phase|Adverse Event|0|||
46936439|NCT01662310|83172848|FG002|Open-Label Extension Phase|Adverse Event|0|||
46936440|NCT01662310|83172849|FG003|Open-Label Extension Phase|Adverse Event|3|||
47060914|NCT01534351|83341012|FG001|Overall Study|Study Terminated Early|0|||
47060915|NCT01534351|83341013|FG002|Overall Study|Study Terminated Early|0|||
46764961|NCT00830804|82983267|FG000|Overall Study|Death|1|||
46764962|NCT00830804|82983267|FG000|Overall Study|Unable to get to clinic|7|||
46764963|NCT00830804|82983267|FG000|Overall Study|Consent withdrawn|2|||
46764964|NCT00830804|82983267|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
47060916|NCT01534273|83341025|FG000|Period 1|Physician Decision|0|||
46764965|NCT00789477|82983277|FG000|Overall Study|Withdrawal by Subject|2|||
46764966|NCT00789477|82983278|FG001|Overall Study|Withdrawal by Subject|1|||
46764967|NCT00789477|82983279|FG002|Overall Study|Withdrawal by Subject|3|||
46764968|NCT00789477|82983280|FG003|Overall Study|Withdrawal by Subject|2|||
46764969|NCT00789477|82983281|FG004|Overall Study|Withdrawal by Subject|3|||
46936441|NCT01662310|83172850|FG004|Open-Label Extension Phase|Adverse Event|0|||
46936442|NCT01662310|83172846|FG000|Open-Label Extension Phase|Death|0|||
46936443|NCT01662310|83172847|FG001|Open-Label Extension Phase|Death|0|||
46936444|NCT01662310|83172848|FG002|Open-Label Extension Phase|Death|0|||
46936445|NCT01662310|83172849|FG003|Open-Label Extension Phase|Death|1|||
46936446|NCT01662310|83172850|FG004|Open-Label Extension Phase|Death|0|||
46936447|NCT01662310|83172846|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
46936448|NCT01662310|83172847|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
46936449|NCT01662310|83172848|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
46936450|NCT01662310|83172849|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
46936451|NCT01662310|83172850|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
46936452|NCT01662310|83172846|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
46936453|NCT01662310|83172847|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
46936454|NCT01662310|83172848|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
46936455|NCT01662310|83172849|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
46936456|NCT01662310|83172850|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
46936457|NCT01662310|83172846|FG000|Open-Label Extension Phase|Pregnancy|0|||
46936458|NCT01662310|83172847|FG001|Open-Label Extension Phase|Pregnancy|0|||
46936459|NCT01662310|83172848|FG002|Open-Label Extension Phase|Pregnancy|0|||
46936460|NCT01662310|83172849|FG003|Open-Label Extension Phase|Pregnancy|1|||
46936461|NCT01662310|83172850|FG004|Open-Label Extension Phase|Pregnancy|0|||
46936462|NCT01662310|83172846|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
46936463|NCT01662310|83172847|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
46936464|NCT01662310|83172848|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
46936465|NCT01662310|83172849|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
46936466|NCT01662310|83172850|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
46936467|NCT00700622|83172864|FG000|Overall Study|Adverse Event|4|||
46936468|NCT00700622|83172865|FG001|Overall Study|Adverse Event|0|||
46936469|NCT00700622|83172864|FG000|Overall Study|Lost to Follow-up|0|||
46936470|NCT00700622|83172865|FG001|Overall Study|Lost to Follow-up|1|||
46936471|NCT00700622|83172864|FG000|Overall Study|Physician Decision|2|||
46936472|NCT00700622|83172865|FG001|Overall Study|Physician Decision|1|||
46936473|NCT00700622|83172864|FG000|Overall Study|Protocol Violation|0|||
46936474|NCT00700622|83172865|FG001|Overall Study|Protocol Violation|1|||
46936475|NCT00700622|83172864|FG000|Overall Study|Withdrawal by Subject|4|||
46936476|NCT00700622|83172865|FG001|Overall Study|Withdrawal by Subject|1|||
46936477|NCT00700622|83172864|FG000|Overall Study|Other|3|||
46936478|NCT00700622|83172865|FG001|Overall Study|Other|1|||
46936479|NCT02553928|83172873|FG000|Overall Study|Adverse Event|2|||
46936480|NCT02553928|83172874|FG001|Overall Study|Adverse Event|1|||
46936481|NCT02553928|83172873|FG000|Overall Study|Lost to Follow-up|0|||
46936482|NCT02553928|83172874|FG001|Overall Study|Lost to Follow-up|1|||
46936483|NCT02553928|83172873|FG000|Overall Study|Administrative reason(s)|0|||
46936484|NCT02553928|83172874|FG001|Overall Study|Administrative reason(s)|1|||
46936485|NCT03076775|83172883|FG000|Overall Study|Lost to Follow-up|1|||
46936486|NCT03076775|83172884|FG001|Overall Study|Lost to Follow-up|0|||
46936487|NCT03058991|83172901|FG000|Overall Study|Lost to Follow-up|17|||
46936488|NCT03058991|83172902|FG001|Overall Study|Lost to Follow-up|12|||
46936489|NCT03058991|83172903|FG002|Overall Study|Lost to Follow-up|12|||
46936490|NCT03058991|83172901|FG000|Overall Study|Withdrawal by Subject|1|||
46936491|NCT03058991|83172902|FG001|Overall Study|Withdrawal by Subject|0|||
46936492|NCT03058991|83172903|FG002|Overall Study|Withdrawal by Subject|0|||
46936493|NCT00700310|83172915|FG000|Overall Study|Adverse Event|6|||
46936494|NCT00700310|83172916|FG001|Overall Study|Adverse Event|10|||
46936495|NCT00700310|83172917|FG002|Overall Study|Adverse Event|5|||
46936496|NCT00700310|83172918|FG003|Overall Study|Adverse Event|11|||
46936497|NCT00700310|83172915|FG000|Overall Study|Lost to Follow-up|4|||
46936498|NCT00700310|83172916|FG001|Overall Study|Lost to Follow-up|1|||
46936499|NCT00700310|83172917|FG002|Overall Study|Lost to Follow-up|0|||
46936500|NCT00700310|83172918|FG003|Overall Study|Lost to Follow-up|1|||
46936501|NCT00700310|83172915|FG000|Overall Study|Withdrawal by Subject|8|||
46764970|NCT00789477|82983277|FG000|Overall Study|Protocol Violation|1|||
47060917|NCT01534273|83341026|FG001|Period 1|Physician Decision|0|||
47060918|NCT01534273|83341027|FG002|Period 1|Physician Decision|0|||
46764971|NCT00789477|82983278|FG001|Overall Study|Protocol Violation|0|||
46764972|NCT00789477|82983279|FG002|Overall Study|Protocol Violation|0|||
46936502|NCT00700310|83172916|FG001|Overall Study|Withdrawal by Subject|9|||
46936503|NCT00700310|83172917|FG002|Overall Study|Withdrawal by Subject|8|||
46936504|NCT00700310|83172918|FG003|Overall Study|Withdrawal by Subject|8|||
46936505|NCT00700310|83172915|FG000|Overall Study|Lack of Efficacy|0|||
46936506|NCT00700310|83172916|FG001|Overall Study|Lack of Efficacy|3|||
46936507|NCT00700310|83172917|FG002|Overall Study|Lack of Efficacy|0|||
46936508|NCT00700310|83172918|FG003|Overall Study|Lack of Efficacy|1|||
46936509|NCT00700310|83172915|FG000|Overall Study|Administrative/Other|1|||
46936510|NCT00700310|83172916|FG001|Overall Study|Administrative/Other|3|||
46936511|NCT00700310|83172917|FG002|Overall Study|Administrative/Other|1|||
46936512|NCT00700310|83172918|FG003|Overall Study|Administrative/Other|3|||
46936513|NCT00700310|83172915|FG000|Overall Study|Randomized, Not Treated|2|||
46936514|NCT00700310|83172916|FG001|Overall Study|Randomized, Not Treated|0|||
46936515|NCT00700310|83172917|FG002|Overall Study|Randomized, Not Treated|2|||
46936516|NCT00700310|83172918|FG003|Overall Study|Randomized, Not Treated|2|||
46936517|NCT01575548|83172939|FG000|Overall Study|Adverse Event|15|||
46936518|NCT01575548|83172940|FG001|Overall Study|Adverse Event|2|||
46936519|NCT01575548|83172939|FG000|Overall Study|Disease progression|12|||
46936520|NCT01575548|83172940|FG001|Overall Study|Disease progression|25|||
46936521|NCT01575548|83172939|FG000|Overall Study|Death|1|||
46936522|NCT01575548|83172940|FG001|Overall Study|Death|0|||
46936523|NCT01575548|83172939|FG000|Overall Study|Other complicating disease|1|||
46936524|NCT01575548|83172940|FG001|Overall Study|Other complicating disease|0|||
46936525|NCT01575548|83172939|FG000|Overall Study|Withdrawal by Subject|7|||
46936526|NCT01575548|83172940|FG001|Overall Study|Withdrawal by Subject|3|||
46936527|NCT01575548|83172939|FG000|Overall Study|Noncompliance|1|||
46936528|NCT01575548|83172940|FG001|Overall Study|Noncompliance|0|||
46936529|NCT01575548|83172939|FG000|Overall Study|Anticipated surgery|0|||
46936530|NCT01575548|83172940|FG001|Overall Study|Anticipated surgery|1|||
46936531|NCT01575548|83172939|FG000|Overall Study|Never started protocol therapy|3|||
46936532|NCT01575548|83172940|FG001|Overall Study|Never started protocol therapy|2|||
46936533|NCT02554786|83172968|FG000|Overall Study|Subject/guardian decision|29|||
46936534|NCT02554786|83172969|FG001|Overall Study|Subject/guardian decision|17|||
46831155|NCT00364832|83049067|FG011|Core Period|Early Withdrawals|0|||
46831156|NCT00364832|83049056|FG000|Extension Year 1|Early Withdrawals|0|||
46831157|NCT00364832|83049057|FG001|Extension Year 1|Early Withdrawals|0|||
46831158|NCT00364832|83049058|FG002|Extension Year 1|Early Withdrawals|0|||
46831159|NCT00364832|83049059|FG003|Extension Year 1|Early Withdrawals|0|||
46831160|NCT00364832|83049060|FG004|Extension Year 1|Early Withdrawals|0|||
46831161|NCT00364832|83049061|FG005|Extension Year 1|Early Withdrawals|0|||
46831162|NCT00364832|83049062|FG006|Extension Year 1|Early Withdrawals|0|||
46831163|NCT00364832|83049063|FG007|Extension Year 1|Early Withdrawals|0|||
46831164|NCT00364832|83049064|FG008|Extension Year 1|Early Withdrawals|0|||
46831165|NCT00364832|83049065|FG009|Extension Year 1|Early Withdrawals|4|||
46831166|NCT00364832|83049066|FG010|Extension Year 1|Early Withdrawals|2|||
46831167|NCT00364832|83049067|FG011|Extension Year 1|Early Withdrawals|10|||
46831168|NCT00364832|83049056|FG000|Extension Year 2|Early Withdrawals|0|||
46831169|NCT00364832|83049057|FG001|Extension Year 2|Early Withdrawals|0|||
46831170|NCT00364832|83049058|FG002|Extension Year 2|Early Withdrawals|0|||
46831171|NCT00364832|83049059|FG003|Extension Year 2|Early Withdrawals|0|||
46831172|NCT00364832|83049060|FG004|Extension Year 2|Early Withdrawals|0|||
46831173|NCT00364832|83049061|FG005|Extension Year 2|Early Withdrawals|0|||
46831174|NCT00364832|83049062|FG006|Extension Year 2|Early Withdrawals|0|||
46831175|NCT00364832|83049063|FG007|Extension Year 2|Early Withdrawals|0|||
46936535|NCT02554786|83172970|FG002|Overall Study|Subject/guardian decision|18|||
46936536|NCT02554786|83172971|FG003|Overall Study|Subject/guardian decision|30|||
46936537|NCT02554786|83172972|FG004|Overall Study|Subject/guardian decision|20|||
46936538|NCT02554786|83172968|FG000|Overall Study|Lost to Follow-up|4|||
46831176|NCT00364832|83049064|FG008|Extension Year 2|Early Withdrawals|0|||
46831177|NCT00364832|83049065|FG009|Extension Year 2|Early Withdrawals|5|||
46831178|NCT00364832|83049066|FG010|Extension Year 2|Early Withdrawals|5|||
46831179|NCT00364832|83049067|FG011|Extension Year 2|Early Withdrawals|3|||
46831180|NCT00235755|83049087|FG000|4-Week Titration Phase|Adverse Event|6|||
46831181|NCT00235755|83049088|FG001|4-Week Titration Phase|Adverse Event|14|||
46831182|NCT00235755|83049089|FG002|4-Week Titration Phase|Adverse Event|20|||
46831183|NCT00235755|83049087|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
46831184|NCT00235755|83049088|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
46936539|NCT02554786|83172969|FG001|Overall Study|Lost to Follow-up|3|||
47060919|NCT01534273|83341028|FG003|Period 1|Physician Decision|1|||
47060920|NCT01534273|83341029|FG004|Period 1|Physician Decision|0|||
46831185|NCT00235755|83049089|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
46936540|NCT02554786|83172970|FG002|Overall Study|Lost to Follow-up|4|||
47060921|NCT01534273|83341030|FG005|Period 1|Physician Decision|0|||
47060922|NCT01534273|83341031|FG006|Period 1|Physician Decision|0|||
47060923|NCT01534195|83341054|FG000|Overall Study|Withdrawal by Subject|1|||
46831186|NCT00235755|83049087|FG000|4-Week Titration Phase|Protocol Violation|2|||
46831187|NCT00235755|83049088|FG001|4-Week Titration Phase|Protocol Violation|2|||
46831188|NCT00235755|83049089|FG002|4-Week Titration Phase|Protocol Violation|1|||
46831189|NCT00235755|83049087|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
46936541|NCT02554786|83172971|FG003|Overall Study|Lost to Follow-up|2|||
46831190|NCT00235755|83049088|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
46936542|NCT02554786|83172972|FG004|Overall Study|Lost to Follow-up|2|||
46936543|NCT02554786|83172968|FG000|Overall Study|Protocol deviation|1|||
46936544|NCT02554786|83172969|FG001|Overall Study|Protocol deviation|3|||
46936545|NCT02554786|83172970|FG002|Overall Study|Protocol deviation|3|||
46936546|NCT02554786|83172971|FG003|Overall Study|Protocol deviation|4|||
47060924|NCT01534195|83341055|FG001|Overall Study|Withdrawal by Subject|1|||
47060925|NCT01560949|83341061|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
47060926|NCT01560949|83341061|FG000|Surgery Phase|Physician Decision|3|||
47060927|NCT01372878|83341069|FG000|Overall Study|Withdrawal by Subject|63|||
47060928|NCT01372878|83341069|FG000|Overall Study|Protocol Violation|17|||
47060929|NCT01372878|83341069|FG000|Overall Study|incomplete study procedure|104|||
47060930|NCT01533493|83341075|FG000|Overall Study|Adverse Event|2|||
47060931|NCT01533493|83341076|FG001|Overall Study|Adverse Event|1|||
47060932|NCT01533493|83341075|FG000|Overall Study|Withdrawal by Subject|1|||
47060933|NCT01533493|83341076|FG001|Overall Study|Withdrawal by Subject|2|||
47060934|NCT01533493|83341075|FG000|Overall Study|Lost to Follow-up|2|||
47060935|NCT01533493|83341076|FG001|Overall Study|Lost to Follow-up|0|||
47060936|NCT01533181|83341152|FG000|Overall Study|Disease progression pre-active treatment|0|||
47060937|NCT01533181|83341153|FG001|Overall Study|Disease progression pre-active treatment|1|||
47060938|NCT01533181|83341152|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
47060939|NCT01533181|83341153|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
47060940|NCT02669082|83341159|FG000|Overall Study|Adverse Event|1|||
46764973|NCT00789477|82983280|FG003|Overall Study|Protocol Violation|1|||
46764974|NCT00789477|82983281|FG004|Overall Study|Protocol Violation|0|||
46764975|NCT00789477|82983277|FG000|Overall Study|Adverse Event|3|||
46764976|NCT00789477|82983278|FG001|Overall Study|Adverse Event|3|||
46764977|NCT00789477|82983279|FG002|Overall Study|Adverse Event|1|||
46764978|NCT00789477|82983280|FG003|Overall Study|Adverse Event|0|||
46764979|NCT00789477|82983281|FG004|Overall Study|Adverse Event|0|||
46764980|NCT00789477|82983277|FG000|Overall Study|Death|1|||
46764981|NCT00789477|82983278|FG001|Overall Study|Death|1|||
46764982|NCT00789477|82983279|FG002|Overall Study|Death|2|||
46764983|NCT00789477|82983280|FG003|Overall Study|Death|2|||
46764984|NCT00789477|82983281|FG004|Overall Study|Death|0|||
46764985|NCT00789477|82983277|FG000|Overall Study|Lost to Follow-up|0|||
46764986|NCT00789477|82983278|FG001|Overall Study|Lost to Follow-up|1|||
46764987|NCT00789477|82983279|FG002|Overall Study|Lost to Follow-up|4|||
46764988|NCT00789477|82983280|FG003|Overall Study|Lost to Follow-up|2|||
46764989|NCT00789477|82983281|FG004|Overall Study|Lost to Follow-up|4|||
46764990|NCT00789477|82983277|FG000|Overall Study|Lack of Efficacy|2|||
46764991|NCT00789477|82983278|FG001|Overall Study|Lack of Efficacy|0|||
46764992|NCT00789477|82983279|FG002|Overall Study|Lack of Efficacy|0|||
46764993|NCT00789477|82983280|FG003|Overall Study|Lack of Efficacy|0|||
46764994|NCT00789477|82983281|FG004|Overall Study|Lack of Efficacy|0|||
46764995|NCT00789477|82983277|FG000|Overall Study|Other|2|||
46764996|NCT00789477|82983278|FG001|Overall Study|Other|0|||
46764997|NCT00789477|82983279|FG002|Overall Study|Other|1|||
46764998|NCT00789477|82983280|FG003|Overall Study|Other|3|||
46764999|NCT00789477|82983281|FG004|Overall Study|Other|0|||
46765000|NCT00796614|82983299|FG000|Overall Study|Adverse Event|1|||
46765001|NCT00796614|82983300|FG001|Overall Study|Adverse Event|2|||
46765002|NCT00796614|82983301|FG002|Overall Study|Adverse Event|0|||
46765003|NCT00796614|82983302|FG003|Overall Study|Adverse Event|0|||
46765004|NCT00796614|82983299|FG000|Overall Study|Protocol Violation|0|||
46765005|NCT00796614|82983300|FG001|Overall Study|Protocol Violation|0|||
46765006|NCT00796614|82983301|FG002|Overall Study|Protocol Violation|2|||
46765007|NCT00796614|82983302|FG003|Overall Study|Protocol Violation|0|||
46765008|NCT00796614|82983299|FG000|Overall Study|Lost to Follow-up|2|||
46765009|NCT00796614|82983300|FG001|Overall Study|Lost to Follow-up|2|||
46765010|NCT00796614|82983301|FG002|Overall Study|Lost to Follow-up|1|||
46765011|NCT00796614|82983302|FG003|Overall Study|Lost to Follow-up|0|||
46765012|NCT00796614|82983299|FG000|Overall Study|Withdrawal by Subject|1|||
46765013|NCT00796614|82983300|FG001|Overall Study|Withdrawal by Subject|0|||
46765014|NCT00796614|82983301|FG002|Overall Study|Withdrawal by Subject|0|||
46765015|NCT00796614|82983302|FG003|Overall Study|Withdrawal by Subject|1|||
46765016|NCT00796614|82983299|FG000|Overall Study|Other than stated|1|||
46831191|NCT00235755|83049089|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
46831192|NCT00235755|83049087|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
47060941|NCT02668692|83341223|FG000|Overall Study|Adverse Event|1|||
46765017|NCT00796614|82983300|FG001|Overall Study|Other than stated|0|||
46765018|NCT00796614|82983301|FG002|Overall Study|Other than stated|0|||
46765019|NCT00796614|82983302|FG003|Overall Study|Other than stated|0|||
46765020|NCT00448747|82983314|FG000|Overall Study|collapsed veins|1|||
46765021|NCT00448747|82983315|FG001|Overall Study|collapsed veins|0|||
46765022|NCT00830180|82983331|FG000|Overall Study|Adverse Event|6|||
46765023|NCT00830180|82983331|FG000|Overall Study|Death|11|||
46765024|NCT00830180|82983331|FG000|Overall Study|Insufficient clinical response|1|||
46765025|NCT00830180|82983331|FG000|Overall Study|Withdrawal by Subject|5|||
46765026|NCT00830180|82983331|FG000|Overall Study|Progressive disease|2|||
46765027|NCT00830180|82983331|FG000|Overall Study|Other - Unspecified|1|||
46765028|NCT00789321|82983339|FG000|Overall Study|Adverse Event|0|||
46765029|NCT00789321|82983340|FG001|Overall Study|Adverse Event|1|||
46765030|NCT00811928|82983348|FG000|Overall Study|AEs and SAEs Including Death|7|||
47060942|NCT02668692|83341224|FG001|Overall Study|Adverse Event|0|||
47060943|NCT02662764|83341238|FG000|Overall Study|Adverse Event|6|||
47060944|NCT02662764|83341238|FG000|Overall Study|Lack of Efficacy|8|||
47060945|NCT02662764|83341238|FG000|Overall Study|Protocol Violation|1|||
46831193|NCT00235755|83049088|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
46637624|NCT01474512|82811387|FG011|Maintenance Period|Physician Decision|0|||
46637625|NCT01474512|82811388|FG012|Maintenance Period|Physician Decision|0|||
46637626|NCT01474512|82811389|FG013|Maintenance Period|Physician Decision|0|||
46637627|NCT01474512|82811390|FG014|Maintenance Period|Physician Decision|0|||
46765031|NCT00811928|82983349|FG001|Overall Study|AEs and SAEs Including Death|11|||
46765032|NCT00811928|82983348|FG000|Overall Study|Withdrawal by Subject|18|||
46765033|NCT00811928|82983349|FG001|Overall Study|Withdrawal by Subject|12|||
46765034|NCT00811928|82983348|FG000|Overall Study|Did Not Take Study Drug|3|||
46765035|NCT00811928|82983349|FG001|Overall Study|Did Not Take Study Drug|0|||
46765036|NCT00811928|82983348|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
46765037|NCT00811928|82983349|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
46831194|NCT00235755|83049089|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
46831195|NCT00235755|83049087|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
46831196|NCT00235755|83049088|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
46831197|NCT00235755|83049089|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
46831198|NCT00235755|83049087|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
46831199|NCT00235755|83049088|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
46831200|NCT00235755|83049089|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
46831201|NCT00235755|83049087|FG000|12-Week Maintenance Phase|Adverse Event|8|||
46831202|NCT00235755|83049088|FG001|12-Week Maintenance Phase|Adverse Event|12|||
46831203|NCT00235755|83049089|FG002|12-Week Maintenance Phase|Adverse Event|26|||
46831204|NCT00235755|83049087|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
46831205|NCT00235755|83049088|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
46831206|NCT00235755|83049089|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
46831207|NCT00235755|83049087|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
46831208|NCT00235755|83049088|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
46831209|NCT00235755|83049089|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
46831210|NCT00235755|83049087|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
46831211|NCT00235755|83049088|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
46831212|NCT00235755|83049089|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
46831213|NCT00235755|83049087|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
46831214|NCT00235755|83049088|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
46831215|NCT00235755|83049089|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
46831216|NCT00235755|83049087|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
46831217|NCT00235755|83049088|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
46831218|NCT00235755|83049089|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
46831219|NCT00337194|83049114|FG000|Overall Study|Adverse Event|5|||
46831220|NCT00337194|83049115|FG001|Overall Study|Adverse Event|1|||
46831221|NCT00337194|83049114|FG000|Overall Study|Death|2|||
46831222|NCT00337194|83049115|FG001|Overall Study|Death|0|||
46831223|NCT00337194|83049114|FG000|Overall Study|Withdrawal by Subject|1|||
46831224|NCT00337194|83049115|FG001|Overall Study|Withdrawal by Subject|0|||
46831225|NCT00337194|83049114|FG000|Overall Study|Disease progression|1|||
46831226|NCT00337194|83049115|FG001|Overall Study|Disease progression|2|||
46831227|NCT00337194|83049114|FG000|Overall Study|Subsequent non-protocol therapy|3|||
46831228|NCT00337194|83049115|FG001|Overall Study|Subsequent non-protocol therapy|1|||
47060946|NCT02662764|83341238|FG000|Overall Study|Withdrawal by Subject|5|||
47060947|NCT02662764|83341238|FG000|Overall Study|Device failure|4|||
47060948|NCT02662764|83341238|FG000|Overall Study|Patient changed treatment|1|||
47060949|NCT02662764|83341238|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
46831229|NCT03826914|83049125|FG000|Overall Study|Withdrawal by Subject|1|||
46936547|NCT02554786|83172972|FG004|Overall Study|Protocol deviation|2|||
47060950|NCT01519817|83341247|FG000|Overall Study|Withdrawal by Subject|1|||
47060951|NCT01519817|83341248|FG001|Overall Study|Withdrawal by Subject|0|||
47060952|NCT01519817|83341249|FG002|Overall Study|Withdrawal by Subject|0|||
47060953|NCT01519817|83341250|FG003|Overall Study|Withdrawal by Subject|0|||
47060954|NCT01519817|83341247|FG000|Overall Study|Off study due to infection|0|||
46765038|NCT00811928|82983348|FG000|Overall Study|Investigator Decision|2|||
46765039|NCT00811928|82983349|FG001|Overall Study|Investigator Decision|1|||
46936548|NCT02554786|83172968|FG000|Overall Study|Technical problems|1|||
47060955|NCT01519817|83341248|FG001|Overall Study|Off study due to infection|0|||
46637628|NCT01474512|82811391|FG015|Maintenance Period|Physician Decision|0|||
46765040|NCT00811928|82983348|FG000|Overall Study|Poor Compliance|2|||
46765041|NCT00811928|82983349|FG001|Overall Study|Poor Compliance|5|||
46831230|NCT03826914|83049126|FG001|Overall Study|Withdrawal by Subject|1|||
46831231|NCT00385736|83049137|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
46831232|NCT00385736|83049138|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
46831233|NCT00385736|83049139|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
46936549|NCT02554786|83172969|FG001|Overall Study|Technical problems|1|||
47060956|NCT01519817|83341249|FG002|Overall Study|Off study due to infection|0|||
47060957|NCT01519817|83341250|FG003|Overall Study|Off study due to infection|1|||
47060958|NCT01519661|83341260|FG000|Overall Study|Protocol deviation|6|||
46831234|NCT00385736|83049137|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
46831235|NCT00385736|83049138|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
46637629|NCT01474512|82811392|FG016|Maintenance Period|Physician Decision|0|||
46765042|NCT00788775|82983357|FG000|Overall Study|Progressive Disease|8|||
46765043|NCT00788775|82983358|FG001|Overall Study|Progressive Disease|6|||
46765044|NCT00788775|82983357|FG000|Overall Study|Withdrawal by Subject|0|||
46765045|NCT00788775|82983358|FG001|Overall Study|Withdrawal by Subject|2|||
46765046|NCT00788775|82983357|FG000|Overall Study|Patient Non-Compliance|1|||
46765047|NCT00788775|82983358|FG001|Overall Study|Patient Non-Compliance|0|||
46765048|NCT00788775|82983357|FG000|Overall Study|Patient's measurable disease resected.|1|||
46765049|NCT00788775|82983358|FG001|Overall Study|Patient's measurable disease resected.|0|||
46831236|NCT00385736|83049139|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
46831237|NCT00385736|83049137|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
46831238|NCT00385736|83049138|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
46831239|NCT00385736|83049139|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
46831240|NCT00385736|83049137|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
46831241|NCT00385736|83049138|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
46831242|NCT00385736|83049139|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
46831243|NCT00385736|83049137|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
46831244|NCT00385736|83049138|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
46831245|NCT00385736|83049139|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
46831246|NCT00385736|83049137|FG000|Efficacy Analysis Set - Induction|Other|0|||
46831247|NCT00385736|83049138|FG001|Efficacy Analysis Set - Induction|Other|0|||
46831248|NCT00385736|83049139|FG002|Efficacy Analysis Set - Induction|Other|1|||
46831249|NCT00385736|83049137|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
46831250|NCT00385736|83049138|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
46831251|NCT00385736|83049139|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
46831252|NCT00385736|83049137|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
46831253|NCT00385736|83049138|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
46831254|NCT00385736|83049139|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
46831255|NCT00385736|83049137|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
46831256|NCT00385736|83049138|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
46831257|NCT00385736|83049139|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
46831258|NCT00385736|83049137|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
46831259|NCT00385736|83049138|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
46831260|NCT00385736|83049139|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
46831261|NCT00385736|83049137|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
46831262|NCT00385736|83049138|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
46831263|NCT00385736|83049139|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
46831264|NCT00385736|83049137|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
46831265|NCT00385736|83049138|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
46831266|NCT00385736|83049139|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
46831267|NCT00385736|83049137|FG000|Safety Analysis Set|Adverse Event|23|||
46831268|NCT00385736|83049138|FG001|Safety Analysis Set|Adverse Event|15|||
46831269|NCT00385736|83049139|FG002|Safety Analysis Set|Adverse Event|23|||
46831270|NCT00385736|83049137|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
46831271|NCT00385736|83049138|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
46831272|NCT00385736|83049139|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
46831273|NCT00385736|83049137|FG000|Safety Analysis Set|Lost to Follow-up|0|||
46831274|NCT00385736|83049138|FG001|Safety Analysis Set|Lost to Follow-up|2|||
46831275|NCT00385736|83049139|FG002|Safety Analysis Set|Lost to Follow-up|2|||
46831276|NCT00385736|83049137|FG000|Safety Analysis Set|Lack of Efficacy|38|||
46831277|NCT00385736|83049138|FG001|Safety Analysis Set|Lack of Efficacy|16|||
46831278|NCT00385736|83049139|FG002|Safety Analysis Set|Lack of Efficacy|31|||
46831279|NCT00385736|83049137|FG000|Safety Analysis Set|Protocol Violation|2|||
47060959|NCT01519661|83341260|FG000|Overall Study|Lost to Follow-up|3|||
47060960|NCT01519661|83341260|FG000|Overall Study|Withdrawal by Subject|17|||
47060961|NCT01519661|83341260|FG000|Overall Study|Lack of Efficacy|6|||
47060962|NCT01519661|83341260|FG000|Overall Study|Adverse Event|29|||
47060963|NCT01519427|83341265|FG000|Overall Study|disease progression|2|||
47060964|NCT01518257|83341271|FG000|Overall Study|Lost to Follow-up|1|||
47060965|NCT01518257|83341272|FG001|Overall Study|Lost to Follow-up|0|||
47060966|NCT01518257|83341271|FG000|Overall Study|Other Miscellaneous Reason|1|||
46765050|NCT00448669|82983366|FG000|Overall Study|Lost to Follow-up|52|||
46831280|NCT00385736|83049138|FG001|Safety Analysis Set|Protocol Violation|1|||
46765051|NCT00448669|82983367|FG001|Overall Study|Lost to Follow-up|63|||
46765052|NCT00448669|82983366|FG000|Overall Study|Withdrawal by Subject|90|||
46831281|NCT00385736|83049139|FG002|Safety Analysis Set|Protocol Violation|6|||
46831282|NCT00385736|83049137|FG000|Safety Analysis Set|Other|1|||
46831283|NCT00385736|83049138|FG001|Safety Analysis Set|Other|4|||
47060967|NCT01518257|83341272|FG001|Overall Study|Other Miscellaneous Reason|0|||
47060968|NCT02668302|83341280|FG000|Overall Study|Withdrawal by Subject|1|||
46831284|NCT00385736|83049139|FG002|Safety Analysis Set|Other|4|||
46831285|NCT00195819|83049150|FG000|Double-Blind|Withdrawal by Subject|1|||
46831286|NCT00195819|83049151|FG001|Double-Blind|Withdrawal by Subject|0|||
46831287|NCT00195819|83049150|FG000|Double-Blind|Moved|1|||
46831288|NCT00195819|83049151|FG001|Double-Blind|Moved|0|||
46831289|NCT00195819|83049150|FG000|Open-label|Adverse Event|0|||
46831290|NCT00195819|83049151|FG001|Open-label|Adverse Event|9|||
46831291|NCT00195819|83049150|FG000|Open-label|Lack of Efficacy|0|||
46831292|NCT00195819|83049151|FG001|Open-label|Lack of Efficacy|2|||
46831293|NCT00195819|83049150|FG000|Open-label|Pregnancy|0|||
46831294|NCT00195819|83049151|FG001|Open-label|Pregnancy|1|||
46831295|NCT00195819|83049150|FG000|Open-label|Protocol Violation|0|||
46831296|NCT00195819|83049151|FG001|Open-label|Protocol Violation|2|||
46831297|NCT00195819|83049150|FG000|Open-label|Moved|0|||
46831298|NCT00195819|83049151|FG001|Open-label|Moved|1|||
46831299|NCT00195819|83049150|FG000|Open-label|Withdrawal by Subject|0|||
46831300|NCT00195819|83049151|FG001|Open-label|Withdrawal by Subject|5|||
46831301|NCT00527735|83049166|FG000|Overall Study|Disease progression|47|||
46831302|NCT00527735|83049167|FG001|Overall Study|Disease progression|61|||
46831303|NCT00527735|83049168|FG002|Overall Study|Disease progression|53|||
46831304|NCT00527735|83049166|FG000|Overall Study|Death|23|||
46831305|NCT00527735|83049167|FG001|Overall Study|Death|13|||
46831306|NCT00527735|83049168|FG002|Overall Study|Death|15|||
46831307|NCT00527735|83049166|FG000|Overall Study|Completed treatment in treatment phase|14|||
46831308|NCT00527735|83049167|FG001|Overall Study|Completed treatment in treatment phase|13|||
46831309|NCT00527735|83049168|FG002|Overall Study|Completed treatment in treatment phase|18|||
46831310|NCT00527735|83049166|FG000|Overall Study|Adverse Event|10|||
46831311|NCT00527735|83049167|FG001|Overall Study|Adverse Event|6|||
46831312|NCT00527735|83049168|FG002|Overall Study|Adverse Event|7|||
46831313|NCT00527735|83049166|FG000|Overall Study|Not identified|5|||
46831314|NCT00527735|83049167|FG001|Overall Study|Not identified|5|||
46831315|NCT00527735|83049168|FG002|Overall Study|Not identified|5|||
46831316|NCT00527735|83049166|FG000|Overall Study|Withdrawal by Subject|5|||
46831317|NCT00527735|83049167|FG001|Overall Study|Withdrawal by Subject|4|||
46831318|NCT00527735|83049168|FG002|Overall Study|Withdrawal by Subject|3|||
46831319|NCT00527735|83049166|FG000|Overall Study|No longer met study criteria|2|||
46831320|NCT00527735|83049167|FG001|Overall Study|No longer met study criteria|2|||
46831321|NCT00527735|83049168|FG002|Overall Study|No longer met study criteria|1|||
46831322|NCT00527735|83049166|FG000|Overall Study|Lost to Follow-up|0|||
46831323|NCT00527735|83049167|FG001|Overall Study|Lost to Follow-up|0|||
46831324|NCT00527735|83049168|FG002|Overall Study|Lost to Follow-up|3|||
46831325|NCT00527735|83049166|FG000|Overall Study|Poor compliance or noncompliance|0|||
46831326|NCT00527735|83049167|FG001|Overall Study|Poor compliance or noncompliance|1|||
46831327|NCT00527735|83049168|FG002|Overall Study|Poor compliance or noncompliance|1|||
46831328|NCT00527735|83049166|FG000|Overall Study|Completed treatment during maintenance|2|||
46765053|NCT00448669|82983367|FG001|Overall Study|Withdrawal by Subject|74|||
46765054|NCT00448669|82983366|FG000|Overall Study|Relocated|49|||
46765055|NCT00448669|82983367|FG001|Overall Study|Relocated|36|||
46765056|NCT00448669|82983366|FG000|Overall Study|Were withdrawn by investigator|10|||
46765057|NCT00448669|82983367|FG001|Overall Study|Were withdrawn by investigator|6|||
46765058|NCT00448669|82983366|FG000|Overall Study|Death|2|||
46765059|NCT00448669|82983367|FG001|Overall Study|Death|4|||
46765060|NCT00448669|82983366|FG000|Overall Study|Had other reasons|5|||
46765061|NCT00448669|82983367|FG001|Overall Study|Had other reasons|6|||
46765062|NCT00448669|82983366|FG000|Overall Study|HIV-infected at enrollment|1|||
46765063|NCT00448669|82983367|FG001|Overall Study|HIV-infected at enrollment|2|||
46765064|NCT00448669|82983366|FG000|Overall Study|Never started drug|9|||
46765065|NCT00448669|82983367|FG001|Overall Study|Never started drug|7|||
46831329|NCT00527735|83049167|FG001|Overall Study|Completed treatment during maintenance|2|||
46831330|NCT00527735|83049168|FG002|Overall Study|Completed treatment during maintenance|1|||
46831331|NCT00336492|83049191|FG000|Overall Study|Adverse Event|4|||
46831332|NCT00336492|83049192|FG001|Overall Study|Adverse Event|3|||
46831333|NCT00336492|83049193|FG002|Overall Study|Adverse Event|6|||
46831334|NCT00336492|83049191|FG000|Overall Study|Lack of Efficacy|6|||
46831335|NCT00336492|83049192|FG001|Overall Study|Lack of Efficacy|1|||
46831336|NCT00336492|83049193|FG002|Overall Study|Lack of Efficacy|4|||
46936550|NCT02554786|83172970|FG002|Overall Study|Technical problems|0|||
46936551|NCT02554786|83172971|FG003|Overall Study|Technical problems|2|||
46831337|NCT00336492|83049191|FG000|Overall Study|Other|5|||
46831338|NCT00336492|83049192|FG001|Overall Study|Other|0|||
46831339|NCT00336492|83049193|FG002|Overall Study|Other|1|||
46831340|NCT00194025|83049201|FG000|Overall Study|Adverse Event|1|||
46831341|NCT00194025|83049201|FG000|Overall Study|non-adherence with study medication|4|||
46831342|NCT00368108|83049208|FG000|Overall Study|Adverse Event|38|||
46831343|NCT00368108|83049209|FG001|Overall Study|Adverse Event|26|||
46765066|NCT00591734|82983375|FG000|Overall Study|Lack of Efficacy|35|||
46765067|NCT00591734|82983375|FG000|Overall Study|Adverse Event|5|||
46831344|NCT00368108|83049210|FG002|Overall Study|Adverse Event|44|||
46831345|NCT00368108|83049208|FG000|Overall Study|Abnormal Laboratory Value|0|||
46831346|NCT00368108|83049209|FG001|Overall Study|Abnormal Laboratory Value|0|||
46831347|NCT00368108|83049210|FG002|Overall Study|Abnormal Laboratory Value|3|||
46831348|NCT00368108|83049208|FG000|Overall Study|Protocol Violation|5|||
46831349|NCT00368108|83049209|FG001|Overall Study|Protocol Violation|9|||
46831350|NCT00368108|83049210|FG002|Overall Study|Protocol Violation|9|||
46831351|NCT00368108|83049208|FG000|Overall Study|Withdrawal by Subject|9|||
46831352|NCT00368108|83049209|FG001|Overall Study|Withdrawal by Subject|3|||
46831353|NCT00368108|83049210|FG002|Overall Study|Withdrawal by Subject|5|||
46831354|NCT00368108|83049208|FG000|Overall Study|Lack of Efficacy|7|||
46831355|NCT00368108|83049209|FG001|Overall Study|Lack of Efficacy|8|||
46831356|NCT00368108|83049210|FG002|Overall Study|Lack of Efficacy|5|||
46831357|NCT00368108|83049208|FG000|Overall Study|Physician Decision|2|||
46831358|NCT00368108|83049209|FG001|Overall Study|Physician Decision|0|||
46831359|NCT00368108|83049210|FG002|Overall Study|Physician Decision|1|||
46831360|NCT00368108|83049208|FG000|Overall Study|Other|3|||
46936552|NCT02554786|83172972|FG004|Overall Study|Technical problems|1|||
47060969|NCT02668302|83341281|FG001|Overall Study|Withdrawal by Subject|0|||
47060970|NCT01517867|83341289|FG000|Overall Study|never started treatment|29|||
47060971|NCT01517867|83341290|FG001|Overall Study|never started treatment|32|||
47060972|NCT01517867|83341289|FG000|Overall Study|Withdrawal by Subject|34|||
47060973|NCT01517867|83341290|FG001|Overall Study|Withdrawal by Subject|30|||
47060974|NCT01517867|83341289|FG000|Overall Study|Still in treatment at study end|0|||
47060975|NCT01517867|83341290|FG001|Overall Study|Still in treatment at study end|3|||
47060976|NCT01514357|83341298|FG000|Overall Study|Screen failure|2|||
47060977|NCT01514357|83341299|FG001|Overall Study|Screen failure|0|||
47060978|NCT01514357|83341298|FG000|Overall Study|Withdrawal by Subject|2|||
47060979|NCT01514357|83341299|FG001|Overall Study|Withdrawal by Subject|0|||
47060980|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
47060981|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
47060982|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
47060983|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
47060984|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
47060985|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
47060986|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
47060987|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
47060988|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
47060989|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
47060990|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
47060991|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
47060992|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
47060993|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
47060994|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
47060995|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
47060996|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
47060997|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
47060998|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
47060999|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
47061000|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
47061001|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
47061002|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
46637630|NCT01474512|82811393|FG017|Maintenance Period|Physician Decision|0|||
46637631|NCT01474512|82811376|FG000|Maintenance Period|Clinical Relapse|0|||
46637632|NCT01474512|82811377|FG001|Maintenance Period|Clinical Relapse|0|||
46637633|NCT01474512|82811378|FG002|Maintenance Period|Clinical Relapse|0|||
46765068|NCT00591734|82983375|FG000|Overall Study|Physician Decision|5|||
46765069|NCT00591734|82983375|FG000|Overall Study|Intercurrent Illness|8|||
46765070|NCT00788697|82983379|FG000|Overall Study|No study drug administered|12|||
46765071|NCT00788697|82983379|FG000|Overall Study|Training Patients|74|||
46765072|NCT00788697|82983379|FG000|Overall Study|no truth standard procedure available|5|||
46765073|NCT00788697|82983379|FG000|Overall Study|Technically inadequate truth standard|1|||
46765074|NCT00788697|82983379|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
46765075|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
46765076|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
46765077|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
46765078|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
46765079|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
46765080|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
46765081|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
46831361|NCT00368108|83049209|FG001|Overall Study|Other|7|||
47061003|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
47061004|NCT01532869|83341307|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
46637634|NCT01474512|82811379|FG003|Maintenance Period|Clinical Relapse|1|||
46831362|NCT00368108|83049210|FG002|Overall Study|Other|1|||
46831363|NCT00364130|83049220|FG000|Intervention Period|Lost to Follow-up|4|||
46936553|NCT02554786|83172968|FG000|Overall Study|Adverse Event|0|||
46936554|NCT02554786|83172969|FG001|Overall Study|Adverse Event|0|||
46936555|NCT02554786|83172970|FG002|Overall Study|Adverse Event|0|||
46936556|NCT02554786|83172971|FG003|Overall Study|Adverse Event|0|||
46936557|NCT02554786|83172972|FG004|Overall Study|Adverse Event|2|||
46936558|NCT02554786|83172968|FG000|Overall Study|Death|0|||
46936559|NCT02554786|83172969|FG001|Overall Study|Death|0|||
47061005|NCT01532869|83341308|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
47061006|NCT01532869|83341307|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
46637635|NCT01474512|82811380|FG004|Maintenance Period|Clinical Relapse|0|||
46637636|NCT01474512|82811381|FG005|Maintenance Period|Clinical Relapse|0|||
46637637|NCT01474512|82811382|FG006|Maintenance Period|Clinical Relapse|0|||
46637638|NCT01474512|82811383|FG007|Maintenance Period|Clinical Relapse|0|||
46637639|NCT01474512|82811384|FG008|Maintenance Period|Clinical Relapse|0|||
46637640|NCT01474512|82811385|FG009|Maintenance Period|Clinical Relapse|0|||
46637641|NCT01474512|82811386|FG010|Maintenance Period|Clinical Relapse|0|||
46637642|NCT01474512|82811387|FG011|Maintenance Period|Clinical Relapse|0|||
46637643|NCT01474512|82811388|FG012|Maintenance Period|Clinical Relapse|0|||
46637644|NCT01474512|82811389|FG013|Maintenance Period|Clinical Relapse|0|||
46637645|NCT01474512|82811390|FG014|Maintenance Period|Clinical Relapse|0|||
46765082|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
46765083|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
46765084|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
46765085|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
46765086|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
46765087|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
46765088|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
46831364|NCT00364130|83049221|FG001|Intervention Period|Lost to Follow-up|3|||
46831365|NCT00364130|83049220|FG000|Intervention Period|Pregnancy|1|||
46765089|NCT00848549|82983393|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
46765090|NCT00848549|82983394|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
46765091|NCT00848549|82983393|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
46765092|NCT00848549|82983394|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
46765093|NCT00848549|82983393|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
46765094|NCT00848549|82983394|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
46765095|NCT00848549|82983393|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
46831366|NCT00364130|83049221|FG001|Intervention Period|Pregnancy|0|||
46831367|NCT00364130|83049220|FG000|Intervention Period|Withdrawal by Subject|4|||
46831368|NCT00364130|83049221|FG001|Intervention Period|Withdrawal by Subject|5|||
46831369|NCT00364130|83049220|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
46831370|NCT00364130|83049221|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
46831371|NCT00521339|83049229|FG000|Treatment Phase|Adverse Event|2|||
46831372|NCT00521339|83049230|FG001|Treatment Phase|Adverse Event|0|||
46831373|NCT00521339|83049231|FG002|Treatment Phase|Adverse Event|0|||
46831374|NCT00521339|83049229|FG000|Treatment Phase|Intolerability to study drug|2|||
46831375|NCT00521339|83049230|FG001|Treatment Phase|Intolerability to study drug|0|||
46831376|NCT00521339|83049231|FG002|Treatment Phase|Intolerability to study drug|0|||
46831377|NCT00521339|83049229|FG000|Treatment Phase|Lack of Efficacy|3|||
46831378|NCT00521339|83049230|FG001|Treatment Phase|Lack of Efficacy|0|||
46831379|NCT00521339|83049231|FG002|Treatment Phase|Lack of Efficacy|0|||
46831380|NCT00521339|83049229|FG000|Treatment Phase|Withdrawal by Subject|3|||
46831381|NCT00521339|83049230|FG001|Treatment Phase|Withdrawal by Subject|0|||
46831382|NCT00521339|83049231|FG002|Treatment Phase|Withdrawal by Subject|0|||
46831383|NCT00521339|83049229|FG000|Treatment Phase|Lost to Follow-up|1|||
46831384|NCT00521339|83049230|FG001|Treatment Phase|Lost to Follow-up|0|||
46831385|NCT00521339|83049231|FG002|Treatment Phase|Lost to Follow-up|0|||
46831386|NCT00521339|83049229|FG000|Treatment Phase|Protocol Violation|1|||
46831387|NCT00521339|83049230|FG001|Treatment Phase|Protocol Violation|0|||
46831388|NCT00521339|83049231|FG002|Treatment Phase|Protocol Violation|0|||
46831389|NCT00521339|83049229|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
46831390|NCT00521339|83049230|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
47061007|NCT01532869|83341308|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
46637646|NCT01474512|82811391|FG015|Maintenance Period|Clinical Relapse|0|||
46637647|NCT01474512|82811392|FG016|Maintenance Period|Clinical Relapse|0|||
46637648|NCT01474512|82811393|FG017|Maintenance Period|Clinical Relapse|0|||
46831391|NCT00521339|83049231|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
46936560|NCT02554786|83172970|FG002|Overall Study|Death|0|||
46936561|NCT02554786|83172971|FG003|Overall Study|Death|1|||
47061008|NCT01532869|83341307|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
46637649|NCT01474512|82811376|FG000|Maintenance Period|Lack of Efficacy|0|||
46831392|NCT00521339|83049229|FG000|Treatment Extension Phase|Death|0|||
46831393|NCT00521339|83049230|FG001|Treatment Extension Phase|Death|0|||
46831394|NCT00521339|83049231|FG002|Treatment Extension Phase|Death|1|||
46831395|NCT00363896|83049254|FG000|Overall Study|Withdrawal by Subject|29|||
46831396|NCT00363896|83049255|FG001|Overall Study|Withdrawal by Subject|16|||
46831397|NCT00363896|83049254|FG000|Overall Study|Adverse Event|24|||
46831398|NCT00363896|83049255|FG001|Overall Study|Adverse Event|13|||
46831399|NCT00363896|83049254|FG000|Overall Study|COPD exacerbation|13|||
46831400|NCT00363896|83049255|FG001|Overall Study|COPD exacerbation|7|||
46831401|NCT00363896|83049254|FG000|Overall Study|Lack of Efficacy|12|||
46831402|NCT00363896|83049255|FG001|Overall Study|Lack of Efficacy|8|||
46831403|NCT00363896|83049254|FG000|Overall Study|Protocol Violation|6|||
46831404|NCT00363896|83049255|FG001|Overall Study|Protocol Violation|1|||
46936562|NCT02554786|83172972|FG004|Overall Study|Death|0|||
46936563|NCT02554786|83172968|FG000|Overall Study|Non-compliance with study treatment|0|||
46936564|NCT02554786|83172969|FG001|Overall Study|Non-compliance with study treatment|1|||
46936565|NCT02554786|83172970|FG002|Overall Study|Non-compliance with study treatment|1|||
46936566|NCT02554786|83172971|FG003|Overall Study|Non-compliance with study treatment|0|||
46936567|NCT02554786|83172972|FG004|Overall Study|Non-compliance with study treatment|1|||
46936568|NCT02554786|83172968|FG000|Overall Study|Physician Decision|0|||
46936569|NCT02554786|83172969|FG001|Overall Study|Physician Decision|1|||
46936570|NCT02554786|83172970|FG002|Overall Study|Physician Decision|4|||
46936571|NCT02554786|83172971|FG003|Overall Study|Physician Decision|1|||
46936572|NCT02554786|83172972|FG004|Overall Study|Physician Decision|1|||
46936573|NCT02554786|83172968|FG000|Overall Study|Pregnancy|0|||
46936574|NCT02554786|83172969|FG001|Overall Study|Pregnancy|0|||
46936575|NCT02554786|83172970|FG002|Overall Study|Pregnancy|0|||
46936576|NCT02554786|83172971|FG003|Overall Study|Pregnancy|1|||
46936577|NCT02554786|83172972|FG004|Overall Study|Pregnancy|1|||
46936578|NCT01347645|83172993|FG000|Overall Study|Death|1|||
46936579|NCT01347645|83172994|FG001|Overall Study|Death|5|||
46936580|NCT01347645|83172995|FG002|Overall Study|Death|2|||
46936581|NCT01347645|83172996|FG003|Overall Study|Death|7|||
46936582|NCT01347645|83172997|FG004|Overall Study|Death|7|||
46936583|NCT01347645|83172993|FG000|Overall Study|Lost to Follow-up|1|||
46936584|NCT01347645|83172994|FG001|Overall Study|Lost to Follow-up|1|||
46936585|NCT01347645|83172995|FG002|Overall Study|Lost to Follow-up|0|||
46936586|NCT01347645|83172996|FG003|Overall Study|Lost to Follow-up|1|||
46936587|NCT01347645|83172997|FG004|Overall Study|Lost to Follow-up|1|||
46936588|NCT01347645|83172993|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
46936589|NCT01347645|83172994|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
46936590|NCT01347645|83172995|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
46936591|NCT01347645|83172996|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
46936592|NCT01347645|83172997|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
46936593|NCT01347645|83172993|FG000|Overall Study|Other|1|||
46936594|NCT01347645|83172994|FG001|Overall Study|Other|0|||
46936595|NCT01347645|83172995|FG002|Overall Study|Other|0|||
46936596|NCT01347645|83172996|FG003|Overall Study|Other|0|||
46936597|NCT01347645|83172997|FG004|Overall Study|Other|1|||
46765096|NCT00848549|82983394|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
46765097|NCT00848549|82983393|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
46765098|NCT00848549|82983394|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
46765099|NCT00848549|82983393|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
46765100|NCT00848549|82983394|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
46765101|NCT00848549|82983393|FG000|E2090-E044-314 (Extension Study)|Other|5|||
46765102|NCT00848549|82983394|FG001|E2090-E044-314 (Extension Study)|Other|6|||
46765103|NCT00788151|82983404|FG000|Overall Study|Other adverse event|0|||
46765104|NCT00788151|82983405|FG001|Overall Study|Other adverse event|2|||
46765105|NCT00788151|82983404|FG000|Overall Study|Protocol Violation|0|||
46765106|NCT00788151|82983405|FG001|Overall Study|Protocol Violation|1|||
46765107|NCT00788151|82983404|FG000|Overall Study|Withdrawal by Subject|13|||
46765108|NCT00788151|82983405|FG001|Overall Study|Withdrawal by Subject|6|||
46765109|NCT00788151|82983404|FG000|Overall Study|Enrolled but not treated|1|||
46765110|NCT00788151|82983405|FG001|Overall Study|Enrolled but not treated|1|||
46765111|NCT00788073|82983413|FG000|STX209 Then Placebo|Adverse Event|1|||
46765112|NCT00788073|82983414|FG001|STX209 Then Placebo|Adverse Event|0|||
46765113|NCT00788073|82983413|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
46765114|NCT00788073|82983414|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
46936598|NCT01347645|83172993|FG000|Overall Study|Withdrawal by Subject|0|||
46936599|NCT01347645|83172994|FG001|Overall Study|Withdrawal by Subject|0|||
47061009|NCT01532869|83341308|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
46936600|NCT01347645|83172995|FG002|Overall Study|Withdrawal by Subject|0|||
46936601|NCT01347645|83172996|FG003|Overall Study|Withdrawal by Subject|3|||
46831405|NCT00363896|83049254|FG000|Overall Study|Lost to Follow-up|3|||
46831406|NCT00363896|83049255|FG001|Overall Study|Lost to Follow-up|0|||
46831407|NCT00363896|83049254|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
46831408|NCT00363896|83049255|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
46831409|NCT00363896|83049254|FG000|Overall Study|Other|1|||
46831410|NCT00363896|83049255|FG001|Overall Study|Other|2|||
46831411|NCT00527423|83049264|FG000|Overall Study|Protocol Violation|1|||
46831412|NCT00527423|83049264|FG000|Overall Study|Adverse Event|5|||
46831413|NCT00527423|83049264|FG000|Overall Study|Physician Decision|4|||
46831414|NCT00527423|83049264|FG000|Overall Study|Withdrawal by Subject|10|||
46831415|NCT00527423|83049264|FG000|Overall Study|Lost to Follow-up|4|||
46831416|NCT00527423|83049264|FG000|Overall Study|OTHER|4|||
46831417|NCT00527423|83049264|FG000|Overall Study|Death|9|||
46831418|NCT00527111|83049272|FG000|Overall Study|Adverse Event|14|||
46831419|NCT00527111|83049273|FG001|Overall Study|Adverse Event|13|||
46831420|NCT00527111|83049272|FG000|Overall Study|Death|0|||
46831421|NCT00527111|83049273|FG001|Overall Study|Death|1|||
46831422|NCT00527111|83049272|FG000|Overall Study|Investigator Request|2|||
46831423|NCT00527111|83049273|FG001|Overall Study|Investigator Request|1|||
46831424|NCT00527111|83049272|FG000|Overall Study|Patient Request|2|||
46831425|NCT00527111|83049273|FG001|Overall Study|Patient Request|5|||
46936602|NCT01347645|83172997|FG004|Overall Study|Withdrawal by Subject|3|||
46936603|NCT01347645|83172993|FG000|Overall Study|Physician Decision|0|||
46936604|NCT01347645|83172994|FG001|Overall Study|Physician Decision|0|||
46936605|NCT01347645|83172995|FG002|Overall Study|Physician Decision|0|||
46936606|NCT01347645|83172996|FG003|Overall Study|Physician Decision|0|||
46936607|NCT01347645|83172997|FG004|Overall Study|Physician Decision|1|||
46936608|NCT01347645|83172993|FG000|Overall Study|Adverse Event|0|||
46936609|NCT01347645|83172994|FG001|Overall Study|Adverse Event|0|||
46936610|NCT01347645|83172995|FG002|Overall Study|Adverse Event|0|||
46936611|NCT01347645|83172996|FG003|Overall Study|Adverse Event|1|||
46936612|NCT01347645|83172997|FG004|Overall Study|Adverse Event|1|||
46936613|NCT00484419|83173035|FG000|Overall Study|Adverse Event|3|||
46936614|NCT00484419|83173036|FG001|Overall Study|Adverse Event|0|||
46936615|NCT00484419|83173037|FG002|Overall Study|Adverse Event|0|||
46936616|NCT00484419|83173035|FG000|Overall Study|Lost to Follow-up|1|||
46936617|NCT00484419|83173036|FG001|Overall Study|Lost to Follow-up|0|||
46936618|NCT00484419|83173037|FG002|Overall Study|Lost to Follow-up|2|||
46936619|NCT00484419|83173035|FG000|Overall Study|Withdrawal by Subject|3|||
46936620|NCT00484419|83173036|FG001|Overall Study|Withdrawal by Subject|1|||
47061010|NCT01532869|83341307|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
47061011|NCT01532869|83341308|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
47061012|NCT01532869|83341307|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
46765115|NCT00788073|82983413|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
46831426|NCT00527111|83049272|FG000|Overall Study|Other|2|||
46831427|NCT00527111|83049273|FG001|Overall Study|Other|2|||
46831428|NCT00384956|83049279|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
46831429|NCT00367640|83049287|FG000|Overall Study|Adverse Event|3|||
46831430|NCT00367640|83049288|FG001|Overall Study|Adverse Event|6|||
46765116|NCT00788073|82983414|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
46765117|NCT00788073|82983413|FG000|STX209 Then Placebo|unable to return due to travel|0|||
46765118|NCT00788073|82983414|FG001|STX209 Then Placebo|unable to return due to travel|1|||
46765119|NCT00788073|82983413|FG000|Placebo Then STX209|Adverse Event|2|||
46765120|NCT00788073|82983414|FG001|Placebo Then STX209|Adverse Event|0|||
46765121|NCT00788073|82983413|FG000|Placebo Then STX209|Protocol Violation|0|||
46765122|NCT00788073|82983414|FG001|Placebo Then STX209|Protocol Violation|1|||
46765123|NCT00848393|82983423|FG000|Overall Study|Protocol Violation|0|||
46765124|NCT00848393|82983424|FG001|Overall Study|Protocol Violation|0|||
46765125|NCT00848393|82983425|FG002|Overall Study|Protocol Violation|1|||
46765126|NCT00848393|82983423|FG000|Overall Study|surgical complications unrelated to stud|0|||
46765127|NCT00848393|82983424|FG001|Overall Study|surgical complications unrelated to stud|0|||
46765128|NCT00848393|82983425|FG002|Overall Study|surgical complications unrelated to stud|2|||
46831431|NCT00367640|83049289|FG002|Overall Study|Adverse Event|8|||
46831432|NCT00367640|83049290|FG003|Overall Study|Adverse Event|0|||
46831433|NCT00367640|83049287|FG000|Overall Study|Withdrawal by Subject|8|||
46831434|NCT00367640|83049288|FG001|Overall Study|Withdrawal by Subject|11|||
46765129|NCT00815516|82983439|FG000|Overall Study|Death|3|||
46936621|NCT00484419|83173037|FG002|Overall Study|Withdrawal by Subject|1|||
46765130|NCT00815516|82983440|FG001|Overall Study|Death|1|||
46936622|NCT00484419|83173035|FG000|Overall Study|subject met discontinuation criteria|2|||
46936623|NCT00484419|83173036|FG001|Overall Study|subject met discontinuation criteria|2|||
46936624|NCT00484419|83173037|FG002|Overall Study|subject met discontinuation criteria|4|||
46936625|NCT00484419|83173035|FG000|Overall Study|required restricted medication|1|||
46831435|NCT00367640|83049289|FG002|Overall Study|Withdrawal by Subject|8|||
46831436|NCT00367640|83049290|FG003|Overall Study|Withdrawal by Subject|6|||
46831437|NCT00367640|83049287|FG000|Overall Study|Any other reason not above-mentioned|7|||
46936626|NCT00484419|83173036|FG001|Overall Study|required restricted medication|0|||
46831438|NCT00367640|83049288|FG001|Overall Study|Any other reason not above-mentioned|5|||
46831439|NCT00367640|83049289|FG002|Overall Study|Any other reason not above-mentioned|3|||
46831440|NCT00367640|83049290|FG003|Overall Study|Any other reason not above-mentioned|4|||
46831441|NCT00367484|83049300|FG000|Overall Study|Adverse Event|7|||
46831442|NCT00367484|83049300|FG000|Overall Study|Withdrew informed consent|5|||
46831443|NCT00367484|83049300|FG000|Overall Study|Travel to USA|1|||
46936627|NCT00484419|83173037|FG002|Overall Study|required restricted medication|1|||
46936628|NCT00484419|83173035|FG000|Overall Study|Physician Decision|1|||
46936629|NCT00484419|83173036|FG001|Overall Study|Physician Decision|1|||
46936630|NCT00484419|83173037|FG002|Overall Study|Physician Decision|1|||
46936631|NCT00484419|83173035|FG000|Overall Study|subject unable to receive medication|1|||
46936632|NCT00484419|83173036|FG001|Overall Study|subject unable to receive medication|0|||
46936633|NCT00484419|83173037|FG002|Overall Study|subject unable to receive medication|0|||
46765131|NCT00815516|82983439|FG000|Overall Study|Physician Decision|1|||
46765132|NCT00815516|82983440|FG001|Overall Study|Physician Decision|0|||
46765133|NCT00787917|82983448|FG000|Blinded Treatment|Adverse Event|1|||
46765134|NCT00787917|82983449|FG001|Blinded Treatment|Adverse Event|0|||
46765135|NCT00787917|82983448|FG000|Blinded Treatment|Lack of Efficacy|1|||
46765136|NCT00787917|82983449|FG001|Blinded Treatment|Lack of Efficacy|0|||
46765137|NCT00787917|82983448|FG000|Blinded Treatment|Administrative problems|3|||
46831444|NCT00367484|83049300|FG000|Overall Study|Lost to Follow-up|1|||
46831445|NCT00367484|83049300|FG000|Overall Study|Protocol Violation|1|||
46831446|NCT00367484|83049300|FG000|Overall Study|The choice of the patient|1|||
46831447|NCT00367484|83049300|FG000|Overall Study|Lack of Efficacy|1|||
46831448|NCT00526799|83049306|FG000|Overall Study|Withdrawal by Subject|1|||
46831449|NCT00526799|83049307|FG001|Overall Study|Withdrawal by Subject|0|||
46831450|NCT00526799|83049306|FG000|Overall Study|Intercurrent Complicating Disease|0|||
46831451|NCT00526799|83049307|FG001|Overall Study|Intercurrent Complicating Disease|1|||
46831452|NCT00526331|83049313|FG000|Overall Study|Sponsor Termination|55|||
46831453|NCT00520481|83049319|FG000|Overall Study|Adverse Event|4|||
46831454|NCT00520481|83049320|FG001|Overall Study|Adverse Event|1|||
46831455|NCT00520481|83049319|FG000|Overall Study|Withdrawal by Subject|3|||
46831456|NCT00520481|83049320|FG001|Overall Study|Withdrawal by Subject|0|||
46831457|NCT00520403|83049328|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
46831458|NCT00520403|83049328|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
46831459|NCT00520403|83049328|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
46831460|NCT00520403|83049328|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
46831461|NCT00520403|83049328|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
46831462|NCT00520403|83049328|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
46831463|NCT00520403|83049328|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
46831464|NCT00520403|83049328|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
46831465|NCT00520013|83049335|FG000|Overall Study|Withdrawal by Subject|0|||
46831466|NCT00520013|83049336|FG001|Overall Study|Withdrawal by Subject|0|||
46831467|NCT00520013|83049337|FG002|Overall Study|Withdrawal by Subject|1|||
46831468|NCT00520013|83049335|FG000|Overall Study|Adverse Event|2|||
46831469|NCT00520013|83049336|FG001|Overall Study|Adverse Event|10|||
46831470|NCT00520013|83049337|FG002|Overall Study|Adverse Event|7|||
46831471|NCT00520013|83049335|FG000|Overall Study|Progressive Disease|7|||
46831472|NCT00520013|83049336|FG001|Overall Study|Progressive Disease|3|||
46831473|NCT00520013|83049337|FG002|Overall Study|Progressive Disease|0|||
46831474|NCT00520013|83049335|FG000|Overall Study|Clinical Progression|3|||
46831475|NCT00520013|83049336|FG001|Overall Study|Clinical Progression|1|||
46831476|NCT00520013|83049337|FG002|Overall Study|Clinical Progression|0|||
46831477|NCT00520013|83049335|FG000|Overall Study|Death|0|||
46831478|NCT00520013|83049336|FG001|Overall Study|Death|1|||
46831479|NCT00520013|83049337|FG002|Overall Study|Death|0|||
46831480|NCT00520013|83049335|FG000|Overall Study|Physician Decision|0|||
46831481|NCT00520013|83049336|FG001|Overall Study|Physician Decision|0|||
46831482|NCT00520013|83049337|FG002|Overall Study|Physician Decision|3|||
46936634|NCT00484419|83173035|FG000|Overall Study|subject relocated|0|||
46936635|NCT00484419|83173036|FG001|Overall Study|subject relocated|1|||
47061013|NCT01532869|83341308|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
47061014|NCT01531387|83341321|FG000|Overall Study|Early termination of study|11|||
47061015|NCT01531387|83341322|FG001|Overall Study|Early termination of study|11|||
47061016|NCT01531153|83341331|FG000|Overall Study|Withdrawal by Subject|10|||
47061017|NCT01531153|83341332|FG001|Overall Study|Withdrawal by Subject|9|||
46765138|NCT00787917|82983449|FG001|Blinded Treatment|Administrative problems|2|||
46765139|NCT00787917|82983448|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
46765140|NCT00787917|82983449|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
46765141|NCT00787917|82983448|FG000|Open Label|Administrative problems|3|||
46831483|NCT00519779|83049345|FG000|Overall Study|Withdrawal by Subject|0|||
46831484|NCT00519779|83049346|FG001|Overall Study|Withdrawal by Subject|1|||
46936636|NCT00484419|83173037|FG002|Overall Study|subject relocated|0|||
46936637|NCT00484419|83173035|FG000|Overall Study|sponsor decision, randomized in error|0|||
47061018|NCT01531153|83341333|FG002|Overall Study|Withdrawal by Subject|15|||
46831485|NCT00526097|83049354|FG000|Overall Study|Adverse Event|6|||
46765142|NCT00787917|82983449|FG001|Open Label|Administrative problems|0|||
46765143|NCT00814892|82983457|FG000|Overall Study|Disease Progression|1|||
46831486|NCT00526097|83049355|FG001|Overall Study|Adverse Event|44|||
46831487|NCT00526097|83049354|FG000|Overall Study|Protocol Violation|4|||
46831488|NCT00526097|83049355|FG001|Overall Study|Protocol Violation|10|||
46831489|NCT00526097|83049354|FG000|Overall Study|Withdrawal by Subject|3|||
47061019|NCT01529749|83341348|FG000|Overall Study|Lost to Follow-up|0|||
47061020|NCT01529749|83341349|FG001|Overall Study|Lost to Follow-up|1|||
47061021|NCT01529749|83341350|FG002|Overall Study|Lost to Follow-up|1|||
47061022|NCT01529749|83341351|FG003|Overall Study|Lost to Follow-up|0|||
47061023|NCT01529749|83341348|FG000|Overall Study|Physician Decision|0|||
47061024|NCT01529749|83341349|FG001|Overall Study|Physician Decision|0|||
47061025|NCT01529749|83341350|FG002|Overall Study|Physician Decision|0|||
47061026|NCT01529749|83341351|FG003|Overall Study|Physician Decision|1|||
47061027|NCT01529749|83341348|FG000|Overall Study|Withdrawal by Subject|0|||
47061028|NCT01529749|83341349|FG001|Overall Study|Withdrawal by Subject|1|||
47061029|NCT01529749|83341350|FG002|Overall Study|Withdrawal by Subject|1|||
47061030|NCT01529749|83341351|FG003|Overall Study|Withdrawal by Subject|0|||
47061031|NCT01529749|83341348|FG000|Overall Study|Protocol Violation|0|||
47061032|NCT01529749|83341349|FG001|Overall Study|Protocol Violation|0|||
47061033|NCT01529749|83341350|FG002|Overall Study|Protocol Violation|0|||
47061034|NCT01529749|83341351|FG003|Overall Study|Protocol Violation|1|||
47061035|NCT01529515|83341363|FG000|TRANSITION PHASE|Adverse Event|16|||
47061036|NCT01529515|83341364|FG001|TRANSITION PHASE|Adverse Event|0|||
47061037|NCT01529515|83341365|FG002|TRANSITION PHASE|Adverse Event|0|||
47061038|NCT01529515|83341366|FG003|TRANSITION PHASE|Adverse Event|0|||
47061039|NCT01529515|83341363|FG000|TRANSITION PHASE|Death|1|||
47061040|NCT01529515|83341364|FG001|TRANSITION PHASE|Death|0|||
47061041|NCT01529515|83341365|FG002|TRANSITION PHASE|Death|0|||
47061042|NCT01529515|83341366|FG003|TRANSITION PHASE|Death|0|||
47061043|NCT01529515|83341363|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
47061044|NCT01529515|83341364|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
47061045|NCT01529515|83341365|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
46765144|NCT00814892|82983457|FG000|Overall Study|Study Termination|1|||
46765145|NCT00787839|82983461|FG000|Overall Study|Failure to have the OGTT was most common|404|||
46765146|NCT00829244|82983484|FG000|Overall Study|Adverse Event|1|||
46765147|NCT00829244|82983485|FG001|Overall Study|Adverse Event|3|||
46765148|NCT00829244|82983484|FG000|Overall Study|Protocol Violation|1|||
46765149|NCT00829244|82983485|FG001|Overall Study|Protocol Violation|0|||
46765150|NCT00829244|82983484|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
46765151|NCT00829244|82983485|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
46765152|NCT00829244|82983484|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
46765153|NCT00829244|82983485|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
46765154|NCT00829244|82983484|FG000|Overall Study|No fertilization|2|||
46765155|NCT00829244|82983485|FG001|Overall Study|No fertilization|2|||
46765156|NCT00829244|82983484|FG000|Overall Study|All embryos discarded|0|||
46765157|NCT00829244|82983485|FG001|Overall Study|All embryos discarded|3|||
46765158|NCT00829244|82983484|FG000|Overall Study|No embryo cleavage|0|||
46765159|NCT00829244|82983485|FG001|Overall Study|No embryo cleavage|2|||
46765160|NCT00787605|82983493|FG000|Overall Study|Administrative Problems|3|||
46765161|NCT00787605|82983494|FG001|Overall Study|Administrative Problems|0|||
46765162|NCT00787605|82983493|FG000|Overall Study|Adverse Event|14|||
46765163|NCT00787605|82983494|FG001|Overall Study|Adverse Event|25|||
46765164|NCT00787605|82983493|FG000|Overall Study|Lost to Follow-up|3|||
46765165|NCT00787605|82983494|FG001|Overall Study|Lost to Follow-up|6|||
46765166|NCT00787605|82983493|FG000|Overall Study|Protocol Violation|7|||
46765167|NCT00787605|82983494|FG001|Overall Study|Protocol Violation|3|||
46765168|NCT00787605|82983493|FG000|Overall Study|Withdrawal by Subject|6|||
46765169|NCT00787605|82983494|FG001|Overall Study|Withdrawal by Subject|13|||
46765170|NCT00787605|82983493|FG000|Overall Study|Lack of Efficacy|13|||
46765171|NCT00787605|82983494|FG001|Overall Study|Lack of Efficacy|9|||
46831490|NCT00526097|83049355|FG001|Overall Study|Withdrawal by Subject|1|||
46936638|NCT00484419|83173036|FG001|Overall Study|sponsor decision, randomized in error|0|||
47061046|NCT01529515|83341366|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
47061047|NCT01529515|83341363|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
47061048|NCT01529515|83341364|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
47061049|NCT01529515|83341365|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
47061050|NCT01529515|83341366|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
47061051|NCT01529515|83341363|FG000|TRANSITION PHASE|Protocol Violation|4|||
47061052|NCT01529515|83341364|FG001|TRANSITION PHASE|Protocol Violation|0|||
47061053|NCT01529515|83341365|FG002|TRANSITION PHASE|Protocol Violation|0|||
46936639|NCT00484419|83173037|FG002|Overall Study|sponsor decision, randomized in error|2|||
46936640|NCT03220724|83173046|FG000|Overall Study|Lost to Follow-up|2|||
46936641|NCT03220724|83173047|FG001|Overall Study|Lost to Follow-up|1|||
46936642|NCT03220724|83173048|FG002|Overall Study|Lost to Follow-up|0|||
47061054|NCT01529515|83341366|FG003|TRANSITION PHASE|Protocol Violation|0|||
47061055|NCT01529515|83341363|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
46831491|NCT00526097|83049354|FG000|Overall Study|Other|2|||
46831492|NCT00526097|83049355|FG001|Overall Study|Other|1|||
46831493|NCT00525785|83049361|FG000|Overall Study|Withdrawal by Subject|1|||
46831494|NCT00525785|83049361|FG000|Overall Study|Lack of Efficacy|1|||
46831495|NCT00525785|83049361|FG000|Overall Study|Physician Decision|1|||
46831496|NCT00525161|83049365|FG000|Overall Study|Adverse Event|1|||
46831497|NCT00524771|83049371|FG000|Overall Study|Protocol Violation|220|||
46831498|NCT00524771|83049372|FG001|Overall Study|Protocol Violation|585|||
46831499|NCT00135694|83049382|FG000|Overall Study|Adverse Event|17|||
46831500|NCT00135694|83049383|FG001|Overall Study|Adverse Event|4|||
46831501|NCT00135694|83049384|FG002|Overall Study|Adverse Event|0|||
46831502|NCT00135694|83049382|FG000|Overall Study|Death|14|||
46831503|NCT00135694|83049383|FG001|Overall Study|Death|1|||
46831504|NCT00135694|83049384|FG002|Overall Study|Death|2|||
46831505|NCT00135694|83049382|FG000|Overall Study|Lost to Follow-up|8|||
46831506|NCT00135694|83049383|FG001|Overall Study|Lost to Follow-up|7|||
46831507|NCT00135694|83049384|FG002|Overall Study|Lost to Follow-up|1|||
46831508|NCT00135694|83049382|FG000|Overall Study|Withdrawal by Subject|41|||
46831509|NCT00135694|83049383|FG001|Overall Study|Withdrawal by Subject|7|||
46831510|NCT00135694|83049384|FG002|Overall Study|Withdrawal by Subject|4|||
46831511|NCT00135694|83049382|FG000|Overall Study|Protocol Violation|19|||
46831512|NCT00135694|83049383|FG001|Overall Study|Protocol Violation|1|||
46831513|NCT00135694|83049384|FG002|Overall Study|Protocol Violation|0|||
46831514|NCT00135694|83049382|FG000|Overall Study|Hepatitis C related reasons|39|||
46831515|NCT00135694|83049383|FG001|Overall Study|Hepatitis C related reasons|1|||
46831516|NCT00135694|83049384|FG002|Overall Study|Hepatitis C related reasons|0|||
46831517|NCT00135694|83049382|FG000|Overall Study|Ineligible for Random assignment|42|||
46831518|NCT00135694|83049383|FG001|Overall Study|Ineligible for Random assignment|0|||
46831519|NCT00135694|83049384|FG002|Overall Study|Ineligible for Random assignment|0|||
46831520|NCT00524459|83049392|FG000|Overall Study|Withdrawal by Subject|1|||
46831521|NCT00524459|83049392|FG000|Overall Study|Other|1|||
46831522|NCT00519623|83049396|FG000|Overall Study|Adverse Event|1|||
46831523|NCT00519077|83049400|FG000|Overall Study|Death|6|||
46831524|NCT00519077|83049400|FG000|Overall Study|Other|2|||
46831525|NCT00124618|83049404|FG000|Overall Study|Ineligible|1|||
46831526|NCT00124462|83049410|FG000|Overall Study|Lost to Follow-up|3|||
46831527|NCT00124462|83049411|FG001|Overall Study|Lost to Follow-up|3|||
46831528|NCT00124462|83049410|FG000|Overall Study|Physician Decision|3|||
46831529|NCT00124462|83049411|FG001|Overall Study|Physician Decision|4|||
46831530|NCT00124462|83049410|FG000|Overall Study|Withdrawal by Subject|4|||
46831531|NCT00124462|83049411|FG001|Overall Study|Withdrawal by Subject|5|||
46831532|NCT00124462|83049410|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
46831533|NCT00124462|83049411|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
46831534|NCT00124072|83049421|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
46831535|NCT00124072|83049422|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
46831536|NCT00124072|83049423|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
46831537|NCT00124072|83049424|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
46831538|NCT00124072|83049421|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
46637650|NCT01474512|82811377|FG001|Maintenance Period|Lack of Efficacy|0|||
46637651|NCT01474512|82811378|FG002|Maintenance Period|Lack of Efficacy|0|||
46765172|NCT00448591|82983500|FG000|Overall Study|Withdrawal by Subject|178|||
46765173|NCT00448591|82983500|FG000|Overall Study|Progressive Disease|1382|||
46765174|NCT00448591|82983500|FG000|Overall Study|Adverse Event|382|||
46765175|NCT00448591|82983500|FG000|Overall Study|Protocol Violation|41|||
46765176|NCT00448591|82983500|FG000|Overall Study|Lost to Follow-up|19|||
46765177|NCT00448591|82983500|FG000|Overall Study|Treatment Regimen Completed|70|||
46765178|NCT00448591|82983500|FG000|Overall Study|Other|154|||
46765179|NCT00448591|82983500|FG000|Overall Study|Termination of Study|70|||
46765180|NCT00651664|82983516|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
46765181|NCT00651664|82983517|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
46831539|NCT00124072|83049422|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
46831540|NCT00124072|83049423|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
46831541|NCT00124072|83049424|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
46831542|NCT00124072|83049421|FG000|Overall Study|Death|499|||
46831543|NCT00124072|83049422|FG001|Overall Study|Death|484|||
46831544|NCT00124072|83049423|FG002|Overall Study|Death|471|||
46831545|NCT00124072|83049424|FG003|Overall Study|Death|480|||
46831546|NCT00362648|83049438|FG000|Overall Study|Adverse Event|12|||
47061056|NCT01529515|83341364|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
46831547|NCT00362648|83049439|FG001|Overall Study|Adverse Event|21|||
46831548|NCT00362648|83049440|FG002|Overall Study|Adverse Event|1|||
46831549|NCT00362648|83049441|FG003|Overall Study|Adverse Event|0|||
46936643|NCT03220724|83173049|FG003|Overall Study|Lost to Follow-up|3|||
46936644|NCT03220724|83173046|FG000|Overall Study|Withdrawal by Subject|1|||
46936645|NCT03220724|83173047|FG001|Overall Study|Withdrawal by Subject|1|||
46936646|NCT03220724|83173048|FG002|Overall Study|Withdrawal by Subject|1|||
46936647|NCT03220724|83173049|FG003|Overall Study|Withdrawal by Subject|0|||
46936648|NCT03056573|83173061|FG000|Overall Study|Death|2|||
46936649|NCT03056573|83173062|FG001|Overall Study|Death|4|||
46936650|NCT03056573|83173061|FG000|Overall Study|Withdrawal by Subject|2|||
46936651|NCT03056573|83173062|FG001|Overall Study|Withdrawal by Subject|0|||
46936652|NCT03056573|83173061|FG000|Overall Study|Lost to Follow-up|1|||
46936653|NCT03056573|83173062|FG001|Overall Study|Lost to Follow-up|1|||
46936654|NCT02553772|83173070|FG000|Overall Study|Adverse Event|2|||
46936655|NCT02553772|83173071|FG001|Overall Study|Adverse Event|3|||
46936656|NCT02553772|83173070|FG000|Overall Study|Lost to Follow-up|2|||
46936657|NCT02553772|83173071|FG001|Overall Study|Lost to Follow-up|1|||
46936658|NCT02553772|83173070|FG000|Overall Study|Withdrawal of Consent|1|||
46831550|NCT00362648|83049438|FG000|Overall Study|Lost to Follow-up|62|||
46831551|NCT00362648|83049439|FG001|Overall Study|Lost to Follow-up|69|||
46831552|NCT00362648|83049440|FG002|Overall Study|Lost to Follow-up|4|||
46831553|NCT00362648|83049441|FG003|Overall Study|Lost to Follow-up|3|||
46831554|NCT00362648|83049438|FG000|Overall Study|Protocol Violation|4|||
46831555|NCT00362648|83049439|FG001|Overall Study|Protocol Violation|2|||
46831556|NCT00362648|83049440|FG002|Overall Study|Protocol Violation|2|||
46831557|NCT00362648|83049441|FG003|Overall Study|Protocol Violation|2|||
46831558|NCT00362648|83049438|FG000|Overall Study|Withdrawal by Subject|48|||
46936659|NCT02553772|83173071|FG001|Overall Study|Withdrawal of Consent|1|||
46936660|NCT02553772|83173070|FG000|Overall Study|Lack of Efficacy|1|||
46936661|NCT02553772|83173071|FG001|Overall Study|Lack of Efficacy|0|||
46936662|NCT02553772|83173070|FG000|Overall Study|Other Miscellaneous Reasons|0|||
46936663|NCT02553772|83173071|FG001|Overall Study|Other Miscellaneous Reasons|1|||
46936664|NCT02553538|83173079|FG000|Overall Study|Could Not Reach by Telephone|133|||
46936665|NCT02553538|83173080|FG001|Overall Study|Could Not Reach by Telephone|0|||
46936666|NCT02553538|83173079|FG000|Overall Study|Died or Left Network|54|||
46936667|NCT02553538|83173080|FG001|Overall Study|Died or Left Network|56|||
46936668|NCT02548156|83173086|FG000|Washout Period 1|Lost to Follow-up|0|||
46936669|NCT02548156|83173087|FG001|Washout Period 1|Lost to Follow-up|0|||
46936670|NCT02548156|83173088|FG002|Washout Period 1|Lost to Follow-up|0|||
46936671|NCT02548156|83173089|FG003|Washout Period 1|Lost to Follow-up|0|||
46936672|NCT02548156|83173090|FG004|Washout Period 1|Lost to Follow-up|1|||
46936673|NCT02548156|83173091|FG005|Washout Period 1|Lost to Follow-up|0|||
46936674|NCT01503515|83173101|FG000|Overall Study|Adverse Event|4|||
46936675|NCT01503515|83173102|FG001|Overall Study|Adverse Event|5|||
46936676|NCT01503515|83173101|FG000|Overall Study|Death|0|||
46637652|NCT01474512|82811379|FG003|Maintenance Period|Lack of Efficacy|1|||
46637653|NCT01474512|82811380|FG004|Maintenance Period|Lack of Efficacy|0|||
46765182|NCT00651664|82983518|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
46765183|NCT00651664|82983519|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
46765184|NCT00651664|82983520|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
46831559|NCT00362648|83049439|FG001|Overall Study|Withdrawal by Subject|42|||
46765185|NCT00651664|82983521|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
46765186|NCT00651664|82983522|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
46765187|NCT00651664|82983523|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
46765188|NCT00651664|82983524|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
46765189|NCT00651664|82983525|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
46765190|NCT00651664|82983516|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
46765191|NCT00651664|82983517|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
46765192|NCT00651664|82983518|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
46765193|NCT00651664|82983519|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
46765194|NCT00651664|82983520|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
46765195|NCT00651664|82983521|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
46765196|NCT00651664|82983522|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
46765197|NCT00651664|82983523|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
46765198|NCT00651664|82983524|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
46831560|NCT00362648|83049440|FG002|Overall Study|Withdrawal by Subject|2|||
46831561|NCT00362648|83049441|FG003|Overall Study|Withdrawal by Subject|6|||
46936677|NCT01503515|83173102|FG001|Overall Study|Death|1|||
46936678|NCT01503515|83173101|FG000|Overall Study|Physician Decision|14|||
46936679|NCT01503515|83173102|FG001|Overall Study|Physician Decision|23|||
46936680|NCT01503515|83173101|FG000|Overall Study|Withdrawal by Subject|0|||
46936681|NCT01503515|83173102|FG001|Overall Study|Withdrawal by Subject|1|||
46936682|NCT01503515|83173101|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
46936683|NCT01503515|83173102|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
46936684|NCT01503515|83173101|FG000|Overall Study|Ineligible|1|||
46936685|NCT01503515|83173102|FG001|Overall Study|Ineligible|1|||
46936686|NCT02742519|83173110|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
46637654|NCT01474512|82811381|FG005|Maintenance Period|Lack of Efficacy|0|||
46831562|NCT00524303|83049458|FG000|Overall Study|Lost to Follow-up|6|||
46831563|NCT00524303|83049459|FG001|Overall Study|Lost to Follow-up|0|||
46831564|NCT00524303|83049460|FG002|Overall Study|Lost to Follow-up|3|||
46831565|NCT00524303|83049458|FG000|Overall Study|Protocol Violation|0|||
46831566|NCT00524303|83049459|FG001|Overall Study|Protocol Violation|1|||
46936687|NCT02742519|83173111|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
46936688|NCT02742519|83173112|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
46936689|NCT02742519|83173110|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
46936690|NCT02742519|83173111|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
46831567|NCT00524303|83049460|FG002|Overall Study|Protocol Violation|1|||
46831568|NCT00524303|83049458|FG000|Overall Study|Withdrawal by Subject|3|||
46831569|NCT00524303|83049459|FG001|Overall Study|Withdrawal by Subject|0|||
46831570|NCT00524303|83049460|FG002|Overall Study|Withdrawal by Subject|4|||
46831571|NCT00524303|83049458|FG000|Overall Study|Death|0|||
46831572|NCT00524303|83049459|FG001|Overall Study|Death|2|||
46831573|NCT00524303|83049460|FG002|Overall Study|Death|3|||
46831574|NCT00524303|83049458|FG000|Overall Study|Adverse Event|1|||
46831575|NCT00524303|83049459|FG001|Overall Study|Adverse Event|2|||
46831576|NCT00524303|83049460|FG002|Overall Study|Adverse Event|3|||
46831577|NCT00524303|83049458|FG000|Overall Study|Did not Complete Study Dosing|1|||
46831578|NCT00524303|83049459|FG001|Overall Study|Did not Complete Study Dosing|0|||
46831579|NCT00524303|83049460|FG002|Overall Study|Did not Complete Study Dosing|0|||
46831580|NCT00524303|83049458|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
46831581|NCT00524303|83049459|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
46831582|NCT00524303|83049460|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
46831583|NCT00524303|83049458|FG000|Overall Study|Disease Progression|0|||
46831584|NCT00524303|83049459|FG001|Overall Study|Disease Progression|4|||
46936691|NCT02742519|83173112|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
46936692|NCT02742519|83173110|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
46936693|NCT02742519|83173111|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
46936694|NCT02742519|83173112|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
46936695|NCT01375010|83173122|FG000|Overall Study|Lost to Follow-up|8|||
46936696|NCT01375010|83173123|FG001|Overall Study|Lost to Follow-up|2|||
46936697|NCT01375010|83173122|FG000|Overall Study|Withdrawal by Subject|4|||
46936698|NCT01375010|83173123|FG001|Overall Study|Withdrawal by Subject|2|||
46936699|NCT00659061|83173147|FG000|Overall Study|Migration due to political unrest|21|||
46936700|NCT00659061|83173148|FG001|Overall Study|Migration due to political unrest|15|||
46936701|NCT02548078|83173165|FG000|Overall Study|Serious adverse event/Adverse event|1|||
46936702|NCT02548078|83173166|FG001|Overall Study|Serious adverse event/Adverse event|0|||
46936703|NCT02548078|83173165|FG000|Overall Study|Moved from study area|3|||
46936704|NCT02548078|83173166|FG001|Overall Study|Moved from study area|3|||
46936705|NCT02548078|83173165|FG000|Overall Study|Lost to Follow-up|1|||
46936706|NCT02548078|83173166|FG001|Overall Study|Lost to Follow-up|3|||
46936707|NCT02916433|83173181|FG000|Overall Study|Withdrawal by Subject|1|||
46936708|NCT02916433|83173182|FG001|Overall Study|Withdrawal by Subject|0|||
46936709|NCT02916433|83173181|FG000|Overall Study|Physician Decision|1|||
46936710|NCT02916433|83173182|FG001|Overall Study|Physician Decision|0|||
46936711|NCT00526227|83173191|FG000|Overall Study|Device not implanted|1|||
46936712|NCT00526227|83173191|FG000|Overall Study|Death|1|||
46936713|NCT02547922|83173199|FG000|Overall Study|Withdrawal by Subject|9|||
46936714|NCT02547922|83173200|FG001|Overall Study|Withdrawal by Subject|6|||
46936715|NCT02547922|83173201|FG002|Overall Study|Withdrawal by Subject|10|||
46936716|NCT02547922|83173199|FG000|Overall Study|Adverse Event|3|||
46936717|NCT02547922|83173200|FG001|Overall Study|Adverse Event|1|||
46936718|NCT02547922|83173201|FG002|Overall Study|Adverse Event|2|||
46936719|NCT02547922|83173199|FG000|Overall Study|Lost to Follow-up|1|||
46936720|NCT02547922|83173200|FG001|Overall Study|Lost to Follow-up|0|||
46936721|NCT02547922|83173201|FG002|Overall Study|Lost to Follow-up|0|||
47061057|NCT01529515|83341365|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
47061058|NCT01529515|83341366|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
47061059|NCT01529515|83341363|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
47061060|NCT01529515|83341364|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
46637655|NCT01474512|82811382|FG006|Maintenance Period|Lack of Efficacy|0|||
46831585|NCT00524303|83049460|FG002|Overall Study|Disease Progression|1|||
47061061|NCT01529515|83341365|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
47061062|NCT01529515|83341366|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
46831586|NCT00524303|83049458|FG000|Overall Study|Disease Recurrence|0|||
46831587|NCT00524303|83049459|FG001|Overall Study|Disease Recurrence|1|||
46936722|NCT02547922|83173199|FG000|Overall Study|Lack of Efficacy|5|||
46936723|NCT02547922|83173200|FG001|Overall Study|Lack of Efficacy|7|||
46936724|NCT02547922|83173201|FG002|Overall Study|Lack of Efficacy|4|||
46936725|NCT02547922|83173199|FG000|Overall Study|Death|1|||
46936726|NCT02547922|83173200|FG001|Overall Study|Death|0|||
46936727|NCT02547922|83173201|FG002|Overall Study|Death|0|||
46831588|NCT00524303|83049460|FG002|Overall Study|Disease Recurrence|0|||
46831589|NCT00524303|83049458|FG000|Overall Study|Sponsor Request|0|||
46936728|NCT02547922|83173199|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
46936729|NCT02547922|83173200|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
46936730|NCT02547922|83173201|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
46936731|NCT02547922|83173199|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
46936732|NCT02547922|83173200|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
46936733|NCT02547922|83173201|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
46936734|NCT02547922|83173199|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
46936735|NCT02547922|83173200|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
46936736|NCT02547922|83173201|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
46936737|NCT02547922|83173199|FG000|Overall Study|Physician Decision|2|||
46936738|NCT02547922|83173200|FG001|Overall Study|Physician Decision|1|||
46936739|NCT02547922|83173201|FG002|Overall Study|Physician Decision|2|||
46936740|NCT02547922|83173199|FG000|Overall Study|Patients did not receive IP|1|||
46936741|NCT02547922|83173200|FG001|Overall Study|Patients did not receive IP|1|||
46936742|NCT02547922|83173201|FG002|Overall Study|Patients did not receive IP|0|||
46936743|NCT02547766|83173215|FG000|Overall Study|Withdrawal by Subject|1|||
46936744|NCT02742441|83173228|FG000|Overall Study|Lost to Follow-up|4|||
46936745|NCT02742441|83173229|FG001|Overall Study|Lost to Follow-up|4|||
46936746|NCT02742441|83173228|FG000|Overall Study|Withdrawal by Subject|2|||
46936747|NCT02742441|83173229|FG001|Overall Study|Withdrawal by Subject|2|||
46936748|NCT02742441|83173228|FG000|Overall Study|Adverse Event|0|||
46936749|NCT02742441|83173229|FG001|Overall Study|Adverse Event|2|||
46936750|NCT02547220|83173237|FG000|Overall Study|Withdrawal by Subject|1|||
46936751|NCT02547220|83173238|FG001|Overall Study|Withdrawal by Subject|0|||
46936752|NCT02547220|83173237|FG000|Overall Study|Study terminated by sponsor|18|||
46936753|NCT02547220|83173238|FG001|Overall Study|Study terminated by sponsor|20|||
46936754|NCT02542072|83173246|FG000|First Intervention (1 Month)|Adverse Event|1|||
46936755|NCT02542072|83173247|FG001|First Intervention (1 Month)|Adverse Event|1|||
46936756|NCT02542072|83173246|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
46936757|NCT02542072|83173247|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
46936758|NCT02542072|83173246|FG000|First Intervention (1 Month)|Lens discomfort|1|||
46936759|NCT02542072|83173247|FG001|First Intervention (1 Month)|Lens discomfort|2|||
46936760|NCT02542072|83173246|FG000|First Intervention (1 Month)|Protocol Violation|1|||
46936761|NCT02542072|83173247|FG001|First Intervention (1 Month)|Protocol Violation|0|||
46936762|NCT02542072|83173246|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
46936763|NCT02542072|83173247|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
46936764|NCT02542072|83173246|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
46936765|NCT02542072|83173247|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
46936766|NCT02547454|83173273|FG000|Overall Study|Due to hemodialysis|53|||
46936767|NCT02547454|83173273|FG000|Overall Study|Due to transplantation|1|||
46765199|NCT00651664|82983525|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
46765200|NCT00651664|82983516|FG000|Overall Study|Progressive Disease|3|||
46765201|NCT00651664|82983517|FG001|Overall Study|Progressive Disease|3|||
46765202|NCT00651664|82983518|FG002|Overall Study|Progressive Disease|3|||
46765203|NCT00651664|82983519|FG003|Overall Study|Progressive Disease|12|||
46765204|NCT00651664|82983520|FG004|Overall Study|Progressive Disease|4|||
46765205|NCT00651664|82983521|FG005|Overall Study|Progressive Disease|1|||
46765206|NCT00651664|82983522|FG006|Overall Study|Progressive Disease|3|||
46765207|NCT00651664|82983523|FG007|Overall Study|Progressive Disease|6|||
46765208|NCT00651664|82983524|FG008|Overall Study|Progressive Disease|5|||
46765209|NCT00651664|82983525|FG009|Overall Study|Progressive Disease|5|||
46765210|NCT00651664|82983516|FG000|Overall Study|Patient Declined Further Treatment|0|||
46765211|NCT00651664|82983517|FG001|Overall Study|Patient Declined Further Treatment|0|||
46765212|NCT00651664|82983518|FG002|Overall Study|Patient Declined Further Treatment|0|||
46765213|NCT00651664|82983519|FG003|Overall Study|Patient Declined Further Treatment|1|||
46765214|NCT00651664|82983520|FG004|Overall Study|Patient Declined Further Treatment|1|||
46765215|NCT00651664|82983521|FG005|Overall Study|Patient Declined Further Treatment|1|||
46765216|NCT00651664|82983522|FG006|Overall Study|Patient Declined Further Treatment|0|||
46765217|NCT00651664|82983523|FG007|Overall Study|Patient Declined Further Treatment|0|||
46765218|NCT00651664|82983524|FG008|Overall Study|Patient Declined Further Treatment|0|||
46765219|NCT00651664|82983525|FG009|Overall Study|Patient Declined Further Treatment|1|||
46765220|NCT00651664|82983516|FG000|Overall Study|Symptomatic Deterioration|0|||
46765221|NCT00651664|82983517|FG001|Overall Study|Symptomatic Deterioration|0|||
46765222|NCT00651664|82983518|FG002|Overall Study|Symptomatic Deterioration|0|||
46765223|NCT00651664|82983519|FG003|Overall Study|Symptomatic Deterioration|1|||
46765224|NCT00651664|82983520|FG004|Overall Study|Symptomatic Deterioration|0|||
46765225|NCT00651664|82983521|FG005|Overall Study|Symptomatic Deterioration|0|||
46765226|NCT00651664|82983522|FG006|Overall Study|Symptomatic Deterioration|1|||
46765227|NCT00651664|82983523|FG007|Overall Study|Symptomatic Deterioration|0|||
46765228|NCT00651664|82983524|FG008|Overall Study|Symptomatic Deterioration|1|||
46765229|NCT00651664|82983525|FG009|Overall Study|Symptomatic Deterioration|0|||
46936768|NCT02547454|83173273|FG000|Overall Study|Due to no further need to treat|4|||
46765230|NCT00651664|82983516|FG000|Overall Study|Reason not Specified|0|||
46936769|NCT02547454|83173273|FG000|Overall Study|Death|38|||
46936770|NCT02547454|83173273|FG000|Overall Study|Lost to Follow-up|26|||
46765231|NCT00651664|82983517|FG001|Overall Study|Reason not Specified|0|||
46765232|NCT00651664|82983518|FG002|Overall Study|Reason not Specified|0|||
46765233|NCT00651664|82983519|FG003|Overall Study|Reason not Specified|0|||
46765234|NCT00651664|82983520|FG004|Overall Study|Reason not Specified|0|||
46765235|NCT00651664|82983521|FG005|Overall Study|Reason not Specified|0|||
46765236|NCT00651664|82983522|FG006|Overall Study|Reason not Specified|1|||
46765237|NCT00651664|82983523|FG007|Overall Study|Reason not Specified|0|||
46765238|NCT00651664|82983524|FG008|Overall Study|Reason not Specified|0|||
46765239|NCT00651664|82983525|FG009|Overall Study|Reason not Specified|0|||
46765240|NCT00787527|82983551|FG000|Overall Study|Toxicity|3|||
46765241|NCT00787137|82983562|FG000|Overall Study|Study Termination|0|||
46765242|NCT00787137|82983563|FG001|Overall Study|Study Termination|0|||
46765243|NCT00787137|82983564|FG002|Overall Study|Study Termination|1|||
46765244|NCT00448435|82983572|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
46765245|NCT00448435|82983573|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
46765246|NCT00448279|82983584|FG000|Overall Study|Lost to Follow-up|2|||
46765247|NCT00448279|82983585|FG001|Overall Study|Lost to Follow-up|2|||
46765248|NCT00448279|82983584|FG000|Overall Study|Adverse Event|1|||
46765249|NCT00448279|82983585|FG001|Overall Study|Adverse Event|1|||
46765250|NCT00448279|82983584|FG000|Overall Study|Disease progression|16|||
46765251|NCT00448279|82983585|FG001|Overall Study|Disease progression|18|||
46765252|NCT00448279|82983584|FG000|Overall Study|Withdrawal by Subject|4|||
46765253|NCT00448279|82983585|FG001|Overall Study|Withdrawal by Subject|3|||
46765254|NCT00448279|82983584|FG000|Overall Study|Other|6|||
46765255|NCT00448279|82983585|FG001|Overall Study|Other|4|||
46765256|NCT00448279|82983584|FG000|Overall Study|Protocol Violation|0|||
46765257|NCT00448279|82983585|FG001|Overall Study|Protocol Violation|1|||
46765258|NCT00448123|82983593|FG000|Overall Study|Lost to Follow-up|9|||
46765259|NCT00448123|82983594|FG001|Overall Study|Lost to Follow-up|6|||
46765260|NCT00448123|82983593|FG000|Overall Study|Physician Decision|6|||
46765261|NCT00448123|82983594|FG001|Overall Study|Physician Decision|6|||
46765262|NCT00447499|82983603|FG000|Overall Study|Adverse Event|1|||
46765263|NCT00447499|82983603|FG000|Overall Study|Patient Decision|4|||
46765264|NCT00447499|82983603|FG000|Overall Study|Sponsor Decision|1|||
46765265|NCT00447499|82983603|FG000|Overall Study|Physician Decision|1|||
46765266|NCT00800436|82983616|FG000|Overall Study|Withdrawal by Subject|0|||
46765267|NCT00800436|82983617|FG001|Overall Study|Withdrawal by Subject|0|||
46765268|NCT00800436|82983618|FG002|Overall Study|Withdrawal by Subject|1|||
46765269|NCT00800436|82983619|FG003|Overall Study|Withdrawal by Subject|1|||
46765270|NCT00800436|82983620|FG004|Overall Study|Withdrawal by Subject|0|||
46765271|NCT00800436|82983621|FG005|Overall Study|Withdrawal by Subject|0|||
46765272|NCT00800436|82983622|FG006|Overall Study|Withdrawal by Subject|0|||
46765273|NCT00655564|82983638|FG000|Overall Study|Adverse Event|1|||
46765274|NCT00655564|82983638|FG000|Overall Study|Lost to Follow-up|1|||
46765275|NCT00655564|82983638|FG000|Overall Study|Desired Alternate Therapy|1|||
46765276|NCT00447421|82983643|FG000|Overall Study|Lack of Efficacy|1|||
46765277|NCT00447421|82983643|FG000|Overall Study|Adverse Event|3|||
46765278|NCT00447421|82983643|FG000|Overall Study|Sponsor Decision|2|||
46765279|NCT00651118|82983651|FG000|Overall Study|Adverse Event|4|||
46765280|NCT00651118|82983652|FG001|Overall Study|Adverse Event|0|||
46765281|NCT00651118|82983653|FG002|Overall Study|Adverse Event|1|||
46765282|NCT00651118|82983654|FG003|Overall Study|Adverse Event|1|||
46831590|NCT00524303|83049459|FG001|Overall Study|Sponsor Request|0|||
46831591|NCT00524303|83049460|FG002|Overall Study|Sponsor Request|1|||
46831592|NCT00524303|83049458|FG000|Overall Study|Physician Decision|0|||
46831593|NCT00524303|83049459|FG001|Overall Study|Physician Decision|0|||
46831594|NCT00524303|83049460|FG002|Overall Study|Physician Decision|1|||
46936771|NCT02547454|83173273|FG000|Overall Study|Other|39|||
46831595|NCT00524303|83049458|FG000|Overall Study|Completed 5 years|0|||
46936772|NCT02547454|83173273|FG000|Overall Study|No data|11|||
46765283|NCT00651118|82983651|FG000|Overall Study|Protocol Violation|2|||
46831596|NCT00524303|83049459|FG001|Overall Study|Completed 5 years|0|||
46637656|NCT01474512|82811383|FG007|Maintenance Period|Lack of Efficacy|11|||
46765284|NCT00651118|82983652|FG001|Overall Study|Protocol Violation|2|||
46765285|NCT00651118|82983653|FG002|Overall Study|Protocol Violation|6|||
46765286|NCT00651118|82983654|FG003|Overall Study|Protocol Violation|2|||
46765287|NCT00651118|82983651|FG000|Overall Study|Lost to Follow-up|2|||
46765288|NCT00651118|82983652|FG001|Overall Study|Lost to Follow-up|0|||
46765289|NCT00651118|82983653|FG002|Overall Study|Lost to Follow-up|1|||
46765290|NCT00651118|82983654|FG003|Overall Study|Lost to Follow-up|2|||
46765291|NCT00651118|82983651|FG000|Overall Study|administrative|1|||
46765292|NCT00651118|82983652|FG001|Overall Study|administrative|4|||
46765293|NCT00651118|82983653|FG002|Overall Study|administrative|2|||
46831597|NCT00524303|83049460|FG002|Overall Study|Completed 5 years|1|||
46831598|NCT00335556|83049477|FG000|Overall Study|Death|0|||
46831599|NCT00335556|83049478|FG001|Overall Study|Death|5|||
46936773|NCT00415623|83173279|FG000|Overall Study|Adverse Event|3|||
46936774|NCT00415623|83173280|FG001|Overall Study|Adverse Event|4|||
46936775|NCT00415623|83173279|FG000|Overall Study|Death|1|||
46936776|NCT00415623|83173280|FG001|Overall Study|Death|0|||
46936777|NCT00415623|83173279|FG000|Overall Study|Withdrawal by Subject|1|||
46936778|NCT00415623|83173280|FG001|Overall Study|Withdrawal by Subject|1|||
46936779|NCT01969409|83173289|FG000|Overall Study|Death|2|||
46936780|NCT01969409|83173290|FG001|Overall Study|Death|2|||
46936781|NCT01969409|83173289|FG000|Overall Study|Transplant|1|||
46936782|NCT01969409|83173290|FG001|Overall Study|Transplant|1|||
46936783|NCT01969409|83173289|FG000|Overall Study|Withdrawal by Subject|0|||
46936784|NCT01969409|83173290|FG001|Overall Study|Withdrawal by Subject|1|||
46936785|NCT00150813|83173296|FG000|Overall Study|Adverse Event|1|||
46936786|NCT00150813|83173296|FG000|Overall Study|Lack of Efficacy|1|||
46936787|NCT00150813|83173296|FG000|Overall Study|Lost to Follow-up|5|||
46936788|NCT00150813|83173296|FG000|Overall Study|Withdrawal by Subject|5|||
46936789|NCT00150813|83173296|FG000|Overall Study|Remission|3|||
46936790|NCT00150813|83173296|FG000|Overall Study|Planned pregancy|1|||
46936791|NCT00150813|83173296|FG000|Overall Study|Switch to commercially available LEV|2|||
46936792|NCT02712788|83173302|FG000|Overall Study|Physician Decision|1|||
46936793|NCT02712788|83173303|FG001|Overall Study|Physician Decision|0|||
46936794|NCT02712788|83173302|FG000|Overall Study|Protocol Violation|1|||
46936795|NCT02712788|83173303|FG001|Overall Study|Protocol Violation|0|||
46936796|NCT02308111|83173311|FG000|Overall Study|Adverse Event|31|||
46936797|NCT02308111|83173312|FG001|Overall Study|Adverse Event|19|||
46936798|NCT02308111|83173311|FG000|Overall Study|Death|9|||
46936799|NCT02308111|83173312|FG001|Overall Study|Death|6|||
46936800|NCT02308111|83173311|FG000|Overall Study|Lost to Follow-up|2|||
46936801|NCT02308111|83173312|FG001|Overall Study|Lost to Follow-up|7|||
46936802|NCT02308111|83173311|FG000|Overall Study|Physician Decision|6|||
46936803|NCT02308111|83173312|FG001|Overall Study|Physician Decision|17|||
46936804|NCT02308111|83173311|FG000|Overall Study|Protocol Violation|0|||
46936805|NCT02308111|83173312|FG001|Overall Study|Protocol Violation|1|||
46936806|NCT02308111|83173311|FG000|Overall Study|Withdrawal by Subject|28|||
46936807|NCT02308111|83173312|FG001|Overall Study|Withdrawal by Subject|38|||
46936808|NCT02308111|83173311|FG000|Overall Study|Study Terminated by Sponsor|72|||
46936809|NCT02308111|83173312|FG001|Overall Study|Study Terminated by Sponsor|61|||
46936810|NCT02308111|83173311|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
46936811|NCT02308111|83173312|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
46936812|NCT02308111|83173311|FG000|Overall Study|Site Closure|3|||
46936813|NCT02308111|83173312|FG001|Overall Study|Site Closure|3|||
46936814|NCT02308111|83173311|FG000|Overall Study|Non-compliance with Study Drug|3|||
46936815|NCT02308111|83173312|FG001|Overall Study|Non-compliance with Study Drug|1|||
46936816|NCT02308111|83173311|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
46765294|NCT00651118|82983654|FG003|Overall Study|administrative|1|||
46765295|NCT00651118|82983651|FG000|Overall Study|Withdrawal by Subject|0|||
46765296|NCT00651118|82983652|FG001|Overall Study|Withdrawal by Subject|1|||
46765297|NCT00651118|82983653|FG002|Overall Study|Withdrawal by Subject|1|||
46765298|NCT00651118|82983654|FG003|Overall Study|Withdrawal by Subject|1|||
46765299|NCT00447265|82983667|FG000|Overall Study|Physician Decision|1|||
46765300|NCT00447265|82983668|FG001|Overall Study|Physician Decision|0|||
46765301|NCT00657358|82983672|FG000|Overall Study|Lack of Efficacy|6|||
46765302|NCT00457639|82983677|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
46765303|NCT00457639|82983678|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
46765304|NCT00457639|82983677|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
46765305|NCT00457639|82983678|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
46765306|NCT00457639|82983677|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
46765307|NCT00457639|82983678|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
46765308|NCT00800202|82983686|FG000|Overall Study|Adverse Event|7|||
46765309|NCT00800202|82983687|FG001|Overall Study|Adverse Event|6|||
46765310|NCT00800202|82983686|FG000|Overall Study|Death|1|||
46765311|NCT00800202|82983687|FG001|Overall Study|Death|0|||
46765312|NCT00800202|82983686|FG000|Overall Study|Other|5|||
46765313|NCT00800202|82983687|FG001|Overall Study|Other|0|||
46765314|NCT00800202|82983686|FG000|Overall Study|Disease Progression|54|||
46936817|NCT02308111|83173312|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
46936818|NCT02308111|83173311|FG000|Overall Study|Liver Transplant|3|||
47061063|NCT01529515|83341363|FG000|TRANSITION PHASE|Other|9|||
46637657|NCT01474512|82811384|FG008|Maintenance Period|Lack of Efficacy|11|||
46765315|NCT00800202|82983687|FG001|Overall Study|Disease Progression|18|||
46765316|NCT00655486|82983693|FG000|Overall Study|Adverse Event|10|||
46765317|NCT00655486|82983693|FG000|Overall Study|Lack of Efficacy|8|||
46936819|NCT02308111|83173312|FG001|Overall Study|Liver Transplant|3|||
46936820|NCT02308111|83173311|FG000|Overall Study|Liver Transplant Waitlist|2|||
46936821|NCT02308111|83173312|FG001|Overall Study|Liver Transplant Waitlist|2|||
46936822|NCT02308111|83173311|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
46936823|NCT02308111|83173312|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
46936824|NCT01346189|83173323|FG000|Overall Study|Withdrawal by Subject|7|||
46936825|NCT01346189|83173324|FG001|Overall Study|Withdrawal by Subject|5|||
46936826|NCT01346189|83173325|FG002|Overall Study|Withdrawal by Subject|3|||
46936827|NCT01346189|83173326|FG003|Overall Study|Withdrawal by Subject|5|||
46936828|NCT01346189|83173323|FG000|Overall Study|Physician Decision|4|||
46936829|NCT01346189|83173324|FG001|Overall Study|Physician Decision|0|||
46936830|NCT01346189|83173325|FG002|Overall Study|Physician Decision|0|||
46936831|NCT01346189|83173326|FG003|Overall Study|Physician Decision|0|||
46936832|NCT01346189|83173323|FG000|Overall Study|Moved|3|||
46936833|NCT01346189|83173324|FG001|Overall Study|Moved|0|||
46936834|NCT01346189|83173325|FG002|Overall Study|Moved|4|||
46936835|NCT01346189|83173326|FG003|Overall Study|Moved|0|||
46936836|NCT01346189|83173323|FG000|Overall Study|Other|2|||
46936837|NCT01346189|83173324|FG001|Overall Study|Other|4|||
46936838|NCT01346189|83173325|FG002|Overall Study|Other|7|||
46936839|NCT01346189|83173326|FG003|Overall Study|Other|3|||
46936840|NCT01346189|83173323|FG000|Overall Study|Death|0|||
46936841|NCT01346189|83173324|FG001|Overall Study|Death|3|||
46936842|NCT01346189|83173325|FG002|Overall Study|Death|0|||
46936843|NCT01346189|83173326|FG003|Overall Study|Death|0|||
46936844|NCT01346189|83173323|FG000|Overall Study|Non-health system primary care physician|0|||
46936845|NCT01346189|83173324|FG001|Overall Study|Non-health system primary care physician|5|||
46936846|NCT01346189|83173325|FG002|Overall Study|Non-health system primary care physician|0|||
46936847|NCT01346189|83173326|FG003|Overall Study|Non-health system primary care physician|0|||
46936848|NCT01346189|83173323|FG000|Overall Study|Travel|0|||
46936849|NCT01346189|83173324|FG001|Overall Study|Travel|0|||
46936850|NCT01346189|83173325|FG002|Overall Study|Travel|0|||
46936851|NCT01346189|83173326|FG003|Overall Study|Travel|3|||
46936852|NCT00369317|83173336|FG000|Overall Study|Adverse Event|3|||
46936853|NCT00369317|83173336|FG000|Overall Study|Death|1|||
46936854|NCT00369317|83173336|FG000|Overall Study|Lack of Efficacy|5|||
46936855|NCT00369317|83173336|FG000|Overall Study|Physician Decision|2|||
46936856|NCT00369317|83173336|FG000|Overall Study|Withdrawal by Subject|8|||
46637658|NCT01474512|82811385|FG009|Maintenance Period|Lack of Efficacy|12|||
46637659|NCT01474512|82811386|FG010|Maintenance Period|Lack of Efficacy|0|||
46637660|NCT01474512|82811387|FG011|Maintenance Period|Lack of Efficacy|0|||
46637661|NCT01474512|82811388|FG012|Maintenance Period|Lack of Efficacy|0|||
46637662|NCT01474512|82811389|FG013|Maintenance Period|Lack of Efficacy|0|||
46637663|NCT01474512|82811390|FG014|Maintenance Period|Lack of Efficacy|0|||
46637664|NCT01474512|82811391|FG015|Maintenance Period|Lack of Efficacy|0|||
46637665|NCT01474512|82811392|FG016|Maintenance Period|Lack of Efficacy|0|||
46637666|NCT01474512|82811393|FG017|Maintenance Period|Lack of Efficacy|0|||
46637667|NCT01474512|82811376|FG000|Maintenance Period|Protocol Violation|0|||
46637668|NCT01474512|82811377|FG001|Maintenance Period|Protocol Violation|0|||
46637669|NCT01474512|82811378|FG002|Maintenance Period|Protocol Violation|0|||
46637670|NCT01474512|82811379|FG003|Maintenance Period|Protocol Violation|1|||
46637671|NCT01474512|82811380|FG004|Maintenance Period|Protocol Violation|0|||
46637672|NCT01474512|82811381|FG005|Maintenance Period|Protocol Violation|0|||
46637673|NCT01474512|82811382|FG006|Maintenance Period|Protocol Violation|0|||
46765318|NCT00655486|82983693|FG000|Overall Study|Withdrawal by Subject|4|||
46765319|NCT00655486|82983693|FG000|Overall Study|Protocol Violation|1|||
46765320|NCT00655486|82983693|FG000|Overall Study|Unsatisfactory compliance|2|||
46765321|NCT00655486|82983693|FG000|Overall Study|Other: Pregnancy|1|||
46765322|NCT00655486|82983693|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
46765323|NCT00655486|82983693|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
46765324|NCT00457249|82983699|FG000|Overall Study|Lost to Follow-up|3|||
46765325|NCT00457249|82983700|FG001|Overall Study|Lost to Follow-up|0|||
46765326|NCT00457249|82983699|FG000|Overall Study|Protocol Violation|4|||
46765327|NCT00457249|82983700|FG001|Overall Study|Protocol Violation|1|||
46765328|NCT00457249|82983699|FG000|Overall Study|Withdrawal by Subject|3|||
46765329|NCT00457249|82983700|FG001|Overall Study|Withdrawal by Subject|1|||
46765330|NCT00457249|82983699|FG000|Overall Study|Serious Adverse Events|2|||
46765331|NCT00457249|82983700|FG001|Overall Study|Serious Adverse Events|0|||
46765332|NCT00457015|82983710|FG000|Overall Study|Left study site against medical advice|0|||
46765333|NCT00457015|82983711|FG001|Overall Study|Left study site against medical advice|1|||
46936857|NCT00369317|83173336|FG000|Overall Study|Ineligible|1|||
46765334|NCT00654940|82983719|FG000|Period 1|Adverse Event|0|||
46765335|NCT00654940|82983720|FG001|Period 1|Adverse Event|1|||
46831600|NCT00335556|83049479|FG002|Overall Study|Death|0|||
46831601|NCT00335556|83049480|FG003|Overall Study|Death|0|||
46936858|NCT03193021|83173343|FG000|Overall Study|Lost to Follow-up|1|||
46936859|NCT03193021|83173344|FG001|Overall Study|Lost to Follow-up|1|||
46936860|NCT03913091|83173352|FG000|Overall Study|Lost to Follow-up|18|||
46637674|NCT01474512|82811383|FG007|Maintenance Period|Protocol Violation|1|||
46637675|NCT01474512|82811384|FG008|Maintenance Period|Protocol Violation|0|||
46637676|NCT01474512|82811385|FG009|Maintenance Period|Protocol Violation|1|||
46637677|NCT01474512|82811386|FG010|Maintenance Period|Protocol Violation|0|||
46831602|NCT00335556|83049481|FG004|Overall Study|Death|1|||
46936861|NCT03913091|83173353|FG001|Overall Study|Lost to Follow-up|11|||
46936862|NCT03913091|83173352|FG000|Overall Study|Required additional meds/surgery|1|||
47061064|NCT01529515|83341364|FG001|TRANSITION PHASE|Other|0|||
46637678|NCT01474512|82811387|FG011|Maintenance Period|Protocol Violation|0|||
46637679|NCT01474512|82811388|FG012|Maintenance Period|Protocol Violation|0|||
46831603|NCT00335556|83049482|FG005|Overall Study|Death|0|||
46831604|NCT00335556|83049477|FG000|Overall Study|Lack of Efficacy|0|||
46831605|NCT00335556|83049478|FG001|Overall Study|Lack of Efficacy|19|||
46831606|NCT00335556|83049479|FG002|Overall Study|Lack of Efficacy|3|||
46831607|NCT00335556|83049480|FG003|Overall Study|Lack of Efficacy|3|||
46831608|NCT00335556|83049481|FG004|Overall Study|Lack of Efficacy|0|||
46637680|NCT01474512|82811389|FG013|Maintenance Period|Protocol Violation|0|||
46637681|NCT01474512|82811390|FG014|Maintenance Period|Protocol Violation|0|||
46637682|NCT01474512|82811391|FG015|Maintenance Period|Protocol Violation|0|||
46637683|NCT01474512|82811392|FG016|Maintenance Period|Protocol Violation|0|||
46637684|NCT01474512|82811393|FG017|Maintenance Period|Protocol Violation|0|||
46637685|NCT01474512|82811376|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
46637686|NCT01474512|82811377|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
46637687|NCT01474512|82811378|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
46637688|NCT01474512|82811379|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
46637689|NCT01474512|82811380|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
46637690|NCT01474512|82811381|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
46637691|NCT01474512|82811382|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
46637692|NCT01474512|82811383|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
46831609|NCT00335556|83049482|FG005|Overall Study|Lack of Efficacy|1|||
46831610|NCT00335556|83049477|FG000|Overall Study|Physician Decision|0|||
46765336|NCT00654940|82983719|FG000|Period 1|Intolerable Pain Level|1|||
46831611|NCT00335556|83049478|FG001|Overall Study|Physician Decision|6|||
46936863|NCT03913091|83173353|FG001|Overall Study|Required additional meds/surgery|2|||
46936864|NCT03913091|83173352|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
46936865|NCT03913091|83173353|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
46765337|NCT00654940|82983720|FG001|Period 1|Intolerable Pain Level|0|||
46765338|NCT00588666|82983732|FG000|Overall Study|Adverse Event|4|||
46765339|NCT00793182|82983747|FG000|Overall Study|Adverse Event|0|||
46936866|NCT01318499|83173377|FG000|Overall Study|Adverse Event|16|||
46936867|NCT01318499|83173378|FG001|Overall Study|Adverse Event|11|||
46936868|NCT01318499|83173379|FG002|Overall Study|Adverse Event|6|||
46936869|NCT01318499|83173377|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
46936870|NCT01318499|83173378|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
46936871|NCT01318499|83173379|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
46936872|NCT01318499|83173377|FG000|Overall Study|Noncompliance|2|||
46936873|NCT01318499|83173378|FG001|Overall Study|Noncompliance|3|||
46936874|NCT01318499|83173379|FG002|Overall Study|Noncompliance|0|||
46936875|NCT01318499|83173377|FG000|Overall Study|Treatment Failure|19|||
46936876|NCT01318499|83173378|FG001|Overall Study|Treatment Failure|19|||
46936877|NCT01318499|83173379|FG002|Overall Study|Treatment Failure|101|||
46936878|NCT01318499|83173377|FG000|Overall Study|Protocol Violation|2|||
46936879|NCT01318499|83173378|FG001|Overall Study|Protocol Violation|4|||
46936880|NCT01318499|83173379|FG002|Overall Study|Protocol Violation|2|||
46936881|NCT01318499|83173377|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
46936882|NCT01318499|83173378|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
46936883|NCT01318499|83173379|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
46936884|NCT01318499|83173377|FG000|Overall Study|Other|7|||
46936885|NCT01318499|83173378|FG001|Overall Study|Other|10|||
47061065|NCT01529515|83341365|FG002|TRANSITION PHASE|Other|0|||
47061066|NCT01529515|83341366|FG003|TRANSITION PHASE|Other|0|||
47061067|NCT01529515|83341363|FG000|MAINTENANCE PHASE|Adverse Event|0|||
46637693|NCT01474512|82811384|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
46637694|NCT01474512|82811385|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
46765340|NCT00793182|82983748|FG001|Overall Study|Adverse Event|1|||
46765341|NCT00793104|82983754|FG000|Overall Study|Lost to Follow-up|1|||
46765342|NCT00446797|82983760|FG000|Overall Study|Lack of Efficacy|0|||
46831612|NCT00335556|83049479|FG002|Overall Study|Physician Decision|2|||
46637695|NCT01474512|82811386|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
46765343|NCT00446797|82983761|FG001|Overall Study|Lack of Efficacy|2|||
46765344|NCT00446797|82983760|FG000|Overall Study|Lost to Follow-up|5|||
46936886|NCT01318499|83173379|FG002|Overall Study|Other|22|||
46936887|NCT02285595|83173413|FG000|Overall Study|Lost to Follow-up|14|||
46936888|NCT02285595|83173413|FG000|Overall Study|Withdrawal by Subject|1|||
46765345|NCT00446797|82983761|FG001|Overall Study|Lost to Follow-up|3|||
46831613|NCT00335556|83049480|FG003|Overall Study|Physician Decision|1|||
46936889|NCT02712398|83173436|FG000|Overall Study|Withdrawal by Subject|6|||
47061068|NCT01529515|83341364|FG001|MAINTENANCE PHASE|Adverse Event|10|||
47061069|NCT01529515|83341365|FG002|MAINTENANCE PHASE|Adverse Event|0|||
46637696|NCT01474512|82811387|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
46637697|NCT01474512|82811388|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
46936890|NCT02712398|83173436|FG000|Overall Study|Lost to Follow-up|6|||
46936891|NCT02712398|83173436|FG000|Overall Study|Sponsor Decision|1|||
47061070|NCT01529515|83341366|FG003|MAINTENANCE PHASE|Adverse Event|0|||
47061071|NCT01529515|83341363|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
47061072|NCT01529515|83341364|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
47061073|NCT01529515|83341365|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
46831614|NCT00335556|83049481|FG004|Overall Study|Physician Decision|0|||
46831615|NCT00335556|83049482|FG005|Overall Study|Physician Decision|0|||
46936892|NCT02712398|83173436|FG000|Overall Study|Physician Decision|1|||
46936893|NCT02712398|83173436|FG000|Overall Study|Death|2|||
46936894|NCT02712398|83173436|FG000|Overall Study|Re-operation|21|||
46936895|NCT00282867|83173443|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
46936896|NCT00282867|83173444|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
46936897|NCT00282867|83173445|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
46936898|NCT00151281|83173455|FG000|Overall Study|Not evaluable|3|||
46936899|NCT01318109|83173470|FG000|Overall Study|Adverse Event|0|||
46936900|NCT01318109|83173471|FG001|Overall Study|Adverse Event|2|||
46936901|NCT01318109|83173472|FG002|Overall Study|Adverse Event|0|||
46936902|NCT01318109|83173470|FG000|Overall Study|Withdrawal by Subject|1|||
46936903|NCT01318109|83173471|FG001|Overall Study|Withdrawal by Subject|0|||
46936904|NCT01318109|83173472|FG002|Overall Study|Withdrawal by Subject|0|||
46936905|NCT01318109|83173470|FG000|Overall Study|Schedule Conflict|0|||
46936906|NCT01318109|83173471|FG001|Overall Study|Schedule Conflict|1|||
46936907|NCT01318109|83173472|FG002|Overall Study|Schedule Conflict|0|||
46936908|NCT02712554|83173482|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
46936909|NCT02712554|83173483|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
46936910|NCT02712554|83173482|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
46936911|NCT02712554|83173483|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
46936912|NCT02712554|83173482|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
46936913|NCT02712554|83173483|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
46936914|NCT02712554|83173482|FG000|Part B: Qualification Phase|Adverse Event|0|||
46936915|NCT02712554|83173483|FG001|Part B: Qualification Phase|Adverse Event|1|||
46936916|NCT02712554|83173482|FG000|Part B: Treatment Phase|Adverse Event|0|||
46831616|NCT00335556|83049477|FG000|Overall Study|Ineligible|2|||
46831617|NCT00335556|83049478|FG001|Overall Study|Ineligible|0|||
46831618|NCT00335556|83049479|FG002|Overall Study|Ineligible|0|||
46831619|NCT00335556|83049480|FG003|Overall Study|Ineligible|0|||
46831620|NCT00335556|83049481|FG004|Overall Study|Ineligible|0|||
46831621|NCT00335556|83049482|FG005|Overall Study|Ineligible|0|||
46831622|NCT00335556|83049477|FG000|Overall Study|Refusal of further protocol therapy|0|||
46831623|NCT00335556|83049478|FG001|Overall Study|Refusal of further protocol therapy|4|||
46831624|NCT00335556|83049479|FG002|Overall Study|Refusal of further protocol therapy|0|||
46831625|NCT00335556|83049480|FG003|Overall Study|Refusal of further protocol therapy|1|||
46831626|NCT00335556|83049481|FG004|Overall Study|Refusal of further protocol therapy|0|||
46831627|NCT00335556|83049482|FG005|Overall Study|Refusal of further protocol therapy|0|||
46831628|NCT00518687|83049503|FG000|Overall Study|Adverse Event|201|||
46831629|NCT00518687|83049504|FG001|Overall Study|Adverse Event|177|||
46831630|NCT00518687|83049503|FG000|Overall Study|Lost to Follow-up|144|||
46831631|NCT00518687|83049504|FG001|Overall Study|Lost to Follow-up|155|||
46831632|NCT00518687|83049503|FG000|Overall Study|Physician Decision|42|||
46831633|NCT00518687|83049504|FG001|Overall Study|Physician Decision|48|||
46831634|NCT00518687|83049503|FG000|Overall Study|Progressive disease|2|||
46831635|NCT00518687|83049504|FG001|Overall Study|Progressive disease|2|||
46831636|NCT00518687|83049503|FG000|Overall Study|Protocol Violation|8|||
46831637|NCT00518687|83049504|FG001|Overall Study|Protocol Violation|10|||
46831638|NCT00518687|83049503|FG000|Overall Study|Study terminated by sponsor|930|||
46831639|NCT00518687|83049504|FG001|Overall Study|Study terminated by sponsor|918|||
46831640|NCT00518687|83049503|FG000|Overall Study|Withdrawal by Subject|110|||
46831641|NCT00518687|83049504|FG001|Overall Study|Withdrawal by Subject|110|||
46831642|NCT00134056|83049512|FG000|Randomization|Not eligible for assigned treatment|22|||
46831643|NCT00134056|83049513|FG001|Randomization|Not eligible for assigned treatment|20|||
46831644|NCT00134056|83049512|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
46831645|NCT00134056|83049513|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
46831646|NCT00134056|83049512|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
46936917|NCT02712554|83173483|FG001|Part B: Treatment Phase|Adverse Event|1|||
46637698|NCT01474512|82811389|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
46637699|NCT01474512|82811390|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
46831647|NCT00134056|83049513|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
46831648|NCT00134056|83049512|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
46831649|NCT00134056|83049513|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
46831650|NCT00134056|83049512|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
46831651|NCT00134056|83049513|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
46831652|NCT00518531|83049524|FG000|Treatment Period 1|Adverse Event|5|||
46936918|NCT02712554|83173482|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
46936919|NCT02712554|83173483|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
46936920|NCT02712554|83173482|FG000|Part B: Treatment Phase|Other|0|||
46936921|NCT02712554|83173483|FG001|Part B: Treatment Phase|Other|1|||
47061074|NCT01529515|83341366|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
46831653|NCT00518531|83049525|FG001|Treatment Period 1|Adverse Event|0|||
46831654|NCT00518531|83049524|FG000|Treatment Period 1|Lost to Follow-up|5|||
46831655|NCT00518531|83049525|FG001|Treatment Period 1|Lost to Follow-up|3|||
46831656|NCT00518531|83049524|FG000|Treatment Period 1|Physician Decision|1|||
46831657|NCT00518531|83049525|FG001|Treatment Period 1|Physician Decision|0|||
46831658|NCT00518531|83049524|FG000|Treatment Period 1|Protocol Violation|2|||
46831659|NCT00518531|83049525|FG001|Treatment Period 1|Protocol Violation|0|||
46831660|NCT00518531|83049524|FG000|Treatment Period 1|Withdrawal by Subject|4|||
46831661|NCT00518531|83049525|FG001|Treatment Period 1|Withdrawal by Subject|6|||
46831662|NCT00518531|83049524|FG000|Treatment Period 1|Early crossover|1|||
46831663|NCT00518531|83049525|FG001|Treatment Period 1|Early crossover|3|||
46831664|NCT00518531|83049524|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46831665|NCT00518531|83049525|FG001|Treatment Period 2|Withdrawal by Subject|8|||
46831666|NCT00518531|83049524|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
46831667|NCT00518531|83049525|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
46831668|NCT00518531|83049524|FG000|Treatment Period 2|Adverse Event|1|||
46831669|NCT00518531|83049525|FG001|Treatment Period 2|Adverse Event|7|||
46831670|NCT00518531|83049524|FG000|Treatment Period 2|Protocol-specified criteria|0|||
46831671|NCT00518531|83049525|FG001|Treatment Period 2|Protocol-specified criteria|1|||
46831672|NCT00518531|83049524|FG000|Treatment Period 2|Non-compliance|1|||
46831673|NCT00518531|83049525|FG001|Treatment Period 2|Non-compliance|2|||
46831674|NCT00351468|83049533|FG000|Overall Study|Adverse Event|42|||
46831675|NCT00351468|83049533|FG000|Overall Study|Withdrawal by Subject|39|||
46831676|NCT00351468|83049533|FG000|Overall Study|Various -follow up w clinical team|39|||
46831677|NCT00351468|83049533|FG000|Overall Study|Lack of Efficacy|32|||
46831678|NCT00351468|83049533|FG000|Overall Study|Non-compliance|8|||
46831679|NCT00351468|83049533|FG000|Overall Study|Lost to Follow-up|4|||
46831680|NCT00351468|83049533|FG000|Overall Study|Protocol Violation|3|||
46831681|NCT00523991|83049540|FG000|Overall Study|Adverse Event|6|||
46831682|NCT00523991|83049541|FG001|Overall Study|Adverse Event|5|||
46831683|NCT00523991|83049540|FG000|Overall Study|Protocol Violation|1|||
46831684|NCT00523991|83049541|FG001|Overall Study|Protocol Violation|4|||
46831685|NCT00523991|83049540|FG000|Overall Study|Lost to Follow-up|4|||
46831686|NCT00523991|83049541|FG001|Overall Study|Lost to Follow-up|1|||
46831687|NCT00523991|83049540|FG000|Overall Study|Withdrawal by Subject|7|||
46831688|NCT00523991|83049541|FG001|Overall Study|Withdrawal by Subject|17|||
46831689|NCT00523991|83049540|FG000|Overall Study|Other reason (not specified)|3|||
46831690|NCT00523991|83049541|FG001|Overall Study|Other reason (not specified)|0|||
46831691|NCT00350844|83049547|FG000|Overall Study|Lost to Follow-up|1|||
46831692|NCT00345540|83049551|FG000|Overall Study|Withdrawal by Subject|1|||
46936922|NCT02712320|83173506|FG000|Overall Study|Lost to Follow-up|1|||
46831693|NCT00335322|83049558|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
46831694|NCT00335322|83049559|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
46936923|NCT02712320|83173506|FG000|Overall Study|Withdrawal by Subject|1|||
46936924|NCT02712320|83173506|FG000|Overall Study|Transferred to another facility|1|||
46936925|NCT02712320|83173506|FG000|Overall Study|Treating with the prohibited medications|2|||
46936926|NCT03052751|83173512|FG000|Dosing Period 1|Adverse Event|0|||
46936927|NCT03052751|83173513|FG001|Dosing Period 1|Adverse Event|1|||
46936928|NCT03052751|83173514|FG002|Dosing Period 1|Adverse Event|0|||
46936929|NCT03052751|83173515|FG003|Dosing Period 1|Adverse Event|0|||
46936930|NCT03052751|83173516|FG004|Dosing Period 1|Adverse Event|0|||
46936931|NCT03052751|83173517|FG005|Dosing Period 1|Adverse Event|0|||
46936932|NCT03052751|83173512|FG000|Dosing Period 2|Adverse Event|0|||
46936933|NCT03052751|83173513|FG001|Dosing Period 2|Adverse Event|0|||
46936934|NCT03052751|83173514|FG002|Dosing Period 2|Adverse Event|3|||
46936935|NCT03052751|83173515|FG003|Dosing Period 2|Adverse Event|0|||
46936936|NCT03052751|83173516|FG004|Dosing Period 2|Adverse Event|0|||
46936937|NCT03052751|83173517|FG005|Dosing Period 2|Adverse Event|0|||
46936938|NCT03052751|83173512|FG000|Observation Period|Adverse Event|0|||
46936939|NCT03052751|83173513|FG001|Observation Period|Adverse Event|0|||
46936940|NCT03052751|83173514|FG002|Observation Period|Adverse Event|0|||
46637700|NCT01474512|82811391|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
46831695|NCT00335322|83049560|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
46831696|NCT00523367|83049571|FG000|Overall Study|19 screen failures|19|||
46831697|NCT00523367|83049571|FG000|Overall Study|4 Withdrawn by PI|4|||
46831698|NCT03755765|83049578|FG000|Overall Study|Withdrawal by Subject|2|||
46936941|NCT03052751|83173515|FG003|Observation Period|Adverse Event|0|||
46637701|NCT01474512|82811392|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
46936942|NCT03052751|83173516|FG004|Observation Period|Adverse Event|1|||
46936943|NCT03052751|83173517|FG005|Observation Period|Adverse Event|0|||
46637702|NCT01474512|82811393|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
46831699|NCT03755765|83049579|FG001|Overall Study|Withdrawal by Subject|4|||
46831700|NCT03755765|83049580|FG002|Overall Study|Withdrawal by Subject|4|||
46831701|NCT00344448|83049588|FG000|Screening|Withdrawal by Subject|0|||
46936944|NCT01317797|83173530|FG000|Overall Study|Other|0|||
46936945|NCT01317797|83173531|FG001|Overall Study|Other|1|||
46936946|NCT01317797|83173532|FG002|Overall Study|Other|0|||
46936947|NCT01317797|83173530|FG000|Overall Study|Withdrawal of Patient|0|||
46936948|NCT01317797|83173531|FG001|Overall Study|Withdrawal of Patient|0|||
46936949|NCT01317797|83173532|FG002|Overall Study|Withdrawal of Patient|1|||
46936950|NCT01343693|83173540|FG000|Overall Study|Lost to Follow-up|9|||
46936951|NCT02712008|83173547|FG000|Baseline (Day 1) up to Week 12|Death|3|||
46936952|NCT02712008|83173548|FG001|Baseline (Day 1) up to Week 12|Death|0|||
46936953|NCT02712008|83173549|FG002|Baseline (Day 1) up to Week 12|Death|0|||
46936954|NCT02712008|83173550|FG003|Baseline (Day 1) up to Week 12|Death|0|||
46936955|NCT02712008|83173551|FG004|Baseline (Day 1) up to Week 12|Death|0|||
46936956|NCT02712008|83173552|FG005|Baseline (Day 1) up to Week 12|Death|0|||
46936957|NCT02712008|83173553|FG006|Baseline (Day 1) up to Week 12|Death|0|||
46936958|NCT02712008|83173554|FG007|Baseline (Day 1) up to Week 12|Death|0|||
46936959|NCT02712008|83173547|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46936960|NCT02712008|83173548|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
46936961|NCT02712008|83173549|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
46936962|NCT02712008|83173550|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46936963|NCT02712008|83173551|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46936964|NCT02712008|83173552|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46936965|NCT02712008|83173553|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46936966|NCT02712008|83173554|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
46936967|NCT02712008|83173547|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
46936968|NCT02712008|83173548|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46936969|NCT02712008|83173549|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
46936970|NCT02712008|83173550|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46936971|NCT02712008|83173551|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46936972|NCT02712008|83173552|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46936973|NCT02712008|83173553|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46936974|NCT02712008|83173554|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
46936975|NCT02712008|83173547|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
46936976|NCT02712008|83173548|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
46936977|NCT02712008|83173549|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
46936978|NCT02712008|83173550|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
46936979|NCT02712008|83173551|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
46936980|NCT02712008|83173552|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
46936981|NCT02712008|83173553|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
46936982|NCT02712008|83173554|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
47061075|NCT01529515|83341363|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
47061076|NCT01529515|83341364|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
47061077|NCT01529515|83341365|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
47061078|NCT01529515|83341366|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
47061079|NCT01529515|83341363|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
47061080|NCT01529515|83341364|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
47061081|NCT01529515|83341365|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
47061082|NCT01529515|83341366|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
46936983|NCT02712008|83173547|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
46936984|NCT02712008|83173548|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
46936985|NCT02712008|83173549|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
46936986|NCT02712008|83173550|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
46936987|NCT02712008|83173551|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
46936988|NCT02712008|83173552|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
46765346|NCT00446797|82983760|FG000|Overall Study|Withdrawal by Subject|2|||
46765347|NCT00446797|82983761|FG001|Overall Study|Withdrawal by Subject|2|||
46765348|NCT00446797|82983760|FG000|Overall Study|Protocol Violation|1|||
46765349|NCT00446797|82983761|FG001|Overall Study|Protocol Violation|3|||
46765350|NCT00446797|82983760|FG000|Overall Study|subject entered at another site|0|||
46765351|NCT00446797|82983761|FG001|Overall Study|subject entered at another site|1|||
46765352|NCT00446797|82983760|FG000|Overall Study|did not meet entrance criteria|0|||
46765353|NCT00446797|82983761|FG001|Overall Study|did not meet entrance criteria|1|||
46765354|NCT00855335|82983772|FG000|Overall Study|Lost to Follow-up|0|||
46765355|NCT00855335|82983773|FG001|Overall Study|Lost to Follow-up|0|||
46765356|NCT00855335|82983774|FG002|Overall Study|Lost to Follow-up|3|||
46765357|NCT00855335|82983775|FG003|Overall Study|Lost to Follow-up|1|||
46765358|NCT00855335|82983776|FG004|Overall Study|Lost to Follow-up|0|||
46765359|NCT00855335|82983772|FG000|Overall Study|Withdrawal by Subject|0|||
46765360|NCT00855335|82983773|FG001|Overall Study|Withdrawal by Subject|0|||
46936989|NCT02712008|83173553|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
46936990|NCT02712008|83173554|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
47061083|NCT01529515|83341363|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
46936991|NCT02712008|83173547|FG000|From Week 12 up to Week 36|Adverse Event|0|||
46936992|NCT02712008|83173548|FG001|From Week 12 up to Week 36|Adverse Event|0|||
46936993|NCT02712008|83173549|FG002|From Week 12 up to Week 36|Adverse Event|0|||
46765361|NCT00855335|82983774|FG002|Overall Study|Withdrawal by Subject|0|||
46936994|NCT02712008|83173550|FG003|From Week 12 up to Week 36|Adverse Event|0|||
46936995|NCT02712008|83173551|FG004|From Week 12 up to Week 36|Adverse Event|1|||
46936996|NCT02712008|83173552|FG005|From Week 12 up to Week 36|Adverse Event|0|||
46936997|NCT02712008|83173553|FG006|From Week 12 up to Week 36|Adverse Event|0|||
46936998|NCT02712008|83173554|FG007|From Week 12 up to Week 36|Adverse Event|2|||
46936999|NCT02712008|83173547|FG000|From Week 12 up to Week 36|Death|1|||
46937000|NCT02712008|83173548|FG001|From Week 12 up to Week 36|Death|0|||
46937001|NCT02712008|83173549|FG002|From Week 12 up to Week 36|Death|0|||
46937002|NCT02712008|83173550|FG003|From Week 12 up to Week 36|Death|0|||
46937003|NCT02712008|83173551|FG004|From Week 12 up to Week 36|Death|0|||
46937004|NCT02712008|83173552|FG005|From Week 12 up to Week 36|Death|0|||
46937005|NCT02712008|83173553|FG006|From Week 12 up to Week 36|Death|1|||
46937006|NCT02712008|83173554|FG007|From Week 12 up to Week 36|Death|0|||
46937007|NCT02712008|83173547|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
46937008|NCT02712008|83173548|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
46937009|NCT02712008|83173549|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
46937010|NCT02712008|83173550|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
46937011|NCT02712008|83173551|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
46937012|NCT02712008|83173552|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
46937013|NCT02712008|83173553|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
46831702|NCT00344448|83049589|FG001|Screening|Withdrawal by Subject|1|||
46831703|NCT00344448|83049588|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
46831704|NCT00344448|83049589|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
46831705|NCT00344448|83049588|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
46831706|NCT00344448|83049589|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
46831707|NCT00344448|83049588|FG000|Open Label|Withdrawal by Subject|1|||
46831708|NCT00344448|83049589|FG001|Open Label|Withdrawal by Subject|1|||
46831709|NCT00344448|83049588|FG000|Open Label|Study terminated|1|||
46831710|NCT00344448|83049589|FG001|Open Label|Study terminated|0|||
46937014|NCT02712008|83173554|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
46937015|NCT02712008|83173547|FG000|From Week 12 up to Week 36|Physician Decision|0|||
46937016|NCT02712008|83173548|FG001|From Week 12 up to Week 36|Physician Decision|0|||
46937017|NCT02712008|83173549|FG002|From Week 12 up to Week 36|Physician Decision|0|||
46937018|NCT02712008|83173550|FG003|From Week 12 up to Week 36|Physician Decision|1|||
46937019|NCT02712008|83173551|FG004|From Week 12 up to Week 36|Physician Decision|1|||
46937020|NCT02712008|83173552|FG005|From Week 12 up to Week 36|Physician Decision|0|||
46937021|NCT02712008|83173553|FG006|From Week 12 up to Week 36|Physician Decision|0|||
46937022|NCT02712008|83173554|FG007|From Week 12 up to Week 36|Physician Decision|0|||
46937023|NCT02712008|83173547|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
46937024|NCT02712008|83173548|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
46937025|NCT02712008|83173549|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
46831711|NCT00324168|83049597|FG000|Overall Study|Lost to Follow-up|19|||
46831712|NCT00324168|83049598|FG001|Overall Study|Lost to Follow-up|18|||
46831713|NCT00324168|83049597|FG000|Overall Study|Death|3|||
46831714|NCT00324168|83049598|FG001|Overall Study|Death|3|||
46831715|NCT00324168|83049597|FG000|Overall Study|Patient did not visit in f/u window|6|||
46831716|NCT00324168|83049598|FG001|Overall Study|Patient did not visit in f/u window|9|||
46937026|NCT02712008|83173550|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
46937027|NCT02712008|83173551|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
46937028|NCT02712008|83173552|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
46937029|NCT02712008|83173553|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
46937030|NCT02712008|83173554|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
46937031|NCT02711306|83173574|FG000|Overall Study|Withdrawal by Subject|2|||
46937032|NCT02711306|83173575|FG001|Overall Study|Withdrawal by Subject|2|||
46937033|NCT02710292|83173581|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
46937034|NCT02710292|83173582|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
47061084|NCT01529515|83341364|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
46831717|NCT00517829|83049606|FG000|Overall Study|Adverse Event|22|||
46831718|NCT00517829|83049607|FG001|Overall Study|Adverse Event|34|||
46831719|NCT00517829|83049606|FG000|Overall Study|Disease Progression|39|||
46831720|NCT00517829|83049607|FG001|Overall Study|Disease Progression|32|||
46831721|NCT00517829|83049606|FG000|Overall Study|Patient Request|6|||
46831722|NCT00517829|83049607|FG001|Overall Study|Patient Request|5|||
46937035|NCT02710292|83173581|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
46937036|NCT02710292|83173582|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
46831723|NCT00517829|83049606|FG000|Overall Study|Investigator Request|5|||
46937037|NCT02710214|83173591|FG000|Overall Study|Lost to Follow-up|1|||
46937038|NCT02710214|83173592|FG001|Overall Study|Lost to Follow-up|0|||
46937039|NCT02710214|83173591|FG000|Overall Study|Lack of Efficacy|0|||
46937040|NCT02710214|83173592|FG001|Overall Study|Lack of Efficacy|1|||
46831724|NCT00517829|83049607|FG001|Overall Study|Investigator Request|3|||
46831725|NCT00517829|83049606|FG000|Overall Study|Other|3|||
46831726|NCT00517829|83049607|FG001|Overall Study|Other|1|||
46937041|NCT02710214|83173591|FG000|Overall Study|Death|0|||
46937042|NCT02710214|83173592|FG001|Overall Study|Death|1|||
46937043|NCT03052517|83173601|FG000|Overall Study|Study Terminated By Sponsor|928|||
46937044|NCT03052517|83173602|FG001|Overall Study|Study Terminated By Sponsor|938|||
46937045|NCT03052517|83173603|FG002|Overall Study|Study Terminated By Sponsor|296|||
46937046|NCT03052517|83173601|FG000|Overall Study|Subject/Guardian Decision|50|||
46937047|NCT03052517|83173602|FG001|Overall Study|Subject/Guardian Decision|45|||
46937048|NCT03052517|83173603|FG002|Overall Study|Subject/Guardian Decision|22|||
46937049|NCT03052517|83173601|FG000|Overall Study|Lack of Efficacy|23|||
46937050|NCT03052517|83173602|FG001|Overall Study|Lack of Efficacy|14|||
46937051|NCT03052517|83173603|FG002|Overall Study|Lack of Efficacy|7|||
46937052|NCT03052517|83173601|FG000|Overall Study|Adverse Event|6|||
46937053|NCT03052517|83173602|FG001|Overall Study|Adverse Event|5|||
46937054|NCT03052517|83173603|FG002|Overall Study|Adverse Event|0|||
46937055|NCT03052517|83173601|FG000|Overall Study|Physician Decision|4|||
46937056|NCT03052517|83173602|FG001|Overall Study|Physician Decision|5|||
46937057|NCT03052517|83173603|FG002|Overall Study|Physician Decision|1|||
46937058|NCT03052517|83173601|FG000|Overall Study|Death|3|||
46937059|NCT03052517|83173602|FG001|Overall Study|Death|0|||
46937060|NCT03052517|83173603|FG002|Overall Study|Death|1|||
46937061|NCT03052517|83173601|FG000|Overall Study|Lost to Follow-up|2|||
46937062|NCT03052517|83173602|FG001|Overall Study|Lost to Follow-up|4|||
46937063|NCT03052517|83173603|FG002|Overall Study|Lost to Follow-up|0|||
46937064|NCT03052517|83173601|FG000|Overall Study|Pregnancy|1|||
46937065|NCT03052517|83173602|FG001|Overall Study|Pregnancy|0|||
46937066|NCT03052517|83173603|FG002|Overall Study|Pregnancy|1|||
46937067|NCT03052517|83173601|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
46937068|NCT03052517|83173602|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
46937069|NCT03052517|83173603|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
46937070|NCT03052517|83173601|FG000|Overall Study|Technical Problems|0|||
46937071|NCT03052517|83173602|FG001|Overall Study|Technical Problems|1|||
46937072|NCT03052517|83173603|FG002|Overall Study|Technical Problems|0|||
46937073|NCT02708498|83173619|FG000|Overall Study|Death|20|||
46937074|NCT02708498|83173620|FG001|Overall Study|Death|19|||
46937075|NCT02708498|83173621|FG002|Overall Study|Death|0|||
46937076|NCT02708498|83173622|FG003|Overall Study|Death|0|||
46937077|NCT02708498|83173623|FG004|Overall Study|Death|1|||
46937078|NCT02708498|83173624|FG005|Overall Study|Death|0|||
46937079|NCT02708498|83173625|FG006|Overall Study|Death|0|||
46937080|NCT02708498|83173626|FG007|Overall Study|Death|0|||
46937081|NCT02708498|83173619|FG000|Overall Study|Unknown reason, missing data|0|||
46937082|NCT02708498|83173620|FG001|Overall Study|Unknown reason, missing data|0|||
46937083|NCT02708498|83173621|FG002|Overall Study|Unknown reason, missing data|62|||
46937084|NCT02708498|83173622|FG003|Overall Study|Unknown reason, missing data|51|||
46937085|NCT02708498|83173623|FG004|Overall Study|Unknown reason, missing data|195|||
46937086|NCT02708498|83173624|FG005|Overall Study|Unknown reason, missing data|132|||
46937087|NCT02708498|83173625|FG006|Overall Study|Unknown reason, missing data|0|||
46937088|NCT02708498|83173626|FG007|Overall Study|Unknown reason, missing data|0|||
46937089|NCT02710136|83173644|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
46937090|NCT02710136|83173645|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
46937091|NCT03702231|83173655|FG000|Overall Study|Withdrawal by Subject|1|||
46937092|NCT03702231|83173656|FG001|Overall Study|Withdrawal by Subject|0|||
47061085|NCT01529515|83341365|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
47061086|NCT01529515|83341366|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
47061087|NCT01529515|83341363|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
47061088|NCT01529515|83341364|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
46765362|NCT00855335|82983775|FG003|Overall Study|Withdrawal by Subject|1|||
46765363|NCT00855335|82983776|FG004|Overall Study|Withdrawal by Subject|0|||
46765364|NCT00855335|82983772|FG000|Overall Study|Adverse Event|2|||
46765365|NCT00855335|82983773|FG001|Overall Study|Adverse Event|0|||
46765366|NCT00855335|82983774|FG002|Overall Study|Adverse Event|0|||
46765367|NCT00855335|82983775|FG003|Overall Study|Adverse Event|0|||
46765368|NCT00855335|82983776|FG004|Overall Study|Adverse Event|0|||
46765369|NCT00855335|82983772|FG000|Overall Study|Physician Decision|1|||
46765370|NCT00855335|82983773|FG001|Overall Study|Physician Decision|1|||
46765371|NCT00855335|82983774|FG002|Overall Study|Physician Decision|0|||
46765372|NCT00855335|82983775|FG003|Overall Study|Physician Decision|0|||
46765373|NCT00855335|82983776|FG004|Overall Study|Physician Decision|0|||
46937093|NCT03702231|83173657|FG002|Overall Study|Withdrawal by Subject|0|||
46937094|NCT03702231|83173655|FG000|Overall Study|Protocol Violation|0|||
46937095|NCT03702231|83173656|FG001|Overall Study|Protocol Violation|0|||
47061089|NCT01529515|83341365|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
47061090|NCT01529515|83341366|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
46765374|NCT00855335|82983772|FG000|Overall Study|Other|2|||
46937096|NCT03702231|83173657|FG002|Overall Study|Protocol Violation|1|||
46937097|NCT03702231|83173655|FG000|Overall Study|Change in CLL Treatment|0|||
46937098|NCT03702231|83173656|FG001|Overall Study|Change in CLL Treatment|0|||
46937099|NCT03702231|83173657|FG002|Overall Study|Change in CLL Treatment|1|||
46937100|NCT03702231|83173655|FG000|Overall Study|COVID Pandemic|1|||
46937101|NCT03702231|83173656|FG001|Overall Study|COVID Pandemic|4|||
46937102|NCT03702231|83173657|FG002|Overall Study|COVID Pandemic|1|||
46937103|NCT03702231|83173655|FG000|Overall Study|Non-compliance|0|||
46937104|NCT03702231|83173656|FG001|Overall Study|Non-compliance|0|||
46937105|NCT03702231|83173657|FG002|Overall Study|Non-compliance|1|||
46937106|NCT02741271|83173667|FG000|Overall Study|Lost to Follow-up|2|||
46937107|NCT02741271|83173668|FG001|Overall Study|Lost to Follow-up|0|||
46937108|NCT02741271|83173667|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46937109|NCT02741271|83173668|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
46937110|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
46937111|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
46937112|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
46937113|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
46937114|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
46937115|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
46937116|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
46937117|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
46937118|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
46937119|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
46937120|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
46937121|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
46937122|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
46937123|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
46937124|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
46937125|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
46937126|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
46937127|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
46937128|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
46937129|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
46937130|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
46937131|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
46937132|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
46937133|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
46937134|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
46937135|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
46937136|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
46937137|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
46937138|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
46937139|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
46937140|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
46937141|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
46937142|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
46937143|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
46937144|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
46937145|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
46937146|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
46937147|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
46937148|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
46937149|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
46937150|NCT02709746|83173681|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
46937151|NCT02709746|83173682|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
46937152|NCT02709746|83173683|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
46937153|NCT02709746|83173684|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
46937154|NCT02709746|83173685|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
46937155|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
46937156|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
46937157|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
46937158|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
47061091|NCT01529515|83341363|FG000|MAINTENANCE PHASE|Other|0|||
47061092|NCT01529515|83341364|FG001|MAINTENANCE PHASE|Other|10|||
47061093|NCT01529515|83341365|FG002|MAINTENANCE PHASE|Other|0|||
47061094|NCT01529515|83341366|FG003|MAINTENANCE PHASE|Other|0|||
46637703|NCT01474512|82811376|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
46637704|NCT01474512|82811377|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
46765375|NCT00855335|82983773|FG001|Overall Study|Other|1|||
46765376|NCT00855335|82983774|FG002|Overall Study|Other|2|||
46937159|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
46937160|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
46937161|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
46937162|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
46937163|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
46937164|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
46937165|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
46937166|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
46937167|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
46937168|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
46937169|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
46937170|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
46937171|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
46937172|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
46937173|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
46937174|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
46937175|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
46937176|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
46937177|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
46831727|NCT00343512|83049613|FG000|Overall Study|Withdrawal by Subject|2|||
46831728|NCT00334542|83049618|FG000|Overall Study|Adverse Event|3|||
46831729|NCT00334542|83049618|FG000|Overall Study|Withdrawal by Subject|1|||
46831730|NCT00334542|83049618|FG000|Overall Study|New cancer diagnosis|1|||
46831731|NCT00112294|83049625|FG000|Overall Study|Still on study|5|||
46831732|NCT00112294|83049626|FG001|Overall Study|Still on study|0|||
46831733|NCT00235443|83049638|FG000|Overall Study|Adverse Event|4|||
46831734|NCT00235443|83049639|FG001|Overall Study|Adverse Event|12|||
46831735|NCT00235443|83049640|FG002|Overall Study|Adverse Event|17|||
46831736|NCT00235443|83049641|FG003|Overall Study|Adverse Event|44|||
46831737|NCT00235443|83049642|FG004|Overall Study|Adverse Event|10|||
46831738|NCT00235443|83049643|FG005|Overall Study|Adverse Event|15|||
46831739|NCT00235443|83049638|FG000|Overall Study|Lack of Efficacy|0|||
46831740|NCT00235443|83049639|FG001|Overall Study|Lack of Efficacy|1|||
46831741|NCT00235443|83049640|FG002|Overall Study|Lack of Efficacy|5|||
46831742|NCT00235443|83049641|FG003|Overall Study|Lack of Efficacy|12|||
46831743|NCT00235443|83049642|FG004|Overall Study|Lack of Efficacy|2|||
46831744|NCT00235443|83049643|FG005|Overall Study|Lack of Efficacy|9|||
46831745|NCT00235443|83049638|FG000|Overall Study|Withdrawal by Subject|3|||
46831746|NCT00235443|83049639|FG001|Overall Study|Withdrawal by Subject|9|||
46831747|NCT00235443|83049640|FG002|Overall Study|Withdrawal by Subject|25|||
46831748|NCT00235443|83049641|FG003|Overall Study|Withdrawal by Subject|24|||
46831749|NCT00235443|83049642|FG004|Overall Study|Withdrawal by Subject|10|||
46831750|NCT00235443|83049643|FG005|Overall Study|Withdrawal by Subject|12|||
46831751|NCT00235443|83049638|FG000|Overall Study|Lost to Follow-up|0|||
46831752|NCT00235443|83049639|FG001|Overall Study|Lost to Follow-up|8|||
46831753|NCT00235443|83049640|FG002|Overall Study|Lost to Follow-up|6|||
46831754|NCT00235443|83049641|FG003|Overall Study|Lost to Follow-up|6|||
46831755|NCT00235443|83049642|FG004|Overall Study|Lost to Follow-up|4|||
46831756|NCT00235443|83049643|FG005|Overall Study|Lost to Follow-up|3|||
46831757|NCT00235443|83049638|FG000|Overall Study|Unsatisfactory compliance|0|||
46831758|NCT00235443|83049639|FG001|Overall Study|Unsatisfactory compliance|2|||
46831759|NCT00235443|83049640|FG002|Overall Study|Unsatisfactory compliance|3|||
46831760|NCT00235443|83049641|FG003|Overall Study|Unsatisfactory compliance|4|||
46831761|NCT00235443|83049642|FG004|Overall Study|Unsatisfactory compliance|1|||
46831762|NCT00235443|83049643|FG005|Overall Study|Unsatisfactory compliance|0|||
46831763|NCT00235443|83049638|FG000|Overall Study|Other reasons for premature termination|1|||
46831764|NCT00235443|83049639|FG001|Overall Study|Other reasons for premature termination|6|||
46831765|NCT00235443|83049640|FG002|Overall Study|Other reasons for premature termination|6|||
46831766|NCT00235443|83049641|FG003|Overall Study|Other reasons for premature termination|7|||
46831767|NCT00235443|83049642|FG004|Overall Study|Other reasons for premature termination|3|||
46831768|NCT00235443|83049643|FG005|Overall Study|Other reasons for premature termination|6|||
46831769|NCT00234039|83049659|FG000|Overall Study|Adverse Event|2|||
46831770|NCT00234039|83049659|FG000|Overall Study|Progression/relapse|34|||
46831771|NCT00234039|83049659|FG000|Overall Study|Other - Not Protocol Specified|3|||
46831772|NCT00234039|83049659|FG000|Overall Study|Ineligible|9|||
46937178|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
46937179|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
46937180|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
46637705|NCT01474512|82811378|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
46831773|NCT00234039|83049659|FG000|Overall Study|No Protocol Treatment Received|2|||
46831774|NCT00323622|83049671|FG000|Overall Study|Other|30|||
46831775|NCT00323622|83049672|FG001|Overall Study|Other|91|||
46831776|NCT00323622|83049673|FG002|Overall Study|Other|4|||
46831777|NCT00323622|83049674|FG003|Overall Study|Other|12|||
46831778|NCT00323622|83049675|FG004|Overall Study|Other|32|||
46831779|NCT00323622|83049676|FG005|Overall Study|Other|74|||
46937181|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
46937182|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
46937183|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
46937184|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
46937185|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
46937186|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
46937187|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
46937188|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
46937189|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
46937190|NCT02709746|83173681|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
46937191|NCT02709746|83173682|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
46937192|NCT02709746|83173683|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
46937193|NCT02709746|83173684|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
46937194|NCT02709746|83173685|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
46937195|NCT01317641|83173706|FG000|Overall Study|Not treated|0|||
46937196|NCT01317641|83173707|FG001|Overall Study|Not treated|0|||
46937197|NCT01317641|83173708|FG002|Overall Study|Not treated|0|||
46937198|NCT01317641|83173709|FG003|Overall Study|Not treated|0|||
46937199|NCT01317641|83173710|FG004|Overall Study|Not treated|0|||
46937200|NCT01317641|83173711|FG005|Overall Study|Not treated|0|||
46937201|NCT01317641|83173712|FG006|Overall Study|Not treated|0|||
46937202|NCT01317641|83173713|FG007|Overall Study|Not treated|1|||
46937203|NCT01317641|83173714|FG008|Overall Study|Not treated|1|||
46937204|NCT01317641|83173706|FG000|Overall Study|Adverse Event|0|||
46937205|NCT01317641|83173707|FG001|Overall Study|Adverse Event|1|||
46937206|NCT01317641|83173708|FG002|Overall Study|Adverse Event|0|||
46937207|NCT01317641|83173709|FG003|Overall Study|Adverse Event|1|||
46937208|NCT01317641|83173710|FG004|Overall Study|Adverse Event|0|||
46937209|NCT01317641|83173711|FG005|Overall Study|Adverse Event|0|||
46937210|NCT01317641|83173712|FG006|Overall Study|Adverse Event|2|||
46937211|NCT01317641|83173713|FG007|Overall Study|Adverse Event|1|||
46937212|NCT01317641|83173714|FG008|Overall Study|Adverse Event|0|||
46937213|NCT01317641|83173706|FG000|Overall Study|Protocol Violation|1|||
46937214|NCT01317641|83173707|FG001|Overall Study|Protocol Violation|0|||
46937215|NCT01317641|83173708|FG002|Overall Study|Protocol Violation|0|||
46937216|NCT01317641|83173709|FG003|Overall Study|Protocol Violation|0|||
46937217|NCT01317641|83173710|FG004|Overall Study|Protocol Violation|0|||
46937218|NCT01317641|83173711|FG005|Overall Study|Protocol Violation|0|||
46937219|NCT01317641|83173712|FG006|Overall Study|Protocol Violation|0|||
46937220|NCT01317641|83173713|FG007|Overall Study|Protocol Violation|0|||
46937221|NCT01317641|83173714|FG008|Overall Study|Protocol Violation|0|||
46937222|NCT01317641|83173706|FG000|Overall Study|Disease progression|0|||
46765377|NCT00855335|82983775|FG003|Overall Study|Other|5|||
46765378|NCT00855335|82983776|FG004|Overall Study|Other|1|||
46765379|NCT00799422|82983801|FG000|First Week of Wear|Lost to Follow-up|0|||
46765380|NCT00799422|82983802|FG001|First Week of Wear|Lost to Follow-up|0|||
46765381|NCT00799422|82983803|FG002|First Week of Wear|Lost to Follow-up|1|||
46765382|NCT00799422|82983804|FG003|First Week of Wear|Lost to Follow-up|0|||
46765383|NCT00799422|82983805|FG004|First Week of Wear|Lost to Follow-up|0|||
46765384|NCT00799422|82983806|FG005|First Week of Wear|Lost to Follow-up|0|||
46765385|NCT00799422|82983801|FG000|First Week of Wear|Adverse Event|0|||
46765386|NCT00799422|82983802|FG001|First Week of Wear|Adverse Event|0|||
46765387|NCT00799422|82983803|FG002|First Week of Wear|Adverse Event|0|||
46765388|NCT00799422|82983804|FG003|First Week of Wear|Adverse Event|1|||
46765389|NCT00799422|82983805|FG004|First Week of Wear|Adverse Event|0|||
46765390|NCT00799422|82983806|FG005|First Week of Wear|Adverse Event|0|||
46765391|NCT00593489|82983816|FG000|Allocation|did not attend workshop; allocation not|2|||
46765392|NCT00593489|82983817|FG001|Allocation|did not attend workshop; allocation not|1|||
46765393|NCT00446641|82983827|FG000|Overall Study|Withdrawal by Subject|8|||
46765394|NCT00446641|82983828|FG001|Overall Study|Withdrawal by Subject|3|||
46765395|NCT00446641|82983827|FG000|Overall Study|poor compliance|8|||
46765396|NCT00446641|82983828|FG001|Overall Study|poor compliance|6|||
46765397|NCT00446641|82983827|FG000|Overall Study|Lost to Follow-up|1|||
46937223|NCT01317641|83173707|FG001|Overall Study|Disease progression|0|||
46937224|NCT01317641|83173708|FG002|Overall Study|Disease progression|0|||
46765398|NCT00446641|82983828|FG001|Overall Study|Lost to Follow-up|1|||
46765399|NCT00646282|82983836|FG000|Overall Study|Protocol terminated|4|||
46765400|NCT00646282|82983837|FG001|Overall Study|Protocol terminated|4|||
46831780|NCT00323622|83049677|FG006|Overall Study|Other|5|||
46937225|NCT01317641|83173709|FG003|Overall Study|Disease progression|0|||
46937226|NCT01317641|83173710|FG004|Overall Study|Disease progression|0|||
46937227|NCT01317641|83173711|FG005|Overall Study|Disease progression|0|||
46937228|NCT01317641|83173712|FG006|Overall Study|Disease progression|0|||
46937229|NCT01317641|83173713|FG007|Overall Study|Disease progression|3|||
47061095|NCT01529515|83341363|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
47061096|NCT01529515|83341364|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
47061097|NCT01529515|83341365|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
47061098|NCT01529515|83341366|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
47061099|NCT01529515|83341363|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
47061100|NCT01529515|83341364|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
47061101|NCT01529515|83341365|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
47061102|NCT01529515|83341366|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
47061103|NCT01529515|83341363|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
47061104|NCT01529515|83341364|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
47061105|NCT01529515|83341365|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
47061106|NCT01529515|83341366|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
47061107|NCT01529515|83341363|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
47061108|NCT01529515|83341364|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
47061109|NCT01529515|83341365|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
47061110|NCT01529515|83341366|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
47061111|NCT01529515|83341363|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
47061112|NCT01529515|83341364|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
47061113|NCT01529515|83341365|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
47061114|NCT01529515|83341366|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
47061115|NCT01529515|83341363|FG000|DOUBLE BLIND PHASE|Other|0|||
47061116|NCT01529515|83341364|FG001|DOUBLE BLIND PHASE|Other|0|||
47061117|NCT01529515|83341365|FG002|DOUBLE BLIND PHASE|Other|9|||
47061118|NCT01529515|83341366|FG003|DOUBLE BLIND PHASE|Other|2|||
47061119|NCT01528969|83341375|FG000|Overall Study|absent from the school at baseline|2|||
47061120|NCT01528969|83341376|FG001|Overall Study|absent from the school at baseline|0|||
47061121|NCT01514201|83341386|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
47061122|NCT01514201|83341387|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
47061123|NCT01514201|83341388|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
47061124|NCT01514201|83341389|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
47061125|NCT01514201|83341386|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
47061126|NCT01514201|83341387|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
47061127|NCT01514201|83341388|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
47061128|NCT01514201|83341389|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
47061129|NCT01514201|83341386|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
47061130|NCT01514201|83341387|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
47061131|NCT01514201|83341388|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
47061132|NCT01514201|83341389|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
47061133|NCT01514201|83341386|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
47061134|NCT01514201|83341387|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
47061135|NCT01514201|83341388|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
47061136|NCT01514201|83341389|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
47061137|NCT01514201|83341386|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
46765401|NCT00792636|82983846|FG000|Overall Study|Protocol Violation|17|||
46765402|NCT00792636|82983847|FG001|Overall Study|Protocol Violation|23|||
46765403|NCT00792636|82983848|FG002|Overall Study|Protocol Violation|20|||
46765404|NCT00792636|82983846|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
46765405|NCT00792636|82983847|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
46765406|NCT00792636|82983848|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
46765407|NCT00792636|82983846|FG000|Overall Study|Lost to Follow-up|13|||
46765408|NCT00792636|82983847|FG001|Overall Study|Lost to Follow-up|19|||
46831781|NCT00323622|83049678|FG007|Overall Study|Other|13|||
46831782|NCT00323622|83049671|FG000|Overall Study|Death|1|||
46831783|NCT00323622|83049672|FG001|Overall Study|Death|1|||
46831784|NCT00323622|83049673|FG002|Overall Study|Death|0|||
46831785|NCT00323622|83049674|FG003|Overall Study|Death|0|||
46831786|NCT00323622|83049675|FG004|Overall Study|Death|7|||
46831787|NCT00323622|83049676|FG005|Overall Study|Death|0|||
46831788|NCT00323622|83049677|FG006|Overall Study|Death|0|||
46831789|NCT00323622|83049678|FG007|Overall Study|Death|2|||
46831790|NCT00189423|83049706|FG000|Overall Study|Death|746|||
47061138|NCT01514201|83341387|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
47061139|NCT01514201|83341388|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
47061140|NCT01514201|83341389|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
47061141|NCT01514201|83341386|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
46831791|NCT00189423|83049707|FG001|Overall Study|Death|747|||
47061142|NCT01514201|83341387|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
47061143|NCT01514201|83341388|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
47061144|NCT01514201|83341389|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
47061145|NCT01514201|83341386|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
47061146|NCT01514201|83341387|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
46765409|NCT00792636|82983848|FG002|Overall Study|Lost to Follow-up|14|||
46765410|NCT00792636|82983846|FG000|Overall Study|Withdrew Consent|10|||
46831792|NCT00189423|83049706|FG000|Overall Study|Withdrawal by Subject|9|||
46765411|NCT00792636|82983847|FG001|Overall Study|Withdrew Consent|13|||
46765412|NCT00792636|82983848|FG002|Overall Study|Withdrew Consent|9|||
46765413|NCT00792636|82983846|FG000|Overall Study|Lack of Efficacy|3|||
46765414|NCT00792636|82983847|FG001|Overall Study|Lack of Efficacy|4|||
46937230|NCT01317641|83173714|FG008|Overall Study|Disease progression|4|||
46937231|NCT01317641|83173706|FG000|Overall Study|Withdrawal by Subject|0|||
46937232|NCT01317641|83173707|FG001|Overall Study|Withdrawal by Subject|0|||
46937233|NCT01317641|83173708|FG002|Overall Study|Withdrawal by Subject|0|||
46937234|NCT01317641|83173709|FG003|Overall Study|Withdrawal by Subject|0|||
46937235|NCT01317641|83173710|FG004|Overall Study|Withdrawal by Subject|0|||
46937236|NCT01317641|83173711|FG005|Overall Study|Withdrawal by Subject|0|||
46937237|NCT01317641|83173712|FG006|Overall Study|Withdrawal by Subject|1|||
46937238|NCT01317641|83173713|FG007|Overall Study|Withdrawal by Subject|0|||
46937239|NCT01317641|83173714|FG008|Overall Study|Withdrawal by Subject|0|||
46937240|NCT03186794|83173750|FG000|Overall Study|Physician Decision|2|||
46937241|NCT03186794|83173750|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
46937242|NCT02290431|83173755|FG000|Overall Study|Adverse Event|20|||
46937243|NCT02290431|83173755|FG000|Overall Study|Progressive disease|4|||
46937244|NCT02290431|83173755|FG000|Overall Study|Study terminated by Sponsor|1|||
46937245|NCT02290431|83173755|FG000|Overall Study|Physician Decision|2|||
46937246|NCT02707952|83173763|FG000|Overall Study|Adverse Event|1|||
46937247|NCT02707952|83173764|FG001|Overall Study|Adverse Event|0|||
46937248|NCT02707952|83173765|FG002|Overall Study|Adverse Event|0|||
46937249|NCT02707952|83173766|FG003|Overall Study|Adverse Event|0|||
46937250|NCT02707952|83173763|FG000|Overall Study|Lost to Follow-up|1|||
46937251|NCT02707952|83173764|FG001|Overall Study|Lost to Follow-up|0|||
46937252|NCT02707952|83173765|FG002|Overall Study|Lost to Follow-up|0|||
46937253|NCT02707952|83173766|FG003|Overall Study|Lost to Follow-up|0|||
46937254|NCT02707952|83173763|FG000|Overall Study|Withdrawal by Subject|0|||
46937255|NCT02707952|83173764|FG001|Overall Study|Withdrawal by Subject|1|||
46937256|NCT02707952|83173765|FG002|Overall Study|Withdrawal by Subject|2|||
46937257|NCT02707952|83173766|FG003|Overall Study|Withdrawal by Subject|0|||
46937258|NCT03050801|83173784|FG000|Experiment 1|Lost to Follow-up|0|||
46937259|NCT03050801|83173785|FG001|Experiment 1|Lost to Follow-up|1|||
46765415|NCT00792636|82983848|FG002|Overall Study|Lack of Efficacy|13|||
46765416|NCT00792636|82983846|FG000|Overall Study|Adverse Event|4|||
46765417|NCT00792636|82983847|FG001|Overall Study|Adverse Event|2|||
46831793|NCT00189423|83049707|FG001|Overall Study|Withdrawal by Subject|9|||
46831794|NCT00189423|83049706|FG000|Overall Study|Lost to Follow-up|10|||
46831795|NCT00189423|83049707|FG001|Overall Study|Lost to Follow-up|10|||
46831796|NCT00323310|83049713|FG000|Overall Study|Withdrawal by Subject|1|||
46831797|NCT00323310|83049713|FG000|Overall Study|a parent refused blood draw|1|||
46831798|NCT00323310|83049713|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
46831799|NCT00186537|83049720|FG000|Overall Study|Withdrawal by Subject|4|||
46831800|NCT00186537|83049721|FG001|Overall Study|Withdrawal by Subject|0|||
46831801|NCT00186537|83049722|FG002|Overall Study|Withdrawal by Subject|3|||
46831802|NCT00186537|83049720|FG000|Overall Study|ALT > 1.5 x ULN|3|||
46831803|NCT00186537|83049721|FG001|Overall Study|ALT > 1.5 x ULN|0|||
46831804|NCT00186537|83049722|FG002|Overall Study|ALT > 1.5 x ULN|0|||
46831805|NCT00517751|83049730|FG000|Overall Study|Death|3|||
46831806|NCT00517751|83049730|FG000|Overall Study|Withdrawal by Subject|37|||
46831807|NCT00517751|83049730|FG000|Overall Study|Lost to Follow-up|4|||
46831808|NCT00517751|83049730|FG000|Overall Study|patient not over due|6|||
46831809|NCT00517751|83049730|FG000|Overall Study|Patient not due for visit|76|||
46831810|NCT00517751|83049730|FG000|Overall Study|Missing|3|||
46831811|NCT00322842|83049736|FG000|Overall Study|Withdrawal by Subject|0|||
46831812|NCT00322842|83049737|FG001|Overall Study|Withdrawal by Subject|1|||
46831813|NCT00322842|83049736|FG000|Overall Study|Lost to Follow-up|0|||
46831814|NCT00322842|83049737|FG001|Overall Study|Lost to Follow-up|1|||
46831815|NCT00322842|83049736|FG000|Overall Study|Refused transplant|1|||
46831816|NCT00322842|83049737|FG001|Overall Study|Refused transplant|0|||
46831817|NCT00322842|83049736|FG000|Overall Study|Death|1|||
46937260|NCT03050801|83173786|FG002|Experiment 1|Lost to Follow-up|0|||
46831818|NCT00322842|83049737|FG001|Overall Study|Death|0|||
46831819|NCT00255723|83049746|FG000|Overall Study|Adverse Event|1|||
46831820|NCT00255723|83049747|FG001|Overall Study|Adverse Event|1|||
46831821|NCT00255723|83049746|FG000|Overall Study|Death|0|||
46831822|NCT00255723|83049747|FG001|Overall Study|Death|1|||
46765418|NCT00792636|82983848|FG002|Overall Study|Adverse Event|3|||
46765419|NCT00792636|82983846|FG000|Overall Study|Investigator Discretion|2|||
46765420|NCT00792636|82983847|FG001|Overall Study|Investigator Discretion|0|||
46831823|NCT00255723|83049746|FG000|Overall Study|Response Data Not Available|1|||
46831824|NCT00255723|83049747|FG001|Overall Study|Response Data Not Available|0|||
46831825|NCT00132808|83049756|FG000|Stratum I|Adverse Event|2|||
46831826|NCT00132808|83049757|FG001|Stratum I|Adverse Event|1|||
46831827|NCT00132808|83049758|FG002|Stratum I|Adverse Event|0|||
46831828|NCT00132808|83049756|FG000|Stratum I|Lost to Follow-up|3|||
46937261|NCT03050801|83173787|FG003|Experiment 1|Lost to Follow-up|0|||
46937262|NCT03050801|83173788|FG004|Experiment 1|Lost to Follow-up|0|||
46937263|NCT03050801|83173789|FG005|Experiment 1|Lost to Follow-up|0|||
46937264|NCT03050801|83173784|FG000|Experiment 1|Physician Decision|0|||
46937265|NCT03050801|83173785|FG001|Experiment 1|Physician Decision|3|||
46937266|NCT03050801|83173786|FG002|Experiment 1|Physician Decision|0|||
46831829|NCT00132808|83049757|FG001|Stratum I|Lost to Follow-up|4|||
46831830|NCT00132808|83049758|FG002|Stratum I|Lost to Follow-up|1|||
46831831|NCT00132808|83049756|FG000|Stratum I|Withdrawal by Subject|4|||
46831832|NCT00132808|83049757|FG001|Stratum I|Withdrawal by Subject|7|||
46831833|NCT00132808|83049758|FG002|Stratum I|Withdrawal by Subject|3|||
46831834|NCT00132808|83049756|FG000|Stratum I|Abnormal test procedure result (s)|0|||
46831835|NCT00132808|83049757|FG001|Stratum I|Abnormal test procedure result (s)|0|||
46831836|NCT00132808|83049758|FG002|Stratum I|Abnormal test procedure result (s)|1|||
46831837|NCT00132808|83049756|FG000|Stratum II|Adverse Event|1|||
46831838|NCT00132808|83049757|FG001|Stratum II|Adverse Event|2|||
46831839|NCT00132808|83049758|FG002|Stratum II|Adverse Event|1|||
46831840|NCT00132808|83049756|FG000|Stratum II|Death|1|||
46831841|NCT00132808|83049757|FG001|Stratum II|Death|0|||
46831842|NCT00132808|83049758|FG002|Stratum II|Death|0|||
46831843|NCT00132808|83049756|FG000|Stratum II|Lost to Follow-up|2|||
46831844|NCT00132808|83049757|FG001|Stratum II|Lost to Follow-up|2|||
46831845|NCT00132808|83049758|FG002|Stratum II|Lost to Follow-up|1|||
46831846|NCT00132808|83049756|FG000|Stratum II|Protocol Violation|0|||
46831847|NCT00132808|83049757|FG001|Stratum II|Protocol Violation|2|||
46831848|NCT00132808|83049758|FG002|Stratum II|Protocol Violation|1|||
46831849|NCT00132808|83049756|FG000|Stratum II|Withdrawal by Subject|4|||
46937267|NCT03050801|83173787|FG003|Experiment 1|Physician Decision|0|||
46937268|NCT03050801|83173788|FG004|Experiment 1|Physician Decision|0|||
46937269|NCT03050801|83173789|FG005|Experiment 1|Physician Decision|0|||
46937270|NCT03050801|83173784|FG000|Experiment 1|Change of experimental design|0|||
46937271|NCT03050801|83173785|FG001|Experiment 1|Change of experimental design|3|||
46937272|NCT03050801|83173786|FG002|Experiment 1|Change of experimental design|0|||
47061147|NCT01514201|83341388|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
47061148|NCT01514201|83341389|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
47061149|NCT01514201|83341386|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
47061150|NCT01514201|83341387|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
47061151|NCT01514201|83341388|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
47061152|NCT01514201|83341389|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
47061153|NCT01514201|83341386|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
47061154|NCT01514201|83341387|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
47061155|NCT01514201|83341388|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
47061156|NCT01514201|83341389|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
47061157|NCT01514201|83341386|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
46765421|NCT00792636|82983848|FG002|Overall Study|Investigator Discretion|2|||
46765422|NCT00446563|82983860|FG000|Overall Study|Adverse Event|4|||
46765423|NCT00446563|82983861|FG001|Overall Study|Adverse Event|3|||
46765424|NCT00446563|82983860|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46765425|NCT00446563|82983861|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46765426|NCT00446563|82983860|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46765427|NCT00446563|82983861|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46765428|NCT00446563|82983860|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46765429|NCT00446563|82983861|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
46765430|NCT00446563|82983860|FG000|Overall Study|Withdrawal by Subject|2|||
47061158|NCT01514201|83341387|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
47061159|NCT01514201|83341388|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
47061160|NCT01514201|83341389|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
47061161|NCT01514201|83341386|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
47061162|NCT01514201|83341387|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
46765431|NCT00446563|82983861|FG001|Overall Study|Withdrawal by Subject|1|||
46765432|NCT00446563|82983860|FG000|Overall Study|Administrative problems|0|||
46765433|NCT00446563|82983861|FG001|Overall Study|Administrative problems|1|||
46765434|NCT00650806|82983871|FG000|Overall Study|Adverse Event|0|||
46831850|NCT00132808|83049757|FG001|Stratum II|Withdrawal by Subject|9|||
46831851|NCT00132808|83049758|FG002|Stratum II|Withdrawal by Subject|6|||
46831852|NCT00517361|83049766|FG000|Overall Study|Death|6|||
46831853|NCT00517361|83049766|FG000|Overall Study|The study was terminated|5|||
46831854|NCT00516893|83049770|FG000|Overall Study|Lost to Follow-up|4|||
46937273|NCT03050801|83173787|FG003|Experiment 1|Change of experimental design|0|||
46937274|NCT03050801|83173788|FG004|Experiment 1|Change of experimental design|0|||
46937275|NCT03050801|83173789|FG005|Experiment 1|Change of experimental design|0|||
46765435|NCT00650806|82983872|FG001|Overall Study|Adverse Event|5|||
46765436|NCT00650806|82983873|FG002|Overall Study|Adverse Event|3|||
46831855|NCT00516893|83049770|FG000|Overall Study|Adverse Event|3|||
46831856|NCT00516893|83049770|FG000|Overall Study|Withdrawal by Subject|2|||
46831857|NCT00516893|83049770|FG000|Overall Study|Noncompliance|2|||
46831858|NCT00516893|83049770|FG000|Overall Study|Death|1|||
46831859|NCT00516893|83049770|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
46831860|NCT00516893|83049770|FG000|Overall Study|Relocated|1|||
46831861|NCT00516893|83049770|FG000|Overall Study|Pregnancy|1|||
46831862|NCT00516893|83049770|FG000|Overall Study|Received Medication From Another Study|1|||
46831863|NCT00522431|83049774|FG000|Overall Study|Adverse Event|5|||
46831864|NCT00522431|83049774|FG000|Overall Study|Protocol Violation|2|||
46831865|NCT00522431|83049774|FG000|Overall Study|Withdrawal by Subject|2|||
46937276|NCT03050801|83173784|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
46937277|NCT03050801|83173785|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
46937278|NCT03050801|83173786|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
46831866|NCT00522431|83049774|FG000|Overall Study|Subject non-compliance|1|||
46831867|NCT00522431|83049774|FG000|Overall Study|Other/unknown|1|||
46937279|NCT03050801|83173787|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
47061163|NCT01514201|83341388|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
47061164|NCT01514201|83341389|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
46637706|NCT01474512|82811379|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
46637707|NCT01474512|82811380|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
46831868|NCT00185211|83049780|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
46831869|NCT00185211|83049781|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
46831870|NCT00185211|83049780|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
46831871|NCT00185211|83049781|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
46831872|NCT00185211|83049780|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
46831873|NCT00185211|83049781|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
46831874|NCT00185211|83049780|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
46831875|NCT00185211|83049781|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
46831876|NCT00185211|83049780|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
46831877|NCT00185211|83049781|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
46831878|NCT00185211|83049780|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
46831879|NCT00185211|83049781|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
46831880|NCT00185211|83049780|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
46831881|NCT00185211|83049781|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
46831882|NCT00185211|83049780|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
46831883|NCT00185211|83049781|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
46831884|NCT00185211|83049780|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
46831885|NCT00185211|83049781|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
46831886|NCT00185211|83049780|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
46831887|NCT00185211|83049781|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
46831888|NCT00185211|83049780|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
46831889|NCT00185211|83049781|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
46831890|NCT00185211|83049780|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
46831891|NCT00185211|83049781|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
46831892|NCT00516737|83049790|FG000|Overall Study|Lost to Follow-up|2|||
46831893|NCT00516737|83049791|FG001|Overall Study|Lost to Follow-up|0|||
46831894|NCT00516737|83049790|FG000|Overall Study|Physician Decision|0|||
46831895|NCT00516737|83049791|FG001|Overall Study|Physician Decision|1|||
46831896|NCT00516737|83049790|FG000|Overall Study|Withdrawal by Subject|0|||
46831897|NCT00516737|83049791|FG001|Overall Study|Withdrawal by Subject|1|||
46831898|NCT00516737|83049790|FG000|Overall Study|Lack of Qualifying Event|9|||
46831899|NCT00516737|83049791|FG001|Overall Study|Lack of Qualifying Event|6|||
46831900|NCT00132730|83049801|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
46831901|NCT00132730|83049802|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
46831902|NCT00132730|83049803|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
46831903|NCT00132730|83049804|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
46831904|NCT00132730|83049805|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
46831905|NCT00132730|83049806|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
46831906|NCT00132730|83049801|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
46831907|NCT00132730|83049802|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
46831908|NCT00132730|83049803|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
46831909|NCT00132730|83049804|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
46831910|NCT00132730|83049805|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
46831911|NCT00132730|83049806|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
46831912|NCT00132730|83049801|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
46831913|NCT00132730|83049802|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
46831914|NCT00132730|83049803|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
46831915|NCT00132730|83049804|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
47061165|NCT01514201|83341386|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
46831916|NCT00132730|83049805|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
46831917|NCT00132730|83049806|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
46831918|NCT00132730|83049801|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
46831919|NCT00132730|83049802|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
46831920|NCT00132730|83049803|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
46831921|NCT00132730|83049804|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
46831922|NCT00132730|83049805|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
46831923|NCT00132730|83049806|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
46831924|NCT00132730|83049801|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
46831925|NCT00132730|83049802|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
46831926|NCT00132730|83049803|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
46831927|NCT00132730|83049804|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
46831928|NCT00132730|83049805|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
46831929|NCT00132730|83049806|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
46831930|NCT00132730|83049801|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
46831931|NCT00132730|83049802|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
46831932|NCT00132730|83049803|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
46831933|NCT00132730|83049804|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
46831934|NCT00132730|83049805|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
46831935|NCT00132730|83049806|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
46937280|NCT03050801|83173788|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
46937281|NCT03050801|83173789|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
46937282|NCT03050801|83173784|FG000|Experiment 2|Lost to Follow-up|0|||
46937283|NCT03050801|83173785|FG001|Experiment 2|Lost to Follow-up|0|||
46937284|NCT03050801|83173786|FG002|Experiment 2|Lost to Follow-up|0|||
46937285|NCT03050801|83173787|FG003|Experiment 2|Lost to Follow-up|1|||
46937286|NCT03050801|83173788|FG004|Experiment 2|Lost to Follow-up|1|||
46937287|NCT03050801|83173789|FG005|Experiment 2|Lost to Follow-up|0|||
46937288|NCT03050801|83173784|FG000|Experiment 2|Physician Decision|0|||
47061166|NCT01514201|83341387|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
47061167|NCT01514201|83341388|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
47061168|NCT01514201|83341389|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
47061169|NCT02666664|83341411|FG000|Overall Study|Physician Decision|0|||
47061170|NCT02666664|83341412|FG001|Overall Study|Physician Decision|1|||
47061171|NCT02666664|83341411|FG000|Overall Study|Protocol Violation|0|||
47061172|NCT02666664|83341412|FG001|Overall Study|Protocol Violation|2|||
47061173|NCT02666664|83341411|FG000|Overall Study|Other|0|||
47061174|NCT02666664|83341412|FG001|Overall Study|Other|1|||
47061175|NCT02666664|83341411|FG000|Overall Study|Adverse Event|12|||
46765437|NCT00650806|82983874|FG003|Overall Study|Adverse Event|4|||
46765438|NCT00650806|82983871|FG000|Overall Study|Lost to Follow-up|7|||
46765439|NCT00650806|82983872|FG001|Overall Study|Lost to Follow-up|6|||
46765440|NCT00650806|82983873|FG002|Overall Study|Lost to Follow-up|11|||
46765441|NCT00650806|82983874|FG003|Overall Study|Lost to Follow-up|10|||
46765442|NCT00650806|82983871|FG000|Overall Study|Protocol Violation|0|||
46765443|NCT00650806|82983872|FG001|Overall Study|Protocol Violation|0|||
46765444|NCT00650806|82983873|FG002|Overall Study|Protocol Violation|0|||
46765445|NCT00650806|82983874|FG003|Overall Study|Protocol Violation|1|||
46765446|NCT00650806|82983871|FG000|Overall Study|Pregnancy|0|||
46765447|NCT00650806|82983872|FG001|Overall Study|Pregnancy|0|||
46765448|NCT00650806|82983873|FG002|Overall Study|Pregnancy|0|||
46831936|NCT00132730|83049801|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
46831937|NCT00132730|83049802|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
46831938|NCT00132730|83049803|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
46831939|NCT00132730|83049804|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
46831940|NCT00132730|83049805|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
46831941|NCT00132730|83049806|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
46831942|NCT00132730|83049801|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
46831943|NCT00132730|83049802|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
46831944|NCT00132730|83049803|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
46831945|NCT00132730|83049804|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
46831946|NCT00132730|83049805|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
46831947|NCT00132730|83049806|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
46831948|NCT00132730|83049801|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
46937289|NCT03050801|83173785|FG001|Experiment 2|Physician Decision|0|||
46937290|NCT03050801|83173786|FG002|Experiment 2|Physician Decision|0|||
46937291|NCT03050801|83173787|FG003|Experiment 2|Physician Decision|0|||
47061176|NCT02666664|83341412|FG001|Overall Study|Adverse Event|37|||
47061177|NCT02666664|83341411|FG000|Overall Study|Withdrawal by participant|23|||
46765449|NCT00650806|82983874|FG003|Overall Study|Pregnancy|1|||
46637708|NCT01474512|82811381|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
46637709|NCT01474512|82811382|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
46637710|NCT01474512|82811383|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
46937292|NCT03050801|83173788|FG004|Experiment 2|Physician Decision|1|||
46937293|NCT03050801|83173789|FG005|Experiment 2|Physician Decision|0|||
46937294|NCT03050801|83173784|FG000|Experiment 2|Pregnancy|0|||
46937295|NCT03050801|83173785|FG001|Experiment 2|Pregnancy|0|||
46937296|NCT03050801|83173786|FG002|Experiment 2|Pregnancy|0|||
46937297|NCT03050801|83173787|FG003|Experiment 2|Pregnancy|0|||
46937298|NCT03050801|83173788|FG004|Experiment 2|Pregnancy|1|||
46937299|NCT03050801|83173789|FG005|Experiment 2|Pregnancy|0|||
46937300|NCT03050801|83173784|FG000|Experiment 2|Withdrawal by Subject|0|||
46937301|NCT03050801|83173785|FG001|Experiment 2|Withdrawal by Subject|0|||
46937302|NCT03050801|83173786|FG002|Experiment 2|Withdrawal by Subject|0|||
46937303|NCT03050801|83173787|FG003|Experiment 2|Withdrawal by Subject|1|||
46937304|NCT03050801|83173788|FG004|Experiment 2|Withdrawal by Subject|0|||
46937305|NCT03050801|83173789|FG005|Experiment 2|Withdrawal by Subject|0|||
46937306|NCT03050801|83173784|FG000|Experiment 2|Poor data quality|0|||
46937307|NCT03050801|83173785|FG001|Experiment 2|Poor data quality|0|||
46937308|NCT03050801|83173786|FG002|Experiment 2|Poor data quality|0|||
46937309|NCT03050801|83173787|FG003|Experiment 2|Poor data quality|4|||
46937310|NCT03050801|83173788|FG004|Experiment 2|Poor data quality|1|||
46937311|NCT03050801|83173789|FG005|Experiment 2|Poor data quality|0|||
46937312|NCT03050801|83173784|FG000|Experiment 2|Discomfort during stimulation|0|||
46937313|NCT03050801|83173785|FG001|Experiment 2|Discomfort during stimulation|0|||
46937314|NCT03050801|83173786|FG002|Experiment 2|Discomfort during stimulation|0|||
46937315|NCT03050801|83173787|FG003|Experiment 2|Discomfort during stimulation|0|||
46937316|NCT03050801|83173788|FG004|Experiment 2|Discomfort during stimulation|0|||
46937317|NCT03050801|83173789|FG005|Experiment 2|Discomfort during stimulation|2|||
46937318|NCT02707640|83173808|FG000|Overall Study|Adverse Event|4|||
46937319|NCT02707640|83173809|FG001|Overall Study|Adverse Event|2|||
46937320|NCT02707640|83173808|FG000|Overall Study|Death|1|||
46937321|NCT02707640|83173809|FG001|Overall Study|Death|2|||
46937322|NCT02707640|83173808|FG000|Overall Study|Physician Decision|2|||
46937323|NCT02707640|83173809|FG001|Overall Study|Physician Decision|0|||
46937324|NCT02707640|83173808|FG000|Overall Study|Withdrawal by Subject|0|||
46637711|NCT01474512|82811384|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
46765450|NCT00650806|82983871|FG000|Overall Study|Withdrawal by Subject|7|||
46765451|NCT00650806|82983872|FG001|Overall Study|Withdrawal by Subject|5|||
46765452|NCT00650806|82983873|FG002|Overall Study|Withdrawal by Subject|8|||
46765453|NCT00650806|82983874|FG003|Overall Study|Withdrawal by Subject|6|||
46765454|NCT00650806|82983871|FG000|Overall Study|Noncompliance with study drug regimen|1|||
46765455|NCT00650806|82983872|FG001|Overall Study|Noncompliance with study drug regimen|1|||
46765456|NCT00650806|82983873|FG002|Overall Study|Noncompliance with study drug regimen|0|||
46765457|NCT00650806|82983874|FG003|Overall Study|Noncompliance with study drug regimen|0|||
46765458|NCT00650806|82983871|FG000|Overall Study|Study terminated by sponsor|2|||
46831949|NCT00132730|83049802|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
46831950|NCT00132730|83049803|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
46831951|NCT00132730|83049804|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
46831952|NCT00132730|83049805|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
46831953|NCT00132730|83049806|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
46831954|NCT00132730|83049801|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
46831955|NCT00132730|83049802|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
46831956|NCT00132730|83049803|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
46831957|NCT00132730|83049804|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
46831958|NCT00132730|83049805|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
46831959|NCT00132730|83049806|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
46831960|NCT00132730|83049801|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
46831961|NCT00132730|83049802|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
46831962|NCT00132730|83049803|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
46831963|NCT00132730|83049804|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
46637712|NCT01474512|82811385|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
46765459|NCT00650806|82983872|FG001|Overall Study|Study terminated by sponsor|3|||
46765460|NCT00650806|82983873|FG002|Overall Study|Study terminated by sponsor|5|||
46831964|NCT00132730|83049805|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
46831965|NCT00132730|83049806|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
46937325|NCT02707640|83173809|FG001|Overall Study|Withdrawal by Subject|1|||
46937326|NCT02707640|83173808|FG000|Overall Study|Participant's Personal Decision|1|||
46937327|NCT02707640|83173809|FG001|Overall Study|Participant's Personal Decision|2|||
46937328|NCT02707640|83173808|FG000|Overall Study|Sponsor Discretion|1|||
46937329|NCT02707640|83173809|FG001|Overall Study|Sponsor Discretion|0|||
46831966|NCT00132730|83049801|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
46937330|NCT02708966|83173817|FG000|Overall Study|Lost to Follow-up|2|||
46937331|NCT02708966|83173818|FG001|Overall Study|Lost to Follow-up|2|||
46937332|NCT02706938|83173826|FG000|First Period, 6 Weeks|Adverse Event|8|||
46937333|NCT02706938|83173827|FG001|First Period, 6 Weeks|Adverse Event|0|||
46937334|NCT02706938|83173826|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
46937335|NCT02706938|83173827|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
46937336|NCT02706938|83173826|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
46937337|NCT02706938|83173827|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
46937338|NCT02706938|83173826|FG000|Second Period, 6 Weeks|Adverse Event|0|||
46937339|NCT02706938|83173827|FG001|Second Period, 6 Weeks|Adverse Event|7|||
46937340|NCT02706938|83173826|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
46937341|NCT02706938|83173827|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
46937342|NCT03053063|83173837|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
46937343|NCT03053063|83173838|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
46937344|NCT03053063|83173839|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
46937345|NCT03053063|83173840|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
46937346|NCT03053063|83173837|FG000|Randomized Phase|Withdrew consent|8|||
46937347|NCT03053063|83173838|FG001|Randomized Phase|Withdrew consent|11|||
46937348|NCT03053063|83173839|FG002|Randomized Phase|Withdrew consent|5|||
46937349|NCT03053063|83173840|FG003|Randomized Phase|Withdrew consent|0|||
46937350|NCT03053063|83173837|FG000|Randomized Phase|Investigator's Discretion|8|||
46937351|NCT03053063|83173838|FG001|Randomized Phase|Investigator's Discretion|6|||
46937352|NCT03053063|83173839|FG002|Randomized Phase|Investigator's Discretion|2|||
46937353|NCT03053063|83173840|FG003|Randomized Phase|Investigator's Discretion|0|||
46937354|NCT03053063|83173837|FG000|Randomized Phase|Lost to Follow-up|3|||
46937355|NCT03053063|83173838|FG001|Randomized Phase|Lost to Follow-up|5|||
46937356|NCT03053063|83173839|FG002|Randomized Phase|Lost to Follow-up|1|||
46937357|NCT03053063|83173840|FG003|Randomized Phase|Lost to Follow-up|0|||
46937358|NCT03053063|83173837|FG000|Randomized Phase|Adverse Event|0|||
46937359|NCT03053063|83173838|FG001|Randomized Phase|Adverse Event|1|||
46937360|NCT03053063|83173839|FG002|Randomized Phase|Adverse Event|0|||
46937361|NCT03053063|83173840|FG003|Randomized Phase|Adverse Event|0|||
46937362|NCT03053063|83173837|FG000|Randomized Phase|Randomized but Never Treated|1|||
46937363|NCT03053063|83173838|FG001|Randomized Phase|Randomized but Never Treated|3|||
46937364|NCT03053063|83173839|FG002|Randomized Phase|Randomized but Never Treated|2|||
46937365|NCT03053063|83173840|FG003|Randomized Phase|Randomized but Never Treated|0|||
46937366|NCT03053063|83173837|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
46937367|NCT03053063|83173838|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
46937368|NCT03053063|83173839|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
46937369|NCT03053063|83173840|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
46937370|NCT03053063|83173837|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
46937371|NCT03053063|83173838|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
46937372|NCT03053063|83173839|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
46937373|NCT03053063|83173840|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
46765461|NCT00650806|82983874|FG003|Overall Study|Study terminated by sponsor|4|||
46765462|NCT00650806|82983871|FG000|Overall Study|Other|1|||
46831967|NCT00132730|83049802|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
46937374|NCT03053063|83173837|FG000|Open-Label Phase|Death|0|||
46937375|NCT03053063|83173838|FG001|Open-Label Phase|Death|0|||
46765463|NCT00650806|82983872|FG001|Overall Study|Other|1|||
46765464|NCT00650806|82983873|FG002|Overall Study|Other|2|||
46765465|NCT00650806|82983874|FG003|Overall Study|Other|0|||
46765466|NCT00863057|82983890|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
46765467|NCT00863057|82983891|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
46765468|NCT00863057|82983892|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
46765469|NCT00863057|82983893|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
46765470|NCT00863057|82983890|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
46765471|NCT00863057|82983891|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
46765472|NCT00863057|82983892|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
46765473|NCT00863057|82983893|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
46765474|NCT00863057|82983890|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
46765475|NCT00863057|82983891|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
46937376|NCT03053063|83173839|FG002|Open-Label Phase|Death|0|||
46937377|NCT03053063|83173840|FG003|Open-Label Phase|Death|2|||
46937378|NCT03053063|83173837|FG000|Open-Label Phase|Investigator's discretion|0|||
46937379|NCT03053063|83173838|FG001|Open-Label Phase|Investigator's discretion|0|||
46937380|NCT03053063|83173839|FG002|Open-Label Phase|Investigator's discretion|0|||
46937381|NCT03053063|83173840|FG003|Open-Label Phase|Investigator's discretion|2|||
46937382|NCT01316939|83173862|FG000|Overall Study|Study closed/terminated|26|||
46937383|NCT01316939|83173863|FG001|Overall Study|Study closed/terminated|25|||
46831968|NCT00132730|83049803|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
46831969|NCT00132730|83049804|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
46831970|NCT00132730|83049805|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
46831971|NCT00132730|83049806|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
46831972|NCT00232557|83049822|FG000|Overall Study|Lost to Follow-up|3|||
46831973|NCT00232557|83049823|FG001|Overall Study|Lost to Follow-up|5|||
46937384|NCT01316939|83173864|FG002|Overall Study|Study closed/terminated|23|||
46937385|NCT01316939|83173862|FG000|Overall Study|Lack of Efficacy|24|||
46765476|NCT00863057|82983892|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
46831974|NCT00522275|83049829|FG000|Overall Study|Adverse Event|35|||
46937386|NCT01316939|83173863|FG001|Overall Study|Lack of Efficacy|25|||
46937387|NCT01316939|83173864|FG002|Overall Study|Lack of Efficacy|25|||
46937388|NCT01316939|83173862|FG000|Overall Study|Adverse Event|9|||
46937389|NCT01316939|83173863|FG001|Overall Study|Adverse Event|12|||
46937390|NCT01316939|83173864|FG002|Overall Study|Adverse Event|11|||
46937391|NCT01316939|83173862|FG000|Overall Study|Withdrawal by Subject|1|||
46937392|NCT01316939|83173863|FG001|Overall Study|Withdrawal by Subject|3|||
46937393|NCT01316939|83173864|FG002|Overall Study|Withdrawal by Subject|6|||
46937394|NCT01316939|83173862|FG000|Overall Study|Physician Decision|2|||
46937395|NCT01316939|83173863|FG001|Overall Study|Physician Decision|2|||
46937396|NCT01316939|83173864|FG002|Overall Study|Physician Decision|1|||
46937397|NCT01316939|83173862|FG000|Overall Study|Lost to Follow-up|0|||
46937398|NCT01316939|83173863|FG001|Overall Study|Lost to Follow-up|0|||
46937399|NCT01316939|83173864|FG002|Overall Study|Lost to Follow-up|2|||
46937400|NCT01316939|83173862|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
46937401|NCT01316939|83173863|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
46937402|NCT01316939|83173864|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
46937403|NCT01316939|83173862|FG000|Overall Study|Protocol Violation|0|||
46937404|NCT01316939|83173863|FG001|Overall Study|Protocol Violation|1|||
46937405|NCT01316939|83173864|FG002|Overall Study|Protocol Violation|0|||
46937406|NCT03044249|83173874|FG000|Overall Study|Adverse Event|4|||
46937407|NCT03044249|83173875|FG001|Overall Study|Adverse Event|9|||
46937408|NCT03044249|83173874|FG000|Overall Study|Lost to Follow-up|1|||
46937409|NCT03044249|83173875|FG001|Overall Study|Lost to Follow-up|0|||
46937410|NCT03044249|83173874|FG000|Overall Study|Non-compliance with Study Drug|1|||
46937411|NCT03044249|83173875|FG001|Overall Study|Non-compliance with Study Drug|0|||
46937412|NCT03044249|83173874|FG000|Overall Study|Study Terminated by Sponsor|2|||
46937413|NCT03044249|83173875|FG001|Overall Study|Study Terminated by Sponsor|0|||
46937414|NCT03044249|83173874|FG000|Overall Study|Withdrawal by Subject|2|||
46937415|NCT03044249|83173875|FG001|Overall Study|Withdrawal by Subject|5|||
46937416|NCT02704130|83173888|FG000|Overall Study|Physician Decision|5|||
46937417|NCT02704130|83173889|FG001|Overall Study|Physician Decision|3|||
46937418|NCT03740009|83173895|FG000|Overall Study|Physician Decision|9|||
47061178|NCT02666664|83341412|FG001|Overall Study|Withdrawal by participant|40|||
47061179|NCT02666664|83341411|FG000|Overall Study|Sponsor decision|0|||
47061180|NCT02666664|83341412|FG001|Overall Study|Sponsor decision|1|||
47061181|NCT02666664|83341411|FG000|Overall Study|Lost to Follow-up|1|||
47061182|NCT02666664|83341412|FG001|Overall Study|Lost to Follow-up|2|||
46831975|NCT00522275|83049829|FG000|Overall Study|Lack of Efficacy|80|||
46831976|NCT00522275|83049829|FG000|Overall Study|Subject withdrew consent|16|||
46831977|NCT00522275|83049829|FG000|Overall Study|Protocol deviation|1|||
46831978|NCT00522275|83049829|FG000|Overall Study|Unsatisfactory compliance|11|||
46937419|NCT03740009|83173895|FG000|Overall Study|Lost to Follow-up|1|||
46937420|NCT03649217|83173899|FG000|Overall Study|subject had severe ataxia not initially found|1|||
46937421|NCT03649217|83173899|FG000|Overall Study|subject had cognitive issues not initially found|1|||
47061183|NCT01528735|83341420|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
47061184|NCT01528735|83341421|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
46765477|NCT00863057|82983893|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
46765478|NCT00863057|82983890|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
46765479|NCT00863057|82983891|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
46765480|NCT00863057|82983892|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
46765481|NCT00863057|82983893|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
46765482|NCT00829166|82983911|FG000|Overall Study|Death|305|||
46765483|NCT00829166|82983912|FG001|Overall Study|Death|333|||
46765484|NCT00829166|82983911|FG000|Overall Study|Lost to Follow-up|5|||
46765485|NCT00829166|82983912|FG001|Overall Study|Lost to Follow-up|4|||
46765486|NCT00829166|82983911|FG000|Overall Study|Physician's Decision|4|||
46831979|NCT00522275|83049829|FG000|Overall Study|Lost to Follow-up|8|||
46937422|NCT03138889|83173928|FG000|Overall Study|Withdrawal by Subject|5|||
46765487|NCT00829166|82983912|FG001|Overall Study|Physician's Decision|3|||
46937423|NCT03138889|83173929|FG001|Overall Study|Withdrawal by Subject|5|||
46937424|NCT03138889|83173930|FG002|Overall Study|Withdrawal by Subject|0|||
46937425|NCT03138889|83173931|FG003|Overall Study|Withdrawal by Subject|2|||
46937426|NCT03138889|83173932|FG004|Overall Study|Withdrawal by Subject|1|||
47061185|NCT01528735|83341420|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
47061186|NCT01528735|83341421|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
46937427|NCT03138889|83173933|FG005|Overall Study|Withdrawal by Subject|3|||
46937428|NCT03138889|83173934|FG006|Overall Study|Withdrawal by Subject|0|||
46937429|NCT03138889|83173935|FG007|Overall Study|Withdrawal by Subject|1|||
46937430|NCT02706392|83173987|FG000|Overall Study|Death|1|||
46831980|NCT00522275|83049829|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
46831981|NCT00522275|83049829|FG000|Overall Study|Other: Subject is pregnant|2|||
46831982|NCT00522275|83049829|FG000|Overall Study|Other: Subject relocated|2|||
46831983|NCT00522275|83049829|FG000|Overall Study|Other: Subject arrested|1|||
46831984|NCT00522275|83049829|FG000|Overall Study|Other: Site / clinic closed|4|||
46831985|NCT00522275|83049829|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
46831986|NCT00522275|83049829|FG000|Overall Study|Other: Sponsor request|2|||
46831987|NCT00522275|83049829|FG000|Overall Study|Other: Subject ran out of medication|1|||
46831988|NCT00522275|83049829|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
46831989|NCT00522041|83049835|FG000|Overall Study|Adverse Event|9|||
46831990|NCT00522041|83049836|FG001|Overall Study|Adverse Event|3|||
46831991|NCT00522041|83049835|FG000|Overall Study|Protocol Violation|2|||
46831992|NCT00522041|83049836|FG001|Overall Study|Protocol Violation|0|||
46831993|NCT00522041|83049835|FG000|Overall Study|Lost to Follow-up|1|||
46831994|NCT00522041|83049836|FG001|Overall Study|Lost to Follow-up|4|||
46831995|NCT00522041|83049835|FG000|Overall Study|Voluntary withdrawal|5|||
46831996|NCT00522041|83049836|FG001|Overall Study|Voluntary withdrawal|4|||
46831997|NCT00522041|83049835|FG000|Overall Study|Did not receive treatment|0|||
46831998|NCT00522041|83049836|FG001|Overall Study|Did not receive treatment|1|||
46831999|NCT00122980|83049845|FG000|Overall Study|Death|0|||
46832000|NCT00122980|83049846|FG001|Overall Study|Death|1|||
46832001|NCT00122980|83049845|FG000|Overall Study|Physician Decision|2|||
46832002|NCT00122980|83049846|FG001|Overall Study|Physician Decision|0|||
46832003|NCT00122980|83049845|FG000|Overall Study|Protocol Violation|5|||
46832004|NCT00122980|83049846|FG001|Overall Study|Protocol Violation|1|||
46832005|NCT00122980|83049845|FG000|Overall Study|Withdrawal by Subject|2|||
46832006|NCT00122980|83049846|FG001|Overall Study|Withdrawal by Subject|3|||
46832007|NCT00122980|83049845|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
46832008|NCT00122980|83049846|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
46832009|NCT00122980|83049845|FG000|Overall Study|Study termination|27|||
46832010|NCT00122980|83049846|FG001|Overall Study|Study termination|35|||
46832011|NCT03868631|83049854|FG000|Baseline to Week 6|Adverse Event|0|||
46832012|NCT03868631|83049855|FG001|Baseline to Week 6|Adverse Event|3|||
46832013|NCT03868631|83049854|FG000|Baseline to Week 6|Protocol Violation|1|||
46832014|NCT03868631|83049855|FG001|Baseline to Week 6|Protocol Violation|1|||
46832015|NCT03868631|83049854|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
46832016|NCT03868631|83049855|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
46832017|NCT03868631|83049854|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
46832018|NCT03868631|83049855|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
46832019|NCT03868631|83049854|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
46832020|NCT03868631|83049855|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
46832021|NCT03868631|83049854|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
46832022|NCT03868631|83049855|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
46832023|NCT05142332|83049863|FG000|Overall Study|Withdrawal by Subject|0|||
46832024|NCT05142332|83049864|FG001|Overall Study|Withdrawal by Subject|1|||
46832025|NCT05142332|83049865|FG002|Overall Study|Withdrawal by Subject|2|||
46832026|NCT05142332|83049866|FG003|Overall Study|Withdrawal by Subject|0|||
46832027|NCT05142332|83049867|FG004|Overall Study|Withdrawal by Subject|0|||
46832028|NCT05142332|83049868|FG005|Overall Study|Withdrawal by Subject|2|||
46832029|NCT05142332|83049869|FG006|Overall Study|Withdrawal by Subject|6|||
46832030|NCT05142332|83049863|FG000|Overall Study|Left ED|3|||
46832031|NCT05142332|83049864|FG001|Overall Study|Left ED|0|||
46832032|NCT05142332|83049865|FG002|Overall Study|Left ED|4|||
46832033|NCT05142332|83049866|FG003|Overall Study|Left ED|6|||
46832034|NCT05142332|83049867|FG004|Overall Study|Left ED|1|||
46832035|NCT05142332|83049868|FG005|Overall Study|Left ED|2|||
46832036|NCT05142332|83049869|FG006|Overall Study|Left ED|6|||
46832037|NCT05142332|83049863|FG000|Overall Study|Physician Decision|0|||
46832038|NCT05142332|83049864|FG001|Overall Study|Physician Decision|0|||
46937431|NCT02706392|83173988|FG001|Overall Study|Death|0|||
46937432|NCT02706392|83173989|FG002|Overall Study|Death|2|||
46937433|NCT02706392|83173990|FG003|Overall Study|Death|2|||
47061187|NCT02661594|83341433|FG000|Overall Study|Protocol Violation|1|||
46765488|NCT00829166|82983911|FG000|Overall Study|Subject's Decision|41|||
46765489|NCT00829166|82983912|FG001|Overall Study|Subject's Decision|55|||
46765490|NCT00829166|82983911|FG000|Overall Study|Sponsor's Decision|137|||
46765491|NCT00829166|82983912|FG001|Overall Study|Sponsor's Decision|98|||
46765492|NCT00829166|82983911|FG000|Overall Study|Reason Not Specified|3|||
46765493|NCT00829166|82983912|FG001|Overall Study|Reason Not Specified|3|||
46765494|NCT00799266|82983921|FG000|Overall Study|Adverse Event|0|||
46765495|NCT00799266|82983922|FG001|Overall Study|Adverse Event|1|||
46765496|NCT00799266|82983921|FG000|Overall Study|Subject withdrew consent|3|||
46765497|NCT00799266|82983922|FG001|Overall Study|Subject withdrew consent|0|||
46937434|NCT02706392|83173991|FG004|Overall Study|Death|5|||
46937435|NCT02706392|83173992|FG005|Overall Study|Death|2|||
46937436|NCT03042767|83174008|FG000|Overall Study|Lost to Follow-up|1|||
46937437|NCT03042767|83174009|FG001|Overall Study|Lost to Follow-up|2|||
46937438|NCT00703820|83174017|FG000|Overall Study|Adverse Event|12|||
46937439|NCT00703820|83174018|FG001|Overall Study|Adverse Event|17|||
46937440|NCT00703820|83174017|FG000|Overall Study|Death|5|||
46937441|NCT00703820|83174018|FG001|Overall Study|Death|0|||
46937442|NCT00703820|83174017|FG000|Overall Study|Lack of Efficacy|11|||
46937443|NCT00703820|83174018|FG001|Overall Study|Lack of Efficacy|11|||
46937444|NCT00703820|83174017|FG000|Overall Study|Received non-protocol therapy|1|||
46937445|NCT00703820|83174018|FG001|Overall Study|Received non-protocol therapy|0|||
46937446|NCT00703820|83174017|FG000|Overall Study|Physician Decision|4|||
46937447|NCT00703820|83174018|FG001|Overall Study|Physician Decision|5|||
46937448|NCT00703820|83174017|FG000|Overall Study|Withdrawal by Subject|2|||
47061188|NCT02661594|83341434|FG001|Overall Study|Protocol Violation|0|||
47061189|NCT02661594|83341435|FG002|Overall Study|Protocol Violation|1|||
46832039|NCT05142332|83049865|FG002|Overall Study|Physician Decision|2|||
46832040|NCT05142332|83049866|FG003|Overall Study|Physician Decision|1|||
46832041|NCT05142332|83049867|FG004|Overall Study|Physician Decision|0|||
46832042|NCT05142332|83049868|FG005|Overall Study|Physician Decision|0|||
46832043|NCT05142332|83049869|FG006|Overall Study|Physician Decision|3|||
46832044|NCT05142332|83049863|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
46832045|NCT05142332|83049864|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
46832046|NCT05142332|83049865|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
46832047|NCT05142332|83049866|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
46832048|NCT05142332|83049867|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
46832049|NCT05142332|83049868|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
46832050|NCT05142332|83049869|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
46832051|NCT04556838|83049903|FG000|Overall Study|Withdrawal by Subject|3|||
46832052|NCT04556838|83049904|FG001|Overall Study|Withdrawal by Subject|1|||
46832053|NCT04556838|83049905|FG002|Overall Study|Withdrawal by Subject|2|||
46832054|NCT04556838|83049903|FG000|Overall Study|Adverse Event|0|||
46832055|NCT04556838|83049904|FG001|Overall Study|Adverse Event|1|||
46832056|NCT04556838|83049905|FG002|Overall Study|Adverse Event|1|||
46832057|NCT04556838|83049903|FG000|Overall Study|Lost to Follow-up|0|||
46832058|NCT04556838|83049904|FG001|Overall Study|Lost to Follow-up|0|||
46832059|NCT04556838|83049905|FG002|Overall Study|Lost to Follow-up|2|||
46832060|NCT04556838|83049903|FG000|Overall Study|Subject travel|0|||
46832061|NCT04556838|83049904|FG001|Overall Study|Subject travel|1|||
46832062|NCT04556838|83049905|FG002|Overall Study|Subject travel|0|||
46832063|NCT04556838|83049903|FG000|Overall Study|Physician Decision|1|||
46832064|NCT04556838|83049904|FG001|Overall Study|Physician Decision|0|||
46832065|NCT04556838|83049905|FG002|Overall Study|Physician Decision|0|||
46832066|NCT04523181|83049924|FG000|Overall Study|Withdrawal by Subject|4|||
46832067|NCT04523181|83049925|FG001|Overall Study|Withdrawal by Subject|5|||
46832068|NCT04523181|83049924|FG000|Overall Study|Lost to Follow-up|2|||
46832069|NCT04523181|83049925|FG001|Overall Study|Lost to Follow-up|3|||
46937449|NCT00703820|83174018|FG001|Overall Study|Withdrawal by Subject|1|||
46937450|NCT03045887|83174036|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
46937451|NCT03045887|83174037|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937452|NCT03045887|83174038|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937453|NCT03045887|83174039|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
47061190|NCT02661594|83341436|FG003|Overall Study|Protocol Violation|0|||
47061191|NCT01528345|83341448|FG000|Overall Study|Adverse Event|10|||
47061192|NCT01528345|83341449|FG001|Overall Study|Adverse Event|1|||
47061193|NCT01528345|83341448|FG000|Overall Study|Death|1|||
47061194|NCT01528345|83341449|FG001|Overall Study|Death|1|||
46637713|NCT01474512|82811386|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
46637714|NCT01474512|82811387|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
46637715|NCT01474512|82811388|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
46765498|NCT00650104|82983928|FG000|Overall Study|Adverse Event|17|||
46765499|NCT00650104|82983928|FG000|Overall Study|Death|2|||
46765500|NCT00650104|82983928|FG000|Overall Study|Withdrawal by Subject|11|||
46765501|NCT00650104|82983928|FG000|Overall Study|Physician Decision|7|||
46765502|NCT00650104|82983928|FG000|Overall Study|Lost to Follow-up|1|||
46765503|NCT00650104|82983928|FG000|Overall Study|Non-compliance|2|||
46765504|NCT00650104|82983928|FG000|Overall Study|Sponsor Terminated Dosing|1|||
46765505|NCT00654238|82983932|FG000|Overall Study|Screen Failures|4|||
46765506|NCT00862979|82983939|FG000|Overall Study|Adverse Event|6|||
46765507|NCT00862979|82983940|FG001|Overall Study|Adverse Event|3|||
46765508|NCT00862979|82983939|FG000|Overall Study|Protocol Violation|0|||
46765509|NCT00862979|82983940|FG001|Overall Study|Protocol Violation|1|||
46765510|NCT00862979|82983939|FG000|Overall Study|Patient withdrew consent|2|||
46765511|NCT00862979|82983940|FG001|Overall Study|Patient withdrew consent|1|||
46765512|NCT00862979|82983939|FG000|Overall Study|Administrative problems|0|||
46937454|NCT03045887|83174040|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937455|NCT03045887|83174041|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937456|NCT03045887|83174042|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937457|NCT03045887|83174043|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937458|NCT03045887|83174044|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937459|NCT03045887|83174045|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
46937460|NCT03045887|83174036|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937461|NCT03045887|83174037|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937462|NCT03045887|83174038|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937463|NCT03045887|83174039|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
46937464|NCT03045887|83174040|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937465|NCT03045887|83174041|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937466|NCT03045887|83174042|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937467|NCT03045887|83174043|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937468|NCT03045887|83174044|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937469|NCT03045887|83174045|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
46937470|NCT03045887|83174036|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
46937471|NCT03045887|83174037|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937472|NCT03045887|83174038|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937473|NCT03045887|83174039|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937474|NCT03045887|83174040|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937475|NCT03045887|83174041|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937476|NCT03045887|83174042|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937477|NCT03045887|83174043|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937478|NCT03045887|83174044|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
46937479|NCT03045887|83174045|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
47061195|NCT01528345|83341448|FG000|Overall Study|Non-compliance with study treatment|1|||
47061196|NCT01528345|83341449|FG001|Overall Study|Non-compliance with study treatment|0|||
47061197|NCT01528345|83341448|FG000|Overall Study|Progressive Disease|26|||
47061198|NCT01528345|83341449|FG001|Overall Study|Progressive Disease|40|||
47061199|NCT01528345|83341448|FG000|Overall Study|Study Terminated by Sponsor|4|||
47061200|NCT01528345|83341449|FG001|Overall Study|Study Terminated by Sponsor|8|||
47061201|NCT01528345|83341448|FG000|Overall Study|Subject/Guardian Decision|5|||
47061202|NCT01528345|83341449|FG001|Overall Study|Subject/Guardian Decision|0|||
47061203|NCT01513967|83341463|FG000|Overall Study|Pregnancy|0|||
47061204|NCT01513967|83341464|FG001|Overall Study|Pregnancy|0|||
47061205|NCT01513967|83341465|FG002|Overall Study|Pregnancy|0|||
47061206|NCT01513967|83341466|FG003|Overall Study|Pregnancy|0|||
47061207|NCT01513967|83341467|FG004|Overall Study|Pregnancy|0|||
46832070|NCT04523181|83049924|FG000|Overall Study|Physician Decision|1|||
46832071|NCT04523181|83049925|FG001|Overall Study|Physician Decision|0|||
46832072|NCT04523181|83049924|FG000|Overall Study|Transferred to external facility.|1|||
46832073|NCT04523181|83049925|FG001|Overall Study|Transferred to external facility.|1|||
46832074|NCT04439799|83049935|FG000|Overall Study|Lost to Follow-up|6|||
46832075|NCT04439799|83049936|FG001|Overall Study|Lost to Follow-up|6|||
46832076|NCT04439799|83049935|FG000|Overall Study|Withdrawal by Subject|2|||
46832077|NCT04439799|83049936|FG001|Overall Study|Withdrawal by Subject|6|||
46832078|NCT04439799|83049935|FG000|Overall Study|Adverse Event|2|||
46832079|NCT04439799|83049936|FG001|Overall Study|Adverse Event|5|||
46832080|NCT04071626|83049952|FG000|Overall Study|Withdrawal by Subject|1|||
46832081|NCT04071626|83049953|FG001|Overall Study|Withdrawal by Subject|1|||
46832082|NCT04071626|83049952|FG000|Overall Study|Protocol Violation|0|||
46832083|NCT04071626|83049953|FG001|Overall Study|Protocol Violation|1|||
46832084|NCT04051008|83049962|FG000|Overall Study|Withdrawal by Subject|2|||
46832085|NCT04051008|83049963|FG001|Overall Study|Withdrawal by Subject|0|||
46832086|NCT04051008|83049964|FG002|Overall Study|Withdrawal by Subject|1|||
46832087|NCT03812185|83049986|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
46832088|NCT03789110|83049992|FG000|Overall Study|Adverse Event|2|||
46832089|NCT03789110|83049992|FG000|Overall Study|Physician Decision|1|||
46832090|NCT03789110|83049992|FG000|Overall Study|Withdrawal by Subject|2|||
46832091|NCT03789110|83049992|FG000|Overall Study|Lack of Efficacy|22|||
46832092|NCT03789110|83049992|FG000|Overall Study|still on treatment|3|||
46832093|NCT03692910|83050009|FG000|Overall Study|Lost to Follow-up|4|||
46832094|NCT03692910|83050010|FG001|Overall Study|Lost to Follow-up|0|||
46832095|NCT03692910|83050011|FG002|Overall Study|Lost to Follow-up|0|||
46832096|NCT03692910|83050009|FG000|Overall Study|Withdrawal by Subject|2|||
46832097|NCT03692910|83050010|FG001|Overall Study|Withdrawal by Subject|0|||
46832098|NCT03692910|83050011|FG002|Overall Study|Withdrawal by Subject|0|||
46937480|NCT03045887|83174036|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46937481|NCT03045887|83174037|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46637716|NCT01474512|82811389|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
46832099|NCT03645863|83050020|FG000|Overall Study|Withdrawal by Subject|1|||
47061208|NCT01513967|83341468|FG005|Overall Study|Pregnancy|0|||
47061209|NCT01513967|83341469|FG006|Overall Study|Pregnancy|1|||
46937482|NCT03045887|83174038|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
46937483|NCT03045887|83174039|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
46937484|NCT03045887|83174040|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46937485|NCT03045887|83174041|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46937486|NCT03045887|83174042|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46937487|NCT03045887|83174043|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46937488|NCT03045887|83174044|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46937489|NCT03045887|83174045|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
46937490|NCT03045887|83174036|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937491|NCT03045887|83174037|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937492|NCT03045887|83174038|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937493|NCT03045887|83174039|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
46937494|NCT03045887|83174040|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937495|NCT03045887|83174041|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937496|NCT03045887|83174042|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937497|NCT03045887|83174043|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937498|NCT03045887|83174044|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937499|NCT03045887|83174045|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46937500|NCT01564537|83174074|FG000|Overall Study|Site Terminated by Sponsor|1|||
46937501|NCT01564537|83174075|FG001|Overall Study|Site Terminated by Sponsor|0|||
46937502|NCT01564537|83174074|FG000|Overall Study|Withdrawal by Subject|12|||
46937503|NCT01564537|83174075|FG001|Overall Study|Withdrawal by Subject|14|||
46937504|NCT01564537|83174074|FG000|Overall Study|Lost to Follow-up|7|||
46937505|NCT01564537|83174075|FG001|Overall Study|Lost to Follow-up|3|||
46937506|NCT01564537|83174074|FG000|Overall Study|Reason not specified|81|||
46937507|NCT01564537|83174075|FG001|Overall Study|Reason not specified|82|||
46937508|NCT03042611|83174086|FG000|Core Phase|Withdrawal by Subject|13|||
46937509|NCT03042611|83174087|FG001|Core Phase|Withdrawal by Subject|4|||
46937510|NCT03042611|83174088|FG002|Core Phase|Withdrawal by Subject|0|||
46937511|NCT03042611|83174089|FG003|Core Phase|Withdrawal by Subject|0|||
46937512|NCT03042611|83174086|FG000|Core Phase|Death|232|||
46937513|NCT03042611|83174087|FG001|Core Phase|Death|110|||
46937514|NCT03042611|83174088|FG002|Core Phase|Death|0|||
46937515|NCT03042611|83174089|FG003|Core Phase|Death|0|||
46937516|NCT03042611|83174086|FG000|Core Phase|Lost to Follow-up|4|||
46937517|NCT03042611|83174087|FG001|Core Phase|Lost to Follow-up|7|||
46937518|NCT03042611|83174088|FG002|Core Phase|Lost to Follow-up|0|||
46937519|NCT03042611|83174089|FG003|Core Phase|Lost to Follow-up|0|||
46937520|NCT03042611|83174086|FG000|Core Phase|Physician Decision|7|||
46937521|NCT03042611|83174087|FG001|Core Phase|Physician Decision|2|||
46937522|NCT03042611|83174088|FG002|Core Phase|Physician Decision|0|||
46937523|NCT03042611|83174089|FG003|Core Phase|Physician Decision|0|||
46937524|NCT03042611|83174086|FG000|Core Phase|Study Closed|0|||
46937525|NCT03042611|83174087|FG001|Core Phase|Study Closed|1|||
46937526|NCT03042611|83174088|FG002|Core Phase|Study Closed|0|||
46937527|NCT03042611|83174089|FG003|Core Phase|Study Closed|0|||
46937528|NCT03042611|83174086|FG000|Extension Phase|Death|0|||
46937529|NCT03042611|83174087|FG001|Extension Phase|Death|0|||
46937530|NCT03042611|83174088|FG002|Extension Phase|Death|34|||
46937531|NCT03042611|83174089|FG003|Extension Phase|Death|16|||
46937532|NCT03042611|83174086|FG000|Extension Phase|Lost to Follow-up|0|||
46937533|NCT03042611|83174087|FG001|Extension Phase|Lost to Follow-up|0|||
46937534|NCT03042611|83174088|FG002|Extension Phase|Lost to Follow-up|1|||
46937535|NCT03042611|83174089|FG003|Extension Phase|Lost to Follow-up|1|||
46937536|NCT03042611|83174086|FG000|Extension Phase|Study Closed|0|||
46937537|NCT03042611|83174087|FG001|Extension Phase|Study Closed|0|||
46937538|NCT03042611|83174088|FG002|Extension Phase|Study Closed|17|||
46937539|NCT03042611|83174089|FG003|Extension Phase|Study Closed|11|||
46937540|NCT02701634|83174097|FG000|Overall Study|Adverse Event|2|||
46937541|NCT02701634|83174098|FG001|Overall Study|Adverse Event|3|||
46937542|NCT02701634|83174097|FG000|Overall Study|Death|1|||
46937543|NCT02701634|83174098|FG001|Overall Study|Death|0|||
46937544|NCT02701634|83174097|FG000|Overall Study|Investigator's Discretion|7|||
46937545|NCT02701634|83174098|FG001|Overall Study|Investigator's Discretion|4|||
46937546|NCT02701634|83174097|FG000|Overall Study|Study terminated by Sponsor|15|||
46937547|NCT02701634|83174098|FG001|Overall Study|Study terminated by Sponsor|17|||
47061210|NCT01513967|83341470|FG007|Overall Study|Pregnancy|0|||
46937548|NCT02701634|83174097|FG000|Overall Study|Withdrew Consent|6|||
46637717|NCT01474512|82811390|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
46937549|NCT02701634|83174098|FG001|Overall Study|Withdrew Consent|7|||
46937550|NCT02701634|83174097|FG000|Overall Study|Randomized but not treated|1|||
46937551|NCT02701634|83174098|FG001|Overall Study|Randomized but not treated|0|||
46937552|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
46937553|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
46937554|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
46937555|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
46937556|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
46937557|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
46937558|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
46937559|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
46937560|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Death|0|||
46937561|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Death|0|||
46937562|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Death|0|||
46937563|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Death|1|||
46937564|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Death|1|||
46937565|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Death|0|||
46937566|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Death|2|||
46937567|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Death|0|||
46937568|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
46937569|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
46937570|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
46937571|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
46937572|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
46937573|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
46937574|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
46937575|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
46937576|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
46937577|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
46937578|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
46937579|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
46937580|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
46937581|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
46937582|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
46937583|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
46937584|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
46937585|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
46937586|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
46937587|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
46937588|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
46937589|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
46937590|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
46937591|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
46937592|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
46937593|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
46937594|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
46937595|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
46937596|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
46937597|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
46937598|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
46937599|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
46937600|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
46937601|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
46937602|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
46937603|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
46937604|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
46832100|NCT03645863|83050021|FG001|Overall Study|Withdrawal by Subject|0|||
46832101|NCT03645863|83050022|FG002|Overall Study|Withdrawal by Subject|0|||
46832102|NCT03220776|83050043|FG000|Overall Study|Claustrophobia|0|||
46832103|NCT03220776|83050044|FG001|Overall Study|Claustrophobia|1|||
46832104|NCT03220776|83050045|FG002|Overall Study|Claustrophobia|1|||
46832105|NCT03220776|83050046|FG003|Overall Study|Claustrophobia|0|||
46832106|NCT03220776|83050047|FG004|Overall Study|Claustrophobia|1|||
46832107|NCT03220776|83050048|FG005|Overall Study|Claustrophobia|0|||
46832108|NCT03220776|83050043|FG000|Overall Study|MRI Equipment Failure|1|||
46832109|NCT03220776|83050044|FG001|Overall Study|MRI Equipment Failure|0|||
46832110|NCT03220776|83050045|FG002|Overall Study|MRI Equipment Failure|0|||
46832111|NCT03220776|83050046|FG003|Overall Study|MRI Equipment Failure|0|||
46832112|NCT03220776|83050047|FG004|Overall Study|MRI Equipment Failure|0|||
46832113|NCT03220776|83050048|FG005|Overall Study|MRI Equipment Failure|0|||
46832114|NCT03220776|83050043|FG000|Overall Study|Inclimate Weather|0|||
46832115|NCT03220776|83050044|FG001|Overall Study|Inclimate Weather|0|||
46832116|NCT03220776|83050045|FG002|Overall Study|Inclimate Weather|0|||
46937605|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
46937606|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
46937607|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
46937608|NCT02442765|83174108|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
46937609|NCT02442765|83174109|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
46937610|NCT02442765|83174110|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
46937611|NCT02442765|83174111|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
46937612|NCT02442765|83174112|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
46832117|NCT03220776|83050046|FG003|Overall Study|Inclimate Weather|0|||
46832118|NCT03220776|83050047|FG004|Overall Study|Inclimate Weather|0|||
46832119|NCT03220776|83050048|FG005|Overall Study|Inclimate Weather|1|||
46832120|NCT03220776|83050043|FG000|Overall Study|Physician Decision|0|||
46832121|NCT03220776|83050044|FG001|Overall Study|Physician Decision|0|||
46937613|NCT02442765|83174113|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
46937614|NCT02442765|83174114|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
46937615|NCT02442765|83174115|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
47061211|NCT01513967|83341463|FG000|Overall Study|missed a study visit|0|||
47061212|NCT01513967|83341464|FG001|Overall Study|missed a study visit|0|||
47061213|NCT01513967|83341465|FG002|Overall Study|missed a study visit|0|||
47061214|NCT01513967|83341466|FG003|Overall Study|missed a study visit|0|||
46937616|NCT02699684|83174146|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
46937617|NCT02699684|83174147|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
46937618|NCT02700698|83174156|FG000|Overall Study|Withdrawal by Subject|1|||
46937619|NCT02700698|83174157|FG001|Overall Study|Withdrawal by Subject|0|||
46937620|NCT01774721|83174165|FG000|Overall Study|Death|133|||
46937621|NCT01774721|83174166|FG001|Overall Study|Death|152|||
46937622|NCT01774721|83174165|FG000|Overall Study|Withdrawal by Subject|20|||
47061215|NCT01513967|83341467|FG004|Overall Study|missed a study visit|0|||
47061216|NCT01513967|83341468|FG005|Overall Study|missed a study visit|0|||
47061217|NCT01513967|83341469|FG006|Overall Study|missed a study visit|1|||
47061218|NCT01513967|83341470|FG007|Overall Study|missed a study visit|0|||
46832122|NCT03220776|83050045|FG002|Overall Study|Physician Decision|0|||
46937623|NCT01774721|83174166|FG001|Overall Study|Withdrawal by Subject|14|||
46937624|NCT01774721|83174165|FG000|Overall Study|Lost to Follow-up|6|||
46937625|NCT01774721|83174166|FG001|Overall Study|Lost to Follow-up|7|||
46937626|NCT01774721|83174165|FG000|Overall Study|Did not meet eligibility criteria|0|||
46937627|NCT01774721|83174166|FG001|Overall Study|Did not meet eligibility criteria|3|||
46937628|NCT01774721|83174165|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
46937629|NCT01774721|83174166|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
46937630|NCT01774721|83174165|FG000|Overall Study|Study terminated by sponsor|5|||
46832123|NCT03220776|83050046|FG003|Overall Study|Physician Decision|1|||
46832124|NCT03220776|83050047|FG004|Overall Study|Physician Decision|0|||
46832125|NCT03220776|83050048|FG005|Overall Study|Physician Decision|0|||
46832126|NCT03220776|83050043|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
46832127|NCT03220776|83050044|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
46832128|NCT03220776|83050045|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
46832129|NCT03220776|83050046|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
46832130|NCT03220776|83050047|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
46832131|NCT03220776|83050048|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
46832132|NCT03220776|83050043|FG000|Overall Study|Protocol Violation|0|||
46832133|NCT03220776|83050044|FG001|Overall Study|Protocol Violation|0|||
46832134|NCT03220776|83050045|FG002|Overall Study|Protocol Violation|0|||
46832135|NCT03220776|83050046|FG003|Overall Study|Protocol Violation|2|||
46832136|NCT03220776|83050047|FG004|Overall Study|Protocol Violation|0|||
46832137|NCT03220776|83050048|FG005|Overall Study|Protocol Violation|1|||
46832138|NCT03220776|83050043|FG000|Overall Study|Withdrawal by Subject|1|||
46832139|NCT03220776|83050044|FG001|Overall Study|Withdrawal by Subject|0|||
46832140|NCT03220776|83050045|FG002|Overall Study|Withdrawal by Subject|0|||
46832141|NCT03220776|83050046|FG003|Overall Study|Withdrawal by Subject|0|||
46832142|NCT03220776|83050047|FG004|Overall Study|Withdrawal by Subject|0|||
46832143|NCT03220776|83050048|FG005|Overall Study|Withdrawal by Subject|0|||
46832144|NCT03201874|83050058|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
46832145|NCT03201874|83050059|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
46832146|NCT03201874|83050058|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
46832147|NCT03201874|83050059|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
46832148|NCT03006926|83050086|FG000|Overall Study|Adverse Event|0|||
46832149|NCT03006926|83050087|FG001|Overall Study|Adverse Event|27|||
46832150|NCT03006926|83050086|FG000|Overall Study|Withdrawal by Subject|0|||
46832151|NCT03006926|83050087|FG001|Overall Study|Withdrawal by Subject|1|||
46832152|NCT03006926|83050086|FG000|Overall Study|Radiological Disease Progression|0|||
46937631|NCT01774721|83174166|FG001|Overall Study|Study terminated by sponsor|0|||
46937632|NCT01774721|83174165|FG000|Overall Study|Disease progression|5|||
46937633|NCT01774721|83174166|FG001|Overall Study|Disease progression|0|||
46937634|NCT02699450|83174178|FG000|Overall Study|Death|2|||
46937635|NCT02699450|83174179|FG001|Overall Study|Death|1|||
46637718|NCT01474512|82811391|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
46637719|NCT01474512|82811392|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
46832153|NCT03006926|83050087|FG001|Overall Study|Radiological Disease Progression|52|||
46937636|NCT02699450|83174180|FG002|Overall Study|Death|2|||
46937637|NCT02699450|83174178|FG000|Overall Study|Met Criteria for Study Exit|0|||
46937638|NCT02699450|83174179|FG001|Overall Study|Met Criteria for Study Exit|0|||
46937639|NCT02699450|83174180|FG002|Overall Study|Met Criteria for Study Exit|1|||
46937640|NCT02699450|83174178|FG000|Overall Study|Protocol Violation|4|||
46937641|NCT02699450|83174179|FG001|Overall Study|Protocol Violation|3|||
46937642|NCT02699450|83174180|FG002|Overall Study|Protocol Violation|5|||
46937643|NCT02699450|83174178|FG000|Overall Study|Lost to Follow-up|3|||
46937644|NCT02699450|83174179|FG001|Overall Study|Lost to Follow-up|0|||
46937645|NCT02699450|83174180|FG002|Overall Study|Lost to Follow-up|5|||
46937646|NCT02699450|83174178|FG000|Overall Study|Physician Decision|2|||
46937647|NCT02699450|83174179|FG001|Overall Study|Physician Decision|0|||
46937648|NCT02699450|83174180|FG002|Overall Study|Physician Decision|0|||
46937649|NCT02699450|83174178|FG000|Overall Study|Withdrawal by Subject|3|||
46937650|NCT02699450|83174179|FG001|Overall Study|Withdrawal by Subject|1|||
46937651|NCT02699450|83174180|FG002|Overall Study|Withdrawal by Subject|2|||
46937652|NCT02699450|83174178|FG000|Overall Study|Adverse Event|1|||
46937653|NCT02699450|83174179|FG001|Overall Study|Adverse Event|0|||
46937654|NCT02699450|83174180|FG002|Overall Study|Adverse Event|0|||
46937655|NCT02699996|83174191|FG000|Overall Study|Withdrawal by Subject|5|||
46937656|NCT02699996|83174192|FG001|Overall Study|Withdrawal by Subject|2|||
46937657|NCT02739321|83174201|FG000|Overall Study|Lack of Efficacy|1|||
46937658|NCT02739321|83174202|FG001|Overall Study|Lack of Efficacy|1|||
46937659|NCT02739321|83174201|FG000|Overall Study|Lost to Follow-up|1|||
46937660|NCT02739321|83174202|FG001|Overall Study|Lost to Follow-up|1|||
46937661|NCT02739321|83174201|FG000|Overall Study|Withdrawal by Subject|1|||
46937662|NCT02739321|83174202|FG001|Overall Study|Withdrawal by Subject|2|||
46937663|NCT02696798|83174220|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
46937664|NCT02696798|83174221|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
46937665|NCT02696798|83174222|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
46937666|NCT02696798|83174220|FG000|Blinded Treatment Dosing Period|Death|0|||
46937667|NCT02696798|83174221|FG001|Blinded Treatment Dosing Period|Death|0|||
46937668|NCT02696798|83174222|FG002|Blinded Treatment Dosing Period|Death|1|||
46937669|NCT02696798|83174220|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
46937670|NCT02696798|83174221|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
46937671|NCT02696798|83174222|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
46937672|NCT02696798|83174220|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
46937673|NCT02696798|83174221|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
46937674|NCT02696798|83174222|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
46937675|NCT02696798|83174220|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
46937676|NCT02696798|83174221|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
46832154|NCT03006926|83050086|FG000|Overall Study|Clinical Disease Progression|0|||
46832155|NCT03006926|83050087|FG001|Overall Study|Clinical Disease Progression|10|||
46832156|NCT03006926|83050086|FG000|Overall Study|Other|0|||
46832157|NCT03006926|83050087|FG001|Overall Study|Other|8|||
46832158|NCT02684058|83050113|FG000|Treatment Period|Progressive disease|4|||
46832159|NCT02684058|83050114|FG001|Treatment Period|Progressive disease|10|||
46832160|NCT02684058|83050115|FG002|Treatment Period|Progressive disease|19|||
46832161|NCT02684058|83050113|FG000|Treatment Period|Adverse Event|3|||
46832162|NCT02684058|83050114|FG001|Treatment Period|Adverse Event|8|||
46832163|NCT02684058|83050115|FG002|Treatment Period|Adverse Event|1|||
46832164|NCT02684058|83050113|FG000|Treatment Period|Physician Decision|5|||
46832165|NCT02684058|83050114|FG001|Treatment Period|Physician Decision|1|||
46832166|NCT02684058|83050115|FG002|Treatment Period|Physician Decision|2|||
46832167|NCT02684058|83050113|FG000|Treatment Period|New therapy for study indication|1|||
46832168|NCT02684058|83050114|FG001|Treatment Period|New therapy for study indication|0|||
46832169|NCT02684058|83050115|FG002|Treatment Period|New therapy for study indication|0|||
46832170|NCT02684058|83050113|FG000|Treatment Period|Protocol deviation|0|||
46832171|NCT02684058|83050114|FG001|Treatment Period|Protocol deviation|1|||
46832172|NCT02684058|83050115|FG002|Treatment Period|Protocol deviation|0|||
46832173|NCT02684058|83050113|FG000|Treatment Period|Subject/guardian decision|4|||
46832174|NCT02684058|83050114|FG001|Treatment Period|Subject/guardian decision|3|||
46832175|NCT02684058|83050115|FG002|Treatment Period|Subject/guardian decision|0|||
46832176|NCT02684058|83050113|FG000|Treatment Period|Death|0|||
46832177|NCT02684058|83050114|FG001|Treatment Period|Death|0|||
46832178|NCT02684058|83050115|FG002|Treatment Period|Death|2|||
46937677|NCT02696798|83174222|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
46832179|NCT02684058|83050113|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
46832180|NCT02684058|83050114|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
46832181|NCT02684058|83050115|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
46937678|NCT02696798|83174220|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
46937679|NCT02696798|83174221|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
46937680|NCT02696798|83174222|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
46937681|NCT02696798|83174220|FG000|Extended Treatment Period|Adverse Event|1|||
46637720|NCT01474512|82811393|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
46937682|NCT02696798|83174221|FG001|Extended Treatment Period|Adverse Event|4|||
46937683|NCT02696798|83174222|FG002|Extended Treatment Period|Adverse Event|5|||
46937684|NCT02696798|83174220|FG000|Extended Treatment Period|Lack of Efficacy|7|||
46937685|NCT02696798|83174221|FG001|Extended Treatment Period|Lack of Efficacy|2|||
46937686|NCT02696798|83174222|FG002|Extended Treatment Period|Lack of Efficacy|2|||
46937687|NCT02696798|83174220|FG000|Extended Treatment Period|Lost to Follow-up|1|||
46937688|NCT02696798|83174221|FG001|Extended Treatment Period|Lost to Follow-up|0|||
46937689|NCT02696798|83174222|FG002|Extended Treatment Period|Lost to Follow-up|0|||
46832182|NCT02684058|83050113|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
46832183|NCT02684058|83050114|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
46832184|NCT02684058|83050115|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
46937690|NCT02696798|83174220|FG000|Extended Treatment Period|Physician Decision|0|||
46937691|NCT02696798|83174221|FG001|Extended Treatment Period|Physician Decision|1|||
46937692|NCT02696798|83174222|FG002|Extended Treatment Period|Physician Decision|0|||
46937693|NCT02696798|83174220|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
46937694|NCT02696798|83174221|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
46937695|NCT02696798|83174222|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
46937696|NCT02696798|83174220|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
46937697|NCT02696798|83174221|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
46937698|NCT02696798|83174222|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
46937699|NCT02696798|83174220|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
46937700|NCT02696798|83174221|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
46937701|NCT02696798|83174222|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
46937702|NCT02696798|83174220|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
46937703|NCT02696798|83174221|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
46937704|NCT02696798|83174222|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
46937705|NCT02696798|83174220|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
46937706|NCT02696798|83174221|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
46937707|NCT02696798|83174222|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
46937708|NCT02696798|83174220|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
46937709|NCT02696798|83174221|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
46937710|NCT02696798|83174222|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
46937711|NCT02696798|83174220|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
46937712|NCT02696798|83174221|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
46937713|NCT02696798|83174222|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
46937714|NCT02698826|83174244|FG000|Overall Study|Death|13|||
46937715|NCT02698826|83174244|FG000|Overall Study|Adverse Event|1|||
46937716|NCT02541604|83174262|FG000|Overall Study|Death|6|||
46937717|NCT02541604|83174263|FG001|Overall Study|Death|5|||
46937718|NCT02541604|83174264|FG002|Overall Study|Death|7|||
46937719|NCT02541604|83174265|FG003|Overall Study|Death|2|||
46832185|NCT02684058|83050113|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
46832186|NCT02684058|83050114|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
46937720|NCT02541604|83174266|FG004|Overall Study|Death|9|||
46937721|NCT02541604|83174267|FG005|Overall Study|Death|8|||
46937722|NCT02541604|83174268|FG006|Overall Study|Death|9|||
46937723|NCT02541604|83174269|FG007|Overall Study|Death|9|||
46937724|NCT02541604|83174270|FG008|Overall Study|Death|3|||
46937725|NCT02541604|83174271|FG009|Overall Study|Death|4|||
46937726|NCT02541604|83174272|FG010|Overall Study|Death|2|||
46937727|NCT02541604|83174273|FG011|Overall Study|Death|3|||
46937728|NCT02541604|83174262|FG000|Overall Study|Lost to Follow-up|2|||
46937729|NCT02541604|83174263|FG001|Overall Study|Lost to Follow-up|0|||
46832187|NCT02684058|83050115|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
46832188|NCT02684058|83050113|FG000|Post-treatment Efficacy Follow-up|Death|0|||
46832189|NCT02684058|83050114|FG001|Post-treatment Efficacy Follow-up|Death|0|||
46832190|NCT02684058|83050115|FG002|Post-treatment Efficacy Follow-up|Death|3|||
46832191|NCT02684058|83050113|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
46832192|NCT02684058|83050114|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
46832193|NCT02684058|83050115|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
46937730|NCT02541604|83174264|FG002|Overall Study|Lost to Follow-up|1|||
46937731|NCT02541604|83174265|FG003|Overall Study|Lost to Follow-up|0|||
46937732|NCT02541604|83174266|FG004|Overall Study|Lost to Follow-up|0|||
46937733|NCT02541604|83174267|FG005|Overall Study|Lost to Follow-up|1|||
46937734|NCT02541604|83174268|FG006|Overall Study|Lost to Follow-up|1|||
46937735|NCT02541604|83174269|FG007|Overall Study|Lost to Follow-up|0|||
46937736|NCT02541604|83174270|FG008|Overall Study|Lost to Follow-up|0|||
46937737|NCT02541604|83174271|FG009|Overall Study|Lost to Follow-up|0|||
46937738|NCT02541604|83174272|FG010|Overall Study|Lost to Follow-up|0|||
46937739|NCT02541604|83174273|FG011|Overall Study|Lost to Follow-up|0|||
46937740|NCT02541604|83174262|FG000|Overall Study|Withdrawal by Subject|2|||
46937741|NCT02541604|83174263|FG001|Overall Study|Withdrawal by Subject|0|||
46937742|NCT02541604|83174264|FG002|Overall Study|Withdrawal by Subject|1|||
46832194|NCT02684058|83050113|FG000|Post-treatment Survival Follow-up|Death|0|||
46832195|NCT02684058|83050114|FG001|Post-treatment Survival Follow-up|Death|0|||
46832196|NCT02684058|83050115|FG002|Post-treatment Survival Follow-up|Death|7|||
46832197|NCT02684058|83050113|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
46832198|NCT02684058|83050114|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
46832199|NCT02684058|83050115|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
46832200|NCT02684058|83050113|FG000|Crossover Treatment Period|Progressive disease|0|||
46832201|NCT02684058|83050114|FG001|Crossover Treatment Period|Progressive disease|1|||
46937743|NCT02541604|83174265|FG003|Overall Study|Withdrawal by Subject|0|||
46937744|NCT02541604|83174266|FG004|Overall Study|Withdrawal by Subject|1|||
46937745|NCT02541604|83174267|FG005|Overall Study|Withdrawal by Subject|1|||
46937746|NCT02541604|83174268|FG006|Overall Study|Withdrawal by Subject|0|||
46832202|NCT02684058|83050115|FG002|Crossover Treatment Period|Progressive disease|0|||
46937747|NCT02541604|83174269|FG007|Overall Study|Withdrawal by Subject|0|||
46937748|NCT02541604|83174270|FG008|Overall Study|Withdrawal by Subject|1|||
46937749|NCT02541604|83174271|FG009|Overall Study|Withdrawal by Subject|0|||
46937750|NCT02541604|83174272|FG010|Overall Study|Withdrawal by Subject|0|||
46937751|NCT02541604|83174273|FG011|Overall Study|Withdrawal by Subject|0|||
46937752|NCT02541604|83174262|FG000|Overall Study|Study Terminated by Sponsor|1|||
46937753|NCT02541604|83174263|FG001|Overall Study|Study Terminated by Sponsor|4|||
46937754|NCT02541604|83174264|FG002|Overall Study|Study Terminated by Sponsor|2|||
46937755|NCT02541604|83174265|FG003|Overall Study|Study Terminated by Sponsor|1|||
46937756|NCT02541604|83174266|FG004|Overall Study|Study Terminated by Sponsor|0|||
46937757|NCT02541604|83174267|FG005|Overall Study|Study Terminated by Sponsor|0|||
46937758|NCT02541604|83174268|FG006|Overall Study|Study Terminated by Sponsor|0|||
46937759|NCT02541604|83174269|FG007|Overall Study|Study Terminated by Sponsor|0|||
46937760|NCT02541604|83174270|FG008|Overall Study|Study Terminated by Sponsor|0|||
46937761|NCT02541604|83174271|FG009|Overall Study|Study Terminated by Sponsor|0|||
46937762|NCT02541604|83174272|FG010|Overall Study|Study Terminated by Sponsor|0|||
46937763|NCT02541604|83174273|FG011|Overall Study|Study Terminated by Sponsor|0|||
46937764|NCT02541604|83174262|FG000|Overall Study|Medical condition may jeopardize safety|0|||
46937765|NCT02541604|83174263|FG001|Overall Study|Medical condition may jeopardize safety|0|||
46937766|NCT02541604|83174264|FG002|Overall Study|Medical condition may jeopardize safety|0|||
46937767|NCT02541604|83174265|FG003|Overall Study|Medical condition may jeopardize safety|0|||
46937768|NCT02541604|83174266|FG004|Overall Study|Medical condition may jeopardize safety|0|||
46937769|NCT02541604|83174267|FG005|Overall Study|Medical condition may jeopardize safety|0|||
46937770|NCT02541604|83174268|FG006|Overall Study|Medical condition may jeopardize safety|0|||
46937771|NCT02541604|83174269|FG007|Overall Study|Medical condition may jeopardize safety|1|||
46937772|NCT02541604|83174270|FG008|Overall Study|Medical condition may jeopardize safety|0|||
46937773|NCT02541604|83174271|FG009|Overall Study|Medical condition may jeopardize safety|0|||
46937774|NCT02541604|83174272|FG010|Overall Study|Medical condition may jeopardize safety|0|||
46937775|NCT02541604|83174273|FG011|Overall Study|Medical condition may jeopardize safety|0|||
46937776|NCT02546674|83174322|FG000|Overall Study|Adverse Event|19|||
46937777|NCT02546674|83174322|FG000|Overall Study|Death|1|||
46832203|NCT02561273|83050132|FG000|Overall Study|Protocol Violation|1|||
46832204|NCT02561273|83050133|FG001|Overall Study|Protocol Violation|0|||
46832205|NCT02006576|83050172|FG000|Overall Study|Withdrawal by Subject|4|||
46832206|NCT02006576|83050173|FG001|Overall Study|Withdrawal by Subject|6|||
46832207|NCT02006576|83050174|FG002|Overall Study|Withdrawal by Subject|2|||
46832208|NCT02006576|83050172|FG000|Overall Study|Death|0|||
46832209|NCT02006576|83050173|FG001|Overall Study|Death|0|||
46832210|NCT02006576|83050174|FG002|Overall Study|Death|1|||
46832211|NCT02006576|83050172|FG000|Overall Study|Lost to Follow-up|1|||
46832212|NCT02006576|83050173|FG001|Overall Study|Lost to Follow-up|0|||
46832213|NCT02006576|83050174|FG002|Overall Study|Lost to Follow-up|1|||
46832214|NCT02006576|83050172|FG000|Overall Study|Screen Failure, too sick, other|13|||
46832215|NCT02006576|83050173|FG001|Overall Study|Screen Failure, too sick, other|1|||
46832216|NCT02006576|83050174|FG002|Overall Study|Screen Failure, too sick, other|13|||
46832217|NCT01651403|83050184|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
46937778|NCT02546674|83174322|FG000|Overall Study|Lost to Follow-up|1|||
46937779|NCT02546674|83174322|FG000|Overall Study|Physician Decision|13|||
46937780|NCT02546674|83174322|FG000|Overall Study|Pregnancy|1|||
46937781|NCT02546674|83174322|FG000|Overall Study|Progressive Disease|2|||
46937782|NCT02546674|83174322|FG000|Overall Study|Protocol Deviation|2|||
46937783|NCT02546674|83174322|FG000|Overall Study|Subject/Guardian Decision|6|||
46937784|NCT02546674|83174322|FG000|Overall Study|Withdrawal of Informed Consent|3|||
46937785|NCT02546362|83174327|FG000|4-week Treatment Period|Lost to Follow-up|1|||
46937786|NCT02546362|83174327|FG000|4-week Treatment Period|Change in medication|2|||
46937787|NCT02546362|83174327|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
46637721|NCT01474512|82811376|FG000|Long-Term Extension Period|Adverse Event|0|||
46832218|NCT01651403|83050185|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
46832219|NCT01651403|83050184|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
46832220|NCT01651403|83050185|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
46832221|NCT01651403|83050184|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
46832222|NCT01651403|83050185|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
46832223|NCT01651403|83050184|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
46832224|NCT01651403|83050185|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
46832225|NCT01651403|83050184|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
46937788|NCT02546362|83174327|FG000|12-week Treatment Period|Lost to Follow-up|2|||
46937789|NCT02546362|83174327|FG000|12-week Treatment Period|Change in medication|1|||
46937790|NCT02698436|83174333|FG000|Overall Study|Adverse Event|1|||
46937791|NCT02698436|83174334|FG001|Overall Study|Adverse Event|0|||
46937792|NCT02698436|83174333|FG000|Overall Study|Withdrawal by Subject|3|||
46937793|NCT02698436|83174334|FG001|Overall Study|Withdrawal by Subject|3|||
46937794|NCT02698436|83174333|FG000|Overall Study|Lost to Follow-up|2|||
46937795|NCT02698436|83174334|FG001|Overall Study|Lost to Follow-up|4|||
46937796|NCT02698436|83174333|FG000|Overall Study|Non-compliance with study regimen|1|||
46937797|NCT02698436|83174334|FG001|Overall Study|Non-compliance with study regimen|0|||
46937798|NCT02694536|83174340|FG000|Overall Study|Progressive Disease|40|||
46937799|NCT02694536|83174340|FG000|Overall Study|Lost to Follow-up|1|||
46937800|NCT02694536|83174340|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
46937801|NCT02694536|83174340|FG000|Overall Study|Withdrawal by Subject|8|||
46937802|NCT02694536|83174340|FG000|Overall Study|Death|8|||
46937803|NCT02694536|83174340|FG000|Overall Study|Other|22|||
46937804|NCT01661686|83174346|FG000|Overall Study|Lost to Follow-up|2|||
46937805|NCT01661686|83174347|FG001|Overall Study|Lost to Follow-up|1|||
46937806|NCT01661686|83174346|FG000|Overall Study|did not receive allocated intervention|0|||
46937807|NCT01661686|83174347|FG001|Overall Study|did not receive allocated intervention|1|||
46937808|NCT02696096|83174353|FG000|Overall Study|ruled out at screening|1|||
46937809|NCT02696096|83174353|FG000|Overall Study|did not attend second fMRI|1|||
46937810|NCT02693834|83174361|FG000|Baseline Measurement|Withdrawal by Subject|1|||
46937811|NCT02693834|83174362|FG001|Baseline Measurement|Withdrawal by Subject|0|||
46937812|NCT02693834|83174361|FG000|Baseline Measurement|Adverse Event|1|||
46937813|NCT02693834|83174362|FG001|Baseline Measurement|Adverse Event|0|||
46937814|NCT02693834|83174361|FG000|Week 2 Practice|Adverse Event|0|||
46937815|NCT02693834|83174362|FG001|Week 2 Practice|Adverse Event|1|||
46937816|NCT02545504|83174370|FG000|Overall Study|Death|174|||
46937817|NCT02545504|83174371|FG001|Overall Study|Death|168|||
46937818|NCT02545504|83174370|FG000|Overall Study|Unknown reason|30|||
46937819|NCT02545504|83174371|FG001|Overall Study|Unknown reason|32|||
46937820|NCT02545504|83174370|FG000|Overall Study|Withdrew consent|9|||
46937821|NCT02545504|83174371|FG001|Overall Study|Withdrew consent|11|||
46937822|NCT02545504|83174370|FG000|Overall Study|Investigator's discretion|3|||
46937823|NCT02545504|83174371|FG001|Overall Study|Investigator's discretion|1|||
46937824|NCT02545504|83174370|FG000|Overall Study|Lost to Follow-up|2|||
46937825|NCT02545504|83174371|FG001|Overall Study|Lost to Follow-up|2|||
46937826|NCT02545270|83174384|FG000|Overall Study|technical difficulties|0|||
46937827|NCT02545270|83174385|FG001|Overall Study|technical difficulties|1|||
46937828|NCT02545270|83174386|FG002|Overall Study|technical difficulties|0|||
46937829|NCT02545270|83174384|FG000|Overall Study|Videos being too similar to other|0|||
47061219|NCT01513967|83341463|FG000|Overall Study|excluded due to positive drug screen|0|||
46832226|NCT01651403|83050185|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
46832227|NCT01651403|83050184|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
46832228|NCT01651403|83050185|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
46832229|NCT01515748|83050198|FG000|Overall Study|Withdrawal by Subject|32|||
46832230|NCT01515748|83050199|FG001|Overall Study|Withdrawal by Subject|41|||
46832231|NCT01515748|83050198|FG000|Overall Study|Lost to Follow-up|2|||
46832232|NCT01515748|83050199|FG001|Overall Study|Lost to Follow-up|4|||
46832233|NCT01515748|83050198|FG000|Overall Study|Other than specified above|5|||
46832234|NCT01515748|83050199|FG001|Overall Study|Other than specified above|10|||
46832235|NCT01309672|83050206|FG000|Overall Study|Lack of Efficacy|20|||
46832236|NCT01309672|83050206|FG000|Overall Study|Other|9|||
46832237|NCT01309672|83050206|FG000|Overall Study|Adverse Event|5|||
46832238|NCT01309672|83050206|FG000|Overall Study|Withdrawal by Subject|3|||
46832239|NCT00340704|83050220|FG000|PK Study|Adverse Event|0|||
46832240|NCT00340704|83050221|FG001|PK Study|Adverse Event|1|||
46832241|NCT00340704|83050222|FG002|PK Study|Adverse Event|0|||
46937830|NCT02545270|83174385|FG001|Overall Study|Videos being too similar to other|0|||
46937831|NCT02545270|83174386|FG002|Overall Study|Videos being too similar to other|2|||
46937832|NCT02540668|83174395|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
46937833|NCT02540668|83174396|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
46937834|NCT02535364|83174420|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
46937835|NCT02535364|83174420|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
46832242|NCT00340704|83050223|FG003|PK Study|Adverse Event|0|||
46832243|NCT00340704|83050224|FG004|PK Study|Adverse Event|0|||
46937836|NCT02535364|83174420|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
46937837|NCT02535364|83174420|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
46937838|NCT02535364|83174420|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
46937839|NCT02535364|83174420|FG000|Part B Screening|Death|2|||
46937840|NCT02535364|83174420|FG000|Part B Screening|Physician Decision|1|||
46937841|NCT02535364|83174420|FG000|Part B Screening|Withdrawal by Subject|1|||
46937842|NCT02535364|83174420|FG000|Part B Screening|Adverse Event|1|||
46937843|NCT02535364|83174420|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
46937844|NCT02535364|83174420|FG000|Study Treatment|Death|1|||
46937845|NCT02535364|83174420|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
46937846|NCT02535364|83174420|FG000|12-Month Follow-up Period|Disease progression|22|||
46937847|NCT02535364|83174420|FG000|12-Month Follow-up Period|Death|5|||
46937848|NCT02535364|83174420|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
46937849|NCT02535364|83174420|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
46937850|NCT02535364|83174420|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
46937851|NCT02540356|83174426|FG000|Overall Study|Terminated due to disease progression|1|||
46937852|NCT02540356|83174427|FG001|Overall Study|Terminated due to disease progression|0|||
46937853|NCT02534896|83174435|FG000|Overall Study|Adverse Event|2|||
46937854|NCT02534896|83174436|FG001|Overall Study|Adverse Event|1|||
46937855|NCT02534896|83174437|FG002|Overall Study|Adverse Event|1|||
46937856|NCT02534896|83174435|FG000|Overall Study|Insufficient therapeutic response|2|||
46937857|NCT02534896|83174436|FG001|Overall Study|Insufficient therapeutic response|0|||
46937858|NCT02534896|83174437|FG002|Overall Study|Insufficient therapeutic response|0|||
46937859|NCT02697734|83174447|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
46937860|NCT02697734|83174448|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
46937861|NCT02697734|83174447|FG000|Core Phase - up to Week 48|Adverse Event|1|||
46937862|NCT02697734|83174448|FG001|Core Phase - up to Week 48|Adverse Event|2|||
46937863|NCT02697734|83174447|FG000|Core Phase - up to Week 48|Physician Decision|1|||
46937864|NCT02697734|83174448|FG001|Core Phase - up to Week 48|Physician Decision|0|||
46937865|NCT02697734|83174447|FG000|Optional Extension Phase|Adverse Event|5|||
46937866|NCT02697734|83174448|FG001|Optional Extension Phase|Adverse Event|1|||
46937867|NCT02697734|83174447|FG000|Optional Extension Phase|Physician Decision|0|||
46937868|NCT02697734|83174448|FG001|Optional Extension Phase|Physician Decision|1|||
46937869|NCT02692586|83174462|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
46937870|NCT02692586|83174462|FG000|Overall Study|Received adjunctive thrombolytics|2|||
46937871|NCT02534350|83174468|FG000|Overall Study|Randomized But Not Treated|1|||
46937872|NCT02534350|83174469|FG001|Overall Study|Randomized But Not Treated|0|||
46937873|NCT02534350|83174468|FG000|Overall Study|Protocol Violation|1|||
46937874|NCT02534350|83174469|FG001|Overall Study|Protocol Violation|0|||
46937875|NCT02534350|83174468|FG000|Overall Study|Withdrew Consent|2|||
46937876|NCT02534350|83174469|FG001|Overall Study|Withdrew Consent|0|||
46937877|NCT02688764|83174477|FG000|Overall Study|Adverse Event|3|||
46937878|NCT02688764|83174478|FG001|Overall Study|Adverse Event|3|||
47061220|NCT01513967|83341464|FG001|Overall Study|excluded due to positive drug screen|0|||
47061221|NCT01513967|83341465|FG002|Overall Study|excluded due to positive drug screen|0|||
47061222|NCT01513967|83341466|FG003|Overall Study|excluded due to positive drug screen|0|||
47061223|NCT01513967|83341467|FG004|Overall Study|excluded due to positive drug screen|0|||
47061224|NCT01513967|83341468|FG005|Overall Study|excluded due to positive drug screen|0|||
46832244|NCT00340704|83050225|FG005|PK Study|Adverse Event|0|||
46832245|NCT00340704|83050226|FG006|PK Study|Adverse Event|0|||
46832246|NCT00340704|83050227|FG007|PK Study|Adverse Event|0|||
46832247|NCT00340704|83050228|FG008|PK Study|Adverse Event|0|||
46832248|NCT00340704|83050220|FG000|PK Study|Not treated|0|||
46832249|NCT00340704|83050221|FG001|PK Study|Not treated|0|||
46832250|NCT00340704|83050222|FG002|PK Study|Not treated|1|||
46832251|NCT00340704|83050223|FG003|PK Study|Not treated|0|||
46832252|NCT00340704|83050224|FG004|PK Study|Not treated|0|||
46832253|NCT00340704|83050225|FG005|PK Study|Not treated|0|||
46832254|NCT00340704|83050226|FG006|PK Study|Not treated|0|||
46832255|NCT00340704|83050227|FG007|PK Study|Not treated|0|||
46832256|NCT00340704|83050228|FG008|PK Study|Not treated|0|||
46832257|NCT00340704|83050220|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
46832258|NCT00340704|83050221|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
46832259|NCT00340704|83050222|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
47061225|NCT01513967|83341469|FG006|Overall Study|excluded due to positive drug screen|0|||
46832260|NCT00340704|83050223|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
46937879|NCT02688764|83174477|FG000|Overall Study|AE/Kidney transplant|1|||
46937880|NCT02688764|83174478|FG001|Overall Study|AE/Kidney transplant|0|||
46937881|NCT02688764|83174477|FG000|Overall Study|AE/Lack of efficacy|1|||
46832261|NCT00340704|83050224|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
46832262|NCT00340704|83050225|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
46832263|NCT00340704|83050226|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
46937882|NCT02688764|83174478|FG001|Overall Study|AE/Lack of efficacy|0|||
46937883|NCT02688764|83174477|FG000|Overall Study|AE/Non-compl.|1|||
46937884|NCT02688764|83174478|FG001|Overall Study|AE/Non-compl.|0|||
46937885|NCT02688764|83174477|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
46832264|NCT00340704|83050227|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
46832265|NCT00340704|83050228|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
46832266|NCT00340704|83050220|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
46832267|NCT00340704|83050221|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
46832268|NCT00340704|83050222|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
47061226|NCT01513967|83341470|FG007|Overall Study|excluded due to positive drug screen|2|||
47061227|NCT01513967|83341463|FG000|Overall Study|Physician Decision|0|||
47061228|NCT01513967|83341464|FG001|Overall Study|Physician Decision|0|||
47061229|NCT01513967|83341465|FG002|Overall Study|Physician Decision|0|||
47061230|NCT01513967|83341466|FG003|Overall Study|Physician Decision|0|||
47061231|NCT01513967|83341467|FG004|Overall Study|Physician Decision|0|||
47061232|NCT01513967|83341468|FG005|Overall Study|Physician Decision|1|||
47061233|NCT01513967|83341469|FG006|Overall Study|Physician Decision|0|||
46832269|NCT00340704|83050223|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
46832270|NCT00340704|83050224|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
46832271|NCT00340704|83050225|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
46832272|NCT00340704|83050226|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
46832273|NCT00340704|83050227|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
46832274|NCT00340704|83050228|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
46832275|NCT00340704|83050220|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
46832276|NCT00340704|83050221|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
46832277|NCT00340704|83050222|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
46832278|NCT00340704|83050223|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
46832279|NCT00340704|83050224|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
46832280|NCT00340704|83050225|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
46832281|NCT00340704|83050226|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
46832282|NCT00340704|83050227|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
46832283|NCT00340704|83050228|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
46832284|NCT00340704|83050220|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
46832285|NCT00340704|83050221|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
46832286|NCT00340704|83050222|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
46832287|NCT00340704|83050223|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
46832288|NCT00340704|83050224|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
46832289|NCT00340704|83050225|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
46832290|NCT00340704|83050226|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
46832291|NCT00340704|83050227|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
46832292|NCT00340704|83050228|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
46832293|NCT00132496|83050256|FG000|Overall Study|Withdrawal by Subject|1|||
46832294|NCT00132496|83050257|FG001|Overall Study|Withdrawal by Subject|2|||
46832295|NCT00132496|83050256|FG000|Overall Study|Physician Decision|1|||
46832296|NCT00132496|83050257|FG001|Overall Study|Physician Decision|0|||
46832297|NCT00231777|83050265|FG000|Overall Study|Lost to Follow-up|3|||
46832298|NCT00231777|83050266|FG001|Overall Study|Lost to Follow-up|0|||
46832299|NCT00231777|83050265|FG000|Overall Study|Other|3|||
46832300|NCT00231777|83050266|FG001|Overall Study|Other|2|||
46832301|NCT00231465|83050272|FG000|Overall Study|Completed only one cycle|1|||
46832302|NCT00231465|83050272|FG000|Overall Study|Did not have follow up CT scans|1|||
46832303|NCT00254397|83050280|FG000|Overall Study|Disease Progression|4|||
46832304|NCT00254397|83050281|FG001|Overall Study|Disease Progression|1|||
46832305|NCT00254397|83050282|FG002|Overall Study|Disease Progression|16|||
46832306|NCT00254397|83050283|FG003|Overall Study|Disease Progression|23|||
46832307|NCT00254397|83050280|FG000|Overall Study|Non-Compliant|0|||
46832308|NCT00254397|83050281|FG001|Overall Study|Non-Compliant|0|||
46832309|NCT00254397|83050282|FG002|Overall Study|Non-Compliant|0|||
46832310|NCT00254397|83050283|FG003|Overall Study|Non-Compliant|1|||
46832311|NCT00254397|83050280|FG000|Overall Study|Adverse Event|2|||
46832312|NCT00254397|83050281|FG001|Overall Study|Adverse Event|0|||
46832313|NCT00254397|83050282|FG002|Overall Study|Adverse Event|3|||
46832314|NCT00254397|83050283|FG003|Overall Study|Adverse Event|1|||
46832315|NCT00254163|83050294|FG000|Overall Study|Adverse Event|29|||
46937886|NCT02688764|83174478|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
46937887|NCT02688764|83174477|FG000|Overall Study|AE/Other|0|||
47061234|NCT01513967|83341470|FG007|Overall Study|Physician Decision|0|||
46637722|NCT01474512|82811377|FG001|Long-Term Extension Period|Adverse Event|0|||
46637723|NCT01474512|82811378|FG002|Long-Term Extension Period|Adverse Event|0|||
46637724|NCT01474512|82811379|FG003|Long-Term Extension Period|Adverse Event|0|||
46937888|NCT02688764|83174478|FG001|Overall Study|AE/Other|1|||
47061235|NCT01511939|83341514|FG000|Overall Study|Withdrawal by Subject|2|||
46832316|NCT00254163|83050295|FG001|Overall Study|Adverse Event|26|||
47061236|NCT01511939|83341515|FG001|Overall Study|Withdrawal by Subject|1|||
46937889|NCT02688764|83174477|FG000|Overall Study|AE/Physician decision|1|||
46937890|NCT02688764|83174478|FG001|Overall Study|AE/Physician decision|0|||
46937891|NCT02688764|83174477|FG000|Overall Study|AE/Withd. parent|3|||
46937892|NCT02688764|83174478|FG001|Overall Study|AE/Withd. parent|0|||
46937893|NCT02688764|83174477|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
46937894|NCT02688764|83174478|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
46937895|NCT02688764|83174477|FG000|Overall Study|AE/Withd. subject|1|||
46937896|NCT02688764|83174478|FG001|Overall Study|AE/Withd. subject|0|||
46937897|NCT02688764|83174477|FG000|Overall Study|Kidney transplant|10|||
46937898|NCT02688764|83174478|FG001|Overall Study|Kidney transplant|4|||
46937899|NCT02688764|83174477|FG000|Overall Study|Lack of Efficacy|3|||
46937900|NCT02688764|83174478|FG001|Overall Study|Lack of Efficacy|2|||
46937901|NCT02688764|83174477|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
46937902|NCT02688764|83174478|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
46937903|NCT02688764|83174477|FG000|Overall Study|Non-compliance with study drug|4|||
46937904|NCT02688764|83174478|FG001|Overall Study|Non-compliance with study drug|0|||
46765513|NCT00862979|82983940|FG001|Overall Study|Administrative problems|1|||
46765514|NCT00862979|82983939|FG000|Overall Study|Death|0|||
46765515|NCT00862979|82983940|FG001|Overall Study|Death|1|||
46832317|NCT00254163|83050294|FG000|Overall Study|Patient request/withdrew consent|6|||
46832318|NCT00254163|83050295|FG001|Overall Study|Patient request/withdrew consent|4|||
46832319|NCT00254163|83050294|FG000|Overall Study|Investigator request|1|||
46832320|NCT00254163|83050295|FG001|Overall Study|Investigator request|3|||
46832321|NCT00254163|83050294|FG000|Overall Study|Failed entry|1|||
46832322|NCT00254163|83050295|FG001|Overall Study|Failed entry|3|||
46832323|NCT00254163|83050294|FG000|Overall Study|Progressive disease|0|||
46832324|NCT00254163|83050295|FG001|Overall Study|Progressive disease|1|||
46832325|NCT00254163|83050294|FG000|Overall Study|Death|0|||
46832326|NCT00254163|83050295|FG001|Overall Study|Death|1|||
46832327|NCT00254163|83050294|FG000|Overall Study|Other|8|||
46832328|NCT00254163|83050295|FG001|Overall Study|Other|8|||
46832329|NCT03869333|83050305|FG000|Overall Study|Lost to Follow-up|1|||
46832330|NCT03869333|83050306|FG001|Overall Study|Lost to Follow-up|0|||
46832331|NCT03869333|83050307|FG002|Overall Study|Lost to Follow-up|0|||
46832332|NCT03869333|83050308|FG003|Overall Study|Lost to Follow-up|0|||
46832333|NCT03869333|83050305|FG000|Overall Study|Pregnancy|1|||
46832334|NCT03869333|83050306|FG001|Overall Study|Pregnancy|0|||
46832335|NCT03869333|83050307|FG002|Overall Study|Pregnancy|0|||
46832336|NCT03869333|83050308|FG003|Overall Study|Pregnancy|0|||
46832337|NCT03869333|83050305|FG000|Overall Study|Physician Decision|0|||
46832338|NCT03869333|83050306|FG001|Overall Study|Physician Decision|1|||
46832339|NCT03869333|83050307|FG002|Overall Study|Physician Decision|0|||
46832340|NCT03869333|83050308|FG003|Overall Study|Physician Decision|0|||
46832341|NCT00110890|83050320|FG000|Overall Study|Adverse Event|30|||
46832342|NCT00110890|83050321|FG001|Overall Study|Adverse Event|7|||
46832343|NCT00110890|83050320|FG000|Overall Study|Death|16|||
46832344|NCT00110890|83050321|FG001|Overall Study|Death|9|||
46832345|NCT00110890|83050320|FG000|Overall Study|Lost to Follow-up|3|||
46832346|NCT00110890|83050321|FG001|Overall Study|Lost to Follow-up|1|||
46832347|NCT00110890|83050320|FG000|Overall Study|Physician Decision|4|||
46832348|NCT00110890|83050321|FG001|Overall Study|Physician Decision|5|||
46832349|NCT00110890|83050320|FG000|Overall Study|Withdrawal by Subject|17|||
46832350|NCT00110890|83050321|FG001|Overall Study|Withdrawal by Subject|5|||
46832351|NCT00110890|83050320|FG000|Overall Study|Protocol Deviation|1|||
46832352|NCT00110890|83050321|FG001|Overall Study|Protocol Deviation|0|||
46937905|NCT02688764|83174477|FG000|Overall Study|Non-compl./Physician decision|2|||
46765516|NCT00483379|82983948|FG000|Treatment Period|Adverse Event|1|||
46765517|NCT00483379|82983949|FG001|Treatment Period|Adverse Event|0|||
46765518|NCT00483379|82983948|FG000|Treatment Period|Withdrawal by Subject|1|||
46765519|NCT00483379|82983949|FG001|Treatment Period|Withdrawal by Subject|0|||
46765520|NCT00446251|82983957|FG000|Overall Study|On-study Transplants|2|||
46765521|NCT00446251|82983957|FG000|Overall Study|Rituximab Infusion Reaction|2|||
46765522|NCT00446251|82983957|FG000|Overall Study|Lost to Follow-up|1|||
46765523|NCT00796224|82983963|FG000|Overall Study|Adverse Event|1|||
46765524|NCT00796224|82983964|FG001|Overall Study|Adverse Event|0|||
46832353|NCT00110890|83050320|FG000|Overall Study|Noncompliance|10|||
46832354|NCT00110890|83050321|FG001|Overall Study|Noncompliance|0|||
46832355|NCT00110890|83050320|FG000|Overall Study|Kidney Transplant|16|||
46832356|NCT00110890|83050321|FG001|Overall Study|Kidney Transplant|12|||
46832357|NCT00110890|83050320|FG000|Overall Study|Invest. Product Commercially Available|217|||
46832358|NCT00110890|83050321|FG001|Overall Study|Invest. Product Commercially Available|110|||
46937906|NCT02688764|83174478|FG001|Overall Study|Non-compl./Physician decision|0|||
46937907|NCT02688764|83174477|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
46832359|NCT00110890|83050320|FG000|Overall Study|Other|34|||
46832360|NCT00110890|83050321|FG001|Overall Study|Other|23|||
46832361|NCT00110890|83050320|FG000|Overall Study|Ineligibility determined|3|||
46832362|NCT00110890|83050321|FG001|Overall Study|Ineligibility determined|0|||
46937908|NCT02688764|83174478|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
46937909|NCT02688764|83174477|FG000|Overall Study|Non-compl./Withd. subject|0|||
46937910|NCT02688764|83174478|FG001|Overall Study|Non-compl./Withd. subject|2|||
46937911|NCT02688764|83174477|FG000|Overall Study|Phosphorus level outside safe range|0|||
46937912|NCT02688764|83174478|FG001|Overall Study|Phosphorus level outside safe range|1|||
46937913|NCT02688764|83174477|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
46937914|NCT02688764|83174478|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
46937915|NCT02688764|83174477|FG000|Overall Study|Study drug taste/Withd. parent|1|||
46937916|NCT02688764|83174478|FG001|Overall Study|Study drug taste/Withd. parent|0|||
46937917|NCT02688764|83174477|FG000|Overall Study|Subject moving out|2|||
46937918|NCT02688764|83174478|FG001|Overall Study|Subject moving out|0|||
46937919|NCT02688764|83174477|FG000|Overall Study|Subject taken off dialysis|1|||
46937920|NCT02688764|83174478|FG001|Overall Study|Subject taken off dialysis|0|||
46937921|NCT02688764|83174477|FG000|Overall Study|Withdrawal by parent|3|||
46937922|NCT02688764|83174478|FG001|Overall Study|Withdrawal by parent|0|||
46937923|NCT02688608|83174487|FG000|Overall Study|Lost to Follow-up|1|||
46937924|NCT02688530|83174495|FG000|Overall Study|Withdrawal by Subject|0|||
46937925|NCT02688530|83174496|FG001|Overall Study|Withdrawal by Subject|1|||
46937926|NCT02688530|83174497|FG002|Overall Study|Withdrawal by Subject|0|||
46937927|NCT02688530|83174498|FG003|Overall Study|Withdrawal by Subject|0|||
46937928|NCT02688530|83174495|FG000|Overall Study|Lost to Follow-up|0|||
46937929|NCT02688530|83174496|FG001|Overall Study|Lost to Follow-up|0|||
46937930|NCT02688530|83174497|FG002|Overall Study|Lost to Follow-up|2|||
46937931|NCT02688530|83174498|FG003|Overall Study|Lost to Follow-up|0|||
46937932|NCT05083559|83174514|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
46937933|NCT05083559|83174515|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
46937934|NCT05083559|83174514|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
46937935|NCT05083559|83174515|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
46937936|NCT05083559|83174514|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
46937937|NCT05083559|83174515|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
46937938|NCT03037307|83174521|FG000|Period 1|Did Not Meet Study Criteria|0|||
46937939|NCT03037307|83174522|FG001|Period 1|Did Not Meet Study Criteria|0|||
46937940|NCT03037307|83174523|FG002|Period 1|Did Not Meet Study Criteria|0|||
46937941|NCT03037307|83174524|FG003|Period 1|Did Not Meet Study Criteria|1|||
46937942|NCT03037307|83174525|FG004|Period 1|Did Not Meet Study Criteria|0|||
46937943|NCT03037307|83174526|FG005|Period 1|Did Not Meet Study Criteria|0|||
46937944|NCT02538094|83174535|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
46937945|NCT02538094|83174536|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
46937946|NCT02538094|83174535|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
46937947|NCT02538094|83174536|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
46937948|NCT02686034|83174544|FG000|Run-In Period 1|Eligibility|12|||
46937949|NCT02686034|83174545|FG001|Run-In Period 1|Eligibility|10|||
46937950|NCT02686034|83174544|FG000|Run-In Period 1|Withdrawal by Subject|4|||
46937951|NCT02686034|83174545|FG001|Run-In Period 1|Withdrawal by Subject|3|||
46937952|NCT02686034|83174544|FG000|Run-In Period 1|Lost to Follow-up|4|||
46937953|NCT02686034|83174545|FG001|Run-In Period 1|Lost to Follow-up|4|||
46832363|NCT00110890|83050320|FG000|Overall Study|Requirement for alternative therapy|0|||
46832364|NCT00110890|83050321|FG001|Overall Study|Requirement for alternative therapy|1|||
46832365|NCT00110890|83050320|FG000|Overall Study|Disease progression|0|||
46832366|NCT00110890|83050321|FG001|Overall Study|Disease progression|1|||
46832367|NCT00110890|83050320|FG000|Overall Study|Parathyroidectomy|0|||
46832368|NCT00110890|83050321|FG001|Overall Study|Parathyroidectomy|1|||
46832369|NCT00110890|83050320|FG000|Overall Study|Did not enter follow-up phase|10|||
46832370|NCT00110890|83050321|FG001|Overall Study|Did not enter follow-up phase|4|||
46832371|NCT00182637|83050327|FG000|Overall Study|Adverse Event|2|||
46832372|NCT00182637|83050327|FG000|Overall Study|Disease Progression|1|||
46832373|NCT00182325|83050334|FG000|Overall Study|Lost to Follow-up|7|||
46832374|NCT00182325|83050335|FG001|Overall Study|Lost to Follow-up|7|||
46832375|NCT00182325|83050334|FG000|Overall Study|Miscarriage|5|||
46832376|NCT00182325|83050335|FG001|Overall Study|Miscarriage|3|||
46937954|NCT02686034|83174544|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
46937955|NCT02686034|83174545|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
46937956|NCT02686034|83174544|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
46937957|NCT02686034|83174545|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
46937958|NCT02686034|83174544|FG000|Randomized Controlled Period 2|Adverse Event|0|||
46937959|NCT02686034|83174545|FG001|Randomized Controlled Period 2|Adverse Event|2|||
46937960|NCT02686034|83174544|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
46937961|NCT02686034|83174545|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
46832377|NCT00182325|83050334|FG000|Overall Study|Did not complete survey|22|||
46832378|NCT00182325|83050335|FG001|Overall Study|Did not complete survey|43|||
46832379|NCT00122278|83050343|FG000|Overall Study|Lost to Follow-up|2|||
46832380|NCT00122278|83050344|FG001|Overall Study|Lost to Follow-up|0|||
46637725|NCT01474512|82811380|FG004|Long-Term Extension Period|Adverse Event|0|||
46937962|NCT02686034|83174544|FG000|Open Label Period 3|Lost to Follow-up|0|||
46937963|NCT02686034|83174545|FG001|Open Label Period 3|Lost to Follow-up|1|||
46937964|NCT02685488|83174553|FG000|Overall Study|Withdrawal by Subject|0|||
46937965|NCT02685488|83174554|FG001|Overall Study|Withdrawal by Subject|1|||
46937966|NCT02533570|83174563|FG000|Overall Study|Adverse Event|0|||
46937967|NCT02533570|83174564|FG001|Overall Study|Adverse Event|1|||
46937968|NCT02533570|83174565|FG002|Overall Study|Adverse Event|1|||
46937969|NCT03036839|83174576|FG000|Overall Study|Adverse Event|0|||
46937970|NCT03036839|83174577|FG001|Overall Study|Adverse Event|0|||
46937971|NCT03036839|83174578|FG002|Overall Study|Adverse Event|1|||
46937972|NCT03036839|83174576|FG000|Overall Study|Death|3|||
46937973|NCT03036839|83174577|FG001|Overall Study|Death|0|||
46937974|NCT03036839|83174578|FG002|Overall Study|Death|3|||
46937975|NCT03036839|83174576|FG000|Overall Study|Withdrew Consent|0|||
46937976|NCT03036839|83174577|FG001|Overall Study|Withdrew Consent|0|||
46937977|NCT03036839|83174578|FG002|Overall Study|Withdrew Consent|1|||
46937978|NCT01286207|83174589|FG000|Overall Study|Adverse Event|27|||
46937979|NCT01286207|83174590|FG001|Overall Study|Adverse Event|41|||
46937980|NCT01286207|83174591|FG002|Overall Study|Adverse Event|8|||
46937981|NCT01286207|83174589|FG000|Overall Study|Lost to Follow-up|49|||
46937982|NCT01286207|83174590|FG001|Overall Study|Lost to Follow-up|43|||
46937983|NCT01286207|83174591|FG002|Overall Study|Lost to Follow-up|20|||
46937984|NCT01286207|83174589|FG000|Overall Study|Withdrawal by Subject|93|||
46937985|NCT01286207|83174590|FG001|Overall Study|Withdrawal by Subject|79|||
46937986|NCT01286207|83174591|FG002|Overall Study|Withdrawal by Subject|41|||
46937987|NCT01286207|83174589|FG000|Overall Study|Lack of Response|92|||
46937988|NCT01286207|83174590|FG001|Overall Study|Lack of Response|38|||
47061237|NCT01511939|83341516|FG002|Overall Study|Withdrawal by Subject|0|||
47061238|NCT01576705|83341528|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
47061239|NCT01576705|83341529|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
46832381|NCT00182091|83050354|FG000|Overall Study|Withdrawal by Subject|1|||
46832382|NCT00182091|83050355|FG001|Overall Study|Withdrawal by Subject|0|||
46832383|NCT00182091|83050356|FG002|Overall Study|Withdrawal by Subject|0|||
46832384|NCT00182091|83050357|FG003|Overall Study|Withdrawal by Subject|0|||
46832385|NCT00181155|83050365|FG000|Overall Study|Physician Decision|1|||
46832386|NCT00181155|83050366|FG001|Overall Study|Physician Decision|0|||
46832387|NCT00181155|83050365|FG000|Overall Study|Withdrawal by Subject|1|||
46832388|NCT00181155|83050366|FG001|Overall Study|Withdrawal by Subject|0|||
46832389|NCT00322452|83050375|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46832390|NCT00322452|83050376|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
46832391|NCT00322452|83050375|FG000|Overall Study|Lost to Follow-up|5|||
46832392|NCT00322452|83050376|FG001|Overall Study|Lost to Follow-up|2|||
46832393|NCT00322452|83050375|FG000|Overall Study|Withdrawal by Subject|19|||
46832394|NCT00322452|83050376|FG001|Overall Study|Withdrawal by Subject|46|||
46832395|NCT00322452|83050375|FG000|Overall Study|Death|223|||
46832396|NCT00322452|83050376|FG001|Overall Study|Death|227|||
46832397|NCT00110812|83050385|FG000|Main Study|Death|0|||
46832398|NCT00110812|83050386|FG001|Main Study|Death|0|||
46832399|NCT00110812|83050387|FG002|Main Study|Death|2|||
46832400|NCT00110812|83050385|FG000|Main Study|Withdrawal by Subject|0|||
46832401|NCT00110812|83050386|FG001|Main Study|Withdrawal by Subject|0|||
46832402|NCT00110812|83050387|FG002|Main Study|Withdrawal by Subject|1|||
46832403|NCT00110812|83050385|FG000|Main Study|Lost to Follow-up|8|||
46832404|NCT00110812|83050386|FG001|Main Study|Lost to Follow-up|11|||
46832405|NCT00110812|83050387|FG002|Main Study|Lost to Follow-up|10|||
46832406|NCT00110812|83050385|FG000|Extended Follow-up|Death|1|||
46832407|NCT00110812|83050386|FG001|Extended Follow-up|Death|0|||
46832408|NCT00110812|83050387|FG002|Extended Follow-up|Death|3|||
46832409|NCT00110812|83050385|FG000|Extended Follow-up|Withdrawal by Subject|0|||
46832410|NCT00110812|83050386|FG001|Extended Follow-up|Withdrawal by Subject|1|||
46832411|NCT00110812|83050387|FG002|Extended Follow-up|Withdrawal by Subject|0|||
46832412|NCT00110812|83050385|FG000|Extended Follow-up|Lost to Follow-up|1|||
46832413|NCT00110812|83050386|FG001|Extended Follow-up|Lost to Follow-up|3|||
46832414|NCT00110812|83050387|FG002|Extended Follow-up|Lost to Follow-up|1|||
46832415|NCT00516269|83050402|FG000|Overall Study|Adverse Event|2|||
46832416|NCT00516269|83050403|FG001|Overall Study|Adverse Event|1|||
46832417|NCT00516269|83050402|FG000|Overall Study|Lost to Follow-up|0|||
46937989|NCT01286207|83174591|FG002|Overall Study|Lack of Response|8|||
46937990|NCT01286207|83174589|FG000|Overall Study|Other|37|||
46937991|NCT01286207|83174590|FG001|Overall Study|Other|47|||
46937992|NCT01286207|83174591|FG002|Overall Study|Other|13|||
46832418|NCT00516269|83050403|FG001|Overall Study|Lost to Follow-up|1|||
46832419|NCT00516269|83050402|FG000|Overall Study|Protocol Violation|0|||
46832420|NCT00516269|83050403|FG001|Overall Study|Protocol Violation|1|||
46832421|NCT00229203|83050411|FG000|Overall Study|Progressive disease|18|||
46832422|NCT00229203|83050412|FG001|Overall Study|Progressive disease|9|||
46832423|NCT00229203|83050411|FG000|Overall Study|Toxicity|6|||
46832424|NCT00229203|83050412|FG001|Overall Study|Toxicity|1|||
46937993|NCT00968201|83174628|FG000|Base Study - (Period II)|Adverse Event|8|||
46937994|NCT00968201|83174629|FG001|Base Study - (Period II)|Adverse Event|0|||
46937995|NCT00968201|83174630|FG002|Base Study - (Period II)|Adverse Event|16|||
46937996|NCT00968201|83174628|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
46937997|NCT00968201|83174629|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
46937998|NCT00968201|83174630|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
46937999|NCT00968201|83174628|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
46938000|NCT00968201|83174629|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
46938001|NCT00968201|83174630|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
46938002|NCT00968201|83174628|FG000|Base Study - (Period II)|Protocol Violation|12|||
46938003|NCT00968201|83174629|FG001|Base Study - (Period II)|Protocol Violation|0|||
46938004|NCT00968201|83174630|FG002|Base Study - (Period II)|Protocol Violation|12|||
46938005|NCT00968201|83174628|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
46938006|NCT00968201|83174629|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
46938007|NCT00968201|83174630|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
46938008|NCT00968201|83174628|FG000|Base Study - (Period II)|Site Error|0|||
46938009|NCT00968201|83174629|FG001|Base Study - (Period II)|Site Error|0|||
46938010|NCT00968201|83174630|FG002|Base Study - (Period II)|Site Error|1|||
46938011|NCT00968201|83174628|FG000|Extension Study - (Period III)|Adverse Event|0|||
46938012|NCT00968201|83174629|FG001|Extension Study - (Period III)|Adverse Event|5|||
46938013|NCT00968201|83174630|FG002|Extension Study - (Period III)|Adverse Event|22|||
46938014|NCT00968201|83174628|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
46938015|NCT00968201|83174629|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
46938016|NCT00968201|83174630|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
46938017|NCT00968201|83174628|FG000|Extension Study - (Period III)|Protocol Violation|0|||
46938018|NCT00968201|83174629|FG001|Extension Study - (Period III)|Protocol Violation|17|||
46938019|NCT00968201|83174630|FG002|Extension Study - (Period III)|Protocol Violation|14|||
46938020|NCT00968201|83174628|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
46938021|NCT00968201|83174629|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
46938022|NCT00968201|83174630|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
46938023|NCT00968201|83174628|FG000|Extension Study - (Period III)|Patient Relocated|0|||
46938024|NCT00968201|83174629|FG001|Extension Study - (Period III)|Patient Relocated|1|||
46938025|NCT00968201|83174630|FG002|Extension Study - (Period III)|Patient Relocated|1|||
46938026|NCT00968201|83174628|FG000|Extension Study - (Period III)|Noncompliance|0|||
46938027|NCT00968201|83174629|FG001|Extension Study - (Period III)|Noncompliance|0|||
46938028|NCT00968201|83174630|FG002|Extension Study - (Period III)|Noncompliance|3|||
46938029|NCT00968201|83174628|FG000|Extension Study - (Period III)|Other|0|||
46938030|NCT00968201|83174629|FG001|Extension Study - (Period III)|Other|0|||
46938031|NCT00968201|83174630|FG002|Extension Study - (Period III)|Other|2|||
46938032|NCT00968201|83174628|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
46938033|NCT00968201|83174629|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
46938034|NCT00968201|83174630|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
46938035|NCT00943397|83174641|FG000|Overall Study|Adverse Event|0|||
46938036|NCT00943397|83174642|FG001|Overall Study|Adverse Event|6|||
46938037|NCT00943397|83174641|FG000|Overall Study|Lost to Follow-up|0|||
46938038|NCT00943397|83174642|FG001|Overall Study|Lost to Follow-up|4|||
46938039|NCT00943397|83174641|FG000|Overall Study|Protocol Violation|2|||
46938040|NCT00943397|83174642|FG001|Overall Study|Protocol Violation|5|||
46938041|NCT00943397|83174641|FG000|Overall Study|Withdrawal by Subject|1|||
46938042|NCT00943397|83174642|FG001|Overall Study|Withdrawal by Subject|1|||
46938043|NCT00943397|83174641|FG000|Overall Study|Site terminated and other|12|||
46938044|NCT00943397|83174642|FG001|Overall Study|Site terminated and other|56|||
46938045|NCT00702845|83174650|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
46938046|NCT00702845|83174651|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
46765525|NCT00796224|82983963|FG000|Overall Study|Protocol Violation|0|||
46765526|NCT00796224|82983964|FG001|Overall Study|Protocol Violation|1|||
46938047|NCT00702845|83174650|FG000|Overall Study|Too high ovarian response|5|||
46938048|NCT00702845|83174651|FG001|Overall Study|Too high ovarian response|1|||
46938049|NCT00702845|83174650|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
46938050|NCT00702845|83174651|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
46938051|NCT00702845|83174650|FG000|Overall Study|Insufficient ovarian response|1|||
46938052|NCT00702845|83174651|FG001|Overall Study|Insufficient ovarian response|0|||
46938053|NCT00702845|83174650|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
46938054|NCT00702845|83174651|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
46938055|NCT00702845|83174650|FG000|Overall Study|No or abnormal fertilization|4|||
46938056|NCT00702845|83174651|FG001|Overall Study|No or abnormal fertilization|2|||
46938057|NCT00702845|83174650|FG000|Overall Study|Patient's decision|2|||
46938058|NCT00702845|83174651|FG001|Overall Study|Patient's decision|1|||
46938059|NCT00702845|83174650|FG000|Overall Study|Not randomized|0|||
46938060|NCT00702845|83174651|FG001|Overall Study|Not randomized|1|||
46938061|NCT01302847|83174665|FG000|Overall Study|Ongoing|0|||
46938062|NCT01302847|83174666|FG001|Overall Study|Ongoing|0|||
46938063|NCT01302847|83174667|FG002|Overall Study|Ongoing|0|||
46938064|NCT01302847|83174668|FG003|Overall Study|Ongoing|0|||
46938065|NCT01302847|83174669|FG004|Overall Study|Ongoing|0|||
46938066|NCT01302847|83174670|FG005|Overall Study|Ongoing|27|||
46938067|NCT01302847|83174671|FG006|Overall Study|Ongoing|22|||
46938068|NCT01302847|83174672|FG007|Overall Study|Ongoing|17|||
46938069|NCT01302847|83174665|FG000|Overall Study|Death|0|||
46938070|NCT01302847|83174666|FG001|Overall Study|Death|1|||
46938071|NCT01302847|83174667|FG002|Overall Study|Death|0|||
46938072|NCT01302847|83174668|FG003|Overall Study|Death|0|||
46938073|NCT01302847|83174669|FG004|Overall Study|Death|0|||
46938074|NCT01302847|83174670|FG005|Overall Study|Death|1|||
46938075|NCT01302847|83174671|FG006|Overall Study|Death|1|||
46938076|NCT01302847|83174672|FG007|Overall Study|Death|0|||
46938077|NCT01302847|83174665|FG000|Overall Study|Pregnancy|2|||
46938078|NCT01302847|83174666|FG001|Overall Study|Pregnancy|0|||
46938079|NCT01302847|83174667|FG002|Overall Study|Pregnancy|0|||
46832425|NCT00229203|83050411|FG000|Overall Study|Death|4|||
46832426|NCT00229203|83050412|FG001|Overall Study|Death|2|||
46832427|NCT00229203|83050411|FG000|Overall Study|Other|3|||
46938080|NCT01302847|83174668|FG003|Overall Study|Pregnancy|0|||
46938081|NCT01302847|83174669|FG004|Overall Study|Pregnancy|0|||
46938082|NCT01302847|83174670|FG005|Overall Study|Pregnancy|0|||
46938083|NCT01302847|83174671|FG006|Overall Study|Pregnancy|0|||
46938084|NCT01302847|83174672|FG007|Overall Study|Pregnancy|0|||
46938085|NCT01302847|83174665|FG000|Overall Study|Virologic failure|0|||
46938086|NCT01302847|83174666|FG001|Overall Study|Virologic failure|2|||
46938087|NCT01302847|83174667|FG002|Overall Study|Virologic failure|2|||
46938088|NCT01302847|83174668|FG003|Overall Study|Virologic failure|0|||
46938089|NCT01302847|83174669|FG004|Overall Study|Virologic failure|1|||
46938090|NCT01302847|83174670|FG005|Overall Study|Virologic failure|1|||
46938091|NCT01302847|83174671|FG006|Overall Study|Virologic failure|0|||
46765527|NCT00791934|82983972|FG000|Overall Study|Withdrawal by Subject|2|||
46765528|NCT00791934|82983972|FG000|Overall Study|Did not consent for extended follow-up|13|||
46765529|NCT00848081|82983978|FG000|Overall Study|Adverse Event|6|||
46765530|NCT00848081|82983979|FG001|Overall Study|Adverse Event|7|||
46765531|NCT00848081|82983978|FG000|Overall Study|Protocol Violation|8|||
46765532|NCT00848081|82983979|FG001|Overall Study|Protocol Violation|5|||
46765533|NCT00848081|82983978|FG000|Overall Study|Lost to Follow-up|1|||
46765534|NCT00848081|82983979|FG001|Overall Study|Lost to Follow-up|0|||
46765535|NCT00848081|82983978|FG000|Overall Study|Physician Decision|0|||
46832428|NCT00229203|83050412|FG001|Overall Study|Other|3|||
46832429|NCT00229203|83050411|FG000|Overall Study|Withdrawal by Subject|1|||
46832430|NCT00229203|83050412|FG001|Overall Study|Withdrawal by Subject|4|||
46832431|NCT00228813|83050418|FG000|Overall Study|Death|4|||
46832432|NCT00322374|83050425|FG000|Starting Dose|Physician Decision|2|||
46832433|NCT00322374|83050426|FG001|Starting Dose|Physician Decision|0|||
46832434|NCT00322374|83050427|FG002|Starting Dose|Physician Decision|0|||
46832435|NCT00322374|83050428|FG003|Starting Dose|Physician Decision|0|||
46832436|NCT00322374|83050425|FG000|Starting Dose|Study Drug Toxicity|4|||
46832437|NCT00322374|83050426|FG001|Starting Dose|Study Drug Toxicity|0|||
46832438|NCT00322374|83050427|FG002|Starting Dose|Study Drug Toxicity|0|||
46832439|NCT00322374|83050428|FG003|Starting Dose|Study Drug Toxicity|0|||
46832440|NCT00322374|83050425|FG000|First Escalation|Documented Disease Progression|0|||
46832441|NCT00322374|83050426|FG001|First Escalation|Documented Disease Progression|6|||
46832442|NCT00322374|83050427|FG002|First Escalation|Documented Disease Progression|0|||
46832443|NCT00322374|83050428|FG003|First Escalation|Documented Disease Progression|0|||
46832444|NCT00322374|83050425|FG000|First Escalation|Physician Decision|0|||
46832445|NCT00322374|83050426|FG001|First Escalation|Physician Decision|12|||
46832446|NCT00322374|83050427|FG002|First Escalation|Physician Decision|0|||
46832447|NCT00322374|83050428|FG003|First Escalation|Physician Decision|0|||
46832448|NCT00322374|83050425|FG000|First Escalation|Study Drug Toxicity|0|||
46832449|NCT00322374|83050426|FG001|First Escalation|Study Drug Toxicity|11|||
46832450|NCT00322374|83050427|FG002|First Escalation|Study Drug Toxicity|0|||
46832451|NCT00322374|83050428|FG003|First Escalation|Study Drug Toxicity|0|||
46938092|NCT01302847|83174672|FG007|Overall Study|Virologic failure|2|||
46765536|NCT00848081|82983979|FG001|Overall Study|Physician Decision|3|||
46765537|NCT00848081|82983978|FG000|Overall Study|Withdrawal by Subject|5|||
46765538|NCT00848081|82983979|FG001|Overall Study|Withdrawal by Subject|3|||
46765539|NCT00654004|82983987|FG000|Overall Study|Lost to Follow-up|1|||
46832452|NCT00322374|83050425|FG000|First Escalation|Participant Request|0|||
46765540|NCT00654004|82983988|FG001|Overall Study|Lost to Follow-up|0|||
46765541|NCT00791778|82983996|FG000|Double-blind Treatment|Adverse Event|49|||
46832453|NCT00322374|83050426|FG001|First Escalation|Participant Request|1|||
46832454|NCT00322374|83050427|FG002|First Escalation|Participant Request|0|||
46832455|NCT00322374|83050428|FG003|First Escalation|Participant Request|0|||
46832456|NCT00322374|83050425|FG000|Second Escalation|Physician Decision|0|||
46938093|NCT01302847|83174665|FG000|Overall Study|Severe debilitation, unable to continue|0|||
46938094|NCT01302847|83174666|FG001|Overall Study|Severe debilitation, unable to continue|0|||
46938095|NCT01302847|83174667|FG002|Overall Study|Severe debilitation, unable to continue|0|||
46938096|NCT01302847|83174668|FG003|Overall Study|Severe debilitation, unable to continue|0|||
46938097|NCT01302847|83174669|FG004|Overall Study|Severe debilitation, unable to continue|0|||
46938098|NCT01302847|83174670|FG005|Overall Study|Severe debilitation, unable to continue|1|||
46938099|NCT01302847|83174671|FG006|Overall Study|Severe debilitation, unable to continue|1|||
46938100|NCT01302847|83174672|FG007|Overall Study|Severe debilitation, unable to continue|0|||
46938101|NCT01302847|83174665|FG000|Overall Study|Not able to get to clinic|1|||
46938102|NCT01302847|83174666|FG001|Overall Study|Not able to get to clinic|1|||
46938103|NCT01302847|83174667|FG002|Overall Study|Not able to get to clinic|0|||
46938104|NCT01302847|83174668|FG003|Overall Study|Not able to get to clinic|0|||
46938105|NCT01302847|83174669|FG004|Overall Study|Not able to get to clinic|0|||
46938106|NCT01302847|83174670|FG005|Overall Study|Not able to get to clinic|0|||
46938107|NCT01302847|83174671|FG006|Overall Study|Not able to get to clinic|0|||
46938108|NCT01302847|83174672|FG007|Overall Study|Not able to get to clinic|0|||
46938109|NCT01302847|83174665|FG000|Overall Study|Site closing|2|||
46938110|NCT01302847|83174666|FG001|Overall Study|Site closing|2|||
46938111|NCT01302847|83174667|FG002|Overall Study|Site closing|0|||
46938112|NCT01302847|83174668|FG003|Overall Study|Site closing|0|||
46938113|NCT01302847|83174669|FG004|Overall Study|Site closing|0|||
46938114|NCT01302847|83174670|FG005|Overall Study|Site closing|0|||
46938115|NCT01302847|83174671|FG006|Overall Study|Site closing|0|||
46938116|NCT01302847|83174672|FG007|Overall Study|Site closing|0|||
46938117|NCT01302847|83174665|FG000|Overall Study|Withdrawal by Subject|1|||
46938118|NCT01302847|83174666|FG001|Overall Study|Withdrawal by Subject|0|||
46938119|NCT01302847|83174667|FG002|Overall Study|Withdrawal by Subject|0|||
46832457|NCT00322374|83050426|FG001|Second Escalation|Physician Decision|0|||
46832458|NCT00322374|83050427|FG002|Second Escalation|Physician Decision|5|||
46938120|NCT01302847|83174668|FG003|Overall Study|Withdrawal by Subject|0|||
46938121|NCT01302847|83174669|FG004|Overall Study|Withdrawal by Subject|1|||
46938122|NCT01302847|83174670|FG005|Overall Study|Withdrawal by Subject|0|||
46938123|NCT01302847|83174671|FG006|Overall Study|Withdrawal by Subject|0|||
46938124|NCT01302847|83174672|FG007|Overall Study|Withdrawal by Subject|1|||
46938125|NCT01302847|83174665|FG000|Overall Study|Not willing to adhere to requirements|5|||
46938126|NCT01302847|83174666|FG001|Overall Study|Not willing to adhere to requirements|0|||
46832459|NCT00322374|83050428|FG003|Second Escalation|Physician Decision|0|||
46832460|NCT00322374|83050425|FG000|Second Escalation|Study Drug Toxicity|0|||
46832461|NCT00322374|83050426|FG001|Second Escalation|Study Drug Toxicity|0|||
46832462|NCT00322374|83050427|FG002|Second Escalation|Study Drug Toxicity|1|||
46938127|NCT01302847|83174667|FG002|Overall Study|Not willing to adhere to requirements|0|||
46938128|NCT01302847|83174668|FG003|Overall Study|Not willing to adhere to requirements|1|||
46938129|NCT01302847|83174669|FG004|Overall Study|Not willing to adhere to requirements|0|||
46938130|NCT01302847|83174670|FG005|Overall Study|Not willing to adhere to requirements|0|||
46938131|NCT01302847|83174671|FG006|Overall Study|Not willing to adhere to requirements|0|||
46938132|NCT01302847|83174672|FG007|Overall Study|Not willing to adhere to requirements|2|||
46938133|NCT01302847|83174665|FG000|Overall Study|Site unable to contact participant|2|||
46765542|NCT00791778|82983997|FG001|Double-blind Treatment|Adverse Event|9|||
46765543|NCT00791778|82983996|FG000|Double-blind Treatment|Physician Decision|6|||
46765544|NCT00791778|82983997|FG001|Double-blind Treatment|Physician Decision|26|||
46765545|NCT00791778|82983996|FG000|Double-blind Treatment|Protocol Violation|0|||
46765546|NCT00791778|82983997|FG001|Double-blind Treatment|Protocol Violation|4|||
46765547|NCT00791778|82983996|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
46938134|NCT01302847|83174666|FG001|Overall Study|Site unable to contact participant|1|||
46938135|NCT01302847|83174667|FG002|Overall Study|Site unable to contact participant|0|||
46938136|NCT01302847|83174668|FG003|Overall Study|Site unable to contact participant|0|||
46938137|NCT01302847|83174669|FG004|Overall Study|Site unable to contact participant|0|||
46832463|NCT00322374|83050428|FG003|Second Escalation|Study Drug Toxicity|0|||
46832464|NCT00174447|83050441|FG000|Overall Study|Adverse Event|19|||
46832465|NCT00174447|83050441|FG000|Overall Study|Withdrawal by Subject|15|||
46832466|NCT00174447|83050441|FG000|Overall Study|Protocol Violation|1|||
46832467|NCT00174447|83050441|FG000|Overall Study|Lack of Efficacy|1|||
46832468|NCT00174447|83050441|FG000|Overall Study|Administrative reason/Other|2|||
46832469|NCT00321984|83050448|FG000|Overall Study|Adverse Event|9|||
46938138|NCT01302847|83174670|FG005|Overall Study|Site unable to contact participant|0|||
46938139|NCT01302847|83174671|FG006|Overall Study|Site unable to contact participant|2|||
46938140|NCT01302847|83174672|FG007|Overall Study|Site unable to contact participant|0|||
46938141|NCT03039569|83174701|FG000|Overall Study|Lost to Follow-up|5|||
46938142|NCT03039569|83174702|FG001|Overall Study|Lost to Follow-up|4|||
46938143|NCT02738775|83174715|FG000|Overall Study|Withdrawal by Subject|0|||
46765548|NCT00791778|82983997|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
46765549|NCT00791778|82983996|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
46765550|NCT00791778|82983997|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
46765551|NCT00791778|82983996|FG000|Follow-up|Withdrawal by Subject|3|||
46765552|NCT00791778|82983997|FG001|Follow-up|Withdrawal by Subject|0|||
46832470|NCT00321984|83050449|FG001|Overall Study|Adverse Event|6|||
46832471|NCT00321984|83050450|FG002|Overall Study|Adverse Event|8|||
46832472|NCT00321984|83050448|FG000|Overall Study|Protocol Violation|0|||
46938144|NCT02738775|83174716|FG001|Overall Study|Withdrawal by Subject|1|||
46938145|NCT02738775|83174717|FG002|Overall Study|Withdrawal by Subject|0|||
46938146|NCT02738775|83174718|FG003|Overall Study|Withdrawal by Subject|0|||
46938147|NCT02738775|83174719|FG004|Overall Study|Withdrawal by Subject|0|||
46938148|NCT02738775|83174720|FG005|Overall Study|Withdrawal by Subject|0|||
46938149|NCT02738775|83174715|FG000|Overall Study|Adverse Event|0|||
46938150|NCT02738775|83174716|FG001|Overall Study|Adverse Event|0|||
46938151|NCT02738775|83174717|FG002|Overall Study|Adverse Event|0|||
46938152|NCT02738775|83174718|FG003|Overall Study|Adverse Event|1|||
46938153|NCT02738775|83174719|FG004|Overall Study|Adverse Event|0|||
46938154|NCT02738775|83174720|FG005|Overall Study|Adverse Event|0|||
46938155|NCT02738775|83174715|FG000|Overall Study|Pregnancy|0|||
46938156|NCT02738775|83174716|FG001|Overall Study|Pregnancy|1|||
46938157|NCT02738775|83174717|FG002|Overall Study|Pregnancy|0|||
46938158|NCT02738775|83174718|FG003|Overall Study|Pregnancy|0|||
46938159|NCT02738775|83174719|FG004|Overall Study|Pregnancy|0|||
46938160|NCT02738775|83174720|FG005|Overall Study|Pregnancy|0|||
46938161|NCT02738775|83174715|FG000|Overall Study|Missing|0|||
46938162|NCT02738775|83174716|FG001|Overall Study|Missing|0|||
46938163|NCT02738775|83174717|FG002|Overall Study|Missing|0|||
46938164|NCT02738775|83174718|FG003|Overall Study|Missing|0|||
46938165|NCT02738775|83174719|FG004|Overall Study|Missing|0|||
46938166|NCT02738775|83174720|FG005|Overall Study|Missing|1|||
46938167|NCT02314923|83174757|FG000|Overall Study|Death|0|||
46938168|NCT02314923|83174758|FG001|Overall Study|Death|0|||
46938169|NCT02314923|83174759|FG002|Overall Study|Death|0|||
46938170|NCT02314923|83174760|FG003|Overall Study|Death|1|||
46938171|NCT02314923|83174761|FG004|Overall Study|Death|0|||
46938172|NCT02314923|83174762|FG005|Overall Study|Death|0|||
46938173|NCT02314923|83174763|FG006|Overall Study|Death|0|||
46938174|NCT02314923|83174764|FG007|Overall Study|Death|0|||
46938175|NCT02314923|83174765|FG008|Overall Study|Death|0|||
46938176|NCT02314923|83174766|FG009|Overall Study|Death|0|||
46938177|NCT02314923|83174757|FG000|Overall Study|Lost to Follow-up|2|||
46938178|NCT02314923|83174758|FG001|Overall Study|Lost to Follow-up|3|||
46938179|NCT02314923|83174759|FG002|Overall Study|Lost to Follow-up|1|||
46938180|NCT02314923|83174760|FG003|Overall Study|Lost to Follow-up|0|||
46938181|NCT02314923|83174761|FG004|Overall Study|Lost to Follow-up|0|||
46938182|NCT02314923|83174762|FG005|Overall Study|Lost to Follow-up|0|||
46938183|NCT02314923|83174763|FG006|Overall Study|Lost to Follow-up|3|||
46938184|NCT02314923|83174764|FG007|Overall Study|Lost to Follow-up|4|||
46938185|NCT02314923|83174765|FG008|Overall Study|Lost to Follow-up|2|||
46938186|NCT02314923|83174766|FG009|Overall Study|Lost to Follow-up|0|||
46938187|NCT02314923|83174757|FG000|Overall Study|Withdrawal by Subject|0|||
46938188|NCT02314923|83174758|FG001|Overall Study|Withdrawal by Subject|0|||
46938189|NCT02314923|83174759|FG002|Overall Study|Withdrawal by Subject|1|||
46938190|NCT02314923|83174760|FG003|Overall Study|Withdrawal by Subject|0|||
46938191|NCT02314923|83174761|FG004|Overall Study|Withdrawal by Subject|1|||
46938192|NCT02314923|83174762|FG005|Overall Study|Withdrawal by Subject|0|||
46938193|NCT02314923|83174763|FG006|Overall Study|Withdrawal by Subject|1|||
46938194|NCT02314923|83174764|FG007|Overall Study|Withdrawal by Subject|0|||
46938195|NCT02314923|83174765|FG008|Overall Study|Withdrawal by Subject|0|||
46938196|NCT02314923|83174766|FG009|Overall Study|Withdrawal by Subject|0|||
46938197|NCT02314923|83174757|FG000|Overall Study|Physician Decision|0|||
46938198|NCT02314923|83174758|FG001|Overall Study|Physician Decision|1|||
46938199|NCT02314923|83174759|FG002|Overall Study|Physician Decision|0|||
47061240|NCT01576705|83341530|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
47061241|NCT01576705|83341531|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
46938200|NCT02314923|83174760|FG003|Overall Study|Physician Decision|0|||
46938201|NCT02314923|83174761|FG004|Overall Study|Physician Decision|0|||
46938202|NCT02314923|83174762|FG005|Overall Study|Physician Decision|0|||
46938203|NCT02314923|83174763|FG006|Overall Study|Physician Decision|0|||
46938204|NCT02314923|83174764|FG007|Overall Study|Physician Decision|0|||
46938205|NCT02314923|83174765|FG008|Overall Study|Physician Decision|0|||
46765553|NCT00791778|82983996|FG000|Follow-up|Lost to Follow-up|2|||
46765554|NCT00791778|82983997|FG001|Follow-up|Lost to Follow-up|1|||
46765555|NCT00798174|82984003|FG000|Overall Study|inability to implant azygos coil|3|||
46765556|NCT00798174|82984004|FG001|Overall Study|inability to implant azygos coil|3|||
46765557|NCT00798174|82984003|FG000|Overall Study|Inability to sedate for DFT testing|1|||
46765558|NCT00798174|82984004|FG001|Overall Study|Inability to sedate for DFT testing|0|||
47061242|NCT01576705|83341528|FG000|Overall Study|invalid ICF|0|||
46765559|NCT00798096|82984008|FG000|Overall Study|Ongoing|2|||
47061243|NCT01576705|83341529|FG001|Overall Study|invalid ICF|1|||
46938206|NCT02314923|83174766|FG009|Overall Study|Physician Decision|0|||
46938207|NCT02314923|83174757|FG000|Overall Study|Participant unavailable|0|||
46938208|NCT02314923|83174758|FG001|Overall Study|Participant unavailable|0|||
46938209|NCT02314923|83174759|FG002|Overall Study|Participant unavailable|0|||
46938210|NCT02314923|83174760|FG003|Overall Study|Participant unavailable|0|||
46938211|NCT02314923|83174761|FG004|Overall Study|Participant unavailable|0|||
46938212|NCT02314923|83174762|FG005|Overall Study|Participant unavailable|1|||
46938213|NCT02314923|83174763|FG006|Overall Study|Participant unavailable|0|||
47061244|NCT01576705|83341530|FG002|Overall Study|invalid ICF|0|||
46938214|NCT02314923|83174764|FG007|Overall Study|Participant unavailable|0|||
46938215|NCT02314923|83174765|FG008|Overall Study|Participant unavailable|0|||
46938216|NCT02314923|83174766|FG009|Overall Study|Participant unavailable|0|||
46938217|NCT02314923|83174757|FG000|Overall Study|Screen failure|0|||
46938218|NCT02314923|83174758|FG001|Overall Study|Screen failure|0|||
46938219|NCT02314923|83174759|FG002|Overall Study|Screen failure|0|||
46938220|NCT02314923|83174760|FG003|Overall Study|Screen failure|0|||
46938221|NCT02314923|83174761|FG004|Overall Study|Screen failure|0|||
46938222|NCT02314923|83174762|FG005|Overall Study|Screen failure|0|||
46938223|NCT02314923|83174763|FG006|Overall Study|Screen failure|1|||
46938224|NCT02314923|83174764|FG007|Overall Study|Screen failure|0|||
46938225|NCT02314923|83174765|FG008|Overall Study|Screen failure|0|||
46938226|NCT02314923|83174766|FG009|Overall Study|Screen failure|0|||
46938227|NCT02314923|83174757|FG000|Overall Study|Participant relocation|1|||
46938228|NCT02314923|83174758|FG001|Overall Study|Participant relocation|0|||
46938229|NCT02314923|83174759|FG002|Overall Study|Participant relocation|0|||
46938230|NCT02314923|83174760|FG003|Overall Study|Participant relocation|0|||
46938231|NCT02314923|83174761|FG004|Overall Study|Participant relocation|0|||
46938232|NCT02314923|83174762|FG005|Overall Study|Participant relocation|0|||
46938233|NCT02314923|83174763|FG006|Overall Study|Participant relocation|0|||
46938234|NCT02314923|83174764|FG007|Overall Study|Participant relocation|1|||
46938235|NCT02314923|83174765|FG008|Overall Study|Participant relocation|0|||
46938236|NCT02314923|83174766|FG009|Overall Study|Participant relocation|0|||
46938237|NCT03023137|83174791|FG000|Overall Study|Multiple pregnancy|2|||
46938238|NCT03023137|83174792|FG001|Overall Study|Multiple pregnancy|4|||
46938239|NCT03023137|83174791|FG000|Overall Study|Lost to Follow-up|1|||
46938240|NCT03023137|83174792|FG001|Overall Study|Lost to Follow-up|1|||
46938241|NCT03023137|83174791|FG000|Overall Study|Protocol Violation|0|||
46938242|NCT03023137|83174792|FG001|Overall Study|Protocol Violation|4|||
46938243|NCT03023137|83174791|FG000|Overall Study|Lost the baby in a car accident|1|||
46938244|NCT03023137|83174792|FG001|Overall Study|Lost the baby in a car accident|0|||
46938245|NCT03049813|83174803|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
46938246|NCT03049813|83174804|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
46938247|NCT03049813|83174805|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
46938248|NCT03049813|83174806|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
46938249|NCT03049813|83174803|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
46832473|NCT00321984|83050449|FG001|Overall Study|Protocol Violation|1|||
46832474|NCT00321984|83050450|FG002|Overall Study|Protocol Violation|1|||
46832475|NCT00321984|83050448|FG000|Overall Study|Lost to Follow-up|2|||
46938250|NCT03049813|83174804|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
46938251|NCT03049813|83174805|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
46938252|NCT03049813|83174806|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
46938253|NCT03049813|83174803|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
46938254|NCT03049813|83174804|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
46938255|NCT03049813|83174805|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
46938256|NCT03049813|83174806|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
47061245|NCT01576705|83341531|FG003|Overall Study|invalid ICF|0|||
47061246|NCT02666430|83341543|FG000|Period 1|Lost to Follow-up|1|||
47061247|NCT02666430|83341544|FG001|Period 1|Lost to Follow-up|0|||
47061248|NCT02666430|83341543|FG000|Period 1|Adverse Event|0|||
47061249|NCT02666430|83341544|FG001|Period 1|Adverse Event|1|||
47061250|NCT02666430|83341543|FG000|Period 2|Withdrawal by Subject|1|||
47061251|NCT02666430|83341544|FG001|Period 2|Withdrawal by Subject|4|||
47061252|NCT02666430|83341543|FG000|Period 3|Lost to Follow-up|1|||
47061253|NCT02666430|83341544|FG001|Period 3|Lost to Follow-up|0|||
47061254|NCT01576549|83341550|FG000|Overall Study|Sponsor Decision|2|||
47061255|NCT01576159|83341563|FG000|Overall Study|Withdrawal by Subject|0|||
47061256|NCT01576159|83341564|FG001|Overall Study|Withdrawal by Subject|1|||
46765560|NCT00795600|82984014|FG000|Overall Study|Adverse Event|1|||
46765561|NCT00795600|82984015|FG001|Overall Study|Adverse Event|1|||
47061257|NCT01576159|83341565|FG002|Overall Study|Withdrawal by Subject|0|||
47061258|NCT01576159|83341566|FG003|Overall Study|Withdrawal by Subject|0|||
46765562|NCT00795600|82984014|FG000|Overall Study|Protocol Violation|1|||
46765563|NCT00795600|82984015|FG001|Overall Study|Protocol Violation|2|||
46765564|NCT00795600|82984014|FG000|Overall Study|Withdrawal by Subject|1|||
46765565|NCT00795600|82984015|FG001|Overall Study|Withdrawal by Subject|0|||
46765566|NCT00795600|82984014|FG000|Overall Study|Unclassified|1|||
46765567|NCT00795600|82984015|FG001|Overall Study|Unclassified|1|||
46765568|NCT00795132|82984021|FG000|Overall Study|Death|1|||
46765569|NCT00795132|82984021|FG000|Overall Study|Relapse|2|||
46765570|NCT00647296|82984037|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
46765571|NCT00647296|82984038|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
46765572|NCT00647296|82984039|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
46765573|NCT00647296|82984040|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
46832476|NCT00321984|83050449|FG001|Overall Study|Lost to Follow-up|4|||
46832477|NCT00321984|83050450|FG002|Overall Study|Lost to Follow-up|2|||
46832478|NCT00321984|83050448|FG000|Overall Study|Withdrawal by Subject|8|||
46832479|NCT00321984|83050449|FG001|Overall Study|Withdrawal by Subject|6|||
46832480|NCT00321984|83050450|FG002|Overall Study|Withdrawal by Subject|5|||
46832481|NCT00321984|83050448|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
46832482|NCT00321984|83050449|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
46832483|NCT00321984|83050450|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
46832484|NCT00321984|83050448|FG000|Overall Study|Lack of Efficacy|3|||
46832485|NCT00321984|83050449|FG001|Overall Study|Lack of Efficacy|1|||
46832486|NCT00321984|83050450|FG002|Overall Study|Lack of Efficacy|3|||
46832487|NCT00321984|83050448|FG000|Overall Study|Noncompliant|0|||
46832488|NCT00321984|83050449|FG001|Overall Study|Noncompliant|0|||
46832489|NCT00321984|83050450|FG002|Overall Study|Noncompliant|2|||
46832490|NCT00321984|83050448|FG000|Overall Study|Pregnancy|0|||
46832491|NCT00321984|83050449|FG001|Overall Study|Pregnancy|1|||
46832492|NCT00321984|83050450|FG002|Overall Study|Pregnancy|0|||
46832493|NCT00321984|83050448|FG000|Overall Study|Per Subject Request|1|||
46832494|NCT00321984|83050449|FG001|Overall Study|Per Subject Request|0|||
46832495|NCT00321984|83050450|FG002|Overall Study|Per Subject Request|0|||
46832496|NCT00321984|83050448|FG000|Overall Study|Per Investigator Request|1|||
46832497|NCT00321984|83050449|FG001|Overall Study|Per Investigator Request|0|||
46832498|NCT00321984|83050450|FG002|Overall Study|Per Investigator Request|0|||
46832499|NCT00321984|83050448|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
46832500|NCT00321984|83050449|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
46832501|NCT00321984|83050450|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
46832502|NCT00515099|83050460|FG000|Overall Study|Lost to Follow-up|0|||
46832503|NCT00515099|83050461|FG001|Overall Study|Lost to Follow-up|4|||
46832504|NCT00515099|83050460|FG000|Overall Study|Withdrawal by Subject|2|||
46832505|NCT00515099|83050461|FG001|Overall Study|Withdrawal by Subject|0|||
46832506|NCT00515099|83050460|FG000|Overall Study|IRB Recommendation|1|||
46832507|NCT00515099|83050461|FG001|Overall Study|IRB Recommendation|0|||
46832508|NCT00110266|83050467|FG000|Overall Study|Adverse Event|27|||
46832509|NCT00110266|83050467|FG000|Overall Study|Abnormal laboratory value|15|||
46832510|NCT00110266|83050467|FG000|Overall Study|Withdrawal by Subject|16|||
46832511|NCT00110266|83050467|FG000|Overall Study|Death|17|||
46832512|NCT00110266|83050467|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46832513|NCT00110266|83050467|FG000|Overall Study|Participant condition no longer requires study drug|1|||
46832514|NCT00174291|83050474|FG000|Overall Study|Lost to Follow-up|1|||
46832515|NCT00174291|83050475|FG001|Overall Study|Lost to Follow-up|1|||
46832516|NCT00174291|83050474|FG000|Overall Study|Protocol Violation|0|||
46832517|NCT00174291|83050475|FG001|Overall Study|Protocol Violation|2|||
46832518|NCT00174291|83050474|FG000|Overall Study|Study terminated by sponsor|1|||
46832519|NCT00174291|83050475|FG001|Overall Study|Study terminated by sponsor|0|||
46832520|NCT00174291|83050474|FG000|Overall Study|Withdrawal by Subject|3|||
46832521|NCT00174291|83050475|FG001|Overall Study|Withdrawal by Subject|3|||
46832522|NCT00366548|83050483|FG000|Infant Series|Adverse Event|1|||
46832523|NCT00366548|83050484|FG001|Infant Series|Adverse Event|3|||
47061259|NCT01576159|83341563|FG000|Overall Study|Physician Decision|0|||
46765574|NCT00647296|82984037|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
46765575|NCT00647296|82984038|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
46765576|NCT00647296|82984039|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
46765577|NCT00647296|82984040|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
46765578|NCT00647296|82984037|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
46765579|NCT00647296|82984038|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
46765580|NCT00647296|82984039|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
46765581|NCT00647296|82984040|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
46765582|NCT00647296|82984037|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
46765583|NCT00647296|82984038|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
46765584|NCT00647296|82984039|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
46832524|NCT00366548|83050483|FG000|Infant Series|Protocol Violation|0|||
46832525|NCT00366548|83050484|FG001|Infant Series|Protocol Violation|1|||
46832526|NCT00366548|83050483|FG000|Infant Series|Withdrawal by Subject|3|||
46765585|NCT00647296|82984040|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
46765586|NCT00647296|82984037|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
46765587|NCT00647296|82984038|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
46832527|NCT00366548|83050484|FG001|Infant Series|Withdrawal by Subject|1|||
46832528|NCT00366548|83050483|FG000|After Infant Series|Withdrawal by Subject|3|||
46832529|NCT00366548|83050484|FG001|After Infant Series|Withdrawal by Subject|1|||
46832530|NCT00366548|83050483|FG000|After Infant Series|Adverse Event|2|||
46832531|NCT00366548|83050484|FG001|After Infant Series|Adverse Event|0|||
46832532|NCT00366548|83050483|FG000|After Infant Series|Lost to Follow-up|1|||
46832533|NCT00366548|83050484|FG001|After Infant Series|Lost to Follow-up|0|||
46832534|NCT00252057|83050510|FG000|Overall Study|Withdrawal by Subject|2|||
46832535|NCT00252057|83050511|FG001|Overall Study|Withdrawal by Subject|5|||
46832536|NCT00252057|83050510|FG000|Overall Study|Death|1|||
46832537|NCT00252057|83050511|FG001|Overall Study|Death|2|||
46832538|NCT00252057|83050510|FG000|Overall Study|Participant previously enrolled|0|||
46832539|NCT00252057|83050511|FG001|Overall Study|Participant previously enrolled|1|||
46938257|NCT03049813|83174803|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
46938258|NCT03049813|83174804|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
46938259|NCT03049813|83174805|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
46938260|NCT03049813|83174806|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
46938261|NCT03022981|83174817|FG000|Overall Study|Adverse Event|0|||
46938262|NCT03022981|83174818|FG001|Overall Study|Adverse Event|1|||
46938263|NCT03022981|83174819|FG002|Overall Study|Adverse Event|0|||
46938264|NCT03022981|83174817|FG000|Overall Study|Investigator's Discretion|0|||
46938265|NCT03022981|83174818|FG001|Overall Study|Investigator's Discretion|1|||
46938266|NCT03022981|83174819|FG002|Overall Study|Investigator's Discretion|2|||
46938267|NCT03022981|83174817|FG000|Overall Study|Lost to Follow-up|6|||
46938268|NCT03022981|83174818|FG001|Overall Study|Lost to Follow-up|2|||
46938269|NCT03022981|83174819|FG002|Overall Study|Lost to Follow-up|1|||
46938270|NCT03022981|83174817|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46938271|NCT03022981|83174818|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46938272|NCT03022981|83174819|FG002|Overall Study|Non-Compliance With Study Drug|2|||
46938273|NCT03022981|83174817|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
46832540|NCT00132028|83050517|FG000|Overall Study|Adverse Event|7|||
46832541|NCT00132028|83050517|FG000|Overall Study|Death|2|||
46832542|NCT00132028|83050517|FG000|Overall Study|Lack of Efficacy|11|||
46832543|NCT00132028|83050517|FG000|Overall Study|Withdrawal by Subject|2|||
46832544|NCT00132028|83050517|FG000|Overall Study|not eligible|2|||
46832545|NCT00132028|83050517|FG000|Overall Study|Physician Decision|3|||
46832546|NCT00131248|83050521|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
46832547|NCT00131248|83050522|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
46832548|NCT00362414|83050528|FG000|Overall Study|Death|2|||
46832549|NCT00362414|83050528|FG000|Overall Study|Adverse Event|1|||
46832550|NCT00096382|83050537|FG000|Overall Study|Not treated|1|||
46832551|NCT00096382|83050538|FG001|Overall Study|Not treated|0|||
46832552|NCT00096382|83050537|FG000|Overall Study|Death during treatment|1|||
46832553|NCT00096382|83050538|FG001|Overall Study|Death during treatment|0|||
46832554|NCT00359294|83050549|FG000|Overall Study|Progressive disease|1|||
46832555|NCT00359294|83050550|FG001|Overall Study|Progressive disease|1|||
46832556|NCT00359294|83050551|FG002|Overall Study|Progressive disease|2|||
46832557|NCT00359294|83050552|FG003|Overall Study|Progressive disease|3|||
46832558|NCT00359294|83050553|FG004|Overall Study|Progressive disease|2|||
46832559|NCT00359294|83050549|FG000|Overall Study|Withdrawal by Subject|0|||
46832560|NCT00359294|83050550|FG001|Overall Study|Withdrawal by Subject|0|||
46832561|NCT00359294|83050551|FG002|Overall Study|Withdrawal by Subject|0|||
46832562|NCT00359294|83050552|FG003|Overall Study|Withdrawal by Subject|0|||
46832563|NCT00359294|83050553|FG004|Overall Study|Withdrawal by Subject|1|||
46832564|NCT00359294|83050549|FG000|Overall Study|Not treated|0|||
46832565|NCT00359294|83050550|FG001|Overall Study|Not treated|0|||
46832566|NCT00359294|83050551|FG002|Overall Study|Not treated|0|||
46832567|NCT00359294|83050552|FG003|Overall Study|Not treated|1|||
46832568|NCT00359294|83050553|FG004|Overall Study|Not treated|0|||
46832569|NCT00359294|83050549|FG000|Overall Study|Physician Decision|0|||
46832570|NCT00359294|83050550|FG001|Overall Study|Physician Decision|0|||
46832571|NCT00359294|83050551|FG002|Overall Study|Physician Decision|1|||
46832572|NCT00359294|83050552|FG003|Overall Study|Physician Decision|0|||
46832573|NCT00359294|83050553|FG004|Overall Study|Physician Decision|0|||
46832574|NCT00384332|83050563|FG000|Overall Study|Lost to Follow-up|4|||
46832575|NCT00384332|83050564|FG001|Overall Study|Lost to Follow-up|0|||
46832576|NCT00096226|83050572|FG000|Overall Study|Ineligible|2|||
46832577|NCT00096226|83050572|FG000|Overall Study|Protocol treatment not started|1|||
46832578|NCT00105508|83050578|FG000|Overall Study|Prephase Dropout|1|||
46832579|NCT00105508|83050579|FG001|Overall Study|Prephase Dropout|0|||
46938274|NCT03022981|83174818|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
46938275|NCT03022981|83174819|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
46938276|NCT03377699|83174839|FG000|Overall Study|Withdrawal by Subject|2|||
46832580|NCT00105508|83050578|FG000|Overall Study|Adverse Event|16|||
46832581|NCT00105508|83050579|FG001|Overall Study|Adverse Event|19|||
46832582|NCT00105508|83050578|FG000|Overall Study|Insufficient Efficacy|1|||
46832583|NCT00105508|83050579|FG001|Overall Study|Insufficient Efficacy|0|||
46832584|NCT00105508|83050578|FG000|Overall Study|Withdrawal by Subject|10|||
46832585|NCT00105508|83050579|FG001|Overall Study|Withdrawal by Subject|6|||
46832586|NCT00105508|83050578|FG000|Overall Study|Lost to Follow-up|3|||
46832587|NCT00105508|83050579|FG001|Overall Study|Lost to Follow-up|0|||
46832588|NCT00105508|83050578|FG000|Overall Study|Protocol Violation|1|||
46938277|NCT03377699|83174840|FG001|Overall Study|Withdrawal by Subject|9|||
47061260|NCT01576159|83341564|FG001|Overall Study|Physician Decision|0|||
46938278|NCT03377699|83174839|FG000|Overall Study|Lost to Follow-up|1|||
46832589|NCT00105508|83050579|FG001|Overall Study|Protocol Violation|2|||
46832590|NCT00105508|83050578|FG000|Overall Study|Other|8|||
46832591|NCT00105508|83050579|FG001|Overall Study|Other|9|||
46832592|NCT00105196|83050587|FG000|Overall Study|Lack of Efficacy|2|||
46832593|NCT00105196|83050588|FG001|Overall Study|Lack of Efficacy|3|||
46832594|NCT00105196|83050587|FG000|Overall Study|Adverse Event|11|||
46938279|NCT03377699|83174840|FG001|Overall Study|Lost to Follow-up|1|||
46938280|NCT03377699|83174839|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
46938281|NCT03377699|83174840|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
46938282|NCT03377699|83174839|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
46938283|NCT03377699|83174840|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
46938284|NCT03377699|83174839|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
46938285|NCT03377699|83174840|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
46938286|NCT03377699|83174839|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
46938287|NCT03377699|83174840|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
46938288|NCT01314443|83174852|FG000|Overall Study|Withdrawal by Subject|2|||
46832595|NCT00105196|83050588|FG001|Overall Study|Adverse Event|3|||
46832596|NCT00105196|83050587|FG000|Overall Study|Withdrawal by Subject|6|||
46832597|NCT00105196|83050588|FG001|Overall Study|Withdrawal by Subject|6|||
46832598|NCT00105196|83050587|FG000|Overall Study|Lost to Follow-up|3|||
46832599|NCT00105196|83050588|FG001|Overall Study|Lost to Follow-up|2|||
46832600|NCT00105196|83050587|FG000|Overall Study|Poor/noncompliance|3|||
46832601|NCT00105196|83050588|FG001|Overall Study|Poor/noncompliance|4|||
46832602|NCT00105196|83050587|FG000|Overall Study|Protocol Violation|5|||
46832603|NCT00105196|83050588|FG001|Overall Study|Protocol Violation|2|||
46832604|NCT00105196|83050587|FG000|Overall Study|pending surgery|0|||
46832605|NCT00105196|83050588|FG001|Overall Study|pending surgery|1|||
46832606|NCT00105196|83050587|FG000|Overall Study|marijuana use|0|||
46832607|NCT00105196|83050588|FG001|Overall Study|marijuana use|1|||
46832608|NCT00105196|83050587|FG000|Overall Study|Subject became unblinded|0|||
46832609|NCT00105196|83050588|FG001|Overall Study|Subject became unblinded|1|||
46832610|NCT03820024|83050596|FG000|Overall Study|Physician Decision|1|||
46832611|NCT03820024|83050597|FG001|Overall Study|Physician Decision|2|||
46832612|NCT03819634|83050603|FG000|Overall Study|Physician Decision|2|||
46832613|NCT00104572|83050610|FG000|Overall Study|Withdrawal by Subject|3|||
46832614|NCT00104572|83050611|FG001|Overall Study|Withdrawal by Subject|3|||
46832615|NCT00104572|83050612|FG002|Overall Study|Withdrawal by Subject|0|||
46832616|NCT00514943|83050622|FG000|Stage 1|Progressive disease|4|||
46832617|NCT00514943|83050623|FG001|Stage 1|Progressive disease|8|||
46832618|NCT00514943|83050622|FG000|Stage 1|Other Adverse Event|16|||
46832619|NCT00514943|83050623|FG001|Stage 1|Other Adverse Event|6|||
46832620|NCT00514943|83050622|FG000|Stage 1|Not treated|1|||
46938289|NCT01314443|83174853|FG001|Overall Study|Withdrawal by Subject|1|||
46938290|NCT01314443|83174854|FG002|Overall Study|Withdrawal by Subject|1|||
46938291|NCT01314443|83174855|FG003|Overall Study|Withdrawal by Subject|1|||
46938292|NCT01314443|83174852|FG000|Overall Study|Protocol Violation|2|||
46938293|NCT01314443|83174853|FG001|Overall Study|Protocol Violation|2|||
46938294|NCT01314443|83174854|FG002|Overall Study|Protocol Violation|1|||
46938295|NCT01314443|83174855|FG003|Overall Study|Protocol Violation|1|||
46938296|NCT02923921|83174867|FG000|Overall Study|Sponsor Decision|39|||
46938297|NCT02923921|83174868|FG001|Overall Study|Sponsor Decision|38|||
46938298|NCT02923921|83174867|FG000|Overall Study|Lost to Follow-up|1|||
46938299|NCT02923921|83174868|FG001|Overall Study|Lost to Follow-up|0|||
46938300|NCT02923921|83174867|FG000|Overall Study|Withdrawal by Subject|6|||
46765588|NCT00647296|82984039|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
46765589|NCT00647296|82984040|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
46765590|NCT00647296|82984037|FG000|Part 2: 4-week Placebo Washout|Death|3|||
46765591|NCT00647296|82984038|FG001|Part 2: 4-week Placebo Washout|Death|0|||
46765592|NCT00647296|82984039|FG002|Part 2: 4-week Placebo Washout|Death|0|||
46765593|NCT00647296|82984040|FG003|Part 2: 4-week Placebo Washout|Death|0|||
46765594|NCT00647296|82984037|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
46832621|NCT00514943|83050623|FG001|Stage 1|Not treated|2|||
46832622|NCT00514943|83050622|FG000|Stage 1|Patient refused to continue study meds|8|||
46832623|NCT00514943|83050623|FG001|Stage 1|Patient refused to continue study meds|3|||
46832624|NCT00514943|83050622|FG000|Stage 1|Other than stated above|1|||
46832625|NCT00514943|83050623|FG001|Stage 1|Other than stated above|7|||
46832626|NCT00514943|83050622|FG000|Stage 2|Progressive disease|27|||
46938301|NCT02923921|83174868|FG001|Overall Study|Withdrawal by Subject|13|||
46938302|NCT02923921|83174867|FG000|Overall Study|Unknown, Not Collected|7|||
46938303|NCT02923921|83174868|FG001|Overall Study|Unknown, Not Collected|6|||
46832627|NCT00514943|83050623|FG001|Stage 2|Progressive disease|24|||
46832628|NCT00514943|83050622|FG000|Stage 2|Other Adverse Event|3|||
46832629|NCT00514943|83050623|FG001|Stage 2|Other Adverse Event|10|||
46832630|NCT00514943|83050622|FG000|Stage 2|Patient refused to continue study meds|2|||
46938304|NCT03039023|83174879|FG000|Overall Study|Withdrawal by Subject|1|||
46938305|NCT03039023|83174880|FG001|Overall Study|Withdrawal by Subject|0|||
46832631|NCT00514943|83050623|FG001|Stage 2|Patient refused to continue study meds|0|||
46938306|NCT03039023|83174881|FG002|Overall Study|Withdrawal by Subject|1|||
46938307|NCT03039023|83174882|FG003|Overall Study|Withdrawal by Subject|1|||
46938308|NCT03039023|83174883|FG004|Overall Study|Withdrawal by Subject|0|||
46938309|NCT03039023|83174879|FG000|Overall Study|Physician Decision|0|||
46938310|NCT03039023|83174880|FG001|Overall Study|Physician Decision|0|||
46938311|NCT03039023|83174881|FG002|Overall Study|Physician Decision|0|||
46938312|NCT03039023|83174882|FG003|Overall Study|Physician Decision|1|||
46938313|NCT03039023|83174883|FG004|Overall Study|Physician Decision|0|||
46938314|NCT03022045|83174897|FG000|Overall Study|Adverse Event|0|||
46938315|NCT03022045|83174898|FG001|Overall Study|Adverse Event|1|||
46938316|NCT03022045|83174897|FG000|Overall Study|Withdrawal by Subject|1|||
46938317|NCT03022045|83174898|FG001|Overall Study|Withdrawal by Subject|1|||
46938318|NCT03037619|83174910|FG000|Overall Study|Lost to Follow-up|0|||
46938319|NCT03037619|83174911|FG001|Overall Study|Lost to Follow-up|1|||
46938320|NCT04771013|83174919|FG000|Overall Study|Withdrawal by Subject|2|||
46938321|NCT04771013|83174920|FG001|Overall Study|Withdrawal by Subject|0|||
46938322|NCT04771013|83174919|FG000|Overall Study|Death|0|||
46938323|NCT04771013|83174920|FG001|Overall Study|Death|5|||
46938324|NCT04771013|83174919|FG000|Overall Study|Referred to another hospital before day 20|0|||
46938325|NCT04771013|83174920|FG001|Overall Study|Referred to another hospital before day 20|1|||
46938326|NCT03021265|83174926|FG000|Overall Study|Adverse Event|29|||
46938327|NCT03021265|83174926|FG000|Overall Study|Lack of Efficacy|3|||
46938328|NCT03021265|83174926|FG000|Overall Study|Improved|17|||
46938329|NCT03021265|83174926|FG000|Overall Study|Lost to Follow-up|67|||
46938330|NCT03021265|83174926|FG000|Overall Study|No reason given|2|||
46938331|NCT03021265|83174926|FG000|Overall Study|No visit since the first visit|4|||
46938332|NCT04611789|83174933|FG000|Overall Study|Lost to Follow-up|1|||
46938333|NCT04611789|83174934|FG001|Overall Study|Lost to Follow-up|0|||
46938334|NCT04611789|83174935|FG002|Overall Study|Lost to Follow-up|0|||
46938335|NCT03561597|83174951|FG000|Overall Study|Lost to Follow-up|20|||
46938336|NCT03034967|83174974|FG000|Overall Study|Withdrawal by Subject|9|||
46938337|NCT03034967|83174975|FG001|Overall Study|Withdrawal by Subject|2|||
46938338|NCT03034967|83174976|FG002|Overall Study|Withdrawal by Subject|6|||
46938339|NCT03034967|83174977|FG003|Overall Study|Withdrawal by Subject|6|||
46938340|NCT03034967|83174978|FG004|Overall Study|Withdrawal by Subject|9|||
46938341|NCT03034967|83174979|FG005|Overall Study|Withdrawal by Subject|2|||
46938342|NCT03034967|83174974|FG000|Overall Study|Physician Decision|1|||
46938343|NCT03034967|83174975|FG001|Overall Study|Physician Decision|0|||
46938344|NCT03034967|83174976|FG002|Overall Study|Physician Decision|1|||
46938345|NCT03034967|83174977|FG003|Overall Study|Physician Decision|1|||
46938346|NCT03034967|83174978|FG004|Overall Study|Physician Decision|1|||
46938347|NCT03034967|83174979|FG005|Overall Study|Physician Decision|0|||
46938348|NCT03034967|83174974|FG000|Overall Study|Lost to Follow-up|0|||
46938349|NCT03034967|83174975|FG001|Overall Study|Lost to Follow-up|0|||
46938350|NCT03034967|83174976|FG002|Overall Study|Lost to Follow-up|0|||
46938351|NCT03034967|83174977|FG003|Overall Study|Lost to Follow-up|1|||
46938352|NCT03034967|83174978|FG004|Overall Study|Lost to Follow-up|0|||
46938353|NCT03034967|83174979|FG005|Overall Study|Lost to Follow-up|2|||
46938354|NCT03034967|83174974|FG000|Overall Study|Liver function test abnormality|0|||
46938355|NCT03034967|83174975|FG001|Overall Study|Liver function test abnormality|0|||
46938356|NCT03034967|83174976|FG002|Overall Study|Liver function test abnormality|1|||
46938357|NCT03034967|83174977|FG003|Overall Study|Liver function test abnormality|0|||
46938358|NCT03034967|83174978|FG004|Overall Study|Liver function test abnormality|0|||
46938359|NCT03034967|83174979|FG005|Overall Study|Liver function test abnormality|0|||
46765595|NCT00647296|82984038|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
46765596|NCT00647296|82984039|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
46765597|NCT00647296|82984040|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
46765598|NCT00647296|82984037|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
46765599|NCT00647296|82984038|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
46938360|NCT03034967|83174974|FG000|Overall Study|Protocol Violation|1|||
46938361|NCT03034967|83174975|FG001|Overall Study|Protocol Violation|0|||
46938362|NCT03034967|83174976|FG002|Overall Study|Protocol Violation|0|||
46938363|NCT03034967|83174977|FG003|Overall Study|Protocol Violation|0|||
46938364|NCT03034967|83174978|FG004|Overall Study|Protocol Violation|0|||
46938365|NCT03034967|83174979|FG005|Overall Study|Protocol Violation|2|||
46765600|NCT00647296|82984039|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
46765601|NCT00647296|82984040|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
46938366|NCT03034967|83174974|FG000|Overall Study|Lack of Efficacy|0|||
46938367|NCT03034967|83174975|FG001|Overall Study|Lack of Efficacy|1|||
46938368|NCT03034967|83174976|FG002|Overall Study|Lack of Efficacy|2|||
46938369|NCT03034967|83174977|FG003|Overall Study|Lack of Efficacy|1|||
46938370|NCT03034967|83174978|FG004|Overall Study|Lack of Efficacy|1|||
46938371|NCT03034967|83174979|FG005|Overall Study|Lack of Efficacy|0|||
46938372|NCT03034967|83174974|FG000|Overall Study|Adverse Event, non-fatal|3|||
46938373|NCT03034967|83174975|FG001|Overall Study|Adverse Event, non-fatal|1|||
46938374|NCT03034967|83174976|FG002|Overall Study|Adverse Event, non-fatal|2|||
46938375|NCT03034967|83174977|FG003|Overall Study|Adverse Event, non-fatal|0|||
46938376|NCT03034967|83174978|FG004|Overall Study|Adverse Event, non-fatal|2|||
46938377|NCT03034967|83174979|FG005|Overall Study|Adverse Event, non-fatal|8|||
46938378|NCT03034967|83174974|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
46938379|NCT03034967|83174975|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
46938380|NCT03034967|83174976|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
46938381|NCT03034967|83174977|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
46938382|NCT03034967|83174978|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
46938383|NCT03034967|83174979|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
46938384|NCT03021187|83175002|FG000|Overall Study|Death|0|||
46938385|NCT03021187|83175003|FG001|Overall Study|Death|0|||
46938386|NCT03021187|83175004|FG002|Overall Study|Death|3|||
46938387|NCT03021187|83175005|FG003|Overall Study|Death|0|||
46938388|NCT03021187|83175002|FG000|Overall Study|Withdrawal by Subject|0|||
46938389|NCT03021187|83175003|FG001|Overall Study|Withdrawal by Subject|6|||
46938390|NCT03021187|83175004|FG002|Overall Study|Withdrawal by Subject|2|||
46938391|NCT03021187|83175005|FG003|Overall Study|Withdrawal by Subject|5|||
46938392|NCT03021187|83175002|FG000|Overall Study|Lost to Follow-up|10|||
46938393|NCT03021187|83175003|FG001|Overall Study|Lost to Follow-up|3|||
46938394|NCT03021187|83175004|FG002|Overall Study|Lost to Follow-up|1|||
46938395|NCT03021187|83175005|FG003|Overall Study|Lost to Follow-up|4|||
46938396|NCT04766333|83175017|FG000|Overall Study|Lost to Follow-up|40|||
46938397|NCT04766333|83175018|FG001|Overall Study|Lost to Follow-up|826|||
46938398|NCT03020641|83175026|FG000|Overall Study|Lost to Follow-up|0|||
46938399|NCT03020641|83175027|FG001|Overall Study|Lost to Follow-up|1|||
46938400|NCT03020641|83175026|FG000|Overall Study|Converted to open surgery|2|||
46938401|NCT03020641|83175027|FG001|Overall Study|Converted to open surgery|1|||
46938402|NCT03020641|83175026|FG000|Overall Study|for surgery not performed|0|||
46938403|NCT03020641|83175027|FG001|Overall Study|for surgery not performed|1|||
46938404|NCT03020407|83175038|FG000|Overall Study|Withdrawal by Subject|2|||
46938405|NCT03020407|83175039|FG001|Overall Study|Withdrawal by Subject|1|||
46938406|NCT03020407|83175038|FG000|Overall Study|Lost to Follow-up|2|||
46938407|NCT03020407|83175039|FG001|Overall Study|Lost to Follow-up|3|||
46938408|NCT03020407|83175038|FG000|Overall Study|Protocol Violation|0|||
46938409|NCT03020407|83175039|FG001|Overall Study|Protocol Violation|1|||
46938410|NCT02536846|83175045|FG000|Overall Study|Withdrawal by Subject|1|||
46938411|NCT03014011|83175050|FG000|First Intervention|Withdrawal by Subject|1|||
46938412|NCT03014011|83175051|FG001|First Intervention|Withdrawal by Subject|0|||
46938413|NCT03014011|83175050|FG000|Washout|Withdrawal by Subject|1|||
46938414|NCT03014011|83175051|FG001|Washout|Withdrawal by Subject|0|||
46938415|NCT03012841|83175057|FG000|Overall Study|Protocol Violation|0|||
46938416|NCT03012841|83175058|FG001|Overall Study|Protocol Violation|10|||
46938417|NCT03012841|83175057|FG000|Overall Study|Lost to Follow-up|6|||
46938418|NCT03012841|83175058|FG001|Overall Study|Lost to Follow-up|1|||
46938419|NCT03012841|83175057|FG000|Overall Study|Withdrawal by Subject|6|||
46938420|NCT03012841|83175058|FG001|Overall Study|Withdrawal by Subject|0|||
46938421|NCT03012841|83175057|FG000|Overall Study|Unable to complete 12 month visit|6|||
46938422|NCT03012841|83175058|FG001|Overall Study|Unable to complete 12 month visit|0|||
46938423|NCT03012841|83175057|FG000|Overall Study|Subject relocation|1|||
46938424|NCT03012841|83175058|FG001|Overall Study|Subject relocation|0|||
46938425|NCT03012841|83175057|FG000|Overall Study|Seasonal winter travel|1|||
46938426|NCT03012841|83175058|FG001|Overall Study|Seasonal winter travel|0|||
46938427|NCT03012841|83175057|FG000|Overall Study|Physician Decision|0|||
46938428|NCT03012841|83175058|FG001|Overall Study|Physician Decision|2|||
46938429|NCT03012841|83175057|FG000|Overall Study|No ablation performed|0|||
46938430|NCT03012841|83175058|FG001|Overall Study|No ablation performed|2|||
46938431|NCT03012841|83175057|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
47061261|NCT01576159|83341565|FG002|Overall Study|Physician Decision|1|||
47061262|NCT01576159|83341566|FG003|Overall Study|Physician Decision|0|||
46938432|NCT03012841|83175058|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
46938433|NCT03012841|83175057|FG000|Overall Study|Insurance change|0|||
46938434|NCT03012841|83175058|FG001|Overall Study|Insurance change|1|||
47061263|NCT01576159|83341563|FG000|Overall Study|Lost to Follow-up|0|||
47061264|NCT01576159|83341564|FG001|Overall Study|Lost to Follow-up|0|||
46637726|NCT01474512|82811381|FG005|Long-Term Extension Period|Adverse Event|0|||
46637727|NCT01474512|82811382|FG006|Long-Term Extension Period|Adverse Event|0|||
46637728|NCT01474512|82811383|FG007|Long-Term Extension Period|Adverse Event|0|||
47061265|NCT01576159|83341565|FG002|Overall Study|Lost to Follow-up|0|||
46765602|NCT00647296|82984037|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
47061266|NCT01576159|83341566|FG003|Overall Study|Lost to Follow-up|1|||
46938435|NCT02359864|83175065|FG000|Overall Study|Withdrawal by Subject|1|||
46938436|NCT02359864|83175066|FG001|Overall Study|Withdrawal by Subject|0|||
46938437|NCT02533258|83175072|FG000|Overall Study|Adverse Event|1|||
46938438|NCT02533258|83175072|FG000|Overall Study|Death|2|||
46938439|NCT02533258|83175072|FG000|Overall Study|Other|1|||
46938440|NCT02533258|83175072|FG000|Overall Study|Economic factor|1|||
46938441|NCT02533258|83175072|FG000|Overall Study|Progression of pleural effusion|1|||
46938442|NCT02533258|83175072|FG000|Overall Study|Lack of Efficacy|2|||
46938443|NCT03019627|83175091|FG000|Overall Study|Adverse Event|8|||
46938444|NCT03019627|83175092|FG001|Overall Study|Adverse Event|0|||
46938445|NCT03019627|83175091|FG000|Overall Study|Unrelated to adverse event|1|||
46938446|NCT03019627|83175092|FG001|Overall Study|Unrelated to adverse event|3|||
46938447|NCT03019627|83175091|FG000|Overall Study|Lost to Follow-up|2|||
46938448|NCT03019627|83175092|FG001|Overall Study|Lost to Follow-up|1|||
46938449|NCT03019627|83175091|FG000|Overall Study|not compliance|2|||
46938450|NCT03019627|83175092|FG001|Overall Study|not compliance|2|||
46938451|NCT03019627|83175091|FG000|Overall Study|Other|2|||
46938452|NCT03019627|83175092|FG001|Overall Study|Other|2|||
46938453|NCT01661140|83175098|FG000|Open-Label Period|Adverse Event|44|||
46938454|NCT01661140|83175099|FG001|Open-Label Period|Adverse Event|0|||
46938455|NCT01661140|83175100|FG002|Open-Label Period|Adverse Event|0|||
46938456|NCT01661140|83175098|FG000|Open-Label Period|Protocol Violation|3|||
46938457|NCT01661140|83175099|FG001|Open-Label Period|Protocol Violation|0|||
46938458|NCT01661140|83175100|FG002|Open-Label Period|Protocol Violation|0|||
46938459|NCT01661140|83175098|FG000|Open-Label Period|Withdrawal by Subject|5|||
46938460|NCT01661140|83175099|FG001|Open-Label Period|Withdrawal by Subject|0|||
46938461|NCT01661140|83175100|FG002|Open-Label Period|Withdrawal by Subject|0|||
46938462|NCT01661140|83175098|FG000|Open-Label Period|Investigator Decision|3|||
46938463|NCT01661140|83175099|FG001|Open-Label Period|Investigator Decision|0|||
46938464|NCT01661140|83175100|FG002|Open-Label Period|Investigator Decision|0|||
46938465|NCT01661140|83175098|FG000|Open-Label Period|Death|1|||
46938466|NCT01661140|83175099|FG001|Open-Label Period|Death|0|||
46938467|NCT01661140|83175100|FG002|Open-Label Period|Death|0|||
46938468|NCT01661140|83175098|FG000|Open-Label Period|Administrative/Other|1|||
46938469|NCT01661140|83175099|FG001|Open-Label Period|Administrative/Other|0|||
46938470|NCT01661140|83175100|FG002|Open-Label Period|Administrative/Other|0|||
46938471|NCT01661140|83175098|FG000|Open-Label Period|Sponsor termination|16|||
46938472|NCT01661140|83175099|FG001|Open-Label Period|Sponsor termination|0|||
46938473|NCT01661140|83175100|FG002|Open-Label Period|Sponsor termination|0|||
46938474|NCT01661140|83175098|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
46938475|NCT01661140|83175099|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
46938476|NCT01661140|83175100|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
46938477|NCT01661140|83175098|FG000|Open-Label Period|Lost to Follow-up|2|||
46938478|NCT01661140|83175099|FG001|Open-Label Period|Lost to Follow-up|0|||
46938479|NCT01661140|83175100|FG002|Open-Label Period|Lost to Follow-up|0|||
46938480|NCT01661140|83175098|FG000|Double-Blind Period|Refused Treatment|0|||
46938481|NCT01661140|83175099|FG001|Double-Blind Period|Refused Treatment|0|||
46938482|NCT01661140|83175100|FG002|Double-Blind Period|Refused Treatment|1|||
46938483|NCT01661140|83175098|FG000|Double-Blind Period|Adverse Event|0|||
47061267|NCT01576159|83341563|FG000|Overall Study|Protocol Violation|1|||
47061268|NCT01576159|83341564|FG001|Overall Study|Protocol Violation|0|||
47061269|NCT01576159|83341565|FG002|Overall Study|Protocol Violation|0|||
46765603|NCT00647296|82984038|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
46832632|NCT00514943|83050622|FG000|Stage 2|Other than stated above|0|||
46832633|NCT00514943|83050623|FG001|Stage 2|Other than stated above|2|||
46832634|NCT03864653|83050644|FG000|Overall Study|Withdrawal by Subject|1|||
46832635|NCT00103402|83050650|FG000|Overall Study|Adverse Event|3|||
46832636|NCT00103402|83050651|FG001|Overall Study|Adverse Event|4|||
46832637|NCT00103402|83050650|FG000|Overall Study|Lost to Follow-up|8|||
46938484|NCT01661140|83175099|FG001|Double-Blind Period|Adverse Event|16|||
47061270|NCT01576159|83341566|FG003|Overall Study|Protocol Violation|0|||
47061271|NCT01510769|83341597|FG000|Overall Study|Adverse Event|7|||
46765604|NCT00647296|82984039|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
46765605|NCT00647296|82984040|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
46765606|NCT00647296|82984037|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
46765607|NCT00647296|82984038|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
46765608|NCT00647296|82984039|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
46765609|NCT00647296|82984040|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
46765610|NCT00647296|82984037|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
46765611|NCT00647296|82984038|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
46765612|NCT00647296|82984039|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
46765613|NCT00647296|82984040|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
46765614|NCT00644878|82984062|FG000|Overall Study|Adverse Event|2|||
46765615|NCT00644878|82984062|FG000|Overall Study|Abnormal laboratory value|3|||
46938485|NCT01661140|83175100|FG002|Double-Blind Period|Adverse Event|18|||
46938486|NCT01661140|83175098|FG000|Double-Blind Period|Protocol Violation|0|||
46938487|NCT01661140|83175099|FG001|Double-Blind Period|Protocol Violation|2|||
46832638|NCT00103402|83050651|FG001|Overall Study|Lost to Follow-up|7|||
46938488|NCT01661140|83175100|FG002|Double-Blind Period|Protocol Violation|3|||
46938489|NCT01661140|83175098|FG000|Double-Blind Period|Withdrawal by Subject|0|||
46938490|NCT01661140|83175099|FG001|Double-Blind Period|Withdrawal by Subject|1|||
46938491|NCT01661140|83175100|FG002|Double-Blind Period|Withdrawal by Subject|3|||
47061272|NCT01510769|83341598|FG001|Overall Study|Adverse Event|6|||
46938492|NCT01661140|83175098|FG000|Double-Blind Period|Investigator's Decision|0|||
46938493|NCT01661140|83175099|FG001|Double-Blind Period|Investigator's Decision|1|||
46938494|NCT01661140|83175100|FG002|Double-Blind Period|Investigator's Decision|2|||
46938495|NCT01661140|83175098|FG000|Double-Blind Period|Sponsor Termination|0|||
46938496|NCT01661140|83175099|FG001|Double-Blind Period|Sponsor Termination|14|||
46938497|NCT01661140|83175100|FG002|Double-Blind Period|Sponsor Termination|17|||
46938498|NCT01661140|83175098|FG000|Double-Blind Period|Administrative/Other|0|||
46938499|NCT01661140|83175099|FG001|Double-Blind Period|Administrative/Other|7|||
46938500|NCT01661140|83175100|FG002|Double-Blind Period|Administrative/Other|6|||
46938501|NCT03019549|83175108|FG000|Washout|DId not meet genotype criteria|11|||
46938502|NCT03019549|83175108|FG000|Period 2|Adverse Event|2|||
46938503|NCT03019549|83175108|FG000|Period 2|Physician Decision|2|||
46938504|NCT03019549|83175108|FG000|Period 2|Withdrawal by Subject|1|||
46938505|NCT01661062|83175117|FG000|Overall Study|Completed Treatment Off Study|3|||
46938506|NCT01661062|83175117|FG000|Overall Study|Withdrawal by Subject|2|||
46938507|NCT02536378|83175123|FG000|Overall Study|Physician Decision|0|||
46938508|NCT02536378|83175124|FG001|Overall Study|Physician Decision|2|||
46938509|NCT02536378|83175123|FG000|Overall Study|Withdrawal by Subject|0|||
46938510|NCT02536378|83175124|FG001|Overall Study|Withdrawal by Subject|1|||
46938511|NCT02536378|83175123|FG000|Overall Study|Death|1|||
46938512|NCT02536378|83175124|FG001|Overall Study|Death|2|||
46938513|NCT02536378|83175123|FG000|Overall Study|Patient refused further follow up|6|||
46938514|NCT02536378|83175124|FG001|Overall Study|Patient refused further follow up|2|||
46938515|NCT01373151|83175139|FG000|Period 1|Lack of Efficacy|3|||
46938516|NCT01373151|83175140|FG001|Period 1|Lack of Efficacy|0|||
46938517|NCT01373151|83175141|FG002|Period 1|Lack of Efficacy|0|||
46938518|NCT01373151|83175142|FG003|Period 1|Lack of Efficacy|0|||
46938519|NCT01373151|83175143|FG004|Period 1|Lack of Efficacy|1|||
46938520|NCT01373151|83175144|FG005|Period 1|Lack of Efficacy|0|||
46938521|NCT01373151|83175145|FG006|Period 1|Lack of Efficacy|0|||
46938522|NCT01373151|83175139|FG000|Period 1|Adverse Event|0|||
46938523|NCT01373151|83175140|FG001|Period 1|Adverse Event|0|||
46938524|NCT01373151|83175141|FG002|Period 1|Adverse Event|1|||
46765616|NCT00644878|82984062|FG000|Overall Study|Protocol deviation|2|||
46765617|NCT00644878|82984062|FG000|Overall Study|Treatment duration completed as per protocol|11|||
46765618|NCT00646906|82984070|FG000|Crossover Period 1|Withdrawal by Subject|1|||
46765619|NCT00646906|82984071|FG001|Crossover Period 1|Withdrawal by Subject|0|||
46765620|NCT00646906|82984072|FG002|Crossover Period 1|Withdrawal by Subject|0|||
46765621|NCT00646906|82984073|FG003|Crossover Period 1|Withdrawal by Subject|0|||
46765622|NCT00646906|82984074|FG004|Crossover Period 1|Withdrawal by Subject|0|||
46765623|NCT00646906|82984075|FG005|Crossover Period 1|Withdrawal by Subject|1|||
46765624|NCT00646906|82984076|FG006|Crossover Period 1|Withdrawal by Subject|0|||
46765625|NCT00646906|82984070|FG000|Crossover Period 2|Withdrawal by Subject|0|||
46765626|NCT00646906|82984071|FG001|Crossover Period 2|Withdrawal by Subject|1|||
46765627|NCT00646906|82984072|FG002|Crossover Period 2|Withdrawal by Subject|2|||
46765628|NCT00646906|82984073|FG003|Crossover Period 2|Withdrawal by Subject|1|||
46765629|NCT00646906|82984074|FG004|Crossover Period 2|Withdrawal by Subject|0|||
46765630|NCT00646906|82984075|FG005|Crossover Period 2|Withdrawal by Subject|0|||
46765631|NCT00646906|82984076|FG006|Crossover Period 2|Withdrawal by Subject|0|||
46765632|NCT00646906|82984070|FG000|Crossover Period 2|Physician Decision|0|||
46765633|NCT00646906|82984071|FG001|Crossover Period 2|Physician Decision|0|||
46765634|NCT00646906|82984072|FG002|Crossover Period 2|Physician Decision|0|||
46765635|NCT00646906|82984073|FG003|Crossover Period 2|Physician Decision|0|||
46765636|NCT00646906|82984074|FG004|Crossover Period 2|Physician Decision|0|||
46765637|NCT00646906|82984075|FG005|Crossover Period 2|Physician Decision|0|||
46765638|NCT00646906|82984076|FG006|Crossover Period 2|Physician Decision|1|||
46765639|NCT00642772|82984089|FG000|Overall Study|Lost to Follow-up|3|||
46832639|NCT00103402|83050650|FG000|Overall Study|Dissatisfied/No longer interested|6|||
46832640|NCT00103402|83050651|FG001|Overall Study|Dissatisfied/No longer interested|6|||
46832641|NCT00103402|83050650|FG000|Overall Study|Personal constraints/Other|5|||
46832642|NCT00103402|83050651|FG001|Overall Study|Personal constraints/Other|0|||
46832643|NCT03864341|83050657|FG000|Overall Study|Withdrawal by Subject|1|||
46832644|NCT00095836|83050661|FG000|Overall Study|Lost to Follow-up|1|||
46832645|NCT00095836|83050661|FG000|Overall Study|Adverse Event|1|||
46832646|NCT00095836|83050661|FG000|Overall Study|Death|2|||
46938525|NCT01373151|83175142|FG003|Period 1|Adverse Event|0|||
46938526|NCT01373151|83175143|FG004|Period 1|Adverse Event|4|||
46938527|NCT01373151|83175144|FG005|Period 1|Adverse Event|3|||
46938528|NCT01373151|83175145|FG006|Period 1|Adverse Event|0|||
46938529|NCT01373151|83175139|FG000|Period 1|Withdrawal by Subject|2|||
46938530|NCT01373151|83175140|FG001|Period 1|Withdrawal by Subject|0|||
46938531|NCT01373151|83175141|FG002|Period 1|Withdrawal by Subject|3|||
46938532|NCT01373151|83175142|FG003|Period 1|Withdrawal by Subject|1|||
46938533|NCT01373151|83175143|FG004|Period 1|Withdrawal by Subject|0|||
46938534|NCT01373151|83175144|FG005|Period 1|Withdrawal by Subject|1|||
46938535|NCT01373151|83175145|FG006|Period 1|Withdrawal by Subject|0|||
46938536|NCT01373151|83175139|FG000|Period 2|Lack of Efficacy|9|||
46938537|NCT01373151|83175140|FG001|Period 2|Lack of Efficacy|0|||
46938538|NCT01373151|83175141|FG002|Period 2|Lack of Efficacy|0|||
46938539|NCT01373151|83175142|FG003|Period 2|Lack of Efficacy|1|||
46938540|NCT01373151|83175143|FG004|Period 2|Lack of Efficacy|2|||
46938541|NCT01373151|83175144|FG005|Period 2|Lack of Efficacy|0|||
46938542|NCT01373151|83175145|FG006|Period 2|Lack of Efficacy|3|||
46938543|NCT01373151|83175139|FG000|Period 2|Adverse Event|0|||
46938544|NCT01373151|83175140|FG001|Period 2|Adverse Event|0|||
46938545|NCT01373151|83175141|FG002|Period 2|Adverse Event|3|||
46938546|NCT01373151|83175142|FG003|Period 2|Adverse Event|3|||
46938547|NCT01373151|83175143|FG004|Period 2|Adverse Event|0|||
46832647|NCT00168831|83050668|FG000|Overall Study|Adverse Event|36|||
46938548|NCT01373151|83175144|FG005|Period 2|Adverse Event|0|||
46938549|NCT01373151|83175145|FG006|Period 2|Adverse Event|1|||
46938550|NCT01373151|83175139|FG000|Period 2|subject request to discontinue|0|||
46938551|NCT01373151|83175140|FG001|Period 2|subject request to discontinue|1|||
46938552|NCT01373151|83175141|FG002|Period 2|subject request to discontinue|0|||
46938553|NCT01373151|83175142|FG003|Period 2|subject request to discontinue|0|||
46938554|NCT01373151|83175143|FG004|Period 2|subject request to discontinue|0|||
46938555|NCT01373151|83175144|FG005|Period 2|subject request to discontinue|0|||
46938556|NCT01373151|83175145|FG006|Period 2|subject request to discontinue|0|||
46938557|NCT01373151|83175139|FG000|Period 2|Withdrawal by Subject|0|||
46938558|NCT01373151|83175140|FG001|Period 2|Withdrawal by Subject|0|||
46938559|NCT01373151|83175141|FG002|Period 2|Withdrawal by Subject|0|||
46938560|NCT01373151|83175142|FG003|Period 2|Withdrawal by Subject|1|||
46938561|NCT01373151|83175143|FG004|Period 2|Withdrawal by Subject|0|||
46938562|NCT01373151|83175144|FG005|Period 2|Withdrawal by Subject|0|||
46938563|NCT01373151|83175145|FG006|Period 2|Withdrawal by Subject|0|||
46938564|NCT01373151|83175139|FG000|Period 2|Other|0|||
46938565|NCT01373151|83175140|FG001|Period 2|Other|0|||
46938566|NCT01373151|83175141|FG002|Period 2|Other|1|||
46938567|NCT01373151|83175142|FG003|Period 2|Other|0|||
46938568|NCT01373151|83175143|FG004|Period 2|Other|0|||
46938569|NCT01373151|83175144|FG005|Period 2|Other|0|||
46938570|NCT01373151|83175145|FG006|Period 2|Other|1|||
46938571|NCT01660906|83175161|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
46938572|NCT03015181|83175181|FG000|Overall Study|Enrolled, but product never administered|1|||
46938573|NCT03015181|83175182|FG001|Overall Study|Enrolled, but product never administered|0|||
46938574|NCT03015181|83175183|FG002|Overall Study|Enrolled, but product never administered|0|||
46938575|NCT03015181|83175184|FG003|Overall Study|Enrolled, but product never administered|0|||
46938576|NCT03015181|83175185|FG004|Overall Study|Enrolled, but product never administered|0|||
46938577|NCT03015181|83175186|FG005|Overall Study|Enrolled, but product never administered|0|||
46938578|NCT03015181|83175187|FG006|Overall Study|Enrolled, but product never administered|0|||
46938579|NCT03015181|83175181|FG000|Overall Study|Withdrawal by Subject|0|||
46938580|NCT03015181|83175182|FG001|Overall Study|Withdrawal by Subject|0|||
46938581|NCT03015181|83175183|FG002|Overall Study|Withdrawal by Subject|0|||
46938582|NCT03015181|83175184|FG003|Overall Study|Withdrawal by Subject|0|||
46938583|NCT03015181|83175185|FG004|Overall Study|Withdrawal by Subject|0|||
46938584|NCT03015181|83175186|FG005|Overall Study|Withdrawal by Subject|1|||
47061273|NCT01510769|83341599|FG002|Overall Study|Adverse Event|4|||
47061274|NCT01510769|83341597|FG000|Overall Study|Gout Flare|0|||
47061275|NCT01510769|83341598|FG001|Overall Study|Gout Flare|3|||
46765640|NCT00642772|82984089|FG000|Overall Study|Withdrawal by Subject|7|||
46765641|NCT00446095|82984098|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
46765642|NCT00446095|82984099|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
46765643|NCT00446095|82984100|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
46765644|NCT00446095|82984101|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
46765645|NCT00446095|82984102|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
46765646|NCT00446095|82984098|FG000|Phase II (8 Weeks)|Adverse Event|0|||
46765647|NCT00446095|82984099|FG001|Phase II (8 Weeks)|Adverse Event|1|||
46765648|NCT00446095|82984100|FG002|Phase II (8 Weeks)|Adverse Event|1|||
46765649|NCT00446095|82984101|FG003|Phase II (8 Weeks)|Adverse Event|0|||
46765650|NCT00446095|82984102|FG004|Phase II (8 Weeks)|Adverse Event|0|||
46765651|NCT00446095|82984098|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
46765652|NCT00446095|82984099|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
46765653|NCT00446095|82984100|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
46938585|NCT03015181|83175187|FG006|Overall Study|Withdrawal by Subject|0|||
46938586|NCT03015181|83175181|FG000|Overall Study|Physician Decision|0|||
46938587|NCT03015181|83175182|FG001|Overall Study|Physician Decision|0|||
46938588|NCT03015181|83175183|FG002|Overall Study|Physician Decision|0|||
46938589|NCT03015181|83175184|FG003|Overall Study|Physician Decision|0|||
46938590|NCT03015181|83175185|FG004|Overall Study|Physician Decision|0|||
47061276|NCT01510769|83341599|FG002|Overall Study|Gout Flare|1|||
46765654|NCT00446095|82984101|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
46765655|NCT00446095|82984102|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
46938591|NCT03015181|83175186|FG005|Overall Study|Physician Decision|0|||
46938592|NCT03015181|83175187|FG006|Overall Study|Physician Decision|1|||
46938593|NCT00960297|83175236|FG000|Overall Study|Physician Decision|1|||
46938594|NCT00960297|83175236|FG000|Overall Study|Venous port infection|1|||
47061277|NCT01510769|83341597|FG000|Overall Study|Protocol Violation|11|||
46832648|NCT00168831|83050669|FG001|Overall Study|Adverse Event|47|||
46832649|NCT00168831|83050670|FG002|Overall Study|Adverse Event|74|||
46832650|NCT00168831|83050668|FG000|Overall Study|Lost to Follow-up|5|||
46832651|NCT00168831|83050669|FG001|Overall Study|Lost to Follow-up|6|||
46832652|NCT00168831|83050670|FG002|Overall Study|Lost to Follow-up|4|||
46832653|NCT00168831|83050668|FG000|Overall Study|Withdrawal by Subject|7|||
46832654|NCT00168831|83050669|FG001|Overall Study|Withdrawal by Subject|14|||
46832655|NCT00168831|83050670|FG002|Overall Study|Withdrawal by Subject|19|||
46832656|NCT00168831|83050668|FG000|Overall Study|Protocol Violation|6|||
46832657|NCT00168831|83050669|FG001|Overall Study|Protocol Violation|11|||
46832658|NCT00168831|83050670|FG002|Overall Study|Protocol Violation|11|||
46938595|NCT00960297|83175236|FG000|Overall Study|Disease progression|1|||
46938596|NCT03018691|83175243|FG000|Overall Study|Adverse Event|1|||
46938597|NCT03018691|83175244|FG001|Overall Study|Adverse Event|1|||
46938598|NCT03018691|83175245|FG002|Overall Study|Adverse Event|4|||
46938599|NCT03018691|83175243|FG000|Overall Study|Lack of Efficacy|0|||
46938600|NCT03018691|83175244|FG001|Overall Study|Lack of Efficacy|0|||
46938601|NCT03018691|83175245|FG002|Overall Study|Lack of Efficacy|1|||
46938602|NCT03018691|83175243|FG000|Overall Study|Withdrawal by Subject|0|||
46938603|NCT03018691|83175244|FG001|Overall Study|Withdrawal by Subject|0|||
46938604|NCT03018691|83175245|FG002|Overall Study|Withdrawal by Subject|1|||
46938605|NCT03018691|83175243|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46938606|NCT03018691|83175244|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46938607|NCT03018691|83175245|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46938608|NCT03012061|83175258|FG000|Overall Study|Withdrawal by Subject|1|||
46938609|NCT03012061|83175259|FG001|Overall Study|Withdrawal by Subject|5|||
46938610|NCT03012061|83175260|FG002|Overall Study|Withdrawal by Subject|4|||
46938611|NCT03012061|83175258|FG000|Overall Study|Investigator Site Closed|1|||
46938612|NCT03012061|83175259|FG001|Overall Study|Investigator Site Closed|2|||
46938613|NCT03012061|83175260|FG002|Overall Study|Investigator Site Closed|0|||
46938614|NCT03012061|83175258|FG000|Overall Study|Lost to Follow-up|2|||
46938615|NCT03012061|83175259|FG001|Overall Study|Lost to Follow-up|1|||
46938616|NCT03012061|83175260|FG002|Overall Study|Lost to Follow-up|0|||
47061278|NCT01510769|83341598|FG001|Overall Study|Protocol Violation|10|||
47061279|NCT01510769|83341599|FG002|Overall Study|Protocol Violation|9|||
47061280|NCT01510769|83341597|FG000|Overall Study|Lost to Follow-up|5|||
47061281|NCT01510769|83341598|FG001|Overall Study|Lost to Follow-up|1|||
47061282|NCT01510769|83341599|FG002|Overall Study|Lost to Follow-up|5|||
46765656|NCT00446095|82984098|FG000|Phase II (8 Weeks)|Physician Decision|1|||
46938617|NCT03012061|83175258|FG000|Overall Study|Study closed/ Terminated|0|||
46938618|NCT03012061|83175259|FG001|Overall Study|Study closed/ Terminated|0|||
46938619|NCT03012061|83175260|FG002|Overall Study|Study closed/ Terminated|1|||
46938620|NCT03012061|83175258|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
46938621|NCT03012061|83175259|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
46765657|NCT00446095|82984099|FG001|Phase II (8 Weeks)|Physician Decision|0|||
46765658|NCT00446095|82984100|FG002|Phase II (8 Weeks)|Physician Decision|0|||
46765659|NCT00446095|82984101|FG003|Phase II (8 Weeks)|Physician Decision|0|||
46765660|NCT00446095|82984102|FG004|Phase II (8 Weeks)|Physician Decision|0|||
46765661|NCT00446095|82984098|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
46765662|NCT00446095|82984099|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
46765663|NCT00446095|82984100|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
46765664|NCT00446095|82984101|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
46765665|NCT00446095|82984102|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
46765666|NCT00446095|82984098|FG000|Phase II (8 Weeks)|Ongoing|0|||
46765667|NCT00446095|82984099|FG001|Phase II (8 Weeks)|Ongoing|0|||
46765668|NCT00446095|82984100|FG002|Phase II (8 Weeks)|Ongoing|1|||
46765669|NCT00446095|82984101|FG003|Phase II (8 Weeks)|Ongoing|0|||
46765670|NCT00446095|82984102|FG004|Phase II (8 Weeks)|Ongoing|0|||
46765671|NCT00446095|82984098|FG000|Phase I (28 Days)|Adverse Event|0|||
46765672|NCT00446095|82984099|FG001|Phase I (28 Days)|Adverse Event|0|||
46765673|NCT00446095|82984100|FG002|Phase I (28 Days)|Adverse Event|0|||
46765674|NCT00446095|82984101|FG003|Phase I (28 Days)|Adverse Event|1|||
46765675|NCT00446095|82984102|FG004|Phase I (28 Days)|Adverse Event|0|||
46765676|NCT00446095|82984098|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
46765677|NCT00446095|82984099|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
46832659|NCT00168831|83050668|FG000|Overall Study|Other|6|||
46938622|NCT03012061|83175260|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
46938623|NCT03012061|83175258|FG000|Overall Study|Protocol Violation|0|||
46765678|NCT00446095|82984100|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
46832660|NCT00168831|83050669|FG001|Overall Study|Other|3|||
46938624|NCT03012061|83175259|FG001|Overall Study|Protocol Violation|0|||
46938625|NCT03012061|83175260|FG002|Overall Study|Protocol Violation|2|||
46765679|NCT00446095|82984101|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
46765680|NCT00446095|82984102|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
46765681|NCT00829010|82984118|FG000|Overall Study|Adverse Event|1|||
46765682|NCT00829010|82984119|FG001|Overall Study|Adverse Event|0|||
46938626|NCT03012061|83175258|FG000|Overall Study|Lack of Efficacy|0|||
46938627|NCT03012061|83175259|FG001|Overall Study|Lack of Efficacy|1|||
46938628|NCT03012061|83175260|FG002|Overall Study|Lack of Efficacy|0|||
46938629|NCT03012061|83175258|FG000|Overall Study|Adverse Event|2|||
46938630|NCT03012061|83175259|FG001|Overall Study|Adverse Event|0|||
46938631|NCT03012061|83175260|FG002|Overall Study|Adverse Event|0|||
46938632|NCT03010501|83175268|FG000|Study Week 1|Withdrawal by Subject|2|||
46938633|NCT03010501|83175269|FG001|Study Week 1|Withdrawal by Subject|1|||
46938634|NCT03010501|83175270|FG002|Study Week 1|Withdrawal by Subject|0|||
46938635|NCT03010501|83175271|FG003|Study Week 1|Withdrawal by Subject|2|||
46938636|NCT03010501|83175272|FG004|Study Week 1|Withdrawal by Subject|0|||
46938637|NCT03010501|83175273|FG005|Study Week 1|Withdrawal by Subject|0|||
46938638|NCT03010501|83175268|FG000|Study Week 3|Withdrawal by Subject|0|||
46938639|NCT03010501|83175269|FG001|Study Week 3|Withdrawal by Subject|0|||
46938640|NCT03010501|83175270|FG002|Study Week 3|Withdrawal by Subject|0|||
46938641|NCT03010501|83175271|FG003|Study Week 3|Withdrawal by Subject|1|||
46938642|NCT03010501|83175272|FG004|Study Week 3|Withdrawal by Subject|0|||
46938643|NCT03010501|83175273|FG005|Study Week 3|Withdrawal by Subject|0|||
46938644|NCT03002623|83175283|FG000|Overall Study|Lost to Follow-up|1|||
46938645|NCT03002623|83175284|FG001|Overall Study|Lost to Follow-up|0|||
46938646|NCT03002623|83175283|FG000|Overall Study|Physician Decision|1|||
46938647|NCT03002623|83175284|FG001|Overall Study|Physician Decision|1|||
46938648|NCT03010423|83175292|FG000|Overall Study|Study termination|8|||
46938649|NCT03002311|83175298|FG000|Overall Study|Lost to Follow-up|13|||
46938650|NCT03002311|83175299|FG001|Overall Study|Lost to Follow-up|26|||
46938651|NCT03002311|83175298|FG000|Overall Study|Referral provider called to schedule app|3|||
46938652|NCT03002311|83175299|FG001|Overall Study|Referral provider called to schedule app|3|||
46938653|NCT03002311|83175298|FG000|Overall Study|Physician Decision|3|||
46938654|NCT03002311|83175299|FG001|Overall Study|Physician Decision|1|||
46938655|NCT03002077|83175305|FG000|Overall Study|Non-compliance with Study Drug|4|||
46938656|NCT03002077|83175305|FG000|Overall Study|Non-compliance w/Background ADT|1|||
46938657|NCT03002077|83175305|FG000|Overall Study|Study Terminated by Sponsor|257|||
47061283|NCT01510769|83341597|FG000|Overall Study|Withdrawal by Subject|3|||
47061284|NCT01510769|83341598|FG001|Overall Study|Withdrawal by Subject|4|||
47061285|NCT01510769|83341599|FG002|Overall Study|Withdrawal by Subject|3|||
47061286|NCT01510769|83341597|FG000|Overall Study|Death|1|||
47061287|NCT01510769|83341598|FG001|Overall Study|Death|1|||
47061288|NCT01510769|83341599|FG002|Overall Study|Death|0|||
47061289|NCT01575769|83341607|FG000|Overall Study|Adverse Event|1|||
47061290|NCT01575769|83341607|FG000|Overall Study|Study terminated by sponsor|40|||
47061291|NCT01510145|83341613|FG000|Overall Study|Adverse Event|6|||
47061292|NCT01510145|83341613|FG000|Overall Study|Lost to Follow-up|5|||
47061293|NCT01510145|83341613|FG000|Overall Study|Withdrawal by Subject|6|||
46765683|NCT00829010|82984120|FG002|Overall Study|Adverse Event|0|||
46765684|NCT00829010|82984121|FG003|Overall Study|Adverse Event|0|||
46765685|NCT00829010|82984122|FG004|Overall Study|Adverse Event|0|||
46765686|NCT00829010|82984118|FG000|Overall Study|Withdrawal by Subject|0|||
46765687|NCT00829010|82984119|FG001|Overall Study|Withdrawal by Subject|1|||
46765688|NCT00829010|82984120|FG002|Overall Study|Withdrawal by Subject|1|||
46765689|NCT00829010|82984121|FG003|Overall Study|Withdrawal by Subject|0|||
46765690|NCT00829010|82984122|FG004|Overall Study|Withdrawal by Subject|2|||
46765691|NCT00829010|82984118|FG000|Overall Study|Lost to Follow-up|1|||
46765692|NCT00829010|82984119|FG001|Overall Study|Lost to Follow-up|0|||
46765693|NCT00829010|82984120|FG002|Overall Study|Lost to Follow-up|2|||
46765694|NCT00829010|82984121|FG003|Overall Study|Lost to Follow-up|0|||
46765695|NCT00829010|82984122|FG004|Overall Study|Lost to Follow-up|0|||
46765696|NCT00829010|82984118|FG000|Overall Study|Fatality|5|||
46765697|NCT00829010|82984119|FG001|Overall Study|Fatality|4|||
46765698|NCT00829010|82984120|FG002|Overall Study|Fatality|0|||
46765699|NCT00829010|82984121|FG003|Overall Study|Fatality|3|||
46765700|NCT00829010|82984122|FG004|Overall Study|Fatality|0|||
46765701|NCT00829010|82984118|FG000|Overall Study|Migrated/Moved from study area|3|||
46765702|NCT00829010|82984119|FG001|Overall Study|Migrated/Moved from study area|4|||
46765703|NCT00829010|82984120|FG002|Overall Study|Migrated/Moved from study area|0|||
46765704|NCT00829010|82984121|FG003|Overall Study|Migrated/Moved from study area|5|||
46765705|NCT00829010|82984122|FG004|Overall Study|Migrated/Moved from study area|0|||
46765706|NCT00644332|82984134|FG000|Overall Study|Adverse Event|11|||
46938658|NCT03002077|83175305|FG000|Overall Study|Site Terminated by Sponsor|5|||
46938659|NCT03002077|83175305|FG000|Overall Study|Miscellaneous Reasons|10|||
46938660|NCT03002077|83175305|FG000|Overall Study|Adverse Event|23|||
46938661|NCT03002077|83175305|FG000|Overall Study|Lack of Efficacy|20|||
46938662|NCT03002077|83175305|FG000|Overall Study|Withdrawal by Subject|72|||
47061294|NCT01510145|83341613|FG000|Overall Study|Relative reported subject withdrew|1|||
46765707|NCT00644332|82984134|FG000|Overall Study|Withdrawal by Subject|6|||
46938663|NCT03002077|83175305|FG000|Overall Study|Lost to Follow-up|21|||
46938664|NCT03002077|83175305|FG000|Overall Study|Pregnancy|4|||
46765708|NCT00644332|82984134|FG000|Overall Study|Completion Status Unknown|2|||
46765709|NCT00644332|82984134|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
46765710|NCT00644332|82984134|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
46938665|NCT03002077|83175305|FG000|Overall Study|Protocol Violation|21|||
46938666|NCT03008005|83175312|FG000|Overall Study|Physician Decision|1|||
46938667|NCT03008005|83175313|FG001|Overall Study|Physician Decision|0|||
46938668|NCT03008005|83175314|FG002|Overall Study|Physician Decision|0|||
46938669|NCT03008005|83175312|FG000|Overall Study|Withdrawal by Subject|1|||
46938670|NCT03008005|83175313|FG001|Overall Study|Withdrawal by Subject|0|||
46938671|NCT03008005|83175314|FG002|Overall Study|Withdrawal by Subject|0|||
46938672|NCT03008005|83175312|FG000|Overall Study|Ineligible|0|||
46938673|NCT03008005|83175313|FG001|Overall Study|Ineligible|1|||
46938674|NCT03008005|83175314|FG002|Overall Study|Ineligible|0|||
46938675|NCT02440425|83175331|FG000|Overall Study|Death likely due to disease progression|1|||
46938676|NCT02440425|83175331|FG000|Overall Study|Withdrawal by Subject|2|||
46832661|NCT00168831|83050670|FG002|Overall Study|Other|6|||
47061295|NCT01528033|83341619|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
47061296|NCT01528033|83341620|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
47061297|NCT01528033|83341619|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
47061298|NCT01528033|83341620|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
47061299|NCT01528033|83341619|FG000|Primary Endpoint Assessment ITT|Death|2|||
47061300|NCT01528033|83341620|FG001|Primary Endpoint Assessment ITT|Death|2|||
47061301|NCT01528033|83341619|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
47061302|NCT01528033|83341620|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
47061303|NCT01528033|83341619|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
47061304|NCT01528033|83341620|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
47061305|NCT01528033|83341619|FG000|Follow Up|No data available|46|||
47061306|NCT01528033|83341620|FG001|Follow Up|No data available|44|||
47061307|NCT01560871|83341637|FG000|Overall Study|transportation issues|2|||
47061308|NCT01560871|83341638|FG001|Overall Study|transportation issues|1|||
47061309|NCT01560871|83341637|FG000|Overall Study|relocation|1|||
47061310|NCT01560871|83341638|FG001|Overall Study|relocation|0|||
47061311|NCT01560871|83341637|FG000|Overall Study|readmission to a hospital|2|||
47061312|NCT01560871|83341638|FG001|Overall Study|readmission to a hospital|1|||
47061313|NCT01560871|83341637|FG000|Overall Study|Lost to Follow-up|1|||
47061314|NCT01560871|83341638|FG001|Overall Study|Lost to Follow-up|0|||
47061315|NCT01509053|83341645|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
47061316|NCT01509053|83341645|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
47061317|NCT01509053|83341645|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
47061318|NCT01509053|83341645|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
47061319|NCT01509053|83341645|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
47061320|NCT01509053|83341645|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
47061321|NCT01560403|83341659|FG000|Overall Study|Lost to Follow-up|0|||
47061322|NCT01560403|83341660|FG001|Overall Study|Lost to Follow-up|1|||
47061323|NCT01527487|83341707|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
47061324|NCT01527487|83341708|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
47061325|NCT01527487|83341707|FG000|Overall Study|Disease Progression|4|||
47061326|NCT01527487|83341708|FG001|Overall Study|Disease Progression|1|||
47061327|NCT01527487|83341707|FG000|Overall Study|Adverse Event|1|||
47061328|NCT01527487|83341708|FG001|Overall Study|Adverse Event|1|||
47061329|NCT01527487|83341707|FG000|Overall Study|Death|0|||
47061330|NCT01527487|83341708|FG001|Overall Study|Death|1|||
47061331|NCT01506947|83341719|FG000|Overall Study|Lost to Follow-up|7|||
47061332|NCT01506947|83341719|FG000|Overall Study|Adverse Event|5|||
47061333|NCT01506947|83341719|FG000|Overall Study|Death|1|||
47061334|NCT01506947|83341719|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
47061335|NCT02665338|83341736|FG000|Overall Study|Withdrawal by Subject|0|||
47061336|NCT02665338|83341737|FG001|Overall Study|Withdrawal by Subject|1|||
47061337|NCT01506479|83341746|FG000|Overall Study|Lost to Follow-up|1|||
47061338|NCT01506479|83341747|FG001|Overall Study|Lost to Follow-up|2|||
47061339|NCT01506479|83341748|FG002|Overall Study|Lost to Follow-up|2|||
47061340|NCT01506479|83341746|FG000|Overall Study|Withdrawal by Subject|1|||
47061341|NCT01506479|83341747|FG001|Overall Study|Withdrawal by Subject|2|||
46832662|NCT00103012|83050681|FG000|Overall Study|Withdrawal by Subject|2|||
46832663|NCT00103012|83050682|FG001|Overall Study|Withdrawal by Subject|1|||
46938677|NCT02440425|83175331|FG000|Overall Study|Adverse Event|1|||
47061342|NCT01506479|83341748|FG002|Overall Study|Withdrawal by Subject|1|||
47061343|NCT01506479|83341746|FG000|Overall Study|Missing assessment|1|||
46938678|NCT02440425|83175331|FG000|Overall Study|Adverse Event/Ineligible|1|||
46938679|NCT03001219|83175346|FG000|Proof of Concept|Study Termination by Sponsor|0|||
46938680|NCT03001219|83175347|FG001|Proof of Concept|Study Termination by Sponsor|1|||
46938681|NCT03001219|83175346|FG000|Proof of Concept|Withdrawal by Subject|0|||
47061344|NCT01506479|83341747|FG001|Overall Study|Missing assessment|0|||
47061345|NCT01506479|83341748|FG002|Overall Study|Missing assessment|0|||
47061346|NCT01506479|83341746|FG000|Overall Study|Adverse Event|0|||
47061347|NCT01506479|83341747|FG001|Overall Study|Adverse Event|1|||
46832664|NCT00103012|83050683|FG002|Overall Study|Withdrawal by Subject|2|||
47061348|NCT01506479|83341748|FG002|Overall Study|Adverse Event|0|||
46938682|NCT03001219|83175347|FG001|Proof of Concept|Withdrawal by Subject|4|||
46938683|NCT03001219|83175346|FG000|Proof of Concept|Protocol Deviation|0|||
46938684|NCT03001219|83175347|FG001|Proof of Concept|Protocol Deviation|1|||
46938685|NCT03001219|83175346|FG000|Proof of Concept|Adverse Event|1|||
46938686|NCT03001219|83175347|FG001|Proof of Concept|Adverse Event|1|||
46938687|NCT03001219|83175346|FG000|Proof of Concept|Physician Decision|1|||
46938688|NCT03001219|83175347|FG001|Proof of Concept|Physician Decision|0|||
46938689|NCT03001219|83175346|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
46938690|NCT03001219|83175347|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
46938691|NCT03001219|83175346|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
46938692|NCT03001219|83175347|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
46938693|NCT03001219|83175346|FG000|Extension Period Analysis|Physician Decision|0|||
46938694|NCT03001219|83175347|FG001|Extension Period Analysis|Physician Decision|1|||
46938695|NCT03001219|83175346|FG000|Extension Period Analysis|Adverse Event|1|||
46938696|NCT03001219|83175347|FG001|Extension Period Analysis|Adverse Event|1|||
46938697|NCT03001219|83175346|FG000|Extension Period Analysis|Protocol Deviation|0|||
46938698|NCT03001219|83175347|FG001|Extension Period Analysis|Protocol Deviation|1|||
46938699|NCT03001219|83175346|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
46938700|NCT03001219|83175347|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
46938701|NCT03000673|83175362|FG000|Overall Study|Withdrawal by Subject|1|||
46938702|NCT03000673|83175363|FG001|Overall Study|Withdrawal by Subject|0|||
46938703|NCT03000673|83175364|FG002|Overall Study|Withdrawal by Subject|0|||
46938704|NCT03000673|83175365|FG003|Overall Study|Withdrawal by Subject|0|||
46938705|NCT02912455|83175378|FG000|Overall Study|Withdrawal by Subject|0|||
46938706|NCT02912455|83175379|FG001|Overall Study|Withdrawal by Subject|1|||
46938707|NCT02912455|83175378|FG000|Overall Study|Lack of Efficacy|0|||
46938708|NCT02912455|83175379|FG001|Overall Study|Lack of Efficacy|1|||
46938709|NCT02912455|83175378|FG000|Overall Study|Lost to Follow-up|2|||
46938710|NCT02912455|83175379|FG001|Overall Study|Lost to Follow-up|1|||
46938711|NCT04524507|83175387|FG000|Overall Study|Lost to Follow-up|2|||
46938712|NCT04524507|83175388|FG001|Overall Study|Lost to Follow-up|4|||
46938713|NCT04524507|83175387|FG000|Overall Study|Withdrawal by Subject|2|||
46938714|NCT04524507|83175388|FG001|Overall Study|Withdrawal by Subject|9|||
46938715|NCT04524507|83175387|FG000|Overall Study|Death|2|||
46938716|NCT04524507|83175388|FG001|Overall Study|Death|10|||
46938717|NCT02999191|83175397|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
46938718|NCT02999191|83175398|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
46938719|NCT02999191|83175399|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
46938720|NCT02531698|83175409|FG000|Overall Study|Adverse Event|2|||
46938721|NCT02531698|83175410|FG001|Overall Study|Adverse Event|1|||
46938722|NCT02531698|83175409|FG000|Overall Study|Withdrawal by Subject|6|||
46938723|NCT02531698|83175410|FG001|Overall Study|Withdrawal by Subject|1|||
46938724|NCT02531698|83175409|FG000|Overall Study|Protocol Violation|2|||
46938725|NCT02531698|83175410|FG001|Overall Study|Protocol Violation|0|||
46938726|NCT02531698|83175409|FG000|Overall Study|Lost to Follow-up|1|||
46938727|NCT02531698|83175410|FG001|Overall Study|Lost to Follow-up|0|||
46938728|NCT02998021|83175427|FG000|Overall Study|Withdrawal by Subject|3|||
46938729|NCT02998021|83175428|FG001|Overall Study|Withdrawal by Subject|1|||
46938730|NCT02998021|83175427|FG000|Overall Study|unsafe home|0|||
46938731|NCT02998021|83175428|FG001|Overall Study|unsafe home|1|||
46938732|NCT03034577|83175442|FG000|Overall Study|Withdrawal by Subject|6|||
46938733|NCT03034577|83175443|FG001|Overall Study|Withdrawal by Subject|9|||
46938734|NCT03034577|83175442|FG000|Overall Study|Lost to Follow-up|25|||
46938735|NCT03034577|83175443|FG001|Overall Study|Lost to Follow-up|26|||
46938736|NCT01659736|83175453|FG000|Treatment Period|Adverse Event|1|||
46938737|NCT01659736|83175454|FG001|Treatment Period|Adverse Event|1|||
46938738|NCT01659736|83175453|FG000|Treatment Period|Protocol Violation|3|||
46938739|NCT01659736|83175454|FG001|Treatment Period|Protocol Violation|1|||
47061349|NCT01506323|83341772|FG000|Overall Study|Lost to Follow-up|5|||
47061350|NCT01506323|83341773|FG001|Overall Study|Lost to Follow-up|4|||
47061351|NCT01506323|83341772|FG000|Overall Study|Withdrawal by Subject|4|||
47061352|NCT01506323|83341773|FG001|Overall Study|Withdrawal by Subject|4|||
47061353|NCT01506323|83341772|FG000|Overall Study|Lack of Efficacy|1|||
46938740|NCT01659736|83175453|FG000|Treatment Period|Withdrawal by Subject|1|||
46938741|NCT01659736|83175454|FG001|Treatment Period|Withdrawal by Subject|0|||
46938742|NCT01659736|83175453|FG000|3-month Follow-up|Lost to Follow-up|0|||
46938743|NCT01659736|83175454|FG001|3-month Follow-up|Lost to Follow-up|1|||
46938744|NCT02997163|83175466|FG000|Overall Study|Adverse Event|1|||
46938745|NCT02997163|83175467|FG001|Overall Study|Adverse Event|0|||
46938746|NCT02997163|83175468|FG002|Overall Study|Adverse Event|0|||
46938747|NCT02997163|83175469|FG003|Overall Study|Adverse Event|1|||
47061354|NCT01506323|83341773|FG001|Overall Study|Lack of Efficacy|3|||
47061355|NCT01506323|83341772|FG000|Overall Study|Moved out of area|5|||
46938748|NCT00458536|83175479|FG000|Overall Study|Disease progression prior to treatment|7|||
46938749|NCT00458536|83175479|FG000|Overall Study|Unable to make vaccine|3|||
46938750|NCT00458536|83175479|FG000|Overall Study|No measurable disease after surgery|2|||
47061356|NCT01506323|83341773|FG001|Overall Study|Moved out of area|2|||
46938751|NCT00458536|83175479|FG000|Overall Study|Did not have renal cell carcinoma|2|||
46938752|NCT00458536|83175479|FG000|Overall Study|Patient did not have surgery|1|||
46938753|NCT00458536|83175479|FG000|Overall Study|Ineligible due to toxicity|1|||
46938754|NCT00458536|83175479|FG000|Overall Study|Withdrawal by Subject|1|||
46938755|NCT00458536|83175479|FG000|Overall Study|Progressive disease during treatment|2|||
46938756|NCT02526550|83175483|FG000|Overall Study|Lost to Follow-up|1|||
46938757|NCT03030989|83175498|FG000|Overall Study|Fever|2|||
46938758|NCT03030989|83175499|FG001|Overall Study|Fever|2|||
46938759|NCT03030989|83175498|FG000|Overall Study|Rash|2|||
46938760|NCT03030989|83175499|FG001|Overall Study|Rash|1|||
46938761|NCT03030989|83175498|FG000|Overall Study|Fatigue/Overwhelmed|1|||
46938762|NCT03030989|83175499|FG001|Overall Study|Fatigue/Overwhelmed|5|||
46938763|NCT03030989|83175498|FG000|Overall Study|Positive Blood Cultures|2|||
46938764|NCT03030989|83175499|FG001|Overall Study|Positive Blood Cultures|1|||
46938765|NCT03030989|83175498|FG000|Overall Study|Line Removed|0|||
46938766|NCT03030989|83175499|FG001|Overall Study|Line Removed|2|||
46938767|NCT03030989|83175498|FG000|Overall Study|No longer interested|5|||
46938768|NCT03030989|83175499|FG001|Overall Study|No longer interested|3|||
46938769|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
46938770|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
46938771|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
46938772|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Other|1|||
46938773|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Other|0|||
46938774|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Other|0|||
46938775|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Physician Decision|3|||
46938776|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Physician Decision|0|||
46938777|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Physician Decision|0|||
46938778|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
46938779|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
46938780|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
46938781|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
46938782|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
46938783|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
46938784|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Adverse Event|18|||
46938785|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Adverse Event|0|||
46938786|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Adverse Event|0|||
46938787|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
46938788|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
46938789|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
46938790|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
46938791|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
46938792|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
46938793|NCT03030599|83175505|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
46938794|NCT03030599|83175506|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
46938795|NCT03030599|83175507|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
46938796|NCT03030599|83175505|FG000|Stable Dose|Protocol deviation|3|||
46938797|NCT03030599|83175506|FG001|Stable Dose|Protocol deviation|0|||
46938798|NCT03030599|83175507|FG002|Stable Dose|Protocol deviation|0|||
46938799|NCT03030599|83175505|FG000|Stable Dose|Adverse Event|1|||
46938800|NCT03030599|83175506|FG001|Stable Dose|Adverse Event|0|||
46938801|NCT03030599|83175507|FG002|Stable Dose|Adverse Event|0|||
46938802|NCT03030599|83175505|FG000|Stable Dose|Lost to Follow-up|1|||
46938803|NCT03030599|83175506|FG001|Stable Dose|Lost to Follow-up|0|||
46938804|NCT03030599|83175507|FG002|Stable Dose|Lost to Follow-up|0|||
46938805|NCT03030599|83175505|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
46938806|NCT03030599|83175506|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
46765711|NCT00445939|82984141|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
46765712|NCT00445939|82984142|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
46765713|NCT00445939|82984143|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
46765714|NCT00445939|82984144|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
46765715|NCT00445939|82984141|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
46765716|NCT00445939|82984142|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
46765717|NCT00445939|82984143|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
46765718|NCT00445939|82984144|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
46765719|NCT00482053|82984164|FG000|Inter-treatment Period|Disease progression|1|||
46765720|NCT00455923|82984170|FG000|Overall Study|Pregnancy|0|||
46765721|NCT00455923|82984171|FG001|Overall Study|Pregnancy|2|||
46765722|NCT00455923|82984170|FG000|Overall Study|Other|3|||
46765723|NCT00455923|82984171|FG001|Overall Study|Other|1|||
46765724|NCT00642616|82984181|FG000|Overall Study|Adverse Event|2|||
46765725|NCT00642616|82984182|FG001|Overall Study|Adverse Event|0|||
46765726|NCT00642616|82984183|FG002|Overall Study|Adverse Event|1|||
46765727|NCT00642616|82984184|FG003|Overall Study|Adverse Event|0|||
46832665|NCT00103012|83050681|FG000|Overall Study|Pregnancy|1|||
46938807|NCT03030599|83175507|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
46938808|NCT03030599|83175505|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
46938809|NCT03030599|83175506|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
46938810|NCT03030599|83175507|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
46938811|NCT03030599|83175505|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
46938812|NCT03030599|83175506|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
46938813|NCT03030599|83175507|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
46938814|NCT03030599|83175505|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
46938815|NCT03030599|83175506|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
46938816|NCT03030599|83175507|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
46938817|NCT03030599|83175505|FG000|Open-label Extension|Adverse Event|3|||
46938818|NCT03030599|83175506|FG001|Open-label Extension|Adverse Event|0|||
46938819|NCT03030599|83175507|FG002|Open-label Extension|Adverse Event|0|||
46938820|NCT03030599|83175505|FG000|Open-label Extension|Lost to Follow-up|2|||
46938821|NCT03030599|83175506|FG001|Open-label Extension|Lost to Follow-up|0|||
46938822|NCT03030599|83175507|FG002|Open-label Extension|Lost to Follow-up|0|||
46938823|NCT03030599|83175505|FG000|Open-label Extension|Lack of Efficacy|1|||
46938824|NCT03030599|83175506|FG001|Open-label Extension|Lack of Efficacy|0|||
46938825|NCT03030599|83175507|FG002|Open-label Extension|Lack of Efficacy|0|||
46938826|NCT03030599|83175505|FG000|Open-label Extension|Other Reason|1|||
46938827|NCT03030599|83175506|FG001|Open-label Extension|Other Reason|0|||
46938828|NCT03030599|83175507|FG002|Open-label Extension|Other Reason|0|||
46938829|NCT03028415|83175515|FG000|Overall Study|Lost to Follow-up|6|||
46938830|NCT03028415|83175516|FG001|Overall Study|Lost to Follow-up|3|||
46938831|NCT03028415|83175515|FG000|Overall Study|Withdrawal by Subject|1|||
46938832|NCT03028415|83175516|FG001|Overall Study|Withdrawal by Subject|0|||
46938833|NCT03028415|83175515|FG000|Overall Study|Discontinued due to COVID-19|1|||
46938834|NCT03028415|83175516|FG001|Overall Study|Discontinued due to COVID-19|0|||
46938835|NCT02692040|83175540|FG000|Overall Study|Protocol Violation|0|||
46938836|NCT02692040|83175541|FG001|Overall Study|Protocol Violation|0|||
46938837|NCT02692040|83175542|FG002|Overall Study|Protocol Violation|0|||
46938838|NCT02692040|83175543|FG003|Overall Study|Protocol Violation|0|||
46938839|NCT02692040|83175544|FG004|Overall Study|Protocol Violation|0|||
46938840|NCT02692040|83175545|FG005|Overall Study|Protocol Violation|0|||
46938841|NCT02692040|83175546|FG006|Overall Study|Protocol Violation|0|||
46938842|NCT02692040|83175547|FG007|Overall Study|Protocol Violation|0|||
46938843|NCT02692040|83175548|FG008|Overall Study|Protocol Violation|0|||
46938844|NCT02692040|83175549|FG009|Overall Study|Protocol Violation|0|||
46938845|NCT02692040|83175550|FG010|Overall Study|Protocol Violation|0|||
46938846|NCT02692040|83175551|FG011|Overall Study|Protocol Violation|0|||
46938847|NCT02692040|83175552|FG012|Overall Study|Protocol Violation|1|||
46938848|NCT02692040|83175553|FG013|Overall Study|Protocol Violation|0|||
46938849|NCT02692040|83175554|FG014|Overall Study|Protocol Violation|0|||
46938850|NCT02692040|83175555|FG015|Overall Study|Protocol Violation|0|||
46938851|NCT02692040|83175556|FG016|Overall Study|Protocol Violation|0|||
46938852|NCT02692040|83175540|FG000|Overall Study|Adverse Event|0|||
46938853|NCT02692040|83175541|FG001|Overall Study|Adverse Event|0|||
46938854|NCT02692040|83175542|FG002|Overall Study|Adverse Event|0|||
46938855|NCT02692040|83175543|FG003|Overall Study|Adverse Event|0|||
46938856|NCT02692040|83175544|FG004|Overall Study|Adverse Event|0|||
46938857|NCT02692040|83175545|FG005|Overall Study|Adverse Event|0|||
46938858|NCT02692040|83175546|FG006|Overall Study|Adverse Event|0|||
46938859|NCT02692040|83175547|FG007|Overall Study|Adverse Event|0|||
46938860|NCT02692040|83175548|FG008|Overall Study|Adverse Event|0|||
46938861|NCT02692040|83175549|FG009|Overall Study|Adverse Event|0|||
46938862|NCT02692040|83175550|FG010|Overall Study|Adverse Event|0|||
46938863|NCT02692040|83175551|FG011|Overall Study|Adverse Event|0|||
46938864|NCT02692040|83175552|FG012|Overall Study|Adverse Event|0|||
47061357|NCT01506323|83341772|FG000|Overall Study|Schedule or Transportation conflict|8|||
47061358|NCT01506323|83341773|FG001|Overall Study|Schedule or Transportation conflict|0|||
47061359|NCT01506323|83341772|FG000|Overall Study|Started another treatment|1|||
47061360|NCT01506323|83341773|FG001|Overall Study|Started another treatment|0|||
47061361|NCT01505387|83341786|FG000|Overall Study|Protocol Violation|1|||
46938865|NCT02692040|83175553|FG013|Overall Study|Adverse Event|3|||
46938866|NCT02692040|83175554|FG014|Overall Study|Adverse Event|1|||
46938867|NCT02692040|83175555|FG015|Overall Study|Adverse Event|1|||
46938868|NCT02692040|83175556|FG016|Overall Study|Adverse Event|0|||
46938869|NCT03029819|83175635|FG000|Overall Study|Lost to Follow-up|3|||
46938870|NCT03029819|83175636|FG001|Overall Study|Lost to Follow-up|5|||
46938871|NCT03029819|83175635|FG000|Overall Study|Removed due to disruptive behavior|0|||
46938872|NCT03029819|83175636|FG001|Overall Study|Removed due to disruptive behavior|1|||
47061362|NCT01505387|83341787|FG001|Overall Study|Protocol Violation|0|||
47061363|NCT01505387|83341786|FG000|Overall Study|Withdrawal by Subject|1|||
46938873|NCT02678390|83175647|FG000|AE (1 Day)|Withdrawal by Subject|0|||
46938874|NCT02678390|83175648|FG001|AE (1 Day)|Withdrawal by Subject|1|||
46938875|NCT03027557|83175657|FG000|Overall Study|Adverse Event|1|||
46938876|NCT03027557|83175658|FG001|Overall Study|Adverse Event|0|||
46938877|NCT03027557|83175659|FG002|Overall Study|Adverse Event|0|||
46938878|NCT03029585|83175669|FG000|Overall Study|Death|1|||
46938879|NCT03029585|83175670|FG001|Overall Study|Death|1|||
46938880|NCT03029585|83175669|FG000|Overall Study|Withdrawal by Subject|1|||
46938881|NCT03029585|83175670|FG001|Overall Study|Withdrawal by Subject|0|||
46938882|NCT02678000|83175681|FG000|PART 2|Adverse Event|0|||
46938883|NCT02678000|83175682|FG001|PART 2|Adverse Event|0|||
46938884|NCT02678000|83175683|FG002|PART 2|Adverse Event|2|||
46938885|NCT02678000|83175684|FG003|PART 2|Adverse Event|1|||
46938886|NCT02678000|83175685|FG004|PART 2|Adverse Event|0|||
46938887|NCT02678000|83175681|FG000|PART 2|Withdrawal by Subject|0|||
46938888|NCT02678000|83175682|FG001|PART 2|Withdrawal by Subject|0|||
46938889|NCT02678000|83175683|FG002|PART 2|Withdrawal by Subject|1|||
46938890|NCT02678000|83175684|FG003|PART 2|Withdrawal by Subject|0|||
46938891|NCT02678000|83175685|FG004|PART 2|Withdrawal by Subject|0|||
46938892|NCT02691572|83175712|FG000|Overall Study|Withdrawal by Subject|1|||
46938893|NCT02691572|83175713|FG001|Overall Study|Withdrawal by Subject|0|||
46938894|NCT02691572|83175712|FG000|Overall Study|Protocol Violation|0|||
46938895|NCT02691572|83175713|FG001|Overall Study|Protocol Violation|1|||
46938896|NCT02677844|83175721|FG000|Period 3|Withdrawal by Subject|0|||
46938897|NCT02677844|83175722|FG001|Period 3|Withdrawal by Subject|0|||
46832666|NCT00103012|83050682|FG001|Overall Study|Pregnancy|0|||
46832667|NCT00103012|83050683|FG002|Overall Study|Pregnancy|0|||
46832668|NCT00103012|83050681|FG000|Overall Study|Adverse Event|0|||
46832669|NCT00103012|83050682|FG001|Overall Study|Adverse Event|0|||
46832670|NCT00103012|83050683|FG002|Overall Study|Adverse Event|1|||
46832671|NCT00103012|83050681|FG000|Overall Study|Subject non-compliant with medications|0|||
46832672|NCT00103012|83050682|FG001|Overall Study|Subject non-compliant with medications|0|||
46832673|NCT00103012|83050683|FG002|Overall Study|Subject non-compliant with medications|1|||
46832674|NCT00512135|83050691|FG000|Overall Study|Not Treated|5|||
46832675|NCT00512135|83050691|FG000|Overall Study|Lack of Efficacy|2|||
46832676|NCT00512135|83050691|FG000|Overall Study|Adverse Event|6|||
46832677|NCT00512135|83050691|FG000|Overall Study|Withdrawal by Subject|22|||
46832678|NCT00512135|83050691|FG000|Overall Study|Lost to Follow-up|27|||
46832679|NCT00512135|83050691|FG000|Overall Study|Other|22|||
46832680|NCT00251979|83050698|FG000|Overall Study|Protocol Violation|3|||
46832681|NCT00251979|83050699|FG001|Overall Study|Protocol Violation|5|||
46832682|NCT00251979|83050698|FG000|Overall Study|Adverse Event|11|||
46938898|NCT02677844|83175723|FG002|Period 3|Withdrawal by Subject|0|||
46938899|NCT02677844|83175724|FG003|Period 3|Withdrawal by Subject|1|||
46938900|NCT02677844|83175725|FG004|Period 3|Withdrawal by Subject|0|||
46938901|NCT02677844|83175726|FG005|Period 3|Withdrawal by Subject|0|||
46938902|NCT02677844|83175727|FG006|Period 3|Withdrawal by Subject|0|||
46938903|NCT02691494|83175749|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
46938904|NCT02691494|83175750|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
46938905|NCT02691494|83175751|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
46938906|NCT02691494|83175749|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
46938907|NCT02691494|83175750|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
46938908|NCT02691494|83175751|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
46938909|NCT02691494|83175749|FG000|Post-Treatment Follow-Up Period|Other|2|||
46938910|NCT02691494|83175750|FG001|Post-Treatment Follow-Up Period|Other|1|||
46938911|NCT02691494|83175751|FG002|Post-Treatment Follow-Up Period|Other|1|||
46938912|NCT02691494|83175749|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
46938913|NCT02691494|83175750|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
46938914|NCT02691494|83175751|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
46938915|NCT02691494|83175749|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
47061364|NCT01505387|83341787|FG001|Overall Study|Withdrawal by Subject|1|||
47061365|NCT01504841|83341875|FG000|Overall Study|Withdrawal by Subject|1|||
47061366|NCT01504841|83341876|FG001|Overall Study|Withdrawal by Subject|1|||
47061367|NCT01504841|83341877|FG002|Overall Study|Withdrawal by Subject|0|||
47061368|NCT01502423|83341890|FG000|Overall Study|Withdrawal by Subject|0|||
47061369|NCT01502423|83341891|FG001|Overall Study|Withdrawal by Subject|1|||
47061370|NCT01502033|83341897|FG000|Overall Study|1 participant had scalp discomfort|1|||
46832683|NCT00251979|83050699|FG001|Overall Study|Adverse Event|17|||
46938916|NCT02691494|83175750|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
46938917|NCT02691494|83175751|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
46938918|NCT02677220|83175759|FG000|Overall Study|Adverse Event|1|||
46938919|NCT02682602|83175766|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
47061371|NCT01502033|83341897|FG000|Overall Study|1 participant had worsening depression|1|||
46832684|NCT00251979|83050698|FG000|Overall Study|Withdrawal by Subject|13|||
46832685|NCT00251979|83050699|FG001|Overall Study|Withdrawal by Subject|7|||
46938920|NCT02682602|83175767|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
46938921|NCT02682602|83175766|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
46938922|NCT02682602|83175767|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
46938923|NCT02681510|83175777|FG000|Overall Study|Withdrawal by Subject|1|||
46938924|NCT02681510|83175777|FG000|Overall Study|Lost to Follow-up|9|||
46938925|NCT02690714|83175781|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
46938926|NCT02690714|83175781|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
46938927|NCT01791543|83175789|FG000|Overall Study|Lost to Follow-up|1|||
46938928|NCT01791543|83175789|FG000|Overall Study|Adverse Event|1|||
46938929|NCT02925455|83175796|FG000|Overall Study|Withdrawal by Subject|2|||
46938930|NCT02925455|83175797|FG001|Overall Study|Withdrawal by Subject|0|||
46938931|NCT03033069|83175807|FG000|Overall Study|Adverse Event|6|||
46938932|NCT03033069|83175808|FG001|Overall Study|Adverse Event|7|||
46938933|NCT03033069|83175809|FG002|Overall Study|Adverse Event|4|||
46938934|NCT03033069|83175810|FG003|Overall Study|Adverse Event|6|||
46938935|NCT03033069|83175807|FG000|Overall Study|Lack of Efficacy|0|||
46938936|NCT03033069|83175808|FG001|Overall Study|Lack of Efficacy|0|||
46938937|NCT03033069|83175809|FG002|Overall Study|Lack of Efficacy|1|||
46938938|NCT03033069|83175810|FG003|Overall Study|Lack of Efficacy|0|||
46938939|NCT03033069|83175807|FG000|Overall Study|Lost to Follow-up|6|||
46938940|NCT03033069|83175808|FG001|Overall Study|Lost to Follow-up|5|||
46938941|NCT03033069|83175809|FG002|Overall Study|Lost to Follow-up|5|||
46938942|NCT03033069|83175810|FG003|Overall Study|Lost to Follow-up|6|||
46938943|NCT03033069|83175807|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46938944|NCT03033069|83175808|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46938945|NCT03033069|83175809|FG002|Overall Study|Non-Compliance With Study Drug|1|||
46938946|NCT03033069|83175810|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46938947|NCT03033069|83175807|FG000|Overall Study|Protocol Deviation|0|||
46938948|NCT03033069|83175808|FG001|Overall Study|Protocol Deviation|1|||
46938949|NCT03033069|83175809|FG002|Overall Study|Protocol Deviation|0|||
46938950|NCT03033069|83175810|FG003|Overall Study|Protocol Deviation|0|||
46938951|NCT03033069|83175807|FG000|Overall Study|Withdrawal by Subject|10|||
46938952|NCT03033069|83175808|FG001|Overall Study|Withdrawal by Subject|10|||
46938953|NCT03033069|83175809|FG002|Overall Study|Withdrawal by Subject|11|||
46938954|NCT03033069|83175810|FG003|Overall Study|Withdrawal by Subject|6|||
46938955|NCT03033069|83175807|FG000|Overall Study|Withdrawal By Caregiver|1|||
46938956|NCT03033069|83175808|FG001|Overall Study|Withdrawal By Caregiver|0|||
46938957|NCT03033069|83175809|FG002|Overall Study|Withdrawal By Caregiver|0|||
46938958|NCT03033069|83175810|FG003|Overall Study|Withdrawal By Caregiver|0|||
46938959|NCT03033069|83175807|FG000|Overall Study|Reason not Specified|0|||
46938960|NCT03033069|83175808|FG001|Overall Study|Reason not Specified|1|||
46938961|NCT03033069|83175809|FG002|Overall Study|Reason not Specified|0|||
46938962|NCT03033069|83175810|FG003|Overall Study|Reason not Specified|1|||
46938963|NCT02917265|83175822|FG000|Overall Study|Physician Decision|1|||
46938964|NCT02917265|83175823|FG001|Overall Study|Physician Decision|0|||
46938965|NCT02917265|83175822|FG000|Overall Study|Withdrawal by Subject|1|||
46938966|NCT02917265|83175823|FG001|Overall Study|Withdrawal by Subject|0|||
46938967|NCT02136069|83175833|FG000|Overall Study|UC flare-up|1|||
46938968|NCT02136069|83175834|FG001|Overall Study|UC flare-up|0|||
46938969|NCT02136069|83175833|FG000|Overall Study|Adverse Event|6|||
46938970|NCT02136069|83175834|FG001|Overall Study|Adverse Event|8|||
46938971|NCT02136069|83175833|FG000|Overall Study|Death|0|||
46938972|NCT02136069|83175834|FG001|Overall Study|Death|1|||
46938973|NCT02136069|83175833|FG000|Overall Study|Lack of Efficacy|10|||
46938974|NCT02136069|83175834|FG001|Overall Study|Lack of Efficacy|4|||
46938975|NCT02136069|83175833|FG000|Overall Study|Lost to Follow-up|1|||
46938976|NCT02136069|83175834|FG001|Overall Study|Lost to Follow-up|0|||
46938977|NCT02136069|83175833|FG000|Overall Study|Non-Compliance|1|||
46938978|NCT02136069|83175834|FG001|Overall Study|Non-Compliance|0|||
46938979|NCT02136069|83175833|FG000|Overall Study|Physician Decision|5|||
46938980|NCT02136069|83175834|FG001|Overall Study|Physician Decision|4|||
46938981|NCT02136069|83175833|FG000|Overall Study|Withdrawal by Subject|10|||
46938982|NCT02136069|83175834|FG001|Overall Study|Withdrawal by Subject|11|||
46938983|NCT02917031|83175843|FG000|Overall Study|Reason not specified|7|||
46938984|NCT02917031|83175844|FG001|Overall Study|Reason not specified|5|||
46938985|NCT02917031|83175845|FG002|Overall Study|Reason not specified|6|||
47061372|NCT01502033|83341897|FG000|Overall Study|1 participant went back to school|1|||
47061373|NCT01500629|83341905|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
46637729|NCT01474512|82811384|FG008|Long-Term Extension Period|Adverse Event|0|||
46765728|NCT00642616|82984181|FG000|Overall Study|Study Terminated by Sponsor|7|||
46938986|NCT02917031|83175843|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
46938987|NCT02917031|83175844|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
46938988|NCT02917031|83175845|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
46938989|NCT02917031|83175843|FG000|Overall Study|Withdrawal by Subject|3|||
46938990|NCT02917031|83175844|FG001|Overall Study|Withdrawal by Subject|3|||
46938991|NCT02917031|83175845|FG002|Overall Study|Withdrawal by Subject|0|||
46938992|NCT02917031|83175843|FG000|Overall Study|Physician Decision|1|||
46938993|NCT02917031|83175844|FG001|Overall Study|Physician Decision|0|||
46938994|NCT02917031|83175845|FG002|Overall Study|Physician Decision|0|||
46938995|NCT02917031|83175843|FG000|Overall Study|Adverse Event|4|||
46938996|NCT02917031|83175844|FG001|Overall Study|Adverse Event|1|||
46938997|NCT02917031|83175845|FG002|Overall Study|Adverse Event|5|||
46938998|NCT02917031|83175843|FG000|Overall Study|Death|2|||
46938999|NCT02917031|83175844|FG001|Overall Study|Death|3|||
46939000|NCT02917031|83175845|FG002|Overall Study|Death|4|||
46939001|NCT01018563|83175854|FG000|Overall Study|Termination of the study by Sponsor|2|||
46939002|NCT01018563|83175855|FG001|Overall Study|Termination of the study by Sponsor|1|||
46939003|NCT02528188|83175868|FG000|Overall Study|Adverse Event|23|||
46939004|NCT02528188|83175869|FG001|Overall Study|Adverse Event|22|||
46939005|NCT02528188|83175870|FG002|Overall Study|Adverse Event|8|||
46939006|NCT02528188|83175868|FG000|Overall Study|Protocol Violation|4|||
46939007|NCT02528188|83175869|FG001|Overall Study|Protocol Violation|6|||
46939008|NCT02528188|83175870|FG002|Overall Study|Protocol Violation|4|||
46939009|NCT02528188|83175868|FG000|Overall Study|Lack of Efficacy|19|||
46939010|NCT02528188|83175869|FG001|Overall Study|Lack of Efficacy|21|||
46939011|NCT02528188|83175870|FG002|Overall Study|Lack of Efficacy|22|||
46939012|NCT02528188|83175868|FG000|Overall Study|Withdrawal by Subject|97|||
46939013|NCT02528188|83175869|FG001|Overall Study|Withdrawal by Subject|104|||
46939014|NCT02528188|83175870|FG002|Overall Study|Withdrawal by Subject|100|||
46939015|NCT02528188|83175868|FG000|Overall Study|Lost to Follow-up|25|||
46939016|NCT02528188|83175869|FG001|Overall Study|Lost to Follow-up|21|||
46939017|NCT02528188|83175870|FG002|Overall Study|Lost to Follow-up|31|||
46939018|NCT02528188|83175868|FG000|Overall Study|Death|4|||
46939019|NCT02528188|83175869|FG001|Overall Study|Death|4|||
46939020|NCT02528188|83175870|FG002|Overall Study|Death|0|||
46939021|NCT02528188|83175868|FG000|Overall Study|Other|89|||
46939022|NCT02528188|83175869|FG001|Overall Study|Other|91|||
46939023|NCT02528188|83175870|FG002|Overall Study|Other|74|||
46939024|NCT02528188|83175868|FG000|Overall Study|Randomized but not treated|6|||
46939025|NCT02528188|83175869|FG001|Overall Study|Randomized but not treated|7|||
46939026|NCT02528188|83175870|FG002|Overall Study|Randomized but not treated|12|||
46939027|NCT03896165|83175878|FG000|Overall Study|Withdrawal by Subject|2|||
46939028|NCT05361304|83175891|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
46939029|NCT05361304|83175892|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
46939030|NCT05361304|83175891|FG000|Overall Study|COVID-19 Related|1|||
46939031|NCT05361304|83175892|FG001|Overall Study|COVID-19 Related|2|||
46939032|NCT05361304|83175891|FG000|Overall Study|Withdrawal by Subject|1|||
46939033|NCT05361304|83175892|FG001|Overall Study|Withdrawal by Subject|0|||
46939034|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
46939035|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
46939036|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
46939037|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
46939038|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
46939039|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
46939040|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
46939041|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
46939042|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
46637730|NCT01474512|82811385|FG009|Long-Term Extension Period|Adverse Event|0|||
46637731|NCT01474512|82811386|FG010|Long-Term Extension Period|Adverse Event|0|||
46765729|NCT00642616|82984182|FG001|Overall Study|Study Terminated by Sponsor|6|||
46765730|NCT00642616|82984183|FG002|Overall Study|Study Terminated by Sponsor|4|||
46765731|NCT00642616|82984184|FG003|Overall Study|Study Terminated by Sponsor|5|||
46765732|NCT00642616|82984181|FG000|Overall Study|Withdrawal by Subject|0|||
46765733|NCT00642616|82984182|FG001|Overall Study|Withdrawal by Subject|1|||
46765734|NCT00642616|82984183|FG002|Overall Study|Withdrawal by Subject|1|||
46765735|NCT00642616|82984184|FG003|Overall Study|Withdrawal by Subject|1|||
46765736|NCT00642616|82984181|FG000|Overall Study|Protocol Violation|0|||
46765737|NCT00642616|82984182|FG001|Overall Study|Protocol Violation|0|||
46765738|NCT00642616|82984183|FG002|Overall Study|Protocol Violation|2|||
46765739|NCT00642616|82984184|FG003|Overall Study|Protocol Violation|0|||
46765740|NCT00642616|82984181|FG000|Overall Study|Physician Decision|0|||
46765741|NCT00642616|82984182|FG001|Overall Study|Physician Decision|0|||
46765742|NCT00642616|82984183|FG002|Overall Study|Physician Decision|1|||
46765743|NCT00642616|82984184|FG003|Overall Study|Physician Decision|1|||
46832686|NCT00251979|83050698|FG000|Overall Study|Lost to Follow-up|8|||
46939043|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
46765744|NCT03844945|82984200|FG000|Overall Study|Adverse Event|1|||
46765745|NCT03844945|82984201|FG001|Overall Study|Adverse Event|1|||
46765746|NCT03844945|82984202|FG002|Overall Study|Adverse Event|4|||
46765747|NCT03844945|82984203|FG003|Overall Study|Adverse Event|0|||
46939044|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
46939045|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
46939046|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
46765748|NCT03844945|82984200|FG000|Overall Study|Withdrawal by Subject|0|||
46939047|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
46939048|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
46939049|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
46939050|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
46939051|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
46939052|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
46939053|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
46939054|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
46939055|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
46939056|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
46939057|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
46939058|NCT02269917|83175915|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
46939059|NCT02269917|83175916|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
46939060|NCT02269917|83175917|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
46939061|NCT02269917|83175915|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
46939062|NCT02269917|83175916|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
46939063|NCT02269917|83175917|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
46939064|NCT02269917|83175915|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
46939065|NCT02269917|83175916|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
46939066|NCT02269917|83175917|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
46939067|NCT02269917|83175915|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
46939068|NCT02269917|83175916|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
46939069|NCT02269917|83175917|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
46939070|NCT02269917|83175915|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
46939071|NCT02269917|83175916|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
46939072|NCT02269917|83175917|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
46939073|NCT02269917|83175915|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
46939074|NCT02269917|83175916|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
46939075|NCT02269917|83175917|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
46939076|NCT02269917|83175915|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
46939077|NCT02269917|83175916|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
46939078|NCT02269917|83175917|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
46939079|NCT02269917|83175915|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
46939080|NCT02269917|83175916|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
46939081|NCT02269917|83175917|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
46939082|NCT02522494|83175928|FG000|Overall Study|Lost to Follow-up|6|||
46939083|NCT02522494|83175929|FG001|Overall Study|Lost to Follow-up|2|||
46939084|NCT02522494|83175928|FG000|Overall Study|Withdrawal by Subject|1|||
46939085|NCT02522494|83175929|FG001|Overall Study|Withdrawal by Subject|0|||
46939086|NCT02522494|83175928|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
46939087|NCT02522494|83175929|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
46939088|NCT02522494|83175928|FG000|Overall Study|Participant did not watch the video|1|||
47061374|NCT01500629|83341906|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
47061375|NCT01500317|83341922|FG000|Overall Study|Withdrawal by Subject|3|||
47061376|NCT01500317|83341923|FG001|Overall Study|Withdrawal by Subject|2|||
47061377|NCT01500317|83341924|FG002|Overall Study|Withdrawal by Subject|0|||
47061378|NCT01500083|83341979|FG000|Overall Study|Adverse Event|4|||
46832687|NCT00251979|83050699|FG001|Overall Study|Lost to Follow-up|6|||
46832688|NCT00251979|83050698|FG000|Overall Study|Death|3|||
46832689|NCT00251979|83050699|FG001|Overall Study|Death|5|||
46832690|NCT00511901|83050707|FG000|Overall Study|Withdrawal by Subject|1|||
46832691|NCT00511901|83050708|FG001|Overall Study|Withdrawal by Subject|3|||
46832692|NCT03862625|83050716|FG000|Overall Study|Lost to Follow-up|0|||
46832693|NCT03862625|83050717|FG001|Overall Study|Lost to Follow-up|1|||
46832694|NCT00163215|83050723|FG000|Overall Study|Lack of Efficacy|3|||
46832695|NCT00163215|83050723|FG000|Overall Study|Withdrawal by Subject|5|||
46832696|NCT00163215|83050723|FG000|Overall Study|Other|7|||
46832697|NCT00228423|83050729|FG000|Overall Study|Adverse Event|2|||
46832698|NCT00228423|83050730|FG001|Overall Study|Adverse Event|5|||
46832699|NCT00228423|83050729|FG000|Overall Study|Withdrawal by Subject|7|||
46832700|NCT00228423|83050730|FG001|Overall Study|Withdrawal by Subject|3|||
46832701|NCT00228423|83050729|FG000|Overall Study|Protocol Violation|1|||
46832702|NCT00228423|83050730|FG001|Overall Study|Protocol Violation|3|||
46832703|NCT00228423|83050729|FG000|Overall Study|Physician Decision|0|||
47061379|NCT01500083|83341980|FG001|Overall Study|Adverse Event|17|||
47061380|NCT01500083|83341979|FG000|Overall Study|Death|0|||
46939089|NCT02522494|83175929|FG001|Overall Study|Participant did not watch the video|0|||
46939090|NCT02522494|83175928|FG000|Overall Study|Death|0|||
46939091|NCT02522494|83175929|FG001|Overall Study|Death|1|||
46939092|NCT01658020|83175937|FG000|Overall Study|Adverse Event|3|||
46939093|NCT01658020|83175938|FG001|Overall Study|Adverse Event|3|||
46832704|NCT00228423|83050730|FG001|Overall Study|Physician Decision|1|||
46832705|NCT00511667|83050738|FG000|Overall Study|Adverse Event|1|||
46832706|NCT00511667|83050739|FG001|Overall Study|Adverse Event|0|||
46832707|NCT00511667|83050738|FG000|Overall Study|Protocol Violation|1|||
46832708|NCT00511667|83050739|FG001|Overall Study|Protocol Violation|1|||
46832709|NCT00511667|83050738|FG000|Overall Study|Withdrawal by Subject|2|||
46832710|NCT00511667|83050739|FG001|Overall Study|Withdrawal by Subject|0|||
46832711|NCT00511667|83050738|FG000|Overall Study|Site terminated|6|||
46939094|NCT01658020|83175937|FG000|Overall Study|Lost to Follow-up|1|||
46939095|NCT01658020|83175938|FG001|Overall Study|Lost to Follow-up|0|||
46939096|NCT01658020|83175937|FG000|Overall Study|Withdrawal by Subject|4|||
46939097|NCT01658020|83175938|FG001|Overall Study|Withdrawal by Subject|5|||
46939098|NCT01658020|83175937|FG000|Overall Study|Protocol Violation|0|||
46939099|NCT01658020|83175938|FG001|Overall Study|Protocol Violation|1|||
46939100|NCT02680574|83175956|FG000|Overall Study|Death|137|||
46939101|NCT02680574|83175957|FG001|Overall Study|Death|137|||
46939102|NCT02680574|83175956|FG000|Overall Study|Withdrawal by Subject|17|||
46939103|NCT02680574|83175957|FG001|Overall Study|Withdrawal by Subject|9|||
46939104|NCT02680574|83175956|FG000|Overall Study|Lost to Follow-up|4|||
46939105|NCT02680574|83175957|FG001|Overall Study|Lost to Follow-up|6|||
46939106|NCT02522884|83175963|FG000|Overall Study|Withdrawal by Subject|6|||
46939107|NCT02522884|83175963|FG000|Overall Study|Death|3|||
46939108|NCT02522884|83175963|FG000|Overall Study|Missed 12-month Follow-up|9|||
46939109|NCT02674568|83175980|FG000|Overall Study|Withdrawal by Subject|5|||
46939110|NCT02674568|83175980|FG000|Overall Study|Death|303|||
46939111|NCT02674568|83175980|FG000|Overall Study|Physician Decision|2|||
46939112|NCT02674568|83175980|FG000|Overall Study|Lost to Follow-up|9|||
46939113|NCT02674568|83175980|FG000|Overall Study|Other, Not Specified|20|||
46939114|NCT03022799|83176009|FG000|Overall Study|Adverse Event|0|||
46939115|NCT03022799|83176010|FG001|Overall Study|Adverse Event|0|||
46939116|NCT03022799|83176011|FG002|Overall Study|Adverse Event|0|||
46939117|NCT03022799|83176012|FG003|Overall Study|Adverse Event|0|||
46939118|NCT03022799|83176013|FG004|Overall Study|Adverse Event|0|||
46939119|NCT03022799|83176014|FG005|Overall Study|Adverse Event|0|||
46939120|NCT03022799|83176015|FG006|Overall Study|Adverse Event|0|||
46939121|NCT03022799|83176016|FG007|Overall Study|Adverse Event|0|||
46939122|NCT03022799|83176017|FG008|Overall Study|Adverse Event|0|||
46939123|NCT03022799|83176018|FG009|Overall Study|Adverse Event|1|||
46939124|NCT03022799|83176019|FG010|Overall Study|Adverse Event|1|||
46939125|NCT03022799|83176020|FG011|Overall Study|Adverse Event|0|||
46939126|NCT03022799|83176021|FG012|Overall Study|Adverse Event|0|||
46939127|NCT02674334|83176068|FG000|Overall Study|Lost to Follow-up|5|||
46939128|NCT02674334|83176069|FG001|Overall Study|Lost to Follow-up|3|||
46939129|NCT02674334|83176068|FG000|Overall Study|participant difficulty breathing|1|||
46939130|NCT02674334|83176069|FG001|Overall Study|participant difficulty breathing|0|||
46939131|NCT02674334|83176068|FG000|Overall Study|NIRS not recording|1|||
46939132|NCT02674334|83176069|FG001|Overall Study|NIRS not recording|0|||
46939133|NCT03026075|83176075|FG000|Overall Study|Physician Decision|1|||
46939134|NCT01373918|83176081|FG000|Overall Study|Physician Decision|0|||
46939135|NCT01373918|83176082|FG001|Overall Study|Physician Decision|1|||
46939136|NCT02667626|83176090|FG000|Overall Study|Withdrawal by Subject|0|||
46939137|NCT02667626|83176091|FG001|Overall Study|Withdrawal by Subject|1|||
46939138|NCT03025217|83176109|FG000|Overall Study|Pregnancy|1|||
46939139|NCT03025217|83176109|FG000|Overall Study|Lost to Follow-up|1|||
46939140|NCT03025217|83176109|FG000|Overall Study|Not eligible, poor English|2|||
46939141|NCT03023813|83176116|FG000|Overall Study|Lost to Follow-up|1|||
46939142|NCT03023813|83176117|FG001|Overall Study|Lost to Follow-up|2|||
46939143|NCT03023813|83176118|FG002|Overall Study|Lost to Follow-up|0|||
46939144|NCT01365130|83176127|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
46765749|NCT03844945|82984201|FG001|Overall Study|Withdrawal by Subject|0|||
46765750|NCT03844945|82984202|FG002|Overall Study|Withdrawal by Subject|1|||
46765751|NCT03844945|82984203|FG003|Overall Study|Withdrawal by Subject|0|||
46765752|NCT03844945|82984200|FG000|Overall Study|Lack of Efficacy|0|||
46765753|NCT03844945|82984201|FG001|Overall Study|Lack of Efficacy|0|||
46765754|NCT03844945|82984202|FG002|Overall Study|Lack of Efficacy|0|||
46765755|NCT03844945|82984203|FG003|Overall Study|Lack of Efficacy|1|||
46765756|NCT00445549|82984213|FG000|Overall Study|progressive disease|12|||
46765757|NCT00445003|82984220|FG000|Overall Study|Death|1|||
46765758|NCT00445003|82984221|FG001|Overall Study|Death|2|||
46765759|NCT00445003|82984222|FG002|Overall Study|Death|1|||
46765760|NCT00445003|82984220|FG000|Overall Study|Missed Visit|3|||
46939145|NCT01657162|83176133|FG000|Overall Study|Adverse Event|26|||
46939146|NCT01657162|83176134|FG001|Overall Study|Adverse Event|36|||
46939147|NCT01657162|83176133|FG000|Overall Study|Withdrawal by Subject|13|||
46939148|NCT01657162|83176134|FG001|Overall Study|Withdrawal by Subject|13|||
46939149|NCT01657162|83176133|FG000|Overall Study|Continuing Significant Deterioration|9|||
46939150|NCT01657162|83176134|FG001|Overall Study|Continuing Significant Deterioration|3|||
46939151|NCT01657162|83176133|FG000|Overall Study|Refusal of Treatment|4|||
46939152|NCT01657162|83176134|FG001|Overall Study|Refusal of Treatment|6|||
46939153|NCT01657162|83176133|FG000|Overall Study|Lost to Follow-up|3|||
46939154|NCT01657162|83176134|FG001|Overall Study|Lost to Follow-up|4|||
46939155|NCT01657162|83176133|FG000|Overall Study|Death|2|||
46939156|NCT01657162|83176134|FG001|Overall Study|Death|3|||
46939157|NCT01657162|83176133|FG000|Overall Study|Inability to Complete Study Procedures|1|||
46939158|NCT01657162|83176134|FG001|Overall Study|Inability to Complete Study Procedures|7|||
46939159|NCT01657162|83176133|FG000|Overall Study|Protocol Violation|1|||
46939160|NCT01657162|83176134|FG001|Overall Study|Protocol Violation|0|||
46939161|NCT01657162|83176133|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
46939162|NCT01657162|83176134|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
46939163|NCT01657162|83176133|FG000|Overall Study|Other than Specified|0|||
46939164|NCT01657162|83176134|FG001|Overall Study|Other than Specified|2|||
46939165|NCT01373294|83176159|FG000|Overall Study|Adverse Event|1|||
46939166|NCT01373294|83176160|FG001|Overall Study|Adverse Event|0|||
46939167|NCT01656304|83176166|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
46939168|NCT03023423|83176173|FG000|Overall Study|Death|5|||
46939169|NCT03023423|83176174|FG001|Overall Study|Death|12|||
46939170|NCT03023423|83176175|FG002|Overall Study|Death|20|||
46939171|NCT03023423|83176173|FG000|Overall Study|Other|0|||
46939172|NCT03023423|83176174|FG001|Overall Study|Other|2|||
46939173|NCT03023423|83176175|FG002|Overall Study|Other|2|||
46939174|NCT03023423|83176173|FG000|Overall Study|Ongoing|2|||
46939175|NCT03023423|83176174|FG001|Overall Study|Ongoing|32|||
46939176|NCT03023423|83176175|FG002|Overall Study|Ongoing|24|||
46939177|NCT03185741|83176190|FG000|Baseline|Withdrawal by Subject|1|||
46939178|NCT03185741|83176191|FG001|Baseline|Withdrawal by Subject|3|||
46939179|NCT03185741|83176192|FG002|Baseline|Withdrawal by Subject|2|||
46939180|NCT03185741|83176190|FG000|Baseline|Lost to Follow-up|1|||
46939181|NCT03185741|83176191|FG001|Baseline|Lost to Follow-up|2|||
46939182|NCT03185741|83176192|FG002|Baseline|Lost to Follow-up|3|||
46832712|NCT00511667|83050739|FG001|Overall Study|Site terminated|1|||
46832713|NCT00511667|83050738|FG000|Overall Study|Other|2|||
46832714|NCT00511667|83050739|FG001|Overall Study|Other|1|||
46832715|NCT00227877|83050755|FG000|Pre-visit Assessment|Technical difficulties|7|||
46832716|NCT00227877|83050756|FG001|Pre-visit Assessment|Technical difficulties|3|||
46832717|NCT00227877|83050757|FG002|Pre-visit Assessment|Technical difficulties|0|||
46832718|NCT00227877|83050758|FG003|Pre-visit Assessment|Technical difficulties|0|||
46939183|NCT03185741|83176190|FG000|3Month|Death|1|||
46939184|NCT03185741|83176191|FG001|3Month|Death|1|||
46939185|NCT03185741|83176192|FG002|3Month|Death|2|||
46939186|NCT03185741|83176190|FG000|3Month|Withdrawal by Subject|1|||
46939187|NCT03185741|83176191|FG001|3Month|Withdrawal by Subject|5|||
46939188|NCT03185741|83176192|FG002|3Month|Withdrawal by Subject|1|||
46939189|NCT03185741|83176190|FG000|3Month|Lost to Follow-up|7|||
46939190|NCT03185741|83176191|FG001|3Month|Lost to Follow-up|9|||
46939191|NCT03185741|83176192|FG002|3Month|Lost to Follow-up|8|||
46939192|NCT03185741|83176190|FG000|3Month|Unavailable for 3Month|11|||
46939193|NCT03185741|83176191|FG001|3Month|Unavailable for 3Month|10|||
46939194|NCT03185741|83176192|FG002|3Month|Unavailable for 3Month|11|||
46939195|NCT03185741|83176190|FG000|3Month|Protocol Violation|0|||
46939196|NCT03185741|83176191|FG001|3Month|Protocol Violation|0|||
46939197|NCT03185741|83176192|FG002|3Month|Protocol Violation|3|||
46939198|NCT03185741|83176190|FG000|6Month|Death|1|||
46939199|NCT03185741|83176191|FG001|6Month|Death|1|||
46939200|NCT03185741|83176192|FG002|6Month|Death|2|||
46939201|NCT03185741|83176190|FG000|6Month|Withdrawal by Subject|2|||
46939202|NCT03185741|83176191|FG001|6Month|Withdrawal by Subject|3|||
46939203|NCT03185741|83176192|FG002|6Month|Withdrawal by Subject|1|||
46765761|NCT00445003|82984221|FG001|Overall Study|Missed Visit|5|||
46765762|NCT00445003|82984222|FG002|Overall Study|Missed Visit|1|||
46765763|NCT00445003|82984220|FG000|Overall Study|Dropped|1|||
46765764|NCT00445003|82984221|FG001|Overall Study|Dropped|3|||
46765765|NCT00445003|82984222|FG002|Overall Study|Dropped|2|||
46765766|NCT00811070|82984236|FG000|Overall Study|Death|0|||
46765767|NCT00811070|82984237|FG001|Overall Study|Death|0|||
46765768|NCT00811070|82984238|FG002|Overall Study|Death|0|||
46765769|NCT00811070|82984239|FG003|Overall Study|Death|2|||
46765770|NCT00811070|82984240|FG004|Overall Study|Death|5|||
46765771|NCT00811070|82984241|FG005|Overall Study|Death|0|||
46765772|NCT00811070|82984236|FG000|Overall Study|Other|1|||
46765773|NCT00811070|82984237|FG001|Overall Study|Other|0|||
46765774|NCT00811070|82984238|FG002|Overall Study|Other|0|||
46765775|NCT00811070|82984239|FG003|Overall Study|Other|0|||
46765776|NCT00811070|82984240|FG004|Overall Study|Other|0|||
46939204|NCT03185741|83176190|FG000|6Month|Lost to Follow-up|16|||
46939205|NCT03185741|83176191|FG001|6Month|Lost to Follow-up|15|||
46939206|NCT03185741|83176192|FG002|6Month|Lost to Follow-up|16|||
46939207|NCT02672852|83176202|FG000|Part A1|Disease Worsening|1|||
46939208|NCT02672852|83176203|FG001|Part A1|Disease Worsening|0|||
46939209|NCT02672852|83176204|FG002|Part A1|Disease Worsening|0|||
46939210|NCT02672852|83176205|FG003|Part A1|Disease Worsening|0|||
46939211|NCT02672852|83176206|FG004|Part A1|Disease Worsening|0|||
46939212|NCT02672852|83176207|FG005|Part A1|Disease Worsening|0|||
46939213|NCT02672852|83176208|FG006|Part A1|Disease Worsening|0|||
46939214|NCT02672852|83176202|FG000|Part A1|Adverse Event|0|||
46939215|NCT02672852|83176203|FG001|Part A1|Adverse Event|1|||
46939216|NCT02672852|83176204|FG002|Part A1|Adverse Event|0|||
46939217|NCT02672852|83176205|FG003|Part A1|Adverse Event|0|||
46939218|NCT02672852|83176206|FG004|Part A1|Adverse Event|0|||
46939219|NCT02672852|83176207|FG005|Part A1|Adverse Event|0|||
46939220|NCT02672852|83176208|FG006|Part A1|Adverse Event|0|||
46939221|NCT02672852|83176202|FG000|Part A1|Lost to Follow-up|1|||
46939222|NCT02672852|83176203|FG001|Part A1|Lost to Follow-up|2|||
46939223|NCT02672852|83176204|FG002|Part A1|Lost to Follow-up|0|||
46832719|NCT00227877|83050755|FG000|Post-visit Checklist|Lost to Follow-up|24|||
46832720|NCT00227877|83050756|FG001|Post-visit Checklist|Lost to Follow-up|13|||
46832721|NCT00227877|83050757|FG002|Post-visit Checklist|Lost to Follow-up|1|||
46939224|NCT02672852|83176205|FG003|Part A1|Lost to Follow-up|0|||
46939225|NCT02672852|83176206|FG004|Part A1|Lost to Follow-up|0|||
46939226|NCT02672852|83176207|FG005|Part A1|Lost to Follow-up|0|||
46939227|NCT02672852|83176208|FG006|Part A1|Lost to Follow-up|0|||
46939228|NCT02672852|83176202|FG000|Part A1|Withdrawal by Subject|1|||
46939229|NCT02672852|83176203|FG001|Part A1|Withdrawal by Subject|1|||
46939230|NCT02672852|83176204|FG002|Part A1|Withdrawal by Subject|0|||
46939231|NCT02672852|83176205|FG003|Part A1|Withdrawal by Subject|0|||
46939232|NCT02672852|83176206|FG004|Part A1|Withdrawal by Subject|0|||
46939233|NCT02672852|83176207|FG005|Part A1|Withdrawal by Subject|0|||
46939234|NCT02672852|83176208|FG006|Part A1|Withdrawal by Subject|0|||
46939235|NCT02672852|83176202|FG000|Part A2|Disease worsening|0|||
46939236|NCT02672852|83176203|FG001|Part A2|Disease worsening|0|||
46939237|NCT02672852|83176204|FG002|Part A2|Disease worsening|1|||
46939238|NCT02672852|83176205|FG003|Part A2|Disease worsening|0|||
46939239|NCT02672852|83176206|FG004|Part A2|Disease worsening|0|||
46939240|NCT02672852|83176207|FG005|Part A2|Disease worsening|0|||
46939241|NCT02672852|83176208|FG006|Part A2|Disease worsening|0|||
46939242|NCT02672852|83176202|FG000|Part A2|Adverse Event|0|||
46939243|NCT02672852|83176203|FG001|Part A2|Adverse Event|0|||
46939244|NCT02672852|83176204|FG002|Part A2|Adverse Event|3|||
46939245|NCT02672852|83176205|FG003|Part A2|Adverse Event|0|||
46939246|NCT02672852|83176206|FG004|Part A2|Adverse Event|0|||
46939247|NCT02672852|83176207|FG005|Part A2|Adverse Event|0|||
46939248|NCT02672852|83176208|FG006|Part A2|Adverse Event|0|||
46939249|NCT02672852|83176202|FG000|Part A2|Lost to Follow-up|0|||
46939250|NCT02672852|83176203|FG001|Part A2|Lost to Follow-up|0|||
47061381|NCT01500083|83341980|FG001|Overall Study|Death|2|||
47061382|NCT01500083|83341979|FG000|Overall Study|Lost to Follow-up|1|||
46765777|NCT00811070|82984241|FG005|Overall Study|Other|0|||
46765778|NCT00811070|82984236|FG000|Overall Study|Withdrawal by Subject|0|||
46765779|NCT00811070|82984237|FG001|Overall Study|Withdrawal by Subject|1|||
46765780|NCT00811070|82984238|FG002|Overall Study|Withdrawal by Subject|0|||
46765781|NCT00811070|82984239|FG003|Overall Study|Withdrawal by Subject|0|||
46765782|NCT00811070|82984240|FG004|Overall Study|Withdrawal by Subject|0|||
46765783|NCT00811070|82984241|FG005|Overall Study|Withdrawal by Subject|0|||
46765784|NCT00811070|82984236|FG000|Overall Study|Physician Decision|0|||
46832722|NCT00227877|83050758|FG003|Post-visit Checklist|Lost to Follow-up|0|||
46832723|NCT00227877|83050755|FG000|3-months Follow-up|Completed late|135|||
46832724|NCT00227877|83050756|FG001|3-months Follow-up|Completed late|128|||
46832725|NCT00227877|83050757|FG002|3-months Follow-up|Completed late|34|||
46832726|NCT00227877|83050758|FG003|3-months Follow-up|Completed late|8|||
46832727|NCT00227877|83050755|FG000|3-months Follow-up|Lost to Follow-up|178|||
46832728|NCT00227877|83050756|FG001|3-months Follow-up|Lost to Follow-up|139|||
46832729|NCT00227877|83050757|FG002|3-months Follow-up|Lost to Follow-up|18|||
46832730|NCT00227877|83050758|FG003|3-months Follow-up|Lost to Follow-up|13|||
46832731|NCT00227877|83050755|FG000|12-months Follow-up|Completed late|78|||
46832732|NCT00227877|83050756|FG001|12-months Follow-up|Completed late|74|||
46832733|NCT00227877|83050757|FG002|12-months Follow-up|Completed late|1|||
46832734|NCT00227877|83050758|FG003|12-months Follow-up|Completed late|0|||
46832735|NCT00227877|83050755|FG000|12-months Follow-up|Lost to Follow-up|232|||
46832736|NCT00227877|83050756|FG001|12-months Follow-up|Lost to Follow-up|189|||
46765785|NCT00811070|82984237|FG001|Overall Study|Physician Decision|0|||
46939251|NCT02672852|83176204|FG002|Part A2|Lost to Follow-up|2|||
46939252|NCT02672852|83176205|FG003|Part A2|Lost to Follow-up|0|||
46939253|NCT02672852|83176206|FG004|Part A2|Lost to Follow-up|0|||
47061383|NCT01500083|83341980|FG001|Overall Study|Lost to Follow-up|0|||
47061384|NCT01500083|83341979|FG000|Overall Study|Withdrawal of Consent|0|||
46939254|NCT02672852|83176207|FG005|Part A2|Lost to Follow-up|0|||
47061385|NCT01500083|83341980|FG001|Overall Study|Withdrawal of Consent|1|||
47061386|NCT01500083|83341979|FG000|Overall Study|Disease Progression|2|||
46765786|NCT00811070|82984238|FG002|Overall Study|Physician Decision|0|||
46765787|NCT00811070|82984239|FG003|Overall Study|Physician Decision|0|||
46765788|NCT00811070|82984240|FG004|Overall Study|Physician Decision|0|||
46832737|NCT00227877|83050757|FG002|12-months Follow-up|Lost to Follow-up|30|||
46939255|NCT02672852|83176208|FG006|Part A2|Lost to Follow-up|0|||
46939256|NCT02672852|83176202|FG000|Part A2|Withdrawal by Subject|0|||
46832738|NCT00227877|83050758|FG003|12-months Follow-up|Lost to Follow-up|26|||
46939257|NCT02672852|83176203|FG001|Part A2|Withdrawal by Subject|0|||
46939258|NCT02672852|83176204|FG002|Part A2|Withdrawal by Subject|1|||
46939259|NCT02672852|83176205|FG003|Part A2|Withdrawal by Subject|0|||
46939260|NCT02672852|83176206|FG004|Part A2|Withdrawal by Subject|0|||
46939261|NCT02672852|83176207|FG005|Part A2|Withdrawal by Subject|0|||
46939262|NCT02672852|83176208|FG006|Part A2|Withdrawal by Subject|0|||
46939263|NCT02672852|83176202|FG000|Part A2|Other|0|||
46939264|NCT02672852|83176203|FG001|Part A2|Other|0|||
46939265|NCT02672852|83176204|FG002|Part A2|Other|3|||
46939266|NCT02672852|83176205|FG003|Part A2|Other|0|||
46939267|NCT02672852|83176206|FG004|Part A2|Other|0|||
46939268|NCT02672852|83176207|FG005|Part A2|Other|0|||
46939269|NCT02672852|83176208|FG006|Part A2|Other|0|||
46939270|NCT02672852|83176202|FG000|Part A2|Not entered in Part B|0|||
46939271|NCT02672852|83176203|FG001|Part A2|Not entered in Part B|0|||
46939272|NCT02672852|83176204|FG002|Part A2|Not entered in Part B|0|||
46939273|NCT02672852|83176205|FG003|Part A2|Not entered in Part B|4|||
46939274|NCT02672852|83176206|FG004|Part A2|Not entered in Part B|0|||
46939275|NCT02672852|83176207|FG005|Part A2|Not entered in Part B|0|||
46939276|NCT02672852|83176208|FG006|Part A2|Not entered in Part B|0|||
46939277|NCT02672852|83176202|FG000|Part B|Disease worsening|0|||
46939278|NCT02672852|83176203|FG001|Part B|Disease worsening|0|||
46939279|NCT02672852|83176204|FG002|Part B|Disease worsening|0|||
46939280|NCT02672852|83176205|FG003|Part B|Disease worsening|0|||
46939281|NCT02672852|83176206|FG004|Part B|Disease worsening|1|||
46939282|NCT02672852|83176207|FG005|Part B|Disease worsening|0|||
46832739|NCT00513695|83050770|FG000|Overall Study|Discontinued therapy|2|||
46832740|NCT00513695|83050770|FG000|Overall Study|Progression prior to surgery|3|||
46832741|NCT00162981|83050776|FG000|Overall Study|Adverse Event|2|||
46832742|NCT00162981|83050777|FG001|Overall Study|Adverse Event|5|||
46832743|NCT00162981|83050776|FG000|Overall Study|Withdrawal by Subject|1|||
46832744|NCT00162981|83050777|FG001|Overall Study|Withdrawal by Subject|1|||
46832745|NCT00162981|83050776|FG000|Overall Study|Physician Decision|1|||
46832746|NCT00162981|83050777|FG001|Overall Study|Physician Decision|0|||
46832747|NCT00511433|83050785|FG000|Overall Study|Adverse Event|5|||
46832748|NCT00511433|83050786|FG001|Overall Study|Adverse Event|0|||
46832749|NCT00511433|83050785|FG000|Overall Study|Other Reason|1|||
46832750|NCT00511433|83050786|FG001|Overall Study|Other Reason|1|||
46832751|NCT00099268|83050796|FG000|Overall Study|Withdrawal by Subject|46|||
46832752|NCT00099268|83050797|FG001|Overall Study|Withdrawal by Subject|28|||
46832753|NCT00099268|83050796|FG000|Overall Study|Adverse Event|19|||
46832754|NCT00099268|83050797|FG001|Overall Study|Adverse Event|19|||
46832755|NCT00099268|83050796|FG000|Overall Study|Protocol Violation|9|||
46832756|NCT00099268|83050797|FG001|Overall Study|Protocol Violation|8|||
46832757|NCT00099268|83050796|FG000|Overall Study|Lost to Follow-up|6|||
46832758|NCT00099268|83050797|FG001|Overall Study|Lost to Follow-up|4|||
46832759|NCT00099268|83050796|FG000|Overall Study|Lack of Efficacy|5|||
46832760|NCT00099268|83050797|FG001|Overall Study|Lack of Efficacy|18|||
46832761|NCT00099268|83050796|FG000|Overall Study|Administrative problems|4|||
46832762|NCT00099268|83050797|FG001|Overall Study|Administrative problems|4|||
46832763|NCT00099268|83050796|FG000|Overall Study|Death|3|||
46832764|NCT00099268|83050797|FG001|Overall Study|Death|1|||
46832765|NCT00511355|83050805|FG000|Overall Study|Adverse Event|4|||
46832766|NCT00511355|83050806|FG001|Overall Study|Adverse Event|4|||
46832767|NCT00511355|83050805|FG000|Overall Study|Pregnancy Wish|1|||
46832768|NCT00511355|83050806|FG001|Overall Study|Pregnancy Wish|0|||
46832769|NCT00511355|83050805|FG000|Overall Study|Lost to Follow-up|2|||
46832770|NCT00511355|83050806|FG001|Overall Study|Lost to Follow-up|1|||
46832771|NCT00511355|83050805|FG000|Overall Study|Other Reason|0|||
46832772|NCT00511355|83050806|FG001|Overall Study|Other Reason|1|||
46832773|NCT00511355|83050805|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
46832774|NCT00511355|83050806|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
46832775|NCT00511355|83050805|FG000|Overall Study|Withdrawal of informed consent|0|||
46832776|NCT00511355|83050806|FG001|Overall Study|Withdrawal of informed consent|1|||
46832777|NCT00511355|83050805|FG000|Overall Study|Other reason pre-treatment|0|||
46832778|NCT00511355|83050806|FG001|Overall Study|Other reason pre-treatment|1|||
46832779|NCT00095212|83050816|FG000|Overall Study|Withdrawal by Subject|1|||
46832780|NCT00095212|83050817|FG001|Overall Study|Withdrawal by Subject|3|||
46832781|NCT00120874|83050825|FG000|Overall Study|Death|0|||
46832782|NCT00120874|83050826|FG001|Overall Study|Death|1|||
46832783|NCT00120406|83050834|FG000|Overall Study|Death|9|||
46832784|NCT00120406|83050835|FG001|Overall Study|Death|4|||
46832785|NCT00120406|83050834|FG000|Overall Study|Withdrawal by Subject|5|||
46832786|NCT00120406|83050835|FG001|Overall Study|Withdrawal by Subject|7|||
46832787|NCT00120406|83050834|FG000|Overall Study|Lost to Follow-up|5|||
46832788|NCT00120406|83050835|FG001|Overall Study|Lost to Follow-up|2|||
46832789|NCT00120406|83050834|FG000|Overall Study|received non-study stent|0|||
46832790|NCT00120406|83050835|FG001|Overall Study|received non-study stent|2|||
46939283|NCT02672852|83176208|FG006|Part B|Disease worsening|1|||
46939284|NCT02672852|83176202|FG000|Part B|Worsening pre-existing condition|0|||
46939285|NCT02672852|83176203|FG001|Part B|Worsening pre-existing condition|0|||
46939286|NCT02672852|83176204|FG002|Part B|Worsening pre-existing condition|0|||
46939287|NCT02672852|83176205|FG003|Part B|Worsening pre-existing condition|0|||
46939288|NCT02672852|83176206|FG004|Part B|Worsening pre-existing condition|0|||
46939289|NCT02672852|83176207|FG005|Part B|Worsening pre-existing condition|1|||
46939290|NCT02672852|83176208|FG006|Part B|Worsening pre-existing condition|0|||
46939291|NCT02672852|83176202|FG000|Part B|Other adverse event|0|||
46939292|NCT02672852|83176203|FG001|Part B|Other adverse event|0|||
46939293|NCT02672852|83176204|FG002|Part B|Other adverse event|0|||
46939294|NCT02672852|83176205|FG003|Part B|Other adverse event|0|||
46939295|NCT02672852|83176206|FG004|Part B|Other adverse event|3|||
46939296|NCT02672852|83176207|FG005|Part B|Other adverse event|5|||
46939297|NCT02672852|83176208|FG006|Part B|Other adverse event|1|||
46939298|NCT02672852|83176202|FG000|Part B|Lost to Follow-up|0|||
46939299|NCT02672852|83176203|FG001|Part B|Lost to Follow-up|0|||
46939300|NCT02672852|83176204|FG002|Part B|Lost to Follow-up|0|||
46939301|NCT02672852|83176205|FG003|Part B|Lost to Follow-up|0|||
46939302|NCT02672852|83176206|FG004|Part B|Lost to Follow-up|3|||
46939303|NCT02672852|83176207|FG005|Part B|Lost to Follow-up|4|||
46939304|NCT02672852|83176208|FG006|Part B|Lost to Follow-up|1|||
46939305|NCT02672852|83176202|FG000|Part B|Withdrawal by Subject|0|||
46939306|NCT02672852|83176203|FG001|Part B|Withdrawal by Subject|0|||
46939307|NCT02672852|83176204|FG002|Part B|Withdrawal by Subject|0|||
46939308|NCT02672852|83176205|FG003|Part B|Withdrawal by Subject|0|||
46939309|NCT02672852|83176206|FG004|Part B|Withdrawal by Subject|5|||
46939310|NCT02672852|83176207|FG005|Part B|Withdrawal by Subject|0|||
46939311|NCT02672852|83176208|FG006|Part B|Withdrawal by Subject|7|||
46939312|NCT02672852|83176202|FG000|Part B|Other|0|||
46939313|NCT02672852|83176203|FG001|Part B|Other|0|||
46939314|NCT02672852|83176204|FG002|Part B|Other|0|||
46939315|NCT02672852|83176205|FG003|Part B|Other|0|||
46939316|NCT02672852|83176206|FG004|Part B|Other|4|||
46939317|NCT02672852|83176207|FG005|Part B|Other|1|||
46939318|NCT02672852|83176208|FG006|Part B|Other|2|||
46939319|NCT02671760|83176219|FG000|Overall Study|Lost to Follow-up|0|||
46939320|NCT02671760|83176220|FG001|Overall Study|Lost to Follow-up|1|||
46939321|NCT02671760|83176221|FG002|Overall Study|Lost to Follow-up|0|||
46939322|NCT02667236|83176231|FG000|Overall Study|Adverse Event|1|||
46939323|NCT02667236|83176232|FG001|Overall Study|Adverse Event|1|||
46939324|NCT02667236|83176231|FG000|Overall Study|Withdrawal by Subject|2|||
46939325|NCT02667236|83176232|FG001|Overall Study|Withdrawal by Subject|0|||
46939326|NCT01126749|83176242|FG000|Phase 1b|Other|0|||
46939327|NCT01126749|83176243|FG001|Phase 1b|Other|1|||
46939328|NCT01126749|83176244|FG002|Phase 1b|Other|0|||
46939329|NCT01126749|83176245|FG003|Phase 1b|Other|0|||
46939330|NCT01126749|83176242|FG000|Phase 1b|Withdrawal by Subject|0|||
47061387|NCT01500083|83341980|FG001|Overall Study|Disease Progression|10|||
46765789|NCT00811070|82984241|FG005|Overall Study|Physician Decision|1|||
46765790|NCT00642460|82984259|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
46765791|NCT00642460|82984260|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
46765792|NCT00642460|82984261|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
46765793|NCT00642460|82984262|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
46765794|NCT00642460|82984263|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
46832791|NCT00120406|83050834|FG000|Overall Study|patient moved but has not withdrawn|0|||
46832792|NCT00120406|83050835|FG001|Overall Study|patient moved but has not withdrawn|1|||
46832793|NCT00120250|83050841|FG000|Overall Study|Lost to Follow-up|1|||
46832794|NCT00120250|83050842|FG001|Overall Study|Lost to Follow-up|1|||
46832795|NCT00120250|83050841|FG000|Overall Study|Protocol Violation|0|||
46832796|NCT00120250|83050842|FG001|Overall Study|Protocol Violation|1|||
46832797|NCT00511199|83050851|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
46939331|NCT01126749|83176243|FG001|Phase 1b|Withdrawal by Subject|1|||
46765795|NCT00642460|82984264|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
46832798|NCT00511199|83050852|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
46939332|NCT01126749|83176244|FG002|Phase 1b|Withdrawal by Subject|0|||
46939333|NCT01126749|83176245|FG003|Phase 1b|Withdrawal by Subject|0|||
47061388|NCT01500083|83341979|FG000|Overall Study|Investigator Discretion|3|||
46832799|NCT00511199|83050851|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
46939334|NCT01126749|83176242|FG000|Phase 1b|Death|3|||
46939335|NCT01126749|83176243|FG001|Phase 1b|Death|4|||
46939336|NCT01126749|83176244|FG002|Phase 1b|Death|0|||
46939337|NCT01126749|83176245|FG003|Phase 1b|Death|0|||
46939338|NCT01126749|83176242|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
46939339|NCT01126749|83176243|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
46765796|NCT00642460|82984259|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
46939340|NCT01126749|83176244|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
46939341|NCT01126749|83176245|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
46939342|NCT01126749|83176242|FG000|Phase 2|Study Termination by Sponsor|0|||
46765797|NCT00642460|82984260|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
46832800|NCT00511199|83050852|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
46939343|NCT01126749|83176243|FG001|Phase 2|Study Termination by Sponsor|0|||
46939344|NCT01126749|83176244|FG002|Phase 2|Study Termination by Sponsor|12|||
46939345|NCT01126749|83176245|FG003|Phase 2|Study Termination by Sponsor|6|||
46939346|NCT01126749|83176242|FG000|Phase 2|Other|0|||
46939347|NCT01126749|83176243|FG001|Phase 2|Other|0|||
46939348|NCT01126749|83176244|FG002|Phase 2|Other|4|||
46832801|NCT00511199|83050851|FG000|Overall Study|Withdrawal of Informed Consent|19|||
46832802|NCT00511199|83050852|FG001|Overall Study|Withdrawal of Informed Consent|4|||
46832803|NCT00511199|83050851|FG000|Overall Study|Pregnancy|6|||
46832804|NCT00511199|83050852|FG001|Overall Study|Pregnancy|3|||
46832805|NCT00511199|83050851|FG000|Overall Study|Pregnancy Wish|16|||
46832806|NCT00511199|83050852|FG001|Overall Study|Pregnancy Wish|8|||
46832807|NCT00511199|83050851|FG000|Overall Study|Lost to Follow-up|40|||
46832808|NCT00511199|83050852|FG001|Overall Study|Lost to Follow-up|17|||
46832809|NCT00511199|83050851|FG000|Overall Study|Other Reason|78|||
46832810|NCT00511199|83050852|FG001|Overall Study|Other Reason|37|||
46832811|NCT00384176|83050863|FG000|Overall Study|Death|239|||
46832812|NCT00384176|83050864|FG001|Overall Study|Death|247|||
46832813|NCT00384176|83050865|FG002|Overall Study|Death|105|||
46832814|NCT00384176|83050863|FG000|Overall Study|Withdrawal by Subject|52|||
46832815|NCT00384176|83050864|FG001|Overall Study|Withdrawal by Subject|48|||
46832816|NCT00384176|83050865|FG002|Overall Study|Withdrawal by Subject|22|||
46832817|NCT00384176|83050863|FG000|Overall Study|Lost to Follow-up|16|||
46832818|NCT00384176|83050864|FG001|Overall Study|Lost to Follow-up|18|||
46832819|NCT00384176|83050865|FG002|Overall Study|Lost to Follow-up|4|||
46832820|NCT00384176|83050863|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
46832821|NCT00384176|83050864|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
46832822|NCT00384176|83050865|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
46832823|NCT00384176|83050863|FG000|Overall Study|Longer QTC as Visit 1|1|||
46832824|NCT00384176|83050864|FG001|Overall Study|Longer QTC as Visit 1|0|||
46832825|NCT00384176|83050865|FG002|Overall Study|Longer QTC as Visit 1|0|||
46832826|NCT00384176|83050863|FG000|Overall Study|Toxicity of treatment|1|||
46832827|NCT00384176|83050864|FG001|Overall Study|Toxicity of treatment|0|||
46832828|NCT00384176|83050865|FG002|Overall Study|Toxicity of treatment|0|||
46832829|NCT00384176|83050863|FG000|Overall Study|Did not receive study treatment|0|||
46832830|NCT00384176|83050864|FG001|Overall Study|Did not receive study treatment|1|||
46832831|NCT00384176|83050865|FG002|Overall Study|Did not receive study treatment|1|||
46832832|NCT00384176|83050863|FG000|Overall Study|Physician Decision|0|||
46765798|NCT00642460|82984261|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
46765799|NCT00642460|82984262|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
46939349|NCT01126749|83176245|FG003|Phase 2|Other|2|||
46939350|NCT01126749|83176242|FG000|Phase 2|Withdrawal by Subject|0|||
46939351|NCT01126749|83176243|FG001|Phase 2|Withdrawal by Subject|0|||
46939352|NCT01126749|83176244|FG002|Phase 2|Withdrawal by Subject|0|||
46939353|NCT01126749|83176245|FG003|Phase 2|Withdrawal by Subject|2|||
46939354|NCT01126749|83176242|FG000|Phase 2|Lost to Follow-up|0|||
46939355|NCT01126749|83176243|FG001|Phase 2|Lost to Follow-up|0|||
46939356|NCT01126749|83176244|FG002|Phase 2|Lost to Follow-up|0|||
46939357|NCT01126749|83176245|FG003|Phase 2|Lost to Follow-up|1|||
46939358|NCT01126749|83176242|FG000|Phase 2|Death|0|||
46939359|NCT01126749|83176243|FG001|Phase 2|Death|0|||
46939360|NCT01126749|83176244|FG002|Phase 2|Death|22|||
46939361|NCT01126749|83176245|FG003|Phase 2|Death|22|||
46939362|NCT01126749|83176242|FG000|Phase 2|Adverse Event|0|||
46939363|NCT01126749|83176243|FG001|Phase 2|Adverse Event|0|||
46939364|NCT01126749|83176244|FG002|Phase 2|Adverse Event|0|||
46765800|NCT00642460|82984263|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
46765801|NCT00642460|82984264|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
46765802|NCT00642460|82984259|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
46765803|NCT00642460|82984260|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
46765804|NCT00642460|82984261|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
46765805|NCT00642460|82984262|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
46765806|NCT00642460|82984263|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
46765807|NCT00642460|82984264|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
46765808|NCT00642460|82984259|FG000|Part II: Open-Label Up to Week 92|Death|0|||
46832833|NCT00384176|83050864|FG001|Overall Study|Physician Decision|2|||
46832834|NCT00384176|83050865|FG002|Overall Study|Physician Decision|0|||
46765809|NCT00642460|82984260|FG001|Part II: Open-Label Up to Week 92|Death|1|||
46765810|NCT00642460|82984261|FG002|Part II: Open-Label Up to Week 92|Death|0|||
46765811|NCT00642460|82984262|FG003|Part II: Open-Label Up to Week 92|Death|2|||
46832835|NCT00384176|83050863|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
46832836|NCT00384176|83050864|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
46832837|NCT00384176|83050865|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
46832838|NCT00513305|83050875|FG000|Overall Study|Adverse Event|6|||
46939365|NCT01126749|83176245|FG003|Phase 2|Adverse Event|1|||
46939366|NCT02521948|83176255|FG000|Overall Study|Adverse Event|2|||
46939367|NCT02521948|83176255|FG000|Overall Study|Death|4|||
46765812|NCT00642460|82984263|FG004|Part II: Open-Label Up to Week 92|Death|0|||
46765813|NCT00642460|82984264|FG005|Part II: Open-Label Up to Week 92|Death|0|||
46832839|NCT00513305|83050876|FG001|Overall Study|Adverse Event|2|||
46832840|NCT00513305|83050875|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
46939368|NCT02521948|83176255|FG000|Overall Study|Lost to Follow-up|1|||
46939369|NCT02521948|83176255|FG000|Overall Study|Did not attend one or both follow-ups|6|||
46939370|NCT04446429|83176264|FG000|Overall Study|Lost to Follow-up|6|||
46939371|NCT04446429|83176265|FG001|Overall Study|Lost to Follow-up|0|||
46939372|NCT02832687|83176273|FG000|Overall Study|Adverse Event|0|||
46939373|NCT02832687|83176274|FG001|Overall Study|Adverse Event|2|||
46939374|NCT01656850|83176299|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
46939375|NCT01656850|83176300|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
46939376|NCT03116685|83176312|FG000|Overall Study|Physician Decision|0|||
47061389|NCT01500083|83341980|FG001|Overall Study|Investigator Discretion|8|||
46765814|NCT00642460|82984259|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
46765815|NCT00642460|82984260|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
46765816|NCT00642460|82984261|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
46765817|NCT00642460|82984262|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
46765818|NCT00642460|82984263|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
46765819|NCT00642460|82984264|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
46832841|NCT00513305|83050876|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
46832842|NCT00513305|83050875|FG000|Overall Study|Lack of Efficacy|8|||
46832843|NCT00513305|83050876|FG001|Overall Study|Lack of Efficacy|13|||
46832844|NCT00513305|83050875|FG000|Overall Study|Withdrawal by Subject|1|||
46832845|NCT00513305|83050876|FG001|Overall Study|Withdrawal by Subject|2|||
46832846|NCT00513305|83050875|FG000|Overall Study|Disease progression|8|||
46832847|NCT00513305|83050876|FG001|Overall Study|Disease progression|5|||
46832848|NCT00513305|83050875|FG000|Overall Study|Eligible for stem cell transplant|1|||
46832849|NCT00513305|83050876|FG001|Overall Study|Eligible for stem cell transplant|0|||
46832850|NCT00513305|83050875|FG000|Overall Study|Hematologic counts did not recover|1|||
46832851|NCT00513305|83050876|FG001|Overall Study|Hematologic counts did not recover|0|||
46832852|NCT00513305|83050875|FG000|Overall Study|Physician Decision|1|||
46832853|NCT00513305|83050876|FG001|Overall Study|Physician Decision|0|||
46832854|NCT00513305|83050875|FG000|Overall Study|Persistent hypocellularity|0|||
46832855|NCT00513305|83050876|FG001|Overall Study|Persistent hypocellularity|1|||
46832856|NCT00513305|83050875|FG000|Overall Study|Sponsor Decision|0|||
46832857|NCT00513305|83050876|FG001|Overall Study|Sponsor Decision|2|||
46832858|NCT00513071|83050882|FG000|Overall Study|Adverse Event|1|||
46832859|NCT00513071|83050882|FG000|Overall Study|Withdrawal by Subject|1|||
46832860|NCT00513071|83050882|FG000|Overall Study|Physician Decision|3|||
46832861|NCT00510887|83050886|FG000|Overall Study|Lost to Follow-up|1|||
46832862|NCT00358826|83050894|FG000|Core Study|Adverse Event|1|||
46832863|NCT00358826|83050895|FG001|Core Study|Adverse Event|3|||
46832864|NCT00358826|83050896|FG002|Core Study|Adverse Event|1|||
46832865|NCT00358826|83050897|FG003|Core Study|Adverse Event|1|||
46832866|NCT00358826|83050898|FG004|Core Study|Adverse Event|0|||
46832867|NCT00358826|83050899|FG005|Core Study|Adverse Event|0|||
46832868|NCT00358826|83050900|FG006|Core Study|Adverse Event|0|||
46832869|NCT00358826|83050901|FG007|Core Study|Adverse Event|0|||
46832870|NCT00358826|83050894|FG000|Core Study|Withdrawal by Subject|2|||
46832871|NCT00358826|83050895|FG001|Core Study|Withdrawal by Subject|2|||
46832872|NCT00358826|83050896|FG002|Core Study|Withdrawal by Subject|0|||
46832873|NCT00358826|83050897|FG003|Core Study|Withdrawal by Subject|0|||
46832874|NCT00358826|83050898|FG004|Core Study|Withdrawal by Subject|0|||
46832875|NCT00358826|83050899|FG005|Core Study|Withdrawal by Subject|0|||
46832876|NCT00358826|83050900|FG006|Core Study|Withdrawal by Subject|0|||
46832877|NCT00358826|83050901|FG007|Core Study|Withdrawal by Subject|0|||
46832878|NCT00358826|83050894|FG000|Core Study|Lost to Follow-up|0|||
46832879|NCT00358826|83050895|FG001|Core Study|Lost to Follow-up|0|||
46832880|NCT00358826|83050896|FG002|Core Study|Lost to Follow-up|0|||
46832881|NCT00358826|83050897|FG003|Core Study|Lost to Follow-up|1|||
46832882|NCT00358826|83050898|FG004|Core Study|Lost to Follow-up|0|||
46832883|NCT00358826|83050899|FG005|Core Study|Lost to Follow-up|0|||
46832884|NCT00358826|83050900|FG006|Core Study|Lost to Follow-up|0|||
46832885|NCT00358826|83050901|FG007|Core Study|Lost to Follow-up|0|||
46832886|NCT00358826|83050894|FG000|Core Study|Physician Decision|0|||
46832887|NCT00358826|83050895|FG001|Core Study|Physician Decision|0|||
46939377|NCT03116685|83176313|FG001|Overall Study|Physician Decision|1|||
47061390|NCT01500083|83341979|FG000|Overall Study|Other Reasons|2|||
46765820|NCT00642460|82984259|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
46765821|NCT00642460|82984260|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
46832888|NCT00358826|83050896|FG002|Core Study|Physician Decision|1|||
46832889|NCT00358826|83050897|FG003|Core Study|Physician Decision|0|||
46832890|NCT00358826|83050898|FG004|Core Study|Physician Decision|0|||
46832891|NCT00358826|83050899|FG005|Core Study|Physician Decision|0|||
47061391|NCT01500083|83341980|FG001|Overall Study|Other Reasons|5|||
46832892|NCT00358826|83050900|FG006|Core Study|Physician Decision|0|||
46832893|NCT00358826|83050901|FG007|Core Study|Physician Decision|0|||
46939378|NCT02666222|83176333|FG000|Overall Study|Death|2|||
46832894|NCT00358826|83050894|FG000|MDCT Substudy|Adverse Event|0|||
46832895|NCT00358826|83050895|FG001|MDCT Substudy|Adverse Event|0|||
46832896|NCT00358826|83050896|FG002|MDCT Substudy|Adverse Event|0|||
46832897|NCT00358826|83050897|FG003|MDCT Substudy|Adverse Event|0|||
46939379|NCT00739401|83176337|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
46939380|NCT00739401|83176337|FG000|Overall Study|Death|3|||
46939381|NCT00739401|83176337|FG000|Overall Study|Withdrawal by Subject|4|||
46939382|NCT01365052|83176343|FG000|Overall Study|Adverse Event|4|||
46939383|NCT01365052|83176344|FG001|Overall Study|Adverse Event|4|||
46939384|NCT01372748|83176352|FG000|Overall Study|Lost to Follow-up|16|||
46939385|NCT01372748|83176353|FG001|Overall Study|Lost to Follow-up|34|||
46939386|NCT01372748|83176352|FG000|Overall Study|Withdrawal by Subject|7|||
46939387|NCT01372748|83176353|FG001|Overall Study|Withdrawal by Subject|5|||
46939388|NCT02736825|83176361|FG000|Overall Study|Lost to Follow-up|10|||
46939389|NCT02736825|83176362|FG001|Overall Study|Lost to Follow-up|11|||
46939390|NCT02736825|83176361|FG000|Overall Study|Early Termination|0|||
46939391|NCT02736825|83176362|FG001|Overall Study|Early Termination|1|||
46939392|NCT02670122|83176369|FG000|Overall Study|Lost to Follow-up|4|||
46939393|NCT03283371|83176382|FG000|Placebo-controlled|Adverse Event|1|||
46939394|NCT03283371|83176383|FG001|Placebo-controlled|Adverse Event|1|||
46939395|NCT03283371|83176384|FG002|Placebo-controlled|Adverse Event|0|||
46939396|NCT03283371|83176385|FG003|Placebo-controlled|Adverse Event|0|||
46939397|NCT03283371|83176382|FG000|Placebo-controlled|Lack of Efficacy|1|||
46939398|NCT03283371|83176383|FG001|Placebo-controlled|Lack of Efficacy|0|||
46939399|NCT03283371|83176384|FG002|Placebo-controlled|Lack of Efficacy|0|||
46939400|NCT03283371|83176385|FG003|Placebo-controlled|Lack of Efficacy|0|||
46939401|NCT03283371|83176382|FG000|Placebo-controlled|Withdrawal by Subject|1|||
46939402|NCT03283371|83176383|FG001|Placebo-controlled|Withdrawal by Subject|1|||
46939403|NCT03283371|83176384|FG002|Placebo-controlled|Withdrawal by Subject|0|||
46939404|NCT03283371|83176385|FG003|Placebo-controlled|Withdrawal by Subject|0|||
46939405|NCT03283371|83176382|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
46939406|NCT03283371|83176383|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
46939407|NCT03283371|83176384|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
46939408|NCT03283371|83176385|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
46939409|NCT03283371|83176382|FG000|Open-label Phase|Adverse Event|0|||
46939410|NCT03283371|83176383|FG001|Open-label Phase|Adverse Event|0|||
46939411|NCT03283371|83176384|FG002|Open-label Phase|Adverse Event|2|||
46939412|NCT03283371|83176385|FG003|Open-label Phase|Adverse Event|0|||
46939413|NCT03283371|83176382|FG000|Open-label Phase|Withdrawal by Subject|0|||
46939414|NCT03283371|83176383|FG001|Open-label Phase|Withdrawal by Subject|0|||
46939415|NCT03283371|83176384|FG002|Open-label Phase|Withdrawal by Subject|1|||
46939416|NCT03283371|83176385|FG003|Open-label Phase|Withdrawal by Subject|0|||
46939417|NCT03283371|83176382|FG000|Open-label Phase|Other|0|||
46939418|NCT03283371|83176383|FG001|Open-label Phase|Other|0|||
46939419|NCT03283371|83176384|FG002|Open-label Phase|Other|1|||
46939420|NCT03283371|83176385|FG003|Open-label Phase|Other|1|||
46939421|NCT03069417|83176397|FG000|Overall Study|Lost to Follow-up|2|||
46939422|NCT03069417|83176398|FG001|Overall Study|Lost to Follow-up|0|||
46939423|NCT03069417|83176397|FG000|Overall Study|Reason Unknown|4|||
46939424|NCT03069417|83176398|FG001|Overall Study|Reason Unknown|7|||
46939425|NCT04930263|83176407|FG000|Overall Study|Withdrawal by Subject|3|||
46939426|NCT04930263|83176408|FG001|Overall Study|Withdrawal by Subject|5|||
46939427|NCT02665286|83176417|FG000|Overall Study|Lost to Follow-up|3|||
46939428|NCT02665286|83176418|FG001|Overall Study|Lost to Follow-up|2|||
46939429|NCT02665286|83176419|FG002|Overall Study|Lost to Follow-up|1|||
46939430|NCT02911519|83176429|FG000|Overall Study|Lost to Follow-up|2|||
46939431|NCT02911519|83176430|FG001|Overall Study|Lost to Follow-up|2|||
46939432|NCT02911519|83176429|FG000|Overall Study|Death|0|||
46939433|NCT02911519|83176430|FG001|Overall Study|Death|2|||
46939434|NCT02911285|83176438|FG000|Overall Study|Lost to Follow-up|8|||
46939435|NCT02911285|83176439|FG001|Overall Study|Lost to Follow-up|5|||
47061392|NCT01499849|83342010|FG000|Overall Study|Adverse Event|28|||
47061393|NCT01499849|83342011|FG001|Overall Study|Adverse Event|32|||
47061394|NCT01499849|83342010|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
47061395|NCT01499849|83342011|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
47061396|NCT01499849|83342010|FG000|Overall Study|Withdrawal by Subject|43|||
47061397|NCT01499849|83342011|FG001|Overall Study|Withdrawal by Subject|43|||
47061398|NCT01499849|83342010|FG000|Overall Study|Death|5|||
47061399|NCT01499849|83342011|FG001|Overall Study|Death|7|||
47061400|NCT01499849|83342010|FG000|Overall Study|Disease Progression|11|||
47061401|NCT01499849|83342011|FG001|Overall Study|Disease Progression|10|||
46939436|NCT02911285|83176438|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
46939437|NCT02911285|83176439|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
46832898|NCT00358826|83050898|FG004|MDCT Substudy|Adverse Event|1|||
47061402|NCT01499849|83342010|FG000|Overall Study|Protocol Violation|11|||
46939438|NCT02910739|83176451|FG000|Overall Study|Adverse Event|1|||
46939439|NCT02910739|83176452|FG001|Overall Study|Adverse Event|0|||
46939440|NCT02910739|83176453|FG002|Overall Study|Adverse Event|0|||
46939441|NCT02910739|83176454|FG003|Overall Study|Adverse Event|0|||
46939442|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
46939443|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
46939444|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
47061403|NCT01499849|83342011|FG001|Overall Study|Protocol Violation|11|||
46832899|NCT00358826|83050899|FG005|MDCT Substudy|Adverse Event|0|||
46832900|NCT00358826|83050900|FG006|MDCT Substudy|Adverse Event|0|||
46832901|NCT00358826|83050901|FG007|MDCT Substudy|Adverse Event|0|||
46832902|NCT00358826|83050894|FG000|MDCT Substudy|Lost to Follow-up|0|||
46832903|NCT00358826|83050895|FG001|MDCT Substudy|Lost to Follow-up|0|||
46832904|NCT00358826|83050896|FG002|MDCT Substudy|Lost to Follow-up|0|||
46832905|NCT00358826|83050897|FG003|MDCT Substudy|Lost to Follow-up|0|||
46832906|NCT00358826|83050898|FG004|MDCT Substudy|Lost to Follow-up|0|||
46832907|NCT00358826|83050899|FG005|MDCT Substudy|Lost to Follow-up|1|||
46832908|NCT00358826|83050900|FG006|MDCT Substudy|Lost to Follow-up|0|||
46832909|NCT00358826|83050901|FG007|MDCT Substudy|Lost to Follow-up|0|||
46832910|NCT00358826|83050894|FG000|MDCT Substudy|Withdrawal by Subject|0|||
46832911|NCT00358826|83050895|FG001|MDCT Substudy|Withdrawal by Subject|0|||
46832912|NCT00358826|83050896|FG002|MDCT Substudy|Withdrawal by Subject|0|||
46832913|NCT00358826|83050897|FG003|MDCT Substudy|Withdrawal by Subject|0|||
46832914|NCT00358826|83050898|FG004|MDCT Substudy|Withdrawal by Subject|0|||
46832915|NCT00358826|83050899|FG005|MDCT Substudy|Withdrawal by Subject|1|||
47061404|NCT01499849|83342010|FG000|Overall Study|Physician Decision|20|||
47061405|NCT01499849|83342011|FG001|Overall Study|Physician Decision|19|||
46637732|NCT01474512|82811387|FG011|Long-Term Extension Period|Adverse Event|1|||
46939445|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
46939446|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
46939447|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
46939448|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
46939449|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
46939450|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
46939451|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
46939452|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
46939453|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
46939454|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
46939455|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
46939456|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
46939457|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
46939458|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
46939459|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
46939460|NCT01069939|83176462|FG000|Randomised and Included in the Analyses|Removal|1|||
46939461|NCT01069939|83176463|FG001|Randomised and Included in the Analyses|Removal|0|||
46637733|NCT01474512|82811388|FG012|Long-Term Extension Period|Adverse Event|57|||
46637734|NCT01474512|82811389|FG013|Long-Term Extension Period|Adverse Event|58|||
46637735|NCT01474512|82811390|FG014|Long-Term Extension Period|Adverse Event|0|||
46637736|NCT01474512|82811391|FG015|Long-Term Extension Period|Adverse Event|0|||
46939462|NCT01069705|83176469|FG000|Overall Study|Adverse Event|1|||
46939463|NCT01069705|83176469|FG000|Overall Study|Withdrawal by Subject|2|||
46939464|NCT01069627|83176473|FG000|Overall Study|Disease progression|7|||
46939465|NCT01069627|83176473|FG000|Overall Study|Adverse Event|12|||
46939466|NCT01069627|83176473|FG000|Overall Study|Protocol Violation|1|||
46939467|NCT03021551|83176477|FG000|Overall Study|Equipment Issues|2|||
46939468|NCT03021551|83176477|FG000|Overall Study|Protocol Violation|1|||
46939469|NCT01585025|83176484|FG000|Overall Study|Withdrawal by Subject|0|||
46939470|NCT01585025|83176485|FG001|Overall Study|Withdrawal by Subject|3|||
46765822|NCT00642460|82984261|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
46765823|NCT00642460|82984262|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
46765824|NCT00642460|82984263|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
46765825|NCT00642460|82984264|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
46765826|NCT00642460|82984259|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
46765827|NCT00642460|82984260|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
46765828|NCT00642460|82984261|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
46765829|NCT00642460|82984262|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
46765830|NCT00642460|82984263|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
46765831|NCT00642460|82984264|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
46939471|NCT01585025|83176486|FG002|Overall Study|Withdrawal by Subject|4|||
46939472|NCT01068769|83176494|FG000|Overall Study|Ineligible|1|||
47061406|NCT01499849|83342010|FG000|Overall Study|Lack of Efficacy|3|||
47061407|NCT01499849|83342011|FG001|Overall Study|Lack of Efficacy|4|||
46832916|NCT00358826|83050900|FG006|MDCT Substudy|Withdrawal by Subject|0|||
46832917|NCT00358826|83050901|FG007|MDCT Substudy|Withdrawal by Subject|0|||
46832918|NCT00510653|83050915|FG000|Overall Study|Withdrawal by Subject|8|||
46832919|NCT00510653|83050915|FG000|Overall Study|Monetary|3|||
46832920|NCT00362336|83050922|FG000|Overall Study|Serious Adverse Event|1|||
46832921|NCT00362336|83050923|FG001|Overall Study|Serious Adverse Event|0|||
46832922|NCT00362336|83050924|FG002|Overall Study|Serious Adverse Event|1|||
46832923|NCT00362336|83050922|FG000|Overall Study|Protocol Violation|0|||
46832924|NCT00362336|83050923|FG001|Overall Study|Protocol Violation|0|||
46832925|NCT00362336|83050924|FG002|Overall Study|Protocol Violation|1|||
46832926|NCT00362336|83050922|FG000|Overall Study|Lost to Follow-up|6|||
46832927|NCT00362336|83050923|FG001|Overall Study|Lost to Follow-up|4|||
46832928|NCT00362336|83050924|FG002|Overall Study|Lost to Follow-up|0|||
46832929|NCT00362336|83050922|FG000|Overall Study|Withdrawal by Subject|3|||
46832930|NCT00362336|83050923|FG001|Overall Study|Withdrawal by Subject|3|||
46832931|NCT00362336|83050924|FG002|Overall Study|Withdrawal by Subject|1|||
46832932|NCT00506285|83050941|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
46832933|NCT00506285|83050942|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
46832934|NCT00506285|83050941|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
46832935|NCT00506285|83050942|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
46832936|NCT00506285|83050941|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
46832937|NCT00506285|83050942|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
46832938|NCT00506285|83050941|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
46832939|NCT00506285|83050942|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
46832940|NCT00506285|83050941|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
46832941|NCT00506285|83050942|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
46832942|NCT00506129|83050950|FG000|Overall Study|Disease Progression/Relapse|15|||
46832943|NCT00506129|83050950|FG000|Overall Study|Death|7|||
46832944|NCT00358670|83050956|FG000|Overall Study|Adverse Event|26|||
47061408|NCT01499849|83342010|FG000|Overall Study|Lost to Follow-up|6|||
47061409|NCT01499849|83342011|FG001|Overall Study|Lost to Follow-up|3|||
47061410|NCT01499849|83342010|FG000|Overall Study|Other Reasons|27|||
47061411|NCT01499849|83342011|FG001|Overall Study|Other Reasons|30|||
47061412|NCT01499303|83342030|FG000|Overall Study|Ongoing|2|||
46637737|NCT01474512|82811392|FG016|Long-Term Extension Period|Adverse Event|0|||
46637738|NCT01474512|82811393|FG017|Long-Term Extension Period|Adverse Event|0|||
46765832|NCT00642460|82984259|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
46832945|NCT00358670|83050957|FG001|Overall Study|Adverse Event|29|||
46832946|NCT00358670|83050956|FG000|Overall Study|Lack of Efficacy|20|||
46832947|NCT00358670|83050957|FG001|Overall Study|Lack of Efficacy|23|||
46832948|NCT00358670|83050956|FG000|Overall Study|Protocol Violation|6|||
46832949|NCT00358670|83050957|FG001|Overall Study|Protocol Violation|9|||
47061413|NCT01499303|83342031|FG001|Overall Study|Ongoing|1|||
46637739|NCT01474512|82811376|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
46637740|NCT01474512|82811377|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
46637741|NCT01474512|82811378|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
46637742|NCT01474512|82811379|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
46765833|NCT00642460|82984260|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
46765834|NCT00642460|82984261|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
46765835|NCT00642460|82984262|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
46765836|NCT00642460|82984263|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
46765837|NCT00642460|82984264|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
46765838|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
46765839|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
46765840|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
46765841|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
46765842|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
46765843|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
46765844|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
46765845|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
46765846|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
46765847|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
46637743|NCT01474512|82811380|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
46765848|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
46765849|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
46765850|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
46765851|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
46765852|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
46832950|NCT00358670|83050956|FG000|Overall Study|Lost to Follow-up|4|||
46832951|NCT00358670|83050957|FG001|Overall Study|Lost to Follow-up|5|||
46832952|NCT00358670|83050956|FG000|Overall Study|Withdrawal by Subject|13|||
46832953|NCT00358670|83050957|FG001|Overall Study|Withdrawal by Subject|24|||
46832954|NCT00358670|83050956|FG000|Overall Study|Protocol Defined Clinical Event|0|||
46832955|NCT00358670|83050957|FG001|Overall Study|Protocol Defined Clinical Event|1|||
46832956|NCT00358670|83050956|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
46832957|NCT00358670|83050957|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
46832958|NCT00358670|83050956|FG000|Overall Study|Administrative|153|||
47061414|NCT01499303|83342030|FG000|Overall Study|Withdrawal by Subject|0|||
46832959|NCT00358670|83050957|FG001|Overall Study|Administrative|125|||
46832960|NCT00505661|83050963|FG000|Overall Study|Not Eligible|4|||
46832961|NCT00383786|83050969|FG000|Overall Study|Protocol Violation|2|||
46832962|NCT00383786|83050970|FG001|Overall Study|Protocol Violation|6|||
46832963|NCT00383786|83050969|FG000|Overall Study|Withdrawal by Subject|2|||
46832964|NCT00383786|83050970|FG001|Overall Study|Withdrawal by Subject|5|||
46832965|NCT00383786|83050969|FG000|Overall Study|Physician Decision|0|||
46832966|NCT00383786|83050970|FG001|Overall Study|Physician Decision|1|||
46832967|NCT00383708|83050976|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
46832968|NCT00383708|83050976|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
46832969|NCT00383708|83050976|FG000|Run-in Period|Protocol Violation|4|||
46832970|NCT00383708|83050976|FG000|Run-in Period|Adverse Event|2|||
46832971|NCT00383708|83050976|FG000|Run-in Period|Claustrophobia|1|||
46832972|NCT00383708|83050976|FG000|Co-administration Period|Adverse Event|5|||
46832973|NCT00504881|83050983|FG000|Overall Study|Lack of Efficacy|1|||
46832974|NCT00504881|83050984|FG001|Overall Study|Lack of Efficacy|5|||
46939473|NCT05114564|83176513|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
46939474|NCT05114564|83176514|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
46939475|NCT05114564|83176513|FG000|First Intervention|Adverse Event|0|||
46939476|NCT05114564|83176514|FG001|First Intervention|Adverse Event|1|||
46939477|NCT04706416|83176522|FG000|Overall Study|Lost to Follow-up|2|||
46939478|NCT04706416|83176523|FG001|Overall Study|Lost to Follow-up|0|||
46939479|NCT04683926|83176536|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
46939480|NCT04683926|83176537|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
46939481|NCT04683926|83176538|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
46939482|NCT04683926|83176539|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
46939483|NCT04343755|83176551|FG000|Overall Study|Death|11|||
46939484|NCT04343755|83176551|FG000|Overall Study|Screen Failure|1|||
46939485|NCT04285346|83176555|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
46939486|NCT04285346|83176556|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
46939487|NCT04285346|83176555|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
46939488|NCT04285346|83176556|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
46939489|NCT04285346|83176555|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
46939490|NCT04285346|83176556|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
46939491|NCT04148287|83176571|FG000|Overall Study|Death|2|||
46939492|NCT03772613|83176599|FG000|Overall Study|Lost to Follow-up|0|||
46939493|NCT03772613|83176600|FG001|Overall Study|Lost to Follow-up|1|||
46939494|NCT03772613|83176601|FG002|Overall Study|Lost to Follow-up|1|||
46939495|NCT03739437|83176611|FG000|Overall Study|Lost to Follow-up|2|||
46939496|NCT03739437|83176612|FG001|Overall Study|Lost to Follow-up|5|||
46939497|NCT03701555|83176654|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
46939498|NCT03701555|83176655|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
46939499|NCT03701555|83176656|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
46939500|NCT03701555|83176657|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
46939501|NCT03701555|83176658|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
46939502|NCT03701555|83176659|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
46939503|NCT03701555|83176660|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
46939504|NCT03701555|83176661|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
46939505|NCT03701555|83176662|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
46939506|NCT03701555|83176663|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
46939507|NCT03701555|83176664|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
46939508|NCT03701555|83176665|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
46939509|NCT03701555|83176666|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
46939510|NCT03701555|83176667|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
46939511|NCT03701555|83176668|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
46765853|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
46765854|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
46765855|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
46765856|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
46765857|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
46765858|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
46765859|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
46765860|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
46832975|NCT00504881|83050983|FG000|Overall Study|Lost to Follow-up|0|||
46939512|NCT03701555|83176669|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
46939513|NCT03701555|83176670|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
46939514|NCT03701555|83176671|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
46939515|NCT03701555|83176672|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
46939516|NCT03701555|83176673|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
46939517|NCT03701555|83176674|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
46939518|NCT03701555|83176675|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
46939519|NCT03701555|83176676|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
46765861|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
46832976|NCT00504881|83050984|FG001|Overall Study|Lost to Follow-up|2|||
46832977|NCT00504881|83050983|FG000|Overall Study|Withdrawal by Subject|1|||
46832978|NCT00504881|83050984|FG001|Overall Study|Withdrawal by Subject|4|||
47061415|NCT01499303|83342031|FG001|Overall Study|Withdrawal by Subject|1|||
47061416|NCT01499303|83342030|FG000|Overall Study|Adverse Event|1|||
47061417|NCT01499303|83342031|FG001|Overall Study|Adverse Event|4|||
47061418|NCT01499303|83342030|FG000|Overall Study|Other|0|||
47061419|NCT01499303|83342031|FG001|Overall Study|Other|1|||
47061420|NCT01498679|83342052|FG000|Overall Study|Adverse Event|1|||
47061421|NCT01498679|83342053|FG001|Overall Study|Adverse Event|4|||
47061422|NCT01498679|83342052|FG000|Overall Study|Lack of Efficacy|72|||
47061423|NCT01498679|83342053|FG001|Overall Study|Lack of Efficacy|12|||
47061424|NCT01498679|83342052|FG000|Overall Study|Protocol Violation|4|||
47061425|NCT01498679|83342053|FG001|Overall Study|Protocol Violation|0|||
47061426|NCT01498679|83342052|FG000|Overall Study|Physician Decision|0|||
47061427|NCT01498679|83342053|FG001|Overall Study|Physician Decision|2|||
47061428|NCT01498679|83342052|FG000|Overall Study|Withdrawal by Subject|12|||
47061429|NCT01498679|83342053|FG001|Overall Study|Withdrawal by Subject|4|||
47061430|NCT01526785|83342076|FG000|Overall Study|Study Terminated by Sponsor|8|||
47061431|NCT01526785|83342076|FG000|Overall Study|Death|2|||
47061432|NCT01526785|83342076|FG000|Overall Study|Physician Decision|1|||
47061433|NCT01526785|83342076|FG000|Overall Study|Withdrawal by Subject|2|||
47061434|NCT01559389|83342082|FG000|Overall Study|Withdrawal by Subject|20|||
47061435|NCT01559389|83342083|FG001|Overall Study|Withdrawal by Subject|20|||
47061436|NCT01526551|83342093|FG000|Overall Study|Lack of returned parental consent form|424|||
47061437|NCT05373108|83342151|FG000|Overall Study|Withdrawal by Subject|2|||
47061438|NCT05052697|83342218|FG000|Substudy A|Lost to Follow-up|0|||
47061439|NCT05052697|83342219|FG001|Substudy A|Lost to Follow-up|0|||
47061440|NCT05052697|83342220|FG002|Substudy A|Lost to Follow-up|0|||
47061441|NCT05052697|83342221|FG003|Substudy A|Lost to Follow-up|0|||
47061442|NCT05052697|83342222|FG004|Substudy A|Lost to Follow-up|0|||
47061443|NCT05052697|83342223|FG005|Substudy A|Lost to Follow-up|1|||
47061444|NCT05052697|83342224|FG006|Substudy A|Lost to Follow-up|0|||
47061445|NCT05052697|83342225|FG007|Substudy A|Lost to Follow-up|0|||
47061446|NCT05052697|83342226|FG008|Substudy A|Lost to Follow-up|0|||
47061447|NCT05052697|83342227|FG009|Substudy A|Lost to Follow-up|0|||
47061448|NCT05052697|83342228|FG010|Substudy A|Lost to Follow-up|0|||
47061449|NCT05052697|83342229|FG011|Substudy A|Lost to Follow-up|0|||
47061450|NCT05052697|83342230|FG012|Substudy A|Lost to Follow-up|0|||
47061451|NCT05052697|83342231|FG013|Substudy A|Lost to Follow-up|0|||
47061452|NCT05052697|83342232|FG014|Substudy A|Lost to Follow-up|0|||
47061453|NCT05052697|83342233|FG015|Substudy A|Lost to Follow-up|2|||
47061454|NCT05052697|83342234|FG016|Substudy A|Lost to Follow-up|0|||
47061455|NCT05052697|83342235|FG017|Substudy A|Lost to Follow-up|0|||
47061456|NCT05052697|83342236|FG018|Substudy A|Lost to Follow-up|0|||
47061457|NCT05052697|83342237|FG019|Substudy A|Lost to Follow-up|0|||
47061458|NCT05052697|83342238|FG020|Substudy A|Lost to Follow-up|0|||
47061459|NCT05052697|83342239|FG021|Substudy A|Lost to Follow-up|0|||
47061460|NCT05052697|83342240|FG022|Substudy A|Lost to Follow-up|0|||
47061461|NCT05052697|83342241|FG023|Substudy A|Lost to Follow-up|0|||
47061462|NCT05052697|83342242|FG024|Substudy A|Lost to Follow-up|0|||
47061463|NCT05052697|83342243|FG025|Substudy A|Lost to Follow-up|0|||
47061464|NCT05052697|83342244|FG026|Substudy A|Lost to Follow-up|0|||
47061465|NCT05052697|83342245|FG027|Substudy A|Lost to Follow-up|0|||
47061466|NCT05052697|83342246|FG028|Substudy A|Lost to Follow-up|0|||
47061467|NCT05052697|83342247|FG029|Substudy A|Lost to Follow-up|0|||
47061468|NCT05052697|83342248|FG030|Substudy A|Lost to Follow-up|0|||
47061469|NCT05052697|83342249|FG031|Substudy A|Lost to Follow-up|0|||
47061470|NCT05052697|83342250|FG032|Substudy A|Lost to Follow-up|0|||
47061471|NCT05052697|83342251|FG033|Substudy A|Lost to Follow-up|0|||
47061472|NCT05052697|83342218|FG000|Substudy A|No longer met eligibility criteria|0|||
47061473|NCT05052697|83342219|FG001|Substudy A|No longer met eligibility criteria|0|||
46637744|NCT01474512|82811381|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
46832979|NCT00504881|83050983|FG000|Overall Study|Non-Compliance|1|||
46939520|NCT03701555|83176677|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
46939521|NCT03701555|83176678|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
47061474|NCT05052697|83342220|FG002|Substudy A|No longer met eligibility criteria|0|||
47061475|NCT05052697|83342221|FG003|Substudy A|No longer met eligibility criteria|0|||
47061476|NCT05052697|83342222|FG004|Substudy A|No longer met eligibility criteria|0|||
47061477|NCT05052697|83342223|FG005|Substudy A|No longer met eligibility criteria|0|||
47061478|NCT05052697|83342224|FG006|Substudy A|No longer met eligibility criteria|0|||
47061479|NCT05052697|83342225|FG007|Substudy A|No longer met eligibility criteria|0|||
47061480|NCT05052697|83342226|FG008|Substudy A|No longer met eligibility criteria|0|||
46939522|NCT03701555|83176679|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
47061481|NCT05052697|83342227|FG009|Substudy A|No longer met eligibility criteria|0|||
47061482|NCT05052697|83342228|FG010|Substudy A|No longer met eligibility criteria|0|||
47061483|NCT05052697|83342229|FG011|Substudy A|No longer met eligibility criteria|0|||
47061484|NCT05052697|83342230|FG012|Substudy A|No longer met eligibility criteria|0|||
46832980|NCT00504881|83050984|FG001|Overall Study|Non-Compliance|0|||
46832981|NCT00504881|83050983|FG000|Overall Study|No Birth Control|0|||
46832982|NCT00504881|83050984|FG001|Overall Study|No Birth Control|1|||
46832983|NCT00504881|83050983|FG000|Overall Study|Safety Visit not performed|0|||
46832984|NCT00504881|83050984|FG001|Overall Study|Safety Visit not performed|1|||
46832985|NCT00504881|83050983|FG000|Overall Study|AE, serious fatal|0|||
46832986|NCT00504881|83050984|FG001|Overall Study|AE, serious fatal|1|||
46832987|NCT00504881|83050983|FG000|Overall Study|SAE, non-fatal|2|||
46939523|NCT03701555|83176680|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
46939524|NCT03701555|83176681|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
46939525|NCT03701555|83176682|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
46832988|NCT00504881|83050984|FG001|Overall Study|SAE, non-fatal|6|||
46832989|NCT00504881|83050983|FG000|Overall Study|AE, non-serious non-fatal|4|||
46832990|NCT00504881|83050984|FG001|Overall Study|AE, non-serious non-fatal|14|||
46832991|NCT00504881|83050983|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
46832992|NCT00504881|83050984|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
46832993|NCT00504881|83050983|FG000|Overall Study|AE of unknown type|1|||
46832994|NCT00504881|83050984|FG001|Overall Study|AE of unknown type|0|||
46832995|NCT00504725|83050994|FG000|Overall Study|Protocol Violation|1|||
46832996|NCT00504725|83050995|FG001|Overall Study|Protocol Violation|0|||
46832997|NCT00383240|83051005|FG000|Overall Study|Adverse Event|4|||
46832998|NCT00383240|83051006|FG001|Overall Study|Adverse Event|6|||
46832999|NCT00383240|83051007|FG002|Overall Study|Adverse Event|9|||
46833000|NCT00383240|83051008|FG003|Overall Study|Adverse Event|7|||
46833001|NCT00383240|83051005|FG000|Overall Study|Treatment Failure|8|||
46833002|NCT00383240|83051006|FG001|Overall Study|Treatment Failure|13|||
46833003|NCT00383240|83051007|FG002|Overall Study|Treatment Failure|47|||
46833004|NCT00383240|83051008|FG003|Overall Study|Treatment Failure|46|||
46833005|NCT00383240|83051005|FG000|Overall Study|Lost to Follow-up|3|||
46833006|NCT00383240|83051006|FG001|Overall Study|Lost to Follow-up|0|||
46833007|NCT00383240|83051007|FG002|Overall Study|Lost to Follow-up|0|||
46833008|NCT00383240|83051008|FG003|Overall Study|Lost to Follow-up|2|||
46833009|NCT00383240|83051005|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
46833010|NCT00383240|83051006|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
46833011|NCT00383240|83051007|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
46833012|NCT00383240|83051008|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
46833013|NCT00383240|83051005|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
46833014|NCT00383240|83051006|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
46833015|NCT00383240|83051007|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
46833016|NCT00383240|83051008|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
46765862|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Other|0|||
46765863|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Other|0|||
46765864|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Other|0|||
46765865|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Other|0|||
46765866|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Other|2|||
46765867|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Other|2|||
46765868|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Death|0|||
46765869|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Death|0|||
46765870|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Death|0|||
46765871|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Death|0|||
46765872|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Death|0|||
46765873|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Death|3|||
46765874|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
46765875|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
46765876|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
46765877|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
46765878|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
46833017|NCT00383240|83051005|FG000|Overall Study|Protocol Violation|4|||
46833018|NCT00383240|83051006|FG001|Overall Study|Protocol Violation|5|||
46833019|NCT00383240|83051007|FG002|Overall Study|Protocol Violation|9|||
46833020|NCT00383240|83051008|FG003|Overall Study|Protocol Violation|6|||
46833021|NCT00383240|83051005|FG000|Overall Study|Did not meet protocol eligibility|9|||
46833022|NCT00383240|83051006|FG001|Overall Study|Did not meet protocol eligibility|4|||
46833023|NCT00383240|83051007|FG002|Overall Study|Did not meet protocol eligibility|9|||
46833024|NCT00383240|83051008|FG003|Overall Study|Did not meet protocol eligibility|3|||
46833025|NCT00383240|83051005|FG000|Overall Study|Administrative|1|||
46833026|NCT00383240|83051006|FG001|Overall Study|Administrative|1|||
46833027|NCT00383240|83051007|FG002|Overall Study|Administrative|0|||
46833028|NCT00383240|83051008|FG003|Overall Study|Administrative|0|||
46833029|NCT00362180|83051028|FG000|Treated Period|Withdrawal by Subject|1|||
46833030|NCT00362180|83051029|FG001|Treated Period|Withdrawal by Subject|0|||
46833031|NCT00362180|83051030|FG002|Treated Period|Withdrawal by Subject|0|||
46833032|NCT00362180|83051031|FG003|Treated Period|Withdrawal by Subject|0|||
46833033|NCT00362180|83051032|FG004|Treated Period|Withdrawal by Subject|0|||
46939526|NCT03701555|83176683|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
46939527|NCT03701555|83176684|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
46939528|NCT03701555|83176685|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
46939529|NCT03701555|83176686|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
46939530|NCT03701555|83176687|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
46939531|NCT03701555|83176688|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
46939532|NCT03701555|83176689|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
46939533|NCT03701555|83176654|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
46939534|NCT03701555|83176655|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
46939535|NCT03701555|83176656|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
46939536|NCT03701555|83176657|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
46939537|NCT03701555|83176658|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
46939538|NCT03701555|83176659|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
46939539|NCT03701555|83176660|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
46939540|NCT03701555|83176661|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
46939541|NCT03701555|83176662|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
46939542|NCT03701555|83176663|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
46939543|NCT03701555|83176664|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
46939544|NCT03701555|83176665|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
46939545|NCT03701555|83176666|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
46939546|NCT03701555|83176667|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
46939547|NCT03701555|83176668|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
46939548|NCT03701555|83176669|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
46833034|NCT00362180|83051033|FG005|Treated Period|Withdrawal by Subject|0|||
46833035|NCT00362180|83051034|FG006|Treated Period|Withdrawal by Subject|0|||
46833036|NCT00362180|83051035|FG007|Treated Period|Withdrawal by Subject|0|||
46833037|NCT00362180|83051036|FG008|Treated Period|Withdrawal by Subject|0|||
46833038|NCT00362180|83051028|FG000|Treated Period|Adverse Event|0|||
46833039|NCT00362180|83051029|FG001|Treated Period|Adverse Event|0|||
46833040|NCT00362180|83051030|FG002|Treated Period|Adverse Event|0|||
46833041|NCT00362180|83051031|FG003|Treated Period|Adverse Event|0|||
46833042|NCT00362180|83051032|FG004|Treated Period|Adverse Event|0|||
46833043|NCT00362180|83051033|FG005|Treated Period|Adverse Event|1|||
46833044|NCT00362180|83051034|FG006|Treated Period|Adverse Event|0|||
46833045|NCT00362180|83051035|FG007|Treated Period|Adverse Event|1|||
46833046|NCT00362180|83051036|FG008|Treated Period|Adverse Event|0|||
46833047|NCT00383162|83051054|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
46833048|NCT00383162|83051055|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
46833049|NCT00383162|83051054|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
46833050|NCT00383162|83051055|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
46833051|NCT00383162|83051054|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
46833052|NCT00383162|83051055|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
46833053|NCT00383162|83051054|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
46833054|NCT00383162|83051055|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
46833055|NCT00383162|83051054|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
46833056|NCT00383162|83051055|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
46833057|NCT00383162|83051054|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
46833058|NCT00383162|83051055|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
46833059|NCT00383162|83051054|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
46833060|NCT00383162|83051055|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
46833061|NCT00383162|83051054|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
46833062|NCT00383162|83051055|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
46833063|NCT00383162|83051054|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
46939549|NCT03701555|83176670|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
46939550|NCT03701555|83176671|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
46939551|NCT03701555|83176672|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
46939552|NCT03701555|83176673|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
46939553|NCT03701555|83176674|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
46939554|NCT03701555|83176675|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
46939555|NCT03701555|83176676|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
46833064|NCT00383162|83051055|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
46939556|NCT03701555|83176677|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
46939557|NCT03701555|83176678|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
46939558|NCT03701555|83176679|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
46939559|NCT03701555|83176680|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
46939560|NCT03701555|83176681|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
46939561|NCT03701555|83176682|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
46939562|NCT03701555|83176683|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
46939563|NCT03701555|83176684|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
46833065|NCT00358436|83051063|FG000|Overall Study|Adverse Event|29|||
46833066|NCT00358436|83051064|FG001|Overall Study|Adverse Event|13|||
46833067|NCT00358436|83051063|FG000|Overall Study|Lack of Efficacy|34|||
46833068|NCT00358436|83051064|FG001|Overall Study|Lack of Efficacy|36|||
46833069|NCT00358436|83051063|FG000|Overall Study|Lost to Follow-up|11|||
46939564|NCT03701555|83176685|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
46939565|NCT03701555|83176686|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
46939566|NCT03701555|83176687|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
46939567|NCT03701555|83176688|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
46939568|NCT03701555|83176689|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
46939569|NCT03701555|83176654|FG000|Part 2 (Day 1)|Other|0|||
46939570|NCT03701555|83176655|FG001|Part 2 (Day 1)|Other|0|||
46939571|NCT03701555|83176656|FG002|Part 2 (Day 1)|Other|0|||
46939572|NCT03701555|83176657|FG003|Part 2 (Day 1)|Other|0|||
46939573|NCT03701555|83176658|FG004|Part 2 (Day 1)|Other|0|||
46939574|NCT03701555|83176659|FG005|Part 2 (Day 1)|Other|0|||
46939575|NCT03701555|83176660|FG006|Part 2 (Day 1)|Other|0|||
46939576|NCT03701555|83176661|FG007|Part 2 (Day 1)|Other|0|||
46939577|NCT03701555|83176662|FG008|Part 2 (Day 1)|Other|0|||
46939578|NCT03701555|83176663|FG009|Part 2 (Day 1)|Other|0|||
46939579|NCT03701555|83176664|FG010|Part 2 (Day 1)|Other|3|||
46939580|NCT03701555|83176665|FG011|Part 2 (Day 1)|Other|1|||
46939581|NCT03701555|83176666|FG012|Part 2 (Day 1)|Other|0|||
46833070|NCT00358436|83051064|FG001|Overall Study|Lost to Follow-up|6|||
46833071|NCT00358436|83051063|FG000|Overall Study|Protocol Violation|8|||
46833072|NCT00358436|83051064|FG001|Overall Study|Protocol Violation|3|||
46833073|NCT00358436|83051063|FG000|Overall Study|Withdrawal by Subject|40|||
46833074|NCT00358436|83051064|FG001|Overall Study|Withdrawal by Subject|17|||
46833075|NCT00358436|83051063|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
46833076|NCT00358436|83051064|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
46833077|NCT00358436|83051063|FG000|Overall Study|COPD exacerbation|22|||
46939582|NCT03701555|83176667|FG013|Part 2 (Day 1)|Other|1|||
46939583|NCT03701555|83176668|FG014|Part 2 (Day 1)|Other|0|||
46939584|NCT03701555|83176669|FG015|Part 2 (Day 1)|Other|2|||
47061485|NCT05052697|83342231|FG013|Substudy A|No longer met eligibility criteria|1|||
47061486|NCT05052697|83342232|FG014|Substudy A|No longer met eligibility criteria|0|||
47061487|NCT05052697|83342233|FG015|Substudy A|No longer met eligibility criteria|0|||
47061488|NCT05052697|83342234|FG016|Substudy A|No longer met eligibility criteria|0|||
47061489|NCT05052697|83342235|FG017|Substudy A|No longer met eligibility criteria|0|||
47061490|NCT05052697|83342236|FG018|Substudy A|No longer met eligibility criteria|0|||
46939585|NCT03701555|83176670|FG016|Part 2 (Day 1)|Other|2|||
46939586|NCT03701555|83176671|FG017|Part 2 (Day 1)|Other|0|||
46939587|NCT03701555|83176672|FG018|Part 2 (Day 1)|Other|0|||
46939588|NCT03701555|83176673|FG019|Part 2 (Day 1)|Other|0|||
46939589|NCT03701555|83176674|FG020|Part 2 (Day 1)|Other|0|||
47061491|NCT05052697|83342237|FG019|Substudy A|No longer met eligibility criteria|0|||
47061492|NCT05052697|83342238|FG020|Substudy A|No longer met eligibility criteria|0|||
46939590|NCT03701555|83176675|FG021|Part 2 (Day 1)|Other|0|||
46939591|NCT03701555|83176676|FG022|Part 2 (Day 1)|Other|0|||
46939592|NCT03701555|83176677|FG023|Part 2 (Day 1)|Other|0|||
46939593|NCT03701555|83176678|FG024|Part 2 (Day 1)|Other|0|||
46939594|NCT03701555|83176679|FG025|Part 2 (Day 1)|Other|0|||
46939595|NCT03701555|83176680|FG026|Part 2 (Day 1)|Other|0|||
46939596|NCT03701555|83176681|FG027|Part 2 (Day 1)|Other|0|||
46939597|NCT03701555|83176682|FG028|Part 2 (Day 1)|Other|0|||
46939598|NCT03701555|83176683|FG029|Part 2 (Day 1)|Other|0|||
46939599|NCT03701555|83176684|FG030|Part 2 (Day 1)|Other|0|||
46939600|NCT03701555|83176685|FG031|Part 2 (Day 1)|Other|0|||
46939601|NCT03701555|83176686|FG032|Part 2 (Day 1)|Other|0|||
46939602|NCT03701555|83176687|FG033|Part 2 (Day 1)|Other|0|||
46939603|NCT03701555|83176688|FG034|Part 2 (Day 1)|Other|0|||
46939604|NCT03701555|83176689|FG035|Part 2 (Day 1)|Other|0|||
46939605|NCT03701555|83176654|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
47061493|NCT05052697|83342239|FG021|Substudy A|No longer met eligibility criteria|0|||
47061494|NCT05052697|83342240|FG022|Substudy A|No longer met eligibility criteria|0|||
46765879|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
46765880|NCT00642460|82984259|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
46765881|NCT00642460|82984260|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
46765882|NCT00642460|82984261|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
46765883|NCT00642460|82984262|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
46765884|NCT00642460|82984263|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
46765885|NCT00642460|82984264|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
46765886|NCT00814658|82984276|FG000|Overall Study|Lost to Follow-up|0|||
46939606|NCT03701555|83176655|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
46939607|NCT03701555|83176656|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
47061495|NCT05052697|83342241|FG023|Substudy A|No longer met eligibility criteria|0|||
46939608|NCT03701555|83176657|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
46765887|NCT00814658|82984277|FG001|Overall Study|Lost to Follow-up|1|||
46833078|NCT00358436|83051064|FG001|Overall Study|COPD exacerbation|10|||
46939609|NCT03701555|83176658|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
46939610|NCT03701555|83176659|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
46939611|NCT03701555|83176660|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
46939612|NCT03701555|83176661|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
46939613|NCT03701555|83176662|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
46939614|NCT03701555|83176663|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
46939615|NCT03701555|83176664|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
46939616|NCT03701555|83176665|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
46939617|NCT03701555|83176666|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
46939618|NCT03701555|83176667|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
46939619|NCT03701555|83176668|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
46939620|NCT03701555|83176669|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
46939621|NCT03701555|83176670|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
46939622|NCT03701555|83176671|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
46939623|NCT03701555|83176672|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
46939624|NCT03701555|83176673|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
46939625|NCT03701555|83176674|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
46939626|NCT03701555|83176675|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
46939627|NCT03701555|83176676|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
46939628|NCT03701555|83176677|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
46939629|NCT03701555|83176678|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
46939630|NCT03701555|83176679|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
46939631|NCT03701555|83176680|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
46939632|NCT03701555|83176681|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
46939633|NCT03701555|83176682|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
46939634|NCT03701555|83176683|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
46939635|NCT03701555|83176684|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
46939636|NCT03701555|83176685|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
46939637|NCT03701555|83176686|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
46939638|NCT03701555|83176687|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
46939639|NCT03701555|83176688|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
46939640|NCT03701555|83176689|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
46939641|NCT03701555|83176654|FG000|Part 3 (Day 1)|Subject Decision|0|||
46939642|NCT03701555|83176655|FG001|Part 3 (Day 1)|Subject Decision|0|||
46939643|NCT03701555|83176656|FG002|Part 3 (Day 1)|Subject Decision|0|||
46939644|NCT03701555|83176657|FG003|Part 3 (Day 1)|Subject Decision|0|||
46939645|NCT03701555|83176658|FG004|Part 3 (Day 1)|Subject Decision|0|||
46939646|NCT03701555|83176659|FG005|Part 3 (Day 1)|Subject Decision|0|||
46939647|NCT03701555|83176660|FG006|Part 3 (Day 1)|Subject Decision|0|||
46939648|NCT03701555|83176661|FG007|Part 3 (Day 1)|Subject Decision|0|||
46939649|NCT03701555|83176662|FG008|Part 3 (Day 1)|Subject Decision|0|||
46939650|NCT03701555|83176663|FG009|Part 3 (Day 1)|Subject Decision|0|||
46939651|NCT03701555|83176664|FG010|Part 3 (Day 1)|Subject Decision|0|||
46939652|NCT03701555|83176665|FG011|Part 3 (Day 1)|Subject Decision|0|||
46939653|NCT03701555|83176666|FG012|Part 3 (Day 1)|Subject Decision|0|||
46939654|NCT03701555|83176667|FG013|Part 3 (Day 1)|Subject Decision|0|||
46939655|NCT03701555|83176668|FG014|Part 3 (Day 1)|Subject Decision|0|||
46939656|NCT03701555|83176669|FG015|Part 3 (Day 1)|Subject Decision|0|||
46939657|NCT03701555|83176670|FG016|Part 3 (Day 1)|Subject Decision|0|||
46939658|NCT03701555|83176671|FG017|Part 3 (Day 1)|Subject Decision|0|||
46939659|NCT03701555|83176672|FG018|Part 3 (Day 1)|Subject Decision|0|||
46939660|NCT03701555|83176673|FG019|Part 3 (Day 1)|Subject Decision|0|||
46939661|NCT03701555|83176674|FG020|Part 3 (Day 1)|Subject Decision|0|||
46939662|NCT03701555|83176675|FG021|Part 3 (Day 1)|Subject Decision|0|||
46939663|NCT03701555|83176676|FG022|Part 3 (Day 1)|Subject Decision|0|||
46939664|NCT03701555|83176677|FG023|Part 3 (Day 1)|Subject Decision|0|||
46939665|NCT03701555|83176678|FG024|Part 3 (Day 1)|Subject Decision|0|||
46833079|NCT00358436|83051063|FG000|Overall Study|Other|6|||
46833080|NCT00358436|83051064|FG001|Overall Study|Other|1|||
46833081|NCT00383084|83051074|FG000|Overall Study|Withdrawal by Subject|12|||
46833082|NCT00383084|83051075|FG001|Overall Study|Withdrawal by Subject|10|||
46833083|NCT00361634|83051081|FG000|Overall Study|Lost to Follow-up|1|||
46833084|NCT00361634|83051081|FG000|Overall Study|Withdrawal by Subject|1|||
46833085|NCT00357968|83051087|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
46833086|NCT00357968|83051088|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
46833087|NCT00357968|83051087|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
46833088|NCT00357968|83051088|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
46833089|NCT00357656|83051111|FG000|Overall Study|Other, No surgery performed|0|||
46939666|NCT03701555|83176679|FG025|Part 3 (Day 1)|Subject Decision|0|||
46939667|NCT03701555|83176680|FG026|Part 3 (Day 1)|Subject Decision|1|||
46939668|NCT03701555|83176681|FG027|Part 3 (Day 1)|Subject Decision|0|||
46939669|NCT03701555|83176682|FG028|Part 3 (Day 1)|Subject Decision|0|||
46939670|NCT03701555|83176683|FG029|Part 3 (Day 1)|Subject Decision|0|||
46939671|NCT03701555|83176684|FG030|Part 3 (Day 1)|Subject Decision|0|||
46939672|NCT03701555|83176685|FG031|Part 3 (Day 1)|Subject Decision|2|||
46939673|NCT03701555|83176686|FG032|Part 3 (Day 1)|Subject Decision|1|||
46939674|NCT03701555|83176687|FG033|Part 3 (Day 1)|Subject Decision|1|||
46939675|NCT03701555|83176688|FG034|Part 3 (Day 1)|Subject Decision|0|||
46765888|NCT00814658|82984276|FG000|Overall Study|Physician Decision|1|||
46765889|NCT00814658|82984277|FG001|Overall Study|Physician Decision|0|||
46765890|NCT00814658|82984276|FG000|Overall Study|Adverse Event|3|||
46765891|NCT00814658|82984277|FG001|Overall Study|Adverse Event|3|||
46765892|NCT00642304|82984293|FG000|Overall Study|Adverse Event|1|||
46939676|NCT03701555|83176689|FG035|Part 3 (Day 1)|Subject Decision|0|||
46939677|NCT03701555|83176654|FG000|Part 3 (Day 1)|Other|0|||
46939678|NCT03701555|83176655|FG001|Part 3 (Day 1)|Other|0|||
46939679|NCT03701555|83176656|FG002|Part 3 (Day 1)|Other|0|||
46939680|NCT03701555|83176657|FG003|Part 3 (Day 1)|Other|0|||
46939681|NCT03701555|83176658|FG004|Part 3 (Day 1)|Other|0|||
46939682|NCT03701555|83176659|FG005|Part 3 (Day 1)|Other|0|||
46939683|NCT03701555|83176660|FG006|Part 3 (Day 1)|Other|0|||
46939684|NCT03701555|83176661|FG007|Part 3 (Day 1)|Other|0|||
46939685|NCT03701555|83176662|FG008|Part 3 (Day 1)|Other|0|||
46939686|NCT03701555|83176663|FG009|Part 3 (Day 1)|Other|0|||
46939687|NCT03701555|83176664|FG010|Part 3 (Day 1)|Other|0|||
46939688|NCT03701555|83176665|FG011|Part 3 (Day 1)|Other|0|||
46939689|NCT03701555|83176666|FG012|Part 3 (Day 1)|Other|0|||
46939690|NCT03701555|83176667|FG013|Part 3 (Day 1)|Other|0|||
46939691|NCT03701555|83176668|FG014|Part 3 (Day 1)|Other|0|||
46939692|NCT03701555|83176669|FG015|Part 3 (Day 1)|Other|0|||
46939693|NCT03701555|83176670|FG016|Part 3 (Day 1)|Other|0|||
46939694|NCT03701555|83176671|FG017|Part 3 (Day 1)|Other|0|||
46939695|NCT03701555|83176672|FG018|Part 3 (Day 1)|Other|0|||
46939696|NCT03701555|83176673|FG019|Part 3 (Day 1)|Other|0|||
46939697|NCT03701555|83176674|FG020|Part 3 (Day 1)|Other|0|||
46939698|NCT03701555|83176675|FG021|Part 3 (Day 1)|Other|0|||
46939699|NCT03701555|83176676|FG022|Part 3 (Day 1)|Other|0|||
46939700|NCT03701555|83176677|FG023|Part 3 (Day 1)|Other|0|||
46939701|NCT03701555|83176678|FG024|Part 3 (Day 1)|Other|1|||
46939702|NCT03701555|83176679|FG025|Part 3 (Day 1)|Other|1|||
46939703|NCT03701555|83176680|FG026|Part 3 (Day 1)|Other|0|||
46939704|NCT03701555|83176681|FG027|Part 3 (Day 1)|Other|0|||
46939705|NCT03701555|83176682|FG028|Part 3 (Day 1)|Other|0|||
46939706|NCT03701555|83176683|FG029|Part 3 (Day 1)|Other|1|||
46939707|NCT03701555|83176684|FG030|Part 3 (Day 1)|Other|1|||
46939708|NCT03701555|83176685|FG031|Part 3 (Day 1)|Other|0|||
46939709|NCT03701555|83176686|FG032|Part 3 (Day 1)|Other|1|||
46939710|NCT03701555|83176687|FG033|Part 3 (Day 1)|Other|1|||
46939711|NCT03701555|83176688|FG034|Part 3 (Day 1)|Other|0|||
46939712|NCT03701555|83176689|FG035|Part 3 (Day 1)|Other|0|||
46939713|NCT02178098|83176816|FG000|Overall Study|Withdrawal by Subject|0|||
46939714|NCT02178098|83176817|FG001|Overall Study|Withdrawal by Subject|6|||
46939715|NCT02178098|83176816|FG000|Overall Study|Adverse Event|1|||
46939716|NCT02178098|83176817|FG001|Overall Study|Adverse Event|2|||
46939717|NCT02178098|83176816|FG000|Overall Study|Protocol Violation|1|||
46939718|NCT02178098|83176817|FG001|Overall Study|Protocol Violation|1|||
46939719|NCT02178098|83176816|FG000|Overall Study|Lost to Follow-up|0|||
46939720|NCT02178098|83176817|FG001|Overall Study|Lost to Follow-up|1|||
46939721|NCT02178098|83176816|FG000|Overall Study|Sponsor Request|1|||
46939722|NCT02178098|83176817|FG001|Overall Study|Sponsor Request|0|||
46939723|NCT02178098|83176816|FG000|Overall Study|Other|2|||
46939724|NCT02178098|83176817|FG001|Overall Study|Other|2|||
46939725|NCT01630434|83176827|FG000|Overall Study|Donor lungs turned down|1|||
46939726|NCT01630434|83176828|FG001|Overall Study|Donor lungs turned down|0|||
46939727|NCT01630434|83176827|FG000|Overall Study|Protocol Violation|9|||
46939728|NCT01630434|83176828|FG001|Overall Study|Protocol Violation|4|||
46939729|NCT01630434|83176827|FG000|Overall Study|Death|20|||
46939730|NCT01630434|83176828|FG001|Overall Study|Death|26|||
46939731|NCT01256398|83176838|FG000|Overall Study|Withdrawal by Subject|1|||
46939732|NCT01151423|83176846|FG000|Overall Study|Study terminated by Sponsor|9|||
46939733|NCT01151423|83176847|FG001|Overall Study|Study terminated by Sponsor|10|||
46939734|NCT01151423|83176846|FG000|Overall Study|Protocol Violation|0|||
46939735|NCT01151423|83176847|FG001|Overall Study|Protocol Violation|1|||
46939736|NCT01151423|83176846|FG000|Overall Study|Physician Decision|1|||
46939737|NCT01151423|83176847|FG001|Overall Study|Physician Decision|1|||
46939738|NCT01151423|83176846|FG000|Overall Study|Pregnancy|0|||
46939739|NCT01151423|83176847|FG001|Overall Study|Pregnancy|1|||
46939740|NCT01151423|83176846|FG000|Overall Study|Death|0|||
46939741|NCT01151423|83176847|FG001|Overall Study|Death|1|||
46939742|NCT01151423|83176846|FG000|Overall Study|Adverse Event|3|||
46939743|NCT01151423|83176847|FG001|Overall Study|Adverse Event|0|||
46939744|NCT01151423|83176846|FG000|Overall Study|Withdrawal by Subject|1|||
46939745|NCT01151423|83176847|FG001|Overall Study|Withdrawal by Subject|3|||
46939746|NCT01151423|83176846|FG000|Overall Study|Lost to Follow-up|1|||
46939747|NCT01151423|83176847|FG001|Overall Study|Lost to Follow-up|0|||
46939748|NCT01151423|83176846|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
46765893|NCT00642304|82984293|FG000|Overall Study|Death|1|||
46939749|NCT01151423|83176847|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
46939750|NCT01151423|83176846|FG000|Overall Study|Participated in other clinical trial|1|||
46939751|NCT01151423|83176847|FG001|Overall Study|Participated in other clinical trial|0|||
46939752|NCT00565617|83176858|FG000|Overall Study|Withdrawal by Subject|1|||
46939753|NCT00453154|83176865|FG000|Double BIind Maintenance|Adverse Event|0|||
46939754|NCT00453154|83176866|FG001|Double BIind Maintenance|Adverse Event|0|||
46939755|NCT00453154|83176867|FG002|Double BIind Maintenance|Adverse Event|3|||
46939756|NCT00453154|83176868|FG003|Double BIind Maintenance|Adverse Event|12|||
46939757|NCT00453154|83176865|FG000|Double BIind Maintenance|Death|0|||
46939758|NCT00453154|83176866|FG001|Double BIind Maintenance|Death|0|||
46939759|NCT00453154|83176867|FG002|Double BIind Maintenance|Death|2|||
46939760|NCT00453154|83176868|FG003|Double BIind Maintenance|Death|1|||
46939761|NCT00453154|83176865|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
46939762|NCT00453154|83176866|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
46939763|NCT00453154|83176867|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
46939764|NCT00453154|83176868|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
46939765|NCT00453154|83176865|FG000|Double BIind Maintenance|Progression|0|||
46939766|NCT00453154|83176866|FG001|Double BIind Maintenance|Progression|0|||
46939767|NCT00453154|83176867|FG002|Double BIind Maintenance|Progression|29|||
46939768|NCT00453154|83176868|FG003|Double BIind Maintenance|Progression|26|||
46939769|NCT00453154|83176865|FG000|Double BIind Maintenance|Medical Issues|0|||
46939770|NCT00453154|83176866|FG001|Double BIind Maintenance|Medical Issues|0|||
46939771|NCT00453154|83176867|FG002|Double BIind Maintenance|Medical Issues|3|||
46939772|NCT00453154|83176868|FG003|Double BIind Maintenance|Medical Issues|1|||
46939773|NCT00453154|83176865|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
46939774|NCT00453154|83176866|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
46939775|NCT00453154|83176867|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
46939776|NCT00453154|83176868|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
46939777|NCT00258960|83176877|FG000|Overall Study|Death|2|||
46939778|NCT00258960|83176877|FG000|Overall Study|Disease Progression|7|||
46939779|NCT00258960|83176877|FG000|Overall Study|Adverse Event|4|||
46939780|NCT00258960|83176877|FG000|Overall Study|Physician Decision|1|||
46939781|NCT00258960|83176877|FG000|Overall Study|Withdrawal by Subject|1|||
46939782|NCT00258960|83176877|FG000|Overall Study|Mistake|2|||
46939783|NCT00121992|83176883|FG000|Overall Study|Treatment not received|2|||
46939784|NCT00121992|83176884|FG001|Overall Study|Treatment not received|11|||
46939785|NCT00070564|83176896|FG000|Overall Study|Progression|2|||
46939786|NCT00070564|83176897|FG001|Overall Study|Progression|4|||
46939787|NCT00070564|83176898|FG002|Overall Study|Progression|7|||
46939788|NCT00070564|83176899|FG003|Overall Study|Progression|7|||
46833090|NCT00357656|83051112|FG001|Overall Study|Other, No surgery performed|3|||
46833091|NCT00357500|83051130|FG000|Overall Study|Adverse Event|3|||
46833092|NCT00357500|83051130|FG000|Overall Study|Withdrawal by Subject|5|||
46833093|NCT00357500|83051130|FG000|Overall Study|Progressive Disease|65|||
46833094|NCT00357500|83051130|FG000|Overall Study|Not Started Protocol Therapy|4|||
46833095|NCT00357110|83051136|FG000|Overall Study|Early study termination|5|||
46833096|NCT00357110|83051137|FG001|Overall Study|Early study termination|5|||
46833097|NCT00098722|83051146|FG000|Double Blind Phase|Adverse Event|7|||
46833098|NCT00098722|83051147|FG001|Double Blind Phase|Adverse Event|7|||
46833099|NCT00098722|83051148|FG002|Double Blind Phase|Adverse Event|3|||
46833100|NCT00098722|83051149|FG003|Double Blind Phase|Adverse Event|0|||
46833101|NCT00098722|83051150|FG004|Double Blind Phase|Adverse Event|0|||
46833102|NCT00098722|83051151|FG005|Double Blind Phase|Adverse Event|0|||
46833103|NCT00098722|83051152|FG006|Double Blind Phase|Adverse Event|0|||
46833104|NCT00098722|83051146|FG000|Double Blind Phase|Death|2|||
46939789|NCT00070564|83176900|FG004|Overall Study|Progression|1|||
46939790|NCT00070564|83176901|FG005|Overall Study|Progression|0|||
46939791|NCT00070564|83176896|FG000|Overall Study|Delinquent|1|||
46765894|NCT00642304|82984293|FG000|Overall Study|Blood transfusion|2|||
46765895|NCT00642304|82984293|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
46765896|NCT00642304|82984293|FG000|Overall Study|Transplantation|1|||
46765897|NCT00814580|82984299|FG000|Overall Study|Adverse Event|6|||
46765898|NCT00814580|82984300|FG001|Overall Study|Adverse Event|15|||
46765899|NCT00814580|82984299|FG000|Overall Study|Lack of Efficacy|18|||
46765900|NCT00814580|82984300|FG001|Overall Study|Lack of Efficacy|25|||
46765901|NCT00814580|82984299|FG000|Overall Study|Protocol Violation|2|||
46765902|NCT00814580|82984300|FG001|Overall Study|Protocol Violation|0|||
46765903|NCT00814580|82984299|FG000|Overall Study|Withdrawal by Subject|2|||
46765904|NCT00814580|82984300|FG001|Overall Study|Withdrawal by Subject|2|||
46765905|NCT00814580|82984299|FG000|Overall Study|Other|1|||
46765906|NCT00814580|82984300|FG001|Overall Study|Other|3|||
46765907|NCT00814580|82984299|FG000|Overall Study|Did Not Take Drug|2|||
46765908|NCT00814580|82984300|FG001|Overall Study|Did Not Take Drug|2|||
46765909|NCT00643162|82984320|FG000|Overall Study|Withdrawal by Subject|1|||
46765910|NCT00643162|82984321|FG001|Overall Study|Withdrawal by Subject|1|||
46833105|NCT00098722|83051147|FG001|Double Blind Phase|Death|5|||
46833106|NCT00098722|83051148|FG002|Double Blind Phase|Death|0|||
46833107|NCT00098722|83051149|FG003|Double Blind Phase|Death|0|||
47061496|NCT05052697|83342242|FG024|Substudy A|No longer met eligibility criteria|0|||
46765911|NCT00643006|82984329|FG000|Overall Study|Lost to Follow-up|5|||
46765912|NCT00643006|82984330|FG001|Overall Study|Lost to Follow-up|4|||
46765913|NCT00814502|82984340|FG000|Overall Study|Adverse Event|1|||
46833108|NCT00098722|83051150|FG004|Double Blind Phase|Death|0|||
46833109|NCT00098722|83051151|FG005|Double Blind Phase|Death|0|||
46833110|NCT00098722|83051152|FG006|Double Blind Phase|Death|0|||
46833111|NCT00098722|83051146|FG000|Double Blind Phase|Lack of Efficacy|21|||
46833112|NCT00098722|83051147|FG001|Double Blind Phase|Lack of Efficacy|23|||
46939792|NCT00070564|83176897|FG001|Overall Study|Delinquent|4|||
46939793|NCT00070564|83176898|FG002|Overall Study|Delinquent|2|||
46939794|NCT00070564|83176899|FG003|Overall Study|Delinquent|0|||
46939795|NCT00070564|83176900|FG004|Overall Study|Delinquent|0|||
46939796|NCT00070564|83176901|FG005|Overall Study|Delinquent|0|||
46939797|NCT00070564|83176896|FG000|Overall Study|Adverse Event|150|||
46939798|NCT00070564|83176897|FG001|Overall Study|Adverse Event|142|||
46939799|NCT00070564|83176898|FG002|Overall Study|Adverse Event|120|||
46939800|NCT00070564|83176899|FG003|Overall Study|Adverse Event|108|||
46939801|NCT00070564|83176900|FG004|Overall Study|Adverse Event|63|||
46939802|NCT00070564|83176901|FG005|Overall Study|Adverse Event|36|||
46939803|NCT00070564|83176896|FG000|Overall Study|Death|4|||
46939804|NCT00070564|83176897|FG001|Overall Study|Death|1|||
46939805|NCT00070564|83176898|FG002|Overall Study|Death|5|||
46939806|NCT00070564|83176899|FG003|Overall Study|Death|3|||
46939807|NCT00070564|83176900|FG004|Overall Study|Death|0|||
46939808|NCT00070564|83176901|FG005|Overall Study|Death|1|||
46939809|NCT00070564|83176896|FG000|Overall Study|Other, not protocol specified|17|||
46939810|NCT00070564|83176897|FG001|Overall Study|Other, not protocol specified|15|||
46939811|NCT00070564|83176898|FG002|Overall Study|Other, not protocol specified|14|||
46939812|NCT00070564|83176899|FG003|Overall Study|Other, not protocol specified|19|||
46939813|NCT00070564|83176900|FG004|Overall Study|Other, not protocol specified|6|||
46939814|NCT00070564|83176901|FG005|Overall Study|Other, not protocol specified|7|||
46939815|NCT00070564|83176896|FG000|Overall Study|Withdrawal by Subject|26|||
46939816|NCT00070564|83176897|FG001|Overall Study|Withdrawal by Subject|37|||
46939817|NCT00070564|83176898|FG002|Overall Study|Withdrawal by Subject|23|||
46939818|NCT00070564|83176899|FG003|Overall Study|Withdrawal by Subject|30|||
46939819|NCT00070564|83176900|FG004|Overall Study|Withdrawal by Subject|8|||
46637745|NCT01474512|82811382|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
46833113|NCT00098722|83051148|FG002|Double Blind Phase|Lack of Efficacy|15|||
46833114|NCT00098722|83051149|FG003|Double Blind Phase|Lack of Efficacy|0|||
46833115|NCT00098722|83051150|FG004|Double Blind Phase|Lack of Efficacy|0|||
46833116|NCT00098722|83051151|FG005|Double Blind Phase|Lack of Efficacy|0|||
46833117|NCT00098722|83051152|FG006|Double Blind Phase|Lack of Efficacy|0|||
46833118|NCT00098722|83051146|FG000|Double Blind Phase|Participant defaulted|16|||
46833119|NCT00098722|83051147|FG001|Double Blind Phase|Participant defaulted|11|||
46939820|NCT00070564|83176901|FG005|Overall Study|Withdrawal by Subject|8|||
46939821|NCT00070564|83176896|FG000|Overall Study|Not reported|0|||
46939822|NCT00070564|83176897|FG001|Overall Study|Not reported|0|||
46939823|NCT00070564|83176898|FG002|Overall Study|Not reported|0|||
46637746|NCT01474512|82811383|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
46637747|NCT01474512|82811384|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
46637748|NCT01474512|82811385|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
46765914|NCT00814502|82984341|FG001|Overall Study|Adverse Event|0|||
46765915|NCT00814502|82984340|FG000|Overall Study|Withdrawal by Subject|0|||
46765916|NCT00814502|82984341|FG001|Overall Study|Withdrawal by Subject|2|||
46765917|NCT00653224|82984351|FG000|Overall Study|Adverse Event|2|||
46765918|NCT00653224|82984352|FG001|Overall Study|Adverse Event|1|||
46765919|NCT00653224|82984351|FG000|Overall Study|Lack of Efficacy|1|||
46765920|NCT00653224|82984352|FG001|Overall Study|Lack of Efficacy|2|||
46765921|NCT00653224|82984351|FG000|Overall Study|Loss of efficacy|1|||
46765922|NCT00653224|82984352|FG001|Overall Study|Loss of efficacy|0|||
46765923|NCT00653224|82984351|FG000|Overall Study|Lost to Follow-up|1|||
46765924|NCT00653224|82984352|FG001|Overall Study|Lost to Follow-up|0|||
46765925|NCT00653224|82984351|FG000|Overall Study|Other|2|||
46765926|NCT00653224|82984352|FG001|Overall Study|Other|4|||
46765927|NCT00444925|82984361|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
46765928|NCT00444925|82984362|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
46765929|NCT00444925|82984363|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
46765930|NCT00444925|82984361|FG000|Double-blind Treatment Period|Death|2|||
46765931|NCT00444925|82984362|FG001|Double-blind Treatment Period|Death|0|||
46765932|NCT00444925|82984363|FG002|Double-blind Treatment Period|Death|0|||
46765933|NCT00444925|82984361|FG000|Double-blind Treatment Period|Adverse Event|6|||
46765934|NCT00444925|82984362|FG001|Double-blind Treatment Period|Adverse Event|28|||
46765935|NCT00444925|82984363|FG002|Double-blind Treatment Period|Adverse Event|44|||
46765936|NCT00444925|82984361|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
46765937|NCT00444925|82984362|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
46939824|NCT00070564|83176899|FG003|Overall Study|Not reported|0|||
46637749|NCT01474512|82811386|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
46765938|NCT00444925|82984363|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
46765939|NCT00444925|82984361|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
46833120|NCT00098722|83051148|FG002|Double Blind Phase|Participant defaulted|9|||
46833121|NCT00098722|83051149|FG003|Double Blind Phase|Participant defaulted|0|||
46833122|NCT00098722|83051150|FG004|Double Blind Phase|Participant defaulted|0|||
46939825|NCT00070564|83176900|FG004|Overall Study|Not reported|1|||
46939826|NCT00070564|83176901|FG005|Overall Study|Not reported|0|||
46939827|NCT02738151|83176927|FG000|Overall Study|Randomized but not treated|4|||
46939828|NCT02738151|83176928|FG001|Overall Study|Randomized but not treated|1|||
46939829|NCT02738151|83176927|FG000|Overall Study|Adverse Event|4|||
46939830|NCT02738151|83176928|FG001|Overall Study|Adverse Event|5|||
46939831|NCT02738151|83176927|FG000|Overall Study|Hypoglycemia|0|||
46939832|NCT02738151|83176928|FG001|Overall Study|Hypoglycemia|1|||
46833123|NCT00098722|83051151|FG005|Double Blind Phase|Participant defaulted|0|||
46833124|NCT00098722|83051152|FG006|Double Blind Phase|Participant defaulted|0|||
46833125|NCT00098722|83051146|FG000|Double Blind Phase|Pregnancy|1|||
46833126|NCT00098722|83051147|FG001|Double Blind Phase|Pregnancy|0|||
46833127|NCT00098722|83051148|FG002|Double Blind Phase|Pregnancy|0|||
46833128|NCT00098722|83051149|FG003|Double Blind Phase|Pregnancy|0|||
46833129|NCT00098722|83051150|FG004|Double Blind Phase|Pregnancy|0|||
46833130|NCT00098722|83051151|FG005|Double Blind Phase|Pregnancy|0|||
46939833|NCT02738151|83176927|FG000|Overall Study|Poor Compliance to Protocol|4|||
46939834|NCT02738151|83176928|FG001|Overall Study|Poor Compliance to Protocol|3|||
46939835|NCT02738151|83176927|FG000|Overall Study|Other than specified above|11|||
46939836|NCT02738151|83176928|FG001|Overall Study|Other than specified above|21|||
46939837|NCT02915159|83176936|FG000|Overall Study|Participant no longer meets criteria|2|||
46939838|NCT02915159|83176937|FG001|Overall Study|Participant no longer meets criteria|0|||
46939839|NCT02915159|83176936|FG000|Overall Study|poor/non-compliance|1|||
46939840|NCT02915159|83176937|FG001|Overall Study|poor/non-compliance|0|||
46939841|NCT02915159|83176936|FG000|Overall Study|Participant withdrew consent|5|||
46939842|NCT02915159|83176937|FG001|Overall Study|Participant withdrew consent|1|||
46939843|NCT02915159|83176936|FG000|Overall Study|Request to discontinue treatment|1|||
46939844|NCT02915159|83176937|FG001|Overall Study|Request to discontinue treatment|2|||
46939845|NCT02915159|83176936|FG000|Overall Study|Adverse Event|2|||
46939846|NCT02915159|83176937|FG001|Overall Study|Adverse Event|2|||
46939847|NCT02915159|83176936|FG000|Overall Study|Lack of Efficacy|0|||
46939848|NCT02915159|83176937|FG001|Overall Study|Lack of Efficacy|3|||
46939849|NCT02924051|83176949|FG000|Overall Study|Withdrawal by Subject|1|||
46939850|NCT02924051|83176950|FG001|Overall Study|Withdrawal by Subject|9|||
46939851|NCT02923427|83176964|FG000|Overall Study|convert to laparatomy|2|||
46939852|NCT02923427|83176965|FG001|Overall Study|convert to laparatomy|2|||
46939853|NCT02923427|83176964|FG000|Overall Study|destaturation|1|||
46939854|NCT02923427|83176965|FG001|Overall Study|destaturation|0|||
46939855|NCT02923427|83176964|FG000|Overall Study|can not replace LMA|1|||
46939856|NCT02923427|83176965|FG001|Overall Study|can not replace LMA|0|||
46939857|NCT02669264|83176978|FG000|Overall Study|Death|5|||
46939858|NCT02669264|83176979|FG001|Overall Study|Death|5|||
46939859|NCT02669264|83176980|FG002|Overall Study|Death|3|||
46939860|NCT02669264|83176981|FG003|Overall Study|Death|3|||
46939861|NCT02669264|83176982|FG004|Overall Study|Death|3|||
46939862|NCT02669264|83176983|FG005|Overall Study|Death|6|||
46939863|NCT02669264|83176984|FG006|Overall Study|Death|3|||
46939864|NCT02669264|83176978|FG000|Overall Study|Withdrawal by Subject|0|||
46939865|NCT02669264|83176979|FG001|Overall Study|Withdrawal by Subject|1|||
46939866|NCT02669264|83176980|FG002|Overall Study|Withdrawal by Subject|0|||
46939867|NCT02669264|83176981|FG003|Overall Study|Withdrawal by Subject|0|||
46939868|NCT02669264|83176982|FG004|Overall Study|Withdrawal by Subject|1|||
46939869|NCT02669264|83176983|FG005|Overall Study|Withdrawal by Subject|0|||
46939870|NCT02669264|83176984|FG006|Overall Study|Withdrawal by Subject|0|||
46939871|NCT02669264|83176978|FG000|Overall Study|Lost to Follow-up|0|||
46833131|NCT00098722|83051152|FG006|Double Blind Phase|Pregnancy|0|||
46939872|NCT02669264|83176979|FG001|Overall Study|Lost to Follow-up|0|||
46939873|NCT02669264|83176980|FG002|Overall Study|Lost to Follow-up|0|||
46939874|NCT02669264|83176981|FG003|Overall Study|Lost to Follow-up|0|||
46765940|NCT00444925|82984362|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
46765941|NCT00444925|82984363|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
46765942|NCT00444925|82984361|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
46765943|NCT00444925|82984362|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
46765944|NCT00444925|82984363|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
46765945|NCT00444925|82984361|FG000|Double-blind Treatment Period|Other|7|||
46765946|NCT00444925|82984362|FG001|Double-blind Treatment Period|Other|7|||
46765947|NCT00444925|82984363|FG002|Double-blind Treatment Period|Other|12|||
46765948|NCT00641056|82984373|FG000|Overall Study|Adverse Event|12|||
46833132|NCT00098722|83051146|FG000|Double Blind Phase|Randomized, not treated|4|||
46833133|NCT00098722|83051147|FG001|Double Blind Phase|Randomized, not treated|3|||
46939875|NCT02669264|83176982|FG004|Overall Study|Lost to Follow-up|1|||
46939876|NCT02669264|83176983|FG005|Overall Study|Lost to Follow-up|0|||
46939877|NCT02669264|83176984|FG006|Overall Study|Lost to Follow-up|0|||
46939878|NCT02669264|83176978|FG000|Overall Study|Miscellaneous|0|||
46939879|NCT02669264|83176979|FG001|Overall Study|Miscellaneous|0|||
46939880|NCT02669264|83176980|FG002|Overall Study|Miscellaneous|0|||
46939881|NCT02669264|83176981|FG003|Overall Study|Miscellaneous|0|||
46939882|NCT02669264|83176982|FG004|Overall Study|Miscellaneous|0|||
46939883|NCT02669264|83176983|FG005|Overall Study|Miscellaneous|0|||
46939884|NCT02669264|83176984|FG006|Overall Study|Miscellaneous|2|||
46939885|NCT02521870|83177010|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939886|NCT02521870|83177011|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
46939887|NCT02521870|83177012|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939888|NCT02521870|83177013|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939889|NCT02521870|83177014|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939890|NCT02521870|83177015|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939891|NCT02521870|83177016|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939892|NCT02521870|83177017|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939893|NCT02521870|83177018|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939894|NCT02521870|83177019|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939895|NCT02521870|83177020|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939896|NCT02521870|83177021|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
46939897|NCT02521870|83177010|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
46939898|NCT02521870|83177011|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
46939899|NCT02521870|83177012|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
46939900|NCT02521870|83177013|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
46939901|NCT02521870|83177014|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
46939902|NCT02521870|83177015|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
46939903|NCT02521870|83177016|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
46939904|NCT02521870|83177017|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
46939905|NCT02521870|83177018|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
46939906|NCT02521870|83177019|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
46939907|NCT02521870|83177020|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
46939908|NCT02521870|83177021|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
46939909|NCT02521870|83177010|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
46939910|NCT02521870|83177011|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
46939911|NCT02521870|83177012|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
46939912|NCT02521870|83177013|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
46939913|NCT02521870|83177014|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
46939914|NCT02521870|83177015|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
46939915|NCT02521870|83177016|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
46939916|NCT02521870|83177017|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
46939917|NCT02521870|83177018|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
46939918|NCT02521870|83177019|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
46939919|NCT02521870|83177020|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
46939920|NCT02521870|83177021|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
46939921|NCT02521870|83177010|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
46939922|NCT02521870|83177011|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
46939923|NCT02521870|83177012|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
46939924|NCT02521870|83177013|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
46939925|NCT02521870|83177014|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
46939926|NCT02521870|83177015|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
46939927|NCT02521870|83177016|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
46939928|NCT02521870|83177017|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
46939929|NCT02521870|83177018|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
46939930|NCT02521870|83177019|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
46765949|NCT00641056|82984374|FG001|Overall Study|Adverse Event|2|||
46939931|NCT02521870|83177020|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
46939932|NCT02521870|83177021|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
46939933|NCT02521870|83177010|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
46939934|NCT02521870|83177011|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
46939935|NCT02521870|83177012|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
46765950|NCT00641056|82984373|FG000|Overall Study|Lost to Follow-up|2|||
46765951|NCT00641056|82984374|FG001|Overall Study|Lost to Follow-up|1|||
46765952|NCT00641056|82984373|FG000|Overall Study|Physician Decision|3|||
46765953|NCT00641056|82984374|FG001|Overall Study|Physician Decision|1|||
46765954|NCT00641056|82984373|FG000|Overall Study|Protocol Violation|2|||
46765955|NCT00641056|82984374|FG001|Overall Study|Protocol Violation|0|||
46765956|NCT00641056|82984373|FG000|Overall Study|Entry Criteria Not Met|3|||
46765957|NCT00641056|82984374|FG001|Overall Study|Entry Criteria Not Met|0|||
46765958|NCT00641056|82984373|FG000|Overall Study|Subject Decision|6|||
46765959|NCT00641056|82984374|FG001|Overall Study|Subject Decision|19|||
46765960|NCT00641056|82984373|FG000|Overall Study|Sponsor Decision|1|||
46765961|NCT00641056|82984374|FG001|Overall Study|Sponsor Decision|2|||
46765962|NCT00814346|82984386|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
46765963|NCT00814346|82984387|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
46765964|NCT00814346|82984386|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
46765965|NCT00814346|82984387|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
46765966|NCT00814346|82984386|FG000|Open Phase (17 Months)|Adverse Event|5|||
46765967|NCT00814346|82984387|FG001|Open Phase (17 Months)|Adverse Event|0|||
46765968|NCT00814346|82984386|FG000|Open Phase (17 Months)|Consent|2|||
46765969|NCT00814346|82984387|FG001|Open Phase (17 Months)|Consent|0|||
46833134|NCT00098722|83051148|FG002|Double Blind Phase|Randomized, not treated|3|||
46833135|NCT00098722|83051149|FG003|Double Blind Phase|Randomized, not treated|0|||
46939936|NCT02521870|83177013|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
46939937|NCT02521870|83177014|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
46939938|NCT02521870|83177015|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
46939939|NCT02521870|83177016|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
46939940|NCT02521870|83177017|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
46939941|NCT02521870|83177018|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
46939942|NCT02521870|83177019|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
46939943|NCT02521870|83177020|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
46939944|NCT02521870|83177021|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
46939945|NCT02521870|83177010|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
46939946|NCT02521870|83177011|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
46939947|NCT02521870|83177012|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
46939948|NCT02521870|83177013|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
46939949|NCT02521870|83177014|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
46939950|NCT02521870|83177015|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
46939951|NCT02521870|83177016|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
46939952|NCT02521870|83177017|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
46939953|NCT02521870|83177018|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
46939954|NCT02521870|83177019|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
46939955|NCT02521870|83177020|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
46939956|NCT02521870|83177021|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
46939957|NCT02521870|83177010|FG000|Phase 2: Dose Expansion|Death|0|||
46939958|NCT02521870|83177011|FG001|Phase 2: Dose Expansion|Death|0|||
46939959|NCT02521870|83177012|FG002|Phase 2: Dose Expansion|Death|0|||
46939960|NCT02521870|83177013|FG003|Phase 2: Dose Expansion|Death|0|||
46939961|NCT02521870|83177014|FG004|Phase 2: Dose Expansion|Death|1|||
46939962|NCT02521870|83177015|FG005|Phase 2: Dose Expansion|Death|1|||
46939963|NCT02521870|83177016|FG006|Phase 2: Dose Expansion|Death|3|||
46939964|NCT02521870|83177017|FG007|Phase 2: Dose Expansion|Death|1|||
46939965|NCT02521870|83177018|FG008|Phase 2: Dose Expansion|Death|1|||
46939966|NCT02521870|83177019|FG009|Phase 2: Dose Expansion|Death|5|||
46939967|NCT02521870|83177020|FG010|Phase 2: Dose Expansion|Death|2|||
46939968|NCT02521870|83177021|FG011|Phase 2: Dose Expansion|Death|2|||
46939969|NCT02521870|83177010|FG000|Phase 2: Dose Expansion|Other|0|||
46939970|NCT02521870|83177011|FG001|Phase 2: Dose Expansion|Other|0|||
46939971|NCT02521870|83177012|FG002|Phase 2: Dose Expansion|Other|0|||
46939972|NCT02521870|83177013|FG003|Phase 2: Dose Expansion|Other|0|||
46939973|NCT02521870|83177014|FG004|Phase 2: Dose Expansion|Other|10|||
46939974|NCT02521870|83177015|FG005|Phase 2: Dose Expansion|Other|3|||
46939975|NCT02521870|83177016|FG006|Phase 2: Dose Expansion|Other|2|||
46939976|NCT02521870|83177017|FG007|Phase 2: Dose Expansion|Other|0|||
46939977|NCT02521870|83177018|FG008|Phase 2: Dose Expansion|Other|10|||
46939978|NCT02521870|83177019|FG009|Phase 2: Dose Expansion|Other|5|||
46939979|NCT02521870|83177020|FG010|Phase 2: Dose Expansion|Other|1|||
46939980|NCT02521870|83177021|FG011|Phase 2: Dose Expansion|Other|7|||
46939981|NCT02521870|83177010|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939982|NCT02521870|83177011|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939983|NCT02521870|83177012|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939984|NCT02521870|83177013|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939985|NCT02521870|83177014|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
46939986|NCT02521870|83177015|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939987|NCT02521870|83177016|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939988|NCT02521870|83177017|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939989|NCT02521870|83177018|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939990|NCT02521870|83177019|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939991|NCT02521870|83177020|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939992|NCT02521870|83177021|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
46939993|NCT02521870|83177010|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46939994|NCT02521870|83177011|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46939995|NCT02521870|83177012|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46939996|NCT02521870|83177013|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46939997|NCT02521870|83177014|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
46939998|NCT02521870|83177015|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46939999|NCT02521870|83177016|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46940000|NCT02521870|83177017|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46940001|NCT02521870|83177018|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46940002|NCT02521870|83177019|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46833136|NCT00098722|83051150|FG004|Double Blind Phase|Randomized, not treated|0|||
46940003|NCT02521870|83177020|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46940004|NCT02521870|83177021|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
46940005|NCT02923349|83177058|FG000|Overall Study|Other|1|||
46940006|NCT02923349|83177059|FG001|Overall Study|Other|2|||
46940007|NCT02923349|83177060|FG002|Overall Study|Other|4|||
47061497|NCT05052697|83342243|FG025|Substudy A|No longer met eligibility criteria|0|||
47061498|NCT05052697|83342244|FG026|Substudy A|No longer met eligibility criteria|0|||
47061499|NCT05052697|83342245|FG027|Substudy A|No longer met eligibility criteria|0|||
47061500|NCT05052697|83342246|FG028|Substudy A|No longer met eligibility criteria|0|||
46940008|NCT02923349|83177061|FG003|Overall Study|Other|1|||
46940009|NCT02923349|83177062|FG004|Overall Study|Other|3|||
46940010|NCT02923349|83177063|FG005|Overall Study|Other|0|||
46940011|NCT02923349|83177064|FG006|Overall Study|Other|1|||
46940012|NCT02923349|83177058|FG000|Overall Study|Withdrawal by Subject|2|||
46940013|NCT02923349|83177059|FG001|Overall Study|Withdrawal by Subject|2|||
46940014|NCT02923349|83177060|FG002|Overall Study|Withdrawal by Subject|8|||
46940015|NCT02923349|83177061|FG003|Overall Study|Withdrawal by Subject|10|||
46940016|NCT02923349|83177062|FG004|Overall Study|Withdrawal by Subject|12|||
46940017|NCT02923349|83177063|FG005|Overall Study|Withdrawal by Subject|3|||
46940018|NCT02923349|83177064|FG006|Overall Study|Withdrawal by Subject|0|||
46940019|NCT02923349|83177058|FG000|Overall Study|Physician Decision|0|||
46940020|NCT02923349|83177059|FG001|Overall Study|Physician Decision|0|||
46940021|NCT02923349|83177060|FG002|Overall Study|Physician Decision|0|||
47061501|NCT05052697|83342247|FG029|Substudy A|No longer met eligibility criteria|0|||
47061502|NCT05052697|83342248|FG030|Substudy A|No longer met eligibility criteria|0|||
47061503|NCT05052697|83342249|FG031|Substudy A|No longer met eligibility criteria|0|||
47061504|NCT05052697|83342250|FG032|Substudy A|No longer met eligibility criteria|0|||
47061505|NCT05052697|83342251|FG033|Substudy A|No longer met eligibility criteria|0|||
46637750|NCT01474512|82811387|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
46637751|NCT01474512|82811388|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
46637752|NCT01474512|82811389|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
46637753|NCT01474512|82811390|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
46637754|NCT01474512|82811391|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
46637755|NCT01474512|82811392|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
46637756|NCT01474512|82811393|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
46637757|NCT01474512|82811376|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
46637758|NCT01474512|82811377|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
46637759|NCT01474512|82811378|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
46637760|NCT01474512|82811379|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
46637761|NCT01474512|82811380|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
46637762|NCT01474512|82811381|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
46637763|NCT01474512|82811382|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
46637764|NCT01474512|82811383|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
46637765|NCT01474512|82811384|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
46637766|NCT01474512|82811385|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
46637767|NCT01474512|82811386|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
46637768|NCT01474512|82811387|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
46637769|NCT01474512|82811388|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
46637770|NCT01474512|82811389|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
46637771|NCT01474512|82811390|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
46637772|NCT01474512|82811391|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
46637773|NCT01474512|82811392|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
46637774|NCT01474512|82811393|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
46637775|NCT01474512|82811376|FG000|Long-Term Extension Period|Physician Decision|0|||
46637776|NCT01474512|82811377|FG001|Long-Term Extension Period|Physician Decision|0|||
46765970|NCT00814346|82984386|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
46940022|NCT02923349|83177061|FG003|Overall Study|Physician Decision|1|||
46637777|NCT01474512|82811378|FG002|Long-Term Extension Period|Physician Decision|0|||
46765971|NCT00814346|82984387|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
46765972|NCT00814346|82984386|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
46765973|NCT00814346|82984387|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
46765974|NCT00569374|82984406|FG000|Overall Study|Withdrawal by Subject|4|||
46765975|NCT00828464|82984410|FG000|Overall Study|Withdrawal by Subject|1|||
46765976|NCT00810602|82984414|FG000|Overall Study|Withdrawal by Subject|8|||
46765977|NCT00810602|82984415|FG001|Overall Study|Withdrawal by Subject|3|||
46765978|NCT00791700|82984423|FG000|Overall Study|Insufficient clinical response|1|||
46765979|NCT00791700|82984424|FG001|Overall Study|Insufficient clinical response|4|||
46765980|NCT00791700|82984425|FG002|Overall Study|Insufficient clinical response|1|||
46765981|NCT00791700|82984426|FG003|Overall Study|Insufficient clinical response|8|||
46765982|NCT00791700|82984423|FG000|Overall Study|No longer willing to participate|1|||
46765983|NCT00791700|82984424|FG001|Overall Study|No longer willing to participate|1|||
46940023|NCT02923349|83177062|FG004|Overall Study|Physician Decision|1|||
46940024|NCT02923349|83177063|FG005|Overall Study|Physician Decision|0|||
46637778|NCT01474512|82811379|FG003|Long-Term Extension Period|Physician Decision|0|||
46637779|NCT01474512|82811380|FG004|Long-Term Extension Period|Physician Decision|0|||
46637780|NCT01474512|82811381|FG005|Long-Term Extension Period|Physician Decision|0|||
46940025|NCT02923349|83177064|FG006|Overall Study|Physician Decision|2|||
46940026|NCT02923349|83177058|FG000|Overall Study|Lost to Follow-up|0|||
46940027|NCT02923349|83177059|FG001|Overall Study|Lost to Follow-up|0|||
46940028|NCT02923349|83177060|FG002|Overall Study|Lost to Follow-up|3|||
46940029|NCT02923349|83177061|FG003|Overall Study|Lost to Follow-up|0|||
46637781|NCT01474512|82811382|FG006|Long-Term Extension Period|Physician Decision|0|||
46637782|NCT01474512|82811383|FG007|Long-Term Extension Period|Physician Decision|0|||
46637783|NCT01474512|82811384|FG008|Long-Term Extension Period|Physician Decision|0|||
46637784|NCT01474512|82811385|FG009|Long-Term Extension Period|Physician Decision|0|||
46637785|NCT01474512|82811386|FG010|Long-Term Extension Period|Physician Decision|0|||
46637786|NCT01474512|82811387|FG011|Long-Term Extension Period|Physician Decision|0|||
46637787|NCT01474512|82811388|FG012|Long-Term Extension Period|Physician Decision|21|||
46637788|NCT01474512|82811389|FG013|Long-Term Extension Period|Physician Decision|21|||
46637789|NCT01474512|82811390|FG014|Long-Term Extension Period|Physician Decision|0|||
46637790|NCT01474512|82811391|FG015|Long-Term Extension Period|Physician Decision|0|||
46637791|NCT01474512|82811392|FG016|Long-Term Extension Period|Physician Decision|0|||
46637792|NCT01474512|82811393|FG017|Long-Term Extension Period|Physician Decision|0|||
46940030|NCT02923349|83177062|FG004|Overall Study|Lost to Follow-up|1|||
46940031|NCT02923349|83177063|FG005|Overall Study|Lost to Follow-up|1|||
46940032|NCT02923349|83177064|FG006|Overall Study|Lost to Follow-up|0|||
46940033|NCT02923349|83177058|FG000|Overall Study|Death|1|||
46940034|NCT02923349|83177059|FG001|Overall Study|Death|0|||
46940035|NCT02923349|83177060|FG002|Overall Study|Death|2|||
46940036|NCT02923349|83177061|FG003|Overall Study|Death|4|||
46940037|NCT02923349|83177062|FG004|Overall Study|Death|2|||
46940038|NCT02923349|83177063|FG005|Overall Study|Death|3|||
46940039|NCT02923349|83177064|FG006|Overall Study|Death|0|||
46940040|NCT02521792|83177080|FG000|Overall Study|Study Terminated|6|||
46637793|NCT01474512|82811376|FG000|Long-Term Extension Period|Clinical Relapse|0|||
46637794|NCT01474512|82811377|FG001|Long-Term Extension Period|Clinical Relapse|0|||
46940041|NCT03020615|83177087|FG000|Overall Study|Physician Decision|3|||
46940042|NCT03020615|83177088|FG001|Overall Study|Physician Decision|1|||
46940043|NCT03020615|83177089|FG002|Overall Study|Physician Decision|2|||
46940044|NCT03020615|83177087|FG000|Overall Study|Parent/guardian/patient choice|3|||
46940045|NCT03020615|83177088|FG001|Overall Study|Parent/guardian/patient choice|0|||
46940046|NCT03020615|83177089|FG002|Overall Study|Parent/guardian/patient choice|4|||
46940047|NCT03020615|83177087|FG000|Overall Study|Screen failure|0|||
46940048|NCT03020615|83177088|FG001|Overall Study|Screen failure|0|||
46940049|NCT03020615|83177089|FG002|Overall Study|Screen failure|1|||
46940050|NCT03020615|83177087|FG000|Overall Study|Death|1|||
46940051|NCT03020615|83177088|FG001|Overall Study|Death|0|||
46940052|NCT03020615|83177089|FG002|Overall Study|Death|0|||
46940053|NCT03020615|83177087|FG000|Overall Study|Lost to Follow-up|0|||
46940054|NCT03020615|83177088|FG001|Overall Study|Lost to Follow-up|1|||
46940055|NCT03020615|83177089|FG002|Overall Study|Lost to Follow-up|0|||
46940056|NCT03020069|83177102|FG000|Overall Study|Lost to Follow-up|0|||
46940057|NCT03020069|83177103|FG001|Overall Study|Lost to Follow-up|1|||
46637795|NCT01474512|82811378|FG002|Long-Term Extension Period|Clinical Relapse|0|||
46637796|NCT01474512|82811379|FG003|Long-Term Extension Period|Clinical Relapse|0|||
46765984|NCT00791700|82984425|FG002|Overall Study|No longer willing to participate|0|||
46765985|NCT00791700|82984426|FG003|Overall Study|No longer willing to participate|8|||
46765986|NCT00791700|82984423|FG000|Overall Study|Non-compliance with study treatment|0|||
46765987|NCT00791700|82984424|FG001|Overall Study|Non-compliance with study treatment|2|||
46765988|NCT00791700|82984425|FG002|Overall Study|Non-compliance with study treatment|0|||
46765989|NCT00791700|82984426|FG003|Overall Study|Non-compliance with study treatment|4|||
46765990|NCT00791700|82984423|FG000|Overall Study|Withdrawn due to pregnancy|0|||
46765991|NCT00791700|82984424|FG001|Overall Study|Withdrawn due to pregnancy|0|||
46765992|NCT00791700|82984425|FG002|Overall Study|Withdrawn due to pregnancy|0|||
46765993|NCT00791700|82984426|FG003|Overall Study|Withdrawn due to pregnancy|1|||
46765994|NCT00791700|82984423|FG000|Overall Study|Other|0|||
46765995|NCT00791700|82984424|FG001|Overall Study|Other|1|||
46765996|NCT00791700|82984425|FG002|Overall Study|Other|0|||
46765997|NCT00791700|82984426|FG003|Overall Study|Other|1|||
46765998|NCT00791700|82984423|FG000|Overall Study|Death|0|||
46765999|NCT00791700|82984424|FG001|Overall Study|Death|0|||
46766000|NCT00791700|82984425|FG002|Overall Study|Death|0|||
46940058|NCT03021005|83177111|FG000|Overall Study|Lost to Follow-up|39|||
46940059|NCT03021005|83177112|FG001|Overall Study|Lost to Follow-up|26|||
46940060|NCT02914457|83177118|FG000|Overall Study|Withdrawal by Subject|1|||
46940061|NCT02914457|83177118|FG000|Overall Study|Physician Decision|1|||
46637797|NCT01474512|82811380|FG004|Long-Term Extension Period|Clinical Relapse|0|||
46637798|NCT01474512|82811381|FG005|Long-Term Extension Period|Clinical Relapse|0|||
46940062|NCT02914457|83177118|FG000|Overall Study|No veins available for lead placement|1|||
46940063|NCT02914457|83177118|FG000|Overall Study|Electrical instability of patient|1|||
46940064|NCT02914457|83177118|FG000|Overall Study|ECG acquisition error due to sweating|1|||
46940065|NCT02914457|83177118|FG000|Overall Study|Protocol Violation|1|||
46940066|NCT02665052|83177126|FG000|Overall Study|Lost to Follow-up|1|||
46940067|NCT02665052|83177127|FG001|Overall Study|Lost to Follow-up|0|||
46940068|NCT02665052|83177128|FG002|Overall Study|Lost to Follow-up|0|||
46940069|NCT02665052|83177129|FG003|Overall Study|Lost to Follow-up|0|||
46940070|NCT02665052|83177126|FG000|Overall Study|Withdrawal by Subject|1|||
46940071|NCT02665052|83177127|FG001|Overall Study|Withdrawal by Subject|1|||
46940072|NCT02665052|83177128|FG002|Overall Study|Withdrawal by Subject|0|||
46940073|NCT02665052|83177129|FG003|Overall Study|Withdrawal by Subject|5|||
46940074|NCT02665052|83177126|FG000|Overall Study|Adverse Event|1|||
46940075|NCT02665052|83177127|FG001|Overall Study|Adverse Event|1|||
46940076|NCT02665052|83177128|FG002|Overall Study|Adverse Event|0|||
46940077|NCT02665052|83177129|FG003|Overall Study|Adverse Event|0|||
46940078|NCT03019289|83177149|FG000|Overall Study|Adverse Event|1|||
46940079|NCT03019289|83177150|FG001|Overall Study|Adverse Event|0|||
46940080|NCT03019289|83177151|FG002|Overall Study|Adverse Event|0|||
46940081|NCT03019289|83177152|FG003|Overall Study|Adverse Event|0|||
46940082|NCT03019289|83177153|FG004|Overall Study|Adverse Event|0|||
46940083|NCT03019289|83177154|FG005|Overall Study|Adverse Event|0|||
46940084|NCT03019289|83177155|FG006|Overall Study|Adverse Event|0|||
46940085|NCT03019289|83177156|FG007|Overall Study|Adverse Event|0|||
46940086|NCT03019289|83177157|FG008|Overall Study|Adverse Event|1|||
46940087|NCT03019289|83177149|FG000|Overall Study|Other|1|||
46940088|NCT03019289|83177150|FG001|Overall Study|Other|0|||
46940089|NCT03019289|83177151|FG002|Overall Study|Other|0|||
46940090|NCT03019289|83177152|FG003|Overall Study|Other|0|||
46940091|NCT03019289|83177153|FG004|Overall Study|Other|0|||
46940092|NCT03019289|83177154|FG005|Overall Study|Other|0|||
46940093|NCT03019289|83177155|FG006|Overall Study|Other|0|||
46940094|NCT03019289|83177156|FG007|Overall Study|Other|0|||
46940095|NCT03019289|83177157|FG008|Overall Study|Other|0|||
46940096|NCT02520388|83177180|FG000|Overall Study|Physician Decision|1|||
46940097|NCT02520388|83177181|FG001|Overall Study|Physician Decision|0|||
46940098|NCT02520388|83177180|FG000|Overall Study|Subject or parent/guardian request|0|||
46940099|NCT02520388|83177181|FG001|Overall Study|Subject or parent/guardian request|6|||
46940100|NCT02520388|83177180|FG000|Overall Study|Adverse Event|1|||
46940101|NCT02520388|83177181|FG001|Overall Study|Adverse Event|4|||
46940102|NCT02520388|83177180|FG000|Overall Study|Lost to Follow-up|3|||
46940103|NCT02520388|83177181|FG001|Overall Study|Lost to Follow-up|2|||
46940104|NCT02520388|83177180|FG000|Overall Study|Other (reason not defined)|4|||
47061506|NCT05052697|83342218|FG000|Substudy A|Not vaccinated|0|||
46833137|NCT00098722|83051151|FG005|Double Blind Phase|Randomized, not treated|0|||
46833138|NCT00098722|83051152|FG006|Double Blind Phase|Randomized, not treated|0|||
46833139|NCT00098722|83051146|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
46833140|NCT00098722|83051147|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
46940105|NCT02520388|83177181|FG001|Overall Study|Other (reason not defined)|4|||
46940106|NCT02668640|83177187|FG000|Overall Study|Lost to Follow-up|13|||
46940107|NCT02668640|83177187|FG000|Overall Study|Other, not specified|1|||
46940108|NCT03014453|83177191|FG000|Overall Study|Lost to Follow-up|12|||
46940109|NCT03014453|83177191|FG000|Overall Study|Discontinued GER|3|||
46940110|NCT03014453|83177191|FG000|Overall Study|Excluded|19|||
46940111|NCT03014453|83177191|FG000|Overall Study|Refused to take part in|37|||
46940112|NCT02664272|83177195|FG000|Overall Study|Fluoroscopic images not made available|2|||
46940113|NCT02663882|83177201|FG000|Overall Study|Lost to Follow-up|4|||
46940114|NCT02663882|83177202|FG001|Overall Study|Lost to Follow-up|2|||
46940115|NCT03011333|83177215|FG000|Overall Study|Lost to Follow-up|0|||
47061507|NCT05052697|83342219|FG001|Substudy A|Not vaccinated|0|||
46833141|NCT00098722|83051148|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
46833142|NCT00098722|83051149|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
46833143|NCT00098722|83051150|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
46833144|NCT00098722|83051151|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
46833145|NCT00098722|83051152|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
47061508|NCT05052697|83342220|FG002|Substudy A|Not vaccinated|0|||
46833146|NCT00098722|83051146|FG000|Double Blind Phase|Other|7|||
46833147|NCT00098722|83051147|FG001|Double Blind Phase|Other|8|||
46940116|NCT03011333|83177216|FG001|Overall Study|Lost to Follow-up|1|||
46940117|NCT03011333|83177217|FG002|Overall Study|Lost to Follow-up|0|||
46940118|NCT03011333|83177218|FG003|Overall Study|Lost to Follow-up|1|||
46940119|NCT03011333|83177219|FG004|Overall Study|Lost to Follow-up|4|||
46940120|NCT03011333|83177220|FG005|Overall Study|Lost to Follow-up|4|||
46940121|NCT03011333|83177221|FG006|Overall Study|Lost to Follow-up|5|||
46940122|NCT03011099|83177239|FG000|Overall Study|Withdrawal by Subject|0|||
46940123|NCT03011099|83177240|FG001|Overall Study|Withdrawal by Subject|2|||
46940124|NCT03013985|83177250|FG000|Overall Study|Protocol Violation|2|||
46940125|NCT03013985|83177251|FG001|Overall Study|Protocol Violation|2|||
46940126|NCT03013985|83177250|FG000|Overall Study|Withdrawal by Subject|14|||
46940127|NCT03013985|83177251|FG001|Overall Study|Withdrawal by Subject|17|||
46940128|NCT03016403|83177261|FG000|Baseline|Death|5|||
46940129|NCT03016403|83177262|FG001|Baseline|Death|8|||
47061509|NCT05052697|83342221|FG003|Substudy A|Not vaccinated|1|||
47061510|NCT05052697|83342222|FG004|Substudy A|Not vaccinated|0|||
46940130|NCT03016403|83177263|FG002|Baseline|Death|1|||
46940131|NCT03016403|83177264|FG003|Baseline|Death|0|||
46940132|NCT03016403|83177261|FG000|Baseline|Withdrawal by Subject|2|||
46940133|NCT03016403|83177262|FG001|Baseline|Withdrawal by Subject|8|||
46940134|NCT03016403|83177263|FG002|Baseline|Withdrawal by Subject|4|||
46940135|NCT03016403|83177264|FG003|Baseline|Withdrawal by Subject|10|||
46940136|NCT03016403|83177261|FG000|Baseline|Lost to Follow-up|9|||
46940137|NCT03016403|83177262|FG001|Baseline|Lost to Follow-up|11|||
46940138|NCT03016403|83177263|FG002|Baseline|Lost to Follow-up|6|||
46940139|NCT03016403|83177264|FG003|Baseline|Lost to Follow-up|24|||
46940140|NCT03016403|83177261|FG000|6-week Follow-up|Death|1|||
46940141|NCT03016403|83177262|FG001|6-week Follow-up|Death|4|||
46940142|NCT03016403|83177263|FG002|6-week Follow-up|Death|0|||
46940143|NCT03016403|83177264|FG003|6-week Follow-up|Death|0|||
46940144|NCT03016403|83177261|FG000|6-week Follow-up|Lost to Follow-up|2|||
46940145|NCT03016403|83177262|FG001|6-week Follow-up|Lost to Follow-up|7|||
46940146|NCT03016403|83177263|FG002|6-week Follow-up|Lost to Follow-up|4|||
46940147|NCT03016403|83177264|FG003|6-week Follow-up|Lost to Follow-up|8|||
46940148|NCT03016403|83177261|FG000|6-week Follow-up|Withdrawal by Subject|0|||
46940149|NCT03016403|83177262|FG001|6-week Follow-up|Withdrawal by Subject|2|||
46940150|NCT03016403|83177263|FG002|6-week Follow-up|Withdrawal by Subject|0|||
46940151|NCT03016403|83177264|FG003|6-week Follow-up|Withdrawal by Subject|1|||
46940152|NCT03016403|83177261|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
46940153|NCT03016403|83177262|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
46940154|NCT03016403|83177263|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
46940155|NCT03016403|83177264|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
46940156|NCT03016403|83177261|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
46940157|NCT03016403|83177262|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
46940158|NCT03016403|83177263|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
46940159|NCT03016403|83177264|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
46940160|NCT03016403|83177261|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
46940161|NCT03016403|83177262|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
46940162|NCT03016403|83177263|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
46940163|NCT03016403|83177264|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
46940164|NCT02520310|83177276|FG000|At 6 Months Clinical Follow-up|Death|1|||
46940165|NCT02520310|83177276|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
46940166|NCT02520310|83177276|FG000|AT 3 Year Clinical Follow-up|Death|2|||
46940167|NCT02520310|83177276|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
46940168|NCT02520310|83177276|FG000|AT 4 Year Clinical Follow-up|Death|1|||
46940169|NCT02520310|83177276|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
46940170|NCT02662556|83177282|FG000|Overall Study|Adverse Event|4|||
46940171|NCT02662556|83177282|FG000|Overall Study|Lack of Efficacy|4|||
46940172|NCT02516098|83177289|FG000|Period 1|Protocol Violation|1|||
46940173|NCT02516098|83177290|FG001|Period 1|Protocol Violation|0|||
46940174|NCT02516098|83177289|FG000|Washout After Period 1|Adverse Event|0|||
46940175|NCT02516098|83177290|FG001|Washout After Period 1|Adverse Event|1|||
46940176|NCT02516098|83177289|FG000|Period 2|Withdrawal by Subject|0|||
46940177|NCT02516098|83177290|FG001|Period 2|Withdrawal by Subject|1|||
46940178|NCT01364428|83177298|FG000|Overall Study|Adverse Event|1|||
46940179|NCT01364428|83177299|FG001|Overall Study|Adverse Event|2|||
46940180|NCT01364428|83177298|FG000|Overall Study|Protocol Violation|2|||
46940181|NCT01364428|83177299|FG001|Overall Study|Protocol Violation|0|||
46940182|NCT01364428|83177298|FG000|Overall Study|Withdrawal Criteria|14|||
46940183|NCT01364428|83177299|FG001|Overall Study|Withdrawal Criteria|10|||
46940184|NCT01364428|83177298|FG000|Overall Study|Other|3|||
46940185|NCT01364428|83177299|FG001|Overall Study|Other|3|||
46940186|NCT02515942|83177308|FG000|Overall Study|Adverse Event|5|||
46940187|NCT02515942|83177309|FG001|Overall Study|Adverse Event|0|||
46940188|NCT02515942|83177310|FG002|Overall Study|Adverse Event|0|||
46940189|NCT02515942|83177308|FG000|Overall Study|Death|0|||
46940190|NCT02515942|83177309|FG001|Overall Study|Death|0|||
46766001|NCT00791700|82984426|FG003|Overall Study|Death|1|||
46940191|NCT02515942|83177310|FG002|Overall Study|Death|1|||
46766002|NCT00791700|82984423|FG000|Overall Study|Lost to Follow-up|4|||
46766003|NCT00791700|82984424|FG001|Overall Study|Lost to Follow-up|3|||
46766004|NCT00791700|82984425|FG002|Overall Study|Lost to Follow-up|4|||
46766005|NCT00791700|82984426|FG003|Overall Study|Lost to Follow-up|6|||
46766006|NCT00791700|82984423|FG000|Overall Study|Adverse Event|0|||
46766007|NCT00791700|82984424|FG001|Overall Study|Adverse Event|0|||
46766008|NCT00791700|82984425|FG002|Overall Study|Adverse Event|1|||
46766009|NCT00791700|82984426|FG003|Overall Study|Adverse Event|1|||
46766010|NCT00810368|82984449|FG000|Overall Study|Lost to Follow-up|4|||
46766011|NCT00810368|82984450|FG001|Overall Study|Lost to Follow-up|2|||
46766012|NCT00810368|82984449|FG000|Overall Study|Lack of Efficacy|2|||
46766013|NCT00810368|82984450|FG001|Overall Study|Lack of Efficacy|0|||
46766014|NCT00628108|82984460|FG000|Overall Study|Adverse Event|0|||
46766015|NCT00628108|82984461|FG001|Overall Study|Adverse Event|3|||
46766016|NCT00628108|82984460|FG000|Overall Study|Withdrawal by Subject|1|||
46940192|NCT02515942|83177308|FG000|Overall Study|Lack of Efficacy|0|||
46940193|NCT02515942|83177309|FG001|Overall Study|Lack of Efficacy|0|||
46940194|NCT02515942|83177310|FG002|Overall Study|Lack of Efficacy|1|||
46940195|NCT02515942|83177308|FG000|Overall Study|Lost to Follow-up|2|||
46940196|NCT02515942|83177309|FG001|Overall Study|Lost to Follow-up|0|||
46940197|NCT02515942|83177310|FG002|Overall Study|Lost to Follow-up|0|||
46940198|NCT02515942|83177308|FG000|Overall Study|Withdrawal by Subject|0|||
46940199|NCT02515942|83177309|FG001|Overall Study|Withdrawal by Subject|3|||
46940200|NCT02515942|83177310|FG002|Overall Study|Withdrawal by Subject|2|||
46940201|NCT02991859|83177337|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940202|NCT02991859|83177338|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
46940203|NCT02991859|83177339|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940204|NCT02991859|83177340|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940205|NCT02991859|83177341|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
46940206|NCT02991859|83177342|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940207|NCT02991859|83177343|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940208|NCT02991859|83177344|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940209|NCT02991859|83177345|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940210|NCT02991859|83177346|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46833148|NCT00098722|83051148|FG002|Double Blind Phase|Other|7|||
46833149|NCT00098722|83051149|FG003|Double Blind Phase|Other|0|||
46833150|NCT00098722|83051150|FG004|Double Blind Phase|Other|0|||
46833151|NCT00098722|83051151|FG005|Double Blind Phase|Other|0|||
46833152|NCT00098722|83051152|FG006|Double Blind Phase|Other|0|||
46833153|NCT00098722|83051146|FG000|Open Label Phase|Adverse Event|0|||
46833154|NCT00098722|83051147|FG001|Open Label Phase|Adverse Event|0|||
46833155|NCT00098722|83051148|FG002|Open Label Phase|Adverse Event|0|||
46833156|NCT00098722|83051149|FG003|Open Label Phase|Adverse Event|5|||
46833157|NCT00098722|83051150|FG004|Open Label Phase|Adverse Event|0|||
46833158|NCT00098722|83051151|FG005|Open Label Phase|Adverse Event|0|||
46833159|NCT00098722|83051152|FG006|Open Label Phase|Adverse Event|0|||
46833160|NCT00098722|83051146|FG000|Open Label Phase|Death|0|||
46833161|NCT00098722|83051147|FG001|Open Label Phase|Death|0|||
46833162|NCT00098722|83051148|FG002|Open Label Phase|Death|0|||
46833163|NCT00098722|83051149|FG003|Open Label Phase|Death|2|||
46833164|NCT00098722|83051150|FG004|Open Label Phase|Death|0|||
46833165|NCT00098722|83051151|FG005|Open Label Phase|Death|0|||
46940211|NCT02991859|83177347|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940212|NCT02991859|83177348|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940213|NCT02991859|83177349|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940214|NCT02991859|83177350|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940215|NCT02991859|83177351|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940216|NCT02991859|83177352|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46940217|NCT02991859|83177353|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
46833166|NCT00098722|83051152|FG006|Open Label Phase|Death|0|||
46833167|NCT00098722|83051146|FG000|Open Label Phase|Lack of Efficacy|0|||
46833168|NCT00098722|83051147|FG001|Open Label Phase|Lack of Efficacy|0|||
46833169|NCT00098722|83051148|FG002|Open Label Phase|Lack of Efficacy|0|||
46833170|NCT00098722|83051149|FG003|Open Label Phase|Lack of Efficacy|8|||
46833171|NCT00098722|83051150|FG004|Open Label Phase|Lack of Efficacy|0|||
46833172|NCT00098722|83051151|FG005|Open Label Phase|Lack of Efficacy|0|||
46833173|NCT00098722|83051152|FG006|Open Label Phase|Lack of Efficacy|0|||
46833174|NCT00098722|83051146|FG000|Open Label Phase|Pregnancy|0|||
46833175|NCT00098722|83051147|FG001|Open Label Phase|Pregnancy|0|||
46833176|NCT00098722|83051148|FG002|Open Label Phase|Pregnancy|0|||
46833177|NCT00098722|83051149|FG003|Open Label Phase|Pregnancy|1|||
46833178|NCT00098722|83051150|FG004|Open Label Phase|Pregnancy|0|||
46833179|NCT00098722|83051151|FG005|Open Label Phase|Pregnancy|0|||
46833180|NCT00098722|83051152|FG006|Open Label Phase|Pregnancy|0|||
46833181|NCT00098722|83051146|FG000|Open Label Phase|Participant defaulted|0|||
46833182|NCT00098722|83051147|FG001|Open Label Phase|Participant defaulted|0|||
46833183|NCT00098722|83051148|FG002|Open Label Phase|Participant defaulted|0|||
46940218|NCT02991859|83177337|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940219|NCT02991859|83177338|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940220|NCT02991859|83177339|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
47061511|NCT05052697|83342223|FG005|Substudy A|Not vaccinated|0|||
46833184|NCT00098722|83051149|FG003|Open Label Phase|Participant defaulted|18|||
46833185|NCT00098722|83051150|FG004|Open Label Phase|Participant defaulted|0|||
46833186|NCT00098722|83051151|FG005|Open Label Phase|Participant defaulted|0|||
46833187|NCT00098722|83051152|FG006|Open Label Phase|Participant defaulted|0|||
46833188|NCT00098722|83051146|FG000|Open Label Phase|Ongoing at cut-off date|0|||
46833189|NCT00098722|83051147|FG001|Open Label Phase|Ongoing at cut-off date|0|||
46833190|NCT00098722|83051148|FG002|Open Label Phase|Ongoing at cut-off date|0|||
46833191|NCT00098722|83051149|FG003|Open Label Phase|Ongoing at cut-off date|220|||
46940221|NCT02991859|83177340|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46833192|NCT00098722|83051150|FG004|Open Label Phase|Ongoing at cut-off date|50|||
46833193|NCT00098722|83051151|FG005|Open Label Phase|Ongoing at cut-off date|0|||
46833194|NCT00098722|83051152|FG006|Open Label Phase|Ongoing at cut-off date|0|||
46833195|NCT00098722|83051146|FG000|Open Label Phase|Other|0|||
46833196|NCT00098722|83051147|FG001|Open Label Phase|Other|0|||
46833197|NCT00098722|83051148|FG002|Open Label Phase|Other|0|||
46833198|NCT00098722|83051149|FG003|Open Label Phase|Other|18|||
46940222|NCT02991859|83177341|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940223|NCT02991859|83177342|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940224|NCT02991859|83177343|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940225|NCT02991859|83177344|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940226|NCT02991859|83177345|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940227|NCT02991859|83177346|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940228|NCT02991859|83177347|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940229|NCT02991859|83177348|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940230|NCT02991859|83177349|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
46940231|NCT02991859|83177350|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
46940232|NCT02991859|83177351|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940233|NCT02991859|83177352|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940234|NCT02991859|83177353|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
46940235|NCT02991859|83177337|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940236|NCT02991859|83177338|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940237|NCT02991859|83177339|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940238|NCT02991859|83177340|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940239|NCT02991859|83177341|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940240|NCT02991859|83177342|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
46940241|NCT02991859|83177343|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940242|NCT02991859|83177344|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940243|NCT02991859|83177345|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940244|NCT02991859|83177346|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940245|NCT02991859|83177347|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940246|NCT02991859|83177348|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940247|NCT02991859|83177349|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940248|NCT02991859|83177350|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940249|NCT02991859|83177351|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46637799|NCT01474512|82811382|FG006|Long-Term Extension Period|Clinical Relapse|0|||
46766017|NCT00628108|82984461|FG001|Overall Study|Withdrawal by Subject|0|||
46766018|NCT00628030|82984469|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
46766019|NCT00628030|82984470|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
46833199|NCT00098722|83051150|FG004|Open Label Phase|Other|0|||
46833200|NCT00098722|83051151|FG005|Open Label Phase|Other|0|||
46833201|NCT00098722|83051152|FG006|Open Label Phase|Other|0|||
46833202|NCT00098722|83051146|FG000|Observation Phase|Death|0|||
46833203|NCT00098722|83051147|FG001|Observation Phase|Death|0|||
46833204|NCT00098722|83051148|FG002|Observation Phase|Death|0|||
46833205|NCT00098722|83051149|FG003|Observation Phase|Death|0|||
46833206|NCT00098722|83051150|FG004|Observation Phase|Death|0|||
46833207|NCT00098722|83051151|FG005|Observation Phase|Death|5|||
46833208|NCT00098722|83051152|FG006|Observation Phase|Death|3|||
46833209|NCT00098722|83051146|FG000|Observation Phase|Lack of Efficacy|0|||
46833210|NCT00098722|83051147|FG001|Observation Phase|Lack of Efficacy|0|||
46833211|NCT00098722|83051148|FG002|Observation Phase|Lack of Efficacy|0|||
46833212|NCT00098722|83051149|FG003|Observation Phase|Lack of Efficacy|0|||
46766020|NCT00628030|82984469|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
46766021|NCT00628030|82984470|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
46766022|NCT00628030|82984469|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
46766023|NCT00628030|82984470|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
46766024|NCT00591578|82984479|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
46766025|NCT00591578|82984480|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
46833213|NCT00098722|83051150|FG004|Observation Phase|Lack of Efficacy|0|||
46833214|NCT00098722|83051151|FG005|Observation Phase|Lack of Efficacy|2|||
46833215|NCT00098722|83051152|FG006|Observation Phase|Lack of Efficacy|0|||
46833216|NCT00098722|83051146|FG000|Observation Phase|Participant defaulted|0|||
46833217|NCT00098722|83051147|FG001|Observation Phase|Participant defaulted|0|||
46833218|NCT00098722|83051148|FG002|Observation Phase|Participant defaulted|0|||
46833219|NCT00098722|83051149|FG003|Observation Phase|Participant defaulted|0|||
46833220|NCT00098722|83051150|FG004|Observation Phase|Participant defaulted|0|||
46833221|NCT00098722|83051151|FG005|Observation Phase|Participant defaulted|17|||
46833222|NCT00098722|83051152|FG006|Observation Phase|Participant defaulted|4|||
46833223|NCT00098722|83051146|FG000|Observation Phase|Other|0|||
46833224|NCT00098722|83051147|FG001|Observation Phase|Other|0|||
46940250|NCT02991859|83177352|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940251|NCT02991859|83177353|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
46940252|NCT02991859|83177337|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940253|NCT02991859|83177338|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940254|NCT02991859|83177339|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940255|NCT02991859|83177340|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940256|NCT02991859|83177341|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940257|NCT02991859|83177342|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940258|NCT02991859|83177343|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940259|NCT02991859|83177344|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940260|NCT02991859|83177345|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940261|NCT02991859|83177346|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
46940262|NCT02991859|83177347|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940263|NCT02991859|83177348|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940264|NCT02991859|83177349|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940265|NCT02991859|83177350|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940266|NCT02991859|83177351|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940267|NCT02991859|83177352|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940268|NCT02991859|83177353|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
46940269|NCT02991859|83177337|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940270|NCT02991859|83177338|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940271|NCT02991859|83177339|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940272|NCT02991859|83177340|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940273|NCT02991859|83177341|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940274|NCT02991859|83177342|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940275|NCT02991859|83177343|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940276|NCT02991859|83177344|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940277|NCT02991859|83177345|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
46833225|NCT00098722|83051148|FG002|Observation Phase|Other|0|||
46833226|NCT00098722|83051149|FG003|Observation Phase|Other|0|||
46940278|NCT02991859|83177346|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940279|NCT02991859|83177347|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940280|NCT02991859|83177348|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940281|NCT02991859|83177349|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940282|NCT02991859|83177350|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940283|NCT02991859|83177351|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940284|NCT02991859|83177352|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940285|NCT02991859|83177353|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
46940286|NCT03016325|83177436|FG000|Treatment Period|Participant withdrew consent|0|||
46940287|NCT03016325|83177437|FG001|Treatment Period|Participant withdrew consent|1|||
46940288|NCT03016325|83177438|FG002|Treatment Period|Participant withdrew consent|0|||
46940289|NCT03016325|83177439|FG003|Treatment Period|Participant withdrew consent|0|||
46940290|NCT03016325|83177440|FG004|Treatment Period|Participant withdrew consent|0|||
46940291|NCT03016325|83177441|FG005|Treatment Period|Participant withdrew consent|0|||
46940292|NCT03016325|83177442|FG006|Treatment Period|Participant withdrew consent|0|||
46940293|NCT03016325|83177443|FG007|Treatment Period|Participant withdrew consent|0|||
46940294|NCT03016325|83177436|FG000|Treatment Period|Death|0|||
46940295|NCT03016325|83177437|FG001|Treatment Period|Death|0|||
46940296|NCT03016325|83177438|FG002|Treatment Period|Death|0|||
46940297|NCT03016325|83177439|FG003|Treatment Period|Death|0|||
46940298|NCT03016325|83177440|FG004|Treatment Period|Death|2|||
46940299|NCT03016325|83177441|FG005|Treatment Period|Death|0|||
46940300|NCT03016325|83177442|FG006|Treatment Period|Death|0|||
46940301|NCT03016325|83177443|FG007|Treatment Period|Death|0|||
46940302|NCT03016325|83177436|FG000|Treatment Period|Participant refuses assessments|0|||
46940303|NCT03016325|83177437|FG001|Treatment Period|Participant refuses assessments|0|||
46940304|NCT03016325|83177438|FG002|Treatment Period|Participant refuses assessments|1|||
46940305|NCT03016325|83177439|FG003|Treatment Period|Participant refuses assessments|0|||
46940306|NCT03016325|83177440|FG004|Treatment Period|Participant refuses assessments|0|||
46940307|NCT03016325|83177441|FG005|Treatment Period|Participant refuses assessments|0|||
46940308|NCT03016325|83177442|FG006|Treatment Period|Participant refuses assessments|0|||
46940309|NCT03016325|83177443|FG007|Treatment Period|Participant refuses assessments|0|||
46940310|NCT03016325|83177436|FG000|32-Day Follow-Up Period|Death|2|||
46940311|NCT03016325|83177437|FG001|32-Day Follow-Up Period|Death|0|||
46940312|NCT03016325|83177438|FG002|32-Day Follow-Up Period|Death|5|||
46637800|NCT01474512|82811383|FG007|Long-Term Extension Period|Clinical Relapse|0|||
46637801|NCT01474512|82811384|FG008|Long-Term Extension Period|Clinical Relapse|0|||
46940313|NCT03016325|83177439|FG003|32-Day Follow-Up Period|Death|6|||
46940314|NCT03016325|83177440|FG004|32-Day Follow-Up Period|Death|3|||
47061512|NCT05052697|83342224|FG006|Substudy A|Not vaccinated|0|||
47061513|NCT05052697|83342225|FG007|Substudy A|Not vaccinated|0|||
46940315|NCT03016325|83177441|FG005|32-Day Follow-Up Period|Death|0|||
46940316|NCT03016325|83177442|FG006|32-Day Follow-Up Period|Death|0|||
46940317|NCT03016325|83177443|FG007|32-Day Follow-Up Period|Death|0|||
47061514|NCT05052697|83342226|FG008|Substudy A|Not vaccinated|1|||
46940318|NCT03016325|83177436|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
46940319|NCT03016325|83177437|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
46940320|NCT03016325|83177438|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
46940321|NCT03016325|83177439|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
46940322|NCT03016325|83177440|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
46940323|NCT03016325|83177441|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
46940324|NCT03016325|83177442|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
46940325|NCT03016325|83177443|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
46940326|NCT03016325|83177436|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
46940327|NCT03016325|83177437|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
46940328|NCT03016325|83177438|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
46940329|NCT03016325|83177439|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
46940330|NCT03016325|83177440|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
46940331|NCT03016325|83177441|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
46940332|NCT03016325|83177442|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
46940333|NCT03016325|83177443|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
46940334|NCT03016325|83177436|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
46940335|NCT03016325|83177437|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
46940336|NCT03016325|83177438|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
46940337|NCT03016325|83177439|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
46940338|NCT03016325|83177440|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
46940339|NCT03016325|83177441|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
46940340|NCT03016325|83177442|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
46940341|NCT03016325|83177443|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
46940342|NCT03016325|83177436|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
46940343|NCT03016325|83177437|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
46940344|NCT03016325|83177438|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
46940345|NCT03016325|83177439|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
46940346|NCT03016325|83177440|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
46940347|NCT03016325|83177441|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
46940348|NCT03016325|83177442|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
46940349|NCT03016325|83177443|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
46940350|NCT03016325|83177436|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
46940351|NCT03016325|83177437|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
46940352|NCT03016325|83177438|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
46940353|NCT03016325|83177439|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
46940354|NCT03016325|83177440|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
46940355|NCT03016325|83177441|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
46940356|NCT03016325|83177442|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
46940357|NCT03016325|83177443|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
46940358|NCT03016325|83177436|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
46940359|NCT03016325|83177437|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
46940360|NCT03016325|83177438|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
46940361|NCT03016325|83177439|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
46940362|NCT03016325|83177440|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
46940363|NCT03016325|83177441|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
46940364|NCT03016325|83177442|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
46940365|NCT03016325|83177443|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
46940366|NCT03016325|83177436|FG000|182-Day Follow-Up Period|Death|3|||
46940367|NCT03016325|83177437|FG001|182-Day Follow-Up Period|Death|3|||
46940368|NCT03016325|83177438|FG002|182-Day Follow-Up Period|Death|11|||
46940369|NCT03016325|83177439|FG003|182-Day Follow-Up Period|Death|12|||
46940370|NCT03016325|83177440|FG004|182-Day Follow-Up Period|Death|9|||
46940371|NCT03016325|83177441|FG005|182-Day Follow-Up Period|Death|0|||
46940372|NCT03016325|83177442|FG006|182-Day Follow-Up Period|Death|0|||
46940373|NCT03016325|83177443|FG007|182-Day Follow-Up Period|Death|1|||
46940374|NCT03016325|83177436|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
46940375|NCT03016325|83177437|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
46940376|NCT03016325|83177438|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
46940377|NCT03016325|83177439|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
46940378|NCT03016325|83177440|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
46766026|NCT00591578|82984481|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
46766027|NCT00591578|82984479|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
46766028|NCT00591578|82984480|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
46766029|NCT00591578|82984481|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
47061515|NCT05052697|83342227|FG009|Substudy A|Not vaccinated|0|||
47061516|NCT05052697|83342228|FG010|Substudy A|Not vaccinated|0|||
47061517|NCT05052697|83342229|FG011|Substudy A|Not vaccinated|0|||
46940379|NCT03016325|83177441|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
46940380|NCT03016325|83177442|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
46940381|NCT03016325|83177443|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
46940382|NCT03016325|83177436|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
46940383|NCT03016325|83177437|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
46940384|NCT03016325|83177438|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
46940385|NCT03016325|83177439|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
46940386|NCT03016325|83177440|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
46940387|NCT03016325|83177441|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
46940388|NCT03016325|83177442|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
46940389|NCT03016325|83177443|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
46940390|NCT03016325|83177436|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
46940391|NCT03016325|83177437|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
46940392|NCT03016325|83177438|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
46940393|NCT03016325|83177439|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
46940394|NCT03016325|83177440|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
46940395|NCT03016325|83177441|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
46940396|NCT03016325|83177442|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
46940397|NCT03016325|83177443|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
46940398|NCT03016325|83177436|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
46940399|NCT03016325|83177437|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
47061518|NCT05052697|83342230|FG012|Substudy A|Not vaccinated|0|||
46766030|NCT00591578|82984479|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
46766031|NCT00591578|82984480|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
46766032|NCT00591578|82984481|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
46766033|NCT00591578|82984479|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
46766034|NCT00591578|82984480|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
46766035|NCT00591578|82984481|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
46766036|NCT00591578|82984479|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
46766037|NCT00591578|82984480|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
46766038|NCT00591578|82984481|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
46766039|NCT00591578|82984479|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
46833227|NCT00098722|83051150|FG004|Observation Phase|Other|0|||
46833228|NCT00098722|83051151|FG005|Observation Phase|Other|21|||
46833229|NCT00098722|83051152|FG006|Observation Phase|Other|10|||
46833230|NCT00098254|83051164|FG000|Overall Study|Adverse Event|2|||
46833231|NCT00098254|83051164|FG000|Overall Study|Death|1|||
46833232|NCT00095056|83051170|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
46833233|NCT00095056|83051171|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
46833234|NCT00095056|83051170|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
46833235|NCT00095056|83051171|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
46833236|NCT00095056|83051170|FG000|Phase A (Weeks 0-12)|Death|1|||
46833237|NCT00095056|83051171|FG001|Phase A (Weeks 0-12)|Death|0|||
46833238|NCT00095056|83051170|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
46833239|NCT00095056|83051171|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
46833240|NCT00095056|83051170|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
46833241|NCT00095056|83051171|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
47061519|NCT05052697|83342231|FG013|Substudy A|Not vaccinated|0|||
47061520|NCT05052697|83342232|FG014|Substudy A|Not vaccinated|0|||
47061521|NCT05052697|83342233|FG015|Substudy A|Not vaccinated|0|||
47061522|NCT05052697|83342234|FG016|Substudy A|Not vaccinated|0|||
47061523|NCT05052697|83342235|FG017|Substudy A|Not vaccinated|0|||
47061524|NCT05052697|83342236|FG018|Substudy A|Not vaccinated|0|||
47061525|NCT05052697|83342237|FG019|Substudy A|Not vaccinated|0|||
47061526|NCT05052697|83342238|FG020|Substudy A|Not vaccinated|0|||
47061527|NCT05052697|83342239|FG021|Substudy A|Not vaccinated|0|||
46766040|NCT00591578|82984480|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
46766041|NCT00591578|82984481|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
46766042|NCT00591578|82984479|FG000|Double-Blind Treatment Phase|Other|4|||
46766043|NCT00591578|82984480|FG001|Double-Blind Treatment Phase|Other|9|||
46766044|NCT00591578|82984481|FG002|Double-Blind Treatment Phase|Other|4|||
46833242|NCT00095056|83051170|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
46940400|NCT03016325|83177438|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
47061528|NCT05052697|83342240|FG022|Substudy A|Not vaccinated|0|||
47061529|NCT05052697|83342241|FG023|Substudy A|Not vaccinated|0|||
47061530|NCT05052697|83342242|FG024|Substudy A|Not vaccinated|0|||
47061531|NCT05052697|83342243|FG025|Substudy A|Not vaccinated|0|||
47061532|NCT05052697|83342244|FG026|Substudy A|Not vaccinated|0|||
46940401|NCT03016325|83177439|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
46940402|NCT03016325|83177440|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
46940403|NCT03016325|83177441|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
46940404|NCT03016325|83177442|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
46940405|NCT03016325|83177443|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
46940406|NCT03016325|83177436|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
46940407|NCT03016325|83177437|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
46833243|NCT00095056|83051171|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
46940408|NCT03016325|83177438|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
46940409|NCT03016325|83177439|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
46940410|NCT03016325|83177440|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
46940411|NCT03016325|83177441|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
46940412|NCT03016325|83177442|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
46940413|NCT03016325|83177443|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
46940414|NCT03016325|83177436|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
46940415|NCT03016325|83177437|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
46940416|NCT03016325|83177438|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
46940417|NCT03016325|83177439|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
46940418|NCT03016325|83177440|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
47061533|NCT05052697|83342245|FG027|Substudy A|Not vaccinated|0|||
47061534|NCT05052697|83342246|FG028|Substudy A|Not vaccinated|0|||
47061535|NCT05052697|83342247|FG029|Substudy A|Not vaccinated|0|||
47061536|NCT05052697|83342248|FG030|Substudy A|Not vaccinated|0|||
46833244|NCT00095056|83051170|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
46833245|NCT00095056|83051171|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
46833246|NCT00095056|83051170|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
46833247|NCT00095056|83051171|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
46833248|NCT00095056|83051170|FG000|Phase B (Weeks 12-54)|Death|3|||
46833249|NCT00095056|83051171|FG001|Phase B (Weeks 12-54)|Death|1|||
46833250|NCT00095056|83051170|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
46833251|NCT00095056|83051171|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
46833252|NCT00095056|83051170|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
46833253|NCT00095056|83051171|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
46833254|NCT00098020|83051177|FG000|Overall Study|Adverse Event|2|||
46833255|NCT00098020|83051177|FG000|Overall Study|Lost to Follow-up|1|||
46940419|NCT03016325|83177441|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
47061537|NCT05052697|83342249|FG031|Substudy A|Not vaccinated|0|||
47061538|NCT05052697|83342250|FG032|Substudy A|Not vaccinated|0|||
47061539|NCT05052697|83342251|FG033|Substudy A|Not vaccinated|0|||
47061540|NCT05052697|83342218|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061541|NCT05052697|83342219|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061542|NCT05052697|83342220|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061543|NCT05052697|83342221|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061544|NCT05052697|83342222|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061545|NCT05052697|83342223|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061546|NCT05052697|83342224|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061547|NCT05052697|83342225|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061548|NCT05052697|83342226|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061549|NCT05052697|83342227|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061550|NCT05052697|83342228|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061551|NCT05052697|83342229|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061552|NCT05052697|83342230|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
46766045|NCT00591578|82984479|FG000|Open-Label Extension Phase|Adverse Event|3|||
46766046|NCT00591578|82984480|FG001|Open-Label Extension Phase|Adverse Event|5|||
46766047|NCT00591578|82984481|FG002|Open-Label Extension Phase|Adverse Event|0|||
46766048|NCT00591578|82984479|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
46766049|NCT00591578|82984480|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
46766050|NCT00591578|82984481|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
46766051|NCT00591578|82984479|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
46766052|NCT00591578|82984480|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
46766053|NCT00591578|82984481|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
46766054|NCT00591578|82984479|FG000|Open-Label Extension Phase|Other|1|||
46766055|NCT00591578|82984480|FG001|Open-Label Extension Phase|Other|0|||
46766056|NCT00591578|82984481|FG002|Open-Label Extension Phase|Other|0|||
46766057|NCT00797862|82984493|FG000|Overall Study|Adverse Event|86|||
46766058|NCT00797862|82984494|FG001|Overall Study|Adverse Event|44|||
46766059|NCT00797862|82984495|FG002|Overall Study|Adverse Event|58|||
46833256|NCT00098020|83051177|FG000|Overall Study|elevated liver enzymes|1|||
46833257|NCT00098020|83051177|FG000|Overall Study|Low urine PCR|1|||
46833258|NCT00098020|83051177|FG000|Overall Study|Low epidermal growth factor receptor|1|||
47061553|NCT05052697|83342231|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
46833259|NCT00360698|83051183|FG000|Run-In|Physician Decision|0|||
46833260|NCT00360698|83051184|FG001|Run-In|Physician Decision|1|||
47061554|NCT05052697|83342232|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061555|NCT05052697|83342233|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061556|NCT05052697|83342234|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061557|NCT05052697|83342235|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061558|NCT05052697|83342236|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
47061559|NCT05052697|83342237|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
47061560|NCT05052697|83342238|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061561|NCT05052697|83342239|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
47061562|NCT05052697|83342240|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
47061563|NCT05052697|83342241|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061564|NCT05052697|83342242|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061565|NCT05052697|83342243|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061566|NCT05052697|83342244|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061567|NCT05052697|83342245|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061568|NCT05052697|83342246|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061569|NCT05052697|83342247|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061570|NCT05052697|83342248|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061571|NCT05052697|83342249|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061572|NCT05052697|83342250|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061573|NCT05052697|83342251|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
47061574|NCT05052697|83342218|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061575|NCT05052697|83342219|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061576|NCT05052697|83342220|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061577|NCT05052697|83342221|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061578|NCT05052697|83342222|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061579|NCT05052697|83342223|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061580|NCT05052697|83342224|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061581|NCT05052697|83342225|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061582|NCT05052697|83342226|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061583|NCT05052697|83342227|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061584|NCT05052697|83342228|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061585|NCT05052697|83342229|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061586|NCT05052697|83342230|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061587|NCT05052697|83342231|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061588|NCT05052697|83342232|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061589|NCT05052697|83342233|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061590|NCT05052697|83342234|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061591|NCT05052697|83342235|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
47061592|NCT05052697|83342236|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061593|NCT05052697|83342237|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061594|NCT05052697|83342238|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061595|NCT05052697|83342239|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061596|NCT05052697|83342240|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061597|NCT05052697|83342241|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061598|NCT05052697|83342242|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061599|NCT05052697|83342243|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061600|NCT05052697|83342244|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061601|NCT05052697|83342245|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061602|NCT05052697|83342246|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
46766060|NCT00797862|82984493|FG000|Overall Study|Abnormal Test Procedure Result|0|||
46766061|NCT00797862|82984494|FG001|Overall Study|Abnormal Test Procedure Result|1|||
46766062|NCT00797862|82984495|FG002|Overall Study|Abnormal Test Procedure Result|1|||
46766063|NCT00797862|82984493|FG000|Overall Study|Lack of Efficacy|1|||
46766064|NCT00797862|82984494|FG001|Overall Study|Lack of Efficacy|7|||
46766065|NCT00797862|82984495|FG002|Overall Study|Lack of Efficacy|6|||
46766066|NCT00797862|82984493|FG000|Overall Study|No longer required study medication|1|||
46766067|NCT00797862|82984494|FG001|Overall Study|No longer required study medication|0|||
46766068|NCT00797862|82984495|FG002|Overall Study|No longer required study medication|0|||
46766069|NCT00797862|82984493|FG000|Overall Study|Withdrawal by Subject|14|||
46766070|NCT00797862|82984494|FG001|Overall Study|Withdrawal by Subject|7|||
46766071|NCT00797862|82984495|FG002|Overall Study|Withdrawal by Subject|7|||
46766072|NCT00797862|82984493|FG000|Overall Study|Lost to Follow-up|11|||
46833261|NCT00360698|83051183|FG000|Run-In|Withdrawal by Subject|0|||
46833262|NCT00360698|83051184|FG001|Run-In|Withdrawal by Subject|2|||
46833263|NCT00360698|83051183|FG000|Run-In|Non compliance with treatment procedure|0|||
47061603|NCT05052697|83342247|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061604|NCT05052697|83342248|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
47061605|NCT05052697|83342249|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
46940420|NCT03016325|83177442|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
46940421|NCT03016325|83177443|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
46940422|NCT03016325|83177436|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
46940423|NCT03016325|83177437|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
46940424|NCT03016325|83177438|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
46940425|NCT03016325|83177439|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
46940426|NCT03016325|83177440|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
46940427|NCT03016325|83177441|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
46940428|NCT03016325|83177442|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
46940429|NCT03016325|83177443|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
46940430|NCT02988115|83177466|FG000|Overall Study|Adverse Event|6|||
46940431|NCT02988115|83177467|FG001|Overall Study|Adverse Event|1|||
46940432|NCT02988115|83177466|FG000|Overall Study|Sponsor Decision|5|||
46940433|NCT02988115|83177467|FG001|Overall Study|Sponsor Decision|2|||
46940434|NCT02988115|83177466|FG000|Overall Study|Withdrawal by Subject|1|||
46940435|NCT02988115|83177467|FG001|Overall Study|Withdrawal by Subject|1|||
46940436|NCT02988115|83177466|FG000|Overall Study|Withdrawn by Mistake|1|||
46940437|NCT02988115|83177467|FG001|Overall Study|Withdrawn by Mistake|0|||
46940438|NCT02988115|83177466|FG000|Overall Study|Lost to Follow-up|1|||
46940439|NCT02988115|83177467|FG001|Overall Study|Lost to Follow-up|0|||
46940440|NCT02921425|83177473|FG000|Overall Study|Protocol Violation|9|||
46940441|NCT03008915|83177477|FG000|Treatment 1|Withdrawal by Subject|0|||
46940442|NCT03008915|83177478|FG001|Treatment 1|Withdrawal by Subject|1|||
46940443|NCT02920957|83177489|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
46940444|NCT02920957|83177490|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
46940445|NCT02920957|83177489|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
46940446|NCT02920957|83177490|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
46940447|NCT02920957|83177489|FG000|First Intervention : 1 Month|Adverse Event|1|||
46940448|NCT02920957|83177490|FG001|First Intervention : 1 Month|Adverse Event|0|||
46940449|NCT02920957|83177489|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
46940450|NCT02920957|83177490|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
46940451|NCT03006887|83177507|FG000|Overall Study|Adverse Event|1|||
46940452|NCT02514772|83177513|FG000|Overall Study|Adverse Event|1|||
46940453|NCT02514772|83177514|FG001|Overall Study|Adverse Event|0|||
46940454|NCT02514772|83177513|FG000|Overall Study|Death|0|||
46940455|NCT02514772|83177514|FG001|Overall Study|Death|1|||
46940456|NCT02514772|83177513|FG000|Overall Study|Withdrawal by Subject|2|||
46940457|NCT02514772|83177514|FG001|Overall Study|Withdrawal by Subject|1|||
46940458|NCT03000179|83177522|FG000|Overall Study|Lost to Follow-up|2|||
46940459|NCT02920177|83177528|FG000|Overall Study|Withdrawal by Subject|1|||
46833264|NCT00360698|83051184|FG001|Run-In|Non compliance with treatment procedure|1|||
46833265|NCT00360698|83051183|FG000|Run-In|Sponsor request|0|||
46833266|NCT00360698|83051184|FG001|Run-In|Sponsor request|2|||
46833267|NCT00360698|83051183|FG000|Run-In|Patient did not meet inclusion criteria|0|||
46833268|NCT00360698|83051184|FG001|Run-In|Patient did not meet inclusion criteria|1|||
46833269|NCT00360698|83051183|FG000|Run-In|Patient personal reasons|0|||
46833270|NCT00360698|83051184|FG001|Run-In|Patient personal reasons|2|||
46833271|NCT00360698|83051183|FG000|Run-In|Need of insulin with meals|0|||
46833272|NCT00360698|83051184|FG001|Run-In|Need of insulin with meals|1|||
46833273|NCT00360698|83051183|FG000|Treatment Period|Non compliance with treatment procedure|1|||
46833274|NCT00360698|83051184|FG001|Treatment Period|Non compliance with treatment procedure|0|||
46833275|NCT00360698|83051183|FG000|Treatment Period|Early termination by error|0|||
46833276|NCT00360698|83051184|FG001|Treatment Period|Early termination by error|1|||
46833277|NCT00380978|83051192|FG000|Overall Study|Refused allocated intervention|0|||
46833278|NCT00380978|83051193|FG001|Overall Study|Refused allocated intervention|6|||
46833279|NCT00380978|83051192|FG000|Overall Study|Wrong study envelope|0|||
46833280|NCT00380978|83051193|FG001|Overall Study|Wrong study envelope|2|||
46833281|NCT00380978|83051192|FG000|Overall Study|Allocation prior to analgesia request|1|||
46833282|NCT00380978|83051193|FG001|Overall Study|Allocation prior to analgesia request|2|||
46833283|NCT00380978|83051192|FG000|Overall Study|Parous patient|1|||
46833284|NCT00380978|83051193|FG001|Overall Study|Parous patient|0|||
46833285|NCT00162123|83051207|FG000|Overall Study|Disease progression|27|||
46833286|NCT00162123|83051208|FG001|Overall Study|Disease progression|19|||
46833287|NCT00162123|83051209|FG002|Overall Study|Disease progression|10|||
46833288|NCT00162123|83051210|FG003|Overall Study|Disease progression|4|||
46833289|NCT00162123|83051211|FG004|Overall Study|Disease progression|8|||
46833290|NCT00162123|83051212|FG005|Overall Study|Disease progression|3|||
46833291|NCT00162123|83051213|FG006|Overall Study|Disease progression|1|||
46940460|NCT02920177|83177529|FG001|Overall Study|Withdrawal by Subject|1|||
46940461|NCT02920177|83177528|FG000|Overall Study|Physician Decision|1|||
46940462|NCT02920177|83177529|FG001|Overall Study|Physician Decision|0|||
46940463|NCT02920177|83177528|FG000|Overall Study|Lost to Follow-up|0|||
46940464|NCT02920177|83177529|FG001|Overall Study|Lost to Follow-up|1|||
46833292|NCT00162123|83051214|FG007|Overall Study|Disease progression|0|||
46940465|NCT03006341|83177539|FG000|Overall Study|Not linked in the EMR|25069|||
46940466|NCT03006341|83177540|FG001|Overall Study|Not linked in the EMR|67505|||
46940467|NCT03006341|83177541|FG002|Overall Study|Not linked in the EMR|30993|||
46940468|NCT03006341|83177542|FG003|Overall Study|Not linked in the EMR|10685|||
46940469|NCT03935594|83177550|FG000|Overall Study|Physician Decision|3|||
46940470|NCT02512042|83177558|FG000|Overall Study|Adverse Event|0|||
46940471|NCT02512042|83177559|FG001|Overall Study|Adverse Event|4|||
46940472|NCT02512042|83177558|FG000|Overall Study|Withdrawal by Subject|6|||
46940473|NCT02512042|83177559|FG001|Overall Study|Withdrawal by Subject|6|||
46940474|NCT02512042|83177558|FG000|Overall Study|Non-compliance with study drug|1|||
46940475|NCT02512042|83177559|FG001|Overall Study|Non-compliance with study drug|2|||
46940476|NCT02512042|83177558|FG000|Overall Study|Lost to Follow-up|5|||
46940477|NCT02512042|83177559|FG001|Overall Study|Lost to Follow-up|2|||
46940478|NCT02512042|83177558|FG000|Overall Study|Other|11|||
46940479|NCT02512042|83177559|FG001|Overall Study|Other|11|||
46940480|NCT02911025|83177565|FG000|Overall Study|Lost to Follow-up|3|||
46940481|NCT02919475|83177574|FG000|Overall Study|Adverse Event|3|||
46940482|NCT02919475|83177575|FG001|Overall Study|Adverse Event|3|||
46940483|NCT02919475|83177576|FG002|Overall Study|Adverse Event|3|||
46940484|NCT02919475|83177577|FG003|Overall Study|Adverse Event|9|||
46940485|NCT02919475|83177578|FG004|Overall Study|Adverse Event|2|||
46940486|NCT02919475|83177574|FG000|Overall Study|Death|0|||
46940487|NCT02919475|83177575|FG001|Overall Study|Death|1|||
46940488|NCT02919475|83177576|FG002|Overall Study|Death|0|||
46940489|NCT02919475|83177577|FG003|Overall Study|Death|0|||
46940490|NCT02919475|83177578|FG004|Overall Study|Death|0|||
46940491|NCT02919475|83177574|FG000|Overall Study|Lost to Follow-up|0|||
46940492|NCT02919475|83177575|FG001|Overall Study|Lost to Follow-up|0|||
46940493|NCT02919475|83177576|FG002|Overall Study|Lost to Follow-up|0|||
46940494|NCT02919475|83177577|FG003|Overall Study|Lost to Follow-up|1|||
46940495|NCT02919475|83177578|FG004|Overall Study|Lost to Follow-up|0|||
46940496|NCT02919475|83177574|FG000|Overall Study|Withdrawal by Subject|2|||
46940497|NCT02919475|83177575|FG001|Overall Study|Withdrawal by Subject|3|||
46940498|NCT02919475|83177576|FG002|Overall Study|Withdrawal by Subject|1|||
46940499|NCT02919475|83177577|FG003|Overall Study|Withdrawal by Subject|2|||
46940500|NCT02919475|83177578|FG004|Overall Study|Withdrawal by Subject|2|||
46940501|NCT02919475|83177574|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
46940502|NCT02919475|83177575|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
46940503|NCT02919475|83177576|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
46940504|NCT02919475|83177577|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
46940505|NCT02919475|83177578|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46940506|NCT01066897|83177592|FG000|Overall Study|Withdrawal by Subject|1|||
46940507|NCT01066897|83177593|FG001|Overall Study|Withdrawal by Subject|0|||
46940508|NCT01066897|83177592|FG000|Overall Study|stopped study after developing the flu.|1|||
46940509|NCT01066897|83177593|FG001|Overall Study|stopped study after developing the flu.|0|||
46940510|NCT02985541|83177600|FG000|Overall Study|Withdrawal by Subject|33|||
46940511|NCT02985541|83177600|FG000|Overall Study|Lost to Follow-up|26|||
46940512|NCT02985541|83177600|FG000|Overall Study|Adverse Event|27|||
46940513|NCT02985541|83177600|FG000|Overall Study|Physician Decision|2|||
46940514|NCT02985541|83177600|FG000|Overall Study|Pregnancy|2|||
46940515|NCT02985541|83177600|FG000|Overall Study|Wish for pregnancy|44|||
46940516|NCT02985541|83177600|FG000|Overall Study|Other reason|5|||
46940517|NCT02985541|83177600|FG000|Overall Study|Not valid for analysis|2|||
46940518|NCT02910037|83177613|FG000|Overall Study|Withdrawal by Subject|4|||
46940519|NCT02910037|83177613|FG000|Overall Study|Lost to Follow-up|6|||
46940520|NCT02511184|83177648|FG000|Overall Study|Death|1|||
46940521|NCT02511184|83177649|FG001|Overall Study|Death|0|||
46940522|NCT02511184|83177648|FG000|Overall Study|Lost to Follow-up|0|||
46940523|NCT02511184|83177649|FG001|Overall Study|Lost to Follow-up|1|||
46940524|NCT02511184|83177648|FG000|Overall Study|Study terminated by sponsor|1|||
46940525|NCT02511184|83177649|FG001|Overall Study|Study terminated by sponsor|5|||
46940526|NCT02511184|83177648|FG000|Overall Study|Withdrawal by Subject|0|||
46940527|NCT02511184|83177649|FG001|Overall Study|Withdrawal by Subject|1|||
46940528|NCT02984995|83177658|FG000|Overall Study|Required stem cell transplant|13|||
46940529|NCT02984995|83177659|FG001|Overall Study|Required stem cell transplant|2|||
46940530|NCT02984995|83177658|FG000|Overall Study|Progressive disease|11|||
47061606|NCT05052697|83342250|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
46940531|NCT02984995|83177659|FG001|Overall Study|Progressive disease|1|||
46940532|NCT02984995|83177658|FG000|Overall Study|Adverse Event|1|||
46940533|NCT02984995|83177659|FG001|Overall Study|Adverse Event|0|||
46940534|NCT02984683|83177683|FG000|Overall Study|Adverse Event|3|||
46940535|NCT02984683|83177684|FG001|Overall Study|Adverse Event|3|||
46940536|NCT02984683|83177683|FG000|Overall Study|Withdrawal by Subject|1|||
46940537|NCT02984683|83177684|FG001|Overall Study|Withdrawal by Subject|0|||
47061607|NCT05052697|83342251|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
46940538|NCT02984683|83177683|FG000|Overall Study|Disease progression|7|||
46940539|NCT02984683|83177684|FG001|Overall Study|Disease progression|9|||
46940540|NCT02909101|83177692|FG000|Overall Study|Lost to Follow-up|1|||
46940541|NCT02909101|83177693|FG001|Overall Study|Lost to Follow-up|1|||
46940542|NCT03004469|83177702|FG000|Overall Study|Adverse Event|6|||
46940543|NCT03004469|83177703|FG001|Overall Study|Adverse Event|4|||
46940544|NCT03004469|83177704|FG002|Overall Study|Adverse Event|6|||
46940545|NCT03004469|83177702|FG000|Overall Study|Lack of Efficacy|1|||
46940546|NCT03004469|83177703|FG001|Overall Study|Lack of Efficacy|0|||
46940547|NCT03004469|83177704|FG002|Overall Study|Lack of Efficacy|1|||
46940548|NCT03004469|83177702|FG000|Overall Study|Lost to Follow-up|23|||
46940549|NCT03004469|83177703|FG001|Overall Study|Lost to Follow-up|14|||
46940550|NCT03004469|83177704|FG002|Overall Study|Lost to Follow-up|6|||
46940551|NCT03004469|83177702|FG000|Overall Study|Non-Compliance with Study Drug|2|||
46940552|NCT03004469|83177703|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46940553|NCT03004469|83177704|FG002|Overall Study|Non-Compliance with Study Drug|0|||
46940554|NCT03004469|83177702|FG000|Overall Study|Protocol Violation|0|||
46940555|NCT03004469|83177703|FG001|Overall Study|Protocol Violation|0|||
46940556|NCT03004469|83177704|FG002|Overall Study|Protocol Violation|1|||
46940557|NCT03004469|83177702|FG000|Overall Study|Withdrawal by Subject|29|||
46940558|NCT03004469|83177703|FG001|Overall Study|Withdrawal by Subject|27|||
46637802|NCT01474512|82811385|FG009|Long-Term Extension Period|Clinical Relapse|0|||
46637803|NCT01474512|82811386|FG010|Long-Term Extension Period|Clinical Relapse|0|||
46637804|NCT01474512|82811387|FG011|Long-Term Extension Period|Clinical Relapse|0|||
46637805|NCT01474512|82811388|FG012|Long-Term Extension Period|Clinical Relapse|9|||
46637806|NCT01474512|82811389|FG013|Long-Term Extension Period|Clinical Relapse|9|||
46637807|NCT01474512|82811390|FG014|Long-Term Extension Period|Clinical Relapse|0|||
46940559|NCT03004469|83177704|FG002|Overall Study|Withdrawal by Subject|10|||
46940560|NCT03004469|83177702|FG000|Overall Study|Other unspecified reason|0|||
46940561|NCT03004469|83177703|FG001|Overall Study|Other unspecified reason|4|||
46940562|NCT03004469|83177704|FG002|Overall Study|Other unspecified reason|1|||
46940563|NCT02910713|83177713|FG000|Overall Study|Protocol Violation|2|||
46940564|NCT02910713|83177713|FG000|Overall Study|Subject Choice|4|||
46940565|NCT02910713|83177713|FG000|Overall Study|Received One Application|10|||
46940566|NCT02910713|83177713|FG000|Overall Study|Received Neither Application|18|||
46940567|NCT02910713|83177713|FG000|Overall Study|Enrollment cap|7|||
46940568|NCT02910713|83177713|FG000|Overall Study|Investigator Discretion|1|||
46940569|NCT02998541|83177721|FG000|Overall Study|Adverse Event|4|||
46940570|NCT02998541|83177722|FG001|Overall Study|Adverse Event|5|||
46940571|NCT02998541|83177723|FG002|Overall Study|Adverse Event|1|||
46940572|NCT02998541|83177721|FG000|Overall Study|Protocol Violation|1|||
46940573|NCT02998541|83177722|FG001|Overall Study|Protocol Violation|0|||
46940574|NCT02998541|83177723|FG002|Overall Study|Protocol Violation|0|||
46940575|NCT02998541|83177721|FG000|Overall Study|Withdrawal by Subject|3|||
46940576|NCT02998541|83177722|FG001|Overall Study|Withdrawal by Subject|1|||
46940577|NCT02998541|83177723|FG002|Overall Study|Withdrawal by Subject|0|||
46940578|NCT02998541|83177721|FG000|Overall Study|Lost to Follow-up|0|||
46940579|NCT02998541|83177722|FG001|Overall Study|Lost to Follow-up|3|||
46940580|NCT02998541|83177723|FG002|Overall Study|Lost to Follow-up|1|||
46940581|NCT02998541|83177721|FG000|Overall Study|Physician Decision|0|||
46940582|NCT02998541|83177722|FG001|Overall Study|Physician Decision|0|||
46940583|NCT02998541|83177723|FG002|Overall Study|Physician Decision|3|||
46940584|NCT02998541|83177721|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46940585|NCT02998541|83177722|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46940586|NCT02998541|83177723|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
46940587|NCT02998151|83177731|FG000|Overall Study|Withdrawal by Subject|3|||
46940588|NCT02998151|83177731|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
46940589|NCT02998151|83177731|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
46940590|NCT01066819|83177762|FG000|Overall Study|Adverse Event|18|||
46940591|NCT01066819|83177763|FG001|Overall Study|Adverse Event|1|||
46940592|NCT01066819|83177764|FG002|Overall Study|Adverse Event|6|||
46940593|NCT01066819|83177765|FG003|Overall Study|Adverse Event|0|||
46940594|NCT01066819|83177766|FG004|Overall Study|Adverse Event|0|||
46940595|NCT01066819|83177767|FG005|Overall Study|Adverse Event|0|||
46940596|NCT01066819|83177762|FG000|Overall Study|Death|5|||
46940597|NCT01066819|83177763|FG001|Overall Study|Death|0|||
46940598|NCT01066819|83177764|FG002|Overall Study|Death|1|||
46833293|NCT00162123|83051207|FG000|Overall Study|Study drug toxicity|6|||
46833294|NCT00162123|83051208|FG001|Overall Study|Study drug toxicity|1|||
46940599|NCT01066819|83177765|FG003|Overall Study|Death|0|||
46940600|NCT01066819|83177766|FG004|Overall Study|Death|0|||
46940601|NCT01066819|83177767|FG005|Overall Study|Death|0|||
46940602|NCT01066819|83177762|FG000|Overall Study|Lack of Efficacy|22|||
46940603|NCT01066819|83177763|FG001|Overall Study|Lack of Efficacy|1|||
46940604|NCT01066819|83177764|FG002|Overall Study|Lack of Efficacy|2|||
46940605|NCT01066819|83177765|FG003|Overall Study|Lack of Efficacy|1|||
46940606|NCT01066819|83177766|FG004|Overall Study|Lack of Efficacy|0|||
46940607|NCT01066819|83177767|FG005|Overall Study|Lack of Efficacy|0|||
46940608|NCT01066819|83177762|FG000|Overall Study|Physician Decision|6|||
46940609|NCT01066819|83177763|FG001|Overall Study|Physician Decision|2|||
46940610|NCT01066819|83177764|FG002|Overall Study|Physician Decision|3|||
46940611|NCT01066819|83177765|FG003|Overall Study|Physician Decision|0|||
46940612|NCT01066819|83177766|FG004|Overall Study|Physician Decision|0|||
46940613|NCT01066819|83177767|FG005|Overall Study|Physician Decision|0|||
46940614|NCT01066819|83177762|FG000|Overall Study|Protocol Violation|12|||
46940615|NCT01066819|83177763|FG001|Overall Study|Protocol Violation|6|||
46940616|NCT01066819|83177764|FG002|Overall Study|Protocol Violation|0|||
46940617|NCT01066819|83177765|FG003|Overall Study|Protocol Violation|0|||
46940618|NCT01066819|83177766|FG004|Overall Study|Protocol Violation|0|||
46940619|NCT01066819|83177767|FG005|Overall Study|Protocol Violation|0|||
46940620|NCT01066819|83177762|FG000|Overall Study|Withdrawal by Subject|29|||
46940621|NCT01066819|83177763|FG001|Overall Study|Withdrawal by Subject|11|||
46940622|NCT01066819|83177764|FG002|Overall Study|Withdrawal by Subject|6|||
46940623|NCT01066819|83177765|FG003|Overall Study|Withdrawal by Subject|0|||
46940624|NCT01066819|83177766|FG004|Overall Study|Withdrawal by Subject|0|||
46940625|NCT01066819|83177767|FG005|Overall Study|Withdrawal by Subject|0|||
46940626|NCT01066819|83177762|FG000|Overall Study|Administrative|6|||
46940627|NCT01066819|83177763|FG001|Overall Study|Administrative|4|||
46940628|NCT01066819|83177764|FG002|Overall Study|Administrative|2|||
46940629|NCT01066819|83177765|FG003|Overall Study|Administrative|0|||
46940630|NCT01066819|83177766|FG004|Overall Study|Administrative|0|||
46940631|NCT01066819|83177767|FG005|Overall Study|Administrative|0|||
46940632|NCT01066819|83177762|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
46940633|NCT01066819|83177763|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
46940634|NCT01066819|83177764|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
46940635|NCT01066819|83177765|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
46940636|NCT01066819|83177766|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
46940637|NCT01066819|83177767|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
46940638|NCT01066819|83177762|FG000|Overall Study|Early termination|2|||
46940639|NCT01066819|83177763|FG001|Overall Study|Early termination|0|||
46940640|NCT01066819|83177764|FG002|Overall Study|Early termination|0|||
46940641|NCT01066819|83177765|FG003|Overall Study|Early termination|0|||
46940642|NCT01066819|83177766|FG004|Overall Study|Early termination|0|||
46940643|NCT01066819|83177767|FG005|Overall Study|Early termination|0|||
46940644|NCT01066819|83177762|FG000|Overall Study|Failed to return|298|||
46940645|NCT01066819|83177763|FG001|Overall Study|Failed to return|107|||
46940646|NCT01066819|83177764|FG002|Overall Study|Failed to return|68|||
46940647|NCT01066819|83177765|FG003|Overall Study|Failed to return|7|||
46940648|NCT01066819|83177766|FG004|Overall Study|Failed to return|2|||
46940649|NCT01066819|83177767|FG005|Overall Study|Failed to return|3|||
46940650|NCT01066819|83177762|FG000|Overall Study|Lab test not done|9|||
46940651|NCT01066819|83177763|FG001|Overall Study|Lab test not done|0|||
46940652|NCT01066819|83177764|FG002|Overall Study|Lab test not done|2|||
46940653|NCT01066819|83177765|FG003|Overall Study|Lab test not done|1|||
46940654|NCT01066819|83177766|FG004|Overall Study|Lab test not done|0|||
46940655|NCT01066819|83177767|FG005|Overall Study|Lab test not done|0|||
46940656|NCT01066819|83177762|FG000|Overall Study|Miscellaneous|28|||
46766073|NCT00797862|82984494|FG001|Overall Study|Lost to Follow-up|0|||
46766074|NCT00797862|82984495|FG002|Overall Study|Lost to Follow-up|5|||
46766075|NCT00797862|82984493|FG000|Overall Study|Administrative Problem|4|||
46766076|NCT00797862|82984494|FG001|Overall Study|Administrative Problem|0|||
46766077|NCT00797862|82984495|FG002|Overall Study|Administrative Problem|0|||
46766078|NCT00797862|82984493|FG000|Overall Study|Protocol Violation|4|||
46766079|NCT00797862|82984494|FG001|Overall Study|Protocol Violation|6|||
46766080|NCT00797862|82984495|FG002|Overall Study|Protocol Violation|8|||
46766081|NCT00797862|82984493|FG000|Overall Study|Mis-randomized|3|||
46766082|NCT00797862|82984494|FG001|Overall Study|Mis-randomized|3|||
46766083|NCT00797862|82984495|FG002|Overall Study|Mis-randomized|1|||
46766084|NCT00794820|82984503|FG000|Overall Study|Adverse Event|11|||
46766085|NCT00794820|82984503|FG000|Overall Study|Secondary Malignancies|2|||
46766086|NCT00794820|82984503|FG000|Overall Study|Resistant Disease|2|||
46766087|NCT00794820|82984503|FG000|Overall Study|Ineligible/Screen Failure|1|||
46766088|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
46766089|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
46940657|NCT01066819|83177763|FG001|Overall Study|Miscellaneous|10|||
46940658|NCT01066819|83177764|FG002|Overall Study|Miscellaneous|18|||
46940659|NCT01066819|83177765|FG003|Overall Study|Miscellaneous|1|||
46766090|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
46766091|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
46940660|NCT01066819|83177766|FG004|Overall Study|Miscellaneous|0|||
46766092|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
46940661|NCT01066819|83177767|FG005|Overall Study|Miscellaneous|0|||
46940662|NCT01066819|83177762|FG000|Overall Study|Non responders|123|||
46940663|NCT01066819|83177763|FG001|Overall Study|Non responders|2|||
46940664|NCT01066819|83177764|FG002|Overall Study|Non responders|7|||
46940665|NCT01066819|83177765|FG003|Overall Study|Non responders|2|||
46940666|NCT01066819|83177766|FG004|Overall Study|Non responders|0|||
46940667|NCT01066819|83177767|FG005|Overall Study|Non responders|1|||
46940668|NCT01066819|83177762|FG000|Overall Study|Not categorised|9|||
46940669|NCT01066819|83177763|FG001|Overall Study|Not categorised|2|||
46940670|NCT01066819|83177764|FG002|Overall Study|Not categorised|6|||
46940671|NCT01066819|83177765|FG003|Overall Study|Not categorised|1|||
46940672|NCT01066819|83177766|FG004|Overall Study|Not categorised|0|||
46940673|NCT01066819|83177767|FG005|Overall Study|Not categorised|0|||
46940674|NCT01066819|83177762|FG000|Overall Study|Relapse|16|||
46940675|NCT01066819|83177763|FG001|Overall Study|Relapse|4|||
46940676|NCT01066819|83177764|FG002|Overall Study|Relapse|3|||
46940677|NCT01066819|83177765|FG003|Overall Study|Relapse|0|||
46940678|NCT01066819|83177766|FG004|Overall Study|Relapse|0|||
46940679|NCT01066819|83177767|FG005|Overall Study|Relapse|0|||
46940680|NCT01066819|83177762|FG000|Overall Study|Results not available|1|||
46940681|NCT01066819|83177763|FG001|Overall Study|Results not available|0|||
46940682|NCT01066819|83177764|FG002|Overall Study|Results not available|0|||
46940683|NCT01066819|83177765|FG003|Overall Study|Results not available|0|||
46940684|NCT01066819|83177766|FG004|Overall Study|Results not available|0|||
46940685|NCT01066819|83177767|FG005|Overall Study|Results not available|0|||
46940686|NCT01066819|83177762|FG000|Overall Study|Screen failure|1|||
46940687|NCT01066819|83177763|FG001|Overall Study|Screen failure|0|||
46940688|NCT01066819|83177764|FG002|Overall Study|Screen failure|0|||
46940689|NCT01066819|83177765|FG003|Overall Study|Screen failure|0|||
46940690|NCT01066819|83177766|FG004|Overall Study|Screen failure|0|||
46940691|NCT01066819|83177767|FG005|Overall Study|Screen failure|0|||
46940692|NCT01066819|83177762|FG000|Overall Study|Spontaneous cure|1|||
46940693|NCT01066819|83177763|FG001|Overall Study|Spontaneous cure|0|||
46940694|NCT01066819|83177764|FG002|Overall Study|Spontaneous cure|0|||
46940695|NCT01066819|83177765|FG003|Overall Study|Spontaneous cure|0|||
46940696|NCT01066819|83177766|FG004|Overall Study|Spontaneous cure|0|||
46940697|NCT01066819|83177767|FG005|Overall Study|Spontaneous cure|0|||
46940698|NCT01066819|83177762|FG000|Overall Study|Treatment never started|85|||
46940699|NCT01066819|83177763|FG001|Overall Study|Treatment never started|19|||
46940700|NCT01066819|83177764|FG002|Overall Study|Treatment never started|19|||
46940701|NCT01066819|83177765|FG003|Overall Study|Treatment never started|3|||
46940702|NCT01066819|83177766|FG004|Overall Study|Treatment never started|2|||
46940703|NCT01066819|83177767|FG005|Overall Study|Treatment never started|2|||
46940704|NCT01066819|83177762|FG000|Overall Study|Treatment stopped|12|||
46940705|NCT01066819|83177763|FG001|Overall Study|Treatment stopped|1|||
46940706|NCT01066819|83177764|FG002|Overall Study|Treatment stopped|2|||
46940707|NCT01066819|83177765|FG003|Overall Study|Treatment stopped|1|||
46940708|NCT01066819|83177766|FG004|Overall Study|Treatment stopped|0|||
46940709|NCT01066819|83177767|FG005|Overall Study|Treatment stopped|0|||
46940710|NCT01066819|83177762|FG000|Overall Study|Other|5|||
46940711|NCT01066819|83177763|FG001|Overall Study|Other|1|||
46940712|NCT01066819|83177764|FG002|Overall Study|Other|1|||
46940713|NCT01066819|83177765|FG003|Overall Study|Other|0|||
46940714|NCT01066819|83177766|FG004|Overall Study|Other|0|||
46940715|NCT01066819|83177767|FG005|Overall Study|Other|0|||
46940716|NCT04056299|83177781|FG000|Overall Study|Sponsor discontinued study|3|||
46940717|NCT04056299|83177782|FG001|Overall Study|Sponsor discontinued study|3|||
46940718|NCT01069523|83177790|FG000|Overall Study|Withdrawal by Subject|4|||
46940719|NCT01069523|83177791|FG001|Overall Study|Withdrawal by Subject|7|||
46940720|NCT01069289|83177801|FG000|Overall Study|Withdrawal by Subject|15|||
46940721|NCT01069289|83177802|FG001|Overall Study|Withdrawal by Subject|26|||
47061608|NCT05052697|83342218|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061609|NCT05052697|83342219|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061610|NCT05052697|83342220|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061611|NCT05052697|83342221|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061612|NCT05052697|83342222|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46766093|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
46766094|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
46766095|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
46766096|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
46766097|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
46766098|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
47061613|NCT05052697|83342223|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061614|NCT05052697|83342224|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46940722|NCT01069289|83177801|FG000|Overall Study|Adverse Event|21|||
46940723|NCT01069289|83177802|FG001|Overall Study|Adverse Event|28|||
46940724|NCT01069289|83177801|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46940725|NCT01069289|83177802|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46940726|NCT01069289|83177801|FG000|Overall Study|Severe non-compliance to protocol|3|||
46940727|NCT01069289|83177802|FG001|Overall Study|Severe non-compliance to protocol|2|||
46940728|NCT01069289|83177801|FG000|Overall Study|Due to deteriorating health condition|1|||
46940729|NCT01069289|83177802|FG001|Overall Study|Due to deteriorating health condition|0|||
46940730|NCT02510794|83177821|FG000|Overall Study|Adverse Event|0|||
46940731|NCT02510794|83177822|FG001|Overall Study|Adverse Event|1|||
46940732|NCT02510794|83177823|FG002|Overall Study|Adverse Event|0|||
46940733|NCT02510794|83177824|FG003|Overall Study|Adverse Event|0|||
46940734|NCT02510794|83177821|FG000|Overall Study|Death|1|||
46940735|NCT02510794|83177822|FG001|Overall Study|Death|2|||
46940736|NCT02510794|83177823|FG002|Overall Study|Death|1|||
46940737|NCT02510794|83177824|FG003|Overall Study|Death|1|||
46940738|NCT02510794|83177821|FG000|Overall Study|Lack of Efficacy|3|||
46940739|NCT02510794|83177822|FG001|Overall Study|Lack of Efficacy|1|||
46940740|NCT02510794|83177823|FG002|Overall Study|Lack of Efficacy|1|||
46940741|NCT02510794|83177824|FG003|Overall Study|Lack of Efficacy|0|||
46940742|NCT02510794|83177821|FG000|Overall Study|Participant moved out of the area|0|||
46940743|NCT02510794|83177822|FG001|Overall Study|Participant moved out of the area|0|||
46940744|NCT02510794|83177823|FG002|Overall Study|Participant moved out of the area|0|||
46940745|NCT02510794|83177824|FG003|Overall Study|Participant moved out of the area|1|||
46940746|NCT02510794|83177821|FG000|Overall Study|Physician Decision|3|||
46940747|NCT02510794|83177822|FG001|Overall Study|Physician Decision|0|||
46940748|NCT02510794|83177823|FG002|Overall Study|Physician Decision|0|||
46940749|NCT02510794|83177824|FG003|Overall Study|Physician Decision|0|||
46940750|NCT02510794|83177821|FG000|Overall Study|Protocol Violation|0|||
46940751|NCT02510794|83177822|FG001|Overall Study|Protocol Violation|0|||
46940752|NCT02510794|83177823|FG002|Overall Study|Protocol Violation|1|||
46940753|NCT02510794|83177824|FG003|Overall Study|Protocol Violation|0|||
46940754|NCT02510794|83177821|FG000|Overall Study|Withdrawal by Subject|1|||
46940755|NCT02510794|83177822|FG001|Overall Study|Withdrawal by Subject|2|||
46940756|NCT02510794|83177823|FG002|Overall Study|Withdrawal by Subject|4|||
46940757|NCT02510794|83177824|FG003|Overall Study|Withdrawal by Subject|3|||
46940758|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
46940759|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
46940760|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
46940761|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
46940762|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
46940763|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
46940764|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
46940765|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
46940766|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
46940767|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
46940768|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
46940769|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
46940770|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
47061615|NCT05052697|83342225|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46833295|NCT00162123|83051209|FG002|Overall Study|Study drug toxicity|5|||
46833296|NCT00162123|83051210|FG003|Overall Study|Study drug toxicity|0|||
46833297|NCT00162123|83051211|FG004|Overall Study|Study drug toxicity|4|||
46833298|NCT00162123|83051212|FG005|Overall Study|Study drug toxicity|1|||
46833299|NCT00162123|83051213|FG006|Overall Study|Study drug toxicity|1|||
46833300|NCT00162123|83051214|FG007|Overall Study|Study drug toxicity|0|||
46833301|NCT00162123|83051207|FG000|Overall Study|Death|3|||
46833302|NCT00162123|83051208|FG001|Overall Study|Death|3|||
46833303|NCT00162123|83051209|FG002|Overall Study|Death|1|||
46833304|NCT00162123|83051210|FG003|Overall Study|Death|1|||
46833305|NCT00162123|83051211|FG004|Overall Study|Death|1|||
46833306|NCT00162123|83051212|FG005|Overall Study|Death|1|||
46833307|NCT00162123|83051213|FG006|Overall Study|Death|0|||
46833308|NCT00162123|83051214|FG007|Overall Study|Death|0|||
46833309|NCT00162123|83051207|FG000|Overall Study|Withdrawal by Subject|2|||
46833310|NCT00162123|83051208|FG001|Overall Study|Withdrawal by Subject|0|||
46833311|NCT00162123|83051209|FG002|Overall Study|Withdrawal by Subject|2|||
46833312|NCT00162123|83051210|FG003|Overall Study|Withdrawal by Subject|1|||
46833313|NCT00162123|83051211|FG004|Overall Study|Withdrawal by Subject|1|||
46833314|NCT00162123|83051212|FG005|Overall Study|Withdrawal by Subject|2|||
46833315|NCT00162123|83051213|FG006|Overall Study|Withdrawal by Subject|1|||
46833316|NCT00162123|83051214|FG007|Overall Study|Withdrawal by Subject|0|||
46833317|NCT00162123|83051207|FG000|Overall Study|Deterioration without progression|2|||
47061616|NCT05052697|83342226|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061617|NCT05052697|83342227|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46940771|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
46940772|NCT02510014|83177849|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
46940773|NCT02510014|83177850|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
47061618|NCT05052697|83342228|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061619|NCT05052697|83342229|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061620|NCT05052697|83342230|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46833318|NCT00162123|83051208|FG001|Overall Study|Deterioration without progression|2|||
46833319|NCT00162123|83051209|FG002|Overall Study|Deterioration without progression|3|||
46833320|NCT00162123|83051210|FG003|Overall Study|Deterioration without progression|0|||
46833321|NCT00162123|83051211|FG004|Overall Study|Deterioration without progression|1|||
46940774|NCT02510014|83177849|FG000|Treatment Period|Adverse Event|11|||
46940775|NCT02510014|83177850|FG001|Treatment Period|Adverse Event|4|||
46940776|NCT02510014|83177849|FG000|Treatment Period|Withdrawal symptoms|3|||
46940777|NCT02510014|83177850|FG001|Treatment Period|Withdrawal symptoms|0|||
46940778|NCT02510014|83177849|FG000|Treatment Period|Lost to Follow-up|80|||
46940779|NCT02510014|83177850|FG001|Treatment Period|Lost to Follow-up|19|||
46940780|NCT02510014|83177849|FG000|Treatment Period|Physician Decision|5|||
46940781|NCT02510014|83177850|FG001|Treatment Period|Physician Decision|0|||
46940782|NCT02510014|83177849|FG000|Treatment Period|Withdrawal by Subject|67|||
46940783|NCT02510014|83177850|FG001|Treatment Period|Withdrawal by Subject|24|||
46940784|NCT02510014|83177849|FG000|Treatment Period|Withdrawn by the investigator|7|||
46940785|NCT02510014|83177850|FG001|Treatment Period|Withdrawn by the investigator|1|||
46940786|NCT02510014|83177849|FG000|Treatment Period|Protocol Violation|4|||
46940787|NCT02510014|83177850|FG001|Treatment Period|Protocol Violation|4|||
46940788|NCT02510014|83177849|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
46940789|NCT02510014|83177850|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
46940790|NCT02509312|83177858|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
46940791|NCT02509312|83177859|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
46940792|NCT02509312|83177858|FG000|Overall Study|Obstetrician refusal|0|||
46940793|NCT02509312|83177859|FG001|Overall Study|Obstetrician refusal|1|||
46940794|NCT02509312|83177858|FG000|Overall Study|Patient elected for TOLAC|1|||
46940795|NCT02509312|83177859|FG001|Overall Study|Patient elected for TOLAC|0|||
46940796|NCT02509312|83177858|FG000|Overall Study|Cesarean deemed stat|1|||
46940797|NCT02509312|83177859|FG001|Overall Study|Cesarean deemed stat|0|||
46940798|NCT02509312|83177858|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
46940799|NCT02509312|83177859|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
46940800|NCT02509156|83177869|FG000|Randomized Phase|Death|1|||
46940801|NCT02509156|83177870|FG001|Randomized Phase|Death|0|||
46940802|NCT02509156|83177869|FG000|Randomized Phase|Withdrawal by Subject|1|||
46940803|NCT02509156|83177870|FG001|Randomized Phase|Withdrawal by Subject|1|||
46940804|NCT01654666|83177879|FG000|Overall Study|Protocol Violation|7|||
46940805|NCT01654666|83177880|FG001|Overall Study|Protocol Violation|4|||
46940806|NCT01654666|83177881|FG002|Overall Study|Protocol Violation|8|||
46940807|NCT01654666|83177879|FG000|Overall Study|Lost to Follow-up|4|||
46940808|NCT01654666|83177880|FG001|Overall Study|Lost to Follow-up|5|||
46940809|NCT01654666|83177881|FG002|Overall Study|Lost to Follow-up|5|||
46940810|NCT01654666|83177879|FG000|Overall Study|Withdrawal by Subject|4|||
46940811|NCT01654666|83177880|FG001|Overall Study|Withdrawal by Subject|4|||
46940812|NCT01654666|83177881|FG002|Overall Study|Withdrawal by Subject|1|||
46940813|NCT02519842|83177891|FG000|Base Study: Cycle 1|Screening Failure|1|||
46940814|NCT02519842|83177892|FG001|Base Study: Cycle 1|Screening Failure|1|||
46940815|NCT02519842|83177893|FG002|Base Study: Cycle 1|Screening Failure|0|||
46940816|NCT02519842|83177891|FG000|Base Study: Cycle 1|Adverse Event|1|||
46940817|NCT02519842|83177892|FG001|Base Study: Cycle 1|Adverse Event|0|||
46940818|NCT02519842|83177893|FG002|Base Study: Cycle 1|Adverse Event|0|||
46940819|NCT02519842|83177891|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
46940820|NCT02519842|83177892|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
46940821|NCT02519842|83177893|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
46940822|NCT02519842|83177891|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
46940823|NCT02519842|83177892|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
46766099|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
46766100|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
46766101|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
46766102|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
46766103|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
46766104|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
46766105|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
46766106|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
46766107|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
46766108|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
46766109|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
46766110|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
46766111|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
46766112|NCT00455533|82984509|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
46766113|NCT00455533|82984510|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
46766114|NCT00455533|82984511|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
46940824|NCT02519842|83177893|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
46940825|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
46940826|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
46940827|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
46940828|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
46940829|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
46940830|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
46940831|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
46940832|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
46940833|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
46940834|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
46940835|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
46940836|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
46940837|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Death|0|||
46940838|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Death|0|||
46940839|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Death|1|||
46940840|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
46940841|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
46940842|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
46940843|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
46940844|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
46940845|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
46940846|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
46940847|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
46940848|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
46940849|NCT02519842|83177891|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
46940850|NCT02519842|83177892|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
46940851|NCT02519842|83177893|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
46940852|NCT02509078|83177903|FG000|Overall Study|Protocol Violation|1|||
46940853|NCT02509078|83177904|FG001|Overall Study|Protocol Violation|1|||
46940854|NCT02993783|83177914|FG000|Overall Study|Reason not Specified|6|||
46940855|NCT02993783|83177915|FG001|Overall Study|Reason not Specified|9|||
46940856|NCT02993471|83177921|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
46940857|NCT02993471|83177921|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
46940858|NCT02988713|83177943|FG000|Overall Study|Withdrawal by Subject|1|||
46940859|NCT02988713|83177943|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
46940860|NCT01068743|83177947|FG000|Period 3|Adverse Event|0|||
46940861|NCT01068743|83177948|FG001|Period 3|Adverse Event|1|||
46940862|NCT01068743|83177949|FG002|Period 3|Adverse Event|0|||
46940863|NCT01068743|83177950|FG003|Period 3|Adverse Event|0|||
46940864|NCT02992691|83177963|FG000|Overall Study|Adverse Event|2|||
46940865|NCT02992691|83177963|FG000|Overall Study|Withdrawal by Subject|1|||
46940866|NCT02921087|83177980|FG000|Overall Study|Withdrawal by Subject|0|||
46940867|NCT02921087|83177981|FG001|Overall Study|Withdrawal by Subject|1|||
46833322|NCT00162123|83051212|FG005|Overall Study|Deterioration without progression|0|||
46833323|NCT00162123|83051213|FG006|Overall Study|Deterioration without progression|0|||
46833324|NCT00162123|83051214|FG007|Overall Study|Deterioration without progression|0|||
46833325|NCT00162123|83051207|FG000|Overall Study|Adverse Event|1|||
46833326|NCT00162123|83051208|FG001|Overall Study|Adverse Event|2|||
46833327|NCT00162123|83051209|FG002|Overall Study|Adverse Event|0|||
46833328|NCT00162123|83051210|FG003|Overall Study|Adverse Event|2|||
46833329|NCT00162123|83051211|FG004|Overall Study|Adverse Event|1|||
46833330|NCT00162123|83051212|FG005|Overall Study|Adverse Event|0|||
46833331|NCT00162123|83051213|FG006|Overall Study|Adverse Event|0|||
46833332|NCT00162123|83051214|FG007|Overall Study|Adverse Event|0|||
46833333|NCT00162123|83051207|FG000|Overall Study|Not specified (before treatment)|2|||
46833334|NCT00162123|83051208|FG001|Overall Study|Not specified (before treatment)|0|||
46940868|NCT02907619|83178000|FG000|Overall Study|Study terminated by sponsor|18|||
46940869|NCT02907619|83178001|FG001|Overall Study|Study terminated by sponsor|18|||
46940870|NCT02907619|83178002|FG002|Overall Study|Study terminated by sponsor|19|||
46940871|NCT02907619|83178000|FG000|Overall Study|Death|0|||
46940872|NCT02907619|83178001|FG001|Overall Study|Death|0|||
46940873|NCT02907619|83178002|FG002|Overall Study|Death|1|||
46940874|NCT02907619|83178000|FG000|Overall Study|Withdrawal by Subject|1|||
46940875|NCT02907619|83178001|FG001|Overall Study|Withdrawal by Subject|1|||
46940876|NCT02907619|83178002|FG002|Overall Study|Withdrawal by Subject|0|||
46940877|NCT02907619|83178000|FG000|Overall Study|Other|0|||
46940878|NCT02907619|83178001|FG001|Overall Study|Other|1|||
46940879|NCT02907619|83178002|FG002|Overall Study|Other|0|||
46940880|NCT02986373|83178012|FG000|Overall Study|Adverse Event|4|||
46940881|NCT02986373|83178012|FG000|Overall Study|Lost to Follow-up|1|||
46940882|NCT02986373|83178012|FG000|Overall Study|Withdrawal by Subject|10|||
46940883|NCT02986373|83178012|FG000|Overall Study|Other|24|||
46833335|NCT00162123|83051209|FG002|Overall Study|Not specified (before treatment)|0|||
46833336|NCT00162123|83051210|FG003|Overall Study|Not specified (before treatment)|0|||
46833337|NCT00162123|83051211|FG004|Overall Study|Not specified (before treatment)|12|||
46940884|NCT02986139|83178018|FG000|Overall Study|Sponsor Decision|1|||
46940885|NCT02986139|83178019|FG001|Overall Study|Sponsor Decision|2|||
46940886|NCT02986139|83178018|FG000|Overall Study|Withdrawal by Subject|0|||
46940887|NCT02986139|83178019|FG001|Overall Study|Withdrawal by Subject|1|||
46940888|NCT02986139|83178018|FG000|Overall Study|Lost to Follow-up|0|||
46940889|NCT02986139|83178019|FG001|Overall Study|Lost to Follow-up|1|||
46940890|NCT02989805|83178031|FG000|Overall Study|invalid consent|6|||
46940891|NCT02989805|83178032|FG001|Overall Study|invalid consent|4|||
46940892|NCT02907463|83178038|FG000|Overall Study|Lost to Follow-up|17|||
46940893|NCT02907463|83178038|FG000|Overall Study|Death|10|||
46940894|NCT02907463|83178038|FG000|Overall Study|Withdrawal by Subject|4|||
46766115|NCT00455533|82984509|FG000|Period Two: Randomized Period|Death|0|||
46766116|NCT00455533|82984510|FG001|Period Two: Randomized Period|Death|0|||
46766117|NCT00455533|82984511|FG002|Period Two: Randomized Period|Death|3|||
46766118|NCT00455533|82984509|FG000|Period Two: Randomized Period|Disease Progression|0|||
46766119|NCT00455533|82984510|FG001|Period Two: Randomized Period|Disease Progression|1|||
46766120|NCT00455533|82984511|FG002|Period Two: Randomized Period|Disease Progression|1|||
46766121|NCT00455533|82984509|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
46766122|NCT00455533|82984510|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
46766123|NCT00455533|82984511|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
46766124|NCT00455533|82984509|FG000|Period Two: Randomized Period|Other - need reasons|0|||
46766125|NCT00455533|82984510|FG001|Period Two: Randomized Period|Other - need reasons|1|||
46766126|NCT00455533|82984511|FG002|Period Two: Randomized Period|Other - need reasons|0|||
46766127|NCT00455533|82984509|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
46833338|NCT00162123|83051212|FG005|Overall Study|Not specified (before treatment)|1|||
46833339|NCT00162123|83051213|FG006|Overall Study|Not specified (before treatment)|0|||
46833340|NCT00162123|83051214|FG007|Overall Study|Not specified (before treatment)|0|||
46833341|NCT00162123|83051207|FG000|Overall Study|Not specified (after start of treatment)|0|||
46833342|NCT00162123|83051208|FG001|Overall Study|Not specified (after start of treatment)|0|||
46833343|NCT00162123|83051209|FG002|Overall Study|Not specified (after start of treatment)|0|||
46833344|NCT00162123|83051210|FG003|Overall Study|Not specified (after start of treatment)|0|||
46833345|NCT00162123|83051211|FG004|Overall Study|Not specified (after start of treatment)|3|||
46833346|NCT00162123|83051212|FG005|Overall Study|Not specified (after start of treatment)|0|||
46833347|NCT00162123|83051213|FG006|Overall Study|Not specified (after start of treatment)|0|||
46833348|NCT00162123|83051214|FG007|Overall Study|Not specified (after start of treatment)|0|||
46833349|NCT00162123|83051207|FG000|Overall Study|Physician Decision|1|||
46833350|NCT00162123|83051208|FG001|Overall Study|Physician Decision|2|||
46833351|NCT00162123|83051209|FG002|Overall Study|Physician Decision|0|||
46833352|NCT00162123|83051210|FG003|Overall Study|Physician Decision|0|||
46833353|NCT00162123|83051211|FG004|Overall Study|Physician Decision|0|||
46833354|NCT00162123|83051212|FG005|Overall Study|Physician Decision|1|||
46833355|NCT00162123|83051213|FG006|Overall Study|Physician Decision|1|||
46833356|NCT00162123|83051214|FG007|Overall Study|Physician Decision|0|||
46833357|NCT00162123|83051207|FG000|Overall Study|Tumor assessment only (not treated)|0|||
46833358|NCT00162123|83051208|FG001|Overall Study|Tumor assessment only (not treated)|0|||
46833359|NCT00162123|83051209|FG002|Overall Study|Tumor assessment only (not treated)|0|||
46833360|NCT00162123|83051210|FG003|Overall Study|Tumor assessment only (not treated)|0|||
46833361|NCT00162123|83051211|FG004|Overall Study|Tumor assessment only (not treated)|0|||
46833362|NCT00162123|83051212|FG005|Overall Study|Tumor assessment only (not treated)|0|||
46833363|NCT00162123|83051213|FG006|Overall Study|Tumor assessment only (not treated)|0|||
46833364|NCT00162123|83051214|FG007|Overall Study|Tumor assessment only (not treated)|1|||
46833365|NCT00162123|83051207|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
46833366|NCT00162123|83051208|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
46833367|NCT00162123|83051209|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
46833368|NCT00162123|83051210|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
46833369|NCT00162123|83051211|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
46833370|NCT00162123|83051212|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
46833371|NCT00162123|83051213|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
46940895|NCT02907463|83178038|FG000|Overall Study|MIS Approach was not used|2|||
46940896|NCT02907463|83178038|FG000|Overall Study|Not Implanted with Study Device|2|||
46940897|NCT02907463|83178038|FG000|Overall Study|Device Explanted|1|||
46637808|NCT01474512|82811391|FG015|Long-Term Extension Period|Clinical Relapse|0|||
46637809|NCT01474512|82811392|FG016|Long-Term Extension Period|Clinical Relapse|0|||
46766128|NCT00455533|82984510|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
46766129|NCT00455533|82984511|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
46833372|NCT00162123|83051214|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
46833373|NCT00227721|83051233|FG000|Overall Study|On study, but never treated.|1|||
46833374|NCT00226941|83051241|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
46833375|NCT00226941|83051242|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
46833376|NCT00226941|83051243|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
46833377|NCT00226941|83051244|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
46940898|NCT02907463|83178038|FG000|Overall Study|Missing Exit Form|1|||
46940899|NCT02906917|83178052|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
46940900|NCT02906917|83178053|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
46940901|NCT02906917|83178052|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
46940902|NCT02906917|83178053|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
46940903|NCT02906917|83178052|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
46940904|NCT02906917|83178053|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
46940905|NCT02906917|83178052|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
46940906|NCT02906917|83178053|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
46940907|NCT02906917|83178052|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
46940908|NCT02906917|83178053|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
46940909|NCT02906917|83178052|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
46940910|NCT02906917|83178053|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
46940911|NCT02906917|83178052|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
46940912|NCT02906917|83178053|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
46940913|NCT02906917|83178052|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
46940914|NCT02906917|83178053|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
46940915|NCT02982187|83178061|FG000|Overall Study|Withdrawal by Subject|0|||
46940916|NCT02982187|83178062|FG001|Overall Study|Withdrawal by Subject|0|||
46940917|NCT02982187|83178063|FG002|Overall Study|Withdrawal by Subject|0|||
46940918|NCT02982187|83178064|FG003|Overall Study|Withdrawal by Subject|0|||
46940919|NCT02982187|83178065|FG004|Overall Study|Withdrawal by Subject|0|||
46940920|NCT02982187|83178066|FG005|Overall Study|Withdrawal by Subject|0|||
46940921|NCT02982187|83178067|FG006|Overall Study|Withdrawal by Subject|1|||
46940922|NCT02982187|83178068|FG007|Overall Study|Withdrawal by Subject|0|||
46940923|NCT02981953|83178078|FG000|Overall Study|Death|9|||
46940924|NCT02981953|83178078|FG000|Overall Study|Withdrawal by Subject|1|||
46940925|NCT02981953|83178078|FG000|Overall Study|Withdrawal to non-compliance|1|||
46940926|NCT01066585|83178094|FG000|Overall Study|Protocol Violation|1|||
46940927|NCT01066585|83178095|FG001|Overall Study|Protocol Violation|0|||
46940928|NCT01066585|83178094|FG000|Overall Study|Withdrawal by Subject|0|||
46940929|NCT01066585|83178095|FG001|Overall Study|Withdrawal by Subject|3|||
46940930|NCT02980783|83178101|FG000|Overall Study|Lost to Follow-up|1|||
46940931|NCT02980705|83178107|FG000|Overall Study|Adverse Event|0|||
46940932|NCT02980705|83178108|FG001|Overall Study|Adverse Event|1|||
46940933|NCT02980705|83178107|FG000|Overall Study|Withdrawal by Subject|6|||
46940934|NCT02980705|83178108|FG001|Overall Study|Withdrawal by Subject|9|||
46940935|NCT02980705|83178107|FG000|Overall Study|withdrew participation|0|||
46940936|NCT02980705|83178108|FG001|Overall Study|withdrew participation|1|||
46940937|NCT02980705|83178107|FG000|Overall Study|Lost to Follow-up|2|||
46940938|NCT02980705|83178108|FG001|Overall Study|Lost to Follow-up|0|||
46940939|NCT02989649|83178115|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
46940940|NCT02989649|83178115|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
46940941|NCT02989649|83178115|FG000|Overall Study|Lost For Observation During Study|3|||
46940942|NCT02989649|83178115|FG000|Overall Study|Reason Not Specified|13|||
46940943|NCT02905435|83178119|FG000|Overall Study|Death|2|||
46940944|NCT02905435|83178119|FG000|Overall Study|Physician Decision|1|||
46940945|NCT02905435|83178119|FG000|Overall Study|Lost to Follow-up|4|||
46940946|NCT02978833|83178126|FG000|Overall Study|Study terminated|1|||
46940947|NCT02978833|83178127|FG001|Overall Study|Study terminated|1|||
46940948|NCT01067339|83178136|FG000|Overall Study|Withdrawal by Subject|6|||
46940949|NCT01067339|83178137|FG001|Overall Study|Withdrawal by Subject|5|||
46940950|NCT02573259|83178150|FG000|Overall Study|Death|1|||
46766130|NCT00455533|82984509|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
46766131|NCT00455533|82984510|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
46766132|NCT00455533|82984511|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
46766133|NCT00627094|82984521|FG000|Overall Study|Adverse Event|8|||
46766134|NCT00627094|82984522|FG001|Overall Study|Adverse Event|7|||
46766135|NCT00627094|82984521|FG000|Overall Study|Lost to Follow-up|1|||
46766136|NCT00627094|82984522|FG001|Overall Study|Lost to Follow-up|0|||
46766137|NCT00627094|82984521|FG000|Overall Study|Withdrawal by Subject|1|||
46766138|NCT00627094|82984522|FG001|Overall Study|Withdrawal by Subject|1|||
46766139|NCT00627094|82984521|FG000|Overall Study|ulcer healed|1|||
46766140|NCT00627094|82984522|FG001|Overall Study|ulcer healed|7|||
46766141|NCT00627094|82984521|FG000|Overall Study|Other reason|1|||
46766142|NCT00627094|82984522|FG001|Overall Study|Other reason|0|||
46940951|NCT02573259|83178151|FG001|Overall Study|Death|6|||
46940952|NCT02573259|83178152|FG002|Overall Study|Death|5|||
46940953|NCT02573259|83178153|FG003|Overall Study|Death|6|||
46940954|NCT02573259|83178154|FG004|Overall Study|Death|9|||
46940955|NCT02573259|83178155|FG005|Overall Study|Death|32|||
46766143|NCT00642850|82984530|FG000|Overall Study|Death|7|||
46766144|NCT00642850|82984530|FG000|Overall Study|Adverse Event|2|||
46766145|NCT00642850|82984530|FG000|Overall Study|Lack of Efficacy|1|||
46766146|NCT00642850|82984530|FG000|Overall Study|Protocol Violation|2|||
46940956|NCT02573259|83178156|FG006|Overall Study|Death|21|||
46940957|NCT02573259|83178150|FG000|Overall Study|Lost to Follow-up|0|||
47061621|NCT05052697|83342231|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46766147|NCT00642850|82984530|FG000|Overall Study|Kidney transplantation|8|||
46766148|NCT00642850|82984530|FG000|Overall Study|Blood transfusion|6|||
46766149|NCT00642850|82984530|FG000|Overall Study|Other reasons|7|||
46766150|NCT00455455|82984534|FG000|Washout|Withdrawal by Subject|0|||
46766151|NCT00455455|82984535|FG001|Washout|Withdrawal by Subject|1|||
46766152|NCT00455455|82984534|FG000|Washout|Withdrawal by Subject|1|||
46766153|NCT00455455|82984535|FG001|Washout|Withdrawal by Subject|0|||
46766154|NCT03840811|82984547|FG000|Overall Study|Lost to Follow-up|0|||
46766155|NCT03840811|82984548|FG001|Overall Study|Lost to Follow-up|0|||
46766156|NCT03840811|82984549|FG002|Overall Study|Lost to Follow-up|1|||
46766157|NCT00640510|82984559|FG000|Overall Study|Lack of Efficacy|0|||
46766158|NCT00640510|82984560|FG001|Overall Study|Lack of Efficacy|1|||
46766159|NCT00640510|82984559|FG000|Overall Study|Protocol Violation|1|||
46766160|NCT00640510|82984560|FG001|Overall Study|Protocol Violation|0|||
46766161|NCT00640510|82984559|FG000|Overall Study|Physician Decision|0|||
46766162|NCT00640510|82984560|FG001|Overall Study|Physician Decision|1|||
46766163|NCT00813800|82984566|FG000|Overall Study|Screen Failure after Consent|2|||
46766164|NCT00813800|82984566|FG000|Overall Study|Adverse Event|1|||
46766165|NCT00813800|82984566|FG000|Overall Study|Worsening of depression|2|||
46766166|NCT00813800|82984566|FG000|Overall Study|Physician Decision|1|||
46766167|NCT00627016|82984572|FG000|Overall Study|Adverse Event|1|||
46766168|NCT00627016|82984573|FG001|Overall Study|Adverse Event|1|||
46833378|NCT00226941|83051241|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
46833379|NCT00226941|83051242|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
46833380|NCT00226941|83051243|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
46833381|NCT00226941|83051244|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
46833382|NCT00356408|83051264|FG000|Overall Study|Adverse Event|9|||
46833383|NCT00356408|83051264|FG000|Overall Study|Lack of Efficacy|36|||
46833384|NCT00356408|83051264|FG000|Overall Study|Lost to Follow-up|2|||
46833385|NCT00356408|83051264|FG000|Overall Study|Withdrawal by Subject|6|||
46833386|NCT00356408|83051264|FG000|Overall Study|Other: Principal investigator discretion|3|||
46833387|NCT00356408|83051264|FG000|Overall Study|Other: Sponsor request|1|||
46833388|NCT00356408|83051264|FG000|Overall Study|Other: Azathioprine stopped|1|||
46833389|NCT00356408|83051264|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
46833390|NCT00356408|83051264|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
46833391|NCT00509795|83051279|FG000|Overall Study|Adverse Event|4|||
46833392|NCT00509795|83051280|FG001|Overall Study|Adverse Event|3|||
46833393|NCT00509795|83051281|FG002|Overall Study|Adverse Event|5|||
46833394|NCT00509795|83051282|FG003|Overall Study|Adverse Event|4|||
46833395|NCT00509795|83051279|FG000|Overall Study|Death|3|||
46833396|NCT00509795|83051280|FG001|Overall Study|Death|1|||
46833397|NCT00509795|83051281|FG002|Overall Study|Death|2|||
46833398|NCT00509795|83051282|FG003|Overall Study|Death|7|||
46833399|NCT00509795|83051279|FG000|Overall Study|Lack of Efficacy|0|||
46833400|NCT00509795|83051280|FG001|Overall Study|Lack of Efficacy|0|||
46833401|NCT00509795|83051281|FG002|Overall Study|Lack of Efficacy|2|||
46833402|NCT00509795|83051282|FG003|Overall Study|Lack of Efficacy|2|||
46833403|NCT00509795|83051279|FG000|Overall Study|Lost to Follow-up|1|||
46833404|NCT00509795|83051280|FG001|Overall Study|Lost to Follow-up|2|||
46833405|NCT00509795|83051281|FG002|Overall Study|Lost to Follow-up|4|||
46833406|NCT00509795|83051282|FG003|Overall Study|Lost to Follow-up|4|||
46833407|NCT00509795|83051279|FG000|Overall Study|OTHER|1|||
46833408|NCT00509795|83051280|FG001|Overall Study|OTHER|0|||
46833409|NCT00509795|83051281|FG002|Overall Study|OTHER|4|||
46833410|NCT00509795|83051282|FG003|Overall Study|OTHER|1|||
47061622|NCT05052697|83342232|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46766169|NCT00627016|82984572|FG000|Overall Study|Protocol Violation|0|||
46766170|NCT00627016|82984573|FG001|Overall Study|Protocol Violation|2|||
46766171|NCT00627016|82984572|FG000|Overall Study|Lost to Follow-up|0|||
46766172|NCT00627016|82984573|FG001|Overall Study|Lost to Follow-up|1|||
46766173|NCT00627016|82984572|FG000|Overall Study|Withdrawal by Subject|2|||
46766174|NCT00627016|82984573|FG001|Overall Study|Withdrawal by Subject|1|||
46766175|NCT00627016|82984572|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
46766176|NCT00627016|82984573|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
46766177|NCT00627016|82984572|FG000|Overall Study|Lack of Efficacy|1|||
46766178|NCT00627016|82984573|FG001|Overall Study|Lack of Efficacy|0|||
46766179|NCT00627016|82984572|FG000|Overall Study|Placed on Excluded Drugs|1|||
46833411|NCT00509795|83051279|FG000|Overall Study|Protocol Violation|3|||
46833412|NCT00509795|83051280|FG001|Overall Study|Protocol Violation|0|||
46833413|NCT00509795|83051281|FG002|Overall Study|Protocol Violation|3|||
46833414|NCT00509795|83051282|FG003|Overall Study|Protocol Violation|1|||
46833415|NCT00509795|83051279|FG000|Overall Study|Withdrawal by Subject|10|||
46833416|NCT00509795|83051280|FG001|Overall Study|Withdrawal by Subject|5|||
46833417|NCT00509795|83051281|FG002|Overall Study|Withdrawal by Subject|7|||
46833418|NCT00509795|83051282|FG003|Overall Study|Withdrawal by Subject|8|||
46766180|NCT00627016|82984573|FG001|Overall Study|Placed on Excluded Drugs|0|||
46766181|NCT00627016|82984572|FG000|Overall Study|Pregnancy|1|||
46940958|NCT02573259|83178151|FG001|Overall Study|Lost to Follow-up|0|||
46940959|NCT02573259|83178152|FG002|Overall Study|Lost to Follow-up|0|||
46940960|NCT02573259|83178153|FG003|Overall Study|Lost to Follow-up|0|||
46940961|NCT02573259|83178154|FG004|Overall Study|Lost to Follow-up|0|||
46940962|NCT02573259|83178155|FG005|Overall Study|Lost to Follow-up|2|||
46940963|NCT02573259|83178156|FG006|Overall Study|Lost to Follow-up|1|||
46940964|NCT02573259|83178150|FG000|Overall Study|Participant refused further follow-up|0|||
46940965|NCT02573259|83178151|FG001|Overall Study|Participant refused further follow-up|2|||
46940966|NCT02573259|83178152|FG002|Overall Study|Participant refused further follow-up|1|||
46940967|NCT02573259|83178153|FG003|Overall Study|Participant refused further follow-up|0|||
46940968|NCT02573259|83178154|FG004|Overall Study|Participant refused further follow-up|3|||
46940969|NCT02573259|83178155|FG005|Overall Study|Participant refused further follow-up|20|||
46940970|NCT02573259|83178156|FG006|Overall Study|Participant refused further follow-up|7|||
46940971|NCT02573259|83178150|FG000|Overall Study|Other|0|||
46940972|NCT02573259|83178151|FG001|Overall Study|Other|0|||
46940973|NCT02573259|83178152|FG002|Overall Study|Other|0|||
46940974|NCT02573259|83178153|FG003|Overall Study|Other|0|||
46940975|NCT02573259|83178154|FG004|Overall Study|Other|1|||
46940976|NCT02573259|83178155|FG005|Overall Study|Other|4|||
46940977|NCT02573259|83178156|FG006|Overall Study|Other|5|||
46940978|NCT02977507|83178193|FG000|Overall Study|Protocol Deviation|1|||
46940979|NCT02977507|83178194|FG001|Overall Study|Protocol Deviation|0|||
46940980|NCT02977507|83178193|FG000|Overall Study|Lost to Follow-up|1|||
46940981|NCT02977507|83178194|FG001|Overall Study|Lost to Follow-up|0|||
46940982|NCT02976103|83178203|FG000|Overall Study|Withdrawal by Subject|1|||
46940983|NCT02976103|83178204|FG001|Overall Study|Withdrawal by Subject|0|||
46940984|NCT02976103|83178203|FG000|Overall Study|Lost to Follow-up|12|||
46940985|NCT02976103|83178204|FG001|Overall Study|Lost to Follow-up|8|||
46940986|NCT01066039|83178211|FG000|Overall Study|Adverse Event|6|||
46940987|NCT01066039|83178211|FG000|Overall Study|Withdrawal by Subject|17|||
46940988|NCT01066039|83178211|FG000|Overall Study|Protocol Violation|2|||
46940989|NCT01066039|83178211|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
46940990|NCT01066039|83178211|FG000|Overall Study|Investigator's Request|1|||
46940991|NCT01066039|83178211|FG000|Overall Study|Dropout due to Insulin Administration|1|||
46940992|NCT01066039|83178211|FG000|Overall Study|Additional Antihypertensive Required|4|||
46940993|NCT01066039|83178211|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
46940994|NCT01066039|83178211|FG000|Overall Study|Failure to Control Blood Pressure|1|||
46940995|NCT01066039|83178211|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
46940996|NCT02919995|83178221|FG000|Overall Study|Adverse Event|0|||
46940997|NCT02919995|83178222|FG001|Overall Study|Adverse Event|0|||
46940998|NCT02919995|83178223|FG002|Overall Study|Adverse Event|0|||
46940999|NCT02919995|83178224|FG003|Overall Study|Adverse Event|0|||
46941000|NCT02919995|83178225|FG004|Overall Study|Adverse Event|0|||
46941001|NCT02919995|83178226|FG005|Overall Study|Adverse Event|1|||
46941002|NCT02919761|83178234|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
46941003|NCT02919761|83178235|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
46941004|NCT02919761|83178236|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
46637810|NCT01474512|82811393|FG017|Long-Term Extension Period|Clinical Relapse|0|||
46637811|NCT01474512|82811376|FG000|Long-Term Extension Period|Death|0|||
46637812|NCT01474512|82811377|FG001|Long-Term Extension Period|Death|0|||
46637813|NCT01474512|82811378|FG002|Long-Term Extension Period|Death|0|||
46637814|NCT01474512|82811379|FG003|Long-Term Extension Period|Death|0|||
46637815|NCT01474512|82811380|FG004|Long-Term Extension Period|Death|0|||
46637816|NCT01474512|82811381|FG005|Long-Term Extension Period|Death|0|||
46766182|NCT00627016|82984573|FG001|Overall Study|Pregnancy|0|||
46766183|NCT00794664|82984581|FG000|Treatment Period|Withdrawal by Subject|0|||
46766184|NCT00794664|82984582|FG001|Treatment Period|Withdrawal by Subject|2|||
46766185|NCT00794664|82984581|FG000|Treatment Period|Protocol non-compliance|0|||
46766186|NCT00794664|82984582|FG001|Treatment Period|Protocol non-compliance|1|||
46766187|NCT00794664|82984581|FG000|Treatment Period|Other|0|||
46766188|NCT00794664|82984582|FG001|Treatment Period|Other|1|||
46766189|NCT00794664|82984581|FG000|Treatment Period|Adverse Event|1|||
46766190|NCT00794664|82984582|FG001|Treatment Period|Adverse Event|8|||
46766191|NCT00794664|82984581|FG000|Follow-up Period|Other|1|||
46637817|NCT01474512|82811382|FG006|Long-Term Extension Period|Death|0|||
46637818|NCT01474512|82811383|FG007|Long-Term Extension Period|Death|0|||
46766192|NCT00794664|82984582|FG001|Follow-up Period|Other|2|||
46941005|NCT02919761|83178234|FG000|Part 1: Open Label|Adverse Event|1|||
46941006|NCT02919761|83178235|FG001|Part 1: Open Label|Adverse Event|0|||
46941007|NCT02919761|83178236|FG002|Part 1: Open Label|Adverse Event|0|||
46766193|NCT00794664|82984581|FG000|Follow-up Period|Withdrawal by Subject|0|||
46766194|NCT00794664|82984582|FG001|Follow-up Period|Withdrawal by Subject|2|||
46941008|NCT02919761|83178234|FG000|Part 1: Open Label|Lost to Follow-up|1|||
46941009|NCT02919761|83178235|FG001|Part 1: Open Label|Lost to Follow-up|0|||
46941010|NCT02919761|83178236|FG002|Part 1: Open Label|Lost to Follow-up|0|||
46637819|NCT01474512|82811384|FG008|Long-Term Extension Period|Death|0|||
46766195|NCT00794664|82984581|FG000|Follow-up Period|Protocol non-compliance|0|||
46941011|NCT02919761|83178234|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
46941012|NCT02919761|83178235|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
46941013|NCT02919761|83178236|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
46941014|NCT02919761|83178234|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
46941015|NCT02919761|83178235|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
46941016|NCT02919761|83178236|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
46941017|NCT02919761|83178234|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
46941018|NCT02919761|83178235|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
46941019|NCT02919761|83178236|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
46941020|NCT02919761|83178234|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
46941021|NCT02919761|83178235|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
46941022|NCT02919761|83178236|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
46941023|NCT02919761|83178234|FG000|Part 1: Open Label|Termination by Sponsor|1|||
46941024|NCT02919761|83178235|FG001|Part 1: Open Label|Termination by Sponsor|0|||
46941025|NCT02919761|83178236|FG002|Part 1: Open Label|Termination by Sponsor|0|||
46941026|NCT02919761|83178234|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
46941027|NCT02919761|83178235|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
46941028|NCT02919761|83178236|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
46941029|NCT02919761|83178234|FG000|Part 2: Double-blind|Adverse Event|0|||
46941030|NCT02919761|83178235|FG001|Part 2: Double-blind|Adverse Event|1|||
46941031|NCT02919761|83178236|FG002|Part 2: Double-blind|Adverse Event|0|||
46941032|NCT02919761|83178234|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
46941033|NCT02919761|83178235|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
46941034|NCT02919761|83178236|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
46941035|NCT02919761|83178234|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
46941036|NCT02919761|83178235|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
46941037|NCT02919761|83178236|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
46941038|NCT02919761|83178234|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
46833419|NCT00165789|83051297|FG000|Overall Study|Adverse Event|0|||
46833420|NCT00165789|83051298|FG001|Overall Study|Adverse Event|3|||
46833421|NCT00165789|83051299|FG002|Overall Study|Adverse Event|0|||
46833422|NCT00165789|83051300|FG003|Overall Study|Adverse Event|12|||
46833423|NCT00165789|83051297|FG000|Overall Study|Withdrawal by Subject|0|||
46833424|NCT00165789|83051298|FG001|Overall Study|Withdrawal by Subject|1|||
46833425|NCT00165789|83051299|FG002|Overall Study|Withdrawal by Subject|1|||
46833426|NCT00165789|83051300|FG003|Overall Study|Withdrawal by Subject|2|||
46833427|NCT00504257|83051310|FG000|Overall Study|Withdrawal by Subject|2|||
46833428|NCT00504257|83051310|FG000|Overall Study|ineligible histology|2|||
46833429|NCT00509093|83051314|FG000|Overall Study|Adverse Event|10|||
46833430|NCT00509093|83051314|FG000|Overall Study|Disease Progression|9|||
46833431|NCT00509093|83051314|FG000|Overall Study|Transformed into MDS|1|||
46833432|NCT00509093|83051314|FG000|Overall Study|Withdrawal by Subject|3|||
46833433|NCT00509093|83051314|FG000|Overall Study|Physician Decision|1|||
46941039|NCT02919761|83178235|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
46941040|NCT02919761|83178236|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
46941041|NCT02919761|83178234|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
46941042|NCT02919761|83178235|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
46941043|NCT02919761|83178236|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
46941044|NCT02919761|83178234|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
46941045|NCT02919761|83178235|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
46766196|NCT00794664|82984582|FG001|Follow-up Period|Protocol non-compliance|1|||
46766197|NCT00444535|82984588|FG000|Overall Study|Withdrawal by Subject|5|||
46766198|NCT00444535|82984588|FG000|Overall Study|Physician Decision|5|||
46766199|NCT00444535|82984588|FG000|Overall Study|progressive disease|1|||
46766200|NCT00444535|82984588|FG000|Overall Study|Adverse Event|2|||
46766201|NCT00847613|82984596|FG000|Overall Study|Ongoing at cut-off date|250|||
46766202|NCT00847613|82984597|FG001|Overall Study|Ongoing at cut-off date|265|||
46766203|NCT00847613|82984598|FG002|Overall Study|Ongoing at cut-off date|64|||
46766204|NCT00847613|82984599|FG003|Overall Study|Ongoing at cut-off date|64|||
46766205|NCT00847613|82984596|FG000|Overall Study|Death|1|||
46766206|NCT00847613|82984597|FG001|Overall Study|Death|1|||
46766207|NCT00847613|82984598|FG002|Overall Study|Death|0|||
46766208|NCT00847613|82984599|FG003|Overall Study|Death|0|||
46766209|NCT00847613|82984596|FG000|Overall Study|Adverse Event|36|||
46766210|NCT00847613|82984597|FG001|Overall Study|Adverse Event|26|||
46766211|NCT00847613|82984598|FG002|Overall Study|Adverse Event|5|||
46766212|NCT00847613|82984599|FG003|Overall Study|Adverse Event|6|||
46766213|NCT00847613|82984596|FG000|Overall Study|Lack of Efficacy|7|||
46766214|NCT00847613|82984597|FG001|Overall Study|Lack of Efficacy|3|||
46766215|NCT00847613|82984598|FG002|Overall Study|Lack of Efficacy|3|||
46766216|NCT00847613|82984599|FG003|Overall Study|Lack of Efficacy|1|||
46833434|NCT00160641|83051318|FG000|Overall Study|Adverse Event|102|||
46833435|NCT00160641|83051318|FG000|Overall Study|Withdrawal by Subject|87|||
46941046|NCT02919761|83178236|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
46941047|NCT02919761|83178234|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
46941048|NCT02919761|83178235|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
46941049|NCT02919761|83178236|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
46941050|NCT02910167|83178247|FG000|Overall Study|Adverse Event|1|||
46941051|NCT02910167|83178247|FG000|Overall Study|Lost to Follow-up|18|||
46941052|NCT01067105|83178251|FG000|Overall Study|Adverse Event|14|||
46941053|NCT01067105|83178251|FG000|Overall Study|Protocol Violation|48|||
46941054|NCT01067105|83178251|FG000|Overall Study|Withdrawal by Subject|36|||
46941055|NCT01067105|83178251|FG000|Overall Study|Lost to Follow-up|6|||
46941056|NCT01067105|83178251|FG000|Overall Study|Physician Decision|6|||
46941057|NCT01067105|83178251|FG000|Overall Study|Other|31|||
46941058|NCT02910089|83178261|FG000|Overall Study|Lost insurance eligibility|22|||
46941059|NCT02910089|83178262|FG001|Overall Study|Lost insurance eligibility|16|||
46941060|NCT02985515|83178270|FG000|Olfaction Testing|Lost to Follow-up|0|||
46941061|NCT02985515|83178271|FG001|Olfaction Testing|Lost to Follow-up|5|||
46941062|NCT02985515|83178270|FG000|Olfaction Testing|Protocol Violation|0|||
46941063|NCT02985515|83178271|FG001|Olfaction Testing|Protocol Violation|3|||
46941064|NCT02910011|83178284|FG000|Overall Study|Physician Decision|2|||
46941065|NCT02908841|83178292|FG000|Overall Study|Physician Decision|4|||
46941066|NCT02908841|83178293|FG001|Overall Study|Physician Decision|0|||
46941067|NCT02909153|83178304|FG000|Overall Study|Withdrawal by Subject|0|||
46941068|NCT02909153|83178305|FG001|Overall Study|Withdrawal by Subject|1|||
46941069|NCT02909153|83178306|FG002|Overall Study|Withdrawal by Subject|0|||
46941070|NCT02909153|83178307|FG003|Overall Study|Withdrawal by Subject|0|||
46941071|NCT02909153|83178308|FG004|Overall Study|Withdrawal by Subject|0|||
46941072|NCT02908529|83178320|FG000|Overall Study|Lost to Follow-up|0|||
46941073|NCT02908529|83178321|FG001|Overall Study|Lost to Follow-up|2|||
46941074|NCT02984267|83178331|FG000|Overall Study|Protocol Violation|1|||
46941075|NCT02984267|83178332|FG001|Overall Study|Protocol Violation|0|||
46941076|NCT02984267|83178331|FG000|Overall Study|Withdrawal by Subject|0|||
46941077|NCT02984267|83178332|FG001|Overall Study|Withdrawal by Subject|1|||
46941078|NCT02675751|83178338|FG000|Overall Study|Lost to Follow-up|16|||
46941079|NCT02974855|83178355|FG000|Overall Study|Adverse Event|0|||
46941080|NCT02974855|83178356|FG001|Overall Study|Adverse Event|1|||
46941081|NCT02974855|83178357|FG002|Overall Study|Adverse Event|0|||
46941082|NCT02974855|83178358|FG003|Overall Study|Adverse Event|1|||
46941083|NCT00455403|83178383|FG000|Overall Study|Lost to Follow-up|2|||
46941084|NCT00455403|83178384|FG001|Overall Study|Lost to Follow-up|1|||
46941085|NCT00455403|83178383|FG000|Overall Study|Withdrawal by Subject|1|||
46941086|NCT00455403|83178384|FG001|Overall Study|Withdrawal by Subject|3|||
46941087|NCT00455403|83178383|FG000|Overall Study|Protocol Violation|0|||
46941088|NCT00455403|83178384|FG001|Overall Study|Protocol Violation|2|||
46941089|NCT02979613|83178392|FG000|Double-Blind Phase|Withdrew Consent|2|||
46941090|NCT02979613|83178393|FG001|Double-Blind Phase|Withdrew Consent|4|||
46941091|NCT02979613|83178392|FG000|Double-Blind Phase|Pregnancy|2|||
46941092|NCT02979613|83178393|FG001|Double-Blind Phase|Pregnancy|2|||
46941093|NCT02979613|83178392|FG000|Double-Blind Phase|Adverse Event|2|||
46941094|NCT02979613|83178393|FG001|Double-Blind Phase|Adverse Event|0|||
46941095|NCT02979613|83178392|FG000|Double-Blind Phase|Lost to Follow-up|1|||
46941096|NCT02979613|83178393|FG001|Double-Blind Phase|Lost to Follow-up|1|||
46941097|NCT02979613|83178392|FG000|Double-Blind Phase|Protocol Violation|1|||
46941098|NCT02979613|83178393|FG001|Double-Blind Phase|Protocol Violation|1|||
46941099|NCT02979613|83178392|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
46941100|NCT02979613|83178393|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
46941101|NCT02979613|83178392|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
46941102|NCT02979613|83178393|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
46941103|NCT02979613|83178392|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
47061623|NCT05052697|83342233|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061624|NCT05052697|83342234|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061625|NCT05052697|83342235|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061626|NCT05052697|83342236|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061627|NCT05052697|83342237|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
47061628|NCT05052697|83342238|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061629|NCT05052697|83342239|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
46637820|NCT01474512|82811385|FG009|Long-Term Extension Period|Death|0|||
46833436|NCT00160641|83051318|FG000|Overall Study|Lost to Follow-up|8|||
46941104|NCT02979613|83178393|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
46941105|NCT02979613|83178392|FG000|Open-Label Extension (OLE) Phase|Death|0|||
46941106|NCT02979613|83178393|FG001|Open-Label Extension (OLE) Phase|Death|1|||
46941107|NCT02979613|83178392|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
46941108|NCT02979613|83178393|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
46941109|NCT01064167|83178403|FG000|Overall Study|Protocol Violation|14|||
46941110|NCT01064167|83178404|FG001|Overall Study|Protocol Violation|15|||
46941111|NCT02974543|83178412|FG000|Overall Study|Withdrawal by Subject|1|||
46637821|NCT01474512|82811386|FG010|Long-Term Extension Period|Death|0|||
46941112|NCT02974543|83178413|FG001|Overall Study|Withdrawal by Subject|0|||
46941113|NCT01064947|83178427|FG000|Overall Study|negative culture|41|||
46941114|NCT02974153|83178438|FG000|Overall Study|Adverse Event|6|||
46941115|NCT02974153|83178439|FG001|Overall Study|Adverse Event|0|||
46941116|NCT02974153|83178440|FG002|Overall Study|Adverse Event|1|||
46941117|NCT02974153|83178438|FG000|Overall Study|Lack of Efficacy|6|||
46941118|NCT02974153|83178439|FG001|Overall Study|Lack of Efficacy|5|||
46941119|NCT02974153|83178440|FG002|Overall Study|Lack of Efficacy|10|||
46941120|NCT02974153|83178438|FG000|Overall Study|Lost to Follow-up|9|||
46941121|NCT02974153|83178439|FG001|Overall Study|Lost to Follow-up|10|||
46941122|NCT02974153|83178440|FG002|Overall Study|Lost to Follow-up|17|||
46941123|NCT02974153|83178438|FG000|Overall Study|Physician Decision|0|||
46941124|NCT02974153|83178439|FG001|Overall Study|Physician Decision|2|||
46941125|NCT02974153|83178440|FG002|Overall Study|Physician Decision|1|||
46941126|NCT02974153|83178438|FG000|Overall Study|Withdrawal by Subject|9|||
46941127|NCT02974153|83178439|FG001|Overall Study|Withdrawal by Subject|16|||
46941128|NCT02974153|83178440|FG002|Overall Study|Withdrawal by Subject|11|||
46941129|NCT02974153|83178438|FG000|Overall Study|Study Burden|8|||
46941130|NCT02974153|83178439|FG001|Overall Study|Study Burden|7|||
46941131|NCT02974153|83178440|FG002|Overall Study|Study Burden|3|||
46941132|NCT02974153|83178438|FG000|Overall Study|Other|14|||
46941133|NCT02974153|83178439|FG001|Overall Study|Other|8|||
46941134|NCT02974153|83178440|FG002|Overall Study|Other|7|||
46941135|NCT02508532|83178455|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941136|NCT02508532|83178456|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941137|NCT02508532|83178457|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941138|NCT02508532|83178458|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941139|NCT02508532|83178459|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941140|NCT02508532|83178460|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941141|NCT02508532|83178461|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
46941142|NCT02508532|83178462|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941143|NCT02508532|83178463|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
46941144|NCT02508532|83178455|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941145|NCT02508532|83178456|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941146|NCT02508532|83178457|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941147|NCT02508532|83178458|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941148|NCT02508532|83178459|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941149|NCT02508532|83178460|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941150|NCT02508532|83178461|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941151|NCT02508532|83178462|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
46941152|NCT02508532|83178463|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
46941153|NCT02508532|83178455|FG000|Part 2 - Treatment|Disease Progression|0|||
46941154|NCT02508532|83178456|FG001|Part 2 - Treatment|Disease Progression|0|||
46941155|NCT02508532|83178457|FG002|Part 2 - Treatment|Disease Progression|0|||
46941156|NCT02508532|83178458|FG003|Part 2 - Treatment|Disease Progression|0|||
46941157|NCT02508532|83178459|FG004|Part 2 - Treatment|Disease Progression|0|||
46941158|NCT02508532|83178460|FG005|Part 2 - Treatment|Disease Progression|0|||
46941159|NCT02508532|83178461|FG006|Part 2 - Treatment|Disease Progression|0|||
46941160|NCT02508532|83178462|FG007|Part 2 - Treatment|Disease Progression|0|||
46941161|NCT02508532|83178463|FG008|Part 2 - Treatment|Disease Progression|118|||
46941162|NCT02508532|83178455|FG000|Part 2 - Treatment|Adverse Event|0|||
46941163|NCT02508532|83178456|FG001|Part 2 - Treatment|Adverse Event|0|||
46941164|NCT02508532|83178457|FG002|Part 2 - Treatment|Adverse Event|0|||
46941165|NCT02508532|83178458|FG003|Part 2 - Treatment|Adverse Event|0|||
46941166|NCT02508532|83178459|FG004|Part 2 - Treatment|Adverse Event|0|||
46941167|NCT02508532|83178460|FG005|Part 2 - Treatment|Adverse Event|0|||
46941168|NCT02508532|83178461|FG006|Part 2 - Treatment|Adverse Event|0|||
46941169|NCT02508532|83178462|FG007|Part 2 - Treatment|Adverse Event|0|||
46941170|NCT02508532|83178463|FG008|Part 2 - Treatment|Adverse Event|49|||
46941171|NCT02508532|83178455|FG000|Part 2 - Treatment|Physician Decision|0|||
46941172|NCT02508532|83178456|FG001|Part 2 - Treatment|Physician Decision|0|||
46941173|NCT02508532|83178457|FG002|Part 2 - Treatment|Physician Decision|0|||
46941174|NCT02508532|83178458|FG003|Part 2 - Treatment|Physician Decision|0|||
46941175|NCT02508532|83178459|FG004|Part 2 - Treatment|Physician Decision|0|||
46941176|NCT02508532|83178460|FG005|Part 2 - Treatment|Physician Decision|0|||
46941177|NCT02508532|83178461|FG006|Part 2 - Treatment|Physician Decision|0|||
46941178|NCT02508532|83178462|FG007|Part 2 - Treatment|Physician Decision|0|||
46941179|NCT02508532|83178463|FG008|Part 2 - Treatment|Physician Decision|12|||
46941180|NCT02508532|83178455|FG000|Part 2 - Treatment|Administrative|0|||
46941181|NCT02508532|83178456|FG001|Part 2 - Treatment|Administrative|0|||
46941182|NCT02508532|83178457|FG002|Part 2 - Treatment|Administrative|0|||
46941183|NCT02508532|83178458|FG003|Part 2 - Treatment|Administrative|0|||
46941184|NCT02508532|83178459|FG004|Part 2 - Treatment|Administrative|0|||
46941185|NCT02508532|83178460|FG005|Part 2 - Treatment|Administrative|0|||
46941186|NCT02508532|83178461|FG006|Part 2 - Treatment|Administrative|0|||
46941187|NCT02508532|83178462|FG007|Part 2 - Treatment|Administrative|0|||
46941188|NCT02508532|83178463|FG008|Part 2 - Treatment|Administrative|3|||
46941189|NCT02508532|83178455|FG000|Part 2 - Treatment|Sponsor Decision|0|||
46941190|NCT02508532|83178456|FG001|Part 2 - Treatment|Sponsor Decision|0|||
46941191|NCT02508532|83178457|FG002|Part 2 - Treatment|Sponsor Decision|0|||
46941192|NCT02508532|83178458|FG003|Part 2 - Treatment|Sponsor Decision|0|||
46941193|NCT02508532|83178459|FG004|Part 2 - Treatment|Sponsor Decision|0|||
46941194|NCT02508532|83178460|FG005|Part 2 - Treatment|Sponsor Decision|0|||
46941195|NCT02508532|83178461|FG006|Part 2 - Treatment|Sponsor Decision|0|||
46941196|NCT02508532|83178462|FG007|Part 2 - Treatment|Sponsor Decision|0|||
46941197|NCT02508532|83178463|FG008|Part 2 - Treatment|Sponsor Decision|28|||
46941198|NCT02508532|83178455|FG000|Part 2 - Treatment|Death|0|||
46941199|NCT02508532|83178456|FG001|Part 2 - Treatment|Death|0|||
46941200|NCT02508532|83178457|FG002|Part 2 - Treatment|Death|0|||
46941201|NCT02508532|83178458|FG003|Part 2 - Treatment|Death|0|||
46941202|NCT02508532|83178459|FG004|Part 2 - Treatment|Death|0|||
46941203|NCT02508532|83178460|FG005|Part 2 - Treatment|Death|0|||
46941204|NCT02508532|83178461|FG006|Part 2 - Treatment|Death|0|||
46941205|NCT02508532|83178462|FG007|Part 2 - Treatment|Death|0|||
46941206|NCT02508532|83178463|FG008|Part 2 - Treatment|Death|1|||
46941207|NCT02508532|83178455|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
46941208|NCT02508532|83178456|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
46941209|NCT02508532|83178457|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
46941210|NCT02508532|83178458|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
46941211|NCT02508532|83178459|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
46941212|NCT02508532|83178460|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
46941213|NCT02508532|83178461|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
46941214|NCT02508532|83178462|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
46941215|NCT02508532|83178463|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
46941216|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
46941217|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
46941218|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
46941219|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
46941220|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
46941221|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
46941222|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
46941223|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
46941224|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
46941225|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
46941226|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
46941227|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
46941228|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
46941229|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
46941230|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
46941231|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
46941232|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
46941233|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
46941234|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Death|0|||
47061630|NCT05052697|83342240|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061631|NCT05052697|83342241|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061632|NCT05052697|83342242|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061633|NCT05052697|83342243|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061634|NCT05052697|83342244|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061635|NCT05052697|83342245|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061636|NCT05052697|83342246|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061637|NCT05052697|83342247|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061638|NCT05052697|83342248|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061639|NCT05052697|83342249|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061640|NCT05052697|83342250|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061641|NCT05052697|83342251|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
47061642|NCT05052697|83342218|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061643|NCT05052697|83342219|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061644|NCT05052697|83342220|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061645|NCT05052697|83342221|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
46637822|NCT01474512|82811387|FG011|Long-Term Extension Period|Death|0|||
46637823|NCT01474512|82811388|FG012|Long-Term Extension Period|Death|9|||
46941235|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Death|4|||
46941236|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Death|2|||
46941237|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Death|4|||
46941238|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Death|3|||
47061646|NCT05052697|83342222|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
46941239|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Death|0|||
46941240|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Death|0|||
46941241|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Death|1|||
46941242|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Death|111|||
46941243|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
46941244|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
46941245|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
46941246|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
46941247|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
46941248|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
46941249|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
46941250|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
46941251|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
46941252|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941253|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941254|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941255|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941256|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941257|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941258|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941259|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
46941260|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
46941261|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
46941262|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
46941263|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
46941264|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
46941265|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
46941266|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
46941267|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
46941268|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
46941269|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
46941270|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941271|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941272|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941273|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941274|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941275|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941276|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941277|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
46941278|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
46941279|NCT02508532|83178455|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
46941280|NCT02508532|83178456|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
46941281|NCT02508532|83178457|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
46941282|NCT02508532|83178458|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
46941283|NCT02508532|83178459|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
46941284|NCT02508532|83178460|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
46941285|NCT02508532|83178461|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
46941286|NCT02508532|83178462|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
46941287|NCT02508532|83178463|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
46941288|NCT02918071|83178492|FG000|Overall Study|Withdrawal by Subject|2|||
46941289|NCT02918071|83178492|FG000|Overall Study|Lost to Follow-up|1|||
46941290|NCT02507752|83178496|FG000|Overall Study|Adverse Event|1|||
46941291|NCT02507752|83178496|FG000|Overall Study|Protocol Violation|6|||
46941292|NCT02507752|83178496|FG000|Overall Study|Lost to Follow-up|7|||
46941293|NCT02507752|83178496|FG000|Overall Study|Infusion reaction at first infusion|1|||
46941294|NCT02507752|83178496|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
46941295|NCT02507752|83178496|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
46941296|NCT02506816|83178500|FG000|Overall Study|Adverse Event|3|||
46941297|NCT02506036|83178506|FG000|First Intervention (4-6 Weeks)|Death|1|||
46941298|NCT02506036|83178507|FG001|First Intervention (4-6 Weeks)|Death|0|||
46941299|NCT02506036|83178506|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
46941300|NCT02506036|83178507|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
46941301|NCT02506036|83178506|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
46833437|NCT00160641|83051318|FG000|Overall Study|Lack of Efficacy|12|||
46833438|NCT00160641|83051318|FG000|Overall Study|Protocol Violation|3|||
46833439|NCT00160641|83051318|FG000|Overall Study|Other|9|||
46833440|NCT00493025|83051322|FG000|Overall Study|Physician Decision|19|||
46833441|NCT00160563|83051330|FG000|Overall Study|Adverse Event|1|||
46833442|NCT00160563|83051331|FG001|Overall Study|Adverse Event|1|||
46833443|NCT00160563|83051332|FG002|Overall Study|Adverse Event|1|||
46833444|NCT00160563|83051330|FG000|Overall Study|Lost to Follow-up|1|||
46833445|NCT00160563|83051331|FG001|Overall Study|Lost to Follow-up|1|||
46833446|NCT00160563|83051332|FG002|Overall Study|Lost to Follow-up|2|||
46833447|NCT00160563|83051330|FG000|Overall Study|Protocol Violation|0|||
46833448|NCT00160563|83051331|FG001|Overall Study|Protocol Violation|0|||
46833449|NCT00160563|83051332|FG002|Overall Study|Protocol Violation|3|||
46833450|NCT00160563|83051330|FG000|Overall Study|Withdrawal by Subject|1|||
46833451|NCT00160563|83051331|FG001|Overall Study|Withdrawal by Subject|2|||
46833452|NCT00160563|83051332|FG002|Overall Study|Withdrawal by Subject|3|||
46833453|NCT00160563|83051330|FG000|Overall Study|Other (listed in the study report)|48|||
46833454|NCT00160563|83051331|FG001|Overall Study|Other (listed in the study report)|40|||
46833455|NCT00160563|83051332|FG002|Overall Study|Other (listed in the study report)|81|||
46833456|NCT00160563|83051330|FG000|Overall Study|Missing reason|0|||
46833457|NCT00160563|83051331|FG001|Overall Study|Missing reason|1|||
46833458|NCT00160563|83051332|FG002|Overall Study|Missing reason|0|||
46833459|NCT00380744|83051348|FG000|Overall Study|Death|0|||
46833460|NCT00380744|83051349|FG001|Overall Study|Death|0|||
46833461|NCT00380744|83051350|FG002|Overall Study|Death|0|||
46833462|NCT00380744|83051351|FG003|Overall Study|Death|0|||
46833463|NCT00380744|83051352|FG004|Overall Study|Death|0|||
46833464|NCT00380744|83051353|FG005|Overall Study|Death|0|||
46833465|NCT00380744|83051354|FG006|Overall Study|Death|1|||
46833466|NCT00380744|83051348|FG000|Overall Study|Withdrawal by Subject|1|||
46833467|NCT00380744|83051349|FG001|Overall Study|Withdrawal by Subject|0|||
46833468|NCT00380744|83051350|FG002|Overall Study|Withdrawal by Subject|0|||
46833469|NCT00380744|83051351|FG003|Overall Study|Withdrawal by Subject|0|||
46833470|NCT00380744|83051352|FG004|Overall Study|Withdrawal by Subject|0|||
46833471|NCT00380744|83051353|FG005|Overall Study|Withdrawal by Subject|0|||
46833472|NCT00380744|83051354|FG006|Overall Study|Withdrawal by Subject|0|||
46833473|NCT00380588|83051373|FG000|Overall Study|Unequivocal Disease Progression|25|||
46833474|NCT00380588|83051374|FG001|Overall Study|Unequivocal Disease Progression|34|||
46833475|NCT00380588|83051373|FG000|Overall Study|Next Cycle Not Started|4|||
46833476|NCT00380588|83051374|FG001|Overall Study|Next Cycle Not Started|0|||
46833477|NCT00380588|83051373|FG000|Overall Study|Adverse Event|7|||
46833478|NCT00380588|83051374|FG001|Overall Study|Adverse Event|3|||
46833479|NCT00380588|83051373|FG000|Overall Study|Withdrawal by Subject|1|||
46833480|NCT00380588|83051374|FG001|Overall Study|Withdrawal by Subject|3|||
46833481|NCT00380588|83051373|FG000|Overall Study|Physician Decision|2|||
46833482|NCT00380588|83051374|FG001|Overall Study|Physician Decision|0|||
46833483|NCT00379808|83051380|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
46833484|NCT00379808|83051381|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
46833485|NCT00355784|83051390|FG000|Overall Study|Withdrawal by Subject|0|||
46833486|NCT00355784|83051391|FG001|Overall Study|Withdrawal by Subject|0|||
46833487|NCT00355784|83051392|FG002|Overall Study|Withdrawal by Subject|2|||
46833488|NCT00355472|83051401|FG000|Overall Study|Physician Decision|1|||
46833489|NCT00492557|83051415|FG000|Overall Study|Subject request|12|||
46833490|NCT00492557|83051416|FG001|Overall Study|Subject request|11|||
46833491|NCT00492557|83051415|FG000|Overall Study|Protocol Violation|7|||
46833492|NCT00492557|83051416|FG001|Overall Study|Protocol Violation|8|||
46833493|NCT00492557|83051415|FG000|Overall Study|Other|2|||
46833494|NCT00492557|83051416|FG001|Overall Study|Other|2|||
46833495|NCT00492557|83051415|FG000|Overall Study|Death|1|||
46833496|NCT00492557|83051416|FG001|Overall Study|Death|1|||
46833497|NCT00492557|83051415|FG000|Overall Study|Adverse Event|1|||
47061647|NCT05052697|83342223|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061648|NCT05052697|83342224|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061649|NCT05052697|83342225|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
46766217|NCT00847613|82984596|FG000|Overall Study|Study terminated by Sponsor|1|||
46766218|NCT00847613|82984597|FG001|Overall Study|Study terminated by Sponsor|0|||
46766219|NCT00847613|82984598|FG002|Overall Study|Study terminated by Sponsor|2|||
46766220|NCT00847613|82984599|FG003|Overall Study|Study terminated by Sponsor|1|||
46766221|NCT00847613|82984596|FG000|Overall Study|Lost to Follow-up|5|||
46766222|NCT00847613|82984597|FG001|Overall Study|Lost to Follow-up|0|||
46766223|NCT00847613|82984598|FG002|Overall Study|Lost to Follow-up|0|||
46766224|NCT00847613|82984599|FG003|Overall Study|Lost to Follow-up|3|||
46833498|NCT00492557|83051416|FG001|Overall Study|Adverse Event|0|||
46833499|NCT00492557|83051415|FG000|Overall Study|Failed to return|1|||
46833500|NCT00492557|83051416|FG001|Overall Study|Failed to return|0|||
47061650|NCT05052697|83342226|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
46833501|NCT00492557|83051415|FG000|Overall Study|Lost to Follow-up|0|||
46766225|NCT00847613|82984596|FG000|Overall Study|Protocol Violation|6|||
47061651|NCT05052697|83342227|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
46766226|NCT00847613|82984597|FG001|Overall Study|Protocol Violation|6|||
46766227|NCT00847613|82984598|FG002|Overall Study|Protocol Violation|3|||
46833502|NCT00492557|83051416|FG001|Overall Study|Lost to Follow-up|1|||
46833503|NCT00508391|83051427|FG000|First Treatment|Withdrawal by Subject|6|||
46833504|NCT00508391|83051428|FG001|First Treatment|Withdrawal by Subject|3|||
46833505|NCT00508391|83051427|FG000|Second Treatment|Withdrawal by Subject|2|||
46833506|NCT00508391|83051428|FG001|Second Treatment|Withdrawal by Subject|0|||
46833507|NCT00508157|83051438|FG000|Overall Study|Adverse Event|0|||
46833508|NCT00508157|83051439|FG001|Overall Study|Adverse Event|1|||
46833509|NCT00508157|83051438|FG000|Overall Study|Subject Withdrew Consent|1|||
46833510|NCT00508157|83051439|FG001|Overall Study|Subject Withdrew Consent|0|||
46833511|NCT00508157|83051438|FG000|Overall Study|Lost to Follow-up|1|||
46833512|NCT00508157|83051439|FG001|Overall Study|Lost to Follow-up|0|||
46833513|NCT00508157|83051438|FG000|Overall Study|Subject no longer met study criteria|0|||
46833514|NCT00508157|83051439|FG001|Overall Study|Subject no longer met study criteria|1|||
46833515|NCT00508157|83051438|FG000|Overall Study|Other known cause|0|||
46833516|NCT00508157|83051439|FG001|Overall Study|Other known cause|1|||
46833517|NCT00378560|83051447|FG000|Overall Study|Adverse Event|1|||
46833518|NCT00378560|83051448|FG001|Overall Study|Adverse Event|0|||
46833519|NCT00378560|83051447|FG000|Overall Study|Lost to Follow-up|24|||
46833520|NCT00378560|83051448|FG001|Overall Study|Lost to Follow-up|29|||
46833521|NCT00378560|83051447|FG000|Overall Study|Protocol Violation|2|||
46833522|NCT00378560|83051448|FG001|Overall Study|Protocol Violation|0|||
46833523|NCT00378560|83051447|FG000|Overall Study|Withdrawal by Subject|17|||
46833524|NCT00378560|83051448|FG001|Overall Study|Withdrawal by Subject|21|||
46833525|NCT00378560|83051447|FG000|Overall Study|Moved|4|||
46833526|NCT00378560|83051448|FG001|Overall Study|Moved|3|||
46833527|NCT00378560|83051447|FG000|Overall Study|Pregnancy|7|||
46833528|NCT00378560|83051448|FG001|Overall Study|Pregnancy|5|||
46833529|NCT00378560|83051447|FG000|Overall Study|Laboratory test values abnormal|1|||
46833530|NCT00378560|83051448|FG001|Overall Study|Laboratory test values abnormal|0|||
46833531|NCT00508001|83051457|FG000|Overall Study|Adverse Event|2|||
46833532|NCT00508001|83051458|FG001|Overall Study|Adverse Event|0|||
46833533|NCT00508001|83051459|FG002|Overall Study|Adverse Event|4|||
46833534|NCT00508001|83051457|FG000|Overall Study|condition under investigation worsened|13|||
46833535|NCT00508001|83051458|FG001|Overall Study|condition under investigation worsened|7|||
46833536|NCT00508001|83051459|FG002|Overall Study|condition under investigation worsened|1|||
46833537|NCT00508001|83051457|FG000|Overall Study|Death|0|||
46833538|NCT00508001|83051458|FG001|Overall Study|Death|1|||
46833539|NCT00508001|83051459|FG002|Overall Study|Death|1|||
46833540|NCT00508001|83051457|FG000|Overall Study|Withdrawal by Subject|4|||
46833541|NCT00508001|83051458|FG001|Overall Study|Withdrawal by Subject|4|||
46833542|NCT00508001|83051459|FG002|Overall Study|Withdrawal by Subject|1|||
46833543|NCT00507689|83051470|FG000|Pre-Randomization Period|Adverse Event|1|||
46833544|NCT00507689|83051471|FG001|Pre-Randomization Period|Adverse Event|0|||
46833545|NCT00507689|83051470|FG000|Pre-Randomization Period|Physician Decision|1|||
46833546|NCT00507689|83051471|FG001|Pre-Randomization Period|Physician Decision|0|||
46833547|NCT00507689|83051470|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
46833548|NCT00507689|83051471|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
46941302|NCT02506036|83178507|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
46941303|NCT01063855|83178515|FG000|Overall Study|Adverse Event|4|||
46941304|NCT01063855|83178516|FG001|Overall Study|Adverse Event|4|||
46941305|NCT01063855|83178515|FG000|Overall Study|Death|0|||
46941306|NCT01063855|83178516|FG001|Overall Study|Death|1|||
46941307|NCT01063855|83178515|FG000|Overall Study|Lost to Follow-up|8|||
46941308|NCT01063855|83178516|FG001|Overall Study|Lost to Follow-up|4|||
46941309|NCT01063855|83178515|FG000|Overall Study|Pregnancy|1|||
46941310|NCT01063855|83178516|FG001|Overall Study|Pregnancy|0|||
46941311|NCT01063855|83178515|FG000|Overall Study|Lack of Efficacy|0|||
46941312|NCT01063855|83178516|FG001|Overall Study|Lack of Efficacy|1|||
46941313|NCT01063855|83178515|FG000|Overall Study|Withdrawal by Subject|11|||
46941314|NCT01063855|83178516|FG001|Overall Study|Withdrawal by Subject|8|||
46941315|NCT01063855|83178515|FG000|Overall Study|Reason not specified|13|||
46941316|NCT01063855|83178516|FG001|Overall Study|Reason not specified|11|||
47061652|NCT05052697|83342228|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061653|NCT05052697|83342229|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061654|NCT05052697|83342230|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061655|NCT05052697|83342231|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061656|NCT05052697|83342232|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061657|NCT05052697|83342233|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061658|NCT05052697|83342234|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061659|NCT05052697|83342235|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
46637824|NCT01474512|82811389|FG013|Long-Term Extension Period|Death|9|||
46833549|NCT00507689|83051470|FG000|Randomized Period|Adverse Event|1|||
46941317|NCT01063153|83178528|FG000|Overall Study|Found Ineligible During Screening|2|||
46833550|NCT00507689|83051471|FG001|Randomized Period|Adverse Event|1|||
46833551|NCT00507689|83051470|FG000|Randomized Period|Withdrawal by Subject|0|||
46833552|NCT00507689|83051471|FG001|Randomized Period|Withdrawal by Subject|1|||
46833553|NCT00491387|83051478|FG000|Overall Study|study terminated|20|||
46833554|NCT00491075|83051482|FG000|Overall Study|Withdrawal by Subject|1|||
46833555|NCT00491075|83051482|FG000|Overall Study|Physician Decision|1|||
46941318|NCT01063153|83178529|FG001|Overall Study|Found Ineligible During Screening|0|||
46941319|NCT01063153|83178528|FG000|Overall Study|Lost to Follow-up|0|||
46766228|NCT00847613|82984599|FG003|Overall Study|Protocol Violation|1|||
46766229|NCT00847613|82984596|FG000|Overall Study|Pregnancy|1|||
46766230|NCT00847613|82984597|FG001|Overall Study|Pregnancy|1|||
46766231|NCT00847613|82984598|FG002|Overall Study|Pregnancy|0|||
46766232|NCT00847613|82984599|FG003|Overall Study|Pregnancy|0|||
46766233|NCT00847613|82984596|FG000|Overall Study|Site closure|1|||
46766234|NCT00847613|82984597|FG001|Overall Study|Site closure|0|||
46833556|NCT00507455|83051489|FG000|Overall Study|Adverse Event|3|||
46833557|NCT00507455|83051490|FG001|Overall Study|Adverse Event|3|||
46833558|NCT00507455|83051491|FG002|Overall Study|Adverse Event|6|||
46833559|NCT00507455|83051489|FG000|Overall Study|Withdrawal by Subject|2|||
46833560|NCT00507455|83051490|FG001|Overall Study|Withdrawal by Subject|1|||
46833561|NCT00507455|83051491|FG002|Overall Study|Withdrawal by Subject|2|||
46833562|NCT00507455|83051489|FG000|Overall Study|Protocol Violation|4|||
46833563|NCT00507455|83051490|FG001|Overall Study|Protocol Violation|1|||
46833564|NCT00507455|83051491|FG002|Overall Study|Protocol Violation|1|||
46941320|NCT01063153|83178529|FG001|Overall Study|Lost to Follow-up|7|||
46941321|NCT01063153|83178528|FG000|Overall Study|Withdrawal by Subject|0|||
46941322|NCT01063153|83178529|FG001|Overall Study|Withdrawal by Subject|1|||
46941323|NCT01063153|83178528|FG000|Overall Study|Physician Decision|0|||
46941324|NCT01063153|83178529|FG001|Overall Study|Physician Decision|4|||
46941325|NCT01062841|83178541|FG000|Overall Study|Indwelling Device Removed|41|||
46941326|NCT01062841|83178542|FG001|Overall Study|Indwelling Device Removed|48|||
46941327|NCT01062841|83178541|FG000|Overall Study|Death|3|||
46941328|NCT01062841|83178542|FG001|Overall Study|Death|5|||
46941329|NCT01062841|83178541|FG000|Overall Study|Withdrawal by Subject|2|||
46941330|NCT01062841|83178542|FG001|Overall Study|Withdrawal by Subject|0|||
46941331|NCT01062841|83178541|FG000|Overall Study|Withdrawal by Study|3|||
46941332|NCT01062841|83178542|FG001|Overall Study|Withdrawal by Study|0|||
46941333|NCT02505334|83178550|FG000|Main Treatment Period|Adverse Event|3|||
47061660|NCT05052697|83342236|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061661|NCT05052697|83342237|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061662|NCT05052697|83342238|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061663|NCT05052697|83342239|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061664|NCT05052697|83342240|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061665|NCT05052697|83342241|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061666|NCT05052697|83342242|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061667|NCT05052697|83342243|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
47061668|NCT05052697|83342244|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061669|NCT05052697|83342245|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
47061670|NCT05052697|83342246|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061671|NCT05052697|83342247|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061672|NCT05052697|83342248|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061673|NCT05052697|83342249|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061674|NCT05052697|83342250|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
46637825|NCT01474512|82811390|FG014|Long-Term Extension Period|Death|0|||
46766235|NCT00847613|82984598|FG002|Overall Study|Site closure|0|||
46941334|NCT02505334|83178551|FG001|Main Treatment Period|Adverse Event|3|||
46941335|NCT02505334|83178550|FG000|Main Treatment Period|Lack of Efficacy|7|||
46941336|NCT02505334|83178551|FG001|Main Treatment Period|Lack of Efficacy|17|||
46941337|NCT02505334|83178550|FG000|Main Treatment Period|Protocol Violation|0|||
46941338|NCT02505334|83178551|FG001|Main Treatment Period|Protocol Violation|1|||
46941339|NCT02505334|83178550|FG000|Main Treatment Period|Withdrawal by Subject|1|||
46941340|NCT02505334|83178551|FG001|Main Treatment Period|Withdrawal by Subject|8|||
46941341|NCT02505334|83178550|FG000|Main Treatment Period|Unclassified|4|||
46941342|NCT02505334|83178551|FG001|Main Treatment Period|Unclassified|10|||
46941343|NCT02505334|83178550|FG000|Extension Treatment Period|Adverse Event|5|||
46941344|NCT02505334|83178551|FG001|Extension Treatment Period|Adverse Event|0|||
46941345|NCT02505334|83178550|FG000|Extension Treatment Period|Lack of Efficacy|4|||
46941346|NCT02505334|83178551|FG001|Extension Treatment Period|Lack of Efficacy|0|||
46941347|NCT02505334|83178550|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
46941348|NCT02505334|83178551|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
46941349|NCT02505334|83178550|FG000|Extension Treatment Period|Unclassified|3|||
46941350|NCT02505334|83178551|FG001|Extension Treatment Period|Unclassified|0|||
46941351|NCT01062061|83178557|FG000|Overall Study|Enrolled more than once|2|||
46766236|NCT00847613|82984599|FG003|Overall Study|Site closure|1|||
46833565|NCT00507455|83051489|FG000|Overall Study|Lost to Follow-up|2|||
46833566|NCT00507455|83051490|FG001|Overall Study|Lost to Follow-up|0|||
46833567|NCT00507455|83051491|FG002|Overall Study|Lost to Follow-up|2|||
46941352|NCT01062061|83178557|FG000|Overall Study|Investigated before study start|13|||
46941353|NCT01062061|83178557|FG000|Overall Study|Outside chief indications|10|||
46941354|NCT01062061|83178557|FG000|Overall Study|Failed to meet inclusion criteria|2|||
46941355|NCT02504320|83178569|FG000|Treatment Period 1|Positive Drug Screen|0|||
46941356|NCT02504320|83178570|FG001|Treatment Period 1|Positive Drug Screen|0|||
47061675|NCT05052697|83342251|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
47061676|NCT05052697|83342218|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46941357|NCT02504320|83178571|FG002|Treatment Period 1|Positive Drug Screen|1|||
46941358|NCT02504320|83178572|FG003|Treatment Period 1|Positive Drug Screen|0|||
46941359|NCT02504320|83178569|FG000|Treatment Period 2|Positive Drug Screen|0|||
46941360|NCT02504320|83178570|FG001|Treatment Period 2|Positive Drug Screen|1|||
46941361|NCT02504320|83178571|FG002|Treatment Period 2|Positive Drug Screen|0|||
46941362|NCT02504320|83178572|FG003|Treatment Period 2|Positive Drug Screen|0|||
46941363|NCT02504320|83178569|FG000|Treatment Period 3|Positive Drug Screen|0|||
46941364|NCT02504320|83178570|FG001|Treatment Period 3|Positive Drug Screen|0|||
46941365|NCT02504320|83178571|FG002|Treatment Period 3|Positive Drug Screen|0|||
46941366|NCT02504320|83178572|FG003|Treatment Period 3|Positive Drug Screen|1|||
46941367|NCT02504320|83178569|FG000|Treatment Period 3|Adverse Event|0|||
46941368|NCT02504320|83178570|FG001|Treatment Period 3|Adverse Event|0|||
46941369|NCT02504320|83178571|FG002|Treatment Period 3|Adverse Event|1|||
46941370|NCT02504320|83178572|FG003|Treatment Period 3|Adverse Event|0|||
46941371|NCT01061671|83178584|FG000|Overall Study|Withdrawal by Subject|16|||
46941372|NCT01061671|83178585|FG001|Overall Study|Withdrawal by Subject|20|||
46941373|NCT01061671|83178584|FG000|Overall Study|Lost to Follow-up|3|||
46941374|NCT01061671|83178585|FG001|Overall Study|Lost to Follow-up|5|||
46941375|NCT01061671|83178584|FG000|Overall Study|Death|28|||
46941376|NCT01061671|83178585|FG001|Overall Study|Death|30|||
46941377|NCT00709995|83178593|FG000|Overall Study|Adverse Event|4|||
46941378|NCT00709995|83178594|FG001|Overall Study|Adverse Event|2|||
46941379|NCT00709995|83178593|FG000|Overall Study|Withdrawal by Subject|1|||
46941380|NCT00709995|83178594|FG001|Overall Study|Withdrawal by Subject|3|||
46941381|NCT02503540|83178603|FG000|Overall Study|Death|2|||
46941382|NCT02503540|83178603|FG000|Overall Study|Withdrawal by Subject|1|||
46941383|NCT02502526|83178610|FG000|Overall Study|Lost to Follow-up|2|||
46941384|NCT02502526|83178611|FG001|Overall Study|Lost to Follow-up|2|||
46941385|NCT02502526|83178612|FG002|Overall Study|Lost to Follow-up|3|||
46941386|NCT02502526|83178610|FG000|Overall Study|Withdrawal by Subject|0|||
46941387|NCT02502526|83178611|FG001|Overall Study|Withdrawal by Subject|1|||
46941388|NCT02502526|83178612|FG002|Overall Study|Withdrawal by Subject|1|||
46941389|NCT02502526|83178610|FG000|Overall Study|Disqualified due to cataract grading|0|||
46941390|NCT02502526|83178611|FG001|Overall Study|Disqualified due to cataract grading|0|||
46941391|NCT02502526|83178612|FG002|Overall Study|Disqualified due to cataract grading|1|||
46941392|NCT02502526|83178610|FG000|Overall Study|Enrollment suspension|4|||
46941393|NCT02502526|83178611|FG001|Overall Study|Enrollment suspension|1|||
46941394|NCT02502526|83178612|FG002|Overall Study|Enrollment suspension|1|||
46941395|NCT02972515|83178621|FG000|Overall Study|Lost to Follow-up|78|||
46941396|NCT02972359|83178625|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
46941397|NCT02972359|83178625|FG000|Overall Study|Lack of Efficacy|1|||
46941398|NCT02972359|83178625|FG000|Overall Study|Adverse Event|4|||
46941399|NCT02972359|83178625|FG000|Overall Study|Death|1|||
46941400|NCT02972359|83178625|FG000|Overall Study|Withdrawal by Subject|30|||
46941401|NCT02972359|83178625|FG000|Overall Study|Protocol Violation|1|||
46941402|NCT02972359|83178625|FG000|Overall Study|Lost to Follow-up|26|||
46941403|NCT02972359|83178625|FG000|Overall Study|Other reasons|5|||
46941404|NCT02972359|83178625|FG000|Overall Study|Missing|1|||
46941405|NCT01060111|83178632|FG000|Overall Study|Adverse Event|9|||
46941406|NCT01060111|83178633|FG001|Overall Study|Adverse Event|5|||
46941407|NCT01060111|83178634|FG002|Overall Study|Adverse Event|18|||
46941408|NCT01060111|83178632|FG000|Overall Study|Lack of Efficacy|2|||
46941409|NCT01060111|83178633|FG001|Overall Study|Lack of Efficacy|1|||
46941410|NCT01060111|83178634|FG002|Overall Study|Lack of Efficacy|0|||
46941411|NCT01060111|83178632|FG000|Overall Study|Inappropriate participant|5|||
46941412|NCT01060111|83178633|FG001|Overall Study|Inappropriate participant|4|||
46941413|NCT01060111|83178634|FG002|Overall Study|Inappropriate participant|5|||
46941414|NCT01060111|83178632|FG000|Overall Study|Participants' evasion for hospital visit|0|||
46941415|NCT01060111|83178633|FG001|Overall Study|Participants' evasion for hospital visit|3|||
46941416|NCT01060111|83178634|FG002|Overall Study|Participants' evasion for hospital visit|2|||
46941417|NCT01060111|83178632|FG000|Overall Study|Participants' non-cooperation|8|||
46941418|NCT01060111|83178633|FG001|Overall Study|Participants' non-cooperation|6|||
46941419|NCT01060111|83178634|FG002|Overall Study|Participants' non-cooperation|6|||
46941420|NCT01060111|83178632|FG000|Overall Study|Adverse event and insufficient effect|0|||
46941421|NCT01060111|83178633|FG001|Overall Study|Adverse event and insufficient effect|1|||
46637826|NCT01474512|82811391|FG015|Long-Term Extension Period|Death|0|||
46941422|NCT01060111|83178634|FG002|Overall Study|Adverse event and insufficient effect|0|||
46833568|NCT00507455|83051489|FG000|Overall Study|Lack of Efficacy|0|||
46941423|NCT01060111|83178632|FG000|Overall Study|Participants' non-cooperation|1|||
46941424|NCT01060111|83178633|FG001|Overall Study|Participants' non-cooperation|0|||
46941425|NCT01060111|83178634|FG002|Overall Study|Participants' non-cooperation|0|||
46941426|NCT01060111|83178632|FG000|Overall Study|Other|2|||
46941427|NCT01060111|83178633|FG001|Overall Study|Other|3|||
46941428|NCT01060111|83178634|FG002|Overall Study|Other|4|||
46941429|NCT02969863|83178645|FG000|Overall Study|Physician Decision|1|||
46941430|NCT02969863|83178646|FG001|Overall Study|Physician Decision|0|||
46941431|NCT02969863|83178647|FG002|Overall Study|Physician Decision|0|||
46941432|NCT02969863|83178648|FG003|Overall Study|Physician Decision|0|||
46941433|NCT02969863|83178649|FG004|Overall Study|Physician Decision|0|||
46941434|NCT02969863|83178650|FG005|Overall Study|Physician Decision|0|||
46941435|NCT02969707|83178666|FG000|Overall Study|Adverse Event|1|||
46941436|NCT02969707|83178667|FG001|Overall Study|Adverse Event|2|||
46941437|NCT02969707|83178666|FG000|Overall Study|Lost to Follow-up|3|||
46941438|NCT02969707|83178667|FG001|Overall Study|Lost to Follow-up|0|||
46941439|NCT02969707|83178666|FG000|Overall Study|Physician Decision|0|||
46941440|NCT02969707|83178667|FG001|Overall Study|Physician Decision|1|||
46941441|NCT02969707|83178666|FG000|Overall Study|Protocol Violation|1|||
46941442|NCT02969707|83178667|FG001|Overall Study|Protocol Violation|1|||
46941443|NCT02969707|83178666|FG000|Overall Study|Withdrawal by Subject|3|||
46941444|NCT02969707|83178667|FG001|Overall Study|Withdrawal by Subject|4|||
46941445|NCT02967055|83178678|FG000|Overall Study|Excluded|40|||
46941446|NCT02967055|83178678|FG000|Overall Study|Screen fail|3|||
46941447|NCT02967055|83178678|FG000|Overall Study|Lost to Follow-up|2|||
46941448|NCT02967055|83178678|FG000|Overall Study|Stopped due to side effects|3|||
46941449|NCT02967055|83178678|FG000|Overall Study|Stopped due to drug cost|1|||
46941450|NCT02904265|83178684|FG000|Overall Study|Physician Decision|1|||
46941451|NCT02904265|83178685|FG001|Overall Study|Physician Decision|2|||
46941452|NCT03461211|83178693|FG000|Overall Study|Adverse Event|1|||
46941453|NCT03461211|83178694|FG001|Overall Study|Adverse Event|1|||
46941454|NCT03461211|83178693|FG000|Overall Study|Lack of Efficacy|0|||
46941455|NCT03461211|83178694|FG001|Overall Study|Lack of Efficacy|1|||
46941456|NCT02967679|83178702|FG000|Overall Study|Adverse Event|1|||
46941457|NCT02966509|83178712|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
46941458|NCT02966509|83178713|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
46941459|NCT02966509|83178712|FG000|Baseline Satisfaction Survey|Death|0|||
46941460|NCT02966509|83178713|FG001|Baseline Satisfaction Survey|Death|1|||
46941461|NCT02966509|83178712|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
46941462|NCT02966509|83178713|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
46941463|NCT02966509|83178712|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
46941464|NCT02966509|83178713|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
46941465|NCT02966509|83178712|FG000|6 Month Satisfaction Decision Survey|Death|22|||
46941466|NCT02966509|83178713|FG001|6 Month Satisfaction Decision Survey|Death|25|||
46941467|NCT02966509|83178712|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
46941468|NCT02966509|83178713|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
46941469|NCT02966509|83178712|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
46941470|NCT02966509|83178713|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
46941471|NCT02966509|83178712|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
46941472|NCT02966509|83178713|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
46941473|NCT02966509|83178712|FG000|6 Month Satisfaction Survey|Death|36|||
46941474|NCT02966509|83178713|FG001|6 Month Satisfaction Survey|Death|33|||
46941475|NCT02966509|83178712|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
46941476|NCT02966509|83178713|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
46941477|NCT02966509|83178712|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
46941478|NCT02966509|83178713|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
46941479|NCT02966509|83178712|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
46941480|NCT02966509|83178713|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
46941481|NCT02966509|83178712|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
46941482|NCT02966509|83178713|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
46941483|NCT02966509|83178712|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
46941484|NCT02966509|83178713|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
46941485|NCT02966353|83178719|FG000|Overall Study|Withdrawal by Subject|7|||
46941486|NCT02966353|83178719|FG000|Overall Study|Adverse Event|4|||
46941487|NCT02966353|83178719|FG000|Overall Study|Death|4|||
46941488|NCT02966353|83178719|FG000|Overall Study|Physician Decision|3|||
46941489|NCT02966353|83178719|FG000|Overall Study|Progressive disease|2|||
46941490|NCT02966353|83178719|FG000|Overall Study|Protocol deviation|2|||
46941491|NCT02965573|83178752|FG000|Overall Study|Lack of Efficacy|1|||
46941492|NCT02965573|83178753|FG001|Overall Study|Lack of Efficacy|0|||
46941493|NCT02964325|83178761|FG000|Overall Study|Lost to Follow-up|3|||
46941494|NCT02964325|83178762|FG001|Overall Study|Lost to Follow-up|3|||
46941495|NCT02964325|83178761|FG000|Overall Study|Physician Decision|5|||
46941496|NCT02964325|83178762|FG001|Overall Study|Physician Decision|4|||
46941497|NCT02964325|83178761|FG000|Overall Study|Death|1|||
46941498|NCT02964325|83178762|FG001|Overall Study|Death|3|||
46941499|NCT02964325|83178761|FG000|Overall Study|Withdrawal by Subject|2|||
46941500|NCT02964325|83178762|FG001|Overall Study|Withdrawal by Subject|1|||
46941501|NCT02964325|83178761|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
46941502|NCT02964325|83178762|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
46637827|NCT01474512|82811392|FG016|Long-Term Extension Period|Death|0|||
46637828|NCT01474512|82811393|FG017|Long-Term Extension Period|Death|0|||
46941503|NCT02964247|83178770|FG000|Overall Study|Lost to Follow-up|2|||
46941504|NCT02964247|83178771|FG001|Overall Study|Lost to Follow-up|0|||
46941505|NCT02964247|83178770|FG000|Overall Study|Withdrawal by Subject|1|||
46941506|NCT02964247|83178771|FG001|Overall Study|Withdrawal by Subject|2|||
46941507|NCT03654729|83178780|FG000|Overall Study|Death|9|||
46941508|NCT03654729|83178781|FG001|Overall Study|Death|9|||
46941509|NCT03654729|83178782|FG002|Overall Study|Death|16|||
46941510|NCT03654729|83178780|FG000|Overall Study|Withdrawal by Subject|8|||
46941511|NCT03654729|83178781|FG001|Overall Study|Withdrawal by Subject|6|||
46941512|NCT03654729|83178782|FG002|Overall Study|Withdrawal by Subject|4|||
46941513|NCT03654729|83178780|FG000|Overall Study|Study terminated by Sponsor|3|||
46941514|NCT03654729|83178781|FG001|Overall Study|Study terminated by Sponsor|5|||
46941515|NCT03654729|83178782|FG002|Overall Study|Study terminated by Sponsor|4|||
46941516|NCT03654729|83178780|FG000|Overall Study|Not reported|2|||
46941517|NCT03654729|83178781|FG001|Overall Study|Not reported|4|||
46941518|NCT03654729|83178782|FG002|Overall Study|Not reported|5|||
46941519|NCT03654729|83178780|FG000|Overall Study|Progressive disease|3|||
46941520|NCT03654729|83178781|FG001|Overall Study|Progressive disease|0|||
46941521|NCT03654729|83178782|FG002|Overall Study|Progressive disease|0|||
46941522|NCT03654729|83178780|FG000|Overall Study|Lost to Follow-up|2|||
46941523|NCT03654729|83178781|FG001|Overall Study|Lost to Follow-up|0|||
46941524|NCT03654729|83178782|FG002|Overall Study|Lost to Follow-up|0|||
46941525|NCT03654729|83178780|FG000|Overall Study|Physician Decision|2|||
46941526|NCT03654729|83178781|FG001|Overall Study|Physician Decision|0|||
46941527|NCT03654729|83178782|FG002|Overall Study|Physician Decision|0|||
46941528|NCT03654729|83178780|FG000|Overall Study|Protocol Violation|1|||
46941529|NCT03654729|83178781|FG001|Overall Study|Protocol Violation|1|||
46941530|NCT03654729|83178782|FG002|Overall Study|Protocol Violation|0|||
46941531|NCT03654729|83178780|FG000|Overall Study|Non-compliance with study drug|0|||
46941532|NCT03654729|83178781|FG001|Overall Study|Non-compliance with study drug|1|||
46941533|NCT03654729|83178782|FG002|Overall Study|Non-compliance with study drug|0|||
46941534|NCT03654729|83178780|FG000|Overall Study|Site terminated by Sponsor|1|||
46941535|NCT03654729|83178781|FG001|Overall Study|Site terminated by Sponsor|0|||
46941536|NCT03654729|83178782|FG002|Overall Study|Site terminated by Sponsor|0|||
46941537|NCT01377987|83178790|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
46941538|NCT01377987|83178791|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
46941539|NCT02898259|83178802|FG000|Overall Study|Adverse Event|0|||
46941540|NCT02898259|83178803|FG001|Overall Study|Adverse Event|0|||
46941541|NCT02898259|83178804|FG002|Overall Study|Adverse Event|1|||
46941542|NCT02898259|83178805|FG003|Overall Study|Adverse Event|0|||
46941543|NCT02898259|83178806|FG004|Overall Study|Adverse Event|0|||
46941544|NCT02898259|83178802|FG000|Overall Study|Lack of Efficacy|1|||
46941545|NCT02898259|83178803|FG001|Overall Study|Lack of Efficacy|1|||
46941546|NCT02898259|83178804|FG002|Overall Study|Lack of Efficacy|3|||
46941547|NCT02898259|83178805|FG003|Overall Study|Lack of Efficacy|0|||
46941548|NCT02898259|83178806|FG004|Overall Study|Lack of Efficacy|0|||
46941549|NCT02898259|83178802|FG000|Overall Study|Lost to Follow-up|0|||
46941550|NCT02898259|83178803|FG001|Overall Study|Lost to Follow-up|0|||
46941551|NCT02898259|83178804|FG002|Overall Study|Lost to Follow-up|1|||
46941552|NCT02898259|83178805|FG003|Overall Study|Lost to Follow-up|0|||
46941553|NCT02898259|83178806|FG004|Overall Study|Lost to Follow-up|0|||
46941554|NCT02898259|83178802|FG000|Overall Study|Transformation before study began|0|||
46941555|NCT02898259|83178803|FG001|Overall Study|Transformation before study began|0|||
46941556|NCT02898259|83178804|FG002|Overall Study|Transformation before study began|0|||
46941557|NCT02898259|83178805|FG003|Overall Study|Transformation before study began|1|||
46941558|NCT02898259|83178806|FG004|Overall Study|Transformation before study began|0|||
46941559|NCT02963935|83178821|FG000|Overall Study|Adverse Event|12|||
46941560|NCT02963935|83178822|FG001|Overall Study|Adverse Event|6|||
46941561|NCT02963935|83178821|FG000|Overall Study|Protocol Violation|2|||
46766237|NCT00847613|82984596|FG000|Overall Study|Withdrawal by Subject|8|||
46766238|NCT00847613|82984597|FG001|Overall Study|Withdrawal by Subject|11|||
46941562|NCT02963935|83178822|FG001|Overall Study|Protocol Violation|1|||
46941563|NCT02963935|83178821|FG000|Overall Study|Lack of Efficacy|0|||
46766239|NCT00847613|82984598|FG002|Overall Study|Withdrawal by Subject|2|||
46941564|NCT02963935|83178822|FG001|Overall Study|Lack of Efficacy|2|||
46941565|NCT02963935|83178821|FG000|Overall Study|Lost to Follow-up|1|||
46766240|NCT00847613|82984599|FG003|Overall Study|Withdrawal by Subject|2|||
46766241|NCT00847613|82984596|FG000|Overall Study|Participant moved|4|||
46766242|NCT00847613|82984597|FG001|Overall Study|Participant moved|1|||
46941566|NCT02963935|83178822|FG001|Overall Study|Lost to Follow-up|6|||
46941567|NCT02963935|83178821|FG000|Overall Study|Unclassified|13|||
46941568|NCT02963935|83178822|FG001|Overall Study|Unclassified|22|||
46766243|NCT00847613|82984598|FG002|Overall Study|Participant moved|0|||
46941569|NCT02963701|83178830|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
46941570|NCT02963701|83178831|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
46941571|NCT01345591|83178837|FG000|Overall Study|Lost to Follow-up|1|||
46941572|NCT02961751|83178846|FG000|Overall Study|Lost to Follow-up|11|||
46941573|NCT02961751|83178846|FG000|Overall Study|Physician Decision|2|||
46941574|NCT02961751|83178846|FG000|Overall Study|Not Eligible at Enrollment|1|||
46941575|NCT02961751|83178846|FG000|Overall Study|Protocol Violation|1|||
46941576|NCT02963311|83178850|FG000|Overall Study|Withdrawal by Subject|1|||
46941577|NCT02963311|83178850|FG000|Overall Study|Screen Failure|4|||
46941578|NCT02962765|83178854|FG000|Overall Study|Protocol Violation|9|||
46941579|NCT02962765|83178854|FG000|Overall Study|Withdrawal by Subject|3|||
46941580|NCT02962765|83178854|FG000|Overall Study|Lost to Follow-up|1|||
46941581|NCT02962765|83178854|FG000|Overall Study|Death|1|||
46941582|NCT02962765|83178854|FG000|Overall Study|Limited access to study medication|3|||
46941583|NCT00965757|83178867|FG000|Double-blind Phase|Progression of concomitant disease|1|||
46941584|NCT00965757|83178868|FG001|Double-blind Phase|Progression of concomitant disease|2|||
46941585|NCT00965757|83178869|FG002|Double-blind Phase|Progression of concomitant disease|0|||
46941586|NCT00965757|83178870|FG003|Double-blind Phase|Progression of concomitant disease|0|||
46941587|NCT00965757|83178867|FG000|Double-blind Phase|Adverse drug reaction|2|||
46941588|NCT00965757|83178868|FG001|Double-blind Phase|Adverse drug reaction|1|||
46941589|NCT00965757|83178869|FG002|Double-blind Phase|Adverse drug reaction|0|||
46941590|NCT00965757|83178870|FG003|Double-blind Phase|Adverse drug reaction|0|||
46941591|NCT00965757|83178867|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
46941592|NCT00965757|83178868|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
46941593|NCT00965757|83178869|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
46941594|NCT00965757|83178870|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
46941595|NCT00965757|83178867|FG000|Double-blind Phase|Lack of Efficacy|7|||
46941596|NCT00965757|83178868|FG001|Double-blind Phase|Lack of Efficacy|11|||
46941597|NCT00965757|83178869|FG002|Double-blind Phase|Lack of Efficacy|0|||
46941598|NCT00965757|83178870|FG003|Double-blind Phase|Lack of Efficacy|0|||
46941599|NCT00965757|83178867|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
46941600|NCT00965757|83178868|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
46941601|NCT00965757|83178869|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
46833569|NCT00507455|83051490|FG001|Overall Study|Lack of Efficacy|1|||
46833570|NCT00507455|83051491|FG002|Overall Study|Lack of Efficacy|0|||
46833571|NCT00507455|83051489|FG000|Overall Study|Other - miscellaneous reason|1|||
46833572|NCT00507455|83051490|FG001|Overall Study|Other - miscellaneous reason|0|||
46833573|NCT00507455|83051491|FG002|Overall Study|Other - miscellaneous reason|1|||
46833574|NCT00506831|83051499|FG000|Overall Study|Death|1|||
46833575|NCT00506831|83051499|FG000|Overall Study|Withdrawal by Subject|1|||
46833576|NCT00506753|83051505|FG000|Overall Study|Lost to Follow-up|21|||
46833577|NCT00506753|83051506|FG001|Overall Study|Lost to Follow-up|15|||
46833578|NCT00490919|83051514|FG000|Open-label Run-in Period|Adverse Event|239|||
46833579|NCT00490919|83051515|FG001|Open-label Run-in Period|Adverse Event|0|||
46941602|NCT00965757|83178870|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
46941603|NCT00965757|83178867|FG000|Double-blind Phase|Lost to Follow-up|0|||
46941604|NCT00965757|83178868|FG001|Double-blind Phase|Lost to Follow-up|1|||
46941605|NCT00965757|83178869|FG002|Double-blind Phase|Lost to Follow-up|0|||
46941606|NCT00965757|83178870|FG003|Double-blind Phase|Lost to Follow-up|0|||
46766244|NCT00847613|82984599|FG003|Overall Study|Participant moved|0|||
46766245|NCT00847613|82984596|FG000|Overall Study|Sponsor request|0|||
46766246|NCT00847613|82984597|FG001|Overall Study|Sponsor request|1|||
46766247|NCT00847613|82984598|FG002|Overall Study|Sponsor request|0|||
46766248|NCT00847613|82984599|FG003|Overall Study|Sponsor request|0|||
46766249|NCT00847613|82984596|FG000|Overall Study|Randomized, but not treated|0|||
46766250|NCT00847613|82984597|FG001|Overall Study|Randomized, but not treated|3|||
46766251|NCT00847613|82984598|FG002|Overall Study|Randomized, but not treated|0|||
46766252|NCT00847613|82984599|FG003|Overall Study|Randomized, but not treated|0|||
46766253|NCT00847613|82984596|FG000|Overall Study|Other|1|||
46766254|NCT00847613|82984597|FG001|Overall Study|Other|1|||
46766255|NCT00847613|82984598|FG002|Overall Study|Other|2|||
46766256|NCT00847613|82984599|FG003|Overall Study|Other|0|||
46766257|NCT00794196|82984618|FG000|Overall Study|Lost to Follow-up|5|||
46766258|NCT00794196|82984619|FG001|Overall Study|Lost to Follow-up|23|||
46766259|NCT00807092|82984627|FG000|Overall Study|Adverse Event|0|||
46766260|NCT00807092|82984628|FG001|Overall Study|Adverse Event|1|||
46766261|NCT00807092|82984627|FG000|Overall Study|Protocol Violation|0|||
46766262|NCT00807092|82984628|FG001|Overall Study|Protocol Violation|2|||
46766263|NCT00807092|82984627|FG000|Overall Study|Withdrawal by Subject|1|||
46766264|NCT00807092|82984628|FG001|Overall Study|Withdrawal by Subject|0|||
46766265|NCT00807092|82984627|FG000|Overall Study|CGMS data collection failed|0|||
46766266|NCT00807092|82984628|FG001|Overall Study|CGMS data collection failed|1|||
46766267|NCT00794118|82984634|FG000|Overall Study|Lost to Follow-up|16|||
46766268|NCT00794118|82984634|FG000|Overall Study|Withdrawal by Subject|9|||
46766269|NCT00794118|82984634|FG000|Overall Study|Changed hospital center|2|||
46766270|NCT00640042|82984638|FG000|Enrollment|Did not receive study drug|83|||
46941607|NCT00965757|83178867|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
46941608|NCT00965757|83178868|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
46941609|NCT00965757|83178869|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
46941610|NCT00965757|83178870|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
46941611|NCT00965757|83178867|FG000|Double-blind Phase|Other|1|||
46941612|NCT00965757|83178868|FG001|Double-blind Phase|Other|0|||
46941613|NCT00965757|83178869|FG002|Double-blind Phase|Other|0|||
46941614|NCT00965757|83178870|FG003|Double-blind Phase|Other|0|||
46941615|NCT00965757|83178867|FG000|Extension Phase|Progression of concomitant disease|0|||
46941616|NCT00965757|83178868|FG001|Extension Phase|Progression of concomitant disease|0|||
46941617|NCT00965757|83178869|FG002|Extension Phase|Progression of concomitant disease|4|||
46941618|NCT00965757|83178870|FG003|Extension Phase|Progression of concomitant disease|2|||
46941619|NCT00965757|83178867|FG000|Extension Phase|Adverse drug reaction|0|||
46941620|NCT00965757|83178868|FG001|Extension Phase|Adverse drug reaction|0|||
46941621|NCT00965757|83178869|FG002|Extension Phase|Adverse drug reaction|6|||
46941622|NCT00965757|83178870|FG003|Extension Phase|Adverse drug reaction|3|||
46941623|NCT00965757|83178867|FG000|Extension Phase|Abnormal Laboratory Value|0|||
46941624|NCT00965757|83178868|FG001|Extension Phase|Abnormal Laboratory Value|0|||
46941625|NCT00965757|83178869|FG002|Extension Phase|Abnormal Laboratory Value|6|||
46941626|NCT00965757|83178870|FG003|Extension Phase|Abnormal Laboratory Value|1|||
46941627|NCT00965757|83178867|FG000|Extension Phase|Lack of Efficacy|0|||
46941628|NCT00965757|83178868|FG001|Extension Phase|Lack of Efficacy|0|||
46941629|NCT00965757|83178869|FG002|Extension Phase|Lack of Efficacy|8|||
46941630|NCT00965757|83178870|FG003|Extension Phase|Lack of Efficacy|12|||
46941631|NCT00965757|83178867|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
46941632|NCT00965757|83178868|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
46941633|NCT00965757|83178869|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
46941634|NCT00965757|83178870|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
46941635|NCT00965757|83178867|FG000|Extension Phase|Lost to Follow-up|0|||
46941636|NCT00965757|83178868|FG001|Extension Phase|Lost to Follow-up|0|||
46941637|NCT00965757|83178869|FG002|Extension Phase|Lost to Follow-up|0|||
46941638|NCT00965757|83178870|FG003|Extension Phase|Lost to Follow-up|1|||
46941639|NCT00965757|83178867|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
46941640|NCT00965757|83178868|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
46941641|NCT00965757|83178869|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
46941642|NCT00965757|83178870|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
46941643|NCT00965757|83178867|FG000|Extension Phase|Protocol Violation|0|||
46941644|NCT00965757|83178868|FG001|Extension Phase|Protocol Violation|0|||
46941645|NCT00965757|83178869|FG002|Extension Phase|Protocol Violation|0|||
46941646|NCT00965757|83178870|FG003|Extension Phase|Protocol Violation|1|||
46941647|NCT00965757|83178867|FG000|Extension Phase|Other|0|||
46941648|NCT00965757|83178868|FG001|Extension Phase|Other|0|||
46941649|NCT00965757|83178869|FG002|Extension Phase|Other|2|||
46941650|NCT00965757|83178870|FG003|Extension Phase|Other|1|||
46941651|NCT03072459|83178878|FG000|Overall Study|Device revised/removed|1|||
46941652|NCT03072459|83178878|FG000|Overall Study|Subject not able to return|1|||
46941653|NCT05254613|83178885|FG000|Overall Study|Lost to Follow-up|0|||
46941654|NCT05254613|83178886|FG001|Overall Study|Lost to Follow-up|0|||
46941655|NCT05254613|83178887|FG002|Overall Study|Lost to Follow-up|1|||
46941656|NCT05020249|83178906|FG000|Overall Study|Protocol Violation|1|||
46941657|NCT05020249|83178907|FG001|Overall Study|Protocol Violation|0|||
46941658|NCT04380753|83178929|FG000|Overall Study|Participants continuing study|4|||
46941659|NCT04380753|83178929|FG000|Overall Study|Death|2|||
46941660|NCT04346108|83178933|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
46941661|NCT04346108|83178934|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
46941662|NCT04346108|83178935|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
46941663|NCT04346108|83178933|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
46941664|NCT04346108|83178934|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
46941665|NCT04346108|83178935|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
46941666|NCT04333433|83178968|FG000|Overall Study|Withdrawal by Subject|6|||
46941667|NCT04333433|83178969|FG001|Overall Study|Withdrawal by Subject|3|||
46941668|NCT04333433|83178968|FG000|Overall Study|Death|3|||
46941669|NCT04333433|83178969|FG001|Overall Study|Death|0|||
46941670|NCT04333433|83178968|FG000|Overall Study|Lost to Follow-up|6|||
46941671|NCT04333433|83178969|FG001|Overall Study|Lost to Follow-up|1|||
46941672|NCT04333433|83178968|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
46941673|NCT04333433|83178969|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
46941674|NCT04153565|83178975|FG000|Overall Study|Death|13|||
46941675|NCT03915951|83178985|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
46941676|NCT03915951|83178986|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
46941677|NCT03915951|83178985|FG000|Overall Study|Adverse Event|12|||
46941678|NCT03915951|83178986|FG001|Overall Study|Adverse Event|6|||
46941679|NCT03915951|83178985|FG000|Overall Study|Disease progression (radiological)|17|||
46637829|NCT01474512|82811376|FG000|Long-Term Extension Period|Sponsor Decision|0|||
46941680|NCT03915951|83178986|FG001|Overall Study|Disease progression (radiological)|15|||
46941681|NCT03915951|83178985|FG000|Overall Study|Disease progression (clinical)|4|||
46941682|NCT03915951|83178986|FG001|Overall Study|Disease progression (clinical)|1|||
46941683|NCT03915951|83178985|FG000|Overall Study|Patient decision|0|||
46941684|NCT03915951|83178986|FG001|Overall Study|Patient decision|4|||
46941685|NCT03915951|83178985|FG000|Overall Study|Investigator decision|0|||
46941686|NCT03915951|83178986|FG001|Overall Study|Investigator decision|1|||
46941687|NCT03915951|83178985|FG000|Overall Study|Consent withdrawn|1|||
46941688|NCT03915951|83178986|FG001|Overall Study|Consent withdrawn|1|||
46941689|NCT03915951|83178985|FG000|Overall Study|Death|0|||
46941690|NCT03915951|83178986|FG001|Overall Study|Death|3|||
46941691|NCT03737994|83179018|FG000|Overall Study|Withdrawal by Subject|0|||
46941692|NCT03737994|83179019|FG001|Overall Study|Withdrawal by Subject|0|||
46941693|NCT03737994|83179020|FG002|Overall Study|Withdrawal by Subject|0|||
46941694|NCT03737994|83179021|FG003|Overall Study|Withdrawal by Subject|0|||
46941695|NCT03737994|83179022|FG004|Overall Study|Withdrawal by Subject|0|||
46941696|NCT03737994|83179023|FG005|Overall Study|Withdrawal by Subject|0|||
46941697|NCT03737994|83179024|FG006|Overall Study|Withdrawal by Subject|1|||
46941698|NCT03690388|83179050|FG000|Overall Study|Adverse Event|8|||
46941699|NCT03690388|83179051|FG001|Overall Study|Adverse Event|1|||
46941700|NCT03690388|83179050|FG000|Overall Study|Radiographic Progression|14|||
46941701|NCT03690388|83179051|FG001|Overall Study|Radiographic Progression|29|||
46941702|NCT03690388|83179050|FG000|Overall Study|Clinical deterioration|10|||
46941703|NCT03690388|83179051|FG001|Overall Study|Clinical deterioration|6|||
46941704|NCT03690388|83179050|FG000|Overall Study|Withdrawal by Subject|2|||
46941705|NCT03690388|83179051|FG001|Overall Study|Withdrawal by Subject|0|||
46941706|NCT03690388|83179050|FG000|Overall Study|Lack of Efficacy|1|||
46941707|NCT03690388|83179051|FG001|Overall Study|Lack of Efficacy|0|||
46941708|NCT03690388|83179050|FG000|Overall Study|Lost to Follow-up|1|||
46941709|NCT03690388|83179051|FG001|Overall Study|Lost to Follow-up|0|||
46941710|NCT03571828|83179059|FG000|Overall Study|Withdrawal by Subject|1|||
46941711|NCT03571828|83179060|FG001|Overall Study|Withdrawal by Subject|0|||
46941712|NCT03571828|83179059|FG000|Overall Study|Decision by sponsor|5|||
46941713|NCT03571828|83179060|FG001|Overall Study|Decision by sponsor|1|||
46941714|NCT03571828|83179059|FG000|Overall Study|Death|2|||
46941715|NCT03571828|83179060|FG001|Overall Study|Death|0|||
46941716|NCT03485365|83179076|FG000|Overall Study|Protocol Violation|0|||
46941717|NCT03485365|83179077|FG001|Overall Study|Protocol Violation|0|||
46941718|NCT03485365|83179078|FG002|Overall Study|Protocol Violation|0|||
46941719|NCT03485365|83179079|FG003|Overall Study|Protocol Violation|1|||
46941720|NCT03485365|83179080|FG004|Overall Study|Protocol Violation|0|||
46941721|NCT03485365|83179081|FG005|Overall Study|Protocol Violation|0|||
46941722|NCT03485365|83179082|FG006|Overall Study|Protocol Violation|1|||
46941723|NCT03485365|83179083|FG007|Overall Study|Protocol Violation|0|||
46941724|NCT03485365|83179084|FG008|Overall Study|Protocol Violation|0|||
46941725|NCT03417999|83179107|FG000|Overall Study|Withdrawal by Subject|1|||
46941726|NCT03417999|83179108|FG001|Overall Study|Withdrawal by Subject|0|||
46941727|NCT03417999|83179109|FG002|Overall Study|Withdrawal by Subject|0|||
46941728|NCT03417999|83179107|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
46941729|NCT03417999|83179108|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
46941730|NCT03417999|83179109|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
46941731|NCT03417999|83179107|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
46941732|NCT03417999|83179108|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
46941733|NCT03417999|83179109|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
46941734|NCT03417999|83179107|FG000|Overall Study|Inadequate study staff available to process samples|0|||
46941735|NCT03417999|83179108|FG001|Overall Study|Inadequate study staff available to process samples|0|||
46941736|NCT03417999|83179109|FG002|Overall Study|Inadequate study staff available to process samples|1|||
46941737|NCT03370276|83179121|FG000|Overall Study|Death|0|||
46941738|NCT03370276|83179122|FG001|Overall Study|Death|2|||
46941739|NCT03370276|83179123|FG002|Overall Study|Death|5|||
46941740|NCT03137433|83179151|FG000|Overall Study|Withdrawal by Subject|11|||
46941741|NCT03137433|83179152|FG001|Overall Study|Withdrawal by Subject|11|||
46941742|NCT03137433|83179151|FG000|Overall Study|Lost to Follow-up|5|||
46941743|NCT03137433|83179152|FG001|Overall Study|Lost to Follow-up|6|||
46941744|NCT03137433|83179151|FG000|Overall Study|Physician Decision|2|||
46941745|NCT03137433|83179152|FG001|Overall Study|Physician Decision|0|||
46941746|NCT03137433|83179151|FG000|Overall Study|Moved out of study area|1|||
46941747|NCT03137433|83179152|FG001|Overall Study|Moved out of study area|0|||
46941748|NCT03137433|83179151|FG000|Overall Study|Too far out of window due to COVID|0|||
46941749|NCT03137433|83179152|FG001|Overall Study|Too far out of window due to COVID|1|||
47061677|NCT05052697|83342219|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061678|NCT05052697|83342220|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46637830|NCT01474512|82811377|FG001|Long-Term Extension Period|Sponsor Decision|0|||
46941750|NCT02908672|83179170|FG000|Overall Study|Death|112|||
46941751|NCT02908672|83179171|FG001|Overall Study|Death|93|||
46941752|NCT02908672|83179170|FG000|Overall Study|Lost to Follow-up|3|||
46941753|NCT02908672|83179171|FG001|Overall Study|Lost to Follow-up|3|||
46941754|NCT02908672|83179170|FG000|Overall Study|Other|2|||
46941755|NCT02908672|83179171|FG001|Overall Study|Other|0|||
46941756|NCT02908672|83179170|FG000|Overall Study|Protocol Violation|1|||
46941757|NCT02908672|83179171|FG001|Overall Study|Protocol Violation|1|||
46941758|NCT02908672|83179170|FG000|Overall Study|Withdrawal by Subject|13|||
46941759|NCT02908672|83179171|FG001|Overall Study|Withdrawal by Subject|18|||
46941760|NCT02908672|83179170|FG000|Overall Study|Study is ongoing|124|||
46941761|NCT02908672|83179171|FG001|Overall Study|Study is ongoing|141|||
46941762|NCT02908672|83179170|FG000|Overall Study|Discontinued the study during run-in|3|||
46941763|NCT02908672|83179171|FG001|Overall Study|Discontinued the study during run-in|0|||
46941764|NCT02735239|83179191|FG000|Overall Study|Adverse Event|0|||
46941765|NCT02735239|83179192|FG001|Overall Study|Adverse Event|0|||
46941766|NCT02735239|83179193|FG002|Overall Study|Adverse Event|4|||
46941767|NCT02735239|83179194|FG003|Overall Study|Adverse Event|0|||
46941768|NCT02735239|83179195|FG004|Overall Study|Adverse Event|0|||
46941769|NCT02735239|83179196|FG005|Overall Study|Adverse Event|0|||
46941770|NCT02735239|83179191|FG000|Overall Study|Death|1|||
46941771|NCT02735239|83179192|FG001|Overall Study|Death|1|||
46941772|NCT02735239|83179193|FG002|Overall Study|Death|0|||
46941773|NCT02735239|83179194|FG003|Overall Study|Death|0|||
46941774|NCT02735239|83179195|FG004|Overall Study|Death|0|||
46941775|NCT02735239|83179196|FG005|Overall Study|Death|0|||
46941776|NCT02735239|83179191|FG000|Overall Study|Physician Decision|0|||
46941777|NCT02735239|83179192|FG001|Overall Study|Physician Decision|0|||
46941778|NCT02735239|83179193|FG002|Overall Study|Physician Decision|1|||
46941779|NCT02735239|83179194|FG003|Overall Study|Physician Decision|0|||
46941780|NCT02735239|83179195|FG004|Overall Study|Physician Decision|0|||
46941781|NCT02735239|83179196|FG005|Overall Study|Physician Decision|0|||
46941782|NCT02735239|83179191|FG000|Overall Study|Progressive disease|3|||
46941783|NCT02735239|83179192|FG001|Overall Study|Progressive disease|1|||
46941784|NCT02735239|83179193|FG002|Overall Study|Progressive disease|3|||
46941785|NCT02735239|83179194|FG003|Overall Study|Progressive disease|0|||
46941786|NCT02735239|83179195|FG004|Overall Study|Progressive disease|0|||
46941787|NCT02735239|83179196|FG005|Overall Study|Progressive disease|2|||
46941788|NCT02735239|83179191|FG000|Overall Study|Withdrawal by Subject|0|||
46941789|NCT02735239|83179192|FG001|Overall Study|Withdrawal by Subject|1|||
46941790|NCT02735239|83179193|FG002|Overall Study|Withdrawal by Subject|0|||
46941791|NCT02735239|83179194|FG003|Overall Study|Withdrawal by Subject|0|||
46941792|NCT02735239|83179195|FG004|Overall Study|Withdrawal by Subject|0|||
46941793|NCT02735239|83179196|FG005|Overall Study|Withdrawal by Subject|0|||
46941794|NCT02421939|83179215|FG000|Overall Study|Progressive disease|70|||
46941795|NCT02421939|83179216|FG001|Overall Study|Progressive disease|16|||
46941796|NCT02421939|83179215|FG000|Overall Study|Lack of Efficacy|21|||
46941797|NCT02421939|83179216|FG001|Overall Study|Lack of Efficacy|31|||
46941798|NCT02421939|83179215|FG000|Overall Study|Death|36|||
46941799|NCT02421939|83179216|FG001|Overall Study|Death|10|||
46941800|NCT02421939|83179215|FG000|Overall Study|Disease relapse|33|||
46941801|NCT02421939|83179216|FG001|Overall Study|Disease relapse|2|||
46941802|NCT02421939|83179215|FG000|Overall Study|Adverse Event|28|||
46941803|NCT02421939|83179216|FG001|Overall Study|Adverse Event|5|||
46941804|NCT02421939|83179215|FG000|Overall Study|Withdrawal by Subject|5|||
46941805|NCT02421939|83179216|FG001|Overall Study|Withdrawal by Subject|24|||
46941806|NCT02421939|83179215|FG000|Overall Study|Physician Decision|11|||
46941807|NCT02421939|83179216|FG001|Overall Study|Physician Decision|11|||
46941808|NCT02421939|83179215|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
46941809|NCT02421939|83179216|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
46941810|NCT02421939|83179215|FG000|Overall Study|Miscellaneous|4|||
46941811|NCT02421939|83179216|FG001|Overall Study|Miscellaneous|5|||
46941812|NCT02421939|83179215|FG000|Overall Study|Protocol deviation|1|||
47061679|NCT05052697|83342221|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46766271|NCT00807014|82984644|FG000|Overall Study|Participant Considered Disease Cured|13|||
46766272|NCT00807014|82984645|FG001|Overall Study|Participant Considered Disease Cured|2|||
46766273|NCT00807014|82984644|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
46766274|NCT00807014|82984645|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
46766275|NCT00807014|82984644|FG000|Overall Study|Protocol Violation|2|||
46766276|NCT00807014|82984645|FG001|Overall Study|Protocol Violation|8|||
46833580|NCT00490919|83051516|FG002|Open-label Run-in Period|Adverse Event|0|||
46941813|NCT02421939|83179216|FG001|Overall Study|Protocol deviation|1|||
46941814|NCT02337686|83179222|FG000|Overall Study|Adverse Event|1|||
46941815|NCT02306161|83179228|FG000|Overall Study|Death|1|||
46941816|NCT02306161|83179229|FG001|Overall Study|Death|3|||
46941817|NCT02306161|83179228|FG000|Overall Study|Lack of Efficacy|20|||
46941818|NCT02306161|83179229|FG001|Overall Study|Lack of Efficacy|43|||
46941819|NCT02306161|83179228|FG000|Overall Study|Physician Decision|30|||
46941820|NCT02306161|83179229|FG001|Overall Study|Physician Decision|18|||
46941821|NCT02306161|83179228|FG000|Overall Study|Withdrawal by Subject|4|||
46941822|NCT02306161|83179229|FG001|Overall Study|Withdrawal by Subject|0|||
46941823|NCT02306161|83179228|FG000|Overall Study|Ineligible|9|||
46941824|NCT02306161|83179229|FG001|Overall Study|Ineligible|5|||
46941825|NCT02112916|83179243|FG000|Overall Study|Adverse Event|6|||
46941826|NCT02112916|83179244|FG001|Overall Study|Adverse Event|9|||
46941827|NCT02112916|83179245|FG002|Overall Study|Adverse Event|3|||
46941828|NCT02112916|83179246|FG003|Overall Study|Adverse Event|2|||
46941829|NCT02112916|83179243|FG000|Overall Study|Death|9|||
46941830|NCT02112916|83179244|FG001|Overall Study|Death|9|||
46941831|NCT02112916|83179245|FG002|Overall Study|Death|3|||
46941832|NCT02112916|83179246|FG003|Overall Study|Death|4|||
46941833|NCT02112916|83179243|FG000|Overall Study|Lost to Follow-up|1|||
46941834|NCT02112916|83179244|FG001|Overall Study|Lost to Follow-up|0|||
46941835|NCT02112916|83179245|FG002|Overall Study|Lost to Follow-up|0|||
46941836|NCT02112916|83179246|FG003|Overall Study|Lost to Follow-up|0|||
46941837|NCT02112916|83179243|FG000|Overall Study|Physician Decision|94|||
46941838|NCT02112916|83179244|FG001|Overall Study|Physician Decision|72|||
46941839|NCT02112916|83179245|FG002|Overall Study|Physician Decision|24|||
46941840|NCT02112916|83179246|FG003|Overall Study|Physician Decision|15|||
46941841|NCT02112916|83179243|FG000|Overall Study|Withdrawal by Subject|5|||
46941842|NCT02112916|83179244|FG001|Overall Study|Withdrawal by Subject|3|||
46941843|NCT02112916|83179245|FG002|Overall Study|Withdrawal by Subject|1|||
46941844|NCT02112916|83179246|FG003|Overall Study|Withdrawal by Subject|1|||
46941845|NCT02112916|83179243|FG000|Overall Study|Ineligible|4|||
46941846|NCT02112916|83179244|FG001|Overall Study|Ineligible|8|||
46941847|NCT02112916|83179245|FG002|Overall Study|Ineligible|3|||
46941848|NCT02112916|83179246|FG003|Overall Study|Ineligible|8|||
46941849|NCT02112916|83179243|FG000|Overall Study|Inevaluable|6|||
46941850|NCT02112916|83179244|FG001|Overall Study|Inevaluable|4|||
46941851|NCT02112916|83179245|FG002|Overall Study|Inevaluable|5|||
46941852|NCT02112916|83179246|FG003|Overall Study|Inevaluable|5|||
46941853|NCT02112916|83179243|FG000|Overall Study|Refusal of further protocol therapy|19|||
46941854|NCT02112916|83179244|FG001|Overall Study|Refusal of further protocol therapy|16|||
46941855|NCT02112916|83179245|FG002|Overall Study|Refusal of further protocol therapy|1|||
46941856|NCT02112916|83179246|FG003|Overall Study|Refusal of further protocol therapy|7|||
46941857|NCT02112916|83179243|FG000|Overall Study|Development of SMN|1|||
46941858|NCT02112916|83179244|FG001|Overall Study|Development of SMN|0|||
46941859|NCT02112916|83179245|FG002|Overall Study|Development of SMN|0|||
46941860|NCT02112916|83179246|FG003|Overall Study|Development of SMN|1|||
46941861|NCT02112916|83179243|FG000|Overall Study|Relapse/Progression|10|||
46941862|NCT02112916|83179244|FG001|Overall Study|Relapse/Progression|18|||
46941863|NCT02112916|83179245|FG002|Overall Study|Relapse/Progression|15|||
46941864|NCT02112916|83179246|FG003|Overall Study|Relapse/Progression|2|||
46941865|NCT02112916|83179243|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
46941866|NCT02112916|83179244|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
46941867|NCT02112916|83179245|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
46941868|NCT02112916|83179246|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
46941869|NCT02112916|83179243|FG000|Overall Study|Still on Therapy|44|||
46941870|NCT02112916|83179244|FG001|Overall Study|Still on Therapy|47|||
46941871|NCT02112916|83179245|FG002|Overall Study|Still on Therapy|3|||
46941872|NCT02112916|83179246|FG003|Overall Study|Still on Therapy|2|||
46941873|NCT02112916|83179243|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
46941874|NCT02112916|83179244|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
46941875|NCT02112916|83179245|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
46941876|NCT02112916|83179246|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
47061680|NCT05052697|83342222|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061681|NCT05052697|83342223|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061682|NCT05052697|83342224|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061683|NCT05052697|83342225|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46941877|NCT02112916|83179243|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
47061684|NCT05052697|83342226|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46637831|NCT01474512|82811378|FG002|Long-Term Extension Period|Sponsor Decision|0|||
46637832|NCT01474512|82811379|FG003|Long-Term Extension Period|Sponsor Decision|0|||
46637833|NCT01474512|82811380|FG004|Long-Term Extension Period|Sponsor Decision|0|||
46637834|NCT01474512|82811381|FG005|Long-Term Extension Period|Sponsor Decision|0|||
46637835|NCT01474512|82811382|FG006|Long-Term Extension Period|Sponsor Decision|0|||
46941878|NCT02112916|83179244|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
46941879|NCT02112916|83179245|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
46941880|NCT02112916|83179246|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
46941881|NCT02101853|83179261|FG000|Block 1 Induction|Adverse Event|11|||
46941882|NCT02101853|83179262|FG001|Block 1 Induction|Adverse Event|0|||
46941883|NCT02101853|83179263|FG002|Block 1 Induction|Adverse Event|0|||
46941884|NCT02101853|83179264|FG003|Block 1 Induction|Adverse Event|0|||
46941885|NCT02101853|83179265|FG004|Block 1 Induction|Adverse Event|0|||
46941886|NCT02101853|83179266|FG005|Block 1 Induction|Adverse Event|0|||
46941887|NCT02101853|83179261|FG000|Block 1 Induction|Death|20|||
46941888|NCT02101853|83179262|FG001|Block 1 Induction|Death|0|||
46941889|NCT02101853|83179263|FG002|Block 1 Induction|Death|0|||
46941890|NCT02101853|83179264|FG003|Block 1 Induction|Death|0|||
46941891|NCT02101853|83179265|FG004|Block 1 Induction|Death|0|||
47061685|NCT05052697|83342227|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46941892|NCT02101853|83179266|FG005|Block 1 Induction|Death|0|||
46941893|NCT02101853|83179261|FG000|Block 1 Induction|Lack of Efficacy|6|||
46941894|NCT02101853|83179262|FG001|Block 1 Induction|Lack of Efficacy|0|||
46941895|NCT02101853|83179263|FG002|Block 1 Induction|Lack of Efficacy|0|||
46941896|NCT02101853|83179264|FG003|Block 1 Induction|Lack of Efficacy|0|||
46941897|NCT02101853|83179265|FG004|Block 1 Induction|Lack of Efficacy|0|||
46941898|NCT02101853|83179266|FG005|Block 1 Induction|Lack of Efficacy|0|||
46941899|NCT02101853|83179261|FG000|Block 1 Induction|Physician Decision|61|||
46941900|NCT02101853|83179262|FG001|Block 1 Induction|Physician Decision|0|||
46941901|NCT02101853|83179263|FG002|Block 1 Induction|Physician Decision|0|||
46941902|NCT02101853|83179264|FG003|Block 1 Induction|Physician Decision|0|||
46941903|NCT02101853|83179265|FG004|Block 1 Induction|Physician Decision|0|||
46941904|NCT02101853|83179266|FG005|Block 1 Induction|Physician Decision|0|||
46941905|NCT02101853|83179261|FG000|Block 1 Induction|Protocol Violation|2|||
46941906|NCT02101853|83179262|FG001|Block 1 Induction|Protocol Violation|0|||
46941907|NCT02101853|83179263|FG002|Block 1 Induction|Protocol Violation|0|||
46941908|NCT02101853|83179264|FG003|Block 1 Induction|Protocol Violation|0|||
46941909|NCT02101853|83179265|FG004|Block 1 Induction|Protocol Violation|0|||
46941910|NCT02101853|83179266|FG005|Block 1 Induction|Protocol Violation|0|||
46941911|NCT02101853|83179261|FG000|Block 1 Induction|Withdrawal by Subject|65|||
46941912|NCT02101853|83179262|FG001|Block 1 Induction|Withdrawal by Subject|0|||
46941913|NCT02101853|83179263|FG002|Block 1 Induction|Withdrawal by Subject|0|||
46941914|NCT02101853|83179264|FG003|Block 1 Induction|Withdrawal by Subject|0|||
46941915|NCT02101853|83179265|FG004|Block 1 Induction|Withdrawal by Subject|0|||
46941916|NCT02101853|83179266|FG005|Block 1 Induction|Withdrawal by Subject|0|||
46941917|NCT02101853|83179261|FG000|Block 1 Induction|Ineligible|8|||
46941918|NCT02101853|83179262|FG001|Block 1 Induction|Ineligible|0|||
46941919|NCT02101853|83179263|FG002|Block 1 Induction|Ineligible|0|||
46941920|NCT02101853|83179264|FG003|Block 1 Induction|Ineligible|0|||
46941921|NCT02101853|83179265|FG004|Block 1 Induction|Ineligible|0|||
46941922|NCT02101853|83179266|FG005|Block 1 Induction|Ineligible|0|||
46941923|NCT02101853|83179261|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
46941924|NCT02101853|83179262|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
46941925|NCT02101853|83179263|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
46941926|NCT02101853|83179264|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
46941927|NCT02101853|83179265|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
46941928|NCT02101853|83179266|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
46941929|NCT02101853|83179261|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
46941930|NCT02101853|83179262|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941931|NCT02101853|83179263|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941932|NCT02101853|83179264|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941933|NCT02101853|83179265|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941934|NCT02101853|83179266|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941935|NCT02101853|83179261|FG000|Post Induction Randomization|Adverse Event|0|||
46941936|NCT02101853|83179262|FG001|Post Induction Randomization|Adverse Event|3|||
46941937|NCT02101853|83179263|FG002|Post Induction Randomization|Adverse Event|8|||
46941938|NCT02101853|83179264|FG003|Post Induction Randomization|Adverse Event|4|||
46941939|NCT02101853|83179265|FG004|Post Induction Randomization|Adverse Event|4|||
46941940|NCT02101853|83179266|FG005|Post Induction Randomization|Adverse Event|0|||
46941941|NCT02101853|83179261|FG000|Post Induction Randomization|Death|0|||
46941942|NCT02101853|83179262|FG001|Post Induction Randomization|Death|9|||
46941943|NCT02101853|83179263|FG002|Post Induction Randomization|Death|2|||
46941944|NCT02101853|83179264|FG003|Post Induction Randomization|Death|2|||
46941945|NCT02101853|83179265|FG004|Post Induction Randomization|Death|0|||
46941946|NCT02101853|83179266|FG005|Post Induction Randomization|Death|0|||
46941947|NCT02101853|83179261|FG000|Post Induction Randomization|Lack of Efficacy|0|||
46941948|NCT02101853|83179262|FG001|Post Induction Randomization|Lack of Efficacy|14|||
46941949|NCT02101853|83179263|FG002|Post Induction Randomization|Lack of Efficacy|23|||
46941950|NCT02101853|83179264|FG003|Post Induction Randomization|Lack of Efficacy|18|||
46941951|NCT02101853|83179265|FG004|Post Induction Randomization|Lack of Efficacy|21|||
46941952|NCT02101853|83179266|FG005|Post Induction Randomization|Lack of Efficacy|0|||
46941953|NCT02101853|83179261|FG000|Post Induction Randomization|Physician Decision|0|||
46941954|NCT02101853|83179262|FG001|Post Induction Randomization|Physician Decision|43|||
46637836|NCT01474512|82811383|FG007|Long-Term Extension Period|Sponsor Decision|0|||
46833581|NCT00490919|83051514|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
46833582|NCT00490919|83051515|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
46833583|NCT00490919|83051516|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
46833584|NCT00490919|83051514|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
46941955|NCT02101853|83179263|FG002|Post Induction Randomization|Physician Decision|23|||
46941956|NCT02101853|83179264|FG003|Post Induction Randomization|Physician Decision|14|||
46941957|NCT02101853|83179265|FG004|Post Induction Randomization|Physician Decision|14|||
46941958|NCT02101853|83179266|FG005|Post Induction Randomization|Physician Decision|0|||
47061686|NCT05052697|83342228|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46833585|NCT00490919|83051515|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
46833586|NCT00490919|83051516|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
46833587|NCT00490919|83051514|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
46833588|NCT00490919|83051515|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
46833589|NCT00490919|83051516|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
46833590|NCT00490919|83051514|FG000|Open-label Run-in Period|Administrative|40|||
46833591|NCT00490919|83051515|FG001|Open-label Run-in Period|Administrative|0|||
46833592|NCT00490919|83051516|FG002|Open-label Run-in Period|Administrative|0|||
46833593|NCT00490919|83051514|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
46833594|NCT00490919|83051515|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
46833595|NCT00490919|83051516|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
46833596|NCT00490919|83051514|FG000|Double-blind Phase|Adverse Event|0|||
46833597|NCT00490919|83051515|FG001|Double-blind Phase|Adverse Event|40|||
46833598|NCT00490919|83051516|FG002|Double-blind Phase|Adverse Event|20|||
46833599|NCT00490919|83051514|FG000|Double-blind Phase|Withdrawal by Subject|0|||
46833600|NCT00490919|83051515|FG001|Double-blind Phase|Withdrawal by Subject|10|||
46833601|NCT00490919|83051516|FG002|Double-blind Phase|Withdrawal by Subject|11|||
46833602|NCT00490919|83051514|FG000|Double-blind Phase|Lost to Follow-up|0|||
46833603|NCT00490919|83051515|FG001|Double-blind Phase|Lost to Follow-up|8|||
46833604|NCT00490919|83051516|FG002|Double-blind Phase|Lost to Follow-up|11|||
46833605|NCT00490919|83051514|FG000|Double-blind Phase|Lack of Efficacy|0|||
46833606|NCT00490919|83051515|FG001|Double-blind Phase|Lack of Efficacy|22|||
46833607|NCT00490919|83051516|FG002|Double-blind Phase|Lack of Efficacy|36|||
46833608|NCT00490919|83051514|FG000|Double-blind Phase|Administrative|0|||
46833609|NCT00490919|83051515|FG001|Double-blind Phase|Administrative|6|||
46833610|NCT00490919|83051516|FG002|Double-blind Phase|Administrative|6|||
46833611|NCT00503867|83051523|FG000|Overall Study|Lost to Follow-up|1|||
46833612|NCT00503867|83051523|FG000|Overall Study|Adverse Event|1|||
46833613|NCT00503399|83051529|FG000|Overall Study|Death|2|||
46833614|NCT00503399|83051530|FG001|Overall Study|Death|1|||
46833615|NCT00503399|83051529|FG000|Overall Study|Protocol Violation|1|||
46833616|NCT00503399|83051530|FG001|Overall Study|Protocol Violation|0|||
46833617|NCT00503399|83051529|FG000|Overall Study|Withdrawal by Subject|4|||
46833618|NCT00503399|83051530|FG001|Overall Study|Withdrawal by Subject|2|||
46833619|NCT00503399|83051529|FG000|Overall Study|Adverse Event|0|||
46833620|NCT00503399|83051530|FG001|Overall Study|Adverse Event|3|||
46833621|NCT00503399|83051529|FG000|Overall Study|Lost to Follow-up|0|||
46833622|NCT00503399|83051530|FG001|Overall Study|Lost to Follow-up|2|||
46833623|NCT00506519|83051539|FG000|Overall Study|Death|4|||
46833624|NCT00506519|83051540|FG001|Overall Study|Death|6|||
46833625|NCT00506519|83051541|FG002|Overall Study|Death|0|||
46833626|NCT00506519|83051539|FG000|Overall Study|Adverse Event|1|||
46833627|NCT00506519|83051540|FG001|Overall Study|Adverse Event|0|||
46833628|NCT00506519|83051541|FG002|Overall Study|Adverse Event|0|||
46833629|NCT00503009|83051555|FG000|Overall Study|Protocol Violation|1|||
46833630|NCT00503009|83051556|FG001|Overall Study|Protocol Violation|0|||
46833631|NCT00503009|83051557|FG002|Overall Study|Protocol Violation|1|||
46833632|NCT00503009|83051555|FG000|Overall Study|Withdrawal by Subject|0|||
46833633|NCT00503009|83051556|FG001|Overall Study|Withdrawal by Subject|1|||
46833634|NCT00503009|83051557|FG002|Overall Study|Withdrawal by Subject|1|||
46833635|NCT00503009|83051555|FG000|Overall Study|Physician Decision|0|||
46833636|NCT00503009|83051556|FG001|Overall Study|Physician Decision|1|||
46833637|NCT00503009|83051557|FG002|Overall Study|Physician Decision|1|||
46833638|NCT00160251|83051571|FG000|Prior to Amendment 2|Adverse Event|2|||
46833639|NCT00160251|83051572|FG001|Prior to Amendment 2|Adverse Event|1|||
46833640|NCT00160251|83051573|FG002|Prior to Amendment 2|Adverse Event|3|||
46833641|NCT00160251|83051574|FG003|Prior to Amendment 2|Adverse Event|1|||
46833642|NCT00160251|83051575|FG004|Prior to Amendment 2|Adverse Event|1|||
46833643|NCT00160251|83051576|FG005|Prior to Amendment 2|Adverse Event|1|||
46833644|NCT00160251|83051577|FG006|Prior to Amendment 2|Adverse Event|1|||
46833645|NCT00160251|83051578|FG007|Prior to Amendment 2|Adverse Event|0|||
46833646|NCT00160251|83051571|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
46833647|NCT00160251|83051572|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
46833648|NCT00160251|83051573|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
46833649|NCT00160251|83051574|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
46833650|NCT00160251|83051575|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
46833651|NCT00160251|83051576|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
46833652|NCT00160251|83051577|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
46833653|NCT00160251|83051578|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
46833654|NCT00160251|83051571|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
46833655|NCT00160251|83051572|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
46941959|NCT02101853|83179261|FG000|Post Induction Randomization|Protocol Violation|0|||
46941960|NCT02101853|83179262|FG001|Post Induction Randomization|Protocol Violation|3|||
46941961|NCT02101853|83179263|FG002|Post Induction Randomization|Protocol Violation|0|||
46941962|NCT02101853|83179264|FG003|Post Induction Randomization|Protocol Violation|0|||
46941963|NCT02101853|83179265|FG004|Post Induction Randomization|Protocol Violation|0|||
46941964|NCT02101853|83179266|FG005|Post Induction Randomization|Protocol Violation|0|||
46941965|NCT02101853|83179261|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
46941966|NCT02101853|83179262|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
46941967|NCT02101853|83179263|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
46941968|NCT02101853|83179264|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
46941969|NCT02101853|83179265|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
46941970|NCT02101853|83179266|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
46941971|NCT02101853|83179261|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941972|NCT02101853|83179262|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941973|NCT02101853|83179263|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941974|NCT02101853|83179264|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
46941975|NCT02101853|83179265|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941976|NCT02101853|83179266|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
46941977|NCT02101853|83179261|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
46941978|NCT02101853|83179262|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
46941979|NCT02101853|83179263|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
46941980|NCT02101853|83179264|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
46941981|NCT02101853|83179265|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
46941982|NCT02101853|83179266|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
46941983|NCT02101853|83179261|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
46941984|NCT02101853|83179262|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
46941985|NCT02101853|83179263|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
46941986|NCT02101853|83179264|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
46941987|NCT02101853|83179265|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
46941988|NCT02101853|83179266|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
46941989|NCT02101853|83179261|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
46941990|NCT02101853|83179262|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
46941991|NCT02101853|83179263|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
46941992|NCT02101853|83179264|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
46941993|NCT02101853|83179265|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
46941994|NCT02101853|83179266|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
46941995|NCT02101853|83179261|FG000|Blinatumomab Salvage Therapy|Death|0|||
46941996|NCT02101853|83179262|FG001|Blinatumomab Salvage Therapy|Death|0|||
46941997|NCT02101853|83179263|FG002|Blinatumomab Salvage Therapy|Death|0|||
46941998|NCT02101853|83179264|FG003|Blinatumomab Salvage Therapy|Death|0|||
46941999|NCT02101853|83179265|FG004|Blinatumomab Salvage Therapy|Death|0|||
46942000|NCT02101853|83179266|FG005|Blinatumomab Salvage Therapy|Death|2|||
46833656|NCT00160251|83051573|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
46833657|NCT00160251|83051574|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
46833658|NCT00160251|83051575|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
46833659|NCT00160251|83051576|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
46833660|NCT00160251|83051577|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
46833661|NCT00160251|83051578|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
46833662|NCT00160251|83051571|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
46833663|NCT00160251|83051572|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
46833664|NCT00160251|83051573|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
46833665|NCT00160251|83051574|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
46833666|NCT00160251|83051575|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
46833667|NCT00160251|83051576|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
46833668|NCT00160251|83051577|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
46833669|NCT00160251|83051578|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
46833670|NCT00160251|83051571|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
46833671|NCT00160251|83051572|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
46833672|NCT00160251|83051573|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
46833673|NCT00160251|83051574|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
46833674|NCT00160251|83051575|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
46942001|NCT02101853|83179261|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
46833675|NCT00160251|83051576|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
46833676|NCT00160251|83051577|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
46942002|NCT02101853|83179262|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
46942003|NCT02101853|83179263|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
46942004|NCT02101853|83179264|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
46942005|NCT02101853|83179265|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
46942006|NCT02101853|83179266|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
46942007|NCT02101853|83179261|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
46942008|NCT02101853|83179262|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
46942009|NCT02101853|83179263|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
46942010|NCT02101853|83179264|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
46942011|NCT02101853|83179265|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
46942012|NCT02101853|83179266|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
46942013|NCT02101853|83179261|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
46942014|NCT02101853|83179262|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
46942015|NCT02101853|83179263|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
46942016|NCT02101853|83179264|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
46942017|NCT02101853|83179265|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
46942018|NCT02101853|83179266|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
46942019|NCT02062463|83179288|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
46942020|NCT02062463|83179289|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
46942021|NCT02062463|83179290|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
46942022|NCT02062463|83179291|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
46942023|NCT02062463|83179288|FG000|Stage 2|Adverse Event|0|||
46942024|NCT02062463|83179289|FG001|Stage 2|Adverse Event|0|||
46942025|NCT02062463|83179290|FG002|Stage 2|Adverse Event|12|||
46942026|NCT02062463|83179291|FG003|Stage 2|Adverse Event|20|||
46942027|NCT02062463|83179288|FG000|Stage 2|Lack of Efficacy|0|||
46942028|NCT02062463|83179289|FG001|Stage 2|Lack of Efficacy|0|||
46942029|NCT02062463|83179290|FG002|Stage 2|Lack of Efficacy|3|||
46942030|NCT02062463|83179291|FG003|Stage 2|Lack of Efficacy|4|||
46942031|NCT02062463|83179288|FG000|Stage 2|Lost to Follow-up|0|||
46942032|NCT02062463|83179289|FG001|Stage 2|Lost to Follow-up|0|||
46942033|NCT02062463|83179290|FG002|Stage 2|Lost to Follow-up|20|||
46942034|NCT02062463|83179291|FG003|Stage 2|Lost to Follow-up|20|||
46942035|NCT02062463|83179288|FG000|Stage 2|Non-Compliance|0|||
46942036|NCT02062463|83179289|FG001|Stage 2|Non-Compliance|0|||
46942037|NCT02062463|83179290|FG002|Stage 2|Non-Compliance|0|||
46942038|NCT02062463|83179291|FG003|Stage 2|Non-Compliance|1|||
47061687|NCT05052697|83342229|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061688|NCT05052697|83342230|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46833677|NCT00160251|83051578|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
46833678|NCT00160251|83051571|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
46833679|NCT00160251|83051572|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
46833680|NCT00160251|83051573|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
46833681|NCT00160251|83051574|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
46833682|NCT00160251|83051575|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
46833683|NCT00160251|83051576|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
46833684|NCT00160251|83051577|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
46833685|NCT00160251|83051578|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
46833686|NCT00160251|83051571|FG000|Post-amendment 2|Adverse Event|0|||
46833687|NCT00160251|83051572|FG001|Post-amendment 2|Adverse Event|0|||
46833688|NCT00160251|83051573|FG002|Post-amendment 2|Adverse Event|0|||
46833689|NCT00160251|83051574|FG003|Post-amendment 2|Adverse Event|0|||
46833690|NCT00160251|83051575|FG004|Post-amendment 2|Adverse Event|0|||
46833691|NCT00160251|83051576|FG005|Post-amendment 2|Adverse Event|0|||
46833692|NCT00160251|83051577|FG006|Post-amendment 2|Adverse Event|0|||
46833693|NCT00160251|83051578|FG007|Post-amendment 2|Adverse Event|20|||
46833694|NCT00160251|83051571|FG000|Post-amendment 2|Lack of Efficacy|0|||
46833695|NCT00160251|83051572|FG001|Post-amendment 2|Lack of Efficacy|0|||
46833696|NCT00160251|83051573|FG002|Post-amendment 2|Lack of Efficacy|0|||
46833697|NCT00160251|83051574|FG003|Post-amendment 2|Lack of Efficacy|0|||
46833698|NCT00160251|83051575|FG004|Post-amendment 2|Lack of Efficacy|0|||
46833699|NCT00160251|83051576|FG005|Post-amendment 2|Lack of Efficacy|0|||
46833700|NCT00160251|83051577|FG006|Post-amendment 2|Lack of Efficacy|0|||
46833701|NCT00160251|83051578|FG007|Post-amendment 2|Lack of Efficacy|24|||
46833702|NCT00160251|83051571|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
46833703|NCT00160251|83051572|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
46833704|NCT00160251|83051573|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
46833705|NCT00160251|83051574|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
46833706|NCT00160251|83051575|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
46833707|NCT00160251|83051576|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
46833708|NCT00160251|83051577|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
46833709|NCT00160251|83051578|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
46833710|NCT00506441|83051635|FG000|Period 1; Open-label Period|Adverse Event|21|||
46833711|NCT00506441|83051636|FG001|Period 1; Open-label Period|Adverse Event|0|||
46833712|NCT00506441|83051635|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
46833713|NCT00506441|83051636|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
46833714|NCT00506441|83051635|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
46833715|NCT00506441|83051636|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
46833716|NCT00506441|83051635|FG000|Period 1; Open-label Period|Physician Decision|5|||
46833717|NCT00506441|83051636|FG001|Period 1; Open-label Period|Physician Decision|0|||
46833718|NCT00506441|83051635|FG000|Period 1; Open-label Period|Protocol Violation|9|||
46833719|NCT00506441|83051636|FG001|Period 1; Open-label Period|Protocol Violation|0|||
46833720|NCT00506441|83051635|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
46833721|NCT00506441|83051636|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
46833722|NCT00506441|83051635|FG000|Period 1; Open-label Period|Other Reasons|13|||
46942039|NCT02062463|83179288|FG000|Stage 2|Other than specified|0|||
46942040|NCT02062463|83179289|FG001|Stage 2|Other than specified|0|||
46942041|NCT02062463|83179290|FG002|Stage 2|Other than specified|3|||
46942042|NCT02062463|83179291|FG003|Stage 2|Other than specified|1|||
46942043|NCT02062463|83179288|FG000|Stage 2|Withdrawal by Subject|0|||
46942044|NCT02062463|83179289|FG001|Stage 2|Withdrawal by Subject|0|||
46942045|NCT02062463|83179290|FG002|Stage 2|Withdrawal by Subject|15|||
46942046|NCT02062463|83179291|FG003|Stage 2|Withdrawal by Subject|10|||
46942047|NCT01924533|83179303|FG000|Overall Study|Death|181|||
46942048|NCT01924533|83179304|FG001|Overall Study|Death|200|||
46942049|NCT01924533|83179303|FG000|Overall Study|Lost to Follow-up|0|||
46942050|NCT01924533|83179304|FG001|Overall Study|Lost to Follow-up|1|||
46942051|NCT01924533|83179303|FG000|Overall Study|Withdrawal by Subject|7|||
46942052|NCT01924533|83179304|FG001|Overall Study|Withdrawal by Subject|3|||
46942053|NCT01924533|83179303|FG000|Overall Study|Other Eligibility criteria|1|||
46942054|NCT01924533|83179304|FG001|Overall Study|Other Eligibility criteria|1|||
46942055|NCT01702805|83179312|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
46942056|NCT01702805|83179313|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
46942057|NCT01702805|83179312|FG000|Overall Study|Incomplete Follow-up|18|||
46942058|NCT01702805|83179313|FG001|Overall Study|Incomplete Follow-up|15|||
46942059|NCT01702805|83179312|FG000|Overall Study|Vital Status Assessment Only|40|||
46942060|NCT01702805|83179313|FG001|Overall Study|Vital Status Assessment Only|39|||
46942061|NCT01702805|83179312|FG000|Overall Study|Lost to Follow-up|5|||
46942062|NCT01702805|83179313|FG001|Overall Study|Lost to Follow-up|5|||
46942063|NCT01652287|83179321|FG000|Overall Study|Withdrawal by Subject|2|||
46942064|NCT01652287|83179322|FG001|Overall Study|Withdrawal by Subject|0|||
46942065|NCT00382070|83179331|FG000|Overall Study|No follow up data mapped to Other|17|||
46942066|NCT00382070|83179332|FG001|Overall Study|No follow up data mapped to Other|19|||
46942067|NCT00382070|83179331|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
46942068|NCT00382070|83179332|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
46942069|NCT00382070|83179331|FG000|Overall Study|No clinical assessment|9|||
46833723|NCT00506441|83051636|FG001|Period 1; Open-label Period|Other Reasons|0|||
46833724|NCT00506441|83051635|FG000|Period 2; Double-blind Period|Adverse Event|0|||
46833725|NCT00506441|83051636|FG001|Period 2; Double-blind Period|Adverse Event|1|||
46833726|NCT00506441|83051635|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
46833727|NCT00506441|83051636|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
46833728|NCT00506441|83051635|FG000|Period 2; Double-blind Period|Physician Decision|1|||
46833729|NCT00506441|83051636|FG001|Period 2; Double-blind Period|Physician Decision|1|||
46833730|NCT00506441|83051635|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
46833731|NCT00506441|83051636|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
46833732|NCT00506441|83051635|FG000|Period 2; Double-blind Period|Other Reason|1|||
46833733|NCT00506441|83051636|FG001|Period 2; Double-blind Period|Other Reason|1|||
46833734|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
46833735|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
46833736|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Graft loss|1|||
46833737|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Graft loss|2|||
46833738|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Death|5|||
46833739|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Death|3|||
46833740|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
46833741|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
46942070|NCT00382070|83179332|FG001|Overall Study|No clinical assessment|11|||
46942071|NCT00350103|83179341|FG000|Overall Study|Adverse Event|12|||
46942072|NCT00350103|83179342|FG001|Overall Study|Adverse Event|29|||
46833742|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
46833743|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
46833744|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
46833745|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
46942073|NCT00350103|83179343|FG002|Overall Study|Adverse Event|17|||
46942074|NCT00350103|83179341|FG000|Overall Study|Lack of Efficacy|5|||
46942075|NCT00350103|83179342|FG001|Overall Study|Lack of Efficacy|1|||
46942076|NCT00350103|83179343|FG002|Overall Study|Lack of Efficacy|3|||
46637837|NCT01474512|82811384|FG008|Long-Term Extension Period|Sponsor Decision|0|||
46637838|NCT01474512|82811385|FG009|Long-Term Extension Period|Sponsor Decision|0|||
46637839|NCT01474512|82811386|FG010|Long-Term Extension Period|Sponsor Decision|0|||
46637840|NCT01474512|82811387|FG011|Long-Term Extension Period|Sponsor Decision|0|||
46637841|NCT01474512|82811388|FG012|Long-Term Extension Period|Sponsor Decision|6|||
46637842|NCT01474512|82811389|FG013|Long-Term Extension Period|Sponsor Decision|6|||
46833746|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
46833747|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
46833748|NCT00378014|83051663|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
46833749|NCT00378014|83051664|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
46637843|NCT01474512|82811390|FG014|Long-Term Extension Period|Sponsor Decision|0|||
46637844|NCT01474512|82811391|FG015|Long-Term Extension Period|Sponsor Decision|0|||
46637845|NCT01474512|82811392|FG016|Long-Term Extension Period|Sponsor Decision|0|||
46637846|NCT01474512|82811393|FG017|Long-Term Extension Period|Sponsor Decision|0|||
46637847|NCT01474512|82811376|FG000|Long-Term Extension Period|Protocol Violation|0|||
46637848|NCT01474512|82811377|FG001|Long-Term Extension Period|Protocol Violation|0|||
46637849|NCT01474512|82811378|FG002|Long-Term Extension Period|Protocol Violation|0|||
46637850|NCT01474512|82811379|FG003|Long-Term Extension Period|Protocol Violation|0|||
46637851|NCT01474512|82811380|FG004|Long-Term Extension Period|Protocol Violation|0|||
46637852|NCT01474512|82811381|FG005|Long-Term Extension Period|Protocol Violation|0|||
46833750|NCT00378014|83051663|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
46833751|NCT00378014|83051664|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
46833752|NCT00378014|83051663|FG000|Extension (Month 12 to Month 59)|Death|1|||
46833753|NCT00378014|83051664|FG001|Extension (Month 12 to Month 59)|Death|2|||
46833754|NCT00378014|83051663|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
46833755|NCT00378014|83051664|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
46833756|NCT00378014|83051663|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
46833757|NCT00378014|83051664|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
46833758|NCT00378014|83051663|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
46833759|NCT00378014|83051664|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
46833760|NCT00378014|83051663|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
46833761|NCT00378014|83051664|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
46833762|NCT00485303|83051672|FG000|Overall Study|Adverse Event|5|||
46833763|NCT00485303|83051672|FG000|Overall Study|Progressive Disease|44|||
46637853|NCT01474512|82811382|FG006|Long-Term Extension Period|Protocol Violation|0|||
46637854|NCT01474512|82811383|FG007|Long-Term Extension Period|Protocol Violation|0|||
46637855|NCT01474512|82811384|FG008|Long-Term Extension Period|Protocol Violation|0|||
46637856|NCT01474512|82811385|FG009|Long-Term Extension Period|Protocol Violation|0|||
46637857|NCT01474512|82811386|FG010|Long-Term Extension Period|Protocol Violation|0|||
46637858|NCT01474512|82811387|FG011|Long-Term Extension Period|Protocol Violation|0|||
46637859|NCT01474512|82811388|FG012|Long-Term Extension Period|Protocol Violation|5|||
46637860|NCT01474512|82811389|FG013|Long-Term Extension Period|Protocol Violation|5|||
46637861|NCT01474512|82811390|FG014|Long-Term Extension Period|Protocol Violation|0|||
46637862|NCT01474512|82811391|FG015|Long-Term Extension Period|Protocol Violation|0|||
46637863|NCT01474512|82811392|FG016|Long-Term Extension Period|Protocol Violation|0|||
46637864|NCT01474512|82811393|FG017|Long-Term Extension Period|Protocol Violation|0|||
46637865|NCT01474512|82811376|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637866|NCT01474512|82811377|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46833764|NCT00485303|83051672|FG000|Overall Study|Other|3|||
46833765|NCT00485303|83051672|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
46833766|NCT00485303|83051672|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
46833767|NCT00490841|83051676|FG000|Overall Study|Death|5|||
46833768|NCT00490841|83051676|FG000|Overall Study|Withdrawal by Subject|4|||
46833769|NCT00490841|83051676|FG000|Overall Study|Lost to Follow-up|1|||
46833770|NCT00490841|83051676|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
46833771|NCT00377858|83051683|FG000|Overall Study|Withdrawal by Subject|12|||
46637867|NCT01474512|82811378|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637868|NCT01474512|82811379|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637869|NCT01474512|82811380|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46766277|NCT00807014|82984644|FG000|Overall Study|Adverse Event|0|||
46766278|NCT00807014|82984645|FG001|Overall Study|Adverse Event|2|||
46766279|NCT00807014|82984644|FG000|Overall Study|Lost to Follow-up|9|||
46766280|NCT00807014|82984645|FG001|Overall Study|Lost to Follow-up|7|||
46766281|NCT00807014|82984644|FG000|Overall Study|Recovery|1|||
46766282|NCT00807014|82984645|FG001|Overall Study|Recovery|0|||
46766283|NCT00807014|82984644|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
46766284|NCT00807014|82984645|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
46766285|NCT00592631|82984653|FG000|Overall Study|Lost to Follow-up|0|||
46766286|NCT00592631|82984654|FG001|Overall Study|Lost to Follow-up|2|||
46766287|NCT00791388|82984665|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
46766288|NCT00791388|82984666|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
46637870|NCT01474512|82811381|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637871|NCT01474512|82811382|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637872|NCT01474512|82811383|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637873|NCT01474512|82811384|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637874|NCT01474512|82811385|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637875|NCT01474512|82811386|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637876|NCT01474512|82811387|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637877|NCT01474512|82811388|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
46637878|NCT01474512|82811389|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
46637879|NCT01474512|82811390|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637880|NCT01474512|82811391|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637881|NCT01474512|82811392|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637882|NCT01474512|82811393|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
46637883|NCT01474512|82811376|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637884|NCT01474512|82811377|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637885|NCT01474512|82811378|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637886|NCT01474512|82811379|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637887|NCT01474512|82811380|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637888|NCT01474512|82811381|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637889|NCT01474512|82811382|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637890|NCT01474512|82811383|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637891|NCT01474512|82811384|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637892|NCT01474512|82811385|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637893|NCT01474512|82811386|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637894|NCT01474512|82811387|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
46637895|NCT01474512|82811388|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637896|NCT01474512|82811389|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637897|NCT01474512|82811390|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637898|NCT01474512|82811391|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637899|NCT01474512|82811392|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637900|NCT01474512|82811393|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
46637901|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
46637902|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
46637903|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
46637904|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
46637905|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
46637906|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
46637907|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
46637908|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
46637909|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
46637910|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
46637911|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
46637912|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
46637913|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
46637914|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
46637915|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
46637916|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
46637917|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
46637918|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
46637919|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637920|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637921|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637922|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637923|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637924|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637925|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637926|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637927|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637928|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637929|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637930|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
47061689|NCT05052697|83342231|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061690|NCT05052697|83342232|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061691|NCT05052697|83342233|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46637931|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637932|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
46637933|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
46637934|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
47061692|NCT05052697|83342234|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46942077|NCT00350103|83179341|FG000|Overall Study|Withdrawal by Subject|6|||
46942078|NCT00350103|83179342|FG001|Overall Study|Withdrawal by Subject|6|||
46942079|NCT00350103|83179343|FG002|Overall Study|Withdrawal by Subject|8|||
46942080|NCT00350103|83179341|FG000|Overall Study|Protocol Violation|0|||
46942081|NCT00350103|83179342|FG001|Overall Study|Protocol Violation|0|||
46942082|NCT00350103|83179343|FG002|Overall Study|Protocol Violation|1|||
46942083|NCT00350103|83179341|FG000|Overall Study|Unsatisfactory Compliance|2|||
46942084|NCT00350103|83179342|FG001|Overall Study|Unsatisfactory Compliance|2|||
46942085|NCT00350103|83179343|FG002|Overall Study|Unsatisfactory Compliance|1|||
46942086|NCT00350103|83179341|FG000|Overall Study|Investigator´s decision|1|||
46942087|NCT00350103|83179342|FG001|Overall Study|Investigator´s decision|1|||
46942088|NCT00350103|83179343|FG002|Overall Study|Investigator´s decision|0|||
46942089|NCT00350103|83179341|FG000|Overall Study|Exclusion criteria met|0|||
46942090|NCT00350103|83179342|FG001|Overall Study|Exclusion criteria met|0|||
46942091|NCT00350103|83179343|FG002|Overall Study|Exclusion criteria met|1|||
46942092|NCT00350103|83179341|FG000|Overall Study|Patient relocated|0|||
46942093|NCT00350103|83179342|FG001|Overall Study|Patient relocated|0|||
46942094|NCT00350103|83179343|FG002|Overall Study|Patient relocated|1|||
46942095|NCT00350103|83179341|FG000|Overall Study|Need for prohibited medication|1|||
46942096|NCT00350103|83179342|FG001|Overall Study|Need for prohibited medication|0|||
46766289|NCT00791388|82984667|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
46766290|NCT00791388|82984668|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
46942097|NCT00350103|83179343|FG002|Overall Study|Need for prohibited medication|0|||
46942098|NCT00350103|83179341|FG000|Overall Study|Personal reasons|0|||
46942099|NCT00350103|83179342|FG001|Overall Study|Personal reasons|0|||
46942100|NCT00350103|83179343|FG002|Overall Study|Personal reasons|1|||
46942101|NCT00350103|83179341|FG000|Overall Study|Patient stopped feeling pain|1|||
46942102|NCT00350103|83179342|FG001|Overall Study|Patient stopped feeling pain|0|||
46942103|NCT00350103|83179343|FG002|Overall Study|Patient stopped feeling pain|0|||
46942104|NCT00350103|83179341|FG000|Overall Study|PR greater than 250ms|0|||
46942105|NCT00350103|83179342|FG001|Overall Study|PR greater than 250ms|0|||
46942106|NCT00350103|83179343|FG002|Overall Study|PR greater than 250ms|1|||
46942107|NCT00350103|83179341|FG000|Overall Study|Wrong calculation of QT interval|0|||
46942108|NCT00350103|83179342|FG001|Overall Study|Wrong calculation of QT interval|0|||
46942109|NCT00350103|83179343|FG002|Overall Study|Wrong calculation of QT interval|1|||
46766291|NCT00791388|82984669|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
46766292|NCT00791388|82984665|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
46766293|NCT00791388|82984666|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
46766294|NCT00791388|82984667|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
46766295|NCT00791388|82984668|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
46766296|NCT00791388|82984669|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
46766297|NCT00791388|82984665|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
46766298|NCT00791388|82984666|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
46766299|NCT00791388|82984667|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
46766300|NCT00791388|82984668|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
46766301|NCT00791388|82984669|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
46766302|NCT00794040|82984683|FG000|Overall Study|Withdrawal by Subject|3|||
46766303|NCT00794040|82984684|FG001|Overall Study|Withdrawal by Subject|4|||
46766304|NCT00794040|82984683|FG000|Overall Study|Physician Decision|0|||
46766305|NCT00794040|82984684|FG001|Overall Study|Physician Decision|1|||
46766306|NCT00813488|82984690|FG000|Titration Period 1|Adverse Event|6|||
46766307|NCT00813488|82984691|FG001|Titration Period 1|Adverse Event|1|||
46766308|NCT00813488|82984690|FG000|Titration Period 1|Lack of Efficacy|9|||
46766309|NCT00813488|82984691|FG001|Titration Period 1|Lack of Efficacy|7|||
46766310|NCT00813488|82984690|FG000|Titration Period 1|Withdrawal by Subject|2|||
46766311|NCT00813488|82984691|FG001|Titration Period 1|Withdrawal by Subject|2|||
46766312|NCT00813488|82984690|FG000|Titration Period 1|Protocol Violation|4|||
46766313|NCT00813488|82984691|FG001|Titration Period 1|Protocol Violation|3|||
46766314|NCT00813488|82984690|FG000|Titration Period 1|Non-compliance to study medication|4|||
46766315|NCT00813488|82984691|FG001|Titration Period 1|Non-compliance to study medication|1|||
46766316|NCT00813488|82984690|FG000|Titration Period 1|Non-compliance to study procedures|2|||
46766317|NCT00813488|82984691|FG001|Titration Period 1|Non-compliance to study procedures|2|||
46942110|NCT00350103|83179341|FG000|Overall Study|Sponsor mistake|1|||
46942111|NCT00350103|83179342|FG001|Overall Study|Sponsor mistake|0|||
46942112|NCT00350103|83179343|FG002|Overall Study|Sponsor mistake|0|||
46942113|NCT00350103|83179341|FG000|Overall Study|Randomization mistake|0|||
46766318|NCT00813488|82984690|FG000|Titration Period 1|Technical Difficulties|0|||
46766319|NCT00813488|82984691|FG001|Titration Period 1|Technical Difficulties|1|||
46766320|NCT00813488|82984690|FG000|Titration Period 2|Adverse Event|2|||
46766321|NCT00813488|82984691|FG001|Titration Period 2|Adverse Event|3|||
46942114|NCT00350103|83179342|FG001|Overall Study|Randomization mistake|1|||
46942115|NCT00350103|83179343|FG002|Overall Study|Randomization mistake|1|||
46942116|NCT00350103|83179341|FG000|Overall Study|Sponsor´s decision|0|||
46942117|NCT00350103|83179342|FG001|Overall Study|Sponsor´s decision|1|||
46942118|NCT00350103|83179343|FG002|Overall Study|Sponsor´s decision|0|||
46942119|NCT00350103|83179341|FG000|Overall Study|Lost, Reason unknown|1|||
46942120|NCT00350103|83179342|FG001|Overall Study|Lost, Reason unknown|1|||
46942121|NCT00350103|83179343|FG002|Overall Study|Lost, Reason unknown|0|||
46942122|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
46942123|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
46942124|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
46942125|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
46942126|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
46942127|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
46942128|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
46942129|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
46942130|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
46942131|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
46942132|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
46942133|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
46942134|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
46942135|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
46942136|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
46942137|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
46942138|NCT01067521|83179353|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
46942139|NCT01067521|83179354|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
46942140|NCT01067521|83179353|FG000|Open-Label Period|Death|3|||
46942141|NCT01067521|83179354|FG001|Open-Label Period|Death|1|||
46942142|NCT01067521|83179353|FG000|Open-Label Period|Adverse Event|30|||
46942143|NCT01067521|83179354|FG001|Open-Label Period|Adverse Event|28|||
46942144|NCT01067521|83179353|FG000|Open-Label Period|Withdrawal by Subject|160|||
46942145|NCT01067521|83179354|FG001|Open-Label Period|Withdrawal by Subject|88|||
46942146|NCT01067521|83179353|FG000|Open-Label Period|Physician Decision|13|||
46942147|NCT01067521|83179354|FG001|Open-Label Period|Physician Decision|11|||
46942148|NCT01067521|83179353|FG000|Open-Label Period|Non-compliance with study drug|5|||
46766322|NCT00813488|82984690|FG000|Titration Period 2|Lack of Efficacy|8|||
46766323|NCT00813488|82984691|FG001|Titration Period 2|Lack of Efficacy|4|||
46766324|NCT00813488|82984690|FG000|Titration Period 2|Protocol Violation|3|||
46766325|NCT00813488|82984691|FG001|Titration Period 2|Protocol Violation|2|||
46766326|NCT00813488|82984690|FG000|Titration Period 2|Lost to Follow-up|1|||
46766327|NCT00813488|82984691|FG001|Titration Period 2|Lost to Follow-up|0|||
46833772|NCT00377858|83051684|FG001|Overall Study|Withdrawal by Subject|11|||
46833773|NCT00377858|83051683|FG000|Overall Study|Lost to Follow-up|6|||
46766328|NCT00813488|82984690|FG000|Titration Period 2|Non-compliance with study procedures|2|||
46766329|NCT00813488|82984691|FG001|Titration Period 2|Non-compliance with study procedures|1|||
46766330|NCT00813488|82984690|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
46766331|NCT00813488|82984691|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
46766332|NCT00813488|82984690|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
46833774|NCT00377858|83051684|FG001|Overall Study|Lost to Follow-up|1|||
46833775|NCT00377858|83051683|FG000|Overall Study|Physician Decision|5|||
46833776|NCT00377858|83051684|FG001|Overall Study|Physician Decision|5|||
46833777|NCT00377858|83051683|FG000|Overall Study|Protocol Violation|3|||
46833778|NCT00377858|83051684|FG001|Overall Study|Protocol Violation|4|||
46833779|NCT00377858|83051683|FG000|Overall Study|Adverse Event|2|||
46833780|NCT00377858|83051684|FG001|Overall Study|Adverse Event|1|||
46833781|NCT00377858|83051683|FG000|Overall Study|Entry Criteria Not Met|2|||
46833782|NCT00377858|83051684|FG001|Overall Study|Entry Criteria Not Met|0|||
46833783|NCT00377858|83051683|FG000|Overall Study|Sponsor Decision|1|||
46833784|NCT00377858|83051684|FG001|Overall Study|Sponsor Decision|2|||
46833785|NCT00377858|83051683|FG000|Overall Study|Death|0|||
46833786|NCT00377858|83051684|FG001|Overall Study|Death|3|||
46833787|NCT00502775|83051693|FG000|Overall Study|Adverse Event|1|||
46833788|NCT00502775|83051694|FG001|Overall Study|Adverse Event|2|||
46942149|NCT01067521|83179354|FG001|Open-Label Period|Non-compliance with study drug|0|||
46942150|NCT01067521|83179353|FG000|Open-Label Period|Protocol Violation|3|||
46942151|NCT01067521|83179354|FG001|Open-Label Period|Protocol Violation|0|||
46942152|NCT01067521|83179353|FG000|Open-Label Period|Pregnancy|14|||
46766333|NCT00813488|82984691|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
46766334|NCT00813488|82984690|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
46766335|NCT00813488|82984691|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
46833789|NCT00502775|83051695|FG002|Overall Study|Adverse Event|1|||
46833790|NCT00502775|83051693|FG000|Overall Study|Protocol Violation|1|||
46833791|NCT00502775|83051694|FG001|Overall Study|Protocol Violation|5|||
46833792|NCT00502775|83051695|FG002|Overall Study|Protocol Violation|2|||
46833793|NCT00502775|83051693|FG000|Overall Study|Withdrawal by Subject|1|||
46833794|NCT00502775|83051694|FG001|Overall Study|Withdrawal by Subject|1|||
46833795|NCT00502775|83051695|FG002|Overall Study|Withdrawal by Subject|2|||
46942153|NCT01067521|83179354|FG001|Open-Label Period|Pregnancy|8|||
46942154|NCT01067521|83179353|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
46942155|NCT01067521|83179354|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
46942156|NCT01067521|83179353|FG000|Open-Label Period|Lost to Follow-up|21|||
46942157|NCT01067521|83179354|FG001|Open-Label Period|Lost to Follow-up|20|||
46942158|NCT02735577|83179365|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
46942159|NCT02735577|83179365|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
46942160|NCT01345123|83179372|FG000|Overall Study|participants no longer with health plan|79|||
46942161|NCT01345123|83179373|FG001|Overall Study|participants no longer with health plan|85|||
46942162|NCT01345123|83179374|FG002|Overall Study|participants no longer with health plan|88|||
46942163|NCT02735421|83179383|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
46942164|NCT02735421|83179383|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
46942165|NCT02735421|83179383|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
46942166|NCT02735421|83179383|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
46833796|NCT00502775|83051693|FG000|Overall Study|Sponsor Terminated Study|1|||
46833797|NCT00502775|83051694|FG001|Overall Study|Sponsor Terminated Study|0|||
46833798|NCT00502775|83051695|FG002|Overall Study|Sponsor Terminated Study|1|||
46833799|NCT00502775|83051693|FG000|Overall Study|Non-compliance with eDiary|4|||
46942167|NCT02735421|83179383|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
46942168|NCT02735421|83179383|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
46942169|NCT02735421|83179383|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
46942170|NCT02983799|83179400|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
46942171|NCT02983799|83179401|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
46942172|NCT02983799|83179402|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
46942173|NCT02983799|83179403|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
46942174|NCT02983799|83179404|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
46942175|NCT02983799|83179400|FG000|Overall Study|Death|20|||
46942176|NCT02983799|83179401|FG001|Overall Study|Death|5|||
46942177|NCT02983799|83179402|FG002|Overall Study|Death|23|||
46942178|NCT02983799|83179403|FG003|Overall Study|Death|47|||
46942179|NCT02983799|83179404|FG004|Overall Study|Death|7|||
46942180|NCT02983799|83179400|FG000|Overall Study|Withdrawal by Subject|1|||
46942181|NCT02983799|83179401|FG001|Overall Study|Withdrawal by Subject|0|||
46942182|NCT02983799|83179402|FG002|Overall Study|Withdrawal by Subject|3|||
46942183|NCT02983799|83179403|FG003|Overall Study|Withdrawal by Subject|4|||
46942184|NCT02983799|83179404|FG004|Overall Study|Withdrawal by Subject|1|||
46942185|NCT02983799|83179400|FG000|Overall Study|Protocol Violation|0|||
46942186|NCT02983799|83179401|FG001|Overall Study|Protocol Violation|1|||
46942187|NCT02983799|83179402|FG002|Overall Study|Protocol Violation|0|||
46833800|NCT00502775|83051694|FG001|Overall Study|Non-compliance with eDiary|1|||
46833801|NCT00502775|83051695|FG002|Overall Study|Non-compliance with eDiary|1|||
46833802|NCT00502775|83051693|FG000|Overall Study|Subject unable to swallow capsule|1|||
46833803|NCT00502775|83051694|FG001|Overall Study|Subject unable to swallow capsule|0|||
46833804|NCT00502775|83051695|FG002|Overall Study|Subject unable to swallow capsule|1|||
46833805|NCT00502775|83051693|FG000|Overall Study|Logpad compliance <80%|1|||
46833806|NCT00502775|83051694|FG001|Overall Study|Logpad compliance <80%|0|||
46942188|NCT02983799|83179403|FG003|Overall Study|Protocol Violation|0|||
46942189|NCT02983799|83179404|FG004|Overall Study|Protocol Violation|1|||
46637935|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
46637936|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
46637937|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637938|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637939|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46766336|NCT00813488|82984690|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
46766337|NCT00813488|82984691|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
46766338|NCT00813488|82984690|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
46766339|NCT00813488|82984691|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
46766340|NCT00813488|82984690|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
46766341|NCT00813488|82984691|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
46766342|NCT00813488|82984690|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
46766343|NCT00813488|82984691|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
46766344|NCT00813488|82984690|FG000|Double-blind Treatment Period 2|Other|1|||
46766345|NCT00813488|82984691|FG001|Double-blind Treatment Period 2|Other|0|||
46766346|NCT00813488|82984690|FG000|Open-label Extension|Adverse Event|1|||
46942190|NCT02983799|83179400|FG000|Overall Study|Lost to Follow-up|1|||
46942191|NCT02983799|83179401|FG001|Overall Study|Lost to Follow-up|0|||
46942192|NCT02983799|83179402|FG002|Overall Study|Lost to Follow-up|1|||
46942193|NCT02983799|83179403|FG003|Overall Study|Lost to Follow-up|0|||
46942194|NCT02983799|83179404|FG004|Overall Study|Lost to Follow-up|0|||
46766347|NCT00813488|82984691|FG001|Open-label Extension|Adverse Event|2|||
46942195|NCT02186847|83179422|FG000|Overall Study|Protocol Violation|3|||
46833807|NCT00502775|83051695|FG002|Overall Study|Logpad compliance <80%|0|||
46833808|NCT00502775|83051693|FG000|Overall Study|Randomized in error|0|||
46942196|NCT02186847|83179423|FG001|Overall Study|Protocol Violation|0|||
46942197|NCT01066871|83179433|FG000|Overall Study|Lost to Follow-up|0|||
46942198|NCT01066871|83179434|FG001|Overall Study|Lost to Follow-up|2|||
46942199|NCT01066871|83179435|FG002|Overall Study|Lost to Follow-up|2|||
46942200|NCT01066871|83179436|FG003|Overall Study|Lost to Follow-up|0|||
46942201|NCT01066871|83179433|FG000|Overall Study|Protocol Violation|1|||
46942202|NCT01066871|83179434|FG001|Overall Study|Protocol Violation|0|||
46942203|NCT01066871|83179435|FG002|Overall Study|Protocol Violation|3|||
46942204|NCT01066871|83179436|FG003|Overall Study|Protocol Violation|2|||
46942205|NCT01066871|83179433|FG000|Overall Study|Lack of Efficacy|0|||
46942206|NCT01066871|83179434|FG001|Overall Study|Lack of Efficacy|0|||
47061693|NCT05052697|83342235|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061694|NCT05052697|83342236|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061695|NCT05052697|83342237|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061696|NCT05052697|83342238|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061697|NCT05052697|83342239|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061698|NCT05052697|83342240|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061699|NCT05052697|83342241|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061700|NCT05052697|83342242|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061701|NCT05052697|83342243|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061702|NCT05052697|83342244|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061703|NCT05052697|83342245|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061704|NCT05052697|83342246|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
47061705|NCT05052697|83342247|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
46637940|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637941|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46766348|NCT00813488|82984690|FG000|Open-label Extension|Lack of Efficacy|3|||
46766349|NCT00813488|82984691|FG001|Open-label Extension|Lack of Efficacy|0|||
46766350|NCT00813488|82984690|FG000|Open-label Extension|Withdrawal by Subject|0|||
46766351|NCT00813488|82984691|FG001|Open-label Extension|Withdrawal by Subject|2|||
47061706|NCT05052697|83342248|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
47061707|NCT05052697|83342249|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
47061708|NCT05052697|83342250|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
47061709|NCT05052697|83342251|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
47061710|NCT05052697|83342218|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061711|NCT05052697|83342219|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061712|NCT05052697|83342220|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061713|NCT05052697|83342221|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061714|NCT05052697|83342222|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
46766352|NCT00813488|82984690|FG000|Open-label Extension|Protocol Violation|1|||
46766353|NCT00813488|82984691|FG001|Open-label Extension|Protocol Violation|2|||
46766354|NCT00813488|82984690|FG000|Open-label Extension|Non-compliance study medication|4|||
46766355|NCT00813488|82984691|FG001|Open-label Extension|Non-compliance study medication|0|||
46766356|NCT00813488|82984690|FG000|Open-label Extension|Non-compliance study procedures|2|||
46833809|NCT00502775|83051694|FG001|Overall Study|Randomized in error|1|||
46833810|NCT00502775|83051695|FG002|Overall Study|Randomized in error|1|||
46833811|NCT00502775|83051693|FG000|Overall Study|Non-compliance|0|||
46833812|NCT00502775|83051694|FG001|Overall Study|Non-compliance|2|||
46833813|NCT00502775|83051695|FG002|Overall Study|Non-compliance|2|||
46833814|NCT00502775|83051693|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
46833815|NCT00502775|83051694|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
46833816|NCT00502775|83051695|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
46833817|NCT00502775|83051693|FG000|Overall Study|Declining pollen counts|0|||
46833818|NCT00502775|83051694|FG001|Overall Study|Declining pollen counts|1|||
46833819|NCT00502775|83051695|FG002|Overall Study|Declining pollen counts|1|||
46833820|NCT00502775|83051693|FG000|Overall Study|Subject in jail|0|||
46833821|NCT00502775|83051694|FG001|Overall Study|Subject in jail|1|||
46833822|NCT00502775|83051695|FG002|Overall Study|Subject in jail|0|||
46766357|NCT00813488|82984691|FG001|Open-label Extension|Non-compliance study procedures|1|||
46766358|NCT00813488|82984690|FG000|Open-label Extension|Other|1|||
46833823|NCT00502775|83051693|FG000|Overall Study|Subject took disallowed drug|0|||
46942207|NCT01066871|83179435|FG002|Overall Study|Lack of Efficacy|0|||
46942208|NCT01066871|83179436|FG003|Overall Study|Lack of Efficacy|1|||
46942209|NCT01066871|83179433|FG000|Overall Study|Withdrawal by Subject|3|||
46942210|NCT01066871|83179434|FG001|Overall Study|Withdrawal by Subject|1|||
46942211|NCT01066871|83179435|FG002|Overall Study|Withdrawal by Subject|0|||
46942212|NCT01066871|83179436|FG003|Overall Study|Withdrawal by Subject|0|||
46833824|NCT00502775|83051694|FG001|Overall Study|Subject took disallowed drug|0|||
46833825|NCT00502775|83051695|FG002|Overall Study|Subject took disallowed drug|1|||
46833826|NCT00502697|83051705|FG000|Overall Study|Withdrawal by Subject|3|||
46942213|NCT01066871|83179433|FG000|Overall Study|Other|0|||
47061715|NCT05052697|83342223|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
46942214|NCT01066871|83179434|FG001|Overall Study|Other|2|||
46942215|NCT01066871|83179435|FG002|Overall Study|Other|1|||
46942216|NCT01066871|83179436|FG003|Overall Study|Other|2|||
46942217|NCT02982863|83179456|FG000|Overall Study|Not eligible patients|809|||
46942218|NCT02982863|83179457|FG001|Overall Study|Not eligible patients|4261|||
46942219|NCT02982863|83179458|FG002|Overall Study|Not eligible patients|1852|||
46942220|NCT02982863|83179459|FG003|Overall Study|Not eligible patients|1400|||
46942221|NCT02982863|83179460|FG004|Overall Study|Not eligible patients|492|||
46942222|NCT04343651|83179503|FG000|Overall Study|Physician Decision|2|||
46942223|NCT04343651|83179504|FG001|Overall Study|Physician Decision|1|||
46942224|NCT04343651|83179503|FG000|Overall Study|Lost to Follow-up|2|||
46942225|NCT04343651|83179504|FG001|Overall Study|Lost to Follow-up|1|||
46942226|NCT04343651|83179503|FG000|Overall Study|Protocol Violation|4|||
46942227|NCT04343651|83179504|FG001|Overall Study|Protocol Violation|6|||
46942228|NCT04343651|83179503|FG000|Overall Study|Missing|3|||
46942229|NCT04343651|83179504|FG001|Overall Study|Missing|9|||
46942230|NCT04343651|83179503|FG000|Overall Study|Withdrawal by Subject|0|||
46942231|NCT04343651|83179504|FG001|Overall Study|Withdrawal by Subject|4|||
46942232|NCT04343651|83179503|FG000|Overall Study|Death|0|||
46942233|NCT04343651|83179504|FG001|Overall Study|Death|1|||
46942234|NCT04343651|83179503|FG000|Overall Study|Did not start treatment|1|||
46942235|NCT04343651|83179504|FG001|Overall Study|Did not start treatment|1|||
46942236|NCT04343651|83179503|FG000|Overall Study|Patient did not complete visits 3-6|0|||
46942237|NCT04343651|83179504|FG001|Overall Study|Patient did not complete visits 3-6|1|||
46942238|NCT02906579|83179512|FG000|Overall Study|Adverse Event|1|||
46942239|NCT02906579|83179512|FG000|Overall Study|Physician Decision|1|||
46942240|NCT01328535|83179532|FG000|Overall Study|Ineligible|1|||
46942241|NCT02905331|83179540|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
46942242|NCT02905331|83179541|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
46942243|NCT02905331|83179542|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
46942244|NCT02905331|83179540|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
46942245|NCT02905331|83179541|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
46942246|NCT02905331|83179542|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
46942247|NCT02905331|83179540|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
46942248|NCT02905331|83179541|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
46942249|NCT02905331|83179542|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
46942250|NCT02905331|83179540|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
46942251|NCT02905331|83179541|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
46942252|NCT02905331|83179542|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
46942253|NCT02905331|83179540|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
46942254|NCT02905331|83179541|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
46942255|NCT02905331|83179542|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
46942256|NCT02979197|83179553|FG000|Overall Study|Adverse Event|4|||
46942257|NCT02979197|83179554|FG001|Overall Study|Adverse Event|2|||
46942258|NCT02979197|83179555|FG002|Overall Study|Adverse Event|0|||
46942259|NCT02979197|83179553|FG000|Overall Study|Protocol Violation|0|||
46942260|NCT02979197|83179554|FG001|Overall Study|Protocol Violation|1|||
47061716|NCT05052697|83342224|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061717|NCT05052697|83342225|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061718|NCT05052697|83342226|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
46942261|NCT02979197|83179555|FG002|Overall Study|Protocol Violation|0|||
46942262|NCT02979197|83179553|FG000|Overall Study|Subject unable to commit to study dates|0|||
46942263|NCT02979197|83179554|FG001|Overall Study|Subject unable to commit to study dates|1|||
46942264|NCT02979197|83179555|FG002|Overall Study|Subject unable to commit to study dates|0|||
46942265|NCT02982239|83179565|FG000|Overall Study|Lost to Follow-up|3|||
46942266|NCT02982239|83179566|FG001|Overall Study|Lost to Follow-up|2|||
46942267|NCT01066793|83179579|FG000|Overall Study|Death|4|||
46942268|NCT01066793|83179580|FG001|Overall Study|Death|1|||
46942269|NCT01066793|83179581|FG002|Overall Study|Death|1|||
46942270|NCT01066793|83179582|FG003|Overall Study|Death|0|||
46942271|NCT01066793|83179583|FG004|Overall Study|Death|0|||
47061719|NCT05052697|83342227|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061720|NCT05052697|83342228|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061721|NCT05052697|83342229|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061722|NCT05052697|83342230|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
46766359|NCT00813488|82984691|FG001|Open-label Extension|Other|0|||
46766360|NCT00797316|82984703|FG000|Overall Study|Administrative problems|1|||
46766361|NCT00797316|82984704|FG001|Overall Study|Administrative problems|0|||
46766362|NCT00797316|82984703|FG000|Overall Study|Adverse Event|5|||
46766363|NCT00797316|82984704|FG001|Overall Study|Adverse Event|3|||
46766364|NCT00797316|82984703|FG000|Overall Study|Lost to Follow-up|4|||
46766365|NCT00797316|82984704|FG001|Overall Study|Lost to Follow-up|8|||
46766366|NCT00797316|82984703|FG000|Overall Study|Protocol Deviation|1|||
46942272|NCT01066793|83179584|FG005|Overall Study|Death|0|||
47061723|NCT05052697|83342231|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
46942273|NCT01066793|83179579|FG000|Overall Study|Lack of Efficacy|2|||
46942274|NCT01066793|83179580|FG001|Overall Study|Lack of Efficacy|1|||
46637942|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637943|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637944|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637945|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
47061724|NCT05052697|83342232|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061725|NCT05052697|83342233|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061726|NCT05052697|83342234|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061727|NCT05052697|83342235|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061728|NCT05052697|83342236|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061729|NCT05052697|83342237|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
46637946|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46766367|NCT00797316|82984704|FG001|Overall Study|Protocol Deviation|2|||
46766368|NCT00797316|82984703|FG000|Overall Study|Patient withdrew consent|12|||
46766369|NCT00797316|82984704|FG001|Overall Study|Patient withdrew consent|6|||
46766370|NCT00797316|82984703|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46766371|NCT00797316|82984704|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
46766372|NCT00587964|82984710|FG000|Overall Study|Withdrawal by Subject|1|||
46766373|NCT00587964|82984710|FG000|Overall Study|Lost to Follow-up|1|||
46766374|NCT00587964|82984710|FG000|Overall Study|Patient found to be ineligible|1|||
46766375|NCT00587964|82984710|FG000|Overall Study|Patient did not receive intervention|5|||
46766376|NCT00587964|82984710|FG000|Overall Study|Progression of Disease|4|||
46833827|NCT00502697|83051706|FG001|Overall Study|Withdrawal by Subject|1|||
46833828|NCT00502697|83051705|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
46833829|NCT00502697|83051706|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
46833830|NCT00502697|83051705|FG000|Overall Study|found not to meet eligibility criteria|3|||
46833831|NCT00502697|83051706|FG001|Overall Study|found not to meet eligibility criteria|4|||
46833832|NCT00502697|83051705|FG000|Overall Study|did not meet assignment criteria|4|||
46833833|NCT00502697|83051706|FG001|Overall Study|did not meet assignment criteria|2|||
46942275|NCT01066793|83179581|FG002|Overall Study|Lack of Efficacy|0|||
46942276|NCT01066793|83179582|FG003|Overall Study|Lack of Efficacy|0|||
46942277|NCT01066793|83179583|FG004|Overall Study|Lack of Efficacy|0|||
46766377|NCT00590954|82984714|FG000|Overall Study|Inevaluable|2|||
46766378|NCT00791076|82984720|FG000|Overall Study|Study was terminated,PI left institution|8|||
46766379|NCT00590720|82984728|FG000|Overall Study|Lost to Follow-up|1|||
46766380|NCT00590720|82984729|FG001|Overall Study|Lost to Follow-up|0|||
46942278|NCT01066793|83179584|FG005|Overall Study|Lack of Efficacy|0|||
46942279|NCT01066793|83179579|FG000|Overall Study|Lost to Follow-up|180|||
46942280|NCT01066793|83179580|FG001|Overall Study|Lost to Follow-up|39|||
46942281|NCT01066793|83179581|FG002|Overall Study|Lost to Follow-up|82|||
46942282|NCT01066793|83179582|FG003|Overall Study|Lost to Follow-up|16|||
46942283|NCT01066793|83179583|FG004|Overall Study|Lost to Follow-up|0|||
46942284|NCT01066793|83179584|FG005|Overall Study|Lost to Follow-up|1|||
46942285|NCT01066793|83179579|FG000|Overall Study|Physician Decision|3|||
46942286|NCT01066793|83179580|FG001|Overall Study|Physician Decision|0|||
46942287|NCT01066793|83179581|FG002|Overall Study|Physician Decision|0|||
46942288|NCT01066793|83179582|FG003|Overall Study|Physician Decision|0|||
46942289|NCT01066793|83179583|FG004|Overall Study|Physician Decision|0|||
46942290|NCT01066793|83179584|FG005|Overall Study|Physician Decision|0|||
46942291|NCT01066793|83179579|FG000|Overall Study|Protocol Violation|3|||
46637947|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637948|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46766381|NCT00590720|82984728|FG000|Overall Study|Withdrawal by Subject|0|||
46766382|NCT00590720|82984729|FG001|Overall Study|Withdrawal by Subject|1|||
46942292|NCT01066793|83179580|FG001|Overall Study|Protocol Violation|2|||
46942293|NCT01066793|83179581|FG002|Overall Study|Protocol Violation|2|||
46766383|NCT00625378|82984737|FG000|Overall Study|Adverse Event|22|||
46766384|NCT00625378|82984738|FG001|Overall Study|Adverse Event|0|||
46766385|NCT00625378|82984737|FG000|Overall Study|Withdrawal by Subject|16|||
46766386|NCT00625378|82984738|FG001|Overall Study|Withdrawal by Subject|0|||
46766387|NCT00625378|82984737|FG000|Overall Study|Death|38|||
46766388|NCT00625378|82984738|FG001|Overall Study|Death|0|||
46942294|NCT01066793|83179582|FG003|Overall Study|Protocol Violation|0|||
46942295|NCT01066793|83179583|FG004|Overall Study|Protocol Violation|0|||
46942296|NCT01066793|83179584|FG005|Overall Study|Protocol Violation|0|||
47061730|NCT05052697|83342238|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061731|NCT05052697|83342239|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
46637949|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46637950|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
46766389|NCT00625378|82984737|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
46766390|NCT00625378|82984738|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
46766391|NCT00625378|82984737|FG000|Overall Study|Lost to Follow-up|17|||
46833834|NCT00485069|83051714|FG000|Overall Study|Adverse Event|10|||
47061732|NCT05052697|83342240|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061733|NCT05052697|83342241|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061734|NCT05052697|83342242|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061735|NCT05052697|83342243|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061736|NCT05052697|83342244|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061737|NCT05052697|83342245|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061738|NCT05052697|83342246|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
47061739|NCT05052697|83342247|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
46942297|NCT01066793|83179579|FG000|Overall Study|Withdrawal by Subject|7|||
46942298|NCT01066793|83179580|FG001|Overall Study|Withdrawal by Subject|4|||
46942299|NCT01066793|83179581|FG002|Overall Study|Withdrawal by Subject|1|||
46942300|NCT01066793|83179582|FG003|Overall Study|Withdrawal by Subject|0|||
46942301|NCT01066793|83179583|FG004|Overall Study|Withdrawal by Subject|0|||
46942302|NCT01066793|83179584|FG005|Overall Study|Withdrawal by Subject|0|||
46942303|NCT01066793|83179579|FG000|Overall Study|Early Termination|3|||
47061740|NCT05052697|83342248|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
47061741|NCT05052697|83342249|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
47061742|NCT05052697|83342250|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
46942304|NCT01066793|83179580|FG001|Overall Study|Early Termination|0|||
46942305|NCT01066793|83179581|FG002|Overall Study|Early Termination|0|||
46942306|NCT01066793|83179582|FG003|Overall Study|Early Termination|0|||
46942307|NCT01066793|83179583|FG004|Overall Study|Early Termination|0|||
46942308|NCT01066793|83179584|FG005|Overall Study|Early Termination|0|||
46942309|NCT01066793|83179579|FG000|Overall Study|Lab test not done|7|||
46942310|NCT01066793|83179580|FG001|Overall Study|Lab test not done|0|||
46942311|NCT01066793|83179581|FG002|Overall Study|Lab test not done|0|||
46942312|NCT01066793|83179582|FG003|Overall Study|Lab test not done|1|||
46942313|NCT01066793|83179583|FG004|Overall Study|Lab test not done|0|||
46942314|NCT01066793|83179584|FG005|Overall Study|Lab test not done|0|||
46942315|NCT01066793|83179579|FG000|Overall Study|Miscellaneous|4|||
46942316|NCT01066793|83179580|FG001|Overall Study|Miscellaneous|5|||
46942317|NCT01066793|83179581|FG002|Overall Study|Miscellaneous|6|||
46942318|NCT01066793|83179582|FG003|Overall Study|Miscellaneous|0|||
46942319|NCT01066793|83179583|FG004|Overall Study|Miscellaneous|0|||
46942320|NCT01066793|83179584|FG005|Overall Study|Miscellaneous|0|||
46942321|NCT01066793|83179579|FG000|Overall Study|Non-responders|104|||
46942322|NCT01066793|83179580|FG001|Overall Study|Non-responders|5|||
46942323|NCT01066793|83179581|FG002|Overall Study|Non-responders|11|||
46942324|NCT01066793|83179582|FG003|Overall Study|Non-responders|25|||
46942325|NCT01066793|83179583|FG004|Overall Study|Non-responders|0|||
46942326|NCT01066793|83179584|FG005|Overall Study|Non-responders|0|||
46942327|NCT01066793|83179579|FG000|Overall Study|Other|15|||
46942328|NCT01066793|83179580|FG001|Overall Study|Other|5|||
46942329|NCT01066793|83179581|FG002|Overall Study|Other|6|||
46942330|NCT01066793|83179582|FG003|Overall Study|Other|2|||
46942331|NCT01066793|83179583|FG004|Overall Study|Other|0|||
46942332|NCT01066793|83179584|FG005|Overall Study|Other|0|||
46942333|NCT01066793|83179579|FG000|Overall Study|Relapse|20|||
46942334|NCT01066793|83179580|FG001|Overall Study|Relapse|8|||
46942335|NCT01066793|83179581|FG002|Overall Study|Relapse|2|||
46942336|NCT01066793|83179582|FG003|Overall Study|Relapse|3|||
46942337|NCT01066793|83179583|FG004|Overall Study|Relapse|0|||
46942338|NCT01066793|83179584|FG005|Overall Study|Relapse|0|||
46942339|NCT01066793|83179579|FG000|Overall Study|Result Not Available|1|||
46942340|NCT01066793|83179580|FG001|Overall Study|Result Not Available|0|||
47061743|NCT05052697|83342251|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
47061744|NCT05052697|83342218|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061745|NCT05052697|83342219|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
46766392|NCT00625378|82984738|FG001|Overall Study|Lost to Follow-up|0|||
46766393|NCT00625378|82984737|FG000|Overall Study|Non-compliant with study medication|3|||
46766394|NCT00625378|82984738|FG001|Overall Study|Non-compliant with study medication|0|||
46766395|NCT00625378|82984737|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
46766396|NCT00625378|82984738|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
46766397|NCT00625378|82984737|FG000|Overall Study|Medical decision|1|||
46942341|NCT01066793|83179581|FG002|Overall Study|Result Not Available|0|||
46942342|NCT01066793|83179582|FG003|Overall Study|Result Not Available|0|||
46942343|NCT01066793|83179583|FG004|Overall Study|Result Not Available|0|||
46942344|NCT01066793|83179584|FG005|Overall Study|Result Not Available|0|||
46942345|NCT01066793|83179579|FG000|Overall Study|Treatment Interrupted|1|||
46942346|NCT01066793|83179580|FG001|Overall Study|Treatment Interrupted|1|||
46942347|NCT01066793|83179581|FG002|Overall Study|Treatment Interrupted|0|||
46942348|NCT01066793|83179582|FG003|Overall Study|Treatment Interrupted|0|||
46942349|NCT01066793|83179583|FG004|Overall Study|Treatment Interrupted|0|||
46942350|NCT01066793|83179584|FG005|Overall Study|Treatment Interrupted|0|||
46942351|NCT01066793|83179579|FG000|Overall Study|Treatment Never Started|18|||
46942352|NCT01066793|83179580|FG001|Overall Study|Treatment Never Started|5|||
46942353|NCT01066793|83179581|FG002|Overall Study|Treatment Never Started|4|||
47061746|NCT05052697|83342220|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061747|NCT05052697|83342221|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061748|NCT05052697|83342222|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061749|NCT05052697|83342223|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061750|NCT05052697|83342224|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061751|NCT05052697|83342225|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061752|NCT05052697|83342226|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061753|NCT05052697|83342227|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061754|NCT05052697|83342228|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061755|NCT05052697|83342229|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061756|NCT05052697|83342230|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061757|NCT05052697|83342231|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061758|NCT05052697|83342232|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061759|NCT05052697|83342233|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061760|NCT05052697|83342234|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061761|NCT05052697|83342235|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061762|NCT05052697|83342236|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061763|NCT05052697|83342237|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061764|NCT05052697|83342238|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061765|NCT05052697|83342239|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061766|NCT05052697|83342240|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061767|NCT05052697|83342241|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061768|NCT05052697|83342242|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061769|NCT05052697|83342243|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061770|NCT05052697|83342244|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061771|NCT05052697|83342245|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061772|NCT05052697|83342246|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061773|NCT05052697|83342247|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061774|NCT05052697|83342248|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061775|NCT05052697|83342249|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061776|NCT05052697|83342250|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
47061777|NCT05052697|83342251|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
47061778|NCT05052697|83342218|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061779|NCT05052697|83342219|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061780|NCT05052697|83342220|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061781|NCT05052697|83342221|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061782|NCT05052697|83342222|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061783|NCT05052697|83342223|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061784|NCT05052697|83342224|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061785|NCT05052697|83342225|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061786|NCT05052697|83342226|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061787|NCT05052697|83342227|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061788|NCT05052697|83342228|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061789|NCT05052697|83342229|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061790|NCT05052697|83342230|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061791|NCT05052697|83342231|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061792|NCT05052697|83342232|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061793|NCT05052697|83342233|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061794|NCT05052697|83342234|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061795|NCT05052697|83342235|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061796|NCT05052697|83342236|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061797|NCT05052697|83342237|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061798|NCT05052697|83342238|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061799|NCT05052697|83342239|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061800|NCT05052697|83342240|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061801|NCT05052697|83342241|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061802|NCT05052697|83342242|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061803|NCT05052697|83342243|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061804|NCT05052697|83342244|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061805|NCT05052697|83342245|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061806|NCT05052697|83342246|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
47061807|NCT05052697|83342247|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
46766398|NCT00625378|82984738|FG001|Overall Study|Medical decision|0|||
46766399|NCT00625378|82984737|FG000|Overall Study|Multiple toxicities|1|||
46766400|NCT00625378|82984738|FG001|Overall Study|Multiple toxicities|0|||
46766401|NCT00625378|82984737|FG000|Overall Study|New cancer|1|||
46766402|NCT00625378|82984738|FG001|Overall Study|New cancer|0|||
46766403|NCT00625378|82984737|FG000|Overall Study|PTA program|2|||
47061808|NCT05052697|83342248|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
47061809|NCT05052697|83342249|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061810|NCT05052697|83342250|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061811|NCT05052697|83342251|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
47061812|NCT04983901|83342383|FG000|Overall Study|Death|1|||
47061813|NCT04983901|83342384|FG001|Overall Study|Death|4|||
47061814|NCT04983901|83342383|FG000|Overall Study|Lost to Follow-up|3|||
47061815|NCT04983901|83342384|FG001|Overall Study|Lost to Follow-up|0|||
47061816|NCT04983901|83342383|FG000|Overall Study|Protocol Violation|1|||
47061817|NCT04983901|83342384|FG001|Overall Study|Protocol Violation|0|||
47061818|NCT04983901|83342383|FG000|Overall Study|Withdrawal by Subject|1|||
47061819|NCT04983901|83342384|FG001|Overall Study|Withdrawal by Subject|2|||
47061820|NCT04973228|83342399|FG000|Overall Study|Adverse Event|2|||
47061821|NCT04973228|83342400|FG001|Overall Study|Adverse Event|3|||
47061822|NCT04973228|83342399|FG000|Overall Study|Lack of Efficacy|1|||
47061823|NCT04973228|83342400|FG001|Overall Study|Lack of Efficacy|3|||
47061824|NCT04973228|83342399|FG000|Overall Study|Lost to Follow-up|12|||
47061825|NCT04973228|83342400|FG001|Overall Study|Lost to Follow-up|4|||
47061826|NCT04973228|83342399|FG000|Overall Study|Withdrawal by Subject|11|||
47061827|NCT04973228|83342400|FG001|Overall Study|Withdrawal by Subject|4|||
47061828|NCT04973228|83342399|FG000|Overall Study|Did not tolerate application|1|||
47061829|NCT04973228|83342400|FG001|Overall Study|Did not tolerate application|0|||
47061830|NCT04973228|83342399|FG000|Overall Study|Wanted to early terminate and use own product|0|||
47061831|NCT04973228|83342400|FG001|Overall Study|Wanted to early terminate and use own product|1|||
47061832|NCT04973228|83342399|FG000|Overall Study|Missed visits due to new work schedule|1|||
47061833|NCT04973228|83342400|FG001|Overall Study|Missed visits due to new work schedule|0|||
47061834|NCT04952389|83342408|FG000|Overall Study|Withdrawal by Subject|8|||
47061835|NCT04952389|83342409|FG001|Overall Study|Withdrawal by Subject|4|||
47061836|NCT04650698|83342421|FG000|Overall Study|Protocol Violation|2|||
47061837|NCT04650698|83342422|FG001|Overall Study|Protocol Violation|1|||
47061838|NCT04650698|83342421|FG000|Overall Study|Withdrawal by Subject|0|||
47061839|NCT04650698|83342422|FG001|Overall Study|Withdrawal by Subject|1|||
47061840|NCT04646044|83342432|FG000|Overall Study|Lost to Follow-up|0|||
46833835|NCT00485069|83051715|FG001|Overall Study|Adverse Event|4|||
46833836|NCT00485069|83051714|FG000|Overall Study|Lack of Efficacy|2|||
46833837|NCT00485069|83051715|FG001|Overall Study|Lack of Efficacy|1|||
46833838|NCT00485069|83051714|FG000|Overall Study|Protocol Violation|0|||
46833839|NCT00485069|83051715|FG001|Overall Study|Protocol Violation|1|||
46833840|NCT00485069|83051714|FG000|Overall Study|Withdrawal by Subject|6|||
46833841|NCT00485069|83051715|FG001|Overall Study|Withdrawal by Subject|6|||
46833842|NCT00355082|83051730|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
46833843|NCT00355082|83051731|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
46833844|NCT00355082|83051732|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
46833845|NCT00355082|83051730|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
46833846|NCT00355082|83051731|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
46833847|NCT00355082|83051732|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
46833848|NCT00355082|83051730|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
46833849|NCT00355082|83051731|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
46833850|NCT00355082|83051732|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
46833851|NCT00355082|83051730|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
46833852|NCT00355082|83051731|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
46833853|NCT00355082|83051732|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
46833854|NCT00355082|83051730|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
46833855|NCT00355082|83051731|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
46833856|NCT00355082|83051732|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
46833857|NCT00355082|83051730|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
46833858|NCT00355082|83051731|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
46833859|NCT00355082|83051732|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
46833860|NCT00355082|83051730|FG000|Continuation Phase|Adverse Event|2|||
46833861|NCT00355082|83051731|FG001|Continuation Phase|Adverse Event|0|||
46833862|NCT00355082|83051732|FG002|Continuation Phase|Adverse Event|1|||
46833863|NCT00355082|83051730|FG000|Continuation Phase|Lost to Follow-up|2|||
46833864|NCT00355082|83051731|FG001|Continuation Phase|Lost to Follow-up|0|||
46833865|NCT00355082|83051732|FG002|Continuation Phase|Lost to Follow-up|1|||
46833866|NCT00355082|83051730|FG000|Continuation Phase|Protocol Violation|1|||
46942354|NCT01066793|83179582|FG003|Overall Study|Treatment Never Started|1|||
46942355|NCT01066793|83179583|FG004|Overall Study|Treatment Never Started|0|||
46833867|NCT00355082|83051731|FG001|Continuation Phase|Protocol Violation|0|||
46833868|NCT00355082|83051732|FG002|Continuation Phase|Protocol Violation|1|||
46833869|NCT00355082|83051730|FG000|Continuation Phase|Withdrawal by Subject|4|||
46833870|NCT00355082|83051731|FG001|Continuation Phase|Withdrawal by Subject|0|||
47061841|NCT04646044|83342433|FG001|Overall Study|Lost to Follow-up|0|||
47061842|NCT04646044|83342434|FG002|Overall Study|Lost to Follow-up|1|||
47061843|NCT04646044|83342435|FG003|Overall Study|Lost to Follow-up|0|||
47061844|NCT04646044|83342432|FG000|Overall Study|Withdrawal by Subject|0|||
47061845|NCT04646044|83342433|FG001|Overall Study|Withdrawal by Subject|1|||
47061846|NCT04646044|83342434|FG002|Overall Study|Withdrawal by Subject|0|||
47061847|NCT04646044|83342435|FG003|Overall Study|Withdrawal by Subject|0|||
47061848|NCT04618471|83342445|FG000|Overall Study|Screen Failure|62|||
47061849|NCT04618471|83342445|FG000|Overall Study|Withdrawal by Subject|6|||
47061850|NCT04618471|83342445|FG000|Overall Study|Physician Decision|2|||
47061851|NCT04618471|83342445|FG000|Overall Study|Lost to Follow-up|1|||
47061852|NCT04618471|83342445|FG000|Overall Study|Various other reasons|2|||
47061853|NCT04618471|83342445|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
47061854|NCT04349033|83342465|FG000|Overall Study|Lost to Follow-up|3|||
47061855|NCT04349033|83342466|FG001|Overall Study|Lost to Follow-up|1|||
47061856|NCT04349033|83342467|FG002|Overall Study|Lost to Follow-up|1|||
47061857|NCT04158648|83342475|FG000|Overall Study|Ongoing in the Study|69|||
47061858|NCT04158648|83342475|FG000|Overall Study|Withdrawal by Subject|4|||
47061859|NCT04152200|83342484|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
47061860|NCT04152200|83342485|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
47061861|NCT04109066|83342495|FG000|Pre-treatment|Participant withdrew consent|2|||
47061862|NCT04109066|83342496|FG001|Pre-treatment|Participant withdrew consent|0|||
47061863|NCT04109066|83342495|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
47061864|NCT04109066|83342496|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
47061865|NCT04109066|83342495|FG000|Treatment|Lack of Efficacy|2|||
47061866|NCT04109066|83342496|FG001|Treatment|Lack of Efficacy|3|||
47061867|NCT04109066|83342495|FG000|Treatment|Adverse Event|19|||
47061868|NCT04109066|83342496|FG001|Treatment|Adverse Event|6|||
47061869|NCT04109066|83342495|FG000|Treatment|Participant request to discontinue Study treatment|12|||
47061870|NCT04109066|83342496|FG001|Treatment|Participant request to discontinue Study treatment|14|||
47061871|NCT04109066|83342495|FG000|Treatment|Withdrawal by Subject|7|||
47061872|NCT04109066|83342496|FG001|Treatment|Withdrawal by Subject|8|||
47061873|NCT04109066|83342495|FG000|Treatment|Death|3|||
47061874|NCT04109066|83342496|FG001|Treatment|Death|0|||
47061875|NCT04109066|83342495|FG000|Treatment|Participant no longer meets study criteria|3|||
47061876|NCT04109066|83342496|FG001|Treatment|Participant no longer meets study criteria|1|||
47061877|NCT04109066|83342495|FG000|Treatment|Administrative reasons by sponsor|2|||
47061878|NCT04109066|83342496|FG001|Treatment|Administrative reasons by sponsor|3|||
47061879|NCT04109066|83342495|FG000|Treatment|Other reasons|17|||
47061880|NCT04109066|83342496|FG001|Treatment|Other reasons|23|||
47061881|NCT04109066|83342495|FG000|Treatment|Disease Progression|4|||
47061882|NCT04109066|83342496|FG001|Treatment|Disease Progression|7|||
47061883|NCT04109066|83342495|FG000|Treatment|Study drug toxicity|13|||
47061884|NCT04109066|83342496|FG001|Treatment|Study drug toxicity|5|||
47061885|NCT04109066|83342495|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
47061886|NCT04109066|83342496|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
47061887|NCT04109066|83342495|FG000|Treatment|Disease Recurrence|0|||
47061888|NCT04109066|83342496|FG001|Treatment|Disease Recurrence|2|||
47061889|NCT04109066|83342495|FG000|Treatment|Not reported|6|||
47061890|NCT04109066|83342496|FG001|Treatment|Not reported|8|||
47061891|NCT04109066|83342495|FG000|Treatment|On-going treatment|48|||
47061892|NCT04109066|83342496|FG001|Treatment|On-going treatment|52|||
47061893|NCT03997383|83342506|FG000|Double-blind Treatment Period|Adverse Event|4|||
47061894|NCT03997383|83342507|FG001|Double-blind Treatment Period|Adverse Event|3|||
47061895|NCT03997383|83342506|FG000|Double-blind Treatment Period|Death|4|||
47061896|NCT03997383|83342507|FG001|Double-blind Treatment Period|Death|4|||
47061897|NCT03997383|83342506|FG000|Double-blind Treatment Period|Physician Decision|2|||
47061898|NCT03997383|83342507|FG001|Double-blind Treatment Period|Physician Decision|0|||
47061899|NCT03997383|83342506|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
47061900|NCT03997383|83342507|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
47061901|NCT03997383|83342506|FG000|Open-label Extension Period|Ongoing|148|||
47061902|NCT03997383|83342507|FG001|Open-label Extension Period|Ongoing|151|||
47061903|NCT03997383|83342506|FG000|Open-label Extension Period|Adverse Event|4|||
47061904|NCT03997383|83342507|FG001|Open-label Extension Period|Adverse Event|1|||
47061905|NCT03997383|83342506|FG000|Open-label Extension Period|Death|8|||
47061906|NCT03997383|83342507|FG001|Open-label Extension Period|Death|9|||
47061907|NCT03997383|83342506|FG000|Open-label Extension Period|Physician Decision|1|||
47061908|NCT03997383|83342507|FG001|Open-label Extension Period|Physician Decision|1|||
47061909|NCT03997383|83342506|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
47061910|NCT03997383|83342507|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
47061911|NCT03997383|83342506|FG000|Open-label Extension Period|Reason Not Specified|2|||
47061912|NCT03997383|83342507|FG001|Open-label Extension Period|Reason Not Specified|0|||
46637951|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
46637952|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
46637953|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
46637954|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
46766404|NCT00625378|82984738|FG001|Overall Study|PTA program|0|||
47061913|NCT03905694|83342543|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
47061914|NCT03629912|83342583|FG000|Overall Study|Lost to Follow-up|19|||
47061915|NCT03629912|83342584|FG001|Overall Study|Lost to Follow-up|7|||
47061916|NCT03629912|83342585|FG002|Overall Study|Lost to Follow-up|5|||
47061917|NCT03629912|83342586|FG003|Overall Study|Lost to Follow-up|1|||
47061918|NCT03629912|83342583|FG000|Overall Study|Withdrawal by Subject|6|||
47061919|NCT03629912|83342584|FG001|Overall Study|Withdrawal by Subject|0|||
47061920|NCT03629912|83342585|FG002|Overall Study|Withdrawal by Subject|1|||
47061921|NCT03629912|83342586|FG003|Overall Study|Withdrawal by Subject|2|||
47061922|NCT03629912|83342583|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
47061923|NCT03629912|83342584|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
47061924|NCT03629912|83342585|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
47061925|NCT03629912|83342586|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
47061926|NCT03629912|83342583|FG000|Overall Study|Death|1|||
47061927|NCT03629912|83342584|FG001|Overall Study|Death|0|||
47061928|NCT03629912|83342585|FG002|Overall Study|Death|0|||
47061929|NCT03629912|83342586|FG003|Overall Study|Death|0|||
47061930|NCT03337724|83342616|FG000|Overall Study|Reason not Specified|12|||
47061931|NCT03337724|83342617|FG001|Overall Study|Reason not Specified|21|||
47061932|NCT03337724|83342618|FG002|Overall Study|Reason not Specified|9|||
47061933|NCT03337724|83342619|FG003|Overall Study|Reason not Specified|9|||
46833871|NCT00355082|83051732|FG002|Continuation Phase|Withdrawal by Subject|0|||
46833872|NCT00355082|83051730|FG000|Continuation Phase|Lack of Efficacy|5|||
46833873|NCT00355082|83051731|FG001|Continuation Phase|Lack of Efficacy|0|||
46833874|NCT00355082|83051732|FG002|Continuation Phase|Lack of Efficacy|0|||
46833875|NCT00355082|83051730|FG000|Continuation Phase|Site Closed by Sponsor|8|||
46833876|NCT00355082|83051731|FG001|Continuation Phase|Site Closed by Sponsor|0|||
46833877|NCT00355082|83051732|FG002|Continuation Phase|Site Closed by Sponsor|0|||
46833878|NCT00355082|83051730|FG000|Continuation Phase|Scheduling Error|1|||
46833879|NCT00355082|83051731|FG001|Continuation Phase|Scheduling Error|0|||
46833880|NCT00355082|83051732|FG002|Continuation Phase|Scheduling Error|0|||
46833881|NCT00355082|83051730|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
46942356|NCT01066793|83179584|FG005|Overall Study|Treatment Never Started|0|||
47061934|NCT03337724|83342620|FG004|Overall Study|Reason not Specified|29|||
47061935|NCT03337724|83342616|FG000|Overall Study|Withdrawal by Subject|13|||
47061936|NCT03337724|83342617|FG001|Overall Study|Withdrawal by Subject|15|||
47061937|NCT03337724|83342618|FG002|Overall Study|Withdrawal by Subject|4|||
47061938|NCT03337724|83342619|FG003|Overall Study|Withdrawal by Subject|15|||
47061939|NCT03337724|83342620|FG004|Overall Study|Withdrawal by Subject|6|||
47061940|NCT03337724|83342616|FG000|Overall Study|Protocol Deviation|0|||
47061941|NCT03337724|83342617|FG001|Overall Study|Protocol Deviation|1|||
46766405|NCT00625378|82984737|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
46766406|NCT00625378|82984738|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
46766407|NCT00625378|82984737|FG000|Overall Study|Sponsor decision|1|||
46766408|NCT00625378|82984738|FG001|Overall Study|Sponsor decision|0|||
46766409|NCT00625378|82984737|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
46766410|NCT00625378|82984738|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
46766411|NCT00625378|82984737|FG000|Overall Study|Switch to commercial drug|6|||
46766412|NCT00625378|82984738|FG001|Overall Study|Switch to commercial drug|1|||
46766413|NCT00625378|82984737|FG000|Overall Study|Missing|2|||
46766414|NCT00625378|82984738|FG001|Overall Study|Missing|0|||
46766415|NCT00625378|82984737|FG000|Overall Study|End of treatment not available|2|||
46766416|NCT00625378|82984738|FG001|Overall Study|End of treatment not available|0|||
46766417|NCT00625378|82984737|FG000|Overall Study|Never treated|2|||
46766418|NCT00625378|82984738|FG001|Overall Study|Never treated|0|||
46766419|NCT00806624|82984747|FG000|Overall Study|Adverse Event|2|||
46766420|NCT00806624|82984748|FG001|Overall Study|Adverse Event|8|||
46766421|NCT00806624|82984749|FG002|Overall Study|Adverse Event|0|||
46766422|NCT00806624|82984747|FG000|Overall Study|Death|0|||
46766423|NCT00806624|82984748|FG001|Overall Study|Death|1|||
46766424|NCT00806624|82984749|FG002|Overall Study|Death|1|||
46766425|NCT00806624|82984747|FG000|Overall Study|Lost to Follow-up|1|||
46766426|NCT00806624|82984748|FG001|Overall Study|Lost to Follow-up|0|||
46766427|NCT00806624|82984749|FG002|Overall Study|Lost to Follow-up|1|||
46766428|NCT00806624|82984747|FG000|Overall Study|Withdrawal by Subject|6|||
46766429|NCT00806624|82984748|FG001|Overall Study|Withdrawal by Subject|3|||
46766430|NCT00806624|82984749|FG002|Overall Study|Withdrawal by Subject|3|||
46766431|NCT00806624|82984747|FG000|Overall Study|discontinued before start of treatment|0|||
46766432|NCT00806624|82984748|FG001|Overall Study|discontinued before start of treatment|0|||
46766433|NCT00806624|82984749|FG002|Overall Study|discontinued before start of treatment|1|||
46766434|NCT00806546|82984757|FG000|Overall Study|Enrolled, not treated|35|||
46766435|NCT00806546|82984757|FG000|Overall Study|Lost to Follow-up|32|||
46766436|NCT00806546|82984757|FG000|Overall Study|Adverse Event|74|||
46766437|NCT00806546|82984757|FG000|Overall Study|Withdrawal by Subject|75|||
46833882|NCT00355082|83051731|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
46833883|NCT00355082|83051732|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
47061942|NCT03337724|83342618|FG002|Overall Study|Protocol Deviation|1|||
47061943|NCT03337724|83342619|FG003|Overall Study|Protocol Deviation|1|||
46833884|NCT00502307|83051743|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
46833885|NCT00502307|83051744|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
47061944|NCT03337724|83342620|FG004|Overall Study|Protocol Deviation|0|||
47061945|NCT03337724|83342616|FG000|Overall Study|Adverse Event|1|||
47061946|NCT03337724|83342617|FG001|Overall Study|Adverse Event|1|||
47061947|NCT03337724|83342618|FG002|Overall Study|Adverse Event|0|||
47061948|NCT03337724|83342619|FG003|Overall Study|Adverse Event|1|||
47061949|NCT03337724|83342620|FG004|Overall Study|Adverse Event|0|||
47061950|NCT03337724|83342616|FG000|Overall Study|Death|40|||
47061951|NCT03337724|83342617|FG001|Overall Study|Death|89|||
47061952|NCT03337724|83342618|FG002|Overall Study|Death|43|||
47061953|NCT03337724|83342619|FG003|Overall Study|Death|76|||
47061954|NCT03337724|83342620|FG004|Overall Study|Death|50|||
47061955|NCT03337724|83342616|FG000|Overall Study|Lost to Follow-up|5|||
46766438|NCT00806546|82984757|FG000|Overall Study|Protocol Violation|49|||
46766439|NCT00806546|82984757|FG000|Overall Study|Various|42|||
47061956|NCT03337724|83342617|FG001|Overall Study|Lost to Follow-up|5|||
47061957|NCT03337724|83342618|FG002|Overall Study|Lost to Follow-up|4|||
47061958|NCT03337724|83342619|FG003|Overall Study|Lost to Follow-up|7|||
46766440|NCT00624832|82984765|FG000|Overall Study|Adverse Event|0|||
46766441|NCT00624832|82984766|FG001|Overall Study|Adverse Event|1|||
46766442|NCT00624832|82984767|FG002|Overall Study|Adverse Event|0|||
46766443|NCT00624832|82984768|FG003|Overall Study|Adverse Event|1|||
46833886|NCT00502307|83051745|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
46833887|NCT00502307|83051743|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
46833888|NCT00502307|83051744|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
46833889|NCT00502307|83051745|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
46833890|NCT00502307|83051743|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
46833891|NCT00502307|83051744|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
46833892|NCT00502307|83051745|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
46833893|NCT00502307|83051743|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
46833894|NCT00502307|83051744|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
46833895|NCT00502307|83051745|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
46833896|NCT00502307|83051743|FG000|Maintenance Period|Progressive disease|80|||
46833897|NCT00502307|83051744|FG001|Maintenance Period|Progressive disease|0|||
46833898|NCT00502307|83051745|FG002|Maintenance Period|Progressive disease|0|||
46833899|NCT00502307|83051743|FG000|Maintenance Period|Discontinued due to other reasons|68|||
46833900|NCT00502307|83051744|FG001|Maintenance Period|Discontinued due to other reasons|0|||
46833901|NCT00502307|83051745|FG002|Maintenance Period|Discontinued due to other reasons|0|||
46833902|NCT00484679|83051762|FG000|Overall Study|Withdrawal by Subject|3|||
46833903|NCT00377312|83051768|FG000|Overall Study|Adverse Event|1|||
46833904|NCT00377312|83051769|FG001|Overall Study|Adverse Event|1|||
47061959|NCT03337724|83342620|FG004|Overall Study|Lost to Follow-up|4|||
46637955|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766444|NCT00624832|82984765|FG000|Overall Study|Abnormal Laboratory Value|2|||
46766445|NCT00624832|82984766|FG001|Overall Study|Abnormal Laboratory Value|0|||
46766446|NCT00624832|82984767|FG002|Overall Study|Abnormal Laboratory Value|0|||
46766447|NCT00624832|82984768|FG003|Overall Study|Abnormal Laboratory Value|0|||
46766448|NCT00633880|82984780|FG000|Open Label Titration|Lack of Efficacy|1|||
46766449|NCT00633880|82984781|FG001|Open Label Titration|Lack of Efficacy|0|||
46766450|NCT00633880|82984782|FG002|Open Label Titration|Lack of Efficacy|0|||
46766451|NCT00633880|82984780|FG000|Open Label Titration|Adverse Event|13|||
46766452|NCT00633880|82984781|FG001|Open Label Titration|Adverse Event|0|||
46766453|NCT00633880|82984782|FG002|Open Label Titration|Adverse Event|0|||
46942357|NCT01066793|83179579|FG000|Overall Study|Treatment Stopped|2|||
46766454|NCT00633880|82984780|FG000|Open Label Titration|Treatment Failure|55|||
46766455|NCT00633880|82984781|FG001|Open Label Titration|Treatment Failure|0|||
46766456|NCT00633880|82984782|FG002|Open Label Titration|Treatment Failure|0|||
46766457|NCT00633880|82984780|FG000|Open Label Titration|Protocol Violation|6|||
46766458|NCT00633880|82984781|FG001|Open Label Titration|Protocol Violation|0|||
46766459|NCT00633880|82984782|FG002|Open Label Titration|Protocol Violation|0|||
46833905|NCT00377234|83051777|FG000|Overall Study|Adverse Event|14|||
46833906|NCT00377234|83051778|FG001|Overall Study|Adverse Event|17|||
46833907|NCT00377234|83051777|FG000|Overall Study|Withdrawal by Subject|11|||
47061960|NCT03337724|83342616|FG000|Overall Study|Physician Decision|16|||
47061961|NCT03337724|83342617|FG001|Overall Study|Physician Decision|34|||
47061962|NCT03337724|83342618|FG002|Overall Study|Physician Decision|14|||
46766460|NCT00633880|82984780|FG000|Open Label Titration|Physician Decision|1|||
46766461|NCT00633880|82984781|FG001|Open Label Titration|Physician Decision|0|||
46766462|NCT00633880|82984782|FG002|Open Label Titration|Physician Decision|0|||
46766463|NCT00633880|82984780|FG000|Open Label Titration|Withdrawal by Subject|4|||
46766464|NCT00633880|82984781|FG001|Open Label Titration|Withdrawal by Subject|0|||
47061963|NCT03337724|83342619|FG003|Overall Study|Physician Decision|34|||
47061964|NCT03337724|83342620|FG004|Overall Study|Physician Decision|13|||
47061965|NCT03337724|83342616|FG000|Overall Study|Progressive Disease|0|||
47061966|NCT03337724|83342617|FG001|Overall Study|Progressive Disease|2|||
47061967|NCT03337724|83342618|FG002|Overall Study|Progressive Disease|1|||
47061968|NCT03337724|83342619|FG003|Overall Study|Progressive Disease|2|||
47061969|NCT03337724|83342620|FG004|Overall Study|Progressive Disease|0|||
47061970|NCT03337724|83342616|FG000|Overall Study|Symptomatic Deterioration|0|||
47061971|NCT03337724|83342617|FG001|Overall Study|Symptomatic Deterioration|0|||
47061972|NCT03337724|83342618|FG002|Overall Study|Symptomatic Deterioration|0|||
47061973|NCT03337724|83342619|FG003|Overall Study|Symptomatic Deterioration|1|||
47061974|NCT03337724|83342620|FG004|Overall Study|Symptomatic Deterioration|0|||
47061975|NCT03298061|83342636|FG000|Overall Study|Adverse Event|3|||
47061976|NCT03298061|83342636|FG000|Overall Study|Lack of Efficacy|6|||
47061977|NCT03298061|83342636|FG000|Overall Study|Protocol Violation|1|||
47061978|NCT03298061|83342636|FG000|Overall Study|Physician Decision|7|||
47061979|NCT03298061|83342636|FG000|Overall Study|Withdrawal by Subject|10|||
47061980|NCT03205982|83342642|FG000|Overall Study|Lost to Follow-up|20|||
47061981|NCT03205982|83342643|FG001|Overall Study|Lost to Follow-up|19|||
47061982|NCT03205982|83342642|FG000|Overall Study|Withdrawal by Subject|4|||
47061983|NCT03205982|83342643|FG001|Overall Study|Withdrawal by Subject|3|||
47061984|NCT03205982|83342642|FG000|Overall Study|Withdrawal by PI|0|||
47061985|NCT03205982|83342643|FG001|Overall Study|Withdrawal by PI|1|||
47061986|NCT02949830|83342656|FG000|Overall Study|Adverse Event|1|||
47061987|NCT02949830|83342656|FG000|Overall Study|Withdrawal by Subject|1|||
47061988|NCT02913612|83342664|FG000|Overall Study|Lost to Follow-up|6|||
47061989|NCT02913612|83342665|FG001|Overall Study|Lost to Follow-up|5|||
47061990|NCT02913612|83342666|FG002|Overall Study|Lost to Follow-up|2|||
47061991|NCT02913612|83342667|FG003|Overall Study|Lost to Follow-up|0|||
47061992|NCT02913612|83342664|FG000|Overall Study|Physician Decision|1|||
47061993|NCT02913612|83342665|FG001|Overall Study|Physician Decision|4|||
47061994|NCT02913612|83342666|FG002|Overall Study|Physician Decision|1|||
47061995|NCT02913612|83342667|FG003|Overall Study|Physician Decision|0|||
47061996|NCT02913612|83342664|FG000|Overall Study|Withdrawal by Subject|2|||
47061997|NCT02913612|83342665|FG001|Overall Study|Withdrawal by Subject|4|||
47061998|NCT02913612|83342666|FG002|Overall Study|Withdrawal by Subject|0|||
47061999|NCT02913612|83342667|FG003|Overall Study|Withdrawal by Subject|0|||
47062000|NCT02913612|83342664|FG000|Overall Study|Hemangioma resolved|1|||
47062001|NCT02913612|83342665|FG001|Overall Study|Hemangioma resolved|0|||
47062002|NCT02913612|83342666|FG002|Overall Study|Hemangioma resolved|0|||
47062003|NCT02913612|83342667|FG003|Overall Study|Hemangioma resolved|0|||
47062004|NCT02913612|83342664|FG000|Overall Study|Local IRB decision|1|||
47062005|NCT02913612|83342665|FG001|Overall Study|Local IRB decision|0|||
47062006|NCT02913612|83342666|FG002|Overall Study|Local IRB decision|0|||
47062007|NCT02913612|83342667|FG003|Overall Study|Local IRB decision|0|||
47062008|NCT02913612|83342664|FG000|Overall Study|Study drug non-compliance|1|||
47062009|NCT02913612|83342665|FG001|Overall Study|Study drug non-compliance|1|||
47062010|NCT02913612|83342666|FG002|Overall Study|Study drug non-compliance|0|||
47062011|NCT02913612|83342667|FG003|Overall Study|Study drug non-compliance|0|||
47062012|NCT02913612|83342664|FG000|Overall Study|Insurance issues|0|||
46766465|NCT00633880|82984782|FG002|Open Label Titration|Withdrawal by Subject|0|||
46766466|NCT00590564|82984789|FG000|Overall Study|Withdrawal by Subject|4|||
46766467|NCT00590564|82984789|FG000|Overall Study|Lost to Follow-up|6|||
46766468|NCT00590564|82984789|FG000|Overall Study|Protocol Violation|1|||
46766469|NCT00590564|82984789|FG000|Overall Study|Patient Found to be Ineligible|1|||
46766470|NCT00590564|82984789|FG000|Overall Study|Patient Non-compliance|6|||
46766471|NCT00631696|82984795|FG000|Overall Study|Entered, not randomized to treatment|1|||
46766472|NCT00631696|82984796|FG001|Overall Study|Entered, not randomized to treatment|1|||
46766473|NCT00631696|82984795|FG000|Overall Study|Discontinued after database release date|1|||
47062013|NCT02913612|83342665|FG001|Overall Study|Insurance issues|1|||
47062014|NCT02913612|83342666|FG002|Overall Study|Insurance issues|0|||
47062015|NCT02913612|83342667|FG003|Overall Study|Insurance issues|0|||
47062016|NCT02913612|83342664|FG000|Overall Study|Needed to treat second hemangioma|0|||
46766474|NCT00631696|82984796|FG001|Overall Study|Discontinued after database release date|0|||
47062017|NCT02913612|83342665|FG001|Overall Study|Needed to treat second hemangioma|1|||
47062018|NCT02913612|83342666|FG002|Overall Study|Needed to treat second hemangioma|0|||
47062019|NCT02913612|83342667|FG003|Overall Study|Needed to treat second hemangioma|0|||
47062020|NCT02913612|83342664|FG000|Overall Study|Study completion criteria not met|0|||
47062021|NCT02913612|83342665|FG001|Overall Study|Study completion criteria not met|1|||
47062022|NCT02913612|83342666|FG002|Overall Study|Study completion criteria not met|0|||
47062023|NCT02913612|83342667|FG003|Overall Study|Study completion criteria not met|0|||
47062024|NCT02913612|83342664|FG000|Overall Study|Ineligible|0|||
47062025|NCT02913612|83342665|FG001|Overall Study|Ineligible|1|||
47062026|NCT02913612|83342666|FG002|Overall Study|Ineligible|0|||
47062027|NCT02913612|83342667|FG003|Overall Study|Ineligible|0|||
47062028|NCT02762266|83342678|FG000|Overall Study|Physician Decision|2|||
47062029|NCT02762266|83342679|FG001|Overall Study|Physician Decision|0|||
47062030|NCT02737306|83342687|FG000|Overall Study|Adverse Event|3|||
47062031|NCT02737306|83342688|FG001|Overall Study|Adverse Event|0|||
47062032|NCT02737306|83342687|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
47062033|NCT02737306|83342688|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
47062034|NCT02711553|83342698|FG000|Overall Study|Withdrawal by Subject|2|||
46766475|NCT00631696|82984795|FG000|Overall Study|Follow up after database release date|1|||
46766476|NCT00631696|82984796|FG001|Overall Study|Follow up after database release date|0|||
47062035|NCT02711553|83342699|FG001|Overall Study|Withdrawal by Subject|1|||
47062036|NCT02711553|83342700|FG002|Overall Study|Withdrawal by Subject|1|||
47062037|NCT02711553|83342701|FG003|Overall Study|Withdrawal by Subject|0|||
47062038|NCT02711553|83342698|FG000|Overall Study|Lost to Follow-up|3|||
47062039|NCT02711553|83342699|FG001|Overall Study|Lost to Follow-up|3|||
47062040|NCT02711553|83342700|FG002|Overall Study|Lost to Follow-up|6|||
47062041|NCT02711553|83342701|FG003|Overall Study|Lost to Follow-up|3|||
47062042|NCT02711553|83342698|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
47062043|NCT02711553|83342699|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
47062044|NCT02711553|83342700|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
47062045|NCT02711553|83342701|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
47062046|NCT02678741|83342722|FG000|Overall Study|Death|4|||
46766477|NCT00631696|82984795|FG000|Overall Study|Lost to Follow-up|7|||
46766478|NCT00631696|82984796|FG001|Overall Study|Lost to Follow-up|10|||
46766479|NCT00631696|82984795|FG000|Overall Study|Withdrawal by Subject|2|||
46766480|NCT00631696|82984796|FG001|Overall Study|Withdrawal by Subject|9|||
46766481|NCT00631696|82984795|FG000|Overall Study|Other|8|||
46766482|NCT00631696|82984796|FG001|Overall Study|Other|8|||
46766483|NCT00631696|82984795|FG000|Overall Study|Protocol Violation|9|||
46766484|NCT00631696|82984796|FG001|Overall Study|Protocol Violation|9|||
46766485|NCT00631696|82984795|FG000|Overall Study|Study terminated by sponsor|3|||
46766486|NCT00631696|82984796|FG001|Overall Study|Study terminated by sponsor|3|||
46766487|NCT00631696|82984795|FG000|Overall Study|Adverse Event|5|||
46766488|NCT00631696|82984796|FG001|Overall Study|Adverse Event|0|||
46766489|NCT00631540|82984802|FG000|Overall Study|Withdrawal by Subject|5|||
46766490|NCT00631540|82984802|FG000|Overall Study|Death|4|||
46766491|NCT00631540|82984802|FG000|Overall Study|Lost to Follow-up|2|||
46766492|NCT00631540|82984802|FG000|Overall Study|Core Lab Data Unavailable|3|||
46766493|NCT00630916|82984806|FG000|Overall Study|Death|110|||
46766494|NCT00630916|82984806|FG000|Overall Study|Explant|8|||
46766495|NCT00630916|82984806|FG000|Overall Study|Lost to Follow-up|5|||
46766496|NCT00630916|82984806|FG000|Overall Study|Withdrawal by Subject|30|||
46766497|NCT00630916|82984806|FG000|Overall Study|Protocol Violation|7|||
46766498|NCT00630916|82984806|FG000|Overall Study|Physician Decision|47|||
46833908|NCT00377234|83051778|FG001|Overall Study|Withdrawal by Subject|9|||
46833909|NCT00377234|83051777|FG000|Overall Study|Lost to Follow-up|4|||
46833910|NCT00377234|83051778|FG001|Overall Study|Lost to Follow-up|2|||
46833911|NCT00377234|83051777|FG000|Overall Study|Administrative|2|||
46833912|NCT00377234|83051778|FG001|Overall Study|Administrative|1|||
46833913|NCT00377234|83051777|FG000|Overall Study|Not assigned|3|||
46833914|NCT00377234|83051778|FG001|Overall Study|Not assigned|2|||
46833915|NCT00377156|83051792|FG000|Overall Study|Death|23|||
46833916|NCT00377156|83051793|FG001|Overall Study|Death|19|||
46833917|NCT00377156|83051792|FG000|Overall Study|Withdrawal by Subject|16|||
46833918|NCT00377156|83051793|FG001|Overall Study|Withdrawal by Subject|24|||
46833919|NCT00377156|83051792|FG000|Overall Study|Had follow-up <90 d|3|||
46833920|NCT00377156|83051793|FG001|Overall Study|Had follow-up <90 d|6|||
47062047|NCT02678741|83342722|FG000|Overall Study|Withdrawal by Subject|1|||
47062048|NCT02678741|83342722|FG000|Overall Study|ineligible|3|||
47062049|NCT02678741|83342722|FG000|Overall Study|Not RECIST Measurable|2|||
47062050|NCT02678741|83342722|FG000|Overall Study|Lack of Efficacy|10|||
47062051|NCT02367040|83342738|FG000|Overall Study|Lost to Follow-up|1|||
47062052|NCT02367040|83342739|FG001|Overall Study|Lost to Follow-up|1|||
47062053|NCT02367040|83342738|FG000|Overall Study|Lack of Efficacy|1|||
47062054|NCT02367040|83342739|FG001|Overall Study|Lack of Efficacy|0|||
47062055|NCT02367040|83342738|FG000|Overall Study|Additional primary malignancy|0|||
46766499|NCT00630916|82984806|FG000|Overall Study|Lack of Efficacy|3|||
47062056|NCT02367040|83342739|FG001|Overall Study|Additional primary malignancy|1|||
46766500|NCT00630292|82984810|FG000|Overall Study|Withdrawal by Subject|1|||
47062057|NCT02367040|83342738|FG000|Overall Study|AE not associated with clinical disease progression|114|||
46766501|NCT00626548|82984816|FG000|Overall Study|Adverse Event|164|||
46833921|NCT00377156|83051792|FG000|Overall Study|Cancellation|1|||
46833922|NCT00377156|83051793|FG001|Overall Study|Cancellation|0|||
46833923|NCT00377156|83051792|FG000|Overall Study|Refused testing|0|||
47062058|NCT02367040|83342739|FG001|Overall Study|AE not associated with clinical disease progression|11|||
47062059|NCT02367040|83342738|FG000|Overall Study|AE associated with clinical disease progression|1|||
47062060|NCT02367040|83342739|FG001|Overall Study|AE associated with clinical disease progression|3|||
47062061|NCT02367040|83342738|FG000|Overall Study|Physician Decision|2|||
47062062|NCT02367040|83342739|FG001|Overall Study|Physician Decision|8|||
47062063|NCT02367040|83342738|FG000|Overall Study|Non-compliance with study drug|1|||
47062064|NCT02367040|83342739|FG001|Overall Study|Non-compliance with study drug|0|||
47062065|NCT02367040|83342738|FG000|Overall Study|Failure to meet continuation criteria|1|||
47062066|NCT02367040|83342739|FG001|Overall Study|Failure to meet continuation criteria|0|||
47062067|NCT02367040|83342738|FG000|Overall Study|Switching to other therapy|2|||
47062068|NCT02367040|83342739|FG001|Overall Study|Switching to other therapy|0|||
47062069|NCT02367040|83342738|FG000|Overall Study|Withdrawal by Subject|46|||
47062070|NCT02367040|83342739|FG001|Overall Study|Withdrawal by Subject|16|||
47062071|NCT02367040|83342738|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
47062072|NCT02367040|83342739|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
47062073|NCT02367040|83342738|FG000|Overall Study|Patient decision|39|||
47062074|NCT02367040|83342739|FG001|Overall Study|Patient decision|14|||
47062075|NCT02367040|83342738|FG000|Overall Study|Required procedure failed|1|||
47062076|NCT02367040|83342739|FG001|Overall Study|Required procedure failed|0|||
47062077|NCT02367040|83342738|FG000|Overall Study|Randomized by mistake with study treatment|1|||
47062078|NCT02367040|83342739|FG001|Overall Study|Randomized by mistake with study treatment|0|||
47062079|NCT02367040|83342738|FG000|Overall Study|Protocol Violation|1|||
47062080|NCT02367040|83342739|FG001|Overall Study|Protocol Violation|0|||
47062081|NCT02367040|83342738|FG000|Overall Study|Progressive disease - radiological progression|51|||
47062082|NCT02367040|83342739|FG001|Overall Study|Progressive disease - radiological progression|78|||
47062083|NCT02367040|83342738|FG000|Overall Study|Progressive disease - clinical progression|6|||
47062084|NCT02367040|83342739|FG001|Overall Study|Progressive disease - clinical progression|6|||
47062085|NCT02367040|83342738|FG000|Overall Study|Drug not administered|3|||
47062086|NCT02367040|83342739|FG001|Overall Study|Drug not administered|2|||
47062087|NCT02367040|83342738|FG000|Overall Study|Progressive disease|0|||
47062088|NCT02367040|83342739|FG001|Overall Study|Progressive disease|1|||
47062089|NCT02367040|83342738|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
47062090|NCT02367040|83342739|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
47062091|NCT02367040|83342738|FG000|Overall Study|Death|2|||
47062092|NCT02367040|83342739|FG001|Overall Study|Death|0|||
47062093|NCT02278120|83342747|FG000|Treatment Period|Progressive disease|234|||
47062094|NCT02278120|83342748|FG001|Treatment Period|Progressive disease|260|||
47062095|NCT02278120|83342747|FG000|Treatment Period|Subject/guardian decision|23|||
47062096|NCT02278120|83342748|FG001|Treatment Period|Subject/guardian decision|20|||
47062097|NCT02278120|83342747|FG000|Treatment Period|Adverse Event|16|||
47062098|NCT02278120|83342748|FG001|Treatment Period|Adverse Event|14|||
47062099|NCT02278120|83342747|FG000|Treatment Period|Physician Decision|14|||
47062100|NCT02278120|83342748|FG001|Treatment Period|Physician Decision|27|||
47062101|NCT02278120|83342747|FG000|Treatment Period|Death|3|||
47062102|NCT02278120|83342748|FG001|Treatment Period|Death|3|||
47062103|NCT02278120|83342747|FG000|Treatment Period|Lost to Follow-up|2|||
47062104|NCT02278120|83342748|FG001|Treatment Period|Lost to Follow-up|0|||
47062105|NCT02278120|83342747|FG000|Treatment Period|Protocol deviation|0|||
47062106|NCT02278120|83342748|FG001|Treatment Period|Protocol deviation|2|||
47062107|NCT02278120|83342747|FG000|Treatment Period|Study terminated as per protocol|43|||
47062108|NCT02278120|83342748|FG001|Treatment Period|Study terminated as per protocol|11|||
47062109|NCT02278120|83342747|FG000|Post-treatment Efficacy Follow-up|Death|0|||
47062110|NCT02278120|83342748|FG001|Post-treatment Efficacy Follow-up|Death|1|||
47062111|NCT02278120|83342747|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
47062112|NCT02278120|83342748|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
47062113|NCT02278120|83342747|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
47062114|NCT02278120|83342748|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
47062115|NCT02278120|83342747|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
47062116|NCT02278120|83342748|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
47062117|NCT02278120|83342747|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
46942358|NCT01066793|83179580|FG001|Overall Study|Treatment Stopped|1|||
47062118|NCT02278120|83342748|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
47062119|NCT02242942|83342762|FG000|Overall Study|Death|17|||
47062120|NCT02242942|83342763|FG001|Overall Study|Death|20|||
47062121|NCT02242942|83342764|FG002|Overall Study|Death|2|||
47062122|NCT02242942|83342762|FG000|Overall Study|Physician Decision|1|||
47062123|NCT02242942|83342763|FG001|Overall Study|Physician Decision|0|||
47062124|NCT02242942|83342764|FG002|Overall Study|Physician Decision|0|||
47062125|NCT02242942|83342762|FG000|Overall Study|Withdrawal by Subject|8|||
47062126|NCT02242942|83342763|FG001|Overall Study|Withdrawal by Subject|10|||
47062127|NCT02242942|83342764|FG002|Overall Study|Withdrawal by Subject|0|||
47062128|NCT02242942|83342762|FG000|Overall Study|On-going in Study|190|||
47062129|NCT02242942|83342763|FG001|Overall Study|On-going in Study|186|||
47062130|NCT02242942|83342764|FG002|Overall Study|On-going in Study|11|||
47062131|NCT02242097|83342774|FG000|Ibrutinib Treatment|Adverse Event|16|||
47062132|NCT02242097|83342774|FG000|Ibrutinib Treatment|Physician Decision|1|||
47062133|NCT02242097|83342774|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
47062134|NCT02242097|83342774|FG000|Ibrutinib Treatment|Death|1|||
46942359|NCT01066793|83179581|FG002|Overall Study|Treatment Stopped|0|||
46942360|NCT01066793|83179582|FG003|Overall Study|Treatment Stopped|1|||
46942361|NCT01066793|83179583|FG004|Overall Study|Treatment Stopped|0|||
46942362|NCT01066793|83179584|FG005|Overall Study|Treatment Stopped|0|||
46942363|NCT03985293|83179605|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
46942364|NCT03985293|83179606|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
46942365|NCT03985293|83179607|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
46942366|NCT03985293|83179608|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
46942367|NCT03985293|83179609|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
46942368|NCT03985293|83179610|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
46942369|NCT03985293|83179605|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
47062135|NCT02242097|83342774|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
47062136|NCT02242097|83342774|FG000|Post Therapy Follow Up|Death|3|||
47062137|NCT02242097|83342774|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
47062138|NCT01953926|83342785|FG000|Overall Study|Withdrawal by Subject|23|||
47062139|NCT01953926|83342786|FG001|Overall Study|Withdrawal by Subject|3|||
47062140|NCT01953926|83342787|FG002|Overall Study|Withdrawal by Subject|3|||
47062141|NCT01953926|83342788|FG003|Overall Study|Withdrawal by Subject|5|||
46833924|NCT00377156|83051793|FG001|Overall Study|Refused testing|1|||
46833925|NCT00377156|83051792|FG000|Overall Study|Ineligible|0|||
46833926|NCT00377156|83051793|FG001|Overall Study|Ineligible|1|||
46833927|NCT00377156|83051792|FG000|Overall Study|Disability or language problem|0|||
46833928|NCT00377156|83051793|FG001|Overall Study|Disability or language problem|1|||
46833929|NCT00377156|83051792|FG000|Overall Study|Other|5|||
46833930|NCT00377156|83051793|FG001|Overall Study|Other|2|||
46833931|NCT00376688|83051801|FG000|Overall Study|Adverse Event|3|||
46833932|NCT00376688|83051801|FG000|Overall Study|Death|1|||
46833933|NCT00376532|83051807|FG000|Overall Study|Lack sufficient blood sample|6|||
46833934|NCT00376532|83051808|FG001|Overall Study|Lack sufficient blood sample|6|||
46833935|NCT00376220|83051816|FG000|Overall Study|Lost to Follow-up|7|||
46833936|NCT00376220|83051817|FG001|Overall Study|Lost to Follow-up|10|||
46833937|NCT00376220|83051816|FG000|Overall Study|Withdrawal by Subject|3|||
46833938|NCT00376220|83051817|FG001|Overall Study|Withdrawal by Subject|2|||
46833939|NCT00375752|83051825|FG000|Overall Study|Lack of Efficacy|4|||
46833940|NCT00375752|83051826|FG001|Overall Study|Lack of Efficacy|4|||
46833941|NCT00375752|83051825|FG000|Overall Study|Adverse Event|1|||
46833942|NCT00375752|83051826|FG001|Overall Study|Adverse Event|6|||
46833943|NCT00375752|83051825|FG000|Overall Study|Withdrawal by Subject|6|||
46833944|NCT00375752|83051826|FG001|Overall Study|Withdrawal by Subject|1|||
46942370|NCT03985293|83179606|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
46942371|NCT03985293|83179607|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
46942372|NCT03985293|83179608|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
46942373|NCT03985293|83179609|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
47062142|NCT01953926|83342789|FG004|Overall Study|Withdrawal by Subject|6|||
47062143|NCT01953926|83342790|FG005|Overall Study|Withdrawal by Subject|0|||
46766502|NCT00626548|82984817|FG001|Overall Study|Adverse Event|44|||
46766503|NCT00626548|82984816|FG000|Overall Study|Withdrawal by Subject|42|||
46766504|NCT00626548|82984817|FG001|Overall Study|Withdrawal by Subject|46|||
46766505|NCT00626548|82984816|FG000|Overall Study|Protocol Violation|4|||
46766506|NCT00626548|82984817|FG001|Overall Study|Protocol Violation|11|||
46766507|NCT00626548|82984816|FG000|Overall Study|Lost to Follow-up|2|||
46766508|NCT00626548|82984817|FG001|Overall Study|Lost to Follow-up|2|||
46766509|NCT00626548|82984816|FG000|Overall Study|Other termination reason|493|||
46766510|NCT00626548|82984817|FG001|Overall Study|Other termination reason|613|||
46766511|NCT00847379|82984826|FG000|Overall Study|Study terminated by Sponsor|59|||
46766512|NCT00847379|82984827|FG001|Overall Study|Study terminated by Sponsor|57|||
46766513|NCT00847379|82984828|FG002|Overall Study|Study terminated by Sponsor|57|||
46766514|NCT00847301|82984838|FG000|Overall Study|Adverse Event|35|||
46766515|NCT00847301|82984838|FG000|Overall Study|Switch to other anticoagulants|16|||
46833945|NCT00375752|83051825|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
47062144|NCT01953926|83342791|FG006|Overall Study|Withdrawal by Subject|1|||
46766516|NCT00847301|82984838|FG000|Overall Study|Lost to Follow-up|1|||
46766517|NCT00847301|82984838|FG000|Overall Study|No prescription after hospital discharge|1|||
46833946|NCT00375752|83051826|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
46833947|NCT00375752|83051825|FG000|Overall Study|Protocol Violation|0|||
46833948|NCT00375752|83051826|FG001|Overall Study|Protocol Violation|2|||
46833949|NCT00375752|83051825|FG000|Overall Study|Administrative Problems|0|||
46833950|NCT00375752|83051826|FG001|Overall Study|Administrative Problems|1|||
47062145|NCT01953926|83342785|FG000|Overall Study|Physician Decision|1|||
47062146|NCT01953926|83342786|FG001|Overall Study|Physician Decision|0|||
47062147|NCT01953926|83342787|FG002|Overall Study|Physician Decision|0|||
47062148|NCT01953926|83342788|FG003|Overall Study|Physician Decision|0|||
47062149|NCT01953926|83342789|FG004|Overall Study|Physician Decision|2|||
47062150|NCT01953926|83342790|FG005|Overall Study|Physician Decision|0|||
47062151|NCT01953926|83342791|FG006|Overall Study|Physician Decision|0|||
47062152|NCT01953926|83342785|FG000|Overall Study|Lost to Follow-up|18|||
47062153|NCT01953926|83342786|FG001|Overall Study|Lost to Follow-up|3|||
47062154|NCT01953926|83342787|FG002|Overall Study|Lost to Follow-up|0|||
47062155|NCT01953926|83342788|FG003|Overall Study|Lost to Follow-up|5|||
47062156|NCT01953926|83342789|FG004|Overall Study|Lost to Follow-up|3|||
47062157|NCT01953926|83342790|FG005|Overall Study|Lost to Follow-up|0|||
47062158|NCT01953926|83342791|FG006|Overall Study|Lost to Follow-up|0|||
47062159|NCT01953926|83342785|FG000|Overall Study|Protocol Violation|1|||
47062160|NCT01953926|83342786|FG001|Overall Study|Protocol Violation|0|||
47062161|NCT01953926|83342787|FG002|Overall Study|Protocol Violation|0|||
47062162|NCT01953926|83342788|FG003|Overall Study|Protocol Violation|0|||
47062163|NCT01953926|83342789|FG004|Overall Study|Protocol Violation|0|||
47062164|NCT01953926|83342790|FG005|Overall Study|Protocol Violation|0|||
47062165|NCT01953926|83342791|FG006|Overall Study|Protocol Violation|0|||
47062166|NCT01953926|83342785|FG000|Overall Study|Other, Disease progression|2|||
47062167|NCT01953926|83342786|FG001|Overall Study|Other, Disease progression|1|||
47062168|NCT01953926|83342787|FG002|Overall Study|Other, Disease progression|0|||
47062169|NCT01953926|83342788|FG003|Overall Study|Other, Disease progression|0|||
47062170|NCT01953926|83342789|FG004|Overall Study|Other, Disease progression|1|||
47062171|NCT01953926|83342790|FG005|Overall Study|Other, Disease progression|0|||
47062172|NCT01953926|83342791|FG006|Overall Study|Other, Disease progression|0|||
47062173|NCT01953926|83342785|FG000|Overall Study|Discontinuation of study by sponsor|41|||
47062174|NCT01953926|83342786|FG001|Overall Study|Discontinuation of study by sponsor|7|||
47062175|NCT01953926|83342787|FG002|Overall Study|Discontinuation of study by sponsor|5|||
47062176|NCT01953926|83342788|FG003|Overall Study|Discontinuation of study by sponsor|12|||
47062177|NCT01953926|83342789|FG004|Overall Study|Discontinuation of study by sponsor|46|||
47062178|NCT01953926|83342790|FG005|Overall Study|Discontinuation of study by sponsor|5|||
47062179|NCT01953926|83342791|FG006|Overall Study|Discontinuation of study by sponsor|6|||
47062180|NCT01953926|83342785|FG000|Overall Study|Not Treated|1|||
47062181|NCT01953926|83342786|FG001|Overall Study|Not Treated|0|||
47062182|NCT01953926|83342787|FG002|Overall Study|Not Treated|1|||
47062183|NCT01953926|83342788|FG003|Overall Study|Not Treated|0|||
47062184|NCT01953926|83342789|FG004|Overall Study|Not Treated|0|||
47062185|NCT01953926|83342790|FG005|Overall Study|Not Treated|0|||
47062186|NCT01953926|83342791|FG006|Overall Study|Not Treated|0|||
47062187|NCT01214330|83342857|FG000|Overall Study|Withdrawal by Subject|2|||
47062188|NCT01214330|83342857|FG000|Overall Study|Withdrawal by Subject|2|||
46766518|NCT00847301|82984838|FG000|Overall Study|Other reason not defined above|1|||
46766519|NCT00624520|82984844|FG000|Overall Study|Withdrawal by Subject|12|||
46766520|NCT00624520|82984845|FG001|Overall Study|Withdrawal by Subject|7|||
46766521|NCT00624520|82984844|FG000|Overall Study|Death|0|||
46766522|NCT00624520|82984845|FG001|Overall Study|Death|1|||
46766523|NCT00847145|82984859|FG000|Overall Study|AE or Death|0|||
46766524|NCT00847145|82984860|FG001|Overall Study|AE or Death|1|||
46766525|NCT00847145|82984861|FG002|Overall Study|AE or Death|1|||
46766526|NCT00847145|82984862|FG003|Overall Study|AE or Death|0|||
46766527|NCT00847145|82984863|FG004|Overall Study|AE or Death|0|||
46766528|NCT00847145|82984864|FG005|Overall Study|AE or Death|0|||
46766529|NCT00847145|82984865|FG006|Overall Study|AE or Death|0|||
46766530|NCT00847145|82984866|FG007|Overall Study|AE or Death|0|||
46766531|NCT00847145|82984859|FG000|Overall Study|Withdrawal by Subject|3|||
46766532|NCT00847145|82984860|FG001|Overall Study|Withdrawal by Subject|4|||
46766533|NCT00847145|82984861|FG002|Overall Study|Withdrawal by Subject|6|||
46766534|NCT00847145|82984862|FG003|Overall Study|Withdrawal by Subject|1|||
47062189|NCT00942877|83342875|FG000|Overall Study|Refused further treatment|1|||
47062190|NCT00942877|83342876|FG001|Overall Study|Refused further treatment|1|||
47062191|NCT00942877|83342875|FG000|Overall Study|Patient was not treated|1|||
47062192|NCT00942877|83342876|FG001|Overall Study|Patient was not treated|0|||
46766535|NCT00847145|82984863|FG004|Overall Study|Withdrawal by Subject|0|||
46766536|NCT00847145|82984864|FG005|Overall Study|Withdrawal by Subject|0|||
47062193|NCT00942877|83342875|FG000|Overall Study|Adverse Event|1|||
46766537|NCT00847145|82984865|FG006|Overall Study|Withdrawal by Subject|1|||
46766538|NCT00847145|82984866|FG007|Overall Study|Withdrawal by Subject|1|||
46766539|NCT00847145|82984859|FG000|Overall Study|Lost to Follow-up|3|||
46766540|NCT00847145|82984860|FG001|Overall Study|Lost to Follow-up|1|||
46766541|NCT00847145|82984861|FG002|Overall Study|Lost to Follow-up|1|||
47062194|NCT00942877|83342876|FG001|Overall Study|Adverse Event|0|||
47062195|NCT00942877|83342875|FG000|Overall Study|Progressive disease|42|||
47062196|NCT00942877|83342876|FG001|Overall Study|Progressive disease|3|||
47062197|NCT00423722|83342885|FG000|Overall Study|Death|4|||
47062198|NCT00423722|83342886|FG001|Overall Study|Death|4|||
47062199|NCT00423722|83342885|FG000|Overall Study|Declined to participate|2|||
47062200|NCT00423722|83342886|FG001|Overall Study|Declined to participate|3|||
47062201|NCT00423722|83342885|FG000|Overall Study|Unable to complete questionnaires|4|||
47062202|NCT00423722|83342886|FG001|Overall Study|Unable to complete questionnaires|4|||
47062203|NCT00423722|83342885|FG000|Overall Study|Withdrawal by Subject|4|||
47062204|NCT00423722|83342886|FG001|Overall Study|Withdrawal by Subject|2|||
47062205|NCT01559311|83342937|FG000|Overall Study|Protocol Violation|0|||
47062206|NCT01559311|83342938|FG001|Overall Study|Protocol Violation|0|||
47062207|NCT01559311|83342939|FG002|Overall Study|Protocol Violation|2|||
46833951|NCT00484289|83051835|FG000|Long Term Phase|Adverse Event|1|||
46833952|NCT00484289|83051836|FG001|Long Term Phase|Adverse Event|17|||
46833953|NCT00484289|83051837|FG002|Long Term Phase|Adverse Event|5|||
46833954|NCT00484289|83051835|FG000|Long Term Phase|Withdrawal by Subject|0|||
46833955|NCT00484289|83051836|FG001|Long Term Phase|Withdrawal by Subject|7|||
46833956|NCT00484289|83051837|FG002|Long Term Phase|Withdrawal by Subject|6|||
46833957|NCT00484289|83051835|FG000|Long Term Phase|Inadequate response|2|||
46833958|NCT00484289|83051836|FG001|Long Term Phase|Inadequate response|7|||
46833959|NCT00484289|83051837|FG002|Long Term Phase|Inadequate response|4|||
46833960|NCT00484289|83051835|FG000|Long Term Phase|Other Reason|0|||
46833961|NCT00484289|83051836|FG001|Long Term Phase|Other Reason|5|||
46833962|NCT00484289|83051837|FG002|Long Term Phase|Other Reason|1|||
46833963|NCT00484289|83051835|FG000|Post Marketing Phase|Adverse Event|0|||
46833964|NCT00484289|83051836|FG001|Post Marketing Phase|Adverse Event|1|||
46833965|NCT00484289|83051837|FG002|Post Marketing Phase|Adverse Event|0|||
46833966|NCT00490529|83051846|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
46833967|NCT00490529|83051846|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
46833968|NCT00490529|83051846|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
46833969|NCT00490529|83051846|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
46833970|NCT00490529|83051846|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
46833971|NCT00490529|83051846|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
46833972|NCT00333840|83051852|FG000|First-line Treatment Period|Adverse Event|38|||
46833973|NCT00333840|83051853|FG001|First-line Treatment Period|Adverse Event|37|||
46833974|NCT00333840|83051854|FG002|First-line Treatment Period|Adverse Event|0|||
46833975|NCT00333840|83051855|FG003|First-line Treatment Period|Adverse Event|0|||
46833976|NCT00333840|83051852|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
46833977|NCT00333840|83051853|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
46833978|NCT00333840|83051854|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
46833979|NCT00333840|83051855|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
46833980|NCT00333840|83051852|FG000|First-line Treatment Period|Abnormal procedure|2|||
46833981|NCT00333840|83051853|FG001|First-line Treatment Period|Abnormal procedure|0|||
46833982|NCT00333840|83051854|FG002|First-line Treatment Period|Abnormal procedure|0|||
47062208|NCT01559311|83342937|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
47062209|NCT01559311|83342938|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
47062210|NCT01559311|83342939|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
47062211|NCT01559311|83342937|FG000|Overall Study|Withdrawal by Subject|2|||
47062212|NCT01559311|83342938|FG001|Overall Study|Withdrawal by Subject|1|||
47062213|NCT01559311|83342939|FG002|Overall Study|Withdrawal by Subject|0|||
47062214|NCT01559311|83342937|FG000|Overall Study|Death|0|||
46637956|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46942374|NCT03985293|83179610|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
47062215|NCT01559311|83342938|FG001|Overall Study|Death|2|||
47062216|NCT01559311|83342939|FG002|Overall Study|Death|3|||
47062217|NCT01559311|83342937|FG000|Overall Study|Lost to Follow-up|0|||
47062218|NCT01559311|83342938|FG001|Overall Study|Lost to Follow-up|3|||
46766542|NCT00847145|82984862|FG003|Overall Study|Lost to Follow-up|0|||
46766543|NCT00847145|82984863|FG004|Overall Study|Lost to Follow-up|4|||
46766544|NCT00847145|82984864|FG005|Overall Study|Lost to Follow-up|4|||
46766545|NCT00847145|82984865|FG006|Overall Study|Lost to Follow-up|8|||
46766546|NCT00847145|82984866|FG007|Overall Study|Lost to Follow-up|2|||
46766547|NCT00847145|82984859|FG000|Overall Study|Inappropriate enrollment|0|||
46766548|NCT00847145|82984860|FG001|Overall Study|Inappropriate enrollment|0|||
46766549|NCT00847145|82984861|FG002|Overall Study|Inappropriate enrollment|0|||
46766550|NCT00847145|82984862|FG003|Overall Study|Inappropriate enrollment|0|||
46766551|NCT00847145|82984863|FG004|Overall Study|Inappropriate enrollment|1|||
46766552|NCT00847145|82984864|FG005|Overall Study|Inappropriate enrollment|0|||
46766553|NCT00847145|82984865|FG006|Overall Study|Inappropriate enrollment|0|||
46766554|NCT00847145|82984866|FG007|Overall Study|Inappropriate enrollment|0|||
46766555|NCT00847145|82984859|FG000|Overall Study|Protocol Violation|0|||
46766556|NCT00847145|82984860|FG001|Overall Study|Protocol Violation|0|||
46833983|NCT00333840|83051855|FG003|First-line Treatment Period|Abnormal procedure|0|||
46833984|NCT00333840|83051852|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
46833985|NCT00333840|83051853|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
46833986|NCT00333840|83051854|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
47062219|NCT01559311|83342939|FG002|Overall Study|Lost to Follow-up|2|||
47062220|NCT01559311|83342937|FG000|Overall Study|Adverse Event|0|||
46766557|NCT00847145|82984861|FG002|Overall Study|Protocol Violation|3|||
46766558|NCT00847145|82984862|FG003|Overall Study|Protocol Violation|0|||
46766559|NCT00847145|82984863|FG004|Overall Study|Protocol Violation|1|||
46766560|NCT00847145|82984864|FG005|Overall Study|Protocol Violation|0|||
46766561|NCT00847145|82984865|FG006|Overall Study|Protocol Violation|0|||
46766562|NCT00847145|82984866|FG007|Overall Study|Protocol Violation|1|||
46766563|NCT00846521|82984893|FG000|Overall Study|Withdrawal by Subject|5|||
46766564|NCT00846521|82984893|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
46766565|NCT00846521|82984893|FG000|Overall Study|Protocol Violation|1|||
46766566|NCT00862823|82984897|FG000|First Intervention|Withdrawal by Subject|1|||
46766567|NCT00862823|82984898|FG001|First Intervention|Withdrawal by Subject|1|||
46766568|NCT00790842|82984906|FG000|Dose Level 1|Adverse Event|1|||
46766569|NCT00790842|82984907|FG001|Dose Level 1|Adverse Event|0|||
46766570|NCT00790842|82984908|FG002|Dose Level 1|Adverse Event|0|||
46766571|NCT00790842|82984909|FG003|Dose Level 1|Adverse Event|2|||
46766572|NCT00790842|82984910|FG004|Dose Level 1|Adverse Event|0|||
46766573|NCT00790842|82984911|FG005|Dose Level 1|Adverse Event|0|||
46766574|NCT00790842|82984912|FG006|Dose Level 1|Adverse Event|0|||
46766575|NCT00790842|82984913|FG007|Dose Level 1|Adverse Event|1|||
46766576|NCT00790842|82984914|FG008|Dose Level 1|Adverse Event|0|||
46766577|NCT00790842|82984915|FG009|Dose Level 1|Adverse Event|0|||
46766578|NCT00790842|82984916|FG010|Dose Level 1|Adverse Event|0|||
46766579|NCT00790842|82984906|FG000|Dose Level 1|Physician Decision|1|||
46766580|NCT00790842|82984907|FG001|Dose Level 1|Physician Decision|0|||
46766581|NCT00790842|82984908|FG002|Dose Level 1|Physician Decision|0|||
46766582|NCT00790842|82984909|FG003|Dose Level 1|Physician Decision|0|||
46766583|NCT00790842|82984910|FG004|Dose Level 1|Physician Decision|0|||
46766584|NCT00790842|82984911|FG005|Dose Level 1|Physician Decision|0|||
46766585|NCT00790842|82984912|FG006|Dose Level 1|Physician Decision|0|||
46766586|NCT00790842|82984913|FG007|Dose Level 1|Physician Decision|1|||
46766587|NCT00790842|82984914|FG008|Dose Level 1|Physician Decision|0|||
46766588|NCT00790842|82984915|FG009|Dose Level 1|Physician Decision|0|||
46766589|NCT00790842|82984916|FG010|Dose Level 1|Physician Decision|0|||
46766590|NCT00790842|82984906|FG000|Dose Level 1|Withdrawal by Subject|1|||
46766591|NCT00790842|82984907|FG001|Dose Level 1|Withdrawal by Subject|0|||
46766592|NCT00790842|82984908|FG002|Dose Level 1|Withdrawal by Subject|0|||
46766593|NCT00790842|82984909|FG003|Dose Level 1|Withdrawal by Subject|0|||
46766594|NCT00790842|82984910|FG004|Dose Level 1|Withdrawal by Subject|0|||
46766595|NCT00790842|82984911|FG005|Dose Level 1|Withdrawal by Subject|0|||
46766596|NCT00790842|82984912|FG006|Dose Level 1|Withdrawal by Subject|0|||
46766597|NCT00790842|82984913|FG007|Dose Level 1|Withdrawal by Subject|0|||
46766598|NCT00790842|82984914|FG008|Dose Level 1|Withdrawal by Subject|0|||
46766599|NCT00790842|82984915|FG009|Dose Level 1|Withdrawal by Subject|0|||
46766600|NCT00790842|82984916|FG010|Dose Level 1|Withdrawal by Subject|0|||
46766601|NCT00790842|82984906|FG000|Dose Level 2|Death|0|||
46766602|NCT00790842|82984907|FG001|Dose Level 2|Death|1|||
46766603|NCT00790842|82984908|FG002|Dose Level 2|Death|0|||
46766604|NCT00790842|82984909|FG003|Dose Level 2|Death|0|||
46766605|NCT00790842|82984910|FG004|Dose Level 2|Death|1|||
46766606|NCT00790842|82984911|FG005|Dose Level 2|Death|0|||
46766607|NCT00790842|82984912|FG006|Dose Level 2|Death|0|||
46766608|NCT00790842|82984913|FG007|Dose Level 2|Death|0|||
46766609|NCT00790842|82984914|FG008|Dose Level 2|Death|0|||
46766610|NCT00790842|82984915|FG009|Dose Level 2|Death|0|||
46766611|NCT00790842|82984916|FG010|Dose Level 2|Death|0|||
46766612|NCT00790842|82984906|FG000|Dose Level 2|Physician Decision|0|||
46766613|NCT00790842|82984907|FG001|Dose Level 2|Physician Decision|1|||
46766614|NCT00790842|82984908|FG002|Dose Level 2|Physician Decision|0|||
46766615|NCT00790842|82984909|FG003|Dose Level 2|Physician Decision|0|||
46766616|NCT00790842|82984910|FG004|Dose Level 2|Physician Decision|0|||
46766617|NCT00790842|82984911|FG005|Dose Level 2|Physician Decision|0|||
46766618|NCT00790842|82984912|FG006|Dose Level 2|Physician Decision|0|||
46766619|NCT00790842|82984913|FG007|Dose Level 2|Physician Decision|0|||
46766620|NCT00790842|82984914|FG008|Dose Level 2|Physician Decision|0|||
46766621|NCT00790842|82984915|FG009|Dose Level 2|Physician Decision|0|||
46766622|NCT00790842|82984916|FG010|Dose Level 2|Physician Decision|0|||
46766623|NCT00790842|82984906|FG000|Dose Level 2|Withdrawal by Subject|0|||
46766624|NCT00790842|82984907|FG001|Dose Level 2|Withdrawal by Subject|1|||
46766625|NCT00790842|82984908|FG002|Dose Level 2|Withdrawal by Subject|0|||
46766626|NCT00790842|82984909|FG003|Dose Level 2|Withdrawal by Subject|0|||
46766627|NCT00790842|82984910|FG004|Dose Level 2|Withdrawal by Subject|0|||
46766628|NCT00790842|82984911|FG005|Dose Level 2|Withdrawal by Subject|0|||
46766629|NCT00790842|82984912|FG006|Dose Level 2|Withdrawal by Subject|0|||
46766630|NCT00790842|82984913|FG007|Dose Level 2|Withdrawal by Subject|0|||
46766631|NCT00790842|82984914|FG008|Dose Level 2|Withdrawal by Subject|0|||
46766632|NCT00790842|82984915|FG009|Dose Level 2|Withdrawal by Subject|0|||
46766633|NCT00790842|82984916|FG010|Dose Level 2|Withdrawal by Subject|0|||
47062221|NCT01559311|83342938|FG001|Overall Study|Adverse Event|0|||
46766634|NCT00790842|82984906|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46766635|NCT00790842|82984907|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46766636|NCT00790842|82984908|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46766637|NCT00790842|82984909|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46766638|NCT00790842|82984910|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46766639|NCT00790842|82984911|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46766640|NCT00790842|82984912|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46766641|NCT00790842|82984913|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46833987|NCT00333840|83051855|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
46833988|NCT00333840|83051852|FG000|First-line Treatment Period|No longer required study drug|21|||
46833989|NCT00333840|83051853|FG001|First-line Treatment Period|No longer required study drug|8|||
46833990|NCT00333840|83051854|FG002|First-line Treatment Period|No longer required study drug|0|||
46833991|NCT00333840|83051855|FG003|First-line Treatment Period|No longer required study drug|0|||
46833992|NCT00333840|83051852|FG000|First-line Treatment Period|Protocol Violation|17|||
46833993|NCT00333840|83051853|FG001|First-line Treatment Period|Protocol Violation|17|||
46833994|NCT00333840|83051854|FG002|First-line Treatment Period|Protocol Violation|0|||
46833995|NCT00333840|83051855|FG003|First-line Treatment Period|Protocol Violation|0|||
46833996|NCT00333840|83051852|FG000|First-line Treatment Period|Subject withdrew consent|57|||
46833997|NCT00333840|83051853|FG001|First-line Treatment Period|Subject withdrew consent|77|||
46833998|NCT00333840|83051854|FG002|First-line Treatment Period|Subject withdrew consent|0|||
46833999|NCT00333840|83051855|FG003|First-line Treatment Period|Subject withdrew consent|0|||
46834000|NCT00333840|83051852|FG000|First-line Treatment Period|Lost to Follow-up|15|||
46834001|NCT00333840|83051853|FG001|First-line Treatment Period|Lost to Follow-up|6|||
46834002|NCT00333840|83051854|FG002|First-line Treatment Period|Lost to Follow-up|0|||
46834003|NCT00333840|83051855|FG003|First-line Treatment Period|Lost to Follow-up|0|||
46834004|NCT00333840|83051852|FG000|First-line Treatment Period|Administrative problems|12|||
46834005|NCT00333840|83051853|FG001|First-line Treatment Period|Administrative problems|6|||
46834006|NCT00333840|83051854|FG002|First-line Treatment Period|Administrative problems|0|||
46834007|NCT00333840|83051855|FG003|First-line Treatment Period|Administrative problems|0|||
46834008|NCT00333840|83051852|FG000|First-line Treatment Period|Death|19|||
46834009|NCT00333840|83051853|FG001|First-line Treatment Period|Death|2|||
46834010|NCT00333840|83051854|FG002|First-line Treatment Period|Death|0|||
46834011|NCT00333840|83051855|FG003|First-line Treatment Period|Death|0|||
46834012|NCT00333840|83051852|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
46834013|NCT00333840|83051853|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
46834014|NCT00333840|83051854|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
46834015|NCT00333840|83051855|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
46834016|NCT00333840|83051852|FG000|Second-line Treatment Period|Adverse Event|0|||
46834017|NCT00333840|83051853|FG001|Second-line Treatment Period|Adverse Event|0|||
46834018|NCT00333840|83051854|FG002|Second-line Treatment Period|Adverse Event|3|||
47062222|NCT01559311|83342939|FG002|Overall Study|Adverse Event|1|||
47062223|NCT01498445|83342962|FG000|Overall Study|Lack of Efficacy|0|||
47062224|NCT01498445|83342963|FG001|Overall Study|Lack of Efficacy|0|||
47062225|NCT01498445|83342964|FG002|Overall Study|Lack of Efficacy|1|||
47062226|NCT01498445|83342965|FG003|Overall Study|Lack of Efficacy|2|||
47062227|NCT01498445|83342966|FG004|Overall Study|Lack of Efficacy|0|||
47062228|NCT01498445|83342967|FG005|Overall Study|Lack of Efficacy|0|||
47062229|NCT01498445|83342962|FG000|Overall Study|Screen Failure|0|||
47062230|NCT01498445|83342963|FG001|Overall Study|Screen Failure|0|||
47062231|NCT01498445|83342964|FG002|Overall Study|Screen Failure|0|||
47062232|NCT01498445|83342965|FG003|Overall Study|Screen Failure|0|||
47062233|NCT01498445|83342966|FG004|Overall Study|Screen Failure|1|||
47062234|NCT01498445|83342967|FG005|Overall Study|Screen Failure|1|||
47062235|NCT01558297|83342984|FG000|Overall Study|Withdrawal by Subject|2|||
47062236|NCT01558297|83342985|FG001|Overall Study|Withdrawal by Subject|2|||
47062237|NCT01558297|83342986|FG002|Overall Study|Withdrawal by Subject|1|||
47062238|NCT01525849|83342996|FG000|Overall Study|Lost to Follow-up|3|||
47062239|NCT01525849|83342997|FG001|Overall Study|Lost to Follow-up|2|||
46637957|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766642|NCT00790842|82984914|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
46766643|NCT00790842|82984915|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
47062240|NCT01525849|83342996|FG000|Overall Study|Withdrawal by Subject|1|||
46637958|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766644|NCT00790842|82984916|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
46834019|NCT00333840|83051855|FG003|Second-line Treatment Period|Adverse Event|34|||
46834020|NCT00333840|83051852|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
46834021|NCT00333840|83051853|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
47062241|NCT01525849|83342997|FG001|Overall Study|Withdrawal by Subject|9|||
47062242|NCT01525849|83342996|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
47062243|NCT01525849|83342997|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
47062244|NCT01525849|83342996|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
46834022|NCT00333840|83051854|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
46834023|NCT00333840|83051855|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
46834024|NCT00333840|83051852|FG000|Second-line Treatment Period|Abnormal procedure|0|||
46834025|NCT00333840|83051853|FG001|Second-line Treatment Period|Abnormal procedure|0|||
46834026|NCT00333840|83051854|FG002|Second-line Treatment Period|Abnormal procedure|0|||
46834027|NCT00333840|83051855|FG003|Second-line Treatment Period|Abnormal procedure|1|||
46834028|NCT00333840|83051852|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
46834029|NCT00333840|83051853|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
46834030|NCT00333840|83051854|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
46834031|NCT00333840|83051855|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
46834032|NCT00333840|83051852|FG000|Second-line Treatment Period|No longer required study drug|0|||
46834033|NCT00333840|83051853|FG001|Second-line Treatment Period|No longer required study drug|0|||
46834034|NCT00333840|83051854|FG002|Second-line Treatment Period|No longer required study drug|1|||
46834035|NCT00333840|83051855|FG003|Second-line Treatment Period|No longer required study drug|14|||
46834036|NCT00333840|83051852|FG000|Second-line Treatment Period|Protocol Violation|0|||
46834037|NCT00333840|83051853|FG001|Second-line Treatment Period|Protocol Violation|0|||
46834038|NCT00333840|83051854|FG002|Second-line Treatment Period|Protocol Violation|1|||
46766645|NCT00790842|82984906|FG000|Dose Level 3|Adverse Event|0|||
46834039|NCT00333840|83051855|FG003|Second-line Treatment Period|Protocol Violation|10|||
46834040|NCT00333840|83051852|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
46834041|NCT00333840|83051853|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
47062245|NCT01525849|83342997|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
47062246|NCT01525615|83343016|FG000|Overall Study|Adverse Event|11|||
47062247|NCT01525615|83343017|FG001|Overall Study|Adverse Event|7|||
46766646|NCT00790842|82984907|FG001|Dose Level 3|Adverse Event|0|||
47062248|NCT01525615|83343018|FG002|Overall Study|Adverse Event|5|||
47062249|NCT01525615|83343016|FG000|Overall Study|Lost to Follow-up|1|||
47062250|NCT01525615|83343017|FG001|Overall Study|Lost to Follow-up|0|||
47062251|NCT01525615|83343018|FG002|Overall Study|Lost to Follow-up|0|||
47062252|NCT01525615|83343016|FG000|Overall Study|Withdrawal by Subject|1|||
46766647|NCT00790842|82984908|FG002|Dose Level 3|Adverse Event|1|||
46766648|NCT00790842|82984909|FG003|Dose Level 3|Adverse Event|0|||
46766649|NCT00790842|82984910|FG004|Dose Level 3|Adverse Event|0|||
46766650|NCT00790842|82984911|FG005|Dose Level 3|Adverse Event|0|||
46766651|NCT00790842|82984912|FG006|Dose Level 3|Adverse Event|0|||
46766652|NCT00790842|82984913|FG007|Dose Level 3|Adverse Event|0|||
46766653|NCT00790842|82984914|FG008|Dose Level 3|Adverse Event|0|||
46766654|NCT00790842|82984915|FG009|Dose Level 3|Adverse Event|0|||
46766655|NCT00790842|82984916|FG010|Dose Level 3|Adverse Event|0|||
46766656|NCT00790842|82984906|FG000|Dose Level 3|Withdrawal by Subject|0|||
46766657|NCT00790842|82984907|FG001|Dose Level 3|Withdrawal by Subject|0|||
46766658|NCT00790842|82984908|FG002|Dose Level 3|Withdrawal by Subject|3|||
46766659|NCT00790842|82984909|FG003|Dose Level 3|Withdrawal by Subject|0|||
46766660|NCT00790842|82984910|FG004|Dose Level 3|Withdrawal by Subject|0|||
46766661|NCT00790842|82984911|FG005|Dose Level 3|Withdrawal by Subject|0|||
46766662|NCT00790842|82984912|FG006|Dose Level 3|Withdrawal by Subject|0|||
46766663|NCT00790842|82984913|FG007|Dose Level 3|Withdrawal by Subject|0|||
46766664|NCT00790842|82984914|FG008|Dose Level 3|Withdrawal by Subject|0|||
46766665|NCT00790842|82984915|FG009|Dose Level 3|Withdrawal by Subject|2|||
46766666|NCT00790842|82984916|FG010|Dose Level 3|Withdrawal by Subject|0|||
46766667|NCT00790842|82984906|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766668|NCT00790842|82984907|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766669|NCT00790842|82984908|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766670|NCT00790842|82984909|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766671|NCT00790842|82984910|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766672|NCT00790842|82984911|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
46766673|NCT00790842|82984912|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766674|NCT00790842|82984913|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766675|NCT00790842|82984914|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766676|NCT00790842|82984915|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766677|NCT00790842|82984916|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
46766678|NCT00790842|82984906|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
47062253|NCT01525615|83343017|FG001|Overall Study|Withdrawal by Subject|0|||
47062254|NCT01525615|83343018|FG002|Overall Study|Withdrawal by Subject|0|||
46766679|NCT00790842|82984907|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766680|NCT00790842|82984908|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
46766681|NCT00790842|82984909|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766682|NCT00790842|82984910|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766683|NCT00790842|82984911|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766684|NCT00790842|82984912|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766685|NCT00790842|82984913|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766686|NCT00790842|82984914|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766687|NCT00790842|82984915|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46766688|NCT00790842|82984916|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
46637959|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46637960|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46637961|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46637962|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
47062255|NCT01525615|83343016|FG000|Overall Study|Other reason not described above|1|||
47062256|NCT01525615|83343017|FG001|Overall Study|Other reason not described above|0|||
47062257|NCT01525615|83343018|FG002|Overall Study|Other reason not described above|1|||
47062258|NCT01525225|83343060|FG000|Enrollment|No longer met study criteria|1|||
47062259|NCT01525225|83343060|FG000|Enrollment|Other|1|||
47062260|NCT01524991|83343077|FG000|Overall Study|Adverse Event|12|||
47062261|NCT01524991|83343077|FG000|Overall Study|Death|1|||
47062262|NCT01524991|83343077|FG000|Overall Study|Disease ProgressionDu|17|||
47062263|NCT01524991|83343077|FG000|Overall Study|Other complicating disease|1|||
46637963|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766689|NCT00790842|82984906|FG000|Dose Level 4|Adverse Event|0|||
46766690|NCT00790842|82984907|FG001|Dose Level 4|Adverse Event|0|||
46766691|NCT00790842|82984908|FG002|Dose Level 4|Adverse Event|0|||
46766692|NCT00790842|82984909|FG003|Dose Level 4|Adverse Event|0|||
46766693|NCT00790842|82984910|FG004|Dose Level 4|Adverse Event|0|||
46766694|NCT00790842|82984911|FG005|Dose Level 4|Adverse Event|0|||
46766695|NCT00790842|82984912|FG006|Dose Level 4|Adverse Event|1|||
46766696|NCT00790842|82984913|FG007|Dose Level 4|Adverse Event|0|||
46766697|NCT00790842|82984914|FG008|Dose Level 4|Adverse Event|0|||
46766698|NCT00790842|82984915|FG009|Dose Level 4|Adverse Event|0|||
46766699|NCT00790842|82984916|FG010|Dose Level 4|Adverse Event|0|||
46766700|NCT00790842|82984906|FG000|Dose Level 4|Physician Decision|0|||
46766701|NCT00790842|82984907|FG001|Dose Level 4|Physician Decision|0|||
46766702|NCT00790842|82984908|FG002|Dose Level 4|Physician Decision|0|||
46834042|NCT00333840|83051854|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
46834043|NCT00333840|83051855|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
46834044|NCT00333840|83051852|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
46834045|NCT00333840|83051853|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
46834046|NCT00333840|83051854|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
46834047|NCT00333840|83051855|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
46834048|NCT00333840|83051852|FG000|Second-line Treatment Period|Administrative problems|0|||
46834049|NCT00333840|83051853|FG001|Second-line Treatment Period|Administrative problems|0|||
46834050|NCT00333840|83051854|FG002|Second-line Treatment Period|Administrative problems|0|||
46834051|NCT00333840|83051855|FG003|Second-line Treatment Period|Administrative problems|7|||
46637964|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46637965|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766703|NCT00790842|82984909|FG003|Dose Level 4|Physician Decision|0|||
46766704|NCT00790842|82984910|FG004|Dose Level 4|Physician Decision|0|||
46834052|NCT00333840|83051852|FG000|Second-line Treatment Period|Death|0|||
46834053|NCT00333840|83051853|FG001|Second-line Treatment Period|Death|0|||
46834054|NCT00333840|83051854|FG002|Second-line Treatment Period|Death|0|||
46834055|NCT00333840|83051855|FG003|Second-line Treatment Period|Death|9|||
46834056|NCT00490451|83051871|FG000|Overall Study|Adverse Event|3|||
46834057|NCT00490451|83051872|FG001|Overall Study|Adverse Event|3|||
46834058|NCT00490451|83051871|FG000|Overall Study|Death|3|||
46834059|NCT00490451|83051872|FG001|Overall Study|Death|1|||
46834060|NCT00490451|83051871|FG000|Overall Study|Withdrawal by Subject|2|||
46834061|NCT00490451|83051872|FG001|Overall Study|Withdrawal by Subject|0|||
46834062|NCT00490451|83051871|FG000|Overall Study|Investigator Decision|1|||
46637966|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766705|NCT00790842|82984911|FG005|Dose Level 4|Physician Decision|0|||
46834063|NCT00490451|83051872|FG001|Overall Study|Investigator Decision|0|||
46834064|NCT00490451|83051871|FG000|Overall Study|Protocol Violation|1|||
46834065|NCT00490451|83051872|FG001|Overall Study|Protocol Violation|0|||
46834066|NCT00490451|83051871|FG000|Overall Study|Progressive Disease|53|||
47062264|NCT01524991|83343077|FG000|Overall Study|Withdrawal by Subject|2|||
46766706|NCT00790842|82984912|FG006|Dose Level 4|Physician Decision|1|||
46766707|NCT00790842|82984913|FG007|Dose Level 4|Physician Decision|0|||
46766708|NCT00790842|82984914|FG008|Dose Level 4|Physician Decision|0|||
47062265|NCT01524991|83343077|FG000|Overall Study|Symptomatic Deterioration|1|||
47062266|NCT01524913|83343084|FG000|Overall Study|Lost to Follow-up|4|||
46766709|NCT00790842|82984915|FG009|Dose Level 4|Physician Decision|0|||
46834067|NCT00490451|83051872|FG001|Overall Study|Progressive Disease|34|||
46834068|NCT00321906|83051880|FG000|Overall Study|Adverse Event|36|||
46834069|NCT00321906|83051881|FG001|Overall Study|Adverse Event|44|||
46834070|NCT00321906|83051880|FG000|Overall Study|Death|9|||
46834071|NCT00321906|83051881|FG001|Overall Study|Death|6|||
46834072|NCT00321906|83051880|FG000|Overall Study|Lost to Follow-up|1|||
46834073|NCT00321906|83051881|FG001|Overall Study|Lost to Follow-up|2|||
46834074|NCT00321906|83051880|FG000|Overall Study|Withdrawal by Subject|0|||
46834075|NCT00321906|83051881|FG001|Overall Study|Withdrawal by Subject|4|||
46834076|NCT00339144|83051890|FG000|Overall Study|Disease progression|5|||
46834077|NCT00339144|83051891|FG001|Overall Study|Disease progression|2|||
46834078|NCT00339144|83051892|FG002|Overall Study|Disease progression|2|||
46834079|NCT00339144|83051890|FG000|Overall Study|Study drug toxicity|3|||
46834080|NCT00339144|83051891|FG001|Overall Study|Study drug toxicity|1|||
46834081|NCT00339144|83051892|FG002|Overall Study|Study drug toxicity|1|||
46834082|NCT00339144|83051890|FG000|Overall Study|Participant's request to discontinuation|1|||
46834083|NCT00339144|83051891|FG001|Overall Study|Participant's request to discontinuation|0|||
46834084|NCT00339144|83051892|FG002|Overall Study|Participant's request to discontinuation|1|||
46834085|NCT00321828|83051901|FG000|Overall Study|Ineligible|3|||
46834086|NCT00321828|83051901|FG000|Overall Study|No follow up data|1|||
46834087|NCT00333138|83051908|FG000|Core Study (6 Months)|Adverse Event|4|||
46834088|NCT00333138|83051909|FG001|Core Study (6 Months)|Adverse Event|5|||
46834089|NCT00333138|83051910|FG002|Core Study (6 Months)|Adverse Event|8|||
46834090|NCT00333138|83051908|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
46834091|NCT00333138|83051909|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
46834092|NCT00333138|83051910|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
46834093|NCT00333138|83051908|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
46834094|NCT00333138|83051909|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
46834095|NCT00333138|83051910|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
46834096|NCT00333138|83051908|FG000|Core Study (6 Months)|Protocol Violation|1|||
46834097|NCT00333138|83051909|FG001|Core Study (6 Months)|Protocol Violation|0|||
46834098|NCT00333138|83051910|FG002|Core Study (6 Months)|Protocol Violation|1|||
46834099|NCT00333138|83051908|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
46834100|NCT00333138|83051909|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
46834101|NCT00333138|83051910|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
46834102|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
46834103|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
46834104|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
46834105|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
46834106|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
46834107|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
46834108|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
46834109|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
46834110|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
46834111|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
46834112|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
46834113|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
46834114|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
46834115|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
46834116|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
46834117|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
46834118|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
46834119|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
46834120|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
46834121|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
46834122|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
46834123|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
46834124|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
46834125|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
46942375|NCT03985293|83179605|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
46766710|NCT00790842|82984916|FG010|Dose Level 4|Physician Decision|1|||
46766711|NCT00790842|82984906|FG000|Dose Level 4|Withdrawal by Subject|0|||
46766712|NCT00790842|82984907|FG001|Dose Level 4|Withdrawal by Subject|0|||
46766713|NCT00790842|82984908|FG002|Dose Level 4|Withdrawal by Subject|0|||
46766714|NCT00790842|82984909|FG003|Dose Level 4|Withdrawal by Subject|0|||
46766715|NCT00790842|82984910|FG004|Dose Level 4|Withdrawal by Subject|0|||
46766716|NCT00790842|82984911|FG005|Dose Level 4|Withdrawal by Subject|0|||
46766717|NCT00790842|82984912|FG006|Dose Level 4|Withdrawal by Subject|0|||
46766718|NCT00790842|82984913|FG007|Dose Level 4|Withdrawal by Subject|0|||
46834126|NCT00333138|83051908|FG000|Extension Study (Month6 to End of Study)|Death|0|||
46766719|NCT00790842|82984914|FG008|Dose Level 4|Withdrawal by Subject|0|||
46766720|NCT00790842|82984915|FG009|Dose Level 4|Withdrawal by Subject|0|||
46766721|NCT00790842|82984916|FG010|Dose Level 4|Withdrawal by Subject|1|||
46834127|NCT00333138|83051909|FG001|Extension Study (Month6 to End of Study)|Death|1|||
46834128|NCT00333138|83051910|FG002|Extension Study (Month6 to End of Study)|Death|0|||
46834129|NCT00332202|83051922|FG000|Overall Study|Adverse Event|72|||
46834130|NCT00332202|83051923|FG001|Overall Study|Adverse Event|28|||
46834131|NCT00332202|83051922|FG000|Overall Study|Lost to Follow-up|2|||
46834132|NCT00332202|83051923|FG001|Overall Study|Lost to Follow-up|1|||
46834133|NCT00332202|83051922|FG000|Overall Study|Physician Decision|6|||
46834134|NCT00332202|83051923|FG001|Overall Study|Physician Decision|8|||
46834135|NCT00332202|83051922|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
47062267|NCT01524913|83343085|FG001|Overall Study|Lost to Follow-up|0|||
47062268|NCT01524913|83343086|FG002|Overall Study|Lost to Follow-up|0|||
47062269|NCT01524679|83343096|FG000|Overall Study|Lost to Follow-up|1|||
47062270|NCT01524679|83343097|FG001|Overall Study|Lost to Follow-up|4|||
47062271|NCT01524679|83343096|FG000|Overall Study|Withdrawal by Subject|4|||
47062272|NCT01524679|83343097|FG001|Overall Study|Withdrawal by Subject|4|||
46637967|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766722|NCT00790842|82984906|FG000|Expansion Cohort|Adverse Event|0|||
46942376|NCT03985293|83179606|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
46942377|NCT03985293|83179607|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
46942378|NCT03985293|83179608|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
46942379|NCT03985293|83179609|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
46942380|NCT03985293|83179610|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
46942381|NCT03985293|83179605|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
46942382|NCT03985293|83179606|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
46942383|NCT03985293|83179607|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
46942384|NCT03985293|83179608|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
46942385|NCT03985293|83179609|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
46942386|NCT03985293|83179610|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
46766723|NCT00790842|82984907|FG001|Expansion Cohort|Adverse Event|0|||
46766724|NCT00790842|82984908|FG002|Expansion Cohort|Adverse Event|0|||
46766725|NCT00790842|82984909|FG003|Expansion Cohort|Adverse Event|0|||
46766726|NCT00790842|82984910|FG004|Expansion Cohort|Adverse Event|0|||
46766727|NCT00790842|82984911|FG005|Expansion Cohort|Adverse Event|0|||
46766728|NCT00790842|82984912|FG006|Expansion Cohort|Adverse Event|1|||
46766729|NCT00790842|82984913|FG007|Expansion Cohort|Adverse Event|0|||
46766730|NCT00790842|82984914|FG008|Expansion Cohort|Adverse Event|0|||
46766731|NCT00790842|82984915|FG009|Expansion Cohort|Adverse Event|0|||
46766732|NCT00790842|82984916|FG010|Expansion Cohort|Adverse Event|0|||
46766733|NCT00790842|82984906|FG000|Expansion Cohort|Death|0|||
46766734|NCT00790842|82984907|FG001|Expansion Cohort|Death|0|||
46766735|NCT00790842|82984908|FG002|Expansion Cohort|Death|2|||
46834136|NCT00332202|83051923|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
46834137|NCT00332202|83051922|FG000|Overall Study|Protocol Violation|7|||
46766736|NCT00790842|82984909|FG003|Expansion Cohort|Death|0|||
46766737|NCT00790842|82984910|FG004|Expansion Cohort|Death|0|||
46766738|NCT00790842|82984911|FG005|Expansion Cohort|Death|0|||
46766739|NCT00790842|82984912|FG006|Expansion Cohort|Death|0|||
46834138|NCT00332202|83051923|FG001|Overall Study|Protocol Violation|2|||
46834139|NCT00332202|83051922|FG000|Overall Study|Sponsor Decision|1|||
46834140|NCT00332202|83051923|FG001|Overall Study|Sponsor Decision|2|||
46834141|NCT00332202|83051922|FG000|Overall Study|Withdrawal by Subject|36|||
46834142|NCT00332202|83051923|FG001|Overall Study|Withdrawal by Subject|17|||
46834143|NCT00332202|83051922|FG000|Overall Study|Progressive Disease|106|||
46942387|NCT03985293|83179605|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
46942388|NCT03985293|83179606|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
46942389|NCT03985293|83179607|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
46942390|NCT03985293|83179608|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
46942391|NCT03985293|83179609|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
46637968|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
47062273|NCT01524679|83343096|FG000|Overall Study|Adverse Event|9|||
46637969|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46766740|NCT00790842|82984913|FG007|Expansion Cohort|Death|0|||
46766741|NCT00790842|82984914|FG008|Expansion Cohort|Death|0|||
46766742|NCT00790842|82984915|FG009|Expansion Cohort|Death|0|||
46834144|NCT00332202|83051923|FG001|Overall Study|Progressive Disease|60|||
46834145|NCT00332202|83051922|FG000|Overall Study|Death|5|||
46834146|NCT00332202|83051923|FG001|Overall Study|Death|2|||
46834147|NCT00331422|83051938|FG000|Overall Study|Did not receive entire study regimen|5|||
46834148|NCT00331344|83051943|FG000|Phase I|Adverse Event|0|||
46834149|NCT00331344|83051944|FG001|Phase I|Adverse Event|0|||
46834150|NCT00331344|83051945|FG002|Phase I|Adverse Event|0|||
46834151|NCT00331344|83051946|FG003|Phase I|Adverse Event|1|||
46766743|NCT00790842|82984916|FG010|Expansion Cohort|Death|0|||
46766744|NCT00790842|82984906|FG000|Expansion Cohort|Physician Decision|0|||
46834152|NCT00331344|83051947|FG004|Phase I|Adverse Event|2|||
46834153|NCT00331344|83051948|FG005|Phase I|Adverse Event|2|||
46834154|NCT00331344|83051949|FG006|Phase I|Adverse Event|0|||
46834155|NCT00331344|83051950|FG007|Phase I|Adverse Event|1|||
46834156|NCT00331344|83051951|FG008|Phase I|Adverse Event|0|||
46834157|NCT00331344|83051943|FG000|Phase II|Death|0|||
46834158|NCT00331344|83051944|FG001|Phase II|Death|0|||
46834159|NCT00331344|83051945|FG002|Phase II|Death|0|||
46834160|NCT00331344|83051946|FG003|Phase II|Death|0|||
46834161|NCT00331344|83051947|FG004|Phase II|Death|0|||
46834162|NCT00331344|83051948|FG005|Phase II|Death|0|||
46834163|NCT00331344|83051949|FG006|Phase II|Death|0|||
46834164|NCT00331344|83051950|FG007|Phase II|Death|0|||
46834165|NCT00331344|83051951|FG008|Phase II|Death|4|||
46942392|NCT03985293|83179610|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
46942393|NCT03985293|83179605|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
46942394|NCT03985293|83179606|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
46942395|NCT03985293|83179607|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
46942396|NCT03985293|83179608|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
47062274|NCT01524679|83343097|FG001|Overall Study|Adverse Event|0|||
47062275|NCT01524679|83343096|FG000|Overall Study|Protocol Violation|1|||
47062276|NCT01524679|83343097|FG001|Overall Study|Protocol Violation|0|||
47062277|NCT01524679|83343096|FG000|Overall Study|Lack of Efficacy|2|||
47062278|NCT01524679|83343097|FG001|Overall Study|Lack of Efficacy|0|||
47062279|NCT01524679|83343096|FG000|Overall Study|e.g.wish for children, relocation|6|||
47062280|NCT01524679|83343097|FG001|Overall Study|e.g.wish for children, relocation|1|||
47062281|NCT01524289|83343114|FG000|Overall Study|Lost to Follow-up|0|||
47062282|NCT01524289|83343115|FG001|Overall Study|Lost to Follow-up|1|||
47062283|NCT01524289|83343114|FG000|Overall Study|Physician Decision|1|||
46766745|NCT00790842|82984907|FG001|Expansion Cohort|Physician Decision|0|||
46766746|NCT00790842|82984908|FG002|Expansion Cohort|Physician Decision|1|||
46766747|NCT00790842|82984909|FG003|Expansion Cohort|Physician Decision|0|||
46766748|NCT00790842|82984910|FG004|Expansion Cohort|Physician Decision|0|||
46766749|NCT00790842|82984911|FG005|Expansion Cohort|Physician Decision|0|||
46766750|NCT00790842|82984912|FG006|Expansion Cohort|Physician Decision|0|||
46766751|NCT00790842|82984913|FG007|Expansion Cohort|Physician Decision|0|||
46766752|NCT00790842|82984914|FG008|Expansion Cohort|Physician Decision|0|||
46766753|NCT00790842|82984915|FG009|Expansion Cohort|Physician Decision|0|||
46766754|NCT00790842|82984916|FG010|Expansion Cohort|Physician Decision|0|||
46766755|NCT00790842|82984906|FG000|Expansion Cohort|Withdrawal by Subject|0|||
46766756|NCT00790842|82984907|FG001|Expansion Cohort|Withdrawal by Subject|0|||
46766757|NCT00790842|82984908|FG002|Expansion Cohort|Withdrawal by Subject|3|||
46766758|NCT00790842|82984909|FG003|Expansion Cohort|Withdrawal by Subject|0|||
46766759|NCT00790842|82984910|FG004|Expansion Cohort|Withdrawal by Subject|0|||
46766760|NCT00790842|82984911|FG005|Expansion Cohort|Withdrawal by Subject|0|||
46766761|NCT00790842|82984912|FG006|Expansion Cohort|Withdrawal by Subject|0|||
46766762|NCT00790842|82984913|FG007|Expansion Cohort|Withdrawal by Subject|0|||
46834166|NCT00321672|83051968|FG000|Overall Study|Withdrawal by Subject|5|||
46834167|NCT00321672|83051969|FG001|Overall Study|Withdrawal by Subject|1|||
46834168|NCT00321672|83051970|FG002|Overall Study|Withdrawal by Subject|2|||
46834169|NCT00321672|83051971|FG003|Overall Study|Withdrawal by Subject|0|||
46834170|NCT00321672|83051968|FG000|Overall Study|Noncompliance|1|||
46834171|NCT00321672|83051969|FG001|Overall Study|Noncompliance|2|||
46834172|NCT00321672|83051970|FG002|Overall Study|Noncompliance|1|||
46834173|NCT00321672|83051971|FG003|Overall Study|Noncompliance|0|||
46834174|NCT00321672|83051968|FG000|Overall Study|Adverse Event|1|||
47062284|NCT01524289|83343115|FG001|Overall Study|Physician Decision|0|||
47062285|NCT01524289|83343114|FG000|Overall Study|Protocol Violation|5|||
46766763|NCT00790842|82984914|FG008|Expansion Cohort|Withdrawal by Subject|0|||
46766764|NCT00790842|82984915|FG009|Expansion Cohort|Withdrawal by Subject|0|||
46766765|NCT00790842|82984916|FG010|Expansion Cohort|Withdrawal by Subject|0|||
46766766|NCT00790842|82984906|FG000|Expansion Cohort|Study Closure|0|||
46766767|NCT00790842|82984907|FG001|Expansion Cohort|Study Closure|0|||
46766768|NCT00790842|82984908|FG002|Expansion Cohort|Study Closure|1|||
46766769|NCT00790842|82984909|FG003|Expansion Cohort|Study Closure|0|||
46766770|NCT00790842|82984910|FG004|Expansion Cohort|Study Closure|0|||
46766771|NCT00790842|82984911|FG005|Expansion Cohort|Study Closure|0|||
46766772|NCT00790842|82984912|FG006|Expansion Cohort|Study Closure|0|||
46766773|NCT00790842|82984913|FG007|Expansion Cohort|Study Closure|0|||
46766774|NCT00790842|82984914|FG008|Expansion Cohort|Study Closure|0|||
46766775|NCT00790842|82984915|FG009|Expansion Cohort|Study Closure|0|||
46834175|NCT00321672|83051969|FG001|Overall Study|Adverse Event|1|||
46834176|NCT00321672|83051970|FG002|Overall Study|Adverse Event|0|||
46834177|NCT00321672|83051971|FG003|Overall Study|Adverse Event|0|||
46834178|NCT00321672|83051968|FG000|Overall Study|Lack of Efficacy|1|||
46834179|NCT00321672|83051969|FG001|Overall Study|Lack of Efficacy|1|||
46834180|NCT00321672|83051970|FG002|Overall Study|Lack of Efficacy|0|||
46942397|NCT03985293|83179609|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
46942398|NCT03985293|83179610|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
46942399|NCT03985293|83179605|FG000|FOLLOW-UP|Lost to Follow-up|0|||
46942400|NCT03985293|83179606|FG001|FOLLOW-UP|Lost to Follow-up|0|||
46942401|NCT03985293|83179607|FG002|FOLLOW-UP|Lost to Follow-up|1|||
46942402|NCT03985293|83179608|FG003|FOLLOW-UP|Lost to Follow-up|0|||
46942403|NCT03985293|83179609|FG004|FOLLOW-UP|Lost to Follow-up|0|||
46942404|NCT03985293|83179610|FG005|FOLLOW-UP|Lost to Follow-up|0|||
46942405|NCT03654755|83179627|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
46942406|NCT03654755|83179628|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
46766776|NCT00790842|82984916|FG010|Expansion Cohort|Study Closure|0|||
46766777|NCT00574288|82984971|FG000|Overall Study|Adverse Event|2|||
46766778|NCT00574288|82984972|FG001|Overall Study|Adverse Event|0|||
46766779|NCT00574288|82984973|FG002|Overall Study|Adverse Event|0|||
46766780|NCT00574288|82984974|FG003|Overall Study|Adverse Event|0|||
46766781|NCT00574288|82984975|FG004|Overall Study|Adverse Event|1|||
46766782|NCT00574288|82984976|FG005|Overall Study|Adverse Event|0|||
46766783|NCT00574288|82984977|FG006|Overall Study|Adverse Event|0|||
46766784|NCT00574288|82984971|FG000|Overall Study|Death|0|||
46766785|NCT00574288|82984972|FG001|Overall Study|Death|0|||
46766786|NCT00574288|82984973|FG002|Overall Study|Death|0|||
46766787|NCT00574288|82984974|FG003|Overall Study|Death|0|||
46766788|NCT00574288|82984975|FG004|Overall Study|Death|0|||
46766789|NCT00574288|82984976|FG005|Overall Study|Death|25|||
46766790|NCT00574288|82984977|FG006|Overall Study|Death|21|||
46834181|NCT00321672|83051971|FG003|Overall Study|Lack of Efficacy|0|||
46834182|NCT00321672|83051968|FG000|Overall Study|Lost to Follow-up|2|||
46942407|NCT03654755|83179629|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
46942408|NCT03654755|83179627|FG000|Overall Study|Withdrawal by Subject|2|||
46942409|NCT03654755|83179628|FG001|Overall Study|Withdrawal by Subject|4|||
46942410|NCT03654755|83179629|FG002|Overall Study|Withdrawal by Subject|8|||
46942411|NCT03654755|83179627|FG000|Overall Study|Lost to Follow-up|1|||
46942412|NCT03654755|83179628|FG001|Overall Study|Lost to Follow-up|3|||
47062286|NCT01524289|83343115|FG001|Overall Study|Protocol Violation|1|||
47062287|NCT01524289|83343114|FG000|Overall Study|Withdrawal by Subject|11|||
47062288|NCT01524289|83343115|FG001|Overall Study|Withdrawal by Subject|7|||
47062289|NCT01524289|83343114|FG000|Overall Study|Adverse Event|12|||
47062290|NCT01524289|83343115|FG001|Overall Study|Adverse Event|5|||
47062291|NCT01524289|83343114|FG000|Overall Study|Did not take study medication|1|||
47062292|NCT01524289|83343115|FG001|Overall Study|Did not take study medication|0|||
47062293|NCT01498289|83343125|FG000|Overall Study|Adverse Event|16|||
47062294|NCT01498289|83343126|FG001|Overall Study|Adverse Event|18|||
47062295|NCT01498289|83343125|FG000|Overall Study|Death|6|||
47062296|NCT01498289|83343126|FG001|Overall Study|Death|8|||
47062297|NCT01498289|83343125|FG000|Overall Study|Withdrawal unrelated to AE|16|||
47062298|NCT01498289|83343126|FG001|Overall Study|Withdrawal unrelated to AE|16|||
47062299|NCT01498289|83343125|FG000|Overall Study|Progression/relapse|53|||
47062300|NCT01498289|83343126|FG001|Overall Study|Progression/relapse|59|||
47062301|NCT01498289|83343125|FG000|Overall Study|Not protocol specified|7|||
46766791|NCT00574288|82984971|FG000|Overall Study|Lost to Follow-up|0|||
46942413|NCT03654755|83179629|FG002|Overall Study|Lost to Follow-up|7|||
46766792|NCT00574288|82984972|FG001|Overall Study|Lost to Follow-up|0|||
46766793|NCT00574288|82984973|FG002|Overall Study|Lost to Follow-up|0|||
46766794|NCT00574288|82984974|FG003|Overall Study|Lost to Follow-up|0|||
46766795|NCT00574288|82984975|FG004|Overall Study|Lost to Follow-up|0|||
47062302|NCT01498289|83343126|FG001|Overall Study|Not protocol specified|2|||
47062303|NCT01498289|83343125|FG000|Overall Study|Reason under review|0|||
46766796|NCT00574288|82984976|FG005|Overall Study|Lost to Follow-up|1|||
46766797|NCT00574288|82984977|FG006|Overall Study|Lost to Follow-up|2|||
47062304|NCT01498289|83343126|FG001|Overall Study|Reason under review|1|||
47062305|NCT01524133|83343139|FG000|Treatment Phase|Withdrawal by Subject|13|||
46637970|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
46637971|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
46637972|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
46637973|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
46637974|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
46637975|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
46637976|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
46637977|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
46637978|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
46637979|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
46637980|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
46637981|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
46637982|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
46637983|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
46637984|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
46637985|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
46637986|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
46637987|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
46766798|NCT00574288|82984971|FG000|Overall Study|Study Terminated By Sponsor|0|||
46766799|NCT00574288|82984972|FG001|Overall Study|Study Terminated By Sponsor|0|||
46766800|NCT00574288|82984973|FG002|Overall Study|Study Terminated By Sponsor|0|||
46766801|NCT00574288|82984974|FG003|Overall Study|Study Terminated By Sponsor|0|||
46766802|NCT00574288|82984975|FG004|Overall Study|Study Terminated By Sponsor|0|||
46766803|NCT00574288|82984976|FG005|Overall Study|Study Terminated By Sponsor|0|||
46766804|NCT00574288|82984977|FG006|Overall Study|Study Terminated By Sponsor|5|||
46766805|NCT00574288|82984971|FG000|Overall Study|Progressive Disease|17|||
46766806|NCT00574288|82984972|FG001|Overall Study|Progressive Disease|2|||
46766807|NCT00574288|82984973|FG002|Overall Study|Progressive Disease|3|||
46766808|NCT00574288|82984974|FG003|Overall Study|Progressive Disease|2|||
46766809|NCT00574288|82984975|FG004|Overall Study|Progressive Disease|1|||
46766810|NCT00574288|82984976|FG005|Overall Study|Progressive Disease|0|||
46766811|NCT00574288|82984977|FG006|Overall Study|Progressive Disease|0|||
46766812|NCT00574288|82984971|FG000|Overall Study|Other|1|||
46766813|NCT00574288|82984972|FG001|Overall Study|Other|1|||
46766814|NCT00574288|82984973|FG002|Overall Study|Other|0|||
46766815|NCT00574288|82984974|FG003|Overall Study|Other|0|||
46766816|NCT00574288|82984975|FG004|Overall Study|Other|0|||
46637988|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
46637989|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
46766817|NCT00574288|82984976|FG005|Overall Study|Other|0|||
46766818|NCT00574288|82984977|FG006|Overall Study|Other|0|||
46766819|NCT00790452|82985005|FG000|Overall Study|Drug supply issue|1|||
46766820|NCT00790452|82985006|FG001|Overall Study|Drug supply issue|0|||
46766821|NCT00626392|82985018|FG000|Run-in Period|Adverse Event|0|||
46766822|NCT00626392|82985019|FG001|Run-in Period|Adverse Event|0|||
46834183|NCT00321672|83051969|FG001|Overall Study|Lost to Follow-up|0|||
46834184|NCT00321672|83051970|FG002|Overall Study|Lost to Follow-up|4|||
46637990|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
46766823|NCT00626392|82985020|FG002|Run-in Period|Adverse Event|1|||
46766824|NCT00626392|82985021|FG003|Run-in Period|Adverse Event|0|||
46834185|NCT00321672|83051971|FG003|Overall Study|Lost to Follow-up|2|||
46834186|NCT00321672|83051968|FG000|Overall Study|Death|1|||
46834187|NCT00321672|83051969|FG001|Overall Study|Death|0|||
46834188|NCT00321672|83051970|FG002|Overall Study|Death|0|||
46834189|NCT00321672|83051971|FG003|Overall Study|Death|0|||
46834190|NCT00321672|83051968|FG000|Overall Study|Too far to travel for visits|1|||
46834191|NCT00321672|83051969|FG001|Overall Study|Too far to travel for visits|0|||
46834192|NCT00321672|83051970|FG002|Overall Study|Too far to travel for visits|0|||
46834193|NCT00321672|83051971|FG003|Overall Study|Too far to travel for visits|0|||
46834194|NCT00321672|83051968|FG000|Overall Study|Incarcerated|0|||
46834195|NCT00321672|83051969|FG001|Overall Study|Incarcerated|0|||
46834196|NCT00321672|83051970|FG002|Overall Study|Incarcerated|2|||
46834197|NCT00321672|83051971|FG003|Overall Study|Incarcerated|0|||
46834198|NCT00321672|83051968|FG000|Overall Study|Moved out of state|0|||
46834199|NCT00321672|83051969|FG001|Overall Study|Moved out of state|1|||
46834200|NCT00321672|83051970|FG002|Overall Study|Moved out of state|1|||
46834201|NCT00321672|83051971|FG003|Overall Study|Moved out of state|0|||
46834202|NCT00321672|83051968|FG000|Overall Study|Protocol Violation|0|||
46834203|NCT00321672|83051969|FG001|Overall Study|Protocol Violation|0|||
46834204|NCT00321672|83051970|FG002|Overall Study|Protocol Violation|1|||
46834205|NCT00321672|83051971|FG003|Overall Study|Protocol Violation|0|||
46834206|NCT00321672|83051968|FG000|Overall Study|Diagnosis of testicular cancer|0|||
46834207|NCT00321672|83051969|FG001|Overall Study|Diagnosis of testicular cancer|1|||
46834208|NCT00321672|83051970|FG002|Overall Study|Diagnosis of testicular cancer|0|||
46834209|NCT00321672|83051971|FG003|Overall Study|Diagnosis of testicular cancer|0|||
46834210|NCT00321672|83051968|FG000|Overall Study|Extensive travel required for new job|0|||
46834211|NCT00321672|83051969|FG001|Overall Study|Extensive travel required for new job|1|||
46834212|NCT00321672|83051970|FG002|Overall Study|Extensive travel required for new job|0|||
46834213|NCT00321672|83051971|FG003|Overall Study|Extensive travel required for new job|0|||
46834214|NCT00321048|83051987|FG000|Overall Study|Withdrawal by Subject|6|||
46834215|NCT00321048|83051988|FG001|Overall Study|Withdrawal by Subject|8|||
46834216|NCT00330174|83051996|FG000|Overall Study|Withdrawal by Subject|7|||
46834217|NCT00330174|83051997|FG001|Overall Study|Withdrawal by Subject|7|||
46834218|NCT00330174|83051996|FG000|Overall Study|Lost to Follow-up|4|||
46637991|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
46766825|NCT00626392|82985022|FG004|Run-in Period|Adverse Event|1|||
46766826|NCT00626392|82985023|FG005|Run-in Period|Adverse Event|0|||
46766827|NCT00626392|82985018|FG000|Run-in Period|Withdrawal by Subject|0|||
46766828|NCT00626392|82985019|FG001|Run-in Period|Withdrawal by Subject|1|||
46766829|NCT00626392|82985020|FG002|Run-in Period|Withdrawal by Subject|1|||
46766830|NCT00626392|82985021|FG003|Run-in Period|Withdrawal by Subject|1|||
46766831|NCT00626392|82985022|FG004|Run-in Period|Withdrawal by Subject|3|||
46766832|NCT00626392|82985023|FG005|Run-in Period|Withdrawal by Subject|1|||
46766833|NCT00626392|82985018|FG000|Run-in Period|Noncompliance|1|||
46766834|NCT00626392|82985019|FG001|Run-in Period|Noncompliance|0|||
46766835|NCT00626392|82985020|FG002|Run-in Period|Noncompliance|1|||
46766836|NCT00626392|82985021|FG003|Run-in Period|Noncompliance|0|||
46766837|NCT00626392|82985022|FG004|Run-in Period|Noncompliance|0|||
46766838|NCT00626392|82985023|FG005|Run-in Period|Noncompliance|0|||
46766839|NCT00626392|82985018|FG000|Coadministration Period|Adverse Event|3|||
46766840|NCT00626392|82985019|FG001|Coadministration Period|Adverse Event|1|||
46766841|NCT00626392|82985020|FG002|Coadministration Period|Adverse Event|7|||
46766842|NCT00626392|82985021|FG003|Coadministration Period|Adverse Event|4|||
46766843|NCT00626392|82985022|FG004|Coadministration Period|Adverse Event|3|||
46766844|NCT00626392|82985023|FG005|Coadministration Period|Adverse Event|4|||
46766845|NCT00626392|82985018|FG000|Coadministration Period|Withdrawal by Subject|1|||
46766846|NCT00626392|82985019|FG001|Coadministration Period|Withdrawal by Subject|1|||
46766847|NCT00626392|82985020|FG002|Coadministration Period|Withdrawal by Subject|0|||
46766848|NCT00626392|82985021|FG003|Coadministration Period|Withdrawal by Subject|1|||
46766849|NCT00626392|82985022|FG004|Coadministration Period|Withdrawal by Subject|0|||
46766850|NCT00626392|82985023|FG005|Coadministration Period|Withdrawal by Subject|1|||
46766851|NCT00626392|82985018|FG000|Coadministration Period|Protocol Violation|0|||
46834219|NCT00330174|83051997|FG001|Overall Study|Lost to Follow-up|1|||
46834220|NCT00330174|83051996|FG000|Overall Study|Clinical deterioration|1|||
46834221|NCT00330174|83051997|FG001|Overall Study|Clinical deterioration|2|||
46834222|NCT00330174|83051996|FG000|Overall Study|Excessive missed visits|3|||
46834223|NCT00330174|83051997|FG001|Overall Study|Excessive missed visits|8|||
46834224|NCT00330174|83051996|FG000|Overall Study|Miscellaneous reasons|7|||
46834225|NCT00330174|83051997|FG001|Overall Study|Miscellaneous reasons|1|||
46766852|NCT00626392|82985019|FG001|Coadministration Period|Protocol Violation|1|||
46766853|NCT00626392|82985020|FG002|Coadministration Period|Protocol Violation|0|||
46766854|NCT00626392|82985021|FG003|Coadministration Period|Protocol Violation|1|||
46766855|NCT00626392|82985022|FG004|Coadministration Period|Protocol Violation|1|||
46834226|NCT00320424|83052003|FG000|Overall Study|Adverse Event|3|||
46834227|NCT00320424|83052003|FG000|Overall Study|Other|3|||
46942414|NCT03654755|83179627|FG000|Overall Study|Physician Decision|0|||
46766856|NCT00626392|82985023|FG005|Coadministration Period|Protocol Violation|0|||
46766857|NCT00626392|82985018|FG000|Coadministration Period|Other|0|||
46766858|NCT00626392|82985019|FG001|Coadministration Period|Other|2|||
46766859|NCT00626392|82985020|FG002|Coadministration Period|Other|3|||
46766860|NCT00626392|82985021|FG003|Coadministration Period|Other|1|||
46766861|NCT00626392|82985022|FG004|Coadministration Period|Other|1|||
46766862|NCT00626392|82985023|FG005|Coadministration Period|Other|1|||
46766863|NCT00624286|82985031|FG000|Overall Study|Protocol Deviation|7|||
46766864|NCT00624286|82985032|FG001|Overall Study|Protocol Deviation|9|||
46766865|NCT00624286|82985031|FG000|Overall Study|Adverse Event|6|||
46766866|NCT00624286|82985032|FG001|Overall Study|Adverse Event|3|||
46766867|NCT00624286|82985031|FG000|Overall Study|Withdrawal by Subject|5|||
46766868|NCT00624286|82985032|FG001|Overall Study|Withdrawal by Subject|4|||
46766869|NCT00624286|82985031|FG000|Overall Study|Lost to Follow-up|3|||
46834228|NCT00338286|83052009|FG000|Overall Study|Withdrawal by Subject|50|||
46834229|NCT00338286|83052010|FG001|Overall Study|Withdrawal by Subject|54|||
46834230|NCT00338286|83052009|FG000|Overall Study|Lost to Follow-up|80|||
46834231|NCT00338286|83052010|FG001|Overall Study|Lost to Follow-up|66|||
46766870|NCT00624286|82985032|FG001|Overall Study|Lost to Follow-up|2|||
46766871|NCT00624286|82985031|FG000|Overall Study|Administrative problems|3|||
46766872|NCT00624286|82985032|FG001|Overall Study|Administrative problems|0|||
46766873|NCT00624286|82985031|FG000|Overall Study|Lack of Efficacy|1|||
46766874|NCT00624286|82985032|FG001|Overall Study|Lack of Efficacy|6|||
46766875|NCT00624286|82985031|FG000|Overall Study|Not stated|0|||
46766876|NCT00624286|82985032|FG001|Overall Study|Not stated|1|||
46766877|NCT00624286|82985031|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46766878|NCT00624286|82985032|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46766879|NCT00624286|82985031|FG000|Overall Study|Death|0|||
46766880|NCT00624286|82985032|FG001|Overall Study|Death|1|||
46766881|NCT00624052|82985042|FG000|Overall Study|Adverse Event|7|||
46834232|NCT00338286|83052009|FG000|Overall Study|Other|103|||
46834233|NCT00338286|83052010|FG001|Overall Study|Other|93|||
46942415|NCT03654755|83179628|FG001|Overall Study|Physician Decision|1|||
46942416|NCT03654755|83179629|FG002|Overall Study|Physician Decision|0|||
46942417|NCT03654755|83179627|FG000|Overall Study|Adverse Event|0|||
46942418|NCT03654755|83179628|FG001|Overall Study|Adverse Event|0|||
46942419|NCT03654755|83179629|FG002|Overall Study|Adverse Event|4|||
46942420|NCT03654755|83179627|FG000|Overall Study|Lack of Efficacy|0|||
46942421|NCT03654755|83179628|FG001|Overall Study|Lack of Efficacy|0|||
46942422|NCT03654755|83179629|FG002|Overall Study|Lack of Efficacy|1|||
46942423|NCT02980601|83179639|FG000|Overall Study|Lost to Follow-up|2|||
46942424|NCT02980601|83179640|FG001|Overall Study|Lost to Follow-up|2|||
46942425|NCT02980601|83179639|FG000|Overall Study|Death|0|||
46942426|NCT02980601|83179640|FG001|Overall Study|Death|1|||
46942427|NCT02980601|83179639|FG000|Overall Study|Graft loss|1|||
46942428|NCT02980601|83179640|FG001|Overall Study|Graft loss|0|||
46834234|NCT00329784|83052020|FG000|Overall Study|Lost to Follow-up|0|||
46834235|NCT00329784|83052021|FG001|Overall Study|Lost to Follow-up|1|||
46834236|NCT00329784|83052022|FG002|Overall Study|Lost to Follow-up|0|||
46834237|NCT00329784|83052023|FG003|Overall Study|Lost to Follow-up|0|||
46834238|NCT00329784|83052020|FG000|Overall Study|Withdrawal by Subject|4|||
46834239|NCT00329784|83052021|FG001|Overall Study|Withdrawal by Subject|2|||
46834240|NCT00329784|83052022|FG002|Overall Study|Withdrawal by Subject|0|||
46834241|NCT00329784|83052023|FG003|Overall Study|Withdrawal by Subject|0|||
46834242|NCT00329784|83052020|FG000|Overall Study|Other|1|||
46834243|NCT00329784|83052021|FG001|Overall Study|Other|2|||
46834244|NCT00329784|83052022|FG002|Overall Study|Other|0|||
46834245|NCT00329784|83052023|FG003|Overall Study|Other|0|||
46834246|NCT00337818|83052038|FG000|Overall Study|Lost to Follow-up|289|||
46942429|NCT02980601|83179639|FG000|Overall Study|Failed to sign consent|2|||
46637992|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
46766882|NCT00624052|82985043|FG001|Overall Study|Adverse Event|6|||
46766883|NCT00624052|82985044|FG002|Overall Study|Adverse Event|0|||
46942430|NCT02980601|83179640|FG001|Overall Study|Failed to sign consent|0|||
46942431|NCT02980523|83179651|FG000|Overall Study|Lost to Follow-up|1|||
46766884|NCT00624052|82985045|FG003|Overall Study|Adverse Event|3|||
46766885|NCT00624052|82985042|FG000|Overall Study|Lack of Efficacy|1|||
46766886|NCT00624052|82985043|FG001|Overall Study|Lack of Efficacy|1|||
46766887|NCT00624052|82985044|FG002|Overall Study|Lack of Efficacy|0|||
46766888|NCT00624052|82985045|FG003|Overall Study|Lack of Efficacy|0|||
46766889|NCT00624052|82985042|FG000|Overall Study|Lost to Follow-up|2|||
46766890|NCT00624052|82985043|FG001|Overall Study|Lost to Follow-up|3|||
46766891|NCT00624052|82985044|FG002|Overall Study|Lost to Follow-up|1|||
46766892|NCT00624052|82985045|FG003|Overall Study|Lost to Follow-up|0|||
46834247|NCT00337818|83052039|FG001|Overall Study|Lost to Follow-up|91|||
46834248|NCT00337818|83052040|FG002|Overall Study|Lost to Follow-up|107|||
46834249|NCT00329550|83052051|FG000|Overall Study|Adverse Event|3|||
46834250|NCT00329550|83052052|FG001|Overall Study|Adverse Event|4|||
46834251|NCT00329550|83052053|FG002|Overall Study|Adverse Event|2|||
46942432|NCT02980523|83179652|FG001|Overall Study|Lost to Follow-up|4|||
46942433|NCT02980523|83179653|FG002|Overall Study|Lost to Follow-up|1|||
46834252|NCT00329550|83052051|FG000|Overall Study|Withdrawal of Consent|1|||
46834253|NCT00329550|83052052|FG001|Overall Study|Withdrawal of Consent|0|||
46834254|NCT00329550|83052053|FG002|Overall Study|Withdrawal of Consent|1|||
46834255|NCT00329550|83052051|FG000|Overall Study|Due to Relocation|0|||
46834256|NCT00329550|83052052|FG001|Overall Study|Due to Relocation|0|||
46834257|NCT00329550|83052053|FG002|Overall Study|Due to Relocation|1|||
46637993|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
46637994|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
46637995|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
46637996|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
46637997|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
46834258|NCT00375674|83052065|FG000|Overall Study|Other|26|||
46834259|NCT00375674|83052066|FG001|Overall Study|Other|18|||
46834260|NCT00375674|83052065|FG000|Overall Study|Death|67|||
46834261|NCT00375674|83052066|FG001|Overall Study|Death|76|||
46834262|NCT00375674|83052065|FG000|Overall Study|Participants refused further follow-up|31|||
46834263|NCT00375674|83052066|FG001|Overall Study|Participants refused further follow-up|30|||
46834264|NCT00375674|83052065|FG000|Overall Study|Lost to Follow-up|17|||
46834265|NCT00375674|83052066|FG001|Overall Study|Lost to Follow-up|15|||
46834266|NCT00375674|83052065|FG000|Overall Study|Enrolled but not treated|3|||
46834267|NCT00375674|83052066|FG001|Overall Study|Enrolled but not treated|2|||
46834268|NCT00350402|83052074|FG000|Overall Study|Lost to Follow-up|1|||
46834269|NCT00350402|83052075|FG001|Overall Study|Lost to Follow-up|1|||
46834270|NCT00320190|83052089|FG000|First 12 Months|Completed but did not enter extension|5|||
46834271|NCT00320190|83052090|FG001|First 12 Months|Completed but did not enter extension|3|||
46834272|NCT00320190|83052089|FG000|First 12 Months|Sponsor terminated study|2|||
46834273|NCT00320190|83052090|FG001|First 12 Months|Sponsor terminated study|2|||
46834274|NCT00320190|83052089|FG000|First 12 Months|Lost to Follow-up|0|||
46834275|NCT00320190|83052090|FG001|First 12 Months|Lost to Follow-up|1|||
46834276|NCT00320190|83052089|FG000|First 12 Months|Enrollment failure|0|||
46834277|NCT00320190|83052090|FG001|First 12 Months|Enrollment failure|1|||
46834278|NCT00320190|83052089|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
46834279|NCT00320190|83052090|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
46834280|NCT00320190|83052089|FG000|First 12 Months|Investigator request|0|||
46834281|NCT00320190|83052090|FG001|First 12 Months|Investigator request|1|||
46834282|NCT00320190|83052089|FG000|First 12 Months|Study drug toxicity|0|||
46834283|NCT00320190|83052090|FG001|First 12 Months|Study drug toxicity|1|||
46834284|NCT00320190|83052089|FG000|First 12 Months|Withdrawal by Subject|0|||
46834285|NCT00320190|83052090|FG001|First 12 Months|Withdrawal by Subject|1|||
46834286|NCT00320190|83052089|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
46834287|NCT00320190|83052090|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
46834288|NCT00320190|83052089|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
46834289|NCT00320190|83052090|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
46834290|NCT00320190|83052089|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
46834291|NCT00320190|83052090|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
46834292|NCT00320112|83052098|FG000|Overall Study|Lost to Follow-up|3|||
46834293|NCT00320112|83052099|FG001|Overall Study|Lost to Follow-up|4|||
46834294|NCT00320112|83052098|FG000|Overall Study|Withdrawal by Subject|3|||
46834295|NCT00320112|83052099|FG001|Overall Study|Withdrawal by Subject|0|||
46834296|NCT00320112|83052098|FG000|Overall Study|Death|2|||
46834297|NCT00320112|83052099|FG001|Overall Study|Death|1|||
46834298|NCT00319956|83052113|FG000|Overall Study|Death|20|||
46834299|NCT00319956|83052114|FG001|Overall Study|Death|24|||
46834300|NCT00349622|83052122|FG000|Overall Study|Death|168|||
46834301|NCT00349622|83052123|FG001|Overall Study|Death|86|||
46834302|NCT00349622|83052122|FG000|Overall Study|Lost to Follow-up|5|||
46834303|NCT00349622|83052123|FG001|Overall Study|Lost to Follow-up|1|||
46834304|NCT00349622|83052122|FG000|Overall Study|Withdrawal by Subject|5|||
46834305|NCT00349622|83052123|FG001|Overall Study|Withdrawal by Subject|9|||
46834306|NCT00354614|83052129|FG000|Overall Study|Lack of Efficacy|28|||
46834307|NCT00360308|83052136|FG000|Overall Study|Adverse Event|15|||
46834308|NCT00360308|83052137|FG001|Overall Study|Adverse Event|14|||
46637998|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
46834309|NCT00360308|83052138|FG002|Overall Study|Adverse Event|25|||
46834310|NCT00360308|83052136|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
46834311|NCT00360308|83052137|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
46834312|NCT00360308|83052138|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
46834313|NCT00360308|83052136|FG000|Overall Study|Protocol Violation|2|||
46834314|NCT00360308|83052137|FG001|Overall Study|Protocol Violation|1|||
46834315|NCT00360308|83052138|FG002|Overall Study|Protocol Violation|2|||
46834316|NCT00360308|83052136|FG000|Overall Study|Withdrawal by Subject|11|||
46834317|NCT00360308|83052137|FG001|Overall Study|Withdrawal by Subject|7|||
46834318|NCT00360308|83052138|FG002|Overall Study|Withdrawal by Subject|14|||
46834319|NCT00360308|83052136|FG000|Overall Study|Lack of Efficacy|3|||
46834320|NCT00360308|83052137|FG001|Overall Study|Lack of Efficacy|0|||
46834321|NCT00360308|83052138|FG002|Overall Study|Lack of Efficacy|2|||
46834322|NCT00360308|83052136|FG000|Overall Study|Other|2|||
46834323|NCT00360308|83052137|FG001|Overall Study|Other|1|||
46834324|NCT00360308|83052138|FG002|Overall Study|Other|1|||
46834325|NCT00360308|83052136|FG000|Overall Study|Study termination by sponsor|43|||
46834326|NCT00360308|83052137|FG001|Overall Study|Study termination by sponsor|55|||
46637999|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
46638000|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
46638001|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
46638002|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
46766893|NCT00624052|82985042|FG000|Overall Study|Non compliant with the protocol|2|||
46766894|NCT00624052|82985043|FG001|Overall Study|Non compliant with the protocol|1|||
46942434|NCT02980523|83179654|FG003|Overall Study|Lost to Follow-up|2|||
46942435|NCT02980523|83179655|FG004|Overall Study|Lost to Follow-up|1|||
46942436|NCT02980523|83179651|FG000|Overall Study|Excluded from analysis|1|||
46942437|NCT02980523|83179652|FG001|Overall Study|Excluded from analysis|3|||
46942438|NCT02980523|83179653|FG002|Overall Study|Excluded from analysis|1|||
46942439|NCT02980523|83179654|FG003|Overall Study|Excluded from analysis|1|||
46942440|NCT02980523|83179655|FG004|Overall Study|Excluded from analysis|1|||
46942441|NCT02980523|83179651|FG000|Overall Study|Lack of Efficacy|1|||
46942442|NCT02980523|83179652|FG001|Overall Study|Lack of Efficacy|4|||
46942443|NCT02980523|83179653|FG002|Overall Study|Lack of Efficacy|4|||
46942444|NCT02980523|83179654|FG003|Overall Study|Lack of Efficacy|5|||
46942445|NCT02980523|83179655|FG004|Overall Study|Lack of Efficacy|8|||
46942446|NCT02980523|83179651|FG000|Overall Study|Did not receive intervention|0|||
46942447|NCT02980523|83179652|FG001|Overall Study|Did not receive intervention|0|||
46942448|NCT02980523|83179653|FG002|Overall Study|Did not receive intervention|0|||
46942449|NCT02980523|83179654|FG003|Overall Study|Did not receive intervention|1|||
46942450|NCT02980523|83179655|FG004|Overall Study|Did not receive intervention|0|||
46942451|NCT02980133|83179674|FG000|Overall Study|Other than specified|1|||
46942452|NCT02980133|83179675|FG001|Overall Study|Other than specified|1|||
46942453|NCT02980133|83179676|FG002|Overall Study|Other than specified|2|||
46942454|NCT02980133|83179677|FG003|Overall Study|Other than specified|2|||
46942455|NCT02980133|83179674|FG000|Overall Study|Lost to Follow-up|0|||
46942456|NCT02980133|83179675|FG001|Overall Study|Lost to Follow-up|0|||
46942457|NCT02980133|83179676|FG002|Overall Study|Lost to Follow-up|1|||
46942458|NCT02980133|83179677|FG003|Overall Study|Lost to Follow-up|3|||
46942459|NCT02980133|83179674|FG000|Overall Study|Protocol Violation|0|||
46942460|NCT02980133|83179675|FG001|Overall Study|Protocol Violation|1|||
46942461|NCT02980133|83179676|FG002|Overall Study|Protocol Violation|0|||
46942462|NCT02980133|83179677|FG003|Overall Study|Protocol Violation|0|||
46942463|NCT02980133|83179674|FG000|Overall Study|Withdrawal by parent/guardian|6|||
46942464|NCT02980133|83179675|FG001|Overall Study|Withdrawal by parent/guardian|3|||
46942465|NCT02980133|83179676|FG002|Overall Study|Withdrawal by parent/guardian|3|||
46942466|NCT02980133|83179677|FG003|Overall Study|Withdrawal by parent/guardian|1|||
46942467|NCT02980133|83179674|FG000|Overall Study|Withdrawal by Subject|0|||
46766895|NCT00624052|82985044|FG002|Overall Study|Non compliant with the protocol|1|||
46766896|NCT00624052|82985045|FG003|Overall Study|Non compliant with the protocol|1|||
46766897|NCT00624052|82985042|FG000|Overall Study|Consent withdrawn|3|||
46766898|NCT00624052|82985043|FG001|Overall Study|Consent withdrawn|1|||
46766899|NCT00624052|82985044|FG002|Overall Study|Consent withdrawn|1|||
46766900|NCT00624052|82985045|FG003|Overall Study|Consent withdrawn|0|||
46766901|NCT00624052|82985042|FG000|Overall Study|Changed job/ran out if meds|0|||
46766902|NCT00624052|82985043|FG001|Overall Study|Changed job/ran out if meds|2|||
46766903|NCT00624052|82985044|FG002|Overall Study|Changed job/ran out if meds|0|||
46766904|NCT00624052|82985045|FG003|Overall Study|Changed job/ran out if meds|0|||
46766905|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
46766906|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
46834327|NCT00360308|83052138|FG002|Overall Study|Study termination by sponsor|44|||
46834328|NCT00348686|83052150|FG000|Overall Study|Withdrawal by Subject|45|||
46834329|NCT00348686|83052150|FG000|Overall Study|Adverse Event|5|||
46834330|NCT00348686|83052150|FG000|Overall Study|Protocol Violation|6|||
46942468|NCT02980133|83179675|FG001|Overall Study|Withdrawal by Subject|0|||
46942469|NCT02980133|83179676|FG002|Overall Study|Withdrawal by Subject|1|||
46942470|NCT02980133|83179677|FG003|Overall Study|Withdrawal by Subject|0|||
46638003|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
46638004|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
46942471|NCT02979431|83179694|FG000|Overall Study|Parent/guardian withdrew consent|2|||
46942472|NCT02979431|83179695|FG001|Overall Study|Parent/guardian withdrew consent|1|||
46638005|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
46766907|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
46766908|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
46834331|NCT00348686|83052150|FG000|Overall Study|Lost to Follow-up|2|||
46942473|NCT02979431|83179696|FG002|Overall Study|Parent/guardian withdrew consent|1|||
46834332|NCT00348686|83052150|FG000|Overall Study|Multiple Reasons|8|||
46834333|NCT00360230|83052161|FG000|Overall Study|Withdrawal by Subject|1|||
46834334|NCT00360230|83052162|FG001|Overall Study|Withdrawal by Subject|1|||
46834335|NCT00360230|83052163|FG002|Overall Study|Withdrawal by Subject|0|||
46834336|NCT00360230|83052164|FG003|Overall Study|Withdrawal by Subject|1|||
46834337|NCT00360230|83052165|FG004|Overall Study|Withdrawal by Subject|1|||
46942474|NCT02979431|83179697|FG003|Overall Study|Parent/guardian withdrew consent|1|||
46942475|NCT02979431|83179694|FG000|Overall Study|Randomized but received no study drug|1|||
46942476|NCT02979431|83179695|FG001|Overall Study|Randomized but received no study drug|1|||
46834338|NCT00360230|83052166|FG005|Overall Study|Withdrawal by Subject|1|||
46834339|NCT00360230|83052167|FG006|Overall Study|Withdrawal by Subject|0|||
46834340|NCT00360230|83052161|FG000|Overall Study|Migrated|4|||
46766909|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
46766910|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
46766911|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
46766912|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
46766913|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
46766914|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
46766915|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
46766916|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
46766917|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
46766918|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
46766919|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
46766920|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
46766921|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
46766922|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
46766923|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
46834341|NCT00360230|83052162|FG001|Overall Study|Migrated|1|||
46834342|NCT00360230|83052163|FG002|Overall Study|Migrated|3|||
46834343|NCT00360230|83052164|FG003|Overall Study|Migrated|1|||
46834344|NCT00360230|83052165|FG004|Overall Study|Migrated|4|||
46834345|NCT00360230|83052166|FG005|Overall Study|Migrated|1|||
46834346|NCT00360230|83052167|FG006|Overall Study|Migrated|1|||
46834347|NCT00360230|83052161|FG000|Overall Study|Other|1|||
46834348|NCT00360230|83052162|FG001|Overall Study|Other|0|||
46834349|NCT00360230|83052163|FG002|Overall Study|Other|0|||
46834350|NCT00360230|83052164|FG003|Overall Study|Other|0|||
46834351|NCT00360230|83052165|FG004|Overall Study|Other|0|||
46834352|NCT00360230|83052166|FG005|Overall Study|Other|0|||
46834353|NCT00360230|83052167|FG006|Overall Study|Other|0|||
46834354|NCT00360230|83052161|FG000|Overall Study|Protocol Violation|0|||
46834355|NCT00360230|83052162|FG001|Overall Study|Protocol Violation|0|||
46834356|NCT00360230|83052163|FG002|Overall Study|Protocol Violation|0|||
46834357|NCT00360230|83052164|FG003|Overall Study|Protocol Violation|0|||
46834358|NCT00360230|83052165|FG004|Overall Study|Protocol Violation|0|||
46834359|NCT00360230|83052166|FG005|Overall Study|Protocol Violation|1|||
46834360|NCT00360230|83052167|FG006|Overall Study|Protocol Violation|0|||
46834361|NCT00360230|83052161|FG000|Overall Study|Death|0|||
46834362|NCT00360230|83052162|FG001|Overall Study|Death|1|||
46834363|NCT00360230|83052163|FG002|Overall Study|Death|0|||
46834364|NCT00360230|83052164|FG003|Overall Study|Death|0|||
46834365|NCT00360230|83052165|FG004|Overall Study|Death|0|||
46834366|NCT00360230|83052166|FG005|Overall Study|Death|1|||
46834367|NCT00360230|83052167|FG006|Overall Study|Death|1|||
46834368|NCT00348374|83052187|FG000|Overall Study|Adverse Event|1|||
46834369|NCT00348374|83052188|FG001|Overall Study|Adverse Event|4|||
46834370|NCT00348374|83052187|FG000|Overall Study|Lost to Follow-up|1|||
46834371|NCT00348374|83052188|FG001|Overall Study|Lost to Follow-up|3|||
46834372|NCT00348374|83052187|FG000|Overall Study|Withdrawal by Subject|5|||
46834373|NCT00348374|83052188|FG001|Overall Study|Withdrawal by Subject|5|||
46834374|NCT00348374|83052187|FG000|Overall Study|Other|11|||
46834375|NCT00348374|83052188|FG001|Overall Study|Other|12|||
46766924|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
46766925|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
46766926|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
46834376|NCT00348374|83052187|FG000|Overall Study|ongoing at date of cutoff|1|||
46834377|NCT00348374|83052188|FG001|Overall Study|ongoing at date of cutoff|1|||
46834378|NCT00348374|83052187|FG000|Overall Study|randomized but did not receive treatment|0|||
46834379|NCT00348374|83052188|FG001|Overall Study|randomized but did not receive treatment|7|||
46834380|NCT00353366|83052195|FG000|Overall Study|Adverse Event|8|||
46834381|NCT00353366|83052195|FG000|Overall Study|Protocol Violation|12|||
46834382|NCT00353366|83052195|FG000|Overall Study|Withdrawal by Subject|12|||
46834383|NCT00353366|83052195|FG000|Overall Study|Lost to Follow-up|92|||
46834384|NCT00353366|83052195|FG000|Overall Study|Other|19|||
46834385|NCT00352664|83052201|FG000|Overall Study|Withdrawal by Subject|7|||
46834386|NCT00352664|83052202|FG001|Overall Study|Withdrawal by Subject|0|||
46834387|NCT00490139|83052212|FG000|Overall Study|Death|106|||
46834388|NCT00490139|83052213|FG001|Overall Study|Death|119|||
46834389|NCT00490139|83052214|FG002|Overall Study|Death|168|||
46834390|NCT00490139|83052215|FG003|Overall Study|Death|135|||
46834391|NCT00490139|83052212|FG000|Overall Study|Lost to Follow-up|56|||
46834392|NCT00490139|83052213|FG001|Overall Study|Lost to Follow-up|46|||
46834393|NCT00490139|83052214|FG002|Overall Study|Lost to Follow-up|58|||
46834394|NCT00490139|83052215|FG003|Overall Study|Lost to Follow-up|56|||
46834395|NCT00490139|83052212|FG000|Overall Study|Participant Withdrew Consent|146|||
46834396|NCT00490139|83052213|FG001|Overall Study|Participant Withdrew Consent|110|||
46834397|NCT00490139|83052214|FG002|Overall Study|Participant Withdrew Consent|208|||
46834398|NCT00490139|83052215|FG003|Overall Study|Participant Withdrew Consent|116|||
46834399|NCT00348140|83052230|FG000|Overall Study|Adverse Event|46|||
46834400|NCT00348140|83052231|FG001|Overall Study|Adverse Event|49|||
46834401|NCT00348140|83052232|FG002|Overall Study|Adverse Event|78|||
46834402|NCT00348140|83052230|FG000|Overall Study|Lost to Follow-up|4|||
46834403|NCT00348140|83052231|FG001|Overall Study|Lost to Follow-up|4|||
46834404|NCT00348140|83052232|FG002|Overall Study|Lost to Follow-up|4|||
46834405|NCT00348140|83052230|FG000|Overall Study|Protocol Violation|12|||
46834406|NCT00348140|83052231|FG001|Overall Study|Protocol Violation|13|||
46834407|NCT00348140|83052232|FG002|Overall Study|Protocol Violation|14|||
46834408|NCT00348140|83052230|FG000|Overall Study|Withdrawal by Subject|32|||
46834409|NCT00348140|83052231|FG001|Overall Study|Withdrawal by Subject|40|||
46834410|NCT00348140|83052232|FG002|Overall Study|Withdrawal by Subject|40|||
46834411|NCT00348140|83052230|FG000|Overall Study|Non-compliance|8|||
46834412|NCT00348140|83052231|FG001|Overall Study|Non-compliance|13|||
46834413|NCT00348140|83052232|FG002|Overall Study|Non-compliance|5|||
46834414|NCT00348140|83052230|FG000|Overall Study|Participant at risk due to study drug|2|||
46834415|NCT00348140|83052231|FG001|Overall Study|Participant at risk due to study drug|0|||
46834416|NCT00348140|83052232|FG002|Overall Study|Participant at risk due to study drug|0|||
46834417|NCT00348140|83052230|FG000|Overall Study|Conditional medication increased dose|1|||
46834418|NCT00348140|83052231|FG001|Overall Study|Conditional medication increased dose|0|||
46834419|NCT00348140|83052232|FG002|Overall Study|Conditional medication increased dose|0|||
46834420|NCT00348140|83052230|FG000|Overall Study|Caregiver related|4|||
46834421|NCT00348140|83052231|FG001|Overall Study|Caregiver related|7|||
46834422|NCT00348140|83052232|FG002|Overall Study|Caregiver related|3|||
46834423|NCT00348140|83052230|FG000|Overall Study|Participant hospitalised|3|||
46834424|NCT00348140|83052231|FG001|Overall Study|Participant hospitalised|0|||
46834425|NCT00348140|83052232|FG002|Overall Study|Participant hospitalised|0|||
46834426|NCT00348140|83052230|FG000|Overall Study|Efficacy related|1|||
46834427|NCT00348140|83052231|FG001|Overall Study|Efficacy related|1|||
46834428|NCT00348140|83052232|FG002|Overall Study|Efficacy related|0|||
46834429|NCT00348140|83052230|FG000|Overall Study|Administration related|3|||
46834430|NCT00348140|83052231|FG001|Overall Study|Administration related|1|||
46834431|NCT00348140|83052232|FG002|Overall Study|Administration related|1|||
46834432|NCT00348140|83052230|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
46834433|NCT00348140|83052231|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
46834434|NCT00348140|83052232|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
46834435|NCT00348140|83052230|FG000|Overall Study|Participant unwell|1|||
46834436|NCT00348140|83052231|FG001|Overall Study|Participant unwell|0|||
46942477|NCT02979431|83179696|FG002|Overall Study|Randomized but received no study drug|0|||
46942478|NCT02979431|83179697|FG003|Overall Study|Randomized but received no study drug|0|||
46942479|NCT02979431|83179694|FG000|Overall Study|Adverse Event|0|||
46942480|NCT02979431|83179695|FG001|Overall Study|Adverse Event|0|||
46942481|NCT02979431|83179696|FG002|Overall Study|Adverse Event|1|||
46942482|NCT02979431|83179697|FG003|Overall Study|Adverse Event|0|||
46942483|NCT02979431|83179694|FG000|Overall Study|Subject left country after Day14|1|||
46766927|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
46766928|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
46766929|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
46766930|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
46766931|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
46766932|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
46766933|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
46766934|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
46834437|NCT00348140|83052232|FG002|Overall Study|Participant unwell|0|||
46834438|NCT00348140|83052230|FG000|Overall Study|Screen failure|1|||
46834439|NCT00348140|83052231|FG001|Overall Study|Screen failure|0|||
46834440|NCT00348140|83052232|FG002|Overall Study|Screen failure|0|||
46834441|NCT00348140|83052230|FG000|Overall Study|Investigator decided to discontinue|4|||
46834442|NCT00348140|83052231|FG001|Overall Study|Investigator decided to discontinue|1|||
46834443|NCT00348140|83052232|FG002|Overall Study|Investigator decided to discontinue|4|||
46942484|NCT02979431|83179695|FG001|Overall Study|Subject left country after Day14|0|||
46834444|NCT00348140|83052230|FG000|Overall Study|Decided to discontinue on their own|1|||
46942485|NCT02979431|83179696|FG002|Overall Study|Subject left country after Day14|0|||
46834445|NCT00348140|83052231|FG001|Overall Study|Decided to discontinue on their own|4|||
46834446|NCT00348140|83052232|FG002|Overall Study|Decided to discontinue on their own|1|||
46834447|NCT00348140|83052230|FG000|Overall Study|Use of prohibited drug|1|||
46834448|NCT00348140|83052231|FG001|Overall Study|Use of prohibited drug|0|||
46766935|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
46766936|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
46834449|NCT00348140|83052232|FG002|Overall Study|Use of prohibited drug|2|||
46834450|NCT00348140|83052230|FG000|Overall Study|Disease progression|1|||
46834451|NCT00348140|83052231|FG001|Overall Study|Disease progression|2|||
46834452|NCT00348140|83052232|FG002|Overall Study|Disease progression|5|||
46834453|NCT00348140|83052230|FG000|Overall Study|Increased risk of cardiac infarction|0|||
46834454|NCT00348140|83052231|FG001|Overall Study|Increased risk of cardiac infarction|1|||
46834455|NCT00348140|83052232|FG002|Overall Study|Increased risk of cardiac infarction|0|||
46834456|NCT00348140|83052230|FG000|Overall Study|Serious adverse event|0|||
46834457|NCT00348140|83052231|FG001|Overall Study|Serious adverse event|1|||
46834458|NCT00348140|83052232|FG002|Overall Study|Serious adverse event|0|||
46834459|NCT00348140|83052230|FG000|Overall Study|Abnormal ECG|0|||
46834460|NCT00348140|83052231|FG001|Overall Study|Abnormal ECG|1|||
46834461|NCT00348140|83052232|FG002|Overall Study|Abnormal ECG|3|||
46834462|NCT00348140|83052230|FG000|Overall Study|Participant died|0|||
46834463|NCT00348140|83052231|FG001|Overall Study|Participant died|1|||
46834464|NCT00348140|83052232|FG002|Overall Study|Participant died|0|||
46834465|NCT00348140|83052230|FG000|Overall Study|Exclusion criteria met|0|||
46834466|NCT00348140|83052231|FG001|Overall Study|Exclusion criteria met|0|||
46834467|NCT00348140|83052232|FG002|Overall Study|Exclusion criteria met|1|||
46942486|NCT02979431|83179697|FG003|Overall Study|Subject left country after Day14|0|||
46942487|NCT02978417|83179709|FG000|Overall Study|Lost to Follow-up|2|||
46942488|NCT02978417|83179710|FG001|Overall Study|Lost to Follow-up|2|||
47062306|NCT01524133|83343140|FG001|Treatment Phase|Withdrawal by Subject|28|||
47062307|NCT01524133|83343141|FG002|Treatment Phase|Withdrawal by Subject|31|||
47062308|NCT01524133|83343139|FG000|Treatment Phase|Physician Decision|6|||
47062309|NCT01524133|83343140|FG001|Treatment Phase|Physician Decision|3|||
47062310|NCT01524133|83343141|FG002|Treatment Phase|Physician Decision|3|||
47062311|NCT01524133|83343139|FG000|Treatment Phase|Lost to Follow-up|0|||
47062312|NCT01524133|83343140|FG001|Treatment Phase|Lost to Follow-up|1|||
47062313|NCT01524133|83343141|FG002|Treatment Phase|Lost to Follow-up|2|||
47062314|NCT01524133|83343139|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
47062315|NCT01524133|83343140|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
47062316|NCT01524133|83343141|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
46766937|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
47062317|NCT01524133|83343139|FG000|Overall Study 52 Weeks|Physician Decision|1|||
47062318|NCT01524133|83343140|FG001|Overall Study 52 Weeks|Physician Decision|0|||
47062319|NCT01524133|83343141|FG002|Overall Study 52 Weeks|Physician Decision|2|||
47062320|NCT01524133|83343139|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
47062321|NCT01524133|83343140|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
47062322|NCT01524133|83343141|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
46766938|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
46766939|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
46766940|NCT00785577|82985064|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
46766941|NCT00785577|82985065|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
46766942|NCT00785577|82985066|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
46766943|NCT00785577|82985067|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
46766944|NCT00785577|82985068|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
46766945|NCT00785577|82985064|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
46766946|NCT00785577|82985065|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
46766947|NCT00785577|82985066|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
46766948|NCT00785577|82985067|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
46766949|NCT00785577|82985068|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
46766950|NCT00785577|82985064|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
46766951|NCT00785577|82985065|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
46834468|NCT00348140|83052230|FG000|Overall Study|Memory declined|0|||
46834469|NCT00348140|83052231|FG001|Overall Study|Memory declined|0|||
46834470|NCT00348140|83052232|FG002|Overall Study|Memory declined|1|||
46942489|NCT02733627|83179733|FG000|Overall Study|Adverse Event|0|||
46942490|NCT02733627|83179734|FG001|Overall Study|Adverse Event|1|||
46834471|NCT00490061|83052241|FG000|Overall Study|Physician Decision|1|||
46834472|NCT00483119|83052247|FG000|Overall Study|Adverse Event|0|||
46834473|NCT00483119|83052248|FG001|Overall Study|Adverse Event|1|||
46942491|NCT02733627|83179735|FG002|Overall Study|Adverse Event|1|||
46942492|NCT02733627|83179736|FG003|Overall Study|Adverse Event|0|||
47062323|NCT04304534|83343175|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
47062324|NCT04304534|83343176|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
46766952|NCT00785577|82985066|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
46766953|NCT00785577|82985067|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
46766954|NCT00785577|82985068|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
46766955|NCT00789828|82985092|FG000|Core Period (48 Weeks)|Administrative problems|0|||
46766956|NCT00789828|82985093|FG001|Core Period (48 Weeks)|Administrative problems|1|||
46766957|NCT00789828|82985092|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
46942493|NCT02733627|83179733|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
46942494|NCT02733627|83179734|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
46766958|NCT00789828|82985093|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
46766959|NCT00789828|82985092|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
46766960|NCT00789828|82985093|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
46766961|NCT00789828|82985092|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
46766962|NCT00789828|82985093|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
46766963|NCT00789828|82985092|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
46766964|NCT00789828|82985093|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
46766965|NCT00789828|82985092|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
46766966|NCT00789828|82985093|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
46766967|NCT00789828|82985092|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
46766968|NCT00789828|82985093|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
46766969|NCT00789828|82985092|FG000|Open-label Extension Period (4 Years)|Death|1|||
46766970|NCT00789828|82985093|FG001|Open-label Extension Period (4 Years)|Death|0|||
46766971|NCT00789828|82985092|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
46766972|NCT00789828|82985093|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
46766973|NCT00789828|82985092|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
46766974|NCT00789828|82985093|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
46766975|NCT00790296|82985104|FG000|Overall Study|Did not meet study eligibility criteria|1|||
46766976|NCT00790296|82985105|FG001|Overall Study|Did not meet study eligibility criteria|1|||
46766977|NCT00790296|82985104|FG000|Overall Study|Adverse Event|0|||
46766978|NCT00790296|82985105|FG001|Overall Study|Adverse Event|1|||
46766979|NCT00623194|82985111|FG000|Overall Study|Lack of Efficacy|1|||
46766980|NCT00623194|82985111|FG000|Overall Study|Protocol Violation|3|||
46766981|NCT00623194|82985111|FG000|Overall Study|Unclassified|1|||
46766982|NCT00784368|82985118|FG000|Overall Study|Physician Decision|0|||
46766983|NCT00784368|82985119|FG001|Overall Study|Physician Decision|0|||
46766984|NCT00784368|82985120|FG002|Overall Study|Physician Decision|6|||
46766985|NCT00784368|82985118|FG000|Overall Study|Lack of Efficacy|2|||
46766986|NCT00784368|82985119|FG001|Overall Study|Lack of Efficacy|0|||
46766987|NCT00784368|82985120|FG002|Overall Study|Lack of Efficacy|1|||
46766988|NCT00784368|82985118|FG000|Overall Study|Adverse Event|6|||
46766989|NCT00784368|82985119|FG001|Overall Study|Adverse Event|9|||
46766990|NCT00784368|82985120|FG002|Overall Study|Adverse Event|2|||
46766991|NCT00784368|82985118|FG000|Overall Study|Diagnosis of fever|0|||
46766992|NCT00784368|82985119|FG001|Overall Study|Diagnosis of fever|0|||
46766993|NCT00784368|82985120|FG002|Overall Study|Diagnosis of fever|1|||
46766994|NCT00784368|82985118|FG000|Overall Study|Worsening of complications|0|||
46766995|NCT00784368|82985119|FG001|Overall Study|Worsening of complications|0|||
46766996|NCT00784368|82985120|FG002|Overall Study|Worsening of complications|1|||
46766997|NCT00784368|82985118|FG000|Overall Study|Worsening of symptoms|0|||
46766998|NCT00784368|82985119|FG001|Overall Study|Worsening of symptoms|1|||
46766999|NCT00784368|82985120|FG002|Overall Study|Worsening of symptoms|0|||
46767000|NCT00784368|82985118|FG000|Overall Study|Withdrawal of informed consent|0|||
46767001|NCT00784368|82985119|FG001|Overall Study|Withdrawal of informed consent|1|||
46767002|NCT00784368|82985120|FG002|Overall Study|Withdrawal of informed consent|0|||
46767003|NCT00622726|82985133|FG000|March, 2008 to August, 2010|Death|5|||
46767004|NCT00622726|82985134|FG001|March, 2008 to August, 2010|Death|2|||
46767005|NCT00622726|82985133|FG000|August, 2010 to April, 2013|Death|1|||
46767006|NCT00622726|82985134|FG001|August, 2010 to April, 2013|Death|5|||
46767007|NCT00623428|82985146|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
46767008|NCT00623428|82985147|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
46767009|NCT00623428|82985146|FG000|Treatment Period|Death|0|||
46767010|NCT00623428|82985147|FG001|Treatment Period|Death|1|||
46767011|NCT00623428|82985146|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
46767012|NCT00623428|82985147|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
46767013|NCT00623428|82985146|FG000|Treatment Period|Insufficient therapeutic response|0|||
46767014|NCT00623428|82985147|FG001|Treatment Period|Insufficient therapeutic response|2|||
46767015|NCT00623428|82985146|FG000|Treatment Period|Other|0|||
46767016|NCT00623428|82985147|FG001|Treatment Period|Other|1|||
46767017|NCT00623428|82985146|FG000|Treatment Period|Withdrawal by Subject|0|||
46767018|NCT00623428|82985147|FG001|Treatment Period|Withdrawal by Subject|1|||
46767019|NCT00623428|82985146|FG000|Follow-up Period|Relapse post-treatment|11|||
46767020|NCT00623428|82985147|FG001|Follow-up Period|Relapse post-treatment|3|||
46834474|NCT00483119|83052247|FG000|Overall Study|Physician Decision|1|||
46834475|NCT00483119|83052248|FG001|Overall Study|Physician Decision|0|||
46834476|NCT00483041|83052256|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
46834477|NCT00483041|83052257|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
46834478|NCT00501293|83052265|FG000|Optimization Period|Enrolled in error|1|||
46834479|NCT00501293|83052266|FG001|Optimization Period|Enrolled in error|0|||
46834480|NCT00501293|83052265|FG000|Maintenance Period|Withdrawal by Subject|14|||
46834481|NCT00501293|83052266|FG001|Maintenance Period|Withdrawal by Subject|13|||
46834482|NCT00501293|83052265|FG000|Maintenance Period|Lost to Follow-up|12|||
46834483|NCT00501293|83052266|FG001|Maintenance Period|Lost to Follow-up|7|||
46834484|NCT00501293|83052265|FG000|Maintenance Period|Adverse Event|6|||
46834485|NCT00501293|83052266|FG001|Maintenance Period|Adverse Event|6|||
46834486|NCT00501293|83052265|FG000|Maintenance Period|Protocol Violation|2|||
46834487|NCT00501293|83052266|FG001|Maintenance Period|Protocol Violation|1|||
46834488|NCT00501293|83052265|FG000|Maintenance Period|Lack of Efficacy|4|||
46834489|NCT00501293|83052266|FG001|Maintenance Period|Lack of Efficacy|1|||
46834490|NCT00501293|83052265|FG000|Maintenance Period|Noncompliant with study medication|5|||
46834491|NCT00501293|83052266|FG001|Maintenance Period|Noncompliant with study medication|0|||
46834492|NCT00501293|83052265|FG000|Maintenance Period|Went into rehabilitation|1|||
46834493|NCT00501293|83052266|FG001|Maintenance Period|Went into rehabilitation|0|||
46834494|NCT00501293|83052265|FG000|Maintenance Period|Would not wear patch|1|||
46834495|NCT00501293|83052266|FG001|Maintenance Period|Would not wear patch|0|||
46834496|NCT00501293|83052265|FG000|Maintenance Period|Application site reaction|1|||
46834497|NCT00501293|83052266|FG001|Maintenance Period|Application site reaction|0|||
46834498|NCT00482729|83052275|FG000|Overall Study|Adverse Event|29|||
46834499|NCT00482729|83052276|FG001|Overall Study|Adverse Event|33|||
46834500|NCT00482729|83052275|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
46834501|NCT00482729|83052276|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
46834502|NCT00482729|83052275|FG000|Overall Study|Hyperglycemia Criteria|7|||
46834503|NCT00482729|83052276|FG001|Overall Study|Hyperglycemia Criteria|5|||
46834504|NCT00482729|83052275|FG000|Overall Study|Lack of Efficacy|4|||
46834505|NCT00482729|83052276|FG001|Overall Study|Lack of Efficacy|16|||
46834506|NCT00482729|83052275|FG000|Overall Study|Lost to Follow-up|86|||
46834507|NCT00482729|83052276|FG001|Overall Study|Lost to Follow-up|66|||
46834508|NCT00482729|83052275|FG000|Overall Study|Physician Decision|10|||
46834509|NCT00482729|83052276|FG001|Overall Study|Physician Decision|7|||
46834510|NCT00482729|83052275|FG000|Overall Study|Pregnancy|4|||
46834511|NCT00482729|83052276|FG001|Overall Study|Pregnancy|2|||
46834512|NCT00482729|83052275|FG000|Overall Study|Protocol Violation|10|||
46834513|NCT00482729|83052276|FG001|Overall Study|Protocol Violation|18|||
46834514|NCT00482729|83052275|FG000|Overall Study|Withdrawal by Subject|67|||
46834515|NCT00482729|83052276|FG001|Overall Study|Withdrawal by Subject|69|||
46834516|NCT00359762|83052284|FG000|Period II|Adverse Event|17|||
46834517|NCT00359762|83052285|FG001|Period II|Adverse Event|0|||
46767021|NCT00623428|82985146|FG000|Follow-up Period|Failure to return|10|||
46767022|NCT00623428|82985147|FG001|Follow-up Period|Failure to return|2|||
46767023|NCT00623428|82985146|FG000|Follow-up Period|Patient withdrew consent|5|||
46767024|NCT00623428|82985147|FG001|Follow-up Period|Patient withdrew consent|4|||
46767025|NCT00623428|82985146|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
46767026|NCT00623428|82985147|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
46767027|NCT00623428|82985146|FG000|Follow-up Period|Did not cooperate|0|||
46767028|NCT00623428|82985147|FG001|Follow-up Period|Did not cooperate|3|||
46767029|NCT00623428|82985146|FG000|Follow-up Period|Reason not specified|1|||
46767030|NCT00623428|82985147|FG001|Follow-up Period|Reason not specified|1|||
46767031|NCT00623428|82985146|FG000|Follow-up Period|Death|0|||
46767032|NCT00623428|82985147|FG001|Follow-up Period|Death|1|||
46767033|NCT00784134|82985155|FG000|Overall Study|Lost to Follow-up|3|||
46767034|NCT00784134|82985156|FG001|Overall Study|Lost to Follow-up|6|||
46834518|NCT00359762|83052286|FG002|Period II|Adverse Event|0|||
46834519|NCT00359762|83052287|FG003|Period II|Adverse Event|0|||
46834520|NCT00359762|83052288|FG004|Period II|Adverse Event|49|||
46767035|NCT00776100|82985164|FG000|Overall Study|Disease Progression|1|||
46767036|NCT00776100|82985165|FG001|Overall Study|Disease Progression|0|||
46767037|NCT00783432|82985173|FG000|Overall Study|Adverse Event|22|||
46767038|NCT00783432|82985174|FG001|Overall Study|Adverse Event|17|||
46767039|NCT00783432|82985173|FG000|Overall Study|Lack of Efficacy|20|||
46834521|NCT00359762|83052284|FG000|Period II|Protocol Violation|18|||
46834522|NCT00359762|83052285|FG001|Period II|Protocol Violation|0|||
46834523|NCT00359762|83052286|FG002|Period II|Protocol Violation|0|||
46834524|NCT00359762|83052287|FG003|Period II|Protocol Violation|0|||
46834525|NCT00359762|83052288|FG004|Period II|Protocol Violation|11|||
46834526|NCT00359762|83052284|FG000|Period II|Physician Decision|17|||
46767040|NCT00783432|82985174|FG001|Overall Study|Lack of Efficacy|21|||
46767041|NCT00783432|82985173|FG000|Overall Study|Lost to Follow-up|11|||
46834527|NCT00359762|83052285|FG001|Period II|Physician Decision|0|||
46834528|NCT00359762|83052286|FG002|Period II|Physician Decision|0|||
46834529|NCT00359762|83052287|FG003|Period II|Physician Decision|0|||
46834530|NCT00359762|83052288|FG004|Period II|Physician Decision|23|||
46767042|NCT00783432|82985174|FG001|Overall Study|Lost to Follow-up|6|||
46767043|NCT00783432|82985173|FG000|Overall Study|Withdrawal by Subject|23|||
46767044|NCT00783432|82985174|FG001|Overall Study|Withdrawal by Subject|20|||
46767045|NCT00783432|82985173|FG000|Overall Study|subject moved|3|||
46767046|NCT00783432|82985174|FG001|Overall Study|subject moved|5|||
46767047|NCT00783432|82985173|FG000|Overall Study|Protocol Violation|6|||
46767048|NCT00783432|82985174|FG001|Overall Study|Protocol Violation|9|||
46767049|NCT00783198|82985183|FG000|Overall Study|Adverse Event|15|||
46767050|NCT00783198|82985184|FG001|Overall Study|Adverse Event|19|||
46834531|NCT00359762|83052284|FG000|Period II|Death|2|||
46834532|NCT00359762|83052285|FG001|Period II|Death|0|||
46834533|NCT00359762|83052286|FG002|Period II|Death|0|||
46834534|NCT00359762|83052287|FG003|Period II|Death|0|||
46834535|NCT00359762|83052288|FG004|Period II|Death|4|||
46834536|NCT00359762|83052284|FG000|Period II|Lack of Efficacy|11|||
46834537|NCT00359762|83052285|FG001|Period II|Lack of Efficacy|0|||
46834538|NCT00359762|83052286|FG002|Period II|Lack of Efficacy|0|||
46834539|NCT00359762|83052287|FG003|Period II|Lack of Efficacy|0|||
46834540|NCT00359762|83052288|FG004|Period II|Lack of Efficacy|8|||
46834541|NCT00359762|83052284|FG000|Period II|Lost to follow up|5|||
46834542|NCT00359762|83052285|FG001|Period II|Lost to follow up|0|||
46834543|NCT00359762|83052286|FG002|Period II|Lost to follow up|0|||
46834544|NCT00359762|83052287|FG003|Period II|Lost to follow up|0|||
46834545|NCT00359762|83052288|FG004|Period II|Lost to follow up|5|||
46834546|NCT00359762|83052284|FG000|Period II|Entry Criteria Not Met|8|||
46834547|NCT00359762|83052285|FG001|Period II|Entry Criteria Not Met|0|||
46834548|NCT00359762|83052286|FG002|Period II|Entry Criteria Not Met|0|||
46834549|NCT00359762|83052287|FG003|Period II|Entry Criteria Not Met|0|||
46834550|NCT00359762|83052288|FG004|Period II|Entry Criteria Not Met|4|||
46834551|NCT00359762|83052284|FG000|Period II|Subject Decision|50|||
46834552|NCT00359762|83052285|FG001|Period II|Subject Decision|0|||
46834553|NCT00359762|83052286|FG002|Period II|Subject Decision|0|||
46834554|NCT00359762|83052287|FG003|Period II|Subject Decision|0|||
46834555|NCT00359762|83052288|FG004|Period II|Subject Decision|70|||
46834556|NCT00359762|83052284|FG000|Period III|Protocol Violation|0|||
47062325|NCT04304534|83343177|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
47062326|NCT04304534|83343178|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
47062327|NCT04304534|83343175|FG000|Overall Study|Non-Compliance with study drug|0|||
46767051|NCT00783198|82985185|FG002|Overall Study|Adverse Event|3|||
46767052|NCT00783198|82985183|FG000|Overall Study|Lost to Follow-up|11|||
46834557|NCT00359762|83052285|FG001|Period III|Protocol Violation|5|||
46834558|NCT00359762|83052286|FG002|Period III|Protocol Violation|3|||
46834559|NCT00359762|83052287|FG003|Period III|Protocol Violation|8|||
46834560|NCT00359762|83052288|FG004|Period III|Protocol Violation|0|||
46834561|NCT00359762|83052284|FG000|Period III|Adverse Event|0|||
46767053|NCT00783198|82985184|FG001|Overall Study|Lost to Follow-up|1|||
46834562|NCT00359762|83052285|FG001|Period III|Adverse Event|3|||
46834563|NCT00359762|83052286|FG002|Period III|Adverse Event|4|||
46834564|NCT00359762|83052287|FG003|Period III|Adverse Event|10|||
46834565|NCT00359762|83052288|FG004|Period III|Adverse Event|0|||
46834566|NCT00359762|83052284|FG000|Period III|Physician Decision|0|||
46834567|NCT00359762|83052285|FG001|Period III|Physician Decision|5|||
46834568|NCT00359762|83052286|FG002|Period III|Physician Decision|9|||
46834569|NCT00359762|83052287|FG003|Period III|Physician Decision|15|||
46834570|NCT00359762|83052288|FG004|Period III|Physician Decision|0|||
46834571|NCT00359762|83052284|FG000|Period III|Lack of Efficacy|0|||
46834572|NCT00359762|83052285|FG001|Period III|Lack of Efficacy|7|||
46834573|NCT00359762|83052286|FG002|Period III|Lack of Efficacy|5|||
46834574|NCT00359762|83052287|FG003|Period III|Lack of Efficacy|9|||
46834575|NCT00359762|83052288|FG004|Period III|Lack of Efficacy|0|||
46834576|NCT00359762|83052284|FG000|Period III|Lost to follow up|0|||
46834577|NCT00359762|83052285|FG001|Period III|Lost to follow up|1|||
46834578|NCT00359762|83052286|FG002|Period III|Lost to follow up|1|||
46834579|NCT00359762|83052287|FG003|Period III|Lost to follow up|2|||
46942495|NCT02733627|83179735|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
46834580|NCT00359762|83052288|FG004|Period III|Lost to follow up|0|||
46834581|NCT00359762|83052284|FG000|Period III|Entry Criteria Not Met|0|||
46834582|NCT00359762|83052285|FG001|Period III|Entry Criteria Not Met|1|||
46834583|NCT00359762|83052286|FG002|Period III|Entry Criteria Not Met|0|||
46834584|NCT00359762|83052287|FG003|Period III|Entry Criteria Not Met|1|||
46834585|NCT00359762|83052288|FG004|Period III|Entry Criteria Not Met|0|||
46767054|NCT00783198|82985185|FG002|Overall Study|Lost to Follow-up|7|||
46767055|NCT00783198|82985183|FG000|Overall Study|Withdrawal by Subject|22|||
46767056|NCT00783198|82985184|FG001|Overall Study|Withdrawal by Subject|14|||
46834586|NCT00359762|83052284|FG000|Period III|Subject Decision|0|||
46834587|NCT00359762|83052285|FG001|Period III|Subject Decision|7|||
46834588|NCT00359762|83052286|FG002|Period III|Subject Decision|8|||
46834589|NCT00359762|83052287|FG003|Period III|Subject Decision|20|||
46834590|NCT00359762|83052288|FG004|Period III|Subject Decision|0|||
46834591|NCT00347438|83052302|FG000|Overall Study|Withdrawal by Subject|1|||
46767057|NCT00783198|82985185|FG002|Overall Study|Withdrawal by Subject|20|||
47062328|NCT04304534|83343176|FG001|Overall Study|Non-Compliance with study drug|1|||
47062329|NCT04304534|83343177|FG002|Overall Study|Non-Compliance with study drug|1|||
47062330|NCT04304534|83343178|FG003|Overall Study|Non-Compliance with study drug|1|||
47062331|NCT04304534|83343175|FG000|Overall Study|Lost to Follow-up|0|||
47062332|NCT04304534|83343176|FG001|Overall Study|Lost to Follow-up|1|||
47062333|NCT04304534|83343177|FG002|Overall Study|Lost to Follow-up|2|||
47062334|NCT04304534|83343178|FG003|Overall Study|Lost to Follow-up|3|||
47062335|NCT04304534|83343175|FG000|Overall Study|Unspecific|4|||
47062336|NCT04304534|83343176|FG001|Overall Study|Unspecific|2|||
46767058|NCT00783198|82985183|FG000|Overall Study|Noncompliance with protocol|7|||
46767059|NCT00783198|82985184|FG001|Overall Study|Noncompliance with protocol|7|||
46767060|NCT00783198|82985185|FG002|Overall Study|Noncompliance with protocol|10|||
46767061|NCT00783198|82985183|FG000|Overall Study|Did not meet protocol eligibility|0|||
46767062|NCT00783198|82985184|FG001|Overall Study|Did not meet protocol eligibility|1|||
46767063|NCT00783198|82985185|FG002|Overall Study|Did not meet protocol eligibility|0|||
46767064|NCT00783198|82985183|FG000|Overall Study|Administrative|2|||
46767065|NCT00783198|82985184|FG001|Overall Study|Administrative|1|||
46767066|NCT00783198|82985185|FG002|Overall Study|Administrative|2|||
46767067|NCT00789360|82985195|FG000|Overall Study|Protocol Violation|3|||
46767068|NCT00789360|82985196|FG001|Overall Study|Protocol Violation|1|||
46767069|NCT00782496|82985205|FG000|Overall Study|Lost to Follow-up|14|||
46834592|NCT00347438|83052302|FG000|Overall Study|Physician Decision|1|||
46834593|NCT00329238|83052308|FG000|Overall Study|Adverse Event|147|||
46834594|NCT00329238|83052309|FG001|Overall Study|Adverse Event|129|||
46834595|NCT00329238|83052308|FG000|Overall Study|Protocol Violation|23|||
46834596|NCT00329238|83052309|FG001|Overall Study|Protocol Violation|34|||
46834597|NCT00329238|83052308|FG000|Overall Study|Lost to Follow-up|2|||
46834598|NCT00329238|83052309|FG001|Overall Study|Lost to Follow-up|6|||
46834599|NCT00329238|83052308|FG000|Overall Study|Withdrawal by Subject|64|||
46834600|NCT00329238|83052309|FG001|Overall Study|Withdrawal by Subject|58|||
46834601|NCT00329238|83052308|FG000|Overall Study|Other reason (not specified)|40|||
46834602|NCT00329238|83052309|FG001|Overall Study|Other reason (not specified)|54|||
46834603|NCT00329160|83052317|FG000|Overall Study|Adverse Event|27|||
46834604|NCT00329160|83052317|FG000|Overall Study|Withdrawal by Subject|13|||
46834605|NCT00329160|83052317|FG000|Overall Study|Protocol Violation|2|||
46834606|NCT00329160|83052317|FG000|Overall Study|Did not Receive Study Drug|1|||
46834607|NCT00329160|83052317|FG000|Overall Study|Incomplete IVUS|45|||
46834608|NCT00328926|83052324|FG000|Overall Study|Pregnancy|2|||
46834609|NCT00328926|83052325|FG001|Overall Study|Pregnancy|1|||
46834610|NCT00328926|83052326|FG002|Overall Study|Pregnancy|0|||
46834611|NCT00328926|83052324|FG000|Overall Study|Lost to Follow-up|0|||
46834612|NCT00328926|83052325|FG001|Overall Study|Lost to Follow-up|1|||
46834613|NCT00328926|83052326|FG002|Overall Study|Lost to Follow-up|0|||
46834614|NCT00328926|83052324|FG000|Overall Study|Death|0|||
46834615|NCT00328926|83052325|FG001|Overall Study|Death|0|||
46834616|NCT00328926|83052326|FG002|Overall Study|Death|1|||
46834617|NCT00328926|83052324|FG000|Overall Study|In vitro fertilization treatment|0|||
46834618|NCT00328926|83052325|FG001|Overall Study|In vitro fertilization treatment|0|||
46834619|NCT00328926|83052326|FG002|Overall Study|In vitro fertilization treatment|1|||
46834620|NCT00328926|83052324|FG000|Overall Study|Lack of ovarian response|0|||
46834621|NCT00328926|83052325|FG001|Overall Study|Lack of ovarian response|1|||
46638006|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
46834622|NCT00328926|83052326|FG002|Overall Study|Lack of ovarian response|0|||
46942496|NCT02733627|83179736|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
46942497|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942498|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
46942499|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942500|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
46942501|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
46942502|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
46767070|NCT00782496|82985206|FG001|Overall Study|Lost to Follow-up|15|||
46942503|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
46767071|NCT00782418|82985213|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
46767072|NCT00782418|82985214|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
46834623|NCT00319254|83052334|FG000|Overall Study|Withdrawal by Subject|4|||
46834624|NCT00319254|83052334|FG000|Overall Study|Death|46|||
46834625|NCT00319254|83052334|FG000|Overall Study|Lost to Follow-up|2|||
46834626|NCT00319254|83052334|FG000|Overall Study|Enrolled, Not Treated|2|||
46834627|NCT00319098|83052342|FG000|Overall Study|Serious adverse event|3|||
46834628|NCT00319098|83052343|FG001|Overall Study|Serious adverse event|0|||
46834629|NCT00319098|83052342|FG000|Overall Study|Adverse Event|20|||
47062337|NCT04304534|83343177|FG002|Overall Study|Unspecific|2|||
46767073|NCT00782418|82985215|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
46834630|NCT00319098|83052343|FG001|Overall Study|Adverse Event|1|||
47062338|NCT04304534|83343178|FG003|Overall Study|Unspecific|2|||
47062339|NCT04304534|83343175|FG000|Overall Study|Technical Problems|2|||
46834631|NCT00319098|83052342|FG000|Overall Study|Withdrawal by Subject|37|||
46834632|NCT00319098|83052343|FG001|Overall Study|Withdrawal by Subject|8|||
46834633|NCT00319098|83052342|FG000|Overall Study|Migrated/moved from study area|2|||
46834634|NCT00319098|83052343|FG001|Overall Study|Migrated/moved from study area|1|||
46834635|NCT00319098|83052342|FG000|Overall Study|Lost to Follow-up|37|||
46834636|NCT00319098|83052343|FG001|Overall Study|Lost to Follow-up|13|||
46834637|NCT00319098|83052342|FG000|Overall Study|Others|33|||
46834638|NCT00319098|83052343|FG001|Overall Study|Others|8|||
46834639|NCT00319098|83052342|FG000|Overall Study|Protocol Violation|3|||
46834640|NCT00319098|83052343|FG001|Overall Study|Protocol Violation|1|||
46834641|NCT00347360|83052368|FG000|Overall Study|Adverse Event|1|||
46834642|NCT00347360|83052369|FG001|Overall Study|Adverse Event|2|||
46834643|NCT00347360|83052370|FG002|Overall Study|Adverse Event|0|||
46834644|NCT00347360|83052371|FG003|Overall Study|Adverse Event|4|||
46834645|NCT00347360|83052372|FG004|Overall Study|Adverse Event|1|||
46834646|NCT00347360|83052373|FG005|Overall Study|Adverse Event|2|||
46834647|NCT00347360|83052374|FG006|Overall Study|Adverse Event|2|||
46834648|NCT00347360|83052375|FG007|Overall Study|Adverse Event|0|||
46834649|NCT00347360|83052376|FG008|Overall Study|Adverse Event|2|||
46834650|NCT00347360|83052377|FG009|Overall Study|Adverse Event|3|||
46834651|NCT00347360|83052378|FG010|Overall Study|Adverse Event|3|||
46834652|NCT00347360|83052379|FG011|Overall Study|Adverse Event|1|||
46834653|NCT00347360|83052380|FG012|Overall Study|Adverse Event|3|||
46834654|NCT00347360|83052381|FG013|Overall Study|Adverse Event|2|||
46834655|NCT00347360|83052382|FG014|Overall Study|Adverse Event|2|||
46834656|NCT00347360|83052368|FG000|Overall Study|Lost to Follow-up|0|||
46834657|NCT00347360|83052369|FG001|Overall Study|Lost to Follow-up|0|||
46834658|NCT00347360|83052370|FG002|Overall Study|Lost to Follow-up|0|||
46834659|NCT00347360|83052371|FG003|Overall Study|Lost to Follow-up|2|||
46834660|NCT00347360|83052372|FG004|Overall Study|Lost to Follow-up|1|||
46834661|NCT00347360|83052373|FG005|Overall Study|Lost to Follow-up|1|||
46834662|NCT00347360|83052374|FG006|Overall Study|Lost to Follow-up|0|||
46834663|NCT00347360|83052375|FG007|Overall Study|Lost to Follow-up|1|||
46834664|NCT00347360|83052376|FG008|Overall Study|Lost to Follow-up|1|||
46834665|NCT00347360|83052377|FG009|Overall Study|Lost to Follow-up|2|||
46834666|NCT00347360|83052378|FG010|Overall Study|Lost to Follow-up|0|||
46834667|NCT00347360|83052379|FG011|Overall Study|Lost to Follow-up|0|||
46834668|NCT00347360|83052380|FG012|Overall Study|Lost to Follow-up|1|||
46834669|NCT00347360|83052381|FG013|Overall Study|Lost to Follow-up|0|||
46834670|NCT00347360|83052382|FG014|Overall Study|Lost to Follow-up|0|||
46834671|NCT00347360|83052368|FG000|Overall Study|Protocol Violation|2|||
46834672|NCT00347360|83052369|FG001|Overall Study|Protocol Violation|3|||
46834673|NCT00347360|83052370|FG002|Overall Study|Protocol Violation|1|||
46834674|NCT00347360|83052371|FG003|Overall Study|Protocol Violation|2|||
46834675|NCT00347360|83052372|FG004|Overall Study|Protocol Violation|1|||
46834676|NCT00347360|83052373|FG005|Overall Study|Protocol Violation|2|||
46834677|NCT00347360|83052374|FG006|Overall Study|Protocol Violation|0|||
46834678|NCT00347360|83052375|FG007|Overall Study|Protocol Violation|0|||
46834679|NCT00347360|83052376|FG008|Overall Study|Protocol Violation|1|||
46834680|NCT00347360|83052377|FG009|Overall Study|Protocol Violation|2|||
46834681|NCT00347360|83052378|FG010|Overall Study|Protocol Violation|0|||
46834682|NCT00347360|83052379|FG011|Overall Study|Protocol Violation|0|||
46834683|NCT00347360|83052380|FG012|Overall Study|Protocol Violation|0|||
46834684|NCT00347360|83052381|FG013|Overall Study|Protocol Violation|1|||
46942504|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942505|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942506|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942507|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46834685|NCT00347360|83052382|FG014|Overall Study|Protocol Violation|0|||
46942508|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942509|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942510|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942511|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46942512|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
46834686|NCT00347360|83052368|FG000|Overall Study|Withdrawal by Subject|0|||
46942513|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
46834687|NCT00347360|83052369|FG001|Overall Study|Withdrawal by Subject|1|||
46834688|NCT00347360|83052370|FG002|Overall Study|Withdrawal by Subject|2|||
46834689|NCT00347360|83052371|FG003|Overall Study|Withdrawal by Subject|4|||
46834690|NCT00347360|83052372|FG004|Overall Study|Withdrawal by Subject|1|||
46834691|NCT00347360|83052373|FG005|Overall Study|Withdrawal by Subject|2|||
46834692|NCT00347360|83052374|FG006|Overall Study|Withdrawal by Subject|1|||
46834693|NCT00347360|83052375|FG007|Overall Study|Withdrawal by Subject|1|||
46834694|NCT00347360|83052376|FG008|Overall Study|Withdrawal by Subject|1|||
46834695|NCT00347360|83052377|FG009|Overall Study|Withdrawal by Subject|1|||
46834696|NCT00347360|83052378|FG010|Overall Study|Withdrawal by Subject|0|||
46834697|NCT00347360|83052379|FG011|Overall Study|Withdrawal by Subject|3|||
46834698|NCT00347360|83052380|FG012|Overall Study|Withdrawal by Subject|4|||
46834699|NCT00347360|83052381|FG013|Overall Study|Withdrawal by Subject|2|||
46834700|NCT00347360|83052382|FG014|Overall Study|Withdrawal by Subject|1|||
46834701|NCT00347360|83052368|FG000|Overall Study|Lack of Efficacy|1|||
46834702|NCT00347360|83052369|FG001|Overall Study|Lack of Efficacy|1|||
46834703|NCT00347360|83052370|FG002|Overall Study|Lack of Efficacy|3|||
46834704|NCT00347360|83052371|FG003|Overall Study|Lack of Efficacy|1|||
46834705|NCT00347360|83052372|FG004|Overall Study|Lack of Efficacy|0|||
46834706|NCT00347360|83052373|FG005|Overall Study|Lack of Efficacy|1|||
46834707|NCT00347360|83052374|FG006|Overall Study|Lack of Efficacy|0|||
46834708|NCT00347360|83052375|FG007|Overall Study|Lack of Efficacy|1|||
46834709|NCT00347360|83052376|FG008|Overall Study|Lack of Efficacy|1|||
46834710|NCT00347360|83052377|FG009|Overall Study|Lack of Efficacy|0|||
46834711|NCT00347360|83052378|FG010|Overall Study|Lack of Efficacy|0|||
46834712|NCT00347360|83052379|FG011|Overall Study|Lack of Efficacy|0|||
46834713|NCT00347360|83052380|FG012|Overall Study|Lack of Efficacy|0|||
46834714|NCT00347360|83052381|FG013|Overall Study|Lack of Efficacy|0|||
46834715|NCT00347360|83052382|FG014|Overall Study|Lack of Efficacy|0|||
46834716|NCT00347360|83052368|FG000|Overall Study|Reason not listed/blank|1|||
46834717|NCT00347360|83052369|FG001|Overall Study|Reason not listed/blank|0|||
46834718|NCT00347360|83052370|FG002|Overall Study|Reason not listed/blank|0|||
46834719|NCT00347360|83052371|FG003|Overall Study|Reason not listed/blank|0|||
46834720|NCT00347360|83052372|FG004|Overall Study|Reason not listed/blank|0|||
46834721|NCT00347360|83052373|FG005|Overall Study|Reason not listed/blank|0|||
46834722|NCT00347360|83052374|FG006|Overall Study|Reason not listed/blank|1|||
46834723|NCT00347360|83052375|FG007|Overall Study|Reason not listed/blank|0|||
46834724|NCT00347360|83052376|FG008|Overall Study|Reason not listed/blank|0|||
46834725|NCT00347360|83052377|FG009|Overall Study|Reason not listed/blank|0|||
46834726|NCT00347360|83052378|FG010|Overall Study|Reason not listed/blank|0|||
46834727|NCT00347360|83052379|FG011|Overall Study|Reason not listed/blank|0|||
46834728|NCT00347360|83052380|FG012|Overall Study|Reason not listed/blank|0|||
46834729|NCT00347360|83052381|FG013|Overall Study|Reason not listed/blank|1|||
46834730|NCT00347360|83052382|FG014|Overall Study|Reason not listed/blank|0|||
46767074|NCT00782418|82985216|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
46767075|NCT00782418|82985217|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
46767076|NCT00782418|82985218|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
46767077|NCT00782418|82985219|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
46834731|NCT00347360|83052368|FG000|Overall Study|Per sponsors instruction|0|||
46834732|NCT00347360|83052369|FG001|Overall Study|Per sponsors instruction|1|||
46834733|NCT00347360|83052370|FG002|Overall Study|Per sponsors instruction|0|||
46834734|NCT00347360|83052371|FG003|Overall Study|Per sponsors instruction|0|||
46834735|NCT00347360|83052372|FG004|Overall Study|Per sponsors instruction|0|||
46834736|NCT00347360|83052373|FG005|Overall Study|Per sponsors instruction|0|||
46834737|NCT00347360|83052374|FG006|Overall Study|Per sponsors instruction|0|||
46834738|NCT00347360|83052375|FG007|Overall Study|Per sponsors instruction|0|||
46834739|NCT00347360|83052376|FG008|Overall Study|Per sponsors instruction|0|||
46834740|NCT00347360|83052377|FG009|Overall Study|Per sponsors instruction|0|||
46834741|NCT00347360|83052378|FG010|Overall Study|Per sponsors instruction|0|||
46834742|NCT00347360|83052379|FG011|Overall Study|Per sponsors instruction|0|||
46834743|NCT00347360|83052380|FG012|Overall Study|Per sponsors instruction|0|||
46834744|NCT00347360|83052381|FG013|Overall Study|Per sponsors instruction|0|||
46834745|NCT00347360|83052382|FG014|Overall Study|Per sponsors instruction|0|||
46767078|NCT00782418|82985213|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
46767079|NCT00782418|82985214|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
46767080|NCT00782418|82985215|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
46767081|NCT00782418|82985216|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
46767082|NCT00782418|82985217|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
46767083|NCT00782418|82985218|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
46767084|NCT00782418|82985219|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
46834746|NCT00347360|83052368|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
46834747|NCT00347360|83052369|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
46834748|NCT00347360|83052370|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
46834749|NCT00347360|83052371|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
46767085|NCT00782340|82985236|FG000|Open Label Titration|Adverse Event|12|||
46767086|NCT00782340|82985237|FG001|Open Label Titration|Adverse Event|0|||
46834750|NCT00347360|83052372|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
46834751|NCT00347360|83052373|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
46834752|NCT00347360|83052374|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
46834753|NCT00347360|83052375|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
46834754|NCT00347360|83052376|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
46834755|NCT00347360|83052377|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
46767087|NCT00782340|82985238|FG002|Open Label Titration|Adverse Event|0|||
46767088|NCT00782340|82985236|FG000|Open Label Titration|Treatment failure|50|||
46834756|NCT00347360|83052378|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
46834757|NCT00347360|83052379|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
46834758|NCT00347360|83052380|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
46834759|NCT00347360|83052381|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
46834760|NCT00347360|83052382|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
46834761|NCT00347360|83052368|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
46834762|NCT00347360|83052369|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
46834763|NCT00347360|83052370|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
46767089|NCT00782340|82985237|FG001|Open Label Titration|Treatment failure|0|||
46767090|NCT00782340|82985238|FG002|Open Label Titration|Treatment failure|0|||
46942514|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
46942515|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
46942516|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
46942517|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
46942518|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
46942519|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
46942520|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
46942521|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
46942522|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
46942523|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
46942524|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
46942525|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
46942526|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
46942527|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
46942528|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
46942529|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
46942530|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
46942531|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46767091|NCT00782340|82985236|FG000|Open Label Titration|Protocol Violation|5|||
46767092|NCT00782340|82985237|FG001|Open Label Titration|Protocol Violation|0|||
46767093|NCT00782340|82985238|FG002|Open Label Titration|Protocol Violation|0|||
46767094|NCT00782340|82985236|FG000|Open Label Titration|Withdrawal by Subject|5|||
46767095|NCT00782340|82985237|FG001|Open Label Titration|Withdrawal by Subject|0|||
46767096|NCT00782340|82985238|FG002|Open Label Titration|Withdrawal by Subject|0|||
46834764|NCT00347360|83052371|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
46834765|NCT00347360|83052372|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
46834766|NCT00347360|83052373|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
46834767|NCT00347360|83052374|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
46834768|NCT00347360|83052375|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
46767097|NCT00782340|82985236|FG000|Open Label Titration|Enrollment capped|16|||
46767098|NCT00782340|82985237|FG001|Open Label Titration|Enrollment capped|0|||
46942532|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46834769|NCT00347360|83052376|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
46834770|NCT00347360|83052377|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
46834771|NCT00347360|83052378|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
46942533|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942534|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942535|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942536|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942537|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942538|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942539|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942540|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942541|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
47062340|NCT04304534|83343176|FG001|Overall Study|Technical Problems|2|||
47062341|NCT04304534|83343177|FG002|Overall Study|Technical Problems|3|||
47062342|NCT04304534|83343178|FG003|Overall Study|Technical Problems|4|||
47062343|NCT04304534|83343175|FG000|Overall Study|Death|7|||
47062344|NCT04304534|83343176|FG001|Overall Study|Death|2|||
47062345|NCT04304534|83343177|FG002|Overall Study|Death|4|||
47062346|NCT04304534|83343178|FG003|Overall Study|Death|3|||
47062347|NCT04304534|83343175|FG000|Overall Study|Withdrawal by Subject|7|||
47062348|NCT04304534|83343176|FG001|Overall Study|Withdrawal by Subject|2|||
46942542|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942543|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
47062349|NCT04304534|83343177|FG002|Overall Study|Withdrawal by Subject|7|||
47062350|NCT04304534|83343178|FG003|Overall Study|Withdrawal by Subject|4|||
47062351|NCT04304534|83343175|FG000|Overall Study|Physician Decision|4|||
46767099|NCT00782340|82985238|FG002|Open Label Titration|Enrollment capped|0|||
46767100|NCT00782340|82985236|FG000|Open Label Titration|Did not meet responder criteria|2|||
46767101|NCT00782340|82985237|FG001|Open Label Titration|Did not meet responder criteria|0|||
46942544|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
46942545|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
46942546|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942547|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
46942548|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
46834772|NCT00347360|83052379|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
46834773|NCT00347360|83052380|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
46834774|NCT00347360|83052381|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
46834775|NCT00347360|83052382|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
46834776|NCT00347360|83052368|FG000|Overall Study|Abnormal lab values|0|||
46834777|NCT00347360|83052369|FG001|Overall Study|Abnormal lab values|0|||
46834778|NCT00347360|83052370|FG002|Overall Study|Abnormal lab values|0|||
46834779|NCT00347360|83052371|FG003|Overall Study|Abnormal lab values|0|||
46834780|NCT00347360|83052372|FG004|Overall Study|Abnormal lab values|0|||
46834781|NCT00347360|83052373|FG005|Overall Study|Abnormal lab values|0|||
46834782|NCT00347360|83052374|FG006|Overall Study|Abnormal lab values|1|||
46834783|NCT00347360|83052375|FG007|Overall Study|Abnormal lab values|0|||
46834784|NCT00347360|83052376|FG008|Overall Study|Abnormal lab values|0|||
46834785|NCT00347360|83052377|FG009|Overall Study|Abnormal lab values|0|||
46834786|NCT00347360|83052378|FG010|Overall Study|Abnormal lab values|0|||
46834787|NCT00347360|83052379|FG011|Overall Study|Abnormal lab values|0|||
46834788|NCT00347360|83052380|FG012|Overall Study|Abnormal lab values|0|||
46834789|NCT00347360|83052381|FG013|Overall Study|Abnormal lab values|0|||
46834790|NCT00347360|83052382|FG014|Overall Study|Abnormal lab values|0|||
46834791|NCT00347360|83052368|FG000|Overall Study|PI recommended early withdrawal|0|||
46834792|NCT00347360|83052369|FG001|Overall Study|PI recommended early withdrawal|0|||
46834793|NCT00347360|83052370|FG002|Overall Study|PI recommended early withdrawal|0|||
46834794|NCT00347360|83052371|FG003|Overall Study|PI recommended early withdrawal|0|||
46834795|NCT00347360|83052372|FG004|Overall Study|PI recommended early withdrawal|0|||
46834796|NCT00347360|83052373|FG005|Overall Study|PI recommended early withdrawal|0|||
46834797|NCT00347360|83052374|FG006|Overall Study|PI recommended early withdrawal|0|||
46834798|NCT00347360|83052375|FG007|Overall Study|PI recommended early withdrawal|0|||
46834799|NCT00347360|83052376|FG008|Overall Study|PI recommended early withdrawal|0|||
46834800|NCT00347360|83052377|FG009|Overall Study|PI recommended early withdrawal|1|||
46834801|NCT00347360|83052378|FG010|Overall Study|PI recommended early withdrawal|0|||
46834802|NCT00347360|83052379|FG011|Overall Study|PI recommended early withdrawal|0|||
46834803|NCT00347360|83052380|FG012|Overall Study|PI recommended early withdrawal|0|||
46834804|NCT00347360|83052381|FG013|Overall Study|PI recommended early withdrawal|0|||
46834805|NCT00347360|83052382|FG014|Overall Study|PI recommended early withdrawal|0|||
46834806|NCT00347360|83052368|FG000|Overall Study|Did not meet criteria before ABPM|0|||
46834807|NCT00347360|83052369|FG001|Overall Study|Did not meet criteria before ABPM|0|||
46834808|NCT00347360|83052370|FG002|Overall Study|Did not meet criteria before ABPM|0|||
46834809|NCT00347360|83052371|FG003|Overall Study|Did not meet criteria before ABPM|0|||
46834810|NCT00347360|83052372|FG004|Overall Study|Did not meet criteria before ABPM|0|||
46834811|NCT00347360|83052373|FG005|Overall Study|Did not meet criteria before ABPM|0|||
46834812|NCT00347360|83052374|FG006|Overall Study|Did not meet criteria before ABPM|0|||
46834813|NCT00347360|83052375|FG007|Overall Study|Did not meet criteria before ABPM|0|||
46834814|NCT00347360|83052376|FG008|Overall Study|Did not meet criteria before ABPM|0|||
46834815|NCT00347360|83052377|FG009|Overall Study|Did not meet criteria before ABPM|0|||
46834816|NCT00347360|83052378|FG010|Overall Study|Did not meet criteria before ABPM|1|||
47062352|NCT04304534|83343176|FG001|Overall Study|Physician Decision|9|||
47062353|NCT04304534|83343177|FG002|Overall Study|Physician Decision|9|||
46767102|NCT00782340|82985238|FG002|Open Label Titration|Did not meet responder criteria|0|||
46767103|NCT00782340|82985236|FG000|Open Label Titration|Lost to Follow-up|5|||
46767104|NCT00782340|82985237|FG001|Open Label Titration|Lost to Follow-up|0|||
46767105|NCT00782340|82985238|FG002|Open Label Titration|Lost to Follow-up|0|||
46767106|NCT00782340|82985236|FG000|Open Label Titration|Randomized in error|6|||
46767107|NCT00782340|82985237|FG001|Open Label Titration|Randomized in error|0|||
46767108|NCT00782340|82985238|FG002|Open Label Titration|Randomized in error|0|||
46834817|NCT00347360|83052379|FG011|Overall Study|Did not meet criteria before ABPM|0|||
46834818|NCT00347360|83052380|FG012|Overall Study|Did not meet criteria before ABPM|0|||
47062354|NCT04304534|83343178|FG003|Overall Study|Physician Decision|5|||
46638007|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
46834819|NCT00347360|83052381|FG013|Overall Study|Did not meet criteria before ABPM|0|||
46834820|NCT00347360|83052382|FG014|Overall Study|Did not meet criteria before ABPM|0|||
46834821|NCT00347360|83052368|FG000|Overall Study|Randomized in error|0|||
47062355|NCT04304534|83343175|FG000|Overall Study|Subject Decision|34|||
46834822|NCT00347360|83052369|FG001|Overall Study|Randomized in error|0|||
46834823|NCT00347360|83052370|FG002|Overall Study|Randomized in error|0|||
46767109|NCT00774852|82985247|FG000|Overall Study|Adverse Event|9|||
46767110|NCT00774852|82985248|FG001|Overall Study|Adverse Event|6|||
46767111|NCT00774852|82985247|FG000|Overall Study|Death|2|||
46767112|NCT00774852|82985248|FG001|Overall Study|Death|1|||
46834824|NCT00347360|83052371|FG003|Overall Study|Randomized in error|0|||
46834825|NCT00347360|83052372|FG004|Overall Study|Randomized in error|0|||
46834826|NCT00347360|83052373|FG005|Overall Study|Randomized in error|0|||
46834827|NCT00347360|83052374|FG006|Overall Study|Randomized in error|0|||
46834828|NCT00347360|83052375|FG007|Overall Study|Randomized in error|0|||
46834829|NCT00347360|83052376|FG008|Overall Study|Randomized in error|0|||
46834830|NCT00347360|83052377|FG009|Overall Study|Randomized in error|0|||
46942549|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
46942550|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
46942551|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
46942552|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942553|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942554|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46834831|NCT00347360|83052378|FG010|Overall Study|Randomized in error|0|||
46834832|NCT00347360|83052379|FG011|Overall Study|Randomized in error|1|||
46834833|NCT00347360|83052380|FG012|Overall Study|Randomized in error|0|||
46834834|NCT00347360|83052381|FG013|Overall Study|Randomized in error|0|||
46834835|NCT00347360|83052382|FG014|Overall Study|Randomized in error|0|||
46834836|NCT00347360|83052368|FG000|Overall Study|Failed inclusion criteria #4|0|||
46834837|NCT00347360|83052369|FG001|Overall Study|Failed inclusion criteria #4|0|||
46834838|NCT00347360|83052370|FG002|Overall Study|Failed inclusion criteria #4|0|||
46834839|NCT00347360|83052371|FG003|Overall Study|Failed inclusion criteria #4|0|||
46834840|NCT00347360|83052372|FG004|Overall Study|Failed inclusion criteria #4|0|||
46834841|NCT00347360|83052373|FG005|Overall Study|Failed inclusion criteria #4|0|||
46834842|NCT00347360|83052374|FG006|Overall Study|Failed inclusion criteria #4|0|||
46834843|NCT00347360|83052375|FG007|Overall Study|Failed inclusion criteria #4|0|||
46834844|NCT00347360|83052376|FG008|Overall Study|Failed inclusion criteria #4|0|||
46834845|NCT00347360|83052377|FG009|Overall Study|Failed inclusion criteria #4|0|||
46834846|NCT00347360|83052378|FG010|Overall Study|Failed inclusion criteria #4|0|||
46942555|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46834847|NCT00347360|83052379|FG011|Overall Study|Failed inclusion criteria #4|1|||
46834848|NCT00347360|83052380|FG012|Overall Study|Failed inclusion criteria #4|0|||
46834849|NCT00347360|83052381|FG013|Overall Study|Failed inclusion criteria #4|0|||
46834850|NCT00347360|83052382|FG014|Overall Study|Failed inclusion criteria #4|0|||
46834851|NCT00347360|83052368|FG000|Overall Study|Prolonged duration between visits|0|||
46834852|NCT00347360|83052369|FG001|Overall Study|Prolonged duration between visits|0|||
46834853|NCT00347360|83052370|FG002|Overall Study|Prolonged duration between visits|0|||
46834854|NCT00347360|83052371|FG003|Overall Study|Prolonged duration between visits|0|||
46942556|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942557|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942558|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942559|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942560|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
46942561|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942562|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46767113|NCT00774852|82985247|FG000|Overall Study|Lack of Efficacy|3|||
46767114|NCT00774852|82985248|FG001|Overall Study|Lack of Efficacy|7|||
46767115|NCT00774852|82985247|FG000|Overall Study|Lost to Follow-up|9|||
46767116|NCT00774852|82985248|FG001|Overall Study|Lost to Follow-up|5|||
46767117|NCT00774852|82985247|FG000|Overall Study|Physician Decision|2|||
46834855|NCT00347360|83052372|FG004|Overall Study|Prolonged duration between visits|0|||
46834856|NCT00347360|83052373|FG005|Overall Study|Prolonged duration between visits|0|||
46834857|NCT00347360|83052374|FG006|Overall Study|Prolonged duration between visits|0|||
46834858|NCT00347360|83052375|FG007|Overall Study|Prolonged duration between visits|0|||
46834859|NCT00347360|83052376|FG008|Overall Study|Prolonged duration between visits|0|||
46834860|NCT00347360|83052377|FG009|Overall Study|Prolonged duration between visits|0|||
46767118|NCT00774852|82985248|FG001|Overall Study|Physician Decision|6|||
46767119|NCT00774852|82985247|FG000|Overall Study|Pregnancy|1|||
46767120|NCT00774852|82985248|FG001|Overall Study|Pregnancy|2|||
46834861|NCT00347360|83052378|FG010|Overall Study|Prolonged duration between visits|0|||
46834862|NCT00347360|83052379|FG011|Overall Study|Prolonged duration between visits|0|||
46834863|NCT00347360|83052380|FG012|Overall Study|Prolonged duration between visits|1|||
46942563|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46834864|NCT00347360|83052381|FG013|Overall Study|Prolonged duration between visits|0|||
46834865|NCT00347360|83052382|FG014|Overall Study|Prolonged duration between visits|0|||
46834866|NCT00347360|83052368|FG000|Overall Study|Subject left town, ran out of study drug|0|||
46834867|NCT00347360|83052369|FG001|Overall Study|Subject left town, ran out of study drug|0|||
46834868|NCT00347360|83052370|FG002|Overall Study|Subject left town, ran out of study drug|0|||
46767121|NCT00774852|82985247|FG000|Overall Study|Withdrawal by Subject|2|||
46767122|NCT00774852|82985248|FG001|Overall Study|Withdrawal by Subject|2|||
46767123|NCT00774852|82985247|FG000|Overall Study|Non-responder|15|||
46834869|NCT00347360|83052371|FG003|Overall Study|Subject left town, ran out of study drug|0|||
46834870|NCT00347360|83052372|FG004|Overall Study|Subject left town, ran out of study drug|0|||
46834871|NCT00347360|83052373|FG005|Overall Study|Subject left town, ran out of study drug|0|||
46834872|NCT00347360|83052374|FG006|Overall Study|Subject left town, ran out of study drug|0|||
46834873|NCT00347360|83052375|FG007|Overall Study|Subject left town, ran out of study drug|0|||
46834874|NCT00347360|83052376|FG008|Overall Study|Subject left town, ran out of study drug|0|||
46834875|NCT00347360|83052377|FG009|Overall Study|Subject left town, ran out of study drug|0|||
46834876|NCT00347360|83052378|FG010|Overall Study|Subject left town, ran out of study drug|0|||
46834877|NCT00347360|83052379|FG011|Overall Study|Subject left town, ran out of study drug|0|||
46834878|NCT00347360|83052380|FG012|Overall Study|Subject left town, ran out of study drug|0|||
46834879|NCT00347360|83052381|FG013|Overall Study|Subject left town, ran out of study drug|1|||
46834880|NCT00347360|83052382|FG014|Overall Study|Subject left town, ran out of study drug|0|||
46834881|NCT00347360|83052368|FG000|Overall Study|Subject refuse to sign updated consent|0|||
46834882|NCT00347360|83052369|FG001|Overall Study|Subject refuse to sign updated consent|0|||
46834883|NCT00347360|83052370|FG002|Overall Study|Subject refuse to sign updated consent|0|||
46834884|NCT00347360|83052371|FG003|Overall Study|Subject refuse to sign updated consent|0|||
46834885|NCT00347360|83052372|FG004|Overall Study|Subject refuse to sign updated consent|0|||
46942564|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
46942565|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942566|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46767124|NCT00774852|82985248|FG001|Overall Study|Non-responder|11|||
46767125|NCT00774852|82985247|FG000|Overall Study|Subject non-compliance|0|||
46767126|NCT00774852|82985248|FG001|Overall Study|Subject non-compliance|1|||
46767127|NCT00774852|82985247|FG000|Overall Study|Protocol Violation|1|||
46767128|NCT00774852|82985248|FG001|Overall Study|Protocol Violation|0|||
46767129|NCT00774852|82985247|FG000|Overall Study|Subject received prohibited medication|1|||
46767130|NCT00774852|82985248|FG001|Overall Study|Subject received prohibited medication|0|||
46767131|NCT00774306|82985268|FG000|Overall Study|Adverse Event|3|||
46767132|NCT00774306|82985269|FG001|Overall Study|Adverse Event|0|||
46767133|NCT00774306|82985270|FG002|Overall Study|Adverse Event|0|||
46767134|NCT00774306|82985271|FG003|Overall Study|Adverse Event|0|||
46767135|NCT00774306|82985268|FG000|Overall Study|Protocol Violation|2|||
46767136|NCT00774306|82985269|FG001|Overall Study|Protocol Violation|0|||
46767137|NCT00774306|82985270|FG002|Overall Study|Protocol Violation|3|||
46767138|NCT00774306|82985271|FG003|Overall Study|Protocol Violation|0|||
46767139|NCT00774306|82985268|FG000|Overall Study|Withdrawal by Subject|6|||
46767140|NCT00774306|82985269|FG001|Overall Study|Withdrawal by Subject|1|||
46767141|NCT00774306|82985270|FG002|Overall Study|Withdrawal by Subject|1|||
46767142|NCT00774306|82985271|FG003|Overall Study|Withdrawal by Subject|0|||
46767143|NCT00774306|82985268|FG000|Overall Study|Lost to Follow-up|6|||
46834886|NCT00347360|83052373|FG005|Overall Study|Subject refuse to sign updated consent|0|||
46834887|NCT00347360|83052374|FG006|Overall Study|Subject refuse to sign updated consent|0|||
46834888|NCT00347360|83052375|FG007|Overall Study|Subject refuse to sign updated consent|0|||
46834889|NCT00347360|83052376|FG008|Overall Study|Subject refuse to sign updated consent|0|||
46834890|NCT00347360|83052377|FG009|Overall Study|Subject refuse to sign updated consent|0|||
46834891|NCT00347360|83052378|FG010|Overall Study|Subject refuse to sign updated consent|0|||
46834892|NCT00347360|83052379|FG011|Overall Study|Subject refuse to sign updated consent|0|||
46834893|NCT00347360|83052380|FG012|Overall Study|Subject refuse to sign updated consent|0|||
46834894|NCT00347360|83052381|FG013|Overall Study|Subject refuse to sign updated consent|0|||
46834895|NCT00347360|83052382|FG014|Overall Study|Subject refuse to sign updated consent|1|||
46834896|NCT00347360|83052368|FG000|Overall Study|Visits conflicted with new job|0|||
46834897|NCT00347360|83052369|FG001|Overall Study|Visits conflicted with new job|0|||
46834898|NCT00347360|83052370|FG002|Overall Study|Visits conflicted with new job|0|||
46834899|NCT00347360|83052371|FG003|Overall Study|Visits conflicted with new job|0|||
46834900|NCT00347360|83052372|FG004|Overall Study|Visits conflicted with new job|0|||
46834901|NCT00347360|83052373|FG005|Overall Study|Visits conflicted with new job|0|||
46942567|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
47062356|NCT04304534|83343176|FG001|Overall Study|Subject Decision|25|||
46767144|NCT00774306|82985269|FG001|Overall Study|Lost to Follow-up|0|||
46767145|NCT00774306|82985270|FG002|Overall Study|Lost to Follow-up|4|||
46767146|NCT00774306|82985271|FG003|Overall Study|Lost to Follow-up|5|||
46834902|NCT00347360|83052374|FG006|Overall Study|Visits conflicted with new job|1|||
46834903|NCT00347360|83052375|FG007|Overall Study|Visits conflicted with new job|0|||
46834904|NCT00347360|83052376|FG008|Overall Study|Visits conflicted with new job|0|||
46834905|NCT00347360|83052377|FG009|Overall Study|Visits conflicted with new job|0|||
46834906|NCT00347360|83052378|FG010|Overall Study|Visits conflicted with new job|0|||
46767147|NCT00774306|82985268|FG000|Overall Study|Death|1|||
46767148|NCT00774306|82985269|FG001|Overall Study|Death|1|||
46767149|NCT00774306|82985270|FG002|Overall Study|Death|0|||
46767150|NCT00774306|82985271|FG003|Overall Study|Death|0|||
46767151|NCT00781326|82985281|FG000|Phase I|Adverse Event|1|||
46942568|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942569|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942570|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942571|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942572|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942573|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942574|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942575|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942576|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
46942577|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942578|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942579|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
46942580|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942581|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942582|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942583|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942584|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942585|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942586|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942587|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942588|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942589|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942590|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942591|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942592|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
46942593|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
46942594|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
46942595|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
46942596|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942597|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942598|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942599|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942600|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942601|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942602|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942603|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942604|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942605|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942606|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942607|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942608|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
46942609|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
46942610|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
46942611|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
46942612|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
46942613|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
46942614|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
46942615|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
46942616|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
46767152|NCT00781326|82985281|FG000|Phase I|Withdrawal by Subject|1|||
46767153|NCT00781326|82985281|FG000|Phase I|Physician Decision|2|||
46767154|NCT00787800|82985287|FG000|Overall Study|Withdrawal by Subject|3|||
46767155|NCT00787800|82985288|FG001|Overall Study|Withdrawal by Subject|5|||
46767156|NCT00787800|82985287|FG000|Overall Study|Death|0|||
46767157|NCT00787800|82985288|FG001|Overall Study|Death|2|||
46767158|NCT00773838|82985295|FG000|Overall Study|Adverse Event|29|||
46767159|NCT00773838|82985295|FG000|Overall Study|Lost to Follow-up|1|||
46767160|NCT00773838|82985295|FG000|Overall Study|Physician Decision|8|||
46767161|NCT00773838|82985295|FG000|Overall Study|Progressive Disease|82|||
46767162|NCT00773838|82985295|FG000|Overall Study|Protocol Violation|2|||
46767163|NCT00773838|82985295|FG000|Overall Study|Withdrawal by Subject|21|||
46767164|NCT00787644|82985301|FG000|Overall Study|Lost to Follow-up|1|||
46834907|NCT00347360|83052379|FG011|Overall Study|Visits conflicted with new job|0|||
46767165|NCT00787644|82985302|FG001|Overall Study|Lost to Follow-up|1|||
46767166|NCT00787644|82985301|FG000|Overall Study|Withdrawal by Subject|1|||
46834908|NCT00347360|83052380|FG012|Overall Study|Visits conflicted with new job|0|||
46767167|NCT00787644|82985302|FG001|Overall Study|Withdrawal by Subject|1|||
46834909|NCT00347360|83052381|FG013|Overall Study|Visits conflicted with new job|0|||
46834910|NCT00347360|83052382|FG014|Overall Study|Visits conflicted with new job|0|||
46834911|NCT00319020|83052416|FG000|Overall Study|Death|2|||
46834912|NCT00319020|83052417|FG001|Overall Study|Death|2|||
46834913|NCT00319020|83052416|FG000|Overall Study|Withdrawal by Subject|4|||
46834914|NCT00319020|83052417|FG001|Overall Study|Withdrawal by Subject|1|||
46834915|NCT00319020|83052416|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
46834916|NCT00319020|83052417|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
46834917|NCT00319020|83052416|FG000|Overall Study|Administrative reason|0|||
46834918|NCT00319020|83052417|FG001|Overall Study|Administrative reason|5|||
46834919|NCT00319020|83052416|FG000|Overall Study|Disease progression|0|||
46834920|NCT00319020|83052417|FG001|Overall Study|Disease progression|2|||
46834921|NCT00319020|83052416|FG000|Overall Study|Transplant|0|||
46942617|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
46942618|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
46767168|NCT00787566|82985311|FG000|Overall Study|AE related to chemotherapy|0|||
46767169|NCT00787566|82985312|FG001|Overall Study|AE related to chemotherapy|1|||
46767170|NCT00787566|82985313|FG002|Overall Study|AE related to chemotherapy|0|||
46767171|NCT00787254|82985323|FG000|Overall Study|Adverse Event|24|||
46767172|NCT00787254|82985324|FG001|Overall Study|Adverse Event|23|||
46767173|NCT00787254|82985323|FG000|Overall Study|Protocol Violation|26|||
46767174|NCT00787254|82985324|FG001|Overall Study|Protocol Violation|23|||
46767175|NCT00787254|82985323|FG000|Overall Study|Withdrawal by Subject|16|||
46767176|NCT00787254|82985324|FG001|Overall Study|Withdrawal by Subject|11|||
46767177|NCT00787254|82985323|FG000|Overall Study|Lack of Efficacy|4|||
46767178|NCT00787254|82985324|FG001|Overall Study|Lack of Efficacy|15|||
46767179|NCT00787254|82985323|FG000|Overall Study|NSAIDs discontinuation|1|||
46767180|NCT00787254|82985324|FG001|Overall Study|NSAIDs discontinuation|2|||
46767181|NCT00787254|82985323|FG000|Overall Study|Institution closed|1|||
46767182|NCT00787254|82985324|FG001|Overall Study|Institution closed|0|||
46767183|NCT00787254|82985323|FG000|Overall Study|Physician Decision|4|||
46767184|NCT00787254|82985324|FG001|Overall Study|Physician Decision|8|||
46767185|NCT00625846|82985334|FG000|Overall Study|Withdrawal by Subject|2|||
46767186|NCT00625846|82985335|FG001|Overall Study|Withdrawal by Subject|0|||
46767187|NCT00625846|82985336|FG002|Overall Study|Withdrawal by Subject|1|||
46767188|NCT00625846|82985337|FG003|Overall Study|Withdrawal by Subject|2|||
46767189|NCT00773292|82985351|FG000|Treatment 48 Weeks|Adverse Event|1|||
46767190|NCT00773292|82985351|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
46767191|NCT00786864|82985357|FG000|Overall Study|Lost to Follow-up|0|||
46767192|NCT00786864|82985358|FG001|Overall Study|Lost to Follow-up|1|||
46767193|NCT00786864|82985357|FG000|Overall Study|Sustained serious back injury|1|||
46767194|NCT00786864|82985358|FG001|Overall Study|Sustained serious back injury|0|||
46767195|NCT00621322|82985370|FG000|Overall Study|Lost to Follow-up|0|||
46767196|NCT00621322|82985371|FG001|Overall Study|Lost to Follow-up|0|||
46767197|NCT00621322|82985372|FG002|Overall Study|Lost to Follow-up|0|||
46767198|NCT00621322|82985373|FG003|Overall Study|Lost to Follow-up|0|||
46767199|NCT00621322|82985374|FG004|Overall Study|Lost to Follow-up|1|||
46767200|NCT00621322|82985375|FG005|Overall Study|Lost to Follow-up|0|||
46767201|NCT00621322|82985370|FG000|Overall Study|Physician Decision|0|||
46767202|NCT00621322|82985371|FG001|Overall Study|Physician Decision|0|||
46767203|NCT00621322|82985372|FG002|Overall Study|Physician Decision|1|||
46767204|NCT00621322|82985373|FG003|Overall Study|Physician Decision|1|||
46767205|NCT00621322|82985374|FG004|Overall Study|Physician Decision|0|||
46767206|NCT00621322|82985375|FG005|Overall Study|Physician Decision|0|||
46767207|NCT00621322|82985370|FG000|Overall Study|Withdrawal by Subject|0|||
46767208|NCT00621322|82985371|FG001|Overall Study|Withdrawal by Subject|0|||
46767209|NCT00621322|82985372|FG002|Overall Study|Withdrawal by Subject|0|||
46767210|NCT00621322|82985373|FG003|Overall Study|Withdrawal by Subject|1|||
46767211|NCT00621322|82985374|FG004|Overall Study|Withdrawal by Subject|0|||
46767212|NCT00621322|82985375|FG005|Overall Study|Withdrawal by Subject|2|||
46942619|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
46767213|NCT00621322|82985370|FG000|Overall Study|Migrated/moved from study area|1|||
46767214|NCT00621322|82985371|FG001|Overall Study|Migrated/moved from study area|0|||
46767215|NCT00621322|82985372|FG002|Overall Study|Migrated/moved from study area|1|||
46767216|NCT00621322|82985373|FG003|Overall Study|Migrated/moved from study area|1|||
46767217|NCT00621322|82985374|FG004|Overall Study|Migrated/moved from study area|0|||
47062357|NCT04304534|83343177|FG002|Overall Study|Subject Decision|25|||
46767218|NCT00621322|82985375|FG005|Overall Study|Migrated/moved from study area|2|||
46767219|NCT00853385|82985394|FG000|Overall Study|Death|0|||
46767220|NCT00853385|82985395|FG001|Overall Study|Death|0|||
46767221|NCT00853385|82985396|FG002|Overall Study|Death|0|||
46767222|NCT00853385|82985397|FG003|Overall Study|Death|0|||
46834922|NCT00319020|83052417|FG001|Overall Study|Transplant|1|||
46834923|NCT00319020|83052416|FG000|Overall Study|Treatment failure|0|||
46834924|NCT00319020|83052417|FG001|Overall Study|Treatment failure|1|||
46767223|NCT00853385|82985398|FG004|Overall Study|Death|1|||
46767224|NCT00853385|82985394|FG000|Overall Study|Adverse Event|24|||
46767225|NCT00853385|82985395|FG001|Overall Study|Adverse Event|24|||
46834925|NCT00319020|83052416|FG000|Overall Study|Adverse Event|0|||
46767226|NCT00853385|82985396|FG002|Overall Study|Adverse Event|2|||
46767227|NCT00853385|82985397|FG003|Overall Study|Adverse Event|5|||
46767228|NCT00853385|82985398|FG004|Overall Study|Adverse Event|22|||
46767229|NCT00853385|82985394|FG000|Overall Study|Lack of Efficacy|6|||
46767230|NCT00853385|82985395|FG001|Overall Study|Lack of Efficacy|7|||
46767231|NCT00853385|82985396|FG002|Overall Study|Lack of Efficacy|3|||
46767232|NCT00853385|82985397|FG003|Overall Study|Lack of Efficacy|3|||
46767233|NCT00853385|82985398|FG004|Overall Study|Lack of Efficacy|6|||
46767234|NCT00853385|82985394|FG000|Overall Study|Lost to Follow-up|2|||
46767235|NCT00853385|82985395|FG001|Overall Study|Lost to Follow-up|1|||
46767236|NCT00853385|82985396|FG002|Overall Study|Lost to Follow-up|0|||
46767237|NCT00853385|82985397|FG003|Overall Study|Lost to Follow-up|0|||
46767238|NCT00853385|82985398|FG004|Overall Study|Lost to Follow-up|0|||
46767239|NCT00853385|82985394|FG000|Overall Study|Withdrawal by Subject|4|||
46767240|NCT00853385|82985395|FG001|Overall Study|Withdrawal by Subject|2|||
46767241|NCT00853385|82985396|FG002|Overall Study|Withdrawal by Subject|0|||
46767242|NCT00853385|82985397|FG003|Overall Study|Withdrawal by Subject|1|||
46767243|NCT00853385|82985398|FG004|Overall Study|Withdrawal by Subject|1|||
46767244|NCT00853385|82985394|FG000|Overall Study|Other|18|||
46767245|NCT00853385|82985395|FG001|Overall Study|Other|9|||
46767246|NCT00853385|82985396|FG002|Overall Study|Other|4|||
46767247|NCT00853385|82985397|FG003|Overall Study|Other|4|||
46834926|NCT00319020|83052417|FG001|Overall Study|Adverse Event|1|||
46942620|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
46942621|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
46942622|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
46942623|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
46767248|NCT00853385|82985398|FG004|Overall Study|Other|12|||
46942624|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
46942625|NCT02958865|83179753|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942626|NCT02958865|83179754|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942627|NCT02958865|83179755|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942628|NCT02958865|83179756|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46834927|NCT00352118|83052425|FG000|Overall Study|Physician Decision|4|||
46834928|NCT00318474|83052431|FG000|Overall Study|Adverse Event|1|||
46834929|NCT00318474|83052432|FG001|Overall Study|Adverse Event|1|||
46942629|NCT02958865|83179757|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
46942630|NCT02958865|83179758|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46834930|NCT00318474|83052431|FG000|Overall Study|Lost to Follow-up|0|||
46834931|NCT00318474|83052432|FG001|Overall Study|Lost to Follow-up|1|||
46834932|NCT00318474|83052431|FG000|Overall Study|Pregnancy|0|||
46834933|NCT00318474|83052432|FG001|Overall Study|Pregnancy|2|||
46834934|NCT00318474|83052431|FG000|Overall Study|Protocol Violation|1|||
46834935|NCT00318474|83052432|FG001|Overall Study|Protocol Violation|0|||
46834936|NCT00318474|83052431|FG000|Overall Study|Withdrawal by Subject|3|||
46834937|NCT00318474|83052432|FG001|Overall Study|Withdrawal by Subject|2|||
46834938|NCT00318474|83052431|FG000|Overall Study|Fall in GFR|3|||
46834939|NCT00318474|83052432|FG001|Overall Study|Fall in GFR|3|||
46834940|NCT00318474|83052431|FG000|Overall Study|Post-therapy hyperflycemia|0|||
46834941|NCT00318474|83052432|FG001|Overall Study|Post-therapy hyperflycemia|1|||
46834942|NCT00318474|83052431|FG000|Overall Study|Trial terminated|10|||
46834943|NCT00318474|83052432|FG001|Overall Study|Trial terminated|7|||
46834944|NCT00350870|83052442|FG000|Overall Study|Withdrawal by Subject|21|||
46834945|NCT00350870|83052443|FG001|Overall Study|Withdrawal by Subject|17|||
46834946|NCT00350870|83052444|FG002|Overall Study|Withdrawal by Subject|15|||
46834947|NCT00350870|83052445|FG003|Overall Study|Withdrawal by Subject|14|||
46834948|NCT00350870|83052442|FG000|Overall Study|Physician Decision|1|||
46834949|NCT00350870|83052443|FG001|Overall Study|Physician Decision|0|||
46942631|NCT02958865|83179759|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46834950|NCT00350870|83052444|FG002|Overall Study|Physician Decision|1|||
46834951|NCT00350870|83052445|FG003|Overall Study|Physician Decision|1|||
46834952|NCT00350792|83052455|FG000|Overall Study|Adverse Event|11|||
46834953|NCT00350792|83052455|FG000|Overall Study|Death from Study Disease|1|||
46834954|NCT00350792|83052455|FG000|Overall Study|Death from Study Drug Toxicity|1|||
46834955|NCT00350792|83052455|FG000|Overall Study|Death Not Study Drug Related|2|||
46834956|NCT00350792|83052455|FG000|Overall Study|Protocol Violation|1|||
46834957|NCT00350792|83052455|FG000|Overall Study|Withdrawal by Subject|4|||
46834958|NCT00350792|83052455|FG000|Overall Study|Physician Decision|2|||
46942632|NCT02958865|83179760|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942633|NCT02958865|83179761|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46767249|NCT00622336|82985420|FG000|Treatment Phase|Progression of Disease|181|||
46767250|NCT00622336|82985420|FG000|Treatment Phase|Adverse Event|46|||
46767251|NCT00622336|82985420|FG000|Treatment Phase|Other|40|||
46767252|NCT00622336|82985420|FG000|Treatment Phase|Death|14|||
46767253|NCT00622336|82985420|FG000|Treatment Phase|Lack of therapeutic effect|13|||
46834959|NCT00350792|83052455|FG000|Overall Study|Lack of Efficacy|11|||
46834960|NCT00317772|83052463|FG000|Overall Study|Adverse Event|0|||
46942634|NCT02958865|83179762|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46834961|NCT00317772|83052464|FG001|Overall Study|Adverse Event|0|||
46834962|NCT00317772|83052465|FG002|Overall Study|Adverse Event|0|||
46834963|NCT00317772|83052466|FG003|Overall Study|Adverse Event|2|||
46834964|NCT00317772|83052463|FG000|Overall Study|Disease Progression|2|||
46834965|NCT00317772|83052464|FG001|Overall Study|Disease Progression|2|||
46834966|NCT00317772|83052465|FG002|Overall Study|Disease Progression|1|||
46834967|NCT00317772|83052466|FG003|Overall Study|Disease Progression|7|||
46942635|NCT02958865|83179763|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46638008|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
46638009|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
46638010|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
46638011|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
46942636|NCT02958865|83179764|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942637|NCT02958865|83179765|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942638|NCT02958865|83179766|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942639|NCT02958865|83179767|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942640|NCT02958865|83179768|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
46942641|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46942642|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46942643|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46942644|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46942645|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46942646|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46942647|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46942648|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
46942649|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
46942650|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
46942651|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
46638012|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
46767254|NCT00622336|82985420|FG000|Treatment Phase|Withdrawal by Subject|13|||
46767255|NCT00622336|82985420|FG000|Treatment Phase|Lost to Follow-up|2|||
46767256|NCT00622336|82985420|FG000|Extension Phase|Adverse Event|2|||
46767257|NCT00622336|82985420|FG000|Extension Phase|Progressive Disease|6|||
46767258|NCT00622336|82985420|FG000|Extension Phase|Lack of therapeutic effect|2|||
46767259|NCT00622336|82985420|FG000|Extension Phase|Withdrawal by Subject|1|||
46767260|NCT00622336|82985420|FG000|Extension Phase|Lost to Follow-up|1|||
46767261|NCT00622336|82985420|FG000|Extension Phase|Other|9|||
46767262|NCT00779766|82985428|FG000|Month 24|Serious Adverse Event|2|||
46767263|NCT00779766|82985429|FG001|Month 24|Serious Adverse Event|3|||
46767264|NCT00779766|82985428|FG000|Month 24|Adverse Event|3|||
46767265|NCT00779766|82985429|FG001|Month 24|Adverse Event|3|||
46767266|NCT00779766|82985428|FG000|Month 24|Protocol Violation|3|||
46767267|NCT00779766|82985429|FG001|Month 24|Protocol Violation|1|||
46767268|NCT00779766|82985428|FG000|Month 24|Withdrawal by Subject|159|||
46767269|NCT00779766|82985429|FG001|Month 24|Withdrawal by Subject|127|||
46767270|NCT00779766|82985428|FG000|Month 24|Migrated/moved from study area|138|||
46767271|NCT00779766|82985429|FG001|Month 24|Migrated/moved from study area|162|||
46767272|NCT00779766|82985428|FG000|Month 24|Lost to Follow-up|9|||
46767273|NCT00779766|82985429|FG001|Month 24|Lost to Follow-up|9|||
46767274|NCT00779766|82985428|FG000|Month 24|Other|18|||
46767275|NCT00779766|82985429|FG001|Month 24|Other|27|||
46767276|NCT00779766|82985428|FG000|Month 48|Withdrawal by Subject|68|||
46942652|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
46942653|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
46638013|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
46638014|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
46638015|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
46767277|NCT00779766|82985429|FG001|Month 48|Withdrawal by Subject|63|||
46767278|NCT00779766|82985428|FG000|Month 48|Migrated/moved from study area|76|||
46767279|NCT00779766|82985429|FG001|Month 48|Migrated/moved from study area|75|||
46767280|NCT00779766|82985428|FG000|Month 48|Lost to Follow-up|29|||
46834968|NCT00350636|83052479|FG000|Overall Study|Adverse Event|19|||
46834969|NCT00350636|83052480|FG001|Overall Study|Adverse Event|13|||
46942654|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
46834970|NCT00350636|83052479|FG000|Overall Study|Protocol Violation|1|||
46638016|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
46638017|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
46638018|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
46767281|NCT00779766|82985429|FG001|Month 48|Lost to Follow-up|30|||
46767282|NCT00779766|82985428|FG000|Month 48|Other|1|||
46767283|NCT00779766|82985429|FG001|Month 48|Other|0|||
46767284|NCT00779766|82985428|FG000|Month 72|Withdrawal by Subject|55|||
46767285|NCT00779766|82985429|FG001|Month 72|Withdrawal by Subject|71|||
46767286|NCT00779766|82985428|FG000|Month 72|Migrated/moved from study area|124|||
46834971|NCT00350636|83052480|FG001|Overall Study|Protocol Violation|3|||
46638019|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
46638020|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
46638021|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
46638022|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
46638023|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
46638024|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
46638025|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
46638026|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
46638027|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638028|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638029|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638030|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638031|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
46834972|NCT00350636|83052479|FG000|Overall Study|Withdrawal by Subject|13|||
46834973|NCT00350636|83052480|FG001|Overall Study|Withdrawal by Subject|17|||
47062358|NCT04304534|83343178|FG003|Overall Study|Subject Decision|26|||
47062359|NCT04304534|83343175|FG000|Overall Study|Adverse Event|35|||
46834974|NCT00350636|83052479|FG000|Overall Study|Lost to Follow-up|9|||
46834975|NCT00350636|83052480|FG001|Overall Study|Lost to Follow-up|8|||
46834976|NCT00350636|83052479|FG000|Overall Study|Physician Decision|0|||
46834977|NCT00350636|83052480|FG001|Overall Study|Physician Decision|2|||
46834978|NCT00350636|83052479|FG000|Overall Study|Other|1|||
46834979|NCT00350636|83052480|FG001|Overall Study|Other|2|||
46942655|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
46942656|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
46638032|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638033|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
46942657|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942658|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942659|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942660|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942661|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942662|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942663|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942664|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942665|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
46942666|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
46942667|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942668|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
46942669|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
47062360|NCT04304534|83343176|FG001|Overall Study|Adverse Event|40|||
47062361|NCT04304534|83343177|FG002|Overall Study|Adverse Event|39|||
47062362|NCT04304534|83343178|FG003|Overall Study|Adverse Event|44|||
47062363|NCT04223609|83343191|FG000|Overall Study|Adverse Event|0|||
47062364|NCT04223609|83343192|FG001|Overall Study|Adverse Event|1|||
47062365|NCT04223609|83343191|FG000|Overall Study|Missed last visit|0|||
47062366|NCT04223609|83343192|FG001|Overall Study|Missed last visit|1|||
47062367|NCT04176458|83343198|FG000|Overall Study|Covid 19|4|||
47062368|NCT03941548|83343204|FG000|Overall Study|Adverse Event|0|||
46638034|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638035|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638036|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638037|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638038|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638039|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638040|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638041|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
46767287|NCT00779766|82985429|FG001|Month 72|Migrated/moved from study area|109|||
46767288|NCT00779766|82985428|FG000|Month 72|Lost to Follow-up|6|||
46767289|NCT00779766|82985429|FG001|Month 72|Lost to Follow-up|8|||
46767290|NCT00779766|82985428|FG000|Month 72|Other|0|||
46767291|NCT00779766|82985429|FG001|Month 72|Other|1|||
46767292|NCT00846365|82985439|FG000|Overall Study|Adverse Event|20|||
46767293|NCT00846365|82985440|FG001|Overall Study|Adverse Event|30|||
46767294|NCT00846365|82985441|FG002|Overall Study|Adverse Event|11|||
46834980|NCT00346268|83052488|FG000|Overall Study|Adverse Event|1|||
46834981|NCT00346268|83052489|FG001|Overall Study|Adverse Event|0|||
46834982|NCT00346268|83052488|FG000|Overall Study|Protocol Violation|1|||
47062369|NCT03941548|83343205|FG001|Overall Study|Adverse Event|1|||
46638042|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638043|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
46767295|NCT00846365|82985439|FG000|Overall Study|Protocol Violation|5|||
46767296|NCT00846365|82985440|FG001|Overall Study|Protocol Violation|4|||
46767297|NCT00846365|82985441|FG002|Overall Study|Protocol Violation|0|||
46767298|NCT00846365|82985439|FG000|Overall Study|Lost to Follow-up|8|||
47062370|NCT03941548|83343204|FG000|Overall Study|Lost to Follow-up|0|||
47062371|NCT03941548|83343205|FG001|Overall Study|Lost to Follow-up|1|||
47062372|NCT03941548|83343204|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
46767299|NCT00846365|82985440|FG001|Overall Study|Lost to Follow-up|2|||
46767300|NCT00846365|82985441|FG002|Overall Study|Lost to Follow-up|5|||
47062373|NCT03941548|83343205|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
47062374|NCT03925727|83343214|FG000|Overall Study|Adverse Event|4|||
47062375|NCT03925727|83343215|FG001|Overall Study|Adverse Event|0|||
47062376|NCT03925727|83343216|FG002|Overall Study|Adverse Event|3|||
47062377|NCT03925727|83343214|FG000|Overall Study|Protocol Violation|1|||
47062378|NCT03925727|83343215|FG001|Overall Study|Protocol Violation|2|||
47062379|NCT03925727|83343216|FG002|Overall Study|Protocol Violation|2|||
47062380|NCT03925727|83343214|FG000|Overall Study|Withdrawal by Subject|3|||
47062381|NCT03925727|83343215|FG001|Overall Study|Withdrawal by Subject|2|||
47062382|NCT03925727|83343216|FG002|Overall Study|Withdrawal by Subject|4|||
47062383|NCT03925727|83343214|FG000|Overall Study|Administrative Reasons|3|||
47062384|NCT03925727|83343215|FG001|Overall Study|Administrative Reasons|1|||
47062385|NCT03925727|83343216|FG002|Overall Study|Administrative Reasons|2|||
47062386|NCT03925727|83343214|FG000|Overall Study|Randomized in error or Disqualified|8|||
47062387|NCT03925727|83343215|FG001|Overall Study|Randomized in error or Disqualified|1|||
47062388|NCT03925727|83343216|FG002|Overall Study|Randomized in error or Disqualified|7|||
46767301|NCT00846365|82985439|FG000|Overall Study|Withdrawal by Subject|11|||
46767302|NCT00846365|82985440|FG001|Overall Study|Withdrawal by Subject|11|||
46767303|NCT00846365|82985441|FG002|Overall Study|Withdrawal by Subject|9|||
46767304|NCT00846365|82985439|FG000|Overall Study|Pregnancy|1|||
46767305|NCT00846365|82985440|FG001|Overall Study|Pregnancy|0|||
46767306|NCT00846365|82985441|FG002|Overall Study|Pregnancy|0|||
46767307|NCT00846365|82985439|FG000|Overall Study|Lack of Efficacy|1|||
46767308|NCT00846365|82985440|FG001|Overall Study|Lack of Efficacy|1|||
46767309|NCT00846365|82985441|FG002|Overall Study|Lack of Efficacy|2|||
46767310|NCT00846365|82985439|FG000|Overall Study|Other|9|||
46767311|NCT00846365|82985440|FG001|Overall Study|Other|1|||
46767312|NCT00846365|82985441|FG002|Overall Study|Other|6|||
46767313|NCT00779142|82985449|FG000|Overall Study|Screen Failures|3|||
46767314|NCT00622180|82985454|FG000|Overall Study|Lost to Follow-up|1|||
46767315|NCT00622180|82985455|FG001|Overall Study|Lost to Follow-up|2|||
47062389|NCT03387150|83343233|FG000|Overall Study|Withdrawal by Subject|3|||
46767316|NCT00773136|82985461|FG000|Overall Study|Physician Decision|2|||
46767317|NCT00853307|82985468|FG000|Overall Study|Adverse Event|1|||
46767318|NCT00853307|82985469|FG001|Overall Study|Adverse Event|2|||
46767319|NCT00853307|82985468|FG000|Overall Study|Withdrawal by Subject|1|||
46767320|NCT00853307|82985469|FG001|Overall Study|Withdrawal by Subject|2|||
46767321|NCT00853307|82985468|FG000|Overall Study|Reason Not Specified|0|||
46767322|NCT00853307|82985469|FG001|Overall Study|Reason Not Specified|1|||
46767323|NCT00778830|82985477|FG000|Overall Study|Ongoing at data cut-off|0|||
47062390|NCT03387150|83343234|FG001|Overall Study|Withdrawal by Subject|0|||
47062391|NCT03387150|83343235|FG002|Overall Study|Withdrawal by Subject|3|||
46834983|NCT00346268|83052489|FG001|Overall Study|Protocol Violation|0|||
46834984|NCT00346268|83052488|FG000|Overall Study|Participant refused|0|||
46834985|NCT00346268|83052489|FG001|Overall Study|Participant refused|3|||
46834986|NCT00327444|83052497|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
46834987|NCT00327444|83052498|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
46834988|NCT00327444|83052497|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
46834989|NCT00327444|83052498|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
46834990|NCT00327444|83052497|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
46834991|NCT00327444|83052498|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
46834992|NCT00327444|83052497|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
46834993|NCT00327444|83052498|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
46834994|NCT00327444|83052497|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
46834995|NCT00327444|83052498|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
46834996|NCT00327444|83052497|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
46834997|NCT00327444|83052498|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
46834998|NCT00327444|83052497|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
46834999|NCT00327444|83052498|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
46835000|NCT00327444|83052497|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
46835001|NCT00327444|83052498|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
46835002|NCT00337610|83052508|FG000|Overall Study|Adverse Event|2|||
46835003|NCT00337610|83052509|FG001|Overall Study|Adverse Event|2|||
46835004|NCT00337610|83052508|FG000|Overall Study|Death|0|||
46835005|NCT00337610|83052509|FG001|Overall Study|Death|1|||
46835006|NCT00337610|83052508|FG000|Overall Study|Lack of Efficacy|6|||
46835007|NCT00337610|83052509|FG001|Overall Study|Lack of Efficacy|3|||
46835008|NCT00337610|83052508|FG000|Overall Study|Lost to Follow-up|3|||
46835009|NCT00337610|83052509|FG001|Overall Study|Lost to Follow-up|3|||
46767324|NCT00778830|82985478|FG001|Overall Study|Ongoing at data cut-off|1|||
46767325|NCT00772668|82985484|FG000|Overall Study|Physician Decision|3|||
46767326|NCT00786474|82985491|FG000|Overall Study|Death|5|||
46767327|NCT00786474|82985492|FG001|Overall Study|Death|4|||
46767328|NCT00786474|82985491|FG000|Overall Study|Withdrawal by Subject|23|||
46767329|NCT00786474|82985492|FG001|Overall Study|Withdrawal by Subject|31|||
46767330|NCT00786474|82985491|FG000|Overall Study|Lost to Follow-up|3|||
46767331|NCT00786474|82985492|FG001|Overall Study|Lost to Follow-up|3|||
46767332|NCT00786474|82985491|FG000|Overall Study|Physician Decision|2|||
46767333|NCT00786474|82985492|FG001|Overall Study|Physician Decision|1|||
46767334|NCT00786474|82985491|FG000|Overall Study|Other|4|||
46767335|NCT00786474|82985492|FG001|Overall Study|Other|4|||
46767336|NCT00784875|82985502|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
46767337|NCT00784875|82985503|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
46767338|NCT00784875|82985504|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
46767339|NCT00784875|82985505|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
46767340|NCT00784875|82985502|FG000|Period A - Baseline|Adverse Event|0|||
46767341|NCT00784875|82985503|FG001|Period A - Baseline|Adverse Event|0|||
46767342|NCT00784875|82985504|FG002|Period A - Baseline|Adverse Event|0|||
46767343|NCT00784875|82985505|FG003|Period A - Baseline|Adverse Event|8|||
46767344|NCT00784875|82985502|FG000|Period A - Baseline|Protocol Violation|0|||
46767345|NCT00784875|82985503|FG001|Period A - Baseline|Protocol Violation|0|||
46767346|NCT00784875|82985504|FG002|Period A - Baseline|Protocol Violation|0|||
46767347|NCT00784875|82985505|FG003|Period A - Baseline|Protocol Violation|25|||
46767348|NCT00784875|82985502|FG000|Period A - Baseline|Withdrawal by Subject|0|||
46767349|NCT00784875|82985503|FG001|Period A - Baseline|Withdrawal by Subject|0|||
46767350|NCT00784875|82985504|FG002|Period A - Baseline|Withdrawal by Subject|0|||
46767351|NCT00784875|82985505|FG003|Period A - Baseline|Withdrawal by Subject|27|||
46767352|NCT00784875|82985502|FG000|Period A - Baseline|Physician Decision|0|||
46767353|NCT00784875|82985503|FG001|Period A - Baseline|Physician Decision|0|||
46767354|NCT00784875|82985504|FG002|Period A - Baseline|Physician Decision|0|||
46767355|NCT00784875|82985505|FG003|Period A - Baseline|Physician Decision|2|||
46767356|NCT00784875|82985502|FG000|Period A - Baseline|Sponsor Decision|0|||
46767357|NCT00784875|82985503|FG001|Period A - Baseline|Sponsor Decision|0|||
46835010|NCT00337610|83052508|FG000|Overall Study|Withdrawal by Subject|6|||
46835011|NCT00337610|83052509|FG001|Overall Study|Withdrawal by Subject|5|||
46835012|NCT00316914|83052517|FG000|Overall Study|Withdrawal by Subject|5|||
46835013|NCT00316914|83052518|FG001|Overall Study|Withdrawal by Subject|3|||
46835014|NCT00316914|83052517|FG000|Overall Study|Adverse Event|8|||
46767358|NCT00784875|82985504|FG002|Period A - Baseline|Sponsor Decision|0|||
46767359|NCT00784875|82985505|FG003|Period A - Baseline|Sponsor Decision|113|||
46767360|NCT00784875|82985502|FG000|Period A - Baseline|Lost to Follow-up|0|||
46767361|NCT00784875|82985503|FG001|Period A - Baseline|Lost to Follow-up|0|||
46767362|NCT00784875|82985504|FG002|Period A - Baseline|Lost to Follow-up|0|||
46767363|NCT00784875|82985505|FG003|Period A - Baseline|Lost to Follow-up|2|||
46767364|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
46835015|NCT00316914|83052518|FG001|Overall Study|Adverse Event|7|||
46835016|NCT00316914|83052517|FG000|Overall Study|Other Problems|6|||
46835017|NCT00316914|83052518|FG001|Overall Study|Other Problems|11|||
46835018|NCT00316914|83052517|FG000|Overall Study|Missing end of treatment documentation|14|||
46835019|NCT00316914|83052518|FG001|Overall Study|Missing end of treatment documentation|15|||
47062392|NCT03387150|83343236|FG003|Overall Study|Withdrawal by Subject|4|||
47062393|NCT03387150|83343237|FG004|Overall Study|Withdrawal by Subject|1|||
47062394|NCT03387150|83343238|FG005|Overall Study|Withdrawal by Subject|2|||
47062395|NCT03387150|83343239|FG006|Overall Study|Withdrawal by Subject|0|||
47062396|NCT03387150|83343233|FG000|Overall Study|Lost to Follow-up|3|||
47062397|NCT03387150|83343234|FG001|Overall Study|Lost to Follow-up|2|||
47062398|NCT03387150|83343235|FG002|Overall Study|Lost to Follow-up|2|||
47062399|NCT03387150|83343236|FG003|Overall Study|Lost to Follow-up|3|||
47062400|NCT03387150|83343237|FG004|Overall Study|Lost to Follow-up|3|||
47062401|NCT03387150|83343238|FG005|Overall Study|Lost to Follow-up|3|||
47062402|NCT03387150|83343239|FG006|Overall Study|Lost to Follow-up|0|||
47062403|NCT03387150|83343233|FG000|Overall Study|Participant unable to adhere to visit|0|||
47062404|NCT03387150|83343234|FG001|Overall Study|Participant unable to adhere to visit|1|||
47062405|NCT03387150|83343235|FG002|Overall Study|Participant unable to adhere to visit|0|||
47062406|NCT03387150|83343236|FG003|Overall Study|Participant unable to adhere to visit|0|||
47062407|NCT03387150|83343237|FG004|Overall Study|Participant unable to adhere to visit|2|||
47062408|NCT03387150|83343238|FG005|Overall Study|Participant unable to adhere to visit|2|||
47062409|NCT03387150|83343239|FG006|Overall Study|Participant unable to adhere to visit|0|||
47062410|NCT03289208|83343271|FG000|Overall Study|Adverse Event|1|||
47062411|NCT03289208|83343272|FG001|Overall Study|Adverse Event|0|||
47062412|NCT03289208|83343273|FG002|Overall Study|Adverse Event|0|||
47062413|NCT03244059|83343283|FG000|Specific Aim 1|Physician Decision|1|||
47062414|NCT03244059|83343284|FG001|Specific Aim 1|Physician Decision|0|||
47062415|NCT03244059|83343283|FG000|Specific Aim 2|Physician Decision|1|||
47062416|NCT03244059|83343284|FG001|Specific Aim 2|Physician Decision|0|||
47062417|NCT03036566|83343290|FG000|Overall Study|Lost to Follow-up|3|||
47062418|NCT02754141|83343321|FG000|Overall Study|Disease progression|11|||
47062419|NCT02754141|83343322|FG001|Overall Study|Disease progression|7|||
47062420|NCT02754141|83343323|FG002|Overall Study|Disease progression|8|||
47062421|NCT02754141|83343324|FG003|Overall Study|Disease progression|5|||
47062422|NCT02754141|83343325|FG004|Overall Study|Disease progression|7|||
47062423|NCT02754141|83343326|FG005|Overall Study|Disease progression|7|||
46767365|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
46767366|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
46767367|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
46835020|NCT00336284|83052526|FG000|Overall Study|Death|52|||
46835021|NCT00336284|83052527|FG001|Overall Study|Death|26|||
46835022|NCT00336284|83052526|FG000|Overall Study|Lost to Follow-up|82|||
46835023|NCT00336284|83052527|FG001|Overall Study|Lost to Follow-up|61|||
46835024|NCT00336284|83052526|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
46835025|NCT00336284|83052527|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
46835026|NCT00316602|83052535|FG000|Overall Study|Withdrawal by Subject|3|||
46835027|NCT00316602|83052536|FG001|Overall Study|Withdrawal by Subject|2|||
46835028|NCT00316602|83052535|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
46835029|NCT00316602|83052536|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
46835030|NCT00316602|83052535|FG000|Overall Study|Adverse Event|1|||
46835031|NCT00316602|83052536|FG001|Overall Study|Adverse Event|0|||
46835032|NCT00316602|83052535|FG000|Overall Study|Other|3|||
46767368|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
46767369|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
46767370|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
46767371|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
46767372|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
46767373|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
46767374|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
46835033|NCT00316602|83052536|FG001|Overall Study|Other|6|||
46835034|NCT00335972|83052544|FG000|Overall Study|not given treatments|0|||
47062424|NCT02754141|83343327|FG006|Overall Study|Disease progression|7|||
46835035|NCT00335972|83052545|FG001|Overall Study|not given treatments|3|||
47062425|NCT02754141|83343328|FG007|Overall Study|Disease progression|6|||
47062426|NCT02754141|83343329|FG008|Overall Study|Disease progression|11|||
47062427|NCT02754141|83343330|FG009|Overall Study|Disease progression|16|||
47062428|NCT02754141|83343331|FG010|Overall Study|Disease progression|18|||
47062429|NCT02754141|83343332|FG011|Overall Study|Disease progression|13|||
47062430|NCT02754141|83343333|FG012|Overall Study|Disease progression|10|||
46835036|NCT00346034|83052551|FG000|Overall Study|Adverse Event|34|||
46835037|NCT00346034|83052551|FG000|Overall Study|Lack of Efficacy|8|||
46835038|NCT00346034|83052551|FG000|Overall Study|Withdrawal by Subject|13|||
46835039|NCT00346034|83052551|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
46835040|NCT00346034|83052551|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
46835041|NCT00345878|83052557|FG000|Overall Study|Adverse Event|1|||
46835042|NCT00345878|83052558|FG001|Overall Study|Adverse Event|0|||
46835043|NCT00345878|83052557|FG000|Overall Study|Lost to Follow-up|2|||
46835044|NCT00345878|83052558|FG001|Overall Study|Lost to Follow-up|1|||
46835045|NCT00345878|83052557|FG000|Overall Study|Other|1|||
46835046|NCT00345878|83052558|FG001|Overall Study|Other|0|||
46835047|NCT00335738|83052566|FG000|Overall Study|Physician Decision|6|||
46835048|NCT00335738|83052567|FG001|Overall Study|Physician Decision|0|||
46835049|NCT00335738|83052566|FG000|Overall Study|Withdrawal by Subject|2|||
46835050|NCT00335738|83052567|FG001|Overall Study|Withdrawal by Subject|0|||
46835051|NCT00335738|83052566|FG000|Overall Study|Ineligible|3|||
46835052|NCT00335738|83052567|FG001|Overall Study|Ineligible|4|||
46835053|NCT00334958|83052585|FG000|Overall Study|Medication Noncompliance|0|||
46835054|NCT00334958|83052586|FG001|Overall Study|Medication Noncompliance|3|||
46835055|NCT00334958|83052585|FG000|Overall Study|Protocol Violation|2|||
46835056|NCT00334958|83052586|FG001|Overall Study|Protocol Violation|2|||
46835057|NCT00334958|83052585|FG000|Overall Study|Request of the investigator or sponsor|0|||
46835058|NCT00334958|83052586|FG001|Overall Study|Request of the investigator or sponsor|1|||
46835059|NCT00334958|83052585|FG000|Overall Study|Withdrawal by Subject|7|||
46835060|NCT00334958|83052586|FG001|Overall Study|Withdrawal by Subject|4|||
46835061|NCT00334958|83052585|FG000|Overall Study|Adverse Event|27|||
46835062|NCT00334958|83052586|FG001|Overall Study|Adverse Event|12|||
46835063|NCT00334958|83052585|FG000|Overall Study|Other|1|||
46835064|NCT00334958|83052586|FG001|Overall Study|Other|2|||
46835065|NCT00326898|83052595|FG000|Overall Study|Disease progression|52|||
46835066|NCT00326898|83052596|FG001|Overall Study|Disease progression|54|||
46835067|NCT00326898|83052597|FG002|Overall Study|Disease progression|102|||
46835068|NCT00326898|83052595|FG000|Overall Study|Adverse Event|124|||
46835069|NCT00326898|83052596|FG001|Overall Study|Adverse Event|128|||
46835070|NCT00326898|83052597|FG002|Overall Study|Adverse Event|33|||
46835071|NCT00326898|83052595|FG000|Overall Study|Death|2|||
46835072|NCT00326898|83052596|FG001|Overall Study|Death|0|||
46835073|NCT00326898|83052597|FG002|Overall Study|Death|0|||
46835074|NCT00326898|83052595|FG000|Overall Study|Withdrawal by Subject|134|||
46835075|NCT00326898|83052596|FG001|Overall Study|Withdrawal by Subject|128|||
46835076|NCT00326898|83052597|FG002|Overall Study|Withdrawal by Subject|32|||
46835077|NCT00326898|83052595|FG000|Overall Study|Alternative therapy|1|||
46835078|NCT00326898|83052596|FG001|Overall Study|Alternative therapy|0|||
46835079|NCT00326898|83052597|FG002|Overall Study|Alternative therapy|0|||
46835080|NCT00326898|83052595|FG000|Overall Study|Other complicating disease|5|||
46835081|NCT00326898|83052596|FG001|Overall Study|Other complicating disease|5|||
46835082|NCT00326898|83052597|FG002|Overall Study|Other complicating disease|4|||
46835083|NCT00326898|83052595|FG000|Overall Study|Other/Missing/Unknown|33|||
46835084|NCT00326898|83052596|FG001|Overall Study|Other/Missing/Unknown|28|||
46835085|NCT00326898|83052597|FG002|Overall Study|Other/Missing/Unknown|32|||
46835086|NCT00326118|83052607|FG000|Active Phase|Withdrawal by Subject|4|||
46835087|NCT00326118|83052608|FG001|Active Phase|Withdrawal by Subject|1|||
46835088|NCT00334802|83052617|FG000|Overall Study|Progressive Disease|2|||
46835089|NCT00334802|83052618|FG001|Overall Study|Progressive Disease|24|||
46835090|NCT00334802|83052617|FG000|Overall Study|Toxicity|1|||
46835091|NCT00334802|83052618|FG001|Overall Study|Toxicity|5|||
47062431|NCT02754141|83343334|FG013|Overall Study|Disease progression|12|||
47062432|NCT02754141|83343335|FG014|Overall Study|Disease progression|12|||
47062433|NCT02754141|83343336|FG015|Overall Study|Disease progression|14|||
46835092|NCT00334802|83052617|FG000|Overall Study|Lack of Efficacy|1|||
46835093|NCT00334802|83052618|FG001|Overall Study|Lack of Efficacy|3|||
46835094|NCT00334802|83052617|FG000|Overall Study|Patient Condition Aggrevated|1|||
47062434|NCT02754141|83343337|FG016|Overall Study|Disease progression|0|||
47062435|NCT02754141|83343338|FG017|Overall Study|Disease progression|1|||
47062436|NCT02754141|83343321|FG000|Overall Study|Study drug toxicity|1|||
46835095|NCT00334802|83052618|FG001|Overall Study|Patient Condition Aggrevated|0|||
47062437|NCT02754141|83343322|FG001|Overall Study|Study drug toxicity|1|||
46835096|NCT00334802|83052617|FG000|Overall Study|Physician Decision|1|||
46835097|NCT00334802|83052618|FG001|Overall Study|Physician Decision|0|||
46835098|NCT00334802|83052617|FG000|Overall Study|Withdrawal by Subject|0|||
46835099|NCT00334802|83052618|FG001|Overall Study|Withdrawal by Subject|4|||
46835100|NCT00334802|83052617|FG000|Overall Study|Adverse Event|0|||
46835101|NCT00334802|83052618|FG001|Overall Study|Adverse Event|3|||
46835102|NCT00334802|83052617|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
46835103|NCT00334802|83052618|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
46835104|NCT00307164|83052629|FG000|Overall Study|Death|1|||
46835105|NCT00307164|83052630|FG001|Overall Study|Death|0|||
47062438|NCT02754141|83343323|FG002|Overall Study|Study drug toxicity|0|||
47062439|NCT02754141|83343324|FG003|Overall Study|Study drug toxicity|0|||
46835106|NCT00307164|83052629|FG000|Overall Study|Severe debilitation, unable to continue|1|||
46835107|NCT00307164|83052630|FG001|Overall Study|Severe debilitation, unable to continue|0|||
46835108|NCT00307164|83052629|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
46835109|NCT00307164|83052630|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
46835110|NCT00307164|83052629|FG000|Overall Study|Withdrawal by Subject|1|||
46835111|NCT00307164|83052630|FG001|Overall Study|Withdrawal by Subject|8|||
46835112|NCT00307164|83052629|FG000|Overall Study|Not compliant with requirements|4|||
46835113|NCT00307164|83052630|FG001|Overall Study|Not compliant with requirements|4|||
46835114|NCT00307164|83052629|FG000|Overall Study|Lost to Follow-up|6|||
46835115|NCT00307164|83052630|FG001|Overall Study|Lost to Follow-up|1|||
46835116|NCT03827564|83052638|FG000|Overall Study|Discontinued due to Study Termination|1|||
46638044|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
46638045|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638046|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638047|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638048|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638049|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638050|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638051|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46767375|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
46942670|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
46942671|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
46942672|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
46942673|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46767376|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
46767377|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
46767378|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
46767379|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
46767380|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
46767381|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
46767382|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
46835117|NCT03827564|83052639|FG001|Overall Study|Discontinued due to Study Termination|0|||
46835118|NCT00307086|83052645|FG000|Overall Study|ineligible|5|||
46835119|NCT00325416|83052651|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
46835120|NCT00325416|83052652|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
46835121|NCT00325416|83052651|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
46835122|NCT00325416|83052652|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
46835123|NCT00325416|83052651|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
46835124|NCT00325416|83052652|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
46835125|NCT00325416|83052651|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
46835126|NCT00325416|83052652|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
46835127|NCT00325416|83052651|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
46835128|NCT00325416|83052652|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
46835129|NCT00325416|83052651|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
46835130|NCT00325416|83052652|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
46835131|NCT00314808|83052658|FG000|Overall Study|Disease Progression without AE|4|||
46835132|NCT00314808|83052658|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
46835133|NCT05845567|83052662|FG000|Overall Study|Withdrawal by Subject|1|||
46835134|NCT05073315|83052683|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
46835135|NCT05073315|83052684|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
46835136|NCT05073315|83052685|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
46835137|NCT05073315|83052683|FG000|Period 1 (Lead-in Period)|Death|1|||
46835138|NCT05073315|83052684|FG001|Period 1 (Lead-in Period)|Death|0|||
46835139|NCT05073315|83052685|FG002|Period 1 (Lead-in Period)|Death|0|||
46835140|NCT05073315|83052683|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
46835141|NCT05073315|83052684|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
46835142|NCT05073315|83052685|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
46835143|NCT05073315|83052683|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
46835144|NCT05073315|83052684|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
46835145|NCT05073315|83052685|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
46835146|NCT05073315|83052683|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
46835147|NCT05073315|83052684|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
46835148|NCT05073315|83052685|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
46942674|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942675|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
47062440|NCT02754141|83343325|FG004|Overall Study|Study drug toxicity|0|||
47062441|NCT02754141|83343326|FG005|Overall Study|Study drug toxicity|0|||
47062442|NCT02754141|83343327|FG006|Overall Study|Study drug toxicity|0|||
47062443|NCT02754141|83343328|FG007|Overall Study|Study drug toxicity|0|||
47062444|NCT02754141|83343329|FG008|Overall Study|Study drug toxicity|0|||
46835149|NCT05073315|83052683|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
46835150|NCT05073315|83052684|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
46835151|NCT05073315|83052685|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
46835152|NCT05073315|83052683|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
46835153|NCT05073315|83052684|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
46835154|NCT05073315|83052685|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
46942676|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942677|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942678|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942679|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46835155|NCT05073315|83052683|FG000|Period 2|Adverse Event|0|||
46835156|NCT05073315|83052684|FG001|Period 2|Adverse Event|3|||
46835157|NCT05073315|83052685|FG002|Period 2|Adverse Event|6|||
46835158|NCT05073315|83052683|FG000|Period 2|Lost to Follow-up|0|||
46835159|NCT05073315|83052684|FG001|Period 2|Lost to Follow-up|5|||
46835160|NCT05073315|83052685|FG002|Period 2|Lost to Follow-up|5|||
46835161|NCT05073315|83052683|FG000|Period 2|Withdrawal by Subject|0|||
46835162|NCT05073315|83052684|FG001|Period 2|Withdrawal by Subject|4|||
46835163|NCT05073315|83052685|FG002|Period 2|Withdrawal by Subject|9|||
46835164|NCT05073315|83052683|FG000|Period 2|Protocol Violation|0|||
46835165|NCT05073315|83052684|FG001|Period 2|Protocol Violation|0|||
46835166|NCT05073315|83052685|FG002|Period 2|Protocol Violation|1|||
46835167|NCT04752566|83052702|FG000|Overall Study|Protocol Violation|0|||
46835168|NCT04752566|83052703|FG001|Overall Study|Protocol Violation|1|||
46835169|NCT04752566|83052702|FG000|Overall Study|Death|1|||
46835170|NCT04752566|83052703|FG001|Overall Study|Death|0|||
46835171|NCT04752566|83052702|FG000|Overall Study|Adverse Event|1|||
46835172|NCT04752566|83052703|FG001|Overall Study|Adverse Event|0|||
46835173|NCT04752566|83052702|FG000|Overall Study|Withdrawal by Subject|2|||
46835174|NCT04752566|83052703|FG001|Overall Study|Withdrawal by Subject|0|||
46835175|NCT04752566|83052702|FG000|Overall Study|Physician Decision|1|||
46835176|NCT04752566|83052703|FG001|Overall Study|Physician Decision|1|||
46835177|NCT04741074|83052711|FG000|Overall Study|Withdrawal by Subject|1|||
46835178|NCT04741074|83052712|FG001|Overall Study|Withdrawal by Subject|1|||
46835179|NCT04741074|83052711|FG000|Overall Study|Study terminated prematurely|1|||
46835180|NCT04741074|83052712|FG001|Overall Study|Study terminated prematurely|0|||
46942680|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942681|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942682|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
46942683|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942684|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46767383|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
46767384|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
46767385|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
46767386|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
46767387|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
46767388|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
46767389|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
46767390|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
46767391|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
46767392|NCT00784875|82985502|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
46767393|NCT00784875|82985503|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
46767394|NCT00784875|82985504|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
46767395|NCT00784875|82985505|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
46767396|NCT00784875|82985502|FG000|Period C|Adverse Event|1|||
46767397|NCT00784875|82985503|FG001|Period C|Adverse Event|0|||
46767398|NCT00784875|82985504|FG002|Period C|Adverse Event|4|||
46767399|NCT00784875|82985505|FG003|Period C|Adverse Event|2|||
46835181|NCT04127786|83052724|FG000|Primary Series|Adverse Event|1|||
46835182|NCT04127786|83052725|FG001|Primary Series|Adverse Event|0|||
46835183|NCT04127786|83052726|FG002|Primary Series|Adverse Event|0|||
46835184|NCT04127786|83052727|FG003|Primary Series|Adverse Event|1|||
46835185|NCT04127786|83052728|FG004|Primary Series|Adverse Event|0|||
46835186|NCT04127786|83052729|FG005|Primary Series|Adverse Event|1|||
46835187|NCT04127786|83052724|FG000|Primary Series|Protocol Violation|5|||
46835188|NCT04127786|83052725|FG001|Primary Series|Protocol Violation|3|||
46942685|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942686|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46942687|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
46835189|NCT04127786|83052726|FG002|Primary Series|Protocol Violation|4|||
46835190|NCT04127786|83052727|FG003|Primary Series|Protocol Violation|3|||
46835191|NCT04127786|83052728|FG004|Primary Series|Protocol Violation|2|||
46942688|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
46942689|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46767400|NCT00784875|82985502|FG000|Period C|Protocol Violation|0|||
46835192|NCT04127786|83052729|FG005|Primary Series|Protocol Violation|0|||
46767401|NCT00784875|82985503|FG001|Period C|Protocol Violation|0|||
46767402|NCT00784875|82985504|FG002|Period C|Protocol Violation|1|||
46767403|NCT00784875|82985505|FG003|Period C|Protocol Violation|2|||
46767404|NCT00784875|82985502|FG000|Period C|Lack of Efficacy|0|||
46767405|NCT00784875|82985503|FG001|Period C|Lack of Efficacy|0|||
46767406|NCT00784875|82985504|FG002|Period C|Lack of Efficacy|1|||
46767407|NCT00784875|82985505|FG003|Period C|Lack of Efficacy|0|||
46767408|NCT00784875|82985502|FG000|Period C|Withdrawal by Subject|1|||
46767409|NCT00784875|82985503|FG001|Period C|Withdrawal by Subject|1|||
46767410|NCT00784875|82985504|FG002|Period C|Withdrawal by Subject|2|||
46767411|NCT00784875|82985505|FG003|Period C|Withdrawal by Subject|0|||
46835193|NCT04127786|83052724|FG000|Primary Series|Withdrawal by Subject|0|||
46835194|NCT04127786|83052725|FG001|Primary Series|Withdrawal by Subject|0|||
46835195|NCT04127786|83052726|FG002|Primary Series|Withdrawal by Subject|0|||
46835196|NCT04127786|83052727|FG003|Primary Series|Withdrawal by Subject|1|||
46942690|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942691|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46835197|NCT04127786|83052728|FG004|Primary Series|Withdrawal by Subject|0|||
46835198|NCT04127786|83052729|FG005|Primary Series|Withdrawal by Subject|0|||
46835199|NCT04127786|83052724|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
46835200|NCT04127786|83052725|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
46835201|NCT04127786|83052726|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
46835202|NCT04127786|83052727|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
46835203|NCT04127786|83052728|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
46835204|NCT04127786|83052729|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
46835205|NCT04127786|83052724|FG000|Booster Phase|Withdrawal by Subject|2|||
46835206|NCT04127786|83052725|FG001|Booster Phase|Withdrawal by Subject|0|||
46835207|NCT04127786|83052726|FG002|Booster Phase|Withdrawal by Subject|0|||
46835208|NCT04127786|83052727|FG003|Booster Phase|Withdrawal by Subject|0|||
46835209|NCT04127786|83052728|FG004|Booster Phase|Withdrawal by Subject|0|||
46835210|NCT04127786|83052729|FG005|Booster Phase|Withdrawal by Subject|0|||
46835211|NCT03553836|83052772|FG000|Overall Study|Ongoing in Study|460|||
46835212|NCT03553836|83052773|FG001|Overall Study|Ongoing in Study|459|||
46835213|NCT03553836|83052772|FG000|Overall Study|Withdrawal by Subject|9|||
46835214|NCT03553836|83052773|FG001|Overall Study|Withdrawal by Subject|10|||
46835215|NCT03553836|83052772|FG000|Overall Study|Lost to Follow-up|1|||
46835216|NCT03553836|83052773|FG001|Overall Study|Lost to Follow-up|3|||
46835217|NCT03553836|83052772|FG000|Overall Study|Death|17|||
46835218|NCT03553836|83052773|FG001|Overall Study|Death|17|||
46835219|NCT03488719|83052783|FG000|Overall Study|Adverse Event|0|||
46835220|NCT03488719|83052784|FG001|Overall Study|Adverse Event|4|||
46835221|NCT03488719|83052785|FG002|Overall Study|Adverse Event|2|||
46835222|NCT03488719|83052783|FG000|Overall Study|Other|0|||
46835223|NCT03488719|83052784|FG001|Overall Study|Other|0|||
46835224|NCT03488719|83052785|FG002|Overall Study|Other|5|||
46942692|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942693|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942694|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942695|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942696|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942697|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942698|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942699|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
46942700|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
46942701|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
46942702|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
46942703|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
47062445|NCT02754141|83343330|FG009|Overall Study|Study drug toxicity|0|||
47062446|NCT02754141|83343331|FG010|Overall Study|Study drug toxicity|2|||
47062447|NCT02754141|83343332|FG011|Overall Study|Study drug toxicity|1|||
47062448|NCT02754141|83343333|FG012|Overall Study|Study drug toxicity|1|||
47062449|NCT02754141|83343334|FG013|Overall Study|Study drug toxicity|0|||
46835225|NCT03488225|83052793|FG000|Overall Study|Off Protocol Therapy|2|||
46767412|NCT00784875|82985502|FG000|Period C|Physician Decision|0|||
46767413|NCT00784875|82985503|FG001|Period C|Physician Decision|0|||
46835226|NCT03488225|83052793|FG000|Overall Study|Stem Cell Transplant|2|||
46835227|NCT03198559|83052797|FG000|Overall Study|Adverse Event|2|||
46835228|NCT03188042|83052804|FG000|Overall Study|Withdrawal by Subject|1|||
46835229|NCT03188042|83052805|FG001|Overall Study|Withdrawal by Subject|1|||
46835230|NCT03113136|83052814|FG000|Overall Study|Lost to Follow-up|22|||
46835231|NCT03113136|83052815|FG001|Overall Study|Lost to Follow-up|47|||
46835232|NCT03113136|83052816|FG002|Overall Study|Lost to Follow-up|54|||
46835233|NCT03113136|83052814|FG000|Overall Study|Withdrawal by Subject|4|||
47062450|NCT02754141|83343335|FG014|Overall Study|Study drug toxicity|0|||
46767414|NCT00784875|82985504|FG002|Period C|Physician Decision|1|||
46767415|NCT00784875|82985505|FG003|Period C|Physician Decision|1|||
46942704|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
46942705|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
46942706|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
46942707|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
46942708|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
46942709|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
46942710|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
46942711|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
46942712|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
47062451|NCT02754141|83343336|FG015|Overall Study|Study drug toxicity|0|||
47062452|NCT02754141|83343337|FG016|Overall Study|Study drug toxicity|0|||
47062453|NCT02754141|83343338|FG017|Overall Study|Study drug toxicity|0|||
47062454|NCT02754141|83343321|FG000|Overall Study|AE unrelated to study drug|1|||
46835234|NCT03113136|83052815|FG001|Overall Study|Withdrawal by Subject|13|||
46835235|NCT03113136|83052816|FG002|Overall Study|Withdrawal by Subject|14|||
46835236|NCT03113136|83052814|FG000|Overall Study|Ineligible|0|||
46835237|NCT03113136|83052815|FG001|Overall Study|Ineligible|2|||
46835238|NCT03113136|83052816|FG002|Overall Study|Ineligible|1|||
46835239|NCT03113136|83052814|FG000|Overall Study|Study Team Decision|1|||
46835240|NCT03113136|83052815|FG001|Overall Study|Study Team Decision|4|||
46835241|NCT03113136|83052816|FG002|Overall Study|Study Team Decision|0|||
46835242|NCT02968004|83052828|FG000|Overall Study|Adverse Event|1|||
46835243|NCT02968004|83052829|FG001|Overall Study|Adverse Event|0|||
46835244|NCT02968004|83052828|FG000|Overall Study|Withdrawal by Subject|0|||
46835245|NCT02968004|83052829|FG001|Overall Study|Withdrawal by Subject|1|||
46835246|NCT02797184|83052835|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
46835247|NCT02797184|83052836|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
46835248|NCT02577406|83052844|FG000|Randomized Period|Death|1|||
46835249|NCT02577406|83052845|FG001|Randomized Period|Death|0|||
46835250|NCT02577406|83052844|FG000|Randomized Period|Other reasons|0|||
46835251|NCT02577406|83052845|FG001|Randomized Period|Other reasons|20|||
46835252|NCT02577406|83052844|FG000|Treatment Period|Transition to commercially available treatment|1|||
46835253|NCT02577406|83052845|FG001|Treatment Period|Transition to commercially available treatment|0|||
46835254|NCT02577406|83052844|FG000|Treatment Period|Progressive disease|47|||
46835255|NCT02577406|83052845|FG001|Treatment Period|Progressive disease|36|||
46835256|NCT02577406|83052844|FG000|Treatment Period|Death|36|||
46835257|NCT02577406|83052845|FG001|Treatment Period|Death|23|||
46835258|NCT02577406|83052844|FG000|Treatment Period|Other reasons|3|||
46835259|NCT02577406|83052845|FG001|Treatment Period|Other reasons|37|||
46835260|NCT02577406|83052844|FG000|Treatment Period|Withdrawal by Subject|10|||
46835261|NCT02577406|83052845|FG001|Treatment Period|Withdrawal by Subject|24|||
46835262|NCT02577406|83052844|FG000|Treatment Period|Adverse Event|17|||
46835263|NCT02577406|83052845|FG001|Treatment Period|Adverse Event|12|||
46835264|NCT02577406|83052844|FG000|Treatment Period|Disease relapse|27|||
46835265|NCT02577406|83052845|FG001|Treatment Period|Disease relapse|1|||
46835266|NCT02577406|83052844|FG000|Treatment Period|HSCT|6|||
46835267|NCT02577406|83052845|FG001|Treatment Period|HSCT|2|||
46835268|NCT02577406|83052844|FG000|Treatment Period|Lost to Follow-up|0|||
46835269|NCT02577406|83052845|FG001|Treatment Period|Lost to Follow-up|1|||
46835270|NCT02577406|83052844|FG000|Treatment Period|Protocol Violation|0|||
46835271|NCT02577406|83052845|FG001|Treatment Period|Protocol Violation|1|||
46835272|NCT02438722|83052857|FG000|Overall Study|Adverse Event|12|||
46835273|NCT02438722|83052858|FG001|Overall Study|Adverse Event|9|||
46942713|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
47062455|NCT02754141|83343322|FG001|Overall Study|AE unrelated to study drug|1|||
47062456|NCT02754141|83343323|FG002|Overall Study|AE unrelated to study drug|0|||
47062457|NCT02754141|83343324|FG003|Overall Study|AE unrelated to study drug|1|||
47062458|NCT02754141|83343325|FG004|Overall Study|AE unrelated to study drug|3|||
46767416|NCT00784875|82985502|FG000|Period C|Sponsor Decision|5|||
46767417|NCT00784875|82985503|FG001|Period C|Sponsor Decision|5|||
46767418|NCT00784875|82985504|FG002|Period C|Sponsor Decision|4|||
46767419|NCT00784875|82985505|FG003|Period C|Sponsor Decision|2|||
46767420|NCT00784875|82985502|FG000|Period D|Adverse Event|0|||
46767421|NCT00784875|82985503|FG001|Period D|Adverse Event|2|||
46767422|NCT00784875|82985504|FG002|Period D|Adverse Event|2|||
46767423|NCT00784875|82985505|FG003|Period D|Adverse Event|0|||
46767424|NCT00784875|82985502|FG000|Period D|Protocol Violation|1|||
46835274|NCT02438722|83052857|FG000|Overall Study|Refusal unrelated to AE|2|||
46835275|NCT02438722|83052858|FG001|Overall Study|Refusal unrelated to AE|5|||
47062459|NCT02754141|83343326|FG005|Overall Study|AE unrelated to study drug|2|||
46767425|NCT00784875|82985503|FG001|Period D|Protocol Violation|0|||
46835276|NCT02438722|83052857|FG000|Overall Study|Disease progression/relapse|46|||
46835277|NCT02438722|83052858|FG001|Overall Study|Disease progression/relapse|51|||
46767426|NCT00784875|82985504|FG002|Period D|Protocol Violation|0|||
46767427|NCT00784875|82985505|FG003|Period D|Protocol Violation|0|||
46835278|NCT02438722|83052857|FG000|Overall Study|Death|0|||
46835279|NCT02438722|83052858|FG001|Overall Study|Death|3|||
46835280|NCT02438722|83052857|FG000|Overall Study|Physician Decision|2|||
46835281|NCT02438722|83052858|FG001|Overall Study|Physician Decision|2|||
46835282|NCT02438722|83052857|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
46835283|NCT02438722|83052858|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
46835284|NCT02438722|83052857|FG000|Overall Study|Withdrawal by Subject|0|||
46835285|NCT02438722|83052858|FG001|Overall Study|Withdrawal by Subject|1|||
46835286|NCT02438722|83052857|FG000|Overall Study|On protocol treatment|15|||
46835287|NCT02438722|83052858|FG001|Overall Study|On protocol treatment|14|||
46835288|NCT02438722|83052857|FG000|Overall Study|Did not receive protocol treatment|5|||
46835289|NCT02438722|83052858|FG001|Overall Study|Did not receive protocol treatment|0|||
46835290|NCT02422498|83052864|FG000|Overall Study|Inevaluable|4|||
46835291|NCT02347891|83052870|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
46835292|NCT02347891|83052871|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
46835293|NCT02347891|83052870|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
46835294|NCT02347891|83052871|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
46835295|NCT02023164|83052889|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
46835296|NCT02023164|83052890|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
46638052|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638053|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638054|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46767428|NCT00784875|82985502|FG000|Period D|Withdrawal by Subject|2|||
46638055|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638056|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638057|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638058|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638059|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
46638060|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46638061|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
46767429|NCT00784875|82985503|FG001|Period D|Withdrawal by Subject|0|||
46767430|NCT00784875|82985504|FG002|Period D|Withdrawal by Subject|2|||
46767431|NCT00784875|82985505|FG003|Period D|Withdrawal by Subject|0|||
46767432|NCT00784875|82985502|FG000|Period D|Physician Decision|0|||
46835297|NCT01959139|83052909|FG000|Phase II|Disease progression|0|||
46835298|NCT01959139|83052910|FG001|Phase II|Disease progression|0|||
46835299|NCT01959139|83052911|FG002|Phase II|Disease progression|26|||
46835300|NCT01959139|83052912|FG003|Phase II|Disease progression|34|||
46835301|NCT01959139|83052909|FG000|Phase II|Adverse Event|0|||
46835302|NCT01959139|83052910|FG001|Phase II|Adverse Event|0|||
46835303|NCT01959139|83052911|FG002|Phase II|Adverse Event|10|||
46835304|NCT01959139|83052912|FG003|Phase II|Adverse Event|11|||
46835305|NCT01959139|83052909|FG000|Phase II|Patient Refusal|0|||
46835306|NCT01959139|83052910|FG001|Phase II|Patient Refusal|0|||
46835307|NCT01959139|83052911|FG002|Phase II|Patient Refusal|5|||
46835308|NCT01959139|83052912|FG003|Phase II|Patient Refusal|4|||
46835309|NCT01959139|83052909|FG000|Phase II|Death|0|||
46835310|NCT01959139|83052910|FG001|Phase II|Death|0|||
46835311|NCT01959139|83052911|FG002|Phase II|Death|3|||
46835312|NCT01959139|83052912|FG003|Phase II|Death|1|||
46835313|NCT01959139|83052909|FG000|Phase II|Other/Unknown|0|||
46835314|NCT01959139|83052910|FG001|Phase II|Other/Unknown|0|||
46835315|NCT01959139|83052911|FG002|Phase II|Other/Unknown|8|||
46835316|NCT01959139|83052912|FG003|Phase II|Other/Unknown|5|||
46835317|NCT01959139|83052909|FG000|Phase II|On treatment|0|||
46767433|NCT00784875|82985503|FG001|Period D|Physician Decision|1|||
46767434|NCT00784875|82985504|FG002|Period D|Physician Decision|0|||
46767435|NCT00784875|82985505|FG003|Period D|Physician Decision|0|||
46767436|NCT00784875|82985502|FG000|Period D|Sponsor Decision|1|||
46767437|NCT00784875|82985503|FG001|Period D|Sponsor Decision|1|||
46767438|NCT00784875|82985504|FG002|Period D|Sponsor Decision|1|||
46835318|NCT01959139|83052910|FG001|Phase II|On treatment|0|||
46835319|NCT01959139|83052911|FG002|Phase II|On treatment|4|||
46638062|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
46638063|NCT01474512|82811376|FG000|Post-Treatment Follow-Up|Death|0|||
46638064|NCT01474512|82811377|FG001|Post-Treatment Follow-Up|Death|0|||
46638065|NCT01474512|82811378|FG002|Post-Treatment Follow-Up|Death|0|||
46835320|NCT01959139|83052912|FG003|Phase II|On treatment|0|||
46835321|NCT01602380|83052929|FG000|Overall Study|Death|147|||
46835322|NCT01602380|83052930|FG001|Overall Study|Death|145|||
46835323|NCT01602380|83052929|FG000|Overall Study|Withdrawal by Subject|39|||
46835324|NCT01602380|83052930|FG001|Overall Study|Withdrawal by Subject|41|||
46835325|NCT01602380|83052929|FG000|Overall Study|Lost to Follow-up|15|||
46767439|NCT00784875|82985505|FG003|Period D|Sponsor Decision|0|||
46767440|NCT00784875|82985502|FG000|Period D|Lost to Follow-up|1|||
46767441|NCT00784875|82985503|FG001|Period D|Lost to Follow-up|0|||
46835326|NCT01602380|83052930|FG001|Overall Study|Lost to Follow-up|12|||
46835327|NCT01602380|83052929|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46835328|NCT01602380|83052930|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
46835329|NCT01602380|83052929|FG000|Overall Study|Other|2|||
46835330|NCT01602380|83052930|FG001|Overall Study|Other|0|||
46835331|NCT01132326|83052958|FG000|Overall Study|Lack of Efficacy|25|||
46835332|NCT01132326|83052958|FG000|Overall Study|Adverse Event|37|||
46835333|NCT01132326|83052958|FG000|Overall Study|Protocol Violation|1|||
46835334|NCT01132326|83052958|FG000|Overall Study|Lost to Follow-up|16|||
46835335|NCT01132326|83052958|FG000|Overall Study|Withdrawal by Subject|40|||
46835336|NCT01132326|83052958|FG000|Overall Study|Physician Decision|10|||
46835337|NCT01132326|83052958|FG000|Overall Study|Study Termination|80|||
46835338|NCT01132326|83052958|FG000|Overall Study|Declining Health|1|||
46835339|NCT01132326|83052958|FG000|Overall Study|Pregnancy|1|||
46835340|NCT01132326|83052958|FG000|Overall Study|Caregiver Withdrew Consent|1|||
46835341|NCT01132326|83052958|FG000|Overall Study|Death|5|||
46835342|NCT01132326|83052958|FG000|Overall Study|Subject Unable to Come To Visits|1|||
46835343|NCT00150709|83052966|FG000|Overall Study|Protocol Violation|7|||
46835344|NCT00150709|83052967|FG001|Overall Study|Protocol Violation|8|||
46835345|NCT00150709|83052968|FG002|Overall Study|Protocol Violation|3|||
46835346|NCT00150709|83052969|FG003|Overall Study|Protocol Violation|1|||
46835347|NCT00150709|83052966|FG000|Overall Study|Adverse Event|8|||
46835348|NCT00150709|83052967|FG001|Overall Study|Adverse Event|2|||
46835349|NCT00150709|83052968|FG002|Overall Study|Adverse Event|2|||
46835350|NCT00150709|83052969|FG003|Overall Study|Adverse Event|3|||
46835351|NCT00150709|83052966|FG000|Overall Study|Lack of Efficacy|6|||
46835352|NCT00150709|83052967|FG001|Overall Study|Lack of Efficacy|11|||
46835353|NCT00150709|83052968|FG002|Overall Study|Lack of Efficacy|9|||
46835354|NCT00150709|83052969|FG003|Overall Study|Lack of Efficacy|0|||
46835355|NCT00150709|83052966|FG000|Overall Study|Withdrawal by Subject|7|||
46835356|NCT00150709|83052967|FG001|Overall Study|Withdrawal by Subject|10|||
46835357|NCT00150709|83052968|FG002|Overall Study|Withdrawal by Subject|5|||
46835358|NCT00150709|83052969|FG003|Overall Study|Withdrawal by Subject|0|||
46835359|NCT00150709|83052966|FG000|Overall Study|Lost to Follow-up|3|||
46835360|NCT00150709|83052967|FG001|Overall Study|Lost to Follow-up|2|||
46835361|NCT00150709|83052968|FG002|Overall Study|Lost to Follow-up|0|||
46835362|NCT00150709|83052969|FG003|Overall Study|Lost to Follow-up|0|||
46835363|NCT00150709|83052966|FG000|Overall Study|Sponsor decision|0|||
46835364|NCT00150709|83052967|FG001|Overall Study|Sponsor decision|0|||
46835365|NCT00150709|83052968|FG002|Overall Study|Sponsor decision|0|||
46835366|NCT00150709|83052969|FG003|Overall Study|Sponsor decision|1|||
46835367|NCT00150709|83052966|FG000|Overall Study|Site/Investigator discontinued the study|5|||
46835368|NCT00150709|83052967|FG001|Overall Study|Site/Investigator discontinued the study|5|||
46835369|NCT00150709|83052968|FG002|Overall Study|Site/Investigator discontinued the study|2|||
46835370|NCT00150709|83052969|FG003|Overall Study|Site/Investigator discontinued the study|0|||
46835371|NCT00150709|83052966|FG000|Overall Study|Decision of parent(s)|1|||
46835372|NCT00150709|83052967|FG001|Overall Study|Decision of parent(s)|2|||
46942714|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
46942715|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
46942716|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
46942717|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
46942718|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
46942719|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
46942720|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
46942721|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942722|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
47062460|NCT02754141|83343327|FG006|Overall Study|AE unrelated to study drug|1|||
47062461|NCT02754141|83343328|FG007|Overall Study|AE unrelated to study drug|0|||
47062462|NCT02754141|83343329|FG008|Overall Study|AE unrelated to study drug|0|||
46835373|NCT00150709|83052968|FG002|Overall Study|Decision of parent(s)|0|||
46835374|NCT00150709|83052969|FG003|Overall Study|Decision of parent(s)|0|||
46835375|NCT00150709|83052966|FG000|Overall Study|Decision of parent(s) and investigator|3|||
47062463|NCT02754141|83343330|FG009|Overall Study|AE unrelated to study drug|0|||
46835376|NCT00150709|83052967|FG001|Overall Study|Decision of parent(s) and investigator|0|||
46835377|NCT00150709|83052968|FG002|Overall Study|Decision of parent(s) and investigator|0|||
46942723|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
47062464|NCT02754141|83343331|FG010|Overall Study|AE unrelated to study drug|0|||
46835378|NCT00150709|83052969|FG003|Overall Study|Decision of parent(s) and investigator|0|||
46835379|NCT00150709|83052966|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
46835380|NCT00150709|83052967|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
46835381|NCT00150709|83052968|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
46835382|NCT00150709|83052969|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
46835383|NCT00150709|83052966|FG000|Overall Study|Investigator decision|1|||
46835384|NCT00150709|83052967|FG001|Overall Study|Investigator decision|0|||
46835385|NCT00150709|83052968|FG002|Overall Study|Investigator decision|0|||
46942724|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
47062465|NCT02754141|83343332|FG011|Overall Study|AE unrelated to study drug|0|||
46942725|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942726|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942727|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942728|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942729|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942730|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942731|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942732|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942733|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942734|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
46942735|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942736|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
46942737|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942738|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942739|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942740|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942741|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
47062466|NCT02754141|83343333|FG012|Overall Study|AE unrelated to study drug|0|||
46767442|NCT00784875|82985504|FG002|Period D|Lost to Follow-up|1|||
46767443|NCT00784875|82985505|FG003|Period D|Lost to Follow-up|1|||
46767444|NCT00592553|82985531|FG000|Overall Study|Protocol Noncompliance|1|||
46767445|NCT00592553|82985532|FG001|Overall Study|Protocol Noncompliance|0|||
46767446|NCT00592553|82985533|FG002|Overall Study|Protocol Noncompliance|0|||
46767447|NCT00853229|82985543|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
46767448|NCT00853229|82985544|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
46767449|NCT00853151|82985556|FG000|Overall Study|Adverse Event|1|||
46767450|NCT00853151|82985557|FG001|Overall Study|Adverse Event|4|||
46767451|NCT00853151|82985558|FG002|Overall Study|Adverse Event|2|||
46767452|NCT00853151|82985559|FG003|Overall Study|Adverse Event|0|||
46767453|NCT00853151|82985556|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
46767454|NCT00853151|82985557|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46767455|NCT00853151|82985558|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46767456|NCT00853151|82985559|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46767457|NCT00853151|82985556|FG000|Overall Study|Lost to Follow-up|2|||
46767458|NCT00853151|82985557|FG001|Overall Study|Lost to Follow-up|0|||
46767459|NCT00853151|82985558|FG002|Overall Study|Lost to Follow-up|3|||
46767460|NCT00853151|82985559|FG003|Overall Study|Lost to Follow-up|0|||
46767461|NCT00853151|82985556|FG000|Overall Study|Death|1|||
46767462|NCT00853151|82985557|FG001|Overall Study|Death|0|||
46767463|NCT00853151|82985558|FG002|Overall Study|Death|0|||
46767464|NCT00853151|82985559|FG003|Overall Study|Death|1|||
46767465|NCT00853151|82985556|FG000|Overall Study|Protocol Violation|0|||
46767466|NCT00853151|82985557|FG001|Overall Study|Protocol Violation|0|||
46767467|NCT00853151|82985558|FG002|Overall Study|Protocol Violation|0|||
46767468|NCT00853151|82985559|FG003|Overall Study|Protocol Violation|1|||
46767469|NCT00853151|82985556|FG000|Overall Study|Withdrawal by Subject|5|||
46767470|NCT00853151|82985557|FG001|Overall Study|Withdrawal by Subject|4|||
46767471|NCT00853151|82985558|FG002|Overall Study|Withdrawal by Subject|2|||
46767472|NCT00853151|82985559|FG003|Overall Study|Withdrawal by Subject|1|||
46767473|NCT00853151|82985556|FG000|Overall Study|Physician Decision|0|||
46767474|NCT00853151|82985557|FG001|Overall Study|Physician Decision|2|||
46767475|NCT00853151|82985558|FG002|Overall Study|Physician Decision|1|||
46767476|NCT00853151|82985559|FG003|Overall Study|Physician Decision|0|||
46767477|NCT00853151|82985556|FG000|Overall Study|Sponsor Decision|0|||
46767478|NCT00853151|82985557|FG001|Overall Study|Sponsor Decision|3|||
46767479|NCT00853151|82985558|FG002|Overall Study|Sponsor Decision|0|||
46767480|NCT00853151|82985559|FG003|Overall Study|Sponsor Decision|0|||
46767481|NCT00853073|82985574|FG000|Overall Study|Withdrawal by Subject|3|||
46767482|NCT00853073|82985575|FG001|Overall Study|Withdrawal by Subject|2|||
46767483|NCT00846053|82985583|FG000|Overall Study|Physician Decision|3|||
46767484|NCT00846053|82985584|FG001|Overall Study|Physician Decision|0|||
46767485|NCT00845897|82985595|FG000|Overall Study|Lost to Follow-up|1|||
46767486|NCT00845897|82985596|FG001|Overall Study|Lost to Follow-up|1|||
46767487|NCT00845897|82985597|FG002|Overall Study|Lost to Follow-up|0|||
46767488|NCT00845897|82985595|FG000|Overall Study|Withdrawal by Subject|0|||
46767489|NCT00845897|82985596|FG001|Overall Study|Withdrawal by Subject|3|||
46767490|NCT00845897|82985597|FG002|Overall Study|Withdrawal by Subject|2|||
46767491|NCT00845897|82985595|FG000|Overall Study|Ulcer did not heal|1|||
46767492|NCT00845897|82985596|FG001|Overall Study|Ulcer did not heal|0|||
46767493|NCT00845897|82985597|FG002|Overall Study|Ulcer did not heal|1|||
46767494|NCT00845897|82985595|FG000|Overall Study|Too ill to participate|0|||
46767495|NCT00845897|82985596|FG001|Overall Study|Too ill to participate|1|||
46767496|NCT00845897|82985597|FG002|Overall Study|Too ill to participate|0|||
46835386|NCT00150709|83052969|FG003|Overall Study|Investigator decision|1|||
46835387|NCT00150709|83052966|FG000|Overall Study|Subject relocated|2|||
46835388|NCT00150709|83052967|FG001|Overall Study|Subject relocated|2|||
46835389|NCT00150709|83052968|FG002|Overall Study|Subject relocated|1|||
46835390|NCT00150709|83052969|FG003|Overall Study|Subject relocated|0|||
46835391|NCT00150709|83052966|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
46835392|NCT00150709|83052967|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
46835393|NCT00150709|83052968|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
46835394|NCT00150709|83052969|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
46835395|NCT00150709|83052966|FG000|Overall Study|Convenience|0|||
46835396|NCT00150709|83052967|FG001|Overall Study|Convenience|1|||
46835397|NCT00150709|83052968|FG002|Overall Study|Convenience|0|||
46835398|NCT00150709|83052969|FG003|Overall Study|Convenience|0|||
46835399|NCT00150709|83052966|FG000|Overall Study|Subject entered new drug study|0|||
46835400|NCT00150709|83052967|FG001|Overall Study|Subject entered new drug study|1|||
46835401|NCT00150709|83052968|FG002|Overall Study|Subject entered new drug study|0|||
46835402|NCT00150709|83052969|FG003|Overall Study|Subject entered new drug study|0|||
46835403|NCT00150709|83052966|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
46835404|NCT00150709|83052967|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
46835405|NCT00150709|83052968|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
46835406|NCT00150709|83052969|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
46835407|NCT00150709|83052966|FG000|Overall Study|Lack of ease of swallowing|0|||
46835408|NCT00150709|83052967|FG001|Overall Study|Lack of ease of swallowing|1|||
46942742|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942743|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942744|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942745|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942746|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942747|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942748|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942749|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
47062467|NCT02754141|83343334|FG013|Overall Study|AE unrelated to study drug|0|||
47062468|NCT02754141|83343335|FG014|Overall Study|AE unrelated to study drug|0|||
46767497|NCT00862277|82985608|FG000|Overall Study|Protocol Violation|1|||
46767498|NCT00862277|82985609|FG001|Overall Study|Protocol Violation|2|||
46767499|NCT00862277|82985610|FG002|Overall Study|Protocol Violation|5|||
46767500|NCT00852995|82985623|FG000|Overall Study|Adverse Event|1|||
46767501|NCT00852995|82985624|FG001|Overall Study|Adverse Event|0|||
46767502|NCT00852995|82985625|FG002|Overall Study|Adverse Event|4|||
46767503|NCT00852995|82985626|FG003|Overall Study|Adverse Event|0|||
46767504|NCT00852995|82985627|FG004|Overall Study|Adverse Event|0|||
46767505|NCT00852995|82985623|FG000|Overall Study|Lost to Follow-up|0|||
46767506|NCT00852995|82985624|FG001|Overall Study|Lost to Follow-up|1|||
46767507|NCT00852995|82985625|FG002|Overall Study|Lost to Follow-up|1|||
46767508|NCT00852995|82985626|FG003|Overall Study|Lost to Follow-up|0|||
46767509|NCT00852995|82985627|FG004|Overall Study|Lost to Follow-up|0|||
46767510|NCT00852995|82985623|FG000|Overall Study|Withdrawal by Subject|4|||
46767511|NCT00852995|82985624|FG001|Overall Study|Withdrawal by Subject|0|||
46767512|NCT00852995|82985625|FG002|Overall Study|Withdrawal by Subject|0|||
46767513|NCT00852995|82985626|FG003|Overall Study|Withdrawal by Subject|1|||
46767514|NCT00852995|82985627|FG004|Overall Study|Withdrawal by Subject|2|||
46767515|NCT00852995|82985623|FG000|Overall Study|Non-Compliance|0|||
46767516|NCT00852995|82985624|FG001|Overall Study|Non-Compliance|0|||
46767517|NCT00852995|82985625|FG002|Overall Study|Non-Compliance|0|||
46767518|NCT00852995|82985626|FG003|Overall Study|Non-Compliance|2|||
46767519|NCT00852995|82985627|FG004|Overall Study|Non-Compliance|0|||
46767520|NCT00852995|82985623|FG000|Overall Study|Progressive Disease|1|||
46767521|NCT00852995|82985624|FG001|Overall Study|Progressive Disease|0|||
46767522|NCT00852995|82985625|FG002|Overall Study|Progressive Disease|0|||
46767523|NCT00852995|82985626|FG003|Overall Study|Progressive Disease|2|||
46767524|NCT00852995|82985627|FG004|Overall Study|Progressive Disease|1|||
46767525|NCT00852995|82985623|FG000|Overall Study|Physician Decision|1|||
46767526|NCT00852995|82985624|FG001|Overall Study|Physician Decision|0|||
46767527|NCT00852995|82985625|FG002|Overall Study|Physician Decision|0|||
46767528|NCT00852995|82985626|FG003|Overall Study|Physician Decision|0|||
46767529|NCT00852995|82985627|FG004|Overall Study|Physician Decision|0|||
46767530|NCT00852995|82985623|FG000|Overall Study|Protocol Violation|0|||
46767531|NCT00852995|82985624|FG001|Overall Study|Protocol Violation|0|||
46767532|NCT00852995|82985625|FG002|Overall Study|Protocol Violation|0|||
46767533|NCT00852995|82985626|FG003|Overall Study|Protocol Violation|0|||
46767534|NCT00852995|82985627|FG004|Overall Study|Protocol Violation|1|||
46767535|NCT00852995|82985623|FG000|Overall Study|Moved Out of Area|1|||
46767536|NCT00852995|82985624|FG001|Overall Study|Moved Out of Area|0|||
46767537|NCT00852995|82985625|FG002|Overall Study|Moved Out of Area|0|||
46835409|NCT00150709|83052968|FG002|Overall Study|Lack of ease of swallowing|0|||
46835410|NCT00150709|83052969|FG003|Overall Study|Lack of ease of swallowing|0|||
46835411|NCT00314574|83052981|FG000|Overall Study|Death|3|||
46835412|NCT00314574|83052982|FG001|Overall Study|Death|0|||
46835413|NCT00314574|83052981|FG000|Overall Study|Adverse Event|11|||
46835414|NCT00314574|83052982|FG001|Overall Study|Adverse Event|16|||
46835415|NCT00314574|83052981|FG000|Overall Study|Lost to Follow-up|19|||
46835416|NCT00314574|83052982|FG001|Overall Study|Lost to Follow-up|25|||
46835417|NCT00314574|83052981|FG000|Overall Study|Withdrawal by Subject|33|||
46835418|NCT00314574|83052982|FG001|Overall Study|Withdrawal by Subject|22|||
46835419|NCT00314574|83052981|FG000|Overall Study|Physician Decision|22|||
46835420|NCT00314574|83052982|FG001|Overall Study|Physician Decision|15|||
46835421|NCT00314574|83052981|FG000|Overall Study|Pregnancy|6|||
46835422|NCT00314574|83052982|FG001|Overall Study|Pregnancy|4|||
46835423|NCT00314574|83052981|FG000|Overall Study|Data unknown at database lock|0|||
46835424|NCT00314574|83052982|FG001|Overall Study|Data unknown at database lock|1|||
46835425|NCT00314340|83052988|FG000|Overall Study|lost interest|1|||
46835426|NCT00306852|83052996|FG000|Overall Study|Death|14|||
47062469|NCT02754141|83343336|FG015|Overall Study|AE unrelated to study drug|0|||
46767538|NCT00852995|82985626|FG003|Overall Study|Moved Out of Area|0|||
46835427|NCT00306852|83052997|FG001|Overall Study|Death|14|||
46835428|NCT00306852|83052996|FG000|Overall Study|Lost to Follow-up|15|||
46835429|NCT00306852|83052997|FG001|Overall Study|Lost to Follow-up|24|||
46835430|NCT00314262|83053003|FG000|Overall Study|Adverse Event|2|||
46835431|NCT00314262|83053003|FG000|Overall Study|Withdrawal by Subject|2|||
46835432|NCT00314262|83053003|FG000|Overall Study|Physician Decision|1|||
46835433|NCT00333866|83053011|FG000|Overall Study|Adverse Event|23|||
46835434|NCT00333866|83053012|FG001|Overall Study|Adverse Event|37|||
46835435|NCT00333866|83053013|FG002|Overall Study|Adverse Event|38|||
46835436|NCT00333866|83053014|FG003|Overall Study|Adverse Event|47|||
46835437|NCT00333866|83053011|FG000|Overall Study|Other|3|||
46835438|NCT00333866|83053012|FG001|Overall Study|Other|2|||
46835439|NCT00333866|83053013|FG002|Overall Study|Other|2|||
46835440|NCT00333866|83053014|FG003|Overall Study|Other|2|||
46835441|NCT00333866|83053011|FG000|Overall Study|Lack of Efficacy|8|||
46835442|NCT00333866|83053012|FG001|Overall Study|Lack of Efficacy|6|||
46835443|NCT00333866|83053013|FG002|Overall Study|Lack of Efficacy|3|||
46835444|NCT00333866|83053014|FG003|Overall Study|Lack of Efficacy|5|||
46835445|NCT00333866|83053011|FG000|Overall Study|Lost to Follow-up|1|||
46835446|NCT00333866|83053012|FG001|Overall Study|Lost to Follow-up|2|||
46835447|NCT00333866|83053013|FG002|Overall Study|Lost to Follow-up|2|||
46835448|NCT00333866|83053014|FG003|Overall Study|Lost to Follow-up|2|||
46835449|NCT00333866|83053011|FG000|Overall Study|Withdrawal by Subject|8|||
46835450|NCT00333866|83053012|FG001|Overall Study|Withdrawal by Subject|14|||
46835451|NCT00333866|83053013|FG002|Overall Study|Withdrawal by Subject|4|||
46835452|NCT00333866|83053014|FG003|Overall Study|Withdrawal by Subject|9|||
46835453|NCT00333866|83053011|FG000|Overall Study|Randomized but not Treated|5|||
46835454|NCT00333866|83053012|FG001|Overall Study|Randomized but not Treated|3|||
46835455|NCT00333866|83053013|FG002|Overall Study|Randomized but not Treated|2|||
46835456|NCT00333866|83053014|FG003|Overall Study|Randomized but not Treated|1|||
46835457|NCT00324740|83053024|FG000|Overall Study|Withdrawal by Subject|1|||
46835458|NCT00324740|83053025|FG001|Overall Study|Withdrawal by Subject|0|||
46835459|NCT00324740|83053026|FG002|Overall Study|Withdrawal by Subject|1|||
46767539|NCT00852995|82985627|FG004|Overall Study|Moved Out of Area|0|||
46767540|NCT00592319|82985646|FG000|Overall Study|Lost to Follow-up|0|||
46767541|NCT00592319|82985647|FG001|Overall Study|Lost to Follow-up|3|||
46767542|NCT00862121|82985657|FG000|Overall Study|Adverse Event|1|||
46767543|NCT00862121|82985658|FG001|Overall Study|Adverse Event|2|||
46767544|NCT00862121|82985657|FG000|Overall Study|Lack of Efficacy|0|||
46767545|NCT00862121|82985658|FG001|Overall Study|Lack of Efficacy|3|||
46767546|NCT00862121|82985657|FG000|Overall Study|Protocol Violation|0|||
46767547|NCT00862121|82985658|FG001|Overall Study|Protocol Violation|1|||
47062470|NCT02754141|83343337|FG016|Overall Study|AE unrelated to study drug|0|||
47062471|NCT02754141|83343338|FG017|Overall Study|AE unrelated to study drug|0|||
46835460|NCT00333788|83053033|FG000|Overall Study|Adverse Event|44|||
46835461|NCT00333788|83053033|FG000|Overall Study|Lack of Efficacy|80|||
46835462|NCT00333788|83053033|FG000|Overall Study|Lost to Follow-up|2|||
46835463|NCT00333788|83053033|FG000|Overall Study|Withdrawal by Subject|24|||
46835464|NCT00333788|83053033|FG000|Overall Study|Other: Non-compliance|2|||
46835465|NCT00333788|83053033|FG000|Overall Study|Other: Moved|2|||
46835466|NCT00333788|83053033|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
46835467|NCT00333788|83053033|FG000|Overall Study|Other: Investigator decision|1|||
46835468|NCT00333788|83053033|FG000|Overall Study|Other: Quality of life concern|1|||
46767548|NCT00862121|82985657|FG000|Overall Study|Exclusion criterion violation|0|||
46767549|NCT00862121|82985658|FG001|Overall Study|Exclusion criterion violation|1|||
46835469|NCT00333788|83053033|FG000|Overall Study|Other: Sponsor decision|1|||
46835470|NCT00333788|83053033|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
46835471|NCT00333788|83053033|FG000|Overall Study|Other: Medical monitor decision|1|||
46835472|NCT00333788|83053033|FG000|Overall Study|Other: Physician decision|1|||
46835473|NCT00333788|83053033|FG000|Overall Study|Other: Signed consent for another study|1|||
46835474|NCT00324116|83053037|FG000|Overall Study|Adverse Event|5|||
46835475|NCT00324116|83053037|FG000|Overall Study|Lack of Efficacy|17|||
46835476|NCT00324116|83053037|FG000|Overall Study|Withdrawal by Subject|5|||
46835477|NCT00324116|83053037|FG000|Overall Study|Other|5|||
46835478|NCT00332696|83053043|FG000|Overall Study|Death|24|||
46767550|NCT00862121|82985657|FG000|Overall Study|Incorrect randomisation|0|||
46767551|NCT00862121|82985658|FG001|Overall Study|Incorrect randomisation|1|||
46767552|NCT00784719|82985671|FG000|Overall Study|Adverse Event|0|||
46767553|NCT00784719|82985672|FG001|Overall Study|Adverse Event|2|||
46767554|NCT00784719|82985673|FG002|Overall Study|Adverse Event|0|||
46767555|NCT00784719|82985674|FG003|Overall Study|Adverse Event|0|||
46767556|NCT00784719|82985675|FG004|Overall Study|Adverse Event|1|||
46942750|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
47062472|NCT02754141|83343321|FG000|Overall Study|Request to discontinue|0|||
47062473|NCT02754141|83343322|FG001|Overall Study|Request to discontinue|0|||
47062474|NCT02754141|83343323|FG002|Overall Study|Request to discontinue|0|||
47062475|NCT02754141|83343324|FG003|Overall Study|Request to discontinue|0|||
47062476|NCT02754141|83343325|FG004|Overall Study|Request to discontinue|0|||
47062477|NCT02754141|83343326|FG005|Overall Study|Request to discontinue|0|||
47062478|NCT02754141|83343327|FG006|Overall Study|Request to discontinue|0|||
47062479|NCT02754141|83343328|FG007|Overall Study|Request to discontinue|0|||
47062480|NCT02754141|83343329|FG008|Overall Study|Request to discontinue|1|||
47062481|NCT02754141|83343330|FG009|Overall Study|Request to discontinue|0|||
46767557|NCT00784719|82985676|FG005|Overall Study|Adverse Event|1|||
46767558|NCT00784719|82985677|FG006|Overall Study|Adverse Event|1|||
46767559|NCT00784719|82985671|FG000|Overall Study|Lost to Follow-up|0|||
46767560|NCT00784719|82985672|FG001|Overall Study|Lost to Follow-up|0|||
46767561|NCT00784719|82985673|FG002|Overall Study|Lost to Follow-up|0|||
46767562|NCT00784719|82985674|FG003|Overall Study|Lost to Follow-up|0|||
46767563|NCT00784719|82985675|FG004|Overall Study|Lost to Follow-up|1|||
46942751|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942752|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
46942753|NCT02958865|83179753|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942754|NCT02958865|83179754|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942755|NCT02958865|83179755|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942756|NCT02958865|83179756|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46767564|NCT00784719|82985676|FG005|Overall Study|Lost to Follow-up|1|||
46767565|NCT00784719|82985677|FG006|Overall Study|Lost to Follow-up|0|||
46767566|NCT00784719|82985671|FG000|Overall Study|Other|2|||
46767567|NCT00784719|82985672|FG001|Overall Study|Other|1|||
46767568|NCT00784719|82985673|FG002|Overall Study|Other|1|||
46767569|NCT00784719|82985674|FG003|Overall Study|Other|0|||
46767570|NCT00784719|82985675|FG004|Overall Study|Other|2|||
46767571|NCT00784719|82985676|FG005|Overall Study|Other|1|||
46767572|NCT00784719|82985677|FG006|Overall Study|Other|3|||
46767573|NCT00784719|82985671|FG000|Overall Study|Withdrawal by Subject|1|||
46767574|NCT00784719|82985672|FG001|Overall Study|Withdrawal by Subject|0|||
46767575|NCT00784719|82985673|FG002|Overall Study|Withdrawal by Subject|0|||
46767576|NCT00784719|82985674|FG003|Overall Study|Withdrawal by Subject|0|||
46835479|NCT00332696|83053044|FG001|Overall Study|Death|14|||
46835480|NCT00332696|83053043|FG000|Overall Study|Insufficient therapeutic effect|4|||
46835481|NCT00332696|83053044|FG001|Overall Study|Insufficient therapeutic effect|11|||
46835482|NCT00332696|83053043|FG000|Overall Study|Adverse Event|1|||
46835483|NCT00332696|83053044|FG001|Overall Study|Adverse Event|2|||
46835484|NCT00332696|83053043|FG000|Overall Study|Condition does not justify treatment|0|||
46835485|NCT00332696|83053044|FG001|Overall Study|Condition does not justify treatment|2|||
46835486|NCT00332696|83053043|FG000|Overall Study|Lost to Follow-up|0|||
46835487|NCT00332696|83053044|FG001|Overall Study|Lost to Follow-up|1|||
46835488|NCT00332696|83053043|FG000|Overall Study|Withdrawal by Subject|1|||
46835489|NCT00332696|83053044|FG001|Overall Study|Withdrawal by Subject|0|||
46835490|NCT00313716|83053056|FG000|Overall Study|Death|3|||
46835491|NCT00313716|83053057|FG001|Overall Study|Death|2|||
46835492|NCT00313716|83053058|FG002|Overall Study|Death|9|||
46767577|NCT00784719|82985675|FG004|Overall Study|Withdrawal by Subject|2|||
46767578|NCT00784719|82985676|FG005|Overall Study|Withdrawal by Subject|0|||
46767579|NCT00784719|82985677|FG006|Overall Study|Withdrawal by Subject|1|||
46767580|NCT00852917|82985697|FG000|Overall Study|Adverse Event|13|||
46767581|NCT00852917|82985698|FG001|Overall Study|Adverse Event|20|||
46835493|NCT00313716|83053059|FG003|Overall Study|Death|3|||
46942757|NCT02958865|83179757|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46967796|NCT02181634|83210375|FG000|Overall Study|Symptomatic progression|1|||
47062482|NCT02754141|83343331|FG010|Overall Study|Request to discontinue|0|||
46767582|NCT00852917|82985699|FG002|Overall Study|Adverse Event|35|||
47062483|NCT02754141|83343332|FG011|Overall Study|Request to discontinue|0|||
47062484|NCT02754141|83343333|FG012|Overall Study|Request to discontinue|0|||
46835494|NCT00313716|83053060|FG004|Overall Study|Death|5|||
46835495|NCT00313716|83053061|FG005|Overall Study|Death|9|||
46942758|NCT02958865|83179758|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942759|NCT02958865|83179759|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942760|NCT02958865|83179760|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942761|NCT02958865|83179761|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46767583|NCT00852917|82985700|FG003|Overall Study|Adverse Event|17|||
46767584|NCT00852917|82985697|FG000|Overall Study|Lack of Efficacy|21|||
46767585|NCT00852917|82985698|FG001|Overall Study|Lack of Efficacy|11|||
46767586|NCT00852917|82985699|FG002|Overall Study|Lack of Efficacy|11|||
46767587|NCT00852917|82985700|FG003|Overall Study|Lack of Efficacy|47|||
46767588|NCT00852917|82985697|FG000|Overall Study|Withdrawal by Subject|4|||
46767589|NCT00852917|82985698|FG001|Overall Study|Withdrawal by Subject|8|||
46767590|NCT00852917|82985699|FG002|Overall Study|Withdrawal by Subject|10|||
46767591|NCT00852917|82985700|FG003|Overall Study|Withdrawal by Subject|9|||
46767592|NCT00852917|82985697|FG000|Overall Study|Physician Decision|6|||
46767593|NCT00852917|82985698|FG001|Overall Study|Physician Decision|7|||
46767594|NCT00852917|82985699|FG002|Overall Study|Physician Decision|2|||
46767595|NCT00852917|82985700|FG003|Overall Study|Physician Decision|19|||
46767596|NCT00852917|82985697|FG000|Overall Study|Death|0|||
46767597|NCT00852917|82985698|FG001|Overall Study|Death|0|||
46835496|NCT00313716|83053056|FG000|Overall Study|Lost to Follow-up|2|||
46835497|NCT00313716|83053057|FG001|Overall Study|Lost to Follow-up|5|||
46835498|NCT00313716|83053058|FG002|Overall Study|Lost to Follow-up|2|||
46835499|NCT00313716|83053059|FG003|Overall Study|Lost to Follow-up|1|||
46942762|NCT02958865|83179762|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
46942763|NCT02958865|83179763|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942764|NCT02958865|83179764|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942765|NCT02958865|83179765|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46835500|NCT00313716|83053060|FG004|Overall Study|Lost to Follow-up|0|||
46835501|NCT00313716|83053061|FG005|Overall Study|Lost to Follow-up|4|||
46835502|NCT00313716|83053056|FG000|Overall Study|Withdrawal by Subject|0|||
46835503|NCT00313716|83053057|FG001|Overall Study|Withdrawal by Subject|1|||
46835504|NCT00313716|83053058|FG002|Overall Study|Withdrawal by Subject|1|||
46835505|NCT00313716|83053059|FG003|Overall Study|Withdrawal by Subject|0|||
46835506|NCT00313716|83053060|FG004|Overall Study|Withdrawal by Subject|1|||
46835507|NCT00313716|83053061|FG005|Overall Study|Withdrawal by Subject|0|||
46835508|NCT00313170|83053082|FG000|Overall Study|Death|2|||
46835509|NCT00313170|83053083|FG001|Overall Study|Death|4|||
46835510|NCT00313170|83053084|FG002|Overall Study|Death|2|||
46835511|NCT00313170|83053082|FG000|Overall Study|Adverse Event|1|||
46835512|NCT00313170|83053083|FG001|Overall Study|Adverse Event|2|||
46835513|NCT00313170|83053084|FG002|Overall Study|Adverse Event|0|||
46835514|NCT00313170|83053082|FG000|Overall Study|Disease progression|31|||
46835515|NCT00313170|83053083|FG001|Overall Study|Disease progression|26|||
46835516|NCT00313170|83053084|FG002|Overall Study|Disease progression|27|||
46835517|NCT00313170|83053082|FG000|Overall Study|Withdrawal by Subject|1|||
46835518|NCT00313170|83053083|FG001|Overall Study|Withdrawal by Subject|0|||
46835519|NCT00313170|83053084|FG002|Overall Study|Withdrawal by Subject|1|||
46835520|NCT00313170|83053082|FG000|Overall Study|Incorrect enrollment|0|||
46835521|NCT00313170|83053083|FG001|Overall Study|Incorrect enrollment|2|||
46835522|NCT00313170|83053084|FG002|Overall Study|Incorrect enrollment|1|||
46835523|NCT00313170|83053082|FG000|Overall Study|Lost to Follow-up|0|||
46835524|NCT00313170|83053083|FG001|Overall Study|Lost to Follow-up|0|||
46835525|NCT00313170|83053084|FG002|Overall Study|Lost to Follow-up|1|||
46835526|NCT00313170|83053082|FG000|Overall Study|Progression (investigators opinion)|1|||
46835527|NCT00313170|83053083|FG001|Overall Study|Progression (investigators opinion)|0|||
46835528|NCT00313170|83053084|FG002|Overall Study|Progression (investigators opinion)|0|||
46835529|NCT00332462|83053093|FG000|Overall Study|Adverse Event|5|||
46835530|NCT00332462|83053093|FG000|Overall Study|Abnormal Lab Value|1|||
46835531|NCT00332462|83053093|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
46835532|NCT00332462|83053093|FG000|Overall Study|no longer requires study drug|1|||
46835533|NCT00332462|83053093|FG000|Overall Study|Death|3|||
46835534|NCT00332462|83053093|FG000|Overall Study|Graft Loss|2|||
46942766|NCT02958865|83179766|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46767598|NCT00852917|82985699|FG002|Overall Study|Death|0|||
46835535|NCT00324038|83053102|FG000|Overall Study|Adverse Event|38|||
46835536|NCT00324038|83053103|FG001|Overall Study|Adverse Event|23|||
46835537|NCT00324038|83053102|FG000|Overall Study|Lack of Efficacy|5|||
46835538|NCT00324038|83053103|FG001|Overall Study|Lack of Efficacy|13|||
46835539|NCT00324038|83053102|FG000|Overall Study|Lost to Follow-up|0|||
46767599|NCT00852917|82985700|FG003|Overall Study|Death|1|||
46835540|NCT00324038|83053103|FG001|Overall Study|Lost to Follow-up|2|||
46835541|NCT00324038|83053102|FG000|Overall Study|Other|6|||
46835542|NCT00324038|83053103|FG001|Overall Study|Other|13|||
46835543|NCT00159861|83053111|FG000|Core Study - 16 Weeks|Death|3|||
46835544|NCT00159861|83053112|FG001|Core Study - 16 Weeks|Death|0|||
46767600|NCT00845429|82985713|FG000|Overall Study|Protocol Violation|5|||
46835545|NCT00159861|83053111|FG000|Core Study - 16 Weeks|Adverse Event|12|||
46835546|NCT00159861|83053112|FG001|Core Study - 16 Weeks|Adverse Event|6|||
46835547|NCT00159861|83053111|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
46835548|NCT00159861|83053112|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
46835549|NCT00159861|83053111|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
46835550|NCT00159861|83053112|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
46835551|NCT00159861|83053111|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
46835552|NCT00159861|83053112|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
46835553|NCT00159861|83053111|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
46835554|NCT00159861|83053112|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
46835555|NCT00159861|83053111|FG000|Extension Study - up to 3 Years|Death|24|||
46835556|NCT00159861|83053112|FG001|Extension Study - up to 3 Years|Death|28|||
46835557|NCT00159861|83053111|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
46835558|NCT00159861|83053112|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
46835559|NCT00159861|83053111|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
46835560|NCT00159861|83053112|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
46835561|NCT00159861|83053111|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
46835562|NCT00159861|83053112|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
46835563|NCT00159861|83053111|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
46835564|NCT00159861|83053112|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
46835565|NCT00331760|83053125|FG000|Overall Study|Ineligible / no protocol treatment|15|||
46835566|NCT00331760|83053126|FG001|Overall Study|Ineligible / no protocol treatment|8|||
46835567|NCT00225147|83053137|FG000|Open-label Phase|Lost to Follow-up|0|||
46835568|NCT00225147|83053138|FG001|Open-label Phase|Lost to Follow-up|0|||
46835569|NCT00225147|83053139|FG002|Open-label Phase|Lost to Follow-up|0|||
46835570|NCT00225147|83053140|FG003|Open-label Phase|Lost to Follow-up|4|||
46835571|NCT00225147|83053137|FG000|Open-label Phase|Withdrawal by Subject|0|||
46835572|NCT00225147|83053138|FG001|Open-label Phase|Withdrawal by Subject|0|||
46835573|NCT00225147|83053139|FG002|Open-label Phase|Withdrawal by Subject|0|||
46835574|NCT00225147|83053140|FG003|Open-label Phase|Withdrawal by Subject|6|||
46835575|NCT00313014|83053155|FG000|Overall Study|Withdrawal by Subject|11|||
46835576|NCT00313014|83053156|FG001|Overall Study|Withdrawal by Subject|7|||
46835577|NCT00313014|83053157|FG002|Overall Study|Withdrawal by Subject|5|||
46835578|NCT00313014|83053155|FG000|Overall Study|Adverse Event|14|||
46835579|NCT00313014|83053156|FG001|Overall Study|Adverse Event|29|||
46835580|NCT00313014|83053157|FG002|Overall Study|Adverse Event|16|||
46835581|NCT00313014|83053155|FG000|Overall Study|Lost to Follow-up|7|||
46835582|NCT00313014|83053156|FG001|Overall Study|Lost to Follow-up|6|||
46835583|NCT00313014|83053157|FG002|Overall Study|Lost to Follow-up|10|||
46835584|NCT00313014|83053155|FG000|Overall Study|Administrative|9|||
46835585|NCT00313014|83053156|FG001|Overall Study|Administrative|6|||
46835586|NCT00313014|83053157|FG002|Overall Study|Administrative|14|||
46835587|NCT00313014|83053155|FG000|Overall Study|Lack of Efficacy|52|||
46835588|NCT00313014|83053156|FG001|Overall Study|Lack of Efficacy|25|||
46835589|NCT00313014|83053157|FG002|Overall Study|Lack of Efficacy|16|||
46835590|NCT00157209|83053168|FG000|Overall Study|Ongoing at data cut-off|10|||
46835591|NCT00157209|83053169|FG001|Overall Study|Ongoing at data cut-off|0|||
46835592|NCT00312858|83053177|FG000|Overall Study|Adverse Event|0|||
46835593|NCT00312858|83053178|FG001|Overall Study|Adverse Event|1|||
46835594|NCT00312858|83053177|FG000|Overall Study|Lost to Follow-up|25|||
46835595|NCT00312858|83053178|FG001|Overall Study|Lost to Follow-up|42|||
46835596|NCT00312858|83053177|FG000|Overall Study|Protocol Violation|3|||
46835597|NCT00312858|83053178|FG001|Overall Study|Protocol Violation|8|||
46835598|NCT00312858|83053177|FG000|Overall Study|Withdraw by Participant|20|||
46835599|NCT00312858|83053178|FG001|Overall Study|Withdraw by Participant|20|||
46835600|NCT00312858|83053177|FG000|Overall Study|Participant Moved|11|||
46835601|NCT00312858|83053178|FG001|Overall Study|Participant Moved|10|||
46835602|NCT00312858|83053177|FG000|Overall Study|Other|9|||
46835603|NCT00312858|83053178|FG001|Overall Study|Other|12|||
46942767|NCT02958865|83179767|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
47062485|NCT02754141|83343334|FG013|Overall Study|Request to discontinue|1|||
47062486|NCT02754141|83343335|FG014|Overall Study|Request to discontinue|1|||
46835604|NCT00312702|83053187|FG000|Immunization Phase|Lost to Follow-up|0|||
46835605|NCT00312702|83053188|FG001|Immunization Phase|Lost to Follow-up|1|||
46835606|NCT00312702|83053189|FG002|Immunization Phase|Lost to Follow-up|0|||
46835607|NCT00156819|83053200|FG000|Overall Study|Lost to Follow-up|1|||
46835608|NCT00156819|83053201|FG001|Overall Study|Lost to Follow-up|1|||
46835609|NCT00156819|83053202|FG002|Overall Study|Lost to Follow-up|3|||
46835610|NCT03825042|83053212|FG000|Overall Study|Adverse Event|1|||
46835611|NCT03825042|83053213|FG001|Overall Study|Adverse Event|0|||
46967797|NCT02181634|83210375|FG000|Overall Study|Patient opted to proceed to surgery|1|||
47062487|NCT02754141|83343336|FG015|Overall Study|Request to discontinue|0|||
46835612|NCT03825042|83053212|FG000|Overall Study|Withdrawal by Subject|1|||
46835613|NCT03825042|83053213|FG001|Overall Study|Withdrawal by Subject|0|||
46835614|NCT00129987|83053221|FG000|1st Educational Session|Withdrawal by Subject|141|||
46835615|NCT00129987|83053222|FG001|1st Educational Session|Withdrawal by Subject|109|||
46835616|NCT00129987|83053221|FG000|1 Year|Withdrawal by Subject|32|||
46835617|NCT00129987|83053222|FG001|1 Year|Withdrawal by Subject|21|||
46835618|NCT00224133|83053228|FG000|Overall Study|Adverse Event|93|||
46835619|NCT00224133|83053228|FG000|Overall Study|Protocol Violation|6|||
46835620|NCT00224133|83053228|FG000|Overall Study|Withdrawal by Subject|33|||
46835621|NCT00224133|83053228|FG000|Overall Study|Lack of Efficacy|58|||
46835622|NCT00224133|83053228|FG000|Overall Study|Lost to Follow-up|21|||
46835623|NCT00224133|83053228|FG000|Overall Study|Physician Decision|1|||
46835624|NCT00224133|83053228|FG000|Overall Study|Other|14|||
46835625|NCT00224055|83053234|FG000|Overall Study|Adverse Event|9|||
46835626|NCT00224055|83053235|FG001|Overall Study|Adverse Event|3|||
46835627|NCT00224055|83053234|FG000|Overall Study|Lost to Follow-up|1|||
46835628|NCT00224055|83053235|FG001|Overall Study|Lost to Follow-up|2|||
46835629|NCT00224055|83053234|FG000|Overall Study|Protocol Violation|1|||
46835630|NCT00224055|83053235|FG001|Overall Study|Protocol Violation|1|||
46835631|NCT00224055|83053234|FG000|Overall Study|Inclusion Violation|3|||
46835632|NCT00224055|83053235|FG001|Overall Study|Inclusion Violation|6|||
46835633|NCT00224055|83053234|FG000|Overall Study|Withdrawal by Subject|0|||
46835634|NCT00224055|83053235|FG001|Overall Study|Withdrawal by Subject|2|||
46835635|NCT00224055|83053234|FG000|Overall Study|Other|1|||
46835636|NCT00224055|83053235|FG001|Overall Study|Other|0|||
46835637|NCT00150345|83053243|FG000|Overall Study|Death|5|||
46835638|NCT00150345|83053244|FG001|Overall Study|Death|2|||
46835639|NCT00150345|83053243|FG000|Overall Study|Adverse Event|8|||
46835640|NCT00150345|83053244|FG001|Overall Study|Adverse Event|6|||
46835641|NCT00150345|83053243|FG000|Overall Study|Lack of Efficacy|5|||
46835642|NCT00150345|83053244|FG001|Overall Study|Lack of Efficacy|4|||
46835643|NCT00150345|83053243|FG000|Overall Study|Withdrawal by Subject|3|||
46835644|NCT00150345|83053244|FG001|Overall Study|Withdrawal by Subject|4|||
46835645|NCT00150345|83053243|FG000|Overall Study|Laboratory abnormality|1|||
46835646|NCT00150345|83053244|FG001|Overall Study|Laboratory abnormality|2|||
46835647|NCT00150345|83053243|FG000|Overall Study|Other|12|||
46835648|NCT00150345|83053244|FG001|Overall Study|Other|14|||
46835649|NCT00223977|83053254|FG000|Overall Study|Adverse Event|7|||
46835650|NCT00223977|83053255|FG001|Overall Study|Adverse Event|10|||
46835651|NCT00223977|83053256|FG002|Overall Study|Adverse Event|0|||
46835652|NCT00223977|83053254|FG000|Overall Study|Protocol Violation|0|||
46835653|NCT00223977|83053255|FG001|Overall Study|Protocol Violation|0|||
46835654|NCT00223977|83053256|FG002|Overall Study|Protocol Violation|1|||
46835655|NCT00223977|83053254|FG000|Overall Study|Withdrawal by Subject|1|||
46835656|NCT00223977|83053255|FG001|Overall Study|Withdrawal by Subject|1|||
46835657|NCT00223977|83053256|FG002|Overall Study|Withdrawal by Subject|2|||
46835658|NCT00223977|83053254|FG000|Overall Study|Other|1|||
46835659|NCT00223977|83053255|FG001|Overall Study|Other|0|||
46835660|NCT00223977|83053256|FG002|Overall Study|Other|0|||
46835661|NCT00148941|83053268|FG000|Overall Study|Lost to Follow-up|17|||
46835662|NCT00148941|83053269|FG001|Overall Study|Lost to Follow-up|24|||
46835663|NCT00148941|83053270|FG002|Overall Study|Lost to Follow-up|18|||
46835664|NCT00148941|83053271|FG003|Overall Study|Lost to Follow-up|22|||
46835665|NCT00148941|83053268|FG000|Overall Study|Withdrawal by Subject|1|||
46835666|NCT00148941|83053269|FG001|Overall Study|Withdrawal by Subject|0|||
46835667|NCT00148941|83053270|FG002|Overall Study|Withdrawal by Subject|1|||
46835668|NCT00148941|83053271|FG003|Overall Study|Withdrawal by Subject|0|||
46835669|NCT00148941|83053268|FG000|Overall Study|Other|0|||
46835670|NCT00148941|83053269|FG001|Overall Study|Other|0|||
46835671|NCT00148941|83053270|FG002|Overall Study|Other|1|||
46835672|NCT00148941|83053271|FG003|Overall Study|Other|2|||
46835673|NCT00148317|83053281|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
46835674|NCT00148317|83053281|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
46835675|NCT00148317|83053281|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
46835676|NCT00323882|83053293|FG000|Overall Study|Adverse Event|2|||
46835677|NCT00323882|83053294|FG001|Overall Study|Adverse Event|1|||
46835678|NCT00323882|83053295|FG002|Overall Study|Adverse Event|1|||
46835679|NCT00323882|83053296|FG003|Overall Study|Adverse Event|1|||
46835680|NCT00323882|83053297|FG004|Overall Study|Adverse Event|3|||
46835681|NCT00323882|83053293|FG000|Overall Study|Disease Progression|6|||
46835682|NCT00323882|83053294|FG001|Overall Study|Disease Progression|4|||
46835683|NCT00323882|83053295|FG002|Overall Study|Disease Progression|10|||
46835684|NCT00323882|83053296|FG003|Overall Study|Disease Progression|5|||
46835685|NCT00323882|83053297|FG004|Overall Study|Disease Progression|22|||
46835686|NCT00323882|83053293|FG000|Overall Study|Death|0|||
46835687|NCT00323882|83053294|FG001|Overall Study|Death|1|||
46835688|NCT00323882|83053295|FG002|Overall Study|Death|1|||
46835689|NCT00323882|83053296|FG003|Overall Study|Death|0|||
46835690|NCT00323882|83053297|FG004|Overall Study|Death|5|||
46835691|NCT00323882|83053293|FG000|Overall Study|Lost to Follow-up|0|||
46835692|NCT00323882|83053294|FG001|Overall Study|Lost to Follow-up|0|||
46835693|NCT00323882|83053295|FG002|Overall Study|Lost to Follow-up|1|||
46835694|NCT00323882|83053296|FG003|Overall Study|Lost to Follow-up|0|||
46835695|NCT00323882|83053297|FG004|Overall Study|Lost to Follow-up|1|||
46835696|NCT00323882|83053293|FG000|Overall Study|Other|0|||
46835697|NCT00323882|83053294|FG001|Overall Study|Other|0|||
46835698|NCT00323882|83053295|FG002|Overall Study|Other|0|||
46835699|NCT00323882|83053296|FG003|Overall Study|Other|1|||
46835700|NCT00323882|83053297|FG004|Overall Study|Other|1|||
46835701|NCT00331682|83053318|FG000|Overall Study|Adverse Event|1|||
46835702|NCT00323492|83053324|FG000|Study Phase 1|Adverse Event|2|||
46835703|NCT00323492|83053325|FG001|Study Phase 1|Adverse Event|0|||
46835704|NCT00323492|83053326|FG002|Study Phase 1|Adverse Event|0|||
46835705|NCT00323492|83053324|FG000|Study Phase 2|Adverse Event|1|||
46835706|NCT00323492|83053325|FG001|Study Phase 2|Adverse Event|0|||
46942768|NCT02958865|83179768|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
46942769|NCT02958553|83179820|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
46942770|NCT02958553|83179820|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
46942771|NCT02501902|83179833|FG000|Overall Study|Subject Refused Further Follow-up|0|||
46942772|NCT02501902|83179834|FG001|Overall Study|Subject Refused Further Follow-up|0|||
46942773|NCT02501902|83179835|FG002|Overall Study|Subject Refused Further Follow-up|0|||
46942774|NCT02501902|83179836|FG003|Overall Study|Subject Refused Further Follow-up|0|||
46942775|NCT02501902|83179837|FG004|Overall Study|Subject Refused Further Follow-up|0|||
46942776|NCT02501902|83179838|FG005|Overall Study|Subject Refused Further Follow-up|0|||
46942777|NCT02501902|83179839|FG006|Overall Study|Subject Refused Further Follow-up|0|||
46942778|NCT02501902|83179840|FG007|Overall Study|Subject Refused Further Follow-up|1|||
46942779|NCT02501902|83179833|FG000|Overall Study|Study Terminated by Sponsor|0|||
46942780|NCT02501902|83179834|FG001|Overall Study|Study Terminated by Sponsor|3|||
46942781|NCT02501902|83179835|FG002|Overall Study|Study Terminated by Sponsor|0|||
46942782|NCT02501902|83179836|FG003|Overall Study|Study Terminated by Sponsor|1|||
46942783|NCT02501902|83179837|FG004|Overall Study|Study Terminated by Sponsor|1|||
46942784|NCT02501902|83179838|FG005|Overall Study|Study Terminated by Sponsor|0|||
46942785|NCT02501902|83179839|FG006|Overall Study|Study Terminated by Sponsor|2|||
46942786|NCT02501902|83179840|FG007|Overall Study|Study Terminated by Sponsor|4|||
46942787|NCT02501902|83179833|FG000|Overall Study|Death|3|||
46942788|NCT02501902|83179834|FG001|Overall Study|Death|4|||
46942789|NCT02501902|83179835|FG002|Overall Study|Death|4|||
46942790|NCT02501902|83179836|FG003|Overall Study|Death|10|||
46942791|NCT02501902|83179837|FG004|Overall Study|Death|10|||
46942792|NCT02501902|83179838|FG005|Overall Study|Death|11|||
46942793|NCT02501902|83179839|FG006|Overall Study|Death|7|||
46942794|NCT02501902|83179840|FG007|Overall Study|Death|15|||
46942795|NCT01955109|83179865|FG000|Overall Study|Adverse Event|2|||
46942796|NCT01955109|83179866|FG001|Overall Study|Adverse Event|0|||
46942797|NCT01955109|83179865|FG000|Overall Study|Participant unwilling to continue|35|||
46942798|NCT01955109|83179866|FG001|Overall Study|Participant unwilling to continue|7|||
46942799|NCT01955109|83179865|FG000|Overall Study|Physician Decision|2|||
46942800|NCT01955109|83179866|FG001|Overall Study|Physician Decision|0|||
46942801|NCT01955109|83179865|FG000|Overall Study|Lost to Follow-up|3|||
46942802|NCT01955109|83179866|FG001|Overall Study|Lost to Follow-up|1|||
46942803|NCT01955109|83179865|FG000|Overall Study|Non-compliance|3|||
46942804|NCT01955109|83179866|FG001|Overall Study|Non-compliance|1|||
46942805|NCT02500732|83179874|FG000|Overall Study|Physician Decision|0|||
46942806|NCT02500732|83179875|FG001|Overall Study|Physician Decision|1|||
46942807|NCT02518048|83179881|FG000|Overall Study|Withdrawal by Subject|1|||
46767601|NCT00845429|82985714|FG001|Overall Study|Protocol Violation|4|||
46767602|NCT00845429|82985715|FG002|Overall Study|Protocol Violation|7|||
46767603|NCT00845429|82985713|FG000|Overall Study|Lost to Follow-up|7|||
46767604|NCT00845429|82985714|FG001|Overall Study|Lost to Follow-up|9|||
46767605|NCT00845429|82985715|FG002|Overall Study|Lost to Follow-up|10|||
46767606|NCT00845429|82985713|FG000|Overall Study|Withdrawal by Subject|2|||
46767607|NCT00845429|82985714|FG001|Overall Study|Withdrawal by Subject|2|||
46767608|NCT00845429|82985715|FG002|Overall Study|Withdrawal by Subject|2|||
46767609|NCT00845429|82985713|FG000|Overall Study|Serious adverse event|0|||
46767610|NCT00845429|82985714|FG001|Overall Study|Serious adverse event|0|||
46767611|NCT00845429|82985715|FG002|Overall Study|Serious adverse event|1|||
46835707|NCT00323492|83053326|FG002|Study Phase 2|Adverse Event|0|||
46835708|NCT00323492|83053324|FG000|Study Phase 2|Physician Decision|1|||
46835709|NCT00323492|83053325|FG001|Study Phase 2|Physician Decision|0|||
46942808|NCT02499952|83179886|FG000|Overall Study|Lost to Follow-up|1|||
46767612|NCT00593333|82985725|FG000|Overall Study|Lost to Follow-up|10|||
46835710|NCT00323492|83053326|FG002|Study Phase 2|Physician Decision|0|||
46942809|NCT02499952|83179886|FG000|Overall Study|Death|9|||
46942810|NCT02499406|83179890|FG000|Overall Study|missed 3 treatment sessions|4|||
46942811|NCT02498392|83179896|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
46942812|NCT02498392|83179897|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
46942813|NCT02498392|83179896|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
46767613|NCT00593333|82985726|FG001|Overall Study|Lost to Follow-up|11|||
46767614|NCT00844883|82985732|FG000|Overall Study|Bridged to liver transplant|3|||
46942814|NCT02498392|83179897|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
46835711|NCT00323492|83053324|FG000|Study Phase 2|Lost to Follow-up|1|||
46942815|NCT02498392|83179896|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
46942816|NCT02498392|83179897|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
46942817|NCT02498392|83179896|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
46942818|NCT02498392|83179897|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
46942819|NCT02498392|83179896|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
46942820|NCT02498392|83179897|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
46942821|NCT02498392|83179896|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
46942822|NCT02498392|83179897|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
46942823|NCT03205605|83179905|FG000|Overall Study|Withdrawal by Subject|1|||
46942824|NCT02498236|83179923|FG000|Overall Study|Did not show for testing|1|||
46942825|NCT02498236|83179924|FG001|Overall Study|Did not show for testing|0|||
46942826|NCT02498236|83179925|FG002|Overall Study|Did not show for testing|0|||
46942827|NCT02498236|83179926|FG003|Overall Study|Did not show for testing|0|||
46942828|NCT02498236|83179927|FG004|Overall Study|Did not show for testing|0|||
46942829|NCT02498236|83179928|FG005|Overall Study|Did not show for testing|0|||
46942830|NCT02498236|83179929|FG006|Overall Study|Did not show for testing|0|||
46942831|NCT02498236|83179930|FG007|Overall Study|Did not show for testing|1|||
46835712|NCT00323492|83053325|FG001|Study Phase 2|Lost to Follow-up|0|||
46835713|NCT00323492|83053326|FG002|Study Phase 2|Lost to Follow-up|0|||
46835714|NCT00323492|83053324|FG000|Study Phase 2|Withdrawal by Subject|0|||
46835715|NCT00323492|83053325|FG001|Study Phase 2|Withdrawal by Subject|1|||
46835716|NCT00323492|83053326|FG002|Study Phase 2|Withdrawal by Subject|0|||
46835717|NCT00323492|83053324|FG000|Study Phase 2|Noncompliance with study schedule|0|||
46835718|NCT00323492|83053325|FG001|Study Phase 2|Noncompliance with study schedule|0|||
46835719|NCT00323492|83053326|FG002|Study Phase 2|Noncompliance with study schedule|1|||
46835720|NCT00323492|83053324|FG000|Study Phase 2|Protocol Violation|1|||
46835721|NCT00323492|83053325|FG001|Study Phase 2|Protocol Violation|0|||
46835722|NCT00323492|83053326|FG002|Study Phase 2|Protocol Violation|0|||
46835723|NCT00331136|83053337|FG000|Overall Study|Adverse Event|3|||
46835724|NCT00331136|83053338|FG001|Overall Study|Adverse Event|5|||
46835725|NCT00331136|83053339|FG002|Overall Study|Adverse Event|0|||
46835726|NCT00331136|83053340|FG003|Overall Study|Adverse Event|1|||
46835727|NCT00331136|83053337|FG000|Overall Study|Withdrawal by Subject|0|||
46835728|NCT00331136|83053338|FG001|Overall Study|Withdrawal by Subject|1|||
46835729|NCT00331136|83053339|FG002|Overall Study|Withdrawal by Subject|0|||
46835730|NCT00331136|83053340|FG003|Overall Study|Withdrawal by Subject|0|||
46835731|NCT00331136|83053337|FG000|Overall Study|Lost to Follow-up|0|||
46835732|NCT00331136|83053338|FG001|Overall Study|Lost to Follow-up|1|||
46835733|NCT00331136|83053339|FG002|Overall Study|Lost to Follow-up|0|||
46835734|NCT00331136|83053340|FG003|Overall Study|Lost to Follow-up|0|||
46835735|NCT00331136|83053337|FG000|Overall Study|Protocol Violation|1|||
46835736|NCT00331136|83053338|FG001|Overall Study|Protocol Violation|0|||
46835737|NCT00331136|83053339|FG002|Overall Study|Protocol Violation|0|||
46835738|NCT00331136|83053340|FG003|Overall Study|Protocol Violation|0|||
46835739|NCT00331136|83053337|FG000|Overall Study|Not treated|1|||
46835740|NCT00331136|83053338|FG001|Overall Study|Not treated|0|||
46942832|NCT02498236|83179923|FG000|Overall Study|Equipment failure|0|||
46942833|NCT02498236|83179924|FG001|Overall Study|Equipment failure|0|||
46942834|NCT02498236|83179925|FG002|Overall Study|Equipment failure|0|||
46942835|NCT02498236|83179926|FG003|Overall Study|Equipment failure|0|||
46767615|NCT00844883|82985732|FG000|Overall Study|Bridged to resection|1|||
46767616|NCT00851903|82985736|FG000|Overall Study|Withdrawal by Subject|2|||
46767617|NCT00587457|82985743|FG000|Overall Study|Adverse Event|1|||
46767618|NCT00587457|82985744|FG001|Overall Study|Adverse Event|2|||
46767619|NCT00587457|82985745|FG002|Overall Study|Adverse Event|1|||
46767620|NCT00587457|82985743|FG000|Overall Study|Disease progression|2|||
46767621|NCT00587457|82985744|FG001|Overall Study|Disease progression|0|||
46767622|NCT00587457|82985745|FG002|Overall Study|Disease progression|2|||
46767623|NCT00587457|82985743|FG000|Overall Study|Initiation of alternative therapy|0|||
46767624|NCT00587457|82985744|FG001|Overall Study|Initiation of alternative therapy|1|||
46767625|NCT00587457|82985745|FG002|Overall Study|Initiation of alternative therapy|0|||
46835741|NCT00331136|83053339|FG002|Overall Study|Not treated|0|||
46942836|NCT02498236|83179927|FG004|Overall Study|Equipment failure|0|||
46942837|NCT02498236|83179928|FG005|Overall Study|Equipment failure|0|||
46638066|NCT01474512|82811379|FG003|Post-Treatment Follow-Up|Death|0|||
46767626|NCT00587457|82985743|FG000|Overall Study|Undefined|0|||
46767627|NCT00587457|82985744|FG001|Overall Study|Undefined|0|||
46835742|NCT00331136|83053340|FG003|Overall Study|Not treated|0|||
46835743|NCT00323414|83053352|FG000|Overall Study|Withdrawal by Subject|0|||
46835744|NCT00323414|83053353|FG001|Overall Study|Withdrawal by Subject|1|||
46835745|NCT00330668|83053359|FG000|BID Dosing Period|Adverse Event|1|||
46835746|NCT00330668|83053359|FG000|BID Dosing Period|Lost to Follow-up|7|||
46942838|NCT02498236|83179929|FG006|Overall Study|Equipment failure|1|||
46942839|NCT02498236|83179930|FG007|Overall Study|Equipment failure|0|||
46942840|NCT02498236|83179923|FG000|Overall Study|Withdrawal by Subject|0|||
46942841|NCT02498236|83179924|FG001|Overall Study|Withdrawal by Subject|0|||
46942842|NCT02498236|83179925|FG002|Overall Study|Withdrawal by Subject|0|||
47062488|NCT02754141|83343337|FG016|Overall Study|Request to discontinue|0|||
47062489|NCT02754141|83343338|FG017|Overall Study|Request to discontinue|0|||
46835747|NCT00330668|83053359|FG000|BID Dosing Period|Non-Compliance|5|||
46835748|NCT00330668|83053359|FG000|BID Dosing Period|Withdrawal by Subject|19|||
46835749|NCT00330668|83053359|FG000|BID Dosing Period|Sponsor's decision|1|||
46835750|NCT00330668|83053359|FG000|BID Dosing Period|Other|3|||
46835751|NCT00330668|83053359|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
46835752|NCT00330668|83053359|FG000|QD Dosing Period|Other|1|||
46835753|NCT00330668|83053359|FG000|QD Dosing Period|Withdrawal by Subject|1|||
46835754|NCT00330668|83053359|FG000|QD Dosing Period|Lost to Follow-up|2|||
46835755|NCT00306384|83053366|FG000|Overall Study|Adverse Event|103|||
46835756|NCT00306384|83053367|FG001|Overall Study|Adverse Event|87|||
46835757|NCT00306384|83053368|FG002|Overall Study|Adverse Event|40|||
46835758|NCT00306384|83053366|FG000|Overall Study|Major protocol deviation|43|||
46835759|NCT00306384|83053367|FG001|Overall Study|Major protocol deviation|51|||
46835760|NCT00306384|83053368|FG002|Overall Study|Major protocol deviation|18|||
46835761|NCT00306384|83053366|FG000|Overall Study|Lost to Follow-up|57|||
46835762|NCT00306384|83053367|FG001|Overall Study|Lost to Follow-up|41|||
46835763|NCT00306384|83053368|FG002|Overall Study|Lost to Follow-up|35|||
46835764|NCT00306384|83053366|FG000|Overall Study|Voluntary withdrawal|199|||
46835765|NCT00306384|83053367|FG001|Overall Study|Voluntary withdrawal|187|||
46835766|NCT00306384|83053368|FG002|Overall Study|Voluntary withdrawal|91|||
46835767|NCT00306384|83053366|FG000|Overall Study|Study termination|1|||
46835768|NCT00306384|83053367|FG001|Overall Study|Study termination|0|||
46835769|NCT00306384|83053368|FG002|Overall Study|Study termination|1|||
46835770|NCT00306384|83053366|FG000|Overall Study|Pregnancy|3|||
46835771|NCT00306384|83053367|FG001|Overall Study|Pregnancy|1|||
46835772|NCT00306384|83053368|FG002|Overall Study|Pregnancy|1|||
46835773|NCT00306384|83053366|FG000|Overall Study|Lack of Efficacy|26|||
46835774|NCT00306384|83053367|FG001|Overall Study|Lack of Efficacy|40|||
46835775|NCT00306384|83053368|FG002|Overall Study|Lack of Efficacy|38|||
46835776|NCT00306384|83053366|FG000|Overall Study|Investigator discretion|28|||
46835777|NCT00306384|83053367|FG001|Overall Study|Investigator discretion|31|||
46835778|NCT00306384|83053368|FG002|Overall Study|Investigator discretion|21|||
46835779|NCT00306384|83053366|FG000|Overall Study|Other|80|||
46835780|NCT00306384|83053367|FG001|Overall Study|Other|70|||
46835781|NCT00306384|83053368|FG002|Overall Study|Other|32|||
46835782|NCT00306384|83053366|FG000|Overall Study|Site closure|2|||
46835783|NCT00306384|83053367|FG001|Overall Study|Site closure|0|||
46835784|NCT00306384|83053368|FG002|Overall Study|Site closure|0|||
46835785|NCT00305604|83053378|FG000|Overall Study|Adverse Event|6|||
46835786|NCT00305604|83053379|FG001|Overall Study|Adverse Event|3|||
46835787|NCT00305604|83053378|FG000|Overall Study|Lack of Efficacy|11|||
46835788|NCT00305604|83053379|FG001|Overall Study|Lack of Efficacy|18|||
46835789|NCT00305604|83053378|FG000|Overall Study|Lost to Follow-up|0|||
46835790|NCT00305604|83053379|FG001|Overall Study|Lost to Follow-up|4|||
46835791|NCT00305604|83053378|FG000|Overall Study|Protocol Violation|2|||
46835792|NCT00305604|83053379|FG001|Overall Study|Protocol Violation|1|||
46835793|NCT00305604|83053378|FG000|Overall Study|Withdrawal by Subject|12|||
46835794|NCT00305604|83053379|FG001|Overall Study|Withdrawal by Subject|21|||
46835795|NCT00305604|83053378|FG000|Overall Study|Patient moved|1|||
46835796|NCT00305604|83053379|FG001|Overall Study|Patient moved|0|||
46835797|NCT00501059|83053387|FG000|Overall Study|Protocol Violation|80|||
46835798|NCT00501059|83053388|FG001|Overall Study|Protocol Violation|69|||
46835799|NCT00501059|83053387|FG000|Overall Study|Death|140|||
46835800|NCT00501059|83053388|FG001|Overall Study|Death|137|||
46835801|NCT00501059|83053387|FG000|Overall Study|Other|236|||
46835802|NCT00501059|83053388|FG001|Overall Study|Other|239|||
46835803|NCT00501059|83053387|FG000|Overall Study|Missing end-of-study page|91|||
46835804|NCT00501059|83053388|FG001|Overall Study|Missing end-of-study page|92|||
46835805|NCT00501059|83053387|FG000|Overall Study|Clinical endpoint reached|110|||
46835806|NCT00501059|83053388|FG001|Overall Study|Clinical endpoint reached|123|||
46835807|NCT00501059|83053387|FG000|Overall Study|Insufficient therapeutic effect|4|||
47062490|NCT02754141|83343321|FG000|Overall Study|Withdrew consent|0|||
46767628|NCT00587457|82985745|FG002|Overall Study|Undefined|1|||
46767629|NCT00587457|82985743|FG000|Overall Study|Development of neutralizing Abs|0|||
46767630|NCT00587457|82985744|FG001|Overall Study|Development of neutralizing Abs|0|||
46767631|NCT00587457|82985745|FG002|Overall Study|Development of neutralizing Abs|1|||
46767632|NCT00851747|82985756|FG000|Overall Study|Physician Decision|6|||
46767633|NCT00851747|82985757|FG001|Overall Study|Physician Decision|6|||
46767634|NCT00851747|82985758|FG002|Overall Study|Physician Decision|6|||
46767635|NCT00767325|82985765|FG000|Overall Study|Lack of Efficacy|2|||
46767636|NCT00767325|82985765|FG000|Overall Study|Adverse Event|7|||
46835808|NCT00501059|83053388|FG001|Overall Study|Insufficient therapeutic effect|5|||
46835809|NCT00501059|83053387|FG000|Overall Study|Consent withdrawn by subject|817|||
46835810|NCT00501059|83053388|FG001|Overall Study|Consent withdrawn by subject|873|||
46835811|NCT00501059|83053387|FG000|Overall Study|Non-compliant with study treatment|23|||
46767637|NCT00767325|82985765|FG000|Overall Study|Lost to Follow-up|3|||
46835812|NCT00501059|83053388|FG001|Overall Study|Non-compliant with study treatment|16|||
46835813|NCT00501059|83053387|FG000|Overall Study|Reason not given|3|||
46835814|NCT00501059|83053388|FG001|Overall Study|Reason not given|1|||
46835815|NCT00501059|83053387|FG000|Overall Study|Adverse Event|129|||
46835816|NCT00501059|83053388|FG001|Overall Study|Adverse Event|122|||
46835817|NCT00501059|83053387|FG000|Overall Study|Lost to Follow-up|210|||
46835818|NCT00501059|83053388|FG001|Overall Study|Lost to Follow-up|198|||
46835819|NCT00501059|83053387|FG000|Overall Study|Not treated|25|||
46835820|NCT00501059|83053388|FG001|Overall Study|Not treated|17|||
46835821|NCT00344318|83053400|FG000|Overall Study|Adverse Event|0|||
46835822|NCT00344318|83053401|FG001|Overall Study|Adverse Event|3|||
46835823|NCT00344318|83053402|FG002|Overall Study|Adverse Event|0|||
46835824|NCT00344318|83053403|FG003|Overall Study|Adverse Event|1|||
46942843|NCT02498236|83179926|FG003|Overall Study|Withdrawal by Subject|0|||
46942844|NCT02498236|83179927|FG004|Overall Study|Withdrawal by Subject|1|||
46942845|NCT02498236|83179928|FG005|Overall Study|Withdrawal by Subject|0|||
46942846|NCT02498236|83179929|FG006|Overall Study|Withdrawal by Subject|0|||
46942847|NCT02498236|83179930|FG007|Overall Study|Withdrawal by Subject|0|||
46638067|NCT01474512|82811380|FG004|Post-Treatment Follow-Up|Death|0|||
46835825|NCT00344318|83053400|FG000|Overall Study|Withdrawal by Subject|2|||
46835826|NCT00344318|83053401|FG001|Overall Study|Withdrawal by Subject|2|||
46835827|NCT00344318|83053402|FG002|Overall Study|Withdrawal by Subject|0|||
46835828|NCT00344318|83053403|FG003|Overall Study|Withdrawal by Subject|2|||
46835829|NCT00344318|83053400|FG000|Overall Study|Lost to Follow-up|2|||
46835830|NCT00344318|83053401|FG001|Overall Study|Lost to Follow-up|0|||
46835831|NCT00344318|83053402|FG002|Overall Study|Lost to Follow-up|1|||
46835832|NCT00344318|83053403|FG003|Overall Study|Lost to Follow-up|0|||
46835833|NCT00323258|83053417|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
46835834|NCT00323258|83053418|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
46835835|NCT00323258|83053417|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
46835836|NCT00323258|83053418|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
46835837|NCT00323258|83053417|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
46835838|NCT00323258|83053418|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
46835839|NCT00323258|83053417|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
46835840|NCT00323258|83053418|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
46835841|NCT00323258|83053417|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
46835842|NCT00323258|83053418|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
46835843|NCT00323258|83053417|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
46835844|NCT00323258|83053418|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
46835845|NCT00323258|83053417|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
46835846|NCT00323258|83053418|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
46835847|NCT00322868|83053424|FG000|Overall Study|disease progression|1|||
46835848|NCT00343382|83053432|FG000|Overall Study|Adverse Event|2|||
46835849|NCT00343382|83053433|FG001|Overall Study|Adverse Event|10|||
46835850|NCT00343382|83053434|FG002|Overall Study|Adverse Event|7|||
46835851|NCT00343382|83053432|FG000|Overall Study|Withdrawal by Subject|1|||
46835852|NCT00343382|83053433|FG001|Overall Study|Withdrawal by Subject|2|||
46835853|NCT00343382|83053434|FG002|Overall Study|Withdrawal by Subject|6|||
46835854|NCT00343382|83053432|FG000|Overall Study|Other Reason Not Specified|1|||
46835855|NCT00343382|83053433|FG001|Overall Study|Other Reason Not Specified|2|||
46835856|NCT00343382|83053434|FG002|Overall Study|Other Reason Not Specified|4|||
46835857|NCT00481871|83053447|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
46835858|NCT00481871|83053448|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
46835859|NCT00481871|83053449|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
46835860|NCT00481871|83053450|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
46835861|NCT00481871|83053451|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
46835862|NCT00329420|83053462|FG000|Re-induction Phase|Lack of Efficacy|0|||
46835863|NCT00329420|83053463|FG001|Re-induction Phase|Lack of Efficacy|1|||
46835864|NCT00329420|83053464|FG002|Re-induction Phase|Lack of Efficacy|0|||
46835865|NCT00329420|83053462|FG000|Re-induction Phase|Withdrawal of Consent|0|||
46835866|NCT00329420|83053463|FG001|Re-induction Phase|Withdrawal of Consent|0|||
46835867|NCT00329420|83053464|FG002|Re-induction Phase|Withdrawal of Consent|1|||
46835868|NCT00329420|83053462|FG000|Re-induction Phase|Did not respond to re-induction|6|||
46835869|NCT00329420|83053463|FG001|Re-induction Phase|Did not respond to re-induction|5|||
46835870|NCT00329420|83053464|FG002|Re-induction Phase|Did not respond to re-induction|7|||
46835871|NCT00329420|83053462|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
46835872|NCT00329420|83053463|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
46835873|NCT00329420|83053464|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
46835874|NCT00329420|83053462|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
46835875|NCT00329420|83053463|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
46835876|NCT00329420|83053464|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
46942848|NCT02496676|83179953|FG000|Phase 1 - Period 1|Adverse Event|0|||
46942849|NCT02496676|83179954|FG001|Phase 1 - Period 1|Adverse Event|1|||
46942850|NCT02496676|83179953|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
46942851|NCT02496676|83179954|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
46942852|NCT02517268|83179970|FG000|Overall Study|Withdrawal by Subject|1|||
46942853|NCT02517268|83179971|FG001|Overall Study|Withdrawal by Subject|0|||
46942854|NCT01160211|83179980|FG000|Overall Study|ongoing|90|||
46942855|NCT01160211|83179981|FG001|Overall Study|ongoing|75|||
46942856|NCT01160211|83179982|FG002|Overall Study|ongoing|79|||
46942857|NCT01160211|83179980|FG000|Overall Study|Withdrawal by Subject|3|||
46942858|NCT01160211|83179981|FG001|Overall Study|Withdrawal by Subject|5|||
46942859|NCT01160211|83179982|FG002|Overall Study|Withdrawal by Subject|3|||
46942860|NCT01160211|83179980|FG000|Overall Study|Physician Decision|2|||
46942861|NCT01160211|83179981|FG001|Overall Study|Physician Decision|0|||
46942862|NCT01160211|83179982|FG002|Overall Study|Physician Decision|0|||
47062491|NCT02754141|83343322|FG001|Overall Study|Withdrew consent|0|||
47062492|NCT02754141|83343323|FG002|Overall Study|Withdrew consent|0|||
47062493|NCT02754141|83343324|FG003|Overall Study|Withdrew consent|0|||
46942863|NCT01160211|83179980|FG000|Overall Study|Lost to Follow-up|4|||
46942864|NCT01160211|83179981|FG001|Overall Study|Lost to Follow-up|7|||
46942865|NCT01160211|83179982|FG002|Overall Study|Lost to Follow-up|5|||
46942866|NCT01064687|83179995|FG000|Overall Study|Adverse Event|9|||
46942867|NCT01064687|83179996|FG001|Overall Study|Adverse Event|4|||
46942868|NCT01064687|83179997|FG002|Overall Study|Adverse Event|10|||
46942869|NCT01064687|83179998|FG003|Overall Study|Adverse Event|3|||
46942870|NCT01064687|83179995|FG000|Overall Study|Death|1|||
46942871|NCT01064687|83179996|FG001|Overall Study|Death|1|||
46942872|NCT01064687|83179997|FG002|Overall Study|Death|0|||
46942873|NCT01064687|83179998|FG003|Overall Study|Death|0|||
46942874|NCT01064687|83179995|FG000|Overall Study|Entry Criteria Not Met|3|||
46942875|NCT01064687|83179996|FG001|Overall Study|Entry Criteria Not Met|0|||
46942876|NCT01064687|83179997|FG002|Overall Study|Entry Criteria Not Met|0|||
46942877|NCT01064687|83179998|FG003|Overall Study|Entry Criteria Not Met|0|||
46942878|NCT01064687|83179995|FG000|Overall Study|Lack of Efficacy|1|||
46942879|NCT01064687|83179996|FG001|Overall Study|Lack of Efficacy|0|||
46942880|NCT01064687|83179997|FG002|Overall Study|Lack of Efficacy|2|||
46942881|NCT01064687|83179998|FG003|Overall Study|Lack of Efficacy|3|||
46942882|NCT01064687|83179995|FG000|Overall Study|Lost to Follow-up|7|||
46942883|NCT01064687|83179996|FG001|Overall Study|Lost to Follow-up|10|||
46942884|NCT01064687|83179997|FG002|Overall Study|Lost to Follow-up|13|||
46942885|NCT01064687|83179998|FG003|Overall Study|Lost to Follow-up|5|||
46942886|NCT01064687|83179995|FG000|Overall Study|Physician Decision|2|||
46942887|NCT01064687|83179996|FG001|Overall Study|Physician Decision|2|||
46942888|NCT01064687|83179997|FG002|Overall Study|Physician Decision|0|||
46942889|NCT01064687|83179998|FG003|Overall Study|Physician Decision|0|||
47062494|NCT02754141|83343325|FG004|Overall Study|Withdrew consent|0|||
47062495|NCT02754141|83343326|FG005|Overall Study|Withdrew consent|0|||
47062496|NCT02754141|83343327|FG006|Overall Study|Withdrew consent|0|||
47062497|NCT02754141|83343328|FG007|Overall Study|Withdrew consent|0|||
46638068|NCT01474512|82811381|FG005|Post-Treatment Follow-Up|Death|0|||
46638069|NCT01474512|82811382|FG006|Post-Treatment Follow-Up|Death|0|||
46638070|NCT01474512|82811383|FG007|Post-Treatment Follow-Up|Death|0|||
46638071|NCT01474512|82811384|FG008|Post-Treatment Follow-Up|Death|0|||
46638072|NCT01474512|82811385|FG009|Post-Treatment Follow-Up|Death|0|||
46638073|NCT01474512|82811386|FG010|Post-Treatment Follow-Up|Death|0|||
46638074|NCT01474512|82811387|FG011|Post-Treatment Follow-Up|Death|0|||
46638075|NCT01474512|82811388|FG012|Post-Treatment Follow-Up|Death|0|||
46638076|NCT01474512|82811389|FG013|Post-Treatment Follow-Up|Death|0|||
46638077|NCT01474512|82811390|FG014|Post-Treatment Follow-Up|Death|0|||
46638078|NCT01474512|82811391|FG015|Post-Treatment Follow-Up|Death|0|||
46638079|NCT01474512|82811392|FG016|Post-Treatment Follow-Up|Death|1|||
46767638|NCT00767325|82985765|FG000|Overall Study|No longer met study criteria|2|||
46767639|NCT00767325|82985765|FG000|Overall Study|Missed visit due to family reasons|1|||
46638080|NCT01474512|82811393|FG017|Post-Treatment Follow-Up|Death|0|||
46638081|NCT01474434|82811427|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
46638082|NCT01474434|82811428|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
46942890|NCT01064687|83179995|FG000|Overall Study|Protocol Violation|1|||
47062498|NCT02754141|83343329|FG008|Overall Study|Withdrew consent|0|||
46638083|NCT01474434|82811429|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
46638084|NCT01474434|82811430|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
46638085|NCT01474434|82811427|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
46942891|NCT01064687|83179996|FG001|Overall Study|Protocol Violation|1|||
46942892|NCT01064687|83179997|FG002|Overall Study|Protocol Violation|0|||
46942893|NCT01064687|83179998|FG003|Overall Study|Protocol Violation|1|||
46942894|NCT01064687|83179995|FG000|Overall Study|Sponsor Decision|0|||
46942895|NCT01064687|83179996|FG001|Overall Study|Sponsor Decision|0|||
46942896|NCT01064687|83179997|FG002|Overall Study|Sponsor Decision|3|||
46942897|NCT01064687|83179998|FG003|Overall Study|Sponsor Decision|0|||
46942898|NCT01064687|83179995|FG000|Overall Study|Withdrawal by Subject|9|||
46942899|NCT01064687|83179996|FG001|Overall Study|Withdrawal by Subject|7|||
46942900|NCT01064687|83179997|FG002|Overall Study|Withdrawal by Subject|12|||
46967798|NCT01595529|83210381|FG000|Overall Study|Adverse Event|2|||
46638086|NCT01474434|82811428|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
46638087|NCT01474434|82811429|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
46638088|NCT01474434|82811430|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
46835877|NCT00329420|83053462|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
46835878|NCT00329420|83053463|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
46835879|NCT00329420|83053464|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
46835880|NCT00329108|83053476|FG000|Overall Study|Adverse Event|2|||
46835881|NCT00329108|83053477|FG001|Overall Study|Adverse Event|2|||
46835882|NCT00329108|83053476|FG000|Overall Study|Lack of Efficacy|3|||
46835883|NCT00329108|83053477|FG001|Overall Study|Lack of Efficacy|3|||
46835884|NCT00329108|83053476|FG000|Overall Study|Withdrawal by Subject|0|||
46835885|NCT00329108|83053477|FG001|Overall Study|Withdrawal by Subject|2|||
46835886|NCT00329108|83053476|FG000|Overall Study|symptomatic deterioration|1|||
46835887|NCT00329108|83053477|FG001|Overall Study|symptomatic deterioration|1|||
46835888|NCT00329108|83053476|FG000|Overall Study|Subject no longer willing to participate|2|||
46835889|NCT00329108|83053477|FG001|Overall Study|Subject no longer willing to participate|2|||
46835890|NCT00329108|83053476|FG000|Overall Study|study terminated by sponsor|1|||
46835891|NCT00329108|83053477|FG001|Overall Study|study terminated by sponsor|0|||
46835892|NCT00329108|83053476|FG000|Overall Study|withdrew patient after SAE resolved|1|||
46835893|NCT00329108|83053477|FG001|Overall Study|withdrew patient after SAE resolved|0|||
46835894|NCT00329108|83053476|FG000|Overall Study|Protocol Violation|0|||
46835895|NCT00329108|83053477|FG001|Overall Study|Protocol Violation|2|||
46835896|NCT00329030|83053485|FG000|Overall Study|Withdrawal by Subject|1|||
46835897|NCT00329030|83053486|FG001|Overall Study|Withdrawal by Subject|3|||
46835898|NCT00329030|83053485|FG000|Overall Study|Progressive Disease|6|||
46835899|NCT00329030|83053486|FG001|Overall Study|Progressive Disease|2|||
46835900|NCT00329030|83053485|FG000|Overall Study|Ineligible Pathology|1|||
46835901|NCT00329030|83053486|FG001|Overall Study|Ineligible Pathology|1|||
46835902|NCT00328562|83053492|FG000|Overall Study|Disease progression|1|||
46835903|NCT00328172|83053501|FG000|Overall Study|Adverse Event|3|||
46835904|NCT00328172|83053502|FG001|Overall Study|Adverse Event|2|||
46835905|NCT00328172|83053503|FG002|Overall Study|Adverse Event|1|||
46835906|NCT00328172|83053504|FG003|Overall Study|Adverse Event|2|||
46835907|NCT00328172|83053505|FG004|Overall Study|Adverse Event|1|||
46835908|NCT00328172|83053501|FG000|Overall Study|Protocol Violation|0|||
46835909|NCT00328172|83053502|FG001|Overall Study|Protocol Violation|1|||
46835910|NCT00328172|83053503|FG002|Overall Study|Protocol Violation|1|||
46835911|NCT00328172|83053504|FG003|Overall Study|Protocol Violation|0|||
46835912|NCT00328172|83053505|FG004|Overall Study|Protocol Violation|0|||
46638089|NCT01474434|82811427|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
46638090|NCT01474434|82811428|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
46638091|NCT01474434|82811429|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
46638092|NCT01474434|82811430|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
46638093|NCT01473732|82811446|FG000|Overall Study|Adverse Event|1|||
46638094|NCT01473732|82811447|FG001|Overall Study|Adverse Event|0|||
46638095|NCT01473732|82811446|FG000|Overall Study|Death|1|||
46638096|NCT01473732|82811447|FG001|Overall Study|Death|0|||
46835913|NCT00328172|83053501|FG000|Overall Study|Lost to Follow-up|1|||
46835914|NCT00328172|83053502|FG001|Overall Study|Lost to Follow-up|1|||
46835915|NCT00328172|83053503|FG002|Overall Study|Lost to Follow-up|2|||
46835916|NCT00328172|83053504|FG003|Overall Study|Lost to Follow-up|1|||
46835917|NCT00328172|83053505|FG004|Overall Study|Lost to Follow-up|1|||
46835918|NCT00328172|83053501|FG000|Overall Study|Withdrawal by Subject|1|||
46835919|NCT00328172|83053502|FG001|Overall Study|Withdrawal by Subject|1|||
46835920|NCT00328172|83053503|FG002|Overall Study|Withdrawal by Subject|1|||
46835921|NCT00328172|83053504|FG003|Overall Study|Withdrawal by Subject|6|||
46835922|NCT00328172|83053505|FG004|Overall Study|Withdrawal by Subject|0|||
46835923|NCT00328172|83053501|FG000|Overall Study|Lack of Efficacy|14|||
46835924|NCT00328172|83053502|FG001|Overall Study|Lack of Efficacy|9|||
47062499|NCT02754141|83343330|FG009|Overall Study|Withdrew consent|1|||
47062500|NCT02754141|83343331|FG010|Overall Study|Withdrew consent|0|||
46835925|NCT00328172|83053503|FG002|Overall Study|Lack of Efficacy|4|||
46835926|NCT00328172|83053504|FG003|Overall Study|Lack of Efficacy|4|||
46835927|NCT00328172|83053505|FG004|Overall Study|Lack of Efficacy|3|||
46835928|NCT00328172|83053501|FG000|Overall Study|Other reason (not specified)|3|||
46835929|NCT00328172|83053502|FG001|Overall Study|Other reason (not specified)|0|||
46835930|NCT00328172|83053503|FG002|Overall Study|Other reason (not specified)|1|||
46638097|NCT01450098|82811455|FG000|Period 3|Protocol Violation|0|||
46638098|NCT01450098|82811456|FG001|Period 3|Protocol Violation|1|||
46835931|NCT00328172|83053504|FG003|Overall Study|Other reason (not specified)|0|||
46835932|NCT00328172|83053505|FG004|Overall Study|Other reason (not specified)|0|||
46835933|NCT00328094|83053519|FG000|Overall Study|Physician Decision|3|||
47062501|NCT02754141|83343332|FG011|Overall Study|Withdrew consent|0|||
46835934|NCT00328094|83053520|FG001|Overall Study|Physician Decision|3|||
46835935|NCT00500903|83053529|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
46835936|NCT00500903|83053530|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
46835937|NCT00500903|83053531|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
46835938|NCT00500903|83053529|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
46835939|NCT00500903|83053530|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
46835940|NCT00500903|83053531|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
46835941|NCT00500903|83053529|FG000|Overall Study|Progressive Disease|41|||
46835942|NCT00500903|83053530|FG001|Overall Study|Progressive Disease|2|||
46835943|NCT00500903|83053531|FG002|Overall Study|Progressive Disease|15|||
46835944|NCT00500903|83053529|FG000|Overall Study|Patient Declined Further Treatment|0|||
46835945|NCT00500903|83053530|FG001|Overall Study|Patient Declined Further Treatment|0|||
46835946|NCT00500903|83053531|FG002|Overall Study|Patient Declined Further Treatment|3|||
46835947|NCT00500903|83053529|FG000|Overall Study|Symptomatic Deterioration|2|||
46835948|NCT00500903|83053530|FG001|Overall Study|Symptomatic Deterioration|0|||
46835949|NCT00500903|83053531|FG002|Overall Study|Symptomatic Deterioration|0|||
46835950|NCT00500903|83053529|FG000|Overall Study|Reason Not Specified|10|||
46835951|NCT00500903|83053530|FG001|Overall Study|Reason Not Specified|0|||
46835952|NCT00500903|83053531|FG002|Overall Study|Reason Not Specified|2|||
46835953|NCT00295932|83053580|FG000|Overall Study|Not Treated|0|||
46835954|NCT00295932|83053581|FG001|Overall Study|Not Treated|0|||
46638099|NCT01450098|82811455|FG000|Period 3|Withdrawal by Subject|0|||
46638100|NCT01450098|82811456|FG001|Period 3|Withdrawal by Subject|2|||
46638101|NCT01449708|82811471|FG000|Overall Study|Protocol Violation|0|||
46638102|NCT01449708|82811472|FG001|Overall Study|Protocol Violation|1|||
46638103|NCT01449708|82811471|FG000|Overall Study|surgical complication|1|||
46638104|NCT01449708|82811472|FG001|Overall Study|surgical complication|2|||
46638105|NCT01449708|82811471|FG000|Overall Study|respiratory failure|1|||
46638106|NCT01449708|82811472|FG001|Overall Study|respiratory failure|0|||
46638107|NCT01449630|82811490|FG000|Period 1|Physician Decision|1|||
46638108|NCT01449630|82811491|FG001|Period 1|Physician Decision|0|||
46835955|NCT00295932|83053582|FG002|Overall Study|Not Treated|0|||
46835956|NCT00295932|83053583|FG003|Overall Study|Not Treated|0|||
46835957|NCT00295932|83053584|FG004|Overall Study|Not Treated|0|||
46835958|NCT00295932|83053585|FG005|Overall Study|Not Treated|0|||
46835959|NCT00295932|83053586|FG006|Overall Study|Not Treated|0|||
46835960|NCT00295932|83053587|FG007|Overall Study|Not Treated|0|||
46835961|NCT00295932|83053588|FG008|Overall Study|Not Treated|0|||
46835962|NCT00295932|83053589|FG009|Overall Study|Not Treated|0|||
46835963|NCT00295932|83053590|FG010|Overall Study|Not Treated|1|||
46835964|NCT00305448|83053619|FG000|Overall Study|Protocol Violation|0|||
46835965|NCT00305448|83053620|FG001|Overall Study|Protocol Violation|1|||
46835966|NCT00305448|83053621|FG002|Overall Study|Protocol Violation|0|||
46835967|NCT00305448|83053619|FG000|Overall Study|Withdrawal by Subject|2|||
46835968|NCT00305448|83053620|FG001|Overall Study|Withdrawal by Subject|0|||
46835969|NCT00305448|83053621|FG002|Overall Study|Withdrawal by Subject|1|||
46835970|NCT00305448|83053619|FG000|Overall Study|Adverse Event|1|||
46835971|NCT00305448|83053620|FG001|Overall Study|Adverse Event|0|||
46835972|NCT00305448|83053621|FG002|Overall Study|Adverse Event|1|||
46835973|NCT00305448|83053619|FG000|Overall Study|Disease Progression|27|||
46835974|NCT00305448|83053620|FG001|Overall Study|Disease Progression|31|||
46835975|NCT00305448|83053621|FG002|Overall Study|Disease Progression|28|||
46835976|NCT00305448|83053619|FG000|Overall Study|Subjective Disease Progression|1|||
46767640|NCT00851591|82985771|FG000|Overall Study|Withdrawal by Subject|2|||
46767641|NCT00851591|82985772|FG001|Overall Study|Withdrawal by Subject|0|||
46767642|NCT00861341|82985778|FG000|Overall Study|Withdrawal by Subject|2|||
46767643|NCT00766467|82985784|FG000|Overall Study|Withdrawal by Subject|7|||
46767644|NCT00766467|82985785|FG001|Overall Study|Withdrawal by Subject|2|||
46767645|NCT00766467|82985784|FG000|Overall Study|Adverse Event|1|||
46767646|NCT00766467|82985785|FG001|Overall Study|Adverse Event|1|||
46767647|NCT00766467|82985784|FG000|Overall Study|Protocol Violation|2|||
46767648|NCT00766467|82985785|FG001|Overall Study|Protocol Violation|4|||
46767649|NCT00766467|82985784|FG000|Overall Study|Tumor Progression on Study|0|||
46767650|NCT00766467|82985785|FG001|Overall Study|Tumor Progression on Study|1|||
46767651|NCT00766467|82985784|FG000|Overall Study|Physician Decision|1|||
46767652|NCT00766467|82985785|FG001|Overall Study|Physician Decision|0|||
46767653|NCT00850499|82985793|FG000|Overall Study|Adverse Event|3|||
46767654|NCT00850499|82985794|FG001|Overall Study|Adverse Event|1|||
46767655|NCT00850499|82985793|FG000|Overall Study|Lack of Efficacy|0|||
46767656|NCT00850499|82985794|FG001|Overall Study|Lack of Efficacy|1|||
46767657|NCT00860951|82985800|FG000|Overall Study|Withdrawal by Subject|2|||
46767658|NCT00860951|82985800|FG000|Overall Study|Lost to Follow-up|5|||
47062502|NCT02754141|83343333|FG012|Overall Study|Withdrew consent|0|||
46638109|NCT01449630|82811492|FG002|Period 1|Physician Decision|0|||
46638110|NCT01449630|82811493|FG003|Period 1|Physician Decision|1|||
46767659|NCT00844805|82985818|FG000|Treatment Phase|Adverse Event|5|||
46767660|NCT00844805|82985819|FG001|Treatment Phase|Adverse Event|1|||
46835977|NCT00305448|83053620|FG001|Overall Study|Subjective Disease Progression|2|||
47062503|NCT02754141|83343334|FG013|Overall Study|Withdrew consent|0|||
46767661|NCT00844805|82985820|FG002|Treatment Phase|Adverse Event|0|||
46767662|NCT00844805|82985821|FG003|Treatment Phase|Adverse Event|0|||
46835978|NCT00305448|83053621|FG002|Overall Study|Subjective Disease Progression|2|||
46835979|NCT00305448|83053619|FG000|Overall Study|Tumor Marker Elevation|0|||
46835980|NCT00305448|83053620|FG001|Overall Study|Tumor Marker Elevation|0|||
46835981|NCT00305448|83053621|FG002|Overall Study|Tumor Marker Elevation|1|||
46835982|NCT00305058|83053632|FG000|Overall Study|Participant too young|1|||
46835983|NCT00305058|83053633|FG001|Overall Study|Participant too young|0|||
46835984|NCT00305058|83053632|FG000|Overall Study|Missing data collection instrument|3|||
46835985|NCT00305058|83053633|FG001|Overall Study|Missing data collection instrument|2|||
46835986|NCT00305058|83053632|FG000|Overall Study|Missing outcome data|3|||
46835987|NCT00305058|83053633|FG001|Overall Study|Missing outcome data|2|||
46835988|NCT00295854|83053642|FG000|Overall Study|Adverse Event|7|||
46835989|NCT00295854|83053643|FG001|Overall Study|Adverse Event|7|||
46835990|NCT00295854|83053644|FG002|Overall Study|Adverse Event|6|||
46835991|NCT00295854|83053642|FG000|Overall Study|Protocol Violation|1|||
46835992|NCT00295854|83053643|FG001|Overall Study|Protocol Violation|1|||
46835993|NCT00295854|83053644|FG002|Overall Study|Protocol Violation|1|||
46835994|NCT00295854|83053642|FG000|Overall Study|Lost to Follow-up|2|||
46835995|NCT00295854|83053643|FG001|Overall Study|Lost to Follow-up|0|||
46835996|NCT00295854|83053644|FG002|Overall Study|Lost to Follow-up|1|||
46835997|NCT00295854|83053642|FG000|Overall Study|Withdrawal by Subject|3|||
46835998|NCT00295854|83053643|FG001|Overall Study|Withdrawal by Subject|7|||
46835999|NCT00295854|83053644|FG002|Overall Study|Withdrawal by Subject|4|||
46836000|NCT00295854|83053642|FG000|Overall Study|did not continue to meet criteria|1|||
46836001|NCT00295854|83053643|FG001|Overall Study|did not continue to meet criteria|1|||
46836002|NCT00295854|83053644|FG002|Overall Study|did not continue to meet criteria|2|||
46836003|NCT00295854|83053642|FG000|Overall Study|required a prohibited medication|1|||
46836004|NCT00295854|83053643|FG001|Overall Study|required a prohibited medication|0|||
46836005|NCT00295854|83053644|FG002|Overall Study|required a prohibited medication|0|||
46836006|NCT00295854|83053642|FG000|Overall Study|Other|3|||
46836007|NCT00295854|83053643|FG001|Overall Study|Other|5|||
46836008|NCT00295854|83053644|FG002|Overall Study|Other|1|||
46836009|NCT00327470|83053654|FG000|Overall Study|Randomized, but not treated|0|||
46836010|NCT00327470|83053655|FG001|Overall Study|Randomized, but not treated|2|||
46836011|NCT00327470|83053654|FG000|Overall Study|Adverse Event|9|||
46836012|NCT00327470|83053655|FG001|Overall Study|Adverse Event|14|||
46836013|NCT00327470|83053654|FG000|Overall Study|Lack of Efficacy|7|||
46836014|NCT00327470|83053655|FG001|Overall Study|Lack of Efficacy|19|||
46836015|NCT00327470|83053654|FG000|Overall Study|Other|5|||
46836016|NCT00327470|83053655|FG001|Overall Study|Other|9|||
46836017|NCT00327470|83053654|FG000|Overall Study|Lost to Follow-up|1|||
46836018|NCT00327470|83053655|FG001|Overall Study|Lost to Follow-up|3|||
46836019|NCT00327470|83053654|FG000|Overall Study|Withdrawal by Subject|6|||
46836020|NCT00327470|83053655|FG001|Overall Study|Withdrawal by Subject|12|||
46836021|NCT00327470|83053654|FG000|Overall Study|Death|1|||
46836022|NCT00327470|83053655|FG001|Overall Study|Death|4|||
46836023|NCT00322556|83053661|FG000|Overall Study|Adverse Event|1|||
46836024|NCT00322556|83053661|FG000|Overall Study|Withdrawal by Subject|1|||
46836025|NCT00322556|83053661|FG000|Overall Study|Lost to Follow-up|3|||
46942901|NCT01064687|83179998|FG003|Overall Study|Withdrawal by Subject|5|||
46942902|NCT01064687|83179995|FG000|Overall Study|Treatment Noncompliance|1|||
46942903|NCT01064687|83179996|FG001|Overall Study|Treatment Noncompliance|1|||
46942904|NCT01064687|83179997|FG002|Overall Study|Treatment Noncompliance|1|||
46638111|NCT01449630|82811494|FG004|Period 1|Physician Decision|0|||
46638112|NCT01449630|82811495|FG005|Period 1|Physician Decision|0|||
46767663|NCT00844805|82985818|FG000|Treatment Phase|Withdrawal by Subject|3|||
46767664|NCT00844805|82985819|FG001|Treatment Phase|Withdrawal by Subject|4|||
46767665|NCT00844805|82985820|FG002|Treatment Phase|Withdrawal by Subject|0|||
46767666|NCT00844805|82985821|FG003|Treatment Phase|Withdrawal by Subject|0|||
46767667|NCT00844805|82985818|FG000|Treatment Phase|Noncompliance With Protocol|1|||
46767668|NCT00844805|82985819|FG001|Treatment Phase|Noncompliance With Protocol|0|||
46767669|NCT00844805|82985820|FG002|Treatment Phase|Noncompliance With Protocol|0|||
46767670|NCT00844805|82985821|FG003|Treatment Phase|Noncompliance With Protocol|0|||
46767671|NCT00844805|82985818|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
46767672|NCT00844805|82985819|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
46767673|NCT00844805|82985820|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
46767674|NCT00844805|82985821|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
46836026|NCT00322556|83053661|FG000|Overall Study|Other Reason|7|||
46942905|NCT01064687|83179998|FG003|Overall Study|Treatment Noncompliance|0|||
46638113|NCT01449630|82811496|FG006|Period 1|Physician Decision|0|||
46767675|NCT00844805|82985818|FG000|Follow-Up Phase|Adverse Event|0|||
46767676|NCT00844805|82985819|FG001|Follow-Up Phase|Adverse Event|0|||
46767677|NCT00844805|82985820|FG002|Follow-Up Phase|Adverse Event|1|||
46767678|NCT00844805|82985821|FG003|Follow-Up Phase|Adverse Event|0|||
46836027|NCT00321932|83053670|FG000|Overall Study|Death|3|||
46836028|NCT00321932|83053671|FG001|Overall Study|Death|6|||
46836029|NCT00321932|83053670|FG000|Overall Study|Withdrawal by Subject|3|||
46942906|NCT02493946|83180022|FG000|DB Period|Withdrawal by Subject|8|||
46836030|NCT00321932|83053671|FG001|Overall Study|Withdrawal by Subject|6|||
46836031|NCT00321932|83053670|FG000|Overall Study|Early relapse|2|||
46836032|NCT00321932|83053671|FG001|Overall Study|Early relapse|8|||
46836033|NCT00321932|83053670|FG000|Overall Study|Missing data|2|||
46836034|NCT00321932|83053671|FG001|Overall Study|Missing data|1|||
46836035|NCT00326612|83053680|FG000|Overall Study|They did not have a seizure requiring tx|129|||
46836036|NCT00326612|83053681|FG001|Overall Study|They did not have a seizure requiring tx|137|||
46836037|NCT00325130|83053693|FG000|Overall Study|Lost to Follow-up|6|||
46836038|NCT00325130|83053694|FG001|Overall Study|Lost to Follow-up|14|||
46836039|NCT00325130|83053693|FG000|Overall Study|Withdrawal by Subject|12|||
46836040|NCT00325130|83053694|FG001|Overall Study|Withdrawal by Subject|14|||
46836041|NCT00325130|83053693|FG000|Overall Study|Protocol Deviation|0|||
46836042|NCT00325130|83053694|FG001|Overall Study|Protocol Deviation|1|||
46836043|NCT00325130|83053693|FG000|Overall Study|Moved|0|||
46836044|NCT00325130|83053694|FG001|Overall Study|Moved|1|||
46836045|NCT00325130|83053693|FG000|Overall Study|Patient Discontinued for Other|1|||
46836046|NCT00325130|83053694|FG001|Overall Study|Patient Discontinued for Other|0|||
46836047|NCT00321854|83053702|FG000|Overall Study|Adverse Event|41|||
46836048|NCT00321854|83053703|FG001|Overall Study|Adverse Event|43|||
46638114|NCT01449630|82811497|FG007|Period 1|Physician Decision|0|||
46638115|NCT01449630|82811498|FG008|Period 1|Physician Decision|0|||
46638116|NCT01449630|82811490|FG000|Period 1|Sponsor Decision|0|||
46638117|NCT01449630|82811491|FG001|Period 1|Sponsor Decision|0|||
46638118|NCT01449630|82811492|FG002|Period 1|Sponsor Decision|0|||
46638119|NCT01449630|82811493|FG003|Period 1|Sponsor Decision|0|||
46638120|NCT01449630|82811494|FG004|Period 1|Sponsor Decision|0|||
46638121|NCT01449630|82811495|FG005|Period 1|Sponsor Decision|1|||
46638122|NCT01449630|82811496|FG006|Period 1|Sponsor Decision|0|||
46638123|NCT01449630|82811497|FG007|Period 1|Sponsor Decision|0|||
46638124|NCT01449630|82811498|FG008|Period 1|Sponsor Decision|0|||
46638125|NCT01449630|82811490|FG000|Period 2|Sponsor Decision|0|||
46767679|NCT00844805|82985818|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
46767680|NCT00844805|82985819|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
46767681|NCT00844805|82985820|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
46767682|NCT00844805|82985821|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
46767683|NCT00844805|82985818|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
46767684|NCT00844805|82985819|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
46767685|NCT00844805|82985820|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
46767686|NCT00844805|82985821|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
46767687|NCT00844805|82985818|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
46767688|NCT00844805|82985819|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
46767689|NCT00844805|82985820|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
46767690|NCT00844805|82985821|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
46767691|NCT00844805|82985818|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
46767692|NCT00844805|82985819|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
46767693|NCT00844805|82985820|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
46767694|NCT00844805|82985821|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
46767695|NCT00765999|82985832|FG000|Overall Study|Adverse Event|203|||
46767696|NCT00765999|82985832|FG000|Overall Study|Insufficient Therapeutic Response|100|||
46767697|NCT00765999|82985832|FG000|Overall Study|Protocol Violation|95|||
46767698|NCT00765999|82985832|FG000|Overall Study|Consent Withdrawn|202|||
46767699|NCT00765999|82985832|FG000|Overall Study|Lost to Follow-up|131|||
46767700|NCT00765999|82985832|FG000|Overall Study|Study Terminated by Sponsor|2|||
46767701|NCT00765999|82985832|FG000|Overall Study|Other Miscellaneous Reasons|51|||
46767702|NCT00765843|82985841|FG000|Overall Study|Lost to Follow-up|1|||
46836049|NCT00321854|83053702|FG000|Overall Study|Lack of Efficacy|9|||
46836050|NCT00321854|83053703|FG001|Overall Study|Lack of Efficacy|14|||
46836051|NCT00321854|83053702|FG000|Overall Study|Protocol Violation|6|||
46836052|NCT00321854|83053703|FG001|Overall Study|Protocol Violation|5|||
46836053|NCT00321854|83053702|FG000|Overall Study|Lost to Follow-up|0|||
46638126|NCT01449630|82811491|FG001|Period 2|Sponsor Decision|0|||
46638127|NCT01449630|82811492|FG002|Period 2|Sponsor Decision|0|||
46767703|NCT00765843|82985842|FG001|Overall Study|Lost to Follow-up|3|||
46767704|NCT00765843|82985843|FG002|Overall Study|Lost to Follow-up|2|||
46836054|NCT00321854|83053703|FG001|Overall Study|Lost to Follow-up|2|||
46836055|NCT00321854|83053702|FG000|Overall Study|Withdrawal by Subject|6|||
46942907|NCT02493946|83180023|FG001|DB Period|Withdrawal by Subject|5|||
46638128|NCT01449630|82811493|FG003|Period 2|Sponsor Decision|0|||
46638129|NCT01449630|82811494|FG004|Period 2|Sponsor Decision|0|||
46638130|NCT01449630|82811495|FG005|Period 2|Sponsor Decision|0|||
46638131|NCT01449630|82811496|FG006|Period 2|Sponsor Decision|1|||
46638132|NCT01449630|82811497|FG007|Period 2|Sponsor Decision|0|||
46638133|NCT01449630|82811498|FG008|Period 2|Sponsor Decision|0|||
46638134|NCT01493778|82811520|FG000|Overall Study|Withdrawal by Subject|8|||
46767705|NCT00765843|82985841|FG000|Overall Study|did not return to receive intervention|0|||
46767706|NCT00765843|82985842|FG001|Overall Study|did not return to receive intervention|1|||
46836056|NCT00321854|83053703|FG001|Overall Study|Withdrawal by Subject|17|||
46836057|NCT00321854|83053702|FG000|Overall Study|Other|1|||
46836058|NCT00321854|83053703|FG001|Overall Study|Other|1|||
46836059|NCT00310388|83053711|FG000|Primary Reporting Phase|Adverse Event|101|||
46836060|NCT00310388|83053712|FG001|Primary Reporting Phase|Adverse Event|0|||
46836061|NCT00310388|83053711|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
46836062|NCT00310388|83053712|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
46836063|NCT00310388|83053711|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
46836064|NCT00310388|83053712|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
46836065|NCT00310388|83053711|FG000|Primary Reporting Phase|Protocol Violation|10|||
46836066|NCT00310388|83053712|FG001|Primary Reporting Phase|Protocol Violation|0|||
46836067|NCT00310388|83053711|FG000|Primary Reporting Phase|Pregnancy|3|||
46836068|NCT00310388|83053712|FG001|Primary Reporting Phase|Pregnancy|0|||
46836069|NCT00310388|83053711|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
46836070|NCT00310388|83053712|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
46836071|NCT00310388|83053711|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
46836072|NCT00310388|83053712|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
46836073|NCT00310388|83053711|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
46836074|NCT00310388|83053712|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
46836075|NCT00310388|83053711|FG000|Primary Reporting Phase|Physician Decision|2|||
46836076|NCT00310388|83053712|FG001|Primary Reporting Phase|Physician Decision|0|||
46836077|NCT00310388|83053711|FG000|Primary Reporting Phase|Request of the sponsor|19|||
46836078|NCT00310388|83053712|FG001|Primary Reporting Phase|Request of the sponsor|0|||
46836079|NCT00310388|83053711|FG000|Primary Reporting Phase|Failed to return|8|||
46836080|NCT00310388|83053712|FG001|Primary Reporting Phase|Failed to return|0|||
46836081|NCT00310388|83053711|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
46836082|NCT00310388|83053712|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
46836083|NCT00310388|83053711|FG000|Primary Reporting Phase|Participant request|2|||
46836084|NCT00310388|83053712|FG001|Primary Reporting Phase|Participant request|0|||
46836085|NCT00310388|83053711|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
46836086|NCT00310388|83053712|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
46836087|NCT00310388|83053711|FG000|Primary Reporting Phase|Discontinuation of study|1|||
46836088|NCT00310388|83053712|FG001|Primary Reporting Phase|Discontinuation of study|0|||
46836089|NCT00310388|83053711|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
46836090|NCT00310388|83053712|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
46836091|NCT00310388|83053711|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
46836092|NCT00310388|83053712|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
46836093|NCT00310388|83053711|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
46836094|NCT00310388|83053712|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
46836095|NCT00310388|83053711|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
46836096|NCT00310388|83053712|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
46836097|NCT00310388|83053711|FG000|Primary Reporting Phase|Participant passed away|1|||
47062504|NCT02754141|83343335|FG014|Overall Study|Withdrew consent|0|||
46638135|NCT01473420|82811535|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
46638136|NCT01473420|82811536|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
46638137|NCT01473420|82811535|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
46767707|NCT00765843|82985843|FG002|Overall Study|did not return to receive intervention|0|||
46767708|NCT00765843|82985841|FG000|Overall Study|Adverse Event|0|||
46767709|NCT00765843|82985842|FG001|Overall Study|Adverse Event|0|||
46767710|NCT00765843|82985843|FG002|Overall Study|Adverse Event|1|||
46767711|NCT00765063|82985851|FG000|Overall Study|Lack of Efficacy|5|||
46767712|NCT00765063|82985851|FG000|Overall Study|Withdrawal by Subject|1|||
46767713|NCT00765063|82985851|FG000|Overall Study|Other|16|||
46767714|NCT00765063|82985851|FG000|Overall Study|Protocol Violation|6|||
46767715|NCT00765063|82985851|FG000|Overall Study|Adverse Event|4|||
46767716|NCT00764751|82985857|FG000|Overall Study|Adverse Event|1|||
46767717|NCT00764751|82985858|FG001|Overall Study|Adverse Event|1|||
46767718|NCT00764751|82985857|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
46767719|NCT00764751|82985858|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
46638138|NCT01473420|82811536|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
46767720|NCT00764673|82985869|FG000|Overall Study|Death|1|||
46767721|NCT00764673|82985869|FG000|Overall Study|Lost to Follow-up|3|||
46767722|NCT00764673|82985869|FG000|Overall Study|Withdrawal by Subject|6|||
46767723|NCT00764673|82985869|FG000|Overall Study|Revision of Device|2|||
46767724|NCT00764517|82985875|FG000|Overall Study|Adverse Event|9|||
46836098|NCT00310388|83053712|FG001|Primary Reporting Phase|Participant passed away|0|||
46836099|NCT00310388|83053711|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
46836100|NCT00310388|83053712|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
46836101|NCT00310388|83053711|FG000|Primary Reporting Phase|Missing|1|||
46836102|NCT00310388|83053712|FG001|Primary Reporting Phase|Missing|0|||
46836103|NCT00310388|83053711|FG000|Primary Reporting Phase|Other|1|||
46836104|NCT00310388|83053712|FG001|Primary Reporting Phase|Other|0|||
46836105|NCT00310388|83053711|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
46836106|NCT00310388|83053712|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
46836107|NCT00310388|83053711|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
46836108|NCT00310388|83053712|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
46836109|NCT00310388|83053711|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
46836110|NCT00310388|83053712|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
46836111|NCT00310388|83053711|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
46836112|NCT00310388|83053712|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
46836113|NCT00500357|83053717|FG000|Overall Study|Death|1|||
46836114|NCT00309842|83053732|FG000|Overall Study|Lost to Follow-up|1|||
46836115|NCT00325754|83053738|FG000|Overall Study|Adverse Event|4|||
46836116|NCT00325754|83053739|FG001|Overall Study|Adverse Event|1|||
46836117|NCT00499889|83053745|FG000|Overall Study|Infection prior to treatment|1|||
46836118|NCT00309608|83053754|FG000|Overall Study|Adverse Event|1|||
46836119|NCT00309608|83053755|FG001|Overall Study|Adverse Event|5|||
46836120|NCT00309608|83053756|FG002|Overall Study|Adverse Event|3|||
46836121|NCT00309608|83053757|FG003|Overall Study|Adverse Event|2|||
46836122|NCT00309608|83053758|FG004|Overall Study|Adverse Event|3|||
46836123|NCT00309608|83053754|FG000|Overall Study|Protocol Violation|2|||
46836124|NCT00309608|83053755|FG001|Overall Study|Protocol Violation|0|||
46836125|NCT00309608|83053756|FG002|Overall Study|Protocol Violation|0|||
46836126|NCT00309608|83053757|FG003|Overall Study|Protocol Violation|0|||
46836127|NCT00309608|83053758|FG004|Overall Study|Protocol Violation|0|||
46836128|NCT00309608|83053754|FG000|Overall Study|Lost to Follow-up|0|||
46836129|NCT00309608|83053755|FG001|Overall Study|Lost to Follow-up|0|||
46836130|NCT00309608|83053756|FG002|Overall Study|Lost to Follow-up|2|||
46836131|NCT00309608|83053757|FG003|Overall Study|Lost to Follow-up|0|||
46836132|NCT00309608|83053758|FG004|Overall Study|Lost to Follow-up|1|||
46836133|NCT00309608|83053754|FG000|Overall Study|Withdrawal by Subject|1|||
46836134|NCT00309608|83053755|FG001|Overall Study|Withdrawal by Subject|4|||
46836135|NCT00309608|83053756|FG002|Overall Study|Withdrawal by Subject|2|||
46836136|NCT00309608|83053757|FG003|Overall Study|Withdrawal by Subject|0|||
46836137|NCT00309608|83053758|FG004|Overall Study|Withdrawal by Subject|0|||
46836138|NCT00309608|83053754|FG000|Overall Study|Other incl. Lack of efficacy|10|||
46836139|NCT00309608|83053755|FG001|Overall Study|Other incl. Lack of efficacy|4|||
46836140|NCT00309608|83053756|FG002|Overall Study|Other incl. Lack of efficacy|3|||
46836141|NCT00309608|83053757|FG003|Overall Study|Other incl. Lack of efficacy|4|||
46836142|NCT00309608|83053758|FG004|Overall Study|Other incl. Lack of efficacy|0|||
46836143|NCT00309452|83053772|FG000|Overall Study|Withdrawal by Subject|3|||
46836144|NCT00309452|83053773|FG001|Overall Study|Withdrawal by Subject|0|||
46836145|NCT00308750|83053782|FG000|Overall Study|Adverse Event|9|||
46836146|NCT00308750|83053783|FG001|Overall Study|Adverse Event|9|||
46836147|NCT00308750|83053784|FG002|Overall Study|Adverse Event|13|||
46836148|NCT00308750|83053782|FG000|Overall Study|Withdrawal by Subject|6|||
46836149|NCT00308750|83053783|FG001|Overall Study|Withdrawal by Subject|2|||
46836150|NCT00308750|83053784|FG002|Overall Study|Withdrawal by Subject|3|||
46836151|NCT00308750|83053782|FG000|Overall Study|Physician Decision|3|||
46836152|NCT00308750|83053783|FG001|Overall Study|Physician Decision|4|||
46836153|NCT00308750|83053784|FG002|Overall Study|Physician Decision|3|||
46836154|NCT00308750|83053782|FG000|Overall Study|Sponsor Decision|1|||
46836155|NCT00308750|83053783|FG001|Overall Study|Sponsor Decision|0|||
46836156|NCT00308750|83053784|FG002|Overall Study|Sponsor Decision|0|||
46836157|NCT00308750|83053782|FG000|Overall Study|Disease Progression|47|||
46836158|NCT00308750|83053783|FG001|Overall Study|Disease Progression|24|||
46836159|NCT00308750|83053784|FG002|Overall Study|Disease Progression|28|||
46836160|NCT00308750|83053782|FG000|Overall Study|Unrelated Complication|3|||
46836161|NCT00308750|83053783|FG001|Overall Study|Unrelated Complication|0|||
47062505|NCT02754141|83343336|FG015|Overall Study|Withdrew consent|0|||
46836162|NCT00308750|83053784|FG002|Overall Study|Unrelated Complication|1|||
46836163|NCT00308750|83053782|FG000|Overall Study|Death|1|||
46836164|NCT00308750|83053783|FG001|Overall Study|Death|0|||
46836165|NCT00308750|83053784|FG002|Overall Study|Death|1|||
46836166|NCT00308750|83053782|FG000|Overall Study|Protocol Violation|1|||
46836167|NCT00308750|83053783|FG001|Overall Study|Protocol Violation|0|||
46836168|NCT00308750|83053784|FG002|Overall Study|Protocol Violation|0|||
46836169|NCT00308750|83053782|FG000|Overall Study|New Primary Disease Identified|1|||
46836170|NCT00308750|83053783|FG001|Overall Study|New Primary Disease Identified|1|||
46836171|NCT00308750|83053784|FG002|Overall Study|New Primary Disease Identified|0|||
46836172|NCT00489359|83053795|FG000|Overall Study|Death|0|||
46836173|NCT00489359|83053796|FG001|Overall Study|Death|2|||
46836174|NCT00489359|83053795|FG000|Overall Study|Progressive Disease|5|||
46836175|NCT00489359|83053796|FG001|Overall Study|Progressive Disease|6|||
46836176|NCT00489359|83053795|FG000|Overall Study|Lost to Follow-up|1|||
46836177|NCT00489359|83053796|FG001|Overall Study|Lost to Follow-up|0|||
46836178|NCT00489359|83053795|FG000|Overall Study|Withdrawal by Subject|1|||
46836179|NCT00489359|83053796|FG001|Overall Study|Withdrawal by Subject|5|||
46836180|NCT00489359|83053795|FG000|Overall Study|Adverse Event|0|||
46836181|NCT00489359|83053796|FG001|Overall Study|Adverse Event|16|||
46836182|NCT00481247|83053809|FG000|Overall Study|Death|0|||
46836183|NCT00481247|83053810|FG001|Overall Study|Death|1|||
46836184|NCT00481247|83053809|FG000|Overall Study|Disease progression|18|||
46836185|NCT00481247|83053810|FG001|Overall Study|Disease progression|22|||
46836186|NCT00481247|83053809|FG000|Overall Study|Intolerance|42|||
46836187|NCT00481247|83053810|FG001|Overall Study|Intolerance|17|||
46836188|NCT00481247|83053809|FG000|Overall Study|Treatment failure|10|||
46836189|NCT00481247|83053810|FG001|Overall Study|Treatment failure|14|||
46836190|NCT00481247|83053809|FG000|Overall Study|AE unrelated to study drug|13|||
46836191|NCT00481247|83053810|FG001|Overall Study|AE unrelated to study drug|4|||
46836192|NCT00481247|83053809|FG000|Overall Study|Withdrawal by Subject|8|||
46836193|NCT00481247|83053810|FG001|Overall Study|Withdrawal by Subject|13|||
46836194|NCT00481247|83053809|FG000|Overall Study|Pregnancy|2|||
46836195|NCT00481247|83053810|FG001|Overall Study|Pregnancy|1|||
46836196|NCT00481247|83053809|FG000|Overall Study|Lost to Follow-up|1|||
46836197|NCT00481247|83053810|FG001|Overall Study|Lost to Follow-up|2|||
46836198|NCT00481247|83053809|FG000|Overall Study|Poor compliance/noncompliance|1|||
46836199|NCT00481247|83053810|FG001|Overall Study|Poor compliance/noncompliance|7|||
46836200|NCT00481247|83053809|FG000|Overall Study|Administrative reason by sponsor|157|||
46836201|NCT00481247|83053810|FG001|Overall Study|Administrative reason by sponsor|162|||
46836202|NCT00481247|83053809|FG000|Overall Study|Varied|6|||
46836203|NCT00481247|83053810|FG001|Overall Study|Varied|15|||
46836204|NCT00481247|83053809|FG000|Overall Study|Did not receive treatment|1|||
46836205|NCT00481247|83053810|FG001|Overall Study|Did not receive treatment|2|||
46836206|NCT00480857|83053816|FG000|Overall Study|Lack of Efficacy|2|||
46836207|NCT00480779|83053822|FG000|Overall Study|Other|2|||
46836208|NCT00480779|83053823|FG001|Overall Study|Other|0|||
46836209|NCT00480779|83053822|FG000|Overall Study|Job and Health-related|0|||
46836210|NCT00480779|83053823|FG001|Overall Study|Job and Health-related|3|||
46836211|NCT00499031|83053829|FG000|Overall Study|Improper pre-protocol treatment|1|||
46836212|NCT00499031|83053829|FG000|Overall Study|Required test not done|1|||
46836213|NCT00499031|83053829|FG000|Overall Study|Never treated|1|||
46836214|NCT00498797|83053835|FG000|Overall Study|Withdrawal by Subject|4|||
46836215|NCT00498797|83053836|FG001|Overall Study|Withdrawal by Subject|2|||
46836216|NCT00498797|83053835|FG000|Overall Study|Adverse Event|12|||
46836217|NCT00498797|83053836|FG001|Overall Study|Adverse Event|5|||
46836218|NCT00498797|83053835|FG000|Overall Study|Condition under investigation worsened|19|||
46836219|NCT00498797|83053836|FG001|Overall Study|Condition under investigation worsened|21|||
46836220|NCT00498797|83053835|FG000|Overall Study|Other|3|||
46836221|NCT00498797|83053836|FG001|Overall Study|Other|1|||
46836222|NCT00498485|83053844|FG000|Overall Study|Adverse Event|1|||
46836223|NCT00498485|83053845|FG001|Overall Study|Adverse Event|5|||
46836224|NCT00480077|83053855|FG000|Overall Study|Death|19|||
46836225|NCT00480077|83053856|FG001|Overall Study|Death|15|||
46836226|NCT00480077|83053855|FG000|Overall Study|early exit|12|||
46836227|NCT00480077|83053856|FG001|Overall Study|early exit|11|||
46836228|NCT00498173|83053864|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
46836229|NCT00498173|83053865|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
46836230|NCT00498173|83053866|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
46638139|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
46638140|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
46836231|NCT00295620|83053876|FG000|Overall Study|Lost to Follow-up|9|||
46836232|NCT00295620|83053877|FG001|Overall Study|Lost to Follow-up|5|||
46836233|NCT00295620|83053876|FG000|Overall Study|Withdrawal by Subject|37|||
46836234|NCT00295620|83053877|FG001|Overall Study|Withdrawal by Subject|50|||
46836235|NCT00295620|83053876|FG000|Overall Study|Death|206|||
46836236|NCT00295620|83053877|FG001|Overall Study|Death|207|||
46836237|NCT00295620|83053876|FG000|Overall Study|Other reasons|10|||
46836238|NCT00295620|83053877|FG001|Overall Study|Other reasons|9|||
46836239|NCT00295620|83053876|FG000|Overall Study|Discontinuation by sponsor|580|||
46836240|NCT00295620|83053877|FG001|Overall Study|Discontinuation by sponsor|593|||
46836241|NCT00295620|83053876|FG000|Overall Study|Protocol Violation|30|||
46836242|NCT00295620|83053877|FG001|Overall Study|Protocol Violation|32|||
46836243|NCT00310440|83053885|FG000|Overall Study|Lost to Follow-up|17|||
46836244|NCT00310440|83053886|FG001|Overall Study|Lost to Follow-up|8|||
46836245|NCT00310440|83053885|FG000|Overall Study|Withdrawal by Subject|2|||
46836246|NCT00310440|83053886|FG001|Overall Study|Withdrawal by Subject|1|||
46836247|NCT00310440|83053885|FG000|Overall Study|Missed 12 Month Visit|7|||
46836248|NCT00310440|83053886|FG001|Overall Study|Missed 12 Month Visit|4|||
46836249|NCT00304356|83053892|FG000|Nitazoxanide|Physician Decision|5|||
46836250|NCT00304356|83053892|FG000|Nitazoxanide|Physician Decision|1|||
46836251|NCT00304356|83053892|FG000|Nitazoxanide|number is 0|1|||
46836252|NCT00304356|83053892|FG000|Nitazoxanide|Physician Decision|1|||
46836253|NCT00304356|83053892|FG000|Nitazoxanide|Physician Decision|1|||
46942908|NCT02493946|83180024|FG002|DB Period|Withdrawal by Subject|0|||
46638141|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
46638142|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
46942909|NCT02493946|83180022|FG000|Open Label Period|Withdrawal by Subject|0|||
46942910|NCT02493946|83180023|FG001|Open Label Period|Withdrawal by Subject|0|||
46942911|NCT02493946|83180024|FG002|Open Label Period|Withdrawal by Subject|74|||
46942912|NCT02493946|83180022|FG000|Open Label Period|Adverse Event|0|||
46942913|NCT02493946|83180023|FG001|Open Label Period|Adverse Event|0|||
46942914|NCT02493946|83180024|FG002|Open Label Period|Adverse Event|4|||
46942915|NCT02493946|83180022|FG000|Open Label Period|Lost to Follow-up|0|||
46942916|NCT02493946|83180023|FG001|Open Label Period|Lost to Follow-up|0|||
46942917|NCT02493946|83180024|FG002|Open Label Period|Lost to Follow-up|1|||
46942918|NCT02493946|83180022|FG000|Open Label Period|Investigator decision, non-compliance|0|||
46942919|NCT02493946|83180023|FG001|Open Label Period|Investigator decision, non-compliance|0|||
46942920|NCT02493946|83180024|FG002|Open Label Period|Investigator decision, non-compliance|2|||
46942921|NCT02493946|83180022|FG000|Open Label Period|Investigator decision, non-availability|0|||
46942922|NCT02493946|83180023|FG001|Open Label Period|Investigator decision, non-availability|0|||
46942923|NCT02493946|83180024|FG002|Open Label Period|Investigator decision, non-availability|1|||
46942924|NCT02493946|83180022|FG000|Open Label Period|Pregnancy|0|||
46942925|NCT02493946|83180023|FG001|Open Label Period|Pregnancy|0|||
46942926|NCT02493946|83180024|FG002|Open Label Period|Pregnancy|3|||
46942927|NCT02493946|83180022|FG000|Open Label Period|Site error|0|||
46942928|NCT02493946|83180023|FG001|Open Label Period|Site error|0|||
46942929|NCT02493946|83180024|FG002|Open Label Period|Site error|1|||
46942930|NCT01064531|83180034|FG000|Overall Study|Lost to Follow-up|0|||
46942931|NCT01064531|83180035|FG001|Overall Study|Lost to Follow-up|2|||
46638143|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
46638144|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
46836254|NCT00304356|83053892|FG000|Nitazoxanide|Physician Decision|1|||
46836255|NCT00321620|83053898|FG000|Overall Study|Death|269|||
46836256|NCT00321620|83053899|FG001|Overall Study|Death|294|||
46836257|NCT00321620|83053898|FG000|Overall Study|Withdrawal by Subject|164|||
46836258|NCT00321620|83053899|FG001|Overall Study|Withdrawal by Subject|147|||
46836259|NCT00321620|83053898|FG000|Overall Study|Disease progression|113|||
46836260|NCT00321620|83053899|FG001|Overall Study|Disease progression|117|||
46836261|NCT00321620|83053898|FG000|Overall Study|Adverse Event|43|||
46836262|NCT00321620|83053899|FG001|Overall Study|Adverse Event|56|||
46836263|NCT00321620|83053898|FG000|Overall Study|Lost to Follow-up|13|||
46836264|NCT00321620|83053899|FG001|Overall Study|Lost to Follow-up|9|||
46836265|NCT00321620|83053898|FG000|Overall Study|Physician Decision|4|||
46836266|NCT00321620|83053899|FG001|Overall Study|Physician Decision|1|||
46836267|NCT00321620|83053898|FG000|Overall Study|Noncompliance|14|||
46836268|NCT00321620|83053899|FG001|Overall Study|Noncompliance|7|||
46836269|NCT00321620|83053898|FG000|Overall Study|Protocol deviation|4|||
46836270|NCT00321620|83053899|FG001|Overall Study|Protocol deviation|3|||
46836271|NCT00321620|83053898|FG000|Overall Study|Ineligibility determined|2|||
46836272|NCT00321620|83053899|FG001|Overall Study|Ineligibility determined|3|||
46836273|NCT00321620|83053898|FG000|Overall Study|Participant request|75|||
46836274|NCT00321620|83053899|FG001|Overall Study|Participant request|52|||
46836275|NCT00321620|83053898|FG000|Overall Study|Other|42|||
46836276|NCT00321620|83053899|FG001|Overall Study|Other|33|||
46836277|NCT00304278|83053905|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
46836278|NCT00304278|83053905|FG000|Overall Study|PT had medical condition preventing TX|1|||
46942932|NCT01064531|83180034|FG000|Overall Study|Physician Decision|0|||
46942933|NCT01064531|83180035|FG001|Overall Study|Physician Decision|1|||
46942934|NCT01064531|83180034|FG000|Overall Study|Withdrawal by Subject|2|||
46638145|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
46638146|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
46767725|NCT00764517|82985876|FG001|Overall Study|Adverse Event|3|||
46942935|NCT01064531|83180035|FG001|Overall Study|Withdrawal by Subject|2|||
46942936|NCT01064531|83180034|FG000|Overall Study|Revision due to femoral stem loosening|1|||
46767726|NCT00764517|82985875|FG000|Overall Study|Death|3|||
46767727|NCT00764517|82985876|FG001|Overall Study|Death|11|||
46767728|NCT00764517|82985875|FG000|Overall Study|Physician Decision|3|||
46767729|NCT00764517|82985876|FG001|Overall Study|Physician Decision|0|||
46767730|NCT00764361|82985884|FG000|Overall Study|Withdrawal by Subject|2|||
46767731|NCT00764361|82985885|FG001|Overall Study|Withdrawal by Subject|3|||
46767732|NCT00764361|82985884|FG000|Overall Study|Adverse Event|0|||
46767733|NCT00764361|82985885|FG001|Overall Study|Adverse Event|1|||
46767734|NCT00763971|82985894|FG000|Overall Study|Adverse Event|5|||
46767735|NCT00763971|82985895|FG001|Overall Study|Adverse Event|2|||
46767736|NCT00763971|82985896|FG002|Overall Study|Adverse Event|4|||
47062506|NCT02754141|83343337|FG016|Overall Study|Withdrew consent|0|||
47062507|NCT02754141|83343338|FG017|Overall Study|Withdrew consent|0|||
46836279|NCT00291018|83053912|FG000|Overall Study|Not Consented or Declined PAS|12|||
46836280|NCT00291018|83053913|FG001|Overall Study|Not Consented or Declined PAS|15|||
46836281|NCT00291018|83053914|FG002|Overall Study|Not Consented or Declined PAS|15|||
46836282|NCT00291018|83053912|FG000|Overall Study|Death|3|||
46836283|NCT00291018|83053913|FG001|Overall Study|Death|3|||
46836284|NCT00291018|83053914|FG002|Overall Study|Death|4|||
46836285|NCT00291018|83053912|FG000|Overall Study|Withdrawal by Subject|2|||
46836286|NCT00291018|83053913|FG001|Overall Study|Withdrawal by Subject|8|||
46836287|NCT00291018|83053914|FG002|Overall Study|Withdrawal by Subject|1|||
46836288|NCT00291018|83053912|FG000|Overall Study|Failures|5|||
46836289|NCT00291018|83053913|FG001|Overall Study|Failures|12|||
46836290|NCT00291018|83053914|FG002|Overall Study|Failures|5|||
46836291|NCT00291018|83053912|FG000|Overall Study|Lost to Follow-up|3|||
46836292|NCT00291018|83053913|FG001|Overall Study|Lost to Follow-up|4|||
46836293|NCT00291018|83053914|FG002|Overall Study|Lost to Follow-up|18|||
46836294|NCT00320606|83053925|FG000|Overall Study|Adverse Event|1|||
46836295|NCT00320606|83053925|FG000|Overall Study|Protocol Violation|1|||
46836296|NCT00320606|83053925|FG000|Overall Study|Withdrawal by Subject|1|||
46836297|NCT00307736|83053930|FG000|Overall Study|Adverse Event|0|||
46836298|NCT00307736|83053931|FG001|Overall Study|Adverse Event|0|||
46836299|NCT00307736|83053932|FG002|Overall Study|Adverse Event|1|||
46836300|NCT00307736|83053933|FG003|Overall Study|Adverse Event|3|||
46836301|NCT00307736|83053930|FG000|Overall Study|Withdrawal by Subject|0|||
46836302|NCT00307736|83053931|FG001|Overall Study|Withdrawal by Subject|0|||
46836303|NCT00307736|83053932|FG002|Overall Study|Withdrawal by Subject|2|||
46836304|NCT00307736|83053933|FG003|Overall Study|Withdrawal by Subject|0|||
46836305|NCT00320528|83053947|FG000|Study Period II|Adverse Event|3|||
46836306|NCT00320528|83053948|FG001|Study Period II|Adverse Event|4|||
46836307|NCT00320528|83053949|FG002|Study Period II|Adverse Event|8|||
46836308|NCT00320528|83053947|FG000|Study Period II|Parent/Caregiver Decision|8|||
46942937|NCT01064531|83180035|FG001|Overall Study|Revision due to femoral stem loosening|0|||
46942938|NCT01064531|83180034|FG000|Overall Study|Revision due to dislocation|0|||
46942939|NCT01064531|83180035|FG001|Overall Study|Revision due to dislocation|1|||
46942940|NCT01064531|83180034|FG000|Overall Study|Death|0|||
46942941|NCT01064531|83180035|FG001|Overall Study|Death|1|||
46942942|NCT02220855|83180041|FG000|Overall Study|Adverse Event|8|||
46942943|NCT02220855|83180041|FG000|Overall Study|Disease Progression|5|||
46942944|NCT02220855|83180041|FG000|Overall Study|Withdrawal by Subject|1|||
46942945|NCT02918279|83180047|FG000|Overall Study|Lost to Follow-up|3|||
46836309|NCT00320528|83053948|FG001|Study Period II|Parent/Caregiver Decision|3|||
46836310|NCT00320528|83053949|FG002|Study Period II|Parent/Caregiver Decision|11|||
46836311|NCT00320528|83053947|FG000|Study Period II|Withdrawal by Subject|0|||
46836312|NCT00320528|83053948|FG001|Study Period II|Withdrawal by Subject|1|||
46836313|NCT00320528|83053949|FG002|Study Period II|Withdrawal by Subject|1|||
46836314|NCT00320528|83053947|FG000|Study Period II|Entry Criteria Exclusion|0|||
46836315|NCT00320528|83053948|FG001|Study Period II|Entry Criteria Exclusion|2|||
46836316|NCT00320528|83053949|FG002|Study Period II|Entry Criteria Exclusion|2|||
46836317|NCT00320528|83053947|FG000|Study Period III|Adverse Event|1|||
46836318|NCT00320528|83053948|FG001|Study Period III|Adverse Event|0|||
46836319|NCT00320528|83053949|FG002|Study Period III|Adverse Event|0|||
46836320|NCT00320528|83053947|FG000|Study Period III|Lost to Follow-up|1|||
46836321|NCT00320528|83053948|FG001|Study Period III|Lost to Follow-up|0|||
46836322|NCT00320528|83053949|FG002|Study Period III|Lost to Follow-up|0|||
46836323|NCT00320528|83053947|FG000|Study Period III|Withdrawal by Subject|1|||
46836324|NCT00320528|83053948|FG001|Study Period III|Withdrawal by Subject|1|||
46836325|NCT00320528|83053949|FG002|Study Period III|Withdrawal by Subject|2|||
46836326|NCT00320528|83053947|FG000|Study Period III|Lack of Efficacy|2|||
46836327|NCT00320528|83053948|FG001|Study Period III|Lack of Efficacy|0|||
46836328|NCT00320528|83053949|FG002|Study Period III|Lack of Efficacy|0|||
46836329|NCT00320528|83053947|FG000|Study Period III|Parent/Caregiver Decision|14|||
46836330|NCT00320528|83053948|FG001|Study Period III|Parent/Caregiver Decision|3|||
47062508|NCT02754141|83343321|FG000|Overall Study|Maximum clinical benefit|0|||
46836331|NCT00320528|83053949|FG002|Study Period III|Parent/Caregiver Decision|11|||
46836332|NCT00320528|83053947|FG000|Study Period III|Protocol Violation|0|||
46836333|NCT00320528|83053948|FG001|Study Period III|Protocol Violation|1|||
46836334|NCT00320528|83053949|FG002|Study Period III|Protocol Violation|0|||
46836335|NCT00320528|83053947|FG000|Study Period III|Physician Decision|0|||
46836336|NCT00320528|83053948|FG001|Study Period III|Physician Decision|1|||
46836337|NCT00320528|83053949|FG002|Study Period III|Physician Decision|2|||
46836338|NCT00320528|83053947|FG000|Study Period III|Sponsor Decision|0|||
46836339|NCT00320528|83053948|FG001|Study Period III|Sponsor Decision|0|||
46836340|NCT00320528|83053949|FG002|Study Period III|Sponsor Decision|1|||
46942946|NCT02918279|83180048|FG001|Overall Study|Lost to Follow-up|6|||
46942947|NCT02918279|83180047|FG000|Overall Study|Withdrawal by Subject|5|||
46942948|NCT02918279|83180048|FG001|Overall Study|Withdrawal by Subject|15|||
47062509|NCT02754141|83343322|FG001|Overall Study|Maximum clinical benefit|0|||
46767737|NCT00763971|82985894|FG000|Overall Study|Protocol Violation|3|||
46767738|NCT00763971|82985895|FG001|Overall Study|Protocol Violation|3|||
46767739|NCT00763971|82985896|FG002|Overall Study|Protocol Violation|2|||
46767740|NCT00763971|82985894|FG000|Overall Study|Withdrawal by Subject|4|||
46767741|NCT00763971|82985895|FG001|Overall Study|Withdrawal by Subject|5|||
46767742|NCT00763971|82985896|FG002|Overall Study|Withdrawal by Subject|5|||
46767743|NCT00763971|82985894|FG000|Overall Study|Lost to Follow-up|0|||
46767744|NCT00763971|82985895|FG001|Overall Study|Lost to Follow-up|1|||
46767745|NCT00763971|82985896|FG002|Overall Study|Lost to Follow-up|0|||
46767746|NCT00763971|82985894|FG000|Overall Study|Lack of Efficacy|11|||
46767747|NCT00763971|82985895|FG001|Overall Study|Lack of Efficacy|22|||
46767748|NCT00763971|82985896|FG002|Overall Study|Lack of Efficacy|54|||
46942949|NCT02918279|83180047|FG000|Overall Study|Withdrawal by parent/guardian|2|||
46942950|NCT02918279|83180048|FG001|Overall Study|Withdrawal by parent/guardian|1|||
46942951|NCT02918279|83180047|FG000|Overall Study|Other|3|||
46942952|NCT02918279|83180048|FG001|Overall Study|Other|1|||
46942953|NCT04268745|83180056|FG000|Overall Study|Lost to Follow-up|2|||
46942954|NCT04268745|83180057|FG001|Overall Study|Lost to Follow-up|3|||
46942955|NCT04268745|83180056|FG000|Overall Study|Withdrawal by Subject|4|||
46942956|NCT04268745|83180057|FG001|Overall Study|Withdrawal by Subject|2|||
46942957|NCT04268745|83180056|FG000|Overall Study|Death in the family|1|||
46942958|NCT04268745|83180057|FG001|Overall Study|Death in the family|0|||
46942959|NCT02956837|83180067|FG000|Overall Study|Serious Adverse Events|0|||
46942960|NCT02956837|83180068|FG001|Overall Study|Serious Adverse Events|1|||
46942961|NCT02956837|83180069|FG002|Overall Study|Serious Adverse Events|0|||
46942962|NCT02956837|83180070|FG003|Overall Study|Serious Adverse Events|0|||
46942963|NCT02956837|83180067|FG000|Overall Study|Withdrawal by Subject|0|||
46942964|NCT02956837|83180068|FG001|Overall Study|Withdrawal by Subject|1|||
46942965|NCT02956837|83180069|FG002|Overall Study|Withdrawal by Subject|0|||
46942966|NCT02956837|83180070|FG003|Overall Study|Withdrawal by Subject|3|||
46942967|NCT02956837|83180067|FG000|Overall Study|Lost to Follow-up|0|||
46942968|NCT02956837|83180068|FG001|Overall Study|Lost to Follow-up|1|||
46942969|NCT02956837|83180069|FG002|Overall Study|Lost to Follow-up|2|||
46942970|NCT02956837|83180070|FG003|Overall Study|Lost to Follow-up|0|||
46942971|NCT01063595|83180083|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
46942972|NCT01063595|83180084|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
46942973|NCT01063595|83180083|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
46942974|NCT01063595|83180084|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
46942975|NCT01063595|83180083|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
46942976|NCT01063595|83180084|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
46942977|NCT01063595|83180083|FG000|First Intervention|Adverse Event|1|||
46942978|NCT01063595|83180084|FG001|First Intervention|Adverse Event|4|||
46942979|NCT01063595|83180083|FG000|First Intervention|Withdrawal by Subject|1|||
46942980|NCT01063595|83180084|FG001|First Intervention|Withdrawal by Subject|0|||
46942981|NCT01063595|83180083|FG000|First Intervention|Reason not Specified|0|||
46942982|NCT01063595|83180084|FG001|First Intervention|Reason not Specified|1|||
46942983|NCT01063283|83180092|FG000|Cycle 1|Adverse Event|2|||
46942984|NCT01063283|83180093|FG001|Cycle 1|Adverse Event|0|||
46942985|NCT01063283|83180094|FG002|Cycle 1|Adverse Event|0|||
46942986|NCT01063283|83180092|FG000|Cycle 1|Technical failure in data collection|1|||
46942987|NCT01063283|83180093|FG001|Cycle 1|Technical failure in data collection|0|||
46942988|NCT01063283|83180094|FG002|Cycle 1|Technical failure in data collection|0|||
46942989|NCT01062971|83180102|FG000|Overall Study|Protocol Violation|1|||
46942990|NCT01062971|83180103|FG001|Overall Study|Protocol Violation|3|||
46942991|NCT01062971|83180102|FG000|Overall Study|Lost to Follow-up|3|||
46767749|NCT00763971|82985894|FG000|Overall Study|Unable to swallow capsule|2|||
46767750|NCT00763971|82985895|FG001|Overall Study|Unable to swallow capsule|1|||
46767751|NCT00763971|82985896|FG002|Overall Study|Unable to swallow capsule|1|||
46767752|NCT00763971|82985894|FG000|Overall Study|Personal reason|3|||
46767753|NCT00763971|82985895|FG001|Overall Study|Personal reason|0|||
46942992|NCT01062971|83180103|FG001|Overall Study|Lost to Follow-up|4|||
46942993|NCT01348165|83180116|FG000|Overall Study|Adverse Event|0|||
46942994|NCT01348165|83180117|FG001|Overall Study|Adverse Event|0|||
46942995|NCT01348165|83180118|FG002|Overall Study|Adverse Event|0|||
46942996|NCT01348165|83180119|FG003|Overall Study|Adverse Event|0|||
46767754|NCT00763971|82985896|FG002|Overall Study|Personal reason|0|||
46767755|NCT00763971|82985894|FG000|Overall Study|Exclusion criteria met|1|||
46942997|NCT01348165|83180120|FG004|Overall Study|Adverse Event|0|||
46942998|NCT01348165|83180121|FG005|Overall Study|Adverse Event|0|||
46942999|NCT01348165|83180122|FG006|Overall Study|Adverse Event|1|||
46943000|NCT02493868|83180142|FG000|Induction Phase: DE Participants|Adverse Event|22|||
46767756|NCT00763971|82985895|FG001|Overall Study|Exclusion criteria met|0|||
46767757|NCT00763971|82985896|FG002|Overall Study|Exclusion criteria met|0|||
46767758|NCT00763971|82985894|FG000|Overall Study|Sponsor decision|1|||
46767759|NCT00763971|82985895|FG001|Overall Study|Sponsor decision|0|||
46943001|NCT02493868|83180143|FG001|Induction Phase: DE Participants|Adverse Event|0|||
46943002|NCT02493868|83180142|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
46638147|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
46638148|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
46767760|NCT00763971|82985896|FG002|Overall Study|Sponsor decision|0|||
46767761|NCT00763971|82985894|FG000|Overall Study|Due to holiday season|2|||
46638149|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
46638150|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
46638151|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
46767762|NCT00763971|82985895|FG001|Overall Study|Due to holiday season|0|||
46767763|NCT00763971|82985896|FG002|Overall Study|Due to holiday season|1|||
46767764|NCT00763971|82985894|FG000|Overall Study|Randomization error|0|||
46767765|NCT00763971|82985895|FG001|Overall Study|Randomization error|0|||
46767766|NCT00763971|82985896|FG002|Overall Study|Randomization error|1|||
46767767|NCT00763971|82985894|FG000|Overall Study|Medical monitor decision|0|||
46767768|NCT00763971|82985895|FG001|Overall Study|Medical monitor decision|0|||
46767769|NCT00763971|82985896|FG002|Overall Study|Medical monitor decision|1|||
46767770|NCT00763971|82985894|FG000|Overall Study|Moved to another country|0|||
46767771|NCT00763971|82985895|FG001|Overall Study|Moved to another country|1|||
46767772|NCT00763971|82985896|FG002|Overall Study|Moved to another country|0|||
46767773|NCT00763971|82985894|FG000|Overall Study|Subject wanted dose reduction|0|||
46767774|NCT00763971|82985895|FG001|Overall Study|Subject wanted dose reduction|1|||
46767775|NCT00763971|82985896|FG002|Overall Study|Subject wanted dose reduction|0|||
46767776|NCT00763971|82985894|FG000|Overall Study|Lack of availability|0|||
46767777|NCT00763971|82985895|FG001|Overall Study|Lack of availability|1|||
46767778|NCT00763971|82985896|FG002|Overall Study|Lack of availability|0|||
46767779|NCT00763971|82985894|FG000|Overall Study|Performed final visit on phone|0|||
46767780|NCT00763971|82985895|FG001|Overall Study|Performed final visit on phone|1|||
46767781|NCT00763971|82985896|FG002|Overall Study|Performed final visit on phone|0|||
46767782|NCT00763971|82985894|FG000|Overall Study|Participation in 489-326 required|1|||
46767783|NCT00763971|82985895|FG001|Overall Study|Participation in 489-326 required|0|||
46767784|NCT00763971|82985896|FG002|Overall Study|Participation in 489-326 required|0|||
46767785|NCT00763815|82985906|FG000|Overall Study|Adverse Event|14|||
46767786|NCT00763815|82985907|FG001|Overall Study|Adverse Event|29|||
46767787|NCT00763815|82985906|FG000|Overall Study|Lack of Efficacy|10|||
46767788|NCT00763815|82985907|FG001|Overall Study|Lack of Efficacy|11|||
46767789|NCT00763815|82985906|FG000|Overall Study|Poor Compliance to Protocol|6|||
46767790|NCT00763815|82985907|FG001|Overall Study|Poor Compliance to Protocol|6|||
46767791|NCT00763815|82985906|FG000|Overall Study|Lost to Follow-up|2|||
46767792|NCT00763815|82985907|FG001|Overall Study|Lost to Follow-up|4|||
46767793|NCT00763815|82985906|FG000|Overall Study|Early Termination|1|||
46767794|NCT00763815|82985907|FG001|Overall Study|Early Termination|0|||
46767795|NCT00763815|82985906|FG000|Overall Study|Familial and Personal Reasons|9|||
46767796|NCT00763815|82985907|FG001|Overall Study|Familial and Personal Reasons|16|||
46767797|NCT00763815|82985906|FG000|Overall Study|Physician Decision|1|||
46767798|NCT00763815|82985907|FG001|Overall Study|Physician Decision|0|||
46767799|NCT00763815|82985906|FG000|Overall Study|Withdrawal by Subject|7|||
46836341|NCT00320528|83053947|FG000|Study Period III|Atomoxetine Commercially Available|68|||
46836342|NCT00320528|83053948|FG001|Study Period III|Atomoxetine Commercially Available|25|||
46836343|NCT00320528|83053949|FG002|Study Period III|Atomoxetine Commercially Available|90|||
46836344|NCT00320372|83053960|FG000|Overall Study|Physician Decision|4|||
46836345|NCT00320372|83053961|FG001|Overall Study|Physician Decision|7|||
46836346|NCT00320372|83053960|FG000|Overall Study|Death|7|||
46836347|NCT00320372|83053961|FG001|Overall Study|Death|8|||
46836348|NCT00320372|83053960|FG000|Overall Study|Withdrawal by Subject|55|||
46836349|NCT00320372|83053961|FG001|Overall Study|Withdrawal by Subject|37|||
46836350|NCT00320372|83053960|FG000|Overall Study|Non-Compliance|40|||
46836351|NCT00320372|83053961|FG001|Overall Study|Non-Compliance|39|||
46836352|NCT00320372|83053960|FG000|Overall Study|Did not Meet (I/E)|3|||
46836353|NCT00320372|83053961|FG001|Overall Study|Did not Meet (I/E)|1|||
46836354|NCT00320372|83053960|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
46836355|NCT00320372|83053961|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
46836356|NCT00294762|83053977|FG000|Overall Study|Did not receive study treatment|3|||
46836357|NCT00294762|83053978|FG001|Overall Study|Did not receive study treatment|3|||
46836358|NCT00294684|83053986|FG000|Overall Study|Lost to Follow-up|5|||
46767800|NCT00763815|82985907|FG001|Overall Study|Withdrawal by Subject|12|||
46767801|NCT00763815|82985906|FG000|Overall Study|Protocol Violation|2|||
46767802|NCT00763815|82985907|FG001|Overall Study|Protocol Violation|5|||
46767803|NCT00763815|82985906|FG000|Overall Study|Sponsor's Decision|0|||
46836359|NCT00294684|83053987|FG001|Overall Study|Lost to Follow-up|8|||
46836360|NCT00307034|83053995|FG000|Overall Study|Adverse Event|1|||
46836361|NCT00307034|83053996|FG001|Overall Study|Adverse Event|2|||
46836362|NCT00307034|83053995|FG000|Overall Study|Withdrawal by Subject|1|||
46836363|NCT00307034|83053996|FG001|Overall Study|Withdrawal by Subject|2|||
46767804|NCT00763815|82985907|FG001|Overall Study|Sponsor's Decision|1|||
46767805|NCT00763269|82985915|FG000|Overall Study|Lost to Follow-up|12|||
46767806|NCT00763269|82985916|FG001|Overall Study|Lost to Follow-up|13|||
46836364|NCT00307034|83053995|FG000|Overall Study|Lost to Follow-up|0|||
46767807|NCT00763035|82985922|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
46767808|NCT00763035|82985923|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
46767809|NCT00763035|82985922|FG000|First Intervention|Adverse Event|0|||
46767810|NCT00763035|82985923|FG001|First Intervention|Adverse Event|1|||
46767811|NCT00763035|82985922|FG000|Second Intervention|Adverse Event|1|||
46767812|NCT00763035|82985923|FG001|Second Intervention|Adverse Event|0|||
46767813|NCT00763035|82985922|FG000|Second Intervention|Physician Decision|2|||
46767814|NCT00763035|82985923|FG001|Second Intervention|Physician Decision|0|||
46767815|NCT00844649|82985931|FG000|Overall Study|Progressive Disease|196|||
46767816|NCT00844649|82985932|FG001|Overall Study|Progressive Disease|245|||
46767817|NCT00844649|82985931|FG000|Overall Study|Adverse Event|128|||
46767818|NCT00844649|82985932|FG001|Overall Study|Adverse Event|73|||
46767819|NCT00844649|82985931|FG000|Overall Study|Physician Decision|25|||
46767820|NCT00844649|82985932|FG001|Overall Study|Physician Decision|18|||
46767821|NCT00844649|82985931|FG000|Overall Study|Protocol Violation|10|||
46767822|NCT00844649|82985932|FG001|Overall Study|Protocol Violation|6|||
46767823|NCT00844649|82985931|FG000|Overall Study|Withdrawal by Subject|28|||
46767824|NCT00844649|82985932|FG001|Overall Study|Withdrawal by Subject|39|||
46767825|NCT00844649|82985931|FG000|Overall Study|Other|7|||
46767826|NCT00844649|82985932|FG001|Overall Study|Other|10|||
46767827|NCT00844649|82985931|FG000|Overall Study|Withdrew prior to starting treatment|11|||
46767828|NCT00844649|82985932|FG001|Overall Study|Withdrew prior to starting treatment|27|||
46767829|NCT00762723|82985943|FG000|Overall Study|Study Terminated slow enrollement|5|||
46767830|NCT00762723|82985944|FG001|Overall Study|Study Terminated slow enrollement|5|||
46767831|NCT00762723|82985945|FG002|Overall Study|Study Terminated slow enrollement|3|||
46767832|NCT00850343|82985957|FG000|Overall Study|Withdrawal by Subject|11|||
46767833|NCT00850343|82985958|FG001|Overall Study|Withdrawal by Subject|0|||
46767834|NCT00850343|82985959|FG002|Overall Study|Withdrawal by Subject|3|||
46767835|NCT00850343|82985960|FG003|Overall Study|Withdrawal by Subject|2|||
46767836|NCT00850343|82985957|FG000|Overall Study|Adverse Event|15|||
46767837|NCT00850343|82985958|FG001|Overall Study|Adverse Event|2|||
46767838|NCT00850343|82985959|FG002|Overall Study|Adverse Event|6|||
46767839|NCT00850343|82985960|FG003|Overall Study|Adverse Event|6|||
46767840|NCT00850343|82985957|FG000|Overall Study|Pregnancy|0|||
46767841|NCT00850343|82985958|FG001|Overall Study|Pregnancy|0|||
46767842|NCT00850343|82985959|FG002|Overall Study|Pregnancy|0|||
46767843|NCT00850343|82985960|FG003|Overall Study|Pregnancy|1|||
46767844|NCT00850343|82985957|FG000|Overall Study|Lack of Efficacy|17|||
46767845|NCT00850343|82985958|FG001|Overall Study|Lack of Efficacy|0|||
46767846|NCT00850343|82985959|FG002|Overall Study|Lack of Efficacy|3|||
46767847|NCT00850343|82985960|FG003|Overall Study|Lack of Efficacy|2|||
46767848|NCT00850343|82985957|FG000|Overall Study|Non-compliance with Study Procedures|1|||
46767849|NCT00850343|82985958|FG001|Overall Study|Non-compliance with Study Procedures|0|||
46767850|NCT00850343|82985959|FG002|Overall Study|Non-compliance with Study Procedures|1|||
46767851|NCT00850343|82985960|FG003|Overall Study|Non-compliance with Study Procedures|1|||
46767852|NCT00850343|82985957|FG000|Overall Study|Physician Decision|2|||
46638152|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
46767853|NCT00850343|82985958|FG001|Overall Study|Physician Decision|1|||
46767854|NCT00850343|82985959|FG002|Overall Study|Physician Decision|1|||
46767855|NCT00850343|82985960|FG003|Overall Study|Physician Decision|1|||
46767856|NCT00849875|82985973|FG000|Overall Study|Death|28|||
46767857|NCT00849875|82985973|FG000|Overall Study|Ongoing (unknown completion status)|11|||
46767858|NCT00849875|82985973|FG000|Overall Study|Others|6|||
46767859|NCT00849875|82985973|FG000|Overall Study|Lost to Follow-up|2|||
46767860|NCT00844415|82985984|FG000|Overall Study|Withdrawal by Subject|1|||
46767861|NCT00843635|82985992|FG000|Overall Study|Adverse Event|2|||
46767862|NCT00843635|82985993|FG001|Overall Study|Adverse Event|2|||
46767863|NCT00843635|82985994|FG002|Overall Study|Adverse Event|0|||
46767864|NCT00843167|82986008|FG000|Treatment Period|Adverse Event|1|||
46767865|NCT00843167|82986009|FG001|Treatment Period|Adverse Event|5|||
46767866|NCT00843167|82986008|FG000|Treatment Period|Withdrawal by Subject|2|||
46767867|NCT00843167|82986009|FG001|Treatment Period|Withdrawal by Subject|3|||
46767868|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
46638153|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
46767869|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
46767870|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
46767871|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
46767872|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
46767873|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
46638154|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
46767874|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
46767875|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
46767876|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
46767877|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
46767878|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
46767879|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
46767880|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
46767881|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
46767882|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
46767883|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
46767884|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
46767885|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
46767886|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
46767887|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
46767888|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
46767889|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
46767890|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
46767891|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
46767892|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
46767893|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
46767894|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
46767895|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
46767896|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
46767897|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
47062510|NCT02754141|83343323|FG002|Overall Study|Maximum clinical benefit|0|||
47062511|NCT02754141|83343324|FG003|Overall Study|Maximum clinical benefit|1|||
47062512|NCT02754141|83343325|FG004|Overall Study|Maximum clinical benefit|0|||
47062513|NCT02754141|83343326|FG005|Overall Study|Maximum clinical benefit|0|||
47062514|NCT02754141|83343327|FG006|Overall Study|Maximum clinical benefit|0|||
47062515|NCT02754141|83343328|FG007|Overall Study|Maximum clinical benefit|0|||
47062516|NCT02754141|83343329|FG008|Overall Study|Maximum clinical benefit|0|||
47062517|NCT02754141|83343330|FG009|Overall Study|Maximum clinical benefit|0|||
47062518|NCT02754141|83343331|FG010|Overall Study|Maximum clinical benefit|0|||
46767898|NCT00849017|82986022|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
46767899|NCT00849017|82986023|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
46836365|NCT00307034|83053996|FG001|Overall Study|Lost to Follow-up|3|||
46836366|NCT00320216|83054007|FG000|Overall Study|Adverse Event|0|||
46836367|NCT00320216|83054008|FG001|Overall Study|Adverse Event|6|||
46836368|NCT00320216|83054009|FG002|Overall Study|Adverse Event|0|||
46836369|NCT00320216|83054010|FG003|Overall Study|Adverse Event|2|||
46836370|NCT00320216|83054011|FG004|Overall Study|Adverse Event|2|||
46836371|NCT00320216|83054007|FG000|Overall Study|Lack of Efficacy|6|||
46836372|NCT00320216|83054008|FG001|Overall Study|Lack of Efficacy|2|||
46836373|NCT00320216|83054009|FG002|Overall Study|Lack of Efficacy|1|||
46836374|NCT00320216|83054010|FG003|Overall Study|Lack of Efficacy|0|||
46836375|NCT00320216|83054011|FG004|Overall Study|Lack of Efficacy|1|||
46836376|NCT00320216|83054007|FG000|Overall Study|Lost to Follow-up|3|||
46836377|NCT00320216|83054008|FG001|Overall Study|Lost to Follow-up|0|||
46836378|NCT00320216|83054009|FG002|Overall Study|Lost to Follow-up|0|||
46836379|NCT00320216|83054010|FG003|Overall Study|Lost to Follow-up|0|||
46836380|NCT00320216|83054011|FG004|Overall Study|Lost to Follow-up|0|||
46836381|NCT00320216|83054007|FG000|Overall Study|Other|7|||
46836382|NCT00320216|83054008|FG001|Overall Study|Other|2|||
46836383|NCT00320216|83054009|FG002|Overall Study|Other|5|||
46836384|NCT00320216|83054010|FG003|Overall Study|Other|1|||
46836385|NCT00320216|83054011|FG004|Overall Study|Other|3|||
46836386|NCT00290706|83054032|FG000|Overall Study|Withdrawal by Subject|2|||
46836387|NCT00290706|83054033|FG001|Overall Study|Withdrawal by Subject|0|||
46836388|NCT00290706|83054034|FG002|Overall Study|Withdrawal by Subject|0|||
46836389|NCT00290706|83054035|FG003|Overall Study|Withdrawal by Subject|0|||
46836390|NCT00290706|83054032|FG000|Overall Study|Progressive Disease|3|||
47062519|NCT02754141|83343332|FG011|Overall Study|Maximum clinical benefit|0|||
46767900|NCT00849017|82986024|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
46767901|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
46767902|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
46767903|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
46767904|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
46767905|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
46767906|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
46767907|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
46767908|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
46836391|NCT00290706|83054033|FG001|Overall Study|Progressive Disease|5|||
46836392|NCT00290706|83054034|FG002|Overall Study|Progressive Disease|4|||
46836393|NCT00290706|83054035|FG003|Overall Study|Progressive Disease|10|||
46836394|NCT00290706|83054032|FG000|Overall Study|Adverse Event|0|||
46836395|NCT00290706|83054033|FG001|Overall Study|Adverse Event|1|||
46836396|NCT00290706|83054034|FG002|Overall Study|Adverse Event|2|||
46836397|NCT00290706|83054035|FG003|Overall Study|Adverse Event|0|||
46836398|NCT00290706|83054032|FG000|Overall Study|Receive auto transplant or radiation|0|||
47062520|NCT02754141|83343333|FG012|Overall Study|Maximum clinical benefit|0|||
46836399|NCT00290706|83054033|FG001|Overall Study|Receive auto transplant or radiation|0|||
46836400|NCT00290706|83054034|FG002|Overall Study|Receive auto transplant or radiation|0|||
46943003|NCT02493868|83180143|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
46943004|NCT02493868|83180142|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
46943005|NCT02493868|83180143|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
46943006|NCT02493868|83180142|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
46943007|NCT02493868|83180143|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
46943008|NCT02493868|83180142|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
46943009|NCT02493868|83180143|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
46943010|NCT02493868|83180142|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
46943011|NCT02493868|83180143|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
46943012|NCT02493868|83180142|FG000|Induction Phase: DE Participants|Other|8|||
46943013|NCT02493868|83180143|FG001|Induction Phase: DE Participants|Other|0|||
46943014|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
46943015|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
46943016|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
46943017|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
46943018|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
46943019|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
46943020|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
46943021|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
46943022|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
46943023|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
46943024|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
46943025|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
46943026|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
46943027|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
46943028|NCT02493868|83180142|FG000|Optimization Phase: DE+TE Participants|Other|10|||
46943029|NCT02493868|83180143|FG001|Optimization Phase: DE+TE Participants|Other|2|||
46836401|NCT00290706|83054035|FG003|Overall Study|Receive auto transplant or radiation|1|||
46836402|NCT00290706|83054032|FG000|Overall Study|Physician Decision|0|||
46836403|NCT00290706|83054033|FG001|Overall Study|Physician Decision|0|||
46836404|NCT00290706|83054034|FG002|Overall Study|Physician Decision|0|||
46836405|NCT00290706|83054035|FG003|Overall Study|Physician Decision|1|||
46836406|NCT00303186|83054046|FG000|Overall Study|Other|52|||
46836407|NCT00294060|83054050|FG000|Overall Study|Death|225|||
46836408|NCT00294060|83054050|FG000|Overall Study|Other|59|||
46836409|NCT00294060|83054050|FG000|Overall Study|Lost to Follow-up|55|||
46836410|NCT00294060|83054050|FG000|Overall Study|Withdrawal by Subject|11|||
46836411|NCT00294060|83054050|FG000|Overall Study|Physician Decision|797|||
46836412|NCT00294060|83054050|FG000|Overall Study|Medical condition|3|||
46836413|NCT00294060|83054050|FG000|Overall Study|Device explanted/not replaced|23|||
46836414|NCT00303108|83054057|FG000|Overall Study|Adverse Event|5|||
46836415|NCT00303108|83054058|FG001|Overall Study|Adverse Event|6|||
46836416|NCT00303108|83054059|FG002|Overall Study|Adverse Event|7|||
46836417|NCT00303108|83054057|FG000|Overall Study|Patient Request|4|||
46836418|NCT00303108|83054058|FG001|Overall Study|Patient Request|2|||
46836419|NCT00303108|83054059|FG002|Overall Study|Patient Request|8|||
46836420|NCT00303108|83054057|FG000|Overall Study|Failed Entry|1|||
46836421|NCT00303108|83054058|FG001|Overall Study|Failed Entry|0|||
46836422|NCT00303108|83054059|FG002|Overall Study|Failed Entry|1|||
46836423|NCT00303108|83054057|FG000|Overall Study|ineligible|2|||
46836424|NCT00303108|83054058|FG001|Overall Study|ineligible|1|||
46836425|NCT00303108|83054059|FG002|Overall Study|ineligible|0|||
46836426|NCT00302952|83054068|FG000|Overall Study|Physician Decision|1|||
46836427|NCT00302952|83054069|FG001|Overall Study|Physician Decision|1|||
46836428|NCT00302952|83054068|FG000|Overall Study|Withdrawal by Subject|2|||
46836429|NCT00302952|83054069|FG001|Overall Study|Withdrawal by Subject|3|||
46836430|NCT00302952|83054068|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
46836431|NCT00302952|83054069|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
46836432|NCT00302718|83054079|FG000|Overall Study|Participant left the hospital|1|||
46943030|NCT02493868|83180142|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
46943031|NCT02493868|83180143|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
46836433|NCT00302718|83054080|FG001|Overall Study|Participant left the hospital|0|||
46943032|NCT02493868|83180142|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
46836434|NCT00302718|83054081|FG002|Overall Study|Participant left the hospital|0|||
46836435|NCT00302718|83054082|FG003|Overall Study|Participant left the hospital|1|||
46836436|NCT00302718|83054079|FG000|Overall Study|Withdrawal by Subject|0|||
46836437|NCT00302718|83054080|FG001|Overall Study|Withdrawal by Subject|1|||
46836438|NCT00302718|83054081|FG002|Overall Study|Withdrawal by Subject|0|||
46836439|NCT00302718|83054082|FG003|Overall Study|Withdrawal by Subject|0|||
46836440|NCT00302718|83054079|FG000|Overall Study|Participant left primary care setting|0|||
46836441|NCT00302718|83054080|FG001|Overall Study|Participant left primary care setting|0|||
46836442|NCT00302718|83054081|FG002|Overall Study|Participant left primary care setting|2|||
46836443|NCT00302718|83054082|FG003|Overall Study|Participant left primary care setting|1|||
46836444|NCT00302328|83054100|FG000|Overall Study|Physician Decision|0|||
46836445|NCT00302328|83054101|FG001|Overall Study|Physician Decision|1|||
46836446|NCT00302328|83054102|FG002|Overall Study|Physician Decision|0|||
46836447|NCT00301080|83054113|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
46836448|NCT00301080|83054114|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
46836449|NCT00301080|83054115|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
46836450|NCT00301080|83054116|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
46836451|NCT00301080|83054117|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
46836452|NCT00290238|83054128|FG000|Overall Study|Study terminated|27|||
46836453|NCT00290238|83054129|FG001|Overall Study|Study terminated|27|||
46836454|NCT00290238|83054128|FG000|Overall Study|Lost to Follow-up|0|||
46836455|NCT00290238|83054129|FG001|Overall Study|Lost to Follow-up|1|||
46836456|NCT00290238|83054128|FG000|Overall Study|Withdrawal by Subject|15|||
46836457|NCT00290238|83054129|FG001|Overall Study|Withdrawal by Subject|13|||
46836458|NCT00289848|83054137|FG000|Overall Study|Adverse Event|6|||
46836459|NCT00289848|83054138|FG001|Overall Study|Adverse Event|4|||
46836460|NCT00289848|83054137|FG000|Overall Study|Death|1|||
46836461|NCT00289848|83054138|FG001|Overall Study|Death|0|||
46836462|NCT00289848|83054137|FG000|Overall Study|Lack of Efficacy|20|||
46836463|NCT00289848|83054138|FG001|Overall Study|Lack of Efficacy|24|||
46836464|NCT00289848|83054137|FG000|Overall Study|Lost to Follow-up|3|||
46836465|NCT00289848|83054138|FG001|Overall Study|Lost to Follow-up|1|||
46836466|NCT00289848|83054137|FG000|Overall Study|Protocol Violation|5|||
46836467|NCT00289848|83054138|FG001|Overall Study|Protocol Violation|2|||
46836468|NCT00289848|83054137|FG000|Overall Study|Withdrawal by Subject|5|||
46836469|NCT00289848|83054138|FG001|Overall Study|Withdrawal by Subject|11|||
46836470|NCT00289848|83054137|FG000|Overall Study|Patient Moved|6|||
46836471|NCT00289848|83054138|FG001|Overall Study|Patient Moved|2|||
46836472|NCT00289848|83054137|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
46836473|NCT00289848|83054138|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
46836474|NCT00289770|83054144|FG000|Year 15|Withdrawal by Subject|1|||
46836475|NCT00289536|83054148|FG000|Period 3|Lost to Follow-up|0|||
46836476|NCT00289536|83054149|FG001|Period 3|Lost to Follow-up|0|||
46836477|NCT00289536|83054150|FG002|Period 3|Lost to Follow-up|1|||
46836478|NCT00289458|83054159|FG000|Overall Study|Death|1|||
46836479|NCT00289458|83054160|FG001|Overall Study|Death|0|||
46836480|NCT00289458|83054161|FG002|Overall Study|Death|0|||
46836481|NCT00289458|83054159|FG000|Overall Study|Physician Decision|3|||
46836482|NCT00289458|83054160|FG001|Overall Study|Physician Decision|4|||
46836483|NCT00289458|83054161|FG002|Overall Study|Physician Decision|2|||
46836484|NCT00289458|83054159|FG000|Overall Study|Withdrawal by Subject|2|||
46836485|NCT00289458|83054160|FG001|Overall Study|Withdrawal by Subject|2|||
46836486|NCT00289458|83054161|FG002|Overall Study|Withdrawal by Subject|4|||
46767909|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
46767910|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
46767911|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
46767912|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
46767913|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
46767914|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
46767915|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
46767916|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
46767917|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
46767918|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
46767919|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
46767920|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
46767921|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
46767922|NCT00849017|82986022|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
46767923|NCT00849017|82986023|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
46767924|NCT00849017|82986024|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
46836487|NCT00288912|83054172|FG000|Overall Study|Developed exclusion criterion|4|||
46836488|NCT00288912|83054173|FG001|Overall Study|Developed exclusion criterion|6|||
46836489|NCT00288912|83054174|FG002|Overall Study|Developed exclusion criterion|7|||
46836490|NCT00288912|83054172|FG000|Overall Study|Lost to Follow-up|9|||
46836491|NCT00288912|83054173|FG001|Overall Study|Lost to Follow-up|6|||
46943033|NCT02493868|83180143|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
46836492|NCT00288912|83054174|FG002|Overall Study|Lost to Follow-up|9|||
46836493|NCT00288912|83054172|FG000|Overall Study|Withdrawal by Subject|4|||
46836494|NCT00288912|83054173|FG001|Overall Study|Withdrawal by Subject|5|||
46836495|NCT00288912|83054174|FG002|Overall Study|Withdrawal by Subject|12|||
46836496|NCT00305864|83054186|FG000|Overall Study|Ineligible / No protocol treatment|0|||
46836497|NCT00305864|83054187|FG001|Overall Study|Ineligible / No protocol treatment|1|||
46836498|NCT00305864|83054188|FG002|Overall Study|Ineligible / No protocol treatment|1|||
46836499|NCT00305864|83054189|FG003|Overall Study|Ineligible / No protocol treatment|13|||
46836500|NCT00295880|83054199|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
46836501|NCT00295880|83054199|FG000|Overall Study|Unit randomization did not occur|1|||
46836502|NCT00319982|83054205|FG000|Overall Study|Withdrawal by Subject|1|||
46836503|NCT00319982|83054206|FG001|Overall Study|Withdrawal by Subject|0|||
46836504|NCT00319592|83054214|FG000|Overall Study|Protocol Violation|1|||
46836505|NCT00319592|83054215|FG001|Overall Study|Protocol Violation|0|||
46836506|NCT00319592|83054214|FG000|Overall Study|Physician Decision|0|||
46836507|NCT00319592|83054215|FG001|Overall Study|Physician Decision|1|||
46836508|NCT00295490|83054225|FG000|Overall Study|Protocol Violation|0|||
46836509|NCT00295490|83054226|FG001|Overall Study|Protocol Violation|0|||
46836510|NCT00295490|83054227|FG002|Overall Study|Protocol Violation|3|||
46836511|NCT00295490|83054228|FG003|Overall Study|Protocol Violation|3|||
46836512|NCT00295490|83054225|FG000|Overall Study|Withdrawal by Subject|0|||
46836513|NCT00295490|83054226|FG001|Overall Study|Withdrawal by Subject|2|||
46836514|NCT00295490|83054227|FG002|Overall Study|Withdrawal by Subject|0|||
46836515|NCT00295490|83054228|FG003|Overall Study|Withdrawal by Subject|1|||
46836516|NCT00295490|83054225|FG000|Overall Study|Lost to Follow-up|0|||
46836517|NCT00295490|83054226|FG001|Overall Study|Lost to Follow-up|0|||
46836518|NCT00295490|83054227|FG002|Overall Study|Lost to Follow-up|1|||
46836519|NCT00295490|83054228|FG003|Overall Study|Lost to Follow-up|0|||
46836520|NCT00295490|83054225|FG000|Overall Study|Adverse Event|1|||
46836521|NCT00295490|83054226|FG001|Overall Study|Adverse Event|0|||
46836522|NCT00295490|83054227|FG002|Overall Study|Adverse Event|0|||
46836523|NCT00295490|83054228|FG003|Overall Study|Adverse Event|0|||
46836524|NCT00295490|83054225|FG000|Overall Study|Other|0|||
46836525|NCT00295490|83054226|FG001|Overall Study|Other|2|||
46836526|NCT00295490|83054227|FG002|Overall Study|Other|0|||
46836527|NCT00295490|83054228|FG003|Overall Study|Other|1|||
46836528|NCT00305006|83054240|FG000|Overall Study|Withdrawal by Subject|1|||
46836529|NCT00305006|83054241|FG001|Overall Study|Withdrawal by Subject|0|||
46836530|NCT00305006|83054240|FG000|Overall Study|Failure to complete pretest|0|||
46836531|NCT00305006|83054241|FG001|Overall Study|Failure to complete pretest|1|||
46836532|NCT00319436|83054249|FG000|Overall Study|Withdrawal by Subject|6|||
46836533|NCT00319436|83054250|FG001|Overall Study|Withdrawal by Subject|7|||
46836534|NCT00319046|83054256|FG000|Overall Study|withdrawal of subject's consent|7|||
46836535|NCT00319046|83054256|FG000|Overall Study|administrative reason|1|||
46836536|NCT00303602|83054262|FG000|Overall Study|Adverse Event|2|||
46836537|NCT00303602|83054263|FG001|Overall Study|Adverse Event|2|||
46836538|NCT00303602|83054262|FG000|Overall Study|Withdrawal by Subject|5|||
46836539|NCT00303602|83054263|FG001|Overall Study|Withdrawal by Subject|6|||
46836540|NCT00303602|83054262|FG000|Overall Study|Lost to Follow-up|5|||
46836541|NCT00303602|83054263|FG001|Overall Study|Lost to Follow-up|2|||
46836542|NCT00303602|83054262|FG000|Overall Study|Protocol entry criteria not met|2|||
46836543|NCT00303602|83054263|FG001|Overall Study|Protocol entry criteria not met|2|||
46836544|NCT00303602|83054262|FG000|Overall Study|Physician Decision|2|||
46836545|NCT00303602|83054263|FG001|Overall Study|Physician Decision|1|||
46836546|NCT00303602|83054262|FG000|Overall Study|Noncompliance|2|||
46836547|NCT00303602|83054263|FG001|Overall Study|Noncompliance|2|||
46836548|NCT00303602|83054262|FG000|Overall Study|Protocol Violation|1|||
46836549|NCT00303602|83054263|FG001|Overall Study|Protocol Violation|0|||
46836550|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
46836551|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
46836552|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
46836553|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Death|1|||
46836554|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Death|3|||
46836555|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Death|1|||
46836556|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
46836557|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
47062521|NCT02754141|83343334|FG013|Overall Study|Maximum clinical benefit|0|||
46638155|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
46836558|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
46836559|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
46836560|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
46836561|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
46836562|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
46836563|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
46836564|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
46836565|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
46836566|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
46836567|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
46836568|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
46836569|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
46836570|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
46836571|NCT00299130|83054272|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
46836572|NCT00299130|83054273|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
46638156|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
46638157|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
46767925|NCT00842543|82986040|FG000|Overall Study|Withdrawal by Subject|2|||
46767926|NCT00842543|82986041|FG001|Overall Study|Withdrawal by Subject|0|||
46767927|NCT00842543|82986042|FG002|Overall Study|Withdrawal by Subject|3|||
46767928|NCT00842543|82986043|FG003|Overall Study|Withdrawal by Subject|4|||
46767929|NCT00785928|82986062|FG000|Treatment Phase|Adverse Event|1|||
46767930|NCT00785928|82986063|FG001|Treatment Phase|Adverse Event|1|||
46767931|NCT00785928|82986064|FG002|Treatment Phase|Adverse Event|2|||
46767932|NCT00785928|82986065|FG003|Treatment Phase|Adverse Event|0|||
46767933|NCT00785928|82986066|FG004|Treatment Phase|Adverse Event|0|||
46767934|NCT00785928|82986067|FG005|Treatment Phase|Adverse Event|0|||
46767935|NCT00785928|82986068|FG006|Treatment Phase|Adverse Event|2|||
46767936|NCT00785928|82986062|FG000|Treatment Phase|Inadequate Response|0|||
46767937|NCT00785928|82986063|FG001|Treatment Phase|Inadequate Response|1|||
46767938|NCT00785928|82986064|FG002|Treatment Phase|Inadequate Response|0|||
46767939|NCT00785928|82986065|FG003|Treatment Phase|Inadequate Response|0|||
46767940|NCT00785928|82986066|FG004|Treatment Phase|Inadequate Response|0|||
46767941|NCT00785928|82986067|FG005|Treatment Phase|Inadequate Response|0|||
46767942|NCT00785928|82986068|FG006|Treatment Phase|Inadequate Response|0|||
46767943|NCT00785928|82986062|FG000|Treatment Phase|Lack of Efficacy|0|||
46767944|NCT00785928|82986063|FG001|Treatment Phase|Lack of Efficacy|1|||
46767945|NCT00785928|82986064|FG002|Treatment Phase|Lack of Efficacy|1|||
46767946|NCT00785928|82986065|FG003|Treatment Phase|Lack of Efficacy|0|||
46767947|NCT00785928|82986066|FG004|Treatment Phase|Lack of Efficacy|0|||
46767948|NCT00785928|82986067|FG005|Treatment Phase|Lack of Efficacy|0|||
46767949|NCT00785928|82986068|FG006|Treatment Phase|Lack of Efficacy|0|||
46767950|NCT00785928|82986062|FG000|Treatment Phase|Physician Decision|0|||
46767951|NCT00785928|82986063|FG001|Treatment Phase|Physician Decision|0|||
46767952|NCT00785928|82986064|FG002|Treatment Phase|Physician Decision|0|||
46767953|NCT00785928|82986065|FG003|Treatment Phase|Physician Decision|0|||
46767954|NCT00785928|82986066|FG004|Treatment Phase|Physician Decision|1|||
46767955|NCT00785928|82986067|FG005|Treatment Phase|Physician Decision|0|||
46767956|NCT00785928|82986068|FG006|Treatment Phase|Physician Decision|0|||
46767957|NCT00785928|82986062|FG000|Treatment Phase|Sponsor Decision|1|||
46767958|NCT00785928|82986063|FG001|Treatment Phase|Sponsor Decision|0|||
46767959|NCT00785928|82986064|FG002|Treatment Phase|Sponsor Decision|0|||
46767960|NCT00785928|82986065|FG003|Treatment Phase|Sponsor Decision|0|||
46767961|NCT00785928|82986066|FG004|Treatment Phase|Sponsor Decision|0|||
46767962|NCT00785928|82986067|FG005|Treatment Phase|Sponsor Decision|0|||
46767963|NCT00785928|82986068|FG006|Treatment Phase|Sponsor Decision|1|||
46767964|NCT00785928|82986062|FG000|Treatment Phase|Withdrawal by Subject|1|||
46767965|NCT00785928|82986063|FG001|Treatment Phase|Withdrawal by Subject|2|||
46767966|NCT00785928|82986064|FG002|Treatment Phase|Withdrawal by Subject|0|||
46767967|NCT00785928|82986065|FG003|Treatment Phase|Withdrawal by Subject|0|||
46767968|NCT00785928|82986066|FG004|Treatment Phase|Withdrawal by Subject|1|||
46767969|NCT00785928|82986067|FG005|Treatment Phase|Withdrawal by Subject|0|||
46767970|NCT00785928|82986068|FG006|Treatment Phase|Withdrawal by Subject|0|||
46767971|NCT00842309|82986108|FG000|Overall Study|Withdrawal by Subject|3|||
46767972|NCT00842309|82986109|FG001|Overall Study|Withdrawal by Subject|1|||
46767973|NCT00842153|82986117|FG000|Overall Study|Adverse Event|0|||
46836573|NCT00299130|83054274|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
46836574|NCT00299130|83054272|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
46836575|NCT00299130|83054273|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
46638158|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
46767974|NCT00842153|82986118|FG001|Overall Study|Adverse Event|1|||
46767975|NCT00842153|82986117|FG000|Overall Study|Lost to Follow-up|1|||
46767976|NCT00842153|82986118|FG001|Overall Study|Lost to Follow-up|2|||
46767977|NCT00762411|82986126|FG000|Initial Treatment|Death|7|||
46767978|NCT00762411|82986127|FG001|Initial Treatment|Death|6|||
46767979|NCT00762411|82986126|FG000|Initial Treatment|Adverse Event|132|||
46767980|NCT00762411|82986127|FG001|Initial Treatment|Adverse Event|40|||
46836576|NCT00299130|83054274|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
46767981|NCT00762411|82986126|FG000|Initial Treatment|Protocol Violation|4|||
46767982|NCT00762411|82986127|FG001|Initial Treatment|Protocol Violation|1|||
46767983|NCT00762411|82986126|FG000|Initial Treatment|Withdrawal by Subject|65|||
46767984|NCT00762411|82986127|FG001|Initial Treatment|Withdrawal by Subject|52|||
46836577|NCT00299130|83054272|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
46836578|NCT00299130|83054273|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
46836579|NCT00299130|83054274|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
46836580|NCT00299130|83054272|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
46836581|NCT00299130|83054273|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
46836582|NCT00299130|83054274|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
46836583|NCT00299130|83054272|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
46836584|NCT00299130|83054273|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
46836585|NCT00299130|83054274|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
46836586|NCT00299130|83054272|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
46836587|NCT00299130|83054273|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
46836588|NCT00299130|83054274|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
46836589|NCT00299130|83054272|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
46836590|NCT00299130|83054273|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
46836591|NCT00299130|83054274|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
46836592|NCT00299130|83054272|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
46836593|NCT00299130|83054273|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
46836594|NCT00299130|83054274|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
46836595|NCT00299130|83054272|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
46836596|NCT00299130|83054273|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
46836597|NCT00299130|83054274|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
46836598|NCT00299130|83054272|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
46836599|NCT00299130|83054273|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
46836600|NCT00299130|83054274|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
46836601|NCT00288054|83054289|FG000|Overall Study|Protocol Violation|2|||
46836602|NCT00288054|83054289|FG000|Overall Study|Lack of Efficacy|16|||
46836603|NCT00288054|83054289|FG000|Overall Study|Adverse Event|3|||
46836604|NCT00288054|83054289|FG000|Overall Study|Withdrawal by Subject|1|||
46836605|NCT00288054|83054289|FG000|Overall Study|Not protocol specified|2|||
46836606|NCT00287586|83054297|FG000|Overall Study|Withdrew Consent|19|||
46836607|NCT00287586|83054298|FG001|Overall Study|Withdrew Consent|30|||
46836608|NCT00287586|83054297|FG000|Overall Study|Lost to Follow-up|5|||
46836609|NCT00287586|83054298|FG001|Overall Study|Lost to Follow-up|4|||
46836610|NCT00287586|83054297|FG000|Overall Study|Death|2|||
46836611|NCT00287586|83054298|FG001|Overall Study|Death|3|||
46836612|NCT00287586|83054297|FG000|Overall Study|Elevated Hematocrit|3|||
46836613|NCT00287586|83054298|FG001|Overall Study|Elevated Hematocrit|0|||
46836614|NCT00287586|83054297|FG000|Overall Study|Rash|3|||
46836615|NCT00287586|83054298|FG001|Overall Study|Rash|0|||
46836616|NCT00287586|83054297|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
46836617|NCT00287586|83054298|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
46836618|NCT00287586|83054297|FG000|Overall Study|Stroke|2|||
46836619|NCT00287586|83054298|FG001|Overall Study|Stroke|0|||
46836620|NCT00287586|83054297|FG000|Overall Study|Myocardial Infarction|1|||
46836621|NCT00287586|83054298|FG001|Overall Study|Myocardial Infarction|0|||
46836622|NCT00287586|83054297|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
46836623|NCT00287586|83054298|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
46943034|NCT02493868|83180142|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
46943035|NCT02493868|83180143|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
46943036|NCT02493868|83180142|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
46943037|NCT02493868|83180143|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
46943038|NCT02493868|83180142|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
46943039|NCT02493868|83180143|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
46943040|NCT02493868|83180142|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
46943041|NCT02493868|83180143|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
46943042|NCT02493868|83180142|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
46943043|NCT02493868|83180143|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
46943044|NCT02493868|83180142|FG000|Follow-up Phase|Lost to Follow-up|1|||
46943045|NCT02493868|83180143|FG001|Follow-up Phase|Lost to Follow-up|0|||
46943046|NCT02493868|83180142|FG000|Follow-up Phase|Withdrawal by Subject|3|||
46943047|NCT02493868|83180143|FG001|Follow-up Phase|Withdrawal by Subject|0|||
46638159|NCT01473420|82811535|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
46836624|NCT00287586|83054297|FG000|Overall Study|Cognitive Impairment|1|||
46836625|NCT00287586|83054298|FG001|Overall Study|Cognitive Impairment|0|||
46836626|NCT00287586|83054297|FG000|Overall Study|Pancreatic Cancer|1|||
46836627|NCT00287586|83054298|FG001|Overall Study|Pancreatic Cancer|3|||
46836628|NCT00287586|83054297|FG000|Overall Study|Sleep Apnea|1|||
46836629|NCT00287586|83054298|FG001|Overall Study|Sleep Apnea|0|||
46836630|NCT00287586|83054297|FG000|Overall Study|Shoulder Pain|1|||
46836631|NCT00287586|83054298|FG001|Overall Study|Shoulder Pain|0|||
46943048|NCT02493868|83180142|FG000|Follow-up Phase|Investigator Decision|5|||
46943049|NCT02493868|83180143|FG001|Follow-up Phase|Investigator Decision|1|||
46836632|NCT00287586|83054297|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
46836633|NCT00287586|83054298|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
46836634|NCT00287586|83054297|FG000|Overall Study|Nonadherence|1|||
46836635|NCT00287586|83054298|FG001|Overall Study|Nonadherence|1|||
46943050|NCT02493868|83180142|FG000|Follow-up Phase|Other|2|||
46943051|NCT02493868|83180143|FG001|Follow-up Phase|Other|1|||
46943052|NCT02516410|83180157|FG000|Overall Study|Adverse Event|0|||
46767985|NCT00762411|82986126|FG000|Initial Treatment|Physician Decision|1|||
46767986|NCT00762411|82986127|FG001|Initial Treatment|Physician Decision|0|||
46767987|NCT00762411|82986126|FG000|Initial Treatment|Sponsor Decision|293|||
46767988|NCT00762411|82986127|FG001|Initial Treatment|Sponsor Decision|401|||
46767989|NCT00762411|82986126|FG000|Initial Treatment|Lost to Follow-up|5|||
46767990|NCT00762411|82986127|FG001|Initial Treatment|Lost to Follow-up|0|||
46767991|NCT00762411|82986126|FG000|Initial Treatment|Caregiver Decision|21|||
46767992|NCT00762411|82986127|FG001|Initial Treatment|Caregiver Decision|16|||
46767993|NCT00762411|82986126|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
46767994|NCT00762411|82986127|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
46767995|NCT00762411|82986126|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
46767996|NCT00762411|82986127|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
46767997|NCT00762411|82986126|FG000|Delayed Start|Adverse Event|0|||
46767998|NCT00762411|82986127|FG001|Delayed Start|Adverse Event|4|||
46767999|NCT00762411|82986126|FG000|Delayed Start|Protocol Violation|0|||
46768000|NCT00762411|82986127|FG001|Delayed Start|Protocol Violation|1|||
46768001|NCT00762411|82986126|FG000|Delayed Start|Sponsor Decision|16|||
46768002|NCT00762411|82986127|FG001|Delayed Start|Sponsor Decision|20|||
46768003|NCT00762411|82986126|FG000|Delayed Start|Caregiver Decision|1|||
46768004|NCT00762411|82986127|FG001|Delayed Start|Caregiver Decision|1|||
46768005|NCT00762411|82986126|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
46768006|NCT00762411|82986127|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
46768007|NCT00762411|82986126|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
46768008|NCT00762411|82986127|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
46768009|NCT00762411|82986126|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
46768010|NCT00762411|82986127|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
46768011|NCT00762411|82986126|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
46768012|NCT00762411|82986127|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
46768013|NCT00762411|82986126|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
46768014|NCT00762411|82986127|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
46768015|NCT00762411|82986126|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
46768016|NCT00762411|82986127|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
46768017|NCT00761865|82986139|FG000|Overall Study|Lost to Follow-up|8|||
46768018|NCT00761865|82986140|FG001|Overall Study|Lost to Follow-up|7|||
46768019|NCT00841763|82986148|FG000|Overall Study|Withdrawal by Subject|60|||
46768020|NCT00841763|82986149|FG001|Overall Study|Withdrawal by Subject|17|||
46768021|NCT00841763|82986150|FG002|Overall Study|Withdrawal by Subject|4|||
46768022|NCT00841763|82986151|FG003|Overall Study|Withdrawal by Subject|1|||
46768023|NCT00841763|82986148|FG000|Overall Study|Adverse Event|9|||
46768024|NCT00841763|82986149|FG001|Overall Study|Adverse Event|10|||
46768025|NCT00841763|82986150|FG002|Overall Study|Adverse Event|3|||
46768026|NCT00841763|82986151|FG003|Overall Study|Adverse Event|2|||
46768027|NCT00841763|82986148|FG000|Overall Study|Lost to Follow-up|63|||
46768028|NCT00841763|82986149|FG001|Overall Study|Lost to Follow-up|25|||
46768029|NCT00841763|82986150|FG002|Overall Study|Lost to Follow-up|0|||
46768030|NCT00841763|82986151|FG003|Overall Study|Lost to Follow-up|0|||
46768031|NCT00841763|82986148|FG000|Overall Study|Protocol Violation|20|||
46768032|NCT00841763|82986149|FG001|Overall Study|Protocol Violation|3|||
46768033|NCT00841763|82986150|FG002|Overall Study|Protocol Violation|1|||
46768034|NCT00841763|82986151|FG003|Overall Study|Protocol Violation|0|||
46768035|NCT00841763|82986148|FG000|Overall Study|Administrative Reasons|3|||
46768036|NCT00841763|82986149|FG001|Overall Study|Administrative Reasons|1|||
46768037|NCT00841763|82986150|FG002|Overall Study|Administrative Reasons|0|||
46768038|NCT00841763|82986151|FG003|Overall Study|Administrative Reasons|0|||
46768039|NCT00841763|82986148|FG000|Overall Study|Unable to Classify|7|||
46768040|NCT00841763|82986149|FG001|Overall Study|Unable to Classify|1|||
46768041|NCT00841763|82986150|FG002|Overall Study|Unable to Classify|0|||
46768042|NCT00841763|82986151|FG003|Overall Study|Unable to Classify|0|||
46768043|NCT00838331|82986196|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
46768044|NCT00785538|82986204|FG000|Treatment Period|Adverse Event|1|||
46768045|NCT00785538|82986205|FG001|Treatment Period|Adverse Event|2|||
46836636|NCT00287586|83054297|FG000|Overall Study|Enrolled in Another Study|1|||
46943053|NCT02516410|83180158|FG001|Overall Study|Adverse Event|1|||
46768046|NCT00785538|82986206|FG002|Treatment Period|Adverse Event|2|||
46768047|NCT00785538|82986207|FG003|Treatment Period|Adverse Event|0|||
46768048|NCT00785538|82986204|FG000|Treatment Period|Withdrawal by Subject|0|||
46768049|NCT00785538|82986205|FG001|Treatment Period|Withdrawal by Subject|0|||
46768050|NCT00785538|82986206|FG002|Treatment Period|Withdrawal by Subject|0|||
46768051|NCT00785538|82986207|FG003|Treatment Period|Withdrawal by Subject|1|||
46836637|NCT00287586|83054298|FG001|Overall Study|Enrolled in Another Study|0|||
46836638|NCT00287586|83054297|FG000|Overall Study|Major Depression|0|||
46836639|NCT00287586|83054298|FG001|Overall Study|Major Depression|2|||
46836640|NCT00287586|83054297|FG000|Overall Study|Lung Cancer|0|||
46836641|NCT00287586|83054298|FG001|Overall Study|Lung Cancer|2|||
46836642|NCT00287586|83054297|FG000|Overall Study|Elevated IPSS Score|0|||
46836643|NCT00287586|83054298|FG001|Overall Study|Elevated IPSS Score|1|||
46836644|NCT00287586|83054297|FG000|Overall Study|Retroperitoneal Cancer|0|||
46836645|NCT00287586|83054298|FG001|Overall Study|Retroperitoneal Cancer|1|||
46836646|NCT00287586|83054297|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
46836647|NCT00287586|83054298|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
46836648|NCT00287586|83054297|FG000|Overall Study|Mood Swings and Irritability|0|||
46836649|NCT00287586|83054298|FG001|Overall Study|Mood Swings and Irritability|1|||
46836650|NCT00287586|83054297|FG000|Overall Study|Bradycardia|0|||
46836651|NCT00287586|83054298|FG001|Overall Study|Bradycardia|1|||
46836652|NCT00287586|83054297|FG000|Overall Study|Itchy Swollen Eyes|0|||
46836653|NCT00287586|83054298|FG001|Overall Study|Itchy Swollen Eyes|1|||
46836654|NCT00287586|83054297|FG000|Overall Study|Recurrent Melanoma|0|||
46836655|NCT00287586|83054298|FG001|Overall Study|Recurrent Melanoma|1|||
46836656|NCT00287118|83054304|FG000|Overall Study|Adverse Event|30|||
46768052|NCT00860405|82986220|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
46836657|NCT00287118|83054304|FG000|Overall Study|Death|1|||
46836658|NCT00287118|83054304|FG000|Overall Study|Lack of Efficacy|11|||
46836659|NCT00287118|83054304|FG000|Overall Study|Lost to Follow-up|1|||
46836660|NCT00287118|83054304|FG000|Overall Study|Protocol Violation|2|||
46836661|NCT00287118|83054304|FG000|Overall Study|Other|7|||
46836662|NCT00293202|83054310|FG000|Overall Study|Withdrawal by Subject|1|||
46836663|NCT00293202|83054311|FG001|Overall Study|Withdrawal by Subject|2|||
46943054|NCT02516410|83180157|FG000|Overall Study|Withdrawal by Subject|0|||
46768053|NCT00860405|82986221|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
46768054|NCT00838097|82986227|FG000|Overall Study|Ineligibility determined|6|||
46768055|NCT00838097|82986227|FG000|Overall Study|Adverse Event|2|||
46943055|NCT02516410|83180158|FG001|Overall Study|Withdrawal by Subject|1|||
46943056|NCT02493712|83180168|FG000|Overall Study|Withdrawal by Subject|1|||
46768056|NCT00838097|82986227|FG000|Overall Study|Withdrawal by Subject|3|||
46768057|NCT00838097|82986227|FG000|Overall Study|Requirement for alternative therapy|2|||
46768058|NCT00838097|82986227|FG000|Overall Study|Physician Decision|4|||
46768059|NCT00838097|82986227|FG000|Overall Study|Lost to Follow-up|11|||
46768060|NCT00838097|82986227|FG000|Overall Study|Death|6|||
46768061|NCT00838097|82986227|FG000|Overall Study|Protocol-specified criteria|142|||
46768062|NCT00840827|82986231|FG000|Overall Study|Adverse Event|1|||
46768063|NCT00840827|82986231|FG000|Overall Study|Lack of Efficacy|4|||
46768064|NCT00840827|82986231|FG000|Overall Study|Physician Decision|1|||
46768065|NCT00860249|82986238|FG000|Overall Study|trial was terminated prior to completion|21|||
46768066|NCT00860249|82986239|FG001|Overall Study|trial was terminated prior to completion|18|||
46768067|NCT00860249|82986240|FG002|Overall Study|trial was terminated prior to completion|21|||
46768068|NCT00840749|82986250|FG000|Overall Study|Death|1|||
46768069|NCT00840749|82986251|FG001|Overall Study|Death|2|||
46836664|NCT00293202|83054310|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
46836665|NCT00293202|83054311|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
46836666|NCT00293202|83054310|FG000|Overall Study|on-hold due to fistula maturation time|1|||
46943057|NCT02493712|83180169|FG001|Overall Study|Withdrawal by Subject|0|||
46836667|NCT00293202|83054311|FG001|Overall Study|on-hold due to fistula maturation time|0|||
46836668|NCT00298896|83054321|FG000|Overall Study|Death|3|||
46836669|NCT00298896|83054321|FG000|Overall Study|Physician Decision|2|||
46836670|NCT00298896|83054321|FG000|Overall Study|Intercurrent Illness|1|||
46836671|NCT00298896|83054321|FG000|Overall Study|Disease Progression|41|||
46836672|NCT00298896|83054321|FG000|Overall Study|Withdrawal by Subject|2|||
46836673|NCT00298896|83054321|FG000|Overall Study|Assigned to treatment in error|1|||
46836674|NCT00286494|83054328|FG000|Overall Study|Hyperglycemic rescue|12|||
46836675|NCT00286494|83054329|FG001|Overall Study|Hyperglycemic rescue|19|||
46836676|NCT00286494|83054330|FG002|Overall Study|Hyperglycemic rescue|18|||
46836677|NCT00286494|83054328|FG000|Overall Study|Withdrawal by Subject|2|||
46836678|NCT00286494|83054329|FG001|Overall Study|Withdrawal by Subject|10|||
46836679|NCT00286494|83054330|FG002|Overall Study|Withdrawal by Subject|9|||
46836680|NCT00286494|83054328|FG000|Overall Study|Adverse Event|3|||
46836681|NCT00286494|83054329|FG001|Overall Study|Adverse Event|8|||
46836682|NCT00286494|83054330|FG002|Overall Study|Adverse Event|6|||
46836683|NCT00286494|83054328|FG000|Overall Study|Physician Decision|5|||
46836684|NCT00286494|83054329|FG001|Overall Study|Physician Decision|5|||
46836685|NCT00286494|83054330|FG002|Overall Study|Physician Decision|1|||
46836686|NCT00286494|83054328|FG000|Overall Study|Lost to Follow-up|3|||
46836687|NCT00286494|83054329|FG001|Overall Study|Lost to Follow-up|1|||
46836688|NCT00286494|83054330|FG002|Overall Study|Lost to Follow-up|3|||
46836689|NCT00286494|83054328|FG000|Overall Study|Protocol Violation|1|||
46836690|NCT00286494|83054329|FG001|Overall Study|Protocol Violation|1|||
46836691|NCT00286494|83054330|FG002|Overall Study|Protocol Violation|2|||
46836692|NCT00298740|83054338|FG000|Overall Study|Lack of Efficacy|6|||
46836693|NCT00298740|83054338|FG000|Overall Study|Withdrawal by Subject|3|||
46836694|NCT00285012|83054344|FG000|Assigned to Study Treatment (Tx)|Other|2|||
46836695|NCT00285012|83054345|FG001|Assigned to Study Treatment (Tx)|Other|3|||
46836696|NCT00285012|83054344|FG000|Received Study Tx|Death|2|||
46836697|NCT00285012|83054345|FG001|Received Study Tx|Death|1|||
46836698|NCT00285012|83054344|FG000|Received Study Tx|Adverse Event|5|||
46836699|NCT00285012|83054345|FG001|Received Study Tx|Adverse Event|11|||
46836700|NCT00285012|83054344|FG000|Received Study Tx|Lack of Efficacy|0|||
46836701|NCT00285012|83054345|FG001|Received Study Tx|Lack of Efficacy|3|||
46836702|NCT00285012|83054344|FG000|Received Study Tx|Lost to Follow-up|29|||
46836703|NCT00285012|83054345|FG001|Received Study Tx|Lost to Follow-up|31|||
46836704|NCT00285012|83054344|FG000|Received Study Tx|Withdrawal by Subject|31|||
46836705|NCT00285012|83054345|FG001|Received Study Tx|Withdrawal by Subject|43|||
46836706|NCT00285012|83054344|FG000|Received Study Tx|Other|5|||
46836707|NCT00285012|83054345|FG001|Received Study Tx|Other|5|||
46836708|NCT00284934|83054353|FG000|Overall Study|Adverse Event|1|||
46836709|NCT00284934|83054354|FG001|Overall Study|Adverse Event|2|||
46836710|NCT00284934|83054353|FG000|Overall Study|Other reasons|3|||
46836711|NCT00284934|83054354|FG001|Overall Study|Other reasons|1|||
46836712|NCT00284856|83054363|FG000|Overall Study|Adverse Event|3|||
46836713|NCT00284856|83054364|FG001|Overall Study|Adverse Event|3|||
46836714|NCT00284856|83054365|FG002|Overall Study|Adverse Event|3|||
46836715|NCT00284856|83054363|FG000|Overall Study|Lack of Efficacy|2|||
46836716|NCT00284856|83054364|FG001|Overall Study|Lack of Efficacy|1|||
46836717|NCT00284856|83054365|FG002|Overall Study|Lack of Efficacy|8|||
46836718|NCT00284856|83054363|FG000|Overall Study|Lost to Follow-up|25|||
46836719|NCT00284856|83054364|FG001|Overall Study|Lost to Follow-up|21|||
46943058|NCT02493712|83180170|FG002|Overall Study|Withdrawal by Subject|2|||
46943059|NCT02493712|83180168|FG000|Overall Study|Protocol Violation|0|||
46943060|NCT02493712|83180169|FG001|Overall Study|Protocol Violation|0|||
46943061|NCT02493712|83180170|FG002|Overall Study|Protocol Violation|1|||
46943062|NCT02493712|83180168|FG000|Overall Study|Lost to Follow-up|1|||
46943063|NCT02493712|83180169|FG001|Overall Study|Lost to Follow-up|0|||
46943064|NCT02493712|83180170|FG002|Overall Study|Lost to Follow-up|0|||
46943065|NCT02493712|83180168|FG000|Overall Study|Physician Decision|0|||
46943066|NCT02493712|83180169|FG001|Overall Study|Physician Decision|1|||
46943067|NCT02493712|83180170|FG002|Overall Study|Physician Decision|0|||
46943068|NCT02493712|83180168|FG000|Overall Study|Lack of Efficacy|0|||
46943069|NCT02493712|83180169|FG001|Overall Study|Lack of Efficacy|5|||
46943070|NCT02493712|83180170|FG002|Overall Study|Lack of Efficacy|3|||
46943071|NCT02516332|83180181|FG000|Overall Study|Withdrawal by Subject|2|||
47062522|NCT02754141|83343335|FG014|Overall Study|Maximum clinical benefit|0|||
46836720|NCT00284856|83054365|FG002|Overall Study|Lost to Follow-up|22|||
46836721|NCT00284856|83054363|FG000|Overall Study|Protocol Violation|5|||
46836722|NCT00284856|83054364|FG001|Overall Study|Protocol Violation|4|||
47062523|NCT02754141|83343336|FG015|Overall Study|Maximum clinical benefit|0|||
47062524|NCT02754141|83343337|FG016|Overall Study|Maximum clinical benefit|0|||
47062525|NCT02754141|83343338|FG017|Overall Study|Maximum clinical benefit|0|||
46836723|NCT00284856|83054365|FG002|Overall Study|Protocol Violation|5|||
46836724|NCT00284856|83054363|FG000|Overall Study|Withdrawal by Subject|12|||
46836725|NCT00284856|83054364|FG001|Overall Study|Withdrawal by Subject|16|||
46836726|NCT00284856|83054365|FG002|Overall Study|Withdrawal by Subject|18|||
46943072|NCT02516332|83180182|FG001|Overall Study|Withdrawal by Subject|1|||
46943073|NCT02516332|83180183|FG002|Overall Study|Withdrawal by Subject|2|||
46943074|NCT02483572|83180193|FG000|Overall Study|Withdrawal by Subject|1|||
46943075|NCT02483572|83180194|FG001|Overall Study|Withdrawal by Subject|0|||
46836727|NCT00284856|83054363|FG000|Overall Study|Other|4|||
46836728|NCT00284856|83054364|FG001|Overall Study|Other|5|||
46836729|NCT00284856|83054365|FG002|Overall Study|Other|4|||
46943076|NCT02483572|83180193|FG000|Overall Study|Lost to Follow-up|1|||
46836730|NCT00298272|83054375|FG000|Double-blind Phase|Adverse Event|2|||
46768070|NCT00840749|82986250|FG000|Overall Study|not treated on study arm|11|||
46836731|NCT00298272|83054376|FG001|Double-blind Phase|Adverse Event|0|||
46836732|NCT00298272|83054375|FG000|Double-blind Phase|Failure to Return|2|||
46836733|NCT00298272|83054376|FG001|Double-blind Phase|Failure to Return|0|||
46836734|NCT00298272|83054375|FG000|Double-blind Phase|Protocol Violation|2|||
46836735|NCT00298272|83054376|FG001|Double-blind Phase|Protocol Violation|0|||
46836736|NCT00298272|83054375|FG000|Double-blind Phase|Withdrawal by Subject|2|||
46836737|NCT00298272|83054376|FG001|Double-blind Phase|Withdrawal by Subject|0|||
46836738|NCT00298272|83054375|FG000|Open Label Retreatment Phase|Adverse Event|1|||
46943077|NCT02483572|83180194|FG001|Overall Study|Lost to Follow-up|0|||
46943078|NCT02483572|83180193|FG000|Overall Study|Physician Decision|0|||
46943079|NCT02483572|83180194|FG001|Overall Study|Physician Decision|1|||
46943080|NCT01062425|83180202|FG000|Overall Study|Protocol Violation|3|||
46943081|NCT01062425|83180203|FG001|Overall Study|Protocol Violation|6|||
46943082|NCT01060553|83180209|FG000|Overall Study|Lost to Follow-up|3|||
46943083|NCT01060553|83180210|FG001|Overall Study|Lost to Follow-up|5|||
46943084|NCT01060553|83180209|FG000|Overall Study|Withdrawal by Subject|5|||
46943085|NCT01060553|83180210|FG001|Overall Study|Withdrawal by Subject|5|||
46943086|NCT01060553|83180209|FG000|Overall Study|Lack of Efficacy|1|||
46943087|NCT01060553|83180210|FG001|Overall Study|Lack of Efficacy|0|||
46943088|NCT02491684|83180217|FG000|Treatment Phase|Adverse Event|2|||
46768071|NCT00840749|82986251|FG001|Overall Study|not treated on study arm|11|||
46768072|NCT00840749|82986250|FG000|Overall Study|study closed|19|||
46768073|NCT00840749|82986251|FG001|Overall Study|study closed|14|||
46836739|NCT00298272|83054376|FG001|Open Label Retreatment Phase|Adverse Event|2|||
46836740|NCT00298272|83054375|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
46836741|NCT00298272|83054376|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
46836742|NCT00298272|83054375|FG000|Open Label Retreatment Phase|Failure to Return|1|||
46836743|NCT00298272|83054376|FG001|Open Label Retreatment Phase|Failure to Return|0|||
46836744|NCT00298272|83054375|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
46836745|NCT00298272|83054376|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
46836746|NCT00298272|83054375|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
46836747|NCT00298272|83054376|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
46836748|NCT00298272|83054375|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
46836749|NCT00298272|83054376|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
46836750|NCT00298272|83054375|FG000|Safety Follow-up Phase|Failure to Return|1|||
46836751|NCT00298272|83054376|FG001|Safety Follow-up Phase|Failure to Return|1|||
46836752|NCT00298272|83054375|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
46836753|NCT00298272|83054376|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
46836754|NCT00298272|83054375|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
46836755|NCT00298272|83054376|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
46836756|NCT00283842|83054390|FG000|Overall Study|Adverse Event|8|||
46943089|NCT02491684|83180218|FG001|Treatment Phase|Adverse Event|2|||
46943090|NCT02491684|83180217|FG000|Treatment Phase|Incorrect randomisation|1|||
46943091|NCT02491684|83180218|FG001|Treatment Phase|Incorrect randomisation|0|||
46943092|NCT02491684|83180217|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
46768074|NCT00859937|82986259|FG000|Overall Study|Protocol Violation|1|||
46768075|NCT00859937|82986260|FG001|Overall Study|Protocol Violation|0|||
46768076|NCT00592007|82986266|FG000|Overall Study|Withdrawal by Subject|1|||
46768077|NCT00592007|82986266|FG000|Overall Study|patient ineligible (out of lab range)|1|||
46768078|NCT00837473|82986270|FG000|Overall Study|Lost to Follow-up|1|||
46768079|NCT00837473|82986270|FG000|Overall Study|Withdrawal by Subject|2|||
46768080|NCT00839423|82986278|FG000|Overall Study|Adverse Event|4|||
46768081|NCT00839423|82986279|FG001|Overall Study|Adverse Event|3|||
46768082|NCT00839423|82986280|FG002|Overall Study|Adverse Event|7|||
46768083|NCT00839423|82986281|FG003|Overall Study|Adverse Event|16|||
46768084|NCT00839423|82986278|FG000|Overall Study|Lack of Efficacy|6|||
46768085|NCT00839423|82986279|FG001|Overall Study|Lack of Efficacy|6|||
46768086|NCT00839423|82986280|FG002|Overall Study|Lack of Efficacy|3|||
46768087|NCT00839423|82986281|FG003|Overall Study|Lack of Efficacy|2|||
46943093|NCT02491684|83180218|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
46768088|NCT00839423|82986278|FG000|Overall Study|Non-compliance|0|||
46768089|NCT00839423|82986279|FG001|Overall Study|Non-compliance|0|||
46768090|NCT00839423|82986280|FG002|Overall Study|Non-compliance|0|||
46836757|NCT00283842|83054391|FG001|Overall Study|Adverse Event|7|||
46836758|NCT00283842|83054392|FG002|Overall Study|Adverse Event|21|||
46836759|NCT00283842|83054393|FG003|Overall Study|Adverse Event|21|||
46836760|NCT00283842|83054394|FG004|Overall Study|Adverse Event|5|||
46836761|NCT00283842|83054390|FG000|Overall Study|Protocol Violation|1|||
46836762|NCT00283842|83054391|FG001|Overall Study|Protocol Violation|5|||
46836763|NCT00283842|83054392|FG002|Overall Study|Protocol Violation|4|||
46836764|NCT00283842|83054393|FG003|Overall Study|Protocol Violation|0|||
46943094|NCT01061723|83180230|FG000|Overall Study|Adverse Event|0|||
46943095|NCT01061723|83180231|FG001|Overall Study|Adverse Event|2|||
46943096|NCT01061723|83180232|FG002|Overall Study|Adverse Event|5|||
46836765|NCT00283842|83054394|FG004|Overall Study|Protocol Violation|0|||
46836766|NCT00283842|83054390|FG000|Overall Study|Protocol deviation|0|||
46836767|NCT00283842|83054391|FG001|Overall Study|Protocol deviation|0|||
46836768|NCT00283842|83054392|FG002|Overall Study|Protocol deviation|0|||
46836769|NCT00283842|83054393|FG003|Overall Study|Protocol deviation|0|||
46836770|NCT00283842|83054394|FG004|Overall Study|Protocol deviation|2|||
46836771|NCT00283842|83054390|FG000|Overall Study|Withdrawal by Subject|2|||
46836772|NCT00283842|83054391|FG001|Overall Study|Withdrawal by Subject|1|||
46943097|NCT01061723|83180233|FG003|Overall Study|Adverse Event|5|||
46943098|NCT01061723|83180234|FG004|Overall Study|Adverse Event|2|||
46943099|NCT01061723|83180235|FG005|Overall Study|Adverse Event|6|||
46943100|NCT01061723|83180230|FG000|Overall Study|Lack of Efficacy|2|||
46943101|NCT01061723|83180231|FG001|Overall Study|Lack of Efficacy|3|||
46943102|NCT01061723|83180232|FG002|Overall Study|Lack of Efficacy|4|||
46943103|NCT01061723|83180233|FG003|Overall Study|Lack of Efficacy|2|||
46943104|NCT01061723|83180234|FG004|Overall Study|Lack of Efficacy|1|||
46836773|NCT00283842|83054392|FG002|Overall Study|Withdrawal by Subject|1|||
46836774|NCT00283842|83054393|FG003|Overall Study|Withdrawal by Subject|5|||
46836775|NCT00283842|83054394|FG004|Overall Study|Withdrawal by Subject|4|||
46836776|NCT00283842|83054390|FG000|Overall Study|Lack of Efficacy|1|||
46836777|NCT00283842|83054391|FG001|Overall Study|Lack of Efficacy|3|||
46836778|NCT00283842|83054392|FG002|Overall Study|Lack of Efficacy|1|||
46836779|NCT00283842|83054393|FG003|Overall Study|Lack of Efficacy|0|||
46836780|NCT00283842|83054394|FG004|Overall Study|Lack of Efficacy|3|||
46836781|NCT00283842|83054390|FG000|Overall Study|Lost to Follow-up|0|||
46836782|NCT00283842|83054391|FG001|Overall Study|Lost to Follow-up|2|||
46836783|NCT00283842|83054392|FG002|Overall Study|Lost to Follow-up|4|||
46836784|NCT00283842|83054393|FG003|Overall Study|Lost to Follow-up|1|||
46836785|NCT00283842|83054394|FG004|Overall Study|Lost to Follow-up|1|||
46836786|NCT00298038|83054408|FG000|Overall Study|Lost to Follow-up|0|||
46836787|NCT00298038|83054409|FG001|Overall Study|Lost to Follow-up|1|||
46836788|NCT00298038|83054408|FG000|Overall Study|Liver Transplant|0|||
46836789|NCT00298038|83054409|FG001|Overall Study|Liver Transplant|1|||
46836790|NCT00298038|83054408|FG000|Overall Study|Protocol Violation|1|||
46836791|NCT00298038|83054409|FG001|Overall Study|Protocol Violation|3|||
46836792|NCT00298038|83054408|FG000|Overall Study|Death|6|||
46836793|NCT00298038|83054409|FG001|Overall Study|Death|3|||
46836794|NCT00298038|83054408|FG000|Overall Study|Withdrawal by Subject|6|||
46836795|NCT00298038|83054409|FG001|Overall Study|Withdrawal by Subject|9|||
46836796|NCT00298038|83054408|FG000|Overall Study|Adverse Event|8|||
46836797|NCT00298038|83054409|FG001|Overall Study|Adverse Event|7|||
46836798|NCT00298038|83054408|FG000|Overall Study|Breakthrough overt HE episode|28|||
46836799|NCT00298038|83054409|FG001|Overall Study|Breakthrough overt HE episode|69|||
46836800|NCT00298038|83054408|FG000|Overall Study|Noncompliance|1|||
46836801|NCT00298038|83054409|FG001|Overall Study|Noncompliance|0|||
46836802|NCT00298038|83054408|FG000|Overall Study|Cocaine Abuse|1|||
46836803|NCT00298038|83054409|FG001|Overall Study|Cocaine Abuse|0|||
46836804|NCT00298038|83054408|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
46836805|NCT00298038|83054409|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
46836806|NCT00283686|83054419|FG000|Overall Study|Death|1|||
46836807|NCT00283686|83054420|FG001|Overall Study|Death|1|||
46943105|NCT01061723|83180235|FG005|Overall Study|Lack of Efficacy|1|||
46943106|NCT01061723|83180230|FG000|Overall Study|Randomized but not treated|0|||
46943107|NCT01061723|83180231|FG001|Overall Study|Randomized but not treated|0|||
46943108|NCT01061723|83180232|FG002|Overall Study|Randomized but not treated|0|||
46943109|NCT01061723|83180233|FG003|Overall Study|Randomized but not treated|0|||
46836808|NCT00283686|83054421|FG002|Overall Study|Death|1|||
46836809|NCT00283686|83054422|FG003|Overall Study|Death|0|||
46836810|NCT00283686|83054419|FG000|Overall Study|Lost to Follow-up|21|||
46836811|NCT00283686|83054420|FG001|Overall Study|Lost to Follow-up|31|||
46836812|NCT00283686|83054421|FG002|Overall Study|Lost to Follow-up|26|||
46836813|NCT00283686|83054422|FG003|Overall Study|Lost to Follow-up|20|||
46836814|NCT00283686|83054419|FG000|Overall Study|Less than full participation|7|||
46836815|NCT00283686|83054420|FG001|Overall Study|Less than full participation|9|||
46836816|NCT00283686|83054421|FG002|Overall Study|Less than full participation|6|||
46836817|NCT00283686|83054422|FG003|Overall Study|Less than full participation|12|||
46836818|NCT00297882|83054434|FG000|Day 14|Lack of Efficacy|12|||
46836819|NCT00297882|83054435|FG001|Day 14|Lack of Efficacy|49|||
46836820|NCT00297882|83054434|FG000|Day 28|Lost to Follow-up|13|||
46836821|NCT00297882|83054435|FG001|Day 28|Lost to Follow-up|23|||
46836822|NCT00297882|83054434|FG000|Day 28|Lack of Efficacy|3|||
46943110|NCT01061723|83180234|FG004|Overall Study|Randomized but not treated|0|||
46836823|NCT00297882|83054435|FG001|Day 28|Lack of Efficacy|0|||
46836824|NCT00297648|83054443|FG000|Overall Study|Adverse Event|13|||
46836825|NCT00297648|83054443|FG000|Overall Study|Lack of Efficacy|18|||
46836826|NCT00297648|83054443|FG000|Overall Study|Lost to Follow-up|1|||
46836827|NCT00297648|83054443|FG000|Overall Study|Withdrawal by Subject|3|||
46836828|NCT00297648|83054443|FG000|Overall Study|Other: Incompliance|1|||
46836829|NCT00283296|83054447|FG000|Overall Study|in-home trial not completed|5|||
46836830|NCT00297492|83054455|FG000|Set Quit Date|Lost to Follow-up|7|||
46836831|NCT00297492|83054456|FG001|Set Quit Date|Lost to Follow-up|13|||
46836832|NCT00297492|83054457|FG002|Set Quit Date|Lost to Follow-up|5|||
46836833|NCT00297492|83054455|FG000|6 Month Follow-up|Lost to Follow-up|63|||
46836834|NCT00297492|83054456|FG001|6 Month Follow-up|Lost to Follow-up|49|||
46836835|NCT00297492|83054457|FG002|6 Month Follow-up|Lost to Follow-up|27|||
46836836|NCT00297258|83054465|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
46836837|NCT00297258|83054465|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
46836838|NCT00297258|83054465|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
46836839|NCT00297258|83054465|FG000|Overall Study|Intercurrent Illness|3|||
46836840|NCT00297258|83054465|FG000|Overall Study|Intercurrent Death|2|||
46836841|NCT00297258|83054465|FG000|Overall Study|Deteriorization of General Condition|1|||
46836842|NCT00297258|83054465|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
46836843|NCT00297258|83054465|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
46836844|NCT00297258|83054465|FG000|Overall Study|Switch to Commercial Treatment|1|||
46836845|NCT00297258|83054465|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
46836846|NCT00496769|83054474|FG000|Double Blind|>=1 reason assigned per patient|558|||
46836847|NCT00496769|83054475|FG001|Double Blind|>=1 reason assigned per patient|649|||
46836848|NCT00496769|83054476|FG002|Double Blind|>=1 reason assigned per patient|0|||
46836849|NCT00496769|83054474|FG000|Open Label|>=1 reason assigned per patient|0|||
46836850|NCT00496769|83054475|FG001|Open Label|>=1 reason assigned per patient|0|||
46836851|NCT00496769|83054476|FG002|Open Label|>=1 reason assigned per patient|1011|||
46836852|NCT00478673|83054485|FG000|30-Days Post-Procedure|Death|2|||
47062526|NCT02754141|83343321|FG000|Overall Study|No longer meets study criteria|0|||
47062527|NCT02754141|83343322|FG001|Overall Study|No longer meets study criteria|0|||
47062528|NCT02754141|83343323|FG002|Overall Study|No longer meets study criteria|0|||
47062529|NCT02754141|83343324|FG003|Overall Study|No longer meets study criteria|1|||
47062530|NCT02754141|83343325|FG004|Overall Study|No longer meets study criteria|0|||
46836853|NCT00478673|83054485|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
46836854|NCT00478673|83054485|FG000|30-Days Post-Procedure|Missed Visit|7|||
46836855|NCT00478673|83054485|FG000|12-Months Post-Procedure|Death|23|||
46836856|NCT00478673|83054485|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
46836857|NCT00478673|83054485|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
46836858|NCT00478673|83054485|FG000|12-Months Post-Procedure|Missed Visit|25|||
46836859|NCT00478673|83054485|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
46836860|NCT00488345|83054492|FG000|Overall Study|Adverse Event|0|||
46836861|NCT00488345|83054493|FG001|Overall Study|Adverse Event|1|||
46836862|NCT00488345|83054494|FG002|Overall Study|Adverse Event|1|||
46836863|NCT00488345|83054492|FG000|Overall Study|Unable to administer antibiotics at home|0|||
46836864|NCT00488345|83054493|FG001|Overall Study|Unable to administer antibiotics at home|1|||
46836865|NCT00488345|83054494|FG002|Overall Study|Unable to administer antibiotics at home|0|||
46836866|NCT00488345|83054492|FG000|Overall Study|Institutional Review Board review|0|||
46836867|NCT00488345|83054493|FG001|Overall Study|Institutional Review Board review|0|||
46836868|NCT00488345|83054494|FG002|Overall Study|Institutional Review Board review|1|||
46836869|NCT00488345|83054492|FG000|Overall Study|Surgical team recommendation|0|||
46836870|NCT00488345|83054493|FG001|Overall Study|Surgical team recommendation|1|||
46836871|NCT00488345|83054494|FG002|Overall Study|Surgical team recommendation|0|||
46836872|NCT00488345|83054492|FG000|Overall Study|Parent/legal guardian request|0|||
46836873|NCT00488345|83054493|FG001|Overall Study|Parent/legal guardian request|1|||
46836874|NCT00488345|83054494|FG002|Overall Study|Parent/legal guardian request|1|||
46943111|NCT01061723|83180235|FG005|Overall Study|Randomized but not treated|1|||
46943112|NCT01061723|83180230|FG000|Overall Study|Other than specified above|2|||
46943113|NCT01061723|83180231|FG001|Overall Study|Other than specified above|1|||
46836875|NCT00283062|83054507|FG000|Overall Study|Did not receive any study medication|5|||
46836876|NCT00283062|83054508|FG001|Overall Study|Did not receive any study medication|4|||
46836877|NCT00283062|83054509|FG002|Overall Study|Did not receive any study medication|36|||
46836878|NCT00283062|83054510|FG003|Overall Study|Did not receive any study medication|45|||
46836879|NCT00283062|83054507|FG000|Overall Study|Adverse Event|2|||
46836880|NCT00283062|83054508|FG001|Overall Study|Adverse Event|0|||
46836881|NCT00283062|83054509|FG002|Overall Study|Adverse Event|1|||
46836882|NCT00283062|83054510|FG003|Overall Study|Adverse Event|0|||
46836883|NCT00283062|83054507|FG000|Overall Study|Lost to Follow-up|1|||
46836884|NCT00283062|83054508|FG001|Overall Study|Lost to Follow-up|0|||
46836885|NCT00283062|83054509|FG002|Overall Study|Lost to Follow-up|1|||
46836886|NCT00283062|83054510|FG003|Overall Study|Lost to Follow-up|0|||
46836887|NCT00283062|83054507|FG000|Overall Study|Progressive disease|0|||
47062531|NCT02754141|83343326|FG005|Overall Study|No longer meets study criteria|0|||
46836888|NCT00283062|83054508|FG001|Overall Study|Progressive disease|0|||
46943114|NCT01061723|83180232|FG002|Overall Study|Other than specified above|1|||
47062532|NCT02754141|83343327|FG006|Overall Study|No longer meets study criteria|0|||
46836889|NCT00283062|83054509|FG002|Overall Study|Progressive disease|1|||
46836890|NCT00283062|83054510|FG003|Overall Study|Progressive disease|0|||
46836891|NCT00283062|83054507|FG000|Overall Study|Participant did not wish to continue|3|||
46836892|NCT00283062|83054508|FG001|Overall Study|Participant did not wish to continue|2|||
46836893|NCT00283062|83054509|FG002|Overall Study|Participant did not wish to continue|1|||
46836894|NCT00283062|83054510|FG003|Overall Study|Participant did not wish to continue|0|||
46943115|NCT01061723|83180233|FG003|Overall Study|Other than specified above|1|||
46836895|NCT00283062|83054507|FG000|Overall Study|Undefined|0|||
46836896|NCT00283062|83054508|FG001|Overall Study|Undefined|1|||
46836897|NCT00283062|83054509|FG002|Overall Study|Undefined|1|||
46836898|NCT00283062|83054510|FG003|Overall Study|Undefined|4|||
46836899|NCT00283062|83054507|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
46836900|NCT00283062|83054508|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
47062533|NCT02754141|83343328|FG007|Overall Study|No longer meets study criteria|0|||
47062534|NCT02754141|83343329|FG008|Overall Study|No longer meets study criteria|0|||
46768091|NCT00839423|82986281|FG003|Overall Study|Non-compliance|1|||
46768092|NCT00839423|82986278|FG000|Overall Study|Protocol Violation|0|||
46836901|NCT00283062|83054509|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
46836902|NCT00283062|83054510|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
46836903|NCT00282984|83054522|FG000|Overall Study|Death|2|||
46836904|NCT00282984|83054523|FG001|Overall Study|Death|5|||
46836905|NCT00282984|83054522|FG000|Overall Study|Adverse Event|8|||
46836906|NCT00282984|83054523|FG001|Overall Study|Adverse Event|5|||
46836907|NCT00282984|83054522|FG000|Overall Study|Lack of Efficacy|0|||
46836908|NCT00282984|83054523|FG001|Overall Study|Lack of Efficacy|2|||
46836909|NCT00282984|83054522|FG000|Overall Study|Lost to Follow-up|14|||
46836910|NCT00282984|83054523|FG001|Overall Study|Lost to Follow-up|10|||
46836911|NCT00282984|83054522|FG000|Overall Study|Withdrawal by Participant|22|||
46836912|NCT00282984|83054523|FG001|Overall Study|Withdrawal by Participant|34|||
46836913|NCT00282984|83054522|FG000|Overall Study|Participant stopped study medication|2|||
46836914|NCT00282984|83054523|FG001|Overall Study|Participant stopped study medication|2|||
46836915|NCT00282984|83054522|FG000|Overall Study|Participant only allowed phone follow-up|0|||
46836916|NCT00282984|83054523|FG001|Overall Study|Participant only allowed phone follow-up|1|||
46836917|NCT00282984|83054522|FG000|Overall Study|Participant used antipsychosis meds|0|||
46836918|NCT00282984|83054523|FG001|Overall Study|Participant used antipsychosis meds|1|||
46836919|NCT00282984|83054522|FG000|Overall Study|lack of motivation|1|||
46836920|NCT00282984|83054523|FG001|Overall Study|lack of motivation|0|||
46836921|NCT00282984|83054522|FG000|Overall Study|in prison|0|||
46836922|NCT00282984|83054523|FG001|Overall Study|in prison|1|||
46836923|NCT00282984|83054522|FG000|Overall Study|Protocol Violation|2|||
46836924|NCT00282984|83054523|FG001|Overall Study|Protocol Violation|0|||
46836925|NCT00282438|83054531|FG000|Overall Study|Lack of Efficacy|1|||
46836926|NCT00282438|83054532|FG001|Overall Study|Lack of Efficacy|0|||
46836927|NCT00282438|83054531|FG000|Overall Study|Death|0|||
46836928|NCT00282438|83054532|FG001|Overall Study|Death|1|||
46836929|NCT00296400|83054541|FG000|Overall Study|Adverse Event|7|||
46836930|NCT00296400|83054542|FG001|Overall Study|Adverse Event|7|||
46836931|NCT00296400|83054543|FG002|Overall Study|Adverse Event|7|||
46836932|NCT00296400|83054541|FG000|Overall Study|Withdrawal by Subject|5|||
46768093|NCT00839423|82986279|FG001|Overall Study|Protocol Violation|1|||
46768094|NCT00839423|82986280|FG002|Overall Study|Protocol Violation|2|||
46768095|NCT00839423|82986281|FG003|Overall Study|Protocol Violation|0|||
46768096|NCT00839423|82986278|FG000|Overall Study|Withdrawal of consent|4|||
46768097|NCT00839423|82986279|FG001|Overall Study|Withdrawal of consent|0|||
46768098|NCT00839423|82986280|FG002|Overall Study|Withdrawal of consent|4|||
46768099|NCT00839423|82986281|FG003|Overall Study|Withdrawal of consent|1|||
46768100|NCT00839423|82986278|FG000|Overall Study|Lost to Follow-up|1|||
46768101|NCT00839423|82986279|FG001|Overall Study|Lost to Follow-up|0|||
46768102|NCT00839423|82986280|FG002|Overall Study|Lost to Follow-up|1|||
46768103|NCT00839423|82986281|FG003|Overall Study|Lost to Follow-up|0|||
46768104|NCT00839423|82986278|FG000|Overall Study|Administrative or other reasons|3|||
46768105|NCT00839423|82986279|FG001|Overall Study|Administrative or other reasons|0|||
46768106|NCT00839423|82986280|FG002|Overall Study|Administrative or other reasons|1|||
47062535|NCT02754141|83343330|FG009|Overall Study|No longer meets study criteria|0|||
47062536|NCT02754141|83343331|FG010|Overall Study|No longer meets study criteria|0|||
46768107|NCT00839423|82986281|FG003|Overall Study|Administrative or other reasons|0|||
46768108|NCT00837161|82986291|FG000|Overall Study|refused hysterectomy|2|||
46768109|NCT00859547|82986295|FG000|Overall Study|Lost to Follow-up|1|||
46768110|NCT00859547|82986295|FG000|Overall Study|Parent withdrew consent|1|||
46768111|NCT00859469|82986299|FG000|Overall Study|Adverse Event|2|||
46836933|NCT00296400|83054542|FG001|Overall Study|Withdrawal by Subject|6|||
46836934|NCT00296400|83054543|FG002|Overall Study|Withdrawal by Subject|2|||
46836935|NCT00296400|83054541|FG000|Overall Study|Incorrect enrollment|2|||
46836936|NCT00296400|83054542|FG001|Overall Study|Incorrect enrollment|0|||
46836937|NCT00296400|83054543|FG002|Overall Study|Incorrect enrollment|0|||
46836938|NCT00296400|83054541|FG000|Overall Study|Protocol Violation|1|||
46836939|NCT00296400|83054542|FG001|Overall Study|Protocol Violation|1|||
46836940|NCT00296400|83054543|FG002|Overall Study|Protocol Violation|1|||
46836941|NCT00296400|83054541|FG000|Overall Study|Lost to Follow-up|1|||
46836942|NCT00296400|83054542|FG001|Overall Study|Lost to Follow-up|1|||
46836943|NCT00296400|83054543|FG002|Overall Study|Lost to Follow-up|2|||
46836944|NCT00296400|83054541|FG000|Overall Study|Study specific discontinuation criteria|0|||
46836945|NCT00296400|83054542|FG001|Overall Study|Study specific discontinuation criteria|0|||
46836946|NCT00296400|83054543|FG002|Overall Study|Study specific discontinuation criteria|1|||
46836947|NCT00296400|83054541|FG000|Overall Study|Visit 10 was performed earlier|0|||
46836948|NCT00296400|83054542|FG001|Overall Study|Visit 10 was performed earlier|1|||
46836949|NCT00296400|83054543|FG002|Overall Study|Visit 10 was performed earlier|0|||
46836950|NCT00296400|83054541|FG000|Overall Study|Pregnancy|1|||
46836951|NCT00296400|83054542|FG001|Overall Study|Pregnancy|2|||
46836952|NCT00296400|83054543|FG002|Overall Study|Pregnancy|0|||
46836953|NCT00296244|83054556|FG000|Overall Study|Underwent retransplant|0|||
46836954|NCT00296244|83054557|FG001|Overall Study|Underwent retransplant|1|||
46836955|NCT00274716|83054574|FG000|Phase A|Other non-reported reason|4|||
46836956|NCT00274716|83054575|FG001|Phase A|Other non-reported reason|2|||
46836957|NCT00274716|83054576|FG002|Phase A|Other non-reported reason|1|||
46836958|NCT00274716|83054577|FG003|Phase A|Other non-reported reason|2|||
46836959|NCT00274716|83054578|FG004|Phase A|Other non-reported reason|0|||
46836960|NCT00274716|83054579|FG005|Phase A|Other non-reported reason|1|||
46836961|NCT00274716|83054574|FG000|Phase A|Participant moved|0|||
46836962|NCT00274716|83054575|FG001|Phase A|Participant moved|0|||
46836963|NCT00274716|83054576|FG002|Phase A|Participant moved|1|||
46836964|NCT00274716|83054577|FG003|Phase A|Participant moved|0|||
46836965|NCT00274716|83054578|FG004|Phase A|Participant moved|0|||
46836966|NCT00274716|83054579|FG005|Phase A|Participant moved|1|||
46836967|NCT00274716|83054574|FG000|Phase A|Site Terminated|0|||
46836968|NCT00274716|83054575|FG001|Phase A|Site Terminated|0|||
46836969|NCT00274716|83054576|FG002|Phase A|Site Terminated|0|||
46836970|NCT00274716|83054577|FG003|Phase A|Site Terminated|1|||
46836971|NCT00274716|83054578|FG004|Phase A|Site Terminated|0|||
46836972|NCT00274716|83054579|FG005|Phase A|Site Terminated|0|||
46836973|NCT00274716|83054574|FG000|Phase A|Protocol Violation|1|||
46836974|NCT00274716|83054575|FG001|Phase A|Protocol Violation|0|||
46836975|NCT00274716|83054576|FG002|Phase A|Protocol Violation|0|||
46836976|NCT00274716|83054577|FG003|Phase A|Protocol Violation|1|||
46836977|NCT00274716|83054578|FG004|Phase A|Protocol Violation|0|||
46836978|NCT00274716|83054579|FG005|Phase A|Protocol Violation|0|||
46836979|NCT00274716|83054574|FG000|Phase A|Met criteria for discontinuation|1|||
46836980|NCT00274716|83054575|FG001|Phase A|Met criteria for discontinuation|1|||
46836981|NCT00274716|83054576|FG002|Phase A|Met criteria for discontinuation|0|||
46836982|NCT00274716|83054577|FG003|Phase A|Met criteria for discontinuation|0|||
46836983|NCT00274716|83054578|FG004|Phase A|Met criteria for discontinuation|0|||
46836984|NCT00274716|83054579|FG005|Phase A|Met criteria for discontinuation|0|||
46836985|NCT00274716|83054574|FG000|Phase A|Withdrawal by Subject|2|||
46836986|NCT00274716|83054575|FG001|Phase A|Withdrawal by Subject|2|||
46836987|NCT00274716|83054576|FG002|Phase A|Withdrawal by Subject|1|||
46836988|NCT00274716|83054577|FG003|Phase A|Withdrawal by Subject|3|||
46836989|NCT00274716|83054578|FG004|Phase A|Withdrawal by Subject|0|||
46836990|NCT00274716|83054579|FG005|Phase A|Withdrawal by Subject|1|||
46836991|NCT00274716|83054574|FG000|Phase A|Adverse Event|2|||
46836992|NCT00274716|83054575|FG001|Phase A|Adverse Event|3|||
46836993|NCT00274716|83054576|FG002|Phase A|Adverse Event|3|||
46836994|NCT00274716|83054577|FG003|Phase A|Adverse Event|0|||
46836995|NCT00274716|83054578|FG004|Phase A|Adverse Event|2|||
46836996|NCT00274716|83054579|FG005|Phase A|Adverse Event|0|||
46836997|NCT00274716|83054574|FG000|Phase A|Completed but did not enter Phase B|1|||
46836998|NCT00274716|83054575|FG001|Phase A|Completed but did not enter Phase B|2|||
46836999|NCT00274716|83054576|FG002|Phase A|Completed but did not enter Phase B|2|||
46837000|NCT00274716|83054577|FG003|Phase A|Completed but did not enter Phase B|2|||
46837001|NCT00274716|83054578|FG004|Phase A|Completed but did not enter Phase B|1|||
46638160|NCT01473420|82811536|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
46837002|NCT00274716|83054579|FG005|Phase A|Completed but did not enter Phase B|1|||
46837003|NCT00274716|83054574|FG000|Phase B|Adverse Event|0|||
46943116|NCT01061723|83180234|FG004|Overall Study|Other than specified above|0|||
46943117|NCT01061723|83180235|FG005|Overall Study|Other than specified above|1|||
46943118|NCT01061567|83180254|FG000|Overall Study|Adverse Event|32|||
46943119|NCT01061567|83180254|FG000|Overall Study|Death|2|||
46638161|NCT01492686|82811550|FG000|Double-blind Phase|Adverse Event|0|||
46638162|NCT01492686|82811551|FG001|Double-blind Phase|Adverse Event|2|||
46837004|NCT00274716|83054575|FG001|Phase B|Adverse Event|0|||
46837005|NCT00274716|83054576|FG002|Phase B|Adverse Event|2|||
46837006|NCT00274716|83054577|FG003|Phase B|Adverse Event|0|||
46837007|NCT00274716|83054578|FG004|Phase B|Adverse Event|0|||
46837008|NCT00274716|83054579|FG005|Phase B|Adverse Event|1|||
46837009|NCT00274716|83054574|FG000|Phase B|Protocol Violation|0|||
46837010|NCT00274716|83054575|FG001|Phase B|Protocol Violation|2|||
46837011|NCT00274716|83054576|FG002|Phase B|Protocol Violation|0|||
46837012|NCT00274716|83054577|FG003|Phase B|Protocol Violation|0|||
46837013|NCT00274716|83054578|FG004|Phase B|Protocol Violation|0|||
46837014|NCT00274716|83054579|FG005|Phase B|Protocol Violation|0|||
46837015|NCT00274716|83054574|FG000|Phase B|Withdrawal by Subject|0|||
46837016|NCT00274716|83054575|FG001|Phase B|Withdrawal by Subject|1|||
46837017|NCT00274716|83054576|FG002|Phase B|Withdrawal by Subject|0|||
46837018|NCT00274716|83054577|FG003|Phase B|Withdrawal by Subject|0|||
46837019|NCT00274716|83054578|FG004|Phase B|Withdrawal by Subject|0|||
46837020|NCT00274716|83054579|FG005|Phase B|Withdrawal by Subject|0|||
46943120|NCT01061567|83180254|FG000|Overall Study|Lack of Efficacy|3|||
46943121|NCT01061567|83180254|FG000|Overall Study|Lost to Follow-up|24|||
46943122|NCT01061567|83180254|FG000|Overall Study|Protocol Violation|1|||
46943123|NCT01061567|83180254|FG000|Overall Study|Withdrawal by Subject|11|||
46943124|NCT01061567|83180254|FG000|Overall Study|Other reason than stated above|3|||
46943125|NCT01061333|83180258|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
46943126|NCT01061333|83180259|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
46943127|NCT02489968|83180272|FG000|Open-label Treatment Period|Adverse Event|14|||
46943128|NCT02489968|83180273|FG001|Open-label Treatment Period|Adverse Event|7|||
46943129|NCT02489968|83180274|FG002|Open-label Treatment Period|Adverse Event|0|||
46943130|NCT02489968|83180275|FG003|Open-label Treatment Period|Adverse Event|0|||
46943131|NCT02489968|83180276|FG004|Open-label Treatment Period|Adverse Event|0|||
46943132|NCT02489968|83180277|FG005|Open-label Treatment Period|Adverse Event|0|||
46943133|NCT02489968|83180272|FG000|Open-label Treatment Period|Protocol Violation|2|||
47062537|NCT02754141|83343332|FG011|Overall Study|No longer meets study criteria|0|||
47062538|NCT02754141|83343333|FG012|Overall Study|No longer meets study criteria|0|||
46768112|NCT00859469|82986299|FG000|Overall Study|Lack of Efficacy|9|||
46768113|NCT00859469|82986299|FG000|Overall Study|Withdrawal by Subject|1|||
46768114|NCT00859469|82986299|FG000|Overall Study|Death|16|||
46768115|NCT00859313|82986303|FG000|Overall Study|Lack of Efficacy|2|||
46768116|NCT00859313|82986303|FG000|Overall Study|Adverse Event|1|||
46768117|NCT00859313|82986303|FG000|Overall Study|staff error|1|||
46768118|NCT00771810|82986310|FG000|Overall Study|Adverse Event|3|||
46768119|NCT00771810|82986311|FG001|Overall Study|Adverse Event|0|||
46768120|NCT00771810|82986312|FG002|Overall Study|Adverse Event|2|||
46768121|NCT00771810|82986310|FG000|Overall Study|Lost to Follow-up|0|||
46768122|NCT00771810|82986311|FG001|Overall Study|Lost to Follow-up|0|||
46768123|NCT00771810|82986312|FG002|Overall Study|Lost to Follow-up|1|||
46768124|NCT00771810|82986310|FG000|Overall Study|Physician Decision|1|||
46768125|NCT00771810|82986311|FG001|Overall Study|Physician Decision|2|||
46768126|NCT00771810|82986312|FG002|Overall Study|Physician Decision|2|||
46768127|NCT00771810|82986310|FG000|Overall Study|Protocol Violation|0|||
46768128|NCT00771810|82986311|FG001|Overall Study|Protocol Violation|1|||
46768129|NCT00771810|82986312|FG002|Overall Study|Protocol Violation|1|||
46768130|NCT00771810|82986310|FG000|Overall Study|Withdrawal by Subject|1|||
46768131|NCT00771810|82986311|FG001|Overall Study|Withdrawal by Subject|2|||
46768132|NCT00771810|82986312|FG002|Overall Study|Withdrawal by Subject|0|||
46768133|NCT00771810|82986310|FG000|Overall Study|Other|0|||
46768134|NCT00771810|82986311|FG001|Overall Study|Other|0|||
46768135|NCT00771810|82986312|FG002|Overall Study|Other|1|||
46768136|NCT00836927|82986326|FG000|Overall Study|Progressive disease|2|||
46768137|NCT00836927|82986327|FG001|Overall Study|Progressive disease|0|||
46768138|NCT00836927|82986328|FG002|Overall Study|Progressive disease|0|||
46768139|NCT00836927|82986329|FG003|Overall Study|Progressive disease|1|||
46768140|NCT00836927|82986330|FG004|Overall Study|Progressive disease|1|||
46768141|NCT00836927|82986326|FG000|Overall Study|Withdrawal by Subject|1|||
46768142|NCT00836927|82986327|FG001|Overall Study|Withdrawal by Subject|0|||
46768143|NCT00836927|82986328|FG002|Overall Study|Withdrawal by Subject|0|||
46837021|NCT00274716|83054574|FG000|Phase B|Participant moved|1|||
46943134|NCT02489968|83180273|FG001|Open-label Treatment Period|Protocol Violation|2|||
47062539|NCT02754141|83343334|FG013|Overall Study|No longer meets study criteria|0|||
47062540|NCT02754141|83343335|FG014|Overall Study|No longer meets study criteria|0|||
47062541|NCT02754141|83343336|FG015|Overall Study|No longer meets study criteria|0|||
47062542|NCT02754141|83343337|FG016|Overall Study|No longer meets study criteria|0|||
47062543|NCT02754141|83343338|FG017|Overall Study|No longer meets study criteria|0|||
47062544|NCT02754141|83343321|FG000|Overall Study|Other reasons|0|||
47062545|NCT02754141|83343322|FG001|Overall Study|Other reasons|0|||
47062546|NCT02754141|83343323|FG002|Overall Study|Other reasons|0|||
47062547|NCT02754141|83343324|FG003|Overall Study|Other reasons|0|||
47062548|NCT02754141|83343325|FG004|Overall Study|Other reasons|0|||
47062549|NCT02754141|83343326|FG005|Overall Study|Other reasons|0|||
46943135|NCT02489968|83180274|FG002|Open-label Treatment Period|Protocol Violation|0|||
46943136|NCT02489968|83180275|FG003|Open-label Treatment Period|Protocol Violation|0|||
47062550|NCT02754141|83343327|FG006|Overall Study|Other reasons|0|||
47062551|NCT02754141|83343328|FG007|Overall Study|Other reasons|1|||
46768144|NCT00836927|82986329|FG003|Overall Study|Withdrawal by Subject|0|||
46768145|NCT00836927|82986330|FG004|Overall Study|Withdrawal by Subject|0|||
46768146|NCT00771030|82986351|FG000|Overall Study|Adverse Event|0|||
46837022|NCT00274716|83054575|FG001|Phase B|Participant moved|0|||
46943137|NCT02489968|83180276|FG004|Open-label Treatment Period|Protocol Violation|0|||
46837023|NCT00274716|83054576|FG002|Phase B|Participant moved|0|||
46837024|NCT00274716|83054577|FG003|Phase B|Participant moved|0|||
46943138|NCT02489968|83180277|FG005|Open-label Treatment Period|Protocol Violation|0|||
46943139|NCT02489968|83180272|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
46943140|NCT02489968|83180273|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
46943141|NCT02489968|83180274|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
46943142|NCT02489968|83180275|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
46943143|NCT02489968|83180276|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
46943144|NCT02489968|83180277|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
46943145|NCT02489968|83180272|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
46943146|NCT02489968|83180273|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
46943147|NCT02489968|83180274|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
47062552|NCT02754141|83343329|FG008|Overall Study|Other reasons|0|||
47062553|NCT02754141|83343330|FG009|Overall Study|Other reasons|0|||
47062554|NCT02754141|83343331|FG010|Overall Study|Other reasons|0|||
47062555|NCT02754141|83343332|FG011|Overall Study|Other reasons|0|||
47062556|NCT02754141|83343333|FG012|Overall Study|Other reasons|2|||
47062557|NCT02754141|83343334|FG013|Overall Study|Other reasons|0|||
47062558|NCT02754141|83343335|FG014|Overall Study|Other reasons|0|||
47062559|NCT02754141|83343336|FG015|Overall Study|Other reasons|0|||
47062560|NCT02754141|83343337|FG016|Overall Study|Other reasons|0|||
47062561|NCT02754141|83343338|FG017|Overall Study|Other reasons|0|||
47062562|NCT02754141|83343321|FG000|Overall Study|Completed treatment as per protocol|0|||
47062563|NCT02754141|83343322|FG001|Overall Study|Completed treatment as per protocol|1|||
47062564|NCT02754141|83343323|FG002|Overall Study|Completed treatment as per protocol|0|||
47062565|NCT02754141|83343324|FG003|Overall Study|Completed treatment as per protocol|0|||
47062566|NCT02754141|83343325|FG004|Overall Study|Completed treatment as per protocol|0|||
47062567|NCT02754141|83343326|FG005|Overall Study|Completed treatment as per protocol|0|||
47062568|NCT02754141|83343327|FG006|Overall Study|Completed treatment as per protocol|0|||
47062569|NCT02754141|83343328|FG007|Overall Study|Completed treatment as per protocol|0|||
47062570|NCT02754141|83343329|FG008|Overall Study|Completed treatment as per protocol|0|||
47062571|NCT02754141|83343330|FG009|Overall Study|Completed treatment as per protocol|0|||
47062572|NCT02754141|83343331|FG010|Overall Study|Completed treatment as per protocol|0|||
47062573|NCT02754141|83343332|FG011|Overall Study|Completed treatment as per protocol|0|||
47062574|NCT02754141|83343333|FG012|Overall Study|Completed treatment as per protocol|1|||
47062575|NCT02754141|83343334|FG013|Overall Study|Completed treatment as per protocol|0|||
47062576|NCT02754141|83343335|FG014|Overall Study|Completed treatment as per protocol|0|||
47062577|NCT02754141|83343336|FG015|Overall Study|Completed treatment as per protocol|0|||
47062578|NCT02754141|83343337|FG016|Overall Study|Completed treatment as per protocol|0|||
47062579|NCT02754141|83343338|FG017|Overall Study|Completed treatment as per protocol|0|||
47062580|NCT02754141|83343321|FG000|Overall Study|Not completing monotherapy|0|||
47062581|NCT02754141|83343322|FG001|Overall Study|Not completing monotherapy|0|||
47062582|NCT02754141|83343323|FG002|Overall Study|Not completing monotherapy|0|||
47062583|NCT02754141|83343324|FG003|Overall Study|Not completing monotherapy|0|||
47062584|NCT02754141|83343325|FG004|Overall Study|Not completing monotherapy|0|||
47062585|NCT02754141|83343326|FG005|Overall Study|Not completing monotherapy|0|||
47062586|NCT02754141|83343327|FG006|Overall Study|Not completing monotherapy|0|||
47062587|NCT02754141|83343328|FG007|Overall Study|Not completing monotherapy|0|||
47062588|NCT02754141|83343329|FG008|Overall Study|Not completing monotherapy|0|||
47062589|NCT02754141|83343330|FG009|Overall Study|Not completing monotherapy|0|||
47062590|NCT02754141|83343331|FG010|Overall Study|Not completing monotherapy|0|||
47062591|NCT02754141|83343332|FG011|Overall Study|Not completing monotherapy|0|||
47062592|NCT02754141|83343333|FG012|Overall Study|Not completing monotherapy|0|||
47062593|NCT02754141|83343334|FG013|Overall Study|Not completing monotherapy|1|||
46768147|NCT00771030|82986352|FG001|Overall Study|Adverse Event|1|||
46768148|NCT00771030|82986353|FG002|Overall Study|Adverse Event|0|||
46768149|NCT00771030|82986354|FG003|Overall Study|Adverse Event|0|||
46768150|NCT00771030|82986355|FG004|Overall Study|Adverse Event|0|||
46768151|NCT00771030|82986356|FG005|Overall Study|Adverse Event|0|||
46768152|NCT00771030|82986357|FG006|Overall Study|Adverse Event|0|||
46768153|NCT00768300|82986380|FG000|Overall Study|Randomized but not treated|1|||
46768154|NCT00768300|82986381|FG001|Overall Study|Randomized but not treated|1|||
46768155|NCT00768300|82986380|FG000|Overall Study|Adverse Event|10|||
46768156|NCT00768300|82986381|FG001|Overall Study|Adverse Event|2|||
46768157|NCT00768300|82986380|FG000|Overall Study|Protocol Violation|6|||
47062594|NCT02754141|83343335|FG014|Overall Study|Not completing monotherapy|0|||
47062595|NCT02754141|83343336|FG015|Overall Study|Not completing monotherapy|0|||
47062596|NCT02754141|83343337|FG016|Overall Study|Not completing monotherapy|0|||
47062597|NCT02754141|83343338|FG017|Overall Study|Not completing monotherapy|0|||
47062598|NCT02659059|83343417|FG000|Overall Study|Other reasons|6|||
47062599|NCT02659059|83343418|FG001|Overall Study|Other reasons|1|||
47062600|NCT02659059|83343417|FG000|Overall Study|Disease Progression|143|||
46768158|NCT00768300|82986381|FG001|Overall Study|Protocol Violation|1|||
46837025|NCT00274716|83054578|FG004|Phase B|Participant moved|0|||
46837026|NCT00274716|83054579|FG005|Phase B|Participant moved|0|||
46943148|NCT02489968|83180275|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
46943149|NCT02489968|83180276|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
46943150|NCT02489968|83180277|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
46943151|NCT02489968|83180272|FG000|Open-label Treatment Period|Other than specified above|204|||
46943152|NCT02489968|83180273|FG001|Open-label Treatment Period|Other than specified above|189|||
46943153|NCT02489968|83180274|FG002|Open-label Treatment Period|Other than specified above|0|||
46943154|NCT02489968|83180275|FG003|Open-label Treatment Period|Other than specified above|0|||
46943155|NCT02489968|83180276|FG004|Open-label Treatment Period|Other than specified above|0|||
46943156|NCT02489968|83180277|FG005|Open-label Treatment Period|Other than specified above|0|||
46943157|NCT02489968|83180272|FG000|Double-blind Treatment Period|Adverse Event|0|||
46943158|NCT02489968|83180273|FG001|Double-blind Treatment Period|Adverse Event|0|||
46943159|NCT02489968|83180274|FG002|Double-blind Treatment Period|Adverse Event|2|||
46943160|NCT02489968|83180275|FG003|Double-blind Treatment Period|Adverse Event|6|||
46943161|NCT02489968|83180276|FG004|Double-blind Treatment Period|Adverse Event|4|||
46943162|NCT02489968|83180277|FG005|Double-blind Treatment Period|Adverse Event|5|||
46943163|NCT02489968|83180272|FG000|Double-blind Treatment Period|Protocol Violation|0|||
46943164|NCT02489968|83180273|FG001|Double-blind Treatment Period|Protocol Violation|0|||
46943165|NCT02489968|83180274|FG002|Double-blind Treatment Period|Protocol Violation|0|||
46943166|NCT02489968|83180275|FG003|Double-blind Treatment Period|Protocol Violation|0|||
46943167|NCT02489968|83180276|FG004|Double-blind Treatment Period|Protocol Violation|1|||
46943168|NCT02489968|83180277|FG005|Double-blind Treatment Period|Protocol Violation|1|||
46943169|NCT02489968|83180272|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
46943170|NCT02489968|83180273|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
46943171|NCT02489968|83180274|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46943172|NCT02489968|83180275|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
46943173|NCT02489968|83180276|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
46943174|NCT02489968|83180277|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
46943175|NCT02489968|83180272|FG000|Double-blind Treatment Period|Other than specified above|0|||
46943176|NCT02489968|83180273|FG001|Double-blind Treatment Period|Other than specified above|0|||
46943177|NCT02489968|83180274|FG002|Double-blind Treatment Period|Other than specified above|0|||
46943178|NCT02489968|83180275|FG003|Double-blind Treatment Period|Other than specified above|0|||
46943179|NCT02489968|83180276|FG004|Double-blind Treatment Period|Other than specified above|1|||
46943180|NCT02489968|83180277|FG005|Double-blind Treatment Period|Other than specified above|0|||
46943181|NCT02483416|83180291|FG000|Overall Study|Other reason|0|||
46943182|NCT02483416|83180292|FG001|Overall Study|Other reason|1|||
46943183|NCT02483416|83180291|FG000|Overall Study|Treatment stop|3|||
46943184|NCT02483416|83180292|FG001|Overall Study|Treatment stop|0|||
46943185|NCT01061177|83180299|FG000|Overall Study|Adverse Event|117|||
46943186|NCT01061177|83180299|FG000|Overall Study|Withdrawal by Subject|27|||
46943187|NCT01061177|83180299|FG000|Overall Study|Disease progression|17|||
46943188|NCT01061177|83180299|FG000|Overall Study|Protocol Violation|11|||
46943189|NCT01061177|83180299|FG000|Overall Study|Lost to Follow-up|9|||
46943190|NCT01061177|83180299|FG000|Overall Study|New cancer therapy|9|||
46943191|NCT01061177|83180299|FG000|Overall Study|Abnormal laboratory values|6|||
46943192|NCT01061177|83180299|FG000|Overall Study|Abnormal test procedure results|4|||
46943193|NCT01061177|83180299|FG000|Overall Study|Administratie problems|4|||
46943194|NCT01061177|83180299|FG000|Overall Study|Death|4|||
46943195|NCT02481934|83180303|FG000|Overall Study|Death|2|||
46943196|NCT02973425|83180309|FG000|Overall Study|Lost to Follow-up|49|||
46943197|NCT02973425|83180310|FG001|Overall Study|Lost to Follow-up|53|||
46943198|NCT02489500|83180319|FG000|Overall Study|Death|1|||
46943199|NCT02489500|83180320|FG001|Overall Study|Death|1|||
46943200|NCT02732847|83180328|FG000|Overall Study|some filled early|42|||
46943201|NCT02732847|83180329|FG001|Overall Study|some filled early|42|||
46943202|NCT02489344|83180335|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
46943203|NCT02489344|83180335|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
46943204|NCT02489344|83180335|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
46943205|NCT02489344|83180335|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
46943206|NCT02488330|83180339|FG000|Overall Study|Adverse Event|1|||
46943207|NCT02488330|83180339|FG000|Overall Study|Physician Decision|2|||
46943208|NCT02488330|83180339|FG000|Overall Study|Death|2|||
46943209|NCT02488330|83180339|FG000|Overall Study|Disease Progression|3|||
46943210|NCT02488330|83180339|FG000|Overall Study|Study Termination by Sponsor|4|||
47062601|NCT02659059|83343418|FG001|Overall Study|Disease Progression|16|||
46943211|NCT02481310|83180346|FG000|Follow up|Still in follow up|0|||
47062602|NCT02659059|83343417|FG000|Overall Study|Study Drug toxicity|56|||
47062603|NCT02659059|83343418|FG001|Overall Study|Study Drug toxicity|9|||
47062604|NCT02659059|83343417|FG000|Overall Study|Death|3|||
47062605|NCT02659059|83343418|FG001|Overall Study|Death|1|||
47062606|NCT02659059|83343417|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
47062607|NCT02659059|83343418|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
46943212|NCT02481310|83180347|FG001|Follow up|Still in follow up|3|||
47062608|NCT02659059|83343417|FG000|Overall Study|Participant request to discontinue study treatment|5|||
46943213|NCT02481310|83180348|FG002|Follow up|Still in follow up|0|||
46943214|NCT02480764|83180355|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
46943215|NCT02480764|83180356|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
46943216|NCT02480764|83180357|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
46943217|NCT02480764|83180355|FG000|Overall Study|Major Protocol Deviation|1|||
46943218|NCT02480764|83180356|FG001|Overall Study|Major Protocol Deviation|4|||
46943219|NCT02480764|83180357|FG002|Overall Study|Major Protocol Deviation|3|||
46943220|NCT02480764|83180355|FG000|Overall Study|Lost to Follow-up|0|||
46943221|NCT02480764|83180356|FG001|Overall Study|Lost to Follow-up|1|||
46943222|NCT02480764|83180357|FG002|Overall Study|Lost to Follow-up|2|||
46943223|NCT02480764|83180355|FG000|Overall Study|Voluntary Withdrawal|6|||
46943224|NCT02480764|83180356|FG001|Overall Study|Voluntary Withdrawal|5|||
46943225|NCT02480764|83180357|FG002|Overall Study|Voluntary Withdrawal|10|||
46837027|NCT00274716|83054574|FG000|Phase B|Other non-reported reason|0|||
46837028|NCT00274716|83054575|FG001|Phase B|Other non-reported reason|0|||
46837029|NCT00274716|83054576|FG002|Phase B|Other non-reported reason|1|||
46837030|NCT00274716|83054577|FG003|Phase B|Other non-reported reason|1|||
46837031|NCT00274716|83054578|FG004|Phase B|Other non-reported reason|0|||
46837032|NCT00274716|83054579|FG005|Phase B|Other non-reported reason|0|||
46943226|NCT02480764|83180355|FG000|Overall Study|Lack of Efficacy|0|||
46943227|NCT02480764|83180356|FG001|Overall Study|Lack of Efficacy|3|||
46943228|NCT02480764|83180357|FG002|Overall Study|Lack of Efficacy|3|||
46943229|NCT02480764|83180355|FG000|Overall Study|Reason not Specified|0|||
46943230|NCT02480764|83180356|FG001|Overall Study|Reason not Specified|1|||
46943231|NCT02480764|83180357|FG002|Overall Study|Reason not Specified|0|||
46943232|NCT02487472|83180365|FG000|Overall Study|Did not complete telephonic interviews|9|||
46943233|NCT02487472|83180365|FG000|Overall Study|Other|2|||
46943234|NCT02451670|83180373|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
46943235|NCT02451670|83180374|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
46943236|NCT02486692|83180382|FG000|Overall Study|did not login for randomization|4|||
46943237|NCT02486692|83180383|FG001|Overall Study|did not login for randomization|7|||
46943238|NCT01060007|83180400|FG000|Overall Study|Withdrawal by Subject|1|||
46943239|NCT01060007|83180400|FG000|Overall Study|Inevaluable for response at surgery|3|||
46943240|NCT02971163|83180409|FG000|Overall Study|Lost to Follow-up|4|||
46943241|NCT02971163|83180410|FG001|Overall Study|Lost to Follow-up|2|||
46837033|NCT00274716|83054574|FG000|Phase B|Lost to Follow-up|0|||
46837034|NCT00274716|83054575|FG001|Phase B|Lost to Follow-up|1|||
46837035|NCT00274716|83054576|FG002|Phase B|Lost to Follow-up|0|||
46837036|NCT00274716|83054577|FG003|Phase B|Lost to Follow-up|0|||
46837037|NCT00274716|83054578|FG004|Phase B|Lost to Follow-up|0|||
46943242|NCT02971007|83180419|FG000|Overall Study|Adverse Event|1|||
46943243|NCT02971007|83180420|FG001|Overall Study|Adverse Event|0|||
46943244|NCT02971007|83180421|FG002|Overall Study|Adverse Event|0|||
46943245|NCT02971007|83180419|FG000|Overall Study|Lost to Follow-up|0|||
46943246|NCT02971007|83180420|FG001|Overall Study|Lost to Follow-up|1|||
46943247|NCT02971007|83180421|FG002|Overall Study|Lost to Follow-up|1|||
46943248|NCT02971007|83180419|FG000|Overall Study|Withdrawal by Subject|0|||
46943249|NCT02971007|83180420|FG001|Overall Study|Withdrawal by Subject|1|||
46943250|NCT02971007|83180421|FG002|Overall Study|Withdrawal by Subject|0|||
46943251|NCT02971007|83180419|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
46943252|NCT02971007|83180420|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
46943253|NCT02971007|83180421|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
46943254|NCT02971007|83180419|FG000|Overall Study|Patient discontinued study drug|0|||
46943255|NCT02971007|83180420|FG001|Overall Study|Patient discontinued study drug|1|||
46943256|NCT02971007|83180421|FG002|Overall Study|Patient discontinued study drug|0|||
46943257|NCT03881553|83180432|FG000|Overall Study|Discharged prior to participation|1|||
46943258|NCT03881553|83180433|FG001|Overall Study|Discharged prior to participation|1|||
46943259|NCT03881553|83180434|FG002|Overall Study|Discharged prior to participation|0|||
46943260|NCT03881553|83180432|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
46943261|NCT03881553|83180433|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
46943262|NCT03881553|83180434|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
47062609|NCT02659059|83343418|FG001|Overall Study|Participant request to discontinue study treatment|0|||
47062610|NCT02659059|83343417|FG000|Overall Study|Participant withdrew consent|6|||
46837038|NCT00274716|83054579|FG005|Phase B|Lost to Follow-up|0|||
46943263|NCT02970929|83180442|FG000|Overall Study|Adverse Event|18|||
46943264|NCT02970929|83180442|FG000|Overall Study|Lack of Efficacy|8|||
46943265|NCT02970929|83180442|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
47062611|NCT02659059|83343418|FG001|Overall Study|Participant withdrew consent|1|||
47062612|NCT01164891|83343433|FG000|Overall Study|Disease Progression|5|||
46943266|NCT02970929|83180442|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
46943267|NCT02970929|83180442|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
46837039|NCT00282048|83054597|FG000|Overall Study|Lack of Efficacy|30|||
46837040|NCT00282048|83054597|FG000|Overall Study|Adverse Event|22|||
46943268|NCT02970929|83180442|FG000|Overall Study|LOST TO FOLLOWUP|6|||
46943269|NCT02970929|83180442|FG000|Overall Study|MOVED OUT OF STATE|1|||
46943270|NCT02970929|83180442|FG000|Overall Study|Withdrawal by Subject|16|||
46943271|NCT02970305|83180459|FG000|Overall Study|Adverse Event|10|||
46943272|NCT02970305|83180460|FG001|Overall Study|Adverse Event|6|||
47062613|NCT01164891|83343433|FG000|Overall Study|Adverse Event|1|||
47062614|NCT01497899|83343442|FG000|Double-Blind Phase|Randomized but not Treated|1|||
47062615|NCT01497899|83343443|FG001|Double-Blind Phase|Randomized but not Treated|0|||
47062616|NCT01497899|83343444|FG002|Double-Blind Phase|Randomized but not Treated|0|||
47062617|NCT01497899|83343445|FG003|Double-Blind Phase|Randomized but not Treated|0|||
47062618|NCT01497899|83343442|FG000|Double-Blind Phase|Adverse Event|1|||
46837041|NCT00282048|83054597|FG000|Overall Study|Withdrawal by Subject|1|||
46837042|NCT00282048|83054597|FG000|Overall Study|Other|8|||
46837043|NCT00282048|83054597|FG000|Overall Study|Ongoing|1|||
46837044|NCT00474539|83054603|FG000|Infant Series|Withdrawal by Subject|3|||
46837045|NCT00474539|83054604|FG001|Infant Series|Withdrawal by Subject|4|||
46837046|NCT00474539|83054603|FG000|Infant Series|Randomization error|5|||
46837047|NCT00474539|83054604|FG001|Infant Series|Randomization error|0|||
46837048|NCT00474539|83054603|FG000|Infant Series|Lost to Follow-up|2|||
46837049|NCT00474539|83054604|FG001|Infant Series|Lost to Follow-up|1|||
46837050|NCT00474539|83054603|FG000|Infant Series|Protocol Violation|0|||
46837051|NCT00474539|83054604|FG001|Infant Series|Protocol Violation|1|||
46837052|NCT00474539|83054603|FG000|After Infant Series|Lost to Follow-up|3|||
46837053|NCT00474539|83054604|FG001|After Infant Series|Lost to Follow-up|0|||
46837054|NCT00474539|83054603|FG000|After Infant Series|Withdrawal by Subject|1|||
46837055|NCT00474539|83054604|FG001|After Infant Series|Withdrawal by Subject|0|||
46837056|NCT00474539|83054603|FG000|Toddler Dose|Protocol Violation|1|||
46638163|NCT01492686|82811550|FG000|Double-blind Phase|Physician Decision|0|||
46837057|NCT00474539|83054604|FG001|Toddler Dose|Protocol Violation|0|||
46837058|NCT00281580|83054651|FG000|Overall Study|Adverse Event|2|||
46943273|NCT02970305|83180459|FG000|Overall Study|Lack of Efficacy|1|||
46943274|NCT02970305|83180460|FG001|Overall Study|Lack of Efficacy|1|||
46943275|NCT02970305|83180459|FG000|Overall Study|Noncompliance with study drug|2|||
46943276|NCT02970305|83180460|FG001|Overall Study|Noncompliance with study drug|4|||
46943277|NCT02970305|83180459|FG000|Overall Study|Protocol Violation|2|||
46837059|NCT00281580|83054652|FG001|Overall Study|Adverse Event|0|||
46837060|NCT00281580|83054653|FG002|Overall Study|Adverse Event|2|||
46837061|NCT00281580|83054654|FG003|Overall Study|Adverse Event|4|||
46837062|NCT00281580|83054655|FG004|Overall Study|Adverse Event|1|||
46943278|NCT02970305|83180460|FG001|Overall Study|Protocol Violation|2|||
46943279|NCT02970305|83180459|FG000|Overall Study|Withdrawal by Subject|12|||
46943280|NCT02970305|83180460|FG001|Overall Study|Withdrawal by Subject|11|||
46943281|NCT02970305|83180459|FG000|Overall Study|Not further specified|1|||
46943282|NCT02970305|83180460|FG001|Overall Study|Not further specified|2|||
46943283|NCT02970305|83180459|FG000|Overall Study|Lost to Follow-up|1|||
46943284|NCT02970305|83180460|FG001|Overall Study|Lost to Follow-up|2|||
46943285|NCT02022033|83180479|FG000|Overall Study|Physician Decision|1|||
46943286|NCT03505671|83180485|FG000|Overall Study|Withdrawal by Subject|2|||
46943287|NCT03505671|83180486|FG001|Overall Study|Withdrawal by Subject|1|||
46943288|NCT03505671|83180485|FG000|Overall Study|Lost to Follow-up|1|||
46943289|NCT03505671|83180486|FG001|Overall Study|Lost to Follow-up|0|||
46943290|NCT01103349|83180507|FG000|Overall Study|Adverse Event|8|||
46943291|NCT01103349|83180508|FG001|Overall Study|Adverse Event|5|||
46943292|NCT01103349|83180509|FG002|Overall Study|Adverse Event|3|||
46943293|NCT01103349|83180507|FG000|Overall Study|Consent withdrawn|1|||
46943294|NCT01103349|83180508|FG001|Overall Study|Consent withdrawn|0|||
46943295|NCT01103349|83180509|FG002|Overall Study|Consent withdrawn|0|||
46943296|NCT01103349|83180507|FG000|Overall Study|Incorrectly included in the trial|1|||
46943297|NCT01103349|83180508|FG001|Overall Study|Incorrectly included in the trial|0|||
46943298|NCT01103349|83180509|FG002|Overall Study|Incorrectly included in the trial|0|||
46943299|NCT01103349|83180507|FG000|Overall Study|Withdrawal by Subject|1|||
46638164|NCT01492686|82811551|FG001|Double-blind Phase|Physician Decision|1|||
46638165|NCT01492686|82811550|FG000|Double-blind Phase|Withdrawal by Subject|0|||
46837063|NCT00281580|83054656|FG005|Overall Study|Adverse Event|0|||
46837064|NCT00281580|83054657|FG006|Overall Study|Adverse Event|1|||
46837065|NCT00281580|83054658|FG007|Overall Study|Adverse Event|0|||
46837066|NCT00281580|83054659|FG008|Overall Study|Adverse Event|1|||
46943300|NCT01103349|83180508|FG001|Overall Study|Withdrawal by Subject|1|||
46943301|NCT01103349|83180509|FG002|Overall Study|Withdrawal by Subject|0|||
47062619|NCT01497899|83343443|FG001|Double-Blind Phase|Adverse Event|0|||
47062620|NCT01497899|83343444|FG002|Double-Blind Phase|Adverse Event|0|||
47062621|NCT01497899|83343445|FG003|Double-Blind Phase|Adverse Event|0|||
47062622|NCT01497899|83343442|FG000|Double-Blind Phase|Lack of Efficacy|0|||
47062623|NCT01497899|83343443|FG001|Double-Blind Phase|Lack of Efficacy|1|||
46837067|NCT00281580|83054660|FG009|Overall Study|Adverse Event|6|||
46837068|NCT00281580|83054661|FG010|Overall Study|Adverse Event|0|||
46837069|NCT00281580|83054662|FG011|Overall Study|Adverse Event|5|||
46943302|NCT01103349|83180507|FG000|Overall Study|did not want to take trial medication|0|||
46837070|NCT00281580|83054663|FG012|Overall Study|Adverse Event|8|||
46837071|NCT00281580|83054664|FG013|Overall Study|Adverse Event|2|||
46837072|NCT00281580|83054665|FG014|Overall Study|Adverse Event|3|||
46837073|NCT00281580|83054666|FG015|Overall Study|Adverse Event|3|||
46837074|NCT00281580|83054651|FG000|Overall Study|Protocol Violation|0|||
46837075|NCT00281580|83054652|FG001|Overall Study|Protocol Violation|0|||
46837076|NCT00281580|83054653|FG002|Overall Study|Protocol Violation|1|||
46837077|NCT00281580|83054654|FG003|Overall Study|Protocol Violation|1|||
46837078|NCT00281580|83054655|FG004|Overall Study|Protocol Violation|0|||
46837079|NCT00281580|83054656|FG005|Overall Study|Protocol Violation|0|||
46837080|NCT00281580|83054657|FG006|Overall Study|Protocol Violation|1|||
46837081|NCT00281580|83054658|FG007|Overall Study|Protocol Violation|0|||
46837082|NCT00281580|83054659|FG008|Overall Study|Protocol Violation|2|||
46837083|NCT00281580|83054660|FG009|Overall Study|Protocol Violation|0|||
46837084|NCT00281580|83054661|FG010|Overall Study|Protocol Violation|1|||
46837085|NCT00281580|83054662|FG011|Overall Study|Protocol Violation|2|||
46837086|NCT00281580|83054663|FG012|Overall Study|Protocol Violation|0|||
46837087|NCT00281580|83054664|FG013|Overall Study|Protocol Violation|1|||
46837088|NCT00281580|83054665|FG014|Overall Study|Protocol Violation|1|||
46837089|NCT00281580|83054666|FG015|Overall Study|Protocol Violation|3|||
46837090|NCT00281580|83054651|FG000|Overall Study|Withdrawal by Subject|3|||
46837091|NCT00281580|83054652|FG001|Overall Study|Withdrawal by Subject|0|||
46837092|NCT00281580|83054653|FG002|Overall Study|Withdrawal by Subject|1|||
46837093|NCT00281580|83054654|FG003|Overall Study|Withdrawal by Subject|1|||
46837094|NCT00281580|83054655|FG004|Overall Study|Withdrawal by Subject|1|||
46837095|NCT00281580|83054656|FG005|Overall Study|Withdrawal by Subject|2|||
46837096|NCT00281580|83054657|FG006|Overall Study|Withdrawal by Subject|2|||
46837097|NCT00281580|83054658|FG007|Overall Study|Withdrawal by Subject|0|||
46837098|NCT00281580|83054659|FG008|Overall Study|Withdrawal by Subject|1|||
46837099|NCT00281580|83054660|FG009|Overall Study|Withdrawal by Subject|4|||
46837100|NCT00281580|83054661|FG010|Overall Study|Withdrawal by Subject|1|||
46837101|NCT00281580|83054662|FG011|Overall Study|Withdrawal by Subject|1|||
46837102|NCT00281580|83054663|FG012|Overall Study|Withdrawal by Subject|2|||
46837103|NCT00281580|83054664|FG013|Overall Study|Withdrawal by Subject|2|||
46837104|NCT00281580|83054665|FG014|Overall Study|Withdrawal by Subject|1|||
46837105|NCT00281580|83054666|FG015|Overall Study|Withdrawal by Subject|5|||
46837106|NCT00281580|83054651|FG000|Overall Study|Lack of Efficacy|2|||
46837107|NCT00281580|83054652|FG001|Overall Study|Lack of Efficacy|1|||
46837108|NCT00281580|83054653|FG002|Overall Study|Lack of Efficacy|1|||
46837109|NCT00281580|83054654|FG003|Overall Study|Lack of Efficacy|6|||
46837110|NCT00281580|83054655|FG004|Overall Study|Lack of Efficacy|2|||
46837111|NCT00281580|83054656|FG005|Overall Study|Lack of Efficacy|0|||
46837112|NCT00281580|83054657|FG006|Overall Study|Lack of Efficacy|0|||
46837113|NCT00281580|83054658|FG007|Overall Study|Lack of Efficacy|0|||
46943303|NCT01103349|83180508|FG001|Overall Study|did not want to take trial medication|1|||
46943304|NCT01103349|83180509|FG002|Overall Study|did not want to take trial medication|0|||
46943305|NCT01103349|83180507|FG000|Overall Study|forgot to take medication|0|||
46943306|NCT01103349|83180508|FG001|Overall Study|forgot to take medication|0|||
46943307|NCT01103349|83180509|FG002|Overall Study|forgot to take medication|1|||
46943308|NCT02959177|83180520|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
46943309|NCT02959177|83180521|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
47062624|NCT01497899|83343444|FG002|Double-Blind Phase|Lack of Efficacy|0|||
47062625|NCT01497899|83343445|FG003|Double-Blind Phase|Lack of Efficacy|0|||
47062626|NCT01497899|83343442|FG000|Double-Blind Phase|Investigator's Discretion|1|||
47062627|NCT01497899|83343443|FG001|Double-Blind Phase|Investigator's Discretion|0|||
47062628|NCT01497899|83343444|FG002|Double-Blind Phase|Investigator's Discretion|0|||
47062629|NCT01497899|83343445|FG003|Double-Blind Phase|Investigator's Discretion|0|||
47062630|NCT01497899|83343442|FG000|Double-Blind Phase|Withdrew Consent|0|||
47062631|NCT01497899|83343443|FG001|Double-Blind Phase|Withdrew Consent|1|||
47062632|NCT01497899|83343444|FG002|Double-Blind Phase|Withdrew Consent|0|||
46768159|NCT00768300|82986380|FG000|Overall Study|Withdrawal by Subject|13|||
46768160|NCT00768300|82986381|FG001|Overall Study|Withdrawal by Subject|7|||
46768161|NCT00768300|82986380|FG000|Overall Study|Physician Decision|2|||
46768162|NCT00768300|82986381|FG001|Overall Study|Physician Decision|3|||
46768163|NCT00768300|82986380|FG000|Overall Study|Study discontinued by Sponsor|271|||
46768164|NCT00768300|82986381|FG001|Overall Study|Study discontinued by Sponsor|140|||
46768165|NCT00768300|82986380|FG000|Overall Study|Death|21|||
46768166|NCT00768300|82986381|FG001|Overall Study|Death|5|||
46768167|NCT00768300|82986380|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
46837114|NCT00281580|83054659|FG008|Overall Study|Lack of Efficacy|0|||
46837115|NCT00281580|83054660|FG009|Overall Study|Lack of Efficacy|0|||
46837116|NCT00281580|83054661|FG010|Overall Study|Lack of Efficacy|0|||
46837117|NCT00281580|83054662|FG011|Overall Study|Lack of Efficacy|1|||
46837118|NCT00281580|83054663|FG012|Overall Study|Lack of Efficacy|0|||
46837119|NCT00281580|83054664|FG013|Overall Study|Lack of Efficacy|2|||
46837120|NCT00281580|83054665|FG014|Overall Study|Lack of Efficacy|1|||
46837121|NCT00281580|83054666|FG015|Overall Study|Lack of Efficacy|0|||
46837122|NCT00281580|83054651|FG000|Overall Study|Lost to Follow-up|0|||
46943310|NCT02959177|83180522|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
46943311|NCT02959177|83180520|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
46943312|NCT02959177|83180521|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
46943313|NCT02959177|83180522|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
46943314|NCT02959177|83180520|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
46943315|NCT02959177|83180521|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
46943316|NCT02959177|83180522|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
46943317|NCT02959177|83180520|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
46943318|NCT02959177|83180521|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
46943319|NCT02959177|83180522|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
46837123|NCT00281580|83054652|FG001|Overall Study|Lost to Follow-up|0|||
46837124|NCT00281580|83054653|FG002|Overall Study|Lost to Follow-up|0|||
46837125|NCT00281580|83054654|FG003|Overall Study|Lost to Follow-up|3|||
46837126|NCT00281580|83054655|FG004|Overall Study|Lost to Follow-up|0|||
46837127|NCT00281580|83054656|FG005|Overall Study|Lost to Follow-up|1|||
46837128|NCT00281580|83054657|FG006|Overall Study|Lost to Follow-up|0|||
46837129|NCT00281580|83054658|FG007|Overall Study|Lost to Follow-up|1|||
46943320|NCT02959177|83180520|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
47062633|NCT01497899|83343445|FG003|Double-Blind Phase|Withdrew Consent|0|||
47062634|NCT01497899|83343442|FG000|Double-Blind Phase|Lost to Follow-up|3|||
47062635|NCT01497899|83343443|FG001|Double-Blind Phase|Lost to Follow-up|2|||
47062636|NCT01497899|83343444|FG002|Double-Blind Phase|Lost to Follow-up|0|||
47062637|NCT01497899|83343445|FG003|Double-Blind Phase|Lost to Follow-up|0|||
47062638|NCT01497899|83343442|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
46943321|NCT02959177|83180521|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
46837130|NCT00281580|83054659|FG008|Overall Study|Lost to Follow-up|2|||
46837131|NCT00281580|83054660|FG009|Overall Study|Lost to Follow-up|1|||
46943322|NCT02959177|83180522|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
46943323|NCT02959177|83180520|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
46943324|NCT02959177|83180521|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
46943325|NCT02959177|83180522|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
46943326|NCT02959177|83180520|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
46943327|NCT02959177|83180521|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
46943328|NCT02959177|83180522|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
47062639|NCT01497899|83343443|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
46837132|NCT00281580|83054661|FG010|Overall Study|Lost to Follow-up|1|||
46837133|NCT00281580|83054662|FG011|Overall Study|Lost to Follow-up|0|||
46967799|NCT01595529|83210382|FG001|Overall Study|Adverse Event|0|||
46967800|NCT01595529|83210381|FG000|Overall Study|Subject Non-Compliant|2|||
46967801|NCT01595529|83210382|FG001|Overall Study|Subject Non-Compliant|0|||
46967802|NCT01595529|83210381|FG000|Overall Study|Lost to Follow-up|8|||
46967803|NCT01595529|83210382|FG001|Overall Study|Lost to Follow-up|14|||
46837134|NCT00281580|83054663|FG012|Overall Study|Lost to Follow-up|1|||
46837135|NCT00281580|83054664|FG013|Overall Study|Lost to Follow-up|0|||
46837136|NCT00281580|83054665|FG014|Overall Study|Lost to Follow-up|0|||
46837137|NCT00281580|83054666|FG015|Overall Study|Lost to Follow-up|0|||
46837138|NCT00281580|83054651|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
46837139|NCT00281580|83054652|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
46837140|NCT00281580|83054653|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
46837141|NCT00281580|83054654|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
46837142|NCT00281580|83054655|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
46837143|NCT00281580|83054656|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
46837144|NCT00281580|83054657|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
46837145|NCT00281580|83054658|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
46837146|NCT00281580|83054659|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
46837147|NCT00281580|83054660|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
46837148|NCT00281580|83054661|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
46837149|NCT00281580|83054662|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
46837150|NCT00281580|83054663|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
46837151|NCT00281580|83054664|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
46837152|NCT00281580|83054665|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
46837153|NCT00281580|83054666|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
46837154|NCT00495755|83054735|FG000|Overall Study|Adverse Event|3|||
46837155|NCT00495677|83054747|FG000|Stage 1 (25 Days)|Adverse Event|0|||
46837156|NCT00495677|83054748|FG001|Stage 1 (25 Days)|Adverse Event|0|||
46837157|NCT00495677|83054749|FG002|Stage 1 (25 Days)|Adverse Event|1|||
47062640|NCT01497899|83343444|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
47062641|NCT01497899|83343445|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
47062642|NCT01497899|83343442|FG000|Open-Label Extension Phase|Adverse Event|1|||
47062643|NCT01497899|83343443|FG001|Open-Label Extension Phase|Adverse Event|0|||
47062644|NCT01497899|83343444|FG002|Open-Label Extension Phase|Adverse Event|0|||
46837158|NCT00495677|83054750|FG003|Stage 1 (25 Days)|Adverse Event|0|||
46837159|NCT00495677|83054751|FG004|Stage 1 (25 Days)|Adverse Event|0|||
46837160|NCT00495677|83054752|FG005|Stage 1 (25 Days)|Adverse Event|0|||
46837161|NCT00495677|83054753|FG006|Stage 1 (25 Days)|Adverse Event|0|||
46837162|NCT00495521|83054771|FG000|Overall Study|Physician Decision|0|||
46837163|NCT00495521|83054772|FG001|Overall Study|Physician Decision|1|||
46768168|NCT00768300|82986381|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
46768169|NCT00768300|82986380|FG000|Overall Study|Screen failure following randomization|1|||
46768170|NCT00768300|82986381|FG001|Overall Study|Screen failure following randomization|0|||
46768171|NCT00768300|82986380|FG000|Overall Study|Received lung transplant|1|||
46768172|NCT00768300|82986381|FG001|Overall Study|Received lung transplant|1|||
46768173|NCT00768300|82986380|FG000|Overall Study|Lost to Follow-up|0|||
46768174|NCT00768300|82986381|FG001|Overall Study|Lost to Follow-up|1|||
46768175|NCT00768300|82986380|FG000|Overall Study|Began prohibited concomitant medication|0|||
46768176|NCT00768300|82986381|FG001|Overall Study|Began prohibited concomitant medication|1|||
46768177|NCT00768300|82986380|FG000|Overall Study|Treated but never dosed with Study drug|1|||
46768178|NCT00768300|82986381|FG001|Overall Study|Treated but never dosed with Study drug|0|||
46768179|NCT00768300|82986380|FG000|Overall Study|Missing data|1|||
46768180|NCT00768300|82986381|FG001|Overall Study|Missing data|0|||
46768181|NCT00768222|82986389|FG000|Overall Study|Lost to Follow-up|1|||
46768182|NCT00768222|82986390|FG001|Overall Study|Lost to Follow-up|1|||
46768183|NCT00768222|82986389|FG000|Overall Study|Withdrawal by Subject|3|||
46768184|NCT00768222|82986390|FG001|Overall Study|Withdrawal by Subject|1|||
46768185|NCT00768222|82986389|FG000|Overall Study|Protocol Violation|0|||
46768186|NCT00768222|82986390|FG001|Overall Study|Protocol Violation|2|||
46768187|NCT00768144|82986396|FG000|Overall Study|Adverse Event|13|||
46768188|NCT00768144|82986396|FG000|Overall Study|Progressive Disease|21|||
46768189|NCT00768144|82986396|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
46768190|NCT00768144|82986396|FG000|Overall Study|Pt Withdrew Consent|1|||
46768191|NCT00784836|82986400|FG000|Overall Study|Early Study Termination|3|||
46768192|NCT00784758|82986406|FG000|Overall Study|Withdrawal by Subject|3|||
46768193|NCT00784758|82986407|FG001|Overall Study|Withdrawal by Subject|0|||
46768194|NCT00784758|82986406|FG000|Overall Study|Adverse Event|1|||
46768195|NCT00784758|82986407|FG001|Overall Study|Adverse Event|0|||
46768196|NCT00768066|82986418|FG000|Overall Study|Did not receive study product injection.|3|||
46768197|NCT00768066|82986419|FG001|Overall Study|Did not receive study product injection.|3|||
46768198|NCT00768066|82986420|FG002|Overall Study|Did not receive study product injection.|0|||
46768199|NCT00767676|82986428|FG000|Overall Study|Investigator error|54|||
46768200|NCT00767520|82986434|FG000|Overall Study|Participants still on treatment|11|||
46837164|NCT00273858|83054778|FG000|Overall Study|Not completed 24 month observation time|334|||
46837165|NCT00273858|83054778|FG000|Overall Study|Lost to Follow-up|101|||
46837166|NCT00273858|83054778|FG000|Overall Study|Withdrawal by Subject|21|||
47062645|NCT01497899|83343445|FG003|Open-Label Extension Phase|Adverse Event|0|||
46768201|NCT00767520|82986435|FG001|Overall Study|Participants still on treatment|15|||
46837167|NCT00273858|83054778|FG000|Overall Study|Adverse Event|81|||
46837168|NCT00494507|83054786|FG000|Double-Blind Phase|Adverse Event|2|||
46837169|NCT00494507|83054787|FG001|Double-Blind Phase|Adverse Event|0|||
46837170|NCT00494507|83054788|FG002|Double-Blind Phase|Adverse Event|1|||
46837171|NCT00494507|83054789|FG003|Double-Blind Phase|Adverse Event|0|||
46837172|NCT00494507|83054786|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
46837173|NCT00494507|83054787|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
46837174|NCT00494507|83054788|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
46837175|NCT00494507|83054789|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
46837176|NCT00494507|83054786|FG000|Double-Blind Phase|Subject Non-compliance|0|||
46837177|NCT00494507|83054787|FG001|Double-Blind Phase|Subject Non-compliance|0|||
46837178|NCT00494507|83054788|FG002|Double-Blind Phase|Subject Non-compliance|1|||
46837179|NCT00494507|83054789|FG003|Double-Blind Phase|Subject Non-compliance|0|||
46837180|NCT00494507|83054786|FG000|Double-Blind Phase|Negative DNA test|0|||
46837181|NCT00494507|83054787|FG001|Double-Blind Phase|Negative DNA test|0|||
46837182|NCT00494507|83054788|FG002|Double-Blind Phase|Negative DNA test|0|||
46837183|NCT00494507|83054789|FG003|Double-Blind Phase|Negative DNA test|1|||
46837184|NCT00494507|83054786|FG000|Open-Label Phase|Adverse Event|0|||
46837185|NCT00494507|83054787|FG001|Open-Label Phase|Adverse Event|1|||
46837186|NCT00494507|83054788|FG002|Open-Label Phase|Adverse Event|5|||
46837187|NCT00494507|83054789|FG003|Open-Label Phase|Adverse Event|3|||
46837188|NCT00494507|83054786|FG000|Open-Label Phase|Worsening Disease|0|||
46837189|NCT00494507|83054787|FG001|Open-Label Phase|Worsening Disease|0|||
46837190|NCT00494507|83054788|FG002|Open-Label Phase|Worsening Disease|0|||
46837191|NCT00494507|83054789|FG003|Open-Label Phase|Worsening Disease|2|||
46837192|NCT00292188|83054811|FG000|Single-Blind|Adverse Event|14|||
46837193|NCT00292188|83054812|FG001|Single-Blind|Adverse Event|0|||
46837194|NCT00292188|83054813|FG002|Single-Blind|Adverse Event|0|||
46837195|NCT00292188|83054811|FG000|Single-Blind|Lack of Efficacy|2|||
46837196|NCT00292188|83054812|FG001|Single-Blind|Lack of Efficacy|0|||
46837197|NCT00292188|83054813|FG002|Single-Blind|Lack of Efficacy|0|||
46837198|NCT00292188|83054811|FG000|Single-Blind|Laboratory Abnormality|5|||
46837199|NCT00292188|83054812|FG001|Single-Blind|Laboratory Abnormality|0|||
46837200|NCT00292188|83054813|FG002|Single-Blind|Laboratory Abnormality|0|||
46837201|NCT00292188|83054811|FG000|Single-Blind|Lost to Follow-up|3|||
46837202|NCT00292188|83054812|FG001|Single-Blind|Lost to Follow-up|0|||
46837203|NCT00292188|83054813|FG002|Single-Blind|Lost to Follow-up|0|||
46837204|NCT00292188|83054811|FG000|Single-Blind|Other|77|||
46837205|NCT00292188|83054812|FG001|Single-Blind|Other|0|||
46837206|NCT00292188|83054813|FG002|Single-Blind|Other|0|||
47062646|NCT01497899|83343442|FG000|Open-Label Extension Phase|Death|1|||
47062647|NCT01497899|83343443|FG001|Open-Label Extension Phase|Death|0|||
47062648|NCT01497899|83343444|FG002|Open-Label Extension Phase|Death|0|||
47062649|NCT01497899|83343445|FG003|Open-Label Extension Phase|Death|0|||
47062650|NCT01497899|83343442|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
47062651|NCT01497899|83343443|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
47062652|NCT01497899|83343444|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
47062653|NCT01497899|83343445|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
47062654|NCT01497899|83343442|FG000|Open-Label Extension Phase|Pregnancy|0|||
47062655|NCT01497899|83343443|FG001|Open-Label Extension Phase|Pregnancy|1|||
47062656|NCT01497899|83343444|FG002|Open-Label Extension Phase|Pregnancy|1|||
47062657|NCT01497899|83343445|FG003|Open-Label Extension Phase|Pregnancy|0|||
47062658|NCT01497899|83343442|FG000|Open-Label Extension Phase|Protocol Violation|0|||
47062659|NCT01497899|83343443|FG001|Open-Label Extension Phase|Protocol Violation|0|||
47062660|NCT01497899|83343444|FG002|Open-Label Extension Phase|Protocol Violation|1|||
46837207|NCT00292188|83054811|FG000|Single-Blind|Withdrawal by Subject|12|||
46837208|NCT00292188|83054812|FG001|Single-Blind|Withdrawal by Subject|0|||
46837209|NCT00292188|83054813|FG002|Single-Blind|Withdrawal by Subject|0|||
46837210|NCT00292188|83054811|FG000|Single-Blind|Did not receive treatment|1|||
46837211|NCT00292188|83054812|FG001|Single-Blind|Did not receive treatment|0|||
46837212|NCT00292188|83054813|FG002|Single-Blind|Did not receive treatment|0|||
46837213|NCT00292188|83054811|FG000|Double-Blind|Adverse Event|0|||
46837214|NCT00292188|83054812|FG001|Double-Blind|Adverse Event|25|||
47062661|NCT01497899|83343445|FG003|Open-Label Extension Phase|Protocol Violation|0|||
47062662|NCT01497899|83343442|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
46837215|NCT00292188|83054813|FG002|Double-Blind|Adverse Event|9|||
46837216|NCT00292188|83054811|FG000|Double-Blind|Lack of Efficacy|0|||
46837217|NCT00292188|83054812|FG001|Double-Blind|Lack of Efficacy|2|||
46837218|NCT00292188|83054813|FG002|Double-Blind|Lack of Efficacy|12|||
46837219|NCT00292188|83054811|FG000|Double-Blind|Lost to Follow-up|0|||
46837220|NCT00292188|83054812|FG001|Double-Blind|Lost to Follow-up|1|||
46837221|NCT00292188|83054813|FG002|Double-Blind|Lost to Follow-up|0|||
46837222|NCT00292188|83054811|FG000|Double-Blind|Other|0|||
46837223|NCT00292188|83054812|FG001|Double-Blind|Other|3|||
46837224|NCT00292188|83054813|FG002|Double-Blind|Other|4|||
46837225|NCT00292188|83054811|FG000|Double-Blind|Withdrawal by Subject|0|||
46837226|NCT00292188|83054812|FG001|Double-Blind|Withdrawal by Subject|0|||
46837227|NCT00292188|83054813|FG002|Double-Blind|Withdrawal by Subject|3|||
46837228|NCT00292188|83054811|FG000|Double-Blind|Laboratory Abnormality|0|||
46837229|NCT00292188|83054812|FG001|Double-Blind|Laboratory Abnormality|0|||
46837230|NCT00292188|83054813|FG002|Double-Blind|Laboratory Abnormality|1|||
46837231|NCT00272844|83054820|FG000|Overall Study|Withdrawal by Subject|5|||
46837232|NCT00271596|83054826|FG000|Overall Study|Protocol Violation|1|||
46943329|NCT04706403|83180539|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
46943330|NCT04706403|83180540|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
46943331|NCT04706403|83180541|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
46943332|NCT04706403|83180542|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
46943333|NCT04706403|83180543|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
46837233|NCT00271596|83054827|FG001|Overall Study|Protocol Violation|0|||
46837234|NCT00271596|83054826|FG000|Overall Study|Withdrawal by Subject|0|||
46837235|NCT00271596|83054827|FG001|Overall Study|Withdrawal by Subject|1|||
46837236|NCT00291642|83054838|FG000|Overall Study|Adverse Event|1|||
46837237|NCT00291642|83054839|FG001|Overall Study|Adverse Event|0|||
46837238|NCT00291642|83054840|FG002|Overall Study|Adverse Event|1|||
46837239|NCT00291642|83054841|FG003|Overall Study|Adverse Event|0|||
46837240|NCT00291642|83054842|FG004|Overall Study|Adverse Event|1|||
46837241|NCT00291642|83054838|FG000|Overall Study|Patient missed visit|0|||
46837242|NCT00291642|83054839|FG001|Overall Study|Patient missed visit|0|||
46837243|NCT00291642|83054840|FG002|Overall Study|Patient missed visit|1|||
46837244|NCT00291642|83054841|FG003|Overall Study|Patient missed visit|0|||
46837245|NCT00291642|83054842|FG004|Overall Study|Patient missed visit|0|||
46837246|NCT00291642|83054838|FG000|Overall Study|Intake of prohibited medication|1|||
46837247|NCT00291642|83054839|FG001|Overall Study|Intake of prohibited medication|0|||
46837248|NCT00291642|83054840|FG002|Overall Study|Intake of prohibited medication|0|||
46837249|NCT00291642|83054841|FG003|Overall Study|Intake of prohibited medication|0|||
46837250|NCT00291642|83054842|FG004|Overall Study|Intake of prohibited medication|0|||
46837251|NCT00280566|83054856|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
46837252|NCT00280566|83054857|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
46837253|NCT00280566|83054858|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
46837254|NCT00280566|83054856|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
46837255|NCT00280566|83054857|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
46837256|NCT00280566|83054858|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
46837257|NCT00280566|83054856|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
46837258|NCT00280566|83054857|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
46837259|NCT00280566|83054858|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
46837260|NCT00280566|83054856|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
46837261|NCT00280566|83054857|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
46837262|NCT00280566|83054858|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
46837263|NCT00280566|83054856|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
46837264|NCT00280566|83054857|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
46837265|NCT00280566|83054858|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
46837266|NCT00280566|83054856|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
46837267|NCT00280566|83054857|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
46943334|NCT02983617|83180557|FG000|Overall Study|Adverse Event|0|||
46943335|NCT02983617|83180558|FG001|Overall Study|Adverse Event|7|||
46943336|NCT02983617|83180557|FG000|Overall Study|Death|0|||
46837268|NCT00280566|83054858|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
46943337|NCT02983617|83180558|FG001|Overall Study|Death|1|||
46837269|NCT00280566|83054856|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
46943338|NCT02983617|83180557|FG000|Overall Study|Investigator's Discretion|0|||
46943339|NCT02983617|83180558|FG001|Overall Study|Investigator's Discretion|1|||
47062663|NCT01497899|83343443|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
47062664|NCT01497899|83343444|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
46837270|NCT00280566|83054857|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
46837271|NCT00280566|83054858|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
46837272|NCT00280566|83054856|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
46837273|NCT00280566|83054857|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
46837274|NCT00280566|83054858|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
46837275|NCT00280566|83054856|FG000|Period 2 Double Blind|Adverse Event|0|||
46837276|NCT00280566|83054857|FG001|Period 2 Double Blind|Adverse Event|11|||
46837277|NCT00280566|83054858|FG002|Period 2 Double Blind|Adverse Event|15|||
46837278|NCT00280566|83054856|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
46837279|NCT00280566|83054857|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
46837280|NCT00280566|83054858|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
46837281|NCT00280566|83054856|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
46837282|NCT00280566|83054857|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
46837283|NCT00280566|83054858|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
46837284|NCT00280566|83054856|FG000|Period 2 Double Blind|miscellaneous|0|||
46837285|NCT00280566|83054857|FG001|Period 2 Double Blind|miscellaneous|10|||
46837286|NCT00280566|83054858|FG002|Period 2 Double Blind|miscellaneous|5|||
46837287|NCT00270894|83054865|FG000|Overall Study|Adverse Event|1|||
46837288|NCT00270894|83054865|FG000|Overall Study|Withdrawal by Subject|1|||
46837289|NCT00317642|83054871|FG000|Overall Study|Not Received Either Study Drug|1|||
46943340|NCT02873689|83180566|FG000|Overall Study|Lack of Efficacy|1|||
46943341|NCT02873689|83180567|FG001|Overall Study|Lack of Efficacy|0|||
46943342|NCT02873689|83180566|FG000|Overall Study|Withdrawal by Subject|2|||
46943343|NCT02873689|83180567|FG001|Overall Study|Withdrawal by Subject|2|||
46943344|NCT02873689|83180566|FG000|Overall Study|Protocol Violation|1|||
46943345|NCT02873689|83180567|FG001|Overall Study|Protocol Violation|0|||
46943346|NCT02873689|83180566|FG000|Overall Study|Adverse Event|2|||
46837290|NCT00317642|83054872|FG001|Overall Study|Not Received Either Study Drug|3|||
46837291|NCT00317642|83054871|FG000|Overall Study|Physician Decision|15|||
46837292|NCT00317642|83054872|FG001|Overall Study|Physician Decision|7|||
46837293|NCT00317642|83054871|FG000|Overall Study|Participant declined treatment|14|||
46837294|NCT00317642|83054872|FG001|Overall Study|Participant declined treatment|3|||
46837295|NCT00317642|83054871|FG000|Overall Study|Adverse Event|17|||
46837296|NCT00317642|83054872|FG001|Overall Study|Adverse Event|5|||
46837297|NCT00317642|83054871|FG000|Overall Study|Treatment Failure|56|||
46837298|NCT00317642|83054872|FG001|Overall Study|Treatment Failure|102|||
46943347|NCT02873689|83180567|FG001|Overall Study|Adverse Event|2|||
46943348|NCT02873689|83180566|FG000|Overall Study|Randomized but not Treated|1|||
46943349|NCT02873689|83180567|FG001|Overall Study|Randomized but not Treated|1|||
46943350|NCT02901431|83180581|FG000|PK Part|Adverse Event|0|||
46943351|NCT02901431|83180582|FG001|PK Part|Adverse Event|1|||
46943352|NCT02901431|83180583|FG002|PK Part|Adverse Event|0|||
46943353|NCT02901431|83180584|FG003|PK Part|Adverse Event|0|||
46943354|NCT02901431|83180585|FG004|PK Part|Adverse Event|0|||
46943355|NCT02901431|83180586|FG005|PK Part|Adverse Event|0|||
46943356|NCT02901431|83180587|FG006|PK Part|Adverse Event|0|||
46943357|NCT02901431|83180588|FG007|PK Part|Adverse Event|0|||
46943358|NCT02901431|83180589|FG008|PK Part|Adverse Event|0|||
46943359|NCT02901431|83180590|FG009|PK Part|Adverse Event|0|||
46943360|NCT02901431|83180591|FG010|PK Part|Adverse Event|0|||
46943361|NCT02901431|83180592|FG011|PK Part|Adverse Event|0|||
46943362|NCT02901431|83180593|FG012|PK Part|Adverse Event|0|||
46943363|NCT02901431|83180581|FG000|PK Part|Lost to Follow-up|0|||
46943364|NCT02901431|83180582|FG001|PK Part|Lost to Follow-up|0|||
46943365|NCT02901431|83180583|FG002|PK Part|Lost to Follow-up|1|||
46943366|NCT02901431|83180584|FG003|PK Part|Lost to Follow-up|0|||
46943367|NCT02901431|83180585|FG004|PK Part|Lost to Follow-up|0|||
46943368|NCT02901431|83180586|FG005|PK Part|Lost to Follow-up|0|||
46943369|NCT02901431|83180587|FG006|PK Part|Lost to Follow-up|0|||
46943370|NCT02901431|83180588|FG007|PK Part|Lost to Follow-up|0|||
46943371|NCT02901431|83180589|FG008|PK Part|Lost to Follow-up|0|||
46943372|NCT02901431|83180590|FG009|PK Part|Lost to Follow-up|0|||
46943373|NCT02901431|83180591|FG010|PK Part|Lost to Follow-up|0|||
46768202|NCT00767520|82986434|FG000|Overall Study|Randomized in error and Never treated|0|||
46768203|NCT00767520|82986435|FG001|Overall Study|Randomized in error and Never treated|2|||
46768204|NCT00838565|82986447|FG000|Overall Study|Withdrawal by Subject|0|||
46768205|NCT00838565|82986448|FG001|Overall Study|Withdrawal by Subject|0|||
46768206|NCT00838565|82986449|FG002|Overall Study|Withdrawal by Subject|1|||
46768207|NCT00838565|82986450|FG003|Overall Study|Withdrawal by Subject|0|||
46768208|NCT00838565|82986451|FG004|Overall Study|Withdrawal by Subject|0|||
46768209|NCT00838565|82986452|FG005|Overall Study|Withdrawal by Subject|2|||
46768210|NCT00838565|82986447|FG000|Overall Study|Other|0|||
46768211|NCT00838565|82986448|FG001|Overall Study|Other|2|||
46768212|NCT00838565|82986449|FG002|Overall Study|Other|0|||
46943374|NCT02901431|83180592|FG011|PK Part|Lost to Follow-up|0|||
46943375|NCT02901431|83180593|FG012|PK Part|Lost to Follow-up|0|||
46768213|NCT00838565|82986450|FG003|Overall Study|Other|0|||
46768214|NCT00838565|82986451|FG004|Overall Study|Other|0|||
46768215|NCT00838565|82986452|FG005|Overall Study|Other|0|||
46837299|NCT00317642|83054871|FG000|Overall Study|Disease Recurrence|1|||
46837300|NCT00317642|83054872|FG001|Overall Study|Disease Recurrence|2|||
46837301|NCT00317642|83054871|FG000|Overall Study|Death|14|||
46943376|NCT02901431|83180581|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
46943377|NCT02901431|83180582|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46837302|NCT00317642|83054872|FG001|Overall Study|Death|7|||
46837303|NCT00317642|83054871|FG000|Overall Study|Not Continue to Consolidation|2|||
46837304|NCT00317642|83054872|FG001|Overall Study|Not Continue to Consolidation|0|||
46837305|NCT00317642|83054871|FG000|Overall Study|Withdrawal by Subject|0|||
46837306|NCT00317642|83054872|FG001|Overall Study|Withdrawal by Subject|1|||
46837307|NCT00317642|83054871|FG000|Overall Study|Referred For Transplantation|1|||
46943378|NCT02901431|83180583|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943379|NCT02901431|83180584|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46837308|NCT00317642|83054872|FG001|Overall Study|Referred For Transplantation|0|||
46837309|NCT00317642|83054871|FG000|Overall Study|AML Not Centrally Confirmed|1|||
46837310|NCT00317642|83054872|FG001|Overall Study|AML Not Centrally Confirmed|5|||
46837311|NCT00295022|83054888|FG000|Overall Study|Adverse Event|1|||
46943380|NCT02901431|83180585|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943381|NCT02901431|83180586|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943382|NCT02901431|83180587|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943383|NCT02901431|83180588|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46837312|NCT00295022|83054889|FG001|Overall Study|Adverse Event|1|||
46837313|NCT00295022|83054890|FG002|Overall Study|Adverse Event|2|||
46837314|NCT00295022|83054888|FG000|Overall Study|Lost to Follow-up|0|||
46837315|NCT00295022|83054889|FG001|Overall Study|Lost to Follow-up|0|||
46837316|NCT00295022|83054890|FG002|Overall Study|Lost to Follow-up|1|||
46943384|NCT02901431|83180589|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943385|NCT02901431|83180590|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943386|NCT02901431|83180591|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943387|NCT02901431|83180592|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943388|NCT02901431|83180593|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
46943389|NCT02901431|83180581|FG000|PK Part|Pending dose confirmation|0|||
46943390|NCT02901431|83180582|FG001|PK Part|Pending dose confirmation|1|||
46943391|NCT02901431|83180583|FG002|PK Part|Pending dose confirmation|0|||
46943392|NCT02901431|83180584|FG003|PK Part|Pending dose confirmation|0|||
46943393|NCT02901431|83180585|FG004|PK Part|Pending dose confirmation|0|||
46943394|NCT02901431|83180586|FG005|PK Part|Pending dose confirmation|0|||
46943395|NCT02901431|83180587|FG006|PK Part|Pending dose confirmation|0|||
46943396|NCT02901431|83180588|FG007|PK Part|Pending dose confirmation|0|||
46943397|NCT02901431|83180589|FG008|PK Part|Pending dose confirmation|0|||
46943398|NCT02901431|83180590|FG009|PK Part|Pending dose confirmation|0|||
46943399|NCT02901431|83180591|FG010|PK Part|Pending dose confirmation|0|||
46638166|NCT01492686|82811551|FG001|Double-blind Phase|Withdrawal by Subject|2|||
46638167|NCT01492686|82811550|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
46638168|NCT01492686|82811551|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
46638169|NCT01492686|82811550|FG000|Open-label Phase|Adverse Event|1|||
46638170|NCT01492686|82811551|FG001|Open-label Phase|Adverse Event|2|||
46638171|NCT01492686|82811550|FG000|Open-label Phase|Physician Decision|1|||
46638172|NCT01492686|82811551|FG001|Open-label Phase|Physician Decision|0|||
46768216|NCT00838565|82986447|FG000|Overall Study|Randomized but not Treated|0|||
46768217|NCT00838565|82986448|FG001|Overall Study|Randomized but not Treated|1|||
46768218|NCT00838565|82986449|FG002|Overall Study|Randomized but not Treated|0|||
46768219|NCT00838565|82986450|FG003|Overall Study|Randomized but not Treated|0|||
46768220|NCT00838565|82986451|FG004|Overall Study|Randomized but not Treated|0|||
46768221|NCT00838565|82986452|FG005|Overall Study|Randomized but not Treated|0|||
46768222|NCT00858845|82986473|FG000|Overall Study|Patient underwent heart transplant.|0|||
46768223|NCT00858845|82986474|FG001|Overall Study|Patient underwent heart transplant.|1|||
46768224|NCT00770562|82986482|FG000|Overall Study|Did not take treatment|1|||
46768225|NCT00770562|82986483|FG001|Overall Study|Did not take treatment|1|||
46768226|NCT00836693|82986492|FG000|Overall Study|Adverse Event|4|||
46768227|NCT00836693|82986493|FG001|Overall Study|Adverse Event|1|||
46768228|NCT00836693|82986492|FG000|Overall Study|Sponsor Decision|0|||
46768229|NCT00836693|82986493|FG001|Overall Study|Sponsor Decision|1|||
46768230|NCT00836693|82986492|FG000|Overall Study|Physician Decision|2|||
46768231|NCT00836693|82986493|FG001|Overall Study|Physician Decision|0|||
46768232|NCT00836693|82986492|FG000|Overall Study|Withdrawal by Subject|9|||
46768233|NCT00836693|82986493|FG001|Overall Study|Withdrawal by Subject|4|||
46768234|NCT00836693|82986492|FG000|Overall Study|Protocol Violation|1|||
46768235|NCT00836693|82986493|FG001|Overall Study|Protocol Violation|0|||
46768236|NCT00836693|82986492|FG000|Overall Study|Lost to Follow-up|1|||
46768237|NCT00836693|82986493|FG001|Overall Study|Lost to Follow-up|0|||
46768238|NCT00770484|82986501|FG000|Overall Study|Withdrawal by Subject|1|||
46768239|NCT00770484|82986502|FG001|Overall Study|Withdrawal by Subject|0|||
46837317|NCT00295022|83054888|FG000|Overall Study|Withdrawal by Subject|0|||
46837318|NCT00295022|83054889|FG001|Overall Study|Withdrawal by Subject|0|||
46768240|NCT00835679|82986512|FG000|Overall Study|Withdrawal by Subject|1|||
46768241|NCT00835679|82986513|FG001|Overall Study|Withdrawal by Subject|0|||
46768242|NCT00835679|82986514|FG002|Overall Study|Withdrawal by Subject|0|||
46768243|NCT00835679|82986515|FG003|Overall Study|Withdrawal by Subject|0|||
46768244|NCT00766506|82986531|FG000|Overall Study|Use rescue medication after 3 hours|3|||
46837319|NCT00295022|83054890|FG002|Overall Study|Withdrawal by Subject|2|||
46943400|NCT02901431|83180592|FG011|PK Part|Pending dose confirmation|0|||
46837320|NCT00303446|83054902|FG000|Overall Study|Withdrawal by Subject|2|||
46837321|NCT00303446|83054903|FG001|Overall Study|Withdrawal by Subject|2|||
46837322|NCT00303446|83054902|FG000|Overall Study|Death|0|||
46837323|NCT00303446|83054903|FG001|Overall Study|Death|1|||
46837324|NCT00303446|83054902|FG000|Overall Study|Physician Decision|0|||
46837325|NCT00303446|83054903|FG001|Overall Study|Physician Decision|1|||
46837326|NCT00316706|83054911|FG000|Overall Study|Lost to Follow-up|38|||
46837327|NCT00316706|83054912|FG001|Overall Study|Lost to Follow-up|48|||
46837328|NCT00291486|83054923|FG000|Overall Study|Adverse Event|0|||
46837329|NCT00291486|83054924|FG001|Overall Study|Adverse Event|3|||
46837330|NCT00291486|83054925|FG002|Overall Study|Adverse Event|0|||
46837331|NCT00291486|83054926|FG003|Overall Study|Adverse Event|1|||
46837332|NCT00291486|83054927|FG004|Overall Study|Adverse Event|0|||
46837333|NCT00291486|83054923|FG000|Overall Study|Withdrawal by Subject|0|||
46837334|NCT00291486|83054924|FG001|Overall Study|Withdrawal by Subject|0|||
47062665|NCT01497899|83343445|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
47062666|NCT01497275|83343452|FG000|Overall Study|Death|1|||
47062667|NCT01497275|83343452|FG000|Overall Study|Adverse Event|1|||
47062668|NCT01557517|83343458|FG000|Overall Study|Death|1|||
47062669|NCT01557517|83343459|FG001|Overall Study|Death|0|||
47062670|NCT01557517|83343458|FG000|Overall Study|Refused further treatment|0|||
47062671|NCT01557517|83343459|FG001|Overall Study|Refused further treatment|2|||
47062672|NCT01557517|83343458|FG000|Overall Study|Adverse Event|0|||
47062673|NCT01557517|83343459|FG001|Overall Study|Adverse Event|2|||
47062674|NCT01557517|83343458|FG000|Overall Study|Pt declined before treatment started|1|||
46837335|NCT00291486|83054925|FG002|Overall Study|Withdrawal by Subject|0|||
46837336|NCT00291486|83054926|FG003|Overall Study|Withdrawal by Subject|0|||
46837337|NCT00291486|83054927|FG004|Overall Study|Withdrawal by Subject|1|||
46837338|NCT00291486|83054923|FG000|Overall Study|Disease progression|1|||
46837339|NCT00291486|83054924|FG001|Overall Study|Disease progression|0|||
46837340|NCT00291486|83054925|FG002|Overall Study|Disease progression|1|||
46837341|NCT00291486|83054926|FG003|Overall Study|Disease progression|0|||
46837342|NCT00291486|83054927|FG004|Overall Study|Disease progression|0|||
46837343|NCT00301964|83054948|FG000|Overall Study|Second primary|2|||
46837344|NCT00301964|83054948|FG000|Overall Study|Wrong primary|1|||
46837345|NCT00301964|83054948|FG000|Overall Study|Inadequate pathology|1|||
46837346|NCT00268242|83054958|FG000|Overall Study|Death|1|||
46837347|NCT00294554|83054964|FG000|Overall Study|Lack of Efficacy|0|||
46943401|NCT02901431|83180593|FG012|PK Part|Pending dose confirmation|0|||
46943402|NCT02901431|83180581|FG000|PK Part|8 weeks of treatment ran out|2|||
46943403|NCT02901431|83180582|FG001|PK Part|8 weeks of treatment ran out|0|||
46943404|NCT02901431|83180583|FG002|PK Part|8 weeks of treatment ran out|0|||
46943405|NCT02901431|83180584|FG003|PK Part|8 weeks of treatment ran out|0|||
46943406|NCT02901431|83180585|FG004|PK Part|8 weeks of treatment ran out|0|||
46943407|NCT02901431|83180586|FG005|PK Part|8 weeks of treatment ran out|0|||
46943408|NCT02901431|83180587|FG006|PK Part|8 weeks of treatment ran out|0|||
46943409|NCT02901431|83180588|FG007|PK Part|8 weeks of treatment ran out|0|||
46943410|NCT02901431|83180589|FG008|PK Part|8 weeks of treatment ran out|0|||
46943411|NCT02901431|83180590|FG009|PK Part|8 weeks of treatment ran out|0|||
46943412|NCT02901431|83180591|FG010|PK Part|8 weeks of treatment ran out|0|||
46837348|NCT00294554|83054965|FG001|Overall Study|Lack of Efficacy|1|||
46837349|NCT00294554|83054964|FG000|Overall Study|Physician Decision|0|||
46943413|NCT02901431|83180592|FG011|PK Part|8 weeks of treatment ran out|0|||
46943414|NCT02901431|83180593|FG012|PK Part|8 weeks of treatment ran out|0|||
46943415|NCT02901431|83180581|FG000|PK Part|Stopped treatment after 8 weeks|1|||
46943416|NCT02901431|83180582|FG001|PK Part|Stopped treatment after 8 weeks|0|||
47062675|NCT01557517|83343459|FG001|Overall Study|Pt declined before treatment started|0|||
47062676|NCT01497197|83343474|FG000|Overall Study|Lost to Follow-up|1|||
46768245|NCT00766506|82986532|FG001|Overall Study|Use rescue medication after 3 hours|0|||
46768246|NCT00766506|82986531|FG000|Overall Study|Other|2|||
46768247|NCT00766506|82986532|FG001|Overall Study|Other|2|||
46768248|NCT00770328|82986540|FG000|Overall Study|Adverse Event|11|||
46768249|NCT00770328|82986541|FG001|Overall Study|Adverse Event|2|||
46768250|NCT00770328|82986540|FG000|Overall Study|Lost to Follow-up|2|||
46768251|NCT00770328|82986541|FG001|Overall Study|Lost to Follow-up|2|||
46768252|NCT00766038|82986549|FG000|Overall Study|Lost to Follow-up|15|||
46837350|NCT00294554|83054965|FG001|Overall Study|Physician Decision|1|||
46837351|NCT00294398|83054973|FG000|Overall Study|Lost to Follow-up|21|||
46837352|NCT00294398|83054974|FG001|Overall Study|Lost to Follow-up|26|||
46837353|NCT00279708|83054982|FG000|Overall Study|Withdrawal by Subject|2|||
46837354|NCT00279708|83054983|FG001|Overall Study|Withdrawal by Subject|3|||
46943417|NCT02901431|83180583|FG002|PK Part|Stopped treatment after 8 weeks|1|||
47062677|NCT01497197|83343475|FG001|Overall Study|Lost to Follow-up|0|||
47062678|NCT01497197|83343474|FG000|Overall Study|Protocol Violation|0|||
47062679|NCT01497197|83343475|FG001|Overall Study|Protocol Violation|2|||
47062680|NCT01497197|83343474|FG000|Overall Study|Withdrawal by Subject|2|||
46768253|NCT00766038|82986550|FG001|Overall Study|Lost to Follow-up|14|||
46768254|NCT00765882|82986561|FG000|Overall Study|Adverse Event|10|||
46837355|NCT00279708|83054982|FG000|Overall Study|Adverse Event|1|||
46837356|NCT00279708|83054983|FG001|Overall Study|Adverse Event|1|||
46837357|NCT00299702|83054991|FG000|Overall Study|Death|1|||
46837358|NCT00299702|83054992|FG001|Overall Study|Death|0|||
46837359|NCT00299702|83054991|FG000|Overall Study|Adverse Event|0|||
46837360|NCT00299702|83054992|FG001|Overall Study|Adverse Event|4|||
46837361|NCT00299702|83054991|FG000|Overall Study|Lost to Follow-up|18|||
46837362|NCT00299702|83054992|FG001|Overall Study|Lost to Follow-up|10|||
46943418|NCT02901431|83180584|FG003|PK Part|Stopped treatment after 8 weeks|0|||
46638173|NCT01492686|82811550|FG000|Open-label Phase|Withdrawal by Subject|6|||
46638174|NCT01492686|82811551|FG001|Open-label Phase|Withdrawal by Subject|7|||
46638175|NCT01492686|82811550|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
46638176|NCT01492686|82811551|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
46638177|NCT01449006|82811561|FG000|Overall Study|Lost to Follow-up|1|||
46638178|NCT01449006|82811562|FG001|Overall Study|Lost to Follow-up|0|||
46768255|NCT00765882|82986562|FG001|Overall Study|Adverse Event|21|||
46768256|NCT00765882|82986563|FG002|Overall Study|Adverse Event|20|||
46768257|NCT00765882|82986561|FG000|Overall Study|Lack of Efficacy|4|||
46768258|NCT00765882|82986562|FG001|Overall Study|Lack of Efficacy|0|||
46768259|NCT00765882|82986563|FG002|Overall Study|Lack of Efficacy|1|||
46768260|NCT00765882|82986561|FG000|Overall Study|Protocol Violation|4|||
46768261|NCT00765882|82986562|FG001|Overall Study|Protocol Violation|3|||
46768262|NCT00765882|82986563|FG002|Overall Study|Protocol Violation|1|||
46768263|NCT00765882|82986561|FG000|Overall Study|Withdrawal by Subject|2|||
46768264|NCT00765882|82986562|FG001|Overall Study|Withdrawal by Subject|6|||
46768265|NCT00765882|82986563|FG002|Overall Study|Withdrawal by Subject|6|||
46768266|NCT00765882|82986561|FG000|Overall Study|Lost to Follow-up|1|||
46768267|NCT00765882|82986562|FG001|Overall Study|Lost to Follow-up|9|||
46768268|NCT00765882|82986563|FG002|Overall Study|Lost to Follow-up|6|||
46768269|NCT00765882|82986561|FG000|Overall Study|Other Reason|3|||
46768270|NCT00765882|82986562|FG001|Overall Study|Other Reason|1|||
46768271|NCT00765882|82986563|FG002|Overall Study|Other Reason|2|||
46768272|NCT00769860|82986573|FG000|Overall Study|Withdrawal by Subject|2|||
46768273|NCT00769860|82986574|FG001|Overall Study|Withdrawal by Subject|0|||
46768274|NCT00858143|82986580|FG000|Overall Study|Adverse Event|16|||
46768275|NCT00858143|82986580|FG000|Overall Study|Lack of Efficacy|4|||
46768276|NCT00858143|82986580|FG000|Overall Study|Death|7|||
46768277|NCT00858143|82986580|FG000|Overall Study|Other|23|||
46768278|NCT00828113|82986586|FG000|Overall Study|Withdrawal by Subject|27|||
46768279|NCT00828113|82986587|FG001|Overall Study|Withdrawal by Subject|26|||
46768280|NCT00828113|82986586|FG000|Overall Study|Lost to Follow-up|3|||
46768281|NCT00828113|82986587|FG001|Overall Study|Lost to Follow-up|5|||
46768282|NCT00769704|82986595|FG000|Overall Study|Lost to Follow-up|3|||
46768283|NCT00769704|82986596|FG001|Overall Study|Lost to Follow-up|2|||
46768284|NCT00769704|82986595|FG000|Overall Study|Death|95|||
46768285|NCT00769704|82986596|FG001|Overall Study|Death|190|||
46768286|NCT00769704|82986595|FG000|Overall Study|Withdrawal by Subject|12|||
46768287|NCT00769704|82986596|FG001|Overall Study|Withdrawal by Subject|5|||
46768288|NCT00769704|82986595|FG000|Overall Study|Other|1|||
46768289|NCT00769704|82986596|FG001|Overall Study|Other|2|||
46768290|NCT00818753|82986606|FG000|Overall Study|Protocol Violation|1|||
46768291|NCT00818753|82986607|FG001|Overall Study|Protocol Violation|0|||
46768292|NCT00818753|82986608|FG002|Overall Study|Protocol Violation|0|||
46837363|NCT00299702|83054991|FG000|Overall Study|Withdrawal by Subject|25|||
46943419|NCT02901431|83180585|FG004|PK Part|Stopped treatment after 8 weeks|0|||
46638179|NCT01449006|82811561|FG000|Overall Study|Withdrawal by Subject|1|||
46768293|NCT00818753|82986606|FG000|Overall Study|Other reason (not specified)|0|||
46768294|NCT00818753|82986607|FG001|Overall Study|Other reason (not specified)|0|||
46768295|NCT00818753|82986608|FG002|Overall Study|Other reason (not specified)|1|||
46768296|NCT00818753|82986606|FG000|Overall Study|Randomised and not treated|2|||
46768297|NCT00818753|82986607|FG001|Overall Study|Randomised and not treated|0|||
46768298|NCT00818753|82986608|FG002|Overall Study|Randomised and not treated|0|||
46768299|NCT00765726|82986616|FG000|Overall Study|Withdrawal by Subject|1|||
46768300|NCT00765726|82986616|FG000|Overall Study|Discontinuation of study by sponsor|8|||
46768301|NCT00765336|82986622|FG000|Overall Study|Protocol Violation|4|||
46768302|NCT00765336|82986623|FG001|Overall Study|Protocol Violation|2|||
46768303|NCT00765336|82986622|FG000|Overall Study|Withdrawal by Subject|6|||
46837364|NCT00299702|83054992|FG001|Overall Study|Withdrawal by Subject|23|||
46943420|NCT02901431|83180586|FG005|PK Part|Stopped treatment after 8 weeks|0|||
46837365|NCT00299702|83054991|FG000|Overall Study|Pregnancy|0|||
46837366|NCT00299702|83054992|FG001|Overall Study|Pregnancy|1|||
46837367|NCT00299702|83054991|FG000|Overall Study|Insufficient Response|4|||
46837368|NCT00299702|83054992|FG001|Overall Study|Insufficient Response|3|||
46837369|NCT00299702|83054991|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
47062681|NCT01497197|83343475|FG001|Overall Study|Withdrawal by Subject|1|||
46837370|NCT00299702|83054992|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
46837371|NCT00291330|83055000|FG000|Overall Study|Adverse Event|47|||
47062682|NCT01497197|83343474|FG000|Overall Study|Excessive/lack of response to treatment|1|||
46837372|NCT00291330|83055001|FG001|Overall Study|Adverse Event|40|||
47062683|NCT01497197|83343475|FG001|Overall Study|Excessive/lack of response to treatment|0|||
47062684|NCT01497197|83343474|FG000|Overall Study|Risk of OHSS|1|||
46638180|NCT01449006|82811562|FG001|Overall Study|Withdrawal by Subject|0|||
46638181|NCT01449006|82811561|FG000|Overall Study|Protocol Violation|1|||
46638182|NCT01449006|82811562|FG001|Overall Study|Protocol Violation|0|||
46638183|NCT01448850|82811570|FG000|Overall Study|Death|3|||
46638184|NCT01448850|82811571|FG001|Overall Study|Death|6|||
46638185|NCT01448850|82811570|FG000|Overall Study|Withdrawal by Subject|13|||
46638186|NCT01448850|82811571|FG001|Overall Study|Withdrawal by Subject|21|||
46638187|NCT01448850|82811570|FG000|Overall Study|Lost to Follow-up|3|||
46638188|NCT01448850|82811571|FG001|Overall Study|Lost to Follow-up|1|||
46638189|NCT01448850|82811570|FG000|Overall Study|Other|15|||
46638190|NCT01448850|82811571|FG001|Overall Study|Other|12|||
46638191|NCT01491672|82811581|FG000|Overall Study|Lost to Follow-up|0|||
46638192|NCT01491672|82811582|FG001|Overall Study|Lost to Follow-up|4|||
46638193|NCT01491672|82811583|FG002|Overall Study|Lost to Follow-up|1|||
46638194|NCT01491672|82811581|FG000|Overall Study|Withdrawal by Subject|6|||
46638195|NCT01491672|82811582|FG001|Overall Study|Withdrawal by Subject|7|||
46638196|NCT01491672|82811583|FG002|Overall Study|Withdrawal by Subject|0|||
46638197|NCT01491672|82811581|FG000|Overall Study|Adverse Event|8|||
46638198|NCT01491672|82811582|FG001|Overall Study|Adverse Event|10|||
46638199|NCT01491672|82811583|FG002|Overall Study|Adverse Event|4|||
46638200|NCT01491672|82811581|FG000|Overall Study|Disease progression|42|||
46638201|NCT01491672|82811582|FG001|Overall Study|Disease progression|34|||
46638202|NCT01491672|82811583|FG002|Overall Study|Disease progression|6|||
46638203|NCT01491672|82811581|FG000|Overall Study|Protocol deviation|0|||
46638204|NCT01491672|82811582|FG001|Overall Study|Protocol deviation|1|||
46638205|NCT01491672|82811583|FG002|Overall Study|Protocol deviation|0|||
46638206|NCT01491672|82811581|FG000|Overall Study|Death|0|||
46638207|NCT01491672|82811582|FG001|Overall Study|Death|4|||
46638208|NCT01491672|82811583|FG002|Overall Study|Death|0|||
46638209|NCT01447446|82811599|FG000|Overall Study|Death|6|||
46638210|NCT01447446|82811600|FG001|Overall Study|Death|3|||
46638211|NCT01447446|82811601|FG002|Overall Study|Death|2|||
46837373|NCT00291330|83055000|FG000|Overall Study|Protocol Violation|13|||
46837374|NCT00291330|83055001|FG001|Overall Study|Protocol Violation|20|||
46837375|NCT00291330|83055000|FG000|Overall Study|Lost to Follow-up|16|||
46837376|NCT00291330|83055001|FG001|Overall Study|Lost to Follow-up|11|||
46837377|NCT00291330|83055000|FG000|Overall Study|Withdrawal by Subject|22|||
46837378|NCT00291330|83055001|FG001|Overall Study|Withdrawal by Subject|25|||
46837379|NCT00291330|83055000|FG000|Overall Study|Other|3|||
46837380|NCT00291330|83055001|FG001|Overall Study|Other|1|||
47062685|NCT01497197|83343475|FG001|Overall Study|Risk of OHSS|0|||
47062686|NCT01497197|83343474|FG000|Overall Study|No oocytes retrieved|3|||
47062687|NCT01497197|83343475|FG001|Overall Study|No oocytes retrieved|2|||
47062688|NCT01497197|83343474|FG000|Overall Study|No fertilisation|6|||
47062689|NCT01497197|83343475|FG001|Overall Study|No fertilisation|5|||
47062690|NCT01497197|83343474|FG000|Overall Study|Intention to freeze all embryos|0|||
47062691|NCT01497197|83343475|FG001|Overall Study|Intention to freeze all embryos|1|||
47062692|NCT01497197|83343474|FG000|Overall Study|All embryos discarded|0|||
47062693|NCT01497197|83343475|FG001|Overall Study|All embryos discarded|3|||
47062694|NCT01497197|83343474|FG000|Overall Study|Other|3|||
47062695|NCT01497197|83343475|FG001|Overall Study|Other|1|||
47062696|NCT01496885|83343481|FG000|Overall Study|Lost to Follow-up|13|||
47062697|NCT01496885|83343481|FG000|Overall Study|Withdrawal by Subject|7|||
47062698|NCT01496885|83343481|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
47062699|NCT01496885|83343481|FG000|Overall Study|Death|1|||
46638212|NCT01447446|82811602|FG003|Overall Study|Death|1|||
46638213|NCT01447446|82811603|FG004|Overall Study|Death|7|||
46638214|NCT01447446|82811604|FG005|Overall Study|Death|0|||
46638215|NCT01447446|82811599|FG000|Overall Study|Adverse Event|3|||
46837381|NCT00267150|83055007|FG000|Overall Study|Adverse Event|1|||
46837382|NCT00278148|83055011|FG000|Phase II - Expansion Phase|Disease progression|0|||
47062700|NCT01557283|83343485|FG000|Overall Study|Lost to Follow-up|7|||
47062701|NCT01557283|83343485|FG000|Overall Study|Non-responder|19|||
47062702|NCT01557283|83343485|FG000|Overall Study|Adverse Event|7|||
46638216|NCT01447446|82811600|FG001|Overall Study|Adverse Event|0|||
46638217|NCT01447446|82811601|FG002|Overall Study|Adverse Event|1|||
46638218|NCT01447446|82811602|FG003|Overall Study|Adverse Event|0|||
46638219|NCT01447446|82811603|FG004|Overall Study|Adverse Event|2|||
46638220|NCT01447446|82811604|FG005|Overall Study|Adverse Event|0|||
46638221|NCT01447446|82811599|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
46638222|NCT01447446|82811600|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
46638223|NCT01447446|82811601|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
46638224|NCT01447446|82811602|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
46638225|NCT01447446|82811603|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
46638226|NCT01447446|82811604|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
46638227|NCT01447446|82811599|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
46638228|NCT01447446|82811600|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
46638229|NCT01447446|82811601|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
46638230|NCT01447446|82811602|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
46638231|NCT01447446|82811603|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
46638232|NCT01447446|82811604|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
46638233|NCT01447446|82811599|FG000|Overall Study|Administrative/Other|34|||
46638234|NCT01447446|82811600|FG001|Overall Study|Administrative/Other|9|||
46638235|NCT01447446|82811601|FG002|Overall Study|Administrative/Other|10|||
46638236|NCT01447446|82811602|FG003|Overall Study|Administrative/Other|2|||
46638237|NCT01447446|82811603|FG004|Overall Study|Administrative/Other|33|||
46638238|NCT01447446|82811604|FG005|Overall Study|Administrative/Other|4|||
46638239|NCT01447446|82811599|FG000|Overall Study|SVR12 Assessment|13|||
46638240|NCT01447446|82811600|FG001|Overall Study|SVR12 Assessment|1|||
46638241|NCT01447446|82811601|FG002|Overall Study|SVR12 Assessment|2|||
46638242|NCT01447446|82811602|FG003|Overall Study|SVR12 Assessment|1|||
46638243|NCT01447446|82811603|FG004|Overall Study|SVR12 Assessment|5|||
46638244|NCT01447446|82811604|FG005|Overall Study|SVR12 Assessment|5|||
46638245|NCT01447446|82811599|FG000|Overall Study|New Treatment Started|8|||
46638246|NCT01447446|82811600|FG001|Overall Study|New Treatment Started|2|||
46638247|NCT01447446|82811601|FG002|Overall Study|New Treatment Started|1|||
46638248|NCT01447446|82811602|FG003|Overall Study|New Treatment Started|0|||
46638249|NCT01447446|82811603|FG004|Overall Study|New Treatment Started|2|||
46638250|NCT01447446|82811604|FG005|Overall Study|New Treatment Started|0|||
46638251|NCT01447446|82811599|FG000|Overall Study|Reason not Specified|1|||
46638252|NCT01447446|82811600|FG001|Overall Study|Reason not Specified|1|||
46638253|NCT01447446|82811601|FG002|Overall Study|Reason not Specified|1|||
46638254|NCT01447446|82811602|FG003|Overall Study|Reason not Specified|1|||
46638255|NCT01447446|82811603|FG004|Overall Study|Reason not Specified|1|||
46638256|NCT01447446|82811604|FG005|Overall Study|Reason not Specified|0|||
46638257|NCT01490814|82811626|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
46638258|NCT01490814|82811627|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
46638259|NCT01490814|82811626|FG000|Overall Study|Physician Decision|1|||
46638260|NCT01490814|82811627|FG001|Overall Study|Physician Decision|0|||
46638261|NCT01490814|82811626|FG000|Overall Study|Withdrawal by Subject|0|||
46837383|NCT00278148|83055012|FG001|Phase II - Expansion Phase|Disease progression|0|||
46638262|NCT01490814|82811627|FG001|Overall Study|Withdrawal by Subject|5|||
46638263|NCT01471782|82811639|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
46638264|NCT01471782|82811640|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
46638265|NCT01471782|82811641|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
46768304|NCT00765336|82986623|FG001|Overall Study|Withdrawal by Subject|4|||
46768305|NCT00765336|82986622|FG000|Overall Study|Lost to Follow-up|7|||
46768306|NCT00765336|82986623|FG001|Overall Study|Lost to Follow-up|9|||
46768307|NCT00765336|82986622|FG000|Overall Study|Adverse Event|2|||
46768308|NCT00765336|82986623|FG001|Overall Study|Adverse Event|1|||
46768309|NCT00818519|82986631|FG000|Overall Study|Adverse Event|2|||
46768310|NCT00818519|82986632|FG001|Overall Study|Adverse Event|2|||
46768311|NCT00818519|82986631|FG000|Overall Study|Lost to Follow-up|4|||
46768312|NCT00818519|82986632|FG001|Overall Study|Lost to Follow-up|6|||
46768313|NCT00818519|82986631|FG000|Overall Study|Protocol Violation|2|||
46768314|NCT00818519|82986632|FG001|Overall Study|Protocol Violation|1|||
46768315|NCT00818519|82986631|FG000|Overall Study|Pregnancy|0|||
46768316|NCT00818519|82986632|FG001|Overall Study|Pregnancy|1|||
46768317|NCT00818519|82986631|FG000|Overall Study|Withdrawal by Subject|4|||
46768318|NCT00818519|82986632|FG001|Overall Study|Withdrawal by Subject|9|||
46837384|NCT00278148|83055013|FG002|Phase II - Expansion Phase|Disease progression|4|||
46837385|NCT00278148|83055011|FG000|Phase II - Expansion Phase|Adverse Event|0|||
46837386|NCT00278148|83055012|FG001|Phase II - Expansion Phase|Adverse Event|0|||
46638266|NCT01471782|82811642|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
46638267|NCT01471782|82811643|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
46638268|NCT01471782|82811644|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
46768319|NCT00818519|82986631|FG000|Overall Study|participant recovered completely|1|||
46768320|NCT00818519|82986632|FG001|Overall Study|participant recovered completely|0|||
46768321|NCT00818519|82986631|FG000|Overall Study|participant will leave for long tme|1|||
46638269|NCT01471782|82811639|FG000|Overall Study|Lack of Efficacy|1|||
46638270|NCT01471782|82811640|FG001|Overall Study|Lack of Efficacy|2|||
46638271|NCT01471782|82811641|FG002|Overall Study|Lack of Efficacy|1|||
46638272|NCT01471782|82811642|FG003|Overall Study|Lack of Efficacy|1|||
46638273|NCT01471782|82811643|FG004|Overall Study|Lack of Efficacy|5|||
46638274|NCT01471782|82811644|FG005|Overall Study|Lack of Efficacy|18|||
46638275|NCT01471782|82811639|FG000|Overall Study|Adverse Event|1|||
46638276|NCT01471782|82811640|FG001|Overall Study|Adverse Event|1|||
46638277|NCT01471782|82811641|FG002|Overall Study|Adverse Event|2|||
46638278|NCT01471782|82811642|FG003|Overall Study|Adverse Event|2|||
46638279|NCT01471782|82811643|FG004|Overall Study|Adverse Event|3|||
46638280|NCT01471782|82811644|FG005|Overall Study|Adverse Event|1|||
46638281|NCT01471782|82811639|FG000|Overall Study|Other|0|||
46638282|NCT01471782|82811640|FG001|Overall Study|Other|0|||
46638283|NCT01471782|82811641|FG002|Overall Study|Other|1|||
46638284|NCT01471782|82811642|FG003|Overall Study|Other|1|||
46638285|NCT01471782|82811643|FG004|Overall Study|Other|6|||
46638286|NCT01471782|82811644|FG005|Overall Study|Other|5|||
46638287|NCT01471782|82811639|FG000|Overall Study|Change of Chemotherapy|1|||
46638288|NCT01471782|82811640|FG001|Overall Study|Change of Chemotherapy|1|||
46638289|NCT01471782|82811641|FG002|Overall Study|Change of Chemotherapy|0|||
46638290|NCT01471782|82811642|FG003|Overall Study|Change of Chemotherapy|0|||
46638291|NCT01471782|82811643|FG004|Overall Study|Change of Chemotherapy|1|||
46638292|NCT01471782|82811644|FG005|Overall Study|Change of Chemotherapy|4|||
46638293|NCT01471782|82811639|FG000|Overall Study|Disease Relapse|0|||
46638294|NCT01471782|82811640|FG001|Overall Study|Disease Relapse|0|||
46638295|NCT01471782|82811641|FG002|Overall Study|Disease Relapse|0|||
46638296|NCT01471782|82811642|FG003|Overall Study|Disease Relapse|1|||
46638297|NCT01471782|82811643|FG004|Overall Study|Disease Relapse|2|||
46638298|NCT01471782|82811644|FG005|Overall Study|Disease Relapse|1|||
46638299|NCT01471782|82811639|FG000|Overall Study|Physician Decision|0|||
46638300|NCT01471782|82811640|FG001|Overall Study|Physician Decision|0|||
46638301|NCT01471782|82811641|FG002|Overall Study|Physician Decision|0|||
46638302|NCT01471782|82811642|FG003|Overall Study|Physician Decision|0|||
46638303|NCT01471782|82811643|FG004|Overall Study|Physician Decision|3|||
46638304|NCT01471782|82811644|FG005|Overall Study|Physician Decision|8|||
46638305|NCT01471782|82811639|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46638306|NCT01471782|82811640|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46638307|NCT01471782|82811641|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
46638308|NCT01471782|82811642|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
46638309|NCT01471782|82811643|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
46638310|NCT01471782|82811644|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
46638311|NCT01471782|82811639|FG000|Overall Study|Death|0|||
46837387|NCT00278148|83055013|FG002|Phase II - Expansion Phase|Adverse Event|2|||
46837388|NCT00299546|83055023|FG000|Overall Study|Death|3|||
46837389|NCT00299546|83055024|FG001|Overall Study|Death|2|||
46837390|NCT00299546|83055025|FG002|Overall Study|Death|0|||
46837391|NCT00299546|83055023|FG000|Overall Study|Lost to Follow-up|2|||
46837392|NCT00299546|83055024|FG001|Overall Study|Lost to Follow-up|2|||
46837393|NCT00299546|83055025|FG002|Overall Study|Lost to Follow-up|5|||
46837394|NCT00299546|83055023|FG000|Overall Study|Adverse Event|37|||
46837395|NCT00299546|83055024|FG001|Overall Study|Adverse Event|22|||
46837396|NCT00299546|83055025|FG002|Overall Study|Adverse Event|27|||
46837397|NCT00299546|83055023|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
46837398|NCT00299546|83055024|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
46837399|NCT00299546|83055025|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
46837400|NCT00299546|83055023|FG000|Overall Study|Other|24|||
46638312|NCT01471782|82811640|FG001|Overall Study|Death|0|||
46638313|NCT01471782|82811641|FG002|Overall Study|Death|0|||
46638314|NCT01471782|82811642|FG003|Overall Study|Death|0|||
46638315|NCT01471782|82811643|FG004|Overall Study|Death|0|||
46638316|NCT01471782|82811644|FG005|Overall Study|Death|1|||
46638317|NCT01490580|82811671|FG000|Overall Study|Parents withdrew consent|0|||
46638318|NCT01490580|82811672|FG001|Overall Study|Parents withdrew consent|2|||
46638319|NCT01490190|82811682|FG000|Overall Study|Withdrawal by Subject|9|||
46638320|NCT01490190|82811682|FG000|Overall Study|Adverse Event|17|||
46638321|NCT01490190|82811682|FG000|Overall Study|Protocol Violation|5|||
46638322|NCT01490190|82811682|FG000|Overall Study|Lost to Follow-up|13|||
46638323|NCT01490190|82811682|FG000|Overall Study|Relocation|1|||
46638324|NCT01490190|82811682|FG000|Overall Study|Inconvenience|1|||
46638325|NCT01490190|82811682|FG000|Overall Study|Ring expulsion|2|||
46638326|NCT01446042|82811689|FG000|Overall Study|Withdrawal by Subject|12|||
46638327|NCT01446042|82811690|FG001|Overall Study|Withdrawal by Subject|2|||
46638328|NCT01446042|82811691|FG002|Overall Study|Withdrawal by Subject|4|||
46638329|NCT01446042|82811689|FG000|Overall Study|Adverse Event|1|||
46638330|NCT01446042|82811690|FG001|Overall Study|Adverse Event|0|||
46638331|NCT01446042|82811691|FG002|Overall Study|Adverse Event|4|||
46638332|NCT01446042|82811689|FG000|Overall Study|Lost to Follow-up|5|||
46638333|NCT01446042|82811690|FG001|Overall Study|Lost to Follow-up|0|||
46638334|NCT01446042|82811691|FG002|Overall Study|Lost to Follow-up|0|||
46638335|NCT01446042|82811689|FG000|Overall Study|Other reasons|2|||
46638336|NCT01446042|82811690|FG001|Overall Study|Other reasons|1|||
46638337|NCT01446042|82811691|FG002|Overall Study|Other reasons|1|||
46638338|NCT01445886|82811699|FG000|Overall Study|Lost to Follow-up|2|||
46638339|NCT01445886|82811699|FG000|Overall Study|Protocol Violation|3|||
46638340|NCT01470612|82811707|FG000|Overall Study|Adverse Event|20|||
46638341|NCT01470612|82811708|FG001|Overall Study|Adverse Event|80|||
46638342|NCT01470612|82811707|FG000|Overall Study|Death|0|||
46638343|NCT01470612|82811708|FG001|Overall Study|Death|1|||
46638344|NCT01470612|82811707|FG000|Overall Study|Lack of Efficacy|20|||
46638345|NCT01470612|82811708|FG001|Overall Study|Lack of Efficacy|326|||
46638346|NCT01470612|82811707|FG000|Overall Study|Lost to Follow-up|2|||
46638347|NCT01470612|82811708|FG001|Overall Study|Lost to Follow-up|5|||
46638348|NCT01470612|82811707|FG000|Overall Study|Did not meet entrance criteria|0|||
46638349|NCT01470612|82811708|FG001|Overall Study|Did not meet entrance criteria|1|||
46638350|NCT01470612|82811707|FG000|Overall Study|Pregnancy|2|||
46638351|NCT01470612|82811708|FG001|Overall Study|Pregnancy|10|||
46638352|NCT01470612|82811707|FG000|Overall Study|Protocol Violation|2|||
46638353|NCT01470612|82811708|FG001|Overall Study|Protocol Violation|7|||
46638354|NCT01470612|82811707|FG000|Overall Study|Withdrawal by Subject|24|||
46638355|NCT01470612|82811708|FG001|Overall Study|Withdrawal by Subject|79|||
46638356|NCT01470612|82811707|FG000|Overall Study|Other|14|||
46638357|NCT01470612|82811708|FG001|Overall Study|Other|156|||
46638358|NCT01445730|82811714|FG000|Overall Study|Adverse Event|1|||
46638359|NCT01445730|82811714|FG000|Overall Study|For the advice of a dentist|1|||
46638360|NCT01445730|82811714|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
46638361|NCT01445652|82811720|FG000|Overall Study|Not comfortable in lenses|5|||
46638362|NCT01445652|82811721|FG001|Overall Study|Not comfortable in lenses|0|||
46638363|NCT01445652|82811720|FG000|Overall Study|Failed to attend scheduled visit|2|||
46638364|NCT01445652|82811721|FG001|Overall Study|Failed to attend scheduled visit|3|||
46638365|NCT01445652|82811720|FG000|Overall Study|Failed teach session|2|||
46638366|NCT01445652|82811721|FG001|Overall Study|Failed teach session|0|||
46638367|NCT01445652|82811720|FG000|Overall Study|Adverse Event|1|||
46638368|NCT01445652|82811721|FG001|Overall Study|Adverse Event|0|||
46638369|NCT01470144|82811727|FG000|Overall Study|Adverse Event|2|||
46638370|NCT01470144|82811727|FG000|Overall Study|Death|1|||
46638371|NCT01470144|82811727|FG000|Overall Study|Lung transplant|6|||
46638372|NCT01470144|82811727|FG000|Overall Study|Patient's and investigator's decision|1|||
46638373|NCT01443858|82811734|FG000|Overall Study|Withdrawal by Subject|9|||
46638374|NCT01443858|82811735|FG001|Overall Study|Withdrawal by Subject|8|||
46638375|NCT01443858|82811736|FG002|Overall Study|Withdrawal by Subject|5|||
46638376|NCT01443858|82811734|FG000|Overall Study|Lack of Efficacy|1|||
46638377|NCT01443858|82811735|FG001|Overall Study|Lack of Efficacy|0|||
46638378|NCT01443858|82811736|FG002|Overall Study|Lack of Efficacy|0|||
46638379|NCT01443858|82811734|FG000|Overall Study|Lost to Follow-up|5|||
46638380|NCT01443858|82811735|FG001|Overall Study|Lost to Follow-up|5|||
46638381|NCT01443858|82811736|FG002|Overall Study|Lost to Follow-up|2|||
46638382|NCT01443078|82811744|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
46638383|NCT01443078|82811744|FG000|Overall Study|Withdrawal by Subject|1|||
46638384|NCT01443078|82811744|FG000|Overall Study|Patient had brain mets|1|||
46638385|NCT01439880|82811750|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
46638386|NCT01439880|82811751|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
46638387|NCT01439880|82811750|FG000|SOC-controlled Period (Year 1)|Death|2|||
46638388|NCT01439880|82811751|FG001|SOC-controlled Period (Year 1)|Death|1|||
46638389|NCT01439880|82811750|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
46638390|NCT01439880|82811751|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
46638391|NCT01439880|82811750|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
46638392|NCT01439880|82811751|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
46638393|NCT01439880|82811750|FG000|SOC-controlled Period (Year 1)|Other|8|||
46638394|NCT01439880|82811751|FG001|SOC-controlled Period (Year 1)|Other|13|||
46768322|NCT00818519|82986632|FG001|Overall Study|participant will leave for long tme|0|||
46768323|NCT00827567|82986638|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
46768324|NCT00765102|82986642|FG000|Overall Study|Progressive disease|18|||
46768325|NCT00765102|82986642|FG000|Overall Study|Adverse Event|6|||
46768326|NCT00765102|82986642|FG000|Overall Study|Physician Decision|4|||
46638395|NCT01439880|82811750|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
46638396|NCT01439880|82811751|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
46768327|NCT00765102|82986642|FG000|Overall Study|Withdrawal by Subject|2|||
46638397|NCT01439880|82811750|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
46638398|NCT01439880|82811751|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
46638399|NCT01439880|82811750|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
46638400|NCT01439880|82811751|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
46638401|NCT01439880|82811750|FG000|All-IP Period (Years 2 to 5)|Death|3|||
46638402|NCT01439880|82811751|FG001|All-IP Period (Years 2 to 5)|Death|13|||
46638403|NCT01439880|82811750|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
47062703|NCT01557283|83343485|FG000|Overall Study|Lack of Efficacy|1|||
46638404|NCT01439880|82811751|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
46638405|NCT01439880|82811750|FG000|All-IP Period (Years 2 to 5)|Other|14|||
46638406|NCT01439880|82811751|FG001|All-IP Period (Years 2 to 5)|Other|31|||
46638407|NCT01439880|82811750|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
46638408|NCT01439880|82811751|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
46638409|NCT01469364|82811768|FG000|Overall Study|Adverse Event|1|||
46638410|NCT01469364|82811768|FG000|Overall Study|Withdrawal by Subject|1|||
46638411|NCT01439724|82811774|FG000|Overall Study|missing consultation|9|||
46638412|NCT01439724|82811775|FG001|Overall Study|missing consultation|8|||
46638413|NCT01439568|82811783|FG000|Overall Study|Lost to Follow-up|1|||
46638414|NCT01439568|82811784|FG001|Overall Study|Lost to Follow-up|0|||
46638415|NCT01439568|82811783|FG000|Overall Study|Withdrawal by Subject|2|||
46638416|NCT01439568|82811784|FG001|Overall Study|Withdrawal by Subject|2|||
46638417|NCT01469052|82811796|FG000|Overall Study|Adverse Event|2|||
46638418|NCT01469052|82811797|FG001|Overall Study|Adverse Event|3|||
46638419|NCT01469052|82811798|FG002|Overall Study|Adverse Event|0|||
46638420|NCT01469052|82811799|FG003|Overall Study|Adverse Event|2|||
46638421|NCT01469052|82811800|FG004|Overall Study|Adverse Event|0|||
46638422|NCT01469052|82811801|FG005|Overall Study|Adverse Event|1|||
46638423|NCT01469052|82811796|FG000|Overall Study|Progressive disease|3|||
46638424|NCT01469052|82811797|FG001|Overall Study|Progressive disease|0|||
46638425|NCT01469052|82811798|FG002|Overall Study|Progressive disease|5|||
46638426|NCT01469052|82811799|FG003|Overall Study|Progressive disease|3|||
46638427|NCT01469052|82811800|FG004|Overall Study|Progressive disease|7|||
46638428|NCT01469052|82811801|FG005|Overall Study|Progressive disease|2|||
46638429|NCT01469052|82811796|FG000|Overall Study|Lack of Efficacy|0|||
46638430|NCT01469052|82811797|FG001|Overall Study|Lack of Efficacy|0|||
46638431|NCT01469052|82811798|FG002|Overall Study|Lack of Efficacy|0|||
46638432|NCT01469052|82811799|FG003|Overall Study|Lack of Efficacy|0|||
46638433|NCT01469052|82811800|FG004|Overall Study|Lack of Efficacy|0|||
46638434|NCT01469052|82811801|FG005|Overall Study|Lack of Efficacy|2|||
46638435|NCT01469052|82811796|FG000|Overall Study|Moved to rollover protocol|1|||
46638436|NCT01469052|82811797|FG001|Overall Study|Moved to rollover protocol|0|||
46638437|NCT01469052|82811798|FG002|Overall Study|Moved to rollover protocol|1|||
46638438|NCT01469052|82811799|FG003|Overall Study|Moved to rollover protocol|0|||
46638439|NCT01469052|82811800|FG004|Overall Study|Moved to rollover protocol|0|||
46638440|NCT01469052|82811801|FG005|Overall Study|Moved to rollover protocol|1|||
46638441|NCT01469052|82811796|FG000|Overall Study|Other|0|||
46638442|NCT01469052|82811797|FG001|Overall Study|Other|1|||
46638443|NCT01469052|82811798|FG002|Overall Study|Other|0|||
46638444|NCT01469052|82811799|FG003|Overall Study|Other|0|||
46638445|NCT01469052|82811800|FG004|Overall Study|Other|1|||
46638446|NCT01469052|82811801|FG005|Overall Study|Other|0|||
46638447|NCT01468818|82811813|FG000|Overall Study|Death during treatment|2|||
46638448|NCT01442376|82811820|FG000|Overall Study|Adverse Event|0|||
46638449|NCT01442376|82811821|FG001|Overall Study|Adverse Event|3|||
46768328|NCT00765102|82986642|FG000|Overall Study|Protocol Violation|1|||
46768329|NCT00809354|82986658|FG000|Overall Study|Adverse Event|32|||
46768330|NCT00809354|82986659|FG001|Overall Study|Adverse Event|45|||
46768331|NCT00809354|82986660|FG002|Overall Study|Adverse Event|37|||
46768332|NCT00809354|82986661|FG003|Overall Study|Adverse Event|53|||
46768333|NCT00809354|82986662|FG004|Overall Study|Adverse Event|26|||
46768334|NCT00809354|82986663|FG005|Overall Study|Adverse Event|33|||
46768335|NCT00809354|82986664|FG006|Overall Study|Adverse Event|44|||
47062704|NCT01557283|83343485|FG000|Overall Study|Non-compliance|1|||
47062705|NCT01557283|83343485|FG000|Overall Study|Withdrawal by Subject|1|||
47062706|NCT01557283|83343485|FG000|Overall Study|Participant's weight too high for dose|1|||
47062707|NCT01557283|83343485|FG000|Overall Study|Worsening of psoriasis|1|||
47062708|NCT01557283|83343485|FG000|Overall Study|Other|6|||
47062709|NCT01523743|83343502|FG000|Period 1|Adverse Event|1|||
47062710|NCT01523743|83343503|FG001|Period 1|Adverse Event|0|||
46768336|NCT00809354|82986665|FG007|Overall Study|Adverse Event|40|||
47062711|NCT01523743|83343502|FG000|Period 1|Withdrawal by Subject|6|||
47062712|NCT01523743|83343503|FG001|Period 1|Withdrawal by Subject|2|||
47062713|NCT01523743|83343502|FG000|Period 1|Lost to Follow-up|1|||
47062714|NCT01523743|83343503|FG001|Period 1|Lost to Follow-up|0|||
46638450|NCT01442376|82811822|FG002|Overall Study|Adverse Event|2|||
46638451|NCT01442376|82811820|FG000|Overall Study|Death|0|||
46638452|NCT01442376|82811821|FG001|Overall Study|Death|1|||
46638453|NCT01442376|82811822|FG002|Overall Study|Death|1|||
46638454|NCT01442376|82811820|FG000|Overall Study|Withdrawal of consent|0|||
46638455|NCT01442376|82811821|FG001|Overall Study|Withdrawal of consent|0|||
46638456|NCT01442376|82811822|FG002|Overall Study|Withdrawal of consent|1|||
46638457|NCT01442376|82811820|FG000|Overall Study|Patients not treated|2|||
47062715|NCT01523743|83343502|FG000|Period 1|Lack of Efficacy|1|||
47062716|NCT01523743|83343503|FG001|Period 1|Lack of Efficacy|0|||
46638458|NCT01442376|82811821|FG001|Overall Study|Patients not treated|3|||
46638459|NCT01442376|82811822|FG002|Overall Study|Patients not treated|1|||
46768337|NCT00809354|82986666|FG008|Overall Study|Adverse Event|46|||
46768338|NCT00809354|82986667|FG009|Overall Study|Adverse Event|26|||
47062717|NCT01523743|83343502|FG000|Period 1|Felt unable to empty bladder|1|||
47062718|NCT01523743|83343503|FG001|Period 1|Felt unable to empty bladder|0|||
47062719|NCT01523743|83343502|FG000|Period 2|Withdrawal by Subject|0|||
46638460|NCT01442376|82811820|FG000|Overall Study|Not eligible for subsequent cycles|1|||
46768339|NCT00809354|82986658|FG000|Overall Study|Lack of Efficacy|23|||
46638461|NCT01442376|82811821|FG001|Overall Study|Not eligible for subsequent cycles|2|||
46638462|NCT01442376|82811822|FG002|Overall Study|Not eligible for subsequent cycles|0|||
46638463|NCT01442064|82811836|FG000|Overall Study|Adverse Event|2|||
46638464|NCT01442064|82811837|FG001|Overall Study|Adverse Event|2|||
46638465|NCT01442064|82811838|FG002|Overall Study|Adverse Event|2|||
46638466|NCT01442064|82811839|FG003|Overall Study|Adverse Event|1|||
46638467|NCT01442064|82811840|FG004|Overall Study|Adverse Event|2|||
46638468|NCT01442064|82811841|FG005|Overall Study|Adverse Event|0|||
46638469|NCT01442064|82811836|FG000|Overall Study|Death|0|||
46638470|NCT01442064|82811837|FG001|Overall Study|Death|1|||
46768340|NCT00809354|82986659|FG001|Overall Study|Lack of Efficacy|23|||
46768341|NCT00809354|82986660|FG002|Overall Study|Lack of Efficacy|22|||
46768342|NCT00809354|82986661|FG003|Overall Study|Lack of Efficacy|15|||
46768343|NCT00809354|82986662|FG004|Overall Study|Lack of Efficacy|40|||
46768344|NCT00809354|82986663|FG005|Overall Study|Lack of Efficacy|19|||
46837401|NCT00299546|83055024|FG001|Overall Study|Other|26|||
46837402|NCT00299546|83055025|FG002|Overall Study|Other|19|||
46837403|NCT00299546|83055023|FG000|Overall Study|Not treated|0|||
46837404|NCT00299546|83055024|FG001|Overall Study|Not treated|1|||
46837405|NCT00299546|83055025|FG002|Overall Study|Not treated|1|||
46837406|NCT00299156|83055037|FG000|Period 2 (Randomized)|Screen Failure|0|||
46837407|NCT00299156|83055038|FG001|Period 2 (Randomized)|Screen Failure|1|||
46837408|NCT00299156|83055039|FG002|Period 2 (Randomized)|Screen Failure|0|||
46837409|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
46837410|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
46943421|NCT02901431|83180587|FG006|PK Part|Stopped treatment after 8 weeks|0|||
46943422|NCT02901431|83180588|FG007|PK Part|Stopped treatment after 8 weeks|0|||
46943423|NCT02901431|83180589|FG008|PK Part|Stopped treatment after 8 weeks|0|||
46943424|NCT02901431|83180590|FG009|PK Part|Stopped treatment after 8 weeks|0|||
46943425|NCT02901431|83180591|FG010|PK Part|Stopped treatment after 8 weeks|0|||
47062720|NCT01523743|83343503|FG001|Period 2|Withdrawal by Subject|2|||
47062721|NCT01523743|83343502|FG000|Period 2|Adverse Event|1|||
46768345|NCT00809354|82986664|FG006|Overall Study|Lack of Efficacy|21|||
46638471|NCT01442064|82811838|FG002|Overall Study|Death|3|||
46768346|NCT00809354|82986665|FG007|Overall Study|Lack of Efficacy|15|||
46768347|NCT00809354|82986666|FG008|Overall Study|Lack of Efficacy|18|||
46768348|NCT00809354|82986667|FG009|Overall Study|Lack of Efficacy|38|||
46768349|NCT00809354|82986658|FG000|Overall Study|Lost to Follow-up|10|||
46768350|NCT00809354|82986659|FG001|Overall Study|Lost to Follow-up|11|||
46768351|NCT00809354|82986660|FG002|Overall Study|Lost to Follow-up|8|||
46837411|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
46837412|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
46837413|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
46837414|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
46837415|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
46837416|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
46837417|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
46837418|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
46837419|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
46837420|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
46837421|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
47062722|NCT01523743|83343503|FG001|Period 2|Adverse Event|0|||
46638472|NCT01442064|82811839|FG003|Overall Study|Death|3|||
46638473|NCT01442064|82811840|FG004|Overall Study|Death|1|||
46638474|NCT01442064|82811841|FG005|Overall Study|Death|3|||
46768352|NCT00809354|82986661|FG003|Overall Study|Lost to Follow-up|13|||
46837422|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
46837423|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
46837424|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
46837425|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
46837426|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
46837427|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
46837428|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
46837429|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
46837430|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
46837431|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
46943426|NCT02901431|83180592|FG011|PK Part|Stopped treatment after 8 weeks|0|||
46768353|NCT00809354|82986662|FG004|Overall Study|Lost to Follow-up|6|||
46768354|NCT00809354|82986663|FG005|Overall Study|Lost to Follow-up|2|||
46768355|NCT00809354|82986664|FG006|Overall Study|Lost to Follow-up|0|||
46837432|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
46837433|NCT00277212|83055047|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
46837434|NCT00277212|83055048|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
46837435|NCT00277212|83055049|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
46837436|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
46837437|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
46837438|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
46837439|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
46837440|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
46837441|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
46837442|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
46837443|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
46837444|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
46837445|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
46837446|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
46837447|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
46837448|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
46837449|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
46837450|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
46837451|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
46837452|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
46837453|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
46837454|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
46837455|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
46837456|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
46943427|NCT02901431|83180593|FG012|PK Part|Stopped treatment after 8 weeks|0|||
46943428|NCT02901431|83180581|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
46943429|NCT02901431|83180582|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943430|NCT02901431|83180583|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
46943431|NCT02901431|83180584|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943432|NCT02901431|83180585|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943433|NCT02901431|83180586|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943434|NCT02901431|83180587|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943435|NCT02901431|83180588|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943436|NCT02901431|83180589|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943437|NCT02901431|83180590|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943438|NCT02901431|83180591|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943439|NCT02901431|83180592|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
47062723|NCT01496807|83343518|FG000|Overall Study|Progressive Disease|21|||
47062724|NCT01496807|83343518|FG000|Overall Study|Participant preference/toxicity|8|||
47062725|NCT01496807|83343518|FG000|Overall Study|Change in diagnosis|1|||
47073133|NCT01045161|83361495|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
47073134|NCT01045161|83361496|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
47073135|NCT00633217|83361515|FG000|Overall Study|Adverse Event|5|||
46768356|NCT00809354|82986665|FG007|Overall Study|Lost to Follow-up|5|||
46768357|NCT00809354|82986666|FG008|Overall Study|Lost to Follow-up|4|||
46768358|NCT00809354|82986667|FG009|Overall Study|Lost to Follow-up|0|||
46768359|NCT00809354|82986658|FG000|Overall Study|Protocol Violation|7|||
46768360|NCT00809354|82986659|FG001|Overall Study|Protocol Violation|14|||
46768361|NCT00809354|82986660|FG002|Overall Study|Protocol Violation|14|||
46768362|NCT00809354|82986661|FG003|Overall Study|Protocol Violation|12|||
46837457|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
46837458|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
46837459|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
46837460|NCT00277212|83055047|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
46837461|NCT00277212|83055048|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
46837462|NCT00277212|83055049|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
46837463|NCT00276744|83055057|FG000|PART A|Reason unknown|98|||
46837464|NCT00251316|83055063|FG000|Overall Study|Physician Decision|2|||
46837465|NCT00251316|83055064|FG001|Overall Study|Physician Decision|3|||
46837466|NCT00293462|83055073|FG000|Overall Study|Withdrawal by Subject|4|||
46837467|NCT00293462|83055074|FG001|Overall Study|Withdrawal by Subject|3|||
46837468|NCT00293462|83055075|FG002|Overall Study|Withdrawal by Subject|8|||
46837469|NCT00293462|83055073|FG000|Overall Study|Death|1|||
47073136|NCT00633217|83361516|FG001|Overall Study|Adverse Event|9|||
47073137|NCT00633217|83361515|FG000|Overall Study|Lack of Efficacy|0|||
47073138|NCT00633217|83361516|FG001|Overall Study|Lack of Efficacy|2|||
46768363|NCT00809354|82986662|FG004|Overall Study|Protocol Violation|14|||
46768364|NCT00809354|82986663|FG005|Overall Study|Protocol Violation|6|||
46837470|NCT00293462|83055074|FG001|Overall Study|Death|0|||
46837471|NCT00293462|83055075|FG002|Overall Study|Death|0|||
46837472|NCT00293462|83055073|FG000|Overall Study|Lost to Follow-up|0|||
46837473|NCT00293462|83055074|FG001|Overall Study|Lost to Follow-up|1|||
46837474|NCT00293462|83055075|FG002|Overall Study|Lost to Follow-up|0|||
46837475|NCT00293462|83055073|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
46837476|NCT00293462|83055074|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
46837477|NCT00293462|83055075|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
46837478|NCT00293462|83055073|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
46837479|NCT00293462|83055074|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
46837480|NCT00293462|83055075|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
46837481|NCT00293462|83055073|FG000|Overall Study|Refuse Radiation Treatment|1|||
46837482|NCT00293462|83055074|FG001|Overall Study|Refuse Radiation Treatment|0|||
46837483|NCT00293462|83055075|FG002|Overall Study|Refuse Radiation Treatment|0|||
46837484|NCT00293462|83055073|FG000|Overall Study|No Show|0|||
46837485|NCT00293462|83055074|FG001|Overall Study|No Show|0|||
46837486|NCT00293462|83055075|FG002|Overall Study|No Show|1|||
46837487|NCT00293462|83055073|FG000|Overall Study|Went back to his home country|0|||
46837488|NCT00293462|83055074|FG001|Overall Study|Went back to his home country|0|||
46837489|NCT00293462|83055075|FG002|Overall Study|Went back to his home country|1|||
46837490|NCT00293462|83055073|FG000|Overall Study|Blood clot after chemotherapy|0|||
46837491|NCT00293462|83055074|FG001|Overall Study|Blood clot after chemotherapy|0|||
46943440|NCT02901431|83180593|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
46943441|NCT02901431|83180581|FG000|PK Part|Discontinued per Sponsor|0|||
46943442|NCT02901431|83180582|FG001|PK Part|Discontinued per Sponsor|3|||
46943443|NCT02901431|83180583|FG002|PK Part|Discontinued per Sponsor|0|||
46943444|NCT02901431|83180584|FG003|PK Part|Discontinued per Sponsor|0|||
47062726|NCT01496183|83343524|FG000|Overall Study|Physician Decision|3|||
46768365|NCT00809354|82986664|FG006|Overall Study|Protocol Violation|4|||
46768366|NCT00809354|82986665|FG007|Overall Study|Protocol Violation|6|||
46768367|NCT00809354|82986666|FG008|Overall Study|Protocol Violation|9|||
46768368|NCT00809354|82986667|FG009|Overall Study|Protocol Violation|3|||
46768369|NCT00809354|82986658|FG000|Overall Study|Withdrawal by Subject|32|||
46768370|NCT00809354|82986659|FG001|Overall Study|Withdrawal by Subject|27|||
46768371|NCT00809354|82986660|FG002|Overall Study|Withdrawal by Subject|31|||
46768372|NCT00809354|82986661|FG003|Overall Study|Withdrawal by Subject|33|||
46768373|NCT00809354|82986662|FG004|Overall Study|Withdrawal by Subject|34|||
46768374|NCT00809354|82986663|FG005|Overall Study|Withdrawal by Subject|29|||
46768375|NCT00809354|82986664|FG006|Overall Study|Withdrawal by Subject|27|||
46768376|NCT00809354|82986665|FG007|Overall Study|Withdrawal by Subject|19|||
46768377|NCT00809354|82986666|FG008|Overall Study|Withdrawal by Subject|18|||
46768378|NCT00809354|82986667|FG009|Overall Study|Withdrawal by Subject|20|||
46768379|NCT00809354|82986658|FG000|Overall Study|Other|10|||
46768380|NCT00809354|82986659|FG001|Overall Study|Other|2|||
46768381|NCT00809354|82986660|FG002|Overall Study|Other|7|||
46768382|NCT00809354|82986661|FG003|Overall Study|Other|10|||
46768383|NCT00809354|82986662|FG004|Overall Study|Other|5|||
46768384|NCT00809354|82986663|FG005|Overall Study|Other|3|||
46768385|NCT00809354|82986664|FG006|Overall Study|Other|2|||
46768386|NCT00809354|82986665|FG007|Overall Study|Other|3|||
46768387|NCT00809354|82986666|FG008|Overall Study|Other|4|||
46768388|NCT00809354|82986667|FG009|Overall Study|Other|3|||
46768389|NCT00809354|82986658|FG000|Overall Study|Study terminated by sponsor|138|||
46768390|NCT00809354|82986659|FG001|Overall Study|Study terminated by sponsor|134|||
46768391|NCT00809354|82986660|FG002|Overall Study|Study terminated by sponsor|129|||
46768392|NCT00809354|82986661|FG003|Overall Study|Study terminated by sponsor|120|||
46768393|NCT00809354|82986662|FG004|Overall Study|Study terminated by sponsor|126|||
46837492|NCT00293462|83055075|FG002|Overall Study|Blood clot after chemotherapy|1|||
46837493|NCT00293462|83055073|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
46837494|NCT00293462|83055074|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
46837495|NCT00293462|83055075|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
46837496|NCT00293462|83055073|FG000|Overall Study|Possible Tracheostomy leakage|0|||
46943445|NCT02901431|83180585|FG004|PK Part|Discontinued per Sponsor|0|||
47062727|NCT01496183|83343525|FG001|Overall Study|Physician Decision|1|||
47062728|NCT01496183|83343524|FG000|Overall Study|Withdrawal by Subject|0|||
47062729|NCT01496183|83343525|FG001|Overall Study|Withdrawal by Subject|1|||
46768394|NCT00809354|82986663|FG005|Overall Study|Study terminated by sponsor|133|||
46768395|NCT00809354|82986664|FG006|Overall Study|Study terminated by sponsor|124|||
46768396|NCT00809354|82986665|FG007|Overall Study|Study terminated by sponsor|148|||
46768397|NCT00809354|82986666|FG008|Overall Study|Study terminated by sponsor|127|||
46768398|NCT00809354|82986667|FG009|Overall Study|Study terminated by sponsor|135|||
46768399|NCT00809354|82986658|FG000|Overall Study|Withdrawn due to pregnancy|0|||
46768400|NCT00809354|82986659|FG001|Overall Study|Withdrawn due to pregnancy|1|||
46768401|NCT00809354|82986660|FG002|Overall Study|Withdrawn due to pregnancy|0|||
46768402|NCT00809354|82986661|FG003|Overall Study|Withdrawn due to pregnancy|0|||
46768403|NCT00809354|82986662|FG004|Overall Study|Withdrawn due to pregnancy|0|||
46768404|NCT00809354|82986663|FG005|Overall Study|Withdrawn due to pregnancy|0|||
46943446|NCT02901431|83180586|FG005|PK Part|Discontinued per Sponsor|0|||
46943447|NCT02901431|83180587|FG006|PK Part|Discontinued per Sponsor|0|||
46943448|NCT02901431|83180588|FG007|PK Part|Discontinued per Sponsor|0|||
46943449|NCT02901431|83180589|FG008|PK Part|Discontinued per Sponsor|0|||
46943450|NCT02901431|83180590|FG009|PK Part|Discontinued per Sponsor|0|||
46943451|NCT02901431|83180591|FG010|PK Part|Discontinued per Sponsor|0|||
46943452|NCT02901431|83180592|FG011|PK Part|Discontinued per Sponsor|0|||
46943453|NCT02901431|83180593|FG012|PK Part|Discontinued per Sponsor|0|||
46943454|NCT02901431|83180581|FG000|PK Part|Withdrawal by Subject|1|||
46943455|NCT02901431|83180582|FG001|PK Part|Withdrawal by Subject|1|||
46943456|NCT02901431|83180583|FG002|PK Part|Withdrawal by Subject|3|||
46837497|NCT00293462|83055074|FG001|Overall Study|Possible Tracheostomy leakage|1|||
46837498|NCT00293462|83055075|FG002|Overall Study|Possible Tracheostomy leakage|0|||
46837499|NCT00293462|83055073|FG000|Overall Study|Low radiation dose in oral cavity|0|||
46837500|NCT00293462|83055074|FG001|Overall Study|Low radiation dose in oral cavity|1|||
46837501|NCT00293462|83055075|FG002|Overall Study|Low radiation dose in oral cavity|0|||
46837502|NCT00293462|83055073|FG000|Overall Study|Physician Decision|0|||
46837503|NCT00293462|83055074|FG001|Overall Study|Physician Decision|1|||
46837504|NCT00293462|83055075|FG002|Overall Study|Physician Decision|0|||
46837505|NCT00316082|83055088|FG000|Overall Study|Lack of Efficacy|2|||
46837506|NCT00316082|83055089|FG001|Overall Study|Lack of Efficacy|3|||
46837507|NCT00316082|83055090|FG002|Overall Study|Lack of Efficacy|3|||
46837508|NCT00316082|83055091|FG003|Overall Study|Lack of Efficacy|4|||
46837509|NCT00316082|83055092|FG004|Overall Study|Lack of Efficacy|6|||
46837510|NCT00316082|83055088|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
46837511|NCT00316082|83055089|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
46837512|NCT00316082|83055090|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
46837513|NCT00316082|83055091|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
46837514|NCT00316082|83055092|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
46837515|NCT00316082|83055088|FG000|Overall Study|Lost to Follow-up|7|||
46837516|NCT00316082|83055089|FG001|Overall Study|Lost to Follow-up|6|||
46837517|NCT00316082|83055090|FG002|Overall Study|Lost to Follow-up|7|||
46837518|NCT00316082|83055091|FG003|Overall Study|Lost to Follow-up|8|||
46837519|NCT00316082|83055092|FG004|Overall Study|Lost to Follow-up|6|||
46837520|NCT00316082|83055088|FG000|Overall Study|Poor/noncompliance|6|||
46837521|NCT00316082|83055089|FG001|Overall Study|Poor/noncompliance|1|||
46837522|NCT00316082|83055090|FG002|Overall Study|Poor/noncompliance|4|||
46837523|NCT00316082|83055091|FG003|Overall Study|Poor/noncompliance|1|||
46837524|NCT00316082|83055092|FG004|Overall Study|Poor/noncompliance|4|||
46837525|NCT00316082|83055088|FG000|Overall Study|Adverse Event|4|||
46837526|NCT00316082|83055089|FG001|Overall Study|Adverse Event|2|||
46837527|NCT00316082|83055090|FG002|Overall Study|Adverse Event|5|||
46837528|NCT00316082|83055091|FG003|Overall Study|Adverse Event|1|||
46943457|NCT02901431|83180584|FG003|PK Part|Withdrawal by Subject|0|||
46943458|NCT02901431|83180585|FG004|PK Part|Withdrawal by Subject|0|||
46943459|NCT02901431|83180586|FG005|PK Part|Withdrawal by Subject|0|||
46943460|NCT02901431|83180587|FG006|PK Part|Withdrawal by Subject|0|||
47062730|NCT01495793|83343532|FG000|Overall Study|Lost to Follow-up|1|||
47062731|NCT01495793|83343532|FG000|Overall Study|Violation of inclusion criteria|1|||
47062732|NCT01494467|83343538|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
46768405|NCT00809354|82986664|FG006|Overall Study|Withdrawn due to pregnancy|0|||
46837529|NCT00316082|83055092|FG004|Overall Study|Adverse Event|3|||
46837530|NCT00316082|83055088|FG000|Overall Study|Subject no longer meets study criteria|3|||
46837531|NCT00316082|83055089|FG001|Overall Study|Subject no longer meets study criteria|1|||
46837532|NCT00316082|83055090|FG002|Overall Study|Subject no longer meets study criteria|2|||
46837533|NCT00316082|83055091|FG003|Overall Study|Subject no longer meets study criteria|2|||
46943461|NCT02901431|83180588|FG007|PK Part|Withdrawal by Subject|0|||
46943462|NCT02901431|83180589|FG008|PK Part|Withdrawal by Subject|0|||
46943463|NCT02901431|83180590|FG009|PK Part|Withdrawal by Subject|0|||
47062733|NCT01494467|83343539|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
46768406|NCT00809354|82986665|FG007|Overall Study|Withdrawn due to pregnancy|0|||
46768407|NCT00809354|82986666|FG008|Overall Study|Withdrawn due to pregnancy|0|||
46768408|NCT00809354|82986667|FG009|Overall Study|Withdrawn due to pregnancy|0|||
46768409|NCT00809354|82986658|FG000|Overall Study|Randomized but not Treated|3|||
46768410|NCT00809354|82986659|FG001|Overall Study|Randomized but not Treated|1|||
46768411|NCT00809354|82986660|FG002|Overall Study|Randomized but not Treated|6|||
46768412|NCT00809354|82986661|FG003|Overall Study|Randomized but not Treated|0|||
46768413|NCT00809354|82986662|FG004|Overall Study|Randomized but not Treated|5|||
46837534|NCT00316082|83055092|FG004|Overall Study|Subject no longer meets study criteria|1|||
46837535|NCT00316082|83055088|FG000|Overall Study|Physician Decision|1|||
46837536|NCT00316082|83055089|FG001|Overall Study|Physician Decision|1|||
46837537|NCT00316082|83055090|FG002|Overall Study|Physician Decision|2|||
46837538|NCT00316082|83055091|FG003|Overall Study|Physician Decision|1|||
46837539|NCT00316082|83055092|FG004|Overall Study|Physician Decision|1|||
46768414|NCT00809354|82986663|FG005|Overall Study|Randomized but not Treated|0|||
46943464|NCT02901431|83180591|FG010|PK Part|Withdrawal by Subject|0|||
46943465|NCT02901431|83180592|FG011|PK Part|Withdrawal by Subject|0|||
46943466|NCT02901431|83180593|FG012|PK Part|Withdrawal by Subject|0|||
46943467|NCT02901431|83180581|FG000|Main Treatment Part|Adverse Event|0|||
46943468|NCT02901431|83180582|FG001|Main Treatment Part|Adverse Event|0|||
46943469|NCT02901431|83180583|FG002|Main Treatment Part|Adverse Event|0|||
46943470|NCT02901431|83180584|FG003|Main Treatment Part|Adverse Event|3|||
46943471|NCT02901431|83180585|FG004|Main Treatment Part|Adverse Event|3|||
46943472|NCT02901431|83180586|FG005|Main Treatment Part|Adverse Event|4|||
46943473|NCT02901431|83180587|FG006|Main Treatment Part|Adverse Event|1|||
46943474|NCT02901431|83180588|FG007|Main Treatment Part|Adverse Event|0|||
46943475|NCT02901431|83180589|FG008|Main Treatment Part|Adverse Event|0|||
46943476|NCT02901431|83180590|FG009|Main Treatment Part|Adverse Event|0|||
46943477|NCT02901431|83180591|FG010|Main Treatment Part|Adverse Event|0|||
46943478|NCT02901431|83180592|FG011|Main Treatment Part|Adverse Event|0|||
46943479|NCT02901431|83180593|FG012|Main Treatment Part|Adverse Event|0|||
46943480|NCT02901431|83180581|FG000|Main Treatment Part|Lack of Efficacy|0|||
46943481|NCT02901431|83180582|FG001|Main Treatment Part|Lack of Efficacy|0|||
46837540|NCT00316082|83055088|FG000|Overall Study|Death|0|||
46837541|NCT00316082|83055089|FG001|Overall Study|Death|0|||
46837542|NCT00316082|83055090|FG002|Overall Study|Death|1|||
46837543|NCT00316082|83055091|FG003|Overall Study|Death|0|||
46837544|NCT00316082|83055092|FG004|Overall Study|Death|0|||
46837545|NCT00316082|83055088|FG000|Overall Study|Administrative reason by sponsor|0|||
46837546|NCT00316082|83055089|FG001|Overall Study|Administrative reason by sponsor|0|||
46837547|NCT00316082|83055090|FG002|Overall Study|Administrative reason by sponsor|1|||
46837548|NCT00316082|83055091|FG003|Overall Study|Administrative reason by sponsor|0|||
46837549|NCT00316082|83055092|FG004|Overall Study|Administrative reason by sponsor|0|||
46837550|NCT00316004|83055111|FG000|Overall Study|Subject was not given study fluid.|14|||
46837551|NCT00316004|83055112|FG001|Overall Study|Subject was not given study fluid.|14|||
46837552|NCT00316004|83055113|FG002|Overall Study|Subject was not given study fluid.|21|||
46768415|NCT00809354|82986664|FG006|Overall Study|Randomized but not Treated|1|||
46943482|NCT02901431|83180583|FG002|Main Treatment Part|Lack of Efficacy|0|||
46943483|NCT02901431|83180584|FG003|Main Treatment Part|Lack of Efficacy|1|||
46943484|NCT02901431|83180585|FG004|Main Treatment Part|Lack of Efficacy|0|||
46943485|NCT02901431|83180586|FG005|Main Treatment Part|Lack of Efficacy|0|||
46943486|NCT02901431|83180587|FG006|Main Treatment Part|Lack of Efficacy|0|||
46943487|NCT02901431|83180588|FG007|Main Treatment Part|Lack of Efficacy|0|||
46943488|NCT02901431|83180589|FG008|Main Treatment Part|Lack of Efficacy|0|||
46943489|NCT02901431|83180590|FG009|Main Treatment Part|Lack of Efficacy|0|||
46943490|NCT02901431|83180591|FG010|Main Treatment Part|Lack of Efficacy|0|||
46943491|NCT02901431|83180592|FG011|Main Treatment Part|Lack of Efficacy|0|||
46943492|NCT02901431|83180593|FG012|Main Treatment Part|Lack of Efficacy|0|||
46943493|NCT02901431|83180581|FG000|Main Treatment Part|Lost to Follow-up|0|||
46837553|NCT00298766|83055121|FG000|Overall Study|Adverse Event|18|||
46837554|NCT00298766|83055121|FG000|Overall Study|Death|2|||
46837555|NCT00298766|83055121|FG000|Overall Study|Withdrawal by Subject|9|||
46943494|NCT02901431|83180582|FG001|Main Treatment Part|Lost to Follow-up|0|||
47062734|NCT01494467|83343538|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
47062735|NCT01494467|83343539|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
47062736|NCT01494467|83343538|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
46638475|NCT01442064|82811836|FG000|Overall Study|Lost to Follow-up|5|||
46768416|NCT00809354|82986665|FG007|Overall Study|Randomized but not Treated|1|||
46768417|NCT00809354|82986666|FG008|Overall Study|Randomized but not Treated|2|||
46768418|NCT00809354|82986667|FG009|Overall Study|Randomized but not Treated|1|||
46768419|NCT00809354|82986658|FG000|Overall Study|Death|0|||
46768420|NCT00809354|82986659|FG001|Overall Study|Death|0|||
46768421|NCT00809354|82986660|FG002|Overall Study|Death|0|||
46768422|NCT00809354|82986661|FG003|Overall Study|Death|0|||
46768423|NCT00809354|82986662|FG004|Overall Study|Death|0|||
46768424|NCT00809354|82986663|FG005|Overall Study|Death|0|||
46837556|NCT00298766|83055121|FG000|Overall Study|Treatment ongoing|4|||
47062737|NCT01494467|83343539|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
46837557|NCT00298766|83055121|FG000|Overall Study|Progression of amyloid markers|4|||
46837558|NCT00298766|83055121|FG000|Overall Study|Deterioration in KPS and organ function|1|||
47062738|NCT01494467|83343538|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
46837559|NCT00298766|83055121|FG000|Overall Study|Subjects overall condition deterioration|4|||
46837560|NCT00298766|83055121|FG000|Overall Study|Other|4|||
46837561|NCT00315458|83055127|FG000|Overall Study|Administrative|0|||
46768425|NCT00809354|82986664|FG006|Overall Study|Death|0|||
46768426|NCT00809354|82986665|FG007|Overall Study|Death|1|||
46768427|NCT00809354|82986666|FG008|Overall Study|Death|0|||
46768428|NCT00809354|82986667|FG009|Overall Study|Death|0|||
46943495|NCT02901431|83180583|FG002|Main Treatment Part|Lost to Follow-up|0|||
46943496|NCT02901431|83180584|FG003|Main Treatment Part|Lost to Follow-up|3|||
46943497|NCT02901431|83180585|FG004|Main Treatment Part|Lost to Follow-up|1|||
46943498|NCT02901431|83180586|FG005|Main Treatment Part|Lost to Follow-up|2|||
46943499|NCT02901431|83180587|FG006|Main Treatment Part|Lost to Follow-up|3|||
46943500|NCT02901431|83180588|FG007|Main Treatment Part|Lost to Follow-up|0|||
46837562|NCT00315458|83055128|FG001|Overall Study|Administrative|3|||
46837563|NCT00315458|83055129|FG002|Overall Study|Administrative|8|||
46837564|NCT00315458|83055130|FG003|Overall Study|Administrative|21|||
46837565|NCT00315458|83055127|FG000|Overall Study|Adverse Event|2|||
46837566|NCT00315458|83055128|FG001|Overall Study|Adverse Event|4|||
46837567|NCT00315458|83055129|FG002|Overall Study|Adverse Event|23|||
46837568|NCT00315458|83055130|FG003|Overall Study|Adverse Event|3|||
46837569|NCT00315458|83055127|FG000|Overall Study|Lost to Follow-up|1|||
46837570|NCT00315458|83055128|FG001|Overall Study|Lost to Follow-up|2|||
46837571|NCT00315458|83055129|FG002|Overall Study|Lost to Follow-up|0|||
46837572|NCT00315458|83055130|FG003|Overall Study|Lost to Follow-up|2|||
46837573|NCT00315458|83055127|FG000|Overall Study|Withdrawal by Subject|0|||
46837574|NCT00315458|83055128|FG001|Overall Study|Withdrawal by Subject|3|||
46837575|NCT00315458|83055129|FG002|Overall Study|Withdrawal by Subject|0|||
46837576|NCT00315458|83055130|FG003|Overall Study|Withdrawal by Subject|2|||
46837577|NCT00315458|83055127|FG000|Overall Study|Lack of Efficacy|0|||
46837578|NCT00315458|83055128|FG001|Overall Study|Lack of Efficacy|0|||
46837579|NCT00315458|83055129|FG002|Overall Study|Lack of Efficacy|20|||
46837580|NCT00315458|83055130|FG003|Overall Study|Lack of Efficacy|1|||
46837581|NCT00315458|83055127|FG000|Overall Study|Did not qualify|0|||
46837582|NCT00315458|83055128|FG001|Overall Study|Did not qualify|0|||
46837583|NCT00315458|83055129|FG002|Overall Study|Did not qualify|1|||
46837584|NCT00315458|83055130|FG003|Overall Study|Did not qualify|0|||
46943501|NCT02901431|83180589|FG008|Main Treatment Part|Lost to Follow-up|0|||
46943502|NCT02901431|83180590|FG009|Main Treatment Part|Lost to Follow-up|0|||
46768429|NCT00834899|82986696|FG000|Overall Study|Withdrawal by Subject|1|||
46768430|NCT00834899|82986697|FG001|Overall Study|Withdrawal by Subject|1|||
46768431|NCT00764946|82986706|FG000|Overall Study|Lack of Efficacy|1|||
46768432|NCT00764946|82986707|FG001|Overall Study|Lack of Efficacy|0|||
46768433|NCT00764946|82986708|FG002|Overall Study|Lack of Efficacy|0|||
46768434|NCT00764946|82986706|FG000|Overall Study|Lost to Follow-up|3|||
46768435|NCT00764946|82986707|FG001|Overall Study|Lost to Follow-up|4|||
46768436|NCT00764946|82986708|FG002|Overall Study|Lost to Follow-up|0|||
46768437|NCT00764946|82986706|FG000|Overall Study|Physician Decision|2|||
46768438|NCT00764946|82986707|FG001|Overall Study|Physician Decision|4|||
46768439|NCT00764946|82986708|FG002|Overall Study|Physician Decision|0|||
46768440|NCT00764946|82986706|FG000|Overall Study|Adverse Event|3|||
46768441|NCT00764946|82986707|FG001|Overall Study|Adverse Event|2|||
46768442|NCT00764946|82986708|FG002|Overall Study|Adverse Event|1|||
46768443|NCT00764946|82986706|FG000|Overall Study|Withdrawal by Subject|3|||
46768444|NCT00764946|82986707|FG001|Overall Study|Withdrawal by Subject|6|||
46768445|NCT00764946|82986708|FG002|Overall Study|Withdrawal by Subject|2|||
46768446|NCT00764946|82986706|FG000|Overall Study|Never Treated|1|||
46768447|NCT00764946|82986707|FG001|Overall Study|Never Treated|1|||
46768448|NCT00764946|82986708|FG002|Overall Study|Never Treated|1|||
46768449|NCT00764868|82986722|FG000|Overall Study|Adverse Event|18|||
46837585|NCT00293384|83055140|FG000|Overall Study|Non-compliance|2|||
46837586|NCT00293384|83055140|FG000|Overall Study|Missed dosage/study drug|1|||
46768450|NCT00764868|82986722|FG000|Overall Study|Withdrawal by Subject|31|||
46768451|NCT00764868|82986722|FG000|Overall Study|Non-compliance|16|||
46768452|NCT00764868|82986722|FG000|Overall Study|Lost to Follow-up|25|||
46768453|NCT00764868|82986722|FG000|Overall Study|Lack of Efficacy|5|||
46768454|NCT00764868|82986722|FG000|Overall Study|Subject moved|7|||
46768455|NCT00764868|82986722|FG000|Overall Study|Pregnancy|3|||
46768456|NCT00764868|82986722|FG000|Overall Study|Prohibited medication|1|||
46837587|NCT00293384|83055140|FG000|Overall Study|Ineligible|2|||
46837588|NCT00297830|83055147|FG000|6 Month Visit|Death|1|||
46837589|NCT00297830|83055148|FG001|6 Month Visit|Death|0|||
46837590|NCT00297830|83055149|FG002|6 Month Visit|Death|2|||
46837591|NCT00297830|83055147|FG000|6 Month Visit|Withdrawal by Subject|2|||
46837592|NCT00297830|83055148|FG001|6 Month Visit|Withdrawal by Subject|1|||
46837593|NCT00297830|83055149|FG002|6 Month Visit|Withdrawal by Subject|1|||
46837594|NCT00297830|83055147|FG000|6 Month Visit|Adverse Event|0|||
47062739|NCT01494467|83343539|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
47062740|NCT01494467|83343538|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
46837595|NCT00297830|83055148|FG001|6 Month Visit|Adverse Event|1|||
46837596|NCT00297830|83055149|FG002|6 Month Visit|Adverse Event|0|||
46837597|NCT00297830|83055147|FG000|12 Month Visit|Lost to Follow-up|1|||
46837598|NCT00297830|83055148|FG001|12 Month Visit|Lost to Follow-up|0|||
46837599|NCT00297830|83055149|FG002|12 Month Visit|Lost to Follow-up|0|||
46837600|NCT00297830|83055147|FG000|12 Month Visit|Adverse Event|0|||
46837601|NCT00297830|83055148|FG001|12 Month Visit|Adverse Event|3|||
46837602|NCT00297830|83055149|FG002|12 Month Visit|Adverse Event|0|||
46837603|NCT00297830|83055147|FG000|12 Month Visit|Withdrawal by Subject|0|||
46837604|NCT00297830|83055148|FG001|12 Month Visit|Withdrawal by Subject|3|||
46837605|NCT00297830|83055149|FG002|12 Month Visit|Withdrawal by Subject|0|||
46837606|NCT00296816|83055159|FG000|Overall Study|Disease Progression|37|||
46837607|NCT00296816|83055159|FG000|Overall Study|Adverse Event|18|||
46837608|NCT00296816|83055159|FG000|Overall Study|Investigator/Participant request|5|||
46837609|NCT00296816|83055159|FG000|Overall Study|Non-compliance|1|||
46837610|NCT00296816|83055159|FG000|Overall Study|Missing for end of treatment|4|||
46837611|NCT00296816|83055159|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
46837612|NCT00296816|83055159|FG000|Overall Study|Poor performance status|1|||
46837613|NCT00296816|83055159|FG000|Overall Study|Relocation to Florida|1|||
46837614|NCT00296816|83055159|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
46837615|NCT00296816|83055159|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
46837616|NCT00296816|83055159|FG000|Overall Study|Neuropathy/patient preference|1|||
46837617|NCT00296816|83055159|FG000|Overall Study|Proteinuria|1|||
46837618|NCT00296816|83055159|FG000|Overall Study|ineligibility due to radiation treatment|1|||
46837619|NCT00314132|83055165|FG000|Overall Study|Lost to Follow-up|3|||
46837620|NCT00314132|83055166|FG001|Overall Study|Lost to Follow-up|13|||
46837621|NCT00314132|83055165|FG000|Overall Study|Withdrawal by Subject|3|||
46837622|NCT00314132|83055166|FG001|Overall Study|Withdrawal by Subject|5|||
46837623|NCT00314132|83055165|FG000|Overall Study|Adverse Event|1|||
46837624|NCT00314132|83055166|FG001|Overall Study|Adverse Event|0|||
46837625|NCT00314132|83055165|FG000|Overall Study|Physician Decision|1|||
46837626|NCT00314132|83055166|FG001|Overall Study|Physician Decision|0|||
46837627|NCT00117988|83055174|FG000|Overall Study|Death|3|||
46837628|NCT00117988|83055174|FG000|Overall Study|Adverse Event|1|||
46837629|NCT00117676|83055180|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
46837630|NCT00117676|83055181|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
46837631|NCT00117676|83055180|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
46837632|NCT00117676|83055181|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
46837633|NCT00117676|83055180|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
46837634|NCT00117676|83055181|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
46837635|NCT00117676|83055180|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
46837636|NCT00117676|83055181|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
46837637|NCT00117676|83055180|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
46837638|NCT00117676|83055181|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
46837639|NCT00117676|83055180|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
47062741|NCT01494467|83343539|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
47062742|NCT01494467|83343538|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
47062743|NCT01494467|83343539|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
47062744|NCT01494467|83343538|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
47062745|NCT01494467|83343539|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
47062746|NCT01494467|83343538|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
47062747|NCT01494467|83343539|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
47073139|NCT00633217|83361515|FG000|Overall Study|Protocol Violation|3|||
46768457|NCT00764868|82986722|FG000|Overall Study|Out of town|1|||
46768458|NCT00764868|82986722|FG000|Overall Study|Misuse and compliance of study drug|1|||
46768459|NCT00764868|82986722|FG000|Overall Study|Subject sent to boarding school|1|||
46768460|NCT00764868|82986722|FG000|Overall Study|Met an exclusion criteria|1|||
46768461|NCT00764868|82986722|FG000|Overall Study|Positive drug screen|2|||
46768462|NCT00764868|82986722|FG000|Overall Study|Sponsor requested withdrawal|1|||
46768463|NCT00764790|82986729|FG000|Overall Study|Protocol Violation|0|||
46768464|NCT00764790|82986730|FG001|Overall Study|Protocol Violation|0|||
46837640|NCT00117676|83055181|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
46837641|NCT00117676|83055180|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
46846488|NCT00131664|83063149|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
46837642|NCT00117676|83055181|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
46837643|NCT00117676|83055180|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
46837644|NCT00117676|83055181|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
46837645|NCT00117676|83055180|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
46837646|NCT00117676|83055181|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
46837647|NCT00117676|83055180|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
46837648|NCT00117676|83055181|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
46837649|NCT00117676|83055180|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
46837650|NCT00117676|83055181|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
46837651|NCT00117676|83055180|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
46837652|NCT00117676|83055181|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
46837653|NCT00117676|83055180|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
46837654|NCT00117676|83055181|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
46837655|NCT00117676|83055180|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
46837656|NCT00117676|83055181|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
46837657|NCT00117676|83055180|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
46837658|NCT00117676|83055181|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
46837659|NCT00117676|83055180|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
46837660|NCT00117676|83055181|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
46837661|NCT00117676|83055180|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
46837662|NCT00117676|83055181|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
46837663|NCT00117676|83055180|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
46837664|NCT00117676|83055181|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
46837665|NCT00117676|83055180|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
46837666|NCT00117676|83055181|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
46837667|NCT00117676|83055180|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
46837668|NCT00117676|83055181|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
46837669|NCT00117676|83055180|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
46837670|NCT00117676|83055181|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
46837671|NCT00117676|83055180|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
46837672|NCT00117676|83055181|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
46837673|NCT00117676|83055180|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
46837674|NCT00117676|83055181|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
46837675|NCT00117676|83055180|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
46837676|NCT00117676|83055181|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
46837677|NCT00117676|83055180|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
46837678|NCT00117676|83055181|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
46837679|NCT00117676|83055180|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
46837680|NCT00117676|83055181|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
46837681|NCT00117676|83055180|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
47062748|NCT01494467|83343538|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
47062749|NCT01494467|83343539|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
46638476|NCT01442064|82811837|FG001|Overall Study|Lost to Follow-up|5|||
46837682|NCT00117676|83055181|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
46837683|NCT00117676|83055180|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
46837684|NCT00117676|83055181|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
46837685|NCT00117676|83055180|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
46837686|NCT00117676|83055181|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
46837687|NCT00117676|83055180|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
46967804|NCT01595529|83210381|FG000|Overall Study|Protocol Violation|1|||
46967805|NCT01595529|83210382|FG001|Overall Study|Protocol Violation|2|||
46967806|NCT01595529|83210381|FG000|Overall Study|Physician Decision|1|||
46967807|NCT01595529|83210382|FG001|Overall Study|Physician Decision|0|||
46967808|NCT01595529|83210381|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
46967809|NCT01595529|83210382|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
46967810|NCT01595529|83210381|FG000|Overall Study|Administrative Decision|1|||
46967811|NCT01595529|83210382|FG001|Overall Study|Administrative Decision|0|||
47062750|NCT01494467|83343538|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
47062751|NCT01494467|83343539|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
47062752|NCT01494467|83343538|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
46638477|NCT01442064|82811838|FG002|Overall Study|Lost to Follow-up|1|||
46638478|NCT01442064|82811839|FG003|Overall Study|Lost to Follow-up|1|||
46638479|NCT01442064|82811840|FG004|Overall Study|Lost to Follow-up|3|||
46638480|NCT01442064|82811841|FG005|Overall Study|Lost to Follow-up|3|||
46638481|NCT01442064|82811836|FG000|Overall Study|Physician Decision|1|||
46943503|NCT02901431|83180591|FG010|Main Treatment Part|Lost to Follow-up|0|||
46943504|NCT02901431|83180592|FG011|Main Treatment Part|Lost to Follow-up|0|||
46837688|NCT00117676|83055181|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
46837689|NCT00117676|83055180|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
46837690|NCT00117676|83055181|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
46837691|NCT00117676|83055180|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
46943505|NCT02901431|83180593|FG012|Main Treatment Part|Lost to Follow-up|0|||
46943506|NCT02901431|83180581|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
46943507|NCT02901431|83180582|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
46943508|NCT02901431|83180583|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
46943509|NCT02901431|83180584|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
46943510|NCT02901431|83180585|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
46837692|NCT00117676|83055181|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
46837693|NCT00117676|83055180|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
46943511|NCT02901431|83180586|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
46943512|NCT02901431|83180587|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
46943513|NCT02901431|83180588|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
46943514|NCT02901431|83180589|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
46943515|NCT02901431|83180590|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
46943516|NCT02901431|83180591|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
46943517|NCT02901431|83180592|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
46943518|NCT02901431|83180593|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
46943519|NCT02901431|83180581|FG000|Main Treatment Part|Physician Decision|0|||
46943520|NCT02901431|83180582|FG001|Main Treatment Part|Physician Decision|0|||
46943521|NCT02901431|83180583|FG002|Main Treatment Part|Physician Decision|0|||
46943522|NCT02901431|83180584|FG003|Main Treatment Part|Physician Decision|1|||
46943523|NCT02901431|83180585|FG004|Main Treatment Part|Physician Decision|0|||
46943524|NCT02901431|83180586|FG005|Main Treatment Part|Physician Decision|0|||
46943525|NCT02901431|83180587|FG006|Main Treatment Part|Physician Decision|1|||
46943526|NCT02901431|83180588|FG007|Main Treatment Part|Physician Decision|0|||
46943527|NCT02901431|83180589|FG008|Main Treatment Part|Physician Decision|0|||
46943528|NCT02901431|83180590|FG009|Main Treatment Part|Physician Decision|0|||
46943529|NCT02901431|83180591|FG010|Main Treatment Part|Physician Decision|0|||
46943530|NCT02901431|83180592|FG011|Main Treatment Part|Physician Decision|0|||
46943531|NCT02901431|83180593|FG012|Main Treatment Part|Physician Decision|0|||
46837694|NCT00117676|83055181|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
46837695|NCT00117676|83055180|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
46837696|NCT00117676|83055181|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
46837697|NCT00117676|83055180|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
46837698|NCT00117676|83055181|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
46837699|NCT00251004|83055195|FG000|Overall Study|Withdrawal by Subject|23|||
46943532|NCT02901431|83180581|FG000|Main Treatment Part|Withdrawal by Subject|0|||
46943533|NCT02901431|83180582|FG001|Main Treatment Part|Withdrawal by Subject|0|||
46943534|NCT02901431|83180583|FG002|Main Treatment Part|Withdrawal by Subject|0|||
46943535|NCT02901431|83180584|FG003|Main Treatment Part|Withdrawal by Subject|18|||
46943536|NCT02901431|83180585|FG004|Main Treatment Part|Withdrawal by Subject|3|||
46943537|NCT02901431|83180586|FG005|Main Treatment Part|Withdrawal by Subject|5|||
46943538|NCT02901431|83180587|FG006|Main Treatment Part|Withdrawal by Subject|6|||
46943539|NCT02901431|83180588|FG007|Main Treatment Part|Withdrawal by Subject|0|||
47073140|NCT00633217|83361516|FG001|Overall Study|Protocol Violation|7|||
46768465|NCT00764790|82986731|FG002|Overall Study|Protocol Violation|1|||
46768466|NCT00764790|82986729|FG000|Overall Study|Withdrawal by Subject|10|||
46768467|NCT00764790|82986730|FG001|Overall Study|Withdrawal by Subject|12|||
46768468|NCT00764790|82986731|FG002|Overall Study|Withdrawal by Subject|6|||
46768469|NCT00764790|82986729|FG000|Overall Study|Lost to Follow-up|28|||
46768470|NCT00764790|82986730|FG001|Overall Study|Lost to Follow-up|29|||
46768471|NCT00764790|82986731|FG002|Overall Study|Lost to Follow-up|23|||
46768472|NCT00756444|82986741|FG000|Overall Study|Adverse Event|1|||
46768473|NCT00756444|82986742|FG001|Overall Study|Adverse Event|1|||
46768474|NCT00756444|82986741|FG000|Overall Study|Withdrawal by Subject|6|||
46768475|NCT00756444|82986742|FG001|Overall Study|Withdrawal by Subject|8|||
46768476|NCT00756444|82986741|FG000|Overall Study|Lost to Follow-up|0|||
46768477|NCT00756444|82986742|FG001|Overall Study|Lost to Follow-up|1|||
46768478|NCT00756444|82986741|FG000|Overall Study|Death|5|||
46768479|NCT00756444|82986742|FG001|Overall Study|Death|4|||
46768480|NCT00756444|82986741|FG000|Overall Study|Disease Progression|2|||
46768481|NCT00756444|82986742|FG001|Overall Study|Disease Progression|7|||
46768482|NCT00756444|82986741|FG000|Overall Study|Ineligibility Determined|1|||
46943540|NCT02901431|83180589|FG008|Main Treatment Part|Withdrawal by Subject|0|||
46943541|NCT02901431|83180590|FG009|Main Treatment Part|Withdrawal by Subject|0|||
46943542|NCT02901431|83180591|FG010|Main Treatment Part|Withdrawal by Subject|0|||
46943543|NCT02901431|83180592|FG011|Main Treatment Part|Withdrawal by Subject|0|||
46943544|NCT02901431|83180593|FG012|Main Treatment Part|Withdrawal by Subject|0|||
46943545|NCT02901431|83180581|FG000|Open Label Part|Adverse Event|0|||
46943546|NCT02901431|83180582|FG001|Open Label Part|Adverse Event|0|||
46943547|NCT02901431|83180583|FG002|Open Label Part|Adverse Event|0|||
46943548|NCT02901431|83180584|FG003|Open Label Part|Adverse Event|0|||
46943549|NCT02901431|83180585|FG004|Open Label Part|Adverse Event|0|||
46837700|NCT00251004|83055196|FG001|Overall Study|Withdrawal by Subject|16|||
46837701|NCT00251004|83055197|FG002|Overall Study|Withdrawal by Subject|14|||
46837702|NCT00251004|83055195|FG000|Overall Study|Death|9|||
46837703|NCT00251004|83055196|FG001|Overall Study|Death|10|||
46837704|NCT00251004|83055197|FG002|Overall Study|Death|8|||
46837705|NCT00251004|83055195|FG000|Overall Study|Lost to Follow-up|1|||
46837706|NCT00251004|83055196|FG001|Overall Study|Lost to Follow-up|2|||
46837707|NCT00251004|83055197|FG002|Overall Study|Lost to Follow-up|1|||
46837708|NCT00251004|83055195|FG000|Overall Study|Graft Loss|12|||
46837709|NCT00251004|83055196|FG001|Overall Study|Graft Loss|13|||
46837710|NCT00251004|83055197|FG002|Overall Study|Graft Loss|8|||
46837711|NCT00275340|83055207|FG000|Overall Study|Lost to Follow-up|2|||
46837712|NCT00275340|83055208|FG001|Overall Study|Lost to Follow-up|4|||
46837713|NCT00275262|83055214|FG000|Overall Study|Adverse Event|2|||
46837714|NCT00275262|83055215|FG001|Overall Study|Adverse Event|0|||
46837715|NCT00275262|83055214|FG000|Overall Study|Disease progression|2|||
46837716|NCT00275262|83055215|FG001|Overall Study|Disease progression|5|||
46837717|NCT00275262|83055214|FG000|Overall Study|Lost to Follow-up|0|||
46837718|NCT00275262|83055215|FG001|Overall Study|Lost to Follow-up|2|||
46837719|NCT00275262|83055214|FG000|Overall Study|Protocol Violation|0|||
46837720|NCT00275262|83055215|FG001|Overall Study|Protocol Violation|2|||
46837721|NCT00275262|83055214|FG000|Overall Study|Death|1|||
46837722|NCT00275262|83055215|FG001|Overall Study|Death|0|||
46837723|NCT00275262|83055214|FG000|Overall Study|Started Chemotherapy|1|||
46837724|NCT00275262|83055215|FG001|Overall Study|Started Chemotherapy|0|||
46837725|NCT00275028|83055221|FG000|Overall Study|Withdrew consent before treatment began|1|||
46837726|NCT00275028|83055221|FG000|Overall Study|Withdrawal by Subject|5|||
46837727|NCT00275028|83055221|FG000|Overall Study|Adverse Event|9|||
46837728|NCT00275028|83055221|FG000|Overall Study|Progressive Disease|30|||
46837729|NCT00275028|83055221|FG000|Overall Study|Physician Decision|2|||
46837730|NCT00471497|83055228|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
46837731|NCT00471497|83055229|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
46837732|NCT00471497|83055230|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
46837733|NCT00471497|83055228|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
46837734|NCT00471497|83055229|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
46837735|NCT00471497|83055230|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
46837736|NCT00471497|83055228|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
46837737|NCT00471497|83055229|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
46837738|NCT00471497|83055230|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
46837739|NCT00471497|83055228|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
46837740|NCT00471497|83055229|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
46837741|NCT00471497|83055230|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
46837742|NCT00471497|83055228|FG000|Core Treatment Phase|Lost to Follow-up|6|||
46837743|NCT00471497|83055229|FG001|Core Treatment Phase|Lost to Follow-up|6|||
46837744|NCT00471497|83055230|FG002|Core Treatment Phase|Lost to Follow-up|3|||
46837745|NCT00471497|83055228|FG000|Core Treatment Phase|Death|3|||
46837746|NCT00471497|83055229|FG001|Core Treatment Phase|Death|9|||
46837747|NCT00471497|83055230|FG002|Core Treatment Phase|Death|3|||
46837748|NCT00471497|83055228|FG000|Core Treatment Phase|Disease Progression|10|||
46837749|NCT00471497|83055229|FG001|Core Treatment Phase|Disease Progression|2|||
46837750|NCT00471497|83055230|FG002|Core Treatment Phase|Disease Progression|4|||
46837751|NCT00471497|83055228|FG000|Core Treatment Phase|Protocol Violation|6|||
46837752|NCT00471497|83055229|FG001|Core Treatment Phase|Protocol Violation|15|||
46837753|NCT00471497|83055230|FG002|Core Treatment Phase|Protocol Violation|11|||
46837754|NCT00471497|83055228|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
46837755|NCT00471497|83055229|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
46837756|NCT00471497|83055230|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
46837757|NCT00471497|83055228|FG000|Core Treatment Phase|Administrative problems|14|||
46837758|NCT00471497|83055229|FG001|Core Treatment Phase|Administrative problems|14|||
46837759|NCT00471497|83055230|FG002|Core Treatment Phase|Administrative problems|12|||
46837760|NCT00471497|83055228|FG000|Core Treatment Phase|Adverse Event|43|||
46837761|NCT00471497|83055229|FG001|Core Treatment Phase|Adverse Event|53|||
46837762|NCT00471497|83055230|FG002|Core Treatment Phase|Adverse Event|89|||
46837763|NCT00471497|83055228|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
46837764|NCT00471497|83055229|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
46837765|NCT00471497|83055230|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
46837766|NCT00471497|83055228|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
46837767|NCT00471497|83055229|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
46943550|NCT02901431|83180586|FG005|Open Label Part|Adverse Event|0|||
46943551|NCT02901431|83180587|FG006|Open Label Part|Adverse Event|0|||
46837768|NCT00471497|83055230|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
46837769|NCT00471497|83055228|FG000|Extension Phase|Adverse Event|9|||
46837770|NCT00471497|83055229|FG001|Extension Phase|Adverse Event|5|||
46837771|NCT00471497|83055230|FG002|Extension Phase|Adverse Event|1|||
46837772|NCT00471497|83055228|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
46837773|NCT00471497|83055229|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
46837774|NCT00471497|83055230|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
46837775|NCT00471497|83055228|FG000|Extension Phase|Withdrawal by Subject|3|||
46837776|NCT00471497|83055229|FG001|Extension Phase|Withdrawal by Subject|1|||
46837777|NCT00471497|83055230|FG002|Extension Phase|Withdrawal by Subject|0|||
46837778|NCT00471497|83055228|FG000|Extension Phase|Lost to Follow-up|2|||
46837779|NCT00471497|83055229|FG001|Extension Phase|Lost to Follow-up|0|||
46837780|NCT00471497|83055230|FG002|Extension Phase|Lost to Follow-up|0|||
46837781|NCT00471497|83055228|FG000|Extension Phase|Death|1|||
46837782|NCT00471497|83055229|FG001|Extension Phase|Death|0|||
46837783|NCT00471497|83055230|FG002|Extension Phase|Death|0|||
46837784|NCT00471497|83055228|FG000|Extension Phase|Disease progression|2|||
46837785|NCT00471497|83055229|FG001|Extension Phase|Disease progression|0|||
46837786|NCT00471497|83055230|FG002|Extension Phase|Disease progression|0|||
46837787|NCT00471497|83055228|FG000|Extension Phase|Protocol Violation|2|||
46837788|NCT00471497|83055229|FG001|Extension Phase|Protocol Violation|2|||
46837789|NCT00471497|83055230|FG002|Extension Phase|Protocol Violation|0|||
46837790|NCT00493649|83055241|FG000|Overall Study|Adverse Event|44|||
46837791|NCT00493649|83055241|FG000|Overall Study|Patient Request|21|||
46837792|NCT00493649|83055241|FG000|Overall Study|Investigator Request|2|||
46837793|NCT00493649|83055241|FG000|Overall Study|Disease Progression|1|||
46837794|NCT00493649|83055241|FG000|Overall Study|Lost to Follow-up|1|||
46837795|NCT00493649|83055241|FG000|Overall Study|Other|13|||
46837796|NCT00471107|83055251|FG000|Overall Study|Technical problems/data loss|3|||
46943552|NCT02901431|83180588|FG007|Open Label Part|Adverse Event|0|||
46943553|NCT02901431|83180589|FG008|Open Label Part|Adverse Event|4|||
46943554|NCT02901431|83180590|FG009|Open Label Part|Adverse Event|4|||
46943555|NCT02901431|83180591|FG010|Open Label Part|Adverse Event|0|||
46943556|NCT02901431|83180592|FG011|Open Label Part|Adverse Event|4|||
46943557|NCT02901431|83180593|FG012|Open Label Part|Adverse Event|1|||
46943558|NCT02901431|83180581|FG000|Open Label Part|Lost to Follow-up|0|||
46943559|NCT02901431|83180582|FG001|Open Label Part|Lost to Follow-up|0|||
46943560|NCT02901431|83180583|FG002|Open Label Part|Lost to Follow-up|0|||
46943561|NCT02901431|83180584|FG003|Open Label Part|Lost to Follow-up|0|||
46943562|NCT02901431|83180585|FG004|Open Label Part|Lost to Follow-up|0|||
46943563|NCT02901431|83180586|FG005|Open Label Part|Lost to Follow-up|0|||
46943564|NCT02901431|83180587|FG006|Open Label Part|Lost to Follow-up|0|||
46943565|NCT02901431|83180588|FG007|Open Label Part|Lost to Follow-up|0|||
46943566|NCT02901431|83180589|FG008|Open Label Part|Lost to Follow-up|2|||
46943567|NCT02901431|83180590|FG009|Open Label Part|Lost to Follow-up|2|||
46943568|NCT02901431|83180591|FG010|Open Label Part|Lost to Follow-up|1|||
46943569|NCT02901431|83180592|FG011|Open Label Part|Lost to Follow-up|1|||
46943570|NCT02901431|83180593|FG012|Open Label Part|Lost to Follow-up|1|||
46943571|NCT02901431|83180581|FG000|Open Label Part|Physician Decision|0|||
47062753|NCT01494467|83343539|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
47062754|NCT01494467|83343538|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
47062755|NCT01494467|83343539|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
46943572|NCT02901431|83180582|FG001|Open Label Part|Physician Decision|0|||
46943573|NCT02901431|83180583|FG002|Open Label Part|Physician Decision|0|||
46638482|NCT01442064|82811837|FG001|Overall Study|Physician Decision|1|||
46638483|NCT01442064|82811838|FG002|Overall Study|Physician Decision|2|||
46638484|NCT01442064|82811839|FG003|Overall Study|Physician Decision|3|||
46638485|NCT01442064|82811840|FG004|Overall Study|Physician Decision|3|||
46837797|NCT00471107|83055252|FG001|Overall Study|Technical problems/data loss|1|||
46837798|NCT00471107|83055253|FG002|Overall Study|Technical problems/data loss|3|||
46837799|NCT00488033|83055263|FG000|Overall Study|Withdrawal by Subject|1|||
46837800|NCT00488033|83055264|FG001|Overall Study|Withdrawal by Subject|0|||
46837801|NCT00117598|83055273|FG000|Prior to Treatment Cross Over|Death|40|||
46837802|NCT00117598|83055274|FG001|Prior to Treatment Cross Over|Death|41|||
46638486|NCT01442064|82811841|FG005|Overall Study|Physician Decision|1|||
46837803|NCT00117598|83055275|FG002|Prior to Treatment Cross Over|Death|37|||
46837804|NCT00117598|83055276|FG003|Prior to Treatment Cross Over|Death|0|||
46837805|NCT00117598|83055277|FG004|Prior to Treatment Cross Over|Death|0|||
46837806|NCT00117598|83055273|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
46837807|NCT00117598|83055274|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
46943574|NCT02901431|83180584|FG003|Open Label Part|Physician Decision|0|||
46943575|NCT02901431|83180585|FG004|Open Label Part|Physician Decision|0|||
46943576|NCT02901431|83180586|FG005|Open Label Part|Physician Decision|0|||
46943577|NCT02901431|83180587|FG006|Open Label Part|Physician Decision|0|||
46943578|NCT02901431|83180588|FG007|Open Label Part|Physician Decision|0|||
46943579|NCT02901431|83180589|FG008|Open Label Part|Physician Decision|1|||
46943580|NCT02901431|83180590|FG009|Open Label Part|Physician Decision|1|||
46837808|NCT00117598|83055275|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
46837809|NCT00117598|83055276|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
46837810|NCT00117598|83055277|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
46837811|NCT00117598|83055273|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
46837812|NCT00117598|83055274|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
46837813|NCT00117598|83055275|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
46837814|NCT00117598|83055276|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
46837815|NCT00117598|83055277|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
46837816|NCT00117598|83055273|FG000|Prior to Treatment Cross Over|Other|15|||
46837817|NCT00117598|83055274|FG001|Prior to Treatment Cross Over|Other|9|||
46837818|NCT00117598|83055275|FG002|Prior to Treatment Cross Over|Other|9|||
46837819|NCT00117598|83055276|FG003|Prior to Treatment Cross Over|Other|0|||
46638487|NCT01442064|82811836|FG000|Overall Study|Withdrawal by Subject|6|||
46638488|NCT01442064|82811837|FG001|Overall Study|Withdrawal by Subject|3|||
46768483|NCT00756444|82986742|FG001|Overall Study|Ineligibility Determined|0|||
46768484|NCT00769002|82986753|FG000|Overall Study|Study was not completed, no data|9|||
46768485|NCT00769002|82986754|FG001|Overall Study|Study was not completed, no data|9|||
46768486|NCT00753012|82986761|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
46768487|NCT00753012|82986762|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
46768488|NCT00753012|82986761|FG000|Overall Study|Adverse Event|2|||
46768489|NCT00753012|82986762|FG001|Overall Study|Adverse Event|0|||
46768490|NCT00753012|82986761|FG000|Overall Study|Withdrawal by Subject|0|||
46768491|NCT00753012|82986762|FG001|Overall Study|Withdrawal by Subject|1|||
46837820|NCT00117598|83055277|FG004|Prior to Treatment Cross Over|Other|0|||
46837821|NCT00117598|83055273|FG000|After Treament Cross Over|Death|0|||
46837822|NCT00117598|83055274|FG001|After Treament Cross Over|Death|0|||
46837823|NCT00117598|83055275|FG002|After Treament Cross Over|Death|0|||
46837824|NCT00117598|83055276|FG003|After Treament Cross Over|Death|1|||
46837825|NCT00117598|83055277|FG004|After Treament Cross Over|Death|2|||
46837826|NCT00117598|83055273|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
46837827|NCT00117598|83055274|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
46837828|NCT00117598|83055275|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
46837829|NCT00117598|83055276|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
46837830|NCT00117598|83055277|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
46837831|NCT00117598|83055273|FG000|After Treament Cross Over|Other|0|||
46837832|NCT00117598|83055274|FG001|After Treament Cross Over|Other|0|||
46837833|NCT00117598|83055275|FG002|After Treament Cross Over|Other|0|||
46837834|NCT00117598|83055276|FG003|After Treament Cross Over|Other|1|||
46837835|NCT00117598|83055277|FG004|After Treament Cross Over|Other|2|||
46837836|NCT00469859|83055289|FG000|Overall Study|Inevaluable|0|||
46837837|NCT00469859|83055290|FG001|Overall Study|Inevaluable|2|||
46837838|NCT00093808|83055296|FG000|Overall Study|Cancel participation before receiving tx|1|||
46837839|NCT00093808|83055296|FG000|Overall Study|Protocol Violation|1|||
46837840|NCT00469079|83055303|FG000|Overall Study|Lack of Efficacy|3|||
46837841|NCT00469079|83055304|FG001|Overall Study|Lack of Efficacy|8|||
46837842|NCT00469079|83055305|FG002|Overall Study|Lack of Efficacy|5|||
46837843|NCT00469079|83055303|FG000|Overall Study|Adverse Event|1|||
46837844|NCT00469079|83055304|FG001|Overall Study|Adverse Event|3|||
46837845|NCT00469079|83055305|FG002|Overall Study|Adverse Event|2|||
46837846|NCT00469079|83055303|FG000|Overall Study|Lost to Follow-up|4|||
46837847|NCT00469079|83055304|FG001|Overall Study|Lost to Follow-up|8|||
46837848|NCT00469079|83055305|FG002|Overall Study|Lost to Follow-up|10|||
46638489|NCT01442064|82811838|FG002|Overall Study|Withdrawal by Subject|2|||
46638490|NCT01442064|82811839|FG003|Overall Study|Withdrawal by Subject|2|||
46837849|NCT00469079|83055303|FG000|Overall Study|Withdrawal by Subject|1|||
46837850|NCT00469079|83055304|FG001|Overall Study|Withdrawal by Subject|2|||
46837851|NCT00469079|83055305|FG002|Overall Study|Withdrawal by Subject|2|||
46837852|NCT00469079|83055303|FG000|Overall Study|Ineligible|0|||
46837853|NCT00469079|83055304|FG001|Overall Study|Ineligible|1|||
46837854|NCT00469079|83055305|FG002|Overall Study|Ineligible|0|||
46837855|NCT00093496|83055321|FG000|Overall Study|Protocol Violation|1|||
46837856|NCT00093496|83055322|FG001|Overall Study|Protocol Violation|3|||
46837857|NCT00117286|83055329|FG000|Overall Study|Adverse Event|12|||
46837858|NCT00117286|83055330|FG001|Overall Study|Adverse Event|6|||
46768492|NCT00753012|82986761|FG000|Overall Study|Lost to Follow-up|4|||
46768493|NCT00753012|82986762|FG001|Overall Study|Lost to Follow-up|0|||
46837859|NCT00117286|83055329|FG000|Overall Study|Lost to Follow-up|2|||
46837860|NCT00117286|83055330|FG001|Overall Study|Lost to Follow-up|0|||
46837861|NCT00117286|83055329|FG000|Overall Study|Protocol Violation|3|||
46837862|NCT00117286|83055330|FG001|Overall Study|Protocol Violation|3|||
46837863|NCT00117286|83055329|FG000|Overall Study|Withdrawal by Subject|6|||
46837864|NCT00117286|83055330|FG001|Overall Study|Withdrawal by Subject|2|||
46837865|NCT00117286|83055329|FG000|Overall Study|Physician Decision|3|||
46837866|NCT00117286|83055330|FG001|Overall Study|Physician Decision|7|||
46837867|NCT00117286|83055329|FG000|Overall Study|Lack of Efficacy|2|||
46837868|NCT00117286|83055330|FG001|Overall Study|Lack of Efficacy|1|||
46837869|NCT00117286|83055329|FG000|Overall Study|Research site closing|0|||
46768494|NCT00753012|82986761|FG000|Overall Study|Confounded endpoint data|1|||
46768495|NCT00753012|82986762|FG001|Overall Study|Confounded endpoint data|0|||
46768496|NCT00806156|82986771|FG000|Overall Study|Death|35|||
46768497|NCT00806156|82986772|FG001|Overall Study|Death|95|||
46768498|NCT00806156|82986771|FG000|Overall Study|Did not meet eligibility criteria|1|||
46768499|NCT00806156|82986772|FG001|Overall Study|Did not meet eligibility criteria|0|||
46837870|NCT00117286|83055330|FG001|Overall Study|Research site closing|2|||
46837871|NCT00265122|83055342|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
46837872|NCT00265122|83055343|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
46768500|NCT00806156|82986771|FG000|Overall Study|Study terminated by Sponsor|2|||
46768501|NCT00806156|82986772|FG001|Overall Study|Study terminated by Sponsor|40|||
46768502|NCT00806156|82986771|FG000|Overall Study|Consent withdrawn by subject|1|||
46768503|NCT00806156|82986772|FG001|Overall Study|Consent withdrawn by subject|3|||
46768504|NCT00806156|82986771|FG000|Overall Study|Lost to Follow-up|0|||
46768505|NCT00806156|82986772|FG001|Overall Study|Lost to Follow-up|1|||
46768506|NCT00764478|82986793|FG000|Overall Study|Adverse Event|1|||
46768507|NCT00764478|82986794|FG001|Overall Study|Adverse Event|1|||
46768508|NCT00764478|82986795|FG002|Overall Study|Adverse Event|1|||
46768509|NCT00764478|82986793|FG000|Overall Study|Withdrawal by Subject|7|||
46768510|NCT00764478|82986794|FG001|Overall Study|Withdrawal by Subject|12|||
46768511|NCT00764478|82986795|FG002|Overall Study|Withdrawal by Subject|1|||
46768512|NCT00764478|82986793|FG000|Overall Study|Lost to Follow-up|7|||
46768513|NCT00764478|82986794|FG001|Overall Study|Lost to Follow-up|8|||
46768514|NCT00764478|82986795|FG002|Overall Study|Lost to Follow-up|5|||
46837873|NCT00265122|83055344|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
46837874|NCT00265122|83055345|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
46837875|NCT00265122|83055346|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
46837876|NCT00265122|83055347|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
46768515|NCT00764478|82986793|FG000|Overall Study|Protocol Violation|0|||
46768516|NCT00764478|82986794|FG001|Overall Study|Protocol Violation|1|||
46768517|NCT00764478|82986795|FG002|Overall Study|Protocol Violation|1|||
46837877|NCT00265122|83055342|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
46837878|NCT00265122|83055343|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
46837879|NCT00265122|83055344|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
46837880|NCT00265122|83055345|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
46837881|NCT00265122|83055346|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
46837882|NCT00265122|83055347|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
46837883|NCT00265122|83055342|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
46837884|NCT00265122|83055343|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
46837885|NCT00265122|83055344|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
46837886|NCT00265122|83055345|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
46837887|NCT00265122|83055346|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
46837888|NCT00265122|83055347|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
46837889|NCT00265122|83055342|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
46837890|NCT00265122|83055343|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
46837891|NCT00265122|83055344|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
46837892|NCT00265122|83055345|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
46837893|NCT00265122|83055346|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
46943581|NCT02901431|83180591|FG010|Open Label Part|Physician Decision|0|||
46638491|NCT01442064|82811840|FG004|Overall Study|Withdrawal by Subject|2|||
46638492|NCT01442064|82811841|FG005|Overall Study|Withdrawal by Subject|1|||
46768518|NCT00805766|82986803|FG000|Screening Period|Adverse Event|1|||
46768519|NCT00805766|82986803|FG000|Screening Period|Lack of Efficacy|2|||
46837894|NCT00265122|83055347|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
46837895|NCT00265122|83055342|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
46837896|NCT00265122|83055343|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
47073141|NCT00633217|83361515|FG000|Overall Study|Lost to Follow-up|2|||
46638493|NCT01442064|82811836|FG000|Overall Study|Sponsor decision|82|||
46768520|NCT00805766|82986803|FG000|Screening Period|Pregnancy|1|||
46768521|NCT00805766|82986803|FG000|Screening Period|Responder|2|||
46768522|NCT00805766|82986803|FG000|Increased Dose Period|Adverse Event|4|||
46768523|NCT00805766|82986803|FG000|Increased Dose Period|Lack of Efficacy|7|||
46837897|NCT00265122|83055344|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
46837898|NCT00265122|83055345|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
46837899|NCT00265122|83055346|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
46837900|NCT00265122|83055347|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
46837901|NCT00265122|83055342|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
46837902|NCT00265122|83055343|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
46837903|NCT00265122|83055344|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
46837904|NCT00265122|83055345|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
46837905|NCT00265122|83055346|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
46768524|NCT00805766|82986803|FG000|Increased Dose Period|Pregnancy|1|||
46768525|NCT00805766|82986803|FG000|Increased Dose Period|Withdrawal by Subject|1|||
46768526|NCT00805532|82986813|FG000|Overall Study|invalid data|0|||
46768527|NCT00805532|82986814|FG001|Overall Study|invalid data|1|||
46768528|NCT00764322|82986824|FG000|Overall Study|Withdrawal by Subject|11|||
46768529|NCT00764322|82986824|FG000|Overall Study|No CYP2D6 genotyping|9|||
46768530|NCT00752856|82986843|FG000|Overall Study|randomized but did not do viral kinetics|0|||
46768531|NCT00752856|82986844|FG001|Overall Study|randomized but did not do viral kinetics|1|||
46768532|NCT00755196|82986850|FG000|Overall Study|Lost to Follow-up|1|||
46768533|NCT00755196|82986850|FG000|Overall Study|Lack of Efficiency|1|||
46768534|NCT00805142|82986857|FG000|Titration Period|Adverse Event|3|||
46768535|NCT00805142|82986858|FG001|Titration Period|Adverse Event|3|||
46768536|NCT00805142|82986857|FG000|Titration Period|Lack of Efficacy|1|||
46768537|NCT00805142|82986858|FG001|Titration Period|Lack of Efficacy|1|||
46768538|NCT00805142|82986857|FG000|Titration Period|Lost to Follow-up|0|||
46768539|NCT00805142|82986858|FG001|Titration Period|Lost to Follow-up|1|||
46768540|NCT00805142|82986857|FG000|Titration Period|Disease Progression|2|||
46768541|NCT00805142|82986858|FG001|Titration Period|Disease Progression|1|||
46768542|NCT00805142|82986857|FG000|Titration Period|Withdrawal of consent|0|||
46768543|NCT00805142|82986858|FG001|Titration Period|Withdrawal of consent|1|||
46768544|NCT00805142|82986857|FG000|Titration Period|Other|0|||
46768545|NCT00805142|82986858|FG001|Titration Period|Other|3|||
46768546|NCT00805142|82986857|FG000|Maintenance Period|Adverse Event|0|||
46768547|NCT00805142|82986858|FG001|Maintenance Period|Adverse Event|1|||
46768548|NCT00805142|82986857|FG000|Maintenance Period|Other|0|||
46943582|NCT02901431|83180592|FG011|Open Label Part|Physician Decision|0|||
46943583|NCT02901431|83180593|FG012|Open Label Part|Physician Decision|0|||
46943584|NCT02901431|83180581|FG000|Open Label Part|Study Terminated By Sponsor|0|||
46943585|NCT02901431|83180582|FG001|Open Label Part|Study Terminated By Sponsor|0|||
46943586|NCT02901431|83180583|FG002|Open Label Part|Study Terminated By Sponsor|0|||
46943587|NCT02901431|83180584|FG003|Open Label Part|Study Terminated By Sponsor|0|||
46943588|NCT02901431|83180585|FG004|Open Label Part|Study Terminated By Sponsor|0|||
46943589|NCT02901431|83180586|FG005|Open Label Part|Study Terminated By Sponsor|0|||
46943590|NCT02901431|83180587|FG006|Open Label Part|Study Terminated By Sponsor|0|||
46943591|NCT02901431|83180588|FG007|Open Label Part|Study Terminated By Sponsor|0|||
46943592|NCT02901431|83180589|FG008|Open Label Part|Study Terminated By Sponsor|35|||
46837906|NCT00265122|83055347|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
46837907|NCT00116584|83055368|FG000|Overall Study|Withdrawal by Subject|1|||
46837908|NCT00116584|83055369|FG001|Overall Study|Withdrawal by Subject|0|||
46837909|NCT00116584|83055368|FG000|Overall Study|Protocol Violation|1|||
46837910|NCT00116584|83055369|FG001|Overall Study|Protocol Violation|1|||
46837911|NCT00096538|83055375|FG000|Overall Study|Withdrawal by Subject|1|||
46943593|NCT02901431|83180590|FG009|Open Label Part|Study Terminated By Sponsor|12|||
46943594|NCT02901431|83180591|FG010|Open Label Part|Study Terminated By Sponsor|21|||
47062756|NCT01494467|83343538|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
46768549|NCT00805142|82986858|FG001|Maintenance Period|Other|1|||
46768550|NCT00761631|82986875|FG000|Overall Study|Parent/legal guardian request|8|||
46768551|NCT00761631|82986876|FG001|Overall Study|Parent/legal guardian request|3|||
46768552|NCT00761631|82986877|FG002|Overall Study|Parent/legal guardian request|8|||
46768553|NCT00761631|82986878|FG003|Overall Study|Parent/legal guardian request|0|||
46837912|NCT00239928|83055379|FG000|Overall Study|Lack of Efficacy|1|||
47062757|NCT01494467|83343539|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
47073142|NCT00633217|83361516|FG001|Overall Study|Lost to Follow-up|2|||
46837913|NCT00239928|83055379|FG000|Overall Study|Adverse Event|4|||
46837914|NCT00239928|83055379|FG000|Overall Study|Not need to continue study|3|||
46837915|NCT00239928|83055379|FG000|Overall Study|Withdrawal by Subject|2|||
46837916|NCT00116428|83055385|FG000|Overall Study|Withdrawal by Subject|2|||
46837917|NCT00116428|83055386|FG001|Overall Study|Withdrawal by Subject|5|||
46837918|NCT00116428|83055385|FG000|Overall Study|Did not meet inclusion criteria|1|||
46837919|NCT00116428|83055386|FG001|Overall Study|Did not meet inclusion criteria|0|||
46768554|NCT00761631|82986879|FG004|Overall Study|Parent/legal guardian request|5|||
46768555|NCT00761631|82986880|FG005|Overall Study|Parent/legal guardian request|0|||
46768556|NCT00761631|82986875|FG000|Overall Study|Lost to Follow-up|2|||
46768557|NCT00761631|82986876|FG001|Overall Study|Lost to Follow-up|4|||
46943595|NCT02901431|83180592|FG011|Open Label Part|Study Terminated By Sponsor|31|||
46837920|NCT00468845|83055398|FG000|Overall Study|Adverse Event|9|||
46837921|NCT00468845|83055399|FG001|Overall Study|Adverse Event|14|||
46837922|NCT00468845|83055400|FG002|Overall Study|Adverse Event|11|||
46837923|NCT00468845|83055398|FG000|Overall Study|Lost to Follow-up|2|||
46837924|NCT00468845|83055399|FG001|Overall Study|Lost to Follow-up|1|||
46837925|NCT00468845|83055400|FG002|Overall Study|Lost to Follow-up|2|||
46837926|NCT00468845|83055398|FG000|Overall Study|Other|4|||
46837927|NCT00468845|83055399|FG001|Overall Study|Other|9|||
46837928|NCT00468845|83055400|FG002|Overall Study|Other|5|||
46837929|NCT00468845|83055398|FG000|Overall Study|No longer willing to participate|5|||
46837930|NCT00468845|83055399|FG001|Overall Study|No longer willing to participate|6|||
46837931|NCT00468845|83055400|FG002|Overall Study|No longer willing to participate|10|||
46837932|NCT00468845|83055398|FG000|Overall Study|Randomized, not treated|1|||
46837933|NCT00468845|83055399|FG001|Overall Study|Randomized, not treated|4|||
46837934|NCT00468845|83055400|FG002|Overall Study|Randomized, not treated|2|||
46837935|NCT00468299|83055410|FG000|Overall Study|Withdrawal by Subject|0|||
46837936|NCT00468299|83055411|FG001|Overall Study|Withdrawal by Subject|1|||
46837937|NCT00468143|83055419|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
46837938|NCT00468143|83055420|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
46837939|NCT00468143|83055419|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
46837940|NCT00468143|83055420|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
46837941|NCT00467831|83055426|FG000|Overall Study|Death|2|||
46837942|NCT00467831|83055426|FG000|Overall Study|Withdrawal by Subject|1|||
46837943|NCT00467753|83055432|FG000|Overall Study|Lost to Follow-up|1|||
46837944|NCT00467753|83055433|FG001|Overall Study|Lost to Follow-up|2|||
46837945|NCT00467753|83055432|FG000|Overall Study|Adverse Event|2|||
46837946|NCT00467753|83055433|FG001|Overall Study|Adverse Event|0|||
46837947|NCT00467597|83055447|FG000|Overall Study|Withdrawal by Subject|2|||
46837948|NCT00467597|83055448|FG001|Overall Study|Withdrawal by Subject|0|||
46837949|NCT00115804|83055458|FG000|Overall Study|Adverse Event|2|||
46837950|NCT00467519|83055466|FG000|Overall Study|Protocol Violation|8|||
46837951|NCT00467519|83055467|FG001|Overall Study|Protocol Violation|4|||
46837952|NCT00467519|83055466|FG000|Overall Study|Lost to Follow-up|2|||
46837953|NCT00467519|83055467|FG001|Overall Study|Lost to Follow-up|9|||
46837954|NCT00467519|83055466|FG000|Overall Study|Withdrawal by Subject|4|||
46837955|NCT00467519|83055467|FG001|Overall Study|Withdrawal by Subject|10|||
46837956|NCT00264810|83055475|FG000|Baseline|Withdrawal by Subject|10|||
46943596|NCT02901431|83180593|FG012|Open Label Part|Study Terminated By Sponsor|0|||
46943597|NCT02901431|83180581|FG000|Open Label Part|Withdrawal by Subject|0|||
46943598|NCT02901431|83180582|FG001|Open Label Part|Withdrawal by Subject|0|||
46943599|NCT02901431|83180583|FG002|Open Label Part|Withdrawal by Subject|0|||
46943600|NCT02901431|83180584|FG003|Open Label Part|Withdrawal by Subject|0|||
46943601|NCT02901431|83180585|FG004|Open Label Part|Withdrawal by Subject|0|||
46943602|NCT02901431|83180586|FG005|Open Label Part|Withdrawal by Subject|0|||
46768558|NCT00761631|82986877|FG002|Overall Study|Lost to Follow-up|7|||
46768559|NCT00761631|82986878|FG003|Overall Study|Lost to Follow-up|1|||
46837957|NCT00264810|83055476|FG001|Baseline|Withdrawal by Subject|10|||
46837958|NCT00264810|83055475|FG000|Baseline|Physician Decision|7|||
46837959|NCT00264810|83055476|FG001|Baseline|Physician Decision|8|||
46837960|NCT00264810|83055475|FG000|Baseline|Subject Compliance Failure|3|||
46837961|NCT00264810|83055476|FG001|Baseline|Subject Compliance Failure|3|||
46837962|NCT00264810|83055475|FG000|Baseline|Insufficient Seizure Frequency|2|||
46837963|NCT00264810|83055476|FG001|Baseline|Insufficient Seizure Frequency|2|||
46837964|NCT00264810|83055475|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
46837965|NCT00264810|83055476|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
46943603|NCT02901431|83180587|FG006|Open Label Part|Withdrawal by Subject|0|||
46943604|NCT02901431|83180588|FG007|Open Label Part|Withdrawal by Subject|0|||
46768560|NCT00761631|82986879|FG004|Overall Study|Lost to Follow-up|6|||
46768561|NCT00761631|82986880|FG005|Overall Study|Lost to Follow-up|1|||
46768562|NCT00761631|82986875|FG000|Overall Study|Protocol Violation|2|||
46768563|NCT00761631|82986876|FG001|Overall Study|Protocol Violation|0|||
46768564|NCT00761631|82986877|FG002|Overall Study|Protocol Violation|0|||
46768565|NCT00761631|82986878|FG003|Overall Study|Protocol Violation|1|||
46768566|NCT00761631|82986879|FG004|Overall Study|Protocol Violation|5|||
46943605|NCT02901431|83180589|FG008|Open Label Part|Withdrawal by Subject|6|||
46943606|NCT02901431|83180590|FG009|Open Label Part|Withdrawal by Subject|5|||
46768567|NCT00761631|82986880|FG005|Overall Study|Protocol Violation|1|||
46768568|NCT00761631|82986875|FG000|Overall Study|Randomized, not treated|1|||
46768569|NCT00761631|82986876|FG001|Overall Study|Randomized, not treated|0|||
46837966|NCT00264810|83055475|FG000|Baseline|Other|0|||
46837967|NCT00264810|83055476|FG001|Baseline|Other|1|||
46837968|NCT00264810|83055475|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
46837969|NCT00264810|83055476|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
46837970|NCT00264810|83055475|FG000|Stimulation Optimization Period|Death|0|||
46837971|NCT00264810|83055476|FG001|Stimulation Optimization Period|Death|1|||
46943607|NCT02901431|83180591|FG010|Open Label Part|Withdrawal by Subject|7|||
46943608|NCT02901431|83180592|FG011|Open Label Part|Withdrawal by Subject|3|||
46837972|NCT00264810|83055475|FG000|Blinded Evaluation Period|Explant due to infection|1|||
46837973|NCT00264810|83055476|FG001|Blinded Evaluation Period|Explant due to infection|1|||
46837974|NCT00264810|83055475|FG000|Open Label Evaluation Period|Explant due to infection|1|||
46837975|NCT00264810|83055476|FG001|Open Label Evaluation Period|Explant due to infection|1|||
46837976|NCT00264810|83055475|FG000|Open Label Evaluation Period|Death|3|||
46837977|NCT00264810|83055476|FG001|Open Label Evaluation Period|Death|2|||
46837978|NCT00264810|83055475|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
46837979|NCT00264810|83055476|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
46837980|NCT00467363|83055486|FG000|Overall Study|Lost to Follow-up|80|||
46837981|NCT00467363|83055487|FG001|Overall Study|Lost to Follow-up|70|||
46837982|NCT00091390|83055493|FG000|Overall Study|Protocol Violation|1|||
46837983|NCT00091390|83055493|FG000|Overall Study|No protocol treatment|3|||
46837984|NCT00239226|83055501|FG000|Overall Study|permAF during stabilization period|0|||
46837985|NCT00239226|83055502|FG001|Overall Study|permAF during stabilization period|0|||
46837986|NCT00239226|83055503|FG002|Overall Study|permAF during stabilization period|0|||
46837987|NCT00239226|83055504|FG003|Overall Study|permAF during stabilization period|3|||
46837988|NCT00239226|83055501|FG000|Overall Study|Lost to Follow-up|1|||
46837989|NCT00239226|83055502|FG001|Overall Study|Lost to Follow-up|0|||
46837990|NCT00239226|83055503|FG002|Overall Study|Lost to Follow-up|1|||
46837991|NCT00239226|83055504|FG003|Overall Study|Lost to Follow-up|0|||
46837992|NCT00467285|83055516|FG000|Overall Study|Lost to Follow-up|4|||
46837993|NCT00467285|83055517|FG001|Overall Study|Lost to Follow-up|4|||
46837994|NCT00264576|83055527|FG000|Overall Study|Lost to Follow-up|1|||
46837995|NCT00264576|83055528|FG001|Overall Study|Lost to Follow-up|1|||
46837996|NCT00466505|83055535|FG000|Overall Study|disease progression|13|||
46837997|NCT00466505|83055535|FG000|Overall Study|Adverse Event|4|||
46837998|NCT00467051|83055539|FG000|Overall Study|Adverse Event|2|||
46837999|NCT00264498|83055546|FG000|Randomized Treatment|Death|0|||
46838000|NCT00264498|83055547|FG001|Randomized Treatment|Death|3|||
46838001|NCT00264498|83055546|FG000|Randomized Treatment|Withdrawal by Subject|0|||
46838002|NCT00264498|83055547|FG001|Randomized Treatment|Withdrawal by Subject|1|||
46838003|NCT00264498|83055546|FG000|Randomized Treatment|Objective disease Progression|13|||
46838004|NCT00264498|83055547|FG001|Randomized Treatment|Objective disease Progression|14|||
46943609|NCT02901431|83180593|FG012|Open Label Part|Withdrawal by Subject|1|||
46838005|NCT00264498|83055546|FG000|Randomized Treatment|Physician Decision|1|||
46838006|NCT00264498|83055547|FG001|Randomized Treatment|Physician Decision|0|||
46838007|NCT00264498|83055546|FG000|Randomized Treatment|Incorrectly randomized|1|||
46838008|NCT00264498|83055547|FG001|Randomized Treatment|Incorrectly randomized|0|||
46838009|NCT00264498|83055546|FG000|Randomized Treatment|Study Closure|1|||
46838010|NCT00264498|83055547|FG001|Randomized Treatment|Study Closure|0|||
46838011|NCT00264498|83055546|FG000|Randomized Treatment|Protocol Violation|1|||
46838012|NCT00264498|83055547|FG001|Randomized Treatment|Protocol Violation|0|||
46838013|NCT00264498|83055546|FG000|Crossover Treatment|Death|1|||
46943610|NCT02873377|83180620|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
46838014|NCT00264498|83055547|FG001|Crossover Treatment|Death|3|||
46838015|NCT00264498|83055546|FG000|Crossover Treatment|Objective disease progression|4|||
46838016|NCT00264498|83055547|FG001|Crossover Treatment|Objective disease progression|5|||
46838017|NCT00264498|83055546|FG000|Crossover Treatment|Study closure|0|||
46838018|NCT00264498|83055547|FG001|Crossover Treatment|Study closure|1|||
46943611|NCT02873377|83180621|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
46943612|NCT02873377|83180620|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
46943613|NCT02873377|83180621|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
46768570|NCT00761631|82986877|FG002|Overall Study|Randomized, not treated|0|||
46768571|NCT00761631|82986878|FG003|Overall Study|Randomized, not treated|0|||
46768572|NCT00761631|82986879|FG004|Overall Study|Randomized, not treated|0|||
46768573|NCT00761631|82986880|FG005|Overall Study|Randomized, not treated|0|||
46768574|NCT00761631|82986875|FG000|Overall Study|Failed to return|1|||
46768575|NCT00761631|82986876|FG001|Overall Study|Failed to return|0|||
46768576|NCT00761631|82986877|FG002|Overall Study|Failed to return|1|||
46768577|NCT00761631|82986878|FG003|Overall Study|Failed to return|1|||
46768578|NCT00761631|82986879|FG004|Overall Study|Failed to return|5|||
46838019|NCT00264498|83055546|FG000|Crossover Treatment|Withdrawal by Subject|1|||
46838020|NCT00264498|83055547|FG001|Crossover Treatment|Withdrawal by Subject|0|||
46838021|NCT00466193|83055555|FG000|Overall Study|Adverse Event|0|||
46838022|NCT00466193|83055556|FG001|Overall Study|Adverse Event|1|||
46838023|NCT00466193|83055555|FG000|Overall Study|Lost to Follow-up|2|||
46838024|NCT00466193|83055556|FG001|Overall Study|Lost to Follow-up|4|||
46838025|NCT00466193|83055555|FG000|Overall Study|Physician Decision|1|||
46838026|NCT00466193|83055556|FG001|Overall Study|Physician Decision|0|||
46768579|NCT00761631|82986880|FG005|Overall Study|Failed to return|2|||
46838027|NCT00466193|83055555|FG000|Overall Study|Protocol Violation|1|||
46838028|NCT00466193|83055556|FG001|Overall Study|Protocol Violation|1|||
46838029|NCT00466193|83055555|FG000|Overall Study|Withdrawal by Subject|7|||
46838030|NCT00466193|83055556|FG001|Overall Study|Withdrawal by Subject|2|||
46838031|NCT00466193|83055555|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
46838032|NCT00466193|83055556|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
46838033|NCT00263562|83055564|FG000|Overall Study|Protocol Violation|3|||
46838034|NCT00263562|83055565|FG001|Overall Study|Protocol Violation|0|||
46838035|NCT00454181|83055575|FG000|Overall Study|Adverse Event|1|||
46838036|NCT00454181|83055576|FG001|Overall Study|Adverse Event|1|||
46838037|NCT00454181|83055575|FG000|Overall Study|Lost to Follow-up|11|||
46838038|NCT00454181|83055576|FG001|Overall Study|Lost to Follow-up|1|||
46838039|NCT00454181|83055575|FG000|Overall Study|Protocol Violation|1|||
46838040|NCT00454181|83055576|FG001|Overall Study|Protocol Violation|1|||
46838041|NCT00454181|83055575|FG000|Overall Study|Withdrawal by Subject|2|||
46838042|NCT00454181|83055576|FG001|Overall Study|Withdrawal by Subject|0|||
46838043|NCT00237744|83055585|FG000|Overall Study|Withdrawal by Subject|3|||
46838044|NCT00237744|83055586|FG001|Overall Study|Withdrawal by Subject|1|||
46838045|NCT00237744|83055587|FG002|Overall Study|Withdrawal by Subject|0|||
46838046|NCT00237042|83055601|FG000|Treatment|Became ineligible post-randomization|0|||
46838047|NCT00237042|83055602|FG001|Treatment|Became ineligible post-randomization|1|||
46838048|NCT00237042|83055603|FG002|Treatment|Became ineligible post-randomization|16|||
46838049|NCT00237042|83055601|FG000|Treatment|Moved out of state|1|||
46838050|NCT00237042|83055602|FG001|Treatment|Moved out of state|1|||
46838051|NCT00237042|83055603|FG002|Treatment|Moved out of state|1|||
46943614|NCT02966795|83180630|FG000|Overall Study|Patient Left the Country|0|||
46943615|NCT02966795|83180631|FG001|Overall Study|Patient Left the Country|1|||
46838052|NCT00237042|83055601|FG000|Treatment|Completed no treatment|5|||
46838053|NCT00237042|83055602|FG001|Treatment|Completed no treatment|5|||
46838054|NCT00237042|83055603|FG002|Treatment|Completed no treatment|21|||
46838055|NCT00237042|83055601|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
46838056|NCT00237042|83055602|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
46838057|NCT00237042|83055603|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
46838058|NCT00237042|83055601|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
46838059|NCT00237042|83055602|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
46943616|NCT02873221|83180639|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
46943617|NCT02873221|83180640|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
46943618|NCT02873221|83180641|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
46943619|NCT02873221|83180639|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
46943620|NCT02873221|83180640|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
46943621|NCT02873221|83180641|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
46943622|NCT02873221|83180639|FG000|Treatment Period|Protocol Violation|2|||
46943623|NCT02873221|83180640|FG001|Treatment Period|Protocol Violation|5|||
46943624|NCT02873221|83180641|FG002|Treatment Period|Protocol Violation|8|||
46943625|NCT02873221|83180639|FG000|Treatment Period|Pregnancy|4|||
46943626|NCT02873221|83180640|FG001|Treatment Period|Pregnancy|6|||
46943627|NCT02873221|83180641|FG002|Treatment Period|Pregnancy|3|||
46943628|NCT02873221|83180639|FG000|Treatment Period|Lack of Qualifying Event|0|||
46943629|NCT02873221|83180640|FG001|Treatment Period|Lack of Qualifying Event|3|||
46943630|NCT02873221|83180641|FG002|Treatment Period|Lack of Qualifying Event|1|||
46943631|NCT02873221|83180639|FG000|Treatment Period|Withdrawal of Consent|52|||
46838060|NCT00237042|83055603|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
46838061|NCT00465647|83055615|FG000|Overall Study|Administrative|2|||
46838062|NCT00465647|83055616|FG001|Overall Study|Administrative|2|||
46838063|NCT00465647|83055617|FG002|Overall Study|Administrative|3|||
46838064|NCT00465647|83055618|FG003|Overall Study|Administrative|2|||
46943632|NCT02873221|83180640|FG001|Treatment Period|Withdrawal of Consent|51|||
46838065|NCT00465647|83055615|FG000|Overall Study|Adverse Event|2|||
46838066|NCT00465647|83055616|FG001|Overall Study|Adverse Event|0|||
46838067|NCT00465647|83055617|FG002|Overall Study|Adverse Event|3|||
46943633|NCT02873221|83180641|FG002|Treatment Period|Withdrawal of Consent|41|||
46943634|NCT02873221|83180639|FG000|Treatment Period|Lack of Efficacy|0|||
46943635|NCT02873221|83180640|FG001|Treatment Period|Lack of Efficacy|17|||
46943636|NCT02873221|83180641|FG002|Treatment Period|Lack of Efficacy|12|||
46943637|NCT02873221|83180639|FG000|Treatment Period|Adverse Event|4|||
46838068|NCT00465647|83055618|FG003|Overall Study|Adverse Event|2|||
46838069|NCT00465647|83055615|FG000|Overall Study|Withdrawal by Subject|1|||
46838070|NCT00465647|83055616|FG001|Overall Study|Withdrawal by Subject|2|||
46838071|NCT00465647|83055617|FG002|Overall Study|Withdrawal by Subject|2|||
46838072|NCT00465647|83055618|FG003|Overall Study|Withdrawal by Subject|7|||
46838073|NCT00465647|83055615|FG000|Overall Study|"The other reasons included loss of IV"|8|||
46838074|NCT00465647|83055616|FG001|Overall Study|"The other reasons included loss of IV"|4|||
46838075|NCT00465647|83055617|FG002|Overall Study|"The other reasons included loss of IV"|3|||
46838076|NCT00465647|83055618|FG003|Overall Study|"The other reasons included loss of IV"|2|||
46943638|NCT02873221|83180640|FG001|Treatment Period|Adverse Event|9|||
46943639|NCT02873221|83180641|FG002|Treatment Period|Adverse Event|11|||
46943640|NCT02873221|83180639|FG000|Treatment Period|Lost to Follow-up|26|||
46943641|NCT02873221|83180640|FG001|Treatment Period|Lost to Follow-up|30|||
46943642|NCT02873221|83180641|FG002|Treatment Period|Lost to Follow-up|26|||
46943643|NCT02873221|83180639|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
46838077|NCT00465569|83055640|FG000|Overall Study|persistent eczema during dose escalation|1|||
46838078|NCT00465569|83055641|FG001|Overall Study|persistent eczema during dose escalation|0|||
46838079|NCT00090766|83055650|FG000|Overall Study|Nephrectomy Planned|0|||
46838080|NCT00090766|83055651|FG001|Overall Study|Nephrectomy Planned|0|||
46838081|NCT00090766|83055652|FG002|Overall Study|Nephrectomy Planned|1|||
46838082|NCT00090766|83055650|FG000|Overall Study|Death|1|||
46838083|NCT00090766|83055651|FG001|Overall Study|Death|0|||
46838084|NCT00090766|83055652|FG002|Overall Study|Death|0|||
46838085|NCT00090766|83055650|FG000|Overall Study|Admin|0|||
46838086|NCT00090766|83055651|FG001|Overall Study|Admin|2|||
46838087|NCT00090766|83055652|FG002|Overall Study|Admin|0|||
46838088|NCT00090766|83055650|FG000|Overall Study|Lost to Follow-up|2|||
46838089|NCT00090766|83055651|FG001|Overall Study|Lost to Follow-up|0|||
46768580|NCT00761631|82986875|FG000|Overall Study|Physician Decision|1|||
46838090|NCT00090766|83055652|FG002|Overall Study|Lost to Follow-up|2|||
46838091|NCT00465179|83055662|FG000|Overall Study|Adverse Event|4|||
46838092|NCT00465179|83055662|FG000|Overall Study|Withdrawal by Subject|2|||
46838093|NCT00465179|83055662|FG000|Overall Study|Progression of Disease|47|||
46838094|NCT00465101|83055666|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
46838095|NCT00465101|83055666|FG000|Overall Study|Change in health precluded follow up|4|||
46838096|NCT00465101|83055666|FG000|Overall Study|Did not meet study criteria|4|||
46838097|NCT00465101|83055666|FG000|Overall Study|Lost to Follow-up|5|||
46838098|NCT00465101|83055666|FG000|Overall Study|Other|6|||
46838099|NCT00465101|83055666|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
46838100|NCT00465101|83055666|FG000|Overall Study|Patient postponed procedure|1|||
46838101|NCT00465101|83055666|FG000|Overall Study|Site closed due to IRB expiration|1|||
46838102|NCT00465101|83055666|FG000|Overall Study|Unable to obtain IRB approval|1|||
46838103|NCT00465101|83055666|FG000|Overall Study|Death|3|||
46838104|NCT00465101|83055666|FG000|Overall Study|Withdrawal by Subject|25|||
46838105|NCT00465101|83055666|FG000|Overall Study|Physician Decision|1|||
46838106|NCT00465101|83055666|FG000|Overall Study|Withdrew consent prior to procedure|3|||
46838107|NCT00084136|83055695|FG000|PI Comparison|Death|10|||
46838108|NCT00084136|83055696|FG001|PI Comparison|Death|9|||
46838109|NCT00084136|83055697|FG002|PI Comparison|Death|0|||
46838110|NCT00084136|83055695|FG000|PI Comparison|Lost to Follow-up|11|||
46838111|NCT00084136|83055696|FG001|PI Comparison|Lost to Follow-up|8|||
46838112|NCT00084136|83055697|FG002|PI Comparison|Lost to Follow-up|0|||
46838113|NCT00084136|83055695|FG000|PI Comparison|Withdrawal by Subject|33|||
46838114|NCT00084136|83055696|FG001|PI Comparison|Withdrawal by Subject|30|||
46838115|NCT00084136|83055697|FG002|PI Comparison|Withdrawal by Subject|0|||
46838116|NCT00084136|83055695|FG000|PI Comparison|Clinic site closed|1|||
46838117|NCT00084136|83055696|FG001|PI Comparison|Clinic site closed|0|||
46838118|NCT00084136|83055697|FG002|PI Comparison|Clinic site closed|0|||
46838119|NCT00084136|83055695|FG000|NRTI Comparison|Death|20|||
46943644|NCT02873221|83180640|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
46943645|NCT02873221|83180641|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
46838120|NCT00084136|83055696|FG001|NRTI Comparison|Death|0|||
46838121|NCT00084136|83055697|FG002|NRTI Comparison|Death|18|||
46838122|NCT00084136|83055695|FG000|NRTI Comparison|Lost to Follow-up|14|||
46838123|NCT00084136|83055696|FG001|NRTI Comparison|Lost to Follow-up|0|||
46943646|NCT02873221|83180639|FG000|Safety Follow-up Period|Protocol Violation|0|||
46943647|NCT02873221|83180640|FG001|Safety Follow-up Period|Protocol Violation|0|||
46768581|NCT00761631|82986876|FG001|Overall Study|Physician Decision|0|||
46768582|NCT00761631|82986877|FG002|Overall Study|Physician Decision|0|||
46768583|NCT00761631|82986878|FG003|Overall Study|Physician Decision|0|||
46768584|NCT00761631|82986879|FG004|Overall Study|Physician Decision|0|||
46768585|NCT00761631|82986880|FG005|Overall Study|Physician Decision|0|||
46768586|NCT00761631|82986875|FG000|Overall Study|Other|0|||
46768587|NCT00761631|82986876|FG001|Overall Study|Other|0|||
46768588|NCT00761631|82986877|FG002|Overall Study|Other|0|||
46768589|NCT00761631|82986878|FG003|Overall Study|Other|0|||
46768590|NCT00761631|82986879|FG004|Overall Study|Other|1|||
46768591|NCT00761631|82986880|FG005|Overall Study|Other|1|||
46768592|NCT00763698|82986903|FG000|Overall Study|Unsuccessful Implant|5|||
46768593|NCT00763698|82986903|FG000|Overall Study|Death|4|||
46768594|NCT00763698|82986903|FG000|Overall Study|Withdrawal by Subject|1|||
46838124|NCT00084136|83055697|FG002|NRTI Comparison|Lost to Follow-up|12|||
46838125|NCT00084136|83055695|FG000|NRTI Comparison|Withdrawal by Subject|54|||
46768595|NCT00763386|82986910|FG000|Overall Study|Adverse Event|43|||
46768596|NCT00763386|82986911|FG001|Overall Study|Adverse Event|33|||
46768597|NCT00763386|82986910|FG000|Overall Study|Death|1|||
46768598|NCT00763386|82986911|FG001|Overall Study|Death|2|||
46768599|NCT00763386|82986910|FG000|Overall Study|Lost to Follow-up|3|||
46838126|NCT00084136|83055696|FG001|NRTI Comparison|Withdrawal by Subject|0|||
46838127|NCT00084136|83055697|FG002|NRTI Comparison|Withdrawal by Subject|38|||
46838128|NCT00084136|83055695|FG000|NRTI Comparison|Clinic site closed|12|||
46838129|NCT00084136|83055696|FG001|NRTI Comparison|Clinic site closed|0|||
46838130|NCT00084136|83055697|FG002|NRTI Comparison|Clinic site closed|14|||
46768600|NCT00763386|82986911|FG001|Overall Study|Lost to Follow-up|3|||
46838131|NCT00084136|83055695|FG000|NRTI Comparison|Not reason above|1|||
46838132|NCT00084136|83055696|FG001|NRTI Comparison|Not reason above|0|||
46838133|NCT00084136|83055697|FG002|NRTI Comparison|Not reason above|0|||
46838134|NCT03812380|83055708|FG000|Overall Study|Protocol Violation|3|||
46838135|NCT03812380|83055709|FG001|Overall Study|Protocol Violation|3|||
46838136|NCT03812380|83055708|FG000|Overall Study|Withdrawal by Subject|5|||
46838137|NCT03812380|83055709|FG001|Overall Study|Withdrawal by Subject|4|||
46838138|NCT03812380|83055708|FG000|Overall Study|Early termination of study|14|||
46838139|NCT03812380|83055709|FG001|Overall Study|Early termination of study|14|||
46838140|NCT00464945|83055717|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
46838141|NCT00464945|83055718|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
46838142|NCT00464945|83055717|FG000|Infant Series|Protocol Violation|1|||
46838143|NCT00464945|83055718|FG001|Infant Series|Protocol Violation|0|||
46838144|NCT00464945|83055717|FG000|Infant Series|Lost to Follow-up|1|||
46838145|NCT00464945|83055718|FG001|Infant Series|Lost to Follow-up|0|||
46838146|NCT00464945|83055717|FG000|After Infant Series|Withdrawal by Subject|0|||
46838147|NCT00464945|83055718|FG001|After Infant Series|Withdrawal by Subject|2|||
46838148|NCT00464945|83055717|FG000|Toddler Dose|Lost to Follow-up|0|||
46838149|NCT00464945|83055718|FG001|Toddler Dose|Lost to Follow-up|1|||
46838150|NCT00464087|83055743|FG000|Overall Study|No PCI per inclusion criteria|0|||
46838151|NCT00464087|83055744|FG001|Overall Study|No PCI per inclusion criteria|0|||
46838152|NCT00464087|83055745|FG002|Overall Study|No PCI per inclusion criteria|29|||
46838153|NCT00452699|83055755|FG000|Overall Study|Adverse Event|10|||
46838154|NCT00452699|83055756|FG001|Overall Study|Adverse Event|3|||
46838155|NCT00452699|83055755|FG000|Overall Study|Lack of Efficacy|6|||
46838156|NCT00452699|83055756|FG001|Overall Study|Lack of Efficacy|4|||
46838157|NCT00452699|83055755|FG000|Overall Study|Lost to Follow-up|6|||
46838158|NCT00452699|83055756|FG001|Overall Study|Lost to Follow-up|9|||
46838159|NCT00452699|83055755|FG000|Overall Study|Protocol Violation|21|||
46838160|NCT00452699|83055756|FG001|Overall Study|Protocol Violation|25|||
46838161|NCT00452699|83055755|FG000|Overall Study|Withdrawal by Subject|26|||
46838162|NCT00452699|83055756|FG001|Overall Study|Withdrawal by Subject|25|||
46838163|NCT00452699|83055755|FG000|Overall Study|Other|12|||
46943648|NCT02873221|83180641|FG002|Safety Follow-up Period|Protocol Violation|1|||
46943649|NCT02873221|83180639|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
46943650|NCT02873221|83180640|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
46943651|NCT02873221|83180641|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
46943652|NCT02873221|83180639|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
46838164|NCT00452699|83055756|FG001|Overall Study|Other|7|||
46838165|NCT00069784|83055764|FG000|Overall Study|Adverse Event|105|||
46838166|NCT00069784|83055765|FG001|Overall Study|Adverse Event|0|||
46838167|NCT00069784|83055764|FG000|Overall Study|Withdrawal by Subject|1090|||
46943653|NCT02873221|83180640|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
46943654|NCT02873221|83180641|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
46943655|NCT02968979|83180649|FG000|Overall Study|Protocol Violation|7|||
46943656|NCT02968979|83180649|FG000|Overall Study|Withdrawal by Subject|1|||
46943657|NCT02966015|83180701|FG000|Inclusion Visit|did not answer questionnaire|8|||
47062758|NCT01494467|83343538|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
47062759|NCT01494467|83343539|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
47062760|NCT01493687|83343553|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
47062761|NCT01493687|83343554|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
47062762|NCT01493687|83343553|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
47062763|NCT01493687|83343554|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
46768601|NCT00763386|82986910|FG000|Overall Study|Withdrawal by Subject|0|||
46768602|NCT00763386|82986911|FG001|Overall Study|Withdrawal by Subject|1|||
46768603|NCT00763386|82986910|FG000|Overall Study|CRF missing|0|||
46768604|NCT00763386|82986911|FG001|Overall Study|CRF missing|1|||
46768605|NCT00763386|82986910|FG000|Overall Study|Study Prosthesis Removed|1|||
46768606|NCT00763386|82986911|FG001|Overall Study|Study Prosthesis Removed|0|||
46768607|NCT00761319|82986919|FG000|Overall Study|Protocol Violation|21|||
46768608|NCT00761319|82986920|FG001|Overall Study|Protocol Violation|14|||
46768609|NCT00761319|82986919|FG000|Overall Study|Adverse Event|11|||
46768610|NCT00761319|82986920|FG001|Overall Study|Adverse Event|7|||
46768611|NCT00761319|82986919|FG000|Overall Study|Withdrawal by Subject|8|||
46768612|NCT00761319|82986920|FG001|Overall Study|Withdrawal by Subject|7|||
46768613|NCT00761319|82986919|FG000|Overall Study|Noncompliance|4|||
46768614|NCT00761319|82986920|FG001|Overall Study|Noncompliance|3|||
46838168|NCT00069784|83055765|FG001|Overall Study|Withdrawal by Subject|0|||
47062764|NCT01493687|83343553|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
47062765|NCT01493687|83343554|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
46768615|NCT00761319|82986919|FG000|Overall Study|Lost to Follow-up|1|||
46838169|NCT00069784|83055764|FG000|Overall Study|Other|17|||
46838170|NCT00069784|83055765|FG001|Overall Study|Other|0|||
46838171|NCT00090610|83055773|FG000|Overall Study|Withdrawal by Subject|1|||
46838172|NCT00090610|83055774|FG001|Overall Study|Withdrawal by Subject|1|||
46838173|NCT00463385|83055784|FG000|Overall Study|Other|4|||
46838174|NCT00463385|83055785|FG001|Overall Study|Other|3|||
46838175|NCT00463385|83055786|FG002|Overall Study|Other|6|||
46838176|NCT00463385|83055787|FG003|Overall Study|Other|4|||
46838177|NCT00463385|83055784|FG000|Overall Study|Adverse Event|5|||
46838178|NCT00463385|83055785|FG001|Overall Study|Adverse Event|8|||
46838179|NCT00463385|83055786|FG002|Overall Study|Adverse Event|4|||
46943658|NCT02966015|83180702|FG001|Inclusion Visit|did not answer questionnaire|3|||
46943659|NCT02968433|83180708|FG000|Overall Study|Withdrawal by Subject|1|||
46943660|NCT02872285|83180720|FG000|Overall Study|Withdrawal by Subject|2|||
46943661|NCT02872285|83180721|FG001|Overall Study|Withdrawal by Subject|0|||
46943662|NCT02872285|83180720|FG000|Overall Study|Lost to Follow-up|2|||
46943663|NCT02872285|83180721|FG001|Overall Study|Lost to Follow-up|2|||
46943664|NCT02872285|83180720|FG000|Overall Study|Discontinued due to back surgery|1|||
46943665|NCT02872285|83180721|FG001|Overall Study|Discontinued due to back surgery|0|||
46943666|NCT02871739|83180731|FG000|Overall Study|Lost to Follow-up|3|||
46943667|NCT02871739|83180732|FG001|Overall Study|Lost to Follow-up|2|||
46943668|NCT02871739|83180733|FG002|Overall Study|Lost to Follow-up|0|||
46943669|NCT02871739|83180734|FG003|Overall Study|Lost to Follow-up|2|||
46943670|NCT02896361|83180744|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
46943671|NCT02896361|83180745|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
46943672|NCT02896361|83180746|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
46943673|NCT02896361|83180744|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
46943674|NCT02896361|83180745|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
46943675|NCT02896361|83180746|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
46943676|NCT02962739|83180769|FG000|Overall Study|Withdrawal by Subject|0|||
46943677|NCT02962739|83180770|FG001|Overall Study|Withdrawal by Subject|1|||
46943678|NCT02962739|83180771|FG002|Overall Study|Withdrawal by Subject|0|||
46943679|NCT02962739|83180772|FG003|Overall Study|Withdrawal by Subject|0|||
46943680|NCT02962739|83180773|FG004|Overall Study|Withdrawal by Subject|0|||
46943681|NCT02962739|83180774|FG005|Overall Study|Withdrawal by Subject|0|||
46943682|NCT02962739|83180769|FG000|Overall Study|Protocol Violation|0|||
46943683|NCT02962739|83180770|FG001|Overall Study|Protocol Violation|0|||
46943684|NCT02962739|83180771|FG002|Overall Study|Protocol Violation|1|||
46943685|NCT02962739|83180772|FG003|Overall Study|Protocol Violation|0|||
46943686|NCT02962739|83180773|FG004|Overall Study|Protocol Violation|1|||
46943687|NCT02962739|83180774|FG005|Overall Study|Protocol Violation|0|||
46943688|NCT01344629|83180782|FG000|Crossover Period 2|Withdrawal by Subject|0|||
47062766|NCT01493687|83343553|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
47062767|NCT01493687|83343554|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
47062768|NCT01493687|83343553|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
47062769|NCT01493687|83343554|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
46943689|NCT01344629|83180783|FG001|Crossover Period 2|Withdrawal by Subject|1|||
46943690|NCT01092117|83180789|FG000|Index Procedure to 1 Month|Death|1|||
47062770|NCT01493687|83343553|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
47062771|NCT01493687|83343554|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
47062772|NCT01493687|83343553|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
47062773|NCT01493687|83343554|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
47062774|NCT01493687|83343553|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
47062775|NCT01493687|83343554|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
47062776|NCT01493687|83343553|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
47062777|NCT01493687|83343554|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
47062778|NCT01493687|83343553|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
47062779|NCT01493687|83343554|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
47062780|NCT01493687|83343553|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
47062781|NCT01493687|83343554|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
47062782|NCT01493687|83343553|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
47062783|NCT01493687|83343554|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
47062784|NCT01493687|83343553|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
47062785|NCT01493687|83343554|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
46943691|NCT01092117|83180789|FG000|1 Month|Death|1|||
46943692|NCT01092117|83180789|FG000|1 Month|Withdrawal by Subject|1|||
47062786|NCT01493687|83343553|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
47062787|NCT01493687|83343554|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
47062788|NCT01493687|83343553|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
46838180|NCT00463385|83055787|FG003|Overall Study|Adverse Event|2|||
46943693|NCT01092117|83180789|FG000|1 Month|Lost to Follow-up|1|||
46943694|NCT01092117|83180789|FG000|6 Months|Death|2|||
46943695|NCT01092117|83180789|FG000|6 Months|Withdrawal by Subject|3|||
46943696|NCT01092117|83180789|FG000|12 Month|Death|11|||
46838181|NCT00463385|83055784|FG000|Overall Study|Lack of Efficacy|6|||
46838182|NCT00463385|83055785|FG001|Overall Study|Lack of Efficacy|6|||
46943697|NCT01092117|83180789|FG000|12 Month|Withdrawal by Subject|2|||
46943698|NCT01092117|83180789|FG000|12 Month|Lost to Follow-up|1|||
46943699|NCT01092117|83180789|FG000|Year 2|Death|5|||
46838183|NCT00463385|83055786|FG002|Overall Study|Lack of Efficacy|7|||
46838184|NCT00463385|83055787|FG003|Overall Study|Lack of Efficacy|9|||
46838185|NCT00463385|83055784|FG000|Overall Study|Withdrawal by Subject|3|||
46838186|NCT00463385|83055785|FG001|Overall Study|Withdrawal by Subject|3|||
46838187|NCT00463385|83055786|FG002|Overall Study|Withdrawal by Subject|3|||
46838188|NCT00463385|83055787|FG003|Overall Study|Withdrawal by Subject|4|||
46838189|NCT00463385|83055784|FG000|Overall Study|Lost to Follow-up|0|||
46838190|NCT00463385|83055785|FG001|Overall Study|Lost to Follow-up|0|||
46838191|NCT00463385|83055786|FG002|Overall Study|Lost to Follow-up|0|||
46838192|NCT00463385|83055787|FG003|Overall Study|Lost to Follow-up|1|||
46838193|NCT00463385|83055784|FG000|Overall Study|Death|2|||
46838194|NCT00463385|83055785|FG001|Overall Study|Death|1|||
46838195|NCT00463385|83055786|FG002|Overall Study|Death|2|||
46838196|NCT00463385|83055787|FG003|Overall Study|Death|0|||
46838197|NCT00463385|83055784|FG000|Overall Study|Missing|2|||
46838198|NCT00463385|83055785|FG001|Overall Study|Missing|0|||
46838199|NCT00463385|83055786|FG002|Overall Study|Missing|0|||
46838200|NCT00463385|83055787|FG003|Overall Study|Missing|2|||
46838201|NCT00463385|83055784|FG000|Overall Study|1 participant received commercial drug|0|||
46838202|NCT00463385|83055785|FG001|Overall Study|1 participant received commercial drug|1|||
46838203|NCT00463385|83055786|FG002|Overall Study|1 participant received commercial drug|0|||
46838204|NCT00463385|83055787|FG003|Overall Study|1 participant received commercial drug|0|||
46838205|NCT00463229|83055807|FG000|Overall Study|Lost to Follow-up|5|||
46838206|NCT00463229|83055808|FG001|Overall Study|Lost to Follow-up|7|||
46838207|NCT00463229|83055807|FG000|Overall Study|Death|4|||
46838208|NCT00463229|83055808|FG001|Overall Study|Death|3|||
46838209|NCT03839693|83055818|FG000|Overall Study|Lost to Follow-up|0|||
46838210|NCT03839693|83055819|FG001|Overall Study|Lost to Follow-up|2|||
46838211|NCT03839693|83055820|FG002|Overall Study|Lost to Follow-up|2|||
46838212|NCT03839693|83055818|FG000|Overall Study|Withdrawal by Subject|1|||
46838213|NCT03839693|83055819|FG001|Overall Study|Withdrawal by Subject|0|||
46838214|NCT03839693|83055820|FG002|Overall Study|Withdrawal by Subject|2|||
47062789|NCT01493687|83343554|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
47062790|NCT01523587|83343586|FG000|Overall Study|Other than listed|5|||
46638494|NCT01442064|82811837|FG001|Overall Study|Sponsor decision|88|||
46638495|NCT01442064|82811838|FG002|Overall Study|Sponsor decision|92|||
46638496|NCT01442064|82811839|FG003|Overall Study|Sponsor decision|88|||
46638497|NCT01442064|82811840|FG004|Overall Study|Sponsor decision|95|||
47062791|NCT01523587|83343587|FG001|Overall Study|Other than listed|5|||
47062792|NCT01523587|83343586|FG000|Overall Study|Worsening of underlying cancer disease|19|||
47062793|NCT01523587|83343587|FG001|Overall Study|Worsening of underlying cancer disease|34|||
47062794|NCT01523587|83343586|FG000|Overall Study|Adverse Event|68|||
47062795|NCT01523587|83343587|FG001|Overall Study|Adverse Event|52|||
47062796|NCT01523587|83343586|FG000|Overall Study|Protocol Violation|5|||
47062797|NCT01523587|83343587|FG001|Overall Study|Protocol Violation|3|||
47062798|NCT01523587|83343586|FG000|Overall Study|Lost to Follow-up|2|||
47062799|NCT01523587|83343587|FG001|Overall Study|Lost to Follow-up|2|||
47062800|NCT01523587|83343586|FG000|Overall Study|Withdrawal by Subject|28|||
47062801|NCT01523587|83343587|FG001|Overall Study|Withdrawal by Subject|20|||
47062802|NCT01523587|83343586|FG000|Overall Study|Withdrew due to Progressive disease|265|||
47062803|NCT01523587|83343587|FG001|Overall Study|Withdrew due to Progressive disease|279|||
47062804|NCT01523587|83343586|FG000|Overall Study|Randomised but bot treated|6|||
47062805|NCT01523587|83343587|FG001|Overall Study|Randomised but bot treated|2|||
47062806|NCT01493531|83343616|FG000|Overall Study|Adverse Event|4|||
47062807|NCT01493531|83343617|FG001|Overall Study|Adverse Event|12|||
47062808|NCT01493531|83343618|FG002|Overall Study|Adverse Event|9|||
47062809|NCT01493531|83343616|FG000|Overall Study|Gout flare|3|||
47062810|NCT01493531|83343617|FG001|Overall Study|Gout flare|0|||
47062811|NCT01493531|83343618|FG002|Overall Study|Gout flare|2|||
47062812|NCT01493531|83343616|FG000|Overall Study|Protocol Violation|8|||
47062813|NCT01493531|83343617|FG001|Overall Study|Protocol Violation|15|||
47062814|NCT01493531|83343618|FG002|Overall Study|Protocol Violation|12|||
47062815|NCT01493531|83343616|FG000|Overall Study|Sponsor terminated study|5|||
46638498|NCT01442064|82811841|FG005|Overall Study|Sponsor decision|87|||
46638499|NCT01442064|82811836|FG000|Overall Study|Subject non-compliance|0|||
47062816|NCT01493531|83343617|FG001|Overall Study|Sponsor terminated study|2|||
47062817|NCT01493531|83343618|FG002|Overall Study|Sponsor terminated study|3|||
47062818|NCT01493531|83343616|FG000|Overall Study|Lost to Follow-up|5|||
47062819|NCT01493531|83343617|FG001|Overall Study|Lost to Follow-up|7|||
47062820|NCT01493531|83343618|FG002|Overall Study|Lost to Follow-up|11|||
46768616|NCT00761319|82986920|FG001|Overall Study|Lost to Follow-up|1|||
46768617|NCT00761319|82986919|FG000|Overall Study|Nonspecified|2|||
46768618|NCT00761319|82986920|FG001|Overall Study|Nonspecified|2|||
46768619|NCT00761319|82986919|FG000|Overall Study|Missing|1|||
46768620|NCT00761319|82986920|FG001|Overall Study|Missing|0|||
46768621|NCT00762996|82986926|FG000|Period One|Protocol Violation|0|||
46768622|NCT00762996|82986927|FG001|Period One|Protocol Violation|0|||
46768623|NCT00762996|82986928|FG002|Period One|Protocol Violation|1|||
46768624|NCT00762996|82986929|FG003|Period One|Protocol Violation|0|||
46768625|NCT00762996|82986926|FG000|Period One|ineligible|0|||
46943700|NCT01092117|83180789|FG000|Year 2|Withdrawal by Subject|4|||
46943701|NCT01092117|83180789|FG000|Year 2|Lost to Follow-up|1|||
46943702|NCT01092117|83180789|FG000|Year 3|Death|7|||
46943703|NCT01092117|83180789|FG000|Year 3|Withdrawal by Subject|9|||
46943704|NCT01092117|83180789|FG000|Year 3|Lost to Follow-up|3|||
46943705|NCT01092117|83180789|FG000|Year 4|Death|8|||
46838215|NCT03839693|83055818|FG000|Overall Study|subject moved out of the area|1|||
46838216|NCT03839693|83055819|FG001|Overall Study|subject moved out of the area|0|||
46838217|NCT03839693|83055820|FG002|Overall Study|subject moved out of the area|0|||
46838218|NCT00068692|83055833|FG000|Step 1: Registration|Disese progression/relapse|5|||
46838219|NCT00068692|83055834|FG001|Step 1: Registration|Disese progression/relapse|0|||
46838220|NCT00068692|83055835|FG002|Step 1: Registration|Disese progression/relapse|0|||
46838221|NCT00068692|83055836|FG003|Step 1: Registration|Disese progression/relapse|0|||
46838222|NCT00068692|83055837|FG004|Step 1: Registration|Disese progression/relapse|0|||
46838223|NCT00068692|83055838|FG005|Step 1: Registration|Disese progression/relapse|0|||
46838224|NCT00068692|83055839|FG006|Step 1: Registration|Disese progression/relapse|0|||
46838225|NCT00068692|83055840|FG007|Step 1: Registration|Disese progression/relapse|0|||
46838226|NCT00068692|83055833|FG000|Step 1: Registration|Adverse Event|7|||
46838227|NCT00068692|83055834|FG001|Step 1: Registration|Adverse Event|0|||
46838228|NCT00068692|83055835|FG002|Step 1: Registration|Adverse Event|0|||
46838229|NCT00068692|83055836|FG003|Step 1: Registration|Adverse Event|0|||
46838230|NCT00068692|83055837|FG004|Step 1: Registration|Adverse Event|0|||
46838231|NCT00068692|83055838|FG005|Step 1: Registration|Adverse Event|0|||
46838232|NCT00068692|83055839|FG006|Step 1: Registration|Adverse Event|0|||
46838233|NCT00068692|83055840|FG007|Step 1: Registration|Adverse Event|0|||
46838234|NCT00068692|83055833|FG000|Step 1: Registration|Death|1|||
46838235|NCT00068692|83055834|FG001|Step 1: Registration|Death|0|||
46838236|NCT00068692|83055835|FG002|Step 1: Registration|Death|0|||
46838237|NCT00068692|83055836|FG003|Step 1: Registration|Death|0|||
46943706|NCT01092117|83180789|FG000|Year 4|Withdrawal by Subject|4|||
46943707|NCT01092117|83180789|FG000|Year 4|Lost to Follow-up|4|||
46943708|NCT01065779|83180802|FG000|Overall Study|Duplicate Investigation|1|||
46943709|NCT01065779|83180802|FG000|Overall Study|Investigation Before Contract Date|37|||
46943710|NCT01065779|83180802|FG000|Overall Study|Non-enrollment Period Administration|10|||
46943711|NCT01065779|83180802|FG000|Overall Study|Not Administered With Study Drug|17|||
46943712|NCT01065779|83180802|FG000|Overall Study|Failed to Follow-up|10|||
46943713|NCT01065779|83180802|FG000|Overall Study|Inclusion Criteria Violation|7|||
46943714|NCT01345253|83180808|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
46943715|NCT01345253|83180809|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
46943716|NCT01345253|83180808|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
46943717|NCT01345253|83180809|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
46943718|NCT01345253|83180808|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
47062821|NCT01493531|83343616|FG000|Overall Study|Withdrawal by Subject|16|||
47062822|NCT01493531|83343617|FG001|Overall Study|Withdrawal by Subject|13|||
47062823|NCT01493531|83343618|FG002|Overall Study|Withdrawal by Subject|11|||
47062824|NCT01493531|83343616|FG000|Overall Study|Death|0|||
46943719|NCT01345253|83180809|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
46943720|NCT01345253|83180808|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
47062825|NCT01493531|83343617|FG001|Overall Study|Death|1|||
47062826|NCT01493531|83343618|FG002|Overall Study|Death|0|||
47062827|NCT01523275|83343642|FG000|Overall Study|Lost to Follow-up|1|||
47062828|NCT01523275|83343643|FG001|Overall Study|Lost to Follow-up|2|||
47062829|NCT01523275|83343642|FG000|Overall Study|Withdrawal by Subject|1|||
47062830|NCT01523275|83343643|FG001|Overall Study|Withdrawal by Subject|0|||
47062831|NCT01492439|83343660|FG000|Overall Study|Withdrew from RTE|4|||
47062832|NCT01492439|83343661|FG001|Overall Study|Withdrew from RTE|9|||
47062833|NCT01572727|83343696|FG000|Overall Study|Adverse Event|43|||
47062834|NCT01572727|83343697|FG001|Overall Study|Adverse Event|15|||
46768626|NCT00762996|82986927|FG001|Period One|ineligible|0|||
46768627|NCT00762996|82986928|FG002|Period One|ineligible|1|||
46768628|NCT00762996|82986929|FG003|Period One|ineligible|1|||
46768629|NCT00762996|82986926|FG000|Period One|Adverse Event|0|||
46768630|NCT00762996|82986927|FG001|Period One|Adverse Event|0|||
46768631|NCT00762996|82986928|FG002|Period One|Adverse Event|1|||
46768632|NCT00762996|82986929|FG003|Period One|Adverse Event|0|||
46768633|NCT00762996|82986926|FG000|Period One|Withdrawal by Subject|0|||
46943721|NCT01345253|83180809|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
47062835|NCT01572727|83343696|FG000|Overall Study|Lost to Follow-up|1|||
46768634|NCT00762996|82986927|FG001|Period One|Withdrawal by Subject|0|||
46768635|NCT00762996|82986928|FG002|Period One|Withdrawal by Subject|1|||
46768636|NCT00762996|82986929|FG003|Period One|Withdrawal by Subject|0|||
46838238|NCT00068692|83055837|FG004|Step 1: Registration|Death|0|||
46838239|NCT00068692|83055838|FG005|Step 1: Registration|Death|0|||
46838240|NCT00068692|83055839|FG006|Step 1: Registration|Death|0|||
46838241|NCT00068692|83055840|FG007|Step 1: Registration|Death|0|||
46838242|NCT00068692|83055833|FG000|Step 1: Registration|Withdrawal by Subject|11|||
46838243|NCT00068692|83055834|FG001|Step 1: Registration|Withdrawal by Subject|0|||
46838244|NCT00068692|83055835|FG002|Step 1: Registration|Withdrawal by Subject|0|||
46838245|NCT00068692|83055836|FG003|Step 1: Registration|Withdrawal by Subject|0|||
46838246|NCT00068692|83055837|FG004|Step 1: Registration|Withdrawal by Subject|0|||
46838247|NCT00068692|83055838|FG005|Step 1: Registration|Withdrawal by Subject|0|||
46838248|NCT00068692|83055839|FG006|Step 1: Registration|Withdrawal by Subject|0|||
46838249|NCT00068692|83055840|FG007|Step 1: Registration|Withdrawal by Subject|0|||
46838250|NCT00068692|83055833|FG000|Step 1: Registration|Alternative therapy|2|||
46838251|NCT00068692|83055834|FG001|Step 1: Registration|Alternative therapy|0|||
46838252|NCT00068692|83055835|FG002|Step 1: Registration|Alternative therapy|0|||
46838253|NCT00068692|83055836|FG003|Step 1: Registration|Alternative therapy|0|||
46838254|NCT00068692|83055837|FG004|Step 1: Registration|Alternative therapy|0|||
46838255|NCT00068692|83055838|FG005|Step 1: Registration|Alternative therapy|0|||
46838256|NCT00068692|83055839|FG006|Step 1: Registration|Alternative therapy|0|||
46838257|NCT00068692|83055840|FG007|Step 1: Registration|Alternative therapy|0|||
46838258|NCT00068692|83055833|FG000|Step 1: Registration|Complicating disease|2|||
46838259|NCT00068692|83055834|FG001|Step 1: Registration|Complicating disease|0|||
46838260|NCT00068692|83055835|FG002|Step 1: Registration|Complicating disease|0|||
46838261|NCT00068692|83055836|FG003|Step 1: Registration|Complicating disease|0|||
46838262|NCT00068692|83055837|FG004|Step 1: Registration|Complicating disease|0|||
46838263|NCT00068692|83055838|FG005|Step 1: Registration|Complicating disease|0|||
46838264|NCT00068692|83055839|FG006|Step 1: Registration|Complicating disease|0|||
46838265|NCT00068692|83055840|FG007|Step 1: Registration|Complicating disease|0|||
46838266|NCT00068692|83055833|FG000|Step 1: Registration|Protocol Violation|1|||
46838267|NCT00068692|83055834|FG001|Step 1: Registration|Protocol Violation|0|||
46838268|NCT00068692|83055835|FG002|Step 1: Registration|Protocol Violation|0|||
46838269|NCT00068692|83055836|FG003|Step 1: Registration|Protocol Violation|0|||
46838270|NCT00068692|83055837|FG004|Step 1: Registration|Protocol Violation|0|||
46838271|NCT00068692|83055838|FG005|Step 1: Registration|Protocol Violation|0|||
46838272|NCT00068692|83055839|FG006|Step 1: Registration|Protocol Violation|0|||
46838273|NCT00068692|83055840|FG007|Step 1: Registration|Protocol Violation|0|||
46838274|NCT00068692|83055833|FG000|Step 1: Registration|Not eligible|6|||
46838275|NCT00068692|83055834|FG001|Step 1: Registration|Not eligible|0|||
46838276|NCT00068692|83055835|FG002|Step 1: Registration|Not eligible|0|||
46838277|NCT00068692|83055836|FG003|Step 1: Registration|Not eligible|0|||
46838278|NCT00068692|83055837|FG004|Step 1: Registration|Not eligible|0|||
46838279|NCT00068692|83055838|FG005|Step 1: Registration|Not eligible|0|||
46838280|NCT00068692|83055839|FG006|Step 1: Registration|Not eligible|0|||
46838281|NCT00068692|83055840|FG007|Step 1: Registration|Not eligible|0|||
46838282|NCT00068692|83055833|FG000|Step 1: Registration|Other|2|||
46838283|NCT00068692|83055834|FG001|Step 1: Registration|Other|0|||
46838284|NCT00068692|83055835|FG002|Step 1: Registration|Other|0|||
46838285|NCT00068692|83055836|FG003|Step 1: Registration|Other|0|||
46838286|NCT00068692|83055837|FG004|Step 1: Registration|Other|0|||
46838287|NCT00068692|83055838|FG005|Step 1: Registration|Other|0|||
46838288|NCT00068692|83055839|FG006|Step 1: Registration|Other|0|||
46838289|NCT00068692|83055840|FG007|Step 1: Registration|Other|0|||
46838290|NCT00068692|83055833|FG000|Step 1: Registration|Not start protocol therapy|3|||
46838291|NCT00068692|83055834|FG001|Step 1: Registration|Not start protocol therapy|0|||
46838292|NCT00068692|83055835|FG002|Step 1: Registration|Not start protocol therapy|0|||
46838293|NCT00068692|83055836|FG003|Step 1: Registration|Not start protocol therapy|0|||
46838294|NCT00068692|83055837|FG004|Step 1: Registration|Not start protocol therapy|0|||
46838295|NCT00068692|83055838|FG005|Step 1: Registration|Not start protocol therapy|0|||
46838296|NCT00068692|83055839|FG006|Step 1: Registration|Not start protocol therapy|0|||
46838297|NCT00068692|83055840|FG007|Step 1: Registration|Not start protocol therapy|0|||
46838298|NCT00068692|83055833|FG000|Step 1: Registration|Registered but not randomized|0|||
46838299|NCT00068692|83055834|FG001|Step 1: Registration|Registered but not randomized|1|||
46838300|NCT00068692|83055835|FG002|Step 1: Registration|Registered but not randomized|0|||
46838301|NCT00068692|83055836|FG003|Step 1: Registration|Registered but not randomized|0|||
46838302|NCT00068692|83055837|FG004|Step 1: Registration|Registered but not randomized|0|||
46838303|NCT00068692|83055838|FG005|Step 1: Registration|Registered but not randomized|0|||
46838304|NCT00068692|83055839|FG006|Step 1: Registration|Registered but not randomized|0|||
46838305|NCT00068692|83055840|FG007|Step 1: Registration|Registered but not randomized|0|||
46838306|NCT00068692|83055833|FG000|Step 2: Randomization|Disesae progression/replase|0|||
46838307|NCT00068692|83055834|FG001|Step 2: Randomization|Disesae progression/replase|0|||
46838308|NCT00068692|83055835|FG002|Step 2: Randomization|Disesae progression/replase|1|||
46838309|NCT00068692|83055836|FG003|Step 2: Randomization|Disesae progression/replase|1|||
46838310|NCT00068692|83055837|FG004|Step 2: Randomization|Disesae progression/replase|0|||
46838311|NCT00068692|83055838|FG005|Step 2: Randomization|Disesae progression/replase|0|||
46838312|NCT00068692|83055839|FG006|Step 2: Randomization|Disesae progression/replase|0|||
46838313|NCT00068692|83055840|FG007|Step 2: Randomization|Disesae progression/replase|0|||
46838314|NCT00068692|83055833|FG000|Step 2: Randomization|Adverse Event|0|||
46838315|NCT00068692|83055834|FG001|Step 2: Randomization|Adverse Event|0|||
47062836|NCT01572727|83343697|FG001|Overall Study|Lost to Follow-up|1|||
46943722|NCT01345253|83180808|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
46943723|NCT01345253|83180809|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
46943724|NCT01345253|83180808|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
46943725|NCT01345253|83180809|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
46943726|NCT01345253|83180808|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
46943727|NCT01345253|83180809|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
46943728|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
46943729|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
46943730|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
46943731|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
46943732|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
46943733|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
46943734|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
46943735|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
46943736|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
46943737|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
46943738|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
46943739|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
46943740|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
46943741|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
46943742|NCT01345253|83180808|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
46943743|NCT01345253|83180809|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
46943744|NCT02477800|83180820|FG000|Placebo-Controlled Period|Adverse Event|16|||
46943745|NCT02477800|83180821|FG001|Placebo-Controlled Period|Adverse Event|25|||
46943746|NCT02477800|83180822|FG002|Placebo-Controlled Period|Adverse Event|28|||
46943747|NCT02477800|83180823|FG003|Placebo-Controlled Period|Adverse Event|0|||
46943748|NCT02477800|83180824|FG004|Placebo-Controlled Period|Adverse Event|0|||
46943749|NCT02477800|83180825|FG005|Placebo-Controlled Period|Adverse Event|0|||
46943750|NCT02477800|83180826|FG006|Placebo-Controlled Period|Adverse Event|0|||
46943751|NCT02477800|83180820|FG000|Placebo-Controlled Period|Change of Treatment|1|||
46943752|NCT02477800|83180821|FG001|Placebo-Controlled Period|Change of Treatment|2|||
46943753|NCT02477800|83180822|FG002|Placebo-Controlled Period|Change of Treatment|1|||
46943754|NCT02477800|83180823|FG003|Placebo-Controlled Period|Change of Treatment|0|||
46943755|NCT02477800|83180824|FG004|Placebo-Controlled Period|Change of Treatment|0|||
46943756|NCT02477800|83180825|FG005|Placebo-Controlled Period|Change of Treatment|0|||
46943757|NCT02477800|83180826|FG006|Placebo-Controlled Period|Change of Treatment|0|||
46943758|NCT02477800|83180820|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
46943759|NCT02477800|83180821|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
46943760|NCT02477800|83180822|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
46943761|NCT02477800|83180823|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
46943762|NCT02477800|83180824|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
46943763|NCT02477800|83180825|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
46943764|NCT02477800|83180826|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
46943765|NCT02477800|83180820|FG000|Placebo-Controlled Period|Death|0|||
46943766|NCT02477800|83180821|FG001|Placebo-Controlled Period|Death|3|||
46943767|NCT02477800|83180822|FG002|Placebo-Controlled Period|Death|2|||
46943768|NCT02477800|83180823|FG003|Placebo-Controlled Period|Death|0|||
46943769|NCT02477800|83180824|FG004|Placebo-Controlled Period|Death|0|||
46943770|NCT02477800|83180825|FG005|Placebo-Controlled Period|Death|0|||
46943771|NCT02477800|83180826|FG006|Placebo-Controlled Period|Death|0|||
46943772|NCT02477800|83180820|FG000|Placebo-Controlled Period|Disease Progression|1|||
46943773|NCT02477800|83180821|FG001|Placebo-Controlled Period|Disease Progression|0|||
46943774|NCT02477800|83180822|FG002|Placebo-Controlled Period|Disease Progression|1|||
46943775|NCT02477800|83180823|FG003|Placebo-Controlled Period|Disease Progression|0|||
46943776|NCT02477800|83180824|FG004|Placebo-Controlled Period|Disease Progression|0|||
46638500|NCT01442064|82811837|FG001|Overall Study|Subject non-compliance|0|||
47062837|NCT01572727|83343696|FG000|Overall Study|Physician Decision|23|||
47062838|NCT01572727|83343697|FG001|Overall Study|Physician Decision|9|||
47062839|NCT01572727|83343696|FG000|Overall Study|Progressive disease|59|||
47062840|NCT01572727|83343697|FG001|Overall Study|Progressive disease|82|||
47062841|NCT01572727|83343696|FG000|Overall Study|Protocol Violation|0|||
47062842|NCT01572727|83343697|FG001|Overall Study|Protocol Violation|1|||
47062843|NCT01572727|83343696|FG000|Overall Study|Study terminated by sponsor|61|||
47062844|NCT01572727|83343697|FG001|Overall Study|Study terminated by sponsor|83|||
46638501|NCT01442064|82811838|FG002|Overall Study|Subject non-compliance|0|||
46638502|NCT01442064|82811839|FG003|Overall Study|Subject non-compliance|0|||
46638503|NCT01442064|82811840|FG004|Overall Study|Subject non-compliance|0|||
46638504|NCT01442064|82811841|FG005|Overall Study|Subject non-compliance|2|||
46943777|NCT02477800|83180825|FG005|Placebo-Controlled Period|Disease Progression|0|||
46943778|NCT02477800|83180826|FG006|Placebo-Controlled Period|Disease Progression|0|||
47062845|NCT01572727|83343696|FG000|Overall Study|Parent/guardian decision|14|||
46943779|NCT02477800|83180820|FG000|Placebo-Controlled Period|Investigator Decision|3|||
46943780|NCT02477800|83180821|FG001|Placebo-Controlled Period|Investigator Decision|2|||
46943781|NCT02477800|83180822|FG002|Placebo-Controlled Period|Investigator Decision|1|||
46943782|NCT02477800|83180823|FG003|Placebo-Controlled Period|Investigator Decision|0|||
46943783|NCT02477800|83180824|FG004|Placebo-Controlled Period|Investigator Decision|0|||
46943784|NCT02477800|83180825|FG005|Placebo-Controlled Period|Investigator Decision|0|||
46943785|NCT02477800|83180826|FG006|Placebo-Controlled Period|Investigator Decision|0|||
46943786|NCT02477800|83180820|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
46943787|NCT02477800|83180821|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
46943788|NCT02477800|83180822|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
46838316|NCT00068692|83055835|FG002|Step 2: Randomization|Adverse Event|4|||
46838317|NCT00068692|83055836|FG003|Step 2: Randomization|Adverse Event|2|||
46838318|NCT00068692|83055837|FG004|Step 2: Randomization|Adverse Event|2|||
46838319|NCT00068692|83055838|FG005|Step 2: Randomization|Adverse Event|3|||
46838320|NCT00068692|83055839|FG006|Step 2: Randomization|Adverse Event|4|||
46838321|NCT00068692|83055840|FG007|Step 2: Randomization|Adverse Event|4|||
46838322|NCT00068692|83055833|FG000|Step 2: Randomization|Death|0|||
46838323|NCT00068692|83055834|FG001|Step 2: Randomization|Death|0|||
46838324|NCT00068692|83055835|FG002|Step 2: Randomization|Death|0|||
46838325|NCT00068692|83055836|FG003|Step 2: Randomization|Death|0|||
46838326|NCT00068692|83055837|FG004|Step 2: Randomization|Death|1|||
46838327|NCT00068692|83055838|FG005|Step 2: Randomization|Death|0|||
46838328|NCT00068692|83055839|FG006|Step 2: Randomization|Death|0|||
46838329|NCT00068692|83055840|FG007|Step 2: Randomization|Death|1|||
46838330|NCT00068692|83055833|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
46838331|NCT00068692|83055834|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
46838332|NCT00068692|83055835|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
46838333|NCT00068692|83055836|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
46838334|NCT00068692|83055837|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
46943789|NCT02477800|83180823|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
46943790|NCT02477800|83180824|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
46943791|NCT02477800|83180825|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
46943792|NCT02477800|83180826|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
46943793|NCT02477800|83180820|FG000|Placebo-Controlled Period|Relocation|2|||
46943794|NCT02477800|83180821|FG001|Placebo-Controlled Period|Relocation|0|||
46943795|NCT02477800|83180822|FG002|Placebo-Controlled Period|Relocation|0|||
46943796|NCT02477800|83180823|FG003|Placebo-Controlled Period|Relocation|0|||
46943797|NCT02477800|83180824|FG004|Placebo-Controlled Period|Relocation|0|||
47062846|NCT01572727|83343697|FG001|Overall Study|Parent/guardian decision|9|||
47062847|NCT01572727|83343696|FG000|Overall Study|Death|2|||
46768637|NCT00762606|82986939|FG000|Overall Study|Lost to Follow-up|18|||
46768638|NCT00762606|82986940|FG001|Overall Study|Lost to Follow-up|13|||
46768639|NCT00818441|82986948|FG000|Overall Study|Death|69|||
46768640|NCT00818441|82986949|FG001|Overall Study|Death|26|||
46768641|NCT00818441|82986948|FG000|Overall Study|Other|5|||
46768642|NCT00818441|82986949|FG001|Overall Study|Other|0|||
46768643|NCT00818441|82986948|FG000|Overall Study|Lost to Follow-up|2|||
46768644|NCT00818441|82986949|FG001|Overall Study|Lost to Follow-up|1|||
46768645|NCT00818441|82986948|FG000|Overall Study|Withdrawal by Subject|2|||
46768646|NCT00818441|82986949|FG001|Overall Study|Withdrawal by Subject|0|||
46768647|NCT00818441|82986948|FG000|Overall Study|Adverse Event|0|||
46768648|NCT00818441|82986949|FG001|Overall Study|Adverse Event|1|||
46768649|NCT00818441|82986948|FG000|Overall Study|Study terminated by sponsor|11|||
46768650|NCT00818441|82986949|FG001|Overall Study|Study terminated by sponsor|2|||
46768651|NCT00826943|82986956|FG000|Overall Study|Withdrawal by Subject|0|||
46768652|NCT00826943|82986957|FG001|Overall Study|Withdrawal by Subject|0|||
46768653|NCT00826943|82986958|FG002|Overall Study|Withdrawal by Subject|0|||
46768654|NCT00826943|82986959|FG003|Overall Study|Withdrawal by Subject|0|||
47062848|NCT01572727|83343697|FG001|Overall Study|Death|2|||
47062849|NCT01572727|83343696|FG000|Overall Study|Untreated|4|||
47062850|NCT01572727|83343697|FG001|Overall Study|Untreated|7|||
46768655|NCT00826943|82986960|FG004|Overall Study|Withdrawal by Subject|1|||
46768656|NCT00826943|82986961|FG005|Overall Study|Withdrawal by Subject|0|||
46838335|NCT00068692|83055838|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
46838336|NCT00068692|83055839|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
46838337|NCT00068692|83055840|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
46838338|NCT00068692|83055833|FG000|Step 2: Randomization|alternative therapy|0|||
46943798|NCT02477800|83180825|FG005|Placebo-Controlled Period|Relocation|0|||
46943799|NCT02477800|83180826|FG006|Placebo-Controlled Period|Relocation|0|||
46943800|NCT02477800|83180820|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
46943801|NCT02477800|83180821|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
46768657|NCT00834041|82986971|FG000|Overall Study|Withdrawal by Subject|1|||
46768658|NCT00834041|82986972|FG001|Overall Study|Withdrawal by Subject|0|||
46768659|NCT00834041|82986971|FG000|Overall Study|Lost to Follow-up|0|||
46943802|NCT02477800|83180822|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
46838339|NCT00068692|83055834|FG001|Step 2: Randomization|alternative therapy|0|||
46838340|NCT00068692|83055835|FG002|Step 2: Randomization|alternative therapy|0|||
46838341|NCT00068692|83055836|FG003|Step 2: Randomization|alternative therapy|1|||
46838342|NCT00068692|83055837|FG004|Step 2: Randomization|alternative therapy|1|||
46838343|NCT00068692|83055838|FG005|Step 2: Randomization|alternative therapy|0|||
46838344|NCT00068692|83055839|FG006|Step 2: Randomization|alternative therapy|0|||
46838345|NCT00068692|83055840|FG007|Step 2: Randomization|alternative therapy|0|||
46838346|NCT00068692|83055833|FG000|Step 2: Randomization|Physician Decision|0|||
46838347|NCT00068692|83055834|FG001|Step 2: Randomization|Physician Decision|0|||
46838348|NCT00068692|83055835|FG002|Step 2: Randomization|Physician Decision|0|||
46943803|NCT02477800|83180823|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
46943804|NCT02477800|83180824|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
46943805|NCT02477800|83180825|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
46943806|NCT02477800|83180826|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
46943807|NCT02477800|83180820|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
46943808|NCT02477800|83180821|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
46838349|NCT00068692|83055836|FG003|Step 2: Randomization|Physician Decision|1|||
46838350|NCT00068692|83055837|FG004|Step 2: Randomization|Physician Decision|1|||
46838351|NCT00068692|83055838|FG005|Step 2: Randomization|Physician Decision|0|||
46838352|NCT00068692|83055839|FG006|Step 2: Randomization|Physician Decision|0|||
46838353|NCT00068692|83055840|FG007|Step 2: Randomization|Physician Decision|0|||
46838354|NCT00068692|83055833|FG000|Step 2: Randomization|Other|0|||
46838355|NCT00068692|83055834|FG001|Step 2: Randomization|Other|0|||
46838356|NCT00068692|83055835|FG002|Step 2: Randomization|Other|0|||
46838357|NCT00068692|83055836|FG003|Step 2: Randomization|Other|1|||
46838358|NCT00068692|83055837|FG004|Step 2: Randomization|Other|0|||
46838359|NCT00068692|83055838|FG005|Step 2: Randomization|Other|1|||
46838360|NCT00068692|83055839|FG006|Step 2: Randomization|Other|0|||
46838361|NCT00068692|83055840|FG007|Step 2: Randomization|Other|0|||
46838362|NCT00068692|83055833|FG000|Step 2: Randomization|never start protocol therapy|0|||
46838363|NCT00068692|83055834|FG001|Step 2: Randomization|never start protocol therapy|0|||
46838364|NCT00068692|83055835|FG002|Step 2: Randomization|never start protocol therapy|1|||
46838365|NCT00068692|83055836|FG003|Step 2: Randomization|never start protocol therapy|0|||
46838366|NCT00068692|83055837|FG004|Step 2: Randomization|never start protocol therapy|1|||
46838367|NCT00068692|83055838|FG005|Step 2: Randomization|never start protocol therapy|0|||
46768660|NCT00834041|82986972|FG001|Overall Study|Lost to Follow-up|1|||
46768661|NCT00760929|82986982|FG000|Overall Study|Adverse Event|2|||
46838368|NCT00068692|83055839|FG006|Step 2: Randomization|never start protocol therapy|0|||
46943809|NCT02477800|83180822|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
46943810|NCT02477800|83180823|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
46943811|NCT02477800|83180824|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
46943812|NCT02477800|83180825|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
46943813|NCT02477800|83180826|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
46768662|NCT00760929|82986983|FG001|Overall Study|Adverse Event|0|||
46768663|NCT00760929|82986984|FG002|Overall Study|Adverse Event|6|||
46768664|NCT00760929|82986985|FG003|Overall Study|Adverse Event|10|||
46768665|NCT00760929|82986982|FG000|Overall Study|Lack of Efficacy|0|||
46768666|NCT00760929|82986983|FG001|Overall Study|Lack of Efficacy|2|||
46838369|NCT00068692|83055840|FG007|Step 2: Randomization|never start protocol therapy|0|||
46838370|NCT00463151|83055857|FG000|Overall Study|Adverse Event|0|||
46838371|NCT00463151|83055858|FG001|Overall Study|Adverse Event|0|||
46838372|NCT00463151|83055859|FG002|Overall Study|Adverse Event|1|||
46838373|NCT00463151|83055860|FG003|Overall Study|Adverse Event|0|||
46838374|NCT00463151|83055857|FG000|Overall Study|Lack of Efficacy|2|||
46838375|NCT00463151|83055858|FG001|Overall Study|Lack of Efficacy|5|||
46838376|NCT00463151|83055859|FG002|Overall Study|Lack of Efficacy|2|||
46838377|NCT00463151|83055860|FG003|Overall Study|Lack of Efficacy|5|||
46838378|NCT00463151|83055857|FG000|Overall Study|Protocol Violation|0|||
46838379|NCT00463151|83055858|FG001|Overall Study|Protocol Violation|0|||
46838380|NCT00463151|83055859|FG002|Overall Study|Protocol Violation|0|||
46838381|NCT00463151|83055860|FG003|Overall Study|Protocol Violation|1|||
46838382|NCT00463151|83055857|FG000|Overall Study|Withdrawal by Subject|0|||
46838383|NCT00463151|83055858|FG001|Overall Study|Withdrawal by Subject|0|||
46838384|NCT00463151|83055859|FG002|Overall Study|Withdrawal by Subject|0|||
46838385|NCT00463151|83055860|FG003|Overall Study|Withdrawal by Subject|1|||
46838386|NCT00068380|83055870|FG000|Overall Study|Withdrawal by Subject|3|||
46838387|NCT00068380|83055870|FG000|Overall Study|Adverse Event|2|||
46838388|NCT00067990|83055876|FG000|Overall Study|Death|5|||
46838389|NCT00067990|83055877|FG001|Overall Study|Death|7|||
46838390|NCT00067990|83055876|FG000|Overall Study|ESRD, Non IF/TA|1|||
46943814|NCT02477800|83180820|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
46838391|NCT00067990|83055877|FG001|Overall Study|ESRD, Non IF/TA|3|||
46838392|NCT00067990|83055876|FG000|Overall Study|Withdrawal by Subject|4|||
46768667|NCT00760929|82986984|FG002|Overall Study|Lack of Efficacy|1|||
46838393|NCT00067990|83055877|FG001|Overall Study|Withdrawal by Subject|12|||
46838394|NCT00090220|83055885|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
46838395|NCT00090220|83055886|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
46838396|NCT00090220|83055887|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
46838397|NCT00090220|83055888|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
46838398|NCT00090220|83055889|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
46838399|NCT00090220|83055890|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
46838400|NCT00090220|83055885|FG000|Base Study Vaccination Period|Adverse Event|6|||
46838401|NCT00090220|83055886|FG001|Base Study Vaccination Period|Adverse Event|1|||
46838402|NCT00090220|83055887|FG002|Base Study Vaccination Period|Adverse Event|0|||
46838403|NCT00090220|83055888|FG003|Base Study Vaccination Period|Adverse Event|0|||
46838404|NCT00090220|83055889|FG004|Base Study Vaccination Period|Adverse Event|0|||
46838405|NCT00090220|83055890|FG005|Base Study Vaccination Period|Adverse Event|0|||
46838406|NCT00090220|83055885|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
46838407|NCT00090220|83055886|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
46838408|NCT00090220|83055887|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
46838409|NCT00090220|83055888|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
46838410|NCT00090220|83055889|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
46838411|NCT00090220|83055890|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
46838412|NCT00090220|83055885|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
46838413|NCT00090220|83055886|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
46838414|NCT00090220|83055887|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
46838415|NCT00090220|83055888|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
46838416|NCT00090220|83055889|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
46838417|NCT00090220|83055890|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
46838418|NCT00090220|83055885|FG000|Base Study Vaccination Period|Patient Moved|6|||
46838419|NCT00090220|83055886|FG001|Base Study Vaccination Period|Patient Moved|2|||
46838420|NCT00090220|83055887|FG002|Base Study Vaccination Period|Patient Moved|0|||
46838421|NCT00090220|83055888|FG003|Base Study Vaccination Period|Patient Moved|0|||
46838422|NCT00090220|83055889|FG004|Base Study Vaccination Period|Patient Moved|0|||
46838423|NCT00090220|83055890|FG005|Base Study Vaccination Period|Patient Moved|0|||
46838424|NCT00090220|83055885|FG000|Base Study Vaccination Period|Other|4|||
46838425|NCT00090220|83055886|FG001|Base Study Vaccination Period|Other|4|||
46838426|NCT00090220|83055887|FG002|Base Study Vaccination Period|Other|0|||
46838427|NCT00090220|83055888|FG003|Base Study Vaccination Period|Other|0|||
46838428|NCT00090220|83055889|FG004|Base Study Vaccination Period|Other|0|||
46838429|NCT00090220|83055890|FG005|Base Study Vaccination Period|Other|0|||
46838430|NCT00090220|83055885|FG000|Base Study Follow-up Period|Adverse Event|6|||
46838431|NCT00090220|83055886|FG001|Base Study Follow-up Period|Adverse Event|1|||
46838432|NCT00090220|83055887|FG002|Base Study Follow-up Period|Adverse Event|0|||
46838433|NCT00090220|83055888|FG003|Base Study Follow-up Period|Adverse Event|0|||
46838434|NCT00090220|83055889|FG004|Base Study Follow-up Period|Adverse Event|0|||
46838435|NCT00090220|83055890|FG005|Base Study Follow-up Period|Adverse Event|0|||
46838436|NCT00090220|83055885|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
46838437|NCT00090220|83055886|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
46838438|NCT00090220|83055887|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
46838439|NCT00090220|83055888|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
46838440|NCT00090220|83055889|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
46838441|NCT00090220|83055890|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
46838442|NCT00090220|83055885|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
46838443|NCT00090220|83055886|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
46838444|NCT00090220|83055887|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
46838445|NCT00090220|83055888|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
46838446|NCT00090220|83055889|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
46838447|NCT00090220|83055890|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
46838448|NCT00090220|83055885|FG000|Base Study Follow-up Period|Patient Moved|20|||
46838449|NCT00090220|83055886|FG001|Base Study Follow-up Period|Patient Moved|28|||
46838450|NCT00090220|83055887|FG002|Base Study Follow-up Period|Patient Moved|0|||
46838451|NCT00090220|83055888|FG003|Base Study Follow-up Period|Patient Moved|0|||
46838452|NCT00090220|83055889|FG004|Base Study Follow-up Period|Patient Moved|0|||
46838453|NCT00090220|83055890|FG005|Base Study Follow-up Period|Patient Moved|0|||
46838454|NCT00090220|83055885|FG000|Base Study Follow-up Period|Other|19|||
46838455|NCT00090220|83055886|FG001|Base Study Follow-up Period|Other|21|||
46838456|NCT00090220|83055887|FG002|Base Study Follow-up Period|Other|0|||
46838457|NCT00090220|83055888|FG003|Base Study Follow-up Period|Other|0|||
46838458|NCT00090220|83055889|FG004|Base Study Follow-up Period|Other|0|||
46838459|NCT00090220|83055890|FG005|Base Study Follow-up Period|Other|0|||
46838460|NCT00090220|83055885|FG000|Extension 1 (EXT1)|Adverse Event|0|||
46838461|NCT00090220|83055886|FG001|Extension 1 (EXT1)|Adverse Event|0|||
46838462|NCT00090220|83055887|FG002|Extension 1 (EXT1)|Adverse Event|4|||
46768668|NCT00760929|82986985|FG003|Overall Study|Lack of Efficacy|0|||
46838463|NCT00090220|83055888|FG003|Extension 1 (EXT1)|Adverse Event|0|||
46838464|NCT00090220|83055889|FG004|Extension 1 (EXT1)|Adverse Event|0|||
46838465|NCT00090220|83055890|FG005|Extension 1 (EXT1)|Adverse Event|0|||
46838466|NCT00090220|83055885|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
46838467|NCT00090220|83055886|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
46838468|NCT00090220|83055887|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
46838469|NCT00090220|83055888|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
46838470|NCT00090220|83055889|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
46838471|NCT00090220|83055890|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
46838472|NCT00090220|83055885|FG000|Extension 1 (EXT1)|Moved|0|||
46838473|NCT00090220|83055886|FG001|Extension 1 (EXT1)|Moved|0|||
46838474|NCT00090220|83055887|FG002|Extension 1 (EXT1)|Moved|2|||
46838475|NCT00090220|83055888|FG003|Extension 1 (EXT1)|Moved|1|||
46838476|NCT00090220|83055889|FG004|Extension 1 (EXT1)|Moved|0|||
46838477|NCT00090220|83055890|FG005|Extension 1 (EXT1)|Moved|0|||
46838478|NCT00090220|83055885|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
46838479|NCT00090220|83055886|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
46838480|NCT00090220|83055887|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
46768669|NCT00760929|82986982|FG000|Overall Study|Withdrawal by Subject|1|||
46768670|NCT00760929|82986983|FG001|Overall Study|Withdrawal by Subject|0|||
46838481|NCT00090220|83055888|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
46838482|NCT00090220|83055889|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
46838483|NCT00090220|83055890|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
46838484|NCT00090220|83055885|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
46838485|NCT00090220|83055886|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
46838486|NCT00090220|83055887|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
46838487|NCT00090220|83055888|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
46838488|NCT00090220|83055889|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
46838489|NCT00090220|83055890|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
46838490|NCT00090220|83055885|FG000|Extension 1 (EXT1)|Other reason|0|||
46838491|NCT00090220|83055886|FG001|Extension 1 (EXT1)|Other reason|0|||
46838492|NCT00090220|83055887|FG002|Extension 1 (EXT1)|Other reason|2|||
46838493|NCT00090220|83055888|FG003|Extension 1 (EXT1)|Other reason|0|||
46838494|NCT00090220|83055889|FG004|Extension 1 (EXT1)|Other reason|0|||
46838495|NCT00090220|83055890|FG005|Extension 1 (EXT1)|Other reason|0|||
46838496|NCT00090220|83055885|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46838497|NCT00090220|83055886|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46838498|NCT00090220|83055887|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46838499|NCT00090220|83055888|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46838500|NCT00090220|83055889|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
46838501|NCT00090220|83055890|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
46838502|NCT00090220|83055885|FG000|Long-term Follow-up (EXT2)|Death|0|||
46838503|NCT00090220|83055886|FG001|Long-term Follow-up (EXT2)|Death|0|||
46838504|NCT00090220|83055887|FG002|Long-term Follow-up (EXT2)|Death|0|||
46838505|NCT00090220|83055888|FG003|Long-term Follow-up (EXT2)|Death|0|||
46838506|NCT00090220|83055889|FG004|Long-term Follow-up (EXT2)|Death|1|||
46768671|NCT00760929|82986984|FG002|Overall Study|Withdrawal by Subject|9|||
46768672|NCT00760929|82986985|FG003|Overall Study|Withdrawal by Subject|1|||
46768673|NCT00760929|82986982|FG000|Overall Study|Lost to Follow-up|0|||
46768674|NCT00760929|82986983|FG001|Overall Study|Lost to Follow-up|0|||
46768675|NCT00760929|82986984|FG002|Overall Study|Lost to Follow-up|1|||
46768676|NCT00760929|82986985|FG003|Overall Study|Lost to Follow-up|0|||
46768677|NCT00760929|82986982|FG000|Overall Study|Progression of Disease|21|||
46768678|NCT00760929|82986983|FG001|Overall Study|Progression of Disease|26|||
46768679|NCT00760929|82986984|FG002|Overall Study|Progression of Disease|38|||
46768680|NCT00760929|82986985|FG003|Overall Study|Progression of Disease|42|||
46768681|NCT00760929|82986982|FG000|Overall Study|Other|2|||
46768682|NCT00760929|82986983|FG001|Overall Study|Other|0|||
46768683|NCT00760929|82986984|FG002|Overall Study|Other|2|||
46768684|NCT00760929|82986985|FG003|Overall Study|Other|1|||
46838507|NCT00090220|83055890|FG005|Long-term Follow-up (EXT2)|Death|1|||
46838508|NCT00090220|83055885|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46943815|NCT02477800|83180821|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
46838509|NCT00090220|83055886|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46838510|NCT00090220|83055887|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46943816|NCT02477800|83180822|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
46943817|NCT02477800|83180823|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
46838511|NCT00090220|83055888|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46838512|NCT00090220|83055889|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
46838513|NCT00090220|83055890|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
46838514|NCT00090220|83055885|FG000|Long-term Follow-up (EXT2)|Other|0|||
46838515|NCT00090220|83055886|FG001|Long-term Follow-up (EXT2)|Other|0|||
46838516|NCT00090220|83055887|FG002|Long-term Follow-up (EXT2)|Other|0|||
46838517|NCT00090220|83055888|FG003|Long-term Follow-up (EXT2)|Other|0|||
46768685|NCT00760929|82986982|FG000|Overall Study|Death|0|||
46768686|NCT00760929|82986983|FG001|Overall Study|Death|0|||
46838518|NCT00090220|83055889|FG004|Long-term Follow-up (EXT2)|Other|1|||
46638505|NCT01442064|82811836|FG000|Overall Study|Condition mandated other intervention|1|||
46943818|NCT02477800|83180824|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
46943819|NCT02477800|83180825|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
46838519|NCT00090220|83055890|FG005|Long-term Follow-up (EXT2)|Other|0|||
46838520|NCT00263328|83055910|FG000|Overall Study|Death|0|||
46838521|NCT00263328|83055911|FG001|Overall Study|Death|0|||
46943820|NCT02477800|83180826|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
46943821|NCT02477800|83180820|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
46943822|NCT02477800|83180821|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
46943823|NCT02477800|83180822|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
46943824|NCT02477800|83180823|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46943825|NCT02477800|83180824|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46943826|NCT02477800|83180825|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46943827|NCT02477800|83180826|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46943828|NCT02477800|83180820|FG000|Placebo-Controlled Period|Reason not Specified|161|||
46943829|NCT02477800|83180821|FG001|Placebo-Controlled Period|Reason not Specified|161|||
46943830|NCT02477800|83180822|FG002|Placebo-Controlled Period|Reason not Specified|189|||
46943831|NCT02477800|83180823|FG003|Placebo-Controlled Period|Reason not Specified|0|||
46943832|NCT02477800|83180824|FG004|Placebo-Controlled Period|Reason not Specified|0|||
46943833|NCT02477800|83180825|FG005|Placebo-Controlled Period|Reason not Specified|0|||
46943834|NCT02477800|83180826|FG006|Placebo-Controlled Period|Reason not Specified|0|||
46943835|NCT02477800|83180820|FG000|Long Term Extension Period|Adverse Event|0|||
46943836|NCT02477800|83180821|FG001|Long Term Extension Period|Adverse Event|0|||
46943837|NCT02477800|83180822|FG002|Long Term Extension Period|Adverse Event|0|||
46943838|NCT02477800|83180823|FG003|Long Term Extension Period|Adverse Event|6|||
46943839|NCT02477800|83180824|FG004|Long Term Extension Period|Adverse Event|2|||
46943840|NCT02477800|83180825|FG005|Long Term Extension Period|Adverse Event|4|||
46943841|NCT02477800|83180826|FG006|Long Term Extension Period|Adverse Event|3|||
46943842|NCT02477800|83180820|FG000|Long Term Extension Period|Death|0|||
46943843|NCT02477800|83180821|FG001|Long Term Extension Period|Death|0|||
46943844|NCT02477800|83180822|FG002|Long Term Extension Period|Death|0|||
46943845|NCT02477800|83180823|FG003|Long Term Extension Period|Death|1|||
46768687|NCT00760929|82986984|FG002|Overall Study|Death|1|||
46838522|NCT00263328|83055912|FG002|Overall Study|Death|1|||
46838523|NCT00263328|83055910|FG000|Overall Study|Lost to Follow-up|1|||
46838524|NCT00263328|83055911|FG001|Overall Study|Lost to Follow-up|1|||
46838525|NCT00263328|83055912|FG002|Overall Study|Lost to Follow-up|0|||
46838526|NCT00263328|83055910|FG000|Overall Study|Withdrawal by Subject|3|||
46838527|NCT00263328|83055911|FG001|Overall Study|Withdrawal by Subject|0|||
46838528|NCT00263328|83055912|FG002|Overall Study|Withdrawal by Subject|1|||
46838529|NCT00263328|83055910|FG000|Overall Study|Other|3|||
46838530|NCT00263328|83055911|FG001|Overall Study|Other|0|||
46838531|NCT00263328|83055912|FG002|Overall Study|Other|1|||
46838532|NCT00263328|83055910|FG000|Overall Study|Adverse Event|1|||
46838533|NCT00263328|83055911|FG001|Overall Study|Adverse Event|1|||
46838534|NCT00263328|83055912|FG002|Overall Study|Adverse Event|4|||
46838535|NCT00262860|83055922|FG000|Overall Study|Adverse Event|2|||
46838536|NCT00236184|83055928|FG000|Overall Study|Adverse Event|5|||
46838537|NCT00236184|83055929|FG001|Overall Study|Adverse Event|2|||
46838538|NCT00236184|83055928|FG000|Overall Study|Lack of Efficacy|0|||
46838539|NCT00236184|83055929|FG001|Overall Study|Lack of Efficacy|1|||
46838540|NCT00236184|83055928|FG000|Overall Study|Lost to Follow-up|3|||
46768688|NCT00760929|82986985|FG003|Overall Study|Death|0|||
46768689|NCT00760929|82986982|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
46838541|NCT00236184|83055929|FG001|Overall Study|Lost to Follow-up|4|||
46838542|NCT00236184|83055928|FG000|Overall Study|Physician Decision|1|||
46768690|NCT00760929|82986983|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
46768691|NCT00760929|82986984|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
46768692|NCT00760929|82986985|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
46768693|NCT00818207|82986996|FG000|Overall Study|Adverse Event|6|||
46768694|NCT00818207|82986997|FG001|Overall Study|Adverse Event|0|||
46768695|NCT00818207|82986996|FG000|Overall Study|Lost to Follow-up|160|||
46768696|NCT00818207|82986997|FG001|Overall Study|Lost to Follow-up|146|||
46768697|NCT00818207|82986996|FG000|Overall Study|Multiple reasons|11|||
46838543|NCT00236184|83055929|FG001|Overall Study|Physician Decision|1|||
46838544|NCT00236184|83055928|FG000|Overall Study|Withdrawal by Subject|3|||
46943846|NCT02477800|83180824|FG004|Long Term Extension Period|Death|1|||
46943847|NCT02477800|83180825|FG005|Long Term Extension Period|Death|1|||
46943848|NCT02477800|83180826|FG006|Long Term Extension Period|Death|2|||
46638506|NCT01442064|82811837|FG001|Overall Study|Condition mandated other intervention|1|||
46838545|NCT00236184|83055929|FG001|Overall Study|Withdrawal by Subject|0|||
46838546|NCT00236184|83055928|FG000|Overall Study|Protocol Violation|3|||
46838547|NCT00236184|83055929|FG001|Overall Study|Protocol Violation|0|||
46838548|NCT00236184|83055928|FG000|Overall Study|non-compliance with study drug|2|||
46943849|NCT02477800|83180820|FG000|Long Term Extension Period|Consent Withdrawn|0|||
46838549|NCT00236184|83055929|FG001|Overall Study|non-compliance with study drug|1|||
46838550|NCT00236184|83055928|FG000|Overall Study|other|1|||
46838551|NCT00236184|83055929|FG001|Overall Study|other|2|||
46838552|NCT00296504|83055943|FG000|Interim Analysis|Withdrawal by Subject|8|||
46838553|NCT00296504|83055944|FG001|Interim Analysis|Withdrawal by Subject|0|||
46838554|NCT00296504|83055945|FG002|Interim Analysis|Withdrawal by Subject|12|||
46838555|NCT00296504|83055946|FG003|Interim Analysis|Withdrawal by Subject|0|||
46838556|NCT00296504|83055947|FG004|Interim Analysis|Withdrawal by Subject|5|||
46838557|NCT00296504|83055948|FG005|Interim Analysis|Withdrawal by Subject|5|||
46838558|NCT00296504|83055949|FG006|Interim Analysis|Withdrawal by Subject|9|||
46838559|NCT00296504|83055950|FG007|Interim Analysis|Withdrawal by Subject|3|||
46838560|NCT00296504|83055951|FG008|Interim Analysis|Withdrawal by Subject|0|||
46943850|NCT02477800|83180821|FG001|Long Term Extension Period|Consent Withdrawn|0|||
46943851|NCT02477800|83180822|FG002|Long Term Extension Period|Consent Withdrawn|0|||
46943852|NCT02477800|83180823|FG003|Long Term Extension Period|Consent Withdrawn|10|||
46943853|NCT02477800|83180824|FG004|Long Term Extension Period|Consent Withdrawn|4|||
46943854|NCT02477800|83180825|FG005|Long Term Extension Period|Consent Withdrawn|13|||
46943855|NCT02477800|83180826|FG006|Long Term Extension Period|Consent Withdrawn|16|||
46943856|NCT02477800|83180820|FG000|Long Term Extension Period|Disease Progression|0|||
46943857|NCT02477800|83180821|FG001|Long Term Extension Period|Disease Progression|0|||
46943858|NCT02477800|83180822|FG002|Long Term Extension Period|Disease Progression|0|||
46943859|NCT02477800|83180823|FG003|Long Term Extension Period|Disease Progression|3|||
46943860|NCT02477800|83180824|FG004|Long Term Extension Period|Disease Progression|1|||
46943861|NCT02477800|83180825|FG005|Long Term Extension Period|Disease Progression|1|||
46943862|NCT02477800|83180826|FG006|Long Term Extension Period|Disease Progression|0|||
46943863|NCT02477800|83180820|FG000|Long Term Extension Period|Investigator Decision|0|||
46943864|NCT02477800|83180821|FG001|Long Term Extension Period|Investigator Decision|0|||
46943865|NCT02477800|83180822|FG002|Long Term Extension Period|Investigator Decision|0|||
46943866|NCT02477800|83180823|FG003|Long Term Extension Period|Investigator Decision|0|||
46943867|NCT02477800|83180824|FG004|Long Term Extension Period|Investigator Decision|0|||
46943868|NCT02477800|83180825|FG005|Long Term Extension Period|Investigator Decision|0|||
46943869|NCT02477800|83180826|FG006|Long Term Extension Period|Investigator Decision|2|||
46943870|NCT02477800|83180820|FG000|Long Term Extension Period|Lost to Follow-up|0|||
46943871|NCT02477800|83180821|FG001|Long Term Extension Period|Lost to Follow-up|0|||
46943872|NCT02477800|83180822|FG002|Long Term Extension Period|Lost to Follow-up|0|||
46943873|NCT02477800|83180823|FG003|Long Term Extension Period|Lost to Follow-up|0|||
46943874|NCT02477800|83180824|FG004|Long Term Extension Period|Lost to Follow-up|1|||
46943875|NCT02477800|83180825|FG005|Long Term Extension Period|Lost to Follow-up|3|||
46943876|NCT02477800|83180826|FG006|Long Term Extension Period|Lost to Follow-up|0|||
46838561|NCT00296504|83055943|FG000|Interim Analysis|Lost to Follow-up|13|||
46838562|NCT00296504|83055944|FG001|Interim Analysis|Lost to Follow-up|3|||
46838563|NCT00296504|83055945|FG002|Interim Analysis|Lost to Follow-up|26|||
46838564|NCT00296504|83055946|FG003|Interim Analysis|Lost to Follow-up|8|||
46838565|NCT00296504|83055947|FG004|Interim Analysis|Lost to Follow-up|14|||
46838566|NCT00296504|83055948|FG005|Interim Analysis|Lost to Follow-up|4|||
46838567|NCT00296504|83055949|FG006|Interim Analysis|Lost to Follow-up|11|||
46838568|NCT00296504|83055950|FG007|Interim Analysis|Lost to Follow-up|4|||
46838569|NCT00296504|83055951|FG008|Interim Analysis|Lost to Follow-up|0|||
46838570|NCT00296504|83055943|FG000|Interim Analysis|Clinical Progression|1|||
46838571|NCT00296504|83055944|FG001|Interim Analysis|Clinical Progression|0|||
46838572|NCT00296504|83055945|FG002|Interim Analysis|Clinical Progression|1|||
46838573|NCT00296504|83055946|FG003|Interim Analysis|Clinical Progression|1|||
46838574|NCT00296504|83055947|FG004|Interim Analysis|Clinical Progression|0|||
46838575|NCT00296504|83055948|FG005|Interim Analysis|Clinical Progression|2|||
46838576|NCT00296504|83055949|FG006|Interim Analysis|Clinical Progression|1|||
46838577|NCT00296504|83055950|FG007|Interim Analysis|Clinical Progression|2|||
46943877|NCT02477800|83180820|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
46943878|NCT02477800|83180821|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
46943879|NCT02477800|83180822|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
46943880|NCT02477800|83180823|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
46638507|NCT01442064|82811838|FG002|Overall Study|Condition mandated other intervention|2|||
46768698|NCT00818207|82986997|FG001|Overall Study|Multiple reasons|12|||
46768699|NCT00818207|82986996|FG000|Overall Study|Withdrawal by Subject|42|||
46768700|NCT00818207|82986997|FG001|Overall Study|Withdrawal by Subject|104|||
46768701|NCT00818207|82986996|FG000|Overall Study|Death|3|||
46768702|NCT00818207|82986997|FG001|Overall Study|Death|5|||
46768703|NCT00760617|82987006|FG000|Overall Study|Adverse Event|5|||
46768704|NCT00760617|82987007|FG001|Overall Study|Adverse Event|2|||
46768705|NCT00760617|82987008|FG002|Overall Study|Adverse Event|0|||
46768706|NCT00760617|82987006|FG000|Overall Study|Lost to Follow-up|0|||
46838578|NCT00296504|83055951|FG008|Interim Analysis|Clinical Progression|0|||
46943881|NCT02477800|83180824|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
46943882|NCT02477800|83180825|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
46943883|NCT02477800|83180826|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
46943884|NCT02477800|83180820|FG000|Long Term Extension Period|Study Visit Burden|0|||
46943885|NCT02477800|83180821|FG001|Long Term Extension Period|Study Visit Burden|0|||
46943886|NCT02477800|83180822|FG002|Long Term Extension Period|Study Visit Burden|0|||
46943887|NCT02477800|83180823|FG003|Long Term Extension Period|Study Visit Burden|3|||
46943888|NCT02477800|83180824|FG004|Long Term Extension Period|Study Visit Burden|0|||
46943889|NCT02477800|83180825|FG005|Long Term Extension Period|Study Visit Burden|2|||
46943890|NCT02477800|83180826|FG006|Long Term Extension Period|Study Visit Burden|2|||
46943891|NCT02477800|83180820|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
46943892|NCT02477800|83180821|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
46943893|NCT02477800|83180822|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
46943894|NCT02477800|83180823|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
46943895|NCT02477800|83180824|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
46943896|NCT02477800|83180825|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
46943897|NCT02477800|83180826|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
46943898|NCT02477800|83180820|FG000|Long Term Extension Period|Reason not Specified|0|||
46943899|NCT02477800|83180821|FG001|Long Term Extension Period|Reason not Specified|0|||
46943900|NCT02477800|83180822|FG002|Long Term Extension Period|Reason not Specified|0|||
46943901|NCT02477800|83180823|FG003|Long Term Extension Period|Reason not Specified|126|||
46943902|NCT02477800|83180824|FG004|Long Term Extension Period|Reason not Specified|140|||
46838579|NCT00296504|83055943|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
46838580|NCT00296504|83055944|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
46838581|NCT00296504|83055945|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
46838582|NCT00296504|83055946|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
46838583|NCT00296504|83055947|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
46838584|NCT00296504|83055948|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
46838585|NCT00296504|83055949|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
46838586|NCT00296504|83055950|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
46838587|NCT00296504|83055951|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
46943903|NCT02477800|83180825|FG005|Long Term Extension Period|Reason not Specified|270|||
46943904|NCT02477800|83180826|FG006|Long Term Extension Period|Reason not Specified|224|||
46943905|NCT02957747|83180840|FG000|Overall Study|Withdrawal by Subject|0|||
46943906|NCT02957747|83180841|FG001|Overall Study|Withdrawal by Subject|3|||
46943907|NCT02957747|83180840|FG000|Overall Study|Lost to Follow-up|10|||
46943908|NCT02957747|83180841|FG001|Overall Study|Lost to Follow-up|5|||
46943909|NCT01344161|83180850|FG000|Overall Study|Lost to Follow-up|4|||
46943910|NCT01344161|83180851|FG001|Overall Study|Lost to Follow-up|1|||
46943911|NCT01344161|83180850|FG000|Overall Study|Pregnancy|0|||
46943912|NCT01344161|83180851|FG001|Overall Study|Pregnancy|1|||
46943913|NCT01344161|83180850|FG000|Overall Study|Protocol Violation|1|||
46943914|NCT01344161|83180851|FG001|Overall Study|Protocol Violation|1|||
46943915|NCT02451358|83180861|FG000|Overall Study|Withdrawal by Subject|1|||
46943916|NCT02451358|83180862|FG001|Overall Study|Withdrawal by Subject|1|||
46943917|NCT02451358|83180863|FG002|Overall Study|Withdrawal by Subject|0|||
46943918|NCT02451358|83180864|FG003|Overall Study|Withdrawal by Subject|0|||
46943919|NCT02451358|83180861|FG000|Overall Study|Protocol Violation|0|||
46943920|NCT02451358|83180862|FG001|Overall Study|Protocol Violation|1|||
46768707|NCT00760617|82987007|FG001|Overall Study|Lost to Follow-up|0|||
46768708|NCT00760617|82987008|FG002|Overall Study|Lost to Follow-up|5|||
46768709|NCT00760383|82987018|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
46768710|NCT00760383|82987019|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
46768711|NCT00759915|82987027|FG000|Overall Study|Withdrawal by Subject|1|||
46768712|NCT00759915|82987028|FG001|Overall Study|Withdrawal by Subject|0|||
46768713|NCT00759915|82987027|FG000|Overall Study|Adverse Event|0|||
46768714|NCT00759915|82987028|FG001|Overall Study|Adverse Event|1|||
46768715|NCT00759759|82987036|FG000|Overall Study|didn't return for period 2|1|||
46768716|NCT00759759|82987037|FG001|Overall Study|didn't return for period 2|0|||
46768717|NCT00759759|82987036|FG000|Overall Study|Didn't receive drug in period 2|1|||
46838588|NCT00296504|83055943|FG000|Interim Analysis|Adverse Event|0|||
46838589|NCT00296504|83055944|FG001|Interim Analysis|Adverse Event|0|||
46838590|NCT00296504|83055945|FG002|Interim Analysis|Adverse Event|13|||
46838591|NCT00296504|83055946|FG003|Interim Analysis|Adverse Event|4|||
46838592|NCT00296504|83055947|FG004|Interim Analysis|Adverse Event|6|||
46838593|NCT00296504|83055948|FG005|Interim Analysis|Adverse Event|3|||
46943921|NCT02451358|83180863|FG002|Overall Study|Protocol Violation|1|||
46638508|NCT01442064|82811839|FG003|Overall Study|Condition mandated other intervention|0|||
46838594|NCT00296504|83055949|FG006|Interim Analysis|Adverse Event|4|||
46838595|NCT00296504|83055950|FG007|Interim Analysis|Adverse Event|5|||
46943922|NCT02451358|83180864|FG003|Overall Study|Protocol Violation|0|||
46943923|NCT02749721|83180874|FG000|Screening|Withdrawal by Subject|1|||
46943924|NCT02749721|83180874|FG000|Screening|Lost to Follow-up|2|||
46943925|NCT02749721|83180874|FG000|Screening|Protocol Violation|3|||
46838596|NCT00296504|83055951|FG008|Interim Analysis|Adverse Event|0|||
46838597|NCT00296504|83055943|FG000|Interim Analysis|Protocol Violation|0|||
46838598|NCT00296504|83055944|FG001|Interim Analysis|Protocol Violation|0|||
46838599|NCT00296504|83055945|FG002|Interim Analysis|Protocol Violation|2|||
46838600|NCT00296504|83055946|FG003|Interim Analysis|Protocol Violation|0|||
46838601|NCT00296504|83055947|FG004|Interim Analysis|Protocol Violation|1|||
46838602|NCT00296504|83055948|FG005|Interim Analysis|Protocol Violation|0|||
46838603|NCT00296504|83055949|FG006|Interim Analysis|Protocol Violation|0|||
46838604|NCT00296504|83055950|FG007|Interim Analysis|Protocol Violation|1|||
46838605|NCT00296504|83055951|FG008|Interim Analysis|Protocol Violation|0|||
46838606|NCT00296504|83055943|FG000|Interim Analysis|Insufficient CD4 Response|0|||
46838607|NCT00296504|83055944|FG001|Interim Analysis|Insufficient CD4 Response|0|||
46838608|NCT00296504|83055945|FG002|Interim Analysis|Insufficient CD4 Response|0|||
46838609|NCT00296504|83055946|FG003|Interim Analysis|Insufficient CD4 Response|0|||
46838610|NCT00296504|83055947|FG004|Interim Analysis|Insufficient CD4 Response|1|||
46838611|NCT00296504|83055948|FG005|Interim Analysis|Insufficient CD4 Response|1|||
46838612|NCT00296504|83055949|FG006|Interim Analysis|Insufficient CD4 Response|0|||
46838613|NCT00296504|83055950|FG007|Interim Analysis|Insufficient CD4 Response|0|||
46838614|NCT00296504|83055951|FG008|Interim Analysis|Insufficient CD4 Response|0|||
46838615|NCT00296504|83055943|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
46838616|NCT00296504|83055944|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
46838617|NCT00296504|83055945|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
46838618|NCT00296504|83055946|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
46838619|NCT00296504|83055947|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
46838620|NCT00296504|83055948|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
46838621|NCT00296504|83055949|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
46838622|NCT00296504|83055950|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
46838623|NCT00296504|83055951|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
46838624|NCT00296504|83055943|FG000|Interim Analysis|Pregnancy|4|||
46838625|NCT00296504|83055944|FG001|Interim Analysis|Pregnancy|1|||
46838626|NCT00296504|83055945|FG002|Interim Analysis|Pregnancy|4|||
46838627|NCT00296504|83055946|FG003|Interim Analysis|Pregnancy|2|||
46838628|NCT00296504|83055947|FG004|Interim Analysis|Pregnancy|0|||
46838629|NCT00296504|83055948|FG005|Interim Analysis|Pregnancy|1|||
46838630|NCT00296504|83055949|FG006|Interim Analysis|Pregnancy|1|||
46838631|NCT00296504|83055950|FG007|Interim Analysis|Pregnancy|1|||
46838632|NCT00296504|83055951|FG008|Interim Analysis|Pregnancy|0|||
46838633|NCT00296504|83055943|FG000|Interim Analysis|Death|1|||
46838634|NCT00296504|83055944|FG001|Interim Analysis|Death|0|||
46838635|NCT00296504|83055945|FG002|Interim Analysis|Death|3|||
46838636|NCT00296504|83055946|FG003|Interim Analysis|Death|0|||
46838637|NCT00296504|83055947|FG004|Interim Analysis|Death|0|||
46838638|NCT00296504|83055948|FG005|Interim Analysis|Death|0|||
46838639|NCT00296504|83055949|FG006|Interim Analysis|Death|0|||
46838640|NCT00296504|83055950|FG007|Interim Analysis|Death|0|||
46838641|NCT00296504|83055951|FG008|Interim Analysis|Death|0|||
46838642|NCT00296504|83055943|FG000|Interim Analysis|Participant Non-compliant|0|||
46838643|NCT00296504|83055944|FG001|Interim Analysis|Participant Non-compliant|1|||
46838644|NCT00296504|83055945|FG002|Interim Analysis|Participant Non-compliant|2|||
46838645|NCT00296504|83055946|FG003|Interim Analysis|Participant Non-compliant|1|||
46838646|NCT00296504|83055947|FG004|Interim Analysis|Participant Non-compliant|1|||
46838647|NCT00296504|83055948|FG005|Interim Analysis|Participant Non-compliant|3|||
46838648|NCT00296504|83055949|FG006|Interim Analysis|Participant Non-compliant|6|||
46838649|NCT00296504|83055950|FG007|Interim Analysis|Participant Non-compliant|2|||
46838650|NCT00296504|83055951|FG008|Interim Analysis|Participant Non-compliant|0|||
46838651|NCT00296504|83055943|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
46838652|NCT00296504|83055944|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
46838653|NCT00296504|83055945|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
46838654|NCT00296504|83055946|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
46838655|NCT00296504|83055947|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
46838656|NCT00296504|83055948|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
46838657|NCT00296504|83055949|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
46838658|NCT00296504|83055950|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
46838659|NCT00296504|83055951|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
46838660|NCT00296504|83055943|FG000|Interim Analysis|To Simplify Treatment|0|||
47062851|NCT01522651|83343744|FG000|Overall Study|Adverse Event|3|||
46838661|NCT00296504|83055944|FG001|Interim Analysis|To Simplify Treatment|0|||
46838662|NCT00296504|83055945|FG002|Interim Analysis|To Simplify Treatment|1|||
46838663|NCT00296504|83055946|FG003|Interim Analysis|To Simplify Treatment|0|||
46838664|NCT00296504|83055947|FG004|Interim Analysis|To Simplify Treatment|0|||
46638509|NCT01442064|82811840|FG004|Overall Study|Condition mandated other intervention|0|||
46838665|NCT00296504|83055948|FG005|Interim Analysis|To Simplify Treatment|0|||
46838666|NCT00296504|83055949|FG006|Interim Analysis|To Simplify Treatment|2|||
46838667|NCT00296504|83055950|FG007|Interim Analysis|To Simplify Treatment|0|||
46838668|NCT00296504|83055951|FG008|Interim Analysis|To Simplify Treatment|0|||
46838669|NCT00296504|83055943|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838670|NCT00296504|83055944|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838671|NCT00296504|83055945|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
46838672|NCT00296504|83055946|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838673|NCT00296504|83055947|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838674|NCT00296504|83055948|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838675|NCT00296504|83055949|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838676|NCT00296504|83055950|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838677|NCT00296504|83055951|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
46838678|NCT00296504|83055943|FG000|Interim Analysis|Participant Moved|1|||
46838679|NCT00296504|83055944|FG001|Interim Analysis|Participant Moved|0|||
46838680|NCT00296504|83055945|FG002|Interim Analysis|Participant Moved|1|||
46838681|NCT00296504|83055946|FG003|Interim Analysis|Participant Moved|0|||
46838682|NCT00296504|83055947|FG004|Interim Analysis|Participant Moved|0|||
46838683|NCT00296504|83055948|FG005|Interim Analysis|Participant Moved|1|||
46838684|NCT00296504|83055949|FG006|Interim Analysis|Participant Moved|1|||
46838685|NCT00296504|83055950|FG007|Interim Analysis|Participant Moved|0|||
46838686|NCT00296504|83055951|FG008|Interim Analysis|Participant Moved|0|||
46838687|NCT00296504|83055943|FG000|Interim Analysis|Participant Was Incarcerated|2|||
46838688|NCT00296504|83055944|FG001|Interim Analysis|Participant Was Incarcerated|0|||
46838689|NCT00296504|83055945|FG002|Interim Analysis|Participant Was Incarcerated|1|||
46838690|NCT00296504|83055946|FG003|Interim Analysis|Participant Was Incarcerated|0|||
46838691|NCT00296504|83055947|FG004|Interim Analysis|Participant Was Incarcerated|0|||
46838692|NCT00296504|83055948|FG005|Interim Analysis|Participant Was Incarcerated|0|||
46838693|NCT00296504|83055949|FG006|Interim Analysis|Participant Was Incarcerated|0|||
46838694|NCT00296504|83055950|FG007|Interim Analysis|Participant Was Incarcerated|0|||
46838695|NCT00296504|83055951|FG008|Interim Analysis|Participant Was Incarcerated|0|||
46943926|NCT02749721|83180874|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
46943927|NCT02749721|83180874|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
46943928|NCT01348139|83180880|FG000|Period 1|Adverse Event|1|||
46943929|NCT01348139|83180881|FG001|Period 1|Adverse Event|0|||
46943930|NCT01348139|83180882|FG002|Period 1|Adverse Event|0|||
46943931|NCT01348139|83180883|FG003|Period 1|Adverse Event|0|||
46943932|NCT01348139|83180884|FG004|Period 1|Adverse Event|0|||
46943933|NCT01348139|83180885|FG005|Period 1|Adverse Event|0|||
46943934|NCT02868229|83180903|FG000|Overall Study|Adverse Event|1|||
46943935|NCT02868229|83180904|FG001|Overall Study|Adverse Event|0|||
46943936|NCT02868229|83180905|FG002|Overall Study|Adverse Event|0|||
46943937|NCT02868229|83180906|FG003|Overall Study|Adverse Event|1|||
46943938|NCT02868229|83180903|FG000|Overall Study|Death|0|||
46943939|NCT02868229|83180904|FG001|Overall Study|Death|0|||
46943940|NCT02868229|83180905|FG002|Overall Study|Death|1|||
46943941|NCT02868229|83180906|FG003|Overall Study|Death|1|||
46943942|NCT02868229|83180903|FG000|Overall Study|Missed dose|0|||
46943943|NCT02868229|83180904|FG001|Overall Study|Missed dose|0|||
46943944|NCT02868229|83180905|FG002|Overall Study|Missed dose|0|||
46943945|NCT02868229|83180906|FG003|Overall Study|Missed dose|3|||
46943946|NCT02956967|83180921|FG000|Overall Study|Adverse Event|3|||
46943947|NCT02956967|83180921|FG000|Overall Study|Reason non-related to neutropenia|10|||
46943948|NCT02956967|83180921|FG000|Overall Study|Lost to Follow-up|5|||
46943949|NCT02956967|83180921|FG000|Overall Study|Missing|1|||
46943950|NCT02956967|83180921|FG000|Overall Study|Termination of Nivestim administration|29|||
46838696|NCT00296504|83055943|FG000|Interim Analysis|Resistance to FPV|0|||
46838697|NCT00296504|83055944|FG001|Interim Analysis|Resistance to FPV|0|||
46943951|NCT02867995|83180945|FG000|Overall Study|Withdrawal by Subject|0|||
46943952|NCT02867995|83180946|FG001|Overall Study|Withdrawal by Subject|1|||
47062852|NCT01522651|83343745|FG001|Overall Study|Adverse Event|4|||
47062853|NCT01522651|83343746|FG002|Overall Study|Adverse Event|4|||
46838698|NCT00296504|83055945|FG002|Interim Analysis|Resistance to FPV|1|||
46838699|NCT00296504|83055946|FG003|Interim Analysis|Resistance to FPV|0|||
46838700|NCT00296504|83055947|FG004|Interim Analysis|Resistance to FPV|0|||
46838701|NCT00296504|83055948|FG005|Interim Analysis|Resistance to FPV|0|||
46838702|NCT00296504|83055949|FG006|Interim Analysis|Resistance to FPV|0|||
46838703|NCT00296504|83055950|FG007|Interim Analysis|Resistance to FPV|0|||
46838704|NCT00296504|83055951|FG008|Interim Analysis|Resistance to FPV|0|||
46838705|NCT00296504|83055943|FG000|Interim Analysis|Physician Decision|0|||
46838706|NCT00296504|83055944|FG001|Interim Analysis|Physician Decision|0|||
46943953|NCT02867995|83180945|FG000|Overall Study|Lost to Follow-up|0|||
46943954|NCT02867995|83180946|FG001|Overall Study|Lost to Follow-up|2|||
46943955|NCT03392883|83180959|FG000|Overall Study|Lost to Follow-up|122|||
46943956|NCT03392883|83180960|FG001|Overall Study|Lost to Follow-up|13|||
46943957|NCT03392883|83180961|FG002|Overall Study|Lost to Follow-up|9|||
46943958|NCT03392883|83180959|FG000|Overall Study|Death|4|||
46943959|NCT03392883|83180960|FG001|Overall Study|Death|0|||
46943960|NCT03392883|83180961|FG002|Overall Study|Death|0|||
46838707|NCT00296504|83055945|FG002|Interim Analysis|Physician Decision|1|||
46943961|NCT03392883|83180959|FG000|Overall Study|Lack of Efficacy|29|||
46943962|NCT03392883|83180960|FG001|Overall Study|Lack of Efficacy|0|||
46943963|NCT03392883|83180961|FG002|Overall Study|Lack of Efficacy|0|||
46943964|NCT03392883|83180959|FG000|Overall Study|Withdrawal by Subject|180|||
46943965|NCT03392883|83180960|FG001|Overall Study|Withdrawal by Subject|0|||
46943966|NCT03392883|83180961|FG002|Overall Study|Withdrawal by Subject|0|||
46943967|NCT03392883|83180959|FG000|Overall Study|Adverse Event|1|||
46943968|NCT03392883|83180960|FG001|Overall Study|Adverse Event|0|||
46943969|NCT03392883|83180961|FG002|Overall Study|Adverse Event|0|||
46967812|NCT01595529|83210381|FG000|Overall Study|Entry Failure/Screening Failure|6|||
46967813|NCT01595529|83210382|FG001|Overall Study|Entry Failure/Screening Failure|1|||
46967814|NCT02615145|83210391|FG000|Overall Study|Did Not Start Treatment|0|||
46967815|NCT02615145|83210392|FG001|Overall Study|Did Not Start Treatment|0|||
46967816|NCT02615145|83210393|FG002|Overall Study|Did Not Start Treatment|1|||
46967817|NCT02615145|83210394|FG003|Overall Study|Did Not Start Treatment|1|||
46967818|NCT02615145|83210391|FG000|Overall Study|Failure to Return|20|||
46967819|NCT02615145|83210392|FG001|Overall Study|Failure to Return|10|||
46967820|NCT02615145|83210393|FG002|Overall Study|Failure to Return|7|||
46967821|NCT02615145|83210394|FG003|Overall Study|Failure to Return|0|||
46967822|NCT02615145|83210391|FG000|Overall Study|Death|2|||
46967823|NCT02615145|83210392|FG001|Overall Study|Death|3|||
46967824|NCT02615145|83210393|FG002|Overall Study|Death|0|||
46967825|NCT02615145|83210394|FG003|Overall Study|Death|0|||
46967826|NCT02615145|83210391|FG000|Overall Study|Other, Not Specified|5|||
46967827|NCT02615145|83210392|FG001|Overall Study|Other, Not Specified|2|||
46967828|NCT02615145|83210393|FG002|Overall Study|Other, Not Specified|0|||
46967829|NCT02615145|83210394|FG003|Overall Study|Other, Not Specified|0|||
46967830|NCT02119156|83210423|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
46967831|NCT02119156|83210424|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
46838708|NCT00296504|83055946|FG003|Interim Analysis|Physician Decision|0|||
46838709|NCT00296504|83055947|FG004|Interim Analysis|Physician Decision|0|||
46838710|NCT00296504|83055948|FG005|Interim Analysis|Physician Decision|0|||
46967832|NCT02119156|83210425|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
46967833|NCT02119156|83210423|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
46967834|NCT02119156|83210424|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
46967835|NCT02119156|83210425|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
46967836|NCT02119156|83210423|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
46967837|NCT02119156|83210424|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
46967838|NCT02119156|83210425|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
46967839|NCT02119156|83210423|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
46967840|NCT02119156|83210424|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
46967841|NCT02119156|83210425|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
46967842|NCT02119156|83210423|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
46967843|NCT02119156|83210424|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
46967844|NCT02119156|83210425|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
46967845|NCT02181556|83210440|FG000|Overall Study|Withdrawal by Subject|1|||
46967846|NCT02614131|83210451|FG000|Overall Study|Withdrawal by Subject|1|||
46638510|NCT01442064|82811841|FG005|Overall Study|Condition mandated other intervention|2|||
46838711|NCT00296504|83055949|FG006|Interim Analysis|Physician Decision|0|||
46838712|NCT00296504|83055950|FG007|Interim Analysis|Physician Decision|0|||
46838713|NCT00296504|83055951|FG008|Interim Analysis|Physician Decision|0|||
46838714|NCT00296504|83055943|FG000|Interim Analysis|Principle Investigator Discretion|2|||
46838715|NCT00296504|83055944|FG001|Interim Analysis|Principle Investigator Discretion|0|||
46838716|NCT00296504|83055945|FG002|Interim Analysis|Principle Investigator Discretion|1|||
46838717|NCT00296504|83055946|FG003|Interim Analysis|Principle Investigator Discretion|1|||
46838718|NCT00296504|83055947|FG004|Interim Analysis|Principle Investigator Discretion|0|||
46838719|NCT00296504|83055948|FG005|Interim Analysis|Principle Investigator Discretion|0|||
46838720|NCT00296504|83055949|FG006|Interim Analysis|Principle Investigator Discretion|0|||
46838721|NCT00296504|83055950|FG007|Interim Analysis|Principle Investigator Discretion|0|||
46838722|NCT00296504|83055951|FG008|Interim Analysis|Principle Investigator Discretion|0|||
46967847|NCT02614131|83210452|FG001|Overall Study|Withdrawal by Subject|0|||
46967848|NCT02614131|83210453|FG002|Overall Study|Withdrawal by Subject|0|||
46967849|NCT02614131|83210454|FG003|Overall Study|Withdrawal by Subject|0|||
46967850|NCT02614131|83210455|FG004|Overall Study|Withdrawal by Subject|0|||
46967851|NCT02614131|83210456|FG005|Overall Study|Withdrawal by Subject|0|||
46967852|NCT02614131|83210457|FG006|Overall Study|Withdrawal by Subject|0|||
46967853|NCT02614131|83210451|FG000|Overall Study|Adverse Event|0|||
46967854|NCT02614131|83210452|FG001|Overall Study|Adverse Event|0|||
46967855|NCT02614131|83210453|FG002|Overall Study|Adverse Event|0|||
46967856|NCT02614131|83210454|FG003|Overall Study|Adverse Event|0|||
46967857|NCT02614131|83210455|FG004|Overall Study|Adverse Event|0|||
46838723|NCT00296504|83055943|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
46838724|NCT00296504|83055944|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
46943970|NCT02748863|83180972|FG000|Treatment Period 1|Adverse Event|0|||
46943971|NCT02748863|83180973|FG001|Treatment Period 1|Adverse Event|1|||
46943972|NCT02748863|83180974|FG002|Treatment Period 1|Adverse Event|0|||
46943973|NCT02748863|83180975|FG003|Treatment Period 1|Adverse Event|0|||
46943974|NCT02748863|83180976|FG004|Treatment Period 1|Adverse Event|0|||
46943975|NCT02748863|83180972|FG000|Treatment Period 1|Lack of Efficacy|0|||
46943976|NCT02748863|83180973|FG001|Treatment Period 1|Lack of Efficacy|0|||
46943977|NCT02748863|83180974|FG002|Treatment Period 1|Lack of Efficacy|1|||
46943978|NCT02748863|83180975|FG003|Treatment Period 1|Lack of Efficacy|0|||
46943979|NCT02748863|83180976|FG004|Treatment Period 1|Lack of Efficacy|0|||
46943980|NCT02748863|83180972|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46943981|NCT02748863|83180973|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46943982|NCT02748863|83180974|FG002|Treatment Period 1|Withdrawal by Subject|1|||
46943983|NCT02748863|83180975|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46943984|NCT02748863|83180976|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46943985|NCT02748863|83180972|FG000|Treatment Period 2|Lost to Follow-up|2|||
46943986|NCT02748863|83180973|FG001|Treatment Period 2|Lost to Follow-up|0|||
46943987|NCT02748863|83180974|FG002|Treatment Period 2|Lost to Follow-up|0|||
46943988|NCT02748863|83180975|FG003|Treatment Period 2|Lost to Follow-up|0|||
46943989|NCT02748863|83180976|FG004|Treatment Period 2|Lost to Follow-up|0|||
46943990|NCT02748863|83180972|FG000|Treatment Period 2|Adverse Event|3|||
47062854|NCT01522651|83343747|FG003|Overall Study|Adverse Event|5|||
46768718|NCT00759759|82987037|FG001|Overall Study|Didn't receive drug in period 2|0|||
46768719|NCT00759759|82987036|FG000|Overall Study|Withdrawal by Subject|2|||
46768720|NCT00759759|82987037|FG001|Overall Study|Withdrawal by Subject|1|||
46768721|NCT00759681|82987045|FG000|Overall Study|Death|2|||
46838725|NCT00296504|83055945|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
46838726|NCT00296504|83055946|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
46838727|NCT00296504|83055947|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
46838728|NCT00296504|83055948|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
46838729|NCT00296504|83055949|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
46838730|NCT00296504|83055950|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
46838731|NCT00296504|83055951|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
46838732|NCT00296504|83055943|FG000|Interim Analysis|Non-adherence|2|||
46838733|NCT00296504|83055944|FG001|Interim Analysis|Non-adherence|0|||
46838734|NCT00296504|83055945|FG002|Interim Analysis|Non-adherence|0|||
46838735|NCT00296504|83055946|FG003|Interim Analysis|Non-adherence|0|||
46838736|NCT00296504|83055947|FG004|Interim Analysis|Non-adherence|1|||
46838737|NCT00296504|83055948|FG005|Interim Analysis|Non-adherence|0|||
46838738|NCT00296504|83055949|FG006|Interim Analysis|Non-adherence|0|||
46838739|NCT00296504|83055950|FG007|Interim Analysis|Non-adherence|1|||
46838740|NCT00296504|83055951|FG008|Interim Analysis|Non-adherence|0|||
46838741|NCT00296504|83055943|FG000|Interim Analysis|Site Closing|1|||
46838742|NCT00296504|83055944|FG001|Interim Analysis|Site Closing|0|||
46838743|NCT00296504|83055945|FG002|Interim Analysis|Site Closing|0|||
46838744|NCT00296504|83055946|FG003|Interim Analysis|Site Closing|0|||
46838745|NCT00296504|83055947|FG004|Interim Analysis|Site Closing|0|||
46838746|NCT00296504|83055948|FG005|Interim Analysis|Site Closing|1|||
46838747|NCT00296504|83055949|FG006|Interim Analysis|Site Closing|2|||
46838748|NCT00296504|83055950|FG007|Interim Analysis|Site Closing|0|||
46838749|NCT00296504|83055951|FG008|Interim Analysis|Site Closing|0|||
46838750|NCT00296504|83055943|FG000|Interim Analysis|Lack of Personnel at Site|1|||
46838751|NCT00296504|83055944|FG001|Interim Analysis|Lack of Personnel at Site|0|||
46838752|NCT00296504|83055945|FG002|Interim Analysis|Lack of Personnel at Site|0|||
46838753|NCT00296504|83055946|FG003|Interim Analysis|Lack of Personnel at Site|0|||
46838754|NCT00296504|83055947|FG004|Interim Analysis|Lack of Personnel at Site|0|||
46838755|NCT00296504|83055948|FG005|Interim Analysis|Lack of Personnel at Site|0|||
46943991|NCT02748863|83180973|FG001|Treatment Period 2|Adverse Event|2|||
46768722|NCT00759681|82987046|FG001|Overall Study|Death|5|||
46768723|NCT00759681|82987045|FG000|Overall Study|Lost to Follow-up|8|||
46768724|NCT00759681|82987046|FG001|Overall Study|Lost to Follow-up|5|||
46768725|NCT00826241|82987053|FG000|Overall Study|Withdrawal from Follow-up|1|||
46768726|NCT00826241|82987053|FG000|Overall Study|Withdrew consent|2|||
46768727|NCT00826241|82987053|FG000|Overall Study|Death|4|||
46768728|NCT00826241|82987053|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
46768729|NCT00826241|82987053|FG000|Overall Study|Non-compliance|1|||
46768730|NCT00826241|82987053|FG000|Overall Study|Progression of disease|1|||
46838756|NCT00296504|83055949|FG006|Interim Analysis|Lack of Personnel at Site|0|||
46838757|NCT00296504|83055950|FG007|Interim Analysis|Lack of Personnel at Site|0|||
46943992|NCT02748863|83180974|FG002|Treatment Period 2|Adverse Event|0|||
46943993|NCT02748863|83180975|FG003|Treatment Period 2|Adverse Event|2|||
46943994|NCT02748863|83180976|FG004|Treatment Period 2|Adverse Event|0|||
46943995|NCT02748863|83180972|FG000|Treatment Period 2|Lack of Efficacy|0|||
46943996|NCT02748863|83180973|FG001|Treatment Period 2|Lack of Efficacy|1|||
46943997|NCT02748863|83180974|FG002|Treatment Period 2|Lack of Efficacy|0|||
46943998|NCT02748863|83180975|FG003|Treatment Period 2|Lack of Efficacy|0|||
46943999|NCT02748863|83180976|FG004|Treatment Period 2|Lack of Efficacy|0|||
46944000|NCT02748863|83180972|FG000|Treatment Period 2|Pregnancy|0|||
46944001|NCT02748863|83180973|FG001|Treatment Period 2|Pregnancy|0|||
46944002|NCT02748863|83180974|FG002|Treatment Period 2|Pregnancy|0|||
46944003|NCT02748863|83180975|FG003|Treatment Period 2|Pregnancy|0|||
46944004|NCT02748863|83180976|FG004|Treatment Period 2|Pregnancy|1|||
46944005|NCT02865499|83180997|FG000|Baseline|Adverse Event|1|||
46944006|NCT02865499|83180997|FG000|Baseline|Withdrawal by Subject|1|||
46944007|NCT02870933|83181003|FG000|Overall Study|Death|2|||
46944008|NCT02870933|83181004|FG001|Overall Study|Death|1|||
46944009|NCT02870933|83181003|FG000|Overall Study|Withdrawal by Subject|0|||
46944010|NCT02870933|83181004|FG001|Overall Study|Withdrawal by Subject|1|||
46944011|NCT02864407|83181011|FG000|Overall Study|Protocol Violation|3|||
46944012|NCT02864407|83181011|FG000|Overall Study|Lost to Follow-up|115|||
46944013|NCT02864407|83181011|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
46944014|NCT02864407|83181011|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
46944015|NCT02864407|83181011|FG000|Overall Study|Consent prior to the contract date|1|||
46944016|NCT02873429|83181017|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
46944017|NCT02873429|83181018|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
46944018|NCT02873429|83181017|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
46944019|NCT02873429|83181018|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
46944020|NCT02873429|83181017|FG000|16 Weeks|Lost to Follow-up|3|||
46944021|NCT02873429|83181018|FG001|16 Weeks|Lost to Follow-up|0|||
46944022|NCT02486302|83181024|FG000|Overall Study|Discontinued prematurely|410|||
46944023|NCT02486302|83181024|FG000|Overall Study|Documentation not completed|255|||
46944024|NCT02486302|83181024|FG000|Overall Study|Excluded due to legal reasons|8|||
46944025|NCT02486302|83181024|FG000|Overall Study|Not treated|3|||
46944026|NCT02747875|83181039|FG000|Overall Study|Physician Decision|1|||
46944027|NCT02747875|83181040|FG001|Overall Study|Physician Decision|0|||
46944028|NCT02747875|83181039|FG000|Overall Study|Adverse Event|0|||
46944029|NCT02747875|83181040|FG001|Overall Study|Adverse Event|1|||
46944030|NCT02451124|83181066|FG000|Overall Study|Withdrawal by Subject|1|||
46944031|NCT02450578|83181078|FG000|Overall Study|ECG abnormality so not treated|1|||
46944032|NCT02450578|83181079|FG001|Overall Study|ECG abnormality so not treated|0|||
46944033|NCT02450578|83181080|FG002|Overall Study|ECG abnormality so not treated|0|||
46944034|NCT02450578|83181081|FG003|Overall Study|ECG abnormality so not treated|0|||
46944035|NCT02449018|83181108|FG000|Overall Study|Abnormal laboratory value|0|||
46838758|NCT00296504|83055951|FG008|Interim Analysis|Lack of Personnel at Site|0|||
46838759|NCT00296504|83055943|FG000|Interim Analysis|Missed Schedule Date|1|||
46838760|NCT00296504|83055944|FG001|Interim Analysis|Missed Schedule Date|0|||
46838761|NCT00296504|83055945|FG002|Interim Analysis|Missed Schedule Date|0|||
46838762|NCT00296504|83055946|FG003|Interim Analysis|Missed Schedule Date|0|||
46838763|NCT00296504|83055947|FG004|Interim Analysis|Missed Schedule Date|0|||
46838764|NCT00296504|83055948|FG005|Interim Analysis|Missed Schedule Date|0|||
46838765|NCT00296504|83055949|FG006|Interim Analysis|Missed Schedule Date|0|||
46838766|NCT00296504|83055950|FG007|Interim Analysis|Missed Schedule Date|0|||
46838767|NCT00296504|83055951|FG008|Interim Analysis|Missed Schedule Date|0|||
46838768|NCT00296504|83055943|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
46838769|NCT00296504|83055944|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
46838770|NCT00296504|83055945|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
46838771|NCT00296504|83055946|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
46838772|NCT00296504|83055947|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
46838773|NCT00296504|83055948|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
46838774|NCT00296504|83055949|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
46838775|NCT00296504|83055950|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
46838776|NCT00296504|83055951|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
46838777|NCT00296504|83055943|FG000|Interim Analysis|Participant Stopped|0|||
46838778|NCT00296504|83055944|FG001|Interim Analysis|Participant Stopped|0|||
46838779|NCT00296504|83055945|FG002|Interim Analysis|Participant Stopped|0|||
46944036|NCT02449018|83181109|FG001|Overall Study|Abnormal laboratory value|1|||
46944037|NCT02449018|83181108|FG000|Overall Study|Administrative problems|1|||
46944038|NCT02449018|83181109|FG001|Overall Study|Administrative problems|0|||
46944039|NCT02449018|83181108|FG000|Overall Study|Adverse Event|5|||
46944040|NCT02449018|83181109|FG001|Overall Study|Adverse Event|1|||
46838780|NCT00296504|83055946|FG003|Interim Analysis|Participant Stopped|0|||
46944041|NCT02449018|83181108|FG000|Overall Study|Protocol deviation|4|||
46944042|NCT02449018|83181109|FG001|Overall Study|Protocol deviation|0|||
46944043|NCT02449018|83181108|FG000|Overall Study|Patient decision|2|||
46944044|NCT02449018|83181109|FG001|Overall Study|Patient decision|0|||
46944045|NCT02859415|83181117|FG000|Overall Study|Physician Decision|1|||
46944046|NCT02859415|83181118|FG001|Overall Study|Physician Decision|0|||
46838781|NCT00296504|83055947|FG004|Interim Analysis|Participant Stopped|1|||
46838782|NCT00296504|83055948|FG005|Interim Analysis|Participant Stopped|0|||
46838783|NCT00296504|83055949|FG006|Interim Analysis|Participant Stopped|0|||
46838784|NCT00296504|83055950|FG007|Interim Analysis|Participant Stopped|0|||
46838785|NCT00296504|83055951|FG008|Interim Analysis|Participant Stopped|0|||
46838786|NCT00296504|83055943|FG000|Interim Analysis|Physician and Participant Decision|0|||
46838787|NCT00296504|83055944|FG001|Interim Analysis|Physician and Participant Decision|0|||
46838788|NCT00296504|83055945|FG002|Interim Analysis|Physician and Participant Decision|0|||
46838789|NCT00296504|83055946|FG003|Interim Analysis|Physician and Participant Decision|0|||
46838790|NCT00296504|83055947|FG004|Interim Analysis|Physician and Participant Decision|0|||
46838791|NCT00296504|83055948|FG005|Interim Analysis|Physician and Participant Decision|1|||
46838792|NCT00296504|83055949|FG006|Interim Analysis|Physician and Participant Decision|0|||
46838793|NCT00296504|83055950|FG007|Interim Analysis|Physician and Participant Decision|0|||
46838794|NCT00296504|83055951|FG008|Interim Analysis|Physician and Participant Decision|0|||
46838795|NCT00296504|83055943|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
46838796|NCT00296504|83055944|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
46838797|NCT00296504|83055945|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
46838798|NCT00296504|83055946|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
46944047|NCT02859415|83181117|FG000|Overall Study|Off treatment due to cardiac event|0|||
46944048|NCT02859415|83181118|FG001|Overall Study|Off treatment due to cardiac event|1|||
46944049|NCT02871791|83181128|FG000|Phase 1b|Death|0|||
46944050|NCT02871791|83181129|FG001|Phase 1b|Death|1|||
46944051|NCT02871791|83181128|FG000|Phase 1b|progressive disease|6|||
46944052|NCT02871791|83181129|FG001|Phase 1b|progressive disease|2|||
46944053|NCT02871791|83181128|FG000|Phase 2|Death|1|||
46944054|NCT02871791|83181129|FG001|Phase 2|Death|0|||
46944055|NCT02871791|83181128|FG000|Phase 2|Lost to Follow-up|2|||
46838799|NCT00296504|83055947|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
46838800|NCT00296504|83055948|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
46838801|NCT00296504|83055949|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
46838802|NCT00296504|83055950|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
46838803|NCT00296504|83055951|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
46838804|NCT00296504|83055943|FG000|Interim Analysis|Study Ended|0|||
46838805|NCT00296504|83055944|FG001|Interim Analysis|Study Ended|0|||
46838806|NCT00296504|83055945|FG002|Interim Analysis|Study Ended|0|||
46838807|NCT00296504|83055946|FG003|Interim Analysis|Study Ended|0|||
46838808|NCT00296504|83055947|FG004|Interim Analysis|Study Ended|0|||
46838809|NCT00296504|83055948|FG005|Interim Analysis|Study Ended|0|||
46838810|NCT00296504|83055949|FG006|Interim Analysis|Study Ended|1|||
46838811|NCT00296504|83055950|FG007|Interim Analysis|Study Ended|0|||
46838812|NCT00296504|83055951|FG008|Interim Analysis|Study Ended|0|||
46838813|NCT00296504|83055943|FG000|Interim Analysis|Participant Needed Interferon|0|||
46838814|NCT00296504|83055944|FG001|Interim Analysis|Participant Needed Interferon|0|||
46838815|NCT00296504|83055945|FG002|Interim Analysis|Participant Needed Interferon|0|||
46838816|NCT00296504|83055946|FG003|Interim Analysis|Participant Needed Interferon|0|||
46838817|NCT00296504|83055947|FG004|Interim Analysis|Participant Needed Interferon|0|||
46838818|NCT00296504|83055948|FG005|Interim Analysis|Participant Needed Interferon|0|||
46838819|NCT00296504|83055949|FG006|Interim Analysis|Participant Needed Interferon|0|||
46838820|NCT00296504|83055950|FG007|Interim Analysis|Participant Needed Interferon|1|||
46838821|NCT00296504|83055951|FG008|Interim Analysis|Participant Needed Interferon|0|||
46944056|NCT02871791|83181129|FG001|Phase 2|Lost to Follow-up|0|||
46944057|NCT02871635|83181137|FG000|Overall Study|Primary lack of efficacy|4|||
46944058|NCT02871635|83181138|FG001|Overall Study|Primary lack of efficacy|4|||
46944059|NCT02871635|83181137|FG000|Overall Study|Protocol Violation|3|||
46768731|NCT00826241|82987053|FG000|Overall Study|Patient refused follow-up|3|||
46768732|NCT00826241|82987053|FG000|Overall Study|Lost to Follow-up|9|||
46768733|NCT00826241|82987053|FG000|Overall Study|Could not obtain records|1|||
46768734|NCT00826241|82987053|FG000|Overall Study|Screen failure|2|||
46768735|NCT00826241|82987053|FG000|Overall Study|Pt unable to proceed to registration|1|||
46768736|NCT00826241|82987053|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
46768737|NCT00758589|82987061|FG000|Overall Study|Adverse Event|3|||
46768738|NCT00758589|82987062|FG001|Overall Study|Adverse Event|2|||
46768739|NCT00758589|82987063|FG002|Overall Study|Adverse Event|5|||
46768740|NCT00758589|82987064|FG003|Overall Study|Adverse Event|4|||
46838822|NCT00296504|83055943|FG000|Interim Analysis|Ongoing|32|||
46838823|NCT00296504|83055944|FG001|Interim Analysis|Ongoing|12|||
46838824|NCT00296504|83055945|FG002|Interim Analysis|Ongoing|16|||
46838825|NCT00296504|83055946|FG003|Interim Analysis|Ongoing|22|||
46838826|NCT00296504|83055947|FG004|Interim Analysis|Ongoing|0|||
46838827|NCT00296504|83055948|FG005|Interim Analysis|Ongoing|0|||
46838828|NCT00296504|83055949|FG006|Interim Analysis|Ongoing|30|||
46838829|NCT00296504|83055950|FG007|Interim Analysis|Ongoing|1|||
46944060|NCT02871635|83181138|FG001|Overall Study|Protocol Violation|1|||
46944061|NCT02871635|83181137|FG000|Overall Study|Lost to Follow-up|1|||
46944062|NCT02871635|83181138|FG001|Overall Study|Lost to Follow-up|2|||
46944063|NCT02871635|83181137|FG000|Overall Study|Pregnancy|0|||
46944064|NCT02871635|83181138|FG001|Overall Study|Pregnancy|2|||
46944065|NCT02871635|83181137|FG000|Overall Study|Physician Decision|1|||
46944066|NCT02871635|83181138|FG001|Overall Study|Physician Decision|1|||
46944067|NCT02871635|83181137|FG000|Overall Study|Withdrawal by Subject|3|||
46944068|NCT02871635|83181138|FG001|Overall Study|Withdrawal by Subject|4|||
46944069|NCT02871635|83181137|FG000|Overall Study|Adverse Event|4|||
46944070|NCT02871635|83181138|FG001|Overall Study|Adverse Event|4|||
46944071|NCT02871635|83181137|FG000|Overall Study|Secondary lack of efficacy|2|||
46944072|NCT02871635|83181138|FG001|Overall Study|Secondary lack of efficacy|1|||
46944073|NCT02477332|83181152|FG000|Overall Study|Adverse Event|0|||
46944074|NCT02477332|83181153|FG001|Overall Study|Adverse Event|1|||
46944075|NCT02477332|83181154|FG002|Overall Study|Adverse Event|1|||
46944076|NCT02477332|83181155|FG003|Overall Study|Adverse Event|2|||
46944077|NCT02477332|83181156|FG004|Overall Study|Adverse Event|1|||
46944078|NCT02477332|83181157|FG005|Overall Study|Adverse Event|2|||
46944079|NCT02477332|83181152|FG000|Overall Study|Lack of Efficacy|1|||
46944080|NCT02477332|83181153|FG001|Overall Study|Lack of Efficacy|2|||
46944081|NCT02477332|83181154|FG002|Overall Study|Lack of Efficacy|1|||
46944082|NCT02477332|83181155|FG003|Overall Study|Lack of Efficacy|2|||
46944083|NCT02477332|83181156|FG004|Overall Study|Lack of Efficacy|1|||
46944084|NCT02477332|83181157|FG005|Overall Study|Lack of Efficacy|1|||
46944085|NCT02477332|83181152|FG000|Overall Study|Non-compliance with study treatment|0|||
46944086|NCT02477332|83181153|FG001|Overall Study|Non-compliance with study treatment|1|||
46944087|NCT02477332|83181154|FG002|Overall Study|Non-compliance with study treatment|2|||
46944088|NCT02477332|83181155|FG003|Overall Study|Non-compliance with study treatment|0|||
46944089|NCT02477332|83181156|FG004|Overall Study|Non-compliance with study treatment|0|||
46944090|NCT02477332|83181157|FG005|Overall Study|Non-compliance with study treatment|0|||
46944091|NCT02477332|83181152|FG000|Overall Study|Pregnancy|0|||
46944092|NCT02477332|83181153|FG001|Overall Study|Pregnancy|0|||
46944093|NCT02477332|83181154|FG002|Overall Study|Pregnancy|0|||
46944094|NCT02477332|83181155|FG003|Overall Study|Pregnancy|1|||
46944095|NCT02477332|83181156|FG004|Overall Study|Pregnancy|0|||
46944096|NCT02477332|83181157|FG005|Overall Study|Pregnancy|0|||
46944097|NCT02477332|83181152|FG000|Overall Study|Protocol Violation|2|||
46944098|NCT02477332|83181153|FG001|Overall Study|Protocol Violation|0|||
46944099|NCT02477332|83181154|FG002|Overall Study|Protocol Violation|3|||
46944100|NCT02477332|83181155|FG003|Overall Study|Protocol Violation|3|||
46944101|NCT02477332|83181156|FG004|Overall Study|Protocol Violation|1|||
46944102|NCT02477332|83181157|FG005|Overall Study|Protocol Violation|1|||
46944103|NCT02477332|83181152|FG000|Overall Study|Technical problems|0|||
46944104|NCT02477332|83181153|FG001|Overall Study|Technical problems|0|||
46944105|NCT02477332|83181154|FG002|Overall Study|Technical problems|1|||
46944106|NCT02477332|83181155|FG003|Overall Study|Technical problems|0|||
46944107|NCT02477332|83181156|FG004|Overall Study|Technical problems|0|||
46944108|NCT02477332|83181157|FG005|Overall Study|Technical problems|0|||
46944109|NCT02477332|83181152|FG000|Overall Study|Lost to Follow-up|0|||
46944110|NCT02477332|83181153|FG001|Overall Study|Lost to Follow-up|0|||
46944111|NCT02477332|83181154|FG002|Overall Study|Lost to Follow-up|2|||
46944112|NCT02477332|83181155|FG003|Overall Study|Lost to Follow-up|0|||
46944113|NCT02477332|83181156|FG004|Overall Study|Lost to Follow-up|0|||
46768741|NCT00758589|82987061|FG000|Overall Study|Withdrawal by Subject|0|||
46768742|NCT00758589|82987062|FG001|Overall Study|Withdrawal by Subject|1|||
46768743|NCT00758589|82987063|FG002|Overall Study|Withdrawal by Subject|1|||
46768744|NCT00758589|82987064|FG003|Overall Study|Withdrawal by Subject|1|||
46768745|NCT00758589|82987061|FG000|Overall Study|Palm stopped to work|0|||
46768746|NCT00758589|82987062|FG001|Overall Study|Palm stopped to work|0|||
46768747|NCT00758589|82987063|FG002|Overall Study|Palm stopped to work|0|||
46768748|NCT00758589|82987064|FG003|Overall Study|Palm stopped to work|1|||
46768749|NCT00833417|82987076|FG000|Overall Study|Adverse Event|5|||
46768750|NCT00833417|82987077|FG001|Overall Study|Adverse Event|16|||
46768751|NCT00833417|82987076|FG000|Overall Study|Death|1|||
46944114|NCT02477332|83181157|FG005|Overall Study|Lost to Follow-up|0|||
46768752|NCT00833417|82987077|FG001|Overall Study|Death|3|||
46768753|NCT00833417|82987076|FG000|Overall Study|Lost to Follow-up|1|||
46838830|NCT00296504|83055951|FG008|Interim Analysis|Ongoing|0|||
46838831|NCT00296504|83055943|FG000|Final Analysis|Withdrawal by Subject|0|||
46838832|NCT00296504|83055944|FG001|Final Analysis|Withdrawal by Subject|0|||
46838833|NCT00296504|83055945|FG002|Final Analysis|Withdrawal by Subject|0|||
46838834|NCT00296504|83055946|FG003|Final Analysis|Withdrawal by Subject|0|||
46838835|NCT00296504|83055947|FG004|Final Analysis|Withdrawal by Subject|0|||
46944115|NCT02477332|83181152|FG000|Overall Study|Physician Decision|0|||
46768754|NCT00833417|82987077|FG001|Overall Study|Lost to Follow-up|2|||
46768755|NCT00833417|82987076|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
46944116|NCT02477332|83181153|FG001|Overall Study|Physician Decision|0|||
46944117|NCT02477332|83181154|FG002|Overall Study|Physician Decision|1|||
46944118|NCT02477332|83181155|FG003|Overall Study|Physician Decision|3|||
46944119|NCT02477332|83181156|FG004|Overall Study|Physician Decision|0|||
46944120|NCT02477332|83181157|FG005|Overall Study|Physician Decision|1|||
46944121|NCT02477332|83181152|FG000|Overall Study|Withdrawal by Subject|0|||
46944122|NCT02477332|83181153|FG001|Overall Study|Withdrawal by Subject|3|||
46944123|NCT02477332|83181154|FG002|Overall Study|Withdrawal by Subject|1|||
46944124|NCT02477332|83181155|FG003|Overall Study|Withdrawal by Subject|2|||
46944125|NCT02477332|83181156|FG004|Overall Study|Withdrawal by Subject|1|||
46944126|NCT02477332|83181157|FG005|Overall Study|Withdrawal by Subject|0|||
46944127|NCT02477020|83181175|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
46944128|NCT02477020|83181176|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
46944129|NCT02477020|83181175|FG000|Overall Study|Voluntary Withdrawal|7|||
46944130|NCT02477020|83181176|FG001|Overall Study|Voluntary Withdrawal|16|||
46944131|NCT02477020|83181175|FG000|Overall Study|Reason not Specified|3|||
46944132|NCT02477020|83181176|FG001|Overall Study|Reason not Specified|1|||
46944133|NCT02477020|83181175|FG000|Overall Study|Lack of Efficacy|14|||
46944134|NCT02477020|83181176|FG001|Overall Study|Lack of Efficacy|5|||
46944135|NCT02862535|83181186|FG000|Overall Study|Death|7|||
46944136|NCT02862535|83181187|FG001|Overall Study|Death|3|||
46944137|NCT02862535|83181188|FG002|Overall Study|Death|2|||
46944138|NCT02862535|83181189|FG003|Overall Study|Death|5|||
46944139|NCT02862535|83181186|FG000|Overall Study|Study Terminated by Sponsor|1|||
46944140|NCT02862535|83181187|FG001|Overall Study|Study Terminated by Sponsor|3|||
46944141|NCT02862535|83181188|FG002|Overall Study|Study Terminated by Sponsor|8|||
46944142|NCT02862535|83181189|FG003|Overall Study|Study Terminated by Sponsor|5|||
46944143|NCT02862535|83181186|FG000|Overall Study|Enrolled, not Treated|1|||
46944144|NCT02862535|83181187|FG001|Overall Study|Enrolled, not Treated|0|||
46944145|NCT02862535|83181188|FG002|Overall Study|Enrolled, not Treated|0|||
46944146|NCT02862535|83181189|FG003|Overall Study|Enrolled, not Treated|1|||
46944147|NCT02448706|83181199|FG000|Overall Study|Withdrawal by Subject|4|||
46944148|NCT02448706|83181200|FG001|Overall Study|Withdrawal by Subject|3|||
46944149|NCT02448706|83181199|FG000|Overall Study|Protocol Violation|1|||
46944150|NCT02448706|83181200|FG001|Overall Study|Protocol Violation|1|||
46944151|NCT02868281|83181210|FG000|Overall Study|Adverse Event|2|||
46944152|NCT02868281|83181211|FG001|Overall Study|Adverse Event|2|||
46768756|NCT00833417|82987077|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
46768757|NCT00833417|82987076|FG000|Overall Study|Patient Decision to Withdraw|4|||
46768758|NCT00833417|82987077|FG001|Overall Study|Patient Decision to Withdraw|23|||
46768759|NCT00833417|82987076|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
46768760|NCT00833417|82987077|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
46768761|NCT00833417|82987076|FG000|Overall Study|Disease Progression|18|||
46768762|NCT00833417|82987077|FG001|Overall Study|Disease Progression|17|||
46838836|NCT00296504|83055948|FG005|Final Analysis|Withdrawal by Subject|0|||
46838837|NCT00296504|83055949|FG006|Final Analysis|Withdrawal by Subject|0|||
46838838|NCT00296504|83055950|FG007|Final Analysis|Withdrawal by Subject|0|||
46838839|NCT00296504|83055951|FG008|Final Analysis|Withdrawal by Subject|1|||
46838840|NCT00296504|83055943|FG000|Final Analysis|Lost to Follow-up|0|||
46838841|NCT00296504|83055944|FG001|Final Analysis|Lost to Follow-up|0|||
46838842|NCT00296504|83055945|FG002|Final Analysis|Lost to Follow-up|0|||
46838843|NCT00296504|83055946|FG003|Final Analysis|Lost to Follow-up|0|||
46838844|NCT00296504|83055947|FG004|Final Analysis|Lost to Follow-up|0|||
46838845|NCT00296504|83055948|FG005|Final Analysis|Lost to Follow-up|0|||
46838846|NCT00296504|83055949|FG006|Final Analysis|Lost to Follow-up|0|||
46838847|NCT00296504|83055950|FG007|Final Analysis|Lost to Follow-up|0|||
46838848|NCT00296504|83055951|FG008|Final Analysis|Lost to Follow-up|5|||
46944153|NCT02868281|83181210|FG000|Overall Study|Protocol Violation|13|||
46944154|NCT02868281|83181211|FG001|Overall Study|Protocol Violation|10|||
46944155|NCT02868281|83181210|FG000|Overall Study|Lost to Follow-up|3|||
46944156|NCT02868281|83181211|FG001|Overall Study|Lost to Follow-up|6|||
46944157|NCT02868281|83181210|FG000|Overall Study|Withdrawal by Subject|11|||
46944158|NCT02868281|83181211|FG001|Overall Study|Withdrawal by Subject|15|||
46944159|NCT02868281|83181210|FG000|Overall Study|Physician Decision|2|||
46944160|NCT02868281|83181211|FG001|Overall Study|Physician Decision|0|||
46944161|NCT02868281|83181210|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
46768763|NCT00833417|82987076|FG000|Overall Study|Reason Not Specified|0|||
46768764|NCT00833417|82987077|FG001|Overall Study|Reason Not Specified|1|||
46768765|NCT00762372|82987087|FG000|Overall Study|Adverse Event|1|||
46768766|NCT00762372|82987088|FG001|Overall Study|Adverse Event|0|||
46768767|NCT00762372|82987089|FG002|Overall Study|Adverse Event|0|||
46768768|NCT00833261|82987103|FG000|Overall Study|Withdrawal by Subject|4|||
46768769|NCT00833105|82987107|FG000|Overall Study|Withdrawal by Subject|1|||
46768770|NCT00833105|82987107|FG000|Overall Study|Adverse Event|2|||
46768771|NCT00833027|82987113|FG000|Overall Study|Adverse Event|33|||
46838849|NCT00296504|83055943|FG000|Final Analysis|Insufficient Viral Load Response|0|||
46838850|NCT00296504|83055944|FG001|Final Analysis|Insufficient Viral Load Response|0|||
46944162|NCT02868281|83181211|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
46944163|NCT02868281|83181210|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
46944164|NCT02868281|83181211|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
46944165|NCT02868281|83181210|FG000|Overall Study|Long journey/moving away|1|||
46944166|NCT02868281|83181211|FG001|Overall Study|Long journey/moving away|1|||
46944167|NCT02476006|83181217|FG000|Overall Study|Death|4|||
46944168|NCT02476006|83181217|FG000|Overall Study|Lack of treatment efficacy|2|||
46944169|NCT02476006|83181217|FG000|Overall Study|Pregnancy|1|||
46944170|NCT02476006|83181217|FG000|Overall Study|Participant did not wish to continue|39|||
46944171|NCT02476006|83181217|FG000|Overall Study|Adverse Event|41|||
46944172|NCT02476006|83181217|FG000|Overall Study|Poor compliance to study protocol|3|||
46944173|NCT02476006|83181217|FG000|Overall Study|Sponsor decision|6|||
46944174|NCT02476006|83181217|FG000|Overall Study|Lost to Follow-up|5|||
46944175|NCT02476006|83181217|FG000|Overall Study|Physician Decision|5|||
46944176|NCT02476006|83181217|FG000|Overall Study|Study ended treatment not available|4|||
46944177|NCT02476006|83181217|FG000|Overall Study|Switched to commercial drug|4|||
46944178|NCT02476006|83181217|FG000|Overall Study|Excluded from study|1|||
46944179|NCT02476006|83181217|FG000|Overall Study|Protocol Violation|1|||
46944180|NCT02476006|83181217|FG000|Overall Study|Enrolled but not treated|4|||
46944181|NCT02475850|83181223|FG000|Overall Study|Death|155|||
46944182|NCT02475850|83181224|FG001|Overall Study|Death|141|||
46944183|NCT02475850|83181223|FG000|Overall Study|Lost to Follow-up|217|||
46944184|NCT02475850|83181224|FG001|Overall Study|Lost to Follow-up|188|||
46944185|NCT02475850|83181223|FG000|Overall Study|Withdrawal by Subject|221|||
46944186|NCT02475850|83181224|FG001|Overall Study|Withdrawal by Subject|155|||
46944187|NCT02419612|83181233|FG000|Short-term Treatment Period|Adverse Event|1|||
46944188|NCT02419612|83181234|FG001|Short-term Treatment Period|Adverse Event|1|||
46944189|NCT02419612|83181233|FG000|Short-term Treatment Period|Death|0|||
46944190|NCT02419612|83181234|FG001|Short-term Treatment Period|Death|2|||
46944191|NCT02419612|83181233|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
46944192|NCT02419612|83181234|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
46944193|NCT02419612|83181233|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
46944194|NCT02419612|83181234|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
46944195|NCT02419612|83181233|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
46944196|NCT02419612|83181234|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
46944197|NCT02419612|83181233|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
46944198|NCT02419612|83181234|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
46944199|NCT02419612|83181233|FG000|Short-term Treatment Period|Worsening of liver function|0|||
46944200|NCT02419612|83181234|FG001|Short-term Treatment Period|Worsening of liver function|1|||
46944201|NCT02419612|83181233|FG000|Short-term Treatment Period|Subject moved out of state|0|||
46944202|NCT02419612|83181234|FG001|Short-term Treatment Period|Subject moved out of state|1|||
46944203|NCT02419612|83181233|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
46944204|NCT02419612|83181234|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
46944205|NCT02419612|83181233|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
46944206|NCT02419612|83181234|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
46944207|NCT02419612|83181233|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
46944208|NCT02419612|83181234|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
46944209|NCT02419612|83181233|FG000|Long-term Treatment Period|Death|0|||
46944210|NCT02419612|83181234|FG001|Long-term Treatment Period|Death|1|||
46944211|NCT02419612|83181233|FG000|Long-term Treatment Period|Adverse Event|0|||
46944212|NCT02419612|83181234|FG001|Long-term Treatment Period|Adverse Event|5|||
46944213|NCT02419612|83181233|FG000|Long-term Treatment Period|Other|4|||
46944214|NCT02419612|83181234|FG001|Long-term Treatment Period|Other|4|||
46944215|NCT02419612|83181233|FG000|Long-term Treatment Period|Subject Decision|2|||
46944216|NCT02419612|83181234|FG001|Long-term Treatment Period|Subject Decision|4|||
46944217|NCT02419612|83181233|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
46944218|NCT02419612|83181234|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
46944219|NCT02447848|83181240|FG000|Overall Study|Patient discharged|3|||
46944220|NCT02447848|83181240|FG000|Overall Study|Lack of Efficacy|4|||
46944221|NCT02447848|83181240|FG000|Overall Study|Withdrawal by Subject|4|||
46944222|NCT02418910|83181244|FG000|Overall Study|Lost to Follow-up|3|||
46944223|NCT02418910|83181244|FG000|Overall Study|Withdrawal by Subject|4|||
46944224|NCT02418754|83181260|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
46944225|NCT02418754|83181261|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
46944226|NCT02418754|83181262|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
47062855|NCT01522651|83343748|FG004|Overall Study|Adverse Event|4|||
47062856|NCT01522651|83343744|FG000|Overall Study|Cardioversion|1|||
47062857|NCT01522651|83343745|FG001|Overall Study|Cardioversion|0|||
46944227|NCT02418754|83181263|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
46944228|NCT02418754|83181264|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
46944229|NCT02418754|83181260|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
46944230|NCT02418754|83181261|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
46944231|NCT02418754|83181262|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
46944232|NCT02418754|83181263|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
46944233|NCT02418754|83181264|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
46944234|NCT02418754|83181260|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
46944235|NCT02418754|83181261|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
46944236|NCT02418754|83181262|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
46944237|NCT02418754|83181263|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
46944238|NCT02418754|83181264|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
46944239|NCT02418754|83181260|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
46944240|NCT02418754|83181261|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
46944241|NCT02418754|83181262|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
46944242|NCT02418754|83181263|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
46944243|NCT02418754|83181264|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
46944244|NCT02418754|83181260|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
46944245|NCT02418754|83181261|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
46768772|NCT00833027|82987113|FG000|Overall Study|Death|1|||
46768773|NCT00833027|82987113|FG000|Overall Study|Lack of Efficacy|12|||
46768774|NCT00833027|82987113|FG000|Overall Study|Lost to Follow-up|24|||
46768775|NCT00833027|82987113|FG000|Overall Study|Protocol Violation|115|||
46768776|NCT00833027|82987113|FG000|Overall Study|Withdrawal by Subject|16|||
46768777|NCT00833027|82987113|FG000|Overall Study|Missing|10|||
46768778|NCT00752622|82987117|FG000|Induction Phase|Adverse Event|3|||
46768779|NCT00752622|82987117|FG000|Induction Phase|Other|3|||
46768780|NCT00752622|82987117|FG000|Induction Phase|Non-responder|14|||
46768781|NCT00752622|82987117|FG000|Induction Phase|Withdrawal by Subject|1|||
46768782|NCT00752622|82987117|FG000|Induction Phase|Premature study termination|14|||
46768783|NCT00752622|82987117|FG000|Observational Phase|Premature Study Termination|36|||
46768784|NCT00752622|82987117|FG000|Observational Phase|Non-responder|2|||
46768785|NCT00752622|82987117|FG000|Observational Phase|Withdrawal by Subject|2|||
46768786|NCT00752622|82987117|FG000|Observational Phase|Adverse Event|1|||
46768787|NCT00752622|82987117|FG000|Observational Phase|Other|2|||
46768788|NCT00752622|82987117|FG000|Interventional Phase|Non-responder|2|||
46768789|NCT00752622|82987117|FG000|Interventional Phase|Physician Decision|1|||
46838851|NCT00296504|83055945|FG002|Final Analysis|Insufficient Viral Load Response|0|||
46838852|NCT00296504|83055946|FG003|Final Analysis|Insufficient Viral Load Response|0|||
46838853|NCT00296504|83055947|FG004|Final Analysis|Insufficient Viral Load Response|0|||
46838854|NCT00296504|83055948|FG005|Final Analysis|Insufficient Viral Load Response|0|||
46838855|NCT00296504|83055949|FG006|Final Analysis|Insufficient Viral Load Response|0|||
46838856|NCT00296504|83055950|FG007|Final Analysis|Insufficient Viral Load Response|0|||
46838857|NCT00296504|83055951|FG008|Final Analysis|Insufficient Viral Load Response|6|||
46838858|NCT00296504|83055943|FG000|Final Analysis|Adverse Event|0|||
46838859|NCT00296504|83055944|FG001|Final Analysis|Adverse Event|0|||
46838860|NCT00296504|83055945|FG002|Final Analysis|Adverse Event|0|||
46838861|NCT00296504|83055946|FG003|Final Analysis|Adverse Event|0|||
46838862|NCT00296504|83055947|FG004|Final Analysis|Adverse Event|0|||
46838863|NCT00296504|83055948|FG005|Final Analysis|Adverse Event|0|||
46838864|NCT00296504|83055949|FG006|Final Analysis|Adverse Event|0|||
46838865|NCT00296504|83055950|FG007|Final Analysis|Adverse Event|0|||
46838866|NCT00296504|83055951|FG008|Final Analysis|Adverse Event|2|||
46838867|NCT00296504|83055943|FG000|Final Analysis|Pregnancy|0|||
46838868|NCT00296504|83055944|FG001|Final Analysis|Pregnancy|0|||
46838869|NCT00296504|83055945|FG002|Final Analysis|Pregnancy|0|||
46838870|NCT00296504|83055946|FG003|Final Analysis|Pregnancy|0|||
46838871|NCT00296504|83055947|FG004|Final Analysis|Pregnancy|0|||
46838872|NCT00296504|83055948|FG005|Final Analysis|Pregnancy|0|||
46838873|NCT00296504|83055949|FG006|Final Analysis|Pregnancy|0|||
46838874|NCT00296504|83055950|FG007|Final Analysis|Pregnancy|0|||
46838875|NCT00296504|83055951|FG008|Final Analysis|Pregnancy|4|||
46838876|NCT00296504|83055943|FG000|Final Analysis|Tuberculosis|0|||
46838877|NCT00296504|83055944|FG001|Final Analysis|Tuberculosis|0|||
46838878|NCT00296504|83055945|FG002|Final Analysis|Tuberculosis|0|||
46838879|NCT00296504|83055946|FG003|Final Analysis|Tuberculosis|0|||
46838880|NCT00296504|83055947|FG004|Final Analysis|Tuberculosis|0|||
46838881|NCT00296504|83055948|FG005|Final Analysis|Tuberculosis|0|||
46838882|NCT00296504|83055949|FG006|Final Analysis|Tuberculosis|0|||
46838883|NCT00296504|83055950|FG007|Final Analysis|Tuberculosis|0|||
46838884|NCT00296504|83055951|FG008|Final Analysis|Tuberculosis|1|||
46838885|NCT00296504|83055943|FG000|Final Analysis|Participant Moved to Another Country|0|||
46838886|NCT00296504|83055944|FG001|Final Analysis|Participant Moved to Another Country|0|||
46838887|NCT00296504|83055945|FG002|Final Analysis|Participant Moved to Another Country|0|||
46838888|NCT00296504|83055946|FG003|Final Analysis|Participant Moved to Another Country|0|||
46838889|NCT00296504|83055947|FG004|Final Analysis|Participant Moved to Another Country|0|||
46838890|NCT00296504|83055948|FG005|Final Analysis|Participant Moved to Another Country|0|||
46838891|NCT00296504|83055949|FG006|Final Analysis|Participant Moved to Another Country|0|||
46838892|NCT00296504|83055950|FG007|Final Analysis|Participant Moved to Another Country|0|||
46838893|NCT00296504|83055951|FG008|Final Analysis|Participant Moved to Another Country|1|||
46838894|NCT00296504|83055943|FG000|Final Analysis|Poor Adherence|0|||
46944246|NCT02418754|83181262|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
46768790|NCT00752622|82987117|FG000|Interventional Phase|Premature Study Termination|5|||
46768791|NCT00754650|82987122|FG000|Overall Study|Disease Progression|2|||
46838895|NCT00296504|83055944|FG001|Final Analysis|Poor Adherence|0|||
46944247|NCT02418754|83181263|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
46967858|NCT02614131|83210456|FG005|Overall Study|Adverse Event|0|||
46838896|NCT00296504|83055945|FG002|Final Analysis|Poor Adherence|0|||
46838897|NCT00296504|83055946|FG003|Final Analysis|Poor Adherence|0|||
46944248|NCT02418754|83181264|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
46944249|NCT02418754|83181260|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
46944250|NCT02418754|83181261|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
46944251|NCT02418754|83181262|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
46944252|NCT02418754|83181263|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
46838898|NCT00296504|83055947|FG004|Final Analysis|Poor Adherence|0|||
46838899|NCT00296504|83055948|FG005|Final Analysis|Poor Adherence|0|||
46838900|NCT00296504|83055949|FG006|Final Analysis|Poor Adherence|0|||
46838901|NCT00296504|83055950|FG007|Final Analysis|Poor Adherence|0|||
46838902|NCT00296504|83055951|FG008|Final Analysis|Poor Adherence|1|||
46838903|NCT00313820|83055978|FG000|Assigned to Treatment|Other|1|||
46944253|NCT02418754|83181264|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
46944254|NCT02418754|83181260|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
46944255|NCT02418754|83181261|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
46944256|NCT02418754|83181262|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
46944257|NCT02418754|83181263|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
46944258|NCT02418754|83181264|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
46944259|NCT02418754|83181260|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
46768792|NCT00761748|82987126|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
46768793|NCT00761748|82987127|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
46768794|NCT00761748|82987126|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
46768795|NCT00761748|82987127|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
46768796|NCT00825305|82987135|FG000|Overall Study|Adverse Event|1|||
46768797|NCT00825305|82987136|FG001|Overall Study|Adverse Event|1|||
46768798|NCT00825305|82987135|FG000|Overall Study|Withdrawal by Subject|6|||
46768799|NCT00825305|82987136|FG001|Overall Study|Withdrawal by Subject|12|||
46768800|NCT00825305|82987135|FG000|Overall Study|Inappropriate inclusion|1|||
46768801|NCT00825305|82987136|FG001|Overall Study|Inappropriate inclusion|0|||
46768802|NCT00825305|82987135|FG000|Overall Study|Protocol Violation|9|||
46838904|NCT00313820|83055979|FG001|Assigned to Treatment|Other|0|||
46768803|NCT00825305|82987136|FG001|Overall Study|Protocol Violation|9|||
46768804|NCT00825305|82987135|FG000|Overall Study|Can not be classified|0|||
46768805|NCT00825305|82987136|FG001|Overall Study|Can not be classified|1|||
46768806|NCT00754572|82987142|FG000|Overall Study|Adverse Event|19|||
46768807|NCT00754572|82987142|FG000|Overall Study|Other|39|||
46768808|NCT00754572|82987142|FG000|Overall Study|Protocol Violation|3|||
46768809|NCT00754572|82987142|FG000|Overall Study|Withdrawal by Subject|3|||
46768810|NCT00754572|82987142|FG000|Overall Study|Lack of Efficacy|2|||
46768811|NCT00754572|82987142|FG000|Overall Study|Death|1|||
46768812|NCT00754572|82987142|FG000|Overall Study|Administrative Reason|3|||
46768813|NCT00754572|82987142|FG000|Overall Study|Lost to Follow-up|1|||
46768814|NCT00824993|82987148|FG000|Overall Study|Withdrawal by Subject|1|||
46768815|NCT00824993|82987149|FG001|Overall Study|Withdrawal by Subject|1|||
46768816|NCT00824993|82987148|FG000|Overall Study|Malignancy Relapse|9|||
46838905|NCT00313820|83055978|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
46838906|NCT00313820|83055979|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
46838907|NCT00313820|83055978|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
46838908|NCT00313820|83055979|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
46838909|NCT00313820|83055978|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
46838910|NCT00313820|83055979|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
46838911|NCT00313820|83055978|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
46838912|NCT00313820|83055979|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
46838913|NCT00313820|83055978|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
46838914|NCT00313820|83055979|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
46838915|NCT00462761|83055985|FG000|Overall Study|Adverse Event|6|||
46838916|NCT00462761|83055985|FG000|Overall Study|Withdrawal by Subject|9|||
46838917|NCT00462761|83055985|FG000|Overall Study|Physician Decision|5|||
46838918|NCT00462761|83055985|FG000|Overall Study|Disease progression|43|||
46838919|NCT00462761|83055985|FG000|Overall Study|Death|12|||
46838920|NCT00462761|83055985|FG000|Overall Study|Other|1|||
46838921|NCT00235872|83056017|FG000|Overall Study|Adverse Event|34|||
46838922|NCT00235872|83056017|FG000|Overall Study|Death|1|||
46838923|NCT00235872|83056017|FG000|Overall Study|Lost to Follow-up|1|||
46838924|NCT00235872|83056017|FG000|Overall Study|Withdrawal by Subject|50|||
46838925|NCT00235872|83056017|FG000|Overall Study|Administrative reason|61|||
46838926|NCT00461981|83056023|FG000|Overall Study|Lost to Follow-up|9|||
46838927|NCT00461981|83056024|FG001|Overall Study|Lost to Follow-up|6|||
46768817|NCT00824993|82987149|FG001|Overall Study|Malignancy Relapse|10|||
46838928|NCT00461981|83056023|FG000|Overall Study|Withdrawal by Subject|2|||
46838929|NCT00461981|83056024|FG001|Overall Study|Withdrawal by Subject|3|||
46838930|NCT00296036|83056032|FG000|Overall Study|Withdrawal by Subject|1|||
46838931|NCT00296036|83056033|FG001|Overall Study|Withdrawal by Subject|0|||
46944260|NCT02418754|83181261|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
46944261|NCT02418754|83181262|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
46944262|NCT02418754|83181263|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
46944263|NCT02418754|83181264|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
46944264|NCT02418754|83181260|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
46944265|NCT02418754|83181261|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
46944266|NCT02418754|83181262|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
46944267|NCT02418754|83181263|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
46944268|NCT02418754|83181264|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
46944269|NCT02418754|83181260|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
46944270|NCT02418754|83181261|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
46838932|NCT00296036|83056034|FG002|Overall Study|Withdrawal by Subject|2|||
46838933|NCT00296036|83056035|FG003|Overall Study|Withdrawal by Subject|1|||
46838934|NCT00296036|83056036|FG004|Overall Study|Withdrawal by Subject|2|||
46838935|NCT00296036|83056037|FG005|Overall Study|Withdrawal by Subject|1|||
46838936|NCT00296036|83056032|FG000|Overall Study|Protocol Violation|0|||
46838937|NCT00296036|83056033|FG001|Overall Study|Protocol Violation|0|||
46838938|NCT00296036|83056034|FG002|Overall Study|Protocol Violation|0|||
46838939|NCT00296036|83056035|FG003|Overall Study|Protocol Violation|0|||
46838940|NCT00296036|83056036|FG004|Overall Study|Protocol Violation|0|||
46838941|NCT00296036|83056037|FG005|Overall Study|Protocol Violation|3|||
46838942|NCT00089674|83056056|FG000|Overall Study|Physician Decision|4|||
46944271|NCT02418754|83181262|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
46838943|NCT00089674|83056057|FG001|Overall Study|Physician Decision|2|||
46944272|NCT02418754|83181263|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
46944273|NCT02418754|83181264|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
46944274|NCT02418754|83181260|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
46944275|NCT02418754|83181261|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
46944276|NCT02418754|83181262|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
46838944|NCT00089674|83056056|FG000|Overall Study|Adverse Event|23|||
46838945|NCT00089674|83056057|FG001|Overall Study|Adverse Event|29|||
46838946|NCT00089674|83056056|FG000|Overall Study|Withdrawal by Subject|143|||
46838947|NCT00089674|83056057|FG001|Overall Study|Withdrawal by Subject|127|||
46944277|NCT02418754|83181263|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
46944278|NCT02418754|83181264|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
46944279|NCT02447458|83181280|FG000|Overall Study|Other|0|||
46944280|NCT02447458|83181281|FG001|Overall Study|Other|0|||
46944281|NCT02447458|83181282|FG002|Overall Study|Other|1|||
46944282|NCT02447458|83181283|FG003|Overall Study|Other|0|||
46944283|NCT02447458|83181284|FG004|Overall Study|Other|0|||
46944284|NCT02447458|83181285|FG005|Overall Study|Other|0|||
46944285|NCT02862457|83181311|FG000|Overall Study|Death|1|||
46944286|NCT02862457|83181312|FG001|Overall Study|Death|3|||
46944287|NCT02862457|83181313|FG002|Overall Study|Death|2|||
46944288|NCT02862457|83181314|FG003|Overall Study|Death|3|||
46944289|NCT02862457|83181315|FG004|Overall Study|Death|0|||
46944290|NCT02862457|83181316|FG005|Overall Study|Death|2|||
46944291|NCT02862457|83181317|FG006|Overall Study|Death|1|||
46944292|NCT02862457|83181311|FG000|Overall Study|Lost to Follow-up|1|||
46944293|NCT02862457|83181312|FG001|Overall Study|Lost to Follow-up|0|||
47062858|NCT01522651|83343746|FG002|Overall Study|Cardioversion|0|||
47062859|NCT01522651|83343747|FG003|Overall Study|Cardioversion|0|||
47062860|NCT01522651|83343748|FG004|Overall Study|Cardioversion|0|||
47062861|NCT01522651|83343744|FG000|Overall Study|Device Malfunction|0|||
46768818|NCT00824993|82987148|FG000|Overall Study|Rapid Bone Loss|0|||
46768819|NCT00824993|82987149|FG001|Overall Study|Rapid Bone Loss|1|||
46768820|NCT00824993|82987148|FG000|Overall Study|Non-Compliant|2|||
46768821|NCT00824993|82987149|FG001|Overall Study|Non-Compliant|1|||
46768822|NCT00824993|82987148|FG000|Overall Study|Insurance Issue|2|||
46768823|NCT00824993|82987149|FG001|Overall Study|Insurance Issue|1|||
46768824|NCT00824993|82987148|FG000|Overall Study|Death|0|||
46768825|NCT00824993|82987149|FG001|Overall Study|Death|3|||
46768826|NCT00832091|82987157|FG000|Overall Study|Adverse Event|1|||
46768827|NCT00832091|82987158|FG001|Overall Study|Adverse Event|1|||
46768828|NCT00832091|82987157|FG000|Overall Study|Protocol Violation|1|||
46768829|NCT00832091|82987158|FG001|Overall Study|Protocol Violation|0|||
46768830|NCT00832091|82987157|FG000|Overall Study|Withdrawal by Subject|2|||
46768831|NCT00832091|82987158|FG001|Overall Study|Withdrawal by Subject|1|||
46838948|NCT00089674|83056056|FG000|Overall Study|Death|43|||
46838949|NCT00089674|83056057|FG001|Overall Study|Death|43|||
46944294|NCT02862457|83181313|FG002|Overall Study|Lost to Follow-up|0|||
46944295|NCT02862457|83181314|FG003|Overall Study|Lost to Follow-up|1|||
46944296|NCT02862457|83181315|FG004|Overall Study|Lost to Follow-up|0|||
46944297|NCT02862457|83181316|FG005|Overall Study|Lost to Follow-up|0|||
46944298|NCT02862457|83181317|FG006|Overall Study|Lost to Follow-up|0|||
46768832|NCT00832091|82987157|FG000|Overall Study|Prohibited Medication|1|||
46838950|NCT00089674|83056056|FG000|Overall Study|Disease progression|21|||
46838951|NCT00089674|83056057|FG001|Overall Study|Disease progression|23|||
46838952|NCT00089674|83056056|FG000|Overall Study|Ineligibility determined|8|||
46838953|NCT00089674|83056057|FG001|Overall Study|Ineligibility determined|10|||
46838954|NCT00089674|83056056|FG000|Overall Study|Lost to Follow-up|21|||
46838955|NCT00089674|83056057|FG001|Overall Study|Lost to Follow-up|17|||
46838956|NCT00089674|83056056|FG000|Overall Study|Noncompliance|7|||
46838957|NCT00089674|83056057|FG001|Overall Study|Noncompliance|3|||
46838958|NCT00089674|83056056|FG000|Overall Study|Other|5|||
46838959|NCT00089674|83056057|FG001|Overall Study|Other|9|||
46838960|NCT00089674|83056056|FG000|Overall Study|Requirement for alternative therapy|14|||
46838961|NCT00089674|83056057|FG001|Overall Study|Requirement for alternative therapy|4|||
46838962|NCT00313586|83056067|FG000|Overall Study|Disease progression|14|||
46838963|NCT00313586|83056068|FG001|Overall Study|Disease progression|19|||
46838964|NCT00313586|83056069|FG002|Overall Study|Disease progression|10|||
46838965|NCT00313586|83056070|FG003|Overall Study|Disease progression|3|||
46838966|NCT00313586|83056067|FG000|Overall Study|Adverse Event|12|||
46838967|NCT00313586|83056068|FG001|Overall Study|Adverse Event|18|||
46838968|NCT00313586|83056069|FG002|Overall Study|Adverse Event|3|||
46838969|NCT00313586|83056070|FG003|Overall Study|Adverse Event|10|||
46838970|NCT00313586|83056067|FG000|Overall Study|Death|11|||
46838971|NCT00313586|83056068|FG001|Overall Study|Death|8|||
46838972|NCT00313586|83056069|FG002|Overall Study|Death|1|||
46838973|NCT00313586|83056070|FG003|Overall Study|Death|7|||
46838974|NCT00313586|83056067|FG000|Overall Study|Withdrawal by Subject|13|||
46838975|NCT00313586|83056068|FG001|Overall Study|Withdrawal by Subject|6|||
46838976|NCT00313586|83056069|FG002|Overall Study|Withdrawal by Subject|6|||
46838977|NCT00313586|83056070|FG003|Overall Study|Withdrawal by Subject|2|||
46838978|NCT00313586|83056067|FG000|Overall Study|Alternative therapy|3|||
46838979|NCT00313586|83056068|FG001|Overall Study|Alternative therapy|6|||
46838980|NCT00313586|83056069|FG002|Overall Study|Alternative therapy|2|||
46944299|NCT02862457|83181311|FG000|Overall Study|Withdrawal by Subject|0|||
46944300|NCT02862457|83181312|FG001|Overall Study|Withdrawal by Subject|0|||
46944301|NCT02862457|83181313|FG002|Overall Study|Withdrawal by Subject|1|||
46768833|NCT00832091|82987158|FG001|Overall Study|Prohibited Medication|0|||
46768834|NCT00761514|82987164|FG000|Overall Study|Adverse Event|1|||
46768835|NCT00761514|82987164|FG000|Overall Study|Withdrawal by Subject|2|||
46768836|NCT00761514|82987164|FG000|Overall Study|Lost to Follow-up|1|||
46768837|NCT00761514|82987164|FG000|Overall Study|Health insurance didn't cover study drug|1|||
46768838|NCT00761514|82987164|FG000|Overall Study|Problem complying with study visit|1|||
46768839|NCT00761514|82987164|FG000|Overall Study|Unable to pay for medications|1|||
46768840|NCT00831779|82987170|FG000|Overall Study|Lost to Follow-up|1|||
46768841|NCT00831779|82987171|FG001|Overall Study|Lost to Follow-up|0|||
46768842|NCT00831779|82987170|FG000|Overall Study|No longer met criteria|0|||
46768843|NCT00831779|82987171|FG001|Overall Study|No longer met criteria|1|||
46768844|NCT00758043|82987181|FG000|Overall Study|Adverse Event|1|||
46768845|NCT00758043|82987182|FG001|Overall Study|Adverse Event|20|||
46768846|NCT00758043|82987183|FG002|Overall Study|Adverse Event|12|||
46768847|NCT00758043|82987184|FG003|Overall Study|Adverse Event|62|||
46768848|NCT00758043|82987181|FG000|Overall Study|Lack of Efficacy|0|||
46768849|NCT00758043|82987182|FG001|Overall Study|Lack of Efficacy|6|||
46768850|NCT00758043|82987183|FG002|Overall Study|Lack of Efficacy|18|||
46768851|NCT00758043|82987184|FG003|Overall Study|Lack of Efficacy|12|||
46768852|NCT00758043|82987181|FG000|Overall Study|Refused Further Treatment|0|||
46768853|NCT00758043|82987182|FG001|Overall Study|Refused Further Treatment|11|||
46768854|NCT00758043|82987183|FG002|Overall Study|Refused Further Treatment|5|||
46768855|NCT00758043|82987184|FG003|Overall Study|Refused Further Treatment|8|||
46768856|NCT00758043|82987181|FG000|Overall Study|Lost to Follow-up|0|||
46838981|NCT00313586|83056070|FG003|Overall Study|Alternative therapy|0|||
46768857|NCT00758043|82987182|FG001|Overall Study|Lost to Follow-up|2|||
46768858|NCT00758043|82987183|FG002|Overall Study|Lost to Follow-up|2|||
46838982|NCT00313586|83056067|FG000|Overall Study|Other complicating disease|2|||
46838983|NCT00313586|83056068|FG001|Overall Study|Other complicating disease|2|||
46838984|NCT00313586|83056069|FG002|Overall Study|Other complicating disease|0|||
46838985|NCT00313586|83056070|FG003|Overall Study|Other complicating disease|0|||
46838986|NCT00313586|83056067|FG000|Overall Study|Did not achieve HI-major/better response|10|||
46838987|NCT00313586|83056068|FG001|Overall Study|Did not achieve HI-major/better response|7|||
46967859|NCT02614131|83210457|FG006|Overall Study|Adverse Event|1|||
46768859|NCT00758043|82987184|FG003|Overall Study|Lost to Follow-up|5|||
46768860|NCT00758043|82987181|FG000|Overall Study|Withdrawal by Subject|0|||
46768861|NCT00758043|82987182|FG001|Overall Study|Withdrawal by Subject|1|||
46838988|NCT00313586|83056069|FG002|Overall Study|Did not achieve HI-major/better response|2|||
46838989|NCT00313586|83056070|FG003|Overall Study|Did not achieve HI-major/better response|1|||
46838990|NCT00313586|83056067|FG000|Overall Study|Physician Decision|2|||
46944302|NCT02862457|83181314|FG003|Overall Study|Withdrawal by Subject|0|||
46944303|NCT02862457|83181315|FG004|Overall Study|Withdrawal by Subject|0|||
46944304|NCT02862457|83181316|FG005|Overall Study|Withdrawal by Subject|1|||
46944305|NCT02862457|83181317|FG006|Overall Study|Withdrawal by Subject|0|||
46944306|NCT02447302|83181344|FG000|Overall Study|Physician Decision|1|||
46944307|NCT02447302|83181345|FG001|Overall Study|Physician Decision|0|||
46944308|NCT02447302|83181346|FG002|Overall Study|Physician Decision|0|||
46944309|NCT02447302|83181344|FG000|Overall Study|Adverse Event|4|||
46944310|NCT02447302|83181345|FG001|Overall Study|Adverse Event|3|||
46944311|NCT02447302|83181346|FG002|Overall Study|Adverse Event|0|||
46944312|NCT02447302|83181344|FG000|Overall Study|Withdrawal by Subject|0|||
46944313|NCT02447302|83181345|FG001|Overall Study|Withdrawal by Subject|1|||
46944314|NCT02447302|83181346|FG002|Overall Study|Withdrawal by Subject|5|||
46944315|NCT02447302|83181344|FG000|Overall Study|Sponsor Decision|0|||
46944316|NCT02447302|83181345|FG001|Overall Study|Sponsor Decision|0|||
46944317|NCT02447302|83181346|FG002|Overall Study|Sponsor Decision|1|||
46944318|NCT02454517|83181356|FG000|Overall Study|Withdrawal by Subject|3|||
46944319|NCT02454517|83181357|FG001|Overall Study|Withdrawal by Subject|0|||
46944320|NCT02454517|83181356|FG000|Overall Study|Lost to Follow-up|4|||
46944321|NCT02454517|83181357|FG001|Overall Study|Lost to Follow-up|7|||
46944322|NCT02454517|83181356|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
46944323|NCT02454517|83181357|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
46944324|NCT03861039|83181368|FG000|Overall Study|Adverse Event|2|||
46944325|NCT03861039|83181369|FG001|Overall Study|Adverse Event|5|||
46944326|NCT03861039|83181370|FG002|Overall Study|Adverse Event|11|||
46944327|NCT03861039|83181368|FG000|Overall Study|Withdrawal by Subject|1|||
46944328|NCT03861039|83181369|FG001|Overall Study|Withdrawal by Subject|3|||
46944329|NCT03861039|83181370|FG002|Overall Study|Withdrawal by Subject|4|||
46944330|NCT02731755|83181380|FG000|First Intervention|Withdrawal by Subject|0|||
46944331|NCT02731755|83181381|FG001|First Intervention|Withdrawal by Subject|2|||
46768862|NCT00758043|82987183|FG002|Overall Study|Withdrawal by Subject|1|||
46768863|NCT00758043|82987184|FG003|Overall Study|Withdrawal by Subject|4|||
46768864|NCT00758043|82987181|FG000|Overall Study|Required Prohibited Medication|0|||
46768865|NCT00758043|82987182|FG001|Overall Study|Required Prohibited Medication|0|||
46768866|NCT00758043|82987183|FG002|Overall Study|Required Prohibited Medication|1|||
46768867|NCT00758043|82987184|FG003|Overall Study|Required Prohibited Medication|3|||
46768868|NCT00758043|82987181|FG000|Overall Study|Non-Compliant With study Drug|0|||
46768869|NCT00758043|82987182|FG001|Overall Study|Non-Compliant With study Drug|0|||
46768870|NCT00758043|82987183|FG002|Overall Study|Non-Compliant With study Drug|0|||
46768871|NCT00758043|82987184|FG003|Overall Study|Non-Compliant With study Drug|1|||
46768872|NCT00758043|82987181|FG000|Overall Study|Other Reasons|0|||
46768873|NCT00758043|82987182|FG001|Overall Study|Other Reasons|1|||
46768874|NCT00758043|82987183|FG002|Overall Study|Other Reasons|0|||
46768875|NCT00758043|82987184|FG003|Overall Study|Other Reasons|5|||
46768876|NCT00831701|82987202|FG000|Overall Study|Withdrawal by Subject|2|||
46768877|NCT00831701|82987203|FG001|Overall Study|Withdrawal by Subject|0|||
46768878|NCT00831701|82987202|FG000|Overall Study|Stone expulsion before first medication|2|||
46768879|NCT00831701|82987203|FG001|Overall Study|Stone expulsion before first medication|2|||
46768880|NCT00831701|82987202|FG000|Overall Study|Lost to Follow-up|1|||
46768881|NCT00831701|82987203|FG001|Overall Study|Lost to Follow-up|3|||
46768882|NCT00752895|82987211|FG000|Overall Study|Withdrawal by Subject|8|||
46768883|NCT00752895|82987212|FG001|Overall Study|Withdrawal by Subject|3|||
46768884|NCT00831389|82987220|FG000|Overall Study|Withdrawal by Subject|0|||
46768885|NCT00831389|82987221|FG001|Overall Study|Withdrawal by Subject|1|||
46768886|NCT00831311|82987229|FG000|Overall Study|Definitive Contraindication|3|||
46768887|NCT00831311|82987230|FG001|Overall Study|Definitive Contraindication|3|||
46768888|NCT00831311|82987229|FG000|Overall Study|Lost to Follow-up|3|||
46768889|NCT00831311|82987230|FG001|Overall Study|Lost to Follow-up|0|||
46768890|NCT00831311|82987229|FG000|Overall Study|Physician Decision|0|||
46768891|NCT00831311|82987230|FG001|Overall Study|Physician Decision|1|||
46768892|NCT00831311|82987229|FG000|Overall Study|Withdrawal by Subject|6|||
46768893|NCT00831311|82987230|FG001|Overall Study|Withdrawal by Subject|4|||
46768894|NCT00831233|82987239|FG000|Overall Study|Adverse Event|0|||
46768895|NCT00831233|82987240|FG001|Overall Study|Adverse Event|1|||
46768896|NCT00831233|82987239|FG000|Overall Study|Protocol Violation|1|||
46768897|NCT00831233|82987240|FG001|Overall Study|Protocol Violation|0|||
46768898|NCT00831233|82987239|FG000|Overall Study|Selection Criteria Not Met|2|||
46768899|NCT00831233|82987240|FG001|Overall Study|Selection Criteria Not Met|0|||
46944332|NCT02866175|83181410|FG000|Overall Study|Adverse Event|56|||
46944333|NCT02866175|83181411|FG001|Overall Study|Adverse Event|54|||
46944334|NCT02866175|83181410|FG000|Overall Study|Withdrawal by Subject|31|||
46944335|NCT02866175|83181411|FG001|Overall Study|Withdrawal by Subject|52|||
46944336|NCT02866175|83181410|FG000|Overall Study|Death|30|||
46944337|NCT02866175|83181411|FG001|Overall Study|Death|23|||
46944338|NCT02866175|83181410|FG000|Overall Study|Other|7|||
46944339|NCT02866175|83181411|FG001|Overall Study|Other|14|||
46944340|NCT02866175|83181410|FG000|Overall Study|Progressive disease|1|||
46944341|NCT02866175|83181411|FG001|Overall Study|Progressive disease|1|||
46944342|NCT02866175|83181410|FG000|Overall Study|Lost to Follow-up|2|||
46944343|NCT02866175|83181411|FG001|Overall Study|Lost to Follow-up|0|||
46944344|NCT02866175|83181410|FG000|Overall Study|Lack of Efficacy|0|||
46944345|NCT02866175|83181411|FG001|Overall Study|Lack of Efficacy|1|||
46944346|NCT02866175|83181410|FG000|Overall Study|Physician Decision|3|||
46944347|NCT02866175|83181411|FG001|Overall Study|Physician Decision|15|||
46944348|NCT02866175|83181410|FG000|Overall Study|Did not receive treatment|5|||
46944349|NCT02866175|83181411|FG001|Overall Study|Did not receive treatment|15|||
46944350|NCT01336205|83181424|FG000|Overall Study|Other|22|||
46944351|NCT01336205|83181425|FG001|Overall Study|Other|9|||
46944352|NCT01336205|83181424|FG000|Overall Study|Lost to Follow-up|40|||
46944353|NCT01336205|83181425|FG001|Overall Study|Lost to Follow-up|20|||
46944354|NCT01336205|83181424|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
46944355|NCT01336205|83181425|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
46944356|NCT01336205|83181424|FG000|Overall Study|Lack of Efficacy|4|||
46944357|NCT01336205|83181425|FG001|Overall Study|Lack of Efficacy|0|||
46944358|NCT01336205|83181424|FG000|Overall Study|Severe noncompliance with protocol|9|||
46944359|NCT01336205|83181425|FG001|Overall Study|Severe noncompliance with protocol|2|||
46838991|NCT00313586|83056068|FG001|Overall Study|Physician Decision|1|||
46838992|NCT00313586|83056069|FG002|Overall Study|Physician Decision|0|||
46838993|NCT00313586|83056070|FG003|Overall Study|Physician Decision|0|||
46838994|NCT00313586|83056067|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
46838995|NCT00313586|83056068|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
46838996|NCT00313586|83056069|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
46838997|NCT00313586|83056070|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
46838998|NCT00313586|83056067|FG000|Overall Study|Lost insurance|0|||
46838999|NCT00313586|83056068|FG001|Overall Study|Lost insurance|1|||
46839000|NCT00313586|83056069|FG002|Overall Study|Lost insurance|0|||
46839001|NCT00313586|83056070|FG003|Overall Study|Lost insurance|0|||
46944360|NCT01336205|83181424|FG000|Overall Study|Adverse Event|56|||
46944361|NCT01336205|83181425|FG001|Overall Study|Adverse Event|6|||
46944362|NCT01336205|83181424|FG000|Overall Study|Death|1|||
46944363|NCT01336205|83181425|FG001|Overall Study|Death|1|||
46944364|NCT01336205|83181424|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
46944365|NCT01336205|83181425|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
47062862|NCT01522651|83343745|FG001|Overall Study|Device Malfunction|1|||
46768900|NCT00761280|82987257|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
46768901|NCT00761280|82987258|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
46768902|NCT00761280|82987257|FG000|Randomization to First Dose|Sponsor decision|1|||
46768903|NCT00761280|82987258|FG001|Randomization to First Dose|Sponsor decision|0|||
46768904|NCT00761280|82987257|FG000|Randomization to First Dose|Other|1|||
46768905|NCT00761280|82987258|FG001|Randomization to First Dose|Other|0|||
46768906|NCT00761280|82987257|FG000|First Dose to End of Study|End of trial|5|||
46768907|NCT00761280|82987258|FG001|First Dose to End of Study|End of trial|5|||
46839002|NCT00313586|83056067|FG000|Overall Study|Moved|0|||
46839003|NCT00313586|83056068|FG001|Overall Study|Moved|1|||
46839004|NCT00313586|83056069|FG002|Overall Study|Moved|0|||
46839005|NCT00313586|83056070|FG003|Overall Study|Moved|0|||
46839006|NCT00313586|83056067|FG000|Overall Study|Death before starting treatment|1|||
46839007|NCT00313586|83056068|FG001|Overall Study|Death before starting treatment|0|||
46839008|NCT00313586|83056069|FG002|Overall Study|Death before starting treatment|0|||
46839009|NCT00313586|83056070|FG003|Overall Study|Death before starting treatment|0|||
46839010|NCT00312572|83056080|FG000|Overall Study|Adverse Event|10|||
46839011|NCT00312572|83056081|FG001|Overall Study|Adverse Event|16|||
46839012|NCT00312572|83056080|FG000|Overall Study|Lost to Follow-up|1|||
46839013|NCT00312572|83056081|FG001|Overall Study|Lost to Follow-up|1|||
46839014|NCT00312572|83056080|FG000|Overall Study|Administrative|4|||
46839015|NCT00312572|83056081|FG001|Overall Study|Administrative|2|||
46839016|NCT00312572|83056080|FG000|Overall Study|Lack of Efficacy|1|||
46944366|NCT01336205|83181424|FG000|Overall Study|Withdrawal by Subject|72|||
46638511|NCT01467960|82811864|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
46839017|NCT00312572|83056081|FG001|Overall Study|Lack of Efficacy|2|||
46944367|NCT01336205|83181425|FG001|Overall Study|Withdrawal by Subject|38|||
47062863|NCT01522651|83343746|FG002|Overall Study|Device Malfunction|0|||
46768908|NCT00761280|82987257|FG000|First Dose to End of Study|Progressive disease|5|||
46839018|NCT00290888|83056091|FG000|Overall Study|Physician Decision|3|||
46839019|NCT00290888|83056092|FG001|Overall Study|Physician Decision|1|||
46839020|NCT00290732|83056101|FG000|Overall Study|Inability to instill drug intraductally.|0|||
46839021|NCT00290732|83056102|FG001|Overall Study|Inability to instill drug intraductally.|1|||
46839022|NCT00290732|83056103|FG002|Overall Study|Inability to instill drug intraductally.|1|||
46839023|NCT00290732|83056104|FG003|Overall Study|Inability to instill drug intraductally.|0|||
46944368|NCT01336205|83181424|FG000|Overall Study|Did not receive treatment|4|||
46944369|NCT01336205|83181425|FG001|Overall Study|Did not receive treatment|0|||
46944370|NCT02865395|83181434|FG000|Overall Study|Physician Decision|6|||
46944371|NCT02865395|83181435|FG001|Overall Study|Physician Decision|10|||
46944372|NCT02865395|83181436|FG002|Overall Study|Physician Decision|7|||
46944373|NCT01123707|83181448|FG000|Overall Study|Lost to Follow-up|3|||
46944374|NCT01123707|83181449|FG001|Overall Study|Lost to Follow-up|1|||
46944375|NCT01123707|83181450|FG002|Overall Study|Lost to Follow-up|3|||
46944376|NCT01123707|83181451|FG003|Overall Study|Lost to Follow-up|2|||
46944377|NCT01123707|83181448|FG000|Overall Study|Adverse Event|5|||
46944378|NCT01123707|83181449|FG001|Overall Study|Adverse Event|7|||
46944379|NCT01123707|83181450|FG002|Overall Study|Adverse Event|5|||
46944380|NCT01123707|83181451|FG003|Overall Study|Adverse Event|3|||
46944381|NCT01123707|83181448|FG000|Overall Study|Sponsor Discontinued Study|30|||
46944382|NCT01123707|83181449|FG001|Overall Study|Sponsor Discontinued Study|24|||
46944383|NCT01123707|83181450|FG002|Overall Study|Sponsor Discontinued Study|25|||
46944384|NCT01123707|83181451|FG003|Overall Study|Sponsor Discontinued Study|40|||
46944385|NCT01123707|83181448|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
46839024|NCT00290732|83056105|FG004|Overall Study|Inability to instill drug intraductally.|0|||
46839025|NCT00312494|83056121|FG000|Overall Study|Randomized; not treated with study drug|9|||
46839026|NCT00312494|83056122|FG001|Overall Study|Randomized; not treated with study drug|10|||
46839027|NCT00312494|83056123|FG002|Overall Study|Randomized; not treated with study drug|5|||
46839028|NCT00312494|83056121|FG000|Overall Study|Adverse Event|33|||
46839029|NCT00312494|83056122|FG001|Overall Study|Adverse Event|15|||
46839030|NCT00312494|83056123|FG002|Overall Study|Adverse Event|11|||
46839031|NCT00312494|83056121|FG000|Overall Study|Lack of Efficacy|4|||
46944386|NCT01123707|83181449|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
46944387|NCT01123707|83181450|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
46944388|NCT01123707|83181451|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
46944389|NCT01123707|83181448|FG000|Overall Study|Investigator Withdrew Participant|0|||
46944390|NCT01123707|83181449|FG001|Overall Study|Investigator Withdrew Participant|1|||
46944391|NCT01123707|83181450|FG002|Overall Study|Investigator Withdrew Participant|1|||
46944392|NCT01123707|83181451|FG003|Overall Study|Investigator Withdrew Participant|1|||
46944393|NCT01123707|83181448|FG000|Overall Study|Subject Withdrew Consent|4|||
46944394|NCT01123707|83181449|FG001|Overall Study|Subject Withdrew Consent|5|||
46944395|NCT01123707|83181450|FG002|Overall Study|Subject Withdrew Consent|1|||
46944396|NCT01123707|83181451|FG003|Overall Study|Subject Withdrew Consent|2|||
46944397|NCT01123707|83181448|FG000|Overall Study|Lack of Efficacy|1|||
46944398|NCT01123707|83181449|FG001|Overall Study|Lack of Efficacy|2|||
46944399|NCT01123707|83181450|FG002|Overall Study|Lack of Efficacy|1|||
46944400|NCT01123707|83181451|FG003|Overall Study|Lack of Efficacy|0|||
46944401|NCT01123707|83181448|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
46944402|NCT01123707|83181449|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
46944403|NCT01123707|83181450|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
46944404|NCT01123707|83181451|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
46944405|NCT02755103|83181463|FG000|Overall Study|Lost to Follow-up|17|||
46944406|NCT02755103|83181464|FG001|Overall Study|Lost to Follow-up|15|||
46944407|NCT02755103|83181463|FG000|Overall Study|Death|0|||
46944408|NCT02755103|83181464|FG001|Overall Study|Death|1|||
46944409|NCT02755103|83181463|FG000|Overall Study|Physician Decision|0|||
46944410|NCT02755103|83181464|FG001|Overall Study|Physician Decision|1|||
46944411|NCT02755103|83181463|FG000|Overall Study|Pregnancy|0|||
46944412|NCT02755103|83181464|FG001|Overall Study|Pregnancy|1|||
46944413|NCT02755103|83181463|FG000|Overall Study|Withdrawal by Subject|3|||
46839032|NCT00312494|83056122|FG001|Overall Study|Lack of Efficacy|6|||
46839033|NCT00312494|83056123|FG002|Overall Study|Lack of Efficacy|8|||
46839034|NCT00312494|83056121|FG000|Overall Study|Laboratory abnormality|1|||
46839035|NCT00312494|83056122|FG001|Overall Study|Laboratory abnormality|0|||
46839036|NCT00312494|83056123|FG002|Overall Study|Laboratory abnormality|0|||
46839037|NCT00312494|83056121|FG000|Overall Study|Lost to Follow-up|8|||
46839038|NCT00312494|83056122|FG001|Overall Study|Lost to Follow-up|8|||
46839039|NCT00312494|83056123|FG002|Overall Study|Lost to Follow-up|8|||
46839040|NCT00312494|83056121|FG000|Overall Study|Withdrawal by Subject|6|||
46839041|NCT00312494|83056122|FG001|Overall Study|Withdrawal by Subject|9|||
46839042|NCT00312494|83056123|FG002|Overall Study|Withdrawal by Subject|10|||
46839043|NCT00312494|83056121|FG000|Overall Study|Other|10|||
46839044|NCT00312494|83056122|FG001|Overall Study|Other|10|||
46839045|NCT00312494|83056123|FG002|Overall Study|Other|1|||
46839046|NCT00312338|83056133|FG000|Overall Study|Adverse Event|7|||
46839047|NCT00312338|83056134|FG001|Overall Study|Adverse Event|2|||
46944414|NCT02755103|83181464|FG001|Overall Study|Withdrawal by Subject|0|||
46944415|NCT01258803|83181474|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
46944416|NCT01258803|83181475|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
46944417|NCT01258803|83181476|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
46944418|NCT01258803|83181477|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
46944419|NCT01258803|83181478|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
46944420|NCT01258803|83181479|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
46944421|NCT01258803|83181474|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
46839048|NCT00312338|83056133|FG000|Overall Study|Lost to Follow-up|9|||
46839049|NCT00312338|83056134|FG001|Overall Study|Lost to Follow-up|1|||
46944422|NCT01258803|83181475|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
46944423|NCT01258803|83181476|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
46944424|NCT01258803|83181477|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
46944425|NCT01258803|83181478|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
46944426|NCT01258803|83181479|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
46944427|NCT01258803|83181474|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
46944428|NCT01258803|83181475|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
46944429|NCT01258803|83181476|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
46944430|NCT01258803|83181477|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
46944431|NCT01258803|83181478|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
46944432|NCT01258803|83181479|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
46944433|NCT02865083|83181495|FG000|Overall Study|Early Termination|3|||
46944434|NCT02865083|83181496|FG001|Overall Study|Early Termination|1|||
46944435|NCT00862251|83181505|FG000|Overall Study|Adverse Event|8|||
46944436|NCT00862251|83181506|FG001|Overall Study|Adverse Event|3|||
46944437|NCT00862251|83181507|FG002|Overall Study|Adverse Event|1|||
46944438|NCT00862251|83181505|FG000|Overall Study|Lost to Follow-up|0|||
46944439|NCT00862251|83181506|FG001|Overall Study|Lost to Follow-up|0|||
46944440|NCT00862251|83181507|FG002|Overall Study|Lost to Follow-up|1|||
46944441|NCT00862251|83181505|FG000|Overall Study|Protocol Violation|2|||
46944442|NCT00862251|83181506|FG001|Overall Study|Protocol Violation|0|||
46944443|NCT00862251|83181507|FG002|Overall Study|Protocol Violation|1|||
46944444|NCT00862251|83181505|FG000|Overall Study|Withdrawal by Subject|9|||
46944445|NCT00862251|83181506|FG001|Overall Study|Withdrawal by Subject|2|||
46944446|NCT00862251|83181507|FG002|Overall Study|Withdrawal by Subject|6|||
46944447|NCT02864381|83181536|FG000|Overall Study|Death|58|||
46944448|NCT02864381|83181537|FG001|Overall Study|Death|61|||
46944449|NCT02864381|83181536|FG000|Overall Study|Withdrew Consent|5|||
46944450|NCT02864381|83181537|FG001|Overall Study|Withdrew Consent|6|||
46944451|NCT02864381|83181536|FG000|Overall Study|Reason Unknown|7|||
46944452|NCT02864381|83181537|FG001|Overall Study|Reason Unknown|3|||
46944453|NCT02864381|83181536|FG000|Overall Study|Lost to Follow-up|1|||
46944454|NCT02864381|83181537|FG001|Overall Study|Lost to Follow-up|1|||
46944455|NCT02864381|83181536|FG000|Overall Study|Investigator's Discretion|1|||
46944456|NCT02864381|83181537|FG001|Overall Study|Investigator's Discretion|0|||
46944457|NCT02864381|83181536|FG000|Overall Study|Protocol Violation|0|||
46944458|NCT02864381|83181537|FG001|Overall Study|Protocol Violation|1|||
46944459|NCT02860169|83181545|FG000|Part A|Withdrawal by Subject|1|||
46944460|NCT02860169|83181545|FG000|Part A|Other (Screening failure)|6|||
46944461|NCT02860169|83181545|FG000|Part A|Other (Survey not completed)|3|||
46944462|NCT02860169|83181545|FG000|Part A|Other (did not completed consent)|1|||
46944463|NCT02860169|83181545|FG000|Part B|Other (Screening failure)|10|||
46638512|NCT01467960|82811865|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
46638513|NCT01467960|82811866|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
46638514|NCT01467960|82811867|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
46638515|NCT01467960|82811868|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
46638516|NCT01467960|82811869|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
46638517|NCT01441596|82811886|FG000|Overall Study|Other reason not defined below|0|||
46944464|NCT02860169|83181545|FG000|Part B|Withdrawal by Subject|1|||
46944465|NCT02860169|83181545|FG000|Part C|Other (Screening failure)|1|||
46944466|NCT00409773|83181556|FG000|Overall Study|Adverse Event|3|||
46944467|NCT00409773|83181557|FG001|Overall Study|Adverse Event|4|||
46944468|NCT00409773|83181558|FG002|Overall Study|Adverse Event|4|||
46944469|NCT00409773|83181559|FG003|Overall Study|Adverse Event|2|||
46944470|NCT00409773|83181560|FG004|Overall Study|Adverse Event|6|||
46944471|NCT00409773|83181556|FG000|Overall Study|Lost to Follow-up|6|||
46944472|NCT00409773|83181557|FG001|Overall Study|Lost to Follow-up|1|||
46944473|NCT00409773|83181558|FG002|Overall Study|Lost to Follow-up|2|||
46944474|NCT00409773|83181559|FG003|Overall Study|Lost to Follow-up|3|||
46638518|NCT01441596|82811887|FG001|Overall Study|Other reason not defined below|2|||
46638519|NCT01441596|82811888|FG002|Overall Study|Other reason not defined below|1|||
46638520|NCT01441596|82811886|FG000|Overall Study|Withdrawal by Subject|4|||
46944475|NCT00409773|83181560|FG004|Overall Study|Lost to Follow-up|1|||
46944476|NCT00409773|83181556|FG000|Overall Study|Physician Decision|0|||
46944477|NCT00409773|83181557|FG001|Overall Study|Physician Decision|0|||
46944478|NCT00409773|83181558|FG002|Overall Study|Physician Decision|0|||
46768909|NCT00761280|82987258|FG001|First Dose to End of Study|Progressive disease|3|||
46768910|NCT00761280|82987257|FG000|First Dose to End of Study|Sponsor decision|1|||
46768911|NCT00761280|82987258|FG001|First Dose to End of Study|Sponsor decision|2|||
46944479|NCT00409773|83181559|FG003|Overall Study|Physician Decision|2|||
46944480|NCT00409773|83181560|FG004|Overall Study|Physician Decision|0|||
46944481|NCT00409773|83181556|FG000|Overall Study|Protocol Violation|0|||
46944482|NCT00409773|83181557|FG001|Overall Study|Protocol Violation|2|||
46944483|NCT00409773|83181558|FG002|Overall Study|Protocol Violation|3|||
46944484|NCT00409773|83181559|FG003|Overall Study|Protocol Violation|3|||
46944485|NCT00409773|83181560|FG004|Overall Study|Protocol Violation|1|||
46944486|NCT00409773|83181556|FG000|Overall Study|Withdrawal by Subject|0|||
46944487|NCT00409773|83181557|FG001|Overall Study|Withdrawal by Subject|0|||
46944488|NCT00409773|83181558|FG002|Overall Study|Withdrawal by Subject|0|||
46944489|NCT00409773|83181559|FG003|Overall Study|Withdrawal by Subject|2|||
46944490|NCT00409773|83181560|FG004|Overall Study|Withdrawal by Subject|1|||
46944491|NCT00409773|83181556|FG000|Overall Study|Lack of Eligibility|0|||
46944492|NCT00409773|83181557|FG001|Overall Study|Lack of Eligibility|0|||
46944493|NCT00409773|83181558|FG002|Overall Study|Lack of Eligibility|0|||
46944494|NCT00409773|83181559|FG003|Overall Study|Lack of Eligibility|0|||
46944495|NCT00409773|83181560|FG004|Overall Study|Lack of Eligibility|1|||
46944496|NCT02861807|83181574|FG000|Overall Study|Lost to Follow-up|7|||
46944497|NCT02861807|83181575|FG001|Overall Study|Lost to Follow-up|6|||
46944498|NCT02861807|83181574|FG000|Overall Study|Withdrawal by Subject|5|||
46944499|NCT02861807|83181575|FG001|Overall Study|Withdrawal by Subject|8|||
46944500|NCT02858401|83181588|FG000|Overall Study|Withdrew Consent|0|||
46944501|NCT02858401|83181589|FG001|Overall Study|Withdrew Consent|0|||
46944502|NCT02858401|83181590|FG002|Overall Study|Withdrew Consent|0|||
46944503|NCT02858401|83181591|FG003|Overall Study|Withdrew Consent|0|||
46944504|NCT02858401|83181592|FG004|Overall Study|Withdrew Consent|0|||
46944505|NCT02858401|83181593|FG005|Overall Study|Withdrew Consent|1|||
46944506|NCT02858401|83181594|FG006|Overall Study|Withdrew Consent|0|||
46944507|NCT02858401|83181588|FG000|Overall Study|Lost to Follow-up|0|||
46944508|NCT02858401|83181589|FG001|Overall Study|Lost to Follow-up|1|||
46944509|NCT02858401|83181590|FG002|Overall Study|Lost to Follow-up|0|||
46944510|NCT02858401|83181591|FG003|Overall Study|Lost to Follow-up|0|||
46944511|NCT02858401|83181592|FG004|Overall Study|Lost to Follow-up|0|||
46944512|NCT02858401|83181593|FG005|Overall Study|Lost to Follow-up|0|||
46944513|NCT02858401|83181594|FG006|Overall Study|Lost to Follow-up|0|||
46944514|NCT02857283|83181621|FG000|First Exposure|Withdrawal by Subject|1|||
46944515|NCT02857283|83181622|FG001|First Exposure|Withdrawal by Subject|0|||
46944516|NCT02746679|83181640|FG000|Overall Study|Lost to Follow-up|4|||
46944517|NCT02746679|83181641|FG001|Overall Study|Lost to Follow-up|6|||
46944518|NCT02731131|83181649|FG000|Overall Study|Psychiatric Disorder|0|||
47062864|NCT01522651|83343747|FG003|Overall Study|Device Malfunction|0|||
47062865|NCT01522651|83343748|FG004|Overall Study|Device Malfunction|0|||
47062866|NCT01522651|83343744|FG000|Overall Study|Investigator's Discretion|0|||
47062867|NCT01522651|83343745|FG001|Overall Study|Investigator's Discretion|1|||
47062868|NCT01522651|83343746|FG002|Overall Study|Investigator's Discretion|0|||
47062869|NCT01522651|83343747|FG003|Overall Study|Investigator's Discretion|0|||
46839050|NCT00312338|83056133|FG000|Overall Study|Withdrawal by Subject|4|||
46839051|NCT00312338|83056134|FG001|Overall Study|Withdrawal by Subject|0|||
46839052|NCT00312338|83056133|FG000|Overall Study|Subsequent infection|2|||
46839053|NCT00312338|83056134|FG001|Overall Study|Subsequent infection|0|||
46839054|NCT00290498|83056142|FG000|Overall Study|Death|2|||
46839055|NCT00290498|83056143|FG001|Overall Study|Death|0|||
46839056|NCT00290498|83056142|FG000|Overall Study|Physician Decision|1|||
46839057|NCT00290498|83056143|FG001|Overall Study|Physician Decision|0|||
46839058|NCT00290498|83056142|FG000|Overall Study|Withdrawal by Subject|1|||
46839059|NCT00290498|83056143|FG001|Overall Study|Withdrawal by Subject|0|||
46839060|NCT00290498|83056142|FG000|Overall Study|Ineligible|3|||
46839061|NCT00290498|83056143|FG001|Overall Study|Ineligible|0|||
46839062|NCT00290498|83056142|FG000|Overall Study|Non-Compliance|1|||
46839063|NCT00290498|83056143|FG001|Overall Study|Non-Compliance|0|||
46839064|NCT00451451|83056154|FG000|Overall Study|Adverse Event|11|||
46839065|NCT00451451|83056155|FG001|Overall Study|Adverse Event|21|||
46839066|NCT00451451|83056156|FG002|Overall Study|Adverse Event|26|||
46839067|NCT00451451|83056157|FG003|Overall Study|Adverse Event|10|||
46839068|NCT00451451|83056154|FG000|Overall Study|Lost to Follow-up|11|||
46839069|NCT00451451|83056155|FG001|Overall Study|Lost to Follow-up|9|||
46839070|NCT00451451|83056156|FG002|Overall Study|Lost to Follow-up|8|||
46839071|NCT00451451|83056157|FG003|Overall Study|Lost to Follow-up|11|||
46839072|NCT00451451|83056154|FG000|Overall Study|Consent Withdrawn|14|||
46839073|NCT00451451|83056155|FG001|Overall Study|Consent Withdrawn|9|||
46839074|NCT00451451|83056156|FG002|Overall Study|Consent Withdrawn|17|||
46839075|NCT00451451|83056157|FG003|Overall Study|Consent Withdrawn|17|||
46839076|NCT00451451|83056154|FG000|Overall Study|Investigator Decision|6|||
46839077|NCT00451451|83056155|FG001|Overall Study|Investigator Decision|2|||
46839078|NCT00451451|83056156|FG002|Overall Study|Investigator Decision|1|||
46839079|NCT00451451|83056157|FG003|Overall Study|Investigator Decision|2|||
46839080|NCT00451451|83056154|FG000|Overall Study|Subject Non-Compliance|8|||
46839081|NCT00451451|83056155|FG001|Overall Study|Subject Non-Compliance|4|||
46839082|NCT00451451|83056156|FG002|Overall Study|Subject Non-Compliance|3|||
46839083|NCT00451451|83056157|FG003|Overall Study|Subject Non-Compliance|3|||
46839084|NCT00451451|83056154|FG000|Overall Study|Death|1|||
46944519|NCT02731131|83181650|FG001|Overall Study|Psychiatric Disorder|1|||
46944520|NCT02731131|83181649|FG000|Overall Study|Refused Therapy|0|||
46944521|NCT02731131|83181650|FG001|Overall Study|Refused Therapy|1|||
46944522|NCT02746705|83181658|FG000|Overall Study|Physician Decision|1|||
46944523|NCT02746705|83181659|FG001|Overall Study|Physician Decision|1|||
46944524|NCT02746705|83181658|FG000|Overall Study|Lost to Follow-up|1|||
46944525|NCT02746705|83181659|FG001|Overall Study|Lost to Follow-up|0|||
46944526|NCT02746705|83181658|FG000|Overall Study|outlier scores deemed not valid|0|||
46944527|NCT02746705|83181659|FG001|Overall Study|outlier scores deemed not valid|1|||
46944528|NCT02746627|83181668|FG000|Overall Study|Withdrawal by Subject|1|||
46944529|NCT02746627|83181669|FG001|Overall Study|Withdrawal by Subject|1|||
46944530|NCT02746627|83181670|FG002|Overall Study|Withdrawal by Subject|1|||
46944531|NCT02856113|83181680|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
46944532|NCT02856113|83181681|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
46944533|NCT02856113|83181680|FG000|Overall Study|Significant Protocol Deviation|1|||
46944534|NCT02856113|83181681|FG001|Overall Study|Significant Protocol Deviation|0|||
46944535|NCT02856113|83181680|FG000|Overall Study|Lost to Follow-up|3|||
46944536|NCT02856113|83181681|FG001|Overall Study|Lost to Follow-up|5|||
46944537|NCT02856113|83181680|FG000|Overall Study|Voluntary Withdrawal|3|||
46944538|NCT02856113|83181681|FG001|Overall Study|Voluntary Withdrawal|5|||
46944539|NCT02856113|83181680|FG000|Overall Study|Pregnancy|0|||
46944540|NCT02856113|83181681|FG001|Overall Study|Pregnancy|1|||
46944541|NCT02856113|83181680|FG000|Overall Study|Principal Investigator Discretion|2|||
46944542|NCT02856113|83181681|FG001|Overall Study|Principal Investigator Discretion|1|||
46944543|NCT02856113|83181680|FG000|Overall Study|Randomized but not Treated|1|||
46944544|NCT02856113|83181681|FG001|Overall Study|Randomized but not Treated|0|||
46944545|NCT02856113|83181680|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
46944546|NCT02856113|83181681|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
46944547|NCT02855411|83181688|FG000|Overall Study|Study terminated by sponsor|21|||
46944548|NCT02855411|83181688|FG000|Overall Study|Does not meet entrance criteria|14|||
46944549|NCT02745145|83181695|FG000|Overall Study|Adverse Event|1|||
46944550|NCT02745145|83181696|FG001|Overall Study|Adverse Event|0|||
46944551|NCT02745145|83181697|FG002|Overall Study|Adverse Event|0|||
46944552|NCT02745145|83181695|FG000|Overall Study|Death|0|||
46768912|NCT00761280|82987257|FG000|First Dose to End of Study|Death|1|||
46768913|NCT00761280|82987258|FG001|First Dose to End of Study|Death|0|||
46768914|NCT00761280|82987257|FG000|First Dose to End of Study|Lost to Follow-up|0|||
46768915|NCT00761280|82987258|FG001|First Dose to End of Study|Lost to Follow-up|1|||
46839085|NCT00451451|83056155|FG001|Overall Study|Death|0|||
46839086|NCT00451451|83056156|FG002|Overall Study|Death|0|||
46839087|NCT00451451|83056157|FG003|Overall Study|Death|1|||
46839088|NCT00451451|83056154|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
46839089|NCT00451451|83056155|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
46839090|NCT00451451|83056156|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
46839091|NCT00451451|83056157|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
46839092|NCT03824912|83056172|FG000|Overall Study|Lost to Follow-up|18|||
46839093|NCT03824912|83056173|FG001|Overall Study|Lost to Follow-up|15|||
46839094|NCT03824912|83056174|FG002|Overall Study|Lost to Follow-up|8|||
46839095|NCT03824912|83056172|FG000|Overall Study|Negative Baseline Culture Result|118|||
46839096|NCT03824912|83056173|FG001|Overall Study|Negative Baseline Culture Result|112|||
46839097|NCT03824912|83056174|FG002|Overall Study|Negative Baseline Culture Result|57|||
46839098|NCT03824912|83056172|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46839099|NCT03824912|83056173|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46839100|NCT03824912|83056174|FG002|Overall Study|Non-Compliance with Study Drug|1|||
46839101|NCT03824912|83056172|FG000|Overall Study|Protocol Violation|1|||
46944553|NCT02745145|83181696|FG001|Overall Study|Death|1|||
46944554|NCT02745145|83181697|FG002|Overall Study|Death|0|||
46944555|NCT02745145|83181695|FG000|Overall Study|Progressive disease|0|||
46768916|NCT00824369|82987270|FG000|Overall Study|Nolonger willing to participate in study|1|||
46768917|NCT00824369|82987271|FG001|Overall Study|Nolonger willing to participate in study|0|||
46768918|NCT00824369|82987272|FG002|Overall Study|Nolonger willing to participate in study|1|||
46768919|NCT00824369|82987273|FG003|Overall Study|Nolonger willing to participate in study|2|||
46768920|NCT00824369|82987274|FG004|Overall Study|Nolonger willing to participate in study|0|||
46768921|NCT00824369|82987275|FG005|Overall Study|Nolonger willing to participate in study|1|||
46768922|NCT00824369|82987270|FG000|Overall Study|Lost to Follow-up|0|||
46768923|NCT00824369|82987271|FG001|Overall Study|Lost to Follow-up|0|||
46768924|NCT00824369|82987272|FG002|Overall Study|Lost to Follow-up|0|||
46944556|NCT02745145|83181696|FG001|Overall Study|Progressive disease|0|||
46638521|NCT01441596|82811887|FG001|Overall Study|Withdrawal by Subject|0|||
46944557|NCT02745145|83181697|FG002|Overall Study|Progressive disease|1|||
46638522|NCT01441596|82811888|FG002|Overall Study|Withdrawal by Subject|2|||
46768925|NCT00824369|82987273|FG003|Overall Study|Lost to Follow-up|0|||
46768926|NCT00824369|82987274|FG004|Overall Study|Lost to Follow-up|1|||
46839102|NCT03824912|83056173|FG001|Overall Study|Protocol Violation|4|||
46768927|NCT00824369|82987275|FG005|Overall Study|Lost to Follow-up|0|||
46839103|NCT03824912|83056174|FG002|Overall Study|Protocol Violation|1|||
46839104|NCT03824912|83056172|FG000|Overall Study|Withdrawal by Subject|3|||
46768928|NCT00824291|82987291|FG000|Overall Study|Adverse Event|15|||
46839105|NCT03824912|83056173|FG001|Overall Study|Withdrawal by Subject|2|||
46944558|NCT02745145|83181695|FG000|Overall Study|Withdrew consent|1|||
46944559|NCT02745145|83181696|FG001|Overall Study|Withdrew consent|1|||
46944560|NCT02745145|83181697|FG002|Overall Study|Withdrew consent|1|||
46768929|NCT00824291|82987292|FG001|Overall Study|Adverse Event|6|||
46768930|NCT00824291|82987291|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
46768931|NCT00824291|82987292|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
46768932|NCT00824291|82987291|FG000|Overall Study|Lost to Follow-up|11|||
46839106|NCT03824912|83056174|FG002|Overall Study|Withdrawal by Subject|1|||
46839107|NCT03824912|83056172|FG000|Overall Study|Participation in another study|0|||
46839108|NCT03824912|83056173|FG001|Overall Study|Participation in another study|1|||
46839109|NCT03824912|83056174|FG002|Overall Study|Participation in another study|0|||
46944561|NCT02745145|83181695|FG000|Overall Study|Study Termination|8|||
46944562|NCT02745145|83181696|FG001|Overall Study|Study Termination|3|||
46944563|NCT02745145|83181697|FG002|Overall Study|Study Termination|7|||
46944564|NCT02854631|83181716|FG000|Overall Study|Adverse Event|1|||
46944565|NCT02854631|83181717|FG001|Overall Study|Adverse Event|2|||
46944566|NCT02854631|83181716|FG000|Overall Study|Withdrew Consent|3|||
46944567|NCT02854631|83181717|FG001|Overall Study|Withdrew Consent|2|||
46944568|NCT02854631|83181716|FG000|Overall Study|Investigator's Discretion|2|||
46944569|NCT02854631|83181717|FG001|Overall Study|Investigator's Discretion|0|||
46944570|NCT02854631|83181716|FG000|Overall Study|Death|12|||
46944571|NCT02854631|83181717|FG001|Overall Study|Death|8|||
46944572|NCT02854631|83181716|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
46944573|NCT02854631|83181717|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
46944574|NCT02854631|83181716|FG000|Overall Study|Protocol Violation|0|||
46944575|NCT02854631|83181717|FG001|Overall Study|Protocol Violation|1|||
46944576|NCT02854631|83181716|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
46944577|NCT02854631|83181717|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
46944578|NCT02854631|83181716|FG000|Overall Study|Lost to Follow-up|4|||
46944579|NCT02854631|83181717|FG001|Overall Study|Lost to Follow-up|2|||
46944580|NCT02855359|83181725|FG000|Overall Study|Death|2|||
46944581|NCT02855359|83181726|FG001|Overall Study|Death|2|||
46944582|NCT02855359|83181727|FG002|Overall Study|Death|0|||
46944583|NCT02855359|83181728|FG003|Overall Study|Death|0|||
46944584|NCT02855359|83181725|FG000|Overall Study|Study Termination by Sponsor|9|||
46944585|NCT02855359|83181726|FG001|Overall Study|Study Termination by Sponsor|11|||
46944586|NCT02855359|83181727|FG002|Overall Study|Study Termination by Sponsor|0|||
46944587|NCT02855359|83181728|FG003|Overall Study|Study Termination by Sponsor|0|||
46944588|NCT02853929|83181742|FG000|Overall Study|Lost to Follow-up|3|||
46944589|NCT02853929|83181743|FG001|Overall Study|Lost to Follow-up|0|||
46944590|NCT02853929|83181742|FG000|Overall Study|Withdrawal by Subject|1|||
46944591|NCT02853929|83181743|FG001|Overall Study|Withdrawal by Subject|0|||
46944592|NCT02853929|83181742|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
46944593|NCT02853929|83181743|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
46944594|NCT02730819|83181779|FG000|Overall Study|Lost to Follow-up|9|||
46944595|NCT02038946|83181783|FG000|Overall Study|Death|5|||
46944596|NCT02038946|83181783|FG000|Overall Study|Withdrawal by Subject|3|||
46768933|NCT00824291|82987292|FG001|Overall Study|Lost to Follow-up|9|||
46768934|NCT00824291|82987291|FG000|Overall Study|Non-compliance|1|||
46839110|NCT00461123|83056184|FG000|Overall Study|Adverse Event|1|||
46839111|NCT00461123|83056185|FG001|Overall Study|Adverse Event|0|||
46839112|NCT00461123|83056184|FG000|Overall Study|Lost to Follow-up|1|||
46839113|NCT00461123|83056185|FG001|Overall Study|Lost to Follow-up|1|||
46839114|NCT00461123|83056184|FG000|Overall Study|Protocol Violation|3|||
46839115|NCT00461123|83056185|FG001|Overall Study|Protocol Violation|2|||
46839116|NCT00461123|83056184|FG000|Overall Study|Withdrawal by Subject|1|||
46839117|NCT00461123|83056185|FG001|Overall Study|Withdrawal by Subject|3|||
46839118|NCT00290342|83056193|FG000|Overall Study|Other|0|||
46839119|NCT00290342|83056194|FG001|Overall Study|Other|1|||
46839120|NCT00290342|83056193|FG000|Overall Study|Withdrawal by Subject|6|||
46839121|NCT00290342|83056194|FG001|Overall Study|Withdrawal by Subject|4|||
46944597|NCT02038946|83181783|FG000|Overall Study|Lost to Follow-up|2|||
46839122|NCT00290342|83056193|FG000|Overall Study|Lost to Follow-up|1|||
46839123|NCT00290342|83056194|FG001|Overall Study|Lost to Follow-up|0|||
46839124|NCT00460811|83056205|FG000|Overall Study|Adverse Event|4|||
46839125|NCT00460811|83056206|FG001|Overall Study|Adverse Event|6|||
46839126|NCT00460811|83056207|FG002|Overall Study|Adverse Event|3|||
46839127|NCT00460811|83056208|FG003|Overall Study|Adverse Event|10|||
46944598|NCT02038946|83181783|FG000|Overall Study|Other reasons|2|||
46944599|NCT03143829|83181789|FG000|Overall Study|Withdrawal by Subject|2|||
46944600|NCT03143829|83181790|FG001|Overall Study|Withdrawal by Subject|5|||
46768935|NCT00824291|82987292|FG001|Overall Study|Non-compliance|1|||
46768936|NCT00824291|82987291|FG000|Overall Study|Protocol Violation|4|||
46768937|NCT00824291|82987292|FG001|Overall Study|Protocol Violation|1|||
46839128|NCT00460811|83056209|FG004|Overall Study|Adverse Event|2|||
46839129|NCT00460811|83056205|FG000|Overall Study|Noncompliance|1|||
46839130|NCT00460811|83056206|FG001|Overall Study|Noncompliance|0|||
46944601|NCT03143829|83181789|FG000|Overall Study|Lost to Follow-up|0|||
46944602|NCT03143829|83181790|FG001|Overall Study|Lost to Follow-up|2|||
46638523|NCT01441596|82811886|FG000|Overall Study|Not treated|0|||
46944603|NCT03143829|83181789|FG000|Overall Study|Death|1|||
46839131|NCT00460811|83056207|FG002|Overall Study|Noncompliance|0|||
46839132|NCT00460811|83056208|FG003|Overall Study|Noncompliance|2|||
46839133|NCT00460811|83056209|FG004|Overall Study|Noncompliance|1|||
46839134|NCT00460811|83056205|FG000|Overall Study|Withdrawal by Subject|7|||
46839135|NCT00460811|83056206|FG001|Overall Study|Withdrawal by Subject|7|||
46839136|NCT00460811|83056207|FG002|Overall Study|Withdrawal by Subject|6|||
46839137|NCT00460811|83056208|FG003|Overall Study|Withdrawal by Subject|3|||
46839138|NCT00460811|83056209|FG004|Overall Study|Withdrawal by Subject|11|||
46839139|NCT00460811|83056205|FG000|Overall Study|Physician Decision|1|||
46839140|NCT00460811|83056206|FG001|Overall Study|Physician Decision|0|||
46839141|NCT00460811|83056207|FG002|Overall Study|Physician Decision|0|||
46839142|NCT00460811|83056208|FG003|Overall Study|Physician Decision|0|||
46839143|NCT00460811|83056209|FG004|Overall Study|Physician Decision|0|||
46839144|NCT00460811|83056205|FG000|Overall Study|Lost to Follow-up|3|||
46839145|NCT00460811|83056206|FG001|Overall Study|Lost to Follow-up|2|||
46839146|NCT00460811|83056207|FG002|Overall Study|Lost to Follow-up|5|||
46839147|NCT00460811|83056208|FG003|Overall Study|Lost to Follow-up|3|||
46839148|NCT00460811|83056209|FG004|Overall Study|Lost to Follow-up|6|||
46839149|NCT00290186|83056228|FG000|Overall Study|Adverse Event|1|||
46839150|NCT00290186|83056229|FG001|Overall Study|Adverse Event|1|||
46839151|NCT00290186|83056228|FG000|Overall Study|Lost to Follow-up|3|||
46839152|NCT00290186|83056229|FG001|Overall Study|Lost to Follow-up|2|||
46839153|NCT00290186|83056228|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
46839154|NCT00290186|83056229|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
46839155|NCT00290186|83056228|FG000|Overall Study|Withdrawal by Subject|0|||
46839156|NCT00290186|83056229|FG001|Overall Study|Withdrawal by Subject|1|||
46839157|NCT00460655|83056239|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
46839158|NCT00460655|83056240|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46839159|NCT00460655|83056241|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46839160|NCT00460655|83056242|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46839161|NCT00460655|83056239|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
46839162|NCT00460655|83056240|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46839163|NCT00460655|83056241|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46839164|NCT00460655|83056242|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46839165|NCT00460655|83056239|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
46839166|NCT00460655|83056240|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
46944604|NCT03143829|83181790|FG001|Overall Study|Death|1|||
46944605|NCT03143829|83181789|FG000|Overall Study|changed treatment, no longer eligible|2|||
46944606|NCT03143829|83181790|FG001|Overall Study|changed treatment, no longer eligible|2|||
46944607|NCT05896761|83181798|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
46944608|NCT05896761|83181799|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
46944609|NCT05896761|83181798|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
46944610|NCT05896761|83181799|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
46944611|NCT05048784|83181824|FG000|Period 1|Adverse Event|3|||
46944612|NCT05048784|83181825|FG001|Period 1|Adverse Event|1|||
46944613|NCT05048784|83181826|FG002|Period 1|Adverse Event|0|||
46944614|NCT05048784|83181827|FG003|Period 1|Adverse Event|0|||
46944615|NCT05048784|83181824|FG000|Period 2|Lost to Follow-up|0|||
46944616|NCT05048784|83181825|FG001|Period 2|Lost to Follow-up|1|||
46944617|NCT05048784|83181826|FG002|Period 2|Lost to Follow-up|0|||
46768938|NCT00824291|82987291|FG000|Overall Study|Withdrawal by Subject|14|||
46768939|NCT00824291|82987292|FG001|Overall Study|Withdrawal by Subject|8|||
46768940|NCT00824291|82987291|FG000|Overall Study|Lack of Efficacy|7|||
46768941|NCT00824291|82987292|FG001|Overall Study|Lack of Efficacy|8|||
46768942|NCT00824291|82987291|FG000|Overall Study|Participant on prohibited medication|1|||
46768943|NCT00824291|82987292|FG001|Overall Study|Participant on prohibited medication|0|||
46768944|NCT00804986|82987304|FG000|Overall Study|Adverse Event|0|||
46768945|NCT00804986|82987305|FG001|Overall Study|Adverse Event|1|||
46768946|NCT00804986|82987306|FG002|Overall Study|Adverse Event|2|||
46768947|NCT00804986|82987307|FG003|Overall Study|Adverse Event|1|||
46768948|NCT00804986|82987308|FG004|Overall Study|Adverse Event|3|||
46839167|NCT00460655|83056241|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
46944618|NCT05048784|83181827|FG003|Period 2|Lost to Follow-up|0|||
46944619|NCT04700280|83181856|FG000|Overall Study|Adverse Event|4|||
46839168|NCT00460655|83056242|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
46839169|NCT00460655|83056239|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
46839170|NCT00460655|83056240|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
46944620|NCT04700280|83181857|FG001|Overall Study|Adverse Event|0|||
46944621|NCT04700280|83181856|FG000|Overall Study|Lack of Efficacy|1|||
46944622|NCT04700280|83181857|FG001|Overall Study|Lack of Efficacy|0|||
46768949|NCT00804986|82987309|FG005|Overall Study|Adverse Event|0|||
46768950|NCT00804986|82987304|FG000|Overall Study|Lack of Efficacy|0|||
46768951|NCT00804986|82987305|FG001|Overall Study|Lack of Efficacy|0|||
46839171|NCT00460655|83056241|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
46839172|NCT00460655|83056242|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
46839173|NCT00460655|83056239|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46944623|NCT04700280|83181856|FG000|Overall Study|Study terminated by sponsor|5|||
46944624|NCT04700280|83181857|FG001|Overall Study|Study terminated by sponsor|3|||
46768952|NCT00804986|82987306|FG002|Overall Study|Lack of Efficacy|0|||
46839174|NCT00460655|83056240|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46839175|NCT00460655|83056241|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
46839176|NCT00460655|83056242|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
46839177|NCT00460655|83056239|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
46839178|NCT00460655|83056240|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
46839179|NCT00460655|83056241|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
46839180|NCT00460655|83056242|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
46839181|NCT00460577|83056254|FG000|Overall Study|Protocol Violation|2|||
46839182|NCT00460577|83056255|FG001|Overall Study|Protocol Violation|6|||
46839183|NCT00289016|83056261|FG000|Overall Study|Disease Progression|29|||
46839184|NCT00289016|83056261|FG000|Overall Study|Death|2|||
46839185|NCT00289016|83056261|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
46839186|NCT00289016|83056261|FG000|Overall Study|Withdrawal by Subject|2|||
46839187|NCT00289016|83056261|FG000|Overall Study|Adverse Event|1|||
46839188|NCT00289016|83056261|FG000|Overall Study|Other|1|||
46839189|NCT00288860|83056267|FG000|Overall Study|Did not complete intake|4|||
46839190|NCT00288860|83056268|FG001|Overall Study|Did not complete intake|8|||
46839191|NCT00288860|83056267|FG000|Overall Study|Death|4|||
46839192|NCT00288860|83056268|FG001|Overall Study|Death|3|||
46839193|NCT00288860|83056267|FG000|Overall Study|Withdrawal by Subject|20|||
46839194|NCT00288860|83056268|FG001|Overall Study|Withdrawal by Subject|15|||
46839195|NCT00288860|83056267|FG000|Overall Study|Lost to Follow-up|74|||
46839196|NCT00288860|83056268|FG001|Overall Study|Lost to Follow-up|71|||
46839197|NCT00288704|83056280|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
46839198|NCT00288704|83056281|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
46839199|NCT00288704|83056282|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
46839200|NCT00288704|83056280|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
46944625|NCT04700280|83181856|FG000|Overall Study|Other than specified|1|||
46944626|NCT04700280|83181857|FG001|Overall Study|Other than specified|0|||
46944627|NCT04679675|83181867|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
46967860|NCT05091307|83210483|FG000|Overall Study|Death|0|||
46768953|NCT00804986|82987307|FG003|Overall Study|Lack of Efficacy|1|||
46768954|NCT00804986|82987308|FG004|Overall Study|Lack of Efficacy|0|||
46768955|NCT00804986|82987309|FG005|Overall Study|Lack of Efficacy|3|||
46768956|NCT00804986|82987304|FG000|Overall Study|Lost to Follow-up|0|||
46768957|NCT00804986|82987305|FG001|Overall Study|Lost to Follow-up|0|||
46768958|NCT00804986|82987306|FG002|Overall Study|Lost to Follow-up|0|||
46768959|NCT00804986|82987307|FG003|Overall Study|Lost to Follow-up|1|||
46768960|NCT00804986|82987308|FG004|Overall Study|Lost to Follow-up|1|||
46768961|NCT00804986|82987309|FG005|Overall Study|Lost to Follow-up|3|||
46768962|NCT00804986|82987304|FG000|Overall Study|Protocol Violation|0|||
46768963|NCT00804986|82987305|FG001|Overall Study|Protocol Violation|1|||
46768964|NCT00804986|82987306|FG002|Overall Study|Protocol Violation|0|||
46768965|NCT00804986|82987307|FG003|Overall Study|Protocol Violation|1|||
46768966|NCT00804986|82987308|FG004|Overall Study|Protocol Violation|0|||
46768967|NCT00804986|82987309|FG005|Overall Study|Protocol Violation|0|||
46768968|NCT00804986|82987304|FG000|Overall Study|Withdrawal by Subject|0|||
46768969|NCT00804986|82987305|FG001|Overall Study|Withdrawal by Subject|3|||
46768970|NCT00804986|82987306|FG002|Overall Study|Withdrawal by Subject|0|||
46768971|NCT00804986|82987307|FG003|Overall Study|Withdrawal by Subject|3|||
46768972|NCT00804986|82987308|FG004|Overall Study|Withdrawal by Subject|5|||
46768973|NCT00804986|82987309|FG005|Overall Study|Withdrawal by Subject|3|||
46768974|NCT00804986|82987304|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
46768975|NCT00804986|82987305|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
46768976|NCT00804986|82987306|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
46768977|NCT00804986|82987307|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
46768978|NCT00804986|82987308|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
46768979|NCT00804986|82987309|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
46768980|NCT00804986|82987304|FG000|Overall Study|Sponsor Decision|0|||
46768981|NCT00804986|82987305|FG001|Overall Study|Sponsor Decision|1|||
46768982|NCT00804986|82987306|FG002|Overall Study|Sponsor Decision|0|||
46768983|NCT00804986|82987307|FG003|Overall Study|Sponsor Decision|0|||
46768984|NCT00804986|82987308|FG004|Overall Study|Sponsor Decision|0|||
46768985|NCT00804986|82987309|FG005|Overall Study|Sponsor Decision|0|||
46768986|NCT00804986|82987304|FG000|Overall Study|Physician Decision|1|||
46768987|NCT00804986|82987305|FG001|Overall Study|Physician Decision|0|||
46768988|NCT00804986|82987306|FG002|Overall Study|Physician Decision|0|||
46768989|NCT00804986|82987307|FG003|Overall Study|Physician Decision|0|||
46768990|NCT00804986|82987308|FG004|Overall Study|Physician Decision|0|||
46768991|NCT00804986|82987309|FG005|Overall Study|Physician Decision|0|||
46768992|NCT00752232|82987330|FG000|Overall Study|Protocol Violation|0|||
46839201|NCT00288704|83056281|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
46839202|NCT00288704|83056282|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
46839203|NCT00288704|83056280|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
46839204|NCT00288704|83056281|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
46839205|NCT00288704|83056282|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
46839206|NCT00288704|83056280|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
46839207|NCT00288704|83056281|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
46839208|NCT00288704|83056282|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
46839209|NCT00288704|83056280|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
46839210|NCT00288704|83056281|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
46839211|NCT00288704|83056282|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
46839212|NCT00288704|83056280|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
46839213|NCT00288704|83056281|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
46839214|NCT00288704|83056282|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
46839215|NCT00288704|83056280|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
46839216|NCT00288704|83056281|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
46839217|NCT00288704|83056282|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
46839218|NCT00288626|83056289|FG000|Overall Study|Death|3|||
46839219|NCT00288626|83056289|FG000|Overall Study|Withdrawal by Subject|4|||
46839220|NCT00087490|83056297|FG000|Overall Study|Death|6|||
46839221|NCT00087490|83056298|FG001|Overall Study|Death|4|||
46839222|NCT00087490|83056297|FG000|Overall Study|Adverse Event|3|||
46839223|NCT00087490|83056298|FG001|Overall Study|Adverse Event|8|||
46839224|NCT00087490|83056297|FG000|Overall Study|Lack of Efficacy|0|||
46944628|NCT04679675|83181868|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
46944629|NCT04679675|83181869|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
46944630|NCT04679675|83181870|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
46944631|NCT04679675|83181867|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
46944632|NCT04679675|83181868|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
46839225|NCT00087490|83056298|FG001|Overall Study|Lack of Efficacy|2|||
46839226|NCT00087490|83056297|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
46839227|NCT00087490|83056298|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
46839228|NCT00087490|83056297|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
46944633|NCT04679675|83181869|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
46944634|NCT04679675|83181870|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
46944635|NCT04626128|83181884|FG000|Overall Study|Withdrawal by Subject|0|||
46944636|NCT04626128|83181885|FG001|Overall Study|Withdrawal by Subject|1|||
46944637|NCT04626128|83181886|FG002|Overall Study|Withdrawal by Subject|0|||
46944638|NCT04626128|83181887|FG003|Overall Study|Withdrawal by Subject|0|||
46944639|NCT04523571|83181903|FG000|Received 2 Doses|Withdrawal by Subject|0|||
46944640|NCT04523571|83181904|FG001|Received 2 Doses|Withdrawal by Subject|0|||
46944641|NCT04523571|83181905|FG002|Received 2 Doses|Withdrawal by Subject|0|||
46944642|NCT04523571|83181906|FG003|Received 2 Doses|Withdrawal by Subject|1|||
46944643|NCT04523571|83181907|FG004|Received 2 Doses|Withdrawal by Subject|1|||
46944644|NCT04523571|83181908|FG005|Received 2 Doses|Withdrawal by Subject|0|||
46944645|NCT04523571|83181903|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
46944646|NCT04523571|83181904|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
46944647|NCT04523571|83181905|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
46944648|NCT04523571|83181906|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
46944649|NCT04523571|83181907|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
46944650|NCT04523571|83181908|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
46944651|NCT04523571|83181903|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
46944652|NCT04523571|83181904|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
47062870|NCT01522651|83343748|FG004|Overall Study|Investigator's Discretion|0|||
47062871|NCT01522651|83343744|FG000|Overall Study|Protocol Violation|3|||
47062872|NCT01522651|83343745|FG001|Overall Study|Protocol Violation|0|||
47062873|NCT01522651|83343746|FG002|Overall Study|Protocol Violation|0|||
46768993|NCT00752232|82987331|FG001|Overall Study|Protocol Violation|0|||
46768994|NCT00752232|82987332|FG002|Overall Study|Protocol Violation|0|||
46768995|NCT00752232|82987333|FG003|Overall Study|Protocol Violation|0|||
46768996|NCT00752232|82987334|FG004|Overall Study|Protocol Violation|0|||
46768997|NCT00752232|82987335|FG005|Overall Study|Protocol Violation|1|||
46768998|NCT00752232|82987336|FG006|Overall Study|Protocol Violation|0|||
46768999|NCT00752232|82987330|FG000|Overall Study|Caregiver request|2|||
46769000|NCT00752232|82987331|FG001|Overall Study|Caregiver request|0|||
46769001|NCT00752232|82987332|FG002|Overall Study|Caregiver request|0|||
46769002|NCT00752232|82987333|FG003|Overall Study|Caregiver request|0|||
46769003|NCT00752232|82987334|FG004|Overall Study|Caregiver request|1|||
46769004|NCT00752232|82987335|FG005|Overall Study|Caregiver request|0|||
46839229|NCT00087490|83056298|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
46839230|NCT00087490|83056297|FG000|Overall Study|Randomized but not treated|7|||
46944653|NCT04523571|83181905|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
46944654|NCT04523571|83181906|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
46944655|NCT04523571|83181907|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
46944656|NCT04523571|83181908|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
46944657|NCT04523571|83181903|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
46944658|NCT04523571|83181904|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
46944659|NCT04523571|83181905|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
46944660|NCT04523571|83181906|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
46944661|NCT04523571|83181907|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
46944662|NCT04523571|83181908|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
46944663|NCT04361617|83181924|FG000|Overall Study|Withdrawal by Subject|0|||
46944664|NCT04361617|83181925|FG001|Overall Study|Withdrawal by Subject|1|||
46944665|NCT04021914|83181931|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
46944666|NCT03850444|83181957|FG000|Overall Study|Adverse Event|16|||
46944667|NCT03850444|83181958|FG001|Overall Study|Adverse Event|10|||
46944668|NCT03850444|83181957|FG000|Overall Study|Death|87|||
46944669|NCT03850444|83181958|FG001|Overall Study|Death|107|||
46944670|NCT03850444|83181957|FG000|Overall Study|Lost to Follow-up|1|||
46944671|NCT03850444|83181958|FG001|Overall Study|Lost to Follow-up|1|||
46944672|NCT03850444|83181957|FG000|Overall Study|Withdrawal by Subject|1|||
46944673|NCT03850444|83181958|FG001|Overall Study|Withdrawal by Subject|5|||
46944674|NCT03850444|83181957|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
46944675|NCT03850444|83181958|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
46944676|NCT03781804|83181968|FG000|Overall Study|Adverse Event|2|||
46944677|NCT03781804|83181969|FG001|Overall Study|Adverse Event|2|||
46944678|NCT03781804|83181970|FG002|Overall Study|Adverse Event|3|||
46944679|NCT03781804|83181968|FG000|Overall Study|Lost to Follow-up|1|||
46944680|NCT03781804|83181969|FG001|Overall Study|Lost to Follow-up|1|||
46944681|NCT03781804|83181970|FG002|Overall Study|Lost to Follow-up|2|||
46944682|NCT03781804|83181968|FG000|Overall Study|Lack of Efficacy|4|||
46944683|NCT03781804|83181969|FG001|Overall Study|Lack of Efficacy|2|||
46839231|NCT00087490|83056298|FG001|Overall Study|Randomized but not treated|18|||
47062874|NCT01522651|83343747|FG003|Overall Study|Protocol Violation|0|||
46638524|NCT01441596|82811887|FG001|Overall Study|Not treated|1|||
46638525|NCT01441596|82811888|FG002|Overall Study|Not treated|1|||
46638526|NCT01441440|82811899|FG000|Overall Study|Death|1|||
46638527|NCT01441440|82811900|FG001|Overall Study|Death|0|||
46638528|NCT01441440|82811901|FG002|Overall Study|Death|1|||
46638529|NCT01441440|82811899|FG000|Overall Study|Adverse Event|2|||
46638530|NCT01441440|82811900|FG001|Overall Study|Adverse Event|9|||
46638531|NCT01441440|82811901|FG002|Overall Study|Adverse Event|9|||
46638532|NCT01441440|82811899|FG000|Overall Study|Lost to Follow-up|0|||
46638533|NCT01441440|82811900|FG001|Overall Study|Lost to Follow-up|2|||
46638534|NCT01441440|82811901|FG002|Overall Study|Lost to Follow-up|1|||
46638535|NCT01441440|82811899|FG000|Overall Study|Withdrawal by Subject|11|||
46638536|NCT01441440|82811900|FG001|Overall Study|Withdrawal by Subject|9|||
46638537|NCT01441440|82811901|FG002|Overall Study|Withdrawal by Subject|9|||
46638538|NCT01441440|82811899|FG000|Overall Study|Pregnancy|1|||
46769005|NCT00752232|82987336|FG006|Overall Study|Caregiver request|0|||
46769006|NCT00752232|82987330|FG000|Overall Study|Investigator request|0|||
46769007|NCT00752232|82987331|FG001|Overall Study|Investigator request|0|||
46769008|NCT00752232|82987332|FG002|Overall Study|Investigator request|0|||
46769009|NCT00752232|82987333|FG003|Overall Study|Investigator request|0|||
46769010|NCT00752232|82987334|FG004|Overall Study|Investigator request|1|||
46638539|NCT01441440|82811900|FG001|Overall Study|Pregnancy|0|||
46769011|NCT00752232|82987335|FG005|Overall Study|Investigator request|0|||
46769012|NCT00752232|82987336|FG006|Overall Study|Investigator request|0|||
46769013|NCT00752232|82987330|FG000|Overall Study|Subject request|0|||
46769014|NCT00752232|82987331|FG001|Overall Study|Subject request|0|||
46769015|NCT00752232|82987332|FG002|Overall Study|Subject request|1|||
46769016|NCT00752232|82987333|FG003|Overall Study|Subject request|0|||
46769017|NCT00752232|82987334|FG004|Overall Study|Subject request|0|||
46839232|NCT00087178|83056306|FG000|Overall Study|No follow up data|5|||
46944684|NCT03781804|83181970|FG002|Overall Study|Lack of Efficacy|9|||
46944685|NCT03781804|83181968|FG000|Overall Study|Protocol Violation|0|||
46944686|NCT03781804|83181969|FG001|Overall Study|Protocol Violation|0|||
46944687|NCT03781804|83181970|FG002|Overall Study|Protocol Violation|1|||
46944688|NCT03781804|83181968|FG000|Overall Study|Withdrawal by Subject|0|||
46944689|NCT03781804|83181969|FG001|Overall Study|Withdrawal by Subject|1|||
46638540|NCT01441440|82811901|FG002|Overall Study|Pregnancy|0|||
46638541|NCT01441440|82811899|FG000|Overall Study|Lack of Efficacy|1|||
46638542|NCT01441440|82811900|FG001|Overall Study|Lack of Efficacy|0|||
46769018|NCT00752232|82987335|FG005|Overall Study|Subject request|0|||
46769019|NCT00752232|82987336|FG006|Overall Study|Subject request|0|||
46638543|NCT01441440|82811901|FG002|Overall Study|Lack of Efficacy|1|||
46638544|NCT01441440|82811899|FG000|Overall Study|Moving|0|||
46638545|NCT01441440|82811900|FG001|Overall Study|Moving|1|||
46638546|NCT01441440|82811901|FG002|Overall Study|Moving|1|||
46638547|NCT01441440|82811899|FG000|Overall Study|Work-related matter|0|||
46638548|NCT01441440|82811900|FG001|Overall Study|Work-related matter|1|||
46638549|NCT01441440|82811901|FG002|Overall Study|Work-related matter|0|||
46638550|NCT01441440|82811899|FG000|Overall Study|Difficllty in keeping the schedule|1|||
46638551|NCT01441440|82811900|FG001|Overall Study|Difficllty in keeping the schedule|1|||
46638552|NCT01441440|82811901|FG002|Overall Study|Difficllty in keeping the schedule|0|||
46638553|NCT01438476|82811911|FG000|Overall Study|Protocol Violation|1|||
46638554|NCT01438476|82811912|FG001|Overall Study|Protocol Violation|0|||
46769020|NCT00752232|82987330|FG000|Overall Study|Group home admission|0|||
46769021|NCT00752232|82987331|FG001|Overall Study|Group home admission|0|||
46769022|NCT00752232|82987332|FG002|Overall Study|Group home admission|0|||
46944690|NCT03781804|83181970|FG002|Overall Study|Withdrawal by Subject|1|||
46944691|NCT03781804|83181968|FG000|Overall Study|Reason not provided|2|||
46944692|NCT03781804|83181969|FG001|Overall Study|Reason not provided|2|||
46944693|NCT03781804|83181970|FG002|Overall Study|Reason not provided|0|||
47062875|NCT01522651|83343748|FG004|Overall Study|Protocol Violation|0|||
47062876|NCT01522651|83343744|FG000|Overall Study|Reason Not Specified|0|||
47062877|NCT01522651|83343745|FG001|Overall Study|Reason Not Specified|0|||
47062878|NCT01522651|83343746|FG002|Overall Study|Reason Not Specified|0|||
47062879|NCT01522651|83343747|FG003|Overall Study|Reason Not Specified|1|||
47062880|NCT01522651|83343748|FG004|Overall Study|Reason Not Specified|0|||
47062881|NCT01522651|83343744|FG000|Overall Study|Participant Non-Compliance|1|||
47062882|NCT01522651|83343745|FG001|Overall Study|Participant Non-Compliance|0|||
47062883|NCT01522651|83343746|FG002|Overall Study|Participant Non-Compliance|0|||
47062884|NCT01522651|83343747|FG003|Overall Study|Participant Non-Compliance|0|||
47062885|NCT01522651|83343748|FG004|Overall Study|Participant Non-Compliance|0|||
47062886|NCT01522651|83343744|FG000|Overall Study|Withdrew Consent|1|||
47062887|NCT01522651|83343745|FG001|Overall Study|Withdrew Consent|1|||
47062888|NCT01522651|83343746|FG002|Overall Study|Withdrew Consent|0|||
47062889|NCT01522651|83343747|FG003|Overall Study|Withdrew Consent|1|||
47062890|NCT01522651|83343748|FG004|Overall Study|Withdrew Consent|1|||
47062891|NCT01522651|83343744|FG000|Overall Study|Randomized but Never Treated|0|||
47062892|NCT01522651|83343745|FG001|Overall Study|Randomized but Never Treated|1|||
47062893|NCT01522651|83343746|FG002|Overall Study|Randomized but Never Treated|0|||
47062894|NCT01522651|83343747|FG003|Overall Study|Randomized but Never Treated|1|||
47062895|NCT01522651|83343748|FG004|Overall Study|Randomized but Never Treated|1|||
47062896|NCT01554241|83343775|FG000|Overall Study|Death|3|||
47062897|NCT01554241|83343776|FG001|Overall Study|Death|1|||
47062898|NCT01554241|83343777|FG002|Overall Study|Death|1|||
47062899|NCT01554241|83343778|FG003|Overall Study|Death|0|||
47062900|NCT01554241|83343775|FG000|Overall Study|protocol specified renal stone|0|||
47062901|NCT01554241|83343776|FG001|Overall Study|protocol specified renal stone|0|||
47062902|NCT01554241|83343777|FG002|Overall Study|protocol specified renal stone|0|||
47062903|NCT01554241|83343778|FG003|Overall Study|protocol specified renal stone|1|||
47062904|NCT01554241|83343775|FG000|Overall Study|protocol specified change in eGFR|0|||
47062905|NCT01554241|83343776|FG001|Overall Study|protocol specified change in eGFR|0|||
47062906|NCT01554241|83343777|FG002|Overall Study|protocol specified change in eGFR|1|||
47062907|NCT01554241|83343778|FG003|Overall Study|protocol specified change in eGFR|0|||
46769023|NCT00752232|82987333|FG003|Overall Study|Group home admission|1|||
46769024|NCT00752232|82987334|FG004|Overall Study|Group home admission|0|||
46769025|NCT00752232|82987335|FG005|Overall Study|Group home admission|0|||
46769026|NCT00752232|82987336|FG006|Overall Study|Group home admission|0|||
46769027|NCT00752232|82987330|FG000|Overall Study|Caregiver could not attend the subject|0|||
46769028|NCT00752232|82987331|FG001|Overall Study|Caregiver could not attend the subject|0|||
46769029|NCT00752232|82987332|FG002|Overall Study|Caregiver could not attend the subject|0|||
46769030|NCT00752232|82987333|FG003|Overall Study|Caregiver could not attend the subject|0|||
46769031|NCT00752232|82987334|FG004|Overall Study|Caregiver could not attend the subject|1|||
46769032|NCT00752232|82987335|FG005|Overall Study|Caregiver could not attend the subject|0|||
46769033|NCT00752232|82987336|FG006|Overall Study|Caregiver could not attend the subject|0|||
46769034|NCT00760266|82987355|FG000|Overall Study|Adverse Event|13|||
46944694|NCT03507686|83181982|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
47062908|NCT01554241|83343775|FG000|Overall Study|Withdrawal by Subject|0|||
47062909|NCT01554241|83343776|FG001|Overall Study|Withdrawal by Subject|0|||
47062910|NCT01554241|83343777|FG002|Overall Study|Withdrawal by Subject|2|||
47062911|NCT01554241|83343778|FG003|Overall Study|Withdrawal by Subject|0|||
47062912|NCT01521559|83343790|FG000|Overall Study|Adverse Event|0|||
47062913|NCT01521559|83343791|FG001|Overall Study|Adverse Event|4|||
47062914|NCT01521559|83343790|FG000|Overall Study|Death|1|||
46638555|NCT01438476|82811911|FG000|Overall Study|Withdrawal by Subject|1|||
46638556|NCT01438476|82811912|FG001|Overall Study|Withdrawal by Subject|0|||
46769035|NCT00760266|82987356|FG001|Overall Study|Adverse Event|7|||
47062915|NCT01521559|83343791|FG001|Overall Study|Death|0|||
47062916|NCT01521559|83343790|FG000|Overall Study|Withdrawal by Subject|9|||
47062917|NCT01521559|83343791|FG001|Overall Study|Withdrawal by Subject|11|||
47062918|NCT01521559|83343790|FG000|Overall Study|Lost to Follow-up|3|||
47062919|NCT01521559|83343791|FG001|Overall Study|Lost to Follow-up|1|||
47062920|NCT01521559|83343790|FG000|Overall Study|Protocol Violation|1|||
47062921|NCT01521559|83343791|FG001|Overall Study|Protocol Violation|0|||
47062922|NCT01521559|83343790|FG000|Overall Study|Other|1|||
47062923|NCT01521559|83343791|FG001|Overall Study|Other|2|||
47062924|NCT01554163|83343800|FG000|Overall Study|Adverse Event|3|||
47062925|NCT01554163|83343801|FG001|Overall Study|Adverse Event|0|||
47062926|NCT01554163|83343800|FG000|Overall Study|Lack of Efficacy|1|||
47062927|NCT01554163|83343801|FG001|Overall Study|Lack of Efficacy|0|||
47062928|NCT01554163|83343800|FG000|Overall Study|Lost to Follow-up|1|||
47062929|NCT01554163|83343801|FG001|Overall Study|Lost to Follow-up|0|||
47062930|NCT01554163|83343800|FG000|Overall Study|Non-Compliance With Study Drug|1|||
47062931|NCT01554163|83343801|FG001|Overall Study|Non-Compliance With Study Drug|1|||
47062932|NCT01554163|83343800|FG000|Overall Study|Protocol Violation|0|||
47062933|NCT01554163|83343801|FG001|Overall Study|Protocol Violation|4|||
47062934|NCT01554163|83343800|FG000|Overall Study|Withdrawal by Subject|1|||
47062935|NCT01554163|83343801|FG001|Overall Study|Withdrawal by Subject|5|||
47062936|NCT01554163|83343800|FG000|Overall Study|Not Treated|1|||
47062937|NCT01554163|83343801|FG001|Overall Study|Not Treated|0|||
47062938|NCT01553851|83343807|FG000|Overall Study|Adverse Event|2|||
47062939|NCT01553851|83343807|FG000|Overall Study|constipation|1|||
47062940|NCT03842163|83343824|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
46944695|NCT03507686|83181983|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
46944696|NCT03507686|83181982|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
46944697|NCT03507686|83181983|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
47062941|NCT03842163|83343824|FG000|Overall Study|Scintigraphy was not performed|44|||
47062942|NCT01552915|83343831|FG000|Overall Study|Adverse Event|3|||
47062943|NCT01552915|83343832|FG001|Overall Study|Adverse Event|14|||
47062944|NCT01552915|83343833|FG002|Overall Study|Adverse Event|3|||
47062945|NCT01552915|83343831|FG000|Overall Study|Lost to Follow-up|4|||
47062946|NCT01552915|83343832|FG001|Overall Study|Lost to Follow-up|6|||
47062947|NCT01552915|83343833|FG002|Overall Study|Lost to Follow-up|5|||
47062948|NCT01552915|83343831|FG000|Overall Study|Withdrawal by Subject|6|||
46638557|NCT01438476|82811911|FG000|Overall Study|No Surgery- Disease|8|||
46638558|NCT01438476|82811912|FG001|Overall Study|No Surgery- Disease|10|||
46839233|NCT00087178|83056307|FG001|Overall Study|No follow up data|15|||
46839234|NCT00087178|83056306|FG000|Overall Study|No clinical assessment|1|||
46839235|NCT00087178|83056307|FG001|Overall Study|No clinical assessment|2|||
46839236|NCT00087178|83056306|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
47062949|NCT01552915|83343832|FG001|Overall Study|Withdrawal by Subject|4|||
47062950|NCT01552915|83343833|FG002|Overall Study|Withdrawal by Subject|5|||
47062951|NCT01552915|83343831|FG000|Overall Study|Protocol Violation|0|||
47062952|NCT01552915|83343832|FG001|Overall Study|Protocol Violation|4|||
47062953|NCT01552915|83343833|FG002|Overall Study|Protocol Violation|4|||
47062954|NCT01552915|83343831|FG000|Overall Study|Lack of Efficacy|8|||
47062955|NCT01552915|83343832|FG001|Overall Study|Lack of Efficacy|1|||
47062956|NCT01552915|83343833|FG002|Overall Study|Lack of Efficacy|4|||
47062957|NCT01552915|83343831|FG000|Overall Study|Other|2|||
47062958|NCT01552915|83343832|FG001|Overall Study|Other|0|||
47062959|NCT01552915|83343833|FG002|Overall Study|Other|6|||
47062960|NCT01552681|83343862|FG000|Overall Study|Withdrawal by Subject|4|||
47062961|NCT01552681|83343863|FG001|Overall Study|Withdrawal by Subject|0|||
47062962|NCT01552681|83343862|FG000|Overall Study|Physician Decision|1|||
47062963|NCT01552681|83343863|FG001|Overall Study|Physician Decision|0|||
47062964|NCT01552681|83343862|FG000|Overall Study|Subject moved away|0|||
47062965|NCT01552681|83343863|FG001|Overall Study|Subject moved away|1|||
46638559|NCT01438476|82811911|FG000|Overall Study|Communication barrier|0|||
46638560|NCT01438476|82811912|FG001|Overall Study|Communication barrier|1|||
46638561|NCT01467570|82811920|FG000|Overall Study|Lost to Follow-up|8|||
46839237|NCT00087178|83056307|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
47062966|NCT01570387|83343895|FG000|Overall Study|Adverse Event|1|||
47062967|NCT01570387|83343896|FG001|Overall Study|Adverse Event|0|||
47062968|NCT01570387|83343897|FG002|Overall Study|Adverse Event|0|||
47062969|NCT01570387|83343898|FG003|Overall Study|Adverse Event|0|||
47062970|NCT01570387|83343895|FG000|Overall Study|Death|0|||
47062971|NCT01570387|83343896|FG001|Overall Study|Death|0|||
47062972|NCT01570387|83343897|FG002|Overall Study|Death|0|||
47062973|NCT01570387|83343898|FG003|Overall Study|Death|1|||
47062974|NCT01570387|83343895|FG000|Overall Study|Withdrawal by Subject|0|||
47062975|NCT01570387|83343896|FG001|Overall Study|Withdrawal by Subject|0|||
47062976|NCT01570387|83343897|FG002|Overall Study|Withdrawal by Subject|0|||
46638562|NCT01467570|82811921|FG001|Overall Study|Lost to Follow-up|9|||
46839238|NCT00288080|83056315|FG000|Overall Study|Withdrawal by Subject|1|||
47062977|NCT01570387|83343898|FG003|Overall Study|Withdrawal by Subject|1|||
47062978|NCT01570309|83343907|FG000|Overall Study|Withdrawal by Subject|3|||
47062979|NCT01570309|83343908|FG001|Overall Study|Withdrawal by Subject|3|||
47062980|NCT01519921|83343920|FG000|Overall Study|Adverse Event|10|||
47062981|NCT01519921|83343921|FG001|Overall Study|Adverse Event|9|||
47062982|NCT01519921|83343920|FG000|Overall Study|Lack of Efficacy|4|||
47062983|NCT01519921|83343921|FG001|Overall Study|Lack of Efficacy|3|||
47062984|NCT01519921|83343920|FG000|Overall Study|Withdrawal by Subject|3|||
47062985|NCT01519921|83343921|FG001|Overall Study|Withdrawal by Subject|0|||
47062986|NCT01519921|83343920|FG000|Overall Study|Lost to Follow-up|2|||
47062987|NCT01519921|83343921|FG001|Overall Study|Lost to Follow-up|1|||
47062988|NCT01519921|83343920|FG000|Overall Study|Treatment refusal|2|||
47062989|NCT01519921|83343921|FG001|Overall Study|Treatment refusal|1|||
46839239|NCT00288080|83056316|FG001|Overall Study|Withdrawal by Subject|3|||
46839240|NCT00288080|83056315|FG000|Overall Study|Protocol Violation|25|||
46944698|NCT03507686|83181982|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
47062990|NCT01519921|83343920|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
47062991|NCT01519921|83343921|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
47062992|NCT01519765|83343929|FG000|Overall Study|Adverse Event|0|||
47062993|NCT01519765|83343930|FG001|Overall Study|Adverse Event|1|||
47062994|NCT01519765|83343929|FG000|Overall Study|Lack of Efficacy|2|||
47062995|NCT01519765|83343930|FG001|Overall Study|Lack of Efficacy|0|||
46944699|NCT03507686|83181983|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
46944700|NCT03507686|83181982|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
46944701|NCT03507686|83181983|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
46944702|NCT03507686|83181982|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
46944703|NCT03507686|83181983|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
46944704|NCT03507686|83181982|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
46944705|NCT03507686|83181983|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
46944706|NCT03471507|83181991|FG000|Overall Study|Lost to Follow-up|1|||
46944707|NCT03471507|83181992|FG001|Overall Study|Lost to Follow-up|3|||
46944708|NCT03471507|83181991|FG000|Overall Study|Physician Decision|0|||
46944709|NCT03471507|83181992|FG001|Overall Study|Physician Decision|1|||
46944710|NCT03471507|83181991|FG000|Overall Study|Withdrawal by Subject|2|||
46944711|NCT03471507|83181992|FG001|Overall Study|Withdrawal by Subject|1|||
46944712|NCT03338894|83181998|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
46944713|NCT03138564|83182006|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
46944714|NCT03138564|83182007|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
46944715|NCT03138564|83182006|FG000|Overall Study|Lost to Follow-up|16|||
46944716|NCT03138564|83182007|FG001|Overall Study|Lost to Follow-up|2|||
46944717|NCT03138564|83182006|FG000|Overall Study|Withdrawal by Subject|48|||
46944718|NCT03138564|83182007|FG001|Overall Study|Withdrawal by Subject|4|||
46944719|NCT03138564|83182006|FG000|Overall Study|No longer met eligibility criteria|2|||
46944720|NCT03138564|83182007|FG001|Overall Study|No longer met eligibility criteria|0|||
46944721|NCT03138564|83182006|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
46944722|NCT03138564|83182007|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
46944723|NCT03138564|83182006|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
46769036|NCT00760266|82987355|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46769037|NCT00760266|82987356|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46769038|NCT00760266|82987355|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46769039|NCT00760266|82987356|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46769040|NCT00760266|82987355|FG000|Overall Study|Lack of Efficacy|2|||
46769041|NCT00760266|82987356|FG001|Overall Study|Lack of Efficacy|2|||
46769042|NCT00760266|82987355|FG000|Overall Study|Protocol deviation|2|||
46769043|NCT00760266|82987356|FG001|Overall Study|Protocol deviation|4|||
46769044|NCT00760266|82987355|FG000|Overall Study|Patient withdrew consent|3|||
46769045|NCT00760266|82987356|FG001|Overall Study|Patient withdrew consent|3|||
46769046|NCT00760266|82987355|FG000|Overall Study|Lost to Follow-up|2|||
46769047|NCT00760266|82987356|FG001|Overall Study|Lost to Follow-up|1|||
46769048|NCT00760266|82987355|FG000|Overall Study|Administrative Problems|0|||
46769049|NCT00760266|82987356|FG001|Overall Study|Administrative Problems|1|||
46944724|NCT03138564|83182007|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
46944725|NCT03138564|83182006|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
46944726|NCT03138564|83182007|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
47062996|NCT01519765|83343929|FG000|Overall Study|Protocol Violation|1|||
47062997|NCT01519765|83343930|FG001|Overall Study|Protocol Violation|0|||
47062998|NCT01519765|83343929|FG000|Overall Study|Withdrawal by Subject|0|||
47062999|NCT01519765|83343930|FG001|Overall Study|Withdrawal by Subject|1|||
46769050|NCT00753714|82987364|FG000|Overall Study|Lack of Efficacy|21|||
46769051|NCT00753714|82987365|FG001|Overall Study|Lack of Efficacy|34|||
46769052|NCT00753714|82987364|FG000|Overall Study|Adverse Event|26|||
46769053|NCT00753714|82987365|FG001|Overall Study|Adverse Event|18|||
47063000|NCT01552603|83343937|FG000|Overall Study|Physician Decision|1|||
47063001|NCT01552369|83343943|FG000|Overall Study|Did not consent to extended follow up|8|||
47063002|NCT01552369|83343944|FG001|Overall Study|Did not consent to extended follow up|9|||
46944727|NCT03138564|83182006|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
46944728|NCT03138564|83182007|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
46944729|NCT02836717|83182033|FG000|Test Phase|Lack of Efficacy|14|||
46944730|NCT02836717|83182034|FG001|Test Phase|Lack of Efficacy|8|||
46944731|NCT02836717|83182035|FG002|Test Phase|Lack of Efficacy|0|||
46944732|NCT02836717|83182033|FG000|Study Phase|Adverse Event|2|||
46944733|NCT02836717|83182034|FG001|Study Phase|Adverse Event|0|||
46944734|NCT02836717|83182035|FG002|Study Phase|Adverse Event|0|||
46944735|NCT02836717|83182033|FG000|Study Phase|Lack of Efficacy|8|||
46944736|NCT02836717|83182034|FG001|Study Phase|Lack of Efficacy|6|||
46944737|NCT02836717|83182035|FG002|Study Phase|Lack of Efficacy|1|||
47063003|NCT01552057|83343954|FG000|Overall Study|Adverse Event|14|||
47063004|NCT01552057|83343955|FG001|Overall Study|Adverse Event|15|||
46944738|NCT02836717|83182033|FG000|Study Phase|Withdrawal by Subject|1|||
46944739|NCT02836717|83182034|FG001|Study Phase|Withdrawal by Subject|0|||
46944740|NCT02836717|83182035|FG002|Study Phase|Withdrawal by Subject|0|||
46944741|NCT02836717|83182033|FG000|Study Phase|Death|1|||
46944742|NCT02836717|83182034|FG001|Study Phase|Death|0|||
47063005|NCT01552057|83343954|FG000|Overall Study|Lack of Efficacy|8|||
47063006|NCT01552057|83343955|FG001|Overall Study|Lack of Efficacy|23|||
47063007|NCT01552057|83343954|FG000|Overall Study|Withdrawal by Subject|5|||
46769054|NCT00753714|82987364|FG000|Overall Study|Protocol Violation|1|||
46769055|NCT00753714|82987365|FG001|Overall Study|Protocol Violation|0|||
46769056|NCT00753714|82987364|FG000|Overall Study|Lost to Follow-up|0|||
46769057|NCT00753714|82987365|FG001|Overall Study|Lost to Follow-up|1|||
46769058|NCT00753714|82987364|FG000|Overall Study|Withdrawal by Subject|2|||
46769059|NCT00753714|82987365|FG001|Overall Study|Withdrawal by Subject|1|||
46769060|NCT00753714|82987364|FG000|Overall Study|Death|3|||
46769061|NCT00753714|82987365|FG001|Overall Study|Death|3|||
46769062|NCT00753714|82987364|FG000|Overall Study|Other|7|||
46769063|NCT00753714|82987365|FG001|Overall Study|Other|5|||
46769064|NCT00759954|82987376|FG000|Overall Study|Personal reason|1|||
46769065|NCT00759954|82987377|FG001|Overall Study|Personal reason|0|||
47063008|NCT01552057|83343955|FG001|Overall Study|Withdrawal by Subject|8|||
47063009|NCT01552057|83343954|FG000|Overall Study|Entry Criteria Not Met|2|||
47063010|NCT01552057|83343955|FG001|Overall Study|Entry Criteria Not Met|2|||
47063011|NCT01552057|83343954|FG000|Overall Study|Physician Decision|1|||
47063012|NCT01552057|83343955|FG001|Overall Study|Physician Decision|0|||
47063013|NCT01551745|83343961|FG000|Overall Study|Withdrawal by Subject|1|||
47063014|NCT01551745|83343961|FG000|Overall Study|Disease Progression|2|||
47063015|NCT01551355|83343971|FG000|Overall Study|Lost to Follow-up|51|||
47063016|NCT01551355|83343972|FG001|Overall Study|Lost to Follow-up|49|||
46769066|NCT00759954|82987376|FG000|Overall Study|Adverse Event|1|||
46769067|NCT00759954|82987377|FG001|Overall Study|Adverse Event|2|||
46769068|NCT00804908|82987386|FG000|Overall Study|Other|115|||
46769069|NCT00804908|82987387|FG001|Overall Study|Other|116|||
46769070|NCT00804908|82987388|FG002|Overall Study|Other|114|||
46769071|NCT00808808|82987399|FG000|Overall Study|Vaccinated; survey not completed|131|||
46769072|NCT00808808|82987400|FG001|Overall Study|Vaccinated; survey not completed|169|||
46769073|NCT00808808|82987401|FG002|Overall Study|Vaccinated; survey not completed|302|||
46769074|NCT00808808|82987399|FG000|Overall Study|Employee was not vaccinated.|2686|||
46769075|NCT00808808|82987400|FG001|Overall Study|Employee was not vaccinated.|2268|||
46769076|NCT00808808|82987401|FG002|Overall Study|Employee was not vaccinated.|2255|||
46769077|NCT00589784|82987417|FG000|Overall Study|Withdrawal by Subject|0|||
46769078|NCT00589784|82987418|FG001|Overall Study|Withdrawal by Subject|6|||
46769079|NCT00589784|82987417|FG000|Overall Study|Patient inevaluable|1|||
46769080|NCT00589784|82987418|FG001|Overall Study|Patient inevaluable|0|||
46769081|NCT00589784|82987417|FG000|Overall Study|Adverse Event|0|||
46769082|NCT00589784|82987418|FG001|Overall Study|Adverse Event|4|||
46944743|NCT02836717|83182035|FG002|Study Phase|Death|0|||
46944744|NCT02836717|83182033|FG000|Study Phase|abdominal surgeries|2|||
46944745|NCT02836717|83182034|FG001|Study Phase|abdominal surgeries|1|||
47063017|NCT01551355|83343973|FG002|Overall Study|Lost to Follow-up|34|||
47063018|NCT01551355|83343974|FG003|Overall Study|Lost to Follow-up|24|||
47063019|NCT01551355|83343975|FG004|Overall Study|Lost to Follow-up|9|||
46769083|NCT00759876|82987423|FG000|Overall Study|Sponsor terminated study early|36|||
46769084|NCT00823979|82987430|FG000|Overall Study|Lack of Efficacy|13|||
46769085|NCT00823979|82987431|FG001|Overall Study|Lack of Efficacy|16|||
46769086|NCT00823979|82987432|FG002|Overall Study|Lack of Efficacy|9|||
46769087|NCT00823979|82987430|FG000|Overall Study|Lost to Follow-up|2|||
46769088|NCT00823979|82987431|FG001|Overall Study|Lost to Follow-up|1|||
46944746|NCT02836717|83182035|FG002|Study Phase|abdominal surgeries|0|||
46769089|NCT00823979|82987432|FG002|Overall Study|Lost to Follow-up|0|||
46769090|NCT00823979|82987430|FG000|Overall Study|Withdrawal by Subject|2|||
46769091|NCT00823979|82987431|FG001|Overall Study|Withdrawal by Subject|3|||
46944747|NCT02743494|83182046|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
46769092|NCT00823979|82987432|FG002|Overall Study|Withdrawal by Subject|2|||
47063020|NCT01551355|83343976|FG005|Overall Study|Lost to Follow-up|6|||
47063021|NCT01569841|83343984|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
47063022|NCT01569841|83343985|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
47063023|NCT01569763|83343995|FG000|Overall Study|Lack of Efficacy|2|||
47063024|NCT01569763|83343996|FG001|Overall Study|Lack of Efficacy|7|||
47063025|NCT01569763|83343995|FG000|Overall Study|Adverse Event|1|||
47063026|NCT01569763|83343996|FG001|Overall Study|Adverse Event|0|||
47063027|NCT01550965|83344002|FG000|Overall Study|Adverse Event|26|||
47063028|NCT01550965|83344002|FG000|Overall Study|Withdrawal by Subject|10|||
47063029|NCT01550965|83344002|FG000|Overall Study|Lost to Follow-up|2|||
47063030|NCT01550965|83344002|FG000|Overall Study|Lack of Efficacy|59|||
47063031|NCT01550965|83344002|FG000|Overall Study|Other|13|||
47063032|NCT01569295|83344123|FG000|Overall Study|Progressive Disease|75|||
47063033|NCT01569295|83344124|FG001|Overall Study|Progressive Disease|139|||
47063034|NCT01569295|83344123|FG000|Overall Study|Adverse Event|39|||
47063035|NCT01569295|83344124|FG001|Overall Study|Adverse Event|14|||
47063036|NCT01569295|83344123|FG000|Overall Study|Withdrawal by Subject|25|||
47063037|NCT01569295|83344124|FG001|Overall Study|Withdrawal by Subject|12|||
47063038|NCT01569295|83344123|FG000|Overall Study|Death|19|||
47063039|NCT01569295|83344124|FG001|Overall Study|Death|15|||
47063040|NCT01569295|83344123|FG000|Overall Study|Physician Decision|13|||
47063041|NCT01569295|83344124|FG001|Overall Study|Physician Decision|18|||
47063042|NCT01569295|83344123|FG000|Overall Study|Study Terminated by Sponsor|24|||
47063043|NCT01569295|83344124|FG001|Overall Study|Study Terminated by Sponsor|2|||
47063044|NCT01569295|83344123|FG000|Overall Study|Other Reason not Specified|3|||
47063045|NCT01569295|83344124|FG001|Overall Study|Other Reason not Specified|5|||
47063046|NCT01569295|83344123|FG000|Overall Study|Non-Compliance with Study Drug|6|||
47063047|NCT01569295|83344124|FG001|Overall Study|Non-Compliance with Study Drug|1|||
47063048|NCT01569295|83344123|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
47063049|NCT01569295|83344124|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
47063050|NCT01569295|83344123|FG000|Overall Study|Lost to Follow-up|1|||
47063051|NCT01569295|83344124|FG001|Overall Study|Lost to Follow-up|1|||
47063052|NCT01549951|83344181|FG000|Overall Study|Adverse Event|15|||
47063053|NCT01549951|83344181|FG000|Overall Study|Withdrawal by Subject|2|||
47063054|NCT01549951|83344181|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
46638563|NCT01437540|82811931|FG000|Overall Study|Not listed below|7|||
46769093|NCT00823979|82987430|FG000|Overall Study|Protocol Violation|1|||
46769094|NCT00823979|82987431|FG001|Overall Study|Protocol Violation|1|||
46769095|NCT00823979|82987432|FG002|Overall Study|Protocol Violation|0|||
46769096|NCT00823979|82987430|FG000|Overall Study|Pregnancy|0|||
46769097|NCT00823979|82987431|FG001|Overall Study|Pregnancy|1|||
46769098|NCT00823979|82987432|FG002|Overall Study|Pregnancy|0|||
46769099|NCT00823979|82987430|FG000|Overall Study|Adverse Event|0|||
46944748|NCT02743494|83182047|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
46769100|NCT00823979|82987431|FG001|Overall Study|Adverse Event|2|||
46769101|NCT00823979|82987432|FG002|Overall Study|Adverse Event|4|||
46769102|NCT00823979|82987430|FG000|Overall Study|Other|2|||
47063055|NCT01549951|83344181|FG000|Overall Study|Progressive disease|29|||
47063056|NCT01549951|83344181|FG000|Overall Study|Symptomatic deterioration|1|||
47063057|NCT01549951|83344181|FG000|Overall Study|Other|2|||
47063058|NCT01517893|83344187|FG000|Overall Study|Withdrawal by Subject|3|||
47063059|NCT01517893|83344188|FG001|Overall Study|Withdrawal by Subject|0|||
47063060|NCT01489891|83344196|FG000|Overall Study|Endoscopy failure|1|||
47063061|NCT01489891|83344197|FG001|Overall Study|Endoscopy failure|0|||
46769103|NCT00823979|82987431|FG001|Overall Study|Other|0|||
47063062|NCT04062240|83344279|FG000|Overall Study|equipment malfunction|1|||
47063063|NCT02790138|83344285|FG000|Overall Study|Adverse Event|5|||
47063064|NCT02790138|83344286|FG001|Overall Study|Adverse Event|2|||
47063065|NCT02790138|83344285|FG000|Overall Study|Significant Protocol Deviation|0|||
47063066|NCT02790138|83344286|FG001|Overall Study|Significant Protocol Deviation|1|||
47063067|NCT02790138|83344285|FG000|Overall Study|Lost to Follow-up|1|||
47063068|NCT02790138|83344286|FG001|Overall Study|Lost to Follow-up|0|||
47063069|NCT02790138|83344285|FG000|Overall Study|Voluntary Withdrawal|8|||
47063070|NCT02790138|83344286|FG001|Overall Study|Voluntary Withdrawal|9|||
47063071|NCT02790138|83344285|FG000|Overall Study|Lack of Efficacy|6|||
47063072|NCT02790138|83344286|FG001|Overall Study|Lack of Efficacy|7|||
47063073|NCT02790138|83344285|FG000|Overall Study|Reason not Specified|1|||
47063074|NCT02790138|83344286|FG001|Overall Study|Reason not Specified|0|||
47063075|NCT05385224|83344439|FG000|Overall Study|Unable to swallow capsule|2|||
47063076|NCT05385224|83344439|FG000|Overall Study|Withdrawal by Subject|2|||
47063077|NCT05385224|83344439|FG000|Overall Study|Did not meet study criteria|1|||
47063078|NCT04710979|83344445|FG000|Overall Study|Lost to Follow-up|2|||
47063079|NCT04710979|83344446|FG001|Overall Study|Lost to Follow-up|4|||
47063080|NCT04710979|83344445|FG000|Overall Study|Withdrawal by Subject|1|||
47063081|NCT04710979|83344446|FG001|Overall Study|Withdrawal by Subject|0|||
47063082|NCT04682639|83344456|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
47063083|NCT04682639|83344457|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
46638564|NCT01437540|82811932|FG001|Overall Study|Not listed below|6|||
46769104|NCT00823979|82987432|FG002|Overall Study|Other|1|||
46769105|NCT00823979|82987430|FG000|Overall Study|Randomized but not Treated|4|||
46769106|NCT00823979|82987431|FG001|Overall Study|Randomized but not Treated|3|||
46769107|NCT00823979|82987432|FG002|Overall Study|Randomized but not Treated|1|||
46769108|NCT00823979|82987430|FG000|Overall Study|Study Terminated by Sponsor|5|||
46769109|NCT00823979|82987431|FG001|Overall Study|Study Terminated by Sponsor|5|||
46769110|NCT00823979|82987432|FG002|Overall Study|Study Terminated by Sponsor|7|||
46769111|NCT00823901|82987442|FG000|Overall Study|Adverse Event|1|||
46769112|NCT00823901|82987443|FG001|Overall Study|Adverse Event|1|||
46769113|NCT00823901|82987442|FG000|Overall Study|Lack of Efficacy|1|||
46769114|NCT00823901|82987443|FG001|Overall Study|Lack of Efficacy|0|||
46769115|NCT00823901|82987442|FG000|Overall Study|Lost to Follow-up|2|||
46769116|NCT00823901|82987443|FG001|Overall Study|Lost to Follow-up|1|||
46769117|NCT00823823|82987451|FG000|Overall Study|Lost to Follow-up|3|||
46769118|NCT00823823|82987452|FG001|Overall Study|Lost to Follow-up|1|||
46769119|NCT00823823|82987451|FG000|Overall Study|Protocol Violation|5|||
46769120|NCT00823823|82987452|FG001|Overall Study|Protocol Violation|5|||
46769121|NCT00759564|82987472|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
46769122|NCT00759564|82987473|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
46769123|NCT00759564|82987474|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
46769124|NCT00759564|82987475|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
46769125|NCT00759564|82987476|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
46769126|NCT00816023|82987512|FG000|Overall Study|Lost to Follow-up|1|||
46769127|NCT00816023|82987513|FG001|Overall Study|Lost to Follow-up|1|||
46769128|NCT00816023|82987514|FG002|Overall Study|Lost to Follow-up|0|||
46769129|NCT00816023|82987515|FG003|Overall Study|Lost to Follow-up|0|||
47063084|NCT04682639|83344458|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
47063085|NCT04682639|83344459|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
46769130|NCT00816023|82987512|FG000|Overall Study|Withdrawal by Subject|1|||
46769131|NCT00816023|82987513|FG001|Overall Study|Withdrawal by Subject|0|||
46769132|NCT00816023|82987514|FG002|Overall Study|Withdrawal by Subject|0|||
47063086|NCT04682639|83344460|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
47063087|NCT04682639|83344456|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
46769133|NCT00816023|82987515|FG003|Overall Study|Withdrawal by Subject|0|||
46769134|NCT00816023|82987512|FG000|Overall Study|Physician Decision|0|||
46769135|NCT00816023|82987513|FG001|Overall Study|Physician Decision|0|||
47063088|NCT04682639|83344457|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
47063089|NCT04682639|83344458|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
47063090|NCT04682639|83344459|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46769136|NCT00816023|82987514|FG002|Overall Study|Physician Decision|1|||
46769137|NCT00816023|82987515|FG003|Overall Study|Physician Decision|0|||
46769138|NCT00816023|82987512|FG000|Overall Study|assessments complete prior to window|1|||
47063091|NCT04682639|83344460|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46769139|NCT00816023|82987513|FG001|Overall Study|assessments complete prior to window|1|||
46769140|NCT00816023|82987514|FG002|Overall Study|assessments complete prior to window|2|||
46769141|NCT00816023|82987515|FG003|Overall Study|assessments complete prior to window|1|||
47063092|NCT04682639|83344456|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
47063093|NCT04682639|83344457|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
47063094|NCT04682639|83344458|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
47063095|NCT04682639|83344459|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
47063096|NCT04682639|83344460|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
47063097|NCT04682639|83344456|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
47063098|NCT04682639|83344457|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
47063099|NCT04682639|83344458|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
47063100|NCT04682639|83344459|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
47063101|NCT04682639|83344460|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
47063102|NCT04682639|83344456|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
47063103|NCT04682639|83344457|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
47063104|NCT04682639|83344458|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
47063105|NCT04682639|83344459|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
47063106|NCT04682639|83344460|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
47063107|NCT04682639|83344456|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
47063108|NCT04682639|83344457|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
47063109|NCT04682639|83344458|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
47063110|NCT04682639|83344459|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
47063111|NCT04682639|83344460|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
47063112|NCT04682639|83344456|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
47063113|NCT04682639|83344457|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
47063114|NCT04682639|83344458|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
47063115|NCT04682639|83344459|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
47063116|NCT04682639|83344460|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
47063117|NCT04682639|83344456|FG000|OLE Period (28 Weeks)|Other|1|||
47063118|NCT04682639|83344457|FG001|OLE Period (28 Weeks)|Other|2|||
47063119|NCT04682639|83344458|FG002|OLE Period (28 Weeks)|Other|0|||
47063120|NCT04682639|83344459|FG003|OLE Period (28 Weeks)|Other|0|||
47063121|NCT04682639|83344460|FG004|OLE Period (28 Weeks)|Other|1|||
47063122|NCT04682639|83344456|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
47063123|NCT04682639|83344457|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
47063124|NCT04682639|83344458|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
47063125|NCT04682639|83344459|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
47063126|NCT04682639|83344460|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
47063127|NCT04682639|83344456|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
47063128|NCT04682639|83344457|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
46769142|NCT00816023|82987512|FG000|Overall Study|Randomized Not Treated|6|||
46769143|NCT00816023|82987513|FG001|Overall Study|Randomized Not Treated|4|||
46769144|NCT00816023|82987514|FG002|Overall Study|Randomized Not Treated|6|||
46769145|NCT00816023|82987515|FG003|Overall Study|Randomized Not Treated|11|||
46769146|NCT00759174|82987527|FG000|Overall Study|Other|0|||
46769147|NCT00759174|82987528|FG001|Overall Study|Other|2|||
46769148|NCT00815633|82987535|FG000|Overall Study|study terminated|1|||
46769149|NCT00830765|82987541|FG000|Overall Study|Protocol Violation|3|||
46769150|NCT00830765|82987542|FG001|Overall Study|Protocol Violation|2|||
46769151|NCT00830375|82987548|FG000|Overall Study|Lost to Follow-up|1|||
46769152|NCT00803270|82987554|FG000|Overall Study|Lost to Follow-up|1|||
46769153|NCT00803270|82987555|FG001|Overall Study|Lost to Follow-up|2|||
46769154|NCT00751998|82987561|FG000|Overall Study|Lost to Follow-up|7|||
46769155|NCT00751998|82987561|FG000|Overall Study|Death|11|||
46769156|NCT00751998|82987561|FG000|Overall Study|Withdrawal by Subject|2|||
46769157|NCT00803738|82987567|FG000|Overall Study|Adverse Event|3|||
46769158|NCT00803738|82987568|FG001|Overall Study|Adverse Event|5|||
46769159|NCT00803738|82987567|FG000|Overall Study|Lost to Follow-up|4|||
47063129|NCT04682639|83344458|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
47063130|NCT04682639|83344459|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
46769160|NCT00803738|82987568|FG001|Overall Study|Lost to Follow-up|4|||
47063131|NCT04682639|83344460|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
47063132|NCT04682639|83344456|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
47063133|NCT04682639|83344457|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
46769161|NCT00803738|82987567|FG000|Overall Study|Protocol Violation|18|||
46769162|NCT00803738|82987568|FG001|Overall Study|Protocol Violation|10|||
46769163|NCT00803738|82987567|FG000|Overall Study|Withdrawal by Subject|1|||
46944749|NCT02743494|83182046|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
47063134|NCT04682639|83344458|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
47063135|NCT04682639|83344459|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
47063136|NCT04682639|83344460|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
47063137|NCT04682639|83344456|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
47063138|NCT04682639|83344457|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
47063139|NCT04682639|83344458|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
47063140|NCT04682639|83344459|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
47063141|NCT04682639|83344460|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
47063142|NCT04470050|83344479|FG000|Double-blind Treatment Phase|Adverse Event|0|||
47063143|NCT04470050|83344480|FG001|Double-blind Treatment Phase|Adverse Event|0|||
47063144|NCT04470050|83344481|FG002|Double-blind Treatment Phase|Adverse Event|0|||
47063145|NCT04470050|83344482|FG003|Double-blind Treatment Phase|Adverse Event|1|||
47063146|NCT04470050|83344483|FG004|Double-blind Treatment Phase|Adverse Event|0|||
47063147|NCT04470050|83344484|FG005|Double-blind Treatment Phase|Adverse Event|0|||
47063148|NCT04470050|83344485|FG006|Double-blind Treatment Phase|Adverse Event|0|||
47063149|NCT04470050|83344479|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
47063150|NCT04470050|83344480|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
47063151|NCT04470050|83344481|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
47063152|NCT04470050|83344482|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
47063153|NCT04470050|83344483|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
47063154|NCT04470050|83344484|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
47063155|NCT04470050|83344485|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
47063156|NCT04470050|83344479|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
47063157|NCT04470050|83344480|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
47063158|NCT04470050|83344481|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
47063159|NCT04470050|83344482|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
47063160|NCT04470050|83344483|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
47063161|NCT04470050|83344484|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
47063162|NCT04470050|83344485|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
47063163|NCT03758066|83344542|FG000|Overall Study|Lost to Follow-up|14|||
47063164|NCT03728933|83344561|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
47063165|NCT03728933|83344562|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
47063166|NCT03728933|83344563|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
47063167|NCT03728933|83344561|FG000|Overall Study|Withdrawal by Subject|0|||
46944750|NCT02743494|83182047|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
46944751|NCT02743494|83182046|FG000|Treatment Period|Completed treatment|229|||
46944752|NCT02743494|83182047|FG001|Treatment Period|Completed treatment|99|||
46944753|NCT02743494|83182046|FG000|Treatment Period|Disease recurrence|149|||
46944754|NCT02743494|83182047|FG001|Treatment Period|Disease recurrence|113|||
46944755|NCT02743494|83182046|FG000|Treatment Period|Study drug toxicity|57|||
46944756|NCT02743494|83182047|FG001|Treatment Period|Study drug toxicity|8|||
46944757|NCT02743494|83182046|FG000|Treatment Period|Death|1|||
47063168|NCT03728933|83344562|FG001|Overall Study|Withdrawal by Subject|0|||
47063169|NCT03728933|83344563|FG002|Overall Study|Withdrawal by Subject|1|||
47063170|NCT03728933|83344561|FG000|Overall Study|Lost to Follow-up|0|||
47063171|NCT03728933|83344562|FG001|Overall Study|Lost to Follow-up|1|||
47063172|NCT03728933|83344563|FG002|Overall Study|Lost to Follow-up|0|||
47063173|NCT03728933|83344561|FG000|Overall Study|Adverse Event|1|||
47063174|NCT03728933|83344562|FG001|Overall Study|Adverse Event|0|||
47063175|NCT03728933|83344563|FG002|Overall Study|Adverse Event|0|||
47063176|NCT03599713|83344582|FG000|Overall Study|Death|26|||
47063177|NCT03599713|83344583|FG001|Overall Study|Death|3|||
47063178|NCT03599713|83344582|FG000|Overall Study|Withdrawal by Subject|6|||
46944758|NCT02743494|83182047|FG001|Treatment Period|Death|0|||
47063179|NCT03599713|83344583|FG001|Overall Study|Withdrawal by Subject|0|||
47063180|NCT03599713|83344582|FG000|Overall Study|Ongoing|69|||
47063181|NCT03599713|83344583|FG001|Overall Study|Ongoing|3|||
47063182|NCT03557281|83344600|FG000|Overall Study|Investigator discretion|0|||
46638565|NCT01437540|82811931|FG000|Overall Study|COPD exacerbation|13|||
47063183|NCT03557281|83344601|FG001|Overall Study|Investigator discretion|0|||
47063184|NCT03557281|83344602|FG002|Overall Study|Investigator discretion|1|||
46769164|NCT00803738|82987568|FG001|Overall Study|Withdrawal by Subject|4|||
46769165|NCT00803738|82987567|FG000|Overall Study|Lack of Efficacy|10|||
47063185|NCT03557281|83344603|FG003|Overall Study|Investigator discretion|0|||
47063186|NCT03557281|83344604|FG004|Overall Study|Investigator discretion|0|||
47063187|NCT03557281|83344600|FG000|Overall Study|Withdrawal by Subject|0|||
47063188|NCT03557281|83344601|FG001|Overall Study|Withdrawal by Subject|1|||
47063189|NCT03557281|83344602|FG002|Overall Study|Withdrawal by Subject|1|||
47063190|NCT03557281|83344603|FG003|Overall Study|Withdrawal by Subject|1|||
47063191|NCT03557281|83344604|FG004|Overall Study|Withdrawal by Subject|2|||
47063192|NCT03557281|83344600|FG000|Overall Study|Randomized, but did not receive treatment|0|||
47063193|NCT03557281|83344601|FG001|Overall Study|Randomized, but did not receive treatment|0|||
47063194|NCT03557281|83344602|FG002|Overall Study|Randomized, but did not receive treatment|0|||
47063195|NCT03557281|83344603|FG003|Overall Study|Randomized, but did not receive treatment|0|||
47063196|NCT03557281|83344604|FG004|Overall Study|Randomized, but did not receive treatment|1|||
47063197|NCT03538041|83344622|FG000|12-Week Treatment Period|Adverse Event|1|||
47063198|NCT03538041|83344623|FG001|12-Week Treatment Period|Adverse Event|1|||
47063199|NCT03538041|83344622|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
47063200|NCT03538041|83344623|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
47063201|NCT03538041|83344622|FG000|Treatment Extension Period|Adverse Event|4|||
47063202|NCT03538041|83344623|FG001|Treatment Extension Period|Adverse Event|0|||
47063203|NCT03538041|83344622|FG000|Treatment Extension Period|Physician Decision|1|||
47063204|NCT03538041|83344623|FG001|Treatment Extension Period|Physician Decision|0|||
47063205|NCT03538041|83344622|FG000|Treatment Extension Period|Lack of Efficacy|1|||
47063206|NCT03538041|83344623|FG001|Treatment Extension Period|Lack of Efficacy|3|||
47063207|NCT03538041|83344622|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
47063208|NCT03538041|83344623|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
47063209|NCT03260894|83344638|FG000|Overall Study|Death|6|||
47063210|NCT03260894|83344639|FG001|Overall Study|Death|8|||
47063211|NCT03260894|83344638|FG000|Overall Study|Withdrawal by Subject|4|||
46944759|NCT02743494|83182046|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
46944760|NCT02743494|83182047|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
46944761|NCT02743494|83182046|FG000|Treatment Period|Participant request to discontinue treatment|30|||
47063212|NCT03260894|83344639|FG001|Overall Study|Withdrawal by Subject|11|||
46769166|NCT00803738|82987568|FG001|Overall Study|Lack of Efficacy|16|||
46769167|NCT00803738|82987567|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
46769168|NCT00803738|82987568|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
46769169|NCT00803738|82987567|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
46769170|NCT00803738|82987568|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
46769171|NCT00758706|82987576|FG000|Overall Study|Adverse Event|4|||
46769172|NCT00758706|82987577|FG001|Overall Study|Adverse Event|4|||
46769173|NCT00591266|82987586|FG000|Overall Study|Adverse Event|2|||
46769174|NCT00591266|82987587|FG001|Overall Study|Adverse Event|2|||
46769175|NCT00591266|82987588|FG002|Overall Study|Adverse Event|3|||
46769176|NCT00591266|82987586|FG000|Overall Study|Lost to Follow-up|0|||
46769177|NCT00591266|82987587|FG001|Overall Study|Lost to Follow-up|1|||
46944762|NCT02743494|83182047|FG001|Treatment Period|Participant request to discontinue treatment|5|||
47063213|NCT03260894|83344638|FG000|Overall Study|On-going at clinical cut off date|36|||
46638566|NCT01437540|82811932|FG001|Overall Study|COPD exacerbation|3|||
46638567|NCT01437540|82811931|FG000|Overall Study|Lost to Follow-up|3|||
46638568|NCT01437540|82811932|FG001|Overall Study|Lost to Follow-up|5|||
46638569|NCT01437540|82811931|FG000|Overall Study|Lack of Efficacy|23|||
46638570|NCT01437540|82811932|FG001|Overall Study|Lack of Efficacy|11|||
46638571|NCT01437540|82811931|FG000|Overall Study|Protocol Violation|24|||
46638572|NCT01437540|82811932|FG001|Overall Study|Protocol Violation|12|||
46638573|NCT01437540|82811931|FG000|Overall Study|Adverse Event|26|||
46638574|NCT01437540|82811932|FG001|Overall Study|Adverse Event|13|||
46638575|NCT01437540|82811931|FG000|Overall Study|Withdrawal by Subject|31|||
46638576|NCT01437540|82811932|FG001|Overall Study|Withdrawal by Subject|15|||
46638577|NCT01440972|82811940|FG000|Overall Study|Withdrawal by Subject|3|||
46638578|NCT01440972|82811941|FG001|Overall Study|Withdrawal by Subject|2|||
46638579|NCT01420536|82811949|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
46638580|NCT01420536|82811950|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
46638581|NCT01420068|82811960|FG000|Overall Study|Administrative problems|1|||
46944763|NCT02743494|83182046|FG000|Treatment Period|Participant withdrew consent|12|||
46944764|NCT02743494|83182047|FG001|Treatment Period|Participant withdrew consent|4|||
46944765|NCT02743494|83182046|FG000|Treatment Period|Lost to Follow-up|0|||
46944766|NCT02743494|83182047|FG001|Treatment Period|Lost to Follow-up|1|||
46944767|NCT02743494|83182046|FG000|Treatment Period|Poor/Non-compliance|1|||
46944768|NCT02743494|83182047|FG001|Treatment Period|Poor/Non-compliance|0|||
46944769|NCT02743494|83182046|FG000|Treatment Period|Other reasons|7|||
46944770|NCT02743494|83182047|FG001|Treatment Period|Other reasons|2|||
46944771|NCT02336282|83182053|FG000|Overall Study|Unrelated illness|1|||
46944772|NCT02336282|83182053|FG000|Overall Study|Uncomfortable with technology|1|||
46944773|NCT02336282|83182053|FG000|Overall Study|Lost to Follow-up|1|||
46944774|NCT02336282|83182053|FG000|Overall Study|Not enough time to complete sessions|2|||
46944775|NCT02272842|83182067|FG000|Overall Study|Lost to Follow-up|8|||
47063214|NCT03260894|83344639|FG001|Overall Study|On-going at clinical cut off date|31|||
47063215|NCT03197935|83344647|FG000|Overall Study|Death due to any cause|26|||
46944776|NCT02272842|83182068|FG001|Overall Study|Lost to Follow-up|8|||
46944777|NCT02272842|83182067|FG000|Overall Study|Withdrawal by Subject|8|||
46944778|NCT02272842|83182068|FG001|Overall Study|Withdrawal by Subject|2|||
46944779|NCT02258659|83182075|FG000|Overall Study|Withdrawal by Subject|1|||
46944780|NCT01990300|83182079|FG000|Overall Study|Case Report Forms Uncollected|89|||
46944781|NCT01990300|83182079|FG000|Overall Study|Protocol Deviation|53|||
47063216|NCT03197935|83344648|FG001|Overall Study|Death due to any cause|15|||
47063217|NCT03197935|83344647|FG000|Overall Study|Lost to Follow-up|3|||
47063218|NCT03197935|83344648|FG001|Overall Study|Lost to Follow-up|5|||
47063219|NCT03197935|83344647|FG000|Overall Study|Physician Decision|2|||
47063220|NCT03197935|83344648|FG001|Overall Study|Physician Decision|1|||
47063221|NCT03197935|83344647|FG000|Overall Study|Withdrawal by Subject|16|||
47063222|NCT03197935|83344648|FG001|Overall Study|Withdrawal by Subject|8|||
47063223|NCT03136965|83344659|FG000|Overall Study|Lost to Follow-up|0|||
47063224|NCT03136965|83344660|FG001|Overall Study|Lost to Follow-up|1|||
47063225|NCT03136965|83344661|FG002|Overall Study|Lost to Follow-up|0|||
47063226|NCT03115151|83344671|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
47063227|NCT03115151|83344672|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
47063228|NCT03115151|83344671|FG000|Overall Study|Epidural catheter removal|1|||
47063229|NCT03115151|83344672|FG001|Overall Study|Epidural catheter removal|0|||
47063230|NCT03115151|83344671|FG000|Overall Study|Withdrawal by Subject|0|||
47063231|NCT03115151|83344672|FG001|Overall Study|Withdrawal by Subject|1|||
47063232|NCT03115151|83344671|FG000|Overall Study|Intervention not received according to the protocol.|1|||
47063233|NCT03115151|83344672|FG001|Overall Study|Intervention not received according to the protocol.|1|||
47063234|NCT03115151|83344671|FG000|Overall Study|Physician Decision|1|||
47063235|NCT03115151|83344672|FG001|Overall Study|Physician Decision|0|||
47063236|NCT03115151|83344671|FG000|Overall Study|Randomization not applied|1|||
47063237|NCT03115151|83344672|FG001|Overall Study|Randomization not applied|1|||
47063238|NCT02908685|83344690|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
47063239|NCT02908685|83344691|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
47063240|NCT02908685|83344692|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
46638582|NCT01420068|82811961|FG001|Overall Study|Administrative problems|3|||
46638583|NCT01420068|82811960|FG000|Overall Study|Withdrawal by Subject|1|||
46638584|NCT01420068|82811961|FG001|Overall Study|Withdrawal by Subject|2|||
46638585|NCT01467492|82811969|FG000|Overall Study|Withdrawal by Subject|6|||
46638586|NCT01467492|82811970|FG001|Overall Study|Withdrawal by Subject|4|||
46638587|NCT01467492|82811969|FG000|Overall Study|Study Terminated by Sponsor|6|||
46638588|NCT01467492|82811970|FG001|Overall Study|Study Terminated by Sponsor|4|||
47063241|NCT02908685|83344693|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
47063242|NCT02908685|83344694|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
46769178|NCT00591266|82987588|FG002|Overall Study|Lost to Follow-up|0|||
47063243|NCT02908685|83344695|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
46638589|NCT01467492|82811969|FG000|Overall Study|Adverse Event|4|||
46944782|NCT01909934|83182083|FG000|Overall Study|Ongoing|23|||
46944783|NCT01909934|83182083|FG000|Overall Study|Withdrawal by Subject|3|||
46944784|NCT01909934|83182083|FG000|Overall Study|Lost to Follow-up|1|||
46944785|NCT01909934|83182083|FG000|Overall Study|Withdrawal of Informed Consent|1|||
46944786|NCT01909934|83182083|FG000|Overall Study|Death|22|||
46944787|NCT01076400|83182098|FG000|Overall Study|Adverse Event|2|||
46944788|NCT01076400|83182099|FG001|Overall Study|Adverse Event|0|||
46944789|NCT01076400|83182100|FG002|Overall Study|Adverse Event|0|||
46944790|NCT01076400|83182098|FG000|Overall Study|Progressive Disease|5|||
46944791|NCT01076400|83182099|FG001|Overall Study|Progressive Disease|0|||
46944792|NCT01076400|83182100|FG002|Overall Study|Progressive Disease|0|||
46944793|NCT01000051|83182106|FG000|Overall Study|Withdrawal by Subject|1|||
46944794|NCT01000051|83182107|FG001|Overall Study|Withdrawal by Subject|1|||
46944795|NCT01000051|83182106|FG000|Overall Study|Disease Progression|1|||
46944796|NCT01000051|83182107|FG001|Overall Study|Disease Progression|0|||
46944797|NCT01000051|83182106|FG000|Overall Study|Serious noncompliance|1|||
46944798|NCT01000051|83182107|FG001|Overall Study|Serious noncompliance|0|||
46944799|NCT00953160|83182113|FG000|Overall Study|Lost to Follow-up|23|||
46944800|NCT00953160|83182113|FG000|Overall Study|Withdrawal by Subject|4|||
46944801|NCT00913497|83182140|FG000|Overall Study|Adverse Event|1|||
46944802|NCT00913497|83182140|FG000|Overall Study|Withdrawal by Subject|2|||
46944803|NCT00874822|83182146|FG000|Overall Study|excluded by criteria|8|||
47063244|NCT02908685|83344696|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
47063245|NCT02908685|83344697|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
47063246|NCT02908685|83344698|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
47063247|NCT02908685|83344699|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
47063248|NCT02908685|83344700|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
46769179|NCT00591266|82987586|FG000|Overall Study|Protocol Violation|0|||
46769180|NCT00591266|82987587|FG001|Overall Study|Protocol Violation|0|||
46769181|NCT00591266|82987588|FG002|Overall Study|Protocol Violation|1|||
46769182|NCT00591266|82987586|FG000|Overall Study|Withdrawal by Subject|6|||
46769183|NCT00591266|82987587|FG001|Overall Study|Withdrawal by Subject|2|||
46944804|NCT00556933|83182163|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
46944805|NCT00556933|83182164|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
47063249|NCT02908685|83344701|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
47063250|NCT02908685|83344690|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
47063251|NCT02908685|83344691|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
47063252|NCT02908685|83344692|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
47063253|NCT02908685|83344693|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
47063254|NCT02908685|83344694|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
47063255|NCT02908685|83344695|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
47063256|NCT02908685|83344696|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
47063257|NCT02908685|83344697|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
47063258|NCT02908685|83344698|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
47063259|NCT02908685|83344699|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
47063260|NCT02908685|83344700|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
47063261|NCT02908685|83344701|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
47063262|NCT02908685|83344690|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
47063263|NCT02908685|83344691|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
47063264|NCT02908685|83344692|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
47063265|NCT02908685|83344693|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
47063266|NCT02908685|83344694|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
47063267|NCT02908685|83344695|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
47063268|NCT02908685|83344696|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
46944806|NCT00556933|83182165|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
46769184|NCT00591266|82987588|FG002|Overall Study|Withdrawal by Subject|5|||
46944807|NCT00556933|83182166|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
46944808|NCT00556933|83182163|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
46944809|NCT00556933|83182164|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
47063269|NCT02908685|83344697|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
47063270|NCT02908685|83344698|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
47063271|NCT02908685|83344699|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
47063272|NCT02908685|83344700|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
47063273|NCT02908685|83344701|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
47063274|NCT02772276|83344731|FG000|Overall Study|Lost to Follow-up|0|||
47063275|NCT02772276|83344732|FG001|Overall Study|Lost to Follow-up|0|||
47063276|NCT02772276|83344733|FG002|Overall Study|Lost to Follow-up|0|||
47063277|NCT02772276|83344734|FG003|Overall Study|Lost to Follow-up|0|||
47063278|NCT02772276|83344735|FG004|Overall Study|Lost to Follow-up|0|||
47063279|NCT02772276|83344736|FG005|Overall Study|Lost to Follow-up|0|||
47063280|NCT02772276|83344737|FG006|Overall Study|Lost to Follow-up|1|||
47063281|NCT02772276|83344738|FG007|Overall Study|Lost to Follow-up|0|||
47063282|NCT02772276|83344739|FG008|Overall Study|Lost to Follow-up|0|||
47063283|NCT02772276|83344740|FG009|Overall Study|Lost to Follow-up|0|||
47063284|NCT02772276|83344741|FG010|Overall Study|Lost to Follow-up|0|||
47063285|NCT02772276|83344742|FG011|Overall Study|Lost to Follow-up|0|||
47063286|NCT02772276|83344743|FG012|Overall Study|Lost to Follow-up|0|||
47063287|NCT02772276|83344731|FG000|Overall Study|Withdrew consent|0|||
47063288|NCT02772276|83344732|FG001|Overall Study|Withdrew consent|0|||
47063289|NCT02772276|83344733|FG002|Overall Study|Withdrew consent|0|||
47063290|NCT02772276|83344734|FG003|Overall Study|Withdrew consent|0|||
46769185|NCT00591266|82987586|FG000|Overall Study|Lack of Efficacy|0|||
47063291|NCT02772276|83344735|FG004|Overall Study|Withdrew consent|0|||
47063292|NCT02772276|83344736|FG005|Overall Study|Withdrew consent|0|||
47063293|NCT02772276|83344737|FG006|Overall Study|Withdrew consent|0|||
46769186|NCT00591266|82987587|FG001|Overall Study|Lack of Efficacy|2|||
46769187|NCT00591266|82987588|FG002|Overall Study|Lack of Efficacy|0|||
46769188|NCT00591266|82987586|FG000|Overall Study|Other|1|||
46769189|NCT00591266|82987587|FG001|Overall Study|Other|4|||
46769190|NCT00591266|82987588|FG002|Overall Study|Other|5|||
46769191|NCT00758394|82987600|FG000|2nd Intervention Order|Lost to Follow-up|0|||
46769192|NCT00758394|82987601|FG001|2nd Intervention Order|Lost to Follow-up|1|||
46769193|NCT00758394|82987602|FG002|2nd Intervention Order|Lost to Follow-up|0|||
46769194|NCT00758394|82987603|FG003|2nd Intervention Order|Lost to Follow-up|0|||
46769195|NCT00758394|82987600|FG000|3rd Intervention|Lost to Follow-up|1|||
46769196|NCT00758394|82987601|FG001|3rd Intervention|Lost to Follow-up|0|||
46769197|NCT00758394|82987602|FG002|3rd Intervention|Lost to Follow-up|0|||
46769198|NCT00758394|82987603|FG003|3rd Intervention|Lost to Follow-up|1|||
47063294|NCT02772276|83344738|FG007|Overall Study|Withdrew consent|1|||
47063295|NCT02772276|83344739|FG008|Overall Study|Withdrew consent|0|||
46769199|NCT04450394|82987616|FG000|Overall Study|Adverse Event|2|||
46769200|NCT04450394|82987617|FG001|Overall Study|Adverse Event|0|||
46769201|NCT04450394|82987618|FG002|Overall Study|Adverse Event|0|||
46769202|NCT04450394|82987616|FG000|Overall Study|Death|0|||
47063296|NCT02772276|83344740|FG009|Overall Study|Withdrew consent|0|||
47063297|NCT02772276|83344741|FG010|Overall Study|Withdrew consent|0|||
47063298|NCT02772276|83344742|FG011|Overall Study|Withdrew consent|0|||
47063299|NCT02772276|83344743|FG012|Overall Study|Withdrew consent|0|||
47063300|NCT02601313|83344796|FG000|Overall Study|Death|2|||
47063301|NCT02601313|83344797|FG001|Overall Study|Death|16|||
47063302|NCT02601313|83344798|FG002|Overall Study|Death|4|||
47063303|NCT02601313|83344796|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
47063304|NCT02601313|83344797|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
47063305|NCT02601313|83344798|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
47063306|NCT02601313|83344796|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
47063307|NCT02601313|83344797|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
47063308|NCT02601313|83344798|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
47063309|NCT02601313|83344796|FG000|Overall Study|Still on study|0|||
47063310|NCT02601313|83344797|FG001|Overall Study|Still on study|52|||
47063311|NCT02601313|83344798|FG002|Overall Study|Still on study|10|||
47063312|NCT02601313|83344796|FG000|Overall Study|Enrolled, did not initiate AC|4|||
47063313|NCT02601313|83344797|FG001|Overall Study|Enrolled, did not initiate AC|0|||
47063314|NCT02601313|83344798|FG002|Overall Study|Enrolled, did not initiate AC|0|||
47063315|NCT02550652|83344808|FG000|Overall Study|Death|1|||
47063316|NCT02550652|83344809|FG001|Overall Study|Death|4|||
47063317|NCT02550652|83344808|FG000|Overall Study|Lack of Efficacy|1|||
47063318|NCT02550652|83344809|FG001|Overall Study|Lack of Efficacy|0|||
47063319|NCT02550652|83344808|FG000|Overall Study|Withdrawal by Subject|3|||
47063320|NCT02550652|83344809|FG001|Overall Study|Withdrawal by Subject|7|||
47063321|NCT02550652|83344808|FG000|Overall Study|Post Trial Access|1|||
47063322|NCT02550652|83344809|FG001|Overall Study|Post Trial Access|0|||
47063323|NCT02550652|83344808|FG000|Overall Study|Lost to Follow-up|1|||
47063324|NCT02550652|83344809|FG001|Overall Study|Lost to Follow-up|3|||
47063325|NCT02550652|83344808|FG000|Overall Study|Physician Decision|0|||
47063326|NCT02550652|83344809|FG001|Overall Study|Physician Decision|2|||
47063327|NCT02550652|83344808|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
47063328|NCT02550652|83344809|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
47063329|NCT02484443|83344815|FG000|Overall Study|Lack of Efficacy|28|||
47063330|NCT02484443|83344815|FG000|Overall Study|Physician Decision|2|||
47063331|NCT02484443|83344815|FG000|Overall Study|Ineligible|2|||
47063332|NCT01041027|83344845|FG000|Overall Study|Withdrawal by Subject|2|||
47063333|NCT01041027|83344845|FG000|Overall Study|Protocol Violation|1|||
47063334|NCT01041027|83344845|FG000|Overall Study|Delayed Radiation Therapy|1|||
47063335|NCT01041027|83344845|FG000|Overall Study|Adverse Event|4|||
47063336|NCT00389610|83344851|FG000|Overall Study|Disease Progression|0|||
47063337|NCT00389610|83344852|FG001|Overall Study|Disease Progression|19|||
47063338|NCT00389610|83344851|FG000|Overall Study|Death|0|||
47063339|NCT00389610|83344852|FG001|Overall Study|Death|1|||
47063340|NCT00389610|83344851|FG000|Overall Study|Physician Decision|0|||
47063341|NCT00389610|83344852|FG001|Overall Study|Physician Decision|1|||
47063342|NCT00389610|83344851|FG000|Overall Study|Withdrawal by Subject|0|||
47063343|NCT00389610|83344852|FG001|Overall Study|Withdrawal by Subject|1|||
47063344|NCT01489189|83344860|FG000|Overall Study|Withdrawal by Subject|20|||
47063345|NCT01489189|83344861|FG001|Overall Study|Withdrawal by Subject|23|||
47063346|NCT01489189|83344860|FG000|Overall Study|Death|10|||
47063347|NCT01489189|83344861|FG001|Overall Study|Death|8|||
47063348|NCT01489189|83344860|FG000|Overall Study|Missed Visit|1|||
47063349|NCT01489189|83344861|FG001|Overall Study|Missed Visit|4|||
47063350|NCT01549873|83344870|FG000|Overall Study|Physician Decision|0|||
47063351|NCT01549873|83344871|FG001|Overall Study|Physician Decision|1|||
47063352|NCT01489111|83344877|FG000|Overall Study|Withdrawal criterion|1|||
47063353|NCT01488487|83344881|FG000|Overall Study|Adverse Event|6|||
47063354|NCT01488487|83344881|FG000|Overall Study|Death|1|||
47063355|NCT01488487|83344881|FG000|Overall Study|Withdrawal by Subject|2|||
47063356|NCT01488097|83344885|FG000|Overall Study|Lost to Follow-up|1|||
47063357|NCT01516879|83344891|FG000|Overall Study|Withdrawal by Subject|9|||
47063358|NCT01516879|83344892|FG001|Overall Study|Withdrawal by Subject|11|||
47063359|NCT01516879|83344891|FG000|Overall Study|Death|0|||
47063360|NCT01516879|83344892|FG001|Overall Study|Death|2|||
47063361|NCT01516879|83344891|FG000|Overall Study|Lost to Follow-up|2|||
47063362|NCT01516879|83344892|FG001|Overall Study|Lost to Follow-up|11|||
47063363|NCT01516879|83344891|FG000|Overall Study|Other|5|||
47063364|NCT01516879|83344892|FG001|Overall Study|Other|10|||
47063365|NCT01515865|83344898|FG000|Part A (Open-label)|Other|3|||
47063366|NCT01515865|83344899|FG001|Part A (Open-label)|Other|0|||
47063367|NCT01515865|83344900|FG002|Part A (Open-label)|Other|0|||
47063368|NCT01515865|83344898|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
47063369|NCT01515865|83344899|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
47063370|NCT01515865|83344900|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
47063371|NCT01515865|83344898|FG000|Part B (Open-label)|Other|1|||
47063372|NCT01515865|83344899|FG001|Part B (Open-label)|Other|0|||
47063373|NCT01515865|83344900|FG002|Part B (Open-label)|Other|0|||
47063374|NCT01547299|83344910|FG000|Overall Study|Withdrawal by Subject|2|||
47063375|NCT01547299|83344911|FG001|Overall Study|Withdrawal by Subject|2|||
47063376|NCT01515475|83344921|FG000|Overall Study|Lost to Follow-up|20|||
47063377|NCT01515475|83344922|FG001|Overall Study|Lost to Follow-up|15|||
46638590|NCT01467492|82811970|FG001|Overall Study|Adverse Event|3|||
46769203|NCT04450394|82987617|FG001|Overall Study|Death|1|||
46769204|NCT04450394|82987618|FG002|Overall Study|Death|0|||
46839241|NCT00288080|83056316|FG001|Overall Study|Protocol Violation|20|||
46839242|NCT00287690|83056324|FG000|Overall Study|Protocol Violation|20|||
46839243|NCT00287690|83056325|FG001|Overall Study|Protocol Violation|26|||
46839244|NCT00286754|83056334|FG000|Overall Study|Adverse Event|2|||
46839245|NCT00286754|83056335|FG001|Overall Study|Adverse Event|2|||
46839246|NCT00286754|83056336|FG002|Overall Study|Adverse Event|3|||
46839247|NCT00286754|83056334|FG000|Overall Study|Withdrawal by Subject|6|||
46839248|NCT00286754|83056335|FG001|Overall Study|Withdrawal by Subject|2|||
46839249|NCT00286754|83056336|FG002|Overall Study|Withdrawal by Subject|0|||
46839250|NCT00286754|83056334|FG000|Overall Study|Lost to Follow-up|12|||
46839251|NCT00286754|83056335|FG001|Overall Study|Lost to Follow-up|14|||
46839252|NCT00286754|83056336|FG002|Overall Study|Lost to Follow-up|6|||
46839253|NCT00286754|83056334|FG000|Overall Study|Moved out of state|0|||
46839254|NCT00286754|83056335|FG001|Overall Study|Moved out of state|0|||
46839255|NCT00286754|83056336|FG002|Overall Study|Moved out of state|1|||
46839256|NCT00066742|83056350|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
46839257|NCT00066742|83056350|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
46839258|NCT00066742|83056350|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
46839259|NCT00066742|83056350|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
46839260|NCT00066742|83056350|FG000|Induction Chemoradiotherapy|Ineligible|3|||
46839261|NCT00066742|83056350|FG000|Consolidation Chemotherapy|not protocol specified|1|||
46839262|NCT00066742|83056350|FG000|Consolidation Chemotherapy|Ineligible|2|||
46839263|NCT00460265|83056358|FG000|Overall Study|Lost to Follow-up|14|||
46839264|NCT00460265|83056359|FG001|Overall Study|Lost to Follow-up|15|||
46839265|NCT00460265|83056358|FG000|Overall Study|Physician Decision|1|||
46839266|NCT00460265|83056359|FG001|Overall Study|Physician Decision|2|||
46839267|NCT00460265|83056358|FG000|Overall Study|Withdrawal by Subject|10|||
46839268|NCT00460265|83056359|FG001|Overall Study|Withdrawal by Subject|25|||
46839269|NCT00460265|83056358|FG000|Overall Study|Ongoing|60|||
46839270|NCT00460265|83056359|FG001|Overall Study|Ongoing|47|||
46839271|NCT00460109|83056365|FG000|Overall Study|Death|1|||
46839272|NCT00065260|83056371|FG000|Overall Study|Death|0|||
46839273|NCT00065260|83056372|FG001|Overall Study|Death|1|||
46839274|NCT00460031|83056378|FG000|Overall Study|Adverse Event|5|||
46839275|NCT00460031|83056378|FG000|Overall Study|Withdrawal by Subject|5|||
46839276|NCT00460031|83056378|FG000|Overall Study|Death|1|||
46839277|NCT00451217|83056386|FG000|Overall Study|Lost to Follow-up|0|||
46839278|NCT00451217|83056387|FG001|Overall Study|Lost to Follow-up|1|||
46839279|NCT00451217|83056388|FG002|Overall Study|Lost to Follow-up|1|||
46839280|NCT00451217|83056389|FG003|Overall Study|Lost to Follow-up|1|||
46839281|NCT00451217|83056386|FG000|Overall Study|Withdrawal by Subject|1|||
46839282|NCT00451217|83056387|FG001|Overall Study|Withdrawal by Subject|0|||
46839283|NCT00451217|83056388|FG002|Overall Study|Withdrawal by Subject|0|||
46839284|NCT00451217|83056389|FG003|Overall Study|Withdrawal by Subject|0|||
46839285|NCT00451217|83056386|FG000|Overall Study|Not Treated|1|||
46839286|NCT00451217|83056387|FG001|Overall Study|Not Treated|1|||
46839287|NCT00451217|83056388|FG002|Overall Study|Not Treated|3|||
46839288|NCT00451217|83056389|FG003|Overall Study|Not Treated|4|||
46839289|NCT00459953|83056401|FG000|Overall Study|not analyzed-household member in study|1|||
46839290|NCT00459953|83056402|FG001|Overall Study|not analyzed-household member in study|1|||
46769205|NCT04450394|82987616|FG000|Overall Study|Lost to Follow-up|0|||
46769206|NCT04450394|82987617|FG001|Overall Study|Lost to Follow-up|3|||
46769207|NCT04450394|82987618|FG002|Overall Study|Lost to Follow-up|0|||
46769208|NCT04450394|82987616|FG000|Overall Study|Physician Decision|0|||
46769209|NCT04450394|82987617|FG001|Overall Study|Physician Decision|1|||
46769210|NCT04450394|82987618|FG002|Overall Study|Physician Decision|0|||
46769211|NCT04450394|82987616|FG000|Overall Study|Protocol Violation|2|||
46769212|NCT04450394|82987617|FG001|Overall Study|Protocol Violation|0|||
46839291|NCT00459875|83056408|FG000|Overall Study|Ineligible participant|1|||
46839292|NCT00459875|83056408|FG000|Overall Study|Adverse Event|2|||
46839293|NCT00311402|83056414|FG000|Overall Study|Adverse Event|118|||
46839294|NCT00311402|83056415|FG001|Overall Study|Adverse Event|105|||
46839295|NCT00311402|83056414|FG000|Overall Study|Lost to Follow-up|0|||
46839296|NCT00311402|83056415|FG001|Overall Study|Lost to Follow-up|3|||
46839297|NCT00311402|83056414|FG000|Overall Study|Withdrawal by Subject|17|||
46839298|NCT00311402|83056415|FG001|Overall Study|Withdrawal by Subject|18|||
46769213|NCT04450394|82987618|FG002|Overall Study|Protocol Violation|0|||
46769214|NCT04450394|82987616|FG000|Overall Study|Withdrawal by Subject|6|||
46769215|NCT04450394|82987617|FG001|Overall Study|Withdrawal by Subject|9|||
46769216|NCT04450394|82987618|FG002|Overall Study|Withdrawal by Subject|0|||
46839299|NCT00311402|83056414|FG000|Overall Study|Lack of Efficacy|58|||
46839300|NCT00311402|83056415|FG001|Overall Study|Lack of Efficacy|42|||
46839301|NCT00311402|83056414|FG000|Overall Study|Protocol Violation|7|||
46839302|NCT00311402|83056415|FG001|Overall Study|Protocol Violation|6|||
46839303|NCT00311402|83056414|FG000|Overall Study|IRB's rejection etc.|10|||
46839304|NCT00311402|83056415|FG001|Overall Study|IRB's rejection etc.|3|||
46839305|NCT00450749|83056424|FG000|Overall Study|Withdrawal by Subject|0|||
46839306|NCT00450749|83056425|FG001|Overall Study|Withdrawal by Subject|0|||
46839307|NCT00450749|83056426|FG002|Overall Study|Withdrawal by Subject|2|||
46839308|NCT00450749|83056424|FG000|Overall Study|Noncompliant|0|||
46839309|NCT00450749|83056425|FG001|Overall Study|Noncompliant|1|||
46839310|NCT00450749|83056426|FG002|Overall Study|Noncompliant|0|||
46839311|NCT00292370|83056437|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
46839312|NCT00292370|83056438|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
46839313|NCT00292370|83056439|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
46839314|NCT00292370|83056437|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
46839315|NCT00292370|83056438|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
46839316|NCT00292370|83056439|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
46839317|NCT00292370|83056437|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
46839318|NCT00292370|83056438|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
46839319|NCT00292370|83056439|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
46839320|NCT00292370|83056437|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
46839321|NCT00292370|83056438|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
46839322|NCT00292370|83056439|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
46839323|NCT00292370|83056437|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
46839324|NCT00292370|83056438|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
46839325|NCT00292370|83056439|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
46839326|NCT00292370|83056437|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
46839327|NCT00292370|83056438|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
46839328|NCT00292370|83056439|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
46839329|NCT00065182|83056448|FG000|Overall Study|Adverse Event|24|||
46839330|NCT00065182|83056449|FG001|Overall Study|Adverse Event|17|||
46839331|NCT00065182|83056448|FG000|Overall Study|Lost to Follow-up|0|||
46839332|NCT00065182|83056449|FG001|Overall Study|Lost to Follow-up|4|||
46839333|NCT00065182|83056448|FG000|Overall Study|Protocol Violation|3|||
46839334|NCT00065182|83056449|FG001|Overall Study|Protocol Violation|4|||
46839335|NCT00065182|83056448|FG000|Overall Study|Serious adverse events (SAE)|1|||
46839336|NCT00065182|83056449|FG001|Overall Study|Serious adverse events (SAE)|0|||
46839337|NCT00065182|83056448|FG000|Overall Study|Sponsor Decision|11|||
46839338|NCT00065182|83056449|FG001|Overall Study|Sponsor Decision|7|||
46839339|NCT00065182|83056448|FG000|Overall Study|Withdrawal by Subject|8|||
46839340|NCT00065182|83056449|FG001|Overall Study|Withdrawal by Subject|3|||
46839341|NCT00065182|83056448|FG000|Overall Study|No clinical benefit|1|||
46839342|NCT00065182|83056449|FG001|Overall Study|No clinical benefit|0|||
46839343|NCT00065182|83056448|FG000|Overall Study|Death|0|||
46839344|NCT00065182|83056449|FG001|Overall Study|Death|1|||
46839345|NCT00065182|83056448|FG000|Overall Study|Decline in Status|0|||
46839346|NCT00065182|83056449|FG001|Overall Study|Decline in Status|1|||
46839347|NCT00064792|83056457|FG000|Overall Study|Withdrawal by Subject|2|||
46839348|NCT00064792|83056458|FG001|Overall Study|Withdrawal by Subject|0|||
46839349|NCT00064792|83056457|FG000|Overall Study|Adverse Event|3|||
46839350|NCT00064792|83056458|FG001|Overall Study|Adverse Event|0|||
46839351|NCT00450437|83056466|FG000|Overall Study|Withdrawal by Subject|10|||
46769217|NCT00758160|82987625|FG000|Overall Study|No Longer Requires Study Medication|4|||
46769218|NCT00758160|82987625|FG000|Overall Study|Administration Problems|3|||
46769219|NCT00758160|82987625|FG000|Overall Study|Adverse Event|15|||
46769220|NCT00758160|82987625|FG000|Overall Study|Lack of Efficacy|10|||
46769221|NCT00758160|82987625|FG000|Overall Study|Lost to Follow-up|14|||
46769222|NCT00758160|82987625|FG000|Overall Study|Protocol Violation|12|||
46769223|NCT00758160|82987625|FG000|Overall Study|Withdrawal by Subject|8|||
46769224|NCT00757848|82987635|FG000|Overall Study|Voluntary discontinuation|1|||
46769225|NCT00757848|82987636|FG001|Overall Study|Voluntary discontinuation|0|||
46769226|NCT00757848|82987635|FG000|Overall Study|Adverse Event|1|||
46769227|NCT00757848|82987636|FG001|Overall Study|Adverse Event|2|||
46769228|NCT00757848|82987635|FG000|Overall Study|Incorrect enrolment|1|||
46769229|NCT00757848|82987636|FG001|Overall Study|Incorrect enrolment|0|||
46769230|NCT00751296|82987642|FG000|Overall Study|Adverse Event|2|||
46769231|NCT00751140|82987646|FG000|Overall Study|benign angioma excluded from analysis|1|||
46769232|NCT00751881|82987657|FG000|Core Treatment Period|Not treated|1|||
46839352|NCT00450437|83056467|FG001|Overall Study|Withdrawal by Subject|2|||
46839353|NCT00450437|83056468|FG002|Overall Study|Withdrawal by Subject|0|||
47063378|NCT01515475|83344923|FG002|Overall Study|Lost to Follow-up|12|||
46769233|NCT00751881|82987658|FG001|Core Treatment Period|Not treated|1|||
46769234|NCT00751881|82987659|FG002|Core Treatment Period|Not treated|2|||
46769235|NCT00751881|82987657|FG000|Core Treatment Period|Adverse Event|26|||
46769236|NCT00751881|82987658|FG001|Core Treatment Period|Adverse Event|54|||
46769237|NCT00751881|82987659|FG002|Core Treatment Period|Adverse Event|58|||
46769238|NCT00751881|82987657|FG000|Core Treatment Period|Lack of Efficacy|37|||
46839354|NCT00450437|83056469|FG003|Overall Study|Withdrawal by Subject|1|||
46839355|NCT00450437|83056466|FG000|Overall Study|Lost to Follow-up|31|||
46839356|NCT00450437|83056467|FG001|Overall Study|Lost to Follow-up|12|||
46839357|NCT00450437|83056468|FG002|Overall Study|Lost to Follow-up|19|||
46839358|NCT00450437|83056469|FG003|Overall Study|Lost to Follow-up|9|||
46839359|NCT00450437|83056466|FG000|Overall Study|Protocol Violation|0|||
46839360|NCT00450437|83056467|FG001|Overall Study|Protocol Violation|1|||
46839361|NCT00450437|83056468|FG002|Overall Study|Protocol Violation|0|||
46839362|NCT00450437|83056469|FG003|Overall Study|Protocol Violation|1|||
46839363|NCT00450437|83056466|FG000|Overall Study|Inappropriate enrollment|4|||
46839364|NCT00450437|83056467|FG001|Overall Study|Inappropriate enrollment|1|||
46839365|NCT00450437|83056468|FG002|Overall Study|Inappropriate enrollment|3|||
46839366|NCT00450437|83056469|FG003|Overall Study|Inappropriate enrollment|0|||
46839367|NCT00450437|83056466|FG000|Overall Study|Administrative reason|0|||
46839368|NCT00450437|83056467|FG001|Overall Study|Administrative reason|0|||
46839369|NCT00450437|83056468|FG002|Overall Study|Administrative reason|1|||
46839370|NCT00450437|83056469|FG003|Overall Study|Administrative reason|0|||
46839371|NCT00450437|83056466|FG000|Overall Study|Unable to Classify|1|||
46839372|NCT00450437|83056467|FG001|Overall Study|Unable to Classify|0|||
46839373|NCT00450437|83056468|FG002|Overall Study|Unable to Classify|1|||
46839374|NCT00450437|83056469|FG003|Overall Study|Unable to Classify|0|||
46839375|NCT00286442|83056486|FG000|Overall Study|Hyperglycemic Rescue|19|||
46839376|NCT00286442|83056487|FG001|Overall Study|Hyperglycemic Rescue|17|||
46839377|NCT00286442|83056488|FG002|Overall Study|Hyperglycemic Rescue|25|||
46839378|NCT00286442|83056486|FG000|Overall Study|Adverse Event|7|||
46839379|NCT00286442|83056487|FG001|Overall Study|Adverse Event|6|||
46839380|NCT00286442|83056488|FG002|Overall Study|Adverse Event|1|||
46839381|NCT00286442|83056486|FG000|Overall Study|Protocol Violation|2|||
46839382|NCT00286442|83056487|FG001|Overall Study|Protocol Violation|4|||
46839383|NCT00286442|83056488|FG002|Overall Study|Protocol Violation|2|||
46839384|NCT00286442|83056486|FG000|Overall Study|Lost to Follow-up|5|||
46839385|NCT00286442|83056487|FG001|Overall Study|Lost to Follow-up|2|||
46839386|NCT00286442|83056488|FG002|Overall Study|Lost to Follow-up|1|||
47063379|NCT01515475|83344924|FG003|Overall Study|Lost to Follow-up|12|||
47063380|NCT01515319|83345010|FG000|Overall Study|Withdrawal by Subject|0|||
47063381|NCT01515319|83345011|FG001|Overall Study|Withdrawal by Subject|0|||
47063382|NCT01515319|83345012|FG002|Overall Study|Withdrawal by Subject|0|||
47063383|NCT01515319|83345013|FG003|Overall Study|Withdrawal by Subject|0|||
47063384|NCT01515319|83345014|FG004|Overall Study|Withdrawal by Subject|0|||
47063385|NCT01515319|83345015|FG005|Overall Study|Withdrawal by Subject|0|||
46638591|NCT01467492|82811969|FG000|Overall Study|Lost to Follow-up|3|||
46638592|NCT01467492|82811970|FG001|Overall Study|Lost to Follow-up|2|||
46769239|NCT00751881|82987658|FG001|Core Treatment Period|Lack of Efficacy|30|||
46769240|NCT00751881|82987659|FG002|Core Treatment Period|Lack of Efficacy|20|||
46769241|NCT00751881|82987657|FG000|Core Treatment Period|Poor compliance to protocol|15|||
46769242|NCT00751881|82987658|FG001|Core Treatment Period|Poor compliance to protocol|3|||
46769243|NCT00751881|82987659|FG002|Core Treatment Period|Poor compliance to protocol|4|||
46839387|NCT00286442|83056486|FG000|Overall Study|Physician Decision|1|||
46839388|NCT00286442|83056487|FG001|Overall Study|Physician Decision|1|||
46769244|NCT00751881|82987657|FG000|Core Treatment Period|Lost to Follow-up|6|||
46769245|NCT00751881|82987658|FG001|Core Treatment Period|Lost to Follow-up|4|||
46769246|NCT00751881|82987659|FG002|Core Treatment Period|Lost to Follow-up|3|||
46769247|NCT00751881|82987657|FG000|Core Treatment Period|Other: protocol deviation|3|||
46769248|NCT00751881|82987658|FG001|Core Treatment Period|Other: protocol deviation|3|||
46769249|NCT00751881|82987659|FG002|Core Treatment Period|Other: protocol deviation|7|||
46769250|NCT00751881|82987657|FG000|Core Treatment Period|Other: wish to parent|5|||
46769251|NCT00751881|82987658|FG001|Core Treatment Period|Other: wish to parent|7|||
46769252|NCT00751881|82987659|FG002|Core Treatment Period|Other: wish to parent|4|||
46769253|NCT00751881|82987657|FG000|Core Treatment Period|Other: personal/family constraints|6|||
46839389|NCT00286442|83056488|FG002|Overall Study|Physician Decision|1|||
46839390|NCT00286442|83056486|FG000|Overall Study|Administrative Error|1|||
46839391|NCT00286442|83056487|FG001|Overall Study|Administrative Error|1|||
46839392|NCT00286442|83056488|FG002|Overall Study|Administrative Error|0|||
46839393|NCT00286442|83056486|FG000|Overall Study|Withdrawal by Subject|2|||
46839394|NCT00286442|83056487|FG001|Overall Study|Withdrawal by Subject|14|||
46839395|NCT00286442|83056488|FG002|Overall Study|Withdrawal by Subject|2|||
46839396|NCT00063934|83056496|FG000|Overall Study|Ineligible|1|||
46839397|NCT00458783|83056502|FG000|Overall Study|Protocol Violation|1228|||
46839398|NCT00458783|83056503|FG001|Overall Study|Protocol Violation|1220|||
46839399|NCT00063154|83056509|FG000|Overall Study|Disease progression|27|||
46839400|NCT00063154|83056509|FG000|Overall Study|Adverse Event|2|||
46839401|NCT00063154|83056509|FG000|Overall Study|Physician Decision|10|||
47063386|NCT01515319|83345016|FG006|Overall Study|Withdrawal by Subject|1|||
47063387|NCT01515319|83345017|FG007|Overall Study|Withdrawal by Subject|0|||
47063388|NCT01515319|83345018|FG008|Overall Study|Withdrawal by Subject|0|||
46769254|NCT00751881|82987658|FG001|Core Treatment Period|Other: personal/family constraints|7|||
46839402|NCT00063154|83056509|FG000|Overall Study|Death|3|||
46839403|NCT00063154|83056509|FG000|Overall Study|Reason unspecified|1|||
46839404|NCT00063154|83056509|FG000|Overall Study|Did not receive treatment|8|||
46839405|NCT00311168|83056515|FG000|First Intervention|Withdrawal by Subject|2|||
46839406|NCT00311168|83056516|FG001|First Intervention|Withdrawal by Subject|2|||
46839407|NCT00311168|83056515|FG000|First Intervention|Lost to Follow-up|1|||
46839408|NCT00311168|83056516|FG001|First Intervention|Lost to Follow-up|1|||
46839409|NCT00311168|83056515|FG000|First Intervention|Protocol Violation|1|||
46839410|NCT00311168|83056516|FG001|First Intervention|Protocol Violation|1|||
46839411|NCT00311168|83056515|FG000|First Intervention|Adverse Event|1|||
46839412|NCT00311168|83056516|FG001|First Intervention|Adverse Event|0|||
46839413|NCT00311168|83056515|FG000|First Intervention|Other|2|||
46839414|NCT00311168|83056516|FG001|First Intervention|Other|2|||
46839415|NCT00311168|83056515|FG000|Second Intervention|Lost to Follow-up|9|||
46839416|NCT00311168|83056516|FG001|Second Intervention|Lost to Follow-up|2|||
46839417|NCT00311168|83056515|FG000|Second Intervention|Withdrawal by Subject|0|||
46839418|NCT00311168|83056516|FG001|Second Intervention|Withdrawal by Subject|1|||
46839419|NCT00311168|83056515|FG000|Second Intervention|Other|1|||
46839420|NCT00311168|83056516|FG001|Second Intervention|Other|1|||
46839421|NCT00458705|83056524|FG000|Overall Study|Adverse Event|4|||
46839422|NCT00458705|83056524|FG000|Overall Study|Not Treated|1|||
46839423|NCT00062374|83056528|FG000|Overall Study|Not treated|12|||
46839424|NCT00285818|83056534|FG000|Overall Study|Withdrawal by Subject|3|||
46839425|NCT00285818|83056535|FG001|Overall Study|Withdrawal by Subject|2|||
46839426|NCT00285818|83056534|FG000|Overall Study|Lost to Follow-up|1|||
46839427|NCT00285818|83056535|FG001|Overall Study|Lost to Follow-up|0|||
46839428|NCT04761627|83056632|FG000|Run-in Period|Death|1|||
46839429|NCT04761627|83056633|FG001|Run-in Period|Death|0|||
46839430|NCT04761627|83056634|FG002|Run-in Period|Death|0|||
46839431|NCT04761627|83056632|FG000|Run-in Period|Required alternative therapy|2|||
46839432|NCT04761627|83056633|FG001|Run-in Period|Required alternative therapy|0|||
46839433|NCT04761627|83056634|FG002|Run-in Period|Required alternative therapy|0|||
46839434|NCT04761627|83056632|FG000|Run-in Period|Lost to Follow-up|2|||
46839435|NCT04761627|83056633|FG001|Run-in Period|Lost to Follow-up|0|||
46839436|NCT04761627|83056634|FG002|Run-in Period|Lost to Follow-up|0|||
46839437|NCT04761627|83056632|FG000|Run-in Period|Protocol Violation|3|||
46839438|NCT04761627|83056633|FG001|Run-in Period|Protocol Violation|0|||
46839439|NCT04761627|83056634|FG002|Run-in Period|Protocol Violation|0|||
46839440|NCT04761627|83056632|FG000|Run-in Period|Abnormal liver function|1|||
46839441|NCT04761627|83056633|FG001|Run-in Period|Abnormal liver function|0|||
46839442|NCT04761627|83056634|FG002|Run-in Period|Abnormal liver function|0|||
47063389|NCT01515319|83345019|FG009|Overall Study|Withdrawal by Subject|0|||
47063390|NCT01515319|83345010|FG000|Overall Study|Adverse Event|0|||
47063391|NCT01515319|83345011|FG001|Overall Study|Adverse Event|0|||
47063392|NCT01515319|83345012|FG002|Overall Study|Adverse Event|0|||
47063393|NCT01515319|83345013|FG003|Overall Study|Adverse Event|0|||
47063394|NCT01515319|83345014|FG004|Overall Study|Adverse Event|0|||
47063395|NCT01515319|83345015|FG005|Overall Study|Adverse Event|0|||
47063396|NCT01515319|83345016|FG006|Overall Study|Adverse Event|0|||
47063397|NCT01515319|83345017|FG007|Overall Study|Adverse Event|0|||
47063398|NCT01515319|83345018|FG008|Overall Study|Adverse Event|3|||
47063399|NCT01515319|83345019|FG009|Overall Study|Adverse Event|0|||
47063400|NCT01515319|83345010|FG000|Overall Study|Protocol Violation|0|||
47063401|NCT01515319|83345011|FG001|Overall Study|Protocol Violation|0|||
47063402|NCT01515319|83345012|FG002|Overall Study|Protocol Violation|0|||
47063403|NCT01515319|83345013|FG003|Overall Study|Protocol Violation|0|||
47063404|NCT01515319|83345014|FG004|Overall Study|Protocol Violation|0|||
47063405|NCT01515319|83345015|FG005|Overall Study|Protocol Violation|0|||
47063406|NCT01515319|83345016|FG006|Overall Study|Protocol Violation|0|||
46839443|NCT04761627|83056632|FG000|Run-in Period|Adverse Event|6|||
46839444|NCT04761627|83056633|FG001|Run-in Period|Adverse Event|0|||
46839445|NCT04761627|83056634|FG002|Run-in Period|Adverse Event|0|||
46839446|NCT04761627|83056632|FG000|Run-in Period|Withdrawal by Subject|7|||
46839447|NCT04761627|83056633|FG001|Run-in Period|Withdrawal by Subject|0|||
46839448|NCT04761627|83056634|FG002|Run-in Period|Withdrawal by Subject|0|||
46839449|NCT04761627|83056632|FG000|Run-in Period|Did not meet PASI 50|15|||
46839450|NCT04761627|83056633|FG001|Run-in Period|Did not meet PASI 50|0|||
46839451|NCT04761627|83056634|FG002|Run-in Period|Did not meet PASI 50|0|||
46839452|NCT04761627|83056632|FG000|Run-in Period|Study site closure|2|||
46839453|NCT04761627|83056633|FG001|Run-in Period|Study site closure|0|||
46839454|NCT04761627|83056634|FG002|Run-in Period|Study site closure|0|||
47063407|NCT01515319|83345017|FG007|Overall Study|Protocol Violation|0|||
47063408|NCT01515319|83345018|FG008|Overall Study|Protocol Violation|2|||
47063409|NCT01515319|83345019|FG009|Overall Study|Protocol Violation|0|||
47063410|NCT01492361|83345056|FG000|Overall Study|Withdrawal by Subject|281|||
47063411|NCT01492361|83345057|FG001|Overall Study|Withdrawal by Subject|297|||
47063412|NCT01492361|83345056|FG000|Overall Study|Physician Decision|12|||
47063413|NCT01492361|83345057|FG001|Overall Study|Physician Decision|12|||
47063414|NCT01492361|83345056|FG000|Overall Study|Lost to Follow-up|6|||
47063415|NCT01492361|83345057|FG001|Overall Study|Lost to Follow-up|13|||
47063416|NCT01492361|83345056|FG000|Overall Study|Other than specified above|106|||
47063417|NCT01492361|83345057|FG001|Overall Study|Other than specified above|138|||
47063418|NCT01514461|83345136|FG000|Overall Study|Adverse Event|2|||
47063419|NCT01514461|83345137|FG001|Overall Study|Adverse Event|1|||
47063420|NCT01514461|83345138|FG002|Overall Study|Adverse Event|3|||
47063421|NCT01514461|83345136|FG000|Overall Study|Physician Decision|1|||
46769255|NCT00751881|82987659|FG002|Core Treatment Period|Other: personal/family constraints|10|||
46839455|NCT04761627|83056632|FG000|Run-in Period|Pregnancy|2|||
46839456|NCT04761627|83056633|FG001|Run-in Period|Pregnancy|0|||
46839457|NCT04761627|83056634|FG002|Run-in Period|Pregnancy|0|||
46839458|NCT04761627|83056632|FG000|Post-randomization Period|Military service|0|||
46839459|NCT04761627|83056633|FG001|Post-randomization Period|Military service|1|||
46839460|NCT04761627|83056634|FG002|Post-randomization Period|Military service|0|||
46839461|NCT04761627|83056632|FG000|Post-randomization Period|Adverse Event|0|||
46944810|NCT00556933|83182165|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
46944811|NCT00556933|83182166|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
46944812|NCT00556933|83182163|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
47063422|NCT01514461|83345137|FG001|Overall Study|Physician Decision|1|||
47063423|NCT01514461|83345138|FG002|Overall Study|Physician Decision|0|||
47063424|NCT01514461|83345136|FG000|Overall Study|Patient/guardian decision|1|||
47063425|NCT01514461|83345137|FG001|Overall Study|Patient/guardian decision|1|||
47063426|NCT01514461|83345138|FG002|Overall Study|Patient/guardian decision|1|||
47063427|NCT01514461|83345136|FG000|Overall Study|Death|1|||
47063428|NCT01514461|83345137|FG001|Overall Study|Death|0|||
47063429|NCT01514461|83345138|FG002|Overall Study|Death|0|||
46944813|NCT00556933|83182164|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
46944814|NCT00556933|83182165|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
46944815|NCT00556933|83182166|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
46944816|NCT00556933|83182163|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
46944817|NCT00556933|83182164|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
46944818|NCT00556933|83182165|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
46944819|NCT00556933|83182166|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
46944820|NCT00556933|83182163|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
46944821|NCT00556933|83182164|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
46944822|NCT00556933|83182165|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
46944823|NCT00556933|83182166|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
46944824|NCT00556933|83182163|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
46944825|NCT00556933|83182164|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
46944826|NCT00556933|83182165|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
47063430|NCT01491737|83345184|FG000|Overall Study|Withdrawal by Subject|20|||
47063431|NCT01491737|83345185|FG001|Overall Study|Withdrawal by Subject|17|||
47063432|NCT01491737|83345184|FG000|Overall Study|Lost to Follow-up|2|||
47063433|NCT01491737|83345185|FG001|Overall Study|Lost to Follow-up|10|||
47063434|NCT01491737|83345184|FG000|Overall Study|Death|63|||
47063435|NCT01491737|83345185|FG001|Overall Study|Death|57|||
47063436|NCT01491737|83345184|FG000|Overall Study|Study Termination by Sponsor|36|||
47063437|NCT01491737|83345185|FG001|Overall Study|Study Termination by Sponsor|36|||
46769256|NCT00751881|82987657|FG000|Core Treatment Period|Other: MS treatment change|6|||
46769257|NCT00751881|82987658|FG001|Core Treatment Period|Other: MS treatment change|4|||
46769258|NCT00751881|82987659|FG002|Core Treatment Period|Other: MS treatment change|4|||
46769259|NCT00751881|82987657|FG000|Core Treatment Period|Other: tolerability complaints|2|||
46769260|NCT00751881|82987658|FG001|Core Treatment Period|Other: tolerability complaints|0|||
46769261|NCT00751881|82987659|FG002|Core Treatment Period|Other: tolerability complaints|0|||
46769262|NCT00751881|82987657|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
46769263|NCT00751881|82987658|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
46769264|NCT00751881|82987659|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
46769265|NCT00751881|82987657|FG000|Extension Study Period|Adverse Event|18|||
46769266|NCT00751881|82987658|FG001|Extension Study Period|Adverse Event|20|||
46769267|NCT00751881|82987659|FG002|Extension Study Period|Adverse Event|21|||
46839462|NCT04761627|83056633|FG001|Post-randomization Period|Adverse Event|4|||
46839463|NCT04761627|83056634|FG002|Post-randomization Period|Adverse Event|2|||
46839464|NCT04761627|83056632|FG000|Post-randomization Period|Lost to Follow-up|0|||
46839465|NCT04761627|83056633|FG001|Post-randomization Period|Lost to Follow-up|6|||
46839466|NCT04761627|83056634|FG002|Post-randomization Period|Lost to Follow-up|6|||
46944827|NCT00556933|83182166|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
47063438|NCT01491737|83345184|FG000|Overall Study|Reason Not Specified|8|||
47063439|NCT01491737|83345185|FG001|Overall Study|Reason Not Specified|9|||
47063440|NCT01487863|83345197|FG000|Overall Study|Death|19|||
47063441|NCT01487863|83345198|FG001|Overall Study|Death|19|||
47063442|NCT01487161|83345217|FG000|Overall Study|Adverse Event|1|||
47063443|NCT01487161|83345218|FG001|Overall Study|Adverse Event|0|||
47063444|NCT01487161|83345219|FG002|Overall Study|Adverse Event|0|||
47063445|NCT01487161|83345220|FG003|Overall Study|Adverse Event|0|||
47063446|NCT01487161|83345217|FG000|Overall Study|Withdrawal by Subject|1|||
46769268|NCT00751881|82987657|FG000|Extension Study Period|Lack of Efficacy|14|||
46769269|NCT00751881|82987658|FG001|Extension Study Period|Lack of Efficacy|10|||
46769270|NCT00751881|82987659|FG002|Extension Study Period|Lack of Efficacy|20|||
46769271|NCT00751881|82987657|FG000|Extension Study Period|Lost to Follow-up|4|||
46769272|NCT00751881|82987658|FG001|Extension Study Period|Lost to Follow-up|9|||
46769273|NCT00751881|82987659|FG002|Extension Study Period|Lost to Follow-up|6|||
46769274|NCT00751881|82987657|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
46769275|NCT00751881|82987658|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
46769276|NCT00751881|82987659|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
46769277|NCT00751881|82987657|FG000|Extension Study Period|Other than specified above|26|||
46769278|NCT00751881|82987658|FG001|Extension Study Period|Other than specified above|30|||
46769279|NCT00751881|82987659|FG002|Extension Study Period|Other than specified above|18|||
46769280|NCT00747474|82987673|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769281|NCT00747474|82987674|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769282|NCT00747474|82987675|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46944828|NCT00556933|83182163|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
46944829|NCT00556933|83182164|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
46944830|NCT00556933|83182165|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
46944831|NCT00556933|83182166|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
46944832|NCT00556933|83182163|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
46944833|NCT00556933|83182164|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
46944834|NCT00556933|83182165|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
46944835|NCT00556933|83182166|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
46944836|NCT00556933|83182163|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
47063447|NCT01487161|83345218|FG001|Overall Study|Withdrawal by Subject|1|||
47063448|NCT01487161|83345219|FG002|Overall Study|Withdrawal by Subject|1|||
47063449|NCT01487161|83345220|FG003|Overall Study|Withdrawal by Subject|2|||
46769283|NCT00747474|82987676|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769284|NCT00747474|82987677|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769285|NCT00747474|82987678|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769286|NCT00747474|82987679|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769287|NCT00747474|82987680|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
46769288|NCT00747474|82987681|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769289|NCT00747474|82987682|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769290|NCT00747474|82987683|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46769291|NCT00747474|82987684|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
46638593|NCT01467492|82811969|FG000|Overall Study|Undefined|2|||
46638594|NCT01467492|82811970|FG001|Overall Study|Undefined|0|||
46638595|NCT01467492|82811969|FG000|Overall Study|Enrolled But Not Treated|1|||
46638596|NCT01467492|82811970|FG001|Overall Study|Enrolled But Not Treated|0|||
46638597|NCT01466790|82811985|FG000|Overall Study|Adverse Event|1|||
46638598|NCT01466790|82811986|FG001|Overall Study|Adverse Event|0|||
46638599|NCT01466790|82811987|FG002|Overall Study|Adverse Event|0|||
46638600|NCT01466790|82811988|FG003|Overall Study|Adverse Event|0|||
46769292|NCT00830063|82987693|FG000|Overall Study|Adverse Event|7|||
46769293|NCT00830063|82987694|FG001|Overall Study|Adverse Event|13|||
46769294|NCT00830063|82987695|FG002|Overall Study|Adverse Event|16|||
46769295|NCT00830063|82987696|FG003|Overall Study|Adverse Event|13|||
46769296|NCT00830063|82987693|FG000|Overall Study|Death|1|||
46769297|NCT00830063|82987694|FG001|Overall Study|Death|0|||
46769298|NCT00830063|82987695|FG002|Overall Study|Death|0|||
47063450|NCT01487161|83345217|FG000|Overall Study|missing data|0|||
46638601|NCT01466790|82811989|FG004|Overall Study|Adverse Event|2|||
46638602|NCT01466790|82811990|FG005|Overall Study|Adverse Event|0|||
46638603|NCT01466790|82811991|FG006|Overall Study|Adverse Event|0|||
46638604|NCT01466790|82811992|FG007|Overall Study|Adverse Event|0|||
46769299|NCT00830063|82987696|FG003|Overall Study|Death|0|||
46769300|NCT00830063|82987693|FG000|Overall Study|Lost to Follow-up|0|||
46769301|NCT00830063|82987694|FG001|Overall Study|Lost to Follow-up|0|||
46769302|NCT00830063|82987695|FG002|Overall Study|Lost to Follow-up|3|||
46769303|NCT00830063|82987696|FG003|Overall Study|Lost to Follow-up|1|||
46769304|NCT00830063|82987693|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
46769305|NCT00830063|82987694|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
46839467|NCT04761627|83056632|FG000|Post-randomization Period|Withdrawal by Subject|0|||
46944837|NCT00556933|83182164|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
47063451|NCT01487161|83345218|FG001|Overall Study|missing data|1|||
46638605|NCT01466790|82811985|FG000|Overall Study|Lost to Follow-up|2|||
46769306|NCT00830063|82987695|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
46769307|NCT00830063|82987696|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
46769308|NCT00830063|82987693|FG000|Overall Study|Lack of Efficacy|51|||
46944838|NCT00556933|83182165|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
47063452|NCT01487161|83345219|FG002|Overall Study|missing data|0|||
47063453|NCT01487161|83345220|FG003|Overall Study|missing data|0|||
47063454|NCT01491035|83345275|FG000|Overall Study|Lost to Follow-up|0|||
47063455|NCT01491035|83345276|FG001|Overall Study|Lost to Follow-up|0|||
47063456|NCT01491035|83345277|FG002|Overall Study|Lost to Follow-up|0|||
47063457|NCT01491035|83345278|FG003|Overall Study|Lost to Follow-up|0|||
47063458|NCT01491035|83345279|FG004|Overall Study|Lost to Follow-up|1|||
47063459|NCT01491035|83345280|FG005|Overall Study|Lost to Follow-up|0|||
47063460|NCT01491035|83345281|FG006|Overall Study|Lost to Follow-up|0|||
47063461|NCT01491035|83345282|FG007|Overall Study|Lost to Follow-up|0|||
47063462|NCT01488071|83345306|FG000|Overall Study|Adverse Event|15|||
47063463|NCT01488071|83345307|FG001|Overall Study|Adverse Event|23|||
47063464|NCT01488071|83345306|FG000|Overall Study|Lack of Efficacy|11|||
47063465|NCT01488071|83345307|FG001|Overall Study|Lack of Efficacy|17|||
47063466|NCT01488071|83345306|FG000|Overall Study|Non-compliance with study drug|2|||
47063467|NCT01488071|83345307|FG001|Overall Study|Non-compliance with study drug|0|||
47063468|NCT01488071|83345306|FG000|Overall Study|Protocol Violation|5|||
47063469|NCT01488071|83345307|FG001|Overall Study|Protocol Violation|7|||
47063470|NCT01488071|83345306|FG000|Overall Study|Withdrawal of Consent|14|||
47063471|NCT01488071|83345307|FG001|Overall Study|Withdrawal of Consent|12|||
47063472|NCT01488071|83345306|FG000|Overall Study|Lost to Follow-up|1|||
47063473|NCT01488071|83345307|FG001|Overall Study|Lost to Follow-up|0|||
47063474|NCT01488071|83345306|FG000|Overall Study|Administrative or Other Reason(s)|5|||
47063475|NCT01488071|83345307|FG001|Overall Study|Administrative or Other Reason(s)|4|||
47063476|NCT01487525|83345315|FG000|Overall Study|Withdrawal by Subject|0|||
47063477|NCT01487525|83345316|FG001|Overall Study|Withdrawal by Subject|1|||
47063478|NCT01486199|83345324|FG000|Two Year Period Between Study Days|Physician Decision|1|||
47063479|NCT01486199|83345325|FG001|Two Year Period Between Study Days|Physician Decision|0|||
46839468|NCT04761627|83056633|FG001|Post-randomization Period|Withdrawal by Subject|7|||
46839469|NCT04761627|83056634|FG002|Post-randomization Period|Withdrawal by Subject|6|||
46839470|NCT04761627|83056632|FG000|Post-randomization Period|Pregnancy|0|||
46839471|NCT04761627|83056633|FG001|Post-randomization Period|Pregnancy|0|||
46839472|NCT04761627|83056634|FG002|Post-randomization Period|Pregnancy|1|||
46839473|NCT04761627|83056632|FG000|Post-randomization Period|Study site closure|0|||
46839474|NCT04761627|83056633|FG001|Post-randomization Period|Study site closure|0|||
46839475|NCT04761627|83056634|FG002|Post-randomization Period|Study site closure|1|||
46839476|NCT04761627|83056632|FG000|Post-randomization Period|Family planning|0|||
46839477|NCT04761627|83056633|FG001|Post-randomization Period|Family planning|1|||
46839478|NCT04761627|83056634|FG002|Post-randomization Period|Family planning|0|||
46839479|NCT04621786|83056651|FG000|Overall Study|Lost to Follow-up|9|||
46839480|NCT04621786|83056651|FG000|Overall Study|Protocol Violation|3|||
46839481|NCT04025710|83056668|FG000|Overall Study|Death|3|||
46839482|NCT04025710|83056668|FG000|Overall Study|Lost to Follow-up|5|||
46769309|NCT00830063|82987694|FG001|Overall Study|Lack of Efficacy|23|||
46769310|NCT00830063|82987695|FG002|Overall Study|Lack of Efficacy|25|||
46769311|NCT00830063|82987696|FG003|Overall Study|Lack of Efficacy|32|||
46769312|NCT00830063|82987693|FG000|Overall Study|Other|5|||
46839483|NCT04025710|83056668|FG000|Overall Study|Withdrawal by Subject|1|||
46839484|NCT04025710|83056668|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
46839485|NCT04025710|83056668|FG000|Overall Study|Drop-out according to protocol|34|||
46944839|NCT00556933|83182166|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
47063480|NCT01485887|83345331|FG000|Overall Study|Withdrawal by Subject|2|||
47063481|NCT01485887|83345331|FG000|Overall Study|Adverse Event|8|||
46769313|NCT00830063|82987694|FG001|Overall Study|Other|5|||
46769314|NCT00830063|82987695|FG002|Overall Study|Other|8|||
46769315|NCT00830063|82987696|FG003|Overall Study|Other|6|||
46769316|NCT00830063|82987693|FG000|Overall Study|Withdrawal by Subject|16|||
46769317|NCT00830063|82987694|FG001|Overall Study|Withdrawal by Subject|10|||
46839486|NCT03147287|83056748|FG000|Overall Study|Randomized Not Treated|2|||
46839487|NCT03147287|83056749|FG001|Overall Study|Randomized Not Treated|1|||
46839488|NCT03147287|83056750|FG002|Overall Study|Randomized Not Treated|1|||
46944840|NCT00556933|83182163|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
47063482|NCT01485887|83345331|FG000|Overall Study|Deterioration of primary disease|1|||
47063483|NCT01485887|83345331|FG000|Overall Study|Primary disease markedly improved|1|||
47063484|NCT01546519|83345339|FG000|Overall Study|Adverse Event|0|||
47063485|NCT01546519|83345340|FG001|Overall Study|Adverse Event|0|||
47063486|NCT01546519|83345341|FG002|Overall Study|Adverse Event|1|||
47063487|NCT01546519|83345342|FG003|Overall Study|Adverse Event|1|||
47063488|NCT01546519|83345339|FG000|Overall Study|Death|0|||
47063489|NCT01546519|83345340|FG001|Overall Study|Death|1|||
47063490|NCT01546519|83345341|FG002|Overall Study|Death|3|||
47063491|NCT01546519|83345342|FG003|Overall Study|Death|1|||
47063492|NCT01546519|83345339|FG000|Overall Study|related to disease progression|2|||
47063493|NCT01546519|83345340|FG001|Overall Study|related to disease progression|2|||
46769318|NCT00830063|82987695|FG002|Overall Study|Withdrawal by Subject|16|||
46944841|NCT00556933|83182164|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
46944842|NCT00556933|83182165|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
46944843|NCT00556933|83182166|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
46944844|NCT00556933|83182163|FG000|CNI Withdrawal vs. Minimization|Death|0|||
46944845|NCT00556933|83182164|FG001|CNI Withdrawal vs. Minimization|Death|0|||
46944846|NCT00556933|83182165|FG002|CNI Withdrawal vs. Minimization|Death|0|||
46944847|NCT00556933|83182166|FG003|CNI Withdrawal vs. Minimization|Death|1|||
46944848|NCT00280917|83182205|FG000|Overall Study|Adverse Event|1|||
46944849|NCT00280917|83182206|FG001|Overall Study|Adverse Event|1|||
46944850|NCT00280917|83182207|FG002|Overall Study|Adverse Event|4|||
46944851|NCT00280917|83182208|FG003|Overall Study|Adverse Event|1|||
46944852|NCT00280917|83182205|FG000|Overall Study|Change Therapy|1|||
46944853|NCT00280917|83182206|FG001|Overall Study|Change Therapy|2|||
46944854|NCT00280917|83182207|FG002|Overall Study|Change Therapy|0|||
46944855|NCT00280917|83182208|FG003|Overall Study|Change Therapy|0|||
46944856|NCT00280917|83182205|FG000|Overall Study|Withdrawal by Subject|0|||
46944857|NCT00280917|83182206|FG001|Overall Study|Withdrawal by Subject|2|||
46944858|NCT00280917|83182207|FG002|Overall Study|Withdrawal by Subject|0|||
46944859|NCT00280917|83182208|FG003|Overall Study|Withdrawal by Subject|1|||
46944860|NCT00280917|83182205|FG000|Overall Study|Noncompliance|0|||
46944861|NCT00280917|83182206|FG001|Overall Study|Noncompliance|1|||
46944862|NCT00280917|83182207|FG002|Overall Study|Noncompliance|2|||
46944863|NCT00280917|83182208|FG003|Overall Study|Noncompliance|0|||
46944864|NCT00006478|83182227|FG000|Overall Study|Vaccine could not be produced|1|||
46944865|NCT00006478|83182227|FG000|Overall Study|Physician Decision|6|||
46944866|NCT05718466|83182233|FG000|Overall Study|Withdrawal by Subject|1|||
46944867|NCT05718466|83182234|FG001|Overall Study|Withdrawal by Subject|2|||
46944868|NCT05718466|83182233|FG000|Overall Study|Death|0|||
46944869|NCT05718466|83182234|FG001|Overall Study|Death|1|||
46944870|NCT04938453|83182242|FG000|Washout Period 1|Adverse Event|1|||
46944871|NCT04938453|83182243|FG001|Washout Period 1|Adverse Event|0|||
46944872|NCT04938453|83182242|FG000|Washout Period 1|Physician Decision|0|||
46944873|NCT04938453|83182243|FG001|Washout Period 1|Physician Decision|1|||
46944874|NCT04147260|83182279|FG000|Overall Study|Adverse Event|1|||
46944875|NCT04147260|83182280|FG001|Overall Study|Adverse Event|0|||
46944876|NCT04147260|83182281|FG002|Overall Study|Adverse Event|1|||
46944877|NCT04147260|83182282|FG003|Overall Study|Adverse Event|2|||
46944878|NCT04147260|83182283|FG004|Overall Study|Adverse Event|0|||
46944879|NCT04147260|83182279|FG000|Overall Study|Withdrawal by Subject|0|||
46944880|NCT04147260|83182280|FG001|Overall Study|Withdrawal by Subject|0|||
46944881|NCT04147260|83182281|FG002|Overall Study|Withdrawal by Subject|1|||
46944882|NCT04147260|83182282|FG003|Overall Study|Withdrawal by Subject|1|||
46944883|NCT04147260|83182283|FG004|Overall Study|Withdrawal by Subject|0|||
46944884|NCT04134728|83182300|FG000|Overall Study|Adverse Event|3|||
46944885|NCT04134728|83182301|FG001|Overall Study|Adverse Event|2|||
46944886|NCT04134728|83182302|FG002|Overall Study|Adverse Event|9|||
46944887|NCT04134728|83182303|FG003|Overall Study|Adverse Event|0|||
46944888|NCT04134728|83182304|FG004|Overall Study|Adverse Event|0|||
46944889|NCT04134728|83182305|FG005|Overall Study|Adverse Event|0|||
46944890|NCT04134728|83182300|FG000|Overall Study|Lack of Efficacy|3|||
46944891|NCT04134728|83182301|FG001|Overall Study|Lack of Efficacy|3|||
46944892|NCT04134728|83182302|FG002|Overall Study|Lack of Efficacy|1|||
46944893|NCT04134728|83182303|FG003|Overall Study|Lack of Efficacy|2|||
46944894|NCT04134728|83182304|FG004|Overall Study|Lack of Efficacy|0|||
46944895|NCT04134728|83182305|FG005|Overall Study|Lack of Efficacy|0|||
46944896|NCT04134728|83182300|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
46944897|NCT04134728|83182301|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
46944898|NCT04134728|83182302|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
46944899|NCT04134728|83182303|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
47063494|NCT01546519|83345341|FG002|Overall Study|related to disease progression|2|||
47063495|NCT01546519|83345342|FG003|Overall Study|related to disease progression|1|||
47063496|NCT01546519|83345339|FG000|Overall Study|Physician Decision|6|||
47063497|NCT01546519|83345340|FG001|Overall Study|Physician Decision|5|||
47063498|NCT01546519|83345341|FG002|Overall Study|Physician Decision|2|||
46769319|NCT00830063|82987696|FG003|Overall Study|Withdrawal by Subject|13|||
46839489|NCT03147287|83056748|FG000|Overall Study|Progressive Disease RECIST|31|||
46944900|NCT04134728|83182304|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
46944901|NCT04134728|83182305|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
46944902|NCT04134728|83182300|FG000|Overall Study|Protocol Deviation|0|||
46944903|NCT04134728|83182301|FG001|Overall Study|Protocol Deviation|0|||
46944904|NCT04134728|83182302|FG002|Overall Study|Protocol Deviation|1|||
46944905|NCT04134728|83182303|FG003|Overall Study|Protocol Deviation|0|||
46944906|NCT04134728|83182304|FG004|Overall Study|Protocol Deviation|0|||
46944907|NCT04134728|83182305|FG005|Overall Study|Protocol Deviation|0|||
47063499|NCT01546519|83345342|FG003|Overall Study|Physician Decision|3|||
46944908|NCT04134728|83182300|FG000|Overall Study|Informed Consent Withdrawn|3|||
46944909|NCT04134728|83182301|FG001|Overall Study|Informed Consent Withdrawn|6|||
46944910|NCT04134728|83182302|FG002|Overall Study|Informed Consent Withdrawn|8|||
46944911|NCT04134728|83182303|FG003|Overall Study|Informed Consent Withdrawn|1|||
46944912|NCT04134728|83182304|FG004|Overall Study|Informed Consent Withdrawn|1|||
46944913|NCT04134728|83182305|FG005|Overall Study|Informed Consent Withdrawn|0|||
46944914|NCT04134728|83182300|FG000|Overall Study|Physician Decision|2|||
46944915|NCT04134728|83182301|FG001|Overall Study|Physician Decision|0|||
46944916|NCT04134728|83182302|FG002|Overall Study|Physician Decision|0|||
46944917|NCT04134728|83182303|FG003|Overall Study|Physician Decision|0|||
46944918|NCT04134728|83182304|FG004|Overall Study|Physician Decision|0|||
46944919|NCT04134728|83182305|FG005|Overall Study|Physician Decision|0|||
46944920|NCT04134728|83182300|FG000|Overall Study|Lost to Follow-up|1|||
46944921|NCT04134728|83182301|FG001|Overall Study|Lost to Follow-up|2|||
46944922|NCT04134728|83182302|FG002|Overall Study|Lost to Follow-up|1|||
46944923|NCT04134728|83182303|FG003|Overall Study|Lost to Follow-up|0|||
46944924|NCT04134728|83182304|FG004|Overall Study|Lost to Follow-up|0|||
46944925|NCT04134728|83182305|FG005|Overall Study|Lost to Follow-up|1|||
46944926|NCT04134728|83182300|FG000|Overall Study|Investigator Site Closed|0|||
46944927|NCT04134728|83182301|FG001|Overall Study|Investigator Site Closed|1|||
46944928|NCT04134728|83182302|FG002|Overall Study|Investigator Site Closed|1|||
46944929|NCT04134728|83182303|FG003|Overall Study|Investigator Site Closed|0|||
46944930|NCT04134728|83182304|FG004|Overall Study|Investigator Site Closed|0|||
46944931|NCT04134728|83182305|FG005|Overall Study|Investigator Site Closed|0|||
46944932|NCT03886272|83182339|FG000|Period 1|Withdrawal by Subject|0|||
46944933|NCT03886272|83182340|FG001|Period 1|Withdrawal by Subject|0|||
46944934|NCT03886272|83182341|FG002|Period 1|Withdrawal by Subject|0|||
46944935|NCT03886272|83182342|FG003|Period 1|Withdrawal by Subject|0|||
46944936|NCT03886272|83182343|FG004|Period 1|Withdrawal by Subject|0|||
46944937|NCT03886272|83182344|FG005|Period 1|Withdrawal by Subject|1|||
46944938|NCT03886272|83182345|FG006|Period 1|Withdrawal by Subject|0|||
46944939|NCT03732833|83182364|FG000|Overall Study|Adverse Event|0|||
46944940|NCT03732833|83182365|FG001|Overall Study|Adverse Event|3|||
46944941|NCT03732833|83182366|FG002|Overall Study|Adverse Event|1|||
46944942|NCT03732833|83182364|FG000|Overall Study|Withdrawal by Subject|11|||
46944943|NCT03732833|83182365|FG001|Overall Study|Withdrawal by Subject|13|||
46944944|NCT03732833|83182366|FG002|Overall Study|Withdrawal by Subject|8|||
46944945|NCT03732833|83182364|FG000|Overall Study|Lost to Follow-up|3|||
46944946|NCT03732833|83182365|FG001|Overall Study|Lost to Follow-up|5|||
46944947|NCT03732833|83182366|FG002|Overall Study|Lost to Follow-up|4|||
46944948|NCT03732833|83182364|FG000|Overall Study|Pregnancy|0|||
46944949|NCT03732833|83182365|FG001|Overall Study|Pregnancy|2|||
47063500|NCT01546519|83345339|FG000|Overall Study|Withdrawal by Subject|1|||
47063501|NCT01546519|83345340|FG001|Overall Study|Withdrawal by Subject|0|||
47063502|NCT01546519|83345341|FG002|Overall Study|Withdrawal by Subject|0|||
47063503|NCT01546519|83345342|FG003|Overall Study|Withdrawal by Subject|0|||
47063504|NCT01484951|83345356|FG000|Overall Study|Adverse Event|3|||
47063505|NCT01484951|83345356|FG000|Overall Study|Personal Reasons|1|||
47063506|NCT01484951|83345356|FG000|Overall Study|Non-Compliance|1|||
47063507|NCT01484873|83345360|FG000|Overall Study|Withdrawal by Subject|2|||
47063508|NCT01486927|83345365|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
47063509|NCT01486927|83345365|FG000|Overall Study|Physician Decision|1|||
47063510|NCT01486927|83345365|FG000|Overall Study|50 Exposure days not reached|2|||
47063511|NCT01486927|83345365|FG000|Overall Study|Withdrawal by Subject|8|||
47063512|NCT01486927|83345365|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
47063513|NCT01513759|83345398|FG000|Overall Study|Protocol Violation|4|||
47063514|NCT01513759|83345398|FG000|Overall Study|Death during catheter placement|1|||
47063515|NCT01484561|83345404|FG000|Overall Study|Lack of Efficacy|3|||
47063516|NCT01484561|83345405|FG001|Overall Study|Lack of Efficacy|1|||
47063517|NCT01484561|83345404|FG000|Overall Study|Lost to Follow-up|1|||
47063518|NCT01484561|83345405|FG001|Overall Study|Lost to Follow-up|0|||
47063519|NCT01484561|83345404|FG000|Overall Study|Withdrawal by Subject|3|||
47063520|NCT01484561|83345405|FG001|Overall Study|Withdrawal by Subject|0|||
47063521|NCT01484561|83345404|FG000|Overall Study|Other|1|||
47063522|NCT01484561|83345405|FG001|Overall Study|Other|1|||
47063523|NCT01484561|83345404|FG000|Overall Study|Adverse Event|1|||
47063524|NCT01484561|83345405|FG001|Overall Study|Adverse Event|4|||
47063525|NCT01546207|83345411|FG000|Overall Study|Death|1|||
47063526|NCT01513291|83345417|FG000|Treatment Period|Adverse Event|8|||
47063527|NCT01513291|83345418|FG001|Treatment Period|Adverse Event|4|||
47063528|NCT01513291|83345419|FG002|Treatment Period|Adverse Event|0|||
46839490|NCT03147287|83056749|FG001|Overall Study|Progressive Disease RECIST|72|||
46944950|NCT03732833|83182366|FG002|Overall Study|Pregnancy|0|||
46944951|NCT03732833|83182364|FG000|Overall Study|Physician Decision|2|||
46944952|NCT03732833|83182365|FG001|Overall Study|Physician Decision|3|||
46944953|NCT03732833|83182366|FG002|Overall Study|Physician Decision|1|||
46944954|NCT03732833|83182364|FG000|Overall Study|Covid-19 related and other reasons|2|||
46944955|NCT03732833|83182365|FG001|Overall Study|Covid-19 related and other reasons|7|||
47063529|NCT01513291|83345420|FG003|Treatment Period|Adverse Event|0|||
46944956|NCT03732833|83182366|FG002|Overall Study|Covid-19 related and other reasons|3|||
47063530|NCT01513291|83345421|FG004|Treatment Period|Adverse Event|0|||
46944957|NCT03493919|83182383|FG000|Overall Study|Other|2|||
46944958|NCT03493919|83182384|FG001|Overall Study|Other|0|||
46944959|NCT03493919|83182385|FG002|Overall Study|Other|1|||
46944960|NCT03493919|83182386|FG003|Overall Study|Other|0|||
46944961|NCT03493919|83182383|FG000|Overall Study|Withdrawal by Subject|9|||
46944962|NCT03493919|83182384|FG001|Overall Study|Withdrawal by Subject|3|||
46944963|NCT03493919|83182385|FG002|Overall Study|Withdrawal by Subject|1|||
46944964|NCT03493919|83182386|FG003|Overall Study|Withdrawal by Subject|1|||
46944965|NCT03493919|83182383|FG000|Overall Study|Lost to Follow-up|5|||
46944966|NCT03493919|83182384|FG001|Overall Study|Lost to Follow-up|0|||
46944967|NCT03493919|83182385|FG002|Overall Study|Lost to Follow-up|0|||
46944968|NCT03493919|83182386|FG003|Overall Study|Lost to Follow-up|3|||
47063531|NCT01513291|83345417|FG000|Treatment Period|Lack of Efficacy|3|||
47063532|NCT01513291|83345418|FG001|Treatment Period|Lack of Efficacy|0|||
47063533|NCT01513291|83345419|FG002|Treatment Period|Lack of Efficacy|0|||
47063534|NCT01513291|83345420|FG003|Treatment Period|Lack of Efficacy|0|||
47063535|NCT01513291|83345421|FG004|Treatment Period|Lack of Efficacy|0|||
47063536|NCT01513291|83345417|FG000|Treatment Period|Lost to Follow-up|2|||
46944969|NCT03493919|83182383|FG000|Overall Study|Adverse Event|0|||
46944970|NCT03493919|83182384|FG001|Overall Study|Adverse Event|1|||
46944971|NCT03493919|83182385|FG002|Overall Study|Adverse Event|0|||
46944972|NCT03493919|83182386|FG003|Overall Study|Adverse Event|0|||
46944973|NCT03280628|83182404|FG000|Overall Study|Lost to Follow-up|8|||
46944974|NCT03280628|83182405|FG001|Overall Study|Lost to Follow-up|6|||
46944975|NCT03280628|83182406|FG002|Overall Study|Lost to Follow-up|11|||
46944976|NCT03058146|83182433|FG000|Overall Study|Withdrawal by Subject|4|||
47063537|NCT01513291|83345418|FG001|Treatment Period|Lost to Follow-up|3|||
47063538|NCT01513291|83345419|FG002|Treatment Period|Lost to Follow-up|0|||
47063539|NCT01513291|83345420|FG003|Treatment Period|Lost to Follow-up|0|||
47063540|NCT01513291|83345421|FG004|Treatment Period|Lost to Follow-up|0|||
47063541|NCT01513291|83345417|FG000|Treatment Period|Physician Decision|1|||
47063542|NCT01513291|83345418|FG001|Treatment Period|Physician Decision|0|||
47063543|NCT01513291|83345419|FG002|Treatment Period|Physician Decision|0|||
47063544|NCT01513291|83345420|FG003|Treatment Period|Physician Decision|0|||
47063545|NCT01513291|83345421|FG004|Treatment Period|Physician Decision|0|||
47063546|NCT01513291|83345417|FG000|Treatment Period|Protocol Violation|1|||
47063547|NCT01513291|83345418|FG001|Treatment Period|Protocol Violation|2|||
47063548|NCT01513291|83345419|FG002|Treatment Period|Protocol Violation|0|||
47063549|NCT01513291|83345420|FG003|Treatment Period|Protocol Violation|0|||
47063550|NCT01513291|83345421|FG004|Treatment Period|Protocol Violation|0|||
46944977|NCT03058146|83182434|FG001|Overall Study|Withdrawal by Subject|1|||
47063551|NCT01513291|83345417|FG000|Treatment Period|Withdrawal by Subject|8|||
47063552|NCT01513291|83345418|FG001|Treatment Period|Withdrawal by Subject|5|||
47063553|NCT01513291|83345419|FG002|Treatment Period|Withdrawal by Subject|0|||
46769320|NCT00830063|82987693|FG000|Overall Study|Protocol Violation|1|||
46769321|NCT00830063|82987694|FG001|Overall Study|Protocol Violation|0|||
46769322|NCT00830063|82987695|FG002|Overall Study|Protocol Violation|3|||
46769323|NCT00830063|82987696|FG003|Overall Study|Protocol Violation|2|||
46769324|NCT00830063|82987693|FG000|Overall Study|Randomized But Not Treated|0|||
46769325|NCT00830063|82987694|FG001|Overall Study|Randomized But Not Treated|2|||
46769326|NCT00830063|82987695|FG002|Overall Study|Randomized But Not Treated|0|||
46769327|NCT00830063|82987696|FG003|Overall Study|Randomized But Not Treated|2|||
46769328|NCT00750438|82987710|FG000|Overall Study|Protocol Violation|4|||
46769329|NCT00750438|82987711|FG001|Overall Study|Protocol Violation|1|||
46769330|NCT00750438|82987710|FG000|Overall Study|Physician Decision|2|||
46769331|NCT00750438|82987711|FG001|Overall Study|Physician Decision|2|||
46769332|NCT00750438|82987710|FG000|Overall Study|Withdrawal by Subject|1|||
46769333|NCT00750438|82987711|FG001|Overall Study|Withdrawal by Subject|1|||
46769334|NCT00586326|82987717|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
46769335|NCT00586326|82987717|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
46769336|NCT00586326|82987717|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
46769337|NCT00586326|82987717|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
46769338|NCT00586326|82987717|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
46769339|NCT00586326|82987717|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
46839491|NCT03147287|83056750|FG002|Overall Study|Progressive Disease RECIST|32|||
46944978|NCT03058146|83182433|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
47063554|NCT01513291|83345420|FG003|Treatment Period|Withdrawal by Subject|0|||
47063555|NCT01513291|83345421|FG004|Treatment Period|Withdrawal by Subject|0|||
46944979|NCT03058146|83182434|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
46944980|NCT02851511|83182446|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
47063556|NCT01513291|83345417|FG000|Treatment Period|Randomized not treated|0|||
46638606|NCT01466790|82811986|FG001|Overall Study|Lost to Follow-up|0|||
46769340|NCT00586326|82987717|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
46769341|NCT00586326|82987717|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
46769342|NCT00586326|82987717|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
46769343|NCT00586326|82987717|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
46944981|NCT02851511|83182447|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
46944982|NCT02851511|83182448|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
46944983|NCT02851511|83182449|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
46944984|NCT02851511|83182446|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
46769344|NCT00586326|82987717|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
46769345|NCT00586326|82987717|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
46769346|NCT00586326|82987717|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
46769347|NCT00586326|82987717|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
47063557|NCT01513291|83345418|FG001|Treatment Period|Randomized not treated|2|||
46944985|NCT02851511|83182447|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
46944986|NCT02851511|83182448|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
46944987|NCT02851511|83182449|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
46944988|NCT02851511|83182446|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
46944989|NCT02851511|83182447|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
46944990|NCT02851511|83182448|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
46944991|NCT02851511|83182449|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
46944992|NCT02851511|83182446|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
46944993|NCT02851511|83182447|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
46944994|NCT02851511|83182448|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
46944995|NCT02851511|83182449|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
46944996|NCT02851511|83182446|FG000|Phase I|Physician Decision|0|||
46944997|NCT02851511|83182447|FG001|Phase I|Physician Decision|0|||
46944998|NCT02851511|83182448|FG002|Phase I|Physician Decision|0|||
46944999|NCT02851511|83182449|FG003|Phase I|Physician Decision|1|||
46945000|NCT02851511|83182446|FG000|Phase I|Withdrawal by Subject|2|||
46945001|NCT02851511|83182447|FG001|Phase I|Withdrawal by Subject|1|||
46945002|NCT02851511|83182448|FG002|Phase I|Withdrawal by Subject|0|||
46945003|NCT02851511|83182449|FG003|Phase I|Withdrawal by Subject|3|||
46945004|NCT02851511|83182446|FG000|Phase II|Physician Decision|18|||
46945005|NCT02851511|83182447|FG001|Phase II|Physician Decision|16|||
46945006|NCT02851511|83182448|FG002|Phase II|Physician Decision|0|||
46945007|NCT02851511|83182449|FG003|Phase II|Physician Decision|0|||
46945008|NCT02851511|83182446|FG000|Phase II|Withdrawal by Subject|18|||
46945009|NCT02851511|83182447|FG001|Phase II|Withdrawal by Subject|16|||
46945010|NCT02851511|83182448|FG002|Phase II|Withdrawal by Subject|0|||
46945011|NCT02851511|83182449|FG003|Phase II|Withdrawal by Subject|0|||
46945012|NCT02851511|83182446|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
46945013|NCT02851511|83182447|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
46945014|NCT02851511|83182448|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
46945015|NCT02851511|83182449|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
46945016|NCT02851511|83182446|FG000|Phase II|Lost to Follow-up|0|||
46945017|NCT02851511|83182447|FG001|Phase II|Lost to Follow-up|1|||
47063558|NCT01513291|83345419|FG002|Treatment Period|Randomized not treated|0|||
47063559|NCT01513291|83345420|FG003|Treatment Period|Randomized not treated|0|||
47063560|NCT01513291|83345421|FG004|Treatment Period|Randomized not treated|0|||
47063561|NCT01513291|83345417|FG000|Run-out Period|Lost to Follow-up|0|||
47063562|NCT01513291|83345418|FG001|Run-out Period|Lost to Follow-up|0|||
47063563|NCT01513291|83345419|FG002|Run-out Period|Lost to Follow-up|0|||
46769348|NCT00586326|82987717|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
46769349|NCT00586326|82987717|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
46769350|NCT00586326|82987717|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
47063564|NCT01513291|83345420|FG003|Run-out Period|Lost to Follow-up|1|||
47063565|NCT01513291|83345421|FG004|Run-out Period|Lost to Follow-up|0|||
47063566|NCT01513291|83345417|FG000|Run-out Period|Withdrawal by Subject|0|||
47063567|NCT01513291|83345418|FG001|Run-out Period|Withdrawal by Subject|0|||
47063568|NCT01513291|83345419|FG002|Run-out Period|Withdrawal by Subject|0|||
47063569|NCT01513291|83345420|FG003|Run-out Period|Withdrawal by Subject|1|||
46769351|NCT00751101|82987727|FG000|Overall Study|Withdrawal by Subject|1|||
46769352|NCT00751101|82987728|FG001|Overall Study|Withdrawal by Subject|0|||
46945018|NCT02851511|83182448|FG002|Phase II|Lost to Follow-up|0|||
47063570|NCT01513291|83345421|FG004|Run-out Period|Withdrawal by Subject|0|||
47063571|NCT01483937|83345435|FG000|Overall Study|Withdrawal by Subject|4|||
46945019|NCT02851511|83182449|FG003|Phase II|Lost to Follow-up|0|||
46945020|NCT02478320|83182470|FG000|Overall Study|Adverse Event|2|||
46945021|NCT02478320|83182471|FG001|Overall Study|Adverse Event|0|||
46945022|NCT02478320|83182470|FG000|Overall Study|Death|1|||
46945023|NCT02478320|83182471|FG001|Overall Study|Death|0|||
46945024|NCT02478320|83182470|FG000|Overall Study|Lack of Efficacy|4|||
46945025|NCT02478320|83182471|FG001|Overall Study|Lack of Efficacy|0|||
46945026|NCT02478320|83182470|FG000|Overall Study|Withdrawal by Subject|2|||
47063572|NCT01483937|83345436|FG001|Overall Study|Withdrawal by Subject|3|||
47063573|NCT01483625|83345447|FG000|Overall Study|Adverse Event|1|||
46769353|NCT00751101|82987727|FG000|Overall Study|No HFS / Never Started Patch/|0|||
47063574|NCT01483625|83345448|FG001|Overall Study|Adverse Event|1|||
46945027|NCT02478320|83182471|FG001|Overall Study|Withdrawal by Subject|0|||
46945028|NCT02478320|83182470|FG000|Overall Study|Screen Failure|3|||
46945029|NCT02478320|83182471|FG001|Overall Study|Screen Failure|0|||
46945030|NCT02252042|83182496|FG000|Overall Study|Adverse Event|9|||
46945031|NCT02252042|83182497|FG001|Overall Study|Adverse Event|6|||
46945032|NCT02252042|83182496|FG000|Overall Study|Death|209|||
46945033|NCT02252042|83182497|FG001|Overall Study|Death|217|||
46945034|NCT02252042|83182496|FG000|Overall Study|Physician Decision|0|||
46945035|NCT02252042|83182497|FG001|Overall Study|Physician Decision|2|||
46945036|NCT02252042|83182496|FG000|Overall Study|Transferred to Extension Study|7|||
47063575|NCT01483625|83345447|FG000|Overall Study|Refused to continue medication|2|||
47063576|NCT01483625|83345448|FG001|Overall Study|Refused to continue medication|1|||
46945037|NCT02252042|83182497|FG001|Overall Study|Transferred to Extension Study|1|||
46945038|NCT02252042|83182496|FG000|Overall Study|Did Not Continue on Extension Study|7|||
46945039|NCT02252042|83182497|FG001|Overall Study|Did Not Continue on Extension Study|2|||
46945040|NCT02252042|83182496|FG000|Overall Study|Withdrawal by Subject|15|||
46945041|NCT02252042|83182497|FG001|Overall Study|Withdrawal by Subject|20|||
46945042|NCT00378482|83182524|FG000|Overall Study|Lost to Follow-up|1|||
46945043|NCT00378482|83182524|FG000|Overall Study|Lack of Efficacy|8|||
46945044|NCT00378482|83182524|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
46945045|NCT00378482|83182524|FG000|Overall Study|Withdrawal by Subject|4|||
46945046|NCT00378482|83182524|FG000|Overall Study|Adverse Event|9|||
46945047|NCT05288673|83182531|FG000|Overall Study|Consent withdrawn by subject|0|||
46945048|NCT05288673|83182532|FG001|Overall Study|Consent withdrawn by subject|0|||
46945049|NCT05288673|83182533|FG002|Overall Study|Consent withdrawn by subject|1|||
47063577|NCT01483625|83345447|FG000|Overall Study|Due to other reason|1|||
47063578|NCT01483625|83345448|FG001|Overall Study|Due to other reason|0|||
47063579|NCT01485991|83345456|FG000|Overall Study|Adverse Event|0|||
47063580|NCT01485991|83345457|FG001|Overall Study|Adverse Event|4|||
46945050|NCT04604795|83182579|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
46945051|NCT04604795|83182580|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
46945052|NCT04604795|83182581|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
46945053|NCT04604795|83182582|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
46945054|NCT04604795|83182583|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
47063581|NCT01485991|83345456|FG000|Overall Study|Lost to Follow-up|13|||
47063582|NCT01485991|83345457|FG001|Overall Study|Lost to Follow-up|10|||
46945055|NCT04604795|83182584|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
46945056|NCT04604795|83182585|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
46945057|NCT04604795|83182586|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
46945058|NCT04604795|83182587|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
46945059|NCT04604795|83182588|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
46945060|NCT04604795|83182579|FG000|Part B: Up to Day 14|Adverse Event|0|||
46945061|NCT04604795|83182580|FG001|Part B: Up to Day 14|Adverse Event|0|||
46945062|NCT04604795|83182581|FG002|Part B: Up to Day 14|Adverse Event|0|||
47063583|NCT01485991|83345456|FG000|Overall Study|Withdrawal by Subject|13|||
47063584|NCT01485991|83345457|FG001|Overall Study|Withdrawal by Subject|20|||
47063585|NCT01485991|83345456|FG000|Overall Study|randomized but not treated|6|||
46945063|NCT04604795|83182582|FG003|Part B: Up to Day 14|Adverse Event|0|||
46945064|NCT04604795|83182583|FG004|Part B: Up to Day 14|Adverse Event|2|||
46945065|NCT04604795|83182584|FG005|Part B: Up to Day 14|Adverse Event|1|||
46945066|NCT04604795|83182585|FG006|Part B: Up to Day 14|Adverse Event|0|||
46945067|NCT04604795|83182586|FG007|Part B: Up to Day 14|Adverse Event|0|||
46945068|NCT04604795|83182587|FG008|Part B: Up to Day 14|Adverse Event|0|||
46945069|NCT04604795|83182588|FG009|Part B: Up to Day 14|Adverse Event|0|||
46945070|NCT04604795|83182579|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945071|NCT04604795|83182580|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945072|NCT04604795|83182581|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945073|NCT04604795|83182582|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945074|NCT04604795|83182583|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945075|NCT04604795|83182584|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945076|NCT04604795|83182585|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945077|NCT04604795|83182586|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945078|NCT04604795|83182587|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
46945079|NCT04604795|83182588|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
46945080|NCT04604795|83182579|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945081|NCT04604795|83182580|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945082|NCT04604795|83182581|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945083|NCT04604795|83182582|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945084|NCT04604795|83182583|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945085|NCT04604795|83182584|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945086|NCT04604795|83182585|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945087|NCT04604795|83182586|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945088|NCT04604795|83182587|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
46945089|NCT04604795|83182588|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
46945090|NCT04604795|83182579|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945091|NCT04604795|83182580|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945092|NCT04604795|83182581|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945093|NCT04604795|83182582|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945094|NCT04604795|83182583|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945095|NCT04604795|83182584|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945096|NCT04604795|83182585|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945097|NCT04604795|83182586|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945098|NCT04604795|83182587|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
46945099|NCT04604795|83182588|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
46945100|NCT04604795|83182579|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945101|NCT04604795|83182580|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945102|NCT04604795|83182581|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945103|NCT04604795|83182582|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945104|NCT04604795|83182583|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945105|NCT04604795|83182584|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945106|NCT04604795|83182585|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945107|NCT04604795|83182586|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945108|NCT04604795|83182587|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
46945109|NCT04604795|83182588|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
46945110|NCT04314284|83182684|FG000|Overall Study|Withdrawal by Subject|4|||
46945111|NCT04314284|83182685|FG001|Overall Study|Withdrawal by Subject|7|||
46945112|NCT04314284|83182684|FG000|Overall Study|Consented but did not complete survey|0|||
46945113|NCT04314284|83182685|FG001|Overall Study|Consented but did not complete survey|6|||
46945114|NCT04203823|83182693|FG000|Overall Study|Withdrawal by Subject|2|||
46638607|NCT01466790|82811987|FG002|Overall Study|Lost to Follow-up|0|||
46638608|NCT01466790|82811988|FG003|Overall Study|Lost to Follow-up|0|||
46769354|NCT00751101|82987728|FG001|Overall Study|No HFS / Never Started Patch/|4|||
46769355|NCT00751101|82987727|FG000|Overall Study|Never began capecitabine|1|||
46769356|NCT00751101|82987728|FG001|Overall Study|Never began capecitabine|0|||
46769357|NCT00751101|82987727|FG000|Overall Study|Physician Decision|0|||
46769358|NCT00751101|82987728|FG001|Overall Study|Physician Decision|1|||
46769359|NCT00750204|82987740|FG000|Overall Study|study halted prematurely|1|||
46769360|NCT00750204|82987741|FG001|Overall Study|study halted prematurely|1|||
46769361|NCT00751023|82987749|FG000|Overall Study|Lost to Follow-up|11|||
46769362|NCT00751023|82987750|FG001|Overall Study|Lost to Follow-up|7|||
46769363|NCT00591773|82987759|FG000|Overall Study|Adverse Event|9|||
46769364|NCT00591773|82987760|FG001|Overall Study|Adverse Event|9|||
46769365|NCT00591773|82987761|FG002|Overall Study|Adverse Event|6|||
46769366|NCT00591773|82987759|FG000|Overall Study|Protocol Violation|2|||
46769367|NCT00591773|82987760|FG001|Overall Study|Protocol Violation|3|||
46769368|NCT00591773|82987761|FG002|Overall Study|Protocol Violation|0|||
46945115|NCT04203823|83182694|FG001|Overall Study|Withdrawal by Subject|2|||
46945116|NCT04203823|83182693|FG000|Overall Study|Adverse Event|1|||
46945117|NCT04203823|83182694|FG001|Overall Study|Adverse Event|1|||
46945118|NCT04203823|83182693|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46945119|NCT04203823|83182694|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
46945120|NCT03703466|83182747|FG000|Overall Study|Death|2|||
46945121|NCT03703466|83182748|FG001|Overall Study|Death|1|||
46945122|NCT03703466|83182749|FG002|Overall Study|Death|0|||
46945123|NCT03703466|83182747|FG000|Overall Study|Protocol Violation|1|||
46945124|NCT03703466|83182748|FG001|Overall Study|Protocol Violation|0|||
46945125|NCT03703466|83182749|FG002|Overall Study|Protocol Violation|0|||
46945126|NCT03703466|83182747|FG000|Overall Study|Withdrawal by Subject|0|||
47063586|NCT01485991|83345457|FG001|Overall Study|randomized but not treated|2|||
47063587|NCT01482767|83345489|FG000|Overall Study|Death|1|||
47063588|NCT01482767|83345490|FG001|Overall Study|Death|1|||
47063589|NCT01482767|83345489|FG000|Overall Study|Withdrawal by Subject|7|||
47063590|NCT01482767|83345490|FG001|Overall Study|Withdrawal by Subject|5|||
47063591|NCT01482767|83345489|FG000|Overall Study|Lost to Follow-up|12|||
46945127|NCT03703466|83182748|FG001|Overall Study|Withdrawal by Subject|3|||
46945128|NCT03703466|83182749|FG002|Overall Study|Withdrawal by Subject|0|||
46945129|NCT03703466|83182747|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
47063592|NCT01482767|83345490|FG001|Overall Study|Lost to Follow-up|6|||
47063593|NCT01482767|83345489|FG000|Overall Study|Adverse Event|0|||
47063594|NCT01482767|83345490|FG001|Overall Study|Adverse Event|3|||
47063595|NCT01482767|83345489|FG000|Overall Study|Site closure|22|||
47063596|NCT01482767|83345490|FG001|Overall Study|Site closure|14|||
47063597|NCT01482767|83345489|FG000|Overall Study|Non-adherence to study requirements|4|||
47063598|NCT01482767|83345490|FG001|Overall Study|Non-adherence to study requirements|7|||
47063599|NCT01482767|83345489|FG000|Overall Study|Alternate HCV treatment|7|||
47063600|NCT01482767|83345490|FG001|Overall Study|Alternate HCV treatment|8|||
47063601|NCT01482767|83345489|FG000|Overall Study|Ineligible|0|||
47063602|NCT01482767|83345490|FG001|Overall Study|Ineligible|5|||
47063603|NCT01482767|83345489|FG000|Overall Study|Nurse error|1|||
47063604|NCT01482767|83345490|FG001|Overall Study|Nurse error|0|||
47063605|NCT01482221|83345519|FG000|Overall Study|Lack of Efficacy|1|||
46769369|NCT00591773|82987759|FG000|Overall Study|Lost to Follow-up|1|||
46769370|NCT00591773|82987760|FG001|Overall Study|Lost to Follow-up|4|||
46769371|NCT00591773|82987761|FG002|Overall Study|Lost to Follow-up|1|||
46769372|NCT00591773|82987759|FG000|Overall Study|Withdrawal by Subject|2|||
46769373|NCT00591773|82987760|FG001|Overall Study|Withdrawal by Subject|5|||
46839492|NCT03147287|83056748|FG000|Overall Study|Progressive Disease not RECIST|13|||
46839493|NCT03147287|83056749|FG001|Overall Study|Progressive Disease not RECIST|21|||
46839494|NCT03147287|83056750|FG002|Overall Study|Progressive Disease not RECIST|13|||
46839495|NCT03147287|83056748|FG000|Overall Study|Physician Decision|1|||
46839496|NCT03147287|83056749|FG001|Overall Study|Physician Decision|2|||
46839497|NCT03147287|83056750|FG002|Overall Study|Physician Decision|1|||
46839498|NCT03147287|83056748|FG000|Overall Study|Intercurrent illness|0|||
46839499|NCT03147287|83056749|FG001|Overall Study|Intercurrent illness|1|||
46839500|NCT03147287|83056750|FG002|Overall Study|Intercurrent illness|0|||
46839501|NCT03147287|83056748|FG000|Overall Study|Withdrawal by Subject|2|||
46839502|NCT03147287|83056749|FG001|Overall Study|Withdrawal by Subject|3|||
46839503|NCT03147287|83056750|FG002|Overall Study|Withdrawal by Subject|2|||
46839504|NCT03147287|83056748|FG000|Overall Study|Patient Non-Compliance|0|||
46839505|NCT03147287|83056749|FG001|Overall Study|Patient Non-Compliance|2|||
46839506|NCT03147287|83056750|FG002|Overall Study|Patient Non-Compliance|0|||
46839507|NCT03147287|83056748|FG000|Overall Study|Patient moved|0|||
46839508|NCT03147287|83056749|FG001|Overall Study|Patient moved|1|||
46839509|NCT03147287|83056750|FG002|Overall Study|Patient moved|0|||
46839510|NCT03147287|83056748|FG000|Overall Study|Arm A crossover without PD|1|||
46769374|NCT00591773|82987761|FG002|Overall Study|Withdrawal by Subject|3|||
46769375|NCT00591773|82987759|FG000|Overall Study|Lack of Efficacy|1|||
46769376|NCT00591773|82987760|FG001|Overall Study|Lack of Efficacy|2|||
46769377|NCT00591773|82987761|FG002|Overall Study|Lack of Efficacy|2|||
46839511|NCT03147287|83056749|FG001|Overall Study|Arm A crossover without PD|0|||
46839512|NCT03147287|83056750|FG002|Overall Study|Arm A crossover without PD|0|||
46839513|NCT03147287|83056748|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
46945130|NCT03703466|83182748|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
47063606|NCT01482221|83345520|FG001|Overall Study|Lack of Efficacy|0|||
47063607|NCT01482221|83345521|FG002|Overall Study|Lack of Efficacy|1|||
47063608|NCT01482221|83345519|FG000|Overall Study|Lost to Follow-up|3|||
47063609|NCT01482221|83345520|FG001|Overall Study|Lost to Follow-up|2|||
47063610|NCT01482221|83345521|FG002|Overall Study|Lost to Follow-up|1|||
47063611|NCT01482221|83345519|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
47063612|NCT01482221|83345520|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
47063613|NCT01482221|83345521|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
46945131|NCT03703466|83182749|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
47063614|NCT01482221|83345519|FG000|Overall Study|Condition under Investigation Worsened|3|||
47063615|NCT01482221|83345520|FG001|Overall Study|Condition under Investigation Worsened|2|||
46839514|NCT03147287|83056749|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
46945132|NCT03248128|83182808|FG000|Overall Study|Lost to Follow-up|1|||
46945133|NCT03248128|83182809|FG001|Overall Study|Lost to Follow-up|0|||
46945134|NCT03248128|83182808|FG000|Overall Study|Withdrawal by Subject|16|||
46945135|NCT03248128|83182809|FG001|Overall Study|Withdrawal by Subject|14|||
46945136|NCT03248128|83182808|FG000|Overall Study|Site Closed|4|||
46945137|NCT03248128|83182809|FG001|Overall Study|Site Closed|3|||
46945138|NCT03248128|83182808|FG000|Overall Study|Randomized, but did not receive treatment|1|||
46839515|NCT03147287|83056750|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
46839516|NCT02865135|83056761|FG000|Overall Study|Death|0|||
46839517|NCT02865135|83056762|FG001|Overall Study|Death|1|||
46839518|NCT02865135|83056763|FG002|Overall Study|Death|0|||
46839519|NCT02865135|83056761|FG000|Overall Study|Progression|6|||
46769378|NCT00591773|82987759|FG000|Overall Study|Other|1|||
46945139|NCT03248128|83182809|FG001|Overall Study|Randomized, but did not receive treatment|3|||
46945140|NCT02802631|83182852|FG000|Overall Study|Withdrawal by Subject|1|||
46945141|NCT02802631|83182853|FG001|Overall Study|Withdrawal by Subject|0|||
46945142|NCT02802631|83182854|FG002|Overall Study|Withdrawal by Subject|0|||
46945143|NCT02802631|83182855|FG003|Overall Study|Withdrawal by Subject|0|||
46945144|NCT02802631|83182856|FG004|Overall Study|Withdrawal by Subject|0|||
46945145|NCT02802631|83182857|FG005|Overall Study|Withdrawal by Subject|0|||
46945146|NCT02802631|83182858|FG006|Overall Study|Withdrawal by Subject|0|||
46945147|NCT02802631|83182859|FG007|Overall Study|Withdrawal by Subject|0|||
46945148|NCT02802631|83182852|FG000|Overall Study|Physician Decision|1|||
46945149|NCT02802631|83182853|FG001|Overall Study|Physician Decision|0|||
46945150|NCT02802631|83182854|FG002|Overall Study|Physician Decision|0|||
46945151|NCT02802631|83182855|FG003|Overall Study|Physician Decision|0|||
46945152|NCT02802631|83182856|FG004|Overall Study|Physician Decision|0|||
46945153|NCT02802631|83182857|FG005|Overall Study|Physician Decision|0|||
46945154|NCT02802631|83182858|FG006|Overall Study|Physician Decision|1|||
46945155|NCT02802631|83182859|FG007|Overall Study|Physician Decision|0|||
46945156|NCT02802631|83182852|FG000|Overall Study|Adverse Event|0|||
46945157|NCT02802631|83182853|FG001|Overall Study|Adverse Event|2|||
46945158|NCT02802631|83182854|FG002|Overall Study|Adverse Event|0|||
46945159|NCT02802631|83182855|FG003|Overall Study|Adverse Event|1|||
46945160|NCT02802631|83182856|FG004|Overall Study|Adverse Event|6|||
46945161|NCT02802631|83182857|FG005|Overall Study|Adverse Event|1|||
46945162|NCT02802631|83182858|FG006|Overall Study|Adverse Event|4|||
46945163|NCT02802631|83182859|FG007|Overall Study|Adverse Event|0|||
46945164|NCT02802631|83182852|FG000|Overall Study|Sponsor Decision|0|||
46945165|NCT02802631|83182853|FG001|Overall Study|Sponsor Decision|0|||
46945166|NCT02802631|83182854|FG002|Overall Study|Sponsor Decision|6|||
46945167|NCT02802631|83182855|FG003|Overall Study|Sponsor Decision|0|||
46769379|NCT00591773|82987760|FG001|Overall Study|Other|1|||
46769380|NCT00591773|82987761|FG002|Overall Study|Other|4|||
46769381|NCT00750867|82987769|FG000|Overall Study|Adverse Event|2|||
46769382|NCT00744042|82987773|FG000|Overall Study|Withdrawal by Subject|1|||
46769383|NCT00829829|82987786|FG000|Overall Study|Protocol Violation|0|||
46769384|NCT00829829|82987787|FG001|Overall Study|Protocol Violation|3|||
46769385|NCT00829829|82987788|FG002|Overall Study|Protocol Violation|0|||
46769386|NCT00829829|82987786|FG000|Overall Study|Adverse Event|4|||
46769387|NCT00829829|82987787|FG001|Overall Study|Adverse Event|4|||
46769388|NCT00829829|82987788|FG002|Overall Study|Adverse Event|3|||
46769389|NCT00829829|82987786|FG000|Overall Study|Withdrawal by Subject|8|||
46769390|NCT00829829|82987787|FG001|Overall Study|Withdrawal by Subject|4|||
46839520|NCT02865135|83056762|FG001|Overall Study|Progression|2|||
46839521|NCT02865135|83056763|FG002|Overall Study|Progression|2|||
46839522|NCT02709720|83056781|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
46839523|NCT02709720|83056781|FG000|Overall Study|Protocol Violation|1|||
46839524|NCT02709720|83056781|FG000|Overall Study|Not take study medication|1|||
46839525|NCT02364557|83056804|FG000|Overall Study|Protocol Violation|3|||
46839526|NCT02364557|83056805|FG001|Overall Study|Protocol Violation|1|||
46839527|NCT01774487|83056820|FG000|Overall Study|Did not tolerate taste|4|||
46839528|NCT01774487|83056821|FG001|Overall Study|Did not tolerate taste|4|||
46945168|NCT02802631|83182856|FG004|Overall Study|Sponsor Decision|2|||
46945169|NCT02802631|83182857|FG005|Overall Study|Sponsor Decision|0|||
46945170|NCT02802631|83182858|FG006|Overall Study|Sponsor Decision|0|||
46769391|NCT00829829|82987788|FG002|Overall Study|Withdrawal by Subject|2|||
46769392|NCT00829829|82987786|FG000|Overall Study|Decision by the Sponsor|1|||
46769393|NCT00829829|82987787|FG001|Overall Study|Decision by the Sponsor|0|||
46839529|NCT00905645|83056859|FG000|Overall Study|Death (not device related)|10|||
46839530|NCT00905645|83056860|FG001|Overall Study|Death (not device related)|4|||
46839531|NCT00905645|83056861|FG002|Overall Study|Death (not device related)|15|||
46839532|NCT00905645|83056862|FG003|Overall Study|Death (not device related)|8|||
46945171|NCT02802631|83182859|FG007|Overall Study|Sponsor Decision|4|||
46945172|NCT02754479|83182891|FG000|Overall Study|Lost to Follow-up|1|||
46945173|NCT02036476|83182904|FG000|Overall Study|Withdrawal by Subject|2|||
46945174|NCT02036476|83182904|FG000|Overall Study|Progressive Disease|4|||
46945175|NCT02036476|83182904|FG000|Overall Study|Unacceptable Toxicity|2|||
46769394|NCT00829829|82987788|FG002|Overall Study|Decision by the Sponsor|2|||
47063616|NCT01482221|83345521|FG002|Overall Study|Condition under Investigation Worsened|4|||
47063617|NCT01482221|83345519|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
47063618|NCT01482221|83345520|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
47063619|NCT01482221|83345521|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
47063620|NCT01482221|83345519|FG000|Overall Study|Adverse Event|1|||
47063621|NCT01482221|83345520|FG001|Overall Study|Adverse Event|7|||
47063622|NCT01482221|83345521|FG002|Overall Study|Adverse Event|3|||
47063623|NCT01482221|83345519|FG000|Overall Study|Withdrawal by Subject|10|||
47063624|NCT01482221|83345520|FG001|Overall Study|Withdrawal by Subject|7|||
46945176|NCT00643994|83182929|FG000|Overall Study|Death|24|||
46945177|NCT00643994|83182929|FG000|Overall Study|Lost to Follow-up|72|||
46945178|NCT00643617|83182935|FG000|Overall Study|Death|6|||
46945179|NCT00643617|83182936|FG001|Overall Study|Death|9|||
46945180|NCT00643617|83182935|FG000|Overall Study|Lost to Follow-up|42|||
46945181|NCT00643617|83182936|FG001|Overall Study|Lost to Follow-up|51|||
46945182|NCT00504582|83182963|FG000|Overall Study|Lost to Follow-up|1|||
46945183|NCT00504582|83182964|FG001|Overall Study|Lost to Follow-up|0|||
46945184|NCT00504582|83182965|FG002|Overall Study|Lost to Follow-up|0|||
46945185|NCT00314366|83182988|FG000|Overall Study|not treated due to patient medical condi|1|||
46945186|NCT00314366|83182989|FG001|Overall Study|not treated due to patient medical condi|0|||
46945187|NCT01595061|83182998|FG000|Overall Study|Never Treated|3|||
46945188|NCT01595061|83182998|FG000|Overall Study|Inadequate Pathology|1|||
46945189|NCT02852005|83183007|FG000|Overall Study|Lost to Follow-up|0|||
47063625|NCT01482221|83345521|FG002|Overall Study|Withdrawal by Subject|12|||
47063626|NCT01482221|83345519|FG000|Overall Study|Incorrect randomization|0|||
47063627|NCT01482221|83345520|FG001|Overall Study|Incorrect randomization|1|||
47063628|NCT01482221|83345521|FG002|Overall Study|Incorrect randomization|0|||
47063629|NCT01482221|83345519|FG000|Overall Study|Physician Decision|0|||
46769395|NCT00829829|82987786|FG000|Overall Study|Lost to Follow-up|7|||
46769396|NCT00829829|82987787|FG001|Overall Study|Lost to Follow-up|3|||
46769397|NCT00829829|82987788|FG002|Overall Study|Lost to Follow-up|3|||
46769398|NCT00829829|82987786|FG000|Overall Study|Other than specified above|2|||
46769399|NCT00829829|82987787|FG001|Overall Study|Other than specified above|2|||
46769400|NCT00829829|82987788|FG002|Overall Study|Other than specified above|1|||
46769401|NCT00823199|82987797|FG000|Overall Study|Withdrawal by Subject|2|||
46769402|NCT00829439|82987802|FG000|Overall Study|Adverse Event|0|||
46769403|NCT00829439|82987803|FG001|Overall Study|Adverse Event|0|||
46769404|NCT00829439|82987804|FG002|Overall Study|Adverse Event|1|||
46769405|NCT00829439|82987805|FG003|Overall Study|Adverse Event|0|||
46769406|NCT00749775|82987809|FG000|Overall Study|Protocol Violation|24|||
46769407|NCT00749775|82987809|FG000|Overall Study|Lost to Follow-up|36|||
46769408|NCT00749775|82987809|FG000|Overall Study|No visit after first day of treatment|44|||
46769409|NCT00749775|82987809|FG000|Overall Study|No drug administration|3|||
46769410|NCT00829283|82987825|FG000|Overall Study|Lost to Follow-up|7|||
46769411|NCT00829283|82987826|FG001|Overall Study|Lost to Follow-up|25|||
46769412|NCT00821873|82987832|FG000|Overall Study|Lost to Follow-up|4|||
46769413|NCT00749463|82987839|FG000|Overall Study|Adverse Event|0|||
46769414|NCT00749463|82987840|FG001|Overall Study|Adverse Event|4|||
46769415|NCT00749463|82987841|FG002|Overall Study|Adverse Event|1|||
46769416|NCT00749463|82987839|FG000|Overall Study|Withdrawal by Subject|1|||
46769417|NCT00749463|82987840|FG001|Overall Study|Withdrawal by Subject|0|||
46769418|NCT00749463|82987841|FG002|Overall Study|Withdrawal by Subject|0|||
46769419|NCT00821327|82987849|FG000|Overall Study|Adverse Event|13|||
46769420|NCT00821327|82987849|FG000|Overall Study|Patient Request|1|||
46769421|NCT00821327|82987849|FG000|Overall Study|Investigator Request|2|||
46769422|NCT00821327|82987849|FG000|Overall Study|Sponsor Request|1|||
46769423|NCT00821327|82987849|FG000|Overall Study|Disease Progression|13|||
46769424|NCT00821327|82987849|FG000|Overall Study|Other/Unknown|5|||
46769425|NCT00821093|82987855|FG000|Overall Study|Adverse Event|20|||
46769426|NCT00821093|82987856|FG001|Overall Study|Adverse Event|12|||
46769427|NCT00821093|82987855|FG000|Overall Study|Withdrawal by Subject|9|||
46769428|NCT00821093|82987856|FG001|Overall Study|Withdrawal by Subject|13|||
46769429|NCT00821093|82987855|FG000|Overall Study|Lost to Follow-up|9|||
47063630|NCT01482221|83345520|FG001|Overall Study|Physician Decision|1|||
46769430|NCT00821093|82987856|FG001|Overall Study|Lost to Follow-up|3|||
46769431|NCT00821093|82987855|FG000|Overall Study|Protocol deviation|3|||
46769432|NCT00821093|82987856|FG001|Overall Study|Protocol deviation|6|||
46769433|NCT00821093|82987855|FG000|Overall Study|Abnormal laboratory value(s)|2|||
46769434|NCT00821093|82987856|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46769435|NCT00821093|82987855|FG000|Overall Study|Lack of Efficacy|2|||
46769436|NCT00821093|82987856|FG001|Overall Study|Lack of Efficacy|2|||
46769437|NCT00821093|82987855|FG000|Overall Study|Death|2|||
46945190|NCT02852005|83183008|FG001|Overall Study|Lost to Follow-up|0|||
46945191|NCT02852005|83183009|FG002|Overall Study|Lost to Follow-up|0|||
47063631|NCT01482221|83345521|FG002|Overall Study|Physician Decision|0|||
47063632|NCT01482065|83345531|FG000|Overall Study|Withdrawal by Subject|0|||
46945192|NCT02852005|83183010|FG003|Overall Study|Lost to Follow-up|0|||
46945193|NCT02852005|83183011|FG004|Overall Study|Lost to Follow-up|1|||
46945194|NCT02852005|83183007|FG000|Overall Study|Withdrawal by Subject|1|||
46945195|NCT02852005|83183008|FG001|Overall Study|Withdrawal by Subject|0|||
46945196|NCT02852005|83183009|FG002|Overall Study|Withdrawal by Subject|0|||
46945197|NCT02852005|83183010|FG003|Overall Study|Withdrawal by Subject|0|||
46945198|NCT02852005|83183011|FG004|Overall Study|Withdrawal by Subject|0|||
46945199|NCT02849743|83183027|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
46945200|NCT02849743|83183028|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
46945201|NCT02849743|83183027|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
46945202|NCT02849743|83183028|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
46945203|NCT02851069|83183063|FG000|Overall Study|Failure to Return|3|||
46945204|NCT02851069|83183063|FG000|Overall Study|Other|3|||
46945205|NCT02849509|83183071|FG000|Overall Study|Worsening of disease under study|1|||
46945206|NCT02849509|83183072|FG001|Overall Study|Worsening of disease under study|1|||
46945207|NCT02849509|83183073|FG002|Overall Study|Worsening of disease under study|1|||
46945208|NCT02849509|83183071|FG000|Overall Study|Worsening of other pre-existing disease|0|||
46945209|NCT02849509|83183072|FG001|Overall Study|Worsening of other pre-existing disease|1|||
46945210|NCT02849509|83183073|FG002|Overall Study|Worsening of other pre-existing disease|2|||
46945211|NCT02849509|83183071|FG000|Overall Study|Other adverse event|36|||
46945212|NCT02849509|83183072|FG001|Overall Study|Other adverse event|41|||
46945213|NCT02849509|83183073|FG002|Overall Study|Other adverse event|8|||
46945214|NCT02849509|83183071|FG000|Overall Study|Withdrawal by Subject|6|||
46945215|NCT02849509|83183072|FG001|Overall Study|Withdrawal by Subject|17|||
46945216|NCT02849509|83183073|FG002|Overall Study|Withdrawal by Subject|12|||
46945217|NCT02849509|83183071|FG000|Overall Study|Lost to Follow-up|27|||
46945218|NCT02849509|83183072|FG001|Overall Study|Lost to Follow-up|67|||
46945219|NCT02849509|83183073|FG002|Overall Study|Lost to Follow-up|36|||
46945220|NCT02849509|83183071|FG000|Overall Study|Other, reason not specified|14|||
46945221|NCT02849509|83183072|FG001|Overall Study|Other, reason not specified|29|||
46945222|NCT02849509|83183073|FG002|Overall Study|Other, reason not specified|25|||
46945223|NCT02849509|83183071|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
46945224|NCT02849509|83183072|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
46945225|NCT02849509|83183073|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
46945226|NCT02848729|83183085|FG000|Overall Study|Withdrawal by Subject|1|||
46945227|NCT02848729|83183086|FG001|Overall Study|Withdrawal by Subject|0|||
46945228|NCT02848729|83183085|FG000|Overall Study|Emesis|15|||
46945229|NCT02848729|83183086|FG001|Overall Study|Emesis|11|||
46945230|NCT00158756|83183104|FG000|Overall Study|Withdrawal by Subject|5|||
46945231|NCT00158756|83183105|FG001|Overall Study|Withdrawal by Subject|0|||
46769438|NCT00821093|82987856|FG001|Overall Study|Death|1|||
46769439|NCT00821093|82987855|FG000|Overall Study|Abnormal test procedure result(s)|1|||
46769440|NCT00821093|82987856|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46769441|NCT00821093|82987855|FG000|Overall Study|Administrative problems|1|||
46945232|NCT00158756|83183106|FG002|Overall Study|Withdrawal by Subject|6|||
46638609|NCT01466790|82811989|FG004|Overall Study|Lost to Follow-up|0|||
46769442|NCT00821093|82987856|FG001|Overall Study|Administrative problems|2|||
46769443|NCT00821015|82987862|FG000|Overall Study|Lost to Follow-up|12|||
46769444|NCT00814463|82987866|FG000|Overall Study|Lost to Follow-up|1|||
46769445|NCT00743652|82987876|FG000|Overall Study|Parent/Legal Guardian Request|3|||
46769446|NCT00743652|82987877|FG001|Overall Study|Parent/Legal Guardian Request|2|||
46769447|NCT00743652|82987878|FG002|Overall Study|Parent/Legal Guardian Request|2|||
46769448|NCT00743652|82987879|FG003|Overall Study|Parent/Legal Guardian Request|2|||
46769449|NCT00743652|82987880|FG004|Overall Study|Parent/Legal Guardian Request|0|||
46769450|NCT00743652|82987876|FG000|Overall Study|Adverse Event|3|||
46769451|NCT00743652|82987877|FG001|Overall Study|Adverse Event|0|||
46839533|NCT00905645|83056859|FG000|Overall Study|Explantation of study device(s)|78|||
46839534|NCT00905645|83056860|FG001|Overall Study|Explantation of study device(s)|47|||
46839535|NCT00905645|83056861|FG002|Overall Study|Explantation of study device(s)|28|||
46839536|NCT00905645|83056862|FG003|Overall Study|Explantation of study device(s)|21|||
46839537|NCT00905645|83056859|FG000|Overall Study|Subject Request|41|||
46839538|NCT00905645|83056860|FG001|Overall Study|Subject Request|17|||
46839539|NCT00905645|83056861|FG002|Overall Study|Subject Request|13|||
46839540|NCT00905645|83056862|FG003|Overall Study|Subject Request|11|||
46769452|NCT00743652|82987878|FG002|Overall Study|Adverse Event|0|||
46945233|NCT00158756|83183107|FG003|Overall Study|Withdrawal by Subject|1|||
46945234|NCT00158756|83183108|FG004|Overall Study|Withdrawal by Subject|3|||
46945235|NCT00158756|83183104|FG000|Overall Study|Adverse Event|0|||
46839541|NCT00905645|83056859|FG000|Overall Study|Lost to Follow-up|299|||
46839542|NCT00905645|83056860|FG001|Overall Study|Lost to Follow-up|103|||
46945236|NCT00158756|83183105|FG001|Overall Study|Adverse Event|0|||
46945237|NCT00158756|83183106|FG002|Overall Study|Adverse Event|1|||
46945238|NCT00158756|83183107|FG003|Overall Study|Adverse Event|0|||
46945239|NCT00158756|83183108|FG004|Overall Study|Adverse Event|0|||
46945240|NCT00158756|83183104|FG000|Overall Study|Serious adverse event|0|||
46945241|NCT00158756|83183105|FG001|Overall Study|Serious adverse event|0|||
46945242|NCT00158756|83183106|FG002|Overall Study|Serious adverse event|1|||
46945243|NCT00158756|83183107|FG003|Overall Study|Serious adverse event|0|||
46945244|NCT00158756|83183108|FG004|Overall Study|Serious adverse event|0|||
46945245|NCT02730195|83183120|FG000|Overall Study|Withdrawal by Subject|1|||
46945246|NCT02730351|83183128|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
46945247|NCT02730351|83183129|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
46945248|NCT02730351|83183128|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
46945249|NCT02730351|83183129|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
46945250|NCT02730351|83183128|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
46945251|NCT02730351|83183129|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
46945252|NCT02730351|83183128|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
46945253|NCT02730351|83183129|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
46945254|NCT02730351|83183128|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
46945255|NCT02730351|83183129|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
46945256|NCT01376349|83183138|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
46945257|NCT01376349|83183139|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
46945258|NCT01376349|83183140|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
46945259|NCT01376349|83183138|FG000|Raondomized Treatment|Adverse Event|13|||
46945260|NCT01376349|83183139|FG001|Raondomized Treatment|Adverse Event|17|||
46945261|NCT01376349|83183140|FG002|Raondomized Treatment|Adverse Event|14|||
46945262|NCT01376349|83183138|FG000|Raondomized Treatment|Unkown|1|||
46945263|NCT01376349|83183139|FG001|Raondomized Treatment|Unkown|2|||
46945264|NCT01376349|83183140|FG002|Raondomized Treatment|Unkown|1|||
46945265|NCT01376349|83183138|FG000|Raondomized Treatment|Alternative Treatment|0|||
46945266|NCT01376349|83183139|FG001|Raondomized Treatment|Alternative Treatment|0|||
46945267|NCT01376349|83183140|FG002|Raondomized Treatment|Alternative Treatment|1|||
46945268|NCT03030261|83183149|FG000|Overall Study|Still receiving continuation therapy|5|||
46945269|NCT00158600|83183184|FG000|Overall Study|unable to commit time to study|0|||
46945270|NCT00158600|83183185|FG001|Overall Study|unable to commit time to study|1|||
46945271|NCT00158600|83183184|FG000|Overall Study|Adverse Event|2|||
46945272|NCT00158600|83183185|FG001|Overall Study|Adverse Event|1|||
46945273|NCT00158600|83183184|FG000|Overall Study|Death|1|||
46945274|NCT00158600|83183185|FG001|Overall Study|Death|0|||
46945275|NCT00158600|83183184|FG000|Overall Study|Withdrawal by Subject|2|||
46945276|NCT00158600|83183185|FG001|Overall Study|Withdrawal by Subject|2|||
46945277|NCT01680458|83183192|FG000|Overall Study|Protocol Violation|3|||
46945278|NCT04543136|83183196|FG000|Overall Study|Withdrawal by Subject|0|||
46945279|NCT04543136|83183197|FG001|Overall Study|Withdrawal by Subject|1|||
46945280|NCT04543136|83183198|FG002|Overall Study|Withdrawal by Subject|0|||
46945281|NCT04543136|83183199|FG003|Overall Study|Withdrawal by Subject|1|||
46945282|NCT04543136|83183200|FG004|Overall Study|Withdrawal by Subject|0|||
46945283|NCT04543136|83183201|FG005|Overall Study|Withdrawal by Subject|0|||
46945284|NCT00709761|83183209|FG000|Overall Study|Withdrawal by Subject|8|||
46945285|NCT00709761|83183209|FG000|Overall Study|study closed/terminated|17|||
46945286|NCT00709761|83183209|FG000|Overall Study|Lost to Follow-up|2|||
46945287|NCT02848651|83183219|FG000|Overall Study|Death|85|||
46945288|NCT02848651|83183219|FG000|Overall Study|Lost to Follow-up|1|||
46945289|NCT02848651|83183219|FG000|Overall Study|Non-Compliance|1|||
46945290|NCT02848651|83183219|FG000|Overall Study|Symptomatic Deterioration|1|||
46945291|NCT02848651|83183219|FG000|Overall Study|Physician Decision|4|||
46945292|NCT02848651|83183219|FG000|Overall Study|Withdrawal by Subject|14|||
46945293|NCT00709059|83183239|FG000|Overall Study|Lost to Follow-up|34|||
47063633|NCT01482065|83345532|FG001|Overall Study|Withdrawal by Subject|1|||
47063634|NCT01545817|83345547|FG000|Pazopanib|Disease progression|51|||
46769453|NCT00743652|82987879|FG003|Overall Study|Adverse Event|0|||
46769454|NCT00743652|82987880|FG004|Overall Study|Adverse Event|0|||
46769455|NCT00743652|82987876|FG000|Overall Study|Death|2|||
46769456|NCT00743652|82987877|FG001|Overall Study|Death|0|||
46769457|NCT00743652|82987878|FG002|Overall Study|Death|0|||
46769458|NCT00743652|82987879|FG003|Overall Study|Death|0|||
46769459|NCT00743652|82987880|FG004|Overall Study|Death|0|||
46769460|NCT00743652|82987876|FG000|Overall Study|Investigator Request|0|||
46945294|NCT00709059|83183239|FG000|Overall Study|Withdrawal by Subject|19|||
46945295|NCT00709059|83183239|FG000|Overall Study|Physician Decision|7|||
46769461|NCT00743652|82987877|FG001|Overall Study|Investigator Request|0|||
46769462|NCT00743652|82987878|FG002|Overall Study|Investigator Request|0|||
46945296|NCT00709059|83183239|FG000|Overall Study|Disease complication|3|||
46945297|NCT00709059|83183239|FG000|Overall Study|Side effects|20|||
46945298|NCT00709059|83183239|FG000|Overall Study|Serious side effects|11|||
46945299|NCT01678820|83183246|FG000|Overall Study|Study Terminated by Sponsor|45|||
46945300|NCT01678820|83183247|FG001|Overall Study|Study Terminated by Sponsor|43|||
46945301|NCT01678820|83183248|FG002|Overall Study|Study Terminated by Sponsor|43|||
46945302|NCT01678820|83183246|FG000|Overall Study|Withdrawal by Subject|2|||
46945303|NCT01678820|83183247|FG001|Overall Study|Withdrawal by Subject|5|||
46945304|NCT01678820|83183248|FG002|Overall Study|Withdrawal by Subject|2|||
46945305|NCT01678820|83183246|FG000|Overall Study|Protocol Specified Criteria|2|||
46945306|NCT01678820|83183247|FG001|Overall Study|Protocol Specified Criteria|3|||
46945307|NCT01678820|83183248|FG002|Overall Study|Protocol Specified Criteria|1|||
46945308|NCT01678820|83183246|FG000|Overall Study|Adverse Event|2|||
46945309|NCT01678820|83183247|FG001|Overall Study|Adverse Event|2|||
46945310|NCT01678820|83183248|FG002|Overall Study|Adverse Event|2|||
46945311|NCT01678820|83183246|FG000|Overall Study|Lost to Follow-up|7|||
46945312|NCT01678820|83183247|FG001|Overall Study|Lost to Follow-up|2|||
46945313|NCT01678820|83183248|FG002|Overall Study|Lost to Follow-up|2|||
46945314|NCT01678820|83183246|FG000|Overall Study|Non-compliance with study drug|0|||
46945315|NCT01678820|83183247|FG001|Overall Study|Non-compliance with study drug|1|||
46945316|NCT01678820|83183248|FG002|Overall Study|Non-compliance with study drug|0|||
46945317|NCT01678820|83183246|FG000|Overall Study|Physician Decision|0|||
46945318|NCT01678820|83183247|FG001|Overall Study|Physician Decision|0|||
46945319|NCT01678820|83183248|FG002|Overall Study|Physician Decision|1|||
46945320|NCT01678820|83183246|FG000|Overall Study|Protocol Violation|4|||
46945321|NCT01678820|83183247|FG001|Overall Study|Protocol Violation|5|||
46945322|NCT01678820|83183248|FG002|Overall Study|Protocol Violation|4|||
46945323|NCT01678820|83183246|FG000|Overall Study|Not treated with double-blind study drug|0|||
46945324|NCT01678820|83183247|FG001|Overall Study|Not treated with double-blind study drug|2|||
46945325|NCT01678820|83183248|FG002|Overall Study|Not treated with double-blind study drug|2|||
46945326|NCT02660138|83183260|FG000|Overall Study|Adverse Event|0|||
46945327|NCT02660138|83183261|FG001|Overall Study|Adverse Event|3|||
46945328|NCT02660138|83183262|FG002|Overall Study|Adverse Event|2|||
46945329|NCT02660138|83183260|FG000|Overall Study|Lack of Efficacy|1|||
46945330|NCT02660138|83183261|FG001|Overall Study|Lack of Efficacy|2|||
46945331|NCT02660138|83183262|FG002|Overall Study|Lack of Efficacy|1|||
46945332|NCT02660138|83183260|FG000|Overall Study|Withdrawal by Subject|7|||
46945333|NCT02660138|83183261|FG001|Overall Study|Withdrawal by Subject|6|||
46945334|NCT02660138|83183262|FG002|Overall Study|Withdrawal by Subject|6|||
46945335|NCT02660138|83183260|FG000|Overall Study|Lost to Follow-up|4|||
46945336|NCT02660138|83183261|FG001|Overall Study|Lost to Follow-up|4|||
46945337|NCT02660138|83183262|FG002|Overall Study|Lost to Follow-up|1|||
46945338|NCT02660138|83183260|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
47063635|NCT01545817|83345548|FG001|Pazopanib|Disease progression|0|||
47063636|NCT01545817|83345547|FG000|Pazopanib|Adverse Event|19|||
47063637|NCT01545817|83345548|FG001|Pazopanib|Adverse Event|0|||
47063638|NCT01545817|83345547|FG000|Pazopanib|Other reason|4|||
47063639|NCT01545817|83345548|FG001|Pazopanib|Other reason|0|||
47063640|NCT01545817|83345547|FG000|Everolimus|Other reason|0|||
47063641|NCT01545817|83345548|FG001|Everolimus|Other reason|7|||
47063642|NCT01545817|83345547|FG000|Everolimus|Disease progression|0|||
47063643|NCT01545817|83345548|FG001|Everolimus|Disease progression|25|||
47063644|NCT01545817|83345547|FG000|Everolimus|Adverse Event|0|||
46839543|NCT00905645|83056861|FG002|Overall Study|Lost to Follow-up|51|||
46839544|NCT00905645|83056862|FG003|Overall Study|Lost to Follow-up|12|||
46839545|NCT00285584|83056874|FG000|Month 3|Lost to Follow-up|3|||
46839546|NCT00285584|83056875|FG001|Month 3|Lost to Follow-up|3|||
46839547|NCT00285584|83056874|FG000|Month 3|Withdrawal by Subject|1|||
46839548|NCT00285584|83056875|FG001|Month 3|Withdrawal by Subject|0|||
47063645|NCT01545817|83345548|FG001|Everolimus|Adverse Event|6|||
47063646|NCT01512979|83345567|FG000|Overall Study|Adverse Event|2|||
47063647|NCT01512979|83345568|FG001|Overall Study|Adverse Event|2|||
47063648|NCT01512979|83345567|FG000|Overall Study|Protocol Violation|1|||
47063649|NCT01512979|83345568|FG001|Overall Study|Protocol Violation|4|||
47063650|NCT01512979|83345567|FG000|Overall Study|Lost to Follow-up|2|||
47063651|NCT01512979|83345568|FG001|Overall Study|Lost to Follow-up|5|||
46839549|NCT00285584|83056874|FG000|Month 6|Lost to Follow-up|0|||
46839550|NCT00285584|83056875|FG001|Month 6|Lost to Follow-up|1|||
46839551|NCT03807700|83056887|FG000|Overall Study|Withdrawal by Subject|2|||
46839552|NCT03807700|83056888|FG001|Overall Study|Withdrawal by Subject|1|||
46839553|NCT00291668|83056898|FG000|Overall Study|Lack of Efficacy|1|||
46945339|NCT02660138|83183261|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
46945340|NCT02660138|83183262|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
46945341|NCT02660138|83183260|FG000|Overall Study|Other|1|||
46945342|NCT02660138|83183261|FG001|Overall Study|Other|1|||
46945343|NCT02660138|83183262|FG002|Overall Study|Other|0|||
46945344|NCT02660138|83183260|FG000|Overall Study|Not treated|0|||
46945345|NCT02660138|83183261|FG001|Overall Study|Not treated|1|||
46945346|NCT02660138|83183262|FG002|Overall Study|Not treated|0|||
46945347|NCT01603394|83183273|FG000|Overall Study|Adverse Event|1|||
46945348|NCT02729025|83183279|FG000|Overall Study|Sponsor Decision|0|||
47063652|NCT01512979|83345567|FG000|Overall Study|Withdrawal by Subject|1|||
47063653|NCT01512979|83345568|FG001|Overall Study|Withdrawal by Subject|2|||
47063654|NCT01512979|83345567|FG000|Overall Study|Reason other than stated above|13|||
47063655|NCT01512979|83345568|FG001|Overall Study|Reason other than stated above|9|||
47063656|NCT01512745|83345580|FG000|Overall Study|Adverse Event|22|||
47063657|NCT01512745|83345581|FG001|Overall Study|Adverse Event|3|||
47063658|NCT01512745|83345580|FG000|Overall Study|Death|9|||
47063659|NCT01512745|83345581|FG001|Overall Study|Death|13|||
47063660|NCT01512745|83345580|FG000|Overall Study|Withdrawal by Subject|2|||
47063661|NCT01512745|83345581|FG001|Overall Study|Withdrawal by Subject|2|||
47063662|NCT01512745|83345580|FG000|Overall Study|Lost to Follow-up|4|||
47063663|NCT01512745|83345581|FG001|Overall Study|Lost to Follow-up|0|||
47063664|NCT01512745|83345580|FG000|Overall Study|Lack of Efficacy|2|||
47063665|NCT01512745|83345581|FG001|Overall Study|Lack of Efficacy|2|||
47063666|NCT01512745|83345580|FG000|Overall Study|Protocol Violation|1|||
47063667|NCT01512745|83345581|FG001|Overall Study|Protocol Violation|0|||
47063668|NCT01478321|83345587|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
47063669|NCT01478321|83345587|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
47063670|NCT01478321|83345587|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
47063671|NCT01478321|83345587|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
47063672|NCT01478321|83345587|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
47063673|NCT01478321|83345587|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
47063674|NCT01478321|83345587|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
47063675|NCT01478321|83345587|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
47063676|NCT01544491|83345593|FG000|Overall Study|Withdrawal by Subject|3|||
47063677|NCT01544491|83345594|FG001|Overall Study|Withdrawal by Subject|2|||
47063678|NCT01544491|83345593|FG000|Overall Study|Lost to Follow-up|0|||
47063679|NCT01544491|83345594|FG001|Overall Study|Lost to Follow-up|1|||
47063680|NCT01544491|83345593|FG000|Overall Study|administrative problems|2|||
47063681|NCT01544491|83345594|FG001|Overall Study|administrative problems|0|||
47063682|NCT01478087|83345613|FG000|Overall Study|due to sponsor closing study|1|||
47063683|NCT01477853|83345631|FG000|Phase A|Adverse Event|1|||
47063684|NCT01477853|83345632|FG001|Phase A|Adverse Event|2|||
47063685|NCT01477853|83345633|FG002|Phase A|Adverse Event|2|||
46945349|NCT02729025|83183280|FG001|Overall Study|Sponsor Decision|1|||
46945350|NCT01603082|83183288|FG000|Overall Study|Adverse Event|0|||
46945351|NCT01603082|83183289|FG001|Overall Study|Adverse Event|1|||
46945352|NCT01603082|83183288|FG000|Overall Study|Withdrawal by Subject|1|||
46945353|NCT01603082|83183289|FG001|Overall Study|Withdrawal by Subject|0|||
46945354|NCT01603082|83183288|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
46945355|NCT01603082|83183289|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
46945356|NCT02846779|83183302|FG000|Overall Study|Lost Enrollment|83|||
46945357|NCT02846779|83183303|FG001|Overall Study|Lost Enrollment|82|||
46945358|NCT02846779|83183304|FG002|Overall Study|Lost Enrollment|86|||
46945359|NCT02846779|83183302|FG000|Overall Study|Less than 31 days of follow-up|56|||
46945360|NCT02846779|83183303|FG001|Overall Study|Less than 31 days of follow-up|45|||
46945361|NCT02846779|83183304|FG002|Overall Study|Less than 31 days of follow-up|52|||
47063686|NCT01477853|83345631|FG000|Phase A|Lost to Follow-up|4|||
47063687|NCT01477853|83345632|FG001|Phase A|Lost to Follow-up|3|||
47063688|NCT01477853|83345633|FG002|Phase A|Lost to Follow-up|2|||
46638610|NCT01466790|82811990|FG005|Overall Study|Lost to Follow-up|0|||
46769463|NCT00743652|82987879|FG003|Overall Study|Investigator Request|2|||
46769464|NCT00743652|82987880|FG004|Overall Study|Investigator Request|0|||
46769465|NCT00743652|82987876|FG000|Overall Study|Other|1|||
46769466|NCT00743652|82987877|FG001|Overall Study|Other|1|||
46769467|NCT00743652|82987878|FG002|Overall Study|Other|0|||
46769468|NCT00743652|82987879|FG003|Overall Study|Other|0|||
46769469|NCT00743652|82987880|FG004|Overall Study|Other|0|||
46769470|NCT00743652|82987876|FG000|Overall Study|Lost to Follow-up|1|||
46769471|NCT00743652|82987877|FG001|Overall Study|Lost to Follow-up|0|||
46769472|NCT00743652|82987878|FG002|Overall Study|Lost to Follow-up|0|||
46769473|NCT00743652|82987879|FG003|Overall Study|Lost to Follow-up|0|||
46769474|NCT00743652|82987880|FG004|Overall Study|Lost to Follow-up|0|||
46769475|NCT00748215|82987898|FG000|Overall Study|Withdrawal by Subject|7|||
46839554|NCT00291668|83056899|FG001|Overall Study|Lack of Efficacy|0|||
46839555|NCT00291668|83056900|FG002|Overall Study|Lack of Efficacy|0|||
46839556|NCT00291668|83056898|FG000|Overall Study|SAE, non-fatal|1|||
46839557|NCT00291668|83056899|FG001|Overall Study|SAE, non-fatal|1|||
46945362|NCT00406393|83183314|FG000|Overall Study|Did not undergo transplantation|2|||
46967861|NCT05091307|83210484|FG001|Overall Study|Death|0|||
47063689|NCT01477853|83345631|FG000|Phase A|Physician Decision|1|||
47063690|NCT01477853|83345632|FG001|Phase A|Physician Decision|0|||
47063691|NCT01477853|83345633|FG002|Phase A|Physician Decision|1|||
47063692|NCT01477853|83345631|FG000|Phase A|Study terminated by sponsor|37|||
47063693|NCT01477853|83345632|FG001|Phase A|Study terminated by sponsor|40|||
47063694|NCT01477853|83345633|FG002|Phase A|Study terminated by sponsor|39|||
47063695|NCT01477853|83345631|FG000|Phase B|Lost to Follow-up|0|||
46839558|NCT00291668|83056900|FG002|Overall Study|SAE, non-fatal|1|||
47063696|NCT01477853|83345632|FG001|Phase B|Lost to Follow-up|1|||
47063697|NCT01477853|83345633|FG002|Phase B|Lost to Follow-up|0|||
47063698|NCT01477853|83345631|FG000|Phase B|Study terminated by sponsor|12|||
47063699|NCT01477853|83345632|FG001|Phase B|Study terminated by sponsor|10|||
47063700|NCT01477853|83345633|FG002|Phase B|Study terminated by sponsor|11|||
47063701|NCT01511419|83345665|FG000|Dose 2|Physician Decision|1|||
47063702|NCT01511419|83345666|FG001|Dose 2|Physician Decision|0|||
47063703|NCT01511107|83345728|FG000|Overall Study|Ineligible|3|||
47063704|NCT01511107|83345729|FG001|Overall Study|Ineligible|2|||
47063705|NCT01511107|83345728|FG000|Overall Study|Lost to Follow-up|10|||
47063706|NCT01511107|83345729|FG001|Overall Study|Lost to Follow-up|19|||
46769476|NCT00748215|82987899|FG001|Overall Study|Withdrawal by Subject|7|||
46769477|NCT00748215|82987898|FG000|Overall Study|Treatment change|2|||
46769478|NCT00748215|82987899|FG001|Overall Study|Treatment change|1|||
46769479|NCT00748215|82987898|FG000|Overall Study|Change in patient condition|0|||
46769480|NCT00748215|82987899|FG001|Overall Study|Change in patient condition|3|||
46769481|NCT00748215|82987898|FG000|Overall Study|Non-compliant|0|||
46769482|NCT00748215|82987899|FG001|Overall Study|Non-compliant|2|||
46769483|NCT00748215|82987898|FG000|Overall Study|Adverse Event|0|||
46769484|NCT00748215|82987899|FG001|Overall Study|Adverse Event|5|||
46769485|NCT00749892|82987905|FG000|Overall Study|Withdrawal by Subject|3|||
46769486|NCT00749580|82987911|FG000|Overall Study|Lost to Follow-up|4|||
46769487|NCT00749580|82987912|FG001|Overall Study|Lost to Follow-up|8|||
46769488|NCT00749580|82987911|FG000|Overall Study|Adverse Event|0|||
46769489|NCT00749580|82987912|FG001|Overall Study|Adverse Event|1|||
46769490|NCT00747006|82987921|FG000|Overall Study|Adverse Event|1|||
46769491|NCT00747006|82987922|FG001|Overall Study|Adverse Event|0|||
46769492|NCT00747006|82987923|FG002|Overall Study|Adverse Event|0|||
46769493|NCT00747006|82987921|FG000|Overall Study|Lost to Follow-up|0|||
46769494|NCT00747006|82987922|FG001|Overall Study|Lost to Follow-up|1|||
46769495|NCT00747006|82987923|FG002|Overall Study|Lost to Follow-up|0|||
46839559|NCT00291668|83056898|FG000|Overall Study|AE, non-serious non-fatal|1|||
46839560|NCT00291668|83056899|FG001|Overall Study|AE, non-serious non-fatal|0|||
46839561|NCT00291668|83056900|FG002|Overall Study|AE, non-serious non-fatal|0|||
46839562|NCT00291668|83056898|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
46839563|NCT00291668|83056899|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
46839564|NCT00291668|83056900|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
46839565|NCT00458393|83056910|FG000|Overall Study|Withdrawal by Subject|67|||
46839566|NCT00458393|83056911|FG001|Overall Study|Withdrawal by Subject|80|||
46839567|NCT00458393|83056910|FG000|Overall Study|Physician Decision|31|||
46839568|NCT00458393|83056911|FG001|Overall Study|Physician Decision|22|||
46839569|NCT00458393|83056910|FG000|Overall Study|Relocated|77|||
46839570|NCT00458393|83056911|FG001|Overall Study|Relocated|81|||
46839571|NCT00458393|83056910|FG000|Overall Study|Lost to Follow-up|115|||
46839572|NCT00458393|83056911|FG001|Overall Study|Lost to Follow-up|92|||
46839573|NCT00458393|83056910|FG000|Overall Study|Sites marked other on the form.|19|||
46839574|NCT00458393|83056911|FG001|Overall Study|Sites marked other on the form.|20|||
47063707|NCT01511107|83345728|FG000|Overall Study|Withdrawal by Subject|9|||
47063708|NCT01511107|83345729|FG001|Overall Study|Withdrawal by Subject|20|||
47063709|NCT01484977|83345764|FG000|Overall Study|Adverse Event|8|||
47063710|NCT01484977|83345764|FG000|Overall Study|Lack of Efficacy|4|||
47063711|NCT01484977|83345764|FG000|Overall Study|Protocol Violation|6|||
47063712|NCT01484977|83345764|FG000|Overall Study|Lost to Follow-up|1|||
47063713|NCT01484977|83345764|FG000|Overall Study|Withdrawal by Subject|4|||
47063714|NCT01484977|83345764|FG000|Overall Study|Subject Protocol Non-compliant|1|||
47063715|NCT01484977|83345764|FG000|Overall Study|Moving Overseas|1|||
47063716|NCT01484977|83345764|FG000|Overall Study|Low White Blood Cell Count|1|||
47063717|NCT01484977|83345764|FG000|Overall Study|Lack of Compliance|1|||
47063718|NCT01475825|83345844|FG000|Overall Study|Adverse Event|41|||
47063719|NCT01475825|83345845|FG001|Overall Study|Adverse Event|15|||
47063720|NCT01475825|83345846|FG002|Overall Study|Adverse Event|27|||
47063721|NCT01475825|83345847|FG003|Overall Study|Adverse Event|11|||
47063722|NCT01475825|83345844|FG000|Overall Study|Death|1|||
47063723|NCT01475825|83345845|FG001|Overall Study|Death|0|||
47063724|NCT01475825|83345846|FG002|Overall Study|Death|1|||
47063725|NCT01475825|83345847|FG003|Overall Study|Death|0|||
47063726|NCT01475825|83345844|FG000|Overall Study|Lack of Efficacy|0|||
47063727|NCT01475825|83345845|FG001|Overall Study|Lack of Efficacy|0|||
46769496|NCT00747006|82987921|FG000|Overall Study|Physician Decision|2|||
46769497|NCT00747006|82987922|FG001|Overall Study|Physician Decision|0|||
47063728|NCT01475825|83345846|FG002|Overall Study|Lack of Efficacy|1|||
47063729|NCT01475825|83345847|FG003|Overall Study|Lack of Efficacy|0|||
46769498|NCT00747006|82987923|FG002|Overall Study|Physician Decision|1|||
46769499|NCT00743340|82987934|FG000|Overall Study|Study medication non-compliance|1|||
46769500|NCT00743340|82987934|FG000|Overall Study|Lost to Follow-up|1|||
46769501|NCT00743340|82987934|FG000|Overall Study|Withdrawal from the Study|5|||
46769502|NCT00743340|82987934|FG000|Overall Study|Protocol Violation|1|||
46839575|NCT00310856|83056922|FG000|Overall Study|Withdrawal by Subject|2|||
46839576|NCT00310856|83056923|FG001|Overall Study|Withdrawal by Subject|2|||
46967862|NCT05091307|83210485|FG002|Overall Study|Death|1|||
47063730|NCT01475825|83345844|FG000|Overall Study|Lost to Follow-up|0|||
47063731|NCT01475825|83345845|FG001|Overall Study|Lost to Follow-up|0|||
47063732|NCT01475825|83345846|FG002|Overall Study|Lost to Follow-up|3|||
47063733|NCT01475825|83345847|FG003|Overall Study|Lost to Follow-up|1|||
46839577|NCT00310856|83056924|FG002|Overall Study|Withdrawal by Subject|2|||
46839578|NCT00310856|83056922|FG000|Overall Study|Lost to Follow-up|1|||
46839579|NCT00310856|83056923|FG001|Overall Study|Lost to Follow-up|2|||
46839580|NCT00310856|83056924|FG002|Overall Study|Lost to Follow-up|6|||
46945363|NCT00406393|83183315|FG001|Overall Study|Did not undergo transplantation|1|||
46945364|NCT02845375|83183324|FG000|Overall Study|upper airway obstruction|1|||
46945365|NCT02845375|83183325|FG001|Overall Study|upper airway obstruction|2|||
46945366|NCT02845375|83183326|FG002|Overall Study|upper airway obstruction|1|||
46945367|NCT02658734|83183334|FG000|Overall Study|Adverse Event|2|||
46945368|NCT02658734|83183334|FG000|Overall Study|Death|4|||
46945369|NCT02658734|83183334|FG000|Overall Study|Lost to Follow-up|7|||
46945370|NCT02658734|83183334|FG000|Overall Study|Withdrawal of Consent|16|||
46945371|NCT02658734|83183334|FG000|Overall Study|Disease Progression|28|||
46945372|NCT02844439|83183338|FG000|Overall Study|Withdrawal by Subject|1|||
46945373|NCT02844439|83183338|FG000|Overall Study|Lost to Follow-up|2|||
46839581|NCT00310856|83056922|FG000|Overall Study|Inappropriate enrollment|1|||
46839582|NCT00310856|83056923|FG001|Overall Study|Inappropriate enrollment|1|||
46839583|NCT00310856|83056924|FG002|Overall Study|Inappropriate enrollment|0|||
46839584|NCT00310856|83056922|FG000|Overall Study|Unable to classify|1|||
46945374|NCT02844439|83183338|FG000|Overall Study|Termination by Sponsor|4|||
46945375|NCT02844439|83183338|FG000|Overall Study|Death|28|||
46945376|NCT02844439|83183338|FG000|Overall Study|Other|5|||
46945377|NCT01677182|83183352|FG000|Overall Study|Adverse Event|2|||
46945378|NCT01677182|83183353|FG001|Overall Study|Adverse Event|1|||
46945379|NCT01677182|83183354|FG002|Overall Study|Adverse Event|8|||
46945380|NCT01677182|83183352|FG000|Overall Study|Protocol Violation|5|||
46945381|NCT01677182|83183353|FG001|Overall Study|Protocol Violation|1|||
46945382|NCT01677182|83183354|FG002|Overall Study|Protocol Violation|4|||
46945383|NCT01677182|83183352|FG000|Overall Study|Lost to Follow-up|4|||
46945384|NCT01677182|83183353|FG001|Overall Study|Lost to Follow-up|0|||
46945385|NCT01677182|83183354|FG002|Overall Study|Lost to Follow-up|3|||
46945386|NCT01677182|83183352|FG000|Overall Study|Withdrawal by Subject|7|||
46945387|NCT01677182|83183353|FG001|Overall Study|Withdrawal by Subject|12|||
46945388|NCT01677182|83183354|FG002|Overall Study|Withdrawal by Subject|10|||
46945389|NCT01677182|83183352|FG000|Overall Study|Study termination|12|||
46945390|NCT01677182|83183353|FG001|Overall Study|Study termination|9|||
46945391|NCT01677182|83183354|FG002|Overall Study|Study termination|11|||
46945392|NCT01677182|83183352|FG000|Overall Study|Lack of Efficacy|3|||
46945393|NCT01677182|83183353|FG001|Overall Study|Lack of Efficacy|0|||
46945394|NCT01677182|83183354|FG002|Overall Study|Lack of Efficacy|1|||
46945395|NCT01677182|83183352|FG000|Overall Study|Other reasons|1|||
46945396|NCT01677182|83183353|FG001|Overall Study|Other reasons|5|||
46945397|NCT01677182|83183354|FG002|Overall Study|Other reasons|2|||
46945398|NCT02843659|83183365|FG000|Overall Study|Subject Withdrew Consent|0|||
46945399|NCT02843659|83183366|FG001|Overall Study|Subject Withdrew Consent|0|||
46945400|NCT02843659|83183367|FG002|Overall Study|Subject Withdrew Consent|1|||
46945401|NCT02843659|83183365|FG000|Overall Study|Administrative Reason by Sponsor|4|||
46769503|NCT00743340|82987934|FG000|Overall Study|Virologic failure|8|||
46839585|NCT00310856|83056923|FG001|Overall Study|Unable to classify|0|||
46839586|NCT00310856|83056924|FG002|Overall Study|Unable to classify|0|||
46839587|NCT00283712|83056935|FG000|Overall Study|Death|0|||
46839588|NCT00283712|83056936|FG001|Overall Study|Death|1|||
46839589|NCT00048724|83056944|FG000|Overall Study|Adverse Event|53|||
46945402|NCT02843659|83183366|FG001|Overall Study|Administrative Reason by Sponsor|5|||
46769504|NCT00743340|82987934|FG000|Overall Study|Pregnancy|1|||
46769505|NCT00743340|82987934|FG000|Overall Study|Rolled over to other Gilead Study|23|||
46769506|NCT00743340|82987934|FG000|Overall Study|Participant Relocated|1|||
46769507|NCT00749190|82987945|FG000|Overall Study|Adverse Event|0|||
46769508|NCT00749190|82987946|FG001|Overall Study|Adverse Event|2|||
46769509|NCT00749190|82987947|FG002|Overall Study|Adverse Event|0|||
46769510|NCT00749190|82987948|FG003|Overall Study|Adverse Event|4|||
46769511|NCT00749190|82987949|FG004|Overall Study|Adverse Event|0|||
46945403|NCT02843659|83183367|FG002|Overall Study|Administrative Reason by Sponsor|4|||
46945404|NCT02843659|83183365|FG000|Overall Study|Adverse Event|0|||
46945405|NCT02843659|83183366|FG001|Overall Study|Adverse Event|1|||
46769512|NCT00749190|82987950|FG005|Overall Study|Adverse Event|3|||
46769513|NCT00749190|82987951|FG006|Overall Study|Adverse Event|0|||
46839590|NCT00048724|83056945|FG001|Overall Study|Adverse Event|12|||
46839591|NCT00048724|83056944|FG000|Overall Study|Withdrawal by Subject|34|||
46839592|NCT00048724|83056945|FG001|Overall Study|Withdrawal by Subject|54|||
46839593|NCT00048724|83056944|FG000|Overall Study|Lost to Follow-up|5|||
46945406|NCT02843659|83183367|FG002|Overall Study|Adverse Event|0|||
46945407|NCT00708435|83183377|FG000|Overall Study|Death / Serious Adverse Event|10|||
46945408|NCT00708435|83183378|FG001|Overall Study|Death / Serious Adverse Event|5|||
46945409|NCT00708435|83183377|FG000|Overall Study|Lost to Follow-up|9|||
46945410|NCT00708435|83183378|FG001|Overall Study|Lost to Follow-up|4|||
46945411|NCT00708435|83183377|FG000|Overall Study|Withdrawal by Subject|3|||
46945412|NCT00708435|83183378|FG001|Overall Study|Withdrawal by Subject|7|||
46945413|NCT00708435|83183377|FG000|Overall Study|Adverse Event|1|||
46945414|NCT00708435|83183378|FG001|Overall Study|Adverse Event|0|||
46945415|NCT00708435|83183377|FG000|Overall Study|Protocol Violation|0|||
46945416|NCT00708435|83183378|FG001|Overall Study|Protocol Violation|1|||
46945417|NCT00708435|83183377|FG000|Overall Study|Intervention by primary care physician|1|||
46945418|NCT00708435|83183378|FG001|Overall Study|Intervention by primary care physician|0|||
46945419|NCT00708435|83183377|FG000|Overall Study|Refused hospitalization|1|||
46945420|NCT00708435|83183378|FG001|Overall Study|Refused hospitalization|0|||
46945421|NCT02841787|83183389|FG000|Overall Study|Lost to Follow-up|1|||
46839594|NCT00048724|83056945|FG001|Overall Study|Lost to Follow-up|5|||
46839595|NCT00048724|83056944|FG000|Overall Study|Protocol-defined Clinical Event|17|||
46839596|NCT00048724|83056945|FG001|Overall Study|Protocol-defined Clinical Event|32|||
46839597|NCT00048724|83056944|FG000|Overall Study|Noncompliance With Protocol|4|||
47063734|NCT01475825|83345844|FG000|Overall Study|Non-compliance with Study Drug|1|||
47063735|NCT01475825|83345845|FG001|Overall Study|Non-compliance with Study Drug|2|||
46945422|NCT02841787|83183390|FG001|Overall Study|Lost to Follow-up|0|||
46945423|NCT02841787|83183391|FG002|Overall Study|Lost to Follow-up|0|||
46945424|NCT02841787|83183389|FG000|Overall Study|Symptoms dropped below threshold|1|||
46945425|NCT02841787|83183390|FG001|Overall Study|Symptoms dropped below threshold|0|||
46945426|NCT02841787|83183391|FG002|Overall Study|Symptoms dropped below threshold|0|||
46945427|NCT02841787|83183389|FG000|Overall Study|Withdrawal by Subject|1|||
46945428|NCT02841787|83183390|FG001|Overall Study|Withdrawal by Subject|4|||
46945429|NCT02841787|83183391|FG002|Overall Study|Withdrawal by Subject|0|||
46945430|NCT01376037|83183401|FG000|Overall Study|Lost to Follow-up|0|||
46945431|NCT01376037|83183402|FG001|Overall Study|Lost to Follow-up|2|||
46945432|NCT02657408|83183410|FG000|Overall Study|Adverse Event|3|||
46945433|NCT02657408|83183411|FG001|Overall Study|Adverse Event|7|||
46945434|NCT02841709|83183417|FG000|5th Intervention|Adverse Event|2|||
46945435|NCT02841709|83183418|FG001|5th Intervention|Adverse Event|0|||
46945436|NCT02841709|83183419|FG002|5th Intervention|Adverse Event|0|||
47063736|NCT01475825|83345846|FG002|Overall Study|Non-compliance with Study Drug|4|||
47063737|NCT01475825|83345847|FG003|Overall Study|Non-compliance with Study Drug|0|||
46769514|NCT00749190|82987945|FG000|Overall Study|Lack of Efficacy|3|||
46769515|NCT00749190|82987946|FG001|Overall Study|Lack of Efficacy|1|||
46769516|NCT00749190|82987947|FG002|Overall Study|Lack of Efficacy|1|||
46769517|NCT00749190|82987948|FG003|Overall Study|Lack of Efficacy|0|||
46769518|NCT00749190|82987949|FG004|Overall Study|Lack of Efficacy|0|||
46769519|NCT00749190|82987950|FG005|Overall Study|Lack of Efficacy|1|||
46769520|NCT00749190|82987951|FG006|Overall Study|Lack of Efficacy|0|||
46769521|NCT00749190|82987945|FG000|Overall Study|Withdrawal by Subject|2|||
46769522|NCT00749190|82987946|FG001|Overall Study|Withdrawal by Subject|1|||
46839598|NCT00048724|83056945|FG001|Overall Study|Noncompliance With Protocol|12|||
47063738|NCT01475825|83345844|FG000|Overall Study|Other: Not available|0|||
47063739|NCT01475825|83345845|FG001|Overall Study|Other: Not available|0|||
47063740|NCT01475825|83345846|FG002|Overall Study|Other: Not available|2|||
47063741|NCT01475825|83345847|FG003|Overall Study|Other: Not available|0|||
47063742|NCT01475825|83345844|FG000|Overall Study|Protocol Violation|1|||
47063743|NCT01475825|83345845|FG001|Overall Study|Protocol Violation|0|||
47063744|NCT01475825|83345846|FG002|Overall Study|Protocol Violation|0|||
46769523|NCT00749190|82987947|FG002|Overall Study|Withdrawal by Subject|0|||
46839599|NCT00048724|83056944|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
46839600|NCT00048724|83056945|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
46839601|NCT00048724|83056944|FG000|Overall Study|Administrative|1|||
46839602|NCT00048724|83056945|FG001|Overall Study|Administrative|1|||
46839603|NCT00449033|83056953|FG000|Treatment Period|Adverse Event|117|||
46839604|NCT00449033|83056954|FG001|Treatment Period|Adverse Event|83|||
46839605|NCT00449033|83056953|FG000|Treatment Period|Death|21|||
46839606|NCT00449033|83056954|FG001|Treatment Period|Death|12|||
46945437|NCT02841709|83183420|FG003|5th Intervention|Adverse Event|0|||
46839607|NCT00449033|83056953|FG000|Treatment Period|Lost to Follow-up|0|||
46839608|NCT00449033|83056954|FG001|Treatment Period|Lost to Follow-up|2|||
46945438|NCT02841709|83183421|FG004|5th Intervention|Adverse Event|2|||
46945439|NCT01353859|83183434|FG000|Overall Study|Adverse Event|3|||
46945440|NCT01353859|83183434|FG000|Overall Study|Lack of Efficacy|1|||
46945441|NCT02850965|83183440|FG000|Overall Study|Other than listed|3|||
47063745|NCT01475825|83345847|FG003|Overall Study|Protocol Violation|0|||
47063746|NCT01475825|83345844|FG000|Overall Study|Physician Decision|0|||
47063747|NCT01475825|83345845|FG001|Overall Study|Physician Decision|1|||
46839609|NCT00449033|83056953|FG000|Treatment Period|Physician Decision|4|||
46839610|NCT00449033|83056954|FG001|Treatment Period|Physician Decision|5|||
46839611|NCT00449033|83056953|FG000|Treatment Period|Protocol Violation|8|||
46945442|NCT02850965|83183441|FG001|Overall Study|Other than listed|4|||
46945443|NCT02850965|83183440|FG000|Overall Study|Protocol Violation|0|||
46945444|NCT02850965|83183441|FG001|Overall Study|Protocol Violation|2|||
46945445|NCT02850965|83183440|FG000|Overall Study|Lost to Follow-up|5|||
46769524|NCT00749190|82987948|FG003|Overall Study|Withdrawal by Subject|0|||
46769525|NCT00749190|82987949|FG004|Overall Study|Withdrawal by Subject|0|||
46769526|NCT00749190|82987950|FG005|Overall Study|Withdrawal by Subject|1|||
46769527|NCT00749190|82987951|FG006|Overall Study|Withdrawal by Subject|0|||
46769528|NCT00749190|82987945|FG000|Overall Study|Protocol Violation|0|||
46769529|NCT00749190|82987946|FG001|Overall Study|Protocol Violation|1|||
46769530|NCT00749190|82987947|FG002|Overall Study|Protocol Violation|0|||
46769531|NCT00749190|82987948|FG003|Overall Study|Protocol Violation|0|||
46769532|NCT00749190|82987949|FG004|Overall Study|Protocol Violation|0|||
46769533|NCT00749190|82987950|FG005|Overall Study|Protocol Violation|0|||
46769534|NCT00749190|82987951|FG006|Overall Study|Protocol Violation|1|||
46769535|NCT00749190|82987945|FG000|Overall Study|Other reason not defined above|0|||
46769536|NCT00749190|82987946|FG001|Overall Study|Other reason not defined above|0|||
46769537|NCT00749190|82987947|FG002|Overall Study|Other reason not defined above|0|||
46769538|NCT00749190|82987948|FG003|Overall Study|Other reason not defined above|1|||
46769539|NCT00749190|82987949|FG004|Overall Study|Other reason not defined above|0|||
46769540|NCT00749190|82987950|FG005|Overall Study|Other reason not defined above|0|||
46769541|NCT00749190|82987951|FG006|Overall Study|Other reason not defined above|0|||
46769542|NCT00748566|82987972|FG000|Overall Study|Adverse Event|49|||
46769543|NCT00748566|82987972|FG000|Overall Study|Death|1|||
46769544|NCT00748566|82987972|FG000|Overall Study|Lack of Efficacy|12|||
46769545|NCT00748566|82987972|FG000|Overall Study|Lost to Follow-up|1|||
46769546|NCT00748566|82987972|FG000|Overall Study|Protocol Violation|13|||
46769547|NCT00748566|82987972|FG000|Overall Study|Withdrawal by Subject|22|||
46769548|NCT00748566|82987972|FG000|Overall Study|Study terminated by sponsor|5|||
46769549|NCT00748566|82987972|FG000|Overall Study|Other|9|||
46769550|NCT00743106|82987978|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
46769551|NCT00743106|82987979|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
46769552|NCT00738699|82987987|FG000|Overall Study|Withdrawal by Subject|5|||
46769553|NCT00738699|82987988|FG001|Overall Study|Withdrawal by Subject|0|||
46769554|NCT00738699|82987987|FG000|Overall Study|Lost to Follow-up|1|||
46769555|NCT00738699|82987988|FG001|Overall Study|Lost to Follow-up|0|||
46769556|NCT00738699|82987987|FG000|Overall Study|Death|144|||
46769557|NCT00738699|82987988|FG001|Overall Study|Death|68|||
46769558|NCT00738699|82987987|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
46769559|NCT00738699|82987988|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
46769560|NCT00738699|82987987|FG000|Overall Study|Other|2|||
46769561|NCT00738699|82987988|FG001|Overall Study|Other|0|||
46769562|NCT00814307|82987998|FG000|Overall Study|Randomized but not treated|1|||
46769563|NCT00814307|82987999|FG001|Overall Study|Randomized but not treated|0|||
46769564|NCT00814307|82988000|FG002|Overall Study|Randomized but not treated|0|||
46769565|NCT00814307|82988001|FG003|Overall Study|Randomized but not treated|0|||
46769566|NCT00814307|82987998|FG000|Overall Study|Adverse Event|3|||
46769567|NCT00814307|82987999|FG001|Overall Study|Adverse Event|9|||
46769568|NCT00814307|82988000|FG002|Overall Study|Adverse Event|3|||
46769569|NCT00814307|82988001|FG003|Overall Study|Adverse Event|2|||
46769570|NCT00814307|82987998|FG000|Overall Study|Lack of Efficacy|1|||
46769571|NCT00814307|82987999|FG001|Overall Study|Lack of Efficacy|1|||
46769572|NCT00814307|82988000|FG002|Overall Study|Lack of Efficacy|3|||
46769573|NCT00814307|82988001|FG003|Overall Study|Lack of Efficacy|4|||
46769574|NCT00814307|82987998|FG000|Overall Study|Other|1|||
46769575|NCT00814307|82987999|FG001|Overall Study|Other|2|||
46769576|NCT00814307|82988000|FG002|Overall Study|Other|0|||
46769577|NCT00814307|82988001|FG003|Overall Study|Other|1|||
46769578|NCT00814307|82987998|FG000|Overall Study|Protocol Violation|2|||
46769579|NCT00814307|82987999|FG001|Overall Study|Protocol Violation|8|||
46769580|NCT00814307|82988000|FG002|Overall Study|Protocol Violation|1|||
46839612|NCT00449033|83056954|FG001|Treatment Period|Protocol Violation|7|||
46839613|NCT00449033|83056953|FG000|Treatment Period|Disease Progression|231|||
46839614|NCT00449033|83056954|FG001|Treatment Period|Disease Progression|288|||
46839615|NCT00449033|83056953|FG000|Treatment Period|Consent Withdrawn|36|||
46839616|NCT00449033|83056954|FG001|Treatment Period|Consent Withdrawn|20|||
46945446|NCT02850965|83183441|FG001|Overall Study|Lost to Follow-up|3|||
46945447|NCT02850965|83183440|FG000|Overall Study|Lack of Efficacy|4|||
46945448|NCT02850965|83183441|FG001|Overall Study|Lack of Efficacy|8|||
47063748|NCT01475825|83345846|FG002|Overall Study|Physician Decision|0|||
46769581|NCT00814307|82988001|FG003|Overall Study|Protocol Violation|1|||
46769582|NCT00814307|82987998|FG000|Overall Study|Withdrawal by Subject|4|||
46945449|NCT02850965|83183440|FG000|Overall Study|Adverse Event|3|||
47063749|NCT01475825|83345847|FG003|Overall Study|Physician Decision|0|||
46769583|NCT00814307|82987999|FG001|Overall Study|Withdrawal by Subject|6|||
46769584|NCT00814307|82988000|FG002|Overall Study|Withdrawal by Subject|0|||
46769585|NCT00814307|82988001|FG003|Overall Study|Withdrawal by Subject|2|||
46769586|NCT00814307|82987998|FG000|Overall Study|Death|0|||
46769587|NCT00814307|82987999|FG001|Overall Study|Death|1|||
46839617|NCT00449033|83056953|FG000|Treatment Period|Amended Protocol Criteria|22|||
46945450|NCT02850965|83183441|FG001|Overall Study|Adverse Event|2|||
46769588|NCT00814307|82988000|FG002|Overall Study|Death|0|||
46769589|NCT00814307|82988001|FG003|Overall Study|Death|0|||
46769590|NCT00748098|82988013|FG000|First Treatment Intervention Period|Adverse Event|1|||
46769591|NCT00748098|82988014|FG001|First Treatment Intervention Period|Adverse Event|1|||
46769592|NCT00748098|82988013|FG000|First Treatment Intervention Period|Protocol Violation|1|||
46769593|NCT00748098|82988014|FG001|First Treatment Intervention Period|Protocol Violation|0|||
46769594|NCT00748098|82988013|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
46769595|NCT00748098|82988014|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
46769596|NCT00748098|82988013|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
46769597|NCT00748098|82988014|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
46769598|NCT00748098|82988013|FG000|First Taper Period|Protocol Violation|1|||
46769599|NCT00748098|82988014|FG001|First Taper Period|Protocol Violation|0|||
46769600|NCT00748098|82988013|FG000|First Taper Period|Withdrawal by Subject|2|||
46769601|NCT00748098|82988014|FG001|First Taper Period|Withdrawal by Subject|0|||
46769602|NCT00748098|82988013|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
46769603|NCT00748098|82988014|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
46769604|NCT00748098|82988013|FG000|1-Week Washout Period|Adverse Event|0|||
46769605|NCT00748098|82988014|FG001|1-Week Washout Period|Adverse Event|1|||
46769606|NCT00748098|82988013|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
46769607|NCT00748098|82988014|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
46769608|NCT00748098|82988013|FG000|Second Treatment Intervention Period|Adverse Event|4|||
46769609|NCT00748098|82988014|FG001|Second Treatment Intervention Period|Adverse Event|1|||
46769610|NCT00748098|82988013|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
46769611|NCT00748098|82988014|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
46769612|NCT00748098|82988013|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
46769613|NCT00748098|82988014|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
46769614|NCT00813995|82988023|FG000|Overall Study|Clinical adverse event|9|||
46769615|NCT00813995|82988024|FG001|Overall Study|Clinical adverse event|3|||
46769616|NCT00813995|82988023|FG000|Overall Study|Laboratory adverse event|0|||
46769617|NCT00813995|82988024|FG001|Overall Study|Laboratory adverse event|2|||
46769618|NCT00813995|82988023|FG000|Overall Study|Lack of Efficacy|1|||
46769619|NCT00813995|82988024|FG001|Overall Study|Lack of Efficacy|0|||
46769620|NCT00813995|82988023|FG000|Overall Study|Lost to Follow-up|4|||
46769621|NCT00813995|82988024|FG001|Overall Study|Lost to Follow-up|2|||
46769622|NCT00813995|82988023|FG000|Overall Study|Other reason|2|||
46769623|NCT00813995|82988024|FG001|Overall Study|Other reason|2|||
46945451|NCT02850965|83183440|FG000|Overall Study|Withdrawal by Subject|3|||
47063750|NCT01475825|83345844|FG000|Overall Study|Withdrawal by Subject|8|||
47063751|NCT01475825|83345845|FG001|Overall Study|Withdrawal by Subject|3|||
46769624|NCT00813995|82988023|FG000|Overall Study|Protocol Violation|3|||
46769625|NCT00813995|82988024|FG001|Overall Study|Protocol Violation|2|||
47063752|NCT01475825|83345846|FG002|Overall Study|Withdrawal by Subject|11|||
47063753|NCT01475825|83345847|FG003|Overall Study|Withdrawal by Subject|7|||
47063754|NCT01475825|83345844|FG000|Overall Study|Did not enter OLC|15|||
47063755|NCT01475825|83345845|FG001|Overall Study|Did not enter OLC|11|||
47063756|NCT01475825|83345846|FG002|Overall Study|Did not enter OLC|15|||
47063757|NCT01475825|83345847|FG003|Overall Study|Did not enter OLC|11|||
47063758|NCT01484431|83345869|FG000|Period 1: High Dose|Physician Decision|0|||
47063759|NCT01484431|83345870|FG001|Period 1: High Dose|Physician Decision|1|||
47063760|NCT01484431|83345871|FG002|Period 1: High Dose|Physician Decision|0|||
47063761|NCT01484431|83345869|FG000|Period 2|Death|0|||
47063762|NCT01484431|83345870|FG001|Period 2|Death|1|||
47063763|NCT01484431|83345871|FG002|Period 2|Death|1|||
47063764|NCT01484431|83345869|FG000|Period 2|Physician Decision|0|||
47063765|NCT01484431|83345870|FG001|Period 2|Physician Decision|0|||
47063766|NCT01484431|83345871|FG002|Period 2|Physician Decision|1|||
47063767|NCT01484431|83345869|FG000|Period 2|Non-Compliance with Study Drug|1|||
47063768|NCT01484431|83345870|FG001|Period 2|Non-Compliance with Study Drug|0|||
47063769|NCT01484431|83345871|FG002|Period 2|Non-Compliance with Study Drug|0|||
47063770|NCT01473953|83345919|FG000|Overall Study|Other|1|||
47063771|NCT01473953|83345920|FG001|Overall Study|Other|0|||
47063772|NCT01473953|83345921|FG002|Overall Study|Other|0|||
47063773|NCT01473953|83345922|FG003|Overall Study|Other|0|||
46769626|NCT00813995|82988023|FG000|Overall Study|Subject moved|4|||
46769627|NCT00813995|82988024|FG001|Overall Study|Subject moved|0|||
46638611|NCT01466790|82811991|FG006|Overall Study|Lost to Follow-up|0|||
47063774|NCT01473953|83345923|FG004|Overall Study|Other|0|||
47063775|NCT01510717|83345937|FG000|Overall Study|Adverse Event|1|||
47063776|NCT01510717|83345938|FG001|Overall Study|Adverse Event|2|||
47063777|NCT01510717|83345937|FG000|Overall Study|Death|1|||
47063778|NCT01510717|83345938|FG001|Overall Study|Death|0|||
47063779|NCT01510717|83345937|FG000|Overall Study|Lost to Follow-up|0|||
46769628|NCT00813995|82988023|FG000|Overall Study|Withdrawal by Subject|0|||
46769629|NCT00813995|82988024|FG001|Overall Study|Withdrawal by Subject|5|||
47063780|NCT01510717|83345938|FG001|Overall Study|Lost to Follow-up|1|||
46945452|NCT02850965|83183441|FG001|Overall Study|Withdrawal by Subject|4|||
46945453|NCT02850965|83183440|FG000|Overall Study|Physician Decision|0|||
46945454|NCT02850965|83183441|FG001|Overall Study|Physician Decision|1|||
46945455|NCT02850965|83183440|FG000|Overall Study|Randomized but not treated|0|||
46945456|NCT02850965|83183441|FG001|Overall Study|Randomized but not treated|1|||
46945457|NCT01375959|83183449|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
46945458|NCT01375959|83183450|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
47063781|NCT01510717|83345937|FG000|Overall Study|Withdrawal by Subject|0|||
47063782|NCT01510717|83345938|FG001|Overall Study|Withdrawal by Subject|2|||
47063783|NCT01473563|83345954|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
47063784|NCT01484275|83345972|FG000|Overall Study|Study terminated by sponsor|28|||
47063785|NCT01484275|83345973|FG001|Overall Study|Study terminated by sponsor|32|||
47063786|NCT01484275|83345972|FG000|Overall Study|Other|10|||
47063787|NCT01484275|83345973|FG001|Overall Study|Other|0|||
47063788|NCT01484275|83345972|FG000|Overall Study|Death|3|||
47063789|NCT01484275|83345973|FG001|Overall Study|Death|4|||
47063790|NCT01484275|83345972|FG000|Overall Study|Withdrawal by Subject|1|||
47063791|NCT01484275|83345973|FG001|Overall Study|Withdrawal by Subject|5|||
47063792|NCT01484275|83345972|FG000|Overall Study|Lost to Follow-up|1|||
47063793|NCT01484275|83345973|FG001|Overall Study|Lost to Follow-up|1|||
47063794|NCT01544335|83345979|FG000|Overall Study|Lost to Follow-up|27|||
47063795|NCT01544335|83345979|FG000|Overall Study|Death|4|||
47063796|NCT01544335|83345979|FG000|Overall Study|Disease progression|3|||
47063797|NCT01544335|83345979|FG000|Overall Study|Baseline Measurements not Available|19|||
47063798|NCT01484197|83345983|FG000|Treatment Period 1|Adverse Event|1|||
47063799|NCT01484197|83345984|FG001|Treatment Period 1|Adverse Event|0|||
47063800|NCT01484197|83345985|FG002|Treatment Period 1|Adverse Event|0|||
47063801|NCT01484197|83345986|FG003|Treatment Period 1|Adverse Event|0|||
47063802|NCT01484197|83345983|FG000|Treatment Period 2|Subject withdrew consent|0|||
47063803|NCT01484197|83345984|FG001|Treatment Period 2|Subject withdrew consent|0|||
47063804|NCT01484197|83345985|FG002|Treatment Period 2|Subject withdrew consent|0|||
47063805|NCT01484197|83345986|FG003|Treatment Period 2|Subject withdrew consent|1|||
47063806|NCT01473407|83345998|FG000|Overall Study|Physician Decision|1|||
47063807|NCT01473407|83345999|FG001|Overall Study|Physician Decision|4|||
47063808|NCT01473407|83345998|FG000|Overall Study|Lost to Follow-up|10|||
47063809|NCT01473407|83345999|FG001|Overall Study|Lost to Follow-up|4|||
47063810|NCT01473407|83345998|FG000|Overall Study|Adverse Event|8|||
47063811|NCT01473407|83345999|FG001|Overall Study|Adverse Event|8|||
47063812|NCT01473407|83345998|FG000|Overall Study|Randomization Error|3|||
47063813|NCT01473407|83345999|FG001|Overall Study|Randomization Error|1|||
47063814|NCT01473407|83345998|FG000|Overall Study|Withdrawal by Subject|4|||
47063815|NCT01473407|83345999|FG001|Overall Study|Withdrawal by Subject|7|||
47063816|NCT01473407|83345998|FG000|Overall Study|Kidney Transplant|7|||
47063817|NCT01473407|83345999|FG001|Overall Study|Kidney Transplant|6|||
47063818|NCT01473407|83345998|FG000|Overall Study|Vacation/Travel|1|||
47063819|NCT01473407|83345999|FG001|Overall Study|Vacation/Travel|1|||
47063820|NCT01473407|83345998|FG000|Overall Study|Elevated Hemoglobin|1|||
47063821|NCT01473407|83345999|FG001|Overall Study|Elevated Hemoglobin|0|||
47063822|NCT01473407|83345998|FG000|Overall Study|Patient Received Aranesp|1|||
47063823|NCT01473407|83345999|FG001|Overall Study|Patient Received Aranesp|0|||
47063824|NCT01473407|83345998|FG000|Overall Study|Patient Lost Green Card Status|1|||
47063825|NCT01473407|83345999|FG001|Overall Study|Patient Lost Green Card Status|0|||
47063826|NCT01473407|83345998|FG000|Overall Study|Temperature Excursion|2|||
47063827|NCT01473407|83345999|FG001|Overall Study|Temperature Excursion|3|||
47063828|NCT01473407|83345998|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
47063829|NCT01473407|83345999|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
47063830|NCT01473407|83345998|FG000|Overall Study|Sponsor's Decision|10|||
47063831|NCT01473407|83345999|FG001|Overall Study|Sponsor's Decision|10|||
47063832|NCT01473407|83345998|FG000|Overall Study|Site Closure|1|||
47063833|NCT01473407|83345999|FG001|Overall Study|Site Closure|0|||
47063834|NCT01472939|83346009|FG000|Overall Study|Adverse Event|3|||
47063835|NCT01472939|83346010|FG001|Overall Study|Adverse Event|7|||
46945459|NCT01375959|83183449|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
46945460|NCT01375959|83183450|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
47063836|NCT01472939|83346011|FG002|Overall Study|Adverse Event|7|||
47063837|NCT01472939|83346012|FG003|Overall Study|Adverse Event|14|||
46945461|NCT01375959|83183449|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
46769630|NCT00737529|82988034|FG000|Overall Study|Disease Progression|95|||
47063838|NCT01472939|83346009|FG000|Overall Study|Lack of Efficacy|1|||
47063839|NCT01472939|83346010|FG001|Overall Study|Lack of Efficacy|0|||
47063840|NCT01472939|83346011|FG002|Overall Study|Lack of Efficacy|0|||
46769631|NCT00737529|82988034|FG000|Overall Study|Adverse Event|24|||
47063841|NCT01472939|83346012|FG003|Overall Study|Lack of Efficacy|1|||
47063842|NCT01472939|83346009|FG000|Overall Study|Lost to Follow-up|3|||
47063843|NCT01472939|83346010|FG001|Overall Study|Lost to Follow-up|0|||
47063844|NCT01472939|83346011|FG002|Overall Study|Lost to Follow-up|2|||
47063845|NCT01472939|83346012|FG003|Overall Study|Lost to Follow-up|0|||
47063846|NCT01472939|83346009|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
47063847|NCT01472939|83346010|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
47063848|NCT01472939|83346011|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
47063849|NCT01472939|83346012|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
47063850|NCT01472939|83346009|FG000|Overall Study|Prohibited Medication|0|||
47063851|NCT01472939|83346010|FG001|Overall Study|Prohibited Medication|1|||
47063852|NCT01472939|83346011|FG002|Overall Study|Prohibited Medication|0|||
47063853|NCT01472939|83346012|FG003|Overall Study|Prohibited Medication|0|||
47063854|NCT01472939|83346009|FG000|Overall Study|Withdrawal By PI|1|||
47063855|NCT01472939|83346010|FG001|Overall Study|Withdrawal By PI|0|||
47063856|NCT01472939|83346011|FG002|Overall Study|Withdrawal By PI|0|||
47063857|NCT01472939|83346012|FG003|Overall Study|Withdrawal By PI|0|||
47063858|NCT01472939|83346009|FG000|Overall Study|Protocol Violation|3|||
47063859|NCT01472939|83346010|FG001|Overall Study|Protocol Violation|3|||
47063860|NCT01472939|83346011|FG002|Overall Study|Protocol Violation|0|||
47063861|NCT01472939|83346012|FG003|Overall Study|Protocol Violation|1|||
47063862|NCT01472939|83346009|FG000|Overall Study|Withdrawal by Subject|9|||
47063863|NCT01472939|83346010|FG001|Overall Study|Withdrawal by Subject|3|||
47063864|NCT01472939|83346011|FG002|Overall Study|Withdrawal by Subject|1|||
47063865|NCT01472939|83346012|FG003|Overall Study|Withdrawal by Subject|4|||
47063866|NCT01544179|83346027|FG000|Overall Study|Death|50|||
47063867|NCT01544179|83346028|FG001|Overall Study|Death|37|||
47063868|NCT01544179|83346027|FG000|Overall Study|Lost to Follow-up|0|||
47063869|NCT01544179|83346028|FG001|Overall Study|Lost to Follow-up|1|||
47063870|NCT01544179|83346027|FG000|Overall Study|Adverse Event|0|||
47063871|NCT01544179|83346028|FG001|Overall Study|Adverse Event|1|||
47063872|NCT01544179|83346027|FG000|Overall Study|Withdrawal by Subject|12|||
47063873|NCT01544179|83346028|FG001|Overall Study|Withdrawal by Subject|7|||
47063874|NCT01544179|83346027|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
47063875|NCT01544179|83346028|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
47063876|NCT01483651|83346034|FG000|Overall Study|Withdrawal by Subject|0|||
47063877|NCT01483651|83346035|FG001|Overall Study|Withdrawal by Subject|1|||
47063878|NCT01483651|83346036|FG002|Overall Study|Withdrawal by Subject|1|||
47063879|NCT01483651|83346037|FG003|Overall Study|Withdrawal by Subject|0|||
47063880|NCT01483651|83346038|FG004|Overall Study|Withdrawal by Subject|0|||
47063881|NCT01483651|83346039|FG005|Overall Study|Withdrawal by Subject|1|||
47063882|NCT01464307|83346049|FG000|Main Period|Death|0|||
47063883|NCT01464307|83346050|FG001|Main Period|Death|1|||
47063884|NCT01464307|83346049|FG000|Main Period|Adverse Event|6|||
47063885|NCT01464307|83346050|FG001|Main Period|Adverse Event|1|||
47063886|NCT01464307|83346049|FG000|Main Period|Lack of Efficacy|2|||
47063887|NCT01464307|83346050|FG001|Main Period|Lack of Efficacy|0|||
47063888|NCT01464307|83346049|FG000|Main Period|Withdrawal by Subject|5|||
47063889|NCT01464307|83346050|FG001|Main Period|Withdrawal by Subject|2|||
47063890|NCT01464307|83346049|FG000|Main Period|Predefined discontinuation criteria|2|||
47063891|NCT01464307|83346050|FG001|Main Period|Predefined discontinuation criteria|1|||
47063892|NCT01464307|83346049|FG000|Open-Label Extension Period|Adverse Event|15|||
47063893|NCT01464307|83346050|FG001|Open-Label Extension Period|Adverse Event|0|||
47063894|NCT01464307|83346049|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
47063895|NCT01464307|83346050|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
47063896|NCT01464307|83346049|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
47063897|NCT01464307|83346050|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
47063898|NCT01464307|83346049|FG000|Open-Label Extension Period|Death|1|||
47063899|NCT01464307|83346050|FG001|Open-Label Extension Period|Death|0|||
47063900|NCT01464307|83346049|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
47063901|NCT01464307|83346050|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
47063902|NCT01464307|83346049|FG000|Open-Label Extension Period|Non-compliance|9|||
47063903|NCT01464307|83346050|FG001|Open-Label Extension Period|Non-compliance|0|||
47063904|NCT01464307|83346049|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
47063905|NCT01464307|83346050|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
47063906|NCT01483183|83346067|FG000|Overall Study|Physician Decision|0|||
47063907|NCT01483183|83346068|FG001|Overall Study|Physician Decision|0|||
47063908|NCT01483183|83346069|FG002|Overall Study|Physician Decision|0|||
47063909|NCT01483183|83346070|FG003|Overall Study|Physician Decision|0|||
47063910|NCT01483183|83346071|FG004|Overall Study|Physician Decision|0|||
47063911|NCT01483183|83346072|FG005|Overall Study|Physician Decision|0|||
47063912|NCT01483183|83346073|FG006|Overall Study|Physician Decision|2|||
47063913|NCT01483183|83346074|FG007|Overall Study|Physician Decision|0|||
47063914|NCT01483183|83346075|FG008|Overall Study|Physician Decision|0|||
47063915|NCT01483183|83346076|FG009|Overall Study|Physician Decision|0|||
47063916|NCT01483183|83346067|FG000|Overall Study|Withdrawal by Subject|0|||
47063917|NCT01483183|83346068|FG001|Overall Study|Withdrawal by Subject|0|||
47063918|NCT01483183|83346069|FG002|Overall Study|Withdrawal by Subject|0|||
47063919|NCT01483183|83346070|FG003|Overall Study|Withdrawal by Subject|0|||
47063920|NCT01483183|83346071|FG004|Overall Study|Withdrawal by Subject|0|||
46638612|NCT01466790|82811992|FG007|Overall Study|Lost to Follow-up|0|||
47063921|NCT01483183|83346072|FG005|Overall Study|Withdrawal by Subject|0|||
47063922|NCT01483183|83346073|FG006|Overall Study|Withdrawal by Subject|0|||
47063923|NCT01483183|83346074|FG007|Overall Study|Withdrawal by Subject|0|||
47063924|NCT01483183|83346075|FG008|Overall Study|Withdrawal by Subject|0|||
47063925|NCT01483183|83346076|FG009|Overall Study|Withdrawal by Subject|1|||
47063926|NCT01483027|83346106|FG000|Overall Study|Administrative Reasons|2|||
47063927|NCT01483027|83346107|FG001|Overall Study|Administrative Reasons|1|||
47063928|NCT01483027|83346106|FG000|Overall Study|Withdrawal by Subject|21|||
47063929|NCT01483027|83346107|FG001|Overall Study|Withdrawal by Subject|32|||
47063930|NCT01483027|83346106|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
47063931|NCT01483027|83346107|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
47063932|NCT01483027|83346106|FG000|Overall Study|Lost to Follow-up|1|||
47063933|NCT01483027|83346107|FG001|Overall Study|Lost to Follow-up|1|||
47063934|NCT01483027|83346106|FG000|Overall Study|Adverse Event|0|||
47063935|NCT01483027|83346107|FG001|Overall Study|Adverse Event|1|||
47063936|NCT01483027|83346106|FG000|Overall Study|Withdrawal by Subject|0|||
47063937|NCT01483027|83346107|FG001|Overall Study|Withdrawal by Subject|1|||
47063938|NCT01463683|83346116|FG000|Overall Study|Adverse Event|2|||
47063939|NCT01463683|83346117|FG001|Overall Study|Adverse Event|0|||
47063940|NCT01463683|83346118|FG002|Overall Study|Adverse Event|0|||
47063941|NCT01463683|83346116|FG000|Overall Study|Lost to Follow-up|10|||
47063942|NCT01463683|83346117|FG001|Overall Study|Lost to Follow-up|9|||
47063943|NCT01463683|83346118|FG002|Overall Study|Lost to Follow-up|7|||
47063944|NCT01463683|83346116|FG000|Overall Study|Physician Decision|0|||
47063945|NCT01463683|83346117|FG001|Overall Study|Physician Decision|3|||
47063946|NCT01463683|83346118|FG002|Overall Study|Physician Decision|1|||
47063947|NCT01463683|83346116|FG000|Overall Study|Pregnancy|2|||
47063948|NCT01463683|83346117|FG001|Overall Study|Pregnancy|2|||
47063949|NCT01463683|83346118|FG002|Overall Study|Pregnancy|1|||
47063950|NCT01463683|83346116|FG000|Overall Study|Withdrawal by Subject|5|||
47063951|NCT01463683|83346117|FG001|Overall Study|Withdrawal by Subject|17|||
47063952|NCT01463683|83346118|FG002|Overall Study|Withdrawal by Subject|2|||
47063953|NCT01482169|83346126|FG000|Overall Study|Physician Decision|2|||
47063954|NCT01481779|83346135|FG000|Overall Study|Adverse Event|23|||
47063955|NCT01481779|83346136|FG001|Overall Study|Adverse Event|5|||
47063956|NCT01481779|83346135|FG000|Overall Study|Lost to Follow-up|3|||
47063957|NCT01481779|83346136|FG001|Overall Study|Lost to Follow-up|2|||
47063958|NCT01481779|83346135|FG000|Overall Study|Protocol Violation|2|||
47063959|NCT01481779|83346136|FG001|Overall Study|Protocol Violation|3|||
47063960|NCT01481779|83346135|FG000|Overall Study|Withdrawal by Subject|26|||
47063961|NCT01481779|83346136|FG001|Overall Study|Withdrawal by Subject|13|||
47063962|NCT01481779|83346135|FG000|Overall Study|Physician Decision|13|||
47063963|NCT01481779|83346136|FG001|Overall Study|Physician Decision|4|||
47063964|NCT01481779|83346135|FG000|Overall Study|Sponsor Decision|3|||
47063965|NCT01481779|83346136|FG001|Overall Study|Sponsor Decision|1|||
47063966|NCT01463527|83346144|FG000|Overall Study|Protocol Violation|1|||
47063967|NCT01463527|83346145|FG001|Overall Study|Protocol Violation|1|||
47063968|NCT01463527|83346144|FG000|Overall Study|Crying >20% of sedation|5|||
47063969|NCT01463527|83346145|FG001|Overall Study|Crying >20% of sedation|6|||
47063970|NCT01509547|83346153|FG000|Overall Study|Lost to Follow-up|24|||
47063971|NCT01509547|83346154|FG001|Overall Study|Lost to Follow-up|14|||
46769632|NCT00737529|82988034|FG000|Overall Study|Withdrawal by Subject|5|||
46769633|NCT00737529|82988034|FG000|Overall Study|Death|4|||
46769634|NCT00737529|82988034|FG000|Overall Study|Protocol Violation|1|||
46769635|NCT00737529|82988034|FG000|Overall Study|Other|4|||
46769636|NCT00813917|82988040|FG000|Overall Study|Adverse Event|0|||
46769637|NCT00813917|82988041|FG001|Overall Study|Adverse Event|1|||
46769638|NCT00813917|82988040|FG000|Overall Study|Withdrawal by Subject|3|||
46769639|NCT00813917|82988041|FG001|Overall Study|Withdrawal by Subject|4|||
47063972|NCT01509547|83346153|FG000|Overall Study|Withdrawal by Subject|11|||
47063973|NCT01509547|83346154|FG001|Overall Study|Withdrawal by Subject|24|||
47063974|NCT01509547|83346153|FG000|Overall Study|Physician Decision|0|||
47063975|NCT01509547|83346154|FG001|Overall Study|Physician Decision|1|||
47063976|NCT01509079|83346162|FG000|Overall Study|Lack of Efficacy|0|||
46638613|NCT01466790|82811985|FG000|Overall Study|Withdrawal by Subject|1|||
47063977|NCT01509079|83346163|FG001|Overall Study|Lack of Efficacy|2|||
47063978|NCT01509079|83346162|FG000|Overall Study|started an excluded medication|0|||
47063979|NCT01509079|83346163|FG001|Overall Study|started an excluded medication|1|||
47063980|NCT01463293|83346172|FG000|Overall Study|Lost to Follow-up|1|||
47063981|NCT01463293|83346173|FG001|Overall Study|Lost to Follow-up|4|||
46638614|NCT01466790|82811986|FG001|Overall Study|Withdrawal by Subject|1|||
47063982|NCT01463293|83346174|FG002|Overall Study|Lost to Follow-up|5|||
47063983|NCT01463293|83346172|FG000|Overall Study|Adverse Event|1|||
47063984|NCT01463293|83346173|FG001|Overall Study|Adverse Event|2|||
47063985|NCT01463293|83346174|FG002|Overall Study|Adverse Event|0|||
47063986|NCT01463293|83346172|FG000|Overall Study|Withdrawal by Subject|4|||
47063987|NCT01463293|83346173|FG001|Overall Study|Withdrawal by Subject|10|||
46769640|NCT00813917|82988040|FG000|Overall Study|Lost to Follow-up|3|||
47063988|NCT01463293|83346174|FG002|Overall Study|Withdrawal by Subject|5|||
47063989|NCT01463293|83346172|FG000|Overall Study|Other|0|||
47063990|NCT01463293|83346173|FG001|Overall Study|Other|0|||
47063991|NCT01463293|83346174|FG002|Overall Study|Other|2|||
47063992|NCT01479985|83346205|FG000|Overall Study|Tablet malfunction, no data saved|1|||
47063993|NCT01479985|83346206|FG001|Overall Study|Tablet malfunction, no data saved|1|||
47063994|NCT01479985|83346205|FG000|Overall Study|No decisional conflict scale responses|0|||
47063995|NCT01479985|83346206|FG001|Overall Study|No decisional conflict scale responses|2|||
47063996|NCT01479985|83346205|FG000|Overall Study|No post-visit survey|5|||
47063997|NCT01479985|83346206|FG001|Overall Study|No post-visit survey|3|||
47063998|NCT01462435|83346220|FG000|Overall Study|Lack of Efficacy|1|||
47063999|NCT01462435|83346221|FG001|Overall Study|Lack of Efficacy|0|||
47064000|NCT01462435|83346222|FG002|Overall Study|Lack of Efficacy|0|||
47064001|NCT01462435|83346223|FG003|Overall Study|Lack of Efficacy|3|||
47064002|NCT01462435|83346220|FG000|Overall Study|Physician Decision|0|||
47064003|NCT01462435|83346221|FG001|Overall Study|Physician Decision|0|||
47064004|NCT01462435|83346222|FG002|Overall Study|Physician Decision|1|||
47064005|NCT01462435|83346223|FG003|Overall Study|Physician Decision|0|||
47064006|NCT01462435|83346220|FG000|Overall Study|Withdrawal by Subject|0|||
47064007|NCT01462435|83346221|FG001|Overall Study|Withdrawal by Subject|0|||
47064008|NCT01462435|83346222|FG002|Overall Study|Withdrawal by Subject|0|||
47064009|NCT01462435|83346223|FG003|Overall Study|Withdrawal by Subject|1|||
47064010|NCT01462435|83346220|FG000|Overall Study|Lost to Follow-up|0|||
47064011|NCT01462435|83346221|FG001|Overall Study|Lost to Follow-up|0|||
46769641|NCT00813917|82988041|FG001|Overall Study|Lost to Follow-up|1|||
46769642|NCT00737061|82988047|FG000|Waiting Period|Lost to Follow-up|6|||
46769643|NCT00737061|82988047|FG000|Waiting Period|Withdrawal by Subject|1|||
46769644|NCT00737061|82988047|FG000|Waiting Period|Bilateral placement failure|34|||
46769645|NCT00737061|82988047|FG000|Waiting Period|Deemed patent following HSG|26|||
46769646|NCT00737061|82988047|FG000|Waiting Period|Alternative contraception failure|3|||
46769647|NCT00737061|82988047|FG000|Waiting Period|Elected surgical tubal ligation|5|||
46769648|NCT00737061|82988047|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
46769649|NCT00737061|82988047|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
46769650|NCT00737061|82988047|FG000|1 Year Wearing Period|Discontinued reilance|3|||
46769651|NCT00737061|82988047|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
46769652|NCT00585975|82988053|FG000|Overall Study|Withdrawal by Subject|3|||
46769653|NCT00585975|82988054|FG001|Overall Study|Withdrawal by Subject|3|||
46769654|NCT00585975|82988053|FG000|Overall Study|Lost to Follow-up|2|||
46769655|NCT00585975|82988054|FG001|Overall Study|Lost to Follow-up|1|||
46769656|NCT00585975|82988053|FG000|Overall Study|Enrollment met/over-enrolled|10|||
46769657|NCT00585975|82988054|FG001|Overall Study|Enrollment met/over-enrolled|9|||
46769658|NCT00585585|82988060|FG000|Overall Study|Adverse Event|1|||
46769659|NCT00734097|82988064|FG000|Screening|Protocol Violation|12|||
46769660|NCT00734097|82988064|FG000|Screening|Withdrawal by Subject|5|||
46769661|NCT00734097|82988064|FG000|Screening|Lost to Follow-up|2|||
46769662|NCT00734097|82988064|FG000|Screening|Unconfirmed pregnancy|1|||
46769663|NCT00734097|82988064|FG000|Open Label|Lost to Follow-up|7|||
46769664|NCT00734097|82988064|FG000|Open Label|Withdrawal by Subject|5|||
46769665|NCT00734097|82988064|FG000|Open Label|Protocol Violation|4|||
46769666|NCT00819767|82988070|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46769667|NCT00819767|82988071|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46769668|NCT00733005|82988079|FG000|Overall Study|Adverse Event|0|||
46769669|NCT00733005|82988080|FG001|Overall Study|Adverse Event|1|||
46769670|NCT00733005|82988079|FG000|Overall Study|Treatment Failure|0|||
46769671|NCT00733005|82988080|FG001|Overall Study|Treatment Failure|1|||
46769672|NCT00733005|82988079|FG000|Overall Study|Withdrawal by Subject|0|||
46769673|NCT00733005|82988080|FG001|Overall Study|Withdrawal by Subject|1|||
47064012|NCT01462435|83346222|FG002|Overall Study|Lost to Follow-up|0|||
47064013|NCT01462435|83346223|FG003|Overall Study|Lost to Follow-up|1|||
47064014|NCT01472081|83346239|FG000|Overall Study|Continuing treatment at time of analysis|1|||
47064015|NCT01472081|83346240|FG001|Overall Study|Continuing treatment at time of analysis|4|||
47064016|NCT01472081|83346241|FG002|Overall Study|Continuing treatment at time of analysis|1|||
47064017|NCT01472081|83346242|FG003|Overall Study|Continuing treatment at time of analysis|8|||
47064018|NCT01472081|83346243|FG004|Overall Study|Continuing treatment at time of analysis|9|||
47064019|NCT01472081|83346244|FG005|Overall Study|Continuing treatment at time of analysis|0|||
46769674|NCT00733005|82988079|FG000|Overall Study|Protocol Violation|2|||
46769675|NCT00733005|82988080|FG001|Overall Study|Protocol Violation|0|||
46769676|NCT00812981|82988088|FG000|Overall Study|Other|0|||
46769677|NCT00812981|82988089|FG001|Overall Study|Other|1|||
46769678|NCT00732615|82988097|FG000|Overall Study|Withdrawal by Subject|3|||
46769679|NCT00732615|82988098|FG001|Overall Study|Withdrawal by Subject|1|||
47064020|NCT01472081|83346239|FG000|Overall Study|Disease Progression|4|||
47064021|NCT01472081|83346240|FG001|Overall Study|Disease Progression|10|||
47064022|NCT01472081|83346241|FG002|Overall Study|Disease Progression|12|||
47064023|NCT01472081|83346242|FG003|Overall Study|Disease Progression|31|||
47064024|NCT01472081|83346243|FG004|Overall Study|Disease Progression|22|||
47064025|NCT01472081|83346244|FG005|Overall Study|Disease Progression|3|||
47064026|NCT01472081|83346239|FG000|Overall Study|Study drug toxicity|2|||
47064027|NCT01472081|83346240|FG001|Overall Study|Study drug toxicity|9|||
47064028|NCT01472081|83346241|FG002|Overall Study|Study drug toxicity|4|||
47064029|NCT01472081|83346242|FG003|Overall Study|Study drug toxicity|6|||
47064030|NCT01472081|83346243|FG004|Overall Study|Study drug toxicity|13|||
47064031|NCT01472081|83346244|FG005|Overall Study|Study drug toxicity|2|||
46945462|NCT01375959|83183450|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
46945463|NCT04022954|83183458|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
46945464|NCT04022954|83183458|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
46945465|NCT04022954|83183458|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
46945466|NCT00708201|83183464|FG000|Overall Study|Adverse Event|4|||
46945467|NCT00708201|83183465|FG001|Overall Study|Adverse Event|4|||
46945468|NCT00708201|83183464|FG000|Overall Study|Withdrawal by Subject|1|||
46945469|NCT00708201|83183465|FG001|Overall Study|Withdrawal by Subject|1|||
46945470|NCT00708201|83183464|FG000|Overall Study|Lost to Follow-up|2|||
46945471|NCT00708201|83183465|FG001|Overall Study|Lost to Follow-up|0|||
46945472|NCT00708201|83183464|FG000|Overall Study|Protocol Violation|0|||
46945473|NCT00708201|83183465|FG001|Overall Study|Protocol Violation|1|||
46945474|NCT02848313|83183473|FG000|Overall Study|Adverse Event|1|||
46945475|NCT02848313|83183474|FG001|Overall Study|Adverse Event|2|||
46945476|NCT02848313|83183473|FG000|Overall Study|Lack of Efficacy|0|||
46945477|NCT02848313|83183474|FG001|Overall Study|Lack of Efficacy|1|||
46945478|NCT02848313|83183473|FG000|Overall Study|Withdrawal by Subject|1|||
46769680|NCT00732615|82988097|FG000|Overall Study|Lost to Follow-up|0|||
46769681|NCT00732615|82988098|FG001|Overall Study|Lost to Follow-up|1|||
46769682|NCT00732615|82988097|FG000|Overall Study|Adverse Event|0|||
46769683|NCT00732615|82988098|FG001|Overall Study|Adverse Event|2|||
46769684|NCT00732615|82988097|FG000|Overall Study|Physician Decision|3|||
46769685|NCT00732615|82988098|FG001|Overall Study|Physician Decision|0|||
46769686|NCT00732615|82988097|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
46769687|NCT00732615|82988098|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
46769688|NCT00732381|82988107|FG000|Overall Study|Adverse Event|1|||
47064032|NCT01472081|83346239|FG000|Overall Study|Death|0|||
47064033|NCT01472081|83346240|FG001|Overall Study|Death|0|||
47064034|NCT01472081|83346241|FG002|Overall Study|Death|0|||
47064035|NCT01472081|83346242|FG003|Overall Study|Death|0|||
47064036|NCT01472081|83346243|FG004|Overall Study|Death|1|||
47064037|NCT01472081|83346244|FG005|Overall Study|Death|0|||
47064038|NCT01472081|83346239|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
47064039|NCT01472081|83346240|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
47064040|NCT01472081|83346241|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
47064041|NCT01472081|83346242|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
47064042|NCT01472081|83346243|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
47064043|NCT01472081|83346244|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
47064044|NCT01472081|83346239|FG000|Overall Study|Withdrawal by Subject|0|||
47064045|NCT01472081|83346240|FG001|Overall Study|Withdrawal by Subject|0|||
47064046|NCT01472081|83346241|FG002|Overall Study|Withdrawal by Subject|0|||
47064047|NCT01472081|83346242|FG003|Overall Study|Withdrawal by Subject|0|||
47064048|NCT01472081|83346243|FG004|Overall Study|Withdrawal by Subject|0|||
47064049|NCT01472081|83346244|FG005|Overall Study|Withdrawal by Subject|1|||
46769689|NCT00732381|82988108|FG001|Overall Study|Adverse Event|0|||
46769690|NCT00732381|82988107|FG000|Overall Study|Treatment Failure|1|||
46945479|NCT02848313|83183474|FG001|Overall Study|Withdrawal by Subject|1|||
46945480|NCT02848313|83183473|FG000|Overall Study|Lost to follow up|1|||
46769691|NCT00732381|82988108|FG001|Overall Study|Treatment Failure|1|||
46769692|NCT00732303|82988114|FG000|Overall Study|Study Terminated|2|||
46769693|NCT00813761|82988120|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
46769694|NCT00813761|82988121|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
46769695|NCT00813761|82988122|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
46769696|NCT00813761|82988123|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
46769697|NCT00813761|82988120|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
46769698|NCT00813761|82988121|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
46769699|NCT00813761|82988122|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
46769700|NCT00813761|82988123|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
46769701|NCT00813761|82988120|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
46769702|NCT00813761|82988121|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
46769703|NCT00813761|82988122|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
46945481|NCT02848313|83183474|FG001|Overall Study|Lost to follow up|0|||
46769704|NCT00813761|82988123|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
46945482|NCT02728089|83183480|FG000|Overall Study|Physician Decision|2|||
46945483|NCT02728089|83183480|FG000|Overall Study|Withdrawal by Subject|1|||
47064050|NCT01472081|83346239|FG000|Overall Study|Poor/non-compliance|0|||
47064051|NCT01472081|83346240|FG001|Overall Study|Poor/non-compliance|0|||
47064052|NCT01472081|83346241|FG002|Overall Study|Poor/non-compliance|1|||
47064053|NCT01472081|83346242|FG003|Overall Study|Poor/non-compliance|0|||
46945484|NCT02840461|83183487|FG000|Overall Study|Adverse Event|1|||
46945485|NCT02840461|83183488|FG001|Overall Study|Adverse Event|5|||
46945486|NCT02840461|83183489|FG002|Overall Study|Adverse Event|3|||
46945487|NCT02840461|83183487|FG000|Overall Study|Lost to Follow-up|10|||
46945488|NCT02840461|83183488|FG001|Overall Study|Lost to Follow-up|7|||
46945489|NCT02840461|83183489|FG002|Overall Study|Lost to Follow-up|6|||
46945490|NCT02840461|83183487|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
46945491|NCT02840461|83183488|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
46945492|NCT02840461|83183489|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
46945493|NCT02840461|83183487|FG000|Overall Study|Protocol Violation|2|||
46945494|NCT02840461|83183488|FG001|Overall Study|Protocol Violation|3|||
46945495|NCT02840461|83183489|FG002|Overall Study|Protocol Violation|1|||
46945496|NCT02840461|83183487|FG000|Overall Study|Withdrawal by Subject|10|||
46945497|NCT02840461|83183488|FG001|Overall Study|Withdrawal by Subject|6|||
46945498|NCT02840461|83183489|FG002|Overall Study|Withdrawal by Subject|2|||
46945499|NCT02840461|83183487|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
46945500|NCT02840461|83183488|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
46945501|NCT02840461|83183489|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
46945502|NCT02839681|83183498|FG000|Overall Study|Death|2|||
46945503|NCT01676012|83183502|FG000|Overall Study|Adverse Event|2|||
46945504|NCT01676012|83183502|FG000|Overall Study|incomplete set of videos|1|||
46945505|NCT02727777|83183518|FG000|Overall Study|Screen Failure|2|||
46945506|NCT02727777|83183519|FG001|Overall Study|Screen Failure|0|||
46945507|NCT02727777|83183520|FG002|Overall Study|Screen Failure|0|||
46945508|NCT02727777|83183518|FG000|Overall Study|Progressive disease|2|||
46945509|NCT02727777|83183519|FG001|Overall Study|Progressive disease|0|||
46945510|NCT02727777|83183520|FG002|Overall Study|Progressive disease|0|||
46945511|NCT00707577|83183530|FG000|Overall Study|Withdrawal by Subject|3|||
46945512|NCT00707577|83183531|FG001|Overall Study|Withdrawal by Subject|2|||
46945513|NCT00707577|83183530|FG000|Overall Study|Lost to Follow-up|34|||
46945514|NCT00707577|83183531|FG001|Overall Study|Lost to Follow-up|25|||
46945515|NCT00707577|83183530|FG000|Overall Study|Left employment|13|||
46945516|NCT00707577|83183531|FG001|Overall Study|Left employment|10|||
46945517|NCT00707577|83183530|FG000|Overall Study|Pregnancy|4|||
46945518|NCT00707577|83183531|FG001|Overall Study|Pregnancy|1|||
46945519|NCT01675622|83183539|FG000|Overall Study|Withdrawal by Subject|2|||
46945520|NCT01675622|83183540|FG001|Overall Study|Withdrawal by Subject|2|||
46945521|NCT01675622|83183539|FG000|Overall Study|Adverse Event|12|||
46945522|NCT01675622|83183540|FG001|Overall Study|Adverse Event|10|||
46945523|NCT01675622|83183539|FG000|Overall Study|Protocol Violation|4|||
46945524|NCT01675622|83183540|FG001|Overall Study|Protocol Violation|1|||
46769705|NCT00813761|82988120|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
46769706|NCT00813761|82988121|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
46769707|NCT00813761|82988122|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
46769708|NCT00813761|82988123|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
46769709|NCT00813761|82988120|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
46769710|NCT00813761|82988121|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
46769711|NCT00813761|82988122|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
46769712|NCT00813761|82988123|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
46769713|NCT00813761|82988120|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
46769714|NCT00813761|82988121|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
46769715|NCT00813761|82988122|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
46769716|NCT00813761|82988123|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
46769717|NCT00813761|82988120|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
46769718|NCT00813761|82988121|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
46769719|NCT00813761|82988122|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
46769720|NCT00813761|82988123|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
46769721|NCT00813761|82988120|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
46769722|NCT00813761|82988121|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
46769723|NCT00813761|82988122|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
46769724|NCT00813761|82988123|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
46769725|NCT00813761|82988120|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
46769726|NCT00813761|82988121|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
46769727|NCT00813761|82988122|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
46769728|NCT00813761|82988123|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
46945525|NCT01675622|83183539|FG000|Overall Study|Lack of Efficacy|2|||
46945526|NCT01675622|83183540|FG001|Overall Study|Lack of Efficacy|4|||
46945527|NCT01675622|83183539|FG000|Overall Study|Lost to Follow-up|1|||
46945528|NCT01675622|83183540|FG001|Overall Study|Lost to Follow-up|3|||
46945529|NCT01675622|83183539|FG000|Overall Study|Other|5|||
46945530|NCT01675622|83183540|FG001|Overall Study|Other|4|||
46945531|NCT03724916|83183550|FG000|Overall Study|Withdrawal by Subject|0|||
46945532|NCT03724916|83183551|FG001|Overall Study|Withdrawal by Subject|1|||
46945533|NCT03724916|83183552|FG002|Overall Study|Withdrawal by Subject|1|||
46945534|NCT03724916|83183553|FG003|Overall Study|Withdrawal by Subject|2|||
46945535|NCT03724916|83183550|FG000|Overall Study|Randomized but not Treated|1|||
46945536|NCT03724916|83183551|FG001|Overall Study|Randomized but not Treated|0|||
46945537|NCT03724916|83183552|FG002|Overall Study|Randomized but not Treated|0|||
46945538|NCT03724916|83183553|FG003|Overall Study|Randomized but not Treated|0|||
46945539|NCT02655224|83183568|FG000|Overall Study|Adverse Event|1|||
46945540|NCT02655224|83183569|FG001|Overall Study|Adverse Event|1|||
46945541|NCT01675544|83183575|FG000|Overall Study|Withdrawal by Subject|2|||
47064054|NCT01472081|83346243|FG004|Overall Study|Poor/non-compliance|1|||
46945542|NCT02838901|83183618|FG000|Overall Study|Withdrawal by Subject|1|||
46945543|NCT02838901|83183619|FG001|Overall Study|Withdrawal by Subject|1|||
46945544|NCT02838901|83183618|FG000|Overall Study|Lost to Follow-up|1|||
46945545|NCT02838901|83183619|FG001|Overall Study|Lost to Follow-up|1|||
46945546|NCT00706797|83183647|FG000|Overall Study|Lack of Efficacy|3|||
46945547|NCT00706797|83183648|FG001|Overall Study|Lack of Efficacy|0|||
46945548|NCT00706797|83183647|FG000|Overall Study|Adverse Event|0|||
46945549|NCT00706797|83183648|FG001|Overall Study|Adverse Event|3|||
46945550|NCT00706797|83183647|FG000|Overall Study|Withdrawal by Subject|8|||
46945551|NCT00706797|83183648|FG001|Overall Study|Withdrawal by Subject|1|||
46945552|NCT00706797|83183647|FG000|Overall Study|Death|1|||
46945553|NCT00706797|83183648|FG001|Overall Study|Death|0|||
46945554|NCT00706797|83183647|FG000|Overall Study|Discontinuation of study by sponsor|52|||
46945555|NCT00706797|83183648|FG001|Overall Study|Discontinuation of study by sponsor|63|||
46945556|NCT00706797|83183647|FG000|Overall Study|Protocol Violation|3|||
46945557|NCT00706797|83183648|FG001|Overall Study|Protocol Violation|2|||
46945558|NCT00706797|83183647|FG000|Overall Study|Lost to Follow-up|1|||
46945559|NCT00706797|83183648|FG001|Overall Study|Lost to Follow-up|2|||
46945560|NCT00706797|83183647|FG000|Overall Study|Other|1|||
46945561|NCT00706797|83183648|FG001|Overall Study|Other|0|||
46945562|NCT00706641|83183654|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
46945563|NCT00706641|83183654|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
46945564|NCT00706641|83183654|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
46945565|NCT01362530|83183660|FG000|Base Study (Cycle 1)|Adverse Event|2|||
46945566|NCT01362530|83183661|FG001|Base Study (Cycle 1)|Adverse Event|0|||
46945567|NCT01362530|83183660|FG000|Base Study (Cycle 1)|Physician Decision|0|||
46945568|NCT01362530|83183661|FG001|Base Study (Cycle 1)|Physician Decision|1|||
46945569|NCT01362530|83183660|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
46945570|NCT01362530|83183661|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
46945571|NCT01362530|83183660|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
47064055|NCT01472081|83346244|FG005|Overall Study|Poor/non-compliance|0|||
47064056|NCT01472081|83346239|FG000|Overall Study|No longer meets study criteria|0|||
47064057|NCT01472081|83346240|FG001|Overall Study|No longer meets study criteria|0|||
47064058|NCT01472081|83346241|FG002|Overall Study|No longer meets study criteria|1|||
47064059|NCT01472081|83346242|FG003|Overall Study|No longer meets study criteria|0|||
47064060|NCT01472081|83346243|FG004|Overall Study|No longer meets study criteria|0|||
46945572|NCT01362530|83183661|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
46945573|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
46945574|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
46945575|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
46945576|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
47064061|NCT01472081|83346244|FG005|Overall Study|No longer meets study criteria|0|||
46769729|NCT00813761|82988120|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
46769730|NCT00813761|82988121|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
46769731|NCT00813761|82988122|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
46769732|NCT00813761|82988123|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
46769733|NCT00813761|82988120|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
46769734|NCT00813761|82988121|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
46769735|NCT00813761|82988122|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
46769736|NCT00813761|82988123|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
46769737|NCT00813761|82988120|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
46769738|NCT00813761|82988121|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
46769739|NCT00813761|82988122|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
46769740|NCT00813761|82988123|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
46839618|NCT00449033|83056954|FG001|Treatment Period|Amended Protocol Criteria|18|||
46945577|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
46945578|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
46945579|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
46945580|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
46945581|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
46945582|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
46945583|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
46945584|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
47064062|NCT01472081|83346239|FG000|Overall Study|Subject request to discontinue treatment|0|||
46945585|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
46945586|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
46945587|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
46945588|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
46945589|NCT01362530|83183660|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
46945590|NCT01362530|83183661|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
46945591|NCT02654054|83183671|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
46945592|NCT02654054|83183672|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
46945593|NCT02654054|83183673|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
46945594|NCT02654054|83183671|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
46945595|NCT02654054|83183672|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
47064063|NCT01472081|83346240|FG001|Overall Study|Subject request to discontinue treatment|3|||
47064064|NCT01472081|83346241|FG002|Overall Study|Subject request to discontinue treatment|1|||
47064065|NCT01472081|83346242|FG003|Overall Study|Subject request to discontinue treatment|1|||
47064066|NCT01472081|83346243|FG004|Overall Study|Subject request to discontinue treatment|0|||
47064067|NCT01472081|83346244|FG005|Overall Study|Subject request to discontinue treatment|0|||
47064068|NCT01471691|83346259|FG000|Overall Study|Lack of Efficacy|0|||
47064069|NCT01471691|83346260|FG001|Overall Study|Lack of Efficacy|1|||
47064070|NCT01471379|83346269|FG000|Overall Study|Adverse Event|1|||
47064071|NCT01471379|83346270|FG001|Overall Study|Adverse Event|0|||
47064072|NCT01471379|83346271|FG002|Overall Study|Adverse Event|0|||
47064073|NCT01471379|83346269|FG000|Overall Study|Study terminated|0|||
47064074|NCT01471379|83346270|FG001|Overall Study|Study terminated|1|||
47064075|NCT01471379|83346271|FG002|Overall Study|Study terminated|0|||
47064076|NCT01470989|83346282|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
47064077|NCT01470989|83346283|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
47064078|NCT01470989|83346282|FG000|Overall Study|Adverse Event|2|||
47064079|NCT01470989|83346283|FG001|Overall Study|Adverse Event|5|||
47064080|NCT01470989|83346282|FG000|Overall Study|Abnormal laboratory value|1|||
47064081|NCT01470989|83346283|FG001|Overall Study|Abnormal laboratory value|1|||
47064082|NCT01470989|83346282|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
47064083|NCT01470989|83346283|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
47064084|NCT01470989|83346282|FG000|Overall Study|Withdrawal by Subject|19|||
47064085|NCT01470989|83346283|FG001|Overall Study|Withdrawal by Subject|17|||
47064086|NCT01470989|83346282|FG000|Overall Study|Lost to Follow-up|18|||
47064087|NCT01470989|83346283|FG001|Overall Study|Lost to Follow-up|13|||
47064088|NCT01470989|83346282|FG000|Overall Study|Administrative problems|2|||
47064089|NCT01470989|83346283|FG001|Overall Study|Administrative problems|4|||
47064090|NCT01470989|83346282|FG000|Overall Study|Death|2|||
47064091|NCT01470989|83346283|FG001|Overall Study|Death|2|||
47064092|NCT01470989|83346282|FG000|Overall Study|Protocol deviation|1|||
47064093|NCT01470989|83346283|FG001|Overall Study|Protocol deviation|2|||
47064094|NCT01470599|83346293|FG000|Overall Study|Did not meet entrance criteria|1|||
47064095|NCT01470599|83346294|FG001|Overall Study|Did not meet entrance criteria|0|||
47064096|NCT01470599|83346293|FG000|Overall Study|Lost to Follow-up|2|||
47064097|NCT01470599|83346294|FG001|Overall Study|Lost to Follow-up|1|||
47064098|NCT01470599|83346293|FG000|Overall Study|Withdrawal by Subject|3|||
47064099|NCT01470599|83346294|FG001|Overall Study|Withdrawal by Subject|4|||
47064100|NCT01470599|83346293|FG000|Overall Study|Other|1|||
47064101|NCT01470599|83346294|FG001|Overall Study|Other|0|||
47064102|NCT01470599|83346293|FG000|Overall Study|Protocol Violation|3|||
47064103|NCT01470599|83346294|FG001|Overall Study|Protocol Violation|1|||
47064104|NCT01470599|83346293|FG000|Overall Study|Adverse event related to study drug|2|||
47064105|NCT01470599|83346294|FG001|Overall Study|Adverse event related to study drug|5|||
47064106|NCT01470599|83346293|FG000|Overall Study|Insufficient clinical response|6|||
47064107|NCT01470599|83346294|FG001|Overall Study|Insufficient clinical response|27|||
47064108|NCT01470599|83346293|FG000|Overall Study|Adverse event not related to study drug|1|||
47064109|NCT01470599|83346294|FG001|Overall Study|Adverse event not related to study drug|5|||
46769741|NCT00732069|82988139|FG000|Washout After First Study Drug|Adverse Event|1|||
46769742|NCT00732069|82988140|FG001|Washout After First Study Drug|Adverse Event|0|||
46769743|NCT00732069|82988141|FG002|Washout After First Study Drug|Adverse Event|0|||
46769744|NCT00732069|82988142|FG003|Washout After First Study Drug|Adverse Event|0|||
46769745|NCT00732069|82988143|FG004|Washout After First Study Drug|Adverse Event|0|||
46769746|NCT00732069|82988144|FG005|Washout After First Study Drug|Adverse Event|0|||
46945596|NCT02654054|83183673|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
46945597|NCT02654054|83183671|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
47064110|NCT01469819|83346300|FG000|Overall Study|Withdrawal by Subject|1|||
47064111|NCT01469819|83346300|FG000|Overall Study|Did not meet inclusionary criteria|2|||
47064112|NCT01469819|83346300|FG000|Overall Study|Could not swallow SmartPill|2|||
47064113|NCT01469819|83346300|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
47064114|NCT01507831|83346312|FG000|Overall Study|Randomized but not treated|0|||
47064115|NCT01507831|83346313|FG001|Overall Study|Randomized but not treated|3|||
46839619|NCT00449033|83056953|FG000|Treatment Period|Non-compliance|7|||
46839620|NCT00449033|83056954|FG001|Treatment Period|Non-compliance|8|||
46839621|NCT00449033|83056953|FG000|Treatment Period|Second Malignancy|0|||
47064116|NCT01507831|83346312|FG000|Overall Study|Adverse Event|48|||
47064117|NCT01507831|83346313|FG001|Overall Study|Adverse Event|113|||
47064118|NCT01507831|83346312|FG000|Overall Study|Death|6|||
46839622|NCT00449033|83056954|FG001|Treatment Period|Second Malignancy|1|||
46839623|NCT00449033|83056953|FG000|Treatment Period|Reason Missing|0|||
46839624|NCT00449033|83056954|FG001|Treatment Period|Reason Missing|4|||
46839625|NCT00449033|83056953|FG000|Treatment Period|Treatment Ongoing|6|||
46839626|NCT00449033|83056954|FG001|Treatment Period|Treatment Ongoing|4|||
46839627|NCT00449033|83056953|FG000|Follow-up Period|Death|299|||
46839628|NCT00449033|83056954|FG001|Follow-up Period|Death|311|||
46839629|NCT00449033|83056953|FG000|Follow-up Period|Lost to Follow-up|6|||
46839630|NCT00449033|83056954|FG001|Follow-up Period|Lost to Follow-up|10|||
46839631|NCT00449033|83056953|FG000|Follow-up Period|Reason Missing|120|||
46839632|NCT00449033|83056954|FG001|Follow-up Period|Reason Missing|113|||
46839633|NCT00448019|83056960|FG000|Overall Study|Withdrawal by Subject|3|||
46839634|NCT00448019|83056960|FG000|Overall Study|Disease progression|1|||
46839635|NCT00448019|83056960|FG000|Overall Study|Death|2|||
46839636|NCT00448019|83056960|FG000|Overall Study|Insurance Issues|1|||
46839637|NCT00457691|83056966|FG000|Overall Study|Adverse Event|4|||
46839638|NCT00457691|83056967|FG001|Overall Study|Adverse Event|1|||
46839639|NCT00457691|83056966|FG000|Overall Study|Death|163|||
46839640|NCT00457691|83056967|FG001|Overall Study|Death|148|||
46839641|NCT00457691|83056966|FG000|Overall Study|Protocol Violation|1|||
46839642|NCT00457691|83056967|FG001|Overall Study|Protocol Violation|3|||
46839643|NCT00457691|83056966|FG000|Overall Study|Lost to Follow-up|23|||
46839644|NCT00457691|83056967|FG001|Overall Study|Lost to Follow-up|14|||
46839645|NCT00457691|83056966|FG000|Overall Study|Study terminated by Sponsor|1|||
46839646|NCT00457691|83056967|FG001|Overall Study|Study terminated by Sponsor|1|||
46839647|NCT00457691|83056966|FG000|Overall Study|Subject refused (reason other than AE)|14|||
46839648|NCT00457691|83056967|FG001|Overall Study|Subject refused (reason other than AE)|19|||
46839649|NCT00457691|83056966|FG000|Overall Study|Disease progression, study terminated|180|||
46839650|NCT00457691|83056967|FG001|Overall Study|Disease progression, study terminated|196|||
46839651|NCT00457301|83056975|FG000|Overall Study|Withdrawal by Subject|3|||
46839652|NCT00457301|83056976|FG001|Overall Study|Withdrawal by Subject|3|||
46839653|NCT00457301|83056975|FG000|Overall Study|Censored out of the study|15|||
46945598|NCT02654054|83183672|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
46945599|NCT02654054|83183673|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
46945600|NCT02654054|83183671|FG000|Post-Treatment Follow-Up Period|Other|1|||
46945601|NCT02654054|83183672|FG001|Post-Treatment Follow-Up Period|Other|0|||
46945602|NCT02654054|83183673|FG002|Post-Treatment Follow-Up Period|Other|4|||
46945603|NCT02654054|83183671|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
46945604|NCT02654054|83183672|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
46945605|NCT02654054|83183673|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
46945606|NCT02653664|83183694|FG000|Post-Treatment|Withdrawal by Subject|6|||
46945607|NCT02653664|83183695|FG001|Post-Treatment|Withdrawal by Subject|5|||
47064119|NCT01507831|83346313|FG001|Overall Study|Death|2|||
47064120|NCT01507831|83346312|FG000|Overall Study|Poor compliance to protocol|38|||
47064121|NCT01507831|83346313|FG001|Overall Study|Poor compliance to protocol|60|||
46638615|NCT01466790|82811987|FG002|Overall Study|Withdrawal by Subject|0|||
46638616|NCT01466790|82811988|FG003|Overall Study|Withdrawal by Subject|0|||
46638617|NCT01466790|82811989|FG004|Overall Study|Withdrawal by Subject|1|||
46638618|NCT01466790|82811990|FG005|Overall Study|Withdrawal by Subject|0|||
46638619|NCT01466790|82811991|FG006|Overall Study|Withdrawal by Subject|1|||
46638620|NCT01466790|82811992|FG007|Overall Study|Withdrawal by Subject|1|||
46638621|NCT01418352|82812010|FG000|Overall Study|Lost to Follow-up|2|||
46638622|NCT01418352|82812011|FG001|Overall Study|Lost to Follow-up|0|||
46638623|NCT01418352|82812012|FG002|Overall Study|Lost to Follow-up|0|||
46638624|NCT01418352|82812013|FG003|Overall Study|Lost to Follow-up|0|||
46638625|NCT01418352|82812010|FG000|Overall Study|Adverse Event|0|||
46638626|NCT01418352|82812011|FG001|Overall Study|Adverse Event|1|||
47064122|NCT01507831|83346312|FG000|Overall Study|Physician Decision|0|||
46638627|NCT01418352|82812012|FG002|Overall Study|Adverse Event|0|||
46638628|NCT01418352|82812013|FG003|Overall Study|Adverse Event|0|||
46839654|NCT00457301|83056976|FG001|Overall Study|Censored out of the study|14|||
46839655|NCT00457301|83056975|FG000|Overall Study|Death|5|||
46638629|NCT01418352|82812010|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
46945608|NCT02653664|83183696|FG002|Post-Treatment|Withdrawal by Subject|7|||
46839656|NCT00457301|83056976|FG001|Overall Study|Death|7|||
46839657|NCT00456755|83056984|FG000|Overall Study|Lost to Follow-up|2|||
46839658|NCT00456755|83056985|FG001|Overall Study|Lost to Follow-up|1|||
46839659|NCT00447005|83056991|FG000|Overall Study|Adverse Event|1|||
46839660|NCT00447005|83056991|FG000|Overall Study|Lack of Efficacy|11|||
46839661|NCT00446849|83056995|FG000|Acute Phase|Lack of Efficacy|64|||
46839662|NCT00446849|83056995|FG000|Acute Phase|Protocol Violation|10|||
46945609|NCT02653664|83183694|FG000|Post-Treatment|Lost to Follow-up|8|||
46945610|NCT02653664|83183695|FG001|Post-Treatment|Lost to Follow-up|1|||
46945611|NCT02653664|83183696|FG002|Post-Treatment|Lost to Follow-up|7|||
46945612|NCT02653664|83183694|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
46945613|NCT02653664|83183695|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
46945614|NCT02653664|83183696|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
46839663|NCT00446849|83056995|FG000|Acute Phase|Consent withdrawn|4|||
46839664|NCT00446849|83056995|FG000|Acute Phase|Lost to Follow-up|2|||
46839665|NCT00446849|83056995|FG000|Acute Phase|Physician Decision|1|||
46839666|NCT00446849|83056995|FG000|Acute Phase|noncompliance|1|||
46839667|NCT00446849|83056995|FG000|Maintenance Phase|Lack of Efficacy|40|||
46839668|NCT00446849|83056995|FG000|Maintenance Phase|Protocol Violation|7|||
46945615|NCT02653664|83183694|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
46945616|NCT02653664|83183695|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
46945617|NCT02653664|83183696|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
46945618|NCT02653664|83183694|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
46945619|NCT02653664|83183695|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
46945620|NCT02653664|83183696|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
46945621|NCT02653664|83183694|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
46945622|NCT02653664|83183695|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
46945623|NCT02653664|83183696|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
46945624|NCT02653664|83183694|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
46945625|NCT02653664|83183695|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
46945626|NCT02653664|83183696|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
46945627|NCT02653664|83183694|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
46769747|NCT00731679|82988154|FG000|Overall Study|Adverse Event|7|||
46945628|NCT02653664|83183695|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
46945629|NCT02653664|83183696|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
46945630|NCT02653664|83183694|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
46945631|NCT02653664|83183695|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
46945632|NCT02653664|83183696|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
46945633|NCT02653664|83183694|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
46945634|NCT02653664|83183695|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
46839669|NCT00446849|83056995|FG000|Maintenance Phase|Adverse Event|6|||
46839670|NCT00446849|83056995|FG000|Maintenance Phase|Consent withdrawn|5|||
46839671|NCT00446849|83056995|FG000|Maintenance Phase|Lost to Follow-up|3|||
46839672|NCT00446849|83056995|FG000|Maintenance Phase|Pregnancy|1|||
46839673|NCT00446849|83056995|FG000|Maintenance Phase|noncompliance|2|||
46839674|NCT00446849|83056995|FG000|Maintenance Phase|prohibited medication use|2|||
46839675|NCT00446849|83056995|FG000|Maintenance Phase|antibiotic use|1|||
46839676|NCT00446849|83056995|FG000|Maintenance Phase|study closure|1|||
46839677|NCT00446849|83056995|FG000|Maintenance Phase|hydrocodone use|1|||
46839678|NCT00446849|83056995|FG000|Maintenance Phase|concomitant medication use|1|||
46839679|NCT00446459|83057000|FG000|8 Months|Protocol Violation|12|||
46839680|NCT00446459|83057000|FG000|12 Months|Protocol Violation|4|||
46839681|NCT00446459|83057000|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
46839682|NCT00456599|83057004|FG000|Overall Study|Non-compliance|1|||
46839683|NCT00456599|83057004|FG000|Overall Study|Withdrawal by Subject|2|||
46839684|NCT00456521|83057010|FG000|Overall Study|Adverse Event|150|||
46945635|NCT02653664|83183696|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
46945636|NCT02488629|83183714|FG000|Overall Study|Lack of Efficacy|3|||
46945637|NCT02488629|83183715|FG001|Overall Study|Lack of Efficacy|1|||
46945638|NCT02488629|83183716|FG002|Overall Study|Lack of Efficacy|0|||
46945639|NCT02488629|83183717|FG003|Overall Study|Lack of Efficacy|0|||
46945640|NCT02488629|83183714|FG000|Overall Study|Withdrawal by Subject|0|||
46945641|NCT02488629|83183715|FG001|Overall Study|Withdrawal by Subject|1|||
46945642|NCT02488629|83183716|FG002|Overall Study|Withdrawal by Subject|0|||
47064123|NCT01507831|83346313|FG001|Overall Study|Physician Decision|4|||
47064124|NCT01507831|83346312|FG000|Overall Study|Participant moved|5|||
46769748|NCT00731679|82988155|FG001|Overall Study|Adverse Event|8|||
46769749|NCT00731679|82988154|FG000|Overall Study|Withdrawal by Subject|8|||
46769750|NCT00731679|82988155|FG001|Overall Study|Withdrawal by Subject|8|||
46769751|NCT00731679|82988154|FG000|Overall Study|Lost to Follow-up|7|||
46769752|NCT00731679|82988155|FG001|Overall Study|Lost to Follow-up|8|||
46769753|NCT00731679|82988154|FG000|Overall Study|Noncompliance|0|||
46769754|NCT00731679|82988155|FG001|Overall Study|Noncompliance|1|||
46769755|NCT00731679|82988154|FG000|Overall Study|Pregnancy|0|||
46769756|NCT00731679|82988155|FG001|Overall Study|Pregnancy|1|||
46769757|NCT00731133|82988161|FG000|Overall Study|Withdrawal by Subject|10|||
46839685|NCT00456521|83057011|FG001|Overall Study|Adverse Event|25|||
46839686|NCT00456521|83057010|FG000|Overall Study|Withdrawal by Subject|43|||
46839687|NCT00456521|83057011|FG001|Overall Study|Withdrawal by Subject|24|||
46839688|NCT00456521|83057010|FG000|Overall Study|Lost to Follow-up|22|||
46839689|NCT00456521|83057011|FG001|Overall Study|Lost to Follow-up|17|||
46839690|NCT00456521|83057010|FG000|Overall Study|Lack of Efficacy|3|||
46839691|NCT00456521|83057011|FG001|Overall Study|Lack of Efficacy|6|||
46945643|NCT02488629|83183717|FG003|Overall Study|Withdrawal by Subject|0|||
46945644|NCT02727699|83183728|FG000|Overall Study|Adverse Event|2|||
46945645|NCT02727699|83183729|FG001|Overall Study|Adverse Event|0|||
46945646|NCT02727699|83183728|FG000|Overall Study|Withdrawal by Subject|5|||
46945647|NCT02727699|83183729|FG001|Overall Study|Withdrawal by Subject|3|||
46945648|NCT02727699|83183728|FG000|Overall Study|Protocol Violation|0|||
46945649|NCT02727699|83183729|FG001|Overall Study|Protocol Violation|1|||
46945650|NCT02727699|83183728|FG000|Overall Study|Physician Decision|0|||
46945651|NCT02727699|83183729|FG001|Overall Study|Physician Decision|1|||
46839692|NCT00456521|83057010|FG000|Overall Study|Protocol Violation|4|||
46839693|NCT00456521|83057011|FG001|Overall Study|Protocol Violation|0|||
46839694|NCT00456521|83057010|FG000|Overall Study|Pregnancy|1|||
46839695|NCT00456521|83057011|FG001|Overall Study|Pregnancy|1|||
46839696|NCT00456521|83057010|FG000|Overall Study|Drug non-compliance, moved, other|26|||
46839697|NCT00456521|83057011|FG001|Overall Study|Drug non-compliance, moved, other|11|||
46839698|NCT00456365|83057020|FG000|Overall Study|Lost to Follow-up|1|||
46945652|NCT02727699|83183728|FG000|Overall Study|Lost to Follow-up|1|||
46945653|NCT02727699|83183729|FG001|Overall Study|Lost to Follow-up|0|||
46945654|NCT02727699|83183728|FG000|Overall Study|Sponsor Decision|1|||
46945655|NCT02727699|83183729|FG001|Overall Study|Sponsor Decision|0|||
46945656|NCT03576716|83183747|FG000|Overall Study|Withdrawal by Subject|0|||
46945657|NCT03576716|83183748|FG001|Overall Study|Withdrawal by Subject|1|||
46945658|NCT02847637|83183758|FG000|Overall Study|Withdrawal by Subject|0|||
46945659|NCT02847637|83183759|FG001|Overall Study|Withdrawal by Subject|1|||
46945660|NCT02847637|83183760|FG002|Overall Study|Withdrawal by Subject|1|||
46945661|NCT02847637|83183761|FG003|Overall Study|Withdrawal by Subject|0|||
46839699|NCT00456365|83057021|FG001|Overall Study|Lost to Follow-up|3|||
47064125|NCT01507831|83346313|FG001|Overall Study|Participant moved|19|||
47064126|NCT01507831|83346312|FG000|Overall Study|Consent withdrawn by participant|34|||
47064127|NCT01507831|83346313|FG001|Overall Study|Consent withdrawn by participant|72|||
47064128|NCT01507831|83346312|FG000|Overall Study|Related to study drug administration|5|||
46839700|NCT00456365|83057020|FG000|Overall Study|Withdrawal by Subject|4|||
46839701|NCT00456365|83057021|FG001|Overall Study|Withdrawal by Subject|7|||
46839702|NCT00456365|83057020|FG000|Overall Study|Pregnancy|1|||
46839703|NCT00456365|83057021|FG001|Overall Study|Pregnancy|1|||
46839704|NCT00456365|83057020|FG000|Overall Study|oncologic diagnosis|1|||
46839705|NCT00456365|83057021|FG001|Overall Study|oncologic diagnosis|1|||
46839706|NCT00455741|83057031|FG000|Overall Study|Physician Decision|0|||
46839707|NCT00455741|83057032|FG001|Overall Study|Physician Decision|1|||
46839708|NCT00445679|83057052|FG000|Overall Study|Adverse Event|22|||
46839709|NCT00445679|83057053|FG001|Overall Study|Adverse Event|12|||
46839710|NCT00445679|83057054|FG002|Overall Study|Adverse Event|30|||
46839711|NCT00445679|83057055|FG003|Overall Study|Adverse Event|19|||
46839712|NCT00445679|83057052|FG000|Overall Study|Failed to return|1|||
46839713|NCT00445679|83057053|FG001|Overall Study|Failed to return|3|||
46839714|NCT00445679|83057054|FG002|Overall Study|Failed to return|2|||
46945662|NCT02847637|83183758|FG000|Overall Study|Lost to Follow-up|1|||
46945663|NCT02847637|83183759|FG001|Overall Study|Lost to Follow-up|1|||
46945664|NCT02847637|83183760|FG002|Overall Study|Lost to Follow-up|0|||
46945665|NCT02847637|83183761|FG003|Overall Study|Lost to Follow-up|0|||
46945666|NCT00706095|83183788|FG000|Overall Study|Progressive Disease|4|||
46945667|NCT00706095|83183789|FG001|Overall Study|Progressive Disease|5|||
47064129|NCT01507831|83346313|FG001|Overall Study|Related to study drug administration|14|||
47064130|NCT01507831|83346312|FG000|Overall Study|Last visit outside protocol visit window|51|||
47064131|NCT01507831|83346313|FG001|Overall Study|Last visit outside protocol visit window|143|||
46945668|NCT00706095|83183790|FG002|Overall Study|Progressive Disease|3|||
46945669|NCT00706095|83183788|FG000|Overall Study|Clinical Progression|1|||
47064132|NCT01507831|83346312|FG000|Overall Study|Selection criteria finally not met|0|||
47064133|NCT01507831|83346313|FG001|Overall Study|Selection criteria finally not met|1|||
46638630|NCT01418352|82812011|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
46638631|NCT01418352|82812012|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
46839715|NCT00445679|83057055|FG003|Overall Study|Failed to return|2|||
46945670|NCT00706095|83183789|FG001|Overall Study|Clinical Progression|2|||
46945671|NCT00706095|83183790|FG002|Overall Study|Clinical Progression|2|||
46945672|NCT00706095|83183788|FG000|Overall Study|Withdrawal by Subject|1|||
46945673|NCT00706095|83183789|FG001|Overall Study|Withdrawal by Subject|0|||
46839716|NCT00445679|83057052|FG000|Overall Study|Physician Decision|0|||
46839717|NCT00445679|83057053|FG001|Overall Study|Physician Decision|0|||
46839718|NCT00445679|83057054|FG002|Overall Study|Physician Decision|1|||
46839719|NCT00445679|83057055|FG003|Overall Study|Physician Decision|0|||
46839720|NCT00445679|83057052|FG000|Overall Study|Lost to Follow-up|10|||
46839721|NCT00445679|83057053|FG001|Overall Study|Lost to Follow-up|6|||
46839722|NCT00445679|83057054|FG002|Overall Study|Lost to Follow-up|6|||
46839723|NCT00445679|83057055|FG003|Overall Study|Lost to Follow-up|5|||
46945674|NCT00706095|83183790|FG002|Overall Study|Withdrawal by Subject|0|||
46945675|NCT02837731|83183800|FG000|Allocation|Admitted to General Floor|3|||
46945676|NCT02837731|83183801|FG001|Allocation|Admitted to General Floor|4|||
46839724|NCT00445679|83057052|FG000|Overall Study|Compliance|3|||
46839725|NCT00445679|83057053|FG001|Overall Study|Compliance|2|||
46839726|NCT00445679|83057054|FG002|Overall Study|Compliance|1|||
47064134|NCT01507831|83346312|FG000|Overall Study|Site closure|0|||
46769758|NCT00730275|82988169|FG000|Overall Study|Withdrawal by Subject|0|||
47064135|NCT01507831|83346313|FG001|Overall Study|Site closure|3|||
47064136|NCT01507831|83346312|FG000|Overall Study|Potential lost to follow-up|3|||
47064137|NCT01507831|83346313|FG001|Overall Study|Potential lost to follow-up|0|||
47064138|NCT01507831|83346312|FG000|Overall Study|Other|3|||
47064139|NCT01507831|83346313|FG001|Overall Study|Other|6|||
47064140|NCT01479595|83346321|FG000|Overall Study|Protocol deviation|0|||
47064141|NCT01479595|83346322|FG001|Overall Study|Protocol deviation|1|||
47064142|NCT01479595|83346321|FG000|Overall Study|Adverse Event|2|||
47064143|NCT01479595|83346322|FG001|Overall Study|Adverse Event|1|||
47064144|NCT01462357|83346331|FG000|Overall Study|Death|0|||
47064145|NCT01462357|83346332|FG001|Overall Study|Death|0|||
47064146|NCT01462357|83346333|FG002|Overall Study|Death|1|||
47064147|NCT01462357|83346331|FG000|Overall Study|Withdrawal by Subject|3|||
47064148|NCT01462357|83346332|FG001|Overall Study|Withdrawal by Subject|11|||
47064149|NCT01462357|83346333|FG002|Overall Study|Withdrawal by Subject|3|||
47064150|NCT01462357|83346331|FG000|Overall Study|Migrated/moved from study area|2|||
47064151|NCT01462357|83346332|FG001|Overall Study|Migrated/moved from study area|3|||
47064152|NCT01462357|83346333|FG002|Overall Study|Migrated/moved from study area|1|||
47064153|NCT01462357|83346331|FG000|Overall Study|Lost to Follow-up|3|||
47064154|NCT01462357|83346332|FG001|Overall Study|Lost to Follow-up|5|||
47064155|NCT01462357|83346333|FG002|Overall Study|Lost to Follow-up|7|||
47064156|NCT01479439|83346344|FG000|Overall Study|Adverse Event|1|||
47064157|NCT01479439|83346345|FG001|Overall Study|Adverse Event|0|||
47064158|NCT01479439|83346346|FG002|Overall Study|Adverse Event|0|||
47064159|NCT01479439|83346344|FG000|Overall Study|Lost to Follow-up|0|||
47064160|NCT01479439|83346345|FG001|Overall Study|Lost to Follow-up|1|||
47064161|NCT01479439|83346346|FG002|Overall Study|Lost to Follow-up|0|||
47064162|NCT01479439|83346344|FG000|Overall Study|Protocol Violation|0|||
47064163|NCT01479439|83346345|FG001|Overall Study|Protocol Violation|0|||
47064164|NCT01479439|83346346|FG002|Overall Study|Protocol Violation|2|||
47064165|NCT01478971|83346357|FG000|Standard of Care Period|Adverse Event|1|||
47064166|NCT01478971|83346357|FG000|Standard of Care Period|Withdrawal by Subject|3|||
47064167|NCT01478971|83346357|FG000|Standard of Care Period|Death|8|||
46769759|NCT00730275|82988170|FG001|Overall Study|Withdrawal by Subject|0|||
46769760|NCT00730275|82988171|FG002|Overall Study|Withdrawal by Subject|0|||
46769761|NCT00730275|82988172|FG003|Overall Study|Withdrawal by Subject|1|||
46769762|NCT00730041|82988190|FG000|Overall Study|Lost to Follow-up|0|||
46769763|NCT00730041|82988191|FG001|Overall Study|Lost to Follow-up|2|||
46839727|NCT00445679|83057055|FG003|Overall Study|Compliance|2|||
46839728|NCT00445679|83057052|FG000|Overall Study|Withdrawal of Informed Consent|0|||
46839729|NCT00445679|83057053|FG001|Overall Study|Withdrawal of Informed Consent|0|||
46839730|NCT00445679|83057054|FG002|Overall Study|Withdrawal of Informed Consent|1|||
46769764|NCT00729651|82988199|FG000|Overall Study|Withdrawal by Subject|5|||
46769765|NCT00729651|82988200|FG001|Overall Study|Withdrawal by Subject|6|||
46769766|NCT00729651|82988199|FG000|Overall Study|Lost to Follow-up|5|||
46769767|NCT00729651|82988200|FG001|Overall Study|Lost to Follow-up|4|||
46769768|NCT00729651|82988199|FG000|Overall Study|Protocol Violation|0|||
46769769|NCT00729651|82988200|FG001|Overall Study|Protocol Violation|1|||
46769770|NCT00729651|82988199|FG000|Overall Study|Adverse Event|7|||
46769771|NCT00729651|82988200|FG001|Overall Study|Adverse Event|3|||
46769772|NCT00729651|82988199|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
46839731|NCT00445679|83057055|FG003|Overall Study|Withdrawal of Informed Consent|0|||
46839732|NCT00445679|83057052|FG000|Overall Study|Protocol Violation|2|||
46839733|NCT00445679|83057053|FG001|Overall Study|Protocol Violation|3|||
46945677|NCT02837731|83183800|FG000|Allocation|Immediate surgery/withdrew|2|||
46945678|NCT02837731|83183801|FG001|Allocation|Immediate surgery/withdrew|0|||
46945679|NCT02837731|83183800|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
47064168|NCT01478971|83346357|FG000|Standard of Care Period|Lost to Follow-up|9|||
47064169|NCT01478971|83346357|FG000|Standard of Care Period|Other|4|||
47064170|NCT01478971|83346357|FG000|Peginesatide Treatment Period|Adverse Event|1|||
47064171|NCT01478971|83346357|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
47064172|NCT01478971|83346357|FG000|Peginesatide Treatment Period|Death|4|||
46769773|NCT00729651|82988200|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
46769774|NCT00729651|82988199|FG000|Overall Study|Subject's private reason|2|||
46769775|NCT00729651|82988200|FG001|Overall Study|Subject's private reason|0|||
46769776|NCT00729183|82988208|FG000|Overall Study|Adverse Event|11|||
46839734|NCT00445679|83057054|FG002|Overall Study|Protocol Violation|3|||
46839735|NCT00445679|83057055|FG003|Overall Study|Protocol Violation|1|||
46839736|NCT00445679|83057052|FG000|Overall Study|Withdrawal by Subject|8|||
46839737|NCT00445679|83057053|FG001|Overall Study|Withdrawal by Subject|14|||
47064173|NCT01478971|83346357|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
47064174|NCT01478971|83346357|FG000|Peginesatide Treatment Period|Other|4|||
47064175|NCT01507051|83346369|FG000|Overall Study|Withdrawal by Subject|1|||
46839738|NCT00445679|83057054|FG002|Overall Study|Withdrawal by Subject|20|||
46839739|NCT00445679|83057055|FG003|Overall Study|Withdrawal by Subject|18|||
46839740|NCT00445679|83057052|FG000|Overall Study|Lack of Efficacy|2|||
46839741|NCT00445679|83057053|FG001|Overall Study|Lack of Efficacy|6|||
46839742|NCT00445679|83057054|FG002|Overall Study|Lack of Efficacy|2|||
46839743|NCT00445679|83057055|FG003|Overall Study|Lack of Efficacy|0|||
46839744|NCT00455429|83057069|FG000|Overall Study|Study Terminated by Sponsor|0|||
46839745|NCT00455429|83057070|FG001|Overall Study|Study Terminated by Sponsor|0|||
46839746|NCT00455429|83057071|FG002|Overall Study|Study Terminated by Sponsor|0|||
46839747|NCT00455429|83057072|FG003|Overall Study|Study Terminated by Sponsor|3|||
46839748|NCT00455429|83057069|FG000|Overall Study|Lost to Follow-up|1|||
46839749|NCT00455429|83057070|FG001|Overall Study|Lost to Follow-up|0|||
46839750|NCT00455429|83057071|FG002|Overall Study|Lost to Follow-up|0|||
46839751|NCT00455429|83057072|FG003|Overall Study|Lost to Follow-up|3|||
46839752|NCT00455429|83057069|FG000|Overall Study|Withdrawal by Subject|0|||
46945680|NCT02837731|83183801|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
46945681|NCT02837731|83183800|FG000|Allocation|Withdrawal by Subject|2|||
46945682|NCT02837731|83183801|FG001|Allocation|Withdrawal by Subject|0|||
46945683|NCT02837731|83183800|FG000|Allocation|Device not available|1|||
46945684|NCT02837731|83183801|FG001|Allocation|Device not available|0|||
46945685|NCT02837731|83183800|FG000|Allocation|Protocol not implemented|7|||
46769777|NCT00729183|82988209|FG001|Overall Study|Adverse Event|5|||
46769778|NCT00729183|82988208|FG000|Overall Study|Lack of Efficacy|0|||
46769779|NCT00729183|82988209|FG001|Overall Study|Lack of Efficacy|1|||
46769780|NCT00729183|82988208|FG000|Overall Study|Lost to Follow-up|3|||
46769781|NCT00729183|82988209|FG001|Overall Study|Lost to Follow-up|1|||
46769782|NCT00729183|82988208|FG000|Overall Study|Physician Decision|1|||
46769783|NCT00729183|82988209|FG001|Overall Study|Physician Decision|1|||
46769784|NCT00729183|82988208|FG000|Overall Study|Protocol Violation|1|||
46769785|NCT00729183|82988209|FG001|Overall Study|Protocol Violation|0|||
46769786|NCT00729183|82988208|FG000|Overall Study|Withdrawal by Subject|9|||
46769787|NCT00729183|82988209|FG001|Overall Study|Withdrawal by Subject|7|||
46769788|NCT00811733|82988217|FG000|Overall Study|Investigator Discretion|10|||
46769789|NCT00811733|82988218|FG001|Overall Study|Investigator Discretion|8|||
46769790|NCT00811733|82988217|FG000|Overall Study|Withdrawal by Subject|1|||
46769791|NCT00811733|82988218|FG001|Overall Study|Withdrawal by Subject|2|||
46769792|NCT00728949|82988226|FG000|Overall Study|Adverse Event|8|||
46769793|NCT00728949|82988227|FG001|Overall Study|Adverse Event|0|||
46769794|NCT00728949|82988226|FG000|Overall Study|Withdrawal by Subject|2|||
46769795|NCT00728949|82988227|FG001|Overall Study|Withdrawal by Subject|2|||
46769796|NCT00728949|82988226|FG000|Overall Study|Abnormal Lab Results|0|||
46769797|NCT00728949|82988227|FG001|Overall Study|Abnormal Lab Results|2|||
46839753|NCT00455429|83057070|FG001|Overall Study|Withdrawal by Subject|1|||
46839754|NCT00455429|83057071|FG002|Overall Study|Withdrawal by Subject|1|||
46839755|NCT00455429|83057072|FG003|Overall Study|Withdrawal by Subject|0|||
46839756|NCT00455429|83057069|FG000|Overall Study|Lack of Efficacy|0|||
46839757|NCT00455429|83057070|FG001|Overall Study|Lack of Efficacy|1|||
46839758|NCT00455429|83057071|FG002|Overall Study|Lack of Efficacy|0|||
46839759|NCT00455429|83057072|FG003|Overall Study|Lack of Efficacy|1|||
46839760|NCT00455429|83057069|FG000|Overall Study|Adverse Event|0|||
46839761|NCT00455429|83057070|FG001|Overall Study|Adverse Event|1|||
46839762|NCT00455429|83057071|FG002|Overall Study|Adverse Event|0|||
46839763|NCT00455429|83057072|FG003|Overall Study|Adverse Event|3|||
46839764|NCT00455429|83057069|FG000|Overall Study|Randomly assigned but not treated|0|||
46839765|NCT00455429|83057070|FG001|Overall Study|Randomly assigned but not treated|0|||
46839766|NCT00455429|83057071|FG002|Overall Study|Randomly assigned but not treated|0|||
46839767|NCT00455429|83057072|FG003|Overall Study|Randomly assigned but not treated|2|||
46839768|NCT00455429|83057069|FG000|Overall Study|Personal Reason|1|||
46839769|NCT00455429|83057070|FG001|Overall Study|Personal Reason|0|||
46839770|NCT00455429|83057071|FG002|Overall Study|Personal Reason|0|||
46839771|NCT00455429|83057072|FG003|Overall Study|Personal Reason|0|||
46839772|NCT00455429|83057069|FG000|Overall Study|Non-compliance|0|||
46839773|NCT00455429|83057070|FG001|Overall Study|Non-compliance|0|||
46839774|NCT00455429|83057071|FG002|Overall Study|Non-compliance|0|||
46839775|NCT00455429|83057072|FG003|Overall Study|Non-compliance|1|||
46945686|NCT02837731|83183801|FG001|Allocation|Protocol not implemented|0|||
46769798|NCT00728949|82988226|FG000|Overall Study|On treatment at cutoff date|1|||
46769799|NCT00728949|82988227|FG001|Overall Study|On treatment at cutoff date|0|||
46769800|NCT00728481|82988235|FG000|Overall Study|Withdrawal by Subject|0|||
46769801|NCT00728481|82988236|FG001|Overall Study|Withdrawal by Subject|1|||
46839776|NCT00455429|83057069|FG000|Overall Study|Other|0|||
46839777|NCT00455429|83057070|FG001|Overall Study|Other|2|||
46839778|NCT00455429|83057071|FG002|Overall Study|Other|0|||
46839779|NCT00455429|83057072|FG003|Overall Study|Other|1|||
46839780|NCT00445601|83057087|FG000|Overall Study|Withdrawal by Subject|11|||
46839781|NCT00445601|83057088|FG001|Overall Study|Withdrawal by Subject|11|||
46839782|NCT00445601|83057087|FG000|Overall Study|TURBT Complication|12|||
46839783|NCT00445601|83057088|FG001|Overall Study|TURBT Complication|8|||
46967863|NCT05091307|83210486|FG003|Overall Study|Death|0|||
46945687|NCT02837731|83183800|FG000|Allocation|Moribund/Do not resuscitate|2|||
46945688|NCT02837731|83183801|FG001|Allocation|Moribund/Do not resuscitate|0|||
46945689|NCT02837731|83183800|FG000|Allocation|Did not meet sepsis criteria|1|||
46945690|NCT02837731|83183801|FG001|Allocation|Did not meet sepsis criteria|2|||
46945691|NCT02837731|83183800|FG000|Allocation|Known aortic abnormalities|0|||
46769802|NCT00728481|82988235|FG000|Overall Study|Adverse Event|0|||
46769803|NCT00728481|82988236|FG001|Overall Study|Adverse Event|1|||
46769804|NCT00728481|82988235|FG000|Overall Study|Study medication non-compliance|0|||
46769805|NCT00728481|82988236|FG001|Overall Study|Study medication non-compliance|2|||
46769806|NCT00728481|82988235|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
46769807|NCT00728481|82988236|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
46769808|NCT00811655|82988242|FG000|Overall Study|Physician Decision|1|||
46769809|NCT00727311|82988246|FG000|Overall Study|Did not receive drug|316|||
46769810|NCT00727311|82988246|FG000|Overall Study|Missing end of therapy data|205|||
46769811|NCT00727311|82988246|FG000|Overall Study|Adverse Event|58|||
46769812|NCT00727311|82988246|FG000|Overall Study|Lack of Efficacy|242|||
46769813|NCT00727311|82988246|FG000|Overall Study|Lost to Follow-up|73|||
46769814|NCT00727311|82988246|FG000|Overall Study|Withdrawal by Subject|77|||
46769815|NCT00727311|82988246|FG000|Overall Study|Other|97|||
46945692|NCT02837731|83183801|FG001|Allocation|Known aortic abnormalities|1|||
46839784|NCT00445601|83057087|FG000|Overall Study|Incorrect Disease Status|6|||
46839785|NCT00445601|83057088|FG001|Overall Study|Incorrect Disease Status|6|||
46839786|NCT00445601|83057087|FG000|Overall Study|Drug Delivery Issue|2|||
46945693|NCT02836873|83183809|FG000|Overall Study|Protocol Violation|0|||
46945694|NCT02836873|83183810|FG001|Overall Study|Protocol Violation|1|||
46945695|NCT02836873|83183809|FG000|Overall Study|Adverse Event|1|||
46945696|NCT02836873|83183810|FG001|Overall Study|Adverse Event|4|||
46945697|NCT02836873|83183809|FG000|Overall Study|Withdrawal by Subject|2|||
46945698|NCT02836873|83183810|FG001|Overall Study|Withdrawal by Subject|2|||
46945699|NCT02836873|83183809|FG000|Overall Study|Lost to Follow-up|1|||
46945700|NCT02836873|83183810|FG001|Overall Study|Lost to Follow-up|3|||
46945701|NCT02836873|83183809|FG000|Overall Study|Physician Decision|0|||
46945702|NCT02836873|83183810|FG001|Overall Study|Physician Decision|1|||
46945703|NCT02836873|83183809|FG000|Overall Study|Other|1|||
46839787|NCT00445601|83057088|FG001|Overall Study|Drug Delivery Issue|2|||
46839788|NCT00445601|83057087|FG000|Overall Study|Adverse Event|2|||
46839789|NCT00445601|83057088|FG001|Overall Study|Adverse Event|0|||
46839790|NCT00445601|83057087|FG000|Overall Study|Death prior to TURBT|0|||
46839791|NCT00445601|83057088|FG001|Overall Study|Death prior to TURBT|1|||
46839792|NCT00444587|83057100|FG000|Overall Study|Death|2|||
46839793|NCT00444587|83057101|FG001|Overall Study|Death|1|||
46839794|NCT00444587|83057100|FG000|Overall Study|Progression of the disease|73|||
46839795|NCT00444587|83057101|FG001|Overall Study|Progression of the disease|8|||
46839796|NCT00444587|83057100|FG000|Overall Study|Refused treatment/did not cooperate|4|||
46839797|NCT00444587|83057101|FG001|Overall Study|Refused treatment/did not cooperate|1|||
46839798|NCT00444587|83057100|FG000|Overall Study|Investigator decision|3|||
46839799|NCT00444587|83057101|FG001|Overall Study|Investigator decision|0|||
46839800|NCT00444587|83057100|FG000|Overall Study|Protocol Violation|1|||
46839801|NCT00444587|83057101|FG001|Overall Study|Protocol Violation|0|||
46839802|NCT00444587|83057100|FG000|Overall Study|Missing|0|||
46839803|NCT00444587|83057101|FG001|Overall Study|Missing|5|||
46839804|NCT00455195|83057111|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
46839805|NCT00455195|83057112|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
46839806|NCT00455195|83057111|FG000|Double-blind Study AGLU02704|Death|1|||
46839807|NCT00455195|83057112|FG001|Double-blind Study AGLU02704|Death|0|||
46839808|NCT00455195|83057111|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
46839809|NCT00455195|83057112|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
46839810|NCT00455195|83057111|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
46839811|NCT00455195|83057112|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
46839812|NCT00235716|83057122|FG000|Overall Study|Death|26|||
46839813|NCT00235716|83057123|FG001|Overall Study|Death|39|||
46839814|NCT00235716|83057124|FG002|Overall Study|Death|32|||
46839815|NCT00235716|83057125|FG003|Overall Study|Death|31|||
46839816|NCT00235716|83057122|FG000|Overall Study|Withdrawal by Subject|23|||
46638632|NCT01418352|82812013|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
46769816|NCT00727311|82988246|FG000|Overall Study|Multiple reasons|39|||
46769817|NCT00726999|82988252|FG000|Overall Study|Physician Decision|0|||
46769818|NCT00726999|82988253|FG001|Overall Study|Physician Decision|1|||
46839817|NCT00235716|83057123|FG001|Overall Study|Withdrawal by Subject|19|||
46839818|NCT00235716|83057124|FG002|Overall Study|Withdrawal by Subject|17|||
46839819|NCT00235716|83057125|FG003|Overall Study|Withdrawal by Subject|18|||
46839820|NCT00235716|83057122|FG000|Overall Study|Lost to Follow-up|12|||
46839821|NCT00235716|83057123|FG001|Overall Study|Lost to Follow-up|7|||
46839822|NCT00235716|83057124|FG002|Overall Study|Lost to Follow-up|14|||
46839823|NCT00235716|83057125|FG003|Overall Study|Lost to Follow-up|10|||
46945704|NCT02836873|83183810|FG001|Overall Study|Other|0|||
46945705|NCT01342081|83183828|FG000|Overall Study|Did not receive allocated intervention|0|||
46945706|NCT01342081|83183829|FG001|Overall Study|Did not receive allocated intervention|0|||
46945707|NCT01342081|83183830|FG002|Overall Study|Did not receive allocated intervention|1|||
46945708|NCT01342081|83183828|FG000|Overall Study|Adverse Event|1|||
46945709|NCT01342081|83183829|FG001|Overall Study|Adverse Event|0|||
46945710|NCT01342081|83183830|FG002|Overall Study|Adverse Event|0|||
46945711|NCT01342081|83183828|FG000|Overall Study|Physician Decision|0|||
46945712|NCT01342081|83183829|FG001|Overall Study|Physician Decision|1|||
46945713|NCT01342081|83183830|FG002|Overall Study|Physician Decision|0|||
46945714|NCT01342081|83183828|FG000|Overall Study|Withdrawal by Subject|1|||
46945715|NCT01342081|83183829|FG001|Overall Study|Withdrawal by Subject|1|||
46945716|NCT01342081|83183830|FG002|Overall Study|Withdrawal by Subject|0|||
46945717|NCT01341457|83183840|FG000|Overall Study|Adverse Event|2|||
46945718|NCT01341457|83183841|FG001|Overall Study|Adverse Event|0|||
46945719|NCT02832037|83183853|FG000|Overall Study|Administrative reasons|0|||
46945720|NCT02832037|83183854|FG001|Overall Study|Administrative reasons|0|||
46945721|NCT02832037|83183855|FG002|Overall Study|Administrative reasons|1|||
46945722|NCT02832037|83183856|FG003|Overall Study|Administrative reasons|0|||
46945723|NCT02832037|83183857|FG004|Overall Study|Administrative reasons|0|||
46945724|NCT02832037|83183853|FG000|Overall Study|Protocol Violation|3|||
46945725|NCT02832037|83183854|FG001|Overall Study|Protocol Violation|0|||
46945726|NCT02832037|83183855|FG002|Overall Study|Protocol Violation|4|||
46945727|NCT02832037|83183856|FG003|Overall Study|Protocol Violation|1|||
46945728|NCT02832037|83183857|FG004|Overall Study|Protocol Violation|2|||
46945729|NCT02832037|83183853|FG000|Overall Study|Lost to Follow-up|2|||
46945730|NCT02832037|83183854|FG001|Overall Study|Lost to Follow-up|0|||
46945731|NCT02832037|83183855|FG002|Overall Study|Lost to Follow-up|3|||
46945732|NCT02832037|83183856|FG003|Overall Study|Lost to Follow-up|0|||
46945733|NCT02832037|83183857|FG004|Overall Study|Lost to Follow-up|5|||
46839824|NCT00235716|83057122|FG000|Overall Study|Adverse Event|1|||
46839825|NCT00235716|83057123|FG001|Overall Study|Adverse Event|1|||
46839826|NCT00235716|83057124|FG002|Overall Study|Adverse Event|1|||
46839827|NCT00235716|83057125|FG003|Overall Study|Adverse Event|0|||
46839828|NCT00235716|83057122|FG000|Overall Study|Physician Decision|0|||
46945734|NCT02832037|83183853|FG000|Overall Study|Withdrawal by Subject|9|||
46945735|NCT02832037|83183854|FG001|Overall Study|Withdrawal by Subject|8|||
46945736|NCT02832037|83183855|FG002|Overall Study|Withdrawal by Subject|0|||
46945737|NCT02832037|83183856|FG003|Overall Study|Withdrawal by Subject|4|||
46945738|NCT02832037|83183857|FG004|Overall Study|Withdrawal by Subject|8|||
46945739|NCT02832037|83183853|FG000|Overall Study|Adverse Event|5|||
46945740|NCT02832037|83183854|FG001|Overall Study|Adverse Event|4|||
46945741|NCT02832037|83183855|FG002|Overall Study|Adverse Event|0|||
46945742|NCT02832037|83183856|FG003|Overall Study|Adverse Event|2|||
46945743|NCT02832037|83183857|FG004|Overall Study|Adverse Event|4|||
46945744|NCT01675154|83183873|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
46945745|NCT01675154|83183874|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
46945746|NCT01675154|83183875|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
46945747|NCT01675154|83183876|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
46945748|NCT02744755|83183900|FG000|Study Period 1|Protocol Violation|2|||
46945749|NCT02744755|83183901|FG001|Study Period 1|Protocol Violation|1|||
46945750|NCT02744755|83183900|FG000|Study Period 1|not defined|0|||
46945751|NCT02744755|83183901|FG001|Study Period 1|not defined|1|||
46945752|NCT02744755|83183900|FG000|Study Period 1|Pregnancy|1|||
46945753|NCT02744755|83183901|FG001|Study Period 1|Pregnancy|0|||
46945754|NCT02744755|83183900|FG000|Study Period 1|Adverse Event|1|||
46945755|NCT02744755|83183901|FG001|Study Period 1|Adverse Event|1|||
46945756|NCT02744755|83183900|FG000|Study Period 1|Lost to Follow-up|1|||
46945757|NCT02744755|83183901|FG001|Study Period 1|Lost to Follow-up|1|||
46769819|NCT00726999|82988252|FG000|Overall Study|Withdrawal by Subject|2|||
46769820|NCT00726999|82988253|FG001|Overall Study|Withdrawal by Subject|0|||
46769821|NCT00726999|82988252|FG000|Overall Study|Protocol Violation|1|||
46769822|NCT00726999|82988253|FG001|Overall Study|Protocol Violation|0|||
46769823|NCT00585351|82988267|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
46769824|NCT00585351|82988268|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
46769825|NCT00585351|82988269|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
46769826|NCT00585351|82988270|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
46769827|NCT00585351|82988271|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
46839829|NCT00235716|83057123|FG001|Overall Study|Physician Decision|1|||
46945758|NCT02744755|83183900|FG000|Study Period 1|Lack of Efficacy|1|||
46945759|NCT02744755|83183901|FG001|Study Period 1|Lack of Efficacy|0|||
46945760|NCT02744755|83183900|FG000|Study Period 1|Withdrawal by Subject|8|||
46945761|NCT02744755|83183901|FG001|Study Period 1|Withdrawal by Subject|4|||
46945762|NCT02744755|83183900|FG000|Study Period 2|Adverse Event|5|||
46945763|NCT02744755|83183901|FG001|Study Period 2|Adverse Event|0|||
46945764|NCT02744755|83183900|FG000|Study Period 2|Protocol Violation|1|||
46945765|NCT02744755|83183901|FG001|Study Period 2|Protocol Violation|0|||
46945766|NCT02744755|83183900|FG000|Study Period 2|not defined|3|||
46945767|NCT02744755|83183901|FG001|Study Period 2|not defined|2|||
46945768|NCT02744755|83183900|FG000|Study Period 2|Lost to Follow-up|0|||
46945769|NCT02744755|83183901|FG001|Study Period 2|Lost to Follow-up|2|||
46945770|NCT02744755|83183900|FG000|Study Period 2|Withdrawal by Subject|2|||
46945771|NCT02744755|83183901|FG001|Study Period 2|Withdrawal by Subject|2|||
46945772|NCT02744755|83183900|FG000|Study Period 2|Lack of Efficacy|3|||
46945773|NCT02744755|83183901|FG001|Study Period 2|Lack of Efficacy|2|||
47064176|NCT01507051|83346370|FG001|Overall Study|Withdrawal by Subject|3|||
46945774|NCT01356589|83183915|FG000|Overall Study|Enrolled, but not treated|3|||
46945775|NCT01356589|83183915|FG000|Overall Study|Dose data not recorded|2|||
46945776|NCT02830087|83183925|FG000|Overall Study|No study staff to follow-up patients|4|||
46945777|NCT02830087|83183926|FG001|Overall Study|No study staff to follow-up patients|4|||
46945778|NCT02830087|83183927|FG002|Overall Study|No study staff to follow-up patients|4|||
47064177|NCT01507051|83346371|FG002|Overall Study|Withdrawal by Subject|1|||
47064178|NCT01507051|83346372|FG003|Overall Study|Withdrawal by Subject|6|||
47064179|NCT01507051|83346369|FG000|Overall Study|Physician Decision|0|||
47064180|NCT01507051|83346370|FG001|Overall Study|Physician Decision|0|||
47064181|NCT01507051|83346371|FG002|Overall Study|Physician Decision|0|||
47064182|NCT01507051|83346372|FG003|Overall Study|Physician Decision|1|||
47064183|NCT01507051|83346369|FG000|Overall Study|Adverse Event|1|||
47064184|NCT01507051|83346370|FG001|Overall Study|Adverse Event|0|||
47064185|NCT01507051|83346371|FG002|Overall Study|Adverse Event|0|||
47064186|NCT01507051|83346372|FG003|Overall Study|Adverse Event|0|||
47064187|NCT01478347|83346382|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
47064188|NCT01478347|83346382|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
47064189|NCT01478347|83346382|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
47064190|NCT01478113|83346388|FG000|Overall Study|Withdrawal by Subject|0|||
46638633|NCT01418352|82812010|FG000|Overall Study|Subject Withdrew Consent|0|||
46945779|NCT02830087|83183928|FG003|Overall Study|No study staff to follow-up patients|3|||
46945780|NCT02830087|83183929|FG004|Overall Study|No study staff to follow-up patients|3|||
46945781|NCT02830087|83183930|FG005|Overall Study|No study staff to follow-up patients|3|||
46945782|NCT02829775|83183953|FG000|Overall Study|Death|1|||
46945783|NCT02829775|83183953|FG000|Overall Study|Withdrawal by Subject|3|||
46945784|NCT02829775|83183953|FG000|Overall Study|Disease remission|1|||
46945785|NCT01355497|83183974|FG000|Overall Study|Death|19|||
46945786|NCT01355497|83183975|FG001|Overall Study|Death|18|||
46945787|NCT01355497|83183974|FG000|Overall Study|Lost to Follow-up|3|||
47064191|NCT01478113|83346389|FG001|Overall Study|Withdrawal by Subject|1|||
47064192|NCT01478113|83346388|FG000|Overall Study|Physician Decision|1|||
46638634|NCT01418352|82812011|FG001|Overall Study|Subject Withdrew Consent|1|||
46638635|NCT01418352|82812012|FG002|Overall Study|Subject Withdrew Consent|2|||
46945788|NCT01355497|83183975|FG001|Overall Study|Lost to Follow-up|0|||
46945789|NCT01355497|83183974|FG000|Overall Study|Protocol Violation|0|||
46945790|NCT01355497|83183975|FG001|Overall Study|Protocol Violation|1|||
46945791|NCT01355497|83183974|FG000|Overall Study|other-not provided|9|||
46945792|NCT01355497|83183975|FG001|Overall Study|other-not provided|4|||
46945793|NCT01355497|83183974|FG000|Overall Study|Withdrawal by Subject|12|||
46945794|NCT01355497|83183975|FG001|Overall Study|Withdrawal by Subject|20|||
46945795|NCT01355497|83183974|FG000|Overall Study|noncompliance|1|||
46945796|NCT01355497|83183975|FG001|Overall Study|noncompliance|2|||
46945797|NCT01355497|83183974|FG000|Overall Study|progressive disease|11|||
46945798|NCT01355497|83183975|FG001|Overall Study|progressive disease|8|||
46945799|NCT01355497|83183974|FG000|Overall Study|Adverse Event|11|||
46945800|NCT01355497|83183975|FG001|Overall Study|Adverse Event|10|||
46945801|NCT01355575|83183981|FG000|Overall Study|Withdrawal by Subject|2|||
46945802|NCT02826421|83183993|FG000|Overall Study|Adverse Event|1|||
46945803|NCT02826421|83183994|FG001|Overall Study|Adverse Event|0|||
46945804|NCT02826421|83183995|FG002|Overall Study|Adverse Event|0|||
46945805|NCT02826421|83183996|FG003|Overall Study|Adverse Event|1|||
46945806|NCT02826421|83183993|FG000|Overall Study|Withdrawal by Subject|1|||
46945807|NCT02826421|83183994|FG001|Overall Study|Withdrawal by Subject|3|||
46945808|NCT02826421|83183995|FG002|Overall Study|Withdrawal by Subject|1|||
46945809|NCT02826421|83183996|FG003|Overall Study|Withdrawal by Subject|1|||
46945810|NCT02826421|83183993|FG000|Overall Study|Reason not given|1|||
46945811|NCT02826421|83183994|FG001|Overall Study|Reason not given|0|||
46945812|NCT02826421|83183995|FG002|Overall Study|Reason not given|1|||
47064193|NCT01478113|83346389|FG001|Overall Study|Physician Decision|0|||
47064194|NCT01506271|83346400|FG000|Overall Study|Progressive disease|0|||
47064195|NCT01506271|83346401|FG001|Overall Study|Progressive disease|1|||
46945813|NCT02826421|83183996|FG003|Overall Study|Reason not given|0|||
46945814|NCT02825251|83184009|FG000|Overall Study|Adverse Event|0|||
46945815|NCT02825251|83184010|FG001|Overall Study|Adverse Event|1|||
46945816|NCT02825251|83184009|FG000|Overall Study|Lost to Follow-up|0|||
46945817|NCT02825251|83184010|FG001|Overall Study|Lost to Follow-up|1|||
46945818|NCT02825251|83184009|FG000|Overall Study|Withdrawal by Subject|1|||
46945819|NCT02825251|83184010|FG001|Overall Study|Withdrawal by Subject|4|||
46945820|NCT02825251|83184009|FG000|Overall Study|Unclassified|2|||
46945821|NCT02825251|83184010|FG001|Overall Study|Unclassified|0|||
46945822|NCT04860505|83184016|FG000|Overall Study|Lost to Follow-up|2|||
46945823|NCT04063865|83184022|FG000|Overall Study|Physician Decision|1|||
46839830|NCT00235716|83057124|FG002|Overall Study|Physician Decision|1|||
46839831|NCT00235716|83057125|FG003|Overall Study|Physician Decision|3|||
47064196|NCT01506271|83346402|FG002|Overall Study|Progressive disease|0|||
46839832|NCT00274742|83057141|FG000|Overall Study|Adverse Event|0|||
46839833|NCT00274742|83057142|FG001|Overall Study|Adverse Event|4|||
46839834|NCT00274742|83057143|FG002|Overall Study|Adverse Event|1|||
46839835|NCT00274742|83057144|FG003|Overall Study|Adverse Event|4|||
46839836|NCT00274742|83057145|FG004|Overall Study|Adverse Event|12|||
46839837|NCT00274742|83057146|FG005|Overall Study|Adverse Event|3|||
46839838|NCT00274742|83057141|FG000|Overall Study|Lost to Follow-up|0|||
46839839|NCT00274742|83057142|FG001|Overall Study|Lost to Follow-up|0|||
46839840|NCT00274742|83057143|FG002|Overall Study|Lost to Follow-up|0|||
46839841|NCT00274742|83057144|FG003|Overall Study|Lost to Follow-up|0|||
46839842|NCT00274742|83057145|FG004|Overall Study|Lost to Follow-up|1|||
46839843|NCT00274742|83057146|FG005|Overall Study|Lost to Follow-up|0|||
46839844|NCT00274742|83057141|FG000|Overall Study|End of Study|0|||
46839845|NCT00274742|83057142|FG001|Overall Study|End of Study|0|||
46839846|NCT00274742|83057143|FG002|Overall Study|End of Study|0|||
46839847|NCT00274742|83057144|FG003|Overall Study|End of Study|1|||
46839848|NCT00274742|83057145|FG004|Overall Study|End of Study|0|||
46839849|NCT00274742|83057146|FG005|Overall Study|End of Study|0|||
46839850|NCT00274742|83057141|FG000|Overall Study|Disease Progression|0|||
46839851|NCT00274742|83057142|FG001|Overall Study|Disease Progression|1|||
46839852|NCT00274742|83057143|FG002|Overall Study|Disease Progression|1|||
46839853|NCT00274742|83057144|FG003|Overall Study|Disease Progression|0|||
46839854|NCT00274742|83057145|FG004|Overall Study|Disease Progression|1|||
46945824|NCT04063865|83184023|FG001|Overall Study|Physician Decision|3|||
46839855|NCT00274742|83057146|FG005|Overall Study|Disease Progression|0|||
46839856|NCT00274742|83057141|FG000|Overall Study|Other|0|||
46839857|NCT00274742|83057142|FG001|Overall Study|Other|3|||
46839858|NCT00274742|83057143|FG002|Overall Study|Other|0|||
46839859|NCT00274742|83057144|FG003|Overall Study|Other|0|||
46839860|NCT00274742|83057145|FG004|Overall Study|Other|2|||
46839861|NCT00274742|83057146|FG005|Overall Study|Other|0|||
46839862|NCT00262314|83057166|FG000|Overall Study|Changing physicians|38|||
46839863|NCT00262314|83057166|FG000|Overall Study|Death|12|||
46839864|NCT00262314|83057166|FG000|Overall Study|Patient's decision|92|||
46945825|NCT04063865|83184022|FG000|Overall Study|Study Closed Prior to Completion|4|||
46945826|NCT04063865|83184023|FG001|Overall Study|Study Closed Prior to Completion|4|||
47064197|NCT01506271|83346400|FG000|Overall Study|Protocol Violation|3|||
47064198|NCT01506271|83346401|FG001|Overall Study|Protocol Violation|1|||
47064199|NCT01506271|83346402|FG002|Overall Study|Protocol Violation|0|||
47064200|NCT01506271|83346400|FG000|Overall Study|Death|0|||
47064201|NCT01506271|83346401|FG001|Overall Study|Death|1|||
47064202|NCT01506271|83346402|FG002|Overall Study|Death|0|||
47064203|NCT01506271|83346400|FG000|Overall Study|Adverse Event|0|||
47064204|NCT01506271|83346401|FG001|Overall Study|Adverse Event|2|||
46638636|NCT01418352|82812013|FG003|Overall Study|Subject Withdrew Consent|1|||
46638637|NCT01418352|82812010|FG000|Overall Study|Protocol Deviation|0|||
46945827|NCT04063865|83184022|FG000|Overall Study|Withdrawal by Subject|1|||
46945828|NCT04063865|83184023|FG001|Overall Study|Withdrawal by Subject|1|||
46769828|NCT00585351|82988272|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
46769829|NCT00585351|82988273|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
46769830|NCT00585351|82988274|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
46769831|NCT00585351|82988267|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
46769832|NCT00585351|82988268|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
46769833|NCT00585351|82988269|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
46769834|NCT00585351|82988270|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
46769835|NCT00585351|82988271|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
46769836|NCT00585351|82988272|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
46945829|NCT03994211|83184031|FG000|Core Phase|Adverse Event|0|||
46945830|NCT03994211|83184032|FG001|Core Phase|Adverse Event|1|||
47064205|NCT01506271|83346402|FG002|Overall Study|Adverse Event|0|||
47064206|NCT01506271|83346400|FG000|Overall Study|Insufficient supply of study drug|1|||
46839865|NCT00262314|83057166|FG000|Overall Study|Other|95|||
46839866|NCT00262314|83057166|FG000|Overall Study|Lost to Follow-up|70|||
46839867|NCT00262314|83057166|FG000|Overall Study|Administrative withdrawal|30|||
46839868|NCT00283400|83057174|FG000|Overall Study|Withdrawal by Subject|1|||
46839869|NCT00283400|83057175|FG001|Overall Study|Withdrawal by Subject|1|||
46839870|NCT00283400|83057176|FG002|Overall Study|Withdrawal by Subject|0|||
46839871|NCT00283400|83057177|FG003|Overall Study|Withdrawal by Subject|0|||
46839872|NCT00283400|83057174|FG000|Overall Study|Death|1|||
46839873|NCT00283400|83057175|FG001|Overall Study|Death|0|||
46839874|NCT00283400|83057176|FG002|Overall Study|Death|1|||
46839875|NCT00283400|83057177|FG003|Overall Study|Death|0|||
46945831|NCT03994211|83184033|FG002|Core Phase|Adverse Event|0|||
47064207|NCT01506271|83346401|FG001|Overall Study|Insufficient supply of study drug|0|||
46839876|NCT00444275|83057190|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
46839877|NCT00444275|83057191|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
46839878|NCT00444275|83057192|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
46839879|NCT00444275|83057193|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
46839880|NCT00444275|83057194|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
46839881|NCT00444275|83057190|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
46839882|NCT00444275|83057191|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
46839883|NCT00444275|83057192|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
46945832|NCT03994211|83184031|FG000|Extension Phase|Adverse Event|0|||
46945833|NCT03994211|83184032|FG001|Extension Phase|Adverse Event|0|||
46945834|NCT03994211|83184033|FG002|Extension Phase|Adverse Event|1|||
46638638|NCT01418352|82812011|FG001|Overall Study|Protocol Deviation|0|||
46638639|NCT01418352|82812012|FG002|Overall Study|Protocol Deviation|1|||
46638640|NCT01418352|82812013|FG003|Overall Study|Protocol Deviation|0|||
46638641|NCT01418352|82812010|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
46638642|NCT01418352|82812011|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
46638643|NCT01418352|82812012|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
46638644|NCT01418352|82812013|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
46638645|NCT01436370|82812031|FG000|Overall Study|Lost to Follow-up|0|||
46638646|NCT01436370|82812032|FG001|Overall Study|Lost to Follow-up|0|||
46638647|NCT01436370|82812033|FG002|Overall Study|Lost to Follow-up|0|||
46638648|NCT01436370|82812034|FG003|Overall Study|Lost to Follow-up|0|||
46638649|NCT01436370|82812035|FG004|Overall Study|Lost to Follow-up|1|||
46638650|NCT01436370|82812036|FG005|Overall Study|Lost to Follow-up|0|||
46638651|NCT01436370|82812037|FG006|Overall Study|Lost to Follow-up|0|||
47064208|NCT01506271|83346402|FG002|Overall Study|Insufficient supply of study drug|0|||
47064209|NCT01506271|83346400|FG000|Overall Study|Withdrawal by Subject|0|||
46945835|NCT03994211|83184031|FG000|Extension Phase|Physician Decision|0|||
46945836|NCT03994211|83184032|FG001|Extension Phase|Physician Decision|0|||
46769837|NCT00585351|82988273|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
46769838|NCT00585351|82988274|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
46769839|NCT00585351|82988267|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
46769840|NCT00585351|82988268|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
46945837|NCT03994211|83184033|FG002|Extension Phase|Physician Decision|1|||
46945838|NCT03994211|83184031|FG000|Extension Phase|Progressive Disease|0|||
46945839|NCT03994211|83184032|FG001|Extension Phase|Progressive Disease|0|||
46945840|NCT03994211|83184033|FG002|Extension Phase|Progressive Disease|20|||
46945841|NCT03994211|83184031|FG000|Extension Phase|Withdrawal by Subject|0|||
46945842|NCT03994211|83184032|FG001|Extension Phase|Withdrawal by Subject|0|||
46945843|NCT03994211|83184033|FG002|Extension Phase|Withdrawal by Subject|2|||
46945844|NCT03818607|83184048|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
46945845|NCT03818607|83184049|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
46945846|NCT03818607|83184048|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
46945847|NCT03818607|83184049|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
46945848|NCT03818607|83184048|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
46945849|NCT03818607|83184049|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
47064210|NCT01506271|83346401|FG001|Overall Study|Withdrawal by Subject|1|||
46769841|NCT00585351|82988269|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
46769842|NCT00585351|82988270|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
46769843|NCT00585351|82988271|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
46769844|NCT00585351|82988272|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
46769845|NCT00585351|82988273|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
46769846|NCT00585351|82988274|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
46769847|NCT00585351|82988267|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
46769848|NCT00585351|82988268|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
46769849|NCT00585351|82988269|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
46769850|NCT00585351|82988270|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
46769851|NCT00585351|82988271|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
46769852|NCT00585351|82988272|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
46769853|NCT00585351|82988273|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
46769854|NCT00585351|82988274|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
46769855|NCT00585351|82988267|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
46839884|NCT00444275|83057193|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
46945850|NCT02422615|83184089|FG000|Treatment Period|Progressive disease|314|||
46945851|NCT02422615|83184090|FG001|Treatment Period|Progressive disease|200|||
46945852|NCT02422615|83184089|FG000|Treatment Period|Adverse Event|51|||
46945853|NCT02422615|83184090|FG001|Treatment Period|Adverse Event|9|||
47064211|NCT01506271|83346402|FG002|Overall Study|Withdrawal by Subject|1|||
47064212|NCT01506271|83346400|FG000|Overall Study|Lost to Follow-up|0|||
47064213|NCT01506271|83346401|FG001|Overall Study|Lost to Follow-up|1|||
46839885|NCT00444275|83057194|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
46839886|NCT00444275|83057190|FG000|Maintenance Treatment Phase|Adverse Event|0|||
46945854|NCT02422615|83184089|FG000|Treatment Period|Physician Decision|32|||
46945855|NCT02422615|83184090|FG001|Treatment Period|Physician Decision|8|||
46945856|NCT02422615|83184089|FG000|Treatment Period|Subject/guardian decision|38|||
46945857|NCT02422615|83184090|FG001|Treatment Period|Subject/guardian decision|8|||
46945858|NCT02422615|83184089|FG000|Treatment Period|Death|2|||
46945859|NCT02422615|83184090|FG001|Treatment Period|Death|1|||
46945860|NCT02422615|83184089|FG000|Treatment Period|Technical problems|0|||
46945861|NCT02422615|83184090|FG001|Treatment Period|Technical problems|1|||
46945862|NCT02422615|83184089|FG000|Treatment Period|Protocol deviation|1|||
46945863|NCT02422615|83184090|FG001|Treatment Period|Protocol deviation|1|||
46945864|NCT02422615|83184089|FG000|Treatment Period|Study terminated as per protocol|46|||
47064214|NCT01506271|83346402|FG002|Overall Study|Lost to Follow-up|2|||
46839887|NCT00444275|83057191|FG001|Maintenance Treatment Phase|Adverse Event|0|||
46839888|NCT00444275|83057192|FG002|Maintenance Treatment Phase|Adverse Event|3|||
46839889|NCT00444275|83057193|FG003|Maintenance Treatment Phase|Adverse Event|2|||
46769856|NCT00585351|82988268|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
46769857|NCT00585351|82988269|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
46769858|NCT00585351|82988270|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
46769859|NCT00585351|82988271|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
46769860|NCT00585351|82988272|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
46769861|NCT00585351|82988273|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
46839890|NCT00444275|83057194|FG004|Maintenance Treatment Phase|Adverse Event|13|||
46839891|NCT00444275|83057190|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
46839892|NCT00444275|83057191|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
46839893|NCT00444275|83057192|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
46839894|NCT00444275|83057193|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
46839895|NCT00444275|83057194|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
46839896|NCT00444275|83057190|FG000|Maintenance Treatment Phase|Patient's wish|0|||
46839897|NCT00444275|83057191|FG001|Maintenance Treatment Phase|Patient's wish|0|||
46839898|NCT00444275|83057192|FG002|Maintenance Treatment Phase|Patient's wish|19|||
46839899|NCT00444275|83057193|FG003|Maintenance Treatment Phase|Patient's wish|9|||
46839900|NCT00444275|83057194|FG004|Maintenance Treatment Phase|Patient's wish|20|||
46839901|NCT00444275|83057190|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
46839902|NCT00444275|83057191|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
46839903|NCT00444275|83057192|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
46839904|NCT00444275|83057193|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
46839905|NCT00444275|83057194|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
46839906|NCT00444275|83057190|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
46839907|NCT00444275|83057191|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
46839908|NCT00444275|83057192|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
46839909|NCT00444275|83057193|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
46839910|NCT00444275|83057194|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
46839911|NCT00454805|83057211|FG000|Overall Study|Withdrawal by Subject|9|||
46839912|NCT00454805|83057212|FG001|Overall Study|Withdrawal by Subject|2|||
46839913|NCT00454805|83057211|FG000|Overall Study|Death|0|||
46839914|NCT00454805|83057212|FG001|Overall Study|Death|2|||
46839915|NCT00454805|83057211|FG000|Overall Study|Disease progression|16|||
46839916|NCT00454805|83057212|FG001|Overall Study|Disease progression|19|||
46839917|NCT00454805|83057211|FG000|Overall Study|In order to begin radiotherapy|1|||
46839918|NCT00454805|83057212|FG001|Overall Study|In order to begin radiotherapy|0|||
46839919|NCT00283244|83057221|FG000|Overall Study|Adverse Event|0|||
46945865|NCT02422615|83184090|FG001|Treatment Period|Study terminated as per protocol|14|||
46945866|NCT02422615|83184089|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
47064215|NCT01506193|83346413|FG000|Overall Study|Protocol Violation|1|||
47064216|NCT01506193|83346414|FG001|Overall Study|Protocol Violation|0|||
47064217|NCT01506193|83346415|FG002|Overall Study|Protocol Violation|1|||
47064218|NCT01506193|83346413|FG000|Overall Study|Migrated/moved from study area|0|||
46769862|NCT00585351|82988274|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
46769863|NCT00585351|82988267|FG000|Enrollment Period (Intervention)|Death|0|||
46769864|NCT00585351|82988268|FG001|Enrollment Period (Intervention)|Death|0|||
46769865|NCT00585351|82988269|FG002|Enrollment Period (Intervention)|Death|0|||
46769866|NCT00585351|82988270|FG003|Enrollment Period (Intervention)|Death|0|||
46839920|NCT00283244|83057222|FG001|Overall Study|Adverse Event|8|||
46839921|NCT00283244|83057223|FG002|Overall Study|Adverse Event|11|||
46638652|NCT01436370|82812038|FG007|Overall Study|Lost to Follow-up|0|||
46839922|NCT00283244|83057221|FG000|Overall Study|Death|4|||
46839923|NCT00283244|83057222|FG001|Overall Study|Death|3|||
46945867|NCT02422615|83184090|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
46945868|NCT02422615|83184089|FG000|Post-treatment Efficacy Follow-up|Death|2|||
46945869|NCT02422615|83184090|FG001|Post-treatment Efficacy Follow-up|Death|1|||
46945870|NCT02422615|83184089|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
46945871|NCT02422615|83184090|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
47064219|NCT01506193|83346414|FG001|Overall Study|Migrated/moved from study area|0|||
47064220|NCT01506193|83346415|FG002|Overall Study|Migrated/moved from study area|1|||
47064221|NCT01506193|83346413|FG000|Overall Study|Adverse event, non-fatal|0|||
47064222|NCT01506193|83346414|FG001|Overall Study|Adverse event, non-fatal|0|||
47064223|NCT01506193|83346415|FG002|Overall Study|Adverse event, non-fatal|1|||
47064224|NCT01506193|83346413|FG000|Overall Study|Withdrawal by Subject|5|||
47064225|NCT01506193|83346414|FG001|Overall Study|Withdrawal by Subject|1|||
47064226|NCT01506193|83346415|FG002|Overall Study|Withdrawal by Subject|8|||
47064227|NCT01506193|83346413|FG000|Overall Study|Lost to Follow-up|8|||
47064228|NCT01506193|83346414|FG001|Overall Study|Lost to Follow-up|3|||
47064229|NCT01506193|83346415|FG002|Overall Study|Lost to Follow-up|3|||
47064230|NCT01505881|83346426|FG000|Overall Study|Adverse Event|0|||
47064231|NCT01505881|83346427|FG001|Overall Study|Adverse Event|1|||
47064232|NCT01505881|83346426|FG000|Overall Study|Lost to Follow-up|2|||
47064233|NCT01505881|83346427|FG001|Overall Study|Lost to Follow-up|0|||
47064234|NCT01505881|83346426|FG000|Overall Study|Withdrawal by Subject|2|||
47064235|NCT01505881|83346427|FG001|Overall Study|Withdrawal by Subject|0|||
47064236|NCT01462045|83346437|FG000|Overall Study|Family matter|0|||
47064237|NCT01462045|83346438|FG001|Overall Study|Family matter|1|||
47064238|NCT01462045|83346439|FG002|Overall Study|Family matter|0|||
47064239|NCT01505647|83346449|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
47064240|NCT01505647|83346450|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
47064241|NCT01505647|83346449|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
47064242|NCT01505647|83346450|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
47064243|NCT01505647|83346449|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
47064244|NCT01505647|83346450|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
47064245|NCT01505647|83346449|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
47064246|NCT01505647|83346450|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
47064247|NCT01505647|83346449|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
47064248|NCT01505647|83346450|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
47064249|NCT01461811|83346458|FG000|Overall Study|Adverse Event|2|||
47064250|NCT01461811|83346459|FG001|Overall Study|Adverse Event|1|||
47064251|NCT01461811|83346458|FG000|Overall Study|Subject decision unrelated to an AE|1|||
47064252|NCT01461811|83346459|FG001|Overall Study|Subject decision unrelated to an AE|1|||
47064253|NCT01461811|83346458|FG000|Overall Study|Noncompliance|1|||
47064254|NCT01461811|83346459|FG001|Overall Study|Noncompliance|1|||
47064255|NCT01505491|83346468|FG000|Overall Study|Other reason not listed|1|||
47064256|NCT01505491|83346469|FG001|Overall Study|Other reason not listed|0|||
47064257|NCT01505491|83346470|FG002|Overall Study|Other reason not listed|0|||
46769867|NCT00585351|82988271|FG004|Enrollment Period (Intervention)|Death|1|||
46769868|NCT00585351|82988272|FG005|Enrollment Period (Intervention)|Death|0|||
46769869|NCT00585351|82988273|FG006|Enrollment Period (Intervention)|Death|1|||
46769870|NCT00585351|82988274|FG007|Enrollment Period (Intervention)|Death|0|||
46769871|NCT00585351|82988267|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
46769872|NCT00585351|82988268|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
46769873|NCT00585351|82988269|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
46769874|NCT00585351|82988270|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
46769875|NCT00585351|82988271|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
46769876|NCT00585351|82988272|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
46769877|NCT00585351|82988273|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
46769878|NCT00585351|82988274|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
46769879|NCT00726609|82988288|FG000|Overall Study|Adverse Event|10|||
46945872|NCT02422615|83184089|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
47064258|NCT01505491|83346468|FG000|Overall Study|Withdrawal by Subject|1|||
46769880|NCT00726609|82988288|FG000|Overall Study|Withdrawal by Subject|2|||
46769881|NCT00726609|82988288|FG000|Overall Study|Lack of Efficacy|25|||
46769882|NCT00726609|82988288|FG000|Overall Study|Other|16|||
46769883|NCT00726609|82988288|FG000|Overall Study|Missing|42|||
47064259|NCT01505491|83346469|FG001|Overall Study|Withdrawal by Subject|1|||
47064260|NCT01505491|83346470|FG002|Overall Study|Withdrawal by Subject|4|||
46769884|NCT00726609|82988288|FG000|Overall Study|Other|3|||
46769885|NCT00726453|82988294|FG000|Primary Enrollment Group|Death|18|||
47064261|NCT01505491|83346468|FG000|Overall Study|Lost to Follow-up|0|||
47064262|NCT01505491|83346469|FG001|Overall Study|Lost to Follow-up|0|||
46769886|NCT00726453|82988295|FG001|Primary Enrollment Group|Death|0|||
47064263|NCT01505491|83346470|FG002|Overall Study|Lost to Follow-up|1|||
46769887|NCT00726453|82988294|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
46769888|NCT00726453|82988295|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
46769889|NCT00726453|82988294|FG000|38 mm Length Group|Death|0|||
47064264|NCT01504867|83346480|FG000|Overall Study|Inclusion criteria not met|2|||
47064265|NCT01504867|83346481|FG001|Overall Study|Inclusion criteria not met|2|||
47064266|NCT01504867|83346480|FG000|Overall Study|Consent revoked|5|||
46945873|NCT02422615|83184090|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
46945874|NCT02422615|83184089|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
46945875|NCT02422615|83184090|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
46945876|NCT02422615|83184089|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
46945877|NCT02422615|83184090|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
46945878|NCT02382406|83184105|FG000|Study Treatment|Disease Progression|8|||
46945879|NCT02382406|83184106|FG001|Study Treatment|Disease Progression|0|||
46945880|NCT02382406|83184107|FG002|Study Treatment|Disease Progression|20|||
46945881|NCT02382406|83184105|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
46945882|NCT02382406|83184106|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
46945883|NCT02382406|83184107|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
46945884|NCT02382406|83184105|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
46945885|NCT02382406|83184106|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
46945886|NCT02382406|83184107|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
46945887|NCT02382406|83184105|FG000|Study Treatment|symptomatic deterioration|1|||
46945888|NCT02382406|83184106|FG001|Study Treatment|symptomatic deterioration|0|||
46945889|NCT02382406|83184107|FG002|Study Treatment|symptomatic deterioration|1|||
46945890|NCT02382406|83184105|FG000|Study Treatment|Death|0|||
46945891|NCT02382406|83184106|FG001|Study Treatment|Death|0|||
46945892|NCT02382406|83184107|FG002|Study Treatment|Death|2|||
46945893|NCT02382406|83184105|FG000|Follow up|Death|11|||
46945894|NCT02382406|83184106|FG001|Follow up|Death|0|||
46945895|NCT02382406|83184107|FG002|Follow up|Death|19|||
46945896|NCT02382406|83184105|FG000|Follow up|Symptomatic deterioration|1|||
46945897|NCT02382406|83184106|FG001|Follow up|Symptomatic deterioration|0|||
46945898|NCT02382406|83184107|FG002|Follow up|Symptomatic deterioration|1|||
46945899|NCT02382406|83184105|FG000|Follow up|Patient Refused Follow-up|1|||
46945900|NCT02382406|83184106|FG001|Follow up|Patient Refused Follow-up|0|||
46945901|NCT02382406|83184107|FG002|Follow up|Patient Refused Follow-up|0|||
46945902|NCT02382406|83184105|FG000|Follow up|Study Terminated|1|||
46945903|NCT02382406|83184106|FG001|Follow up|Study Terminated|0|||
46945904|NCT02382406|83184107|FG002|Follow up|Study Terminated|8|||
46945905|NCT02382406|83184105|FG000|Follow up|Withdrawal by Subject|0|||
46945906|NCT02382406|83184106|FG001|Follow up|Withdrawal by Subject|0|||
46945907|NCT02382406|83184107|FG002|Follow up|Withdrawal by Subject|2|||
46945908|NCT02101268|83184127|FG000|Randomized Treatment Phase|Subject Decision|8|||
46945909|NCT02101268|83184128|FG001|Randomized Treatment Phase|Subject Decision|4|||
46945910|NCT02101268|83184129|FG002|Randomized Treatment Phase|Subject Decision|0|||
46945911|NCT02101268|83184130|FG003|Randomized Treatment Phase|Subject Decision|0|||
46945912|NCT02101268|83184127|FG000|Randomized Treatment Phase|Physician Decision|4|||
46945913|NCT02101268|83184128|FG001|Randomized Treatment Phase|Physician Decision|1|||
46945914|NCT02101268|83184129|FG002|Randomized Treatment Phase|Physician Decision|0|||
46945915|NCT02101268|83184130|FG003|Randomized Treatment Phase|Physician Decision|0|||
46945916|NCT02101268|83184127|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
46945917|NCT02101268|83184128|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
46945918|NCT02101268|83184129|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
46945919|NCT02101268|83184130|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
46945920|NCT02101268|83184127|FG000|Randomized Treatment Phase|Adverse Event|6|||
47064267|NCT01504867|83346481|FG001|Overall Study|Consent revoked|1|||
46769890|NCT00726453|82988295|FG001|38 mm Length Group|Death|3|||
46769891|NCT00726063|82988302|FG000|Overall Study|Adverse Event|9|||
46769892|NCT00726063|82988303|FG001|Overall Study|Adverse Event|7|||
46769893|NCT00808028|82988313|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
46769894|NCT00808028|82988314|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
46769895|NCT00808028|82988315|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
46769896|NCT00808028|82988316|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
46769897|NCT00808028|82988313|FG000|Stage 1 (6 Months)|Other|1|||
46769898|NCT00808028|82988314|FG001|Stage 1 (6 Months)|Other|0|||
46769899|NCT00808028|82988315|FG002|Stage 1 (6 Months)|Other|2|||
46769900|NCT00808028|82988316|FG003|Stage 1 (6 Months)|Other|4|||
46769901|NCT00808028|82988313|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
46769902|NCT00808028|82988314|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
46769903|NCT00808028|82988315|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
46839924|NCT00283244|83057223|FG002|Overall Study|Death|2|||
46945921|NCT02101268|83184128|FG001|Randomized Treatment Phase|Adverse Event|0|||
46945922|NCT02101268|83184129|FG002|Randomized Treatment Phase|Adverse Event|0|||
46945923|NCT02101268|83184130|FG003|Randomized Treatment Phase|Adverse Event|0|||
46945924|NCT02101268|83184127|FG000|Randomized Treatment Phase|Death|5|||
46945925|NCT02101268|83184128|FG001|Randomized Treatment Phase|Death|4|||
46769904|NCT00808028|82988316|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
46945926|NCT02101268|83184129|FG002|Randomized Treatment Phase|Death|0|||
46945927|NCT02101268|83184130|FG003|Randomized Treatment Phase|Death|0|||
46967864|NCT05091307|83210483|FG000|Overall Study|Lost to Follow-up|33|||
46839925|NCT00283244|83057221|FG000|Overall Study|Lack of Efficacy|8|||
47064268|NCT01476475|83346489|FG000|Overall Study|Adverse Event|6|||
47064269|NCT01476475|83346490|FG001|Overall Study|Adverse Event|0|||
47064270|NCT01476475|83346489|FG000|Overall Study|Poor compliance to protocol|1|||
47064271|NCT01476475|83346490|FG001|Overall Study|Poor compliance to protocol|1|||
47064272|NCT01476475|83346489|FG000|Overall Study|Other reasons|4|||
46839926|NCT00283244|83057222|FG001|Overall Study|Lack of Efficacy|32|||
46839927|NCT00283244|83057223|FG002|Overall Study|Lack of Efficacy|26|||
46839928|NCT00283244|83057221|FG000|Overall Study|Withdrawal by Subject|1|||
46839929|NCT00283244|83057222|FG001|Overall Study|Withdrawal by Subject|2|||
46839930|NCT00283244|83057223|FG002|Overall Study|Withdrawal by Subject|2|||
46839931|NCT00283244|83057221|FG000|Overall Study|Physician Decision|0|||
46839932|NCT00283244|83057222|FG001|Overall Study|Physician Decision|0|||
46839933|NCT00283244|83057223|FG002|Overall Study|Physician Decision|1|||
46839934|NCT00283244|83057221|FG000|Overall Study|Medical illness (other complicating dz)|4|||
46945928|NCT02101268|83184127|FG000|Randomized Treatment Phase|Disease Progression|4|||
46945929|NCT02101268|83184128|FG001|Randomized Treatment Phase|Disease Progression|1|||
46945930|NCT02101268|83184129|FG002|Randomized Treatment Phase|Disease Progression|0|||
46945931|NCT02101268|83184130|FG003|Randomized Treatment Phase|Disease Progression|0|||
46945932|NCT02101268|83184127|FG000|Extended Treatment Phase|Subject Decision|0|||
46945933|NCT02101268|83184128|FG001|Extended Treatment Phase|Subject Decision|0|||
46945934|NCT02101268|83184129|FG002|Extended Treatment Phase|Subject Decision|3|||
46945935|NCT02101268|83184130|FG003|Extended Treatment Phase|Subject Decision|2|||
46945936|NCT02101268|83184127|FG000|Extended Treatment Phase|Physician Decision|0|||
46945937|NCT02101268|83184128|FG001|Extended Treatment Phase|Physician Decision|0|||
46945938|NCT02101268|83184129|FG002|Extended Treatment Phase|Physician Decision|5|||
46945939|NCT02101268|83184130|FG003|Extended Treatment Phase|Physician Decision|2|||
46945940|NCT02101268|83184127|FG000|Extended Treatment Phase|Adverse Event|0|||
46945941|NCT02101268|83184128|FG001|Extended Treatment Phase|Adverse Event|0|||
46945942|NCT02101268|83184129|FG002|Extended Treatment Phase|Adverse Event|14|||
46945943|NCT02101268|83184130|FG003|Extended Treatment Phase|Adverse Event|18|||
46945944|NCT02101268|83184127|FG000|Extended Treatment Phase|Death|0|||
46945945|NCT02101268|83184128|FG001|Extended Treatment Phase|Death|0|||
47064273|NCT01476475|83346490|FG001|Overall Study|Other reasons|2|||
47064274|NCT01475851|83346499|FG000|Overall Study|Protocol defined stopping criteria|1|||
47064275|NCT01475851|83346500|FG001|Overall Study|Protocol defined stopping criteria|0|||
47064276|NCT01460719|83346506|FG000|Overall Study|Adverse Event|1|||
46638653|NCT01465464|82812066|FG000|Overall Study|Adverse Event|96|||
46638654|NCT01465464|82812067|FG001|Overall Study|Adverse Event|49|||
46839935|NCT00283244|83057222|FG001|Overall Study|Medical illness (other complicating dz)|3|||
46839936|NCT00283244|83057223|FG002|Overall Study|Medical illness (other complicating dz)|6|||
46839937|NCT00283244|83057221|FG000|Overall Study|Clinical deterioration|1|||
46839938|NCT00283244|83057222|FG001|Overall Study|Clinical deterioration|3|||
46839939|NCT00283244|83057223|FG002|Overall Study|Clinical deterioration|3|||
46839940|NCT00282464|83057234|FG000|Overall Study|Adverse Event|26|||
46839941|NCT00282464|83057235|FG001|Overall Study|Adverse Event|20|||
46638655|NCT01465464|82812066|FG000|Overall Study|Lack of Efficacy|139|||
46638656|NCT01465464|82812067|FG001|Overall Study|Lack of Efficacy|190|||
46769905|NCT00808028|82988313|FG000|Stage 1 (6 Months)|Adverse Event|0|||
46769906|NCT00808028|82988314|FG001|Stage 1 (6 Months)|Adverse Event|0|||
46769907|NCT00808028|82988315|FG002|Stage 1 (6 Months)|Adverse Event|1|||
46769908|NCT00808028|82988316|FG003|Stage 1 (6 Months)|Adverse Event|2|||
46769909|NCT00808028|82988313|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
46769910|NCT00808028|82988314|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
46769911|NCT00808028|82988315|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
46839942|NCT00282464|83057234|FG000|Overall Study|Lack of Efficacy|8|||
46839943|NCT00282464|83057235|FG001|Overall Study|Lack of Efficacy|8|||
46839944|NCT00282464|83057234|FG000|Overall Study|Lost to Follow-up|10|||
46839945|NCT00282464|83057235|FG001|Overall Study|Lost to Follow-up|10|||
46839946|NCT00282464|83057234|FG000|Overall Study|Withdrawal by Subject|24|||
46839947|NCT00282464|83057235|FG001|Overall Study|Withdrawal by Subject|10|||
46945946|NCT02101268|83184129|FG002|Extended Treatment Phase|Death|5|||
46945947|NCT02101268|83184130|FG003|Extended Treatment Phase|Death|1|||
46638657|NCT01465464|82812066|FG000|Overall Study|Physician Decision|13|||
46638658|NCT01465464|82812067|FG001|Overall Study|Physician Decision|5|||
46638659|NCT01465464|82812066|FG000|Overall Study|Protocol Violation|1|||
46769912|NCT00808028|82988316|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
46638660|NCT01465464|82812067|FG001|Overall Study|Protocol Violation|1|||
46769913|NCT00808028|82988313|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
46769914|NCT00808028|82988314|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
46839948|NCT00282464|83057234|FG000|Overall Study|laboratory abnormality|1|||
46839949|NCT00282464|83057235|FG001|Overall Study|laboratory abnormality|2|||
46839950|NCT00282464|83057234|FG000|Overall Study|Protocol Violation|0|||
46839951|NCT00282464|83057235|FG001|Overall Study|Protocol Violation|7|||
46839952|NCT00282464|83057234|FG000|Overall Study|Patient moved|1|||
46839953|NCT00282464|83057235|FG001|Overall Study|Patient moved|0|||
47064277|NCT01460719|83346506|FG000|Overall Study|Withdrawal by Subject|1|||
47064278|NCT01468181|83346576|FG000|Overall Study|Adverse Event|8|||
47064279|NCT01468181|83346577|FG001|Overall Study|Adverse Event|1|||
47064280|NCT01468181|83346578|FG002|Overall Study|Adverse Event|6|||
47064281|NCT01468181|83346579|FG003|Overall Study|Adverse Event|2|||
47064282|NCT01468181|83346580|FG004|Overall Study|Adverse Event|2|||
47064283|NCT01468181|83346576|FG000|Overall Study|Protocol Violation|2|||
47064284|NCT01468181|83346577|FG001|Overall Study|Protocol Violation|0|||
47064285|NCT01468181|83346578|FG002|Overall Study|Protocol Violation|1|||
47064286|NCT01468181|83346579|FG003|Overall Study|Protocol Violation|0|||
46945948|NCT02101268|83184127|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
46945949|NCT02101268|83184128|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
46945950|NCT02101268|83184129|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
46945951|NCT02101268|83184130|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
46945952|NCT02101268|83184127|FG000|Extended Treatment Phase|Disease Progression|0|||
46945953|NCT02101268|83184128|FG001|Extended Treatment Phase|Disease Progression|0|||
46945954|NCT02101268|83184129|FG002|Extended Treatment Phase|Disease Progression|13|||
46945955|NCT02101268|83184130|FG003|Extended Treatment Phase|Disease Progression|6|||
46945956|NCT02101268|83184127|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
46945957|NCT02101268|83184128|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
47064287|NCT01468181|83346580|FG004|Overall Study|Protocol Violation|1|||
47064288|NCT01468181|83346576|FG000|Overall Study|Physician Decision|0|||
47064289|NCT01468181|83346577|FG001|Overall Study|Physician Decision|0|||
47064290|NCT01468181|83346578|FG002|Overall Study|Physician Decision|0|||
47064291|NCT01468181|83346579|FG003|Overall Study|Physician Decision|1|||
47064292|NCT01468181|83346580|FG004|Overall Study|Physician Decision|1|||
46839954|NCT00282464|83057234|FG000|Overall Study|patient non-compliant|3|||
46839955|NCT00282464|83057235|FG001|Overall Study|patient non-compliant|0|||
46839956|NCT00282464|83057234|FG000|Overall Study|patient no show|0|||
46839957|NCT00282464|83057235|FG001|Overall Study|patient no show|1|||
46839958|NCT00282464|83057234|FG000|Overall Study|patient incarcerated|0|||
46839959|NCT00282464|83057235|FG001|Overall Study|patient incarcerated|1|||
46839960|NCT00282464|83057234|FG000|Overall Study|family crisis|0|||
46839961|NCT00282464|83057235|FG001|Overall Study|family crisis|1|||
46839962|NCT00282464|83057234|FG000|Overall Study|dispensed wrong kit|0|||
46839963|NCT00282464|83057235|FG001|Overall Study|dispensed wrong kit|1|||
46839964|NCT00282464|83057234|FG000|Overall Study|dropped due to missed visits|0|||
46839965|NCT00282464|83057235|FG001|Overall Study|dropped due to missed visits|1|||
46839966|NCT00273182|83057241|FG000|Overall Study|Death|450|||
47064293|NCT01468181|83346576|FG000|Overall Study|Lost to Follow-up|0|||
46839967|NCT00273182|83057241|FG000|Overall Study|Lost to Follow-up|88|||
46839968|NCT00273182|83057241|FG000|Overall Study|Withdrawal by Subject|257|||
46839969|NCT00273182|83057241|FG000|Overall Study|Device/System Explant|154|||
47064294|NCT01468181|83346577|FG001|Overall Study|Lost to Follow-up|0|||
47064295|NCT01468181|83346578|FG002|Overall Study|Lost to Follow-up|1|||
46769915|NCT00808028|82988315|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
46769916|NCT00808028|82988316|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
46769917|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
46769918|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
46769919|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
46769920|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
46769921|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
46769922|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
46769923|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
46769924|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
46769925|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
46769926|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
46769927|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
46769928|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
46769929|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
46769930|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
46769931|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
46839970|NCT00273182|83057241|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
46839971|NCT00209274|83057248|FG000|Overall Study|Missed visit|3|||
46839972|NCT00209274|83057249|FG001|Overall Study|Missed visit|2|||
46839973|NCT00209274|83057248|FG000|Overall Study|Death|32|||
47064296|NCT01468181|83346579|FG003|Overall Study|Lost to Follow-up|0|||
46945958|NCT02101268|83184129|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
46945959|NCT02101268|83184130|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
46945960|NCT01898650|83184147|FG000|Overall Study|the subject would not lie still for imaging|1|||
46945961|NCT01880515|83184153|FG000|Overall Study|Lost to Follow-up|3|||
46945962|NCT01880515|83184154|FG001|Overall Study|Lost to Follow-up|2|||
46945963|NCT01880515|83184153|FG000|Overall Study|Disease Progression|5|||
46945964|NCT01880515|83184154|FG001|Overall Study|Disease Progression|7|||
46945965|NCT01668719|83184164|FG000|Phase I|On treatment|1|||
46945966|NCT01668719|83184165|FG001|Phase I|On treatment|0|||
46945967|NCT01668719|83184166|FG002|Phase I|On treatment|0|||
46945968|NCT01668719|83184164|FG000|Phase I|Adverse Event|2|||
46945969|NCT01668719|83184165|FG001|Phase I|Adverse Event|0|||
46945970|NCT01668719|83184166|FG002|Phase I|Adverse Event|0|||
46945971|NCT01668719|83184164|FG000|Phase I|Progression/relapse|1|||
46945972|NCT01668719|83184165|FG001|Phase I|Progression/relapse|0|||
46945973|NCT01668719|83184166|FG002|Phase I|Progression/relapse|0|||
46945974|NCT01668719|83184164|FG000|Phase I|not protocol specified|2|||
46945975|NCT01668719|83184165|FG001|Phase I|not protocol specified|0|||
46945976|NCT01668719|83184166|FG002|Phase I|not protocol specified|0|||
46945977|NCT01668719|83184164|FG000|Phase II|On treatment|0|||
46945978|NCT01668719|83184165|FG001|Phase II|On treatment|4|||
46945979|NCT01668719|83184166|FG002|Phase II|On treatment|3|||
46945980|NCT01668719|83184164|FG000|Phase II|Adverse Event|0|||
46945981|NCT01668719|83184165|FG001|Phase II|Adverse Event|18|||
46945982|NCT01668719|83184166|FG002|Phase II|Adverse Event|18|||
46945983|NCT01668719|83184164|FG000|Phase II|Refusal unrelated to adverse event|0|||
46945984|NCT01668719|83184165|FG001|Phase II|Refusal unrelated to adverse event|4|||
46945985|NCT01668719|83184166|FG002|Phase II|Refusal unrelated to adverse event|1|||
46945986|NCT01668719|83184164|FG000|Phase II|Progression/relapse|0|||
46945987|NCT01668719|83184165|FG001|Phase II|Progression/relapse|13|||
46945988|NCT01668719|83184166|FG002|Phase II|Progression/relapse|17|||
46945989|NCT01668719|83184164|FG000|Phase II|Death|0|||
46945990|NCT01668719|83184165|FG001|Phase II|Death|0|||
46945991|NCT01668719|83184166|FG002|Phase II|Death|2|||
46945992|NCT01668719|83184164|FG000|Phase II|not protocol specified|0|||
47064297|NCT01468181|83346580|FG004|Overall Study|Lost to Follow-up|1|||
46638661|NCT01465464|82812066|FG000|Overall Study|Withdrawal by Subject|46|||
46638662|NCT01465464|82812067|FG001|Overall Study|Withdrawal by Subject|30|||
47064298|NCT01468181|83346576|FG000|Overall Study|Withdrawal by Subject|0|||
46638663|NCT01465464|82812066|FG000|Overall Study|Other|9|||
46638664|NCT01465464|82812067|FG001|Overall Study|Other|3|||
46638665|NCT01465464|82812066|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
47064299|NCT01468181|83346577|FG001|Overall Study|Withdrawal by Subject|1|||
47064300|NCT01468181|83346578|FG002|Overall Study|Withdrawal by Subject|0|||
47064301|NCT01468181|83346579|FG003|Overall Study|Withdrawal by Subject|0|||
47064302|NCT01468181|83346580|FG004|Overall Study|Withdrawal by Subject|0|||
47064303|NCT01693562|83346615|FG000|Escalation Phase|Withdrawal by Subject|0|||
46638666|NCT01465464|82812067|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
46638667|NCT01417104|82812075|FG000|Overall Study|Withdrawal by Subject|5|||
46769932|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
46769933|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
46769934|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
46769935|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
46769936|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
46769937|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
46769938|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
46769939|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
46769940|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
46769941|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
46769942|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
46769943|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
46769944|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
46769945|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
46769946|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
46769947|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
46769948|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
46769949|NCT00808028|82988313|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
46945993|NCT01668719|83184165|FG001|Phase II|not protocol specified|13|||
46945994|NCT01668719|83184166|FG002|Phase II|not protocol specified|7|||
46945995|NCT01642901|83184178|FG000|12-month Follow-up|Withdrawal by Subject|1|||
46945996|NCT01642901|83184179|FG001|12-month Follow-up|Withdrawal by Subject|0|||
46945997|NCT01488045|83184187|FG000|Overall Study|Withdrawal by Subject|6|||
47064304|NCT01693562|83346616|FG001|Escalation Phase|Withdrawal by Subject|1|||
46945998|NCT01488045|83184188|FG001|Overall Study|Withdrawal by Subject|11|||
46945999|NCT01488045|83184187|FG000|Overall Study|Failure to present for colonoscopy|3|||
46946000|NCT01488045|83184188|FG001|Overall Study|Failure to present for colonoscopy|6|||
46946001|NCT01488045|83184187|FG000|Overall Study|Failure to report exclusion criteria|0|||
46839974|NCT00209274|83057249|FG001|Overall Study|Death|15|||
46839975|NCT00209274|83057248|FG000|Overall Study|Withdrawal by Subject|30|||
46839976|NCT00209274|83057249|FG001|Overall Study|Withdrawal by Subject|15|||
46839977|NCT00209274|83057248|FG000|Overall Study|Randomized not treated (RNT)|6|||
46839978|NCT00209274|83057249|FG001|Overall Study|Randomized not treated (RNT)|15|||
46839979|NCT03841331|83057257|FG000|Overall Study|Withdrawal by Subject|4|||
46839980|NCT03841331|83057258|FG001|Overall Study|Withdrawal by Subject|9|||
46839981|NCT03841331|83057257|FG000|Overall Study|Lost to Follow-up|5|||
46839982|NCT03841331|83057258|FG001|Overall Study|Lost to Follow-up|1|||
46839983|NCT00262080|83057267|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
46839984|NCT00262080|83057268|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
46839985|NCT00262080|83057269|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
46839986|NCT00262080|83057267|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
46839987|NCT00262080|83057268|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
46839988|NCT00262080|83057269|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
46839989|NCT00262080|83057267|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
46638668|NCT01417104|82812076|FG001|Overall Study|Withdrawal by Subject|1|||
46839990|NCT00262080|83057268|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
46839991|NCT00262080|83057269|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
46839992|NCT00262080|83057267|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
46839993|NCT00262080|83057268|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
46839994|NCT00262080|83057269|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
46946002|NCT01488045|83184188|FG001|Overall Study|Failure to report exclusion criteria|1|||
46946003|NCT00946712|83184207|FG000|Overall Study|Adverse Event|118|||
46946004|NCT00946712|83184208|FG001|Overall Study|Adverse Event|124|||
46946005|NCT00946712|83184207|FG000|Overall Study|Disease progression|308|||
46839995|NCT00262080|83057267|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
46839996|NCT00262080|83057268|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
46839997|NCT00262080|83057269|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
46839998|NCT00262080|83057267|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
46839999|NCT00262080|83057268|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
46840000|NCT00262080|83057269|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
46840001|NCT00282308|83057279|FG000|Treatment Period|Lost to Follow-up|1|||
46840002|NCT00282308|83057280|FG001|Treatment Period|Lost to Follow-up|0|||
46840003|NCT00282308|83057281|FG002|Treatment Period|Lost to Follow-up|0|||
46840004|NCT00282308|83057279|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
46840005|NCT00282308|83057280|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
46946006|NCT00946712|83184208|FG001|Overall Study|Disease progression|404|||
46946007|NCT00946712|83184207|FG000|Overall Study|Death|21|||
46946008|NCT00946712|83184208|FG001|Overall Study|Death|22|||
46946009|NCT00946712|83184207|FG000|Overall Study|No treatment given|25|||
46946010|NCT00946712|83184208|FG001|Overall Study|No treatment given|29|||
46946011|NCT00946712|83184207|FG000|Overall Study|Other reasons|61|||
46946012|NCT00946712|83184208|FG001|Overall Study|Other reasons|73|||
46946013|NCT00946712|83184207|FG000|Overall Study|On Treatment|0|||
47064305|NCT01693562|83346617|FG002|Escalation Phase|Withdrawal by Subject|0|||
46638669|NCT01417104|82812075|FG000|Overall Study|Failure to make contact|0|||
46769950|NCT00808028|82988314|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
46769951|NCT00808028|82988315|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
46769952|NCT00808028|82988316|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
46769953|NCT00809783|82988339|FG000|Overall Study|Death|1|||
46769954|NCT00809783|82988340|FG001|Overall Study|Death|0|||
46769955|NCT00809783|82988341|FG002|Overall Study|Death|0|||
46769956|NCT00809783|82988339|FG000|Overall Study|Adverse Event|34|||
46769957|NCT00809783|82988340|FG001|Overall Study|Adverse Event|52|||
46769958|NCT00809783|82988341|FG002|Overall Study|Adverse Event|71|||
46769959|NCT00809783|82988339|FG000|Overall Study|Lack of Efficacy|39|||
46769960|NCT00809783|82988340|FG001|Overall Study|Lack of Efficacy|52|||
46840006|NCT00282308|83057281|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
46840007|NCT00282308|83057279|FG000|Treatment Period|Adverse Event|0|||
46840008|NCT00282308|83057280|FG001|Treatment Period|Adverse Event|2|||
46840009|NCT00282308|83057281|FG002|Treatment Period|Adverse Event|0|||
46946014|NCT00946712|83184208|FG001|Overall Study|On Treatment|4|||
46946015|NCT00946712|83184207|FG000|Overall Study|Ineligible|14|||
47064306|NCT01693562|83346618|FG003|Escalation Phase|Withdrawal by Subject|0|||
46638670|NCT01417104|82812076|FG001|Overall Study|Failure to make contact|1|||
46769961|NCT00809783|82988341|FG002|Overall Study|Lack of Efficacy|63|||
46769962|NCT00809783|82988339|FG000|Overall Study|Lost to Follow-up|0|||
46769963|NCT00809783|82988340|FG001|Overall Study|Lost to Follow-up|3|||
46769964|NCT00809783|82988341|FG002|Overall Study|Lost to Follow-up|4|||
46840010|NCT00282308|83057279|FG000|Treatment Period|Not Treated with Study Drug|1|||
46840011|NCT00282308|83057280|FG001|Treatment Period|Not Treated with Study Drug|0|||
46946016|NCT00946712|83184208|FG001|Overall Study|Ineligible|6|||
46946017|NCT00656669|83184215|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
46946018|NCT00656669|83184215|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
47064307|NCT01693562|83346619|FG004|Escalation Phase|Withdrawal by Subject|0|||
47064308|NCT01693562|83346620|FG005|Escalation Phase|Withdrawal by Subject|2|||
47064309|NCT01693562|83346621|FG006|Escalation Phase|Withdrawal by Subject|0|||
47064310|NCT01693562|83346622|FG007|Escalation Phase|Withdrawal by Subject|0|||
47064311|NCT01693562|83346623|FG008|Escalation Phase|Withdrawal by Subject|0|||
47064312|NCT01693562|83346624|FG009|Escalation Phase|Withdrawal by Subject|0|||
47064313|NCT01693562|83346625|FG010|Escalation Phase|Withdrawal by Subject|0|||
47064314|NCT01693562|83346626|FG011|Escalation Phase|Withdrawal by Subject|0|||
46840012|NCT00282308|83057281|FG002|Treatment Period|Not Treated with Study Drug|0|||
46840013|NCT00282308|83057279|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
47064315|NCT01693562|83346627|FG012|Escalation Phase|Withdrawal by Subject|0|||
47064316|NCT01693562|83346628|FG013|Escalation Phase|Withdrawal by Subject|0|||
47064317|NCT01693562|83346629|FG014|Escalation Phase|Withdrawal by Subject|0|||
46638671|NCT01417104|82812075|FG000|Overall Study|Adverse Event|1|||
46638672|NCT01417104|82812076|FG001|Overall Study|Adverse Event|0|||
46638673|NCT01465386|82812082|FG000|Overall Study|Lack of Efficacy|3|||
46638674|NCT01465386|82812082|FG000|Overall Study|Adverse Event|1|||
47064318|NCT01693562|83346630|FG015|Escalation Phase|Withdrawal by Subject|0|||
47064319|NCT01693562|83346631|FG016|Escalation Phase|Withdrawal by Subject|0|||
47064320|NCT01693562|83346632|FG017|Escalation Phase|Withdrawal by Subject|0|||
47064321|NCT01693562|83346633|FG018|Escalation Phase|Withdrawal by Subject|0|||
47064322|NCT01693562|83346634|FG019|Escalation Phase|Withdrawal by Subject|0|||
47064323|NCT01693562|83346635|FG020|Escalation Phase|Withdrawal by Subject|0|||
47064324|NCT01693562|83346636|FG021|Escalation Phase|Withdrawal by Subject|0|||
47064325|NCT01693562|83346637|FG022|Escalation Phase|Withdrawal by Subject|0|||
47064326|NCT01693562|83346615|FG000|Escalation Phase|Death|4|||
47064327|NCT01693562|83346616|FG001|Escalation Phase|Death|2|||
47064328|NCT01693562|83346617|FG002|Escalation Phase|Death|0|||
47064329|NCT01693562|83346618|FG003|Escalation Phase|Death|3|||
47064330|NCT01693562|83346619|FG004|Escalation Phase|Death|6|||
47064331|NCT01693562|83346620|FG005|Escalation Phase|Death|4|||
47064332|NCT01693562|83346621|FG006|Escalation Phase|Death|0|||
47064333|NCT01693562|83346622|FG007|Escalation Phase|Death|0|||
47064334|NCT01693562|83346623|FG008|Escalation Phase|Death|0|||
47064335|NCT01693562|83346624|FG009|Escalation Phase|Death|0|||
47064336|NCT01693562|83346625|FG010|Escalation Phase|Death|0|||
47064337|NCT01693562|83346626|FG011|Escalation Phase|Death|0|||
46769965|NCT00809783|82988339|FG000|Overall Study|Withdrawal by Subject|47|||
46769966|NCT00809783|82988340|FG001|Overall Study|Withdrawal by Subject|72|||
46769967|NCT00809783|82988341|FG002|Overall Study|Withdrawal by Subject|64|||
46769968|NCT00809783|82988339|FG000|Overall Study|Protocol Violation|2|||
46769969|NCT00809783|82988340|FG001|Overall Study|Protocol Violation|6|||
46769970|NCT00809783|82988341|FG002|Overall Study|Protocol Violation|5|||
46769971|NCT00809783|82988339|FG000|Overall Study|Randomized, but not treated|3|||
46769972|NCT00809783|82988340|FG001|Overall Study|Randomized, but not treated|0|||
46769973|NCT00809783|82988341|FG002|Overall Study|Randomized, but not treated|2|||
46769974|NCT00809783|82988339|FG000|Overall Study|Study Terminated by Sponsor|378|||
46769975|NCT00809783|82988340|FG001|Overall Study|Study Terminated by Sponsor|626|||
46769976|NCT00809783|82988341|FG002|Overall Study|Study Terminated by Sponsor|565|||
46769977|NCT00809783|82988339|FG000|Overall Study|Other|21|||
46769978|NCT00809783|82988340|FG001|Overall Study|Other|21|||
46769979|NCT00809783|82988341|FG002|Overall Study|Other|16|||
46769980|NCT00809471|82988352|FG000|Overall Study|Protocol non-compliance|15|||
46769981|NCT00809471|82988353|FG001|Overall Study|Protocol non-compliance|15|||
46769982|NCT00809471|82988354|FG002|Overall Study|Protocol non-compliance|6|||
46769983|NCT00809471|82988352|FG000|Overall Study|Lost to Follow-up|4|||
46769984|NCT00809471|82988353|FG001|Overall Study|Lost to Follow-up|2|||
46769985|NCT00809471|82988354|FG002|Overall Study|Lost to Follow-up|9|||
46769986|NCT00809471|82988352|FG000|Overall Study|Adverse Event|0|||
46769987|NCT00809471|82988353|FG001|Overall Study|Adverse Event|2|||
46769988|NCT00809471|82988354|FG002|Overall Study|Adverse Event|2|||
46769989|NCT00809471|82988352|FG000|Overall Study|Requirement for restricted medication|1|||
46769990|NCT00809471|82988353|FG001|Overall Study|Requirement for restricted medication|1|||
46769991|NCT00809471|82988354|FG002|Overall Study|Requirement for restricted medication|0|||
46638675|NCT01465230|82812086|FG000|Overall Study|Withdrawal by Subject|2|||
46769992|NCT00807248|82988366|FG000|Overall Study|Adverse Event|1|||
46638676|NCT01435356|82812092|FG000|Overall Study|Adverse Event|2|||
46638677|NCT01435356|82812093|FG001|Overall Study|Adverse Event|0|||
46769993|NCT00807248|82988367|FG001|Overall Study|Adverse Event|2|||
46769994|NCT00807248|82988368|FG002|Overall Study|Adverse Event|2|||
46769995|NCT00807248|82988369|FG003|Overall Study|Adverse Event|6|||
46769996|NCT00807248|82988366|FG000|Overall Study|Lack of Efficacy|14|||
46769997|NCT00807248|82988367|FG001|Overall Study|Lack of Efficacy|4|||
46769998|NCT00807248|82988368|FG002|Overall Study|Lack of Efficacy|8|||
47064338|NCT01693562|83346627|FG012|Escalation Phase|Death|0|||
47064339|NCT01693562|83346628|FG013|Escalation Phase|Death|0|||
47064340|NCT01693562|83346629|FG014|Escalation Phase|Death|0|||
47064341|NCT01693562|83346630|FG015|Escalation Phase|Death|0|||
47064342|NCT01693562|83346631|FG016|Escalation Phase|Death|0|||
46769999|NCT00807248|82988369|FG003|Overall Study|Lack of Efficacy|3|||
46770000|NCT00807248|82988366|FG000|Overall Study|Protocol Violation|0|||
46770001|NCT00807248|82988367|FG001|Overall Study|Protocol Violation|1|||
46770002|NCT00807248|82988368|FG002|Overall Study|Protocol Violation|1|||
46770003|NCT00807248|82988369|FG003|Overall Study|Protocol Violation|0|||
46770004|NCT00807248|82988366|FG000|Overall Study|Withdrawal of Consent|5|||
46770005|NCT00807248|82988367|FG001|Overall Study|Withdrawal of Consent|5|||
46770006|NCT00807248|82988368|FG002|Overall Study|Withdrawal of Consent|5|||
46770007|NCT00807248|82988369|FG003|Overall Study|Withdrawal of Consent|5|||
46840014|NCT00282308|83057280|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
46840015|NCT00282308|83057281|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
46840016|NCT00282308|83057279|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
46840017|NCT00282308|83057280|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
47064343|NCT01693562|83346632|FG017|Escalation Phase|Death|0|||
47064344|NCT01693562|83346633|FG018|Escalation Phase|Death|0|||
47064345|NCT01693562|83346634|FG019|Escalation Phase|Death|0|||
47064346|NCT01693562|83346635|FG020|Escalation Phase|Death|0|||
47064347|NCT01693562|83346636|FG021|Escalation Phase|Death|0|||
47064348|NCT01693562|83346637|FG022|Escalation Phase|Death|0|||
47064349|NCT01693562|83346615|FG000|Escalation Phase|Lost to Follow-up|0|||
47064350|NCT01693562|83346616|FG001|Escalation Phase|Lost to Follow-up|1|||
47064351|NCT01693562|83346617|FG002|Escalation Phase|Lost to Follow-up|1|||
47064352|NCT01693562|83346618|FG003|Escalation Phase|Lost to Follow-up|0|||
47064353|NCT01693562|83346619|FG004|Escalation Phase|Lost to Follow-up|0|||
47064354|NCT01693562|83346620|FG005|Escalation Phase|Lost to Follow-up|0|||
47064355|NCT01693562|83346621|FG006|Escalation Phase|Lost to Follow-up|0|||
47064356|NCT01693562|83346622|FG007|Escalation Phase|Lost to Follow-up|0|||
47064357|NCT01693562|83346623|FG008|Escalation Phase|Lost to Follow-up|0|||
47064358|NCT01693562|83346624|FG009|Escalation Phase|Lost to Follow-up|0|||
47064359|NCT01693562|83346625|FG010|Escalation Phase|Lost to Follow-up|0|||
47064360|NCT01693562|83346626|FG011|Escalation Phase|Lost to Follow-up|0|||
47064361|NCT01693562|83346627|FG012|Escalation Phase|Lost to Follow-up|0|||
47064362|NCT01693562|83346628|FG013|Escalation Phase|Lost to Follow-up|0|||
47064363|NCT01693562|83346629|FG014|Escalation Phase|Lost to Follow-up|0|||
47064364|NCT01693562|83346630|FG015|Escalation Phase|Lost to Follow-up|0|||
47064365|NCT01693562|83346631|FG016|Escalation Phase|Lost to Follow-up|0|||
47064366|NCT01693562|83346632|FG017|Escalation Phase|Lost to Follow-up|0|||
47064367|NCT01693562|83346633|FG018|Escalation Phase|Lost to Follow-up|0|||
47064368|NCT01693562|83346634|FG019|Escalation Phase|Lost to Follow-up|0|||
47064369|NCT01693562|83346635|FG020|Escalation Phase|Lost to Follow-up|0|||
47064370|NCT01693562|83346636|FG021|Escalation Phase|Lost to Follow-up|0|||
47064371|NCT01693562|83346637|FG022|Escalation Phase|Lost to Follow-up|0|||
47064372|NCT01693562|83346615|FG000|Escalation Phase|Other|0|||
47064373|NCT01693562|83346616|FG001|Escalation Phase|Other|0|||
47064374|NCT01693562|83346617|FG002|Escalation Phase|Other|2|||
47064375|NCT01693562|83346618|FG003|Escalation Phase|Other|0|||
47064376|NCT01693562|83346619|FG004|Escalation Phase|Other|0|||
47064377|NCT01693562|83346620|FG005|Escalation Phase|Other|1|||
47064378|NCT01693562|83346621|FG006|Escalation Phase|Other|0|||
47064379|NCT01693562|83346622|FG007|Escalation Phase|Other|0|||
47064380|NCT01693562|83346623|FG008|Escalation Phase|Other|0|||
47064381|NCT01693562|83346624|FG009|Escalation Phase|Other|0|||
47064382|NCT01693562|83346625|FG010|Escalation Phase|Other|0|||
47064383|NCT01693562|83346626|FG011|Escalation Phase|Other|0|||
47064384|NCT01693562|83346627|FG012|Escalation Phase|Other|0|||
47064385|NCT01693562|83346628|FG013|Escalation Phase|Other|0|||
47064386|NCT01693562|83346629|FG014|Escalation Phase|Other|0|||
47064387|NCT01693562|83346630|FG015|Escalation Phase|Other|0|||
46770008|NCT00807248|82988366|FG000|Overall Study|Lost to Follow-up|1|||
46770009|NCT00807248|82988367|FG001|Overall Study|Lost to Follow-up|0|||
46840018|NCT00282308|83057281|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
46946019|NCT00656669|83184215|FG000|AC (Cycles 6-9)|Adverse Event|1|||
47064388|NCT01693562|83346631|FG016|Escalation Phase|Other|0|||
47064389|NCT01693562|83346632|FG017|Escalation Phase|Other|0|||
47064390|NCT01693562|83346633|FG018|Escalation Phase|Other|0|||
47064391|NCT01693562|83346634|FG019|Escalation Phase|Other|0|||
47064392|NCT01693562|83346635|FG020|Escalation Phase|Other|0|||
47064393|NCT01693562|83346636|FG021|Escalation Phase|Other|0|||
47064394|NCT01693562|83346637|FG022|Escalation Phase|Other|0|||
47064395|NCT01693562|83346615|FG000|Exploration Phase|Withdrawal by Subject|0|||
47064396|NCT01693562|83346616|FG001|Exploration Phase|Withdrawal by Subject|0|||
46770010|NCT00807248|82988368|FG002|Overall Study|Lost to Follow-up|0|||
46770011|NCT00807248|82988369|FG003|Overall Study|Lost to Follow-up|0|||
46770012|NCT00807248|82988366|FG000|Overall Study|Other Reason|0|||
46946020|NCT00656669|83184215|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
47064397|NCT01693562|83346617|FG002|Exploration Phase|Withdrawal by Subject|0|||
47064398|NCT01693562|83346618|FG003|Exploration Phase|Withdrawal by Subject|0|||
46770013|NCT00807248|82988367|FG001|Overall Study|Other Reason|0|||
46770014|NCT00807248|82988368|FG002|Overall Study|Other Reason|2|||
46770015|NCT00807248|82988369|FG003|Overall Study|Other Reason|0|||
46770016|NCT00589628|82988381|FG000|Overall Study|Lost to Follow-up|0|||
46770017|NCT00589628|82988382|FG001|Overall Study|Lost to Follow-up|1|||
46770018|NCT00588848|82988390|FG000|Overall Study|Physician Decision|0|||
46770019|NCT00588848|82988391|FG001|Overall Study|Physician Decision|3|||
46770020|NCT00797108|82988402|FG000|Overall Study|Adverse Event|1|||
46770021|NCT00797108|82988403|FG001|Overall Study|Adverse Event|0|||
46770022|NCT00797108|82988404|FG002|Overall Study|Adverse Event|3|||
46770023|NCT00797108|82988402|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
46770024|NCT00797108|82988403|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
46770025|NCT00797108|82988404|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
46770026|NCT00797108|82988402|FG000|Overall Study|Global Deterioration of Health Status|0|||
46770027|NCT00797108|82988403|FG001|Overall Study|Global Deterioration of Health Status|1|||
46946021|NCT01338493|83184224|FG000|Enrolled|Withdrawal by Subject|1|||
46946022|NCT01338493|83184224|FG000|Enrolled|Patient not implanted|4|||
46946023|NCT01338493|83184224|FG000|Discharge|Death|1|||
46946024|NCT01338493|83184224|FG000|Discharge|Missed visit|1|||
46946025|NCT01338493|83184224|FG000|6 Months Follow up|Lost to Follow-up|11|||
46946026|NCT01338493|83184224|FG000|6 Months Follow up|Missed visit|8|||
46946027|NCT01338493|83184224|FG000|12 Months Follow up|Lost to Follow-up|9|||
47064399|NCT01693562|83346619|FG004|Exploration Phase|Withdrawal by Subject|0|||
47064400|NCT01693562|83346620|FG005|Exploration Phase|Withdrawal by Subject|0|||
47064401|NCT01693562|83346621|FG006|Exploration Phase|Withdrawal by Subject|2|||
47064402|NCT01693562|83346622|FG007|Exploration Phase|Withdrawal by Subject|0|||
47064403|NCT01693562|83346623|FG008|Exploration Phase|Withdrawal by Subject|0|||
47064404|NCT01693562|83346624|FG009|Exploration Phase|Withdrawal by Subject|0|||
47064405|NCT01693562|83346625|FG010|Exploration Phase|Withdrawal by Subject|0|||
47064406|NCT01693562|83346626|FG011|Exploration Phase|Withdrawal by Subject|0|||
47064407|NCT01693562|83346627|FG012|Exploration Phase|Withdrawal by Subject|0|||
47064408|NCT01693562|83346628|FG013|Exploration Phase|Withdrawal by Subject|0|||
47064409|NCT01693562|83346629|FG014|Exploration Phase|Withdrawal by Subject|0|||
47064410|NCT01693562|83346630|FG015|Exploration Phase|Withdrawal by Subject|0|||
46770028|NCT00797108|82988404|FG002|Overall Study|Global Deterioration of Health Status|0|||
46770029|NCT00797108|82988402|FG000|Overall Study|Lack of Efficacy|1|||
46770030|NCT00797108|82988403|FG001|Overall Study|Lack of Efficacy|0|||
46770031|NCT00797108|82988404|FG002|Overall Study|Lack of Efficacy|1|||
46770032|NCT00797108|82988402|FG000|Overall Study|Other|0|||
46770033|NCT00797108|82988403|FG001|Overall Study|Other|0|||
46770034|NCT00797108|82988404|FG002|Overall Study|Other|2|||
46770035|NCT00797108|82988402|FG000|Overall Study|Randomized but not Treated|2|||
46770036|NCT00797108|82988403|FG001|Overall Study|Randomized but not Treated|0|||
46770037|NCT00797108|82988404|FG002|Overall Study|Randomized but not Treated|0|||
46770038|NCT00742560|82988417|FG000|Overall Study|Adverse Event|0|||
46770039|NCT00742560|82988418|FG001|Overall Study|Adverse Event|0|||
46770040|NCT00742560|82988419|FG002|Overall Study|Adverse Event|1|||
46770041|NCT00742560|82988420|FG003|Overall Study|Adverse Event|1|||
46770042|NCT00742560|82988421|FG004|Overall Study|Adverse Event|1|||
46770043|NCT00742560|82988417|FG000|Overall Study|Death|0|||
46770044|NCT00742560|82988418|FG001|Overall Study|Death|2|||
46770045|NCT00742560|82988419|FG002|Overall Study|Death|0|||
46770046|NCT00742560|82988420|FG003|Overall Study|Death|2|||
46770047|NCT00742560|82988421|FG004|Overall Study|Death|3|||
46770048|NCT00742560|82988417|FG000|Overall Study|Subject's Decision|1|||
46770049|NCT00742560|82988418|FG001|Overall Study|Subject's Decision|0|||
46770050|NCT00742560|82988419|FG002|Overall Study|Subject's Decision|2|||
46770051|NCT00742560|82988420|FG003|Overall Study|Subject's Decision|3|||
46770052|NCT00742560|82988421|FG004|Overall Study|Subject's Decision|3|||
46770053|NCT00742560|82988417|FG000|Overall Study|Investigator's Decision|0|||
46770054|NCT00742560|82988418|FG001|Overall Study|Investigator's Decision|0|||
46770055|NCT00742560|82988419|FG002|Overall Study|Investigator's Decision|4|||
46770056|NCT00742560|82988420|FG003|Overall Study|Investigator's Decision|1|||
46770057|NCT00742560|82988421|FG004|Overall Study|Investigator's Decision|0|||
46770058|NCT00742560|82988417|FG000|Overall Study|Disease Progression|1|||
46770059|NCT00742560|82988418|FG001|Overall Study|Disease Progression|0|||
46770060|NCT00742560|82988419|FG002|Overall Study|Disease Progression|5|||
46770061|NCT00742560|82988420|FG003|Overall Study|Disease Progression|17|||
46770062|NCT00742560|82988421|FG004|Overall Study|Disease Progression|16|||
46770063|NCT00742560|82988417|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
46770064|NCT00742560|82988418|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
46770065|NCT00742560|82988419|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
46770066|NCT00742560|82988420|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
46946028|NCT01362296|83184230|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
46770067|NCT00742560|82988421|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
46946029|NCT01362296|83184231|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
46946030|NCT01362296|83184232|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
46840019|NCT00282308|83057279|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
46840020|NCT00282308|83057280|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
46840021|NCT00282308|83057281|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
46840022|NCT00282308|83057279|FG000|Safety Follow-up Period|Adverse Event|0|||
46840023|NCT00282308|83057280|FG001|Safety Follow-up Period|Adverse Event|0|||
46840024|NCT00282308|83057281|FG002|Safety Follow-up Period|Adverse Event|1|||
46840025|NCT00282308|83057279|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
46840026|NCT00282308|83057280|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
46840027|NCT00282308|83057281|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
46840028|NCT00282308|83057279|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
46638678|NCT01435356|82812092|FG000|Overall Study|Disease progression/recurrence|17|||
46638679|NCT01435356|82812093|FG001|Overall Study|Disease progression/recurrence|10|||
46638680|NCT01435356|82812092|FG000|Overall Study|Protocol Violation|0|||
46638681|NCT01435356|82812093|FG001|Overall Study|Protocol Violation|1|||
46840029|NCT00282308|83057280|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
47064411|NCT01693562|83346631|FG016|Exploration Phase|Withdrawal by Subject|0|||
47064412|NCT01693562|83346632|FG017|Exploration Phase|Withdrawal by Subject|0|||
47064413|NCT01693562|83346633|FG018|Exploration Phase|Withdrawal by Subject|0|||
47064414|NCT01693562|83346634|FG019|Exploration Phase|Withdrawal by Subject|0|||
47064415|NCT01693562|83346635|FG020|Exploration Phase|Withdrawal by Subject|0|||
47064416|NCT01693562|83346636|FG021|Exploration Phase|Withdrawal by Subject|0|||
46840030|NCT00282308|83057281|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
46840031|NCT00282308|83057279|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
46840032|NCT00282308|83057280|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
46840033|NCT00282308|83057281|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
46840034|NCT00282152|83057293|FG000|Overall Study|Withdrawal by Subject|1|||
46840035|NCT00282152|83057294|FG001|Overall Study|Withdrawal by Subject|0|||
46946031|NCT01362296|83184233|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
46946032|NCT01362296|83184230|FG000|Randomized Phase (RP)|Physician Decision|1|||
46946033|NCT01362296|83184231|FG001|Randomized Phase (RP)|Physician Decision|9|||
46946034|NCT01362296|83184232|FG002|Randomized Phase (RP)|Physician Decision|0|||
46946035|NCT01362296|83184233|FG003|Randomized Phase (RP)|Physician Decision|0|||
46946036|NCT01362296|83184230|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
46840036|NCT00281840|83057301|FG000|Overall Study|Adverse Event|12|||
46840037|NCT00281840|83057301|FG000|Overall Study|Physician Decision|6|||
46840038|NCT00281840|83057301|FG000|Overall Study|Withdrawal by Subject|3|||
46840039|NCT00281840|83057301|FG000|Overall Study|Disease Progression|2|||
46840040|NCT00281840|83057301|FG000|Overall Study|exceed maximum delay in treatment|1|||
46840041|NCT00281840|83057301|FG000|Overall Study|Complicating Disease|1|||
46840042|NCT00281684|83057310|FG000|Overall Study|Lost to Follow-up|0|||
46840043|NCT00281684|83057311|FG001|Overall Study|Lost to Follow-up|0|||
46840044|NCT00281684|83057312|FG002|Overall Study|Lost to Follow-up|1|||
46840045|NCT00281684|83057313|FG003|Overall Study|Lost to Follow-up|0|||
46840046|NCT00281684|83057310|FG000|Overall Study|Withdrawal by Subject|1|||
46840047|NCT00281684|83057311|FG001|Overall Study|Withdrawal by Subject|0|||
46840048|NCT00281684|83057312|FG002|Overall Study|Withdrawal by Subject|0|||
46840049|NCT00281684|83057313|FG003|Overall Study|Withdrawal by Subject|0|||
46840050|NCT00272792|83057327|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
46840051|NCT00272792|83057328|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
46840052|NCT00272792|83057327|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
46840053|NCT00272792|83057328|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
46840054|NCT00272792|83057327|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
46840055|NCT00272792|83057328|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
46946037|NCT01362296|83184231|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
46946038|NCT01362296|83184232|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
46946039|NCT01362296|83184233|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
46946040|NCT01362296|83184230|FG000|Randomized Phase (RP)|Adverse Event|20|||
46946041|NCT01362296|83184231|FG001|Randomized Phase (RP)|Adverse Event|4|||
46946042|NCT01362296|83184232|FG002|Randomized Phase (RP)|Adverse Event|0|||
46946043|NCT01362296|83184233|FG003|Randomized Phase (RP)|Adverse Event|0|||
46946044|NCT01362296|83184230|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
47064417|NCT01693562|83346637|FG022|Exploration Phase|Withdrawal by Subject|0|||
47064418|NCT01693562|83346615|FG000|Exploration Phase|Death|0|||
47064419|NCT01693562|83346616|FG001|Exploration Phase|Death|0|||
46946045|NCT01362296|83184231|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
47064420|NCT01693562|83346617|FG002|Exploration Phase|Death|0|||
47064421|NCT01693562|83346618|FG003|Exploration Phase|Death|0|||
46638682|NCT01435356|82812092|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
46840056|NCT00272792|83057327|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
46840057|NCT00272792|83057328|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
46946046|NCT01362296|83184232|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
46946047|NCT01362296|83184233|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
46946048|NCT01362296|83184230|FG000|Crossover Phase|PD including Death due to PD|0|||
46946049|NCT01362296|83184231|FG001|Crossover Phase|PD including Death due to PD|0|||
46946050|NCT01362296|83184232|FG002|Crossover Phase|PD including Death due to PD|16|||
46946051|NCT01362296|83184233|FG003|Crossover Phase|PD including Death due to PD|1|||
46946052|NCT01362296|83184230|FG000|Crossover Phase|Withdrawal by Subject|0|||
46946053|NCT01362296|83184231|FG001|Crossover Phase|Withdrawal by Subject|0|||
47064422|NCT01693562|83346619|FG004|Exploration Phase|Death|0|||
46840058|NCT00048568|83057336|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
46840059|NCT00048568|83057337|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
46840060|NCT00048568|83057338|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
46840061|NCT00048568|83057336|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
46840062|NCT00048568|83057337|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
46840063|NCT00048568|83057338|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
46840064|NCT00048568|83057336|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
46840065|NCT00048568|83057337|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
46840066|NCT00048568|83057338|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
46840067|NCT00048568|83057336|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
46840068|NCT00048568|83057337|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
46840069|NCT00048568|83057338|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
46840070|NCT00048568|83057336|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
46840071|NCT00048568|83057337|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
46840072|NCT00048568|83057338|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
46840073|NCT00048568|83057336|FG000|Double-Blind Period Days 170 to 365|Death|1|||
46840074|NCT00048568|83057337|FG001|Double-Blind Period Days 170 to 365|Death|1|||
47064423|NCT01693562|83346620|FG005|Exploration Phase|Death|0|||
47064424|NCT01693562|83346621|FG006|Exploration Phase|Death|17|||
46840075|NCT00048568|83057338|FG002|Double-Blind Period Days 170 to 365|Death|0|||
46840076|NCT00048568|83057336|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
46840077|NCT00048568|83057337|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
46840078|NCT00048568|83057338|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
46840079|NCT00048568|83057336|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
46840080|NCT00048568|83057337|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
46840081|NCT00048568|83057338|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
46840082|NCT00048568|83057336|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
46840083|NCT00048568|83057337|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
46840084|NCT00048568|83057338|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
46840085|NCT00048568|83057336|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
46840086|NCT00048568|83057337|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
47064425|NCT01693562|83346622|FG007|Exploration Phase|Death|0|||
47064426|NCT01693562|83346623|FG008|Exploration Phase|Death|0|||
47064427|NCT01693562|83346624|FG009|Exploration Phase|Death|0|||
47064428|NCT01693562|83346625|FG010|Exploration Phase|Death|0|||
47064429|NCT01693562|83346626|FG011|Exploration Phase|Death|0|||
47064430|NCT01693562|83346627|FG012|Exploration Phase|Death|0|||
47064431|NCT01693562|83346628|FG013|Exploration Phase|Death|0|||
47064432|NCT01693562|83346629|FG014|Exploration Phase|Death|0|||
47064433|NCT01693562|83346630|FG015|Exploration Phase|Death|0|||
47064434|NCT01693562|83346631|FG016|Exploration Phase|Death|0|||
47064435|NCT01693562|83346632|FG017|Exploration Phase|Death|0|||
47064436|NCT01693562|83346633|FG018|Exploration Phase|Death|0|||
47064437|NCT01693562|83346634|FG019|Exploration Phase|Death|0|||
47064438|NCT01693562|83346635|FG020|Exploration Phase|Death|0|||
46840087|NCT00048568|83057338|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
46840088|NCT00048568|83057336|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
46840089|NCT00048568|83057337|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
46840090|NCT00048568|83057338|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
46840091|NCT00048568|83057336|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
46840092|NCT00048568|83057337|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
46840093|NCT00048568|83057338|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
46840094|NCT00048568|83057336|FG000|Open-Label Period|Death|0|||
46840095|NCT00048568|83057337|FG001|Open-Label Period|Death|0|||
46840096|NCT00048568|83057338|FG002|Open-Label Period|Death|13|||
46840097|NCT00048568|83057336|FG000|Open-Label Period|Adverse Event|0|||
47064439|NCT01693562|83346636|FG021|Exploration Phase|Death|0|||
47064440|NCT01693562|83346637|FG022|Exploration Phase|Death|0|||
47064441|NCT01693562|83346615|FG000|Exploration Phase|Other|0|||
46840098|NCT00048568|83057337|FG001|Open-Label Period|Adverse Event|0|||
46840099|NCT00048568|83057338|FG002|Open-Label Period|Adverse Event|49|||
46946054|NCT01362296|83184232|FG002|Crossover Phase|Withdrawal by Subject|2|||
47064442|NCT01693562|83346616|FG001|Exploration Phase|Other|0|||
47064443|NCT01693562|83346617|FG002|Exploration Phase|Other|0|||
47064444|NCT01693562|83346618|FG003|Exploration Phase|Other|0|||
47064445|NCT01693562|83346619|FG004|Exploration Phase|Other|0|||
47064446|NCT01693562|83346620|FG005|Exploration Phase|Other|0|||
46840100|NCT00048568|83057336|FG000|Open-Label Period|Lack of Efficacy|0|||
47064447|NCT01693562|83346621|FG006|Exploration Phase|Other|2|||
47064448|NCT01693562|83346622|FG007|Exploration Phase|Other|0|||
47064449|NCT01693562|83346623|FG008|Exploration Phase|Other|0|||
47064450|NCT01693562|83346624|FG009|Exploration Phase|Other|0|||
46770068|NCT00742560|82988417|FG000|Overall Study|Other|0|||
46840101|NCT00048568|83057337|FG001|Open-Label Period|Lack of Efficacy|0|||
46840102|NCT00048568|83057338|FG002|Open-Label Period|Lack of Efficacy|32|||
46840103|NCT00048568|83057336|FG000|Open-Label Period|Withdrawal by Subject|0|||
46840104|NCT00048568|83057337|FG001|Open-Label Period|Withdrawal by Subject|0|||
46840105|NCT00048568|83057338|FG002|Open-Label Period|Withdrawal by Subject|26|||
46840106|NCT00048568|83057336|FG000|Open-Label Period|Pregnancy|0|||
46840107|NCT00048568|83057337|FG001|Open-Label Period|Pregnancy|0|||
46840108|NCT00048568|83057338|FG002|Open-Label Period|Pregnancy|5|||
46840109|NCT00048568|83057336|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
46840110|NCT00048568|83057337|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
46840111|NCT00048568|83057338|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
46840112|NCT00048568|83057336|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
46840113|NCT00048568|83057337|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
46840114|NCT00048568|83057338|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
46946055|NCT01362296|83184233|FG003|Crossover Phase|Withdrawal by Subject|1|||
46946056|NCT01362296|83184230|FG000|Crossover Phase|Adverse Event|0|||
46946057|NCT01362296|83184231|FG001|Crossover Phase|Adverse Event|0|||
46946058|NCT01362296|83184232|FG002|Crossover Phase|Adverse Event|4|||
46946059|NCT01362296|83184233|FG003|Crossover Phase|Adverse Event|0|||
46946060|NCT01362296|83184230|FG000|Crossover Phase|Study Closed/Terminated|0|||
46946061|NCT01362296|83184231|FG001|Crossover Phase|Study Closed/Terminated|0|||
46946062|NCT01362296|83184232|FG002|Crossover Phase|Study Closed/Terminated|1|||
46946063|NCT01362296|83184233|FG003|Crossover Phase|Study Closed/Terminated|0|||
46946064|NCT01338415|83184245|FG000|Core + Extension|Adverse Event|8|||
46946065|NCT01338415|83184246|FG001|Core + Extension|Adverse Event|6|||
46946066|NCT01338415|83184247|FG002|Core + Extension|Adverse Event|0|||
46946067|NCT01338415|83184245|FG000|Core + Extension|Withdrawal by Subject|1|||
46946068|NCT01338415|83184246|FG001|Core + Extension|Withdrawal by Subject|1|||
46946069|NCT01338415|83184247|FG002|Core + Extension|Withdrawal by Subject|0|||
46946070|NCT01338415|83184245|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
46946071|NCT01338415|83184246|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
46946072|NCT01338415|83184247|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
46946073|NCT01338415|83184245|FG000|Core + Extension|Other (administrative reason)|1|||
46946074|NCT01338415|83184246|FG001|Core + Extension|Other (administrative reason)|0|||
47064451|NCT01693562|83346625|FG010|Exploration Phase|Other|0|||
47064452|NCT01693562|83346626|FG011|Exploration Phase|Other|0|||
47064453|NCT01693562|83346627|FG012|Exploration Phase|Other|0|||
47064454|NCT01693562|83346628|FG013|Exploration Phase|Other|0|||
47064455|NCT01693562|83346629|FG014|Exploration Phase|Other|0|||
46770069|NCT00742560|82988418|FG001|Overall Study|Other|1|||
46770070|NCT00742560|82988419|FG002|Overall Study|Other|8|||
46770071|NCT00742560|82988420|FG003|Overall Study|Other|9|||
46770072|NCT00742560|82988421|FG004|Overall Study|Other|9|||
46770073|NCT00742560|82988417|FG000|Overall Study|MIssing|0|||
46770074|NCT00742560|82988418|FG001|Overall Study|MIssing|0|||
46770075|NCT00742560|82988419|FG002|Overall Study|MIssing|0|||
46770076|NCT00742560|82988420|FG003|Overall Study|MIssing|0|||
46770077|NCT00742560|82988421|FG004|Overall Study|MIssing|1|||
46770078|NCT00740220|82988452|FG000|Overall Study|screen failures (non-COPD patients)|9|||
46770079|NCT00796718|82988456|FG000|Overall Study|Adverse Event|2|||
46770080|NCT00796718|82988456|FG000|Overall Study|Exclusion Criteria|1|||
46770081|NCT00796718|82988456|FG000|Overall Study|Lost to Follow-up|5|||
46770082|NCT00796718|82988456|FG000|Overall Study|Withdrawal by Informed Consent|1|||
46770083|NCT00809159|82988464|FG000|Part 1|Adverse Event|1|||
46840115|NCT00048568|83057336|FG000|Open-Label Period|Unknown Reasons|0|||
46840116|NCT00048568|83057337|FG001|Open-Label Period|Unknown Reasons|0|||
46840117|NCT00048568|83057338|FG002|Open-Label Period|Unknown Reasons|25|||
46840118|NCT00048568|83057336|FG000|Open-Label Period|Lost to Follow-up|0|||
46840119|NCT00048568|83057337|FG001|Open-Label Period|Lost to Follow-up|0|||
46638683|NCT01435356|82812093|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
46840120|NCT00048568|83057338|FG002|Open-Label Period|Lost to Follow-up|7|||
46946075|NCT01338415|83184247|FG002|Core + Extension|Other (administrative reason)|0|||
46946076|NCT01338415|83184245|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
46946077|NCT01338415|83184246|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
46967865|NCT05091307|83210484|FG001|Overall Study|Lost to Follow-up|33|||
47064456|NCT01693562|83346630|FG015|Exploration Phase|Other|0|||
46770084|NCT00809159|82988465|FG001|Part 1|Adverse Event|1|||
46770085|NCT00809159|82988466|FG002|Part 1|Adverse Event|0|||
46770086|NCT00809159|82988467|FG003|Part 1|Adverse Event|0|||
46840121|NCT00262002|83057366|FG000|Overall Study|Adverse Event|2|||
47064457|NCT01693562|83346631|FG016|Exploration Phase|Other|0|||
46770087|NCT00809159|82988468|FG004|Part 1|Adverse Event|0|||
46770088|NCT00809159|82988469|FG005|Part 1|Adverse Event|0|||
46770089|NCT00809159|82988464|FG000|Part 1|Lost to Follow-up|1|||
46770090|NCT00809159|82988465|FG001|Part 1|Lost to Follow-up|0|||
46770091|NCT00809159|82988466|FG002|Part 1|Lost to Follow-up|0|||
46770092|NCT00809159|82988467|FG003|Part 1|Lost to Follow-up|0|||
46946078|NCT01338415|83184247|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
46946079|NCT01338415|83184245|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
46946080|NCT01338415|83184246|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
46946081|NCT01338415|83184247|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
46946082|NCT01338415|83184245|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
46946083|NCT01338415|83184246|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
46946084|NCT01338415|83184247|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
46946085|NCT01338415|83184245|FG000|Exceptional Use Treatment Period|Death|0|||
46946086|NCT01338415|83184246|FG001|Exceptional Use Treatment Period|Death|0|||
46840122|NCT00262002|83057367|FG001|Overall Study|Adverse Event|1|||
46840123|NCT00262002|83057368|FG002|Overall Study|Adverse Event|0|||
46840124|NCT00262002|83057369|FG003|Overall Study|Adverse Event|0|||
46840125|NCT00262002|83057370|FG004|Overall Study|Adverse Event|0|||
46840126|NCT00262002|83057371|FG005|Overall Study|Adverse Event|1|||
46840127|NCT00262002|83057372|FG006|Overall Study|Adverse Event|0|||
46840128|NCT00262002|83057366|FG000|Overall Study|Withdrawal by Subject|4|||
46840129|NCT00262002|83057367|FG001|Overall Study|Withdrawal by Subject|2|||
46840130|NCT00262002|83057368|FG002|Overall Study|Withdrawal by Subject|0|||
46840131|NCT00262002|83057369|FG003|Overall Study|Withdrawal by Subject|1|||
46840132|NCT00262002|83057370|FG004|Overall Study|Withdrawal by Subject|2|||
46840133|NCT00262002|83057371|FG005|Overall Study|Withdrawal by Subject|2|||
46840134|NCT00262002|83057372|FG006|Overall Study|Withdrawal by Subject|2|||
46840135|NCT00262002|83057366|FG000|Overall Study|Lost to Follow-up|2|||
46840136|NCT00262002|83057367|FG001|Overall Study|Lost to Follow-up|0|||
46840137|NCT00262002|83057368|FG002|Overall Study|Lost to Follow-up|0|||
46840138|NCT00262002|83057369|FG003|Overall Study|Lost to Follow-up|2|||
46840139|NCT00262002|83057370|FG004|Overall Study|Lost to Follow-up|0|||
46840140|NCT00262002|83057371|FG005|Overall Study|Lost to Follow-up|1|||
46638684|NCT01435356|82812092|FG000|Overall Study|Withdrawal by Subject|1|||
46638685|NCT01435356|82812093|FG001|Overall Study|Withdrawal by Subject|1|||
46638686|NCT01435356|82812092|FG000|Overall Study|Facial palsy|1|||
46638687|NCT01435356|82812093|FG001|Overall Study|Facial palsy|0|||
46638688|NCT01435356|82812092|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
46638689|NCT01435356|82812093|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
46638690|NCT01435356|82812092|FG000|Overall Study|Physician Decision|1|||
46638691|NCT01435356|82812093|FG001|Overall Study|Physician Decision|0|||
46638692|NCT01435356|82812092|FG000|Overall Study|Patient decision|3|||
46638693|NCT01435356|82812093|FG001|Overall Study|Patient decision|0|||
46638694|NCT01435356|82812092|FG000|Overall Study|Patient moved to another city|1|||
46840141|NCT00262002|83057372|FG006|Overall Study|Lost to Follow-up|0|||
46840142|NCT00262002|83057366|FG000|Overall Study|Inapropriate enrollment|0|||
46840143|NCT00262002|83057367|FG001|Overall Study|Inapropriate enrollment|1|||
46840144|NCT00262002|83057368|FG002|Overall Study|Inapropriate enrollment|0|||
46840145|NCT00262002|83057369|FG003|Overall Study|Inapropriate enrollment|0|||
46638695|NCT01435356|82812093|FG001|Overall Study|Patient moved to another city|1|||
46638696|NCT01435122|82812099|FG000|Overall Study|Early withdrawal due to toxicity|8|||
46770093|NCT00809159|82988468|FG004|Part 1|Lost to Follow-up|0|||
46770094|NCT00809159|82988469|FG005|Part 1|Lost to Follow-up|0|||
46770095|NCT00809159|82988464|FG000|Part 1|Withdrawal by Subject|3|||
46770096|NCT00809159|82988465|FG001|Part 1|Withdrawal by Subject|1|||
46770097|NCT00809159|82988466|FG002|Part 1|Withdrawal by Subject|0|||
46770098|NCT00809159|82988467|FG003|Part 1|Withdrawal by Subject|0|||
46770099|NCT00809159|82988468|FG004|Part 1|Withdrawal by Subject|0|||
46770100|NCT00809159|82988469|FG005|Part 1|Withdrawal by Subject|0|||
46770101|NCT00809159|82988464|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
46840146|NCT00262002|83057370|FG004|Overall Study|Inapropriate enrollment|0|||
46946087|NCT01338415|83184247|FG002|Exceptional Use Treatment Period|Death|1|||
46946088|NCT05258149|83184257|FG000|Period 1|Protocol Deviation|1|||
46638697|NCT01434810|82812114|FG000|Overall Study|Did not receive treatment|11|||
46638698|NCT01434810|82812115|FG001|Overall Study|Did not receive treatment|3|||
46770102|NCT00809159|82988465|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
46770103|NCT00809159|82988466|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
46770104|NCT00809159|82988467|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
46770105|NCT00809159|82988468|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
46840147|NCT00262002|83057371|FG005|Overall Study|Inapropriate enrollment|0|||
46840148|NCT00262002|83057372|FG006|Overall Study|Inapropriate enrollment|0|||
46840149|NCT00262002|83057366|FG000|Overall Study|Protocol Violation|3|||
46840150|NCT00262002|83057367|FG001|Overall Study|Protocol Violation|2|||
46840151|NCT00262002|83057368|FG002|Overall Study|Protocol Violation|0|||
46770106|NCT00809159|82988469|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
46946089|NCT05258149|83184258|FG001|Period 1|Protocol Deviation|0|||
46946090|NCT05258149|83184257|FG000|Period 1|Adverse Event|0|||
46946091|NCT05258149|83184258|FG001|Period 1|Adverse Event|1|||
46946092|NCT05258149|83184257|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
46840152|NCT00262002|83057369|FG003|Overall Study|Protocol Violation|2|||
46840153|NCT00262002|83057370|FG004|Overall Study|Protocol Violation|5|||
46840154|NCT00262002|83057371|FG005|Overall Study|Protocol Violation|3|||
46840155|NCT00262002|83057372|FG006|Overall Study|Protocol Violation|2|||
46840156|NCT00262002|83057366|FG000|Overall Study|Unable to classify|0|||
46840157|NCT00262002|83057367|FG001|Overall Study|Unable to classify|0|||
46840158|NCT00262002|83057368|FG002|Overall Study|Unable to classify|0|||
46946093|NCT05258149|83184258|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
46946094|NCT05258149|83184257|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
46946095|NCT05258149|83184258|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
46946096|NCT05258149|83184257|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
46946097|NCT05258149|83184258|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
46946098|NCT01371643|83184266|FG000|Overall Study|Withdrawal by Subject|3|||
46946099|NCT01371643|83184267|FG001|Overall Study|Withdrawal by Subject|0|||
46946100|NCT01371565|83184273|FG000|Overall Study|Withdrawal by Subject|1|||
46946101|NCT01371565|83184273|FG000|Overall Study|Death|1|||
46946102|NCT01371565|83184273|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
46946103|NCT02821819|83184281|FG000|Overall Study|Protocol Violation|1|||
46946104|NCT03926611|83184292|FG000|Overall Study|Adverse Event|0|||
46946105|NCT03926611|83184293|FG001|Overall Study|Adverse Event|0|||
46946106|NCT03926611|83184294|FG002|Overall Study|Adverse Event|0|||
46946107|NCT03926611|83184295|FG003|Overall Study|Adverse Event|3|||
46946108|NCT03926611|83184296|FG004|Overall Study|Adverse Event|1|||
46946109|NCT03926611|83184297|FG005|Overall Study|Adverse Event|3|||
46946110|NCT03926611|83184298|FG006|Overall Study|Adverse Event|0|||
47064458|NCT01693562|83346632|FG017|Exploration Phase|Other|0|||
47064459|NCT01693562|83346633|FG018|Exploration Phase|Other|0|||
47064460|NCT01693562|83346634|FG019|Exploration Phase|Other|0|||
47064461|NCT01693562|83346635|FG020|Exploration Phase|Other|0|||
47064462|NCT01693562|83346636|FG021|Exploration Phase|Other|0|||
47064463|NCT01693562|83346637|FG022|Exploration Phase|Other|0|||
47064464|NCT01693562|83346615|FG000|Expansion Phase|Withdrawal by Subject|0|||
47064465|NCT01693562|83346616|FG001|Expansion Phase|Withdrawal by Subject|0|||
47064466|NCT01693562|83346617|FG002|Expansion Phase|Withdrawal by Subject|0|||
46638699|NCT01434810|82812114|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
46770107|NCT00809159|82988464|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
46770108|NCT00809159|82988465|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
46770109|NCT00809159|82988466|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
46770110|NCT00809159|82988467|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
46770111|NCT00809159|82988468|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
46770112|NCT00809159|82988469|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
46770113|NCT00809159|82988464|FG000|Part 1 and 2|Administrative problems|0|||
46770114|NCT00809159|82988465|FG001|Part 1 and 2|Administrative problems|0|||
46770115|NCT00809159|82988466|FG002|Part 1 and 2|Administrative problems|0|||
46770116|NCT00809159|82988467|FG003|Part 1 and 2|Administrative problems|1|||
46840159|NCT00262002|83057369|FG003|Overall Study|Unable to classify|0|||
46840160|NCT00262002|83057370|FG004|Overall Study|Unable to classify|0|||
46840161|NCT00262002|83057371|FG005|Overall Study|Unable to classify|0|||
46840162|NCT00262002|83057372|FG006|Overall Study|Unable to classify|2|||
46840163|NCT00281528|83057440|FG000|Overall Study|Progressive Disease|28|||
46840164|NCT00281528|83057441|FG001|Overall Study|Progressive Disease|18|||
46840165|NCT00281528|83057442|FG002|Overall Study|Progressive Disease|27|||
46840166|NCT00281528|83057440|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
46840167|NCT00281528|83057441|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
46840168|NCT00281528|83057442|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
46840169|NCT00281528|83057440|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
46840170|NCT00281528|83057441|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
46840171|NCT00281528|83057442|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
46840172|NCT00281528|83057440|FG000|Overall Study|Physician Decision|11|||
46840173|NCT00281528|83057441|FG001|Overall Study|Physician Decision|4|||
46770117|NCT00809159|82988468|FG004|Part 1 and 2|Administrative problems|0|||
46840174|NCT00281528|83057442|FG002|Overall Study|Physician Decision|5|||
46840175|NCT00281528|83057440|FG000|Overall Study|Protocol Violation|1|||
46840176|NCT00281528|83057441|FG001|Overall Study|Protocol Violation|0|||
46840177|NCT00281528|83057442|FG002|Overall Study|Protocol Violation|1|||
46946111|NCT03926611|83184292|FG000|Overall Study|Lack of Efficacy|1|||
46946112|NCT03926611|83184293|FG001|Overall Study|Lack of Efficacy|2|||
46946113|NCT03926611|83184294|FG002|Overall Study|Lack of Efficacy|0|||
46946114|NCT03926611|83184295|FG003|Overall Study|Lack of Efficacy|0|||
46946115|NCT03926611|83184296|FG004|Overall Study|Lack of Efficacy|1|||
47064467|NCT01693562|83346618|FG003|Expansion Phase|Withdrawal by Subject|0|||
47064468|NCT01693562|83346619|FG004|Expansion Phase|Withdrawal by Subject|0|||
47064469|NCT01693562|83346620|FG005|Expansion Phase|Withdrawal by Subject|0|||
47064470|NCT01693562|83346621|FG006|Expansion Phase|Withdrawal by Subject|0|||
47064471|NCT01693562|83346622|FG007|Expansion Phase|Withdrawal by Subject|16|||
47064472|NCT01693562|83346623|FG008|Expansion Phase|Withdrawal by Subject|2|||
47064473|NCT01693562|83346624|FG009|Expansion Phase|Withdrawal by Subject|54|||
47064474|NCT01693562|83346625|FG010|Expansion Phase|Withdrawal by Subject|2|||
47064475|NCT01693562|83346626|FG011|Expansion Phase|Withdrawal by Subject|2|||
47064476|NCT01693562|83346627|FG012|Expansion Phase|Withdrawal by Subject|3|||
47064477|NCT01693562|83346628|FG013|Expansion Phase|Withdrawal by Subject|5|||
47064478|NCT01693562|83346629|FG014|Expansion Phase|Withdrawal by Subject|16|||
47064479|NCT01693562|83346630|FG015|Expansion Phase|Withdrawal by Subject|7|||
46946116|NCT03926611|83184297|FG005|Overall Study|Lack of Efficacy|0|||
46946117|NCT03926611|83184298|FG006|Overall Study|Lack of Efficacy|1|||
46946118|NCT03926611|83184292|FG000|Overall Study|Physician Decision|0|||
46946119|NCT03926611|83184293|FG001|Overall Study|Physician Decision|0|||
46840178|NCT00281528|83057440|FG000|Overall Study|Withdrawal by Subject|5|||
46840179|NCT00281528|83057441|FG001|Overall Study|Withdrawal by Subject|5|||
46840180|NCT00281528|83057442|FG002|Overall Study|Withdrawal by Subject|7|||
46840181|NCT00281528|83057440|FG000|Overall Study|Other|6|||
46840182|NCT00281528|83057441|FG001|Overall Study|Other|3|||
46840183|NCT00281528|83057442|FG002|Overall Study|Other|5|||
46840184|NCT00280748|83057450|FG000|Overall Study|Decline in performance|3|||
46840185|NCT00280748|83057450|FG000|Overall Study|Extra-cranial disease progression|1|||
46840186|NCT00271856|83057456|FG000|Overall Study|Withdrawal by Subject|1|||
46840187|NCT00271856|83057457|FG001|Overall Study|Withdrawal by Subject|7|||
46840188|NCT00271856|83057456|FG000|Overall Study|Lost to Follow-up|10|||
46840189|NCT00271856|83057457|FG001|Overall Study|Lost to Follow-up|11|||
46840190|NCT00061048|83057463|FG000|Overall Study|Adverse Event|2|||
46840191|NCT00061048|83057463|FG000|Overall Study|disease progression|20|||
46840192|NCT00270998|83057470|FG000|3 Month Follow-up|Adverse Event|1|||
46840193|NCT00270998|83057471|FG001|3 Month Follow-up|Adverse Event|0|||
46840194|NCT00270998|83057472|FG002|3 Month Follow-up|Adverse Event|0|||
47064480|NCT01693562|83346631|FG016|Expansion Phase|Withdrawal by Subject|40|||
47064481|NCT01693562|83346632|FG017|Expansion Phase|Withdrawal by Subject|4|||
47064482|NCT01693562|83346633|FG018|Expansion Phase|Withdrawal by Subject|8|||
47064483|NCT01693562|83346634|FG019|Expansion Phase|Withdrawal by Subject|3|||
46840195|NCT00270998|83057470|FG000|3 Month Follow-up|Lack of Efficacy|1|||
46840196|NCT00270998|83057471|FG001|3 Month Follow-up|Lack of Efficacy|2|||
46840197|NCT00270998|83057472|FG002|3 Month Follow-up|Lack of Efficacy|1|||
46840198|NCT00270998|83057470|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
46840199|NCT00270998|83057471|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
46840200|NCT00270998|83057472|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
46840201|NCT00270998|83057470|FG000|3 Month Follow-up|Pessary did not fit|12|||
46840202|NCT00270998|83057471|FG001|3 Month Follow-up|Pessary did not fit|0|||
46840203|NCT00270998|83057472|FG002|3 Month Follow-up|Pessary did not fit|0|||
46840204|NCT00270998|83057470|FG000|3 Month Follow-up|Personal/family health|1|||
46840205|NCT00270998|83057471|FG001|3 Month Follow-up|Personal/family health|1|||
46840206|NCT00270998|83057472|FG002|3 Month Follow-up|Personal/family health|0|||
46840207|NCT00270998|83057470|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
46840208|NCT00270998|83057471|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
46840209|NCT00270998|83057472|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
46840210|NCT00270998|83057470|FG000|12 Month Follow-up|Lack of Efficacy|5|||
46840211|NCT00270998|83057471|FG001|12 Month Follow-up|Lack of Efficacy|4|||
46840212|NCT00270998|83057472|FG002|12 Month Follow-up|Lack of Efficacy|3|||
46946120|NCT03926611|83184294|FG002|Overall Study|Physician Decision|0|||
47064484|NCT01693562|83346635|FG020|Expansion Phase|Withdrawal by Subject|1|||
47064485|NCT01693562|83346636|FG021|Expansion Phase|Withdrawal by Subject|8|||
47064486|NCT01693562|83346637|FG022|Expansion Phase|Withdrawal by Subject|1|||
47064487|NCT01693562|83346615|FG000|Expansion Phase|Death|0|||
47064488|NCT01693562|83346616|FG001|Expansion Phase|Death|0|||
47064489|NCT01693562|83346617|FG002|Expansion Phase|Death|0|||
46840213|NCT00270998|83057470|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
46840214|NCT00270998|83057471|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
46840215|NCT00270998|83057472|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
46840216|NCT00270998|83057470|FG000|12 Month Follow-up|Pessary did not fit|1|||
46840217|NCT00270998|83057471|FG001|12 Month Follow-up|Pessary did not fit|0|||
46840218|NCT00270998|83057472|FG002|12 Month Follow-up|Pessary did not fit|0|||
46946121|NCT03926611|83184295|FG003|Overall Study|Physician Decision|0|||
46946122|NCT03926611|83184296|FG004|Overall Study|Physician Decision|0|||
46946123|NCT03926611|83184297|FG005|Overall Study|Physician Decision|1|||
47064490|NCT01693562|83346618|FG003|Expansion Phase|Death|0|||
47064491|NCT01693562|83346619|FG004|Expansion Phase|Death|0|||
46946124|NCT03926611|83184298|FG006|Overall Study|Physician Decision|0|||
46946125|NCT03926611|83184292|FG000|Overall Study|Protocol Violation|1|||
47064492|NCT01693562|83346620|FG005|Expansion Phase|Death|0|||
47064493|NCT01693562|83346621|FG006|Expansion Phase|Death|0|||
47064494|NCT01693562|83346622|FG007|Expansion Phase|Death|42|||
47064495|NCT01693562|83346623|FG008|Expansion Phase|Death|17|||
47064496|NCT01693562|83346624|FG009|Expansion Phase|Death|208|||
47064497|NCT01693562|83346625|FG010|Expansion Phase|Death|30|||
47064498|NCT01693562|83346626|FG011|Expansion Phase|Death|8|||
47064499|NCT01693562|83346627|FG012|Expansion Phase|Death|19|||
47064500|NCT01693562|83346628|FG013|Expansion Phase|Death|42|||
47064501|NCT01693562|83346629|FG014|Expansion Phase|Death|23|||
46770118|NCT00809159|82988469|FG005|Part 1 and 2|Administrative problems|0|||
46770119|NCT00809159|82988464|FG000|Part 1 and 2|Adverse Event|0|||
46770120|NCT00809159|82988465|FG001|Part 1 and 2|Adverse Event|0|||
46770121|NCT00809159|82988466|FG002|Part 1 and 2|Adverse Event|1|||
46770122|NCT00809159|82988467|FG003|Part 1 and 2|Adverse Event|0|||
46770123|NCT00809159|82988468|FG004|Part 1 and 2|Adverse Event|1|||
46770124|NCT00809159|82988469|FG005|Part 1 and 2|Adverse Event|1|||
46770125|NCT00809159|82988464|FG000|Part 1 and 2|Lost to Follow-up|0|||
46770126|NCT00809159|82988465|FG001|Part 1 and 2|Lost to Follow-up|0|||
46770127|NCT00809159|82988466|FG002|Part 1 and 2|Lost to Follow-up|1|||
46770128|NCT00809159|82988467|FG003|Part 1 and 2|Lost to Follow-up|1|||
46770129|NCT00809159|82988468|FG004|Part 1 and 2|Lost to Follow-up|0|||
46770130|NCT00809159|82988469|FG005|Part 1 and 2|Lost to Follow-up|0|||
46770131|NCT00809159|82988464|FG000|Part 1 and 2|Withdrawal by Subject|0|||
46770132|NCT00809159|82988465|FG001|Part 1 and 2|Withdrawal by Subject|0|||
46770133|NCT00809159|82988466|FG002|Part 1 and 2|Withdrawal by Subject|4|||
46770134|NCT00809159|82988467|FG003|Part 1 and 2|Withdrawal by Subject|0|||
46770135|NCT00809159|82988468|FG004|Part 1 and 2|Withdrawal by Subject|0|||
46770136|NCT00809159|82988469|FG005|Part 1 and 2|Withdrawal by Subject|1|||
46770137|NCT00745368|82988483|FG000|Overall Study|Unable to provide sample|3|||
46770138|NCT00589472|82988487|FG000|Overall Study|Adverse Event|1|||
46770139|NCT00811577|82988493|FG000|Overall Study|Lost to Follow-up|7|||
46770140|NCT00811577|82988494|FG001|Overall Study|Lost to Follow-up|1|||
46770141|NCT00811577|82988493|FG000|Overall Study|Withdrawal by Subject|3|||
46840219|NCT00270998|83057470|FG000|12 Month Follow-up|Personal/family health|0|||
46840220|NCT00270998|83057471|FG001|12 Month Follow-up|Personal/family health|5|||
46840221|NCT00270998|83057472|FG002|12 Month Follow-up|Personal/family health|1|||
46840222|NCT00270998|83057470|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
46840223|NCT00270998|83057471|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
46840224|NCT00270998|83057472|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
46840225|NCT00279812|83057488|FG000|Overall Study|Protocol Violation|1|||
46840226|NCT00279812|83057489|FG001|Overall Study|Protocol Violation|1|||
46840227|NCT00279812|83057490|FG002|Overall Study|Protocol Violation|0|||
46840228|NCT00279812|83057491|FG003|Overall Study|Protocol Violation|0|||
46840229|NCT00279812|83057492|FG004|Overall Study|Protocol Violation|1|||
46840230|NCT00279812|83057493|FG005|Overall Study|Protocol Violation|0|||
46840231|NCT00279812|83057488|FG000|Overall Study|Withdrawal by Subject|0|||
46840232|NCT00279812|83057489|FG001|Overall Study|Withdrawal by Subject|4|||
46840233|NCT00279812|83057490|FG002|Overall Study|Withdrawal by Subject|2|||
46840234|NCT00279812|83057491|FG003|Overall Study|Withdrawal by Subject|0|||
46840235|NCT00279812|83057492|FG004|Overall Study|Withdrawal by Subject|0|||
46840236|NCT00279812|83057493|FG005|Overall Study|Withdrawal by Subject|0|||
46840237|NCT00279812|83057488|FG000|Overall Study|Adverse Event|0|||
46840238|NCT00279812|83057489|FG001|Overall Study|Adverse Event|1|||
46770142|NCT00811577|82988494|FG001|Overall Study|Withdrawal by Subject|0|||
46770143|NCT00802178|82988543|FG000|Overall Study|Lack of Efficacy|36|||
46770144|NCT00802178|82988543|FG000|Overall Study|Insufficient tolerability (IT)|17|||
46770145|NCT00802178|82988543|FG000|Overall Study|Withdrawal by Subject|18|||
46770146|NCT00802178|82988543|FG000|Overall Study|Other|32|||
46770147|NCT00802178|82988543|FG000|Overall Study|Lack of efficacy and patient wish|1|||
46770148|NCT00802178|82988543|FG000|Overall Study|IT and patient wish|8|||
46770149|NCT00802178|82988543|FG000|Overall Study|Patients wish and other reason|1|||
46770150|NCT00744978|82988549|FG000|Period 1|Lost to Follow-up|1|||
46770151|NCT00744978|82988550|FG001|Period 1|Lost to Follow-up|0|||
46770152|NCT00744978|82988549|FG000|Period 1|Withdrawal by Subject|0|||
46840239|NCT00279812|83057490|FG002|Overall Study|Adverse Event|1|||
46770153|NCT00744978|82988550|FG001|Period 1|Withdrawal by Subject|2|||
46770154|NCT00744978|82988549|FG000|Period 1|Other|0|||
46840240|NCT00279812|83057491|FG003|Overall Study|Adverse Event|0|||
47064502|NCT01693562|83346630|FG015|Expansion Phase|Death|23|||
46770155|NCT00744978|82988550|FG001|Period 1|Other|2|||
46770156|NCT00744978|82988549|FG000|Period 1|Adverse Event|4|||
46840241|NCT00279812|83057492|FG004|Overall Study|Adverse Event|2|||
46840242|NCT00279812|83057493|FG005|Overall Study|Adverse Event|1|||
46840243|NCT00207714|83057512|FG000|Overall Study|Adverse Event|6|||
46840244|NCT00207714|83057513|FG001|Overall Study|Adverse Event|2|||
47064503|NCT01693562|83346631|FG016|Expansion Phase|Death|128|||
47064504|NCT01693562|83346632|FG017|Expansion Phase|Death|16|||
46770157|NCT00744978|82988550|FG001|Period 1|Adverse Event|0|||
46770158|NCT00744978|82988549|FG000|Period 1|Randomized but not Treated|1|||
46770159|NCT00744978|82988550|FG001|Period 1|Randomized but not Treated|1|||
46770160|NCT00744978|82988549|FG000|Period 2|Adverse Event|0|||
46770161|NCT00744978|82988550|FG001|Period 2|Adverse Event|1|||
47064505|NCT01693562|83346633|FG018|Expansion Phase|Death|36|||
47064506|NCT01693562|83346634|FG019|Expansion Phase|Death|16|||
47064507|NCT01693562|83346635|FG020|Expansion Phase|Death|17|||
47064508|NCT01693562|83346636|FG021|Expansion Phase|Death|35|||
46770162|NCT00739908|82988558|FG000|Overall Study|Adverse Event|5|||
46770163|NCT00739908|82988559|FG001|Overall Study|Adverse Event|6|||
46770164|NCT00739908|82988558|FG000|Overall Study|Withdrawal by Subject|4|||
46770165|NCT00739908|82988559|FG001|Overall Study|Withdrawal by Subject|2|||
46770166|NCT00739908|82988558|FG000|Overall Study|Lost to Follow-up|14|||
46770167|NCT00739908|82988559|FG001|Overall Study|Lost to Follow-up|9|||
46770168|NCT00739908|82988558|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
46770169|NCT00739908|82988559|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
46770170|NCT00739908|82988558|FG000|Overall Study|Non-Compliance With Study Medication|0|||
46770171|NCT00739908|82988559|FG001|Overall Study|Non-Compliance With Study Medication|3|||
46770172|NCT00739908|82988558|FG000|Overall Study|Lack of Efficacy|0|||
46770173|NCT00739908|82988559|FG001|Overall Study|Lack of Efficacy|1|||
46770174|NCT00739908|82988558|FG000|Overall Study|Relocation|0|||
46770175|NCT00739908|82988559|FG001|Overall Study|Relocation|1|||
46770176|NCT00739596|82988569|FG000|Overall Study|Adverse Event|12|||
46770177|NCT00739596|82988570|FG001|Overall Study|Adverse Event|6|||
46840245|NCT00207714|83057514|FG002|Overall Study|Adverse Event|4|||
46840246|NCT00207714|83057515|FG003|Overall Study|Adverse Event|3|||
46840247|NCT00207714|83057516|FG004|Overall Study|Adverse Event|1|||
46840248|NCT00207714|83057512|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
46840249|NCT00207714|83057513|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
46840250|NCT00207714|83057514|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
46770178|NCT00739596|82988569|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
46770179|NCT00739596|82988570|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46840251|NCT00207714|83057515|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
46840252|NCT00207714|83057516|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
47064509|NCT01693562|83346637|FG022|Expansion Phase|Death|7|||
47064510|NCT01693562|83346615|FG000|Expansion Phase|Lost to Follow-up|0|||
47064511|NCT01693562|83346616|FG001|Expansion Phase|Lost to Follow-up|0|||
46638700|NCT01434810|82812115|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
46770180|NCT00739596|82988569|FG000|Overall Study|Patient Withdrew Consent|8|||
46770181|NCT00739596|82988570|FG001|Overall Study|Patient Withdrew Consent|8|||
46770182|NCT00739596|82988569|FG000|Overall Study|Lost to Follow-up|0|||
46770183|NCT00739596|82988570|FG001|Overall Study|Lost to Follow-up|2|||
46770184|NCT00739596|82988569|FG000|Overall Study|Protocol Deviation|1|||
46770185|NCT00739596|82988570|FG001|Overall Study|Protocol Deviation|1|||
46770186|NCT00742326|82988578|FG000|Overall Study|Physician Decision|0|||
46770187|NCT00742326|82988579|FG001|Overall Study|Physician Decision|1|||
46840253|NCT00207714|83057512|FG000|Overall Study|Other|3|||
46840254|NCT00207714|83057513|FG001|Overall Study|Other|2|||
46840255|NCT00207714|83057514|FG002|Overall Study|Other|5|||
46840256|NCT00207714|83057515|FG003|Overall Study|Other|1|||
46840257|NCT00207714|83057516|FG004|Overall Study|Other|0|||
46840258|NCT00207090|83057535|FG000|Overall Study|Study drug toxicity|3|||
46840259|NCT00207090|83057535|FG000|Overall Study|Chest wall mass larger|1|||
46840260|NCT00207090|83057535|FG000|Overall Study|Disease progression/relapse|2|||
46840261|NCT00207090|83057535|FG000|Overall Study|Physician Decision|1|||
46840262|NCT00059332|83057546|FG000|Overall Study|Withdrawal by Subject|2|||
46840263|NCT00059332|83057547|FG001|Overall Study|Withdrawal by Subject|1|||
46840264|NCT00059332|83057546|FG000|Overall Study|Lost to Follow-up|1|||
46840265|NCT00059332|83057547|FG001|Overall Study|Lost to Follow-up|1|||
46946126|NCT03926611|83184293|FG001|Overall Study|Protocol Violation|0|||
46946127|NCT03926611|83184294|FG002|Overall Study|Protocol Violation|0|||
46840266|NCT00233454|83057553|FG000|Overall Study|Death|6|||
46840267|NCT00047320|83057557|FG000|Overall Study|Lack of Efficacy|8|||
46946128|NCT03926611|83184295|FG003|Overall Study|Protocol Violation|1|||
46946129|NCT03926611|83184296|FG004|Overall Study|Protocol Violation|1|||
46946130|NCT03926611|83184297|FG005|Overall Study|Protocol Violation|1|||
46946131|NCT03926611|83184298|FG006|Overall Study|Protocol Violation|1|||
46946132|NCT03926611|83184292|FG000|Overall Study|Technical problems|0|||
46946133|NCT03926611|83184293|FG001|Overall Study|Technical problems|0|||
46946134|NCT03926611|83184294|FG002|Overall Study|Technical problems|0|||
46946135|NCT03926611|83184295|FG003|Overall Study|Technical problems|0|||
46946136|NCT03926611|83184296|FG004|Overall Study|Technical problems|0|||
46946137|NCT03926611|83184297|FG005|Overall Study|Technical problems|1|||
46946138|NCT03926611|83184298|FG006|Overall Study|Technical problems|0|||
46638701|NCT01393626|82812125|FG000|Overall Study|Adverse Event|2|||
46840268|NCT00047320|83057557|FG000|Overall Study|Lost to Follow-up|1|||
46840269|NCT00047320|83057557|FG000|Overall Study|Physician Decision|8|||
46840270|NCT00047320|83057557|FG000|Overall Study|Withdrawal by Subject|9|||
46840271|NCT00047320|83057557|FG000|Overall Study|Ineligible|2|||
46946139|NCT03926611|83184292|FG000|Overall Study|Withdrawal by Subject|1|||
46946140|NCT03926611|83184293|FG001|Overall Study|Withdrawal by Subject|1|||
46946141|NCT03926611|83184294|FG002|Overall Study|Withdrawal by Subject|1|||
47064512|NCT01693562|83346617|FG002|Expansion Phase|Lost to Follow-up|0|||
47064513|NCT01693562|83346618|FG003|Expansion Phase|Lost to Follow-up|0|||
47064514|NCT01693562|83346619|FG004|Expansion Phase|Lost to Follow-up|0|||
47064515|NCT01693562|83346620|FG005|Expansion Phase|Lost to Follow-up|0|||
47064516|NCT01693562|83346621|FG006|Expansion Phase|Lost to Follow-up|0|||
47064517|NCT01693562|83346622|FG007|Expansion Phase|Lost to Follow-up|1|||
47064518|NCT01693562|83346623|FG008|Expansion Phase|Lost to Follow-up|2|||
46638702|NCT01393626|82812126|FG001|Overall Study|Adverse Event|1|||
46638703|NCT01393626|82812127|FG002|Overall Study|Adverse Event|5|||
46638704|NCT01393626|82812128|FG003|Overall Study|Adverse Event|0|||
46638705|NCT01393626|82812125|FG000|Overall Study|Did not meet entrance criteria|1|||
46638706|NCT01393626|82812126|FG001|Overall Study|Did not meet entrance criteria|0|||
46638707|NCT01393626|82812127|FG002|Overall Study|Did not meet entrance criteria|0|||
46638708|NCT01393626|82812128|FG003|Overall Study|Did not meet entrance criteria|0|||
46638709|NCT01393626|82812125|FG000|Overall Study|Lack of Efficacy|6|||
46638710|NCT01393626|82812126|FG001|Overall Study|Lack of Efficacy|6|||
46638711|NCT01393626|82812127|FG002|Overall Study|Lack of Efficacy|4|||
46638712|NCT01393626|82812128|FG003|Overall Study|Lack of Efficacy|1|||
46638713|NCT01393626|82812125|FG000|Overall Study|Lost to Follow-up|1|||
46638714|NCT01393626|82812126|FG001|Overall Study|Lost to Follow-up|1|||
46638715|NCT01393626|82812127|FG002|Overall Study|Lost to Follow-up|1|||
46638716|NCT01393626|82812128|FG003|Overall Study|Lost to Follow-up|0|||
46638717|NCT01393626|82812125|FG000|Overall Study|Withdrawal by Subject|6|||
46638718|NCT01393626|82812126|FG001|Overall Study|Withdrawal by Subject|4|||
46638719|NCT01393626|82812127|FG002|Overall Study|Withdrawal by Subject|0|||
46638720|NCT01393626|82812128|FG003|Overall Study|Withdrawal by Subject|0|||
46638721|NCT01393626|82812125|FG000|Overall Study|Other|1|||
46638722|NCT01393626|82812126|FG001|Overall Study|Other|0|||
46638723|NCT01393626|82812127|FG002|Overall Study|Other|0|||
46638724|NCT01393626|82812128|FG003|Overall Study|Other|0|||
46638725|NCT01393626|82812125|FG000|Overall Study|Protocol Violation|1|||
47064519|NCT01693562|83346624|FG009|Expansion Phase|Lost to Follow-up|10|||
47064520|NCT01693562|83346625|FG010|Expansion Phase|Lost to Follow-up|4|||
47064521|NCT01693562|83346626|FG011|Expansion Phase|Lost to Follow-up|4|||
47064522|NCT01693562|83346627|FG012|Expansion Phase|Lost to Follow-up|1|||
47064523|NCT01693562|83346628|FG013|Expansion Phase|Lost to Follow-up|3|||
47064524|NCT01693562|83346629|FG014|Expansion Phase|Lost to Follow-up|0|||
47064525|NCT01693562|83346630|FG015|Expansion Phase|Lost to Follow-up|1|||
47064526|NCT01693562|83346631|FG016|Expansion Phase|Lost to Follow-up|1|||
47064527|NCT01693562|83346632|FG017|Expansion Phase|Lost to Follow-up|0|||
47064528|NCT01693562|83346633|FG018|Expansion Phase|Lost to Follow-up|2|||
47064529|NCT01693562|83346634|FG019|Expansion Phase|Lost to Follow-up|1|||
47064530|NCT01693562|83346635|FG020|Expansion Phase|Lost to Follow-up|2|||
47064531|NCT01693562|83346636|FG021|Expansion Phase|Lost to Follow-up|2|||
47064532|NCT01693562|83346637|FG022|Expansion Phase|Lost to Follow-up|1|||
47064533|NCT01693562|83346615|FG000|Expansion Phase|Other|0|||
47064534|NCT01693562|83346616|FG001|Expansion Phase|Other|0|||
47064535|NCT01693562|83346617|FG002|Expansion Phase|Other|0|||
47064536|NCT01693562|83346618|FG003|Expansion Phase|Other|0|||
47064537|NCT01693562|83346619|FG004|Expansion Phase|Other|0|||
47064538|NCT01693562|83346620|FG005|Expansion Phase|Other|0|||
47064539|NCT01693562|83346621|FG006|Expansion Phase|Other|0|||
47064540|NCT01693562|83346622|FG007|Expansion Phase|Other|3|||
47064541|NCT01693562|83346623|FG008|Expansion Phase|Other|1|||
47064542|NCT01693562|83346624|FG009|Expansion Phase|Other|28|||
47064543|NCT01693562|83346625|FG010|Expansion Phase|Other|4|||
47064544|NCT01693562|83346626|FG011|Expansion Phase|Other|7|||
47064545|NCT01693562|83346627|FG012|Expansion Phase|Other|0|||
47064546|NCT01693562|83346628|FG013|Expansion Phase|Other|1|||
47064547|NCT01693562|83346629|FG014|Expansion Phase|Other|1|||
47064548|NCT01693562|83346630|FG015|Expansion Phase|Other|0|||
47064549|NCT01693562|83346631|FG016|Expansion Phase|Other|28|||
46770188|NCT00741936|82988587|FG000|Overall Study|Lost to Follow-up|1|||
46770189|NCT00741936|82988588|FG001|Overall Study|Lost to Follow-up|1|||
46770190|NCT00741936|82988587|FG000|Overall Study|Adverse Event|3|||
46638726|NCT01393626|82812126|FG001|Overall Study|Protocol Violation|0|||
47064550|NCT01693562|83346632|FG017|Expansion Phase|Other|0|||
47064551|NCT01693562|83346633|FG018|Expansion Phase|Other|1|||
47064552|NCT01693562|83346634|FG019|Expansion Phase|Other|0|||
46638727|NCT01393626|82812127|FG002|Overall Study|Protocol Violation|2|||
46638728|NCT01393626|82812128|FG003|Overall Study|Protocol Violation|0|||
46638729|NCT01434654|82812147|FG000|Overall Study|Withdrawal by Subject|1|||
46638730|NCT01434654|82812148|FG001|Overall Study|Withdrawal by Subject|0|||
46770191|NCT00741936|82988588|FG001|Overall Study|Adverse Event|4|||
46770192|NCT00741936|82988587|FG000|Overall Study|Pregnancy|0|||
47064553|NCT01693562|83346635|FG020|Expansion Phase|Other|1|||
47064554|NCT01693562|83346636|FG021|Expansion Phase|Other|17|||
47064555|NCT01693562|83346637|FG022|Expansion Phase|Other|1|||
47064556|NCT01467713|83346734|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
47064557|NCT01467713|83346735|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
47064558|NCT01467713|83346736|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
47064559|NCT01467713|83346737|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
46770193|NCT00741936|82988588|FG001|Overall Study|Pregnancy|1|||
46638731|NCT01434654|82812147|FG000|Overall Study|Lost to Follow-up|1|||
46638732|NCT01434654|82812148|FG001|Overall Study|Lost to Follow-up|0|||
46638733|NCT01393158|82812158|FG000|Overall Study|Adverse Event|1|||
46638734|NCT01393158|82812159|FG001|Overall Study|Adverse Event|0|||
46638735|NCT01413360|82812171|FG000|Overall Study|Lost to Follow-up|2|||
46638736|NCT01413360|82812171|FG000|Overall Study|Adverse Event|1|||
46638737|NCT01413204|82812178|FG000|Overall Study|Adverse Event|1|||
46638738|NCT01413204|82812179|FG001|Overall Study|Adverse Event|2|||
46638739|NCT01413204|82812180|FG002|Overall Study|Adverse Event|2|||
46638740|NCT01413204|82812178|FG000|Overall Study|Physician Decision|3|||
46638741|NCT01413204|82812179|FG001|Overall Study|Physician Decision|0|||
46638742|NCT01413204|82812180|FG002|Overall Study|Physician Decision|2|||
46638743|NCT01413204|82812178|FG000|Overall Study|Withdrawal by Subject|1|||
46770194|NCT00741936|82988587|FG000|Overall Study|Protocol Violation|2|||
46770195|NCT00741936|82988588|FG001|Overall Study|Protocol Violation|0|||
46770196|NCT00741936|82988587|FG000|Overall Study|Lack of Efficacy|0|||
46770197|NCT00741936|82988588|FG001|Overall Study|Lack of Efficacy|2|||
46770198|NCT00741936|82988587|FG000|Overall Study|Low compliance|3|||
46770199|NCT00741936|82988588|FG001|Overall Study|Low compliance|0|||
46770200|NCT00811187|82988596|FG000|Overall Study|Unable to place device / procedure abort|3|||
46770201|NCT00811187|82988597|FG001|Overall Study|Unable to place device / procedure abort|3|||
46770202|NCT00591149|82988603|FG000|Overall Study|Adverse Event|4|||
46770203|NCT00591149|82988603|FG000|Overall Study|Withdrawal by Subject|1|||
46770204|NCT00735072|82988609|FG000|Overall Study|interrupted study med during ARV change|1|||
46770205|NCT00735072|82988610|FG001|Overall Study|interrupted study med during ARV change|0|||
46770206|NCT00735072|82988609|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
46770207|NCT00735072|82988610|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
46770208|NCT00810641|82988621|FG000|Overall Study|Withdrawal by Subject|0|||
46770209|NCT00810641|82988622|FG001|Overall Study|Withdrawal by Subject|1|||
46770210|NCT00810641|82988623|FG002|Overall Study|Withdrawal by Subject|2|||
46770211|NCT00793598|82988636|FG000|Overall Study|Patient Request|0|||
46770212|NCT00793598|82988637|FG001|Overall Study|Patient Request|1|||
46770213|NCT00793598|82988638|FG002|Overall Study|Patient Request|0|||
46770214|NCT00793598|82988639|FG003|Overall Study|Patient Request|0|||
46770215|NCT00793598|82988640|FG004|Overall Study|Patient Request|0|||
46770216|NCT00793598|82988641|FG005|Overall Study|Patient Request|0|||
46770217|NCT00793598|82988642|FG006|Overall Study|Patient Request|0|||
46770218|NCT00793598|82988643|FG007|Overall Study|Patient Request|0|||
46770219|NCT00793598|82988636|FG000|Overall Study|Protocol Violation|0|||
46770220|NCT00793598|82988637|FG001|Overall Study|Protocol Violation|0|||
46770221|NCT00793598|82988638|FG002|Overall Study|Protocol Violation|0|||
46770222|NCT00793598|82988639|FG003|Overall Study|Protocol Violation|0|||
46770223|NCT00793598|82988640|FG004|Overall Study|Protocol Violation|0|||
46770224|NCT00793598|82988641|FG005|Overall Study|Protocol Violation|0|||
46770225|NCT00793598|82988642|FG006|Overall Study|Protocol Violation|0|||
46770226|NCT00793598|82988643|FG007|Overall Study|Protocol Violation|1|||
46770227|NCT00793598|82988636|FG000|Overall Study|Subject not dosed|0|||
46770228|NCT00793598|82988637|FG001|Overall Study|Subject not dosed|0|||
46770229|NCT00793598|82988638|FG002|Overall Study|Subject not dosed|0|||
46770230|NCT00793598|82988639|FG003|Overall Study|Subject not dosed|0|||
46770231|NCT00793598|82988640|FG004|Overall Study|Subject not dosed|0|||
46770232|NCT00793598|82988641|FG005|Overall Study|Subject not dosed|1|||
46770233|NCT00793598|82988642|FG006|Overall Study|Subject not dosed|0|||
46770234|NCT00793598|82988643|FG007|Overall Study|Subject not dosed|0|||
46770235|NCT00796562|82988665|FG000|Overall Study|Death|49|||
46770236|NCT00801632|82988669|FG000|Overall Study|Re-transplant|1|||
46770237|NCT00806819|82988675|FG000|Overall Study|progressive disease (modified RECIST )|217|||
46770238|NCT00806819|82988676|FG001|Overall Study|progressive disease (modified RECIST )|216|||
46770239|NCT00806819|82988675|FG000|Overall Study|Worsening or AE of underlying disease|18|||
46770240|NCT00806819|82988676|FG001|Overall Study|Worsening or AE of underlying disease|25|||
46770241|NCT00806819|82988675|FG000|Overall Study|Other AE|38|||
46638744|NCT01413204|82812179|FG001|Overall Study|Withdrawal by Subject|4|||
46638745|NCT01413204|82812180|FG002|Overall Study|Withdrawal by Subject|4|||
46638746|NCT01413204|82812178|FG000|Overall Study|Clearly not eligible for the study|0|||
46638747|NCT01413204|82812179|FG001|Overall Study|Clearly not eligible for the study|0|||
46638748|NCT01413204|82812180|FG002|Overall Study|Clearly not eligible for the study|1|||
46638749|NCT01413204|82812178|FG000|Overall Study|Fasting plasma glucose level increased|1|||
46770242|NCT00806819|82988676|FG001|Overall Study|Other AE|40|||
46770243|NCT00806819|82988675|FG000|Overall Study|Protocol Violation|9|||
46770244|NCT00806819|82988676|FG001|Overall Study|Protocol Violation|4|||
46770245|NCT00806819|82988675|FG000|Overall Study|Lost to Follow-up|1|||
46967866|NCT05091307|83210485|FG002|Overall Study|Lost to Follow-up|2|||
46770246|NCT00806819|82988676|FG001|Overall Study|Lost to Follow-up|0|||
46770247|NCT00806819|82988675|FG000|Overall Study|Withdrawal by Subject|32|||
46770248|NCT00806819|82988676|FG001|Overall Study|Withdrawal by Subject|29|||
46770249|NCT00806819|82988675|FG000|Overall Study|Not treated|6|||
46770250|NCT00806819|82988676|FG001|Overall Study|Not treated|3|||
47064560|NCT01467713|83346734|FG000|Overall Study|Major Protocol Deviation|2|||
47064561|NCT01467713|83346735|FG001|Overall Study|Major Protocol Deviation|4|||
47064562|NCT01467713|83346736|FG002|Overall Study|Major Protocol Deviation|4|||
47064563|NCT01467713|83346737|FG003|Overall Study|Major Protocol Deviation|1|||
47064564|NCT01467713|83346734|FG000|Overall Study|Lost to Follow-up|9|||
47064565|NCT01467713|83346735|FG001|Overall Study|Lost to Follow-up|12|||
47064566|NCT01467713|83346736|FG002|Overall Study|Lost to Follow-up|6|||
46638750|NCT01413204|82812179|FG001|Overall Study|Fasting plasma glucose level increased|0|||
46638751|NCT01413204|82812180|FG002|Overall Study|Fasting plasma glucose level increased|10|||
46638752|NCT01392378|82812193|FG000|Infant Series|Adverse Event|0|||
46770251|NCT00806819|82988675|FG000|Overall Study|Reasons other than stated above|25|||
46770252|NCT00806819|82988676|FG001|Overall Study|Reasons other than stated above|41|||
46770253|NCT00801242|82988683|FG000|Overall Study|Adverse Event|10|||
47064567|NCT01467713|83346737|FG003|Overall Study|Lost to Follow-up|9|||
47064568|NCT01467713|83346734|FG000|Overall Study|Voluntary Withdrawal|18|||
47064569|NCT01467713|83346735|FG001|Overall Study|Voluntary Withdrawal|14|||
47064570|NCT01467713|83346736|FG002|Overall Study|Voluntary Withdrawal|21|||
47064571|NCT01467713|83346737|FG003|Overall Study|Voluntary Withdrawal|20|||
47064572|NCT01467713|83346734|FG000|Overall Study|Study Termination|23|||
47064573|NCT01467713|83346735|FG001|Overall Study|Study Termination|33|||
47064574|NCT01467713|83346736|FG002|Overall Study|Study Termination|28|||
47064575|NCT01467713|83346737|FG003|Overall Study|Study Termination|29|||
47064576|NCT01467713|83346734|FG000|Overall Study|Pregnancy|0|||
47064577|NCT01467713|83346735|FG001|Overall Study|Pregnancy|1|||
46770254|NCT00801242|82988683|FG000|Overall Study|Withdrawal by Subject|13|||
46840272|NCT00233064|83057563|FG000|Overall Study|Lost to Follow-up|7|||
46840273|NCT00233064|83057564|FG001|Overall Study|Lost to Follow-up|7|||
46840274|NCT00233064|83057563|FG000|Overall Study|Withdrawal by Subject|5|||
46840275|NCT00233064|83057564|FG001|Overall Study|Withdrawal by Subject|3|||
46840276|NCT00233064|83057563|FG000|Overall Study|Death|0|||
46840277|NCT00233064|83057564|FG001|Overall Study|Death|1|||
46840278|NCT00233064|83057563|FG000|Overall Study|Relocation|0|||
46840279|NCT00233064|83057564|FG001|Overall Study|Relocation|1|||
46840280|NCT00233064|83057563|FG000|Overall Study|Protocol Violation|1|||
46840281|NCT00233064|83057564|FG001|Overall Study|Protocol Violation|0|||
46840282|NCT00233064|83057563|FG000|Overall Study|Moved to Dom. Republic|1|||
46840283|NCT00233064|83057564|FG001|Overall Study|Moved to Dom. Republic|0|||
46840284|NCT00268892|83057574|FG000|Overall Study|Adverse Event|14|||
46840285|NCT00268892|83057575|FG001|Overall Study|Adverse Event|17|||
46840286|NCT00268892|83057576|FG002|Overall Study|Adverse Event|20|||
46840287|NCT00268892|83057574|FG000|Overall Study|Lack of Efficacy|1|||
46840288|NCT00268892|83057575|FG001|Overall Study|Lack of Efficacy|3|||
46840289|NCT00268892|83057576|FG002|Overall Study|Lack of Efficacy|0|||
46840290|NCT00268892|83057574|FG000|Overall Study|Withdrawal by Subject|14|||
47064578|NCT01467713|83346736|FG002|Overall Study|Pregnancy|1|||
47064579|NCT01467713|83346737|FG003|Overall Study|Pregnancy|3|||
47064580|NCT01467713|83346734|FG000|Overall Study|Relapse|35|||
47064581|NCT01467713|83346735|FG001|Overall Study|Relapse|25|||
47064582|NCT01467713|83346736|FG002|Overall Study|Relapse|28|||
47064583|NCT01467713|83346737|FG003|Overall Study|Relapse|35|||
47064584|NCT01467713|83346734|FG000|Overall Study|Reason not Specified|6|||
47064585|NCT01467713|83346735|FG001|Overall Study|Reason not Specified|11|||
47064586|NCT01467713|83346736|FG002|Overall Study|Reason not Specified|8|||
47064587|NCT01467713|83346737|FG003|Overall Study|Reason not Specified|7|||
47064588|NCT01693250|83346767|FG000|Overall Study|Lost to Follow-up|2|||
46770255|NCT00801242|82988683|FG000|Overall Study|Protocol Violation|5|||
46770256|NCT00801242|82988683|FG000|Overall Study|Physician Decision|3|||
46770257|NCT00801242|82988683|FG000|Overall Study|Lost to Follow-up|1|||
46770258|NCT00801242|82988683|FG000|Overall Study|Miscellaneous reasons|20|||
46840291|NCT00268892|83057575|FG001|Overall Study|Withdrawal by Subject|15|||
46840292|NCT00268892|83057576|FG002|Overall Study|Withdrawal by Subject|13|||
46840293|NCT00268892|83057574|FG000|Overall Study|Physician Decision|0|||
46840294|NCT00268892|83057575|FG001|Overall Study|Physician Decision|1|||
46840295|NCT00268892|83057576|FG002|Overall Study|Physician Decision|0|||
46840296|NCT00268892|83057574|FG000|Overall Study|Lost to Follow-up|5|||
46840297|NCT00268892|83057575|FG001|Overall Study|Lost to Follow-up|2|||
46840298|NCT00268892|83057576|FG002|Overall Study|Lost to Follow-up|4|||
46840299|NCT00268892|83057574|FG000|Overall Study|Protocol Violation|0|||
46840300|NCT00268892|83057575|FG001|Overall Study|Protocol Violation|1|||
47064589|NCT01693250|83346768|FG001|Overall Study|Lost to Follow-up|2|||
47064590|NCT01590758|83346791|FG000|Overall Study|Withdrawal by Subject|0|||
47064591|NCT01590758|83346792|FG001|Overall Study|Withdrawal by Subject|3|||
47064592|NCT01590758|83346791|FG000|Overall Study|Physician Decision|1|||
47064593|NCT01590758|83346792|FG001|Overall Study|Physician Decision|2|||
47064594|NCT01590758|83346791|FG000|Overall Study|Lost to Follow-up|4|||
47064595|NCT01590758|83346792|FG001|Overall Study|Lost to Follow-up|2|||
46770259|NCT00800540|82988696|FG000|Period One: 6 Weeks|Noncompliance|1|||
46840301|NCT00268892|83057576|FG002|Overall Study|Protocol Violation|0|||
46840302|NCT00268892|83057574|FG000|Overall Study|Disease Progression|1|||
46638753|NCT01392378|82812194|FG001|Infant Series|Adverse Event|0|||
46638754|NCT01392378|82812195|FG002|Infant Series|Adverse Event|0|||
46638755|NCT01392378|82812196|FG003|Infant Series|Adverse Event|1|||
46840303|NCT00268892|83057575|FG001|Overall Study|Disease Progression|1|||
47064596|NCT01590212|83346801|FG000|Overall Study|Withdrawal by Subject|2|||
47064597|NCT01590212|83346802|FG001|Overall Study|Withdrawal by Subject|2|||
47064598|NCT01590212|83346803|FG002|Overall Study|Withdrawal by Subject|2|||
47064599|NCT01590212|83346801|FG000|Overall Study|Lost to Follow-up|1|||
47064600|NCT01590212|83346802|FG001|Overall Study|Lost to Follow-up|2|||
47064601|NCT01590212|83346803|FG002|Overall Study|Lost to Follow-up|3|||
47064602|NCT01692938|83346814|FG000|Overall Study|Protocol Deviation|1|||
47064603|NCT01692938|83346815|FG001|Overall Study|Protocol Deviation|1|||
47064604|NCT01692938|83346814|FG000|Overall Study|Study completed prior to site completion|3|||
47064605|NCT01692938|83346815|FG001|Overall Study|Study completed prior to site completion|3|||
47064606|NCT01692782|83346828|FG000|Overall Study|Adverse Event|12|||
47064607|NCT01692782|83346829|FG001|Overall Study|Adverse Event|32|||
47064608|NCT01692782|83346830|FG002|Overall Study|Adverse Event|2|||
47064609|NCT01692782|83346828|FG000|Overall Study|Lack of Efficacy|1|||
47064610|NCT01692782|83346829|FG001|Overall Study|Lack of Efficacy|2|||
47064611|NCT01692782|83346830|FG002|Overall Study|Lack of Efficacy|0|||
47064612|NCT01692782|83346828|FG000|Overall Study|Lost to Follow-up|2|||
47064613|NCT01692782|83346829|FG001|Overall Study|Lost to Follow-up|7|||
47064614|NCT01692782|83346830|FG002|Overall Study|Lost to Follow-up|1|||
47064615|NCT01692782|83346828|FG000|Overall Study|Pregnancy|1|||
47064616|NCT01692782|83346829|FG001|Overall Study|Pregnancy|0|||
47064617|NCT01692782|83346830|FG002|Overall Study|Pregnancy|0|||
47064618|NCT01692782|83346828|FG000|Overall Study|Protocol Violation|1|||
47064619|NCT01692782|83346829|FG001|Overall Study|Protocol Violation|0|||
46638756|NCT01392378|82812197|FG004|Infant Series|Adverse Event|0|||
46770260|NCT00800540|82988697|FG001|Period One: 6 Weeks|Noncompliance|0|||
46770261|NCT00800540|82988696|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
46770262|NCT00800540|82988697|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
46770263|NCT00800540|82988696|FG000|Period 2: 6 Weeks|Adverse Event|0|||
46840304|NCT00268892|83057576|FG002|Overall Study|Disease Progression|0|||
46840305|NCT00268892|83057574|FG000|Overall Study|Trial Site Closed|4|||
46840306|NCT00268892|83057575|FG001|Overall Study|Trial Site Closed|2|||
46840307|NCT00268892|83057576|FG002|Overall Study|Trial Site Closed|2|||
46840308|NCT00206076|83057586|FG000|Overall Study|Physician Decision|2|||
46840309|NCT00206076|83057587|FG001|Overall Study|Physician Decision|0|||
46840310|NCT00206076|83057586|FG000|Overall Study|Withdrawal by Subject|1|||
46840311|NCT00206076|83057587|FG001|Overall Study|Withdrawal by Subject|1|||
46840312|NCT00278954|83057595|FG000|Overall Study|Adverse Event|3|||
46840313|NCT00278954|83057595|FG000|Overall Study|Lost to Follow-up|1|||
46946142|NCT03926611|83184295|FG003|Overall Study|Withdrawal by Subject|0|||
46946143|NCT03926611|83184296|FG004|Overall Study|Withdrawal by Subject|0|||
46946144|NCT03926611|83184297|FG005|Overall Study|Withdrawal by Subject|1|||
46946145|NCT03926611|83184298|FG006|Overall Study|Withdrawal by Subject|3|||
46946146|NCT03926611|83184292|FG000|Overall Study|Covid-19 pandemic|0|||
46946147|NCT03926611|83184293|FG001|Overall Study|Covid-19 pandemic|0|||
46946148|NCT03926611|83184294|FG002|Overall Study|Covid-19 pandemic|1|||
46946149|NCT03926611|83184295|FG003|Overall Study|Covid-19 pandemic|0|||
46770264|NCT00800540|82988697|FG001|Period 2: 6 Weeks|Adverse Event|1|||
46770265|NCT00800384|82988705|FG000|Overall Study|Withdrawal by Subject|24|||
46770266|NCT00800384|82988706|FG001|Overall Study|Withdrawal by Subject|17|||
46770267|NCT00800384|82988705|FG000|Overall Study|Lost to Follow-up|17|||
46770268|NCT00800384|82988706|FG001|Overall Study|Lost to Follow-up|26|||
46770269|NCT00796328|82988713|FG000|Overall Study|experienced hypotension requiring tx|6|||
46770270|NCT00588692|82988719|FG000|Overall Study|Withdrawal by Subject|4|||
46770271|NCT00588692|82988720|FG001|Overall Study|Withdrawal by Subject|2|||
46840314|NCT00278954|83057595|FG000|Overall Study|Withdrawal by Subject|1|||
46840315|NCT00278564|83057599|FG000|Overall Study|Lack of Efficacy|4|||
46840316|NCT00268346|83057605|FG000|Overall Study|Adverse Event|0|||
46946150|NCT03926611|83184296|FG004|Overall Study|Covid-19 pandemic|1|||
47064620|NCT01692782|83346830|FG002|Overall Study|Protocol Violation|2|||
47064621|NCT01692782|83346828|FG000|Overall Study|Non-complance with study drug|0|||
47064622|NCT01692782|83346829|FG001|Overall Study|Non-complance with study drug|4|||
46638757|NCT01392378|82812193|FG000|Infant Series|Lost to Follow-up|0|||
46946151|NCT03926611|83184297|FG005|Overall Study|Covid-19 pandemic|2|||
46638758|NCT01392378|82812194|FG001|Infant Series|Lost to Follow-up|0|||
46638759|NCT01392378|82812195|FG002|Infant Series|Lost to Follow-up|0|||
46770272|NCT00588692|82988719|FG000|Overall Study|Hip Surgery|0|||
46770273|NCT00588692|82988720|FG001|Overall Study|Hip Surgery|1|||
47064623|NCT01692782|83346830|FG002|Overall Study|Non-complance with study drug|1|||
47064624|NCT01692782|83346828|FG000|Overall Study|Non-compliant with study visits|0|||
46770274|NCT00588692|82988719|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
46840317|NCT00268346|83057606|FG001|Overall Study|Adverse Event|1|||
46840318|NCT00268346|83057605|FG000|Overall Study|Death|0|||
46840319|NCT00268346|83057606|FG001|Overall Study|Death|1|||
46946152|NCT03926611|83184298|FG006|Overall Study|Covid-19 pandemic|0|||
47064625|NCT01692782|83346829|FG001|Overall Study|Non-compliant with study visits|0|||
47064626|NCT01692782|83346830|FG002|Overall Study|Non-compliant with study visits|1|||
47064627|NCT01692782|83346828|FG000|Overall Study|SAE not related to study drug|0|||
47064628|NCT01692782|83346829|FG001|Overall Study|SAE not related to study drug|1|||
46770275|NCT00588692|82988720|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
46946153|NCT02818777|83184327|FG000|Overall Study|Adverse Event|3|||
46946154|NCT02817841|83184341|FG000|Overall Study|Lost to Follow-up|287|||
46946155|NCT02817841|83184341|FG000|Overall Study|Withdrawal by Subject|183|||
46946156|NCT02817841|83184341|FG000|Overall Study|Adverse event not related to bleeding|131|||
46946157|NCT02817841|83184341|FG000|Overall Study|Adverse event related to bleeding|51|||
46946158|NCT02817841|83184341|FG000|Overall Study|Pregnancy|32|||
46946159|NCT02817841|83184341|FG000|Overall Study|Pregnancy wish|17|||
46946160|NCT02817841|83184341|FG000|Overall Study|Other reasons|53|||
46946161|NCT02817841|83184341|FG000|Overall Study|Protocol Violation|94|||
46946162|NCT02814565|83184351|FG000|Overall Study|Lack of Efficacy|0|||
46946163|NCT02814565|83184352|FG001|Overall Study|Lack of Efficacy|1|||
46946164|NCT02814565|83184351|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
46946165|NCT02814565|83184352|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
46946166|NCT02650466|83184358|FG000|Overall Study|Physician Decision|1|||
46946167|NCT02650466|83184358|FG000|Overall Study|Withdrawal by Subject|5|||
46946168|NCT02650466|83184358|FG000|Overall Study|Lost to Follow-up|1|||
46946169|NCT02815735|83184364|FG000|First Intervention (4 Weeks)|Discomfort|1|||
46946170|NCT02815735|83184365|FG001|First Intervention (4 Weeks)|Discomfort|0|||
46946171|NCT02815735|83184364|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
46946172|NCT02815735|83184365|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
46946173|NCT02815735|83184364|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
46946174|NCT02815735|83184365|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
46946175|NCT02815735|83184364|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
46946176|NCT02815735|83184365|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
46946177|NCT02814643|83184382|FG000|Overall Study|Lost to Follow-up|0|||
46946178|NCT02814643|83184383|FG001|Overall Study|Lost to Follow-up|1|||
46946179|NCT02814643|83184382|FG000|Overall Study|Withdrawal by Subject|1|||
46946180|NCT02814643|83184383|FG001|Overall Study|Withdrawal by Subject|2|||
46946181|NCT02724111|83184391|FG000|Overall Study|Protocol Violation|2|||
46946182|NCT02724111|83184392|FG001|Overall Study|Protocol Violation|5|||
46946183|NCT02649218|83184398|FG000|Overall Study|Adverse Event|8|||
46946184|NCT02649218|83184398|FG000|Overall Study|Lack of Efficacy|8|||
46946185|NCT02649218|83184398|FG000|Overall Study|Pregnancy|3|||
46946186|NCT02649218|83184398|FG000|Overall Study|Protocol Violation|3|||
46946187|NCT02649218|83184398|FG000|Overall Study|Physician Decision|1|||
46946188|NCT02649218|83184398|FG000|Overall Study|Withdrawal by Subject|2|||
46946189|NCT02814175|83184405|FG000|Part 1|Adverse Event|2|||
46946190|NCT02814175|83184406|FG001|Part 1|Adverse Event|3|||
46946191|NCT02814175|83184407|FG002|Part 1|Adverse Event|0|||
46946192|NCT02814175|83184408|FG003|Part 1|Adverse Event|0|||
46946193|NCT02814175|83184409|FG004|Part 1|Adverse Event|0|||
46946194|NCT02814175|83184410|FG005|Part 1|Adverse Event|0|||
46946195|NCT02814175|83184405|FG000|Part 1|Withdrawal Consent|8|||
46770276|NCT00588692|82988719|FG000|Overall Study|Cancer|1|||
46770277|NCT00588692|82988720|FG001|Overall Study|Cancer|0|||
46770278|NCT00588692|82988719|FG000|Overall Study|Death|1|||
46770279|NCT00588692|82988720|FG001|Overall Study|Death|0|||
46770280|NCT00588146|82988728|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
46770281|NCT00588146|82988729|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
46770282|NCT00795704|82988737|FG000|Overall Study|Withdrawal by Subject|3|||
46770283|NCT00795704|82988738|FG001|Overall Study|Withdrawal by Subject|2|||
46770284|NCT00795704|82988737|FG000|Overall Study|Adverse Event|1|||
47064629|NCT01692782|83346830|FG002|Overall Study|SAE not related to study drug|0|||
47064630|NCT01692782|83346828|FG000|Overall Study|Withdrawal by Subject|3|||
47064631|NCT01692782|83346829|FG001|Overall Study|Withdrawal by Subject|10|||
47064632|NCT01692782|83346830|FG002|Overall Study|Withdrawal by Subject|3|||
46770285|NCT00795704|82988738|FG001|Overall Study|Adverse Event|1|||
46770286|NCT00444457|82988748|FG000|Infant Series|Other|0|||
46770287|NCT00444457|82988749|FG001|Infant Series|Other|1|||
46946196|NCT02814175|83184406|FG001|Part 1|Withdrawal Consent|1|||
46946197|NCT02814175|83184407|FG002|Part 1|Withdrawal Consent|0|||
46946198|NCT02814175|83184408|FG003|Part 1|Withdrawal Consent|0|||
46946199|NCT02814175|83184409|FG004|Part 1|Withdrawal Consent|0|||
47064633|NCT01692626|83346838|FG000|Overall Study|Death|0|||
46770288|NCT00444457|82988750|FG002|Infant Series|Other|0|||
46770289|NCT00444457|82988751|FG003|Infant Series|Other|0|||
46946200|NCT02814175|83184410|FG005|Part 1|Withdrawal Consent|0|||
46946201|NCT02814175|83184405|FG000|Part 1|Lost to Follow-up|1|||
46946202|NCT02814175|83184406|FG001|Part 1|Lost to Follow-up|0|||
46946203|NCT02814175|83184407|FG002|Part 1|Lost to Follow-up|0|||
46946204|NCT02814175|83184408|FG003|Part 1|Lost to Follow-up|0|||
46946205|NCT02814175|83184409|FG004|Part 1|Lost to Follow-up|0|||
46946206|NCT02814175|83184410|FG005|Part 1|Lost to Follow-up|0|||
46946207|NCT02814175|83184405|FG000|Part 1|Lack of Efficacy|1|||
47064634|NCT01692626|83346839|FG001|Overall Study|Death|1|||
47064635|NCT01692626|83346838|FG000|Overall Study|Adverse Event|2|||
47064636|NCT01692626|83346839|FG001|Overall Study|Adverse Event|3|||
47064637|NCT01692626|83346838|FG000|Overall Study|Protocol Violation|1|||
47064638|NCT01692626|83346839|FG001|Overall Study|Protocol Violation|2|||
47064639|NCT01692626|83346838|FG000|Overall Study|Withdrawal by Subject|1|||
47064640|NCT01692626|83346839|FG001|Overall Study|Withdrawal by Subject|0|||
47064641|NCT01475461|83346865|FG000|Run-in Period|Not meet eligibility criteria|16|||
47064642|NCT01475461|83346866|FG001|Run-in Period|Not meet eligibility criteria|0|||
47064643|NCT01475461|83346867|FG002|Run-in Period|Not meet eligibility criteria|0|||
47064644|NCT01475461|83346868|FG003|Run-in Period|Not meet eligibility criteria|0|||
47064645|NCT01475461|83346869|FG004|Run-in Period|Not meet eligibility criteria|0|||
47064646|NCT01475461|83346870|FG005|Run-in Period|Not meet eligibility criteria|0|||
47064647|NCT01475461|83346871|FG006|Run-in Period|Not meet eligibility criteria|0|||
47064648|NCT01475461|83346865|FG000|Run-in Period|Lost to Follow-up|7|||
47064649|NCT01475461|83346866|FG001|Run-in Period|Lost to Follow-up|0|||
47064650|NCT01475461|83346867|FG002|Run-in Period|Lost to Follow-up|0|||
46770290|NCT00444457|82988748|FG000|Infant Series|Parent or legal guardian request|18|||
46770291|NCT00444457|82988749|FG001|Infant Series|Parent or legal guardian request|29|||
46770292|NCT00444457|82988750|FG002|Infant Series|Parent or legal guardian request|34|||
46770293|NCT00444457|82988751|FG003|Infant Series|Parent or legal guardian request|14|||
46770294|NCT00444457|82988748|FG000|Infant Series|Lost to Follow-up|10|||
46770295|NCT00444457|82988749|FG001|Infant Series|Lost to Follow-up|11|||
46770296|NCT00444457|82988750|FG002|Infant Series|Lost to Follow-up|7|||
46770297|NCT00444457|82988751|FG003|Infant Series|Lost to Follow-up|6|||
46770298|NCT00444457|82988748|FG000|Infant Series|Protocol Violation|16|||
46770299|NCT00444457|82988749|FG001|Infant Series|Protocol Violation|8|||
47064651|NCT01475461|83346868|FG003|Run-in Period|Lost to Follow-up|0|||
47064652|NCT01475461|83346869|FG004|Run-in Period|Lost to Follow-up|0|||
47064653|NCT01475461|83346870|FG005|Run-in Period|Lost to Follow-up|0|||
47064654|NCT01475461|83346871|FG006|Run-in Period|Lost to Follow-up|0|||
47064655|NCT01475461|83346865|FG000|Run-in Period|Withdrawal by Subject|11|||
46770300|NCT00444457|82988750|FG002|Infant Series|Protocol Violation|6|||
46770301|NCT00444457|82988751|FG003|Infant Series|Protocol Violation|3|||
46770302|NCT00444457|82988748|FG000|Infant Series|Failed to return|5|||
46770303|NCT00444457|82988749|FG001|Infant Series|Failed to return|4|||
46770304|NCT00444457|82988750|FG002|Infant Series|Failed to return|4|||
46770305|NCT00444457|82988751|FG003|Infant Series|Failed to return|2|||
46770306|NCT00444457|82988748|FG000|Infant Series|Investigator request|4|||
46770307|NCT00444457|82988749|FG001|Infant Series|Investigator request|3|||
46770308|NCT00444457|82988750|FG002|Infant Series|Investigator request|3|||
46770309|NCT00444457|82988751|FG003|Infant Series|Investigator request|2|||
46770310|NCT00444457|82988748|FG000|Infant Series|Other|0|||
46770311|NCT00444457|82988749|FG001|Infant Series|Other|2|||
46770312|NCT00444457|82988750|FG002|Infant Series|Other|4|||
46770313|NCT00444457|82988751|FG003|Infant Series|Other|0|||
46770314|NCT00444457|82988748|FG000|Infant Series|Adverse Event|1|||
46770315|NCT00444457|82988749|FG001|Infant Series|Adverse Event|2|||
46770316|NCT00444457|82988750|FG002|Infant Series|Adverse Event|2|||
46770317|NCT00444457|82988751|FG003|Infant Series|Adverse Event|0|||
46770318|NCT00444457|82988748|FG000|Infant Series|Death|0|||
46770319|NCT00444457|82988749|FG001|Infant Series|Death|1|||
46770320|NCT00444457|82988750|FG002|Infant Series|Death|1|||
46770321|NCT00444457|82988751|FG003|Infant Series|Death|1|||
46770322|NCT00444457|82988748|FG000|After Infant Series|Other|0|||
46770323|NCT00444457|82988749|FG001|After Infant Series|Other|1|||
46770324|NCT00444457|82988750|FG002|After Infant Series|Other|1|||
46770325|NCT00444457|82988751|FG003|After Infant Series|Other|1|||
46770326|NCT00444457|82988748|FG000|After Infant Series|Parent or legal guardian request|4|||
46770327|NCT00444457|82988749|FG001|After Infant Series|Parent or legal guardian request|11|||
46770328|NCT00444457|82988750|FG002|After Infant Series|Parent or legal guardian request|6|||
46770329|NCT00444457|82988751|FG003|After Infant Series|Parent or legal guardian request|3|||
47064656|NCT01475461|83346866|FG001|Run-in Period|Withdrawal by Subject|0|||
46770330|NCT00444457|82988748|FG000|After Infant Series|Failed to return|7|||
46770331|NCT00444457|82988749|FG001|After Infant Series|Failed to return|6|||
46770332|NCT00444457|82988750|FG002|After Infant Series|Failed to return|5|||
46770333|NCT00444457|82988751|FG003|After Infant Series|Failed to return|1|||
46770334|NCT00444457|82988748|FG000|After Infant Series|Lost to Follow-up|5|||
46770335|NCT00444457|82988749|FG001|After Infant Series|Lost to Follow-up|5|||
47064657|NCT01475461|83346867|FG002|Run-in Period|Withdrawal by Subject|0|||
47064658|NCT01475461|83346868|FG003|Run-in Period|Withdrawal by Subject|0|||
47064659|NCT01475461|83346869|FG004|Run-in Period|Withdrawal by Subject|0|||
47064660|NCT01475461|83346870|FG005|Run-in Period|Withdrawal by Subject|0|||
46770336|NCT00444457|82988750|FG002|After Infant Series|Lost to Follow-up|5|||
46770337|NCT00444457|82988751|FG003|After Infant Series|Lost to Follow-up|2|||
46770338|NCT00444457|82988748|FG000|After Infant Series|Protocol Violation|2|||
46770339|NCT00444457|82988749|FG001|After Infant Series|Protocol Violation|4|||
46946208|NCT02814175|83184406|FG001|Part 1|Lack of Efficacy|2|||
46946209|NCT02814175|83184407|FG002|Part 1|Lack of Efficacy|0|||
46946210|NCT02814175|83184408|FG003|Part 1|Lack of Efficacy|0|||
46946211|NCT02814175|83184409|FG004|Part 1|Lack of Efficacy|0|||
46946212|NCT02814175|83184410|FG005|Part 1|Lack of Efficacy|0|||
46946213|NCT02814175|83184405|FG000|Part 2|Adverse Event|0|||
46946214|NCT02814175|83184406|FG001|Part 2|Adverse Event|0|||
46946215|NCT02814175|83184407|FG002|Part 2|Adverse Event|0|||
46946216|NCT02814175|83184408|FG003|Part 2|Adverse Event|1|||
46946217|NCT02814175|83184409|FG004|Part 2|Adverse Event|1|||
46946218|NCT02814175|83184410|FG005|Part 2|Adverse Event|2|||
46946219|NCT02814175|83184405|FG000|Part 2|Withdrawal Consent|0|||
46946220|NCT02814175|83184406|FG001|Part 2|Withdrawal Consent|0|||
46946221|NCT02814175|83184407|FG002|Part 2|Withdrawal Consent|0|||
46946222|NCT02814175|83184408|FG003|Part 2|Withdrawal Consent|2|||
47064661|NCT01475461|83346871|FG006|Run-in Period|Withdrawal by Subject|0|||
46946223|NCT02814175|83184409|FG004|Part 2|Withdrawal Consent|1|||
46946224|NCT02814175|83184410|FG005|Part 2|Withdrawal Consent|1|||
46946225|NCT02814175|83184405|FG000|Part 2|Lost to Follow-up|0|||
46946226|NCT02814175|83184406|FG001|Part 2|Lost to Follow-up|0|||
46946227|NCT02814175|83184407|FG002|Part 2|Lost to Follow-up|0|||
46946228|NCT02814175|83184408|FG003|Part 2|Lost to Follow-up|1|||
46946229|NCT02814175|83184409|FG004|Part 2|Lost to Follow-up|0|||
46946230|NCT02814175|83184410|FG005|Part 2|Lost to Follow-up|0|||
46946231|NCT02814175|83184405|FG000|Part 2|Lack of Efficacy|0|||
46946232|NCT02814175|83184406|FG001|Part 2|Lack of Efficacy|0|||
47064662|NCT01475461|83346865|FG000|Run-in Period|Other|3|||
47064663|NCT01475461|83346866|FG001|Run-in Period|Other|0|||
47064664|NCT01475461|83346867|FG002|Run-in Period|Other|0|||
47064665|NCT01475461|83346868|FG003|Run-in Period|Other|0|||
46638760|NCT01392378|82812196|FG003|Infant Series|Lost to Follow-up|1|||
46638761|NCT01392378|82812197|FG004|Infant Series|Lost to Follow-up|0|||
46638762|NCT01392378|82812193|FG000|Infant Series|Protocol Violation|0|||
46638763|NCT01392378|82812194|FG001|Infant Series|Protocol Violation|1|||
46638764|NCT01392378|82812195|FG002|Infant Series|Protocol Violation|0|||
46638765|NCT01392378|82812196|FG003|Infant Series|Protocol Violation|0|||
46840320|NCT00268346|83057605|FG000|Overall Study|Withdrawal by Subject|0|||
46840321|NCT00268346|83057606|FG001|Overall Study|Withdrawal by Subject|1|||
46840322|NCT00203892|83057615|FG000|Overall Study|Physician Decision|1|||
46840323|NCT00203892|83057616|FG001|Overall Study|Physician Decision|2|||
46840324|NCT00203892|83057617|FG002|Overall Study|Physician Decision|0|||
46840325|NCT00203892|83057615|FG000|Overall Study|Death|1|||
46638766|NCT01392378|82812197|FG004|Infant Series|Protocol Violation|0|||
46638767|NCT01392378|82812193|FG000|Infant Series|Withdrawal by Parent|4|||
47064666|NCT01475461|83346869|FG004|Run-in Period|Other|0|||
47064667|NCT01475461|83346870|FG005|Run-in Period|Other|0|||
47064668|NCT01475461|83346871|FG006|Run-in Period|Other|0|||
47064669|NCT01475461|83346865|FG000|Run-in Period|Protocol Violation|4|||
46638768|NCT01392378|82812194|FG001|Infant Series|Withdrawal by Parent|1|||
46638769|NCT01392378|82812195|FG002|Infant Series|Withdrawal by Parent|0|||
46638770|NCT01392378|82812196|FG003|Infant Series|Withdrawal by Parent|0|||
46638771|NCT01392378|82812197|FG004|Infant Series|Withdrawal by Parent|0|||
46638772|NCT01392378|82812193|FG000|After Infant Series|Lost to Follow-up|0|||
46840326|NCT00203892|83057616|FG001|Overall Study|Death|0|||
46840327|NCT00203892|83057617|FG002|Overall Study|Death|0|||
46840328|NCT00250718|83057625|FG000|Overall Study|Death|1|||
46638773|NCT01392378|82812194|FG001|After Infant Series|Lost to Follow-up|0|||
46638774|NCT01392378|82812195|FG002|After Infant Series|Lost to Follow-up|1|||
46638775|NCT01392378|82812196|FG003|After Infant Series|Lost to Follow-up|0|||
46638776|NCT01392378|82812197|FG004|After Infant Series|Lost to Follow-up|0|||
46638777|NCT01392378|82812193|FG000|After Infant Series|Withdrawal by Parent|0|||
46638778|NCT01392378|82812194|FG001|After Infant Series|Withdrawal by Parent|1|||
46840329|NCT00250718|83057625|FG000|Overall Study|Adverse Event|1|||
46840330|NCT00250718|83057625|FG000|Overall Study|Withdrawal by Subject|1|||
46840331|NCT00276614|83057629|FG000|Overall Study|Progression of disease under study|3|||
46946233|NCT02814175|83184407|FG002|Part 2|Lack of Efficacy|0|||
46946234|NCT02814175|83184408|FG003|Part 2|Lack of Efficacy|0|||
46946235|NCT02814175|83184409|FG004|Part 2|Lack of Efficacy|0|||
46946236|NCT02814175|83184410|FG005|Part 2|Lack of Efficacy|3|||
46946237|NCT01335997|83184426|FG000|Period I and II|Adverse Event|63|||
46946238|NCT01335997|83184427|FG001|Period I and II|Adverse Event|43|||
47064670|NCT01475461|83346866|FG001|Run-in Period|Protocol Violation|0|||
46638779|NCT01392378|82812195|FG002|After Infant Series|Withdrawal by Parent|1|||
46638780|NCT01392378|82812196|FG003|After Infant Series|Withdrawal by Parent|0|||
46840332|NCT00276458|83057635|FG000|Overall Study|Adverse Event|0|||
46840333|NCT00276458|83057636|FG001|Overall Study|Adverse Event|2|||
46840334|NCT00276458|83057635|FG000|Overall Study|Lost to Follow-up|2|||
46946239|NCT01335997|83184426|FG000|Period I and II|Noncompliance with Study Drug|1|||
46946240|NCT01335997|83184427|FG001|Period I and II|Noncompliance with Study Drug|1|||
46946241|NCT01335997|83184426|FG000|Period I and II|Lost to Follow-up|3|||
46946242|NCT01335997|83184427|FG001|Period I and II|Lost to Follow-up|5|||
47064671|NCT01475461|83346867|FG002|Run-in Period|Protocol Violation|0|||
47064672|NCT01475461|83346868|FG003|Run-in Period|Protocol Violation|0|||
47064673|NCT01475461|83346869|FG004|Run-in Period|Protocol Violation|0|||
47064674|NCT01475461|83346870|FG005|Run-in Period|Protocol Violation|0|||
47064675|NCT01475461|83346871|FG006|Run-in Period|Protocol Violation|0|||
47064676|NCT01475461|83346865|FG000|Treatment Period|Death|0|||
47064677|NCT01475461|83346866|FG001|Treatment Period|Death|0|||
47064678|NCT01475461|83346867|FG002|Treatment Period|Death|0|||
47064679|NCT01475461|83346868|FG003|Treatment Period|Death|1|||
47064680|NCT01475461|83346869|FG004|Treatment Period|Death|0|||
47064681|NCT01475461|83346870|FG005|Treatment Period|Death|0|||
47064682|NCT01475461|83346871|FG006|Treatment Period|Death|0|||
47064683|NCT01475461|83346865|FG000|Treatment Period|Lost to Follow-up|0|||
47064684|NCT01475461|83346866|FG001|Treatment Period|Lost to Follow-up|3|||
47064685|NCT01475461|83346867|FG002|Treatment Period|Lost to Follow-up|2|||
47064686|NCT01475461|83346868|FG003|Treatment Period|Lost to Follow-up|3|||
47064687|NCT01475461|83346869|FG004|Treatment Period|Lost to Follow-up|1|||
47064688|NCT01475461|83346870|FG005|Treatment Period|Lost to Follow-up|2|||
47064689|NCT01475461|83346871|FG006|Treatment Period|Lost to Follow-up|1|||
47064690|NCT01475461|83346865|FG000|Treatment Period|Withdrawal by Subject|0|||
47064691|NCT01475461|83346866|FG001|Treatment Period|Withdrawal by Subject|2|||
47064692|NCT01475461|83346867|FG002|Treatment Period|Withdrawal by Subject|2|||
47064693|NCT01475461|83346868|FG003|Treatment Period|Withdrawal by Subject|0|||
47064694|NCT01475461|83346869|FG004|Treatment Period|Withdrawal by Subject|2|||
46638781|NCT01392378|82812197|FG004|After Infant Series|Withdrawal by Parent|1|||
46638782|NCT01392378|82812193|FG000|Toddler Dose|Lost to Follow-up|0|||
46638783|NCT01392378|82812194|FG001|Toddler Dose|Lost to Follow-up|0|||
46638784|NCT01392378|82812195|FG002|Toddler Dose|Lost to Follow-up|0|||
46638785|NCT01392378|82812196|FG003|Toddler Dose|Lost to Follow-up|1|||
46638786|NCT01392378|82812197|FG004|Toddler Dose|Lost to Follow-up|0|||
46638787|NCT01392378|82812193|FG000|Toddler Dose|Withdrawal by Parent|0|||
46638788|NCT01392378|82812194|FG001|Toddler Dose|Withdrawal by Parent|1|||
46770340|NCT00444457|82988750|FG002|After Infant Series|Protocol Violation|2|||
46770341|NCT00444457|82988751|FG003|After Infant Series|Protocol Violation|2|||
46770342|NCT00444457|82988748|FG000|After Infant Series|Adverse Event|2|||
46770343|NCT00444457|82988749|FG001|After Infant Series|Adverse Event|2|||
46770344|NCT00444457|82988750|FG002|After Infant Series|Adverse Event|0|||
46770345|NCT00444457|82988751|FG003|After Infant Series|Adverse Event|0|||
46770346|NCT00444457|82988748|FG000|After Infant Series|Investigator request|0|||
46770347|NCT00444457|82988749|FG001|After Infant Series|Investigator request|0|||
46770348|NCT00444457|82988750|FG002|After Infant Series|Investigator request|0|||
46770349|NCT00444457|82988751|FG003|After Infant Series|Investigator request|1|||
46770350|NCT00444457|82988748|FG000|After Infant Series|Other|0|||
46770351|NCT00444457|82988749|FG001|After Infant Series|Other|1|||
46770352|NCT00444457|82988750|FG002|After Infant Series|Other|0|||
46770353|NCT00444457|82988751|FG003|After Infant Series|Other|0|||
46770354|NCT00444457|82988748|FG000|Toddler Dose|Lost to Follow-up|4|||
46770355|NCT00444457|82988749|FG001|Toddler Dose|Lost to Follow-up|1|||
46770356|NCT00444457|82988750|FG002|Toddler Dose|Lost to Follow-up|1|||
46770357|NCT00444457|82988751|FG003|Toddler Dose|Lost to Follow-up|3|||
46770358|NCT00444457|82988748|FG000|Toddler Dose|Failed to return|2|||
46770359|NCT00444457|82988749|FG001|Toddler Dose|Failed to return|2|||
46770360|NCT00444457|82988750|FG002|Toddler Dose|Failed to return|1|||
46770361|NCT00444457|82988751|FG003|Toddler Dose|Failed to return|3|||
46770362|NCT00444457|82988748|FG000|Toddler Dose|Parent or legal guardian request|0|||
46770363|NCT00444457|82988749|FG001|Toddler Dose|Parent or legal guardian request|3|||
46770364|NCT00444457|82988750|FG002|Toddler Dose|Parent or legal guardian request|2|||
46770365|NCT00444457|82988751|FG003|Toddler Dose|Parent or legal guardian request|1|||
46770366|NCT00444457|82988748|FG000|Toddler Dose|Protocol Violation|1|||
46770367|NCT00444457|82988749|FG001|Toddler Dose|Protocol Violation|0|||
46770368|NCT00444457|82988750|FG002|Toddler Dose|Protocol Violation|0|||
46770369|NCT00444457|82988751|FG003|Toddler Dose|Protocol Violation|1|||
47064695|NCT01475461|83346870|FG005|Treatment Period|Withdrawal by Subject|2|||
46770370|NCT00799058|82988775|FG000|Overall Study|Withdrawal by Subject|2|||
47064696|NCT01475461|83346871|FG006|Treatment Period|Withdrawal by Subject|0|||
47064697|NCT01475461|83346865|FG000|Treatment Period|Other|0|||
47064698|NCT01475461|83346866|FG001|Treatment Period|Other|1|||
47064699|NCT01475461|83346867|FG002|Treatment Period|Other|0|||
47064700|NCT01475461|83346868|FG003|Treatment Period|Other|0|||
47064701|NCT01475461|83346869|FG004|Treatment Period|Other|0|||
47064702|NCT01475461|83346870|FG005|Treatment Period|Other|0|||
46638789|NCT01392378|82812195|FG002|Toddler Dose|Withdrawal by Parent|0|||
46638790|NCT01392378|82812196|FG003|Toddler Dose|Withdrawal by Parent|1|||
46770371|NCT00799058|82988776|FG001|Overall Study|Withdrawal by Subject|2|||
46770372|NCT00799058|82988777|FG002|Overall Study|Withdrawal by Subject|2|||
46770373|NCT00799058|82988775|FG000|Overall Study|Lost to Follow-up|1|||
46770374|NCT00799058|82988776|FG001|Overall Study|Lost to Follow-up|2|||
46770375|NCT00799058|82988777|FG002|Overall Study|Lost to Follow-up|1|||
46770376|NCT00799058|82988775|FG000|Overall Study|Adverse Event|0|||
46770377|NCT00799058|82988776|FG001|Overall Study|Adverse Event|2|||
47064703|NCT01475461|83346871|FG006|Treatment Period|Other|0|||
47064704|NCT01475461|83346865|FG000|Treatment Period|Protocol Violation|0|||
47064705|NCT01475461|83346866|FG001|Treatment Period|Protocol Violation|1|||
47064706|NCT01475461|83346867|FG002|Treatment Period|Protocol Violation|0|||
47064707|NCT01475461|83346868|FG003|Treatment Period|Protocol Violation|0|||
47064708|NCT01475461|83346869|FG004|Treatment Period|Protocol Violation|0|||
47064709|NCT01475461|83346870|FG005|Treatment Period|Protocol Violation|0|||
47064710|NCT01475461|83346871|FG006|Treatment Period|Protocol Violation|1|||
47064711|NCT01475461|83346865|FG000|Treatment Period|Lack of Efficacy|0|||
47064712|NCT01475461|83346866|FG001|Treatment Period|Lack of Efficacy|2|||
47064713|NCT01475461|83346867|FG002|Treatment Period|Lack of Efficacy|0|||
47064714|NCT01475461|83346868|FG003|Treatment Period|Lack of Efficacy|2|||
47064715|NCT01475461|83346869|FG004|Treatment Period|Lack of Efficacy|1|||
47064716|NCT01475461|83346870|FG005|Treatment Period|Lack of Efficacy|1|||
47064717|NCT01475461|83346871|FG006|Treatment Period|Lack of Efficacy|0|||
47064718|NCT01475461|83346865|FG000|Treatment Period|Medication Error|0|||
47064719|NCT01475461|83346866|FG001|Treatment Period|Medication Error|0|||
47064720|NCT01475461|83346867|FG002|Treatment Period|Medication Error|0|||
47064721|NCT01475461|83346868|FG003|Treatment Period|Medication Error|1|||
47064722|NCT01475461|83346869|FG004|Treatment Period|Medication Error|0|||
47064723|NCT01475461|83346870|FG005|Treatment Period|Medication Error|0|||
47064724|NCT01475461|83346871|FG006|Treatment Period|Medication Error|0|||
47064725|NCT01475461|83346865|FG000|Treatment Period|Adverse Event|0|||
47064726|NCT01475461|83346866|FG001|Treatment Period|Adverse Event|0|||
47064727|NCT01475461|83346867|FG002|Treatment Period|Adverse Event|0|||
47064728|NCT01475461|83346868|FG003|Treatment Period|Adverse Event|1|||
47064729|NCT01475461|83346869|FG004|Treatment Period|Adverse Event|0|||
47064730|NCT01475461|83346870|FG005|Treatment Period|Adverse Event|0|||
47064731|NCT01475461|83346871|FG006|Treatment Period|Adverse Event|0|||
47064732|NCT01589822|83346907|FG000|Overall Study|Withdrawal by Subject|1|||
47064733|NCT01589822|83346908|FG001|Overall Study|Withdrawal by Subject|2|||
47064734|NCT01589822|83346909|FG002|Overall Study|Withdrawal by Subject|0|||
47064735|NCT01589822|83346907|FG000|Overall Study|Death|1|||
47064736|NCT01589822|83346908|FG001|Overall Study|Death|0|||
47064737|NCT01589822|83346909|FG002|Overall Study|Death|0|||
47064738|NCT01589822|83346907|FG000|Overall Study|Missed 90 day visit|2|||
47064739|NCT01589822|83346908|FG001|Overall Study|Missed 90 day visit|1|||
47064740|NCT01589822|83346909|FG002|Overall Study|Missed 90 day visit|1|||
47064741|NCT01565642|83346921|FG000|Overall Study|Withdrawal by Subject|2|||
47064742|NCT01565642|83346922|FG001|Overall Study|Withdrawal by Subject|1|||
47064743|NCT01475071|83346928|FG000|Overall Study|Physician Decision|1|||
47064744|NCT01475071|83346928|FG000|Overall Study|Withdrawal by Subject|6|||
47064745|NCT01475071|83346928|FG000|Overall Study|Lost to Follow-up|1|||
47064746|NCT01474993|83346936|FG000|Overall Study|Lost to Follow-up|1|||
47064747|NCT01474993|83346937|FG001|Overall Study|Lost to Follow-up|2|||
47064748|NCT01474993|83346936|FG000|Overall Study|Adverse Event|0|||
47064749|NCT01474993|83346937|FG001|Overall Study|Adverse Event|1|||
47064750|NCT01691768|83346947|FG000|Overall Study|Death|0|||
47064751|NCT01691768|83346948|FG001|Overall Study|Death|2|||
47064752|NCT01691768|83346947|FG000|Overall Study|Lost to Follow-up|4|||
47064753|NCT01691768|83346948|FG001|Overall Study|Lost to Follow-up|3|||
47064754|NCT01691768|83346947|FG000|Overall Study|Withdrawal by Subject|10|||
47064755|NCT01691768|83346948|FG001|Overall Study|Withdrawal by Subject|9|||
47064756|NCT01691768|83346947|FG000|Overall Study|Relocated|0|||
47064757|NCT01691768|83346948|FG001|Overall Study|Relocated|1|||
46770378|NCT00799058|82988777|FG002|Overall Study|Adverse Event|0|||
46770379|NCT00799058|82988775|FG000|Overall Study|Pregnancy|1|||
46770380|NCT00799058|82988776|FG001|Overall Study|Pregnancy|0|||
46770381|NCT00799058|82988777|FG002|Overall Study|Pregnancy|0|||
46770382|NCT00799058|82988775|FG000|Overall Study|Not adherent|3|||
46770383|NCT00799058|82988776|FG001|Overall Study|Not adherent|2|||
46770384|NCT00799058|82988777|FG002|Overall Study|Not adherent|1|||
46770385|NCT00799058|82988775|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
46770386|NCT00799058|82988776|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
46770387|NCT00799058|82988777|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
46770388|NCT00799058|82988775|FG000|Overall Study|IP dispensing error|1|||
47064758|NCT01691768|83346947|FG000|Overall Study|Investigator decision|1|||
47064759|NCT01691768|83346948|FG001|Overall Study|Investigator decision|1|||
47064760|NCT01503229|83346955|FG000|Overall Study|Withdrew consent|1|||
46770389|NCT00799058|82988776|FG001|Overall Study|IP dispensing error|0|||
47064761|NCT01691612|83346959|FG000|Overall Study|deemed ineligible after 1st visit|6|||
47064762|NCT01691612|83346959|FG000|Overall Study|Adverse Event|1|||
47064763|NCT01565564|83346965|FG000|Overall Study|Lost to Follow-up|5|||
47064764|NCT01565564|83346966|FG001|Overall Study|Lost to Follow-up|1|||
47064765|NCT01460407|83346972|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
47064766|NCT01460407|83346973|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
47064767|NCT01502371|83346985|FG000|Overall Study|Withdrawal by Subject|1|||
47064768|NCT01502371|83346986|FG001|Overall Study|Withdrawal by Subject|2|||
47064769|NCT01502371|83346987|FG002|Overall Study|Withdrawal by Subject|1|||
46770390|NCT00799058|82988777|FG002|Overall Study|IP dispensing error|0|||
47064770|NCT01502371|83346988|FG003|Overall Study|Withdrawal by Subject|1|||
47064771|NCT01502371|83346989|FG004|Overall Study|Withdrawal by Subject|1|||
47064772|NCT01502371|83346985|FG000|Overall Study|Adverse Event|2|||
47064773|NCT01502371|83346986|FG001|Overall Study|Adverse Event|1|||
47064774|NCT01502371|83346987|FG002|Overall Study|Adverse Event|0|||
47064775|NCT01502371|83346988|FG003|Overall Study|Adverse Event|4|||
47064776|NCT01502371|83346989|FG004|Overall Study|Adverse Event|3|||
47064777|NCT01502371|83346985|FG000|Overall Study|Treatment Failure|22|||
47064778|NCT01502371|83346986|FG001|Overall Study|Treatment Failure|20|||
47064779|NCT01502371|83346987|FG002|Overall Study|Treatment Failure|12|||
47064780|NCT01502371|83346988|FG003|Overall Study|Treatment Failure|19|||
47064781|NCT01502371|83346989|FG004|Overall Study|Treatment Failure|30|||
47064782|NCT01502371|83346985|FG000|Overall Study|Lack of Efficacy|3|||
47064783|NCT01502371|83346986|FG001|Overall Study|Lack of Efficacy|3|||
47064784|NCT01502371|83346987|FG002|Overall Study|Lack of Efficacy|2|||
47064785|NCT01502371|83346988|FG003|Overall Study|Lack of Efficacy|2|||
47064786|NCT01502371|83346989|FG004|Overall Study|Lack of Efficacy|4|||
47064787|NCT01502371|83346985|FG000|Overall Study|Physician Decision|3|||
47064788|NCT01502371|83346986|FG001|Overall Study|Physician Decision|0|||
47064789|NCT01502371|83346987|FG002|Overall Study|Physician Decision|0|||
46840335|NCT00276458|83057636|FG001|Overall Study|Lost to Follow-up|2|||
47064790|NCT01502371|83346988|FG003|Overall Study|Physician Decision|0|||
47064791|NCT01502371|83346989|FG004|Overall Study|Physician Decision|1|||
47064792|NCT01502371|83346985|FG000|Overall Study|Noncompliance with Study Drug|0|||
47064793|NCT01502371|83346986|FG001|Overall Study|Noncompliance with Study Drug|0|||
47064794|NCT01502371|83346987|FG002|Overall Study|Noncompliance with Study Drug|1|||
47064795|NCT01502371|83346988|FG003|Overall Study|Noncompliance with Study Drug|2|||
47064796|NCT01502371|83346989|FG004|Overall Study|Noncompliance with Study Drug|1|||
46770391|NCT00799058|82988775|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
46770392|NCT00799058|82988776|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
46770393|NCT00799058|82988777|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
46840336|NCT00276458|83057635|FG000|Overall Study|Protocol Violation|4|||
46840337|NCT00276458|83057636|FG001|Overall Study|Protocol Violation|3|||
46840338|NCT00276380|83057644|FG000|Overall Study|Adverse Event|5|||
46638791|NCT01392378|82812197|FG004|Toddler Dose|Withdrawal by Parent|1|||
46638792|NCT01412424|82812219|FG000|Core Treatment Period|Treatment Failure|24|||
46638793|NCT01412424|82812219|FG000|Core Treatment Period|Adverse Event|21|||
46638794|NCT01412424|82812219|FG000|Core Treatment Period|Patient Request|5|||
46638795|NCT01412424|82812219|FG000|Core Treatment Period|Lost to Follow-up|2|||
46638796|NCT01412424|82812219|FG000|Core Treatment Period|Sponsor Request|1|||
46770394|NCT00799058|82988775|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
46770395|NCT00799058|82988776|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
46770396|NCT00799058|82988777|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
46770397|NCT00799058|82988775|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
47064797|NCT01502371|83346985|FG000|Overall Study|Technical Problems|1|||
47064798|NCT01502371|83346986|FG001|Overall Study|Technical Problems|0|||
46770398|NCT00799058|82988776|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
46770399|NCT00799058|82988777|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
46770400|NCT00799058|82988775|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
46775775|NCT00793793|82994208|FG004|Overall Study|reason not specified|1|||
46840339|NCT00276380|83057645|FG001|Overall Study|Adverse Event|3|||
46840340|NCT00276380|83057644|FG000|Overall Study|Lost to Follow-up|1|||
46840341|NCT00276380|83057645|FG001|Overall Study|Lost to Follow-up|1|||
46840342|NCT00276380|83057644|FG000|Overall Study|Withdrawal by Subject|3|||
46840343|NCT00276380|83057645|FG001|Overall Study|Withdrawal by Subject|6|||
46840344|NCT00276380|83057644|FG000|Overall Study|Death|5|||
46840345|NCT00276380|83057645|FG001|Overall Study|Death|3|||
46840346|NCT00276380|83057644|FG000|Overall Study|Abnormal aPPT Levels|0|||
46840347|NCT00276380|83057645|FG001|Overall Study|Abnormal aPPT Levels|1|||
46840348|NCT00267956|83057654|FG000|Controlled Period|Adverse Event|4|||
46840349|NCT00267956|83057655|FG001|Controlled Period|Adverse Event|1|||
46840350|NCT00267956|83057656|FG002|Controlled Period|Adverse Event|0|||
46840351|NCT00267956|83057657|FG003|Controlled Period|Adverse Event|0|||
47064799|NCT01502371|83346987|FG002|Overall Study|Technical Problems|2|||
46840352|NCT00267956|83057654|FG000|Controlled Period|Lack of Efficacy|4|||
47064800|NCT01502371|83346988|FG003|Overall Study|Technical Problems|4|||
47064801|NCT01502371|83346989|FG004|Overall Study|Technical Problems|1|||
47064802|NCT01502371|83346985|FG000|Overall Study|Protocol Violation|9|||
47064803|NCT01502371|83346986|FG001|Overall Study|Protocol Violation|5|||
47064804|NCT01502371|83346987|FG002|Overall Study|Protocol Violation|6|||
47064805|NCT01502371|83346988|FG003|Overall Study|Protocol Violation|5|||
46840353|NCT00267956|83057655|FG001|Controlled Period|Lack of Efficacy|2|||
46840354|NCT00267956|83057656|FG002|Controlled Period|Lack of Efficacy|0|||
46840355|NCT00267956|83057657|FG003|Controlled Period|Lack of Efficacy|0|||
46840356|NCT00267956|83057654|FG000|Controlled Period|Lost to Follow-up|2|||
47064806|NCT01502371|83346989|FG004|Overall Study|Protocol Violation|10|||
47064807|NCT01502371|83346985|FG000|Overall Study|Excluded Medication|0|||
47064808|NCT01502371|83346986|FG001|Overall Study|Excluded Medication|1|||
47064809|NCT01502371|83346987|FG002|Overall Study|Excluded Medication|1|||
47064810|NCT01502371|83346988|FG003|Overall Study|Excluded Medication|0|||
47064811|NCT01502371|83346989|FG004|Overall Study|Excluded Medication|1|||
47064812|NCT01588496|83347005|FG000|Overall Study|Withdrawal by Subject|0|||
47064813|NCT01588496|83347006|FG001|Overall Study|Withdrawal by Subject|1|||
47064814|NCT01588496|83347007|FG002|Overall Study|Withdrawal by Subject|0|||
47064815|NCT01502293|83347018|FG000|Overall Study|Progressive Disease|20|||
47064816|NCT01502293|83347019|FG001|Overall Study|Progressive Disease|12|||
47064817|NCT01502293|83347020|FG002|Overall Study|Progressive Disease|2|||
47064818|NCT01502293|83347018|FG000|Overall Study|Withdrawal by Subject|3|||
47064819|NCT01502293|83347019|FG001|Overall Study|Withdrawal by Subject|3|||
47064820|NCT01502293|83347020|FG002|Overall Study|Withdrawal by Subject|1|||
47064821|NCT01502293|83347018|FG000|Overall Study|Adverse Event|0|||
47064822|NCT01502293|83347019|FG001|Overall Study|Adverse Event|2|||
47064823|NCT01502293|83347020|FG002|Overall Study|Adverse Event|0|||
47064824|NCT01502293|83347018|FG000|Overall Study|Reason Not Specified|2|||
47064825|NCT01502293|83347019|FG001|Overall Study|Reason Not Specified|0|||
47064826|NCT01502293|83347020|FG002|Overall Study|Reason Not Specified|0|||
47064827|NCT01502293|83347018|FG000|Overall Study|Physician Decision|0|||
47064828|NCT01502293|83347019|FG001|Overall Study|Physician Decision|0|||
47064829|NCT01502293|83347020|FG002|Overall Study|Physician Decision|1|||
47064830|NCT01474681|83347033|FG000|Overall Study|Death|0|||
47064831|NCT01474681|83347034|FG001|Overall Study|Death|3|||
47064832|NCT01474681|83347035|FG002|Overall Study|Death|2|||
47064833|NCT01474681|83347036|FG003|Overall Study|Death|6|||
47064834|NCT01459783|83347052|FG000|Baseline to 6 Months|Death|1|||
47064835|NCT01459783|83347053|FG001|Baseline to 6 Months|Death|0|||
47064836|NCT01459783|83347052|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
47064837|NCT01459783|83347053|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
47064838|NCT01459783|83347052|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
47064839|NCT01459783|83347053|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
46770401|NCT00799058|82988776|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
46770402|NCT00799058|82988777|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
46770403|NCT00725985|82988790|FG000|ITP- Treatment Disposition|Adverse Event|20|||
46770404|NCT00725985|82988791|FG001|ITP- Treatment Disposition|Adverse Event|10|||
46770405|NCT00725985|82988792|FG002|ITP- Treatment Disposition|Adverse Event|5|||
46770406|NCT00725985|82988793|FG003|ITP- Treatment Disposition|Adverse Event|0|||
46770407|NCT00725985|82988794|FG004|ITP- Treatment Disposition|Adverse Event|0|||
46770408|NCT00725985|82988795|FG005|ITP- Treatment Disposition|Adverse Event|0|||
46770409|NCT00725985|82988796|FG006|ITP- Treatment Disposition|Adverse Event|0|||
46840357|NCT00267956|83057655|FG001|Controlled Period|Lost to Follow-up|0|||
46840358|NCT00267956|83057656|FG002|Controlled Period|Lost to Follow-up|0|||
46840359|NCT00267956|83057657|FG003|Controlled Period|Lost to Follow-up|0|||
46840360|NCT00267956|83057654|FG000|Controlled Period|Withdrew consent|3|||
46840361|NCT00267956|83057655|FG001|Controlled Period|Withdrew consent|1|||
46840362|NCT00267956|83057656|FG002|Controlled Period|Withdrew consent|0|||
46840363|NCT00267956|83057657|FG003|Controlled Period|Withdrew consent|0|||
46840364|NCT00267956|83057654|FG000|After Controlled Period|Adverse Event|0|||
46840365|NCT00267956|83057655|FG001|After Controlled Period|Adverse Event|0|||
46840366|NCT00267956|83057656|FG002|After Controlled Period|Adverse Event|2|||
46638797|NCT01412424|82812219|FG000|Extension Treatment Period|Adverse Event|2|||
47064840|NCT01459783|83347052|FG000|6 Months to 12 Months|Death|0|||
46638798|NCT01412424|82812219|FG000|Extension Treatment Period|Treatment Failure|2|||
46840367|NCT00267956|83057657|FG003|After Controlled Period|Adverse Event|1|||
46840368|NCT00267956|83057654|FG000|After Controlled Period|Lack of Efficacy|0|||
46840369|NCT00267956|83057655|FG001|After Controlled Period|Lack of Efficacy|0|||
46840370|NCT00267956|83057656|FG002|After Controlled Period|Lack of Efficacy|1|||
46840371|NCT00267956|83057657|FG003|After Controlled Period|Lack of Efficacy|1|||
46840372|NCT00267956|83057654|FG000|After Controlled Period|Lost to Follow-up|0|||
46840373|NCT00267956|83057655|FG001|After Controlled Period|Lost to Follow-up|0|||
46840374|NCT00267956|83057656|FG002|After Controlled Period|Lost to Follow-up|1|||
46840375|NCT00267956|83057657|FG003|After Controlled Period|Lost to Follow-up|0|||
47064841|NCT01459783|83347053|FG001|6 Months to 12 Months|Death|1|||
47064842|NCT01459783|83347052|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
47064843|NCT01459783|83347053|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
47064844|NCT01459783|83347052|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
47064845|NCT01459783|83347053|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
46770410|NCT00725985|82988797|FG007|ITP- Treatment Disposition|Adverse Event|0|||
46770411|NCT00725985|82988798|FG008|ITP- Treatment Disposition|Adverse Event|0|||
46840376|NCT00267956|83057654|FG000|After Controlled Period|Withdrew consent|0|||
46840377|NCT00267956|83057655|FG001|After Controlled Period|Withdrew consent|0|||
46840378|NCT00267956|83057656|FG002|After Controlled Period|Withdrew consent|1|||
46840379|NCT00267956|83057657|FG003|After Controlled Period|Withdrew consent|0|||
47064846|NCT01459783|83347052|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
47064847|NCT01459783|83347053|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
47064848|NCT01588184|83347065|FG000|Overall Study|Death|1|||
47064849|NCT01588184|83347066|FG001|Overall Study|Death|0|||
46638799|NCT01412424|82812219|FG000|Extension Treatment Period|Patient Request|2|||
46638800|NCT01433250|82812231|FG000|Overall Study|Protocol Violation|0|||
46638801|NCT01433250|82812232|FG001|Overall Study|Protocol Violation|1|||
46638802|NCT01433250|82812231|FG000|Overall Study|Withdrawal by Subject|3|||
46638803|NCT01433250|82812232|FG001|Overall Study|Withdrawal by Subject|2|||
46638804|NCT01433172|82812241|FG000|Overall Study|Withdrawal by Subject|0|||
46638805|NCT01433172|82812242|FG001|Overall Study|Withdrawal by Subject|1|||
46638806|NCT01433172|82812243|FG002|Overall Study|Withdrawal by Subject|0|||
46638807|NCT01433172|82812241|FG000|Overall Study|Disease Progression|0|||
46638808|NCT01433172|82812242|FG001|Overall Study|Disease Progression|0|||
46638809|NCT01433172|82812243|FG002|Overall Study|Disease Progression|1|||
46638810|NCT01433172|82812241|FG000|Overall Study|Death|0|||
46946243|NCT01335997|83184426|FG000|Period I and II|Withdrawal by Subject|9|||
46946244|NCT01335997|83184427|FG001|Period I and II|Withdrawal by Subject|4|||
46946245|NCT01335997|83184426|FG000|Period I and II|Study Terminated by Sponsor|406|||
46946246|NCT01335997|83184427|FG001|Period I and II|Study Terminated by Sponsor|415|||
46946247|NCT01335997|83184426|FG000|Period I and II|Protocol Violation|9|||
46946248|NCT01335997|83184427|FG001|Period I and II|Protocol Violation|10|||
46946249|NCT01335997|83184426|FG000|Period I and II|Physician Decision|2|||
46946250|NCT01335997|83184427|FG001|Period I and II|Physician Decision|1|||
46946251|NCT01335997|83184426|FG000|Period III|Adverse Event|0|||
46946252|NCT01335997|83184427|FG001|Period III|Adverse Event|2|||
46946253|NCT01335997|83184426|FG000|Period III|Study Terminated by Sponsor|77|||
46946254|NCT01335997|83184427|FG001|Period III|Study Terminated by Sponsor|76|||
46946255|NCT01335997|83184426|FG000|Period III|Protocol Violation|0|||
46946256|NCT01335997|83184427|FG001|Period III|Protocol Violation|1|||
46946257|NCT01335997|83184426|FG000|Period III|Lost to Follow-up|1|||
46946258|NCT01335997|83184427|FG001|Period III|Lost to Follow-up|0|||
46946259|NCT02725671|83184435|FG000|Overall Study|Lost to Follow-up|1|||
46946260|NCT02446990|83184443|FG000|Overall Study|Death|485|||
46946261|NCT02446990|83184444|FG001|Overall Study|Death|458|||
46946262|NCT02446990|83184443|FG000|Overall Study|Lost to Follow-up|3|||
46946263|NCT02446990|83184444|FG001|Overall Study|Lost to Follow-up|1|||
46946264|NCT02446990|83184443|FG000|Overall Study|Physician Decision|1|||
46946265|NCT02446990|83184444|FG001|Overall Study|Physician Decision|0|||
46946266|NCT02446990|83184443|FG000|Overall Study|Withdrawal by Subject|231|||
46946267|NCT02446990|83184444|FG001|Overall Study|Withdrawal by Subject|199|||
46946268|NCT02725515|83184452|FG000|Overall Study|Refused infusion (no study treatment)|1|||
46946269|NCT02725515|83184453|FG001|Overall Study|Refused infusion (no study treatment)|0|||
46946270|NCT02725515|83184452|FG000|Overall Study|Loss of Improvement per Protocol|14|||
46946271|NCT02725515|83184453|FG001|Overall Study|Loss of Improvement per Protocol|25|||
46946272|NCT02725515|83184452|FG000|Overall Study|Withdrawal by Subject|2|||
46946273|NCT02725515|83184453|FG001|Overall Study|Withdrawal by Subject|1|||
47064850|NCT01588184|83347067|FG002|Overall Study|Death|0|||
47064851|NCT01588184|83347068|FG003|Overall Study|Death|1|||
46946274|NCT02725515|83184452|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46946275|NCT02725515|83184453|FG001|Overall Study|Non-Compliance With Study Drug|3|||
46946276|NCT02725515|83184452|FG000|Overall Study|Lost to Follow-up|1|||
46946277|NCT02725515|83184453|FG001|Overall Study|Lost to Follow-up|1|||
46946278|NCT02725515|83184452|FG000|Overall Study|Adverse Event|7|||
46946279|NCT02725515|83184453|FG001|Overall Study|Adverse Event|2|||
46946280|NCT02725515|83184452|FG000|Overall Study|No Documented Disease Improvement|0|||
46946281|NCT02725515|83184453|FG001|Overall Study|No Documented Disease Improvement|1|||
46946282|NCT02725515|83184452|FG000|Overall Study|Completed Study Under Original Protocol|0|||
46946283|NCT02725515|83184453|FG001|Overall Study|Completed Study Under Original Protocol|1|||
47064852|NCT01588184|83347069|FG004|Overall Study|Death|1|||
47064853|NCT01588184|83347070|FG005|Overall Study|Death|1|||
47064854|NCT01588184|83347065|FG000|Overall Study|Withdrawal by Subject|2|||
47064855|NCT01588184|83347066|FG001|Overall Study|Withdrawal by Subject|4|||
47064856|NCT01588184|83347067|FG002|Overall Study|Withdrawal by Subject|0|||
47064857|NCT01588184|83347068|FG003|Overall Study|Withdrawal by Subject|1|||
46638811|NCT01433172|82812242|FG001|Overall Study|Death|2|||
46946284|NCT02725515|83184452|FG000|Overall Study|Lack of Response|0|||
46946285|NCT02725515|83184453|FG001|Overall Study|Lack of Response|1|||
46946286|NCT02416180|83184459|FG000|Overall Study|Withdrawal by Subject|1|||
46946287|NCT02473510|83184465|FG000|Overall Study|Lost to Follow-up|1|||
47064858|NCT01588184|83347069|FG004|Overall Study|Withdrawal by Subject|0|||
46946288|NCT02473510|83184466|FG001|Overall Study|Lost to Follow-up|2|||
46946289|NCT02445586|83184472|FG000|Overall Study|Death|14|||
46946290|NCT02445586|83184472|FG000|Overall Study|Withdrawal by Subject|13|||
46638812|NCT01433172|82812243|FG002|Overall Study|Death|0|||
46638813|NCT01432938|82812251|FG000|First Intervention|Protocol Violation|1|||
46638814|NCT01432938|82812252|FG001|First Intervention|Protocol Violation|0|||
46946291|NCT02445586|83184472|FG000|Overall Study|Disease Progression|10|||
46946292|NCT02445586|83184472|FG000|Overall Study|Protocol Violation|1|||
46946293|NCT02445586|83184472|FG000|Overall Study|Medical Condition|1|||
46946294|NCT01674062|83184478|FG000|Overall Study|Insufficient Therapeutic Response|56|||
46946295|NCT01674062|83184479|FG001|Overall Study|Insufficient Therapeutic Response|26|||
46946296|NCT01674062|83184478|FG000|Overall Study|Other|8|||
46946297|NCT01674062|83184479|FG001|Overall Study|Other|1|||
46946298|NCT01674062|83184478|FG000|Overall Study|Adverse Event|1|||
46840380|NCT00267488|83057665|FG000|Overall Study|Sponsor Terminated Study|9|||
46840381|NCT00267488|83057665|FG000|Overall Study|Protocol Violation|1|||
46840382|NCT00267488|83057665|FG000|Overall Study|Other (Disease Progression)|1|||
46840383|NCT00058552|83057671|FG000|Overall Study|Died prior to receiving treatment|4|||
46840384|NCT00058552|83057672|FG001|Overall Study|Died prior to receiving treatment|2|||
46840385|NCT00058552|83057671|FG000|Overall Study|Disease progression|52|||
46946299|NCT01674062|83184479|FG001|Overall Study|Adverse Event|1|||
46946300|NCT01674062|83184478|FG000|Overall Study|Death|0|||
46946301|NCT01674062|83184479|FG001|Overall Study|Death|1|||
46946302|NCT01674062|83184478|FG000|Overall Study|Programming Error|1|||
46946303|NCT01674062|83184479|FG001|Overall Study|Programming Error|0|||
46946304|NCT02472886|83184488|FG000|Overall Study|Lack of Efficacy|0|||
46946305|NCT02472886|83184489|FG001|Overall Study|Lack of Efficacy|2|||
46946306|NCT02472886|83184490|FG002|Overall Study|Lack of Efficacy|1|||
46946307|NCT02472652|83184503|FG000|Overall Study|Lost to Follow-up|1|||
46946308|NCT02807857|83184507|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
46946309|NCT02807857|83184507|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
46946310|NCT02807857|83184507|FG000|Follow-Up Set|Withdrawal by Subject|8|||
46946311|NCT02807857|83184507|FG000|Follow-Up Set|Lost to Follow-up|7|||
46840386|NCT00058552|83057672|FG001|Overall Study|Disease progression|44|||
46840387|NCT00058552|83057671|FG000|Overall Study|Adverse Event|4|||
46946312|NCT02807857|83184507|FG000|Follow-Up Set|Physician Decision|6|||
47064859|NCT01588184|83347070|FG005|Overall Study|Withdrawal by Subject|0|||
47064860|NCT01588184|83347065|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
47064861|NCT01588184|83347066|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
47064862|NCT01588184|83347067|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
47064863|NCT01588184|83347068|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
47064864|NCT01588184|83347069|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
47064865|NCT01588184|83347070|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
47064866|NCT01588184|83347065|FG000|Overall Study|multiple reasons|0|||
47064867|NCT01588184|83347066|FG001|Overall Study|multiple reasons|3|||
47064868|NCT01588184|83347067|FG002|Overall Study|multiple reasons|0|||
47064869|NCT01588184|83347068|FG003|Overall Study|multiple reasons|1|||
47064870|NCT01588184|83347069|FG004|Overall Study|multiple reasons|0|||
46840388|NCT00058552|83057672|FG001|Overall Study|Adverse Event|2|||
46946313|NCT02807857|83184507|FG000|Follow-Up Set|Adverse Event|3|||
46946314|NCT02807857|83184507|FG000|Follow-Up Set|Death|27|||
46946315|NCT02807857|83184507|FG000|Follow-Up Set|Relocation|2|||
46946316|NCT02648438|83184520|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46946317|NCT02648438|83184521|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
46946318|NCT02648438|83184522|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
46946319|NCT02648438|83184520|FG000|Overall Study|Protocol Violation|2|||
46840389|NCT00058552|83057671|FG000|Overall Study|Withdrawal by Subject|3|||
46840390|NCT00058552|83057672|FG001|Overall Study|Withdrawal by Subject|5|||
46840391|NCT00058552|83057671|FG000|Overall Study|Physician Decision|2|||
46840392|NCT00058552|83057672|FG001|Overall Study|Physician Decision|5|||
46840393|NCT00058552|83057671|FG000|Overall Study|Clinical disease progression|0|||
46840394|NCT00058552|83057672|FG001|Overall Study|Clinical disease progression|4|||
46840395|NCT00044512|83057680|FG000|Follow Up|Lost to Follow-up|2|||
46946320|NCT02648438|83184521|FG001|Overall Study|Protocol Violation|0|||
46946321|NCT02648438|83184522|FG002|Overall Study|Protocol Violation|0|||
46840396|NCT03805438|83057684|FG000|Overall Study|Lack of Efficacy|1|||
46840397|NCT03805438|83057684|FG000|Overall Study|Protocol Violation|1|||
46840398|NCT05369806|83057697|FG000|Overall Study|Lost to Follow-up|1|||
46946322|NCT02648438|83184520|FG000|Overall Study|Withdrawal by Subject|1|||
46946323|NCT02648438|83184521|FG001|Overall Study|Withdrawal by Subject|1|||
46946324|NCT02648438|83184522|FG002|Overall Study|Withdrawal by Subject|0|||
46946325|NCT02415556|83184542|FG000|Overall Study|Adverse Event|3|||
46946326|NCT02415556|83184543|FG001|Overall Study|Adverse Event|4|||
46946327|NCT02415556|83184544|FG002|Overall Study|Adverse Event|2|||
46946328|NCT02415556|83184545|FG003|Overall Study|Adverse Event|4|||
46946329|NCT02415556|83184542|FG000|Overall Study|Lost to Follow-up|4|||
46946330|NCT02415556|83184543|FG001|Overall Study|Lost to Follow-up|5|||
47064871|NCT01588184|83347070|FG005|Overall Study|multiple reasons|0|||
47064872|NCT01588106|83347086|FG000|Overall Study|Withdrawal by Subject|5|||
47064873|NCT01588106|83347087|FG001|Overall Study|Withdrawal by Subject|4|||
47064874|NCT01564862|83347096|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
47064875|NCT01564862|83347097|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
46946331|NCT02415556|83184544|FG002|Overall Study|Lost to Follow-up|4|||
46946332|NCT02415556|83184545|FG003|Overall Study|Lost to Follow-up|1|||
46946333|NCT02415556|83184542|FG000|Overall Study|Withdrawal by Subject|13|||
46946334|NCT02415556|83184543|FG001|Overall Study|Withdrawal by Subject|4|||
46946335|NCT02415556|83184544|FG002|Overall Study|Withdrawal by Subject|14|||
46946336|NCT02415556|83184545|FG003|Overall Study|Withdrawal by Subject|12|||
46946337|NCT02415556|83184542|FG000|Overall Study|Physician Decision|1|||
46946338|NCT02415556|83184543|FG001|Overall Study|Physician Decision|3|||
46946339|NCT02415556|83184544|FG002|Overall Study|Physician Decision|1|||
46946340|NCT02415556|83184545|FG003|Overall Study|Physician Decision|2|||
46946341|NCT02415556|83184542|FG000|Overall Study|Censored - study completion|4|||
46946342|NCT02415556|83184543|FG001|Overall Study|Censored - study completion|5|||
46946343|NCT02415556|83184544|FG002|Overall Study|Censored - study completion|1|||
46946344|NCT02415556|83184545|FG003|Overall Study|Censored - study completion|0|||
46946345|NCT02415556|83184542|FG000|Overall Study|Family-related issues|0|||
46946346|NCT02415556|83184543|FG001|Overall Study|Family-related issues|0|||
46946347|NCT02415556|83184544|FG002|Overall Study|Family-related issues|0|||
46946348|NCT02415556|83184545|FG003|Overall Study|Family-related issues|1|||
46946349|NCT02807623|83184558|FG000|Overall Study|Lost to Follow-up|23|||
46946350|NCT02807623|83184559|FG001|Overall Study|Lost to Follow-up|18|||
46946351|NCT02807623|83184560|FG002|Overall Study|Lost to Follow-up|22|||
46946352|NCT02807623|83184558|FG000|Overall Study|Drug intolerance|0|||
46946353|NCT02807623|83184559|FG001|Overall Study|Drug intolerance|1|||
46946354|NCT02807623|83184560|FG002|Overall Study|Drug intolerance|0|||
46946355|NCT02807623|83184558|FG000|Overall Study|incomplete blood draw|0|||
46946356|NCT02807623|83184559|FG001|Overall Study|incomplete blood draw|2|||
46946357|NCT02807623|83184560|FG002|Overall Study|incomplete blood draw|1|||
46946358|NCT02805907|83184579|FG000|Overall Study|Lost to Follow-up|3|||
46946359|NCT02805907|83184580|FG001|Overall Study|Lost to Follow-up|3|||
46946360|NCT02723175|83184588|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
46946361|NCT02723175|83184589|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
46946362|NCT02723175|83184588|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
46946363|NCT02723175|83184589|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
46946364|NCT02801617|83184597|FG000|Overall Study|Protocol Violation|2|||
46946365|NCT02801617|83184598|FG001|Overall Study|Protocol Violation|6|||
46946366|NCT01334515|83184610|FG000|Overall Study|Adverse Event|1|||
46946367|NCT01334515|83184611|FG001|Overall Study|Adverse Event|6|||
46946368|NCT01334515|83184610|FG000|Overall Study|Death|1|||
46946369|NCT01334515|83184611|FG001|Overall Study|Death|0|||
46946370|NCT01334515|83184610|FG000|Overall Study|Lack of Efficacy|8|||
46946371|NCT01334515|83184611|FG001|Overall Study|Lack of Efficacy|21|||
46946372|NCT01334515|83184610|FG000|Overall Study|Physician Decision|1|||
46946373|NCT01334515|83184611|FG001|Overall Study|Physician Decision|1|||
46946374|NCT01334515|83184610|FG000|Overall Study|Withdrawal by Subject|1|||
46946375|NCT01334515|83184611|FG001|Overall Study|Withdrawal by Subject|1|||
46946376|NCT02802319|83184619|FG000|Overall Study|Physician Decision|2|||
46946377|NCT02802319|83184620|FG001|Overall Study|Physician Decision|1|||
46946378|NCT02802319|83184619|FG000|Overall Study|Lost to Follow-up|0|||
46946379|NCT02802319|83184620|FG001|Overall Study|Lost to Follow-up|4|||
46946380|NCT02415400|83184630|FG000|Overall Study|Adverse Event|0|||
46946381|NCT02415400|83184631|FG001|Overall Study|Adverse Event|1|||
46946382|NCT02415400|83184632|FG002|Overall Study|Adverse Event|1|||
46946383|NCT02415400|83184633|FG003|Overall Study|Adverse Event|2|||
47064876|NCT01564862|83347098|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
47064877|NCT01564862|83347096|FG000|Overall Study|Major Protocol Deviation|3|||
47064878|NCT01564862|83347097|FG001|Overall Study|Major Protocol Deviation|3|||
46840399|NCT05195528|83057708|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
46946384|NCT02415400|83184630|FG000|Overall Study|Participant request to stop therapy|4|||
46946385|NCT02415400|83184631|FG001|Overall Study|Participant request to stop therapy|3|||
46946386|NCT02415400|83184632|FG002|Overall Study|Participant request to stop therapy|8|||
46946387|NCT02415400|83184633|FG003|Overall Study|Participant request to stop therapy|6|||
46946388|NCT02415400|83184630|FG000|Overall Study|Participant withdrew consent|14|||
46946389|NCT02415400|83184631|FG001|Overall Study|Participant withdrew consent|12|||
46946390|NCT02415400|83184632|FG002|Overall Study|Participant withdrew consent|30|||
46946391|NCT02415400|83184633|FG003|Overall Study|Participant withdrew consent|21|||
46946392|NCT02415400|83184630|FG000|Overall Study|Death|39|||
46946393|NCT02415400|83184631|FG001|Overall Study|Death|41|||
47064879|NCT01564862|83347098|FG002|Overall Study|Major Protocol Deviation|4|||
46946394|NCT02415400|83184632|FG002|Overall Study|Death|35|||
46946395|NCT02415400|83184633|FG003|Overall Study|Death|42|||
46946396|NCT02415400|83184630|FG000|Overall Study|Lost to Follow-up|3|||
46946397|NCT02415400|83184631|FG001|Overall Study|Lost to Follow-up|3|||
46840400|NCT05195528|83057709|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
46946398|NCT02415400|83184632|FG002|Overall Study|Lost to Follow-up|2|||
46946399|NCT02415400|83184633|FG003|Overall Study|Lost to Follow-up|5|||
46946400|NCT02415400|83184630|FG000|Overall Study|Poor/Non-Compliance|0|||
46946401|NCT02415400|83184631|FG001|Overall Study|Poor/Non-Compliance|1|||
46946402|NCT02415400|83184632|FG002|Overall Study|Poor/Non-Compliance|3|||
47064880|NCT01564862|83347096|FG000|Overall Study|Lost to Follow-up|10|||
46946403|NCT02415400|83184633|FG003|Overall Study|Poor/Non-Compliance|4|||
46946404|NCT02415400|83184630|FG000|Overall Study|Participant no longer meets criteria|2|||
46946405|NCT02415400|83184631|FG001|Overall Study|Participant no longer meets criteria|0|||
46946406|NCT02415400|83184632|FG002|Overall Study|Participant no longer meets criteria|0|||
46946407|NCT02415400|83184633|FG003|Overall Study|Participant no longer meets criteria|1|||
46946408|NCT02415400|83184630|FG000|Overall Study|Participant doesn't answer phone|1|||
46946409|NCT02415400|83184631|FG001|Overall Study|Participant doesn't answer phone|0|||
46946410|NCT02415400|83184632|FG002|Overall Study|Participant doesn't answer phone|0|||
46946411|NCT02415400|83184633|FG003|Overall Study|Participant doesn't answer phone|0|||
46946412|NCT02415400|83184630|FG000|Overall Study|Participant wanted home visits|1|||
46840401|NCT05195528|83057710|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
46840402|NCT05195528|83057711|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
46946413|NCT02415400|83184631|FG001|Overall Study|Participant wanted home visits|0|||
46946414|NCT02415400|83184632|FG002|Overall Study|Participant wanted home visits|0|||
46946415|NCT02415400|83184633|FG003|Overall Study|Participant wanted home visits|0|||
46946416|NCT02415400|83184630|FG000|Overall Study|Randomized in error|2|||
46946417|NCT02415400|83184631|FG001|Overall Study|Randomized in error|0|||
46946418|NCT02415400|83184632|FG002|Overall Study|Randomized in error|0|||
46946419|NCT02415400|83184633|FG003|Overall Study|Randomized in error|0|||
46946420|NCT02415400|83184630|FG000|Overall Study|No study drug on site|0|||
46946421|NCT02415400|83184631|FG001|Overall Study|No study drug on site|1|||
46946422|NCT02415400|83184632|FG002|Overall Study|No study drug on site|0|||
46840403|NCT05195528|83057712|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
46840404|NCT05195528|83057708|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
46840405|NCT05195528|83057709|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
46840406|NCT05195528|83057710|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
46840407|NCT05195528|83057711|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
46840408|NCT05195528|83057712|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
46840409|NCT05195528|83057708|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
46840410|NCT05195528|83057709|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
46840411|NCT05195528|83057710|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
46840412|NCT05195528|83057711|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
46946423|NCT02415400|83184633|FG003|Overall Study|No study drug on site|0|||
46946424|NCT02415400|83184630|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
46946425|NCT02415400|83184631|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
46946426|NCT02415400|83184632|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
46946427|NCT02415400|83184633|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
46946428|NCT02415400|83184630|FG000|Overall Study|Coagulation values cannot be set|0|||
47064881|NCT01564862|83347097|FG001|Overall Study|Lost to Follow-up|8|||
46946429|NCT02415400|83184631|FG001|Overall Study|Coagulation values cannot be set|0|||
46946430|NCT02415400|83184632|FG002|Overall Study|Coagulation values cannot be set|1|||
46946431|NCT02415400|83184633|FG003|Overall Study|Coagulation values cannot be set|0|||
46946432|NCT02415400|83184630|FG000|Overall Study|State regulations prevent participation|0|||
46946433|NCT02415400|83184631|FG001|Overall Study|State regulations prevent participation|0|||
46946434|NCT02415400|83184632|FG002|Overall Study|State regulations prevent participation|1|||
46946435|NCT02415400|83184633|FG003|Overall Study|State regulations prevent participation|0|||
46946436|NCT02415400|83184630|FG000|Overall Study|Poor treatment monitoring|0|||
46946437|NCT02415400|83184631|FG001|Overall Study|Poor treatment monitoring|0|||
46946438|NCT02415400|83184632|FG002|Overall Study|Poor treatment monitoring|1|||
46946439|NCT02415400|83184633|FG003|Overall Study|Poor treatment monitoring|0|||
46946440|NCT02415400|83184630|FG000|Overall Study|Participant in jail|0|||
46946441|NCT02415400|83184631|FG001|Overall Study|Participant in jail|0|||
46946442|NCT02415400|83184632|FG002|Overall Study|Participant in jail|1|||
46946443|NCT02415400|83184633|FG003|Overall Study|Participant in jail|0|||
46946444|NCT02415400|83184630|FG000|Overall Study|Investigator decision|0|||
46946445|NCT02415400|83184631|FG001|Overall Study|Investigator decision|0|||
46946446|NCT02415400|83184632|FG002|Overall Study|Investigator decision|1|||
46946447|NCT02415400|83184633|FG003|Overall Study|Investigator decision|1|||
46946448|NCT02415400|83184630|FG000|Overall Study|Site closure; participant won't transfer|0|||
46946449|NCT02415400|83184631|FG001|Overall Study|Site closure; participant won't transfer|0|||
47064882|NCT01564862|83347098|FG002|Overall Study|Lost to Follow-up|6|||
47064883|NCT01564862|83347096|FG000|Overall Study|Voluntary Withdrawal|9|||
46946450|NCT02415400|83184632|FG002|Overall Study|Site closure; participant won't transfer|0|||
46946451|NCT02415400|83184633|FG003|Overall Study|Site closure; participant won't transfer|1|||
46946452|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
46946453|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
46946454|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
47064884|NCT01564862|83347097|FG001|Overall Study|Voluntary Withdrawal|6|||
46946455|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
46946456|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
46946457|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
46946458|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
46946459|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
46946460|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
46946461|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
46946462|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
46946463|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
46946464|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
46946465|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
46946466|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
46946467|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
46946468|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
46946469|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
46946470|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
46946471|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
46946472|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
46946473|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
46946474|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
46946475|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
46946476|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
46946477|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
46946478|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
46946479|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
46946480|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
46946481|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
46946482|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
46946483|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
46946484|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
46946485|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
46840413|NCT05195528|83057712|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
46840414|NCT05195528|83057708|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
46840415|NCT05195528|83057709|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
46840416|NCT05195528|83057710|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
46840417|NCT05195528|83057711|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
46840418|NCT05195528|83057712|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
46840419|NCT05195528|83057708|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
46840420|NCT05195528|83057709|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
46840421|NCT05195528|83057710|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
46840422|NCT05195528|83057711|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
46840423|NCT05195528|83057712|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
46840424|NCT05195528|83057708|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
46840425|NCT05195528|83057709|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
46840426|NCT05195528|83057710|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
46840427|NCT05195528|83057711|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
46840428|NCT05195528|83057712|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
46840429|NCT05195528|83057708|FG000|Placebo-controlled Treatment Period|Other|0|||
46840430|NCT05195528|83057709|FG001|Placebo-controlled Treatment Period|Other|0|||
46840431|NCT05195528|83057710|FG002|Placebo-controlled Treatment Period|Other|1|||
46840432|NCT05195528|83057711|FG003|Placebo-controlled Treatment Period|Other|0|||
46840433|NCT05195528|83057712|FG004|Placebo-controlled Treatment Period|Other|0|||
46840434|NCT05195528|83057708|FG000|Extension Period|PTE or AE or SAE|0|||
46840435|NCT05195528|83057709|FG001|Extension Period|PTE or AE or SAE|4|||
46840436|NCT05195528|83057710|FG002|Extension Period|PTE or AE or SAE|5|||
46840437|NCT05195528|83057711|FG003|Extension Period|PTE or AE or SAE|4|||
46840438|NCT05195528|83057712|FG004|Extension Period|PTE or AE or SAE|4|||
46840439|NCT05195528|83057708|FG000|Extension Period|Protocol Violation|0|||
46946486|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
46946487|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
46946488|NCT04194801|83184650|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
46946489|NCT04194801|83184651|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
46946490|NCT04194801|83184652|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
46840440|NCT05195528|83057709|FG001|Extension Period|Protocol Violation|2|||
46946491|NCT04194801|83184650|FG000|Part Ib/II End of Study|Death|2|||
46638815|NCT01432938|82812251|FG000|First Intervention|Physician Decision|1|||
46840441|NCT05195528|83057710|FG002|Extension Period|Protocol Violation|1|||
47064885|NCT01564862|83347098|FG002|Overall Study|Voluntary Withdrawal|8|||
47064886|NCT01564862|83347096|FG000|Overall Study|Lack of Efficacy|1|||
47064887|NCT01564862|83347097|FG001|Overall Study|Lack of Efficacy|5|||
47064888|NCT01564862|83347098|FG002|Overall Study|Lack of Efficacy|6|||
47064889|NCT01564862|83347096|FG000|Overall Study|Other reason(s)|1|||
47064890|NCT01564862|83347097|FG001|Overall Study|Other reason(s)|0|||
47064891|NCT01564862|83347098|FG002|Overall Study|Other reason(s)|0|||
47064892|NCT01691378|83347108|FG000|Overall Study|Withdrawal by Subject|2|||
47064893|NCT01691378|83347109|FG001|Overall Study|Withdrawal by Subject|0|||
47064894|NCT01691378|83347108|FG000|Overall Study|Lost to Follow-up|5|||
47064895|NCT01691378|83347109|FG001|Overall Study|Lost to Follow-up|2|||
47064896|NCT01467479|83347118|FG000|Overall Study|No Study Medication|1|||
47064897|NCT01467479|83347119|FG001|Overall Study|No Study Medication|0|||
47064898|NCT01467479|83347120|FG002|Overall Study|No Study Medication|2|||
47064899|NCT01467479|83347118|FG000|Overall Study|Adverse Event|1|||
47064900|NCT01467479|83347119|FG001|Overall Study|Adverse Event|2|||
47064901|NCT01467479|83347120|FG002|Overall Study|Adverse Event|0|||
47064902|NCT01467479|83347118|FG000|Overall Study|Death|0|||
47064903|NCT01467479|83347119|FG001|Overall Study|Death|0|||
47064904|NCT01467479|83347120|FG002|Overall Study|Death|1|||
47064905|NCT01467479|83347118|FG000|Overall Study|Lost to Follow-up|2|||
47064906|NCT01467479|83347119|FG001|Overall Study|Lost to Follow-up|5|||
47064907|NCT01467479|83347120|FG002|Overall Study|Lost to Follow-up|3|||
47064908|NCT01467479|83347118|FG000|Overall Study|Withdrawal of Consent|3|||
47064909|NCT01467479|83347119|FG001|Overall Study|Withdrawal of Consent|7|||
47064910|NCT01467479|83347120|FG002|Overall Study|Withdrawal of Consent|7|||
47064911|NCT01467479|83347118|FG000|Overall Study|Study Terminated by Sponsor|1|||
47064912|NCT01467479|83347119|FG001|Overall Study|Study Terminated by Sponsor|3|||
47064913|NCT01467479|83347120|FG002|Overall Study|Study Terminated by Sponsor|3|||
47064914|NCT01467479|83347118|FG000|Overall Study|Other|1|||
47064915|NCT01467479|83347119|FG001|Overall Study|Other|0|||
47064916|NCT01467479|83347120|FG002|Overall Study|Other|0|||
47064917|NCT01466387|83347135|FG000|Overall Study|Adverse Event|0|||
47064918|NCT01466387|83347136|FG001|Overall Study|Adverse Event|0|||
47064919|NCT01466387|83347137|FG002|Overall Study|Adverse Event|1|||
47064920|NCT01466387|83347138|FG003|Overall Study|Adverse Event|1|||
47064921|NCT01466387|83347139|FG004|Overall Study|Adverse Event|0|||
47064922|NCT01466387|83347140|FG005|Overall Study|Adverse Event|0|||
47064923|NCT01466387|83347135|FG000|Overall Study|Lost to Follow-up|0|||
47064924|NCT01466387|83347136|FG001|Overall Study|Lost to Follow-up|0|||
46770412|NCT00725985|82988799|FG009|ITP- Treatment Disposition|Adverse Event|0|||
46770413|NCT00725985|82988800|FG010|ITP- Treatment Disposition|Adverse Event|0|||
46770414|NCT00725985|82988801|FG011|ITP- Treatment Disposition|Adverse Event|0|||
46946492|NCT04194801|83184651|FG001|Part Ib/II End of Study|Death|3|||
46946493|NCT04194801|83184652|FG002|Part Ib/II End of Study|Death|3|||
46946494|NCT04194801|83184650|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
46946495|NCT04194801|83184651|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
46946496|NCT04194801|83184652|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
47064925|NCT01466387|83347137|FG002|Overall Study|Lost to Follow-up|0|||
47064926|NCT01466387|83347138|FG003|Overall Study|Lost to Follow-up|0|||
47064927|NCT01466387|83347139|FG004|Overall Study|Lost to Follow-up|0|||
47064928|NCT01466387|83347140|FG005|Overall Study|Lost to Follow-up|1|||
47064929|NCT01466387|83347135|FG000|Overall Study|Protocol Violation|1|||
46770415|NCT00725985|82988790|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770416|NCT00725985|82988791|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770417|NCT00725985|82988792|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
46770418|NCT00725985|82988793|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770419|NCT00725985|82988794|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770420|NCT00725985|82988795|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770421|NCT00725985|82988796|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770422|NCT00725985|82988797|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770423|NCT00725985|82988798|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
46946497|NCT04194801|83184650|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
47064930|NCT01466387|83347136|FG001|Overall Study|Protocol Violation|0|||
47064931|NCT01466387|83347137|FG002|Overall Study|Protocol Violation|0|||
47064932|NCT01466387|83347138|FG003|Overall Study|Protocol Violation|1|||
47064933|NCT01466387|83347139|FG004|Overall Study|Protocol Violation|0|||
47064934|NCT01466387|83347140|FG005|Overall Study|Protocol Violation|0|||
47064935|NCT01564784|83347271|FG000|Overall Study|Other|1|||
46770424|NCT00725985|82988799|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770425|NCT00725985|82988800|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
46946498|NCT04194801|83184651|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
47064936|NCT01564784|83347272|FG001|Overall Study|Other|0|||
47064937|NCT01564784|83347271|FG000|Overall Study|Subject refused further follow-up|1|||
47064938|NCT01564784|83347272|FG001|Overall Study|Subject refused further follow-up|6|||
47064939|NCT01564784|83347271|FG000|Overall Study|Lost to Follow-up|1|||
47064940|NCT01564784|83347272|FG001|Overall Study|Lost to Follow-up|1|||
47064941|NCT01564784|83347271|FG000|Overall Study|Death|131|||
47064942|NCT01564784|83347272|FG001|Overall Study|Death|126|||
47064943|NCT01564394|83347323|FG000|Overall Study|Withdrawal by Subject|6|||
47064944|NCT01564394|83347324|FG001|Overall Study|Withdrawal by Subject|10|||
47064945|NCT01690988|83347338|FG000|Overall Study|Withdrawal by Subject|2|||
47064946|NCT01690988|83347339|FG001|Overall Study|Withdrawal by Subject|2|||
47064947|NCT01690988|83347340|FG002|Overall Study|Withdrawal by Subject|3|||
47064948|NCT01690988|83347338|FG000|Overall Study|Physician Decision|0|||
47064949|NCT01690988|83347339|FG001|Overall Study|Physician Decision|0|||
47064950|NCT01690988|83347340|FG002|Overall Study|Physician Decision|1|||
47064951|NCT01690988|83347338|FG000|Overall Study|Operation Cancelled|1|||
47064952|NCT01690988|83347339|FG001|Overall Study|Operation Cancelled|1|||
47064953|NCT01690988|83347340|FG002|Overall Study|Operation Cancelled|0|||
47064954|NCT01690988|83347338|FG000|Overall Study|Determined ineligible|1|||
47064955|NCT01690988|83347339|FG001|Overall Study|Determined ineligible|0|||
47064956|NCT01690988|83347340|FG002|Overall Study|Determined ineligible|0|||
47064957|NCT01690988|83347338|FG000|Overall Study|Death|1|||
47064958|NCT01690988|83347339|FG001|Overall Study|Death|1|||
47064959|NCT01690988|83347340|FG002|Overall Study|Death|1|||
47064960|NCT01690988|83347338|FG000|Overall Study|Sedated|1|||
47064961|NCT01690988|83347339|FG001|Overall Study|Sedated|1|||
47064962|NCT01690988|83347340|FG002|Overall Study|Sedated|2|||
47064963|NCT01466153|83347371|FG000|Overall Study|Disease Progression|2|||
47064964|NCT01466153|83347372|FG001|Overall Study|Disease Progression|2|||
47064965|NCT01466153|83347373|FG002|Overall Study|Disease Progression|0|||
47064966|NCT01466153|83347371|FG000|Overall Study|Adverse Event|14|||
46946499|NCT04194801|83184652|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
46946500|NCT04194801|83184650|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
46946501|NCT04194801|83184651|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
46946502|NCT04194801|83184652|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
46946503|NCT04194801|83184650|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
46946504|NCT04194801|83184651|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
46946505|NCT04194801|83184652|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
46946506|NCT02802865|83184676|FG000|Overall Study|Pregnancy|1|||
46946507|NCT02802865|83184677|FG001|Overall Study|Pregnancy|1|||
46946508|NCT02802865|83184676|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
46946509|NCT02802865|83184677|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
46946510|NCT02414932|83184685|FG000|Overall Study|Withdrawal by Subject|2|||
46946511|NCT02414932|83184686|FG001|Overall Study|Withdrawal by Subject|3|||
47064967|NCT01466153|83347372|FG001|Overall Study|Adverse Event|13|||
47064968|NCT01466153|83347373|FG002|Overall Study|Adverse Event|17|||
47064969|NCT01466153|83347371|FG000|Overall Study|Withdrawal of Consent|2|||
47064970|NCT01466153|83347372|FG001|Overall Study|Withdrawal of Consent|0|||
47064971|NCT01466153|83347373|FG002|Overall Study|Withdrawal of Consent|0|||
47064972|NCT01466153|83347371|FG000|Overall Study|Investigator Discretion|3|||
47064973|NCT01466153|83347372|FG001|Overall Study|Investigator Discretion|2|||
47064974|NCT01466153|83347373|FG002|Overall Study|Investigator Discretion|2|||
47064975|NCT01466153|83347371|FG000|Overall Study|Randomized-Not Treated|2|||
47064976|NCT01466153|83347372|FG001|Overall Study|Randomized-Not Treated|3|||
47064977|NCT01466153|83347373|FG002|Overall Study|Randomized-Not Treated|4|||
47064978|NCT01466153|83347371|FG000|Overall Study|Other-Unspecified|6|||
47064979|NCT01466153|83347372|FG001|Overall Study|Other-Unspecified|4|||
47064980|NCT01466153|83347373|FG002|Overall Study|Other-Unspecified|2|||
47064981|NCT01474291|83347394|FG000|Overall Study|Not Evaluable for Efficacy|26|||
47064982|NCT01474291|83347394|FG000|Overall Study|Lack of Treatment Efficacy|88|||
47064983|NCT01474291|83347394|FG000|Overall Study|Adverse Event|53|||
47064984|NCT01474291|83347394|FG000|Overall Study|Lost to Follow-up|29|||
47064985|NCT01474291|83347394|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
47064986|NCT01474291|83347394|FG000|Overall Study|No Reason Reported|10|||
47064987|NCT01474291|83347394|FG000|Overall Study|Death|2|||
47064988|NCT01465997|83347403|FG000|Overall Study|Adverse Event|12|||
46770426|NCT00725985|82988801|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
46770427|NCT00725985|82988790|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
46770428|NCT00725985|82988791|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
46770429|NCT00725985|82988792|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
46770430|NCT00725985|82988793|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
47064989|NCT01465997|83347404|FG001|Overall Study|Adverse Event|22|||
47064990|NCT01465997|83347403|FG000|Overall Study|Lack of Efficacy|13|||
47064991|NCT01465997|83347404|FG001|Overall Study|Lack of Efficacy|1|||
47064992|NCT01465997|83347403|FG000|Overall Study|Protocol Violation|1|||
46946512|NCT02414932|83184685|FG000|Overall Study|Adverse Event|1|||
46946513|NCT02414932|83184686|FG001|Overall Study|Adverse Event|0|||
46946514|NCT00704535|83184692|FG000|Overall Study|Adverse Event|2|||
46946515|NCT00704535|83184692|FG000|Overall Study|Death|2|||
47064993|NCT01465997|83347404|FG001|Overall Study|Protocol Violation|4|||
47064994|NCT01465997|83347403|FG000|Overall Study|Lost to Follow-up|6|||
47064995|NCT01465997|83347404|FG001|Overall Study|Lost to Follow-up|9|||
47064996|NCT01465997|83347403|FG000|Overall Study|Withdrawal by Subject|32|||
47064997|NCT01465997|83347404|FG001|Overall Study|Withdrawal by Subject|35|||
47064998|NCT01465997|83347403|FG000|Overall Study|investigator's decision|1|||
47064999|NCT01465997|83347404|FG001|Overall Study|investigator's decision|1|||
47065000|NCT01465997|83347403|FG000|Overall Study|Death|0|||
47065001|NCT01465997|83347404|FG001|Overall Study|Death|1|||
47065002|NCT01465997|83347403|FG000|Overall Study|sponsor's decision|1|||
47065003|NCT01465997|83347404|FG001|Overall Study|sponsor's decision|1|||
47065004|NCT01465997|83347403|FG000|Overall Study|subject withdrew consent|1|||
47065005|NCT01465997|83347404|FG001|Overall Study|subject withdrew consent|0|||
47065006|NCT01465997|83347403|FG000|Overall Study|local lab unblinded site|1|||
47065007|NCT01465997|83347404|FG001|Overall Study|local lab unblinded site|0|||
47065008|NCT01465997|83347403|FG000|Overall Study|withdrew before follow-up|0|||
47065009|NCT01465997|83347404|FG001|Overall Study|withdrew before follow-up|13|||
47065010|NCT01465997|83347403|FG000|Overall Study|decision by site staff|0|||
47065011|NCT01465997|83347404|FG001|Overall Study|decision by site staff|1|||
47065012|NCT01465997|83347403|FG000|Overall Study|subject left participation SP0993|0|||
47065013|NCT01465997|83347404|FG001|Overall Study|subject left participation SP0993|1|||
47065014|NCT01465763|83347425|FG000|Overall Study|Withdrawal by Subject|4|||
47065015|NCT01465763|83347426|FG001|Overall Study|Withdrawal by Subject|0|||
47065016|NCT01465763|83347427|FG002|Overall Study|Withdrawal by Subject|1|||
47065017|NCT01465763|83347425|FG000|Overall Study|Insufficient Clinical Response|11|||
47065018|NCT01465763|83347426|FG001|Overall Study|Insufficient Clinical Response|0|||
47065019|NCT01465763|83347427|FG002|Overall Study|Insufficient Clinical Response|1|||
47065020|NCT01465763|83347425|FG000|Overall Study|Adverse Event|9|||
47065021|NCT01465763|83347426|FG001|Overall Study|Adverse Event|0|||
47065022|NCT01465763|83347427|FG002|Overall Study|Adverse Event|1|||
47065023|NCT01465763|83347425|FG000|Overall Study|Other|2|||
47065024|NCT01465763|83347426|FG001|Overall Study|Other|0|||
47065025|NCT01465763|83347427|FG002|Overall Study|Other|0|||
47065026|NCT01465763|83347425|FG000|Overall Study|Protocol Violation|4|||
47065027|NCT01465763|83347426|FG001|Overall Study|Protocol Violation|1|||
47065028|NCT01465763|83347427|FG002|Overall Study|Protocol Violation|1|||
47065029|NCT01465763|83347425|FG000|Overall Study|Death|1|||
47065030|NCT01465763|83347426|FG001|Overall Study|Death|0|||
47065031|NCT01465763|83347427|FG002|Overall Study|Death|0|||
47065032|NCT01690520|83347460|FG000|Overall Study|Death|25|||
47065033|NCT01690520|83347461|FG001|Overall Study|Death|21|||
47065034|NCT01690520|83347460|FG000|Overall Study|Lost to Follow-up|2|||
47065035|NCT01690520|83347461|FG001|Overall Study|Lost to Follow-up|3|||
47065036|NCT01690520|83347460|FG000|Overall Study|Withdrawal by Subject|2|||
46840442|NCT05195528|83057711|FG003|Extension Period|Protocol Violation|0|||
46946516|NCT00704535|83184692|FG000|Overall Study|Lost to Follow-up|8|||
46770431|NCT00725985|82988794|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
46770432|NCT00725985|82988795|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
46770433|NCT00725985|82988796|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
46770434|NCT00725985|82988797|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
46770435|NCT00725985|82988798|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
46770436|NCT00725985|82988799|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
46770437|NCT00725985|82988800|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
46770438|NCT00725985|82988801|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
46770439|NCT00725985|82988790|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
46840443|NCT05195528|83057712|FG004|Extension Period|Protocol Violation|1|||
46840444|NCT05195528|83057708|FG000|Extension Period|Lost to Follow-up|0|||
46840445|NCT05195528|83057709|FG001|Extension Period|Lost to Follow-up|6|||
46840446|NCT05195528|83057710|FG002|Extension Period|Lost to Follow-up|13|||
46840447|NCT05195528|83057711|FG003|Extension Period|Lost to Follow-up|3|||
46946517|NCT00704535|83184692|FG000|Overall Study|Protocol Violation|10|||
46946518|NCT00704535|83184692|FG000|Overall Study|Completed status not on Case Report Form|124|||
46946519|NCT01740687|83184696|FG000|Overall Study|Lost to Follow-up|11|||
46946520|NCT01740687|83184696|FG000|Overall Study|Withdrawal by Subject|2|||
46770440|NCT00725985|82988791|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
47065037|NCT01690520|83347461|FG001|Overall Study|Withdrawal by Subject|0|||
47065038|NCT01690520|83347460|FG000|Overall Study|Relapse|0|||
47065039|NCT01690520|83347461|FG001|Overall Study|Relapse|1|||
47065040|NCT01690520|83347460|FG000|Overall Study|Other|0|||
47065041|NCT01690520|83347461|FG001|Overall Study|Other|1|||
47065042|NCT01690520|83347460|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
47065043|NCT01690520|83347461|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
46770441|NCT00725985|82988792|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
46840448|NCT05195528|83057712|FG004|Extension Period|Lost to Follow-up|7|||
46840449|NCT05195528|83057708|FG000|Extension Period|Withdrawal by Subject|0|||
46946521|NCT01740687|83184696|FG000|Overall Study|other reason|22|||
46946522|NCT01740687|83184696|FG000|Overall Study|treatment not received|2|||
46946523|NCT02648204|83184704|FG000|Overall Study|Withdrawal by Subject|12|||
46946524|NCT02648204|83184705|FG001|Overall Study|Withdrawal by Subject|8|||
46946525|NCT02648204|83184706|FG002|Overall Study|Withdrawal by Subject|2|||
46946526|NCT02648204|83184707|FG003|Overall Study|Withdrawal by Subject|6|||
46946527|NCT02648204|83184704|FG000|Overall Study|Lost to Follow-up|5|||
46946528|NCT02648204|83184705|FG001|Overall Study|Lost to Follow-up|8|||
46946529|NCT02648204|83184706|FG002|Overall Study|Lost to Follow-up|4|||
46946530|NCT02648204|83184707|FG003|Overall Study|Lost to Follow-up|6|||
46946531|NCT02648204|83184704|FG000|Overall Study|Missing follow-up information|4|||
46946532|NCT02648204|83184705|FG001|Overall Study|Missing follow-up information|4|||
46946533|NCT02648204|83184706|FG002|Overall Study|Missing follow-up information|4|||
46946534|NCT02648204|83184707|FG003|Overall Study|Missing follow-up information|2|||
46946535|NCT02648204|83184704|FG000|Overall Study|Death|1|||
46946536|NCT02648204|83184705|FG001|Overall Study|Death|1|||
46946537|NCT02648204|83184706|FG002|Overall Study|Death|2|||
46946538|NCT02648204|83184707|FG003|Overall Study|Death|2|||
46946539|NCT02648204|83184704|FG000|Overall Study|Adverse Event|0|||
46946540|NCT02648204|83184705|FG001|Overall Study|Adverse Event|0|||
46946541|NCT02648204|83184706|FG002|Overall Study|Adverse Event|1|||
46946542|NCT02648204|83184707|FG003|Overall Study|Adverse Event|0|||
46946543|NCT02799745|83184719|FG000|Overall Study|Participant moved out of state|1|||
46946544|NCT02799745|83184720|FG001|Overall Study|Participant moved out of state|0|||
46946545|NCT02799745|83184719|FG000|Overall Study|Discontinued due to planned surgery|1|||
46946546|NCT02799745|83184720|FG001|Overall Study|Discontinued due to planned surgery|0|||
46946547|NCT02799745|83184719|FG000|Overall Study|Withdrawal by Subject|16|||
46946548|NCT02799745|83184720|FG001|Overall Study|Withdrawal by Subject|25|||
46946549|NCT02799745|83184719|FG000|Overall Study|Protocol Deviation|4|||
46946550|NCT02799745|83184720|FG001|Overall Study|Protocol Deviation|5|||
46946551|NCT02799745|83184719|FG000|Overall Study|Progressive Disease|28|||
46946552|NCT02799745|83184720|FG001|Overall Study|Progressive Disease|38|||
46946553|NCT02799745|83184719|FG000|Overall Study|Lost to Follow-up|3|||
46946554|NCT02799745|83184720|FG001|Overall Study|Lost to Follow-up|2|||
46946555|NCT02799745|83184719|FG000|Overall Study|Death|3|||
46946556|NCT02799745|83184720|FG001|Overall Study|Death|0|||
46946557|NCT02799745|83184719|FG000|Overall Study|Adverse Event|0|||
47065044|NCT01563536|83347482|FG000|Overall Study|Withdrawal by Subject|0|||
47065045|NCT01563536|83347483|FG001|Overall Study|Withdrawal by Subject|2|||
47065046|NCT01563536|83347482|FG000|Overall Study|Lost to Follow-up|1|||
47065047|NCT01563536|83347483|FG001|Overall Study|Lost to Follow-up|0|||
47065048|NCT01690130|83347491|FG000|Overall Study|Subject have cancelled visit.|1|||
47065049|NCT01690130|83347492|FG001|Overall Study|Subject have cancelled visit.|0|||
47065050|NCT01690052|83347498|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
47065051|NCT01690052|83347499|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
47065052|NCT01689974|83347526|FG000|Overall Study|Termination of Study|5|||
47065053|NCT01689974|83347527|FG001|Overall Study|Termination of Study|5|||
47065054|NCT01587014|83347533|FG000|Overall Study|Death|2|||
47065055|NCT01458535|83347637|FG000|Overall Study|Other|0|||
47065056|NCT01458535|83347638|FG001|Overall Study|Other|0|||
47065057|NCT01458535|83347639|FG002|Overall Study|Other|0|||
47065058|NCT01458535|83347640|FG003|Overall Study|Other|0|||
47065059|NCT01458535|83347641|FG004|Overall Study|Other|1|||
47065060|NCT01458535|83347642|FG005|Overall Study|Other|1|||
47065061|NCT01458535|83347637|FG000|Overall Study|Withdrawal by Subject|0|||
47065062|NCT01458535|83347638|FG001|Overall Study|Withdrawal by Subject|0|||
47065063|NCT01458535|83347639|FG002|Overall Study|Withdrawal by Subject|2|||
47065064|NCT01458535|83347640|FG003|Overall Study|Withdrawal by Subject|0|||
47065065|NCT01458535|83347641|FG004|Overall Study|Withdrawal by Subject|1|||
47065066|NCT01458535|83347642|FG005|Overall Study|Withdrawal by Subject|1|||
47065067|NCT01458535|83347637|FG000|Overall Study|Lost to Follow-up|0|||
47065068|NCT01458535|83347638|FG001|Overall Study|Lost to Follow-up|2|||
47065069|NCT01458535|83347639|FG002|Overall Study|Lost to Follow-up|0|||
47065070|NCT01458535|83347640|FG003|Overall Study|Lost to Follow-up|3|||
46946558|NCT02799745|83184720|FG001|Overall Study|Adverse Event|1|||
46946559|NCT00705159|83184730|FG000|Overall Study|Withdrawal by Subject|0|||
47065071|NCT01458535|83347641|FG004|Overall Study|Lost to Follow-up|2|||
47065072|NCT01458535|83347642|FG005|Overall Study|Lost to Follow-up|2|||
47065073|NCT01458535|83347637|FG000|Overall Study|Adverse Event|0|||
47065074|NCT01458535|83347638|FG001|Overall Study|Adverse Event|0|||
46946560|NCT00705159|83184731|FG001|Overall Study|Withdrawal by Subject|1|||
46946561|NCT00705159|83184732|FG002|Overall Study|Withdrawal by Subject|1|||
46946562|NCT00705159|83184733|FG003|Overall Study|Withdrawal by Subject|1|||
46946563|NCT00705159|83184730|FG000|Overall Study|Protocol Violation|0|||
46946564|NCT00705159|83184731|FG001|Overall Study|Protocol Violation|1|||
46946565|NCT00705159|83184732|FG002|Overall Study|Protocol Violation|0|||
46946566|NCT00705159|83184733|FG003|Overall Study|Protocol Violation|0|||
46946567|NCT00705159|83184730|FG000|Overall Study|Adverse Event|0|||
47065075|NCT01458535|83347639|FG002|Overall Study|Adverse Event|0|||
47065076|NCT01458535|83347640|FG003|Overall Study|Adverse Event|1|||
47065077|NCT01458535|83347641|FG004|Overall Study|Adverse Event|0|||
47065078|NCT01458535|83347642|FG005|Overall Study|Adverse Event|0|||
47065079|NCT01464827|83347670|FG000|Overall Study|Adverse Event|0|||
47065080|NCT01464827|83347671|FG001|Overall Study|Adverse Event|0|||
47065081|NCT01464827|83347672|FG002|Overall Study|Adverse Event|0|||
47065082|NCT01464827|83347673|FG003|Overall Study|Adverse Event|0|||
47065083|NCT01464827|83347674|FG004|Overall Study|Adverse Event|0|||
47065084|NCT01464827|83347675|FG005|Overall Study|Adverse Event|0|||
47065085|NCT01464827|83347676|FG006|Overall Study|Adverse Event|0|||
47065086|NCT01464827|83347677|FG007|Overall Study|Adverse Event|0|||
47065087|NCT01464827|83347678|FG008|Overall Study|Adverse Event|0|||
47065088|NCT01464827|83347679|FG009|Overall Study|Adverse Event|0|||
47065089|NCT01464827|83347680|FG010|Overall Study|Adverse Event|0|||
47065090|NCT01464827|83347681|FG011|Overall Study|Adverse Event|0|||
46946568|NCT00705159|83184731|FG001|Overall Study|Adverse Event|0|||
46946569|NCT00705159|83184732|FG002|Overall Study|Adverse Event|1|||
47065091|NCT01464827|83347682|FG012|Overall Study|Adverse Event|1|||
47065092|NCT01464827|83347683|FG013|Overall Study|Adverse Event|0|||
46946570|NCT00705159|83184733|FG003|Overall Study|Adverse Event|0|||
47065093|NCT01464827|83347670|FG000|Overall Study|Withdrawal by Subject|1|||
47065094|NCT01464827|83347671|FG001|Overall Study|Withdrawal by Subject|0|||
47065095|NCT01464827|83347672|FG002|Overall Study|Withdrawal by Subject|0|||
47065096|NCT01464827|83347673|FG003|Overall Study|Withdrawal by Subject|0|||
47065097|NCT01464827|83347674|FG004|Overall Study|Withdrawal by Subject|1|||
47065098|NCT01464827|83347675|FG005|Overall Study|Withdrawal by Subject|0|||
47065099|NCT01464827|83347676|FG006|Overall Study|Withdrawal by Subject|0|||
47065100|NCT01464827|83347677|FG007|Overall Study|Withdrawal by Subject|1|||
47065101|NCT01464827|83347678|FG008|Overall Study|Withdrawal by Subject|0|||
47065102|NCT01464827|83347679|FG009|Overall Study|Withdrawal by Subject|0|||
47065103|NCT01464827|83347680|FG010|Overall Study|Withdrawal by Subject|0|||
47065104|NCT01464827|83347681|FG011|Overall Study|Withdrawal by Subject|0|||
47065105|NCT01464827|83347682|FG012|Overall Study|Withdrawal by Subject|0|||
47065106|NCT01464827|83347683|FG013|Overall Study|Withdrawal by Subject|0|||
47065107|NCT01464827|83347670|FG000|Overall Study|Lost to Follow-up|0|||
47065108|NCT01464827|83347671|FG001|Overall Study|Lost to Follow-up|2|||
47065109|NCT01464827|83347672|FG002|Overall Study|Lost to Follow-up|0|||
47065110|NCT01464827|83347673|FG003|Overall Study|Lost to Follow-up|2|||
47065111|NCT01464827|83347674|FG004|Overall Study|Lost to Follow-up|3|||
47065112|NCT01464827|83347675|FG005|Overall Study|Lost to Follow-up|1|||
47065113|NCT01464827|83347676|FG006|Overall Study|Lost to Follow-up|2|||
47065114|NCT01464827|83347677|FG007|Overall Study|Lost to Follow-up|2|||
47065115|NCT01464827|83347678|FG008|Overall Study|Lost to Follow-up|0|||
47065116|NCT01464827|83347679|FG009|Overall Study|Lost to Follow-up|0|||
47065117|NCT01464827|83347680|FG010|Overall Study|Lost to Follow-up|0|||
47065118|NCT01464827|83347681|FG011|Overall Study|Lost to Follow-up|1|||
46770442|NCT00725985|82988793|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
46770443|NCT00725985|82988794|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
46770444|NCT00725985|82988795|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
46770445|NCT00725985|82988796|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
47065119|NCT01464827|83347682|FG012|Overall Study|Lost to Follow-up|0|||
46770446|NCT00725985|82988797|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
46770447|NCT00725985|82988798|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
46770448|NCT00725985|82988799|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
46770449|NCT00725985|82988800|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
46770450|NCT00725985|82988801|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
46770451|NCT00725985|82988790|FG000|ITP- Treatment Disposition|Other|50|||
46770452|NCT00725985|82988791|FG001|ITP- Treatment Disposition|Other|38|||
46770453|NCT00725985|82988792|FG002|ITP- Treatment Disposition|Other|24|||
46770454|NCT00725985|82988793|FG003|ITP- Treatment Disposition|Other|0|||
46946571|NCT00705159|83184730|FG000|Overall Study|Lost to Follow-up|0|||
47065120|NCT01464827|83347683|FG013|Overall Study|Lost to Follow-up|1|||
47065121|NCT01464827|83347670|FG000|Overall Study|Other|2|||
47065122|NCT01464827|83347671|FG001|Overall Study|Other|3|||
47065123|NCT01464827|83347672|FG002|Overall Study|Other|0|||
46946572|NCT00705159|83184731|FG001|Overall Study|Lost to Follow-up|0|||
47065124|NCT01464827|83347673|FG003|Overall Study|Other|2|||
47065125|NCT01464827|83347674|FG004|Overall Study|Other|3|||
47065126|NCT01464827|83347675|FG005|Overall Study|Other|0|||
47065127|NCT01464827|83347676|FG006|Overall Study|Other|1|||
46770455|NCT00725985|82988794|FG004|ITP- Treatment Disposition|Other|0|||
46946573|NCT00705159|83184732|FG002|Overall Study|Lost to Follow-up|3|||
46946574|NCT00705159|83184733|FG003|Overall Study|Lost to Follow-up|2|||
46946575|NCT00705159|83184730|FG000|Overall Study|Screen Failure|0|||
46946576|NCT00705159|83184731|FG001|Overall Study|Screen Failure|0|||
46946577|NCT00705159|83184732|FG002|Overall Study|Screen Failure|0|||
46946578|NCT00705159|83184733|FG003|Overall Study|Screen Failure|1|||
46946579|NCT01673984|83184745|FG000|Overall Study|Adverse Event|1|||
47065128|NCT01464827|83347677|FG007|Overall Study|Other|0|||
47065129|NCT01464827|83347678|FG008|Overall Study|Other|3|||
47065130|NCT01464827|83347679|FG009|Overall Study|Other|1|||
47065131|NCT01464827|83347680|FG010|Overall Study|Other|2|||
47065132|NCT01464827|83347681|FG011|Overall Study|Other|0|||
47065133|NCT01464827|83347682|FG012|Overall Study|Other|1|||
47065134|NCT01464827|83347683|FG013|Overall Study|Other|0|||
47065135|NCT01464827|83347670|FG000|Overall Study|Not Treated|0|||
47065136|NCT01464827|83347671|FG001|Overall Study|Not Treated|2|||
47065137|NCT01464827|83347672|FG002|Overall Study|Not Treated|0|||
47065138|NCT01464827|83347673|FG003|Overall Study|Not Treated|0|||
47065139|NCT01464827|83347674|FG004|Overall Study|Not Treated|1|||
47065140|NCT01464827|83347675|FG005|Overall Study|Not Treated|0|||
46946580|NCT01673984|83184746|FG001|Overall Study|Adverse Event|0|||
46946581|NCT01673984|83184745|FG000|Overall Study|Study termination|9|||
47065141|NCT01464827|83347676|FG006|Overall Study|Not Treated|1|||
47065142|NCT01464827|83347677|FG007|Overall Study|Not Treated|0|||
47065143|NCT01464827|83347678|FG008|Overall Study|Not Treated|0|||
47065144|NCT01464827|83347679|FG009|Overall Study|Not Treated|2|||
47065145|NCT01464827|83347680|FG010|Overall Study|Not Treated|0|||
47065146|NCT01464827|83347681|FG011|Overall Study|Not Treated|1|||
47065147|NCT01464827|83347682|FG012|Overall Study|Not Treated|0|||
47065148|NCT01464827|83347683|FG013|Overall Study|Not Treated|2|||
47065149|NCT01463111|83347724|FG000|Overall Study|Withdrawal by Subject|2|||
47065150|NCT01463111|83347724|FG000|Overall Study|Lost to Follow-up|5|||
46638816|NCT01432938|82812252|FG001|First Intervention|Physician Decision|0|||
46638817|NCT01432938|82812251|FG000|Second Intervention|Adverse Event|1|||
46638818|NCT01432938|82812252|FG001|Second Intervention|Adverse Event|0|||
46638819|NCT01392300|82812261|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
46946582|NCT01673984|83184746|FG001|Overall Study|Study termination|6|||
47065151|NCT01463111|83347724|FG000|Overall Study|Physician Decision|2|||
46946583|NCT02332928|83184765|FG000|Overall Study|Withdrawal by Subject|0|||
46946584|NCT02332928|83184766|FG001|Overall Study|Withdrawal by Subject|2|||
46946585|NCT02332928|83184765|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
47065152|NCT01463033|83347730|FG000|Overall Study|Lost to Follow-up|4|||
47065153|NCT01463033|83347731|FG001|Overall Study|Lost to Follow-up|4|||
46638820|NCT01392300|82812262|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
46638821|NCT01392300|82812263|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
46638822|NCT01392300|82812261|FG000|Main Period (MP)|Withdrawal by Subject|5|||
46638823|NCT01392300|82812262|FG001|Main Period (MP)|Withdrawal by Subject|1|||
46638824|NCT01392300|82812263|FG002|Main Period (MP)|Withdrawal by Subject|0|||
46638825|NCT01392300|82812261|FG000|Main Period (MP)|Lost to Follow-up|3|||
46638826|NCT01392300|82812262|FG001|Main Period (MP)|Lost to Follow-up|3|||
46638827|NCT01392300|82812263|FG002|Main Period (MP)|Lost to Follow-up|0|||
46638828|NCT01392300|82812261|FG000|Main Period (MP)|Non-compliance|1|||
46638829|NCT01392300|82812262|FG001|Main Period (MP)|Non-compliance|0|||
46638830|NCT01392300|82812263|FG002|Main Period (MP)|Non-compliance|0|||
46638831|NCT01392300|82812261|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
46638832|NCT01392300|82812262|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
46638833|NCT01392300|82812263|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
47065154|NCT01463033|83347730|FG000|Overall Study|Death|3|||
47065155|NCT01463033|83347731|FG001|Overall Study|Death|2|||
47065156|NCT01461707|83347740|FG000|Overall Study|Withdrawal by Subject|1|||
47065157|NCT01461707|83347741|FG001|Overall Study|Withdrawal by Subject|0|||
46638834|NCT01392300|82812261|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
46840450|NCT05195528|83057709|FG001|Extension Period|Withdrawal by Subject|12|||
46946586|NCT02332928|83184766|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
47065158|NCT01461551|83347750|FG000|Overall Study|Physician Decision|2|||
47065159|NCT01461551|83347751|FG001|Overall Study|Physician Decision|1|||
47065160|NCT01461551|83347752|FG002|Overall Study|Physician Decision|2|||
47065161|NCT01461005|83347760|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
47065162|NCT01460381|83347767|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
47065163|NCT01460381|83347768|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
47065164|NCT01473589|83347852|FG000|Overall Study|Adverse Event|1|||
47065165|NCT01473589|83347853|FG001|Overall Study|Adverse Event|1|||
47065166|NCT01473589|83347852|FG000|Overall Study|Death|2|||
46638835|NCT01392300|82812262|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
46946587|NCT02647658|83184774|FG000|Overall Study|Consent refusal|15|||
46946588|NCT02647658|83184775|FG001|Overall Study|Consent refusal|24|||
46946589|NCT00703677|83184781|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
47065167|NCT01473589|83347853|FG001|Overall Study|Death|0|||
47065168|NCT01473589|83347852|FG000|Overall Study|Lost to Follow-up|2|||
46638836|NCT01392300|82812263|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
46638837|NCT01392300|82812261|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
46638838|NCT01392300|82812262|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
46638839|NCT01392300|82812263|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
46638840|NCT01392300|82812261|FG000|Open Label Extension (OLEX) Period|Death|0|||
46638841|NCT01392300|82812262|FG001|Open Label Extension (OLEX) Period|Death|0|||
46638842|NCT01392300|82812263|FG002|Open Label Extension (OLEX) Period|Death|4|||
46638843|NCT01392300|82812261|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
46638844|NCT01392300|82812262|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
46638845|NCT01392300|82812263|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
46638846|NCT01392300|82812261|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
46638847|NCT01392300|82812262|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
46638848|NCT01392300|82812263|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
47065169|NCT01473589|83347853|FG001|Overall Study|Lost to Follow-up|2|||
47065170|NCT01473589|83347852|FG000|Overall Study|Protocol Violation|1|||
47065171|NCT01473589|83347853|FG001|Overall Study|Protocol Violation|0|||
47065172|NCT01473589|83347852|FG000|Overall Study|Withdrawal by Subject|5|||
47065173|NCT01473589|83347853|FG001|Overall Study|Withdrawal by Subject|11|||
47065174|NCT01473589|83347852|FG000|Overall Study|Physician Decision|0|||
47065175|NCT01473589|83347853|FG001|Overall Study|Physician Decision|1|||
47065176|NCT01473589|83347852|FG000|Overall Study|Entry criteria not met|0|||
47065177|NCT01473589|83347853|FG001|Overall Study|Entry criteria not met|1|||
47065178|NCT01500187|83347872|FG000|Overall Study|Lost to Follow-up|6|||
47065179|NCT01500187|83347873|FG001|Overall Study|Lost to Follow-up|0|||
47065180|NCT01500031|83347891|FG000|Overall Study|Death|1|||
47065181|NCT01500031|83347891|FG000|Overall Study|Withdrawal by Subject|4|||
46638849|NCT01392300|82812261|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
46638850|NCT01392300|82812262|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
46770456|NCT00725985|82988795|FG005|ITP- Treatment Disposition|Other|0|||
46770457|NCT00725985|82988796|FG006|ITP- Treatment Disposition|Other|0|||
46770458|NCT00725985|82988797|FG007|ITP- Treatment Disposition|Other|0|||
46770459|NCT00725985|82988798|FG008|ITP- Treatment Disposition|Other|0|||
46770460|NCT00725985|82988799|FG009|ITP- Treatment Disposition|Other|0|||
46946590|NCT00703911|83184789|FG000|Overall Study|Death|1|||
46946591|NCT00703911|83184789|FG000|Overall Study|Physician Decision|6|||
46946592|NCT00703911|83184789|FG000|Overall Study|Lost to Follow-up|1|||
46946593|NCT00703911|83184789|FG000|Overall Study|Withdrawal by Subject|2|||
46946594|NCT02055547|83184793|FG000|Overall Study|Protocol Violation|0|||
46946595|NCT02055547|83184794|FG001|Overall Study|Protocol Violation|0|||
46946596|NCT02055547|83184795|FG002|Overall Study|Protocol Violation|1|||
47065182|NCT01473355|83347904|FG000|Overall Study|Protocol Violation|2|||
47065183|NCT01473355|83347904|FG000|Overall Study|Adverse Event|2|||
47065184|NCT01473355|83347904|FG000|Overall Study|Lost to Follow-up|2|||
46770461|NCT00725985|82988800|FG010|ITP- Treatment Disposition|Other|0|||
46770462|NCT00725985|82988801|FG011|ITP- Treatment Disposition|Other|0|||
46770463|NCT00725985|82988790|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46770464|NCT00725985|82988791|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46770465|NCT00725985|82988792|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46770466|NCT00725985|82988793|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
46770467|NCT00725985|82988794|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
46770468|NCT00725985|82988795|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
46770469|NCT00725985|82988796|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46770470|NCT00725985|82988797|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
47065185|NCT01472965|83347914|FG000|Overall Study|Withdrawal by Subject|1|||
46638851|NCT01392300|82812263|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
46946597|NCT02055547|83184796|FG003|Overall Study|Protocol Violation|0|||
46946598|NCT02055547|83184797|FG004|Overall Study|Protocol Violation|0|||
47065186|NCT01472965|83347915|FG001|Overall Study|Withdrawal by Subject|0|||
47065187|NCT01457053|83347925|FG000|Overall Study|Unable to undergo selected treatment|1|||
47065188|NCT01457053|83347926|FG001|Overall Study|Unable to undergo selected treatment|1|||
46770471|NCT00725985|82988798|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46770472|NCT00725985|82988799|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46946599|NCT02055547|83184798|FG005|Overall Study|Protocol Violation|0|||
46946600|NCT02055547|83184799|FG006|Overall Study|Protocol Violation|1|||
46946601|NCT02055547|83184800|FG007|Overall Study|Protocol Violation|0|||
46946602|NCT02055547|83184801|FG008|Overall Study|Protocol Violation|0|||
46946603|NCT02055547|83184802|FG009|Overall Study|Protocol Violation|0|||
46946604|NCT02055547|83184803|FG010|Overall Study|Protocol Violation|0|||
46946605|NCT02055547|83184804|FG011|Overall Study|Protocol Violation|0|||
46946606|NCT02055547|83184805|FG012|Overall Study|Protocol Violation|0|||
46946607|NCT02055547|83184806|FG013|Overall Study|Protocol Violation|0|||
46946608|NCT02055547|83184807|FG014|Overall Study|Protocol Violation|0|||
46946609|NCT02055547|83184808|FG015|Overall Study|Protocol Violation|0|||
46946610|NCT02055547|83184809|FG016|Overall Study|Protocol Violation|0|||
46946611|NCT02055547|83184810|FG017|Overall Study|Protocol Violation|0|||
46946612|NCT02055547|83184811|FG018|Overall Study|Protocol Violation|0|||
46946613|NCT02055547|83184793|FG000|Overall Study|Physician Decision|0|||
46946614|NCT02055547|83184794|FG001|Overall Study|Physician Decision|1|||
46946615|NCT02055547|83184795|FG002|Overall Study|Physician Decision|1|||
46946616|NCT02055547|83184796|FG003|Overall Study|Physician Decision|0|||
46946617|NCT02055547|83184797|FG004|Overall Study|Physician Decision|1|||
46946618|NCT02055547|83184798|FG005|Overall Study|Physician Decision|0|||
46946619|NCT02055547|83184799|FG006|Overall Study|Physician Decision|0|||
46946620|NCT02055547|83184800|FG007|Overall Study|Physician Decision|0|||
46946621|NCT02055547|83184801|FG008|Overall Study|Physician Decision|0|||
46946622|NCT02055547|83184802|FG009|Overall Study|Physician Decision|1|||
46946623|NCT02055547|83184803|FG010|Overall Study|Physician Decision|1|||
46946624|NCT02055547|83184804|FG011|Overall Study|Physician Decision|0|||
46946625|NCT02055547|83184805|FG012|Overall Study|Physician Decision|0|||
46946626|NCT02055547|83184806|FG013|Overall Study|Physician Decision|0|||
46946627|NCT02055547|83184807|FG014|Overall Study|Physician Decision|0|||
46946628|NCT02055547|83184808|FG015|Overall Study|Physician Decision|0|||
46946629|NCT02055547|83184809|FG016|Overall Study|Physician Decision|0|||
46946630|NCT02055547|83184810|FG017|Overall Study|Physician Decision|0|||
46946631|NCT02055547|83184811|FG018|Overall Study|Physician Decision|0|||
46946632|NCT02055547|83184793|FG000|Overall Study|Adverse Event|0|||
46946633|NCT02055547|83184794|FG001|Overall Study|Adverse Event|0|||
46946634|NCT02055547|83184795|FG002|Overall Study|Adverse Event|0|||
46638852|NCT01432626|82812270|FG000|Overall Study|LV function recovered|2|||
46638853|NCT01432626|82812270|FG000|Overall Study|Withdrawal by Subject|2|||
46638854|NCT01432626|82812270|FG000|Overall Study|Only 1 image competed|2|||
46638855|NCT01432626|82812270|FG000|Overall Study|Imaging agent not available|1|||
46638856|NCT01410474|82812276|FG000|Overall Study|Withdrawal by Subject|0|||
46638857|NCT01410474|82812277|FG001|Overall Study|Withdrawal by Subject|1|||
46638858|NCT01391130|82812292|FG000|Overall Study|Withdrawal by Subject|3|||
46638859|NCT01391130|82812293|FG001|Overall Study|Withdrawal by Subject|2|||
46946635|NCT02055547|83184796|FG003|Overall Study|Adverse Event|0|||
46638860|NCT01391130|82812292|FG000|Overall Study|Physician Decision|2|||
46638861|NCT01391130|82812293|FG001|Overall Study|Physician Decision|3|||
46638862|NCT01391130|82812292|FG000|Overall Study|Did not Receive Drug|1|||
46638863|NCT01391130|82812293|FG001|Overall Study|Did not Receive Drug|1|||
46638864|NCT01410240|82812302|FG000|Overall Study|Physician Decision|0|||
46638865|NCT01410240|82812303|FG001|Overall Study|Physician Decision|0|||
46946636|NCT02055547|83184797|FG004|Overall Study|Adverse Event|0|||
46946637|NCT02055547|83184798|FG005|Overall Study|Adverse Event|0|||
46946638|NCT02055547|83184799|FG006|Overall Study|Adverse Event|1|||
46946639|NCT02055547|83184800|FG007|Overall Study|Adverse Event|0|||
46946640|NCT02055547|83184801|FG008|Overall Study|Adverse Event|1|||
46946641|NCT02055547|83184802|FG009|Overall Study|Adverse Event|0|||
46946642|NCT02055547|83184803|FG010|Overall Study|Adverse Event|0|||
46946643|NCT02055547|83184804|FG011|Overall Study|Adverse Event|0|||
46946644|NCT02055547|83184805|FG012|Overall Study|Adverse Event|0|||
46946645|NCT02055547|83184806|FG013|Overall Study|Adverse Event|0|||
46946646|NCT02055547|83184807|FG014|Overall Study|Adverse Event|0|||
46638866|NCT01410240|82812304|FG002|Overall Study|Physician Decision|1|||
46638867|NCT01410240|82812302|FG000|Overall Study|Missed week 6 assessments|1|||
46638868|NCT01410240|82812303|FG001|Overall Study|Missed week 6 assessments|1|||
46638869|NCT01410240|82812304|FG002|Overall Study|Missed week 6 assessments|1|||
46840451|NCT05195528|83057710|FG002|Extension Period|Withdrawal by Subject|9|||
46946647|NCT02055547|83184808|FG015|Overall Study|Adverse Event|0|||
46946648|NCT02055547|83184809|FG016|Overall Study|Adverse Event|0|||
46946649|NCT02055547|83184810|FG017|Overall Study|Adverse Event|0|||
46946650|NCT02055547|83184811|FG018|Overall Study|Adverse Event|0|||
46946651|NCT02055547|83184793|FG000|Overall Study|Withdrawal by Subject|0|||
46946652|NCT02055547|83184794|FG001|Overall Study|Withdrawal by Subject|0|||
46946653|NCT02055547|83184795|FG002|Overall Study|Withdrawal by Subject|0|||
46946654|NCT02055547|83184796|FG003|Overall Study|Withdrawal by Subject|0|||
46946655|NCT02055547|83184797|FG004|Overall Study|Withdrawal by Subject|0|||
46946656|NCT02055547|83184798|FG005|Overall Study|Withdrawal by Subject|1|||
46946657|NCT02055547|83184799|FG006|Overall Study|Withdrawal by Subject|0|||
46946658|NCT02055547|83184800|FG007|Overall Study|Withdrawal by Subject|0|||
46946659|NCT02055547|83184801|FG008|Overall Study|Withdrawal by Subject|1|||
46946660|NCT02055547|83184802|FG009|Overall Study|Withdrawal by Subject|0|||
46946661|NCT02055547|83184803|FG010|Overall Study|Withdrawal by Subject|0|||
46946662|NCT02055547|83184804|FG011|Overall Study|Withdrawal by Subject|0|||
46946663|NCT02055547|83184805|FG012|Overall Study|Withdrawal by Subject|0|||
46946664|NCT02055547|83184806|FG013|Overall Study|Withdrawal by Subject|1|||
46946665|NCT02055547|83184807|FG014|Overall Study|Withdrawal by Subject|0|||
46946666|NCT02055547|83184808|FG015|Overall Study|Withdrawal by Subject|1|||
46946667|NCT02055547|83184809|FG016|Overall Study|Withdrawal by Subject|0|||
46946668|NCT02055547|83184810|FG017|Overall Study|Withdrawal by Subject|0|||
46946669|NCT02055547|83184811|FG018|Overall Study|Withdrawal by Subject|0|||
46946670|NCT02055547|83184793|FG000|Overall Study|Lost to Follow-up|0|||
46946671|NCT02055547|83184794|FG001|Overall Study|Lost to Follow-up|0|||
46946672|NCT02055547|83184795|FG002|Overall Study|Lost to Follow-up|1|||
46946673|NCT02055547|83184796|FG003|Overall Study|Lost to Follow-up|0|||
46946674|NCT02055547|83184797|FG004|Overall Study|Lost to Follow-up|0|||
46946675|NCT02055547|83184798|FG005|Overall Study|Lost to Follow-up|0|||
46946676|NCT02055547|83184799|FG006|Overall Study|Lost to Follow-up|0|||
46946677|NCT02055547|83184800|FG007|Overall Study|Lost to Follow-up|0|||
46946678|NCT02055547|83184801|FG008|Overall Study|Lost to Follow-up|0|||
46770473|NCT00725985|82988800|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46770474|NCT00725985|82988801|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
46946679|NCT02055547|83184802|FG009|Overall Study|Lost to Follow-up|0|||
46946680|NCT02055547|83184803|FG010|Overall Study|Lost to Follow-up|0|||
46946681|NCT02055547|83184804|FG011|Overall Study|Lost to Follow-up|0|||
46946682|NCT02055547|83184805|FG012|Overall Study|Lost to Follow-up|0|||
46946683|NCT02055547|83184806|FG013|Overall Study|Lost to Follow-up|0|||
46946684|NCT02055547|83184807|FG014|Overall Study|Lost to Follow-up|0|||
46946685|NCT02055547|83184808|FG015|Overall Study|Lost to Follow-up|0|||
46946686|NCT02055547|83184809|FG016|Overall Study|Lost to Follow-up|0|||
47065189|NCT01472341|83347941|FG000|Overall Study|Started insulin therapy|55|||
47065190|NCT01472341|83347941|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
47065191|NCT01472341|83347941|FG000|Overall Study|Withdrawal by Subject|39|||
47065192|NCT01472341|83347941|FG000|Overall Study|Lost to Follow-up|52|||
47065193|NCT01472341|83347941|FG000|Overall Study|Laboratory parameters unavailable|25|||
47065194|NCT01472341|83347941|FG000|Overall Study|Death|9|||
47065195|NCT01472185|83347947|FG000|Overall Study|Randomized but Not Treated|0|||
47065196|NCT01472185|83347948|FG001|Overall Study|Randomized but Not Treated|1|||
47065197|NCT01472185|83347947|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
47065198|NCT01472185|83347948|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
47065199|NCT01472185|83347947|FG000|Overall Study|Hyperglycemia|5|||
47065200|NCT01472185|83347948|FG001|Overall Study|Hyperglycemia|2|||
47065201|NCT01472185|83347947|FG000|Overall Study|Investigator's Discretion|3|||
46946687|NCT02055547|83184810|FG017|Overall Study|Lost to Follow-up|0|||
46946688|NCT02055547|83184811|FG018|Overall Study|Lost to Follow-up|0|||
47065202|NCT01472185|83347948|FG001|Overall Study|Investigator's Discretion|1|||
47065203|NCT01472185|83347947|FG000|Overall Study|Lost to Follow-up|4|||
47065204|NCT01472185|83347948|FG001|Overall Study|Lost to Follow-up|1|||
47065205|NCT01472185|83347947|FG000|Overall Study|Protocol Violation|5|||
46946689|NCT02414854|83184849|FG000|Overall Study|Adverse Event|9|||
46946690|NCT02414854|83184850|FG001|Overall Study|Adverse Event|7|||
46946691|NCT02414854|83184851|FG002|Overall Study|Adverse Event|1|||
46946692|NCT02414854|83184852|FG003|Overall Study|Adverse Event|12|||
46946693|NCT02414854|83184849|FG000|Overall Study|Poor compliance to protocol|1|||
46946694|NCT02414854|83184850|FG001|Overall Study|Poor compliance to protocol|1|||
46946695|NCT02414854|83184851|FG002|Overall Study|Poor compliance to protocol|2|||
46946696|NCT02414854|83184852|FG003|Overall Study|Poor compliance to protocol|2|||
46946697|NCT02414854|83184849|FG000|Overall Study|Other than specified above|12|||
46946698|NCT02414854|83184850|FG001|Overall Study|Other than specified above|37|||
47065206|NCT01472185|83347948|FG001|Overall Study|Protocol Violation|1|||
47065207|NCT01472185|83347947|FG000|Overall Study|Subject Noncompliance|8|||
47065208|NCT01472185|83347948|FG001|Overall Study|Subject Noncompliance|15|||
47065209|NCT01472185|83347947|FG000|Overall Study|Subject Withdrew Consent|6|||
47065210|NCT01472185|83347948|FG001|Overall Study|Subject Withdrew Consent|3|||
47065211|NCT01456897|83347969|FG000|Overall Study|Adverse Event|19|||
47065212|NCT01456897|83347970|FG001|Overall Study|Adverse Event|22|||
47065213|NCT01456897|83347969|FG000|Overall Study|Protocol Violation|3|||
47065214|NCT01456897|83347970|FG001|Overall Study|Protocol Violation|4|||
47065215|NCT01456897|83347969|FG000|Overall Study|Physician Decision|5|||
47065216|NCT01456897|83347970|FG001|Overall Study|Physician Decision|3|||
47065217|NCT01456897|83347969|FG000|Overall Study|Withdrawal by Subject|44|||
47065218|NCT01456897|83347970|FG001|Overall Study|Withdrawal by Subject|17|||
47065219|NCT01456897|83347969|FG000|Overall Study|Lack of Efficacy|4|||
47065220|NCT01456897|83347970|FG001|Overall Study|Lack of Efficacy|11|||
47065221|NCT01456195|83347983|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
47065222|NCT01456195|83347984|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
47065223|NCT01456195|83347985|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
47065224|NCT01456195|83347983|FG000|Overall Study|Lost to Follow-up|3|||
46946699|NCT02414854|83184851|FG002|Overall Study|Other than specified above|17|||
46946700|NCT02414854|83184852|FG003|Overall Study|Other than specified above|37|||
46946701|NCT03332498|83184865|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
46946702|NCT03332498|83184866|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
46946703|NCT03332498|83184867|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
46840452|NCT05195528|83057711|FG003|Extension Period|Withdrawal by Subject|6|||
46840453|NCT05195528|83057712|FG004|Extension Period|Withdrawal by Subject|5|||
47065225|NCT01456195|83347984|FG001|Overall Study|Lost to Follow-up|1|||
47065226|NCT01456195|83347985|FG002|Overall Study|Lost to Follow-up|3|||
47065227|NCT01456195|83347983|FG000|Overall Study|Voluntary Withdrawal|5|||
47065228|NCT01456195|83347984|FG001|Overall Study|Voluntary Withdrawal|3|||
47065229|NCT01456195|83347985|FG002|Overall Study|Voluntary Withdrawal|7|||
47065230|NCT01456195|83347983|FG000|Overall Study|Lack of Efficacy|0|||
47065231|NCT01456195|83347984|FG001|Overall Study|Lack of Efficacy|1|||
47065232|NCT01456195|83347985|FG002|Overall Study|Lack of Efficacy|0|||
47065233|NCT01456195|83347983|FG000|Overall Study|Other Reasons|2|||
47065234|NCT01456195|83347984|FG001|Overall Study|Other Reasons|1|||
47065235|NCT01456195|83347985|FG002|Overall Study|Other Reasons|3|||
47065236|NCT01456039|83348049|FG000|Phase 1 (First Step)|Disease Progression|1|||
47065237|NCT01456039|83348050|FG001|Phase 1 (First Step)|Disease Progression|1|||
47065238|NCT01456039|83348051|FG002|Phase 1 (First Step)|Disease Progression|0|||
47065239|NCT01456039|83348049|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
47065240|NCT01456039|83348050|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
47065241|NCT01456039|83348051|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
47065242|NCT01456039|83348049|FG000|Phase 1 (First Step)|Adverse Event|0|||
47065243|NCT01456039|83348050|FG001|Phase 1 (First Step)|Adverse Event|3|||
47065244|NCT01456039|83348051|FG002|Phase 1 (First Step)|Adverse Event|0|||
47065245|NCT01456039|83348049|FG000|Phase 1 (First Step)|Other|0|||
47065246|NCT01456039|83348050|FG001|Phase 1 (First Step)|Other|1|||
47065247|NCT01456039|83348051|FG002|Phase 1 (First Step)|Other|0|||
47065248|NCT01456039|83348049|FG000|Phase 2 (Second Step)|Disease Progression|0|||
47065249|NCT01456039|83348050|FG001|Phase 2 (Second Step)|Disease Progression|0|||
47065250|NCT01456039|83348051|FG002|Phase 2 (Second Step)|Disease Progression|17|||
46946704|NCT01334125|83184876|FG000|Overall Study|Lost to Follow-up|3|||
46946705|NCT01334125|83184877|FG001|Overall Study|Lost to Follow-up|3|||
46946706|NCT02414152|83184884|FG000|Overall Study|Withdrawal by Subject|1|||
47065251|NCT01456039|83348049|FG000|Phase 2 (Second Step)|Adverse Event|0|||
47065252|NCT01456039|83348050|FG001|Phase 2 (Second Step)|Adverse Event|0|||
47065253|NCT01456039|83348051|FG002|Phase 2 (Second Step)|Adverse Event|10|||
47065254|NCT01456039|83348049|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
46840454|NCT05195528|83057708|FG000|Extension Period|Lack of Efficacy|0|||
46840455|NCT05195528|83057709|FG001|Extension Period|Lack of Efficacy|3|||
46840456|NCT05195528|83057710|FG002|Extension Period|Lack of Efficacy|0|||
46840457|NCT05195528|83057711|FG003|Extension Period|Lack of Efficacy|0|||
46840458|NCT05195528|83057712|FG004|Extension Period|Lack of Efficacy|2|||
46946707|NCT02414152|83184884|FG000|Overall Study|Lack of Efficacy|1|||
47065255|NCT01456039|83348050|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
47065256|NCT01456039|83348051|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
47065257|NCT01456039|83348049|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
47065258|NCT01456039|83348050|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
47065259|NCT01456039|83348051|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
46840459|NCT05195528|83057708|FG000|Extension Period|Not Treated|0|||
46840460|NCT05195528|83057709|FG001|Extension Period|Not Treated|0|||
47065260|NCT01456039|83348049|FG000|Phase 2 (Second Step)|Other|0|||
47065261|NCT01456039|83348050|FG001|Phase 2 (Second Step)|Other|0|||
47065262|NCT01456039|83348051|FG002|Phase 2 (Second Step)|Other|1|||
47065263|NCT01455415|83348069|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
47065264|NCT01455415|83348070|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
46840461|NCT05195528|83057710|FG002|Extension Period|Not Treated|2|||
47065265|NCT01455415|83348069|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
47065266|NCT01455415|83348070|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
47065267|NCT01455415|83348069|FG000|Period 1|Drug Error not Associated to AE|0|||
47065268|NCT01455415|83348070|FG001|Period 1|Drug Error not Associated to AE|1|||
47065269|NCT01455415|83348069|FG000|Period 1|AE Not Related to Study Drug|2|||
47065270|NCT01455415|83348070|FG001|Period 1|AE Not Related to Study Drug|6|||
47065271|NCT01455415|83348069|FG000|Period 1|Withdrawal by Subject|4|||
47065272|NCT01455415|83348070|FG001|Period 1|Withdrawal by Subject|5|||
47065273|NCT01455415|83348069|FG000|Period 1|Unspecified Reason|1|||
47065274|NCT01455415|83348070|FG001|Period 1|Unspecified Reason|1|||
47065275|NCT01455415|83348069|FG000|Period 1|Protocol Violation|0|||
47065276|NCT01455415|83348070|FG001|Period 1|Protocol Violation|2|||
47065277|NCT01455415|83348069|FG000|Washout|AE Related to Study Drug|2|||
47065278|NCT01455415|83348070|FG001|Washout|AE Related to Study Drug|0|||
47065279|NCT01455415|83348069|FG000|Washout|Lost to Follow-up|1|||
47065280|NCT01455415|83348070|FG001|Washout|Lost to Follow-up|0|||
47065281|NCT01455415|83348069|FG000|Washout|Drug Error not Associated to AE|2|||
47065282|NCT01455415|83348070|FG001|Washout|Drug Error not Associated to AE|1|||
47065283|NCT01455415|83348069|FG000|Washout|AE Not Related to Study Drug|2|||
47065284|NCT01455415|83348070|FG001|Washout|AE Not Related to Study Drug|3|||
47065285|NCT01455415|83348069|FG000|Washout|Unspecified Reason|1|||
46946708|NCT02413996|83184890|FG000|Overall Study|not comfortable with the intervention|9|||
46946709|NCT02413996|83184891|FG001|Overall Study|not comfortable with the intervention|2|||
46946710|NCT01333501|83184899|FG000|Overall Study|Adverse Event|3|||
46946711|NCT01333501|83184900|FG001|Overall Study|Adverse Event|1|||
46946712|NCT01333501|83184899|FG000|Overall Study|Abnormal laboratory value|2|||
46946713|NCT01333501|83184900|FG001|Overall Study|Abnormal laboratory value|1|||
46946714|NCT01333501|83184899|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46946715|NCT01333501|83184900|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
46946716|NCT01333501|83184899|FG000|Overall Study|Withdrawn consent|3|||
46946717|NCT01333501|83184900|FG001|Overall Study|Withdrawn consent|12|||
46946718|NCT01362140|83184908|FG000|Overall Study|Noncompliance|1|||
46946719|NCT01362140|83184909|FG001|Overall Study|Noncompliance|0|||
46946720|NCT01362140|83184908|FG000|Overall Study|Adverse Event|2|||
46946721|NCT01362140|83184909|FG001|Overall Study|Adverse Event|2|||
46946722|NCT01362140|83184908|FG000|Overall Study|Withdrawal by Subject|3|||
46946723|NCT01362140|83184909|FG001|Overall Study|Withdrawal by Subject|3|||
47065286|NCT01455415|83348070|FG001|Washout|Unspecified Reason|2|||
47065287|NCT01455415|83348069|FG000|Washout|Protocol Violation|0|||
47065288|NCT01455415|83348070|FG001|Washout|Protocol Violation|1|||
47065289|NCT01455415|83348069|FG000|Period 2|AE Related to Study Drug|1|||
47065290|NCT01455415|83348070|FG001|Period 2|AE Related to Study Drug|2|||
47065291|NCT01455415|83348069|FG000|Period 2|Lost to Follow-up|2|||
47065292|NCT01455415|83348070|FG001|Period 2|Lost to Follow-up|1|||
47065293|NCT01455415|83348069|FG000|Period 2|AE Not Related to Study Drug|2|||
47065294|NCT01455415|83348070|FG001|Period 2|AE Not Related to Study Drug|1|||
47065295|NCT01455415|83348069|FG000|Period 2|Lack of Efficacy|2|||
47065296|NCT01455415|83348070|FG001|Period 2|Lack of Efficacy|0|||
47065297|NCT01455415|83348069|FG000|Period 2|Withdrawal by Subject|2|||
47065298|NCT01455415|83348070|FG001|Period 2|Withdrawal by Subject|3|||
47065299|NCT01455415|83348069|FG000|Period 2|Unspecified Reason|2|||
47065300|NCT01455415|83348070|FG001|Period 2|Unspecified Reason|3|||
47065301|NCT01455415|83348069|FG000|Period 2|Protocol Violation|2|||
47065302|NCT01455415|83348070|FG001|Period 2|Protocol Violation|0|||
47065303|NCT01455415|83348069|FG000|Follow-up|AE Related to Study Drug|0|||
47065304|NCT01455415|83348070|FG001|Follow-up|AE Related to Study Drug|1|||
47065305|NCT01455415|83348069|FG000|Follow-up|Lack of Efficacy|0|||
47065306|NCT01455415|83348070|FG001|Follow-up|Lack of Efficacy|1|||
47065307|NCT01455415|83348069|FG000|Follow-up|Withdrawal by Subject|2|||
47065308|NCT01455415|83348070|FG001|Follow-up|Withdrawal by Subject|0|||
46638870|NCT01409928|82812313|FG000|Overall Study|Physician Decision|12|||
46638871|NCT01431534|82812320|FG000|Treatment Phase|Adverse Event|0|||
46638872|NCT01431534|82812321|FG001|Treatment Phase|Adverse Event|0|||
46638873|NCT01431534|82812322|FG002|Treatment Phase|Adverse Event|1|||
46770475|NCT00725985|82988790|FG000|OLMP (Up to 96 Weeks)|Death|0|||
47065309|NCT01455415|83348069|FG000|Follow-up|Unspecified Reason|1|||
47065310|NCT01455415|83348070|FG001|Follow-up|Unspecified Reason|0|||
47065311|NCT01471171|83348076|FG000|Treatment Period 1|Adverse Event|4|||
47065312|NCT01471171|83348077|FG001|Treatment Period 1|Adverse Event|1|||
47065313|NCT01471171|83348076|FG000|Treatment Period 2|Adverse Event|1|||
47065314|NCT01471171|83348077|FG001|Treatment Period 2|Adverse Event|0|||
47065315|NCT01471093|83348085|FG000|Overall Study|Adverse Event|1|||
46770476|NCT00725985|82988791|FG001|OLMP (Up to 96 Weeks)|Death|0|||
46946724|NCT01362140|83184908|FG000|Overall Study|Administrative Decision|0|||
47065316|NCT01471093|83348086|FG001|Overall Study|Adverse Event|0|||
46770477|NCT00725985|82988792|FG002|OLMP (Up to 96 Weeks)|Death|0|||
46946725|NCT01362140|83184909|FG001|Overall Study|Administrative Decision|1|||
47065317|NCT01471093|83348087|FG002|Overall Study|Adverse Event|0|||
47065318|NCT01471093|83348088|FG003|Overall Study|Adverse Event|0|||
47065319|NCT01471015|83348097|FG000|Overall Study|Death|0|||
47065320|NCT01471015|83348098|FG001|Overall Study|Death|1|||
47065321|NCT01471015|83348099|FG002|Overall Study|Death|1|||
47065322|NCT01497067|83348107|FG000|Overall Study|Lost to Follow-up|56|||
47065323|NCT01497067|83348107|FG000|Overall Study|Adverse Event|3|||
47065324|NCT01497067|83348107|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
47065325|NCT01497067|83348107|FG000|Overall Study|Other|13|||
47065326|NCT01470469|83348137|FG000|Overall Study|Withdrawal by Subject|4|||
47065327|NCT01470469|83348138|FG001|Overall Study|Withdrawal by Subject|6|||
47065328|NCT01470469|83348137|FG000|Overall Study|Lack of Efficacy|1|||
47065329|NCT01470469|83348138|FG001|Overall Study|Lack of Efficacy|7|||
47065330|NCT01470469|83348137|FG000|Overall Study|Adverse Event|0|||
47065331|NCT01470469|83348138|FG001|Overall Study|Adverse Event|7|||
47065332|NCT01470469|83348137|FG000|Overall Study|Lost to Follow-up|2|||
47065333|NCT01470469|83348138|FG001|Overall Study|Lost to Follow-up|2|||
47065334|NCT01470469|83348137|FG000|Overall Study|Protocol Violation|1|||
47065335|NCT01470469|83348138|FG001|Overall Study|Protocol Violation|1|||
47065336|NCT01470469|83348137|FG000|Overall Study|Other|2|||
47065337|NCT01470469|83348138|FG001|Overall Study|Other|1|||
47065338|NCT01470001|83348146|FG000|Overall Study|Lost to Follow-up|1|||
47065339|NCT01470001|83348147|FG001|Overall Study|Lost to Follow-up|1|||
47065340|NCT01470001|83348146|FG000|Overall Study|Physician Decision|2|||
47065341|NCT01470001|83348147|FG001|Overall Study|Physician Decision|0|||
47065342|NCT01470001|83348146|FG000|Overall Study|Withdrawal by Subject|2|||
47065343|NCT01470001|83348147|FG001|Overall Study|Withdrawal by Subject|1|||
47065344|NCT01469377|83348156|FG000|Overall Study|Protocol Deviation|7|||
47065345|NCT01469377|83348157|FG001|Overall Study|Protocol Deviation|10|||
47065346|NCT01469377|83348158|FG002|Overall Study|Protocol Deviation|10|||
47065347|NCT01469377|83348156|FG000|Overall Study|Lost to Follow-up|3|||
47065348|NCT01469377|83348157|FG001|Overall Study|Lost to Follow-up|2|||
47065349|NCT01469377|83348158|FG002|Overall Study|Lost to Follow-up|5|||
47065350|NCT01469377|83348156|FG000|Overall Study|Withdrawal of Consent|12|||
47065351|NCT01469377|83348157|FG001|Overall Study|Withdrawal of Consent|14|||
47065352|NCT01469377|83348158|FG002|Overall Study|Withdrawal of Consent|15|||
47065353|NCT01469377|83348156|FG000|Overall Study|Adverse Event|8|||
47065354|NCT01469377|83348157|FG001|Overall Study|Adverse Event|18|||
47065355|NCT01469377|83348158|FG002|Overall Study|Adverse Event|36|||
47065356|NCT01469377|83348156|FG000|Overall Study|Insufficient Therapeutic Response|3|||
47065357|NCT01469377|83348157|FG001|Overall Study|Insufficient Therapeutic Response|4|||
47065358|NCT01469377|83348158|FG002|Overall Study|Insufficient Therapeutic Response|0|||
47065359|NCT01469377|83348156|FG000|Overall Study|Other Miscellaneous Reasons|2|||
47065360|NCT01469377|83348157|FG001|Overall Study|Other Miscellaneous Reasons|0|||
47065361|NCT01469377|83348158|FG002|Overall Study|Other Miscellaneous Reasons|0|||
47065362|NCT01469221|83348168|FG000|Double Blind Phase|Protocol Violation|1|||
47065363|NCT01469221|83348169|FG001|Double Blind Phase|Protocol Violation|0|||
47065364|NCT01469221|83348170|FG002|Double Blind Phase|Protocol Violation|0|||
47065365|NCT01469221|83348168|FG000|Double Blind Phase|Physician Decision|1|||
47065366|NCT01469221|83348169|FG001|Double Blind Phase|Physician Decision|1|||
47065367|NCT01469221|83348170|FG002|Double Blind Phase|Physician Decision|0|||
47065368|NCT01469221|83348168|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
47065369|NCT01469221|83348169|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
47065370|NCT01469221|83348170|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
47065371|NCT01453855|83348179|FG000|Overall Study|Adverse Event|3|||
47065372|NCT01453855|83348180|FG001|Overall Study|Adverse Event|4|||
47065373|NCT01453855|83348179|FG000|Overall Study|Lost to Follow-up|2|||
47065374|NCT01453855|83348180|FG001|Overall Study|Lost to Follow-up|1|||
47065375|NCT01453855|83348179|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
47065376|NCT01453855|83348180|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
46770478|NCT00725985|82988793|FG003|OLMP (Up to 96 Weeks)|Death|0|||
46770479|NCT00725985|82988794|FG004|OLMP (Up to 96 Weeks)|Death|1|||
46770480|NCT00725985|82988795|FG005|OLMP (Up to 96 Weeks)|Death|0|||
46770481|NCT00725985|82988796|FG006|OLMP (Up to 96 Weeks)|Death|0|||
46770482|NCT00725985|82988797|FG007|OLMP (Up to 96 Weeks)|Death|0|||
46770483|NCT00725985|82988798|FG008|OLMP (Up to 96 Weeks)|Death|0|||
46770484|NCT00725985|82988799|FG009|OLMP (Up to 96 Weeks)|Death|0|||
46770485|NCT00725985|82988800|FG010|OLMP (Up to 96 Weeks)|Death|0|||
46770486|NCT00725985|82988801|FG011|OLMP (Up to 96 Weeks)|Death|0|||
46770487|NCT00725985|82988790|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
47065377|NCT01453855|83348179|FG000|Overall Study|Noncompliance|1|||
47065378|NCT01453855|83348180|FG001|Overall Study|Noncompliance|0|||
47065379|NCT01453855|83348179|FG000|Overall Study|Inadequate Control of IOP|1|||
47065380|NCT01453855|83348180|FG001|Overall Study|Inadequate Control of IOP|5|||
47065381|NCT01453855|83348179|FG000|Overall Study|Other|0|||
47065382|NCT01453855|83348180|FG001|Overall Study|Other|1|||
47065383|NCT01469065|83348191|FG000|Overall Study|Lack of Efficacy|0|||
47065384|NCT01469065|83348192|FG001|Overall Study|Lack of Efficacy|0|||
47065385|NCT01469065|83348193|FG002|Overall Study|Lack of Efficacy|0|||
46770488|NCT00725985|82988791|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
47065386|NCT01469065|83348194|FG003|Overall Study|Lack of Efficacy|0|||
46946726|NCT01362140|83184908|FG000|Overall Study|Death|2|||
47065387|NCT01469065|83348195|FG004|Overall Study|Lack of Efficacy|1|||
47065388|NCT01469065|83348191|FG000|Overall Study|Other|0|||
47065389|NCT01469065|83348192|FG001|Overall Study|Other|1|||
47065390|NCT01469065|83348193|FG002|Overall Study|Other|0|||
47065391|NCT01469065|83348194|FG003|Overall Study|Other|0|||
47065392|NCT01469065|83348195|FG004|Overall Study|Other|0|||
47065393|NCT01586624|83348219|FG000|Overall Study|Adverse Event|3|||
47065394|NCT01586624|83348220|FG001|Overall Study|Adverse Event|0|||
47065395|NCT01586624|83348221|FG002|Overall Study|Adverse Event|2|||
47065396|NCT01586624|83348222|FG003|Overall Study|Adverse Event|1|||
47065397|NCT01586624|83348223|FG004|Overall Study|Adverse Event|3|||
47065398|NCT01586624|83348224|FG005|Overall Study|Adverse Event|3|||
47065399|NCT01586624|83348225|FG006|Overall Study|Adverse Event|2|||
47065400|NCT01586624|83348226|FG007|Overall Study|Adverse Event|3|||
47065401|NCT01586624|83348219|FG000|Overall Study|Physician Decision|0|||
47065402|NCT01586624|83348220|FG001|Overall Study|Physician Decision|1|||
47065403|NCT01586624|83348221|FG002|Overall Study|Physician Decision|1|||
47065404|NCT01586624|83348222|FG003|Overall Study|Physician Decision|0|||
47065405|NCT01586624|83348223|FG004|Overall Study|Physician Decision|2|||
47065406|NCT01586624|83348224|FG005|Overall Study|Physician Decision|0|||
47065407|NCT01586624|83348225|FG006|Overall Study|Physician Decision|1|||
47065408|NCT01586624|83348226|FG007|Overall Study|Physician Decision|1|||
47065409|NCT01586624|83348219|FG000|Overall Study|Withdrawal by Subject|0|||
47065410|NCT01586624|83348220|FG001|Overall Study|Withdrawal by Subject|0|||
47065411|NCT01586624|83348221|FG002|Overall Study|Withdrawal by Subject|0|||
47065412|NCT01586624|83348222|FG003|Overall Study|Withdrawal by Subject|1|||
47065413|NCT01586624|83348223|FG004|Overall Study|Withdrawal by Subject|0|||
47065414|NCT01586624|83348224|FG005|Overall Study|Withdrawal by Subject|0|||
47065415|NCT01586624|83348225|FG006|Overall Study|Withdrawal by Subject|0|||
47065416|NCT01586624|83348226|FG007|Overall Study|Withdrawal by Subject|0|||
47065417|NCT01586624|83348219|FG000|Overall Study|Evidence of disease progression|1|||
47065418|NCT01586624|83348220|FG001|Overall Study|Evidence of disease progression|3|||
47065419|NCT01586624|83348221|FG002|Overall Study|Evidence of disease progression|2|||
47065420|NCT01586624|83348222|FG003|Overall Study|Evidence of disease progression|5|||
47065421|NCT01586624|83348223|FG004|Overall Study|Evidence of disease progression|3|||
47065422|NCT01586624|83348224|FG005|Overall Study|Evidence of disease progression|5|||
47065423|NCT01586624|83348225|FG006|Overall Study|Evidence of disease progression|4|||
47065424|NCT01586624|83348226|FG007|Overall Study|Evidence of disease progression|6|||
47065425|NCT01586624|83348219|FG000|Overall Study|Screen failure (no treatment received)|0|||
47065426|NCT01586624|83348220|FG001|Overall Study|Screen failure (no treatment received)|0|||
47065427|NCT01586624|83348221|FG002|Overall Study|Screen failure (no treatment received)|0|||
47065428|NCT01586624|83348222|FG003|Overall Study|Screen failure (no treatment received)|0|||
47065429|NCT01586624|83348223|FG004|Overall Study|Screen failure (no treatment received)|0|||
47065430|NCT01586624|83348224|FG005|Overall Study|Screen failure (no treatment received)|0|||
47065431|NCT01586624|83348225|FG006|Overall Study|Screen failure (no treatment received)|1|||
47065432|NCT01586624|83348226|FG007|Overall Study|Screen failure (no treatment received)|0|||
47065433|NCT01586156|83348248|FG000|Overall Study|Pregnancy|0|||
47065434|NCT01586156|83348249|FG001|Overall Study|Pregnancy|1|||
47065435|NCT01586156|83348250|FG002|Overall Study|Pregnancy|0|||
47065436|NCT01459913|83348262|FG000|Overall Study|Adverse Event|0|||
47065437|NCT01459913|83348263|FG001|Overall Study|Adverse Event|0|||
47065438|NCT01459913|83348264|FG002|Overall Study|Adverse Event|0|||
47065439|NCT01459913|83348265|FG003|Overall Study|Adverse Event|3|||
47065440|NCT01459913|83348262|FG000|Overall Study|Withdrawal by Subject|4|||
47065441|NCT01459913|83348263|FG001|Overall Study|Withdrawal by Subject|0|||
47065442|NCT01459913|83348264|FG002|Overall Study|Withdrawal by Subject|0|||
47065443|NCT01459913|83348265|FG003|Overall Study|Withdrawal by Subject|5|||
47065444|NCT01459913|83348262|FG000|Overall Study|Lost to Follow-up|7|||
47065445|NCT01459913|83348263|FG001|Overall Study|Lost to Follow-up|4|||
46638874|NCT01431534|82812320|FG000|Treatment Phase|Progressive Disease|4|||
46638875|NCT01431534|82812321|FG001|Treatment Phase|Progressive Disease|3|||
47065446|NCT01459913|83348264|FG002|Overall Study|Lost to Follow-up|1|||
47065447|NCT01459913|83348265|FG003|Overall Study|Lost to Follow-up|8|||
47065448|NCT01459913|83348262|FG000|Overall Study|Death|0|||
47065449|NCT01459913|83348263|FG001|Overall Study|Death|0|||
47065450|NCT01459913|83348264|FG002|Overall Study|Death|0|||
47065451|NCT01459913|83348265|FG003|Overall Study|Death|1|||
47065452|NCT01459913|83348262|FG000|Overall Study|Non- Compliance|0|||
47065453|NCT01459913|83348263|FG001|Overall Study|Non- Compliance|0|||
47065454|NCT01459913|83348264|FG002|Overall Study|Non- Compliance|0|||
47065455|NCT01459913|83348265|FG003|Overall Study|Non- Compliance|3|||
47065456|NCT01459913|83348262|FG000|Overall Study|Physician Decision|0|||
47065457|NCT01459913|83348263|FG001|Overall Study|Physician Decision|1|||
47065458|NCT01459913|83348264|FG002|Overall Study|Physician Decision|0|||
47065459|NCT01459913|83348265|FG003|Overall Study|Physician Decision|0|||
47065460|NCT01459913|83348262|FG000|Overall Study|Study Terminated by Sponsor|30|||
47065461|NCT01459913|83348263|FG001|Overall Study|Study Terminated by Sponsor|15|||
47065462|NCT01459913|83348264|FG002|Overall Study|Study Terminated by Sponsor|9|||
47065463|NCT01459913|83348265|FG003|Overall Study|Study Terminated by Sponsor|11|||
47065464|NCT01459913|83348262|FG000|Overall Study|Other|0|||
47065465|NCT01459913|83348263|FG001|Overall Study|Other|0|||
47065466|NCT01459913|83348264|FG002|Overall Study|Other|3|||
47065467|NCT01459913|83348265|FG003|Overall Study|Other|1|||
47065468|NCT01459913|83348262|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
47065469|NCT01459913|83348263|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
47065470|NCT01459913|83348264|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
47065471|NCT01459913|83348265|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
47065472|NCT01458587|83348279|FG000|Overall Study|Withdrawal by Subject|1|||
47065473|NCT01458587|83348280|FG001|Overall Study|Withdrawal by Subject|0|||
47065474|NCT01458275|83348291|FG000|Overall Study|Adverse Event|3|||
47065475|NCT01458275|83348292|FG001|Overall Study|Adverse Event|4|||
47065476|NCT01458275|83348293|FG002|Overall Study|Adverse Event|1|||
47065477|NCT01458275|83348291|FG000|Overall Study|Lost to Follow-up|3|||
47065478|NCT01458275|83348292|FG001|Overall Study|Lost to Follow-up|2|||
47065479|NCT01458275|83348293|FG002|Overall Study|Lost to Follow-up|5|||
47065480|NCT01458275|83348291|FG000|Overall Study|Protocol Violation|5|||
47065481|NCT01458275|83348292|FG001|Overall Study|Protocol Violation|5|||
47065482|NCT01458275|83348293|FG002|Overall Study|Protocol Violation|2|||
47065483|NCT01458275|83348291|FG000|Overall Study|Withdrawal by Subject|3|||
47065484|NCT01458275|83348292|FG001|Overall Study|Withdrawal by Subject|2|||
47065485|NCT01458275|83348293|FG002|Overall Study|Withdrawal by Subject|1|||
47065486|NCT01458119|83348303|FG000|Overall Study|Physician Decision|4|||
47065487|NCT01458119|83348303|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
47065488|NCT01458119|83348303|FG000|Overall Study|Pregnancy|1|||
47065489|NCT01458119|83348303|FG000|Overall Study|Death|2|||
47065490|NCT01458119|83348303|FG000|Overall Study|Adverse Event|1|||
47065491|NCT01458119|83348303|FG000|Overall Study|Consent Withdrawn by Participant|8|||
47065492|NCT01458119|83348303|FG000|Overall Study|Non-compliance With Study Drug|3|||
47065493|NCT01688726|83348318|FG000|Overall Study|Adverse Event|1|||
47065494|NCT01688726|83348319|FG001|Overall Study|Adverse Event|0|||
47065495|NCT01688726|83348318|FG000|Overall Study|Relocated abroad|0|||
47065496|NCT01688726|83348319|FG001|Overall Study|Relocated abroad|1|||
47065497|NCT01585766|83348335|FG000|Overall Study|Withdrawal by Subject|0|||
47065498|NCT01585766|83348336|FG001|Overall Study|Withdrawal by Subject|1|||
47065499|NCT01585766|83348337|FG002|Overall Study|Withdrawal by Subject|1|||
47065500|NCT01585766|83348338|FG003|Overall Study|Withdrawal by Subject|0|||
47065501|NCT01585766|83348339|FG004|Overall Study|Withdrawal by Subject|0|||
47065502|NCT01585766|83348340|FG005|Overall Study|Withdrawal by Subject|0|||
47065503|NCT01585766|83348335|FG000|Overall Study|Death|0|||
47065504|NCT01585766|83348336|FG001|Overall Study|Death|1|||
47065505|NCT01585766|83348337|FG002|Overall Study|Death|0|||
47065506|NCT01585766|83348338|FG003|Overall Study|Death|0|||
47065507|NCT01585766|83348339|FG004|Overall Study|Death|0|||
47065508|NCT01585766|83348340|FG005|Overall Study|Death|0|||
46840462|NCT05195528|83057711|FG003|Extension Period|Not Treated|3|||
46840463|NCT05195528|83057712|FG004|Extension Period|Not Treated|0|||
46946727|NCT01362140|83184909|FG001|Overall Study|Death|1|||
46946728|NCT01362140|83184908|FG000|Overall Study|Other|1|||
46946729|NCT01362140|83184909|FG001|Overall Study|Other|1|||
47065509|NCT01585766|83348335|FG000|Overall Study|Physician Decision|0|||
47065510|NCT01585766|83348336|FG001|Overall Study|Physician Decision|0|||
47065511|NCT01585766|83348337|FG002|Overall Study|Physician Decision|1|||
47065512|NCT01585766|83348338|FG003|Overall Study|Physician Decision|0|||
47065513|NCT01585766|83348339|FG004|Overall Study|Physician Decision|0|||
47065514|NCT01585766|83348340|FG005|Overall Study|Physician Decision|0|||
47065515|NCT01562444|83348364|FG000|Overall Study|Did not meet entry criteria|2|||
47065516|NCT01562444|83348365|FG001|Overall Study|Did not meet entry criteria|0|||
46840464|NCT05195528|83057708|FG000|Extension Period|Other|0|||
47065517|NCT01562444|83348366|FG002|Overall Study|Did not meet entry criteria|3|||
47065518|NCT01562444|83348364|FG000|Overall Study|Did not comply with blood draw schedule|1|||
47065519|NCT01562444|83348365|FG001|Overall Study|Did not comply with blood draw schedule|0|||
47065520|NCT01562444|83348366|FG002|Overall Study|Did not comply with blood draw schedule|1|||
47065521|NCT01562444|83348364|FG000|Overall Study|Unavailable serological results|0|||
47065522|NCT01562444|83348365|FG001|Overall Study|Unavailable serological results|2|||
47065523|NCT01562444|83348366|FG002|Overall Study|Unavailable serological results|2|||
47065524|NCT01562444|83348364|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
47065525|NCT01562444|83348365|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
47065526|NCT01562444|83348366|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
47065527|NCT01562444|83348364|FG000|Overall Study|Protocol forbidden medication|1|||
47065528|NCT01562444|83348365|FG001|Overall Study|Protocol forbidden medication|0|||
47065529|NCT01562444|83348366|FG002|Overall Study|Protocol forbidden medication|0|||
46946730|NCT01362140|83184908|FG000|Overall Study|Protocol-specified Criteria|1|||
47065530|NCT01457339|83348376|FG000|Period 3 (100 mg)|Adverse Event|0|||
47065531|NCT01457339|83348377|FG001|Period 3 (100 mg)|Adverse Event|1|||
47065532|NCT01457339|83348376|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
47065533|NCT01457339|83348377|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
47065534|NCT01457339|83348376|FG000|Period 6 (250 mg)|Family Emergency|1|||
47065535|NCT01457339|83348377|FG001|Period 6 (250 mg)|Family Emergency|0|||
47065536|NCT01457339|83348376|FG000|Period 6 (250 mg)|Personal appointment|0|||
47065537|NCT01457339|83348377|FG001|Period 6 (250 mg)|Personal appointment|1|||
47065538|NCT01456949|83348400|FG000|Enrollment|PI death- incomplete data|6|||
47065539|NCT01456949|83348400|FG000|Enrollment|Death|1|||
47065540|NCT01456949|83348400|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
47065541|NCT01456949|83348400|FG000|Enrollment|Physician Decision|10|||
47065542|NCT01456949|83348400|FG000|Enrollment|Withdrawal by Subject|7|||
47065543|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
47065544|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
47065545|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
47065546|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
47065547|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
47065548|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
47065549|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
47065550|NCT01456949|83348400|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
47065551|NCT01456169|83348407|FG000|Overall Study|Adverse Event|1|||
47065552|NCT01456169|83348408|FG001|Overall Study|Adverse Event|2|||
47065553|NCT01456169|83348409|FG002|Overall Study|Adverse Event|7|||
47065554|NCT01456169|83348407|FG000|Overall Study|Major Protocol Deviation|3|||
47065555|NCT01456169|83348408|FG001|Overall Study|Major Protocol Deviation|2|||
47065556|NCT01456169|83348409|FG002|Overall Study|Major Protocol Deviation|3|||
46770489|NCT00725985|82988792|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46770490|NCT00725985|82988793|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
46770491|NCT00725985|82988794|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46770492|NCT00725985|82988795|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46840465|NCT05195528|83057709|FG001|Extension Period|Other|1|||
46840466|NCT05195528|83057710|FG002|Extension Period|Other|1|||
46840467|NCT05195528|83057711|FG003|Extension Period|Other|0|||
46840468|NCT05195528|83057712|FG004|Extension Period|Other|0|||
46840469|NCT05135156|83057726|FG000|Overall Study|Lost to Follow-up|0|||
46840470|NCT05135156|83057727|FG001|Overall Study|Lost to Follow-up|0|||
46840471|NCT05135156|83057728|FG002|Overall Study|Lost to Follow-up|2|||
46840472|NCT04956666|83057735|FG000|Overall Study|Adverse Event|18|||
46840473|NCT04956666|83057735|FG000|Overall Study|Physician Decision|5|||
46840474|NCT04738318|83057741|FG000|Overall Study|Protocol Violation|1|||
46840475|NCT04738318|83057742|FG001|Overall Study|Protocol Violation|0|||
46840476|NCT04726709|83057750|FG000|Overall Study|Withdrawal by Subject|2|||
46840477|NCT04726709|83057751|FG001|Overall Study|Withdrawal by Subject|2|||
46840478|NCT04684420|83057764|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
46840479|NCT04684420|83057765|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
46946731|NCT01362140|83184909|FG001|Overall Study|Protocol-specified Criteria|2|||
46946732|NCT01362140|83184908|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
46770493|NCT00725985|82988796|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46770494|NCT00725985|82988797|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46770495|NCT00725985|82988798|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46770496|NCT00725985|82988799|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46770497|NCT00725985|82988800|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46946733|NCT01362140|83184909|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
46946734|NCT01333189|83184917|FG000|Overall Study|Time constraints|1|||
46946735|NCT01333189|83184918|FG001|Overall Study|Time constraints|0|||
46946736|NCT01333189|83184917|FG000|Overall Study|Adverse Event|1|||
46946737|NCT01333189|83184918|FG001|Overall Study|Adverse Event|0|||
46946738|NCT01333189|83184917|FG000|Overall Study|Transportation difficulties|0|||
46946739|NCT01333189|83184918|FG001|Overall Study|Transportation difficulties|1|||
46946740|NCT01333189|83184917|FG000|Overall Study|Moved from region|0|||
47065557|NCT01456169|83348407|FG000|Overall Study|Voluntary Withdrawal|3|||
47065558|NCT01456169|83348408|FG001|Overall Study|Voluntary Withdrawal|0|||
46770498|NCT00725985|82988801|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
46840480|NCT04684420|83057766|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
46840481|NCT04684420|83057767|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
47065559|NCT01456169|83348409|FG002|Overall Study|Voluntary Withdrawal|2|||
47065560|NCT01456169|83348407|FG000|Overall Study|Lack of Efficacy|2|||
47065561|NCT01456169|83348408|FG001|Overall Study|Lack of Efficacy|0|||
46770499|NCT00725985|82988790|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
46840482|NCT04684420|83057764|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
46840483|NCT04684420|83057765|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
46946741|NCT01333189|83184918|FG001|Overall Study|Moved from region|1|||
47065562|NCT01456169|83348409|FG002|Overall Study|Lack of Efficacy|0|||
47065563|NCT01456169|83348407|FG000|Overall Study|Other|1|||
47065564|NCT01456169|83348408|FG001|Overall Study|Other|1|||
47065565|NCT01456169|83348409|FG002|Overall Study|Other|0|||
46638876|NCT01431534|82812322|FG002|Treatment Phase|Progressive Disease|10|||
46638877|NCT01409382|82812332|FG000|Overall Study|Lost to Follow-up|1|||
46638878|NCT01409382|82812333|FG001|Overall Study|Lost to Follow-up|1|||
46638879|NCT01409382|82812332|FG000|Overall Study|Protocol Violation|0|||
47065566|NCT01454531|83348418|FG000|Overall Study|Adverse Event|14|||
47065567|NCT01454531|83348418|FG000|Overall Study|Withdrawal by Subject|5|||
47065568|NCT01454531|83348418|FG000|Overall Study|Lost to Follow-up|1|||
47065569|NCT01454531|83348418|FG000|Overall Study|Physician Decision|1|||
47065570|NCT01454531|83348418|FG000|Overall Study|Delay in IMP administration|1|||
47065571|NCT01454531|83348418|FG000|Overall Study|Other|1|||
47065572|NCT01454063|83348424|FG000|Randomized|Adverse Event|1|||
47065573|NCT01454063|83348425|FG001|Randomized|Adverse Event|1|||
47065574|NCT01454063|83348424|FG000|Randomized|Protocol Violation|0|||
47065575|NCT01454063|83348425|FG001|Randomized|Protocol Violation|1|||
47065576|NCT01453595|83348434|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
47065577|NCT01453595|83348435|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
47065578|NCT01453595|83348436|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
47065579|NCT01453439|83348444|FG000|Treatment Phase|Withdrawal by Subject|13|||
47065580|NCT01453439|83348445|FG001|Treatment Phase|Withdrawal by Subject|10|||
47065581|NCT01453439|83348444|FG000|Treatment Phase|Suicidal Ideation|2|||
47065582|NCT01453439|83348445|FG001|Treatment Phase|Suicidal Ideation|0|||
47065583|NCT01453439|83348444|FG000|Treatment Phase|Need for higher level of care|1|||
47065584|NCT01453439|83348445|FG001|Treatment Phase|Need for higher level of care|1|||
47065585|NCT01453439|83348444|FG000|Treatment Phase|Therapist conflict of interest|1|||
47065586|NCT01453439|83348445|FG001|Treatment Phase|Therapist conflict of interest|0|||
46946742|NCT01333111|83184927|FG000|Overall Study|patient undergoing major surgery|0|||
46946743|NCT01333111|83184928|FG001|Overall Study|patient undergoing major surgery|2|||
46946744|NCT01333111|83184929|FG002|Overall Study|patient undergoing major surgery|0|||
46946745|NCT01333111|83184927|FG000|Overall Study|personal reasons|0|||
46946746|NCT01333111|83184928|FG001|Overall Study|personal reasons|0|||
47065587|NCT01453439|83348444|FG000|Follow-up|Withdrawal by Subject|0|||
47065588|NCT01453439|83348445|FG001|Follow-up|Withdrawal by Subject|1|||
47065589|NCT01453439|83348444|FG000|Follow-up|Lost to Follow-up|5|||
47065590|NCT01453439|83348445|FG001|Follow-up|Lost to Follow-up|10|||
47065591|NCT01453361|83348451|FG000|Overall Study|Disease Progression|6|||
47065592|NCT01453361|83348451|FG000|Overall Study|Screen-Failures|10|||
47065593|NCT01585298|83348455|FG000|Overall Study|Study completion was not documented.|1|||
47065594|NCT01585298|83348455|FG000|Overall Study|Protocol deviation|1|||
47065595|NCT01585298|83348455|FG000|Overall Study|Administrative problems|4|||
47065596|NCT01585298|83348455|FG000|Overall Study|Lost to Follow-up|2|||
47065597|NCT01585298|83348455|FG000|Overall Study|Withdrawal by Subject|4|||
47065598|NCT01585298|83348455|FG000|Overall Study|Abnormal test procedure results|1|||
47065599|NCT01585298|83348455|FG000|Overall Study|Adverse Event|24|||
47065600|NCT01453205|83348462|FG000|Overall Study|Lost to Follow-up|3|||
47065601|NCT01453205|83348463|FG001|Overall Study|Lost to Follow-up|0|||
46638880|NCT01409382|82812333|FG001|Overall Study|Protocol Violation|3|||
46638881|NCT01409382|82812332|FG000|Overall Study|Multiple pregnancy|2|||
46638882|NCT01409382|82812333|FG001|Overall Study|Multiple pregnancy|4|||
46638883|NCT01409382|82812332|FG000|Overall Study|Still pregnant when study ended|13|||
47065602|NCT01453205|83348464|FG002|Overall Study|Lost to Follow-up|1|||
46770500|NCT00725985|82988791|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
46770501|NCT00725985|82988792|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
46770502|NCT00725985|82988793|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
46770503|NCT00725985|82988794|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
46770504|NCT00725985|82988795|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
46770505|NCT00725985|82988796|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
46770506|NCT00725985|82988797|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
46770507|NCT00725985|82988798|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
47065603|NCT01453205|83348462|FG000|Overall Study|Withdrawal by Subject|8|||
47065604|NCT01453205|83348463|FG001|Overall Study|Withdrawal by Subject|3|||
47065605|NCT01453205|83348464|FG002|Overall Study|Withdrawal by Subject|0|||
47065606|NCT01453205|83348462|FG000|Overall Study|Death|24|||
47065607|NCT01453205|83348463|FG001|Overall Study|Death|22|||
46638884|NCT01409382|82812333|FG001|Overall Study|Still pregnant when study ended|2|||
46638885|NCT01409382|82812332|FG000|Overall Study|Did not manage to get pregnant|64|||
46770508|NCT00725985|82988799|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
47065608|NCT01453205|83348464|FG002|Overall Study|Death|18|||
47065609|NCT01453205|83348462|FG000|Overall Study|Other|45|||
47065610|NCT01453205|83348463|FG001|Overall Study|Other|27|||
47065611|NCT01453205|83348464|FG002|Overall Study|Other|35|||
47065612|NCT01453049|83348477|FG000|Overall Study|Protocol Violation|2|||
46770509|NCT00725985|82988800|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
47065613|NCT01453049|83348478|FG001|Overall Study|Protocol Violation|5|||
47065614|NCT01453049|83348477|FG000|Overall Study|Lost to Follow-up|2|||
47065615|NCT01453049|83348478|FG001|Overall Study|Lost to Follow-up|1|||
47065616|NCT01453049|83348477|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
47065617|NCT01453049|83348478|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
46946747|NCT01333111|83184929|FG002|Overall Study|personal reasons|1|||
46946748|NCT01333111|83184927|FG000|Overall Study|unclassified|1|||
46946749|NCT01333111|83184928|FG001|Overall Study|unclassified|0|||
46946750|NCT01333111|83184929|FG002|Overall Study|unclassified|0|||
46946751|NCT01333111|83184927|FG000|Overall Study|withdrawal criteria|0|||
46946752|NCT01333111|83184928|FG001|Overall Study|withdrawal criteria|1|||
46946753|NCT01333111|83184929|FG002|Overall Study|withdrawal criteria|0|||
46946754|NCT01333111|83184927|FG000|Overall Study|Non-compliance|1|||
46946755|NCT01333111|83184928|FG001|Overall Study|Non-compliance|0|||
46946756|NCT01333111|83184929|FG002|Overall Study|Non-compliance|0|||
46946757|NCT01333111|83184927|FG000|Overall Study|Ineffective therapy|0|||
46946758|NCT01333111|83184928|FG001|Overall Study|Ineffective therapy|0|||
46946759|NCT01333111|83184929|FG002|Overall Study|Ineffective therapy|1|||
46946760|NCT00702507|83184937|FG000|Initial Treatment Phase|Adverse Event|2|||
46946761|NCT00702507|83184937|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
46946762|NCT00702507|83184937|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
46946763|NCT00702507|83184937|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
46946764|NCT00702507|83184937|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
46946765|NCT00702507|83184937|FG000|Follow-up Phase|Protocol Violation|2|||
46946766|NCT00702507|83184937|FG000|Follow-up Phase|Lost to Follow-up|23|||
46946767|NCT00702507|83184937|FG000|Follow-up Phase|Late Enrollment|1|||
46946768|NCT01673594|83184953|FG000|Overall Study|Adverse Event|3|||
46946769|NCT01673594|83184954|FG001|Overall Study|Adverse Event|1|||
46946770|NCT01673594|83184953|FG000|Overall Study|Lost to Follow-up|1|||
46946771|NCT01673594|83184954|FG001|Overall Study|Lost to Follow-up|0|||
47065618|NCT01453049|83348477|FG000|Overall Study|Withdrawal by Subject|1|||
47065619|NCT01453049|83348478|FG001|Overall Study|Withdrawal by Subject|0|||
47065620|NCT01453049|83348477|FG000|Overall Study|Randomized in Error|1|||
47065621|NCT01453049|83348478|FG001|Overall Study|Randomized in Error|0|||
47065622|NCT01452347|83348486|FG000|Overall Study|Adverse Event|2|||
47065623|NCT01452347|83348487|FG001|Overall Study|Adverse Event|1|||
47065624|NCT01452347|83348486|FG000|Overall Study|Non compliance protocol|2|||
47065625|NCT01452347|83348487|FG001|Overall Study|Non compliance protocol|0|||
46770510|NCT00725985|82988801|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
46770511|NCT00725985|82988790|FG000|OLMP (Up to 96 Weeks)|Other|0|||
46770512|NCT00725985|82988791|FG001|OLMP (Up to 96 Weeks)|Other|0|||
46770513|NCT00725985|82988792|FG002|OLMP (Up to 96 Weeks)|Other|0|||
46770514|NCT00725985|82988793|FG003|OLMP (Up to 96 Weeks)|Other|15|||
46770515|NCT00725985|82988794|FG004|OLMP (Up to 96 Weeks)|Other|20|||
46770516|NCT00725985|82988795|FG005|OLMP (Up to 96 Weeks)|Other|44|||
46840484|NCT04684420|83057766|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
46840485|NCT04684420|83057767|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
46840486|NCT04352101|83057780|FG000|Overall Study|Physician Decision|2|||
46840487|NCT04352101|83057781|FG001|Overall Study|Physician Decision|1|||
46840488|NCT04208087|83057792|FG000|Overall Study|Adverse Event|1|||
46840489|NCT04208087|83057793|FG001|Overall Study|Adverse Event|0|||
46840490|NCT04208087|83057794|FG002|Overall Study|Adverse Event|0|||
46840491|NCT04208087|83057795|FG003|Overall Study|Adverse Event|0|||
46840492|NCT04208087|83057796|FG004|Overall Study|Adverse Event|0|||
46840493|NCT04208087|83057792|FG000|Overall Study|Withdrawal by Subject|0|||
46840494|NCT04208087|83057793|FG001|Overall Study|Withdrawal by Subject|0|||
46840495|NCT04208087|83057794|FG002|Overall Study|Withdrawal by Subject|1|||
46840496|NCT04208087|83057795|FG003|Overall Study|Withdrawal by Subject|0|||
46840497|NCT04208087|83057796|FG004|Overall Study|Withdrawal by Subject|0|||
46840498|NCT04208087|83057792|FG000|Overall Study|Other|0|||
46840499|NCT04208087|83057793|FG001|Overall Study|Other|0|||
46840500|NCT04208087|83057794|FG002|Overall Study|Other|0|||
46946772|NCT01673594|83184953|FG000|Overall Study|Physician Decision|2|||
46946773|NCT01673594|83184954|FG001|Overall Study|Physician Decision|4|||
46946774|NCT01673594|83184953|FG000|Overall Study|Withdrawal by Subject|0|||
46946775|NCT01673594|83184954|FG001|Overall Study|Withdrawal by Subject|1|||
46946776|NCT02721147|83184963|FG000|Overall Study|Lost to Follow-up|2|||
46840501|NCT04208087|83057795|FG003|Overall Study|Other|0|||
46840502|NCT04208087|83057796|FG004|Overall Study|Other|1|||
47065626|NCT01452347|83348486|FG000|Overall Study|Lost to Follow-up|2|||
46840503|NCT04140227|83057807|FG000|Overall Study|Withdrawal by Subject|26|||
47065627|NCT01452347|83348487|FG001|Overall Study|Lost to Follow-up|0|||
47065628|NCT01452347|83348486|FG000|Overall Study|Withdrawal by Subject|3|||
46770517|NCT00725985|82988796|FG006|OLMP (Up to 96 Weeks)|Other|0|||
46770518|NCT00725985|82988797|FG007|OLMP (Up to 96 Weeks)|Other|0|||
46946777|NCT02721147|83184964|FG001|Overall Study|Lost to Follow-up|0|||
46946778|NCT02721147|83184965|FG002|Overall Study|Lost to Follow-up|0|||
46946779|NCT02720757|83184973|FG000|Overall Study|Other reason|5|||
46946780|NCT02720757|83184973|FG000|Overall Study|Loss of contact|4|||
46946781|NCT02720757|83184973|FG000|Overall Study|Informed consent withdrawal|1|||
46946782|NCT02720757|83184973|FG000|Overall Study|Patients wish to withdraw|2|||
46946783|NCT02720757|83184973|FG000|Overall Study|Missing|3|||
46946784|NCT02720757|83184973|FG000|Overall Study|General exclusion|3|||
46946785|NCT02646566|83185003|FG000|Overall Study|Lost to Follow-up|5|||
46946786|NCT02646566|83185004|FG001|Overall Study|Lost to Follow-up|4|||
46946787|NCT02646566|83185005|FG002|Overall Study|Lost to Follow-up|5|||
46946788|NCT02646566|83185003|FG000|Overall Study|Treatment failure|1|||
46946789|NCT02646566|83185004|FG001|Overall Study|Treatment failure|0|||
46946790|NCT02646566|83185005|FG002|Overall Study|Treatment failure|0|||
46946791|NCT02720523|83185021|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
46946792|NCT02720523|83185022|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
46946793|NCT02720523|83185023|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
46946794|NCT02720523|83185024|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
46946795|NCT02720523|83185025|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
46946796|NCT02720523|83185026|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
46946797|NCT02720523|83185027|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
46946798|NCT02720523|83185021|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
46946799|NCT02720523|83185022|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46946800|NCT02720523|83185023|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46946801|NCT02720523|83185024|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46946802|NCT02720523|83185025|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46946803|NCT02720523|83185026|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46946804|NCT02720523|83185027|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46946805|NCT02720523|83185021|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
46946806|NCT02720523|83185022|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
46946807|NCT02720523|83185023|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
46946808|NCT02720523|83185024|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
46946809|NCT02720523|83185025|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
46946810|NCT02720523|83185026|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
46946811|NCT02720523|83185027|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
46946812|NCT02720523|83185021|FG000|Period 1: Placebo-controlled Period|Other|0|||
47065629|NCT01452347|83348487|FG001|Overall Study|Withdrawal by Subject|3|||
47065630|NCT01452347|83348486|FG000|Overall Study|Not treated|6|||
47065631|NCT01452347|83348487|FG001|Overall Study|Not treated|3|||
47065632|NCT01452347|83348486|FG000|Overall Study|Other reason not defined above|2|||
46840504|NCT04140227|83057807|FG000|Overall Study|Lost to Follow-up|8|||
46840505|NCT04140227|83057807|FG000|Overall Study|Adverse Event|8|||
46840506|NCT04140227|83057807|FG000|Overall Study|Death|1|||
46840507|NCT04140227|83057807|FG000|Overall Study|Other|3|||
46840508|NCT04140227|83057807|FG000|Overall Study|Protocol Violation|2|||
47065633|NCT01452347|83348487|FG001|Overall Study|Other reason not defined above|0|||
46770519|NCT00725985|82988798|FG008|OLMP (Up to 96 Weeks)|Other|0|||
46770520|NCT00725985|82988799|FG009|OLMP (Up to 96 Weeks)|Other|0|||
46770521|NCT00725985|82988800|FG010|OLMP (Up to 96 Weeks)|Other|0|||
46770522|NCT00725985|82988801|FG011|OLMP (Up to 96 Weeks)|Other|0|||
46770523|NCT00725985|82988790|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770524|NCT00725985|82988791|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770525|NCT00725985|82988792|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770526|NCT00725985|82988793|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770527|NCT00725985|82988794|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770528|NCT00725985|82988795|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770529|NCT00725985|82988796|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770530|NCT00725985|82988797|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
46770531|NCT00725985|82988798|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770532|NCT00725985|82988799|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770533|NCT00725985|82988800|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770534|NCT00725985|82988801|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
46770535|NCT00725985|82988790|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770536|NCT00725985|82988791|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46840509|NCT03782259|83057813|FG000|Overall Study|Lost to Follow-up|1|||
47065634|NCT01451723|83348497|FG000|Overall Study|study halted|6|||
46770537|NCT00725985|82988792|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770538|NCT00725985|82988793|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770539|NCT00725985|82988794|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770540|NCT00725985|82988795|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770541|NCT00725985|82988796|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770542|NCT00725985|82988797|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46840510|NCT03782259|83057814|FG001|Overall Study|Lost to Follow-up|1|||
46946813|NCT02720523|83185022|FG001|Period 1: Placebo-controlled Period|Other|0|||
46946814|NCT02720523|83185023|FG002|Period 1: Placebo-controlled Period|Other|1|||
46946815|NCT02720523|83185024|FG003|Period 1: Placebo-controlled Period|Other|1|||
46946816|NCT02720523|83185025|FG004|Period 1: Placebo-controlled Period|Other|0|||
47065635|NCT01451723|83348498|FG001|Overall Study|study halted|5|||
47065636|NCT01451645|83348506|FG000|Overall Study|Protocol Violation|1|||
47065637|NCT01451645|83348507|FG001|Overall Study|Protocol Violation|0|||
47065638|NCT01451645|83348506|FG000|Overall Study|Adverse Event|0|||
47065639|NCT01451645|83348507|FG001|Overall Study|Adverse Event|3|||
47065640|NCT01451645|83348506|FG000|Overall Study|Withdrawal by Subject|4|||
47065641|NCT01451645|83348507|FG001|Overall Study|Withdrawal by Subject|2|||
46946817|NCT02720523|83185026|FG005|Period 1: Placebo-controlled Period|Other|0|||
46946818|NCT02720523|83185027|FG006|Period 1: Placebo-controlled Period|Other|0|||
46946819|NCT02720523|83185021|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
46946820|NCT02720523|83185022|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
46946821|NCT02720523|83185023|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
46946822|NCT02720523|83185024|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
46946823|NCT02720523|83185025|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
46946824|NCT02720523|83185026|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
46946825|NCT02720523|83185027|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
46946826|NCT02720523|83185021|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
46946827|NCT02720523|83185022|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
46946828|NCT02720523|83185023|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
46946829|NCT02720523|83185024|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
46946830|NCT02720523|83185025|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
46946831|NCT02720523|83185026|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
46946832|NCT02720523|83185027|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
46946833|NCT02720523|83185021|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
46946834|NCT02720523|83185022|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
46946835|NCT02720523|83185023|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
47065642|NCT01451645|83348506|FG000|Overall Study|Lost to Follow-up|4|||
47065643|NCT01451645|83348507|FG001|Overall Study|Lost to Follow-up|3|||
47065644|NCT01450943|83348516|FG000|Overall Study|Screen failure, loss to follow-up|2|||
47065645|NCT01450943|83348517|FG001|Overall Study|Screen failure, loss to follow-up|7|||
47065646|NCT01450943|83348518|FG002|Overall Study|Screen failure, loss to follow-up|6|||
47065647|NCT01450631|83348532|FG000|Overall Study|Lost to Follow-up|2|||
47065648|NCT01450631|83348533|FG001|Overall Study|Lost to Follow-up|4|||
47065649|NCT01450631|83348532|FG000|Overall Study|Withdrawal by Subject|1|||
47065650|NCT01450631|83348533|FG001|Overall Study|Withdrawal by Subject|0|||
47065651|NCT01450007|83348542|FG000|Overall Study|Late exclusion before treatment|2|||
47065652|NCT01450007|83348543|FG001|Overall Study|Late exclusion before treatment|3|||
47065653|NCT01450007|83348544|FG002|Overall Study|Late exclusion before treatment|2|||
47065654|NCT01450007|83348542|FG000|Overall Study|Protocol Violation|0|||
47065655|NCT01450007|83348543|FG001|Overall Study|Protocol Violation|1|||
47065656|NCT01450007|83348544|FG002|Overall Study|Protocol Violation|1|||
47065657|NCT01450007|83348542|FG000|Overall Study|Adverse Event|0|||
47065658|NCT01450007|83348543|FG001|Overall Study|Adverse Event|1|||
47065659|NCT01450007|83348544|FG002|Overall Study|Adverse Event|0|||
47065660|NCT01496365|83348559|FG000|Overall Study|Adverse Event|2|||
47065661|NCT01496365|83348560|FG001|Overall Study|Adverse Event|3|||
47065662|NCT01496365|83348561|FG002|Overall Study|Adverse Event|3|||
47065663|NCT01496365|83348562|FG003|Overall Study|Adverse Event|2|||
46638886|NCT01409382|82812333|FG001|Overall Study|Did not manage to get pregnant|70|||
46770543|NCT00725985|82988798|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
46770544|NCT00725985|82988799|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770545|NCT00725985|82988800|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
46770546|NCT00725985|82988801|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
47065664|NCT01496365|83348563|FG004|Overall Study|Adverse Event|5|||
47065665|NCT01496365|83348564|FG005|Overall Study|Adverse Event|6|||
47065666|NCT01496365|83348565|FG006|Overall Study|Adverse Event|4|||
47065667|NCT01496365|83348559|FG000|Overall Study|Withdrawal by Subject|6|||
47065668|NCT01496365|83348560|FG001|Overall Study|Withdrawal by Subject|6|||
47065669|NCT01496365|83348561|FG002|Overall Study|Withdrawal by Subject|0|||
47065670|NCT01496365|83348562|FG003|Overall Study|Withdrawal by Subject|1|||
47065671|NCT01496365|83348563|FG004|Overall Study|Withdrawal by Subject|3|||
46770547|NCT00725985|82988790|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46770548|NCT00725985|82988791|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46967867|NCT05091307|83210486|FG003|Overall Study|Lost to Follow-up|0|||
47065672|NCT01496365|83348564|FG005|Overall Study|Withdrawal by Subject|2|||
47065673|NCT01496365|83348565|FG006|Overall Study|Withdrawal by Subject|1|||
47065674|NCT01496365|83348559|FG000|Overall Study|Protocol Violation|2|||
47065675|NCT01496365|83348560|FG001|Overall Study|Protocol Violation|1|||
46770549|NCT00725985|82988792|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
47065676|NCT01496365|83348561|FG002|Overall Study|Protocol Violation|1|||
47065677|NCT01496365|83348562|FG003|Overall Study|Protocol Violation|0|||
47065678|NCT01496365|83348563|FG004|Overall Study|Protocol Violation|0|||
47065679|NCT01496365|83348564|FG005|Overall Study|Protocol Violation|1|||
47065680|NCT01496365|83348565|FG006|Overall Study|Protocol Violation|0|||
47065681|NCT01496365|83348559|FG000|Overall Study|Lack of Efficacy|1|||
47065682|NCT01496365|83348560|FG001|Overall Study|Lack of Efficacy|0|||
47065683|NCT01496365|83348561|FG002|Overall Study|Lack of Efficacy|0|||
47065684|NCT01496365|83348562|FG003|Overall Study|Lack of Efficacy|0|||
47065685|NCT01496365|83348563|FG004|Overall Study|Lack of Efficacy|0|||
47065686|NCT01496365|83348564|FG005|Overall Study|Lack of Efficacy|1|||
47065687|NCT01496365|83348565|FG006|Overall Study|Lack of Efficacy|0|||
47065688|NCT01496365|83348559|FG000|Overall Study|Lost to Follow-up|0|||
47065689|NCT01496365|83348560|FG001|Overall Study|Lost to Follow-up|1|||
46770550|NCT00725985|82988793|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46770551|NCT00725985|82988794|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46770552|NCT00725985|82988795|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46770553|NCT00725985|82988796|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
46770554|NCT00725985|82988797|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
46770555|NCT00725985|82988798|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
46770556|NCT00725985|82988799|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46770557|NCT00725985|82988800|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46840511|NCT03782259|83057813|FG000|Overall Study|Moved out of state|0|||
46840512|NCT03782259|83057814|FG001|Overall Study|Moved out of state|2|||
46840513|NCT03782259|83057813|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
46840514|NCT03782259|83057814|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
46840515|NCT03782259|83057813|FG000|Overall Study|Subject discontinued intervention|1|||
46840516|NCT03782259|83057814|FG001|Overall Study|Subject discontinued intervention|0|||
46840517|NCT03743194|83057827|FG000|Overall Study|Protocol Violation|7|||
46840518|NCT03743194|83057828|FG001|Overall Study|Protocol Violation|7|||
46840519|NCT03743194|83057827|FG000|Overall Study|Physician Decision|0|||
46840520|NCT03743194|83057828|FG001|Overall Study|Physician Decision|2|||
46840521|NCT03461146|83057843|FG000|Overall Study|Adverse Event|2|||
46840522|NCT03461146|83057843|FG000|Overall Study|Physician Decision|1|||
46840523|NCT03460704|83057849|FG000|Overall Study|Withdrawal by Subject|11|||
46840524|NCT03460704|83057850|FG001|Overall Study|Withdrawal by Subject|14|||
46840525|NCT03460704|83057849|FG000|Overall Study|Study terminated by the Sponsor|29|||
46840526|NCT03460704|83057850|FG001|Overall Study|Study terminated by the Sponsor|19|||
46770558|NCT00725985|82988801|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
46770559|NCT00725985|82988790|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770560|NCT00725985|82988791|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770561|NCT00725985|82988792|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770562|NCT00725985|82988793|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770563|NCT00725985|82988794|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770564|NCT00725985|82988795|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770565|NCT00725985|82988796|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770566|NCT00725985|82988797|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770567|NCT00725985|82988798|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
46770568|NCT00725985|82988799|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
46770569|NCT00725985|82988800|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
46770570|NCT00725985|82988801|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
46770571|NCT00793910|82988829|FG000|Overall Study|discarded study pills|0|||
46770572|NCT00793910|82988830|FG001|Overall Study|discarded study pills|1|||
46770573|NCT00793910|82988829|FG000|Overall Study|did not pick up medications|1|||
46770574|NCT00793910|82988830|FG001|Overall Study|did not pick up medications|1|||
46770575|NCT00793910|82988829|FG000|Overall Study|ineligible based on entry criteria|2|||
46770576|NCT00793910|82988830|FG001|Overall Study|ineligible based on entry criteria|3|||
46770577|NCT00793910|82988829|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
46840527|NCT03460704|83057849|FG000|Overall Study|Adverse Event|10|||
47065690|NCT01496365|83348561|FG002|Overall Study|Lost to Follow-up|0|||
47065691|NCT01496365|83348562|FG003|Overall Study|Lost to Follow-up|0|||
46770578|NCT00793910|82988830|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
46770579|NCT00793910|82988829|FG000|Overall Study|Withdrawal by Subject|0|||
46770580|NCT00793910|82988830|FG001|Overall Study|Withdrawal by Subject|1|||
46840528|NCT03460704|83057850|FG001|Overall Study|Adverse Event|5|||
47065692|NCT01496365|83348563|FG004|Overall Study|Lost to Follow-up|2|||
47065693|NCT01496365|83348564|FG005|Overall Study|Lost to Follow-up|0|||
47065694|NCT01496365|83348565|FG006|Overall Study|Lost to Follow-up|0|||
46770581|NCT00444145|82988836|FG000|Overall Study|Withdrawal by Subject|2|||
46840529|NCT03460704|83057849|FG000|Overall Study|Death|3|||
46840530|NCT03460704|83057850|FG001|Overall Study|Death|2|||
46840531|NCT03460704|83057849|FG000|Overall Study|Non-Compliance with Study Drug|3|||
47065695|NCT01496365|83348559|FG000|Overall Study|Other|4|||
47065696|NCT01496365|83348560|FG001|Overall Study|Other|4|||
47065697|NCT01496365|83348561|FG002|Overall Study|Other|2|||
47065698|NCT01496365|83348562|FG003|Overall Study|Other|1|||
47065699|NCT01496365|83348563|FG004|Overall Study|Other|3|||
47065700|NCT01496365|83348564|FG005|Overall Study|Other|0|||
47065701|NCT01496365|83348565|FG006|Overall Study|Other|1|||
47065702|NCT01496287|83348581|FG000|Overall Study|Lost to Follow-up|1|||
47065703|NCT01496287|83348581|FG000|Overall Study|Incomplete anesthesia|5|||
47065704|NCT01495975|83348588|FG000|Overall Study|Lost to Follow-up|1|||
47065705|NCT01495975|83348589|FG001|Overall Study|Lost to Follow-up|0|||
47065706|NCT01468987|83348597|FG000|Overall Study|Adverse Event|12|||
47065707|NCT01468987|83348598|FG001|Overall Study|Adverse Event|9|||
47065708|NCT01468987|83348597|FG000|Overall Study|Death|4|||
47065709|NCT01468987|83348598|FG001|Overall Study|Death|1|||
46946836|NCT02720523|83185024|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
46946837|NCT02720523|83185025|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
46946838|NCT02720523|83185026|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
46946839|NCT02720523|83185027|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
46946840|NCT02720523|83185021|FG000|Period 2: Long-term Extension Period|Other|0|||
46946841|NCT02720523|83185022|FG001|Period 2: Long-term Extension Period|Other|0|||
46946842|NCT02720523|83185023|FG002|Period 2: Long-term Extension Period|Other|0|||
47065710|NCT01468987|83348597|FG000|Overall Study|Lost to Follow-up|10|||
47065711|NCT01468987|83348598|FG001|Overall Study|Lost to Follow-up|5|||
47065712|NCT01468987|83348597|FG000|Overall Study|Protocol Violation|8|||
47065713|NCT01468987|83348598|FG001|Overall Study|Protocol Violation|2|||
46840532|NCT03460704|83057850|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46840533|NCT03460704|83057849|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
46840534|NCT03460704|83057850|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
46840535|NCT03460704|83057849|FG000|Overall Study|Other|2|||
47065714|NCT01468987|83348597|FG000|Overall Study|Withdrawal by Subject|28|||
47065715|NCT01468987|83348598|FG001|Overall Study|Withdrawal by Subject|28|||
47065716|NCT01468987|83348597|FG000|Overall Study|Physician Decision|8|||
47065717|NCT01468987|83348598|FG001|Overall Study|Physician Decision|15|||
47065718|NCT01468987|83348597|FG000|Overall Study|Sponsor Decision|1|||
47065719|NCT01468987|83348598|FG001|Overall Study|Sponsor Decision|0|||
47065720|NCT01687712|83348608|FG000|Cycle 1|Not Biochemically Pregnant|386|||
47065721|NCT01687712|83348609|FG001|Cycle 1|Not Biochemically Pregnant|348|||
46770582|NCT00444145|82988836|FG000|Overall Study|Lost to Follow-up|1|||
46840536|NCT03460704|83057850|FG001|Overall Study|Other|1|||
46840537|NCT03430843|83057858|FG000|Overall Study|Death|233|||
46770583|NCT00444145|82988836|FG000|Overall Study|non-compliant|11|||
46770584|NCT00444145|82988836|FG000|Overall Study|Screen Failures|5|||
46770585|NCT00725283|82988840|FG000|Overall Study|Missing Code|3|||
46770586|NCT00725283|82988840|FG000|Overall Study|Death|5|||
46840538|NCT03430843|83057859|FG001|Overall Study|Death|233|||
46840539|NCT03430843|83057858|FG000|Overall Study|Sponsor Decision|17|||
46770587|NCT00725283|82988840|FG000|Overall Study|Other|6|||
46840540|NCT03430843|83057859|FG001|Overall Study|Sponsor Decision|6|||
46840541|NCT03430843|83057858|FG000|Overall Study|Withdrawal by Subject|5|||
46946843|NCT02720523|83185024|FG003|Period 2: Long-term Extension Period|Other|0|||
46946844|NCT02720523|83185025|FG004|Period 2: Long-term Extension Period|Other|2|||
46946845|NCT02720523|83185026|FG005|Period 2: Long-term Extension Period|Other|0|||
47065722|NCT01687712|83348608|FG000|Cycle 1|Early Pregnancy Loss|43|||
47065723|NCT01687712|83348609|FG001|Cycle 1|Early Pregnancy Loss|60|||
47065724|NCT01687712|83348608|FG000|Cycle 1|Ectopic Pregnancy|5|||
47065725|NCT01687712|83348609|FG001|Cycle 1|Ectopic Pregnancy|5|||
47065726|NCT01687712|83348608|FG000|Cycle 1|Heterotropic Pregnancy|1|||
47065727|NCT01687712|83348609|FG001|Cycle 1|Heterotropic Pregnancy|0|||
47065728|NCT01687712|83348608|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
47065729|NCT01687712|83348609|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
47065730|NCT01687712|83348608|FG000|Cycle 1|Abortion|3|||
47065731|NCT01687712|83348609|FG001|Cycle 1|Abortion|0|||
47065732|NCT01687712|83348608|FG000|Cycle 1|Intrauterine Fetal Death|0|||
47065733|NCT01687712|83348609|FG001|Cycle 1|Intrauterine Fetal Death|1|||
46770588|NCT00725283|82988840|FG000|Overall Study|Withdrawal by Subject|10|||
46770589|NCT00444067|82988846|FG000|Overall Study|Lost to Follow-up|0|||
46770590|NCT00444067|82988847|FG001|Overall Study|Lost to Follow-up|1|||
46770591|NCT00789854|82988856|FG000|Overall Study|Adverse Event|28|||
46770592|NCT00789854|82988857|FG001|Overall Study|Adverse Event|23|||
46770593|NCT00789854|82988858|FG002|Overall Study|Adverse Event|18|||
46770594|NCT00789854|82988856|FG000|Overall Study|Lost to Follow-up|1|||
46770595|NCT00789854|82988857|FG001|Overall Study|Lost to Follow-up|1|||
46770596|NCT00789854|82988858|FG002|Overall Study|Lost to Follow-up|4|||
47065734|NCT01687712|83348608|FG000|Cycle 1|Lost to Follow-up|1|||
47065735|NCT01687712|83348609|FG001|Cycle 1|Lost to Follow-up|1|||
47065736|NCT01687712|83348608|FG000|Cycle 2|Not Biochemically Pregnant|74|||
46770597|NCT00789854|82988856|FG000|Overall Study|Withdrawal by Subject|9|||
46770598|NCT00789854|82988857|FG001|Overall Study|Withdrawal by Subject|6|||
46770599|NCT00789854|82988858|FG002|Overall Study|Withdrawal by Subject|17|||
46840542|NCT03430843|83057859|FG001|Overall Study|Withdrawal by Subject|14|||
47065737|NCT01687712|83348609|FG001|Cycle 2|Not Biochemically Pregnant|77|||
46946846|NCT02720523|83185027|FG006|Period 2: Long-term Extension Period|Other|3|||
46946847|NCT02646332|83185042|FG000|Overall Study|Lost to Follow-up|0|||
46946848|NCT02646332|83185043|FG001|Overall Study|Lost to Follow-up|3|||
46946849|NCT02471716|83185054|FG000|Overall Study|Withdrawal by Subject|0|||
46946850|NCT02471716|83185055|FG001|Overall Study|Withdrawal by Subject|1|||
46946851|NCT02471716|83185056|FG002|Overall Study|Withdrawal by Subject|0|||
46946852|NCT02471716|83185057|FG003|Overall Study|Withdrawal by Subject|2|||
46946853|NCT02471716|83185058|FG004|Overall Study|Withdrawal by Subject|5|||
47065738|NCT01687712|83348608|FG000|Cycle 2|Early Pregnancy Loss|18|||
47065739|NCT01687712|83348609|FG001|Cycle 2|Early Pregnancy Loss|16|||
47065740|NCT01687712|83348608|FG000|Cycle 2|Ectopic Pregnancy|0|||
47065741|NCT01687712|83348609|FG001|Cycle 2|Ectopic Pregnancy|1|||
47065742|NCT01687712|83348608|FG000|Cycle 2|Still Birth|1|||
47065743|NCT01687712|83348609|FG001|Cycle 2|Still Birth|0|||
47065744|NCT01687712|83348608|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
47065745|NCT01687712|83348609|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
47065746|NCT01687712|83348608|FG000|Cycle 3|Not Biochemically Pregnant|21|||
47065747|NCT01687712|83348609|FG001|Cycle 3|Not Biochemically Pregnant|22|||
47065748|NCT01687712|83348608|FG000|Cycle 3|Early Pregnancy Loss|1|||
47065749|NCT01687712|83348609|FG001|Cycle 3|Early Pregnancy Loss|2|||
47065750|NCT01687712|83348608|FG000|Cycle 3|Ectopic Pregnancy|1|||
47065751|NCT01687712|83348609|FG001|Cycle 3|Ectopic Pregnancy|0|||
47065752|NCT01687712|83348608|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
47065753|NCT01687712|83348609|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
47065754|NCT01603628|83348622|FG000|Overall Study|Personal Reasons|1|||
47065755|NCT01603628|83348623|FG001|Overall Study|Personal Reasons|1|||
47065756|NCT01603628|83348624|FG002|Overall Study|Personal Reasons|2|||
47065757|NCT01603628|83348622|FG000|Overall Study|Protocol Violation|1|||
47065758|NCT01603628|83348623|FG001|Overall Study|Protocol Violation|1|||
47065759|NCT01603628|83348624|FG002|Overall Study|Protocol Violation|0|||
47065760|NCT01603628|83348622|FG000|Overall Study|Lost to Follow-up|0|||
47065761|NCT01603628|83348623|FG001|Overall Study|Lost to Follow-up|1|||
47065762|NCT01603628|83348624|FG002|Overall Study|Lost to Follow-up|0|||
47065763|NCT01603628|83348622|FG000|Overall Study|Other Miscellaneous Reason|1|||
47065764|NCT01603628|83348623|FG001|Overall Study|Other Miscellaneous Reason|0|||
47065765|NCT01603628|83348624|FG002|Overall Study|Other Miscellaneous Reason|0|||
47065766|NCT01453153|83348635|FG000|Overall Study|Physician Decision|0|||
47065767|NCT01453153|83348636|FG001|Overall Study|Physician Decision|0|||
47065768|NCT01453153|83348637|FG002|Overall Study|Physician Decision|1|||
47065769|NCT01453153|83348635|FG000|Overall Study|Progressive Disease|3|||
47065770|NCT01453153|83348636|FG001|Overall Study|Progressive Disease|2|||
47065771|NCT01453153|83348637|FG002|Overall Study|Progressive Disease|16|||
47065772|NCT01453153|83348635|FG000|Overall Study|Withdrawal by Subject|0|||
47065773|NCT01453153|83348636|FG001|Overall Study|Withdrawal by Subject|1|||
47065774|NCT01453153|83348637|FG002|Overall Study|Withdrawal by Subject|2|||
47065775|NCT01453153|83348635|FG000|Overall Study|Adverse Event|1|||
47065776|NCT01453153|83348636|FG001|Overall Study|Adverse Event|1|||
47065777|NCT01453153|83348637|FG002|Overall Study|Adverse Event|1|||
47065778|NCT01584440|83348651|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
47065779|NCT01584440|83348652|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
46770600|NCT00789854|82988856|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46770601|NCT00789854|82988857|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
46770602|NCT00789854|82988858|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
46770603|NCT00789854|82988856|FG000|Overall Study|Severe non-compliance to the protocol|3|||
46770604|NCT00789854|82988857|FG001|Overall Study|Severe non-compliance to the protocol|0|||
46770605|NCT00789854|82988858|FG002|Overall Study|Severe non-compliance to the protocol|0|||
46946854|NCT02471716|83185054|FG000|Overall Study|Study Terminiated by sponsor|0|||
46946855|NCT02471716|83185055|FG001|Overall Study|Study Terminiated by sponsor|0|||
46946856|NCT02471716|83185056|FG002|Overall Study|Study Terminiated by sponsor|0|||
46946857|NCT02471716|83185057|FG003|Overall Study|Study Terminiated by sponsor|1|||
46946858|NCT02471716|83185058|FG004|Overall Study|Study Terminiated by sponsor|0|||
46946859|NCT02471716|83185054|FG000|Overall Study|Lost to Follow-up|0|||
46946860|NCT02471716|83185055|FG001|Overall Study|Lost to Follow-up|0|||
47065780|NCT01584440|83348653|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
46946861|NCT02471716|83185056|FG002|Overall Study|Lost to Follow-up|0|||
47065781|NCT01584440|83348654|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
46946862|NCT02471716|83185057|FG003|Overall Study|Lost to Follow-up|3|||
47065782|NCT01584440|83348655|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
47065783|NCT01584440|83348651|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
46770606|NCT00789854|82988856|FG000|Overall Study|Safety reasons|0|||
46946863|NCT02471716|83185058|FG004|Overall Study|Lost to Follow-up|2|||
47065784|NCT01584440|83348652|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
47065785|NCT01584440|83348653|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
47065786|NCT01584440|83348654|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
47065787|NCT01584440|83348655|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
47065788|NCT01584440|83348651|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
47065789|NCT01584440|83348652|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
47065790|NCT01584440|83348653|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
47065791|NCT01584440|83348654|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
47065792|NCT01584440|83348655|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
47065793|NCT01584440|83348651|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
47065794|NCT01584440|83348652|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
47065795|NCT01584440|83348653|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
47065796|NCT01584440|83348654|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
47065797|NCT01584440|83348655|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
47065798|NCT01584440|83348651|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
47065799|NCT01584440|83348652|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
47065800|NCT01584440|83348653|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
47065801|NCT01584440|83348654|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
47065802|NCT01584440|83348655|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
47065803|NCT01584440|83348651|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
47065804|NCT01584440|83348652|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
47065805|NCT01584440|83348653|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
47065806|NCT01584440|83348654|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
47065807|NCT01584440|83348655|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
47065808|NCT01584440|83348651|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
47065809|NCT01584440|83348652|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
47065810|NCT01584440|83348653|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
47065811|NCT01584440|83348654|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
47065812|NCT01584440|83348655|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
47065813|NCT01584440|83348651|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
47065814|NCT01584440|83348652|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
47065815|NCT01584440|83348653|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
47065816|NCT01584440|83348654|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
47065817|NCT01584440|83348655|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
47065818|NCT01584440|83348651|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
47065819|NCT01584440|83348652|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
47065820|NCT01584440|83348653|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
47065821|NCT01584440|83348654|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
47065822|NCT01584440|83348655|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
47065823|NCT01687478|83348670|FG000|Overall Study|Adverse Event|3|||
47065824|NCT01687478|83348671|FG001|Overall Study|Adverse Event|10|||
47065825|NCT01687478|83348670|FG000|Overall Study|Lost to Follow-up|1|||
47065826|NCT01687478|83348671|FG001|Overall Study|Lost to Follow-up|3|||
47065827|NCT01687478|83348670|FG000|Overall Study|Protocol Violation|0|||
47065828|NCT01687478|83348671|FG001|Overall Study|Protocol Violation|2|||
47065829|NCT01687478|83348670|FG000|Overall Study|Withdrawal by Subject|21|||
47065830|NCT01687478|83348671|FG001|Overall Study|Withdrawal by Subject|19|||
47065831|NCT01687478|83348670|FG000|Overall Study|Physician Decision|1|||
47065832|NCT01687478|83348671|FG001|Overall Study|Physician Decision|3|||
47065833|NCT01687478|83348670|FG000|Overall Study|Entry Criteria Not Met|6|||
47065834|NCT01687478|83348671|FG001|Overall Study|Entry Criteria Not Met|2|||
47065835|NCT01468909|83348679|FG000|Overall Study|Never Treated|2|||
47065836|NCT01468909|83348680|FG001|Overall Study|Never Treated|2|||
47065837|NCT01468597|83348686|FG000|Overall Study|Found ineligible|17|||
47065838|NCT01468597|83348686|FG000|Overall Study|concomitant valves|12|||
47065839|NCT01468597|83348686|FG000|Overall Study|off-pump CABG|1|||
47065840|NCT01468597|83348686|FG000|Overall Study|no platelet function data|5|||
47065841|NCT01687166|83348694|FG000|Overall Study|Attempt subject|2|||
47065842|NCT01687166|83348695|FG001|Overall Study|Attempt subject|3|||
47065843|NCT01687166|83348696|FG002|Overall Study|Attempt subject|2|||
47065844|NCT01687166|83348697|FG003|Overall Study|Attempt subject|0|||
47065845|NCT01687166|83348694|FG000|Overall Study|Did not meet eligibility criteria|4|||
47065846|NCT01687166|83348695|FG001|Overall Study|Did not meet eligibility criteria|6|||
47065847|NCT01687166|83348696|FG002|Overall Study|Did not meet eligibility criteria|1|||
46770607|NCT00789854|82988857|FG001|Overall Study|Safety reasons|0|||
46770608|NCT00789854|82988858|FG002|Overall Study|Safety reasons|2|||
46770609|NCT00789854|82988856|FG000|Overall Study|Other|6|||
47065848|NCT01687166|83348697|FG003|Overall Study|Did not meet eligibility criteria|1|||
47065849|NCT01687166|83348694|FG000|Overall Study|Adverse Event|2|||
47065850|NCT01687166|83348695|FG001|Overall Study|Adverse Event|1|||
47065851|NCT01687166|83348696|FG002|Overall Study|Adverse Event|0|||
47065852|NCT01687166|83348697|FG003|Overall Study|Adverse Event|0|||
47065853|NCT01687166|83348694|FG000|Overall Study|Physician Decision|3|||
47065854|NCT01687166|83348695|FG001|Overall Study|Physician Decision|2|||
47065855|NCT01687166|83348696|FG002|Overall Study|Physician Decision|1|||
47065856|NCT01687166|83348697|FG003|Overall Study|Physician Decision|0|||
47065857|NCT01687166|83348694|FG000|Overall Study|Withdrawal by Subject|11|||
47065858|NCT01687166|83348695|FG001|Overall Study|Withdrawal by Subject|4|||
47065859|NCT01687166|83348696|FG002|Overall Study|Withdrawal by Subject|3|||
46770610|NCT00789854|82988857|FG001|Overall Study|Other|0|||
47065860|NCT01687166|83348697|FG003|Overall Study|Withdrawal by Subject|0|||
46770611|NCT00789854|82988858|FG002|Overall Study|Other|5|||
47065861|NCT01687166|83348694|FG000|Overall Study|Lost to Follow-up|2|||
47065862|NCT01687166|83348695|FG001|Overall Study|Lost to Follow-up|5|||
47065863|NCT01687166|83348696|FG002|Overall Study|Lost to Follow-up|1|||
47065864|NCT01687166|83348697|FG003|Overall Study|Lost to Follow-up|0|||
47065865|NCT01687166|83348694|FG000|Overall Study|Equipment/Device Availability|0|||
47065866|NCT01687166|83348695|FG001|Overall Study|Equipment/Device Availability|1|||
47065867|NCT01687166|83348696|FG002|Overall Study|Equipment/Device Availability|0|||
47065868|NCT01687166|83348697|FG003|Overall Study|Equipment/Device Availability|0|||
47065869|NCT01687166|83348694|FG000|Overall Study|Death|1|||
47065870|NCT01687166|83348695|FG001|Overall Study|Death|1|||
47065871|NCT01687166|83348696|FG002|Overall Study|Death|0|||
47065872|NCT01687166|83348697|FG003|Overall Study|Death|0|||
47065873|NCT01687166|83348694|FG000|Overall Study|Protocol Violation|1|||
47065874|NCT01687166|83348695|FG001|Overall Study|Protocol Violation|1|||
47065875|NCT01687166|83348696|FG002|Overall Study|Protocol Violation|1|||
47065876|NCT01687166|83348697|FG003|Overall Study|Protocol Violation|0|||
47065877|NCT01687166|83348694|FG000|Overall Study|Subject moved out of state|0|||
47065878|NCT01687166|83348695|FG001|Overall Study|Subject moved out of state|1|||
47065879|NCT01687166|83348696|FG002|Overall Study|Subject moved out of state|0|||
47065880|NCT01687166|83348697|FG003|Overall Study|Subject moved out of state|0|||
47065881|NCT01687166|83348694|FG000|Overall Study|Patient unable to be compliant|1|||
47065882|NCT01687166|83348695|FG001|Overall Study|Patient unable to be compliant|0|||
46638887|NCT01409382|82812332|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
46638888|NCT01409382|82812333|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
46770612|NCT00725205|82988866|FG000|Overall Study|Adverse Event|22|||
46770613|NCT00725205|82988866|FG000|Overall Study|Investigator Discontinued|1|||
46770614|NCT00725205|82988866|FG000|Overall Study|Non-compliance With Protocol|14|||
46770615|NCT00725205|82988866|FG000|Overall Study|Other|8|||
46770616|NCT00725205|82988866|FG000|Overall Study|Protocol Defined Clinical Event|1|||
46770617|NCT00725205|82988866|FG000|Overall Study|Treatment Failure|41|||
46770618|NCT00443755|82988872|FG000|Overall Study|Withdrawal by Subject|2|||
46770619|NCT00443755|82988873|FG001|Overall Study|Withdrawal by Subject|1|||
46770620|NCT00724971|82988879|FG000|Overall Study|Adverse Event|5|||
46770621|NCT00724971|82988879|FG000|Overall Study|Withdrawal by Subject|1|||
46770622|NCT00443599|82988885|FG000|Overall Study|Physician Decision|2|||
46770623|NCT00443599|82988886|FG001|Overall Study|Physician Decision|1|||
46770624|NCT00443599|82988885|FG000|Overall Study|Death|1|||
46770625|NCT00443599|82988886|FG001|Overall Study|Death|1|||
46770626|NCT00443599|82988885|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
46770627|NCT00443599|82988886|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
46770628|NCT00455143|82988892|FG000|Overall Study|Physician Decision|1|||
46840543|NCT03430843|83057858|FG000|Overall Study|Lost to Follow-up|1|||
46840544|NCT03430843|83057859|FG001|Overall Study|Lost to Follow-up|3|||
46840545|NCT03382600|83057867|FG000|Overall Study|Adverse Event|3|||
46840546|NCT03382600|83057868|FG001|Overall Study|Adverse Event|3|||
46840547|NCT03382600|83057867|FG000|Overall Study|Clinical Disease Progression|2|||
46840548|NCT03382600|83057868|FG001|Overall Study|Clinical Disease Progression|4|||
46946864|NCT02471716|83185054|FG000|Overall Study|Death|0|||
46946865|NCT02471716|83185055|FG001|Overall Study|Death|0|||
46840549|NCT03382600|83057867|FG000|Overall Study|Radiological Progression|40|||
46840550|NCT03382600|83057868|FG001|Overall Study|Radiological Progression|31|||
46840551|NCT03382600|83057867|FG000|Overall Study|Withdrawal by Subject|0|||
46840552|NCT03382600|83057868|FG001|Overall Study|Withdrawal by Subject|1|||
46840553|NCT03382600|83057867|FG000|Overall Study|Other|9|||
46840554|NCT03382600|83057868|FG001|Overall Study|Other|7|||
46840555|NCT02759861|83057883|FG000|Overall Study|Death|1|||
46840556|NCT01524705|83057915|FG000|Overall Study|Adverse Event|2|||
46840557|NCT01524705|83057916|FG001|Overall Study|Adverse Event|0|||
46840558|NCT01524705|83057915|FG000|Overall Study|Death|1|||
46840559|NCT01524705|83057916|FG001|Overall Study|Death|0|||
46946866|NCT02471716|83185056|FG002|Overall Study|Death|0|||
46946867|NCT02471716|83185057|FG003|Overall Study|Death|1|||
47065883|NCT01687166|83348696|FG002|Overall Study|Patient unable to be compliant|0|||
47065884|NCT01687166|83348697|FG003|Overall Study|Patient unable to be compliant|0|||
47065885|NCT01687166|83348694|FG000|Overall Study|Physician choice to use different device|1|||
47065886|NCT01687166|83348695|FG001|Overall Study|Physician choice to use different device|2|||
47065887|NCT01687166|83348696|FG002|Overall Study|Physician choice to use different device|4|||
47065888|NCT01687166|83348697|FG003|Overall Study|Physician choice to use different device|0|||
47065889|NCT01687166|83348694|FG000|Overall Study|Insurance|0|||
47065890|NCT01687166|83348695|FG001|Overall Study|Insurance|0|||
47065891|NCT01687166|83348696|FG002|Overall Study|Insurance|1|||
46946868|NCT02471716|83185058|FG004|Overall Study|Death|0|||
46946869|NCT02471716|83185054|FG000|Overall Study|Other|0|||
46946870|NCT02471716|83185055|FG001|Overall Study|Other|0|||
46770629|NCT00455143|82988892|FG000|Overall Study|Withdrawal by Subject|1|||
46770630|NCT00455143|82988892|FG000|Overall Study|Staff was not avail to follow patient|2|||
46840560|NCT01524705|83057915|FG000|Overall Study|Lost to Follow-up|0|||
46840561|NCT01524705|83057916|FG001|Overall Study|Lost to Follow-up|1|||
46770631|NCT00455143|82988892|FG000|Overall Study|No longer met Inclusion Criteria|1|||
46770632|NCT00455143|82988892|FG000|Overall Study|Surgical time, staff not available|1|||
46770633|NCT00454987|82988900|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
46770634|NCT00454987|82988901|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
46770635|NCT00454987|82988902|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
46770636|NCT00454987|82988900|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
46770637|NCT00454987|82988901|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
46770638|NCT00454987|82988902|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
46770639|NCT00454987|82988900|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
46770640|NCT00454987|82988901|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
46770641|NCT00454987|82988902|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
46770642|NCT00724893|82988913|FG000|Overall Study|Adverse Event|76|||
46770643|NCT00724893|82988914|FG001|Overall Study|Adverse Event|142|||
46770644|NCT00724893|82988913|FG000|Overall Study|Withdrawal by Subject|0|||
46770645|NCT00724893|82988914|FG001|Overall Study|Withdrawal by Subject|1|||
46770646|NCT00724893|82988913|FG000|Overall Study|Lack of virologic response|94|||
46770647|NCT00724893|82988914|FG001|Overall Study|Lack of virologic response|202|||
47065892|NCT01687166|83348697|FG003|Overall Study|Insurance|1|||
47065893|NCT01561976|83348711|FG000|Period 1|Adverse Event|0|||
47065894|NCT01561976|83348712|FG001|Period 1|Adverse Event|0|||
47065895|NCT01561976|83348713|FG002|Period 1|Adverse Event|1|||
47065896|NCT01561976|83348714|FG003|Period 1|Adverse Event|0|||
47065897|NCT01561976|83348715|FG004|Period 1|Adverse Event|0|||
47065898|NCT01561976|83348716|FG005|Period 1|Adverse Event|0|||
47065899|NCT01561976|83348711|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
47065900|NCT01561976|83348712|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
47065901|NCT01561976|83348713|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
47065902|NCT01561976|83348714|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
47065903|NCT01561976|83348715|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
47065904|NCT01561976|83348716|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
47065905|NCT01561976|83348711|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47065906|NCT01561976|83348712|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47065907|NCT01561976|83348713|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47065908|NCT01561976|83348714|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47065909|NCT01561976|83348715|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
47065910|NCT01561976|83348716|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
47065911|NCT01561976|83348711|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
47065912|NCT01561976|83348712|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
47065913|NCT01561976|83348713|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
47065914|NCT01561976|83348714|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
47065915|NCT01561976|83348715|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
47065916|NCT01561976|83348716|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
46770648|NCT00724893|82988913|FG000|Overall Study|Reason not specified|193|||
46770649|NCT00724893|82988914|FG001|Overall Study|Reason not specified|7|||
46770650|NCT00724893|82988913|FG000|Overall Study|Patient choice|0|||
46770651|NCT00724893|82988914|FG001|Overall Study|Patient choice|26|||
46770652|NCT00724893|82988913|FG000|Overall Study|Geographic reasons|0|||
46770653|NCT00724893|82988914|FG001|Overall Study|Geographic reasons|11|||
46770654|NCT00724893|82988913|FG000|Overall Study|Incarceration|0|||
46770655|NCT00724893|82988914|FG001|Overall Study|Incarceration|9|||
46770656|NCT00724893|82988913|FG000|Overall Study|Substance abuse|0|||
46770657|NCT00724893|82988914|FG001|Overall Study|Substance abuse|3|||
46770658|NCT00724893|82988913|FG000|Overall Study|Financial reasons|0|||
46770659|NCT00724893|82988914|FG001|Overall Study|Financial reasons|2|||
46770660|NCT00724893|82988913|FG000|Overall Study|Assigned shorter treatment|0|||
46770661|NCT00724893|82988914|FG001|Overall Study|Assigned shorter treatment|2|||
46770662|NCT00724893|82988913|FG000|Overall Study|Lost to Follow-up|0|||
46770663|NCT00724893|82988914|FG001|Overall Study|Lost to Follow-up|52|||
46770664|NCT00724893|82988913|FG000|Overall Study|Unknown, missing data|1|||
46770665|NCT00724893|82988914|FG001|Overall Study|Unknown, missing data|1|||
46770666|NCT00789698|82988939|FG000|Overall Study|Lack of Efficacy|10|||
46770667|NCT00789698|82988940|FG001|Overall Study|Lack of Efficacy|4|||
47065917|NCT01686932|83348726|FG000|Period 1|Adverse Event|1|||
47065918|NCT01686932|83348727|FG001|Period 1|Adverse Event|1|||
46770668|NCT00789698|82988941|FG002|Overall Study|Lack of Efficacy|5|||
46770669|NCT00789698|82988942|FG003|Overall Study|Lack of Efficacy|18|||
46946871|NCT02471716|83185056|FG002|Overall Study|Other|0|||
47065919|NCT01468207|83348735|FG000|Treatment Period 1|Adverse Event|1|||
47065920|NCT01468207|83348736|FG001|Treatment Period 1|Adverse Event|0|||
47065921|NCT01468207|83348737|FG002|Treatment Period 1|Adverse Event|0|||
47065922|NCT01468207|83348738|FG003|Treatment Period 1|Adverse Event|0|||
47065923|NCT01468207|83348739|FG004|Treatment Period 1|Adverse Event|0|||
46770670|NCT00789698|82988939|FG000|Overall Study|Adverse Event|5|||
46770671|NCT00789698|82988940|FG001|Overall Study|Adverse Event|5|||
46770672|NCT00789698|82988941|FG002|Overall Study|Adverse Event|3|||
46770673|NCT00789698|82988942|FG003|Overall Study|Adverse Event|4|||
47065924|NCT01468207|83348740|FG005|Treatment Period 1|Adverse Event|0|||
47065925|NCT01468207|83348735|FG000|Treatment Period 1|Protocol Violation|1|||
47065926|NCT01468207|83348736|FG001|Treatment Period 1|Protocol Violation|1|||
47065927|NCT01468207|83348737|FG002|Treatment Period 1|Protocol Violation|0|||
47065928|NCT01468207|83348738|FG003|Treatment Period 1|Protocol Violation|0|||
47065929|NCT01468207|83348739|FG004|Treatment Period 1|Protocol Violation|0|||
47065930|NCT01468207|83348740|FG005|Treatment Period 1|Protocol Violation|0|||
47065931|NCT01468207|83348735|FG000|Treatment Period 1|Withdrawal by Subject|5|||
47065932|NCT01468207|83348736|FG001|Treatment Period 1|Withdrawal by Subject|4|||
47065933|NCT01468207|83348737|FG002|Treatment Period 1|Withdrawal by Subject|0|||
47065934|NCT01468207|83348738|FG003|Treatment Period 1|Withdrawal by Subject|0|||
47065935|NCT01468207|83348739|FG004|Treatment Period 1|Withdrawal by Subject|0|||
47065936|NCT01468207|83348740|FG005|Treatment Period 1|Withdrawal by Subject|0|||
47065937|NCT01468207|83348735|FG000|Treatment Period 1|Lost to Follow-up|2|||
47065938|NCT01468207|83348736|FG001|Treatment Period 1|Lost to Follow-up|1|||
46946872|NCT02471716|83185057|FG003|Overall Study|Other|8|||
46946873|NCT02471716|83185058|FG004|Overall Study|Other|9|||
47065939|NCT01468207|83348737|FG002|Treatment Period 1|Lost to Follow-up|0|||
47065940|NCT01468207|83348738|FG003|Treatment Period 1|Lost to Follow-up|0|||
47065941|NCT01468207|83348739|FG004|Treatment Period 1|Lost to Follow-up|0|||
47065942|NCT01468207|83348740|FG005|Treatment Period 1|Lost to Follow-up|0|||
47065943|NCT01468207|83348735|FG000|Treatment Period 1|Other|0|||
47065944|NCT01468207|83348736|FG001|Treatment Period 1|Other|2|||
47065945|NCT01468207|83348737|FG002|Treatment Period 1|Other|0|||
47065946|NCT01468207|83348738|FG003|Treatment Period 1|Other|0|||
47065947|NCT01468207|83348739|FG004|Treatment Period 1|Other|0|||
47065948|NCT01468207|83348740|FG005|Treatment Period 1|Other|0|||
47065949|NCT01468207|83348735|FG000|Treatment Period 2|Adverse Event|0|||
47065950|NCT01468207|83348736|FG001|Treatment Period 2|Adverse Event|0|||
47065951|NCT01468207|83348737|FG002|Treatment Period 2|Adverse Event|6|||
47065952|NCT01468207|83348738|FG003|Treatment Period 2|Adverse Event|1|||
47065953|NCT01468207|83348739|FG004|Treatment Period 2|Adverse Event|2|||
47065954|NCT01468207|83348740|FG005|Treatment Period 2|Adverse Event|1|||
47065955|NCT01468207|83348735|FG000|Treatment Period 2|Lack of Efficacy|0|||
46770674|NCT00789698|82988939|FG000|Overall Study|Lost to Follow-up|5|||
46770675|NCT00789698|82988940|FG001|Overall Study|Lost to Follow-up|5|||
46770676|NCT00789698|82988941|FG002|Overall Study|Lost to Follow-up|2|||
46946874|NCT01370863|83185074|FG000|Overall Study|Adverse Event|1|||
46946875|NCT01370863|83185075|FG001|Overall Study|Adverse Event|1|||
46770677|NCT00789698|82988942|FG003|Overall Study|Lost to Follow-up|9|||
46770678|NCT00789698|82988939|FG000|Overall Study|Protocol Violation|6|||
46770679|NCT00789698|82988940|FG001|Overall Study|Protocol Violation|1|||
46770680|NCT00789698|82988941|FG002|Overall Study|Protocol Violation|2|||
46770681|NCT00789698|82988942|FG003|Overall Study|Protocol Violation|1|||
46770682|NCT00789698|82988939|FG000|Overall Study|Withdrawal by Subject|14|||
46770683|NCT00789698|82988940|FG001|Overall Study|Withdrawal by Subject|15|||
46770684|NCT00789698|82988941|FG002|Overall Study|Withdrawal by Subject|12|||
46770685|NCT00789698|82988942|FG003|Overall Study|Withdrawal by Subject|19|||
46840562|NCT01524705|83057915|FG000|Overall Study|Withdrawal by Subject|0|||
46840563|NCT01524705|83057916|FG001|Overall Study|Withdrawal by Subject|1|||
46840564|NCT01524705|83057915|FG000|Overall Study|Pancreatic Cancer|0|||
46840565|NCT01524705|83057916|FG001|Overall Study|Pancreatic Cancer|1|||
46840566|NCT01072539|83057928|FG000|Overall Study|Treated prior to the Site Initiation|1|||
46840567|NCT01072539|83057928|FG000|Overall Study|Protocol Violation|2|||
46840568|NCT00147537|83057936|FG000|Phase 1b|Death|0|||
46840569|NCT00147537|83057937|FG001|Phase 1b|Death|1|||
46840570|NCT00147537|83057938|FG002|Phase 1b|Death|2|||
46840571|NCT00147537|83057939|FG003|Phase 1b|Death|1|||
46840572|NCT00147537|83057940|FG004|Phase 1b|Death|2|||
46840573|NCT00147537|83057941|FG005|Phase 1b|Death|2|||
46946876|NCT01370863|83185074|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
46946877|NCT01370863|83185075|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
46946878|NCT01370863|83185074|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
46946879|NCT01370863|83185075|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
46946880|NCT02444182|83185083|FG000|Overall Study|non-compliance|2|||
46946881|NCT02444182|83185084|FG001|Overall Study|non-compliance|1|||
47065956|NCT01468207|83348736|FG001|Treatment Period 2|Lack of Efficacy|0|||
47065957|NCT01468207|83348737|FG002|Treatment Period 2|Lack of Efficacy|1|||
46770686|NCT00789698|82988939|FG000|Overall Study|Administrative|0|||
47065958|NCT01468207|83348738|FG003|Treatment Period 2|Lack of Efficacy|1|||
47065959|NCT01468207|83348739|FG004|Treatment Period 2|Lack of Efficacy|0|||
47065960|NCT01468207|83348740|FG005|Treatment Period 2|Lack of Efficacy|2|||
47065961|NCT01468207|83348735|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46770687|NCT00789698|82988940|FG001|Overall Study|Administrative|3|||
47065962|NCT01468207|83348736|FG001|Treatment Period 2|Withdrawal by Subject|0|||
47065963|NCT01468207|83348737|FG002|Treatment Period 2|Withdrawal by Subject|5|||
46770688|NCT00789698|82988941|FG002|Overall Study|Administrative|3|||
46840574|NCT00147537|83057942|FG006|Phase 1b|Death|1|||
46840575|NCT00147537|83057943|FG007|Phase 1b|Death|3|||
46840576|NCT00147537|83057944|FG008|Phase 1b|Death|9|||
46946882|NCT02444182|83185083|FG000|Overall Study|Lost to Follow-up|0|||
46946883|NCT02444182|83185084|FG001|Overall Study|Lost to Follow-up|4|||
46946884|NCT02471404|83185093|FG000|Overall Study|Adverse Event|7|||
46946885|NCT02471404|83185094|FG001|Overall Study|Adverse Event|1|||
46946886|NCT02471404|83185095|FG002|Overall Study|Adverse Event|2|||
47065964|NCT01468207|83348738|FG003|Treatment Period 2|Withdrawal by Subject|0|||
47065965|NCT01468207|83348739|FG004|Treatment Period 2|Withdrawal by Subject|0|||
47065966|NCT01468207|83348740|FG005|Treatment Period 2|Withdrawal by Subject|2|||
47065967|NCT01468207|83348735|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
47065968|NCT01468207|83348736|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
47065969|NCT01468207|83348737|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
47065970|NCT01468207|83348738|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
47065971|NCT01468207|83348739|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
47065972|NCT01468207|83348740|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
47065973|NCT01468207|83348735|FG000|Treatment Period 2|Lost to Follow-up|0|||
47065974|NCT01468207|83348736|FG001|Treatment Period 2|Lost to Follow-up|0|||
46770689|NCT00789698|82988942|FG003|Overall Study|Administrative|1|||
46770690|NCT00724815|82988953|FG000|Overall Study|Randomized, not treated|31|||
46770691|NCT00724815|82988954|FG001|Overall Study|Randomized, not treated|30|||
46770692|NCT00724815|82988953|FG000|Overall Study|Adverse Event|5|||
46770693|NCT00724815|82988954|FG001|Overall Study|Adverse Event|3|||
46770694|NCT00724815|82988953|FG000|Overall Study|Lost to Follow-up|4|||
46770695|NCT00724815|82988954|FG001|Overall Study|Lost to Follow-up|1|||
46770696|NCT00724815|82988953|FG000|Overall Study|Other Various|3|||
46770697|NCT00724815|82988954|FG001|Overall Study|Other Various|5|||
46770698|NCT00454909|82988963|FG000|Overall Study|Withdrawal by Subject|1|||
46770699|NCT00454909|82988964|FG001|Overall Study|Withdrawal by Subject|0|||
46770700|NCT00454909|82988965|FG002|Overall Study|Withdrawal by Subject|0|||
46770701|NCT00454909|82988963|FG000|Overall Study|Migrated/moved from study area|0|||
46770702|NCT00454909|82988964|FG001|Overall Study|Migrated/moved from study area|0|||
46770703|NCT00454909|82988965|FG002|Overall Study|Migrated/moved from study area|1|||
46770704|NCT00454909|82988963|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
46770705|NCT00454909|82988964|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
46770706|NCT00454909|82988965|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
46770707|NCT00454909|82988963|FG000|Overall Study|Others|1|||
46770708|NCT00454909|82988964|FG001|Overall Study|Others|0|||
46770709|NCT00454909|82988965|FG002|Overall Study|Others|0|||
46770710|NCT00798590|82988976|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
46770711|NCT00798590|82988977|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
46770712|NCT00481195|82988985|FG000|Overall Study|Adverse Event|16|||
46770713|NCT00481195|82988986|FG001|Overall Study|Adverse Event|11|||
46770714|NCT00481195|82988985|FG000|Overall Study|Lack of Efficacy|1|||
46770715|NCT00481195|82988986|FG001|Overall Study|Lack of Efficacy|3|||
46770716|NCT00481195|82988985|FG000|Overall Study|Lost to Follow-up|4|||
46770717|NCT00481195|82988986|FG001|Overall Study|Lost to Follow-up|6|||
46770718|NCT00481195|82988985|FG000|Overall Study|Physician Decision|3|||
46770719|NCT00481195|82988986|FG001|Overall Study|Physician Decision|1|||
46770720|NCT00481195|82988985|FG000|Overall Study|Protocol Violation|10|||
46770721|NCT00481195|82988986|FG001|Overall Study|Protocol Violation|7|||
46770722|NCT00481195|82988985|FG000|Overall Study|Withdrawal by Subject|3|||
47065975|NCT01468207|83348737|FG002|Treatment Period 2|Lost to Follow-up|5|||
47065976|NCT01468207|83348738|FG003|Treatment Period 2|Lost to Follow-up|1|||
46770723|NCT00481195|82988986|FG001|Overall Study|Withdrawal by Subject|9|||
46770724|NCT00481195|82988985|FG000|Overall Study|Miscellaneous|2|||
46770725|NCT00481195|82988986|FG001|Overall Study|Miscellaneous|2|||
46770726|NCT00454363|82989003|FG000|Overall Study|Adverse Event|1|||
46770727|NCT00454363|82989004|FG001|Overall Study|Adverse Event|2|||
46770728|NCT00454363|82989003|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
46770729|NCT00454363|82989004|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
46770730|NCT00454207|82989011|FG000|Overall Study|Adverse Event|3|||
46770731|NCT00454207|82989012|FG001|Overall Study|Adverse Event|1|||
46770732|NCT00454207|82989011|FG000|Overall Study|Lack of Efficacy|1|||
46946887|NCT02471404|83185093|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
47065977|NCT01468207|83348739|FG004|Treatment Period 2|Lost to Follow-up|0|||
47065978|NCT01468207|83348740|FG005|Treatment Period 2|Lost to Follow-up|0|||
47065979|NCT01468207|83348735|FG000|Treatment Period 2|Other|0|||
46770733|NCT00454207|82989012|FG001|Overall Study|Lack of Efficacy|0|||
46770734|NCT00454207|82989011|FG000|Overall Study|Protocol Violation|0|||
46770735|NCT00454207|82989012|FG001|Overall Study|Protocol Violation|1|||
46770736|NCT00738894|82989032|FG000|Overall Study|Lost to Follow-up|23|||
46770737|NCT00738894|82989033|FG001|Overall Study|Lost to Follow-up|13|||
46946888|NCT02471404|83185094|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
47065980|NCT01468207|83348736|FG001|Treatment Period 2|Other|0|||
47065981|NCT01468207|83348737|FG002|Treatment Period 2|Other|5|||
47065982|NCT01468207|83348738|FG003|Treatment Period 2|Other|1|||
47065983|NCT01468207|83348739|FG004|Treatment Period 2|Other|1|||
47065984|NCT01468207|83348740|FG005|Treatment Period 2|Other|2|||
47065985|NCT01494649|83348760|FG000|Overall Study|Lost to Follow-up|0|||
47065986|NCT01494649|83348761|FG001|Overall Study|Lost to Follow-up|1|||
47065987|NCT01686152|83348772|FG000|Overall Study|Withdrawal by Subject|11|||
47065988|NCT01686152|83348773|FG001|Overall Study|Withdrawal by Subject|11|||
47065989|NCT01686152|83348774|FG002|Overall Study|Withdrawal by Subject|3|||
47065990|NCT01686152|83348772|FG000|Overall Study|Drug Code Unblinded|0|||
47065991|NCT01686152|83348773|FG001|Overall Study|Drug Code Unblinded|1|||
47065992|NCT01686152|83348774|FG002|Overall Study|Drug Code Unblinded|0|||
47065993|NCT01686152|83348772|FG000|Overall Study|Protocol Violation|6|||
47065994|NCT01686152|83348773|FG001|Overall Study|Protocol Violation|1|||
47065995|NCT01686152|83348774|FG002|Overall Study|Protocol Violation|0|||
47065996|NCT01686152|83348772|FG000|Overall Study|Adverse Event|12|||
46946889|NCT02471404|83185095|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
46946890|NCT02471404|83185093|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
46946891|NCT02471404|83185094|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
46946892|NCT02471404|83185095|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
47065997|NCT01686152|83348773|FG001|Overall Study|Adverse Event|11|||
47065998|NCT01686152|83348774|FG002|Overall Study|Adverse Event|0|||
47065999|NCT01686152|83348772|FG000|Overall Study|Lack of Efficacy|0|||
47066000|NCT01686152|83348773|FG001|Overall Study|Lack of Efficacy|0|||
47066001|NCT01686152|83348774|FG002|Overall Study|Lack of Efficacy|1|||
47066002|NCT01686152|83348772|FG000|Overall Study|IP Non-compliance|5|||
47066003|NCT01686152|83348773|FG001|Overall Study|IP Non-compliance|5|||
47066004|NCT01686152|83348774|FG002|Overall Study|IP Non-compliance|0|||
47066005|NCT01686152|83348772|FG000|Overall Study|Lost to Follow-up|7|||
47066006|NCT01686152|83348773|FG001|Overall Study|Lost to Follow-up|6|||
47066007|NCT01686152|83348774|FG002|Overall Study|Lost to Follow-up|5|||
47066008|NCT01452919|83348782|FG000|Open-Label Treatment|Adverse Event|5|||
47066009|NCT01452919|83348783|FG001|Open-Label Treatment|Adverse Event|0|||
47066010|NCT01452919|83348784|FG002|Open-Label Treatment|Adverse Event|0|||
47066011|NCT01452919|83348782|FG000|Open-Label Treatment|Lost to Follow-up|4|||
47066012|NCT01452919|83348783|FG001|Open-Label Treatment|Lost to Follow-up|0|||
47066013|NCT01452919|83348784|FG002|Open-Label Treatment|Lost to Follow-up|0|||
47066014|NCT01452919|83348782|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
47066015|NCT01452919|83348783|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
47066016|NCT01452919|83348784|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
47066017|NCT01452919|83348782|FG000|Open-Label Treatment|Protocol Violation|4|||
47066018|NCT01452919|83348783|FG001|Open-Label Treatment|Protocol Violation|0|||
46946893|NCT02471404|83185093|FG000|Overall Study|Lost to Follow-up|1|||
47066019|NCT01452919|83348784|FG002|Open-Label Treatment|Protocol Violation|0|||
47066020|NCT01452919|83348782|FG000|Open-Label Treatment|Sponsor Decision|1|||
47066021|NCT01452919|83348783|FG001|Open-Label Treatment|Sponsor Decision|0|||
47066022|NCT01452919|83348784|FG002|Open-Label Treatment|Sponsor Decision|0|||
47066023|NCT01452919|83348782|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
47066024|NCT01452919|83348783|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
47066025|NCT01452919|83348784|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
47066026|NCT01452919|83348782|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
46840577|NCT00147537|83057945|FG009|Phase 1b|Death|0|||
46840578|NCT00147537|83057946|FG010|Phase 1b|Death|0|||
46840579|NCT00147537|83057936|FG000|Phase 1b|Lost to Follow-up|2|||
46840580|NCT00147537|83057937|FG001|Phase 1b|Lost to Follow-up|1|||
46840581|NCT00147537|83057938|FG002|Phase 1b|Lost to Follow-up|0|||
46840582|NCT00147537|83057939|FG003|Phase 1b|Lost to Follow-up|0|||
46840583|NCT00147537|83057940|FG004|Phase 1b|Lost to Follow-up|0|||
46840584|NCT00147537|83057941|FG005|Phase 1b|Lost to Follow-up|0|||
46840585|NCT00147537|83057942|FG006|Phase 1b|Lost to Follow-up|2|||
46840586|NCT00147537|83057943|FG007|Phase 1b|Lost to Follow-up|0|||
47066027|NCT01452919|83348783|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
47066028|NCT01452919|83348784|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
47066029|NCT01452919|83348782|FG000|Randomization Treatment|Adverse Event|0|||
47066030|NCT01452919|83348783|FG001|Randomization Treatment|Adverse Event|0|||
47066031|NCT01452919|83348784|FG002|Randomization Treatment|Adverse Event|2|||
47066032|NCT01452919|83348782|FG000|Randomization Treatment|Sponsor Decision|0|||
47066033|NCT01452919|83348783|FG001|Randomization Treatment|Sponsor Decision|1|||
47066034|NCT01452919|83348784|FG002|Randomization Treatment|Sponsor Decision|0|||
46840587|NCT00147537|83057944|FG008|Phase 1b|Lost to Follow-up|1|||
47066035|NCT01452919|83348782|FG000|Randomization Treatment|Withdrawal by Subject|0|||
47066036|NCT01452919|83348783|FG001|Randomization Treatment|Withdrawal by Subject|1|||
47066037|NCT01452919|83348784|FG002|Randomization Treatment|Withdrawal by Subject|0|||
46840588|NCT00147537|83057945|FG009|Phase 1b|Lost to Follow-up|0|||
46840589|NCT00147537|83057946|FG010|Phase 1b|Lost to Follow-up|0|||
47066038|NCT01452919|83348782|FG000|Randomization Treatment|Subject is moving or has moved|0|||
47066039|NCT01452919|83348783|FG001|Randomization Treatment|Subject is moving or has moved|1|||
47066040|NCT01452919|83348784|FG002|Randomization Treatment|Subject is moving or has moved|0|||
47066041|NCT01582178|83348796|FG000|Overall Study|Physician Decision|6|||
47066042|NCT01582178|83348797|FG001|Overall Study|Physician Decision|5|||
47066043|NCT01561898|83348807|FG000|Overall Study|Withdrawal by Subject|0|||
47066044|NCT01561898|83348808|FG001|Overall Study|Withdrawal by Subject|8|||
47066045|NCT01561898|83348809|FG002|Overall Study|Withdrawal by Subject|12|||
47066046|NCT01561898|83348810|FG003|Overall Study|Withdrawal by Subject|5|||
47066047|NCT01561898|83348807|FG000|Overall Study|Lack of Efficacy|0|||
47066048|NCT01561898|83348808|FG001|Overall Study|Lack of Efficacy|8|||
47066049|NCT01561898|83348809|FG002|Overall Study|Lack of Efficacy|10|||
47066050|NCT01561898|83348810|FG003|Overall Study|Lack of Efficacy|5|||
47066051|NCT01561898|83348807|FG000|Overall Study|Worsening of complications|0|||
47066052|NCT01561898|83348808|FG001|Overall Study|Worsening of complications|1|||
47066053|NCT01561898|83348809|FG002|Overall Study|Worsening of complications|0|||
47066054|NCT01561898|83348810|FG003|Overall Study|Worsening of complications|0|||
47066055|NCT01561898|83348807|FG000|Overall Study|Lost to Follow-up|0|||
47066056|NCT01561898|83348808|FG001|Overall Study|Lost to Follow-up|0|||
47066057|NCT01561898|83348809|FG002|Overall Study|Lost to Follow-up|1|||
47066058|NCT01561898|83348810|FG003|Overall Study|Lost to Follow-up|0|||
47066059|NCT01561898|83348807|FG000|Overall Study|Adverse Event|1|||
47066060|NCT01561898|83348808|FG001|Overall Study|Adverse Event|19|||
47066061|NCT01561898|83348809|FG002|Overall Study|Adverse Event|14|||
47066062|NCT01561898|83348810|FG003|Overall Study|Adverse Event|9|||
47066063|NCT01561898|83348807|FG000|Overall Study|Physician Decision|1|||
47066064|NCT01561898|83348808|FG001|Overall Study|Physician Decision|5|||
47066065|NCT01561898|83348809|FG002|Overall Study|Physician Decision|7|||
47066066|NCT01561898|83348810|FG003|Overall Study|Physician Decision|1|||
47066067|NCT01685840|83348820|FG000|Overall Study|Death|77|||
47066068|NCT01685840|83348821|FG001|Overall Study|Death|66|||
47066069|NCT01685840|83348820|FG000|Overall Study|Lost to Follow-up|27|||
47066070|NCT01685840|83348821|FG001|Overall Study|Lost to Follow-up|25|||
47066071|NCT01685840|83348820|FG000|Overall Study|Physician Decision|3|||
47066072|NCT01685840|83348821|FG001|Overall Study|Physician Decision|7|||
47066073|NCT01685840|83348820|FG000|Overall Study|Withdrawal by Subject|14|||
47066074|NCT01685840|83348821|FG001|Overall Study|Withdrawal by Subject|17|||
47066075|NCT01685840|83348820|FG000|Overall Study|Futility|197|||
47066076|NCT01685840|83348821|FG001|Overall Study|Futility|200|||
46770738|NCT00738894|82989032|FG000|Overall Study|Withdrawal by Subject|10|||
46770739|NCT00738894|82989033|FG001|Overall Study|Withdrawal by Subject|15|||
46770740|NCT00738894|82989032|FG000|Overall Study|Physician Decision|4|||
46770741|NCT00738894|82989033|FG001|Overall Study|Physician Decision|5|||
46770742|NCT00738894|82989032|FG000|Overall Study|Death|2|||
46770743|NCT00738894|82989033|FG001|Overall Study|Death|0|||
46770744|NCT00480493|82989041|FG000|Overall Study|moved|2|||
46770745|NCT00480493|82989042|FG001|Overall Study|moved|7|||
46770746|NCT00734994|82989050|FG000|Overall Study|Withdrawal by Subject|1|||
46770747|NCT00798434|82989057|FG000|Double-Blind|Adverse Event|22|||
46770748|NCT00798434|82989058|FG001|Double-Blind|Adverse Event|46|||
46770749|NCT00798434|82989057|FG000|Double-Blind|Death|0|||
46770750|NCT00798434|82989058|FG001|Double-Blind|Death|1|||
46770751|NCT00798434|82989057|FG000|Double-Blind|Lost to Follow-up|1|||
46770752|NCT00798434|82989058|FG001|Double-Blind|Lost to Follow-up|0|||
46770753|NCT00798434|82989057|FG000|Double-Blind|Lack of Efficacy|8|||
46770754|NCT00798434|82989058|FG001|Double-Blind|Lack of Efficacy|12|||
46770755|NCT00798434|82989057|FG000|Double-Blind|Withdrawal by Subject|17|||
46770756|NCT00798434|82989058|FG001|Double-Blind|Withdrawal by Subject|14|||
46770757|NCT00798434|82989057|FG000|Double-Blind|Protocol Violation|1|||
46770758|NCT00798434|82989058|FG001|Double-Blind|Protocol Violation|4|||
46770759|NCT00798434|82989057|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
47066077|NCT01685840|83348820|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
47066078|NCT01685840|83348821|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
47066079|NCT01452529|83348831|FG000|Run-in Period|Adverse Event|96|||
47066080|NCT01452529|83348832|FG001|Run-in Period|Adverse Event|0|||
47066081|NCT01452529|83348833|FG002|Run-in Period|Adverse Event|0|||
47066082|NCT01452529|83348831|FG000|Run-in Period|Withdrawal by Subject|49|||
47066083|NCT01452529|83348832|FG001|Run-in Period|Withdrawal by Subject|0|||
47066084|NCT01452529|83348833|FG002|Run-in Period|Withdrawal by Subject|0|||
47066085|NCT01452529|83348831|FG000|Run-in Period|Lost to Follow-up|19|||
47066086|NCT01452529|83348832|FG001|Run-in Period|Lost to Follow-up|0|||
47066087|NCT01452529|83348833|FG002|Run-in Period|Lost to Follow-up|0|||
46770760|NCT00798434|82989058|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
46770761|NCT00798434|82989057|FG000|Double-Blind|Other|1|||
46770762|NCT00798434|82989058|FG001|Double-Blind|Other|0|||
46770763|NCT00798434|82989057|FG000|Double-Blind|Not Treated|3|||
46770764|NCT00798434|82989058|FG001|Double-Blind|Not Treated|6|||
46770765|NCT00798434|82989057|FG000|Open-Label|Adverse Event|33|||
46770766|NCT00798434|82989058|FG001|Open-Label|Adverse Event|11|||
46770767|NCT00798434|82989057|FG000|Open-Label|Lack of Efficacy|5|||
47066088|NCT01452529|83348831|FG000|Run-in Period|Lack of Efficacy|46|||
47066089|NCT01452529|83348832|FG001|Run-in Period|Lack of Efficacy|0|||
47066090|NCT01452529|83348833|FG002|Run-in Period|Lack of Efficacy|0|||
47066091|NCT01452529|83348831|FG000|Run-in Period|Confirmed or suspected diversion|23|||
47066092|NCT01452529|83348832|FG001|Run-in Period|Confirmed or suspected diversion|0|||
47066093|NCT01452529|83348833|FG002|Run-in Period|Confirmed or suspected diversion|0|||
47066094|NCT01452529|83348831|FG000|Run-in Period|Administrative|21|||
47066095|NCT01452529|83348832|FG001|Run-in Period|Administrative|0|||
47066096|NCT01452529|83348833|FG002|Run-in Period|Administrative|0|||
47066097|NCT01452529|83348831|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
47066098|NCT01452529|83348832|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
47066099|NCT01452529|83348833|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
47066100|NCT01452529|83348831|FG000|Double-blind (DB) Period|Adverse Event|0|||
47066101|NCT01452529|83348832|FG001|Double-blind (DB) Period|Adverse Event|18|||
47066102|NCT01452529|83348833|FG002|Double-blind (DB) Period|Adverse Event|11|||
47066103|NCT01452529|83348831|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
47066104|NCT01452529|83348832|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
47066105|NCT01452529|83348833|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
47066106|NCT01452529|83348831|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
47066107|NCT01452529|83348832|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
47066108|NCT01452529|83348833|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
47066109|NCT01452529|83348831|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
47066110|NCT01452529|83348832|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
47066111|NCT01452529|83348833|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
47066112|NCT01452529|83348831|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
47066113|NCT01452529|83348832|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
47066114|NCT01452529|83348833|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
47066115|NCT01452529|83348831|FG000|Double-blind (DB) Period|Administrative|0|||
47066116|NCT01452529|83348832|FG001|Double-blind (DB) Period|Administrative|11|||
47066117|NCT01452529|83348833|FG002|Double-blind (DB) Period|Administrative|7|||
47066118|NCT01685606|83348840|FG000|Overall Study|Withdrawal by Subject|1|||
47066119|NCT01685372|83348846|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
47066120|NCT01685372|83348847|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
47066121|NCT01685216|83348853|FG000|Overall Study|Did not receive study drug|1|||
47066122|NCT01685138|83348857|FG000|Overall Study|Lost to Follow-up|1|||
47066123|NCT01685138|83348857|FG000|Overall Study|Protocol Violation|1|||
47066124|NCT01685138|83348857|FG000|Overall Study|No longer requires treatment|1|||
47066125|NCT01685138|83348857|FG000|Overall Study|Subject/guardian decision|2|||
47066126|NCT01685138|83348857|FG000|Overall Study|Physician Decision|6|||
47066127|NCT01685138|83348857|FG000|Overall Study|Death|10|||
47066128|NCT01685138|83348857|FG000|Overall Study|Adverse Event|18|||
47066129|NCT01685138|83348857|FG000|Overall Study|Progressive disease|53|||
47066130|NCT01685060|83348861|FG000|Overall Study|Rollover patients|16|||
47066131|NCT01685060|83348861|FG000|Overall Study|Adverse Event|12|||
47066132|NCT01685060|83348861|FG000|Overall Study|Progressive disease|69|||
46770768|NCT00798434|82989058|FG001|Open-Label|Lack of Efficacy|11|||
46770769|NCT00798434|82989057|FG000|Open-Label|Withdrawal by Subject|2|||
46770770|NCT00798434|82989058|FG001|Open-Label|Withdrawal by Subject|7|||
46770771|NCT00798434|82989057|FG000|Open-Label|Protocol Violation|1|||
46770772|NCT00798434|82989058|FG001|Open-Label|Protocol Violation|0|||
46770773|NCT00798434|82989057|FG000|Open-Label|Other|1|||
46770774|NCT00798434|82989058|FG001|Open-Label|Other|2|||
46770775|NCT00798434|82989057|FG000|Open-Label|Not Treated|0|||
46770776|NCT00798434|82989058|FG001|Open-Label|Not Treated|1|||
46770777|NCT00724503|82989071|FG000|Overall Study|Lost to Follow-up|4|||
46770778|NCT00724503|82989072|FG001|Overall Study|Lost to Follow-up|8|||
46770779|NCT00724503|82989071|FG000|Overall Study|Withdrawal by Subject|11|||
46770780|NCT00724503|82989072|FG001|Overall Study|Withdrawal by Subject|23|||
46770781|NCT00724503|82989071|FG000|Overall Study|Death|190|||
46770782|NCT00724503|82989072|FG001|Overall Study|Death|182|||
46770783|NCT00724503|82989071|FG000|Overall Study|Adverse Event|1|||
46770784|NCT00724503|82989072|FG001|Overall Study|Adverse Event|0|||
46770785|NCT00724503|82989071|FG000|Overall Study|Not otherwise specified|4|||
46770786|NCT00724503|82989072|FG001|Overall Study|Not otherwise specified|7|||
46770787|NCT00791648|82989082|FG000|Overall Study|Physician Decision|0|||
46770788|NCT00791648|82989083|FG001|Overall Study|Physician Decision|1|||
46770789|NCT00791648|82989082|FG000|Overall Study|Withdrawal by Subject|0|||
46770790|NCT00791648|82989083|FG001|Overall Study|Withdrawal by Subject|1|||
47066133|NCT01685060|83348861|FG000|Overall Study|Physician Decision|14|||
47066134|NCT01685060|83348861|FG000|Overall Study|Subject/guardian decision|20|||
46770791|NCT00791492|82989091|FG000|Overall Study|Withdrawal by Subject|1|||
46770792|NCT00791492|82989092|FG001|Overall Study|Withdrawal by Subject|2|||
46770793|NCT00791492|82989091|FG000|Overall Study|Liver transplantation|5|||
46770794|NCT00791492|82989092|FG001|Overall Study|Liver transplantation|1|||
46770795|NCT00723957|82989100|FG000|Overall Study|Adverse event unrelated to study drug|1|||
46770796|NCT00723957|82989101|FG001|Overall Study|Adverse event unrelated to study drug|4|||
46770797|NCT00723957|82989100|FG000|Overall Study|Death|3|||
47066135|NCT01685060|83348861|FG000|Overall Study|Lost to Follow-up|1|||
47066136|NCT01685060|83348861|FG000|Overall Study|Death|8|||
47066137|NCT01582100|83348865|FG000|Overall Study|Adverse Event|1|||
47066138|NCT01582100|83348865|FG000|Overall Study|Withdrawal by Subject|1|||
47066139|NCT01579916|83348871|FG000|Overall Study|Lost to Follow-up|6|||
47066140|NCT01579916|83348872|FG001|Overall Study|Lost to Follow-up|1|||
47066141|NCT01579916|83348871|FG000|Overall Study|Withdrawal by Subject|1|||
47066142|NCT01579916|83348872|FG001|Overall Study|Withdrawal by Subject|1|||
47066143|NCT01579916|83348871|FG000|Overall Study|Death|1|||
47066144|NCT01579916|83348872|FG001|Overall Study|Death|0|||
47066145|NCT01684202|83348882|FG000|Dose-escalation Period|Adverse Event|0|||
46770798|NCT00723957|82989101|FG001|Overall Study|Death|4|||
46770799|NCT00723957|82989100|FG000|Overall Study|Disease progression|27|||
46770800|NCT00723957|82989101|FG001|Overall Study|Disease progression|25|||
46770801|NCT00723957|82989100|FG000|Overall Study|Maximum clinical benefit|4|||
46770802|NCT00723957|82989101|FG001|Overall Study|Maximum clinical benefit|5|||
46770803|NCT00723957|82989100|FG000|Overall Study|Investigator decision|1|||
46770804|NCT00723957|82989101|FG001|Overall Study|Investigator decision|1|||
46770805|NCT00723957|82989100|FG000|Overall Study|Study drug toxicity|4|||
46770806|NCT00723957|82989101|FG001|Overall Study|Study drug toxicity|6|||
46770807|NCT00723957|82989100|FG000|Overall Study|Withdrawal by Subject|7|||
46770808|NCT00723957|82989101|FG001|Overall Study|Withdrawal by Subject|5|||
46770809|NCT00723957|82989100|FG000|Overall Study|Reason not analyzed|1|||
46770810|NCT00723957|82989101|FG001|Overall Study|Reason not analyzed|0|||
46770811|NCT00723957|82989100|FG000|Overall Study|Never received treatment|3|||
46770812|NCT00723957|82989101|FG001|Overall Study|Never received treatment|3|||
46770813|NCT00723801|82989109|FG000|Overall Study|Lost to Follow-up|1|||
46770814|NCT00723801|82989110|FG001|Overall Study|Lost to Follow-up|2|||
46770815|NCT00723801|82989109|FG000|Overall Study|Protocol Violation|2|||
46770816|NCT00723801|82989110|FG001|Overall Study|Protocol Violation|1|||
46770817|NCT00797966|82989120|FG000|Phase A|Lost to Follow-up|0|||
46770818|NCT00797966|82989121|FG001|Phase A|Lost to Follow-up|0|||
46770819|NCT00797966|82989122|FG002|Phase A|Lost to Follow-up|0|||
46770820|NCT00797966|82989123|FG003|Phase A|Lost to Follow-up|0|||
46770821|NCT00797966|82989124|FG004|Phase A|Lost to Follow-up|33|||
46770822|NCT00797966|82989125|FG005|Phase A|Lost to Follow-up|0|||
46770823|NCT00797966|82989120|FG000|Phase A|Adverse Event|0|||
46770824|NCT00797966|82989121|FG001|Phase A|Adverse Event|0|||
46770825|NCT00797966|82989122|FG002|Phase A|Adverse Event|0|||
46770826|NCT00797966|82989123|FG003|Phase A|Adverse Event|0|||
46770827|NCT00797966|82989124|FG004|Phase A|Adverse Event|46|||
46770828|NCT00797966|82989125|FG005|Phase A|Adverse Event|0|||
46770829|NCT00797966|82989120|FG000|Phase A|Met withdrawal criteria|0|||
46770830|NCT00797966|82989121|FG001|Phase A|Met withdrawal criteria|0|||
46770831|NCT00797966|82989122|FG002|Phase A|Met withdrawal criteria|0|||
46770832|NCT00797966|82989123|FG003|Phase A|Met withdrawal criteria|0|||
46770833|NCT00797966|82989124|FG004|Phase A|Met withdrawal criteria|4|||
46770834|NCT00797966|82989125|FG005|Phase A|Met withdrawal criteria|0|||
46770835|NCT00797966|82989120|FG000|Phase A|Physician Decision|0|||
46770836|NCT00797966|82989121|FG001|Phase A|Physician Decision|0|||
46770837|NCT00797966|82989122|FG002|Phase A|Physician Decision|0|||
46770838|NCT00797966|82989123|FG003|Phase A|Physician Decision|0|||
46770839|NCT00797966|82989124|FG004|Phase A|Physician Decision|13|||
46770840|NCT00797966|82989125|FG005|Phase A|Physician Decision|0|||
46770841|NCT00797966|82989120|FG000|Phase A|Withdrawal by Subject|0|||
46770842|NCT00797966|82989121|FG001|Phase A|Withdrawal by Subject|0|||
46770843|NCT00797966|82989122|FG002|Phase A|Withdrawal by Subject|0|||
46840590|NCT00147537|83057936|FG000|Phase 1b|Other|0|||
46840591|NCT00147537|83057937|FG001|Phase 1b|Other|0|||
46840592|NCT00147537|83057938|FG002|Phase 1b|Other|2|||
46840593|NCT00147537|83057939|FG003|Phase 1b|Other|1|||
47066146|NCT01684202|83348883|FG001|Dose-escalation Period|Adverse Event|1|||
47066147|NCT01684202|83348884|FG002|Dose-escalation Period|Adverse Event|0|||
47066148|NCT01684202|83348885|FG003|Dose-escalation Period|Adverse Event|0|||
47066149|NCT01684202|83348882|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
46638889|NCT01408914|82812346|FG000|Overall Study|Could not complete tx in protocol period|5|||
46770844|NCT00797966|82989123|FG003|Phase A|Withdrawal by Subject|0|||
46770845|NCT00797966|82989124|FG004|Phase A|Withdrawal by Subject|33|||
46770846|NCT00797966|82989125|FG005|Phase A|Withdrawal by Subject|0|||
46770847|NCT00797966|82989120|FG000|Phase A|Protocol deviation|0|||
46770848|NCT00797966|82989121|FG001|Phase A|Protocol deviation|0|||
46770849|NCT00797966|82989122|FG002|Phase A|Protocol deviation|0|||
46770850|NCT00797966|82989123|FG003|Phase A|Protocol deviation|0|||
46770851|NCT00797966|82989124|FG004|Phase A|Protocol deviation|56|||
46770852|NCT00797966|82989125|FG005|Phase A|Protocol deviation|0|||
46770853|NCT00797966|82989120|FG000|Phase B|Lost to Follow-up|0|||
46770854|NCT00797966|82989121|FG001|Phase B|Lost to Follow-up|1|||
46770855|NCT00797966|82989122|FG002|Phase B|Lost to Follow-up|3|||
46770856|NCT00797966|82989123|FG003|Phase B|Lost to Follow-up|0|||
46770857|NCT00797966|82989124|FG004|Phase B|Lost to Follow-up|0|||
46840594|NCT00147537|83057940|FG004|Phase 1b|Other|1|||
46840595|NCT00147537|83057941|FG005|Phase 1b|Other|1|||
47066150|NCT01684202|83348883|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
47066151|NCT01684202|83348884|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
47066152|NCT01684202|83348885|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
46946894|NCT02471404|83185094|FG001|Overall Study|Lost to Follow-up|1|||
46946895|NCT02471404|83185095|FG002|Overall Study|Lost to Follow-up|3|||
46946896|NCT02471404|83185093|FG000|Overall Study|Protocol Violation|1|||
46946897|NCT02471404|83185094|FG001|Overall Study|Protocol Violation|0|||
46946898|NCT02471404|83185095|FG002|Overall Study|Protocol Violation|0|||
46946899|NCT02471404|83185093|FG000|Overall Study|Withdrawal by Subject|8|||
46946900|NCT02471404|83185094|FG001|Overall Study|Withdrawal by Subject|4|||
46946901|NCT02471404|83185095|FG002|Overall Study|Withdrawal by Subject|5|||
46946902|NCT02471404|83185093|FG000|Overall Study|Other reasons not specified|10|||
47066153|NCT01684202|83348882|FG000|Maintenance Period|Adverse Event|1|||
47066154|NCT01684202|83348883|FG001|Maintenance Period|Adverse Event|1|||
47066155|NCT01684202|83348884|FG002|Maintenance Period|Adverse Event|1|||
47066156|NCT01684202|83348885|FG003|Maintenance Period|Adverse Event|1|||
47066157|NCT01684202|83348882|FG000|Maintenance Period|Physician Decision|0|||
47066158|NCT01684202|83348883|FG001|Maintenance Period|Physician Decision|1|||
47066159|NCT01684202|83348884|FG002|Maintenance Period|Physician Decision|0|||
47066160|NCT01684202|83348885|FG003|Maintenance Period|Physician Decision|0|||
47066161|NCT01684202|83348882|FG000|Maintenance Period|Withdrawal by Subject|0|||
47066162|NCT01684202|83348883|FG001|Maintenance Period|Withdrawal by Subject|1|||
47066163|NCT01684202|83348884|FG002|Maintenance Period|Withdrawal by Subject|0|||
47066164|NCT01684202|83348885|FG003|Maintenance Period|Withdrawal by Subject|0|||
47066165|NCT01684046|83348895|FG000|Period 1, First 30 Days|Adverse Event|0|||
47066166|NCT01684046|83348896|FG001|Period 1, First 30 Days|Adverse Event|2|||
47066167|NCT01559090|83348905|FG000|Stage I|Withdrawal by Subject|2|||
47066168|NCT01559090|83348906|FG001|Stage I|Withdrawal by Subject|2|||
47066169|NCT01559090|83348907|FG002|Stage I|Withdrawal by Subject|3|||
47066170|NCT01559090|83348905|FG000|Stage II|Withdrawal by Subject|1|||
47066171|NCT01559090|83348906|FG001|Stage II|Withdrawal by Subject|0|||
47066172|NCT01559090|83348907|FG002|Stage II|Withdrawal by Subject|0|||
47066173|NCT01683266|83348917|FG000|Overall Study|Adverse Event|5|||
47066174|NCT01683266|83348918|FG001|Overall Study|Adverse Event|4|||
47066175|NCT01683266|83348917|FG000|Overall Study|Lack of Efficacy|5|||
47066176|NCT01683266|83348918|FG001|Overall Study|Lack of Efficacy|2|||
47066177|NCT01683266|83348917|FG000|Overall Study|Protocol Violation|13|||
47066178|NCT01683266|83348918|FG001|Overall Study|Protocol Violation|6|||
47066179|NCT01683266|83348917|FG000|Overall Study|Personal Reason|17|||
47066180|NCT01683266|83348918|FG001|Overall Study|Personal Reason|25|||
47066181|NCT01683266|83348917|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
47066182|NCT01683266|83348918|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
47066183|NCT01683266|83348917|FG000|Overall Study|Lost to Follow-up|5|||
47066184|NCT01683266|83348918|FG001|Overall Study|Lost to Follow-up|0|||
47066185|NCT01683266|83348917|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
47066186|NCT01683266|83348918|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
47066187|NCT01683266|83348917|FG000|Overall Study|Nonserious Hypoglycemia|0|||
47066188|NCT01683266|83348918|FG001|Overall Study|Nonserious Hypoglycemia|3|||
46840596|NCT00147537|83057942|FG006|Phase 1b|Other|14|||
46840597|NCT00147537|83057943|FG007|Phase 1b|Other|4|||
46840598|NCT00147537|83057944|FG008|Phase 1b|Other|4|||
46840599|NCT00147537|83057945|FG009|Phase 1b|Other|0|||
46840600|NCT00147537|83057946|FG010|Phase 1b|Other|0|||
46840601|NCT00147537|83057936|FG000|Phase 1b|Withdrawal by Subject|0|||
46840602|NCT00147537|83057937|FG001|Phase 1b|Withdrawal by Subject|0|||
46840603|NCT00147537|83057938|FG002|Phase 1b|Withdrawal by Subject|0|||
46840604|NCT00147537|83057939|FG003|Phase 1b|Withdrawal by Subject|0|||
46840605|NCT00147537|83057940|FG004|Phase 1b|Withdrawal by Subject|0|||
46840606|NCT00147537|83057941|FG005|Phase 1b|Withdrawal by Subject|0|||
46840607|NCT00147537|83057942|FG006|Phase 1b|Withdrawal by Subject|0|||
46946903|NCT02471404|83185094|FG001|Overall Study|Other reasons not specified|7|||
47066189|NCT01683266|83348917|FG000|Overall Study|Perceived Lack of Efficacy|1|||
47066190|NCT01683266|83348918|FG001|Overall Study|Perceived Lack of Efficacy|1|||
47066191|NCT01683266|83348917|FG000|Overall Study|Possibly Hypoglycemia|1|||
47066192|NCT01683266|83348918|FG001|Overall Study|Possibly Hypoglycemia|0|||
46840608|NCT00147537|83057943|FG007|Phase 1b|Withdrawal by Subject|0|||
46840609|NCT00147537|83057944|FG008|Phase 1b|Withdrawal by Subject|2|||
46840610|NCT00147537|83057945|FG009|Phase 1b|Withdrawal by Subject|0|||
47066193|NCT01683266|83348917|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
47066194|NCT01683266|83348918|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
47066195|NCT01467661|83348924|FG000|Overall Study|Adverse Event|16|||
47066196|NCT01467661|83348924|FG000|Overall Study|Withdrawal by Subject|1|||
46840611|NCT00147537|83057946|FG010|Phase 1b|Withdrawal by Subject|0|||
47066197|NCT01467661|83348924|FG000|Overall Study|Lack of Efficacy|3|||
46840612|NCT00147537|83057936|FG000|Phase 1b|Randomized but not treated|0|||
46946904|NCT02471404|83185095|FG002|Overall Study|Other reasons not specified|12|||
46946905|NCT02471014|83185105|FG000|Overall Study|Lost to Follow-up|2|||
47066198|NCT01467661|83348924|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
47066199|NCT01577186|83348930|FG000|Overall Study|Adverse Event|23|||
47066200|NCT01577186|83348930|FG000|Overall Study|Death|1|||
47066201|NCT01577186|83348930|FG000|Overall Study|Lost to Follow-up|28|||
46946906|NCT02471014|83185106|FG001|Overall Study|Lost to Follow-up|2|||
46946907|NCT02413372|83185115|FG000|Treatment|Lost to Follow-up|0|||
46946908|NCT02413372|83185116|FG001|Treatment|Lost to Follow-up|2|||
46946909|NCT02413372|83185117|FG002|Treatment|Lost to Follow-up|1|||
46946910|NCT02413372|83185115|FG000|Treatment|Withdrawal by Subject|1|||
46946911|NCT02413372|83185116|FG001|Treatment|Withdrawal by Subject|0|||
46946912|NCT02413372|83185117|FG002|Treatment|Withdrawal by Subject|0|||
46946913|NCT02413372|83185115|FG000|Follow-up|Lost to Follow-up|1|||
46946914|NCT02413372|83185116|FG001|Follow-up|Lost to Follow-up|1|||
46946915|NCT02413372|83185117|FG002|Follow-up|Lost to Follow-up|0|||
46946916|NCT02413372|83185115|FG000|Follow-up|Subject Withdrew Consent|1|||
47066202|NCT01577186|83348930|FG000|Overall Study|Withdrawal by Subject|35|||
47066203|NCT01577186|83348930|FG000|Overall Study|Insufficient Response|18|||
47066204|NCT01577186|83348930|FG000|Overall Study|Ineligible to Continue|15|||
47066205|NCT01577186|83348930|FG000|Overall Study|Non-Compliant|8|||
47066206|NCT01577186|83348930|FG000|Overall Study|Other|2|||
47066207|NCT01559012|83348936|FG000|Overall Study|Withdrawal by Subject|0|||
47066208|NCT01559012|83348937|FG001|Overall Study|Withdrawal by Subject|1|||
47066209|NCT01451827|83348962|FG000|Overall Study|Adverse Event|2|||
47066210|NCT01451827|83348963|FG001|Overall Study|Adverse Event|0|||
47066211|NCT01451827|83348964|FG002|Overall Study|Adverse Event|1|||
47066212|NCT01451827|83348965|FG003|Overall Study|Adverse Event|1|||
47066213|NCT01451827|83348962|FG000|Overall Study|Protocol deviation|1|||
47066214|NCT01451827|83348963|FG001|Overall Study|Protocol deviation|0|||
47066215|NCT01451827|83348964|FG002|Overall Study|Protocol deviation|0|||
47066216|NCT01451827|83348965|FG003|Overall Study|Protocol deviation|0|||
47066217|NCT01451827|83348962|FG000|Overall Study|Lost to Follow-up|0|||
46770858|NCT00797966|82989125|FG005|Phase B|Lost to Follow-up|0|||
46770859|NCT00797966|82989120|FG000|Phase B|Adverse Event|2|||
46770860|NCT00797966|82989121|FG001|Phase B|Adverse Event|1|||
46770861|NCT00797966|82989122|FG002|Phase B|Adverse Event|3|||
46770862|NCT00797966|82989123|FG003|Phase B|Adverse Event|1|||
46770863|NCT00797966|82989124|FG004|Phase B|Adverse Event|0|||
46770864|NCT00797966|82989125|FG005|Phase B|Adverse Event|0|||
46770865|NCT00797966|82989120|FG000|Phase B|Met Withdrawal Criteria|3|||
46770866|NCT00797966|82989121|FG001|Phase B|Met Withdrawal Criteria|3|||
46770867|NCT00797966|82989122|FG002|Phase B|Met Withdrawal Criteria|6|||
46770868|NCT00797966|82989123|FG003|Phase B|Met Withdrawal Criteria|1|||
46770869|NCT00797966|82989124|FG004|Phase B|Met Withdrawal Criteria|0|||
46770870|NCT00797966|82989125|FG005|Phase B|Met Withdrawal Criteria|0|||
46840613|NCT00147537|83057937|FG001|Phase 1b|Randomized but not treated|0|||
46840614|NCT00147537|83057938|FG002|Phase 1b|Randomized but not treated|0|||
46840615|NCT00147537|83057939|FG003|Phase 1b|Randomized but not treated|0|||
46840616|NCT00147537|83057940|FG004|Phase 1b|Randomized but not treated|0|||
46840617|NCT00147537|83057941|FG005|Phase 1b|Randomized but not treated|0|||
46840618|NCT00147537|83057942|FG006|Phase 1b|Randomized but not treated|1|||
46840619|NCT00147537|83057943|FG007|Phase 1b|Randomized but not treated|0|||
46840620|NCT00147537|83057944|FG008|Phase 1b|Randomized but not treated|1|||
46840621|NCT00147537|83057945|FG009|Phase 1b|Randomized but not treated|0|||
46840622|NCT00147537|83057946|FG010|Phase 1b|Randomized but not treated|0|||
46840623|NCT00147537|83057936|FG000|Phase 2|Death|0|||
46840624|NCT00147537|83057937|FG001|Phase 2|Death|0|||
46840625|NCT00147537|83057938|FG002|Phase 2|Death|0|||
46840626|NCT00147537|83057939|FG003|Phase 2|Death|0|||
46840627|NCT00147537|83057940|FG004|Phase 2|Death|0|||
46840628|NCT00147537|83057941|FG005|Phase 2|Death|0|||
46840629|NCT00147537|83057942|FG006|Phase 2|Death|0|||
46840630|NCT00147537|83057943|FG007|Phase 2|Death|0|||
47066218|NCT01451827|83348963|FG001|Overall Study|Lost to Follow-up|3|||
47066219|NCT01451827|83348964|FG002|Overall Study|Lost to Follow-up|0|||
47066220|NCT01451827|83348965|FG003|Overall Study|Lost to Follow-up|2|||
47066221|NCT01451827|83348962|FG000|Overall Study|Participant met withdrawal criteria|0|||
46770871|NCT00797966|82989120|FG000|Phase B|Physician Decision|1|||
46946917|NCT02413372|83185116|FG001|Follow-up|Subject Withdrew Consent|0|||
47066222|NCT01451827|83348963|FG001|Overall Study|Participant met withdrawal criteria|2|||
46840631|NCT00147537|83057944|FG008|Phase 2|Death|0|||
47066223|NCT01451827|83348964|FG002|Overall Study|Participant met withdrawal criteria|0|||
46770872|NCT00797966|82989121|FG001|Phase B|Physician Decision|0|||
46946918|NCT02413372|83185117|FG002|Follow-up|Subject Withdrew Consent|1|||
46770873|NCT00797966|82989122|FG002|Phase B|Physician Decision|3|||
46770874|NCT00797966|82989123|FG003|Phase B|Physician Decision|1|||
46840632|NCT00147537|83057945|FG009|Phase 2|Death|85|||
46840633|NCT00147537|83057946|FG010|Phase 2|Death|31|||
46840634|NCT00147537|83057936|FG000|Phase 2|Lost to Follow-up|0|||
47066224|NCT01451827|83348965|FG003|Overall Study|Participant met withdrawal criteria|0|||
47066225|NCT01451827|83348962|FG000|Overall Study|Withdrawal by Subject|0|||
47066226|NCT01451827|83348963|FG001|Overall Study|Withdrawal by Subject|0|||
47066227|NCT01451827|83348964|FG002|Overall Study|Withdrawal by Subject|1|||
47066228|NCT01451827|83348965|FG003|Overall Study|Withdrawal by Subject|1|||
47066229|NCT01557920|83348975|FG000|Overall Study|Withdrawal by Subject|2|||
47066230|NCT01557920|83348976|FG001|Overall Study|Withdrawal by Subject|3|||
47066231|NCT01557920|83348975|FG000|Overall Study|Lack of Efficacy|1|||
47066232|NCT01557920|83348976|FG001|Overall Study|Lack of Efficacy|0|||
47066233|NCT01688882|83349011|FG000|Overall Study|Adverse Event|1|||
47066234|NCT01688882|83349012|FG001|Overall Study|Adverse Event|0|||
47066235|NCT01688882|83349011|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
47066236|NCT01688882|83349012|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
47066237|NCT01688882|83349011|FG000|Overall Study|Administrative problems|1|||
47066238|NCT01688882|83349012|FG001|Overall Study|Administrative problems|0|||
47066239|NCT01467583|83349025|FG000|Overall Study|Death|1|||
47066240|NCT01467583|83349026|FG001|Overall Study|Death|1|||
47066241|NCT01467583|83349027|FG002|Overall Study|Death|0|||
47066242|NCT01467583|83349025|FG000|Overall Study|Withdrawal by Subject|1|||
47066243|NCT01467583|83349026|FG001|Overall Study|Withdrawal by Subject|0|||
47066244|NCT01467583|83349027|FG002|Overall Study|Withdrawal by Subject|0|||
47066245|NCT01467583|83349025|FG000|Overall Study|Protocol Violation|0|||
47066246|NCT01467583|83349026|FG001|Overall Study|Protocol Violation|0|||
47066247|NCT01467583|83349027|FG002|Overall Study|Protocol Violation|2|||
47066248|NCT01576718|83349044|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
47066249|NCT01576718|83349045|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47066250|NCT01576718|83349046|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47066251|NCT01576718|83349047|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47066252|NCT01576718|83349048|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47066253|NCT01576718|83349049|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47066254|NCT01576718|83349050|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
47066255|NCT01576718|83349044|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
47066256|NCT01576718|83349045|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47066257|NCT01576718|83349046|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47066258|NCT01576718|83349047|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47066259|NCT01576718|83349048|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47066260|NCT01576718|83349049|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47066261|NCT01576718|83349050|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
47066262|NCT01576718|83349044|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
47066263|NCT01576718|83349045|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47066264|NCT01576718|83349046|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47066265|NCT01576718|83349047|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
46638890|NCT01408914|82812347|FG001|Overall Study|Could not complete tx in protocol period|5|||
46638891|NCT01408914|82812348|FG002|Overall Study|Could not complete tx in protocol period|6|||
47066266|NCT01576718|83349048|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47066267|NCT01576718|83349049|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47066268|NCT01576718|83349050|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
47066269|NCT01576718|83349044|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
47066270|NCT01576718|83349045|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47066271|NCT01576718|83349046|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47066272|NCT01576718|83349047|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47066273|NCT01576718|83349048|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47066274|NCT01576718|83349049|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47066275|NCT01576718|83349050|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
47066276|NCT01576718|83349044|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
46638892|NCT01408914|82812346|FG000|Overall Study|Lost to Follow-up|4|||
46638893|NCT01408914|82812347|FG001|Overall Study|Lost to Follow-up|1|||
46770875|NCT00797966|82989124|FG004|Phase B|Physician Decision|0|||
46770876|NCT00797966|82989125|FG005|Phase B|Physician Decision|0|||
46770877|NCT00797966|82989120|FG000|Phase B|Withdrawal by Subject|1|||
46770878|NCT00797966|82989121|FG001|Phase B|Withdrawal by Subject|4|||
46770879|NCT00797966|82989122|FG002|Phase B|Withdrawal by Subject|3|||
46770880|NCT00797966|82989123|FG003|Phase B|Withdrawal by Subject|3|||
46770881|NCT00797966|82989124|FG004|Phase B|Withdrawal by Subject|0|||
46770882|NCT00797966|82989125|FG005|Phase B|Withdrawal by Subject|0|||
46638894|NCT01408914|82812348|FG002|Overall Study|Lost to Follow-up|2|||
46770883|NCT00797966|82989120|FG000|Phase B|Protocol Deviation|4|||
46770884|NCT00797966|82989121|FG001|Phase B|Protocol Deviation|8|||
46770885|NCT00797966|82989122|FG002|Phase B|Protocol Deviation|2|||
47066277|NCT01576718|83349045|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47066278|NCT01576718|83349046|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47066279|NCT01576718|83349047|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47066280|NCT01576718|83349048|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47066281|NCT01576718|83349049|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47066282|NCT01576718|83349050|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
47066283|NCT01576718|83349044|FG000|Treatment Period|Adverse Event|0|||
47066284|NCT01576718|83349045|FG001|Treatment Period|Adverse Event|1|||
47066285|NCT01576718|83349046|FG002|Treatment Period|Adverse Event|1|||
47066286|NCT01576718|83349047|FG003|Treatment Period|Adverse Event|1|||
47066287|NCT01576718|83349048|FG004|Treatment Period|Adverse Event|1|||
47066288|NCT01576718|83349049|FG005|Treatment Period|Adverse Event|1|||
47066289|NCT01576718|83349050|FG006|Treatment Period|Adverse Event|0|||
47066290|NCT01576718|83349044|FG000|Treatment Period|Withdrawal by Subject|0|||
47066291|NCT01576718|83349045|FG001|Treatment Period|Withdrawal by Subject|1|||
47066292|NCT01576718|83349046|FG002|Treatment Period|Withdrawal by Subject|1|||
47066293|NCT01576718|83349047|FG003|Treatment Period|Withdrawal by Subject|0|||
47066294|NCT01576718|83349048|FG004|Treatment Period|Withdrawal by Subject|2|||
47066295|NCT01576718|83349049|FG005|Treatment Period|Withdrawal by Subject|4|||
47066296|NCT01576718|83349050|FG006|Treatment Period|Withdrawal by Subject|2|||
47066297|NCT01576718|83349044|FG000|Treatment Period|Physician Decision|0|||
47066298|NCT01576718|83349045|FG001|Treatment Period|Physician Decision|1|||
47066299|NCT01576718|83349046|FG002|Treatment Period|Physician Decision|1|||
47066300|NCT01576718|83349047|FG003|Treatment Period|Physician Decision|1|||
47066301|NCT01576718|83349048|FG004|Treatment Period|Physician Decision|1|||
47066302|NCT01576718|83349049|FG005|Treatment Period|Physician Decision|0|||
47066303|NCT01576718|83349050|FG006|Treatment Period|Physician Decision|0|||
47066304|NCT01576718|83349044|FG000|Treatment Period|Protocol Violation|0|||
46840635|NCT00147537|83057937|FG001|Phase 2|Lost to Follow-up|0|||
46840636|NCT00147537|83057938|FG002|Phase 2|Lost to Follow-up|0|||
46840637|NCT00147537|83057939|FG003|Phase 2|Lost to Follow-up|0|||
46840638|NCT00147537|83057940|FG004|Phase 2|Lost to Follow-up|0|||
46946919|NCT02413372|83185115|FG000|Follow-up|Subject unable to return for visit|0|||
46840639|NCT00147537|83057941|FG005|Phase 2|Lost to Follow-up|0|||
46840640|NCT00147537|83057942|FG006|Phase 2|Lost to Follow-up|0|||
46946920|NCT02413372|83185116|FG001|Follow-up|Subject unable to return for visit|0|||
46946921|NCT02413372|83185117|FG002|Follow-up|Subject unable to return for visit|1|||
46946922|NCT02413294|83185125|FG000|Overall Study|Withdrawal by Subject|1|||
46946923|NCT02719353|83185138|FG000|First Intervention|Physician Decision|0|||
46946924|NCT02719353|83185139|FG001|First Intervention|Physician Decision|1|||
46946925|NCT01362062|83185148|FG000|Overall Study|Adverse Event|1|||
46840641|NCT00147537|83057943|FG007|Phase 2|Lost to Follow-up|0|||
46946926|NCT01362062|83185149|FG001|Overall Study|Adverse Event|0|||
46946927|NCT01362062|83185148|FG000|Overall Study|Lost to Follow-up|11|||
46946928|NCT01362062|83185149|FG001|Overall Study|Lost to Follow-up|0|||
46946929|NCT01362062|83185148|FG000|Overall Study|Withdrawal by Subject|2|||
46946930|NCT01362062|83185149|FG001|Overall Study|Withdrawal by Subject|0|||
46946931|NCT01362062|83185148|FG000|Overall Study|Non-compliant participant|2|||
46946932|NCT01362062|83185149|FG001|Overall Study|Non-compliant participant|0|||
46946933|NCT01362062|83185148|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
46946934|NCT01362062|83185149|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
46946935|NCT01362062|83185148|FG000|Overall Study|Had significant improvement|9|||
46946936|NCT01362062|83185149|FG001|Overall Study|Had significant improvement|0|||
46946937|NCT01361594|83185156|FG000|Overall Study|Withdrawal by Subject|1|||
46946938|NCT01361594|83185157|FG001|Overall Study|Withdrawal by Subject|2|||
46946939|NCT02642432|83185163|FG000|Overall Study|Adverse Event|2|||
46946940|NCT02642432|83185163|FG000|Overall Study|Withdrew Consent|1|||
46946941|NCT02642432|83185163|FG000|Overall Study|Lost to Follow-up|2|||
46946942|NCT02642432|83185163|FG000|Overall Study|Other|3|||
46840642|NCT00147537|83057944|FG008|Phase 2|Lost to Follow-up|0|||
46840643|NCT00147537|83057945|FG009|Phase 2|Lost to Follow-up|12|||
46946943|NCT02640482|83185169|FG000|Overall Study|Lost to Follow-up|3|||
46946944|NCT02640482|83185170|FG001|Overall Study|Lost to Follow-up|0|||
46946945|NCT02719743|83185181|FG000|Overall Study|Consent withdrawal|0|||
47066305|NCT01576718|83349045|FG001|Treatment Period|Protocol Violation|5|||
47066306|NCT01576718|83349046|FG002|Treatment Period|Protocol Violation|4|||
47066307|NCT01576718|83349047|FG003|Treatment Period|Protocol Violation|10|||
47066308|NCT01576718|83349048|FG004|Treatment Period|Protocol Violation|6|||
46946946|NCT02719743|83185182|FG001|Overall Study|Consent withdrawal|2|||
46946947|NCT02719743|83185183|FG002|Overall Study|Consent withdrawal|0|||
47066309|NCT01576718|83349049|FG005|Treatment Period|Protocol Violation|8|||
46840644|NCT00147537|83057946|FG010|Phase 2|Lost to Follow-up|4|||
46840645|NCT00147537|83057936|FG000|Phase 2|Other|0|||
46840646|NCT00147537|83057937|FG001|Phase 2|Other|0|||
46946948|NCT02719743|83185184|FG003|Overall Study|Consent withdrawal|1|||
47066310|NCT01576718|83349050|FG006|Treatment Period|Protocol Violation|12|||
47066311|NCT01576718|83349044|FG000|Treatment Period|Sponsor request|0|||
47066312|NCT01576718|83349045|FG001|Treatment Period|Sponsor request|1|||
47066313|NCT01576718|83349046|FG002|Treatment Period|Sponsor request|0|||
47066314|NCT01576718|83349047|FG003|Treatment Period|Sponsor request|0|||
46946949|NCT02719743|83185185|FG004|Overall Study|Consent withdrawal|0|||
46946950|NCT02719743|83185181|FG000|Overall Study|Migrated/moved from study area|0|||
46946951|NCT02719743|83185182|FG001|Overall Study|Migrated/moved from study area|0|||
46946952|NCT02719743|83185183|FG002|Overall Study|Migrated/moved from study area|0|||
46946953|NCT02719743|83185184|FG003|Overall Study|Migrated/moved from study area|0|||
46946954|NCT02719743|83185185|FG004|Overall Study|Migrated/moved from study area|2|||
46946955|NCT02719743|83185181|FG000|Overall Study|Lost to Follow-up|1|||
47066315|NCT01576718|83349048|FG004|Treatment Period|Sponsor request|0|||
47066316|NCT01576718|83349049|FG005|Treatment Period|Sponsor request|1|||
46946956|NCT02719743|83185182|FG001|Overall Study|Lost to Follow-up|1|||
46946957|NCT02719743|83185183|FG002|Overall Study|Lost to Follow-up|0|||
46946958|NCT02719743|83185184|FG003|Overall Study|Lost to Follow-up|0|||
46946959|NCT02719743|83185185|FG004|Overall Study|Lost to Follow-up|0|||
46946960|NCT02641730|83185200|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
46946961|NCT02641730|83185201|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46946962|NCT02641730|83185202|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46946963|NCT02641730|83185203|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
46946964|NCT02641730|83185204|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
46946965|NCT02641730|83185200|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
46946966|NCT02641730|83185201|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
46946967|NCT02641730|83185202|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
46946968|NCT02641730|83185203|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
46946969|NCT02641730|83185204|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
46946970|NCT02641730|83185200|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
46946971|NCT02641730|83185201|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
46946972|NCT02641730|83185202|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
46946973|NCT02641730|83185203|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
46946974|NCT02641730|83185204|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
46946975|NCT02641730|83185200|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
46946976|NCT02641730|83185201|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
46946977|NCT02641730|83185202|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
46946978|NCT02641730|83185203|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
47066317|NCT01576718|83349050|FG006|Treatment Period|Sponsor request|0|||
46946979|NCT02641730|83185204|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
46946980|NCT02641730|83185200|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
46946981|NCT02641730|83185201|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
46946982|NCT02641730|83185202|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
46946983|NCT02641730|83185203|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
46946984|NCT02641730|83185204|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
46946985|NCT02641730|83185200|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
46946986|NCT02641730|83185201|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
46946987|NCT02641730|83185202|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
46946988|NCT02641730|83185203|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
46946989|NCT02641730|83185204|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
46946990|NCT02797951|83185218|FG000|Overall Study|Adverse Event|4|||
47066318|NCT01576718|83349044|FG000|Treatment Period|Met stopping criteria|0|||
46770886|NCT00797966|82989123|FG003|Phase B|Protocol Deviation|6|||
46770887|NCT00797966|82989124|FG004|Phase B|Protocol Deviation|0|||
46770888|NCT00797966|82989125|FG005|Phase B|Protocol Deviation|0|||
46770889|NCT00797966|82989120|FG000|Phase B|Lack of Efficacy|0|||
46770890|NCT00797966|82989121|FG001|Phase B|Lack of Efficacy|1|||
46770891|NCT00797966|82989122|FG002|Phase B|Lack of Efficacy|1|||
46770892|NCT00797966|82989123|FG003|Phase B|Lack of Efficacy|4|||
46770893|NCT00797966|82989124|FG004|Phase B|Lack of Efficacy|0|||
46770894|NCT00797966|82989125|FG005|Phase B|Lack of Efficacy|0|||
46770895|NCT00797966|82989120|FG000|Phase A+|Lost to Follow-up|0|||
46770896|NCT00797966|82989121|FG001|Phase A+|Lost to Follow-up|0|||
46770897|NCT00797966|82989122|FG002|Phase A+|Lost to Follow-up|0|||
46770898|NCT00797966|82989123|FG003|Phase A+|Lost to Follow-up|0|||
46770899|NCT00797966|82989124|FG004|Phase A+|Lost to Follow-up|0|||
46770900|NCT00797966|82989125|FG005|Phase A+|Lost to Follow-up|9|||
46770901|NCT00797966|82989120|FG000|Phase A+|Met withdrawal criteria|0|||
46946991|NCT02797951|83185218|FG000|Overall Study|Death|1|||
46946992|NCT02797951|83185218|FG000|Overall Study|Lack of Efficacy|19|||
47066319|NCT01576718|83349045|FG001|Treatment Period|Met stopping criteria|16|||
47066320|NCT01576718|83349046|FG002|Treatment Period|Met stopping criteria|13|||
47066321|NCT01576718|83349047|FG003|Treatment Period|Met stopping criteria|19|||
46770902|NCT00797966|82989121|FG001|Phase A+|Met withdrawal criteria|0|||
46770903|NCT00797966|82989122|FG002|Phase A+|Met withdrawal criteria|0|||
46770904|NCT00797966|82989123|FG003|Phase A+|Met withdrawal criteria|0|||
46770905|NCT00797966|82989124|FG004|Phase A+|Met withdrawal criteria|0|||
46770906|NCT00797966|82989125|FG005|Phase A+|Met withdrawal criteria|5|||
46946993|NCT02797951|83185218|FG000|Overall Study|Lost to Follow-up|4|||
46946994|NCT02797951|83185218|FG000|Overall Study|Physician Decision|6|||
46946995|NCT02797951|83185218|FG000|Overall Study|Withdrawal by Subject|15|||
46946996|NCT00701805|83185226|FG000|Overall Study|Withdrawal by Subject|3|||
46946997|NCT00701805|83185227|FG001|Overall Study|Withdrawal by Subject|1|||
46946998|NCT00701805|83185228|FG002|Overall Study|Withdrawal by Subject|4|||
46946999|NCT00701805|83185229|FG003|Overall Study|Withdrawal by Subject|3|||
46947000|NCT00701805|83185226|FG000|Overall Study|Adverse Event|0|||
46947001|NCT00701805|83185227|FG001|Overall Study|Adverse Event|1|||
46947002|NCT00701805|83185228|FG002|Overall Study|Adverse Event|1|||
46947003|NCT00701805|83185229|FG003|Overall Study|Adverse Event|0|||
46947004|NCT00701805|83185226|FG000|Overall Study|Missed 7 consecutive doses|0|||
46947005|NCT00701805|83185227|FG001|Overall Study|Missed 7 consecutive doses|1|||
46947006|NCT00701805|83185228|FG002|Overall Study|Missed 7 consecutive doses|0|||
46947007|NCT00701805|83185229|FG003|Overall Study|Missed 7 consecutive doses|0|||
46947008|NCT00701805|83185226|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
46947009|NCT00701805|83185227|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
46947010|NCT00701805|83185228|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
46947011|NCT00701805|83185229|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
46947012|NCT00701805|83185226|FG000|Overall Study|Physician decision, change of therapy|0|||
46947013|NCT00701805|83185227|FG001|Overall Study|Physician decision, change of therapy|0|||
46947014|NCT00701805|83185228|FG002|Overall Study|Physician decision, change of therapy|0|||
47066322|NCT01576718|83349048|FG004|Treatment Period|Met stopping criteria|16|||
47066323|NCT01576718|83349049|FG005|Treatment Period|Met stopping criteria|33|||
47066324|NCT01576718|83349050|FG006|Treatment Period|Met stopping criteria|15|||
47066325|NCT01576718|83349044|FG000|Treatment Period|Lost to Follow-up|0|||
47066326|NCT01576718|83349045|FG001|Treatment Period|Lost to Follow-up|0|||
47066327|NCT01576718|83349046|FG002|Treatment Period|Lost to Follow-up|0|||
46638895|NCT01408914|82812346|FG000|Overall Study|Physician Decision|1|||
46638896|NCT01408914|82812347|FG001|Overall Study|Physician Decision|1|||
46638897|NCT01408914|82812348|FG002|Overall Study|Physician Decision|0|||
46770907|NCT00797966|82989120|FG000|Phase A+|Withdrawal by Subject|0|||
46770908|NCT00797966|82989121|FG001|Phase A+|Withdrawal by Subject|0|||
46770909|NCT00797966|82989122|FG002|Phase A+|Withdrawal by Subject|0|||
46770910|NCT00797966|82989123|FG003|Phase A+|Withdrawal by Subject|0|||
46770911|NCT00797966|82989124|FG004|Phase A+|Withdrawal by Subject|0|||
46770912|NCT00797966|82989125|FG005|Phase A+|Withdrawal by Subject|6|||
46770913|NCT00797966|82989120|FG000|Phase A+|Adverse Event|0|||
46770914|NCT00797966|82989121|FG001|Phase A+|Adverse Event|0|||
46770915|NCT00797966|82989122|FG002|Phase A+|Adverse Event|0|||
46770916|NCT00797966|82989123|FG003|Phase A+|Adverse Event|0|||
46770917|NCT00797966|82989124|FG004|Phase A+|Adverse Event|0|||
46770918|NCT00797966|82989125|FG005|Phase A+|Adverse Event|4|||
46770919|NCT00797966|82989120|FG000|Phase A+|Protocol deviation|0|||
46770920|NCT00797966|82989121|FG001|Phase A+|Protocol deviation|0|||
46770921|NCT00797966|82989122|FG002|Phase A+|Protocol deviation|0|||
46770922|NCT00797966|82989123|FG003|Phase A+|Protocol deviation|0|||
46840647|NCT00147537|83057938|FG002|Phase 2|Other|0|||
46840648|NCT00147537|83057939|FG003|Phase 2|Other|0|||
46840649|NCT00147537|83057940|FG004|Phase 2|Other|0|||
46840650|NCT00147537|83057941|FG005|Phase 2|Other|0|||
46840651|NCT00147537|83057942|FG006|Phase 2|Other|0|||
46840652|NCT00147537|83057943|FG007|Phase 2|Other|0|||
46840653|NCT00147537|83057944|FG008|Phase 2|Other|0|||
46840654|NCT00147537|83057945|FG009|Phase 2|Other|47|||
46840655|NCT00147537|83057946|FG010|Phase 2|Other|12|||
46840656|NCT00147537|83057936|FG000|Phase 2|Withdrawal by Subject|0|||
46840657|NCT00147537|83057937|FG001|Phase 2|Withdrawal by Subject|0|||
46840658|NCT00147537|83057938|FG002|Phase 2|Withdrawal by Subject|0|||
46947015|NCT00701805|83185229|FG003|Overall Study|Physician decision, change of therapy|1|||
46947016|NCT00701805|83185226|FG000|Overall Study|Difficult to travel to dialysis site|0|||
46947017|NCT00701805|83185227|FG001|Overall Study|Difficult to travel to dialysis site|0|||
46947018|NCT00701805|83185228|FG002|Overall Study|Difficult to travel to dialysis site|1|||
46947019|NCT00701805|83185229|FG003|Overall Study|Difficult to travel to dialysis site|0|||
46947020|NCT00701805|83185226|FG000|Overall Study|Resumption criteria were not met|0|||
46840659|NCT00147537|83057939|FG003|Phase 2|Withdrawal by Subject|0|||
46840660|NCT00147537|83057940|FG004|Phase 2|Withdrawal by Subject|0|||
46947021|NCT00701805|83185227|FG001|Overall Study|Resumption criteria were not met|1|||
47066328|NCT01576718|83349047|FG003|Treatment Period|Lost to Follow-up|0|||
46638898|NCT01408914|82812346|FG000|Overall Study|Withdrawal by Subject|1|||
46770923|NCT00797966|82989124|FG004|Phase A+|Protocol deviation|0|||
46770924|NCT00797966|82989125|FG005|Phase A+|Protocol deviation|4|||
46770925|NCT00723489|82989141|FG000|Overall Study|Physician Decision|0|||
46770926|NCT00723489|82989142|FG001|Overall Study|Physician Decision|1|||
46770927|NCT00723489|82989143|FG002|Overall Study|Physician Decision|0|||
46770928|NCT00723489|82989144|FG003|Overall Study|Physician Decision|0|||
46840661|NCT00147537|83057941|FG005|Phase 2|Withdrawal by Subject|0|||
46840662|NCT00147537|83057942|FG006|Phase 2|Withdrawal by Subject|0|||
46947022|NCT00701805|83185228|FG002|Overall Study|Resumption criteria were not met|0|||
47066329|NCT01576718|83349048|FG004|Treatment Period|Lost to Follow-up|1|||
47066330|NCT01576718|83349049|FG005|Treatment Period|Lost to Follow-up|0|||
47066331|NCT01576718|83349050|FG006|Treatment Period|Lost to Follow-up|0|||
47066332|NCT01576718|83349044|FG000|Treatment Period|Noncompliance to study medication|0|||
47066333|NCT01576718|83349045|FG001|Treatment Period|Noncompliance to study medication|0|||
47066334|NCT01576718|83349046|FG002|Treatment Period|Noncompliance to study medication|0|||
47066335|NCT01576718|83349047|FG003|Treatment Period|Noncompliance to study medication|0|||
47066336|NCT01576718|83349048|FG004|Treatment Period|Noncompliance to study medication|0|||
47066337|NCT01576718|83349049|FG005|Treatment Period|Noncompliance to study medication|1|||
47066338|NCT01576718|83349050|FG006|Treatment Period|Noncompliance to study medication|1|||
47066339|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
47066340|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
47066341|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
47066342|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
47066343|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
47066344|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
47066345|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
47066346|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
46947023|NCT00701805|83185229|FG003|Overall Study|Resumption criteria were not met|0|||
46947024|NCT02715765|83185242|FG000|Overall Study|Study Termination|3|||
46947025|NCT02715765|83185243|FG001|Overall Study|Study Termination|0|||
46947026|NCT02715765|83185244|FG002|Overall Study|Study Termination|0|||
46947027|NCT04542291|83185252|FG000|Overall Study|Adverse Event|1|||
46947028|NCT04542291|83185252|FG000|Overall Study|Physician Decision|2|||
46947029|NCT02795767|83185259|FG000|Overall Study|Received Commercial Emicizumab|1|||
46947030|NCT02795767|83185260|FG001|Overall Study|Received Commercial Emicizumab|0|||
46947031|NCT02795767|83185261|FG002|Overall Study|Received Commercial Emicizumab|0|||
47066347|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
47066348|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
47066349|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
47066350|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
47066351|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
47066352|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
46638899|NCT01408914|82812347|FG001|Overall Study|Withdrawal by Subject|0|||
46947032|NCT02796391|83185288|FG000|Overall Study|Lost to Follow-up|2|||
46947033|NCT02796391|83185289|FG001|Overall Study|Lost to Follow-up|2|||
46638900|NCT01408914|82812348|FG002|Overall Study|Withdrawal by Subject|1|||
46638901|NCT01408914|82812346|FG000|Overall Study|Moved out of study jurisdiction|1|||
46638902|NCT01408914|82812347|FG001|Overall Study|Moved out of study jurisdiction|1|||
46638903|NCT01408914|82812348|FG002|Overall Study|Moved out of study jurisdiction|0|||
46638904|NCT01408914|82812346|FG000|Overall Study|Late exclusion|0|||
46638905|NCT01408914|82812347|FG001|Overall Study|Late exclusion|3|||
46947034|NCT02796391|83185290|FG002|Overall Study|Lost to Follow-up|13|||
46947035|NCT02796391|83185291|FG003|Overall Study|Lost to Follow-up|8|||
46947036|NCT02796391|83185292|FG004|Overall Study|Lost to Follow-up|14|||
46947037|NCT02796391|83185293|FG005|Overall Study|Lost to Follow-up|13|||
46947038|NCT02796391|83185288|FG000|Overall Study|COVID|0|||
46947039|NCT02796391|83185289|FG001|Overall Study|COVID|0|||
46947040|NCT02796391|83185290|FG002|Overall Study|COVID|5|||
47066353|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
46638906|NCT01408914|82812348|FG002|Overall Study|Late exclusion|3|||
46770929|NCT00723489|82989141|FG000|Overall Study|Pregnancy|0|||
46770930|NCT00723489|82989142|FG001|Overall Study|Pregnancy|0|||
46770931|NCT00723489|82989143|FG002|Overall Study|Pregnancy|0|||
46770932|NCT00723489|82989144|FG003|Overall Study|Pregnancy|1|||
46770933|NCT00723489|82989141|FG000|Overall Study|Withdrawal by Subject|0|||
46770934|NCT00723489|82989142|FG001|Overall Study|Withdrawal by Subject|0|||
46770935|NCT00723489|82989143|FG002|Overall Study|Withdrawal by Subject|0|||
46770936|NCT00723489|82989144|FG003|Overall Study|Withdrawal by Subject|1|||
46840663|NCT00147537|83057943|FG007|Phase 2|Withdrawal by Subject|0|||
46840664|NCT00147537|83057944|FG008|Phase 2|Withdrawal by Subject|0|||
46840665|NCT00147537|83057945|FG009|Phase 2|Withdrawal by Subject|16|||
46840666|NCT00147537|83057946|FG010|Phase 2|Withdrawal by Subject|4|||
46840667|NCT00147537|83057936|FG000|Phase 2|Randomized but not treated|0|||
46840668|NCT00147537|83057937|FG001|Phase 2|Randomized but not treated|0|||
46770937|NCT00723489|82989141|FG000|Overall Study|Seropositive at baseline|1|||
46840669|NCT00147537|83057938|FG002|Phase 2|Randomized but not treated|0|||
46947041|NCT02796391|83185291|FG003|Overall Study|COVID|5|||
46947042|NCT02796391|83185292|FG004|Overall Study|COVID|2|||
46638907|NCT01408914|82812346|FG000|Overall Study|Change in local TB/HIV norms|0|||
46770938|NCT00723489|82989142|FG001|Overall Study|Seropositive at baseline|0|||
46947043|NCT02796391|83185293|FG005|Overall Study|COVID|4|||
46947044|NCT02796391|83185288|FG000|Overall Study|Participant did not like study cigarettes|0|||
46947045|NCT02796391|83185289|FG001|Overall Study|Participant did not like study cigarettes|0|||
46947046|NCT02796391|83185290|FG002|Overall Study|Participant did not like study cigarettes|3|||
46947047|NCT02796391|83185291|FG003|Overall Study|Participant did not like study cigarettes|0|||
46947048|NCT02796391|83185292|FG004|Overall Study|Participant did not like study cigarettes|0|||
46947049|NCT02796391|83185293|FG005|Overall Study|Participant did not like study cigarettes|0|||
46947050|NCT02796391|83185288|FG000|Overall Study|Withdrawal by Subject|1|||
46947051|NCT02796391|83185289|FG001|Overall Study|Withdrawal by Subject|1|||
46947052|NCT02796391|83185290|FG002|Overall Study|Withdrawal by Subject|4|||
46947053|NCT02796391|83185291|FG003|Overall Study|Withdrawal by Subject|3|||
46947054|NCT02796391|83185292|FG004|Overall Study|Withdrawal by Subject|4|||
46947055|NCT02796391|83185293|FG005|Overall Study|Withdrawal by Subject|3|||
46947056|NCT02796391|83185288|FG000|Overall Study|Adverse Event|0|||
46947057|NCT02796391|83185289|FG001|Overall Study|Adverse Event|0|||
46947058|NCT02796391|83185290|FG002|Overall Study|Adverse Event|0|||
46840670|NCT00147537|83057939|FG003|Phase 2|Randomized but not treated|0|||
46947059|NCT02796391|83185291|FG003|Overall Study|Adverse Event|1|||
46947060|NCT02796391|83185292|FG004|Overall Study|Adverse Event|0|||
46947061|NCT02796391|83185293|FG005|Overall Study|Adverse Event|0|||
46947062|NCT02796391|83185288|FG000|Overall Study|Protocol Violation|0|||
46947063|NCT02796391|83185289|FG001|Overall Study|Protocol Violation|0|||
46947064|NCT02796391|83185290|FG002|Overall Study|Protocol Violation|0|||
46947065|NCT02796391|83185291|FG003|Overall Study|Protocol Violation|1|||
46947066|NCT02796391|83185292|FG004|Overall Study|Protocol Violation|0|||
46840671|NCT00147537|83057940|FG004|Phase 2|Randomized but not treated|0|||
46840672|NCT00147537|83057941|FG005|Phase 2|Randomized but not treated|0|||
46947067|NCT02796391|83185293|FG005|Overall Study|Protocol Violation|0|||
46947068|NCT01370317|83185309|FG000|Overall Study|Participant withdrew consent|1|||
46947069|NCT01370317|83185310|FG001|Overall Study|Participant withdrew consent|0|||
46947070|NCT01370317|83185309|FG000|Overall Study|Protocol deviation|0|||
46947071|NCT01370317|83185310|FG001|Overall Study|Protocol deviation|1|||
46947072|NCT01370083|83185318|FG000|Overall Study|Lost to Follow-up|2|||
46947073|NCT01370083|83185319|FG001|Overall Study|Lost to Follow-up|0|||
46947074|NCT01370083|83185318|FG000|Overall Study|Adverse Event|0|||
46840673|NCT00147537|83057942|FG006|Phase 2|Randomized but not treated|0|||
46840674|NCT00147537|83057943|FG007|Phase 2|Randomized but not treated|0|||
46840675|NCT00147537|83057944|FG008|Phase 2|Randomized but not treated|0|||
46840676|NCT00147537|83057945|FG009|Phase 2|Randomized but not treated|1|||
46840677|NCT00147537|83057946|FG010|Phase 2|Randomized but not treated|1|||
46840678|NCT00222729|83057991|FG000|Overall Study|Adverse Event|3|||
46947075|NCT01370083|83185319|FG001|Overall Study|Adverse Event|1|||
46947076|NCT03350815|83185325|FG000|Period 1|Adverse Event|10|||
46947077|NCT03350815|83185326|FG001|Period 1|Adverse Event|0|||
46947078|NCT03350815|83185327|FG002|Period 1|Adverse Event|0|||
46840679|NCT00147225|83058001|FG000|Overall Study|Withdrawal by Subject|1|||
46947079|NCT03350815|83185328|FG003|Period 1|Adverse Event|0|||
46947080|NCT03350815|83185325|FG000|Period 1|Technical problems|1|||
46947081|NCT03350815|83185326|FG001|Period 1|Technical problems|0|||
46947082|NCT03350815|83185327|FG002|Period 1|Technical problems|0|||
46840680|NCT00147225|83058002|FG001|Overall Study|Withdrawal by Subject|0|||
46840681|NCT00147225|83058003|FG002|Overall Study|Withdrawal by Subject|1|||
46947083|NCT03350815|83185328|FG003|Period 1|Technical problems|0|||
46947084|NCT03350815|83185325|FG000|Period 1|Lost to Follow-up|3|||
46947085|NCT03350815|83185326|FG001|Period 1|Lost to Follow-up|0|||
46947086|NCT03350815|83185327|FG002|Period 1|Lost to Follow-up|0|||
46947087|NCT03350815|83185328|FG003|Period 1|Lost to Follow-up|0|||
46947088|NCT03350815|83185325|FG000|Period 1|Physician Decision|1|||
46947089|NCT03350815|83185326|FG001|Period 1|Physician Decision|0|||
46947090|NCT03350815|83185327|FG002|Period 1|Physician Decision|0|||
46947091|NCT03350815|83185328|FG003|Period 1|Physician Decision|0|||
47066354|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
47066355|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
47066356|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
47066357|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Early termination|0|||
47066358|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Early termination|0|||
46947092|NCT03350815|83185325|FG000|Period 1|Withdrawal by Subject|8|||
46947093|NCT03350815|83185326|FG001|Period 1|Withdrawal by Subject|0|||
46947094|NCT03350815|83185327|FG002|Period 1|Withdrawal by Subject|0|||
46947095|NCT03350815|83185328|FG003|Period 1|Withdrawal by Subject|0|||
46947096|NCT03350815|83185325|FG000|Period 1|Lack of Efficacy|15|||
46947097|NCT03350815|83185326|FG001|Period 1|Lack of Efficacy|0|||
46947098|NCT03350815|83185327|FG002|Period 1|Lack of Efficacy|0|||
46947099|NCT03350815|83185328|FG003|Period 1|Lack of Efficacy|0|||
46840682|NCT00147225|83058004|FG003|Overall Study|Withdrawal by Subject|0|||
46840683|NCT00147225|83058005|FG004|Overall Study|Withdrawal by Subject|0|||
46947100|NCT03350815|83185325|FG000|Period 1|Non-compliance with study treatment|2|||
46947101|NCT03350815|83185326|FG001|Period 1|Non-compliance with study treatment|0|||
46947102|NCT03350815|83185327|FG002|Period 1|Non-compliance with study treatment|0|||
46947103|NCT03350815|83185328|FG003|Period 1|Non-compliance with study treatment|0|||
46947104|NCT03350815|83185325|FG000|Period 1|Protocol Violation|3|||
46947105|NCT03350815|83185326|FG001|Period 1|Protocol Violation|0|||
46947106|NCT03350815|83185327|FG002|Period 1|Protocol Violation|0|||
46947107|NCT03350815|83185328|FG003|Period 1|Protocol Violation|0|||
46947108|NCT03350815|83185325|FG000|Period 2|Adverse Event|0|||
46947109|NCT03350815|83185326|FG001|Period 2|Adverse Event|3|||
46947110|NCT03350815|83185327|FG002|Period 2|Adverse Event|5|||
46947111|NCT03350815|83185328|FG003|Period 2|Adverse Event|0|||
46947112|NCT03350815|83185325|FG000|Period 2|Technical problem|0|||
46840684|NCT00147225|83058006|FG005|Overall Study|Withdrawal by Subject|1|||
46840685|NCT00147225|83058001|FG000|Overall Study|Adverse Event|0|||
46840686|NCT00147225|83058002|FG001|Overall Study|Adverse Event|0|||
46840687|NCT00147225|83058003|FG002|Overall Study|Adverse Event|1|||
46840688|NCT00147225|83058004|FG003|Overall Study|Adverse Event|1|||
46840689|NCT00147225|83058005|FG004|Overall Study|Adverse Event|0|||
46840690|NCT00147225|83058006|FG005|Overall Study|Adverse Event|0|||
46840691|NCT00147225|83058001|FG000|Overall Study|Screen Failure|0|||
46840692|NCT00147225|83058002|FG001|Overall Study|Screen Failure|0|||
46840693|NCT00147225|83058003|FG002|Overall Study|Screen Failure|0|||
46840694|NCT00147225|83058004|FG003|Overall Study|Screen Failure|0|||
46840695|NCT00147225|83058005|FG004|Overall Study|Screen Failure|1|||
46840696|NCT00147225|83058006|FG005|Overall Study|Screen Failure|0|||
46840697|NCT00147225|83058001|FG000|Overall Study|Chemotherapy Changed|0|||
46840698|NCT00147225|83058002|FG001|Overall Study|Chemotherapy Changed|0|||
46840699|NCT00147225|83058003|FG002|Overall Study|Chemotherapy Changed|0|||
46840700|NCT00147225|83058004|FG003|Overall Study|Chemotherapy Changed|0|||
46840701|NCT00147225|83058005|FG004|Overall Study|Chemotherapy Changed|0|||
46840702|NCT00147225|83058006|FG005|Overall Study|Chemotherapy Changed|1|||
46840703|NCT00222105|83058020|FG000|Overall Study|Removed due to wrong diagnosis|1|||
46840704|NCT00222105|83058020|FG000|Overall Study|Withdrawal by Subject|1|||
46840705|NCT00222105|83058020|FG000|Overall Study|Adverse Event|8|||
46840706|NCT00222105|83058020|FG000|Overall Study|Treatment delays|2|||
46840707|NCT00222105|83058020|FG000|Overall Study|Death|2|||
46840708|NCT00146757|83058024|FG000|Overall Study|Death|1|||
46840709|NCT00146757|83058025|FG001|Overall Study|Death|0|||
46840710|NCT00146757|83058024|FG000|Overall Study|Adverse Event|1|||
46840711|NCT00146757|83058025|FG001|Overall Study|Adverse Event|0|||
46840712|NCT00267098|83058039|FG000|Overall Study|Death|0|||
46840713|NCT00267098|83058040|FG001|Overall Study|Death|0|||
46840714|NCT00267098|83058041|FG002|Overall Study|Death|57|||
46770939|NCT00723489|82989143|FG002|Overall Study|Seropositive at baseline|0|||
46770940|NCT00723489|82989144|FG003|Overall Study|Seropositive at baseline|0|||
46770941|NCT00723489|82989141|FG000|Overall Study|Prohibited Medication|0|||
46770942|NCT00723489|82989142|FG001|Overall Study|Prohibited Medication|0|||
46770943|NCT00723489|82989143|FG002|Overall Study|Prohibited Medication|0|||
46770944|NCT00723489|82989144|FG003|Overall Study|Prohibited Medication|1|||
46770945|NCT00723489|82989141|FG000|Overall Study|Samples Collected Out of Window|0|||
46770946|NCT00723489|82989142|FG001|Overall Study|Samples Collected Out of Window|3|||
46770947|NCT00723489|82989143|FG002|Overall Study|Samples Collected Out of Window|0|||
46770948|NCT00723489|82989144|FG003|Overall Study|Samples Collected Out of Window|0|||
46770949|NCT00587990|82989170|FG000|Overall Study|Death|0|||
46770950|NCT00587990|82989171|FG001|Overall Study|Death|0|||
46770951|NCT00587990|82989172|FG002|Overall Study|Death|1|||
46770952|NCT00723255|82989180|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
46770953|NCT00723255|82989180|FG000|Overall Study|Ineligible: Second primary|1|||
46770954|NCT00723255|82989180|FG000|Overall Study|Ineligible: Wrong Primary|2|||
46770955|NCT00791258|82989196|FG000|Overall Study|Adverse Event|87|||
46840715|NCT00267098|83058042|FG003|Overall Study|Death|66|||
46840716|NCT00267098|83058043|FG004|Overall Study|Death|14|||
46840717|NCT00267098|83058044|FG005|Overall Study|Death|23|||
46947113|NCT03350815|83185326|FG001|Period 2|Technical problem|1|||
46947114|NCT03350815|83185327|FG002|Period 2|Technical problem|0|||
46840718|NCT00267098|83058045|FG006|Overall Study|Death|28|||
46840719|NCT00267098|83058046|FG007|Overall Study|Death|9|||
46947115|NCT03350815|83185328|FG003|Period 2|Technical problem|0|||
46947116|NCT03350815|83185325|FG000|Period 2|Lost to Follow-up|0|||
46770956|NCT00791258|82989196|FG000|Overall Study|Lost to Follow-up|18|||
46840720|NCT00267098|83058039|FG000|Overall Study|Lost to Follow-up|0|||
46840721|NCT00267098|83058040|FG001|Overall Study|Lost to Follow-up|0|||
46947117|NCT03350815|83185326|FG001|Period 2|Lost to Follow-up|3|||
46947118|NCT03350815|83185327|FG002|Period 2|Lost to Follow-up|3|||
46770957|NCT00791258|82989196|FG000|Overall Study|Protocol Violation|109|||
46840722|NCT00267098|83058041|FG002|Overall Study|Lost to Follow-up|6|||
46840723|NCT00267098|83058042|FG003|Overall Study|Lost to Follow-up|5|||
46840724|NCT00267098|83058043|FG004|Overall Study|Lost to Follow-up|2|||
46840725|NCT00267098|83058044|FG005|Overall Study|Lost to Follow-up|3|||
46840726|NCT00267098|83058045|FG006|Overall Study|Lost to Follow-up|1|||
46947119|NCT03350815|83185328|FG003|Period 2|Lost to Follow-up|0|||
46840727|NCT00267098|83058046|FG007|Overall Study|Lost to Follow-up|1|||
46840728|NCT00267098|83058039|FG000|Overall Study|Withdrawal by Subject|8|||
46840729|NCT00267098|83058040|FG001|Overall Study|Withdrawal by Subject|0|||
46840730|NCT00267098|83058041|FG002|Overall Study|Withdrawal by Subject|24|||
46840731|NCT00267098|83058042|FG003|Overall Study|Withdrawal by Subject|21|||
46840732|NCT00267098|83058043|FG004|Overall Study|Withdrawal by Subject|12|||
46840733|NCT00267098|83058044|FG005|Overall Study|Withdrawal by Subject|9|||
46840734|NCT00267098|83058045|FG006|Overall Study|Withdrawal by Subject|12|||
46840735|NCT00267098|83058046|FG007|Overall Study|Withdrawal by Subject|5|||
46840736|NCT00267098|83058039|FG000|Overall Study|Physician Decision|5|||
46840737|NCT00267098|83058040|FG001|Overall Study|Physician Decision|0|||
46840738|NCT00267098|83058041|FG002|Overall Study|Physician Decision|7|||
46840739|NCT00267098|83058042|FG003|Overall Study|Physician Decision|11|||
46840740|NCT00267098|83058043|FG004|Overall Study|Physician Decision|5|||
46840741|NCT00267098|83058044|FG005|Overall Study|Physician Decision|4|||
46840742|NCT00267098|83058045|FG006|Overall Study|Physician Decision|3|||
46840743|NCT00267098|83058046|FG007|Overall Study|Physician Decision|0|||
46840744|NCT00267098|83058039|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
46840745|NCT00267098|83058040|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46840746|NCT00267098|83058041|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46840747|NCT00267098|83058042|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46840748|NCT00267098|83058043|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
46840749|NCT00267098|83058044|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46840750|NCT00267098|83058045|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46840751|NCT00267098|83058046|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46840752|NCT00267098|83058039|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
46840753|NCT00267098|83058040|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
46840754|NCT00267098|83058041|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
46840755|NCT00267098|83058042|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
46840756|NCT00267098|83058043|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
46840757|NCT00267098|83058044|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
46840758|NCT00267098|83058045|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
46840759|NCT00267098|83058046|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
46947120|NCT03350815|83185325|FG000|Period 2|Physician Decision|0|||
46947121|NCT03350815|83185326|FG001|Period 2|Physician Decision|0|||
46947122|NCT03350815|83185327|FG002|Period 2|Physician Decision|1|||
46947123|NCT03350815|83185328|FG003|Period 2|Physician Decision|0|||
46947124|NCT03350815|83185325|FG000|Period 2|Withdrawal by Subject|0|||
46947125|NCT03350815|83185326|FG001|Period 2|Withdrawal by Subject|3|||
46947126|NCT03350815|83185327|FG002|Period 2|Withdrawal by Subject|4|||
46947127|NCT03350815|83185328|FG003|Period 2|Withdrawal by Subject|0|||
46947128|NCT03350815|83185325|FG000|Period 2|Lack of Efficacy|0|||
46947129|NCT03350815|83185326|FG001|Period 2|Lack of Efficacy|6|||
46947130|NCT03350815|83185327|FG002|Period 2|Lack of Efficacy|2|||
46947131|NCT03350815|83185328|FG003|Period 2|Lack of Efficacy|0|||
46947132|NCT03350815|83185325|FG000|Period 2|Protocol Violation|0|||
46947133|NCT03350815|83185326|FG001|Period 2|Protocol Violation|0|||
46947134|NCT03350815|83185327|FG002|Period 2|Protocol Violation|1|||
46947135|NCT03350815|83185328|FG003|Period 2|Protocol Violation|0|||
46947136|NCT03350815|83185325|FG000|Period 2|New therapy for study indication|0|||
46770958|NCT00791258|82989196|FG000|Overall Study|Withdrawal by Subject|40|||
46770959|NCT00791258|82989196|FG000|Overall Study|Did not take medication for >3 days|1|||
46770960|NCT00791258|82989196|FG000|Overall Study|subject left area|2|||
46770961|NCT00791258|82989196|FG000|Overall Study|non-compliance|3|||
46770962|NCT00791258|82989196|FG000|Overall Study|Subject incarcerated|1|||
46770963|NCT00791258|82989196|FG000|Overall Study|Subject required restricted medication|1|||
46770964|NCT00791258|82989196|FG000|Overall Study|Lack of Efficacy|1|||
46770965|NCT00808067|82989202|FG000|Overall Study|Major/minor bleed|30|||
46770966|NCT00808067|82989203|FG001|Overall Study|Major/minor bleed|44|||
46770967|NCT00808067|82989202|FG000|Overall Study|Outcome event - other|33|||
46840760|NCT00267098|83058039|FG000|Overall Study|Site closure|0|||
46840761|NCT00267098|83058040|FG001|Overall Study|Site closure|0|||
46840762|NCT00267098|83058041|FG002|Overall Study|Site closure|0|||
46840763|NCT00267098|83058042|FG003|Overall Study|Site closure|1|||
46840764|NCT00267098|83058043|FG004|Overall Study|Site closure|0|||
46840765|NCT00267098|83058044|FG005|Overall Study|Site closure|1|||
46840766|NCT00267098|83058045|FG006|Overall Study|Site closure|1|||
46840767|NCT00267098|83058046|FG007|Overall Study|Site closure|0|||
46840768|NCT00267098|83058039|FG000|Overall Study|Explanted Medtronic device|0|||
46840769|NCT00267098|83058040|FG001|Overall Study|Explanted Medtronic device|0|||
46840770|NCT00267098|83058041|FG002|Overall Study|Explanted Medtronic device|0|||
46947137|NCT03350815|83185326|FG001|Period 2|New therapy for study indication|0|||
46947138|NCT03350815|83185327|FG002|Period 2|New therapy for study indication|1|||
46947139|NCT03350815|83185328|FG003|Period 2|New therapy for study indication|0|||
46947140|NCT00854295|83185343|FG000|Overall Study|Death|7|||
46947141|NCT00854295|83185344|FG001|Overall Study|Death|0|||
46947142|NCT00854295|83185345|FG002|Overall Study|Death|1|||
46947143|NCT00854295|83185346|FG003|Overall Study|Death|1|||
46947144|NCT00854295|83185343|FG000|Overall Study|Adverse Event|6|||
46947145|NCT00854295|83185344|FG001|Overall Study|Adverse Event|1|||
46947146|NCT00854295|83185345|FG002|Overall Study|Adverse Event|1|||
46947147|NCT00854295|83185346|FG003|Overall Study|Adverse Event|3|||
46947148|NCT00854295|83185343|FG000|Overall Study|Lost to Follow-up|18|||
46947149|NCT00854295|83185344|FG001|Overall Study|Lost to Follow-up|5|||
46947150|NCT00854295|83185345|FG002|Overall Study|Lost to Follow-up|21|||
46947151|NCT00854295|83185346|FG003|Overall Study|Lost to Follow-up|21|||
46947152|NCT00854295|83185343|FG000|Overall Study|Physician Decision|10|||
46947153|NCT00854295|83185344|FG001|Overall Study|Physician Decision|0|||
46947154|NCT00854295|83185345|FG002|Overall Study|Physician Decision|0|||
46947155|NCT00854295|83185346|FG003|Overall Study|Physician Decision|0|||
46947156|NCT02792959|83185357|FG000|Overall Study|Protocol Violation|1|||
46947157|NCT01652872|83185363|FG000|Overall Study|Death|36|||
46947158|NCT01652872|83185364|FG001|Overall Study|Death|39|||
46947159|NCT01652872|83185363|FG000|Overall Study|Lost to Follow-up|28|||
46947160|NCT01652872|83185364|FG001|Overall Study|Lost to Follow-up|23|||
46840771|NCT00267098|83058042|FG003|Overall Study|Explanted Medtronic device|1|||
46840772|NCT00267098|83058043|FG004|Overall Study|Explanted Medtronic device|0|||
46840773|NCT00267098|83058044|FG005|Overall Study|Explanted Medtronic device|0|||
46840774|NCT00267098|83058045|FG006|Overall Study|Explanted Medtronic device|0|||
46840775|NCT00267098|83058046|FG007|Overall Study|Explanted Medtronic device|0|||
46840776|NCT00267098|83058039|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
46840777|NCT00267098|83058040|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
46840778|NCT00267098|83058041|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
46947161|NCT01652872|83185363|FG000|Overall Study|Decision by sponsor|5|||
46947162|NCT01652872|83185364|FG001|Overall Study|Decision by sponsor|7|||
46947163|NCT01652872|83185363|FG000|Overall Study|Withdrawal by Subject|76|||
46947164|NCT01652872|83185364|FG001|Overall Study|Withdrawal by Subject|84|||
46770968|NCT00808067|82989203|FG001|Overall Study|Outcome event - other|25|||
46770969|NCT00808067|82989202|FG000|Overall Study|Adverse Event|111|||
46770970|NCT00808067|82989203|FG001|Overall Study|Adverse Event|121|||
46770971|NCT00808067|82989202|FG000|Overall Study|Hospitalization (not including surgery)|18|||
46770972|NCT00808067|82989203|FG001|Overall Study|Hospitalization (not including surgery)|17|||
46770973|NCT00808067|82989202|FG000|Overall Study|Hospitalization due to surgery|37|||
46770974|NCT00808067|82989203|FG001|Overall Study|Hospitalization due to surgery|40|||
46770975|NCT00808067|82989202|FG000|Overall Study|Reduced creatinine clearance|53|||
46770976|NCT00808067|82989203|FG001|Overall Study|Reduced creatinine clearance|55|||
46770977|NCT00808067|82989202|FG000|Overall Study|Elevated LFT results|7|||
46770978|NCT00808067|82989203|FG001|Overall Study|Elevated LFT results|3|||
46770979|NCT00808067|82989202|FG000|Overall Study|Patient refused to take study medication|65|||
46770980|NCT00808067|82989203|FG001|Overall Study|Patient refused to take study medication|76|||
46770981|NCT00808067|82989202|FG000|Overall Study|Missing|1|||
46770982|NCT00808067|82989203|FG001|Overall Study|Missing|0|||
46770983|NCT00808067|82989202|FG000|Overall Study|Death|1|||
46770984|NCT00808067|82989203|FG001|Overall Study|Death|1|||
46770985|NCT00808067|82989202|FG000|Overall Study|Procedure|6|||
46770986|NCT00808067|82989203|FG001|Overall Study|Procedure|7|||
46770987|NCT00808067|82989202|FG000|Overall Study|Withdrawal by Subject|21|||
46770988|NCT00808067|82989203|FG001|Overall Study|Withdrawal by Subject|25|||
46770989|NCT00808067|82989202|FG000|Overall Study|Site closed|4|||
46770990|NCT00808067|82989203|FG001|Overall Study|Site closed|3|||
46770991|NCT00808067|82989202|FG000|Overall Study|Physician Decision|47|||
46770992|NCT00808067|82989203|FG001|Overall Study|Physician Decision|38|||
46770993|NCT00808067|82989202|FG000|Overall Study|Protocol Violation|3|||
46770994|NCT00808067|82989203|FG001|Overall Study|Protocol Violation|11|||
46770995|NCT00808067|82989202|FG000|Overall Study|Patient elected|7|||
46770996|NCT00808067|82989203|FG001|Overall Study|Patient elected|9|||
46770997|NCT00808067|82989202|FG000|Overall Study|Site closed for cause|19|||
46770998|NCT00808067|82989203|FG001|Overall Study|Site closed for cause|19|||
46770999|NCT00808067|82989202|FG000|Overall Study|Other reason not defined above|5|||
46840779|NCT00267098|83058042|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
46771000|NCT00808067|82989203|FG001|Overall Study|Other reason not defined above|5|||
46771001|NCT00808067|82989202|FG000|Overall Study|Excluded from analysis|13|||
46771002|NCT00808067|82989203|FG001|Overall Study|Excluded from analysis|19|||
46771003|NCT00723021|82989209|FG000|Intervention Period 4|Adverse Event|0|||
46947165|NCT04251273|83185372|FG000|Overall Study|Lost to Follow-up|331|||
46947166|NCT04251273|83185373|FG001|Overall Study|Lost to Follow-up|290|||
46947167|NCT02443402|83185381|FG000|Overall Study|Withdrawal by Subject|3|||
46947168|NCT02443402|83185382|FG001|Overall Study|Withdrawal by Subject|1|||
46947169|NCT02443402|83185381|FG000|Overall Study|Screen Failure|1|||
46947170|NCT02443402|83185382|FG001|Overall Study|Screen Failure|2|||
46947171|NCT01370005|83185391|FG000|Overall Study|Not treated|1|||
46947172|NCT01370005|83185392|FG001|Overall Study|Not treated|0|||
46771004|NCT00723021|82989210|FG001|Intervention Period 4|Adverse Event|0|||
46771005|NCT00723021|82989211|FG002|Intervention Period 4|Adverse Event|0|||
46771006|NCT00723021|82989212|FG003|Intervention Period 4|Adverse Event|0|||
46771007|NCT00723021|82989213|FG004|Intervention Period 4|Adverse Event|1|||
46771008|NCT00721227|82989234|FG000|Overall Study|Lost to Follow-up|3|||
46771009|NCT00721227|82989235|FG001|Overall Study|Lost to Follow-up|0|||
46771010|NCT00721227|82989234|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
46771011|NCT00721227|82989235|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
46771012|NCT00807599|82989243|FG000|Overall Study|Not treated on protocol study|0|||
46771013|NCT00807599|82989244|FG001|Overall Study|Not treated on protocol study|0|||
46840780|NCT00267098|83058043|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
46840781|NCT00267098|83058044|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
46840782|NCT00267098|83058045|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
46840783|NCT00267098|83058046|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
46771014|NCT00807599|82989245|FG002|Overall Study|Not treated on protocol study|2|||
46771015|NCT00807599|82989243|FG000|Overall Study|Adverse Event|0|||
46771016|NCT00807599|82989244|FG001|Overall Study|Adverse Event|0|||
46771017|NCT00807599|82989245|FG002|Overall Study|Adverse Event|5|||
46771018|NCT00807599|82989243|FG000|Overall Study|Inadequate response to induction|0|||
46840784|NCT00267098|83058039|FG000|Overall Study|Subject listed for heart transplant|0|||
46840785|NCT00267098|83058040|FG001|Overall Study|Subject listed for heart transplant|0|||
46840786|NCT00267098|83058041|FG002|Overall Study|Subject listed for heart transplant|0|||
46638908|NCT01408914|82812347|FG001|Overall Study|Change in local TB/HIV norms|1|||
46638909|NCT01408914|82812348|FG002|Overall Study|Change in local TB/HIV norms|1|||
46638910|NCT01431144|82812358|FG000|Overall Study|Implant mobility and removal|2|||
46638911|NCT01431144|82812359|FG001|Overall Study|Implant mobility and removal|0|||
46638912|NCT01430754|82812368|FG000|Run-In Phase|Circadian Period Ineligible|24|||
46638913|NCT01430754|82812369|FG001|Run-In Phase|Circadian Period Ineligible|0|||
46840787|NCT00267098|83058042|FG003|Overall Study|Subject listed for heart transplant|0|||
46840788|NCT00267098|83058043|FG004|Overall Study|Subject listed for heart transplant|0|||
46840789|NCT00267098|83058044|FG005|Overall Study|Subject listed for heart transplant|0|||
46840790|NCT00267098|83058045|FG006|Overall Study|Subject listed for heart transplant|1|||
46840791|NCT00267098|83058046|FG007|Overall Study|Subject listed for heart transplant|0|||
46840792|NCT00267098|83058039|FG000|Overall Study|Sponsor withdrew subject|0|||
46840793|NCT00267098|83058040|FG001|Overall Study|Sponsor withdrew subject|0|||
46840794|NCT00267098|83058041|FG002|Overall Study|Sponsor withdrew subject|0|||
46840795|NCT00267098|83058042|FG003|Overall Study|Sponsor withdrew subject|1|||
46840796|NCT00267098|83058043|FG004|Overall Study|Sponsor withdrew subject|0|||
46840797|NCT00267098|83058044|FG005|Overall Study|Sponsor withdrew subject|0|||
46840798|NCT00267098|83058045|FG006|Overall Study|Sponsor withdrew subject|0|||
46840799|NCT00267098|83058046|FG007|Overall Study|Sponsor withdrew subject|0|||
46840800|NCT00247676|83058069|FG000|Overall Study|Death|5|||
46840801|NCT00247676|83058069|FG000|Overall Study|Adverse Event|11|||
46840802|NCT00247676|83058069|FG000|Overall Study|Lack of Efficacy|15|||
46840803|NCT00247676|83058069|FG000|Overall Study|Other|3|||
46840804|NCT00247676|83058069|FG000|Overall Study|Withdrawal by Subject|2|||
46840805|NCT00267020|83058075|FG000|Overall Study|Adverse Event|22|||
46840806|NCT00267020|83058076|FG001|Overall Study|Adverse Event|5|||
46840807|NCT00267020|83058075|FG000|Overall Study|Death|2|||
46840808|NCT00267020|83058076|FG001|Overall Study|Death|1|||
46840809|NCT00267020|83058075|FG000|Overall Study|Withdrawal by Subject|17|||
46840810|NCT00267020|83058076|FG001|Overall Study|Withdrawal by Subject|7|||
46840811|NCT00267020|83058075|FG000|Overall Study|Physician Decision|3|||
46840812|NCT00267020|83058076|FG001|Overall Study|Physician Decision|2|||
46840813|NCT00267020|83058075|FG000|Overall Study|Disease Progression|39|||
46840814|NCT00267020|83058076|FG001|Overall Study|Disease Progression|25|||
46840815|NCT00267020|83058075|FG000|Overall Study|Unrelated Complication|1|||
46840816|NCT00267020|83058076|FG001|Overall Study|Unrelated Complication|1|||
46840817|NCT00267020|83058075|FG000|Overall Study|Sponsor Request|1|||
46840818|NCT00267020|83058076|FG001|Overall Study|Sponsor Request|0|||
46840819|NCT00267020|83058075|FG000|Overall Study|Other|1|||
46840820|NCT00267020|83058076|FG001|Overall Study|Other|2|||
46840821|NCT00242216|83058084|FG000|Overall Study|Lost to Follow-up|12|||
46840822|NCT00242216|83058085|FG001|Overall Study|Lost to Follow-up|17|||
46638914|NCT01430754|82812368|FG000|Run-In Phase|Protocol Violation|6|||
46638915|NCT01430754|82812369|FG001|Run-In Phase|Protocol Violation|0|||
46638916|NCT01430754|82812368|FG000|Run-In Phase|Adverse Event|2|||
46771019|NCT00807599|82989244|FG001|Overall Study|Inadequate response to induction|0|||
46771020|NCT00807599|82989245|FG002|Overall Study|Inadequate response to induction|9|||
46840823|NCT00242216|83058084|FG000|Overall Study|Death|4|||
46771021|NCT00807599|82989243|FG000|Overall Study|Withdrawal by Subject|0|||
46771022|NCT00807599|82989244|FG001|Overall Study|Withdrawal by Subject|0|||
46840824|NCT00242216|83058085|FG001|Overall Study|Death|2|||
46840825|NCT00242216|83058084|FG000|Overall Study|Lack of Efficacy|1|||
46840826|NCT00242216|83058085|FG001|Overall Study|Lack of Efficacy|2|||
46840827|NCT00242216|83058084|FG000|Overall Study|no medicaiton dispensed|1|||
46840828|NCT00242216|83058085|FG001|Overall Study|no medicaiton dispensed|1|||
46638917|NCT01430754|82812369|FG001|Run-In Phase|Adverse Event|0|||
46638918|NCT01430754|82812368|FG000|Run-In Phase|Other|2|||
46638919|NCT01430754|82812369|FG001|Run-In Phase|Other|0|||
46638920|NCT01430754|82812368|FG000|Run-In Phase|Withdrawal by Subject|2|||
46638921|NCT01430754|82812369|FG001|Run-In Phase|Withdrawal by Subject|0|||
46638922|NCT01430754|82812368|FG000|Run-In Phase|Lost to Follow-up|1|||
46638923|NCT01430754|82812369|FG001|Run-In Phase|Lost to Follow-up|0|||
46771023|NCT00807599|82989245|FG002|Overall Study|Withdrawal by Subject|1|||
46771024|NCT00721149|82989251|FG000|Overall Study|Physician Decision|1|||
46771025|NCT00788372|82989255|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
46947173|NCT01370005|83185393|FG002|Overall Study|Not treated|0|||
46947174|NCT01370005|83185391|FG000|Overall Study|Adverse Event|5|||
46947175|NCT01370005|83185392|FG001|Overall Study|Adverse Event|5|||
46947176|NCT01370005|83185393|FG002|Overall Study|Adverse Event|6|||
46947177|NCT01370005|83185391|FG000|Overall Study|Lack of Efficacy|1|||
46947178|NCT01370005|83185392|FG001|Overall Study|Lack of Efficacy|0|||
46947179|NCT01370005|83185393|FG002|Overall Study|Lack of Efficacy|0|||
46947180|NCT01370005|83185391|FG000|Overall Study|Non compliant with protocol|0|||
46947181|NCT01370005|83185392|FG001|Overall Study|Non compliant with protocol|1|||
46947182|NCT01370005|83185393|FG002|Overall Study|Non compliant with protocol|2|||
46947183|NCT01370005|83185391|FG000|Overall Study|Lost to Follow-up|1|||
46947184|NCT01370005|83185392|FG001|Overall Study|Lost to Follow-up|1|||
46947185|NCT01370005|83185393|FG002|Overall Study|Lost to Follow-up|1|||
46947186|NCT01370005|83185391|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
46947187|NCT01370005|83185392|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
46947188|NCT01370005|83185393|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
46947189|NCT01370005|83185391|FG000|Overall Study|Other reason not defined above|3|||
46947190|NCT01370005|83185392|FG001|Overall Study|Other reason not defined above|0|||
46771026|NCT00788372|82989255|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
46771027|NCT00788372|82989255|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
46771028|NCT00788372|82989255|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
46771029|NCT00788372|82989255|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
46771030|NCT00788372|82989255|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
46840829|NCT00240110|83058093|FG000|Overall Study|Lost to Follow-up|6|||
46840830|NCT00240110|83058094|FG001|Overall Study|Lost to Follow-up|7|||
46840831|NCT00239720|83058104|FG000|Overall Study|Adverse Event|1|||
46840832|NCT00239720|83058105|FG001|Overall Study|Adverse Event|0|||
46840833|NCT00239720|83058104|FG000|Overall Study|Lost to Follow-up|0|||
46840834|NCT00239720|83058105|FG001|Overall Study|Lost to Follow-up|1|||
46840835|NCT00266864|83058113|FG000|Overall Study|Lost to Follow-up|4|||
46840836|NCT00266864|83058114|FG001|Overall Study|Lost to Follow-up|1|||
46840837|NCT00266864|83058113|FG000|Overall Study|Withdrawal by Subject|1|||
46840838|NCT00266864|83058114|FG001|Overall Study|Withdrawal by Subject|1|||
46840839|NCT00266708|83058122|FG000|Overall Study|No renal function|1|||
46840840|NCT00266708|83058123|FG001|Overall Study|No renal function|1|||
46840841|NCT00266708|83058122|FG000|Overall Study|Refused biopsy|3|||
46840842|NCT00266708|83058123|FG001|Overall Study|Refused biopsy|6|||
46840843|NCT00266708|83058122|FG000|Overall Study|Asthma|0|||
46840844|NCT00266708|83058123|FG001|Overall Study|Asthma|2|||
46840845|NCT00266630|83058131|FG000|Overall Study|Adverse Event|8|||
46840846|NCT00266630|83058132|FG001|Overall Study|Adverse Event|6|||
46840847|NCT00266630|83058131|FG000|Overall Study|Lack of Efficacy|1|||
46840848|NCT00266630|83058132|FG001|Overall Study|Lack of Efficacy|4|||
46840849|NCT00266630|83058131|FG000|Overall Study|Entry Criteria not met|1|||
46840850|NCT00266630|83058132|FG001|Overall Study|Entry Criteria not met|0|||
46840851|NCT00266630|83058131|FG000|Overall Study|Protocol Violation|1|||
46840852|NCT00266630|83058132|FG001|Overall Study|Protocol Violation|3|||
46840853|NCT00266630|83058131|FG000|Overall Study|Physician Decision|1|||
46840854|NCT00266630|83058132|FG001|Overall Study|Physician Decision|2|||
46947191|NCT01370005|83185393|FG002|Overall Study|Other reason not defined above|2|||
46947192|NCT02442778|83185404|FG000|Overall Study|Adverse Event|2|||
46771031|NCT00788372|82989255|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
46840855|NCT00266630|83058131|FG000|Overall Study|Withdrawal by Subject|10|||
46840856|NCT00266630|83058132|FG001|Overall Study|Withdrawal by Subject|2|||
46840857|NCT00266630|83058131|FG000|Overall Study|Lost to Follow-up|1|||
46840858|NCT00266630|83058132|FG001|Overall Study|Lost to Follow-up|0|||
46840859|NCT00266630|83058131|FG000|Overall Study|Other|19|||
46947193|NCT02442778|83185405|FG001|Overall Study|Adverse Event|6|||
46947194|NCT02442778|83185406|FG002|Overall Study|Adverse Event|6|||
46947195|NCT02442778|83185404|FG000|Overall Study|Death|0|||
46947196|NCT02442778|83185405|FG001|Overall Study|Death|2|||
47066359|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Early termination|34|||
46638924|NCT01390428|82812383|FG000|Overall Study|Elective Surgery|0|||
46840860|NCT00266630|83058132|FG001|Overall Study|Other|11|||
46840861|NCT00129129|83058143|FG000|Primary Phase|Adverse Event|2|||
46840862|NCT00129129|83058144|FG001|Primary Phase|Adverse Event|1|||
46840863|NCT00129129|83058145|FG002|Primary Phase|Adverse Event|0|||
46840864|NCT00129129|83058146|FG003|Primary Phase|Adverse Event|0|||
46638925|NCT01390428|82812384|FG001|Overall Study|Elective Surgery|0|||
46947197|NCT02442778|83185406|FG002|Overall Study|Death|0|||
46947198|NCT02442778|83185404|FG000|Overall Study|Lack of Efficacy|1|||
46947199|NCT02442778|83185405|FG001|Overall Study|Lack of Efficacy|0|||
46947200|NCT02442778|83185406|FG002|Overall Study|Lack of Efficacy|0|||
46947201|NCT02442778|83185404|FG000|Overall Study|Lost to Follow-up|1|||
46947202|NCT02442778|83185405|FG001|Overall Study|Lost to Follow-up|1|||
46947203|NCT02442778|83185406|FG002|Overall Study|Lost to Follow-up|1|||
46947204|NCT02442778|83185404|FG000|Overall Study|Non-compliance with study drug|2|||
46947205|NCT02442778|83185405|FG001|Overall Study|Non-compliance with study drug|0|||
46947206|NCT02442778|83185406|FG002|Overall Study|Non-compliance with study drug|1|||
46947207|NCT02442778|83185404|FG000|Overall Study|Physician Decision|1|||
46947208|NCT02442778|83185405|FG001|Overall Study|Physician Decision|1|||
46947209|NCT02442778|83185406|FG002|Overall Study|Physician Decision|1|||
46947210|NCT02442778|83185404|FG000|Overall Study|Protocol Deviation|3|||
46947211|NCT02442778|83185405|FG001|Overall Study|Protocol Deviation|0|||
46947212|NCT02442778|83185406|FG002|Overall Study|Protocol Deviation|1|||
46947213|NCT02442778|83185404|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
46947214|NCT02442778|83185405|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
46947215|NCT02442778|83185406|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
46947216|NCT02442778|83185404|FG000|Overall Study|Withdrawal by Subject|4|||
46947217|NCT02442778|83185405|FG001|Overall Study|Withdrawal by Subject|4|||
46947218|NCT02442778|83185406|FG002|Overall Study|Withdrawal by Subject|3|||
46947219|NCT02442778|83185404|FG000|Overall Study|Reason not specified|1|||
46947220|NCT02442778|83185405|FG001|Overall Study|Reason not specified|4|||
46947221|NCT02442778|83185406|FG002|Overall Study|Reason not specified|0|||
46947222|NCT02412436|83185414|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
46947223|NCT02412436|83185414|FG000|Overall Study|Lost to Follow-up|6|||
46947224|NCT02412436|83185414|FG000|Overall Study|Unable to get to clinic|3|||
46947225|NCT02412436|83185414|FG000|Overall Study|Death|1|||
46947226|NCT02412436|83185414|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
46947227|NCT01651000|83185420|FG000|Overall Study|Adverse Event|2|||
46947228|NCT01651000|83185421|FG001|Overall Study|Adverse Event|8|||
46947229|NCT01651000|83185420|FG000|Overall Study|Lost to Follow-up|3|||
46947230|NCT01651000|83185421|FG001|Overall Study|Lost to Follow-up|2|||
46947231|NCT01651000|83185420|FG000|Overall Study|Protocol Violation|0|||
46947232|NCT01651000|83185421|FG001|Overall Study|Protocol Violation|3|||
46947233|NCT01651000|83185420|FG000|Overall Study|Withdrawal by Subject|2|||
46947234|NCT01651000|83185421|FG001|Overall Study|Withdrawal by Subject|10|||
46947235|NCT01651000|83185420|FG000|Overall Study|Subject noncompliance|0|||
46947236|NCT01651000|83185421|FG001|Overall Study|Subject noncompliance|3|||
46947237|NCT01651000|83185420|FG000|Overall Study|Lack of Efficacy|1|||
46947238|NCT01651000|83185421|FG001|Overall Study|Lack of Efficacy|1|||
46947239|NCT01651000|83185420|FG000|Overall Study|Physician Decision|1|||
46947240|NCT01651000|83185421|FG001|Overall Study|Physician Decision|0|||
46947241|NCT01651000|83185420|FG000|Overall Study|Administrative reason|1|||
46947242|NCT01651000|83185421|FG001|Overall Study|Administrative reason|0|||
46947243|NCT01651000|83185420|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
46947244|NCT01651000|83185421|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
46947245|NCT02469610|83185429|FG000|Overall Study|Death|1|||
46947246|NCT02469610|83185430|FG001|Overall Study|Death|0|||
46947247|NCT02469610|83185429|FG000|Overall Study|Lost to Follow-up|1|||
46840865|NCT00129129|83058147|FG004|Primary Phase|Adverse Event|0|||
46840866|NCT00129129|83058143|FG000|Primary Phase|Withdrawal by Subject|12|||
46840867|NCT00129129|83058144|FG001|Primary Phase|Withdrawal by Subject|10|||
46840868|NCT00129129|83058145|FG002|Primary Phase|Withdrawal by Subject|0|||
46840869|NCT00129129|83058146|FG003|Primary Phase|Withdrawal by Subject|0|||
46840870|NCT00129129|83058147|FG004|Primary Phase|Withdrawal by Subject|0|||
46840871|NCT00129129|83058143|FG000|Primary Phase|Migration from study area|1|||
46840872|NCT00129129|83058144|FG001|Primary Phase|Migration from study area|3|||
46840873|NCT00129129|83058145|FG002|Primary Phase|Migration from study area|0|||
46840874|NCT00129129|83058146|FG003|Primary Phase|Migration from study area|0|||
46840875|NCT00129129|83058147|FG004|Primary Phase|Migration from study area|0|||
46840876|NCT00129129|83058143|FG000|Primary Phase|Lost to Follow-up|8|||
46840877|NCT00129129|83058144|FG001|Primary Phase|Lost to Follow-up|6|||
46947248|NCT02469610|83185430|FG001|Overall Study|Lost to Follow-up|0|||
46947249|NCT02469610|83185429|FG000|Overall Study|exclusion criteria|2|||
46947250|NCT02469610|83185430|FG001|Overall Study|exclusion criteria|1|||
46947251|NCT02469298|83185440|FG000|Overall Study|Protocol Violation|0|||
46947252|NCT02469298|83185441|FG001|Overall Study|Protocol Violation|1|||
46947253|NCT02469298|83185442|FG002|Overall Study|Protocol Violation|1|||
46947254|NCT02469298|83185443|FG003|Overall Study|Protocol Violation|0|||
46947255|NCT02469298|83185440|FG000|Overall Study|Lost to Follow-up|1|||
46947256|NCT02469298|83185441|FG001|Overall Study|Lost to Follow-up|0|||
46947257|NCT02469298|83185442|FG002|Overall Study|Lost to Follow-up|1|||
46947258|NCT02469298|83185443|FG003|Overall Study|Lost to Follow-up|0|||
46947259|NCT02469298|83185440|FG000|Overall Study|Physician Decision|0|||
46947260|NCT02469298|83185441|FG001|Overall Study|Physician Decision|0|||
46947261|NCT02469298|83185442|FG002|Overall Study|Physician Decision|0|||
46947262|NCT02469298|83185443|FG003|Overall Study|Physician Decision|1|||
46947263|NCT02469298|83185440|FG000|Overall Study|Withdrawal by Subject|0|||
46947264|NCT02469298|83185441|FG001|Overall Study|Withdrawal by Subject|0|||
46947265|NCT02469298|83185442|FG002|Overall Study|Withdrawal by Subject|0|||
46947266|NCT02469298|83185443|FG003|Overall Study|Withdrawal by Subject|1|||
46947267|NCT04163991|83185465|FG000|Overall Study|Adverse Event|0|||
46947268|NCT04163991|83185466|FG001|Overall Study|Adverse Event|0|||
46947269|NCT04163991|83185467|FG002|Overall Study|Adverse Event|0|||
46947270|NCT04163991|83185468|FG003|Overall Study|Adverse Event|1|||
46947271|NCT04163991|83185469|FG004|Overall Study|Adverse Event|0|||
46947272|NCT04163991|83185465|FG000|Overall Study|Death|0|||
46947273|NCT04163991|83185466|FG001|Overall Study|Death|0|||
46947274|NCT04163991|83185467|FG002|Overall Study|Death|1|||
46947275|NCT04163991|83185468|FG003|Overall Study|Death|0|||
46947276|NCT04163991|83185469|FG004|Overall Study|Death|0|||
46947277|NCT04163991|83185465|FG000|Overall Study|Lost to Follow-up|0|||
46947278|NCT04163991|83185466|FG001|Overall Study|Lost to Follow-up|1|||
46947279|NCT04163991|83185467|FG002|Overall Study|Lost to Follow-up|0|||
46947280|NCT04163991|83185468|FG003|Overall Study|Lost to Follow-up|0|||
46947281|NCT04163991|83185469|FG004|Overall Study|Lost to Follow-up|0|||
46947282|NCT04163991|83185465|FG000|Overall Study|Withdrawal by Subject|1|||
46947283|NCT04163991|83185466|FG001|Overall Study|Withdrawal by Subject|1|||
46947284|NCT04163991|83185467|FG002|Overall Study|Withdrawal by Subject|3|||
46947285|NCT04163991|83185468|FG003|Overall Study|Withdrawal by Subject|1|||
46947286|NCT04163991|83185469|FG004|Overall Study|Withdrawal by Subject|1|||
46947287|NCT04163991|83185465|FG000|Overall Study|Other, Not Specified|0|||
46947288|NCT04163991|83185466|FG001|Overall Study|Other, Not Specified|1|||
46947289|NCT04163991|83185467|FG002|Overall Study|Other, Not Specified|1|||
46947290|NCT04163991|83185468|FG003|Overall Study|Other, Not Specified|1|||
46947291|NCT04163991|83185469|FG004|Overall Study|Other, Not Specified|0|||
46947292|NCT02442622|83185487|FG000|Overall Study|Withdrawal by Subject|3|||
46947293|NCT02442622|83185488|FG001|Overall Study|Withdrawal by Subject|1|||
46947294|NCT02411578|83185496|FG000|Crossover Trial Phase|Pregnancy|0|||
46947295|NCT02411578|83185497|FG001|Crossover Trial Phase|Pregnancy|1|||
46947296|NCT02442310|83185505|FG000|Overall Study|Adverse Event|2|||
46947297|NCT02442310|83185505|FG000|Overall Study|Withdrawal by Subject|1|||
46947298|NCT02411110|83185517|FG000|Treatment Period 1|Adverse Event|4|||
46947299|NCT02411110|83185518|FG001|Treatment Period 1|Adverse Event|2|||
46947300|NCT02411110|83185517|FG000|Treatment Period 1|Lost to Follow-up|1|||
46840878|NCT00129129|83058145|FG002|Primary Phase|Lost to Follow-up|0|||
46840879|NCT00129129|83058146|FG003|Primary Phase|Lost to Follow-up|0|||
46840880|NCT00129129|83058147|FG004|Primary Phase|Lost to Follow-up|0|||
46840881|NCT00129129|83058143|FG000|Primary Phase|Other|2|||
46840882|NCT00129129|83058144|FG001|Primary Phase|Other|5|||
46840883|NCT00129129|83058145|FG002|Primary Phase|Other|0|||
46840884|NCT00129129|83058146|FG003|Primary Phase|Other|0|||
46840885|NCT00129129|83058147|FG004|Primary Phase|Other|0|||
46840886|NCT00129129|83058143|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
46840887|NCT00129129|83058144|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
46840888|NCT00129129|83058145|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
46840889|NCT00129129|83058146|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
46840890|NCT00129129|83058147|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
46840891|NCT00129129|83058143|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
46840892|NCT00129129|83058144|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
46840893|NCT00129129|83058145|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
46840894|NCT00129129|83058146|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
46947301|NCT02411110|83185518|FG001|Treatment Period 1|Lost to Follow-up|0|||
46947302|NCT02411110|83185517|FG000|Treatment Period 1|Personal Reasons|2|||
46947303|NCT02411110|83185518|FG001|Treatment Period 1|Personal Reasons|5|||
46947304|NCT02411110|83185517|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
46947305|NCT02411110|83185518|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
46947306|NCT02411110|83185517|FG000|Treatment Period 2|Adverse Event|1|||
46947307|NCT02411110|83185518|FG001|Treatment Period 2|Adverse Event|0|||
46947308|NCT02411110|83185517|FG000|Treatment Period 2|Lost to Follow-up|0|||
46840895|NCT00129129|83058147|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
46840896|NCT00129129|83058143|FG000|Fourth Dose Phase|Migration from study area|0|||
46947309|NCT02411110|83185518|FG001|Treatment Period 2|Lost to Follow-up|2|||
46947310|NCT02411110|83185517|FG000|Treatment Period 2|Personal Reasons|0|||
46947311|NCT02411110|83185518|FG001|Treatment Period 2|Personal Reasons|2|||
46947312|NCT01369849|83185529|FG000|Overall Study|Ineligible prior to treatment|0|||
46947313|NCT01369849|83185530|FG001|Overall Study|Ineligible prior to treatment|0|||
46840897|NCT00129129|83058144|FG001|Fourth Dose Phase|Migration from study area|0|||
46840898|NCT00129129|83058145|FG002|Fourth Dose Phase|Migration from study area|0|||
46947314|NCT01369849|83185531|FG002|Overall Study|Ineligible prior to treatment|1|||
46947315|NCT01369849|83185529|FG000|Overall Study|Ineligible after receiving treatment|0|||
46947316|NCT01369849|83185530|FG001|Overall Study|Ineligible after receiving treatment|1|||
46947317|NCT01369849|83185531|FG002|Overall Study|Ineligible after receiving treatment|0|||
46840899|NCT00129129|83058146|FG003|Fourth Dose Phase|Migration from study area|0|||
46840900|NCT00129129|83058147|FG004|Fourth Dose Phase|Migration from study area|2|||
46840901|NCT00129129|83058143|FG000|Fourth Dose Phase|Other|0|||
46840902|NCT00129129|83058144|FG001|Fourth Dose Phase|Other|0|||
46840903|NCT00129129|83058145|FG002|Fourth Dose Phase|Other|0|||
46840904|NCT00129129|83058146|FG003|Fourth Dose Phase|Other|1|||
46840905|NCT00129129|83058147|FG004|Fourth Dose Phase|Other|1|||
46840906|NCT00129129|83058143|FG000|Fourth Dose Phase|Protocol Violation|0|||
46840907|NCT00129129|83058144|FG001|Fourth Dose Phase|Protocol Violation|0|||
46840908|NCT00129129|83058145|FG002|Fourth Dose Phase|Protocol Violation|0|||
46947318|NCT02716779|83185544|FG000|Monotherapy|Adverse Event|0|||
46947319|NCT02716779|83185545|FG001|Monotherapy|Adverse Event|1|||
46947320|NCT02716779|83185546|FG002|Monotherapy|Adverse Event|1|||
46947321|NCT02716779|83185544|FG000|Combination Therapy|Adverse Event|0|||
46947322|NCT02716779|83185545|FG001|Combination Therapy|Adverse Event|2|||
46947323|NCT02716779|83185546|FG002|Combination Therapy|Adverse Event|1|||
46947324|NCT01369615|83185562|FG000|Overall Study|Withdrawal by Subject|0|||
46947325|NCT01369615|83185563|FG001|Overall Study|Withdrawal by Subject|1|||
46947326|NCT01369615|83185562|FG000|Overall Study|Lost to Follow-up|0|||
46947327|NCT01369615|83185563|FG001|Overall Study|Lost to Follow-up|1|||
46947328|NCT02468674|83185587|FG000|Overall Study|Adverse Event|0|||
46947329|NCT02468674|83185588|FG001|Overall Study|Adverse Event|0|||
46947330|NCT02468674|83185589|FG002|Overall Study|Adverse Event|0|||
46947331|NCT02468674|83185590|FG003|Overall Study|Adverse Event|1|||
46947332|NCT02468674|83185591|FG004|Overall Study|Adverse Event|0|||
46947333|NCT02468674|83185592|FG005|Overall Study|Adverse Event|1|||
46947334|NCT02468674|83185593|FG006|Overall Study|Adverse Event|0|||
46947335|NCT02468674|83185594|FG007|Overall Study|Adverse Event|0|||
46947336|NCT02468674|83185595|FG008|Overall Study|Adverse Event|0|||
46947337|NCT02468674|83185587|FG000|Overall Study|Lost to Follow-up|1|||
46947338|NCT02468674|83185588|FG001|Overall Study|Lost to Follow-up|0|||
46947339|NCT02468674|83185589|FG002|Overall Study|Lost to Follow-up|0|||
46947340|NCT02468674|83185590|FG003|Overall Study|Lost to Follow-up|0|||
46947341|NCT02468674|83185591|FG004|Overall Study|Lost to Follow-up|0|||
46947342|NCT02468674|83185592|FG005|Overall Study|Lost to Follow-up|0|||
46947343|NCT02468674|83185593|FG006|Overall Study|Lost to Follow-up|0|||
46947344|NCT02468674|83185594|FG007|Overall Study|Lost to Follow-up|1|||
46947345|NCT02468674|83185595|FG008|Overall Study|Lost to Follow-up|1|||
46947346|NCT02468674|83185587|FG000|Overall Study|Physician Decision|0|||
46947347|NCT02468674|83185588|FG001|Overall Study|Physician Decision|0|||
46947348|NCT02468674|83185589|FG002|Overall Study|Physician Decision|0|||
46947349|NCT02468674|83185590|FG003|Overall Study|Physician Decision|0|||
46947350|NCT02468674|83185591|FG004|Overall Study|Physician Decision|0|||
46947351|NCT02468674|83185592|FG005|Overall Study|Physician Decision|0|||
46947352|NCT02468674|83185593|FG006|Overall Study|Physician Decision|1|||
46947353|NCT02468674|83185594|FG007|Overall Study|Physician Decision|0|||
46947354|NCT02468674|83185595|FG008|Overall Study|Physician Decision|0|||
46840909|NCT00129129|83058146|FG003|Fourth Dose Phase|Protocol Violation|1|||
46840910|NCT00129129|83058147|FG004|Fourth Dose Phase|Protocol Violation|0|||
46840911|NCT00221403|83058170|FG000|Overall Study|Protocol Violation|1|||
46840912|NCT00221403|83058171|FG001|Overall Study|Protocol Violation|0|||
46840913|NCT00221403|83058172|FG002|Overall Study|Protocol Violation|0|||
46840914|NCT00221403|83058170|FG000|Overall Study|Physician Decision|1|||
46840915|NCT00221403|83058171|FG001|Overall Study|Physician Decision|0|||
46840916|NCT00221403|83058172|FG002|Overall Study|Physician Decision|0|||
46840917|NCT00221403|83058170|FG000|Overall Study|Withdrawal by Subject|0|||
46840918|NCT00221403|83058171|FG001|Overall Study|Withdrawal by Subject|3|||
46840919|NCT00221403|83058172|FG002|Overall Study|Withdrawal by Subject|0|||
46840920|NCT00221403|83058170|FG000|Overall Study|Lack of Efficacy|0|||
46840921|NCT00221403|83058171|FG001|Overall Study|Lack of Efficacy|1|||
46840922|NCT00221403|83058172|FG002|Overall Study|Lack of Efficacy|0|||
46947355|NCT02468674|83185587|FG000|Overall Study|Patient/Guardian Decision|0|||
46947356|NCT02468674|83185588|FG001|Overall Study|Patient/Guardian Decision|0|||
46840923|NCT00221403|83058170|FG000|Overall Study|Adverse Event|0|||
46840924|NCT00221403|83058171|FG001|Overall Study|Adverse Event|1|||
46840925|NCT00221403|83058172|FG002|Overall Study|Adverse Event|0|||
46840926|NCT00145977|83058182|FG000|Overall Study|Lack of Efficacy|0|||
46947357|NCT02468674|83185589|FG002|Overall Study|Patient/Guardian Decision|0|||
46947358|NCT02468674|83185590|FG003|Overall Study|Patient/Guardian Decision|0|||
46947359|NCT02468674|83185591|FG004|Overall Study|Patient/Guardian Decision|1|||
46947360|NCT02468674|83185592|FG005|Overall Study|Patient/Guardian Decision|0|||
46840927|NCT00145977|83058183|FG001|Overall Study|Lack of Efficacy|4|||
46840928|NCT00145977|83058182|FG000|Overall Study|Lost to Follow-up|1|||
46947361|NCT02468674|83185593|FG006|Overall Study|Patient/Guardian Decision|0|||
46947362|NCT02468674|83185594|FG007|Overall Study|Patient/Guardian Decision|2|||
46947363|NCT02468674|83185595|FG008|Overall Study|Patient/Guardian Decision|1|||
46947364|NCT02468674|83185587|FG000|Overall Study|Protocol Deviation|0|||
46840929|NCT00145977|83058183|FG001|Overall Study|Lost to Follow-up|0|||
46840930|NCT00145977|83058182|FG000|Overall Study|Withdrawal by Subject|1|||
46840931|NCT00145977|83058183|FG001|Overall Study|Withdrawal by Subject|0|||
46840932|NCT00238238|83058192|FG000|Overall Study|Withdrawal by Subject|0|||
46840933|NCT00238238|83058193|FG001|Overall Study|Withdrawal by Subject|3|||
46840934|NCT00238238|83058194|FG002|Overall Study|Withdrawal by Subject|0|||
46840935|NCT00128661|83058204|FG000|Overall Study|Adverse Event|14|||
46840936|NCT00128661|83058205|FG001|Overall Study|Adverse Event|11|||
46840937|NCT00128661|83058204|FG000|Overall Study|Lost to Follow-up|10|||
46840938|NCT00128661|83058205|FG001|Overall Study|Lost to Follow-up|7|||
46947365|NCT02468674|83185588|FG001|Overall Study|Protocol Deviation|0|||
46947366|NCT02468674|83185589|FG002|Overall Study|Protocol Deviation|0|||
46947367|NCT02468674|83185590|FG003|Overall Study|Protocol Deviation|0|||
46947368|NCT02468674|83185591|FG004|Overall Study|Protocol Deviation|0|||
46947369|NCT02468674|83185592|FG005|Overall Study|Protocol Deviation|0|||
46947370|NCT02468674|83185593|FG006|Overall Study|Protocol Deviation|0|||
46947371|NCT02468674|83185594|FG007|Overall Study|Protocol Deviation|1|||
46947372|NCT02468674|83185595|FG008|Overall Study|Protocol Deviation|1|||
46947373|NCT02467192|83185615|FG000|Overall Study|Death|1|||
46947374|NCT02467192|83185615|FG000|Overall Study|revealed to have pneumonia before|2|||
46947375|NCT02410954|83185625|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
46947376|NCT02410954|83185626|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
46947377|NCT02410954|83185625|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
46947378|NCT02410954|83185626|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
46947379|NCT05153499|83185647|FG000|Overall Study|Withdrawal by Subject|1|||
46947380|NCT05153499|83185648|FG001|Overall Study|Withdrawal by Subject|0|||
46947381|NCT05153499|83185647|FG000|Overall Study|Clinical Hold|1|||
46947382|NCT05153499|83185648|FG001|Overall Study|Clinical Hold|0|||
46947383|NCT05153499|83185647|FG000|Overall Study|Study Termination|6|||
46947384|NCT05153499|83185648|FG001|Overall Study|Study Termination|5|||
46947385|NCT05047770|83185658|FG000|Overall Study|Withdrawal by Subject|15|||
46947386|NCT05047770|83185659|FG001|Overall Study|Withdrawal by Subject|10|||
46947387|NCT05047770|83185660|FG002|Overall Study|Withdrawal by Subject|6|||
46947388|NCT05047770|83185661|FG003|Overall Study|Withdrawal by Subject|12|||
46947389|NCT05047770|83185658|FG000|Overall Study|Lost to Follow-up|7|||
46947390|NCT05047770|83185659|FG001|Overall Study|Lost to Follow-up|5|||
46947391|NCT05047770|83185660|FG002|Overall Study|Lost to Follow-up|12|||
46947392|NCT05047770|83185661|FG003|Overall Study|Lost to Follow-up|13|||
46947393|NCT05047770|83185658|FG000|Overall Study|Other|1|||
46947394|NCT05047770|83185659|FG001|Overall Study|Other|0|||
46947395|NCT05047770|83185660|FG002|Overall Study|Other|1|||
46947396|NCT05047770|83185661|FG003|Overall Study|Other|0|||
46947397|NCT04624672|83185707|FG000|Overall Study|Early Study Closure|2|||
46947398|NCT04624672|83185708|FG001|Overall Study|Early Study Closure|1|||
46947399|NCT04476108|83185745|FG000|Overall Study|Adverse Event|4|||
46947400|NCT04476108|83185746|FG001|Overall Study|Adverse Event|1|||
46947401|NCT04476108|83185745|FG000|Overall Study|Lost to Follow-up|1|||
46947402|NCT04476108|83185746|FG001|Overall Study|Lost to Follow-up|0|||
46947403|NCT04476108|83185745|FG000|Overall Study|Inadvertent Enrollment|1|||
46947404|NCT04476108|83185746|FG001|Overall Study|Inadvertent Enrollment|0|||
46947405|NCT04476108|83185745|FG000|Overall Study|Protocol Violation|1|||
46947406|NCT04476108|83185746|FG001|Overall Study|Protocol Violation|1|||
46947407|NCT04476108|83185745|FG000|Overall Study|Withdrawal by Subject|1|||
46947408|NCT04476108|83185746|FG001|Overall Study|Withdrawal by Subject|1|||
46947409|NCT04456686|83185754|FG000|Overall Study|Adverse Event|2|||
46947410|NCT04456686|83185755|FG001|Overall Study|Adverse Event|1|||
46947411|NCT04456686|83185754|FG000|Overall Study|Lack of Efficacy|3|||
46947412|NCT04456686|83185755|FG001|Overall Study|Lack of Efficacy|1|||
46947413|NCT04456686|83185754|FG000|Overall Study|Withdrew consent|3|||
46947414|NCT04456686|83185755|FG001|Overall Study|Withdrew consent|1|||
46947415|NCT04456686|83185754|FG000|Overall Study|Physician Decision|2|||
46947416|NCT04456686|83185755|FG001|Overall Study|Physician Decision|2|||
47066360|NCT01493557|83349067|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
47066361|NCT01493557|83349068|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
47066362|NCT01493557|83349069|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
47066363|NCT01493557|83349067|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
47066364|NCT01493557|83349068|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
47066365|NCT01493557|83349069|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
47066366|NCT01493557|83349067|FG000|Randomized to Management Strategies|Other adverse event|8|||
46947417|NCT04456686|83185754|FG000|Overall Study|Withdrawal by Subject|5|||
46947418|NCT04456686|83185755|FG001|Overall Study|Withdrawal by Subject|1|||
46947419|NCT04456686|83185754|FG000|Overall Study|Protocol Violation|0|||
46947420|NCT04456686|83185755|FG001|Overall Study|Protocol Violation|1|||
46947421|NCT04269889|83185794|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
46947422|NCT04269889|83185794|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
46947423|NCT04099251|83185816|FG000|Pre-Treatment|Other reasons|1|||
46840939|NCT00128661|83058204|FG000|Overall Study|Withdrawal by Subject|243|||
46947424|NCT04099251|83185817|FG001|Pre-Treatment|Other reasons|0|||
46947425|NCT04099251|83185816|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
46947426|NCT04099251|83185817|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
46947427|NCT04099251|83185816|FG000|Blinded Treatment Phase|Other reasons|16|||
46947428|NCT04099251|83185817|FG001|Blinded Treatment Phase|Other reasons|7|||
46947429|NCT04099251|83185816|FG000|Blinded Treatment Phase|Disease recurrence|26|||
46947430|NCT04099251|83185817|FG001|Blinded Treatment Phase|Disease recurrence|41|||
46947431|NCT04099251|83185816|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
46947432|NCT04099251|83185817|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
46947433|NCT04099251|83185816|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
46947434|NCT04099251|83185817|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
46947435|NCT04099251|83185816|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
46947436|NCT04099251|83185817|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
46947437|NCT04099251|83185816|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
46947438|NCT04099251|83185817|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
46947439|NCT04099251|83185816|FG000|Blinded Treatment Phase|Death|6|||
46947440|NCT04099251|83185817|FG001|Blinded Treatment Phase|Death|2|||
46947441|NCT04099251|83185816|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
46947442|NCT04099251|83185817|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
46947443|NCT04099251|83185816|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
46947444|NCT04099251|83185817|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
46947445|NCT04099251|83185816|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
46947446|NCT04099251|83185817|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
46947447|NCT04099251|83185816|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
46947448|NCT04099251|83185817|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
46947449|NCT04099251|83185816|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
46947450|NCT04099251|83185817|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
46947451|NCT04099251|83185816|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
46947452|NCT04099251|83185817|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
46947453|NCT04099251|83185816|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
46947454|NCT04099251|83185817|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
46947455|NCT04099251|83185816|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
46947456|NCT04099251|83185817|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
46947457|NCT04099251|83185816|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
46947458|NCT04099251|83185817|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
46947459|NCT04066491|83185827|FG000|Overall Study|Randomized, not treated|0|||
46638926|NCT01390428|82812385|FG002|Overall Study|Elective Surgery|0|||
46840940|NCT00128661|83058205|FG001|Overall Study|Withdrawal by Subject|232|||
46840941|NCT00128661|83058204|FG000|Overall Study|Other|7|||
46840942|NCT00128661|83058205|FG001|Overall Study|Other|8|||
46840943|NCT00145509|83058213|FG000|Overall Study|Adverse Event|10|||
46840944|NCT00145509|83058214|FG001|Overall Study|Adverse Event|3|||
46840945|NCT00145509|83058213|FG000|Overall Study|Lack of Efficacy|3|||
46840946|NCT00145509|83058214|FG001|Overall Study|Lack of Efficacy|1|||
46840947|NCT00145509|83058213|FG000|Overall Study|Lost to Follow-up|5|||
46840948|NCT00145509|83058214|FG001|Overall Study|Lost to Follow-up|9|||
46840949|NCT00145509|83058213|FG000|Overall Study|Withdrew Consent|2|||
46840950|NCT00145509|83058214|FG001|Overall Study|Withdrew Consent|7|||
46840951|NCT00145509|83058213|FG000|Overall Study|Reason not provided|2|||
46840952|NCT00145509|83058214|FG001|Overall Study|Reason not provided|1|||
46840953|NCT00145119|83058220|FG000|Overall Study|Death|45|||
46840954|NCT00220779|83058227|FG000|Overall Study|Adverse Event|1|||
46840955|NCT00220779|83058228|FG001|Overall Study|Adverse Event|0|||
46840956|NCT00220779|83058229|FG002|Overall Study|Adverse Event|0|||
46840957|NCT00220779|83058227|FG000|Overall Study|Withdrawal by Subject|1|||
46840958|NCT00220779|83058228|FG001|Overall Study|Withdrawal by Subject|4|||
46840959|NCT00220779|83058229|FG002|Overall Study|Withdrawal by Subject|1|||
46840960|NCT00220779|83058227|FG000|Overall Study|Non-compliance|1|||
46840961|NCT00220779|83058228|FG001|Overall Study|Non-compliance|0|||
46840962|NCT00220779|83058229|FG002|Overall Study|Non-compliance|0|||
46840963|NCT00220779|83058227|FG000|Overall Study|Too time consuming|1|||
46840964|NCT00220779|83058228|FG001|Overall Study|Too time consuming|0|||
46840965|NCT00220779|83058229|FG002|Overall Study|Too time consuming|0|||
46840966|NCT00220779|83058227|FG000|Overall Study|Pregnancy|0|||
46947460|NCT04066491|83185828|FG001|Overall Study|Randomized, not treated|0|||
47066367|NCT01493557|83349068|FG001|Randomized to Management Strategies|Other adverse event|5|||
46840967|NCT00220779|83058228|FG001|Overall Study|Pregnancy|0|||
46840968|NCT00220779|83058229|FG002|Overall Study|Pregnancy|2|||
46840969|NCT00220779|83058227|FG000|Overall Study|Lack of Efficacy|3|||
46840970|NCT00220779|83058228|FG001|Overall Study|Lack of Efficacy|0|||
46840971|NCT00220779|83058229|FG002|Overall Study|Lack of Efficacy|1|||
46840972|NCT00207740|83058241|FG000|Overall Study|Adverse Event|4|||
46771032|NCT00738582|82989259|FG000|Combination Therapy|Completed Combination Therapy|1|||
46771033|NCT00738582|82989260|FG001|Combination Therapy|Completed Combination Therapy|0|||
46771034|NCT00738582|82989259|FG000|Combination Therapy|Physician Decision|1|||
46771035|NCT00738582|82989260|FG001|Combination Therapy|Physician Decision|0|||
46771036|NCT00738582|82989259|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
46771037|NCT00738582|82989260|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
46840973|NCT00207740|83058242|FG001|Overall Study|Adverse Event|14|||
46840974|NCT00207740|83058243|FG002|Overall Study|Adverse Event|14|||
46840975|NCT00207740|83058244|FG003|Overall Study|Adverse Event|11|||
46840976|NCT00207740|83058241|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46840977|NCT00207740|83058242|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46840978|NCT00207740|83058243|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
46840979|NCT00207740|83058244|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
46840980|NCT00207740|83058241|FG000|Overall Study|Lost to Follow-up|0|||
46840981|NCT00207740|83058242|FG001|Overall Study|Lost to Follow-up|2|||
46840982|NCT00207740|83058243|FG002|Overall Study|Lost to Follow-up|1|||
46840983|NCT00207740|83058244|FG003|Overall Study|Lost to Follow-up|1|||
46840984|NCT00207740|83058241|FG000|Overall Study|Death|0|||
46840985|NCT00207740|83058242|FG001|Overall Study|Death|0|||
46840986|NCT00207740|83058243|FG002|Overall Study|Death|0|||
46840987|NCT00207740|83058244|FG003|Overall Study|Death|1|||
46840988|NCT00207740|83058241|FG000|Overall Study|Sponsor Directive|22|||
46840989|NCT00207740|83058242|FG001|Overall Study|Sponsor Directive|15|||
46840990|NCT00207740|83058243|FG002|Overall Study|Sponsor Directive|16|||
46840991|NCT00207740|83058244|FG003|Overall Study|Sponsor Directive|21|||
46840992|NCT00207740|83058241|FG000|Overall Study|Other|2|||
46840993|NCT00207740|83058242|FG001|Overall Study|Other|10|||
46840994|NCT00207740|83058243|FG002|Overall Study|Other|7|||
46840995|NCT00207740|83058244|FG003|Overall Study|Other|5|||
46840996|NCT00265382|83058258|FG000|Overall Study|Adverse Event|21|||
46840997|NCT00265382|83058258|FG000|Overall Study|Laboratory Abnormality|1|||
46840998|NCT00265382|83058258|FG000|Overall Study|Lost to Follow-up|3|||
46840999|NCT00265382|83058258|FG000|Overall Study|Lack of Efficacy|6|||
46841000|NCT00265382|83058258|FG000|Overall Study|Miscellaneous|6|||
46841001|NCT00265382|83058258|FG000|Overall Study|Withdrawal by Subject|13|||
46841002|NCT00265382|83058258|FG000|Overall Study|Study terminated by sponsor|94|||
46841003|NCT00265382|83058258|FG000|Overall Study|Death|1|||
46841004|NCT00206726|83058262|FG000|Overall Study|Delayed recovery of blood counts|1|||
46771038|NCT00738582|82989259|FG000|Combination Therapy|Other|5|||
46771039|NCT00738582|82989260|FG001|Combination Therapy|Other|0|||
46771040|NCT00738582|82989259|FG000|Combination Therapy|Adverse Event|16|||
46841005|NCT00206726|83058262|FG000|Overall Study|Progressive disease or relapsed disease|18|||
46841006|NCT00206726|83058262|FG000|Overall Study|Placed on new protocol|1|||
46841007|NCT00206726|83058262|FG000|Overall Study|Bone marrow transplant|1|||
46841008|NCT00206726|83058262|FG000|Overall Study|Adverse Event|17|||
46841009|NCT00206726|83058262|FG000|Overall Study|Death|4|||
46841010|NCT00206726|83058262|FG000|Overall Study|Protocol Violation|1|||
46841011|NCT00206726|83058262|FG000|Overall Study|Withdrawal by Subject|8|||
46841012|NCT00237692|83058270|FG000|Overall Study|Lost to Follow-up|9|||
46841013|NCT00237692|83058271|FG001|Overall Study|Lost to Follow-up|3|||
46841014|NCT00237692|83058272|FG002|Overall Study|Lost to Follow-up|5|||
46841015|NCT00237692|83058273|FG003|Overall Study|Lost to Follow-up|3|||
46841016|NCT00237692|83058270|FG000|Overall Study|Death|1|||
46841017|NCT00237692|83058271|FG001|Overall Study|Death|2|||
46841018|NCT00237692|83058272|FG002|Overall Study|Death|2|||
46841019|NCT00237692|83058273|FG003|Overall Study|Death|3|||
46947461|NCT04066491|83185829|FG002|Overall Study|Randomized, not treated|2|||
46947462|NCT03883828|83185840|FG000|Overall Study|Did not start radiotherapy|1|||
47066368|NCT01493557|83349069|FG002|Randomized to Management Strategies|Other adverse event|0|||
47066369|NCT01493557|83349067|FG000|Randomized to Management Strategies|Protocol Violation|3|||
47066370|NCT01493557|83349068|FG001|Randomized to Management Strategies|Protocol Violation|0|||
47066371|NCT01493557|83349069|FG002|Randomized to Management Strategies|Protocol Violation|0|||
47066372|NCT01493557|83349067|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
47066373|NCT01493557|83349068|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
47066374|NCT01493557|83349069|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
47066375|NCT01493557|83349067|FG000|Randomized to Management Strategies|Other than stated above|1|||
46638927|NCT01390428|82812386|FG003|Overall Study|Elective Surgery|0|||
46638928|NCT01390428|82812387|FG004|Overall Study|Elective Surgery|1|||
46771041|NCT00738582|82989260|FG001|Combination Therapy|Adverse Event|0|||
46841020|NCT00237692|83058270|FG000|Overall Study|Excluded - did not meet criteria|4|||
46841021|NCT00237692|83058271|FG001|Overall Study|Excluded - did not meet criteria|3|||
46841022|NCT00237692|83058272|FG002|Overall Study|Excluded - did not meet criteria|5|||
46841023|NCT00237692|83058273|FG003|Overall Study|Excluded - did not meet criteria|9|||
46841024|NCT00237692|83058270|FG000|Overall Study|Withdrawal by Subject|4|||
46841025|NCT00237692|83058271|FG001|Overall Study|Withdrawal by Subject|6|||
46947463|NCT03883828|83185841|FG001|Overall Study|Did not start radiotherapy|2|||
47066376|NCT01493557|83349068|FG001|Randomized to Management Strategies|Other than stated above|3|||
46947464|NCT03844269|83185847|FG000|Overall Study|Withdrawal pre-intervention|1|||
46947465|NCT03844269|83185847|FG000|Overall Study|Did not complete the intervention|2|||
46947466|NCT03777917|83185864|FG000|Overall Study|Withdrawal by Subject|1|||
46947467|NCT03777917|83185865|FG001|Overall Study|Withdrawal by Subject|0|||
46947468|NCT03777917|83185864|FG000|Overall Study|Physician Decision|1|||
46947469|NCT03777917|83185865|FG001|Overall Study|Physician Decision|0|||
46947470|NCT03777917|83185864|FG000|Overall Study|Lost to Follow-up|6|||
46947471|NCT03777917|83185865|FG001|Overall Study|Lost to Follow-up|2|||
46947472|NCT03777917|83185864|FG000|Overall Study|Other|1|||
46947473|NCT03777917|83185865|FG001|Overall Study|Other|0|||
46947474|NCT03594123|83185874|FG000|Overall Study|Lost to Follow-up|0|||
46947475|NCT03594123|83185875|FG001|Overall Study|Lost to Follow-up|1|||
46947476|NCT03594123|83185874|FG000|Overall Study|Adverse Event|8|||
46947477|NCT03594123|83185875|FG001|Overall Study|Adverse Event|5|||
46947478|NCT03594123|83185874|FG000|Overall Study|Site Terminated by Sponsor|4|||
46947479|NCT03594123|83185875|FG001|Overall Study|Site Terminated by Sponsor|1|||
46947480|NCT03594123|83185874|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
46947481|NCT03594123|83185875|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
46947482|NCT03594123|83185874|FG000|Overall Study|Lack of Efficacy|1|||
46947483|NCT03594123|83185875|FG001|Overall Study|Lack of Efficacy|0|||
46947484|NCT03594123|83185874|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
46947485|NCT03594123|83185875|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
46947486|NCT03583359|83185883|FG000|Overall Study|Withdrawal by Subject|15|||
46947487|NCT03583359|83185884|FG001|Overall Study|Withdrawal by Subject|6|||
46947488|NCT03583359|83185883|FG000|Overall Study|Lost to Follow-up|12|||
46947489|NCT03583359|83185884|FG001|Overall Study|Lost to Follow-up|3|||
46947490|NCT03583359|83185883|FG000|Overall Study|Adverse Event|0|||
46947491|NCT03583359|83185884|FG001|Overall Study|Adverse Event|1|||
46947492|NCT03583359|83185883|FG000|Overall Study|Protocol Violation|0|||
46947493|NCT03583359|83185884|FG001|Overall Study|Protocol Violation|1|||
46947494|NCT03583359|83185883|FG000|Overall Study|Other|2|||
46947495|NCT03583359|83185884|FG001|Overall Study|Other|1|||
46947496|NCT03537651|83185890|FG000|Overall Study|Adverse Event|2|||
46947497|NCT03537651|83185890|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
46947498|NCT03537651|83185890|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
46947499|NCT03537651|83185890|FG000|Overall Study|Other|1|||
46947500|NCT03506438|83185903|FG000|Overall Study|Lost to Follow-up|8|||
46947501|NCT03506438|83185904|FG001|Overall Study|Lost to Follow-up|7|||
46947502|NCT03506438|83185905|FG002|Overall Study|Lost to Follow-up|8|||
46947503|NCT03506438|83185906|FG003|Overall Study|Lost to Follow-up|7|||
46947504|NCT03506438|83185907|FG004|Overall Study|Lost to Follow-up|0|||
46947505|NCT03506438|83185908|FG005|Overall Study|Lost to Follow-up|0|||
46947506|NCT03493542|83185921|FG000|Overall Study|Ongoing|2|||
46947507|NCT03493542|83185922|FG001|Overall Study|Ongoing|3|||
46947508|NCT03493542|83185921|FG000|Overall Study|Withdrawal by parent or guardian|3|||
46947509|NCT03493542|83185922|FG001|Overall Study|Withdrawal by parent or guardian|0|||
46947510|NCT03493542|83185921|FG000|Overall Study|Withdrawal by Subject|2|||
46947511|NCT03493542|83185922|FG001|Overall Study|Withdrawal by Subject|6|||
46947512|NCT03253744|83185964|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
46947513|NCT03253744|83185965|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
46947514|NCT03253744|83185966|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
46947515|NCT03253744|83185967|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
46947516|NCT03104400|83185996|FG000|Overall Study|Adverse Event|5|||
46947517|NCT03104400|83185997|FG001|Overall Study|Adverse Event|7|||
46947518|NCT03104400|83185998|FG002|Overall Study|Adverse Event|11|||
46947519|NCT03104400|83185999|FG003|Overall Study|Adverse Event|9|||
46947520|NCT03104400|83186000|FG004|Overall Study|Adverse Event|21|||
46947521|NCT03104400|83185996|FG000|Overall Study|Withdrawal by Subject|17|||
47066377|NCT01493557|83349069|FG002|Randomized to Management Strategies|Other than stated above|0|||
47066378|NCT01493557|83349067|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
47066379|NCT01493557|83349068|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
47066380|NCT01493557|83349069|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
46947522|NCT03104400|83185997|FG001|Overall Study|Withdrawal by Subject|19|||
46947523|NCT03104400|83185998|FG002|Overall Study|Withdrawal by Subject|29|||
46947524|NCT03104400|83185999|FG003|Overall Study|Withdrawal by Subject|25|||
46947525|NCT03104400|83186000|FG004|Overall Study|Withdrawal by Subject|24|||
46947526|NCT03104400|83185996|FG000|Overall Study|Lost to Follow-up|4|||
46947527|NCT03104400|83185997|FG001|Overall Study|Lost to Follow-up|1|||
46947528|NCT03104400|83185998|FG002|Overall Study|Lost to Follow-up|4|||
46947529|NCT03104400|83185999|FG003|Overall Study|Lost to Follow-up|8|||
46947530|NCT03104400|83186000|FG004|Overall Study|Lost to Follow-up|7|||
46947531|NCT03104400|83185996|FG000|Overall Study|Lack of Efficacy|6|||
46947532|NCT03104400|83185997|FG001|Overall Study|Lack of Efficacy|3|||
46947533|NCT03104400|83185998|FG002|Overall Study|Lack of Efficacy|8|||
46947534|NCT03104400|83185999|FG003|Overall Study|Lack of Efficacy|2|||
46947535|NCT03104400|83186000|FG004|Overall Study|Lack of Efficacy|1|||
46947536|NCT03104400|83185996|FG000|Overall Study|COVID Logistical Restrictions|0|||
46947537|NCT03104400|83185997|FG001|Overall Study|COVID Logistical Restrictions|0|||
46947538|NCT03104400|83185998|FG002|Overall Study|COVID Logistical Restrictions|0|||
46947539|NCT03104400|83185999|FG003|Overall Study|COVID Logistical Restrictions|1|||
46947540|NCT03104400|83186000|FG004|Overall Study|COVID Logistical Restrictions|0|||
46947541|NCT03104400|83185996|FG000|Overall Study|Other|2|||
46947542|NCT03104400|83185997|FG001|Overall Study|Other|3|||
46947543|NCT03104400|83185998|FG002|Overall Study|Other|7|||
46947544|NCT03104400|83185999|FG003|Overall Study|Other|6|||
46947545|NCT03104400|83186000|FG004|Overall Study|Other|4|||
46947546|NCT03104400|83185996|FG000|Overall Study|Other|0|||
46947547|NCT03104400|83185997|FG001|Overall Study|Other|1|||
46947548|NCT03104400|83185998|FG002|Overall Study|Other|0|||
46947549|NCT03104400|83185999|FG003|Overall Study|Other|0|||
46947550|NCT03104400|83186000|FG004|Overall Study|Other|0|||
46947551|NCT03034044|83186023|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
46947552|NCT02878798|83186029|FG000|Overall Study|Withdrawal by Subject|5|||
46947553|NCT02878798|83186030|FG001|Overall Study|Withdrawal by Subject|4|||
46947554|NCT02878798|83186029|FG000|Overall Study|Lost to Follow-up|2|||
46947555|NCT02878798|83186030|FG001|Overall Study|Lost to Follow-up|2|||
46947556|NCT02878798|83186029|FG000|Overall Study|Protocol Violation|0|||
46947557|NCT02878798|83186030|FG001|Overall Study|Protocol Violation|1|||
46947558|NCT02854436|83186036|FG000|Overall Study|Adverse Event|1|||
46947559|NCT02854436|83186036|FG000|Overall Study|Death|208|||
46947560|NCT02854436|83186036|FG000|Overall Study|Lost to Follow-up|5|||
46947561|NCT02854436|83186036|FG000|Overall Study|Withdrawal by Subject|12|||
46947562|NCT02854436|83186036|FG000|Overall Study|Other|45|||
46947563|NCT02854436|83186036|FG000|Overall Study|Ongoing|18|||
46947564|NCT02741193|83186040|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
46947565|NCT02741193|83186040|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
46947566|NCT02725177|83186044|FG000|Overall Study|Physician Decision|4|||
46947567|NCT02725177|83186044|FG000|Overall Study|Adverse Event|1|||
46947568|NCT02488759|83186054|FG000|Overall Study|Disease progression|73|||
46947569|NCT02488759|83186055|FG001|Overall Study|Disease progression|111|||
46947570|NCT02488759|83186056|FG002|Overall Study|Disease progression|62|||
46947571|NCT02488759|83186057|FG003|Overall Study|Disease progression|7|||
46947572|NCT02488759|83186058|FG004|Overall Study|Disease progression|4|||
46947573|NCT02488759|83186059|FG005|Overall Study|Disease progression|2|||
46947574|NCT02488759|83186054|FG000|Overall Study|Study drug toxicity|11|||
46947575|NCT02488759|83186055|FG001|Overall Study|Study drug toxicity|33|||
46947576|NCT02488759|83186056|FG002|Overall Study|Study drug toxicity|31|||
46947577|NCT02488759|83186057|FG003|Overall Study|Study drug toxicity|0|||
46947578|NCT02488759|83186058|FG004|Overall Study|Study drug toxicity|0|||
46841026|NCT00237692|83058272|FG002|Overall Study|Withdrawal by Subject|10|||
46841027|NCT00237692|83058273|FG003|Overall Study|Withdrawal by Subject|4|||
46841028|NCT00237458|83058283|FG000|Overall Study|Lack of Efficacy|1|||
46947579|NCT02488759|83186059|FG005|Overall Study|Study drug toxicity|2|||
46947580|NCT02488759|83186054|FG000|Overall Study|Adverse event unrelated to study drug|9|||
46841029|NCT00237458|83058283|FG000|Overall Study|Adverse Event|1|||
46841030|NCT00237458|83058283|FG000|Overall Study|Withdrawal by Subject|1|||
46841031|NCT00265148|83058289|FG000|Overall Study|Adverse Event|2|||
46841032|NCT00265148|83058290|FG001|Overall Study|Adverse Event|2|||
46947581|NCT02488759|83186055|FG001|Overall Study|Adverse event unrelated to study drug|11|||
46947582|NCT02488759|83186056|FG002|Overall Study|Adverse event unrelated to study drug|7|||
46638929|NCT01390428|82812388|FG005|Overall Study|Elective Surgery|0|||
46771042|NCT00738582|82989259|FG000|Combination Therapy|Progressive Disease|9|||
46771043|NCT00738582|82989260|FG001|Combination Therapy|Progressive Disease|0|||
46771044|NCT00738582|82989259|FG000|Maintenance Therapy|Other|0|||
46771045|NCT00738582|82989260|FG001|Maintenance Therapy|Other|2|||
46771046|NCT00738582|82989259|FG000|Maintenance Therapy|Adverse Event|0|||
46771047|NCT00738582|82989260|FG001|Maintenance Therapy|Adverse Event|6|||
46771048|NCT00738582|82989259|FG000|Maintenance Therapy|Progressive Disease|0|||
46771049|NCT00738582|82989260|FG001|Maintenance Therapy|Progressive Disease|47|||
46771050|NCT00738582|82989259|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
46841033|NCT00265148|83058289|FG000|Overall Study|Lack of Efficacy|0|||
46841034|NCT00265148|83058290|FG001|Overall Study|Lack of Efficacy|2|||
46947583|NCT02488759|83186057|FG003|Overall Study|Adverse event unrelated to study drug|0|||
46841035|NCT00265148|83058289|FG000|Overall Study|Protocol Violation|3|||
46947584|NCT02488759|83186058|FG004|Overall Study|Adverse event unrelated to study drug|1|||
46947585|NCT02488759|83186059|FG005|Overall Study|Adverse event unrelated to study drug|0|||
46947586|NCT02488759|83186054|FG000|Overall Study|Participant request to discontinue study treatment|6|||
46947587|NCT02488759|83186055|FG001|Overall Study|Participant request to discontinue study treatment|8|||
46638930|NCT01390428|82812383|FG000|Overall Study|Withdrawal by Subject|0|||
46771051|NCT00738582|82989260|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
46947588|NCT02488759|83186056|FG002|Overall Study|Participant request to discontinue study treatment|4|||
46947589|NCT02488759|83186057|FG003|Overall Study|Participant request to discontinue study treatment|0|||
46947590|NCT02488759|83186058|FG004|Overall Study|Participant request to discontinue study treatment|0|||
46947591|NCT02488759|83186059|FG005|Overall Study|Participant request to discontinue study treatment|0|||
46947592|NCT02488759|83186054|FG000|Overall Study|Withdrawal by Subject|4|||
46947593|NCT02488759|83186055|FG001|Overall Study|Withdrawal by Subject|0|||
46947594|NCT02488759|83186056|FG002|Overall Study|Withdrawal by Subject|3|||
46947595|NCT02488759|83186057|FG003|Overall Study|Withdrawal by Subject|0|||
46947596|NCT02488759|83186058|FG004|Overall Study|Withdrawal by Subject|0|||
46947597|NCT02488759|83186059|FG005|Overall Study|Withdrawal by Subject|2|||
46947598|NCT02488759|83186054|FG000|Overall Study|Lost to Follow-up|0|||
46947599|NCT02488759|83186055|FG001|Overall Study|Lost to Follow-up|0|||
46947600|NCT02488759|83186056|FG002|Overall Study|Lost to Follow-up|2|||
46947601|NCT02488759|83186057|FG003|Overall Study|Lost to Follow-up|0|||
46947602|NCT02488759|83186058|FG004|Overall Study|Lost to Follow-up|0|||
46947603|NCT02488759|83186059|FG005|Overall Study|Lost to Follow-up|0|||
46947604|NCT02488759|83186054|FG000|Overall Study|Maximum clinical benefit|3|||
46947605|NCT02488759|83186055|FG001|Overall Study|Maximum clinical benefit|0|||
46947606|NCT02488759|83186056|FG002|Overall Study|Maximum clinical benefit|1|||
46947607|NCT02488759|83186057|FG003|Overall Study|Maximum clinical benefit|0|||
46947608|NCT02488759|83186058|FG004|Overall Study|Maximum clinical benefit|0|||
46947609|NCT02488759|83186059|FG005|Overall Study|Maximum clinical benefit|0|||
46947610|NCT02488759|83186054|FG000|Overall Study|Other reasons|7|||
46947611|NCT02488759|83186055|FG001|Overall Study|Other reasons|32|||
46947612|NCT02488759|83186056|FG002|Overall Study|Other reasons|23|||
46947613|NCT02488759|83186057|FG003|Overall Study|Other reasons|1|||
46947614|NCT02488759|83186058|FG004|Overall Study|Other reasons|1|||
46947615|NCT02488759|83186059|FG005|Overall Study|Other reasons|1|||
46947616|NCT02466685|83186075|FG000|Overall Study|Adverse Event|5|||
46947617|NCT02466685|83186076|FG001|Overall Study|Adverse Event|2|||
46947618|NCT02466685|83186075|FG000|Overall Study|Lost to Follow-up|1|||
46947619|NCT02466685|83186076|FG001|Overall Study|Lost to Follow-up|1|||
46947620|NCT02466685|83186075|FG000|Overall Study|Withdrawal by Subject|1|||
46947621|NCT02466685|83186076|FG001|Overall Study|Withdrawal by Subject|0|||
46947622|NCT02466685|83186075|FG000|Overall Study|Physician Decision|1|||
46947623|NCT02466685|83186076|FG001|Overall Study|Physician Decision|1|||
47066381|NCT01493557|83349067|FG000|Adding the Second Strategy|Other adverse event|1|||
47066382|NCT01493557|83349068|FG001|Adding the Second Strategy|Other adverse event|2|||
47066383|NCT01493557|83349069|FG002|Adding the Second Strategy|Other adverse event|0|||
47066384|NCT01493557|83349067|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
46771052|NCT00720759|82989271|FG000|Overall Study|Lost to Follow-up|0|||
46771053|NCT00720759|82989272|FG001|Overall Study|Lost to Follow-up|1|||
46771054|NCT00720759|82989273|FG002|Overall Study|Lost to Follow-up|1|||
46771055|NCT00720759|82989274|FG003|Overall Study|Lost to Follow-up|0|||
46771056|NCT00720213|82989284|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
46771057|NCT00720213|82989285|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
46771058|NCT00720213|82989286|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
46771059|NCT00810407|82989294|FG000|Overall Study|Protocol Violation|3|||
46771060|NCT00810407|82989294|FG000|Overall Study|No Visit After First Day of Treatment|3|||
46771061|NCT00720057|82989300|FG000|Overall Study|Lost to Follow-up|0|||
46771062|NCT00720057|82989301|FG001|Overall Study|Lost to Follow-up|2|||
46771063|NCT00720057|82989300|FG000|Overall Study|Protocol Violation|1|||
46771064|NCT00720057|82989301|FG001|Overall Study|Protocol Violation|0|||
46771065|NCT00720057|82989300|FG000|Overall Study|Withdrawal by Subject|0|||
46841036|NCT00265148|83058290|FG001|Overall Study|Protocol Violation|2|||
46841037|NCT00265148|83058289|FG000|Overall Study|Lost to Follow-up|0|||
46841038|NCT00265148|83058290|FG001|Overall Study|Lost to Follow-up|1|||
46841039|NCT00265148|83058289|FG000|Overall Study|Withdrawal by Subject|2|||
46841040|NCT00265148|83058290|FG001|Overall Study|Withdrawal by Subject|1|||
46841041|NCT00265148|83058289|FG000|Overall Study|Physician Decision|1|||
46841042|NCT00265148|83058290|FG001|Overall Study|Physician Decision|0|||
46841043|NCT00265148|83058289|FG000|Overall Study|Increasing frailty|0|||
46841044|NCT00265148|83058290|FG001|Overall Study|Increasing frailty|1|||
46841045|NCT00265148|83058289|FG000|Overall Study|Subject chose to change of the dose|1|||
46841046|NCT00265148|83058290|FG001|Overall Study|Subject chose to change of the dose|0|||
46947624|NCT02312206|83186087|FG000|Overall Study|Adverse Event|3|||
46947625|NCT02312206|83186088|FG001|Overall Study|Adverse Event|6|||
46947626|NCT02312206|83186087|FG000|Overall Study|Withdrawal by Subject|6|||
46947627|NCT02312206|83186088|FG001|Overall Study|Withdrawal by Subject|6|||
47066385|NCT01493557|83349068|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
46841047|NCT00043186|83058306|FG000|Overall Study|Physician Decision|0|||
46841048|NCT00043186|83058307|FG001|Overall Study|Physician Decision|0|||
46841049|NCT00043186|83058308|FG002|Overall Study|Physician Decision|3|||
46947628|NCT02312206|83186087|FG000|Overall Study|Physician Decision|7|||
46947629|NCT02312206|83186088|FG001|Overall Study|Physician Decision|6|||
46947630|NCT02312206|83186087|FG000|Overall Study|Death|31|||
47066386|NCT01493557|83349069|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
46947631|NCT02312206|83186088|FG001|Overall Study|Death|36|||
46947632|NCT02312206|83186087|FG000|Overall Study|Study Terminated by Sponsor|81|||
46947633|NCT02312206|83186088|FG001|Overall Study|Study Terminated by Sponsor|74|||
46947634|NCT02312206|83186087|FG000|Overall Study|Patient transferred to hospice|0|||
46947635|NCT02312206|83186088|FG001|Overall Study|Patient transferred to hospice|1|||
46947636|NCT02312206|83186087|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
46947637|NCT02312206|83186088|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
46947638|NCT02312206|83186087|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
46947639|NCT02312206|83186088|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
46947640|NCT02312206|83186087|FG000|Overall Study|Disease Progression|1|||
46841050|NCT00043186|83058309|FG003|Overall Study|Physician Decision|0|||
46841051|NCT00043186|83058310|FG004|Overall Study|Physician Decision|1|||
46841052|NCT00043186|83058311|FG005|Overall Study|Physician Decision|0|||
46947641|NCT02312206|83186088|FG001|Overall Study|Disease Progression|0|||
46947642|NCT02264665|83186099|FG000|Overall Study|Other|0|||
46947643|NCT02264665|83186100|FG001|Overall Study|Other|0|||
46947644|NCT02264665|83186101|FG002|Overall Study|Other|3|||
46947645|NCT02264665|83186102|FG003|Overall Study|Other|0|||
46947646|NCT02264665|83186103|FG004|Overall Study|Other|0|||
46947647|NCT02264665|83186104|FG005|Overall Study|Other|0|||
46947648|NCT02264665|83186105|FG006|Overall Study|Other|0|||
46947649|NCT02264665|83186099|FG000|Overall Study|Death|9|||
46947650|NCT02264665|83186100|FG001|Overall Study|Death|8|||
46947651|NCT02264665|83186101|FG002|Overall Study|Death|13|||
46947652|NCT02264665|83186102|FG003|Overall Study|Death|5|||
46947653|NCT02264665|83186103|FG004|Overall Study|Death|0|||
46947654|NCT02264665|83186104|FG005|Overall Study|Death|0|||
46947655|NCT02264665|83186105|FG006|Overall Study|Death|1|||
46947656|NCT02264665|83186099|FG000|Overall Study|Lost to Follow-up|1|||
46947657|NCT02264665|83186100|FG001|Overall Study|Lost to Follow-up|0|||
47066387|NCT01451749|83349078|FG000|Overall Study|Protocol Violation|14|||
46638931|NCT01390428|82812384|FG001|Overall Study|Withdrawal by Subject|0|||
46638932|NCT01390428|82812385|FG002|Overall Study|Withdrawal by Subject|1|||
46841053|NCT00043186|83058312|FG006|Overall Study|Physician Decision|0|||
46841054|NCT00043186|83058313|FG007|Overall Study|Physician Decision|1|||
46841055|NCT00043186|83058314|FG008|Overall Study|Physician Decision|1|||
46841056|NCT00043186|83058306|FG000|Overall Study|Adverse Event|2|||
46841057|NCT00043186|83058307|FG001|Overall Study|Adverse Event|2|||
46947658|NCT02264665|83186101|FG002|Overall Study|Lost to Follow-up|2|||
46947659|NCT02264665|83186102|FG003|Overall Study|Lost to Follow-up|1|||
46947660|NCT02264665|83186103|FG004|Overall Study|Lost to Follow-up|0|||
47066388|NCT01451749|83349079|FG001|Overall Study|Protocol Violation|7|||
47066389|NCT01451749|83349078|FG000|Overall Study|Lost to Follow-up|15|||
47066390|NCT01451749|83349079|FG001|Overall Study|Lost to Follow-up|5|||
47066391|NCT01451749|83349078|FG000|Overall Study|Meet the exclusion criteria,and|1|||
47066392|NCT01451749|83349079|FG001|Overall Study|Meet the exclusion criteria,and|1|||
47066393|NCT01451749|83349078|FG000|Overall Study|Adverse Event|2|||
47066394|NCT01451749|83349079|FG001|Overall Study|Adverse Event|0|||
47066395|NCT01451749|83349078|FG000|Overall Study|Withdrawal by Subject|0|||
47066396|NCT01451749|83349079|FG001|Overall Study|Withdrawal by Subject|1|||
47066397|NCT01576484|83349089|FG000|Overall Study|Adverse Event|1|||
47066398|NCT01576484|83349090|FG001|Overall Study|Adverse Event|1|||
46638933|NCT01390428|82812386|FG003|Overall Study|Withdrawal by Subject|0|||
46638934|NCT01390428|82812387|FG004|Overall Study|Withdrawal by Subject|0|||
46771066|NCT00720057|82989301|FG001|Overall Study|Withdrawal by Subject|1|||
46771067|NCT00790868|82989309|FG000|Overall Study|Withdrawal by Subject|4|||
46771068|NCT00790868|82989310|FG001|Overall Study|Withdrawal by Subject|5|||
46771069|NCT00790868|82989309|FG000|Overall Study|Lost to Follow-up|2|||
46771070|NCT00790868|82989310|FG001|Overall Study|Lost to Follow-up|12|||
46771071|NCT00719901|82989318|FG000|Overall Study|Adverse Event|5|||
46771072|NCT00719901|82989318|FG000|Overall Study|Withdrawal by Subject|1|||
46771073|NCT00719901|82989318|FG000|Overall Study|Alternate Treatment|1|||
46771074|NCT00719901|82989318|FG000|Overall Study|Disease Progression|3|||
46771075|NCT00719901|82989318|FG000|Overall Study|Availability of Study Drug|1|||
46771076|NCT00807365|82989322|FG000|Overall Study|Study Terminated|5|||
46771077|NCT00719355|82989328|FG000|Overall Study|Death|0|||
46771078|NCT00719355|82989329|FG001|Overall Study|Death|1|||
46771079|NCT00719355|82989328|FG000|Overall Study|Medical|14|||
46947661|NCT02264665|83186104|FG005|Overall Study|Lost to Follow-up|0|||
46947662|NCT02264665|83186105|FG006|Overall Study|Lost to Follow-up|0|||
46771080|NCT00719355|82989329|FG001|Overall Study|Medical|5|||
46771081|NCT00719355|82989328|FG000|Overall Study|Compliance|4|||
46771082|NCT00719355|82989329|FG001|Overall Study|Compliance|6|||
46947663|NCT02264665|83186099|FG000|Overall Study|Participant decision|0|||
46841058|NCT00043186|83058308|FG002|Overall Study|Adverse Event|2|||
46841059|NCT00043186|83058309|FG003|Overall Study|Adverse Event|3|||
46841060|NCT00043186|83058310|FG004|Overall Study|Adverse Event|2|||
46947664|NCT02264665|83186100|FG001|Overall Study|Participant decision|0|||
46947665|NCT02264665|83186101|FG002|Overall Study|Participant decision|0|||
46771083|NCT00719355|82989328|FG000|Overall Study|Moved|0|||
46841061|NCT00043186|83058311|FG005|Overall Study|Adverse Event|1|||
47066399|NCT01576484|83349089|FG000|Overall Study|Protocol Violation|0|||
47066400|NCT01576484|83349090|FG001|Overall Study|Protocol Violation|2|||
46841062|NCT00043186|83058312|FG006|Overall Study|Adverse Event|2|||
46841063|NCT00043186|83058313|FG007|Overall Study|Adverse Event|1|||
46841064|NCT00043186|83058314|FG008|Overall Study|Adverse Event|3|||
46841065|NCT00043186|83058306|FG000|Overall Study|Withdrawal by Subject|11|||
46841066|NCT00043186|83058307|FG001|Overall Study|Withdrawal by Subject|8|||
46841067|NCT00043186|83058308|FG002|Overall Study|Withdrawal by Subject|11|||
46841068|NCT00043186|83058309|FG003|Overall Study|Withdrawal by Subject|13|||
46841069|NCT00043186|83058310|FG004|Overall Study|Withdrawal by Subject|14|||
46841070|NCT00043186|83058311|FG005|Overall Study|Withdrawal by Subject|6|||
46841071|NCT00043186|83058312|FG006|Overall Study|Withdrawal by Subject|12|||
46841072|NCT00043186|83058313|FG007|Overall Study|Withdrawal by Subject|9|||
46841073|NCT00043186|83058314|FG008|Overall Study|Withdrawal by Subject|10|||
46841074|NCT00043186|83058306|FG000|Overall Study|Death|0|||
46841075|NCT00043186|83058307|FG001|Overall Study|Death|0|||
46841076|NCT00043186|83058308|FG002|Overall Study|Death|1|||
46841077|NCT00043186|83058309|FG003|Overall Study|Death|0|||
46841078|NCT00043186|83058310|FG004|Overall Study|Death|0|||
46841079|NCT00043186|83058311|FG005|Overall Study|Death|0|||
46841080|NCT00043186|83058312|FG006|Overall Study|Death|2|||
46841081|NCT00043186|83058313|FG007|Overall Study|Death|0|||
46841082|NCT00043186|83058314|FG008|Overall Study|Death|0|||
46841083|NCT00043186|83058306|FG000|Overall Study|Disease progression|1|||
46841084|NCT00043186|83058307|FG001|Overall Study|Disease progression|0|||
46841085|NCT00043186|83058308|FG002|Overall Study|Disease progression|0|||
46841086|NCT00043186|83058309|FG003|Overall Study|Disease progression|3|||
46947666|NCT02264665|83186102|FG003|Overall Study|Participant decision|1|||
46947667|NCT02264665|83186103|FG004|Overall Study|Participant decision|0|||
46947668|NCT02264665|83186104|FG005|Overall Study|Participant decision|0|||
46947669|NCT02264665|83186105|FG006|Overall Study|Participant decision|0|||
46947670|NCT02264665|83186099|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
46947671|NCT02264665|83186100|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
46947672|NCT02264665|83186101|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
46947673|NCT02264665|83186102|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
46947674|NCT02264665|83186103|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
46947675|NCT02264665|83186104|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
46947676|NCT02264665|83186105|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
46947677|NCT02264665|83186099|FG000|Overall Study|Data Missing|0|||
46947678|NCT02264665|83186100|FG001|Overall Study|Data Missing|0|||
46947679|NCT02264665|83186101|FG002|Overall Study|Data Missing|1|||
46947680|NCT02264665|83186102|FG003|Overall Study|Data Missing|0|||
46947681|NCT02264665|83186103|FG004|Overall Study|Data Missing|0|||
47066401|NCT01576484|83349089|FG000|Overall Study|Sponsor Decision|2|||
47066402|NCT01576484|83349090|FG001|Overall Study|Sponsor Decision|8|||
47066403|NCT01576484|83349089|FG000|Overall Study|Withdrawal by Subject|0|||
47066404|NCT01576484|83349090|FG001|Overall Study|Withdrawal by Subject|3|||
47066405|NCT01576484|83349089|FG000|Overall Study|Other|2|||
47066406|NCT01576484|83349090|FG001|Overall Study|Other|5|||
47066407|NCT01467505|83349100|FG000|Overall Study|Adverse Event|1|||
47066408|NCT01467505|83349101|FG001|Overall Study|Adverse Event|0|||
47066409|NCT01467505|83349100|FG000|Overall Study|Withdrawal by Subject|4|||
47066410|NCT01467505|83349101|FG001|Overall Study|Withdrawal by Subject|0|||
47066411|NCT01467505|83349100|FG000|Overall Study|Study Terminated by Sponsor|28|||
47066412|NCT01467505|83349101|FG001|Overall Study|Study Terminated by Sponsor|3|||
46841087|NCT00043186|83058310|FG004|Overall Study|Disease progression|0|||
46841088|NCT00043186|83058311|FG005|Overall Study|Disease progression|0|||
46841089|NCT00043186|83058312|FG006|Overall Study|Disease progression|0|||
46841090|NCT00043186|83058313|FG007|Overall Study|Disease progression|4|||
46841091|NCT00043186|83058314|FG008|Overall Study|Disease progression|0|||
46841092|NCT00043186|83058306|FG000|Overall Study|Ineligibility determined|0|||
46841093|NCT00043186|83058307|FG001|Overall Study|Ineligibility determined|0|||
46841094|NCT00043186|83058308|FG002|Overall Study|Ineligibility determined|0|||
46947682|NCT02264665|83186104|FG005|Overall Study|Data Missing|0|||
47066413|NCT01467271|83349107|FG000|Overall Study|Death|84|||
47066414|NCT01467271|83349107|FG000|Overall Study|Lost to Follow-up|83|||
47066415|NCT01467271|83349107|FG000|Overall Study|Retraction of patient's consent|21|||
46947683|NCT02264665|83186105|FG006|Overall Study|Data Missing|0|||
46947684|NCT02155712|83186132|FG000|Overall Study|Death|12|||
46947685|NCT02155712|83186133|FG001|Overall Study|Death|0|||
46947686|NCT02155712|83186132|FG000|Overall Study|Lost to Follow-up|37|||
46947687|NCT02155712|83186133|FG001|Overall Study|Lost to Follow-up|22|||
46947688|NCT02155712|83186132|FG000|Overall Study|Revision of device|4|||
46947689|NCT02155712|83186133|FG001|Overall Study|Revision of device|3|||
46947690|NCT02155712|83186132|FG000|Overall Study|Withdrawal by Subject|39|||
46947691|NCT02155712|83186133|FG001|Overall Study|Withdrawal by Subject|21|||
46947692|NCT02155712|83186132|FG000|Overall Study|Site termination|77|||
46947693|NCT02155712|83186133|FG001|Overall Study|Site termination|19|||
46947694|NCT02155712|83186132|FG000|Overall Study|Sponsor terminated study early|150|||
46947695|NCT02155712|83186133|FG001|Overall Study|Sponsor terminated study early|0|||
46947696|NCT02155712|83186132|FG000|Overall Study|Missed final 5-year protocol visit|0|||
46947697|NCT02155712|83186133|FG001|Overall Study|Missed final 5-year protocol visit|32|||
46947698|NCT02155712|83186132|FG000|Overall Study|Censored because surgery cancelled|6|||
46947699|NCT02155712|83186133|FG001|Overall Study|Censored because surgery cancelled|10|||
46947700|NCT02155712|83186132|FG000|Overall Study|Censored because study device was not implanted|61|||
46947701|NCT02155712|83186133|FG001|Overall Study|Censored because study device was not implanted|66|||
46947702|NCT02155712|83186132|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
46947703|NCT02155712|83186133|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
46947704|NCT01972217|83186147|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
46947705|NCT01972217|83186148|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
46947706|NCT01972217|83186149|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
46947707|NCT01972217|83186150|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
46947708|NCT01972217|83186147|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
46947709|NCT01972217|83186148|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
46947710|NCT01972217|83186149|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
46947711|NCT01972217|83186150|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
46947712|NCT01972217|83186147|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
46947713|NCT01972217|83186148|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
46947714|NCT01972217|83186149|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
46947715|NCT01972217|83186150|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
46947716|NCT01972217|83186147|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
46947717|NCT01972217|83186148|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
46947718|NCT01972217|83186149|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
46771084|NCT00719355|82989329|FG001|Overall Study|Moved|1|||
46771085|NCT00590759|82989335|FG000|Overall Study|Death|52|||
46771086|NCT00590759|82989335|FG000|Overall Study|Lost to Follow-up|28|||
46771087|NCT00734604|82989345|FG000|Overall Study|Adverse Event|0|||
46771088|NCT00734604|82989346|FG001|Overall Study|Adverse Event|2|||
46771089|NCT00734604|82989347|FG002|Overall Study|Adverse Event|0|||
46771090|NCT00734604|82989348|FG003|Overall Study|Adverse Event|2|||
46771091|NCT00734604|82989349|FG004|Overall Study|Adverse Event|1|||
46771092|NCT00734604|82989350|FG005|Overall Study|Adverse Event|1|||
46771093|NCT00734604|82989345|FG000|Overall Study|Serious Adverse Event|1|||
46771094|NCT00734604|82989346|FG001|Overall Study|Serious Adverse Event|0|||
46771095|NCT00734604|82989347|FG002|Overall Study|Serious Adverse Event|1|||
46771096|NCT00734604|82989348|FG003|Overall Study|Serious Adverse Event|2|||
46771097|NCT00734604|82989349|FG004|Overall Study|Serious Adverse Event|0|||
46771098|NCT00734604|82989350|FG005|Overall Study|Serious Adverse Event|1|||
46771099|NCT00734604|82989345|FG000|Overall Study|Lost to Follow-up|1|||
46841095|NCT00043186|83058309|FG003|Overall Study|Ineligibility determined|0|||
46841096|NCT00043186|83058310|FG004|Overall Study|Ineligibility determined|0|||
46841097|NCT00043186|83058311|FG005|Overall Study|Ineligibility determined|0|||
46841098|NCT00043186|83058312|FG006|Overall Study|Ineligibility determined|0|||
46841099|NCT00043186|83058313|FG007|Overall Study|Ineligibility determined|0|||
46841100|NCT00043186|83058314|FG008|Overall Study|Ineligibility determined|1|||
46841101|NCT00043186|83058306|FG000|Overall Study|Lost to Follow-up|3|||
46841102|NCT00043186|83058307|FG001|Overall Study|Lost to Follow-up|5|||
47066416|NCT01467271|83349107|FG000|Overall Study|Other reason|14|||
47066417|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Adverse Event|5|||
46771100|NCT00734604|82989346|FG001|Overall Study|Lost to Follow-up|2|||
46771101|NCT00734604|82989347|FG002|Overall Study|Lost to Follow-up|2|||
46841103|NCT00043186|83058308|FG002|Overall Study|Lost to Follow-up|1|||
46841104|NCT00043186|83058309|FG003|Overall Study|Lost to Follow-up|1|||
46841105|NCT00043186|83058310|FG004|Overall Study|Lost to Follow-up|1|||
46841106|NCT00043186|83058311|FG005|Overall Study|Lost to Follow-up|1|||
46841107|NCT00043186|83058312|FG006|Overall Study|Lost to Follow-up|1|||
46771102|NCT00734604|82989348|FG003|Overall Study|Lost to Follow-up|4|||
46771103|NCT00734604|82989349|FG004|Overall Study|Lost to Follow-up|2|||
46771104|NCT00734604|82989350|FG005|Overall Study|Lost to Follow-up|3|||
46841108|NCT00043186|83058313|FG007|Overall Study|Lost to Follow-up|1|||
46947719|NCT01972217|83186150|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
46947720|NCT01972217|83186147|FG000|Part B Double-blind, Randomised Period|Death|0|||
46947721|NCT01972217|83186148|FG001|Part B Double-blind, Randomised Period|Death|0|||
46947722|NCT01972217|83186149|FG002|Part B Double-blind, Randomised Period|Death|43|||
46947723|NCT01972217|83186150|FG003|Part B Double-blind, Randomised Period|Death|44|||
46947724|NCT01972217|83186147|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
46947725|NCT01972217|83186148|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
46947726|NCT01972217|83186149|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
46947727|NCT01972217|83186150|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
46947728|NCT01972217|83186147|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
46947729|NCT01972217|83186148|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
46947730|NCT01972217|83186149|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
46947731|NCT01972217|83186150|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
46947732|NCT01972217|83186147|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
46947733|NCT01972217|83186148|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
46947734|NCT01972217|83186149|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
46947735|NCT01972217|83186150|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
46947736|NCT01972217|83186147|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
46947737|NCT01972217|83186148|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
46947738|NCT01972217|83186149|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
46947739|NCT01972217|83186150|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
46947740|NCT01918007|83186173|FG000|Overall Study|Baseline oximetry not acceptable|11|||
46947741|NCT01918007|83186174|FG001|Overall Study|Baseline oximetry not acceptable|7|||
46947742|NCT01918007|83186173|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
46947743|NCT01918007|83186174|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
46947744|NCT01918007|83186173|FG000|Overall Study|Lost to Follow-up|4|||
46947745|NCT01918007|83186174|FG001|Overall Study|Lost to Follow-up|7|||
46947746|NCT01863446|83186184|FG000|Overall Study|Withdrawal by Subject|1|||
46947747|NCT01863446|83186185|FG001|Overall Study|Withdrawal by Subject|0|||
46947748|NCT01863446|83186186|FG002|Overall Study|Withdrawal by Subject|1|||
46947749|NCT01863446|83186187|FG003|Overall Study|Withdrawal by Subject|2|||
46947750|NCT01863446|83186184|FG000|Overall Study|Physician Decision|0|||
46947751|NCT01863446|83186185|FG001|Overall Study|Physician Decision|0|||
46947752|NCT01863446|83186186|FG002|Overall Study|Physician Decision|1|||
46947753|NCT01863446|83186187|FG003|Overall Study|Physician Decision|0|||
46947754|NCT01809691|83186199|FG000|Overall Study|Currently on Treatment|192|||
46947755|NCT01809691|83186200|FG001|Overall Study|Currently on Treatment|100|||
46947756|NCT01809691|83186199|FG000|Overall Study|No Protocol Treatment|10|||
46947757|NCT01809691|83186200|FG001|Overall Study|No Protocol Treatment|11|||
46947758|NCT01809691|83186199|FG000|Overall Study|Adverse Event|80|||
46947759|NCT01809691|83186200|FG001|Overall Study|Adverse Event|21|||
46947760|NCT01809691|83186199|FG000|Overall Study|Disease Progression|226|||
46947761|NCT01809691|83186200|FG001|Overall Study|Disease Progression|372|||
46947762|NCT01809691|83186199|FG000|Overall Study|Death|26|||
46947763|NCT01809691|83186200|FG001|Overall Study|Death|13|||
46947764|NCT01809691|83186199|FG000|Overall Study|Participant Refusal|70|||
46947765|NCT01809691|83186200|FG001|Overall Study|Participant Refusal|72|||
46947766|NCT01809691|83186199|FG000|Overall Study|Other, Not Specified|34|||
46947767|NCT01809691|83186200|FG001|Overall Study|Other, Not Specified|52|||
46947768|NCT01532388|83186217|FG000|3-month Follow-up|Lost to Follow-up|68|||
46947769|NCT01532388|83186218|FG001|3-month Follow-up|Lost to Follow-up|68|||
46947770|NCT01532388|83186217|FG000|6-month Follow-up|Lost to Follow-up|74|||
46947771|NCT01532388|83186218|FG001|6-month Follow-up|Lost to Follow-up|66|||
46947772|NCT01532388|83186217|FG000|12-month Follow-up|Lost to Follow-up|69|||
47066418|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Adverse Event|13|||
47066419|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Adverse Event|0|||
47066420|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
47066421|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
46947773|NCT01532388|83186218|FG001|12-month Follow-up|Lost to Follow-up|67|||
46947774|NCT01106534|83186233|FG000|Overall Study|Withdrawal by Subject|18|||
46947775|NCT01106534|83186233|FG000|Overall Study|Lost to Follow-up|2|||
46947776|NCT01106534|83186233|FG000|Overall Study|Death|16|||
46947777|NCT01106534|83186233|FG000|Overall Study|Physician Decision|1|||
46947778|NCT00961064|83186238|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
46947779|NCT00961064|83186238|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
46947780|NCT00961064|83186238|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
46947781|NCT00961064|83186238|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
46947782|NCT00961064|83186238|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
46947783|NCT00961064|83186238|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
46947784|NCT00961064|83186238|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
46947785|NCT00961064|83186238|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
46947786|NCT00321555|83186250|FG000|Overall Study|Developed antibodies|1|||
46947787|NCT00321555|83186250|FG000|Overall Study|Switched to alternative treatment|3|||
46947788|NCT00321555|83186250|FG000|Overall Study|Physician Decision|1|||
46947789|NCT00321555|83186250|FG000|Overall Study|Disease progression on study|1|||
46947790|NCT02689453|83186280|FG000|Overall Study|Progressive disease|0|||
46947791|NCT02689453|83186281|FG001|Overall Study|Progressive disease|1|||
46947792|NCT02689453|83186282|FG002|Overall Study|Progressive disease|1|||
46947793|NCT00701103|83186317|FG000|Overall Study|Adverse Event|0|||
46947794|NCT00701103|83186318|FG001|Overall Study|Adverse Event|0|||
46947795|NCT00701103|83186319|FG002|Overall Study|Adverse Event|1|||
46947796|NCT00701103|83186320|FG003|Overall Study|Adverse Event|1|||
46947797|NCT00701103|83186321|FG004|Overall Study|Adverse Event|0|||
46841109|NCT00043186|83058314|FG008|Overall Study|Lost to Follow-up|2|||
46841110|NCT00043186|83058306|FG000|Overall Study|Noncompliance|0|||
46841111|NCT00043186|83058307|FG001|Overall Study|Noncompliance|0|||
46841112|NCT00043186|83058308|FG002|Overall Study|Noncompliance|1|||
46841113|NCT00043186|83058309|FG003|Overall Study|Noncompliance|1|||
46841114|NCT00043186|83058310|FG004|Overall Study|Noncompliance|0|||
46841115|NCT00043186|83058311|FG005|Overall Study|Noncompliance|0|||
46841116|NCT00043186|83058312|FG006|Overall Study|Noncompliance|0|||
46841117|NCT00043186|83058313|FG007|Overall Study|Noncompliance|0|||
46841118|NCT00043186|83058314|FG008|Overall Study|Noncompliance|0|||
46841119|NCT00043186|83058306|FG000|Overall Study|Other|0|||
46841120|NCT00043186|83058307|FG001|Overall Study|Other|0|||
46841121|NCT00043186|83058308|FG002|Overall Study|Other|1|||
46841122|NCT00043186|83058309|FG003|Overall Study|Other|1|||
46841123|NCT00043186|83058310|FG004|Overall Study|Other|0|||
46841124|NCT00043186|83058311|FG005|Overall Study|Other|0|||
46841125|NCT00043186|83058312|FG006|Overall Study|Other|0|||
46841126|NCT00043186|83058313|FG007|Overall Study|Other|0|||
46841127|NCT00043186|83058314|FG008|Overall Study|Other|0|||
46841128|NCT00041470|83058335|FG000|Overall Study|Loss of Funding|38|||
46841129|NCT00206102|83058341|FG000|Overall Study|Adverse Event|119|||
46841130|NCT00206102|83058342|FG001|Overall Study|Adverse Event|82|||
46841131|NCT00206102|83058341|FG000|Overall Study|Protocol Violation|0|||
46841132|NCT00206102|83058342|FG001|Overall Study|Protocol Violation|2|||
46841133|NCT00206102|83058341|FG000|Overall Study|Lack of therapeutic response|16|||
46841134|NCT00206102|83058342|FG001|Overall Study|Lack of therapeutic response|11|||
46841135|NCT00206102|83058341|FG000|Overall Study|Lost to Follow-up|95|||
46841136|NCT00206102|83058342|FG001|Overall Study|Lost to Follow-up|66|||
46841137|NCT00206102|83058341|FG000|Overall Study|Withdrawal by Subject|118|||
46841138|NCT00206102|83058342|FG001|Overall Study|Withdrawal by Subject|101|||
46841139|NCT00206102|83058341|FG000|Overall Study|Study-specific discontinuation criteria|18|||
46841140|NCT00206102|83058342|FG001|Overall Study|Study-specific discontinuation criteria|17|||
46841141|NCT00206102|83058341|FG000|Overall Study|None of those categories|42|||
46841142|NCT00206102|83058342|FG001|Overall Study|None of those categories|36|||
46841143|NCT00041080|83058350|FG000|Overall Study|Adverse Event|21|||
46841144|NCT00041080|83058351|FG001|Overall Study|Adverse Event|1|||
46841145|NCT00041080|83058350|FG000|Overall Study|Withdrawal by Subject|6|||
46841146|NCT00041080|83058351|FG001|Overall Study|Withdrawal by Subject|6|||
46841147|NCT00041080|83058350|FG000|Overall Study|Concommitant Illness/Other|1|||
46841148|NCT00041080|83058351|FG001|Overall Study|Concommitant Illness/Other|2|||
46841149|NCT00041080|83058350|FG000|Overall Study|Did not start therapy|1|||
46841150|NCT00041080|83058351|FG001|Overall Study|Did not start therapy|1|||
46841151|NCT00041080|83058350|FG000|Overall Study|Ineligible|1|||
46841152|NCT00041080|83058351|FG001|Overall Study|Ineligible|0|||
46947798|NCT00701103|83186322|FG005|Overall Study|Adverse Event|1|||
46947799|NCT00701103|83186323|FG006|Overall Study|Adverse Event|1|||
46947800|NCT00701103|83186324|FG007|Overall Study|Adverse Event|0|||
46947801|NCT00701103|83186325|FG008|Overall Study|Adverse Event|0|||
47066422|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
47066423|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
47066424|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
47066425|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
47066426|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
47066427|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
47066428|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
46841153|NCT00205712|83058359|FG000|Overall Study|Lost to Follow-up|0|||
46841154|NCT00205712|83058360|FG001|Overall Study|Lost to Follow-up|1|||
46841155|NCT00203294|83058370|FG000|Overall Study|Withdrawal by Subject|8|||
46947802|NCT00701103|83186326|FG009|Overall Study|Adverse Event|2|||
47066429|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
47066430|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
46841156|NCT00203294|83058371|FG001|Overall Study|Withdrawal by Subject|13|||
46947803|NCT00701103|83186327|FG010|Overall Study|Adverse Event|0|||
46947804|NCT00701103|83186317|FG000|Overall Study|Progressive Disease|5|||
47066431|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
47066432|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
46947805|NCT00701103|83186318|FG001|Overall Study|Progressive Disease|2|||
46947806|NCT00701103|83186319|FG002|Overall Study|Progressive Disease|6|||
46947807|NCT00701103|83186320|FG003|Overall Study|Progressive Disease|5|||
46947808|NCT00701103|83186321|FG004|Overall Study|Progressive Disease|6|||
46947809|NCT00701103|83186322|FG005|Overall Study|Progressive Disease|5|||
46947810|NCT00701103|83186323|FG006|Overall Study|Progressive Disease|7|||
46947811|NCT00701103|83186324|FG007|Overall Study|Progressive Disease|7|||
46947812|NCT00701103|83186325|FG008|Overall Study|Progressive Disease|8|||
46947813|NCT00701103|83186326|FG009|Overall Study|Progressive Disease|8|||
46947814|NCT00701103|83186327|FG010|Overall Study|Progressive Disease|11|||
46947815|NCT00701103|83186317|FG000|Overall Study|Withdrawal by Subject|0|||
46947816|NCT00701103|83186318|FG001|Overall Study|Withdrawal by Subject|1|||
46947817|NCT00701103|83186319|FG002|Overall Study|Withdrawal by Subject|1|||
46947818|NCT00701103|83186320|FG003|Overall Study|Withdrawal by Subject|0|||
46947819|NCT00701103|83186321|FG004|Overall Study|Withdrawal by Subject|0|||
46947820|NCT00701103|83186322|FG005|Overall Study|Withdrawal by Subject|0|||
46947821|NCT00701103|83186323|FG006|Overall Study|Withdrawal by Subject|0|||
46947822|NCT00701103|83186324|FG007|Overall Study|Withdrawal by Subject|0|||
46947823|NCT00701103|83186325|FG008|Overall Study|Withdrawal by Subject|0|||
46947824|NCT00701103|83186326|FG009|Overall Study|Withdrawal by Subject|0|||
46947825|NCT00701103|83186327|FG010|Overall Study|Withdrawal by Subject|0|||
46947826|NCT00701103|83186317|FG000|Overall Study|Other|0|||
46947827|NCT00701103|83186318|FG001|Overall Study|Other|0|||
47066433|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
46947828|NCT00701103|83186319|FG002|Overall Study|Other|0|||
46947829|NCT00701103|83186320|FG003|Overall Study|Other|0|||
46947830|NCT00701103|83186321|FG004|Overall Study|Other|0|||
46947831|NCT00701103|83186322|FG005|Overall Study|Other|0|||
46947832|NCT00701103|83186323|FG006|Overall Study|Other|0|||
46947833|NCT00701103|83186324|FG007|Overall Study|Other|0|||
46947834|NCT00701103|83186325|FG008|Overall Study|Other|1|||
46947835|NCT00701103|83186326|FG009|Overall Study|Other|1|||
46947836|NCT00701103|83186327|FG010|Overall Study|Other|0|||
46947837|NCT01369225|83186361|FG000|Overall Study|Withdrawal by Subject|1|||
46947838|NCT01369225|83186362|FG001|Overall Study|Withdrawal by Subject|0|||
46947839|NCT01369225|83186363|FG002|Overall Study|Withdrawal by Subject|2|||
46947840|NCT01369225|83186364|FG003|Overall Study|Withdrawal by Subject|1|||
46947841|NCT01369225|83186365|FG004|Overall Study|Withdrawal by Subject|0|||
46947842|NCT01369225|83186366|FG005|Overall Study|Withdrawal by Subject|0|||
46947843|NCT01369225|83186361|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
46947844|NCT01369225|83186362|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
46841157|NCT00264290|83058379|FG000|Intervention (8 Weeks)|Adverse Event|1|||
46841158|NCT00264290|83058380|FG001|Intervention (8 Weeks)|Adverse Event|0|||
46841159|NCT00234494|83058390|FG000|Overall Study|Protocol Violation|2|||
46841160|NCT00234104|83058398|FG000|Overall Study|Adverse Event|4|||
46841161|NCT00234104|83058399|FG001|Overall Study|Adverse Event|0|||
46841162|NCT00234104|83058400|FG002|Overall Study|Adverse Event|3|||
46841163|NCT00234104|83058401|FG003|Overall Study|Adverse Event|5|||
46841164|NCT00234104|83058398|FG000|Overall Study|Protocol Violation|0|||
46841165|NCT00234104|83058399|FG001|Overall Study|Protocol Violation|0|||
46841166|NCT00234104|83058400|FG002|Overall Study|Protocol Violation|0|||
46841167|NCT00234104|83058401|FG003|Overall Study|Protocol Violation|1|||
46841168|NCT00234104|83058398|FG000|Overall Study|Physician Decision|0|||
46841169|NCT00234104|83058399|FG001|Overall Study|Physician Decision|1|||
46841170|NCT00234104|83058400|FG002|Overall Study|Physician Decision|2|||
46841171|NCT00234104|83058401|FG003|Overall Study|Physician Decision|2|||
46841172|NCT00263666|83058413|FG000|Overall Study|Adverse Event|6|||
46841173|NCT00263666|83058414|FG001|Overall Study|Adverse Event|8|||
46841174|NCT00263666|83058413|FG000|Overall Study|Lost to Follow-up|1|||
46841175|NCT00263666|83058414|FG001|Overall Study|Lost to Follow-up|2|||
46841176|NCT00263666|83058413|FG000|Overall Study|Withdrawal by Subject|0|||
46841177|NCT00263666|83058414|FG001|Overall Study|Withdrawal by Subject|1|||
46841178|NCT00195338|83058420|FG000|Overall Study|Lost to Follow-up|2|||
46947845|NCT01369225|83186363|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
46947846|NCT01369225|83186364|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
46947847|NCT01369225|83186365|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
46841179|NCT00195338|83058420|FG000|Overall Study|Adverse Event|5|||
46947848|NCT01369225|83186366|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
46841180|NCT00195338|83058420|FG000|Overall Study|Lack of Efficacy|1|||
46841181|NCT00195338|83058420|FG000|Overall Study|Early closure of the site|4|||
46841182|NCT00035932|83058427|FG000|Overall Study|Adverse Event|10|||
46841183|NCT00035932|83058428|FG001|Overall Study|Adverse Event|9|||
46841184|NCT00035932|83058429|FG002|Overall Study|Adverse Event|9|||
46841185|NCT00035932|83058427|FG000|Overall Study|Death|0|||
46947849|NCT01369225|83186361|FG000|Overall Study|Other|1|||
46947850|NCT01369225|83186362|FG001|Overall Study|Other|0|||
46947851|NCT01369225|83186363|FG002|Overall Study|Other|0|||
46947852|NCT01369225|83186364|FG003|Overall Study|Other|0|||
46947853|NCT01369225|83186365|FG004|Overall Study|Other|1|||
46947854|NCT01369225|83186366|FG005|Overall Study|Other|0|||
46947855|NCT01369225|83186361|FG000|Overall Study|Adverse Event|0|||
46841186|NCT00035932|83058428|FG001|Overall Study|Death|0|||
46841187|NCT00035932|83058429|FG002|Overall Study|Death|1|||
46841188|NCT00035932|83058427|FG000|Overall Study|Disease Progression / Relapse|1|||
46841189|NCT00035932|83058428|FG001|Overall Study|Disease Progression / Relapse|1|||
46841190|NCT00035932|83058429|FG002|Overall Study|Disease Progression / Relapse|0|||
46841191|NCT00035932|83058427|FG000|Overall Study|Lost to Follow-up|4|||
46841192|NCT00035932|83058428|FG001|Overall Study|Lost to Follow-up|4|||
46841193|NCT00035932|83058429|FG002|Overall Study|Lost to Follow-up|3|||
46841194|NCT00035932|83058427|FG000|Overall Study|Noncompliance|6|||
46841195|NCT00035932|83058428|FG001|Overall Study|Noncompliance|7|||
46841196|NCT00035932|83058429|FG002|Overall Study|Noncompliance|6|||
46841197|NCT00035932|83058427|FG000|Overall Study|Protocol Violation While on Study|0|||
46841198|NCT00035932|83058428|FG001|Overall Study|Protocol Violation While on Study|1|||
46841199|NCT00035932|83058429|FG002|Overall Study|Protocol Violation While on Study|2|||
46841200|NCT00035932|83058427|FG000|Overall Study|Withdrawal by Subject|1|||
46841201|NCT00035932|83058428|FG001|Overall Study|Withdrawal by Subject|5|||
46841202|NCT00035932|83058429|FG002|Overall Study|Withdrawal by Subject|0|||
46841203|NCT00035932|83058427|FG000|Overall Study|Study Termination by Sponsor|1|||
46841204|NCT00035932|83058428|FG001|Overall Study|Study Termination by Sponsor|0|||
46841205|NCT00035932|83058429|FG002|Overall Study|Study Termination by Sponsor|0|||
46841206|NCT00035932|83058427|FG000|Overall Study|Lack of Efficacy|33|||
46841207|NCT00035932|83058428|FG001|Overall Study|Lack of Efficacy|33|||
46841208|NCT00035932|83058429|FG002|Overall Study|Lack of Efficacy|28|||
46841209|NCT00022516|83058444|FG000|Overall Study|Adverse Event|0|||
46841210|NCT00022516|83058445|FG001|Overall Study|Adverse Event|59|||
46841211|NCT00022516|83058444|FG000|Overall Study|Lack of Efficacy|0|||
46841212|NCT00022516|83058445|FG001|Overall Study|Lack of Efficacy|27|||
46841213|NCT00022516|83058444|FG000|Overall Study|Physician Decision|0|||
46841214|NCT00022516|83058445|FG001|Overall Study|Physician Decision|1|||
46841215|NCT00022516|83058444|FG000|Overall Study|Protocol Violation|1|||
46841216|NCT00022516|83058445|FG001|Overall Study|Protocol Violation|3|||
46841217|NCT00022516|83058444|FG000|Overall Study|Withdrawal by Subject|2|||
46841218|NCT00022516|83058445|FG001|Overall Study|Withdrawal by Subject|113|||
46841219|NCT00022516|83058444|FG000|Overall Study|Incomplete documentation|0|||
46841220|NCT00022516|83058445|FG001|Overall Study|Incomplete documentation|27|||
46841221|NCT00033514|83058453|FG000|Overall Study|Lost to Follow-up|1|||
46841222|NCT00033514|83058454|FG001|Overall Study|Lost to Follow-up|1|||
46841223|NCT00033514|83058453|FG000|Overall Study|Withdrawal by Subject|0|||
46841224|NCT00033514|83058454|FG001|Overall Study|Withdrawal by Subject|3|||
46841225|NCT00006916|83058461|FG000|Overall Study|Device not inserted|4|||
46841226|NCT00006916|83058461|FG000|Overall Study|Complication of device insertion|1|||
46841227|NCT00454649|83058475|FG000|Overall Study|Lack of Efficacy|2|||
46841228|NCT00454649|83058476|FG001|Overall Study|Lack of Efficacy|2|||
46841229|NCT00454649|83058477|FG002|Overall Study|Lack of Efficacy|10|||
46841230|NCT00454649|83058478|FG003|Overall Study|Lack of Efficacy|3|||
46841231|NCT00454649|83058479|FG004|Overall Study|Lack of Efficacy|0|||
46841232|NCT00454649|83058480|FG005|Overall Study|Lack of Efficacy|4|||
46841233|NCT00454649|83058481|FG006|Overall Study|Lack of Efficacy|5|||
46841234|NCT00454649|83058482|FG007|Overall Study|Lack of Efficacy|13|||
46841235|NCT00454649|83058483|FG008|Overall Study|Lack of Efficacy|10|||
46841236|NCT00454649|83058484|FG009|Overall Study|Lack of Efficacy|2|||
46841237|NCT00454649|83058475|FG000|Overall Study|Adverse Event|0|||
46841238|NCT00454649|83058476|FG001|Overall Study|Adverse Event|1|||
46841239|NCT00454649|83058477|FG002|Overall Study|Adverse Event|3|||
46841240|NCT00454649|83058478|FG003|Overall Study|Adverse Event|0|||
46841241|NCT00454649|83058479|FG004|Overall Study|Adverse Event|1|||
46841242|NCT00454649|83058480|FG005|Overall Study|Adverse Event|2|||
46841243|NCT00454649|83058481|FG006|Overall Study|Adverse Event|3|||
46841244|NCT00454649|83058482|FG007|Overall Study|Adverse Event|4|||
46841245|NCT00454649|83058483|FG008|Overall Study|Adverse Event|6|||
46841246|NCT00454649|83058484|FG009|Overall Study|Adverse Event|2|||
46638935|NCT01390428|82812388|FG005|Overall Study|Withdrawal by Subject|0|||
46841247|NCT00454649|83058475|FG000|Overall Study|Lost to Follow-up|0|||
46841248|NCT00454649|83058476|FG001|Overall Study|Lost to Follow-up|0|||
46841249|NCT00454649|83058477|FG002|Overall Study|Lost to Follow-up|1|||
46841250|NCT00454649|83058478|FG003|Overall Study|Lost to Follow-up|0|||
46841251|NCT00454649|83058479|FG004|Overall Study|Lost to Follow-up|0|||
46841252|NCT00454649|83058480|FG005|Overall Study|Lost to Follow-up|0|||
46841253|NCT00454649|83058481|FG006|Overall Study|Lost to Follow-up|1|||
46841254|NCT00454649|83058482|FG007|Overall Study|Lost to Follow-up|0|||
46841255|NCT00454649|83058483|FG008|Overall Study|Lost to Follow-up|0|||
46841256|NCT00454649|83058484|FG009|Overall Study|Lost to Follow-up|0|||
46841257|NCT00454649|83058475|FG000|Overall Study|Other|1|||
46841258|NCT00454649|83058476|FG001|Overall Study|Other|1|||
46841259|NCT00454649|83058477|FG002|Overall Study|Other|5|||
46841260|NCT00454649|83058478|FG003|Overall Study|Other|3|||
46841261|NCT00454649|83058479|FG004|Overall Study|Other|0|||
46841262|NCT00454649|83058480|FG005|Overall Study|Other|0|||
46841263|NCT00454649|83058481|FG006|Overall Study|Other|0|||
46947856|NCT01369225|83186362|FG001|Overall Study|Adverse Event|0|||
46947857|NCT01369225|83186363|FG002|Overall Study|Adverse Event|0|||
46947858|NCT01369225|83186364|FG003|Overall Study|Adverse Event|1|||
46947859|NCT01369225|83186365|FG004|Overall Study|Adverse Event|1|||
46947860|NCT01369225|83186366|FG005|Overall Study|Adverse Event|0|||
46947861|NCT02639546|83186388|FG000|Overall Study|Death|2|||
46947862|NCT02639546|83186389|FG001|Overall Study|Death|2|||
46947863|NCT02639546|83186390|FG002|Overall Study|Death|1|||
46947864|NCT02639546|83186391|FG003|Overall Study|Death|2|||
46947865|NCT02639546|83186392|FG004|Overall Study|Death|2|||
46947866|NCT02639546|83186393|FG005|Overall Study|Death|2|||
46947867|NCT02639546|83186394|FG006|Overall Study|Death|0|||
46947868|NCT02639546|83186395|FG007|Overall Study|Death|0|||
46947869|NCT02639546|83186388|FG000|Overall Study|Lost to Follow-up|0|||
46947870|NCT02639546|83186389|FG001|Overall Study|Lost to Follow-up|0|||
46947871|NCT02639546|83186390|FG002|Overall Study|Lost to Follow-up|1|||
46947872|NCT02639546|83186391|FG003|Overall Study|Lost to Follow-up|0|||
46947873|NCT02639546|83186392|FG004|Overall Study|Lost to Follow-up|1|||
46947874|NCT02639546|83186393|FG005|Overall Study|Lost to Follow-up|1|||
46947875|NCT02639546|83186394|FG006|Overall Study|Lost to Follow-up|0|||
46947876|NCT02639546|83186395|FG007|Overall Study|Lost to Follow-up|1|||
46947877|NCT02639546|83186388|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
46947878|NCT02639546|83186389|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
46947879|NCT02639546|83186390|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
46947880|NCT02639546|83186391|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
46947881|NCT02639546|83186392|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
46947882|NCT02639546|83186393|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
46947883|NCT02639546|83186394|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
46947884|NCT02639546|83186395|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
46947885|NCT02639546|83186388|FG000|Overall Study|Study Terminated By Sponsor|0|||
46947886|NCT02639546|83186389|FG001|Overall Study|Study Terminated By Sponsor|2|||
46771105|NCT00734604|82989345|FG000|Overall Study|Physician Decision|0|||
46771106|NCT00734604|82989346|FG001|Overall Study|Physician Decision|1|||
46771107|NCT00734604|82989347|FG002|Overall Study|Physician Decision|1|||
46771108|NCT00734604|82989348|FG003|Overall Study|Physician Decision|0|||
46771109|NCT00734604|82989349|FG004|Overall Study|Physician Decision|0|||
46771110|NCT00734604|82989350|FG005|Overall Study|Physician Decision|0|||
46947887|NCT02639546|83186390|FG002|Overall Study|Study Terminated By Sponsor|3|||
46947888|NCT02639546|83186391|FG003|Overall Study|Study Terminated By Sponsor|4|||
46947889|NCT02639546|83186392|FG004|Overall Study|Study Terminated By Sponsor|4|||
46947890|NCT02639546|83186393|FG005|Overall Study|Study Terminated By Sponsor|3|||
46947891|NCT02639546|83186394|FG006|Overall Study|Study Terminated By Sponsor|3|||
46947892|NCT02639546|83186395|FG007|Overall Study|Study Terminated By Sponsor|9|||
46947893|NCT02639546|83186388|FG000|Overall Study|Withdrawal by Subject|2|||
46947894|NCT02639546|83186389|FG001|Overall Study|Withdrawal by Subject|2|||
46947895|NCT02639546|83186390|FG002|Overall Study|Withdrawal by Subject|1|||
46947896|NCT02639546|83186391|FG003|Overall Study|Withdrawal by Subject|0|||
46947897|NCT02639546|83186392|FG004|Overall Study|Withdrawal by Subject|0|||
46947898|NCT02639546|83186393|FG005|Overall Study|Withdrawal by Subject|1|||
46947899|NCT02639546|83186394|FG006|Overall Study|Withdrawal by Subject|2|||
46947900|NCT02639546|83186395|FG007|Overall Study|Withdrawal by Subject|1|||
46947901|NCT02639390|83186429|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
47066434|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
47066435|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Physician Decision|2|||
46841264|NCT00454649|83058482|FG007|Overall Study|Other|0|||
46841265|NCT00454649|83058483|FG008|Overall Study|Other|3|||
46841266|NCT00454649|83058484|FG009|Overall Study|Other|1|||
46841267|NCT00454649|83058475|FG000|Overall Study|Withdrawal by Subject|0|||
46841268|NCT00454649|83058476|FG001|Overall Study|Withdrawal by Subject|0|||
46841269|NCT00454649|83058477|FG002|Overall Study|Withdrawal by Subject|0|||
46841270|NCT00454649|83058478|FG003|Overall Study|Withdrawal by Subject|0|||
46841271|NCT00454649|83058479|FG004|Overall Study|Withdrawal by Subject|0|||
46947902|NCT02639390|83186430|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
46947903|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
46841272|NCT00454649|83058480|FG005|Overall Study|Withdrawal by Subject|1|||
46947904|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
46841273|NCT00454649|83058481|FG006|Overall Study|Withdrawal by Subject|0|||
46947905|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
46947906|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
46947907|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
46947908|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
46947909|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
46947910|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
46967868|NCT05091307|83210483|FG000|Overall Study|Physician Decision|1|||
46771111|NCT00734604|82989345|FG000|Overall Study|Protocol Violation|0|||
46947911|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
46947912|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
46947913|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
46947914|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
46947915|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
46947916|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
46947917|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
46947918|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
46947919|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
46947920|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
46947921|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
46947922|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
46947923|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
46947924|NCT02718417|83186439|FG000|Chemotherapy Phase (CP)|Other|2|||
46947925|NCT02718417|83186440|FG001|Chemotherapy Phase (CP)|Other|0|||
46947926|NCT02718417|83186441|FG002|Chemotherapy Phase (CP)|Other|1|||
46947927|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Adverse Event|21|||
46947928|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Adverse Event|26|||
46947929|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Adverse Event|0|||
46947930|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
46638936|NCT01430130|82812402|FG000|Overall Study|Lost to Follow-up|1|||
46771112|NCT00734604|82989346|FG001|Overall Study|Protocol Violation|2|||
46771113|NCT00734604|82989347|FG002|Overall Study|Protocol Violation|0|||
46771114|NCT00734604|82989348|FG003|Overall Study|Protocol Violation|0|||
46771115|NCT00734604|82989349|FG004|Overall Study|Protocol Violation|1|||
46841274|NCT00454649|83058482|FG007|Overall Study|Withdrawal by Subject|2|||
46841275|NCT00454649|83058483|FG008|Overall Study|Withdrawal by Subject|1|||
46841276|NCT00454649|83058484|FG009|Overall Study|Withdrawal by Subject|0|||
46841277|NCT00454571|83058527|FG000|Overall Study|Adverse Event|2|||
46841278|NCT00454571|83058528|FG001|Overall Study|Adverse Event|0|||
46841279|NCT00454571|83058527|FG000|Overall Study|Physician Decision|0|||
46841280|NCT00454571|83058528|FG001|Overall Study|Physician Decision|1|||
46841281|NCT00454571|83058527|FG000|Overall Study|Protocol Violation|1|||
46841282|NCT00454571|83058528|FG001|Overall Study|Protocol Violation|0|||
46841283|NCT00454571|83058527|FG000|Overall Study|Withdrawal by Subject|10|||
46841284|NCT00454571|83058528|FG001|Overall Study|Withdrawal by Subject|5|||
46841285|NCT03837743|83058534|FG000|Overall Study|Adverse Event|1|||
46841286|NCT03837743|83058534|FG000|Overall Study|Withdrawal by Subject|2|||
46841287|NCT03836729|83058542|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
46841288|NCT00443729|83058552|FG000|Overall Study|Never Treated|0|||
46841289|NCT00443729|83058553|FG001|Overall Study|Never Treated|1|||
46841290|NCT00443729|83058552|FG000|Overall Study|Lack of Efficacy|4|||
46841291|NCT00443729|83058553|FG001|Overall Study|Lack of Efficacy|2|||
46841292|NCT00443729|83058552|FG000|Overall Study|Lost to Follow-up|0|||
46841293|NCT00443729|83058553|FG001|Overall Study|Lost to Follow-up|1|||
46841294|NCT00443729|83058552|FG000|Overall Study|Physician Decision|2|||
46841295|NCT00443729|83058553|FG001|Overall Study|Physician Decision|1|||
46841296|NCT00443729|83058552|FG000|Overall Study|Protocol Violation|1|||
46841297|NCT00443729|83058553|FG001|Overall Study|Protocol Violation|1|||
46841298|NCT00443729|83058552|FG000|Overall Study|Withdrawal by Subject|3|||
46841299|NCT00443729|83058553|FG001|Overall Study|Withdrawal by Subject|1|||
46841300|NCT00443651|83058561|FG000|Overall Study|Death|1|||
46841301|NCT00443651|83058562|FG001|Overall Study|Death|5|||
46841302|NCT00443651|83058561|FG000|Overall Study|Adverse Event|5|||
46841303|NCT00443651|83058562|FG001|Overall Study|Adverse Event|6|||
46841304|NCT00443651|83058561|FG000|Overall Study|Lost to Follow-up|18|||
46947931|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
46771116|NCT00734604|82989350|FG005|Overall Study|Protocol Violation|0|||
46771117|NCT00734604|82989345|FG000|Overall Study|Sponsor Decision|1|||
46771118|NCT00734604|82989346|FG001|Overall Study|Sponsor Decision|2|||
46771119|NCT00734604|82989347|FG002|Overall Study|Sponsor Decision|1|||
46771120|NCT00734604|82989348|FG003|Overall Study|Sponsor Decision|0|||
46841305|NCT00443651|83058562|FG001|Overall Study|Lost to Follow-up|12|||
46947932|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
46947933|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
46947934|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
46638937|NCT01430130|82812402|FG000|Overall Study|Infection on Control Side of Incision|1|||
46771121|NCT00734604|82989349|FG004|Overall Study|Sponsor Decision|2|||
46841306|NCT00443651|83058561|FG000|Overall Study|Patient's/Guardian's Decision|58|||
46841307|NCT00443651|83058562|FG001|Overall Study|Patient's/Guardian's Decision|30|||
46841308|NCT00443651|83058561|FG000|Overall Study|Physician Decision|13|||
46771122|NCT00734604|82989350|FG005|Overall Study|Sponsor Decision|0|||
46841309|NCT00443651|83058562|FG001|Overall Study|Physician Decision|4|||
46841310|NCT00443651|83058561|FG000|Overall Study|Pregnancy|0|||
46841311|NCT00443651|83058562|FG001|Overall Study|Pregnancy|1|||
46841312|NCT00443261|83058568|FG000|Overall Study|Death|1|||
46947935|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
46947936|NCT02718417|83186439|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
46947937|NCT02718417|83186440|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
46947938|NCT02718417|83186441|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
46947939|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Physician's decision|6|||
46947940|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Physician's decision|7|||
46947941|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Physician's decision|0|||
46947942|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Progressive disease|100|||
46947943|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Progressive disease|88|||
47066436|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Physician Decision|3|||
46771123|NCT00734604|82989345|FG000|Overall Study|Withdrawal by Subject|0|||
46771124|NCT00734604|82989346|FG001|Overall Study|Withdrawal by Subject|2|||
46771125|NCT00734604|82989347|FG002|Overall Study|Withdrawal by Subject|0|||
46841313|NCT00439517|83058574|FG000|Overall Study|Subject on treatment|1|||
46841314|NCT00439517|83058575|FG001|Overall Study|Subject on treatment|0|||
46841315|NCT00439517|83058574|FG000|Overall Study|Subject in survival follow-up|1|||
46841316|NCT00439517|83058575|FG001|Overall Study|Subject in survival follow-up|0|||
46841317|NCT00438815|83058581|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
46841318|NCT00438815|83058581|FG000|Overall Study|3-month follow-up no longer required|12|||
46841319|NCT00438815|83058581|FG000|Overall Study|Noncompliance with protocol requirements|9|||
46841320|NCT00438815|83058581|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
46841321|NCT00438815|83058581|FG000|Overall Study|Lost to Follow-up|6|||
46841322|NCT00438815|83058581|FG000|Overall Study|Withdrawal by Subject|6|||
46841323|NCT00438815|83058581|FG000|Overall Study|Death|1|||
46841324|NCT00438659|83058587|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
46841325|NCT00438659|83058588|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
46841326|NCT00438659|83058587|FG000|Overall Study|Cancel|5|||
46841327|NCT00438659|83058588|FG001|Overall Study|Cancel|2|||
46841328|NCT00437645|83058597|FG000|Overall Study|Adverse Event|15|||
46841329|NCT00437645|83058598|FG001|Overall Study|Adverse Event|84|||
46841330|NCT00437645|83058597|FG000|Overall Study|Withdrawal by Subject|10|||
46841331|NCT00437645|83058598|FG001|Overall Study|Withdrawal by Subject|22|||
46841332|NCT00437645|83058597|FG000|Overall Study|Protocol Violation|3|||
46771126|NCT00734604|82989348|FG003|Overall Study|Withdrawal by Subject|1|||
46771127|NCT00734604|82989349|FG004|Overall Study|Withdrawal by Subject|2|||
46771128|NCT00734604|82989350|FG005|Overall Study|Withdrawal by Subject|1|||
46771129|NCT00734604|82989345|FG000|Overall Study|Lack of Efficacy|0|||
46771130|NCT00734604|82989346|FG001|Overall Study|Lack of Efficacy|1|||
46771131|NCT00734604|82989347|FG002|Overall Study|Lack of Efficacy|1|||
46771132|NCT00734604|82989348|FG003|Overall Study|Lack of Efficacy|0|||
46771133|NCT00734604|82989349|FG004|Overall Study|Lack of Efficacy|0|||
46771134|NCT00734604|82989350|FG005|Overall Study|Lack of Efficacy|0|||
46771135|NCT00590681|82989361|FG000|Overall Study|Withdrawal by Subject|7|||
46771136|NCT00590681|82989361|FG000|Overall Study|Adverse Event|8|||
46771137|NCT00590681|82989361|FG000|Overall Study|Death|3|||
46771138|NCT00590681|82989361|FG000|Overall Study|Lost to Follow-up|1|||
46771139|NCT00590681|82989361|FG000|Overall Study|disease progression|1|||
46771140|NCT00727272|82989365|FG000|Washout Period A|Adverse Event|0|||
46771141|NCT00727272|82989366|FG001|Washout Period A|Adverse Event|0|||
46771142|NCT00727272|82989367|FG002|Washout Period A|Adverse Event|1|||
46771143|NCT00727272|82989365|FG000|Washout Period B|Withdrawal by Subject|0|||
46771144|NCT00727272|82989366|FG001|Washout Period B|Withdrawal by Subject|0|||
46771145|NCT00727272|82989367|FG002|Washout Period B|Withdrawal by Subject|1|||
46771146|NCT00805025|82989377|FG000|Overall Study|Screened but not enrolled/treated|42|||
46771147|NCT00805025|82989377|FG000|Overall Study|Adverse Event|4|||
46771148|NCT00805025|82989377|FG000|Overall Study|Withdrawal by Subject|2|||
46841333|NCT00437645|83058598|FG001|Overall Study|Protocol Violation|3|||
46841334|NCT00437645|83058597|FG000|Overall Study|Lost to Follow-up|2|||
47066437|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Physician Decision|0|||
47066438|NCT01449929|83349113|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
47066439|NCT01449929|83349114|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
47066440|NCT01449929|83349115|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
47066441|NCT01449929|83349113|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
46771149|NCT00805025|82989377|FG000|Overall Study|Physician Decision|1|||
46771150|NCT00734214|82989383|FG000|Overall Study|Withdrawal by Subject|3|||
46771151|NCT00734214|82989384|FG001|Overall Study|Withdrawal by Subject|4|||
46771152|NCT00734214|82989383|FG000|Overall Study|MD withdrawal|1|||
46771153|NCT00734214|82989384|FG001|Overall Study|MD withdrawal|0|||
46771154|NCT00787202|82989395|FG000|Overall Study|Adverse Event|3|||
46771155|NCT00787202|82989396|FG001|Overall Study|Adverse Event|2|||
46841335|NCT00437645|83058598|FG001|Overall Study|Lost to Follow-up|3|||
47066442|NCT01449929|83349114|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
46841336|NCT00437645|83058597|FG000|Overall Study|Administrative problems|2|||
46841337|NCT00437645|83058598|FG001|Overall Study|Administrative problems|1|||
46967869|NCT05091307|83210484|FG001|Overall Study|Physician Decision|0|||
46841338|NCT00437645|83058597|FG000|Overall Study|Lack of Efficacy|2|||
46841339|NCT00437645|83058598|FG001|Overall Study|Lack of Efficacy|1|||
46841340|NCT00437645|83058597|FG000|Overall Study|Condition no longer requires study drug|1|||
46841341|NCT00437645|83058598|FG001|Overall Study|Condition no longer requires study drug|1|||
46947944|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Progressive disease|0|||
46947945|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Other|2|||
46947946|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Other|1|||
46947947|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Other|0|||
46947948|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
46947949|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
46947950|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
46947951|NCT02718417|83186439|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
46947952|NCT02718417|83186440|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
46947953|NCT02718417|83186441|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
46947954|NCT02718417|83186439|FG000|Observation Phase (OP)|Adverse Event|0|||
46947955|NCT02718417|83186440|FG001|Observation Phase (OP)|Adverse Event|0|||
46947956|NCT02718417|83186441|FG002|Observation Phase (OP)|Adverse Event|1|||
46947957|NCT02718417|83186439|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
46947958|NCT02718417|83186440|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
46947959|NCT02718417|83186441|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
46947960|NCT02718417|83186439|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
46947961|NCT02718417|83186440|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
46841342|NCT00437489|83058606|FG000|Overall Study|Study terminated by sponsor|23|||
46841343|NCT00437489|83058607|FG001|Overall Study|Study terminated by sponsor|21|||
46841344|NCT00437489|83058606|FG000|Overall Study|Lost to Follow-up|0|||
46947962|NCT02718417|83186441|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
46947963|NCT02718417|83186439|FG000|Observation Phase (OP)|Physician Decision|0|||
46947964|NCT02718417|83186440|FG001|Observation Phase (OP)|Physician Decision|0|||
46947965|NCT02718417|83186441|FG002|Observation Phase (OP)|Physician Decision|9|||
46947966|NCT02718417|83186439|FG000|Observation Phase (OP)|Progressive disease|0|||
46947967|NCT02718417|83186440|FG001|Observation Phase (OP)|Progressive disease|0|||
46947968|NCT02718417|83186441|FG002|Observation Phase (OP)|Progressive disease|92|||
46947969|NCT02718417|83186439|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
46947970|NCT02718417|83186440|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
46947971|NCT02718417|83186441|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
46947972|NCT02718417|83186439|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
46947973|NCT02718417|83186440|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
46947974|NCT02718417|83186441|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
46947975|NCT02718417|83186439|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
46947976|NCT02718417|83186440|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
46947977|NCT02718417|83186441|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
46947978|NCT02718417|83186439|FG000|Observation Phase (OP)|Other|0|||
46947979|NCT02718417|83186440|FG001|Observation Phase (OP)|Other|0|||
46947980|NCT02718417|83186441|FG002|Observation Phase (OP)|Other|7|||
46947981|NCT02718417|83186439|FG000|Follow-up Phase|Adverse Event|3|||
46947982|NCT02718417|83186440|FG001|Follow-up Phase|Adverse Event|1|||
46947983|NCT02718417|83186441|FG002|Follow-up Phase|Adverse Event|1|||
46947984|NCT02718417|83186439|FG000|Follow-up Phase|Other|4|||
46947985|NCT02718417|83186440|FG001|Follow-up Phase|Other|6|||
46947986|NCT02718417|83186441|FG002|Follow-up Phase|Other|4|||
46947987|NCT02718417|83186439|FG000|Follow-up Phase|Withdrawal by Subject|19|||
46947988|NCT02718417|83186440|FG001|Follow-up Phase|Withdrawal by Subject|17|||
47066443|NCT01449929|83349115|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
47066444|NCT01449929|83349113|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
47066445|NCT01449929|83349114|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
46771156|NCT00787202|82989397|FG002|Overall Study|Adverse Event|0|||
46771157|NCT00787202|82989398|FG003|Overall Study|Adverse Event|0|||
46771158|NCT00787202|82989399|FG004|Overall Study|Adverse Event|2|||
46771159|NCT00787202|82989395|FG000|Overall Study|Lack of Efficacy|5|||
46771160|NCT00787202|82989396|FG001|Overall Study|Lack of Efficacy|6|||
46771161|NCT00787202|82989397|FG002|Overall Study|Lack of Efficacy|5|||
46771162|NCT00787202|82989398|FG003|Overall Study|Lack of Efficacy|2|||
46771163|NCT00787202|82989399|FG004|Overall Study|Lack of Efficacy|1|||
46771164|NCT00787202|82989395|FG000|Overall Study|Lost to Follow-up|1|||
46841345|NCT00437489|83058607|FG001|Overall Study|Lost to Follow-up|1|||
46947989|NCT02718417|83186441|FG002|Follow-up Phase|Withdrawal by Subject|5|||
46947990|NCT02718417|83186439|FG000|Follow-up Phase|Study terminated by sponsor|100|||
46947991|NCT02718417|83186440|FG001|Follow-up Phase|Study terminated by sponsor|138|||
46841346|NCT00442559|83058615|FG000|Overall Study|Lost to Follow-up|32|||
46841347|NCT00442559|83058616|FG001|Overall Study|Lost to Follow-up|34|||
46947992|NCT02718417|83186441|FG002|Follow-up Phase|Study terminated by sponsor|6|||
46947993|NCT02718417|83186439|FG000|Follow-up Phase|Lost to Follow-up|2|||
46947994|NCT02718417|83186440|FG001|Follow-up Phase|Lost to Follow-up|3|||
46947995|NCT02718417|83186441|FG002|Follow-up Phase|Lost to Follow-up|0|||
46841348|NCT00442559|83058615|FG000|Overall Study|Protocol Violation|1|||
46841349|NCT00442559|83058616|FG001|Overall Study|Protocol Violation|1|||
46841350|NCT00442559|83058615|FG000|Overall Study|Withdrawal by Subject|1|||
46841351|NCT00442559|83058616|FG001|Overall Study|Withdrawal by Subject|0|||
46841352|NCT00441701|83058638|FG000|Overall Study|Adverse Event|3|||
46841353|NCT00441701|83058639|FG001|Overall Study|Adverse Event|2|||
46841354|NCT00441701|83058640|FG002|Overall Study|Adverse Event|1|||
46841355|NCT00441701|83058641|FG003|Overall Study|Adverse Event|0|||
46841356|NCT00441701|83058642|FG004|Overall Study|Adverse Event|2|||
46841357|NCT00441701|83058643|FG005|Overall Study|Adverse Event|2|||
46841358|NCT00441701|83058644|FG006|Overall Study|Adverse Event|0|||
46841359|NCT00441701|83058645|FG007|Overall Study|Adverse Event|0|||
46841360|NCT00441701|83058646|FG008|Overall Study|Adverse Event|0|||
46841361|NCT00441701|83058647|FG009|Overall Study|Adverse Event|0|||
46841362|NCT00441701|83058638|FG000|Overall Study|Lack of Efficacy|2|||
46841363|NCT00441701|83058639|FG001|Overall Study|Lack of Efficacy|0|||
46841364|NCT00441701|83058640|FG002|Overall Study|Lack of Efficacy|2|||
46841365|NCT00441701|83058641|FG003|Overall Study|Lack of Efficacy|2|||
46841366|NCT00441701|83058642|FG004|Overall Study|Lack of Efficacy|0|||
46841367|NCT00441701|83058643|FG005|Overall Study|Lack of Efficacy|1|||
46841368|NCT00441701|83058644|FG006|Overall Study|Lack of Efficacy|0|||
46841369|NCT00441701|83058645|FG007|Overall Study|Lack of Efficacy|0|||
46841370|NCT00441701|83058646|FG008|Overall Study|Lack of Efficacy|0|||
46841371|NCT00441701|83058647|FG009|Overall Study|Lack of Efficacy|0|||
46841372|NCT00441701|83058638|FG000|Overall Study|Withdrawal by Subject|0|||
46841373|NCT00441701|83058639|FG001|Overall Study|Withdrawal by Subject|2|||
46841374|NCT00441701|83058640|FG002|Overall Study|Withdrawal by Subject|1|||
46841375|NCT00441701|83058641|FG003|Overall Study|Withdrawal by Subject|1|||
46841376|NCT00441701|83058642|FG004|Overall Study|Withdrawal by Subject|0|||
46841377|NCT00441701|83058643|FG005|Overall Study|Withdrawal by Subject|0|||
46841378|NCT00441701|83058644|FG006|Overall Study|Withdrawal by Subject|0|||
46841379|NCT00441701|83058645|FG007|Overall Study|Withdrawal by Subject|0|||
46841380|NCT00441701|83058646|FG008|Overall Study|Withdrawal by Subject|0|||
46841381|NCT00441701|83058647|FG009|Overall Study|Withdrawal by Subject|0|||
46841382|NCT00441545|83058665|FG000|First Intervention|Adverse Event|6|||
46841383|NCT00441545|83058666|FG001|First Intervention|Adverse Event|5|||
46841384|NCT00441545|83058665|FG000|First Intervention|Protocol Violation|2|||
46841385|NCT00441545|83058666|FG001|First Intervention|Protocol Violation|2|||
46841386|NCT00441545|83058665|FG000|First Intervention|Withdrawal by Subject|3|||
46841387|NCT00441545|83058666|FG001|First Intervention|Withdrawal by Subject|3|||
46841388|NCT00441545|83058665|FG000|First Intervention|Kidney transplant|1|||
46841389|NCT00441545|83058666|FG001|First Intervention|Kidney transplant|1|||
46841390|NCT00441545|83058665|FG000|First Intervention|Lack of Efficacy|2|||
46841391|NCT00441545|83058666|FG001|First Intervention|Lack of Efficacy|0|||
46841392|NCT00441545|83058665|FG000|First Intervention|Subject exceeded safety criteria|0|||
46841393|NCT00441545|83058666|FG001|First Intervention|Subject exceeded safety criteria|1|||
46841394|NCT00441545|83058665|FG000|First Intervention|Subject met an exclusionary criteria|1|||
46841395|NCT00441545|83058666|FG001|First Intervention|Subject met an exclusionary criteria|0|||
46841396|NCT00441545|83058665|FG000|First Intervention|Extended hospitalization|1|||
46841397|NCT00441545|83058666|FG001|First Intervention|Extended hospitalization|0|||
46841398|NCT00441545|83058665|FG000|First Intervention|Site error|1|||
46841399|NCT00441545|83058666|FG001|First Intervention|Site error|0|||
46841400|NCT00441545|83058665|FG000|First Intervention|Sponsor's request|1|||
46841401|NCT00441545|83058666|FG001|First Intervention|Sponsor's request|0|||
46841402|NCT00441545|83058665|FG000|Second Intervention|Adverse Event|5|||
46841403|NCT00441545|83058666|FG001|Second Intervention|Adverse Event|2|||
46841404|NCT00441545|83058665|FG000|Second Intervention|Protocol Violation|4|||
46841405|NCT00441545|83058666|FG001|Second Intervention|Protocol Violation|1|||
46841406|NCT00441545|83058665|FG000|Second Intervention|Withdrawal by Subject|1|||
46841407|NCT00441545|83058666|FG001|Second Intervention|Withdrawal by Subject|1|||
46841408|NCT00441545|83058665|FG000|Second Intervention|Kidney Transplant|1|||
46841409|NCT00441545|83058666|FG001|Second Intervention|Kidney Transplant|1|||
46841410|NCT00441545|83058665|FG000|Second Intervention|Lack of Efficacy|0|||
46841411|NCT00441545|83058666|FG001|Second Intervention|Lack of Efficacy|1|||
46841412|NCT00441545|83058665|FG000|Second Intervention|Subject exceeded safety criteria|1|||
46841413|NCT00441545|83058666|FG001|Second Intervention|Subject exceeded safety criteria|0|||
46841414|NCT00441545|83058665|FG000|Second Intervention|Subject moved|0|||
46841415|NCT00441545|83058666|FG001|Second Intervention|Subject moved|1|||
46841416|NCT00436553|83058675|FG000|Overall Study|Adverse Event|4|||
46841417|NCT00436553|83058676|FG001|Overall Study|Adverse Event|3|||
46841418|NCT00436553|83058677|FG002|Overall Study|Adverse Event|4|||
46841419|NCT00436553|83058675|FG000|Overall Study|Death|3|||
46841420|NCT00436553|83058676|FG001|Overall Study|Death|1|||
46841421|NCT00436553|83058677|FG002|Overall Study|Death|3|||
46841422|NCT00436553|83058675|FG000|Overall Study|Lost to Follow-up|0|||
46841423|NCT00436553|83058676|FG001|Overall Study|Lost to Follow-up|2|||
46841424|NCT00436553|83058677|FG002|Overall Study|Lost to Follow-up|0|||
46947996|NCT02718417|83186439|FG000|Follow-up Phase|Death leading to discontinuation|7|||
46947997|NCT02718417|83186440|FG001|Follow-up Phase|Death leading to discontinuation|7|||
46947998|NCT02718417|83186441|FG002|Follow-up Phase|Death leading to discontinuation|3|||
46947999|NCT02718417|83186439|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
46948000|NCT02718417|83186440|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
46948001|NCT02718417|83186441|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
46948002|NCT02718417|83186439|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
46948003|NCT02718417|83186440|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
46948004|NCT02718417|83186441|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
46948005|NCT02718417|83186439|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
46948006|NCT02718417|83186440|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
46948007|NCT02718417|83186441|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
46948008|NCT02718417|83186439|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
46948009|NCT02718417|83186440|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
46948010|NCT02718417|83186441|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
46948011|NCT02718417|83186439|FG000|Long-term Follow-up Phase|Other|0|||
46948012|NCT02718417|83186440|FG001|Long-term Follow-up Phase|Other|2|||
46948013|NCT02718417|83186441|FG002|Long-term Follow-up Phase|Other|0|||
46948014|NCT02640404|83186458|FG000|Overall Study|Protocol Violation|1|||
46948015|NCT02640404|83186459|FG001|Overall Study|Protocol Violation|0|||
46948016|NCT02640404|83186458|FG000|Overall Study|Withdrawal by Subject|1|||
46948017|NCT02640404|83186459|FG001|Overall Study|Withdrawal by Subject|0|||
46948018|NCT00701727|83186465|FG000|First Treatment Period|Adverse Event|0|||
46948019|NCT00701727|83186466|FG001|First Treatment Period|Adverse Event|0|||
46948020|NCT00701727|83186465|FG000|First Treatment Period|Withdrawal by Subject|1|||
46948021|NCT00701727|83186466|FG001|First Treatment Period|Withdrawal by Subject|0|||
46948022|NCT00701727|83186465|FG000|First Treatment Period|sponsor decision|0|||
46948023|NCT00701727|83186466|FG001|First Treatment Period|sponsor decision|1|||
46948024|NCT00701727|83186465|FG000|First Treatment Period|Lost to Follow-up|0|||
46948025|NCT00701727|83186466|FG001|First Treatment Period|Lost to Follow-up|1|||
46948026|NCT00701727|83186465|FG000|Second Treatment Period|Withdrawal by Subject|2|||
46948027|NCT00701727|83186466|FG001|Second Treatment Period|Withdrawal by Subject|0|||
46948028|NCT01369069|83186483|FG000|Overall Study|Lost to Follow-up|8|||
46948029|NCT01369069|83186484|FG001|Overall Study|Lost to Follow-up|9|||
46948030|NCT01369069|83186483|FG000|Overall Study|Withdrawal by Subject|9|||
46948031|NCT01369069|83186484|FG001|Overall Study|Withdrawal by Subject|7|||
46948032|NCT02441218|83186492|FG000|Overall Study|Death|503|||
46948033|NCT02441218|83186493|FG001|Overall Study|Death|553|||
47066446|NCT01449929|83349115|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
47066447|NCT01449929|83349113|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
46771165|NCT00787202|82989396|FG001|Overall Study|Lost to Follow-up|0|||
46771166|NCT00787202|82989397|FG002|Overall Study|Lost to Follow-up|0|||
46771167|NCT00787202|82989398|FG003|Overall Study|Lost to Follow-up|0|||
46771168|NCT00787202|82989399|FG004|Overall Study|Lost to Follow-up|0|||
46771169|NCT00787202|82989395|FG000|Overall Study|Withdrawal by Subject|2|||
46771170|NCT00787202|82989396|FG001|Overall Study|Withdrawal by Subject|2|||
46771171|NCT00787202|82989397|FG002|Overall Study|Withdrawal by Subject|2|||
46771172|NCT00787202|82989398|FG003|Overall Study|Withdrawal by Subject|0|||
46771173|NCT00787202|82989399|FG004|Overall Study|Withdrawal by Subject|0|||
46771174|NCT00787202|82989395|FG000|Overall Study|Protocol Violation|2|||
46771175|NCT00787202|82989396|FG001|Overall Study|Protocol Violation|1|||
46771176|NCT00787202|82989397|FG002|Overall Study|Protocol Violation|0|||
46771177|NCT00787202|82989398|FG003|Overall Study|Protocol Violation|0|||
46841425|NCT00436553|83058675|FG000|Overall Study|Protocol Violation|1|||
46841426|NCT00436553|83058676|FG001|Overall Study|Protocol Violation|0|||
46841427|NCT00436553|83058677|FG002|Overall Study|Protocol Violation|0|||
46841428|NCT00436553|83058675|FG000|Overall Study|Withdrawal by Subject|5|||
46841429|NCT00436553|83058676|FG001|Overall Study|Withdrawal by Subject|6|||
46841430|NCT00436553|83058677|FG002|Overall Study|Withdrawal by Subject|3|||
46841431|NCT00441467|83058685|FG000|Overall Study|Adverse Event|6|||
46841432|NCT00441467|83058685|FG000|Overall Study|Withdrawal by Subject|3|||
46841433|NCT00441467|83058685|FG000|Overall Study|Progressive disease|9|||
46948034|NCT02441218|83186492|FG000|Overall Study|Withdrawal by Subject|73|||
46948035|NCT02441218|83186493|FG001|Overall Study|Withdrawal by Subject|58|||
46948036|NCT02441218|83186492|FG000|Overall Study|Lost to Follow-up|2|||
46948037|NCT02441218|83186493|FG001|Overall Study|Lost to Follow-up|1|||
46948038|NCT02410252|83186499|FG000|Overall Study|Withdrawal by Subject|4|||
46948039|NCT02410252|83186499|FG000|Overall Study|Physician Decision|2|||
46948040|NCT02440594|83186513|FG000|Overall Study|Lost to Follow-up|34|||
46948041|NCT02440594|83186514|FG001|Overall Study|Lost to Follow-up|33|||
47066448|NCT01449929|83349114|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
46771178|NCT00787202|82989399|FG004|Overall Study|Protocol Violation|1|||
46841434|NCT00436163|83058689|FG000|Overall Study|Lost to Follow-up|2|||
46948042|NCT02440594|83186515|FG002|Overall Study|Lost to Follow-up|54|||
46841435|NCT00436163|83058689|FG000|Overall Study|Adverse Event|1|||
46948043|NCT02440594|83186516|FG003|Overall Study|Lost to Follow-up|47|||
46948044|NCT02440594|83186517|FG004|Overall Study|Lost to Follow-up|5|||
46948045|NCT02440594|83186518|FG005|Overall Study|Lost to Follow-up|4|||
46771179|NCT00787202|82989395|FG000|Overall Study|Randomized, not treated|1|||
46771180|NCT00787202|82989396|FG001|Overall Study|Randomized, not treated|0|||
46771181|NCT00787202|82989397|FG002|Overall Study|Randomized, not treated|0|||
46771182|NCT00787202|82989398|FG003|Overall Study|Randomized, not treated|0|||
46771183|NCT00787202|82989399|FG004|Overall Study|Randomized, not treated|0|||
46771184|NCT04033367|82989417|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
46771185|NCT04033367|82989418|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
46771186|NCT04033367|82989417|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
46771187|NCT04033367|82989418|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
46771188|NCT04033367|82989417|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
46771189|NCT04033367|82989418|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
46771190|NCT04033367|82989417|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
46841436|NCT00006604|83058701|FG000|Overall Study|Met study objective - no further FU|1|||
46841437|NCT00006604|83058702|FG001|Overall Study|Met study objective - no further FU|0|||
46841438|NCT00006604|83058703|FG002|Overall Study|Met study objective - no further FU|0|||
46841439|NCT00006604|83058704|FG003|Overall Study|Met study objective - no further FU|0|||
46841440|NCT00006604|83058705|FG004|Overall Study|Met study objective - no further FU|0|||
46841441|NCT00006604|83058706|FG005|Overall Study|Met study objective - no further FU|0|||
46841442|NCT00006604|83058707|FG006|Overall Study|Met study objective - no further FU|0|||
46841443|NCT00006604|83058708|FG007|Overall Study|Met study objective - no further FU|0|||
46841444|NCT00006604|83058709|FG008|Overall Study|Met study objective - no further FU|0|||
46841445|NCT00006604|83058710|FG009|Overall Study|Met study objective - no further FU|0|||
46841446|NCT00006604|83058711|FG010|Overall Study|Met study objective - no further FU|0|||
46841447|NCT00006604|83058712|FG011|Overall Study|Met study objective - no further FU|0|||
46841448|NCT00006604|83058713|FG012|Overall Study|Met study objective - no further FU|0|||
46841449|NCT00006604|83058714|FG013|Overall Study|Met study objective - no further FU|0|||
46841450|NCT00006604|83058715|FG014|Overall Study|Met study objective - no further FU|1|||
46841451|NCT00006604|83058716|FG015|Overall Study|Met study objective - no further FU|1|||
46841452|NCT00006604|83058717|FG016|Overall Study|Met study objective - no further FU|0|||
46841453|NCT00006604|83058701|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
46841454|NCT00006604|83058702|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
46841455|NCT00006604|83058703|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
46841456|NCT00006604|83058704|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
46841457|NCT00006604|83058705|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
46841458|NCT00006604|83058706|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
46841459|NCT00006604|83058707|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
46841460|NCT00006604|83058708|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
46841461|NCT00006604|83058709|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
46841462|NCT00006604|83058710|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
46841463|NCT00006604|83058711|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
46841464|NCT00006604|83058712|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
46841465|NCT00006604|83058713|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
46841466|NCT00006604|83058714|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
46841467|NCT00006604|83058715|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
46841468|NCT00006604|83058716|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
46841469|NCT00006604|83058717|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
46841470|NCT00006604|83058701|FG000|Overall Study|Death|0|||
46841471|NCT00006604|83058702|FG001|Overall Study|Death|0|||
46841472|NCT00006604|83058703|FG002|Overall Study|Death|0|||
46841473|NCT00006604|83058704|FG003|Overall Study|Death|0|||
46841474|NCT00006604|83058705|FG004|Overall Study|Death|0|||
46841475|NCT00006604|83058706|FG005|Overall Study|Death|0|||
46841476|NCT00006604|83058707|FG006|Overall Study|Death|0|||
46841477|NCT00006604|83058708|FG007|Overall Study|Death|0|||
46841478|NCT00006604|83058709|FG008|Overall Study|Death|0|||
46841479|NCT00006604|83058710|FG009|Overall Study|Death|1|||
46841480|NCT00006604|83058711|FG010|Overall Study|Death|1|||
46841481|NCT00006604|83058712|FG011|Overall Study|Death|1|||
46841482|NCT00006604|83058713|FG012|Overall Study|Death|0|||
46841483|NCT00006604|83058714|FG013|Overall Study|Death|0|||
46841484|NCT00006604|83058715|FG014|Overall Study|Death|0|||
46948046|NCT02440594|83186519|FG006|Overall Study|Lost to Follow-up|28|||
46841485|NCT00006604|83058716|FG015|Overall Study|Death|0|||
46948047|NCT02440594|83186520|FG007|Overall Study|Lost to Follow-up|48|||
46841486|NCT00006604|83058717|FG016|Overall Study|Death|0|||
46841487|NCT00006604|83058701|FG000|Overall Study|Severe debilitation, unable to continue|0|||
46841488|NCT00006604|83058702|FG001|Overall Study|Severe debilitation, unable to continue|0|||
46841489|NCT00006604|83058703|FG002|Overall Study|Severe debilitation, unable to continue|0|||
46948048|NCT02440594|83186513|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
46638938|NCT01407354|82812408|FG000|First Intervention|Withdrawal by Subject|0|||
46948049|NCT02440594|83186514|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
46948050|NCT02440594|83186515|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
46948051|NCT02440594|83186516|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
46948052|NCT02440594|83186517|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
46948053|NCT02440594|83186518|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
46948054|NCT02440594|83186519|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
46948055|NCT02440594|83186520|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
46771191|NCT04033367|82989418|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
46771192|NCT00733980|82989430|FG000|Overall Study|Adverse Event|5|||
46771193|NCT00733980|82989431|FG001|Overall Study|Adverse Event|2|||
46771194|NCT00733980|82989430|FG000|Overall Study|Lack of Efficacy|0|||
46771195|NCT00733980|82989431|FG001|Overall Study|Lack of Efficacy|1|||
46771196|NCT00733980|82989430|FG000|Overall Study|Protocol Violation|2|||
46771197|NCT00733980|82989431|FG001|Overall Study|Protocol Violation|1|||
46771198|NCT00733980|82989430|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
46771199|NCT00733980|82989431|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
46771200|NCT00733980|82989430|FG000|Overall Study|Lost to Follow-up|6|||
46771201|NCT00733980|82989431|FG001|Overall Study|Lost to Follow-up|11|||
46771202|NCT00733980|82989430|FG000|Overall Study|Physician Decision|2|||
46771203|NCT00733980|82989431|FG001|Overall Study|Physician Decision|3|||
46771204|NCT00733980|82989430|FG000|Overall Study|Withdrawal by Subject|6|||
46771205|NCT00733980|82989431|FG001|Overall Study|Withdrawal by Subject|2|||
46771206|NCT00806585|82989443|FG000|Overall Study|Study terminated by Sponsor|0|||
46771207|NCT00806585|82989444|FG001|Overall Study|Study terminated by Sponsor|0|||
46771208|NCT00806585|82989445|FG002|Overall Study|Study terminated by Sponsor|1|||
46771209|NCT00806585|82989446|FG003|Overall Study|Study terminated by Sponsor|2|||
46771210|NCT00806585|82989447|FG004|Overall Study|Study terminated by Sponsor|0|||
46771211|NCT00806585|82989443|FG000|Overall Study|Protocol Violation|3|||
46771212|NCT00806585|82989444|FG001|Overall Study|Protocol Violation|1|||
46771213|NCT00806585|82989445|FG002|Overall Study|Protocol Violation|2|||
46771214|NCT00806585|82989446|FG003|Overall Study|Protocol Violation|0|||
46771215|NCT00806585|82989447|FG004|Overall Study|Protocol Violation|0|||
46771216|NCT00806585|82989443|FG000|Overall Study|Physician Decision|0|||
46771217|NCT00806585|82989444|FG001|Overall Study|Physician Decision|2|||
46771218|NCT00806585|82989445|FG002|Overall Study|Physician Decision|3|||
46771219|NCT00806585|82989446|FG003|Overall Study|Physician Decision|0|||
46771220|NCT00806585|82989447|FG004|Overall Study|Physician Decision|1|||
46771221|NCT00806585|82989443|FG000|Overall Study|Lost to Follow-up|2|||
46771222|NCT00806585|82989444|FG001|Overall Study|Lost to Follow-up|1|||
46771223|NCT00806585|82989445|FG002|Overall Study|Lost to Follow-up|2|||
46771224|NCT00806585|82989446|FG003|Overall Study|Lost to Follow-up|2|||
46771225|NCT00806585|82989447|FG004|Overall Study|Lost to Follow-up|5|||
46771226|NCT00806585|82989443|FG000|Overall Study|Lack of Efficacy|1|||
46771227|NCT00806585|82989444|FG001|Overall Study|Lack of Efficacy|0|||
46771228|NCT00806585|82989445|FG002|Overall Study|Lack of Efficacy|0|||
46771229|NCT00806585|82989446|FG003|Overall Study|Lack of Efficacy|0|||
46771230|NCT00806585|82989447|FG004|Overall Study|Lack of Efficacy|0|||
46771231|NCT00806585|82989443|FG000|Overall Study|Adverse Event|1|||
46771232|NCT00806585|82989444|FG001|Overall Study|Adverse Event|5|||
46771233|NCT00806585|82989445|FG002|Overall Study|Adverse Event|3|||
46771234|NCT00806585|82989446|FG003|Overall Study|Adverse Event|4|||
46771235|NCT00806585|82989447|FG004|Overall Study|Adverse Event|2|||
46771236|NCT00806585|82989443|FG000|Overall Study|Withdrawal by Subject|10|||
46771237|NCT00806585|82989444|FG001|Overall Study|Withdrawal by Subject|8|||
46771238|NCT00806585|82989445|FG002|Overall Study|Withdrawal by Subject|9|||
46771239|NCT00806585|82989446|FG003|Overall Study|Withdrawal by Subject|3|||
46771240|NCT00806585|82989447|FG004|Overall Study|Withdrawal by Subject|11|||
46771241|NCT00806585|82989443|FG000|Overall Study|Completion status unknown|15|||
46771242|NCT00806585|82989444|FG001|Overall Study|Completion status unknown|14|||
46771243|NCT00806585|82989445|FG002|Overall Study|Completion status unknown|12|||
46771244|NCT00806585|82989446|FG003|Overall Study|Completion status unknown|4|||
46771245|NCT00806585|82989447|FG004|Overall Study|Completion status unknown|12|||
46771246|NCT00480025|82989461|FG000|Overall Study|Protocol Violation|12|||
46771247|NCT00480025|82989462|FG001|Overall Study|Protocol Violation|7|||
46948056|NCT02440594|83186513|FG000|Overall Study|Withdrawal by Subject|81|||
46771248|NCT00480025|82989461|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
46771249|NCT00480025|82989462|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
46771250|NCT00480025|82989461|FG000|Overall Study|Disease Progression / Recurrence|449|||
46771251|NCT00480025|82989462|FG001|Overall Study|Disease Progression / Recurrence|224|||
46771252|NCT00480025|82989461|FG000|Overall Study|Adverse Event|44|||
46771253|NCT00480025|82989462|FG001|Overall Study|Adverse Event|12|||
46771254|NCT00480025|82989461|FG000|Overall Study|Other|70|||
46771255|NCT00480025|82989462|FG001|Overall Study|Other|29|||
46967870|NCT05091307|83210485|FG002|Overall Study|Physician Decision|0|||
46771256|NCT00480025|82989461|FG000|Overall Study|SAE including intercurrent illness|76|||
46771257|NCT00480025|82989462|FG001|Overall Study|SAE including intercurrent illness|42|||
46771258|NCT00806351|82989476|FG000|Overall Study|Death|5|||
46948057|NCT02440594|83186514|FG001|Overall Study|Withdrawal by Subject|67|||
46948058|NCT02440594|83186515|FG002|Overall Study|Withdrawal by Subject|59|||
46948059|NCT02440594|83186516|FG003|Overall Study|Withdrawal by Subject|38|||
46948060|NCT02440594|83186517|FG004|Overall Study|Withdrawal by Subject|2|||
46948061|NCT02440594|83186518|FG005|Overall Study|Withdrawal by Subject|2|||
46948062|NCT02440594|83186519|FG006|Overall Study|Withdrawal by Subject|7|||
46841490|NCT00006604|83058704|FG003|Overall Study|Severe debilitation, unable to continue|0|||
46841491|NCT00006604|83058705|FG004|Overall Study|Severe debilitation, unable to continue|0|||
46841492|NCT00006604|83058706|FG005|Overall Study|Severe debilitation, unable to continue|0|||
46841493|NCT00006604|83058707|FG006|Overall Study|Severe debilitation, unable to continue|3|||
46841494|NCT00006604|83058708|FG007|Overall Study|Severe debilitation, unable to continue|0|||
46841495|NCT00006604|83058709|FG008|Overall Study|Severe debilitation, unable to continue|0|||
46841496|NCT00006604|83058710|FG009|Overall Study|Severe debilitation, unable to continue|5|||
46841497|NCT00006604|83058711|FG010|Overall Study|Severe debilitation, unable to continue|0|||
46841498|NCT00006604|83058712|FG011|Overall Study|Severe debilitation, unable to continue|2|||
46841499|NCT00006604|83058713|FG012|Overall Study|Severe debilitation, unable to continue|1|||
46841500|NCT00006604|83058714|FG013|Overall Study|Severe debilitation, unable to continue|0|||
46841501|NCT00006604|83058715|FG014|Overall Study|Severe debilitation, unable to continue|2|||
46841502|NCT00006604|83058716|FG015|Overall Study|Severe debilitation, unable to continue|0|||
46841503|NCT00006604|83058717|FG016|Overall Study|Severe debilitation, unable to continue|0|||
46841504|NCT00006604|83058701|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
46841505|NCT00006604|83058702|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
46841506|NCT00006604|83058703|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
46841507|NCT00006604|83058704|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
46841508|NCT00006604|83058705|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
46841509|NCT00006604|83058706|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
46841510|NCT00006604|83058707|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
46841511|NCT00006604|83058708|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
46841512|NCT00006604|83058709|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
46841513|NCT00006604|83058710|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
46841514|NCT00006604|83058711|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
46841515|NCT00006604|83058712|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
46841516|NCT00006604|83058713|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
46841517|NCT00006604|83058714|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
46841518|NCT00006604|83058715|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
46841519|NCT00006604|83058716|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
46841520|NCT00006604|83058717|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
46841521|NCT00006604|83058701|FG000|Overall Study|Site closing|0|||
46841522|NCT00006604|83058702|FG001|Overall Study|Site closing|0|||
46841523|NCT00006604|83058703|FG002|Overall Study|Site closing|1|||
46841524|NCT00006604|83058704|FG003|Overall Study|Site closing|1|||
46841525|NCT00006604|83058705|FG004|Overall Study|Site closing|0|||
46841526|NCT00006604|83058706|FG005|Overall Study|Site closing|0|||
46841527|NCT00006604|83058707|FG006|Overall Study|Site closing|0|||
46841528|NCT00006604|83058708|FG007|Overall Study|Site closing|1|||
46841529|NCT00006604|83058709|FG008|Overall Study|Site closing|0|||
46841530|NCT00006604|83058710|FG009|Overall Study|Site closing|0|||
46841531|NCT00006604|83058711|FG010|Overall Study|Site closing|0|||
46841532|NCT00006604|83058712|FG011|Overall Study|Site closing|1|||
46841533|NCT00006604|83058713|FG012|Overall Study|Site closing|1|||
46841534|NCT00006604|83058714|FG013|Overall Study|Site closing|1|||
46841535|NCT00006604|83058715|FG014|Overall Study|Site closing|0|||
46841536|NCT00006604|83058716|FG015|Overall Study|Site closing|0|||
46841537|NCT00006604|83058717|FG016|Overall Study|Site closing|1|||
46841538|NCT00006604|83058701|FG000|Overall Study|Withdrawal by Subject|1|||
46841539|NCT00006604|83058702|FG001|Overall Study|Withdrawal by Subject|0|||
46841540|NCT00006604|83058703|FG002|Overall Study|Withdrawal by Subject|2|||
46841541|NCT00006604|83058704|FG003|Overall Study|Withdrawal by Subject|0|||
46841542|NCT00006604|83058705|FG004|Overall Study|Withdrawal by Subject|1|||
46841543|NCT00006604|83058706|FG005|Overall Study|Withdrawal by Subject|2|||
46841544|NCT00006604|83058707|FG006|Overall Study|Withdrawal by Subject|2|||
46841545|NCT00006604|83058708|FG007|Overall Study|Withdrawal by Subject|0|||
46841546|NCT00006604|83058709|FG008|Overall Study|Withdrawal by Subject|1|||
46841547|NCT00006604|83058710|FG009|Overall Study|Withdrawal by Subject|3|||
46948063|NCT02440594|83186520|FG007|Overall Study|Withdrawal by Subject|7|||
46948064|NCT02440594|83186513|FG000|Overall Study|Administratively w/drawn|3|||
46948065|NCT02440594|83186514|FG001|Overall Study|Administratively w/drawn|2|||
46841548|NCT00006604|83058711|FG010|Overall Study|Withdrawal by Subject|2|||
46841549|NCT00006604|83058712|FG011|Overall Study|Withdrawal by Subject|0|||
46841550|NCT00006604|83058713|FG012|Overall Study|Withdrawal by Subject|1|||
46841551|NCT00006604|83058714|FG013|Overall Study|Withdrawal by Subject|2|||
46948066|NCT02440594|83186515|FG002|Overall Study|Administratively w/drawn|0|||
46948067|NCT02440594|83186516|FG003|Overall Study|Administratively w/drawn|0|||
46948068|NCT02440594|83186517|FG004|Overall Study|Administratively w/drawn|0|||
46948069|NCT02440594|83186518|FG005|Overall Study|Administratively w/drawn|0|||
46948070|NCT02440594|83186519|FG006|Overall Study|Administratively w/drawn|2|||
46948071|NCT02440594|83186520|FG007|Overall Study|Administratively w/drawn|1|||
46948072|NCT03836001|83186547|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
46948073|NCT03836001|83186548|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
46948074|NCT03836001|83186549|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
46948075|NCT03836001|83186547|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
46948076|NCT03836001|83186548|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
46948077|NCT03836001|83186549|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
46841552|NCT00006604|83058715|FG014|Overall Study|Withdrawal by Subject|1|||
46841553|NCT00006604|83058716|FG015|Overall Study|Withdrawal by Subject|0|||
46841554|NCT00006604|83058717|FG016|Overall Study|Withdrawal by Subject|1|||
46841555|NCT00006604|83058701|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
46841556|NCT00006604|83058702|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
46841557|NCT00006604|83058703|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
46841558|NCT00006604|83058704|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
46841559|NCT00006604|83058705|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
46841560|NCT00006604|83058706|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
46841561|NCT00006604|83058707|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
46841562|NCT00006604|83058708|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
46841563|NCT00006604|83058709|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
46841564|NCT00006604|83058710|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
46841565|NCT00006604|83058711|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
46841566|NCT00006604|83058712|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
46841567|NCT00006604|83058713|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
46841568|NCT00006604|83058714|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
46841569|NCT00006604|83058715|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
46841570|NCT00006604|83058716|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
46841571|NCT00006604|83058717|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
46841572|NCT00006604|83058701|FG000|Overall Study|Lost to Follow-up|0|||
46841573|NCT00006604|83058702|FG001|Overall Study|Lost to Follow-up|0|||
46841574|NCT00006604|83058703|FG002|Overall Study|Lost to Follow-up|0|||
46841575|NCT00006604|83058704|FG003|Overall Study|Lost to Follow-up|0|||
46841576|NCT00006604|83058705|FG004|Overall Study|Lost to Follow-up|0|||
46841577|NCT00006604|83058706|FG005|Overall Study|Lost to Follow-up|0|||
46841578|NCT00006604|83058707|FG006|Overall Study|Lost to Follow-up|0|||
46841579|NCT00006604|83058708|FG007|Overall Study|Lost to Follow-up|1|||
46841580|NCT00006604|83058709|FG008|Overall Study|Lost to Follow-up|0|||
46841581|NCT00006604|83058710|FG009|Overall Study|Lost to Follow-up|2|||
46841582|NCT00006604|83058711|FG010|Overall Study|Lost to Follow-up|0|||
46841583|NCT00006604|83058712|FG011|Overall Study|Lost to Follow-up|0|||
46841584|NCT00006604|83058713|FG012|Overall Study|Lost to Follow-up|0|||
46948078|NCT03836001|83186547|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
47066449|NCT01449929|83349115|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
47066450|NCT01449539|83349125|FG000|Overall Study|Withdrawal by Subject|3|||
47066451|NCT01449539|83349125|FG000|Overall Study|Toxicity not study related|1|||
47066452|NCT01451515|83349132|FG000|Overall Study|Death|0|||
47066453|NCT01451515|83349133|FG001|Overall Study|Death|1|||
47066454|NCT01451515|83349134|FG002|Overall Study|Death|0|||
47066455|NCT01451515|83349132|FG000|Overall Study|Withdrawal by Subject|0|||
47066456|NCT01451515|83349133|FG001|Overall Study|Withdrawal by Subject|1|||
47066457|NCT01451515|83349134|FG002|Overall Study|Withdrawal by Subject|0|||
46771259|NCT00806351|82989477|FG001|Overall Study|Death|4|||
46771260|NCT00733902|82989487|FG000|Overall Study|Death|0|||
46771261|NCT00733902|82989488|FG001|Overall Study|Death|0|||
46771262|NCT00733902|82989489|FG002|Overall Study|Death|0|||
46771263|NCT00733902|82989490|FG003|Overall Study|Death|1|||
46771264|NCT00733902|82989487|FG000|Overall Study|Adverse Event|3|||
46771265|NCT00733902|82989488|FG001|Overall Study|Adverse Event|4|||
46771266|NCT00733902|82989489|FG002|Overall Study|Adverse Event|7|||
46771267|NCT00733902|82989490|FG003|Overall Study|Adverse Event|11|||
46771268|NCT00733902|82989487|FG000|Overall Study|Lack of Efficacy|56|||
46771269|NCT00733902|82989488|FG001|Overall Study|Lack of Efficacy|21|||
46771270|NCT00733902|82989489|FG002|Overall Study|Lack of Efficacy|34|||
46771271|NCT00733902|82989490|FG003|Overall Study|Lack of Efficacy|23|||
46771272|NCT00733902|82989487|FG000|Overall Study|Protocol Violation|4|||
46771273|NCT00733902|82989488|FG001|Overall Study|Protocol Violation|6|||
46771274|NCT00733902|82989489|FG002|Overall Study|Protocol Violation|3|||
46771275|NCT00733902|82989490|FG003|Overall Study|Protocol Violation|3|||
46771276|NCT00733902|82989487|FG000|Overall Study|Withdrawal by Subject|10|||
46771277|NCT00733902|82989488|FG001|Overall Study|Withdrawal by Subject|5|||
46771278|NCT00733902|82989489|FG002|Overall Study|Withdrawal by Subject|4|||
46948079|NCT03836001|83186548|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
46948080|NCT03836001|83186549|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
46948081|NCT03836001|83186547|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
46948082|NCT03836001|83186548|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
46771279|NCT00733902|82989490|FG003|Overall Study|Withdrawal by Subject|16|||
46771280|NCT00733902|82989487|FG000|Overall Study|Entered extension study|89|||
46771281|NCT00733902|82989488|FG001|Overall Study|Entered extension study|124|||
46948083|NCT03836001|83186549|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
46948084|NCT02465866|83186556|FG000|Period 3|Withdrawal by Subject|0|||
46948085|NCT02465866|83186557|FG001|Period 3|Withdrawal by Subject|1|||
46948086|NCT02465866|83186558|FG002|Period 3|Withdrawal by Subject|0|||
46948087|NCT02465866|83186559|FG003|Period 3|Withdrawal by Subject|0|||
46948088|NCT02439970|83186571|FG000|Overall Study|Study Terminated|2|||
46948089|NCT02439970|83186572|FG001|Overall Study|Study Terminated|3|||
46948090|NCT02437864|83186580|FG000|Overall Study|Protocol Violation|4|||
46948091|NCT02437864|83186581|FG001|Overall Study|Protocol Violation|0|||
46948092|NCT02408068|83186587|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
46948093|NCT02408068|83186588|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
47066458|NCT01451515|83349132|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
46771282|NCT00733902|82989489|FG002|Overall Study|Entered extension study|111|||
46771283|NCT00733902|82989490|FG003|Overall Study|Entered extension study|109|||
46771284|NCT00733902|82989487|FG000|Overall Study|Randomized but not treated|2|||
46771285|NCT00733902|82989488|FG001|Overall Study|Randomized but not treated|2|||
47066459|NCT01451515|83349133|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
46771286|NCT00733902|82989489|FG002|Overall Study|Randomized but not treated|2|||
46771287|NCT00733902|82989490|FG003|Overall Study|Randomized but not treated|1|||
46771288|NCT00790790|82989503|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
46771289|NCT00790790|82989504|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
46771290|NCT00790790|82989505|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
46771291|NCT00790790|82989503|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
46771292|NCT00790790|82989504|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
46771293|NCT00790790|82989505|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
46771294|NCT00790790|82989503|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
46771295|NCT00790790|82989504|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
46771296|NCT00790790|82989505|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
46771297|NCT00790790|82989503|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
46771298|NCT00790790|82989504|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
46771299|NCT00790790|82989505|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
46771300|NCT00790790|82989503|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
46771301|NCT00790790|82989504|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
46771302|NCT00790790|82989505|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
46771303|NCT00719043|82989525|FG000|Overall Study|Adverse Event|5|||
46771304|NCT00719043|82989526|FG001|Overall Study|Adverse Event|1|||
46771305|NCT00719043|82989527|FG002|Overall Study|Adverse Event|2|||
46771306|NCT00719043|82989528|FG003|Overall Study|Adverse Event|2|||
46771307|NCT00719043|82989529|FG004|Overall Study|Adverse Event|1|||
46771308|NCT00719043|82989530|FG005|Overall Study|Adverse Event|4|||
46771309|NCT00719043|82989531|FG006|Overall Study|Adverse Event|4|||
46771310|NCT00719043|82989525|FG000|Overall Study|Lost to Follow-up|14|||
46771311|NCT00719043|82989526|FG001|Overall Study|Lost to Follow-up|10|||
46771312|NCT00719043|82989527|FG002|Overall Study|Lost to Follow-up|8|||
46771313|NCT00719043|82989528|FG003|Overall Study|Lost to Follow-up|9|||
46771314|NCT00719043|82989529|FG004|Overall Study|Lost to Follow-up|10|||
46771315|NCT00719043|82989530|FG005|Overall Study|Lost to Follow-up|9|||
46771316|NCT00719043|82989531|FG006|Overall Study|Lost to Follow-up|9|||
46771317|NCT00719043|82989525|FG000|Overall Study|Protocol Violation|0|||
46771318|NCT00719043|82989526|FG001|Overall Study|Protocol Violation|0|||
46771319|NCT00719043|82989527|FG002|Overall Study|Protocol Violation|0|||
46771320|NCT00719043|82989528|FG003|Overall Study|Protocol Violation|0|||
46771321|NCT00719043|82989529|FG004|Overall Study|Protocol Violation|0|||
46771322|NCT00719043|82989530|FG005|Overall Study|Protocol Violation|1|||
46771323|NCT00719043|82989531|FG006|Overall Study|Protocol Violation|0|||
46771324|NCT00719043|82989525|FG000|Overall Study|Other|1|||
46771325|NCT00719043|82989526|FG001|Overall Study|Other|0|||
46771326|NCT00719043|82989527|FG002|Overall Study|Other|1|||
46771327|NCT00719043|82989528|FG003|Overall Study|Other|2|||
46771328|NCT00719043|82989529|FG004|Overall Study|Other|0|||
46948094|NCT02408068|83186589|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
46771329|NCT00719043|82989530|FG005|Overall Study|Other|2|||
46948095|NCT02408068|83186590|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
46948096|NCT02408068|83186591|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
46948097|NCT02408068|83186592|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
46771330|NCT00719043|82989531|FG006|Overall Study|Other|1|||
46948098|NCT01361126|83186605|FG000|Overall Study|Sponsor decision|0|||
46771331|NCT00719043|82989525|FG000|Overall Study|Withdrawal by Subject|12|||
46948099|NCT01361126|83186606|FG001|Overall Study|Sponsor decision|2|||
46948100|NCT04428645|83186613|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
46948101|NCT01368835|83186617|FG000|Overall Study|Inclusion criteria/photography quality|22|||
46948102|NCT01368835|83186617|FG000|Overall Study|Lost to Follow-up|11|||
46948103|NCT02407990|83186636|FG000|Overall Study|Death|2|||
46948104|NCT02407990|83186637|FG001|Overall Study|Death|22|||
46948105|NCT02407990|83186638|FG002|Overall Study|Death|23|||
46948106|NCT02407990|83186639|FG003|Overall Study|Death|7|||
46948107|NCT02407990|83186640|FG004|Overall Study|Death|17|||
46948108|NCT02407990|83186641|FG005|Overall Study|Death|16|||
46948109|NCT02407990|83186642|FG006|Overall Study|Death|10|||
46948110|NCT02407990|83186643|FG007|Overall Study|Death|248|||
46948111|NCT02407990|83186636|FG000|Overall Study|Lost to Follow-up|0|||
46948112|NCT02407990|83186637|FG001|Overall Study|Lost to Follow-up|1|||
46948113|NCT02407990|83186638|FG002|Overall Study|Lost to Follow-up|0|||
46948114|NCT02407990|83186639|FG003|Overall Study|Lost to Follow-up|0|||
46948115|NCT02407990|83186640|FG004|Overall Study|Lost to Follow-up|0|||
46948116|NCT02407990|83186641|FG005|Overall Study|Lost to Follow-up|0|||
46948117|NCT02407990|83186642|FG006|Overall Study|Lost to Follow-up|0|||
46948118|NCT02407990|83186643|FG007|Overall Study|Lost to Follow-up|17|||
46948119|NCT02407990|83186636|FG000|Overall Study|Progressive Disease|0|||
46948120|NCT02407990|83186637|FG001|Overall Study|Progressive Disease|0|||
46948121|NCT02407990|83186638|FG002|Overall Study|Progressive Disease|0|||
46948122|NCT02407990|83186639|FG003|Overall Study|Progressive Disease|0|||
46948123|NCT02407990|83186640|FG004|Overall Study|Progressive Disease|0|||
46948124|NCT02407990|83186641|FG005|Overall Study|Progressive Disease|0|||
46948125|NCT02407990|83186642|FG006|Overall Study|Progressive Disease|0|||
46948126|NCT02407990|83186643|FG007|Overall Study|Progressive Disease|1|||
46948127|NCT02407990|83186636|FG000|Overall Study|Withdrawal by Subject|0|||
46948128|NCT02407990|83186637|FG001|Overall Study|Withdrawal by Subject|0|||
46948129|NCT02407990|83186638|FG002|Overall Study|Withdrawal by Subject|0|||
46948130|NCT02407990|83186639|FG003|Overall Study|Withdrawal by Subject|0|||
46948131|NCT02407990|83186640|FG004|Overall Study|Withdrawal by Subject|1|||
46948132|NCT02407990|83186641|FG005|Overall Study|Withdrawal by Subject|0|||
46948133|NCT02407990|83186642|FG006|Overall Study|Withdrawal by Subject|0|||
46948134|NCT02407990|83186643|FG007|Overall Study|Withdrawal by Subject|30|||
46948135|NCT02407990|83186636|FG000|Overall Study|Study Terminated by Sponsor|1|||
46948136|NCT02407990|83186637|FG001|Overall Study|Study Terminated by Sponsor|3|||
46948137|NCT02407990|83186638|FG002|Overall Study|Study Terminated by Sponsor|3|||
46948138|NCT02407990|83186639|FG003|Overall Study|Study Terminated by Sponsor|0|||
46948139|NCT02407990|83186640|FG004|Overall Study|Study Terminated by Sponsor|3|||
46948140|NCT02407990|83186641|FG005|Overall Study|Study Terminated by Sponsor|4|||
46948141|NCT02407990|83186642|FG006|Overall Study|Study Terminated by Sponsor|3|||
46948142|NCT02407990|83186643|FG007|Overall Study|Study Terminated by Sponsor|37|||
46638939|NCT01407354|82812409|FG001|First Intervention|Withdrawal by Subject|2|||
46841585|NCT00006604|83058714|FG013|Overall Study|Lost to Follow-up|0|||
46841586|NCT00006604|83058715|FG014|Overall Study|Lost to Follow-up|0|||
46841587|NCT00006604|83058716|FG015|Overall Study|Lost to Follow-up|1|||
46841588|NCT00006604|83058717|FG016|Overall Study|Lost to Follow-up|3|||
46841589|NCT00006604|83058701|FG000|Overall Study|Other Reason|0|||
46841590|NCT00006604|83058702|FG001|Overall Study|Other Reason|0|||
46841591|NCT00006604|83058703|FG002|Overall Study|Other Reason|0|||
46841592|NCT00006604|83058704|FG003|Overall Study|Other Reason|0|||
46841593|NCT00006604|83058705|FG004|Overall Study|Other Reason|0|||
46841594|NCT00006604|83058706|FG005|Overall Study|Other Reason|1|||
46841595|NCT00006604|83058707|FG006|Overall Study|Other Reason|0|||
46841596|NCT00006604|83058708|FG007|Overall Study|Other Reason|0|||
46841597|NCT00006604|83058709|FG008|Overall Study|Other Reason|0|||
46841598|NCT00006604|83058710|FG009|Overall Study|Other Reason|1|||
46841599|NCT00006604|83058711|FG010|Overall Study|Other Reason|0|||
46841600|NCT00006604|83058712|FG011|Overall Study|Other Reason|0|||
46948143|NCT02407990|83186636|FG000|Overall Study|Logistics|0|||
46841601|NCT00006604|83058713|FG012|Overall Study|Other Reason|0|||
46948144|NCT02407990|83186637|FG001|Overall Study|Logistics|0|||
46948145|NCT02407990|83186638|FG002|Overall Study|Logistics|0|||
46638940|NCT01407354|82812408|FG000|First Intervention|Adverse Event|1|||
46841602|NCT00006604|83058714|FG013|Overall Study|Other Reason|0|||
46841603|NCT00006604|83058715|FG014|Overall Study|Other Reason|0|||
46841604|NCT00006604|83058716|FG015|Overall Study|Other Reason|0|||
46948146|NCT02407990|83186639|FG003|Overall Study|Logistics|0|||
46948147|NCT02407990|83186640|FG004|Overall Study|Logistics|0|||
46948148|NCT02407990|83186641|FG005|Overall Study|Logistics|0|||
46948149|NCT02407990|83186642|FG006|Overall Study|Logistics|0|||
46948150|NCT02407990|83186643|FG007|Overall Study|Logistics|1|||
46841605|NCT00006604|83058717|FG016|Overall Study|Other Reason|0|||
46841606|NCT00436007|83058743|FG000|Overall Study|Withdrawal by Subject|5|||
46948151|NCT02407990|83186636|FG000|Overall Study|Rolled into long-term extension study|0|||
46948152|NCT02407990|83186637|FG001|Overall Study|Rolled into long-term extension study|0|||
46948153|NCT02407990|83186638|FG002|Overall Study|Rolled into long-term extension study|0|||
46948154|NCT02407990|83186639|FG003|Overall Study|Rolled into long-term extension study|0|||
46948155|NCT02407990|83186640|FG004|Overall Study|Rolled into long-term extension study|0|||
46948156|NCT02407990|83186641|FG005|Overall Study|Rolled into long-term extension study|0|||
46948157|NCT02407990|83186642|FG006|Overall Study|Rolled into long-term extension study|0|||
46948158|NCT02407990|83186643|FG007|Overall Study|Rolled into long-term extension study|1|||
46948159|NCT03288129|83186667|FG000|Overall Study|Adverse Event|10|||
46948160|NCT03288129|83186667|FG000|Overall Study|Lost to Follow-up|3|||
46948161|NCT03288129|83186667|FG000|Overall Study|Withdrawal by Subject|3|||
46948162|NCT03288129|83186667|FG000|Overall Study|Withdrawal of consent/assent|1|||
46638941|NCT01407354|82812409|FG001|First Intervention|Adverse Event|0|||
46841607|NCT00436007|83058744|FG001|Overall Study|Withdrawal by Subject|3|||
46841608|NCT00436007|83058745|FG002|Overall Study|Withdrawal by Subject|4|||
46841609|NCT00436007|83058743|FG000|Overall Study|Lost to Follow-up|14|||
46841610|NCT00436007|83058744|FG001|Overall Study|Lost to Follow-up|10|||
46841611|NCT00436007|83058745|FG002|Overall Study|Lost to Follow-up|13|||
46841612|NCT00436007|83058743|FG000|Overall Study|Physician Decision|0|||
46948163|NCT03288129|83186667|FG000|Overall Study|Other|5|||
46948164|NCT01673282|83186673|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
46948165|NCT01673282|83186674|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
46948166|NCT01673282|83186673|FG000|Overall Study|Lack of Efficacy|9|||
46948167|NCT01673282|83186674|FG001|Overall Study|Lack of Efficacy|2|||
46948168|NCT01673282|83186673|FG000|Overall Study|Lost to Follow-up|11|||
46948169|NCT01673282|83186674|FG001|Overall Study|Lost to Follow-up|10|||
46948170|NCT01673282|83186673|FG000|Overall Study|Withdrawal by Subject|3|||
46948171|NCT01673282|83186674|FG001|Overall Study|Withdrawal by Subject|3|||
46948172|NCT01673282|83186673|FG000|Overall Study|Other|1|||
46948173|NCT01673282|83186674|FG001|Overall Study|Other|6|||
46948174|NCT04157751|83186682|FG000|Overall Study|Withdrawal by Subject|12|||
46638942|NCT01407354|82812408|FG000|First Intervention|Physician Decision|1|||
46638943|NCT01407354|82812409|FG001|First Intervention|Physician Decision|0|||
46638944|NCT01407276|82812424|FG000|Overall Study|Withdrawal by Subject|0|||
46638945|NCT01407276|82812425|FG001|Overall Study|Withdrawal by Subject|0|||
46948175|NCT04157751|83186683|FG001|Overall Study|Withdrawal by Subject|17|||
46948176|NCT04157751|83186682|FG000|Overall Study|Lost to Follow-up|6|||
46948177|NCT04157751|83186683|FG001|Overall Study|Lost to Follow-up|2|||
46948178|NCT04157751|83186682|FG000|Overall Study|Adverse Event|34|||
46948179|NCT04157751|83186683|FG001|Overall Study|Adverse Event|23|||
46948180|NCT04157751|83186682|FG000|Overall Study|Not treated|1|||
46948181|NCT04157751|83186683|FG001|Overall Study|Not treated|5|||
46948182|NCT04157751|83186682|FG000|Overall Study|Other reason not stated above|10|||
46948183|NCT04157751|83186683|FG001|Overall Study|Other reason not stated above|10|||
46948184|NCT01673126|83186691|FG000|Overall Study|change of diagnosis|4|||
46948185|NCT01673126|83186692|FG001|Overall Study|change of diagnosis|3|||
46948186|NCT02407054|83186701|FG000|Overall Study|Adverse Event|1|||
46948187|NCT02407054|83186702|FG001|Overall Study|Adverse Event|4|||
46948188|NCT02407054|83186703|FG002|Overall Study|Adverse Event|1|||
47066460|NCT01451515|83349134|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
47066461|NCT01451515|83349132|FG000|Overall Study|Relapse (except CNS)|1|||
46638946|NCT01407276|82812426|FG002|Overall Study|Withdrawal by Subject|0|||
46638947|NCT01407276|82812427|FG003|Overall Study|Withdrawal by Subject|0|||
46638948|NCT01407276|82812428|FG004|Overall Study|Withdrawal by Subject|0|||
46638949|NCT01407276|82812429|FG005|Overall Study|Withdrawal by Subject|0|||
46771332|NCT00719043|82989526|FG001|Overall Study|Withdrawal by Subject|14|||
46771333|NCT00719043|82989527|FG002|Overall Study|Withdrawal by Subject|9|||
46771334|NCT00719043|82989528|FG003|Overall Study|Withdrawal by Subject|10|||
46771335|NCT00719043|82989529|FG004|Overall Study|Withdrawal by Subject|16|||
46771336|NCT00719043|82989530|FG005|Overall Study|Withdrawal by Subject|18|||
46771337|NCT00719043|82989531|FG006|Overall Study|Withdrawal by Subject|14|||
46771338|NCT00786422|82989559|FG000|Rivaroxaban Treatment|Death|2|||
46771339|NCT00786422|82989559|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
46771340|NCT00786422|82989559|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
46771341|NCT00786422|82989559|FG000|Rivaroxaban Treatment|Physician Decision|1|||
46771342|NCT00786422|82989559|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
46771343|NCT00786422|82989559|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
46771344|NCT00786422|82989559|FG000|Rivaroxaban Treatment|Adverse Event|2|||
46771345|NCT00786422|82989559|FG000|Follow-up Period|Death|1|||
46771346|NCT00786422|82989559|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
46771347|NCT00718887|82989567|FG000|Overall Study|Withdrawal by Subject|3|||
46948189|NCT02407054|83186701|FG000|Overall Study|Non-compliance with Study|0|||
46948190|NCT02407054|83186702|FG001|Overall Study|Non-compliance with Study|2|||
46948191|NCT02407054|83186703|FG002|Overall Study|Non-compliance with Study|1|||
46948192|NCT02407054|83186701|FG000|Overall Study|Physician Decision|1|||
46948193|NCT02407054|83186702|FG001|Overall Study|Physician Decision|3|||
46948194|NCT02407054|83186703|FG002|Overall Study|Physician Decision|3|||
46948195|NCT02407054|83186701|FG000|Overall Study|Withdrawal by Subject|5|||
46948196|NCT02407054|83186702|FG001|Overall Study|Withdrawal by Subject|9|||
46948197|NCT02407054|83186703|FG002|Overall Study|Withdrawal by Subject|2|||
46841613|NCT00436007|83058744|FG001|Overall Study|Physician Decision|0|||
46841614|NCT00436007|83058745|FG002|Overall Study|Physician Decision|2|||
46841615|NCT00436007|83058743|FG000|Overall Study|Death|0|||
46841616|NCT00436007|83058744|FG001|Overall Study|Death|1|||
46841617|NCT00436007|83058745|FG002|Overall Study|Death|3|||
46841618|NCT00436007|83058743|FG000|Overall Study|Other|0|||
46841619|NCT00436007|83058744|FG001|Overall Study|Other|0|||
46841620|NCT00436007|83058745|FG002|Overall Study|Other|1|||
46841621|NCT00435461|83058761|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
46841622|NCT00435461|83058762|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
46841623|NCT00435461|83058763|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
46841624|NCT00435461|83058761|FG000|Overall Study|Protocol Violation|6|||
46841625|NCT00435461|83058762|FG001|Overall Study|Protocol Violation|9|||
46841626|NCT00435461|83058763|FG002|Overall Study|Protocol Violation|10|||
46841627|NCT00435461|83058761|FG000|Overall Study|Participant randomized(inadequate score)|1|||
46841628|NCT00435461|83058762|FG001|Overall Study|Participant randomized(inadequate score)|0|||
46841629|NCT00435461|83058763|FG002|Overall Study|Participant randomized(inadequate score)|0|||
46841630|NCT00435461|83058761|FG000|Overall Study|Compliance less than 80 percent|1|||
46841631|NCT00435461|83058762|FG001|Overall Study|Compliance less than 80 percent|0|||
46841632|NCT00435461|83058763|FG002|Overall Study|Compliance less than 80 percent|0|||
46841633|NCT00435461|83058761|FG000|Overall Study|In error, two study medications switched|1|||
46841634|NCT00435461|83058762|FG001|Overall Study|In error, two study medications switched|0|||
46841635|NCT00435461|83058763|FG002|Overall Study|In error, two study medications switched|0|||
46841636|NCT00435461|83058761|FG000|Overall Study|Lack of Efficacy|2|||
46841637|NCT00435461|83058762|FG001|Overall Study|Lack of Efficacy|1|||
46841638|NCT00435461|83058763|FG002|Overall Study|Lack of Efficacy|0|||
46841639|NCT00435461|83058761|FG000|Overall Study|Withdrawal by Subject|1|||
46841640|NCT00435461|83058762|FG001|Overall Study|Withdrawal by Subject|0|||
46841641|NCT00435461|83058763|FG002|Overall Study|Withdrawal by Subject|2|||
46841642|NCT00435461|83058761|FG000|Overall Study|Randomized in error|1|||
46841643|NCT00435461|83058762|FG001|Overall Study|Randomized in error|0|||
46841644|NCT00435461|83058763|FG002|Overall Study|Randomized in error|0|||
46841645|NCT00435461|83058761|FG000|Overall Study|Participant could not tolerate symptoms|0|||
46841646|NCT00435461|83058762|FG001|Overall Study|Participant could not tolerate symptoms|0|||
46841647|NCT00435461|83058763|FG002|Overall Study|Participant could not tolerate symptoms|1|||
46841648|NCT00435461|83058761|FG000|Overall Study|Participant could not swallow capsule|0|||
46841649|NCT00435461|83058762|FG001|Overall Study|Participant could not swallow capsule|0|||
46841650|NCT00435461|83058763|FG002|Overall Study|Participant could not swallow capsule|1|||
46841651|NCT00435461|83058761|FG000|Overall Study|Pregnancy|2|||
46841652|NCT00435461|83058762|FG001|Overall Study|Pregnancy|0|||
46841653|NCT00435461|83058763|FG002|Overall Study|Pregnancy|0|||
46841654|NCT00435461|83058761|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
46841655|NCT00435461|83058762|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
46841656|NCT00435461|83058763|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
46841657|NCT00435461|83058761|FG000|Overall Study|Participant ended study one day early|1|||
46841658|NCT00435461|83058762|FG001|Overall Study|Participant ended study one day early|0|||
46841659|NCT00435461|83058763|FG002|Overall Study|Participant ended study one day early|0|||
46841660|NCT00435461|83058761|FG000|Overall Study|Noncompliance with study requirements|1|||
46841661|NCT00435461|83058762|FG001|Overall Study|Noncompliance with study requirements|1|||
46841662|NCT00435461|83058763|FG002|Overall Study|Noncompliance with study requirements|1|||
46841663|NCT00435461|83058761|FG000|Overall Study|Adverse Event|1|||
46841664|NCT00435461|83058762|FG001|Overall Study|Adverse Event|2|||
46841665|NCT00435461|83058763|FG002|Overall Study|Adverse Event|6|||
46841666|NCT00435461|83058761|FG000|Overall Study|Non-Compliance of diary|2|||
46841667|NCT00435461|83058762|FG001|Overall Study|Non-Compliance of diary|0|||
46841668|NCT00435461|83058763|FG002|Overall Study|Non-Compliance of diary|1|||
46841669|NCT00435461|83058761|FG000|Overall Study|Lost to Follow-up|1|||
46841670|NCT00435461|83058762|FG001|Overall Study|Lost to Follow-up|1|||
46841671|NCT00435461|83058763|FG002|Overall Study|Lost to Follow-up|2|||
46841672|NCT00434759|83058773|FG000|Overall Study|Lack of Efficacy|5|||
46841673|NCT00434759|83058774|FG001|Overall Study|Lack of Efficacy|4|||
46841674|NCT00434759|83058773|FG000|Overall Study|Withdrawal by Subject|17|||
46841675|NCT00434759|83058774|FG001|Overall Study|Withdrawal by Subject|1|||
46841676|NCT00434759|83058773|FG000|Overall Study|family affairs|2|||
46841677|NCT00434759|83058774|FG001|Overall Study|family affairs|0|||
46841678|NCT00440999|83058784|FG000|Overall Study|Adverse Event|0|||
46841679|NCT00440999|83058785|FG001|Overall Study|Adverse Event|2|||
46841680|NCT00440999|83058784|FG000|Overall Study|Lack of Efficacy|6|||
46841681|NCT00440999|83058785|FG001|Overall Study|Lack of Efficacy|7|||
46841682|NCT00440999|83058784|FG000|Overall Study|Lost to Follow-up|19|||
46841683|NCT00440999|83058785|FG001|Overall Study|Lost to Follow-up|12|||
46841684|NCT00440999|83058784|FG000|Overall Study|Protocol Violation|1|||
46841685|NCT00440999|83058785|FG001|Overall Study|Protocol Violation|0|||
46841686|NCT00440999|83058784|FG000|Overall Study|Withdrawal by Subject|2|||
46841687|NCT00440999|83058785|FG001|Overall Study|Withdrawal by Subject|5|||
46948198|NCT01652716|83186714|FG000|Overall Study|Loss of glucose control|1|||
46948199|NCT01652716|83186715|FG001|Overall Study|Loss of glucose control|0|||
46948200|NCT01652716|83186714|FG000|Overall Study|Administrative|0|||
46948201|NCT01652716|83186715|FG001|Overall Study|Administrative|2|||
46948202|NCT01652716|83186714|FG000|Overall Study|Investigator decision|1|||
46948203|NCT01652716|83186715|FG001|Overall Study|Investigator decision|4|||
46948204|NCT01652716|83186714|FG000|Overall Study|Lost to Follow-up|12|||
46948205|NCT01652716|83186715|FG001|Overall Study|Lost to Follow-up|11|||
46948206|NCT01652716|83186714|FG000|Overall Study|Protocol Violation|2|||
46948207|NCT01652716|83186715|FG001|Overall Study|Protocol Violation|1|||
46948208|NCT01652716|83186714|FG000|Overall Study|Adverse Event|7|||
46948209|NCT01652716|83186715|FG001|Overall Study|Adverse Event|10|||
46948210|NCT01652716|83186714|FG000|Overall Study|Withdrawal by Subject|33|||
46948211|NCT01652716|83186715|FG001|Overall Study|Withdrawal by Subject|18|||
46948212|NCT02790073|83186721|FG000|Overall Study|Death|1|||
46948213|NCT02790073|83186721|FG000|Overall Study|Withdrawal from HD|1|||
46948214|NCT02790073|83186721|FG000|Overall Study|Withdrawal by Subject|1|||
46948215|NCT02789137|83186725|FG000|Overall Study|Dropped out/Died|58|||
46948216|NCT01672970|83186730|FG000|Overall Study|Lack of Efficacy|12|||
46948217|NCT01672970|83186730|FG000|Overall Study|Adverse Event|18|||
46948218|NCT01672970|83186730|FG000|Overall Study|Withdrawal by Subject|2|||
46948219|NCT01672970|83186730|FG000|Overall Study|Lost to Follow-up|5|||
46948220|NCT01672970|83186730|FG000|Overall Study|Other|9|||
46948221|NCT01672970|83186730|FG000|Overall Study|Enrolled but not treated|1|||
46948222|NCT02788747|83186737|FG000|Overall Study|Adverse Event|1|||
46948223|NCT02788747|83186738|FG001|Overall Study|Adverse Event|0|||
46948224|NCT02788747|83186739|FG002|Overall Study|Adverse Event|0|||
46948225|NCT02406742|83186753|FG000|Overall Study|Progression of Disease|5|||
46948226|NCT02406742|83186754|FG001|Overall Study|Progression of Disease|1|||
46948227|NCT02406742|83186755|FG002|Overall Study|Progression of Disease|6|||
46948228|NCT02406742|83186753|FG000|Overall Study|Adverse Event|3|||
46948229|NCT02406742|83186754|FG001|Overall Study|Adverse Event|0|||
46948230|NCT02406742|83186755|FG002|Overall Study|Adverse Event|2|||
46948231|NCT02406742|83186753|FG000|Overall Study|Death|1|||
46948232|NCT02406742|83186754|FG001|Overall Study|Death|0|||
46948233|NCT02406742|83186755|FG002|Overall Study|Death|0|||
46948234|NCT02406742|83186753|FG000|Overall Study|Lack of Efficacy|0|||
46948235|NCT02406742|83186754|FG001|Overall Study|Lack of Efficacy|0|||
46948236|NCT02406742|83186755|FG002|Overall Study|Lack of Efficacy|1|||
46948237|NCT02406742|83186753|FG000|Overall Study|Withdrawal by Participant|1|||
46948238|NCT02406742|83186754|FG001|Overall Study|Withdrawal by Participant|2|||
46948239|NCT02406742|83186755|FG002|Overall Study|Withdrawal by Participant|0|||
46948240|NCT02406742|83186753|FG000|Overall Study|Physician Decision|1|||
46948241|NCT02406742|83186754|FG001|Overall Study|Physician Decision|2|||
46948242|NCT02406742|83186755|FG002|Overall Study|Physician Decision|1|||
46948243|NCT02406742|83186753|FG000|Overall Study|Transition to other treatment|2|||
46948244|NCT02406742|83186754|FG001|Overall Study|Transition to other treatment|0|||
46948245|NCT02406742|83186755|FG002|Overall Study|Transition to other treatment|1|||
46948246|NCT02406742|83186753|FG000|Overall Study|Other Reasons|1|||
46948247|NCT02406742|83186754|FG001|Overall Study|Other Reasons|11|||
46948248|NCT02406742|83186755|FG002|Overall Study|Other Reasons|5|||
46948249|NCT02714595|83186765|FG000|Overall Study|Lost to Follow-up|1|||
46948250|NCT02714595|83186766|FG001|Overall Study|Lost to Follow-up|0|||
46638950|NCT01407276|82812430|FG006|Overall Study|Withdrawal by Subject|0|||
46638951|NCT01407276|82812431|FG007|Overall Study|Withdrawal by Subject|1|||
46638952|NCT01390272|82812458|FG000|Overall Study|Death|3|||
46638953|NCT01390272|82812459|FG001|Overall Study|Death|2|||
46638954|NCT01390272|82812458|FG000|Overall Study|Withdrawal by Subject|9|||
46638955|NCT01390272|82812459|FG001|Overall Study|Withdrawal by Subject|5|||
46638956|NCT01390272|82812458|FG000|Overall Study|Patient moved, no longer eligible|5|||
46638957|NCT01390272|82812459|FG001|Overall Study|Patient moved, no longer eligible|8|||
46638958|NCT01429584|82812467|FG000|Overall Study|Withdrawal by Subject|1|||
46948251|NCT02714595|83186765|FG000|Overall Study|Withdrawal by Subject|1|||
46948252|NCT02714595|83186766|FG001|Overall Study|Withdrawal by Subject|2|||
46948253|NCT02714595|83186765|FG000|Overall Study|Lack of Efficacy|0|||
46948254|NCT02714595|83186766|FG001|Overall Study|Lack of Efficacy|1|||
47066462|NCT01451515|83349133|FG001|Overall Study|Relapse (except CNS)|1|||
46638959|NCT01429584|82812468|FG001|Overall Study|Withdrawal by Subject|0|||
46771348|NCT00718887|82989568|FG001|Overall Study|Withdrawal by Subject|2|||
46771349|NCT00718887|82989567|FG000|Overall Study|Not identified|2|||
46771350|NCT00718887|82989568|FG001|Overall Study|Not identified|7|||
46771351|NCT00786188|82989582|FG000|Overall Study|Adverse Event|3|||
46771352|NCT00786188|82989583|FG001|Overall Study|Adverse Event|1|||
46771353|NCT00786188|82989582|FG000|Overall Study|Withdrawal by Subject|2|||
46771354|NCT00786188|82989583|FG001|Overall Study|Withdrawal by Subject|0|||
46771355|NCT00790556|82989591|FG000|Treatment Period 1|Physician Decision|1|||
46771356|NCT00790556|82989592|FG001|Treatment Period 1|Physician Decision|0|||
46771357|NCT00790556|82989591|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46948255|NCT02714595|83186765|FG000|Overall Study|Death|30|||
46948256|NCT02714595|83186766|FG001|Overall Study|Death|9|||
46948257|NCT02714595|83186765|FG000|Overall Study|Other-Miscellaneous|0|||
46841688|NCT00440999|83058784|FG000|Overall Study|Subjets missed the visit|1|||
46841689|NCT00440999|83058785|FG001|Overall Study|Subjets missed the visit|0|||
46771358|NCT00790556|82989592|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46771359|NCT00733824|82989603|FG000|Phase I|Withdrawal by Subject|1|||
46771360|NCT00733824|82989604|FG001|Phase I|Withdrawal by Subject|0|||
46771361|NCT00733824|82989605|FG002|Phase I|Withdrawal by Subject|0|||
46771362|NCT00733824|82989606|FG003|Phase I|Withdrawal by Subject|0|||
46771363|NCT00733824|82989607|FG004|Phase I|Withdrawal by Subject|0|||
46771364|NCT00718809|82989623|FG000|Overall Study|Disease progression|9|||
46771365|NCT00718809|82989624|FG001|Overall Study|Disease progression|7|||
46771366|NCT00718809|82989623|FG000|Overall Study|Adverse Event|1|||
46771367|NCT00718809|82989624|FG001|Overall Study|Adverse Event|1|||
46771368|NCT00718809|82989623|FG000|Overall Study|Withdrawal by Subject|0|||
46841690|NCT00440999|83058784|FG000|Overall Study|Mixed infection at entry|1|||
46841691|NCT00440999|83058785|FG001|Overall Study|Mixed infection at entry|0|||
46841692|NCT00440999|83058784|FG000|Overall Study|P. falciparum malaria|5|||
46638960|NCT01429584|82812467|FG000|Overall Study|Protocol Violation|0|||
46638961|NCT01429584|82812468|FG001|Overall Study|Protocol Violation|1|||
46771369|NCT00718809|82989624|FG001|Overall Study|Withdrawal by Subject|1|||
46771370|NCT00718809|82989623|FG000|Overall Study|Lost to Follow-up|1|||
46841693|NCT00440999|83058785|FG001|Overall Study|P. falciparum malaria|14|||
46841694|NCT00440999|83058784|FG000|Overall Study|Subj left hosp without inform staff|0|||
46841695|NCT00440999|83058785|FG001|Overall Study|Subj left hosp without inform staff|1|||
46841696|NCT00434213|83058793|FG000|Overall Study|Adverse Event|12|||
46841697|NCT00434213|83058793|FG000|Overall Study|Lack of Efficacy|9|||
46841698|NCT00434213|83058793|FG000|Overall Study|Lost to Follow-up|14|||
46841699|NCT00434213|83058793|FG000|Overall Study|Withdrawal by Subject|7|||
46841700|NCT00434213|83058793|FG000|Overall Study|Protocol Violation|3|||
46841701|NCT00434213|83058793|FG000|Overall Study|Unable to comply with study visit window|2|||
46841702|NCT00434213|83058793|FG000|Overall Study|Application site reaction|1|||
46841703|NCT00434213|83058793|FG000|Overall Study|Non-compliant to study schedule|1|||
46841704|NCT00006184|83058799|FG000|Overall Study|Death|1|||
46841705|NCT00006184|83058800|FG001|Overall Study|Death|0|||
46841706|NCT00434057|83058806|FG000|Overall Study|Withdrawal by Subject|1|||
46841707|NCT00433199|83058812|FG000|Double-Blind Period|Adverse Event|0|||
46841708|NCT00433199|83058813|FG001|Double-Blind Period|Adverse Event|25|||
46841709|NCT00433199|83058812|FG000|Double-Blind Period|Lack of Efficacy|0|||
46841710|NCT00433199|83058813|FG001|Double-Blind Period|Lack of Efficacy|2|||
46841711|NCT00433199|83058812|FG000|Double-Blind Period|Lost to Follow-up|2|||
46841712|NCT00433199|83058813|FG001|Double-Blind Period|Lost to Follow-up|5|||
46841713|NCT00433199|83058812|FG000|Double-Blind Period|Withdrawal by Subject|8|||
46841714|NCT00433199|83058813|FG001|Double-Blind Period|Withdrawal by Subject|19|||
46841715|NCT00433199|83058812|FG000|Double-Blind Period|Protocol Violation|1|||
46841716|NCT00433199|83058813|FG001|Double-Blind Period|Protocol Violation|10|||
46841717|NCT00433199|83058812|FG000|Double-Blind Period|Administrative|1|||
46841718|NCT00433199|83058813|FG001|Double-Blind Period|Administrative|5|||
46841719|NCT00433199|83058812|FG000|Open-Label Period|Adverse Event|0|||
46841720|NCT00433199|83058813|FG001|Open-Label Period|Adverse Event|19|||
46771371|NCT00718809|82989624|FG001|Overall Study|Lost to Follow-up|0|||
46841721|NCT00433199|83058812|FG000|Open-Label Period|Lack of Efficacy|0|||
46841722|NCT00433199|83058813|FG001|Open-Label Period|Lack of Efficacy|2|||
46841723|NCT00433199|83058812|FG000|Open-Label Period|Lost to Follow-up|0|||
46841724|NCT00433199|83058813|FG001|Open-Label Period|Lost to Follow-up|3|||
46841725|NCT00433199|83058812|FG000|Open-Label Period|Withdrawal by Subject|0|||
46841726|NCT00433199|83058813|FG001|Open-Label Period|Withdrawal by Subject|7|||
46948258|NCT02714595|83186766|FG001|Overall Study|Other-Miscellaneous|1|||
46948259|NCT02437162|83186793|FG000|Overall Study|Protocol Violation|0|||
46771372|NCT00718809|82989623|FG000|Overall Study|Noncompliance|1|||
46948260|NCT02437162|83186794|FG001|Overall Study|Protocol Violation|1|||
46948261|NCT02437162|83186795|FG002|Overall Study|Protocol Violation|0|||
46638962|NCT01406652|82812476|FG000|Overall Study|Lost-to-follow-up|3|||
46771373|NCT00718809|82989624|FG001|Overall Study|Noncompliance|0|||
46948262|NCT02437162|83186793|FG000|Overall Study|Randomized but not treated|0|||
46841727|NCT00433199|83058812|FG000|Open-Label Period|Protocol Violation|0|||
46841728|NCT00433199|83058813|FG001|Open-Label Period|Protocol Violation|2|||
46841729|NCT00433199|83058812|FG000|Open-Label Period|Administrative|0|||
46841730|NCT00433199|83058813|FG001|Open-Label Period|Administrative|1|||
46948263|NCT02437162|83186794|FG001|Overall Study|Randomized but not treated|0|||
46948264|NCT02437162|83186795|FG002|Overall Study|Randomized but not treated|1|||
46948265|NCT02437162|83186793|FG000|Overall Study|Study discontinued by Sponsor|93|||
46948266|NCT02437162|83186794|FG001|Overall Study|Study discontinued by Sponsor|98|||
46638963|NCT01406652|82812477|FG001|Overall Study|Lost-to-follow-up|4|||
46771374|NCT00585039|82989632|FG000|Overall Study|medication spilled|2|||
46771375|NCT00585039|82989633|FG001|Overall Study|medication spilled|0|||
46771376|NCT00806195|82989645|FG000|Overall Study|Death|6|||
46771377|NCT00806195|82989646|FG001|Overall Study|Death|0|||
46771378|NCT00806195|82989647|FG002|Overall Study|Death|1|||
46771379|NCT00806195|82989648|FG003|Overall Study|Death|0|||
46771380|NCT00806195|82989645|FG000|Overall Study|Adverse Event|25|||
46771381|NCT00806195|82989646|FG001|Overall Study|Adverse Event|5|||
46841731|NCT00005908|83058824|FG000|Overall Study|Withdrawal by Subject|1|||
46841732|NCT00005908|83058825|FG001|Overall Study|Withdrawal by Subject|0|||
46841733|NCT00432965|83058836|FG000|Overall Study|Lost to Follow-up|22|||
46841734|NCT00432965|83058837|FG001|Overall Study|Lost to Follow-up|19|||
46841735|NCT00432965|83058836|FG000|Overall Study|Withdrawal by Subject|13|||
46841736|NCT00432965|83058837|FG001|Overall Study|Withdrawal by Subject|13|||
46841737|NCT00432965|83058836|FG000|Overall Study|Physician Decision|14|||
46841738|NCT00432965|83058837|FG001|Overall Study|Physician Decision|13|||
46841739|NCT00432965|83058836|FG000|Overall Study|Lack of Efficacy|8|||
46841740|NCT00432965|83058837|FG001|Overall Study|Lack of Efficacy|13|||
46841741|NCT00432965|83058836|FG000|Overall Study|Non-compliance|7|||
46841742|NCT00432965|83058837|FG001|Overall Study|Non-compliance|0|||
46841743|NCT00432965|83058836|FG000|Overall Study|Adverse Event|22|||
46841744|NCT00432965|83058837|FG001|Overall Study|Adverse Event|19|||
46841745|NCT00432965|83058836|FG000|Overall Study|Death|3|||
46841746|NCT00432965|83058837|FG001|Overall Study|Death|4|||
46841747|NCT00432965|83058836|FG000|Overall Study|Exclusionary Methods|1|||
46841748|NCT00432965|83058837|FG001|Overall Study|Exclusionary Methods|2|||
46841749|NCT00432965|83058836|FG000|Overall Study|Incomplete Data|4|||
46841750|NCT00432965|83058837|FG001|Overall Study|Incomplete Data|3|||
46841751|NCT00440297|83058845|FG000|Overall Study|Adverse Event|8|||
46841752|NCT00440297|83058846|FG001|Overall Study|Adverse Event|5|||
46841753|NCT00440297|83058845|FG000|Overall Study|Lost to Follow-up|1|||
46841754|NCT00440297|83058846|FG001|Overall Study|Lost to Follow-up|0|||
46841755|NCT00440297|83058845|FG000|Overall Study|Physician Decision|1|||
46841756|NCT00440297|83058846|FG001|Overall Study|Physician Decision|0|||
46841757|NCT00440297|83058845|FG000|Overall Study|Protocol Violation|11|||
46841758|NCT00440297|83058846|FG001|Overall Study|Protocol Violation|7|||
46841759|NCT00440297|83058845|FG000|Overall Study|Withdrawal by Subject|1|||
46841760|NCT00440297|83058846|FG001|Overall Study|Withdrawal by Subject|6|||
46841761|NCT00440297|83058845|FG000|Overall Study|Randomized by mistake|1|||
46841762|NCT00440297|83058846|FG001|Overall Study|Randomized by mistake|0|||
46841763|NCT00432809|83058855|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
46841764|NCT00432809|83058856|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
46841765|NCT00432809|83058857|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
46841766|NCT00432809|83058855|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
46841767|NCT00432809|83058856|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
46841768|NCT00432809|83058857|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
46841769|NCT00431951|83058869|FG000|Overall Study|Inability to follow study procedures|1|||
46841770|NCT00431951|83058870|FG001|Overall Study|Inability to follow study procedures|0|||
46841771|NCT00431951|83058871|FG002|Overall Study|Inability to follow study procedures|1|||
46841772|NCT00431951|83058872|FG003|Overall Study|Inability to follow study procedures|2|||
46841773|NCT00431951|83058869|FG000|Overall Study|Lost to Follow-up|0|||
46841774|NCT00431951|83058870|FG001|Overall Study|Lost to Follow-up|1|||
46841775|NCT00431951|83058871|FG002|Overall Study|Lost to Follow-up|0|||
46841776|NCT00431951|83058872|FG003|Overall Study|Lost to Follow-up|0|||
46841777|NCT00431951|83058869|FG000|Overall Study|Withdrawal by Subject|0|||
46638964|NCT01406652|82812476|FG000|Overall Study|Withdrawal by Subject|2|||
46841778|NCT00431951|83058870|FG001|Overall Study|Withdrawal by Subject|1|||
46841779|NCT00431951|83058871|FG002|Overall Study|Withdrawal by Subject|0|||
46841780|NCT00431951|83058872|FG003|Overall Study|Withdrawal by Subject|0|||
46841781|NCT00431951|83058869|FG000|Overall Study|Adverse Event|0|||
46841782|NCT00431951|83058870|FG001|Overall Study|Adverse Event|0|||
46948267|NCT02437162|83186795|FG002|Overall Study|Study discontinued by Sponsor|97|||
46948268|NCT02437162|83186793|FG000|Overall Study|Withdrawal by Subject|13|||
46771382|NCT00806195|82989647|FG002|Overall Study|Adverse Event|11|||
46771383|NCT00806195|82989648|FG003|Overall Study|Adverse Event|2|||
46841783|NCT00431951|83058871|FG002|Overall Study|Adverse Event|1|||
46841784|NCT00431951|83058872|FG003|Overall Study|Adverse Event|0|||
46841785|NCT00004978|83058888|FG000|Overall Study|Death|107|||
46841786|NCT00004978|83058889|FG001|Overall Study|Death|116|||
46948269|NCT02437162|83186794|FG001|Overall Study|Withdrawal by Subject|7|||
46948270|NCT02437162|83186795|FG002|Overall Study|Withdrawal by Subject|9|||
46948271|NCT02437162|83186793|FG000|Overall Study|Adverse Event|0|||
46948272|NCT02437162|83186794|FG001|Overall Study|Adverse Event|1|||
46948273|NCT02437162|83186795|FG002|Overall Study|Adverse Event|0|||
46948274|NCT02437162|83186793|FG000|Overall Study|Lost to Follow-up|1|||
46948275|NCT02437162|83186794|FG001|Overall Study|Lost to Follow-up|0|||
46948276|NCT02437162|83186795|FG002|Overall Study|Lost to Follow-up|1|||
46948277|NCT02437162|83186793|FG000|Overall Study|Death|0|||
46948278|NCT02437162|83186794|FG001|Overall Study|Death|1|||
46948279|NCT02437162|83186795|FG002|Overall Study|Death|0|||
46948280|NCT02437162|83186793|FG000|Overall Study|Other|0|||
46948281|NCT02437162|83186794|FG001|Overall Study|Other|0|||
46948282|NCT02437162|83186795|FG002|Overall Study|Other|1|||
46948283|NCT01368211|83186810|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
46948284|NCT01368211|83186811|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
46948285|NCT02437084|83186817|FG000|Overall Study|Withdrawal by Subject|2|||
46948286|NCT02437084|83186817|FG000|Overall Study|Physician Decision|1|||
46948287|NCT02406586|83186824|FG000|Overall Study|Lost to Follow-up|0|||
46948288|NCT02406586|83186825|FG001|Overall Study|Lost to Follow-up|4|||
46948289|NCT02406586|83186826|FG002|Overall Study|Lost to Follow-up|2|||
46948290|NCT02406586|83186824|FG000|Overall Study|Withdrawal by Subject|1|||
46948291|NCT02406586|83186825|FG001|Overall Study|Withdrawal by Subject|0|||
46948292|NCT02406586|83186826|FG002|Overall Study|Withdrawal by Subject|0|||
46948293|NCT02460562|83186839|FG000|Overall Study|Lost to Follow-up|15|||
46948294|NCT02460562|83186840|FG001|Overall Study|Lost to Follow-up|16|||
46948295|NCT02788357|83186857|FG000|Overall Study|Lost to Follow-up|3|||
46948296|NCT02788357|83186858|FG001|Overall Study|Lost to Follow-up|0|||
46948297|NCT02457910|83186870|FG000|Overall Study|Withdrawal by Subject|0|||
46948298|NCT02457910|83186871|FG001|Overall Study|Withdrawal by Subject|0|||
46948299|NCT02457910|83186872|FG002|Overall Study|Withdrawal by Subject|0|||
46948300|NCT02457910|83186873|FG003|Overall Study|Withdrawal by Subject|0|||
46948301|NCT02457910|83186874|FG004|Overall Study|Withdrawal by Subject|0|||
46948302|NCT02457910|83186875|FG005|Overall Study|Withdrawal by Subject|1|||
46948303|NCT02457910|83186870|FG000|Overall Study|Adverse Event|0|||
46948304|NCT02457910|83186871|FG001|Overall Study|Adverse Event|2|||
46948305|NCT02457910|83186872|FG002|Overall Study|Adverse Event|1|||
46948306|NCT02457910|83186873|FG003|Overall Study|Adverse Event|1|||
46948307|NCT02457910|83186874|FG004|Overall Study|Adverse Event|1|||
46948308|NCT02457910|83186875|FG005|Overall Study|Adverse Event|3|||
46948309|NCT02457910|83186870|FG000|Overall Study|Disease progression|3|||
46948310|NCT02457910|83186871|FG001|Overall Study|Disease progression|3|||
46948311|NCT02457910|83186872|FG002|Overall Study|Disease progression|1|||
46948312|NCT02457910|83186873|FG003|Overall Study|Disease progression|1|||
46948313|NCT02457910|83186874|FG004|Overall Study|Disease progression|4|||
46948314|NCT02457910|83186875|FG005|Overall Study|Disease progression|6|||
46948315|NCT02457910|83186870|FG000|Overall Study|Other complicating illness|0|||
46948316|NCT02457910|83186871|FG001|Overall Study|Other complicating illness|0|||
46948317|NCT02457910|83186872|FG002|Overall Study|Other complicating illness|0|||
46948318|NCT02457910|83186873|FG003|Overall Study|Other complicating illness|0|||
46948319|NCT02457910|83186874|FG004|Overall Study|Other complicating illness|0|||
46948320|NCT02457910|83186875|FG005|Overall Study|Other complicating illness|1|||
46948321|NCT02457910|83186870|FG000|Overall Study|Death|0|||
46948322|NCT02457910|83186871|FG001|Overall Study|Death|0|||
46948323|NCT02457910|83186872|FG002|Overall Study|Death|1|||
46948324|NCT02457910|83186873|FG003|Overall Study|Death|0|||
46948325|NCT02457910|83186874|FG004|Overall Study|Death|0|||
46948326|NCT02457910|83186875|FG005|Overall Study|Death|0|||
46948327|NCT02405962|83186894|FG000|Overall Study|Lost to Follow-up|1|||
46948328|NCT02405962|83186895|FG001|Overall Study|Lost to Follow-up|4|||
47066463|NCT01451515|83349134|FG002|Overall Study|Relapse (except CNS)|0|||
47066464|NCT01466881|83349145|FG000|Overall Study|Ineligible|5|||
47066465|NCT01466881|83349145|FG000|Overall Study|Adverse Event|6|||
47066466|NCT01466881|83349145|FG000|Overall Study|Progression/relapse|20|||
47066467|NCT01466881|83349145|FG000|Overall Study|Death|4|||
47066468|NCT01466881|83349145|FG000|Overall Study|Other reason not protocol specified|5|||
47066469|NCT01576406|83349157|FG000|Overall Study|Lost to Follow-up|1|||
46638965|NCT01406652|82812477|FG001|Overall Study|Withdrawal by Subject|2|||
46948329|NCT02405962|83186894|FG000|Overall Study|A participant has moved to another place|0|||
46948330|NCT02405962|83186895|FG001|Overall Study|A participant has moved to another place|1|||
47066470|NCT01576406|83349158|FG001|Overall Study|Lost to Follow-up|2|||
46948331|NCT02436304|83186904|FG000|Overall Study|Lost to Follow-up|0|||
46948332|NCT02436304|83186905|FG001|Overall Study|Lost to Follow-up|1|||
46948333|NCT02436304|83186906|FG002|Overall Study|Lost to Follow-up|0|||
46948334|NCT02436304|83186904|FG000|Overall Study|Withdrawal by Subject|0|||
46948335|NCT02436304|83186905|FG001|Overall Study|Withdrawal by Subject|1|||
46948336|NCT02436304|83186906|FG002|Overall Study|Withdrawal by Subject|0|||
46948337|NCT02436304|83186904|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
47066471|NCT01576406|83349159|FG002|Overall Study|Lost to Follow-up|0|||
46948338|NCT02436304|83186905|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
46948339|NCT02436304|83186906|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
46948340|NCT02402218|83186918|FG000|Overall Study|Did not pickup study medication|12|||
46948341|NCT02402218|83186919|FG001|Overall Study|Did not pickup study medication|9|||
46948342|NCT02402218|83186920|FG002|Overall Study|Did not pickup study medication|13|||
46948343|NCT02402218|83186918|FG000|Overall Study|Lack of Efficacy|0|||
46948344|NCT02402218|83186919|FG001|Overall Study|Lack of Efficacy|1|||
46948345|NCT02402218|83186920|FG002|Overall Study|Lack of Efficacy|1|||
46948346|NCT02402218|83186918|FG000|Overall Study|Death|1|||
46948347|NCT02402218|83186919|FG001|Overall Study|Death|0|||
46948348|NCT02402218|83186920|FG002|Overall Study|Death|0|||
46948349|NCT02402218|83186918|FG000|Overall Study|Reinfection|0|||
46841787|NCT00004978|83058888|FG000|Overall Study|Lost to Follow-up|101|||
46841788|NCT00004978|83058889|FG001|Overall Study|Lost to Follow-up|108|||
46841789|NCT00004978|83058888|FG000|Overall Study|Withdrawal by Subject|17|||
46948350|NCT02402218|83186919|FG001|Overall Study|Reinfection|0|||
46948351|NCT02402218|83186920|FG002|Overall Study|Reinfection|1|||
46948352|NCT02402218|83186918|FG000|Overall Study|Adverse Event|0|||
46948353|NCT02402218|83186919|FG001|Overall Study|Adverse Event|2|||
46948354|NCT02402218|83186920|FG002|Overall Study|Adverse Event|1|||
46948355|NCT02402218|83186918|FG000|Overall Study|Withdrawal by Subject|1|||
46948356|NCT02402218|83186919|FG001|Overall Study|Withdrawal by Subject|1|||
46948357|NCT02402218|83186920|FG002|Overall Study|Withdrawal by Subject|1|||
46948358|NCT02457520|83186928|FG000|Active Treatment Phase|Adverse Event|10|||
46948359|NCT02457520|83186928|FG000|Active Treatment Phase|Lost to Follow-up|8|||
46948360|NCT02457520|83186928|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
46948361|NCT02457520|83186928|FG000|Active Treatment Phase|other|4|||
46948362|NCT02457520|83186928|FG000|Active Treatment Phase|Physician Decision|1|||
46948363|NCT02457520|83186928|FG000|Active Treatment Phase|Protocol Violation|1|||
46948364|NCT02457520|83186928|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
46948365|NCT02457520|83186928|FG000|Post-treatment Period|Other: Retreatment Required|7|||
46948366|NCT02457520|83186928|FG000|Post-treatment Period|Lost to Follow-up|23|||
46948367|NCT02457520|83186928|FG000|Post-treatment Period|Other|3|||
46948368|NCT02457520|83186928|FG000|Post-treatment Period|Physician Decision|1|||
46948369|NCT02457520|83186928|FG000|Post-treatment Period|Withdrawal by Subject|14|||
46948370|NCT02788279|83186961|FG000|Overall Study|Death|62|||
46948371|NCT02788279|83186962|FG001|Overall Study|Death|136|||
46948372|NCT02788279|83186963|FG002|Overall Study|Death|72|||
46948373|NCT02788279|83186961|FG000|Overall Study|Withdrawal by Subject|10|||
46948374|NCT02788279|83186962|FG001|Overall Study|Withdrawal by Subject|15|||
46948375|NCT02788279|83186963|FG002|Overall Study|Withdrawal by Subject|5|||
46948376|NCT02788279|83186961|FG000|Overall Study|Lost to Follow-up|0|||
46948377|NCT02788279|83186962|FG001|Overall Study|Lost to Follow-up|3|||
46948378|NCT02788279|83186963|FG002|Overall Study|Lost to Follow-up|2|||
46948379|NCT02788279|83186961|FG000|Overall Study|Sponsor decision|18|||
46948380|NCT02788279|83186962|FG001|Overall Study|Sponsor decision|29|||
46948381|NCT02788279|83186963|FG002|Overall Study|Sponsor decision|11|||
46948382|NCT02435992|83186979|FG000|Overall Study|non compliance with protocol|2|||
46948383|NCT02435992|83186980|FG001|Overall Study|non compliance with protocol|0|||
46948384|NCT02435992|83186981|FG002|Overall Study|non compliance with protocol|1|||
46948385|NCT02435992|83186982|FG003|Overall Study|non compliance with protocol|0|||
46948386|NCT02435992|83186983|FG004|Overall Study|non compliance with protocol|0|||
46948387|NCT02435992|83186979|FG000|Overall Study|Adverse Event|11|||
46948388|NCT02435992|83186980|FG001|Overall Study|Adverse Event|6|||
46948389|NCT02435992|83186981|FG002|Overall Study|Adverse Event|12|||
46948390|NCT02435992|83186982|FG003|Overall Study|Adverse Event|0|||
46948391|NCT02435992|83186983|FG004|Overall Study|Adverse Event|0|||
46948392|NCT02435992|83186979|FG000|Overall Study|Lack of Efficacy|4|||
46948393|NCT02435992|83186980|FG001|Overall Study|Lack of Efficacy|10|||
46948394|NCT02435992|83186981|FG002|Overall Study|Lack of Efficacy|9|||
46948395|NCT02435992|83186982|FG003|Overall Study|Lack of Efficacy|0|||
46948396|NCT02435992|83186983|FG004|Overall Study|Lack of Efficacy|0|||
47066472|NCT01576406|83349160|FG003|Overall Study|Lost to Follow-up|0|||
47066473|NCT01576406|83349161|FG004|Overall Study|Lost to Follow-up|0|||
46771384|NCT00806195|82989645|FG000|Overall Study|Withdrawal by Subject|119|||
46948397|NCT02435992|83186979|FG000|Overall Study|Withdrawal by Subject|10|||
46771385|NCT00806195|82989646|FG001|Overall Study|Withdrawal by Subject|31|||
46771386|NCT00806195|82989647|FG002|Overall Study|Withdrawal by Subject|76|||
46771387|NCT00806195|82989648|FG003|Overall Study|Withdrawal by Subject|35|||
46771388|NCT00806195|82989645|FG000|Overall Study|Lost to Follow-up|217|||
46771389|NCT00806195|82989646|FG001|Overall Study|Lost to Follow-up|66|||
46771390|NCT00806195|82989647|FG002|Overall Study|Lost to Follow-up|90|||
46771391|NCT00806195|82989648|FG003|Overall Study|Lost to Follow-up|34|||
46771392|NCT00806195|82989645|FG000|Overall Study|Inappropriate Enrollment|0|||
46771393|NCT00806195|82989646|FG001|Overall Study|Inappropriate Enrollment|1|||
46771394|NCT00806195|82989647|FG002|Overall Study|Inappropriate Enrollment|0|||
46841790|NCT00004978|83058889|FG001|Overall Study|Withdrawal by Subject|26|||
47066474|NCT01576406|83349162|FG005|Overall Study|Lost to Follow-up|0|||
46948398|NCT02435992|83186980|FG001|Overall Study|Withdrawal by Subject|8|||
46948399|NCT02435992|83186981|FG002|Overall Study|Withdrawal by Subject|20|||
46948400|NCT02435992|83186982|FG003|Overall Study|Withdrawal by Subject|0|||
46948401|NCT02435992|83186983|FG004|Overall Study|Withdrawal by Subject|0|||
46948402|NCT02435992|83186979|FG000|Overall Study|Other Reason|1|||
46948403|NCT02435992|83186980|FG001|Overall Study|Other Reason|0|||
46948404|NCT02435992|83186981|FG002|Overall Study|Other Reason|0|||
46948405|NCT02435992|83186982|FG003|Overall Study|Other Reason|0|||
46948406|NCT02435992|83186983|FG004|Overall Study|Other Reason|0|||
46948407|NCT02435992|83186979|FG000|Overall Study|Physician Decision|0|||
46948408|NCT02435992|83186980|FG001|Overall Study|Physician Decision|0|||
46948409|NCT02435992|83186981|FG002|Overall Study|Physician Decision|1|||
46948410|NCT02435992|83186982|FG003|Overall Study|Physician Decision|0|||
46948411|NCT02435992|83186983|FG004|Overall Study|Physician Decision|0|||
46948412|NCT02788513|83187000|FG000|Overall Study|Withdrawal by Subject|3|||
46948413|NCT02788513|83187001|FG001|Overall Study|Withdrawal by Subject|0|||
46948414|NCT02788513|83187002|FG002|Overall Study|Withdrawal by Subject|2|||
46771395|NCT00806195|82989648|FG003|Overall Study|Inappropriate Enrollment|0|||
46771396|NCT00806195|82989645|FG000|Overall Study|Administrative Reason|113|||
46771397|NCT00806195|82989646|FG001|Overall Study|Administrative Reason|35|||
46771398|NCT00806195|82989647|FG002|Overall Study|Administrative Reason|66|||
46771399|NCT00806195|82989648|FG003|Overall Study|Administrative Reason|26|||
46771400|NCT00806195|82989645|FG000|Overall Study|Protocol Violation|34|||
46841791|NCT00004978|83058888|FG000|Overall Study|site closure - not in analysis cohort|19|||
46841792|NCT00004978|83058889|FG001|Overall Study|site closure - not in analysis cohort|20|||
46841793|NCT00430937|83058897|FG000|Overall Study|Adverse Event|3|||
46841794|NCT00430937|83058898|FG001|Overall Study|Adverse Event|8|||
46841795|NCT00430937|83058897|FG000|Overall Study|Death|0|||
46841796|NCT00430937|83058898|FG001|Overall Study|Death|1|||
46841797|NCT00430937|83058897|FG000|Overall Study|Lost to Follow-up|6|||
46841798|NCT00430937|83058898|FG001|Overall Study|Lost to Follow-up|6|||
46841799|NCT00430937|83058897|FG000|Overall Study|Withdrawal by Subject|5|||
46771401|NCT00806195|82989646|FG001|Overall Study|Protocol Violation|24|||
46771402|NCT00806195|82989647|FG002|Overall Study|Protocol Violation|26|||
46771403|NCT00806195|82989648|FG003|Overall Study|Protocol Violation|9|||
46771404|NCT00733746|82989660|FG000|Overall Study|Ineligible|5|||
46841800|NCT00430937|83058898|FG001|Overall Study|Withdrawal by Subject|2|||
46841801|NCT00430937|83058897|FG000|Overall Study|Protocol Violation|3|||
46841802|NCT00430937|83058898|FG001|Overall Study|Protocol Violation|2|||
46841803|NCT00430937|83058897|FG000|Overall Study|Lack of Efficacy|6|||
46841804|NCT00430937|83058898|FG001|Overall Study|Lack of Efficacy|5|||
46841805|NCT00430937|83058897|FG000|Overall Study|Inappropriate enrollment|2|||
46841806|NCT00430937|83058898|FG001|Overall Study|Inappropriate enrollment|1|||
46841807|NCT00430937|83058897|FG000|Overall Study|Administrative reasons|1|||
46841808|NCT00430937|83058898|FG001|Overall Study|Administrative reasons|0|||
46841809|NCT00430937|83058897|FG000|Overall Study|Protocol discontinuation criteria met|1|||
46841810|NCT00430937|83058898|FG001|Overall Study|Protocol discontinuation criteria met|2|||
46841811|NCT00430937|83058897|FG000|Overall Study|Unable to classify|0|||
46841812|NCT00430937|83058898|FG001|Overall Study|Unable to classify|1|||
46841813|NCT00004888|83058906|FG000|Overall Study|Adverse Event|5|||
46841814|NCT00004888|83058907|FG001|Overall Study|Adverse Event|10|||
46841815|NCT00004888|83058906|FG000|Overall Study|Withdrawal by Subject|0|||
46841816|NCT00004888|83058907|FG001|Overall Study|Withdrawal by Subject|3|||
46841817|NCT00004888|83058906|FG000|Overall Study|Physician Decision|1|||
46841818|NCT00004888|83058907|FG001|Overall Study|Physician Decision|1|||
46841819|NCT00004888|83058906|FG000|Overall Study|Progressive Disease|4|||
46841820|NCT00004888|83058907|FG001|Overall Study|Progressive Disease|9|||
46841821|NCT00004888|83058906|FG000|Overall Study|Death without progressive disease|0|||
46841822|NCT00004888|83058907|FG001|Overall Study|Death without progressive disease|1|||
46841823|NCT00004888|83058906|FG000|Overall Study|Toxic death|1|||
46841824|NCT00004888|83058907|FG001|Overall Study|Toxic death|0|||
46841825|NCT00004732|83058915|FG000|Overall Study|Withdrawal by Subject|36|||
46841826|NCT00004732|83058916|FG001|Overall Study|Withdrawal by Subject|64|||
46841827|NCT00004732|83058915|FG000|Overall Study|Lost to Follow-up|33|||
46841828|NCT00004732|83058916|FG001|Overall Study|Lost to Follow-up|47|||
46841829|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
46948415|NCT02788513|83187003|FG003|Overall Study|Withdrawal by Subject|3|||
46948416|NCT02788513|83187004|FG004|Overall Study|Withdrawal by Subject|1|||
46771405|NCT00718419|82989666|FG000|Overall Study|Adverse Event|2|||
46771406|NCT00718419|82989667|FG001|Overall Study|Adverse Event|1|||
46841830|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
46841831|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
46841832|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
46948417|NCT02788513|83187000|FG000|Overall Study|Lost to Follow-up|1|||
46948418|NCT02788513|83187001|FG001|Overall Study|Lost to Follow-up|0|||
46948419|NCT02788513|83187002|FG002|Overall Study|Lost to Follow-up|0|||
46948420|NCT02788513|83187003|FG003|Overall Study|Lost to Follow-up|0|||
46948421|NCT02788513|83187004|FG004|Overall Study|Lost to Follow-up|1|||
46948422|NCT02788513|83187000|FG000|Overall Study|Adverse Event|5|||
46948423|NCT02788513|83187001|FG001|Overall Study|Adverse Event|8|||
46948424|NCT02788513|83187002|FG002|Overall Study|Adverse Event|4|||
46948425|NCT02788513|83187003|FG003|Overall Study|Adverse Event|2|||
46948426|NCT02788513|83187004|FG004|Overall Study|Adverse Event|2|||
46948427|NCT02788513|83187000|FG000|Overall Study|Protocol Violation|0|||
46948428|NCT02788513|83187001|FG001|Overall Study|Protocol Violation|0|||
46841833|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
46841834|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
46841835|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
46948429|NCT02788513|83187002|FG002|Overall Study|Protocol Violation|1|||
46948430|NCT02788513|83187003|FG003|Overall Study|Protocol Violation|1|||
46948431|NCT02788513|83187004|FG004|Overall Study|Protocol Violation|0|||
46948432|NCT02788513|83187000|FG000|Overall Study|Subject decided to stop taking treatment|0|||
46948433|NCT02788513|83187001|FG001|Overall Study|Subject decided to stop taking treatment|0|||
46948434|NCT02788513|83187002|FG002|Overall Study|Subject decided to stop taking treatment|1|||
46841836|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
46841837|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
46841838|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
46841839|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
46841840|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
46841841|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
46841842|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
46841843|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
46841844|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
46841845|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
46841846|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
46841847|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Death|0|||
46841848|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Death|1|||
46841849|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Death|0|||
46841850|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
46841851|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
46841852|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
46841853|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
46841854|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
46841855|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
46841856|NCT00430781|83058927|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
46841857|NCT00430781|83058928|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
46841858|NCT00430781|83058929|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
46841859|NCT00430781|83058927|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
46841860|NCT00430781|83058928|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
46841861|NCT00430781|83058929|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
46841862|NCT00430781|83058927|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
46841863|NCT00430781|83058928|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
46841864|NCT00430781|83058929|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
46841865|NCT00430781|83058927|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
46841866|NCT00430781|83058928|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
46841867|NCT00430781|83058929|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
46841868|NCT00430781|83058927|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
46841869|NCT00430781|83058928|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
46841870|NCT00430781|83058929|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
46841871|NCT00430781|83058927|FG000|Final Analysis; 31 July 2008|Other|0|||
46841872|NCT00430781|83058928|FG001|Final Analysis; 31 July 2008|Other|1|||
46841873|NCT00430781|83058929|FG002|Final Analysis; 31 July 2008|Other|0|||
46841874|NCT00430781|83058927|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
46841875|NCT00430781|83058928|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
46841876|NCT00430781|83058929|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
46841877|NCT00430781|83058927|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
46841878|NCT00430781|83058928|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
46841879|NCT00430781|83058929|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
46841880|NCT00430781|83058927|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
46841881|NCT00430781|83058928|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
46841882|NCT00430781|83058929|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
46841883|NCT00430781|83058927|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
46948435|NCT02788513|83187003|FG003|Overall Study|Subject decided to stop taking treatment|0|||
46948436|NCT02788513|83187004|FG004|Overall Study|Subject decided to stop taking treatment|0|||
46948437|NCT02788513|83187000|FG000|Overall Study|Decision by the study team|0|||
46948438|NCT02788513|83187001|FG001|Overall Study|Decision by the study team|0|||
46948439|NCT02788513|83187002|FG002|Overall Study|Decision by the study team|0|||
46948440|NCT02788513|83187003|FG003|Overall Study|Decision by the study team|0|||
46948441|NCT02788513|83187004|FG004|Overall Study|Decision by the study team|1|||
46948442|NCT03077828|83187016|FG000|Treatment Cycles|Death|1|||
46948443|NCT03077828|83187016|FG000|Treatment Cycles|Withdrawal by Subject|1|||
46948444|NCT03077828|83187016|FG000|Treatment Cycles|Screen Fail|2|||
46948445|NCT03077828|83187016|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
46948446|NCT03077828|83187016|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
46948447|NCT03077828|83187016|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
46948448|NCT03077828|83187016|FG000|Follow-up|Patients still in follow-up|15|||
46948449|NCT02401672|83187022|FG000|Overall Study|Withdrawal by Subject|1|||
46948450|NCT02401672|83187023|FG001|Overall Study|Withdrawal by Subject|3|||
46948451|NCT02435914|83187033|FG000|Overall Study|Ocular Adverse Event|1|||
46948452|NCT02435914|83187034|FG001|Overall Study|Ocular Adverse Event|0|||
46948453|NCT02435914|83187035|FG002|Overall Study|Ocular Adverse Event|0|||
46948454|NCT02435914|83187036|FG003|Overall Study|Ocular Adverse Event|0|||
46948455|NCT02435914|83187033|FG000|Overall Study|Withdrawal by Subject|0|||
46948456|NCT02435914|83187034|FG001|Overall Study|Withdrawal by Subject|1|||
46948457|NCT02435914|83187035|FG002|Overall Study|Withdrawal by Subject|0|||
46948458|NCT02435914|83187036|FG003|Overall Study|Withdrawal by Subject|0|||
46948459|NCT02435914|83187033|FG000|Overall Study|Other Miscellaneous Reason|0|||
46948460|NCT02435914|83187034|FG001|Overall Study|Other Miscellaneous Reason|0|||
46948461|NCT02435914|83187035|FG002|Overall Study|Other Miscellaneous Reason|1|||
46948462|NCT02435914|83187036|FG003|Overall Study|Other Miscellaneous Reason|0|||
46948463|NCT02786953|83187048|FG000|Overall Study|Withdrawal by Subject|3|||
46948464|NCT02786953|83187049|FG001|Overall Study|Withdrawal by Subject|0|||
46948465|NCT02786953|83187048|FG000|Overall Study|Physician Decision|0|||
46948466|NCT02786953|83187049|FG001|Overall Study|Physician Decision|1|||
46948467|NCT02435836|83187055|FG000|Overall Study|Lost to Follow-up|21|||
46948468|NCT02435836|83187055|FG000|Overall Study|Lack of Efficacy|1|||
46948469|NCT02435836|83187055|FG000|Overall Study|Withdrawal by Subject|236|||
46948470|NCT02435836|83187055|FG000|Overall Study|Insufficient Clinical Response|26|||
46948471|NCT02435836|83187055|FG000|Overall Study|Adverse Event|44|||
46948472|NCT02435836|83187055|FG000|Overall Study|Sponsor discontinued trial|167|||
46948473|NCT02435836|83187055|FG000|Overall Study|Noncompliance|27|||
46948474|NCT02435836|83187055|FG000|Overall Study|Protocol Violation|6|||
46948475|NCT02435836|83187055|FG000|Overall Study|Met Withdrawal Criteria|7|||
46948476|NCT02435836|83187055|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
46948477|NCT02788201|83187065|FG000|Overall Study|Death|1|||
46948478|NCT02788201|83187066|FG001|Overall Study|Death|1|||
46948479|NCT02788201|83187067|FG002|Overall Study|Death|1|||
46948480|NCT02788201|83187068|FG003|Overall Study|Death|1|||
46948481|NCT02788201|83187069|FG004|Overall Study|Death|0|||
46948482|NCT02788201|83187070|FG005|Overall Study|Death|1|||
46948483|NCT02788201|83187065|FG000|Overall Study|Ineligible|0|||
46948484|NCT02788201|83187066|FG001|Overall Study|Ineligible|0|||
46948485|NCT02788201|83187067|FG002|Overall Study|Ineligible|0|||
46948486|NCT02788201|83187068|FG003|Overall Study|Ineligible|0|||
46948487|NCT02788201|83187069|FG004|Overall Study|Ineligible|0|||
46948488|NCT02788201|83187070|FG005|Overall Study|Ineligible|1|||
46948489|NCT02788201|83187065|FG000|Overall Study|Withdrawal by Subject|0|||
46948490|NCT02788201|83187066|FG001|Overall Study|Withdrawal by Subject|0|||
46948491|NCT02788201|83187067|FG002|Overall Study|Withdrawal by Subject|0|||
46948492|NCT02788201|83187068|FG003|Overall Study|Withdrawal by Subject|0|||
46948493|NCT02788201|83187069|FG004|Overall Study|Withdrawal by Subject|0|||
46948494|NCT02788201|83187070|FG005|Overall Study|Withdrawal by Subject|1|||
46948495|NCT02456740|83187089|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
46948496|NCT02456740|83187090|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
46948497|NCT02456740|83187091|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
46948498|NCT02456740|83187092|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
46948499|NCT02456740|83187093|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
46948500|NCT02456740|83187094|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
46948501|NCT02456740|83187095|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
46948502|NCT02456740|83187096|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
46948503|NCT02456740|83187097|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
46948504|NCT02456740|83187089|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
46948505|NCT02456740|83187090|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
46771407|NCT00718419|82989666|FG000|Overall Study|Physician Decision|1|||
46948506|NCT02456740|83187091|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
46948507|NCT02456740|83187092|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
46948508|NCT02456740|83187093|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
46948509|NCT02456740|83187094|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
46948510|NCT02456740|83187095|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
46948511|NCT02456740|83187096|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
46967871|NCT05091307|83210486|FG003|Overall Study|Physician Decision|0|||
46948512|NCT02456740|83187097|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
46948513|NCT02456740|83187089|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
46948514|NCT02456740|83187090|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
46948515|NCT02456740|83187091|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
46948516|NCT02456740|83187092|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
46948517|NCT02456740|83187093|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
46948518|NCT02456740|83187094|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
46948519|NCT02456740|83187095|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
46948520|NCT02456740|83187096|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
46948521|NCT02456740|83187097|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
46948522|NCT02456740|83187089|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
46948523|NCT02456740|83187090|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
46948524|NCT02456740|83187091|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
46948525|NCT02456740|83187092|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
46948526|NCT02456740|83187093|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
46948527|NCT02456740|83187094|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
46948528|NCT02456740|83187095|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
46948529|NCT02456740|83187096|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
46948530|NCT02456740|83187097|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
46948531|NCT02456740|83187089|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
46948532|NCT02456740|83187090|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
46948533|NCT02456740|83187091|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
46948534|NCT02456740|83187092|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
46948535|NCT02456740|83187093|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
46948536|NCT02456740|83187094|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
46948537|NCT02456740|83187095|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
46948538|NCT02456740|83187096|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
46948539|NCT02456740|83187097|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
46948540|NCT02456740|83187089|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46948541|NCT02456740|83187090|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46948542|NCT02456740|83187091|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46948543|NCT02456740|83187092|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46948544|NCT02456740|83187093|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46771408|NCT00718419|82989667|FG001|Overall Study|Physician Decision|6|||
46771409|NCT00718419|82989666|FG000|Overall Study|Sponsor decision|0|||
46771410|NCT00718419|82989667|FG001|Overall Study|Sponsor decision|1|||
46771411|NCT00718419|82989666|FG000|Overall Study|Withdrawal by Subject|0|||
46771412|NCT00718419|82989667|FG001|Overall Study|Withdrawal by Subject|5|||
46771413|NCT00718419|82989666|FG000|Overall Study|Progressive Disease|7|||
46771414|NCT00718419|82989667|FG001|Overall Study|Progressive Disease|25|||
46948545|NCT02456740|83187094|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46948546|NCT02456740|83187095|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46948547|NCT02456740|83187096|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
46948548|NCT02456740|83187097|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
46948549|NCT02456740|83187089|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46948550|NCT02456740|83187090|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46948551|NCT02456740|83187091|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46948552|NCT02456740|83187092|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
46948553|NCT02456740|83187093|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
46948554|NCT02456740|83187094|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
46948555|NCT02456740|83187095|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
46948556|NCT02456740|83187096|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
46948557|NCT02456740|83187097|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
46948558|NCT02400580|83187109|FG000|Overall Study|Withdrawal by Subject|1|||
46948559|NCT02400580|83187110|FG001|Overall Study|Withdrawal by Subject|1|||
46948560|NCT02400580|83187109|FG000|Overall Study|Adverse Event|1|||
46948561|NCT02400580|83187110|FG001|Overall Study|Adverse Event|0|||
46948562|NCT01367119|83187118|FG000|Overall Study|Adverse Event|1|||
46948563|NCT01367119|83187119|FG001|Overall Study|Adverse Event|0|||
46948564|NCT01367119|83187118|FG000|Overall Study|Withdrawal by Subject|1|||
46948565|NCT01367119|83187119|FG001|Overall Study|Withdrawal by Subject|1|||
46948566|NCT02635724|83187128|FG000|Overall Study|Withdrawal by Subject|0|||
46948567|NCT02635724|83187129|FG001|Overall Study|Withdrawal by Subject|1|||
46948568|NCT02635724|83187130|FG002|Overall Study|Withdrawal by Subject|0|||
46771415|NCT00718419|82989666|FG000|Overall Study|Death Due to Progressive Disease|2|||
46771416|NCT00718419|82989667|FG001|Overall Study|Death Due to Progressive Disease|0|||
46771417|NCT00718419|82989666|FG000|Overall Study|Death Due to Study Drug Related|0|||
46948569|NCT02635646|83187140|FG000|Overall Study|Lost to Follow-up|24|||
46948570|NCT02635646|83187141|FG001|Overall Study|Lost to Follow-up|25|||
46948571|NCT02635646|83187140|FG000|Overall Study|Pregnancy|1|||
46948572|NCT02635646|83187141|FG001|Overall Study|Pregnancy|1|||
46948573|NCT02634788|83187157|FG000|Overall Study|Adverse Event|0|||
46948574|NCT02634788|83187158|FG001|Overall Study|Adverse Event|8|||
46948575|NCT02634788|83187159|FG002|Overall Study|Adverse Event|3|||
46948576|NCT02634788|83187160|FG003|Overall Study|Adverse Event|1|||
46948577|NCT02634788|83187157|FG000|Overall Study|Lack of Efficacy|4|||
46948578|NCT02634788|83187158|FG001|Overall Study|Lack of Efficacy|0|||
46948579|NCT02634788|83187159|FG002|Overall Study|Lack of Efficacy|1|||
46948580|NCT02634788|83187160|FG003|Overall Study|Lack of Efficacy|4|||
46948581|NCT02634788|83187157|FG000|Overall Study|Lost to Follow-up|0|||
46948582|NCT02634788|83187158|FG001|Overall Study|Lost to Follow-up|1|||
46948583|NCT02634788|83187159|FG002|Overall Study|Lost to Follow-up|0|||
46948584|NCT02634788|83187160|FG003|Overall Study|Lost to Follow-up|0|||
46948585|NCT02634788|83187157|FG000|Overall Study|Withdrawal by Subject|0|||
46948586|NCT02634788|83187158|FG001|Overall Study|Withdrawal by Subject|1|||
46948587|NCT02634788|83187159|FG002|Overall Study|Withdrawal by Subject|1|||
46948588|NCT02634788|83187160|FG003|Overall Study|Withdrawal by Subject|0|||
46948589|NCT02785939|83187172|FG000|Overall Study|Progression|25|||
46948590|NCT02785939|83187173|FG001|Overall Study|Progression|8|||
46948591|NCT02785939|83187172|FG000|Overall Study|Adverse Event|3|||
46948592|NCT02785939|83187173|FG001|Overall Study|Adverse Event|1|||
46948593|NCT02785939|83187172|FG000|Overall Study|Death|1|||
46948594|NCT02785939|83187173|FG001|Overall Study|Death|0|||
46948595|NCT02785939|83187172|FG000|Overall Study|Refusal|1|||
46948596|NCT02785939|83187173|FG001|Overall Study|Refusal|0|||
46948597|NCT02785939|83187172|FG000|Overall Study|Deteriorating health|1|||
46948598|NCT02785939|83187173|FG001|Overall Study|Deteriorating health|0|||
46948599|NCT02785939|83187172|FG000|Overall Study|Not protocol specified|0|||
46948600|NCT02785939|83187173|FG001|Overall Study|Not protocol specified|1|||
46948601|NCT02634320|83187187|FG000|Overall Study|Adverse Event|2|||
46948602|NCT02634320|83187187|FG000|Overall Study|Lost to Follow-up|3|||
46948603|NCT02634320|83187187|FG000|Overall Study|Moved out of area|2|||
46948604|NCT02634320|83187187|FG000|Overall Study|Out of window for study visits|1|||
46948605|NCT02634320|83187187|FG000|Overall Study|Protocol Violation|1|||
46948606|NCT02634320|83187187|FG000|Overall Study|Withdrawal by Subject|5|||
46948607|NCT02634320|83187187|FG000|Overall Study|Lack of Efficacy|2|||
46948608|NCT02435680|83187194|FG000|Overall Study|Physician Decision|3|||
46948609|NCT02435680|83187195|FG001|Overall Study|Physician Decision|0|||
46948610|NCT02435680|83187196|FG002|Overall Study|Physician Decision|0|||
46948611|NCT02435680|83187194|FG000|Overall Study|subject / guardian decision|0|||
46948612|NCT02435680|83187195|FG001|Overall Study|subject / guardian decision|3|||
46948613|NCT02435680|83187196|FG002|Overall Study|subject / guardian decision|2|||
46948614|NCT02435680|83187194|FG000|Overall Study|Adverse Event|8|||
46948615|NCT02435680|83187195|FG001|Overall Study|Adverse Event|3|||
46948616|NCT02435680|83187196|FG002|Overall Study|Adverse Event|2|||
46948617|NCT02435680|83187194|FG000|Overall Study|progressive disease|10|||
46948618|NCT02435680|83187195|FG001|Overall Study|progressive disease|7|||
46948619|NCT02435680|83187196|FG002|Overall Study|progressive disease|11|||
46948620|NCT02435680|83187194|FG000|Overall Study|not treated|0|||
46948621|NCT02435680|83187195|FG001|Overall Study|not treated|0|||
46948622|NCT02435680|83187196|FG002|Overall Study|not treated|1|||
46948623|NCT03371732|83187210|FG000|Overall Study|Withdrawal by Subject|9|||
46948624|NCT03371732|83187211|FG001|Overall Study|Withdrawal by Subject|3|||
46948625|NCT03371732|83187210|FG000|Overall Study|Refusal to continue|3|||
46948626|NCT03371732|83187211|FG001|Overall Study|Refusal to continue|4|||
46948627|NCT02745119|83187223|FG000|Overall Study|Adverse Event|1|||
46948628|NCT02745119|83187224|FG001|Overall Study|Adverse Event|0|||
46948629|NCT02745119|83187225|FG002|Overall Study|Adverse Event|1|||
46948630|NCT02745119|83187226|FG003|Overall Study|Adverse Event|3|||
46948631|NCT02745119|83187223|FG000|Overall Study|Death|3|||
46948632|NCT02745119|83187224|FG001|Overall Study|Death|3|||
46948633|NCT02745119|83187225|FG002|Overall Study|Death|0|||
46948634|NCT02745119|83187226|FG003|Overall Study|Death|4|||
46948635|NCT02745119|83187223|FG000|Overall Study|Lost to Follow-up|0|||
46948636|NCT02745119|83187224|FG001|Overall Study|Lost to Follow-up|0|||
46948637|NCT02745119|83187225|FG002|Overall Study|Lost to Follow-up|0|||
46948638|NCT02745119|83187226|FG003|Overall Study|Lost to Follow-up|1|||
46948639|NCT02745119|83187223|FG000|Overall Study|Protocol Deviation|0|||
46948640|NCT02745119|83187224|FG001|Overall Study|Protocol Deviation|0|||
46948641|NCT02745119|83187225|FG002|Overall Study|Protocol Deviation|0|||
46948642|NCT02745119|83187226|FG003|Overall Study|Protocol Deviation|1|||
46948643|NCT02745119|83187223|FG000|Overall Study|Withdrawal by Subject|7|||
46948644|NCT02745119|83187224|FG001|Overall Study|Withdrawal by Subject|15|||
46948645|NCT02745119|83187225|FG002|Overall Study|Withdrawal by Subject|8|||
46948646|NCT02745119|83187226|FG003|Overall Study|Withdrawal by Subject|14|||
46948647|NCT02745119|83187223|FG000|Overall Study|Study Terminated by Sponsor|134|||
46948648|NCT02745119|83187224|FG001|Overall Study|Study Terminated by Sponsor|252|||
46948649|NCT02745119|83187225|FG002|Overall Study|Study Terminated by Sponsor|135|||
46948650|NCT02745119|83187226|FG003|Overall Study|Study Terminated by Sponsor|251|||
46948651|NCT02745119|83187223|FG000|Overall Study|Physician Decision|0|||
46948652|NCT02745119|83187224|FG001|Overall Study|Physician Decision|2|||
46948653|NCT02745119|83187225|FG002|Overall Study|Physician Decision|2|||
46948654|NCT02745119|83187226|FG003|Overall Study|Physician Decision|2|||
46948655|NCT02745119|83187223|FG000|Overall Study|Reason Not Specified|0|||
46948656|NCT02745119|83187224|FG001|Overall Study|Reason Not Specified|2|||
46948657|NCT02745119|83187225|FG002|Overall Study|Reason Not Specified|0|||
46948658|NCT02745119|83187226|FG003|Overall Study|Reason Not Specified|1|||
46948659|NCT01367665|83187240|FG000|Overall Study|Death|102|||
46948660|NCT01367665|83187241|FG001|Overall Study|Death|19|||
46948661|NCT01367665|83187240|FG000|Overall Study|Lost to Follow-up|222|||
46948662|NCT01367665|83187241|FG001|Overall Study|Lost to Follow-up|22|||
46948663|NCT01367665|83187240|FG000|Overall Study|Not Done|118|||
46948664|NCT01367665|83187241|FG001|Overall Study|Not Done|14|||
46948665|NCT02576847|83187248|FG000|Overall Study|Adverse Event|27|||
46948666|NCT02576847|83187248|FG000|Overall Study|Lost to Follow-up|22|||
46948667|NCT02576847|83187248|FG000|Overall Study|Physician Decision|1|||
46948668|NCT02576847|83187248|FG000|Overall Study|Pregnancy|1|||
46948669|NCT02576847|83187248|FG000|Overall Study|Protocol Violation|3|||
46948670|NCT02576847|83187248|FG000|Overall Study|Withdrawal by Subject|78|||
46948671|NCT02576847|83187248|FG000|Overall Study|Other|5|||
46948672|NCT02135029|83187264|FG000|Overall Study|Adverse Event|2|||
46948673|NCT02135029|83187265|FG001|Overall Study|Adverse Event|2|||
46948674|NCT02135029|83187266|FG002|Overall Study|Adverse Event|2|||
46948675|NCT02135029|83187264|FG000|Overall Study|Lost to Follow-up|0|||
46948676|NCT02135029|83187265|FG001|Overall Study|Lost to Follow-up|1|||
46948677|NCT02135029|83187266|FG002|Overall Study|Lost to Follow-up|0|||
46948678|NCT02135029|83187264|FG000|Overall Study|Withdrawal by Subject|2|||
46948679|NCT02135029|83187265|FG001|Overall Study|Withdrawal by Subject|0|||
46948680|NCT02135029|83187266|FG002|Overall Study|Withdrawal by Subject|1|||
46948681|NCT02135029|83187264|FG000|Overall Study|Other|0|||
46948682|NCT02135029|83187265|FG001|Overall Study|Other|1|||
46948683|NCT02135029|83187266|FG002|Overall Study|Other|0|||
46948684|NCT02135029|83187264|FG000|Overall Study|Death|0|||
46948685|NCT02135029|83187265|FG001|Overall Study|Death|1|||
46948686|NCT02135029|83187266|FG002|Overall Study|Death|0|||
46948687|NCT02842151|83187275|FG000|Overall Study|Adverse Event|1|||
46948688|NCT02842151|83187275|FG000|Overall Study|Subject moved too far away|1|||
46948689|NCT02842073|83187281|FG000|Overall Study|Withdrawal by Subject|1|||
46948690|NCT01367275|83187285|FG000|Overall Study|Ineligible|1|||
46948691|NCT01367275|83187285|FG000|Overall Study|Disease Progression|2|||
46948692|NCT02842853|83187293|FG000|Overall Study|Non-compliance with the protocol|3|||
46948693|NCT02842853|83187294|FG001|Overall Study|Non-compliance with the protocol|7|||
46948694|NCT02842853|83187295|FG002|Overall Study|Non-compliance with the protocol|2|||
46948695|NCT02842853|83187296|FG003|Overall Study|Non-compliance with the protocol|5|||
46948696|NCT02842853|83187293|FG000|Overall Study|Subject met exclusion criteria|0|||
46948697|NCT02842853|83187294|FG001|Overall Study|Subject met exclusion criteria|1|||
46948698|NCT02842853|83187295|FG002|Overall Study|Subject met exclusion criteria|0|||
46948699|NCT02842853|83187296|FG003|Overall Study|Subject met exclusion criteria|0|||
46948700|NCT02842853|83187293|FG000|Overall Study|Withdrawal by Subject|11|||
46948701|NCT02842853|83187294|FG001|Overall Study|Withdrawal by Subject|13|||
46948702|NCT02842853|83187295|FG002|Overall Study|Withdrawal by Subject|9|||
46948703|NCT02842853|83187296|FG003|Overall Study|Withdrawal by Subject|8|||
46948704|NCT02842853|83187293|FG000|Overall Study|Lost to Follow-up|9|||
46948705|NCT02842853|83187294|FG001|Overall Study|Lost to Follow-up|13|||
46948706|NCT02842853|83187295|FG002|Overall Study|Lost to Follow-up|10|||
46948707|NCT02842853|83187296|FG003|Overall Study|Lost to Follow-up|11|||
46948708|NCT02433340|83187312|FG000|Overall Study|Adverse Event|0|||
46948709|NCT02433340|83187313|FG001|Overall Study|Adverse Event|0|||
46948710|NCT02433340|83187314|FG002|Overall Study|Adverse Event|1|||
46948711|NCT02433340|83187315|FG003|Overall Study|Adverse Event|0|||
46948712|NCT02433340|83187312|FG000|Overall Study|Withdrawal by Subject|1|||
46948713|NCT02433340|83187313|FG001|Overall Study|Withdrawal by Subject|0|||
46948714|NCT02433340|83187314|FG002|Overall Study|Withdrawal by Subject|1|||
46948715|NCT02433340|83187315|FG003|Overall Study|Withdrawal by Subject|2|||
46948716|NCT02433340|83187312|FG000|Overall Study|Lost to Follow-up|0|||
46948717|NCT02433340|83187313|FG001|Overall Study|Lost to Follow-up|1|||
46948718|NCT02433340|83187314|FG002|Overall Study|Lost to Follow-up|0|||
46948719|NCT02433340|83187315|FG003|Overall Study|Lost to Follow-up|0|||
46948720|NCT02433340|83187312|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
46948721|NCT02433340|83187313|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
46948722|NCT02433340|83187314|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
46948723|NCT02433340|83187315|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
46948724|NCT02433340|83187312|FG000|Overall Study|Other|0|||
46948725|NCT02433340|83187313|FG001|Overall Study|Other|1|||
46948726|NCT02433340|83187314|FG002|Overall Study|Other|0|||
46948727|NCT02433340|83187315|FG003|Overall Study|Other|0|||
46948728|NCT02400346|83187327|FG000|Overall Study|Adverse Event|24|||
46948729|NCT02400346|83187327|FG000|Overall Study|Lack of Efficacy|9|||
46948730|NCT02400346|83187327|FG000|Overall Study|Non-compliance with IMP|1|||
46948731|NCT02400346|83187327|FG000|Overall Study|Withdrawal by Subject|7|||
46948732|NCT02400346|83187327|FG000|Overall Study|Administrative or other reason(s)|2|||
46948733|NCT02400346|83187327|FG000|Overall Study|Lost to Follow-up|1|||
46948734|NCT02399254|83187331|FG000|Overall Study|Physician Decision|2|||
46948735|NCT02456662|83187338|FG000|Overall Study|Lost to Follow-up|2|||
46948736|NCT02456662|83187339|FG001|Overall Study|Lost to Follow-up|1|||
46948737|NCT01653262|83187345|FG000|Overall Study|Lack of Efficacy|1|||
46948738|NCT01653262|83187345|FG000|Overall Study|SAE, non-fatal|1|||
46948739|NCT01653262|83187345|FG000|Overall Study|AE, non-serious non-fatal|1|||
46948740|NCT02455336|83187351|FG000|Overall Study|Withdrawal by Subject|0|||
46948741|NCT02455336|83187352|FG001|Overall Study|Withdrawal by Subject|2|||
46948742|NCT02455336|83187351|FG000|Overall Study|Adverse Event|3|||
46948743|NCT02455336|83187352|FG001|Overall Study|Adverse Event|0|||
46948744|NCT02455336|83187351|FG000|Overall Study|Non-responder to treatment|2|||
46948745|NCT02455336|83187352|FG001|Overall Study|Non-responder to treatment|0|||
46948746|NCT04525703|83187379|FG000|Overall Study|Lost to Follow-up|6|||
46948747|NCT04525703|83187380|FG001|Overall Study|Lost to Follow-up|15|||
46948748|NCT04525703|83187381|FG002|Overall Study|Lost to Follow-up|8|||
46948749|NCT04509076|83187394|FG000|Overall Study|Withdrawal by Subject|1|||
46948750|NCT04509076|83187395|FG001|Overall Study|Withdrawal by Subject|2|||
46948751|NCT04509076|83187394|FG000|Overall Study|Lost to Follow-up|1|||
46638966|NCT01406652|82812476|FG000|Overall Study|Insufficient follow-up|5|||
46638967|NCT01406652|82812477|FG001|Overall Study|Insufficient follow-up|4|||
46638968|NCT01406652|82812476|FG000|Overall Study|Infection not sure|10|||
46638969|NCT01406652|82812477|FG001|Overall Study|Infection not sure|10|||
46638970|NCT01406574|82812485|FG000|Overall Study|Adverse Event|0|||
46638971|NCT01406574|82812486|FG001|Overall Study|Adverse Event|0|||
46638972|NCT01406574|82812487|FG002|Overall Study|Adverse Event|1|||
46638973|NCT01406574|82812488|FG003|Overall Study|Adverse Event|3|||
46638974|NCT01406574|82812485|FG000|Overall Study|Physician Decision|0|||
46638975|NCT01406574|82812486|FG001|Overall Study|Physician Decision|0|||
46948752|NCT04509076|83187395|FG001|Overall Study|Lost to Follow-up|2|||
46948753|NCT04267614|83187409|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
46948754|NCT04267614|83187409|FG000|Overall Study|Lost to Follow-up|115|||
46948755|NCT03735680|83187420|FG000|Overall Study|Withdrawal by Subject|0|||
46948756|NCT03735680|83187421|FG001|Overall Study|Withdrawal by Subject|1|||
46948757|NCT03735680|83187422|FG002|Overall Study|Withdrawal by Subject|0|||
46948758|NCT03735680|83187423|FG003|Overall Study|Withdrawal by Subject|0|||
46948759|NCT03735680|83187424|FG004|Overall Study|Withdrawal by Subject|0|||
46948760|NCT03735680|83187425|FG005|Overall Study|Withdrawal by Subject|1|||
46948761|NCT03735680|83187420|FG000|Overall Study|Patient unable or unwilling to continue|0|||
46948762|NCT03735680|83187421|FG001|Overall Study|Patient unable or unwilling to continue|0|||
46948763|NCT03735680|83187422|FG002|Overall Study|Patient unable or unwilling to continue|1|||
46948764|NCT03735680|83187423|FG003|Overall Study|Patient unable or unwilling to continue|0|||
47066475|NCT01576406|83349157|FG000|Overall Study|Death|3|||
46771418|NCT00718419|82989667|FG001|Overall Study|Death Due to Study Drug Related|1|||
46771419|NCT00718419|82989666|FG000|Overall Study|Death Due to Adverse Events|1|||
46771420|NCT00718419|82989667|FG001|Overall Study|Death Due to Adverse Events|0|||
46771421|NCT00717249|82989675|FG000|Overall Study|Lens Discomfort|4|||
46771422|NCT00717249|82989676|FG001|Overall Study|Lens Discomfort|1|||
46771423|NCT00717249|82989675|FG000|Overall Study|Unsatisfactory visual Response|0|||
46771424|NCT00717249|82989676|FG001|Overall Study|Unsatisfactory visual Response|2|||
46771425|NCT00717249|82989675|FG000|Overall Study|Adverse Event|4|||
46948765|NCT03735680|83187424|FG004|Overall Study|Patient unable or unwilling to continue|0|||
46948766|NCT03735680|83187425|FG005|Overall Study|Patient unable or unwilling to continue|0|||
46948767|NCT03726658|83187461|FG000|Overall Study|Lost to Follow-up|0|||
46948768|NCT03726658|83187462|FG001|Overall Study|Lost to Follow-up|0|||
46948769|NCT03726658|83187463|FG002|Overall Study|Lost to Follow-up|2|||
46948770|NCT03726658|83187464|FG003|Overall Study|Lost to Follow-up|0|||
46948771|NCT03726658|83187465|FG004|Overall Study|Lost to Follow-up|0|||
46638976|NCT01406574|82812487|FG002|Overall Study|Physician Decision|0|||
46638977|NCT01406574|82812488|FG003|Overall Study|Physician Decision|1|||
46638978|NCT01406574|82812485|FG000|Overall Study|Withdrawal by Subject|0|||
46771426|NCT00717249|82989676|FG001|Overall Study|Adverse Event|2|||
46771427|NCT00717249|82989675|FG000|Overall Study|Lost to Follow-up|2|||
46948772|NCT03726658|83187466|FG005|Overall Study|Lost to Follow-up|1|||
46948773|NCT03726658|83187467|FG006|Overall Study|Lost to Follow-up|1|||
46948774|NCT03726658|83187461|FG000|Overall Study|Withdrawal by Subject|1|||
46948775|NCT03726658|83187462|FG001|Overall Study|Withdrawal by Subject|0|||
46948776|NCT03726658|83187463|FG002|Overall Study|Withdrawal by Subject|0|||
46948777|NCT03726658|83187464|FG003|Overall Study|Withdrawal by Subject|0|||
46948778|NCT03726658|83187465|FG004|Overall Study|Withdrawal by Subject|6|||
46948779|NCT03726658|83187466|FG005|Overall Study|Withdrawal by Subject|4|||
46948780|NCT03726658|83187467|FG006|Overall Study|Withdrawal by Subject|2|||
46948781|NCT03726658|83187461|FG000|Overall Study|Pregnancy|0|||
46948782|NCT03726658|83187462|FG001|Overall Study|Pregnancy|0|||
46948783|NCT03726658|83187463|FG002|Overall Study|Pregnancy|0|||
46948784|NCT03726658|83187464|FG003|Overall Study|Pregnancy|0|||
46948785|NCT03726658|83187465|FG004|Overall Study|Pregnancy|0|||
46948786|NCT03726658|83187466|FG005|Overall Study|Pregnancy|0|||
46948787|NCT03726658|83187467|FG006|Overall Study|Pregnancy|1|||
46948788|NCT03726658|83187461|FG000|Overall Study|Not Reported|0|||
46948789|NCT03726658|83187462|FG001|Overall Study|Not Reported|0|||
46948790|NCT03726658|83187463|FG002|Overall Study|Not Reported|0|||
46948791|NCT03726658|83187464|FG003|Overall Study|Not Reported|0|||
46948792|NCT03726658|83187465|FG004|Overall Study|Not Reported|0|||
46948793|NCT03726658|83187466|FG005|Overall Study|Not Reported|0|||
46948794|NCT03726658|83187467|FG006|Overall Study|Not Reported|1|||
46948795|NCT03062358|83187527|FG000|Overall Study|Death|220|||
46948796|NCT03062358|83187528|FG001|Overall Study|Death|127|||
46948797|NCT03062358|83187527|FG000|Overall Study|Withdrawal by Subject|2|||
46948798|NCT03062358|83187528|FG001|Overall Study|Withdrawal by Subject|1|||
46948799|NCT03062358|83187527|FG000|Overall Study|Ongoing in Trial|78|||
46948800|NCT03062358|83187528|FG001|Overall Study|Ongoing in Trial|25|||
46948801|NCT02706873|83187539|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
46948802|NCT02706873|83187540|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
46948803|NCT02706873|83187541|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
46948804|NCT02706873|83187542|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
46948805|NCT02706873|83187539|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
46948806|NCT02706873|83187540|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
46948807|NCT02706873|83187541|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
46948808|NCT02706873|83187542|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
46948809|NCT02706873|83187539|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
46948810|NCT02706873|83187540|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
46948811|NCT02706873|83187541|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
46948812|NCT02706873|83187542|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
46948813|NCT02706873|83187539|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
46948814|NCT02706873|83187540|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
46948815|NCT02706873|83187541|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
46948816|NCT02706873|83187542|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
46948817|NCT02706873|83187539|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
46948818|NCT02706873|83187540|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
46948819|NCT02706873|83187541|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
46948820|NCT02706873|83187542|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
46948821|NCT02706873|83187539|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
46948822|NCT02706873|83187540|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
46948823|NCT02706873|83187541|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
46948824|NCT02706873|83187542|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
46948825|NCT02706873|83187539|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
46948826|NCT02706873|83187540|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
46948827|NCT02706873|83187541|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
46948828|NCT02706873|83187542|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
46948829|NCT02706873|83187539|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
46948830|NCT02706873|83187540|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
46948831|NCT02706873|83187541|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
46948832|NCT02706873|83187542|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
46948833|NCT02706873|83187539|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
46948834|NCT02706873|83187540|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
46948835|NCT02706873|83187541|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
46638979|NCT01406574|82812486|FG001|Overall Study|Withdrawal by Subject|1|||
46948836|NCT02706873|83187542|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
46948837|NCT02706873|83187539|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
46948838|NCT02706873|83187540|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
46948839|NCT02706873|83187541|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
46948840|NCT02706873|83187542|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
46948841|NCT02706873|83187539|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
46948842|NCT02706873|83187540|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
46948843|NCT02706873|83187541|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
46948844|NCT02706873|83187542|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
46948845|NCT02706873|83187539|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
46948846|NCT02706873|83187540|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
46948847|NCT02706873|83187541|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
46948848|NCT02706873|83187542|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
46948849|NCT02706873|83187539|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
46948850|NCT02706873|83187540|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
46638980|NCT01406574|82812487|FG002|Overall Study|Withdrawal by Subject|0|||
46638981|NCT01406574|82812488|FG003|Overall Study|Withdrawal by Subject|0|||
46841884|NCT00430781|83058928|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
46841885|NCT00430781|83058929|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
46841886|NCT00430781|83058927|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
46841887|NCT00430781|83058928|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
46841888|NCT00430781|83058929|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
46841889|NCT00430781|83058927|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
46841890|NCT00430781|83058928|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
46841891|NCT00430781|83058929|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
46841892|NCT00430781|83058927|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
46841893|NCT00430781|83058928|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
46841894|NCT00430781|83058929|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
46841895|NCT00429299|83058943|FG000|Overall Study|Disease Progression|1|||
46841896|NCT00429299|83058944|FG001|Overall Study|Disease Progression|1|||
46841897|NCT00429299|83058945|FG002|Overall Study|Disease Progression|0|||
46841898|NCT00429299|83058943|FG000|Overall Study|Adverse Event|2|||
46841899|NCT00429299|83058944|FG001|Overall Study|Adverse Event|5|||
46841900|NCT00429299|83058945|FG002|Overall Study|Adverse Event|1|||
46841901|NCT00429299|83058943|FG000|Overall Study|Protocol Violation|1|||
46841902|NCT00429299|83058944|FG001|Overall Study|Protocol Violation|0|||
46841903|NCT00429299|83058945|FG002|Overall Study|Protocol Violation|0|||
46841904|NCT00429299|83058943|FG000|Overall Study|Withdrawal by Subject|0|||
46841905|NCT00429299|83058944|FG001|Overall Study|Withdrawal by Subject|1|||
46841906|NCT00429299|83058945|FG002|Overall Study|Withdrawal by Subject|3|||
46841907|NCT00428597|83058955|FG000|Overall Study|Randomized but not treated|3|||
46841908|NCT00428597|83058956|FG001|Overall Study|Randomized but not treated|3|||
46841909|NCT00428597|83058955|FG000|Overall Study|Objective Progression or Relapse|19|||
46841910|NCT00428597|83058956|FG001|Overall Study|Objective Progression or Relapse|47|||
46841911|NCT00428597|83058955|FG000|Overall Study|Study Terminated by Sponsor|41|||
46841912|NCT00428597|83058956|FG001|Overall Study|Study Terminated by Sponsor|16|||
46841913|NCT00428597|83058955|FG000|Overall Study|Adverse Event|15|||
46841914|NCT00428597|83058956|FG001|Overall Study|Adverse Event|7|||
46841915|NCT00428597|83058955|FG000|Overall Study|Global Deterioration of Health Status|1|||
46841916|NCT00428597|83058956|FG001|Overall Study|Global Deterioration of Health Status|5|||
46841917|NCT00428597|83058955|FG000|Overall Study|Protocol Violation|2|||
46841918|NCT00428597|83058956|FG001|Overall Study|Protocol Violation|1|||
46841919|NCT00428597|83058955|FG000|Overall Study|Withdrawal by Subject|2|||
46841920|NCT00428597|83058956|FG001|Overall Study|Withdrawal by Subject|1|||
46841921|NCT00428597|83058955|FG000|Overall Study|Other|1|||
46841922|NCT00428597|83058956|FG001|Overall Study|Other|1|||
46841923|NCT00428597|83058955|FG000|Overall Study|Lost to Follow-up|0|||
46841924|NCT00428597|83058956|FG001|Overall Study|Lost to Follow-up|1|||
46841925|NCT00428597|83058955|FG000|Overall Study|Pregnancy|1|||
46841926|NCT00428597|83058956|FG001|Overall Study|Pregnancy|0|||
46841927|NCT00428597|83058955|FG000|Overall Study|Death|1|||
46841928|NCT00428597|83058956|FG001|Overall Study|Death|3|||
46841929|NCT00428441|83058962|FG000|Overall Study|Lost to Follow-up|1|||
46841930|NCT00144339|83058968|FG000|Overall Study|Adverse Event|746|||
46841931|NCT00144339|83058969|FG001|Overall Study|Adverse Event|627|||
46841932|NCT00144339|83058968|FG000|Overall Study|Protocol Violation|75|||
46841933|NCT00144339|83058969|FG001|Overall Study|Protocol Violation|48|||
46841934|NCT00144339|83058968|FG000|Overall Study|Withdrawal by Subject|403|||
46841935|NCT00144339|83058969|FG001|Overall Study|Withdrawal by Subject|300|||
46841936|NCT00144339|83058968|FG000|Overall Study|Lost to Follow-up|76|||
46841937|NCT00144339|83058969|FG001|Overall Study|Lost to Follow-up|64|||
46841938|NCT00144339|83058968|FG000|Overall Study|Other|58|||
46948851|NCT02706873|83187541|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
46638982|NCT01406574|82812485|FG000|Overall Study|Definite progression of primary disease|1|||
46841939|NCT00144339|83058969|FG001|Overall Study|Other|60|||
46841940|NCT00144027|83058977|FG000|Overall Study|Lost to Follow-up|1|||
46841941|NCT00144027|83058978|FG001|Overall Study|Lost to Follow-up|3|||
46948852|NCT02706873|83187542|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
46948853|NCT02584634|83187565|FG000|Overall Study|Adverse Event|3|||
46948854|NCT02584634|83187566|FG001|Overall Study|Adverse Event|5|||
46638983|NCT01406574|82812486|FG001|Overall Study|Definite progression of primary disease|0|||
46841942|NCT00144027|83058977|FG000|Overall Study|Withdrawal by Subject|2|||
46841943|NCT00144027|83058978|FG001|Overall Study|Withdrawal by Subject|2|||
46841944|NCT00144027|83058977|FG000|Overall Study|did not complete baseline assessment|0|||
46841945|NCT00144027|83058978|FG001|Overall Study|did not complete baseline assessment|6|||
46841946|NCT00127803|83058988|FG000|Overall Study|Adverse Event|2|||
46841947|NCT00127803|83058989|FG001|Overall Study|Adverse Event|0|||
46948855|NCT02584634|83187565|FG000|Overall Study|Death|0|||
46948856|NCT02584634|83187566|FG001|Overall Study|Death|1|||
46948857|NCT02584634|83187565|FG000|Overall Study|Lost to Follow-up|0|||
46948858|NCT02584634|83187566|FG001|Overall Study|Lost to Follow-up|1|||
46948859|NCT02584634|83187565|FG000|Overall Study|Physician Decision|1|||
46948860|NCT02584634|83187566|FG001|Overall Study|Physician Decision|2|||
46948861|NCT02584634|83187565|FG000|Overall Study|Progressive disease|7|||
46948862|NCT02584634|83187566|FG001|Overall Study|Progressive disease|15|||
46948863|NCT02584634|83187565|FG000|Overall Study|Withdrawal by Subject|1|||
46948864|NCT02584634|83187566|FG001|Overall Study|Withdrawal by Subject|1|||
46948865|NCT02584634|83187565|FG000|Overall Study|Other|0|||
46948866|NCT02584634|83187566|FG001|Overall Study|Other|6|||
46948867|NCT01275729|83187580|FG000|Overall Study|Death|3|||
46948868|NCT01275729|83187580|FG000|Overall Study|Withdrawal by Subject|1|||
46948869|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
46948870|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
46948871|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
46948872|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
46948873|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Adverse Event|198|||
46948874|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Adverse Event|0|||
46948875|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Adverse Event|0|||
46948876|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Adverse Event|0|||
46948877|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Death|62|||
46948878|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Death|0|||
46948879|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Death|0|||
46948880|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Death|0|||
46948881|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
46948882|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
46948883|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
46948884|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
46948885|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Complicating disease|13|||
46948886|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Complicating disease|0|||
46948887|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Complicating disease|0|||
46948888|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Complicating disease|0|||
46948889|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
46948890|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
47066476|NCT01576406|83349158|FG001|Overall Study|Death|4|||
47066477|NCT01576406|83349159|FG002|Overall Study|Death|8|||
47066478|NCT01576406|83349160|FG003|Overall Study|Death|5|||
47066479|NCT01576406|83349161|FG004|Overall Study|Death|7|||
47066480|NCT01576406|83349162|FG005|Overall Study|Death|9|||
46841948|NCT00127803|83058990|FG002|Overall Study|Adverse Event|0|||
46841949|NCT00127803|83058991|FG003|Overall Study|Adverse Event|0|||
46841950|NCT00127803|83058988|FG000|Overall Study|Withdrawal by Subject|1|||
46841951|NCT00127803|83058989|FG001|Overall Study|Withdrawal by Subject|0|||
46841952|NCT00127803|83058990|FG002|Overall Study|Withdrawal by Subject|0|||
46841953|NCT00127803|83058991|FG003|Overall Study|Withdrawal by Subject|0|||
46841954|NCT00127803|83058988|FG000|Overall Study|Lost to Follow-up|0|||
46841955|NCT00127803|83058989|FG001|Overall Study|Lost to Follow-up|0|||
46841956|NCT00127803|83058990|FG002|Overall Study|Lost to Follow-up|0|||
46841957|NCT00127803|83058991|FG003|Overall Study|Lost to Follow-up|1|||
46841958|NCT00127413|83059005|FG000|Overall Study|Lost to Follow-up|6|||
46841959|NCT00127413|83059006|FG001|Overall Study|Lost to Follow-up|4|||
46841960|NCT00127413|83059007|FG002|Overall Study|Lost to Follow-up|8|||
46841961|NCT00127413|83059008|FG003|Overall Study|Lost to Follow-up|2|||
46948891|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
46948892|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
46948893|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
46948894|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
46948895|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
46948896|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
46948897|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Non-compliance|4|||
46948898|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Non-compliance|0|||
46948899|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Non-compliance|0|||
46948900|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Non-compliance|0|||
46948901|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Pain|4|||
46948902|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Pain|0|||
46948903|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Pain|0|||
46948904|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Pain|0|||
46948905|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
46948906|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
46948907|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
46948908|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
46967872|NCT05091307|83210483|FG000|Overall Study|Protocol Violation|1|||
47066481|NCT01576406|83349157|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
46841962|NCT00143403|83059020|FG000|Overall Study|Adverse Event|3|||
46948909|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Hospice care|1|||
46948910|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Hospice care|0|||
46948911|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Hospice care|0|||
46948912|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Hospice care|0|||
46948913|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Physician Decision|1|||
46948914|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Physician Decision|0|||
46948915|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Physician Decision|0|||
46948916|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Physician Decision|0|||
46948917|NCT01107626|83187588|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
46948918|NCT01107626|83187589|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
46948919|NCT01107626|83187590|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
46948920|NCT01107626|83187591|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
46948921|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
46948922|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
47066482|NCT01576406|83349158|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
47066483|NCT01576406|83349159|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
47066484|NCT01576406|83349160|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
47066485|NCT01576406|83349161|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
47066486|NCT01576406|83349162|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
47066487|NCT01576406|83349157|FG000|Overall Study|Withdrawal the consent|2|||
47066488|NCT01576406|83349158|FG001|Overall Study|Withdrawal the consent|2|||
47066489|NCT01576406|83349159|FG002|Overall Study|Withdrawal the consent|5|||
47066490|NCT01576406|83349160|FG003|Overall Study|Withdrawal the consent|1|||
47066491|NCT01576406|83349161|FG004|Overall Study|Withdrawal the consent|1|||
46638984|NCT01406574|82812487|FG002|Overall Study|Definite progression of primary disease|0|||
46638985|NCT01406574|82812488|FG003|Overall Study|Definite progression of primary disease|0|||
46638986|NCT01405950|82812501|FG000|Overall Study|Withdrawal by Subject|1|||
46638987|NCT01405950|82812502|FG001|Overall Study|Withdrawal by Subject|0|||
46638988|NCT01405950|82812503|FG002|Overall Study|Withdrawal by Subject|0|||
46638989|NCT01405950|82812504|FG003|Overall Study|Withdrawal by Subject|0|||
46638990|NCT01405560|82812512|FG000|Overall Study|Physician Decision|1|||
46638991|NCT01428882|82812518|FG000|Overall Study|Lack of Efficacy|2|||
46638992|NCT01428882|82812519|FG001|Overall Study|Lack of Efficacy|7|||
46638993|NCT01428882|82812518|FG000|Overall Study|Protocol Violation|4|||
46638994|NCT01428882|82812519|FG001|Overall Study|Protocol Violation|3|||
46638995|NCT01428258|82812527|FG000|Intervention 1|Withdrawal by Subject|2|||
46638996|NCT01428258|82812528|FG001|Intervention 1|Withdrawal by Subject|0|||
46638997|NCT01389882|82812544|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
46638998|NCT01389882|82812545|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
46638999|NCT01389882|82812544|FG000|Overall Study|Withdrawal by Subject|0|||
46639000|NCT01389882|82812545|FG001|Overall Study|Withdrawal by Subject|1|||
46639001|NCT01442688|82812553|FG000|First Intervention|Withdrawal by Subject|1|||
46639002|NCT01442688|82812554|FG001|First Intervention|Withdrawal by Subject|0|||
46639003|NCT01442688|82812553|FG000|First Intervention|subject incarcerated|1|||
46639004|NCT01442688|82812554|FG001|First Intervention|subject incarcerated|0|||
46639005|NCT01442688|82812553|FG000|Second Intervention|Adverse Event|1|||
46841963|NCT00143403|83059021|FG001|Overall Study|Adverse Event|8|||
46841964|NCT00143403|83059020|FG000|Overall Study|Death|1|||
47066492|NCT01576406|83349162|FG005|Overall Study|Withdrawal the consent|3|||
47066493|NCT01576406|83349157|FG000|Overall Study|Other|0|||
47066494|NCT01576406|83349158|FG001|Overall Study|Other|0|||
47066495|NCT01576406|83349159|FG002|Overall Study|Other|2|||
47066496|NCT01576406|83349160|FG003|Overall Study|Other|2|||
46639006|NCT01442688|82812554|FG001|Second Intervention|Adverse Event|0|||
46948923|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
46948924|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
46948925|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
46948926|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
46948927|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
46948928|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
46639007|NCT01466166|82812560|FG000|Overall Study|Death|1|||
46639008|NCT01466166|82812560|FG000|Overall Study|Lost to Follow-up|7|||
46639009|NCT01466166|82812560|FG000|Overall Study|Infusion Reaction (IR)|27|||
46771428|NCT00717249|82989676|FG001|Overall Study|Lost to Follow-up|0|||
46948929|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Death|0|||
46639010|NCT01466166|82812560|FG000|Overall Study|Adverse Event (Other than IR)|11|||
46639011|NCT01466166|82812560|FG000|Overall Study|Elevated Serum Uric Acid|78|||
46639012|NCT01466166|82812560|FG000|Overall Study|Withdrawal by Subject|13|||
46639013|NCT01466166|82812560|FG000|Overall Study|Sponsor Decision|4|||
46639014|NCT01466166|82812560|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
46639015|NCT01466166|82812560|FG000|Overall Study|Other|20|||
46639016|NCT01426854|82812566|FG000|Overall Study|Adverse Event|1|||
46639017|NCT01426854|82812567|FG001|Overall Study|Adverse Event|5|||
46639018|NCT01426854|82812566|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
46639019|NCT01426854|82812567|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
46639020|NCT01426854|82812566|FG000|Overall Study|Lost to Follow-up|3|||
46639021|NCT01426854|82812567|FG001|Overall Study|Lost to Follow-up|0|||
46639022|NCT01426854|82812566|FG000|Overall Study|Noncompliance|0|||
46639023|NCT01426854|82812567|FG001|Overall Study|Noncompliance|1|||
46639024|NCT01426854|82812566|FG000|Overall Study|Treatment Failure|0|||
46639025|NCT01426854|82812567|FG001|Overall Study|Treatment Failure|16|||
46639026|NCT01426854|82812566|FG000|Overall Study|Protocol Deviation|0|||
46639027|NCT01426854|82812567|FG001|Overall Study|Protocol Deviation|1|||
46639028|NCT01426854|82812566|FG000|Overall Study|Other|3|||
46639029|NCT01426854|82812567|FG001|Overall Study|Other|2|||
46639030|NCT01426386|82812579|FG000|Overall Study|Adverse Event|0|||
46639031|NCT01426386|82812580|FG001|Overall Study|Adverse Event|1|||
46639032|NCT01426386|82812581|FG002|Overall Study|Adverse Event|0|||
46639033|NCT01426386|82812582|FG003|Overall Study|Adverse Event|0|||
46639034|NCT01426386|82812583|FG004|Overall Study|Adverse Event|0|||
46639035|NCT01426386|82812584|FG005|Overall Study|Adverse Event|0|||
46639036|NCT01426386|82812579|FG000|Overall Study|Did not attend scheduled visit|1|||
46771429|NCT00717249|82989675|FG000|Overall Study|Withdrawal by Subject|1|||
46771430|NCT00717249|82989676|FG001|Overall Study|Withdrawal by Subject|2|||
46948930|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Death|8|||
46841965|NCT00143403|83059021|FG001|Overall Study|Death|0|||
46841966|NCT00143403|83059020|FG000|Overall Study|Withdrawal by Subject|3|||
46948931|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Death|2|||
46948932|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Death|13|||
46948933|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
47066497|NCT01576406|83349161|FG004|Overall Study|Other|0|||
47066498|NCT01576406|83349162|FG005|Overall Study|Other|0|||
47066499|NCT01576172|83349178|FG000|Overall Study|Ineligible|2|||
46771431|NCT00717249|82989675|FG000|Overall Study|Pregnancy|6|||
46771432|NCT00717249|82989676|FG001|Overall Study|Pregnancy|3|||
46771433|NCT00717249|82989675|FG000|Overall Study|Protocol Violation|0|||
46771434|NCT00717249|82989676|FG001|Overall Study|Protocol Violation|2|||
46771435|NCT00717249|82989675|FG000|Overall Study|Subject became Ineligible|1|||
46771436|NCT00717249|82989676|FG001|Overall Study|Subject became Ineligible|1|||
46771437|NCT00717249|82989675|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
46771438|NCT00717249|82989676|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
46771439|NCT00717249|82989675|FG000|Overall Study|Gastric Surgery|0|||
46771440|NCT00717249|82989676|FG001|Overall Study|Gastric Surgery|1|||
46771441|NCT00717249|82989675|FG000|Overall Study|Diagnosed with Diabetes|1|||
46771442|NCT00717249|82989676|FG001|Overall Study|Diagnosed with Diabetes|0|||
46771443|NCT00717249|82989675|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
46771444|NCT00717249|82989676|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
46841967|NCT00143403|83059021|FG001|Overall Study|Withdrawal by Subject|12|||
46841968|NCT00143403|83059020|FG000|Overall Study|Relapse|15|||
46841969|NCT00143403|83059021|FG001|Overall Study|Relapse|7|||
46841970|NCT00143403|83059020|FG000|Overall Study|Protocol Violation|2|||
46841971|NCT00143403|83059021|FG001|Overall Study|Protocol Violation|2|||
46841972|NCT00143403|83059020|FG000|Overall Study|specified by site|4|||
46841973|NCT00143403|83059021|FG001|Overall Study|specified by site|9|||
46841974|NCT00143403|83059020|FG000|Overall Study|Randomized Not Treated|7|||
46841975|NCT00143403|83059021|FG001|Overall Study|Randomized Not Treated|8|||
46841976|NCT00220701|83059029|FG000|Overall Study|Lost to Follow-up|5|||
47066500|NCT01576172|83349179|FG001|Overall Study|Ineligible|1|||
46771445|NCT00717249|82989675|FG000|Overall Study|Subject relocated|1|||
47066501|NCT01576172|83349178|FG000|Overall Study|Withdrawal by Subject|2|||
47066502|NCT01576172|83349179|FG001|Overall Study|Withdrawal by Subject|0|||
47066503|NCT01576172|83349178|FG000|Overall Study|Insurance issue|1|||
46771446|NCT00717249|82989676|FG001|Overall Study|Subject relocated|0|||
46639037|NCT01426386|82812580|FG001|Overall Study|Did not attend scheduled visit|4|||
46639038|NCT01426386|82812581|FG002|Overall Study|Did not attend scheduled visit|0|||
46771447|NCT00717249|82989675|FG000|Overall Study|Headaches|1|||
46841977|NCT00220701|83059030|FG001|Overall Study|Lost to Follow-up|4|||
46841978|NCT00127101|83059042|FG000|Base Protocol|Adverse Event|0|||
46639039|NCT01426386|82812582|FG003|Overall Study|Did not attend scheduled visit|0|||
46639040|NCT01426386|82812583|FG004|Overall Study|Did not attend scheduled visit|2|||
46841979|NCT00127101|83059043|FG001|Base Protocol|Adverse Event|2|||
46841980|NCT00127101|83059044|FG002|Base Protocol|Adverse Event|1|||
46948934|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
47066504|NCT01576172|83349179|FG001|Overall Study|Insurance issue|0|||
46771448|NCT00717249|82989676|FG001|Overall Study|Headaches|0|||
46771449|NCT00727194|82989682|FG000|Screening Period|Low QMG scores|0|||
46771450|NCT00727194|82989683|FG001|Screening Period|Low QMG scores|0|||
46771451|NCT00727194|82989684|FG002|Screening Period|Low QMG scores|6|||
46771452|NCT00727194|82989682|FG000|Screening Period|Lacked AChR antibodies|0|||
46771453|NCT00727194|82989683|FG001|Screening Period|Lacked AChR antibodies|0|||
46771454|NCT00727194|82989684|FG002|Screening Period|Lacked AChR antibodies|5|||
46771455|NCT00727194|82989682|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
46771456|NCT00727194|82989683|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
46771457|NCT00727194|82989684|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
46771458|NCT00727194|82989682|FG000|Screening Period|Severe infections|0|||
46771459|NCT00727194|82989683|FG001|Screening Period|Severe infections|0|||
46771460|NCT00727194|82989684|FG002|Screening Period|Severe infections|2|||
46771461|NCT00727194|82989682|FG000|Screening Period|History of thymoma|0|||
46771462|NCT00727194|82989683|FG001|Screening Period|History of thymoma|0|||
46771463|NCT00727194|82989684|FG002|Screening Period|History of thymoma|1|||
46771464|NCT00727194|82989682|FG000|Treatment Period 2|Lack of Efficacy|0|||
46771465|NCT00727194|82989683|FG001|Treatment Period 2|Lack of Efficacy|1|||
46771466|NCT00727194|82989684|FG002|Treatment Period 2|Lack of Efficacy|0|||
46771467|NCT00717093|82989700|FG000|Overall Study|Adverse Event|19|||
46771468|NCT00717093|82989701|FG001|Overall Study|Adverse Event|9|||
46771469|NCT00717093|82989700|FG000|Overall Study|Lack of Efficacy|3|||
46771470|NCT00717093|82989701|FG001|Overall Study|Lack of Efficacy|13|||
46771471|NCT00717093|82989700|FG000|Overall Study|Lost to Follow-up|9|||
46771472|NCT00717093|82989701|FG001|Overall Study|Lost to Follow-up|6|||
46771473|NCT00717093|82989700|FG000|Overall Study|Withdrawal by Subject|12|||
46771474|NCT00717093|82989701|FG001|Overall Study|Withdrawal by Subject|19|||
46771475|NCT00717093|82989700|FG000|Overall Study|Other|0|||
46771476|NCT00717093|82989701|FG001|Overall Study|Other|1|||
46771477|NCT00717093|82989700|FG000|Overall Study|Randomized but not treated|1|||
46771478|NCT00717093|82989701|FG001|Overall Study|Randomized but not treated|0|||
46771479|NCT00716859|82989709|FG000|Overall Study|Adverse Event|4|||
46771480|NCT00716859|82989710|FG001|Overall Study|Adverse Event|1|||
46771481|NCT00716859|82989709|FG000|Overall Study|Lack of Efficacy|3|||
46771482|NCT00716859|82989710|FG001|Overall Study|Lack of Efficacy|0|||
46771483|NCT00716859|82989709|FG000|Overall Study|Withdrawal by Subject|1|||
46771484|NCT00716859|82989710|FG001|Overall Study|Withdrawal by Subject|3|||
46771485|NCT00716859|82989709|FG000|Overall Study|Not treated|1|||
46771486|NCT00716859|82989710|FG001|Overall Study|Not treated|1|||
46771487|NCT00589121|82989718|FG000|Overall Study|Protocol Violation|2|||
46771488|NCT00589121|82989719|FG001|Overall Study|Protocol Violation|6|||
46771489|NCT00589121|82989718|FG000|Overall Study|No protocol treatment received|0|||
46771490|NCT00589121|82989719|FG001|Overall Study|No protocol treatment received|1|||
46771491|NCT00590135|82989728|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
46771492|NCT00589667|82989733|FG000|Overall Study|Adverse Event|2|||
46771493|NCT00589667|82989733|FG000|Overall Study|Withdrawal by Subject|1|||
46771494|NCT00737568|82989739|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
46771495|NCT00737568|82989740|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
46771496|NCT00737568|82989739|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
46771497|NCT00737568|82989740|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
46771498|NCT00737568|82989739|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
46771499|NCT00737568|82989740|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
46841981|NCT00127101|83059045|FG003|Base Protocol|Adverse Event|0|||
46841982|NCT00127101|83059046|FG004|Base Protocol|Adverse Event|0|||
46841983|NCT00127101|83059047|FG005|Base Protocol|Adverse Event|0|||
46841984|NCT00127101|83059042|FG000|Base Protocol|Lack of Efficacy|1|||
46841985|NCT00127101|83059043|FG001|Base Protocol|Lack of Efficacy|0|||
46841986|NCT00127101|83059044|FG002|Base Protocol|Lack of Efficacy|0|||
46841987|NCT00127101|83059045|FG003|Base Protocol|Lack of Efficacy|0|||
46771500|NCT00737568|82989739|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
46771501|NCT00737568|82989740|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
46771502|NCT00737568|82989739|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
46771503|NCT00737568|82989740|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
46771504|NCT00737568|82989739|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
46771505|NCT00737568|82989740|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
46771506|NCT00737568|82989739|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
46841988|NCT00127101|83059046|FG004|Base Protocol|Lack of Efficacy|2|||
46841989|NCT00127101|83059047|FG005|Base Protocol|Lack of Efficacy|0|||
46841990|NCT00127101|83059042|FG000|Base Protocol|Withdrawal by Subject|1|||
46948935|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
46948936|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
46948937|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
46948938|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
46948939|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
46948940|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
46948941|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
46948942|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
46948943|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
46948944|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
46948945|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
46948946|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
47066505|NCT01542788|83349189|FG000|Overall Study|Randomized but Not Treated|2|||
47066506|NCT01542788|83349190|FG001|Overall Study|Randomized but Not Treated|0|||
46639041|NCT01426386|82812584|FG005|Overall Study|Did not attend scheduled visit|1|||
46639042|NCT01426386|82812579|FG000|Overall Study|Poor response|2|||
46841991|NCT00127101|83059043|FG001|Base Protocol|Withdrawal by Subject|2|||
46841992|NCT00127101|83059044|FG002|Base Protocol|Withdrawal by Subject|1|||
46841993|NCT00127101|83059045|FG003|Base Protocol|Withdrawal by Subject|0|||
46841994|NCT00127101|83059046|FG004|Base Protocol|Withdrawal by Subject|0|||
46841995|NCT00127101|83059047|FG005|Base Protocol|Withdrawal by Subject|1|||
46841996|NCT00127101|83059042|FG000|Continuation Phase|Adverse Event|0|||
46841997|NCT00127101|83059043|FG001|Continuation Phase|Adverse Event|0|||
46841998|NCT00127101|83059044|FG002|Continuation Phase|Adverse Event|0|||
46841999|NCT00127101|83059045|FG003|Continuation Phase|Adverse Event|0|||
46842000|NCT00127101|83059046|FG004|Continuation Phase|Adverse Event|1|||
46842001|NCT00127101|83059047|FG005|Continuation Phase|Adverse Event|1|||
46842002|NCT00127101|83059042|FG000|Continuation Phase|Lack of Efficacy|0|||
46842003|NCT00127101|83059043|FG001|Continuation Phase|Lack of Efficacy|0|||
46842004|NCT00127101|83059044|FG002|Continuation Phase|Lack of Efficacy|0|||
46842005|NCT00127101|83059045|FG003|Continuation Phase|Lack of Efficacy|0|||
46842006|NCT00127101|83059046|FG004|Continuation Phase|Lack of Efficacy|0|||
46842007|NCT00127101|83059047|FG005|Continuation Phase|Lack of Efficacy|1|||
46771507|NCT00737568|82989740|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
46771508|NCT00737568|82989739|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
46771509|NCT00737568|82989740|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
46771510|NCT00737568|82989739|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
46771511|NCT00737568|82989740|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
46842008|NCT00127101|83059042|FG000|Continuation Phase|Withdrawal by Subject|0|||
46842009|NCT00127101|83059043|FG001|Continuation Phase|Withdrawal by Subject|0|||
46842010|NCT00127101|83059044|FG002|Continuation Phase|Withdrawal by Subject|1|||
46842011|NCT00127101|83059045|FG003|Continuation Phase|Withdrawal by Subject|0|||
46842012|NCT00127101|83059046|FG004|Continuation Phase|Withdrawal by Subject|2|||
46842013|NCT00127101|83059047|FG005|Continuation Phase|Withdrawal by Subject|1|||
46842014|NCT00126555|83059061|FG000|Overall Study|Withdrawal by Subject|1|||
46842015|NCT00126555|83059061|FG000|Overall Study|Adverse Event|2|||
46842016|NCT00126555|83059061|FG000|Overall Study|Progressive Disease|3|||
46639043|NCT01426386|82812580|FG001|Overall Study|Poor response|1|||
46639044|NCT01426386|82812581|FG002|Overall Study|Poor response|2|||
46639045|NCT01426386|82812582|FG003|Overall Study|Poor response|0|||
46639046|NCT01426386|82812583|FG004|Overall Study|Poor response|1|||
46639047|NCT01426386|82812584|FG005|Overall Study|Poor response|0|||
46771512|NCT00737100|82989749|FG000|Overall Study|Adverse Event|6|||
46771513|NCT00737100|82989750|FG001|Overall Study|Adverse Event|5|||
46771514|NCT00737100|82989751|FG002|Overall Study|Adverse Event|3|||
46842017|NCT00004228|83059084|FG000|Overall Study|Adverse Event|0|||
46842018|NCT00004228|83059085|FG001|Overall Study|Adverse Event|1|||
46842019|NCT00004228|83059086|FG002|Overall Study|Adverse Event|0|||
46842020|NCT00004228|83059087|FG003|Overall Study|Adverse Event|0|||
46948947|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
46948948|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
46842021|NCT00004228|83059088|FG004|Overall Study|Adverse Event|1|||
46948949|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
46948950|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
47066507|NCT01542788|83349189|FG000|Overall Study|Lack of Efficacy|41|||
47066508|NCT01542788|83349190|FG001|Overall Study|Lack of Efficacy|71|||
46639048|NCT01426386|82812579|FG000|Overall Study|Personal reasons|0|||
46771515|NCT00737100|82989749|FG000|Overall Study|Lost to Follow-up|0|||
46842022|NCT00004228|83059089|FG005|Overall Study|Adverse Event|0|||
46842023|NCT00004228|83059090|FG006|Overall Study|Adverse Event|0|||
46842024|NCT00004228|83059084|FG000|Overall Study|Death|0|||
46842025|NCT00004228|83059085|FG001|Overall Study|Death|1|||
46948951|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
46948952|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
46948953|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
46948954|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
46948955|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
46948956|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
46948957|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
46948958|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
46948959|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
46948960|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
46948961|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
46948962|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
46948963|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
46948964|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
46948965|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
46948966|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
46948967|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
46948968|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
46948969|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
46948970|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
46948971|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
46948972|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
46948973|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Pain|0|||
46948974|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Pain|0|||
46948975|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Pain|0|||
46948976|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Pain|1|||
46948977|NCT01107626|83187588|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
46948978|NCT01107626|83187589|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
46948979|NCT01107626|83187590|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
46948980|NCT01107626|83187591|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
46948981|NCT00828009|83187600|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
46948982|NCT00828009|83187600|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
46948983|NCT00828009|83187600|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
46948984|NCT00828009|83187600|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
46948985|NCT00828009|83187600|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
46948986|NCT00828009|83187600|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
46948987|NCT00828009|83187600|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
46948988|NCT00828009|83187600|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
47066509|NCT01542788|83349189|FG000|Overall Study|Lost to Follow-up|5|||
47066510|NCT01542788|83349190|FG001|Overall Study|Lost to Follow-up|0|||
46948989|NCT00828009|83187600|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
46948990|NCT00828009|83187600|FG000|Step 2 - Maintenance Therapy|Death|1|||
46948991|NCT00828009|83187600|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
46948992|NCT00828009|83187600|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
46948993|NCT00828009|83187600|FG000|Step 2 - Maintenance Therapy|Other|1|||
46948994|NCT00068393|83187620|FG000|Overall Study|Adverse Event|2|||
46948995|NCT00068393|83187620|FG000|Overall Study|Death|3|||
46948996|NCT00068393|83187620|FG000|Overall Study|Withdrawal by Subject|3|||
46842026|NCT00004228|83059086|FG002|Overall Study|Death|2|||
46842027|NCT00004228|83059087|FG003|Overall Study|Death|0|||
46842028|NCT00004228|83059088|FG004|Overall Study|Death|1|||
46948997|NCT00068393|83187620|FG000|Overall Study|Alternative treatment|1|||
46948998|NCT00068393|83187620|FG000|Overall Study|Quality of life worsening|1|||
46948999|NCT00062010|83187624|FG000|Overall Study|Ineligible|3|||
46949000|NCT00061568|83187630|FG000|Overall Study|Lost to Follow-up|12|||
46949001|NCT00061568|83187631|FG001|Overall Study|Lost to Follow-up|0|||
47066511|NCT01542788|83349189|FG000|Overall Study|Death|3|||
46771516|NCT00737100|82989750|FG001|Overall Study|Lost to Follow-up|1|||
46771517|NCT00737100|82989751|FG002|Overall Study|Lost to Follow-up|0|||
46771518|NCT00737100|82989749|FG000|Overall Study|Withdrawal by Subject|0|||
46771519|NCT00737100|82989750|FG001|Overall Study|Withdrawal by Subject|0|||
46771520|NCT00737100|82989751|FG002|Overall Study|Withdrawal by Subject|3|||
47066512|NCT01542788|83349190|FG001|Overall Study|Death|0|||
46771521|NCT00737100|82989749|FG000|Overall Study|Reason discontinued not explained above|1|||
46771522|NCT00737100|82989750|FG001|Overall Study|Reason discontinued not explained above|1|||
46771523|NCT00737100|82989751|FG002|Overall Study|Reason discontinued not explained above|1|||
46771524|NCT00732498|82989761|FG000|Overall Study|Ineligible|1|||
46771525|NCT00732498|82989761|FG000|Overall Study|Adverse Event|2|||
46771526|NCT00732498|82989761|FG000|Overall Study|Physician Decision|3|||
46771527|NCT00726882|82989765|FG000|Overall Study|Withdrawal by Subject|5|||
46771528|NCT00726882|82989765|FG000|Overall Study|Lost to Follow-up|7|||
46771529|NCT00726882|82989765|FG000|Overall Study|Other|10|||
46842029|NCT00004228|83059089|FG005|Overall Study|Death|0|||
46949002|NCT00061568|83187630|FG000|Overall Study|Death|6|||
46949003|NCT00061568|83187631|FG001|Overall Study|Death|0|||
46949004|NCT00061568|83187630|FG000|Overall Study|Withdrawal by Subject|1|||
46949005|NCT00061568|83187631|FG001|Overall Study|Withdrawal by Subject|0|||
46949006|NCT00047008|83187638|FG000|Overall Study|Withdrawn consent|2|||
46949007|NCT00047008|83187639|FG001|Overall Study|Withdrawn consent|3|||
46949008|NCT00047008|83187638|FG000|Overall Study|Ineligible|9|||
46949009|NCT00047008|83187639|FG001|Overall Study|Ineligible|8|||
46949010|NCT02397694|83187647|FG000|Double-Blinded Phase|Adverse Event|1|||
46949011|NCT02397694|83187648|FG001|Double-Blinded Phase|Adverse Event|0|||
46949012|NCT02397694|83187647|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
46949013|NCT02397694|83187648|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
46949014|NCT02397694|83187647|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
46949015|NCT02397694|83187648|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
46949016|NCT02397694|83187647|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
46949017|NCT02397694|83187648|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
46949018|NCT02397694|83187647|FG000|Open Label Extension Phase|Protocol Violation|1|||
46949019|NCT02397694|83187648|FG001|Open Label Extension Phase|Protocol Violation|0|||
46949020|NCT02397694|83187647|FG000|Open Label Extension Phase|Withdrew Consent|3|||
46949021|NCT02397694|83187648|FG001|Open Label Extension Phase|Withdrew Consent|1|||
46949022|NCT02397694|83187647|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
46949023|NCT02397694|83187648|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
46949024|NCT02783599|83187658|FG000|Overall Study|Progressive disease|23|||
46949025|NCT02783599|83187658|FG000|Overall Study|Surgical Resection|10|||
46949026|NCT02783599|83187658|FG000|Overall Study|Adverse Event|4|||
46949027|NCT02783599|83187658|FG000|Overall Study|Physician Decision|2|||
46949028|NCT02783599|83187658|FG000|Overall Study|Death|1|||
46949029|NCT02838017|83187671|FG000|Overall Study|Lost to Follow-up|14|||
46949030|NCT02838017|83187672|FG001|Overall Study|Lost to Follow-up|11|||
46949031|NCT03188666|83187680|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
46949032|NCT03188666|83187681|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
46949033|NCT03188666|83187682|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
46949034|NCT03188666|83187683|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
46949035|NCT03188666|83187680|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
46949036|NCT03188666|83187681|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
46949037|NCT03188666|83187682|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
46949038|NCT03188666|83187683|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
46949039|NCT03188666|83187680|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
46842030|NCT00004228|83059090|FG006|Overall Study|Death|0|||
46842031|NCT00004228|83059084|FG000|Overall Study|Lack of Efficacy|1|||
46842032|NCT00004228|83059085|FG001|Overall Study|Lack of Efficacy|6|||
46842033|NCT00004228|83059086|FG002|Overall Study|Lack of Efficacy|5|||
46842034|NCT00004228|83059087|FG003|Overall Study|Lack of Efficacy|3|||
46949040|NCT03188666|83187681|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
46949041|NCT03188666|83187682|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
46949042|NCT03188666|83187683|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
46949043|NCT03188666|83187680|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
46949044|NCT03188666|83187681|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
46949045|NCT03188666|83187682|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
46949046|NCT03188666|83187683|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
46949047|NCT02836769|83187697|FG000|Overall Study|Lost to Follow-up|10|||
46949048|NCT02836769|83187697|FG000|Overall Study|Medical withdrawal|2|||
46949049|NCT02836769|83187697|FG000|Overall Study|Withdrawal by Subject|3|||
46949050|NCT02836613|83187703|FG000|Overall Study|Accidental drowning|1|||
46639049|NCT01426386|82812580|FG001|Overall Study|Personal reasons|0|||
46949051|NCT02836613|83187704|FG001|Overall Study|Accidental drowning|0|||
46949052|NCT02836613|83187703|FG000|Overall Study|Lost to Follow-up|0|||
46949053|NCT02836613|83187704|FG001|Overall Study|Lost to Follow-up|1|||
46949054|NCT02836613|83187703|FG000|Overall Study|Withdrawal by Subject|0|||
46639050|NCT01426386|82812581|FG002|Overall Study|Personal reasons|0|||
46771530|NCT00790400|82989773|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
46949055|NCT02836613|83187704|FG001|Overall Study|Withdrawal by Subject|2|||
46949056|NCT02397460|83187718|FG000|Treatment Period 2|Adverse Event|0|||
46949057|NCT02397460|83187719|FG001|Treatment Period 2|Adverse Event|0|||
46949058|NCT02397460|83187720|FG002|Treatment Period 2|Adverse Event|0|||
46949059|NCT02397460|83187721|FG003|Treatment Period 2|Adverse Event|0|||
46949060|NCT02397460|83187722|FG004|Treatment Period 2|Adverse Event|0|||
46771531|NCT00790400|82989774|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
46771532|NCT00790400|82989773|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
46771533|NCT00790400|82989774|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
46771534|NCT00790400|82989773|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
46771535|NCT00790400|82989774|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
46771536|NCT00790400|82989773|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
46842035|NCT00004228|83059088|FG004|Overall Study|Lack of Efficacy|9|||
46842036|NCT00004228|83059089|FG005|Overall Study|Lack of Efficacy|8|||
46842037|NCT00004228|83059090|FG006|Overall Study|Lack of Efficacy|4|||
46949061|NCT02397460|83187723|FG005|Treatment Period 2|Adverse Event|0|||
46949062|NCT02397460|83187724|FG006|Treatment Period 2|Adverse Event|0|||
46949063|NCT02397460|83187725|FG007|Treatment Period 2|Adverse Event|1|||
46949064|NCT02397460|83187718|FG000|Treatment Period 4|Adverse Event|0|||
46949065|NCT02397460|83187719|FG001|Treatment Period 4|Adverse Event|1|||
46949066|NCT02397460|83187720|FG002|Treatment Period 4|Adverse Event|0|||
46949067|NCT02397460|83187721|FG003|Treatment Period 4|Adverse Event|0|||
46949068|NCT02397460|83187722|FG004|Treatment Period 4|Adverse Event|0|||
46949069|NCT02397460|83187723|FG005|Treatment Period 4|Adverse Event|0|||
46949070|NCT02397460|83187724|FG006|Treatment Period 4|Adverse Event|0|||
46949071|NCT02397460|83187725|FG007|Treatment Period 4|Adverse Event|0|||
46949072|NCT02397460|83187718|FG000|Treatment Period 4|Physician Decision|0|||
46949073|NCT02397460|83187719|FG001|Treatment Period 4|Physician Decision|0|||
46949074|NCT02397460|83187720|FG002|Treatment Period 4|Physician Decision|0|||
46949075|NCT02397460|83187721|FG003|Treatment Period 4|Physician Decision|0|||
46949076|NCT02397460|83187722|FG004|Treatment Period 4|Physician Decision|1|||
46949077|NCT02397460|83187723|FG005|Treatment Period 4|Physician Decision|0|||
46949078|NCT02397460|83187724|FG006|Treatment Period 4|Physician Decision|0|||
46949079|NCT02397460|83187725|FG007|Treatment Period 4|Physician Decision|0|||
47066513|NCT01542788|83349189|FG000|Overall Study|Protocol Violation|2|||
47066514|NCT01542788|83349190|FG001|Overall Study|Protocol Violation|0|||
47066515|NCT01542788|83349189|FG000|Overall Study|Physician Decision|1|||
46639051|NCT01426386|82812582|FG003|Overall Study|Personal reasons|0|||
46639052|NCT01426386|82812583|FG004|Overall Study|Personal reasons|1|||
46639053|NCT01426386|82812584|FG005|Overall Study|Personal reasons|0|||
46639054|NCT01404234|82812598|FG000|Overall Study|Withdrawal by Subject|2|||
46639055|NCT01403610|82812606|FG000|Overall Study|Withdrawal by Subject|2|||
46771537|NCT00790400|82989774|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
46771538|NCT00790400|82989773|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
46771539|NCT00790400|82989774|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
46771540|NCT00790400|82989773|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
46771541|NCT00790400|82989774|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
46771542|NCT00790400|82989773|FG000|Double-blind Period (Core Phase)|Death|1|||
46842038|NCT00004228|83059084|FG000|Overall Study|Lost to Follow-up|0|||
46842039|NCT00004228|83059085|FG001|Overall Study|Lost to Follow-up|0|||
46842040|NCT00004228|83059086|FG002|Overall Study|Lost to Follow-up|1|||
46842041|NCT00004228|83059087|FG003|Overall Study|Lost to Follow-up|0|||
46842042|NCT00004228|83059088|FG004|Overall Study|Lost to Follow-up|0|||
46842043|NCT00004228|83059089|FG005|Overall Study|Lost to Follow-up|0|||
46842044|NCT00004228|83059090|FG006|Overall Study|Lost to Follow-up|0|||
46842045|NCT00004228|83059084|FG000|Overall Study|Physician Decision|1|||
46842046|NCT00004228|83059085|FG001|Overall Study|Physician Decision|0|||
46842047|NCT00004228|83059086|FG002|Overall Study|Physician Decision|3|||
46842048|NCT00004228|83059087|FG003|Overall Study|Physician Decision|2|||
46842049|NCT00004228|83059088|FG004|Overall Study|Physician Decision|1|||
46842050|NCT00004228|83059089|FG005|Overall Study|Physician Decision|1|||
46842051|NCT00004228|83059090|FG006|Overall Study|Physician Decision|1|||
46842052|NCT00004228|83059084|FG000|Overall Study|Protocol Violation|0|||
46842053|NCT00004228|83059085|FG001|Overall Study|Protocol Violation|5|||
46842054|NCT00004228|83059086|FG002|Overall Study|Protocol Violation|2|||
46842055|NCT00004228|83059087|FG003|Overall Study|Protocol Violation|1|||
46842056|NCT00004228|83059088|FG004|Overall Study|Protocol Violation|1|||
46842057|NCT00004228|83059089|FG005|Overall Study|Protocol Violation|2|||
46842058|NCT00004228|83059090|FG006|Overall Study|Protocol Violation|0|||
46842059|NCT00004228|83059084|FG000|Overall Study|Withdrawal by Subject|3|||
46842060|NCT00004228|83059085|FG001|Overall Study|Withdrawal by Subject|0|||
46842061|NCT00004228|83059086|FG002|Overall Study|Withdrawal by Subject|1|||
46949080|NCT02834819|83187801|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
46639056|NCT01403610|82812607|FG001|Overall Study|Withdrawal by Subject|0|||
46949081|NCT02834819|83187802|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
46842062|NCT00004228|83059087|FG003|Overall Study|Withdrawal by Subject|0|||
46842063|NCT00004228|83059088|FG004|Overall Study|Withdrawal by Subject|2|||
46842064|NCT00004228|83059089|FG005|Overall Study|Withdrawal by Subject|1|||
46842065|NCT00004228|83059090|FG006|Overall Study|Withdrawal by Subject|2|||
46949082|NCT02454478|83187808|FG000|Overall Study|Incomplete DLT Evaluation|1|||
47066516|NCT01542788|83349190|FG001|Overall Study|Physician Decision|0|||
47066517|NCT01542788|83349189|FG000|Overall Study|Withdrawal by Subject|1|||
46639057|NCT01403610|82812608|FG002|Overall Study|Withdrawal by Subject|0|||
46771543|NCT00790400|82989774|FG001|Double-blind Period (Core Phase)|Death|0|||
46842066|NCT00004228|83059084|FG000|Overall Study|Other|0|||
46842067|NCT00004228|83059085|FG001|Overall Study|Other|0|||
46639058|NCT01403610|82812609|FG003|Overall Study|Withdrawal by Subject|0|||
46639059|NCT01403610|82812606|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
46842068|NCT00004228|83059086|FG002|Overall Study|Other|1|||
46842069|NCT00004228|83059087|FG003|Overall Study|Other|0|||
46842070|NCT00004228|83059088|FG004|Overall Study|Other|0|||
46949083|NCT01341587|83187814|FG000|Overall Study|Lost to Follow-up|2|||
46949084|NCT01341587|83187815|FG001|Overall Study|Lost to Follow-up|0|||
46949085|NCT01341587|83187814|FG000|Overall Study|stopped using the meters|2|||
46949086|NCT01341587|83187815|FG001|Overall Study|stopped using the meters|10|||
46949087|NCT01358825|83187823|FG000|Overall Study|Blood sample not drawn|0|||
46949088|NCT01358825|83187824|FG001|Overall Study|Blood sample not drawn|1|||
46949089|NCT02453386|83187833|FG000|Overall Study|Adverse Event|22|||
46949090|NCT02453386|83187834|FG001|Overall Study|Adverse Event|30|||
46949091|NCT02453386|83187835|FG002|Overall Study|Adverse Event|15|||
46949092|NCT02453386|83187833|FG000|Overall Study|Protocol Violation|1|||
46949093|NCT02453386|83187834|FG001|Overall Study|Protocol Violation|0|||
46949094|NCT02453386|83187835|FG002|Overall Study|Protocol Violation|1|||
46949095|NCT02453386|83187833|FG000|Overall Study|Withdrawal by Subject|10|||
46949096|NCT02453386|83187834|FG001|Overall Study|Withdrawal by Subject|9|||
46949097|NCT02453386|83187835|FG002|Overall Study|Withdrawal by Subject|9|||
46949098|NCT02453386|83187833|FG000|Overall Study|Sponsor Terminated Study|14|||
46949099|NCT02453386|83187834|FG001|Overall Study|Sponsor Terminated Study|8|||
46949100|NCT02453386|83187835|FG002|Overall Study|Sponsor Terminated Study|11|||
46949101|NCT02453386|83187833|FG000|Overall Study|Subject Terminated by Sponsor|1|||
46949102|NCT02453386|83187834|FG001|Overall Study|Subject Terminated by Sponsor|1|||
46949103|NCT02453386|83187835|FG002|Overall Study|Subject Terminated by Sponsor|1|||
46949104|NCT02453386|83187833|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
46949105|NCT02453386|83187834|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
46949106|NCT02453386|83187835|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
46949107|NCT02453386|83187833|FG000|Overall Study|Lost to Follow-up|0|||
46949108|NCT02453386|83187834|FG001|Overall Study|Lost to Follow-up|0|||
46949109|NCT02453386|83187835|FG002|Overall Study|Lost to Follow-up|1|||
46949110|NCT02453386|83187833|FG000|Overall Study|Other|1|||
46949111|NCT02453386|83187834|FG001|Overall Study|Other|0|||
46949112|NCT02453386|83187835|FG002|Overall Study|Other|1|||
46949113|NCT02431468|83187853|FG000|Overall Study|Adverse Event|2|||
46949114|NCT02431468|83187854|FG001|Overall Study|Adverse Event|4|||
46949115|NCT02431468|83187855|FG002|Overall Study|Adverse Event|5|||
46949116|NCT02431468|83187853|FG000|Overall Study|Withdrawal by Subject|4|||
46949117|NCT02431468|83187854|FG001|Overall Study|Withdrawal by Subject|12|||
46949118|NCT02431468|83187855|FG002|Overall Study|Withdrawal by Subject|2|||
46949119|NCT02431468|83187853|FG000|Overall Study|noncompliance, investigator termination,|2|||
46949120|NCT02431468|83187854|FG001|Overall Study|noncompliance, investigator termination,|2|||
46949121|NCT02431468|83187855|FG002|Overall Study|noncompliance, investigator termination,|2|||
46949122|NCT02452762|83187871|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
46949123|NCT02452762|83187872|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
46949124|NCT02452762|83187871|FG000|Overall Study|Withdrawal by Subject|1|||
46949125|NCT02452762|83187872|FG001|Overall Study|Withdrawal by Subject|0|||
46949126|NCT02633306|83187879|FG000|Overall Study|Withdrawal by Subject|3|||
46949127|NCT02396758|83187888|FG000|Overall Study|Withdrawal by Subject|2|||
46949128|NCT02396758|83187889|FG001|Overall Study|Withdrawal by Subject|0|||
46949129|NCT02396758|83187890|FG002|Overall Study|Withdrawal by Subject|0|||
46949130|NCT02396758|83187891|FG003|Overall Study|Withdrawal by Subject|1|||
46949131|NCT02396758|83187888|FG000|Overall Study|Lost to Follow-up|8|||
46949132|NCT02396758|83187889|FG001|Overall Study|Lost to Follow-up|5|||
46949133|NCT02396758|83187890|FG002|Overall Study|Lost to Follow-up|3|||
46949134|NCT02396758|83187891|FG003|Overall Study|Lost to Follow-up|3|||
46949135|NCT02396758|83187888|FG000|Overall Study|Death|1|||
46949136|NCT02396758|83187889|FG001|Overall Study|Death|1|||
46949137|NCT02396758|83187890|FG002|Overall Study|Death|0|||
46949138|NCT02396758|83187891|FG003|Overall Study|Death|1|||
46949139|NCT02396758|83187888|FG000|Overall Study|Randomized but not treated|1|||
46949140|NCT02396758|83187889|FG001|Overall Study|Randomized but not treated|0|||
46949141|NCT02396758|83187890|FG002|Overall Study|Randomized but not treated|1|||
46949142|NCT02396758|83187891|FG003|Overall Study|Randomized but not treated|0|||
46639060|NCT01403610|82812607|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
46639061|NCT01403610|82812608|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
46949143|NCT02632838|83187903|FG000|Overall Study|Withdrawal by Subject|3|||
46949144|NCT02632838|83187904|FG001|Overall Study|Withdrawal by Subject|0|||
46949145|NCT02632838|83187903|FG000|Overall Study|Lost to Follow-up|0|||
46949146|NCT02632838|83187904|FG001|Overall Study|Lost to Follow-up|2|||
46949147|NCT02396212|83187914|FG000|Overall Study|Adverse Event|1|||
46949148|NCT02396212|83187914|FG000|Overall Study|Lack of Efficacy|2|||
46949149|NCT02395822|83187918|FG000|Overall Study|Withdrawal by Subject|1|||
46949150|NCT02395822|83187918|FG000|Overall Study|Death|1|||
46949151|NCT01651936|83187924|FG000|Base Study|Adverse Event|3|||
46949152|NCT01651936|83187925|FG001|Base Study|Adverse Event|0|||
46949153|NCT01651936|83187926|FG002|Base Study|Adverse Event|0|||
46949154|NCT01651936|83187924|FG000|Base Study|Withdrawal by Subject|1|||
46771544|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
46949155|NCT01651936|83187925|FG001|Base Study|Withdrawal by Subject|1|||
46949156|NCT01651936|83187926|FG002|Base Study|Withdrawal by Subject|0|||
46949157|NCT01651936|83187924|FG000|Base Study|Early Escape|2|||
46949158|NCT01651936|83187925|FG001|Base Study|Early Escape|8|||
46949159|NCT01651936|83187926|FG002|Base Study|Early Escape|0|||
46949160|NCT01651936|83187924|FG000|Base Study|Study terminated by sponsor|21|||
46949161|NCT01651936|83187925|FG001|Base Study|Study terminated by sponsor|16|||
46949162|NCT01651936|83187926|FG002|Base Study|Study terminated by sponsor|0|||
46949163|NCT01651936|83187924|FG000|Extension Study|Lack of Efficacy|0|||
46949164|NCT01651936|83187925|FG001|Extension Study|Lack of Efficacy|0|||
46842071|NCT00004228|83059089|FG005|Overall Study|Other|0|||
46842072|NCT00004228|83059090|FG006|Overall Study|Other|0|||
46842073|NCT00004228|83059084|FG000|Overall Study|ineligible|4|||
46842074|NCT00004228|83059085|FG001|Overall Study|ineligible|2|||
46842075|NCT00004228|83059086|FG002|Overall Study|ineligible|4|||
46842076|NCT00004228|83059087|FG003|Overall Study|ineligible|1|||
46842077|NCT00004228|83059088|FG004|Overall Study|ineligible|1|||
46842078|NCT00004228|83059089|FG005|Overall Study|ineligible|2|||
46842079|NCT00004228|83059090|FG006|Overall Study|ineligible|5|||
46842080|NCT00003526|83059107|FG000|Overall Study|Not evaluable|6|||
46842081|NCT00195260|83059113|FG000|Part 1: Dose Escalation|Adverse Event|0|||
46842082|NCT00195260|83059114|FG001|Part 1: Dose Escalation|Adverse Event|1|||
46842083|NCT00195260|83059115|FG002|Part 1: Dose Escalation|Adverse Event|0|||
46842084|NCT00195260|83059116|FG003|Part 1: Dose Escalation|Adverse Event|1|||
46842085|NCT00195260|83059117|FG004|Part 1: Dose Escalation|Adverse Event|1|||
46842086|NCT00195260|83059118|FG005|Part 1: Dose Escalation|Adverse Event|0|||
46842087|NCT00195260|83059119|FG006|Part 1: Dose Escalation|Adverse Event|3|||
46842088|NCT00195260|83059120|FG007|Part 1: Dose Escalation|Adverse Event|0|||
46842089|NCT00195260|83059121|FG008|Part 1: Dose Escalation|Adverse Event|0|||
46842090|NCT00195260|83059122|FG009|Part 1: Dose Escalation|Adverse Event|0|||
46842091|NCT00195260|83059123|FG010|Part 1: Dose Escalation|Adverse Event|0|||
46842092|NCT00195260|83059113|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842093|NCT00195260|83059114|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842094|NCT00195260|83059115|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842095|NCT00195260|83059116|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842096|NCT00195260|83059117|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
46842097|NCT00195260|83059118|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842098|NCT00195260|83059119|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842099|NCT00195260|83059120|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
46842100|NCT00195260|83059121|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842101|NCT00195260|83059122|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842102|NCT00195260|83059123|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
46842103|NCT00195260|83059113|FG000|Part 1: Dose Escalation|Death|0|||
46842104|NCT00195260|83059114|FG001|Part 1: Dose Escalation|Death|0|||
46842105|NCT00195260|83059115|FG002|Part 1: Dose Escalation|Death|0|||
46842106|NCT00195260|83059116|FG003|Part 1: Dose Escalation|Death|0|||
46842107|NCT00195260|83059117|FG004|Part 1: Dose Escalation|Death|0|||
46842108|NCT00195260|83059118|FG005|Part 1: Dose Escalation|Death|0|||
46842109|NCT00195260|83059119|FG006|Part 1: Dose Escalation|Death|0|||
46842110|NCT00195260|83059120|FG007|Part 1: Dose Escalation|Death|1|||
46842111|NCT00195260|83059121|FG008|Part 1: Dose Escalation|Death|0|||
46842112|NCT00195260|83059122|FG009|Part 1: Dose Escalation|Death|0|||
46842113|NCT00195260|83059123|FG010|Part 1: Dose Escalation|Death|0|||
46842114|NCT00195260|83059113|FG000|Part 1: Dose Escalation|Disease Progression|3|||
46842115|NCT00195260|83059114|FG001|Part 1: Dose Escalation|Disease Progression|2|||
46842116|NCT00195260|83059115|FG002|Part 1: Dose Escalation|Disease Progression|5|||
46842117|NCT00195260|83059116|FG003|Part 1: Dose Escalation|Disease Progression|6|||
46842118|NCT00195260|83059117|FG004|Part 1: Dose Escalation|Disease Progression|4|||
46842119|NCT00195260|83059118|FG005|Part 1: Dose Escalation|Disease Progression|6|||
46842120|NCT00195260|83059119|FG006|Part 1: Dose Escalation|Disease Progression|7|||
46842121|NCT00195260|83059120|FG007|Part 1: Dose Escalation|Disease Progression|4|||
46842122|NCT00195260|83059121|FG008|Part 1: Dose Escalation|Disease Progression|0|||
46842123|NCT00195260|83059122|FG009|Part 1: Dose Escalation|Disease Progression|0|||
46842124|NCT00195260|83059123|FG010|Part 1: Dose Escalation|Disease Progression|0|||
46949165|NCT01651936|83187926|FG002|Extension Study|Lack of Efficacy|1|||
46842125|NCT00195260|83059113|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
46842126|NCT00195260|83059114|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
46842127|NCT00195260|83059115|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
46842128|NCT00195260|83059116|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
46842129|NCT00195260|83059117|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
46842130|NCT00195260|83059118|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
46842131|NCT00195260|83059119|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
46842132|NCT00195260|83059120|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
46842133|NCT00195260|83059121|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
46949166|NCT01651936|83187924|FG000|Extension Study|Study terminated by sponsor|0|||
46949167|NCT01651936|83187925|FG001|Extension Study|Study terminated by sponsor|0|||
46842134|NCT00195260|83059122|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
46842135|NCT00195260|83059123|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
46949168|NCT01651936|83187926|FG002|Extension Study|Study terminated by sponsor|13|||
46949169|NCT02395042|83187936|FG000|Treatment 1 Period|Adverse Event|1|||
46949170|NCT02395042|83187937|FG001|Treatment 1 Period|Adverse Event|3|||
46949171|NCT02395042|83187938|FG002|Treatment 1 Period|Adverse Event|1|||
46949172|NCT02395042|83187936|FG000|Treatment 1 Period|Lack of Efficacy|1|||
46949173|NCT02395042|83187937|FG001|Treatment 1 Period|Lack of Efficacy|1|||
46949174|NCT02395042|83187938|FG002|Treatment 1 Period|Lack of Efficacy|0|||
46949175|NCT02395042|83187936|FG000|Treatment 1 Period|Lost to Follow-up|1|||
46949176|NCT02395042|83187937|FG001|Treatment 1 Period|Lost to Follow-up|0|||
46949177|NCT02395042|83187938|FG002|Treatment 1 Period|Lost to Follow-up|0|||
46949178|NCT02395042|83187936|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
46949179|NCT02395042|83187937|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
46949180|NCT02395042|83187938|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
46949181|NCT02395042|83187936|FG000|Treatment 2 Period|Lack of Efficacy|1|||
46949182|NCT02395042|83187937|FG001|Treatment 2 Period|Lack of Efficacy|1|||
46949183|NCT02395042|83187938|FG002|Treatment 2 Period|Lack of Efficacy|0|||
46949184|NCT02394808|83187949|FG000|Period 1|Unsatisfactory lens fitting|0|||
46949185|NCT02394808|83187950|FG001|Period 1|Unsatisfactory lens fitting|1|||
46949186|NCT02394808|83187949|FG000|Period 2|Lost to Follow-up|1|||
46949187|NCT02394808|83187950|FG001|Period 2|Lost to Follow-up|0|||
46949188|NCT02630966|83187958|FG000|Overall Study|Adverse Event|1|||
46949189|NCT02630966|83187959|FG001|Overall Study|Adverse Event|3|||
46949190|NCT02630966|83187958|FG000|Overall Study|Significant Protocol Deviation|0|||
46949191|NCT02630966|83187959|FG001|Overall Study|Significant Protocol Deviation|2|||
46949192|NCT02630966|83187958|FG000|Overall Study|Voluntary Withdrawal|1|||
46949193|NCT02630966|83187959|FG001|Overall Study|Voluntary Withdrawal|1|||
46949194|NCT02630966|83187958|FG000|Overall Study|Lack of Efficacy|0|||
46949195|NCT02630966|83187959|FG001|Overall Study|Lack of Efficacy|2|||
46949196|NCT01651780|83187967|FG000|Overall Study|Physician decision: No 30-day visit|2|||
46949197|NCT01651780|83187968|FG001|Overall Study|Physician decision: No 30-day visit|1|||
46949198|NCT01651780|83187967|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
46949199|NCT01651780|83187968|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
46842136|NCT00195260|83059113|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46842137|NCT00195260|83059114|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46842138|NCT00195260|83059115|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46842139|NCT00195260|83059116|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46949200|NCT01651780|83187967|FG000|Overall Study|Withdrawal by Subject|2|||
46949201|NCT01651780|83187968|FG001|Overall Study|Withdrawal by Subject|0|||
46949202|NCT01651780|83187967|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
46949203|NCT01651780|83187968|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46842140|NCT00195260|83059117|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46842141|NCT00195260|83059118|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46842142|NCT00195260|83059119|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46842143|NCT00195260|83059120|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
46842144|NCT00195260|83059121|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
46842145|NCT00195260|83059122|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
46842146|NCT00195260|83059123|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
46842147|NCT00195260|83059113|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842148|NCT00195260|83059114|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842149|NCT00195260|83059115|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842150|NCT00195260|83059116|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842151|NCT00195260|83059117|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842152|NCT00195260|83059118|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842153|NCT00195260|83059119|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842154|NCT00195260|83059120|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
46842155|NCT00195260|83059121|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
46842156|NCT00195260|83059122|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
46842157|NCT00195260|83059123|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
46842158|NCT00195260|83059113|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46842159|NCT00195260|83059114|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46842160|NCT00195260|83059115|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46842161|NCT00195260|83059116|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46842162|NCT00195260|83059117|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46842163|NCT00195260|83059118|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46842164|NCT00195260|83059119|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46842165|NCT00195260|83059120|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
46949204|NCT01651780|83187967|FG000|Overall Study|Lost to Follow-up|1|||
46949205|NCT01651780|83187968|FG001|Overall Study|Lost to Follow-up|2|||
46949206|NCT01651780|83187967|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
46949207|NCT01651780|83187968|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
46949208|NCT02394730|83187980|FG000|Overall Study|Lost to Follow-up|1|||
46949209|NCT02394730|83187981|FG001|Overall Study|Lost to Follow-up|0|||
46949210|NCT02394730|83187980|FG000|Overall Study|Withdrawal by Subject|0|||
46949211|NCT02394730|83187981|FG001|Overall Study|Withdrawal by Subject|1|||
46949212|NCT02430532|83187989|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
46949213|NCT02430532|83187990|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
46949214|NCT02430532|83187989|FG000|Overall Study|Consent Withdrawn|0|||
46949215|NCT02430532|83187990|FG001|Overall Study|Consent Withdrawn|2|||
46949216|NCT02430532|83187989|FG000|Overall Study|Adverse Event|0|||
46949217|NCT02430532|83187990|FG001|Overall Study|Adverse Event|1|||
46949218|NCT02394340|83187998|FG000|Overall Study|Failed drug screen test|1|||
46949219|NCT02394340|83187998|FG000|Overall Study|Adverse Event|1|||
46949220|NCT01672736|83188002|FG000|Overall Study|Available drug expired on 31 May 16|3|||
46949221|NCT01560637|83188006|FG000|Overall Study|Adverse Event|63|||
46771545|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
46771546|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
46771547|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
46771548|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
46771549|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
46771550|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
46771551|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
46771552|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
46771553|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
46771554|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Death|1|||
46771555|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Death|0|||
46771556|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
46771557|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
46771558|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
46949222|NCT01560637|83188006|FG000|Overall Study|Death|69|||
46949223|NCT01560637|83188006|FG000|Overall Study|Lost to Follow-up|8|||
46949224|NCT01560637|83188006|FG000|Overall Study|Protocol Violation|8|||
46949225|NCT01560637|83188006|FG000|Overall Study|Withdrawal by Subject|24|||
46949226|NCT01560637|83188006|FG000|Overall Study|Progressive Disease|20|||
46949227|NCT01560637|83188006|FG000|Overall Study|Other Reason Not Specified|6|||
46949228|NCT01353911|83188018|FG000|Overall Study|Lost to Follow-up|2|||
46949229|NCT01353911|83188019|FG001|Overall Study|Lost to Follow-up|6|||
46949230|NCT01353911|83188020|FG002|Overall Study|Lost to Follow-up|4|||
46949231|NCT01353911|83188021|FG003|Overall Study|Lost to Follow-up|0|||
46949232|NCT01353911|83188022|FG004|Overall Study|Lost to Follow-up|4|||
46949233|NCT01353911|83188023|FG005|Overall Study|Lost to Follow-up|4|||
46949234|NCT01353911|83188024|FG006|Overall Study|Lost to Follow-up|3|||
46949235|NCT01353911|83188025|FG007|Overall Study|Lost to Follow-up|6|||
46949236|NCT01353911|83188018|FG000|Overall Study|Withdrawal by Subject|2|||
46949237|NCT01353911|83188019|FG001|Overall Study|Withdrawal by Subject|3|||
46949238|NCT01353911|83188020|FG002|Overall Study|Withdrawal by Subject|4|||
46949239|NCT01353911|83188021|FG003|Overall Study|Withdrawal by Subject|2|||
46949240|NCT01353911|83188022|FG004|Overall Study|Withdrawal by Subject|2|||
46949241|NCT01353911|83188023|FG005|Overall Study|Withdrawal by Subject|3|||
46949242|NCT01353911|83188024|FG006|Overall Study|Withdrawal by Subject|3|||
46949243|NCT01353911|83188025|FG007|Overall Study|Withdrawal by Subject|9|||
46949244|NCT01353911|83188018|FG000|Overall Study|Status Not Recorded|4|||
46949245|NCT01353911|83188019|FG001|Overall Study|Status Not Recorded|0|||
46949246|NCT01353911|83188020|FG002|Overall Study|Status Not Recorded|1|||
46949247|NCT01353911|83188021|FG003|Overall Study|Status Not Recorded|0|||
46949248|NCT01353911|83188022|FG004|Overall Study|Status Not Recorded|0|||
46949249|NCT01353911|83188023|FG005|Overall Study|Status Not Recorded|0|||
46949250|NCT01353911|83188024|FG006|Overall Study|Status Not Recorded|0|||
46949251|NCT01353911|83188025|FG007|Overall Study|Status Not Recorded|0|||
46949252|NCT01671488|83188043|FG000|Overall Study|Withdrawal by Subject|1|||
46949253|NCT02783911|83188049|FG000|Overall Study|Lost to Follow-up|3|||
46949254|NCT02783911|83188050|FG001|Overall Study|Lost to Follow-up|32|||
46949255|NCT01358357|83188058|FG000|Open Label Phase|Adverse Event|0|||
46949256|NCT01358357|83188059|FG001|Open Label Phase|Adverse Event|0|||
46949257|NCT01358357|83188060|FG002|Open Label Phase|Adverse Event|59|||
46949258|NCT01358357|83188058|FG000|Open Label Phase|Lack of Efficacy|0|||
46949259|NCT01358357|83188059|FG001|Open Label Phase|Lack of Efficacy|0|||
46639062|NCT01403610|82812609|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
46639063|NCT01403064|82812623|FG000|Overall Study|Death|0|||
46949260|NCT01358357|83188060|FG002|Open Label Phase|Lack of Efficacy|107|||
46949261|NCT01358357|83188058|FG000|Open Label Phase|Lost to Follow-up|0|||
46949262|NCT01358357|83188059|FG001|Open Label Phase|Lost to Follow-up|0|||
46949263|NCT01358357|83188060|FG002|Open Label Phase|Lost to Follow-up|76|||
46949264|NCT01358357|83188058|FG000|Open Label Phase|Protocol Violation|0|||
46949265|NCT01358357|83188059|FG001|Open Label Phase|Protocol Violation|0|||
46949266|NCT01358357|83188060|FG002|Open Label Phase|Protocol Violation|45|||
46949267|NCT01358357|83188058|FG000|Open Label Phase|Withdrawal by Subject|0|||
46949268|NCT01358357|83188059|FG001|Open Label Phase|Withdrawal by Subject|0|||
46949269|NCT01358357|83188060|FG002|Open Label Phase|Withdrawal by Subject|112|||
46949270|NCT01358357|83188058|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
46949271|NCT01358357|83188059|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
46949272|NCT01358357|83188060|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
46949273|NCT01358357|83188058|FG000|Open Label Phase|Terminated at study completion|0|||
46949274|NCT01358357|83188059|FG001|Open Label Phase|Terminated at study completion|0|||
46949275|NCT01358357|83188060|FG002|Open Label Phase|Terminated at study completion|5|||
46949276|NCT01358357|83188058|FG000|Open Label Phase|Mood episode|0|||
46949277|NCT01358357|83188059|FG001|Open Label Phase|Mood episode|0|||
46949278|NCT01358357|83188060|FG002|Open Label Phase|Mood episode|42|||
46949279|NCT01358357|83188058|FG000|Double-Blind Phase|Adverse Event|8|||
46949280|NCT01358357|83188059|FG001|Double-Blind Phase|Adverse Event|5|||
46949281|NCT01358357|83188060|FG002|Double-Blind Phase|Adverse Event|0|||
46949282|NCT01358357|83188058|FG000|Double-Blind Phase|Lost to Follow-up|5|||
46949283|NCT01358357|83188059|FG001|Double-Blind Phase|Lost to Follow-up|7|||
46949284|NCT01358357|83188060|FG002|Double-Blind Phase|Lost to Follow-up|0|||
46949285|NCT01358357|83188058|FG000|Double-Blind Phase|Protocol Violation|1|||
46949286|NCT01358357|83188059|FG001|Double-Blind Phase|Protocol Violation|11|||
46949287|NCT01358357|83188060|FG002|Double-Blind Phase|Protocol Violation|0|||
46949288|NCT01358357|83188058|FG000|Double-Blind Phase|Protocol Violation|16|||
46949289|NCT01358357|83188059|FG001|Double-Blind Phase|Protocol Violation|12|||
46949290|NCT01358357|83188060|FG002|Double-Blind Phase|Protocol Violation|0|||
46949291|NCT01358357|83188058|FG000|Double-Blind Phase|Terminated at study completion|2|||
46949292|NCT01358357|83188059|FG001|Double-Blind Phase|Terminated at study completion|0|||
46949293|NCT01358357|83188060|FG002|Double-Blind Phase|Terminated at study completion|0|||
46949294|NCT01358357|83188058|FG000|Double-Blind Phase|Recurrence of mood event|48|||
46949295|NCT01358357|83188059|FG001|Double-Blind Phase|Recurrence of mood event|64|||
46949296|NCT01358357|83188060|FG002|Double-Blind Phase|Recurrence of mood event|0|||
46949297|NCT01358357|83188058|FG000|Double-Blind Phase|Administrative|0|||
46949298|NCT01358357|83188059|FG001|Double-Blind Phase|Administrative|1|||
46949299|NCT01358357|83188060|FG002|Double-Blind Phase|Administrative|0|||
46949300|NCT02831387|83188069|FG000|Overall Study|Withdrawal by Subject|1|||
46949301|NCT02831387|83188070|FG001|Overall Study|Withdrawal by Subject|1|||
46949302|NCT02831387|83188069|FG000|Overall Study|Discontinued due to stock recovery|0|||
46949303|NCT02831387|83188070|FG001|Overall Study|Discontinued due to stock recovery|1|||
46949304|NCT02831855|83188076|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
46949305|NCT02831855|83188077|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
46949306|NCT02831855|83188078|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
46949307|NCT02831855|83188076|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
46949308|NCT02831855|83188077|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
46949309|NCT02831855|83188078|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
46949310|NCT02831855|83188076|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
46771559|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
46771560|NCT00790400|82989773|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
46771561|NCT00790400|82989774|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
46771562|NCT00786032|82989783|FG000|Overall Study|Death|4|||
46771563|NCT00786032|82989783|FG000|Overall Study|Withdrawal by Subject|14|||
46771564|NCT00786032|82989783|FG000|Overall Study|Did not complete in the timeframe|6|||
46771565|NCT00785486|82989789|FG000|Midazolam Alone|Withdrawal by Subject|1|||
46949311|NCT02831855|83188077|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
46949312|NCT02831855|83188078|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
46949313|NCT02831855|83188076|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
46949314|NCT02831855|83188077|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
46949315|NCT02831855|83188078|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
46949316|NCT02831855|83188076|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
46949317|NCT02831855|83188077|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
46949318|NCT02831855|83188078|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
46949319|NCT02831855|83188076|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
46949320|NCT02831855|83188077|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
46949321|NCT02831855|83188078|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
46949322|NCT02831855|83188076|FG000|Open Label Phase (24 Weeks)|Other|4|||
46949323|NCT02831855|83188077|FG001|Open Label Phase (24 Weeks)|Other|0|||
46949324|NCT02831855|83188078|FG002|Open Label Phase (24 Weeks)|Other|0|||
46949325|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
46949326|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
46949327|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
46949328|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Death|0|||
46949329|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Death|0|||
46949330|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Death|2|||
46949331|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
46771566|NCT00589979|82989812|FG000|Run-In Period|Adverse Event|5|||
46949332|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
46949333|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
46949334|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
46949335|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
46949336|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
46949337|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
46949338|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
46949339|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
46949340|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Other|0|||
46949341|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Other|2|||
46949342|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Other|5|||
46949343|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
46949344|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
46949345|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
46949346|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
46949347|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
46949348|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
46949349|NCT02831855|83188076|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
46949350|NCT02831855|83188077|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
46949351|NCT02831855|83188078|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
46949352|NCT02628938|83188091|FG000|Overall Study|Did not attend the follow up recall|2|||
46949353|NCT02628938|83188092|FG001|Overall Study|Did not attend the follow up recall|2|||
46949354|NCT02628938|83188093|FG002|Overall Study|Did not attend the follow up recall|1|||
46949355|NCT02628938|83188091|FG000|Overall Study|Failure to comply with the instructions|3|||
46949356|NCT02628938|83188092|FG001|Overall Study|Failure to comply with the instructions|0|||
46949357|NCT02628938|83188093|FG002|Overall Study|Failure to comply with the instructions|3|||
46949358|NCT01356407|83188107|FG000|Overall Study|Lost to Follow-up|2|||
46949359|NCT01356407|83188108|FG001|Overall Study|Lost to Follow-up|0|||
46949360|NCT01356407|83188107|FG000|Overall Study|Patient Withdrew Consent|2|||
46949361|NCT01356407|83188108|FG001|Overall Study|Patient Withdrew Consent|1|||
46949362|NCT01356407|83188107|FG000|Overall Study|Could not afford IMP administration|0|||
46949363|NCT01356407|83188108|FG001|Overall Study|Could not afford IMP administration|1|||
46949364|NCT01356407|83188107|FG000|Overall Study|Not complete Endoscopy|2|||
46949365|NCT01356407|83188108|FG001|Overall Study|Not complete Endoscopy|2|||
46949366|NCT00109837|83188114|FG000|Overall Study|Adverse Event|2|||
46949367|NCT00109837|83188114|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
46949368|NCT00109837|83188114|FG000|Overall Study|Death|1|||
46949369|NCT00109837|83188114|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
46949370|NCT00109837|83188114|FG000|Overall Study|Not treated|1|||
46949371|NCT00109837|83188114|FG000|Overall Study|Ineligible|1|||
46949372|NCT02828111|83188127|FG000|Overall Study|Withdrawal by Subject|0|||
46949373|NCT02828111|83188128|FG001|Overall Study|Withdrawal by Subject|0|||
46949374|NCT02828111|83188129|FG002|Overall Study|Withdrawal by Subject|2|||
46949375|NCT02828111|83188130|FG003|Overall Study|Withdrawal by Subject|0|||
46949376|NCT02828111|83188131|FG004|Overall Study|Withdrawal by Subject|0|||
46949377|NCT02828111|83188127|FG000|Overall Study|Lost to Follow-up|0|||
46771567|NCT00589979|82989813|FG001|Run-In Period|Adverse Event|0|||
46771568|NCT00589979|82989814|FG002|Run-In Period|Adverse Event|0|||
46771569|NCT00589979|82989812|FG000|Run-In Period|Protocol Violation|3|||
46771570|NCT00589979|82989813|FG001|Run-In Period|Protocol Violation|0|||
46771571|NCT00589979|82989814|FG002|Run-In Period|Protocol Violation|0|||
46771572|NCT00589979|82989812|FG000|Run-In Period|Did not qualify for randomization|54|||
46771573|NCT00589979|82989813|FG001|Run-In Period|Did not qualify for randomization|0|||
46771574|NCT00589979|82989814|FG002|Run-In Period|Did not qualify for randomization|0|||
46771575|NCT00589979|82989812|FG000|Run-In Period|Withdrawal by Subject|10|||
46771576|NCT00589979|82989813|FG001|Run-In Period|Withdrawal by Subject|0|||
46771577|NCT00589979|82989814|FG002|Run-In Period|Withdrawal by Subject|0|||
46771578|NCT00589979|82989812|FG000|Run-In Period|Informed Consent Withdrawn|4|||
46949378|NCT02828111|83188128|FG001|Overall Study|Lost to Follow-up|0|||
46949379|NCT02828111|83188129|FG002|Overall Study|Lost to Follow-up|0|||
46949380|NCT02828111|83188130|FG003|Overall Study|Lost to Follow-up|1|||
46949381|NCT02828111|83188131|FG004|Overall Study|Lost to Follow-up|1|||
46949382|NCT01671332|83188154|FG000|Overall Study|Withdrawal by Subject|1|||
46949383|NCT01671332|83188155|FG001|Overall Study|Withdrawal by Subject|1|||
46949384|NCT01355627|83188163|FG000|Overall Study|Request By the Patient to Discontinue|5|||
46949385|NCT01355627|83188164|FG001|Overall Study|Request By the Patient to Discontinue|7|||
46949386|NCT01355627|83188163|FG000|Overall Study|Lost to Follow-up|8|||
46949387|NCT01355627|83188164|FG001|Overall Study|Lost to Follow-up|7|||
46949388|NCT01355627|83188163|FG000|Overall Study|Fatal Adverse Event|19|||
46949389|NCT01355627|83188164|FG001|Overall Study|Fatal Adverse Event|23|||
47066518|NCT01542788|83349190|FG001|Overall Study|Withdrawal by Subject|0|||
47066519|NCT01542632|83349202|FG000|Overall Study|Withdrawal of Consent|0|||
46949390|NCT01355627|83188163|FG000|Overall Study|Other|1|||
46949391|NCT01355627|83188164|FG001|Overall Study|Other|1|||
46949392|NCT00100802|83188170|FG000|Overall Study|Adverse Event|9|||
46949393|NCT00100802|83188170|FG000|Overall Study|Death|1|||
46949394|NCT00100802|83188170|FG000|Overall Study|Lack of Efficacy|47|||
46949395|NCT00100802|83188170|FG000|Overall Study|Physician Decision|5|||
46949396|NCT00100802|83188170|FG000|Overall Study|Protocol Violation|1|||
46949397|NCT00100802|83188170|FG000|Overall Study|Withdrawal by Subject|5|||
46949398|NCT00100802|83188170|FG000|Overall Study|Ineligible|12|||
46949399|NCT01355159|83188176|FG000|Overall Study|Withdrew consent|39|||
46949400|NCT01355159|83188177|FG001|Overall Study|Withdrew consent|47|||
46949401|NCT01355159|83188176|FG000|Overall Study|No primary outcome data|17|||
46949402|NCT01355159|83188177|FG001|Overall Study|No primary outcome data|11|||
46949403|NCT01355159|83188176|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
46949404|NCT01355159|83188177|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
46949405|NCT01355159|83188176|FG000|Overall Study|Early intrauterine fetal death|6|||
46949406|NCT01355159|83188177|FG001|Overall Study|Early intrauterine fetal death|6|||
46949407|NCT02630186|83188183|FG000|Overall Study|Withdrawal by Subject|1|||
46949408|NCT01669928|83188189|FG000|First Intervention|Withdrawal by Subject|3|||
46949409|NCT01669928|83188190|FG001|First Intervention|Withdrawal by Subject|5|||
46949410|NCT01355081|83188201|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
46949411|NCT01355081|83188202|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
46949412|NCT01355081|83188203|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
46949413|NCT01355081|83188201|FG000|Overall Study|Major Protocol Deviation|0|||
46949414|NCT01355081|83188202|FG001|Overall Study|Major Protocol Deviation|1|||
46949415|NCT01355081|83188203|FG002|Overall Study|Major Protocol Deviation|0|||
46949416|NCT01355081|83188201|FG000|Overall Study|Lost to Follow-up|0|||
46949417|NCT01355081|83188202|FG001|Overall Study|Lost to Follow-up|0|||
46949418|NCT01355081|83188203|FG002|Overall Study|Lost to Follow-up|1|||
46949419|NCT01355081|83188201|FG000|Overall Study|Withdrawal of Consent|2|||
46949420|NCT01355081|83188202|FG001|Overall Study|Withdrawal of Consent|3|||
46949421|NCT01355081|83188203|FG002|Overall Study|Withdrawal of Consent|3|||
46949422|NCT01355081|83188201|FG000|Overall Study|Lack of Efficacy|2|||
46949423|NCT01355081|83188202|FG001|Overall Study|Lack of Efficacy|1|||
46949424|NCT01355081|83188203|FG002|Overall Study|Lack of Efficacy|1|||
46949425|NCT01355081|83188201|FG000|Overall Study|Non Compliance with Study Medication|0|||
46949426|NCT01355081|83188202|FG001|Overall Study|Non Compliance with Study Medication|1|||
46639064|NCT01403064|82812624|FG001|Overall Study|Death|0|||
46949427|NCT01355081|83188203|FG002|Overall Study|Non Compliance with Study Medication|0|||
46949428|NCT01354223|83188213|FG000|Overall Study|Withdrawal by Subject|3|||
46949429|NCT01354223|83188214|FG001|Overall Study|Withdrawal by Subject|1|||
46949430|NCT04043455|83188224|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
46949431|NCT04043455|83188225|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
46949432|NCT04043455|83188226|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
46949433|NCT04043455|83188227|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
46949434|NCT04043455|83188228|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
46949435|NCT04043455|83188229|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
46949436|NCT04043455|83188224|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
46949437|NCT04043455|83188225|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
46949438|NCT04043455|83188226|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
46949439|NCT04043455|83188227|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
46949440|NCT04043455|83188228|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
46949441|NCT04043455|83188229|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
46949442|NCT04043455|83188224|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
46949443|NCT04043455|83188225|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
46949444|NCT04043455|83188226|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
46949445|NCT04043455|83188227|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
46949446|NCT04043455|83188228|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
46949447|NCT04043455|83188229|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
46949448|NCT04043455|83188224|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
46949449|NCT04043455|83188225|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
46949450|NCT04043455|83188226|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
46949451|NCT04043455|83188227|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
46949452|NCT04043455|83188228|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
46949453|NCT04043455|83188229|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
46949454|NCT04043455|83188224|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
46949455|NCT04043455|83188225|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
46949456|NCT04043455|83188226|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
46949457|NCT04043455|83188227|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
46949458|NCT04043455|83188228|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
46949459|NCT04043455|83188229|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
46949460|NCT04043455|83188224|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
46949461|NCT04043455|83188225|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
46949462|NCT04043455|83188226|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
46949463|NCT04043455|83188227|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
46949464|NCT04043455|83188228|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
46949465|NCT04043455|83188229|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
46949466|NCT04043455|83188224|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
46949467|NCT04043455|83188225|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
46949468|NCT04043455|83188226|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
46949469|NCT04043455|83188227|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
46949470|NCT04043455|83188228|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
46949471|NCT04043455|83188229|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
46949472|NCT04043455|83188224|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
46949473|NCT04043455|83188225|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
46949474|NCT04043455|83188226|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
46949475|NCT04043455|83188227|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
46949476|NCT04043455|83188228|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
46949477|NCT04043455|83188229|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
46949478|NCT04043455|83188224|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
46949479|NCT04043455|83188225|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
46949480|NCT04043455|83188226|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
46949481|NCT04043455|83188227|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
46949482|NCT04043455|83188228|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
46949483|NCT04043455|83188229|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
46949484|NCT04043455|83188224|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
46949485|NCT04043455|83188225|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
46949486|NCT04043455|83188226|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
46949487|NCT04043455|83188227|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
46949488|NCT04043455|83188228|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
46949489|NCT04043455|83188229|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
46949490|NCT04043455|83188224|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
46639065|NCT01403064|82812625|FG002|Overall Study|Death|1|||
46949491|NCT04043455|83188225|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
46949492|NCT04043455|83188226|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
46949493|NCT04043455|83188227|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
46949494|NCT04043455|83188228|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
46949495|NCT04043455|83188229|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
46949496|NCT02627144|83188247|FG000|Overall Study|Serious adverse event|32|||
46949497|NCT02627144|83188247|FG000|Overall Study|Cancer progression|171|||
46949498|NCT02627144|83188247|FG000|Overall Study|Death from cancer|20|||
46949499|NCT02627144|83188247|FG000|Overall Study|Death from other cause|8|||
46949500|NCT02627144|83188247|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
46949501|NCT02627144|83188247|FG000|Overall Study|Administrative reasons|65|||
46639066|NCT01403064|82812626|FG003|Overall Study|Death|1|||
46639067|NCT01403064|82812623|FG000|Overall Study|Withdrawal by Subject|0|||
46639068|NCT01403064|82812624|FG001|Overall Study|Withdrawal by Subject|0|||
46639069|NCT01403064|82812625|FG002|Overall Study|Withdrawal by Subject|1|||
46639070|NCT01403064|82812626|FG003|Overall Study|Withdrawal by Subject|1|||
46771579|NCT00589979|82989813|FG001|Run-In Period|Informed Consent Withdrawn|0|||
46771580|NCT00589979|82989814|FG002|Run-In Period|Informed Consent Withdrawn|0|||
46771581|NCT00589979|82989812|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
46771582|NCT00589979|82989813|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
46771583|NCT00589979|82989814|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
46771584|NCT00589979|82989812|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
46771585|NCT00589979|82989813|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
46771586|NCT00589979|82989814|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
46771587|NCT00589979|82989812|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
46771588|NCT00589979|82989813|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
46771589|NCT00589979|82989814|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
46771590|NCT00589979|82989812|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
46771591|NCT00589979|82989813|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
46639071|NCT01403064|82812623|FG000|Overall Study|Other|1|||
46949502|NCT02627144|83188247|FG000|Overall Study|Lost to Follow-up|8|||
46949503|NCT02627144|83188247|FG000|Overall Study|Enrolled, not treated|6|||
46949504|NCT02627144|83188247|FG000|Overall Study|Other|17|||
46949505|NCT02626520|83188253|FG000|Overall Study|Physician Decision|1|||
46949506|NCT02626520|83188254|FG001|Overall Study|Physician Decision|1|||
46949507|NCT02626520|83188253|FG000|Overall Study|Adverse Event|0|||
46949508|NCT02626520|83188254|FG001|Overall Study|Adverse Event|4|||
46949509|NCT02626520|83188253|FG000|Overall Study|Lack of Efficacy|0|||
46949510|NCT02626520|83188254|FG001|Overall Study|Lack of Efficacy|2|||
46771592|NCT00589979|82989814|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
46771593|NCT00589979|82989812|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
46771594|NCT00589979|82989813|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
46771595|NCT00589979|82989814|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
46771596|NCT00589979|82989812|FG000|Double-Blind Treatment Period 2|Other|0|||
46949511|NCT02626520|83188253|FG000|Overall Study|Did not start protocol therapy|0|||
46949512|NCT02626520|83188254|FG001|Overall Study|Did not start protocol therapy|2|||
46949513|NCT02626520|83188253|FG000|Overall Study|Study terminated|0|||
46949514|NCT02626520|83188254|FG001|Overall Study|Study terminated|1|||
46949515|NCT04522141|83188262|FG000|Overall Study|Withdrawal by Subject|1|||
46949516|NCT04522141|83188263|FG001|Overall Study|Withdrawal by Subject|0|||
46949517|NCT01329029|83188286|FG000|Overall Study|Withdrawal by Subject|117|||
46949518|NCT01329029|83188287|FG001|Overall Study|Withdrawal by Subject|87|||
46949519|NCT01329029|83188286|FG000|Overall Study|Adverse Event|82|||
46949520|NCT01329029|83188287|FG001|Overall Study|Adverse Event|29|||
46949521|NCT01329029|83188286|FG000|Overall Study|Death|16|||
46949522|NCT01329029|83188287|FG001|Overall Study|Death|19|||
46949523|NCT01329029|83188286|FG000|Overall Study|Other|14|||
46949524|NCT01329029|83188287|FG001|Overall Study|Other|20|||
46949525|NCT01329029|83188286|FG000|Overall Study|COPD Exacerbation|11|||
46949526|NCT01329029|83188287|FG001|Overall Study|COPD Exacerbation|18|||
46949527|NCT01329029|83188286|FG000|Overall Study|Physician Decision|16|||
46949528|NCT01329029|83188287|FG001|Overall Study|Physician Decision|13|||
46949529|NCT01329029|83188286|FG000|Overall Study|Lost to Follow-up|8|||
46949530|NCT01329029|83188287|FG001|Overall Study|Lost to Follow-up|5|||
46949531|NCT01329029|83188286|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
46949532|NCT01329029|83188287|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
46949533|NCT01372085|83188303|FG000|Washout Period 2|Physician Decision|0|||
46949534|NCT01372085|83188304|FG001|Washout Period 2|Physician Decision|0|||
46949535|NCT01372085|83188305|FG002|Washout Period 2|Physician Decision|0|||
46949536|NCT01372085|83188306|FG003|Washout Period 2|Physician Decision|0|||
46949537|NCT01372085|83188307|FG004|Washout Period 2|Physician Decision|1|||
46949538|NCT01372085|83188308|FG005|Washout Period 2|Physician Decision|0|||
46949539|NCT01372085|83188309|FG006|Washout Period 2|Physician Decision|0|||
46949540|NCT01372085|83188310|FG007|Washout Period 2|Physician Decision|0|||
46949541|NCT01372085|83188311|FG008|Washout Period 2|Physician Decision|0|||
46949542|NCT01372085|83188312|FG009|Washout Period 2|Physician Decision|0|||
46949543|NCT01372085|83188303|FG000|Washout Period 3|Withdrawal by Subject|0|||
46949544|NCT01372085|83188304|FG001|Washout Period 3|Withdrawal by Subject|0|||
46949545|NCT01372085|83188305|FG002|Washout Period 3|Withdrawal by Subject|0|||
46949546|NCT01372085|83188306|FG003|Washout Period 3|Withdrawal by Subject|0|||
46949547|NCT01372085|83188307|FG004|Washout Period 3|Withdrawal by Subject|0|||
46949548|NCT01372085|83188308|FG005|Washout Period 3|Withdrawal by Subject|2|||
46949549|NCT01372085|83188309|FG006|Washout Period 3|Withdrawal by Subject|0|||
46949550|NCT01372085|83188310|FG007|Washout Period 3|Withdrawal by Subject|0|||
46949551|NCT01372085|83188311|FG008|Washout Period 3|Withdrawal by Subject|0|||
46949552|NCT01372085|83188312|FG009|Washout Period 3|Withdrawal by Subject|0|||
46949553|NCT04012853|83188338|FG000|Overall Study|Withdrawal by Subject|1|||
46949554|NCT04012853|83188339|FG001|Overall Study|Withdrawal by Subject|1|||
46949555|NCT04012853|83188338|FG000|Overall Study|Protocol Violation|1|||
46949556|NCT04012853|83188339|FG001|Overall Study|Protocol Violation|0|||
46949557|NCT04012853|83188338|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
46949558|NCT04012853|83188339|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
46949559|NCT02941549|83188348|FG000|Overall Study|Adverse Event|1|||
46949560|NCT02941549|83188349|FG001|Overall Study|Adverse Event|0|||
46639072|NCT01403064|82812624|FG001|Overall Study|Other|0|||
46949561|NCT02941549|83188350|FG002|Overall Study|Adverse Event|0|||
46949562|NCT02941549|83188348|FG000|Overall Study|Withdrawal by Subject|2|||
46639073|NCT01403064|82812625|FG002|Overall Study|Other|2|||
46639074|NCT01403064|82812626|FG003|Overall Study|Other|1|||
46949563|NCT02941549|83188349|FG001|Overall Study|Withdrawal by Subject|1|||
46949564|NCT02941549|83188350|FG002|Overall Study|Withdrawal by Subject|2|||
46949565|NCT02394028|83188372|FG000|Induction Phase|Adverse Event|2|||
46949566|NCT02394028|83188373|FG001|Induction Phase|Adverse Event|4|||
46949567|NCT02394028|83188374|FG002|Induction Phase|Adverse Event|1|||
46949568|NCT02394028|83188375|FG003|Induction Phase|Adverse Event|2|||
46949569|NCT02394028|83188376|FG004|Induction Phase|Adverse Event|5|||
46949570|NCT02394028|83188377|FG005|Induction Phase|Adverse Event|2|||
46949571|NCT02394028|83188378|FG006|Induction Phase|Adverse Event|0|||
46949572|NCT02394028|83188379|FG007|Induction Phase|Adverse Event|0|||
46949573|NCT02394028|83188380|FG008|Induction Phase|Adverse Event|0|||
46949574|NCT02394028|83188381|FG009|Induction Phase|Adverse Event|0|||
46949575|NCT02394028|83188382|FG010|Induction Phase|Adverse Event|0|||
46949576|NCT02394028|83188372|FG000|Induction Phase|Lack of Efficacy|3|||
46949577|NCT02394028|83188373|FG001|Induction Phase|Lack of Efficacy|6|||
46949578|NCT02394028|83188374|FG002|Induction Phase|Lack of Efficacy|2|||
46949579|NCT02394028|83188375|FG003|Induction Phase|Lack of Efficacy|17|||
46949580|NCT02394028|83188376|FG004|Induction Phase|Lack of Efficacy|14|||
46949581|NCT02394028|83188377|FG005|Induction Phase|Lack of Efficacy|8|||
46949582|NCT02394028|83188378|FG006|Induction Phase|Lack of Efficacy|17|||
46949583|NCT02394028|83188379|FG007|Induction Phase|Lack of Efficacy|23|||
46949584|NCT02394028|83188380|FG008|Induction Phase|Lack of Efficacy|0|||
46949585|NCT02394028|83188381|FG009|Induction Phase|Lack of Efficacy|0|||
46949586|NCT02394028|83188382|FG010|Induction Phase|Lack of Efficacy|0|||
46949587|NCT02394028|83188372|FG000|Induction Phase|Lost to Follow-up|1|||
46949588|NCT02394028|83188373|FG001|Induction Phase|Lost to Follow-up|0|||
46949589|NCT02394028|83188374|FG002|Induction Phase|Lost to Follow-up|0|||
46949590|NCT02394028|83188375|FG003|Induction Phase|Lost to Follow-up|1|||
46949591|NCT02394028|83188376|FG004|Induction Phase|Lost to Follow-up|0|||
46949592|NCT02394028|83188377|FG005|Induction Phase|Lost to Follow-up|0|||
46949593|NCT02394028|83188378|FG006|Induction Phase|Lost to Follow-up|1|||
46949594|NCT02394028|83188379|FG007|Induction Phase|Lost to Follow-up|0|||
46949595|NCT02394028|83188380|FG008|Induction Phase|Lost to Follow-up|0|||
46949596|NCT02394028|83188381|FG009|Induction Phase|Lost to Follow-up|0|||
46949597|NCT02394028|83188382|FG010|Induction Phase|Lost to Follow-up|0|||
46949598|NCT02394028|83188372|FG000|Induction Phase|Non-compliance|0|||
46949599|NCT02394028|83188373|FG001|Induction Phase|Non-compliance|1|||
46949600|NCT02394028|83188374|FG002|Induction Phase|Non-compliance|3|||
46949601|NCT02394028|83188375|FG003|Induction Phase|Non-compliance|1|||
46949602|NCT02394028|83188376|FG004|Induction Phase|Non-compliance|3|||
46949603|NCT02394028|83188377|FG005|Induction Phase|Non-compliance|0|||
46949604|NCT02394028|83188378|FG006|Induction Phase|Non-compliance|1|||
46949605|NCT02394028|83188379|FG007|Induction Phase|Non-compliance|1|||
46949606|NCT02394028|83188380|FG008|Induction Phase|Non-compliance|0|||
46949607|NCT02394028|83188381|FG009|Induction Phase|Non-compliance|0|||
46949608|NCT02394028|83188382|FG010|Induction Phase|Non-compliance|0|||
46949609|NCT02394028|83188372|FG000|Induction Phase|Physician Decision|0|||
46949610|NCT02394028|83188373|FG001|Induction Phase|Physician Decision|0|||
46949611|NCT02394028|83188374|FG002|Induction Phase|Physician Decision|1|||
46949612|NCT02394028|83188375|FG003|Induction Phase|Physician Decision|4|||
46949613|NCT02394028|83188376|FG004|Induction Phase|Physician Decision|0|||
46949614|NCT02394028|83188377|FG005|Induction Phase|Physician Decision|2|||
46949615|NCT02394028|83188378|FG006|Induction Phase|Physician Decision|1|||
46949616|NCT02394028|83188379|FG007|Induction Phase|Physician Decision|0|||
46949617|NCT02394028|83188380|FG008|Induction Phase|Physician Decision|0|||
46949618|NCT02394028|83188381|FG009|Induction Phase|Physician Decision|0|||
46949619|NCT02394028|83188382|FG010|Induction Phase|Physician Decision|0|||
46949620|NCT02394028|83188372|FG000|Induction Phase|Protocol Violation|0|||
46949621|NCT02394028|83188373|FG001|Induction Phase|Protocol Violation|2|||
46949622|NCT02394028|83188374|FG002|Induction Phase|Protocol Violation|0|||
46949623|NCT02394028|83188375|FG003|Induction Phase|Protocol Violation|3|||
46949624|NCT02394028|83188376|FG004|Induction Phase|Protocol Violation|0|||
46949625|NCT02394028|83188377|FG005|Induction Phase|Protocol Violation|1|||
46949626|NCT02394028|83188378|FG006|Induction Phase|Protocol Violation|1|||
46949627|NCT02394028|83188379|FG007|Induction Phase|Protocol Violation|0|||
46949628|NCT02394028|83188380|FG008|Induction Phase|Protocol Violation|0|||
46949629|NCT02394028|83188381|FG009|Induction Phase|Protocol Violation|0|||
46949630|NCT02394028|83188382|FG010|Induction Phase|Protocol Violation|0|||
46949631|NCT02394028|83188372|FG000|Induction Phase|Withdrawal by Subject|1|||
46949632|NCT02394028|83188373|FG001|Induction Phase|Withdrawal by Subject|2|||
46949633|NCT02394028|83188374|FG002|Induction Phase|Withdrawal by Subject|4|||
46949634|NCT02394028|83188375|FG003|Induction Phase|Withdrawal by Subject|6|||
46949635|NCT02394028|83188376|FG004|Induction Phase|Withdrawal by Subject|7|||
46949636|NCT02394028|83188377|FG005|Induction Phase|Withdrawal by Subject|4|||
46949637|NCT02394028|83188378|FG006|Induction Phase|Withdrawal by Subject|3|||
46949638|NCT02394028|83188379|FG007|Induction Phase|Withdrawal by Subject|6|||
46949639|NCT02394028|83188380|FG008|Induction Phase|Withdrawal by Subject|0|||
46949640|NCT02394028|83188381|FG009|Induction Phase|Withdrawal by Subject|0|||
46949641|NCT02394028|83188382|FG010|Induction Phase|Withdrawal by Subject|0|||
46949642|NCT02394028|83188372|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949643|NCT02394028|83188373|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949644|NCT02394028|83188374|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949645|NCT02394028|83188375|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949646|NCT02394028|83188376|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
46967873|NCT05091307|83210484|FG001|Overall Study|Protocol Violation|0|||
46949647|NCT02394028|83188377|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949648|NCT02394028|83188378|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
46949649|NCT02394028|83188379|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949650|NCT02394028|83188380|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949651|NCT02394028|83188381|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949652|NCT02394028|83188382|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
46949653|NCT02394028|83188372|FG000|Induction Phase|Sponsor decision|0|||
46949654|NCT02394028|83188373|FG001|Induction Phase|Sponsor decision|1|||
46949655|NCT02394028|83188374|FG002|Induction Phase|Sponsor decision|2|||
46949656|NCT02394028|83188375|FG003|Induction Phase|Sponsor decision|0|||
46949657|NCT02394028|83188376|FG004|Induction Phase|Sponsor decision|0|||
46949658|NCT02394028|83188377|FG005|Induction Phase|Sponsor decision|0|||
46949659|NCT02394028|83188378|FG006|Induction Phase|Sponsor decision|0|||
46949660|NCT02394028|83188379|FG007|Induction Phase|Sponsor decision|0|||
46949661|NCT02394028|83188380|FG008|Induction Phase|Sponsor decision|0|||
46949662|NCT02394028|83188381|FG009|Induction Phase|Sponsor decision|0|||
46949663|NCT02394028|83188382|FG010|Induction Phase|Sponsor decision|0|||
46949664|NCT02394028|83188372|FG000|Induction Phase|Technical reason|0|||
46949665|NCT02394028|83188373|FG001|Induction Phase|Technical reason|0|||
46949666|NCT02394028|83188374|FG002|Induction Phase|Technical reason|0|||
46949667|NCT02394028|83188375|FG003|Induction Phase|Technical reason|1|||
46949668|NCT02394028|83188376|FG004|Induction Phase|Technical reason|0|||
46949669|NCT02394028|83188377|FG005|Induction Phase|Technical reason|0|||
46949670|NCT02394028|83188378|FG006|Induction Phase|Technical reason|0|||
46949671|NCT02394028|83188379|FG007|Induction Phase|Technical reason|0|||
46949672|NCT02394028|83188380|FG008|Induction Phase|Technical reason|0|||
46949673|NCT02394028|83188381|FG009|Induction Phase|Technical reason|0|||
46949674|NCT02394028|83188382|FG010|Induction Phase|Technical reason|0|||
46949675|NCT02394028|83188372|FG000|Induction Phase|:ack of calculation|0|||
46949676|NCT02394028|83188373|FG001|Induction Phase|:ack of calculation|0|||
46949677|NCT02394028|83188374|FG002|Induction Phase|:ack of calculation|0|||
46949678|NCT02394028|83188375|FG003|Induction Phase|:ack of calculation|0|||
46949679|NCT02394028|83188376|FG004|Induction Phase|:ack of calculation|0|||
46949680|NCT02394028|83188377|FG005|Induction Phase|:ack of calculation|0|||
46949681|NCT02394028|83188378|FG006|Induction Phase|:ack of calculation|0|||
46949682|NCT02394028|83188379|FG007|Induction Phase|:ack of calculation|1|||
46949683|NCT02394028|83188380|FG008|Induction Phase|:ack of calculation|0|||
46949684|NCT02394028|83188381|FG009|Induction Phase|:ack of calculation|0|||
46949685|NCT02394028|83188382|FG010|Induction Phase|:ack of calculation|0|||
46949686|NCT02394028|83188372|FG000|Maintenance Phase|Protocol Violation|0|||
46949687|NCT02394028|83188373|FG001|Maintenance Phase|Protocol Violation|0|||
46949688|NCT02394028|83188374|FG002|Maintenance Phase|Protocol Violation|0|||
46949689|NCT02394028|83188375|FG003|Maintenance Phase|Protocol Violation|0|||
46949690|NCT02394028|83188376|FG004|Maintenance Phase|Protocol Violation|0|||
46949691|NCT02394028|83188377|FG005|Maintenance Phase|Protocol Violation|0|||
46949692|NCT02394028|83188378|FG006|Maintenance Phase|Protocol Violation|0|||
46949693|NCT02394028|83188379|FG007|Maintenance Phase|Protocol Violation|0|||
46949694|NCT02394028|83188380|FG008|Maintenance Phase|Protocol Violation|0|||
46949695|NCT02394028|83188381|FG009|Maintenance Phase|Protocol Violation|0|||
46949696|NCT02394028|83188382|FG010|Maintenance Phase|Protocol Violation|1|||
46949697|NCT02394028|83188372|FG000|Maintenance Phase|Physician Decision|0|||
46949698|NCT02394028|83188373|FG001|Maintenance Phase|Physician Decision|0|||
46949699|NCT02394028|83188374|FG002|Maintenance Phase|Physician Decision|0|||
46949700|NCT02394028|83188375|FG003|Maintenance Phase|Physician Decision|0|||
46949701|NCT02394028|83188376|FG004|Maintenance Phase|Physician Decision|0|||
46771597|NCT00589979|82989813|FG001|Double-Blind Treatment Period 2|Other|0|||
46771598|NCT00589979|82989814|FG002|Double-Blind Treatment Period 2|Other|1|||
46771599|NCT00589979|82989812|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
46771600|NCT00589979|82989813|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
46771601|NCT00589979|82989814|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
46771602|NCT00589979|82989812|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
46771603|NCT00589979|82989813|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
46949702|NCT02394028|83188377|FG005|Maintenance Phase|Physician Decision|0|||
46949703|NCT02394028|83188378|FG006|Maintenance Phase|Physician Decision|0|||
47066520|NCT01542632|83349203|FG001|Overall Study|Withdrawal of Consent|0|||
46771604|NCT00589979|82989814|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
46771605|NCT00797732|82989828|FG000|Overall Study|Withdrawal by Subject|3|||
46771606|NCT00797732|82989829|FG001|Overall Study|Withdrawal by Subject|3|||
46949704|NCT02394028|83188379|FG007|Maintenance Phase|Physician Decision|0|||
46949705|NCT02394028|83188380|FG008|Maintenance Phase|Physician Decision|1|||
46949706|NCT02394028|83188381|FG009|Maintenance Phase|Physician Decision|3|||
46949707|NCT02394028|83188382|FG010|Maintenance Phase|Physician Decision|2|||
47066521|NCT01542632|83349204|FG002|Overall Study|Withdrawal of Consent|0|||
46949708|NCT02394028|83188372|FG000|Maintenance Phase|Lack of Efficacy|0|||
46771607|NCT00797732|82989830|FG002|Overall Study|Withdrawal by Subject|0|||
46771608|NCT00797732|82989828|FG000|Overall Study|Lost to Follow-up|1|||
46771609|NCT00797732|82989829|FG001|Overall Study|Lost to Follow-up|0|||
46771610|NCT00797732|82989830|FG002|Overall Study|Lost to Follow-up|0|||
46771611|NCT00797732|82989828|FG000|Overall Study|Death|1|||
46771612|NCT00797732|82989829|FG001|Overall Study|Death|0|||
46771613|NCT00797732|82989830|FG002|Overall Study|Death|0|||
46771614|NCT00797732|82989828|FG000|Overall Study|Not meet inclusion criteria|0|||
46771615|NCT00797732|82989829|FG001|Overall Study|Not meet inclusion criteria|0|||
46771616|NCT00797732|82989830|FG002|Overall Study|Not meet inclusion criteria|7|||
46771617|NCT00797732|82989828|FG000|Overall Study|Excluded due to time constraints|0|||
46771618|NCT00797732|82989829|FG001|Overall Study|Excluded due to time constraints|0|||
46771619|NCT00797732|82989830|FG002|Overall Study|Excluded due to time constraints|24|||
46771620|NCT00797732|82989828|FG000|Overall Study|Refused to Participate|0|||
46771621|NCT00797732|82989829|FG001|Overall Study|Refused to Participate|0|||
46771622|NCT00797732|82989830|FG002|Overall Study|Refused to Participate|123|||
46771623|NCT00790088|82989836|FG000|Overall Study|Protocol Violation|11|||
46771624|NCT00790088|82989836|FG000|Overall Study|Withdrawal by Subject|17|||
46771625|NCT00790088|82989836|FG000|Overall Study|Lost to Follow-up|7|||
46771626|NCT00790088|82989836|FG000|Overall Study|Physician Decision|4|||
46771627|NCT00736944|82989842|FG000|Induction|Death|1|||
46771628|NCT00736944|82989842|FG000|Definitive Treatment|Physician Decision|1|||
46771629|NCT00736476|82989851|FG000|Overall Study|Adverse Event|1|||
46771630|NCT00736476|82989852|FG001|Overall Study|Adverse Event|0|||
46771631|NCT00715299|82989864|FG000|Overall Study|Withdrawal by Subject|1|||
46771632|NCT00715299|82989864|FG000|Overall Study|Adverse Event|3|||
46771633|NCT00715299|82989864|FG000|Overall Study|failed the pre-screen exercise test|2|||
46771634|NCT00730236|82989868|FG000|Overall Study|Adverse Event|4|||
46771635|NCT00730236|82989868|FG000|Overall Study|Withdrawal by Subject|1|||
46771636|NCT00730236|82989868|FG000|Overall Study|Non-compliance|1|||
46771637|NCT00714285|82989876|FG000|Overall Study|Lost to Follow-up|0|||
46771638|NCT00714285|82989877|FG001|Overall Study|Lost to Follow-up|2|||
46771639|NCT00714285|82989878|FG002|Overall Study|Lost to Follow-up|0|||
46771640|NCT00714285|82989879|FG003|Overall Study|Lost to Follow-up|1|||
46771641|NCT00714285|82989876|FG000|Overall Study|Migrated/moved from study area|0|||
46771642|NCT00714285|82989877|FG001|Overall Study|Migrated/moved from study area|1|||
46771643|NCT00714285|82989878|FG002|Overall Study|Migrated/moved from study area|0|||
46771644|NCT00714285|82989879|FG003|Overall Study|Migrated/moved from study area|0|||
46771645|NCT00776984|82989893|FG000|Overall Study|Adverse Event|8|||
46771646|NCT00776984|82989894|FG001|Overall Study|Adverse Event|2|||
46771647|NCT00776984|82989893|FG000|Overall Study|Protocol Violation|4|||
46771648|NCT00776984|82989894|FG001|Overall Study|Protocol Violation|2|||
46771649|NCT00776984|82989893|FG000|Overall Study|Lost to Follow-up|2|||
46771650|NCT00776984|82989894|FG001|Overall Study|Lost to Follow-up|0|||
46771651|NCT00776984|82989893|FG000|Overall Study|Withdrawal by Subject|12|||
46771652|NCT00776984|82989894|FG001|Overall Study|Withdrawal by Subject|7|||
46771653|NCT00776984|82989893|FG000|Overall Study|Lack of Efficacy|0|||
46771654|NCT00776984|82989894|FG001|Overall Study|Lack of Efficacy|1|||
46771655|NCT00776984|82989893|FG000|Overall Study|Other|5|||
46771656|NCT00776984|82989894|FG001|Overall Study|Other|9|||
46771657|NCT00714051|82989902|FG000|Overall Study|Withdrawal by Subject|1|||
46771658|NCT00714051|82989903|FG001|Overall Study|Withdrawal by Subject|0|||
46771659|NCT00714051|82989902|FG000|Overall Study|Death|0|||
46771660|NCT00714051|82989903|FG001|Overall Study|Death|1|||
46771661|NCT00784784|82989911|FG000|Overall Study|Withdrawal by Subject|2|||
46949709|NCT02394028|83188373|FG001|Maintenance Phase|Lack of Efficacy|0|||
46949710|NCT02394028|83188374|FG002|Maintenance Phase|Lack of Efficacy|0|||
46949711|NCT02394028|83188375|FG003|Maintenance Phase|Lack of Efficacy|0|||
46949712|NCT02394028|83188376|FG004|Maintenance Phase|Lack of Efficacy|0|||
46949713|NCT02394028|83188377|FG005|Maintenance Phase|Lack of Efficacy|0|||
46949714|NCT02394028|83188378|FG006|Maintenance Phase|Lack of Efficacy|0|||
46949715|NCT02394028|83188379|FG007|Maintenance Phase|Lack of Efficacy|0|||
46771662|NCT00784784|82989912|FG001|Overall Study|Withdrawal by Subject|2|||
46771663|NCT00801983|82989920|FG000|Period 1|Lost to Follow-up|2|||
46771664|NCT00801983|82989921|FG001|Period 1|Lost to Follow-up|0|||
46771665|NCT00801983|82989920|FG000|Period 1|Withdrawal by Subject|2|||
46771666|NCT00801983|82989921|FG001|Period 1|Withdrawal by Subject|8|||
46771667|NCT00801983|82989920|FG000|Period 2|Withdrawal by Subject|2|||
46771668|NCT00801983|82989921|FG001|Period 2|Withdrawal by Subject|1|||
46771669|NCT00587288|82989929|FG000|Overall Study|Adverse Event|0|||
46771670|NCT00587288|82989930|FG001|Overall Study|Adverse Event|1|||
46771671|NCT00587288|82989929|FG000|Overall Study|Lack of Efficacy|2|||
46771672|NCT00587288|82989930|FG001|Overall Study|Lack of Efficacy|8|||
46949716|NCT02394028|83188380|FG008|Maintenance Phase|Lack of Efficacy|7|||
46771673|NCT00587288|82989929|FG000|Overall Study|Protocol Violation|1|||
46949717|NCT02394028|83188381|FG009|Maintenance Phase|Lack of Efficacy|25|||
46949718|NCT02394028|83188382|FG010|Maintenance Phase|Lack of Efficacy|33|||
46949719|NCT02394028|83188372|FG000|Maintenance Phase|Death|0|||
46949720|NCT02394028|83188373|FG001|Maintenance Phase|Death|0|||
46949721|NCT02394028|83188374|FG002|Maintenance Phase|Death|0|||
46949722|NCT02394028|83188375|FG003|Maintenance Phase|Death|0|||
46949723|NCT02394028|83188376|FG004|Maintenance Phase|Death|0|||
46949724|NCT02394028|83188377|FG005|Maintenance Phase|Death|0|||
46949725|NCT02394028|83188378|FG006|Maintenance Phase|Death|0|||
46949726|NCT02394028|83188379|FG007|Maintenance Phase|Death|0|||
46949727|NCT02394028|83188380|FG008|Maintenance Phase|Death|0|||
46949728|NCT02394028|83188381|FG009|Maintenance Phase|Death|0|||
46949729|NCT02394028|83188382|FG010|Maintenance Phase|Death|1|||
46949730|NCT02394028|83188372|FG000|Maintenance Phase|Adverse Event|0|||
46949731|NCT02394028|83188373|FG001|Maintenance Phase|Adverse Event|0|||
46949732|NCT02394028|83188374|FG002|Maintenance Phase|Adverse Event|0|||
46949733|NCT02394028|83188375|FG003|Maintenance Phase|Adverse Event|0|||
46949734|NCT02394028|83188376|FG004|Maintenance Phase|Adverse Event|0|||
46949735|NCT02394028|83188377|FG005|Maintenance Phase|Adverse Event|0|||
46949736|NCT02394028|83188378|FG006|Maintenance Phase|Adverse Event|0|||
46949737|NCT02394028|83188379|FG007|Maintenance Phase|Adverse Event|0|||
46949738|NCT02394028|83188380|FG008|Maintenance Phase|Adverse Event|1|||
46949739|NCT02394028|83188381|FG009|Maintenance Phase|Adverse Event|1|||
46949740|NCT02394028|83188382|FG010|Maintenance Phase|Adverse Event|3|||
46949741|NCT02394028|83188372|FG000|Maintenance Phase|Site closure|0|||
46949742|NCT02394028|83188373|FG001|Maintenance Phase|Site closure|0|||
46949743|NCT02394028|83188374|FG002|Maintenance Phase|Site closure|0|||
46949744|NCT02394028|83188375|FG003|Maintenance Phase|Site closure|0|||
46949745|NCT02394028|83188376|FG004|Maintenance Phase|Site closure|0|||
46949746|NCT02394028|83188377|FG005|Maintenance Phase|Site closure|0|||
46949747|NCT02394028|83188378|FG006|Maintenance Phase|Site closure|0|||
46949748|NCT02394028|83188379|FG007|Maintenance Phase|Site closure|0|||
46949749|NCT02394028|83188380|FG008|Maintenance Phase|Site closure|0|||
46949750|NCT02394028|83188381|FG009|Maintenance Phase|Site closure|1|||
46949751|NCT02394028|83188382|FG010|Maintenance Phase|Site closure|0|||
46949752|NCT02394028|83188372|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46949753|NCT02394028|83188373|FG001|Maintenance Phase|Withdrawal by Subject|0|||
46949754|NCT02394028|83188374|FG002|Maintenance Phase|Withdrawal by Subject|0|||
46949755|NCT02394028|83188375|FG003|Maintenance Phase|Withdrawal by Subject|0|||
46949756|NCT02394028|83188376|FG004|Maintenance Phase|Withdrawal by Subject|0|||
46949757|NCT02394028|83188377|FG005|Maintenance Phase|Withdrawal by Subject|0|||
46949758|NCT02394028|83188378|FG006|Maintenance Phase|Withdrawal by Subject|0|||
46949759|NCT02394028|83188379|FG007|Maintenance Phase|Withdrawal by Subject|0|||
46949760|NCT02394028|83188380|FG008|Maintenance Phase|Withdrawal by Subject|3|||
46949761|NCT02394028|83188381|FG009|Maintenance Phase|Withdrawal by Subject|12|||
46949762|NCT02394028|83188382|FG010|Maintenance Phase|Withdrawal by Subject|12|||
46949763|NCT01371539|83188436|FG000|Period One: One Week|Lost to Follow-up|0|||
46771674|NCT00587288|82989930|FG001|Overall Study|Protocol Violation|0|||
46771675|NCT00800735|82989938|FG000|Overall Study|Administrative/Other|2|||
46771676|NCT00800735|82989938|FG000|Overall Study|Insufficient Therapeutic Response|2|||
46771677|NCT00800735|82989938|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
46771678|NCT00800735|82989938|FG000|Overall Study|Withdrew Consent|3|||
46771679|NCT00730158|82989944|FG000|Overall Study|Withdrawal by Subject|1|||
46771680|NCT00730158|82989945|FG001|Overall Study|Withdrawal by Subject|1|||
46771681|NCT00784550|82989957|FG000|Overall Study|Adverse Event|12|||
46771682|NCT00784550|82989958|FG001|Overall Study|Adverse Event|10|||
46771683|NCT00784550|82989957|FG000|Overall Study|Lack of Efficacy|0|||
46771684|NCT00784550|82989958|FG001|Overall Study|Lack of Efficacy|1|||
46949764|NCT01371539|83188437|FG001|Period One: One Week|Lost to Follow-up|1|||
46949765|NCT01371539|83188436|FG000|Period Two: One Week|Lost to Follow-up|0|||
46949766|NCT01371539|83188437|FG001|Period Two: One Week|Lost to Follow-up|1|||
46949767|NCT01371539|83188436|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
46949768|NCT01371539|83188437|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
46949769|NCT01371539|83188436|FG000|Period Two: One Week|Time/job conflict|0|||
46949770|NCT01371539|83188437|FG001|Period Two: One Week|Time/job conflict|1|||
46949771|NCT02819297|83188445|FG000|Overall Study|Withdrawal by Subject|25|||
46771685|NCT00784550|82989957|FG000|Overall Study|Protocol Violation|10|||
46949772|NCT02819297|83188446|FG001|Overall Study|Withdrawal by Subject|13|||
46949773|NCT02819297|83188445|FG000|Overall Study|Lost to Follow-up|12|||
46949774|NCT02819297|83188446|FG001|Overall Study|Lost to Follow-up|14|||
46949775|NCT02819297|83188445|FG000|Overall Study|Adverse Event|12|||
46949776|NCT02819297|83188446|FG001|Overall Study|Adverse Event|10|||
46949777|NCT02819297|83188445|FG000|Overall Study|Physician Decision|5|||
46949778|NCT02819297|83188446|FG001|Overall Study|Physician Decision|5|||
46771686|NCT00784550|82989958|FG001|Overall Study|Protocol Violation|10|||
46949779|NCT02819297|83188445|FG000|Overall Study|Lack of Efficacy|5|||
46949780|NCT02819297|83188446|FG001|Overall Study|Lack of Efficacy|8|||
46949781|NCT02819297|83188445|FG000|Overall Study|Protocol Violation|1|||
46949782|NCT02819297|83188446|FG001|Overall Study|Protocol Violation|2|||
46949783|NCT02429830|83188452|FG000|Overall Study|Lost to Follow-up|1|||
46949784|NCT02429830|83188452|FG000|Overall Study|Device Explant|2|||
46949785|NCT02821715|83188456|FG000|Overall Study|Protocol Violation|1|||
46949786|NCT02821715|83188457|FG001|Overall Study|Protocol Violation|0|||
46949787|NCT02821715|83188458|FG002|Overall Study|Protocol Violation|0|||
46949788|NCT02821715|83188459|FG003|Overall Study|Protocol Violation|0|||
46949789|NCT02821715|83188460|FG004|Overall Study|Protocol Violation|0|||
46949790|NCT02821715|83188461|FG005|Overall Study|Protocol Violation|0|||
46949791|NCT02813681|83188472|FG000|Overall Study|Physician Decision|5|||
46949792|NCT02813681|83188473|FG001|Overall Study|Physician Decision|5|||
46949793|NCT02813681|83188474|FG002|Overall Study|Physician Decision|0|||
46949794|NCT02813681|83188472|FG000|Overall Study|Lost to Follow-up|0|||
46949795|NCT02813681|83188473|FG001|Overall Study|Lost to Follow-up|1|||
46949796|NCT02813681|83188474|FG002|Overall Study|Lost to Follow-up|0|||
46949797|NCT02393950|83188486|FG000|Overall Study|Adverse Event|1|||
46949798|NCT02393950|83188487|FG001|Overall Study|Adverse Event|0|||
46949799|NCT02393950|83188486|FG000|Overall Study|Withdrawal by Subject|0|||
46949800|NCT02393950|83188487|FG001|Overall Study|Withdrawal by Subject|1|||
46949801|NCT02815397|83188522|FG000|Overall Study|Physician Decision|2|||
46949802|NCT02427958|83188526|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
46949803|NCT02427958|83188526|FG000|Overall Study|Lost to Follow-up|6|||
46949804|NCT02427958|83188526|FG000|Overall Study|Withdrawal by Subject|14|||
46949805|NCT02427958|83188526|FG000|Overall Study|Lack of Efficacy|1|||
46949806|NCT02392624|83188533|FG000|Overall Study|Withdrawal by Subject|15|||
46949807|NCT02392624|83188534|FG001|Overall Study|Withdrawal by Subject|12|||
46949808|NCT02392624|83188535|FG002|Overall Study|Withdrawal by Subject|9|||
46949809|NCT02392624|83188533|FG000|Overall Study|Adverse Event|4|||
46949810|NCT02392624|83188534|FG001|Overall Study|Adverse Event|1|||
46949811|NCT02392624|83188535|FG002|Overall Study|Adverse Event|2|||
46949812|NCT02392624|83188533|FG000|Overall Study|Pregnancy|1|||
46949813|NCT02392624|83188534|FG001|Overall Study|Pregnancy|0|||
46949814|NCT02392624|83188535|FG002|Overall Study|Pregnancy|0|||
46949815|NCT02392624|83188533|FG000|Overall Study|Protocol Violation|0|||
46949816|NCT02392624|83188534|FG001|Overall Study|Protocol Violation|0|||
46949817|NCT02392624|83188535|FG002|Overall Study|Protocol Violation|1|||
46949818|NCT02392624|83188533|FG000|Overall Study|Sponsor/Investigator Decision|2|||
46771687|NCT00784550|82989957|FG000|Overall Study|Lost to Follow-up|8|||
46771688|NCT00784550|82989958|FG001|Overall Study|Lost to Follow-up|5|||
46771689|NCT00784550|82989957|FG000|Overall Study|Physician Decision|2|||
46771690|NCT00784550|82989958|FG001|Overall Study|Physician Decision|3|||
46771691|NCT00784550|82989957|FG000|Overall Study|Withdrawal by Subject|4|||
46771692|NCT00784550|82989958|FG001|Overall Study|Withdrawal by Subject|13|||
46771693|NCT00729690|82989967|FG000|Overall Study|IT Catheter Malfunction|0|||
46771694|NCT00729690|82989968|FG001|Overall Study|IT Catheter Malfunction|2|||
46771695|NCT00729690|82989969|FG002|Overall Study|IT Catheter Malfunction|2|||
46771696|NCT00784238|82989977|FG000|Overall Study|Adverse Event|14|||
46771697|NCT00784238|82989977|FG000|Overall Study|Death|2|||
46771698|NCT00784238|82989977|FG000|Overall Study|Lack of Efficacy|33|||
46949819|NCT02392624|83188534|FG001|Overall Study|Sponsor/Investigator Decision|1|||
46949820|NCT02392624|83188535|FG002|Overall Study|Sponsor/Investigator Decision|0|||
46949821|NCT02392624|83188533|FG000|Overall Study|Other|49|||
46949822|NCT02392624|83188534|FG001|Overall Study|Other|1|||
46949823|NCT02392624|83188535|FG002|Overall Study|Other|1|||
46771699|NCT00784238|82989977|FG000|Overall Study|Lost to Follow-up|29|||
46771700|NCT00784238|82989977|FG000|Overall Study|Pregnancy|1|||
46771701|NCT00784238|82989977|FG000|Overall Study|Withdrawal by Subject|26|||
46771702|NCT00784238|82989977|FG000|Overall Study|Other|14|||
46771703|NCT00729612|82989984|FG000|Overall Study|Non evaluable for response|10|||
46771704|NCT00585546|82989988|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
46771705|NCT00585546|82989988|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
46771706|NCT00768248|82989994|FG000|Overall Study|Research coordinator didn't collect data|1|||
46771707|NCT00768248|82989995|FG001|Overall Study|Research coordinator didn't collect data|1|||
46949824|NCT02387164|83188545|FG000|Overall Study|Lost to Follow-up|2|||
46771708|NCT00775268|82990003|FG000|Baseline|Drug not synthesize dose|1|||
46771709|NCT00775268|82990004|FG001|Baseline|Drug not synthesize dose|0|||
46949825|NCT02387164|83188546|FG001|Overall Study|Lost to Follow-up|0|||
46949826|NCT02387164|83188545|FG000|Overall Study|Diagnosed|1|||
46949827|NCT02387164|83188546|FG001|Overall Study|Diagnosed|2|||
46949828|NCT02392234|83188564|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
46949829|NCT02392234|83188565|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
46771710|NCT00775268|82990003|FG000|Baseline|Not treated-ineligible per CT|0|||
46949830|NCT02392234|83188566|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
46949831|NCT02392234|83188567|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
46771711|NCT00775268|82990004|FG001|Baseline|Not treated-ineligible per CT|1|||
46949832|NCT02392234|83188568|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
46949833|NCT02392234|83188569|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
46949834|NCT02392234|83188564|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
46949835|NCT02392234|83188565|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
46949836|NCT02392234|83188566|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
46949837|NCT02392234|83188567|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
46949838|NCT02392234|83188568|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
46949839|NCT02392234|83188569|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
46949840|NCT02392234|83188564|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
46949841|NCT02392234|83188565|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
46949842|NCT02392234|83188566|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
46949843|NCT02392234|83188567|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
46949844|NCT02392234|83188568|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
46949845|NCT02392234|83188569|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
46949846|NCT02392234|83188564|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
46949847|NCT02392234|83188565|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
46949848|NCT02392234|83188566|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
46949849|NCT02392234|83188567|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
46949850|NCT02392234|83188568|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
46949851|NCT02392234|83188569|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
46949852|NCT02392234|83188564|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
46949853|NCT02392234|83188565|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
46949854|NCT02392234|83188566|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
46949855|NCT02392234|83188567|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
46949856|NCT02392234|83188568|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
46949857|NCT02392234|83188569|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
46949858|NCT02392234|83188564|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
46949859|NCT02392234|83188565|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
46949860|NCT02392234|83188566|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
46949861|NCT02392234|83188567|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
46949862|NCT02392234|83188568|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
46949863|NCT02392234|83188569|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
46949864|NCT02392234|83188564|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
46949865|NCT02392234|83188565|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
46949866|NCT02392234|83188566|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
46949867|NCT02392234|83188567|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
46949868|NCT02392234|83188568|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
46949869|NCT02392234|83188569|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
46949870|NCT02392234|83188564|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
46949871|NCT02392234|83188565|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
46949872|NCT02392234|83188566|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
46949873|NCT02392234|83188567|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
46949874|NCT02392234|83188568|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
46949875|NCT02392234|83188569|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
46949876|NCT02963090|83188583|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
46949877|NCT02963090|83188584|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
46949878|NCT02427802|83188596|FG000|Overall Study|Adverse Event|11|||
46949879|NCT02427802|83188597|FG001|Overall Study|Adverse Event|3|||
46949880|NCT02427802|83188598|FG002|Overall Study|Adverse Event|7|||
46949881|NCT02427802|83188596|FG000|Overall Study|Death|0|||
46949882|NCT02427802|83188597|FG001|Overall Study|Death|4|||
46949883|NCT02427802|83188598|FG002|Overall Study|Death|1|||
46949884|NCT02427802|83188596|FG000|Overall Study|Lost to Follow-up|13|||
46949885|NCT02427802|83188597|FG001|Overall Study|Lost to Follow-up|8|||
46949886|NCT02427802|83188598|FG002|Overall Study|Lost to Follow-up|8|||
46949887|NCT02427802|83188596|FG000|Overall Study|Physician Decision|4|||
46949888|NCT02427802|83188597|FG001|Overall Study|Physician Decision|2|||
46639075|NCT01402986|82812645|FG000|Overall Study|Withdrawal by Subject|7|||
46639076|NCT01402986|82812646|FG001|Overall Study|Withdrawal by Subject|10|||
46639077|NCT01402986|82812647|FG002|Overall Study|Withdrawal by Subject|7|||
46639078|NCT01402986|82812648|FG003|Overall Study|Withdrawal by Subject|13|||
46639079|NCT01402986|82812645|FG000|Overall Study|Death|0|||
46771712|NCT00775268|82990003|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
46771713|NCT00775268|82990004|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
46771714|NCT00775268|82990003|FG000|After Completion|Participant missed scan appointment|1|||
46771715|NCT00775268|82990004|FG001|After Completion|Participant missed scan appointment|0|||
46771716|NCT00775190|82990023|FG000|Overall Study|Lost to Follow-up|2|||
46639080|NCT01402986|82812646|FG001|Overall Study|Death|0|||
46949889|NCT02427802|83188598|FG002|Overall Study|Physician Decision|4|||
46639081|NCT01402986|82812647|FG002|Overall Study|Death|0|||
46771717|NCT00775190|82990024|FG001|Overall Study|Lost to Follow-up|3|||
46949890|NCT02427802|83188596|FG000|Overall Study|Withdrawal by Subject|10|||
46949891|NCT02427802|83188597|FG001|Overall Study|Withdrawal by Subject|5|||
46949892|NCT02427802|83188598|FG002|Overall Study|Withdrawal by Subject|11|||
46949893|NCT02427802|83188596|FG000|Overall Study|Protocol Violation|3|||
46949894|NCT02427802|83188597|FG001|Overall Study|Protocol Violation|1|||
46949895|NCT02427802|83188598|FG002|Overall Study|Protocol Violation|1|||
46949896|NCT02427802|83188596|FG000|Overall Study|protocol specific treatment unrelated|18|||
46949897|NCT02427802|83188597|FG001|Overall Study|protocol specific treatment unrelated|11|||
46949898|NCT02427802|83188598|FG002|Overall Study|protocol specific treatment unrelated|11|||
46949899|NCT02427646|83188608|FG000|Overall Study|Lack of Efficacy|2|||
46949900|NCT02427646|83188609|FG001|Overall Study|Lack of Efficacy|3|||
46949901|NCT02427646|83188608|FG000|Overall Study|Physician Decision|1|||
46949902|NCT02427646|83188609|FG001|Overall Study|Physician Decision|4|||
46949903|NCT02427646|83188608|FG000|Overall Study|Protocol Violation|3|||
46949904|NCT02427646|83188609|FG001|Overall Study|Protocol Violation|3|||
46949905|NCT02427646|83188608|FG000|Overall Study|Bothersome hand weakness|2|||
46949906|NCT02427646|83188609|FG001|Overall Study|Bothersome hand weakness|4|||
46949907|NCT02392000|83188617|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
46949908|NCT02392000|83188617|FG000|Overall Study|Withdrawal by Subject|1|||
46949909|NCT02392000|83188617|FG000|Overall Study|Lost to Follow-up|8|||
46949910|NCT02385526|83188625|FG000|Overall Study|Withdrawal by Subject|0|||
46949911|NCT02385526|83188626|FG001|Overall Study|Withdrawal by Subject|2|||
46949912|NCT02385526|83188627|FG002|Overall Study|Withdrawal by Subject|0|||
46949913|NCT02385526|83188625|FG000|Overall Study|Lost to Follow-up|0|||
46949914|NCT02385526|83188626|FG001|Overall Study|Lost to Follow-up|1|||
46949915|NCT02385526|83188627|FG002|Overall Study|Lost to Follow-up|0|||
46949916|NCT02385526|83188625|FG000|Overall Study|Physician Decision|1|||
46949917|NCT02385526|83188626|FG001|Overall Study|Physician Decision|0|||
46949918|NCT02385526|83188627|FG002|Overall Study|Physician Decision|0|||
46949919|NCT02385526|83188625|FG000|Overall Study|Protocol Violation|1|||
46949920|NCT02385526|83188626|FG001|Overall Study|Protocol Violation|0|||
46949921|NCT02385526|83188627|FG002|Overall Study|Protocol Violation|0|||
46949922|NCT02808143|83188637|FG000|Maintenance Phase|Disease recurrence|1|||
46949923|NCT02808143|83188638|FG001|Maintenance Phase|Disease recurrence|3|||
46949924|NCT02808143|83188637|FG000|Maintenance Phase|Disease progression|1|||
46949925|NCT02808143|83188638|FG001|Maintenance Phase|Disease progression|2|||
46949926|NCT02808143|83188637|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
46949927|NCT02808143|83188638|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
46949928|NCT02808143|83188637|FG000|Survival Follow-Up|Disease recurrence|0|||
46949929|NCT02808143|83188638|FG001|Survival Follow-Up|Disease recurrence|2|||
46949930|NCT02808143|83188637|FG000|Survival Follow-Up|Adverse Event|0|||
46949931|NCT02808143|83188638|FG001|Survival Follow-Up|Adverse Event|1|||
46949932|NCT02808143|83188637|FG000|Survival Follow-Up|Death|1|||
46949933|NCT02808143|83188638|FG001|Survival Follow-Up|Death|0|||
46949934|NCT02427100|83188648|FG000|Overall Study|Lost to Follow-up|0|||
46949935|NCT02427100|83188649|FG001|Overall Study|Lost to Follow-up|2|||
46949936|NCT02806973|83188655|FG000|Period 1|Withdrawal by Subject|0|||
46949937|NCT02806973|83188656|FG001|Period 1|Withdrawal by Subject|2|||
46949938|NCT02806973|83188657|FG002|Period 1|Withdrawal by Subject|1|||
46949939|NCT02806973|83188658|FG003|Period 1|Withdrawal by Subject|1|||
46949940|NCT02806973|83188655|FG000|Period 1|Adverse Event|0|||
46949941|NCT02806973|83188656|FG001|Period 1|Adverse Event|0|||
46949942|NCT02806973|83188657|FG002|Period 1|Adverse Event|0|||
46949943|NCT02806973|83188658|FG003|Period 1|Adverse Event|1|||
46949944|NCT02806973|83188655|FG000|Period 3|Withdrawal by Subject|0|||
46949945|NCT02806973|83188656|FG001|Period 3|Withdrawal by Subject|0|||
46949946|NCT02806973|83188657|FG002|Period 3|Withdrawal by Subject|0|||
46949947|NCT02806973|83188658|FG003|Period 3|Withdrawal by Subject|3|||
46949948|NCT02806973|83188655|FG000|Period 3|Adverse Event|0|||
46949949|NCT02806973|83188656|FG001|Period 3|Adverse Event|0|||
47066522|NCT01542632|83349205|FG003|Overall Study|Withdrawal of Consent|2|||
47066523|NCT01542632|83349206|FG004|Overall Study|Withdrawal of Consent|3|||
47066524|NCT01542632|83349207|FG005|Overall Study|Withdrawal of Consent|0|||
47066525|NCT01542632|83349202|FG000|Overall Study|Adverse Event|0|||
46949950|NCT02806973|83188657|FG002|Period 3|Adverse Event|1|||
46949951|NCT02806973|83188658|FG003|Period 3|Adverse Event|0|||
46949952|NCT02806505|83188670|FG000|Overall Study|Adverse event/intercurrent illness|1|||
46639082|NCT01402986|82812648|FG003|Overall Study|Death|2|||
46771718|NCT00775190|82990023|FG000|Overall Study|Withdrawal by Subject|1|||
46771719|NCT00775190|82990024|FG001|Overall Study|Withdrawal by Subject|2|||
46949953|NCT02806505|83188671|FG001|Overall Study|Adverse event/intercurrent illness|3|||
47066526|NCT01542632|83349203|FG001|Overall Study|Adverse Event|0|||
46949954|NCT02806505|83188670|FG000|Overall Study|Death|4|||
47066527|NCT01542632|83349204|FG002|Overall Study|Adverse Event|1|||
46771720|NCT00775190|82990023|FG000|Overall Study|Protocol Violation|1|||
46949955|NCT02806505|83188671|FG001|Overall Study|Death|0|||
46949956|NCT02806505|83188670|FG000|Overall Study|Did not cooperate/refused treatment|3|||
46949957|NCT02806505|83188671|FG001|Overall Study|Did not cooperate/refused treatment|3|||
46949958|NCT02806505|83188670|FG000|Overall Study|Failure to return|0|||
46949959|NCT02806505|83188671|FG001|Overall Study|Failure to return|1|||
46949960|NCT02806505|83188670|FG000|Overall Study|Insufficient therapeutic response|2|||
46949961|NCT02806505|83188671|FG001|Overall Study|Insufficient therapeutic response|4|||
46949962|NCT02807363|83188681|FG000|Dosing Period|Adverse Event|0|||
46949963|NCT02807363|83188682|FG001|Dosing Period|Adverse Event|1|||
46949964|NCT02807363|83188683|FG002|Dosing Period|Adverse Event|0|||
46949965|NCT02807363|83188684|FG003|Dosing Period|Adverse Event|0|||
46949966|NCT02383966|83188698|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
46949967|NCT02383966|83188699|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
46949968|NCT02383966|83188698|FG000|Overall Study|Randomized, but not treated|1|||
46949969|NCT02383966|83188699|FG001|Overall Study|Randomized, but not treated|3|||
46949970|NCT02383576|83188707|FG000|Overall Study|Death|53|||
46949971|NCT02383576|83188708|FG001|Overall Study|Death|33|||
46949972|NCT02383576|83188707|FG000|Overall Study|Lost to Follow-up|7|||
46949973|NCT02383576|83188708|FG001|Overall Study|Lost to Follow-up|1|||
46949974|NCT02383576|83188707|FG000|Overall Study|Withdrew Consent|1|||
46949975|NCT02383576|83188708|FG001|Overall Study|Withdrew Consent|6|||
46949976|NCT02383576|83188707|FG000|Overall Study|Investigator's Decision|0|||
46949977|NCT02383576|83188708|FG001|Overall Study|Investigator's Decision|1|||
46949978|NCT02383576|83188707|FG000|Overall Study|Administrative/Other|2|||
46949979|NCT02383576|83188708|FG001|Overall Study|Administrative/Other|4|||
46949980|NCT02748317|83188714|FG000|Overall Study|Withdrawal by Subject|14|||
46949981|NCT02748317|83188714|FG000|Overall Study|Lost to Follow-up|8|||
46949982|NCT02748317|83188714|FG000|Overall Study|Death|1|||
46949983|NCT02426086|83188720|FG000|Overall Study|Death|33|||
46949984|NCT02426086|83188721|FG001|Overall Study|Death|36|||
46949985|NCT02426086|83188720|FG000|Overall Study|Lost to Follow-up|2|||
46949986|NCT02426086|83188721|FG001|Overall Study|Lost to Follow-up|0|||
46949987|NCT02426086|83188720|FG000|Overall Study|Study Terminated by Sponsor|5|||
46949988|NCT02426086|83188721|FG001|Overall Study|Study Terminated by Sponsor|14|||
46949989|NCT02426086|83188720|FG000|Overall Study|Withdrawal by Subject|8|||
46949990|NCT02426086|83188721|FG001|Overall Study|Withdrawal by Subject|9|||
46949991|NCT02422264|83188734|FG000|Overall Study|Serious Adverse Event|1|||
46949992|NCT02422264|83188735|FG001|Overall Study|Serious Adverse Event|0|||
46949993|NCT02422264|83188734|FG000|Overall Study|Withdrawal by Subject|1|||
46949994|NCT02422264|83188735|FG001|Overall Study|Withdrawal by Subject|2|||
46949995|NCT02422264|83188734|FG000|Overall Study|Migrated/moved from study area|3|||
46949996|NCT02422264|83188735|FG001|Overall Study|Migrated/moved from study area|1|||
46949997|NCT02422264|83188734|FG000|Overall Study|Subject vaccinated outside of the study|0|||
46949998|NCT02422264|83188735|FG001|Overall Study|Subject vaccinated outside of the study|1|||
46949999|NCT02390362|83188743|FG000|Overall Study|Withdrawal by Subject|0|||
46950000|NCT02390362|83188744|FG001|Overall Study|Withdrawal by Subject|1|||
46950001|NCT02389894|83188753|FG000|Overall Study|Death|4|||
46950002|NCT02389894|83188754|FG001|Overall Study|Death|5|||
46950003|NCT02389894|83188755|FG002|Overall Study|Death|3|||
47066528|NCT01542632|83349205|FG003|Overall Study|Adverse Event|0|||
47066529|NCT01542632|83349206|FG004|Overall Study|Adverse Event|0|||
47066530|NCT01542632|83349207|FG005|Overall Study|Adverse Event|0|||
46771721|NCT00775190|82990024|FG001|Overall Study|Protocol Violation|0|||
46771722|NCT00479557|82990037|FG000|Overall Study|Death|0|||
46771723|NCT00479557|82990038|FG001|Overall Study|Death|0|||
46771724|NCT00479557|82990039|FG002|Overall Study|Death|0|||
46771725|NCT00479557|82990040|FG003|Overall Study|Death|0|||
46771726|NCT00479557|82990041|FG004|Overall Study|Death|0|||
46771727|NCT00479557|82990042|FG005|Overall Study|Death|1|||
46771728|NCT00479557|82990043|FG006|Overall Study|Death|0|||
46771729|NCT00479557|82990037|FG000|Overall Study|Lack of Efficacy|1|||
46771730|NCT00479557|82990038|FG001|Overall Study|Lack of Efficacy|0|||
46771731|NCT00479557|82990039|FG002|Overall Study|Lack of Efficacy|0|||
46771732|NCT00479557|82990040|FG003|Overall Study|Lack of Efficacy|0|||
46771733|NCT00479557|82990041|FG004|Overall Study|Lack of Efficacy|0|||
46771734|NCT00479557|82990042|FG005|Overall Study|Lack of Efficacy|0|||
46771735|NCT00479557|82990043|FG006|Overall Study|Lack of Efficacy|0|||
46771736|NCT00479557|82990037|FG000|Overall Study|Lost to Follow-up|0|||
46771737|NCT00479557|82990038|FG001|Overall Study|Lost to Follow-up|2|||
46771738|NCT00479557|82990039|FG002|Overall Study|Lost to Follow-up|0|||
46771739|NCT00479557|82990040|FG003|Overall Study|Lost to Follow-up|2|||
46771740|NCT00479557|82990041|FG004|Overall Study|Lost to Follow-up|0|||
46771741|NCT00479557|82990042|FG005|Overall Study|Lost to Follow-up|0|||
46771742|NCT00479557|82990043|FG006|Overall Study|Lost to Follow-up|0|||
46950004|NCT02389894|83188753|FG000|Overall Study|Withdrawal by Subject|2|||
46950005|NCT02389894|83188754|FG001|Overall Study|Withdrawal by Subject|4|||
46950006|NCT02389894|83188755|FG002|Overall Study|Withdrawal by Subject|5|||
46950007|NCT02389894|83188753|FG000|Overall Study|Lost to Follow-up|2|||
46950008|NCT02389894|83188754|FG001|Overall Study|Lost to Follow-up|1|||
46950009|NCT02389894|83188755|FG002|Overall Study|Lost to Follow-up|1|||
46950010|NCT02389816|83188766|FG000|Overall Study|Randomized but Not Treated|1|||
46950011|NCT02389816|83188767|FG001|Overall Study|Randomized but Not Treated|0|||
46950012|NCT02389816|83188768|FG002|Overall Study|Randomized but Not Treated|0|||
46950013|NCT02389816|83188766|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
46950014|NCT02389816|83188767|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
46950015|NCT02389816|83188768|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
46950016|NCT02389816|83188766|FG000|Overall Study|Major Protocol Deviation|1|||
46950017|NCT02389816|83188767|FG001|Overall Study|Major Protocol Deviation|0|||
46842166|NCT00195260|83059121|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
46842167|NCT00195260|83059122|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
46842168|NCT00195260|83059123|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
46950018|NCT02389816|83188768|FG002|Overall Study|Major Protocol Deviation|0|||
46950019|NCT02389816|83188766|FG000|Overall Study|Lost to Follow-up|1|||
46950020|NCT02389816|83188767|FG001|Overall Study|Lost to Follow-up|0|||
46950021|NCT02389816|83188768|FG002|Overall Study|Lost to Follow-up|0|||
46950022|NCT02389816|83188766|FG000|Overall Study|Withdrawal of Consent|6|||
46950023|NCT02389816|83188767|FG001|Overall Study|Withdrawal of Consent|4|||
46950024|NCT02389816|83188768|FG002|Overall Study|Withdrawal of Consent|4|||
46950025|NCT02389816|83188766|FG000|Overall Study|Lack of Efficacy|1|||
46950026|NCT02389816|83188767|FG001|Overall Study|Lack of Efficacy|0|||
46950027|NCT02389816|83188768|FG002|Overall Study|Lack of Efficacy|0|||
46950028|NCT02389816|83188766|FG000|Overall Study|Non Compliance with Study Drug|1|||
46950029|NCT02389816|83188767|FG001|Overall Study|Non Compliance with Study Drug|1|||
46950030|NCT02389816|83188768|FG002|Overall Study|Non Compliance with Study Drug|1|||
46950031|NCT02389816|83188766|FG000|Overall Study|Reason not Specified|0|||
46950032|NCT02389816|83188767|FG001|Overall Study|Reason not Specified|2|||
46950033|NCT02389816|83188768|FG002|Overall Study|Reason not Specified|0|||
46950034|NCT02388724|83188778|FG000|Overall Study|Reason not Specified|0|||
46950035|NCT02388724|83188779|FG001|Overall Study|Reason not Specified|1|||
46950036|NCT02388724|83188778|FG000|Overall Study|Major Protocol Deviation|3|||
46950037|NCT02388724|83188779|FG001|Overall Study|Major Protocol Deviation|3|||
46950038|NCT02388724|83188778|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
46950039|NCT02388724|83188779|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
46950040|NCT02388724|83188778|FG000|Overall Study|Voluntary Withdrawal|6|||
46950041|NCT02388724|83188779|FG001|Overall Study|Voluntary Withdrawal|5|||
46950042|NCT02388724|83188778|FG000|Overall Study|Randomized but not Treated|0|||
46950043|NCT02388724|83188779|FG001|Overall Study|Randomized but not Treated|2|||
46950044|NCT02382796|83188785|FG000|Overall Study|Global deterioration of health status|1|||
46950045|NCT02382796|83188785|FG000|Overall Study|Objective progression or relapse|3|||
46950046|NCT02382796|83188785|FG000|Overall Study|Commercial dacomitinib became available|3|||
46950047|NCT02382640|83188793|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
46950048|NCT02382640|83188794|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
46950049|NCT02382640|83188795|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
46950050|NCT02382640|83188796|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
46950051|NCT02801669|83188808|FG000|Overall Study|Death|66|||
46950052|NCT02801669|83188809|FG001|Overall Study|Death|69|||
46950053|NCT02801669|83188808|FG000|Overall Study|Withdrawal by Subject|81|||
46950054|NCT02801669|83188809|FG001|Overall Study|Withdrawal by Subject|77|||
46950055|NCT02801669|83188808|FG000|Overall Study|Other|4|||
46950056|NCT02801669|83188809|FG001|Overall Study|Other|6|||
46950057|NCT02804399|83188815|FG000|Period 2|Adverse Event|0|||
46950058|NCT02804399|83188816|FG001|Period 2|Adverse Event|1|||
46950059|NCT01333943|83188827|FG000|Overall Study|Known neuropathy|1|||
46950060|NCT01333943|83188828|FG001|Overall Study|Known neuropathy|0|||
46950061|NCT01333865|83188834|FG000|Overall Study|Adverse Event|2|||
46950062|NCT01333475|83188840|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
46771743|NCT00479557|82990037|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
46771744|NCT00479557|82990038|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
46771745|NCT00479557|82990039|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
46771746|NCT00479557|82990040|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
46771747|NCT00479557|82990041|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
46771748|NCT00479557|82990042|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
46771749|NCT00479557|82990043|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
46771750|NCT00479557|82990037|FG000|Overall Study|AE not related to Study Drug|1|||
46771751|NCT00479557|82990038|FG001|Overall Study|AE not related to Study Drug|3|||
46771752|NCT00479557|82990039|FG002|Overall Study|AE not related to Study Drug|0|||
46771753|NCT00479557|82990040|FG003|Overall Study|AE not related to Study Drug|0|||
46842169|NCT00195260|83059113|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46950063|NCT01333475|83188841|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
46950064|NCT01333475|83188840|FG000|Overall Study|Toxicity|1|||
46842170|NCT00195260|83059114|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46842171|NCT00195260|83059115|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46842172|NCT00195260|83059116|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46950065|NCT01333475|83188841|FG001|Overall Study|Toxicity|3|||
46950066|NCT01333397|83188853|FG000|Overall Study|Lost to Follow-up|1|||
46950067|NCT01333397|83188854|FG001|Overall Study|Lost to Follow-up|0|||
46950068|NCT01333397|83188855|FG002|Overall Study|Lost to Follow-up|0|||
46950069|NCT01333397|83188856|FG003|Overall Study|Lost to Follow-up|1|||
46950070|NCT01333397|83188857|FG004|Overall Study|Lost to Follow-up|0|||
46950071|NCT02798861|83188878|FG000|Overall Study|Lost to Follow-up|22|||
46950072|NCT02798861|83188878|FG000|Overall Study|Withdrawal by Subject|1|||
46771754|NCT00479557|82990041|FG004|Overall Study|AE not related to Study Drug|2|||
46771755|NCT00479557|82990042|FG005|Overall Study|AE not related to Study Drug|2|||
46950073|NCT02798315|83188882|FG000|Overall Study|Failure to return|1|||
46950074|NCT02796755|83188888|FG000|Overall Study|Adverse Event|2|||
46950075|NCT02796755|83188889|FG001|Overall Study|Adverse Event|0|||
46950076|NCT02382016|83188897|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
46950077|NCT02382016|83188898|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
46950078|NCT02382016|83188897|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
46950079|NCT02382016|83188898|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
46950080|NCT02382016|83188897|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
46950081|NCT02382016|83188898|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
46950082|NCT02382016|83188897|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
46950083|NCT02382016|83188898|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
46950084|NCT02382016|83188897|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
46950085|NCT02382016|83188898|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
46950086|NCT02382016|83188897|FG000|Open-label (OL) Treatment Period|Death|4|||
46950087|NCT02382016|83188898|FG001|Open-label (OL) Treatment Period|Death|0|||
46950088|NCT02382016|83188897|FG000|OL Extension Period|Physician Decision|3|||
46950089|NCT02382016|83188898|FG001|OL Extension Period|Physician Decision|0|||
46950090|NCT02382016|83188897|FG000|OL Extension Period|Death|2|||
46950091|NCT02382016|83188898|FG001|OL Extension Period|Death|0|||
46950092|NCT02382016|83188897|FG000|OL Extension Period|Withdrawal by Subject|1|||
46950093|NCT02382016|83188898|FG001|OL Extension Period|Withdrawal by Subject|0|||
46950094|NCT02422186|83188908|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
46950095|NCT02422186|83188909|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
46950096|NCT02422186|83188908|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
46950097|NCT02422186|83188909|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
46950098|NCT02422186|83188908|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
46950099|NCT02422186|83188909|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
46950100|NCT02422186|83188908|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
46950101|NCT02422186|83188909|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
46950102|NCT02422186|83188908|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
46950103|NCT02422186|83188909|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
46950104|NCT02422186|83188908|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
46950105|NCT02422186|83188909|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
46950106|NCT02422186|83188908|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
46950107|NCT02422186|83188909|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
46950108|NCT02422186|83188908|FG000|Follow-up Phase (2 Weeks)|Other|3|||
46950109|NCT02422186|83188909|FG001|Follow-up Phase (2 Weeks)|Other|0|||
46950110|NCT02421952|83188917|FG000|Overall Study|Diary Not Returned|93|||
46950111|NCT02421952|83188917|FG000|Overall Study|Failed seriation task|13|||
46950112|NCT02421952|83188917|FG000|Overall Study|Subject uncooperative for baseline test|2|||
46950113|NCT02421952|83188917|FG000|Overall Study|Surgery cancelled|1|||
46950114|NCT02796677|83188928|FG000|Overall Study|Adverse Event|11|||
46950115|NCT02796677|83188929|FG001|Overall Study|Adverse Event|22|||
46771756|NCT00479557|82990043|FG006|Overall Study|AE not related to Study Drug|1|||
46771757|NCT00479557|82990037|FG000|Overall Study|Caregiver Request|2|||
46771758|NCT00479557|82990038|FG001|Overall Study|Caregiver Request|2|||
46771759|NCT00479557|82990039|FG002|Overall Study|Caregiver Request|2|||
46771760|NCT00479557|82990040|FG003|Overall Study|Caregiver Request|0|||
46950116|NCT02796677|83188930|FG002|Overall Study|Adverse Event|14|||
46950117|NCT02796677|83188931|FG003|Overall Study|Adverse Event|14|||
46950118|NCT02796677|83188928|FG000|Overall Study|Protocol Violation|7|||
46950119|NCT02796677|83188929|FG001|Overall Study|Protocol Violation|5|||
46950120|NCT02796677|83188930|FG002|Overall Study|Protocol Violation|4|||
46950121|NCT02796677|83188931|FG003|Overall Study|Protocol Violation|8|||
46950122|NCT02796677|83188928|FG000|Overall Study|Lost to Follow-up|1|||
46950123|NCT02796677|83188929|FG001|Overall Study|Lost to Follow-up|5|||
46950124|NCT02796677|83188930|FG002|Overall Study|Lost to Follow-up|2|||
46950125|NCT02796677|83188931|FG003|Overall Study|Lost to Follow-up|2|||
46950126|NCT02796677|83188928|FG000|Overall Study|Lack of Efficacy|7|||
46950127|NCT02796677|83188929|FG001|Overall Study|Lack of Efficacy|9|||
46771761|NCT00479557|82990041|FG004|Overall Study|Caregiver Request|1|||
46771762|NCT00479557|82990042|FG005|Overall Study|Caregiver Request|2|||
46950128|NCT02796677|83188930|FG002|Overall Study|Lack of Efficacy|14|||
46950129|NCT02796677|83188931|FG003|Overall Study|Lack of Efficacy|20|||
46950130|NCT02796677|83188928|FG000|Overall Study|Withdrawal by Subject|4|||
46950131|NCT02796677|83188929|FG001|Overall Study|Withdrawal by Subject|14|||
46950132|NCT02796677|83188930|FG002|Overall Study|Withdrawal by Subject|6|||
46950133|NCT02796677|83188931|FG003|Overall Study|Withdrawal by Subject|7|||
46950134|NCT02796677|83188928|FG000|Overall Study|Progressive disease|6|||
46950135|NCT02796677|83188929|FG001|Overall Study|Progressive disease|15|||
46771763|NCT00479557|82990043|FG006|Overall Study|Caregiver Request|0|||
46950136|NCT02796677|83188930|FG002|Overall Study|Progressive disease|13|||
46950137|NCT02796677|83188931|FG003|Overall Study|Progressive disease|18|||
46950138|NCT02796677|83188928|FG000|Overall Study|Reason not mentioned|2|||
46950139|NCT02796677|83188929|FG001|Overall Study|Reason not mentioned|3|||
46950140|NCT02796677|83188930|FG002|Overall Study|Reason not mentioned|0|||
46950141|NCT02796677|83188931|FG003|Overall Study|Reason not mentioned|5|||
46950142|NCT02421172|83188945|FG000|Period 1|Adverse Event|1|||
46950143|NCT02421172|83188946|FG001|Period 1|Adverse Event|0|||
46950144|NCT02421172|83188947|FG002|Period 1|Adverse Event|0|||
46950145|NCT02421172|83188948|FG003|Period 1|Adverse Event|0|||
46950146|NCT02421172|83188949|FG004|Period 1|Adverse Event|0|||
46950147|NCT02421172|83188945|FG000|Period 1|Lost to Follow-up|3|||
46950148|NCT02421172|83188946|FG001|Period 1|Lost to Follow-up|1|||
46950149|NCT02421172|83188947|FG002|Period 1|Lost to Follow-up|0|||
46950150|NCT02421172|83188948|FG003|Period 1|Lost to Follow-up|0|||
46950151|NCT02421172|83188949|FG004|Period 1|Lost to Follow-up|0|||
46950152|NCT02421172|83188945|FG000|Period 1|Patient/guardian decision|0|||
46950153|NCT02421172|83188946|FG001|Period 1|Patient/guardian decision|1|||
46950154|NCT02421172|83188947|FG002|Period 1|Patient/guardian decision|0|||
46950155|NCT02421172|83188948|FG003|Period 1|Patient/guardian decision|0|||
46950156|NCT02421172|83188949|FG004|Period 1|Patient/guardian decision|0|||
46950157|NCT02421172|83188945|FG000|Period 2|Adverse Event|0|||
46950158|NCT02421172|83188946|FG001|Period 2|Adverse Event|0|||
46950159|NCT02421172|83188947|FG002|Period 2|Adverse Event|4|||
46950160|NCT02421172|83188948|FG003|Period 2|Adverse Event|0|||
46950161|NCT02421172|83188949|FG004|Period 2|Adverse Event|0|||
46950162|NCT02421172|83188945|FG000|Period 2|Lost to Follow-up|0|||
46950163|NCT02421172|83188946|FG001|Period 2|Lost to Follow-up|0|||
46950164|NCT02421172|83188947|FG002|Period 2|Lost to Follow-up|0|||
46950165|NCT02421172|83188948|FG003|Period 2|Lost to Follow-up|1|||
46950166|NCT02421172|83188949|FG004|Period 2|Lost to Follow-up|0|||
46950167|NCT02421172|83188945|FG000|Period 2|Patient/guardian decision|0|||
46950168|NCT02421172|83188946|FG001|Period 2|Patient/guardian decision|0|||
46950169|NCT02421172|83188947|FG002|Period 2|Patient/guardian decision|3|||
46950170|NCT02421172|83188948|FG003|Period 2|Patient/guardian decision|2|||
46950171|NCT02421172|83188949|FG004|Period 2|Patient/guardian decision|1|||
46950172|NCT02379052|83188962|FG000|Overall Study|Protocol Violation|0|||
46950173|NCT02379052|83188963|FG001|Overall Study|Protocol Violation|1|||
46950174|NCT02379052|83188962|FG000|Overall Study|Adverse Event|0|||
46950175|NCT02379052|83188963|FG001|Overall Study|Adverse Event|1|||
46950176|NCT02379052|83188962|FG000|Overall Study|Physician Decision|1|||
46950177|NCT02379052|83188963|FG001|Overall Study|Physician Decision|1|||
46950178|NCT02379052|83188962|FG000|Overall Study|Withdrawal by Subject|2|||
46950179|NCT02379052|83188963|FG001|Overall Study|Withdrawal by Subject|0|||
46950180|NCT02379052|83188962|FG000|Overall Study|Lost to Follow-up|2|||
46950181|NCT02379052|83188963|FG001|Overall Study|Lost to Follow-up|1|||
46771764|NCT00479557|82990037|FG000|Overall Study|Investigator Request|0|||
46771765|NCT00479557|82990038|FG001|Overall Study|Investigator Request|0|||
46771766|NCT00479557|82990039|FG002|Overall Study|Investigator Request|1|||
46771767|NCT00479557|82990040|FG003|Overall Study|Investigator Request|0|||
46771768|NCT00479557|82990041|FG004|Overall Study|Investigator Request|0|||
46771769|NCT00479557|82990042|FG005|Overall Study|Investigator Request|0|||
46771770|NCT00479557|82990043|FG006|Overall Study|Investigator Request|0|||
46771771|NCT00479557|82990037|FG000|Overall Study|Subject Request|3|||
46771772|NCT00479557|82990038|FG001|Overall Study|Subject Request|0|||
46771773|NCT00479557|82990039|FG002|Overall Study|Subject Request|1|||
46771774|NCT00479557|82990040|FG003|Overall Study|Subject Request|1|||
46771775|NCT00479557|82990041|FG004|Overall Study|Subject Request|1|||
46950182|NCT02379052|83188962|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
46950183|NCT02379052|83188963|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
46950184|NCT02379052|83188962|FG000|Overall Study|Subject was Incarcerated|0|||
46771776|NCT00479557|82990042|FG005|Overall Study|Subject Request|4|||
46771777|NCT00479557|82990043|FG006|Overall Study|Subject Request|1|||
46771778|NCT00479557|82990037|FG000|Overall Study|Other|2|||
46771779|NCT00479557|82990038|FG001|Overall Study|Other|3|||
46771780|NCT00479557|82990039|FG002|Overall Study|Other|1|||
46950185|NCT02379052|83188963|FG001|Overall Study|Subject was Incarcerated|1|||
46950186|NCT02378662|83188971|FG000|Overall Study|Early Discontinuation|2|||
46950187|NCT02378662|83188972|FG001|Overall Study|Early Discontinuation|0|||
46950188|NCT02378506|83188978|FG000|Overall Study|Lack of Efficacy|3|||
46771781|NCT00479557|82990040|FG003|Overall Study|Other|0|||
46950189|NCT02378506|83188978|FG000|Overall Study|Withdrawal by Subject|4|||
46950190|NCT02378506|83188978|FG000|Overall Study|Protocol Violation|2|||
46950191|NCT02378506|83188978|FG000|Overall Study|Death|1|||
46950192|NCT02378506|83188978|FG000|Overall Study|Adverse Event|14|||
46950193|NCT02378506|83188978|FG000|Overall Study|Randomized But Not Treated|1|||
46950194|NCT02347774|83188985|FG000|Study Participation|Lost to Follow-up|3|||
46950195|NCT02347774|83188986|FG001|Study Participation|Lost to Follow-up|6|||
46950196|NCT02347774|83188987|FG002|Study Participation|Lost to Follow-up|2|||
46950197|NCT02347774|83188985|FG000|Study Participation|Withdrawal by Subject|8|||
46950198|NCT02347774|83188986|FG001|Study Participation|Withdrawal by Subject|9|||
46950199|NCT02347774|83188987|FG002|Study Participation|Withdrawal by Subject|15|||
46950200|NCT02347774|83188985|FG000|Study Participation|Adverse Event|1|||
46950201|NCT02347774|83188986|FG001|Study Participation|Adverse Event|4|||
46950202|NCT02347774|83188987|FG002|Study Participation|Adverse Event|6|||
46950203|NCT02347774|83188985|FG000|Study Participation|withdrew consent|1|||
46950204|NCT02347774|83188986|FG001|Study Participation|withdrew consent|1|||
46950205|NCT02347774|83188987|FG002|Study Participation|withdrew consent|1|||
46950206|NCT02347774|83188985|FG000|Study Participation|Met Prolonged QT criteria|1|||
46950207|NCT02347774|83188986|FG001|Study Participation|Met Prolonged QT criteria|0|||
46950208|NCT02347774|83188987|FG002|Study Participation|Met Prolonged QT criteria|0|||
46950209|NCT02347774|83188985|FG000|Study Participation|non-compliance with study drug|0|||
46950210|NCT02347774|83188986|FG001|Study Participation|non-compliance with study drug|1|||
46950211|NCT02347774|83188987|FG002|Study Participation|non-compliance with study drug|0|||
46950212|NCT02347774|83188985|FG000|Study Participation|incarceration|1|||
46950213|NCT02347774|83188986|FG001|Study Participation|incarceration|0|||
46950214|NCT02347774|83188987|FG002|Study Participation|incarceration|0|||
46950215|NCT02347774|83188985|FG000|Study Participation|randomized in error|0|||
46950216|NCT02347774|83188986|FG001|Study Participation|randomized in error|0|||
46950217|NCT02347774|83188987|FG002|Study Participation|randomized in error|1|||
46950218|NCT02347774|83188985|FG000|On Study Treatment|Adverse Event|9|||
46950219|NCT02347774|83188986|FG001|On Study Treatment|Adverse Event|15|||
46950220|NCT02347774|83188987|FG002|On Study Treatment|Adverse Event|19|||
46950221|NCT02347774|83188985|FG000|On Study Treatment|Lack of Efficacy|3|||
46950222|NCT02347774|83188986|FG001|On Study Treatment|Lack of Efficacy|0|||
46950223|NCT02347774|83188987|FG002|On Study Treatment|Lack of Efficacy|2|||
46950224|NCT02347774|83188985|FG000|On Study Treatment|non-complicance with study medication|0|||
46950225|NCT02347774|83188986|FG001|On Study Treatment|non-complicance with study medication|2|||
46950226|NCT02347774|83188987|FG002|On Study Treatment|non-complicance with study medication|0|||
46950227|NCT02347774|83188985|FG000|On Study Treatment|Protocol Violation|0|||
46950228|NCT02347774|83188986|FG001|On Study Treatment|Protocol Violation|0|||
46950229|NCT02347774|83188987|FG002|On Study Treatment|Protocol Violation|1|||
46950230|NCT02347774|83188985|FG000|On Study Treatment|withdrew consent|9|||
46950231|NCT02347774|83188986|FG001|On Study Treatment|withdrew consent|8|||
46950232|NCT02347774|83188987|FG002|On Study Treatment|withdrew consent|12|||
46950233|NCT02347774|83188985|FG000|On Study Treatment|Lost to Follow-up|2|||
46950234|NCT02347774|83188986|FG001|On Study Treatment|Lost to Follow-up|6|||
46950235|NCT02347774|83188987|FG002|On Study Treatment|Lost to Follow-up|1|||
46950236|NCT02347774|83188985|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
46950237|NCT02347774|83188986|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
46950238|NCT02347774|83188987|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
46950239|NCT02347774|83188985|FG000|On Study Treatment|ranomized in error|0|||
46950240|NCT02347774|83188986|FG001|On Study Treatment|ranomized in error|0|||
46950241|NCT02347774|83188987|FG002|On Study Treatment|ranomized in error|1|||
46950242|NCT02794883|83188998|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
46950243|NCT02794883|83188999|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
46950244|NCT02794883|83189000|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
46950245|NCT02794883|83188998|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
46950246|NCT02794883|83188999|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
46950247|NCT02794883|83189000|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
46950248|NCT02794883|83188998|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
46950249|NCT02794883|83188999|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
46950250|NCT02794883|83189000|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
46950251|NCT02794883|83188998|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
46950252|NCT02794883|83188999|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
46950253|NCT02794883|83189000|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
46950254|NCT02794883|83188998|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
46950255|NCT02794883|83188999|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
46950256|NCT02794883|83189000|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
46950257|NCT02794883|83188998|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
46950258|NCT02794883|83188999|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
46950259|NCT02794883|83189000|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
46950260|NCT02794883|83188998|FG000|Follow-up Period (up to 2 Years)|Death|12|||
46950261|NCT02794883|83188999|FG001|Follow-up Period (up to 2 Years)|Death|10|||
46950262|NCT02794883|83189000|FG002|Follow-up Period (up to 2 Years)|Death|10|||
46950263|NCT01370603|83189010|FG000|Period 1|Adverse Event|5|||
46950264|NCT01370603|83189011|FG001|Period 1|Adverse Event|3|||
46950265|NCT01370603|83189010|FG000|Period 1|Lost to Follow-up|2|||
46950266|NCT01370603|83189011|FG001|Period 1|Lost to Follow-up|0|||
46950267|NCT01370603|83189010|FG000|Period 1|Protocol Violation|2|||
46950268|NCT01370603|83189011|FG001|Period 1|Protocol Violation|2|||
46950269|NCT01370603|83189010|FG000|Period 1|Withdrawal by Subject|5|||
46950270|NCT01370603|83189011|FG001|Period 1|Withdrawal by Subject|5|||
46950271|NCT01370603|83189010|FG000|Crossover Washout|Adverse Event|2|||
46950272|NCT01370603|83189011|FG001|Crossover Washout|Adverse Event|1|||
46950273|NCT01370603|83189010|FG000|Crossover Washout|Lost to Follow-up|2|||
46950274|NCT01370603|83189011|FG001|Crossover Washout|Lost to Follow-up|0|||
46950275|NCT01370603|83189010|FG000|Crossover Washout|Protocol Violation|1|||
46950276|NCT01370603|83189011|FG001|Crossover Washout|Protocol Violation|0|||
46950277|NCT01370603|83189010|FG000|Crossover Washout|Withdrawal by Subject|4|||
46950278|NCT01370603|83189011|FG001|Crossover Washout|Withdrawal by Subject|1|||
46950279|NCT01370603|83189010|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
46950280|NCT01370603|83189011|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
46950281|NCT01370603|83189010|FG000|Period 2|Adverse Event|1|||
46950282|NCT01370603|83189011|FG001|Period 2|Adverse Event|4|||
46950283|NCT01370603|83189010|FG000|Period 2|Lost to Follow-up|1|||
46950284|NCT01370603|83189011|FG001|Period 2|Lost to Follow-up|0|||
46950285|NCT01370603|83189010|FG000|Period 2|Withdrawal by Subject|1|||
46950286|NCT01370603|83189011|FG001|Period 2|Withdrawal by Subject|0|||
46950287|NCT02347072|83189017|FG000|Overall Study|Adverse Event|2|||
46950288|NCT02347072|83189017|FG000|Overall Study|Withdrawal by Subject|6|||
46950289|NCT02347072|83189017|FG000|Overall Study|Physician Decision|1|||
46950290|NCT02347072|83189017|FG000|Overall Study|Lost to Follow-up|2|||
46950291|NCT02347072|83189017|FG000|Overall Study|Protocol Violation|1|||
46950292|NCT02347072|83189017|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
46950293|NCT02794103|83189025|FG000|Overall Study|Loss to follow up due to high sedation|3|||
46950294|NCT02346370|83189032|FG000|Overall Study|Not treated|1|||
46950295|NCT02346370|83189033|FG001|Overall Study|Not treated|0|||
46950296|NCT02346370|83189034|FG002|Overall Study|Not treated|0|||
46950297|NCT02346370|83189032|FG000|Overall Study|Withdrawal of consent|1|||
46950298|NCT02346370|83189033|FG001|Overall Study|Withdrawal of consent|0|||
46950299|NCT02346370|83189034|FG002|Overall Study|Withdrawal of consent|0|||
46950300|NCT02346370|83189032|FG000|Overall Study|Death|1|||
46950301|NCT02346370|83189033|FG001|Overall Study|Death|3|||
46950302|NCT02346370|83189034|FG002|Overall Study|Death|1|||
46950303|NCT02346370|83189032|FG000|Overall Study|Sponsor discontinued study|5|||
46950304|NCT02346370|83189033|FG001|Overall Study|Sponsor discontinued study|0|||
46950305|NCT02346370|83189034|FG002|Overall Study|Sponsor discontinued study|2|||
46950306|NCT02346370|83189032|FG000|Overall Study|Radiologic progression|0|||
46950307|NCT02346370|83189033|FG001|Overall Study|Radiologic progression|0|||
46950308|NCT02346370|83189034|FG002|Overall Study|Radiologic progression|1|||
46950309|NCT02346370|83189032|FG000|Overall Study|Physician Decision|0|||
46950310|NCT02346370|83189033|FG001|Overall Study|Physician Decision|1|||
46950311|NCT02346370|83189034|FG002|Overall Study|Physician Decision|0|||
46950312|NCT02346136|83189046|FG000|Overall Study|Withdrawal by Subject|7|||
46950313|NCT02346136|83189047|FG001|Overall Study|Withdrawal by Subject|5|||
46950314|NCT02346136|83189046|FG000|Overall Study|Death|1|||
46950315|NCT02346136|83189047|FG001|Overall Study|Death|0|||
46950316|NCT02346136|83189046|FG000|Overall Study|Study termination|14|||
46950317|NCT02346136|83189047|FG001|Overall Study|Study termination|18|||
46950318|NCT02793947|83189055|FG000|Overall Study|Death|1|||
46950319|NCT02793947|83189056|FG001|Overall Study|Death|0|||
46950320|NCT02793947|83189055|FG000|Overall Study|Physician Decision|1|||
46950321|NCT02793947|83189056|FG001|Overall Study|Physician Decision|5|||
46950322|NCT02345512|83189062|FG000|Overall Study|Adverse Event|1|||
46950323|NCT02345512|83189062|FG000|Overall Study|Withdrawal by Subject|1|||
46950324|NCT02345434|83189073|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
46950325|NCT02345434|83189074|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
46950326|NCT01370213|83189083|FG000|Overall Study|Early Death|1|||
46950327|NCT01370213|83189084|FG001|Overall Study|Early Death|0|||
46950328|NCT01370213|83189085|FG002|Overall Study|Early Death|0|||
46950329|NCT01370213|83189083|FG000|Overall Study|Not evaluable|0|||
46950330|NCT01370213|83189084|FG001|Overall Study|Not evaluable|2|||
46950331|NCT01370213|83189085|FG002|Overall Study|Not evaluable|0|||
46950332|NCT01370525|83189094|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
46950333|NCT01370525|83189095|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
46950334|NCT01370525|83189094|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46950335|NCT01370525|83189095|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46950336|NCT01370525|83189094|FG000|Overall Study|Adverse Event|0|||
46950337|NCT01370525|83189095|FG001|Overall Study|Adverse Event|1|||
46950338|NCT01370525|83189094|FG000|Overall Study|Protocol Violation|2|||
46950339|NCT01370525|83189095|FG001|Overall Study|Protocol Violation|1|||
46950340|NCT01370525|83189094|FG000|Overall Study|Lost to follow up|2|||
46950341|NCT01370525|83189095|FG001|Overall Study|Lost to follow up|6|||
46950342|NCT02792777|83189103|FG000|Overall Study|Withdrawal by Subject|2|||
46950343|NCT02792777|83189104|FG001|Overall Study|Withdrawal by Subject|0|||
46950344|NCT02792777|83189103|FG000|Overall Study|Recording malfunction|2|||
46950345|NCT02792777|83189104|FG001|Overall Study|Recording malfunction|0|||
46950346|NCT02792777|83189103|FG000|Overall Study|Later determined to be ineligible|2|||
46950347|NCT02792777|83189104|FG001|Overall Study|Later determined to be ineligible|0|||
47066531|NCT01542632|83349202|FG000|Overall Study|Lost to Follow-up|0|||
46950348|NCT02792777|83189103|FG000|Overall Study|Participant interviewed twice|1|||
46950349|NCT02792777|83189104|FG001|Overall Study|Participant interviewed twice|0|||
46771782|NCT00479557|82990041|FG004|Overall Study|Other|0|||
46771783|NCT00479557|82990042|FG005|Overall Study|Other|3|||
46771784|NCT00479557|82990043|FG006|Overall Study|Other|0|||
46771785|NCT00774800|82990065|FG000|Intervention 4|Withdrawal by Subject|1|||
46771786|NCT00439309|82990077|FG000|Follow-Up|Death|1|||
46950350|NCT02625974|83189113|FG000|Overall Study|Adverse Event|12|||
46950351|NCT02625974|83189114|FG001|Overall Study|Adverse Event|2|||
46950352|NCT02625974|83189113|FG000|Overall Study|Withdrawal by Subject|3|||
46950353|NCT02625974|83189114|FG001|Overall Study|Withdrawal by Subject|1|||
46950354|NCT02625974|83189113|FG000|Overall Study|positive parasitemia|1|||
46950355|NCT02625974|83189114|FG001|Overall Study|positive parasitemia|0|||
46950356|NCT02625974|83189113|FG000|Overall Study|non-compliance with study drug|0|||
46950357|NCT02625974|83189114|FG001|Overall Study|non-compliance with study drug|2|||
46950358|NCT02625974|83189113|FG000|Overall Study|Protocol Violation|0|||
46950359|NCT02625974|83189114|FG001|Overall Study|Protocol Violation|1|||
46950360|NCT02792699|83189159|FG000|Overall Study|Adverse Event|1|||
46950361|NCT02792699|83189160|FG001|Overall Study|Adverse Event|2|||
46950362|NCT02792699|83189161|FG002|Overall Study|Adverse Event|4|||
46950363|NCT02792699|83189159|FG000|Overall Study|Withdrawal by Subject|4|||
46950364|NCT02792699|83189160|FG001|Overall Study|Withdrawal by Subject|4|||
46950365|NCT02792699|83189161|FG002|Overall Study|Withdrawal by Subject|3|||
46950366|NCT02792699|83189159|FG000|Overall Study|Lost to Follow-up|0|||
46950367|NCT02792699|83189160|FG001|Overall Study|Lost to Follow-up|1|||
46950368|NCT02792699|83189161|FG002|Overall Study|Lost to Follow-up|2|||
46950369|NCT02792699|83189159|FG000|Overall Study|Physician Decision|2|||
46950370|NCT02792699|83189160|FG001|Overall Study|Physician Decision|0|||
46950371|NCT02792699|83189161|FG002|Overall Study|Physician Decision|0|||
46950372|NCT02792699|83189159|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
46950373|NCT02792699|83189160|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
46950374|NCT02792699|83189161|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
46950375|NCT02792699|83189159|FG000|Overall Study|Other|1|||
46950376|NCT02792699|83189160|FG001|Overall Study|Other|0|||
46950377|NCT02792699|83189161|FG002|Overall Study|Other|0|||
46950378|NCT03010319|83189178|FG000|Overall Study|Adverse Event|15|||
46950379|NCT03010319|83189179|FG001|Overall Study|Adverse Event|9|||
46950380|NCT03010319|83189178|FG000|Overall Study|Withdrawal by Subject|1|||
46950381|NCT03010319|83189179|FG001|Overall Study|Withdrawal by Subject|6|||
46950382|NCT03010319|83189178|FG000|Overall Study|Physician Decision|2|||
46950383|NCT03010319|83189179|FG001|Overall Study|Physician Decision|4|||
46771787|NCT00439309|82990078|FG001|Follow-Up|Death|0|||
46771788|NCT00439309|82990077|FG000|Follow-Up|Lost to Follow-up|2|||
46950384|NCT03010319|83189178|FG000|Overall Study|Sponsor requested withdrawal|2|||
46950385|NCT03010319|83189179|FG001|Overall Study|Sponsor requested withdrawal|2|||
46950386|NCT03010319|83189178|FG000|Overall Study|Death|1|||
46950387|NCT03010319|83189179|FG001|Overall Study|Death|0|||
46950388|NCT03010319|83189178|FG000|Overall Study|Lost to Follow-up|0|||
46950389|NCT03010319|83189179|FG001|Overall Study|Lost to Follow-up|1|||
46950390|NCT03010319|83189178|FG000|Overall Study|Other Reason|5|||
46950391|NCT03010319|83189179|FG001|Overall Study|Other Reason|7|||
46950392|NCT01369511|83189189|FG000|Overall Study|Adverse Event|1|||
46950393|NCT01369511|83189190|FG001|Overall Study|Adverse Event|1|||
46950394|NCT01369511|83189191|FG002|Overall Study|Adverse Event|5|||
46950395|NCT01369511|83189192|FG003|Overall Study|Adverse Event|0|||
46950396|NCT01369511|83189189|FG000|Overall Study|Entry criteria not met|2|||
46950397|NCT01369511|83189190|FG001|Overall Study|Entry criteria not met|0|||
46950398|NCT01369511|83189191|FG002|Overall Study|Entry criteria not met|0|||
47066532|NCT01542632|83349203|FG001|Overall Study|Lost to Follow-up|1|||
46771789|NCT00439309|82990078|FG001|Follow-Up|Lost to Follow-up|0|||
46771790|NCT00439309|82990077|FG000|Follow-Up|Withdrawal by Subject|0|||
46771791|NCT00439309|82990078|FG001|Follow-Up|Withdrawal by Subject|1|||
46771792|NCT00439309|82990077|FG000|Follow-Up|Late response by subject|0|||
46771793|NCT00439309|82990078|FG001|Follow-Up|Late response by subject|1|||
46771794|NCT00479167|82990084|FG000|Overall Study|Withdrawal by Subject|1|||
46950399|NCT01369511|83189192|FG003|Overall Study|Entry criteria not met|1|||
46950400|NCT01369511|83189189|FG000|Overall Study|Lost to Follow-up|0|||
46950401|NCT01369511|83189190|FG001|Overall Study|Lost to Follow-up|1|||
46950402|NCT01369511|83189191|FG002|Overall Study|Lost to Follow-up|1|||
46950403|NCT01369511|83189192|FG003|Overall Study|Lost to Follow-up|2|||
46950404|NCT01369511|83189189|FG000|Overall Study|Protocol Violation|0|||
46950405|NCT01369511|83189190|FG001|Overall Study|Protocol Violation|1|||
46950406|NCT01369511|83189191|FG002|Overall Study|Protocol Violation|0|||
46950407|NCT01369511|83189192|FG003|Overall Study|Protocol Violation|2|||
46771795|NCT00725712|82990091|FG000|Overall Study|Withdrawal by Subject|2|||
46771796|NCT00725712|82990092|FG001|Overall Study|Withdrawal by Subject|1|||
46950408|NCT01369511|83189189|FG000|Overall Study|Physician Decision|3|||
46950409|NCT01369511|83189190|FG001|Overall Study|Physician Decision|4|||
46950410|NCT01369511|83189191|FG002|Overall Study|Physician Decision|0|||
46950411|NCT01369511|83189192|FG003|Overall Study|Physician Decision|0|||
46950412|NCT01369511|83189189|FG000|Overall Study|Sponsor decision|2|||
46771797|NCT00725712|82990091|FG000|Overall Study|Protocol Violation|1|||
46771798|NCT00725712|82990092|FG001|Overall Study|Protocol Violation|0|||
46771799|NCT00725712|82990091|FG000|Overall Study|Progressive disease|37|||
46950413|NCT01369511|83189190|FG001|Overall Study|Sponsor decision|0|||
46950414|NCT01369511|83189191|FG002|Overall Study|Sponsor decision|1|||
46950415|NCT01369511|83189192|FG003|Overall Study|Sponsor decision|0|||
46950416|NCT01369511|83189189|FG000|Overall Study|Withdrawal by Subject|5|||
46950417|NCT01369511|83189190|FG001|Overall Study|Withdrawal by Subject|6|||
46950418|NCT01369511|83189191|FG002|Overall Study|Withdrawal by Subject|4|||
46950419|NCT01369511|83189192|FG003|Overall Study|Withdrawal by Subject|6|||
46950420|NCT01369433|83189204|FG000|Overall Study|Adverse Event|31|||
46950421|NCT01369433|83189205|FG001|Overall Study|Adverse Event|1|||
46950422|NCT01369433|83189204|FG000|Overall Study|Required significant surgical procedure|1|||
46950423|NCT01369433|83189205|FG001|Overall Study|Required significant surgical procedure|0|||
46950424|NCT01369433|83189204|FG000|Overall Study|Non-compliance|1|||
46950425|NCT01369433|83189205|FG001|Overall Study|Non-compliance|0|||
46950426|NCT01369433|83189204|FG000|Overall Study|Withdrawal by Subject|5|||
46950427|NCT01369433|83189205|FG001|Overall Study|Withdrawal by Subject|2|||
46950428|NCT01369433|83189204|FG000|Overall Study|Study terminated by Sponsor|67|||
46950429|NCT01369433|83189205|FG001|Overall Study|Study terminated by Sponsor|0|||
46950430|NCT01369433|83189204|FG000|Overall Study|Lost to Follow-up|1|||
46950431|NCT01369433|83189205|FG001|Overall Study|Lost to Follow-up|0|||
46950432|NCT01369433|83189204|FG000|Overall Study|Death|5|||
46950433|NCT01369433|83189205|FG001|Overall Study|Death|0|||
46950434|NCT01369433|83189204|FG000|Overall Study|Investigator discretion|6|||
46950435|NCT01369433|83189205|FG001|Overall Study|Investigator discretion|1|||
46950436|NCT01369433|83189204|FG000|Overall Study|Progressive Disease|92|||
46950437|NCT01369433|83189205|FG001|Overall Study|Progressive Disease|12|||
46950438|NCT02624492|83189214|FG000|Overall Study|Adverse Event|2|||
46950439|NCT02624492|83189215|FG001|Overall Study|Adverse Event|2|||
46950440|NCT02624492|83189216|FG002|Overall Study|Adverse Event|2|||
46950441|NCT02624492|83189214|FG000|Overall Study|Progressive disease|0|||
46950442|NCT02624492|83189215|FG001|Overall Study|Progressive disease|2|||
46950443|NCT02624492|83189216|FG002|Overall Study|Progressive disease|3|||
46950444|NCT01975831|83189233|FG000|Overall Study|Adverse Event|1|||
46950445|NCT01975831|83189234|FG001|Overall Study|Adverse Event|2|||
46950446|NCT01975831|83189235|FG002|Overall Study|Adverse Event|2|||
46950447|NCT01975831|83189236|FG003|Overall Study|Adverse Event|0|||
46950448|NCT01975831|83189237|FG004|Overall Study|Adverse Event|1|||
46950449|NCT01975831|83189238|FG005|Overall Study|Adverse Event|1|||
46950450|NCT01975831|83189239|FG006|Overall Study|Adverse Event|3|||
46950451|NCT01975831|83189240|FG007|Overall Study|Adverse Event|4|||
46950452|NCT01975831|83189241|FG008|Overall Study|Adverse Event|1|||
46950453|NCT01975831|83189233|FG000|Overall Study|Death|1|||
46950454|NCT01975831|83189234|FG001|Overall Study|Death|1|||
46950455|NCT01975831|83189235|FG002|Overall Study|Death|0|||
46950456|NCT01975831|83189236|FG003|Overall Study|Death|0|||
46950457|NCT01975831|83189237|FG004|Overall Study|Death|1|||
46950458|NCT01975831|83189238|FG005|Overall Study|Death|0|||
46950459|NCT01975831|83189239|FG006|Overall Study|Death|1|||
46950460|NCT01975831|83189240|FG007|Overall Study|Death|0|||
46950461|NCT01975831|83189241|FG008|Overall Study|Death|0|||
46950462|NCT01975831|83189233|FG000|Overall Study|Progressive Disease|1|||
46950463|NCT01975831|83189234|FG001|Overall Study|Progressive Disease|3|||
46950464|NCT01975831|83189235|FG002|Overall Study|Progressive Disease|2|||
46950465|NCT01975831|83189236|FG003|Overall Study|Progressive Disease|4|||
46950466|NCT01975831|83189237|FG004|Overall Study|Progressive Disease|13|||
46950467|NCT01975831|83189238|FG005|Overall Study|Progressive Disease|9|||
46950468|NCT01975831|83189239|FG006|Overall Study|Progressive Disease|10|||
46950469|NCT01975831|83189240|FG007|Overall Study|Progressive Disease|8|||
47066533|NCT01542632|83349204|FG002|Overall Study|Lost to Follow-up|0|||
46771800|NCT00725712|82990092|FG001|Overall Study|Progressive disease|16|||
46771801|NCT00725712|82990091|FG000|Overall Study|Clinical progression not based on RECIST|0|||
46950470|NCT01975831|83189241|FG008|Overall Study|Progressive Disease|10|||
46950471|NCT01975831|83189233|FG000|Overall Study|Withdrawal by Subject|0|||
46950472|NCT01975831|83189234|FG001|Overall Study|Withdrawal by Subject|3|||
46950473|NCT01975831|83189235|FG002|Overall Study|Withdrawal by Subject|0|||
46950474|NCT01975831|83189236|FG003|Overall Study|Withdrawal by Subject|0|||
46771802|NCT00725712|82990092|FG001|Overall Study|Clinical progression not based on RECIST|3|||
46950475|NCT01975831|83189237|FG004|Overall Study|Withdrawal by Subject|3|||
46950476|NCT01975831|83189238|FG005|Overall Study|Withdrawal by Subject|1|||
46950477|NCT01975831|83189239|FG006|Overall Study|Withdrawal by Subject|1|||
46950478|NCT01975831|83189240|FG007|Overall Study|Withdrawal by Subject|0|||
46950479|NCT01975831|83189241|FG008|Overall Study|Withdrawal by Subject|0|||
46950480|NCT01975831|83189233|FG000|Overall Study|Physician Decision|0|||
46771803|NCT00725712|82990091|FG000|Overall Study|Adverse Event|5|||
46950481|NCT01975831|83189234|FG001|Overall Study|Physician Decision|0|||
46950482|NCT01975831|83189235|FG002|Overall Study|Physician Decision|0|||
46950483|NCT01975831|83189236|FG003|Overall Study|Physician Decision|0|||
46950484|NCT01975831|83189237|FG004|Overall Study|Physician Decision|0|||
46950485|NCT01975831|83189238|FG005|Overall Study|Physician Decision|1|||
46950486|NCT01975831|83189239|FG006|Overall Study|Physician Decision|0|||
46950487|NCT01975831|83189240|FG007|Overall Study|Physician Decision|1|||
46950488|NCT01975831|83189241|FG008|Overall Study|Physician Decision|0|||
46950489|NCT01975831|83189233|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
46950490|NCT01975831|83189234|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
46950491|NCT01975831|83189235|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
46950492|NCT01975831|83189236|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
46950493|NCT01975831|83189237|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
46950494|NCT01975831|83189238|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
46950495|NCT01975831|83189239|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
46950496|NCT01975831|83189240|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
46950497|NCT01975831|83189241|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
46950498|NCT01975831|83189233|FG000|Overall Study|Entered Hospice|0|||
46950499|NCT01975831|83189234|FG001|Overall Study|Entered Hospice|0|||
46950500|NCT01975831|83189235|FG002|Overall Study|Entered Hospice|0|||
46950501|NCT01975831|83189236|FG003|Overall Study|Entered Hospice|0|||
46950502|NCT01975831|83189237|FG004|Overall Study|Entered Hospice|0|||
46950503|NCT01975831|83189238|FG005|Overall Study|Entered Hospice|1|||
46950504|NCT01975831|83189239|FG006|Overall Study|Entered Hospice|0|||
46950505|NCT01975831|83189240|FG007|Overall Study|Entered Hospice|0|||
46950506|NCT01975831|83189241|FG008|Overall Study|Entered Hospice|0|||
46950507|NCT01975831|83189233|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
46950508|NCT01975831|83189234|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
46950509|NCT01975831|83189235|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
46950510|NCT01975831|83189236|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
46950511|NCT01975831|83189237|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
46950512|NCT01975831|83189238|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
46950513|NCT01975831|83189239|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
46950514|NCT01975831|83189240|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
46950515|NCT01975831|83189241|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
46950516|NCT00700713|83189264|FG000|Overall Study|Protocol Violation|1|||
46950517|NCT00700713|83189265|FG001|Overall Study|Protocol Violation|0|||
46950518|NCT00700713|83189266|FG002|Overall Study|Protocol Violation|1|||
46950519|NCT00700713|83189264|FG000|Overall Study|Withdrawal by Subject|0|||
46950520|NCT00700713|83189265|FG001|Overall Study|Withdrawal by Subject|0|||
46950521|NCT00700713|83189266|FG002|Overall Study|Withdrawal by Subject|1|||
46950522|NCT02622386|83189274|FG000|First Assignment|Withdrawal by Subject|3|||
47066534|NCT01542632|83349205|FG003|Overall Study|Lost to Follow-up|0|||
47066535|NCT01542632|83349206|FG004|Overall Study|Lost to Follow-up|0|||
47066536|NCT01542632|83349207|FG005|Overall Study|Lost to Follow-up|0|||
46771804|NCT00725712|82990092|FG001|Overall Study|Adverse Event|5|||
46771805|NCT00725712|82990091|FG000|Overall Study|Death|2|||
46771806|NCT00725712|82990092|FG001|Overall Study|Death|0|||
46771807|NCT00725712|82990091|FG000|Overall Study|Other: Death|1|||
46771808|NCT00725712|82990092|FG001|Overall Study|Other: Death|0|||
46771809|NCT00725712|82990091|FG000|Overall Study|Hospitalized, unable to continue|0|||
46771810|NCT00725712|82990092|FG001|Overall Study|Hospitalized, unable to continue|1|||
46771811|NCT00729378|82990104|FG000|Baseline|Did not complete study measurements|72|||
46771812|NCT00729378|82990105|FG001|Baseline|Did not complete study measurements|33|||
46771813|NCT00729378|82990104|FG000|Baseline|Withdrawal by Subject|66|||
46771814|NCT00729378|82990105|FG001|Baseline|Withdrawal by Subject|59|||
46771815|NCT00729378|82990104|FG000|12-months|Lost to Follow-up|100|||
46771816|NCT00729378|82990105|FG001|12-months|Lost to Follow-up|65|||
46771817|NCT00729378|82990104|FG000|24-months|Lost to Follow-up|72|||
46771818|NCT00729378|82990105|FG001|24-months|Lost to Follow-up|51|||
46771819|NCT00729378|82990104|FG000|36-months|Lost to Follow-up|15|||
46771820|NCT00729378|82990105|FG001|36-months|Lost to Follow-up|6|||
46771821|NCT00478933|82990114|FG000|Overall Study|Protocol Violation|22|||
46771822|NCT00478933|82990114|FG000|Overall Study|Informed consent not verified|3|||
46950523|NCT02622386|83189275|FG001|First Assignment|Withdrawal by Subject|2|||
47066537|NCT01542632|83349202|FG000|Overall Study|Sponsor/Investigator Decision|0|||
47066538|NCT01542632|83349203|FG001|Overall Study|Sponsor/Investigator Decision|0|||
47066539|NCT01542632|83349204|FG002|Overall Study|Sponsor/Investigator Decision|0|||
46771823|NCT00478933|82990114|FG000|Overall Study|Inadequate data available|53|||
46771824|NCT00725322|82990140|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
46771825|NCT00725322|82990141|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
46950524|NCT02622386|83189274|FG000|Washout|Withdrawal by Subject|4|||
46950525|NCT02622386|83189275|FG001|Washout|Withdrawal by Subject|4|||
46950526|NCT02622386|83189274|FG000|Second Assignment|Withdrawal by Subject|0|||
46950527|NCT02622386|83189275|FG001|Second Assignment|Withdrawal by Subject|2|||
46950528|NCT02792231|83189283|FG000|Overall Study|Patient/guardian decision|32|||
46950529|NCT02792231|83189284|FG001|Overall Study|Patient/guardian decision|42|||
46950530|NCT02792231|83189283|FG000|Overall Study|Adverse Event|15|||
46950531|NCT02792231|83189284|FG001|Overall Study|Adverse Event|11|||
46950532|NCT02792231|83189283|FG000|Overall Study|Physician Decision|14|||
46950533|NCT02792231|83189284|FG001|Overall Study|Physician Decision|12|||
46950534|NCT02792231|83189283|FG000|Overall Study|Lack of Efficacy|7|||
46950535|NCT02792231|83189284|FG001|Overall Study|Lack of Efficacy|9|||
46950536|NCT02792231|83189283|FG000|Overall Study|Lost to Follow-up|9|||
46950537|NCT02792231|83189284|FG001|Overall Study|Lost to Follow-up|5|||
46771826|NCT00725322|82990140|FG000|Washout (28 Days)|Protocol Violation|0|||
46771827|NCT00725322|82990141|FG001|Washout (28 Days)|Protocol Violation|1|||
46950538|NCT02792231|83189283|FG000|Overall Study|Pregnancy|1|||
46950539|NCT02792231|83189284|FG001|Overall Study|Pregnancy|3|||
46950540|NCT02792231|83189283|FG000|Overall Study|Non-compliance with study treatment|2|||
46950541|NCT02792231|83189284|FG001|Overall Study|Non-compliance with study treatment|1|||
46950542|NCT02792231|83189283|FG000|Overall Study|Protocol deviation|2|||
46950543|NCT02792231|83189284|FG001|Overall Study|Protocol deviation|0|||
46950544|NCT02792231|83189283|FG000|Overall Study|Technical problems|0|||
46950545|NCT02792231|83189284|FG001|Overall Study|Technical problems|1|||
46950546|NCT00700401|83189290|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
46950547|NCT00700401|83189290|FG000|Overall Study|Adverse Event|5|||
46771828|NCT00725010|82990147|FG000|Overall Study|Toxicity|9|||
46771829|NCT00725010|82990147|FG000|Overall Study|Tumor Progression|7|||
46771830|NCT00725010|82990147|FG000|Overall Study|Withdrawal by Subject|2|||
46771831|NCT00725010|82990147|FG000|Overall Study|Death|1|||
46771832|NCT00725010|82990147|FG000|Overall Study|Lost to Follow-up|1|||
46771833|NCT00725010|82990147|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
46771834|NCT00725010|82990147|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
46771835|NCT00725010|82990147|FG000|Overall Study|No further documentation|1|||
46771836|NCT00725010|82990147|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
46950548|NCT00700401|83189290|FG000|Overall Study|Refused Treatment|2|||
46950549|NCT00700401|83189290|FG000|Overall Study|Lost to Follow-up|1|||
46950550|NCT00700401|83189290|FG000|Overall Study|Treatment never started|1|||
46950551|NCT00700401|83189290|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
46950552|NCT00700401|83189290|FG000|Overall Study|Withdrawal by Subject|2|||
46950553|NCT02621606|83189297|FG000|Overall Study|Withdrawal by Subject|0|||
46950554|NCT02621606|83189298|FG001|Overall Study|Withdrawal by Subject|1|||
46950555|NCT02621606|83189299|FG002|Overall Study|Withdrawal by Subject|0|||
46950556|NCT02871401|83189309|FG000|Overall Study|Adverse Event|1|||
46950557|NCT02871401|83189310|FG001|Overall Study|Adverse Event|0|||
46950558|NCT02619812|83189320|FG000|Overall Study|Withdrawal by Subject|0|||
46950559|NCT02619812|83189321|FG001|Overall Study|Withdrawal by Subject|0|||
46950560|NCT02619812|83189322|FG002|Overall Study|Withdrawal by Subject|1|||
46950561|NCT02619812|83189323|FG003|Overall Study|Withdrawal by Subject|2|||
46950562|NCT02623322|83189336|FG000|Overall Study|Lost to Follow-up|2|||
46950563|NCT02623322|83189337|FG001|Overall Study|Lost to Follow-up|1|||
46950564|NCT02623322|83189338|FG002|Overall Study|Lost to Follow-up|0|||
46950565|NCT00105157|83189352|FG000|Double-Blind (DB)|Never Treated|1|||
46950566|NCT00105157|83189353|FG001|Double-Blind (DB)|Never Treated|0|||
46950567|NCT00105157|83189354|FG002|Double-Blind (DB)|Never Treated|0|||
46950568|NCT00105157|83189355|FG003|Double-Blind (DB)|Never Treated|0|||
46950569|NCT00105157|83189352|FG000|Double-Blind (DB)|Adverse Event|2|||
46950570|NCT00105157|83189353|FG001|Double-Blind (DB)|Adverse Event|0|||
46950571|NCT00105157|83189354|FG002|Double-Blind (DB)|Adverse Event|1|||
46950572|NCT00105157|83189355|FG003|Double-Blind (DB)|Adverse Event|1|||
46950573|NCT00105157|83189352|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
46950574|NCT00105157|83189353|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
46950575|NCT00105157|83189354|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
46950576|NCT00105157|83189355|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
46950577|NCT00105157|83189352|FG000|Open-Label Continuation of DB|Adverse Event|3|||
46950578|NCT00105157|83189353|FG001|Open-Label Continuation of DB|Adverse Event|1|||
46950579|NCT00105157|83189354|FG002|Open-Label Continuation of DB|Adverse Event|0|||
46950580|NCT00105157|83189355|FG003|Open-Label Continuation of DB|Adverse Event|0|||
46950581|NCT00105157|83189352|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
46950582|NCT00105157|83189353|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
46950583|NCT00105157|83189354|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
46639083|NCT01402986|82812645|FG000|Overall Study|Lost to Follow-up|0|||
46771837|NCT00767000|82990158|FG000|54-week Study|Adverse Event|4|||
46639084|NCT01402986|82812646|FG001|Overall Study|Lost to Follow-up|0|||
46771838|NCT00767000|82990159|FG001|54-week Study|Adverse Event|6|||
46950584|NCT00105157|83189355|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
46950585|NCT00105157|83189352|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
46950586|NCT00105157|83189353|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
46771839|NCT00767000|82990160|FG002|54-week Study|Adverse Event|6|||
46950587|NCT00105157|83189354|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
46950588|NCT00105157|83189355|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
46950589|NCT00105157|83189352|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
46950590|NCT00105157|83189353|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
46950591|NCT00105157|83189354|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
46950592|NCT00105157|83189355|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
46950593|NCT00105157|83189352|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
46950594|NCT00105157|83189353|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
46950595|NCT00105157|83189354|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
46950596|NCT00105157|83189355|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
46950597|NCT00105157|83189352|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
46950598|NCT00105157|83189353|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
46950599|NCT00105157|83189354|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
46950600|NCT00105157|83189355|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
46950601|NCT00105157|83189352|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
46950602|NCT00105157|83189353|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
46950603|NCT00105157|83189354|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
46950604|NCT00105157|83189355|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
46950605|NCT00105157|83189352|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
46950606|NCT00105157|83189353|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
46950607|NCT00105157|83189354|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
46950608|NCT00105157|83189355|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
46950609|NCT00105157|83189352|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
46950610|NCT00105157|83189353|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
46950611|NCT00105157|83189354|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
46950612|NCT00105157|83189355|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
46950613|NCT00105157|83189352|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
46950614|NCT00105157|83189353|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
46950615|NCT00105157|83189354|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
46771840|NCT00767000|82990161|FG003|54-week Study|Adverse Event|8|||
46771841|NCT00767000|82990162|FG004|54-week Study|Adverse Event|4|||
46771842|NCT00767000|82990158|FG000|54-week Study|Creaninine/creatinine clearance|2|||
46771843|NCT00767000|82990159|FG001|54-week Study|Creaninine/creatinine clearance|1|||
46771844|NCT00767000|82990160|FG002|54-week Study|Creaninine/creatinine clearance|2|||
46771845|NCT00767000|82990161|FG003|54-week Study|Creaninine/creatinine clearance|2|||
46771846|NCT00767000|82990162|FG004|54-week Study|Creaninine/creatinine clearance|4|||
46771847|NCT00767000|82990158|FG000|54-week Study|Hyperglycemia|0|||
46771848|NCT00767000|82990159|FG001|54-week Study|Hyperglycemia|0|||
46771849|NCT00767000|82990160|FG002|54-week Study|Hyperglycemia|1|||
46950616|NCT00105157|83189355|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
46950617|NCT00105157|83189352|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
46771850|NCT00767000|82990161|FG003|54-week Study|Hyperglycemia|0|||
46842173|NCT00195260|83059117|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46842174|NCT00195260|83059118|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46842175|NCT00195260|83059119|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46842176|NCT00195260|83059120|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
46842177|NCT00195260|83059121|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
46842178|NCT00195260|83059122|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
46842179|NCT00195260|83059123|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
46842180|NCT00031486|83059153|FG000|Overall Study|Adverse Event|1|||
46842181|NCT00031486|83059154|FG001|Overall Study|Adverse Event|0|||
46842182|NCT00031486|83059153|FG000|Overall Study|Lost to Follow-up|0|||
46842183|NCT00031486|83059154|FG001|Overall Study|Lost to Follow-up|1|||
46842184|NCT00031486|83059153|FG000|Overall Study|Withdrawal by Subject|3|||
46842185|NCT00031486|83059154|FG001|Overall Study|Withdrawal by Subject|2|||
46842186|NCT00031486|83059153|FG000|Overall Study|Death|0|||
46842187|NCT00031486|83059154|FG001|Overall Study|Death|3|||
46842188|NCT00031486|83059153|FG000|Overall Study|Non-compliant|0|||
46842189|NCT00031486|83059154|FG001|Overall Study|Non-compliant|4|||
46842190|NCT00031486|83059153|FG000|Overall Study|Did not meet eligibility requirement|2|||
46842191|NCT00031486|83059154|FG001|Overall Study|Did not meet eligibility requirement|1|||
46842192|NCT00031486|83059153|FG000|Overall Study|Other|1|||
46842193|NCT00031486|83059154|FG001|Overall Study|Other|1|||
46842194|NCT00003508|83059162|FG000|Overall Study|Not evaluable|5|||
46842195|NCT00003472|83059166|FG000|Overall Study|Not evaluable|3|||
46842196|NCT00003298|83059170|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
46842197|NCT00003298|83059170|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
46842198|NCT00003298|83059170|FG000|Surgery|Unresectable at surgery|3|||
46842199|NCT00003298|83059170|FG000|Surgery|Progression before surgery|2|||
46842200|NCT00003298|83059170|FG000|Surgery|Unevaluable and off study|2|||
46950618|NCT00105157|83189353|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
46771851|NCT00767000|82990162|FG004|54-week Study|Hyperglycemia|1|||
46771852|NCT00767000|82990158|FG000|54-week Study|Hypoglycemia|0|||
46950619|NCT00105157|83189354|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
46950620|NCT00105157|83189355|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
46950621|NCT02148133|83189376|FG000|Overall Study|Investigator discretion|1|||
46950622|NCT02148133|83189376|FG000|Overall Study|Lack of Efficacy|1|||
46950623|NCT02148133|83189376|FG000|Overall Study|Protocol deviation|1|||
46950624|NCT02148133|83189376|FG000|Overall Study|Protocol-defined stopping criteria|2|||
46950625|NCT00803569|83189380|FG000|Overall Study|Progressive Disease|3|||
46950626|NCT00803569|83189380|FG000|Overall Study|Noncompliance|1|||
46950627|NCT00112957|83189384|FG000|Overall Study|Progressive disease|18|||
46950628|NCT00112957|83189384|FG000|Overall Study|Physician Decision|1|||
46950629|NCT02376790|83189391|FG000|Overall Study|Withdrawal by Subject|43|||
46950630|NCT02376790|83189392|FG001|Overall Study|Withdrawal by Subject|36|||
46950631|NCT02376790|83189393|FG002|Overall Study|Withdrawal by Subject|37|||
46950632|NCT02376790|83189391|FG000|Overall Study|Decision by Sponsor|2|||
46950633|NCT02376790|83189392|FG001|Overall Study|Decision by Sponsor|1|||
46950634|NCT02376790|83189393|FG002|Overall Study|Decision by Sponsor|4|||
46950635|NCT02376790|83189391|FG000|Overall Study|Lost to Follow-up|15|||
46950636|NCT02376790|83189392|FG001|Overall Study|Lost to Follow-up|10|||
46950637|NCT02376790|83189393|FG002|Overall Study|Lost to Follow-up|12|||
46950638|NCT02376166|83189401|FG000|Overall Study|Adverse Event|1|||
46950639|NCT02376166|83189401|FG000|Overall Study|Discontinued metformin early|2|||
46950640|NCT02311894|83189405|FG000|Overall Study|Discontinued in error|1|||
46950641|NCT02311894|83189405|FG000|Overall Study|Lost to Follow-up|1|||
46950642|NCT02311894|83189405|FG000|Overall Study|Adverse Event|1|||
46950643|NCT02311894|83189405|FG000|Overall Study|Withdrawal by Subject|1|||
46950644|NCT02310646|83189411|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
46950645|NCT02310646|83189412|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
46950646|NCT02310646|83189411|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
46950647|NCT02310646|83189412|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
46950648|NCT02375698|83189436|FG000|Overall Study|Withdrawal by Subject|0|||
46950649|NCT02375698|83189437|FG001|Overall Study|Withdrawal by Subject|2|||
46950650|NCT02375698|83189436|FG000|Overall Study|Physician Decision|2|||
46950651|NCT02375698|83189437|FG001|Overall Study|Physician Decision|0|||
46950652|NCT02374918|83189447|FG000|Overall Study|Protocol Violation|2|||
46950653|NCT02374918|83189448|FG001|Overall Study|Protocol Violation|0|||
46950654|NCT02374918|83189449|FG002|Overall Study|Protocol Violation|2|||
46950655|NCT02374918|83189450|FG003|Overall Study|Protocol Violation|1|||
46950656|NCT02374918|83189447|FG000|Overall Study|Withdrawal by Subject|1|||
46950657|NCT02374918|83189448|FG001|Overall Study|Withdrawal by Subject|1|||
46950658|NCT02374918|83189449|FG002|Overall Study|Withdrawal by Subject|1|||
46950659|NCT02374918|83189450|FG003|Overall Study|Withdrawal by Subject|0|||
46771853|NCT00767000|82990159|FG001|54-week Study|Hypoglycemia|1|||
46771854|NCT00767000|82990160|FG002|54-week Study|Hypoglycemia|0|||
46771855|NCT00767000|82990161|FG003|54-week Study|Hypoglycemia|0|||
46771856|NCT00767000|82990162|FG004|54-week Study|Hypoglycemia|0|||
46771857|NCT00767000|82990158|FG000|54-week Study|Interruption of study medication|0|||
46771858|NCT00767000|82990159|FG001|54-week Study|Interruption of study medication|0|||
46771859|NCT00767000|82990160|FG002|54-week Study|Interruption of study medication|1|||
46771860|NCT00767000|82990161|FG003|54-week Study|Interruption of study medication|0|||
46771861|NCT00767000|82990162|FG004|54-week Study|Interruption of study medication|0|||
46771862|NCT00767000|82990158|FG000|54-week Study|Lack of Efficacy|2|||
46771863|NCT00767000|82990159|FG001|54-week Study|Lack of Efficacy|0|||
46771864|NCT00767000|82990160|FG002|54-week Study|Lack of Efficacy|1|||
46771865|NCT00767000|82990161|FG003|54-week Study|Lack of Efficacy|0|||
46771866|NCT00767000|82990162|FG004|54-week Study|Lack of Efficacy|5|||
46771867|NCT00767000|82990158|FG000|54-week Study|Lost to Follow-up|4|||
46771868|NCT00767000|82990159|FG001|54-week Study|Lost to Follow-up|0|||
46771869|NCT00767000|82990160|FG002|54-week Study|Lost to Follow-up|1|||
46771870|NCT00767000|82990161|FG003|54-week Study|Lost to Follow-up|4|||
46771871|NCT00767000|82990162|FG004|54-week Study|Lost to Follow-up|2|||
46771872|NCT00767000|82990158|FG000|54-week Study|Physician Decision|4|||
46950660|NCT02374918|83189447|FG000|Overall Study|Lack of Efficacy|0|||
46950661|NCT02374918|83189448|FG001|Overall Study|Lack of Efficacy|0|||
46950662|NCT02374918|83189449|FG002|Overall Study|Lack of Efficacy|1|||
46950663|NCT02374918|83189450|FG003|Overall Study|Lack of Efficacy|1|||
46950664|NCT02344576|83189462|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
46950665|NCT02344576|83189463|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
46950666|NCT02344576|83189464|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
46950667|NCT02344576|83189465|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
46950668|NCT02344576|83189462|FG000|1-Month Follow-Up|Death|13|||
46950669|NCT02344576|83189463|FG001|1-Month Follow-Up|Death|8|||
46950670|NCT02344576|83189464|FG002|1-Month Follow-Up|Death|0|||
46950671|NCT02344576|83189465|FG003|1-Month Follow-Up|Death|0|||
46950672|NCT02344576|83189462|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
46950673|NCT02344576|83189463|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
46950674|NCT02344576|83189464|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
46950675|NCT02344576|83189465|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
46950676|NCT02344576|83189462|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
46950677|NCT02344576|83189463|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
46950678|NCT02344576|83189464|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
46950679|NCT02344576|83189465|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
46950680|NCT02344576|83189462|FG000|6-Month Follow-Up|Death|14|||
46950681|NCT02344576|83189463|FG001|6-Month Follow-Up|Death|14|||
46950682|NCT02344576|83189464|FG002|6-Month Follow-Up|Death|0|||
46950683|NCT02344576|83189465|FG003|6-Month Follow-Up|Death|0|||
46950684|NCT02344576|83189462|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
46950685|NCT02344576|83189463|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
46950686|NCT02344576|83189464|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
46950687|NCT02344576|83189465|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
46950688|NCT02344576|83189462|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
46950689|NCT02344576|83189463|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
46950690|NCT02344576|83189464|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
46950691|NCT02344576|83189465|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
46950692|NCT02344342|83189481|FG000|Overall Study|Industry partner dropped out|11|||
46950693|NCT02344342|83189482|FG001|Overall Study|Industry partner dropped out|9|||
46950694|NCT02344342|83189483|FG002|Overall Study|Industry partner dropped out|14|||
47066540|NCT01542632|83349205|FG003|Overall Study|Sponsor/Investigator Decision|0|||
47066541|NCT01542632|83349206|FG004|Overall Study|Sponsor/Investigator Decision|1|||
47066542|NCT01542632|83349207|FG005|Overall Study|Sponsor/Investigator Decision|0|||
47066543|NCT01557842|83349228|FG000|Overall Study|Lost to Follow-up|0|||
46842201|NCT00003298|83059170|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
46842202|NCT00003298|83059170|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
46842203|NCT00003298|83059170|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
46842204|NCT00003298|83059170|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
46842205|NCT00003298|83059170|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
47066544|NCT01557842|83349229|FG001|Overall Study|Lost to Follow-up|1|||
47066545|NCT01557842|83349228|FG000|Overall Study|Death|1|||
47066546|NCT01557842|83349229|FG001|Overall Study|Death|0|||
47066547|NCT01557842|83349228|FG000|Overall Study|Lack of Efficacy|0|||
46771873|NCT00767000|82990159|FG001|54-week Study|Physician Decision|0|||
46771874|NCT00767000|82990160|FG002|54-week Study|Physician Decision|1|||
46771875|NCT00767000|82990161|FG003|54-week Study|Physician Decision|1|||
46771876|NCT00767000|82990162|FG004|54-week Study|Physician Decision|1|||
46771877|NCT00767000|82990158|FG000|54-week Study|Progressive disease|0|||
46771878|NCT00767000|82990159|FG001|54-week Study|Progressive disease|0|||
46771879|NCT00767000|82990160|FG002|54-week Study|Progressive disease|1|||
46771880|NCT00767000|82990161|FG003|54-week Study|Progressive disease|0|||
46771881|NCT00767000|82990162|FG004|54-week Study|Progressive disease|0|||
46771882|NCT00767000|82990158|FG000|54-week Study|Protocol Violation|0|||
46771883|NCT00767000|82990159|FG001|54-week Study|Protocol Violation|0|||
46771884|NCT00767000|82990160|FG002|54-week Study|Protocol Violation|1|||
46771885|NCT00767000|82990161|FG003|54-week Study|Protocol Violation|2|||
46771886|NCT00767000|82990162|FG004|54-week Study|Protocol Violation|0|||
46771887|NCT00767000|82990158|FG000|54-week Study|Withdrawal by Subject|2|||
46771888|NCT00767000|82990159|FG001|54-week Study|Withdrawal by Subject|3|||
46771889|NCT00767000|82990160|FG002|54-week Study|Withdrawal by Subject|5|||
46771890|NCT00767000|82990161|FG003|54-week Study|Withdrawal by Subject|11|||
46771891|NCT00767000|82990162|FG004|54-week Study|Withdrawal by Subject|13|||
46771892|NCT00767000|82990158|FG000|54-week Study|Study terminated by sponsor|90|||
46771893|NCT00767000|82990159|FG001|54-week Study|Study terminated by sponsor|102|||
46771894|NCT00767000|82990160|FG002|54-week Study|Study terminated by sponsor|89|||
46771895|NCT00767000|82990161|FG003|54-week Study|Study terminated by sponsor|196|||
46771896|NCT00767000|82990162|FG004|54-week Study|Study terminated by sponsor|194|||
46771897|NCT00767000|82990158|FG000|54-week Study|Reason not reported|0|||
46771898|NCT00767000|82990159|FG001|54-week Study|Reason not reported|0|||
46771899|NCT00767000|82990160|FG002|54-week Study|Reason not reported|0|||
46771900|NCT00767000|82990161|FG003|54-week Study|Reason not reported|1|||
46771901|NCT00767000|82990162|FG004|54-week Study|Reason not reported|0|||
46842206|NCT00003298|83059170|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
46842207|NCT00003298|83059170|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
46842208|NCT00003298|83059170|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
46950695|NCT02344342|83189484|FG003|Overall Study|Industry partner dropped out|10|||
46950696|NCT02310568|83189503|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
47066548|NCT01557842|83349229|FG001|Overall Study|Lack of Efficacy|1|||
46842209|NCT00003298|83059170|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
46950697|NCT02310568|83189504|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
46950698|NCT02310568|83189505|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
47066549|NCT01557842|83349228|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
46771902|NCT00767000|82990158|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
46771903|NCT00767000|82990159|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
46771904|NCT00767000|82990160|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
46950699|NCT02310568|83189506|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
46950700|NCT02310568|83189507|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
46950701|NCT02310568|83189503|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
46950702|NCT02310568|83189504|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
46950703|NCT02310568|83189505|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
46950704|NCT02310568|83189506|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
46950705|NCT02310568|83189507|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
46950706|NCT02310568|83189503|FG000|Stage 1 ( 4 Weeks)|Other|1|||
46950707|NCT02310568|83189504|FG001|Stage 1 ( 4 Weeks)|Other|1|||
46950708|NCT02310568|83189505|FG002|Stage 1 ( 4 Weeks)|Other|0|||
46639085|NCT01402986|82812647|FG002|Overall Study|Lost to Follow-up|0|||
46639086|NCT01402986|82812648|FG003|Overall Study|Lost to Follow-up|1|||
46639087|NCT01402986|82812645|FG000|Overall Study|Other|2|||
46639088|NCT01402986|82812646|FG001|Overall Study|Other|5|||
46639089|NCT01402986|82812647|FG002|Overall Study|Other|1|||
46639090|NCT01402986|82812648|FG003|Overall Study|Other|6|||
46639091|NCT01402908|82812660|FG000|Overall Study|Withdrawal by Subject|30|||
46639092|NCT01402908|82812661|FG001|Overall Study|Withdrawal by Subject|17|||
46639093|NCT01402908|82812660|FG000|Overall Study|Lost to Follow-up|3|||
46639094|NCT01402908|82812661|FG001|Overall Study|Lost to Follow-up|1|||
46639095|NCT01402908|82812660|FG000|Overall Study|Physician Decision|1|||
46639096|NCT01402908|82812661|FG001|Overall Study|Physician Decision|0|||
46639097|NCT01389258|82812667|FG000|Overall Study|Lost to Follow-up|5|||
46639098|NCT01389102|82812677|FG000|Overall Study|Adverse Event|1|||
46771905|NCT00767000|82990161|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
46771906|NCT00767000|82990162|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
46771907|NCT00724932|82990176|FG000|Overall Study|Lost to Follow-up|1|||
46771908|NCT00724932|82990177|FG001|Overall Study|Lost to Follow-up|0|||
46950709|NCT02310568|83189506|FG003|Stage 1 ( 4 Weeks)|Other|0|||
46950710|NCT02310568|83189507|FG004|Stage 1 ( 4 Weeks)|Other|0|||
46950711|NCT02310568|83189503|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
46950712|NCT02310568|83189504|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
46950713|NCT02310568|83189505|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
46950714|NCT02310568|83189506|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
46950715|NCT02310568|83189507|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
46950716|NCT02310568|83189503|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
46950717|NCT02310568|83189504|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
46950718|NCT02310568|83189505|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
46950719|NCT02310568|83189506|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
46950720|NCT02310568|83189507|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
46950721|NCT02310568|83189503|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
46950722|NCT02310568|83189504|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
46950723|NCT02310568|83189505|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
46950724|NCT02310568|83189506|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
46950725|NCT02310568|83189507|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
46950726|NCT02310568|83189503|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
46950727|NCT02310568|83189504|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
46950728|NCT02310568|83189505|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
46950729|NCT02310568|83189506|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
46950730|NCT02310568|83189507|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
46950731|NCT02310568|83189503|FG000|Stage 2 (4 Weeks)|Other|0|||
46950732|NCT02310568|83189504|FG001|Stage 2 (4 Weeks)|Other|1|||
46950733|NCT02310568|83189505|FG002|Stage 2 (4 Weeks)|Other|1|||
46950734|NCT02310568|83189506|FG003|Stage 2 (4 Weeks)|Other|0|||
46950735|NCT02310568|83189507|FG004|Stage 2 (4 Weeks)|Other|0|||
47066550|NCT01557842|83349229|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
46771909|NCT00724932|82990176|FG000|Overall Study|Not treated|4|||
46771910|NCT00724932|82990177|FG001|Overall Study|Not treated|3|||
46771911|NCT00766532|82990185|FG000|Overall Study|Protocol Violation|2|||
46771912|NCT00774566|82990191|FG000|Overall Study|Protocol Violation|18|||
46771913|NCT00774566|82990192|FG001|Overall Study|Protocol Violation|15|||
46771914|NCT00766376|82990198|FG000|Overall Study|Withdrawal by Subject|27|||
46950736|NCT02310568|83189503|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
47066551|NCT01557842|83349228|FG000|Overall Study|Study Terminated by Sponsor|3|||
46639099|NCT01389102|82812678|FG001|Overall Study|Adverse Event|3|||
46771915|NCT00587054|82990202|FG000|Overall Study|Patient not treated|9|||
46950737|NCT02310568|83189504|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
46950738|NCT02310568|83189505|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
46950739|NCT02310568|83189506|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
46950740|NCT02310568|83189507|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
46950741|NCT02310568|83189503|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
46950742|NCT02310568|83189504|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
46950743|NCT02310568|83189505|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
47066552|NCT01557842|83349229|FG001|Overall Study|Study Terminated by Sponsor|4|||
46639100|NCT01389102|82812679|FG002|Overall Study|Adverse Event|2|||
46771916|NCT00766142|82990206|FG000|Overall Study|Protocol Violation|4|||
46639101|NCT01389102|82812680|FG003|Overall Study|Adverse Event|2|||
46639102|NCT01389102|82812681|FG004|Overall Study|Adverse Event|2|||
46639103|NCT01389102|82812682|FG005|Overall Study|Adverse Event|2|||
46950744|NCT02310568|83189506|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
46950745|NCT02310568|83189507|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
46950746|NCT02310568|83189503|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
46950747|NCT02310568|83189504|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
46950748|NCT02310568|83189505|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
46950749|NCT02310568|83189506|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
46950750|NCT02310568|83189507|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
46950751|NCT02310100|83189525|FG000|Overall Study|Physician Decision|3|||
46950752|NCT02310100|83189525|FG000|Overall Study|Withdrawal by Subject|10|||
46950753|NCT02310100|83189525|FG000|Overall Study|Enrollment closure|1|||
46950754|NCT02310100|83189525|FG000|Overall Study|Unapproved ablation operator|1|||
46950755|NCT02310100|83189525|FG000|Overall Study|Visit compliance|1|||
46950756|NCT02310100|83189525|FG000|Overall Study|Lost to Follow-up|2|||
46950757|NCT02780167|83189535|FG000|Overall Study|Adverse Event|9|||
46950758|NCT02780167|83189536|FG001|Overall Study|Adverse Event|8|||
46950759|NCT02780167|83189537|FG002|Overall Study|Adverse Event|8|||
46950760|NCT02780167|83189538|FG003|Overall Study|Adverse Event|12|||
46950761|NCT02780167|83189539|FG004|Overall Study|Adverse Event|8|||
46950762|NCT02780167|83189535|FG000|Overall Study|Lack of Efficacy|6|||
46950763|NCT02780167|83189536|FG001|Overall Study|Lack of Efficacy|5|||
46950764|NCT02780167|83189537|FG002|Overall Study|Lack of Efficacy|6|||
46950765|NCT02780167|83189538|FG003|Overall Study|Lack of Efficacy|1|||
46950766|NCT02780167|83189539|FG004|Overall Study|Lack of Efficacy|0|||
46950767|NCT02780167|83189535|FG000|Overall Study|Lost to Follow-up|2|||
46950768|NCT02780167|83189536|FG001|Overall Study|Lost to Follow-up|0|||
46950769|NCT02780167|83189537|FG002|Overall Study|Lost to Follow-up|1|||
46950770|NCT02780167|83189538|FG003|Overall Study|Lost to Follow-up|0|||
46950771|NCT02780167|83189539|FG004|Overall Study|Lost to Follow-up|0|||
46950772|NCT02780167|83189535|FG000|Overall Study|Does not meet entrance criteria|0|||
46950773|NCT02780167|83189536|FG001|Overall Study|Does not meet entrance criteria|0|||
46950774|NCT02780167|83189537|FG002|Overall Study|Does not meet entrance criteria|1|||
46950775|NCT02780167|83189538|FG003|Overall Study|Does not meet entrance criteria|0|||
46950776|NCT02780167|83189539|FG004|Overall Study|Does not meet entrance criteria|0|||
46771917|NCT00724854|82990212|FG000|Overall Study|Lack of Efficacy|187|||
46771918|NCT00724854|82990213|FG001|Overall Study|Lack of Efficacy|13|||
46771919|NCT00724854|82990212|FG000|Overall Study|Lost to Follow-up|87|||
46771920|NCT00724854|82990213|FG001|Overall Study|Lost to Follow-up|10|||
46771921|NCT00724854|82990212|FG000|Overall Study|Adverse Event|62|||
46771922|NCT00724854|82990213|FG001|Overall Study|Adverse Event|4|||
46842210|NCT00003298|83059170|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
46842211|NCT00002842|83059175|FG000|Overall Study|ineligible for surgical resection|27|||
46842212|NCT00143247|83059179|FG000|Overall Study|Death|8|||
46842213|NCT00143247|83059179|FG000|Overall Study|Adverse Event|19|||
46842214|NCT00143247|83059179|FG000|Overall Study|Lack of Efficacy|3|||
46842215|NCT00143247|83059179|FG000|Overall Study|Withdrawal by Subject|55|||
46842216|NCT00143247|83059179|FG000|Overall Study|Study terminated by sponsor|31|||
46842217|NCT00143247|83059179|FG000|Overall Study|Protocol Violation|15|||
46842218|NCT00143247|83059179|FG000|Overall Study|Lost to Follow-up|12|||
46842219|NCT00143247|83059179|FG000|Overall Study|following inaccurate lab adverse event|1|||
46842220|NCT00143247|83059179|FG000|Overall Study|Other|12|||
46842221|NCT00125853|83059183|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
46950777|NCT02780167|83189535|FG000|Overall Study|No longer meets eligibility criteria|0|||
46771923|NCT00724854|82990212|FG000|Overall Study|Other|42|||
46771924|NCT00724854|82990213|FG001|Overall Study|Other|3|||
46771925|NCT00724854|82990212|FG000|Overall Study|Death|11|||
46771926|NCT00724854|82990213|FG001|Overall Study|Death|0|||
46771927|NCT00724854|82990212|FG000|Overall Study|Change of treatment|7|||
46771928|NCT00724854|82990213|FG001|Overall Study|Change of treatment|0|||
46771929|NCT00724854|82990212|FG000|Overall Study|Withdrawal by Subject|5|||
46771930|NCT00724854|82990213|FG001|Overall Study|Withdrawal by Subject|0|||
46771931|NCT00724854|82990212|FG000|Overall Study|Adverse event + lack of efficacy|2|||
46771932|NCT00724854|82990213|FG001|Overall Study|Adverse event + lack of efficacy|1|||
46771933|NCT00728988|82990222|FG000|Overall Study|Not Treated|2|||
46771934|NCT00728988|82990223|FG001|Overall Study|Not Treated|2|||
46842222|NCT00125853|83059184|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
46842223|NCT00219141|83059193|FG000|Overall Study|Adverse Event|4|||
46842224|NCT00219141|83059194|FG001|Overall Study|Adverse Event|10|||
46950778|NCT02780167|83189536|FG001|Overall Study|No longer meets eligibility criteria|0|||
46950779|NCT02780167|83189537|FG002|Overall Study|No longer meets eligibility criteria|0|||
46950780|NCT02780167|83189538|FG003|Overall Study|No longer meets eligibility criteria|1|||
46771935|NCT00728988|82990222|FG000|Overall Study|Death|1|||
46771936|NCT00728988|82990223|FG001|Overall Study|Death|1|||
46771937|NCT00728988|82990222|FG000|Overall Study|Adverse Event|3|||
46771938|NCT00728988|82990223|FG001|Overall Study|Adverse Event|2|||
46771939|NCT00728988|82990222|FG000|Overall Study|Other|85|||
46950781|NCT02780167|83189539|FG004|Overall Study|No longer meets eligibility criteria|1|||
46950782|NCT02780167|83189535|FG000|Overall Study|Protocol Violation|5|||
46950783|NCT02780167|83189536|FG001|Overall Study|Protocol Violation|5|||
46950784|NCT02780167|83189537|FG002|Overall Study|Protocol Violation|1|||
46950785|NCT02780167|83189538|FG003|Overall Study|Protocol Violation|1|||
46950786|NCT02780167|83189539|FG004|Overall Study|Protocol Violation|2|||
46950787|NCT02780167|83189535|FG000|Overall Study|Withdrawal by Subject|6|||
46950788|NCT02780167|83189536|FG001|Overall Study|Withdrawal by Subject|4|||
46950789|NCT02780167|83189537|FG002|Overall Study|Withdrawal by Subject|4|||
46950790|NCT02780167|83189538|FG003|Overall Study|Withdrawal by Subject|3|||
46950791|NCT02780167|83189539|FG004|Overall Study|Withdrawal by Subject|4|||
46950792|NCT02780167|83189535|FG000|Overall Study|Other|0|||
46950793|NCT02780167|83189536|FG001|Overall Study|Other|0|||
46950794|NCT02780167|83189537|FG002|Overall Study|Other|3|||
46950795|NCT02780167|83189538|FG003|Overall Study|Other|1|||
46842225|NCT00219141|83059195|FG002|Overall Study|Adverse Event|5|||
46950796|NCT02780167|83189539|FG004|Overall Study|Other|2|||
46950797|NCT02779075|83189551|FG000|Overall Study|Withdrawal by Subject|1|||
46950798|NCT02779075|83189552|FG001|Overall Study|Withdrawal by Subject|3|||
46950799|NCT02779075|83189551|FG000|Overall Study|IV lost during 2nd study|1|||
46950800|NCT02779075|83189552|FG001|Overall Study|IV lost during 2nd study|0|||
46950801|NCT00105079|83189564|FG000|Overall Study|Adverse Event|5|||
46842226|NCT00219141|83059193|FG000|Overall Study|Lack of Efficacy|3|||
46842227|NCT00219141|83059194|FG001|Overall Study|Lack of Efficacy|2|||
46842228|NCT00219141|83059195|FG002|Overall Study|Lack of Efficacy|0|||
46842229|NCT00219141|83059193|FG000|Overall Study|Administrative problems|0|||
46842230|NCT00219141|83059194|FG001|Overall Study|Administrative problems|1|||
46842231|NCT00219141|83059195|FG002|Overall Study|Administrative problems|0|||
46842232|NCT00219141|83059193|FG000|Overall Study|Lost to Follow-up|2|||
46842233|NCT00219141|83059194|FG001|Overall Study|Lost to Follow-up|4|||
46950802|NCT00105079|83189565|FG001|Overall Study|Adverse Event|12|||
46842234|NCT00219141|83059195|FG002|Overall Study|Lost to Follow-up|1|||
46842235|NCT00219141|83059193|FG000|Overall Study|Protocol Violation|3|||
46842236|NCT00219141|83059194|FG001|Overall Study|Protocol Violation|1|||
46842237|NCT00219141|83059195|FG002|Overall Study|Protocol Violation|1|||
46842238|NCT00219141|83059193|FG000|Overall Study|Withdrawal by Subject|1|||
46842239|NCT00219141|83059194|FG001|Overall Study|Withdrawal by Subject|3|||
46842240|NCT00219141|83059195|FG002|Overall Study|Withdrawal by Subject|5|||
46842241|NCT00219141|83059193|FG000|Overall Study|Condition no longer requires study drug|1|||
46842242|NCT00219141|83059194|FG001|Overall Study|Condition no longer requires study drug|0|||
46842243|NCT00219141|83059195|FG002|Overall Study|Condition no longer requires study drug|0|||
46842244|NCT00142935|83059206|FG000|Overall Study|Other reason|1|||
46842245|NCT00142935|83059207|FG001|Overall Study|Other reason|1|||
46842246|NCT00142935|83059208|FG002|Overall Study|Other reason|1|||
46842247|NCT00142935|83059206|FG000|Overall Study|Lost to Follow-up|2|||
46842248|NCT00142935|83059207|FG001|Overall Study|Lost to Follow-up|5|||
46842249|NCT00142935|83059208|FG002|Overall Study|Lost to Follow-up|5|||
46842250|NCT00142935|83059206|FG000|Overall Study|Death|0|||
46842251|NCT00142935|83059207|FG001|Overall Study|Death|2|||
46842252|NCT00142935|83059208|FG002|Overall Study|Death|1|||
46842253|NCT00233948|83059222|FG000|Overall Study|Adverse Event|1|||
46842254|NCT00233948|83059223|FG001|Overall Study|Adverse Event|0|||
46842255|NCT00233948|83059224|FG002|Overall Study|Adverse Event|0|||
46842256|NCT00233948|83059225|FG003|Overall Study|Adverse Event|0|||
46842257|NCT00233948|83059226|FG004|Overall Study|Adverse Event|0|||
46842258|NCT00233948|83059227|FG005|Overall Study|Adverse Event|0|||
46842259|NCT00233480|83059244|FG000|Overall Study|Underwent status II heart transplant|0|||
46842260|NCT00233480|83059245|FG001|Overall Study|Underwent status II heart transplant|1|||
46842261|NCT03801928|83059259|FG000|Overall Study|Adverse Event|1|||
46842262|NCT03801928|83059260|FG001|Overall Study|Adverse Event|0|||
46842263|NCT03801928|83059261|FG002|Overall Study|Adverse Event|1|||
46842264|NCT03801928|83059262|FG003|Overall Study|Adverse Event|2|||
46950803|NCT00105079|83189564|FG000|Overall Study|Death|3|||
47066553|NCT01557842|83349228|FG000|Overall Study|Not Ablated|2|||
47066554|NCT01557842|83349229|FG001|Overall Study|Not Ablated|0|||
47066555|NCT01541930|83349235|FG000|Overall Study|Withdrawal by Subject|1|||
47066556|NCT01576016|83349252|FG000|Lead Safety|Death|132|||
46639104|NCT01389102|82812677|FG000|Overall Study|Hurricane Katrina|4|||
46842265|NCT03801928|83059263|FG004|Overall Study|Adverse Event|0|||
46842266|NCT03801928|83059264|FG005|Overall Study|Adverse Event|2|||
46842267|NCT03801928|83059259|FG000|Overall Study|Lack of Efficacy|0|||
46950804|NCT00105079|83189565|FG001|Overall Study|Death|1|||
46950805|NCT00105079|83189564|FG000|Overall Study|Lost to Follow-up|12|||
46950806|NCT00105079|83189565|FG001|Overall Study|Lost to Follow-up|12|||
46950807|NCT00105079|83189564|FG000|Overall Study|Lack of Efficacy|9|||
46842268|NCT03801928|83059260|FG001|Overall Study|Lack of Efficacy|0|||
46842269|NCT03801928|83059261|FG002|Overall Study|Lack of Efficacy|1|||
46950808|NCT00105079|83189565|FG001|Overall Study|Lack of Efficacy|3|||
46950809|NCT00105079|83189564|FG000|Overall Study|Refused treatment|6|||
46950810|NCT00105079|83189565|FG001|Overall Study|Refused treatment|4|||
47066557|NCT01576016|83349253|FG001|Lead Safety|Death|0|||
47066558|NCT01576016|83349252|FG000|Lead Safety|Withdrawal by Subject|81|||
47066559|NCT01576016|83349253|FG001|Lead Safety|Withdrawal by Subject|0|||
46950811|NCT00105079|83189564|FG000|Overall Study|Violation of selection criteria at entry|0|||
46950812|NCT00105079|83189565|FG001|Overall Study|Violation of selection criteria at entry|2|||
46950813|NCT00105079|83189564|FG000|Overall Study|Protocol Violation|1|||
46950814|NCT00105079|83189565|FG001|Overall Study|Protocol Violation|0|||
46950815|NCT00105079|83189564|FG000|Overall Study|Other|3|||
46950816|NCT00105079|83189565|FG001|Overall Study|Other|1|||
46950817|NCT02777827|83189571|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
46950818|NCT02777827|83189572|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
46950819|NCT02777827|83189573|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
46950820|NCT02777827|83189574|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
46950821|NCT02777827|83189575|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
46950822|NCT02777827|83189576|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
46950823|NCT02712333|83189592|FG000|First Period|Withdrawal by Subject|3|||
46950824|NCT02712333|83189593|FG001|First Period|Withdrawal by Subject|2|||
46950825|NCT02343406|83189609|FG000|Overall Study|Progressive disease|72|||
46950826|NCT02343406|83189610|FG001|Overall Study|Progressive disease|70|||
46950827|NCT02343406|83189611|FG002|Overall Study|Progressive disease|43|||
46950828|NCT02343406|83189612|FG003|Overall Study|Progressive disease|15|||
46950829|NCT02343406|83189613|FG004|Overall Study|Progressive disease|5|||
46950830|NCT02343406|83189609|FG000|Overall Study|Adverse Event|6|||
46950831|NCT02343406|83189610|FG001|Overall Study|Adverse Event|8|||
46950832|NCT02343406|83189611|FG002|Overall Study|Adverse Event|6|||
46950833|NCT02343406|83189612|FG003|Overall Study|Adverse Event|3|||
46950834|NCT02343406|83189613|FG004|Overall Study|Adverse Event|0|||
46950835|NCT02343406|83189609|FG000|Overall Study|Withdrawal by Subject|6|||
46950836|NCT02343406|83189610|FG001|Overall Study|Withdrawal by Subject|4|||
46950837|NCT02343406|83189611|FG002|Overall Study|Withdrawal by Subject|8|||
46842270|NCT03801928|83059262|FG003|Overall Study|Lack of Efficacy|0|||
46842271|NCT03801928|83059263|FG004|Overall Study|Lack of Efficacy|0|||
46842272|NCT03801928|83059264|FG005|Overall Study|Lack of Efficacy|0|||
46842273|NCT03801928|83059259|FG000|Overall Study|Lost to Follow-up|5|||
46842274|NCT03801928|83059260|FG001|Overall Study|Lost to Follow-up|1|||
46842275|NCT03801928|83059261|FG002|Overall Study|Lost to Follow-up|1|||
46842276|NCT03801928|83059262|FG003|Overall Study|Lost to Follow-up|4|||
46842277|NCT03801928|83059263|FG004|Overall Study|Lost to Follow-up|4|||
46842278|NCT03801928|83059264|FG005|Overall Study|Lost to Follow-up|2|||
46842279|NCT03801928|83059259|FG000|Overall Study|Withdrawal by Subject|0|||
46842280|NCT03801928|83059260|FG001|Overall Study|Withdrawal by Subject|0|||
46842281|NCT03801928|83059261|FG002|Overall Study|Withdrawal by Subject|2|||
46842282|NCT03801928|83059262|FG003|Overall Study|Withdrawal by Subject|1|||
46842283|NCT03801928|83059263|FG004|Overall Study|Withdrawal by Subject|0|||
46842284|NCT03801928|83059264|FG005|Overall Study|Withdrawal by Subject|0|||
46842285|NCT03801928|83059259|FG000|Overall Study|Other|0|||
46842286|NCT03801928|83059260|FG001|Overall Study|Other|2|||
46842287|NCT03801928|83059261|FG002|Overall Study|Other|0|||
46842288|NCT03801928|83059262|FG003|Overall Study|Other|1|||
46842289|NCT03801928|83059263|FG004|Overall Study|Other|0|||
46842290|NCT03801928|83059264|FG005|Overall Study|Other|1|||
46842291|NCT00263588|83059283|FG000|Overall Study|Death|54|||
46842292|NCT00263588|83059284|FG001|Overall Study|Death|90|||
46842293|NCT00263588|83059283|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
46842294|NCT00263588|83059284|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
46842295|NCT00263588|83059283|FG000|Overall Study|Lost to Follow-up|7|||
46842296|NCT00263588|83059284|FG001|Overall Study|Lost to Follow-up|10|||
46842297|NCT00263588|83059283|FG000|Overall Study|Withdrawal by Subject|3|||
46842298|NCT00263588|83059284|FG001|Overall Study|Withdrawal by Subject|4|||
46842299|NCT00263588|83059283|FG000|Overall Study|Protocol Violation|0|||
46842300|NCT00263588|83059284|FG001|Overall Study|Protocol Violation|1|||
46842301|NCT00263588|83059283|FG000|Overall Study|Investigator decision|7|||
46950838|NCT02343406|83189612|FG003|Overall Study|Withdrawal by Subject|3|||
46950839|NCT02343406|83189613|FG004|Overall Study|Withdrawal by Subject|0|||
46950840|NCT02343406|83189609|FG000|Overall Study|Death|2|||
46950841|NCT02343406|83189610|FG001|Overall Study|Death|1|||
46950842|NCT02343406|83189611|FG002|Overall Study|Death|0|||
46950843|NCT02343406|83189612|FG003|Overall Study|Death|0|||
46842302|NCT00263588|83059284|FG001|Overall Study|Investigator decision|15|||
46842303|NCT00263588|83059283|FG000|Overall Study|Sponsor terminated study|0|||
46842304|NCT00263588|83059284|FG001|Overall Study|Sponsor terminated study|1|||
46842305|NCT00213135|83059294|FG000|Overall Study|Adverse Event|9|||
46842306|NCT00213135|83059295|FG001|Overall Study|Adverse Event|5|||
46842307|NCT00213135|83059296|FG002|Overall Study|Adverse Event|5|||
46842308|NCT00213135|83059294|FG000|Overall Study|Lost to Follow-up|11|||
46842309|NCT00213135|83059295|FG001|Overall Study|Lost to Follow-up|8|||
46842310|NCT00213135|83059296|FG002|Overall Study|Lost to Follow-up|4|||
46842311|NCT00213135|83059294|FG000|Overall Study|Protocol Violation|4|||
46842312|NCT00213135|83059295|FG001|Overall Study|Protocol Violation|4|||
46950844|NCT02343406|83189613|FG004|Overall Study|Death|0|||
46950845|NCT02343406|83189609|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
46950846|NCT02343406|83189610|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
46950847|NCT02343406|83189611|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
46950848|NCT02343406|83189612|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
46950849|NCT02343406|83189613|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
46950850|NCT02343406|83189609|FG000|Overall Study|Other primary malignancy|0|||
46950851|NCT02343406|83189610|FG001|Overall Study|Other primary malignancy|1|||
46950852|NCT02343406|83189611|FG002|Overall Study|Other primary malignancy|0|||
46950853|NCT02343406|83189612|FG003|Overall Study|Other primary malignancy|0|||
46950854|NCT02343406|83189613|FG004|Overall Study|Other primary malignancy|0|||
46950855|NCT02343406|83189609|FG000|Overall Study|Other, not specified|2|||
46950856|NCT02343406|83189610|FG001|Overall Study|Other, not specified|1|||
46950857|NCT02343406|83189611|FG002|Overall Study|Other, not specified|1|||
46950858|NCT02343406|83189612|FG003|Overall Study|Other, not specified|4|||
46950859|NCT02343406|83189613|FG004|Overall Study|Other, not specified|0|||
46950860|NCT02710071|83189626|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
46950861|NCT02710071|83189627|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
46950862|NCT02710071|83189626|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
46950863|NCT02710071|83189627|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
46950864|NCT02373202|83189638|FG000|Overall Study|Adverse Event|2|||
46950865|NCT02373202|83189639|FG001|Overall Study|Adverse Event|5|||
46950866|NCT02373202|83189640|FG002|Overall Study|Adverse Event|2|||
46950867|NCT02373202|83189641|FG003|Overall Study|Adverse Event|1|||
46950868|NCT02373202|83189638|FG000|Overall Study|Lack of Efficacy|0|||
46950869|NCT02373202|83189639|FG001|Overall Study|Lack of Efficacy|0|||
46950870|NCT02373202|83189640|FG002|Overall Study|Lack of Efficacy|1|||
46950871|NCT02373202|83189641|FG003|Overall Study|Lack of Efficacy|0|||
46950872|NCT02373202|83189638|FG000|Overall Study|Other|0|||
46950873|NCT02373202|83189639|FG001|Overall Study|Other|1|||
46950874|NCT02373202|83189640|FG002|Overall Study|Other|0|||
46950875|NCT02373202|83189641|FG003|Overall Study|Other|0|||
46950876|NCT02622074|83189657|FG000|Overall Study|Death|4|||
46950877|NCT02622074|83189658|FG001|Overall Study|Death|0|||
46950878|NCT02622074|83189659|FG002|Overall Study|Death|0|||
46950879|NCT02622074|83189660|FG003|Overall Study|Death|1|||
46950880|NCT02622074|83189661|FG004|Overall Study|Death|1|||
46950881|NCT02622074|83189662|FG005|Overall Study|Death|0|||
46950882|NCT02622074|83189657|FG000|Overall Study|Withdrawal by Subject|0|||
46950883|NCT02622074|83189658|FG001|Overall Study|Withdrawal by Subject|1|||
46950884|NCT02622074|83189659|FG002|Overall Study|Withdrawal by Subject|0|||
46950885|NCT02622074|83189660|FG003|Overall Study|Withdrawal by Subject|0|||
46950886|NCT02622074|83189661|FG004|Overall Study|Withdrawal by Subject|0|||
46950887|NCT02622074|83189662|FG005|Overall Study|Withdrawal by Subject|0|||
46950888|NCT02308696|83189678|FG000|Overall Study|Lost to Follow-up|28|||
46950889|NCT02308696|83189679|FG001|Overall Study|Lost to Follow-up|21|||
46950890|NCT02308696|83189678|FG000|Overall Study|Death|8|||
46950891|NCT02308696|83189679|FG001|Overall Study|Death|4|||
46950892|NCT02308696|83189678|FG000|Overall Study|Moved to a Higher Level of Care|17|||
46950893|NCT02308696|83189679|FG001|Overall Study|Moved to a Higher Level of Care|6|||
46950894|NCT02342704|83189687|FG000|Overall Study|Physician Decision|0|||
46950895|NCT02342704|83189688|FG001|Overall Study|Physician Decision|3|||
46950896|NCT02342704|83189687|FG000|Overall Study|Sponsor Termination|49|||
46950897|NCT02342704|83189688|FG001|Overall Study|Sponsor Termination|43|||
46950898|NCT02342704|83189687|FG000|Overall Study|Other|0|||
46950899|NCT02342704|83189688|FG001|Overall Study|Other|1|||
47066560|NCT01576016|83349252|FG000|Lead Safety|System Explanted without Replacement|24|||
47066561|NCT01576016|83349253|FG001|Lead Safety|System Explanted without Replacement|0|||
46771940|NCT00728988|82990223|FG001|Overall Study|Other|77|||
46771941|NCT00728988|82990222|FG000|Overall Study|Withdrawal by Subject|2|||
46950900|NCT02342704|83189687|FG000|Overall Study|Withdrawal by Subject|1|||
46950901|NCT02342704|83189688|FG001|Overall Study|Withdrawal by Subject|0|||
46950902|NCT02342704|83189687|FG000|Overall Study|Lost to Follow-up|2|||
46771942|NCT00728988|82990223|FG001|Overall Study|Withdrawal by Subject|6|||
46950903|NCT02342704|83189688|FG001|Overall Study|Lost to Follow-up|1|||
46950904|NCT02342704|83189687|FG000|Overall Study|Adverse Event|1|||
46950905|NCT02342704|83189688|FG001|Overall Study|Adverse Event|3|||
46950906|NCT02342548|83189697|FG000|Overall Study|Adverse Event|12|||
46950907|NCT02342548|83189698|FG001|Overall Study|Adverse Event|17|||
46950908|NCT02342548|83189699|FG002|Overall Study|Adverse Event|13|||
46950909|NCT02342548|83189697|FG000|Overall Study|Lost to Follow-up|0|||
46950910|NCT02342548|83189698|FG001|Overall Study|Lost to Follow-up|1|||
46950911|NCT02342548|83189699|FG002|Overall Study|Lost to Follow-up|0|||
46950912|NCT02342548|83189697|FG000|Overall Study|Study terminated by sponsor|20|||
46950913|NCT02342548|83189698|FG001|Overall Study|Study terminated by sponsor|39|||
46950914|NCT02342548|83189699|FG002|Overall Study|Study terminated by sponsor|25|||
47066562|NCT01576016|83349252|FG000|Lead Safety|Physician Decision|14|||
46771943|NCT00728754|82990232|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
46950915|NCT02342548|83189697|FG000|Overall Study|Protocol Violation|0|||
46950916|NCT02342548|83189698|FG001|Overall Study|Protocol Violation|1|||
46950917|NCT02342548|83189699|FG002|Overall Study|Protocol Violation|0|||
46950918|NCT02342548|83189697|FG000|Overall Study|Withdrawal by Subject|1|||
46950919|NCT02342548|83189698|FG001|Overall Study|Withdrawal by Subject|3|||
46950920|NCT02342548|83189699|FG002|Overall Study|Withdrawal by Subject|4|||
46950921|NCT02342548|83189697|FG000|Overall Study|Other|1|||
46950922|NCT02342548|83189698|FG001|Overall Study|Other|1|||
46950923|NCT02342548|83189699|FG002|Overall Study|Other|1|||
46950924|NCT03142191|83189712|FG000|Placebo Controlled Period|Death|0|||
46950925|NCT03142191|83189713|FG001|Placebo Controlled Period|Death|1|||
46950926|NCT03142191|83189714|FG002|Placebo Controlled Period|Death|1|||
46950927|NCT03142191|83189715|FG003|Placebo Controlled Period|Death|0|||
46950928|NCT03142191|83189716|FG004|Placebo Controlled Period|Death|0|||
46950929|NCT03142191|83189712|FG000|Placebo Controlled Period|Adverse Event|4|||
46950930|NCT03142191|83189713|FG001|Placebo Controlled Period|Adverse Event|5|||
46950931|NCT03142191|83189714|FG002|Placebo Controlled Period|Adverse Event|1|||
46950932|NCT03142191|83189715|FG003|Placebo Controlled Period|Adverse Event|0|||
46950933|NCT03142191|83189716|FG004|Placebo Controlled Period|Adverse Event|0|||
46950934|NCT03142191|83189712|FG000|Placebo Controlled Period|Progressive Disease|1|||
46950935|NCT03142191|83189713|FG001|Placebo Controlled Period|Progressive Disease|0|||
46950936|NCT03142191|83189714|FG002|Placebo Controlled Period|Progressive Disease|1|||
46950937|NCT03142191|83189715|FG003|Placebo Controlled Period|Progressive Disease|0|||
46950938|NCT03142191|83189716|FG004|Placebo Controlled Period|Progressive Disease|0|||
46950939|NCT03142191|83189712|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
46950940|NCT03142191|83189713|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
46950941|NCT03142191|83189714|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
46950942|NCT03142191|83189715|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
46950943|NCT03142191|83189716|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
46950944|NCT03142191|83189712|FG000|Placebo Controlled Period|Other Reasons|1|||
46950945|NCT03142191|83189713|FG001|Placebo Controlled Period|Other Reasons|0|||
46950946|NCT03142191|83189714|FG002|Placebo Controlled Period|Other Reasons|0|||
46950947|NCT03142191|83189715|FG003|Placebo Controlled Period|Other Reasons|0|||
46950948|NCT03142191|83189716|FG004|Placebo Controlled Period|Other Reasons|0|||
46950949|NCT03142191|83189712|FG000|Active Treatment Extension Period|Death|2|||
46950950|NCT03142191|83189713|FG001|Active Treatment Extension Period|Death|1|||
46950951|NCT03142191|83189714|FG002|Active Treatment Extension Period|Death|1|||
46950952|NCT03142191|83189715|FG003|Active Treatment Extension Period|Death|1|||
46950953|NCT03142191|83189716|FG004|Active Treatment Extension Period|Death|0|||
46842313|NCT00213135|83059296|FG002|Overall Study|Protocol Violation|10|||
46842314|NCT00213135|83059294|FG000|Overall Study|Death|1|||
46950954|NCT03142191|83189712|FG000|Active Treatment Extension Period|Adverse Event|6|||
46950955|NCT03142191|83189713|FG001|Active Treatment Extension Period|Adverse Event|5|||
46950956|NCT03142191|83189714|FG002|Active Treatment Extension Period|Adverse Event|4|||
46950957|NCT03142191|83189715|FG003|Active Treatment Extension Period|Adverse Event|1|||
46950958|NCT03142191|83189716|FG004|Active Treatment Extension Period|Adverse Event|0|||
46950959|NCT03142191|83189712|FG000|Active Treatment Extension Period|Progressive Disease|10|||
46950960|NCT03142191|83189713|FG001|Active Treatment Extension Period|Progressive Disease|5|||
46771944|NCT00728754|82990233|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
46771945|NCT00728754|82990232|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
46771946|NCT00728754|82990233|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
46771947|NCT00728754|82990232|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
46771948|NCT00728754|82990233|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
46771949|NCT00728130|82990239|FG000|Overall Study|Withdrawal by Subject|1|||
46771950|NCT00728130|82990239|FG000|Overall Study|Paperwork not completed in time|1|||
46771951|NCT00728130|82990239|FG000|Overall Study|Physician Decision|1|||
46842315|NCT00213135|83059295|FG001|Overall Study|Death|1|||
46842316|NCT00213135|83059296|FG002|Overall Study|Death|2|||
46842317|NCT00213135|83059294|FG000|Overall Study|Disease progression|4|||
46771952|NCT00735696|82990243|FG000|Overall Study|Withdrawal by Subject|1|||
46842318|NCT00213135|83059295|FG001|Overall Study|Disease progression|5|||
46842319|NCT00213135|83059296|FG002|Overall Study|Disease progression|21|||
46950961|NCT03142191|83189714|FG002|Active Treatment Extension Period|Progressive Disease|4|||
46950962|NCT03142191|83189715|FG003|Active Treatment Extension Period|Progressive Disease|1|||
46950963|NCT03142191|83189716|FG004|Active Treatment Extension Period|Progressive Disease|2|||
46950964|NCT03142191|83189712|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
46950965|NCT03142191|83189713|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
46950966|NCT03142191|83189714|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
46950967|NCT03142191|83189715|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
46950968|NCT03142191|83189716|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
46967874|NCT05091307|83210485|FG002|Overall Study|Protocol Violation|0|||
46771953|NCT00735696|82990243|FG000|Overall Study|Enrolled but never Treated|1|||
46771954|NCT00478231|82990252|FG000|Overall Study|Death|7|||
46842320|NCT00213135|83059294|FG000|Overall Study|Other|21|||
46842321|NCT00213135|83059295|FG001|Overall Study|Other|12|||
46842322|NCT00213135|83059296|FG002|Overall Study|Other|15|||
46842323|NCT00077974|83059304|FG000|Overall Study|Adverse Event|22|||
46842324|NCT00077974|83059304|FG000|Overall Study|Protocol Violation|1|||
46950969|NCT03142191|83189712|FG000|Active Treatment Extension Period|Physician Decision|2|||
46950970|NCT03142191|83189713|FG001|Active Treatment Extension Period|Physician Decision|0|||
46950971|NCT03142191|83189714|FG002|Active Treatment Extension Period|Physician Decision|0|||
46950972|NCT03142191|83189715|FG003|Active Treatment Extension Period|Physician Decision|0|||
46950973|NCT03142191|83189716|FG004|Active Treatment Extension Period|Physician Decision|0|||
46950974|NCT03142191|83189712|FG000|Active Treatment Extension Period|Other Reasons|3|||
46950975|NCT03142191|83189713|FG001|Active Treatment Extension Period|Other Reasons|3|||
46950976|NCT03142191|83189714|FG002|Active Treatment Extension Period|Other Reasons|3|||
46950977|NCT03142191|83189715|FG003|Active Treatment Extension Period|Other Reasons|8|||
46950978|NCT03142191|83189716|FG004|Active Treatment Extension Period|Other Reasons|3|||
46950979|NCT03142191|83189712|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
46950980|NCT03142191|83189713|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
46950981|NCT03142191|83189714|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
46950982|NCT03142191|83189715|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
46950983|NCT03142191|83189716|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
46950984|NCT02617628|83189745|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
46950985|NCT02617628|83189746|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
46950986|NCT02308540|83189762|FG000|Overall Study|Lost to Follow-up|0|||
46950987|NCT02308540|83189763|FG001|Overall Study|Lost to Follow-up|0|||
46950988|NCT02308540|83189764|FG002|Overall Study|Lost to Follow-up|0|||
46950989|NCT02308540|83189765|FG003|Overall Study|Lost to Follow-up|0|||
46950990|NCT02308540|83189766|FG004|Overall Study|Lost to Follow-up|0|||
46950991|NCT02308540|83189767|FG005|Overall Study|Lost to Follow-up|1|||
46950992|NCT02308228|83189818|FG000|Overall Study|Adverse Event|3|||
46950993|NCT02308228|83189819|FG001|Overall Study|Adverse Event|4|||
46950994|NCT02308228|83189818|FG000|Overall Study|Withdrawal by Subject|5|||
46950995|NCT02308228|83189819|FG001|Overall Study|Withdrawal by Subject|3|||
46950996|NCT02616614|83189837|FG000|Overall Study|Withdrawal by Subject|10|||
46950997|NCT02616614|83189838|FG001|Overall Study|Withdrawal by Subject|5|||
46950998|NCT02616614|83189839|FG002|Overall Study|Withdrawal by Subject|6|||
46950999|NCT02616614|83189837|FG000|Overall Study|Physician Decision|2|||
46951000|NCT02616614|83189838|FG001|Overall Study|Physician Decision|1|||
46951001|NCT02616614|83189839|FG002|Overall Study|Physician Decision|0|||
46951002|NCT02616614|83189837|FG000|Overall Study|Adverse Event|1|||
46951003|NCT02616614|83189838|FG001|Overall Study|Adverse Event|4|||
46951004|NCT02616614|83189839|FG002|Overall Study|Adverse Event|1|||
46951005|NCT02616614|83189837|FG000|Overall Study|Protocol Violation|0|||
46951006|NCT02616614|83189838|FG001|Overall Study|Protocol Violation|3|||
46951007|NCT02616614|83189839|FG002|Overall Study|Protocol Violation|1|||
46951008|NCT02616614|83189837|FG000|Overall Study|Prohibited Medication|12|||
46951009|NCT02616614|83189838|FG001|Overall Study|Prohibited Medication|9|||
46951010|NCT02616614|83189839|FG002|Overall Study|Prohibited Medication|5|||
46951011|NCT02616614|83189837|FG000|Overall Study|More than 3 applications missed|6|||
46951012|NCT02616614|83189838|FG001|Overall Study|More than 3 applications missed|8|||
46771955|NCT00478231|82990252|FG000|Overall Study|Lack of Efficacy|47|||
46771956|NCT00478231|82990252|FG000|Overall Study|Lost to Follow-up|7|||
46771957|NCT00478231|82990252|FG000|Overall Study|Withdrawal by Subject|6|||
46771958|NCT00478231|82990252|FG000|Overall Study|Other|9|||
46771959|NCT00478231|82990252|FG000|Overall Study|Adverse Event|5|||
46771960|NCT00478231|82990252|FG000|Overall Study|Randomized, not treated|3|||
46771961|NCT00474175|82990259|FG000|Overall Study|Lack of Efficacy|0|||
46771962|NCT00474175|82990260|FG001|Overall Study|Lack of Efficacy|0|||
46771963|NCT00474175|82990261|FG002|Overall Study|Lack of Efficacy|1|||
46771964|NCT00474175|82990259|FG000|Overall Study|Withdrawal by Subject|0|||
46771965|NCT00474175|82990260|FG001|Overall Study|Withdrawal by Subject|1|||
46771966|NCT00474175|82990261|FG002|Overall Study|Withdrawal by Subject|1|||
46771967|NCT00474175|82990259|FG000|Overall Study|Ineligible|1|||
46771968|NCT00474175|82990260|FG001|Overall Study|Ineligible|3|||
46771969|NCT00474175|82990261|FG002|Overall Study|Ineligible|1|||
46771970|NCT00474175|82990259|FG000|Overall Study|Protocol Violation|0|||
46771971|NCT00474175|82990260|FG001|Overall Study|Protocol Violation|2|||
46771972|NCT00474175|82990261|FG002|Overall Study|Protocol Violation|1|||
46951013|NCT02616614|83189839|FG002|Overall Study|More than 3 applications missed|1|||
46951014|NCT02616614|83189837|FG000|Overall Study|Lost to Follow-up|31|||
46951015|NCT02616614|83189838|FG001|Overall Study|Lost to Follow-up|28|||
46951016|NCT02616614|83189839|FG002|Overall Study|Lost to Follow-up|13|||
46951017|NCT02616614|83189837|FG000|Overall Study|Pregnancy|2|||
46771973|NCT00474175|82990259|FG000|Overall Study|Administrative|0|||
46771974|NCT00474175|82990260|FG001|Overall Study|Administrative|1|||
46771975|NCT00474175|82990261|FG002|Overall Study|Administrative|0|||
46771976|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
46771977|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
46842325|NCT00077974|83059304|FG000|Overall Study|Withdrawal by Subject|3|||
46951018|NCT02616614|83189838|FG001|Overall Study|Pregnancy|0|||
46951019|NCT02616614|83189839|FG002|Overall Study|Pregnancy|1|||
46951020|NCT02616614|83189837|FG000|Overall Study|Other|1|||
46951021|NCT02616614|83189838|FG001|Overall Study|Other|2|||
46639105|NCT01389102|82812678|FG001|Overall Study|Hurricane Katrina|2|||
46639106|NCT01389102|82812679|FG002|Overall Study|Hurricane Katrina|3|||
46639107|NCT01389102|82812680|FG003|Overall Study|Hurricane Katrina|0|||
46639108|NCT01389102|82812681|FG004|Overall Study|Hurricane Katrina|3|||
46639109|NCT01389102|82812682|FG005|Overall Study|Hurricane Katrina|1|||
46639110|NCT01389102|82812677|FG000|Overall Study|Lost to Follow-up|4|||
46639111|NCT01389102|82812678|FG001|Overall Study|Lost to Follow-up|1|||
46639112|NCT01389102|82812679|FG002|Overall Study|Lost to Follow-up|1|||
46639113|NCT01389102|82812680|FG003|Overall Study|Lost to Follow-up|2|||
46842326|NCT00077974|83059304|FG000|Overall Study|Lack of Efficacy|76|||
46842327|NCT00077974|83059304|FG000|Overall Study|Decision of Sponsor|2|||
46842328|NCT00124917|83059308|FG000|Overall Study|Physician Decision|3|||
46951022|NCT02616614|83189839|FG002|Overall Study|Other|1|||
46951023|NCT02616380|83189865|FG000|Overall Study|Lost to Follow-up|1|||
46951024|NCT02616380|83189865|FG000|Overall Study|Other|2|||
46951025|NCT04436822|83189875|FG000|Overall Study|Physician Decision|2|||
46951026|NCT04436822|83189876|FG001|Overall Study|Physician Decision|0|||
46951027|NCT04436822|83189875|FG000|Overall Study|Sponsor request|1|||
46951028|NCT04436822|83189876|FG001|Overall Study|Sponsor request|0|||
46951029|NCT04436822|83189875|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46951030|NCT04436822|83189876|FG001|Overall Study|Withdrawal by parent/guardian|3|||
46951031|NCT04436822|83189875|FG000|Overall Study|Unsuccessful procedure|0|||
46951032|NCT04436822|83189876|FG001|Overall Study|Unsuccessful procedure|1|||
46951033|NCT04436822|83189875|FG000|Overall Study|Withdrawal due to Covid-19|8|||
46951034|NCT04436822|83189876|FG001|Overall Study|Withdrawal due to Covid-19|1|||
46951035|NCT04436822|83189875|FG000|Overall Study|Withdrawal by Subject|1|||
46951036|NCT04436822|83189876|FG001|Overall Study|Withdrawal by Subject|0|||
46951037|NCT04436822|83189875|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
46951038|NCT04436822|83189876|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
46951039|NCT01596062|83189886|FG000|Overall Study|Adverse Event|1|||
46951040|NCT01596062|83189887|FG001|Overall Study|Adverse Event|0|||
46951041|NCT01596062|83189888|FG002|Overall Study|Adverse Event|2|||
46951042|NCT01596062|83189886|FG000|Overall Study|Lack of Efficacy|0|||
46951043|NCT01596062|83189887|FG001|Overall Study|Lack of Efficacy|0|||
46951044|NCT01596062|83189888|FG002|Overall Study|Lack of Efficacy|1|||
46951045|NCT02614898|83189907|FG000|Overall Study|Participated until study termination|10|||
46951046|NCT02614898|83189908|FG001|Overall Study|Participated until study termination|26|||
46951047|NCT02614898|83189907|FG000|Overall Study|Lost to Follow-up|0|||
46951048|NCT02614898|83189908|FG001|Overall Study|Lost to Follow-up|2|||
46951049|NCT02614898|83189907|FG000|Overall Study|Physician Decision|1|||
46951050|NCT02614898|83189908|FG001|Overall Study|Physician Decision|8|||
46951051|NCT02614898|83189907|FG000|Overall Study|Study Terminated by Sponsor|3|||
46951052|NCT02614898|83189908|FG001|Overall Study|Study Terminated by Sponsor|0|||
46951053|NCT02614898|83189907|FG000|Overall Study|Withdrawal by Subject|0|||
46951054|NCT02614898|83189908|FG001|Overall Study|Withdrawal by Subject|2|||
46951055|NCT02614898|83189907|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
46951056|NCT02614898|83189908|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
46951057|NCT02614898|83189907|FG000|Overall Study|Other-Additional Information Unavailable|0|||
46951058|NCT02614898|83189908|FG001|Overall Study|Other-Additional Information Unavailable|11|||
46951059|NCT02614898|83189907|FG000|Overall Study|Missing|0|||
46951060|NCT02614898|83189908|FG001|Overall Study|Missing|1|||
46771978|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
46771979|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
46771980|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
46771981|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
46771982|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
46771983|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
46771984|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
46771985|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
46951061|NCT02776033|83189928|FG000|Overall Study|Withdrawal by Subject|0|||
46771986|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
46951062|NCT02776033|83189929|FG001|Overall Study|Withdrawal by Subject|0|||
46951063|NCT02776033|83189930|FG002|Overall Study|Withdrawal by Subject|2|||
46951064|NCT02776033|83189928|FG000|Overall Study|Physician Decision|2|||
46951065|NCT02776033|83189929|FG001|Overall Study|Physician Decision|0|||
46951066|NCT02776033|83189930|FG002|Overall Study|Physician Decision|0|||
46951067|NCT02776033|83189928|FG000|Overall Study|Lost to Follow-up|1|||
46639114|NCT01389102|82812681|FG004|Overall Study|Lost to Follow-up|4|||
46842329|NCT00141921|83059313|FG000|Overall Study|Remain on Study|28|||
46951068|NCT02776033|83189929|FG001|Overall Study|Lost to Follow-up|0|||
46951069|NCT02776033|83189930|FG002|Overall Study|Lost to Follow-up|0|||
46951070|NCT02776033|83189928|FG000|Overall Study|Adverse Event|1|||
46951071|NCT02776033|83189929|FG001|Overall Study|Adverse Event|2|||
46951072|NCT02776033|83189930|FG002|Overall Study|Adverse Event|0|||
46951073|NCT02777125|83189946|FG000|Overall Study|Consent form violation|14|||
46842330|NCT00141921|83059313|FG000|Overall Study|Withdrawal by Subject|42|||
46842331|NCT00141921|83059313|FG000|Overall Study|Lost to Follow-up|19|||
46842332|NCT00141921|83059313|FG000|Overall Study|Noncompliance|17|||
46842333|NCT00141921|83059313|FG000|Overall Study|Disease Progression|7|||
46842334|NCT00141921|83059313|FG000|Overall Study|Protocol Deviation|7|||
46842335|NCT00141921|83059313|FG000|Overall Study|Adverse Event|5|||
46842336|NCT00141921|83059313|FG000|Overall Study|Administrative Decision|2|||
46842337|NCT00141921|83059313|FG000|Overall Study|Pregnancy|4|||
46842338|NCT00141921|83059313|FG000|Overall Study|Ineligibility Determined|2|||
46842339|NCT00141921|83059313|FG000|Overall Study|Other|8|||
46842340|NCT00029146|83059319|FG000|Overall Study|Lost to Follow-up|2|||
46842341|NCT00029146|83059320|FG001|Overall Study|Lost to Follow-up|1|||
46842342|NCT00026494|83059330|FG000|Overall Study|Withdrawal by Subject|1|||
46842343|NCT00026494|83059331|FG001|Overall Study|Withdrawal by Subject|0|||
46842344|NCT00026494|83059332|FG002|Overall Study|Withdrawal by Subject|1|||
46842345|NCT00026494|83059333|FG003|Overall Study|Withdrawal by Subject|0|||
46842346|NCT00026494|83059330|FG000|Overall Study|Patient non-compliance|1|||
46842347|NCT00026494|83059331|FG001|Overall Study|Patient non-compliance|0|||
46842348|NCT00026494|83059332|FG002|Overall Study|Patient non-compliance|0|||
46842349|NCT00026494|83059333|FG003|Overall Study|Patient non-compliance|0|||
46842350|NCT00026494|83059330|FG000|Overall Study|Patient not treated|0|||
46842351|NCT00026494|83059331|FG001|Overall Study|Patient not treated|0|||
46842352|NCT00026494|83059332|FG002|Overall Study|Patient not treated|2|||
46842353|NCT00026494|83059333|FG003|Overall Study|Patient not treated|0|||
46842354|NCT00026494|83059330|FG000|Overall Study|Clinical progression|0|||
46842355|NCT00026494|83059331|FG001|Overall Study|Clinical progression|0|||
46842356|NCT00026494|83059332|FG002|Overall Study|Clinical progression|3|||
46842357|NCT00026494|83059333|FG003|Overall Study|Clinical progression|0|||
46842358|NCT00023764|83059343|FG000|Overall Study|Other|1|||
46842359|NCT00023764|83059343|FG000|Overall Study|Adverse Event|4|||
46842360|NCT00023764|83059343|FG000|Overall Study|Withdrawal by Subject|1|||
46842361|NCT00023764|83059343|FG000|Overall Study|Progression of disease|6|||
46842362|NCT00023764|83059343|FG000|Overall Study|patient received other treatment|1|||
46842363|NCT00023764|83059343|FG000|Overall Study|delay in obtaining staging images|1|||
46842364|NCT00189488|83059350|FG000|Overall Study|Ineligibility determined|1|||
46842365|NCT00189488|83059351|FG001|Overall Study|Ineligibility determined|0|||
46842366|NCT00189488|83059350|FG000|Overall Study|Protocol deviation|2|||
46842367|NCT00189488|83059351|FG001|Overall Study|Protocol deviation|1|||
46842368|NCT00189488|83059350|FG000|Overall Study|Adverse Event|2|||
46842369|NCT00189488|83059351|FG001|Overall Study|Adverse Event|1|||
46842370|NCT00189488|83059350|FG000|Overall Study|Withdrawal by Subject|2|||
46842371|NCT00189488|83059351|FG001|Overall Study|Withdrawal by Subject|6|||
46842372|NCT00189488|83059350|FG000|Overall Study|Disease progression|2|||
46842373|NCT00189488|83059351|FG001|Overall Study|Disease progression|4|||
46842374|NCT00189488|83059350|FG000|Overall Study|Administrative Decision|0|||
46842375|NCT00189488|83059351|FG001|Overall Study|Administrative Decision|2|||
46842376|NCT00189488|83059350|FG000|Overall Study|Death|5|||
46842377|NCT00189488|83059351|FG001|Overall Study|Death|8|||
46842378|NCT00189488|83059350|FG000|Overall Study|Other|1|||
46842379|NCT00189488|83059351|FG001|Overall Study|Other|0|||
46842380|NCT00233402|83059360|FG000|Overall Study|No pathology data|12|||
46842381|NCT00233402|83059361|FG001|Overall Study|No pathology data|9|||
46951074|NCT02777125|83189947|FG001|Overall Study|Consent form violation|12|||
46951075|NCT02777125|83189946|FG000|Overall Study|Assent form violation|21|||
46951076|NCT02777125|83189947|FG001|Overall Study|Assent form violation|23|||
46842382|NCT00233402|83059360|FG000|Overall Study|No Ta/T1|89|||
46842383|NCT00233402|83059361|FG001|Overall Study|No Ta/T1|94|||
46842384|NCT00233402|83059360|FG000|Overall Study|Lost to follow up etc|3|||
46951077|NCT02777125|83189946|FG000|Overall Study|Protocol Violation|8|||
46639115|NCT01389102|82812682|FG005|Overall Study|Lost to Follow-up|1|||
46842385|NCT00233402|83059361|FG001|Overall Study|Lost to follow up etc|21|||
46842386|NCT00233324|83059373|FG000|Main Study|Death|68|||
46842387|NCT00233324|83059374|FG001|Main Study|Death|60|||
46842388|NCT00233324|83059375|FG002|Main Study|Death|62|||
46842389|NCT00233324|83059376|FG003|Main Study|Death|47|||
46842390|NCT00233324|83059373|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
46842391|NCT00233324|83059374|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
46842392|NCT00233324|83059375|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
46842393|NCT00233324|83059376|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
46842394|NCT00233324|83059373|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
46842395|NCT00233324|83059374|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
46842396|NCT00233324|83059375|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
46842397|NCT00233324|83059376|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
46951078|NCT02777125|83189947|FG001|Overall Study|Protocol Violation|12|||
46842398|NCT00023452|83059395|FG000|Overall Study|Ineligible for Study|163|||
46842399|NCT00023452|83059396|FG001|Overall Study|Ineligible for Study|159|||
46842400|NCT00023452|83059395|FG000|Overall Study|Out of Window|129|||
46842401|NCT00023452|83059396|FG001|Overall Study|Out of Window|69|||
46842402|NCT00023452|83059395|FG000|Overall Study|Death|2|||
46842403|NCT00023452|83059396|FG001|Overall Study|Death|0|||
46842404|NCT00023452|83059395|FG000|Overall Study|Withdrawal by Subject|66|||
46842405|NCT00023452|83059396|FG001|Overall Study|Withdrawal by Subject|54|||
46842406|NCT00023452|83059395|FG000|Overall Study|Adverse Event|139|||
46842407|NCT00023452|83059396|FG001|Overall Study|Adverse Event|196|||
46842408|NCT00023452|83059395|FG000|Overall Study|Lost to Follow-up|293|||
46842409|NCT00023452|83059396|FG001|Overall Study|Lost to Follow-up|60|||
46842410|NCT00023452|83059395|FG000|Overall Study|Physician Decision|49|||
46842411|NCT00023452|83059396|FG001|Overall Study|Physician Decision|21|||
46842412|NCT00023452|83059395|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
46842413|NCT00023452|83059396|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
46842414|NCT00023452|83059395|FG000|Overall Study|Pregnant|53|||
46842415|NCT00023452|83059396|FG001|Overall Study|Pregnant|20|||
46842416|NCT00023452|83059395|FG000|Overall Study|Other|204|||
46842417|NCT00023452|83059396|FG001|Overall Study|Other|69|||
46842418|NCT00022672|83059408|FG000|Main Phase: 24 Months|Adverse Event|6|||
46842419|NCT00022672|83059409|FG001|Main Phase: 24 Months|Adverse Event|0|||
46842420|NCT00022672|83059408|FG000|Main Phase: 24 Months|Death|0|||
46842421|NCT00022672|83059409|FG001|Main Phase: 24 Months|Death|3|||
46842422|NCT00022672|83059408|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
46842423|NCT00022672|83059409|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
46842424|NCT00022672|83059408|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
46842425|NCT00022672|83059409|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
46842426|NCT00022672|83059408|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
46842427|NCT00022672|83059409|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
46842428|NCT00022672|83059408|FG000|Main Phase: 24 Months|Refused Treatment|3|||
46842429|NCT00022672|83059409|FG001|Main Phase: 24 Months|Refused Treatment|4|||
46842430|NCT00022672|83059408|FG000|Main Phase: 24 Months|Failure to Return|1|||
46842431|NCT00022672|83059409|FG001|Main Phase: 24 Months|Failure to Return|1|||
46842432|NCT00022672|83059408|FG000|Main Phase: 24 Months|Other|1|||
46842433|NCT00022672|83059409|FG001|Main Phase: 24 Months|Other|0|||
46842434|NCT00022672|83059408|FG000|Extension Phase|Adverse Event|1|||
46842435|NCT00022672|83059409|FG001|Extension Phase|Adverse Event|3|||
46842436|NCT00022672|83059408|FG000|Extension Phase|Death|0|||
46771987|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
46771988|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
46771989|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
46771990|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
46771991|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
46771992|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
46951079|NCT02769481|83189972|FG000|Overall Study|Protocol Violation|1|||
46951080|NCT02769481|83189973|FG001|Overall Study|Protocol Violation|0|||
46951081|NCT02769481|83189972|FG000|Overall Study|Adverse Event|3|||
46951082|NCT02769481|83189973|FG001|Overall Study|Adverse Event|6|||
46951083|NCT02769481|83189972|FG000|Overall Study|Entry Criteria Not Met|1|||
46951084|NCT02769481|83189973|FG001|Overall Study|Entry Criteria Not Met|2|||
46951085|NCT02769481|83189972|FG000|Overall Study|Withdrawal by Subject|14|||
46951086|NCT02769481|83189973|FG001|Overall Study|Withdrawal by Subject|16|||
46951087|NCT02769481|83189972|FG000|Overall Study|Lost to Follow-up|9|||
46951088|NCT02769481|83189973|FG001|Overall Study|Lost to Follow-up|9|||
46951089|NCT02769481|83189972|FG000|Overall Study|Physician Decision|0|||
46951090|NCT02769481|83189973|FG001|Overall Study|Physician Decision|1|||
46951091|NCT02769481|83189972|FG000|Overall Study|Terminated by Sponsor|1|||
46951092|NCT02769481|83189973|FG001|Overall Study|Terminated by Sponsor|0|||
46951093|NCT02769481|83189972|FG000|Overall Study|Death|0|||
46951094|NCT02769481|83189973|FG001|Overall Study|Death|1|||
46639116|NCT01389102|82812677|FG000|Overall Study|Protocol Violation|0|||
46951095|NCT02769481|83189972|FG000|Overall Study|Undefined|4|||
46951096|NCT02769481|83189973|FG001|Overall Study|Undefined|1|||
46842437|NCT00022672|83059409|FG001|Extension Phase|Death|1|||
46842438|NCT00022672|83059408|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
46842439|NCT00022672|83059409|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
46951097|NCT02769247|83189983|FG000|Overall Study|Withdrawal by Subject|1|||
46951098|NCT02769247|83189984|FG001|Overall Study|Withdrawal by Subject|0|||
46951099|NCT02769247|83189985|FG002|Overall Study|Withdrawal by Subject|0|||
46951100|NCT02769247|83189986|FG003|Overall Study|Withdrawal by Subject|1|||
46951101|NCT02769247|83189983|FG000|Overall Study|Protocol Violation|0|||
46951102|NCT02769247|83189984|FG001|Overall Study|Protocol Violation|0|||
46771993|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
46771994|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Missing|2|||
46771995|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Missing|1|||
46951103|NCT02769247|83189985|FG002|Overall Study|Protocol Violation|1|||
46842440|NCT00022672|83059408|FG000|Extension Phase|Refused Treatment|0|||
46842441|NCT00022672|83059409|FG001|Extension Phase|Refused Treatment|2|||
46842442|NCT00022672|83059408|FG000|Extension Phase|Other|1|||
46842443|NCT00022672|83059409|FG001|Extension Phase|Other|1|||
46842444|NCT00076804|83059418|FG000|Overall Study|Death|9|||
46842445|NCT00076804|83059419|FG001|Overall Study|Death|20|||
46842446|NCT00076804|83059418|FG000|Overall Study|Lost to Follow-up|9|||
46842447|NCT00076804|83059419|FG001|Overall Study|Lost to Follow-up|9|||
46842448|NCT00076804|83059418|FG000|Overall Study|Withdrawal by Subject|10|||
46842449|NCT00076804|83059419|FG001|Overall Study|Withdrawal by Subject|8|||
46842450|NCT00076804|83059418|FG000|Overall Study|Early study Closure|32|||
46842451|NCT00076804|83059419|FG001|Overall Study|Early study Closure|32|||
46842452|NCT00141453|83059427|FG000|Overall Study|Protocol Violation|6|||
46842453|NCT00141453|83059428|FG001|Overall Study|Protocol Violation|5|||
46842454|NCT00076570|83059436|FG000|Overall Study|Drug intolerance|8|||
46842455|NCT00076570|83059437|FG001|Overall Study|Drug intolerance|8|||
46842456|NCT00124449|83059445|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
46842457|NCT00124449|83059446|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
46842458|NCT00124449|83059445|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
46842459|NCT00124449|83059446|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
46842460|NCT00124449|83059445|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
46842461|NCT00124449|83059446|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
46842462|NCT00124449|83059445|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
46842463|NCT00124449|83059446|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
46842464|NCT00124449|83059445|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
46842465|NCT00124449|83059446|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
46842466|NCT00124449|83059445|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
46842467|NCT00124449|83059446|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
46842468|NCT00124449|83059445|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
46842469|NCT00124449|83059446|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
46842470|NCT00124449|83059445|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
46842471|NCT00124449|83059446|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
46842472|NCT00124449|83059445|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
46842473|NCT00124449|83059446|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
46842474|NCT00124449|83059445|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
46842475|NCT00124449|83059446|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
46842476|NCT00124449|83059445|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
46842477|NCT00124449|83059446|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
46842478|NCT00124449|83059445|FG000|18-Month Untreated Observation Period|Relocated|1|||
46842479|NCT00124449|83059446|FG001|18-Month Untreated Observation Period|Relocated|0|||
46842480|NCT00076336|83059455|FG000|Overall Study|Death|13|||
46951104|NCT02769247|83189986|FG003|Overall Study|Protocol Violation|0|||
46639117|NCT01389102|82812678|FG001|Overall Study|Protocol Violation|0|||
46951105|NCT02769247|83189983|FG000|Overall Study|Physician Decision|1|||
46951106|NCT02769247|83189984|FG001|Overall Study|Physician Decision|0|||
46951107|NCT02769247|83189985|FG002|Overall Study|Physician Decision|0|||
46951108|NCT02769247|83189986|FG003|Overall Study|Physician Decision|0|||
46951109|NCT02773537|83190003|FG000|Overall Study|Lost to Follow-up|0|||
46951110|NCT02773537|83190004|FG001|Overall Study|Lost to Follow-up|1|||
46951111|NCT02773537|83190005|FG002|Overall Study|Lost to Follow-up|4|||
46951112|NCT02780713|83190013|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
46951113|NCT02780713|83190014|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
46951114|NCT02780713|83190015|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
46951115|NCT02780713|83190016|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
46951116|NCT02780713|83190017|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
46951117|NCT02767765|83190036|FG000|Overall Study|Adverse Event|4|||
46842481|NCT00076336|83059456|FG001|Overall Study|Death|17|||
46842482|NCT00076336|83059455|FG000|Overall Study|Adverse Event|4|||
46842483|NCT00076336|83059456|FG001|Overall Study|Adverse Event|4|||
46842484|NCT00076336|83059455|FG000|Overall Study|Lost to Follow-up|4|||
46842485|NCT00076336|83059456|FG001|Overall Study|Lost to Follow-up|4|||
46842486|NCT00076336|83059455|FG000|Overall Study|Non-Compliance|2|||
46842487|NCT00076336|83059456|FG001|Overall Study|Non-Compliance|0|||
46842488|NCT00076336|83059455|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
46842489|NCT00076336|83059456|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
46842490|NCT00076336|83059455|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
46842491|NCT00076336|83059456|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
46842492|NCT00076336|83059455|FG000|Overall Study|Liver Transplantation|3|||
46842493|NCT00076336|83059456|FG001|Overall Study|Liver Transplantation|3|||
46842494|NCT00076336|83059455|FG000|Overall Study|Virologic Breakthrough|14|||
46842495|NCT00076336|83059456|FG001|Overall Study|Virologic Breakthrough|16|||
46842496|NCT00076336|83059455|FG000|Overall Study|Treatment failure|4|||
46842497|NCT00076336|83059456|FG001|Overall Study|Treatment failure|5|||
46842498|NCT00185588|83059466|FG000|Overall Study|Adverse Event|3|||
46842499|NCT00185588|83059467|FG001|Overall Study|Adverse Event|1|||
46842500|NCT00185588|83059468|FG002|Overall Study|Adverse Event|4|||
46842501|NCT00185588|83059469|FG003|Overall Study|Adverse Event|2|||
46842502|NCT00185588|83059466|FG000|Overall Study|Lost to Follow-up|0|||
46842503|NCT00185588|83059467|FG001|Overall Study|Lost to Follow-up|0|||
46842504|NCT00185588|83059468|FG002|Overall Study|Lost to Follow-up|1|||
46842505|NCT00185588|83059469|FG003|Overall Study|Lost to Follow-up|2|||
46842506|NCT00185588|83059466|FG000|Overall Study|Withdrawal by Subject|0|||
46842507|NCT00185588|83059467|FG001|Overall Study|Withdrawal by Subject|1|||
46842508|NCT00185588|83059468|FG002|Overall Study|Withdrawal by Subject|0|||
46842509|NCT00185588|83059469|FG003|Overall Study|Withdrawal by Subject|0|||
46842510|NCT00185588|83059466|FG000|Overall Study|Physician Decision|0|||
46842511|NCT00185588|83059467|FG001|Overall Study|Physician Decision|0|||
46842512|NCT00185588|83059468|FG002|Overall Study|Physician Decision|1|||
46842513|NCT00185588|83059469|FG003|Overall Study|Physician Decision|0|||
46842514|NCT00232544|83059481|FG000|Overall Study|Lost to Follow-up|20|||
46842515|NCT00232544|83059482|FG001|Overall Study|Lost to Follow-up|15|||
46842516|NCT00231842|83059488|FG000|Overall Study|Withdrawal by Subject|3|||
46842517|NCT00231842|83059488|FG000|Overall Study|Did not complete the last 3 cycle|8|||
46842518|NCT00076102|83059493|FG000|Overall Study|Clinical progression|1|||
46842519|NCT00076102|83059493|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
46842520|NCT00076102|83059493|FG000|Overall Study|plexiform neurofibroma surgery|1|||
46842521|NCT00076102|83059493|FG000|Overall Study|refusal of further therapy|2|||
46842522|NCT00231062|83059507|FG000|Overall Study|Physician Decision|6|||
46842523|NCT00184028|83059511|FG000|Overall Study|Death|1|||
46842524|NCT00184028|83059511|FG000|Overall Study|Lack of Efficacy|4|||
46842525|NCT00184028|83059511|FG000|Overall Study|Adverse Event|2|||
46842526|NCT00184028|83059511|FG000|Overall Study|Withdrawal by Subject|1|||
46842527|NCT00184028|83059511|FG000|Overall Study|Non-compliance|2|||
46842528|NCT00183872|83059516|FG000|Overall Study|Death|3|||
46842529|NCT00183872|83059516|FG000|Overall Study|Adverse Event|9|||
46842530|NCT00183872|83059516|FG000|Overall Study|Withdrawal by Subject|2|||
46842531|NCT00183872|83059516|FG000|Overall Study|Drug delayed more than 28 days|2|||
46842532|NCT03815175|83059520|FG000|Overall Study|Subject Lost to Follow-up|6|||
46842533|NCT03815175|83059520|FG000|Overall Study|Subject Withdrew Consent|48|||
46842534|NCT03815175|83059520|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
46842535|NCT03815175|83059520|FG000|Overall Study|Death|86|||
46842536|NCT03815175|83059520|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
46842537|NCT03815175|83059520|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
46842538|NCT03815175|83059520|FG000|Overall Study|Other Status Change Reason|1|||
46842539|NCT03815175|83059520|FG000|Overall Study|Missed Visit|12|||
46842540|NCT00262028|83059533|FG000|Overall Study|Withdrawal by Subject|6|||
46842541|NCT00262028|83059534|FG001|Overall Study|Withdrawal by Subject|3|||
46842542|NCT00262028|83059535|FG002|Overall Study|Withdrawal by Subject|6|||
46842543|NCT00262028|83059536|FG003|Overall Study|Withdrawal by Subject|5|||
46951118|NCT02767765|83190036|FG000|Overall Study|Death|1|||
46951119|NCT02767765|83190036|FG000|Overall Study|Insufficient response|1|||
47066563|NCT01576016|83349253|FG001|Lead Safety|Physician Decision|0|||
46639118|NCT01389102|82812679|FG002|Overall Study|Protocol Violation|3|||
46842544|NCT00262028|83059537|FG004|Overall Study|Withdrawal by Subject|2|||
46842545|NCT00262028|83059538|FG005|Overall Study|Withdrawal by Subject|3|||
46842546|NCT00262028|83059539|FG006|Overall Study|Withdrawal by Subject|5|||
46842547|NCT00262028|83059540|FG007|Overall Study|Withdrawal by Subject|7|||
46842548|NCT00262028|83059541|FG008|Overall Study|Withdrawal by Subject|2|||
46842549|NCT00262028|83059533|FG000|Overall Study|Lost to Follow-up|7|||
46842550|NCT00262028|83059534|FG001|Overall Study|Lost to Follow-up|7|||
46842551|NCT00262028|83059535|FG002|Overall Study|Lost to Follow-up|5|||
46842552|NCT00262028|83059536|FG003|Overall Study|Lost to Follow-up|5|||
46842553|NCT00262028|83059537|FG004|Overall Study|Lost to Follow-up|4|||
46842554|NCT00262028|83059538|FG005|Overall Study|Lost to Follow-up|3|||
46842555|NCT00262028|83059539|FG006|Overall Study|Lost to Follow-up|3|||
46842556|NCT00262028|83059540|FG007|Overall Study|Lost to Follow-up|5|||
46842557|NCT00262028|83059541|FG008|Overall Study|Lost to Follow-up|6|||
46842558|NCT00262028|83059533|FG000|Overall Study|Administrative Reason|11|||
46842559|NCT00262028|83059534|FG001|Overall Study|Administrative Reason|14|||
46842560|NCT00262028|83059535|FG002|Overall Study|Administrative Reason|9|||
46842561|NCT00262028|83059536|FG003|Overall Study|Administrative Reason|12|||
46842562|NCT00262028|83059537|FG004|Overall Study|Administrative Reason|6|||
46842563|NCT00262028|83059538|FG005|Overall Study|Administrative Reason|7|||
46842564|NCT00262028|83059539|FG006|Overall Study|Administrative Reason|4|||
46842565|NCT00262028|83059540|FG007|Overall Study|Administrative Reason|6|||
46842566|NCT00262028|83059541|FG008|Overall Study|Administrative Reason|10|||
46842567|NCT00262028|83059533|FG000|Overall Study|Protocol Violation|0|||
46842568|NCT00262028|83059534|FG001|Overall Study|Protocol Violation|0|||
46842569|NCT00262028|83059535|FG002|Overall Study|Protocol Violation|0|||
46842570|NCT00262028|83059536|FG003|Overall Study|Protocol Violation|1|||
46842571|NCT00262028|83059537|FG004|Overall Study|Protocol Violation|0|||
46842572|NCT00262028|83059538|FG005|Overall Study|Protocol Violation|0|||
46842573|NCT00262028|83059539|FG006|Overall Study|Protocol Violation|0|||
46842574|NCT00262028|83059540|FG007|Overall Study|Protocol Violation|0|||
46842575|NCT00262028|83059541|FG008|Overall Study|Protocol Violation|0|||
46842576|NCT00262028|83059533|FG000|Overall Study|Unable to classify|0|||
46842577|NCT00262028|83059534|FG001|Overall Study|Unable to classify|3|||
46842578|NCT00262028|83059535|FG002|Overall Study|Unable to classify|0|||
46842579|NCT00262028|83059536|FG003|Overall Study|Unable to classify|0|||
46842580|NCT00262028|83059537|FG004|Overall Study|Unable to classify|0|||
46842581|NCT00262028|83059538|FG005|Overall Study|Unable to classify|0|||
46842582|NCT00262028|83059539|FG006|Overall Study|Unable to classify|0|||
46842583|NCT00262028|83059540|FG007|Overall Study|Unable to classify|0|||
46842584|NCT00262028|83059541|FG008|Overall Study|Unable to classify|1|||
46842585|NCT00183248|83059585|FG000|Overall Study|Lost to Follow-up|0|||
46842586|NCT00183248|83059586|FG001|Overall Study|Lost to Follow-up|1|||
46842587|NCT00183248|83059585|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
46842588|NCT00183248|83059586|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
46842589|NCT00183170|83059594|FG000|First Intervention|Did not complete study|1|||
46842590|NCT00183170|83059595|FG001|First Intervention|Did not complete study|0|||
46842591|NCT00183170|83059594|FG000|First Intervention|Did not meet targeted BrAC|1|||
46842592|NCT00183170|83059595|FG001|First Intervention|Did not meet targeted BrAC|0|||
46842593|NCT00183170|83059594|FG000|Washout 1 Week|Did not complete study|6|||
46842594|NCT00183170|83059595|FG001|Washout 1 Week|Did not complete study|8|||
46842595|NCT00183170|83059594|FG000|Second Intervention|Did not complete study|1|||
46842596|NCT00183170|83059595|FG001|Second Intervention|Did not complete study|0|||
46842597|NCT00183170|83059594|FG000|Second Intervention|Did not meet targeted BrAC|0|||
46842598|NCT00183170|83059595|FG001|Second Intervention|Did not meet targeted BrAC|2|||
46842599|NCT00230282|83059601|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
46842600|NCT00230282|83059601|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
46842601|NCT00230282|83059601|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
46842602|NCT00230282|83059601|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
46842603|NCT00261950|83059605|FG000|Overall Study|Lost to Follow-up|2|||
46842604|NCT00261950|83059605|FG000|Overall Study|Death|6|||
46842605|NCT00261950|83059605|FG000|Overall Study|Withdrawal by Subject|5|||
46842606|NCT00261950|83059605|FG000|Overall Study|Other|1|||
46842607|NCT00261950|83059605|FG000|Overall Study|Physician Decision|1|||
46842608|NCT00261950|83059605|FG000|Overall Study|Protocol specified Criteria|11|||
46842609|NCT00230048|83059611|FG000|Overall Study|Lost to Follow-up|13|||
46842610|NCT00230048|83059612|FG001|Overall Study|Lost to Follow-up|18|||
46842611|NCT00229658|83059622|FG000|Overall Study|Administrative|2|||
46842612|NCT00229658|83059623|FG001|Overall Study|Administrative|1|||
46842613|NCT00229658|83059622|FG000|Overall Study|Investigator decision|13|||
46842614|NCT00229658|83059623|FG001|Overall Study|Investigator decision|10|||
46842615|NCT00229658|83059622|FG000|Overall Study|Other|80|||
46842616|NCT00229658|83059623|FG001|Overall Study|Other|60|||
46842617|NCT00229658|83059622|FG000|Overall Study|Lost to Follow-up|82|||
46842618|NCT00229658|83059623|FG001|Overall Study|Lost to Follow-up|55|||
46842619|NCT00229658|83059622|FG000|Overall Study|Serious Adverse Event|2|||
46842620|NCT00229658|83059623|FG001|Overall Study|Serious Adverse Event|2|||
46842621|NCT00229658|83059622|FG000|Overall Study|Withdrawal of consent|46|||
46842622|NCT00229658|83059623|FG001|Overall Study|Withdrawal of consent|39|||
46842623|NCT00182078|83059631|FG000|Overall Study|Withdrawal by Subject|1|||
46842624|NCT00182078|83059632|FG001|Overall Study|Withdrawal by Subject|0|||
46842625|NCT00181844|83059638|FG000|Signed Consent|Withdrawal by Subject|5|||
46842626|NCT00181844|83059638|FG000|Signed Consent|Did not meet entrance criteria|7|||
46842627|NCT00181844|83059638|FG000|Exposed to Study Medication|Adverse Event|10|||
46842628|NCT00181844|83059638|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
46842629|NCT00181844|83059638|FG000|Exposed to Study Medication|Non-compliance|2|||
46951120|NCT02767765|83190036|FG000|Overall Study|Lost to Follow-up|2|||
46842630|NCT00181844|83059638|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
46842631|NCT00181844|83059638|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
46842632|NCT00181766|83059642|FG000|Overall Study|Lost to Follow-up|6|||
46842633|NCT00181766|83059642|FG000|Overall Study|Adverse Event|4|||
46842634|NCT00181766|83059642|FG000|Overall Study|non-compliance|2|||
46842635|NCT00180674|83059646|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
46842636|NCT00180674|83059646|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
46842637|NCT00076024|83059657|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
46842638|NCT00076024|83059658|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
46842639|NCT00076024|83059659|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
46842640|NCT00076024|83059660|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
46842641|NCT00076024|83059657|FG000|Phase 1, Lead-in|Adverse Event|1|||
46842642|NCT00076024|83059658|FG001|Phase 1, Lead-in|Adverse Event|0|||
46842643|NCT00076024|83059659|FG002|Phase 1, Lead-in|Adverse Event|0|||
46842644|NCT00076024|83059660|FG003|Phase 1, Lead-in|Adverse Event|0|||
46842645|NCT00076024|83059657|FG000|Phase 1, Lead-in|Clinical progression|1|||
46842646|NCT00076024|83059658|FG001|Phase 1, Lead-in|Clinical progression|0|||
46842647|NCT00076024|83059659|FG002|Phase 1, Lead-in|Clinical progression|0|||
46842648|NCT00076024|83059660|FG003|Phase 1, Lead-in|Clinical progression|0|||
46842649|NCT00076024|83059657|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
46842650|NCT00076024|83059658|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
46842651|NCT00076024|83059659|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
46842652|NCT00076024|83059660|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
46842653|NCT00076024|83059657|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
46842654|NCT00076024|83059658|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
46842655|NCT00076024|83059659|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
46842656|NCT00076024|83059660|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
46842657|NCT00076024|83059657|FG000|Phase 2, Double-blind|Adverse Event|0|||
46842658|NCT00076024|83059658|FG001|Phase 2, Double-blind|Adverse Event|25|||
46842659|NCT00076024|83059659|FG002|Phase 2, Double-blind|Adverse Event|6|||
46842660|NCT00076024|83059660|FG003|Phase 2, Double-blind|Adverse Event|0|||
46842661|NCT00076024|83059657|FG000|Phase 2, Double-blind|Un-specified|0|||
46842662|NCT00076024|83059658|FG001|Phase 2, Double-blind|Un-specified|14|||
46842663|NCT00076024|83059659|FG002|Phase 2, Double-blind|Un-specified|6|||
46842664|NCT00076024|83059660|FG003|Phase 2, Double-blind|Un-specified|0|||
46842665|NCT00076024|83059657|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
46842666|NCT00076024|83059658|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
46842667|NCT00076024|83059659|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
46842668|NCT00076024|83059660|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
46842669|NCT00076024|83059657|FG000|Phase 2, Open-label|Adverse Event|0|||
46842670|NCT00076024|83059658|FG001|Phase 2, Open-label|Adverse Event|0|||
46842671|NCT00076024|83059659|FG002|Phase 2, Open-label|Adverse Event|0|||
46842672|NCT00076024|83059660|FG003|Phase 2, Open-label|Adverse Event|2|||
46842673|NCT00076024|83059657|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
46842674|NCT00076024|83059658|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
46842675|NCT00076024|83059659|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
46842676|NCT00076024|83059660|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
46842677|NCT00076024|83059657|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
46842678|NCT00076024|83059658|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
46842679|NCT00076024|83059659|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
46842680|NCT00076024|83059660|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
46842681|NCT00076024|83059657|FG000|Phase 2, Open-label|Other|0|||
46842682|NCT00076024|83059658|FG001|Phase 2, Open-label|Other|0|||
47066564|NCT01576016|83349252|FG000|Lead Safety|Lost to Follow-up|13|||
47066565|NCT01576016|83349253|FG001|Lead Safety|Lost to Follow-up|0|||
46951121|NCT02767765|83190036|FG000|Overall Study|Investigator decision|1|||
46951122|NCT02767765|83190036|FG000|Overall Study|Non-Compliance|1|||
46951123|NCT02767765|83190036|FG000|Overall Study|Withdrawal by Subject|1|||
46951124|NCT02772757|83190043|FG000|Overall Study|Withdrawal by Subject|1|||
46951125|NCT02772757|83190044|FG001|Overall Study|Withdrawal by Subject|0|||
46951126|NCT02772757|83190045|FG002|Overall Study|Withdrawal by Subject|1|||
46951127|NCT02772757|83190043|FG000|Overall Study|Protocol Violation|0|||
46951128|NCT02772757|83190044|FG001|Overall Study|Protocol Violation|0|||
46951129|NCT02772757|83190045|FG002|Overall Study|Protocol Violation|1|||
47066566|NCT01576016|83349252|FG000|Lead Safety|Unsuccessful implant|2|||
46842683|NCT00076024|83059659|FG002|Phase 2, Open-label|Other|0|||
46842684|NCT00076024|83059660|FG003|Phase 2, Open-label|Other|2|||
46842685|NCT00075478|83059671|FG000|Overall Study|not eligible|1|||
46842686|NCT00075478|83059672|FG001|Overall Study|not eligible|0|||
47066567|NCT01576016|83349253|FG001|Lead Safety|Unsuccessful implant|0|||
46842687|NCT00075478|83059671|FG000|Overall Study|Physician Decision|0|||
46842688|NCT00075478|83059672|FG001|Overall Study|Physician Decision|1|||
46842689|NCT00175916|83059678|FG000|Overall Study|Death|19|||
46842690|NCT00175916|83059678|FG000|Overall Study|Adverse Event|81|||
46842691|NCT00175916|83059678|FG000|Overall Study|Lack of Efficacy|354|||
46842692|NCT00175916|83059678|FG000|Overall Study|Lost to Follow-up|17|||
46842693|NCT00175916|83059678|FG000|Overall Study|Subject Choice|98|||
46842694|NCT00175916|83059678|FG000|Overall Study|Lack of compliance|8|||
46842695|NCT00175916|83059678|FG000|Overall Study|Patient cannot record seizures|1|||
46842696|NCT00175916|83059678|FG000|Overall Study|Sponsor decision|17|||
46842697|NCT00175916|83059678|FG000|Overall Study|Vigabatrin intake|1|||
46842698|NCT00175916|83059678|FG000|Overall Study|Suicidal behaviour|1|||
46842699|NCT00175916|83059678|FG000|Overall Study|Withdrawal by Subject|1|||
46842700|NCT00175916|83059678|FG000|Overall Study|Seizure - free|4|||
46842701|NCT00175916|83059678|FG000|Overall Study|Administrative reason|1|||
46842702|NCT00175916|83059678|FG000|Overall Study|Pregnancy|1|||
46842703|NCT00175916|83059678|FG000|Overall Study|Patient's request|2|||
46842704|NCT00175916|83059678|FG000|Overall Study|Treating physiciant's choice|1|||
46842705|NCT00175916|83059678|FG000|Overall Study|Moved overseas|1|||
46842706|NCT00175916|83059678|FG000|Overall Study|Loss of job and economic burden|1|||
46842707|NCT00175916|83059678|FG000|Overall Study|Site was closed|9|||
46842708|NCT00175916|83059678|FG000|Overall Study|Patient went to prison|1|||
46842709|NCT00075400|83059683|FG000|Overall Study|Ineligible: wrong primary|1|||
46842710|NCT00075400|83059683|FG000|Overall Study|Never treated|2|||
46842711|NCT00228566|83059692|FG000|Overall Study|Adverse Event|31|||
46842712|NCT00228566|83059692|FG000|Overall Study|Lack of Efficacy|14|||
46842713|NCT00228566|83059692|FG000|Overall Study|Lost to Follow-up|16|||
46842714|NCT00228566|83059692|FG000|Overall Study|Physician Decision|5|||
46842715|NCT00228566|83059692|FG000|Overall Study|Withdrawal by Subject|4|||
46842716|NCT00228566|83059692|FG000|Overall Study|Miscellaneous|1|||
46842717|NCT00074152|83059698|FG000|Overall Study|Death|21|||
46842718|NCT00074152|83059699|FG001|Overall Study|Death|9|||
46842719|NCT00074152|83059698|FG000|Overall Study|Lack of Efficacy|34|||
46842720|NCT00074152|83059699|FG001|Overall Study|Lack of Efficacy|24|||
46842721|NCT00261846|83059715|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
46842722|NCT00261846|83059716|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
46842723|NCT00261846|83059717|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
46842724|NCT00261846|83059718|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842725|NCT00261846|83059719|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842726|NCT00261846|83059720|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842727|NCT00261846|83059721|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842728|NCT00261846|83059722|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842729|NCT00261846|83059723|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842730|NCT00261846|83059724|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842731|NCT00261846|83059725|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842732|NCT00261846|83059726|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
46842733|NCT00261846|83059715|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842734|NCT00261846|83059716|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842735|NCT00261846|83059717|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842736|NCT00261846|83059718|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
46842737|NCT00261846|83059719|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842738|NCT00261846|83059720|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842739|NCT00261846|83059721|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842740|NCT00261846|83059722|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842741|NCT00261846|83059723|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
46842742|NCT00261846|83059724|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842743|NCT00261846|83059725|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842744|NCT00261846|83059726|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
46842745|NCT00261846|83059715|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
46842746|NCT00261846|83059716|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
46842747|NCT00261846|83059717|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
46842748|NCT00261846|83059718|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
46842749|NCT00261846|83059719|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
46951130|NCT02772757|83190043|FG000|Overall Study|Physician Decision|0|||
46951131|NCT02772757|83190044|FG001|Overall Study|Physician Decision|3|||
46951132|NCT02772757|83190045|FG002|Overall Study|Physician Decision|3|||
46951133|NCT00103207|83190054|FG000|Overall Study|Adverse Event|3|||
46951134|NCT00103207|83190054|FG000|Overall Study|Death|1|||
46951135|NCT00103207|83190054|FG000|Overall Study|Withdrawal by Subject|2|||
46951136|NCT00103207|83190054|FG000|Overall Study|Other complicating disease|1|||
46842750|NCT00261846|83059720|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
46842751|NCT00261846|83059721|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
46951137|NCT00103207|83190054|FG000|Overall Study|Ineligible|4|||
46951138|NCT00103207|83190054|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
46951139|NCT01369355|83190066|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
46842752|NCT00261846|83059722|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
46951140|NCT01369355|83190067|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
46951141|NCT01369355|83190068|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
46951142|NCT01369355|83190069|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
46842753|NCT00261846|83059723|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
46842754|NCT00261846|83059724|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
46842755|NCT00261846|83059725|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
46842756|NCT00261846|83059726|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
46842757|NCT00261846|83059715|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
46842758|NCT00261846|83059716|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
46842759|NCT00261846|83059717|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
46842760|NCT00261846|83059718|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
46842761|NCT00261846|83059719|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
46842762|NCT00261846|83059720|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
46842763|NCT00261846|83059721|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
46842764|NCT00261846|83059722|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
46842765|NCT00261846|83059723|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
46842766|NCT00261846|83059724|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
46842767|NCT00261846|83059725|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
46842768|NCT00261846|83059726|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
46842769|NCT00261846|83059715|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
46842770|NCT00261846|83059716|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
46842771|NCT00261846|83059717|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
46842772|NCT00261846|83059718|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
46842773|NCT00261846|83059719|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
46842774|NCT00261846|83059720|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
46842775|NCT00261846|83059721|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
46842776|NCT00261846|83059722|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
46842777|NCT00261846|83059723|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
46842778|NCT00261846|83059724|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
46842779|NCT00261846|83059725|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
46842780|NCT00261846|83059726|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
46842781|NCT00261846|83059715|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
46951143|NCT01369355|83190070|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
46951144|NCT01369355|83190071|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
46951145|NCT01369355|83190072|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
46951146|NCT01369355|83190073|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
46951147|NCT01369355|83190074|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
46951148|NCT01369355|83190066|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
46951149|NCT01369355|83190067|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
46951150|NCT01369355|83190068|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
46951151|NCT01369355|83190069|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
46951152|NCT01369355|83190070|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
46951153|NCT01369355|83190071|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
46951154|NCT01369355|83190072|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
46951155|NCT01369355|83190073|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
46951156|NCT01369355|83190074|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
46951157|NCT01369355|83190066|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
46951158|NCT01369355|83190067|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
46951159|NCT01369355|83190068|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
46951160|NCT01369355|83190069|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
46951161|NCT01369355|83190070|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
46951162|NCT01369355|83190071|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
46951163|NCT01369355|83190072|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
46951164|NCT01369355|83190073|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
46951165|NCT01369355|83190074|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
46951166|NCT01369355|83190066|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
46951167|NCT01369355|83190067|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
46951168|NCT01369355|83190068|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
46951169|NCT01369355|83190069|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
46951170|NCT01369355|83190070|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
46951171|NCT01369355|83190071|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
46951172|NCT01369355|83190072|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
46951173|NCT01369355|83190073|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
46951174|NCT01369355|83190074|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
46842782|NCT00261846|83059716|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
46842783|NCT00261846|83059717|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
46842784|NCT00261846|83059718|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
46842785|NCT00261846|83059719|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
46951175|NCT01369355|83190066|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
46951176|NCT01369355|83190067|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
46842786|NCT00261846|83059720|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
46842787|NCT00261846|83059721|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
46842788|NCT00261846|83059722|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
46951177|NCT01369355|83190068|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
46951178|NCT01369355|83190069|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
46967875|NCT05091307|83210486|FG003|Overall Study|Protocol Violation|0|||
46951179|NCT01369355|83190070|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
46951180|NCT01369355|83190071|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
46951181|NCT01369355|83190072|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
46951182|NCT01369355|83190073|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
46951183|NCT01369355|83190074|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
46951184|NCT01369355|83190066|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
46951185|NCT01369355|83190067|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
46951186|NCT01369355|83190068|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
46951187|NCT01369355|83190069|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
46951188|NCT01369355|83190070|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
46951189|NCT01369355|83190071|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
46951190|NCT01369355|83190072|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
46951191|NCT01369355|83190073|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
46951192|NCT01369355|83190074|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
46951193|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
46951194|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
46951195|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
46951196|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
46951197|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
46771996|NCT00443209|82990292|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
46842789|NCT00261846|83059723|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
46842790|NCT00261846|83059724|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
46842791|NCT00261846|83059725|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
46842792|NCT00261846|83059726|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
46842793|NCT00261846|83059715|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
46842794|NCT00261846|83059716|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
46842795|NCT00261846|83059717|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
46842796|NCT00261846|83059718|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
46842797|NCT00261846|83059719|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
46842798|NCT00261846|83059720|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
46842799|NCT00261846|83059721|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
46842800|NCT00261846|83059722|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
46842801|NCT00261846|83059723|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
46842802|NCT00261846|83059724|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
46842803|NCT00261846|83059725|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
46842804|NCT00261846|83059726|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
46842805|NCT00169442|83059771|FG000|Overall Study|Withdrawal by Subject|0|||
46842806|NCT00169442|83059772|FG001|Overall Study|Withdrawal by Subject|0|||
46842807|NCT00169442|83059773|FG002|Overall Study|Withdrawal by Subject|1|||
46842808|NCT00169442|83059774|FG003|Overall Study|Withdrawal by Subject|0|||
46842809|NCT00169442|83059775|FG004|Overall Study|Withdrawal by Subject|0|||
46842810|NCT00169442|83059776|FG005|Overall Study|Withdrawal by Subject|0|||
46842811|NCT00169442|83059771|FG000|Overall Study|Migrated/moved from study area|0|||
46842812|NCT00169442|83059772|FG001|Overall Study|Migrated/moved from study area|0|||
46842813|NCT00169442|83059773|FG002|Overall Study|Migrated/moved from study area|0|||
46842814|NCT00169442|83059774|FG003|Overall Study|Migrated/moved from study area|0|||
46842815|NCT00169442|83059775|FG004|Overall Study|Migrated/moved from study area|0|||
46842816|NCT00169442|83059776|FG005|Overall Study|Migrated/moved from study area|2|||
46842817|NCT00169442|83059771|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
46842818|NCT00169442|83059772|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
46842819|NCT00169442|83059773|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
46842820|NCT00169442|83059774|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
46842821|NCT00169442|83059775|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
46842822|NCT00169442|83059776|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
46951198|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
46771997|NCT00443209|82990293|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
46771998|NCT00443209|82990292|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
46771999|NCT00443209|82990293|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
46772000|NCT00443209|82990292|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
46772001|NCT00443209|82990293|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
46772002|NCT00443209|82990292|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
46842823|NCT00169442|83059771|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
46951199|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
46951200|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
46951201|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
46951202|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Death|0|||
46951203|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Death|0|||
46951204|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Death|0|||
46951205|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Death|0|||
46772003|NCT00443209|82990293|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
46842824|NCT00169442|83059772|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
46842825|NCT00169442|83059773|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
46842826|NCT00169442|83059774|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
46842827|NCT00169442|83059775|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
46842828|NCT00169442|83059776|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
46842829|NCT00261716|83059794|FG000|Overall Study|Withdrawal by Subject|6|||
46842830|NCT00261716|83059795|FG001|Overall Study|Withdrawal by Subject|8|||
46842831|NCT00261716|83059794|FG000|Overall Study|Lost to Follow-up|0|||
46842832|NCT00261716|83059795|FG001|Overall Study|Lost to Follow-up|2|||
46951206|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Death|0|||
46842833|NCT03809104|83059805|FG000|Overall Study|Withdrawal by Subject|3|||
46842834|NCT00203502|83059809|FG000|Overall Study|Death|1|||
46842835|NCT03799198|83059815|FG000|Overall Study|Lost to Follow-up|4|||
46842836|NCT03799198|83059816|FG001|Overall Study|Lost to Follow-up|8|||
46951207|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Death|0|||
46951208|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Death|0|||
46951209|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Death|1|||
46951210|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Death|3|||
46951211|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
46951212|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
46951213|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
46951214|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
46951215|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
46951216|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
46951217|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
46951218|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
46951219|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
46951220|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
46951221|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
46951222|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
46951223|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
46951224|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
46951225|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
46951226|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
46951227|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
46772004|NCT00443209|82990292|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
46772005|NCT00443209|82990293|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
46772006|NCT00443209|82990292|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
46772007|NCT00443209|82990293|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
46772008|NCT00443209|82990292|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
46772009|NCT00443209|82990293|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
46772010|NCT00439231|82990299|FG000|Overall Study|Lack of Efficacy|28|||
46772011|NCT00437983|82990305|FG000|Overall Study|Adverse Event|6|||
46772012|NCT00437983|82990306|FG001|Overall Study|Adverse Event|6|||
46772013|NCT00437983|82990305|FG000|Overall Study|Protocol Violation|2|||
46772014|NCT00437983|82990306|FG001|Overall Study|Protocol Violation|1|||
46772015|NCT00437983|82990305|FG000|Overall Study|Withdrawal by Subject|5|||
46772016|NCT00437983|82990306|FG001|Overall Study|Withdrawal by Subject|6|||
46772017|NCT00783692|82990315|FG000|Induction Phase|Adverse Event|7|||
46772018|NCT00783692|82990316|FG001|Induction Phase|Adverse Event|9|||
46772019|NCT00783692|82990317|FG002|Induction Phase|Adverse Event|24|||
46772020|NCT00783692|82990318|FG003|Induction Phase|Adverse Event|0|||
46772021|NCT00783692|82990319|FG004|Induction Phase|Adverse Event|0|||
46772022|NCT00783692|82990320|FG005|Induction Phase|Adverse Event|0|||
46772023|NCT00783692|82990321|FG006|Induction Phase|Adverse Event|0|||
46772024|NCT00783692|82990315|FG000|Induction Phase|Protocol Violation|0|||
46772025|NCT00783692|82990316|FG001|Induction Phase|Protocol Violation|0|||
46772026|NCT00783692|82990317|FG002|Induction Phase|Protocol Violation|1|||
46772027|NCT00783692|82990318|FG003|Induction Phase|Protocol Violation|0|||
46772028|NCT00783692|82990319|FG004|Induction Phase|Protocol Violation|0|||
46772029|NCT00783692|82990320|FG005|Induction Phase|Protocol Violation|0|||
46772030|NCT00783692|82990321|FG006|Induction Phase|Protocol Violation|0|||
46772031|NCT00783692|82990315|FG000|Induction Phase|Lack of Efficacy|1|||
46772032|NCT00783692|82990316|FG001|Induction Phase|Lack of Efficacy|3|||
46772033|NCT00783692|82990317|FG002|Induction Phase|Lack of Efficacy|28|||
46772034|NCT00783692|82990318|FG003|Induction Phase|Lack of Efficacy|0|||
46772035|NCT00783692|82990319|FG004|Induction Phase|Lack of Efficacy|0|||
46772036|NCT00783692|82990320|FG005|Induction Phase|Lack of Efficacy|0|||
46772037|NCT00783692|82990321|FG006|Induction Phase|Lack of Efficacy|0|||
46772038|NCT00783692|82990315|FG000|Induction Phase|Withdrawal by Subject|3|||
46772039|NCT00783692|82990316|FG001|Induction Phase|Withdrawal by Subject|9|||
46772040|NCT00783692|82990317|FG002|Induction Phase|Withdrawal by Subject|16|||
46772041|NCT00783692|82990318|FG003|Induction Phase|Withdrawal by Subject|0|||
46772042|NCT00783692|82990319|FG004|Induction Phase|Withdrawal by Subject|0|||
46951228|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
46951229|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
46951230|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
46951231|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
46951232|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
46951233|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
46951234|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
46951235|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
46951236|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
46951237|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
46951238|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
46951239|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
47066568|NCT01576016|83349252|FG000|Lead Safety|Sponsor request|1|||
47066569|NCT01576016|83349253|FG001|Lead Safety|Sponsor request|0|||
47066570|NCT01576016|83349252|FG000|Lead Safety|Device replaced with CRT-D|1|||
46951240|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
46951241|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
46951242|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
46951243|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
46951244|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
46951245|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
46951246|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
46951247|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
46951248|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
46951249|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
46951250|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
46951251|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
46951252|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
46951253|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
46951254|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
46951255|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
46951256|NCT01369355|83190066|FG000|Long-term Extension (Week 44-272)|Other|0|||
47066571|NCT01576016|83349253|FG001|Lead Safety|Device replaced with CRT-D|0|||
47066572|NCT01576016|83349252|FG000|Lead Safety|Patient on Palliative Care|1|||
47066573|NCT01576016|83349253|FG001|Lead Safety|Patient on Palliative Care|0|||
47066574|NCT01576016|83349252|FG000|Lead Safety|Patient noncompliance|1|||
47066575|NCT01576016|83349253|FG001|Lead Safety|Patient noncompliance|0|||
47066576|NCT01576016|83349252|FG000|Lead Safety|Too far from study site|1|||
47066577|NCT01576016|83349253|FG001|Lead Safety|Too far from study site|0|||
47066578|NCT01576016|83349252|FG000|Lead Safety|System deactivated|1|||
47066579|NCT01576016|83349253|FG001|Lead Safety|System deactivated|0|||
47066580|NCT01576016|83349252|FG000|Lead Safety|Patient no longer followed by study PI|1|||
47066581|NCT01576016|83349253|FG001|Lead Safety|Patient no longer followed by study PI|0|||
47066582|NCT01576016|83349252|FG000|MRI Safety|Withdrawal by Subject|0|||
47066583|NCT01576016|83349253|FG001|MRI Safety|Withdrawal by Subject|10|||
47066584|NCT01576016|83349252|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
47066585|NCT01576016|83349253|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
47066586|NCT01576016|83349252|FG000|MRI Safety|Has not yet completed MRI scan|0|||
46639119|NCT01389102|82812680|FG003|Overall Study|Protocol Violation|0|||
46772043|NCT00783692|82990320|FG005|Induction Phase|Withdrawal by Subject|0|||
46772044|NCT00783692|82990321|FG006|Induction Phase|Withdrawal by Subject|0|||
46772045|NCT00783692|82990315|FG000|Induction Phase|Lost to Follow-up|0|||
46772046|NCT00783692|82990316|FG001|Induction Phase|Lost to Follow-up|0|||
46772047|NCT00783692|82990317|FG002|Induction Phase|Lost to Follow-up|3|||
46951257|NCT01369355|83190067|FG001|Long-term Extension (Week 44-272)|Other|0|||
46951258|NCT01369355|83190068|FG002|Long-term Extension (Week 44-272)|Other|0|||
46951259|NCT01369355|83190069|FG003|Long-term Extension (Week 44-272)|Other|0|||
46951260|NCT01369355|83190070|FG004|Long-term Extension (Week 44-272)|Other|0|||
46951261|NCT01369355|83190071|FG005|Long-term Extension (Week 44-272)|Other|0|||
46951262|NCT01369355|83190072|FG006|Long-term Extension (Week 44-272)|Other|110|||
47066587|NCT01576016|83349253|FG001|MRI Safety|Has not yet completed MRI scan|56|||
47066588|NCT01576016|83349252|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
47066589|NCT01576016|83349253|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
47066590|NCT01540838|83349263|FG000|Overall Study|Open nasogastric tube|9|||
47066591|NCT01540838|83349264|FG001|Overall Study|Open nasogastric tube|7|||
46639120|NCT01389102|82812681|FG004|Overall Study|Protocol Violation|1|||
46639121|NCT01389102|82812682|FG005|Overall Study|Protocol Violation|1|||
46772048|NCT00783692|82990318|FG003|Induction Phase|Lost to Follow-up|0|||
46639122|NCT01389102|82812677|FG000|Overall Study|Withdrawal by Subject|7|||
46639123|NCT01389102|82812678|FG001|Overall Study|Withdrawal by Subject|4|||
46772049|NCT00783692|82990319|FG004|Induction Phase|Lost to Follow-up|0|||
46951263|NCT01369355|83190073|FG007|Long-term Extension (Week 44-272)|Other|9|||
46951264|NCT01369355|83190074|FG008|Long-term Extension (Week 44-272)|Other|17|||
46951265|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Adverse Event|8|||
46951266|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Adverse Event|5|||
46951267|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Adverse Event|9|||
46951268|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Adverse Event|0|||
46951269|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Adverse Event|0|||
46951270|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Adverse Event|0|||
46951271|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
46951272|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
46951273|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
46951274|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
46951275|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
46951276|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
46951277|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
46951278|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
46951279|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
46951280|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
46951281|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
46951282|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
46951283|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Physician Decision|4|||
46951284|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Physician Decision|0|||
46951285|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Physician Decision|2|||
46951286|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Physician Decision|0|||
46951287|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Physician Decision|0|||
46951288|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Physician Decision|0|||
46951289|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Pregnancy|1|||
46951290|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Pregnancy|2|||
46951291|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Pregnancy|0|||
46951292|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Pregnancy|0|||
46951293|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Pregnancy|0|||
46951294|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Pregnancy|0|||
46951295|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
46951296|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
46951297|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
46951298|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
46951299|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
46951300|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
46951301|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
46951302|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
46772050|NCT00783692|82990320|FG005|Induction Phase|Lost to Follow-up|0|||
46772051|NCT00783692|82990321|FG006|Induction Phase|Lost to Follow-up|0|||
46772052|NCT00783692|82990315|FG000|Induction Phase|Other|0|||
46772053|NCT00783692|82990316|FG001|Induction Phase|Other|0|||
46842837|NCT03799198|83059815|FG000|Overall Study|Death|0|||
46842838|NCT03799198|83059816|FG001|Overall Study|Death|1|||
46772054|NCT00783692|82990317|FG002|Induction Phase|Other|2|||
46772055|NCT00783692|82990318|FG003|Induction Phase|Other|0|||
46772056|NCT00783692|82990319|FG004|Induction Phase|Other|0|||
46772057|NCT00783692|82990320|FG005|Induction Phase|Other|0|||
46842839|NCT00232596|83059824|FG000|6-Week Titration Phase|Adverse Event|6|||
46842840|NCT00232596|83059825|FG001|6-Week Titration Phase|Adverse Event|19|||
46842841|NCT00232596|83059824|FG000|6-Week Titration Phase|Failed to Return|2|||
46842842|NCT00232596|83059825|FG001|6-Week Titration Phase|Failed to Return|1|||
46842843|NCT00232596|83059824|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
46951303|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
46951304|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
46951305|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
46951306|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
46772058|NCT00783692|82990321|FG006|Induction Phase|Other|0|||
46772059|NCT00783692|82990315|FG000|Maintenance Phase|Adverse Event|7|||
46842844|NCT00232596|83059825|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
46842845|NCT00232596|83059824|FG000|6-Week Titration Phase|Protocol Violation|1|||
46842846|NCT00232596|83059825|FG001|6-Week Titration Phase|Protocol Violation|3|||
46951307|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
46951308|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
46951309|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
46951310|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
46951311|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
46951312|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
46772060|NCT00783692|82990316|FG001|Maintenance Phase|Adverse Event|0|||
46842847|NCT00232596|83059824|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
46951313|NCT02614196|83190097|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
46951314|NCT02614196|83190098|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
46951315|NCT02614196|83190099|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
46951316|NCT02614196|83190100|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
46951317|NCT02614196|83190101|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
46951318|NCT02614196|83190102|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
46951319|NCT02614196|83190097|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
46951320|NCT02614196|83190098|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
46951321|NCT02614196|83190099|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
46951322|NCT02614196|83190100|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
46951323|NCT02614196|83190101|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
46951324|NCT02614196|83190102|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
46951325|NCT02614196|83190097|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
46951326|NCT02614196|83190098|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
46951327|NCT02614196|83190099|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
46951328|NCT02614196|83190100|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
46951329|NCT02614196|83190101|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
46951330|NCT02614196|83190102|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
46951331|NCT02614196|83190097|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
46951332|NCT02614196|83190098|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
46951333|NCT02614196|83190099|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
46951334|NCT02614196|83190100|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
46951335|NCT02614196|83190101|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
46951336|NCT02614196|83190102|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
46842848|NCT00232596|83059825|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
46842849|NCT00232596|83059824|FG000|6-Week Titration Phase|Other|3|||
46842850|NCT00232596|83059825|FG001|6-Week Titration Phase|Other|3|||
46842851|NCT00232596|83059824|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
46951337|NCT02614196|83190097|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
46951338|NCT02614196|83190098|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
46951339|NCT02614196|83190099|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
46951340|NCT02614196|83190100|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
46951341|NCT02614196|83190101|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
46951342|NCT02614196|83190102|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
46951343|NCT02765035|83190132|FG000|First Intervention (90 Days)|Adverse Event|1|||
46951344|NCT02765035|83190133|FG001|First Intervention (90 Days)|Adverse Event|1|||
46951345|NCT02765035|83190132|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
46951346|NCT02765035|83190133|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
46951347|NCT02307682|83190143|FG000|Overall Study|Adverse Event|9|||
46951348|NCT02307682|83190144|FG001|Overall Study|Adverse Event|8|||
46842852|NCT00232596|83059825|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
46951349|NCT02307682|83190145|FG002|Overall Study|Adverse Event|12|||
46951350|NCT02307682|83190143|FG000|Overall Study|Lack of Efficacy|1|||
46951351|NCT02307682|83190144|FG001|Overall Study|Lack of Efficacy|0|||
46951352|NCT02307682|83190145|FG002|Overall Study|Lack of Efficacy|1|||
46951353|NCT02307682|83190143|FG000|Overall Study|Physician Decision|2|||
46951354|NCT02307682|83190144|FG001|Overall Study|Physician Decision|2|||
46951355|NCT02307682|83190145|FG002|Overall Study|Physician Decision|8|||
46951356|NCT02307682|83190143|FG000|Overall Study|Progressive Disease|1|||
46951357|NCT02307682|83190144|FG001|Overall Study|Progressive Disease|0|||
46951358|NCT02307682|83190145|FG002|Overall Study|Progressive Disease|0|||
46951359|NCT02307682|83190143|FG000|Overall Study|Withdrawal by Subject|26|||
46951360|NCT02307682|83190144|FG001|Overall Study|Withdrawal by Subject|34|||
46951361|NCT02307682|83190145|FG002|Overall Study|Withdrawal by Subject|23|||
46951362|NCT02307682|83190143|FG000|Overall Study|Death|9|||
46951363|NCT02307682|83190144|FG001|Overall Study|Death|7|||
46951364|NCT02307682|83190145|FG002|Overall Study|Death|12|||
46951365|NCT02307682|83190143|FG000|Overall Study|Lost to Follow-up|1|||
46951366|NCT02307682|83190144|FG001|Overall Study|Lost to Follow-up|5|||
46951367|NCT02307682|83190145|FG002|Overall Study|Lost to Follow-up|6|||
46951368|NCT02307682|83190143|FG000|Overall Study|Protocol Deviation|0|||
46951369|NCT02307682|83190144|FG001|Overall Study|Protocol Deviation|0|||
46951370|NCT02307682|83190145|FG002|Overall Study|Protocol Deviation|2|||
46951371|NCT02307682|83190143|FG000|Overall Study|Other|1|||
46951372|NCT02307682|83190144|FG001|Overall Study|Other|1|||
46951373|NCT02307682|83190145|FG002|Overall Study|Other|0|||
46639124|NCT01389102|82812679|FG002|Overall Study|Withdrawal by Subject|9|||
46639125|NCT01389102|82812680|FG003|Overall Study|Withdrawal by Subject|2|||
46842853|NCT00232596|83059824|FG000|12-Week Maintenance Phase|Adverse Event|7|||
46842854|NCT00232596|83059825|FG001|12-Week Maintenance Phase|Adverse Event|22|||
46951374|NCT02615990|83190155|FG000|Overall Study|study terminated|1|||
46951375|NCT02615990|83190156|FG001|Overall Study|study terminated|1|||
46951376|NCT02613884|83190162|FG000|Overall Study|Death|1|||
46951377|NCT02613884|83190162|FG000|Overall Study|Lost to Follow-up|1|||
46951378|NCT02791763|83190170|FG000|Overall Study|Protocol Violation|0|||
46951379|NCT02791763|83190171|FG001|Overall Study|Protocol Violation|0|||
46951380|NCT02791763|83190172|FG002|Overall Study|Protocol Violation|1|||
46951381|NCT02791763|83190170|FG000|Overall Study|Withdrawal by Subject|5|||
46951382|NCT02791763|83190171|FG001|Overall Study|Withdrawal by Subject|1|||
46951383|NCT02791763|83190172|FG002|Overall Study|Withdrawal by Subject|0|||
46951384|NCT02791763|83190170|FG000|Overall Study|Physician Decision|0|||
46951385|NCT02791763|83190171|FG001|Overall Study|Physician Decision|1|||
46951386|NCT02791763|83190172|FG002|Overall Study|Physician Decision|0|||
46951387|NCT02791763|83190170|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
46951388|NCT02791763|83190171|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
46951389|NCT02791763|83190172|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
46951390|NCT02791763|83190170|FG000|Overall Study|Cancer event|1|||
46951391|NCT02791763|83190171|FG001|Overall Study|Cancer event|3|||
46951392|NCT02791763|83190172|FG002|Overall Study|Cancer event|0|||
46951393|NCT02791763|83190170|FG000|Overall Study|Participant had renal transplant|3|||
46951394|NCT02791763|83190171|FG001|Overall Study|Participant had renal transplant|0|||
46951395|NCT02791763|83190172|FG002|Overall Study|Participant had renal transplant|0|||
46951396|NCT02791763|83190170|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
46951397|NCT02791763|83190171|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
46951398|NCT02791763|83190172|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
46951399|NCT02791763|83190170|FG000|Overall Study|Adverse Event|12|||
46951400|NCT02791763|83190171|FG001|Overall Study|Adverse Event|13|||
46951401|NCT02791763|83190172|FG002|Overall Study|Adverse Event|7|||
46951402|NCT02613572|83190192|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
46951403|NCT02613572|83190193|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
46951404|NCT02613572|83190194|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
46951405|NCT02613572|83190192|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
46951406|NCT02613572|83190193|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
46951407|NCT02613572|83190194|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
46951408|NCT02087189|83190206|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
46951409|NCT02341456|83190213|FG000|Overall Study|Disease progression|2|||
46951410|NCT02341456|83190214|FG001|Overall Study|Disease progression|3|||
46951411|NCT02341456|83190215|FG002|Overall Study|Disease progression|1|||
46951412|NCT02341456|83190213|FG000|Overall Study|Death|1|||
46842855|NCT00232596|83059824|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
46842856|NCT00232596|83059825|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
46842857|NCT00232596|83059824|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
46842858|NCT00232596|83059825|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
46842859|NCT00232596|83059824|FG000|12-Week Maintenance Phase|Other|1|||
46842860|NCT00232596|83059825|FG001|12-Week Maintenance Phase|Other|3|||
46842861|NCT00073918|83059843|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
46842862|NCT00073918|83059843|FG000|Overall Study|Rapid disease progression|2|||
46842863|NCT00073918|83059843|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
46951413|NCT02341456|83190214|FG001|Overall Study|Death|1|||
46951414|NCT02341456|83190215|FG002|Overall Study|Death|1|||
46951415|NCT02341456|83190213|FG000|Overall Study|Withdrawal by Subject|0|||
46951416|NCT02341456|83190214|FG001|Overall Study|Withdrawal by Subject|1|||
46951417|NCT02341456|83190215|FG002|Overall Study|Withdrawal by Subject|1|||
46951418|NCT02341456|83190213|FG000|Overall Study|Moved to local access programme.|0|||
46951419|NCT02341456|83190214|FG001|Overall Study|Moved to local access programme.|1|||
46951420|NCT02341456|83190215|FG002|Overall Study|Moved to local access programme.|1|||
46951421|NCT02341456|83190213|FG000|Overall Study|Physician Decision|1|||
46951422|NCT02341456|83190214|FG001|Overall Study|Physician Decision|0|||
46951423|NCT02341456|83190215|FG002|Overall Study|Physician Decision|0|||
46951424|NCT02370784|83190225|FG000|Overall Study|Patient started prohibited medication|0|||
46951425|NCT02370784|83190226|FG001|Overall Study|Patient started prohibited medication|1|||
46951426|NCT02307370|83190234|FG000|Overall Study|Death|5|||
46951427|NCT02307370|83190234|FG000|Overall Study|Lost to Follow-up|1|||
47066592|NCT01540838|83349263|FG000|Overall Study|Treatment doses missing|8|||
46951428|NCT02307370|83190234|FG000|Overall Study|Withdrawal by Subject|1|||
46951429|NCT02307370|83190234|FG000|Overall Study|Declined Addendum ICF|6|||
46951430|NCT02307370|83190234|FG000|Overall Study|No response during telephone contact|5|||
46951431|NCT02307370|83190234|FG000|Overall Study|Protocol Violation|1|||
46951432|NCT02370394|83190242|FG000|Overall Study|Lost to Follow-up|2|||
46951433|NCT02370394|83190243|FG001|Overall Study|Lost to Follow-up|1|||
47066593|NCT01540838|83349264|FG001|Overall Study|Treatment doses missing|12|||
47066594|NCT01540838|83349263|FG000|Overall Study|Additional antibiotic treatment|1|||
46842864|NCT00231894|83059849|FG000|Overall Study|Withdrawal by Subject|1|||
46842865|NCT00231894|83059850|FG001|Overall Study|Withdrawal by Subject|1|||
46951434|NCT02370394|83190242|FG000|Overall Study|Withdrawal by Subject|0|||
46951435|NCT02370394|83190243|FG001|Overall Study|Withdrawal by Subject|1|||
46951436|NCT01595438|83190252|FG000|Overall Study|Lost to Follow-up|20|||
46951437|NCT01595438|83190253|FG001|Overall Study|Lost to Follow-up|20|||
46951438|NCT01595438|83190252|FG000|Overall Study|Withdrawal by Subject|12|||
46951439|NCT01595438|83190253|FG001|Overall Study|Withdrawal by Subject|12|||
46951440|NCT01595438|83190252|FG000|Overall Study|Other Eligibility criteria|11|||
46951441|NCT01595438|83190253|FG001|Overall Study|Other Eligibility criteria|9|||
46951442|NCT02340520|83190259|FG000|Overall Study|Lost to Follow-up|1|||
46951443|NCT02340520|83190259|FG000|Overall Study|Patient did not take drug as specified|1|||
46951444|NCT02340520|83190259|FG000|Overall Study|Withdrawal by Subject|1|||
46951445|NCT02339584|83190265|FG000|Overall Study|Adverse Event|11|||
46951446|NCT02339584|83190266|FG001|Overall Study|Adverse Event|7|||
46951447|NCT02339584|83190265|FG000|Overall Study|Lack of Efficacy|0|||
46951448|NCT02339584|83190266|FG001|Overall Study|Lack of Efficacy|1|||
46951449|NCT02339584|83190265|FG000|Overall Study|Physician Decision|1|||
46951450|NCT02339584|83190266|FG001|Overall Study|Physician Decision|2|||
46951451|NCT02339584|83190265|FG000|Overall Study|Protocol Violation|1|||
46951452|NCT02339584|83190266|FG001|Overall Study|Protocol Violation|1|||
46951453|NCT02339584|83190265|FG000|Overall Study|Withdrawal by Subject|2|||
46951454|NCT02339584|83190266|FG001|Overall Study|Withdrawal by Subject|4|||
46842866|NCT00203424|83059862|FG000|Treatment Period|Withdrawal by Subject|4|||
46842867|NCT00203424|83059862|FG000|Treatment Period|Adverse Event|5|||
46842868|NCT00203424|83059862|FG000|Treatment Period|progressive disease|2|||
46842869|NCT00203424|83059862|FG000|Follow-up Period|Withdrawal by Subject|1|||
46842870|NCT00203424|83059862|FG000|Follow-up Period|progressive disease|4|||
46842871|NCT00203424|83059862|FG000|Follow-up Period|Lost to Follow-up|1|||
46842872|NCT00203268|83059866|FG000|Early Treatment|only treated one headache|2|||
46842873|NCT00203268|83059866|FG000|Early Treatment|Lost to Follow-up|1|||
46842874|NCT00203268|83059866|FG000|Early Treatment|Withdrawal by Subject|1|||
46842875|NCT00168818|83059875|FG000|Overall Study|Adverse Event|23|||
46842876|NCT00168818|83059876|FG001|Overall Study|Adverse Event|29|||
46842877|NCT00168818|83059877|FG002|Overall Study|Adverse Event|31|||
46842878|NCT00168818|83059875|FG000|Overall Study|Protocol Violation|16|||
46842879|NCT00168818|83059876|FG001|Overall Study|Protocol Violation|11|||
46842880|NCT00168818|83059877|FG002|Overall Study|Protocol Violation|11|||
46842881|NCT00168818|83059875|FG000|Overall Study|Lost to Follow-up|13|||
46842882|NCT00168818|83059876|FG001|Overall Study|Lost to Follow-up|4|||
46842883|NCT00168818|83059877|FG002|Overall Study|Lost to Follow-up|15|||
46842884|NCT00168818|83059875|FG000|Overall Study|Withdrawal by Subject|43|||
46842885|NCT00168818|83059876|FG001|Overall Study|Withdrawal by Subject|41|||
46842886|NCT00168818|83059877|FG002|Overall Study|Withdrawal by Subject|37|||
46842887|NCT00168818|83059875|FG000|Overall Study|Other|22|||
46842888|NCT00168818|83059876|FG001|Overall Study|Other|24|||
46842889|NCT00168818|83059877|FG002|Overall Study|Other|30|||
46842890|NCT00168818|83059875|FG000|Treatment|Adverse Event|77|||
46842891|NCT00168818|83059876|FG001|Treatment|Adverse Event|89|||
46842892|NCT00168818|83059877|FG002|Treatment|Adverse Event|68|||
46842893|NCT00168818|83059875|FG000|Treatment|Protocol Violation|8|||
46842894|NCT00168818|83059876|FG001|Treatment|Protocol Violation|11|||
46772061|NCT00783692|82990317|FG002|Maintenance Phase|Adverse Event|0|||
46772062|NCT00783692|82990318|FG003|Maintenance Phase|Adverse Event|15|||
46772063|NCT00783692|82990319|FG004|Maintenance Phase|Adverse Event|12|||
46772064|NCT00783692|82990320|FG005|Maintenance Phase|Adverse Event|9|||
46772065|NCT00783692|82990321|FG006|Maintenance Phase|Adverse Event|38|||
46772066|NCT00783692|82990315|FG000|Maintenance Phase|Protocol Violation|0|||
46772067|NCT00783692|82990316|FG001|Maintenance Phase|Protocol Violation|0|||
46772068|NCT00783692|82990317|FG002|Maintenance Phase|Protocol Violation|0|||
46772069|NCT00783692|82990318|FG003|Maintenance Phase|Protocol Violation|1|||
46772070|NCT00783692|82990319|FG004|Maintenance Phase|Protocol Violation|2|||
46772071|NCT00783692|82990320|FG005|Maintenance Phase|Protocol Violation|3|||
46772072|NCT00783692|82990321|FG006|Maintenance Phase|Protocol Violation|4|||
46772073|NCT00783692|82990315|FG000|Maintenance Phase|Lack of Efficacy|79|||
46772074|NCT00783692|82990316|FG001|Maintenance Phase|Lack of Efficacy|0|||
46772075|NCT00783692|82990317|FG002|Maintenance Phase|Lack of Efficacy|0|||
46842895|NCT00168818|83059877|FG002|Treatment|Protocol Violation|11|||
46951455|NCT02339506|83190272|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
46951456|NCT02339506|83190273|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
46951457|NCT02339506|83190272|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
46842896|NCT00168818|83059875|FG000|Treatment|Lost to Follow-up|0|||
47066595|NCT01540838|83349264|FG001|Overall Study|Additional antibiotic treatment|2|||
46772076|NCT00783692|82990318|FG003|Maintenance Phase|Lack of Efficacy|64|||
46772077|NCT00783692|82990319|FG004|Maintenance Phase|Lack of Efficacy|58|||
46842897|NCT00168818|83059876|FG001|Treatment|Lost to Follow-up|2|||
46842898|NCT00168818|83059877|FG002|Treatment|Lost to Follow-up|1|||
46842899|NCT00168818|83059875|FG000|Treatment|Withdrawal by Subject|25|||
46842900|NCT00168818|83059876|FG001|Treatment|Withdrawal by Subject|20|||
46842901|NCT00168818|83059877|FG002|Treatment|Withdrawal by Subject|22|||
46842902|NCT00168818|83059875|FG000|Treatment|Other|23|||
46842903|NCT00168818|83059876|FG001|Treatment|Other|29|||
46842904|NCT00168818|83059877|FG002|Treatment|Other|31|||
46951458|NCT02339506|83190273|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
46951459|NCT02305888|83190282|FG000|Overall Study|Lost to Follow-up|0|||
46951460|NCT02305888|83190283|FG001|Overall Study|Lost to Follow-up|0|||
46951461|NCT02305888|83190284|FG002|Overall Study|Lost to Follow-up|1|||
46951462|NCT02305888|83190282|FG000|Overall Study|Adverse Event|0|||
46951463|NCT02305888|83190283|FG001|Overall Study|Adverse Event|1|||
46951464|NCT02305888|83190284|FG002|Overall Study|Adverse Event|0|||
46951465|NCT02338882|83190294|FG000|Overall Study|Death|1|||
46951466|NCT02338882|83190295|FG001|Overall Study|Death|0|||
46951467|NCT02338882|83190294|FG000|Overall Study|Lost to Follow-up|6|||
46951468|NCT02338882|83190295|FG001|Overall Study|Lost to Follow-up|3|||
46951469|NCT01594970|83190307|FG000|Overall Study|Non-Adverse Event Related|4|||
46951470|NCT01594970|83190308|FG001|Overall Study|Non-Adverse Event Related|5|||
46951471|NCT01594970|83190309|FG002|Overall Study|Non-Adverse Event Related|6|||
46951472|NCT01594970|83190307|FG000|Overall Study|Adverse Event|17|||
46951473|NCT01594970|83190308|FG001|Overall Study|Adverse Event|23|||
46951474|NCT01594970|83190309|FG002|Overall Study|Adverse Event|23|||
46951475|NCT01594970|83190307|FG000|Overall Study|Lost to Follow-up|54|||
46951476|NCT01594970|83190308|FG001|Overall Study|Lost to Follow-up|54|||
46951477|NCT01594970|83190309|FG002|Overall Study|Lost to Follow-up|37|||
46951478|NCT02338492|83190317|FG000|Overall Study|Death|32|||
46951479|NCT02338492|83190317|FG000|Overall Study|Adverse Event|3|||
46951480|NCT02338492|83190317|FG000|Overall Study|Lost to Follow-up|4|||
46951481|NCT02338492|83190317|FG000|Overall Study|Reason not captured above|6|||
46951482|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
46951483|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
46951484|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
46951485|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
46951486|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
46951487|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
46951488|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
46951489|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
46951490|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
46951491|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
46951492|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
46951493|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
46951494|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
46951495|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
46951496|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
46951497|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
46951498|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
46951499|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
46951500|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
46951501|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
46951502|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
46951503|NCT02337946|83190321|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
46951504|NCT02337946|83190322|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
46951505|NCT02337946|83190323|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
46951506|NCT02337946|83190321|FG000|In-between Period|Without Informed Consent|1|||
46951507|NCT02337946|83190322|FG001|In-between Period|Without Informed Consent|0|||
46951508|NCT02337946|83190323|FG002|In-between Period|Without Informed Consent|0|||
46951509|NCT02337946|83190321|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
46951510|NCT02337946|83190322|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
46951511|NCT02337946|83190323|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
46951512|NCT02337946|83190321|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
46951513|NCT02337946|83190322|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
46951514|NCT02337946|83190323|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
46951515|NCT02337946|83190321|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
46951516|NCT02337946|83190322|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
46951517|NCT02337946|83190323|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
46951518|NCT02337946|83190321|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
46951519|NCT02337946|83190322|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
46772078|NCT00783692|82990320|FG005|Maintenance Phase|Lack of Efficacy|48|||
46772079|NCT00783692|82990321|FG006|Maintenance Phase|Lack of Efficacy|177|||
46772080|NCT00783692|82990315|FG000|Maintenance Phase|Withdrawal by Subject|7|||
46772081|NCT00783692|82990316|FG001|Maintenance Phase|Withdrawal by Subject|0|||
46772082|NCT00783692|82990317|FG002|Maintenance Phase|Withdrawal by Subject|0|||
46772083|NCT00783692|82990318|FG003|Maintenance Phase|Withdrawal by Subject|7|||
46772084|NCT00783692|82990319|FG004|Maintenance Phase|Withdrawal by Subject|6|||
46772085|NCT00783692|82990320|FG005|Maintenance Phase|Withdrawal by Subject|9|||
46951520|NCT02337946|83190323|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
46772086|NCT00783692|82990321|FG006|Maintenance Phase|Withdrawal by Subject|24|||
46772087|NCT00783692|82990315|FG000|Maintenance Phase|Lost to Follow-up|2|||
46951521|NCT02337946|83190321|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
46951522|NCT02337946|83190322|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
46951523|NCT02337946|83190323|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
46951524|NCT02337946|83190321|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
46951525|NCT02337946|83190322|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
46951526|NCT02337946|83190323|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
46951527|NCT01369199|83190329|FG000|Overall Study|Withdrawal by Subject|1|||
46951528|NCT01369199|83190329|FG000|Overall Study|Lost to Follow-up|2|||
46951529|NCT01368965|83190333|FG000|Overall Study|Lost to Follow-up|12|||
46951530|NCT02610140|83190341|FG000|Randomization and Treatment Period|Radiological progression|23|||
46951531|NCT02610140|83190342|FG001|Randomization and Treatment Period|Radiological progression|15|||
46951532|NCT02610140|83190341|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
46951533|NCT02610140|83190342|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
46951534|NCT02610140|83190341|FG000|Randomization and Treatment Period|Protocol Violation|1|||
46951535|NCT02610140|83190342|FG001|Randomization and Treatment Period|Protocol Violation|0|||
46951536|NCT02610140|83190341|FG000|Randomization and Treatment Period|Physician Decision|0|||
46951537|NCT02610140|83190342|FG001|Randomization and Treatment Period|Physician Decision|1|||
46951538|NCT02610140|83190341|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
46951539|NCT02610140|83190342|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
46951540|NCT02610140|83190341|FG000|Randomization and Treatment Period|Death|7|||
46951541|NCT02610140|83190342|FG001|Randomization and Treatment Period|Death|1|||
46951542|NCT02610140|83190341|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
46951543|NCT02610140|83190342|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
46951544|NCT02610140|83190341|FG000|Randomization and Treatment Period|Adverse Event|44|||
46951545|NCT02610140|83190342|FG001|Randomization and Treatment Period|Adverse Event|13|||
46951546|NCT02610140|83190341|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
46951547|NCT02610140|83190342|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
46951548|NCT02610140|83190341|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
46951549|NCT02610140|83190342|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
46951550|NCT02610140|83190341|FG000|Randomization and Treatment Period|Not treated|3|||
46951551|NCT02610140|83190342|FG001|Randomization and Treatment Period|Not treated|10|||
46951552|NCT02610140|83190341|FG000|Safety Follow-up|Other|0|||
46951553|NCT02610140|83190342|FG001|Safety Follow-up|Other|2|||
46951554|NCT02610140|83190341|FG000|Safety Follow-up|Lost to Follow-up|1|||
46951555|NCT02610140|83190342|FG001|Safety Follow-up|Lost to Follow-up|0|||
46951556|NCT02610140|83190341|FG000|Safety Follow-up|No follow-up|5|||
46951557|NCT02610140|83190342|FG001|Safety Follow-up|No follow-up|3|||
46951558|NCT02610140|83190341|FG000|Safety Follow-up|Death|12|||
46951559|NCT02610140|83190342|FG001|Safety Follow-up|Death|2|||
46951560|NCT02610140|83190341|FG000|Safety Follow-up|Deterioration of general conditions|15|||
46951561|NCT02610140|83190342|FG001|Safety Follow-up|Deterioration of general conditions|5|||
46951562|NCT02610140|83190341|FG000|Safety Follow-up|Withdrawal by Subject|12|||
46951563|NCT02610140|83190342|FG001|Safety Follow-up|Withdrawal by Subject|12|||
46639126|NCT01389102|82812681|FG004|Overall Study|Withdrawal by Subject|3|||
46842905|NCT00260832|83059887|FG000|Overall Study|Adverse Event|26|||
46842906|NCT00260832|83059888|FG001|Overall Study|Adverse Event|19|||
46842907|NCT00260832|83059887|FG000|Overall Study|Progression|116|||
46842908|NCT00260832|83059888|FG001|Overall Study|Progression|96|||
46842909|NCT00260832|83059887|FG000|Overall Study|Withdrawal by Subject|15|||
46842910|NCT00260832|83059888|FG001|Overall Study|Withdrawal by Subject|17|||
46842911|NCT00260832|83059887|FG000|Overall Study|Physician Decision|15|||
46842912|NCT00260832|83059888|FG001|Overall Study|Physician Decision|9|||
46842913|NCT00260832|83059887|FG000|Overall Study|Death|43|||
46842914|NCT00260832|83059888|FG001|Overall Study|Death|62|||
46842915|NCT00260832|83059887|FG000|Overall Study|Other|10|||
46842916|NCT00260832|83059888|FG001|Overall Study|Other|7|||
46842917|NCT00260832|83059887|FG000|Overall Study|Protocol Violation|3|||
46842918|NCT00260832|83059888|FG001|Overall Study|Protocol Violation|1|||
46842919|NCT00168038|83059894|FG000|Overall Study|Adverse Event|1|||
46842920|NCT00168038|83059894|FG000|Overall Study|Therapy failure|1|||
46842921|NCT00167414|83059898|FG000|Overall Study|Death|10|||
46842922|NCT00166712|83059904|FG000|Overall Study|Death|0|||
46842923|NCT00166712|83059905|FG001|Overall Study|Death|1|||
46842924|NCT00166712|83059904|FG000|Overall Study|Adverse Event|1|||
46951564|NCT02610140|83190341|FG000|Active Follow-up|Progressive disease - radiological|30|||
46951565|NCT02610140|83190342|FG001|Active Follow-up|Progressive disease - radiological|22|||
46951566|NCT02610140|83190341|FG000|Active Follow-up|Death|8|||
46639127|NCT01389102|82812682|FG005|Overall Study|Withdrawal by Subject|3|||
46842925|NCT00166712|83059905|FG001|Overall Study|Adverse Event|0|||
46951567|NCT02610140|83190342|FG001|Active Follow-up|Death|1|||
46842926|NCT00166712|83059904|FG000|Overall Study|Withdrawal by Subject|1|||
46842927|NCT00166712|83059905|FG001|Overall Study|Withdrawal by Subject|2|||
46842928|NCT00166712|83059904|FG000|Overall Study|Physician Decision|0|||
46842929|NCT00166712|83059905|FG001|Overall Study|Physician Decision|2|||
46842930|NCT00073528|83059917|FG000|Overall Study|Death|488|||
46842931|NCT00073528|83059918|FG001|Overall Study|Death|473|||
46951568|NCT02610140|83190341|FG000|Active Follow-up|Withdrawal by Subject|4|||
46951569|NCT02610140|83190342|FG001|Active Follow-up|Withdrawal by Subject|0|||
46951570|NCT02610140|83190341|FG000|Active Follow-up|Progressive disease - clinical|1|||
46951571|NCT02610140|83190342|FG001|Active Follow-up|Progressive disease - clinical|2|||
46951572|NCT02610140|83190341|FG000|Active Follow-up|Deterioration of general conditions|1|||
46951573|NCT02610140|83190342|FG001|Active Follow-up|Deterioration of general conditions|0|||
46951574|NCT02610140|83190341|FG000|Active Follow-up|Ongoing but not completed|4|||
46951575|NCT02610140|83190342|FG001|Active Follow-up|Ongoing but not completed|1|||
46951576|NCT02610140|83190341|FG000|Long-term Follow-up|Death|86|||
46951577|NCT02610140|83190342|FG001|Long-term Follow-up|Death|44|||
46842932|NCT00073528|83059917|FG000|Overall Study|Lost to Follow-up|52|||
46842933|NCT00073528|83059918|FG001|Overall Study|Lost to Follow-up|45|||
46842934|NCT00073528|83059917|FG000|Overall Study|Withdrawal by Subject|50|||
46842935|NCT00073528|83059918|FG001|Overall Study|Withdrawal by Subject|45|||
46842936|NCT00073528|83059917|FG000|Overall Study|Study terminated by Sponsor|10|||
46842937|NCT00073528|83059918|FG001|Overall Study|Study terminated by Sponsor|29|||
46842938|NCT00073528|83059917|FG000|Overall Study|Other|18|||
46842939|NCT00073528|83059918|FG001|Overall Study|Other|19|||
46842940|NCT00073528|83059917|FG000|Overall Study|Other|9|||
46842941|NCT00073528|83059918|FG001|Overall Study|Other|12|||
46842942|NCT00073528|83059917|FG000|Overall Study|Protocol Violation|3|||
46842943|NCT00073528|83059918|FG001|Overall Study|Protocol Violation|5|||
46842944|NCT03801148|83059928|FG000|Period 1 (2 Days)|Adverse Event|1|||
46842945|NCT03801148|83059929|FG001|Period 1 (2 Days)|Adverse Event|1|||
46842946|NCT03801148|83059930|FG002|Period 1 (2 Days)|Adverse Event|0|||
46842947|NCT03801148|83059931|FG003|Period 1 (2 Days)|Adverse Event|0|||
46842948|NCT03801148|83059928|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
46842949|NCT03801148|83059929|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
46842950|NCT03801148|83059930|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
46842951|NCT03801148|83059931|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
46842952|NCT03801148|83059928|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46842953|NCT03801148|83059929|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46842954|NCT03801148|83059930|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
46842955|NCT03801148|83059931|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46842956|NCT03801148|83059928|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
46842957|NCT03801148|83059929|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
46842958|NCT03801148|83059930|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
47066596|NCT01540838|83349263|FG000|Overall Study|Died before treatment initiation|1|||
47066597|NCT01540838|83349264|FG001|Overall Study|Died before treatment initiation|1|||
47066598|NCT01540838|83349263|FG000|Overall Study|Not BM. Other treatment|3|||
47066599|NCT01540838|83349264|FG001|Overall Study|Not BM. Other treatment|1|||
46772088|NCT00783692|82990316|FG001|Maintenance Phase|Lost to Follow-up|0|||
46772089|NCT00783692|82990317|FG002|Maintenance Phase|Lost to Follow-up|0|||
46772090|NCT00783692|82990318|FG003|Maintenance Phase|Lost to Follow-up|1|||
46772091|NCT00783692|82990319|FG004|Maintenance Phase|Lost to Follow-up|3|||
46772092|NCT00783692|82990320|FG005|Maintenance Phase|Lost to Follow-up|2|||
46772093|NCT00783692|82990321|FG006|Maintenance Phase|Lost to Follow-up|5|||
46772094|NCT00783692|82990315|FG000|Maintenance Phase|Other|0|||
46772095|NCT00783692|82990316|FG001|Maintenance Phase|Other|0|||
46772096|NCT00783692|82990317|FG002|Maintenance Phase|Other|0|||
46772097|NCT00783692|82990318|FG003|Maintenance Phase|Other|1|||
46772098|NCT00783692|82990319|FG004|Maintenance Phase|Other|0|||
46772099|NCT00783692|82990320|FG005|Maintenance Phase|Other|1|||
46772100|NCT00783692|82990321|FG006|Maintenance Phase|Other|1|||
46772101|NCT04992273|82990336|FG000|Overall Study|Lost to Follow-up|0|||
46772102|NCT04992273|82990337|FG001|Overall Study|Lost to Follow-up|1|||
46772103|NCT00783302|82990344|FG000|Overall Study|Lost to Follow-up|17|||
46772104|NCT00783302|82990344|FG000|Overall Study|Technical Problems|11|||
46772105|NCT00783302|82990344|FG000|Overall Study|Protocol Violation|3|||
46772106|NCT00783302|82990344|FG000|Overall Study|Physician Decision|1|||
46772107|NCT00783302|82990344|FG000|Overall Study|Withdrawal by Subject|3|||
46772108|NCT00783224|82990366|FG000|Overall Study|Adverse Event|0|||
46772109|NCT00783224|82990367|FG001|Overall Study|Adverse Event|0|||
46772110|NCT00783224|82990368|FG002|Overall Study|Adverse Event|1|||
46772111|NCT00783224|82990369|FG003|Overall Study|Adverse Event|0|||
46772112|NCT00783224|82990366|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
46842959|NCT03801148|83059931|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
46842960|NCT00072280|83059943|FG000|Treatment|Found ineligible|1|||
46951578|NCT02610140|83190341|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
46951579|NCT02610140|83190342|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
46772113|NCT00783224|82990367|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
46842961|NCT00072280|83059944|FG001|Treatment|Found ineligible|2|||
46842962|NCT00072280|83059943|FG000|Follow-up|Early termination of study|2|||
46842963|NCT00072280|83059944|FG001|Follow-up|Early termination of study|2|||
47066600|NCT01451437|83349279|FG000|Overall Study|Adverse Event|0|||
46951580|NCT02610140|83190341|FG000|Long-term Follow-up|Lost to Follow-up|1|||
46951581|NCT02610140|83190342|FG001|Long-term Follow-up|Lost to Follow-up|2|||
46951582|NCT02610140|83190341|FG000|Long-term Follow-up|Ongoing but not completed|30|||
46951583|NCT02610140|83190342|FG001|Long-term Follow-up|Ongoing but not completed|17|||
46951584|NCT02789657|83190352|FG000|Overall Study|Withdrawal by Subject|2|||
46951585|NCT02789657|83190353|FG001|Overall Study|Withdrawal by Subject|0|||
46951586|NCT02789657|83190354|FG002|Overall Study|Withdrawal by Subject|0|||
46951587|NCT02789657|83190355|FG003|Overall Study|Withdrawal by Subject|0|||
46951588|NCT02609984|83190366|FG000|Overall Study|Death|29|||
46951589|NCT02609984|83190367|FG001|Overall Study|Death|26|||
46951590|NCT02609984|83190366|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
46951591|NCT02609984|83190367|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
46951592|NCT02609984|83190366|FG000|Overall Study|Lost to Follow-up|1|||
46951593|NCT02609984|83190367|FG001|Overall Study|Lost to Follow-up|2|||
46951594|NCT02609984|83190366|FG000|Overall Study|Withdrawal by Subject|0|||
46951595|NCT02609984|83190367|FG001|Overall Study|Withdrawal by Subject|1|||
46951596|NCT02609984|83190366|FG000|Overall Study|Disease Progression|2|||
46951597|NCT02609984|83190367|FG001|Overall Study|Disease Progression|0|||
46951598|NCT02609672|83190375|FG000|Overall Study|Lost to Follow-up|3|||
46951599|NCT02609672|83190376|FG001|Overall Study|Lost to Follow-up|1|||
46951600|NCT02611778|83190384|FG000|Overall Study|Withdrawal by Subject|2|||
46951601|NCT02611778|83190385|FG001|Overall Study|Withdrawal by Subject|8|||
46951602|NCT02611778|83190384|FG000|Overall Study|Adverse Event|1|||
46951603|NCT02611778|83190385|FG001|Overall Study|Adverse Event|2|||
46951604|NCT02611778|83190384|FG000|Overall Study|Death|2|||
46951605|NCT02611778|83190385|FG001|Overall Study|Death|1|||
46951606|NCT02611778|83190384|FG000|Overall Study|Protocol Violation|1|||
46951607|NCT02611778|83190385|FG001|Overall Study|Protocol Violation|0|||
46951608|NCT02611778|83190384|FG000|Overall Study|Lost to Follow-up|3|||
46951609|NCT02611778|83190385|FG001|Overall Study|Lost to Follow-up|1|||
46951610|NCT02611778|83190384|FG000|Overall Study|Need for alternative treatment|1|||
46951611|NCT02611778|83190385|FG001|Overall Study|Need for alternative treatment|0|||
46951612|NCT02611778|83190384|FG000|Overall Study|Other Reason|2|||
46951613|NCT02611778|83190385|FG001|Overall Study|Other Reason|1|||
46951614|NCT02709369|83190392|FG000|Overall Study|Lost to Follow-up|15|||
46951615|NCT02709369|83190392|FG000|Overall Study|Withdrawal by Subject|10|||
46951616|NCT02709369|83190392|FG000|Overall Study|Did not received intervention|2|||
46951617|NCT02613182|83190396|FG000|Overall Study|Death|6|||
46951618|NCT02613182|83190396|FG000|Overall Study|Physician Decision|1|||
46951619|NCT02613182|83190396|FG000|Overall Study|Study Terminated by Sponsor|21|||
46951620|NCT02613182|83190396|FG000|Overall Study|Withdrawal by Subject|6|||
46951621|NCT04843579|83190422|FG000|Overall Study|Adverse Event|1|||
46951622|NCT04843579|83190422|FG000|Overall Study|Disease Progression|1|||
46951623|NCT04567693|83190442|FG000|Overall Study|Death|0|||
46951624|NCT04567693|83190443|FG001|Overall Study|Death|0|||
46951625|NCT04567693|83190444|FG002|Overall Study|Death|2|||
46951626|NCT04567693|83190442|FG000|Overall Study|Lost to Follow-up|1|||
46951627|NCT04567693|83190443|FG001|Overall Study|Lost to Follow-up|0|||
46951628|NCT04567693|83190444|FG002|Overall Study|Lost to Follow-up|2|||
46951629|NCT04567693|83190442|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
46951630|NCT04567693|83190443|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
46951631|NCT04567693|83190444|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
46951632|NCT04238663|83190455|FG000|Overall Study|Lost to Follow-up|0|||
46951633|NCT04238663|83190456|FG001|Overall Study|Lost to Follow-up|1|||
46951634|NCT04238663|83190457|FG002|Overall Study|Lost to Follow-up|0|||
46951635|NCT04139642|83190477|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
46951636|NCT04139642|83190478|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
46951637|NCT03510468|83190537|FG000|Overall Study|Lost to Follow-up|1|||
46951638|NCT03510468|83190537|FG000|Overall Study|Adverse Event|5|||
46951639|NCT03510468|83190537|FG000|Overall Study|Physician Decision|1|||
46951640|NCT03510468|83190537|FG000|Overall Study|non-compliant with treatment|2|||
46951641|NCT03510468|83190537|FG000|Overall Study|Missed visit|1|||
46951642|NCT03374202|83190544|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
46951643|NCT03374202|83190545|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
46951644|NCT03374202|83190546|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
46951645|NCT03374202|83190544|FG000|Five Year Long Term Follow Up|Death|0|||
46951646|NCT03374202|83190545|FG001|Five Year Long Term Follow Up|Death|1|||
46951647|NCT03374202|83190546|FG002|Five Year Long Term Follow Up|Death|0|||
46951648|NCT03218826|83190568|FG000|Overall Study|Non-compliance with protocol|1|||
46951649|NCT03218826|83190569|FG001|Overall Study|Non-compliance with protocol|0|||
46951650|NCT03218826|83190570|FG002|Overall Study|Non-compliance with protocol|2|||
46951651|NCT03218826|83190571|FG003|Overall Study|Non-compliance with protocol|1|||
46951652|NCT03218826|83190572|FG004|Overall Study|Non-compliance with protocol|1|||
46951653|NCT03075215|83190584|FG000|12-Month Primary Endpoint|Death|152|||
47066601|NCT01451437|83349280|FG001|Overall Study|Adverse Event|0|||
46951654|NCT03075215|83190584|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
46951655|NCT03075215|83190584|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
46951656|NCT03075215|83190584|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
46951657|NCT03063632|83190590|FG000|Overall Study|Death|4|||
46951658|NCT03063632|83190591|FG001|Overall Study|Death|6|||
46951659|NCT03063632|83190590|FG000|Overall Study|Lost to Follow-up|0|||
46951660|NCT03063632|83190591|FG001|Overall Study|Lost to Follow-up|1|||
46951661|NCT03063632|83190590|FG000|Overall Study|Withdrawal by Subject|0|||
46951662|NCT03063632|83190591|FG001|Overall Study|Withdrawal by Subject|2|||
46951663|NCT03063632|83190590|FG000|Overall Study|Physician Decision|2|||
46951664|NCT03063632|83190591|FG001|Overall Study|Physician Decision|0|||
46951665|NCT03063632|83190590|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
46951666|NCT03063632|83190591|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
46951667|NCT02759731|83190599|FG000|Overall Study|Did not complete treatment.|8|||
46951668|NCT02665117|83190607|FG000|Overall Study|Physician Decision|1|||
46951669|NCT02665117|83190608|FG001|Overall Study|Physician Decision|0|||
46951670|NCT02617485|83190616|FG000|Treatment and Observation Period|Adverse Event|9|||
46951671|NCT02617485|83190617|FG001|Treatment and Observation Period|Adverse Event|1|||
46951672|NCT02617485|83190616|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
46951673|NCT02617485|83190617|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
46951674|NCT02617485|83190616|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
46951675|NCT02617485|83190617|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
46951676|NCT02617485|83190616|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
46951677|NCT02617485|83190617|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
46951678|NCT02617485|83190616|FG000|Treatment and Observation Period|Physician Decision|0|||
46951679|NCT02617485|83190617|FG001|Treatment and Observation Period|Physician Decision|1|||
46951680|NCT02617485|83190616|FG000|Follow-up Period|Adverse Event|1|||
46951681|NCT02617485|83190617|FG001|Follow-up Period|Adverse Event|0|||
46951682|NCT02617485|83190616|FG000|Follow-up Period|Withdrawal by Subject|1|||
46951683|NCT02617485|83190617|FG001|Follow-up Period|Withdrawal by Subject|0|||
46951684|NCT02617485|83190616|FG000|Follow-up Period|Disease progression|2|||
46951685|NCT02617485|83190617|FG001|Follow-up Period|Disease progression|1|||
46951686|NCT02617485|83190616|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
46951687|NCT02617485|83190617|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
46951688|NCT02617485|83190616|FG000|Follow-up Period|Patient needed radiotherapy|9|||
46951689|NCT02617485|83190617|FG001|Follow-up Period|Patient needed radiotherapy|5|||
46951690|NCT02617485|83190616|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
46951691|NCT02617485|83190617|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
46951692|NCT02485860|83190625|FG000|Overall Study|Lost to Follow-up|4|||
46951693|NCT02485860|83190626|FG001|Overall Study|Lost to Follow-up|1|||
46951694|NCT02485860|83190625|FG000|Overall Study|Physician Decision|1|||
46842964|NCT00071812|83059953|FG000|24-Week Double-Blind Period|Adverse Event|2|||
46842965|NCT00071812|83059954|FG001|24-Week Double-Blind Period|Adverse Event|3|||
46842966|NCT00071812|83059955|FG002|24-Week Double-Blind Period|Adverse Event|4|||
46842967|NCT00071812|83059956|FG003|24-Week Double-Blind Period|Adverse Event|4|||
46842968|NCT00071812|83059953|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
46842969|NCT00071812|83059954|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
46842970|NCT00071812|83059955|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
46951695|NCT02485860|83190626|FG001|Overall Study|Physician Decision|2|||
46951696|NCT02485860|83190625|FG000|Overall Study|Health context (COVID-19)|1|||
46951697|NCT02485860|83190626|FG001|Overall Study|Health context (COVID-19)|0|||
47066602|NCT01451437|83349281|FG002|Overall Study|Adverse Event|0|||
46772114|NCT00783224|82990368|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
46772115|NCT00783224|82990369|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
46772116|NCT00783224|82990366|FG000|Overall Study|Inappropriate as a study subject|0|||
46772117|NCT00783224|82990367|FG001|Overall Study|Inappropriate as a study subject|0|||
46772118|NCT00783224|82990368|FG002|Overall Study|Inappropriate as a study subject|0|||
46772119|NCT00783224|82990369|FG003|Overall Study|Inappropriate as a study subject|1|||
46772120|NCT00782834|82990378|FG000|Treatment Phase|fibrous tumor not GIST|1|||
46772121|NCT00584805|82990382|FG000|Overall Study|No longer at risk of exposure|39|||
46772122|NCT00584805|82990382|FG000|Overall Study|Relocation|36|||
46772123|NCT00584805|82990382|FG000|Overall Study|Withdrawal by Subject|18|||
46842971|NCT00071812|83059956|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
46842972|NCT00071812|83059953|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
46842973|NCT00071812|83059954|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
46842974|NCT00071812|83059955|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
46842975|NCT00071812|83059956|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
46951698|NCT02385123|83190632|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
46951699|NCT02097420|83190636|FG000|Overall Study|Death|6|||
46951700|NCT02097420|83190636|FG000|Overall Study|Valve explanted|13|||
46951701|NCT02097420|83190636|FG000|Overall Study|Other Reason|1|||
46951702|NCT02000115|83190643|FG000|Overall Study|Death|56|||
46951703|NCT02000115|83190644|FG001|Overall Study|Death|45|||
46951704|NCT02000115|83190645|FG002|Overall Study|Death|0|||
46951705|NCT02000115|83190646|FG003|Overall Study|Death|0|||
46951706|NCT02000115|83190643|FG000|Overall Study|Missed Visit|6|||
46951707|NCT02000115|83190644|FG001|Overall Study|Missed Visit|8|||
46951708|NCT02000115|83190645|FG002|Overall Study|Missed Visit|1|||
46951709|NCT02000115|83190646|FG003|Overall Study|Missed Visit|0|||
46951710|NCT02000115|83190643|FG000|Overall Study|Protocol Violation|2|||
46951711|NCT02000115|83190644|FG001|Overall Study|Protocol Violation|1|||
46951712|NCT02000115|83190645|FG002|Overall Study|Protocol Violation|0|||
46951713|NCT02000115|83190646|FG003|Overall Study|Protocol Violation|0|||
46951714|NCT02000115|83190643|FG000|Overall Study|Physician Decision|2|||
46951715|NCT02000115|83190644|FG001|Overall Study|Physician Decision|0|||
46951716|NCT02000115|83190645|FG002|Overall Study|Physician Decision|0|||
46951717|NCT02000115|83190646|FG003|Overall Study|Physician Decision|0|||
46951718|NCT02000115|83190643|FG000|Overall Study|Withdrawal by Subject|11|||
46951719|NCT02000115|83190644|FG001|Overall Study|Withdrawal by Subject|11|||
46951720|NCT02000115|83190645|FG002|Overall Study|Withdrawal by Subject|0|||
46951721|NCT02000115|83190646|FG003|Overall Study|Withdrawal by Subject|0|||
46951722|NCT02000115|83190643|FG000|Overall Study|Lost to Follow-up|0|||
46951723|NCT02000115|83190644|FG001|Overall Study|Lost to Follow-up|1|||
46951724|NCT02000115|83190645|FG002|Overall Study|Lost to Follow-up|0|||
46951725|NCT02000115|83190646|FG003|Overall Study|Lost to Follow-up|0|||
46951726|NCT02000115|83190643|FG000|Overall Study|Non-compliance|2|||
46951727|NCT02000115|83190644|FG001|Overall Study|Non-compliance|1|||
46951728|NCT02000115|83190645|FG002|Overall Study|Non-compliance|0|||
46951729|NCT02000115|83190646|FG003|Overall Study|Non-compliance|0|||
46951730|NCT02000115|83190643|FG000|Overall Study|Withdrawn on day of randomization|0|||
46951731|NCT02000115|83190644|FG001|Overall Study|Withdrawn on day of randomization|1|||
46951732|NCT02000115|83190645|FG002|Overall Study|Withdrawn on day of randomization|0|||
46951733|NCT02000115|83190646|FG003|Overall Study|Withdrawn on day of randomization|0|||
46951734|NCT02000115|83190643|FG000|Overall Study|Still on Study|0|||
46951735|NCT02000115|83190644|FG001|Overall Study|Still on Study|0|||
46951736|NCT02000115|83190645|FG002|Overall Study|Still on Study|0|||
46951737|NCT02000115|83190646|FG003|Overall Study|Still on Study|53|||
46951738|NCT00113360|83190682|FG000|Overall Study|Adverse Event|3|||
46951739|NCT00113360|83190682|FG000|Overall Study|Subject required surgery|1|||
46951740|NCT00113360|83190682|FG000|Overall Study|Did not meet eligibility criteria|3|||
46951741|NCT00087685|83190686|FG000|Overall Study|Adverse Event|5|||
46951742|NCT00087685|83190686|FG000|Overall Study|Non-Compliance|1|||
46951743|NCT00087685|83190686|FG000|Overall Study|Progressive Disease|5|||
46951744|NCT00087685|83190686|FG000|Overall Study|Withdrawal by Subject|3|||
46951745|NCT02610842|83190690|FG000|Overall Study|Lost to Follow-up|5|||
46951746|NCT01648582|83190699|FG000|Overall Study|Adverse Event|6|||
46951747|NCT01648582|83190700|FG001|Overall Study|Adverse Event|11|||
46639128|NCT01389102|82812677|FG000|Overall Study|Subject Traveling Out of Country|0|||
46639129|NCT01389102|82812678|FG001|Overall Study|Subject Traveling Out of Country|0|||
46639130|NCT01389102|82812679|FG002|Overall Study|Subject Traveling Out of Country|0|||
46639131|NCT01389102|82812680|FG003|Overall Study|Subject Traveling Out of Country|1|||
46639132|NCT01389102|82812681|FG004|Overall Study|Subject Traveling Out of Country|0|||
46772124|NCT00584805|82990382|FG000|Overall Study|Non-compliance|1|||
46772125|NCT00584805|82990382|FG000|Overall Study|Lost to follow up|3|||
46772126|NCT00584805|82990382|FG000|Overall Study|Screen failures|2|||
46772127|NCT00765674|82990392|FG000|Overall Study|Adverse Event|7|||
46772128|NCT00765674|82990393|FG001|Overall Study|Adverse Event|2|||
46772129|NCT00765674|82990394|FG002|Overall Study|Adverse Event|8|||
46772130|NCT00765674|82990395|FG003|Overall Study|Adverse Event|11|||
46772131|NCT00765674|82990392|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
46772132|NCT00765674|82990393|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
46772133|NCT00765674|82990394|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
46772134|NCT00765674|82990395|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
46772135|NCT00765674|82990392|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
46951748|NCT01648582|83190701|FG002|Overall Study|Adverse Event|2|||
46951749|NCT01648582|83190699|FG000|Overall Study|Lost to Follow-up|9|||
46951750|NCT01648582|83190700|FG001|Overall Study|Lost to Follow-up|6|||
46951751|NCT01648582|83190701|FG002|Overall Study|Lost to Follow-up|8|||
46951752|NCT01648582|83190699|FG000|Overall Study|Protocol Violation|1|||
46951753|NCT01648582|83190700|FG001|Overall Study|Protocol Violation|2|||
46951754|NCT01648582|83190701|FG002|Overall Study|Protocol Violation|1|||
46639133|NCT01389102|82812682|FG005|Overall Study|Subject Traveling Out of Country|0|||
46772136|NCT00765674|82990393|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
46951755|NCT01648582|83190699|FG000|Overall Study|Withdrawal by Subject|15|||
46951756|NCT01648582|83190700|FG001|Overall Study|Withdrawal by Subject|17|||
46951757|NCT01648582|83190701|FG002|Overall Study|Withdrawal by Subject|17|||
46772137|NCT00765674|82990394|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
46772138|NCT00765674|82990395|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
46951758|NCT01648582|83190699|FG000|Overall Study|Physician Decision|0|||
46951759|NCT01648582|83190700|FG001|Overall Study|Physician Decision|1|||
46951760|NCT01648582|83190701|FG002|Overall Study|Physician Decision|3|||
46951761|NCT01648582|83190699|FG000|Overall Study|Death|1|||
46951762|NCT01648582|83190700|FG001|Overall Study|Death|0|||
46951763|NCT01648582|83190701|FG002|Overall Study|Death|0|||
46951764|NCT01648582|83190699|FG000|Overall Study|Sponsor Decision|0|||
46951765|NCT01648582|83190700|FG001|Overall Study|Sponsor Decision|1|||
46951766|NCT01648582|83190701|FG002|Overall Study|Sponsor Decision|1|||
46951767|NCT03040622|83190712|FG000|Overall Study|unable to implant device|3|||
46951768|NCT02607800|83190720|FG000|Overall Study|Lost to Follow-up|7|||
46951769|NCT02607800|83190721|FG001|Overall Study|Lost to Follow-up|10|||
46951770|NCT02607800|83190720|FG000|Overall Study|Withdrew Consent|2|||
46951771|NCT02607800|83190721|FG001|Overall Study|Withdrew Consent|0|||
46951772|NCT02607800|83190720|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
46951773|NCT02607800|83190721|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
46951774|NCT02304484|83190728|FG000|Overall Study|Death|9|||
46951775|NCT02304484|83190728|FG000|Overall Study|Withdrawal by Subject|14|||
46951776|NCT02304484|83190728|FG000|Overall Study|Lost to Follow-up|2|||
46951777|NCT02708355|83190735|FG000|Overall Study|Adverse Event|1|||
46951778|NCT02708355|83190736|FG001|Overall Study|Adverse Event|0|||
46951779|NCT02708355|83190737|FG002|Overall Study|Adverse Event|0|||
46951780|NCT02708277|83190747|FG000|Overall Study|Lost to Follow-up|7|||
46951781|NCT02708277|83190748|FG001|Overall Study|Lost to Follow-up|4|||
46951782|NCT02337478|83190754|FG000|Overall Study|Lack of Efficacy|5|||
46842976|NCT00071812|83059953|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
46951783|NCT02303704|83190760|FG000|Overall Study|Protocol Violation|5|||
46951784|NCT02303704|83190761|FG001|Overall Study|Protocol Violation|9|||
46951785|NCT02608892|83190769|FG000|Overall Study|Lost to Follow-up|1|||
46951786|NCT02608892|83190770|FG001|Overall Study|Lost to Follow-up|0|||
46951787|NCT02708121|83190779|FG000|Overall Study|Withdrawn by Study Team|1|||
46951788|NCT02708121|83190780|FG001|Overall Study|Withdrawn by Study Team|1|||
46951789|NCT02708121|83190779|FG000|Overall Study|Withdrawal by Subject|0|||
46639134|NCT01389102|82812677|FG000|Overall Study|Subject Moved|2|||
46639135|NCT01389102|82812678|FG001|Overall Study|Subject Moved|0|||
46639136|NCT01389102|82812679|FG002|Overall Study|Subject Moved|1|||
46842977|NCT00071812|83059954|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
46842978|NCT00071812|83059955|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
46842979|NCT00071812|83059956|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
46842980|NCT00071812|83059953|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
46842981|NCT00071812|83059954|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
46842982|NCT00071812|83059955|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
46842983|NCT00071812|83059956|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
46842984|NCT00071812|83059953|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
46842985|NCT00071812|83059954|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
46842986|NCT00071812|83059955|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
46842987|NCT00071812|83059956|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
46842988|NCT00071812|83059953|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
46842989|NCT00071812|83059954|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
46842990|NCT00071812|83059955|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
46842991|NCT00071812|83059956|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
46842992|NCT00071812|83059953|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
46842993|NCT00071812|83059954|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
46842994|NCT00071812|83059955|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
46842995|NCT00071812|83059956|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
46842996|NCT00071812|83059953|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
46951790|NCT02708121|83190780|FG001|Overall Study|Withdrawal by Subject|4|||
46951791|NCT02707965|83190795|FG000|Overall Study|Withdrawal by Subject|0|||
47066603|NCT01451437|83349282|FG003|Overall Study|Adverse Event|0|||
46772139|NCT00765674|82990392|FG000|Overall Study|Lack of Efficacy|2|||
46772140|NCT00765674|82990393|FG001|Overall Study|Lack of Efficacy|3|||
46772141|NCT00765674|82990394|FG002|Overall Study|Lack of Efficacy|1|||
46772142|NCT00765674|82990395|FG003|Overall Study|Lack of Efficacy|2|||
46772143|NCT00765674|82990392|FG000|Overall Study|Protocol Violation|2|||
46772144|NCT00765674|82990393|FG001|Overall Study|Protocol Violation|0|||
46772145|NCT00765674|82990394|FG002|Overall Study|Protocol Violation|1|||
46842997|NCT00071812|83059954|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
46951792|NCT02707965|83190796|FG001|Overall Study|Withdrawal by Subject|0|||
46639137|NCT01389102|82812680|FG003|Overall Study|Subject Moved|0|||
46639138|NCT01389102|82812681|FG004|Overall Study|Subject Moved|0|||
46772146|NCT00765674|82990395|FG003|Overall Study|Protocol Violation|0|||
46842998|NCT00071812|83059955|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
46951793|NCT02707965|83190797|FG002|Overall Study|Withdrawal by Subject|1|||
46951794|NCT02707965|83190798|FG003|Overall Study|Withdrawal by Subject|0|||
46951795|NCT02707965|83190799|FG004|Overall Study|Withdrawal by Subject|0|||
46951796|NCT02707965|83190800|FG005|Overall Study|Withdrawal by Subject|0|||
46951797|NCT02707965|83190801|FG006|Overall Study|Withdrawal by Subject|0|||
47066604|NCT01451437|83349283|FG004|Overall Study|Adverse Event|0|||
46842999|NCT00071812|83059956|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
46843000|NCT00071812|83059953|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
46843001|NCT00071812|83059954|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
46843002|NCT00071812|83059955|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
46843003|NCT00071812|83059956|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
46843004|NCT00071110|83059970|FG000|Overall Study|Protocol Violation|0|||
46843005|NCT00071110|83059971|FG001|Overall Study|Protocol Violation|4|||
46843006|NCT00071032|83059979|FG000|Overall Study|Lost to Follow-up|1|||
46843007|NCT00071032|83059980|FG001|Overall Study|Lost to Follow-up|1|||
46843008|NCT00071032|83059979|FG000|Overall Study|Withdrawal by Subject|8|||
46843009|NCT00071032|83059980|FG001|Overall Study|Withdrawal by Subject|6|||
46843010|NCT00071032|83059979|FG000|Overall Study|Missing Primary Outcome|0|||
46843011|NCT00071032|83059980|FG001|Overall Study|Missing Primary Outcome|1|||
46843012|NCT00259610|83059991|FG000|Overall Study|Withdrawal by Subject|33|||
46843013|NCT00259610|83059992|FG001|Overall Study|Withdrawal by Subject|25|||
46843014|NCT00259610|83059993|FG002|Overall Study|Withdrawal by Subject|29|||
46843015|NCT00259610|83059994|FG003|Overall Study|Withdrawal by Subject|19|||
46951798|NCT02707965|83190802|FG007|Overall Study|Withdrawal by Subject|2|||
46951799|NCT02707965|83190803|FG008|Overall Study|Withdrawal by Subject|0|||
46951800|NCT02707965|83190804|FG009|Overall Study|Withdrawal by Subject|0|||
46951801|NCT02707965|83190805|FG010|Overall Study|Withdrawal by Subject|0|||
46951802|NCT02707965|83190806|FG011|Overall Study|Withdrawal by Subject|0|||
46951803|NCT02707965|83190807|FG012|Overall Study|Withdrawal by Subject|0|||
46951804|NCT02707965|83190808|FG013|Overall Study|Withdrawal by Subject|0|||
46951805|NCT02707965|83190809|FG014|Overall Study|Withdrawal by Subject|0|||
46951806|NCT02707965|83190810|FG015|Overall Study|Withdrawal by Subject|0|||
46951807|NCT02707965|83190795|FG000|Overall Study|PI decisions|0|||
46951808|NCT02707965|83190796|FG001|Overall Study|PI decisions|0|||
46951809|NCT02707965|83190797|FG002|Overall Study|PI decisions|0|||
46951810|NCT02707965|83190798|FG003|Overall Study|PI decisions|0|||
46951811|NCT02707965|83190799|FG004|Overall Study|PI decisions|0|||
46951812|NCT02707965|83190800|FG005|Overall Study|PI decisions|0|||
46951813|NCT02707965|83190801|FG006|Overall Study|PI decisions|0|||
46951814|NCT02707965|83190802|FG007|Overall Study|PI decisions|0|||
46843016|NCT00259610|83059991|FG000|Overall Study|Lost to Follow-up|19|||
46843017|NCT00259610|83059992|FG001|Overall Study|Lost to Follow-up|8|||
46843018|NCT00259610|83059993|FG002|Overall Study|Lost to Follow-up|18|||
46843019|NCT00259610|83059994|FG003|Overall Study|Lost to Follow-up|15|||
46843020|NCT00259610|83059991|FG000|Overall Study|Physician Decision|6|||
46843021|NCT00259610|83059992|FG001|Overall Study|Physician Decision|4|||
46843022|NCT00259610|83059993|FG002|Overall Study|Physician Decision|7|||
46843023|NCT00259610|83059994|FG003|Overall Study|Physician Decision|2|||
46951815|NCT02707965|83190803|FG008|Overall Study|PI decisions|0|||
46951816|NCT02707965|83190804|FG009|Overall Study|PI decisions|0|||
46951817|NCT02707965|83190805|FG010|Overall Study|PI decisions|0|||
46951818|NCT02707965|83190806|FG011|Overall Study|PI decisions|0|||
46951819|NCT02707965|83190807|FG012|Overall Study|PI decisions|0|||
46951820|NCT02707965|83190808|FG013|Overall Study|PI decisions|0|||
46951821|NCT02707965|83190809|FG014|Overall Study|PI decisions|2|||
46951822|NCT02707965|83190810|FG015|Overall Study|PI decisions|0|||
46951823|NCT02707965|83190795|FG000|Overall Study|Protocol deviation|1|||
46951824|NCT02707965|83190796|FG001|Overall Study|Protocol deviation|1|||
46951825|NCT02707965|83190797|FG002|Overall Study|Protocol deviation|0|||
46951826|NCT02707965|83190798|FG003|Overall Study|Protocol deviation|0|||
46951827|NCT02707965|83190799|FG004|Overall Study|Protocol deviation|0|||
46951828|NCT02707965|83190800|FG005|Overall Study|Protocol deviation|0|||
46951829|NCT02707965|83190801|FG006|Overall Study|Protocol deviation|0|||
46951830|NCT02707965|83190802|FG007|Overall Study|Protocol deviation|1|||
46951831|NCT02707965|83190803|FG008|Overall Study|Protocol deviation|0|||
46639139|NCT01389102|82812682|FG005|Overall Study|Subject Moved|0|||
46639140|NCT01389102|82812677|FG000|Overall Study|Unavailable due to husband's illness|0|||
46639141|NCT01389102|82812678|FG001|Overall Study|Unavailable due to husband's illness|1|||
46951832|NCT02707965|83190804|FG009|Overall Study|Protocol deviation|0|||
46951833|NCT02707965|83190805|FG010|Overall Study|Protocol deviation|0|||
46951834|NCT02707965|83190806|FG011|Overall Study|Protocol deviation|0|||
46951835|NCT02707965|83190807|FG012|Overall Study|Protocol deviation|0|||
46951836|NCT02707965|83190808|FG013|Overall Study|Protocol deviation|0|||
46951837|NCT02707965|83190809|FG014|Overall Study|Protocol deviation|0|||
46951838|NCT02707965|83190810|FG015|Overall Study|Protocol deviation|0|||
46843024|NCT00259610|83059991|FG000|Overall Study|Death|1|||
46843025|NCT00259610|83059992|FG001|Overall Study|Death|1|||
46843026|NCT00259610|83059993|FG002|Overall Study|Death|2|||
46843027|NCT00259610|83059994|FG003|Overall Study|Death|0|||
46843028|NCT00259610|83059991|FG000|Overall Study|non medical reason|6|||
46951839|NCT01667900|83190848|FG000|Part B|Death|0|||
46843029|NCT00259610|83059992|FG001|Overall Study|non medical reason|2|||
46843030|NCT00259610|83059993|FG002|Overall Study|non medical reason|10|||
46843031|NCT00259610|83059994|FG003|Overall Study|non medical reason|3|||
46951840|NCT01667900|83190849|FG001|Part B|Death|0|||
46951841|NCT01667900|83190850|FG002|Part B|Death|0|||
46951842|NCT01667900|83190851|FG003|Part B|Death|0|||
46951843|NCT01667900|83190852|FG004|Part B|Death|0|||
46951844|NCT01667900|83190853|FG005|Part B|Death|0|||
46951845|NCT01667900|83190854|FG006|Part B|Death|0|||
46951846|NCT01667900|83190855|FG007|Part B|Death|0|||
46951847|NCT01667900|83190856|FG008|Part B|Death|0|||
46951848|NCT01667900|83190857|FG009|Part B|Death|0|||
46951849|NCT01667900|83190858|FG010|Part B|Death|0|||
46951850|NCT01667900|83190859|FG011|Part B|Death|0|||
46951851|NCT01667900|83190860|FG012|Part B|Death|0|||
46951852|NCT01667900|83190861|FG013|Part B|Death|0|||
46951853|NCT01667900|83190862|FG014|Part B|Death|0|||
46951854|NCT01667900|83190863|FG015|Part B|Death|0|||
46951855|NCT01667900|83190864|FG016|Part B|Death|1|||
46951856|NCT01667900|83190865|FG017|Part B|Death|0|||
46951857|NCT01667900|83190866|FG018|Part B|Death|0|||
46951858|NCT01667900|83190867|FG019|Part B|Death|0|||
46951859|NCT02605928|83190896|FG000|Overall Study|Model tuning phase|28|||
46951860|NCT02605928|83190896|FG000|Overall Study|Lack of Efficacy|5|||
46951861|NCT02706717|83190902|FG000|Overall Study|Withdrawal by Subject|1|||
46951862|NCT02706717|83190903|FG001|Overall Study|Withdrawal by Subject|8|||
46951863|NCT02706717|83190902|FG000|Overall Study|Lost to Follow-up|0|||
46951864|NCT02706717|83190903|FG001|Overall Study|Lost to Follow-up|1|||
46951865|NCT02706717|83190902|FG000|Overall Study|Physician Decision|0|||
46951866|NCT02706717|83190903|FG001|Overall Study|Physician Decision|1|||
46951867|NCT02706717|83190902|FG000|Overall Study|Death|0|||
46951868|NCT02706717|83190903|FG001|Overall Study|Death|1|||
46951869|NCT01331837|83190911|FG000|Overall Study|Death|30|||
46951870|NCT01331837|83190912|FG001|Overall Study|Death|34|||
46951871|NCT01331837|83190911|FG000|Overall Study|Lost to Follow-up|3|||
46951872|NCT01331837|83190912|FG001|Overall Study|Lost to Follow-up|1|||
46951873|NCT01331837|83190911|FG000|Overall Study|Info not recorded|10|||
46951874|NCT01331837|83190912|FG001|Overall Study|Info not recorded|16|||
46951875|NCT01331837|83190911|FG000|Overall Study|Withdrawal by Subject|13|||
46951876|NCT01331837|83190912|FG001|Overall Study|Withdrawal by Subject|16|||
46951877|NCT02706483|83190918|FG000|Overall Study|Adverse Event|97|||
46951878|NCT02706483|83190918|FG000|Overall Study|Death|1|||
46951879|NCT02706483|83190918|FG000|Overall Study|Lack of Efficacy|39|||
46951880|NCT02706483|83190918|FG000|Overall Study|Lost to Follow-up|101|||
46951881|NCT02706483|83190918|FG000|Overall Study|Non-compliance with study drug|15|||
46951882|NCT02706483|83190918|FG000|Overall Study|Physician Decision|6|||
46951883|NCT02706483|83190918|FG000|Overall Study|Pregnancy|6|||
46951884|NCT02706483|83190918|FG000|Overall Study|Protocol Violation|18|||
47066605|NCT01451437|83349284|FG005|Overall Study|Adverse Event|1|||
47066606|NCT01451437|83349285|FG006|Overall Study|Adverse Event|1|||
46843032|NCT00259610|83059991|FG000|Overall Study|Adverse Event|3|||
46843033|NCT00259610|83059992|FG001|Overall Study|Adverse Event|4|||
46843034|NCT00259610|83059993|FG002|Overall Study|Adverse Event|5|||
46843035|NCT00259610|83059994|FG003|Overall Study|Adverse Event|2|||
46843036|NCT00259610|83059991|FG000|Overall Study|Serious Adverse Event|8|||
46843037|NCT00259610|83059992|FG001|Overall Study|Serious Adverse Event|2|||
46843038|NCT00259610|83059993|FG002|Overall Study|Serious Adverse Event|2|||
46843039|NCT00259610|83059994|FG003|Overall Study|Serious Adverse Event|2|||
46843040|NCT00165776|83060008|FG000|Overall Study|Lack of Efficacy|0|||
46843041|NCT00165776|83060009|FG001|Overall Study|Lack of Efficacy|0|||
46843042|NCT00165776|83060010|FG002|Overall Study|Lack of Efficacy|0|||
46843043|NCT00165776|83060011|FG003|Overall Study|Lack of Efficacy|1|||
46843044|NCT00165776|83060008|FG000|Overall Study|Withdrawal by Subject|4|||
46843045|NCT00165776|83060009|FG001|Overall Study|Withdrawal by Subject|1|||
46951885|NCT02706483|83190918|FG000|Overall Study|Withdrawal by Subject|136|||
46951886|NCT02706483|83190918|FG000|Overall Study|Non-compliance with visits|6|||
46951887|NCT02706483|83190918|FG000|Overall Study|Site closure|4|||
46951888|NCT02706483|83190918|FG000|Overall Study|Subject moved|1|||
46951889|NCT01648348|83190925|FG000|Overall Study|Cancel|1|||
46951890|NCT01648348|83190926|FG001|Overall Study|Cancel|0|||
46951891|NCT01648348|83190927|FG002|Overall Study|Cancel|0|||
46951892|NCT01648348|83190928|FG003|Overall Study|Cancel|0|||
46951893|NCT01648348|83190929|FG004|Overall Study|Cancel|3|||
46951894|NCT01648348|83190930|FG005|Overall Study|Cancel|6|||
46951895|NCT01648348|83190925|FG000|Overall Study|Replaced for MTD analysis|1|||
46951896|NCT01648348|83190926|FG001|Overall Study|Replaced for MTD analysis|0|||
46951897|NCT01648348|83190927|FG002|Overall Study|Replaced for MTD analysis|1|||
47066607|NCT01451437|83349286|FG007|Overall Study|Adverse Event|2|||
46843046|NCT00165776|83060010|FG002|Overall Study|Withdrawal by Subject|2|||
46843047|NCT00165776|83060011|FG003|Overall Study|Withdrawal by Subject|0|||
46843048|NCT00165776|83060008|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
46843049|NCT00165776|83060009|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
46951898|NCT01648348|83190928|FG003|Overall Study|Replaced for MTD analysis|0|||
46951899|NCT01648348|83190929|FG004|Overall Study|Replaced for MTD analysis|0|||
46951900|NCT01648348|83190930|FG005|Overall Study|Replaced for MTD analysis|0|||
46951901|NCT01648270|83190943|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
47066608|NCT01451437|83349287|FG008|Overall Study|Adverse Event|1|||
46951902|NCT02302846|83190953|FG000|Overall Study|Withdrawal by Subject|1|||
46951903|NCT02336230|83190957|FG000|Overall Study|Adverse Event|1|||
46951904|NCT02336230|83190957|FG000|Overall Study|Withdrawal of consent|1|||
46951905|NCT02336230|83190957|FG000|Overall Study|Death|9|||
46951906|NCT02336230|83190957|FG000|Overall Study|Dose not received due to shipping delay|1|||
46951907|NCT02336230|83190957|FG000|Overall Study|Discontinuation of MSC infusion|1|||
46951908|NCT02302222|83190963|FG000|Overall Study|Physician Decision|0|||
46772147|NCT00765674|82990392|FG000|Overall Study|Withdrawal by Subject|5|||
46772148|NCT00765674|82990393|FG001|Overall Study|Withdrawal by Subject|7|||
46772149|NCT00765674|82990394|FG002|Overall Study|Withdrawal by Subject|3|||
46772150|NCT00765674|82990395|FG003|Overall Study|Withdrawal by Subject|8|||
46772151|NCT00765674|82990392|FG000|Overall Study|Lost to Follow-up|4|||
46772152|NCT00765674|82990393|FG001|Overall Study|Lost to Follow-up|6|||
46772153|NCT00765674|82990394|FG002|Overall Study|Lost to Follow-up|2|||
46772154|NCT00765674|82990395|FG003|Overall Study|Lost to Follow-up|1|||
46772155|NCT00765674|82990392|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
46772156|NCT00765674|82990393|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
46772157|NCT00765674|82990394|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
46772158|NCT00765674|82990395|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
46772159|NCT00765362|82990405|FG000|Overall Study|Death|9|||
46772160|NCT00765362|82990405|FG000|Overall Study|Adverse Event|2|||
46772161|NCT00765362|82990405|FG000|Overall Study|Protocol Violation|18|||
46772162|NCT00765362|82990405|FG000|Overall Study|Withdrawal by Subject|13|||
46772163|NCT00765362|82990405|FG000|Overall Study|Lost to Follow-up|95|||
46951909|NCT02302222|83190964|FG001|Overall Study|Physician Decision|4|||
46951910|NCT02302222|83190963|FG000|Overall Study|Lost to Follow-up|1|||
46951911|NCT02302222|83190964|FG001|Overall Study|Lost to Follow-up|0|||
46951912|NCT02302222|83190963|FG000|Overall Study|Treatment discontinued before day 5|0|||
46951913|NCT02302222|83190964|FG001|Overall Study|Treatment discontinued before day 5|1|||
46951914|NCT02302222|83190963|FG000|Overall Study|Withdrawn prior to any treatment|0|||
46951915|NCT02302222|83190964|FG001|Overall Study|Withdrawn prior to any treatment|1|||
46951916|NCT02335450|83190970|FG000|Overall Study|Pregnancy|1|||
46951917|NCT02302066|83190984|FG000|Overall Study|Adverse Event|1|||
46951918|NCT02302066|83190985|FG001|Overall Study|Adverse Event|1|||
46951919|NCT02302066|83190986|FG002|Overall Study|Adverse Event|3|||
46951920|NCT02302066|83190987|FG003|Overall Study|Adverse Event|0|||
46951921|NCT02302066|83190984|FG000|Overall Study|Lost to Follow-up|4|||
46951922|NCT02302066|83190985|FG001|Overall Study|Lost to Follow-up|5|||
46951923|NCT02302066|83190986|FG002|Overall Study|Lost to Follow-up|24|||
46951924|NCT02302066|83190987|FG003|Overall Study|Lost to Follow-up|7|||
46951925|NCT02302066|83190984|FG000|Overall Study|Withdrawal by Subject|25|||
46951926|NCT02302066|83190985|FG001|Overall Study|Withdrawal by Subject|58|||
46951927|NCT02302066|83190986|FG002|Overall Study|Withdrawal by Subject|124|||
46951928|NCT02302066|83190987|FG003|Overall Study|Withdrawal by Subject|33|||
46951929|NCT02302066|83190984|FG000|Overall Study|Pregnancy|2|||
46951930|NCT02302066|83190985|FG001|Overall Study|Pregnancy|10|||
46951931|NCT02302066|83190986|FG002|Overall Study|Pregnancy|12|||
46951932|NCT02302066|83190987|FG003|Overall Study|Pregnancy|0|||
46951933|NCT02302066|83190984|FG000|Overall Study|Reason Not Specified|1|||
46951934|NCT02302066|83190985|FG001|Overall Study|Reason Not Specified|1|||
46951935|NCT02302066|83190986|FG002|Overall Study|Reason Not Specified|9|||
46951936|NCT02302066|83190987|FG003|Overall Study|Reason Not Specified|1|||
46951937|NCT02301988|83191009|FG000|Overall Study|Withdrawal by Subject|2|||
46951938|NCT02301988|83191010|FG001|Overall Study|Withdrawal by Subject|1|||
46951939|NCT02301988|83191009|FG000|Overall Study|Physician Decision|2|||
46951940|NCT02301988|83191010|FG001|Overall Study|Physician Decision|2|||
46951941|NCT02301988|83191009|FG000|Overall Study|Unknown Reason|1|||
46951942|NCT02301988|83191010|FG001|Overall Study|Unknown Reason|3|||
46951943|NCT02301988|83191009|FG000|Overall Study|Lack of Efficacy|3|||
46951944|NCT02301988|83191010|FG001|Overall Study|Lack of Efficacy|2|||
46951945|NCT02301988|83191009|FG000|Overall Study|Death|1|||
46951946|NCT02301988|83191010|FG001|Overall Study|Death|0|||
46951947|NCT02301988|83191009|FG000|Overall Study|Adverse Event|1|||
46951948|NCT02301988|83191010|FG001|Overall Study|Adverse Event|1|||
46951949|NCT02334748|83191025|FG000|Overall Study|Adverse Event|1|||
46951950|NCT02334748|83191025|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
46951951|NCT02334748|83191025|FG000|Overall Study|Patient no longer required study drug|2|||
46772164|NCT00586898|82990409|FG000|Overall Study|Adverse Event|1|||
46772165|NCT00586898|82990409|FG000|Overall Study|Patiemt Non-compliance|1|||
46772166|NCT00586898|82990409|FG000|Overall Study|Evaluable for Toxicity Only|5|||
46951952|NCT02334748|83191025|FG000|Overall Study|Lack of Efficacy|4|||
46951953|NCT02332876|83191031|FG000|Overall Study|Lost to Follow-up|1|||
46951954|NCT02332876|83191032|FG001|Overall Study|Lost to Follow-up|1|||
46951955|NCT02332798|83191041|FG000|Overall Study|Unwilling to Participate in Study|0|||
46951956|NCT02332798|83191042|FG001|Overall Study|Unwilling to Participate in Study|1|||
46951957|NCT02332798|83191043|FG002|Overall Study|Unwilling to Participate in Study|1|||
46951958|NCT02332798|83191041|FG000|Overall Study|Positive Urine Drug Test|0|||
46951959|NCT02332798|83191042|FG001|Overall Study|Positive Urine Drug Test|1|||
46951960|NCT02332798|83191043|FG002|Overall Study|Positive Urine Drug Test|0|||
46951961|NCT02332798|83191041|FG000|Overall Study|Abnormal Laboratory Findings|1|||
46951962|NCT02332798|83191042|FG001|Overall Study|Abnormal Laboratory Findings|0|||
46951963|NCT02332798|83191043|FG002|Overall Study|Abnormal Laboratory Findings|0|||
46951964|NCT02790437|83191053|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
46951965|NCT02790437|83191054|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
46951966|NCT02790437|83191053|FG000|Overall Study|Adverse Event|1|||
46951967|NCT02790437|83191054|FG001|Overall Study|Adverse Event|0|||
46951968|NCT02790437|83191053|FG000|Overall Study|Withdrawal by Subject|1|||
46951969|NCT02790437|83191054|FG001|Overall Study|Withdrawal by Subject|0|||
47066609|NCT01451437|83349279|FG000|Overall Study|Physician Decision|1|||
47066610|NCT01451437|83349280|FG001|Overall Study|Physician Decision|1|||
47066611|NCT01451437|83349281|FG002|Overall Study|Physician Decision|2|||
47066612|NCT01451437|83349282|FG003|Overall Study|Physician Decision|0|||
46639142|NCT01389102|82812679|FG002|Overall Study|Unavailable due to husband's illness|0|||
46639143|NCT01389102|82812680|FG003|Overall Study|Unavailable due to husband's illness|0|||
46772167|NCT04912245|82990413|FG000|Overall Study|Withdrawal by Subject|21|||
46772168|NCT04912245|82990414|FG001|Overall Study|Withdrawal by Subject|4|||
46772169|NCT04912245|82990413|FG000|Overall Study|Lost to Follow-up|5|||
46772170|NCT04912245|82990414|FG001|Overall Study|Lost to Follow-up|11|||
46772171|NCT00796991|82990421|FG000|Overall Study|Adverse Event|0|||
46951970|NCT02604212|83191071|FG000|Overall Study|Study Terminated by Sponsor|2|||
46951971|NCT02604212|83191072|FG001|Overall Study|Study Terminated by Sponsor|1|||
46951972|NCT02604212|83191073|FG002|Overall Study|Study Terminated by Sponsor|3|||
46951973|NCT02604212|83191074|FG003|Overall Study|Study Terminated by Sponsor|3|||
46951974|NCT02604212|83191071|FG000|Overall Study|Withdrawal by Subject|0|||
46951975|NCT02604212|83191072|FG001|Overall Study|Withdrawal by Subject|0|||
46951976|NCT02604212|83191073|FG002|Overall Study|Withdrawal by Subject|1|||
46951977|NCT02604212|83191074|FG003|Overall Study|Withdrawal by Subject|0|||
46951978|NCT02789111|83191091|FG000|Overall Study|Withdrawal by Subject|1|||
46951979|NCT02789111|83191092|FG001|Overall Study|Withdrawal by Subject|4|||
46951980|NCT01359644|83191110|FG000|Treatment Period|Lack of Efficacy|0|||
46951981|NCT01359644|83191111|FG001|Treatment Period|Lack of Efficacy|1|||
46951982|NCT01359644|83191112|FG002|Treatment Period|Lack of Efficacy|0|||
46951983|NCT01359644|83191113|FG003|Treatment Period|Lack of Efficacy|0|||
46951984|NCT01359644|83191114|FG004|Treatment Period|Lack of Efficacy|0|||
46951985|NCT01359644|83191115|FG005|Treatment Period|Lack of Efficacy|0|||
46951986|NCT01359644|83191116|FG006|Treatment Period|Lack of Efficacy|0|||
46951987|NCT01359644|83191117|FG007|Treatment Period|Lack of Efficacy|0|||
46951988|NCT01359644|83191118|FG008|Treatment Period|Lack of Efficacy|0|||
46951989|NCT01359644|83191119|FG009|Treatment Period|Lack of Efficacy|0|||
46951990|NCT01359644|83191110|FG000|Treatment Period|Adverse Event|0|||
46951991|NCT01359644|83191111|FG001|Treatment Period|Adverse Event|0|||
46951992|NCT01359644|83191112|FG002|Treatment Period|Adverse Event|1|||
46951993|NCT01359644|83191113|FG003|Treatment Period|Adverse Event|0|||
46951994|NCT01359644|83191114|FG004|Treatment Period|Adverse Event|0|||
46951995|NCT01359644|83191115|FG005|Treatment Period|Adverse Event|1|||
46951996|NCT01359644|83191116|FG006|Treatment Period|Adverse Event|0|||
46951997|NCT01359644|83191117|FG007|Treatment Period|Adverse Event|0|||
46951998|NCT01359644|83191118|FG008|Treatment Period|Adverse Event|0|||
46951999|NCT01359644|83191119|FG009|Treatment Period|Adverse Event|0|||
46952000|NCT01359644|83191110|FG000|Treatment Period|Lost to Follow-up|0|||
46952001|NCT01359644|83191111|FG001|Treatment Period|Lost to Follow-up|0|||
46772172|NCT00796991|82990422|FG001|Overall Study|Adverse Event|0|||
46772173|NCT00796991|82990423|FG002|Overall Study|Adverse Event|1|||
46772174|NCT00796991|82990421|FG000|Overall Study|Death|2|||
46772175|NCT00796991|82990422|FG001|Overall Study|Death|0|||
46772176|NCT00796991|82990423|FG002|Overall Study|Death|0|||
46772177|NCT00796991|82990421|FG000|Overall Study|Disease Progression|10|||
46772178|NCT00796991|82990422|FG001|Overall Study|Disease Progression|9|||
46772179|NCT00796991|82990423|FG002|Overall Study|Disease Progression|7|||
46772180|NCT00796991|82990421|FG000|Overall Study|Study Drug Toxicity|3|||
46843050|NCT00165776|83060010|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
46952002|NCT01359644|83191112|FG002|Treatment Period|Lost to Follow-up|0|||
46952003|NCT01359644|83191113|FG003|Treatment Period|Lost to Follow-up|0|||
46952004|NCT01359644|83191114|FG004|Treatment Period|Lost to Follow-up|0|||
46952005|NCT01359644|83191115|FG005|Treatment Period|Lost to Follow-up|1|||
46952006|NCT01359644|83191116|FG006|Treatment Period|Lost to Follow-up|0|||
47066613|NCT01451437|83349283|FG004|Overall Study|Physician Decision|0|||
46772181|NCT00796991|82990422|FG001|Overall Study|Study Drug Toxicity|3|||
46952007|NCT01359644|83191117|FG007|Treatment Period|Lost to Follow-up|0|||
46952008|NCT01359644|83191118|FG008|Treatment Period|Lost to Follow-up|0|||
46952009|NCT01359644|83191119|FG009|Treatment Period|Lost to Follow-up|0|||
46952010|NCT01359644|83191110|FG000|Follow-up Period|Withdrawal by Subject|0|||
46952011|NCT01359644|83191111|FG001|Follow-up Period|Withdrawal by Subject|0|||
46952012|NCT01359644|83191112|FG002|Follow-up Period|Withdrawal by Subject|0|||
46843051|NCT00165776|83060011|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
47066614|NCT01451437|83349284|FG005|Overall Study|Physician Decision|0|||
46952013|NCT01359644|83191113|FG003|Follow-up Period|Withdrawal by Subject|0|||
46952014|NCT01359644|83191114|FG004|Follow-up Period|Withdrawal by Subject|0|||
46952015|NCT01359644|83191115|FG005|Follow-up Period|Withdrawal by Subject|1|||
46952016|NCT01359644|83191116|FG006|Follow-up Period|Withdrawal by Subject|0|||
46952017|NCT01359644|83191117|FG007|Follow-up Period|Withdrawal by Subject|0|||
46952018|NCT01359644|83191118|FG008|Follow-up Period|Withdrawal by Subject|0|||
46952019|NCT01359644|83191119|FG009|Follow-up Period|Withdrawal by Subject|0|||
46952020|NCT01359644|83191110|FG000|Follow-up Period|Lost to Follow-up|0|||
46952021|NCT01359644|83191111|FG001|Follow-up Period|Lost to Follow-up|0|||
46952022|NCT01359644|83191112|FG002|Follow-up Period|Lost to Follow-up|0|||
46952023|NCT01359644|83191113|FG003|Follow-up Period|Lost to Follow-up|0|||
46952024|NCT01359644|83191114|FG004|Follow-up Period|Lost to Follow-up|0|||
46952025|NCT01359644|83191115|FG005|Follow-up Period|Lost to Follow-up|0|||
46952026|NCT01359644|83191116|FG006|Follow-up Period|Lost to Follow-up|1|||
46952027|NCT01359644|83191117|FG007|Follow-up Period|Lost to Follow-up|2|||
46952028|NCT01359644|83191118|FG008|Follow-up Period|Lost to Follow-up|0|||
46952029|NCT01359644|83191119|FG009|Follow-up Period|Lost to Follow-up|0|||
46952030|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
46952031|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
46952032|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
46952033|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
46952034|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
46952035|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
46952036|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Death|2|||
46952037|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Death|0|||
46952038|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
46952039|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
46952040|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
46952041|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
46952042|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
46952043|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
46952044|NCT02603120|83191154|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
46952045|NCT02603120|83191155|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
46952046|NCT02603120|83191154|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
46952047|NCT02603120|83191155|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
46952048|NCT02603120|83191154|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
46952049|NCT02603120|83191155|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
46952050|NCT02603120|83191154|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
46952051|NCT02603120|83191155|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
46952052|NCT02603120|83191154|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
46952053|NCT02603120|83191155|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
46952054|NCT02603120|83191154|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
46952055|NCT02603120|83191155|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
46843052|NCT00165698|83060023|FG000|Overall Study|Adverse Event|2|||
46952056|NCT02603120|83191154|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
46952057|NCT02603120|83191155|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
46952058|NCT02599688|83191163|FG000|Overall Study|Lack of Efficacy|1|||
46952059|NCT02599688|83191163|FG000|Overall Study|Withdrawal by Subject|1|||
46952060|NCT02599688|83191163|FG000|Overall Study|Termination by Sponsor|2|||
46952061|NCT01331291|83191169|FG000|Overall Study|Lack of Efficacy|2|||
46952062|NCT01331291|83191170|FG001|Overall Study|Lack of Efficacy|8|||
46772182|NCT00796991|82990423|FG002|Overall Study|Study Drug Toxicity|5|||
46772183|NCT00796991|82990421|FG000|Overall Study|Withdrawal by Subject|0|||
46843053|NCT00165698|83060024|FG001|Overall Study|Adverse Event|10|||
46772184|NCT00796991|82990422|FG001|Overall Study|Withdrawal by Subject|0|||
46772185|NCT00796991|82990423|FG002|Overall Study|Withdrawal by Subject|1|||
46772186|NCT00799487|82990434|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
46772187|NCT00799487|82990435|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
46772188|NCT00799487|82990436|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
46772189|NCT00799487|82990434|FG000|Dose Adjustment Period|Adverse Event|2|||
46772190|NCT00799487|82990435|FG001|Dose Adjustment Period|Adverse Event|0|||
46772191|NCT00799487|82990436|FG002|Dose Adjustment Period|Adverse Event|0|||
46772192|NCT00799487|82990434|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
46843054|NCT00165698|83060023|FG000|Overall Study|Lost to Follow-up|2|||
46952063|NCT01331291|83191169|FG000|Overall Study|Death|0|||
46952064|NCT01331291|83191170|FG001|Overall Study|Death|1|||
46952065|NCT02601560|83191183|FG000|Overall Study|Other|0|||
46952066|NCT02601560|83191184|FG001|Overall Study|Other|0|||
46952067|NCT02601560|83191185|FG002|Overall Study|Other|0|||
46952068|NCT02601560|83191186|FG003|Overall Study|Other|0|||
46952069|NCT02601560|83191187|FG004|Overall Study|Other|0|||
46772193|NCT00799487|82990435|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
46843055|NCT00165698|83060024|FG001|Overall Study|Lost to Follow-up|2|||
46952070|NCT02601560|83191188|FG005|Overall Study|Other|0|||
46952071|NCT02601560|83191189|FG006|Overall Study|Other|1|||
46952072|NCT02601560|83191190|FG007|Overall Study|Other|0|||
46952073|NCT02595398|83191221|FG000|Overall Study|Non-compliance|1|||
46952074|NCT02595398|83191222|FG001|Overall Study|Non-compliance|0|||
46952075|NCT02595398|83191221|FG000|Overall Study|Withdrawal by Subject|2|||
46952076|NCT02595398|83191222|FG001|Overall Study|Withdrawal by Subject|1|||
46952077|NCT02595398|83191221|FG000|Overall Study|Lost to Follow-up|1|||
46952078|NCT02595398|83191222|FG001|Overall Study|Lost to Follow-up|0|||
46952079|NCT01368497|83191228|FG000|Overall Study|Lost to Follow-up|2|||
46952080|NCT02595008|83191234|FG000|Overall Study|Enrolled In Error|1|||
46952081|NCT02595008|83191235|FG001|Overall Study|Enrolled In Error|0|||
46952082|NCT02598128|83191241|FG000|Period A: Days -7 to -1|Adverse Event|1|||
46952083|NCT02598128|83191242|FG001|Period A: Days -7 to -1|Adverse Event|0|||
46952084|NCT02598128|83191243|FG002|Period A: Days -7 to -1|Adverse Event|0|||
46952085|NCT02598128|83191244|FG003|Period A: Days -7 to -1|Adverse Event|0|||
46952086|NCT05041439|83191292|FG000|Overall Study|Withdrawal by Subject|1|||
46952087|NCT05041439|83191293|FG001|Overall Study|Withdrawal by Subject|1|||
46952088|NCT05041439|83191292|FG000|Overall Study|Death|1|||
46952089|NCT05041439|83191293|FG001|Overall Study|Death|0|||
46952090|NCT05037409|83191302|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
46952091|NCT05037409|83191303|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
46952092|NCT05037409|83191304|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
46952093|NCT04999111|83191318|FG000|Overall Study|Lost to Follow-up|21|||
46952094|NCT04999111|83191319|FG001|Overall Study|Lost to Follow-up|16|||
46952095|NCT04999111|83191320|FG002|Overall Study|Lost to Follow-up|2|||
46952096|NCT04999111|83191321|FG003|Overall Study|Lost to Follow-up|26|||
46952097|NCT04999111|83191322|FG004|Overall Study|Lost to Follow-up|30|||
46952098|NCT04999111|83191323|FG005|Overall Study|Lost to Follow-up|6|||
46952099|NCT04999111|83191318|FG000|Overall Study|Physician Decision|1|||
46952100|NCT04999111|83191319|FG001|Overall Study|Physician Decision|3|||
46952101|NCT04999111|83191320|FG002|Overall Study|Physician Decision|0|||
46952102|NCT04999111|83191321|FG003|Overall Study|Physician Decision|1|||
46952103|NCT04999111|83191322|FG004|Overall Study|Physician Decision|2|||
46772194|NCT00799487|82990436|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
46772195|NCT00799487|82990434|FG000|Dose Adjustment Period|Investigator Discretion|2|||
46772196|NCT00799487|82990435|FG001|Dose Adjustment Period|Investigator Discretion|0|||
46772197|NCT00799487|82990436|FG002|Dose Adjustment Period|Investigator Discretion|0|||
46772198|NCT00799487|82990434|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
46772199|NCT00799487|82990435|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
46772200|NCT00799487|82990436|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
46772201|NCT00799487|82990434|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
46772202|NCT00799487|82990435|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
46772203|NCT00799487|82990436|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
46772204|NCT00799487|82990434|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
46772205|NCT00799487|82990435|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
46772206|NCT00799487|82990436|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
46772207|NCT00799487|82990434|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
46772208|NCT00799487|82990435|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
46772209|NCT00799487|82990436|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
46772210|NCT00799487|82990434|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
46772211|NCT00799487|82990435|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
46772212|NCT00799487|82990436|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
46772213|NCT00799487|82990434|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
46772214|NCT00799487|82990435|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
46843056|NCT00165698|83060023|FG000|Overall Study|Withdrawal by Subject|2|||
46843057|NCT00165698|83060024|FG001|Overall Study|Withdrawal by Subject|1|||
46843058|NCT00165698|83060023|FG000|Overall Study|Protocol Violation|1|||
46843059|NCT00165698|83060024|FG001|Overall Study|Protocol Violation|0|||
46843060|NCT00165698|83060023|FG000|Overall Study|Not Taken/Lost the medicine|1|||
46843061|NCT00165698|83060024|FG001|Overall Study|Not Taken/Lost the medicine|2|||
46772215|NCT00799487|82990436|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
46772216|NCT00799487|82990434|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
46843062|NCT00225758|83060030|FG000|Overall Study|Adverse Event|4|||
46952104|NCT04999111|83191323|FG005|Overall Study|Physician Decision|0|||
47066615|NCT01451437|83349285|FG006|Overall Study|Physician Decision|0|||
46952105|NCT04999111|83191318|FG000|Overall Study|Withdrawal by Subject|23|||
46952106|NCT04999111|83191319|FG001|Overall Study|Withdrawal by Subject|29|||
46952107|NCT04999111|83191320|FG002|Overall Study|Withdrawal by Subject|15|||
46952108|NCT04999111|83191321|FG003|Overall Study|Withdrawal by Subject|30|||
46952109|NCT04999111|83191322|FG004|Overall Study|Withdrawal by Subject|35|||
46952110|NCT04999111|83191323|FG005|Overall Study|Withdrawal by Subject|10|||
46952111|NCT04999111|83191318|FG000|Overall Study|Other|6|||
46952112|NCT04999111|83191319|FG001|Overall Study|Other|6|||
46952113|NCT04999111|83191320|FG002|Overall Study|Other|3|||
46952114|NCT04999111|83191321|FG003|Overall Study|Other|8|||
46952115|NCT04999111|83191322|FG004|Overall Study|Other|8|||
46952116|NCT04999111|83191323|FG005|Overall Study|Other|5|||
46952117|NCT04999111|83191318|FG000|Overall Study|Non-compliance with study schedule|1|||
46952118|NCT04999111|83191319|FG001|Overall Study|Non-compliance with study schedule|0|||
46843063|NCT00259298|83060036|FG000|Overall Study|Withdrawal by Subject|1|||
46843064|NCT00259298|83060036|FG000|Overall Study|Physician Decision|2|||
46843065|NCT03789292|83060042|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
46843066|NCT03789292|83060043|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
46843067|NCT03789292|83060044|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
46843068|NCT03789292|83060042|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
46843069|NCT03789292|83060043|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
46843070|NCT03789292|83060044|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
46843071|NCT03789292|83060042|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
46843072|NCT03789292|83060043|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
46843073|NCT03789292|83060044|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
46843074|NCT03789292|83060042|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
46843075|NCT03789292|83060043|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
46843076|NCT03789292|83060044|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
46843077|NCT03789292|83060042|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
46843078|NCT03789292|83060043|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
46843079|NCT03789292|83060044|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
46843080|NCT03789292|83060042|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
46843081|NCT03789292|83060043|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
46843082|NCT03789292|83060044|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
46843083|NCT03789292|83060042|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
46843084|NCT03789292|83060043|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
46843085|NCT03789292|83060044|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
46843086|NCT03789292|83060042|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
46843087|NCT03789292|83060043|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
46843088|NCT03789292|83060044|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
46843089|NCT03789292|83060042|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
46843090|NCT03789292|83060043|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
46843091|NCT03789292|83060044|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
46843092|NCT03789292|83060042|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
46843093|NCT03789292|83060043|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
46843094|NCT03789292|83060044|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
46843095|NCT03789292|83060042|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
46843096|NCT03789292|83060043|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
46843097|NCT03789292|83060044|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
46843098|NCT03789292|83060042|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
46843099|NCT03789292|83060043|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
46843100|NCT03789292|83060044|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
46843101|NCT03789292|83060042|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
46843102|NCT03789292|83060043|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
46843103|NCT03789292|83060044|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
46843104|NCT03781336|83060060|FG000|Overall Study|Withdrawal by Subject|2|||
46843105|NCT03781336|83060061|FG001|Overall Study|Withdrawal by Subject|2|||
46843106|NCT03780400|83060067|FG000|Overall Study|Lost to Follow-up|5|||
46843107|NCT03780400|83060067|FG000|Overall Study|Withdrawal by Subject|2|||
46843108|NCT03780244|83060073|FG000|Overall Study|Lost to Follow-up|1|||
46843109|NCT03780244|83060074|FG001|Overall Study|Lost to Follow-up|0|||
46843110|NCT03785548|83060082|FG000|Overall Study|age > 80|1|||
46843111|NCT03785548|83060083|FG001|Overall Study|age > 80|0|||
46843112|NCT03785548|83060082|FG000|Overall Study|no Postop queries|1|||
46843113|NCT03785548|83060083|FG001|Overall Study|no Postop queries|0|||
46843114|NCT00141297|83060091|FG000|Overall Study|Adverse Event|0|||
46843115|NCT00141297|83060092|FG001|Overall Study|Adverse Event|0|||
46843116|NCT00141297|83060093|FG002|Overall Study|Adverse Event|1|||
46843117|NCT00141297|83060094|FG003|Overall Study|Adverse Event|0|||
46843118|NCT00141297|83060095|FG004|Overall Study|Adverse Event|1|||
46843119|NCT00141297|83060096|FG005|Overall Study|Adverse Event|1|||
46843120|NCT00141297|83060097|FG006|Overall Study|Adverse Event|0|||
46843121|NCT00141297|83060098|FG007|Overall Study|Adverse Event|1|||
46843122|NCT00141297|83060099|FG008|Overall Study|Adverse Event|1|||
46843123|NCT00141297|83060100|FG009|Overall Study|Adverse Event|0|||
46952119|NCT04999111|83191320|FG002|Overall Study|Non-compliance with study schedule|0|||
46952120|NCT04999111|83191321|FG003|Overall Study|Non-compliance with study schedule|1|||
46952121|NCT04999111|83191322|FG004|Overall Study|Non-compliance with study schedule|1|||
46952122|NCT04999111|83191323|FG005|Overall Study|Non-compliance with study schedule|1|||
46952123|NCT04999111|83191318|FG000|Overall Study|Randomized but not vaccinated|1|||
46952124|NCT04999111|83191319|FG001|Overall Study|Randomized but not vaccinated|2|||
46952125|NCT04999111|83191320|FG002|Overall Study|Randomized but not vaccinated|0|||
46952126|NCT04999111|83191321|FG003|Overall Study|Randomized but not vaccinated|3|||
46952127|NCT04999111|83191322|FG004|Overall Study|Randomized but not vaccinated|3|||
46952128|NCT04999111|83191323|FG005|Overall Study|Randomized but not vaccinated|0|||
46952129|NCT04999111|83191318|FG000|Overall Study|Adverse Event|1|||
46952130|NCT04999111|83191319|FG001|Overall Study|Adverse Event|1|||
46952131|NCT04999111|83191320|FG002|Overall Study|Adverse Event|0|||
46952132|NCT04999111|83191321|FG003|Overall Study|Adverse Event|0|||
46952133|NCT04999111|83191322|FG004|Overall Study|Adverse Event|0|||
46952134|NCT04999111|83191323|FG005|Overall Study|Adverse Event|0|||
46952135|NCT04999111|83191318|FG000|Overall Study|Initiated prohibited medication|0|||
46952136|NCT04999111|83191319|FG001|Overall Study|Initiated prohibited medication|0|||
46952137|NCT04999111|83191320|FG002|Overall Study|Initiated prohibited medication|0|||
46952138|NCT04999111|83191321|FG003|Overall Study|Initiated prohibited medication|0|||
46952139|NCT04999111|83191322|FG004|Overall Study|Initiated prohibited medication|1|||
46952140|NCT04999111|83191323|FG005|Overall Study|Initiated prohibited medication|0|||
46952141|NCT04964557|83191343|FG000|Overall Study|Withdrawal by Subject|3|||
46952142|NCT04964557|83191344|FG001|Overall Study|Withdrawal by Subject|2|||
46952143|NCT04964557|83191343|FG000|Overall Study|Lost to Follow-up|1|||
46952144|NCT04964557|83191344|FG001|Overall Study|Lost to Follow-up|2|||
46952145|NCT04964557|83191343|FG000|Overall Study|Physician Decision|2|||
46952146|NCT04964557|83191344|FG001|Overall Study|Physician Decision|0|||
46952147|NCT04964557|83191343|FG000|Overall Study|Death|3|||
46952148|NCT04964557|83191344|FG001|Overall Study|Death|0|||
46952149|NCT04964557|83191343|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
46952150|NCT04964557|83191344|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
46952151|NCT04798027|83191357|FG000|Overall Study|Protocol Violation|0|||
46952152|NCT04798027|83191358|FG001|Overall Study|Protocol Violation|0|||
46952153|NCT04798027|83191359|FG002|Overall Study|Protocol Violation|0|||
46952154|NCT04798027|83191360|FG003|Overall Study|Protocol Violation|0|||
46952155|NCT04798027|83191361|FG004|Overall Study|Protocol Violation|1|||
46952156|NCT04798027|83191362|FG005|Overall Study|Protocol Violation|0|||
46952157|NCT04798027|83191363|FG006|Overall Study|Protocol Violation|0|||
46952158|NCT04798027|83191364|FG007|Overall Study|Protocol Violation|1|||
46952159|NCT04798027|83191365|FG008|Overall Study|Protocol Violation|0|||
46952160|NCT04798027|83191357|FG000|Overall Study|Withdrawal by Subject|1|||
46952161|NCT04798027|83191358|FG001|Overall Study|Withdrawal by Subject|0|||
47066616|NCT01451437|83349286|FG007|Overall Study|Physician Decision|0|||
47066617|NCT01451437|83349287|FG008|Overall Study|Physician Decision|0|||
46639144|NCT01389102|82812681|FG004|Overall Study|Unavailable due to husband's illness|0|||
46639145|NCT01389102|82812682|FG005|Overall Study|Unavailable due to husband's illness|0|||
46772217|NCT00799487|82990435|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
46772218|NCT00799487|82990436|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
46772219|NCT00799487|82990434|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
46772220|NCT00799487|82990435|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
46772221|NCT00799487|82990436|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
46772222|NCT00584727|82990447|FG000|First Intervention|Discontinuation|0|||
46772223|NCT00584727|82990448|FG001|First Intervention|Discontinuation|0|||
46772224|NCT00584727|82990449|FG002|First Intervention|Discontinuation|1|||
46772225|NCT00584727|82990450|FG003|First Intervention|Discontinuation|0|||
46772226|NCT00584727|82990451|FG004|First Intervention|Discontinuation|0|||
46772227|NCT00584727|82990452|FG005|First Intervention|Discontinuation|0|||
46772228|NCT00584727|82990447|FG000|Third Intervention|Protocol Violation|0|||
46772229|NCT00584727|82990448|FG001|Third Intervention|Protocol Violation|0|||
46772230|NCT00584727|82990449|FG002|Third Intervention|Protocol Violation|1|||
46772231|NCT00584727|82990450|FG003|Third Intervention|Protocol Violation|0|||
46772232|NCT00584727|82990451|FG004|Third Intervention|Protocol Violation|4|||
46772233|NCT00584727|82990452|FG005|Third Intervention|Protocol Violation|2|||
46772234|NCT00799409|82990466|FG000|Overall Study|Withdrawal by Subject|1|||
46772235|NCT00799409|82990467|FG001|Overall Study|Withdrawal by Subject|0|||
46772236|NCT00799409|82990468|FG002|Overall Study|Withdrawal by Subject|0|||
46772237|NCT00799409|82990466|FG000|Overall Study|Lost to Follow-up|1|||
46772238|NCT00799409|82990467|FG001|Overall Study|Lost to Follow-up|0|||
46772239|NCT00799409|82990468|FG002|Overall Study|Lost to Follow-up|0|||
46772240|NCT00799409|82990466|FG000|Overall Study|Optimal Dose Not Achieved|2|||
46952162|NCT04798027|83191359|FG002|Overall Study|Withdrawal by Subject|1|||
46952163|NCT04798027|83191360|FG003|Overall Study|Withdrawal by Subject|1|||
46952164|NCT04798027|83191361|FG004|Overall Study|Withdrawal by Subject|1|||
46952165|NCT04798027|83191362|FG005|Overall Study|Withdrawal by Subject|1|||
46952166|NCT04798027|83191363|FG006|Overall Study|Withdrawal by Subject|3|||
46843124|NCT00141297|83060091|FG000|Overall Study|Death|1|||
46843125|NCT00141297|83060092|FG001|Overall Study|Death|0|||
46843126|NCT00141297|83060093|FG002|Overall Study|Death|0|||
46843127|NCT00141297|83060094|FG003|Overall Study|Death|0|||
46843128|NCT00141297|83060095|FG004|Overall Study|Death|0|||
46843129|NCT00141297|83060096|FG005|Overall Study|Death|0|||
46952167|NCT04798027|83191364|FG007|Overall Study|Withdrawal by Subject|2|||
46952168|NCT04798027|83191365|FG008|Overall Study|Withdrawal by Subject|2|||
46952169|NCT04798027|83191357|FG000|Overall Study|Lost to Follow-up|1|||
46952170|NCT04798027|83191358|FG001|Overall Study|Lost to Follow-up|3|||
46952171|NCT04798027|83191359|FG002|Overall Study|Lost to Follow-up|0|||
46952172|NCT04798027|83191360|FG003|Overall Study|Lost to Follow-up|0|||
46952173|NCT04798027|83191361|FG004|Overall Study|Lost to Follow-up|0|||
46952174|NCT04798027|83191362|FG005|Overall Study|Lost to Follow-up|1|||
46952175|NCT04798027|83191363|FG006|Overall Study|Lost to Follow-up|0|||
46952176|NCT04798027|83191364|FG007|Overall Study|Lost to Follow-up|0|||
46952177|NCT04798027|83191365|FG008|Overall Study|Lost to Follow-up|1|||
46952178|NCT04798027|83191357|FG000|Overall Study|Withdrawal by Sponsor|8|||
46952179|NCT04798027|83191358|FG001|Overall Study|Withdrawal by Sponsor|22|||
46952180|NCT04798027|83191359|FG002|Overall Study|Withdrawal by Sponsor|9|||
46952181|NCT04798027|83191360|FG003|Overall Study|Withdrawal by Sponsor|26|||
46952182|NCT04798027|83191361|FG004|Overall Study|Withdrawal by Sponsor|24|||
46952183|NCT04798027|83191362|FG005|Overall Study|Withdrawal by Sponsor|11|||
46952184|NCT04798027|83191363|FG006|Overall Study|Withdrawal by Sponsor|25|||
46952185|NCT04798027|83191364|FG007|Overall Study|Withdrawal by Sponsor|26|||
46952186|NCT04798027|83191365|FG008|Overall Study|Withdrawal by Sponsor|11|||
46952187|NCT04682405|83191392|FG000|Overall Study|Adverse Event|0|||
46952188|NCT04682405|83191393|FG001|Overall Study|Adverse Event|1|||
46952189|NCT04607980|83191405|FG000|Overall Study|Adverse Event|3|||
46952190|NCT04607980|83191406|FG001|Overall Study|Adverse Event|4|||
46952191|NCT04607980|83191405|FG000|Overall Study|Death|0|||
46952192|NCT04607980|83191406|FG001|Overall Study|Death|1|||
46952193|NCT04607980|83191405|FG000|Overall Study|Withdrawal by Subject|2|||
46952194|NCT04607980|83191406|FG001|Overall Study|Withdrawal by Subject|5|||
46952195|NCT04607980|83191405|FG000|Overall Study|Lost to Follow-up|4|||
46952196|NCT04607980|83191406|FG001|Overall Study|Lost to Follow-up|8|||
46952197|NCT04607980|83191405|FG000|Overall Study|Protocol Violation|0|||
46952198|NCT04607980|83191406|FG001|Overall Study|Protocol Violation|3|||
46952199|NCT04607980|83191405|FG000|Overall Study|Other|3|||
46952200|NCT04607980|83191406|FG001|Overall Study|Other|0|||
46952201|NCT04543279|83191426|FG000|Overall Study|Withdrawal by Subject|1|||
46952202|NCT04543279|83191427|FG001|Overall Study|Withdrawal by Subject|0|||
46952203|NCT04543279|83191426|FG000|Overall Study|Adverse Event|1|||
46952204|NCT04543279|83191427|FG001|Overall Study|Adverse Event|0|||
46952205|NCT04543279|83191426|FG000|Overall Study|Physician Decision|1|||
46952206|NCT04543279|83191427|FG001|Overall Study|Physician Decision|0|||
46952207|NCT04540913|83191435|FG000|Overall Study|Withdrawal by Subject|14|||
46952208|NCT04540913|83191436|FG001|Overall Study|Withdrawal by Subject|3|||
46952209|NCT04540133|83191447|FG000|Overall Study|Lost to Follow-up|1|||
46952210|NCT04540133|83191448|FG001|Overall Study|Lost to Follow-up|0|||
46952211|NCT04494633|83191456|FG000|Overall Study|Lost to Follow-up|5|||
46952212|NCT04494633|83191457|FG001|Overall Study|Lost to Follow-up|3|||
46952213|NCT04494633|83191456|FG000|Overall Study|Protocol Violation|1|||
46952214|NCT04494633|83191457|FG001|Overall Study|Protocol Violation|1|||
46952215|NCT04233801|83191467|FG000|Overall Study|Other than listed|0|||
46952216|NCT04233801|83191468|FG001|Overall Study|Other than listed|0|||
46952217|NCT04233801|83191469|FG002|Overall Study|Other than listed|1|||
46952218|NCT04233801|83191467|FG000|Overall Study|Withdrawal by Subject|0|||
46952219|NCT04233801|83191468|FG001|Overall Study|Withdrawal by Subject|2|||
46952220|NCT04233801|83191469|FG002|Overall Study|Withdrawal by Subject|3|||
46952221|NCT04033003|83191489|FG000|T1 3rd Trimester|Lost to Follow-up|113|||
46952222|NCT04033003|83191490|FG001|T1 3rd Trimester|Lost to Follow-up|190|||
46952223|NCT04033003|83191489|FG000|T1 3rd Trimester|Protocol Violation|115|||
46843130|NCT00141297|83060097|FG006|Overall Study|Death|0|||
46952224|NCT04033003|83191490|FG001|T1 3rd Trimester|Protocol Violation|0|||
46952225|NCT04033003|83191489|FG000|T1 3rd Trimester|Withdrawal by Subject|2|||
46952226|NCT04033003|83191490|FG001|T1 3rd Trimester|Withdrawal by Subject|6|||
46952227|NCT04033003|83191489|FG000|T1 3rd Trimester|No longer meets criteria|30|||
46843131|NCT00141297|83060098|FG007|Overall Study|Death|0|||
46952228|NCT04033003|83191490|FG001|T1 3rd Trimester|No longer meets criteria|19|||
46952229|NCT04033003|83191489|FG000|T1 3rd Trimester|Death|0|||
46952230|NCT04033003|83191490|FG001|T1 3rd Trimester|Death|1|||
46952231|NCT04033003|83191489|FG000|T2 Post Delivery|Lost to Follow-up|133|||
46952232|NCT04033003|83191490|FG001|T2 Post Delivery|Lost to Follow-up|247|||
46952233|NCT04033003|83191489|FG000|T2 Post Delivery|Protocol Violation|4|||
46952234|NCT04033003|83191490|FG001|T2 Post Delivery|Protocol Violation|0|||
46952235|NCT04033003|83191489|FG000|T2 Post Delivery|Withdrawal by Subject|5|||
46952236|NCT04033003|83191490|FG001|T2 Post Delivery|Withdrawal by Subject|3|||
46952237|NCT04033003|83191489|FG000|T2 Post Delivery|No longer meets criteria|1|||
46843132|NCT00141297|83060099|FG008|Overall Study|Death|1|||
46952238|NCT04033003|83191490|FG001|T2 Post Delivery|No longer meets criteria|10|||
46952239|NCT04033003|83191489|FG000|T2 Post Delivery|Death|2|||
46952240|NCT04033003|83191490|FG001|T2 Post Delivery|Death|2|||
46952241|NCT03221257|83191517|FG000|Overall Study|Lost to Follow-up|0|||
46952242|NCT03221257|83191518|FG001|Overall Study|Lost to Follow-up|1|||
46952243|NCT03221257|83191517|FG000|Overall Study|Withdrawal by Subject|1|||
46952244|NCT03221257|83191518|FG001|Overall Study|Withdrawal by Subject|1|||
46952245|NCT02978326|83191527|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
46952246|NCT02978326|83191528|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
46952247|NCT02978326|83191529|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
46952248|NCT02978326|83191527|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
46952249|NCT02978326|83191528|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
46843133|NCT00141297|83060100|FG009|Overall Study|Death|0|||
46843134|NCT00141297|83060091|FG000|Overall Study|Withdrawal by Subject|0|||
46843135|NCT00141297|83060092|FG001|Overall Study|Withdrawal by Subject|0|||
46843136|NCT00141297|83060093|FG002|Overall Study|Withdrawal by Subject|0|||
46843137|NCT00141297|83060094|FG003|Overall Study|Withdrawal by Subject|0|||
46843138|NCT00141297|83060095|FG004|Overall Study|Withdrawal by Subject|0|||
46843139|NCT00141297|83060096|FG005|Overall Study|Withdrawal by Subject|0|||
46843140|NCT00141297|83060097|FG006|Overall Study|Withdrawal by Subject|0|||
46843141|NCT00141297|83060098|FG007|Overall Study|Withdrawal by Subject|0|||
46843142|NCT00141297|83060099|FG008|Overall Study|Withdrawal by Subject|1|||
46843143|NCT00141297|83060100|FG009|Overall Study|Withdrawal by Subject|0|||
46843144|NCT00141297|83060091|FG000|Overall Study|Other|0|||
46843145|NCT00141297|83060092|FG001|Overall Study|Other|0|||
46843146|NCT00141297|83060093|FG002|Overall Study|Other|0|||
46843147|NCT00141297|83060094|FG003|Overall Study|Other|1|||
46843148|NCT00141297|83060095|FG004|Overall Study|Other|5|||
46952250|NCT02978326|83191529|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
46952251|NCT02978326|83191527|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
46952252|NCT02978326|83191528|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
46952253|NCT02978326|83191529|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
46952254|NCT02978326|83191527|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
46952255|NCT02978326|83191528|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
46952256|NCT02978326|83191529|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
46952257|NCT02834403|83191555|FG000|Overall Study|Physician Decision|2|||
46952258|NCT02834403|83191556|FG001|Overall Study|Physician Decision|1|||
46772241|NCT00799409|82990467|FG001|Overall Study|Optimal Dose Not Achieved|0|||
46772242|NCT00799409|82990468|FG002|Overall Study|Optimal Dose Not Achieved|0|||
46772243|NCT00799409|82990466|FG000|Overall Study|Failure to follow study protocol)|1|||
46772244|NCT00799409|82990467|FG001|Overall Study|Failure to follow study protocol)|0|||
46843149|NCT00141297|83060096|FG005|Overall Study|Other|0|||
46843150|NCT00141297|83060097|FG006|Overall Study|Other|0|||
46843151|NCT00141297|83060098|FG007|Overall Study|Other|0|||
46843152|NCT00141297|83060099|FG008|Overall Study|Other|2|||
46843153|NCT00141297|83060100|FG009|Overall Study|Other|0|||
46843154|NCT00141297|83060091|FG000|Overall Study|Progressive Disease|2|||
46843155|NCT00141297|83060092|FG001|Overall Study|Progressive Disease|3|||
46843156|NCT00141297|83060093|FG002|Overall Study|Progressive Disease|6|||
46843157|NCT00141297|83060094|FG003|Overall Study|Progressive Disease|2|||
46843158|NCT00141297|83060095|FG004|Overall Study|Progressive Disease|15|||
46843159|NCT00141297|83060096|FG005|Overall Study|Progressive Disease|2|||
46843160|NCT00141297|83060097|FG006|Overall Study|Progressive Disease|3|||
46843161|NCT00141297|83060098|FG007|Overall Study|Progressive Disease|3|||
46952259|NCT02834403|83191557|FG002|Overall Study|Physician Decision|2|||
46772245|NCT00799409|82990468|FG002|Overall Study|Failure to follow study protocol)|0|||
46772246|NCT00799409|82990466|FG000|Overall Study|Did not attend lab school day 1|1|||
46772247|NCT00799409|82990467|FG001|Overall Study|Did not attend lab school day 1|0|||
46772248|NCT00799409|82990468|FG002|Overall Study|Did not attend lab school day 1|0|||
46772249|NCT00799409|82990466|FG000|Overall Study|medication compliance|1|||
46772250|NCT00799409|82990467|FG001|Overall Study|medication compliance|0|||
46843162|NCT00141297|83060099|FG008|Overall Study|Progressive Disease|15|||
46843163|NCT00141297|83060100|FG009|Overall Study|Progressive Disease|6|||
46843164|NCT00141297|83060091|FG000|Overall Study|Transitioned|0|||
46843165|NCT00141297|83060092|FG001|Overall Study|Transitioned|0|||
46843166|NCT00141297|83060093|FG002|Overall Study|Transitioned|0|||
46843167|NCT00141297|83060094|FG003|Overall Study|Transitioned|0|||
46843168|NCT00141297|83060095|FG004|Overall Study|Transitioned|1|||
46952260|NCT02834403|83191558|FG003|Overall Study|Physician Decision|1|||
47066618|NCT01451437|83349279|FG000|Overall Study|Disease Progression|0|||
47066619|NCT01451437|83349280|FG001|Overall Study|Disease Progression|0|||
47066620|NCT01451437|83349281|FG002|Overall Study|Disease Progression|1|||
46843169|NCT00141297|83060096|FG005|Overall Study|Transitioned|0|||
46843170|NCT00141297|83060097|FG006|Overall Study|Transitioned|0|||
46952261|NCT02834403|83191559|FG004|Overall Study|Physician Decision|1|||
46952262|NCT02834403|83191560|FG005|Overall Study|Physician Decision|2|||
46843171|NCT00141297|83060098|FG007|Overall Study|Transitioned|0|||
46952263|NCT02834403|83191561|FG006|Overall Study|Physician Decision|12|||
47066621|NCT01451437|83349282|FG003|Overall Study|Disease Progression|1|||
46843172|NCT00141297|83060099|FG008|Overall Study|Transitioned|0|||
46843173|NCT00141297|83060100|FG009|Overall Study|Transitioned|0|||
46843174|NCT00141219|83060135|FG000|Overall Study|Protocol violations|5|||
46843175|NCT00141219|83060136|FG001|Overall Study|Protocol violations|4|||
46843176|NCT00141219|83060135|FG000|Overall Study|Adverse Event|8|||
46843177|NCT00141219|83060136|FG001|Overall Study|Adverse Event|6|||
46843178|NCT00141219|83060135|FG000|Overall Study|Lack of Efficacy|5|||
46952264|NCT02834403|83191555|FG000|Overall Study|Adverse Event|0|||
46952265|NCT02834403|83191556|FG001|Overall Study|Adverse Event|0|||
46952266|NCT02834403|83191557|FG002|Overall Study|Adverse Event|0|||
46952267|NCT02834403|83191558|FG003|Overall Study|Adverse Event|0|||
46952268|NCT02834403|83191559|FG004|Overall Study|Adverse Event|1|||
46952269|NCT02834403|83191560|FG005|Overall Study|Adverse Event|1|||
46952270|NCT02834403|83191561|FG006|Overall Study|Adverse Event|3|||
46952271|NCT02834403|83191555|FG000|Overall Study|Withdrawal by Subject|0|||
46952272|NCT02834403|83191556|FG001|Overall Study|Withdrawal by Subject|1|||
46952273|NCT02834403|83191557|FG002|Overall Study|Withdrawal by Subject|0|||
46952274|NCT02834403|83191558|FG003|Overall Study|Withdrawal by Subject|0|||
46952275|NCT02834403|83191559|FG004|Overall Study|Withdrawal by Subject|1|||
46952276|NCT02834403|83191560|FG005|Overall Study|Withdrawal by Subject|0|||
46952277|NCT02834403|83191561|FG006|Overall Study|Withdrawal by Subject|0|||
46952278|NCT02834403|83191555|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
46952279|NCT02834403|83191556|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
46952280|NCT02834403|83191557|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
46952281|NCT02834403|83191558|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
46952282|NCT02834403|83191559|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
46952283|NCT02834403|83191560|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
46952284|NCT02834403|83191561|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
46952285|NCT01966731|83191583|FG000|Overall Study|Death|2|||
46952286|NCT01966731|83191583|FG000|Overall Study|Lost to Follow-up|1|||
46952287|NCT01966731|83191583|FG000|Overall Study|Physician Decision|2|||
46952288|NCT01966731|83191583|FG000|Overall Study|Follow up is not complete|600|||
46952289|NCT01966731|83191583|FG000|Overall Study|Screening Failure|29|||
46952290|NCT01966731|83191583|FG000|Overall Study|Found to be ineligible|1|||
46952291|NCT02788175|83191596|FG000|Overall Study|Protocol Violation|3|||
46952292|NCT02788175|83191596|FG000|Overall Study|Withdrawal by Subject|4|||
46952293|NCT02788175|83191596|FG000|Overall Study|Ineligible prior to study agent|6|||
46952294|NCT02787083|83191602|FG000|Overall Study|Adverse Event|1|||
46952295|NCT02787083|83191603|FG001|Overall Study|Adverse Event|0|||
46952296|NCT02787083|83191602|FG000|Overall Study|Withdrawal by Subject|2|||
46952297|NCT02787083|83191603|FG001|Overall Study|Withdrawal by Subject|2|||
46952298|NCT02787863|83191617|FG000|Overall Study|Death|1|||
46952299|NCT02787863|83191618|FG001|Overall Study|Death|0|||
46952300|NCT02787863|83191619|FG002|Overall Study|Death|1|||
46952301|NCT02787863|83191620|FG003|Overall Study|Death|0|||
46952302|NCT02787863|83191621|FG004|Overall Study|Death|0|||
46952303|NCT02787863|83191622|FG005|Overall Study|Death|0|||
46952304|NCT02787863|83191623|FG006|Overall Study|Death|0|||
46952305|NCT02787863|83191624|FG007|Overall Study|Death|0|||
46952306|NCT02787863|83191617|FG000|Overall Study|Withdrawal by Subject|0|||
46952307|NCT02787863|83191618|FG001|Overall Study|Withdrawal by Subject|1|||
46952308|NCT02787863|83191619|FG002|Overall Study|Withdrawal by Subject|1|||
46952309|NCT02787863|83191620|FG003|Overall Study|Withdrawal by Subject|0|||
46952310|NCT02787863|83191621|FG004|Overall Study|Withdrawal by Subject|0|||
46952311|NCT02787863|83191622|FG005|Overall Study|Withdrawal by Subject|0|||
46952312|NCT02787863|83191623|FG006|Overall Study|Withdrawal by Subject|0|||
46952313|NCT02787863|83191624|FG007|Overall Study|Withdrawal by Subject|0|||
46952314|NCT02596958|83191665|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
46952315|NCT02596958|83191665|FG000|Overall Study|Cancer Progression|441|||
46639146|NCT01389102|82812677|FG000|Overall Study|Investigator Judgement|0|||
46639147|NCT01389102|82812678|FG001|Overall Study|Investigator Judgement|1|||
46772251|NCT00799409|82990468|FG002|Overall Study|medication compliance|0|||
46772252|NCT00782210|82990479|FG000|Overall Study|Adverse Event|21|||
46772253|NCT00782210|82990480|FG001|Overall Study|Adverse Event|17|||
46772254|NCT00782210|82990481|FG002|Overall Study|Adverse Event|16|||
46772255|NCT00782210|82990479|FG000|Overall Study|Lost to Follow-up|2|||
46772256|NCT00782210|82990480|FG001|Overall Study|Lost to Follow-up|1|||
46772257|NCT00782210|82990481|FG002|Overall Study|Lost to Follow-up|2|||
46772258|NCT00782210|82990479|FG000|Overall Study|Withdrawal by Subject|11|||
46843179|NCT00141219|83060136|FG001|Overall Study|Lack of Efficacy|4|||
46772259|NCT00782210|82990480|FG001|Overall Study|Withdrawal by Subject|8|||
46772260|NCT00782210|82990481|FG002|Overall Study|Withdrawal by Subject|11|||
46772261|NCT00782210|82990479|FG000|Overall Study|Non compliance with protocol|0|||
46952316|NCT02596958|83191665|FG000|Overall Study|Death From Cancer|112|||
46952317|NCT02596958|83191665|FG000|Overall Study|Death From Other Cause|33|||
46843180|NCT00141219|83060135|FG000|Overall Study|Withdrawal by Subject|6|||
46952318|NCT02596958|83191665|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
46952319|NCT02596958|83191665|FG000|Overall Study|Administrative Reasons/Other|231|||
46952320|NCT02596958|83191665|FG000|Overall Study|Lost to Follow-up|33|||
46952321|NCT02596958|83191665|FG000|Overall Study|Missing|32|||
46952322|NCT02596958|83191665|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
46952323|NCT01367249|83191671|FG000|Overall Study|Withdrawal by Subject|6|||
46952324|NCT01367249|83191672|FG001|Overall Study|Withdrawal by Subject|6|||
46952325|NCT01367249|83191671|FG000|Overall Study|Other|3|||
46952326|NCT01367249|83191672|FG001|Overall Study|Other|10|||
46952327|NCT02786927|83191678|FG000|Overall Study|Adverse Event|1|||
46952328|NCT02786927|83191678|FG000|Overall Study|Protocol Violation|4|||
46952329|NCT02592434|83191683|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
46952330|NCT02592434|83191684|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
46952331|NCT02592434|83191685|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
46952332|NCT02592434|83191683|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
46952333|NCT02592434|83191684|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
46952334|NCT02592434|83191685|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
46952335|NCT02592434|83191683|FG000|Open-Label Phase (18 Weeks)|Other|3|||
46952336|NCT02592434|83191684|FG001|Open-Label Phase (18 Weeks)|Other|0|||
46952337|NCT02592434|83191685|FG002|Open-Label Phase (18 Weeks)|Other|0|||
46952338|NCT02592434|83191683|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
46952339|NCT02592434|83191684|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
46952340|NCT02592434|83191685|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
46952341|NCT02592434|83191683|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
46952342|NCT02592434|83191684|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
46952343|NCT02592434|83191685|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
46952344|NCT02592434|83191683|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
46952345|NCT02592434|83191684|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
46952346|NCT02592434|83191685|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
46952347|NCT02592434|83191683|FG000|Double Blind Phase (26 Weeks)|Other|0|||
46952348|NCT02592434|83191684|FG001|Double Blind Phase (26 Weeks)|Other|1|||
46952349|NCT02592434|83191685|FG002|Double Blind Phase (26 Weeks)|Other|0|||
46952350|NCT02592434|83191683|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
46952351|NCT02592434|83191684|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
46952352|NCT02592434|83191685|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
46952353|NCT02592434|83191683|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
46952354|NCT02592434|83191684|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
46952355|NCT02592434|83191685|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
46952356|NCT02592434|83191683|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
46952357|NCT02592434|83191684|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
46952358|NCT02592434|83191685|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
46952359|NCT02785913|83191693|FG000|Overall Study|Adverse Event|5|||
46952360|NCT02785913|83191693|FG000|Overall Study|Death|2|||
46952361|NCT02785913|83191693|FG000|Overall Study|Progression|18|||
46952362|NCT02785913|83191693|FG000|Overall Study|Not protocol specified|1|||
46952363|NCT02590562|83191702|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
46952364|NCT02783729|83191729|FG000|Overall Study|Lack of Efficacy|1|||
46952365|NCT02783729|83191730|FG001|Overall Study|Lack of Efficacy|0|||
46952366|NCT02783729|83191731|FG002|Overall Study|Lack of Efficacy|0|||
46952367|NCT02783729|83191732|FG003|Overall Study|Lack of Efficacy|0|||
46952368|NCT02783729|83191729|FG000|Overall Study|Adverse Event|2|||
46952369|NCT02783729|83191730|FG001|Overall Study|Adverse Event|6|||
46952370|NCT02783729|83191731|FG002|Overall Study|Adverse Event|2|||
46952371|NCT02783729|83191732|FG003|Overall Study|Adverse Event|3|||
46952372|NCT02783729|83191729|FG000|Overall Study|Other|1|||
46952373|NCT02783729|83191730|FG001|Overall Study|Other|6|||
46952374|NCT02783729|83191731|FG002|Overall Study|Other|2|||
46952375|NCT02783729|83191732|FG003|Overall Study|Other|3|||
46952376|NCT02783729|83191729|FG000|Overall Study|Withdrawal by Subject|2|||
46952377|NCT02783729|83191730|FG001|Overall Study|Withdrawal by Subject|3|||
46952378|NCT02783729|83191731|FG002|Overall Study|Withdrawal by Subject|1|||
46952379|NCT02783729|83191732|FG003|Overall Study|Withdrawal by Subject|2|||
46952380|NCT02783729|83191729|FG000|Overall Study|Participant's choice|2|||
46952381|NCT02783729|83191730|FG001|Overall Study|Participant's choice|1|||
46952382|NCT02783729|83191731|FG002|Overall Study|Participant's choice|2|||
46952383|NCT02783729|83191732|FG003|Overall Study|Participant's choice|1|||
46952384|NCT02783729|83191729|FG000|Overall Study|Lost to Follow-up|2|||
46952385|NCT02783729|83191730|FG001|Overall Study|Lost to Follow-up|1|||
46952386|NCT02783729|83191731|FG002|Overall Study|Lost to Follow-up|1|||
46952387|NCT02783729|83191732|FG003|Overall Study|Lost to Follow-up|0|||
46952388|NCT02784431|83191771|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
46952389|NCT02784431|83191771|FG000|Overall Study|Early Study Termination|19|||
46952390|NCT02590406|83191777|FG000|Overall Study|Adverse Event|1|||
46952391|NCT02590406|83191778|FG001|Overall Study|Adverse Event|0|||
46952392|NCT02590406|83191777|FG000|Overall Study|Saturometer malfunction|0|||
46952393|NCT02590406|83191778|FG001|Overall Study|Saturometer malfunction|1|||
46952394|NCT01359254|83191786|FG000|Overall Study|Death|1|||
46952395|NCT01359254|83191787|FG001|Overall Study|Death|0|||
46952396|NCT01667432|83191793|FG000|Overall Study|Premature Study Termination|26|||
46952397|NCT01667432|83191793|FG000|Overall Study|Failure to Return|10|||
46952398|NCT01667432|83191793|FG000|Overall Study|Moved to Another Center|3|||
46952399|NCT01667432|83191793|FG000|Overall Study|Lost to Follow-up|3|||
46952400|NCT01667432|83191793|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
46952401|NCT01667432|83191793|FG000|Overall Study|Insufficient Therapeutic Response|4|||
46952402|NCT01667432|83191793|FG000|Overall Study|Adverse Event|1|||
46952403|NCT01667432|83191793|FG000|Overall Study|Protocol Deviation|2|||
46952404|NCT01667432|83191793|FG000|Overall Study|Principal Investigator Decision|1|||
46952405|NCT01667432|83191793|FG000|Overall Study|Reason Not Specified|2|||
46952406|NCT01667432|83191793|FG000|Overall Study|Missing Information|4|||
46952407|NCT01563107|83191801|FG000|Overall Study|Physician Decision|0|||
46952408|NCT01563107|83191802|FG001|Overall Study|Physician Decision|1|||
46952409|NCT01563107|83191803|FG002|Overall Study|Physician Decision|1|||
46952410|NCT01563107|83191804|FG003|Overall Study|Physician Decision|3|||
46952411|NCT01563107|83191801|FG000|Overall Study|Withdrawal by Subject|1|||
46952412|NCT01563107|83191802|FG001|Overall Study|Withdrawal by Subject|2|||
46952413|NCT01563107|83191803|FG002|Overall Study|Withdrawal by Subject|1|||
46952414|NCT01563107|83191804|FG003|Overall Study|Withdrawal by Subject|2|||
46952415|NCT02589626|83191866|FG000|Overall Study|Other than the reason specified|1|||
46952416|NCT02589626|83191867|FG001|Overall Study|Other than the reason specified|0|||
46952417|NCT02589626|83191866|FG000|Overall Study|Withdrawal by Subject|1|||
46952418|NCT02589626|83191867|FG001|Overall Study|Withdrawal by Subject|1|||
46952419|NCT02589626|83191866|FG000|Overall Study|Adverse Event|1|||
46952420|NCT02589626|83191867|FG001|Overall Study|Adverse Event|1|||
46952421|NCT01666730|83191882|FG000|Overall Study|Adverse Event|16|||
46952422|NCT01666730|83191882|FG000|Overall Study|Death|2|||
46952423|NCT01666730|83191882|FG000|Overall Study|Physician Decision|5|||
46952424|NCT01666730|83191882|FG000|Overall Study|Withdrawal by Subject|9|||
46952425|NCT01666730|83191882|FG000|Overall Study|Disease progression/relapse|18|||
46952426|NCT00103285|83191895|FG000|Induction|Adverse Event|14|||
46952427|NCT00103285|83191896|FG001|Induction|Adverse Event|0|||
46952428|NCT00103285|83191897|FG002|Induction|Adverse Event|0|||
46952429|NCT00103285|83191898|FG003|Induction|Adverse Event|0|||
46952430|NCT00103285|83191899|FG004|Induction|Adverse Event|0|||
46952431|NCT00103285|83191900|FG005|Induction|Adverse Event|0|||
46952432|NCT00103285|83191901|FG006|Induction|Adverse Event|0|||
46952433|NCT00103285|83191902|FG007|Induction|Adverse Event|0|||
46952434|NCT00103285|83191895|FG000|Induction|Death|24|||
46952435|NCT00103285|83191896|FG001|Induction|Death|0|||
46772262|NCT00782210|82990480|FG001|Overall Study|Non compliance with protocol|3|||
46843181|NCT00141219|83060136|FG001|Overall Study|Withdrawal by Subject|2|||
46952436|NCT00103285|83191897|FG002|Induction|Death|0|||
46952437|NCT00103285|83191898|FG003|Induction|Death|0|||
46952438|NCT00103285|83191899|FG004|Induction|Death|0|||
46952439|NCT00103285|83191900|FG005|Induction|Death|0|||
46952440|NCT00103285|83191901|FG006|Induction|Death|0|||
46772263|NCT00782210|82990481|FG002|Overall Study|Non compliance with protocol|2|||
46772264|NCT00782210|82990479|FG000|Overall Study|Lack of Efficacy|13|||
46772265|NCT00782210|82990480|FG001|Overall Study|Lack of Efficacy|4|||
46772266|NCT00782210|82990481|FG002|Overall Study|Lack of Efficacy|1|||
46772267|NCT00782210|82990479|FG000|Overall Study|Other reason not described above|3|||
46952441|NCT00103285|83191902|FG007|Induction|Death|0|||
46772268|NCT00782210|82990480|FG001|Overall Study|Other reason not described above|2|||
46772269|NCT00782210|82990481|FG002|Overall Study|Other reason not described above|3|||
46772270|NCT01558115|82990498|FG000|Overall Study|Withdrawal by Subject|3|||
46772271|NCT01558115|82990498|FG000|Overall Study|Study closed due to poor enrollment|4|||
46772272|NCT00764660|82990512|FG000|Overall Study|Adverse Event|6|||
46772273|NCT00764660|82990513|FG001|Overall Study|Adverse Event|3|||
46772274|NCT00764660|82990512|FG000|Overall Study|Lost to Follow-up|3|||
46772275|NCT00764660|82990513|FG001|Overall Study|Lost to Follow-up|4|||
46772276|NCT00764660|82990512|FG000|Overall Study|Withdrawal by Subject|7|||
46772277|NCT00764660|82990513|FG001|Overall Study|Withdrawal by Subject|3|||
46772278|NCT00764660|82990512|FG000|Overall Study|Noncompliance With Protocol|5|||
46843182|NCT00162266|83060145|FG000|Double-Blind Period|Adverse Event|5|||
46952442|NCT00103285|83191895|FG000|Induction|Physician Decision|103|||
46952443|NCT00103285|83191896|FG001|Induction|Physician Decision|0|||
46952444|NCT00103285|83191897|FG002|Induction|Physician Decision|0|||
46952445|NCT00103285|83191898|FG003|Induction|Physician Decision|0|||
46952446|NCT00103285|83191899|FG004|Induction|Physician Decision|0|||
46952447|NCT00103285|83191900|FG005|Induction|Physician Decision|0|||
46952448|NCT00103285|83191901|FG006|Induction|Physician Decision|0|||
46772279|NCT00764660|82990513|FG001|Overall Study|Noncompliance With Protocol|1|||
46772280|NCT00764660|82990512|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
46843183|NCT00162266|83060146|FG001|Double-Blind Period|Adverse Event|9|||
46952449|NCT00103285|83191902|FG007|Induction|Physician Decision|0|||
46952450|NCT00103285|83191895|FG000|Induction|Withdrawal by Subject|1|||
46952451|NCT00103285|83191896|FG001|Induction|Withdrawal by Subject|0|||
46952452|NCT00103285|83191897|FG002|Induction|Withdrawal by Subject|0|||
46952453|NCT00103285|83191898|FG003|Induction|Withdrawal by Subject|0|||
46952454|NCT00103285|83191899|FG004|Induction|Withdrawal by Subject|0|||
46952455|NCT00103285|83191900|FG005|Induction|Withdrawal by Subject|0|||
46952456|NCT00103285|83191901|FG006|Induction|Withdrawal by Subject|0|||
46952457|NCT00103285|83191902|FG007|Induction|Withdrawal by Subject|0|||
46952458|NCT00103285|83191895|FG000|Induction|Ineligible|43|||
46952459|NCT00103285|83191896|FG001|Induction|Ineligible|0|||
46952460|NCT00103285|83191897|FG002|Induction|Ineligible|0|||
46952461|NCT00103285|83191898|FG003|Induction|Ineligible|0|||
46952462|NCT00103285|83191899|FG004|Induction|Ineligible|0|||
46952463|NCT00103285|83191900|FG005|Induction|Ineligible|0|||
46952464|NCT00103285|83191901|FG006|Induction|Ineligible|0|||
46952465|NCT00103285|83191902|FG007|Induction|Ineligible|0|||
46952466|NCT00103285|83191895|FG000|Induction|Refusal|906|||
46952467|NCT00103285|83191896|FG001|Induction|Refusal|0|||
46952468|NCT00103285|83191897|FG002|Induction|Refusal|0|||
46952469|NCT00103285|83191898|FG003|Induction|Refusal|0|||
46952470|NCT00103285|83191899|FG004|Induction|Refusal|0|||
46952471|NCT00103285|83191900|FG005|Induction|Refusal|0|||
46952472|NCT00103285|83191901|FG006|Induction|Refusal|0|||
46952473|NCT00103285|83191902|FG007|Induction|Refusal|0|||
46952474|NCT00103285|83191895|FG000|Induction|Other|258|||
46952475|NCT00103285|83191896|FG001|Induction|Other|0|||
46952476|NCT00103285|83191897|FG002|Induction|Other|0|||
46952477|NCT00103285|83191898|FG003|Induction|Other|0|||
46952478|NCT00103285|83191899|FG004|Induction|Other|0|||
46952479|NCT00103285|83191900|FG005|Induction|Other|0|||
46952480|NCT00103285|83191901|FG006|Induction|Other|0|||
46952481|NCT00103285|83191902|FG007|Induction|Other|0|||
46952482|NCT00103285|83191895|FG000|Response Assignment|Adverse Event|0|||
46952483|NCT00103285|83191896|FG001|Response Assignment|Adverse Event|8|||
46952484|NCT00103285|83191897|FG002|Response Assignment|Adverse Event|3|||
46952485|NCT00103285|83191898|FG003|Response Assignment|Adverse Event|2|||
46952486|NCT00103285|83191899|FG004|Response Assignment|Adverse Event|3|||
46952487|NCT00103285|83191900|FG005|Response Assignment|Adverse Event|1|||
46952488|NCT00103285|83191901|FG006|Response Assignment|Adverse Event|1|||
46952489|NCT00103285|83191902|FG007|Response Assignment|Adverse Event|2|||
46952490|NCT00103285|83191895|FG000|Response Assignment|Death|0|||
46952491|NCT00103285|83191896|FG001|Response Assignment|Death|5|||
46952492|NCT00103285|83191897|FG002|Response Assignment|Death|2|||
46952493|NCT00103285|83191898|FG003|Response Assignment|Death|2|||
46952494|NCT00103285|83191899|FG004|Response Assignment|Death|3|||
46772281|NCT00764660|82990513|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
46772282|NCT00584415|82990519|FG000|Overall Study|Adverse Event|7|||
46772283|NCT00764504|82990527|FG000|Overall Study|Death|12|||
46772284|NCT00764504|82990528|FG001|Overall Study|Death|6|||
46772285|NCT00764504|82990529|FG002|Overall Study|Death|13|||
46952495|NCT00103285|83191900|FG005|Response Assignment|Death|1|||
46952496|NCT00103285|83191901|FG006|Response Assignment|Death|0|||
46952497|NCT00103285|83191902|FG007|Response Assignment|Death|8|||
46952498|NCT00103285|83191895|FG000|Response Assignment|Lost to Follow-up|0|||
46952499|NCT00103285|83191896|FG001|Response Assignment|Lost to Follow-up|9|||
46952500|NCT00103285|83191897|FG002|Response Assignment|Lost to Follow-up|5|||
46952501|NCT00103285|83191898|FG003|Response Assignment|Lost to Follow-up|5|||
46952502|NCT00103285|83191899|FG004|Response Assignment|Lost to Follow-up|1|||
46952503|NCT00103285|83191900|FG005|Response Assignment|Lost to Follow-up|2|||
46952504|NCT00103285|83191901|FG006|Response Assignment|Lost to Follow-up|2|||
46952505|NCT00103285|83191902|FG007|Response Assignment|Lost to Follow-up|5|||
46952506|NCT00103285|83191895|FG000|Response Assignment|Physician Decision|0|||
46952507|NCT00103285|83191896|FG001|Response Assignment|Physician Decision|13|||
46952508|NCT00103285|83191897|FG002|Response Assignment|Physician Decision|14|||
46772286|NCT00764504|82990527|FG000|Overall Study|Revision of Device|12|||
46772287|NCT00764504|82990528|FG001|Overall Study|Revision of Device|23|||
46952509|NCT00103285|83191898|FG003|Response Assignment|Physician Decision|9|||
46952510|NCT00103285|83191899|FG004|Response Assignment|Physician Decision|13|||
46952511|NCT00103285|83191900|FG005|Response Assignment|Physician Decision|7|||
46952512|NCT00103285|83191901|FG006|Response Assignment|Physician Decision|4|||
46952513|NCT00103285|83191902|FG007|Response Assignment|Physician Decision|35|||
46952514|NCT00103285|83191895|FG000|Response Assignment|Protocol Violation|0|||
46952515|NCT00103285|83191896|FG001|Response Assignment|Protocol Violation|2|||
46952516|NCT00103285|83191897|FG002|Response Assignment|Protocol Violation|0|||
46952517|NCT00103285|83191898|FG003|Response Assignment|Protocol Violation|0|||
46952518|NCT00103285|83191899|FG004|Response Assignment|Protocol Violation|0|||
46952519|NCT00103285|83191900|FG005|Response Assignment|Protocol Violation|0|||
46772288|NCT00764504|82990529|FG002|Overall Study|Revision of Device|14|||
46772289|NCT00764504|82990527|FG000|Overall Study|Physician Decision|1|||
46772290|NCT00764504|82990528|FG001|Overall Study|Physician Decision|0|||
46952520|NCT00103285|83191901|FG006|Response Assignment|Protocol Violation|0|||
46952521|NCT00103285|83191902|FG007|Response Assignment|Protocol Violation|0|||
46952522|NCT00103285|83191895|FG000|Response Assignment|Withdrawal by Subject|0|||
46952523|NCT00103285|83191896|FG001|Response Assignment|Withdrawal by Subject|4|||
46952524|NCT00103285|83191897|FG002|Response Assignment|Withdrawal by Subject|1|||
46952525|NCT00103285|83191898|FG003|Response Assignment|Withdrawal by Subject|1|||
46952526|NCT00103285|83191899|FG004|Response Assignment|Withdrawal by Subject|2|||
46952527|NCT00103285|83191900|FG005|Response Assignment|Withdrawal by Subject|2|||
46952528|NCT00103285|83191901|FG006|Response Assignment|Withdrawal by Subject|0|||
46952529|NCT00103285|83191902|FG007|Response Assignment|Withdrawal by Subject|2|||
46952530|NCT00103285|83191895|FG000|Response Assignment|Ineligible|0|||
46952531|NCT00103285|83191896|FG001|Response Assignment|Ineligible|8|||
46952532|NCT00103285|83191897|FG002|Response Assignment|Ineligible|6|||
46952533|NCT00103285|83191898|FG003|Response Assignment|Ineligible|2|||
46952534|NCT00103285|83191899|FG004|Response Assignment|Ineligible|0|||
46952535|NCT00103285|83191900|FG005|Response Assignment|Ineligible|3|||
46952536|NCT00103285|83191901|FG006|Response Assignment|Ineligible|1|||
46952537|NCT00103285|83191902|FG007|Response Assignment|Ineligible|5|||
46952538|NCT00103285|83191895|FG000|Response Assignment|Refusal|0|||
46952539|NCT00103285|83191896|FG001|Response Assignment|Refusal|53|||
46952540|NCT00103285|83191897|FG002|Response Assignment|Refusal|5|||
46952541|NCT00103285|83191898|FG003|Response Assignment|Refusal|3|||
46952542|NCT00103285|83191899|FG004|Response Assignment|Refusal|25|||
46952543|NCT00103285|83191900|FG005|Response Assignment|Refusal|15|||
46952544|NCT00103285|83191901|FG006|Response Assignment|Refusal|30|||
46952545|NCT00103285|83191902|FG007|Response Assignment|Refusal|10|||
46952546|NCT00103285|83191895|FG000|Response Assignment|Other|0|||
46952547|NCT00103285|83191896|FG001|Response Assignment|Other|30|||
46952548|NCT00103285|83191897|FG002|Response Assignment|Other|48|||
46952549|NCT00103285|83191898|FG003|Response Assignment|Other|38|||
46952550|NCT00103285|83191899|FG004|Response Assignment|Other|37|||
46952551|NCT00103285|83191900|FG005|Response Assignment|Other|17|||
46952552|NCT00103285|83191901|FG006|Response Assignment|Other|11|||
46952553|NCT00103285|83191902|FG007|Response Assignment|Other|53|||
46952554|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
46952555|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
46952556|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
46952557|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Death|4|||
46952558|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Death|2|||
46952559|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Death|3|||
46952560|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
46952561|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
46952562|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
46952563|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
46952564|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
46952565|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
46952566|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
46952567|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
46952568|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
46952569|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
46952570|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
46952571|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
46952572|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
46952573|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
46952574|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
46952575|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
46952576|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
46952577|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
46952578|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
46952579|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
46952580|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
46952581|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
46952582|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
46952583|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
46639148|NCT01389102|82812679|FG002|Overall Study|Investigator Judgement|0|||
46639149|NCT01389102|82812680|FG003|Overall Study|Investigator Judgement|0|||
46952584|NCT02783573|83191930|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
46952585|NCT02783573|83191931|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
46952586|NCT02783573|83191932|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
46772291|NCT00764504|82990529|FG002|Overall Study|Physician Decision|0|||
46952587|NCT02783573|83191930|FG000|Delayed-Start Period|Sponsor Decision|0|||
46952588|NCT02783573|83191931|FG001|Delayed-Start Period|Sponsor Decision|17|||
46952589|NCT02783573|83191932|FG002|Delayed-Start Period|Sponsor Decision|12|||
46952590|NCT01666652|83191948|FG000|Overall Study|Serious Adverse Event|0|||
46952591|NCT01666652|83191949|FG001|Overall Study|Serious Adverse Event|0|||
46952592|NCT01666652|83191950|FG002|Overall Study|Serious Adverse Event|0|||
46952593|NCT01666652|83191951|FG003|Overall Study|Serious Adverse Event|1|||
46952594|NCT01666652|83191952|FG004|Overall Study|Serious Adverse Event|0|||
46952595|NCT01666652|83191948|FG000|Overall Study|Withdrawal by Subject|0|||
46952596|NCT01666652|83191949|FG001|Overall Study|Withdrawal by Subject|0|||
46952597|NCT01666652|83191950|FG002|Overall Study|Withdrawal by Subject|0|||
46952598|NCT01666652|83191951|FG003|Overall Study|Withdrawal by Subject|0|||
46952599|NCT01666652|83191952|FG004|Overall Study|Withdrawal by Subject|1|||
46952600|NCT01666652|83191948|FG000|Overall Study|Moved from study area|1|||
46952601|NCT01666652|83191949|FG001|Overall Study|Moved from study area|0|||
46952602|NCT01666652|83191950|FG002|Overall Study|Moved from study area|0|||
46952603|NCT01666652|83191951|FG003|Overall Study|Moved from study area|2|||
46952604|NCT01666652|83191952|FG004|Overall Study|Moved from study area|0|||
46952605|NCT01666652|83191948|FG000|Overall Study|Lost to Follow-up|1|||
46952606|NCT01666652|83191949|FG001|Overall Study|Lost to Follow-up|1|||
46952607|NCT01666652|83191950|FG002|Overall Study|Lost to Follow-up|1|||
46952608|NCT01666652|83191951|FG003|Overall Study|Lost to Follow-up|1|||
46952609|NCT01666652|83191952|FG004|Overall Study|Lost to Follow-up|0|||
46952610|NCT00109733|83191966|FG000|Overall Study|Protocol Violation|0|||
46952611|NCT00109733|83191967|FG001|Overall Study|Protocol Violation|1|||
46952612|NCT00109733|83191966|FG000|Overall Study|Stopped taking study drug|1|||
46952613|NCT00109733|83191967|FG001|Overall Study|Stopped taking study drug|1|||
46952614|NCT00109733|83191966|FG000|Overall Study|Non-compliant|0|||
46952615|NCT00109733|83191967|FG001|Overall Study|Non-compliant|1|||
46952616|NCT00109733|83191966|FG000|Overall Study|Could not commit time for study|1|||
46952617|NCT00109733|83191967|FG001|Overall Study|Could not commit time for study|1|||
46952618|NCT02706405|83191981|FG000|Overall Study|Death|3|||
46952619|NCT02706405|83191982|FG001|Overall Study|Death|2|||
46952620|NCT02706405|83191983|FG002|Overall Study|Death|0|||
46952621|NCT02706405|83191984|FG003|Overall Study|Death|1|||
46952622|NCT02706405|83191985|FG004|Overall Study|Death|0|||
46952623|NCT02706405|83191986|FG005|Overall Study|Death|0|||
46952624|NCT02706405|83191987|FG006|Overall Study|Death|3|||
46952625|NCT02706405|83191988|FG007|Overall Study|Death|4|||
46952626|NCT02706405|83191981|FG000|Overall Study|Disease progression|0|||
46952627|NCT02706405|83191982|FG001|Overall Study|Disease progression|0|||
46952628|NCT02706405|83191983|FG002|Overall Study|Disease progression|0|||
46952629|NCT02706405|83191984|FG003|Overall Study|Disease progression|0|||
46952630|NCT02706405|83191985|FG004|Overall Study|Disease progression|0|||
46952631|NCT02706405|83191986|FG005|Overall Study|Disease progression|0|||
46952632|NCT02706405|83191987|FG006|Overall Study|Disease progression|0|||
47066622|NCT01451437|83349283|FG004|Overall Study|Disease Progression|3|||
47066623|NCT01451437|83349284|FG005|Overall Study|Disease Progression|2|||
47066624|NCT01451437|83349285|FG006|Overall Study|Disease Progression|3|||
47066625|NCT01451437|83349286|FG007|Overall Study|Disease Progression|1|||
46772292|NCT00764504|82990527|FG000|Overall Study|Withdrawal by Subject|1|||
46772293|NCT00764504|82990528|FG001|Overall Study|Withdrawal by Subject|7|||
46772294|NCT00764504|82990529|FG002|Overall Study|Withdrawal by Subject|4|||
46772295|NCT00764504|82990527|FG000|Overall Study|Lost to Follow-up|40|||
46772296|NCT00764504|82990528|FG001|Overall Study|Lost to Follow-up|34|||
46772297|NCT00764504|82990529|FG002|Overall Study|Lost to Follow-up|72|||
46772298|NCT00763958|82990539|FG000|Overall Study|did not meet final criteria|4|||
46772299|NCT00763958|82990540|FG001|Overall Study|did not meet final criteria|4|||
46772300|NCT00763958|82990539|FG000|Overall Study|Lost to Follow-up|10|||
46772301|NCT00763958|82990540|FG001|Overall Study|Lost to Follow-up|2|||
46772302|NCT00763958|82990539|FG000|Overall Study|Believed they were receiving placebo|0|||
46843184|NCT00162266|83060147|FG002|Double-Blind Period|Adverse Event|11|||
46843185|NCT00162266|83060148|FG003|Double-Blind Period|Adverse Event|0|||
46952633|NCT02706405|83191988|FG007|Overall Study|Disease progression|1|||
46952634|NCT02706405|83191981|FG000|Overall Study|Pt moved to new therapy|0|||
46952635|NCT02706405|83191982|FG001|Overall Study|Pt moved to new therapy|0|||
46952636|NCT02706405|83191983|FG002|Overall Study|Pt moved to new therapy|0|||
46952637|NCT02706405|83191984|FG003|Overall Study|Pt moved to new therapy|0|||
46952638|NCT02706405|83191985|FG004|Overall Study|Pt moved to new therapy|0|||
46952639|NCT02706405|83191986|FG005|Overall Study|Pt moved to new therapy|1|||
46952640|NCT02706405|83191987|FG006|Overall Study|Pt moved to new therapy|0|||
46952641|NCT02706405|83191988|FG007|Overall Study|Pt moved to new therapy|1|||
47066626|NCT01451437|83349287|FG008|Overall Study|Disease Progression|3|||
46843186|NCT00162266|83060145|FG000|Double-Blind Period|Death|0|||
47066627|NCT01451437|83349279|FG000|Overall Study|Protocol Violation|0|||
47066628|NCT01451437|83349280|FG001|Overall Study|Protocol Violation|0|||
46772303|NCT00763958|82990540|FG001|Overall Study|Believed they were receiving placebo|5|||
46843187|NCT00162266|83060146|FG001|Double-Blind Period|Death|1|||
46952642|NCT02706405|83191981|FG000|Overall Study|Physician Decision|1|||
46952643|NCT02706405|83191982|FG001|Overall Study|Physician Decision|0|||
46952644|NCT02706405|83191983|FG002|Overall Study|Physician Decision|0|||
46952645|NCT02706405|83191984|FG003|Overall Study|Physician Decision|0|||
46952646|NCT02706405|83191985|FG004|Overall Study|Physician Decision|0|||
46952647|NCT02706405|83191986|FG005|Overall Study|Physician Decision|0|||
46772304|NCT00763256|82990549|FG000|Overall Study|Didn't return for appointments|7|||
46772305|NCT00763256|82990550|FG001|Overall Study|Didn't return for appointments|10|||
46772306|NCT00762788|82990562|FG000|Overall Study|Lost to Follow-up|26|||
46772307|NCT00762788|82990563|FG001|Overall Study|Lost to Follow-up|37|||
46772308|NCT00762788|82990564|FG002|Overall Study|Lost to Follow-up|21|||
46772309|NCT00762788|82990565|FG003|Overall Study|Lost to Follow-up|26|||
46952648|NCT02706405|83191987|FG006|Overall Study|Physician Decision|0|||
46952649|NCT02706405|83191988|FG007|Overall Study|Physician Decision|0|||
46952650|NCT02761993|83192017|FG000|Overall Study|Adverse Event|0|||
46952651|NCT02761993|83192018|FG001|Overall Study|Adverse Event|2|||
46952652|NCT02761993|83192019|FG002|Overall Study|Adverse Event|0|||
46952653|NCT02761993|83192017|FG000|Overall Study|Lost to Follow-up|1|||
46952654|NCT02761993|83192018|FG001|Overall Study|Lost to Follow-up|3|||
46952655|NCT02761993|83192019|FG002|Overall Study|Lost to Follow-up|2|||
46952656|NCT02761993|83192017|FG000|Overall Study|Withdrawal by Subject|1|||
46952657|NCT02761993|83192018|FG001|Overall Study|Withdrawal by Subject|1|||
46952658|NCT02761993|83192019|FG002|Overall Study|Withdrawal by Subject|2|||
46952659|NCT02766283|83192027|FG000|Overall Study|Lost to Follow-up|27|||
46952660|NCT02761915|83192061|FG000|Overall Study|Death|3|||
46952661|NCT02761915|83192062|FG001|Overall Study|Death|1|||
46952662|NCT02761915|83192063|FG002|Overall Study|Death|1|||
46952663|NCT02761915|83192064|FG003|Overall Study|Death|1|||
46952664|NCT02761915|83192065|FG004|Overall Study|Death|0|||
46952665|NCT02761915|83192066|FG005|Overall Study|Death|1|||
46952666|NCT02761915|83192061|FG000|Overall Study|Withdrawal by Subject|1|||
46952667|NCT02761915|83192062|FG001|Overall Study|Withdrawal by Subject|0|||
46952668|NCT02761915|83192063|FG002|Overall Study|Withdrawal by Subject|0|||
46952669|NCT02761915|83192064|FG003|Overall Study|Withdrawal by Subject|0|||
46952670|NCT02761915|83192065|FG004|Overall Study|Withdrawal by Subject|1|||
46952671|NCT02761915|83192066|FG005|Overall Study|Withdrawal by Subject|2|||
46952672|NCT02761915|83192061|FG000|Overall Study|Disease Progression|0|||
46952673|NCT02761915|83192062|FG001|Overall Study|Disease Progression|0|||
46952674|NCT02761915|83192063|FG002|Overall Study|Disease Progression|0|||
46952675|NCT02761915|83192064|FG003|Overall Study|Disease Progression|2|||
46952676|NCT02761915|83192065|FG004|Overall Study|Disease Progression|2|||
46952677|NCT02761915|83192066|FG005|Overall Study|Disease Progression|2|||
46952678|NCT02706327|83192087|FG000|Overall Study|Lost to Follow-up|1|||
46952679|NCT02706327|83192088|FG001|Overall Study|Lost to Follow-up|1|||
46952680|NCT02706327|83192089|FG002|Overall Study|Lost to Follow-up|2|||
46952681|NCT02764333|83192097|FG000|Overall Study|Ineligible|1|||
46952682|NCT02705625|83192104|FG000|Overall Study|Protocol Violation|1|||
46952683|NCT02705625|83192105|FG001|Overall Study|Protocol Violation|0|||
46952684|NCT02705625|83192106|FG002|Overall Study|Protocol Violation|0|||
46952685|NCT02705625|83192104|FG000|Overall Study|Adverse Event|6|||
46952686|NCT02705625|83192105|FG001|Overall Study|Adverse Event|5|||
46952687|NCT02705625|83192106|FG002|Overall Study|Adverse Event|2|||
47066629|NCT01451437|83349281|FG002|Overall Study|Protocol Violation|0|||
47066630|NCT01451437|83349282|FG003|Overall Study|Protocol Violation|0|||
47066631|NCT01451437|83349283|FG004|Overall Study|Protocol Violation|0|||
47066632|NCT01451437|83349284|FG005|Overall Study|Protocol Violation|0|||
47066633|NCT01451437|83349285|FG006|Overall Study|Protocol Violation|1|||
46639150|NCT01389102|82812681|FG004|Overall Study|Investigator Judgement|0|||
46639151|NCT01389102|82812682|FG005|Overall Study|Investigator Judgement|0|||
46639152|NCT01402284|82812702|FG000|Overall Study|Withdrawal consent|2|||
46772310|NCT00762788|82990566|FG004|Overall Study|Lost to Follow-up|13|||
46772311|NCT00762788|82990567|FG005|Overall Study|Lost to Follow-up|21|||
46772312|NCT00583947|82990583|FG000|Cross-over Period|Adverse Event|2|||
46772313|NCT00583947|82990584|FG001|Cross-over Period|Adverse Event|0|||
46772314|NCT00583947|82990583|FG000|Cross-over Period|Withdrawal by Subject|2|||
46772315|NCT00583947|82990584|FG001|Cross-over Period|Withdrawal by Subject|0|||
46772316|NCT00583947|82990583|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
46772317|NCT00583947|82990584|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
46772318|NCT00583947|82990583|FG000|Cross-over Period|Other|1|||
46772319|NCT00583947|82990584|FG001|Cross-over Period|Other|1|||
46772320|NCT00772928|82990594|FG000|Overall Study|Lost to Follow-up|9|||
46952688|NCT02705625|83192104|FG000|Overall Study|Death|0|||
46952689|NCT02705625|83192105|FG001|Overall Study|Death|0|||
46952690|NCT02705625|83192106|FG002|Overall Study|Death|1|||
46952691|NCT02705625|83192104|FG000|Overall Study|Withdrawal by Subject|1|||
46952692|NCT02705625|83192105|FG001|Overall Study|Withdrawal by Subject|4|||
46952693|NCT02705625|83192106|FG002|Overall Study|Withdrawal by Subject|5|||
46952694|NCT02705625|83192104|FG000|Overall Study|Lost to Follow-up|0|||
46772321|NCT00772928|82990595|FG001|Overall Study|Lost to Follow-up|6|||
46772322|NCT00772928|82990594|FG000|Overall Study|Protocol Violation|10|||
46952695|NCT02705625|83192105|FG001|Overall Study|Lost to Follow-up|0|||
46952696|NCT02705625|83192106|FG002|Overall Study|Lost to Follow-up|1|||
46952697|NCT02705625|83192104|FG000|Overall Study|Non-compliance|0|||
46952698|NCT02705625|83192105|FG001|Overall Study|Non-compliance|1|||
46952699|NCT02705625|83192106|FG002|Overall Study|Non-compliance|1|||
46952700|NCT02705625|83192104|FG000|Overall Study|Overdosing|0|||
46952701|NCT02705625|83192105|FG001|Overall Study|Overdosing|0|||
46952702|NCT02705625|83192106|FG002|Overall Study|Overdosing|1|||
46952703|NCT02588612|83192114|FG000|Overall Study|Physician Decision|1|||
46952704|NCT02588612|83192114|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
46952705|NCT02588612|83192114|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
46952706|NCT02588612|83192114|FG000|Overall Study|Death prior to T-cell infusion|1|||
46952707|NCT02704689|83192127|FG000|Overall Study|Physician Decision|1|||
46952708|NCT02704689|83192127|FG000|Overall Study|Study device not implanted|2|||
46952709|NCT02704143|83192131|FG000|Overall Study|disease progression|10|||
46952710|NCT02586506|83192135|FG000|Overall Study|Protocol Violation|6|||
46952711|NCT02586506|83192135|FG000|Overall Study|Lost to Follow-up|1|||
46952712|NCT02586506|83192135|FG000|Overall Study|Other Reason|2|||
46952713|NCT00109031|83192143|FG000|Overall Study|Adverse Event|0|||
46952714|NCT00109031|83192144|FG001|Overall Study|Adverse Event|0|||
46952715|NCT00109031|83192145|FG002|Overall Study|Adverse Event|1|||
46952716|NCT00109031|83192146|FG003|Overall Study|Adverse Event|0|||
46952717|NCT00109031|83192143|FG000|Overall Study|Withdrawal by Subject|0|||
46952718|NCT00109031|83192144|FG001|Overall Study|Withdrawal by Subject|1|||
46952719|NCT00109031|83192145|FG002|Overall Study|Withdrawal by Subject|0|||
46952720|NCT00109031|83192146|FG003|Overall Study|Withdrawal by Subject|0|||
46952721|NCT00109031|83192143|FG000|Overall Study|Physician Decision|0|||
46952722|NCT00109031|83192144|FG001|Overall Study|Physician Decision|1|||
46952723|NCT00109031|83192145|FG002|Overall Study|Physician Decision|0|||
46952724|NCT00109031|83192146|FG003|Overall Study|Physician Decision|0|||
46952725|NCT00109031|83192143|FG000|Overall Study|Protocol Violation|0|||
46952726|NCT00109031|83192144|FG001|Overall Study|Protocol Violation|0|||
46952727|NCT00109031|83192145|FG002|Overall Study|Protocol Violation|1|||
46952728|NCT00109031|83192146|FG003|Overall Study|Protocol Violation|0|||
46952729|NCT01664624|83192160|FG000|Overall Study|Adverse Event|0|||
46952730|NCT01664624|83192161|FG001|Overall Study|Adverse Event|1|||
46952731|NCT01664624|83192162|FG002|Overall Study|Adverse Event|0|||
46952732|NCT01664624|83192163|FG003|Overall Study|Adverse Event|0|||
46952733|NCT02702193|83192175|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
46952734|NCT02702193|83192176|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
46952735|NCT02702193|83192175|FG000|4 Month Follow up|Withdrawal by Subject|1|||
46952736|NCT02702193|83192176|FG001|4 Month Follow up|Withdrawal by Subject|0|||
46952737|NCT02702193|83192175|FG000|4 Month Follow up|Lost to Follow-up|17|||
46952738|NCT02702193|83192176|FG001|4 Month Follow up|Lost to Follow-up|18|||
46952739|NCT02702193|83192175|FG000|8 Month Follow up|Withdrawal by Subject|1|||
46639153|NCT01402284|82812702|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
46639154|NCT01402284|82812702|FG000|Overall Study|Physician Decision|1|||
46772323|NCT00772928|82990595|FG001|Overall Study|Protocol Violation|12|||
46843188|NCT00162266|83060147|FG002|Double-Blind Period|Death|0|||
46639155|NCT01402284|82812702|FG000|Overall Study|Disease progression on study|10|||
46639156|NCT01388790|82812706|FG000|Overall Study|Ongoing at data cut-off date|8|||
46639157|NCT01388478|82812710|FG000|Overall Study|Adverse Event|4|||
46639158|NCT01388478|82812710|FG000|Overall Study|Withdrawal by Subject|1|||
46639159|NCT01424670|82812716|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
46772324|NCT00772928|82990594|FG000|Overall Study|Withdrawal by Subject|25|||
46843189|NCT00162266|83060148|FG003|Double-Blind Period|Death|0|||
46843190|NCT00162266|83060145|FG000|Double-Blind Period|Lost to Follow-up|1|||
46843191|NCT00162266|83060146|FG001|Double-Blind Period|Lost to Follow-up|2|||
46843192|NCT00162266|83060147|FG002|Double-Blind Period|Lost to Follow-up|0|||
46772325|NCT00772928|82990595|FG001|Overall Study|Withdrawal by Subject|22|||
46772326|NCT00772928|82990594|FG000|Overall Study|Did not receive vaccine|0|||
46772327|NCT00772928|82990595|FG001|Overall Study|Did not receive vaccine|1|||
46772328|NCT00762476|82990603|FG000|Overall Study|Adverse Event|7|||
46772329|NCT00762476|82990604|FG001|Overall Study|Adverse Event|1|||
46772330|NCT00762476|82990603|FG000|Overall Study|Lost to Follow-up|2|||
46772331|NCT00762476|82990604|FG001|Overall Study|Lost to Follow-up|0|||
46772332|NCT00762476|82990603|FG000|Overall Study|Protocol Violation|5|||
46772333|NCT00762476|82990604|FG001|Overall Study|Protocol Violation|6|||
46772334|NCT00762476|82990603|FG000|Overall Study|Physician Decision|2|||
46772335|NCT00762476|82990604|FG001|Overall Study|Physician Decision|14|||
46772336|NCT00762476|82990603|FG000|Overall Study|Withdrawal by Subject|6|||
46843193|NCT00162266|83060148|FG003|Double-Blind Period|Lost to Follow-up|0|||
46952740|NCT02702193|83192176|FG001|8 Month Follow up|Withdrawal by Subject|0|||
46952741|NCT02702193|83192175|FG000|8 Month Follow up|Lost to Follow-up|14|||
46952742|NCT02702193|83192176|FG001|8 Month Follow up|Lost to Follow-up|18|||
46639160|NCT01424670|82812717|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
46772337|NCT00762476|82990604|FG001|Overall Study|Withdrawal by Subject|12|||
46843194|NCT00162266|83060145|FG000|Double-Blind Period|Other Reason|1|||
46952743|NCT02702193|83192175|FG000|12 Month Follow up|Withdrawal by Subject|1|||
46952744|NCT02702193|83192176|FG001|12 Month Follow up|Withdrawal by Subject|0|||
46952745|NCT02702193|83192175|FG000|12 Month Follow up|Lost to Follow-up|16|||
46952746|NCT02702193|83192176|FG001|12 Month Follow up|Lost to Follow-up|18|||
46952747|NCT02761057|83192186|FG000|Overall Study|Currently On Study Treatment|0|||
46952748|NCT02761057|83192187|FG001|Overall Study|Currently On Study Treatment|3|||
46952749|NCT02761057|83192188|FG002|Overall Study|Currently On Study Treatment|0|||
46952750|NCT02761057|83192189|FG003|Overall Study|Currently On Study Treatment|0|||
46952751|NCT02761057|83192186|FG000|Overall Study|Adverse Event|11|||
46952752|NCT02761057|83192187|FG001|Overall Study|Adverse Event|9|||
46952753|NCT02761057|83192188|FG002|Overall Study|Adverse Event|5|||
46952754|NCT02761057|83192189|FG003|Overall Study|Adverse Event|3|||
46952755|NCT02761057|83192186|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
46952756|NCT02761057|83192187|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
46952757|NCT02761057|83192188|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
46952758|NCT02761057|83192189|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
46952759|NCT02761057|83192186|FG000|Overall Study|Progression/Relapse|29|||
46952760|NCT02761057|83192187|FG001|Overall Study|Progression/Relapse|27|||
46952761|NCT02761057|83192188|FG002|Overall Study|Progression/Relapse|20|||
46952762|NCT02761057|83192189|FG003|Overall Study|Progression/Relapse|23|||
46952763|NCT02761057|83192186|FG000|Overall Study|Death|2|||
46952764|NCT02761057|83192187|FG001|Overall Study|Death|2|||
46952765|NCT02761057|83192188|FG002|Overall Study|Death|1|||
46952766|NCT02761057|83192189|FG003|Overall Study|Death|1|||
46952767|NCT02761057|83192186|FG000|Overall Study|Other - Not Protocol Specified|2|||
46952768|NCT02761057|83192187|FG001|Overall Study|Other - Not Protocol Specified|1|||
46952769|NCT02761057|83192188|FG002|Overall Study|Other - Not Protocol Specified|2|||
46952770|NCT02761057|83192189|FG003|Overall Study|Other - Not Protocol Specified|0|||
46952771|NCT05085730|83192199|FG000|Overall Study|Withdrawal by Subject|4|||
46952772|NCT05085730|83192199|FG000|Overall Study|Physician Decision|1|||
46952773|NCT04886596|83192211|FG000|Overall Study|Adverse Event|73|||
46952774|NCT04886596|83192212|FG001|Overall Study|Adverse Event|78|||
46952775|NCT04886596|83192211|FG000|Overall Study|Lost to Follow-up|104|||
46952776|NCT04886596|83192212|FG001|Overall Study|Lost to Follow-up|104|||
46952777|NCT04886596|83192211|FG000|Overall Study|Ongoing|12095|||
46952778|NCT04886596|83192212|FG001|Overall Study|Ongoing|12107|||
46952779|NCT04886596|83192211|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
46952780|NCT04886596|83192212|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
46952781|NCT04886596|83192211|FG000|Overall Study|Migrated / Moved from the study area|17|||
46952782|NCT04886596|83192212|FG001|Overall Study|Migrated / Moved from the study area|14|||
46952783|NCT04886596|83192211|FG000|Overall Study|Unknown reason|16|||
46952784|NCT04886596|83192212|FG001|Overall Study|Unknown reason|23|||
46952785|NCT04839380|83192218|FG000|Overall Study|Withdrawal by Subject|2|||
46952786|NCT04839380|83192218|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
46952787|NCT04788147|83192224|FG000|Overall Study|Screen Failure|3|||
46952788|NCT04788147|83192225|FG001|Overall Study|Screen Failure|10|||
46952789|NCT04788147|83192224|FG000|Overall Study|Incomplete RMRS image session|2|||
46952790|NCT04788147|83192225|FG001|Overall Study|Incomplete RMRS image session|0|||
46952791|NCT04770155|83192246|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952792|NCT04770155|83192247|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952793|NCT04770155|83192248|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952794|NCT04770155|83192249|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952795|NCT04770155|83192250|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952796|NCT04770155|83192251|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952797|NCT04770155|83192252|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952798|NCT04770155|83192253|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
46952799|NCT04471207|83192273|FG000|Overall Study|Lost to Follow-up|4|||
46952800|NCT04471207|83192274|FG001|Overall Study|Lost to Follow-up|1|||
46952801|NCT04471207|83192273|FG000|Overall Study|Medication Contraindication|0|||
46952802|NCT04471207|83192274|FG001|Overall Study|Medication Contraindication|1|||
46952803|NCT04471207|83192273|FG000|Overall Study|Loss of Interest|2|||
46952804|NCT04471207|83192274|FG001|Overall Study|Loss of Interest|1|||
46952805|NCT04471207|83192273|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
46952806|NCT04471207|83192274|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
46952807|NCT04471207|83192273|FG000|Overall Study|Scheduling Conflicts|3|||
46952808|NCT04471207|83192274|FG001|Overall Study|Scheduling Conflicts|1|||
46952809|NCT04471207|83192273|FG000|Overall Study|Physician Decision|1|||
46952810|NCT04471207|83192274|FG001|Overall Study|Physician Decision|0|||
46952811|NCT04471207|83192273|FG000|Overall Study|Unwilling to Use System|0|||
46952812|NCT04471207|83192274|FG001|Overall Study|Unwilling to Use System|1|||
46952813|NCT04356040|83192286|FG000|Overall Study|Death|2|||
46952814|NCT04356040|83192287|FG001|Overall Study|Death|0|||
46952815|NCT04356040|83192286|FG000|Overall Study|Lost to Follow-up|1|||
46952816|NCT04356040|83192287|FG001|Overall Study|Lost to Follow-up|0|||
46952817|NCT04356040|83192286|FG000|Overall Study|Physician Decision|0|||
46952818|NCT04356040|83192287|FG001|Overall Study|Physician Decision|1|||
46952819|NCT04356040|83192286|FG000|Overall Study|Withdrawal by Subject|13|||
46952820|NCT04356040|83192287|FG001|Overall Study|Withdrawal by Subject|1|||
46952821|NCT04356040|83192286|FG000|Overall Study|Enrollment Pause|10|||
46952822|NCT04356040|83192287|FG001|Overall Study|Enrollment Pause|0|||
46952823|NCT04356040|83192286|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
46952824|NCT04356040|83192287|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
46952825|NCT04356040|83192286|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
46639161|NCT01424670|82812716|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
46639162|NCT01424670|82812717|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
46639163|NCT01424670|82812716|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
46639164|NCT01424670|82812717|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
46639165|NCT01424670|82812716|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
46639166|NCT01424670|82812717|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
46639167|NCT01424670|82812716|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
46639168|NCT01424670|82812717|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
46639169|NCT01424670|82812716|FG000|Continuation Period|Adverse Event|13|||
46639170|NCT01424670|82812717|FG001|Continuation Period|Adverse Event|5|||
46639171|NCT01424670|82812716|FG000|Continuation Period|Lost to Follow-up|2|||
46639172|NCT01424670|82812717|FG001|Continuation Period|Lost to Follow-up|0|||
46639173|NCT01424670|82812716|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
46639174|NCT01424670|82812717|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
46639175|NCT01424670|82812716|FG000|Continuation Period|Physician Decision|5|||
46639176|NCT01424670|82812717|FG001|Continuation Period|Physician Decision|4|||
46639177|NCT01424670|82812716|FG000|Continuation Period|Withdrawal by Subject|13|||
46639178|NCT01424670|82812717|FG001|Continuation Period|Withdrawal by Subject|4|||
46639179|NCT01424514|82812725|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
46639180|NCT01424514|82812726|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
46639181|NCT01424514|82812725|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
46639182|NCT01424514|82812726|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
46639183|NCT01400958|82812739|FG000|Overall Study|Physician Decision|0|||
46639184|NCT01400958|82812740|FG001|Overall Study|Physician Decision|1|||
46639185|NCT01400958|82812739|FG000|Overall Study|Withdrawal by Subject|0|||
46639186|NCT01400958|82812740|FG001|Overall Study|Withdrawal by Subject|1|||
46639187|NCT01400958|82812739|FG000|Overall Study|Adverse Event|1|||
46639188|NCT01400958|82812740|FG001|Overall Study|Adverse Event|0|||
46639189|NCT01388166|82812746|FG000|Overall Study|Adverse Event|16|||
46639190|NCT01388166|82812746|FG000|Overall Study|Lost to Follow-up|30|||
46639191|NCT01388166|82812746|FG000|Overall Study|Others than specified above|13|||
46639192|NCT01400412|82812752|FG000|Overall Study|Lost to Follow-up|4|||
46639193|NCT01400412|82812753|FG001|Overall Study|Lost to Follow-up|7|||
46639194|NCT01400412|82812752|FG000|Overall Study|Withdrawal by Subject|3|||
46639195|NCT01400412|82812753|FG001|Overall Study|Withdrawal by Subject|4|||
46639196|NCT01400412|82812752|FG000|Overall Study|Unable to complete|3|||
46639197|NCT01400412|82812753|FG001|Overall Study|Unable to complete|3|||
46639198|NCT01400412|82812752|FG000|Overall Study|Never started study treatment|0|||
46639199|NCT01400412|82812753|FG001|Overall Study|Never started study treatment|3|||
46639200|NCT01422876|82812771|FG000|Week 24|Lost to Follow-up|1|||
46639201|NCT01422876|82812772|FG001|Week 24|Lost to Follow-up|1|||
46639202|NCT01422876|82812773|FG002|Week 24|Lost to Follow-up|2|||
46639203|NCT01422876|82812774|FG003|Week 24|Lost to Follow-up|4|||
46639204|NCT01422876|82812775|FG004|Week 24|Lost to Follow-up|2|||
46639205|NCT01422876|82812776|FG005|Week 24|Lost to Follow-up|0|||
46843195|NCT00162266|83060146|FG001|Double-Blind Period|Other Reason|0|||
46843196|NCT00162266|83060147|FG002|Double-Blind Period|Other Reason|1|||
46952826|NCT04356040|83192287|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
46952827|NCT04356040|83192286|FG000|Overall Study|PI left institution|3|||
46952828|NCT04356040|83192287|FG001|Overall Study|PI left institution|0|||
46952829|NCT04349631|83192293|FG000|Overall Study|Lost to Follow-up|3|||
46952830|NCT04349631|83192293|FG000|Overall Study|Withdrawal by Subject|7|||
46952831|NCT03961204|83192297|FG000|Overall Study|Withdrawal by Subject|2|||
46952832|NCT03961204|83192297|FG000|Overall Study|Lost to Follow-up|3|||
46952833|NCT03961204|83192297|FG000|Overall Study|Other|1|||
46952834|NCT03961204|83192297|FG000|Overall Study|Missing|1|||
46952835|NCT03816007|83192303|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
46639206|NCT01422876|82812777|FG006|Week 24|Lost to Follow-up|1|||
46639207|NCT01422876|82812778|FG007|Week 24|Lost to Follow-up|3|||
46843197|NCT00162266|83060148|FG003|Double-Blind Period|Other Reason|0|||
46952836|NCT03816007|83192304|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
46952837|NCT03816007|83192303|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
46952838|NCT03816007|83192304|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
46639208|NCT01422876|82812779|FG008|Week 24|Lost to Follow-up|3|||
46639209|NCT01422876|82812780|FG009|Week 24|Lost to Follow-up|4|||
46639210|NCT01422876|82812771|FG000|Week 24|Consent withdrawn|5|||
46843198|NCT00162266|83060145|FG000|Double-Blind Period|Lack of Efficacy|13|||
47066634|NCT01451437|83349286|FG007|Overall Study|Protocol Violation|0|||
46843199|NCT00162266|83060146|FG001|Double-Blind Period|Lack of Efficacy|17|||
46843200|NCT00162266|83060147|FG002|Double-Blind Period|Lack of Efficacy|30|||
46843201|NCT00162266|83060148|FG003|Double-Blind Period|Lack of Efficacy|0|||
46843202|NCT00162266|83060145|FG000|Double-Blind Period|Withdrawal by Subject|5|||
46952839|NCT03816007|83192303|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
46952840|NCT03816007|83192304|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
46952841|NCT03712449|83192312|FG000|Overall Study|Withdraw Consent|0|||
46952842|NCT03712449|83192313|FG001|Overall Study|Withdraw Consent|1|||
46952843|NCT03343483|83192321|FG000|Overall Study|Death|0|||
46843203|NCT00162266|83060146|FG001|Double-Blind Period|Withdrawal by Subject|2|||
46843204|NCT00162266|83060147|FG002|Double-Blind Period|Withdrawal by Subject|6|||
46843205|NCT00162266|83060148|FG003|Double-Blind Period|Withdrawal by Subject|0|||
46952844|NCT03343483|83192322|FG001|Overall Study|Death|3|||
46952845|NCT03343483|83192321|FG000|Overall Study|Lost to Follow-up|9|||
46952846|NCT03343483|83192322|FG001|Overall Study|Lost to Follow-up|13|||
46952847|NCT03343483|83192321|FG000|Overall Study|Withdrawal by Subject|8|||
46952848|NCT03343483|83192322|FG001|Overall Study|Withdrawal by Subject|17|||
46952849|NCT03035409|83192328|FG000|Overall Study|Adverse Event|5|||
46952850|NCT03035409|83192328|FG000|Overall Study|Death|2|||
46952851|NCT03035409|83192328|FG000|Overall Study|Withdrawal by Subject|2|||
46952852|NCT03035409|83192328|FG000|Overall Study|Non compliance|4|||
46952853|NCT03035409|83192328|FG000|Overall Study|Patient was jittery|1|||
46952854|NCT03035409|83192328|FG000|Overall Study|Did not like Questionnaire|1|||
46952855|NCT03035409|83192328|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
46952856|NCT03035409|83192328|FG000|Overall Study|Did not like taking drugs|1|||
46952857|NCT02948088|83192332|FG000|Overall Study|Lost to Follow-up|8|||
46952858|NCT02948088|83192332|FG000|Overall Study|Death|1|||
46952859|NCT02948088|83192332|FG000|Overall Study|Withdrawal by Subject|4|||
46952860|NCT02948088|83192332|FG000|Overall Study|Other|2|||
46952861|NCT02943915|83192371|FG000|Overall Study|Withdrawal by Subject|2|||
46952862|NCT02943915|83192372|FG001|Overall Study|Withdrawal by Subject|1|||
46952863|NCT02943915|83192373|FG002|Overall Study|Withdrawal by Subject|0|||
46952864|NCT02943915|83192374|FG003|Overall Study|Withdrawal by Subject|0|||
46952865|NCT02943915|83192371|FG000|Overall Study|Lost to Follow-up|3|||
46952866|NCT02943915|83192372|FG001|Overall Study|Lost to Follow-up|1|||
46952867|NCT02943915|83192373|FG002|Overall Study|Lost to Follow-up|0|||
46952868|NCT02943915|83192374|FG003|Overall Study|Lost to Follow-up|0|||
46952869|NCT02943915|83192371|FG000|Overall Study|excluded|0|||
46952870|NCT02943915|83192372|FG001|Overall Study|excluded|1|||
46952871|NCT02943915|83192373|FG002|Overall Study|excluded|0|||
46952872|NCT02943915|83192374|FG003|Overall Study|excluded|0|||
46952873|NCT02763384|83192383|FG000|Overall Study|Physician Decision|1|||
46952874|NCT02763384|83192383|FG000|Overall Study|Rapid decline - went on hospice|1|||
47066635|NCT01451437|83349287|FG008|Overall Study|Protocol Violation|0|||
47066636|NCT01451437|83349279|FG000|Overall Study|Withdrawal by Subject|0|||
46843206|NCT00162266|83060145|FG000|Open-Label Period|Death|0|||
46843207|NCT00162266|83060146|FG001|Open-Label Period|Death|0|||
46843208|NCT00162266|83060147|FG002|Open-Label Period|Death|0|||
46843209|NCT00162266|83060148|FG003|Open-Label Period|Death|7|||
46639211|NCT01422876|82812772|FG001|Week 24|Consent withdrawn|1|||
46843210|NCT00162266|83060145|FG000|Open-Label Period|Adverse Event|0|||
46843211|NCT00162266|83060146|FG001|Open-Label Period|Adverse Event|0|||
46843212|NCT00162266|83060147|FG002|Open-Label Period|Adverse Event|0|||
46843213|NCT00162266|83060148|FG003|Open-Label Period|Adverse Event|46|||
46952875|NCT02649855|83192390|FG000|Overall Study|Refused further treatment|2|||
46952876|NCT02649855|83192391|FG001|Overall Study|Refused further treatment|1|||
46952877|NCT02649855|83192392|FG002|Overall Study|Refused further treatment|1|||
46952878|NCT02649855|83192390|FG000|Overall Study|Withdrew consent|0|||
47066637|NCT01451437|83349280|FG001|Overall Study|Withdrawal by Subject|0|||
47066638|NCT01451437|83349281|FG002|Overall Study|Withdrawal by Subject|0|||
47066639|NCT01451437|83349282|FG003|Overall Study|Withdrawal by Subject|0|||
46952879|NCT02649855|83192391|FG001|Overall Study|Withdrew consent|1|||
46952880|NCT02649855|83192392|FG002|Overall Study|Withdrew consent|0|||
46952881|NCT02649855|83192390|FG000|Overall Study|Switched to alternative treatment|0|||
46952882|NCT02649855|83192391|FG001|Overall Study|Switched to alternative treatment|1|||
47066640|NCT01451437|83349283|FG004|Overall Study|Withdrawal by Subject|1|||
46843214|NCT00162266|83060145|FG000|Open-Label Period|Lack of Efficacy|0|||
46952883|NCT02649855|83192392|FG002|Overall Study|Switched to alternative treatment|1|||
46952884|NCT02649855|83192390|FG000|Overall Study|Principal investigator discretion|0|||
46952885|NCT02649855|83192391|FG001|Overall Study|Principal investigator discretion|1|||
46952886|NCT02649855|83192392|FG002|Overall Study|Principal investigator discretion|1|||
46952887|NCT02649855|83192390|FG000|Overall Study|No treatment, per protocol|1|||
46843215|NCT00162266|83060146|FG001|Open-Label Period|Lack of Efficacy|0|||
46843216|NCT00162266|83060147|FG002|Open-Label Period|Lack of Efficacy|0|||
47066641|NCT01451437|83349284|FG005|Overall Study|Withdrawal by Subject|0|||
46843217|NCT00162266|83060148|FG003|Open-Label Period|Lack of Efficacy|26|||
46843218|NCT00162266|83060145|FG000|Open-Label Period|Lost to Follow-up|0|||
46952888|NCT02649855|83192391|FG001|Overall Study|No treatment, per protocol|0|||
46952889|NCT02649855|83192392|FG002|Overall Study|No treatment, per protocol|0|||
46952890|NCT02649855|83192390|FG000|Overall Study|Initiate new treatment|1|||
46952891|NCT02649855|83192391|FG001|Overall Study|Initiate new treatment|0|||
46952892|NCT02649855|83192392|FG002|Overall Study|Initiate new treatment|0|||
46952893|NCT02619682|83192400|FG000|Overall Study|Withdrawal by Subject|3|||
46952894|NCT02619682|83192400|FG000|Overall Study|Lack of Efficacy|8|||
46952895|NCT02619682|83192400|FG000|Overall Study|new secondary cancer|1|||
46952896|NCT02619682|83192400|FG000|Overall Study|post surgery complications|2|||
46952897|NCT02613507|83192407|FG000|Overall Study|Disease Progression|237|||
46952898|NCT02613507|83192408|FG001|Overall Study|Disease Progression|109|||
46952899|NCT02613507|83192407|FG000|Overall Study|Study Drug Toxicity|15|||
46952900|NCT02613507|83192408|FG001|Overall Study|Study Drug Toxicity|14|||
46952901|NCT02613507|83192407|FG000|Overall Study|Death|3|||
46952902|NCT02613507|83192408|FG001|Overall Study|Death|0|||
46952903|NCT02613507|83192407|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
46952904|NCT02613507|83192408|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
46952905|NCT02613507|83192407|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
46952906|NCT02613507|83192408|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
46952907|NCT02613507|83192407|FG000|Overall Study|Participant Withdrew Consent|0|||
46952908|NCT02613507|83192408|FG001|Overall Study|Participant Withdrew Consent|2|||
46952909|NCT02613507|83192407|FG000|Overall Study|Lost to Follow-up|1|||
46952910|NCT02613507|83192408|FG001|Overall Study|Lost to Follow-up|0|||
46952911|NCT02613507|83192407|FG000|Overall Study|Maximum Clinical Benefit|4|||
46952912|NCT02613507|83192408|FG001|Overall Study|Maximum Clinical Benefit|10|||
46952913|NCT02613507|83192407|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
46952914|NCT02613507|83192408|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
46952915|NCT02613507|83192407|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
46952916|NCT02613507|83192408|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
46952917|NCT02613507|83192407|FG000|Overall Study|Randomized but not Treated|1|||
46952918|NCT02613507|83192408|FG001|Overall Study|Randomized but not Treated|10|||
46952919|NCT02521285|83192429|FG000|Overall Study|Lost to Follow-up|1|||
46952920|NCT02521285|83192430|FG001|Overall Study|Lost to Follow-up|1|||
46952921|NCT02521285|83192429|FG000|Overall Study|Withdrawal by Subject|1|||
46952922|NCT02521285|83192430|FG001|Overall Study|Withdrawal by Subject|1|||
46952923|NCT02521285|83192429|FG000|Overall Study|Adverse Event|0|||
46952924|NCT02521285|83192430|FG001|Overall Study|Adverse Event|1|||
46952925|NCT02331134|83192463|FG000|Overall Study|Withdrawal by Subject|1|||
46952926|NCT02243605|83192469|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
46952927|NCT02243605|83192470|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
46952928|NCT02243605|83192469|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
46952929|NCT02243605|83192470|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
46952930|NCT02243605|83192469|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
46952931|NCT02243605|83192470|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
46952932|NCT02243605|83192469|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
46952933|NCT02243605|83192470|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
46952934|NCT02243605|83192469|FG000|Stage 2 - Final Analysis Population|Progression|0|||
46952935|NCT02243605|83192470|FG001|Stage 2 - Final Analysis Population|Progression|1|||
46952936|NCT01284348|83192497|FG000|Overall Study|Death|1|||
46952937|NCT01284348|83192498|FG001|Overall Study|Death|1|||
46952938|NCT01284348|83192497|FG000|Overall Study|Withdrew consent|0|||
46952939|NCT01284348|83192498|FG001|Overall Study|Withdrew consent|1|||
46952940|NCT01284348|83192497|FG000|Overall Study|Status not recorded|9|||
46952941|NCT01284348|83192498|FG001|Overall Study|Status not recorded|10|||
46952942|NCT00727025|83192504|FG000|Overall Study|Physician Decision|23|||
46952943|NCT02701413|83192514|FG000|Overall Study|Withdrawal by Subject|7|||
46952944|NCT02701413|83192515|FG001|Overall Study|Withdrawal by Subject|11|||
46952945|NCT02582684|83192521|FG000|Overall Study|Unable to contact subject/parent|4|||
46952946|NCT02582684|83192521|FG000|Overall Study|Subject not able to get to clinic|10|||
46952947|NCT02582684|83192521|FG000|Overall Study|Subject withdrew consent|1|||
46952948|NCT02582684|83192521|FG000|Overall Study|Found to be ineligible after enrollment|2|||
46952949|NCT02585960|83192528|FG000|PK/Safety Assessment Period|Physician Decision|0|||
46952950|NCT02585960|83192529|FG001|PK/Safety Assessment Period|Physician Decision|1|||
46952951|NCT02585960|83192530|FG002|PK/Safety Assessment Period|Physician Decision|0|||
46952952|NCT02585960|83192528|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
46952953|NCT02585960|83192529|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
46952954|NCT02585960|83192530|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
46952955|NCT02585960|83192528|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
46952956|NCT02585960|83192529|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
46952957|NCT02585960|83192530|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
46952958|NCT02585960|83192528|FG000|PK/Safety Assessment Period|Other|4|||
46952959|NCT02585960|83192529|FG001|PK/Safety Assessment Period|Other|4|||
46952960|NCT02585960|83192530|FG002|PK/Safety Assessment Period|Other|0|||
46952961|NCT02585960|83192528|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
46952962|NCT02585960|83192529|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
46952963|NCT02585960|83192530|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
46952964|NCT02585960|83192528|FG000|PK/Safety Assessment Period|Screen Failure|0|||
46952965|NCT02585960|83192529|FG001|PK/Safety Assessment Period|Screen Failure|0|||
46952966|NCT02585960|83192530|FG002|PK/Safety Assessment Period|Screen Failure|1|||
46952967|NCT02585960|83192528|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
46952968|NCT02585960|83192529|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
46952969|NCT02585960|83192530|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
46952970|NCT02585960|83192528|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
46952971|NCT02585960|83192529|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
46952972|NCT02585960|83192530|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
46952973|NCT02699463|83192543|FG000|Overall Study|Lost to Follow-up|11|||
46952974|NCT02699463|83192544|FG001|Overall Study|Lost to Follow-up|8|||
46952975|NCT02699463|83192543|FG000|Overall Study|Withdrawal by Subject|4|||
46952976|NCT02699463|83192544|FG001|Overall Study|Withdrawal by Subject|1|||
46952977|NCT00100789|83192550|FG000|Overall Study|Adverse Event|10|||
46952978|NCT00100789|83192550|FG000|Overall Study|Withdrawal by Subject|1|||
46952979|NCT00100789|83192550|FG000|Overall Study|Progression/relapse|42|||
46952980|NCT00100789|83192550|FG000|Overall Study|Death|2|||
46952981|NCT00100789|83192550|FG000|Overall Study|Not protocol specified|5|||
46952982|NCT00100789|83192550|FG000|Overall Study|Ineligible|3|||
46952983|NCT00100789|83192550|FG000|Overall Study|Never received treatment|1|||
46952984|NCT00708123|83192555|FG000|Period 1|Protocol Violation|0|||
46952985|NCT00708123|83192556|FG001|Period 1|Protocol Violation|1|||
46952986|NCT00708123|83192557|FG002|Period 1|Protocol Violation|0|||
46952987|NCT00708123|83192558|FG003|Period 1|Protocol Violation|1|||
46952988|NCT00708123|83192559|FG004|Period 1|Protocol Violation|0|||
46952989|NCT00708123|83192555|FG000|Period 1|Adverse Event|0|||
46952990|NCT00708123|83192556|FG001|Period 1|Adverse Event|0|||
46952991|NCT00708123|83192557|FG002|Period 1|Adverse Event|1|||
46952992|NCT00708123|83192558|FG003|Period 1|Adverse Event|0|||
46952993|NCT00708123|83192559|FG004|Period 1|Adverse Event|0|||
46952994|NCT00708123|83192555|FG000|Period 2|Protocol Violation|0|||
46952995|NCT00708123|83192556|FG001|Period 2|Protocol Violation|0|||
46952996|NCT00708123|83192557|FG002|Period 2|Protocol Violation|0|||
46952997|NCT00708123|83192558|FG003|Period 2|Protocol Violation|1|||
46952998|NCT00708123|83192559|FG004|Period 2|Protocol Violation|0|||
46952999|NCT00708123|83192555|FG000|Period 2|Other Reason|1|||
46953000|NCT00708123|83192556|FG001|Period 2|Other Reason|0|||
46953001|NCT00708123|83192557|FG002|Period 2|Other Reason|0|||
46843219|NCT00162266|83060146|FG001|Open-Label Period|Lost to Follow-up|0|||
46843220|NCT00162266|83060147|FG002|Open-Label Period|Lost to Follow-up|0|||
46843221|NCT00162266|83060148|FG003|Open-Label Period|Lost to Follow-up|3|||
46843222|NCT00162266|83060145|FG000|Open-Label Period|Withdrawal by Subject|0|||
46843223|NCT00162266|83060146|FG001|Open-Label Period|Withdrawal by Subject|0|||
46843224|NCT00162266|83060147|FG002|Open-Label Period|Withdrawal by Subject|0|||
46843225|NCT00162266|83060148|FG003|Open-Label Period|Withdrawal by Subject|31|||
46953002|NCT00708123|83192558|FG003|Period 2|Other Reason|0|||
46953003|NCT00708123|83192559|FG004|Period 2|Other Reason|0|||
46953004|NCT00708123|83192555|FG000|Period 3|Lost to Follow-up|0|||
46953005|NCT00708123|83192556|FG001|Period 3|Lost to Follow-up|0|||
46953006|NCT00708123|83192557|FG002|Period 3|Lost to Follow-up|1|||
46953007|NCT00708123|83192558|FG003|Period 3|Lost to Follow-up|1|||
46953008|NCT00708123|83192559|FG004|Period 3|Lost to Follow-up|0|||
46772338|NCT00762476|82990603|FG000|Overall Study|antibiotic use|0|||
46772339|NCT00762476|82990604|FG001|Overall Study|antibiotic use|1|||
46772340|NCT00762476|82990603|FG000|Overall Study|non-compliance with study visits|0|||
46772341|NCT00762476|82990604|FG001|Overall Study|non-compliance with study visits|2|||
46772342|NCT00762476|82990603|FG000|Overall Study|Seasonal allergies|1|||
46772343|NCT00762476|82990604|FG001|Overall Study|Seasonal allergies|0|||
46772344|NCT00762164|82990613|FG000|Overall Study|Lost to Follow-up|1|||
46772345|NCT00762164|82990614|FG001|Overall Study|Lost to Follow-up|1|||
46772346|NCT00762164|82990613|FG000|Overall Study|Discontinued medication|2|||
46772347|NCT00762164|82990614|FG001|Overall Study|Discontinued medication|0|||
46772348|NCT00762164|82990613|FG000|Overall Study|Withdrawal by Subject|0|||
46772349|NCT00762164|82990614|FG001|Overall Study|Withdrawal by Subject|1|||
46772350|NCT00762086|82990622|FG000|Overall Study|Adverse Event|2|||
46772351|NCT00762086|82990623|FG001|Overall Study|Adverse Event|0|||
46772352|NCT00762086|82990622|FG000|Overall Study|Lost to Follow-up|0|||
46772353|NCT00762086|82990623|FG001|Overall Study|Lost to Follow-up|2|||
46772354|NCT00762086|82990622|FG000|Overall Study|Non compliance|1|||
46953009|NCT00708123|83192555|FG000|Period 4|Protocol Violation|0|||
46772355|NCT00762086|82990623|FG001|Overall Study|Non compliance|0|||
46772356|NCT00762086|82990622|FG000|Overall Study|Withdrawal by Subject|2|||
46772357|NCT00762086|82990623|FG001|Overall Study|Withdrawal by Subject|2|||
46843226|NCT00162266|83060145|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
46639212|NCT01422876|82812773|FG002|Week 24|Consent withdrawn|3|||
46953010|NCT00708123|83192556|FG001|Period 4|Protocol Violation|1|||
46953011|NCT00708123|83192557|FG002|Period 4|Protocol Violation|0|||
46953012|NCT00708123|83192558|FG003|Period 4|Protocol Violation|0|||
46953013|NCT00708123|83192559|FG004|Period 4|Protocol Violation|0|||
46953014|NCT02165215|83192578|FG000|Induction Phase|Adverse Event|1|||
46953015|NCT02165215|83192579|FG001|Induction Phase|Adverse Event|0|||
46953016|NCT02165215|83192580|FG002|Induction Phase|Adverse Event|0|||
46953017|NCT02165215|83192578|FG000|Induction Phase|Withdrawal by Subject|10|||
46953018|NCT02165215|83192579|FG001|Induction Phase|Withdrawal by Subject|0|||
46953019|NCT02165215|83192580|FG002|Induction Phase|Withdrawal by Subject|0|||
46953020|NCT02165215|83192578|FG000|Induction Phase|Protocol Violation|1|||
46953021|NCT02165215|83192579|FG001|Induction Phase|Protocol Violation|0|||
46953022|NCT02165215|83192580|FG002|Induction Phase|Protocol Violation|0|||
46953023|NCT02165215|83192578|FG000|Induction Phase|Physician Decision|1|||
46953024|NCT02165215|83192579|FG001|Induction Phase|Physician Decision|0|||
46953025|NCT02165215|83192580|FG002|Induction Phase|Physician Decision|0|||
46953026|NCT02165215|83192578|FG000|Induction Phase|Lack of Efficacy|2|||
46953027|NCT02165215|83192579|FG001|Induction Phase|Lack of Efficacy|0|||
46953028|NCT02165215|83192580|FG002|Induction Phase|Lack of Efficacy|0|||
46953029|NCT02165215|83192578|FG000|Induction Phase|Non-Compliance|2|||
46953030|NCT02165215|83192579|FG001|Induction Phase|Non-Compliance|0|||
46953031|NCT02165215|83192580|FG002|Induction Phase|Non-Compliance|0|||
46953032|NCT02165215|83192578|FG000|Induction Phase|Lost to Follow-up|6|||
46953033|NCT02165215|83192579|FG001|Induction Phase|Lost to Follow-up|0|||
46953034|NCT02165215|83192580|FG002|Induction Phase|Lost to Follow-up|0|||
46953035|NCT02165215|83192578|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46953036|NCT02165215|83192579|FG001|Maintenance Phase|Withdrawal by Subject|7|||
46953037|NCT02165215|83192580|FG002|Maintenance Phase|Withdrawal by Subject|3|||
46953038|NCT02165215|83192578|FG000|Maintenance Phase|Multiple reasons|0|||
46953039|NCT02165215|83192579|FG001|Maintenance Phase|Multiple reasons|2|||
46953040|NCT02165215|83192580|FG002|Maintenance Phase|Multiple reasons|1|||
46953041|NCT02165215|83192578|FG000|Maintenance Phase|Lost to Follow-up|0|||
46953042|NCT02165215|83192579|FG001|Maintenance Phase|Lost to Follow-up|2|||
46953043|NCT02165215|83192580|FG002|Maintenance Phase|Lost to Follow-up|0|||
46953044|NCT02165215|83192578|FG000|Maintenance Phase|Adverse Event|0|||
46953045|NCT02165215|83192579|FG001|Maintenance Phase|Adverse Event|1|||
46953046|NCT02165215|83192580|FG002|Maintenance Phase|Adverse Event|1|||
46953047|NCT02757625|83192595|FG000|Overall Study|Investigator's discretion|0|||
46953048|NCT02757625|83192596|FG001|Overall Study|Investigator's discretion|0|||
46953049|NCT02757625|83192597|FG002|Overall Study|Investigator's discretion|1|||
46953050|NCT02757625|83192598|FG003|Overall Study|Investigator's discretion|0|||
46953051|NCT02757625|83192595|FG000|Overall Study|Adverse Event|0|||
46953052|NCT02757625|83192596|FG001|Overall Study|Adverse Event|0|||
46953053|NCT02757625|83192597|FG002|Overall Study|Adverse Event|1|||
46953054|NCT02757625|83192598|FG003|Overall Study|Adverse Event|0|||
46953055|NCT02581202|83192610|FG000|Overall Study|Lack of Efficacy|2|||
46953056|NCT02581202|83192610|FG000|Overall Study|Withdrawal by Subject|4|||
46953057|NCT02581202|83192610|FG000|Overall Study|Lost to Follow-up|5|||
46953058|NCT02581202|83192610|FG000|Overall Study|Pregnancy|3|||
46953059|NCT02758171|83192617|FG000|Wash-out|Withdrawal by Subject|1|||
46953060|NCT02758171|83192618|FG001|Wash-out|Withdrawal by Subject|0|||
46953061|NCT02758171|83192617|FG000|Wash-out|Other reason|1|||
46953062|NCT02758171|83192618|FG001|Wash-out|Other reason|0|||
46953063|NCT01664078|83192633|FG000|Overall Study|Death|9|||
46953064|NCT01664078|83192633|FG000|Overall Study|Withdrawal by Subject|4|||
46953065|NCT01664078|83192633|FG000|Overall Study|Lost to Follow-up|2|||
46772358|NCT00762086|82990622|FG000|Overall Study|Ineligible to participate in the study|1|||
46953066|NCT01664078|83192633|FG000|Overall Study|missed 5 year visit|1|||
46953067|NCT01664078|83192633|FG000|Overall Study|Other|53|||
46953068|NCT03367403|83192686|FG000|Overall Study|Adverse Event|20|||
46953069|NCT03367403|83192687|FG001|Overall Study|Adverse Event|6|||
46953070|NCT03367403|83192688|FG002|Overall Study|Adverse Event|2|||
46953071|NCT03367403|83192686|FG000|Overall Study|Withdrawal by Subject|12|||
46953072|NCT03367403|83192687|FG001|Overall Study|Withdrawal by Subject|13|||
46953073|NCT03367403|83192688|FG002|Overall Study|Withdrawal by Subject|1|||
46953074|NCT03367403|83192686|FG000|Overall Study|Death|1|||
46772359|NCT00762086|82990623|FG001|Overall Study|Ineligible to participate in the study|0|||
46772360|NCT00761774|82990629|FG000|Overall Study|Adverse Event|17|||
46772361|NCT00761774|82990629|FG000|Overall Study|Lack of Efficacy|37|||
46772362|NCT00761774|82990629|FG000|Overall Study|Lost to Follow-up|2|||
46772363|NCT00761774|82990629|FG000|Overall Study|Withdrawal by Subject|9|||
46772364|NCT00761774|82990629|FG000|Overall Study|Non-compliance|4|||
46772365|NCT00761774|82990629|FG000|Overall Study|End of study|2|||
46772366|NCT00761774|82990629|FG000|Overall Study|Reclassification of seizures|1|||
46772367|NCT00761774|82990629|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
46953075|NCT03367403|83192687|FG001|Overall Study|Death|2|||
46953076|NCT03367403|83192688|FG002|Overall Study|Death|0|||
46953077|NCT03367403|83192686|FG000|Overall Study|Physician Decision|0|||
46953078|NCT03367403|83192687|FG001|Overall Study|Physician Decision|1|||
46953079|NCT03367403|83192688|FG002|Overall Study|Physician Decision|0|||
46953080|NCT03367403|83192686|FG000|Overall Study|Protocol Violation|1|||
46953081|NCT03367403|83192687|FG001|Overall Study|Protocol Violation|1|||
46953082|NCT03367403|83192688|FG002|Overall Study|Protocol Violation|0|||
46953083|NCT03367403|83192686|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
46953084|NCT03367403|83192687|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
46953085|NCT03367403|83192688|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
46953086|NCT03367403|83192686|FG000|Overall Study|COVID-19|3|||
46953087|NCT03367403|83192687|FG001|Overall Study|COVID-19|6|||
46953088|NCT03367403|83192688|FG002|Overall Study|COVID-19|0|||
46953089|NCT03367403|83192686|FG000|Overall Study|Abuse of Alcohol Intake|0|||
46953090|NCT03367403|83192687|FG001|Overall Study|Abuse of Alcohol Intake|1|||
46953091|NCT03367403|83192688|FG002|Overall Study|Abuse of Alcohol Intake|0|||
46953092|NCT03367403|83192686|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
46953093|NCT03367403|83192687|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
46953094|NCT03367403|83192688|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
46953095|NCT02577146|83192696|FG000|Overall Study|Lost to Follow-up|8|||
46953096|NCT02577146|83192696|FG000|Overall Study|Physician Decision|3|||
46953097|NCT02577146|83192696|FG000|Overall Study|Screen Failure|17|||
46953098|NCT00109967|83192702|FG000|Overall Study|Cancel Prior to Treatment|2|||
46953099|NCT00109967|83192703|FG001|Overall Study|Cancel Prior to Treatment|0|||
46953100|NCT00109967|83192702|FG000|Overall Study|Adverse Event|12|||
46953101|NCT00109967|83192703|FG001|Overall Study|Adverse Event|1|||
46953102|NCT00109967|83192702|FG000|Overall Study|Withdrawal by Subject|5|||
46953103|NCT00109967|83192703|FG001|Overall Study|Withdrawal by Subject|0|||
46953104|NCT00109967|83192702|FG000|Overall Study|Physician Decision|1|||
46953105|NCT00109967|83192703|FG001|Overall Study|Physician Decision|3|||
46953106|NCT00109967|83192702|FG000|Overall Study|Death|0|||
46953107|NCT00109967|83192703|FG001|Overall Study|Death|2|||
46953108|NCT02579096|83192711|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
46953109|NCT02579096|83192712|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
46953110|NCT02579096|83192711|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
46953111|NCT02579096|83192712|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
46953112|NCT02579096|83192711|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
46953113|NCT02579096|83192712|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
46953114|NCT02579096|83192711|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
46953115|NCT02579096|83192712|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
46953116|NCT02579096|83192711|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
46953117|NCT02579096|83192712|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
46953118|NCT02579096|83192711|FG000|Phase 2, Weeks 25 - 48|Death|2|||
46953119|NCT02579096|83192712|FG001|Phase 2, Weeks 25 - 48|Death|4|||
46953120|NCT02579096|83192711|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
46953121|NCT02579096|83192712|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
46953122|NCT02579096|83192711|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
46953123|NCT02579096|83192712|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
46843227|NCT00162266|83060146|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
46843228|NCT00162266|83060147|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
46639213|NCT01422876|82812774|FG003|Week 24|Consent withdrawn|4|||
46639214|NCT01422876|82812775|FG004|Week 24|Consent withdrawn|5|||
46843229|NCT00162266|83060148|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
46843230|NCT00162266|83060145|FG000|Open-Label Period|Other Reasons|0|||
46843231|NCT00162266|83060146|FG001|Open-Label Period|Other Reasons|0|||
46843232|NCT00162266|83060147|FG002|Open-Label Period|Other Reasons|0|||
46843233|NCT00162266|83060148|FG003|Open-Label Period|Other Reasons|15|||
46843234|NCT00225212|83060200|FG000|Overall Study|Disease progression|2|||
46843235|NCT00225212|83060200|FG000|Overall Study|Death|1|||
46843236|NCT00225212|83060200|FG000|Overall Study|Adverse Event|2|||
46843237|NCT00225212|83060200|FG000|Overall Study|Intercurrent illness|1|||
46843238|NCT00162032|83060206|FG000|Overall Study|Lost to Follow-up|4|||
46843239|NCT00162032|83060207|FG001|Overall Study|Lost to Follow-up|2|||
46843240|NCT00162032|83060206|FG000|Overall Study|Reason not specified|1|||
46843241|NCT00162032|83060207|FG001|Overall Study|Reason not specified|0|||
46843242|NCT00258674|83060221|FG000|Overall Study|Death|32|||
46843243|NCT00258674|83060222|FG001|Overall Study|Death|53|||
46639215|NCT01422876|82812776|FG005|Week 24|Consent withdrawn|6|||
46843244|NCT00258674|83060223|FG002|Overall Study|Death|34|||
46843245|NCT00258440|83060234|FG000|Overall Study|Withdrawal by Subject|0|||
46843246|NCT00258440|83060235|FG001|Overall Study|Withdrawal by Subject|0|||
46843247|NCT00258440|83060236|FG002|Overall Study|Withdrawal by Subject|1|||
46953124|NCT02579096|83192711|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
46953125|NCT02579096|83192712|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
46953126|NCT02579096|83192711|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
46953127|NCT02579096|83192712|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
46843248|NCT00224120|83060246|FG000|Overall Study|Adverse Event|10|||
46953128|NCT02579096|83192711|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
46953129|NCT02579096|83192712|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
46953130|NCT02579096|83192711|FG000|Phase 3, Weeks 49 - 72|Death|3|||
46953131|NCT02579096|83192712|FG001|Phase 3, Weeks 49 - 72|Death|2|||
46953132|NCT02579096|83192711|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
46953133|NCT02579096|83192712|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
46953134|NCT02579096|83192711|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
46953135|NCT02579096|83192712|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
46953136|NCT02579096|83192711|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
46953137|NCT02579096|83192712|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
46953138|NCT02579096|83192711|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
46953139|NCT02579096|83192712|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
46953140|NCT02579096|83192711|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
46953141|NCT02579096|83192712|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
46953142|NCT02579096|83192711|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
46953143|NCT02579096|83192712|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
46953144|NCT02578940|83192718|FG000|Overall Study|Screening failure|5|||
46953145|NCT02578940|83192718|FG000|Overall Study|Lost to Follow-up|1|||
46772368|NCT00761774|82990629|FG000|Overall Study|Sponsor decision|1|||
46772369|NCT00761774|82990629|FG000|Overall Study|Investigator clinical judgement|1|||
46953146|NCT02578862|83192726|FG000|Overall Study|Withdrawal by Subject|0|||
46953147|NCT02578862|83192727|FG001|Overall Study|Withdrawal by Subject|1|||
46953148|NCT02578862|83192726|FG000|Overall Study|Unplanned unilateral procedure|0|||
46953149|NCT02578862|83192727|FG001|Overall Study|Unplanned unilateral procedure|1|||
46953150|NCT02578706|83192736|FG000|Overall Study|Withdrawal by Subject|1|||
46953151|NCT02578706|83192737|FG001|Overall Study|Withdrawal by Subject|0|||
46953152|NCT02578706|83192738|FG002|Overall Study|Withdrawal by Subject|0|||
46953153|NCT02578706|83192736|FG000|Overall Study|Lost to Follow-up|0|||
46953154|NCT02578706|83192737|FG001|Overall Study|Lost to Follow-up|4|||
46953155|NCT02578706|83192738|FG002|Overall Study|Lost to Follow-up|0|||
46953156|NCT02578706|83192736|FG000|Overall Study|Physician Decision|0|||
46953157|NCT02578706|83192737|FG001|Overall Study|Physician Decision|1|||
46953158|NCT02578706|83192738|FG002|Overall Study|Physician Decision|0|||
46953159|NCT00108953|83192748|FG000|Follow-up|Death|18|||
46953160|NCT00108953|83192749|FG001|Follow-up|Death|26|||
46953161|NCT00108953|83192748|FG000|Follow-up|Lost to Follow-up|1|||
46953162|NCT00108953|83192749|FG001|Follow-up|Lost to Follow-up|1|||
46953163|NCT00108953|83192748|FG000|Follow-up|Study terminated by sponsor|10|||
46953164|NCT00108953|83192749|FG001|Follow-up|Study terminated by sponsor|6|||
46953165|NCT02578316|83192757|FG000|Extension Phase|Progression of disease|6|||
46953166|NCT02576678|83192768|FG000|Overall Study|Adverse Event|0|||
46953167|NCT02576678|83192769|FG001|Overall Study|Adverse Event|0|||
46953168|NCT02576678|83192770|FG002|Overall Study|Adverse Event|2|||
46953169|NCT02576678|83192768|FG000|Overall Study|Withdrawal by Subject|3|||
46953170|NCT02576678|83192769|FG001|Overall Study|Withdrawal by Subject|1|||
46953171|NCT02576678|83192770|FG002|Overall Study|Withdrawal by Subject|2|||
46953172|NCT02576678|83192768|FG000|Overall Study|Lost to Follow-up|0|||
46953173|NCT02576678|83192769|FG001|Overall Study|Lost to Follow-up|0|||
46953174|NCT02576678|83192770|FG002|Overall Study|Lost to Follow-up|1|||
46953175|NCT02576678|83192768|FG000|Overall Study|Miscellaneous|2|||
46953176|NCT02576678|83192769|FG001|Overall Study|Miscellaneous|0|||
46953177|NCT02576678|83192770|FG002|Overall Study|Miscellaneous|0|||
46953178|NCT00108745|83192781|FG000|Overall Study|Withdrawal by Subject|19|||
46953179|NCT00108745|83192782|FG001|Overall Study|Withdrawal by Subject|12|||
46953180|NCT00108745|83192783|FG002|Overall Study|Withdrawal by Subject|12|||
46953181|NCT00108745|83192781|FG000|Overall Study|Never Treated|8|||
46953182|NCT00108745|83192782|FG001|Overall Study|Never Treated|10|||
46772370|NCT00761774|82990629|FG000|Overall Study|Patient moved out of study area|1|||
46772371|NCT00761774|82990629|FG000|Overall Study|Coordinator leaving site|1|||
46772372|NCT00761774|82990629|FG000|Overall Study|Subject IP non-compliance|1|||
46772373|NCT00761774|82990629|FG000|Overall Study|IP stopped by hospital physician|1|||
46953183|NCT00108745|83192783|FG002|Overall Study|Never Treated|12|||
46953184|NCT00108745|83192781|FG000|Overall Study|Ineligible|7|||
46953185|NCT00108745|83192782|FG001|Overall Study|Ineligible|13|||
46772374|NCT00583791|82990635|FG000|Overall Study|Other|67|||
46772375|NCT00583791|82990635|FG000|Overall Study|Death|6|||
46953186|NCT00108745|83192783|FG002|Overall Study|Ineligible|13|||
46953187|NCT02716805|83192813|FG000|Overall Study|Progressive disease|2|||
46953188|NCT02716805|83192814|FG001|Overall Study|Progressive disease|0|||
46953189|NCT02716805|83192815|FG002|Overall Study|Progressive disease|0|||
46953190|NCT02716805|83192816|FG003|Overall Study|Progressive disease|0|||
46953191|NCT02581982|83192820|FG000|Overall Study|Lack of Efficacy|12|||
46953192|NCT02581982|83192820|FG000|Overall Study|Adverse Event|3|||
46953193|NCT02581982|83192820|FG000|Overall Study|Physician Decision|1|||
46953194|NCT04318132|83192874|FG000|Overall Study|Protocol Violation|0|||
46953195|NCT04318132|83192875|FG001|Overall Study|Protocol Violation|0|||
46953196|NCT04318132|83192876|FG002|Overall Study|Protocol Violation|3|||
46953197|NCT04318132|83192877|FG003|Overall Study|Protocol Violation|0|||
46953198|NCT04271254|83192893|FG000|Overall Study|Withdrawal by Subject|3|||
46953199|NCT03970837|83192913|FG000|Overall Study|Adverse Event|23|||
46953200|NCT03970837|83192914|FG001|Overall Study|Adverse Event|20|||
46953201|NCT03970837|83192915|FG002|Overall Study|Adverse Event|16|||
46953202|NCT03970837|83192916|FG003|Overall Study|Adverse Event|6|||
46953203|NCT03970837|83192917|FG004|Overall Study|Adverse Event|4|||
46953204|NCT03970837|83192918|FG005|Overall Study|Adverse Event|5|||
46953205|NCT03970837|83192919|FG006|Overall Study|Adverse Event|1|||
46953206|NCT03970837|83192920|FG007|Overall Study|Adverse Event|5|||
46953207|NCT03970837|83192921|FG008|Overall Study|Adverse Event|0|||
46953208|NCT03970837|83192922|FG009|Overall Study|Adverse Event|0|||
46953209|NCT03970837|83192923|FG010|Overall Study|Adverse Event|1|||
46953210|NCT03970837|83192924|FG011|Overall Study|Adverse Event|1|||
46953211|NCT03970837|83192913|FG000|Overall Study|Lack of Efficacy|14|||
46953212|NCT03970837|83192914|FG001|Overall Study|Lack of Efficacy|12|||
46953213|NCT03970837|83192915|FG002|Overall Study|Lack of Efficacy|1|||
46953214|NCT03970837|83192916|FG003|Overall Study|Lack of Efficacy|2|||
46953215|NCT03970837|83192917|FG004|Overall Study|Lack of Efficacy|3|||
46953216|NCT03970837|83192918|FG005|Overall Study|Lack of Efficacy|4|||
46953217|NCT03970837|83192919|FG006|Overall Study|Lack of Efficacy|6|||
46953218|NCT03970837|83192920|FG007|Overall Study|Lack of Efficacy|1|||
46772376|NCT00781274|82990639|FG000|Overall Study|Withdrawal by Subject|2|||
46772377|NCT00780416|82990645|FG000|Overall Study|Physician Decision|3|||
46772378|NCT00780416|82990646|FG001|Overall Study|Physician Decision|3|||
46639216|NCT01422876|82812777|FG006|Week 24|Consent withdrawn|5|||
46639217|NCT01422876|82812778|FG007|Week 24|Consent withdrawn|4|||
46953219|NCT03970837|83192921|FG008|Overall Study|Lack of Efficacy|1|||
46953220|NCT03970837|83192922|FG009|Overall Study|Lack of Efficacy|0|||
46953221|NCT03970837|83192923|FG010|Overall Study|Lack of Efficacy|0|||
46953222|NCT03970837|83192924|FG011|Overall Study|Lack of Efficacy|0|||
46953223|NCT03970837|83192913|FG000|Overall Study|Lost to Follow-up|6|||
46953224|NCT03970837|83192914|FG001|Overall Study|Lost to Follow-up|5|||
46953225|NCT03970837|83192915|FG002|Overall Study|Lost to Follow-up|5|||
46953226|NCT03970837|83192916|FG003|Overall Study|Lost to Follow-up|1|||
46953227|NCT03970837|83192917|FG004|Overall Study|Lost to Follow-up|0|||
46953228|NCT03970837|83192918|FG005|Overall Study|Lost to Follow-up|2|||
46953229|NCT03970837|83192919|FG006|Overall Study|Lost to Follow-up|0|||
46953230|NCT03970837|83192920|FG007|Overall Study|Lost to Follow-up|0|||
46953231|NCT03970837|83192921|FG008|Overall Study|Lost to Follow-up|0|||
46953232|NCT03970837|83192922|FG009|Overall Study|Lost to Follow-up|0|||
46953233|NCT03970837|83192923|FG010|Overall Study|Lost to Follow-up|0|||
46953234|NCT03970837|83192924|FG011|Overall Study|Lost to Follow-up|0|||
46953235|NCT03970837|83192913|FG000|Overall Study|Protocol Violation|1|||
46953236|NCT03970837|83192914|FG001|Overall Study|Protocol Violation|0|||
46953237|NCT03970837|83192915|FG002|Overall Study|Protocol Violation|0|||
46953238|NCT03970837|83192916|FG003|Overall Study|Protocol Violation|0|||
46953239|NCT03970837|83192917|FG004|Overall Study|Protocol Violation|0|||
46953240|NCT03970837|83192918|FG005|Overall Study|Protocol Violation|0|||
46953241|NCT03970837|83192919|FG006|Overall Study|Protocol Violation|0|||
47066642|NCT01451437|83349285|FG006|Overall Study|Withdrawal by Subject|1|||
46772379|NCT00780416|82990645|FG000|Overall Study|Protocol Violation|1|||
46843249|NCT00224120|83060247|FG001|Overall Study|Adverse Event|4|||
46843250|NCT00224120|83060246|FG000|Overall Study|Protocol Violation|1|||
46953242|NCT03970837|83192920|FG007|Overall Study|Protocol Violation|0|||
46772380|NCT00780416|82990646|FG001|Overall Study|Protocol Violation|0|||
46772381|NCT00780416|82990645|FG000|Overall Study|Withdrawal by Subject|8|||
46772382|NCT00780416|82990646|FG001|Overall Study|Withdrawal by Subject|6|||
46772383|NCT00761462|82990654|FG000|Treatment|Subjects never received study medication|23|||
46772384|NCT00761462|82990655|FG001|Treatment|Subjects never received study medication|12|||
46772385|NCT00761462|82990654|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
46772386|NCT00761462|82990655|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
47066643|NCT01451437|83349286|FG007|Overall Study|Withdrawal by Subject|0|||
46639218|NCT01422876|82812779|FG008|Week 24|Consent withdrawn|3|||
46843251|NCT00224120|83060247|FG001|Overall Study|Protocol Violation|0|||
46953243|NCT03970837|83192921|FG008|Overall Study|Protocol Violation|0|||
46953244|NCT03970837|83192922|FG009|Overall Study|Protocol Violation|0|||
46953245|NCT03970837|83192923|FG010|Overall Study|Protocol Violation|0|||
46953246|NCT03970837|83192924|FG011|Overall Study|Protocol Violation|0|||
46953247|NCT03970837|83192913|FG000|Overall Study|Physician Decision|5|||
46953248|NCT03970837|83192914|FG001|Overall Study|Physician Decision|8|||
46953249|NCT03970837|83192915|FG002|Overall Study|Physician Decision|4|||
47066644|NCT01451437|83349287|FG008|Overall Study|Withdrawal by Subject|0|||
46953250|NCT03970837|83192916|FG003|Overall Study|Physician Decision|1|||
46953251|NCT03970837|83192917|FG004|Overall Study|Physician Decision|5|||
46953252|NCT03970837|83192918|FG005|Overall Study|Physician Decision|2|||
46953253|NCT03970837|83192919|FG006|Overall Study|Physician Decision|4|||
46953254|NCT03970837|83192920|FG007|Overall Study|Physician Decision|5|||
46953255|NCT03970837|83192921|FG008|Overall Study|Physician Decision|0|||
46953256|NCT03970837|83192922|FG009|Overall Study|Physician Decision|1|||
46953257|NCT03970837|83192923|FG010|Overall Study|Physician Decision|0|||
46953258|NCT03970837|83192924|FG011|Overall Study|Physician Decision|0|||
46953259|NCT03970837|83192913|FG000|Overall Study|Withdrawal by Subject|32|||
46953260|NCT03970837|83192914|FG001|Overall Study|Withdrawal by Subject|35|||
46953261|NCT03970837|83192915|FG002|Overall Study|Withdrawal by Subject|12|||
46953262|NCT03970837|83192916|FG003|Overall Study|Withdrawal by Subject|8|||
46953263|NCT03970837|83192917|FG004|Overall Study|Withdrawal by Subject|6|||
46953264|NCT03970837|83192918|FG005|Overall Study|Withdrawal by Subject|8|||
46953265|NCT03970837|83192919|FG006|Overall Study|Withdrawal by Subject|2|||
46953266|NCT03970837|83192920|FG007|Overall Study|Withdrawal by Subject|3|||
46953267|NCT03970837|83192921|FG008|Overall Study|Withdrawal by Subject|0|||
46953268|NCT03970837|83192922|FG009|Overall Study|Withdrawal by Subject|0|||
46953269|NCT03970837|83192923|FG010|Overall Study|Withdrawal by Subject|0|||
46953270|NCT03970837|83192924|FG011|Overall Study|Withdrawal by Subject|1|||
46953271|NCT03970837|83192913|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
46953272|NCT03970837|83192914|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
46953273|NCT03970837|83192915|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
46953274|NCT03970837|83192916|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
46953275|NCT03970837|83192917|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
46953276|NCT03970837|83192918|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
46953277|NCT03970837|83192919|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
46953278|NCT03970837|83192920|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
46953279|NCT03970837|83192921|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
46953280|NCT03970837|83192922|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
46953281|NCT03970837|83192923|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
46953282|NCT03970837|83192924|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
46953283|NCT03970837|83192913|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
46953284|NCT03970837|83192914|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
46953285|NCT03970837|83192915|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
46843252|NCT00224120|83060246|FG000|Overall Study|Withdrawal by Subject|5|||
46843253|NCT00224120|83060247|FG001|Overall Study|Withdrawal by Subject|10|||
46953286|NCT03970837|83192916|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
46953287|NCT03970837|83192917|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
46953288|NCT03970837|83192918|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
46953289|NCT03970837|83192919|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
46953290|NCT03970837|83192920|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
46953291|NCT03970837|83192921|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
46953292|NCT03970837|83192922|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
46953293|NCT03970837|83192923|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
46953294|NCT03970837|83192924|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
46953295|NCT03938636|83192979|FG000|Overall Study|Protocol Violation|0|||
46953296|NCT03938636|83192980|FG001|Overall Study|Protocol Violation|1|||
46953297|NCT03938636|83192981|FG002|Overall Study|Protocol Violation|1|||
46953298|NCT03938636|83192979|FG000|Overall Study|Subject withdrew due to death in family|0|||
46953299|NCT03938636|83192980|FG001|Overall Study|Subject withdrew due to death in family|1|||
46953300|NCT03938636|83192981|FG002|Overall Study|Subject withdrew due to death in family|0|||
46953301|NCT03938636|83192979|FG000|Overall Study|Missed visit|0|||
46953302|NCT03938636|83192980|FG001|Overall Study|Missed visit|1|||
46953303|NCT03938636|83192981|FG002|Overall Study|Missed visit|0|||
46953304|NCT03938636|83192979|FG000|Overall Study|Adverse Event|0|||
46953305|NCT03938636|83192980|FG001|Overall Study|Adverse Event|0|||
46953306|NCT03938636|83192981|FG002|Overall Study|Adverse Event|1|||
46953307|NCT03938636|83192979|FG000|Overall Study|Lost to Follow-up|0|||
46953308|NCT03938636|83192980|FG001|Overall Study|Lost to Follow-up|0|||
46953309|NCT03938636|83192981|FG002|Overall Study|Lost to Follow-up|1|||
46953310|NCT03836716|83193006|FG000|Overall Study|Adverse Event|3|||
46639219|NCT01422876|82812780|FG009|Week 24|Consent withdrawn|6|||
46639220|NCT01422876|82812771|FG000|Week 24|Death|0|||
46843254|NCT00224120|83060246|FG000|Overall Study|Lack of Efficacy|0|||
46953311|NCT03836716|83193006|FG000|Overall Study|Death|22|||
46953312|NCT03836716|83193006|FG000|Overall Study|Withdrawal by Subject|8|||
46953313|NCT03836716|83193006|FG000|Overall Study|Study terminated by sponsor|87|||
46953314|NCT03686215|83193013|FG000|Overall Study|Adverse Event|0|||
46953315|NCT03686215|83193014|FG001|Overall Study|Adverse Event|0|||
46953316|NCT03686215|83193015|FG002|Overall Study|Adverse Event|7|||
46953317|NCT03686215|83193013|FG000|Overall Study|Physician Decision|0|||
46953318|NCT03686215|83193014|FG001|Overall Study|Physician Decision|0|||
46953319|NCT03686215|83193015|FG002|Overall Study|Physician Decision|1|||
46953320|NCT03686215|83193013|FG000|Overall Study|Protocol Violation|0|||
46953321|NCT03686215|83193014|FG001|Overall Study|Protocol Violation|0|||
46953322|NCT03686215|83193015|FG002|Overall Study|Protocol Violation|4|||
46953323|NCT03686215|83193013|FG000|Overall Study|Device issue|1|||
46953324|NCT03686215|83193014|FG001|Overall Study|Device issue|0|||
46843255|NCT00224120|83060247|FG001|Overall Study|Lack of Efficacy|2|||
46843256|NCT00224120|83060246|FG000|Overall Study|Lost to Follow-up|2|||
46953325|NCT03686215|83193015|FG002|Overall Study|Device issue|2|||
46953326|NCT03665077|83193023|FG000|Overall Study|Lost to Follow-up|2|||
46953327|NCT03665077|83193023|FG000|Overall Study|Physician Decision|2|||
46953328|NCT03606174|83193038|FG000|Overall Study|Death|37|||
46953329|NCT03606174|83193039|FG001|Overall Study|Death|15|||
46953330|NCT03606174|83193040|FG002|Overall Study|Death|15|||
46953331|NCT03606174|83193041|FG003|Overall Study|Death|7|||
46953332|NCT03606174|83193042|FG004|Overall Study|Death|35|||
46953333|NCT03606174|83193043|FG005|Overall Study|Death|12|||
46953334|NCT03606174|83193044|FG006|Overall Study|Death|35|||
46953335|NCT03606174|83193045|FG007|Overall Study|Death|8|||
46953336|NCT03606174|83193046|FG008|Overall Study|Death|5|||
46953337|NCT03606174|83193047|FG009|Overall Study|Death|3|||
46953338|NCT03606174|83193048|FG010|Overall Study|Death|0|||
46953339|NCT03606174|83193038|FG000|Overall Study|Lost to Follow-up|0|||
46953340|NCT03606174|83193039|FG001|Overall Study|Lost to Follow-up|0|||
46953341|NCT03606174|83193040|FG002|Overall Study|Lost to Follow-up|0|||
46953342|NCT03606174|83193041|FG003|Overall Study|Lost to Follow-up|0|||
46953343|NCT03606174|83193042|FG004|Overall Study|Lost to Follow-up|1|||
46953344|NCT03606174|83193043|FG005|Overall Study|Lost to Follow-up|1|||
46953345|NCT03606174|83193044|FG006|Overall Study|Lost to Follow-up|0|||
46953346|NCT03606174|83193045|FG007|Overall Study|Lost to Follow-up|0|||
46953347|NCT03606174|83193046|FG008|Overall Study|Lost to Follow-up|0|||
46953348|NCT03606174|83193047|FG009|Overall Study|Lost to Follow-up|0|||
46953349|NCT03606174|83193048|FG010|Overall Study|Lost to Follow-up|0|||
46953350|NCT03606174|83193038|FG000|Overall Study|Withdrawal by Subject|6|||
46953351|NCT03606174|83193039|FG001|Overall Study|Withdrawal by Subject|0|||
46953352|NCT03606174|83193040|FG002|Overall Study|Withdrawal by Subject|0|||
46953353|NCT03606174|83193041|FG003|Overall Study|Withdrawal by Subject|1|||
46953354|NCT03606174|83193042|FG004|Overall Study|Withdrawal by Subject|2|||
46953355|NCT03606174|83193043|FG005|Overall Study|Withdrawal by Subject|1|||
46953356|NCT03606174|83193044|FG006|Overall Study|Withdrawal by Subject|4|||
46953357|NCT03606174|83193045|FG007|Overall Study|Withdrawal by Subject|0|||
46953358|NCT03606174|83193046|FG008|Overall Study|Withdrawal by Subject|0|||
46953359|NCT03606174|83193047|FG009|Overall Study|Withdrawal by Subject|0|||
46953360|NCT03606174|83193048|FG010|Overall Study|Withdrawal by Subject|1|||
46953361|NCT03606174|83193038|FG000|Overall Study|Study Terminated by Sponsor|5|||
46953362|NCT03606174|83193039|FG001|Overall Study|Study Terminated by Sponsor|7|||
46953363|NCT03606174|83193040|FG002|Overall Study|Study Terminated by Sponsor|3|||
46772387|NCT00761462|82990654|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
46772388|NCT00761462|82990655|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
46772389|NCT00761462|82990654|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
46772390|NCT00761462|82990655|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
46772391|NCT00761306|82990661|FG000|Overall Study|Adverse Event|5|||
46772392|NCT00761306|82990661|FG000|Overall Study|Lack of Efficacy|4|||
46843257|NCT00224120|83060247|FG001|Overall Study|Lost to Follow-up|3|||
46843258|NCT00224120|83060246|FG000|Overall Study|Other|4|||
46843259|NCT00224120|83060247|FG001|Overall Study|Other|5|||
46843260|NCT00257660|83060255|FG000|Overall Study|Lack of Efficacy|5|||
46843261|NCT00257660|83060256|FG001|Overall Study|Lack of Efficacy|23|||
46843262|NCT00257660|83060255|FG000|Overall Study|Withdrawal by Subject|2|||
46843263|NCT00257660|83060256|FG001|Overall Study|Withdrawal by Subject|0|||
46843264|NCT00257660|83060255|FG000|Overall Study|Lost to Follow-up|1|||
46843265|NCT00257660|83060256|FG001|Overall Study|Lost to Follow-up|0|||
46843266|NCT00257660|83060255|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
46843267|NCT00257660|83060256|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
46843268|NCT00257660|83060255|FG000|Overall Study|No longer wanted to do blood draws|1|||
46843269|NCT00257660|83060256|FG001|Overall Study|No longer wanted to do blood draws|0|||
46953364|NCT03606174|83193041|FG003|Overall Study|Study Terminated by Sponsor|0|||
46953365|NCT03606174|83193042|FG004|Overall Study|Study Terminated by Sponsor|11|||
46953366|NCT03606174|83193043|FG005|Overall Study|Study Terminated by Sponsor|6|||
46953367|NCT03606174|83193044|FG006|Overall Study|Study Terminated by Sponsor|12|||
46772393|NCT00761306|82990661|FG000|Overall Study|Protocol Violation|2|||
46953368|NCT03606174|83193045|FG007|Overall Study|Study Terminated by Sponsor|1|||
46772394|NCT00761306|82990661|FG000|Overall Study|Withdrawal of Consent|3|||
46772395|NCT00761306|82990661|FG000|Overall Study|Lost to Follow-up|1|||
46772396|NCT00761306|82990661|FG000|Overall Study|Administrative or Other Reasons|5|||
46953369|NCT03606174|83193046|FG008|Overall Study|Study Terminated by Sponsor|3|||
46953370|NCT03606174|83193047|FG009|Overall Study|Study Terminated by Sponsor|1|||
46953371|NCT03606174|83193048|FG010|Overall Study|Study Terminated by Sponsor|2|||
46953372|NCT03606174|83193038|FG000|Overall Study|Miscellaneous|1|||
46953373|NCT03606174|83193039|FG001|Overall Study|Miscellaneous|1|||
46953374|NCT03606174|83193040|FG002|Overall Study|Miscellaneous|0|||
46843270|NCT00224042|83060264|FG000|Overall Study|Adverse Event|2|||
46953375|NCT03606174|83193041|FG003|Overall Study|Miscellaneous|1|||
46953376|NCT03606174|83193042|FG004|Overall Study|Miscellaneous|4|||
46953377|NCT03606174|83193043|FG005|Overall Study|Miscellaneous|7|||
46953378|NCT03606174|83193044|FG006|Overall Study|Miscellaneous|5|||
46953379|NCT03606174|83193045|FG007|Overall Study|Miscellaneous|0|||
46953380|NCT03606174|83193046|FG008|Overall Study|Miscellaneous|0|||
46953381|NCT03606174|83193047|FG009|Overall Study|Miscellaneous|0|||
46953382|NCT03606174|83193048|FG010|Overall Study|Miscellaneous|1|||
46953383|NCT03450707|83193078|FG000|Overall Study|Outside enrollment window|4|||
46953384|NCT03450707|83193079|FG001|Overall Study|Outside enrollment window|1|||
46953385|NCT03450707|83193078|FG000|Overall Study|Death|1|||
46953386|NCT03450707|83193079|FG001|Overall Study|Death|0|||
46953387|NCT03450707|83193078|FG000|Overall Study|Indication for thiamine|1|||
46843271|NCT00224042|83060265|FG001|Overall Study|Adverse Event|1|||
46843272|NCT00224042|83060264|FG000|Overall Study|Protocol Violation|0|||
46843273|NCT00224042|83060265|FG001|Overall Study|Protocol Violation|1|||
46843274|NCT00224042|83060264|FG000|Overall Study|Physician Decision|0|||
46843275|NCT00224042|83060265|FG001|Overall Study|Physician Decision|1|||
46843276|NCT00224042|83060264|FG000|Overall Study|Did not meet lab incusion criteria|2|||
46843277|NCT00224042|83060265|FG001|Overall Study|Did not meet lab incusion criteria|3|||
46843278|NCT00224042|83060264|FG000|Overall Study|Other|2|||
46843279|NCT00224042|83060265|FG001|Overall Study|Other|0|||
46843280|NCT00160706|83060271|FG000|Overall Study|Adverse Event|53|||
46953388|NCT03450707|83193079|FG001|Overall Study|Indication for thiamine|1|||
46953389|NCT03450707|83193078|FG000|Overall Study|Evidence of traumatic brain injury|1|||
46953390|NCT03450707|83193079|FG001|Overall Study|Evidence of traumatic brain injury|0|||
46953391|NCT03450707|83193078|FG000|Overall Study|Following commands|0|||
46953392|NCT03450707|83193079|FG001|Overall Study|Following commands|3|||
46953393|NCT03450707|83193078|FG000|Overall Study|Lactate < 3.5|0|||
46953394|NCT03450707|83193079|FG001|Overall Study|Lactate < 3.5|2|||
46953395|NCT03450707|83193078|FG000|Overall Study|Rearrest with ECMO|0|||
46953396|NCT03450707|83193079|FG001|Overall Study|Rearrest with ECMO|1|||
46953397|NCT03450707|83193078|FG000|Overall Study|Indication for thiamine + head CT results|0|||
46953398|NCT03450707|83193079|FG001|Overall Study|Indication for thiamine + head CT results|1|||
46953399|NCT03450707|83193078|FG000|Overall Study|Family/patient goals of care|0|||
46953400|NCT03450707|83193079|FG001|Overall Study|Family/patient goals of care|1|||
46953401|NCT03296527|83193087|FG000|Overall Study|Adverse Event|15|||
46953402|NCT03296527|83193088|FG001|Overall Study|Adverse Event|33|||
46953403|NCT03296527|83193087|FG000|Overall Study|Protocol Deviation|4|||
46953404|NCT03296527|83193088|FG001|Overall Study|Protocol Deviation|0|||
46953405|NCT03296527|83193087|FG000|Overall Study|Participant withdrew consent|3|||
46953406|NCT03296527|83193088|FG001|Overall Study|Participant withdrew consent|1|||
46953407|NCT03296527|83193087|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
46772397|NCT00772538|82990667|FG000|Overall Study|Adverse Event|6|||
46772398|NCT00772538|82990668|FG001|Overall Study|Adverse Event|6|||
46772399|NCT00772538|82990667|FG000|Overall Study|Protocol Violation|3|||
46772400|NCT00772538|82990668|FG001|Overall Study|Protocol Violation|3|||
46843281|NCT00160706|83060271|FG000|Overall Study|Adverse Event and Other Reason|105|||
46843282|NCT00160706|83060271|FG000|Overall Study|Protocol Violation|3|||
46843283|NCT00160706|83060271|FG000|Overall Study|Withdrawal by Subject|41|||
46772401|NCT00772538|82990667|FG000|Overall Study|Lost to Follow-up|1|||
46772402|NCT00772538|82990668|FG001|Overall Study|Lost to Follow-up|1|||
46772403|NCT00772538|82990667|FG000|Overall Study|Withdrawal by Subject|3|||
46772404|NCT00772538|82990668|FG001|Overall Study|Withdrawal by Subject|8|||
46772405|NCT00772538|82990667|FG000|Overall Study|Lack of Efficacy|0|||
46772406|NCT00772538|82990668|FG001|Overall Study|Lack of Efficacy|1|||
46772407|NCT00772538|82990667|FG000|Overall Study|Other|7|||
46772408|NCT00772538|82990668|FG001|Overall Study|Other|7|||
46772409|NCT00761150|82990677|FG000|Open-label Period|Adverse Event|36|||
46772410|NCT00761150|82990678|FG001|Open-label Period|Adverse Event|0|||
46772411|NCT00761150|82990679|FG002|Open-label Period|Adverse Event|0|||
46772412|NCT00761150|82990677|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
46772413|NCT00761150|82990678|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
46772414|NCT00761150|82990679|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
46843284|NCT00160706|83060271|FG000|Overall Study|Withdrawal by Subject and Other|12|||
46843285|NCT00160706|83060271|FG000|Overall Study|Physician Decision|10|||
46843286|NCT00160706|83060271|FG000|Overall Study|Physician Decision and Other|3|||
46843287|NCT00160706|83060271|FG000|Overall Study|Lost to Follow-up|4|||
46843288|NCT00160706|83060271|FG000|Overall Study|Lost to Follow-up and Other|1|||
46772415|NCT00761150|82990677|FG000|Open-label Period|Lost to Follow-up|7|||
46843289|NCT00160706|83060271|FG000|Overall Study|Lack of Efficacy|42|||
46843290|NCT00160706|83060271|FG000|Overall Study|Lack of Efficacy and Other|1|||
46953408|NCT03296527|83193088|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
46953409|NCT03296527|83193087|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
47066645|NCT01451203|83349318|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
46953410|NCT03296527|83193088|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
47066646|NCT01451203|83349319|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
46772416|NCT00761150|82990678|FG001|Open-label Period|Lost to Follow-up|0|||
46843291|NCT00160706|83060271|FG000|Overall Study|Other Reason|11|||
46953411|NCT03296527|83193087|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
46953412|NCT03296527|83193088|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
46953413|NCT03296527|83193087|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
46953414|NCT03296527|83193088|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
46953415|NCT03296527|83193087|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
46953416|NCT03296527|83193088|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
46953417|NCT03228680|83193097|FG000|Overall Study|Adverse Event|13|||
46953418|NCT03228680|83193098|FG001|Overall Study|Adverse Event|18|||
46953419|NCT03228680|83193097|FG000|Overall Study|Randomization failure|0|||
46953420|NCT03228680|83193098|FG001|Overall Study|Randomization failure|1|||
46953421|NCT03228680|83193097|FG000|Overall Study|Withdrawal by Subject|1|||
46953422|NCT03228680|83193098|FG001|Overall Study|Withdrawal by Subject|0|||
46953423|NCT03228680|83193097|FG000|Overall Study|Other|9|||
46953424|NCT03228680|83193098|FG001|Overall Study|Other|16|||
46953425|NCT03194542|83193109|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
46953426|NCT03194542|83193110|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
46953427|NCT03194542|83193111|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
46953428|NCT03194542|83193112|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
46953429|NCT03194542|83193109|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
46953430|NCT03194542|83193110|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
46953431|NCT03194542|83193111|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
46953432|NCT03194542|83193112|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
46953433|NCT03194542|83193109|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
46953434|NCT03194542|83193110|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
46953435|NCT03194542|83193111|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
46953436|NCT03194542|83193112|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
46953437|NCT03194542|83193109|FG000|Overall Study|Loss of Response|4|||
46953438|NCT03194542|83193110|FG001|Overall Study|Loss of Response|2|||
46953439|NCT03194542|83193111|FG002|Overall Study|Loss of Response|3|||
46953440|NCT03194542|83193112|FG003|Overall Study|Loss of Response|4|||
46953441|NCT03194542|83193109|FG000|Overall Study|Physician Decision|0|||
46953442|NCT03194542|83193110|FG001|Overall Study|Physician Decision|1|||
46953443|NCT03194542|83193111|FG002|Overall Study|Physician Decision|0|||
46953444|NCT03194542|83193112|FG003|Overall Study|Physician Decision|0|||
46953445|NCT03194542|83193109|FG000|Overall Study|Lack of Efficacy|2|||
46953446|NCT03194542|83193110|FG001|Overall Study|Lack of Efficacy|2|||
46953447|NCT03194542|83193111|FG002|Overall Study|Lack of Efficacy|2|||
46953448|NCT03194542|83193112|FG003|Overall Study|Lack of Efficacy|6|||
46953449|NCT03194542|83193109|FG000|Overall Study|Withdrawal by Subject|2|||
46953450|NCT03194542|83193110|FG001|Overall Study|Withdrawal by Subject|1|||
46953451|NCT03194542|83193111|FG002|Overall Study|Withdrawal by Subject|5|||
46953452|NCT03194542|83193112|FG003|Overall Study|Withdrawal by Subject|4|||
46953453|NCT03194542|83193109|FG000|Overall Study|Progressive Disease|1|||
46953454|NCT03194542|83193110|FG001|Overall Study|Progressive Disease|0|||
46953455|NCT03194542|83193111|FG002|Overall Study|Progressive Disease|1|||
46953456|NCT03194542|83193112|FG003|Overall Study|Progressive Disease|1|||
46953457|NCT03194542|83193109|FG000|Overall Study|Adverse Event|1|||
46953458|NCT03194542|83193110|FG001|Overall Study|Adverse Event|2|||
46953459|NCT03194542|83193111|FG002|Overall Study|Adverse Event|0|||
46953460|NCT03194542|83193112|FG003|Overall Study|Adverse Event|5|||
46953461|NCT03194542|83193109|FG000|Overall Study|Death|1|||
46953462|NCT03194542|83193110|FG001|Overall Study|Death|2|||
46953463|NCT03194542|83193111|FG002|Overall Study|Death|0|||
46953464|NCT03194542|83193112|FG003|Overall Study|Death|5|||
46843292|NCT00257192|83060277|FG000|Overall Study|Adverse Event|21|||
46843293|NCT00257192|83060278|FG001|Overall Study|Adverse Event|10|||
46843294|NCT00257192|83060277|FG000|Overall Study|Laboratory abnormality|1|||
46843295|NCT00257192|83060278|FG001|Overall Study|Laboratory abnormality|1|||
46843296|NCT00257192|83060277|FG000|Overall Study|Lost to Follow-up|3|||
46953465|NCT03194542|83193109|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
46953466|NCT03194542|83193110|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
46953467|NCT03194542|83193111|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
46953468|NCT03194542|83193112|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
46953469|NCT02328014|83193133|FG000|Overall Study|Adverse Event|1|||
46953470|NCT02328014|83193134|FG001|Overall Study|Adverse Event|0|||
46953471|NCT02328014|83193135|FG002|Overall Study|Adverse Event|0|||
46953472|NCT02328014|83193136|FG003|Overall Study|Adverse Event|1|||
46953473|NCT02328014|83193133|FG000|Overall Study|Death|0|||
46953474|NCT02328014|83193134|FG001|Overall Study|Death|0|||
46953475|NCT02328014|83193135|FG002|Overall Study|Death|0|||
46953476|NCT02328014|83193136|FG003|Overall Study|Death|4|||
46953477|NCT02328014|83193133|FG000|Overall Study|Physician Decision|0|||
46843297|NCT00257192|83060278|FG001|Overall Study|Lost to Follow-up|3|||
46953478|NCT02328014|83193134|FG001|Overall Study|Physician Decision|0|||
46953479|NCT02328014|83193135|FG002|Overall Study|Physician Decision|0|||
46953480|NCT02328014|83193136|FG003|Overall Study|Physician Decision|1|||
46953481|NCT02328014|83193133|FG000|Overall Study|Disease Progression|1|||
46953482|NCT02328014|83193134|FG001|Overall Study|Disease Progression|0|||
46953483|NCT02328014|83193135|FG002|Overall Study|Disease Progression|1|||
46953484|NCT02328014|83193136|FG003|Overall Study|Disease Progression|3|||
46953485|NCT02328014|83193133|FG000|Overall Study|Study Terminated by Sponsor|4|||
46953486|NCT02328014|83193134|FG001|Overall Study|Study Terminated by Sponsor|1|||
46953487|NCT02328014|83193135|FG002|Overall Study|Study Terminated by Sponsor|1|||
46953488|NCT02328014|83193136|FG003|Overall Study|Study Terminated by Sponsor|0|||
46953489|NCT02328014|83193133|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
46953490|NCT02328014|83193134|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
46953491|NCT02328014|83193135|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
46953492|NCT02328014|83193136|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
46953493|NCT02328014|83193133|FG000|Overall Study|Withdrawal by Subject|0|||
46953494|NCT02328014|83193134|FG001|Overall Study|Withdrawal by Subject|0|||
46953495|NCT02328014|83193135|FG002|Overall Study|Withdrawal by Subject|0|||
46953496|NCT02328014|83193136|FG003|Overall Study|Withdrawal by Subject|1|||
46953497|NCT02213926|83193146|FG000|Overall Study|Death|59|||
46953498|NCT02213926|83193146|FG000|Overall Study|Withdrawal by Subject|10|||
46953499|NCT02213926|83193146|FG000|Overall Study|study terminated by sponsor|51|||
46953500|NCT02213926|83193146|FG000|Overall Study|Lost to Follow-up|3|||
46953501|NCT02213926|83193146|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
46953502|NCT01892085|83193153|FG000|Overall Study|Death|4|||
46953503|NCT01892085|83193154|FG001|Overall Study|Death|1|||
46953504|NCT01892085|83193155|FG002|Overall Study|Death|3|||
46953505|NCT01892085|83193153|FG000|Overall Study|Withdrawal by Subject|2|||
46953506|NCT01892085|83193154|FG001|Overall Study|Withdrawal by Subject|0|||
46953507|NCT01892085|83193155|FG002|Overall Study|Withdrawal by Subject|2|||
46953508|NCT04510285|83193172|FG000|Overall Study|Death|1|||
46953509|NCT02576054|83193176|FG000|Overall Study|Withdrawal by Subject|1|||
46953510|NCT01606202|83193184|FG000|Overall Study|Adverse Event|5|||
46953511|NCT01606202|83193185|FG001|Overall Study|Adverse Event|0|||
46953512|NCT01606202|83193184|FG000|Overall Study|Withdrawal by Subject|2|||
46953513|NCT01606202|83193185|FG001|Overall Study|Withdrawal by Subject|1|||
46953514|NCT01606202|83193184|FG000|Overall Study|Personal problems|0|||
46953515|NCT01606202|83193185|FG001|Overall Study|Personal problems|1|||
46953516|NCT01606202|83193184|FG000|Overall Study|Problems with administration|0|||
46953517|NCT01606202|83193185|FG001|Overall Study|Problems with administration|1|||
46953518|NCT01493960|83193193|FG000|Overall Study|Adverse Event|0|||
46953519|NCT01493960|83193194|FG001|Overall Study|Adverse Event|1|||
46953520|NCT01493960|83193193|FG000|Overall Study|Lack of Efficacy|15|||
46953521|NCT01493960|83193194|FG001|Overall Study|Lack of Efficacy|9|||
46953522|NCT01493960|83193193|FG000|Overall Study|Protocol Violation|3|||
46953523|NCT01493960|83193194|FG001|Overall Study|Protocol Violation|0|||
46953524|NCT01493960|83193193|FG000|Overall Study|Withdrawal by Subject|10|||
46953525|NCT01493960|83193194|FG001|Overall Study|Withdrawal by Subject|4|||
46953526|NCT01493960|83193193|FG000|Overall Study|Non-specified|4|||
46953527|NCT01493960|83193194|FG001|Overall Study|Non-specified|4|||
46953528|NCT02630459|83193204|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
46953529|NCT02630459|83193205|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
46953530|NCT02630459|83193206|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
46953531|NCT02630459|83193207|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
46953532|NCT02630459|83193208|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
46953533|NCT02630459|83193209|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
46953534|NCT02630459|83193210|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
46953535|NCT02630459|83193211|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
46953536|NCT02630459|83193204|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
46953537|NCT02630459|83193205|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
46953538|NCT02630459|83193206|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
47066647|NCT01451203|83349318|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
47066648|NCT01451203|83349319|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
47066649|NCT01451203|83349318|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
47066650|NCT01451203|83349319|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
47066651|NCT01451203|83349318|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
46772417|NCT00761150|82990679|FG002|Open-label Period|Lost to Follow-up|0|||
46953539|NCT02630459|83193207|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
46953540|NCT02630459|83193208|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
46953541|NCT02630459|83193209|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
46953542|NCT02630459|83193210|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
46953543|NCT02630459|83193211|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
46953544|NCT02630459|83193204|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
46953545|NCT02630459|83193205|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
46953546|NCT02630459|83193206|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
46953547|NCT02630459|83193207|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
46953548|NCT02630459|83193208|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
46953549|NCT02630459|83193209|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
46953550|NCT02630459|83193210|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
46953551|NCT02630459|83193211|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
46953552|NCT02630459|83193204|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
46953553|NCT02630459|83193205|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
46953554|NCT02630459|83193206|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
46953555|NCT02630459|83193207|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
46953556|NCT02630459|83193208|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
46953557|NCT02630459|83193209|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
46953558|NCT02630459|83193210|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
46953559|NCT02630459|83193211|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
46953560|NCT02630459|83193204|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
46953561|NCT02630459|83193205|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
46953562|NCT02630459|83193206|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
46953563|NCT02630459|83193207|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
46953564|NCT02630459|83193208|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
46953565|NCT02630459|83193209|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
46953566|NCT02630459|83193210|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
46953567|NCT02630459|83193211|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
46953568|NCT02630459|83193204|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
46953569|NCT02630459|83193205|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
46953570|NCT02630459|83193206|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
46953571|NCT02630459|83193207|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
46953572|NCT02630459|83193208|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
46953573|NCT02630459|83193209|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
46953574|NCT02630459|83193210|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
46953575|NCT02630459|83193211|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
46953576|NCT02630459|83193204|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
46953577|NCT02630459|83193205|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
46953578|NCT02630459|83193206|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
46953579|NCT02630459|83193207|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
46953580|NCT02630459|83193208|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
46953581|NCT02630459|83193209|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
46953582|NCT02630459|83193210|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
46953583|NCT02630459|83193211|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
46953584|NCT02573948|83193236|FG000|Longitudinal Cohort|Death|9|||
46953585|NCT02573948|83193236|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
46953586|NCT02573948|83193236|FG000|Longitudinal Cohort|Incarcerated|25|||
46953587|NCT01464593|83193243|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
46953588|NCT05279131|83193247|FG000|Overall Study|Lost to Follow-up|1|||
46953589|NCT05279131|83193247|FG000|Overall Study|Death|1|||
46953590|NCT05279131|83193247|FG000|Overall Study|Physician Decision|1|||
46953591|NCT05028517|83193258|FG000|Overall Study|Lost to Follow-up|13|||
46953592|NCT05028517|83193259|FG001|Overall Study|Lost to Follow-up|20|||
46953593|NCT05028517|83193260|FG002|Overall Study|Lost to Follow-up|12|||
46953594|NCT05028517|83193258|FG000|Overall Study|Withdrawal by Subject|0|||
46953595|NCT05028517|83193259|FG001|Overall Study|Withdrawal by Subject|0|||
46953596|NCT05028517|83193260|FG002|Overall Study|Withdrawal by Subject|1|||
46953597|NCT04363944|83193283|FG000|Overall Study|Withdrawal by Subject|2|||
46953598|NCT04363944|83193284|FG001|Overall Study|Withdrawal by Subject|0|||
46953599|NCT04335110|83193297|FG000|Overall Study|Withdrawal by Subject|1|||
46953600|NCT04335110|83193298|FG001|Overall Study|Withdrawal by Subject|1|||
47066652|NCT01451203|83349319|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
47066653|NCT01451203|83349318|FG000|Double-blind Treatment Period|Adverse Event|6|||
47066654|NCT01451203|83349319|FG001|Double-blind Treatment Period|Adverse Event|9|||
47066655|NCT01451203|83349318|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
47066656|NCT01451203|83349319|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
47066657|NCT01451203|83349318|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
46953601|NCT04335110|83193297|FG000|Overall Study|Death|0|||
46953602|NCT04335110|83193298|FG001|Overall Study|Death|1|||
46953603|NCT04156620|83193314|FG000|Overall Study|Adverse event - TP 1|5|||
46953604|NCT04156620|83193315|FG001|Overall Study|Adverse event - TP 1|2|||
46953605|NCT04156620|83193314|FG000|Overall Study|Lost to follow-up TP 1|1|||
46953606|NCT04156620|83193315|FG001|Overall Study|Lost to follow-up TP 1|1|||
46953607|NCT04156620|83193314|FG000|Overall Study|Progressive disease - TP 1|0|||
46953608|NCT04156620|83193315|FG001|Overall Study|Progressive disease - TP 1|1|||
46953609|NCT04156620|83193314|FG000|Overall Study|Subject decision - TP 1|3|||
46953610|NCT04156620|83193315|FG001|Overall Study|Subject decision - TP 1|5|||
46953611|NCT04156620|83193314|FG000|Overall Study|Adverse event - TP 2|5|||
46953612|NCT04156620|83193315|FG001|Overall Study|Adverse event - TP 2|6|||
46953613|NCT04156620|83193314|FG000|Overall Study|Death - TP 2|1|||
46953614|NCT04156620|83193315|FG001|Overall Study|Death - TP 2|0|||
46953615|NCT04156620|83193314|FG000|Overall Study|Lost to follow-up - TP 2|5|||
46953616|NCT04156620|83193315|FG001|Overall Study|Lost to follow-up - TP 2|2|||
46953617|NCT04156620|83193314|FG000|Overall Study|Physician decision - TP 2|4|||
46953618|NCT04156620|83193315|FG001|Overall Study|Physician decision - TP 2|2|||
46953619|NCT04156620|83193314|FG000|Overall Study|Pregnancy - TP 2|1|||
46953620|NCT04156620|83193315|FG001|Overall Study|Pregnancy - TP 2|1|||
46953621|NCT04156620|83193314|FG000|Overall Study|Subject decision - TP 2|11|||
46953622|NCT04156620|83193315|FG001|Overall Study|Subject decision - TP 2|9|||
46953623|NCT04156620|83193314|FG000|Overall Study|New therapy for study indication - TP 2|1|||
46953624|NCT04156620|83193315|FG001|Overall Study|New therapy for study indication - TP 2|0|||
46953625|NCT03621189|83193336|FG000|Overall Study|Withdrawal by Subject|0|||
46953626|NCT03621189|83193337|FG001|Overall Study|Withdrawal by Subject|3|||
46953627|NCT03621189|83193336|FG000|Overall Study|Physician Decision|0|||
46953628|NCT03621189|83193337|FG001|Overall Study|Physician Decision|2|||
46953629|NCT03486834|83193347|FG000|Overall Study|Withdrawal by Subject|46|||
46953630|NCT03486834|83193348|FG001|Overall Study|Withdrawal by Subject|46|||
46953631|NCT03486834|83193349|FG002|Overall Study|Withdrawal by Subject|52|||
46953632|NCT03486834|83193347|FG000|Overall Study|Adverse Event|8|||
46953633|NCT03486834|83193348|FG001|Overall Study|Adverse Event|7|||
46953634|NCT03486834|83193349|FG002|Overall Study|Adverse Event|0|||
46953635|NCT03486834|83193347|FG000|Overall Study|Lost to Follow-up|41|||
46953636|NCT03486834|83193348|FG001|Overall Study|Lost to Follow-up|24|||
46953637|NCT03486834|83193349|FG002|Overall Study|Lost to Follow-up|39|||
46953638|NCT03486834|83193347|FG000|Overall Study|Non-compliance with Study Drug|2|||
46953639|NCT03486834|83193348|FG001|Overall Study|Non-compliance with Study Drug|2|||
46953640|NCT03486834|83193349|FG002|Overall Study|Non-compliance with Study Drug|0|||
46953641|NCT03486834|83193347|FG000|Overall Study|Physician Decision|5|||
46953642|NCT03486834|83193348|FG001|Overall Study|Physician Decision|2|||
46953643|NCT03486834|83193349|FG002|Overall Study|Physician Decision|3|||
46953644|NCT03486834|83193347|FG000|Overall Study|Pregnancy|10|||
46953645|NCT03486834|83193348|FG001|Overall Study|Pregnancy|12|||
46953646|NCT03486834|83193349|FG002|Overall Study|Pregnancy|12|||
46953647|NCT03486834|83193347|FG000|Overall Study|Protocol Deviation|2|||
46953648|NCT03486834|83193348|FG001|Overall Study|Protocol Deviation|3|||
46953649|NCT03486834|83193349|FG002|Overall Study|Protocol Deviation|3|||
46953650|NCT03486834|83193347|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
46953651|NCT03486834|83193348|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
46953652|NCT03486834|83193349|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
46953653|NCT03486834|83193347|FG000|Overall Study|Randomized but not treated|4|||
46953654|NCT03486834|83193348|FG001|Overall Study|Randomized but not treated|4|||
46953655|NCT03486834|83193349|FG002|Overall Study|Randomized but not treated|1|||
46953656|NCT03356145|83193365|FG000|Overall Study|Withdrawal by Subject|2|||
46953657|NCT03356145|83193366|FG001|Overall Study|Withdrawal by Subject|1|||
46953658|NCT03356145|83193365|FG000|Overall Study|Did not meet inclusion criteria|1|||
46953659|NCT03356145|83193366|FG001|Overall Study|Did not meet inclusion criteria|0|||
46953660|NCT03312738|83193374|FG000|Overall Study|Progressive disease|58|||
46953661|NCT03312738|83193375|FG001|Overall Study|Progressive disease|67|||
46772418|NCT00761150|82990677|FG000|Open-label Period|Lack of Efficacy|4|||
46772419|NCT00761150|82990678|FG001|Open-label Period|Lack of Efficacy|0|||
46772420|NCT00761150|82990679|FG002|Open-label Period|Lack of Efficacy|0|||
46772421|NCT00761150|82990677|FG000|Open-label Period|Withdrawal by Subject|5|||
46772422|NCT00761150|82990678|FG001|Open-label Period|Withdrawal by Subject|0|||
46772423|NCT00761150|82990679|FG002|Open-label Period|Withdrawal by Subject|0|||
46953662|NCT03312738|83193374|FG000|Overall Study|Patient/guardian decision|13|||
46953663|NCT03312738|83193375|FG001|Overall Study|Patient/guardian decision|5|||
46953664|NCT03312738|83193374|FG000|Overall Study|Adverse Event|5|||
46953665|NCT03312738|83193375|FG001|Overall Study|Adverse Event|3|||
46953666|NCT03312738|83193374|FG000|Overall Study|Protocol deviation|2|||
46953667|NCT03312738|83193375|FG001|Overall Study|Protocol deviation|0|||
46953668|NCT03312738|83193374|FG000|Overall Study|Technical problems|0|||
46953669|NCT03312738|83193375|FG001|Overall Study|Technical problems|1|||
46953670|NCT03312738|83193374|FG000|Overall Study|Physician Decision|2|||
46953671|NCT03312738|83193375|FG001|Overall Study|Physician Decision|3|||
46953672|NCT03268954|83193385|FG000|Overall Study|Ongoing|23|||
46953673|NCT03268954|83193386|FG001|Overall Study|Ongoing|31|||
46953674|NCT03268954|83193385|FG000|Overall Study|Adverse Event|53|||
46953675|NCT03268954|83193386|FG001|Overall Study|Adverse Event|62|||
46953676|NCT03268954|83193385|FG000|Overall Study|Withdrawal by Subject|25|||
46953677|NCT03268954|83193386|FG001|Overall Study|Withdrawal by Subject|16|||
46953678|NCT03268954|83193385|FG000|Overall Study|Progressive Disease|61|||
46953679|NCT03268954|83193386|FG001|Overall Study|Progressive Disease|48|||
46953680|NCT03268954|83193385|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
46953681|NCT03268954|83193386|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
46953682|NCT03268954|83193385|FG000|Overall Study|Reason not Specified|40|||
46953683|NCT03268954|83193386|FG001|Overall Study|Reason not Specified|40|||
46953684|NCT02663622|83193431|FG000|Overall Study|Death|3|||
46953685|NCT02663622|83193432|FG001|Overall Study|Death|1|||
46953686|NCT02663622|83193433|FG002|Overall Study|Death|1|||
46953687|NCT02663622|83193434|FG003|Overall Study|Death|8|||
46953688|NCT02663622|83193431|FG000|Overall Study|Protocol Violation|0|||
46953689|NCT02663622|83193432|FG001|Overall Study|Protocol Violation|0|||
46953690|NCT02663622|83193433|FG002|Overall Study|Protocol Violation|0|||
46953691|NCT02663622|83193434|FG003|Overall Study|Protocol Violation|1|||
46953692|NCT02637713|83193445|FG000|Overall Study|Screen Failure|2|||
46953693|NCT01651208|83193482|FG000|Overall Study|Lost to Follow-up|14|||
46953694|NCT01651208|83193483|FG001|Overall Study|Lost to Follow-up|16|||
46953695|NCT02572388|83193494|FG000|Overall Study|Withdrawal by Subject|1|||
46953696|NCT02572388|83193495|FG001|Overall Study|Withdrawal by Subject|1|||
46953697|NCT02572388|83193496|FG002|Overall Study|Withdrawal by Subject|2|||
46953698|NCT02572388|83193497|FG003|Overall Study|Withdrawal by Subject|2|||
46953699|NCT02573870|83193509|FG000|Overall Study|Adverse Event|0|||
46953700|NCT02573870|83193510|FG001|Overall Study|Adverse Event|2|||
46953701|NCT02573870|83193509|FG000|Overall Study|Lack of Efficacy|0|||
46953702|NCT02573870|83193510|FG001|Overall Study|Lack of Efficacy|1|||
46953703|NCT02573870|83193509|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
46953704|NCT02573870|83193510|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
46953705|NCT02573870|83193509|FG000|Overall Study|Lost to Follow-up|0|||
46953706|NCT02573870|83193510|FG001|Overall Study|Lost to Follow-up|1|||
46953707|NCT02573870|83193509|FG000|Overall Study|Other: Fail to Meet Visit|0|||
46953708|NCT02573870|83193510|FG001|Overall Study|Other: Fail to Meet Visit|2|||
46953709|NCT02572076|83193516|FG000|Overall Study|Protocol Violation|1|||
46953710|NCT02571452|83193522|FG000|Overall Study Treatment|Protocol Violation|0|||
46953711|NCT02571452|83193523|FG001|Overall Study Treatment|Protocol Violation|1|||
46843298|NCT00257192|83060277|FG000|Overall Study|Insufficient clinical response|18|||
46843299|NCT00257192|83060278|FG001|Overall Study|Insufficient clinical response|18|||
46843300|NCT00257192|83060277|FG000|Overall Study|Withdrawal by Subject|14|||
46843301|NCT00257192|83060278|FG001|Overall Study|Withdrawal by Subject|2|||
46843302|NCT00257192|83060277|FG000|Overall Study|Randomized but not treated|0|||
46843303|NCT00257192|83060278|FG001|Overall Study|Randomized but not treated|1|||
46843304|NCT00257192|83060277|FG000|Overall Study|Study terminated by sponsor|1|||
46843305|NCT00257192|83060278|FG001|Overall Study|Study terminated by sponsor|0|||
46843306|NCT00257192|83060277|FG000|Overall Study|Miscellaneous|0|||
46843307|NCT00257192|83060278|FG001|Overall Study|Miscellaneous|4|||
46843308|NCT00256724|83060286|FG000|Overall Study|Physician Decision|2|||
46843309|NCT00256724|83060287|FG001|Overall Study|Physician Decision|5|||
46843310|NCT00256724|83060286|FG000|Overall Study|Protocol Violation|3|||
46843311|NCT00256724|83060287|FG001|Overall Study|Protocol Violation|3|||
46843312|NCT00157820|83060296|FG000|Randomized|Physician Decision|4|||
46843313|NCT00157820|83060297|FG001|Randomized|Physician Decision|2|||
46843314|NCT00157820|83060298|FG002|Randomized|Physician Decision|3|||
46843315|NCT00157820|83060296|FG000|Randomized|Withdrawal by Subject|1|||
46843316|NCT00157820|83060297|FG001|Randomized|Withdrawal by Subject|2|||
46843317|NCT00157820|83060298|FG002|Randomized|Withdrawal by Subject|3|||
46843318|NCT00157820|83060296|FG000|Randomized|Protocol Violation|2|||
46843319|NCT00157820|83060297|FG001|Randomized|Protocol Violation|1|||
46843320|NCT00157820|83060298|FG002|Randomized|Protocol Violation|2|||
46843321|NCT00157820|83060296|FG000|1st 8 Month|Death|7|||
46953712|NCT02571452|83193522|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
47066658|NCT01451203|83349319|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
47066659|NCT01451203|83349318|FG000|Double-blind Treatment Period|Investigator decision|2|||
47066660|NCT01451203|83349319|FG001|Double-blind Treatment Period|Investigator decision|0|||
47066661|NCT01451203|83349318|FG000|Post-treatment Period|Consent withdrawn|2|||
46843322|NCT00157820|83060297|FG001|1st 8 Month|Death|8|||
46843323|NCT00157820|83060298|FG002|1st 8 Month|Death|3|||
46953713|NCT02571452|83193523|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
46953714|NCT02571452|83193522|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
46953715|NCT02571452|83193523|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
46953716|NCT02574260|83193529|FG000|Overall Study|Disease Progression|1|||
46843324|NCT00157820|83060296|FG000|1st 8 Month|Lost to Follow-up|1|||
46843325|NCT00157820|83060297|FG001|1st 8 Month|Lost to Follow-up|2|||
46953717|NCT02570126|83193535|FG000|Overall Study|Lost to Follow-up|2|||
46953718|NCT02570126|83193536|FG001|Overall Study|Lost to Follow-up|0|||
46843326|NCT00157820|83060298|FG002|1st 8 Month|Lost to Follow-up|1|||
46843327|NCT00157820|83060296|FG000|1st 8 Month|Premature cross-over|0|||
46953719|NCT02570126|83193535|FG000|Overall Study|Unable To Arrange Visit 3|1|||
46953720|NCT02570126|83193536|FG001|Overall Study|Unable To Arrange Visit 3|0|||
46953721|NCT02570126|83193535|FG000|Overall Study|Violation Of Procedures GSK|0|||
46953722|NCT02570126|83193536|FG001|Overall Study|Violation Of Procedures GSK|1|||
46953723|NCT02570126|83193535|FG000|Overall Study|Protocol Violation|0|||
46953724|NCT02570126|83193536|FG001|Overall Study|Protocol Violation|1|||
46953725|NCT02570126|83193535|FG000|Overall Study|Withdrawal by Subject|3|||
46953726|NCT02570126|83193536|FG001|Overall Study|Withdrawal by Subject|7|||
46953727|NCT02755831|83193544|FG000|Overall Study|Lost to Follow-up|3|||
46953728|NCT02755831|83193545|FG001|Overall Study|Lost to Follow-up|3|||
46953729|NCT02573246|83193556|FG000|Overall Study|Lost to Follow-up|2|||
46953730|NCT02573246|83193557|FG001|Overall Study|Lost to Follow-up|0|||
46953731|NCT02573246|83193558|FG002|Overall Study|Lost to Follow-up|0|||
46953732|NCT02573246|83193559|FG003|Overall Study|Lost to Follow-up|0|||
46953733|NCT02573246|83193560|FG004|Overall Study|Lost to Follow-up|1|||
46953734|NCT02573246|83193556|FG000|Overall Study|Withdrawal by Subject|0|||
46953735|NCT02573246|83193557|FG001|Overall Study|Withdrawal by Subject|0|||
46953736|NCT02573246|83193558|FG002|Overall Study|Withdrawal by Subject|0|||
46953737|NCT02573246|83193559|FG003|Overall Study|Withdrawal by Subject|0|||
46953738|NCT02573246|83193560|FG004|Overall Study|Withdrawal by Subject|1|||
46953739|NCT02573246|83193556|FG000|Overall Study|Physician Decision|1|||
46953740|NCT02573246|83193557|FG001|Overall Study|Physician Decision|1|||
46953741|NCT02573246|83193558|FG002|Overall Study|Physician Decision|3|||
46953742|NCT02573246|83193559|FG003|Overall Study|Physician Decision|2|||
46772424|NCT00761150|82990677|FG000|Open-label Period|Noncompliance|2|||
46772425|NCT00761150|82990678|FG001|Open-label Period|Noncompliance|0|||
46772426|NCT00761150|82990679|FG002|Open-label Period|Noncompliance|0|||
46772427|NCT00761150|82990677|FG000|Open-label Period|Other|5|||
46772428|NCT00761150|82990678|FG001|Open-label Period|Other|0|||
46772429|NCT00761150|82990679|FG002|Open-label Period|Other|0|||
46772430|NCT00761150|82990677|FG000|Double-blind Period|Lack of Efficacy|0|||
46772431|NCT00761150|82990678|FG001|Double-blind Period|Lack of Efficacy|2|||
46772432|NCT00761150|82990679|FG002|Double-blind Period|Lack of Efficacy|19|||
46772433|NCT00761150|82990677|FG000|Double-blind Period|Adverse Event|0|||
46772434|NCT00761150|82990678|FG001|Double-blind Period|Adverse Event|3|||
46772435|NCT00761150|82990679|FG002|Double-blind Period|Adverse Event|3|||
46772436|NCT00761150|82990677|FG000|Double-blind Period|Withdrawal by Subject|0|||
46772437|NCT00761150|82990678|FG001|Double-blind Period|Withdrawal by Subject|3|||
46772438|NCT00761150|82990679|FG002|Double-blind Period|Withdrawal by Subject|2|||
46772439|NCT00761150|82990677|FG000|Double-blind Period|Lost to Follow-up|0|||
46772440|NCT00761150|82990678|FG001|Double-blind Period|Lost to Follow-up|2|||
46772441|NCT00761150|82990679|FG002|Double-blind Period|Lost to Follow-up|1|||
46772442|NCT00761150|82990677|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
46772443|NCT00761150|82990678|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
46772444|NCT00761150|82990679|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
46772445|NCT00761150|82990677|FG000|Double-blind Period|Noncompliance|0|||
46772446|NCT00761150|82990678|FG001|Double-blind Period|Noncompliance|1|||
46772447|NCT00761150|82990679|FG002|Double-blind Period|Noncompliance|0|||
46772448|NCT00761150|82990677|FG000|Double-blind Period|Other|0|||
46772449|NCT00761150|82990678|FG001|Double-blind Period|Other|3|||
46772450|NCT00761150|82990679|FG002|Double-blind Period|Other|3|||
46772451|NCT00760994|82990689|FG000|Overall Study|Lost to Follow-up|4|||
46772452|NCT00760994|82990690|FG001|Overall Study|Lost to Follow-up|4|||
46772453|NCT00760994|82990691|FG002|Overall Study|Lost to Follow-up|3|||
46772454|NCT00583557|82990701|FG000|Overall Study|Withdrawal by Subject|18|||
46772455|NCT00583557|82990701|FG000|Overall Study|Adverse Event|9|||
46772456|NCT00583557|82990701|FG000|Overall Study|Lack of Efficacy|31|||
46772457|NCT00583557|82990701|FG000|Overall Study|Lack of Compliance|5|||
46772458|NCT00583557|82990701|FG000|Overall Study|Other|5|||
46772459|NCT00583557|82990701|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
46772460|NCT00586820|82990707|FG000|Overall Study|Unsuccessful PCI|1|||
46772461|NCT00586820|82990708|FG001|Overall Study|Unsuccessful PCI|0|||
46953743|NCT02573246|83193560|FG004|Overall Study|Physician Decision|2|||
46953744|NCT02570750|83193579|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
46772462|NCT00760838|82990716|FG000|Overall Study|Adverse Event|1|||
46772463|NCT00760838|82990717|FG001|Overall Study|Adverse Event|1|||
46772464|NCT00760838|82990716|FG000|Overall Study|Lack of Efficacy|1|||
46772465|NCT00760838|82990717|FG001|Overall Study|Lack of Efficacy|0|||
46953745|NCT02570750|83193580|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
46953746|NCT02570750|83193579|FG000|Overall Study|Protocol deviation|4|||
46953747|NCT02570750|83193580|FG001|Overall Study|Protocol deviation|2|||
46772466|NCT00760838|82990716|FG000|Overall Study|Lost to Follow-up|2|||
46772467|NCT00760838|82990717|FG001|Overall Study|Lost to Follow-up|0|||
46772468|NCT00760838|82990716|FG000|Overall Study|Withdrawal by Subject|1|||
46772469|NCT00760838|82990717|FG001|Overall Study|Withdrawal by Subject|1|||
46772470|NCT00586664|82990726|FG000|Overall Study|Withdrawal by Subject|3|||
46772471|NCT00586664|82990727|FG001|Overall Study|Withdrawal by Subject|7|||
46953748|NCT02570750|83193579|FG000|Overall Study|Withdrawal by Subject|5|||
46843328|NCT00157820|83060297|FG001|1st 8 Month|Premature cross-over|2|||
46843329|NCT00157820|83060298|FG002|1st 8 Month|Premature cross-over|2|||
46843330|NCT00157820|83060296|FG000|2nd 8 Months|Death|3|||
46843331|NCT00157820|83060297|FG001|2nd 8 Months|Death|1|||
46843332|NCT00157820|83060298|FG002|2nd 8 Months|Death|3|||
47066662|NCT01451203|83349319|FG001|Post-treatment Period|Consent withdrawn|4|||
46843333|NCT00157820|83060296|FG000|2nd 8 Months|Lost to Follow-up|1|||
46843334|NCT00157820|83060297|FG001|2nd 8 Months|Lost to Follow-up|5|||
46843335|NCT00157820|83060298|FG002|2nd 8 Months|Lost to Follow-up|2|||
46843336|NCT00157820|83060296|FG000|2nd 8 Months|Premature cross-over|1|||
46843337|NCT00157820|83060297|FG001|2nd 8 Months|Premature cross-over|7|||
46843338|NCT00157820|83060298|FG002|2nd 8 Months|Premature cross-over|9|||
46843339|NCT00223808|83060310|FG000|Overall Study|<5 hrs therapy before discharge|3|||
46843340|NCT00223808|83060311|FG001|Overall Study|<5 hrs therapy before discharge|5|||
46843341|NCT00223808|83060312|FG002|Overall Study|<5 hrs therapy before discharge|5|||
47066663|NCT01451203|83349318|FG000|Post-treatment Period|Lack of Efficacy|12|||
47066664|NCT01451203|83349319|FG001|Post-treatment Period|Lack of Efficacy|28|||
47066665|NCT01451203|83349318|FG000|Post-treatment Period|Adverse Event|0|||
47066666|NCT01451203|83349319|FG001|Post-treatment Period|Adverse Event|1|||
47066667|NCT01451203|83349318|FG000|Post-treatment Period|Investigator decision|0|||
47066668|NCT01451203|83349319|FG001|Post-treatment Period|Investigator decision|1|||
47066669|NCT01556438|83349327|FG000|Overall Study|Adverse Event|4|||
46772472|NCT00586664|82990728|FG002|Overall Study|Withdrawal by Subject|1|||
46772473|NCT00586664|82990726|FG000|Overall Study|Exclusion criteria met|2|||
46772474|NCT00586664|82990727|FG001|Overall Study|Exclusion criteria met|0|||
46772475|NCT00586664|82990728|FG002|Overall Study|Exclusion criteria met|0|||
46772476|NCT00437281|82990756|FG000|Overall Study|Adverse Event|0|||
46953749|NCT02570750|83193580|FG001|Overall Study|Withdrawal by Subject|0|||
46953750|NCT02570750|83193579|FG000|Overall Study|Lost to Follow-up|2|||
46953751|NCT02570750|83193580|FG001|Overall Study|Lost to Follow-up|2|||
46953752|NCT02570750|83193579|FG000|Overall Study|Adverse Event|2|||
46953753|NCT02570750|83193580|FG001|Overall Study|Adverse Event|1|||
46953754|NCT02573012|83193588|FG000|Overall Study|Adverse Event|5|||
46953755|NCT02573012|83193589|FG001|Overall Study|Adverse Event|5|||
46953756|NCT02573012|83193588|FG000|Overall Study|Lack of Efficacy|5|||
46772477|NCT00437281|82990757|FG001|Overall Study|Adverse Event|0|||
46772478|NCT00437281|82990758|FG002|Overall Study|Adverse Event|0|||
46772479|NCT00437281|82990759|FG003|Overall Study|Adverse Event|1|||
46772480|NCT00437281|82990760|FG004|Overall Study|Adverse Event|0|||
46772481|NCT00437281|82990761|FG005|Overall Study|Adverse Event|1|||
46843342|NCT00154310|83060322|FG000|Overall Study|Adverse Event|19|||
46843343|NCT00154310|83060323|FG001|Overall Study|Adverse Event|9|||
46843344|NCT00154310|83060322|FG000|Overall Study|Lack of Efficacy|5|||
46843345|NCT00154310|83060323|FG001|Overall Study|Lack of Efficacy|4|||
46843346|NCT00154310|83060322|FG000|Overall Study|Protocol Violation|4|||
46843347|NCT00154310|83060323|FG001|Overall Study|Protocol Violation|2|||
46843348|NCT00154310|83060322|FG000|Overall Study|Withdrawal by Subject|9|||
46843349|NCT00154310|83060323|FG001|Overall Study|Withdrawal by Subject|3|||
46843350|NCT00154310|83060322|FG000|Overall Study|Lost to Follow-up|0|||
46843351|NCT00154310|83060323|FG001|Overall Study|Lost to Follow-up|8|||
46843352|NCT00154310|83060322|FG000|Overall Study|Administrative problems|0|||
46843353|NCT00154310|83060323|FG001|Overall Study|Administrative problems|1|||
46843354|NCT00154310|83060322|FG000|Overall Study|Death|0|||
46843355|NCT00154310|83060323|FG001|Overall Study|Death|1|||
46843356|NCT03771352|83060329|FG000|Overall Study|Screen failure|2|||
46843357|NCT03771352|83060329|FG000|Overall Study|Withdrawal by Subject|2|||
46843358|NCT03770728|83060337|FG000|Overall Study|Adverse Event|1|||
46843359|NCT03770728|83060338|FG001|Overall Study|Adverse Event|0|||
46843360|NCT03770728|83060339|FG002|Overall Study|Adverse Event|1|||
46843361|NCT03770728|83060340|FG003|Overall Study|Adverse Event|0|||
46843362|NCT03770728|83060337|FG000|Overall Study|Poor compliance to protocol|0|||
46843363|NCT03770728|83060338|FG001|Overall Study|Poor compliance to protocol|0|||
46843364|NCT03770728|83060339|FG002|Overall Study|Poor compliance to protocol|1|||
46843365|NCT03770728|83060340|FG003|Overall Study|Poor compliance to protocol|0|||
46843366|NCT03770728|83060337|FG000|Overall Study|Withdrawal by Subject|13|||
46953757|NCT02573012|83193589|FG001|Overall Study|Lack of Efficacy|4|||
46772482|NCT00437281|82990762|FG006|Overall Study|Adverse Event|0|||
46843367|NCT03770728|83060338|FG001|Overall Study|Withdrawal by Subject|8|||
46843368|NCT03770728|83060339|FG002|Overall Study|Withdrawal by Subject|9|||
46953758|NCT02573012|83193588|FG000|Overall Study|Non-compliance|1|||
47066670|NCT01556438|83349328|FG001|Overall Study|Adverse Event|2|||
46772483|NCT00437281|82990763|FG007|Overall Study|Adverse Event|0|||
46772484|NCT00437281|82990764|FG008|Overall Study|Adverse Event|0|||
46843369|NCT03770728|83060340|FG003|Overall Study|Withdrawal by Subject|13|||
46843370|NCT03770728|83060337|FG000|Overall Study|Other than specified|24|||
46843371|NCT03770728|83060338|FG001|Overall Study|Other than specified|23|||
46843372|NCT03770728|83060339|FG002|Overall Study|Other than specified|21|||
46843373|NCT03770728|83060340|FG003|Overall Study|Other than specified|22|||
47066671|NCT01556438|83349327|FG000|Overall Study|Sponsor Decision|0|||
46953759|NCT02573012|83193589|FG001|Overall Study|Non-compliance|2|||
46953760|NCT02573012|83193588|FG000|Overall Study|Withdrawal by Subject|2|||
46953761|NCT02573012|83193589|FG001|Overall Study|Withdrawal by Subject|2|||
46953762|NCT02573012|83193588|FG000|Overall Study|Study Ended per Protocol|1|||
46953763|NCT02573012|83193589|FG001|Overall Study|Study Ended per Protocol|0|||
46953764|NCT02573012|83193588|FG000|Overall Study|Physician Decision|1|||
46953765|NCT02573012|83193589|FG001|Overall Study|Physician Decision|2|||
46953766|NCT02752633|83193595|FG000|Overall Study|Withdrawal by Subject|1|||
46953767|NCT02752087|83193599|FG000|Washout|Physician Decision|1|||
46953768|NCT02752087|83193600|FG001|Washout|Physician Decision|0|||
46953769|NCT04766996|83193609|FG000|Overall Study|Withdrawal by Subject|1|||
46953770|NCT04766996|83193610|FG001|Overall Study|Withdrawal by Subject|0|||
46953771|NCT04766996|83193611|FG002|Overall Study|Withdrawal by Subject|13|||
46953772|NCT02563028|83193617|FG000|Overall Study|Lack of equipment|1|||
46953773|NCT02563028|83193617|FG000|Overall Study|Unable to elicit VEP post induction|1|||
47066672|NCT01556438|83349328|FG001|Overall Study|Sponsor Decision|2|||
47066673|NCT01556438|83349327|FG000|Overall Study|Progressive Disease|0|||
47066674|NCT01556438|83349328|FG001|Overall Study|Progressive Disease|6|||
47066675|NCT01556438|83349327|FG000|Overall Study|Death|0|||
47066676|NCT01556438|83349328|FG001|Overall Study|Death|1|||
47066677|NCT01554176|83349354|FG000|Treatment Phase|Protocol Violation|1|||
47066678|NCT01554176|83349355|FG001|Treatment Phase|Protocol Violation|2|||
47066679|NCT01554176|83349356|FG002|Treatment Phase|Protocol Violation|0|||
47066680|NCT01554176|83349357|FG003|Treatment Phase|Protocol Violation|0|||
47066681|NCT01554176|83349358|FG004|Treatment Phase|Protocol Violation|0|||
47066682|NCT01554176|83349354|FG000|Treatment Phase|Physician Decision|1|||
46772485|NCT00437281|82990765|FG009|Overall Study|Adverse Event|1|||
46772486|NCT00437281|82990766|FG010|Overall Study|Adverse Event|0|||
46772487|NCT00437281|82990767|FG011|Overall Study|Adverse Event|0|||
46772488|NCT00437281|82990768|FG012|Overall Study|Adverse Event|0|||
46772489|NCT00437281|82990769|FG013|Overall Study|Adverse Event|1|||
46772490|NCT00437281|82990770|FG014|Overall Study|Adverse Event|1|||
46772491|NCT00437281|82990771|FG015|Overall Study|Adverse Event|0|||
46772492|NCT00437281|82990772|FG016|Overall Study|Adverse Event|0|||
46772493|NCT00437281|82990773|FG017|Overall Study|Adverse Event|0|||
46772494|NCT00437281|82990774|FG018|Overall Study|Adverse Event|1|||
46772495|NCT00437281|82990775|FG019|Overall Study|Adverse Event|0|||
46772496|NCT00437281|82990756|FG000|Overall Study|Lost to Follow-up|0|||
46772497|NCT00437281|82990757|FG001|Overall Study|Lost to Follow-up|0|||
46772498|NCT00437281|82990758|FG002|Overall Study|Lost to Follow-up|0|||
46772499|NCT00437281|82990759|FG003|Overall Study|Lost to Follow-up|0|||
46772500|NCT00437281|82990760|FG004|Overall Study|Lost to Follow-up|0|||
46772501|NCT00437281|82990761|FG005|Overall Study|Lost to Follow-up|0|||
46772502|NCT00437281|82990762|FG006|Overall Study|Lost to Follow-up|0|||
46772503|NCT00437281|82990763|FG007|Overall Study|Lost to Follow-up|0|||
46772504|NCT00437281|82990764|FG008|Overall Study|Lost to Follow-up|0|||
46772505|NCT00437281|82990765|FG009|Overall Study|Lost to Follow-up|0|||
46772506|NCT00437281|82990766|FG010|Overall Study|Lost to Follow-up|0|||
46772507|NCT00437281|82990767|FG011|Overall Study|Lost to Follow-up|0|||
46772508|NCT00437281|82990768|FG012|Overall Study|Lost to Follow-up|0|||
46772509|NCT00437281|82990769|FG013|Overall Study|Lost to Follow-up|0|||
46772510|NCT00437281|82990770|FG014|Overall Study|Lost to Follow-up|0|||
46772511|NCT00437281|82990771|FG015|Overall Study|Lost to Follow-up|0|||
46772512|NCT00437281|82990772|FG016|Overall Study|Lost to Follow-up|0|||
46772513|NCT00437281|82990773|FG017|Overall Study|Lost to Follow-up|0|||
46953774|NCT02192827|83193623|FG000|Overall Study|Lost to Follow-up|25|||
47066683|NCT01554176|83349355|FG001|Treatment Phase|Physician Decision|1|||
47066684|NCT01554176|83349356|FG002|Treatment Phase|Physician Decision|0|||
46639221|NCT01422876|82812772|FG001|Week 24|Death|1|||
46639222|NCT01422876|82812773|FG002|Week 24|Death|0|||
46639223|NCT01422876|82812774|FG003|Week 24|Death|0|||
46772514|NCT00437281|82990774|FG018|Overall Study|Lost to Follow-up|0|||
46772515|NCT00437281|82990775|FG019|Overall Study|Lost to Follow-up|1|||
46772516|NCT00741039|82990849|FG000|Overall Study|Patient non-compliance|2|||
46772517|NCT00741039|82990850|FG001|Overall Study|Patient non-compliance|0|||
46772518|NCT00772382|82990856|FG000|Overall Study|Adverse Event|19|||
46772519|NCT00772382|82990856|FG000|Overall Study|Death|6|||
46953775|NCT02192827|83193624|FG001|Overall Study|Lost to Follow-up|27|||
46953776|NCT02192827|83193623|FG000|Overall Study|Given additional steroids with admission|13|||
46953777|NCT02192827|83193624|FG001|Overall Study|Given additional steroids with admission|11|||
46953778|NCT02562482|83193632|FG000|Overall Study|Enrolled, but did not receive product|4|||
47066685|NCT01554176|83349357|FG003|Treatment Phase|Physician Decision|0|||
46772520|NCT00772382|82990856|FG000|Overall Study|Lack of Efficacy|4|||
46772521|NCT00772382|82990856|FG000|Overall Study|Physician Decision|5|||
46639224|NCT01422876|82812775|FG004|Week 24|Death|0|||
46772522|NCT00772382|82990856|FG000|Overall Study|Protocol Violation|1|||
46772523|NCT00772382|82990856|FG000|Overall Study|Withdrawal by Subject|10|||
46953779|NCT02562482|83193633|FG001|Overall Study|Enrolled, but did not receive product|0|||
46953780|NCT02562482|83193632|FG000|Overall Study|Lost to Follow-up|9|||
46953781|NCT02562482|83193633|FG001|Overall Study|Lost to Follow-up|6|||
46953782|NCT02562482|83193632|FG000|Overall Study|Moved from area|2|||
46953783|NCT02562482|83193633|FG001|Overall Study|Moved from area|3|||
46953784|NCT02562482|83193632|FG000|Overall Study|Withdrawal by Subject|5|||
46953785|NCT02562482|83193633|FG001|Overall Study|Withdrawal by Subject|3|||
46953786|NCT02562482|83193632|FG000|Overall Study|Physician Decision|1|||
46953787|NCT02562482|83193633|FG001|Overall Study|Physician Decision|3|||
46953788|NCT02562482|83193632|FG000|Overall Study|Illness/Injury unrelated to product|0|||
46953789|NCT02562482|83193633|FG001|Overall Study|Illness/Injury unrelated to product|1|||
46953790|NCT02568254|83193648|FG000|Period 2|Adverse Event|0|||
46953791|NCT02568254|83193649|FG001|Period 2|Adverse Event|0|||
46953792|NCT02568254|83193650|FG002|Period 2|Adverse Event|1|||
46953793|NCT02568254|83193651|FG003|Period 2|Adverse Event|0|||
46953794|NCT02568254|83193652|FG004|Period 2|Adverse Event|0|||
46953795|NCT02568254|83193653|FG005|Period 2|Adverse Event|0|||
46953796|NCT02568254|83193648|FG000|Period 3|Unstatisfactory Lens fitting|0|||
46953797|NCT02568254|83193649|FG001|Period 3|Unstatisfactory Lens fitting|0|||
46953798|NCT02568254|83193650|FG002|Period 3|Unstatisfactory Lens fitting|0|||
46953799|NCT02568254|83193651|FG003|Period 3|Unstatisfactory Lens fitting|0|||
46953800|NCT02568254|83193652|FG004|Period 3|Unstatisfactory Lens fitting|1|||
46953801|NCT02568254|83193653|FG005|Period 3|Unstatisfactory Lens fitting|0|||
46953802|NCT02567708|83193661|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
46953803|NCT02567708|83193662|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
46953804|NCT02567708|83193661|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
46953805|NCT02567708|83193662|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
46953806|NCT02567708|83193661|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
46953807|NCT02567708|83193662|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
46953808|NCT02567708|83193661|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
46953809|NCT02567708|83193662|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
46953810|NCT02562716|83193671|FG000|Overall Study|Adverse Event|7|||
46953811|NCT02562716|83193672|FG001|Overall Study|Adverse Event|14|||
46953812|NCT02562716|83193671|FG000|Overall Study|Withdrawal unrelated to AE|7|||
46953813|NCT02562716|83193672|FG001|Overall Study|Withdrawal unrelated to AE|1|||
46843374|NCT03769090|83060355|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
46843375|NCT03769090|83060356|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
46843376|NCT03769090|83060357|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
46843377|NCT03769090|83060355|FG000|Overall Study|Withdrawal by Subject|52|||
46843378|NCT03769090|83060356|FG001|Overall Study|Withdrawal by Subject|62|||
46953814|NCT02562716|83193671|FG000|Overall Study|Progression|8|||
46953815|NCT02562716|83193672|FG001|Overall Study|Progression|10|||
46953816|NCT02562716|83193671|FG000|Overall Study|Death|2|||
46953817|NCT02562716|83193672|FG001|Overall Study|Death|1|||
46953818|NCT02562716|83193671|FG000|Overall Study|Not protocol specified|4|||
46953819|NCT02562716|83193672|FG001|Overall Study|Not protocol specified|2|||
46953820|NCT02751931|83193682|FG000|Overall Study|Adverse Event|3|||
46953821|NCT02751931|83193683|FG001|Overall Study|Adverse Event|0|||
46639225|NCT01422876|82812776|FG005|Week 24|Death|0|||
46639226|NCT01422876|82812777|FG006|Week 24|Death|0|||
46639227|NCT01422876|82812778|FG007|Week 24|Death|0|||
46639228|NCT01422876|82812779|FG008|Week 24|Death|0|||
46772524|NCT00772382|82990856|FG000|Overall Study|Other Reasons|10|||
46772525|NCT00798707|82990863|FG000|Overall Study|Adverse Event|6|||
46772526|NCT00798707|82990864|FG001|Overall Study|Adverse Event|8|||
46772527|NCT00798707|82990865|FG002|Overall Study|Adverse Event|8|||
46772528|NCT00798707|82990863|FG000|Overall Study|Failed to return|2|||
46772529|NCT00798707|82990864|FG001|Overall Study|Failed to return|2|||
46772530|NCT00798707|82990865|FG002|Overall Study|Failed to return|0|||
46772531|NCT00798707|82990863|FG000|Overall Study|Investigator|0|||
46843379|NCT03769090|83060357|FG002|Overall Study|Withdrawal by Subject|74|||
46843380|NCT03769090|83060355|FG000|Overall Study|Death|4|||
46953822|NCT02751931|83193682|FG000|Overall Study|Other: Miscelleneous|10|||
46953823|NCT02751931|83193683|FG001|Overall Study|Other: Miscelleneous|8|||
46953824|NCT02561156|83193708|FG000|Part 2|Adverse Event|0|||
46953825|NCT02561156|83193709|FG001|Part 2|Adverse Event|0|||
46639229|NCT01422876|82812780|FG009|Week 24|Death|0|||
46639230|NCT01422876|82812771|FG000|Week 52|Lost to Follow-up|3|||
46772532|NCT00798707|82990864|FG001|Overall Study|Investigator|1|||
46953826|NCT02561156|83193710|FG002|Part 2|Adverse Event|0|||
46953827|NCT02561156|83193711|FG003|Part 2|Adverse Event|0|||
46953828|NCT02561156|83193712|FG004|Part 2|Adverse Event|0|||
46953829|NCT02561156|83193713|FG005|Part 2|Adverse Event|0|||
46953830|NCT02561156|83193714|FG006|Part 2|Adverse Event|0|||
46953831|NCT02561156|83193715|FG007|Part 2|Adverse Event|0|||
46953832|NCT02561156|83193716|FG008|Part 2|Adverse Event|0|||
46953833|NCT02561156|83193717|FG009|Part 2|Adverse Event|0|||
46953834|NCT02561156|83193718|FG010|Part 2|Adverse Event|0|||
46639231|NCT01422876|82812772|FG001|Week 52|Lost to Follow-up|5|||
46639232|NCT01422876|82812773|FG002|Week 52|Lost to Follow-up|7|||
46639233|NCT01422876|82812774|FG003|Week 52|Lost to Follow-up|5|||
46639234|NCT01422876|82812775|FG004|Week 52|Lost to Follow-up|8|||
46639235|NCT01422876|82812776|FG005|Week 52|Lost to Follow-up|5|||
46639236|NCT01422876|82812777|FG006|Week 52|Lost to Follow-up|5|||
46639237|NCT01422876|82812778|FG007|Week 52|Lost to Follow-up|8|||
46639238|NCT01422876|82812779|FG008|Week 52|Lost to Follow-up|7|||
46639239|NCT01422876|82812780|FG009|Week 52|Lost to Follow-up|8|||
46639240|NCT01422876|82812771|FG000|Week 52|Consent withdrawn|9|||
46639241|NCT01422876|82812772|FG001|Week 52|Consent withdrawn|4|||
46639242|NCT01422876|82812773|FG002|Week 52|Consent withdrawn|6|||
46639243|NCT01422876|82812774|FG003|Week 52|Consent withdrawn|12|||
46639244|NCT01422876|82812775|FG004|Week 52|Consent withdrawn|7|||
46639245|NCT01422876|82812776|FG005|Week 52|Consent withdrawn|12|||
46639246|NCT01422876|82812777|FG006|Week 52|Consent withdrawn|10|||
46639247|NCT01422876|82812778|FG007|Week 52|Consent withdrawn|12|||
46639248|NCT01422876|82812779|FG008|Week 52|Consent withdrawn|13|||
46639249|NCT01422876|82812780|FG009|Week 52|Consent withdrawn|9|||
46639250|NCT01422876|82812771|FG000|Week 52|Death|0|||
46639251|NCT01422876|82812772|FG001|Week 52|Death|1|||
46953835|NCT02561156|83193719|FG011|Part 2|Adverse Event|1|||
46953836|NCT02561156|83193720|FG012|Part 2|Adverse Event|0|||
46953837|NCT02561078|83193766|FG000|Overall Study|Adverse Event|5|||
46953838|NCT02561078|83193767|FG001|Overall Study|Adverse Event|2|||
46953839|NCT02561078|83193766|FG000|Overall Study|Death|2|||
46953840|NCT02561078|83193767|FG001|Overall Study|Death|1|||
46953841|NCT02561078|83193766|FG000|Overall Study|Lost to Follow-up|2|||
46953842|NCT02561078|83193767|FG001|Overall Study|Lost to Follow-up|6|||
46953843|NCT02561078|83193766|FG000|Overall Study|Non-Compliance with Study Drug|6|||
46953844|NCT02561078|83193767|FG001|Overall Study|Non-Compliance with Study Drug|3|||
46953845|NCT02561078|83193766|FG000|Overall Study|Physician Decision|2|||
46953846|NCT02561078|83193767|FG001|Overall Study|Physician Decision|3|||
46772533|NCT00798707|82990865|FG002|Overall Study|Investigator|2|||
46772534|NCT00798707|82990863|FG000|Overall Study|Lack of Efficacy|2|||
46772535|NCT00798707|82990864|FG001|Overall Study|Lack of Efficacy|2|||
46772536|NCT00798707|82990865|FG002|Overall Study|Lack of Efficacy|1|||
46772537|NCT00798707|82990863|FG000|Overall Study|Lost to Follow-up|5|||
46772538|NCT00798707|82990864|FG001|Overall Study|Lost to Follow-up|6|||
46772539|NCT00798707|82990865|FG002|Overall Study|Lost to Follow-up|6|||
46772540|NCT00798707|82990863|FG000|Overall Study|Other|0|||
46772541|NCT00798707|82990864|FG001|Overall Study|Other|1|||
46772542|NCT00798707|82990865|FG002|Overall Study|Other|0|||
46772543|NCT00798707|82990863|FG000|Overall Study|Protocol Violation|4|||
46772544|NCT00798707|82990864|FG001|Overall Study|Protocol Violation|0|||
46772545|NCT00798707|82990865|FG002|Overall Study|Protocol Violation|2|||
46772546|NCT00798707|82990863|FG000|Overall Study|Withdrawal by Subject|3|||
46772547|NCT00798707|82990864|FG001|Overall Study|Withdrawal by Subject|8|||
46953847|NCT02561078|83193766|FG000|Overall Study|Withdrawal by Subject|13|||
46953848|NCT02561078|83193767|FG001|Overall Study|Withdrawal by Subject|10|||
46953849|NCT04881448|83193773|FG000|Overall Study|Study cancelled by sponsor|220|||
46953850|NCT04881448|83193773|FG000|Overall Study|Withdrawal by Subject|2|||
46953851|NCT04881448|83193773|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
46953852|NCT04275310|83193804|FG000|Overall Study|Non-randomized due to running out of funding|4|||
46953853|NCT04275310|83193805|FG001|Overall Study|Non-randomized due to running out of funding|0|||
46953854|NCT04157088|83193811|FG000|Overall Study|Study terminated by sponsor|23|||
46953855|NCT04157088|83193811|FG000|Overall Study|Withdrawal by Subject|4|||
46953856|NCT04157088|83193811|FG000|Overall Study|Lost to Follow-up|2|||
46953857|NCT04157088|83193811|FG000|Overall Study|Death|1|||
46953858|NCT04140266|83193819|FG000|Overall Study|Physician Decision|2|||
46639252|NCT01422876|82812773|FG002|Week 52|Death|0|||
46639253|NCT01422876|82812774|FG003|Week 52|Death|1|||
46639254|NCT01422876|82812775|FG004|Week 52|Death|0|||
46639255|NCT01422876|82812776|FG005|Week 52|Death|0|||
46639256|NCT01422876|82812777|FG006|Week 52|Death|1|||
46639257|NCT01422876|82812778|FG007|Week 52|Death|3|||
46639258|NCT01422876|82812779|FG008|Week 52|Death|1|||
46639259|NCT01422876|82812780|FG009|Week 52|Death|0|||
46772548|NCT00798707|82990865|FG002|Overall Study|Withdrawal by Subject|2|||
46772549|NCT00798707|82990863|FG000|Overall Study|Randomized not treated|4|||
46639260|NCT01422720|82812798|FG000|Overall Study|Adverse Event|16|||
46639261|NCT01422720|82812798|FG000|Overall Study|Lack of Efficacy|1|||
46639262|NCT01422720|82812798|FG000|Overall Study|Withdrawal by Subject|4|||
46772550|NCT00798707|82990864|FG001|Overall Study|Randomized not treated|5|||
46953859|NCT04140266|83193820|FG001|Overall Study|Physician Decision|0|||
46639263|NCT01422720|82812798|FG000|Overall Study|Ineligibility|1|||
46639264|NCT01387932|82812808|FG000|Randomized and Treated|Physician Decision|3|||
46639265|NCT01387932|82812809|FG001|Randomized and Treated|Physician Decision|2|||
46639266|NCT01387932|82812808|FG000|Randomized and Treated|Withdrawal by Subject|4|||
46953860|NCT04140266|83193819|FG000|Overall Study|Withdrawal by Subject|4|||
46953861|NCT04140266|83193820|FG001|Overall Study|Withdrawal by Subject|2|||
46953862|NCT03926143|83193843|FG000|Overall Study|Physician Decision|3|||
46953863|NCT03926143|83193843|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
46953864|NCT03926143|83193843|FG000|Overall Study|Adverse Event|2|||
46953865|NCT03926143|83193843|FG000|Overall Study|Progressive disease|3|||
46953866|NCT03018080|83193860|FG000|Overall Study|Death|12|||
46953867|NCT03018080|83193861|FG001|Overall Study|Death|19|||
46953868|NCT02781090|83193869|FG000|3-Month Follow-Up|Missed Visit|20|||
46953869|NCT02781090|83193870|FG001|3-Month Follow-Up|Missed Visit|20|||
46953870|NCT02781090|83193869|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
46953871|NCT02781090|83193870|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
46953872|NCT02781090|83193869|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
46953873|NCT02781090|83193870|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
46953874|NCT02781090|83193869|FG000|3-Month Follow-Up|Death|1|||
46953875|NCT02781090|83193870|FG001|3-Month Follow-Up|Death|0|||
46953876|NCT02781090|83193869|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
46953877|NCT02781090|83193870|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
46953878|NCT02781090|83193869|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
46953879|NCT02781090|83193870|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
46953880|NCT02781090|83193869|FG000|6-Month Follow-Up|Death|0|||
46953881|NCT02781090|83193870|FG001|6-Month Follow-Up|Death|1|||
46953882|NCT02774291|83193878|FG000|Overall Study|Lost to Follow-up|1|||
46953883|NCT01207778|83193886|FG000|Overall Study|Lost to Follow-up|0|||
46953884|NCT01207778|83193887|FG001|Overall Study|Lost to Follow-up|3|||
46953885|NCT01207778|83193888|FG002|Overall Study|Lost to Follow-up|3|||
46953886|NCT02567552|83193898|FG000|Overall Study|Adverse Event|0|||
46953887|NCT02567552|83193899|FG001|Overall Study|Adverse Event|1|||
46953888|NCT02561000|83193913|FG000|Overall Study|Withdrawal by Subject|2|||
46953889|NCT02561000|83193914|FG001|Overall Study|Withdrawal by Subject|3|||
46953890|NCT02561000|83193915|FG002|Overall Study|Withdrawal by Subject|0|||
46953891|NCT02561000|83193913|FG000|Overall Study|Adverse Event|0|||
46953892|NCT02561000|83193914|FG001|Overall Study|Adverse Event|1|||
46953893|NCT02561000|83193915|FG002|Overall Study|Adverse Event|0|||
46953894|NCT01663532|83193925|FG000|Overall Study|Lost to Follow-up|9|||
46953895|NCT01663532|83193926|FG001|Overall Study|Lost to Follow-up|10|||
46953896|NCT01663532|83193925|FG000|Overall Study|Adverse Event|7|||
46953897|NCT01663532|83193926|FG001|Overall Study|Adverse Event|13|||
46953898|NCT01663532|83193925|FG000|Overall Study|Met Withdrawal Criteria|7|||
46953899|NCT01663532|83193926|FG001|Overall Study|Met Withdrawal Criteria|6|||
46953900|NCT01663532|83193925|FG000|Overall Study|Physician Decision|1|||
46953901|NCT01663532|83193926|FG001|Overall Study|Physician Decision|1|||
46953902|NCT01663532|83193925|FG000|Overall Study|Withdrawal by Subject|35|||
46953903|NCT01663532|83193926|FG001|Overall Study|Withdrawal by Subject|17|||
46953904|NCT01663532|83193925|FG000|Overall Study|Lack of Efficacy|15|||
46953905|NCT01663532|83193926|FG001|Overall Study|Lack of Efficacy|60|||
46953906|NCT02525939|83193934|FG000|Overall Study|Lost to Follow-up|27|||
46953907|NCT02525939|83193935|FG001|Overall Study|Lost to Follow-up|24|||
46953908|NCT02525939|83193934|FG000|Overall Study|Physician Decision|0|||
46953909|NCT02525939|83193935|FG001|Overall Study|Physician Decision|1|||
46953910|NCT02525939|83193934|FG000|Overall Study|Withdrawal by Subject|24|||
46953911|NCT02525939|83193935|FG001|Overall Study|Withdrawal by Subject|39|||
46639267|NCT01387932|82812809|FG001|Randomized and Treated|Withdrawal by Subject|2|||
46639268|NCT01387932|82812808|FG000|Survival Follow-up|Liver Transplant|24|||
46772551|NCT00798707|82990865|FG002|Overall Study|Randomized not treated|1|||
46772552|NCT00760214|82990876|FG000|Overall Study|Adverse Event|8|||
46772553|NCT00760214|82990877|FG001|Overall Study|Adverse Event|9|||
46772554|NCT00760214|82990878|FG002|Overall Study|Adverse Event|12|||
46772555|NCT00760214|82990876|FG000|Overall Study|Protocol Violation|3|||
46772556|NCT00760214|82990877|FG001|Overall Study|Protocol Violation|0|||
46772557|NCT00760214|82990878|FG002|Overall Study|Protocol Violation|3|||
46772558|NCT00760214|82990876|FG000|Overall Study|Lost to Follow-up|0|||
46772559|NCT00760214|82990877|FG001|Overall Study|Lost to Follow-up|0|||
46772560|NCT00760214|82990878|FG002|Overall Study|Lost to Follow-up|1|||
46772561|NCT00760214|82990876|FG000|Overall Study|Withdrawal by Subject|12|||
46772562|NCT00760214|82990877|FG001|Overall Study|Withdrawal by Subject|14|||
46772563|NCT00760214|82990878|FG002|Overall Study|Withdrawal by Subject|13|||
46772564|NCT00760214|82990876|FG000|Overall Study|Lack of Efficacy|3|||
46953912|NCT02525939|83193934|FG000|Overall Study|Death|180|||
46953913|NCT02525939|83193935|FG001|Overall Study|Death|179|||
46953914|NCT02697591|83193972|FG000|Overall Study|Lost to Follow-up|0|||
46953915|NCT02697591|83193973|FG001|Overall Study|Lost to Follow-up|0|||
46953916|NCT02697591|83193974|FG002|Overall Study|Lost to Follow-up|0|||
46953917|NCT02697591|83193975|FG003|Overall Study|Lost to Follow-up|0|||
46953918|NCT02697591|83193976|FG004|Overall Study|Lost to Follow-up|0|||
46772565|NCT00760214|82990877|FG001|Overall Study|Lack of Efficacy|2|||
46772566|NCT00760214|82990878|FG002|Overall Study|Lack of Efficacy|4|||
46772567|NCT00760214|82990876|FG000|Overall Study|Pregnancy|0|||
46772568|NCT00760214|82990877|FG001|Overall Study|Pregnancy|0|||
46953919|NCT02697591|83193977|FG005|Overall Study|Lost to Follow-up|1|||
46953920|NCT02697591|83193978|FG006|Overall Study|Lost to Follow-up|1|||
46953921|NCT02697591|83193979|FG007|Overall Study|Lost to Follow-up|0|||
46953922|NCT02697591|83193980|FG008|Overall Study|Lost to Follow-up|0|||
46953923|NCT02697591|83193981|FG009|Overall Study|Lost to Follow-up|1|||
46953924|NCT02697591|83193972|FG000|Overall Study|Withdrawal by Subject|1|||
46953925|NCT02697591|83193973|FG001|Overall Study|Withdrawal by Subject|1|||
46953926|NCT02697591|83193974|FG002|Overall Study|Withdrawal by Subject|2|||
46953927|NCT02697591|83193975|FG003|Overall Study|Withdrawal by Subject|1|||
46953928|NCT02697591|83193976|FG004|Overall Study|Withdrawal by Subject|7|||
46953929|NCT02697591|83193977|FG005|Overall Study|Withdrawal by Subject|6|||
46953930|NCT02697591|83193978|FG006|Overall Study|Withdrawal by Subject|9|||
46953931|NCT02697591|83193979|FG007|Overall Study|Withdrawal by Subject|1|||
46953932|NCT02697591|83193980|FG008|Overall Study|Withdrawal by Subject|6|||
46953933|NCT02697591|83193981|FG009|Overall Study|Withdrawal by Subject|10|||
46953934|NCT02697591|83193972|FG000|Overall Study|Physician Decision|1|||
46953935|NCT02697591|83193973|FG001|Overall Study|Physician Decision|0|||
46953936|NCT02697591|83193974|FG002|Overall Study|Physician Decision|0|||
46953937|NCT02697591|83193975|FG003|Overall Study|Physician Decision|0|||
46953938|NCT02697591|83193976|FG004|Overall Study|Physician Decision|1|||
46953939|NCT02697591|83193977|FG005|Overall Study|Physician Decision|2|||
46953940|NCT02697591|83193978|FG006|Overall Study|Physician Decision|0|||
46953941|NCT02697591|83193979|FG007|Overall Study|Physician Decision|0|||
46953942|NCT02697591|83193980|FG008|Overall Study|Physician Decision|1|||
46953943|NCT02697591|83193981|FG009|Overall Study|Physician Decision|1|||
46953944|NCT02697591|83193972|FG000|Overall Study|Death|2|||
46953945|NCT02697591|83193973|FG001|Overall Study|Death|3|||
46953946|NCT02697591|83193974|FG002|Overall Study|Death|1|||
46953947|NCT02697591|83193975|FG003|Overall Study|Death|1|||
46953948|NCT02697591|83193976|FG004|Overall Study|Death|4|||
46953949|NCT02697591|83193977|FG005|Overall Study|Death|5|||
46953950|NCT02697591|83193978|FG006|Overall Study|Death|3|||
46953951|NCT02697591|83193979|FG007|Overall Study|Death|1|||
46953952|NCT02697591|83193980|FG008|Overall Study|Death|1|||
46953953|NCT02697591|83193981|FG009|Overall Study|Death|5|||
46953954|NCT02697591|83193972|FG000|Overall Study|Reason not Specified|0|||
46953955|NCT02697591|83193973|FG001|Overall Study|Reason not Specified|0|||
46953956|NCT02697591|83193974|FG002|Overall Study|Reason not Specified|0|||
46953957|NCT02697591|83193975|FG003|Overall Study|Reason not Specified|1|||
46953958|NCT02697591|83193976|FG004|Overall Study|Reason not Specified|1|||
46953959|NCT02697591|83193977|FG005|Overall Study|Reason not Specified|2|||
46953960|NCT02697591|83193978|FG006|Overall Study|Reason not Specified|3|||
46953961|NCT02697591|83193979|FG007|Overall Study|Reason not Specified|1|||
46953962|NCT02697591|83193980|FG008|Overall Study|Reason not Specified|1|||
46953963|NCT02697591|83193981|FG009|Overall Study|Reason not Specified|3|||
46953964|NCT02697435|83194006|FG000|Overall Study|Withdrawal by Subject|1|||
46953965|NCT02697435|83194007|FG001|Overall Study|Withdrawal by Subject|0|||
46953966|NCT02697435|83194006|FG000|Overall Study|Physician Decision|0|||
46953967|NCT02697435|83194007|FG001|Overall Study|Physician Decision|4|||
46953968|NCT02174861|83194014|FG000|Overall Study|Decision by sponsor|8|||
46953969|NCT02174861|83194014|FG000|Overall Study|Withdrawal by Subject|124|||
46953970|NCT02174861|83194014|FG000|Overall Study|Lost to Follow-up|26|||
46953971|NCT00140855|83194020|FG000|Overall Study|Progressive disease|2|||
46953972|NCT00700635|83194027|FG000|Overall Study|Adverse Event|1|||
46953973|NCT00700635|83194028|FG001|Overall Study|Adverse Event|0|||
46953974|NCT00700635|83194029|FG002|Overall Study|Adverse Event|0|||
46953975|NCT00700635|83194027|FG000|Overall Study|Lost to Follow-up|1|||
46953976|NCT00700635|83194028|FG001|Overall Study|Lost to Follow-up|3|||
46953977|NCT00700635|83194029|FG002|Overall Study|Lost to Follow-up|0|||
46953978|NCT00700635|83194027|FG000|Overall Study|Protocol Violation|2|||
47066686|NCT01554176|83349358|FG004|Treatment Phase|Physician Decision|0|||
47066687|NCT01554176|83349354|FG000|Treatment Phase|Lack of Efficacy|0|||
47066688|NCT01554176|83349355|FG001|Treatment Phase|Lack of Efficacy|1|||
47066689|NCT01554176|83349356|FG002|Treatment Phase|Lack of Efficacy|0|||
47066690|NCT01554176|83349357|FG003|Treatment Phase|Lack of Efficacy|0|||
46953979|NCT00700635|83194028|FG001|Overall Study|Protocol Violation|2|||
46953980|NCT00700635|83194029|FG002|Overall Study|Protocol Violation|0|||
47066691|NCT01554176|83349358|FG004|Treatment Phase|Lack of Efficacy|0|||
47066692|NCT01554176|83349354|FG000|Treatment Phase|Adverse event, non-fatal|1|||
47066693|NCT01554176|83349355|FG001|Treatment Phase|Adverse event, non-fatal|1|||
46953981|NCT00700635|83194027|FG000|Overall Study|Withdrawal by Subject|7|||
46953982|NCT00700635|83194028|FG001|Overall Study|Withdrawal by Subject|3|||
46953983|NCT00700635|83194029|FG002|Overall Study|Withdrawal by Subject|1|||
46953984|NCT02780687|83194039|FG000|Overall Study|Adverse Event|1|||
46953985|NCT02780687|83194040|FG001|Overall Study|Adverse Event|1|||
46953986|NCT02780687|83194039|FG000|Overall Study|Withdrawal by Subject|2|||
46953987|NCT02780687|83194040|FG001|Overall Study|Withdrawal by Subject|1|||
46953988|NCT02780687|83194039|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
46953989|NCT02780687|83194040|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
46953990|NCT02780687|83194039|FG000|Overall Study|progressive disease|29|||
46953991|NCT02780687|83194040|FG001|Overall Study|progressive disease|6|||
46953992|NCT02698371|83194045|FG000|All Participants Flow|Lost to Follow-up|3|||
47066694|NCT01554176|83349356|FG002|Treatment Phase|Adverse event, non-fatal|0|||
46953993|NCT02698371|83194045|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
46953994|NCT02698371|83194045|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
46953995|NCT02698371|83194045|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
46953996|NCT02698371|83194045|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
46953997|NCT02698371|83194045|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
46953998|NCT02698371|83194045|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
46953999|NCT02781311|83194064|FG000|Overall Study|Adverse Event|2|||
46954000|NCT02781311|83194065|FG001|Overall Study|Adverse Event|6|||
46954001|NCT02781311|83194066|FG002|Overall Study|Adverse Event|1|||
46954002|NCT02781311|83194064|FG000|Overall Study|Withdrawal of Consent|11|||
46954003|NCT02781311|83194065|FG001|Overall Study|Withdrawal of Consent|12|||
46954004|NCT02781311|83194066|FG002|Overall Study|Withdrawal of Consent|2|||
46954005|NCT02781311|83194064|FG000|Overall Study|Lost to Follow-up|11|||
46954006|NCT02781311|83194065|FG001|Overall Study|Lost to Follow-up|8|||
46772569|NCT00760214|82990878|FG002|Overall Study|Pregnancy|1|||
46954007|NCT02781311|83194066|FG002|Overall Study|Lost to Follow-up|1|||
46954008|NCT02781311|83194064|FG000|Overall Study|Non-Compliance with Study Drug|2|||
46954009|NCT02781311|83194065|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46954010|NCT02781311|83194066|FG002|Overall Study|Non-Compliance with Study Drug|0|||
46954011|NCT02564198|83194076|FG000|Overall Study|Withdrawal by Subject|2|||
46772570|NCT00760214|82990876|FG000|Overall Study|Physician Decision|1|||
46843381|NCT03769090|83060356|FG001|Overall Study|Death|2|||
46772571|NCT00760214|82990877|FG001|Overall Study|Physician Decision|1|||
46772572|NCT00760214|82990878|FG002|Overall Study|Physician Decision|1|||
46772573|NCT00760214|82990876|FG000|Overall Study|Other|3|||
46772574|NCT00760214|82990877|FG001|Overall Study|Other|4|||
46772575|NCT00760214|82990878|FG002|Overall Study|Other|6|||
46772576|NCT00802841|82990888|FG000|Overall Study|Administrative problems|1|||
46772577|NCT00802841|82990889|FG001|Overall Study|Administrative problems|0|||
46954012|NCT02564198|83194077|FG001|Overall Study|Withdrawal by Subject|4|||
46954013|NCT02564198|83194078|FG002|Overall Study|Withdrawal by Subject|0|||
46954014|NCT02564198|83194076|FG000|Overall Study|Adverse Event|0|||
46954015|NCT02564198|83194077|FG001|Overall Study|Adverse Event|1|||
46954016|NCT02564198|83194078|FG002|Overall Study|Adverse Event|0|||
46954017|NCT02564120|83194093|FG000|Overall Study|Did not return release forms|160|||
46954018|NCT02564120|83194093|FG000|Overall Study|Death|58|||
46772578|NCT00802841|82990888|FG000|Overall Study|Lost to Follow-up|2|||
46772579|NCT00802841|82990889|FG001|Overall Study|Lost to Follow-up|1|||
46772580|NCT00802841|82990888|FG000|Overall Study|Death|1|||
46772581|NCT00802841|82990889|FG001|Overall Study|Death|2|||
46772582|NCT00802841|82990888|FG000|Overall Study|Adverse Event|8|||
46772583|NCT00802841|82990889|FG001|Overall Study|Adverse Event|2|||
46772584|NCT00802841|82990888|FG000|Overall Study|Disease progression|7|||
46772585|NCT00802841|82990889|FG001|Overall Study|Disease progression|3|||
46772586|NCT00802841|82990888|FG000|Overall Study|Withdrawal by Subject|9|||
46772587|NCT00802841|82990889|FG001|Overall Study|Withdrawal by Subject|5|||
46772588|NCT00802841|82990888|FG000|Overall Study|Protocol deviation|2|||
46772589|NCT00802841|82990889|FG001|Overall Study|Protocol deviation|6|||
46772590|NCT00802841|82990888|FG000|Overall Study|Treatment duration completed|66|||
46772591|NCT00802841|82990889|FG001|Overall Study|Treatment duration completed|76|||
46772592|NCT00772148|82990899|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
46772593|NCT00772148|82990900|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
46772594|NCT00772148|82990899|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
46772595|NCT00772148|82990900|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
46772596|NCT00772148|82990899|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
46772597|NCT00772148|82990900|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
46772598|NCT00772148|82990899|FG000|Maintenance Phase (Week 52)|Death|2|||
46772599|NCT00772148|82990900|FG001|Maintenance Phase (Week 52)|Death|2|||
46772600|NCT00772148|82990899|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
46772601|NCT00772148|82990900|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
46772602|NCT00772148|82990899|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
46843382|NCT03769090|83060357|FG002|Overall Study|Death|2|||
46772603|NCT00772148|82990900|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
46843383|NCT03769090|83060355|FG000|Overall Study|Adverse Event|7|||
46843384|NCT03769090|83060356|FG001|Overall Study|Adverse Event|7|||
46954019|NCT02564120|83194093|FG000|Overall Study|Withdrawal by Subject|204|||
46954020|NCT02564120|83194093|FG000|Overall Study|Other medical condition|24|||
46954021|NCT00705783|83194109|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
46954022|NCT00705783|83194110|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
46954023|NCT00705783|83194111|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
46954024|NCT00705783|83194109|FG000|Conversion Phase|Lost to Follow-up|13|||
46772604|NCT00772148|82990899|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
46772605|NCT00772148|82990900|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
46772606|NCT00759902|82990908|FG000|Overall Study|Adverse Event|0|||
46772607|NCT00759902|82990909|FG001|Overall Study|Adverse Event|1|||
46843385|NCT03769090|83060357|FG002|Overall Study|Adverse Event|8|||
46954025|NCT00705783|83194110|FG001|Conversion Phase|Lost to Follow-up|0|||
46954026|NCT00705783|83194111|FG002|Conversion Phase|Lost to Follow-up|0|||
46954027|NCT00705783|83194109|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
46954028|NCT00705783|83194110|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
46954029|NCT00705783|83194111|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
46954030|NCT00705783|83194109|FG000|Conversion Phase|Withdrawn by Investigator|4|||
46954031|NCT00705783|83194110|FG001|Conversion Phase|Withdrawn by Investigator|0|||
46954032|NCT00705783|83194111|FG002|Conversion Phase|Withdrawn by Investigator|0|||
46954033|NCT00705783|83194109|FG000|Conversion Phase|Withdrew Consent|24|||
46954034|NCT00705783|83194110|FG001|Conversion Phase|Withdrew Consent|0|||
46954035|NCT00705783|83194111|FG002|Conversion Phase|Withdrew Consent|0|||
46954036|NCT00705783|83194109|FG000|Conversion Phase|Protocol Deviation|2|||
46954037|NCT00705783|83194110|FG001|Conversion Phase|Protocol Deviation|0|||
46954038|NCT00705783|83194111|FG002|Conversion Phase|Protocol Deviation|0|||
46954039|NCT00705783|83194109|FG000|Conversion Phase|Adverse Event|11|||
46954040|NCT00705783|83194110|FG001|Conversion Phase|Adverse Event|0|||
46954041|NCT00705783|83194111|FG002|Conversion Phase|Adverse Event|0|||
46954042|NCT00705783|83194109|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
46954043|NCT00705783|83194110|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
46843386|NCT03769090|83060355|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
46843387|NCT03769090|83060356|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
46843388|NCT03769090|83060357|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
46843389|NCT03769090|83060355|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
46843390|NCT03769090|83060356|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
46954044|NCT00705783|83194111|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
46954045|NCT00705783|83194109|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
46954046|NCT00705783|83194110|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
46954047|NCT00705783|83194111|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
46954048|NCT00705783|83194109|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
46954049|NCT00705783|83194110|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
46954050|NCT00705783|83194111|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
46954051|NCT00705783|83194109|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
46954052|NCT00705783|83194110|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
46954053|NCT00705783|83194111|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
46954054|NCT00705783|83194109|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
46954055|NCT00705783|83194110|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
46954056|NCT00705783|83194111|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
46954057|NCT00705783|83194109|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
46954058|NCT00705783|83194110|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
46954059|NCT00705783|83194111|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
46954060|NCT00705783|83194109|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
46954061|NCT00705783|83194110|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
46954062|NCT00705783|83194111|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
46954063|NCT00705783|83194109|FG000|Oral Stabilization Phase|Adverse Event|14|||
46954064|NCT00705783|83194110|FG001|Oral Stabilization Phase|Adverse Event|0|||
46954065|NCT00705783|83194111|FG002|Oral Stabilization Phase|Adverse Event|0|||
46954066|NCT00705783|83194109|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
46954067|NCT00705783|83194110|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
46954068|NCT00705783|83194111|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
46954069|NCT00705783|83194109|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
46954070|NCT00705783|83194110|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
46954071|NCT00705783|83194111|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
46954072|NCT00705783|83194109|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
47066695|NCT01554176|83349357|FG003|Treatment Phase|Adverse event, non-fatal|0|||
47066696|NCT01554176|83349358|FG004|Treatment Phase|Adverse event, non-fatal|0|||
47066697|NCT01554176|83349354|FG000|Treatment Phase|Non-compliance with study drug|1|||
47066698|NCT01554176|83349355|FG001|Treatment Phase|Non-compliance with study drug|0|||
46843391|NCT03769090|83060357|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
46843392|NCT03769090|83060355|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
46843393|NCT03769090|83060356|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
46843394|NCT03769090|83060357|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
46954073|NCT00705783|83194110|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
46954074|NCT00705783|83194111|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
47066699|NCT01554176|83349356|FG002|Treatment Phase|Non-compliance with study drug|0|||
46954075|NCT00705783|83194109|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
46954076|NCT00705783|83194110|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
46954077|NCT00705783|83194111|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
46954078|NCT00705783|83194109|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
47066700|NCT01554176|83349357|FG003|Treatment Phase|Non-compliance with study drug|0|||
46954079|NCT00705783|83194110|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
46954080|NCT00705783|83194111|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
46954081|NCT00705783|83194109|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
46954082|NCT00705783|83194110|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
46954083|NCT00705783|83194111|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
46954084|NCT00705783|83194109|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
46954085|NCT00705783|83194110|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
46954086|NCT00705783|83194111|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
46954087|NCT00705783|83194109|FG000|Depot Stabilization Phase|Adverse Event|17|||
46954088|NCT00705783|83194110|FG001|Depot Stabilization Phase|Adverse Event|0|||
46954089|NCT00705783|83194111|FG002|Depot Stabilization Phase|Adverse Event|0|||
46954090|NCT00705783|83194109|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
46954091|NCT00705783|83194110|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
46954092|NCT00705783|83194111|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
46954093|NCT00705783|83194109|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
46954094|NCT00705783|83194110|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
46954095|NCT00705783|83194111|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
46954096|NCT00705783|83194109|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
46954097|NCT00705783|83194110|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
46954098|NCT00705783|83194111|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
46954099|NCT00705783|83194109|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
46954100|NCT00705783|83194110|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
46954101|NCT00705783|83194111|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
46954102|NCT00705783|83194109|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
46954103|NCT00705783|83194110|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
46954104|NCT00705783|83194111|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
46954105|NCT00705783|83194109|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
46954106|NCT00705783|83194110|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
46954107|NCT00705783|83194111|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
46954108|NCT00705783|83194109|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
46954109|NCT00705783|83194110|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
46954110|NCT00705783|83194111|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
46954111|NCT00705783|83194109|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
46954112|NCT00705783|83194110|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
46954113|NCT00705783|83194111|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
46954114|NCT00705783|83194109|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
46954115|NCT00705783|83194110|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
46954116|NCT00705783|83194111|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
46954117|NCT00705783|83194109|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
46954118|NCT00705783|83194110|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
46954119|NCT00705783|83194111|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
46954120|NCT00705783|83194109|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
46954121|NCT00705783|83194110|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
46954122|NCT00705783|83194111|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
46954123|NCT02694549|83194120|FG000|Overall Study|screen failures|2|||
46954124|NCT02782325|83194126|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
46954125|NCT02782325|83194127|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
46954126|NCT02782325|83194128|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
46954127|NCT02782325|83194126|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
46954128|NCT02782325|83194127|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
46954129|NCT02782325|83194128|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
46954130|NCT02693691|83194136|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
46954131|NCT02693691|83194136|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
46843395|NCT03769090|83060355|FG000|Overall Study|Protocol Violation|5|||
46954132|NCT02693691|83194136|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
46954133|NCT02693691|83194136|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
46954134|NCT02693691|83194136|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
46954135|NCT02693691|83194136|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
47066701|NCT01554176|83349358|FG004|Treatment Phase|Non-compliance with study drug|0|||
47066702|NCT01554176|83349354|FG000|Treatment Phase|Withdrawal by Subject|1|||
46843396|NCT03769090|83060356|FG001|Overall Study|Protocol Violation|6|||
46843397|NCT03769090|83060357|FG002|Overall Study|Protocol Violation|8|||
46843398|NCT03769090|83060355|FG000|Overall Study|Pregnancy|1|||
46843399|NCT03769090|83060356|FG001|Overall Study|Pregnancy|0|||
46954136|NCT02693691|83194136|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
46954137|NCT04203667|83194140|FG000|Overall Study|Withdrawal by Subject|1|||
46954138|NCT04203667|83194140|FG000|Overall Study|Lost to Follow-up|1|||
46843400|NCT03769090|83060357|FG002|Overall Study|Pregnancy|3|||
46954139|NCT04203667|83194140|FG000|Overall Study|Death|1|||
46954140|NCT04203667|83194140|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
46954141|NCT02782169|83194147|FG000|Overall Study|Lost to Follow-up|1|||
46954142|NCT02782169|83194148|FG001|Overall Study|Lost to Follow-up|2|||
46954143|NCT02564042|83194160|FG000|Overall Study|Adverse Event|4|||
46954144|NCT02564042|83194161|FG001|Overall Study|Adverse Event|4|||
46954145|NCT02564042|83194162|FG002|Overall Study|Adverse Event|3|||
46954146|NCT02564042|83194163|FG003|Overall Study|Adverse Event|0|||
46639269|NCT01387932|82812809|FG001|Survival Follow-up|Liver Transplant|28|||
46639270|NCT01387932|82812808|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
46639271|NCT01387932|82812809|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
46639272|NCT01387932|82812808|FG000|Survival Follow-up|Withdrawal by Subject|2|||
46639273|NCT01387932|82812809|FG001|Survival Follow-up|Withdrawal by Subject|4|||
46639274|NCT01387932|82812808|FG000|Survival Follow-up|Lost to Follow-up|6|||
46639275|NCT01387932|82812809|FG001|Survival Follow-up|Lost to Follow-up|5|||
46639276|NCT01422408|82812817|FG000|Overall Study|Adverse Event|1|||
46639277|NCT01422408|82812817|FG000|Overall Study|Withdrawal by Subject|3|||
46639278|NCT01399788|82812821|FG000|First Intervention Period|Adverse Event|1|||
46639279|NCT01399788|82812822|FG001|First Intervention Period|Adverse Event|0|||
47066703|NCT01554176|83349355|FG001|Treatment Phase|Withdrawal by Subject|0|||
46639280|NCT01387542|82812828|FG000|Overall Study|Adverse Event|3|||
46639281|NCT01387542|82812828|FG000|Overall Study|Withdrawal by Subject|1|||
46639282|NCT01387542|82812828|FG000|Overall Study|Changed diagnosis|1|||
46639283|NCT01387542|82812828|FG000|Overall Study|Insufficient response|1|||
46639284|NCT01387542|82812828|FG000|Overall Study|Non-compliant|1|||
46639285|NCT01387542|82812828|FG000|Overall Study|Lost to Follow-up|1|||
46639286|NCT01387230|82812835|FG000|Overall Study|Adverse Event|0|||
46639287|NCT01387230|82812836|FG001|Overall Study|Adverse Event|1|||
46772608|NCT00772070|82990917|FG000|Overall Study|Lost to Follow-up|0|||
46772609|NCT00772070|82990918|FG001|Overall Study|Lost to Follow-up|8|||
46772610|NCT00772070|82990917|FG000|Overall Study|Withdrawal by Subject|0|||
46772611|NCT00772070|82990918|FG001|Overall Study|Withdrawal by Subject|2|||
46772612|NCT00772070|82990917|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
46772613|NCT00772070|82990918|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
46772614|NCT00796757|82990924|FG000|Overall Study|Withdrawal by Subject|14|||
46772615|NCT00796757|82990924|FG000|Overall Study|Death|61|||
46772616|NCT00796757|82990924|FG000|Overall Study|Protocol Violation|1|||
46772617|NCT00796757|82990924|FG000|Overall Study|Participant noncompliance|1|||
46772618|NCT00796757|82990924|FG000|Overall Study|Investigator's decision|2|||
46772619|NCT00796757|82990924|FG000|Overall Study|Other|7|||
46772620|NCT00759356|82990930|FG000|Overall Study|Adverse Event|0|||
46772621|NCT00759356|82990931|FG001|Overall Study|Adverse Event|1|||
46772622|NCT00759356|82990930|FG000|Overall Study|Withdrawal by Subject|0|||
46772623|NCT00759356|82990931|FG001|Overall Study|Withdrawal by Subject|2|||
46772624|NCT00759356|82990930|FG000|Overall Study|Subject was unable to return|1|||
46772625|NCT00759356|82990931|FG001|Overall Study|Subject was unable to return|0|||
46772626|NCT00721734|82990942|FG000|Overall Study|Progressive Disease|3|||
46772627|NCT00721734|82990943|FG001|Overall Study|Progressive Disease|10|||
46772628|NCT00721734|82990944|FG002|Overall Study|Progressive Disease|4|||
46772629|NCT00721734|82990945|FG003|Overall Study|Progressive Disease|5|||
46772630|NCT00721734|82990946|FG004|Overall Study|Progressive Disease|2|||
46772631|NCT00721734|82990942|FG000|Overall Study|Adverse Event|3|||
46772632|NCT00721734|82990943|FG001|Overall Study|Adverse Event|1|||
46772633|NCT00721734|82990944|FG002|Overall Study|Adverse Event|4|||
46772634|NCT00721734|82990945|FG003|Overall Study|Adverse Event|0|||
46772635|NCT00721734|82990946|FG004|Overall Study|Adverse Event|3|||
46772636|NCT00721734|82990942|FG000|Overall Study|Withdrawal by Subject|2|||
46772637|NCT00721734|82990943|FG001|Overall Study|Withdrawal by Subject|1|||
46772638|NCT00721734|82990944|FG002|Overall Study|Withdrawal by Subject|0|||
46772639|NCT00721734|82990945|FG003|Overall Study|Withdrawal by Subject|0|||
46772640|NCT00721734|82990946|FG004|Overall Study|Withdrawal by Subject|1|||
46772641|NCT00721734|82990942|FG000|Overall Study|Other|0|||
46772642|NCT00721734|82990943|FG001|Overall Study|Other|0|||
46772643|NCT00721734|82990944|FG002|Overall Study|Other|0|||
46772644|NCT00721734|82990945|FG003|Overall Study|Other|1|||
46772645|NCT00721734|82990946|FG004|Overall Study|Other|0|||
46772646|NCT00798317|82990960|FG000|Overall Study|Physician Decision|0|||
46772647|NCT00798317|82990961|FG001|Overall Study|Physician Decision|1|||
46772648|NCT00798317|82990960|FG000|Overall Study|Withdrawal by Subject|5|||
46772649|NCT00798317|82990961|FG001|Overall Study|Withdrawal by Subject|4|||
46639288|NCT01387230|82812837|FG002|Overall Study|Adverse Event|3|||
46772650|NCT00798317|82990960|FG000|Overall Study|Lost to Follow-up|2|||
46772651|NCT00798317|82990961|FG001|Overall Study|Lost to Follow-up|2|||
46772652|NCT00798317|82990960|FG000|Overall Study|Adverse Event|2|||
46954147|NCT02564042|83194164|FG004|Overall Study|Adverse Event|0|||
46954148|NCT02564042|83194165|FG005|Overall Study|Adverse Event|1|||
46954149|NCT02564042|83194160|FG000|Overall Study|Lost to Follow-up|1|||
46772653|NCT00798317|82990961|FG001|Overall Study|Adverse Event|0|||
46843401|NCT03769090|83060355|FG000|Overall Study|Lost to Follow-up|19|||
46843402|NCT03769090|83060356|FG001|Overall Study|Lost to Follow-up|25|||
46843403|NCT03769090|83060357|FG002|Overall Study|Lost to Follow-up|21|||
46843404|NCT03769090|83060355|FG000|Overall Study|Condition under investigation worsened|2|||
46843405|NCT03769090|83060356|FG001|Overall Study|Condition under investigation worsened|0|||
46843406|NCT03769090|83060357|FG002|Overall Study|Condition under investigation worsened|1|||
46843407|NCT03769090|83060355|FG000|Overall Study|Lack of Efficacy|1|||
46843408|NCT03769090|83060356|FG001|Overall Study|Lack of Efficacy|2|||
46843409|NCT03769090|83060357|FG002|Overall Study|Lack of Efficacy|2|||
46843410|NCT03769090|83060355|FG000|Overall Study|Other reasons|8|||
46843411|NCT03769090|83060356|FG001|Overall Study|Other reasons|12|||
46843412|NCT03769090|83060357|FG002|Overall Study|Other reasons|15|||
46843413|NCT03559270|83060381|FG000|Overall Study|Adverse Event|6|||
46843414|NCT03559270|83060382|FG001|Overall Study|Adverse Event|5|||
46843415|NCT03559270|83060383|FG002|Overall Study|Adverse Event|3|||
46843416|NCT03559270|83060384|FG003|Overall Study|Adverse Event|0|||
46843417|NCT03559270|83060381|FG000|Overall Study|Lack of Efficacy|34|||
46639289|NCT01387230|82812835|FG000|Overall Study|Lack of Efficacy|8|||
46639290|NCT01387230|82812836|FG001|Overall Study|Lack of Efficacy|5|||
46639291|NCT01387230|82812837|FG002|Overall Study|Lack of Efficacy|4|||
46639292|NCT01387230|82812835|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
46954150|NCT02564042|83194161|FG001|Overall Study|Lost to Follow-up|1|||
46954151|NCT02564042|83194162|FG002|Overall Study|Lost to Follow-up|1|||
46954152|NCT02564042|83194163|FG003|Overall Study|Lost to Follow-up|0|||
46954153|NCT02564042|83194164|FG004|Overall Study|Lost to Follow-up|1|||
46954154|NCT02564042|83194165|FG005|Overall Study|Lost to Follow-up|1|||
46954155|NCT02564042|83194160|FG000|Overall Study|Physician Decision|1|||
46954156|NCT02564042|83194161|FG001|Overall Study|Physician Decision|0|||
46954157|NCT02564042|83194162|FG002|Overall Study|Physician Decision|0|||
46954158|NCT02564042|83194163|FG003|Overall Study|Physician Decision|1|||
46954159|NCT02564042|83194164|FG004|Overall Study|Physician Decision|0|||
46954160|NCT02564042|83194165|FG005|Overall Study|Physician Decision|0|||
46954161|NCT02564042|83194160|FG000|Overall Study|Withdrawal by Subject|5|||
46954162|NCT02564042|83194161|FG001|Overall Study|Withdrawal by Subject|3|||
46954163|NCT02564042|83194162|FG002|Overall Study|Withdrawal by Subject|2|||
46954164|NCT02564042|83194163|FG003|Overall Study|Withdrawal by Subject|2|||
46954165|NCT02564042|83194164|FG004|Overall Study|Withdrawal by Subject|10|||
46954166|NCT02564042|83194165|FG005|Overall Study|Withdrawal by Subject|12|||
46954167|NCT02695719|83194198|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
46954168|NCT02695719|83194199|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
46954169|NCT02695719|83194198|FG000|Overall Study|Significant Protocol Deviation|0|||
46954170|NCT02695719|83194199|FG001|Overall Study|Significant Protocol Deviation|1|||
46954171|NCT02695719|83194198|FG000|Overall Study|Voluntary Withdrawal|1|||
46954172|NCT02695719|83194199|FG001|Overall Study|Voluntary Withdrawal|0|||
46954173|NCT02563106|83194216|FG000|Overall Study|Withdrawal by Subject|7|||
46954174|NCT02563106|83194217|FG001|Overall Study|Withdrawal by Subject|8|||
46954175|NCT02563106|83194216|FG000|Overall Study|Adverse Event|17|||
46954176|NCT02563106|83194217|FG001|Overall Study|Adverse Event|15|||
46954177|NCT02563106|83194216|FG000|Overall Study|Protocol Violation|1|||
46954178|NCT02563106|83194217|FG001|Overall Study|Protocol Violation|0|||
46954179|NCT02563106|83194216|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
46954180|NCT02563106|83194217|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
46954181|NCT02563106|83194216|FG000|Overall Study|Lost to Follow-up|3|||
46954182|NCT02563106|83194217|FG001|Overall Study|Lost to Follow-up|2|||
46954183|NCT02563106|83194216|FG000|Overall Study|Physician Decision|3|||
46954184|NCT02563106|83194217|FG001|Overall Study|Physician Decision|1|||
46954185|NCT02563106|83194216|FG000|Overall Study|Other reason - not specified|2|||
46954186|NCT02563106|83194217|FG001|Overall Study|Other reason - not specified|1|||
46954187|NCT02691741|83194225|FG000|Overall Study|Adverse Event|0|||
46954188|NCT02691741|83194226|FG001|Overall Study|Adverse Event|2|||
46843418|NCT03559270|83060382|FG001|Overall Study|Lack of Efficacy|52|||
47066704|NCT01554176|83349356|FG002|Treatment Phase|Withdrawal by Subject|0|||
47066705|NCT01554176|83349357|FG003|Treatment Phase|Withdrawal by Subject|0|||
46639293|NCT01387230|82812836|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
46843419|NCT03559270|83060383|FG002|Overall Study|Lack of Efficacy|37|||
46843420|NCT03559270|83060384|FG003|Overall Study|Lack of Efficacy|2|||
46843421|NCT03559270|83060381|FG000|Overall Study|Death|0|||
46843422|NCT03559270|83060382|FG001|Overall Study|Death|2|||
46843423|NCT03559270|83060383|FG002|Overall Study|Death|0|||
46843424|NCT03559270|83060384|FG003|Overall Study|Death|0|||
46843425|NCT03559270|83060381|FG000|Overall Study|Lost to Follow-up|16|||
46954189|NCT02691741|83194225|FG000|Overall Study|Lost to Follow-up|1|||
46954190|NCT02691741|83194226|FG001|Overall Study|Lost to Follow-up|0|||
46954191|NCT02691741|83194225|FG000|Overall Study|Physician Decision|0|||
46954192|NCT02691741|83194226|FG001|Overall Study|Physician Decision|1|||
46954193|NCT02691741|83194225|FG000|Overall Study|Withdrawal by Subject|0|||
46639294|NCT01387230|82812837|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
46843426|NCT03559270|83060382|FG001|Overall Study|Lost to Follow-up|4|||
46954194|NCT02691741|83194226|FG001|Overall Study|Withdrawal by Subject|4|||
46954195|NCT02691507|83194239|FG000|Overall Study|Missed Visit 3|0|||
46954196|NCT02691507|83194240|FG001|Overall Study|Missed Visit 3|1|||
46954197|NCT04579393|83194248|FG000|Overall Study|Withdrawal by Subject|2|||
46954198|NCT04579393|83194249|FG001|Overall Study|Withdrawal by Subject|2|||
46954199|NCT04579393|83194248|FG000|Overall Study|Death|1|||
46954200|NCT04579393|83194249|FG001|Overall Study|Death|3|||
46954201|NCT02776553|83194258|FG000|Overall Study|Lost to Follow-up|1|||
46954202|NCT02776553|83194259|FG001|Overall Study|Lost to Follow-up|0|||
46954203|NCT02776553|83194258|FG000|Overall Study|got liver transplant|1|||
46954204|NCT02776553|83194259|FG001|Overall Study|got liver transplant|2|||
46954205|NCT02776553|83194258|FG000|Overall Study|had other surgery|1|||
46843427|NCT03559270|83060383|FG002|Overall Study|Lost to Follow-up|12|||
46843428|NCT03559270|83060384|FG003|Overall Study|Lost to Follow-up|3|||
46843429|NCT03559270|83060381|FG000|Overall Study|Sponsor Decision|38|||
46843430|NCT03559270|83060382|FG001|Overall Study|Sponsor Decision|31|||
46843431|NCT03559270|83060383|FG002|Overall Study|Sponsor Decision|35|||
46772654|NCT00798317|82990960|FG000|Overall Study|Death|1|||
46772655|NCT00798317|82990961|FG001|Overall Study|Death|0|||
46772656|NCT00779402|82990969|FG000|Treatment Phase 1|Disease Progression|1|||
46772657|NCT00779402|82990970|FG001|Treatment Phase 1|Disease Progression|0|||
46772658|NCT00779402|82990969|FG000|Treatment Phase 1|Adverse Event|2|||
46843432|NCT03559270|83060384|FG003|Overall Study|Sponsor Decision|18|||
46843433|NCT03559270|83060381|FG000|Overall Study|Withdrawal by Subject|19|||
46843434|NCT03559270|83060382|FG001|Overall Study|Withdrawal by Subject|21|||
46954206|NCT02776553|83194259|FG001|Overall Study|had other surgery|0|||
46954207|NCT02776553|83194258|FG000|Overall Study|Protocol Violation|0|||
46954208|NCT02776553|83194259|FG001|Overall Study|Protocol Violation|1|||
46954209|NCT02690727|83194265|FG000|Overall Study|Adverse Event|2|||
46954210|NCT02690727|83194266|FG001|Overall Study|Adverse Event|2|||
46954211|NCT02777333|83194276|FG000|Overall Study|Withdrawal by Subject|0|||
46954212|NCT02777333|83194277|FG001|Overall Study|Withdrawal by Subject|1|||
46954213|NCT02777333|83194276|FG000|Overall Study|Lost to Follow-up|0|||
46954214|NCT02777333|83194277|FG001|Overall Study|Lost to Follow-up|1|||
46954215|NCT02695329|83194285|FG000|Overall Study|Adverse Event|1|||
46954216|NCT02695329|83194286|FG001|Overall Study|Adverse Event|0|||
46954217|NCT02695329|83194285|FG000|Overall Study|Poor X-ray quality for measurement|4|||
46954218|NCT02695329|83194286|FG001|Overall Study|Poor X-ray quality for measurement|5|||
46954219|NCT02690649|83194294|FG000|Overall Study|Withdrawal by Subject|1|||
46954220|NCT02690649|83194295|FG001|Overall Study|Withdrawal by Subject|1|||
46954221|NCT02690649|83194294|FG000|Overall Study|Protocol Violation|0|||
46954222|NCT02690649|83194295|FG001|Overall Study|Protocol Violation|3|||
46954223|NCT01358864|83194311|FG000|Overall Study|Adverse Event|0|||
46954224|NCT01358864|83194312|FG001|Overall Study|Adverse Event|6|||
46954225|NCT01358864|83194313|FG002|Overall Study|Adverse Event|9|||
47066706|NCT01554176|83349358|FG004|Treatment Phase|Withdrawal by Subject|0|||
47066707|NCT01554176|83349354|FG000|Treatment Phase|Lost to Follow-up|3|||
46772659|NCT00779402|82990970|FG001|Treatment Phase 1|Adverse Event|0|||
46772660|NCT00779402|82990969|FG000|Treatment Phase 1|Protocol Violation|1|||
46772661|NCT00779402|82990970|FG001|Treatment Phase 1|Protocol Violation|0|||
46772662|NCT00779402|82990969|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
46772663|NCT00779402|82990970|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
46772664|NCT00779402|82990969|FG000|Treatment Phase 1|Lost to Follow-up|0|||
46772665|NCT00779402|82990970|FG001|Treatment Phase 1|Lost to Follow-up|1|||
46772666|NCT00779402|82990969|FG000|Treatment Phase 1|Death|0|||
46772667|NCT00779402|82990970|FG001|Treatment Phase 1|Death|1|||
46772668|NCT00779402|82990969|FG000|Treatment Phase 1|Intercurrent Illness|1|||
46772669|NCT00779402|82990970|FG001|Treatment Phase 1|Intercurrent Illness|1|||
46772670|NCT00779402|82990969|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
46772671|NCT00779402|82990970|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
46772672|NCT00779402|82990969|FG000|Treatment Phase 1|Other|4|||
46843435|NCT03559270|83060383|FG002|Overall Study|Withdrawal by Subject|18|||
46954226|NCT01358864|83194314|FG003|Overall Study|Adverse Event|0|||
46954227|NCT01358864|83194315|FG004|Overall Study|Adverse Event|4|||
46954228|NCT01358864|83194316|FG005|Overall Study|Adverse Event|8|||
46954229|NCT01358864|83194317|FG006|Overall Study|Adverse Event|12|||
46954230|NCT01358864|83194318|FG007|Overall Study|Adverse Event|7|||
46954231|NCT01358864|83194311|FG000|Overall Study|Lack of Efficacy|26|||
46954232|NCT01358864|83194312|FG001|Overall Study|Lack of Efficacy|3|||
47066708|NCT01554176|83349355|FG001|Treatment Phase|Lost to Follow-up|0|||
47066709|NCT01554176|83349356|FG002|Treatment Phase|Lost to Follow-up|0|||
47066710|NCT01554176|83349357|FG003|Treatment Phase|Lost to Follow-up|0|||
47066711|NCT01554176|83349358|FG004|Treatment Phase|Lost to Follow-up|0|||
47066712|NCT01554176|83349354|FG000|Run-out Phase|Protocol Violation|0|||
47066713|NCT01554176|83349355|FG001|Run-out Phase|Protocol Violation|0|||
47066714|NCT01554176|83349356|FG002|Run-out Phase|Protocol Violation|0|||
47066715|NCT01554176|83349357|FG003|Run-out Phase|Protocol Violation|1|||
46843436|NCT03559270|83060384|FG003|Overall Study|Withdrawal by Subject|7|||
46954233|NCT01358864|83194313|FG002|Overall Study|Lack of Efficacy|4|||
46954234|NCT01358864|83194314|FG003|Overall Study|Lack of Efficacy|19|||
46954235|NCT01358864|83194315|FG004|Overall Study|Lack of Efficacy|7|||
46954236|NCT01358864|83194316|FG005|Overall Study|Lack of Efficacy|4|||
46954237|NCT01358864|83194317|FG006|Overall Study|Lack of Efficacy|49|||
46954238|NCT01358864|83194318|FG007|Overall Study|Lack of Efficacy|44|||
46954239|NCT01358864|83194311|FG000|Overall Study|Lost to Follow-up|0|||
46954240|NCT01358864|83194312|FG001|Overall Study|Lost to Follow-up|0|||
46954241|NCT01358864|83194313|FG002|Overall Study|Lost to Follow-up|1|||
46954242|NCT01358864|83194314|FG003|Overall Study|Lost to Follow-up|0|||
46954243|NCT01358864|83194315|FG004|Overall Study|Lost to Follow-up|0|||
46954244|NCT01358864|83194316|FG005|Overall Study|Lost to Follow-up|0|||
46954245|NCT01358864|83194317|FG006|Overall Study|Lost to Follow-up|0|||
46954246|NCT01358864|83194318|FG007|Overall Study|Lost to Follow-up|1|||
46954247|NCT01358864|83194311|FG000|Overall Study|Withdrawal by Subject|3|||
46954248|NCT01358864|83194312|FG001|Overall Study|Withdrawal by Subject|4|||
46954249|NCT01358864|83194313|FG002|Overall Study|Withdrawal by Subject|2|||
46954250|NCT01358864|83194314|FG003|Overall Study|Withdrawal by Subject|0|||
46954251|NCT01358864|83194315|FG004|Overall Study|Withdrawal by Subject|0|||
46954252|NCT01358864|83194316|FG005|Overall Study|Withdrawal by Subject|1|||
46954253|NCT01358864|83194317|FG006|Overall Study|Withdrawal by Subject|1|||
46954254|NCT01358864|83194318|FG007|Overall Study|Withdrawal by Subject|3|||
46954255|NCT01358864|83194311|FG000|Overall Study|Other reason not defined above|2|||
46954256|NCT01358864|83194312|FG001|Overall Study|Other reason not defined above|0|||
46954257|NCT01358864|83194313|FG002|Overall Study|Other reason not defined above|0|||
46954258|NCT01358864|83194314|FG003|Overall Study|Other reason not defined above|0|||
46954259|NCT01358864|83194315|FG004|Overall Study|Other reason not defined above|0|||
46954260|NCT01358864|83194316|FG005|Overall Study|Other reason not defined above|0|||
46954261|NCT01358864|83194317|FG006|Overall Study|Other reason not defined above|2|||
46954262|NCT01358864|83194318|FG007|Overall Study|Other reason not defined above|0|||
46954263|NCT01358864|83194311|FG000|Overall Study|Not treated|0|||
46954264|NCT01358864|83194312|FG001|Overall Study|Not treated|0|||
46954265|NCT01358864|83194313|FG002|Overall Study|Not treated|0|||
46954266|NCT01358864|83194314|FG003|Overall Study|Not treated|0|||
46954267|NCT01358864|83194315|FG004|Overall Study|Not treated|0|||
46954268|NCT01358864|83194316|FG005|Overall Study|Not treated|0|||
46843437|NCT03559270|83060381|FG000|Overall Study|Physician Decision|3|||
46843438|NCT03559270|83060382|FG001|Overall Study|Physician Decision|2|||
46843439|NCT03559270|83060383|FG002|Overall Study|Physician Decision|1|||
46843440|NCT03559270|83060384|FG003|Overall Study|Physician Decision|0|||
46843441|NCT03559270|83060381|FG000|Overall Study|Pregnancy|0|||
46843442|NCT03559270|83060382|FG001|Overall Study|Pregnancy|1|||
46843443|NCT03559270|83060383|FG002|Overall Study|Pregnancy|0|||
46843444|NCT03559270|83060384|FG003|Overall Study|Pregnancy|0|||
46843445|NCT03559270|83060381|FG000|Overall Study|Protocol Violation|1|||
46954269|NCT01358864|83194317|FG006|Overall Study|Not treated|1|||
46772673|NCT00779402|82990970|FG001|Treatment Phase 1|Other|2|||
46772674|NCT00779402|82990969|FG000|Treatment Phase 1|Closure of Study|3|||
46772675|NCT00779402|82990970|FG001|Treatment Phase 1|Closure of Study|2|||
46772676|NCT00779402|82990969|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
46772677|NCT00779402|82990970|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
46772678|NCT00779402|82990969|FG000|Surveillance Phase|Protocol Violation|0|||
46772679|NCT00779402|82990970|FG001|Surveillance Phase|Protocol Violation|1|||
46772680|NCT00779402|82990969|FG000|Surveillance Phase|Patient refused to continue|22|||
46772681|NCT00779402|82990970|FG001|Surveillance Phase|Patient refused to continue|14|||
46772682|NCT00779402|82990969|FG000|Surveillance Phase|Lost to Follow-up|2|||
46772683|NCT00779402|82990970|FG001|Surveillance Phase|Lost to Follow-up|1|||
46772684|NCT00779402|82990969|FG000|Surveillance Phase|Death|0|||
46772685|NCT00779402|82990970|FG001|Surveillance Phase|Death|1|||
46772686|NCT00779402|82990969|FG000|Surveillance Phase|Intercurrent Illness|2|||
46772687|NCT00779402|82990970|FG001|Surveillance Phase|Intercurrent Illness|0|||
46954270|NCT01358864|83194318|FG007|Overall Study|Not treated|0|||
46954271|NCT02750761|83194344|FG000|Overall Study|Lost to Follow-up|0|||
46639295|NCT01387230|82812835|FG000|Overall Study|Lost to Follow-up|0|||
46772688|NCT00779402|82990969|FG000|Surveillance Phase|Other|5|||
46772689|NCT00779402|82990970|FG001|Surveillance Phase|Other|5|||
46772690|NCT00779402|82990969|FG000|Surveillance Phase|Withdrawal by Subject|4|||
46772691|NCT00779402|82990970|FG001|Surveillance Phase|Withdrawal by Subject|1|||
46843446|NCT03559270|83060382|FG001|Overall Study|Protocol Violation|0|||
46843447|NCT03559270|83060383|FG002|Overall Study|Protocol Violation|2|||
46954272|NCT02750761|83194345|FG001|Overall Study|Lost to Follow-up|0|||
46954273|NCT02750761|83194346|FG002|Overall Study|Lost to Follow-up|1|||
46954274|NCT02750761|83194347|FG003|Overall Study|Lost to Follow-up|0|||
46954275|NCT02750761|83194348|FG004|Overall Study|Lost to Follow-up|0|||
46843448|NCT03559270|83060384|FG003|Overall Study|Protocol Violation|0|||
46843449|NCT00114777|83060439|FG000|Randomization to Month 36|Death|10|||
46843450|NCT00114777|83060440|FG001|Randomization to Month 36|Death|4|||
46954276|NCT02750761|83194349|FG005|Overall Study|Lost to Follow-up|0|||
46954277|NCT02688933|83194392|FG000|Overall Study|Adverse Event|3|||
46843451|NCT00114777|83060441|FG002|Randomization to Month 36|Death|3|||
46772692|NCT00779402|82990969|FG000|Surveillance Phase|Closure of study|5|||
46772693|NCT00779402|82990970|FG001|Surveillance Phase|Closure of study|6|||
46772694|NCT00779402|82990969|FG000|Surveillance Phase|Completed Protocol Visits|3|||
46772695|NCT00779402|82990970|FG001|Surveillance Phase|Completed Protocol Visits|2|||
46772696|NCT00779402|82990969|FG000|Long-term Follow-up|Patient refused to continue|2|||
46772697|NCT00779402|82990970|FG001|Long-term Follow-up|Patient refused to continue|0|||
46772698|NCT00779402|82990969|FG000|Long-term Follow-up|Other|5|||
46772699|NCT00779402|82990970|FG001|Long-term Follow-up|Other|0|||
46772700|NCT00779402|82990969|FG000|Long-term Follow-up|Closure of Study|8|||
46772701|NCT00779402|82990970|FG001|Long-term Follow-up|Closure of Study|4|||
46772702|NCT00779402|82990969|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
46772703|NCT00779402|82990970|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
46772704|NCT00771914|82990980|FG000|Overall Study|Physician Decision|0|||
46772705|NCT00771914|82990981|FG001|Overall Study|Physician Decision|0|||
46772706|NCT00771914|82990982|FG002|Overall Study|Physician Decision|0|||
46772707|NCT00771914|82990983|FG003|Overall Study|Physician Decision|1|||
46772708|NCT00771914|82990980|FG000|Overall Study|Lost to Follow-up|0|||
46772709|NCT00771914|82990981|FG001|Overall Study|Lost to Follow-up|0|||
46772710|NCT00771914|82990982|FG002|Overall Study|Lost to Follow-up|0|||
46772711|NCT00771914|82990983|FG003|Overall Study|Lost to Follow-up|1|||
46772712|NCT00779324|82990995|FG000|Overall Study|Lost to Follow-up|2|||
46772713|NCT00779324|82990996|FG001|Overall Study|Lost to Follow-up|1|||
46843452|NCT00114777|83060439|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
46843453|NCT00114777|83060440|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
46843454|NCT00114777|83060441|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
46843455|NCT00114777|83060439|FG000|Randomization to Month 36|Lack of Efficacy|19|||
46843456|NCT00114777|83060440|FG001|Randomization to Month 36|Lack of Efficacy|15|||
46843457|NCT00114777|83060441|FG002|Randomization to Month 36|Lack of Efficacy|17|||
46843458|NCT00114777|83060439|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
46843459|NCT00114777|83060440|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
46843460|NCT00114777|83060441|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
46843461|NCT00114777|83060439|FG000|Randomization to Month 36|Adverse Event|34|||
46843462|NCT00114777|83060440|FG001|Randomization to Month 36|Adverse Event|35|||
46843463|NCT00114777|83060441|FG002|Randomization to Month 36|Adverse Event|44|||
46843464|NCT00114777|83060439|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
46843465|NCT00114777|83060440|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
46843466|NCT00114777|83060441|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
46843467|NCT00114777|83060439|FG000|Randomization to Month 36|Other|9|||
46843468|NCT00114777|83060440|FG001|Randomization to Month 36|Other|3|||
46843469|NCT00114777|83060441|FG002|Randomization to Month 36|Other|12|||
46843470|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Death|8|||
46843471|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Death|13|||
46843472|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Death|7|||
46843473|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
46843474|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
46843475|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
46843476|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
46843477|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
46954278|NCT02688933|83194393|FG001|Overall Study|Adverse Event|1|||
46954279|NCT02688933|83194392|FG000|Overall Study|Lack of Efficacy|2|||
46954280|NCT02688933|83194393|FG001|Overall Study|Lack of Efficacy|2|||
46954281|NCT02688933|83194392|FG000|Overall Study|Poor compliance to protocol|7|||
46954282|NCT02688933|83194393|FG001|Overall Study|Poor compliance to protocol|4|||
46954283|NCT02688933|83194392|FG000|Overall Study|Hypoglycemia|2|||
46954284|NCT02688933|83194393|FG001|Overall Study|Hypoglycemia|0|||
46954285|NCT02688933|83194392|FG000|Overall Study|Other than Specified|14|||
46843478|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
46843479|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
46843480|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
46843481|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
46843482|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
46954286|NCT02688933|83194393|FG001|Overall Study|Other than Specified|25|||
46772714|NCT00779324|82990995|FG000|Overall Study|Withdrawal by Subject|4|||
46772715|NCT00779324|82990996|FG001|Overall Study|Withdrawal by Subject|2|||
46772716|NCT00779324|82990995|FG000|Overall Study|Missed visit|1|||
46843483|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
46954287|NCT02688933|83194392|FG000|Overall Study|Lost to Follow-up|1|||
46954288|NCT02688933|83194393|FG001|Overall Study|Lost to Follow-up|5|||
46954289|NCT02688621|83194401|FG000|Overall Study|Pregnancy|1|||
46954290|NCT02688621|83194402|FG001|Overall Study|Pregnancy|3|||
46954291|NCT02688621|83194401|FG000|Overall Study|Lost to Follow-up|38|||
46954292|NCT02688621|83194402|FG001|Overall Study|Lost to Follow-up|15|||
46954293|NCT02688621|83194401|FG000|Overall Study|Withdrawal by Subject|1|||
47066716|NCT01554176|83349358|FG004|Run-out Phase|Protocol Violation|0|||
47066717|NCT01466491|83349374|FG000|Overall Study|Protocol Violation|0|||
47066718|NCT01466491|83349375|FG001|Overall Study|Protocol Violation|3|||
47066719|NCT01466491|83349376|FG002|Overall Study|Protocol Violation|2|||
47066720|NCT01466491|83349377|FG003|Overall Study|Protocol Violation|0|||
47066721|NCT01466491|83349374|FG000|Overall Study|Missing Data|0|||
47066722|NCT01466491|83349375|FG001|Overall Study|Missing Data|0|||
47066723|NCT01466491|83349376|FG002|Overall Study|Missing Data|1|||
47066724|NCT01466491|83349377|FG003|Overall Study|Missing Data|0|||
46772717|NCT00779324|82990996|FG001|Overall Study|Missed visit|1|||
46843484|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
46843485|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
46843486|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
46843487|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
46843488|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
46843489|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
46843490|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
46843491|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
46843492|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
46843493|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
46843494|NCT00114777|83060439|FG000|Long-Term Extension to Month 84|Other|2|||
46843495|NCT00114777|83060440|FG001|Long-Term Extension to Month 84|Other|0|||
46843496|NCT00114777|83060441|FG002|Long-Term Extension to Month 84|Other|2|||
46954294|NCT02688621|83194402|FG001|Overall Study|Withdrawal by Subject|0|||
46954295|NCT04227704|83194414|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
46954296|NCT04227704|83194415|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
46954297|NCT04227704|83194416|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
46954298|NCT04227704|83194414|FG000|Overall Study|due to C/S being cancelled|1|||
46954299|NCT04227704|83194415|FG001|Overall Study|due to C/S being cancelled|0|||
46954300|NCT04227704|83194416|FG002|Overall Study|due to C/S being cancelled|0|||
46954301|NCT03530293|83194437|FG000|Pre-randomization|Adverse Event|12|||
46954302|NCT03530293|83194438|FG001|Pre-randomization|Adverse Event|0|||
46954303|NCT03530293|83194439|FG002|Pre-randomization|Adverse Event|0|||
46954304|NCT03530293|83194437|FG000|Pre-randomization|Protocol Violation|2|||
46954305|NCT03530293|83194438|FG001|Pre-randomization|Protocol Violation|0|||
46954306|NCT03530293|83194439|FG002|Pre-randomization|Protocol Violation|0|||
46954307|NCT03530293|83194437|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
46954308|NCT03530293|83194438|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
46954309|NCT03530293|83194439|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
46954310|NCT03530293|83194437|FG000|Pre-randomization|Withdrawal by Subject|5|||
46954311|NCT03530293|83194438|FG001|Pre-randomization|Withdrawal by Subject|0|||
46954312|NCT03530293|83194439|FG002|Pre-randomization|Withdrawal by Subject|0|||
47066725|NCT01466179|83349387|FG000|Overall Study|Ongoing in core study|2|||
47066726|NCT01466179|83349387|FG000|Overall Study|Physician Decision|46|||
46772718|NCT00779246|82991004|FG000|Overall Study|Missing sufficient data for analysis|33|||
46772719|NCT00779246|82991005|FG001|Overall Study|Missing sufficient data for analysis|53|||
46772720|NCT00771758|82991014|FG000|Overall Study|Adverse Event|2|||
46772721|NCT00771758|82991015|FG001|Overall Study|Adverse Event|8|||
46772722|NCT00771758|82991016|FG002|Overall Study|Adverse Event|1|||
46772723|NCT00771758|82991014|FG000|Overall Study|Lack of Efficacy|0|||
46772724|NCT00771758|82991015|FG001|Overall Study|Lack of Efficacy|2|||
46772725|NCT00771758|82991016|FG002|Overall Study|Lack of Efficacy|1|||
46772726|NCT00771758|82991014|FG000|Overall Study|Lost to Follow-up|1|||
46772727|NCT00771758|82991015|FG001|Overall Study|Lost to Follow-up|0|||
46772728|NCT00771758|82991016|FG002|Overall Study|Lost to Follow-up|0|||
46772729|NCT00771758|82991014|FG000|Overall Study|Protocol Violation|1|||
46772730|NCT00771758|82991015|FG001|Overall Study|Protocol Violation|0|||
46772731|NCT00771758|82991016|FG002|Overall Study|Protocol Violation|0|||
46772732|NCT00771758|82991014|FG000|Overall Study|Withdrawal by Subject|1|||
46772733|NCT00771758|82991015|FG001|Overall Study|Withdrawal by Subject|0|||
46772734|NCT00771758|82991016|FG002|Overall Study|Withdrawal by Subject|0|||
46772735|NCT00771758|82991014|FG000|Overall Study|Other|3|||
46772736|NCT00771758|82991015|FG001|Overall Study|Other|2|||
46772737|NCT00771758|82991016|FG002|Overall Study|Other|0|||
46843497|NCT00139737|83060450|FG000|Overall Study|Withdrawal by Subject|190|||
46954313|NCT03530293|83194437|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
46954314|NCT03530293|83194438|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
47066727|NCT01466179|83349387|FG000|Overall Study|Progressive disease|43|||
46772738|NCT00758498|82991044|FG000|Overall Study|Adverse Event|2|||
46843498|NCT00139737|83060450|FG000|Overall Study|Adverse Event|58|||
46772739|NCT00758498|82991045|FG001|Overall Study|Adverse Event|2|||
46772740|NCT00758498|82991046|FG002|Overall Study|Adverse Event|3|||
47066728|NCT01466179|83349387|FG000|Overall Study|Adverse Event|32|||
46772741|NCT00758498|82991044|FG000|Overall Study|Subject legally detained out of state|1|||
46772742|NCT00758498|82991045|FG001|Overall Study|Subject legally detained out of state|0|||
46954315|NCT03530293|83194439|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
46954316|NCT03530293|83194437|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
46954317|NCT03530293|83194438|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
46954318|NCT03530293|83194439|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
46954319|NCT03530293|83194437|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
46954320|NCT03530293|83194438|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
46954321|NCT03530293|83194439|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
46954322|NCT03530293|83194437|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
46954323|NCT03530293|83194438|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
46954324|NCT03530293|83194439|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
47066729|NCT01466179|83349387|FG000|Overall Study|Disease relapse|23|||
46843499|NCT00139737|83060450|FG000|Overall Study|Lack of Efficacy|40|||
46843500|NCT00139737|83060450|FG000|Overall Study|Lost to Follow-up|8|||
46843501|NCT00139737|83060450|FG000|Overall Study|Death|3|||
46843502|NCT00139737|83060450|FG000|Overall Study|Laboratory Abnormality|2|||
46843503|NCT00139737|83060450|FG000|Overall Study|Protocol Violation|18|||
46843504|NCT00139737|83060450|FG000|Overall Study|Withdrew During Screening Phase|8|||
46843505|NCT00139737|83060450|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
46843506|NCT00139737|83060450|FG000|Overall Study|Screened, Not Treated|13|||
46843507|NCT00122187|83060456|FG000|Overall Study|Withdrew because of resource limitations|2|||
46843508|NCT00122187|83060457|FG001|Overall Study|Withdrew because of resource limitations|2|||
46843509|NCT00139659|83060467|FG000|Overall Study|Adverse Event|12|||
46843510|NCT00139659|83060468|FG001|Overall Study|Adverse Event|1|||
46843511|NCT00139659|83060467|FG000|Overall Study|Lack of Efficacy|1|||
46843512|NCT00139659|83060468|FG001|Overall Study|Lack of Efficacy|1|||
47066730|NCT01466179|83349387|FG000|Overall Study|Lack of Efficacy|14|||
47066731|NCT01466179|83349387|FG000|Overall Study|Death|7|||
47066732|NCT01466179|83349387|FG000|Overall Study|Withdrawal by Subject|7|||
47066733|NCT01466179|83349387|FG000|Overall Study|Protocol Violation|2|||
46772743|NCT00758498|82991046|FG002|Overall Study|Subject legally detained out of state|0|||
46772744|NCT00758498|82991044|FG000|Overall Study|Withdrawal by Subject|0|||
46772745|NCT00758498|82991045|FG001|Overall Study|Withdrawal by Subject|0|||
46772746|NCT00758498|82991046|FG002|Overall Study|Withdrawal by Subject|1|||
46843513|NCT00139659|83060467|FG000|Overall Study|Lost to Follow-up|7|||
46843514|NCT00139659|83060468|FG001|Overall Study|Lost to Follow-up|3|||
46843515|NCT00139659|83060467|FG000|Overall Study|Reason not Specified|6|||
46772747|NCT00758498|82991044|FG000|Overall Study|Noncompliance to study procedures|0|||
46772748|NCT00758498|82991045|FG001|Overall Study|Noncompliance to study procedures|0|||
46772749|NCT00758498|82991046|FG002|Overall Study|Noncompliance to study procedures|1|||
46772750|NCT00798161|82991061|FG000|Overall Study|Adverse Event|3|||
46772751|NCT00798161|82991062|FG001|Overall Study|Adverse Event|4|||
46772752|NCT00798161|82991063|FG002|Overall Study|Adverse Event|6|||
46772753|NCT00798161|82991064|FG003|Overall Study|Adverse Event|6|||
46772754|NCT00798161|82991065|FG004|Overall Study|Adverse Event|5|||
46843516|NCT00139659|83060468|FG001|Overall Study|Reason not Specified|3|||
46843517|NCT00139659|83060467|FG000|Overall Study|Withdrawal by Subject|14|||
46843518|NCT00139659|83060468|FG001|Overall Study|Withdrawal by Subject|10|||
46843519|NCT00137631|83060480|FG000|Overall Study|Lost to Follow-up|37|||
46843520|NCT00137631|83060481|FG001|Overall Study|Lost to Follow-up|41|||
46843521|NCT00114231|83060489|FG000|Overall Study|No consent|2|||
46843522|NCT00114231|83060490|FG001|Overall Study|No consent|0|||
46843523|NCT00114231|83060489|FG000|Overall Study|QARC requirement not met|1|||
46843524|NCT00114231|83060490|FG001|Overall Study|QARC requirement not met|0|||
46843525|NCT00114231|83060489|FG000|Overall Study|Suspected metastatic disease|1|||
46843526|NCT00114231|83060490|FG001|Overall Study|Suspected metastatic disease|0|||
46843527|NCT00114231|83060489|FG000|Overall Study|No adenocarcinoma|1|||
46843528|NCT00114231|83060490|FG001|Overall Study|No adenocarcinoma|0|||
46843529|NCT00114231|83060489|FG000|Overall Study|Low creatinine clearance|0|||
46843530|NCT00114231|83060490|FG001|Overall Study|Low creatinine clearance|1|||
46843531|NCT00114231|83060489|FG000|Overall Study|Tumor size > 4cm|1|||
46843532|NCT00114231|83060490|FG001|Overall Study|Tumor size > 4cm|0|||
46843533|NCT00114231|83060489|FG000|Overall Study|Tumor fixed on digital exam|0|||
46843534|NCT00114231|83060490|FG001|Overall Study|Tumor fixed on digital exam|1|||
46843535|NCT00114231|83060489|FG000|Overall Study|No Absolute Neutrophil Count|2|||
46843536|NCT00114231|83060490|FG001|Overall Study|No Absolute Neutrophil Count|0|||
46843537|NCT00114231|83060489|FG000|Overall Study|Biopsy done after registration|1|||
46843538|NCT00114231|83060490|FG001|Overall Study|Biopsy done after registration|0|||
46843539|NCT00113919|83060495|FG000|Overall Study|Physician Decision|8|||
46843540|NCT00113919|83060495|FG000|Overall Study|Death|6|||
46843541|NCT00113841|83060501|FG000|Overall Study|Disease progression|0|||
47066734|NCT01466179|83349387|FG000|Overall Study|Other|3|||
47066735|NCT01493089|83349396|FG000|Overall Study|Protocol Violation|2|||
46772755|NCT00798161|82991066|FG005|Overall Study|Adverse Event|2|||
46843542|NCT00113841|83060502|FG001|Overall Study|Disease progression|2|||
46843543|NCT00113841|83060501|FG000|Overall Study|Non-compliant|1|||
46843544|NCT00113841|83060502|FG001|Overall Study|Non-compliant|0|||
46843545|NCT00113607|83060510|FG000|Overall Study|Adverse Event|40|||
46843546|NCT00113607|83060511|FG001|Overall Study|Adverse Event|71|||
46843547|NCT00113607|83060510|FG000|Overall Study|Death|8|||
46843548|NCT00113607|83060511|FG001|Overall Study|Death|8|||
46843549|NCT00113607|83060510|FG000|Overall Study|Withdrawal by Subject|50|||
46843550|NCT00113607|83060511|FG001|Overall Study|Withdrawal by Subject|58|||
46843551|NCT00113607|83060510|FG000|Overall Study|Lost to Follow-up|0|||
46843552|NCT00113607|83060511|FG001|Overall Study|Lost to Follow-up|2|||
46843553|NCT00113607|83060510|FG000|Overall Study|Disease Progression|180|||
46843554|NCT00113607|83060511|FG001|Overall Study|Disease Progression|142|||
46843555|NCT00113607|83060510|FG000|Overall Study|Complete Response (Confirmed)|14|||
46843556|NCT00113607|83060511|FG001|Overall Study|Complete Response (Confirmed)|24|||
46843557|NCT00113607|83060510|FG000|Overall Study|Other|43|||
46843558|NCT00113607|83060511|FG001|Overall Study|Other|32|||
46843559|NCT00113529|83060518|FG000|Overall Study|Adverse Event|4|||
46843560|NCT00113529|83060518|FG000|Overall Study|Lack of Efficacy|20|||
46843561|NCT00113529|83060518|FG000|Overall Study|Decision of sponsor|6|||
46843562|NCT00113529|83060518|FG000|Overall Study|Withdrawal by Subject|4|||
46843563|NCT00134901|83060524|FG000|Overall Study|Lost to Follow-up|5|||
46843564|NCT00134901|83060525|FG001|Overall Study|Lost to Follow-up|5|||
46843565|NCT00134901|83060524|FG000|Overall Study|discontinued intervention|12|||
46843566|NCT00134901|83060525|FG001|Overall Study|discontinued intervention|10|||
46843567|NCT00122109|83060535|FG000|Overall Study|Did not meet criteria|6|||
46843568|NCT00122109|83060536|FG001|Overall Study|Did not meet criteria|7|||
46843569|NCT00113373|83060545|FG000|Overall Study|Ineligible: wrong primary|1|||
46843570|NCT00113373|83060545|FG000|Overall Study|Ineligible: second primary|1|||
46843571|NCT00113373|83060545|FG000|Overall Study|Never Treated|1|||
46843572|NCT00113295|83060556|FG000|Overall Study|Adverse Event|4|||
46843573|NCT00113295|83060557|FG001|Overall Study|Adverse Event|1|||
46843574|NCT00113295|83060556|FG000|Overall Study|Unrelated Medical Illness|1|||
46843575|NCT00113295|83060557|FG001|Overall Study|Unrelated Medical Illness|0|||
46843576|NCT00112905|83060565|FG000|Overall Study|Adverse Event|4|||
46843577|NCT00112905|83060565|FG000|Overall Study|Death|1|||
46843578|NCT00112905|83060565|FG000|Overall Study|Ineligibility|5|||
46843579|NCT00112905|83060565|FG000|Overall Study|Alternative treatment|1|||
46843580|NCT00112905|83060565|FG000|Overall Study|performance status was deteiorating|1|||
46843581|NCT00427895|83060573|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
46843582|NCT00427895|83060574|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
46843583|NCT00427895|83060575|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
46843584|NCT00427895|83060576|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
46843585|NCT00427895|83060577|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
46843586|NCT00427895|83060578|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
46843587|NCT00427895|83060579|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
46843588|NCT00427895|83060580|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
46843589|NCT00427895|83060573|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
46843590|NCT00427895|83060574|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
46843591|NCT00427895|83060575|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
46843592|NCT00427895|83060576|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
46843593|NCT00427895|83060577|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
46843594|NCT00427895|83060578|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
46843595|NCT00427895|83060579|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
46843596|NCT00427895|83060580|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
46843597|NCT00427895|83060573|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
46843598|NCT00427895|83060574|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
46843599|NCT00427895|83060575|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
46843600|NCT00427895|83060576|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
47066736|NCT01493089|83349397|FG001|Overall Study|Protocol Violation|2|||
46639296|NCT01387230|82812836|FG001|Overall Study|Lost to Follow-up|0|||
46639297|NCT01387230|82812837|FG002|Overall Study|Lost to Follow-up|1|||
46639298|NCT01387230|82812835|FG000|Overall Study|Withdrawal by Subject|4|||
46772756|NCT00798161|82991067|FG006|Overall Study|Adverse Event|4|||
46772757|NCT00798161|82991061|FG000|Overall Study|Protocol Violation|2|||
46772758|NCT00798161|82991062|FG001|Overall Study|Protocol Violation|1|||
46772759|NCT00798161|82991063|FG002|Overall Study|Protocol Violation|3|||
46772760|NCT00798161|82991064|FG003|Overall Study|Protocol Violation|3|||
46772761|NCT00798161|82991065|FG004|Overall Study|Protocol Violation|3|||
46772762|NCT00798161|82991066|FG005|Overall Study|Protocol Violation|2|||
46772763|NCT00798161|82991067|FG006|Overall Study|Protocol Violation|0|||
46772764|NCT00798161|82991061|FG000|Overall Study|Lost to Follow-up|1|||
46772765|NCT00798161|82991062|FG001|Overall Study|Lost to Follow-up|3|||
46772766|NCT00798161|82991063|FG002|Overall Study|Lost to Follow-up|4|||
46772767|NCT00798161|82991064|FG003|Overall Study|Lost to Follow-up|3|||
46772768|NCT00798161|82991065|FG004|Overall Study|Lost to Follow-up|4|||
46843601|NCT00427895|83060577|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
46843602|NCT00427895|83060578|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
46772769|NCT00798161|82991066|FG005|Overall Study|Lost to Follow-up|0|||
46772770|NCT00798161|82991067|FG006|Overall Study|Lost to Follow-up|0|||
46772771|NCT00798161|82991061|FG000|Overall Study|Withdrawal by Subject|5|||
46843603|NCT00427895|83060579|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
46843604|NCT00427895|83060580|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
46843605|NCT00427895|83060573|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
46843606|NCT00427895|83060574|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
46843607|NCT00427895|83060575|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
46843608|NCT00427895|83060576|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
46843609|NCT00427895|83060577|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
46843610|NCT00427895|83060578|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
46843611|NCT00427895|83060579|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
46843612|NCT00427895|83060580|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
46843613|NCT00427895|83060573|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
46843614|NCT00427895|83060574|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
46843615|NCT00427895|83060575|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
46843616|NCT00427895|83060576|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
46843617|NCT00427895|83060577|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
46843618|NCT00427895|83060578|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
46843619|NCT00427895|83060579|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
46843620|NCT00427895|83060580|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
46843621|NCT00427895|83060573|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
46843622|NCT00427895|83060574|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
46843623|NCT00427895|83060575|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
46843624|NCT00427895|83060576|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
46843625|NCT00427895|83060577|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
46843626|NCT00427895|83060578|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
46843627|NCT00427895|83060579|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
46843628|NCT00427895|83060580|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
46772772|NCT00798161|82991062|FG001|Overall Study|Withdrawal by Subject|4|||
46772773|NCT00798161|82991063|FG002|Overall Study|Withdrawal by Subject|5|||
46772774|NCT00798161|82991064|FG003|Overall Study|Withdrawal by Subject|4|||
46772775|NCT00798161|82991065|FG004|Overall Study|Withdrawal by Subject|2|||
46772776|NCT00798161|82991066|FG005|Overall Study|Withdrawal by Subject|3|||
46772777|NCT00798161|82991067|FG006|Overall Study|Withdrawal by Subject|1|||
46772778|NCT00798161|82991061|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
46772779|NCT00798161|82991062|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
46772780|NCT00798161|82991063|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
46772781|NCT00798161|82991064|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
46772782|NCT00798161|82991065|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
46772783|NCT00798161|82991066|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
46772784|NCT00798161|82991067|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
46772785|NCT00588341|82991083|FG000|Overall Study|Withdrawal by Subject|3|||
46843629|NCT00427895|83060573|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
46843630|NCT00427895|83060574|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
46843631|NCT00427895|83060575|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
46843632|NCT00427895|83060576|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
46843633|NCT00427895|83060577|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
46843634|NCT00427895|83060578|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
46843635|NCT00427895|83060579|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
46843636|NCT00427895|83060580|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
46843637|NCT00427895|83060573|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
46843638|NCT00427895|83060574|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
46843639|NCT00427895|83060575|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
46843640|NCT00427895|83060576|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
46843641|NCT00427895|83060577|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
46843642|NCT00427895|83060578|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
46843643|NCT00427895|83060579|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
46843644|NCT00427895|83060580|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
46843645|NCT00427895|83060573|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
46843646|NCT00427895|83060574|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
46843647|NCT00427895|83060575|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
46843648|NCT00427895|83060576|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
46843649|NCT00427895|83060577|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
46772786|NCT00588341|82991083|FG000|Overall Study|Not treated due to metastatic disease|1|||
46772787|NCT00588341|82991083|FG000|Overall Study|Patient ineligible|1|||
46772788|NCT00802529|82991089|FG000|Overall Study|Lost to Follow-up|0|||
46772789|NCT00802529|82991090|FG001|Overall Study|Lost to Follow-up|1|||
46772790|NCT00758264|82991099|FG000|Active Phase|Withdrawal by Subject|0|||
46843650|NCT00427895|83060578|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
46843651|NCT00427895|83060579|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
46954325|NCT03530293|83194437|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
46954326|NCT03530293|83194438|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
46954327|NCT03530293|83194439|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
46954328|NCT03335371|83194468|FG000|Overall Study|Lost to Follow-up|0|||
46954329|NCT03335371|83194469|FG001|Overall Study|Lost to Follow-up|0|||
46954330|NCT03335371|83194470|FG002|Overall Study|Lost to Follow-up|0|||
46954331|NCT03335371|83194471|FG003|Overall Study|Lost to Follow-up|0|||
46954332|NCT03335371|83194472|FG004|Overall Study|Lost to Follow-up|1|||
46954333|NCT03335371|83194468|FG000|Overall Study|Withdrawal by Subject|0|||
46954334|NCT03335371|83194469|FG001|Overall Study|Withdrawal by Subject|0|||
46954335|NCT03335371|83194470|FG002|Overall Study|Withdrawal by Subject|0|||
46954336|NCT03335371|83194471|FG003|Overall Study|Withdrawal by Subject|0|||
46954337|NCT03335371|83194472|FG004|Overall Study|Withdrawal by Subject|1|||
46954338|NCT03335371|83194468|FG000|Overall Study|Randomization Error|0|||
46954339|NCT03335371|83194469|FG001|Overall Study|Randomization Error|0|||
46954340|NCT03335371|83194470|FG002|Overall Study|Randomization Error|1|||
46954341|NCT03335371|83194471|FG003|Overall Study|Randomization Error|0|||
46954342|NCT03335371|83194472|FG004|Overall Study|Randomization Error|0|||
46954343|NCT02762929|83194504|FG000|Overall Study|Adverse Event|0|||
46954344|NCT02762929|83194505|FG001|Overall Study|Adverse Event|0|||
46954345|NCT02762929|83194506|FG002|Overall Study|Adverse Event|0|||
46954346|NCT02762929|83194507|FG003|Overall Study|Adverse Event|1|||
46954347|NCT02762929|83194508|FG004|Overall Study|Adverse Event|0|||
46954348|NCT02762929|83194509|FG005|Overall Study|Adverse Event|0|||
46954349|NCT02762929|83194504|FG000|Overall Study|Lost to Follow-up|1|||
46954350|NCT02762929|83194505|FG001|Overall Study|Lost to Follow-up|2|||
46954351|NCT02762929|83194506|FG002|Overall Study|Lost to Follow-up|0|||
46954352|NCT02762929|83194507|FG003|Overall Study|Lost to Follow-up|1|||
46954353|NCT02762929|83194508|FG004|Overall Study|Lost to Follow-up|0|||
46954354|NCT02762929|83194509|FG005|Overall Study|Lost to Follow-up|0|||
46843652|NCT00427895|83060580|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
46843653|NCT00427895|83060573|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
46843654|NCT00427895|83060574|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
46843655|NCT00427895|83060575|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
46843656|NCT00427895|83060576|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
46843657|NCT00427895|83060577|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
46954355|NCT02762929|83194504|FG000|Overall Study|Withdrawal by Subject|0|||
46954356|NCT02762929|83194505|FG001|Overall Study|Withdrawal by Subject|1|||
46954357|NCT02762929|83194506|FG002|Overall Study|Withdrawal by Subject|0|||
46954358|NCT02762929|83194507|FG003|Overall Study|Withdrawal by Subject|0|||
46954359|NCT02762929|83194508|FG004|Overall Study|Withdrawal by Subject|0|||
46954360|NCT02762929|83194509|FG005|Overall Study|Withdrawal by Subject|0|||
46954361|NCT02762929|83194504|FG000|Overall Study|exclusionary medication disclosed late|0|||
46954362|NCT02762929|83194505|FG001|Overall Study|exclusionary medication disclosed late|0|||
46954363|NCT02762929|83194506|FG002|Overall Study|exclusionary medication disclosed late|0|||
46954364|NCT02762929|83194507|FG003|Overall Study|exclusionary medication disclosed late|1|||
46954365|NCT02762929|83194508|FG004|Overall Study|exclusionary medication disclosed late|0|||
46954366|NCT02762929|83194509|FG005|Overall Study|exclusionary medication disclosed late|0|||
46954367|NCT03301051|83194530|FG000|Overall Study|Adverse Event|0|||
46954368|NCT03301051|83194531|FG001|Overall Study|Adverse Event|4|||
46954369|NCT03301051|83194530|FG000|Overall Study|Withdrawal by Subject|59|||
46954370|NCT03301051|83194531|FG001|Overall Study|Withdrawal by Subject|65|||
46954371|NCT03301051|83194530|FG000|Overall Study|Lost to Follow-up|263|||
46954372|NCT03301051|83194531|FG001|Overall Study|Lost to Follow-up|282|||
46954373|NCT03301051|83194530|FG000|Overall Study|Protocol Violation|1|||
46772791|NCT00758264|82991100|FG001|Active Phase|Withdrawal by Subject|0|||
46772792|NCT00758264|82991101|FG002|Active Phase|Withdrawal by Subject|1|||
46772793|NCT00758264|82991099|FG000|Active Phase|Lost to Follow-up|1|||
46772794|NCT00758264|82991100|FG001|Active Phase|Lost to Follow-up|0|||
46772795|NCT00758264|82991101|FG002|Active Phase|Lost to Follow-up|0|||
46772796|NCT00758264|82991099|FG000|Active Phase|Other|0|||
46772797|NCT00758264|82991100|FG001|Active Phase|Other|0|||
46772798|NCT00758264|82991101|FG002|Active Phase|Other|4|||
46772799|NCT00588731|82991111|FG000|Overall Study|Withdrawal by Subject|3|||
46772800|NCT00588731|82991112|FG001|Overall Study|Withdrawal by Subject|2|||
46772801|NCT00757172|82991118|FG000|Overall Study|Withdrawal by Subject|4|||
46772802|NCT00757172|82991118|FG000|Overall Study|Physician Decision|3|||
46772803|NCT00757172|82991118|FG000|Overall Study|Progression|4|||
46772804|NCT00797225|82991126|FG000|Weeks 1 to 12|Adverse Event|0|||
46772805|NCT00797225|82991127|FG001|Weeks 1 to 12|Adverse Event|0|||
46772806|NCT00797225|82991128|FG002|Weeks 1 to 12|Adverse Event|1|||
46772807|NCT00797225|82991129|FG003|Weeks 1 to 12|Adverse Event|0|||
46772808|NCT00797225|82991130|FG004|Weeks 1 to 12|Adverse Event|0|||
46954374|NCT03301051|83194531|FG001|Overall Study|Protocol Violation|3|||
46954375|NCT03301051|83194530|FG000|Overall Study|Physician Decision|1|||
46954376|NCT03301051|83194531|FG001|Overall Study|Physician Decision|3|||
46954377|NCT03301051|83194530|FG000|Overall Study|Death|1|||
46954378|NCT03301051|83194531|FG001|Overall Study|Death|1|||
46954379|NCT03301051|83194530|FG000|Overall Study|Miscellaneous|8|||
46954380|NCT03301051|83194531|FG001|Overall Study|Miscellaneous|4|||
46954381|NCT03301051|83194530|FG000|Overall Study|Randomized, not vaccinated|13|||
46954382|NCT03301051|83194531|FG001|Overall Study|Randomized, not vaccinated|10|||
46954383|NCT01662986|83194539|FG000|Overall Study|Adverse Event|5|||
46954384|NCT01662986|83194540|FG001|Overall Study|Adverse Event|4|||
46954385|NCT01662986|83194539|FG000|Overall Study|Protocol Violation|2|||
46954386|NCT01662986|83194540|FG001|Overall Study|Protocol Violation|3|||
46954387|NCT01662986|83194539|FG000|Overall Study|Lost to Follow-up|5|||
46954388|NCT01662986|83194540|FG001|Overall Study|Lost to Follow-up|4|||
46954389|NCT01662986|83194539|FG000|Overall Study|Withdrawal by Subject|2|||
46954390|NCT01662986|83194540|FG001|Overall Study|Withdrawal by Subject|2|||
46954391|NCT01662986|83194539|FG000|Overall Study|Not Treated|1|||
46954392|NCT01662986|83194540|FG001|Overall Study|Not Treated|0|||
46954393|NCT01662986|83194539|FG000|Overall Study|Other than stated above|3|||
46954394|NCT01662986|83194540|FG001|Overall Study|Other than stated above|0|||
46954395|NCT01337167|83194548|FG000|Infant Series|Adverse Event|1|||
46954396|NCT01337167|83194549|FG001|Infant Series|Adverse Event|1|||
46954397|NCT01337167|83194548|FG000|Infant Series|Death|1|||
46954398|NCT01337167|83194549|FG001|Infant Series|Death|1|||
46954399|NCT01337167|83194548|FG000|Infant Series|Lost to Follow-up|13|||
46954400|NCT01337167|83194549|FG001|Infant Series|Lost to Follow-up|7|||
46954401|NCT01337167|83194548|FG000|Infant Series|Non-compliance with study drug|2|||
46954402|NCT01337167|83194549|FG001|Infant Series|Non-compliance with study drug|1|||
46954403|NCT01337167|83194548|FG000|Infant Series|Physician Decision|3|||
46954404|NCT01337167|83194549|FG001|Infant Series|Physician Decision|1|||
46954405|NCT01337167|83194548|FG000|Infant Series|Protocol Violation|22|||
46954406|NCT01337167|83194549|FG001|Infant Series|Protocol Violation|9|||
46954407|NCT01337167|83194548|FG000|Infant Series|Withdrawal by Subject|15|||
46954408|NCT01337167|83194549|FG001|Infant Series|Withdrawal by Subject|4|||
46954409|NCT01337167|83194548|FG000|Infant Series|Randomized but not vaccinated|5|||
46954410|NCT01337167|83194549|FG001|Infant Series|Randomized but not vaccinated|3|||
46954411|NCT01337167|83194548|FG000|Interim Period|Lost to Follow-up|51|||
46954412|NCT01337167|83194549|FG001|Interim Period|Lost to Follow-up|23|||
46954413|NCT01337167|83194548|FG000|Interim Period|Non-compliance with study drug|1|||
46772809|NCT00797225|82991131|FG005|Weeks 1 to 12|Adverse Event|0|||
46772810|NCT00797225|82991132|FG006|Weeks 1 to 12|Adverse Event|0|||
46772811|NCT00797225|82991133|FG007|Weeks 1 to 12|Adverse Event|0|||
46772812|NCT00797225|82991126|FG000|Weeks 1 to 12|Non-compliance|0|||
46772813|NCT00797225|82991127|FG001|Weeks 1 to 12|Non-compliance|1|||
46772814|NCT00797225|82991128|FG002|Weeks 1 to 12|Non-compliance|0|||
46772815|NCT00797225|82991129|FG003|Weeks 1 to 12|Non-compliance|0|||
46772816|NCT00797225|82991130|FG004|Weeks 1 to 12|Non-compliance|0|||
46772817|NCT00797225|82991131|FG005|Weeks 1 to 12|Non-compliance|0|||
46772818|NCT00797225|82991132|FG006|Weeks 1 to 12|Non-compliance|0|||
46843658|NCT00427895|83060578|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
46843659|NCT00427895|83060579|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
46843660|NCT00427895|83060580|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
46843661|NCT00427895|83060573|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
46843662|NCT00427895|83060574|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
46843663|NCT00427895|83060575|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
46843664|NCT00427895|83060576|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
46843665|NCT00427895|83060577|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
46843666|NCT00427895|83060578|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
46843667|NCT00427895|83060579|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
46843668|NCT00427895|83060580|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
46843669|NCT00427895|83060573|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
46954414|NCT01337167|83194549|FG001|Interim Period|Non-compliance with study drug|0|||
46954415|NCT01337167|83194548|FG000|Interim Period|Physician Decision|6|||
46954416|NCT01337167|83194549|FG001|Interim Period|Physician Decision|3|||
46954417|NCT01337167|83194548|FG000|Interim Period|Protocol Violation|5|||
46954418|NCT01337167|83194549|FG001|Interim Period|Protocol Violation|3|||
46772819|NCT00797225|82991133|FG007|Weeks 1 to 12|Non-compliance|0|||
46843670|NCT00427895|83060574|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
46954419|NCT01337167|83194548|FG000|Interim Period|Withdrawal by Subject|18|||
46954420|NCT01337167|83194549|FG001|Interim Period|Withdrawal by Subject|10|||
46954421|NCT01337167|83194548|FG000|Interim Period|Other protocol criterion not met|0|||
46772820|NCT00797225|82991126|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
46954422|NCT01337167|83194549|FG001|Interim Period|Other protocol criterion not met|1|||
46954423|NCT01337167|83194548|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
46954424|NCT01337167|83194549|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
46954425|NCT01337167|83194548|FG000|Toddler Vaccinations|Protocol Violation|0|||
46954426|NCT01337167|83194549|FG001|Toddler Vaccinations|Protocol Violation|1|||
46954427|NCT01337167|83194548|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
46954428|NCT01337167|83194549|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
46954429|NCT01338025|83194557|FG000|Overall Study|Unexpected closure of study|10|||
46954430|NCT01338025|83194558|FG001|Overall Study|Unexpected closure of study|9|||
46954431|NCT01338025|83194557|FG000|Overall Study|Withdrawal by Subject|0|||
46954432|NCT01338025|83194558|FG001|Overall Study|Withdrawal by Subject|2|||
46954433|NCT01338025|83194557|FG000|Overall Study|Found ineligible after starting|1|||
46954434|NCT01338025|83194558|FG001|Overall Study|Found ineligible after starting|0|||
46954435|NCT02559206|83194602|FG000|Overall Study|Adverse Event|0|||
46954436|NCT02559206|83194603|FG001|Overall Study|Adverse Event|4|||
46954437|NCT02559206|83194604|FG002|Overall Study|Adverse Event|1|||
46954438|NCT02559206|83194605|FG003|Overall Study|Adverse Event|5|||
46954439|NCT02559206|83194606|FG004|Overall Study|Adverse Event|3|||
46954440|NCT02559206|83194607|FG005|Overall Study|Adverse Event|0|||
46954441|NCT02559206|83194608|FG006|Overall Study|Adverse Event|1|||
46954442|NCT02559206|83194609|FG007|Overall Study|Adverse Event|0|||
46954443|NCT02559206|83194602|FG000|Overall Study|Protocol Violation|1|||
46954444|NCT02559206|83194603|FG001|Overall Study|Protocol Violation|0|||
46954445|NCT02559206|83194604|FG002|Overall Study|Protocol Violation|1|||
46954446|NCT02559206|83194605|FG003|Overall Study|Protocol Violation|0|||
46954447|NCT02559206|83194606|FG004|Overall Study|Protocol Violation|0|||
46954448|NCT02559206|83194607|FG005|Overall Study|Protocol Violation|2|||
46954449|NCT02559206|83194608|FG006|Overall Study|Protocol Violation|0|||
46954450|NCT02559206|83194609|FG007|Overall Study|Protocol Violation|0|||
46954451|NCT02559206|83194602|FG000|Overall Study|Withdrawal by Subject|3|||
46954452|NCT02559206|83194603|FG001|Overall Study|Withdrawal by Subject|3|||
46954453|NCT02559206|83194604|FG002|Overall Study|Withdrawal by Subject|1|||
46954454|NCT02559206|83194605|FG003|Overall Study|Withdrawal by Subject|3|||
46954455|NCT02559206|83194606|FG004|Overall Study|Withdrawal by Subject|5|||
46954456|NCT02559206|83194607|FG005|Overall Study|Withdrawal by Subject|4|||
46954457|NCT02559206|83194608|FG006|Overall Study|Withdrawal by Subject|1|||
46954458|NCT02559206|83194609|FG007|Overall Study|Withdrawal by Subject|2|||
46954459|NCT02559206|83194602|FG000|Overall Study|Lost to Follow-up|3|||
46954460|NCT02559206|83194603|FG001|Overall Study|Lost to Follow-up|5|||
46954461|NCT02559206|83194604|FG002|Overall Study|Lost to Follow-up|3|||
46954462|NCT02559206|83194605|FG003|Overall Study|Lost to Follow-up|3|||
46954463|NCT02559206|83194606|FG004|Overall Study|Lost to Follow-up|2|||
46954464|NCT02559206|83194607|FG005|Overall Study|Lost to Follow-up|5|||
46954465|NCT02559206|83194608|FG006|Overall Study|Lost to Follow-up|1|||
46954466|NCT02559206|83194609|FG007|Overall Study|Lost to Follow-up|4|||
46954467|NCT02559206|83194602|FG000|Overall Study|Lack of Efficacy|1|||
46954468|NCT02559206|83194603|FG001|Overall Study|Lack of Efficacy|0|||
46954469|NCT02559206|83194604|FG002|Overall Study|Lack of Efficacy|3|||
46954470|NCT02559206|83194605|FG003|Overall Study|Lack of Efficacy|2|||
46954471|NCT02559206|83194606|FG004|Overall Study|Lack of Efficacy|2|||
46954472|NCT02559206|83194607|FG005|Overall Study|Lack of Efficacy|3|||
46954473|NCT02559206|83194608|FG006|Overall Study|Lack of Efficacy|3|||
46954474|NCT02559206|83194609|FG007|Overall Study|Lack of Efficacy|3|||
46954475|NCT02559206|83194602|FG000|Overall Study|Other Not Specified|0|||
46954476|NCT02559206|83194603|FG001|Overall Study|Other Not Specified|0|||
46954477|NCT02559206|83194604|FG002|Overall Study|Other Not Specified|0|||
46772821|NCT00797225|82991127|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
46772822|NCT00797225|82991128|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
46772823|NCT00797225|82991129|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
46772824|NCT00797225|82991130|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
46772825|NCT00797225|82991131|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
46772826|NCT00797225|82991132|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
46772827|NCT00797225|82991133|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
46772828|NCT00797225|82991126|FG000|Weeks 1 to 12|Sponsor Decision|1|||
46772829|NCT00797225|82991127|FG001|Weeks 1 to 12|Sponsor Decision|0|||
46772830|NCT00797225|82991128|FG002|Weeks 1 to 12|Sponsor Decision|0|||
46772831|NCT00797225|82991129|FG003|Weeks 1 to 12|Sponsor Decision|0|||
46772832|NCT00797225|82991130|FG004|Weeks 1 to 12|Sponsor Decision|0|||
46954478|NCT02559206|83194605|FG003|Overall Study|Other Not Specified|1|||
46772833|NCT00797225|82991131|FG005|Weeks 1 to 12|Sponsor Decision|0|||
46772834|NCT00797225|82991132|FG006|Weeks 1 to 12|Sponsor Decision|0|||
46954479|NCT02559206|83194606|FG004|Overall Study|Other Not Specified|0|||
46954480|NCT02559206|83194607|FG005|Overall Study|Other Not Specified|0|||
46954481|NCT02559206|83194608|FG006|Overall Study|Other Not Specified|0|||
46954482|NCT02559206|83194609|FG007|Overall Study|Other Not Specified|0|||
46954483|NCT02558894|83194629|FG000|Overall Study|Death; any cause, entire study duration|28|||
46954484|NCT02558894|83194630|FG001|Overall Study|Death; any cause, entire study duration|31|||
46954485|NCT02558894|83194629|FG000|Overall Study|Withdrawal by Subject|2|||
46772835|NCT00797225|82991133|FG007|Weeks 1 to 12|Sponsor Decision|0|||
46954486|NCT02558894|83194630|FG001|Overall Study|Withdrawal by Subject|1|||
46954487|NCT02558894|83194629|FG000|Overall Study|Closure of Part A|2|||
46954488|NCT02558894|83194630|FG001|Overall Study|Closure of Part A|1|||
46954489|NCT02688387|83194640|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954490|NCT02688387|83194641|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954491|NCT02688387|83194642|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
46954492|NCT02688387|83194643|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954493|NCT02688387|83194644|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954494|NCT02688387|83194645|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954495|NCT02688387|83194646|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954496|NCT02688387|83194647|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954497|NCT02688387|83194648|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954498|NCT02688387|83194649|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954499|NCT02688387|83194650|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954500|NCT02688387|83194651|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954501|NCT02688387|83194652|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954502|NCT02688387|83194653|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954503|NCT02688387|83194654|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954504|NCT02688387|83194655|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954505|NCT02688387|83194656|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954506|NCT02688387|83194657|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954507|NCT02688387|83194658|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954508|NCT02688387|83194659|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954509|NCT02688387|83194660|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954510|NCT02688387|83194661|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
46954511|NCT02688387|83194640|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954512|NCT02688387|83194641|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954513|NCT02688387|83194642|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954514|NCT02688387|83194643|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
46954515|NCT02688387|83194644|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954516|NCT02688387|83194645|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954517|NCT02688387|83194646|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954518|NCT02688387|83194647|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954519|NCT02688387|83194648|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954520|NCT02688387|83194649|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954521|NCT02688387|83194650|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954522|NCT02688387|83194651|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954523|NCT02688387|83194652|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954524|NCT02688387|83194653|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954525|NCT02688387|83194654|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954526|NCT02688387|83194655|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954527|NCT02688387|83194656|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954528|NCT02688387|83194657|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954529|NCT02688387|83194658|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954530|NCT02688387|83194659|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954531|NCT02688387|83194660|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954532|NCT02688387|83194661|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954533|NCT02688387|83194640|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954534|NCT02688387|83194641|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
46954535|NCT02688387|83194642|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954536|NCT02688387|83194643|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954537|NCT02688387|83194644|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954538|NCT02688387|83194645|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954539|NCT02688387|83194646|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954540|NCT02688387|83194647|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954541|NCT02688387|83194648|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954542|NCT02688387|83194649|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954543|NCT02688387|83194650|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954544|NCT02688387|83194651|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954545|NCT02688387|83194652|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954546|NCT02688387|83194653|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954547|NCT02688387|83194654|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954548|NCT02688387|83194655|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954549|NCT02688387|83194656|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954550|NCT02688387|83194657|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954551|NCT02688387|83194658|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954552|NCT02688387|83194659|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
47066737|NCT01493089|83349396|FG000|Overall Study|Withdrawal by Subject|1|||
47066738|NCT01493089|83349397|FG001|Overall Study|Withdrawal by Subject|0|||
47066739|NCT01493089|83349396|FG000|Overall Study|Physician Decision|0|||
46954553|NCT02688387|83194660|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954554|NCT02688387|83194661|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
46954555|NCT02688387|83194640|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954556|NCT02688387|83194641|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954557|NCT02688387|83194642|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
46954558|NCT02688387|83194643|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954559|NCT02688387|83194644|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
46954560|NCT02688387|83194645|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954561|NCT02688387|83194646|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954562|NCT02688387|83194647|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954563|NCT02688387|83194648|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954564|NCT02688387|83194649|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954565|NCT02688387|83194650|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954566|NCT02688387|83194651|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46843671|NCT00427895|83060575|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
46843672|NCT00427895|83060576|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
46843673|NCT00427895|83060577|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
46843674|NCT00427895|83060578|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
46843675|NCT00427895|83060579|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
46843676|NCT00427895|83060580|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
46843677|NCT00427895|83060573|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
46843678|NCT00427895|83060574|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
46954567|NCT02688387|83194652|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954568|NCT02688387|83194653|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954569|NCT02688387|83194654|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46639299|NCT01387230|82812836|FG001|Overall Study|Withdrawal by Subject|1|||
46639300|NCT01387230|82812837|FG002|Overall Study|Withdrawal by Subject|0|||
46639301|NCT01387074|82812845|FG000|Overall Study|Lost to Follow-up|7|||
46639302|NCT01387074|82812845|FG000|Overall Study|Lack of Efficacy|1|||
46639303|NCT01386606|82812853|FG000|Overall Study|Adverse Event|0|||
46843679|NCT00427895|83060575|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
46843680|NCT00427895|83060576|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
46843681|NCT00427895|83060577|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
46843682|NCT00427895|83060578|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
46843683|NCT00427895|83060579|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
46843684|NCT00427895|83060580|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
46843685|NCT00427895|83060573|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
46843686|NCT00427895|83060574|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
46843687|NCT00427895|83060575|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
46843688|NCT00427895|83060576|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
46843689|NCT00427895|83060577|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
46843690|NCT00427895|83060578|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
46843691|NCT00427895|83060579|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
46843692|NCT00427895|83060580|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
46843693|NCT00427895|83060573|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
46843694|NCT00427895|83060574|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
46843695|NCT00427895|83060575|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
46843696|NCT00427895|83060576|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
46843697|NCT00427895|83060577|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
46843698|NCT00427895|83060578|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
46843699|NCT00427895|83060579|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
46843700|NCT00427895|83060580|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
46843701|NCT00427895|83060573|FG000|Vax 1/Year 1 Follow-up|Death|1|||
46843702|NCT00427895|83060574|FG001|Vax 1/Year 1 Follow-up|Death|0|||
46843703|NCT00427895|83060575|FG002|Vax 1/Year 1 Follow-up|Death|0|||
46843704|NCT00427895|83060576|FG003|Vax 1/Year 1 Follow-up|Death|0|||
46954570|NCT02688387|83194655|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954571|NCT02688387|83194656|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954572|NCT02688387|83194657|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
47066740|NCT01493089|83349397|FG001|Overall Study|Physician Decision|1|||
46639304|NCT01386606|82812854|FG001|Overall Study|Adverse Event|1|||
46639305|NCT01386606|82812855|FG002|Overall Study|Adverse Event|0|||
46639306|NCT01386606|82812856|FG003|Overall Study|Adverse Event|0|||
46843705|NCT00427895|83060577|FG004|Vax 1/Year 1 Follow-up|Death|0|||
46843706|NCT00427895|83060578|FG005|Vax 1/Year 1 Follow-up|Death|0|||
46843707|NCT00427895|83060579|FG006|Vax 1/Year 1 Follow-up|Death|0|||
46843708|NCT00427895|83060580|FG007|Vax 1/Year 1 Follow-up|Death|0|||
46843709|NCT00427895|83060573|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
46843710|NCT00427895|83060574|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
46843711|NCT00427895|83060575|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
46843712|NCT00427895|83060576|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
46843713|NCT00427895|83060577|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
46843714|NCT00427895|83060578|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
46843715|NCT00427895|83060579|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
46843716|NCT00427895|83060580|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
46843717|NCT00427895|83060573|FG000|Vax 1/Year 1 Follow-up|Other|0|||
46843718|NCT00427895|83060574|FG001|Vax 1/Year 1 Follow-up|Other|0|||
46843719|NCT00427895|83060575|FG002|Vax 1/Year 1 Follow-up|Other|0|||
47066741|NCT01450813|83349409|FG000|Overall Study|Physician Decision|1|||
47066742|NCT01450813|83349410|FG001|Overall Study|Physician Decision|1|||
47066743|NCT01450813|83349411|FG002|Overall Study|Physician Decision|0|||
47066744|NCT01450813|83349412|FG003|Overall Study|Physician Decision|3|||
47066745|NCT01539512|83349426|FG000|Overall Study|Adverse Event|9|||
47066746|NCT01539512|83349427|FG001|Overall Study|Adverse Event|7|||
47066747|NCT01539512|83349426|FG000|Overall Study|Physician Decision|1|||
47066748|NCT01539512|83349427|FG001|Overall Study|Physician Decision|1|||
47066749|NCT01539512|83349426|FG000|Overall Study|Withdrawal by Subject|12|||
47066750|NCT01539512|83349427|FG001|Overall Study|Withdrawal by Subject|5|||
46772836|NCT00797225|82991126|FG000|Weeks 13 to 24|Non-compliance|0|||
46772837|NCT00797225|82991127|FG001|Weeks 13 to 24|Non-compliance|2|||
46772838|NCT00797225|82991128|FG002|Weeks 13 to 24|Non-compliance|0|||
46772839|NCT00797225|82991129|FG003|Weeks 13 to 24|Non-compliance|0|||
46772840|NCT00797225|82991130|FG004|Weeks 13 to 24|Non-compliance|0|||
46772841|NCT00797225|82991131|FG005|Weeks 13 to 24|Non-compliance|0|||
46772842|NCT00797225|82991132|FG006|Weeks 13 to 24|Non-compliance|0|||
46843720|NCT00427895|83060576|FG003|Vax 1/Year 1 Follow-up|Other|2|||
46843721|NCT00427895|83060577|FG004|Vax 1/Year 1 Follow-up|Other|0|||
46843722|NCT00427895|83060578|FG005|Vax 1/Year 1 Follow-up|Other|0|||
46843723|NCT00427895|83060579|FG006|Vax 1/Year 1 Follow-up|Other|0|||
46843724|NCT00427895|83060580|FG007|Vax 1/Year 1 Follow-up|Other|0|||
46843725|NCT00427895|83060573|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
46843726|NCT00427895|83060574|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
46639307|NCT01386606|82812853|FG000|Overall Study|Withdrawal by Subject|0|||
46639308|NCT01386606|82812854|FG001|Overall Study|Withdrawal by Subject|1|||
46639309|NCT01386606|82812855|FG002|Overall Study|Withdrawal by Subject|1|||
46772843|NCT00797225|82991133|FG007|Weeks 13 to 24|Non-compliance|0|||
46954573|NCT02688387|83194658|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954574|NCT02688387|83194659|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954575|NCT02688387|83194660|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954576|NCT02688387|83194661|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
46954577|NCT02688387|83194640|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
46954578|NCT02688387|83194641|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46843727|NCT00427895|83060575|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
46843728|NCT00427895|83060576|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
46954579|NCT02688387|83194642|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954580|NCT02688387|83194643|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954581|NCT02688387|83194644|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954582|NCT02688387|83194645|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954583|NCT02688387|83194646|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954584|NCT02688387|83194647|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954585|NCT02688387|83194648|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954586|NCT02688387|83194649|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954587|NCT02688387|83194650|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954588|NCT02688387|83194651|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954589|NCT02688387|83194652|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
47066751|NCT01539512|83349426|FG000|Overall Study|Richter's Transformation|1|||
46843729|NCT00427895|83060577|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
47066752|NCT01539512|83349427|FG001|Overall Study|Richter's Transformation|0|||
47066753|NCT01449955|83349435|FG000|Overall Study|Withdrawal by Subject|1|||
47066754|NCT01449955|83349436|FG001|Overall Study|Withdrawal by Subject|2|||
46639310|NCT01386606|82812856|FG003|Overall Study|Withdrawal by Subject|0|||
46843730|NCT00427895|83060578|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
46843731|NCT00427895|83060579|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
46639311|NCT01386606|82812853|FG000|Overall Study|Protocol Violation|1|||
46639312|NCT01386606|82812854|FG001|Overall Study|Protocol Violation|0|||
46843732|NCT00427895|83060580|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
46843733|NCT00425945|83060621|FG000|Overall Study|Concern about Supplement|2|||
46843734|NCT00425945|83060622|FG001|Overall Study|Concern about Supplement|0|||
46843735|NCT00425945|83060621|FG000|Overall Study|Inconvenience|0|||
46772844|NCT00797225|82991126|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
46843736|NCT00425945|83060622|FG001|Overall Study|Inconvenience|2|||
47066755|NCT01574612|83349449|FG000|Overall Study|Adverse Event|3|||
46954590|NCT02688387|83194653|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954591|NCT02688387|83194654|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954592|NCT02688387|83194655|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954593|NCT02688387|83194656|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954594|NCT02688387|83194657|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954595|NCT02688387|83194658|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954596|NCT02688387|83194659|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954597|NCT02688387|83194660|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954598|NCT02688387|83194661|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
46954599|NCT02688387|83194640|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954600|NCT02688387|83194641|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954601|NCT02688387|83194642|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954602|NCT02688387|83194643|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954603|NCT02688387|83194644|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954604|NCT02688387|83194645|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954605|NCT02688387|83194646|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954606|NCT02688387|83194647|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954607|NCT02688387|83194648|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954608|NCT02688387|83194649|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954609|NCT02688387|83194650|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
46954610|NCT02688387|83194651|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954611|NCT02688387|83194652|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954612|NCT02688387|83194653|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954613|NCT02688387|83194654|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954614|NCT02688387|83194655|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954615|NCT02688387|83194656|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954616|NCT02688387|83194657|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954617|NCT02688387|83194658|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954618|NCT02688387|83194659|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954619|NCT02688387|83194660|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954620|NCT02688387|83194661|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
46954621|NCT02688387|83194640|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954622|NCT02688387|83194641|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954623|NCT02688387|83194642|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954624|NCT02688387|83194643|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954625|NCT02688387|83194644|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954626|NCT02688387|83194645|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954627|NCT02688387|83194646|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954628|NCT02688387|83194647|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954629|NCT02688387|83194648|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954630|NCT02688387|83194649|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954631|NCT02688387|83194650|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954632|NCT02688387|83194651|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954633|NCT02688387|83194652|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954634|NCT02688387|83194653|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954635|NCT02688387|83194654|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
46954636|NCT02688387|83194655|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954637|NCT02688387|83194656|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954638|NCT02688387|83194657|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954639|NCT02688387|83194658|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954640|NCT02688387|83194659|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954641|NCT02688387|83194660|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954642|NCT02688387|83194661|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
46954643|NCT02688387|83194640|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954644|NCT02688387|83194641|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954645|NCT02688387|83194642|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954646|NCT02688387|83194643|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954647|NCT02688387|83194644|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954648|NCT02688387|83194645|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954649|NCT02688387|83194646|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954650|NCT02688387|83194647|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954651|NCT02688387|83194648|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46639313|NCT01386606|82812855|FG002|Overall Study|Protocol Violation|1|||
46639314|NCT01386606|82812856|FG003|Overall Study|Protocol Violation|1|||
46954652|NCT02688387|83194649|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954653|NCT02688387|83194650|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954654|NCT02688387|83194651|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954655|NCT02688387|83194652|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954656|NCT02688387|83194653|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954657|NCT02688387|83194654|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954658|NCT02688387|83194655|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954659|NCT02688387|83194656|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954660|NCT02688387|83194657|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954661|NCT02688387|83194658|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954662|NCT02688387|83194659|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954663|NCT02688387|83194660|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
46954664|NCT02688387|83194661|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
46954665|NCT02688387|83194640|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954666|NCT02688387|83194641|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954667|NCT02688387|83194642|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954668|NCT02688387|83194643|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954669|NCT02688387|83194644|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954670|NCT02688387|83194645|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954671|NCT02688387|83194646|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954672|NCT02688387|83194647|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954673|NCT02688387|83194648|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46843737|NCT00425945|83060621|FG000|Overall Study|Lost to Follow-up|0|||
46843738|NCT00425945|83060622|FG001|Overall Study|Lost to Follow-up|2|||
46843739|NCT00425945|83060621|FG000|Overall Study|Began hypertension medication|1|||
46843740|NCT00425945|83060622|FG001|Overall Study|Began hypertension medication|0|||
46843741|NCT00425945|83060621|FG000|Overall Study|Began cancer treatments|1|||
46843742|NCT00425945|83060622|FG001|Overall Study|Began cancer treatments|0|||
46843743|NCT00425945|83060621|FG000|Overall Study|Moved from area|0|||
46843744|NCT00425945|83060622|FG001|Overall Study|Moved from area|1|||
46843745|NCT00416195|83060632|FG000|Overall Study|Adverse Event|1|||
46843746|NCT00416195|83060633|FG001|Overall Study|Adverse Event|2|||
46843747|NCT00416195|83060632|FG000|Overall Study|Protocol Violation|1|||
46843748|NCT00416195|83060633|FG001|Overall Study|Protocol Violation|1|||
46843749|NCT00416195|83060632|FG000|Overall Study|Other|0|||
46843750|NCT00416195|83060633|FG001|Overall Study|Other|1|||
46843751|NCT00121641|83060643|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
46843752|NCT00121641|83060644|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
46843753|NCT00121641|83060645|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
46843754|NCT00121641|83060646|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
46843755|NCT00121641|83060647|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
46843756|NCT00121641|83060643|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
46843757|NCT00121641|83060644|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
46843758|NCT00121641|83060645|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
46843759|NCT00121641|83060646|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
46843760|NCT00121641|83060647|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
46954674|NCT02688387|83194649|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954675|NCT02688387|83194650|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
47066756|NCT01574612|83349449|FG000|Overall Study|non compliant with drug|2|||
47066757|NCT01574612|83349449|FG000|Overall Study|Withdrawal by Subject|1|||
46772845|NCT00797225|82991127|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
46772846|NCT00797225|82991128|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
46772847|NCT00797225|82991129|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
46772848|NCT00797225|82991130|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
46772849|NCT00797225|82991131|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
46772850|NCT00797225|82991132|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
46772851|NCT00797225|82991133|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
46772852|NCT00797225|82991126|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
46772853|NCT00797225|82991127|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
46772854|NCT00797225|82991128|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
46772855|NCT00797225|82991129|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
46772856|NCT00797225|82991130|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
46772857|NCT00797225|82991131|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
46772858|NCT00797225|82991132|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
46772859|NCT00797225|82991133|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
46772860|NCT00797225|82991126|FG000|Weeks 13 to 24|Adverse Event|0|||
46772861|NCT00797225|82991127|FG001|Weeks 13 to 24|Adverse Event|1|||
46772862|NCT00797225|82991128|FG002|Weeks 13 to 24|Adverse Event|0|||
46772863|NCT00797225|82991129|FG003|Weeks 13 to 24|Adverse Event|0|||
46772864|NCT00797225|82991130|FG004|Weeks 13 to 24|Adverse Event|0|||
46772865|NCT00797225|82991131|FG005|Weeks 13 to 24|Adverse Event|0|||
46772866|NCT00797225|82991132|FG006|Weeks 13 to 24|Adverse Event|1|||
46772867|NCT00797225|82991133|FG007|Weeks 13 to 24|Adverse Event|0|||
46843761|NCT00121641|83060643|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
46843762|NCT00121641|83060644|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
46843763|NCT00121641|83060645|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
46954676|NCT02688387|83194651|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954677|NCT02688387|83194652|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954678|NCT02688387|83194653|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46772868|NCT00797225|82991126|FG000|Weeks 13 to 24|Sponsor Decision|0|||
46954679|NCT02688387|83194654|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954680|NCT02688387|83194655|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954681|NCT02688387|83194656|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954682|NCT02688387|83194657|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954683|NCT02688387|83194658|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
46954684|NCT02688387|83194659|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954685|NCT02688387|83194660|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
46954686|NCT02688387|83194661|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
46954687|NCT02688387|83194640|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954688|NCT02688387|83194641|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954689|NCT02688387|83194642|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954690|NCT02688387|83194643|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954691|NCT02688387|83194644|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954692|NCT02688387|83194645|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954693|NCT02688387|83194646|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954694|NCT02688387|83194647|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954695|NCT02688387|83194648|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954696|NCT02688387|83194649|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954697|NCT02688387|83194650|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954698|NCT02688387|83194651|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954699|NCT02688387|83194652|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954700|NCT02688387|83194653|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954701|NCT02688387|83194654|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954702|NCT02688387|83194655|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954703|NCT02688387|83194656|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954704|NCT02688387|83194657|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954705|NCT02688387|83194658|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954706|NCT02688387|83194659|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
46954707|NCT02688387|83194660|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954708|NCT02688387|83194661|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
46954709|NCT02476201|83194707|FG000|Overall Study|Unable to program MPP|9|||
46954710|NCT02476201|83194707|FG000|Overall Study|Study echo not performed|5|||
46954711|NCT02476201|83194707|FG000|Overall Study|Adverse Event|4|||
46954712|NCT02476201|83194707|FG000|Overall Study|Death|2|||
46954713|NCT02476201|83194707|FG000|Overall Study|Lost to Follow-up|2|||
46954714|NCT02476201|83194707|FG000|Overall Study|MPP programmed to OFF|2|||
46954715|NCT02476201|83194707|FG000|Overall Study|Withdrawal by Subject|1|||
46954716|NCT02476201|83194707|FG000|Overall Study|Unsuccessful implant|1|||
46954717|NCT02688153|83194714|FG000|Overall Study|Death|7|||
46954718|NCT02688153|83194715|FG001|Overall Study|Death|5|||
46954719|NCT02688153|83194714|FG000|Overall Study|Withdrawal by Subject|4|||
46772869|NCT00797225|82991127|FG001|Weeks 13 to 24|Sponsor Decision|0|||
46772870|NCT00797225|82991128|FG002|Weeks 13 to 24|Sponsor Decision|0|||
46772871|NCT00797225|82991129|FG003|Weeks 13 to 24|Sponsor Decision|0|||
46772872|NCT00797225|82991130|FG004|Weeks 13 to 24|Sponsor Decision|0|||
46772873|NCT00797225|82991131|FG005|Weeks 13 to 24|Sponsor Decision|0|||
46772874|NCT00797225|82991132|FG006|Weeks 13 to 24|Sponsor Decision|1|||
46772875|NCT00797225|82991133|FG007|Weeks 13 to 24|Sponsor Decision|0|||
46772876|NCT00778700|82991153|FG000|Overall Study|Adverse Event|6|||
46772877|NCT00778700|82991154|FG001|Overall Study|Adverse Event|1|||
46772878|NCT00778700|82991155|FG002|Overall Study|Adverse Event|3|||
46772879|NCT00778700|82991156|FG003|Overall Study|Adverse Event|5|||
46772880|NCT00778700|82991153|FG000|Overall Study|Protocol Violation|1|||
46772881|NCT00778700|82991154|FG001|Overall Study|Protocol Violation|1|||
46772882|NCT00778700|82991155|FG002|Overall Study|Protocol Violation|0|||
46772883|NCT00778700|82991156|FG003|Overall Study|Protocol Violation|0|||
46639315|NCT01386606|82812853|FG000|Overall Study|Lost to Follow-up|2|||
46772884|NCT00778700|82991153|FG000|Overall Study|Subject Withdrew Consent|6|||
46954720|NCT02688153|83194715|FG001|Overall Study|Withdrawal by Subject|2|||
46954721|NCT02688153|83194714|FG000|Overall Study|Valve Explant|1|||
47066758|NCT01574612|83349449|FG000|Overall Study|Lost to Follow-up|2|||
46772885|NCT00778700|82991154|FG001|Overall Study|Subject Withdrew Consent|4|||
46772886|NCT00778700|82991155|FG002|Overall Study|Subject Withdrew Consent|1|||
46843764|NCT00121641|83060646|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
46843765|NCT00121641|83060647|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
46843766|NCT00121641|83060643|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
46843767|NCT00121641|83060644|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
46843768|NCT00121641|83060645|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
46843769|NCT00121641|83060646|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
46843770|NCT00121641|83060647|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
46843771|NCT00121641|83060643|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
46843772|NCT00121641|83060644|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
46843773|NCT00121641|83060645|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
46843774|NCT00121641|83060646|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
46843775|NCT00121641|83060647|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
46843776|NCT00121641|83060643|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
46843777|NCT00121641|83060644|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
46843778|NCT00121641|83060645|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
46843779|NCT00121641|83060646|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
46843780|NCT00121641|83060647|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
46843781|NCT00121641|83060643|FG000|24-week Short-term Treatment Period|Other Reason|1|||
46843782|NCT00121641|83060644|FG001|24-week Short-term Treatment Period|Other Reason|0|||
46843783|NCT00121641|83060645|FG002|24-week Short-term Treatment Period|Other Reason|0|||
46843784|NCT00121641|83060646|FG003|24-week Short-term Treatment Period|Other Reason|0|||
46843785|NCT00121641|83060647|FG004|24-week Short-term Treatment Period|Other Reason|0|||
46843786|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
46843787|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
46843788|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
46843789|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
46843790|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
46954722|NCT02688153|83194715|FG001|Overall Study|Valve Explant|0|||
46954723|NCT02688153|83194714|FG000|Overall Study|Conversion to Commercial Valve|3|||
47066759|NCT01573910|83349455|FG000|Overall Study|Adverse Event|4|||
47066760|NCT01573910|83349456|FG001|Overall Study|Adverse Event|4|||
47066761|NCT01573910|83349455|FG000|Overall Study|Lost to Follow-up|2|||
47066762|NCT01573910|83349456|FG001|Overall Study|Lost to Follow-up|1|||
47066763|NCT01573910|83349455|FG000|Overall Study|Withdrawal by Subject|0|||
47066764|NCT01573910|83349456|FG001|Overall Study|Withdrawal by Subject|1|||
47066765|NCT01573910|83349455|FG000|Overall Study|Protocol Violation|3|||
47066766|NCT01573910|83349456|FG001|Overall Study|Protocol Violation|0|||
47066767|NCT01573910|83349455|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
47066768|NCT01573910|83349456|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
47066769|NCT01491919|83349465|FG000|Overall Study|Insufficient PK sampling|1|||
47066770|NCT01491919|83349466|FG001|Overall Study|Insufficient PK sampling|2|||
47066771|NCT01491919|83349467|FG002|Overall Study|Insufficient PK sampling|1|||
46772887|NCT00778700|82991156|FG003|Overall Study|Subject Withdrew Consent|4|||
46772888|NCT00778700|82991153|FG000|Overall Study|Lost to Follow-up|3|||
46772889|NCT00778700|82991154|FG001|Overall Study|Lost to Follow-up|1|||
46772890|NCT00778700|82991155|FG002|Overall Study|Lost to Follow-up|0|||
46772891|NCT00778700|82991156|FG003|Overall Study|Lost to Follow-up|1|||
46772892|NCT00778700|82991153|FG000|Overall Study|Reason not Specified|2|||
46772893|NCT00778700|82991154|FG001|Overall Study|Reason not Specified|0|||
46772894|NCT00778700|82991155|FG002|Overall Study|Reason not Specified|1|||
46772895|NCT00778700|82991156|FG003|Overall Study|Reason not Specified|3|||
46772896|NCT00778700|82991153|FG000|Overall Study|Other|0|||
46772897|NCT00778700|82991154|FG001|Overall Study|Other|0|||
46772898|NCT00778700|82991155|FG002|Overall Study|Other|1|||
46772899|NCT00778700|82991156|FG003|Overall Study|Other|0|||
46772900|NCT00793403|82991170|FG000|Overall Study|Other|73|||
46772901|NCT00793325|82991174|FG000|Overall Study|Protocol Violation|18|||
46772902|NCT00793325|82991174|FG000|Overall Study|Lost to Follow-up|1|||
46772903|NCT00778622|82991200|FG000|Overall Study|Adverse Event|5|||
46772904|NCT00778622|82991201|FG001|Overall Study|Adverse Event|4|||
46772905|NCT00778622|82991202|FG002|Overall Study|Adverse Event|7|||
46843791|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
46843792|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
47066772|NCT01573442|83349479|FG000|Overall Study|Cancels|9|||
47066773|NCT01573442|83349480|FG001|Overall Study|Cancels|10|||
47066774|NCT01491841|83349549|FG000|Overall Study|Screen Failure|10|||
47066775|NCT01491841|83349549|FG000|Overall Study|Withdrawal by Subject|1|||
46954724|NCT02688153|83194715|FG001|Overall Study|Conversion to Commercial Valve|0|||
46954725|NCT02687919|83194724|FG000|Overall Study|Withdrawal by Subject|6|||
46954726|NCT02687919|83194725|FG001|Overall Study|Withdrawal by Subject|6|||
46954727|NCT02687919|83194724|FG000|Overall Study|Protocol Violation|2|||
46954728|NCT02687919|83194725|FG001|Overall Study|Protocol Violation|0|||
46954729|NCT02687451|83194737|FG000|Overall Study|Withdrawal by Subject|1|||
46954730|NCT02687451|83194738|FG001|Overall Study|Withdrawal by Subject|0|||
46954731|NCT02687451|83194739|FG002|Overall Study|Withdrawal by Subject|0|||
46954732|NCT02687451|83194740|FG003|Overall Study|Withdrawal by Subject|0|||
46954733|NCT02687451|83194741|FG004|Overall Study|Withdrawal by Subject|0|||
46954734|NCT02687451|83194742|FG005|Overall Study|Withdrawal by Subject|1|||
46954735|NCT02557646|83194758|FG000|Overall Study|Adverse Event|40|||
46954736|NCT02557646|83194758|FG000|Overall Study|Death|1|||
46954737|NCT02557646|83194758|FG000|Overall Study|Lack of Efficacy|186|||
46954738|NCT02557646|83194758|FG000|Overall Study|Withdrawal by Subject|18|||
46954739|NCT02557646|83194758|FG000|Overall Study|Lost to Follow-up|17|||
46954740|NCT02557646|83194758|FG000|Overall Study|Other|14|||
46954741|NCT02679573|83194764|FG000|Overall Study|Adverse Event|13|||
46954742|NCT02679573|83194765|FG001|Overall Study|Adverse Event|6|||
46954743|NCT02679573|83194764|FG000|Overall Study|Lack of Efficacy|12|||
46954744|NCT02679573|83194765|FG001|Overall Study|Lack of Efficacy|15|||
46954745|NCT02679573|83194764|FG000|Overall Study|Could not complete required study visits|6|||
46954746|NCT02679573|83194765|FG001|Overall Study|Could not complete required study visits|2|||
46954747|NCT02679573|83194764|FG000|Overall Study|Withdrawal by Subject|2|||
46954748|NCT02679573|83194765|FG001|Overall Study|Withdrawal by Subject|9|||
46954749|NCT02679573|83194764|FG000|Overall Study|Death|2|||
46954750|NCT02679573|83194765|FG001|Overall Study|Death|0|||
46954751|NCT02679573|83194764|FG000|Overall Study|Physician Decision|2|||
46954752|NCT02679573|83194765|FG001|Overall Study|Physician Decision|4|||
46954753|NCT02679573|83194764|FG000|Overall Study|Lost to Follow-up|0|||
46954754|NCT02679573|83194765|FG001|Overall Study|Lost to Follow-up|3|||
46954755|NCT02685033|83194773|FG000|Overall Study|Withdrawal of Consent|0|||
46954756|NCT02685033|83194774|FG001|Overall Study|Withdrawal of Consent|1|||
46954757|NCT02685033|83194773|FG000|Overall Study|Lost to Follow-up|2|||
46954758|NCT02685033|83194774|FG001|Overall Study|Lost to Follow-up|1|||
46954759|NCT02685033|83194773|FG000|Overall Study|Adverse Event|1|||
46843793|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
46843794|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
46843795|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
46843796|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
46843797|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
46843798|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
46954760|NCT02685033|83194774|FG001|Overall Study|Adverse Event|0|||
46954761|NCT02684097|83194782|FG000|Overall Study|Lack of Efficacy|13|||
46954762|NCT02684097|83194783|FG001|Overall Study|Lack of Efficacy|6|||
46954763|NCT02555618|83194791|FG000|Overall Study|Sponsor's Circumstances|1|||
46772906|NCT00778622|82991200|FG000|Overall Study|Withdrawal by Subject|4|||
46772907|NCT00778622|82991201|FG001|Overall Study|Withdrawal by Subject|5|||
46772908|NCT00778622|82991202|FG002|Overall Study|Withdrawal by Subject|5|||
46772909|NCT00778622|82991200|FG000|Overall Study|Lost to Follow-up|3|||
46772910|NCT00778622|82991201|FG001|Overall Study|Lost to Follow-up|3|||
46772911|NCT00778622|82991202|FG002|Overall Study|Lost to Follow-up|2|||
46954764|NCT02555618|83194792|FG001|Overall Study|Sponsor's Circumstances|0|||
46954765|NCT02557100|83194818|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
46954766|NCT02557100|83194819|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
46954767|NCT02557100|83194820|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
46954768|NCT02557100|83194818|FG000|Single Blind Treatment Period|Death|0|||
46954769|NCT02557100|83194819|FG001|Single Blind Treatment Period|Death|1|||
46954770|NCT02557100|83194820|FG002|Single Blind Treatment Period|Death|0|||
46954771|NCT02557100|83194818|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
46639316|NCT01386606|82812854|FG001|Overall Study|Lost to Follow-up|0|||
46639317|NCT01386606|82812855|FG002|Overall Study|Lost to Follow-up|0|||
46843799|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
46639318|NCT01386606|82812856|FG003|Overall Study|Lost to Follow-up|0|||
46954772|NCT02557100|83194819|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
46772912|NCT00778622|82991200|FG000|Overall Study|Protocol Violation|0|||
46954773|NCT02557100|83194820|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
46954774|NCT02557100|83194818|FG000|Single Blind Treatment Period|Adverse Event|0|||
46954775|NCT02557100|83194819|FG001|Single Blind Treatment Period|Adverse Event|1|||
46772913|NCT00778622|82991201|FG001|Overall Study|Protocol Violation|3|||
46772914|NCT00778622|82991202|FG002|Overall Study|Protocol Violation|0|||
46772915|NCT00778622|82991200|FG000|Overall Study|Lack of Efficacy|2|||
46954776|NCT02557100|83194820|FG002|Single Blind Treatment Period|Adverse Event|0|||
46954777|NCT02557100|83194818|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
46639319|NCT01386606|82812853|FG000|Overall Study|Subject incarcerated|0|||
46639320|NCT01386606|82812854|FG001|Overall Study|Subject incarcerated|1|||
46639321|NCT01386606|82812855|FG002|Overall Study|Subject incarcerated|0|||
46639322|NCT01386606|82812856|FG003|Overall Study|Subject incarcerated|0|||
46639323|NCT01386606|82812853|FG000|Overall Study|Unable to draw PK|1|||
46639324|NCT01386606|82812854|FG001|Overall Study|Unable to draw PK|0|||
46639325|NCT01386606|82812855|FG002|Overall Study|Unable to draw PK|0|||
46639326|NCT01386606|82812856|FG003|Overall Study|Unable to draw PK|0|||
46639327|NCT01386606|82812853|FG000|Overall Study|T levels too high|0|||
46639328|NCT01386606|82812854|FG001|Overall Study|T levels too high|1|||
46954778|NCT02557100|83194819|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
46639329|NCT01386606|82812855|FG002|Overall Study|T levels too high|1|||
46639330|NCT01386606|82812856|FG003|Overall Study|T levels too high|0|||
46639331|NCT01385748|82812873|FG000|Overall Study|Withdrawal by Subject|7|||
46639332|NCT01385748|82812874|FG001|Overall Study|Withdrawal by Subject|4|||
46639333|NCT01385748|82812875|FG002|Overall Study|Withdrawal by Subject|5|||
46639334|NCT01385748|82812873|FG000|Overall Study|Noncompliance|3|||
46639335|NCT01385748|82812874|FG001|Overall Study|Noncompliance|1|||
46639336|NCT01385748|82812875|FG002|Overall Study|Noncompliance|6|||
46639337|NCT01385748|82812873|FG000|Overall Study|Other|1|||
46639338|NCT01385748|82812874|FG001|Overall Study|Other|7|||
46639339|NCT01385748|82812875|FG002|Overall Study|Other|1|||
46639340|NCT01385748|82812873|FG000|Overall Study|Adverse Event|4|||
46639341|NCT01385748|82812874|FG001|Overall Study|Adverse Event|2|||
46639342|NCT01385748|82812875|FG002|Overall Study|Adverse Event|1|||
46639343|NCT01397448|82812890|FG000|Overall Study|Adverse Event|4|||
46639344|NCT01397448|82812891|FG001|Overall Study|Adverse Event|4|||
46639345|NCT01397448|82812892|FG002|Overall Study|Adverse Event|6|||
46639346|NCT01397448|82812890|FG000|Overall Study|Withdrawal by Subject|4|||
46772916|NCT00778622|82991201|FG001|Overall Study|Lack of Efficacy|0|||
46772917|NCT00778622|82991202|FG002|Overall Study|Lack of Efficacy|0|||
46954779|NCT02557100|83194820|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
46954780|NCT02557100|83194818|FG000|Cumulative Abatacept Period|Other Reasons|0|||
46954781|NCT02557100|83194819|FG001|Cumulative Abatacept Period|Other Reasons|0|||
46954782|NCT02557100|83194820|FG002|Cumulative Abatacept Period|Other Reasons|1|||
46954783|NCT02557100|83194818|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
46954784|NCT02557100|83194819|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
46954785|NCT02557100|83194820|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
46954786|NCT02557100|83194818|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
46954787|NCT02557100|83194819|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
46954788|NCT02557100|83194820|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
46954789|NCT01337635|83194830|FG000|Overall Study|Lost to Follow-up|0|||
46954790|NCT01337635|83194831|FG001|Overall Study|Lost to Follow-up|1|||
46954791|NCT02556710|83194839|FG000|Overall Study|Surgical treatment|3|||
46954792|NCT02556710|83194840|FG001|Overall Study|Surgical treatment|0|||
46954793|NCT02556710|83194839|FG000|Overall Study|Required proscribed pain medication|2|||
46954794|NCT02556710|83194840|FG001|Overall Study|Required proscribed pain medication|1|||
46954795|NCT02556710|83194839|FG000|Overall Study|Lack of Efficacy|1|||
46954796|NCT02556710|83194840|FG001|Overall Study|Lack of Efficacy|0|||
46954797|NCT02556710|83194839|FG000|Overall Study|Worsening osteoarthritis|1|||
46772918|NCT00778622|82991200|FG000|Overall Study|immigration|1|||
46772919|NCT00778622|82991201|FG001|Overall Study|immigration|0|||
46772920|NCT00778622|82991202|FG002|Overall Study|immigration|0|||
46772921|NCT00778622|82991200|FG000|Overall Study|Other|1|||
46772922|NCT00778622|82991201|FG001|Overall Study|Other|0|||
46772923|NCT00778622|82991202|FG002|Overall Study|Other|1|||
46772924|NCT00777920|82991214|FG000|Overall Study|Adverse Event|39|||
46843800|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
46843801|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
46954798|NCT02556710|83194840|FG001|Overall Study|Worsening osteoarthritis|0|||
46954799|NCT02556710|83194839|FG000|Overall Study|Moved out of state|1|||
46954800|NCT02556710|83194840|FG001|Overall Study|Moved out of state|0|||
46954801|NCT02556710|83194839|FG000|Overall Study|Missing reason|3|||
46954802|NCT02556710|83194840|FG001|Overall Study|Missing reason|1|||
46954803|NCT02556710|83194839|FG000|Overall Study|Pain as lack of efficacy|0|||
46954804|NCT02556710|83194840|FG001|Overall Study|Pain as lack of efficacy|4|||
46954805|NCT02556632|83194851|FG000|Overall Study|Lost to Follow-up|1|||
46639347|NCT01397448|82812891|FG001|Overall Study|Withdrawal by Subject|4|||
46639348|NCT01397448|82812892|FG002|Overall Study|Withdrawal by Subject|3|||
46639349|NCT01397448|82812890|FG000|Overall Study|Lack of Efficacy|2|||
46639350|NCT01397448|82812891|FG001|Overall Study|Lack of Efficacy|0|||
46639351|NCT01397448|82812892|FG002|Overall Study|Lack of Efficacy|5|||
46639352|NCT01397448|82812890|FG000|Overall Study|Other|8|||
46639353|NCT01397448|82812891|FG001|Overall Study|Other|7|||
46639354|NCT01397448|82812892|FG002|Overall Study|Other|4|||
46639355|NCT01385202|82812900|FG000|Overall Study|Lost to Follow-up|6|||
46772925|NCT00777920|82991214|FG000|Overall Study|Withdrawal of Consent|4|||
46772926|NCT00777920|82991214|FG000|Overall Study|Lost to Follow-up|1|||
46772927|NCT00777920|82991214|FG000|Overall Study|Investigator's discretion|1|||
46772928|NCT00777920|82991214|FG000|Overall Study|Clinical status did not improve|1|||
46954806|NCT02556632|83194852|FG001|Overall Study|Lost to Follow-up|0|||
46954807|NCT02556632|83194853|FG002|Overall Study|Lost to Follow-up|0|||
46954808|NCT02556632|83194851|FG000|Overall Study|Disliked Intervention|1|||
46954809|NCT02556632|83194852|FG001|Overall Study|Disliked Intervention|1|||
46954810|NCT02556632|83194853|FG002|Overall Study|Disliked Intervention|1|||
46954811|NCT02556632|83194851|FG000|Overall Study|No Reason|1|||
46954812|NCT02556632|83194852|FG001|Overall Study|No Reason|0|||
46954813|NCT02556632|83194853|FG002|Overall Study|No Reason|1|||
46954814|NCT02556632|83194851|FG000|Overall Study|Personal Issues|0|||
46954815|NCT02556632|83194852|FG001|Overall Study|Personal Issues|1|||
46954816|NCT02556632|83194853|FG002|Overall Study|Personal Issues|1|||
46954817|NCT02556632|83194851|FG000|Overall Study|Changed Mind|0|||
46954818|NCT02556632|83194852|FG001|Overall Study|Changed Mind|1|||
46954819|NCT02556632|83194853|FG002|Overall Study|Changed Mind|0|||
46954820|NCT02556632|83194851|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
46954821|NCT02556632|83194852|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
46954822|NCT02556632|83194853|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
46954823|NCT02556632|83194851|FG000|Overall Study|Unrelated Adverse Event|1|||
46954824|NCT02556632|83194852|FG001|Overall Study|Unrelated Adverse Event|0|||
46954825|NCT02556632|83194853|FG002|Overall Study|Unrelated Adverse Event|3|||
46954826|NCT02556632|83194851|FG000|Overall Study|Related Adverse Event|0|||
46954827|NCT02556632|83194852|FG001|Overall Study|Related Adverse Event|1|||
46954828|NCT02556632|83194853|FG002|Overall Study|Related Adverse Event|0|||
46954829|NCT02556632|83194851|FG000|Overall Study|Possibly Related Adverse Event|0|||
46954830|NCT02556632|83194852|FG001|Overall Study|Possibly Related Adverse Event|0|||
46954831|NCT02556632|83194853|FG002|Overall Study|Possibly Related Adverse Event|1|||
46954832|NCT02556632|83194851|FG000|Overall Study|Did Not Start RT|0|||
46954833|NCT02556632|83194852|FG001|Overall Study|Did Not Start RT|1|||
46954834|NCT02556632|83194853|FG002|Overall Study|Did Not Start RT|0|||
46954835|NCT02556632|83194851|FG000|Overall Study|Ineligible|0|||
46954836|NCT02556632|83194852|FG001|Overall Study|Ineligible|1|||
46954837|NCT02556632|83194853|FG002|Overall Study|Ineligible|0|||
46954838|NCT02556632|83194851|FG000|Overall Study|Disliked Study Procedures|0|||
46954839|NCT02556632|83194852|FG001|Overall Study|Disliked Study Procedures|0|||
46954840|NCT02556632|83194853|FG002|Overall Study|Disliked Study Procedures|1|||
46954841|NCT02556632|83194851|FG000|Overall Study|Treatment or Change Delay|0|||
46954842|NCT02556632|83194852|FG001|Overall Study|Treatment or Change Delay|0|||
46954843|NCT02556632|83194853|FG002|Overall Study|Treatment or Change Delay|1|||
46954844|NCT01662440|83194865|FG000|Overall Study|Adverse Event|1|||
46954845|NCT01662440|83194866|FG001|Overall Study|Adverse Event|0|||
46954846|NCT01662440|83194867|FG002|Overall Study|Adverse Event|0|||
46954847|NCT01662440|83194868|FG003|Overall Study|Adverse Event|1|||
46954848|NCT01662440|83194865|FG000|Overall Study|Death|0|||
46954849|NCT01662440|83194866|FG001|Overall Study|Death|1|||
46954850|NCT01662440|83194867|FG002|Overall Study|Death|0|||
46954851|NCT01662440|83194868|FG003|Overall Study|Death|0|||
46954852|NCT01662440|83194865|FG000|Overall Study|Lost to Follow-up|2|||
46954853|NCT01662440|83194866|FG001|Overall Study|Lost to Follow-up|2|||
46954854|NCT01662440|83194867|FG002|Overall Study|Lost to Follow-up|4|||
46954855|NCT01662440|83194868|FG003|Overall Study|Lost to Follow-up|1|||
47066776|NCT01553318|83349568|FG000|Overall Study|Protocol Violation|3|||
47066777|NCT01553318|83349569|FG001|Overall Study|Protocol Violation|2|||
47066778|NCT01572740|83349588|FG000|Overall Study|Adverse Event|1|||
46772929|NCT00777920|82991214|FG000|Overall Study|Other, not specified|4|||
46772930|NCT04236141|82991220|FG000|Overall Study|Death|18|||
46772931|NCT04236141|82991221|FG001|Overall Study|Death|10|||
46772932|NCT04236141|82991220|FG000|Overall Study|Withdrawal by Participant|1|||
46772933|NCT04236141|82991221|FG001|Overall Study|Withdrawal by Participant|0|||
46954856|NCT01662440|83194865|FG000|Overall Study|Subject moved to another country.|0|||
46639356|NCT01385202|82812900|FG000|Overall Study|Not Eligible|11|||
46639357|NCT01385202|82812900|FG000|Overall Study|Withdrawn|1|||
46772934|NCT04236141|82991220|FG000|Overall Study|Reason not Specified|1|||
46954857|NCT01662440|83194866|FG001|Overall Study|Subject moved to another country.|1|||
46954858|NCT01662440|83194867|FG002|Overall Study|Subject moved to another country.|0|||
46954859|NCT01662440|83194868|FG003|Overall Study|Subject moved to another country.|0|||
46954860|NCT01662440|83194865|FG000|Overall Study|Protocol Violation|1|||
46954861|NCT01662440|83194866|FG001|Overall Study|Protocol Violation|0|||
46954862|NCT01662440|83194867|FG002|Overall Study|Protocol Violation|0|||
46954863|NCT01662440|83194868|FG003|Overall Study|Protocol Violation|0|||
46954864|NCT01662440|83194865|FG000|Overall Study|Withdrawal by Subject|5|||
46954865|NCT01662440|83194866|FG001|Overall Study|Withdrawal by Subject|2|||
46772935|NCT04236141|82991221|FG001|Overall Study|Reason not Specified|0|||
46954866|NCT01662440|83194867|FG002|Overall Study|Withdrawal by Subject|2|||
46954867|NCT01662440|83194868|FG003|Overall Study|Withdrawal by Subject|2|||
46954868|NCT01662362|83194888|FG000|Overall Study|Lost to Follow-up|38|||
46954869|NCT02554682|83194903|FG000|Overall Study|Lost to Follow-up|11|||
46772936|NCT04236141|82991220|FG000|Overall Study|Study terminated by Sponsor|8|||
46954870|NCT02554682|83194904|FG001|Overall Study|Lost to Follow-up|9|||
46954871|NCT02554682|83194905|FG002|Overall Study|Lost to Follow-up|4|||
46954872|NCT02554682|83194906|FG003|Overall Study|Lost to Follow-up|3|||
46954873|NCT02554682|83194907|FG004|Overall Study|Lost to Follow-up|2|||
46954874|NCT02554682|83194908|FG005|Overall Study|Lost to Follow-up|1|||
46954875|NCT02554682|83194909|FG006|Overall Study|Lost to Follow-up|6|||
46954876|NCT02554682|83194910|FG007|Overall Study|Lost to Follow-up|6|||
46954877|NCT02554682|83194911|FG008|Overall Study|Lost to Follow-up|2|||
46954878|NCT02554682|83194912|FG009|Overall Study|Lost to Follow-up|2|||
46954879|NCT02554682|83194903|FG000|Overall Study|Withdrawal by Subject|2|||
46954880|NCT02554682|83194904|FG001|Overall Study|Withdrawal by Subject|1|||
46954881|NCT02554682|83194905|FG002|Overall Study|Withdrawal by Subject|0|||
46954882|NCT02554682|83194906|FG003|Overall Study|Withdrawal by Subject|0|||
46954883|NCT02554682|83194907|FG004|Overall Study|Withdrawal by Subject|0|||
46954884|NCT02554682|83194908|FG005|Overall Study|Withdrawal by Subject|0|||
46954885|NCT02554682|83194909|FG006|Overall Study|Withdrawal by Subject|0|||
46954886|NCT02554682|83194910|FG007|Overall Study|Withdrawal by Subject|0|||
46954887|NCT02554682|83194911|FG008|Overall Study|Withdrawal by Subject|0|||
46954888|NCT02554682|83194912|FG009|Overall Study|Withdrawal by Subject|0|||
46954889|NCT02554682|83194903|FG000|Overall Study|Physician Decision|2|||
46954890|NCT02554682|83194904|FG001|Overall Study|Physician Decision|2|||
46954891|NCT02554682|83194905|FG002|Overall Study|Physician Decision|0|||
46954892|NCT02554682|83194906|FG003|Overall Study|Physician Decision|0|||
46954893|NCT02554682|83194907|FG004|Overall Study|Physician Decision|0|||
46954894|NCT02554682|83194908|FG005|Overall Study|Physician Decision|0|||
46954895|NCT02554682|83194909|FG006|Overall Study|Physician Decision|0|||
46954896|NCT02554682|83194910|FG007|Overall Study|Physician Decision|0|||
46954897|NCT02554682|83194911|FG008|Overall Study|Physician Decision|0|||
46954898|NCT02554682|83194912|FG009|Overall Study|Physician Decision|0|||
46954899|NCT00154063|83194948|FG000|Overall Study|Adverse Event|4|||
46954900|NCT00154063|83194949|FG001|Overall Study|Adverse Event|8|||
46954901|NCT00154063|83194948|FG000|Overall Study|Protocol Violation|1|||
46954902|NCT00154063|83194949|FG001|Overall Study|Protocol Violation|1|||
46954903|NCT00154063|83194948|FG000|Overall Study|Investigator or Sponsor Request|0|||
46954904|NCT00154063|83194949|FG001|Overall Study|Investigator or Sponsor Request|1|||
46954905|NCT00154063|83194948|FG000|Overall Study|Withdrawal by Subject|4|||
46954906|NCT00154063|83194949|FG001|Overall Study|Withdrawal by Subject|9|||
46954907|NCT00154063|83194948|FG000|Overall Study|Other|3|||
46954908|NCT00154063|83194949|FG001|Overall Study|Other|3|||
46954909|NCT02683941|83194961|FG000|Double-blind Phase|Adverse Event|0|||
46954910|NCT02683941|83194962|FG001|Double-blind Phase|Adverse Event|1|||
46954911|NCT02683941|83194961|FG000|Double-blind Phase|Withdrawal by Subject|4|||
46954912|NCT02683941|83194962|FG001|Double-blind Phase|Withdrawal by Subject|2|||
46954913|NCT02683941|83194961|FG000|Double-blind Phase|Lost to Follow-up|1|||
46954914|NCT02683941|83194962|FG001|Double-blind Phase|Lost to Follow-up|0|||
46954915|NCT02683941|83194961|FG000|Double-blind Phase|Disease Progression|5|||
46772937|NCT04236141|82991221|FG001|Overall Study|Study terminated by Sponsor|4|||
46772938|NCT00796445|82991229|FG000|Overall Study|Protocol Violation|5|||
46772939|NCT00796445|82991230|FG001|Overall Study|Protocol Violation|3|||
46772940|NCT00796445|82991229|FG000|Overall Study|Adverse event, serious fatal|10|||
46772941|NCT00796445|82991230|FG001|Overall Study|Adverse event, serious fatal|5|||
46772942|NCT00796445|82991229|FG000|Overall Study|Adverse event, non-fatal|4|||
46772943|NCT00796445|82991230|FG001|Overall Study|Adverse event, non-fatal|0|||
46772944|NCT00796445|82991229|FG000|Overall Study|Disease progression/recurrence|537|||
46772945|NCT00796445|82991230|FG001|Overall Study|Disease progression/recurrence|268|||
46772946|NCT00796445|82991229|FG000|Overall Study|Other|10|||
46772947|NCT00796445|82991230|FG001|Overall Study|Other|7|||
46772948|NCT00796445|82991229|FG000|Overall Study|Withdrawal by Subject|18|||
46772949|NCT00796445|82991230|FG001|Overall Study|Withdrawal by Subject|9|||
46954916|NCT02683941|83194962|FG001|Double-blind Phase|Disease Progression|2|||
46954917|NCT02683941|83194961|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
46954918|NCT02683941|83194962|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
46954919|NCT02683941|83194961|FG000|Open-label Treatment Phase|Disease Progression|1|||
46954920|NCT02683941|83194962|FG001|Open-label Treatment Phase|Disease Progression|2|||
46954921|NCT02683941|83194961|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
46954922|NCT02683941|83194962|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
47066779|NCT01572740|83349589|FG001|Overall Study|Adverse Event|1|||
46954923|NCT02683941|83194961|FG000|Open-label Treatment Phase|Other|1|||
46954924|NCT02683941|83194962|FG001|Open-label Treatment Phase|Other|0|||
46954925|NCT02683941|83194961|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
46954926|NCT02683941|83194962|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
46954927|NCT02683941|83194961|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
46954928|NCT02683941|83194962|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
46954929|NCT02683941|83194961|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
46772950|NCT00796445|82991229|FG000|Overall Study|Invalid Informed Consent Form|1|||
46772951|NCT00796445|82991230|FG001|Overall Study|Invalid Informed Consent Form|0|||
46954930|NCT02683941|83194962|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
46954931|NCT02683941|83194961|FG000|Open-label Follow-up Phase|Other|8|||
46954932|NCT02683941|83194962|FG001|Open-label Follow-up Phase|Other|1|||
46954933|NCT02678247|83194974|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
46954934|NCT02678247|83194975|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
46954935|NCT02678247|83194974|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
46954936|NCT02678247|83194975|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
46954937|NCT02678247|83194974|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
46954938|NCT02678247|83194975|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
46954939|NCT02678247|83194974|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
46954940|NCT02678247|83194975|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
46954941|NCT02678247|83194974|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
46954942|NCT02678247|83194975|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
46954943|NCT02678247|83194974|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
46954944|NCT02678247|83194975|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
46954945|NCT02683785|83194988|FG000|Overall Study|Withdrawal by Subject|1|||
46954946|NCT02683785|83194989|FG001|Overall Study|Withdrawal by Subject|1|||
46954947|NCT02683785|83194988|FG000|Overall Study|Lost to Follow-up|0|||
46954948|NCT02683785|83194989|FG001|Overall Study|Lost to Follow-up|1|||
46954949|NCT02683785|83194988|FG000|Overall Study|Adverse Event|0|||
46954950|NCT02683785|83194989|FG001|Overall Study|Adverse Event|2|||
46954951|NCT02543294|83194997|FG000|Overall Study|Lost to Follow-up|3|||
46954952|NCT02543294|83194997|FG000|Overall Study|Physician Decision|2|||
46954953|NCT02543294|83194997|FG000|Overall Study|Withdrawal by Subject|7|||
46954954|NCT02551874|83195004|FG000|Overall Study|Lost to Follow-up|0|||
46954955|NCT02551874|83195005|FG001|Overall Study|Lost to Follow-up|2|||
46954956|NCT02551874|83195004|FG000|Overall Study|Pregnancy|0|||
46954957|NCT02551874|83195005|FG001|Overall Study|Pregnancy|1|||
46954958|NCT02551874|83195004|FG000|Overall Study|Reason not reported|10|||
46954959|NCT02551874|83195005|FG001|Overall Study|Reason not reported|4|||
46954960|NCT02551874|83195004|FG000|Overall Study|Did not receive randomized treatment|0|||
46954961|NCT02551874|83195005|FG001|Overall Study|Did not receive randomized treatment|7|||
46954962|NCT02551874|83195004|FG000|Overall Study|Did not enter long-term study|18|||
46954963|NCT02551874|83195005|FG001|Overall Study|Did not enter long-term study|25|||
46954964|NCT02550938|83195028|FG000|Overall Study|Lost to Follow-up|8|||
46954965|NCT02550938|83195029|FG001|Overall Study|Lost to Follow-up|7|||
46954966|NCT02550938|83195030|FG002|Overall Study|Lost to Follow-up|12|||
46954967|NCT02550938|83195031|FG003|Overall Study|Lost to Follow-up|11|||
46954968|NCT02769065|83195071|FG000|Overall Study|Voluntary Withdrawal|1|||
46954969|NCT02769065|83195072|FG001|Overall Study|Voluntary Withdrawal|0|||
46954970|NCT02769065|83195073|FG002|Overall Study|Voluntary Withdrawal|0|||
46954971|NCT02769065|83195074|FG003|Overall Study|Voluntary Withdrawal|0|||
46954972|NCT02769065|83195075|FG004|Overall Study|Voluntary Withdrawal|0|||
46954973|NCT02769065|83195076|FG005|Overall Study|Voluntary Withdrawal|0|||
46954974|NCT02769065|83195077|FG006|Overall Study|Voluntary Withdrawal|0|||
46954975|NCT02769065|83195078|FG007|Overall Study|Voluntary Withdrawal|0|||
47066780|NCT01572740|83349588|FG000|Overall Study|Withdrawal by Subject|1|||
47066781|NCT01572740|83349589|FG001|Overall Study|Withdrawal by Subject|1|||
46843802|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
46954976|NCT02769065|83195079|FG008|Overall Study|Voluntary Withdrawal|0|||
47066782|NCT01572740|83349588|FG000|Overall Study|unclassified|4|||
47066783|NCT01572740|83349589|FG001|Overall Study|unclassified|3|||
47066784|NCT01491607|83349599|FG000|Overall Study|Lost to Follow-up|7|||
47066785|NCT01491607|83349599|FG000|Overall Study|Withdrawal by Subject|3|||
47066786|NCT01449721|83349682|FG000|Overall Study|Physician Decision|0|||
46772952|NCT03939819|82991246|FG000|Overall Study|Death|2|||
46772953|NCT03939819|82991247|FG001|Overall Study|Death|0|||
46772954|NCT00756938|82991256|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
46772955|NCT00756938|82991257|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
46772956|NCT00756938|82991258|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
46772957|NCT00756938|82991259|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
46772958|NCT00756938|82991256|FG000|12-week Base Study|Protocol Violation|0|||
46843803|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
46954977|NCT02769065|83195080|FG009|Overall Study|Voluntary Withdrawal|0|||
46954978|NCT02769065|83195081|FG010|Overall Study|Voluntary Withdrawal|0|||
47066787|NCT01449721|83349683|FG001|Overall Study|Physician Decision|1|||
47066788|NCT01449721|83349682|FG000|Overall Study|Physician Decision|0|||
46772959|NCT00756938|82991257|FG001|12-week Base Study|Protocol Violation|0|||
46843804|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
46954979|NCT02769065|83195082|FG011|Overall Study|Voluntary Withdrawal|0|||
46954980|NCT02769065|83195083|FG012|Overall Study|Voluntary Withdrawal|0|||
46954981|NCT02769065|83195084|FG013|Overall Study|Voluntary Withdrawal|0|||
46772960|NCT00756938|82991258|FG002|12-week Base Study|Protocol Violation|1|||
46772961|NCT00756938|82991259|FG003|12-week Base Study|Protocol Violation|0|||
46954982|NCT02769065|83195085|FG014|Overall Study|Voluntary Withdrawal|0|||
46954983|NCT02769065|83195086|FG015|Overall Study|Voluntary Withdrawal|0|||
46954984|NCT02769065|83195087|FG016|Overall Study|Voluntary Withdrawal|0|||
46954985|NCT02769065|83195088|FG017|Overall Study|Voluntary Withdrawal|0|||
46954986|NCT02769065|83195089|FG018|Overall Study|Voluntary Withdrawal|0|||
46954987|NCT02769065|83195090|FG019|Overall Study|Voluntary Withdrawal|0|||
46954988|NCT02769065|83195091|FG020|Overall Study|Voluntary Withdrawal|0|||
46954989|NCT02769065|83195092|FG021|Overall Study|Voluntary Withdrawal|0|||
46954990|NCT02769065|83195093|FG022|Overall Study|Voluntary Withdrawal|0|||
46954991|NCT02769065|83195094|FG023|Overall Study|Voluntary Withdrawal|0|||
46954992|NCT02769065|83195095|FG024|Overall Study|Voluntary Withdrawal|0|||
46954993|NCT02769065|83195096|FG025|Overall Study|Voluntary Withdrawal|0|||
46954994|NCT02769065|83195097|FG026|Overall Study|Voluntary Withdrawal|0|||
46954995|NCT02769065|83195098|FG027|Overall Study|Voluntary Withdrawal|0|||
46954996|NCT02769065|83195099|FG028|Overall Study|Voluntary Withdrawal|0|||
46954997|NCT02769065|83195100|FG029|Overall Study|Voluntary Withdrawal|0|||
46954998|NCT02769065|83195071|FG000|Overall Study|Reason Not Specified|0|||
46954999|NCT02769065|83195072|FG001|Overall Study|Reason Not Specified|0|||
46955000|NCT02769065|83195073|FG002|Overall Study|Reason Not Specified|0|||
46955001|NCT02769065|83195074|FG003|Overall Study|Reason Not Specified|0|||
46955002|NCT02769065|83195075|FG004|Overall Study|Reason Not Specified|0|||
46955003|NCT02769065|83195076|FG005|Overall Study|Reason Not Specified|0|||
46955004|NCT02769065|83195077|FG006|Overall Study|Reason Not Specified|1|||
46955005|NCT02769065|83195078|FG007|Overall Study|Reason Not Specified|0|||
46955006|NCT02769065|83195079|FG008|Overall Study|Reason Not Specified|0|||
46955007|NCT02769065|83195080|FG009|Overall Study|Reason Not Specified|0|||
46955008|NCT02769065|83195081|FG010|Overall Study|Reason Not Specified|0|||
46955009|NCT02769065|83195082|FG011|Overall Study|Reason Not Specified|0|||
46955010|NCT02769065|83195083|FG012|Overall Study|Reason Not Specified|0|||
46955011|NCT02769065|83195084|FG013|Overall Study|Reason Not Specified|0|||
46955012|NCT02769065|83195085|FG014|Overall Study|Reason Not Specified|0|||
46955013|NCT02769065|83195086|FG015|Overall Study|Reason Not Specified|0|||
46955014|NCT02769065|83195087|FG016|Overall Study|Reason Not Specified|0|||
46955015|NCT02769065|83195088|FG017|Overall Study|Reason Not Specified|0|||
46955016|NCT02769065|83195089|FG018|Overall Study|Reason Not Specified|0|||
46955017|NCT02769065|83195090|FG019|Overall Study|Reason Not Specified|0|||
46955018|NCT02769065|83195091|FG020|Overall Study|Reason Not Specified|0|||
46955019|NCT02769065|83195092|FG021|Overall Study|Reason Not Specified|0|||
46955020|NCT02769065|83195093|FG022|Overall Study|Reason Not Specified|0|||
46955021|NCT02769065|83195094|FG023|Overall Study|Reason Not Specified|0|||
46955022|NCT02769065|83195095|FG024|Overall Study|Reason Not Specified|0|||
46955023|NCT02769065|83195096|FG025|Overall Study|Reason Not Specified|0|||
46955024|NCT02769065|83195097|FG026|Overall Study|Reason Not Specified|0|||
46955025|NCT02769065|83195098|FG027|Overall Study|Reason Not Specified|0|||
47066789|NCT01449721|83349683|FG001|Overall Study|Physician Decision|1|||
47066790|NCT01553084|83349692|FG000|Overall Study|Withdrawal by Subject|15|||
47066791|NCT01553084|83349693|FG001|Overall Study|Withdrawal by Subject|13|||
47066792|NCT01553084|83349694|FG002|Overall Study|Withdrawal by Subject|35|||
47066793|NCT01536860|83349704|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
47066794|NCT01536860|83349705|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
47066795|NCT01536860|83349706|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
47066796|NCT01552928|83349718|FG000|Period 3|Adverse Event|0|||
47066797|NCT01552928|83349719|FG001|Period 3|Adverse Event|0|||
47066798|NCT01552928|83349720|FG002|Period 3|Adverse Event|1|||
47066799|NCT01552928|83349721|FG003|Period 3|Adverse Event|0|||
47066800|NCT01448707|83349740|FG000|Overall Study|Adverse Event|3|||
47066801|NCT01448707|83349741|FG001|Overall Study|Adverse Event|1|||
47066802|NCT01448707|83349740|FG000|Overall Study|Lost to Follow-up|2|||
47066803|NCT01448707|83349741|FG001|Overall Study|Lost to Follow-up|6|||
47066804|NCT01448707|83349740|FG000|Overall Study|Withdrawal by Subject|6|||
47066805|NCT01448707|83349741|FG001|Overall Study|Withdrawal by Subject|7|||
47066806|NCT01448707|83349740|FG000|Overall Study|Other|7|||
47066807|NCT01448707|83349741|FG001|Overall Study|Other|4|||
47066808|NCT01536704|83349747|FG000|Washout Period 1|Withdrawal by Subject|1|||
47066809|NCT01536704|83349748|FG001|Washout Period 1|Withdrawal by Subject|2|||
46955026|NCT02769065|83195099|FG028|Overall Study|Reason Not Specified|0|||
47066810|NCT01536704|83349749|FG002|Washout Period 1|Withdrawal by Subject|0|||
47066811|NCT01536704|83349750|FG003|Washout Period 1|Withdrawal by Subject|0|||
47066812|NCT01536704|83349747|FG000|Washout Period 2|Adverse Event|1|||
47066813|NCT01536704|83349748|FG001|Washout Period 2|Adverse Event|0|||
47066814|NCT01536704|83349749|FG002|Washout Period 2|Adverse Event|0|||
46955027|NCT02769065|83195100|FG029|Overall Study|Reason Not Specified|0|||
46955028|NCT02769065|83195071|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
47066815|NCT01536704|83349750|FG003|Washout Period 2|Adverse Event|0|||
47066816|NCT01536704|83349747|FG000|Washout Period 2|Withdrawal by Subject|0|||
47066817|NCT01536704|83349748|FG001|Washout Period 2|Withdrawal by Subject|0|||
46843805|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
46955029|NCT02769065|83195072|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955030|NCT02769065|83195073|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955031|NCT02769065|83195074|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955032|NCT02769065|83195075|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955033|NCT02769065|83195076|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955034|NCT02769065|83195077|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955035|NCT02769065|83195078|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955036|NCT02769065|83195079|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955037|NCT02769065|83195080|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955038|NCT02769065|83195081|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
46955039|NCT02769065|83195082|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955040|NCT02769065|83195083|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955041|NCT02769065|83195084|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955042|NCT02769065|83195085|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955043|NCT02769065|83195086|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955044|NCT02769065|83195087|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955045|NCT02769065|83195088|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955046|NCT02769065|83195089|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955047|NCT02769065|83195090|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955048|NCT02769065|83195091|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955049|NCT02769065|83195092|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955050|NCT02769065|83195093|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955051|NCT02769065|83195094|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
47066818|NCT01536704|83349749|FG002|Washout Period 2|Withdrawal by Subject|0|||
46772962|NCT00756938|82991256|FG000|12-week Base Study|Lost to Follow-up|1|||
46772963|NCT00756938|82991257|FG001|12-week Base Study|Lost to Follow-up|0|||
46772964|NCT00756938|82991258|FG002|12-week Base Study|Lost to Follow-up|0|||
46772965|NCT00756938|82991259|FG003|12-week Base Study|Lost to Follow-up|0|||
46772966|NCT00756938|82991256|FG000|Optional Extension|Lack of Efficacy|0|||
46772967|NCT00756938|82991257|FG001|Optional Extension|Lack of Efficacy|0|||
46772968|NCT00756938|82991258|FG002|Optional Extension|Lack of Efficacy|0|||
46772969|NCT00756938|82991259|FG003|Optional Extension|Lack of Efficacy|1|||
46772970|NCT00756938|82991256|FG000|Optional Extension|End of Study|0|||
46772971|NCT00756938|82991257|FG001|Optional Extension|End of Study|0|||
46772972|NCT00756938|82991258|FG002|Optional Extension|End of Study|0|||
46772973|NCT00756938|82991259|FG003|Optional Extension|End of Study|11|||
46772974|NCT00756938|82991256|FG000|Optional Extension|Protocol-specific criteria met|0|||
46772975|NCT00756938|82991257|FG001|Optional Extension|Protocol-specific criteria met|0|||
47066819|NCT01536704|83349750|FG003|Washout Period 2|Withdrawal by Subject|1|||
47066820|NCT01536704|83349747|FG000|Period 3|Adverse Event|0|||
47066821|NCT01536704|83349748|FG001|Period 3|Adverse Event|0|||
46772976|NCT00756938|82991258|FG002|Optional Extension|Protocol-specific criteria met|0|||
46772977|NCT00756938|82991259|FG003|Optional Extension|Protocol-specific criteria met|9|||
46772978|NCT00756938|82991256|FG000|Optional Extension|Physician Decision|0|||
46772979|NCT00756938|82991257|FG001|Optional Extension|Physician Decision|0|||
46772980|NCT00756938|82991258|FG002|Optional Extension|Physician Decision|0|||
46772981|NCT00756938|82991259|FG003|Optional Extension|Physician Decision|3|||
46843806|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
46955052|NCT02769065|83195095|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955053|NCT02769065|83195096|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955054|NCT02769065|83195097|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
47066822|NCT01536704|83349749|FG002|Period 3|Adverse Event|0|||
47066823|NCT01536704|83349750|FG003|Period 3|Adverse Event|1|||
47066824|NCT01536704|83349747|FG000|Washout Period 3|Adverse Event|0|||
47066825|NCT01536704|83349748|FG001|Washout Period 3|Adverse Event|0|||
47066826|NCT01536704|83349749|FG002|Washout Period 3|Adverse Event|1|||
47066827|NCT01536704|83349750|FG003|Washout Period 3|Adverse Event|0|||
47066828|NCT04121546|83349766|FG000|Overall Study|Lost to Follow-up|1|||
47066829|NCT04121546|83349767|FG001|Overall Study|Lost to Follow-up|3|||
47066830|NCT01552772|83349773|FG000|Overall Study|Lost to Follow-up|2|||
47066831|NCT01552772|83349773|FG000|Overall Study|Adverse Event|1|||
47066832|NCT01552772|83349773|FG000|Overall Study|Protocol Deviation|1|||
47066833|NCT01552694|83349780|FG000|Overall Study|Lost to Follow-up|0|||
47066834|NCT01552694|83349781|FG001|Overall Study|Lost to Follow-up|1|||
47066835|NCT01552694|83349780|FG000|Overall Study|Protocol Violation|0|||
46772982|NCT00756938|82991256|FG000|Optional Extension|Lost to Follow-up|0|||
46772983|NCT00756938|82991257|FG001|Optional Extension|Lost to Follow-up|0|||
46772984|NCT00756938|82991258|FG002|Optional Extension|Lost to Follow-up|0|||
46772985|NCT00756938|82991259|FG003|Optional Extension|Lost to Follow-up|1|||
46843807|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
47066836|NCT01552694|83349781|FG001|Overall Study|Protocol Violation|1|||
47066837|NCT01464931|83349789|FG000|Overall Study|Withdrawal by Subject|1|||
46772986|NCT00756938|82991256|FG000|Optional Extension|Protocol Violation|0|||
46772987|NCT00756938|82991257|FG001|Optional Extension|Protocol Violation|0|||
46955055|NCT02769065|83195098|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955056|NCT02769065|83195099|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955057|NCT02769065|83195100|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
46955058|NCT02681523|83195193|FG000|Overall Study|Adverse Event|1|||
46955059|NCT02681523|83195193|FG000|Overall Study|Patient Non-compliance|1|||
46955060|NCT02540954|83195199|FG000|Overall Study|Physician Decision|3|||
46955061|NCT02540954|83195200|FG001|Overall Study|Physician Decision|1|||
46955062|NCT02540954|83195199|FG000|Overall Study|Withdrawal by Subject|6|||
46955063|NCT02540954|83195200|FG001|Overall Study|Withdrawal by Subject|5|||
46955064|NCT02540954|83195199|FG000|Overall Study|Lost to Follow-up|1|||
46955065|NCT02540954|83195200|FG001|Overall Study|Lost to Follow-up|1|||
46955066|NCT02540954|83195199|FG000|Overall Study|Adverse Event|4|||
46955067|NCT02540954|83195200|FG001|Overall Study|Adverse Event|2|||
46955068|NCT02540954|83195199|FG000|Overall Study|Death|0|||
46955069|NCT02540954|83195200|FG001|Overall Study|Death|3|||
46955070|NCT02540954|83195199|FG000|Overall Study|Treatment failure|1|||
46955071|NCT02540954|83195200|FG001|Overall Study|Treatment failure|0|||
46955072|NCT02540954|83195199|FG000|Overall Study|Other reason|4|||
46955073|NCT02540954|83195200|FG001|Overall Study|Other reason|2|||
46955074|NCT02658812|83195206|FG000|Overall Study|Disease Progression|7|||
46955075|NCT02658812|83195206|FG000|Overall Study|Unrelated to study treatment|1|||
46955076|NCT02658812|83195206|FG000|Overall Study|Adverse Event|1|||
46955077|NCT02680665|83195210|FG000|Overall Study|No visit after the first prescription|5|||
46955078|NCT00154375|83195216|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
46955079|NCT00154375|83195217|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
46955080|NCT00154375|83195216|FG000|Overall Study|Adverse Event|18|||
46955081|NCT00154375|83195217|FG001|Overall Study|Adverse Event|20|||
46955082|NCT00154375|83195216|FG000|Overall Study|Withdrawal by Subject|14|||
46955083|NCT00154375|83195217|FG001|Overall Study|Withdrawal by Subject|10|||
46955084|NCT00154375|83195216|FG000|Overall Study|Death|5|||
46955085|NCT00154375|83195217|FG001|Overall Study|Death|13|||
46955086|NCT00154375|83195216|FG000|Overall Study|Study drug no longer required|5|||
46955087|NCT00154375|83195217|FG001|Overall Study|Study drug no longer required|3|||
46955088|NCT00154375|83195216|FG000|Overall Study|Lost to Follow-up|2|||
46955089|NCT00154375|83195217|FG001|Overall Study|Lost to Follow-up|1|||
46955090|NCT00154375|83195216|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46955091|NCT00154375|83195217|FG001|Overall Study|Abnormal laboratory value(s)|2|||
46955092|NCT00154375|83195216|FG000|Overall Study|Protocol Violation|0|||
46955093|NCT00154375|83195217|FG001|Overall Study|Protocol Violation|1|||
46955094|NCT00154375|83195216|FG000|Overall Study|Suspected progression of disease|44|||
46955095|NCT00154375|83195217|FG001|Overall Study|Suspected progression of disease|30|||
46955096|NCT02765399|83195226|FG000|Overall Study|Nausea|1|||
46955097|NCT02765399|83195227|FG001|Overall Study|Nausea|0|||
46955098|NCT02676765|83195235|FG000|Overall Study|Lost to Follow-up|0|||
46955099|NCT02676765|83195236|FG001|Overall Study|Lost to Follow-up|1|||
46955100|NCT02680041|83195242|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
46955101|NCT02680041|83195242|FG000|Overall Study|Lost to Follow-up|2|||
46955102|NCT02547974|83195251|FG000|Overall Study|Withdrawal by Subject|1|||
46955103|NCT02547974|83195252|FG001|Overall Study|Withdrawal by Subject|0|||
46955104|NCT02547974|83195253|FG002|Overall Study|Withdrawal by Subject|0|||
46955105|NCT02547974|83195254|FG003|Overall Study|Withdrawal by Subject|0|||
46955106|NCT00154297|83195269|FG000|Overall Study|Death|5|||
46772988|NCT00756938|82991258|FG002|Optional Extension|Protocol Violation|0|||
46955107|NCT00154297|83195270|FG001|Overall Study|Death|2|||
46772989|NCT00756938|82991259|FG003|Optional Extension|Protocol Violation|1|||
46772990|NCT00756938|82991256|FG000|Optional Extension|Withdrawal by Subject|0|||
46772991|NCT00756938|82991257|FG001|Optional Extension|Withdrawal by Subject|0|||
46772992|NCT00756938|82991258|FG002|Optional Extension|Withdrawal by Subject|0|||
46772993|NCT00756938|82991259|FG003|Optional Extension|Withdrawal by Subject|10|||
46772994|NCT00756938|82991256|FG000|Optional Extension|Adverse Event|0|||
46772995|NCT00756938|82991257|FG001|Optional Extension|Adverse Event|0|||
46955108|NCT00154297|83195269|FG000|Overall Study|Withdrawal by Subject|0|||
46955109|NCT00154297|83195270|FG001|Overall Study|Withdrawal by Subject|5|||
46955110|NCT00154297|83195269|FG000|Overall Study|Lost to Follow-up|3|||
46955111|NCT00154297|83195270|FG001|Overall Study|Lost to Follow-up|0|||
46955112|NCT02679729|83195285|FG000|Overall Study|Lost to Follow-up|0|||
46955113|NCT02679729|83195286|FG001|Overall Study|Lost to Follow-up|1|||
46955114|NCT02679729|83195287|FG002|Overall Study|Lost to Follow-up|0|||
46955115|NCT02679729|83195288|FG003|Overall Study|Lost to Follow-up|0|||
46955116|NCT02679729|83195289|FG004|Overall Study|Lost to Follow-up|1|||
46955117|NCT02679729|83195290|FG005|Overall Study|Lost to Follow-up|0|||
46955118|NCT02679729|83195291|FG006|Overall Study|Lost to Follow-up|0|||
46955119|NCT02679729|83195292|FG007|Overall Study|Lost to Follow-up|0|||
46955120|NCT02679729|83195293|FG008|Overall Study|Lost to Follow-up|0|||
46955121|NCT02679729|83195285|FG000|Overall Study|Participant decision|0|||
46955122|NCT02679729|83195286|FG001|Overall Study|Participant decision|1|||
46955123|NCT02679729|83195287|FG002|Overall Study|Participant decision|0|||
46955124|NCT02679729|83195288|FG003|Overall Study|Participant decision|0|||
46955125|NCT02679729|83195289|FG004|Overall Study|Participant decision|0|||
46955126|NCT02679729|83195290|FG005|Overall Study|Participant decision|0|||
46955127|NCT02679729|83195291|FG006|Overall Study|Participant decision|1|||
46955128|NCT02679729|83195292|FG007|Overall Study|Participant decision|0|||
46955129|NCT02679729|83195293|FG008|Overall Study|Participant decision|0|||
46955130|NCT02765165|83195332|FG000|Treatment Period|Progressive disease|3|||
46955131|NCT02765165|83195333|FG001|Treatment Period|Progressive disease|2|||
46955132|NCT02765165|83195334|FG002|Treatment Period|Progressive disease|3|||
46955133|NCT02765165|83195335|FG003|Treatment Period|Progressive disease|3|||
46955134|NCT02765165|83195336|FG004|Treatment Period|Progressive disease|4|||
46955135|NCT02765165|83195337|FG005|Treatment Period|Progressive disease|2|||
46955136|NCT02765165|83195338|FG006|Treatment Period|Progressive disease|2|||
46955137|NCT02765165|83195332|FG000|Treatment Period|Physician Decision|0|||
46955138|NCT02765165|83195333|FG001|Treatment Period|Physician Decision|1|||
46955139|NCT02765165|83195334|FG002|Treatment Period|Physician Decision|0|||
46955140|NCT02765165|83195335|FG003|Treatment Period|Physician Decision|0|||
46955141|NCT02765165|83195336|FG004|Treatment Period|Physician Decision|0|||
46955142|NCT02765165|83195337|FG005|Treatment Period|Physician Decision|0|||
46955143|NCT02765165|83195338|FG006|Treatment Period|Physician Decision|0|||
46955144|NCT02765165|83195332|FG000|Treatment Period|Adverse Event|0|||
46955145|NCT02765165|83195333|FG001|Treatment Period|Adverse Event|1|||
46639358|NCT01384734|82812911|FG000|Overall Study|Adverse Event|0|||
46772996|NCT00756938|82991258|FG002|Optional Extension|Adverse Event|0|||
46955146|NCT02765165|83195334|FG002|Treatment Period|Adverse Event|0|||
46955147|NCT02765165|83195335|FG003|Treatment Period|Adverse Event|0|||
46955148|NCT02765165|83195336|FG004|Treatment Period|Adverse Event|0|||
46955149|NCT02765165|83195337|FG005|Treatment Period|Adverse Event|0|||
46955150|NCT02765165|83195338|FG006|Treatment Period|Adverse Event|0|||
46955151|NCT02765165|83195332|FG000|Treatment Period|Withdrawal by Subject|0|||
46955152|NCT02765165|83195333|FG001|Treatment Period|Withdrawal by Subject|0|||
46955153|NCT02765165|83195334|FG002|Treatment Period|Withdrawal by Subject|0|||
46955154|NCT02765165|83195335|FG003|Treatment Period|Withdrawal by Subject|0|||
47066838|NCT01464931|83349790|FG001|Overall Study|Withdrawal by Subject|0|||
47066839|NCT01536392|83349815|FG000|Overall Study|Adverse Event|2|||
47066840|NCT01536392|83349816|FG001|Overall Study|Adverse Event|2|||
46639359|NCT01384734|82812912|FG001|Overall Study|Adverse Event|3|||
46639360|NCT01384734|82812913|FG002|Overall Study|Adverse Event|0|||
46639361|NCT01384734|82812914|FG003|Overall Study|Adverse Event|2|||
46772997|NCT00756938|82991259|FG003|Optional Extension|Adverse Event|1|||
46772998|NCT00796367|82991280|FG000|Overall Study|Adverse Event|6|||
46772999|NCT00796367|82991281|FG001|Overall Study|Adverse Event|4|||
46773000|NCT00796367|82991282|FG002|Overall Study|Adverse Event|7|||
46773001|NCT00796367|82991280|FG000|Overall Study|Lost to Follow-up|5|||
46773002|NCT00796367|82991281|FG001|Overall Study|Lost to Follow-up|4|||
46773003|NCT00796367|82991282|FG002|Overall Study|Lost to Follow-up|21|||
46773004|NCT00796367|82991280|FG000|Overall Study|Withdrawal by Subject|9|||
46773005|NCT00796367|82991281|FG001|Overall Study|Withdrawal by Subject|11|||
46773006|NCT00796367|82991282|FG002|Overall Study|Withdrawal by Subject|12|||
46773007|NCT00796367|82991280|FG000|Overall Study|Lack of Efficacy|2|||
46843808|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
46843809|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
46843810|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
46843811|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
46955155|NCT02765165|83195336|FG004|Treatment Period|Withdrawal by Subject|2|||
46955156|NCT02765165|83195337|FG005|Treatment Period|Withdrawal by Subject|0|||
46955157|NCT02765165|83195338|FG006|Treatment Period|Withdrawal by Subject|0|||
46773008|NCT00796367|82991281|FG001|Overall Study|Lack of Efficacy|1|||
46773009|NCT00796367|82991282|FG002|Overall Study|Lack of Efficacy|0|||
46773010|NCT00796367|82991280|FG000|Overall Study|non compliance|3|||
46773011|NCT00796367|82991281|FG001|Overall Study|non compliance|1|||
46773012|NCT00796367|82991282|FG002|Overall Study|non compliance|1|||
46955158|NCT02765165|83195332|FG000|Treatment Period|Study terminated|0|||
46955159|NCT02765165|83195333|FG001|Treatment Period|Study terminated|0|||
46955160|NCT02765165|83195334|FG002|Treatment Period|Study terminated|0|||
46955161|NCT02765165|83195335|FG003|Treatment Period|Study terminated|0|||
47066841|NCT01536392|83349815|FG000|Overall Study|Physician Decision|2|||
46773013|NCT00796367|82991280|FG000|Overall Study|Pregnancy|1|||
46773014|NCT00796367|82991281|FG001|Overall Study|Pregnancy|0|||
46773015|NCT00796367|82991282|FG002|Overall Study|Pregnancy|1|||
46955162|NCT02765165|83195336|FG004|Treatment Period|Study terminated|0|||
46955163|NCT02765165|83195337|FG005|Treatment Period|Study terminated|1|||
46955164|NCT02765165|83195338|FG006|Treatment Period|Study terminated|2|||
46955165|NCT02765165|83195332|FG000|Post-treatment Follow-up|Death|1|||
46955166|NCT02765165|83195333|FG001|Post-treatment Follow-up|Death|2|||
46955167|NCT02765165|83195334|FG002|Post-treatment Follow-up|Death|1|||
46955168|NCT02765165|83195335|FG003|Post-treatment Follow-up|Death|1|||
46955169|NCT02765165|83195336|FG004|Post-treatment Follow-up|Death|1|||
46955170|NCT02765165|83195337|FG005|Post-treatment Follow-up|Death|1|||
46955171|NCT02765165|83195338|FG006|Post-treatment Follow-up|Death|0|||
46955172|NCT02765165|83195332|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
46955173|NCT02765165|83195333|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
46955174|NCT02765165|83195334|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
46955175|NCT02765165|83195335|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
46955176|NCT02765165|83195336|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
46955177|NCT02765165|83195337|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
46955178|NCT02765165|83195338|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
46955179|NCT02765165|83195332|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
46955180|NCT02765165|83195333|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
46955181|NCT02765165|83195334|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
46955182|NCT02765165|83195335|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
46955183|NCT02765165|83195336|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
46955184|NCT02765165|83195337|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
46955185|NCT02765165|83195338|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
46955186|NCT02765165|83195332|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
46955187|NCT02765165|83195333|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
46955188|NCT02765165|83195334|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
46955189|NCT02765165|83195335|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
46955190|NCT02765165|83195336|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
46955191|NCT02765165|83195337|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
46955192|NCT02765165|83195338|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
46955193|NCT02765165|83195332|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
46955194|NCT02765165|83195333|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
46955195|NCT02765165|83195334|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
46955196|NCT02765165|83195335|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
47066842|NCT01536392|83349816|FG001|Overall Study|Physician Decision|3|||
47066843|NCT01536392|83349815|FG000|Overall Study|Withdrawal by Subject|3|||
47066844|NCT01536392|83349816|FG001|Overall Study|Withdrawal by Subject|6|||
47066845|NCT01536392|83349815|FG000|Overall Study|Non Compliance|3|||
47066846|NCT01536392|83349816|FG001|Overall Study|Non Compliance|4|||
47066847|NCT01536392|83349815|FG000|Overall Study|Completed therapy early|3|||
46843812|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
46843813|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
46843814|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
46843815|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
46843816|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
46843817|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
46843818|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
46843819|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
46843820|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
46843821|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
46843822|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
46843823|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
46843824|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
46843825|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
46843826|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Death|0|||
46843827|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Death|0|||
46843828|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Death|0|||
46843829|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Death|1|||
46843830|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Death|0|||
46843831|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Missing|0|||
46843832|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Missing|0|||
46843833|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Missing|1|||
47066848|NCT01536392|83349816|FG001|Overall Study|Completed therapy early|0|||
47066849|NCT01464619|83349824|FG000|Overall Study|Lost to Follow-up|3|||
47066850|NCT01464619|83349825|FG001|Overall Study|Lost to Follow-up|4|||
47066851|NCT01490125|83349891|FG000|Period I|Adverse Event|4|||
47066852|NCT01490125|83349892|FG001|Period I|Adverse Event|1|||
46843834|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Missing|0|||
46843835|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Missing|0|||
46843836|NCT00121641|83060643|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
46843837|NCT00121641|83060644|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
46843838|NCT00121641|83060645|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
46843839|NCT00121641|83060646|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
46843840|NCT00121641|83060647|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
46843841|NCT00425555|83060663|FG000|Overall Study|Withdrawal by Subject|11|||
46843842|NCT00425555|83060664|FG001|Overall Study|Withdrawal by Subject|8|||
46843843|NCT00425555|83060663|FG000|Overall Study|Lost to Follow-up|0|||
46843844|NCT00425555|83060664|FG001|Overall Study|Lost to Follow-up|1|||
46843845|NCT00425555|83060663|FG000|Overall Study|Administrative problems|3|||
46843846|NCT00425555|83060664|FG001|Overall Study|Administrative problems|0|||
46843847|NCT00425555|83060663|FG000|Overall Study|Death|1|||
46843848|NCT00425555|83060664|FG001|Overall Study|Death|2|||
46843849|NCT00425555|83060663|FG000|Overall Study|New cancer therapy|2|||
46773016|NCT00796367|82991280|FG000|Overall Study|Requirement for restricted medication|2|||
46773017|NCT00796367|82991281|FG001|Overall Study|Requirement for restricted medication|0|||
46843850|NCT00425555|83060664|FG001|Overall Study|New cancer therapy|1|||
46843851|NCT00425555|83060663|FG000|Overall Study|Disease progression|36|||
46843852|NCT00425555|83060664|FG001|Overall Study|Disease progression|33|||
46843853|NCT00425555|83060663|FG000|Overall Study|Adverse Event|25|||
46843854|NCT00425555|83060664|FG001|Overall Study|Adverse Event|15|||
46843855|NCT00425555|83060663|FG000|Overall Study|Protocol Violation|1|||
46843856|NCT00425555|83060664|FG001|Overall Study|Protocol Violation|0|||
46843857|NCT00424775|83060673|FG000|Overall Study|Adverse Event|2|||
46843858|NCT00424775|83060674|FG001|Overall Study|Adverse Event|0|||
46843859|NCT00424775|83060673|FG000|Overall Study|Lack of Efficacy|1|||
46843860|NCT00424775|83060674|FG001|Overall Study|Lack of Efficacy|0|||
46843861|NCT00121485|83060680|FG000|Overall Study|Not implanted|1|||
46843862|NCT00121485|83060681|FG001|Overall Study|Not implanted|5|||
46843863|NCT00121485|83060680|FG000|Overall Study|Crossover|0|||
46843864|NCT00121485|83060681|FG001|Overall Study|Crossover|2|||
46843865|NCT01763866|83060712|FG000|Overall Study|Withdrawal by Subject|2|||
46843866|NCT01763866|83060713|FG001|Overall Study|Withdrawal by Subject|1|||
46843867|NCT01763866|83060714|FG002|Overall Study|Withdrawal by Subject|4|||
46843868|NCT01763866|83060715|FG003|Overall Study|Withdrawal by Subject|0|||
46843869|NCT01763866|83060716|FG004|Overall Study|Withdrawal by Subject|0|||
46843870|NCT01763866|83060717|FG005|Overall Study|Withdrawal by Subject|3|||
46843871|NCT01763866|83060718|FG006|Overall Study|Withdrawal by Subject|4|||
46843872|NCT01763866|83060719|FG007|Overall Study|Withdrawal by Subject|0|||
46843873|NCT01763866|83060720|FG008|Overall Study|Withdrawal by Subject|1|||
46843874|NCT01763866|83060721|FG009|Overall Study|Withdrawal by Subject|1|||
46843875|NCT01763866|83060722|FG010|Overall Study|Withdrawal by Subject|2|||
46843876|NCT01763866|83060723|FG011|Overall Study|Withdrawal by Subject|2|||
46843877|NCT01763866|83060724|FG012|Overall Study|Withdrawal by Subject|2|||
46843878|NCT01763866|83060725|FG013|Overall Study|Withdrawal by Subject|0|||
46843879|NCT01763866|83060726|FG014|Overall Study|Withdrawal by Subject|6|||
46843880|NCT01763866|83060727|FG015|Overall Study|Withdrawal by Subject|3|||
46843881|NCT01763866|83060728|FG016|Overall Study|Withdrawal by Subject|0|||
46843882|NCT01763866|83060729|FG017|Overall Study|Withdrawal by Subject|1|||
46843883|NCT01763866|83060730|FG018|Overall Study|Withdrawal by Subject|1|||
46843884|NCT01763866|83060731|FG019|Overall Study|Withdrawal by Subject|1|||
46843885|NCT01763866|83060732|FG020|Overall Study|Withdrawal by Subject|2|||
46843886|NCT01763866|83060733|FG021|Overall Study|Withdrawal by Subject|1|||
46843887|NCT01763866|83060734|FG022|Overall Study|Withdrawal by Subject|2|||
46773018|NCT00796367|82991282|FG002|Overall Study|Requirement for restricted medication|2|||
46773019|NCT00796367|82991280|FG000|Overall Study|other|2|||
46773020|NCT00796367|82991281|FG001|Overall Study|other|4|||
46773021|NCT00796367|82991282|FG002|Overall Study|other|3|||
46773022|NCT00770588|82991292|FG000|Overall Study|Adverse Event|9|||
46843888|NCT01763866|83060735|FG023|Overall Study|Withdrawal by Subject|1|||
46843889|NCT01763866|83060712|FG000|Overall Study|Decision by sponsor|0|||
46843890|NCT01763866|83060713|FG001|Overall Study|Decision by sponsor|0|||
46843891|NCT01763866|83060714|FG002|Overall Study|Decision by sponsor|1|||
46843892|NCT01763866|83060715|FG003|Overall Study|Decision by sponsor|0|||
46843893|NCT01763866|83060716|FG004|Overall Study|Decision by sponsor|2|||
46843894|NCT01763866|83060717|FG005|Overall Study|Decision by sponsor|0|||
46773023|NCT00770588|82991293|FG001|Overall Study|Adverse Event|2|||
46773024|NCT00770588|82991292|FG000|Overall Study|Death caused by progression of disease|70|||
46843895|NCT01763866|83060718|FG006|Overall Study|Decision by sponsor|2|||
46843896|NCT01763866|83060719|FG007|Overall Study|Decision by sponsor|0|||
46843897|NCT01763866|83060720|FG008|Overall Study|Decision by sponsor|2|||
46843898|NCT01763866|83060721|FG009|Overall Study|Decision by sponsor|0|||
46843899|NCT01763866|83060722|FG010|Overall Study|Decision by sponsor|6|||
46843900|NCT01763866|83060723|FG011|Overall Study|Decision by sponsor|0|||
46843901|NCT01763866|83060724|FG012|Overall Study|Decision by sponsor|1|||
46639362|NCT01384734|82812915|FG004|Overall Study|Adverse Event|7|||
46639363|NCT01384734|82812911|FG000|Overall Study|Death|1|||
46639364|NCT01384734|82812912|FG001|Overall Study|Death|0|||
46639365|NCT01384734|82812913|FG002|Overall Study|Death|1|||
46639366|NCT01384734|82812914|FG003|Overall Study|Death|0|||
46639367|NCT01384734|82812915|FG004|Overall Study|Death|0|||
46639368|NCT01384734|82812911|FG000|Overall Study|Continuation criteria not met|0|||
46639369|NCT01384734|82812912|FG001|Overall Study|Continuation criteria not met|0|||
46639370|NCT01384734|82812913|FG002|Overall Study|Continuation criteria not met|1|||
46843902|NCT01763866|83060725|FG013|Overall Study|Decision by sponsor|0|||
46843903|NCT01763866|83060726|FG014|Overall Study|Decision by sponsor|5|||
46843904|NCT01763866|83060727|FG015|Overall Study|Decision by sponsor|0|||
46843905|NCT01763866|83060728|FG016|Overall Study|Decision by sponsor|0|||
46843906|NCT01763866|83060729|FG017|Overall Study|Decision by sponsor|0|||
46843907|NCT01763866|83060730|FG018|Overall Study|Decision by sponsor|4|||
46843908|NCT01763866|83060731|FG019|Overall Study|Decision by sponsor|0|||
46843909|NCT01763866|83060732|FG020|Overall Study|Decision by sponsor|2|||
46843910|NCT01763866|83060733|FG021|Overall Study|Decision by sponsor|0|||
46843911|NCT01763866|83060734|FG022|Overall Study|Decision by sponsor|1|||
46843912|NCT01763866|83060735|FG023|Overall Study|Decision by sponsor|0|||
46843913|NCT01763866|83060712|FG000|Overall Study|Lost to Follow-up|0|||
46843914|NCT01763866|83060713|FG001|Overall Study|Lost to Follow-up|0|||
46843915|NCT01763866|83060714|FG002|Overall Study|Lost to Follow-up|0|||
46843916|NCT01763866|83060715|FG003|Overall Study|Lost to Follow-up|0|||
46843917|NCT01763866|83060716|FG004|Overall Study|Lost to Follow-up|0|||
46843918|NCT01763866|83060717|FG005|Overall Study|Lost to Follow-up|0|||
46843919|NCT01763866|83060718|FG006|Overall Study|Lost to Follow-up|1|||
46843920|NCT01763866|83060719|FG007|Overall Study|Lost to Follow-up|0|||
46843921|NCT01763866|83060720|FG008|Overall Study|Lost to Follow-up|0|||
46843922|NCT01763866|83060721|FG009|Overall Study|Lost to Follow-up|0|||
46843923|NCT01763866|83060722|FG010|Overall Study|Lost to Follow-up|0|||
46843924|NCT01763866|83060723|FG011|Overall Study|Lost to Follow-up|0|||
46843925|NCT01763866|83060724|FG012|Overall Study|Lost to Follow-up|1|||
46843926|NCT01763866|83060725|FG013|Overall Study|Lost to Follow-up|0|||
46843927|NCT01763866|83060726|FG014|Overall Study|Lost to Follow-up|1|||
46843928|NCT01763866|83060727|FG015|Overall Study|Lost to Follow-up|0|||
46843929|NCT01763866|83060728|FG016|Overall Study|Lost to Follow-up|0|||
46843930|NCT01763866|83060729|FG017|Overall Study|Lost to Follow-up|0|||
46843931|NCT01763866|83060730|FG018|Overall Study|Lost to Follow-up|1|||
46843932|NCT01763866|83060731|FG019|Overall Study|Lost to Follow-up|1|||
46843933|NCT01763866|83060732|FG020|Overall Study|Lost to Follow-up|0|||
46843934|NCT01763866|83060733|FG021|Overall Study|Lost to Follow-up|0|||
46843935|NCT01763866|83060734|FG022|Overall Study|Lost to Follow-up|0|||
46843936|NCT01763866|83060735|FG023|Overall Study|Lost to Follow-up|1|||
46843937|NCT01763866|83060712|FG000|Overall Study|Death|0|||
46843938|NCT01763866|83060713|FG001|Overall Study|Death|0|||
46843939|NCT01763866|83060714|FG002|Overall Study|Death|0|||
46843940|NCT01763866|83060715|FG003|Overall Study|Death|0|||
46843941|NCT01763866|83060716|FG004|Overall Study|Death|0|||
46843942|NCT01763866|83060717|FG005|Overall Study|Death|0|||
46843943|NCT01763866|83060718|FG006|Overall Study|Death|0|||
46843944|NCT01763866|83060719|FG007|Overall Study|Death|0|||
46843945|NCT01763866|83060720|FG008|Overall Study|Death|0|||
46955197|NCT02765165|83195336|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
46955198|NCT02765165|83195337|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
46955199|NCT02765165|83195338|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
46955200|NCT02765165|83195332|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
46955201|NCT02765165|83195333|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
46955202|NCT02765165|83195334|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
46955203|NCT02765165|83195335|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
46955204|NCT02765165|83195336|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
46955205|NCT02765165|83195337|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
46955206|NCT02765165|83195338|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
46955207|NCT02675907|83195360|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
46955208|NCT02675907|83195361|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
46955209|NCT02675907|83195360|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
46955210|NCT02675907|83195361|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
46955211|NCT02675907|83195360|FG000|Study Overall|Lack of Efficacy|1|||
46843946|NCT01763866|83060721|FG009|Overall Study|Death|0|||
46843947|NCT01763866|83060722|FG010|Overall Study|Death|0|||
46955212|NCT02675907|83195361|FG001|Study Overall|Lack of Efficacy|0|||
46639371|NCT01384734|82812914|FG003|Overall Study|Continuation criteria not met|1|||
46843948|NCT01763866|83060723|FG011|Overall Study|Death|0|||
46843949|NCT01763866|83060724|FG012|Overall Study|Death|0|||
46843950|NCT01763866|83060725|FG013|Overall Study|Death|0|||
46843951|NCT01763866|83060726|FG014|Overall Study|Death|0|||
46843952|NCT01763866|83060727|FG015|Overall Study|Death|0|||
46843953|NCT01763866|83060728|FG016|Overall Study|Death|1|||
46843954|NCT01763866|83060729|FG017|Overall Study|Death|0|||
46639372|NCT01384734|82812915|FG004|Overall Study|Continuation criteria not met|0|||
46773025|NCT00770588|82991293|FG001|Overall Study|Death caused by progression of disease|91|||
46843955|NCT01763866|83060730|FG018|Overall Study|Death|0|||
46843956|NCT01763866|83060731|FG019|Overall Study|Death|0|||
46843957|NCT01763866|83060732|FG020|Overall Study|Death|0|||
46843958|NCT01763866|83060733|FG021|Overall Study|Death|0|||
46843959|NCT01763866|83060734|FG022|Overall Study|Death|0|||
46843960|NCT01763866|83060735|FG023|Overall Study|Death|0|||
46843961|NCT00132873|83060785|FG000|Overall Study|Adverse Event|3|||
46843962|NCT00132873|83060785|FG000|Overall Study|Lost to Follow-up|1|||
46843963|NCT00132873|83060785|FG000|Overall Study|Lack of Efficacy|1|||
46843964|NCT00132873|83060785|FG000|Overall Study|Withdrawal by Subject|3|||
46843965|NCT00132873|83060785|FG000|Overall Study|Planned Pregnancy|1|||
46843966|NCT00120627|83060791|FG000|Overall Study|Withdrawal by Subject|5|||
46843967|NCT00120627|83060792|FG001|Overall Study|Withdrawal by Subject|5|||
46843968|NCT03762616|83060807|FG000|Overall Study|Protocol Violation|2|||
46843969|NCT04246996|83060815|FG000|Overall Study|Physician Decision|1|||
46773026|NCT00770588|82991292|FG000|Overall Study|Lost to Follow-up|1|||
46773027|NCT00770588|82991293|FG001|Overall Study|Lost to Follow-up|1|||
46773028|NCT00770588|82991292|FG000|Overall Study|Withdrawal by Subject|1|||
46773029|NCT00770588|82991293|FG001|Overall Study|Withdrawal by Subject|1|||
46773030|NCT00777608|82991302|FG000|Overall Study|Lost to Follow-up|1|||
46773031|NCT00777608|82991303|FG001|Overall Study|Lost to Follow-up|1|||
46773032|NCT00777608|82991302|FG000|Overall Study|Withdrawal by Subject|1|||
46773033|NCT00777608|82991303|FG001|Overall Study|Withdrawal by Subject|3|||
46843970|NCT04246996|83060816|FG001|Overall Study|Physician Decision|1|||
46843971|NCT04246996|83060815|FG000|Overall Study|Did not meet eligibility criteria|1|||
46843972|NCT04246996|83060816|FG001|Overall Study|Did not meet eligibility criteria|4|||
46843973|NCT00424463|83060825|FG000|Overall Study|Adverse Event|2|||
46843974|NCT00424463|83060826|FG001|Overall Study|Adverse Event|3|||
46843975|NCT00424463|83060827|FG002|Overall Study|Adverse Event|2|||
46843976|NCT00424463|83060825|FG000|Overall Study|Physician Decision|0|||
46843977|NCT00424463|83060826|FG001|Overall Study|Physician Decision|2|||
46843978|NCT00424463|83060827|FG002|Overall Study|Physician Decision|2|||
46843979|NCT00424463|83060825|FG000|Overall Study|Withdrawal by Subject|4|||
46843980|NCT00424463|83060826|FG001|Overall Study|Withdrawal by Subject|2|||
46843981|NCT00424463|83060827|FG002|Overall Study|Withdrawal by Subject|5|||
46843982|NCT00424463|83060825|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
46843983|NCT00424463|83060826|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
46843984|NCT00424463|83060827|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
46843985|NCT00424463|83060825|FG000|Overall Study|Patient's convenience|0|||
46843986|NCT00424463|83060826|FG001|Overall Study|Patient's convenience|0|||
46843987|NCT00424463|83060827|FG002|Overall Study|Patient's convenience|1|||
46843988|NCT00424385|83060835|FG000|Cohort 0|Withdrawal by Subject|5|||
46639373|NCT01384734|82812911|FG000|Overall Study|Lack of Efficacy|3|||
46773034|NCT00777608|82991302|FG000|Overall Study|Protocol Violation|1|||
46773035|NCT00777608|82991303|FG001|Overall Study|Protocol Violation|0|||
46773036|NCT00777608|82991302|FG000|Overall Study|Investigator Decision|1|||
46773037|NCT00777608|82991303|FG001|Overall Study|Investigator Decision|2|||
46773038|NCT00792935|82991311|FG000|Overall Study|Adverse Event|2|||
46773039|NCT00792935|82991312|FG001|Overall Study|Adverse Event|1|||
46773040|NCT00792935|82991311|FG000|Overall Study|Lost to Follow-up|0|||
46773041|NCT00792935|82991312|FG001|Overall Study|Lost to Follow-up|1|||
46773042|NCT00792935|82991311|FG000|Overall Study|Protocol Violation|2|||
46773043|NCT00792935|82991312|FG001|Overall Study|Protocol Violation|0|||
46773044|NCT00792935|82991311|FG000|Overall Study|Withdrawal by Subject|0|||
46773045|NCT00792935|82991312|FG001|Overall Study|Withdrawal by Subject|1|||
46773046|NCT00770510|82991318|FG000|Overall Study|Lost to Follow-up|2|||
46843989|NCT00424385|83060835|FG000|Cohort 0|Physician Decision|1|||
46843990|NCT00424385|83060835|FG000|Cohort 1|Withdrawal by Subject|1|||
46843991|NCT00423917|83060841|FG000|Overall Study|Cancel|2|||
46843992|NCT00423917|83060841|FG000|Overall Study|Ineligible|1|||
47066853|NCT01490125|83349893|FG002|Period I|Adverse Event|1|||
46773047|NCT00770510|82991318|FG000|Overall Study|Pregnancy|1|||
46773048|NCT00770510|82991318|FG000|Overall Study|Withdrawal by Subject|2|||
46773049|NCT00770432|82991332|FG000|Overall Study|Other|4|||
46773050|NCT00770432|82991333|FG001|Overall Study|Other|6|||
46773051|NCT00770432|82991332|FG000|Overall Study|Non-compliance|0|||
46773052|NCT00770432|82991333|FG001|Overall Study|Non-compliance|1|||
46773053|NCT00792701|82991341|FG000|Overall Study|Adverse Event|0|||
46773054|NCT00792701|82991342|FG001|Overall Study|Adverse Event|22|||
46773055|NCT00792701|82991341|FG000|Overall Study|Ineligible|1|||
46773056|NCT00792701|82991342|FG001|Overall Study|Ineligible|3|||
46773057|NCT00792701|82991341|FG000|Overall Study|Withdrawal by Subject|1|||
46773058|NCT00792701|82991342|FG001|Overall Study|Withdrawal by Subject|19|||
46773059|NCT00792701|82991341|FG000|Overall Study|Not protocol specified|17|||
46773060|NCT00792701|82991342|FG001|Overall Study|Not protocol specified|0|||
46773061|NCT00777296|82991354|FG000|Overall Study|Adverse Event|0|||
46843993|NCT00845026|83060847|FG000|Study Period III|Adverse Event|23|||
46843994|NCT00845026|83060848|FG001|Study Period III|Adverse Event|19|||
46843995|NCT00845026|83060847|FG000|Study Period III|Perceived lack of efficacy|27|||
46955213|NCT02675907|83195360|FG000|Study Overall|Withdrawal by Subject|2|||
46955214|NCT02675907|83195361|FG001|Study Overall|Withdrawal by Subject|2|||
46955215|NCT02675907|83195360|FG000|Study Overall|Lost to Follow-up|0|||
46955216|NCT02675907|83195361|FG001|Study Overall|Lost to Follow-up|2|||
46955217|NCT02675517|83195367|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
46955218|NCT02675517|83195367|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
46955219|NCT02764775|83195371|FG000|Overall Study|Death|1|||
46955220|NCT02764775|83195371|FG000|Overall Study|Lost to Follow-up|2|||
46955221|NCT02764775|83195371|FG000|Overall Study|Withdrawal by Subject|3|||
46955222|NCT02774681|83195375|FG000|Treatment on Study|Progressive Disease|7|||
46955223|NCT02774681|83195375|FG000|Follow-Up for 3 Years|Death|11|||
46955224|NCT02774681|83195375|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
46955225|NCT02547428|83195381|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
46955226|NCT02547428|83195382|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
46955227|NCT02547428|83195381|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
46955228|NCT02547428|83195382|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
46955229|NCT02547428|83195381|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
46955230|NCT02547428|83195382|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
46955231|NCT02547428|83195381|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
46955232|NCT02547428|83195382|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
46955233|NCT02547428|83195381|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
46955234|NCT02547428|83195382|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
46843996|NCT00845026|83060848|FG001|Study Period III|Perceived lack of efficacy|15|||
46843997|NCT00845026|83060847|FG000|Study Period III|Withdrawal by Subject|19|||
46843998|NCT00845026|83060848|FG001|Study Period III|Withdrawal by Subject|15|||
46843999|NCT00845026|83060847|FG000|Study Period III|Entry Criteria not met|8|||
46844000|NCT00845026|83060848|FG001|Study Period III|Entry Criteria not met|11|||
46844001|NCT00845026|83060847|FG000|Study Period III|Lost to Follow-up|4|||
46844002|NCT00845026|83060848|FG001|Study Period III|Lost to Follow-up|5|||
46844003|NCT00845026|83060847|FG000|Study Period III|Protocol Violation|8|||
46844004|NCT00845026|83060848|FG001|Study Period III|Protocol Violation|1|||
46844005|NCT00845026|83060847|FG000|Study Period III|Scheduled conflict|3|||
46844006|NCT00845026|83060848|FG001|Study Period III|Scheduled conflict|1|||
46844007|NCT00845026|83060847|FG000|Study Period III|Subject is moving or has moved|2|||
46955235|NCT02547428|83195381|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
46955236|NCT02547428|83195382|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
46955237|NCT02547428|83195381|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
46955238|NCT02547428|83195382|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
46955239|NCT02547428|83195381|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
46955240|NCT02547428|83195382|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
46955241|NCT01374087|83195397|FG000|Overall Study|Adverse Event|1|||
46955242|NCT01374087|83195398|FG001|Overall Study|Adverse Event|0|||
46955243|NCT01374087|83195397|FG000|Overall Study|Disease progression|2|||
46955244|NCT01374087|83195398|FG001|Overall Study|Disease progression|2|||
46955245|NCT01374087|83195397|FG000|Overall Study|Study discontinued|13|||
46955246|NCT01374087|83195398|FG001|Overall Study|Study discontinued|13|||
46773062|NCT00777296|82991355|FG001|Overall Study|Adverse Event|1|||
46773063|NCT00777296|82991356|FG002|Overall Study|Adverse Event|0|||
46773064|NCT00777296|82991357|FG003|Overall Study|Adverse Event|1|||
46773065|NCT00777296|82991354|FG000|Overall Study|Withdrawal by Subject|1|||
46773066|NCT00777296|82991355|FG001|Overall Study|Withdrawal by Subject|0|||
46773067|NCT00777296|82991356|FG002|Overall Study|Withdrawal by Subject|0|||
46773068|NCT00777296|82991357|FG003|Overall Study|Withdrawal by Subject|0|||
46844008|NCT00845026|83060848|FG001|Study Period III|Subject is moving or has moved|4|||
46844009|NCT00845026|83060847|FG000|Study Period III|Transportation issues|1|||
46844010|NCT00845026|83060848|FG001|Study Period III|Transportation issues|1|||
46844011|NCT00845026|83060847|FG000|Study Period IV|Adverse Event|4|||
46844012|NCT00845026|83060848|FG001|Study Period IV|Adverse Event|0|||
46844013|NCT00845026|83060847|FG000|Study Period IV|Perceived lack of efficacy|2|||
46844014|NCT00845026|83060848|FG001|Study Period IV|Perceived lack of efficacy|1|||
46844015|NCT00845026|83060847|FG000|Study Period IV|Protocol Violation|3|||
46955247|NCT00152971|83195407|FG000|Overall Study|Adverse Event|12|||
46955248|NCT00152971|83195408|FG001|Overall Study|Adverse Event|10|||
46955249|NCT00152971|83195409|FG002|Overall Study|Adverse Event|9|||
46955250|NCT00152971|83195407|FG000|Overall Study|Protocol Violation|10|||
46955251|NCT00152971|83195408|FG001|Overall Study|Protocol Violation|11|||
46955252|NCT00152971|83195409|FG002|Overall Study|Protocol Violation|8|||
46773069|NCT00777296|82991354|FG000|Overall Study|CRF form not completed|0|||
46773070|NCT00777296|82991355|FG001|Overall Study|CRF form not completed|0|||
46773071|NCT00777296|82991356|FG002|Overall Study|CRF form not completed|2|||
46773072|NCT00777296|82991357|FG003|Overall Study|CRF form not completed|0|||
46955253|NCT00152971|83195407|FG000|Overall Study|Lost to Follow-up|17|||
46955254|NCT00152971|83195408|FG001|Overall Study|Lost to Follow-up|14|||
46955255|NCT00152971|83195409|FG002|Overall Study|Lost to Follow-up|13|||
46955256|NCT00152971|83195407|FG000|Overall Study|Withdrawal by Subject|9|||
46955257|NCT00152971|83195408|FG001|Overall Study|Withdrawal by Subject|8|||
46955258|NCT00152971|83195409|FG002|Overall Study|Withdrawal by Subject|14|||
46955259|NCT00152971|83195407|FG000|Overall Study|Other|3|||
46955260|NCT00152971|83195408|FG001|Overall Study|Other|5|||
46955261|NCT00152971|83195409|FG002|Overall Study|Other|5|||
46955262|NCT00152971|83195407|FG000|Treatment|Adverse Event|49|||
46955263|NCT00152971|83195408|FG001|Treatment|Adverse Event|40|||
46955264|NCT00152971|83195409|FG002|Treatment|Adverse Event|54|||
46955265|NCT00152971|83195407|FG000|Treatment|Protocol Violation|8|||
46955266|NCT00152971|83195408|FG001|Treatment|Protocol Violation|6|||
46955267|NCT00152971|83195409|FG002|Treatment|Protocol Violation|10|||
46955268|NCT00152971|83195407|FG000|Treatment|Lost to Follow-up|1|||
46955269|NCT00152971|83195408|FG001|Treatment|Lost to Follow-up|2|||
46955270|NCT00152971|83195409|FG002|Treatment|Lost to Follow-up|1|||
46955271|NCT00152971|83195407|FG000|Treatment|Withdrawal by Subject|4|||
46955272|NCT00152971|83195408|FG001|Treatment|Withdrawal by Subject|4|||
46955273|NCT00152971|83195409|FG002|Treatment|Withdrawal by Subject|5|||
46955274|NCT00152971|83195407|FG000|Treatment|Other|9|||
46955275|NCT00152971|83195408|FG001|Treatment|Other|11|||
46955276|NCT00152971|83195409|FG002|Treatment|Other|10|||
46955277|NCT02538614|83195417|FG000|Overall Study|Progressive Disease|2|||
46955278|NCT04620135|83195425|FG000|Study Completion|Adverse Event|2|||
46955279|NCT04620135|83195426|FG001|Study Completion|Adverse Event|3|||
46955280|NCT04620135|83195425|FG000|Study Completion|Withdrawal by Subject|2|||
46955281|NCT04620135|83195426|FG001|Study Completion|Withdrawal by Subject|0|||
46955282|NCT02552966|83195432|FG000|Overall Study|Lost to Follow-up|2|||
46955283|NCT02552966|83195432|FG000|Overall Study|Withdrawal by Subject|3|||
46955284|NCT02552888|83195438|FG000|Overall Study|Lost to Follow-up|1|||
46955285|NCT02552888|83195439|FG001|Overall Study|Lost to Follow-up|1|||
46955286|NCT01373931|83195458|FG000|Lead-in Period|Adverse Event|2|||
46955287|NCT01373931|83195459|FG001|Lead-in Period|Adverse Event|0|||
46955288|NCT01373931|83195458|FG000|Period 1|Adverse Event|2|||
46955289|NCT01373931|83195459|FG001|Period 1|Adverse Event|0|||
46844016|NCT00845026|83060848|FG001|Study Period IV|Protocol Violation|1|||
46844017|NCT00845026|83060847|FG000|Study Period IV|Lost to Follow-up|1|||
46844018|NCT00845026|83060848|FG001|Study Period IV|Lost to Follow-up|0|||
46844019|NCT00845026|83060847|FG000|Study Period IV|Withdrawal by Subject|4|||
46844020|NCT00845026|83060848|FG001|Study Period IV|Withdrawal by Subject|1|||
46844021|NCT00845026|83060847|FG000|Study Period IV|Entry Criteria Not Met|1|||
46844022|NCT00845026|83060848|FG001|Study Period IV|Entry Criteria Not Met|0|||
46844023|NCT00845026|83060847|FG000|Study Period IV|Subject is moving or has moved|0|||
46844024|NCT00845026|83060848|FG001|Study Period IV|Subject is moving or has moved|1|||
46844025|NCT00845026|83060847|FG000|Study Period IV|Scheduling conflict|1|||
46844026|NCT00845026|83060848|FG001|Study Period IV|Scheduling conflict|0|||
46844027|NCT00691678|83060856|FG000|Overall Study|Adverse Event|5|||
46955290|NCT01373931|83195458|FG000|Period 1|Withdrawal by Subject|0|||
46955291|NCT01373931|83195459|FG001|Period 1|Withdrawal by Subject|2|||
46955292|NCT02552732|83195466|FG000|Overall Study|Lost to Follow-up|2|||
46955293|NCT02552732|83195466|FG000|Overall Study|Physician Decision|1|||
46955294|NCT02552732|83195466|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
46955295|NCT02552732|83195466|FG000|Overall Study|Withdrawal by Subject|6|||
46955296|NCT02547038|83195473|FG000|Overall Study|Lost to Follow-up|3|||
46955297|NCT02547038|83195474|FG001|Overall Study|Lost to Follow-up|2|||
46955298|NCT02764697|83195480|FG000|Overall Study|Lack of Efficacy|3|||
47066854|NCT01490125|83349894|FG003|Period I|Adverse Event|3|||
47066855|NCT01490125|83349895|FG004|Period I|Adverse Event|2|||
47066856|NCT01490125|83349896|FG005|Period I|Adverse Event|4|||
47066857|NCT01490125|83349891|FG000|Period I|Protocol Violation|1|||
46639374|NCT01384734|82812912|FG001|Overall Study|Lack of Efficacy|7|||
46639375|NCT01384734|82812913|FG002|Overall Study|Lack of Efficacy|4|||
46844028|NCT00691678|83060856|FG000|Overall Study|life events, pain|11|||
46844029|NCT00423605|83060860|FG000|Overall Study|Adverse Event|129|||
46844030|NCT00423605|83060860|FG000|Overall Study|Withdrawal by Subject|36|||
46955299|NCT02673489|83195486|FG000|Treatment Period|Lost to Follow-up|3|||
46955300|NCT02673489|83195487|FG001|Treatment Period|Lost to Follow-up|0|||
47066858|NCT01490125|83349892|FG001|Period I|Protocol Violation|1|||
46955301|NCT02673489|83195486|FG000|Treatment Period|Participant request to discontinue|1|||
46955302|NCT02673489|83195487|FG001|Treatment Period|Participant request to discontinue|1|||
46955303|NCT02673489|83195486|FG000|Treatment Period|Participant moved to another province|1|||
46955304|NCT02673489|83195487|FG001|Treatment Period|Participant moved to another province|0|||
46955305|NCT02673489|83195486|FG000|Treatment Period|Participant was incarcerated|0|||
46955306|NCT02673489|83195487|FG001|Treatment Period|Participant was incarcerated|1|||
46955307|NCT02673489|83195486|FG000|Treatment Period|Adverse Event|0|||
46955308|NCT02673489|83195487|FG001|Treatment Period|Adverse Event|1|||
46955309|NCT02673489|83195486|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
46844031|NCT00423605|83060860|FG000|Overall Study|Lost to Follow-up|15|||
46844032|NCT00423605|83060860|FG000|Overall Study|Lack of Efficacy|38|||
46844033|NCT00423605|83060860|FG000|Overall Study|Sponsor Decision|3|||
46844034|NCT00423605|83060860|FG000|Overall Study|Physician Decision|8|||
46844035|NCT00423605|83060860|FG000|Overall Study|Protocol Violation|7|||
46844036|NCT00423605|83060860|FG000|Overall Study|Not one of the pre-specified options|5|||
46844037|NCT00423449|83060864|FG000|Overall Study|Clinical Adverse Event|1|||
46844038|NCT00423449|83060865|FG001|Overall Study|Clinical Adverse Event|0|||
46844039|NCT00423449|83060866|FG002|Overall Study|Clinical Adverse Event|1|||
46844040|NCT00423449|83060867|FG003|Overall Study|Clinical Adverse Event|8|||
46844041|NCT00423449|83060868|FG004|Overall Study|Clinical Adverse Event|2|||
46955310|NCT02673489|83195487|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
46955311|NCT02673489|83195486|FG000|Follow Up Period|Unable to return for follow-up|0|||
46955312|NCT02673489|83195487|FG001|Follow Up Period|Unable to return for follow-up|1|||
46955313|NCT02772809|83195494|FG000|Overall Study|not completed some tasks|6|||
46955314|NCT02537678|83195505|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
46955315|NCT02537678|83195506|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
46955316|NCT02537678|83195505|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
46955317|NCT02537678|83195506|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
46955318|NCT02537678|83195505|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
46955319|NCT02537678|83195506|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
46955320|NCT02537678|83195505|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
46955321|NCT02537678|83195506|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
46955322|NCT02537678|83195505|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
46955323|NCT02537678|83195506|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
46955324|NCT02537678|83195505|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
46955325|NCT02537678|83195506|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
46955326|NCT02537678|83195505|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
46955327|NCT02537678|83195506|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
46955328|NCT02766023|83195518|FG000|Overall Study|Lost to Follow-up|23|||
46955329|NCT02766023|83195519|FG001|Overall Study|Lost to Follow-up|11|||
46955330|NCT02766023|83195518|FG000|Overall Study|Pregnancy|1|||
46955331|NCT02766023|83195519|FG001|Overall Study|Pregnancy|0|||
46955332|NCT02766023|83195518|FG000|Overall Study|Adverse Event|1|||
46955333|NCT02766023|83195519|FG001|Overall Study|Adverse Event|0|||
46955334|NCT02766023|83195518|FG000|Overall Study|Withdrawal by Subject|4|||
46955335|NCT02766023|83195519|FG001|Overall Study|Withdrawal by Subject|5|||
46955336|NCT02766023|83195518|FG000|Overall Study|Physician Decision|1|||
46955337|NCT02766023|83195519|FG001|Overall Study|Physician Decision|0|||
46955338|NCT02766023|83195518|FG000|Overall Study|Not Eligible at Enrollment|0|||
46955339|NCT02766023|83195519|FG001|Overall Study|Not Eligible at Enrollment|1|||
46955340|NCT02764229|83195525|FG000|Overall Study|Withdrawal by Subject|15|||
46955341|NCT02764229|83195525|FG000|Overall Study|Adverse Event|9|||
46955342|NCT02764229|83195525|FG000|Overall Study|Physician Decision|5|||
46955343|NCT02764229|83195525|FG000|Overall Study|Lost to Follow-up|3|||
46955344|NCT02764229|83195525|FG000|Overall Study|Lack of Efficacy|1|||
46955345|NCT02764229|83195525|FG000|Overall Study|Study Stopped by Sponsor|69|||
46955346|NCT02537522|83195529|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
46955347|NCT02537522|83195530|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
46955348|NCT02537522|83195531|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
46955349|NCT02537522|83195532|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
46955350|NCT02537522|83195529|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
46955351|NCT02537522|83195530|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
46955352|NCT02537522|83195531|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
46955353|NCT02537522|83195532|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
46955354|NCT02537522|83195529|FG000|Phase I - Contralateral|incorrect randomization|0|||
46639376|NCT01384734|82812914|FG003|Overall Study|Lack of Efficacy|4|||
46639377|NCT01384734|82812915|FG004|Overall Study|Lack of Efficacy|2|||
46773073|NCT00756470|82991379|FG000|Overall Study|Withdrawal by Subject|1|||
46773074|NCT00756470|82991379|FG000|Overall Study|Adverse Event|4|||
46773075|NCT00792623|82991383|FG000|Overall Study|Adverse Event|2|||
46773076|NCT00792623|82991383|FG000|Overall Study|Withdrawal by Subject|5|||
46773077|NCT00756314|82991390|FG000|Overall Study|Lost to Follow-up|2|||
46773078|NCT00756314|82991391|FG001|Overall Study|Lost to Follow-up|59|||
46773079|NCT00727506|82991403|FG000|Overall Study|Adverse Event|0|||
46773080|NCT00727506|82991404|FG001|Overall Study|Adverse Event|0|||
46844042|NCT00423449|83060864|FG000|Overall Study|Death|1|||
46844043|NCT00423449|83060865|FG001|Overall Study|Death|0|||
46844044|NCT00423449|83060866|FG002|Overall Study|Death|2|||
46955355|NCT02537522|83195530|FG001|Phase I - Contralateral|incorrect randomization|1|||
46773081|NCT00727506|82991405|FG002|Overall Study|Adverse Event|4|||
46844045|NCT00423449|83060867|FG003|Overall Study|Death|1|||
46955356|NCT02537522|83195531|FG002|Phase I - Contralateral|incorrect randomization|0|||
46955357|NCT02537522|83195532|FG003|Phase I - Contralateral|incorrect randomization|0|||
46955358|NCT02537522|83195529|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
46955359|NCT02537522|83195530|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
46955360|NCT02537522|83195531|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
46955361|NCT02537522|83195532|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
46955362|NCT02537522|83195529|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
46955363|NCT02537522|83195530|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
46955364|NCT02537522|83195531|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
46955365|NCT02537522|83195532|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
46955366|NCT02536976|83195540|FG000|Overall Study|Physician Decision|0|||
46955367|NCT02536976|83195541|FG001|Overall Study|Physician Decision|1|||
46955368|NCT02672553|83195551|FG000|Overall Study|Death|3|||
46955369|NCT02672553|83195552|FG001|Overall Study|Death|5|||
46955370|NCT02672553|83195551|FG000|Overall Study|Valve Explant|1|||
46955371|NCT02672553|83195552|FG001|Overall Study|Valve Explant|0|||
46955372|NCT02672553|83195551|FG000|Overall Study|Conversion to Commercial Valve|3|||
46955373|NCT02672553|83195552|FG001|Overall Study|Conversion to Commercial Valve|0|||
46955374|NCT02672553|83195551|FG000|Overall Study|Withdrawal by Subject|3|||
46955375|NCT02672553|83195552|FG001|Overall Study|Withdrawal by Subject|3|||
46955376|NCT02672553|83195551|FG000|Overall Study|Intraoperative screen failure|2|||
46955377|NCT02672553|83195552|FG001|Overall Study|Intraoperative screen failure|0|||
46955378|NCT01373229|83195559|FG000|Overall Study|Death|3|||
46955379|NCT01373229|83195559|FG000|Overall Study|Physician Decision|3|||
46955380|NCT02671461|83195566|FG000|Treatment|Adverse Event|0|||
46955381|NCT02671461|83195567|FG001|Treatment|Adverse Event|0|||
46955382|NCT02671461|83195568|FG002|Treatment|Adverse Event|1|||
46955383|NCT02671461|83195566|FG000|Treatment|Administrative Reason by Sponsor|1|||
46955384|NCT02671461|83195567|FG001|Treatment|Administrative Reason by Sponsor|3|||
46955385|NCT02671461|83195568|FG002|Treatment|Administrative Reason by Sponsor|4|||
46955386|NCT02671461|83195566|FG000|Treatment|Randomized, not treated|1|||
46955387|NCT02671461|83195567|FG001|Treatment|Randomized, not treated|0|||
46955388|NCT02671461|83195568|FG002|Treatment|Randomized, not treated|0|||
46955389|NCT02671461|83195566|FG000|Follow-up|Withdrawal by Subject|1|||
46955390|NCT02671461|83195567|FG001|Follow-up|Withdrawal by Subject|0|||
46955391|NCT02671461|83195568|FG002|Follow-up|Withdrawal by Subject|0|||
46955392|NCT02671461|83195566|FG000|Follow-up|Lost to Follow-up|0|||
46955393|NCT02671461|83195567|FG001|Follow-up|Lost to Follow-up|0|||
46955394|NCT02671461|83195568|FG002|Follow-up|Lost to Follow-up|1|||
46955395|NCT02671461|83195566|FG000|Follow-up|Administrative Reason by Sponsor|0|||
46955396|NCT02671461|83195567|FG001|Follow-up|Administrative Reason by Sponsor|1|||
46955397|NCT02671461|83195568|FG002|Follow-up|Administrative Reason by Sponsor|0|||
46955398|NCT02535416|83195585|FG000|Overall Study|Family bereavement overseas|1|||
46955399|NCT02535416|83195586|FG001|Overall Study|Family bereavement overseas|0|||
46955400|NCT02535416|83195587|FG002|Overall Study|Family bereavement overseas|0|||
46955401|NCT02535416|83195588|FG003|Overall Study|Family bereavement overseas|0|||
46955402|NCT02535416|83195589|FG004|Overall Study|Family bereavement overseas|0|||
46955403|NCT02535416|83195590|FG005|Overall Study|Family bereavement overseas|0|||
46955404|NCT02535416|83195591|FG006|Overall Study|Family bereavement overseas|0|||
46773082|NCT00727506|82991406|FG003|Overall Study|Adverse Event|4|||
46773083|NCT00727506|82991407|FG004|Overall Study|Adverse Event|1|||
46773084|NCT00727506|82991408|FG005|Overall Study|Adverse Event|8|||
46773085|NCT00727506|82991403|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
46773086|NCT00727506|82991404|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46773087|NCT00727506|82991405|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
46844046|NCT00423449|83060868|FG004|Overall Study|Death|1|||
46773088|NCT00727506|82991406|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46773089|NCT00727506|82991407|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46844047|NCT00423449|83060864|FG000|Overall Study|Progressive Disease|1|||
46844048|NCT00423449|83060865|FG001|Overall Study|Progressive Disease|3|||
46844049|NCT00423449|83060866|FG002|Overall Study|Progressive Disease|8|||
46844050|NCT00423449|83060867|FG003|Overall Study|Progressive Disease|11|||
46844051|NCT00423449|83060868|FG004|Overall Study|Progressive Disease|4|||
46955405|NCT02535416|83195592|FG007|Overall Study|Family bereavement overseas|0|||
46955406|NCT02535416|83195593|FG008|Overall Study|Family bereavement overseas|0|||
46955407|NCT02670915|83195643|FG000|Overall Study|Withdrawal by Subject|0|||
46955408|NCT02670915|83195644|FG001|Overall Study|Withdrawal by Subject|1|||
46773090|NCT00727506|82991408|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
46773091|NCT00727506|82991403|FG000|Overall Study|Progressive disease|4|||
46955409|NCT02670915|83195645|FG002|Overall Study|Withdrawal by Subject|4|||
46955410|NCT02670915|83195643|FG000|Overall Study|Withdrawal by parent/guardian|4|||
46955411|NCT02670915|83195644|FG001|Overall Study|Withdrawal by parent/guardian|4|||
46955412|NCT02670915|83195645|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46955413|NCT02670915|83195643|FG000|Overall Study|Unclassified|0|||
46955414|NCT02670915|83195644|FG001|Overall Study|Unclassified|3|||
46955415|NCT02670915|83195645|FG002|Overall Study|Unclassified|0|||
46955416|NCT02764151|83195657|FG000|Overall Study|Subject refused further follow-up|0|||
46955417|NCT02764151|83195658|FG001|Overall Study|Subject refused further follow-up|0|||
46955418|NCT02764151|83195659|FG002|Overall Study|Subject refused further follow-up|0|||
46955419|NCT02764151|83195660|FG003|Overall Study|Subject refused further follow-up|1|||
46955420|NCT02764151|83195657|FG000|Overall Study|Other|0|||
46955421|NCT02764151|83195658|FG001|Overall Study|Other|0|||
46955422|NCT02764151|83195659|FG002|Overall Study|Other|0|||
46955423|NCT02764151|83195660|FG003|Overall Study|Other|2|||
46955424|NCT02545322|83195670|FG000|Overall Study|Withdrawal by Subject|3|||
46955425|NCT02763215|83195674|FG000|Overall Study|Participants withdrew from study|3|||
46955426|NCT02763215|83195674|FG000|Overall Study|Missed visit|1|||
46955427|NCT02763215|83195674|FG000|Overall Study|Visit outside visit-window|1|||
46955428|NCT02763215|83195674|FG000|Overall Study|Death|1|||
46955429|NCT02763215|83195674|FG000|Overall Study|Lost to Follow-up|1|||
46955430|NCT02770547|83195693|FG000|Overall Study|Patient non-compliant|1|||
46955431|NCT02770547|83195694|FG001|Overall Study|Patient non-compliant|0|||
46955432|NCT02770547|83195693|FG000|Overall Study|Adverse Event|0|||
46955433|NCT02770547|83195694|FG001|Overall Study|Adverse Event|1|||
46955434|NCT01661972|83195702|FG000|Overall Study|Adverse Event|1|||
46955435|NCT01661972|83195703|FG001|Overall Study|Adverse Event|2|||
46955436|NCT01661972|83195702|FG000|Overall Study|Death during Treatment period|1|||
46955437|NCT01661972|83195703|FG001|Overall Study|Death during Treatment period|1|||
46955438|NCT01661972|83195702|FG000|Overall Study|Withdrawal by Subject|0|||
46955439|NCT01661972|83195703|FG001|Overall Study|Withdrawal by Subject|1|||
46844052|NCT00423449|83060864|FG000|Overall Study|Laboratory Adverse Event|0|||
46844053|NCT00423449|83060865|FG001|Overall Study|Laboratory Adverse Event|1|||
46844054|NCT00423449|83060866|FG002|Overall Study|Laboratory Adverse Event|2|||
46844055|NCT00423449|83060867|FG003|Overall Study|Laboratory Adverse Event|0|||
46844056|NCT00423449|83060868|FG004|Overall Study|Laboratory Adverse Event|0|||
46844057|NCT00423449|83060864|FG000|Overall Study|Other|0|||
46844058|NCT00423449|83060865|FG001|Overall Study|Other|0|||
46844059|NCT00423449|83060866|FG002|Overall Study|Other|0|||
46844060|NCT00423449|83060867|FG003|Overall Study|Other|1|||
46844061|NCT00423449|83060868|FG004|Overall Study|Other|0|||
46844062|NCT00423449|83060864|FG000|Overall Study|Protocol Violation|0|||
46844063|NCT00423449|83060865|FG001|Overall Study|Protocol Violation|0|||
46844064|NCT00423449|83060866|FG002|Overall Study|Protocol Violation|2|||
46844065|NCT00423449|83060867|FG003|Overall Study|Protocol Violation|1|||
46844066|NCT00423449|83060868|FG004|Overall Study|Protocol Violation|0|||
46844067|NCT00423293|83060881|FG000|Overall Study|Ineligible / No protocol treatment|11|||
46844068|NCT00423137|83060889|FG000|Overall Study|Lost to Follow-up|0|||
46844069|NCT00423137|83060890|FG001|Overall Study|Lost to Follow-up|0|||
46844070|NCT00423137|83060891|FG002|Overall Study|Lost to Follow-up|1|||
46955440|NCT00888355|83195715|FG000|Overall Study|Adverse Event|10|||
46955441|NCT00888355|83195716|FG001|Overall Study|Adverse Event|0|||
46955442|NCT00888355|83195717|FG002|Overall Study|Adverse Event|3|||
46955443|NCT00888355|83195718|FG003|Overall Study|Adverse Event|3|||
46773092|NCT00727506|82991404|FG001|Overall Study|Progressive disease|7|||
46773093|NCT00727506|82991405|FG002|Overall Study|Progressive disease|9|||
46773094|NCT00727506|82991406|FG003|Overall Study|Progressive disease|28|||
46773095|NCT00727506|82991407|FG004|Overall Study|Progressive disease|38|||
46773096|NCT00727506|82991408|FG005|Overall Study|Progressive disease|28|||
46773097|NCT00727506|82991403|FG000|Overall Study|Refused to continue medication|0|||
46773098|NCT00727506|82991404|FG001|Overall Study|Refused to continue medication|1|||
46773099|NCT00727506|82991405|FG002|Overall Study|Refused to continue medication|2|||
46773100|NCT00727506|82991406|FG003|Overall Study|Refused to continue medication|3|||
46773101|NCT00727506|82991407|FG004|Overall Study|Refused to continue medication|1|||
46773102|NCT00727506|82991408|FG005|Overall Study|Refused to continue medication|2|||
46773103|NCT00727506|82991403|FG000|Overall Study|Other reason not described above|0|||
46844071|NCT00423137|83060892|FG003|Overall Study|Lost to Follow-up|0|||
46955444|NCT00888355|83195715|FG000|Overall Study|Lack of Efficacy|9|||
46955445|NCT00888355|83195716|FG001|Overall Study|Lack of Efficacy|2|||
46955446|NCT00888355|83195717|FG002|Overall Study|Lack of Efficacy|5|||
46955447|NCT00888355|83195718|FG003|Overall Study|Lack of Efficacy|2|||
46955448|NCT00888355|83195715|FG000|Overall Study|Lost to Follow-up|0|||
46955449|NCT00888355|83195716|FG001|Overall Study|Lost to Follow-up|2|||
46955450|NCT00888355|83195717|FG002|Overall Study|Lost to Follow-up|2|||
46773104|NCT00727506|82991404|FG001|Overall Study|Other reason not described above|0|||
46773105|NCT00727506|82991405|FG002|Overall Study|Other reason not described above|1|||
46773106|NCT00727506|82991406|FG003|Overall Study|Other reason not described above|4|||
46844072|NCT00423137|83060889|FG000|Overall Study|Protocol Violation|0|||
46844073|NCT00423137|83060890|FG001|Overall Study|Protocol Violation|0|||
46844074|NCT00423137|83060891|FG002|Overall Study|Protocol Violation|0|||
46955451|NCT00888355|83195718|FG003|Overall Study|Lost to Follow-up|0|||
46955452|NCT00888355|83195715|FG000|Overall Study|Protocol Violation|3|||
46955453|NCT00888355|83195716|FG001|Overall Study|Protocol Violation|2|||
46844075|NCT00423137|83060892|FG003|Overall Study|Protocol Violation|1|||
46844076|NCT00423137|83060889|FG000|Overall Study|Adverse Event Study disease worse|1|||
46844077|NCT00423137|83060890|FG001|Overall Study|Adverse Event Study disease worse|0|||
46844078|NCT00423137|83060891|FG002|Overall Study|Adverse Event Study disease worse|3|||
46844079|NCT00423137|83060892|FG003|Overall Study|Adverse Event Study disease worse|1|||
46844080|NCT00423137|83060889|FG000|Overall Study|Adverse Event Other|0|||
46844081|NCT00423137|83060890|FG001|Overall Study|Adverse Event Other|0|||
46955454|NCT00888355|83195717|FG002|Overall Study|Protocol Violation|1|||
46955455|NCT00888355|83195718|FG003|Overall Study|Protocol Violation|2|||
46955456|NCT00888355|83195715|FG000|Overall Study|Withdrawal by Subject|0|||
46955457|NCT00888355|83195716|FG001|Overall Study|Withdrawal by Subject|3|||
46955458|NCT00888355|83195717|FG002|Overall Study|Withdrawal by Subject|1|||
46955459|NCT00888355|83195718|FG003|Overall Study|Withdrawal by Subject|3|||
46955460|NCT00794677|83195726|FG000|First Intervention|Withdrawal by Subject|2|||
46955461|NCT00794677|83195727|FG001|First Intervention|Withdrawal by Subject|0|||
46955462|NCT02770391|83195731|FG000|Overall Study|Lost to Follow-up|2|||
46955463|NCT02770391|83195731|FG000|Overall Study|Withdrawal by Subject|1|||
46955464|NCT02770391|83195731|FG000|Overall Study|Surgery delayed unevaluable|2|||
46955465|NCT02770391|83195731|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
46955466|NCT02536508|83195738|FG000|Overall Study|Withdrawal by Subject|18|||
46844082|NCT00423137|83060891|FG002|Overall Study|Adverse Event Other|2|||
46844083|NCT00423137|83060892|FG003|Overall Study|Adverse Event Other|0|||
46844084|NCT00422903|83060907|FG000|Overall Study|Disease Progression|3|||
46844085|NCT00422903|83060908|FG001|Overall Study|Disease Progression|1|||
46844086|NCT00422903|83060907|FG000|Overall Study|Adverse Event|0|||
46844087|NCT00422903|83060908|FG001|Overall Study|Adverse Event|2|||
46844088|NCT00422903|83060907|FG000|Overall Study|Informed Consent Withdrawn|1|||
46955467|NCT02536508|83195739|FG001|Overall Study|Withdrawal by Subject|13|||
46955468|NCT02536508|83195740|FG002|Overall Study|Withdrawal by Subject|7|||
46955469|NCT02536508|83195738|FG000|Overall Study|Adverse Event|14|||
46955470|NCT02536508|83195739|FG001|Overall Study|Adverse Event|13|||
46955471|NCT02536508|83195740|FG002|Overall Study|Adverse Event|6|||
46955472|NCT02536508|83195738|FG000|Overall Study|Lost to Follow-up|12|||
46955473|NCT02536508|83195739|FG001|Overall Study|Lost to Follow-up|4|||
46955474|NCT02536508|83195740|FG002|Overall Study|Lost to Follow-up|0|||
46955475|NCT02536508|83195738|FG000|Overall Study|Lack of Efficacy|3|||
46955476|NCT02536508|83195739|FG001|Overall Study|Lack of Efficacy|5|||
46955477|NCT02536508|83195740|FG002|Overall Study|Lack of Efficacy|4|||
46955478|NCT02536508|83195738|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
46955479|NCT02536508|83195739|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
47066859|NCT01490125|83349893|FG002|Period I|Protocol Violation|1|||
46773107|NCT00727506|82991407|FG004|Overall Study|Other reason not described above|1|||
46773108|NCT00727506|82991408|FG005|Overall Study|Other reason not described above|1|||
46844089|NCT00422903|83060908|FG001|Overall Study|Informed Consent Withdrawn|2|||
46844090|NCT00422669|83060917|FG000|Overall Study|The study was terminated early.|98|||
46844091|NCT00422669|83060918|FG001|Overall Study|The study was terminated early.|100|||
46844092|NCT00422669|83060919|FG002|Overall Study|The study was terminated early.|7|||
46844093|NCT00422591|83060925|FG000|Overall Study|Physician Decision|4|||
46844094|NCT00422591|83060925|FG000|Overall Study|Withdrawal by Subject|2|||
46844095|NCT00422513|83060931|FG000|Overall Study|Lack of Efficacy|4|||
46844096|NCT00422513|83060932|FG001|Overall Study|Lack of Efficacy|5|||
46844097|NCT00422513|83060931|FG000|Overall Study|Protocol Violation|23|||
46844098|NCT00422513|83060932|FG001|Overall Study|Protocol Violation|7|||
46844099|NCT00422513|83060931|FG000|Overall Study|Refused Treatment|4|||
46773109|NCT00789815|82991430|FG000|Overall Study|Protocol Violation|6|||
46773110|NCT00789815|82991431|FG001|Overall Study|Protocol Violation|1|||
46773111|NCT00789815|82991430|FG000|Overall Study|Intubation due to massive bleeding|1|||
46773112|NCT00789815|82991431|FG001|Overall Study|Intubation due to massive bleeding|0|||
46773113|NCT00721578|82991437|FG000|Overall Study|Death|1|||
46773114|NCT00721578|82991438|FG001|Overall Study|Death|1|||
46844100|NCT00422513|83060932|FG001|Overall Study|Refused Treatment|2|||
46844101|NCT00422513|83060931|FG000|Overall Study|Withdrawal by Subject|2|||
46955480|NCT02536508|83195740|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
47066860|NCT01490125|83349894|FG003|Period I|Protocol Violation|1|||
46639378|NCT01384734|82812911|FG000|Overall Study|Lost to Follow-up|5|||
46639379|NCT01384734|82812912|FG001|Overall Study|Lost to Follow-up|3|||
46639380|NCT01384734|82812913|FG002|Overall Study|Lost to Follow-up|3|||
46773115|NCT00721578|82991437|FG000|Overall Study|Withdrawal by Subject|1|||
46773116|NCT00721578|82991438|FG001|Overall Study|Withdrawal by Subject|1|||
46773117|NCT00789737|82991446|FG000|Overall Study|Withdrawal by Subject|13|||
46844102|NCT00422513|83060932|FG001|Overall Study|Withdrawal by Subject|1|||
46844103|NCT00422513|83060931|FG000|Overall Study|early termination of the study|67|||
46844104|NCT00422513|83060932|FG001|Overall Study|early termination of the study|80|||
46844105|NCT00422513|83060931|FG000|Overall Study|Adverse Event|4|||
46955481|NCT02536508|83195738|FG000|Overall Study|Physician Decision|0|||
46955482|NCT02536508|83195739|FG001|Overall Study|Physician Decision|4|||
46955483|NCT02536508|83195740|FG002|Overall Study|Physician Decision|2|||
46955484|NCT02536508|83195738|FG000|Overall Study|Major Protocol Deviation|2|||
46955485|NCT02536508|83195739|FG001|Overall Study|Major Protocol Deviation|2|||
46955486|NCT02536508|83195740|FG002|Overall Study|Major Protocol Deviation|2|||
46955487|NCT02536508|83195738|FG000|Overall Study|Administrative Reasons|0|||
46955488|NCT02536508|83195739|FG001|Overall Study|Administrative Reasons|1|||
46955489|NCT02536508|83195740|FG002|Overall Study|Administrative Reasons|0|||
46955490|NCT00103259|83195757|FG000|Overall Study|Death|3|||
46955491|NCT00103259|83195758|FG001|Overall Study|Death|2|||
46955492|NCT00103259|83195757|FG000|Overall Study|Withdrawal by Subject|2|||
46955493|NCT00103259|83195758|FG001|Overall Study|Withdrawal by Subject|3|||
46955494|NCT00103259|83195757|FG000|Overall Study|alternative therapy|1|||
46955495|NCT00103259|83195758|FG001|Overall Study|alternative therapy|0|||
46955496|NCT00103259|83195757|FG000|Overall Study|other (reasons were not specified)|2|||
46955497|NCT00103259|83195758|FG001|Overall Study|other (reasons were not specified)|1|||
46955498|NCT00103259|83195757|FG000|Overall Study|ineligible/no protocol therapy|4|||
46955499|NCT00103259|83195758|FG001|Overall Study|ineligible/no protocol therapy|6|||
46955500|NCT02544152|83195768|FG000|Overall Study|Adverse Event|0|||
46955501|NCT02544152|83195769|FG001|Overall Study|Adverse Event|4|||
46955502|NCT02544152|83195768|FG000|Overall Study|Withdrawal by Subject|0|||
46955503|NCT02544152|83195769|FG001|Overall Study|Withdrawal by Subject|3|||
46955504|NCT02544152|83195768|FG000|Overall Study|Other|1|||
46955505|NCT02544152|83195769|FG001|Overall Study|Other|0|||
46955506|NCT02534324|83195777|FG000|Overall Study|Protocol Violation|4|||
46955507|NCT02534324|83195778|FG001|Overall Study|Protocol Violation|1|||
46955508|NCT02534324|83195777|FG000|Overall Study|Lost to Follow-up|20|||
46955509|NCT02534324|83195778|FG001|Overall Study|Lost to Follow-up|7|||
46955510|NCT02534324|83195777|FG000|Overall Study|Adverse Event|1|||
46955511|NCT02534324|83195778|FG001|Overall Study|Adverse Event|0|||
46955512|NCT02761733|83195788|FG000|Overall Study|Death|3|||
46844106|NCT00422513|83060932|FG001|Overall Study|Adverse Event|4|||
46844107|NCT00422513|83060931|FG000|Overall Study|Death|3|||
46844108|NCT00422513|83060932|FG001|Overall Study|Death|7|||
46844109|NCT00202878|83060940|FG000|Overall Study|Death|964|||
46844110|NCT00202878|83060941|FG001|Overall Study|Death|968|||
46844111|NCT00202878|83060940|FG000|Overall Study|Only Vital Status Known|357|||
46844112|NCT00202878|83060941|FG001|Overall Study|Only Vital Status Known|356|||
46844113|NCT00202878|83060940|FG000|Overall Study|Lost to Follow-up|44|||
46844114|NCT00202878|83060941|FG001|Overall Study|Lost to Follow-up|49|||
46844115|NCT00202878|83060940|FG000|Overall Study|Site Closure|39|||
46844116|NCT00202878|83060941|FG001|Overall Study|Site Closure|36|||
46844117|NCT00202878|83060940|FG000|Overall Study|Withdrawal by Subject|795|||
46844118|NCT00202878|83060941|FG001|Overall Study|Withdrawal by Subject|808|||
46844119|NCT00414011|83060947|FG000|Overall Study|Physician Decision|3|||
46844120|NCT00414011|83060947|FG000|Overall Study|Withdrawal by Subject|2|||
46844121|NCT00231816|83060954|FG000|Overall Study|Adverse Event|1|||
46844122|NCT00231816|83060955|FG001|Overall Study|Adverse Event|0|||
46844123|NCT00231816|83060954|FG000|Overall Study|Lost to Follow-up|8|||
46844124|NCT00231816|83060955|FG001|Overall Study|Lost to Follow-up|5|||
46844125|NCT00231816|83060954|FG000|Overall Study|Protocol Violation|2|||
46844126|NCT00231816|83060955|FG001|Overall Study|Protocol Violation|3|||
46844127|NCT00231816|83060954|FG000|Overall Study|Withdrawal by Subject|3|||
46844128|NCT00231816|83060955|FG001|Overall Study|Withdrawal by Subject|3|||
46844129|NCT00231816|83060954|FG000|Overall Study|Other|2|||
46844130|NCT00231816|83060955|FG001|Overall Study|Other|1|||
46844131|NCT00260208|83060964|FG000|Overall Study|Subject withdrew consent|11|||
46844132|NCT00260208|83060965|FG001|Overall Study|Subject withdrew consent|7|||
46844133|NCT00260208|83060964|FG000|Overall Study|Lost to Follow-up|6|||
46844134|NCT00260208|83060965|FG001|Overall Study|Lost to Follow-up|1|||
46844135|NCT00260208|83060964|FG000|Overall Study|Death|12|||
47066861|NCT01490125|83349895|FG004|Period I|Protocol Violation|0|||
46844136|NCT00260208|83060965|FG001|Overall Study|Death|10|||
46844137|NCT00260208|83060964|FG000|Overall Study|Missing|18|||
46844138|NCT00260208|83060965|FG001|Overall Study|Missing|16|||
46955513|NCT02761733|83195789|FG001|Overall Study|Death|5|||
46955514|NCT02761733|83195790|FG002|Overall Study|Death|1|||
46955515|NCT02761733|83195791|FG003|Overall Study|Death|1|||
46955516|NCT02761733|83195788|FG000|Overall Study|Lost to Follow-up|6|||
46955517|NCT02761733|83195789|FG001|Overall Study|Lost to Follow-up|7|||
46955518|NCT02761733|83195790|FG002|Overall Study|Lost to Follow-up|0|||
46955519|NCT02761733|83195791|FG003|Overall Study|Lost to Follow-up|3|||
47066862|NCT01490125|83349896|FG005|Period I|Protocol Violation|0|||
47066863|NCT01490125|83349891|FG000|Period I|Withdrawal by Subject|1|||
47066864|NCT01490125|83349892|FG001|Period I|Withdrawal by Subject|3|||
46844139|NCT00202644|83060973|FG000|Overall Study|Adverse Event|12|||
46844140|NCT00202644|83060974|FG001|Overall Study|Adverse Event|13|||
46844141|NCT00202644|83060973|FG000|Overall Study|Withdrawal by Subject|8|||
46844142|NCT00202644|83060974|FG001|Overall Study|Withdrawal by Subject|6|||
46844143|NCT00202644|83060973|FG000|Overall Study|Lack of Efficacy|6|||
46844144|NCT00202644|83060974|FG001|Overall Study|Lack of Efficacy|6|||
46844145|NCT00202644|83060973|FG000|Overall Study|Lost to Follow-up|0|||
46955520|NCT02761733|83195788|FG000|Overall Study|Physician Decision|4|||
46955521|NCT02761733|83195789|FG001|Overall Study|Physician Decision|0|||
46844146|NCT00202644|83060974|FG001|Overall Study|Lost to Follow-up|1|||
46844147|NCT00202644|83060973|FG000|Overall Study|Other|9|||
46844148|NCT00202644|83060974|FG001|Overall Study|Other|1|||
46955522|NCT02761733|83195790|FG002|Overall Study|Physician Decision|0|||
46955523|NCT02761733|83195791|FG003|Overall Study|Physician Decision|0|||
46955524|NCT02761733|83195788|FG000|Overall Study|Withdrawal by Subject|2|||
46955525|NCT02761733|83195789|FG001|Overall Study|Withdrawal by Subject|0|||
46955526|NCT02761733|83195790|FG002|Overall Study|Withdrawal by Subject|0|||
46955527|NCT02761733|83195791|FG003|Overall Study|Withdrawal by Subject|0|||
46955528|NCT02761733|83195788|FG000|Overall Study|Discharged from Study Site|10|||
46955529|NCT02761733|83195789|FG001|Overall Study|Discharged from Study Site|9|||
46955530|NCT02761733|83195790|FG002|Overall Study|Discharged from Study Site|25|||
46955531|NCT02761733|83195791|FG003|Overall Study|Discharged from Study Site|11|||
46955532|NCT02761733|83195788|FG000|Overall Study|Cognitive Impairment|5|||
46955533|NCT02761733|83195789|FG001|Overall Study|Cognitive Impairment|0|||
46955534|NCT02761733|83195790|FG002|Overall Study|Cognitive Impairment|1|||
46955535|NCT02761733|83195791|FG003|Overall Study|Cognitive Impairment|0|||
46955536|NCT03715465|83195803|FG000|Overall Study|Withdrawal by Subject|1|||
46955537|NCT03715465|83195804|FG001|Overall Study|Withdrawal by Subject|2|||
46955538|NCT00840073|83195812|FG000|Second Intervention|Missed 72 hour blood draw|1|||
46955539|NCT00840073|83195813|FG001|Second Intervention|Missed 72 hour blood draw|1|||
46955540|NCT00838279|83195819|FG000|Washout|Protocol Violation|1|||
46773118|NCT00789737|82991447|FG001|Overall Study|Withdrawal by Subject|22|||
46773119|NCT00789737|82991446|FG000|Overall Study|Lost to Follow-up|10|||
46773120|NCT00789737|82991447|FG001|Overall Study|Lost to Follow-up|14|||
46773121|NCT00789737|82991446|FG000|Overall Study|Adverse Event|8|||
46773122|NCT00789737|82991447|FG001|Overall Study|Adverse Event|8|||
46773123|NCT00789737|82991446|FG000|Overall Study|Protocol Violation|3|||
46773124|NCT00789737|82991447|FG001|Overall Study|Protocol Violation|0|||
46844149|NCT01235962|83060984|FG000|Overall Study|Withdrawal by Subject|20|||
46844150|NCT01235962|83060985|FG001|Overall Study|Withdrawal by Subject|19|||
46844151|NCT01235962|83060986|FG002|Overall Study|Withdrawal by Subject|62|||
46844152|NCT01235962|83060987|FG003|Overall Study|Withdrawal by Subject|49|||
46844153|NCT01235962|83060984|FG000|Overall Study|Lost to Follow-up|21|||
46844154|NCT01235962|83060985|FG001|Overall Study|Lost to Follow-up|16|||
46844155|NCT01235962|83060986|FG002|Overall Study|Lost to Follow-up|47|||
46844156|NCT01235962|83060987|FG003|Overall Study|Lost to Follow-up|32|||
46844157|NCT01235962|83060984|FG000|Overall Study|Physician Decision|5|||
46844158|NCT01235962|83060985|FG001|Overall Study|Physician Decision|0|||
46844159|NCT01235962|83060986|FG002|Overall Study|Physician Decision|9|||
46844160|NCT01235962|83060987|FG003|Overall Study|Physician Decision|5|||
46844161|NCT00259740|83061007|FG000|Overall Study|Physician Decision|1|||
46844162|NCT00259740|83061008|FG001|Overall Study|Physician Decision|1|||
46844163|NCT00259740|83061007|FG000|Overall Study|Adverse Event|0|||
46844164|NCT00259740|83061008|FG001|Overall Study|Adverse Event|2|||
46844165|NCT00259740|83061007|FG000|Overall Study|Withdrawal by Subject|2|||
46844166|NCT00259740|83061008|FG001|Overall Study|Withdrawal by Subject|6|||
46844167|NCT00259740|83061007|FG000|Overall Study|Death|1|||
46955541|NCT00838279|83195820|FG001|Washout|Protocol Violation|0|||
46955542|NCT00838279|83195819|FG000|Washout|Withdrawal by Subject|0|||
46955543|NCT00838279|83195820|FG001|Washout|Withdrawal by Subject|1|||
46955544|NCT02759939|83195828|FG000|Overall Study|Missing data on first outcome assessed|11|||
46955545|NCT02759939|83195829|FG001|Overall Study|Missing data on first outcome assessed|2|||
46955546|NCT02759939|83195830|FG002|Overall Study|Missing data on first outcome assessed|5|||
46955547|NCT02759939|83195831|FG003|Overall Study|Missing data on first outcome assessed|2|||
46955548|NCT02759939|83195828|FG000|Overall Study|Ineligible for T2 and T3|310|||
46955549|NCT02759939|83195829|FG001|Overall Study|Ineligible for T2 and T3|179|||
46955550|NCT02759939|83195830|FG002|Overall Study|Ineligible for T2 and T3|366|||
46955551|NCT02759939|83195831|FG003|Overall Study|Ineligible for T2 and T3|391|||
46955552|NCT02759939|83195828|FG000|Overall Study|Lost to Follow-up|735|||
46955553|NCT02759939|83195829|FG001|Overall Study|Lost to Follow-up|791|||
46773125|NCT00789737|82991446|FG000|Overall Study|Lack of Efficacy|3|||
46773126|NCT00789737|82991447|FG001|Overall Study|Lack of Efficacy|0|||
46844168|NCT00259740|83061008|FG001|Overall Study|Death|1|||
46955554|NCT02759939|83195830|FG002|Overall Study|Lost to Follow-up|783|||
46955555|NCT02759939|83195831|FG003|Overall Study|Lost to Follow-up|650|||
46773127|NCT00789737|82991446|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
46955556|NCT00835705|83195850|FG000|First Intervention|Difficulty with vein|1|||
47066865|NCT01490125|83349893|FG002|Period I|Withdrawal by Subject|2|||
46773128|NCT00789737|82991447|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
46773129|NCT00789737|82991446|FG000|Overall Study|Other|11|||
46773130|NCT00789737|82991447|FG001|Overall Study|Other|7|||
46844169|NCT00259740|83061007|FG000|Overall Study|Disease progression|19|||
46844170|NCT00259740|83061008|FG001|Overall Study|Disease progression|36|||
46844171|NCT00259740|83061007|FG000|Overall Study|Ongoing|17|||
46844172|NCT00259740|83061008|FG001|Overall Study|Ongoing|3|||
46844173|NCT00259740|83061007|FG000|Overall Study|Other|3|||
46844174|NCT00259740|83061008|FG001|Overall Study|Other|0|||
46955557|NCT00835705|83195851|FG001|First Intervention|Difficulty with vein|0|||
46955558|NCT00835705|83195850|FG000|Second Intervention|Difficulty with vein|1|||
46955559|NCT00835705|83195851|FG001|Second Intervention|Difficulty with vein|0|||
46955560|NCT02759471|83195855|FG000|Overall Study|discomfort|2|||
46955561|NCT00835549|83195863|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
46955562|NCT00835549|83195864|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
46955563|NCT03945825|83195874|FG000|Overall Study|Enrolled but treatment not administered|0|||
46955564|NCT03945825|83195875|FG001|Overall Study|Enrolled but treatment not administered|0|||
46955565|NCT03945825|83195876|FG002|Overall Study|Enrolled but treatment not administered|0|||
46955566|NCT03945825|83195877|FG003|Overall Study|Enrolled but treatment not administered|0|||
46955567|NCT03945825|83195878|FG004|Overall Study|Enrolled but treatment not administered|1|||
46955568|NCT03945825|83195879|FG005|Overall Study|Enrolled but treatment not administered|0|||
46955569|NCT03945825|83195874|FG000|Overall Study|Lost to Follow-up|1|||
46955570|NCT03945825|83195875|FG001|Overall Study|Lost to Follow-up|5|||
46955571|NCT03945825|83195876|FG002|Overall Study|Lost to Follow-up|0|||
46955572|NCT03945825|83195877|FG003|Overall Study|Lost to Follow-up|1|||
46955573|NCT03945825|83195878|FG004|Overall Study|Lost to Follow-up|2|||
46955574|NCT03945825|83195879|FG005|Overall Study|Lost to Follow-up|2|||
46955575|NCT03945825|83195874|FG000|Overall Study|Withdrawal by Subject|1|||
46955576|NCT03945825|83195875|FG001|Overall Study|Withdrawal by Subject|0|||
46955577|NCT03945825|83195876|FG002|Overall Study|Withdrawal by Subject|1|||
46955578|NCT03945825|83195877|FG003|Overall Study|Withdrawal by Subject|1|||
46955579|NCT03945825|83195878|FG004|Overall Study|Withdrawal by Subject|0|||
46955580|NCT03945825|83195879|FG005|Overall Study|Withdrawal by Subject|1|||
46955581|NCT02759315|83195924|FG000|Overall Study|Adverse Event|0|||
46955582|NCT02759315|83195925|FG001|Overall Study|Adverse Event|0|||
46955583|NCT02759315|83195926|FG002|Overall Study|Adverse Event|0|||
46955584|NCT02759315|83195927|FG003|Overall Study|Adverse Event|1|||
46955585|NCT02759315|83195928|FG004|Overall Study|Adverse Event|0|||
46955586|NCT02759315|83195924|FG000|Overall Study|Death|0|||
46955587|NCT02759315|83195925|FG001|Overall Study|Death|0|||
46955588|NCT02759315|83195926|FG002|Overall Study|Death|1|||
46955589|NCT02759315|83195927|FG003|Overall Study|Death|0|||
46955590|NCT02759315|83195928|FG004|Overall Study|Death|0|||
46955591|NCT02759315|83195924|FG000|Overall Study|Lost to Follow-up|2|||
46955592|NCT02759315|83195925|FG001|Overall Study|Lost to Follow-up|0|||
46955593|NCT02759315|83195926|FG002|Overall Study|Lost to Follow-up|4|||
46955594|NCT02759315|83195927|FG003|Overall Study|Lost to Follow-up|0|||
46955595|NCT02759315|83195928|FG004|Overall Study|Lost to Follow-up|0|||
46955596|NCT02759315|83195924|FG000|Overall Study|Protocol Violation|0|||
46955597|NCT02759315|83195925|FG001|Overall Study|Protocol Violation|1|||
46955598|NCT02759315|83195926|FG002|Overall Study|Protocol Violation|0|||
46955599|NCT02759315|83195927|FG003|Overall Study|Protocol Violation|0|||
46955600|NCT02759315|83195928|FG004|Overall Study|Protocol Violation|0|||
46955601|NCT02759315|83195924|FG000|Overall Study|Study terminated prior to completion|2|||
46955602|NCT02759315|83195925|FG001|Overall Study|Study terminated prior to completion|0|||
46955603|NCT02759315|83195926|FG002|Overall Study|Study terminated prior to completion|5|||
46955604|NCT02759315|83195927|FG003|Overall Study|Study terminated prior to completion|0|||
46955605|NCT02759315|83195928|FG004|Overall Study|Study terminated prior to completion|1|||
46955606|NCT00835081|83195944|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
46955607|NCT00835081|83195945|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
46955608|NCT02543918|83195951|FG000|Overall Study|Never treated|0|||
46955609|NCT02543918|83195952|FG001|Overall Study|Never treated|1|||
46955610|NCT02543918|83195951|FG000|Overall Study|Lost to Follow-up|1|||
46955611|NCT02543918|83195952|FG001|Overall Study|Lost to Follow-up|1|||
46639381|NCT01384734|82812914|FG003|Overall Study|Lost to Follow-up|8|||
46639382|NCT01384734|82812915|FG004|Overall Study|Lost to Follow-up|5|||
46639383|NCT01384734|82812911|FG000|Overall Study|Non-compliance with study drug|1|||
46639384|NCT01384734|82812912|FG001|Overall Study|Non-compliance with study drug|2|||
46955612|NCT02543918|83195951|FG000|Overall Study|Withdrawal by Subject|1|||
46955613|NCT02543918|83195952|FG001|Overall Study|Withdrawal by Subject|1|||
46955614|NCT02543918|83195951|FG000|Overall Study|Adverse Event|1|||
46955615|NCT02543918|83195952|FG001|Overall Study|Adverse Event|1|||
46955616|NCT01372995|83195961|FG000|Overall Study|Spouse withdrew participant from study|0|||
46955617|NCT01372995|83195962|FG001|Overall Study|Spouse withdrew participant from study|1|||
46955618|NCT01372995|83195963|FG002|Overall Study|Spouse withdrew participant from study|0|||
46955619|NCT01372995|83195961|FG000|Overall Study|Physician Decision|0|||
46955620|NCT01372995|83195962|FG001|Overall Study|Physician Decision|0|||
46955621|NCT01372995|83195963|FG002|Overall Study|Physician Decision|1|||
46955622|NCT02757521|83195973|FG000|Overall Study|Adverse Event|1|||
46955623|NCT02757521|83195974|FG001|Overall Study|Adverse Event|0|||
46955624|NCT00834613|83195982|FG000|First Intervention|Protocol Violation|1|||
46955625|NCT00834613|83195983|FG001|First Intervention|Protocol Violation|0|||
46639385|NCT01384734|82812913|FG002|Overall Study|Non-compliance with study drug|6|||
46955626|NCT00834067|83196000|FG000|Washout of 21 Days|Protocol Violation|0|||
46955627|NCT00834067|83196001|FG001|Washout of 21 Days|Protocol Violation|1|||
46955628|NCT02758613|83196009|FG000|Treatment|Physician and Sponsor Decision|1|||
46955629|NCT02758613|83196010|FG001|Treatment|Physician and Sponsor Decision|0|||
46955630|NCT02758613|83196011|FG002|Treatment|Physician and Sponsor Decision|0|||
46955631|NCT02758613|83196012|FG003|Treatment|Physician and Sponsor Decision|0|||
46955632|NCT02758613|83196009|FG000|Treatment|Withdrawal by Subject|1|||
46955633|NCT02758613|83196010|FG001|Treatment|Withdrawal by Subject|0|||
46955634|NCT02758613|83196011|FG002|Treatment|Withdrawal by Subject|1|||
46844175|NCT00259740|83061007|FG000|Overall Study|Requirement for alternative therapy|0|||
46844176|NCT00259740|83061008|FG001|Overall Study|Requirement for alternative therapy|4|||
46844177|NCT00201006|83061017|FG000|Overall Study|Withdrawal by Subject|7|||
46844178|NCT00201006|83061018|FG001|Overall Study|Withdrawal by Subject|2|||
46844179|NCT00201006|83061019|FG002|Overall Study|Withdrawal by Subject|3|||
46844180|NCT00201006|83061017|FG000|Overall Study|Adverse Event|1|||
46844181|NCT00201006|83061018|FG001|Overall Study|Adverse Event|0|||
46844182|NCT00201006|83061019|FG002|Overall Study|Adverse Event|1|||
46844183|NCT00200850|83061030|FG000|Overall Study|relocation|1|||
46844184|NCT00200850|83061031|FG001|Overall Study|relocation|0|||
46844185|NCT00200850|83061032|FG002|Overall Study|relocation|1|||
46844186|NCT00200850|83061030|FG000|Overall Study|too busy|1|||
46844187|NCT00200850|83061031|FG001|Overall Study|too busy|0|||
46844188|NCT00200850|83061032|FG002|Overall Study|too busy|0|||
46844189|NCT00200850|83061030|FG000|Overall Study|Pregnancy|0|||
46844190|NCT00200850|83061031|FG001|Overall Study|Pregnancy|0|||
46955635|NCT02758613|83196012|FG003|Treatment|Withdrawal by Subject|0|||
46955636|NCT02758301|83196027|FG000|Overall Study|Death|12|||
46955637|NCT02758301|83196028|FG001|Overall Study|Death|0|||
46955638|NCT02758301|83196027|FG000|Overall Study|Physician Decision|10|||
46955639|NCT02758301|83196028|FG001|Overall Study|Physician Decision|1|||
46955640|NCT02758301|83196027|FG000|Overall Study|Withdrawal by Subject|5|||
46955641|NCT02758301|83196028|FG001|Overall Study|Withdrawal by Subject|6|||
46955642|NCT02758301|83196027|FG000|Overall Study|Lost to Follow-up|7|||
46955643|NCT02758301|83196028|FG001|Overall Study|Lost to Follow-up|0|||
46955644|NCT02758301|83196027|FG000|Overall Study|Protocol Violation|0|||
46955645|NCT02758301|83196028|FG001|Overall Study|Protocol Violation|1|||
46955646|NCT02669667|83196048|FG000|Overall Study|Lost to Follow-up|0|||
46844191|NCT00200850|83061032|FG002|Overall Study|Pregnancy|1|||
46955647|NCT02669667|83196049|FG001|Overall Study|Lost to Follow-up|0|||
46955648|NCT02669667|83196050|FG002|Overall Study|Lost to Follow-up|0|||
46955649|NCT02669667|83196051|FG003|Overall Study|Lost to Follow-up|0|||
46955650|NCT02669667|83196052|FG004|Overall Study|Lost to Follow-up|0|||
46955651|NCT02669667|83196053|FG005|Overall Study|Lost to Follow-up|1|||
46955652|NCT02669667|83196054|FG006|Overall Study|Lost to Follow-up|0|||
46955653|NCT02669433|83196079|FG000|Overall Study|Protocol Violation|0|||
46955654|NCT02669433|83196080|FG001|Overall Study|Protocol Violation|4|||
46955655|NCT02669433|83196081|FG002|Overall Study|Protocol Violation|1|||
46955656|NCT02669433|83196079|FG000|Overall Study|Disease Progression|1|||
46955657|NCT02669433|83196080|FG001|Overall Study|Disease Progression|0|||
46955658|NCT02669433|83196081|FG002|Overall Study|Disease Progression|0|||
46955659|NCT02669433|83196079|FG000|Overall Study|Physician Decision|1|||
46955660|NCT02669433|83196080|FG001|Overall Study|Physician Decision|1|||
46955661|NCT02669433|83196081|FG002|Overall Study|Physician Decision|0|||
46955662|NCT02669433|83196079|FG000|Overall Study|Adverse Event|6|||
46955663|NCT02669433|83196080|FG001|Overall Study|Adverse Event|7|||
46955664|NCT02669433|83196081|FG002|Overall Study|Adverse Event|10|||
46955665|NCT02669433|83196079|FG000|Overall Study|Sponsor Termination|1|||
46955666|NCT02669433|83196080|FG001|Overall Study|Sponsor Termination|0|||
46955667|NCT02669433|83196081|FG002|Overall Study|Sponsor Termination|1|||
46955668|NCT02669433|83196079|FG000|Overall Study|Withdrawal by Subject|5|||
46955669|NCT02669433|83196080|FG001|Overall Study|Withdrawal by Subject|1|||
46955670|NCT02669433|83196081|FG002|Overall Study|Withdrawal by Subject|0|||
46955671|NCT02669433|83196079|FG000|Overall Study|Withdrawal by Caregiver|1|||
46955672|NCT02669433|83196080|FG001|Overall Study|Withdrawal by Caregiver|0|||
46639386|NCT01384734|82812914|FG003|Overall Study|Non-compliance with study drug|0|||
46955673|NCT02669433|83196081|FG002|Overall Study|Withdrawal by Caregiver|2|||
46844192|NCT00200850|83061030|FG000|Overall Study|Poor adherence|0|||
46955674|NCT02669433|83196079|FG000|Overall Study|Death|0|||
46955675|NCT02669433|83196080|FG001|Overall Study|Death|1|||
46955676|NCT02669433|83196081|FG002|Overall Study|Death|1|||
46955677|NCT02756819|83196089|FG000|Overall Study|Lost for observation|23|||
46955678|NCT02756819|83196089|FG000|Overall Study|Patient's unwillingness|16|||
46844193|NCT00200850|83061031|FG001|Overall Study|Poor adherence|0|||
46844194|NCT00200850|83061032|FG002|Overall Study|Poor adherence|1|||
46844195|NCT00200850|83061030|FG000|Overall Study|optic neuritis|0|||
46844196|NCT00200850|83061031|FG001|Overall Study|optic neuritis|0|||
46844197|NCT00200850|83061032|FG002|Overall Study|optic neuritis|1|||
46844198|NCT00200850|83061030|FG000|Overall Study|Adverse Event|1|||
46955679|NCT02756819|83196089|FG000|Overall Study|Insufficient efficacy|2|||
46955680|NCT02756819|83196089|FG000|Overall Study|Adverse Event|2|||
46955681|NCT02756819|83196089|FG000|Overall Study|Reason not Specified|9|||
46955682|NCT00829309|83196095|FG000|Washout: 7 Days|Protocol Violation|1|||
46955683|NCT00829309|83196096|FG001|Washout: 7 Days|Protocol Violation|0|||
46773131|NCT00792467|82991453|FG000|Overall Study|progression of disease|17|||
46773132|NCT00792467|82991453|FG000|Overall Study|Adverse Event|1|||
46773133|NCT00792467|82991453|FG000|Overall Study|patient request|1|||
46773134|NCT00792467|82991453|FG000|Overall Study|Lost to Follow-up|1|||
46773135|NCT00792467|82991453|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
46773136|NCT00792467|82991453|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
46773137|NCT00585468|82991458|FG000|First Intervention|Withdrawal by Subject|1|||
46773138|NCT00585468|82991459|FG001|First Intervention|Withdrawal by Subject|1|||
46773139|NCT00724152|82991472|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
46773140|NCT00724152|82991473|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
46773141|NCT00724152|82991474|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
46773142|NCT00724152|82991472|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
46773143|NCT00724152|82991473|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
46773144|NCT00724152|82991474|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
46773145|NCT00721110|82991488|FG000|Overall Study|Ultram use|1|||
46773146|NCT00721110|82991489|FG001|Overall Study|Ultram use|0|||
46773147|NCT00721110|82991490|FG002|Overall Study|Ultram use|0|||
46773148|NCT00721110|82991491|FG003|Overall Study|Ultram use|0|||
46773149|NCT00721110|82991488|FG000|Overall Study|vertical incision|0|||
46773150|NCT00721110|82991489|FG001|Overall Study|vertical incision|0|||
46773151|NCT00721110|82991490|FG002|Overall Study|vertical incision|1|||
46639387|NCT01384734|82812915|FG004|Overall Study|Non-compliance with study drug|2|||
46639388|NCT01384734|82812911|FG000|Overall Study|Pregnancy|0|||
46639389|NCT01384734|82812912|FG001|Overall Study|Pregnancy|1|||
46639390|NCT01384734|82812913|FG002|Overall Study|Pregnancy|0|||
46639391|NCT01384734|82812914|FG003|Overall Study|Pregnancy|0|||
46639392|NCT01384734|82812915|FG004|Overall Study|Pregnancy|1|||
46639393|NCT01384734|82812911|FG000|Overall Study|Sponsor terminated|0|||
46955684|NCT02669121|83196102|FG000|Overall Study|Adverse Event|4|||
46955685|NCT02669121|83196103|FG001|Overall Study|Adverse Event|5|||
46955686|NCT02669121|83196102|FG000|Overall Study|Lost to Follow-up|15|||
46955687|NCT02669121|83196103|FG001|Overall Study|Lost to Follow-up|27|||
46955688|NCT02669121|83196102|FG000|Overall Study|Withdrawal by Subject|132|||
46955689|NCT02669121|83196103|FG001|Overall Study|Withdrawal by Subject|140|||
46955690|NCT02669121|83196102|FG000|Overall Study|Pregnancy|0|||
46955691|NCT02669121|83196103|FG001|Overall Study|Pregnancy|1|||
46955692|NCT02669121|83196102|FG000|Overall Study|Discharged from US Military Active Service|117|||
46955693|NCT02669121|83196103|FG001|Overall Study|Discharged from US Military Active Service|91|||
46955694|NCT02669121|83196102|FG000|Overall Study|Reason not Specified|22|||
46955695|NCT02669121|83196103|FG001|Overall Study|Reason not Specified|18|||
46955696|NCT02743117|83196111|FG000|Overall Study|Lost to Follow-up|0|||
46955697|NCT02743117|83196112|FG001|Overall Study|Lost to Follow-up|1|||
46955698|NCT02743117|83196111|FG000|Overall Study|Other|1|||
46955699|NCT02743117|83196112|FG001|Overall Study|Other|0|||
46955700|NCT02669043|83196127|FG000|Overall Study|Didn't meet I/E criteria|4|||
46955701|NCT00805129|83196131|FG000|Overall Study|Not treated|1|||
46955702|NCT02668185|83196135|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
46955703|NCT02668185|83196136|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
46955704|NCT02668185|83196135|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
46639394|NCT01384734|82812912|FG001|Overall Study|Sponsor terminated|0|||
46639395|NCT01384734|82812913|FG002|Overall Study|Sponsor terminated|0|||
46773152|NCT00721110|82991491|FG003|Overall Study|vertical incision|0|||
46844199|NCT00200850|83061031|FG001|Overall Study|Adverse Event|1|||
46844200|NCT00200850|83061032|FG002|Overall Study|Adverse Event|2|||
46844201|NCT00231114|83061042|FG000|Randomized|Withdrawal by Subject|6|||
46955705|NCT02668185|83196136|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
46639396|NCT01384734|82812914|FG003|Overall Study|Sponsor terminated|0|||
46639397|NCT01384734|82812915|FG004|Overall Study|Sponsor terminated|1|||
46639398|NCT01384734|82812911|FG000|Overall Study|Withdrawal by Subject|5|||
46639399|NCT01384734|82812912|FG001|Overall Study|Withdrawal by Subject|5|||
46844202|NCT00231114|83061043|FG001|Randomized|Withdrawal by Subject|3|||
46844203|NCT00231114|83061042|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
46844204|NCT00231114|83061043|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
46955706|NCT02668185|83196135|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
46955707|NCT02668185|83196136|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
46955708|NCT02668185|83196135|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
46955709|NCT02668185|83196136|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
46639400|NCT01384734|82812913|FG002|Overall Study|Withdrawal by Subject|6|||
46639401|NCT01384734|82812914|FG003|Overall Study|Withdrawal by Subject|7|||
46773153|NCT00791999|82991505|FG000|Overall Study|Protocol planed withdrawal|14|||
46773154|NCT00791999|82991506|FG001|Overall Study|Protocol planed withdrawal|11|||
46844205|NCT00231114|83061042|FG000|Post-Treatment Period|Lost to Follow-up|6|||
46844206|NCT00231114|83061043|FG001|Post-Treatment Period|Lost to Follow-up|1|||
46639402|NCT01384734|82812915|FG004|Overall Study|Withdrawal by Subject|9|||
46844207|NCT00231114|83061042|FG000|Post-Treatment Period|Physician Decision|1|||
46844208|NCT00231114|83061043|FG001|Post-Treatment Period|Physician Decision|0|||
46844209|NCT00231114|83061042|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
46844210|NCT00231114|83061043|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
46844211|NCT03543046|83061053|FG000|Overall Study|Adverse Event|1|||
46844212|NCT03543046|83061054|FG001|Overall Study|Adverse Event|1|||
46844213|NCT03543046|83061053|FG000|Overall Study|Physician Decision|1|||
46844214|NCT03543046|83061054|FG001|Overall Study|Physician Decision|1|||
46844215|NCT03543046|83061053|FG000|Overall Study|Protocol Violation|1|||
46955710|NCT02742181|83196147|FG000|Overall Study|Physician Decision|1|||
46955711|NCT02742181|83196148|FG001|Overall Study|Physician Decision|0|||
46955712|NCT02742103|83196156|FG000|Overall Study|Protocol Violation|1|||
46955713|NCT02742103|83196157|FG001|Overall Study|Protocol Violation|0|||
46844216|NCT03543046|83061054|FG001|Overall Study|Protocol Violation|0|||
46844217|NCT00259272|83061073|FG000|Overall Study|Adverse Event|2|||
46844218|NCT00259272|83061074|FG001|Overall Study|Adverse Event|1|||
46844219|NCT00259272|83061075|FG002|Overall Study|Adverse Event|0|||
46955714|NCT02742103|83196156|FG000|Overall Study|Death|2|||
46773155|NCT00791999|82991507|FG002|Overall Study|Protocol planed withdrawal|11|||
46773156|NCT00791999|82991508|FG003|Overall Study|Protocol planed withdrawal|45|||
46773157|NCT00791999|82991505|FG000|Overall Study|Withdrawal by Subject|0|||
46773158|NCT00791999|82991506|FG001|Overall Study|Withdrawal by Subject|1|||
46773159|NCT00791999|82991507|FG002|Overall Study|Withdrawal by Subject|0|||
46773160|NCT00791999|82991508|FG003|Overall Study|Withdrawal by Subject|2|||
46773161|NCT00791999|82991505|FG000|Overall Study|Protocol Violation|3|||
46773162|NCT00791999|82991506|FG001|Overall Study|Protocol Violation|0|||
46773163|NCT00791999|82991507|FG002|Overall Study|Protocol Violation|1|||
46773164|NCT00791999|82991508|FG003|Overall Study|Protocol Violation|0|||
46773165|NCT00791999|82991505|FG000|Overall Study|Adverse Event|3|||
46773166|NCT00791999|82991506|FG001|Overall Study|Adverse Event|3|||
46773167|NCT00791999|82991507|FG002|Overall Study|Adverse Event|7|||
46773168|NCT00791999|82991508|FG003|Overall Study|Adverse Event|3|||
46773169|NCT00791999|82991505|FG000|Overall Study|Lack of Efficacy|0|||
46773170|NCT00791999|82991506|FG001|Overall Study|Lack of Efficacy|1|||
46773171|NCT00791999|82991507|FG002|Overall Study|Lack of Efficacy|0|||
46844220|NCT00259272|83061076|FG003|Overall Study|Adverse Event|3|||
46955715|NCT02742103|83196157|FG001|Overall Study|Death|2|||
46955716|NCT02742103|83196156|FG000|Overall Study|Adverse Event|1|||
46955717|NCT02742103|83196157|FG001|Overall Study|Adverse Event|0|||
46955718|NCT02742103|83196156|FG000|Overall Study|Moved to another town|0|||
47066866|NCT01490125|83349894|FG003|Period I|Withdrawal by Subject|1|||
47066867|NCT01490125|83349895|FG004|Period I|Withdrawal by Subject|2|||
47066868|NCT01490125|83349896|FG005|Period I|Withdrawal by Subject|1|||
47066869|NCT01490125|83349891|FG000|Period II|Adverse Event|2|||
47066870|NCT01490125|83349892|FG001|Period II|Adverse Event|3|||
47066871|NCT01490125|83349893|FG002|Period II|Adverse Event|2|||
47066872|NCT01490125|83349894|FG003|Period II|Adverse Event|2|||
47066873|NCT01490125|83349895|FG004|Period II|Adverse Event|4|||
47066874|NCT01490125|83349896|FG005|Period II|Adverse Event|2|||
47066875|NCT01490125|83349891|FG000|Period II|Protocol Violation|0|||
47066876|NCT01490125|83349892|FG001|Period II|Protocol Violation|0|||
47066877|NCT01490125|83349893|FG002|Period II|Protocol Violation|1|||
47066878|NCT01490125|83349894|FG003|Period II|Protocol Violation|1|||
47066879|NCT01490125|83349895|FG004|Period II|Protocol Violation|0|||
47066880|NCT01490125|83349896|FG005|Period II|Protocol Violation|0|||
47066881|NCT01490125|83349891|FG000|Period II|Lost to Follow-up|0|||
46955719|NCT02742103|83196157|FG001|Overall Study|Moved to another town|1|||
46955720|NCT02742103|83196156|FG000|Overall Study|Withdrawal by Subject|5|||
46955721|NCT02742103|83196157|FG001|Overall Study|Withdrawal by Subject|2|||
46955722|NCT02741713|83196165|FG000|Overall Study|Surgery type changed intra-operatively|2|||
47066882|NCT01490125|83349892|FG001|Period II|Lost to Follow-up|1|||
47066883|NCT01490125|83349893|FG002|Period II|Lost to Follow-up|0|||
47066884|NCT01490125|83349894|FG003|Period II|Lost to Follow-up|0|||
47066885|NCT01490125|83349895|FG004|Period II|Lost to Follow-up|0|||
47066886|NCT01490125|83349896|FG005|Period II|Lost to Follow-up|0|||
46773172|NCT00791999|82991508|FG003|Overall Study|Lack of Efficacy|2|||
46773173|NCT00791999|82991505|FG000|Overall Study|Reason other than those above|1|||
46773174|NCT00791999|82991506|FG001|Overall Study|Reason other than those above|0|||
46773175|NCT00791999|82991507|FG002|Overall Study|Reason other than those above|1|||
46773176|NCT00791999|82991508|FG003|Overall Study|Reason other than those above|0|||
46773177|NCT00585078|82991522|FG000|Overall Study|Withdrawal by Subject|4|||
46773178|NCT00585078|82991522|FG000|Overall Study|Poor performance status|1|||
47066887|NCT01490125|83349891|FG000|Period II|Withdrawal by Subject|1|||
47066888|NCT01490125|83349892|FG001|Period II|Withdrawal by Subject|0|||
47066889|NCT01490125|83349893|FG002|Period II|Withdrawal by Subject|0|||
46844221|NCT00259272|83061073|FG000|Overall Study|Lack of Efficacy|5|||
46844222|NCT00259272|83061074|FG001|Overall Study|Lack of Efficacy|1|||
46844223|NCT00259272|83061075|FG002|Overall Study|Lack of Efficacy|2|||
47066890|NCT01490125|83349894|FG003|Period II|Withdrawal by Subject|0|||
47066891|NCT01490125|83349895|FG004|Period II|Withdrawal by Subject|0|||
46955723|NCT02741713|83196166|FG001|Overall Study|Surgery type changed intra-operatively|1|||
46955724|NCT02663271|83196173|FG000|Overall Study|Withdrawal by Subject|5|||
46955725|NCT02663271|83196173|FG000|Overall Study|Lack of Efficacy|1|||
46955726|NCT02742649|83196180|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
46955727|NCT02742649|83196181|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
46955728|NCT02742649|83196182|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
46955729|NCT02742649|83196183|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
46955730|NCT02742649|83196184|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
46955731|NCT02742649|83196180|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46955732|NCT02742649|83196181|FG001|Double-Blind Treatment Period|Adverse Event|1|||
46955733|NCT02742649|83196182|FG002|Double-Blind Treatment Period|Adverse Event|0|||
46955734|NCT02742649|83196183|FG003|Double-Blind Treatment Period|Adverse Event|0|||
46955735|NCT02742649|83196184|FG004|Double-Blind Treatment Period|Adverse Event|0|||
46955736|NCT02742649|83196180|FG000|Open-Label Period|Lost to Follow-up|0|||
46955737|NCT02742649|83196181|FG001|Open-Label Period|Lost to Follow-up|0|||
46955738|NCT02742649|83196182|FG002|Open-Label Period|Lost to Follow-up|0|||
46955739|NCT02742649|83196183|FG003|Open-Label Period|Lost to Follow-up|0|||
46955740|NCT02742649|83196184|FG004|Open-Label Period|Lost to Follow-up|1|||
46955741|NCT02665689|83196197|FG000|Overall Study|Adverse Event|1|||
46955742|NCT02665689|83196198|FG001|Overall Study|Adverse Event|0|||
46955743|NCT02665689|83196197|FG000|Overall Study|Trial termination|1|||
46955744|NCT02665689|83196198|FG001|Overall Study|Trial termination|1|||
46955745|NCT02665689|83196197|FG000|Overall Study|Lost to Follow-up|0|||
46955746|NCT02665689|83196198|FG001|Overall Study|Lost to Follow-up|1|||
46955747|NCT02665455|83196204|FG000|Overall Study|Withdrawal by Subject|6|||
46955748|NCT02665455|83196204|FG000|Overall Study|Lost to Follow-up|1|||
46955749|NCT02665455|83196204|FG000|Overall Study|Adverse Event|1|||
46955750|NCT02665455|83196204|FG000|Overall Study|Protocol Violation|1|||
46955751|NCT02755805|83196210|FG000|Overall Study|Lost to Follow-up|1|||
46955752|NCT02755805|83196211|FG001|Overall Study|Lost to Follow-up|2|||
46955753|NCT02755805|83196210|FG000|Overall Study|Refused assessments|1|||
46955754|NCT02755805|83196211|FG001|Overall Study|Refused assessments|0|||
46955755|NCT02755805|83196210|FG000|Overall Study|Withdrawal by Subject|0|||
46955756|NCT02755805|83196211|FG001|Overall Study|Withdrawal by Subject|2|||
46955757|NCT02755649|83196220|FG000|Overall Study|Transitioned into OLE study|99|||
46955758|NCT02755649|83196221|FG001|Overall Study|Transitioned into OLE study|98|||
46955759|NCT02755649|83196222|FG002|Overall Study|Transitioned into OLE study|100|||
46955760|NCT02755649|83196220|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
46955761|NCT02755649|83196221|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
46955762|NCT02755649|83196222|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
46955763|NCT02755649|83196220|FG000|Overall Study|Physician Decision|0|||
46955764|NCT02755649|83196221|FG001|Overall Study|Physician Decision|0|||
46955765|NCT02755649|83196222|FG002|Overall Study|Physician Decision|2|||
46955766|NCT02755649|83196220|FG000|Overall Study|Withdrawal by Subject|0|||
46955767|NCT02755649|83196221|FG001|Overall Study|Withdrawal by Subject|1|||
46955768|NCT02755649|83196222|FG002|Overall Study|Withdrawal by Subject|0|||
46955769|NCT02755649|83196220|FG000|Overall Study|Undecided|1|||
46955770|NCT02755649|83196221|FG001|Overall Study|Undecided|0|||
46955771|NCT02755649|83196222|FG002|Overall Study|Undecided|0|||
46955772|NCT00151411|83196232|FG000|Overall Study|Lost to Follow-up|15|||
46955773|NCT00151411|83196233|FG001|Overall Study|Lost to Follow-up|19|||
46955774|NCT00151411|83196232|FG000|Overall Study|Withdrawal by Subject|12|||
46955775|NCT00151411|83196233|FG001|Overall Study|Withdrawal by Subject|20|||
46955776|NCT00151411|83196232|FG000|Overall Study|Adverse Event|6|||
46955777|NCT00151411|83196233|FG001|Overall Study|Adverse Event|0|||
46955778|NCT00151411|83196232|FG000|Overall Study|Pregnancy|0|||
46955779|NCT00151411|83196233|FG001|Overall Study|Pregnancy|4|||
46955780|NCT02662569|83196243|FG000|Overall Study|Withdrawal by Subject|6|||
47066892|NCT01490125|83349896|FG005|Period II|Withdrawal by Subject|0|||
47066893|NCT01490125|83349891|FG000|Period III|Adverse Event|3|||
46955781|NCT02662569|83196244|FG001|Overall Study|Withdrawal by Subject|1|||
46955782|NCT02662569|83196245|FG002|Overall Study|Withdrawal by Subject|6|||
47066894|NCT01490125|83349892|FG001|Period III|Adverse Event|1|||
46955783|NCT02662569|83196246|FG003|Overall Study|Withdrawal by Subject|4|||
46955784|NCT02662569|83196243|FG000|Overall Study|Lost to Follow-up|1|||
46955785|NCT02662569|83196244|FG001|Overall Study|Lost to Follow-up|0|||
47066895|NCT01490125|83349893|FG002|Period III|Adverse Event|0|||
47066896|NCT01490125|83349894|FG003|Period III|Adverse Event|1|||
47066897|NCT01490125|83349895|FG004|Period III|Adverse Event|0|||
46955786|NCT02662569|83196245|FG002|Overall Study|Lost to Follow-up|0|||
46955787|NCT02662569|83196246|FG003|Overall Study|Lost to Follow-up|0|||
46955788|NCT02741635|83196256|FG000|Overall Study|Withdrawal by Subject|1|||
46955789|NCT02753075|83196264|FG000|Overall Study|Adverse Event|2|||
46955790|NCT02753075|83196265|FG001|Overall Study|Adverse Event|1|||
46955791|NCT02753075|83196266|FG002|Overall Study|Adverse Event|0|||
46955792|NCT02753075|83196264|FG000|Overall Study|Lost to Follow-up|2|||
46955793|NCT02753075|83196265|FG001|Overall Study|Lost to Follow-up|0|||
46955794|NCT02753075|83196266|FG002|Overall Study|Lost to Follow-up|0|||
46955795|NCT02753075|83196264|FG000|Overall Study|Withdrawal of Consent|1|||
46955796|NCT02753075|83196265|FG001|Overall Study|Withdrawal of Consent|1|||
46955797|NCT02753075|83196266|FG002|Overall Study|Withdrawal of Consent|3|||
46955798|NCT02753075|83196264|FG000|Overall Study|Physician Decision|3|||
46955799|NCT02753075|83196265|FG001|Overall Study|Physician Decision|1|||
46955800|NCT02753075|83196266|FG002|Overall Study|Physician Decision|0|||
46955801|NCT02332720|83196298|FG000|Part A and Part B|Lost to Follow-up|1|||
46955802|NCT02332720|83196299|FG001|Part A and Part B|Lost to Follow-up|0|||
46955803|NCT02332720|83196300|FG002|Part A and Part B|Lost to Follow-up|0|||
46955804|NCT02332720|83196301|FG003|Part A and Part B|Lost to Follow-up|0|||
46955805|NCT02332720|83196302|FG004|Part A and Part B|Lost to Follow-up|0|||
46955806|NCT02332720|83196303|FG005|Part A and Part B|Lost to Follow-up|2|||
46955807|NCT02332720|83196304|FG006|Part A and Part B|Lost to Follow-up|1|||
46955808|NCT02332720|83196305|FG007|Part A and Part B|Lost to Follow-up|1|||
46955809|NCT02332720|83196306|FG008|Part A and Part B|Lost to Follow-up|0|||
46955810|NCT02332720|83196307|FG009|Part A and Part B|Lost to Follow-up|0|||
46955811|NCT02332720|83196308|FG010|Part A and Part B|Lost to Follow-up|0|||
46955812|NCT02332720|83196309|FG011|Part A and Part B|Lost to Follow-up|0|||
46955813|NCT02332720|83196310|FG012|Part A and Part B|Lost to Follow-up|0|||
46955814|NCT02332720|83196311|FG013|Part A and Part B|Lost to Follow-up|0|||
46955815|NCT02332720|83196312|FG014|Part A and Part B|Lost to Follow-up|0|||
46955816|NCT02332720|83196313|FG015|Part A and Part B|Lost to Follow-up|1|||
46955817|NCT02332720|83196314|FG016|Part A and Part B|Lost to Follow-up|0|||
46955818|NCT02332720|83196315|FG017|Part A and Part B|Lost to Follow-up|0|||
46955819|NCT02332720|83196316|FG018|Part A and Part B|Lost to Follow-up|0|||
46955820|NCT02332720|83196317|FG019|Part A and Part B|Lost to Follow-up|0|||
46955821|NCT02332720|83196318|FG020|Part A and Part B|Lost to Follow-up|0|||
46955822|NCT02332720|83196319|FG021|Part A and Part B|Lost to Follow-up|0|||
46955823|NCT02332720|83196320|FG022|Part A and Part B|Lost to Follow-up|0|||
46955824|NCT02332720|83196298|FG000|Part A and Part B|Adverse Event|0|||
46955825|NCT02332720|83196299|FG001|Part A and Part B|Adverse Event|0|||
46955826|NCT02332720|83196300|FG002|Part A and Part B|Adverse Event|0|||
46955827|NCT02332720|83196301|FG003|Part A and Part B|Adverse Event|0|||
46955828|NCT02332720|83196302|FG004|Part A and Part B|Adverse Event|0|||
46955829|NCT02332720|83196303|FG005|Part A and Part B|Adverse Event|0|||
46955830|NCT02332720|83196304|FG006|Part A and Part B|Adverse Event|0|||
46955831|NCT02332720|83196305|FG007|Part A and Part B|Adverse Event|0|||
46955832|NCT02332720|83196306|FG008|Part A and Part B|Adverse Event|0|||
46955833|NCT02332720|83196307|FG009|Part A and Part B|Adverse Event|0|||
46955834|NCT02332720|83196308|FG010|Part A and Part B|Adverse Event|0|||
46955835|NCT02332720|83196309|FG011|Part A and Part B|Adverse Event|0|||
46955836|NCT02332720|83196310|FG012|Part A and Part B|Adverse Event|0|||
46955837|NCT02332720|83196311|FG013|Part A and Part B|Adverse Event|0|||
46955838|NCT02332720|83196312|FG014|Part A and Part B|Adverse Event|0|||
46955839|NCT02332720|83196313|FG015|Part A and Part B|Adverse Event|0|||
46955840|NCT02332720|83196314|FG016|Part A and Part B|Adverse Event|0|||
46955841|NCT02332720|83196315|FG017|Part A and Part B|Adverse Event|1|||
46955842|NCT02332720|83196316|FG018|Part A and Part B|Adverse Event|0|||
46955843|NCT02332720|83196317|FG019|Part A and Part B|Adverse Event|0|||
47066898|NCT01490125|83349896|FG005|Period III|Adverse Event|0|||
47066899|NCT01490125|83349891|FG000|Period III|Death|0|||
46955844|NCT02332720|83196318|FG020|Part A and Part B|Adverse Event|0|||
46955845|NCT02332720|83196319|FG021|Part A and Part B|Adverse Event|0|||
46955846|NCT02332720|83196320|FG022|Part A and Part B|Adverse Event|0|||
47066900|NCT01490125|83349892|FG001|Period III|Death|0|||
47066901|NCT01490125|83349893|FG002|Period III|Death|0|||
46773179|NCT00585078|82991522|FG000|Overall Study|Disease Progression|24|||
46773180|NCT00585078|82991522|FG000|Overall Study|Adverse Event|10|||
46773181|NCT00585078|82991522|FG000|Overall Study|Death|1|||
46955847|NCT02332720|83196298|FG000|Part A and Part B|Physician Decision|0|||
46955848|NCT02332720|83196299|FG001|Part A and Part B|Physician Decision|0|||
46773182|NCT00720876|82991526|FG000|Overall Study|found to be ineligible after starting tx|2|||
46773183|NCT00723840|82991530|FG000|Overall Study|Lost to Follow-up|2|||
46773184|NCT00723840|82991530|FG000|Overall Study|Failure to return|18|||
46773185|NCT00723840|82991530|FG000|Overall Study|Withdrawal by Subject|55|||
46773186|NCT00723840|82991530|FG000|Overall Study|Serious Adverse Events|3|||
46773187|NCT00723840|82991530|FG000|Overall Study|Other Medical Event|2|||
46773188|NCT00723840|82991530|FG000|Overall Study|Unspecified reason|2|||
46955849|NCT02332720|83196300|FG002|Part A and Part B|Physician Decision|0|||
46955850|NCT02332720|83196301|FG003|Part A and Part B|Physician Decision|0|||
46955851|NCT02332720|83196302|FG004|Part A and Part B|Physician Decision|0|||
46955852|NCT02332720|83196303|FG005|Part A and Part B|Physician Decision|0|||
46955853|NCT02332720|83196304|FG006|Part A and Part B|Physician Decision|0|||
46955854|NCT02332720|83196305|FG007|Part A and Part B|Physician Decision|0|||
47066902|NCT01490125|83349894|FG003|Period III|Death|1|||
47066903|NCT01490125|83349895|FG004|Period III|Death|0|||
46773189|NCT00789581|82991543|FG000|AC Therapy|Adverse Event|2|||
47066904|NCT01490125|83349896|FG005|Period III|Death|0|||
46955855|NCT02332720|83196306|FG008|Part A and Part B|Physician Decision|0|||
46955856|NCT02332720|83196307|FG009|Part A and Part B|Physician Decision|0|||
46955857|NCT02332720|83196308|FG010|Part A and Part B|Physician Decision|0|||
46955858|NCT02332720|83196309|FG011|Part A and Part B|Physician Decision|0|||
46955859|NCT02332720|83196310|FG012|Part A and Part B|Physician Decision|0|||
46955860|NCT02332720|83196311|FG013|Part A and Part B|Physician Decision|0|||
46955861|NCT02332720|83196312|FG014|Part A and Part B|Physician Decision|0|||
46955862|NCT02332720|83196313|FG015|Part A and Part B|Physician Decision|0|||
46955863|NCT02332720|83196314|FG016|Part A and Part B|Physician Decision|0|||
46955864|NCT02332720|83196315|FG017|Part A and Part B|Physician Decision|0|||
46955865|NCT02332720|83196316|FG018|Part A and Part B|Physician Decision|1|||
46955866|NCT02332720|83196317|FG019|Part A and Part B|Physician Decision|0|||
46955867|NCT02332720|83196318|FG020|Part A and Part B|Physician Decision|0|||
46955868|NCT02332720|83196319|FG021|Part A and Part B|Physician Decision|0|||
46955869|NCT02332720|83196320|FG022|Part A and Part B|Physician Decision|0|||
46955870|NCT02332720|83196298|FG000|Part A and Part B|Withdrawal by Subject|0|||
46955871|NCT02332720|83196299|FG001|Part A and Part B|Withdrawal by Subject|0|||
46955872|NCT02332720|83196300|FG002|Part A and Part B|Withdrawal by Subject|0|||
46955873|NCT02332720|83196301|FG003|Part A and Part B|Withdrawal by Subject|0|||
46955874|NCT02332720|83196302|FG004|Part A and Part B|Withdrawal by Subject|0|||
46955875|NCT02332720|83196303|FG005|Part A and Part B|Withdrawal by Subject|1|||
46955876|NCT02332720|83196304|FG006|Part A and Part B|Withdrawal by Subject|0|||
46955877|NCT02332720|83196305|FG007|Part A and Part B|Withdrawal by Subject|0|||
46955878|NCT02332720|83196306|FG008|Part A and Part B|Withdrawal by Subject|0|||
46955879|NCT02332720|83196307|FG009|Part A and Part B|Withdrawal by Subject|0|||
46955880|NCT02332720|83196308|FG010|Part A and Part B|Withdrawal by Subject|0|||
46955881|NCT02332720|83196309|FG011|Part A and Part B|Withdrawal by Subject|0|||
46955882|NCT02332720|83196310|FG012|Part A and Part B|Withdrawal by Subject|0|||
46955883|NCT02332720|83196311|FG013|Part A and Part B|Withdrawal by Subject|0|||
46955884|NCT02332720|83196312|FG014|Part A and Part B|Withdrawal by Subject|0|||
46955885|NCT02332720|83196313|FG015|Part A and Part B|Withdrawal by Subject|0|||
46955886|NCT02332720|83196314|FG016|Part A and Part B|Withdrawal by Subject|0|||
46955887|NCT02332720|83196315|FG017|Part A and Part B|Withdrawal by Subject|0|||
46955888|NCT02332720|83196316|FG018|Part A and Part B|Withdrawal by Subject|0|||
46955889|NCT02332720|83196317|FG019|Part A and Part B|Withdrawal by Subject|1|||
46955890|NCT02332720|83196318|FG020|Part A and Part B|Withdrawal by Subject|0|||
46955891|NCT02332720|83196319|FG021|Part A and Part B|Withdrawal by Subject|0|||
46955892|NCT02332720|83196320|FG022|Part A and Part B|Withdrawal by Subject|0|||
46955893|NCT02331394|83196392|FG000|Overall Study|Disease progression|1|||
46955894|NCT01645930|83196403|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
46955895|NCT01645930|83196403|FG000|Overall Study|Progressive Disease|12|||
46955896|NCT01645930|83196403|FG000|Overall Study|Adverse Event|4|||
46955897|NCT01645930|83196403|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
46955898|NCT01645930|83196403|FG000|Overall Study|Withdrawal by Participant|2|||
46955899|NCT01645930|83196403|FG000|Overall Study|Reason not Defined|1|||
46955900|NCT02299336|83196407|FG000|Overall Study|Withdrawal by Subject|11|||
46955901|NCT02299336|83196407|FG000|Overall Study|Adverse Event|1|||
46955902|NCT02299336|83196407|FG000|Overall Study|Death|1|||
46955903|NCT02299336|83196407|FG000|Overall Study|Lost to Follow-up|1|||
46955904|NCT02664441|83196413|FG000|Randomization|Withdrawal by Subject|0|||
46955905|NCT02664441|83196414|FG001|Randomization|Withdrawal by Subject|1|||
46955906|NCT02664441|83196413|FG000|36-week Randomized Trial|Adverse Event|2|||
46955907|NCT02664441|83196414|FG001|36-week Randomized Trial|Adverse Event|0|||
46955908|NCT02664441|83196413|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
46955909|NCT02664441|83196414|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
46955910|NCT02664441|83196413|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
46955911|NCT02664441|83196414|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
46955912|NCT02664441|83196413|FG000|18-week Open Label Extension|Adverse Event|1|||
46955913|NCT02664441|83196414|FG001|18-week Open Label Extension|Adverse Event|0|||
46955914|NCT02664441|83196413|FG000|18-week Open Label Extension|Physician Decision|1|||
46955915|NCT02664441|83196414|FG001|18-week Open Label Extension|Physician Decision|0|||
46955916|NCT02664441|83196413|FG000|18-week Open Label Extension|Death|1|||
46955917|NCT02664441|83196414|FG001|18-week Open Label Extension|Death|0|||
46955918|NCT02664441|83196413|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
46955919|NCT02664441|83196414|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
46955920|NCT02298946|83196423|FG000|Overall Study|Did not receive treatment|2|||
46955921|NCT02298946|83196424|FG001|Overall Study|Did not receive treatment|0|||
46955922|NCT02298946|83196423|FG000|Overall Study|Unevaluable|2|||
46955923|NCT02298946|83196424|FG001|Overall Study|Unevaluable|1|||
46955924|NCT02328040|83196431|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
46955925|NCT02328040|83196432|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
46955926|NCT01647958|83196440|FG000|Initial Study|Lost to Follow-up|2|||
46639403|NCT01384734|82812911|FG000|Overall Study|Investigator relocating|0|||
46955927|NCT01647958|83196441|FG001|Initial Study|Lost to Follow-up|3|||
46955928|NCT01647958|83196440|FG000|Continuation Phase|treatment received during Overall Study|39|||
46955929|NCT01647958|83196441|FG001|Continuation Phase|treatment received during Overall Study|0|||
46955930|NCT01647958|83196440|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
46955931|NCT01647958|83196441|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
46955932|NCT02298868|83196456|FG000|Overall Study|Adverse Event|1|||
46844224|NCT00259272|83061076|FG003|Overall Study|Lack of Efficacy|6|||
46844225|NCT00259272|83061073|FG000|Overall Study|Physician Decision|1|||
46844226|NCT00259272|83061074|FG001|Overall Study|Physician Decision|2|||
46844227|NCT00259272|83061075|FG002|Overall Study|Physician Decision|1|||
46844228|NCT00259272|83061076|FG003|Overall Study|Physician Decision|3|||
46844229|NCT00259272|83061073|FG000|Overall Study|Protocol Violation|2|||
46955933|NCT02298868|83196456|FG000|Overall Study|Death|1|||
46955934|NCT02298868|83196456|FG000|Overall Study|Patient underwent transplant|1|||
46955935|NCT02327260|83196463|FG000|Overall Study|Lost to Follow-up|2|||
46955936|NCT02327260|83196464|FG001|Overall Study|Lost to Follow-up|3|||
46955937|NCT02327260|83196465|FG002|Overall Study|Lost to Follow-up|2|||
46955938|NCT02327260|83196463|FG000|Overall Study|invalid phone number|1|||
46955939|NCT02327260|83196464|FG001|Overall Study|invalid phone number|1|||
46955940|NCT02327260|83196465|FG002|Overall Study|invalid phone number|0|||
46955941|NCT02327260|83196463|FG000|Overall Study|non-adherence to protocol|2|||
46955942|NCT02327260|83196464|FG001|Overall Study|non-adherence to protocol|0|||
46955943|NCT02327260|83196465|FG002|Overall Study|non-adherence to protocol|0|||
46955944|NCT02327260|83196463|FG000|Overall Study|cognitive concerns|1|||
46955945|NCT02327260|83196464|FG001|Overall Study|cognitive concerns|0|||
46955946|NCT02327260|83196465|FG002|Overall Study|cognitive concerns|0|||
46955947|NCT02296840|83196476|FG000|Overall Study|Adverse Event|1|||
46773190|NCT00789581|82991544|FG001|AC Therapy|Adverse Event|3|||
46773191|NCT00789581|82991543|FG000|AC Therapy|Withdrawal by Subject|4|||
46773192|NCT00789581|82991544|FG001|AC Therapy|Withdrawal by Subject|7|||
46773193|NCT00789581|82991543|FG000|AC Therapy|Disease recurrence|3|||
46844230|NCT00259272|83061074|FG001|Overall Study|Protocol Violation|0|||
46844231|NCT00259272|83061075|FG002|Overall Study|Protocol Violation|0|||
46844232|NCT00259272|83061076|FG003|Overall Study|Protocol Violation|1|||
46844233|NCT00259272|83061073|FG000|Overall Study|Sponsor Decision|0|||
46844234|NCT00259272|83061074|FG001|Overall Study|Sponsor Decision|1|||
46844235|NCT00259272|83061075|FG002|Overall Study|Sponsor Decision|0|||
46844236|NCT00259272|83061076|FG003|Overall Study|Sponsor Decision|0|||
46844237|NCT00259272|83061073|FG000|Overall Study|Withdrawal by Subject|4|||
46844238|NCT00259272|83061074|FG001|Overall Study|Withdrawal by Subject|2|||
46844239|NCT00259272|83061075|FG002|Overall Study|Withdrawal by Subject|2|||
46844240|NCT00259272|83061076|FG003|Overall Study|Withdrawal by Subject|7|||
46844241|NCT00259272|83061073|FG000|Overall Study|Lost to Follow-up|1|||
46844242|NCT00259272|83061074|FG001|Overall Study|Lost to Follow-up|0|||
46844243|NCT00259272|83061075|FG002|Overall Study|Lost to Follow-up|0|||
46773194|NCT00789581|82991544|FG001|AC Therapy|Disease recurrence|1|||
46773195|NCT00789581|82991543|FG000|AC Therapy|Intercurrent Illness|1|||
46773196|NCT00789581|82991544|FG001|AC Therapy|Intercurrent Illness|0|||
46773197|NCT00789581|82991543|FG000|AC Therapy|Never Treated|1|||
46773198|NCT00789581|82991544|FG001|AC Therapy|Never Treated|4|||
46773199|NCT00789581|82991543|FG000|AC Therapy|Other|0|||
46773200|NCT00789581|82991544|FG001|AC Therapy|Other|2|||
46773201|NCT00789581|82991543|FG000|Adjuvant Therapy|Never treated|2|||
46773202|NCT00789581|82991544|FG001|Adjuvant Therapy|Never treated|2|||
46773203|NCT00789581|82991543|FG000|Adjuvant Therapy|Adverse Event|20|||
46773204|NCT00789581|82991544|FG001|Adjuvant Therapy|Adverse Event|44|||
46773205|NCT00789581|82991543|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
46773206|NCT00789581|82991544|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
46773207|NCT00789581|82991543|FG000|Adjuvant Therapy|Disease recurrence|2|||
46773208|NCT00789581|82991544|FG001|Adjuvant Therapy|Disease recurrence|1|||
46844244|NCT00259272|83061076|FG003|Overall Study|Lost to Follow-up|1|||
46844245|NCT00421889|83061109|FG000|Overall Study|Adverse Event|1|||
46955948|NCT02296840|83196477|FG001|Overall Study|Adverse Event|1|||
46955949|NCT02296840|83196476|FG000|Overall Study|Protocol Violation|2|||
46955950|NCT02296840|83196477|FG001|Overall Study|Protocol Violation|1|||
46955951|NCT02296840|83196476|FG000|Overall Study|Lost to Follow-up|6|||
46955952|NCT02296840|83196477|FG001|Overall Study|Lost to Follow-up|17|||
46844246|NCT00421889|83061110|FG001|Overall Study|Adverse Event|0|||
46955953|NCT02663895|83196486|FG000|Overall Study|Adverse Event|3|||
46844247|NCT00421889|83061111|FG002|Overall Study|Adverse Event|1|||
46844248|NCT00421889|83061112|FG003|Overall Study|Adverse Event|1|||
46844249|NCT00421889|83061113|FG004|Overall Study|Adverse Event|1|||
46844250|NCT00421889|83061114|FG005|Overall Study|Adverse Event|4|||
46844251|NCT00421889|83061115|FG006|Overall Study|Adverse Event|1|||
46844252|NCT00421889|83061116|FG007|Overall Study|Adverse Event|0|||
46844253|NCT00421889|83061117|FG008|Overall Study|Adverse Event|2|||
46955954|NCT02663895|83196486|FG000|Overall Study|Physician Decision|2|||
46955955|NCT02663895|83196486|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
46955956|NCT02663895|83196486|FG000|Overall Study|Withdrawal by Subject|1|||
46639404|NCT01384734|82812912|FG001|Overall Study|Investigator relocating|2|||
46773209|NCT00789581|82991543|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
46955957|NCT02663817|83196491|FG000|Overall Study|Screen failure|2|||
46955958|NCT01372605|83196499|FG000|Overall Study|Death|1|||
46955959|NCT01372605|83196500|FG001|Overall Study|Death|2|||
46955960|NCT01372605|83196499|FG000|Overall Study|Lost to Follow-up|2|||
46955961|NCT01372605|83196500|FG001|Overall Study|Lost to Follow-up|1|||
46955962|NCT01372605|83196499|FG000|Overall Study|Withdrawal by Subject|4|||
46955963|NCT01372605|83196500|FG001|Overall Study|Withdrawal by Subject|7|||
46955964|NCT01372605|83196499|FG000|Overall Study|Moved|3|||
46955965|NCT01372605|83196500|FG001|Overall Study|Moved|0|||
46955966|NCT01372605|83196499|FG000|Overall Study|Changed medical home|2|||
46955967|NCT01372605|83196500|FG001|Overall Study|Changed medical home|0|||
46955968|NCT02751983|83196508|FG000|Treatment|Stopped ACT, but Remained in study|2|||
46955969|NCT02751983|83196509|FG001|Treatment|Stopped ACT, but Remained in study|0|||
46955970|NCT02751983|83196508|FG000|Treatment|Discharged prior to beginning ACT|2|||
46955971|NCT02751983|83196509|FG001|Treatment|Discharged prior to beginning ACT|0|||
46955972|NCT02751983|83196508|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
46955973|NCT02751983|83196509|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
46955974|NCT02751983|83196508|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
46955975|NCT02751983|83196509|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
46955976|NCT02751983|83196508|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
46955977|NCT02751983|83196509|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
46955978|NCT00232141|83196529|FG000|Overall Study|Adverse Event|9|||
46955979|NCT00232141|83196530|FG001|Overall Study|Adverse Event|4|||
46955980|NCT00232141|83196529|FG000|Overall Study|Lack of Efficacy|0|||
46955981|NCT00232141|83196530|FG001|Overall Study|Lack of Efficacy|3|||
46955982|NCT00232141|83196529|FG000|Overall Study|Lost to Follow-up|9|||
46955983|NCT00232141|83196530|FG001|Overall Study|Lost to Follow-up|6|||
46955984|NCT00232141|83196529|FG000|Overall Study|Other|8|||
46955985|NCT00232141|83196530|FG001|Overall Study|Other|10|||
46955986|NCT00232141|83196529|FG000|Overall Study|Withdrawal by Subject|5|||
46955987|NCT00232141|83196530|FG001|Overall Study|Withdrawal by Subject|3|||
46955988|NCT02741245|83196559|FG000|Overall Study|Adverse Event|0|||
46955989|NCT02741245|83196560|FG001|Overall Study|Adverse Event|0|||
46955990|NCT02741245|83196561|FG002|Overall Study|Adverse Event|0|||
46955991|NCT02741245|83196562|FG003|Overall Study|Adverse Event|2|||
46955992|NCT02741245|83196563|FG004|Overall Study|Adverse Event|2|||
46955993|NCT02741245|83196559|FG000|Overall Study|Protocol Violation|0|||
46955994|NCT02741245|83196560|FG001|Overall Study|Protocol Violation|1|||
46955995|NCT02741245|83196561|FG002|Overall Study|Protocol Violation|0|||
46955996|NCT02741245|83196562|FG003|Overall Study|Protocol Violation|1|||
46955997|NCT02741245|83196563|FG004|Overall Study|Protocol Violation|0|||
46955998|NCT02741245|83196559|FG000|Overall Study|Withdrawal by Subject|0|||
46955999|NCT02741245|83196560|FG001|Overall Study|Withdrawal by Subject|0|||
46956000|NCT02741245|83196561|FG002|Overall Study|Withdrawal by Subject|0|||
46956001|NCT02741245|83196562|FG003|Overall Study|Withdrawal by Subject|1|||
46956002|NCT02741245|83196563|FG004|Overall Study|Withdrawal by Subject|0|||
46956003|NCT02751827|83196589|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
46956004|NCT02751827|83196590|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
46956005|NCT02751827|83196591|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
46956006|NCT04896593|83196599|FG000|Overall Study|Withdrawal by Subject|2|||
46956007|NCT04896593|83196599|FG000|Overall Study|Lost to Follow-up|1|||
46956008|NCT04896593|83196599|FG000|Overall Study|Did not complete onboarding|2|||
46773210|NCT00789581|82991544|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
46773211|NCT00789581|82991543|FG000|Adjuvant Therapy|Protocol Violation|1|||
46773212|NCT00789581|82991544|FG001|Adjuvant Therapy|Protocol Violation|1|||
46773213|NCT00789581|82991543|FG000|Adjuvant Therapy|Other|0|||
46773214|NCT00789581|82991544|FG001|Adjuvant Therapy|Other|1|||
46773215|NCT00717756|82991551|FG000|Overall Study|Withdrawal by Subject|1|||
46773216|NCT00717522|82991555|FG000|Overall Study|Disease Progression|5|||
46773217|NCT00717522|82991555|FG000|Overall Study|Adverse Event|1|||
46773218|NCT00717522|82991555|FG000|Overall Study|Death|1|||
46956009|NCT04601272|83196606|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
46956010|NCT04601272|83196607|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
46773219|NCT00791921|82991561|FG000|Overall Study|Protocol planed|24|||
46773220|NCT00791921|82991562|FG001|Overall Study|Protocol planed|88|||
46956011|NCT04601272|83196608|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
46956012|NCT03965091|83196619|FG000|Overall Study|Adverse Event|0|||
46639405|NCT01384734|82812913|FG002|Overall Study|Investigator relocating|0|||
46956013|NCT03965091|83196620|FG001|Overall Study|Adverse Event|2|||
46956014|NCT03965091|83196621|FG002|Overall Study|Adverse Event|3|||
46956015|NCT03965091|83196619|FG000|Overall Study|Withdrawal by Subject|11|||
46956016|NCT03965091|83196620|FG001|Overall Study|Withdrawal by Subject|3|||
46956017|NCT03965091|83196621|FG002|Overall Study|Withdrawal by Subject|5|||
46956018|NCT03965091|83196619|FG000|Overall Study|Non-compliance with study drug|0|||
46844254|NCT00421889|83061109|FG000|Overall Study|Withdrawal by Subject|1|||
46844255|NCT00421889|83061110|FG001|Overall Study|Withdrawal by Subject|3|||
46844256|NCT00421889|83061111|FG002|Overall Study|Withdrawal by Subject|0|||
46844257|NCT00421889|83061112|FG003|Overall Study|Withdrawal by Subject|0|||
46844258|NCT00421889|83061113|FG004|Overall Study|Withdrawal by Subject|2|||
46844259|NCT00421889|83061114|FG005|Overall Study|Withdrawal by Subject|0|||
46844260|NCT00421889|83061115|FG006|Overall Study|Withdrawal by Subject|0|||
46844261|NCT00421889|83061116|FG007|Overall Study|Withdrawal by Subject|0|||
46956019|NCT03965091|83196620|FG001|Overall Study|Non-compliance with study drug|0|||
46956020|NCT03965091|83196621|FG002|Overall Study|Non-compliance with study drug|1|||
46956021|NCT03965091|83196619|FG000|Overall Study|Lost to Follow-up|1|||
46956022|NCT03965091|83196620|FG001|Overall Study|Lost to Follow-up|1|||
46956023|NCT03965091|83196621|FG002|Overall Study|Lost to Follow-up|1|||
46956024|NCT03965091|83196619|FG000|Overall Study|Lack of Efficacy|2|||
46956025|NCT03965091|83196620|FG001|Overall Study|Lack of Efficacy|0|||
46956026|NCT03965091|83196621|FG002|Overall Study|Lack of Efficacy|0|||
46956027|NCT03965091|83196619|FG000|Overall Study|Other than specified|9|||
46956028|NCT03965091|83196620|FG001|Overall Study|Other than specified|11|||
46956029|NCT03965091|83196621|FG002|Overall Study|Other than specified|8|||
46956030|NCT03359096|83196652|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
46956031|NCT03359096|83196653|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
46956032|NCT03359096|83196652|FG000|First Intervention (4 Weeks)|Death|1|||
46956033|NCT03359096|83196653|FG001|First Intervention (4 Weeks)|Death|0|||
46956034|NCT03359096|83196652|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
46956035|NCT03359096|83196653|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
46956036|NCT03019588|83196670|FG000|Overall Study|Death|44|||
46956037|NCT03019588|83196671|FG001|Overall Study|Death|46|||
46956038|NCT03019588|83196670|FG000|Overall Study|Study terminated by Sponsor|3|||
46956039|NCT03019588|83196671|FG001|Overall Study|Study terminated by Sponsor|1|||
46956040|NCT02270450|83196703|FG000|Overall Study|Refusal unrelated to adverse event|3|||
46956041|NCT02270450|83196704|FG001|Overall Study|Refusal unrelated to adverse event|1|||
46956042|NCT02270450|83196705|FG002|Overall Study|Refusal unrelated to adverse event|5|||
46956043|NCT02270450|83196706|FG003|Overall Study|Refusal unrelated to adverse event|14|||
46956044|NCT02270450|83196703|FG000|Overall Study|Progression/relapse|1|||
46639406|NCT01384734|82812914|FG003|Overall Study|Investigator relocating|3|||
46639407|NCT01384734|82812915|FG004|Overall Study|Investigator relocating|1|||
46639408|NCT01384734|82812911|FG000|Overall Study|Unable to come back for visit|1|||
46639409|NCT01384734|82812912|FG001|Overall Study|Unable to come back for visit|0|||
46639410|NCT01384734|82812913|FG002|Overall Study|Unable to come back for visit|1|||
46639411|NCT01384734|82812914|FG003|Overall Study|Unable to come back for visit|1|||
46639412|NCT01384734|82812915|FG004|Overall Study|Unable to come back for visit|0|||
46639413|NCT01384734|82812911|FG000|Overall Study|Prison|0|||
46639414|NCT01384734|82812912|FG001|Overall Study|Prison|0|||
46639415|NCT01384734|82812913|FG002|Overall Study|Prison|1|||
46639416|NCT01384734|82812914|FG003|Overall Study|Prison|0|||
46773221|NCT00791921|82991561|FG000|Overall Study|Withdrawal by Subject|1|||
46773222|NCT00791921|82991562|FG001|Overall Study|Withdrawal by Subject|2|||
46773223|NCT00791921|82991561|FG000|Overall Study|Adverse Event|8|||
46773224|NCT00791921|82991562|FG001|Overall Study|Adverse Event|2|||
46773225|NCT00791921|82991561|FG000|Overall Study|Lack of Efficacy|0|||
46773226|NCT00791921|82991562|FG001|Overall Study|Lack of Efficacy|2|||
46773227|NCT00791921|82991561|FG000|Overall Study|Lack of study drug administration|1|||
46773228|NCT00791921|82991562|FG001|Overall Study|Lack of study drug administration|1|||
46773229|NCT00791921|82991561|FG000|Overall Study|Reason other than those above|0|||
46773230|NCT00791921|82991562|FG001|Overall Study|Reason other than those above|1|||
46773231|NCT00582933|82991568|FG000|Overall Study|Physician Decision|3|||
46773232|NCT00791765|82991574|FG000|Weeks 1 to 12|Adverse Event|0|||
46773233|NCT00791765|82991575|FG001|Weeks 1 to 12|Adverse Event|1|||
46773234|NCT00791765|82991574|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
46773235|NCT00791765|82991575|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
46773236|NCT00791765|82991574|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
46773237|NCT00791765|82991575|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
46773238|NCT00791765|82991574|FG000|Weeks 1 to 12|Physician Decision|1|||
46773239|NCT00791765|82991575|FG001|Weeks 1 to 12|Physician Decision|0|||
46773240|NCT00791765|82991574|FG000|Weeks 1 to 12|Disease progression|3|||
46773241|NCT00791765|82991575|FG001|Weeks 1 to 12|Disease progression|0|||
46773242|NCT00791765|82991574|FG000|Weeks 1 to 12|Ineligibility determined|0|||
46773243|NCT00791765|82991575|FG001|Weeks 1 to 12|Ineligibility determined|3|||
46844262|NCT00421889|83061117|FG008|Overall Study|Withdrawal by Subject|0|||
46844263|NCT00421889|83061109|FG000|Overall Study|Death|0|||
46639417|NCT01384734|82812915|FG004|Overall Study|Prison|0|||
46773244|NCT00791765|82991574|FG000|Weeks 13 to 24|Protocol deviation|2|||
46773245|NCT00791765|82991575|FG001|Weeks 13 to 24|Protocol deviation|0|||
46844264|NCT00421889|83061110|FG001|Overall Study|Death|0|||
46956045|NCT02270450|83196704|FG001|Overall Study|Progression/relapse|2|||
46956046|NCT02270450|83196705|FG002|Overall Study|Progression/relapse|4|||
46956047|NCT02270450|83196706|FG003|Overall Study|Progression/relapse|9|||
46639418|NCT01384734|82812911|FG000|Overall Study|As per Exclusion criteria|0|||
46639419|NCT01384734|82812912|FG001|Overall Study|As per Exclusion criteria|1|||
46639420|NCT01384734|82812913|FG002|Overall Study|As per Exclusion criteria|0|||
46639421|NCT01384734|82812914|FG003|Overall Study|As per Exclusion criteria|0|||
46639422|NCT01384734|82812915|FG004|Overall Study|As per Exclusion criteria|0|||
46639423|NCT01384734|82812911|FG000|Overall Study|Missed End of treatment visit|0|||
46639424|NCT01384734|82812912|FG001|Overall Study|Missed End of treatment visit|0|||
46639425|NCT01384734|82812913|FG002|Overall Study|Missed End of treatment visit|0|||
46639426|NCT01384734|82812914|FG003|Overall Study|Missed End of treatment visit|1|||
46639427|NCT01384734|82812915|FG004|Overall Study|Missed End of treatment visit|0|||
46639428|NCT01384734|82812911|FG000|Overall Study|Adhesion problem|0|||
46639429|NCT01384734|82812912|FG001|Overall Study|Adhesion problem|0|||
46639430|NCT01384734|82812913|FG002|Overall Study|Adhesion problem|0|||
46639431|NCT01384734|82812914|FG003|Overall Study|Adhesion problem|1|||
46639432|NCT01384734|82812915|FG004|Overall Study|Adhesion problem|0|||
46639433|NCT01384734|82812911|FG000|Overall Study|Early termination|0|||
46639434|NCT01384734|82812912|FG001|Overall Study|Early termination|0|||
46639435|NCT01384734|82812913|FG002|Overall Study|Early termination|0|||
46639436|NCT01384734|82812914|FG003|Overall Study|Early termination|0|||
46639437|NCT01384734|82812915|FG004|Overall Study|Early termination|1|||
46639438|NCT01384734|82812911|FG000|Overall Study|Physician Decision|1|||
46639439|NCT01384734|82812912|FG001|Overall Study|Physician Decision|0|||
46773246|NCT00791765|82991574|FG000|Weeks 13 to 24|Adverse Event|0|||
46773247|NCT00791765|82991575|FG001|Weeks 13 to 24|Adverse Event|3|||
46773248|NCT00791765|82991574|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
46956048|NCT02270450|83196703|FG000|Overall Study|Death|19|||
46956049|NCT02270450|83196704|FG001|Overall Study|Death|19|||
46956050|NCT02270450|83196705|FG002|Overall Study|Death|31|||
46956051|NCT02270450|83196706|FG003|Overall Study|Death|59|||
46956052|NCT01565499|83196727|FG000|Overall Study|Physician Decision|1|||
46956053|NCT01565499|83196727|FG000|Overall Study|Adverse Event|5|||
46956054|NCT01565499|83196727|FG000|Overall Study|Withdrawal by Subject|2|||
46956055|NCT01036087|83196731|FG000|Overall Study|Adverse Event|2|||
46956056|NCT01036087|83196731|FG000|Overall Study|Lack of Efficacy|1|||
46956057|NCT00572156|83196748|FG000|Overall Study|Adverse Event|3|||
46956058|NCT00572156|83196749|FG001|Overall Study|Adverse Event|1|||
46956059|NCT00572156|83196750|FG002|Overall Study|Adverse Event|5|||
46956060|NCT00572156|83196751|FG003|Overall Study|Adverse Event|1|||
46956061|NCT00572156|83196748|FG000|Overall Study|Lost to Follow-up|1|||
46956062|NCT00572156|83196749|FG001|Overall Study|Lost to Follow-up|1|||
46956063|NCT00572156|83196750|FG002|Overall Study|Lost to Follow-up|1|||
46956064|NCT00572156|83196751|FG003|Overall Study|Lost to Follow-up|0|||
46956065|NCT00572156|83196748|FG000|Overall Study|Protocol Violation|1|||
46956066|NCT00572156|83196749|FG001|Overall Study|Protocol Violation|2|||
46956067|NCT00572156|83196750|FG002|Overall Study|Protocol Violation|0|||
46956068|NCT00572156|83196751|FG003|Overall Study|Protocol Violation|2|||
46956069|NCT00572156|83196748|FG000|Overall Study|Patient/Parent Decision|1|||
46956070|NCT00572156|83196749|FG001|Overall Study|Patient/Parent Decision|6|||
46956071|NCT00572156|83196750|FG002|Overall Study|Patient/Parent Decision|4|||
46956072|NCT00572156|83196751|FG003|Overall Study|Patient/Parent Decision|3|||
46956073|NCT00572156|83196748|FG000|Overall Study|Sponsor Decision|20|||
46956074|NCT00572156|83196749|FG001|Overall Study|Sponsor Decision|16|||
46956075|NCT00572156|83196750|FG002|Overall Study|Sponsor Decision|17|||
46956076|NCT00572156|83196751|FG003|Overall Study|Sponsor Decision|19|||
46956077|NCT00447772|83196761|FG000|Overall Study|Lack of Efficacy|3|||
46956078|NCT00447772|83196761|FG000|Overall Study|Insufficient compliance|6|||
46956079|NCT00447772|83196761|FG000|Overall Study|Discontinuation of drug therapy|1|||
46956080|NCT00447772|83196761|FG000|Overall Study|Lost to Follow-up|9|||
46956081|NCT00447772|83196761|FG000|Overall Study|Withdrawal by Subject|1|||
46956082|NCT00447772|83196761|FG000|Overall Study|Unable to attend all study visits|2|||
46956083|NCT00447772|83196761|FG000|Overall Study|Adverse Event|1|||
46956084|NCT00447772|83196761|FG000|Overall Study|Patient relocated|1|||
46956085|NCT00447772|83196761|FG000|Overall Study|Incomplete documentation at visit 1|1|||
46956086|NCT00447772|83196761|FG000|Overall Study|Chemotherapy for lung cancer|1|||
46956087|NCT00447772|83196761|FG000|Overall Study|Premature re-injection required|1|||
46956088|NCT02296138|83196770|FG000|Overall Study|Adverse Event|348|||
46956089|NCT02296138|83196771|FG001|Overall Study|Adverse Event|259|||
46956090|NCT02296138|83196770|FG000|Overall Study|Lack of Efficacy|59|||
46956091|NCT02296138|83196771|FG001|Overall Study|Lack of Efficacy|37|||
46956092|NCT02296138|83196770|FG000|Overall Study|Protocol Violation|35|||
46956093|NCT02296138|83196771|FG001|Overall Study|Protocol Violation|36|||
46639440|NCT01384734|82812913|FG002|Overall Study|Physician Decision|0|||
46639441|NCT01384734|82812914|FG003|Overall Study|Physician Decision|0|||
46639442|NCT01384734|82812915|FG004|Overall Study|Physician Decision|0|||
46639443|NCT01396512|82812926|FG000|Overall Study|Withdrawal by Subject|0|||
46773249|NCT00791765|82991575|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
46956094|NCT02296138|83196770|FG000|Overall Study|Lost to Follow-up|9|||
46956095|NCT02296138|83196771|FG001|Overall Study|Lost to Follow-up|12|||
46956096|NCT02296138|83196770|FG000|Overall Study|Withdrawal by Subject|184|||
46956097|NCT02296138|83196771|FG001|Overall Study|Withdrawal by Subject|131|||
46956098|NCT02296138|83196770|FG000|Overall Study|Not Treated|1|||
46956099|NCT02296138|83196771|FG001|Overall Study|Not Treated|1|||
46956100|NCT02296138|83196770|FG000|Overall Study|Patients with data irregularities|10|||
46844265|NCT00421889|83061111|FG002|Overall Study|Death|0|||
46844266|NCT00421889|83061112|FG003|Overall Study|Death|0|||
46844267|NCT00421889|83061113|FG004|Overall Study|Death|1|||
46844268|NCT00421889|83061114|FG005|Overall Study|Death|1|||
46844269|NCT00421889|83061115|FG006|Overall Study|Death|0|||
46844270|NCT00421889|83061116|FG007|Overall Study|Death|0|||
46844271|NCT00421889|83061117|FG008|Overall Study|Death|0|||
46844272|NCT00421889|83061109|FG000|Overall Study|Progressive disease|3|||
46844273|NCT00421889|83061110|FG001|Overall Study|Progressive disease|2|||
46844274|NCT00421889|83061111|FG002|Overall Study|Progressive disease|2|||
46844275|NCT00421889|83061112|FG003|Overall Study|Progressive disease|3|||
46844276|NCT00421889|83061113|FG004|Overall Study|Progressive disease|2|||
46844277|NCT00421889|83061114|FG005|Overall Study|Progressive disease|21|||
46844278|NCT00421889|83061115|FG006|Overall Study|Progressive disease|3|||
46844279|NCT00421889|83061116|FG007|Overall Study|Progressive disease|1|||
46844280|NCT00421889|83061117|FG008|Overall Study|Progressive disease|5|||
46844281|NCT00421889|83061109|FG000|Overall Study|Patient/Investigator request|0|||
46844282|NCT00421889|83061110|FG001|Overall Study|Patient/Investigator request|0|||
46844283|NCT00421889|83061111|FG002|Overall Study|Patient/Investigator request|0|||
46844284|NCT00421889|83061112|FG003|Overall Study|Patient/Investigator request|0|||
46844285|NCT00421889|83061113|FG004|Overall Study|Patient/Investigator request|0|||
46844286|NCT00421889|83061114|FG005|Overall Study|Patient/Investigator request|9|||
46844287|NCT00421889|83061115|FG006|Overall Study|Patient/Investigator request|0|||
46844288|NCT00421889|83061116|FG007|Overall Study|Patient/Investigator request|1|||
46844289|NCT00421889|83061117|FG008|Overall Study|Patient/Investigator request|3|||
46844290|NCT00421889|83061109|FG000|Overall Study|Lost to Follow-up|0|||
46844291|NCT00421889|83061110|FG001|Overall Study|Lost to Follow-up|0|||
46844292|NCT00421889|83061111|FG002|Overall Study|Lost to Follow-up|0|||
46956101|NCT02296138|83196771|FG001|Overall Study|Patients with data irregularities|11|||
46956102|NCT02296138|83196770|FG000|Overall Study|Other than specified|15|||
46956103|NCT02296138|83196771|FG001|Overall Study|Other than specified|13|||
46956104|NCT01306942|83196780|FG000|Phase I|Adverse Event|2|||
46956105|NCT01306942|83196781|FG001|Phase I|Adverse Event|2|||
46956106|NCT01306942|83196782|FG002|Phase I|Adverse Event|0|||
46956107|NCT01306942|83196783|FG003|Phase I|Adverse Event|0|||
46956108|NCT01306942|83196780|FG000|Phase I|Physician Decision|3|||
46956109|NCT01306942|83196781|FG001|Phase I|Physician Decision|1|||
46956110|NCT01306942|83196782|FG002|Phase I|Physician Decision|0|||
46956111|NCT01306942|83196783|FG003|Phase I|Physician Decision|0|||
46956112|NCT01306942|83196780|FG000|Phase II|Adverse Event|0|||
46956113|NCT01306942|83196781|FG001|Phase II|Adverse Event|0|||
46956114|NCT01306942|83196782|FG002|Phase II|Adverse Event|0|||
46956115|NCT01306942|83196783|FG003|Phase II|Adverse Event|6|||
46956116|NCT01306942|83196780|FG000|Phase II|Physician Decision|2|||
46956117|NCT01306942|83196781|FG001|Phase II|Physician Decision|0|||
46956118|NCT01306942|83196782|FG002|Phase II|Physician Decision|0|||
46956119|NCT01306942|83196783|FG003|Phase II|Physician Decision|5|||
46956120|NCT01306942|83196780|FG000|Phase II|Withdrawal by Subject|0|||
46956121|NCT01306942|83196781|FG001|Phase II|Withdrawal by Subject|0|||
46956122|NCT01306942|83196782|FG002|Phase II|Withdrawal by Subject|0|||
46956123|NCT01306942|83196783|FG003|Phase II|Withdrawal by Subject|2|||
46956124|NCT01306942|83196780|FG000|Phase II|Death|0|||
46956125|NCT01306942|83196781|FG001|Phase II|Death|0|||
46956126|NCT01306942|83196782|FG002|Phase II|Death|0|||
46956127|NCT01306942|83196783|FG003|Phase II|Death|1|||
46956128|NCT01306942|83196780|FG000|Phase II|Not finished treatment|0|||
46956129|NCT01306942|83196781|FG001|Phase II|Not finished treatment|0|||
46956130|NCT01306942|83196782|FG002|Phase II|Not finished treatment|0|||
46844293|NCT00421889|83061112|FG003|Overall Study|Lost to Follow-up|0|||
46844294|NCT00421889|83061113|FG004|Overall Study|Lost to Follow-up|0|||
46844295|NCT00421889|83061114|FG005|Overall Study|Lost to Follow-up|0|||
46844296|NCT00421889|83061115|FG006|Overall Study|Lost to Follow-up|0|||
46844297|NCT00421889|83061116|FG007|Overall Study|Lost to Follow-up|0|||
46844298|NCT00421889|83061117|FG008|Overall Study|Lost to Follow-up|1|||
46844299|NCT00421733|83061144|FG000|Overall Study|Adverse Event|4|||
46844300|NCT00421733|83061145|FG001|Overall Study|Adverse Event|9|||
46956131|NCT01306942|83196783|FG003|Phase II|Not finished treatment|1|||
46956132|NCT01306942|83196780|FG000|Phase II|Protocol Violation|0|||
46956133|NCT01306942|83196781|FG001|Phase II|Protocol Violation|0|||
46956134|NCT01306942|83196782|FG002|Phase II|Protocol Violation|0|||
46956135|NCT01306942|83196783|FG003|Phase II|Protocol Violation|1|||
46956136|NCT02324842|83196798|FG000|Overall Study|Lost to Follow-up|1|||
46956137|NCT02324842|83196799|FG001|Overall Study|Lost to Follow-up|1|||
46956138|NCT02324842|83196800|FG002|Overall Study|Lost to Follow-up|2|||
46956139|NCT02295280|83196810|FG000|Overall Study|Adverse Event|0|||
46956140|NCT02295280|83196811|FG001|Overall Study|Adverse Event|1|||
46956141|NCT05263505|83196819|FG000|Overall Study|Adverse Event|0|||
46956142|NCT05263505|83196820|FG001|Overall Study|Adverse Event|1|||
46956143|NCT02294734|83196828|FG000|Overall Study|Adverse Event|5|||
46956144|NCT02294734|83196829|FG001|Overall Study|Adverse Event|5|||
46956145|NCT02294734|83196828|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
46956146|NCT02294734|83196829|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
46956147|NCT02294734|83196828|FG000|Overall Study|Lost to Follow-up|2|||
46956148|NCT02294734|83196829|FG001|Overall Study|Lost to Follow-up|0|||
46956149|NCT02294734|83196828|FG000|Overall Study|Physician Decision|2|||
46956150|NCT02294734|83196829|FG001|Overall Study|Physician Decision|1|||
46956151|NCT02294734|83196828|FG000|Overall Study|Withdrawal by Subject|4|||
46956152|NCT02294734|83196829|FG001|Overall Study|Withdrawal by Subject|2|||
46956153|NCT02323204|83196850|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
46956154|NCT02323204|83196851|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
46956155|NCT02323204|83196852|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
46956156|NCT02323204|83196853|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
46956157|NCT02323204|83196850|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
46956158|NCT02323204|83196851|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
46956159|NCT02323204|83196852|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
46956160|NCT02323204|83196853|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
46956161|NCT02323204|83196850|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
46956162|NCT02323204|83196851|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
46956163|NCT02323204|83196852|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
46956164|NCT02323204|83196853|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
46956165|NCT02323204|83196850|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
46956166|NCT02323204|83196851|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
46956167|NCT02323204|83196852|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
46956168|NCT02323204|83196853|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
46956169|NCT02323204|83196850|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
46956170|NCT02323204|83196851|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
46956171|NCT02323204|83196852|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
46956172|NCT02323204|83196853|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
46956173|NCT02323204|83196850|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
46956174|NCT02323204|83196851|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
46956175|NCT02323204|83196852|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
46956176|NCT02323204|83196853|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
46956177|NCT02323204|83196850|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
46956178|NCT02323204|83196851|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
46956179|NCT02323204|83196852|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
46956180|NCT02323204|83196853|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
46956181|NCT02323204|83196850|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
46956182|NCT02323204|83196851|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
46956183|NCT02323204|83196852|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
46956184|NCT02323204|83196853|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
46956185|NCT02323204|83196850|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
46956186|NCT02323204|83196851|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
46956187|NCT02323204|83196852|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
46956188|NCT02323204|83196853|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
46956189|NCT02322892|83196865|FG000|Overall Study|Surgery cancelled|1|||
46956190|NCT02322892|83196866|FG001|Overall Study|Surgery cancelled|2|||
46956191|NCT02322892|83196865|FG000|Overall Study|Met exclusion criteria|0|||
46956192|NCT02322892|83196866|FG001|Overall Study|Met exclusion criteria|1|||
46956193|NCT02322892|83196865|FG000|Overall Study|Protocol Violation|1|||
46956194|NCT02322892|83196866|FG001|Overall Study|Protocol Violation|0|||
46956195|NCT03916081|83196875|FG000|Overall Study|Adverse Event|1|||
46956196|NCT03916081|83196876|FG001|Overall Study|Adverse Event|0|||
46956197|NCT03916081|83196877|FG002|Overall Study|Adverse Event|0|||
47066905|NCT01490125|83349891|FG000|Period III|Lack of Efficacy|0|||
47066906|NCT01490125|83349892|FG001|Period III|Lack of Efficacy|0|||
47066907|NCT01490125|83349893|FG002|Period III|Lack of Efficacy|0|||
47066908|NCT01490125|83349894|FG003|Period III|Lack of Efficacy|0|||
47066909|NCT01490125|83349895|FG004|Period III|Lack of Efficacy|1|||
47066910|NCT01490125|83349896|FG005|Period III|Lack of Efficacy|0|||
47066911|NCT01446913|83349907|FG000|Overall Study|Significant illness|1|||
47066912|NCT01446913|83349908|FG001|Overall Study|Significant illness|1|||
47066913|NCT01446913|83349909|FG002|Overall Study|Significant illness|1|||
46956198|NCT03916081|83196875|FG000|Overall Study|Physician Decision|0|||
46956199|NCT03916081|83196876|FG001|Overall Study|Physician Decision|0|||
46956200|NCT03916081|83196877|FG002|Overall Study|Physician Decision|1|||
46956201|NCT03916081|83196875|FG000|Overall Study|Lost to Follow-up|0|||
46956202|NCT03916081|83196876|FG001|Overall Study|Lost to Follow-up|1|||
46956203|NCT03916081|83196877|FG002|Overall Study|Lost to Follow-up|0|||
46956204|NCT03916081|83196875|FG000|Overall Study|Withdrawal by Subject|3|||
46956205|NCT03916081|83196876|FG001|Overall Study|Withdrawal by Subject|0|||
46956206|NCT03916081|83196877|FG002|Overall Study|Withdrawal by Subject|1|||
46956207|NCT03916081|83196875|FG000|Overall Study|Worsening of AD|0|||
46956208|NCT03916081|83196876|FG001|Overall Study|Worsening of AD|0|||
46956209|NCT03916081|83196877|FG002|Overall Study|Worsening of AD|1|||
46639444|NCT01396512|82812927|FG001|Overall Study|Withdrawal by Subject|1|||
46639445|NCT01396434|82812936|FG000|Overall Study|Lost to Follow-up|1|||
46639446|NCT01396434|82812937|FG001|Overall Study|Lost to Follow-up|0|||
46639447|NCT01396434|82812938|FG002|Overall Study|Lost to Follow-up|0|||
46639448|NCT01396434|82812936|FG000|Overall Study|Other|10|||
46639449|NCT01396434|82812937|FG001|Overall Study|Other|0|||
46639450|NCT01396434|82812938|FG002|Overall Study|Other|0|||
46639451|NCT01383954|82812946|FG000|Overall Study|Lack of Efficacy|2|||
46639452|NCT01383954|82812946|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
46639453|NCT01383954|82812946|FG000|Overall Study|Adverse Event|1|||
46639454|NCT01383954|82812946|FG000|Overall Study|Reason Not Specified|9|||
46844301|NCT00421733|83061146|FG002|Overall Study|Adverse Event|2|||
46844302|NCT00421733|83061144|FG000|Overall Study|Lost to Follow-up|1|||
46844303|NCT00421733|83061145|FG001|Overall Study|Lost to Follow-up|2|||
46844304|NCT00421733|83061146|FG002|Overall Study|Lost to Follow-up|4|||
46844305|NCT00421733|83061144|FG000|Overall Study|Withdrawal by Subject|1|||
46844306|NCT00421733|83061145|FG001|Overall Study|Withdrawal by Subject|2|||
46844307|NCT00421733|83061146|FG002|Overall Study|Withdrawal by Subject|7|||
46844308|NCT00421733|83061144|FG000|Overall Study|Death|0|||
46844309|NCT00421733|83061145|FG001|Overall Study|Death|3|||
46844310|NCT00421733|83061146|FG002|Overall Study|Death|0|||
46844311|NCT00421733|83061144|FG000|Overall Study|Required dialysis|1|||
46844312|NCT00421733|83061145|FG001|Overall Study|Required dialysis|0|||
46844313|NCT00421733|83061146|FG002|Overall Study|Required dialysis|0|||
46844314|NCT00421733|83061144|FG000|Overall Study|Administrative|2|||
46844315|NCT00421733|83061145|FG001|Overall Study|Administrative|0|||
46956210|NCT03116113|83196894|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
46639455|NCT01383486|82812950|FG000|Overall Study|Lost to Follow-up|10|||
46639456|NCT01383486|82812950|FG000|Overall Study|Incomplete information for analysis|2|||
46956211|NCT03116113|83196895|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
46956212|NCT03116113|83196896|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
46956213|NCT03116113|83196897|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
46956214|NCT03116113|83196898|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
46956215|NCT03116113|83196899|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
46956216|NCT03116113|83196900|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
46956217|NCT03116113|83196901|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
46956218|NCT03116113|83196902|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
46956219|NCT02739997|83196927|FG000|Overall Study|Death|1|||
46639457|NCT01383486|82812950|FG000|Overall Study|Did not take any product|6|||
46639458|NCT01383174|82812957|FG000|3 Month Assessment|Death|0|||
46639459|NCT01383174|82812958|FG001|3 Month Assessment|Death|1|||
46639460|NCT01383174|82812957|FG000|3 Month Assessment|Lost to Follow-up|2|||
46639461|NCT01383174|82812958|FG001|3 Month Assessment|Lost to Follow-up|0|||
46639462|NCT01383174|82812957|FG000|3 Month Assessment|Refused to complete|4|||
46639463|NCT01383174|82812958|FG001|3 Month Assessment|Refused to complete|0|||
46639464|NCT01383174|82812957|FG000|6 Month Assessment|Lost to Follow-up|1|||
46639465|NCT01383174|82812958|FG001|6 Month Assessment|Lost to Follow-up|1|||
46639466|NCT01383174|82812957|FG000|6 Month Assessment|Refused to complete|4|||
46639467|NCT01383174|82812958|FG001|6 Month Assessment|Refused to complete|0|||
46639468|NCT01396278|82812969|FG000|Overall Study|Adverse Event|0|||
46639469|NCT01396278|82812970|FG001|Overall Study|Adverse Event|0|||
46956220|NCT02739997|83196927|FG000|Overall Study|Withdrawal by Subject|1|||
46956221|NCT02221037|83196935|FG000|Overall Study|Physician Decision|0|||
46639470|NCT01396278|82812971|FG002|Overall Study|Adverse Event|0|||
46639471|NCT01396278|82812972|FG003|Overall Study|Adverse Event|2|||
46639472|NCT01396278|82812973|FG004|Overall Study|Adverse Event|0|||
46639473|NCT01396278|82812969|FG000|Overall Study|Withdraw due to trial termination|2|||
46844316|NCT00421733|83061146|FG002|Overall Study|Administrative|0|||
46844317|NCT00421733|83061144|FG000|Overall Study|Did not satisfy entry criteria|1|||
46956222|NCT02221037|83196936|FG001|Overall Study|Physician Decision|0|||
47066914|NCT01446913|83349907|FG000|Overall Study|Withdrawal by Subject|5|||
46639474|NCT01396278|82812970|FG001|Overall Study|Withdraw due to trial termination|1|||
46639475|NCT01396278|82812971|FG002|Overall Study|Withdraw due to trial termination|1|||
46639476|NCT01396278|82812972|FG003|Overall Study|Withdraw due to trial termination|0|||
46639477|NCT01396278|82812973|FG004|Overall Study|Withdraw due to trial termination|2|||
46639478|NCT01383096|82812988|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
46844318|NCT00421733|83061145|FG001|Overall Study|Did not satisfy entry criteria|3|||
46844319|NCT00421733|83061146|FG002|Overall Study|Did not satisfy entry criteria|2|||
46844320|NCT00421733|83061144|FG000|Overall Study|Sponsor request|1|||
46956223|NCT02221037|83196937|FG002|Overall Study|Physician Decision|1|||
46956224|NCT02221037|83196938|FG003|Overall Study|Physician Decision|0|||
46956225|NCT02704429|83196954|FG000|Part A: 24 Weeks|Adverse Event|3|||
46956226|NCT02704429|83196955|FG001|Part A: 24 Weeks|Adverse Event|0|||
46956227|NCT02704429|83196954|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
46956228|NCT02704429|83196955|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
46956229|NCT02751359|83196962|FG000|Overall Study|Lost to Follow-up|1|||
46956230|NCT02750813|83196981|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
46956231|NCT02750813|83196982|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
46956232|NCT02750813|83196981|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
46956233|NCT02750813|83196982|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
46956234|NCT00503035|83196998|FG000|Overall Study|Lost to Follow-up|2|||
46956235|NCT00503035|83196998|FG000|Overall Study|Physician Decision|3|||
46956236|NCT00503035|83196998|FG000|Overall Study|Ineligible|15|||
46844321|NCT00421733|83061145|FG001|Overall Study|Sponsor request|0|||
46844322|NCT00421733|83061146|FG002|Overall Study|Sponsor request|3|||
46844323|NCT00421733|83061144|FG000|Overall Study|Protocol deviation|4|||
46844324|NCT00421733|83061145|FG001|Overall Study|Protocol deviation|7|||
46844325|NCT00421733|83061146|FG002|Overall Study|Protocol deviation|2|||
46844326|NCT00421343|83061158|FG000|Overall Study|Death|1|||
46956237|NCT04486313|83197005|FG000|Overall Study|Lost to Follow-up|7|||
46956238|NCT04486313|83197006|FG001|Overall Study|Lost to Follow-up|9|||
46956239|NCT04486313|83197005|FG000|Overall Study|Withdrawal by Subject|8|||
46639479|NCT01383096|82812989|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
46844327|NCT00421343|83061158|FG000|Overall Study|Withdrawal by Subject|2|||
46844328|NCT00421343|83061158|FG000|Overall Study|Lost to Follow-up|3|||
46844329|NCT00230178|83061165|FG000|Overall Study|Adverse Event|1|||
46844330|NCT00230178|83061166|FG001|Overall Study|Adverse Event|5|||
46844331|NCT00230178|83061167|FG002|Overall Study|Adverse Event|2|||
46844332|NCT00230178|83061165|FG000|Overall Study|Withdrawal by Subject|0|||
46844333|NCT00230178|83061166|FG001|Overall Study|Withdrawal by Subject|0|||
46844334|NCT00230178|83061167|FG002|Overall Study|Withdrawal by Subject|1|||
46844335|NCT00230178|83061165|FG000|Overall Study|Various other reasons|3|||
46844336|NCT00230178|83061166|FG001|Overall Study|Various other reasons|2|||
46844337|NCT00230178|83061167|FG002|Overall Study|Various other reasons|4|||
46844338|NCT00413777|83061177|FG000|Fixed-dose Period|Lost to Follow-up|1|||
46844339|NCT00413777|83061178|FG001|Fixed-dose Period|Lost to Follow-up|1|||
46844340|NCT00413777|83061177|FG000|Fixed-dose Period|Adverse Event|2|||
46956240|NCT04486313|83197006|FG001|Overall Study|Withdrawal by Subject|6|||
46956241|NCT04486313|83197005|FG000|Overall Study|Physician Decision|1|||
46956242|NCT04486313|83197006|FG001|Overall Study|Physician Decision|1|||
46639480|NCT01383096|82812990|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
46639481|NCT01383096|82812988|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
46639482|NCT01383096|82812989|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
46639483|NCT01383096|82812990|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
46639484|NCT01383096|82812988|FG000|Third Intervention (8 Days)|Elevated AST|0|||
46773250|NCT00791765|82991574|FG000|Weeks 13 to 24|Disease progression|0|||
46773251|NCT00791765|82991575|FG001|Weeks 13 to 24|Disease progression|1|||
46773252|NCT00791765|82991574|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
46773253|NCT00791765|82991575|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
46773254|NCT00791765|82991574|FG000|Weeks 13 to 24|Other|0|||
46773255|NCT00791765|82991575|FG001|Weeks 13 to 24|Other|1|||
46773256|NCT00789191|82991583|FG000|Overall Study|Adverse Event|2|||
46773257|NCT00789191|82991584|FG001|Overall Study|Adverse Event|4|||
46773258|NCT00789191|82991583|FG000|Overall Study|Lack of Efficacy|0|||
46773259|NCT00789191|82991584|FG001|Overall Study|Lack of Efficacy|5|||
46773260|NCT00789191|82991583|FG000|Overall Study|Protocol Violation|5|||
46773261|NCT00789191|82991584|FG001|Overall Study|Protocol Violation|3|||
46773262|NCT00789191|82991583|FG000|Overall Study|Withdrawal Criteria|2|||
46773263|NCT00789191|82991584|FG001|Overall Study|Withdrawal Criteria|4|||
46773264|NCT00789191|82991583|FG000|Overall Study|Unclassified|5|||
46773265|NCT00789191|82991584|FG001|Overall Study|Unclassified|3|||
46773266|NCT00789035|82991595|FG000|Overall Study|Adverse Event|0|||
46773267|NCT00789035|82991596|FG001|Overall Study|Adverse Event|2|||
46773268|NCT00789035|82991597|FG002|Overall Study|Adverse Event|0|||
46773269|NCT00789035|82991598|FG003|Overall Study|Adverse Event|1|||
46773270|NCT00789035|82991599|FG004|Overall Study|Adverse Event|3|||
46773271|NCT00789035|82991595|FG000|Overall Study|Lack of Efficacy|3|||
46844341|NCT00413777|83061178|FG001|Fixed-dose Period|Adverse Event|1|||
46844342|NCT00413777|83061177|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
46844343|NCT00413777|83061178|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
46844344|NCT00413777|83061177|FG000|Fixed-dose Period|Withdrew Consent|0|||
46844345|NCT00413777|83061178|FG001|Fixed-dose Period|Withdrew Consent|1|||
46844346|NCT00197028|83061186|FG000|Overall Study|Adverse Event|2|||
46956243|NCT04486313|83197005|FG000|Overall Study|Death|2|||
46956244|NCT04486313|83197006|FG001|Overall Study|Death|0|||
46956245|NCT04486313|83197005|FG000|Overall Study|Protocol Violation|1|||
46956246|NCT04486313|83197006|FG001|Overall Study|Protocol Violation|1|||
46956247|NCT03137381|83197016|FG000|Overall Study|Adverse Event|3|||
46956248|NCT03137381|83197017|FG001|Overall Study|Adverse Event|0|||
46956249|NCT03137381|83197018|FG002|Overall Study|Adverse Event|2|||
46956250|NCT03137381|83197019|FG003|Overall Study|Adverse Event|0|||
46956251|NCT03137381|83197016|FG000|Overall Study|Lost to Follow-up|2|||
46956252|NCT03137381|83197017|FG001|Overall Study|Lost to Follow-up|1|||
46956253|NCT03137381|83197018|FG002|Overall Study|Lost to Follow-up|1|||
46956254|NCT03137381|83197019|FG003|Overall Study|Lost to Follow-up|0|||
46956255|NCT03137381|83197016|FG000|Overall Study|Protocol deviation|1|||
46956256|NCT03137381|83197017|FG001|Overall Study|Protocol deviation|1|||
46956257|NCT03137381|83197018|FG002|Overall Study|Protocol deviation|0|||
46956258|NCT03137381|83197019|FG003|Overall Study|Protocol deviation|1|||
46956259|NCT03137381|83197016|FG000|Overall Study|Withdrawal by Investigator|0|||
46956260|NCT03137381|83197017|FG001|Overall Study|Withdrawal by Investigator|1|||
46956261|NCT03137381|83197018|FG002|Overall Study|Withdrawal by Investigator|1|||
46956262|NCT03137381|83197019|FG003|Overall Study|Withdrawal by Investigator|0|||
46956263|NCT03137381|83197016|FG000|Overall Study|Withdrawal by Subject|3|||
46956264|NCT03137381|83197017|FG001|Overall Study|Withdrawal by Subject|4|||
46956265|NCT03137381|83197018|FG002|Overall Study|Withdrawal by Subject|3|||
46956266|NCT03137381|83197019|FG003|Overall Study|Withdrawal by Subject|0|||
46956267|NCT03137381|83197016|FG000|Overall Study|Pregnancy|0|||
46956268|NCT03137381|83197017|FG001|Overall Study|Pregnancy|0|||
46956269|NCT03137381|83197018|FG002|Overall Study|Pregnancy|1|||
46956270|NCT03137381|83197019|FG003|Overall Study|Pregnancy|0|||
46956271|NCT03926117|83197033|FG000|Overall Study|Unclassified|1|||
46956272|NCT03926117|83197034|FG001|Overall Study|Unclassified|4|||
46956273|NCT03926117|83197035|FG002|Overall Study|Unclassified|1|||
46956274|NCT03926117|83197036|FG003|Overall Study|Unclassified|4|||
46956275|NCT03926117|83197033|FG000|Overall Study|Withdrawal by Subject|3|||
46956276|NCT03926117|83197034|FG001|Overall Study|Withdrawal by Subject|0|||
46956277|NCT03926117|83197035|FG002|Overall Study|Withdrawal by Subject|1|||
46956278|NCT03926117|83197036|FG003|Overall Study|Withdrawal by Subject|1|||
46956279|NCT03926117|83197033|FG000|Overall Study|Lost to Follow-up|0|||
46956280|NCT03926117|83197034|FG001|Overall Study|Lost to Follow-up|2|||
46956281|NCT03926117|83197035|FG002|Overall Study|Lost to Follow-up|1|||
46956282|NCT03926117|83197036|FG003|Overall Study|Lost to Follow-up|0|||
46956283|NCT03926117|83197033|FG000|Overall Study|Adverse Event|1|||
46956284|NCT03926117|83197034|FG001|Overall Study|Adverse Event|2|||
46956285|NCT03926117|83197035|FG002|Overall Study|Adverse Event|3|||
46956286|NCT03926117|83197036|FG003|Overall Study|Adverse Event|1|||
46956287|NCT03926117|83197033|FG000|Overall Study|Randomized but not treated|1|||
46956288|NCT03926117|83197034|FG001|Overall Study|Randomized but not treated|1|||
46956289|NCT03926117|83197035|FG002|Overall Study|Randomized but not treated|0|||
46956290|NCT03926117|83197036|FG003|Overall Study|Randomized but not treated|1|||
46956291|NCT02750501|83197063|FG000|Overall Study|Adverse Event|4|||
46956292|NCT02750501|83197063|FG000|Overall Study|Physician Decision|1|||
46956293|NCT02750501|83197063|FG000|Overall Study|Protocol Violation|1|||
46956294|NCT02750501|83197063|FG000|Overall Study|G-tube came out|1|||
46956295|NCT02750501|83197063|FG000|Overall Study|Non-compliant use of PERT|1|||
46956296|NCT01337297|83197086|FG000|Overall Study|They entered to single anodal tDCS|4|||
46956297|NCT01337297|83197087|FG001|Overall Study|They entered to single anodal tDCS|3|||
46956298|NCT01337297|83197086|FG000|Overall Study|Lost to Follow-up|1|||
46956299|NCT01337297|83197087|FG001|Overall Study|Lost to Follow-up|3|||
46956300|NCT02302963|83197095|FG000|Overall Study|Withdrawal by Subject|2|||
46956301|NCT02302963|83197096|FG001|Overall Study|Withdrawal by Subject|1|||
46956302|NCT02302963|83197095|FG000|Overall Study|Steroid injection|0|||
46956303|NCT02302963|83197096|FG001|Overall Study|Steroid injection|1|||
46956304|NCT02302963|83197095|FG000|Overall Study|Physician Decision|1|||
46956305|NCT02302963|83197096|FG001|Overall Study|Physician Decision|0|||
46956306|NCT03507439|83197117|FG000|Overall Study|Other|2|||
46956307|NCT03507439|83197118|FG001|Overall Study|Other|1|||
46956308|NCT03507439|83197117|FG000|Overall Study|Withdrawal by Subject|1|||
46956309|NCT03507439|83197118|FG001|Overall Study|Withdrawal by Subject|0|||
46773272|NCT00789035|82991596|FG001|Overall Study|Lack of Efficacy|0|||
46773273|NCT00789035|82991597|FG002|Overall Study|Lack of Efficacy|0|||
46773274|NCT00789035|82991598|FG003|Overall Study|Lack of Efficacy|0|||
46773275|NCT00789035|82991599|FG004|Overall Study|Lack of Efficacy|2|||
46773276|NCT00789035|82991595|FG000|Overall Study|Protocol Violation|1|||
46773277|NCT00789035|82991596|FG001|Overall Study|Protocol Violation|0|||
46773278|NCT00789035|82991597|FG002|Overall Study|Protocol Violation|0|||
46773279|NCT00789035|82991598|FG003|Overall Study|Protocol Violation|0|||
46956310|NCT03507439|83197117|FG000|Overall Study|Death|1|||
46956311|NCT03507439|83197118|FG001|Overall Study|Death|1|||
46956312|NCT03507127|83197126|FG000|Overall Study|Withdrawal by Subject|1|||
46956313|NCT03507127|83197127|FG001|Overall Study|Withdrawal by Subject|0|||
46956314|NCT03507127|83197126|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
46956315|NCT03507127|83197127|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
46956316|NCT02322190|83197150|FG000|Overall Study|Death on study|1|||
46956317|NCT02322190|83197151|FG001|Overall Study|Death on study|0|||
46956318|NCT02321800|83197167|FG000|Overall Study|Withdrawal by Subject|3|||
46956319|NCT02321800|83197168|FG001|Overall Study|Withdrawal by Subject|3|||
46956320|NCT02321800|83197167|FG000|Overall Study|Death|1|||
46956321|NCT02321800|83197168|FG001|Overall Study|Death|0|||
46956322|NCT02321800|83197167|FG000|Overall Study|Protocol Violation|1|||
46956323|NCT02321800|83197168|FG001|Overall Study|Protocol Violation|0|||
46956324|NCT02321800|83197167|FG000|Overall Study|Lost to Follow-up|10|||
46956325|NCT02321800|83197168|FG001|Overall Study|Lost to Follow-up|4|||
46956326|NCT02321800|83197167|FG000|Overall Study|Adverse Event|2|||
46956327|NCT02321800|83197168|FG001|Overall Study|Adverse Event|3|||
46956328|NCT02321800|83197167|FG000|Overall Study|Other, Miscellaneous|3|||
46956329|NCT02321800|83197168|FG001|Overall Study|Other, Miscellaneous|1|||
46956330|NCT02292784|83197214|FG000|Overall Study|Lost to Follow-up|1|||
46956331|NCT02292784|83197215|FG001|Overall Study|Lost to Follow-up|17|||
46956332|NCT02292784|83197216|FG002|Overall Study|Lost to Follow-up|18|||
46956333|NCT02292784|83197214|FG000|Overall Study|Withdrawal by Subject|0|||
46956334|NCT02292784|83197215|FG001|Overall Study|Withdrawal by Subject|3|||
46956335|NCT02292784|83197216|FG002|Overall Study|Withdrawal by Subject|3|||
46956336|NCT02320396|83197226|FG000|Overall Study|Adverse Event|2|||
46956337|NCT02320396|83197227|FG001|Overall Study|Adverse Event|2|||
46956338|NCT02320396|83197226|FG000|Overall Study|Pregnancy|0|||
46956339|NCT02320396|83197227|FG001|Overall Study|Pregnancy|1|||
46956340|NCT02320396|83197226|FG000|Overall Study|Protocol Violation|0|||
46956341|NCT02320396|83197227|FG001|Overall Study|Protocol Violation|1|||
46844347|NCT00197028|83061187|FG001|Overall Study|Adverse Event|2|||
46844348|NCT00197028|83061186|FG000|Overall Study|Protocol Violation|2|||
46844349|NCT00197028|83061187|FG001|Overall Study|Protocol Violation|1|||
46844350|NCT00197028|83061186|FG000|Overall Study|Withdrawal by Subject|8|||
46844351|NCT00197028|83061187|FG001|Overall Study|Withdrawal by Subject|12|||
46844352|NCT00197028|83061186|FG000|Overall Study|Lost to Follow-up|1|||
46844353|NCT00197028|83061187|FG001|Overall Study|Lost to Follow-up|0|||
46844354|NCT00197028|83061186|FG000|Overall Study|Other|3|||
46844355|NCT00197028|83061187|FG001|Overall Study|Other|6|||
46844356|NCT00420641|83061196|FG000|Overall Study|Adverse Event|3|||
46844357|NCT00420641|83061197|FG001|Overall Study|Adverse Event|25|||
46844358|NCT00420641|83061198|FG002|Overall Study|Adverse Event|10|||
46956342|NCT02320396|83197226|FG000|Overall Study|Withdrawal by Subject|2|||
46956343|NCT02320396|83197227|FG001|Overall Study|Withdrawal by Subject|0|||
46956344|NCT02292238|83197235|FG000|Overall Study|Protocol Violation|1|||
46956345|NCT02292238|83197236|FG001|Overall Study|Protocol Violation|2|||
46956346|NCT02292238|83197235|FG000|Overall Study|Withdrawal by Subject|2|||
46956347|NCT02292238|83197236|FG001|Overall Study|Withdrawal by Subject|1|||
46956348|NCT02292238|83197235|FG000|Overall Study|Lost to Follow-up|1|||
46956349|NCT02292238|83197236|FG001|Overall Study|Lost to Follow-up|0|||
46956350|NCT02292238|83197235|FG000|Overall Study|Physician Decision|0|||
46956351|NCT02292238|83197236|FG001|Overall Study|Physician Decision|1|||
46956352|NCT02234843|83197273|FG000|Overall Study|Death|1|||
46956353|NCT02234843|83197274|FG001|Overall Study|Death|0|||
46956354|NCT02234843|83197275|FG002|Overall Study|Death|0|||
46639485|NCT01383096|82812989|FG001|Third Intervention (8 Days)|Elevated AST|1|||
46844359|NCT00420641|83061196|FG000|Overall Study|Lost to Follow-up|2|||
46844360|NCT00420641|83061197|FG001|Overall Study|Lost to Follow-up|4|||
46844361|NCT00420641|83061198|FG002|Overall Study|Lost to Follow-up|2|||
46844362|NCT00420641|83061196|FG000|Overall Study|Protocol Violation|8|||
46844363|NCT00420641|83061197|FG001|Overall Study|Protocol Violation|8|||
46956355|NCT02234843|83197276|FG003|Overall Study|Death|0|||
46956356|NCT02234843|83197277|FG004|Overall Study|Death|0|||
46956357|NCT02234843|83197278|FG005|Overall Study|Death|0|||
46956358|NCT02234843|83197279|FG006|Overall Study|Death|0|||
46956359|NCT02234843|83197280|FG007|Overall Study|Death|0|||
46956360|NCT02234843|83197281|FG008|Overall Study|Death|0|||
46639486|NCT01383096|82812990|FG002|Third Intervention (8 Days)|Elevated AST|0|||
46639487|NCT01383096|82812988|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
46639488|NCT01383096|82812989|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
46639489|NCT01383096|82812990|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
46956361|NCT02234843|83197282|FG009|Overall Study|Death|0|||
46956362|NCT02234843|83197273|FG000|Overall Study|Protocol Violation|1|||
46956363|NCT02234843|83197274|FG001|Overall Study|Protocol Violation|0|||
46844364|NCT00420641|83061198|FG002|Overall Study|Protocol Violation|7|||
46956364|NCT02234843|83197275|FG002|Overall Study|Protocol Violation|1|||
46956365|NCT02234843|83197276|FG003|Overall Study|Protocol Violation|0|||
46956366|NCT02234843|83197277|FG004|Overall Study|Protocol Violation|0|||
46956367|NCT02234843|83197278|FG005|Overall Study|Protocol Violation|0|||
46956368|NCT02234843|83197279|FG006|Overall Study|Protocol Violation|0|||
46956369|NCT02234843|83197280|FG007|Overall Study|Protocol Violation|0|||
46844365|NCT00420641|83061196|FG000|Overall Study|Withdrawal by Subject|15|||
46844366|NCT00420641|83061197|FG001|Overall Study|Withdrawal by Subject|21|||
46844367|NCT00420641|83061198|FG002|Overall Study|Withdrawal by Subject|14|||
46956370|NCT02234843|83197281|FG008|Overall Study|Protocol Violation|0|||
46956371|NCT02234843|83197282|FG009|Overall Study|Protocol Violation|0|||
46956372|NCT02234843|83197273|FG000|Overall Study|Efficacy outcome reached|2|||
46844368|NCT00420641|83061196|FG000|Overall Study|Lack of Efficacy|6|||
46844369|NCT00420641|83061197|FG001|Overall Study|Lack of Efficacy|5|||
46844370|NCT00420641|83061198|FG002|Overall Study|Lack of Efficacy|4|||
46844371|NCT00420641|83061196|FG000|Overall Study|Non-compliance|7|||
46844372|NCT00420641|83061197|FG001|Overall Study|Non-compliance|5|||
46844373|NCT00420641|83061198|FG002|Overall Study|Non-compliance|4|||
46844374|NCT00420641|83061196|FG000|Overall Study|Other|4|||
46844375|NCT00420641|83061197|FG001|Overall Study|Other|4|||
46844376|NCT00420641|83061198|FG002|Overall Study|Other|3|||
46844377|NCT00257556|83061208|FG000|Overall Study|Adverse Event|1|||
46844378|NCT00257556|83061209|FG001|Overall Study|Adverse Event|4|||
46844379|NCT00257556|83061208|FG000|Overall Study|Physician Decision|6|||
46844380|NCT00257556|83061209|FG001|Overall Study|Physician Decision|0|||
46844381|NCT00257556|83061208|FG000|Overall Study|Did not meet hCG criterion|3|||
46844382|NCT00257556|83061209|FG001|Overall Study|Did not meet hCG criterion|0|||
46844383|NCT00257556|83061208|FG000|Overall Study|other reason|4|||
46844384|NCT00257556|83061209|FG001|Overall Study|other reason|6|||
46844385|NCT00228384|83061217|FG000|Overall Study|Death|9|||
46844386|NCT00228384|83061218|FG001|Overall Study|Death|3|||
46844387|NCT00228384|83061217|FG000|Overall Study|Lost to Follow-up|6|||
46844388|NCT00228384|83061218|FG001|Overall Study|Lost to Follow-up|10|||
46844389|NCT00228384|83061217|FG000|Overall Study|Surgical Intervention (bypass)|5|||
46844390|NCT00228384|83061218|FG001|Overall Study|Surgical Intervention (bypass)|5|||
46844391|NCT00228384|83061217|FG000|Overall Study|Withdrawal by Subject|9|||
46844392|NCT00228384|83061218|FG001|Overall Study|Withdrawal by Subject|10|||
46844393|NCT00228384|83061217|FG000|Overall Study|Physician Decision|0|||
46844394|NCT00228384|83061218|FG001|Overall Study|Physician Decision|1|||
46844395|NCT00257166|83061226|FG000|Overall Study|Adverse Event|18|||
46956373|NCT02234843|83197274|FG001|Overall Study|Efficacy outcome reached|0|||
46956374|NCT02234843|83197275|FG002|Overall Study|Efficacy outcome reached|0|||
46844396|NCT00257166|83061227|FG001|Overall Study|Adverse Event|13|||
46844397|NCT00257166|83061226|FG000|Overall Study|Laboratory abnormality|1|||
46844398|NCT00257166|83061227|FG001|Overall Study|Laboratory abnormality|0|||
46844399|NCT00257166|83061226|FG000|Overall Study|Lost to Follow-up|8|||
46956375|NCT02234843|83197276|FG003|Overall Study|Efficacy outcome reached|0|||
46956376|NCT02234843|83197277|FG004|Overall Study|Efficacy outcome reached|0|||
46956377|NCT02234843|83197278|FG005|Overall Study|Efficacy outcome reached|2|||
46956378|NCT02234843|83197279|FG006|Overall Study|Efficacy outcome reached|0|||
46956379|NCT02234843|83197280|FG007|Overall Study|Efficacy outcome reached|0|||
46956380|NCT02234843|83197281|FG008|Overall Study|Efficacy outcome reached|0|||
46956381|NCT02234843|83197282|FG009|Overall Study|Efficacy outcome reached|0|||
46956382|NCT02234843|83197273|FG000|Overall Study|Patient convenience|2|||
46956383|NCT02234843|83197274|FG001|Overall Study|Patient convenience|0|||
46956384|NCT02234843|83197275|FG002|Overall Study|Patient convenience|0|||
46956385|NCT02234843|83197276|FG003|Overall Study|Patient convenience|0|||
46956386|NCT02234843|83197277|FG004|Overall Study|Patient convenience|0|||
46956387|NCT02234843|83197278|FG005|Overall Study|Patient convenience|1|||
46956388|NCT02234843|83197279|FG006|Overall Study|Patient convenience|0|||
46956389|NCT02234843|83197280|FG007|Overall Study|Patient convenience|0|||
46956390|NCT02234843|83197281|FG008|Overall Study|Patient convenience|0|||
46956391|NCT02234843|83197282|FG009|Overall Study|Patient convenience|0|||
46956392|NCT02234843|83197273|FG000|Overall Study|Withdrawal by Subject|5|||
46956393|NCT02234843|83197274|FG001|Overall Study|Withdrawal by Subject|1|||
46956394|NCT02234843|83197275|FG002|Overall Study|Withdrawal by Subject|1|||
46844400|NCT00257166|83061227|FG001|Overall Study|Lost to Follow-up|1|||
46844401|NCT00257166|83061226|FG000|Overall Study|Withdrawal by Subject|9|||
46844402|NCT00257166|83061227|FG001|Overall Study|Withdrawal by Subject|2|||
46844403|NCT00257166|83061226|FG000|Overall Study|Other|16|||
46844404|NCT00257166|83061227|FG001|Overall Study|Other|21|||
46844405|NCT00257166|83061226|FG000|Overall Study|Randomized, but not treated|1|||
46844406|NCT00257166|83061227|FG001|Overall Study|Randomized, but not treated|0|||
46844407|NCT00227370|83061235|FG000|Overall Study|Withdrawal by Subject|1|||
46844408|NCT00227370|83061236|FG001|Overall Study|Withdrawal by Subject|2|||
46956395|NCT02234843|83197276|FG003|Overall Study|Withdrawal by Subject|0|||
46956396|NCT02234843|83197277|FG004|Overall Study|Withdrawal by Subject|0|||
46844409|NCT00227370|83061235|FG000|Overall Study|Death|3|||
46844410|NCT00227370|83061236|FG001|Overall Study|Death|4|||
46844411|NCT00227370|83061235|FG000|Overall Study|Adverse Event|6|||
46844412|NCT00227370|83061236|FG001|Overall Study|Adverse Event|11|||
46956397|NCT02234843|83197278|FG005|Overall Study|Withdrawal by Subject|7|||
46956398|NCT02234843|83197279|FG006|Overall Study|Withdrawal by Subject|0|||
46956399|NCT02234843|83197280|FG007|Overall Study|Withdrawal by Subject|0|||
46844413|NCT00227370|83061235|FG000|Overall Study|Physician Decision|9|||
46844414|NCT00227370|83061236|FG001|Overall Study|Physician Decision|6|||
46844415|NCT00227370|83061235|FG000|Overall Study|Other reasons|2|||
46844416|NCT00227370|83061236|FG001|Overall Study|Other reasons|1|||
46844417|NCT00191100|83061244|FG000|Overall Study|Adverse Event|18|||
46844418|NCT00191100|83061245|FG001|Overall Study|Adverse Event|1|||
46844419|NCT00191100|83061244|FG000|Overall Study|Lost to Follow-up|2|||
46844420|NCT00191100|83061245|FG001|Overall Study|Lost to Follow-up|0|||
46844421|NCT00191100|83061244|FG000|Overall Study|Patient Moved|0|||
46844422|NCT00191100|83061245|FG001|Overall Study|Patient Moved|1|||
46844423|NCT00191100|83061244|FG000|Overall Study|Withdrawal by Subject|9|||
46844424|NCT00191100|83061245|FG001|Overall Study|Withdrawal by Subject|3|||
46844425|NCT00191100|83061244|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
46844426|NCT00191100|83061245|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
46844427|NCT00191100|83061244|FG000|Overall Study|Clinical Relapse|2|||
46844428|NCT00191100|83061245|FG001|Overall Study|Clinical Relapse|1|||
46844429|NCT00191100|83061244|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
46844430|NCT00191100|83061245|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
46844431|NCT00191100|83061244|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
46844432|NCT00191100|83061245|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
46844433|NCT00191100|83061244|FG000|Overall Study|Physician Decision|3|||
46844434|NCT00191100|83061245|FG001|Overall Study|Physician Decision|1|||
46844435|NCT00191100|83061244|FG000|Overall Study|Death from Study Drug Toxicity|2|||
46844436|NCT00191100|83061245|FG001|Overall Study|Death from Study Drug Toxicity|0|||
46844437|NCT00191100|83061244|FG000|Overall Study|Protocol Violation|1|||
46844438|NCT00191100|83061245|FG001|Overall Study|Protocol Violation|1|||
46844439|NCT00191100|83061244|FG000|Overall Study|Death from Other Cause|1|||
46844440|NCT00191100|83061245|FG001|Overall Study|Death from Other Cause|0|||
46844441|NCT00191100|83061244|FG000|Overall Study|Reason Not Specified|0|||
46639490|NCT01383096|82812988|FG000|Third Intervention (8 Days)|Adverse Event|1|||
46639491|NCT01383096|82812989|FG001|Third Intervention (8 Days)|Adverse Event|0|||
46639492|NCT01383096|82812990|FG002|Third Intervention (8 Days)|Adverse Event|0|||
46639493|NCT01383096|82812988|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
46956400|NCT02234843|83197281|FG008|Overall Study|Withdrawal by Subject|0|||
46956401|NCT02234843|83197282|FG009|Overall Study|Withdrawal by Subject|0|||
46956402|NCT02234843|83197273|FG000|Overall Study|Recovery|1|||
46956403|NCT02234843|83197274|FG001|Overall Study|Recovery|0|||
46956404|NCT02234843|83197275|FG002|Overall Study|Recovery|0|||
46956405|NCT02234843|83197276|FG003|Overall Study|Recovery|0|||
46956406|NCT02234843|83197277|FG004|Overall Study|Recovery|0|||
46956407|NCT02234843|83197278|FG005|Overall Study|Recovery|0|||
46956408|NCT02234843|83197279|FG006|Overall Study|Recovery|0|||
46956409|NCT02234843|83197280|FG007|Overall Study|Recovery|0|||
46956410|NCT02234843|83197281|FG008|Overall Study|Recovery|0|||
46956411|NCT02234843|83197282|FG009|Overall Study|Recovery|0|||
46639494|NCT01383096|82812989|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
46639495|NCT01383096|82812990|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
46639496|NCT01383096|82812988|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
46639497|NCT01383096|82812989|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
46844442|NCT00191100|83061245|FG001|Overall Study|Reason Not Specified|1|||
46844443|NCT00189540|83061253|FG000|Overall Study|Withdrawal by Subject|3|||
46844444|NCT00189540|83061254|FG001|Overall Study|Withdrawal by Subject|0|||
46844445|NCT00189540|83061253|FG000|Overall Study|Death|4|||
46844446|NCT00189540|83061254|FG001|Overall Study|Death|1|||
46844447|NCT00257010|83061260|FG000|Overall Study|Lack of Efficacy|11|||
46844448|NCT00257010|83061260|FG000|Overall Study|Lost to Follow-up|53|||
46844449|NCT00257010|83061260|FG000|Overall Study|Withdrawal by Subject|34|||
46844450|NCT00257010|83061260|FG000|Overall Study|Adverse Event|10|||
46844451|NCT00257010|83061260|FG000|Overall Study|various|11|||
46844452|NCT00257010|83061260|FG000|Overall Study|no headache reported|9|||
46844453|NCT00256854|83061270|FG000|Overall Study|Withdrawal by Subject|2|||
46844454|NCT00256854|83061271|FG001|Overall Study|Withdrawal by Subject|3|||
46844455|NCT00256854|83061272|FG002|Overall Study|Withdrawal by Subject|0|||
46844456|NCT00256854|83061273|FG003|Overall Study|Withdrawal by Subject|0|||
46844457|NCT00256854|83061274|FG004|Overall Study|Withdrawal by Subject|0|||
46844458|NCT00256854|83061275|FG005|Overall Study|Withdrawal by Subject|0|||
46844459|NCT00256854|83061270|FG000|Overall Study|Lack of Efficacy|1|||
46844460|NCT00256854|83061271|FG001|Overall Study|Lack of Efficacy|0|||
46844461|NCT00256854|83061272|FG002|Overall Study|Lack of Efficacy|0|||
46844462|NCT00256854|83061273|FG003|Overall Study|Lack of Efficacy|0|||
46844463|NCT00256854|83061274|FG004|Overall Study|Lack of Efficacy|0|||
46844464|NCT00256854|83061275|FG005|Overall Study|Lack of Efficacy|0|||
46844465|NCT00256854|83061270|FG000|Overall Study|Protocol Violation|0|||
46844466|NCT00256854|83061271|FG001|Overall Study|Protocol Violation|1|||
46844467|NCT00256854|83061272|FG002|Overall Study|Protocol Violation|1|||
46844468|NCT00256854|83061273|FG003|Overall Study|Protocol Violation|1|||
46844469|NCT00256854|83061274|FG004|Overall Study|Protocol Violation|0|||
46956412|NCT02234843|83197273|FG000|Overall Study|Other|0|||
46639498|NCT01383096|82812990|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
46844470|NCT00256854|83061275|FG005|Overall Study|Protocol Violation|0|||
46956413|NCT02234843|83197274|FG001|Overall Study|Other|2|||
46956414|NCT02234843|83197275|FG002|Overall Study|Other|0|||
46844471|NCT00256854|83061270|FG000|Overall Study|Adverse Event|0|||
46844472|NCT00256854|83061271|FG001|Overall Study|Adverse Event|0|||
46956415|NCT02234843|83197276|FG003|Overall Study|Other|1|||
46844473|NCT00256854|83061272|FG002|Overall Study|Adverse Event|2|||
46844474|NCT00256854|83061273|FG003|Overall Study|Adverse Event|2|||
46844475|NCT00256854|83061274|FG004|Overall Study|Adverse Event|0|||
46844476|NCT00256854|83061275|FG005|Overall Study|Adverse Event|1|||
46844477|NCT00256854|83061270|FG000|Overall Study|Not compliant with the study drug|0|||
46844478|NCT00256854|83061271|FG001|Overall Study|Not compliant with the study drug|0|||
46956416|NCT02234843|83197277|FG004|Overall Study|Other|0|||
46956417|NCT02234843|83197278|FG005|Overall Study|Other|1|||
46956418|NCT02234843|83197279|FG006|Overall Study|Other|0|||
46956419|NCT02234843|83197280|FG007|Overall Study|Other|1|||
46956420|NCT02234843|83197281|FG008|Overall Study|Other|0|||
46956421|NCT02234843|83197282|FG009|Overall Study|Other|0|||
46844479|NCT00256854|83061272|FG002|Overall Study|Not compliant with the study drug|0|||
46844480|NCT00256854|83061273|FG003|Overall Study|Not compliant with the study drug|0|||
46844481|NCT00256854|83061274|FG004|Overall Study|Not compliant with the study drug|1|||
46956422|NCT02234843|83197273|FG000|Overall Study|Physician Decision|4|||
46956423|NCT02234843|83197274|FG001|Overall Study|Physician Decision|1|||
46773280|NCT00789035|82991599|FG004|Overall Study|Protocol Violation|0|||
46773281|NCT00789035|82991595|FG000|Overall Study|Withdrawal by Subject|0|||
46773282|NCT00789035|82991596|FG001|Overall Study|Withdrawal by Subject|2|||
46773283|NCT00789035|82991597|FG002|Overall Study|Withdrawal by Subject|0|||
46773284|NCT00789035|82991598|FG003|Overall Study|Withdrawal by Subject|0|||
46773285|NCT00789035|82991599|FG004|Overall Study|Withdrawal by Subject|0|||
46844482|NCT00256854|83061275|FG005|Overall Study|Not compliant with the study drug|0|||
46844483|NCT00189462|83061292|FG000|Overall Study|Lack of Efficacy|5|||
46844484|NCT00189462|83061293|FG001|Overall Study|Lack of Efficacy|1|||
46844485|NCT00189462|83061292|FG000|Overall Study|Lost to Follow-up|18|||
46844486|NCT00189462|83061293|FG001|Overall Study|Lost to Follow-up|20|||
46844487|NCT00256698|83061301|FG000|Overall Study|Withdrawal by Subject|7|||
46844488|NCT00256698|83061302|FG001|Overall Study|Withdrawal by Subject|7|||
46844489|NCT00256698|83061301|FG000|Overall Study|Adverse Event|13|||
46844490|NCT00256698|83061302|FG001|Overall Study|Adverse Event|6|||
46773286|NCT00789035|82991595|FG000|Overall Study|Other reason not defined above|2|||
46773287|NCT00789035|82991596|FG001|Overall Study|Other reason not defined above|3|||
46773288|NCT00789035|82991597|FG002|Overall Study|Other reason not defined above|1|||
46773289|NCT00789035|82991598|FG003|Overall Study|Other reason not defined above|0|||
46773290|NCT00789035|82991599|FG004|Overall Study|Other reason not defined above|1|||
46773291|NCT03326193|82991623|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
46773292|NCT03326193|82991623|FG000|Overall Study|Death|19|||
46773293|NCT03326193|82991623|FG000|Overall Study|Withdrawal by Subject|8|||
46773294|NCT00437203|82991646|FG000|Overall Study|Death|0|||
46773295|NCT00437203|82991647|FG001|Overall Study|Death|0|||
46773296|NCT00437203|82991648|FG002|Overall Study|Death|1|||
46773297|NCT00437203|82991649|FG003|Overall Study|Death|0|||
46773298|NCT00437203|82991650|FG004|Overall Study|Death|0|||
46773299|NCT00437203|82991651|FG005|Overall Study|Death|0|||
46773300|NCT00437203|82991652|FG006|Overall Study|Death|0|||
46773301|NCT00437203|82991653|FG007|Overall Study|Death|1|||
46773302|NCT00437203|82991654|FG008|Overall Study|Death|0|||
46844491|NCT00256698|83061301|FG000|Overall Study|Protocol Violation|6|||
46844492|NCT00256698|83061302|FG001|Overall Study|Protocol Violation|5|||
46844493|NCT00256698|83061301|FG000|Overall Study|Lost to Follow-up|1|||
46844494|NCT00256698|83061302|FG001|Overall Study|Lost to Follow-up|3|||
46956424|NCT02234843|83197275|FG002|Overall Study|Physician Decision|0|||
46956425|NCT02234843|83197276|FG003|Overall Study|Physician Decision|1|||
46956426|NCT02234843|83197277|FG004|Overall Study|Physician Decision|0|||
46956427|NCT02234843|83197278|FG005|Overall Study|Physician Decision|0|||
46773303|NCT00437203|82991655|FG009|Overall Study|Death|1|||
46773304|NCT00437203|82991646|FG000|Overall Study|Adverse Event|1|||
46844495|NCT00256698|83061301|FG000|Overall Study|disease progression|97|||
46844496|NCT00256698|83061302|FG001|Overall Study|disease progression|105|||
46773305|NCT00437203|82991647|FG001|Overall Study|Adverse Event|1|||
46773306|NCT00437203|82991648|FG002|Overall Study|Adverse Event|0|||
46844497|NCT00256698|83061301|FG000|Overall Study|still ongoing at data cut-off|41|||
46844498|NCT00256698|83061302|FG001|Overall Study|still ongoing at data cut-off|46|||
46844499|NCT00256698|83061301|FG000|Overall Study|withdrawn due to osteoporosis|1|||
46773307|NCT00437203|82991649|FG003|Overall Study|Adverse Event|0|||
46844500|NCT00256698|83061302|FG001|Overall Study|withdrawn due to osteoporosis|0|||
46956428|NCT02234843|83197279|FG006|Overall Study|Physician Decision|0|||
46956429|NCT02234843|83197280|FG007|Overall Study|Physician Decision|1|||
46956430|NCT02234843|83197281|FG008|Overall Study|Physician Decision|0|||
46773308|NCT00437203|82991650|FG004|Overall Study|Adverse Event|0|||
46773309|NCT00437203|82991651|FG005|Overall Study|Adverse Event|0|||
46773310|NCT00437203|82991652|FG006|Overall Study|Adverse Event|0|||
46773311|NCT00437203|82991653|FG007|Overall Study|Adverse Event|1|||
46844501|NCT00256698|83061301|FG000|Overall Study|Prematurely Discontinued|1|||
46956431|NCT02234843|83197282|FG009|Overall Study|Physician Decision|0|||
47066915|NCT01446913|83349908|FG001|Overall Study|Withdrawal by Subject|3|||
46773312|NCT00437203|82991654|FG008|Overall Study|Adverse Event|0|||
46956432|NCT02234843|83197273|FG000|Overall Study|Adverse Event|5|||
46956433|NCT02234843|83197274|FG001|Overall Study|Adverse Event|1|||
46956434|NCT02234843|83197275|FG002|Overall Study|Adverse Event|1|||
46956435|NCT02234843|83197276|FG003|Overall Study|Adverse Event|3|||
46956436|NCT02234843|83197277|FG004|Overall Study|Adverse Event|2|||
46956437|NCT02234843|83197278|FG005|Overall Study|Adverse Event|1|||
46956438|NCT02234843|83197279|FG006|Overall Study|Adverse Event|0|||
46956439|NCT02234843|83197280|FG007|Overall Study|Adverse Event|0|||
46956440|NCT02234843|83197281|FG008|Overall Study|Adverse Event|1|||
46956441|NCT02234843|83197282|FG009|Overall Study|Adverse Event|0|||
46956442|NCT02234843|83197273|FG000|Overall Study|Non-compliance with study drug|1|||
46956443|NCT02234843|83197274|FG001|Overall Study|Non-compliance with study drug|0|||
46956444|NCT02234843|83197275|FG002|Overall Study|Non-compliance with study drug|0|||
46956445|NCT02234843|83197276|FG003|Overall Study|Non-compliance with study drug|0|||
46956446|NCT02234843|83197277|FG004|Overall Study|Non-compliance with study drug|0|||
46956447|NCT02234843|83197278|FG005|Overall Study|Non-compliance with study drug|1|||
46956448|NCT02234843|83197279|FG006|Overall Study|Non-compliance with study drug|1|||
46844502|NCT00256698|83061302|FG001|Overall Study|Prematurely Discontinued|0|||
46844503|NCT00189306|83061308|FG000|Treatment Period|Withdrawal by Subject|2|||
46844504|NCT00189306|83061308|FG000|Treatment Period|Adverse Event|2|||
46844505|NCT00189306|83061308|FG000|Treatment Period|Protocol Violation|1|||
46844506|NCT00189306|83061308|FG000|Posttreatment Period|Death|1|||
46844507|NCT00189306|83061308|FG000|Posttreatment Period|Withdrawal by Subject|2|||
46844508|NCT00189306|83061308|FG000|Posttreatment Period|Noncompliance|1|||
46844509|NCT00189306|83061308|FG000|Posttreatment Period|Target lesion excised|1|||
46844510|NCT00189306|83061308|FG000|Posttreatment Period|Protocol Violation|1|||
46844511|NCT00189306|83061308|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
46844512|NCT00189306|83061308|FG000|Posttreatment Period|Local skin reaction/sign|1|||
46844513|NCT00189306|83061308|FG000|Long-Term Follow-up|Adverse Event|2|||
46844514|NCT00189306|83061308|FG000|Long-Term Follow-up|Death|4|||
46844515|NCT00189306|83061308|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
46844516|NCT00189306|83061308|FG000|Long-Term Follow-up|Intercurrent disease|2|||
46844517|NCT00189306|83061308|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
46844518|NCT00189306|83061308|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
46844519|NCT00187278|83061314|FG000|Overall Study|Protocol Violation|10|||
46844520|NCT00187278|83061315|FG001|Overall Study|Protocol Violation|13|||
46844521|NCT00256308|83061323|FG000|Overall Study|Death|2|||
46956449|NCT02234843|83197280|FG007|Overall Study|Non-compliance with study drug|0|||
46956450|NCT02234843|83197281|FG008|Overall Study|Non-compliance with study drug|0|||
46956451|NCT02234843|83197282|FG009|Overall Study|Non-compliance with study drug|0|||
46956452|NCT02234843|83197273|FG000|Overall Study|Lost to Follow-up|0|||
46956453|NCT02234843|83197274|FG001|Overall Study|Lost to Follow-up|1|||
46956454|NCT02234843|83197275|FG002|Overall Study|Lost to Follow-up|0|||
46956455|NCT02234843|83197276|FG003|Overall Study|Lost to Follow-up|0|||
47066916|NCT01446913|83349909|FG002|Overall Study|Withdrawal by Subject|5|||
47066917|NCT01446913|83349907|FG000|Overall Study|Physician Decision|0|||
46773313|NCT00437203|82991655|FG009|Overall Study|Adverse Event|1|||
46773314|NCT00437203|82991646|FG000|Overall Study|Study terminated by sponsor|0|||
46773315|NCT00437203|82991647|FG001|Overall Study|Study terminated by sponsor|0|||
46773316|NCT00437203|82991648|FG002|Overall Study|Study terminated by sponsor|0|||
46773317|NCT00437203|82991649|FG003|Overall Study|Study terminated by sponsor|0|||
46773318|NCT00437203|82991650|FG004|Overall Study|Study terminated by sponsor|0|||
46773319|NCT00437203|82991651|FG005|Overall Study|Study terminated by sponsor|0|||
46773320|NCT00437203|82991652|FG006|Overall Study|Study terminated by sponsor|0|||
46773321|NCT00437203|82991653|FG007|Overall Study|Study terminated by sponsor|0|||
46773322|NCT00437203|82991654|FG008|Overall Study|Study terminated by sponsor|1|||
46773323|NCT00437203|82991655|FG009|Overall Study|Study terminated by sponsor|0|||
46773324|NCT00437203|82991646|FG000|Overall Study|Objective progression or relapse|5|||
46773325|NCT00437203|82991647|FG001|Overall Study|Objective progression or relapse|6|||
46773326|NCT00437203|82991648|FG002|Overall Study|Objective progression or relapse|2|||
46773327|NCT00437203|82991649|FG003|Overall Study|Objective progression or relapse|3|||
46773328|NCT00437203|82991650|FG004|Overall Study|Objective progression or relapse|3|||
46773329|NCT00437203|82991651|FG005|Overall Study|Objective progression or relapse|3|||
46773330|NCT00437203|82991652|FG006|Overall Study|Objective progression or relapse|6|||
46773331|NCT00437203|82991653|FG007|Overall Study|Objective progression or relapse|1|||
46773332|NCT00437203|82991654|FG008|Overall Study|Objective progression or relapse|2|||
46773333|NCT00437203|82991655|FG009|Overall Study|Objective progression or relapse|2|||
46773334|NCT00437203|82991646|FG000|Overall Study|Other|0|||
46773335|NCT00437203|82991647|FG001|Overall Study|Other|1|||
46773336|NCT00437203|82991648|FG002|Overall Study|Other|0|||
46773337|NCT00437203|82991649|FG003|Overall Study|Other|0|||
46773338|NCT00437203|82991650|FG004|Overall Study|Other|0|||
46773339|NCT00437203|82991651|FG005|Overall Study|Other|0|||
46773340|NCT00437203|82991652|FG006|Overall Study|Other|1|||
46956456|NCT02234843|83197277|FG004|Overall Study|Lost to Follow-up|0|||
46844522|NCT00255840|83061329|FG000|Overall Study|Lost to Follow-up|10|||
47066918|NCT01446913|83349908|FG001|Overall Study|Physician Decision|0|||
47066919|NCT01446913|83349909|FG002|Overall Study|Physician Decision|2|||
47066920|NCT01446913|83349907|FG000|Overall Study|Lost to Follow-up|3|||
47066921|NCT01446913|83349908|FG001|Overall Study|Lost to Follow-up|5|||
47066922|NCT01446913|83349909|FG002|Overall Study|Lost to Follow-up|3|||
47066923|NCT01420549|83349940|FG000|Overall Study|Adverse Event|1|||
47066924|NCT01420549|83349941|FG001|Overall Study|Adverse Event|1|||
47066925|NCT01420549|83349940|FG000|Overall Study|Lost to Follow-up|2|||
47066926|NCT01420549|83349941|FG001|Overall Study|Lost to Follow-up|2|||
47066927|NCT01420549|83349940|FG000|Overall Study|Protocol Violation|0|||
47066928|NCT01420549|83349941|FG001|Overall Study|Protocol Violation|1|||
46956457|NCT02234843|83197278|FG005|Overall Study|Lost to Follow-up|0|||
46956458|NCT02234843|83197279|FG006|Overall Study|Lost to Follow-up|1|||
46956459|NCT02234843|83197280|FG007|Overall Study|Lost to Follow-up|0|||
46956460|NCT02234843|83197281|FG008|Overall Study|Lost to Follow-up|0|||
46956461|NCT02234843|83197282|FG009|Overall Study|Lost to Follow-up|0|||
46956462|NCT02740231|83197319|FG000|Overall Study|Withdrawal by Subject|1|||
46956463|NCT02740231|83197320|FG001|Overall Study|Withdrawal by Subject|1|||
46956464|NCT02740231|83197321|FG002|Overall Study|Withdrawal by Subject|1|||
46773341|NCT00437203|82991653|FG007|Overall Study|Other|0|||
46773342|NCT00437203|82991654|FG008|Overall Study|Other|0|||
46773343|NCT00437203|82991655|FG009|Overall Study|Other|0|||
46773344|NCT00753272|82991688|FG000|Overall Study|Adverse Event|878|||
46773345|NCT00753272|82991689|FG001|Overall Study|Adverse Event|869|||
46773346|NCT00753272|82991688|FG000|Overall Study|Protocol Violation|28|||
46773347|NCT00753272|82991689|FG001|Overall Study|Protocol Violation|46|||
46773348|NCT00753272|82991688|FG000|Overall Study|Withdrawal by Subject|2481|||
46773349|NCT00753272|82991689|FG001|Overall Study|Withdrawal by Subject|2407|||
47066929|NCT01420549|83349940|FG000|Overall Study|Non-adherence to medication|4|||
47066930|NCT01420549|83349941|FG001|Overall Study|Non-adherence to medication|1|||
46956465|NCT02740231|83197322|FG003|Overall Study|Withdrawal by Subject|0|||
46956466|NCT02740231|83197319|FG000|Overall Study|Lack of Efficacy|0|||
46956467|NCT02740231|83197320|FG001|Overall Study|Lack of Efficacy|1|||
46956468|NCT02740231|83197321|FG002|Overall Study|Lack of Efficacy|0|||
46956469|NCT02740231|83197322|FG003|Overall Study|Lack of Efficacy|4|||
47066931|NCT01440595|83349962|FG000|Overall Study|Lost to Follow-up|0|||
47066932|NCT01440595|83349963|FG001|Overall Study|Lost to Follow-up|1|||
46639499|NCT01383096|82812988|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
46639500|NCT01383096|82812989|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
46639501|NCT01383096|82812990|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
46639502|NCT01383096|82812988|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
46639503|NCT01383096|82812989|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
46639504|NCT01383096|82812990|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
46639505|NCT01383096|82812988|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
46639506|NCT01383096|82812989|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
46639507|NCT01383096|82812990|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
46639508|NCT01383096|82812988|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
46639509|NCT01383096|82812989|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
46639510|NCT01383096|82812990|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
46639511|NCT01383018|82813031|FG000|Overall Study|Adverse Event|14|||
46639512|NCT01383018|82813031|FG000|Overall Study|Death|10|||
46639513|NCT01383018|82813031|FG000|Overall Study|Lost to Follow-up|5|||
46639514|NCT01383018|82813031|FG000|Overall Study|Physician Decision|5|||
46639515|NCT01383018|82813031|FG000|Overall Study|Withdrawal by Subject|9|||
46639516|NCT01383018|82813031|FG000|Overall Study|Subject not implanted|76|||
46639517|NCT01383018|82813031|FG000|Overall Study|Missed Visit|247|||
46639518|NCT01383018|82813031|FG000|Overall Study|Site closed early-not compliance related|7|||
46639519|NCT01383018|82813031|FG000|Overall Study|Patient moved away from site|1|||
46639520|NCT01383018|82813031|FG000|Overall Study|Subject Incarcerated|1|||
46639521|NCT01382940|82813045|FG000|Overall Study|Adverse Event|19|||
46639522|NCT01382940|82813045|FG000|Overall Study|Lost to Follow-up|4|||
46639523|NCT01382940|82813045|FG000|Overall Study|Physician Decision|7|||
46639524|NCT01382940|82813045|FG000|Overall Study|Withdrawal by Subject|23|||
46773350|NCT00753272|82991688|FG000|Overall Study|Lost to Follow-up|491|||
46956470|NCT02740231|83197319|FG000|Overall Study|Lost to Follow-up|1|||
46956471|NCT02740231|83197320|FG001|Overall Study|Lost to Follow-up|3|||
47066933|NCT01440595|83349964|FG002|Overall Study|Lost to Follow-up|0|||
46639525|NCT01382940|82813045|FG000|Overall Study|Protocol Violation|20|||
46773351|NCT00753272|82991689|FG001|Overall Study|Lost to Follow-up|497|||
46773352|NCT00753272|82991688|FG000|Overall Study|Other|1104|||
46956472|NCT02740231|83197321|FG002|Overall Study|Lost to Follow-up|0|||
47066934|NCT01440595|83349962|FG000|Overall Study|Study terminated by sponsor.|1|||
46956473|NCT02740231|83197322|FG003|Overall Study|Lost to Follow-up|3|||
47066935|NCT01440595|83349963|FG001|Overall Study|Study terminated by sponsor.|2|||
46956474|NCT02740231|83197319|FG000|Overall Study|Adverse Event|0|||
46956475|NCT02740231|83197320|FG001|Overall Study|Adverse Event|1|||
46956476|NCT02740231|83197321|FG002|Overall Study|Adverse Event|0|||
46956477|NCT02740231|83197322|FG003|Overall Study|Adverse Event|1|||
46956478|NCT02750345|83197332|FG000|Intervention 1|Adverse Event|0|||
46956479|NCT02750345|83197333|FG001|Intervention 1|Adverse Event|0|||
46956480|NCT02750345|83197334|FG002|Intervention 1|Adverse Event|0|||
46956481|NCT02750345|83197335|FG003|Intervention 1|Adverse Event|0|||
46956482|NCT02750345|83197336|FG004|Intervention 1|Adverse Event|1|||
47066936|NCT01440595|83349964|FG002|Overall Study|Study terminated by sponsor.|1|||
46956483|NCT02750345|83197337|FG005|Intervention 1|Adverse Event|0|||
46956484|NCT02640625|83197347|FG000|Overall Study|Adverse Event|1|||
46956485|NCT01329263|83197354|FG000|Overall Study|Lost to Follow-up|4|||
46956486|NCT01329263|83197355|FG001|Overall Study|Lost to Follow-up|21|||
46956487|NCT01329263|83197354|FG000|Overall Study|Withdrawal by Subject|1|||
46956488|NCT01329263|83197355|FG001|Overall Study|Withdrawal by Subject|2|||
46956489|NCT02474329|83197363|FG000|Overall Study|Withdraw or did not contribute data.|13|||
46956490|NCT01388491|83197370|FG000|Overall Study|Adverse Event|10|||
46956491|NCT01388491|83197371|FG001|Overall Study|Adverse Event|9|||
46956492|NCT01388491|83197370|FG000|Overall Study|Sponsor Request|9|||
46956493|NCT01388491|83197371|FG001|Overall Study|Sponsor Request|7|||
46956494|NCT01388491|83197370|FG000|Overall Study|Withdrawal by Subject|6|||
46956495|NCT01388491|83197371|FG001|Overall Study|Withdrawal by Subject|10|||
46956496|NCT01388491|83197370|FG000|Overall Study|Lost to Follow-up|4|||
46956497|NCT01388491|83197371|FG001|Overall Study|Lost to Follow-up|3|||
46956498|NCT01388491|83197370|FG000|Overall Study|Protocol Violation|2|||
46956499|NCT01388491|83197371|FG001|Overall Study|Protocol Violation|0|||
46956500|NCT01388491|83197370|FG000|Overall Study|Noncompliance|2|||
46956501|NCT01388491|83197371|FG001|Overall Study|Noncompliance|0|||
46956502|NCT01388491|83197370|FG000|Overall Study|Pregnancy|1|||
46956503|NCT01388491|83197371|FG001|Overall Study|Pregnancy|0|||
46956504|NCT03253393|83197380|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
46956505|NCT03253393|83197381|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
46956506|NCT03253393|83197382|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
46956507|NCT03128671|83197398|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
46956508|NCT03128671|83197399|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
46956509|NCT03128671|83197398|FG000|Allocation|Death|1|||
46956510|NCT03128671|83197399|FG001|Allocation|Death|0|||
46956511|NCT03128671|83197398|FG000|Allocation|Withdrawal by Subject|4|||
46956512|NCT03128671|83197399|FG001|Allocation|Withdrawal by Subject|0|||
46956513|NCT03128671|83197398|FG000|Intervention|Withdrawal by Subject|11|||
46956514|NCT03128671|83197399|FG001|Intervention|Withdrawal by Subject|10|||
46956515|NCT03128671|83197398|FG000|Intervention|Palliative/hospice care initiated|9|||
47066937|NCT01440517|83349970|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
47066938|NCT01440283|83349974|FG000|Overall Study|Death|3|||
47066939|NCT01440283|83349974|FG000|Overall Study|Withdrawal by Subject|4|||
47066940|NCT01440283|83349974|FG000|Overall Study|Physician Decision|3|||
47066941|NCT01440049|83349984|FG000|Overall Study|Adverse Event|5|||
47066942|NCT01439971|83350045|FG000|Overall Study|Required number in cohort dosed|0|||
47066943|NCT01439971|83350046|FG001|Overall Study|Required number in cohort dosed|1|||
47066944|NCT01439971|83350047|FG002|Overall Study|Required number in cohort dosed|2|||
47066945|NCT01439971|83350048|FG003|Overall Study|Required number in cohort dosed|0|||
47066946|NCT01439971|83350049|FG004|Overall Study|Required number in cohort dosed|1|||
46773353|NCT00753272|82991689|FG001|Overall Study|Other|1088|||
46773354|NCT00437125|82991698|FG000|Overall Study|Adverse Event|12|||
46773355|NCT00437125|82991698|FG000|Overall Study|Death|1|||
46773356|NCT00437125|82991698|FG000|Overall Study|Clinical Relapse|1|||
46773357|NCT00437125|82991698|FG000|Overall Study|Lack of Efficacy|1|||
46773358|NCT00437125|82991698|FG000|Overall Study|Lost to Follow-up|1|||
46773359|NCT00437125|82991698|FG000|Overall Study|Withdrawal by Subject|13|||
46773360|NCT00437125|82991698|FG000|Overall Study|Withdrawal by Caregiver|2|||
46773361|NCT00437125|82991698|FG000|Overall Study|Physician Decision|1|||
46773362|NCT00582309|82991714|FG000|Overall Study|Protocol Violation|0|||
46773363|NCT00582309|82991715|FG001|Overall Study|Protocol Violation|0|||
46773364|NCT00582309|82991716|FG002|Overall Study|Protocol Violation|2|||
46773365|NCT00443053|82991726|FG000|Overall Study|Adverse Event|2|||
46773366|NCT00443053|82991727|FG001|Overall Study|Adverse Event|1|||
46956516|NCT03128671|83197399|FG001|Intervention|Palliative/hospice care initiated|10|||
46956517|NCT03128671|83197398|FG000|Intervention|Death|13|||
46956518|NCT03128671|83197399|FG001|Intervention|Death|11|||
46956519|NCT03128671|83197398|FG000|Intervention|Interrupted by hurricane|1|||
46956520|NCT03128671|83197399|FG001|Intervention|Interrupted by hurricane|0|||
46773367|NCT00443053|82991726|FG000|Overall Study|Withdrawal by Subject|9|||
46956521|NCT03128671|83197398|FG000|Intervention|Physician Decision|2|||
46956522|NCT03128671|83197399|FG001|Intervention|Physician Decision|3|||
46956523|NCT02925338|83197410|FG000|Overall Study|Death|0|||
46773368|NCT00443053|82991727|FG001|Overall Study|Withdrawal by Subject|18|||
46956524|NCT02925338|83197411|FG001|Overall Study|Death|2|||
46956525|NCT02925338|83197412|FG002|Overall Study|Death|1|||
46956526|NCT02925338|83197413|FG003|Overall Study|Death|0|||
46956527|NCT02925338|83197414|FG004|Overall Study|Death|0|||
46956528|NCT02925338|83197410|FG000|Overall Study|Lost to Follow-up|30|||
46956529|NCT02925338|83197411|FG001|Overall Study|Lost to Follow-up|10|||
46956530|NCT02925338|83197412|FG002|Overall Study|Lost to Follow-up|1|||
46956531|NCT02925338|83197413|FG003|Overall Study|Lost to Follow-up|16|||
46956532|NCT02925338|83197414|FG004|Overall Study|Lost to Follow-up|3|||
46956533|NCT02925338|83197410|FG000|Overall Study|Withdrawal by Subject|3|||
46956534|NCT02925338|83197411|FG001|Overall Study|Withdrawal by Subject|0|||
46956535|NCT02925338|83197412|FG002|Overall Study|Withdrawal by Subject|3|||
46956536|NCT02925338|83197413|FG003|Overall Study|Withdrawal by Subject|2|||
46956537|NCT02925338|83197414|FG004|Overall Study|Withdrawal by Subject|2|||
46956538|NCT02925338|83197410|FG000|Overall Study|Missing|38|||
46956539|NCT02925338|83197411|FG001|Overall Study|Missing|27|||
46956540|NCT02925338|83197412|FG002|Overall Study|Missing|0|||
46956541|NCT02925338|83197413|FG003|Overall Study|Missing|3|||
47066947|NCT01447927|83350112|FG000|Overall Study|Adverse Event|4|||
47066948|NCT01447927|83350113|FG001|Overall Study|Adverse Event|3|||
47066949|NCT01447927|83350112|FG000|Overall Study|Withdrawal by Subject|1|||
47066950|NCT01447927|83350113|FG001|Overall Study|Withdrawal by Subject|0|||
47066951|NCT01551758|83350135|FG000|Overall Study|Adverse Event|29|||
47066952|NCT01551758|83350136|FG001|Overall Study|Adverse Event|43|||
47066953|NCT01551758|83350135|FG000|Overall Study|Lack of Efficacy|0|||
47066954|NCT01551758|83350136|FG001|Overall Study|Lack of Efficacy|1|||
46844523|NCT00255840|83061330|FG001|Overall Study|Lost to Follow-up|14|||
46844524|NCT00255840|83061329|FG000|Overall Study|Discontinued intervention|53|||
46844525|NCT00255840|83061330|FG001|Overall Study|Discontinued intervention|56|||
46844526|NCT00224874|83061340|FG000|Overall Study|Withdrawal by Subject|0|||
46844527|NCT00224874|83061341|FG001|Overall Study|Withdrawal by Subject|0|||
46956542|NCT02925338|83197414|FG004|Overall Study|Missing|2|||
47066955|NCT01551758|83350135|FG000|Overall Study|Protocol Violation|5|||
47066956|NCT01551758|83350136|FG001|Overall Study|Protocol Violation|6|||
47066957|NCT01551758|83350135|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
47066958|NCT01551758|83350136|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
47066959|NCT01551758|83350135|FG000|Overall Study|Lost to Follow-up|29|||
47066960|NCT01551758|83350136|FG001|Overall Study|Lost to Follow-up|25|||
47066961|NCT01551758|83350135|FG000|Overall Study|Physician Decision|9|||
47066962|NCT01551758|83350136|FG001|Overall Study|Physician Decision|3|||
47066963|NCT01551758|83350135|FG000|Overall Study|Withdrawal by Subject|14|||
47066964|NCT01551758|83350136|FG001|Overall Study|Withdrawal by Subject|17|||
47066965|NCT01449461|83350339|FG000|Overall Study|Adverse Event|0|||
46773369|NCT00443053|82991726|FG000|Overall Study|Lost to Follow-up|4|||
47066966|NCT01449461|83350340|FG001|Overall Study|Adverse Event|3|||
46773370|NCT00443053|82991727|FG001|Overall Study|Lost to Follow-up|5|||
46773371|NCT00443053|82991726|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
46773372|NCT00443053|82991727|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
46773373|NCT00443053|82991726|FG000|Overall Study|Noncompliance|2|||
46773374|NCT00443053|82991727|FG001|Overall Study|Noncompliance|1|||
46773375|NCT00443053|82991726|FG000|Overall Study|Other|3|||
46773376|NCT00443053|82991727|FG001|Overall Study|Other|4|||
46773377|NCT00443053|82991726|FG000|Overall Study|Physician Decision|0|||
46773378|NCT00443053|82991727|FG001|Overall Study|Physician Decision|4|||
46773379|NCT00720798|82991733|FG000|Overall Study|Adverse Event|304|||
47066967|NCT01449461|83350341|FG002|Overall Study|Adverse Event|2|||
46773380|NCT00720798|82991733|FG000|Overall Study|Death|39|||
46773381|NCT00720798|82991733|FG000|Overall Study|Insufficient Therapeutic Response|129|||
46773382|NCT00720798|82991733|FG000|Overall Study|Protocol Violation|4|||
46773383|NCT00720798|82991733|FG000|Overall Study|Refused Treatment|151|||
46773384|NCT00720798|82991733|FG000|Overall Study|Failure to Return|46|||
46773385|NCT00720798|82991733|FG000|Overall Study|Reason not Specified|83|||
46773386|NCT00756002|82991743|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
47066968|NCT01449461|83350342|FG003|Overall Study|Adverse Event|3|||
47066969|NCT01449461|83350343|FG004|Overall Study|Adverse Event|4|||
47066970|NCT01449461|83350344|FG005|Overall Study|Adverse Event|4|||
46773387|NCT00756002|82991744|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
46844528|NCT00224874|83061342|FG002|Overall Study|Withdrawal by Subject|1|||
46844529|NCT00224874|83061343|FG003|Overall Study|Withdrawal by Subject|0|||
47066971|NCT01449461|83350339|FG000|Overall Study|Death|0|||
46773388|NCT00756002|82991743|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46773389|NCT00756002|82991744|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
46773390|NCT00756002|82991743|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
46844530|NCT00186186|83061353|FG000|Overall Study|Lack of Efficacy|3|||
46956543|NCT02925338|83197410|FG000|Overall Study|Participant's Decision|11|||
46956544|NCT02925338|83197411|FG001|Overall Study|Participant's Decision|7|||
46956545|NCT02925338|83197412|FG002|Overall Study|Participant's Decision|3|||
47066972|NCT01449461|83350340|FG001|Overall Study|Death|2|||
47066973|NCT01449461|83350341|FG002|Overall Study|Death|0|||
46773391|NCT00756002|82991744|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
46773392|NCT00756002|82991743|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
46773393|NCT00756002|82991744|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
46773394|NCT00756002|82991743|FG000|Double-Blind Treatment Period|Other|2|||
46773395|NCT00756002|82991744|FG001|Double-Blind Treatment Period|Other|2|||
46773396|NCT00717366|82991752|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
46773397|NCT00717366|82991753|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
46844531|NCT00186186|83061353|FG000|Overall Study|Withdrawal by Subject|3|||
46844532|NCT00186186|83061353|FG000|Overall Study|Not reported as to reason|2|||
46844533|NCT00185640|83061358|FG000|Overall Study|Not Eligible|4|||
46844534|NCT00185640|83061358|FG000|Overall Study|Withdrawal by Subject|3|||
46844535|NCT00185640|83061358|FG000|Overall Study|Death|138|||
46844536|NCT03760666|83061365|FG000|Overall Study|Adverse Event|2|||
46844537|NCT03760666|83061366|FG001|Overall Study|Adverse Event|4|||
46844538|NCT03760666|83061367|FG002|Overall Study|Adverse Event|1|||
46844539|NCT03760666|83061365|FG000|Overall Study|AML Disease Progression|3|||
46844540|NCT03760666|83061366|FG001|Overall Study|AML Disease Progression|3|||
46844541|NCT03760666|83061367|FG002|Overall Study|AML Disease Progression|0|||
46844542|NCT03760666|83061365|FG000|Overall Study|Physician Decision|0|||
46844543|NCT03760666|83061366|FG001|Overall Study|Physician Decision|3|||
46844544|NCT03760666|83061367|FG002|Overall Study|Physician Decision|0|||
46844545|NCT03760666|83061365|FG000|Overall Study|Withdrawal by Subject|0|||
46844546|NCT03760666|83061366|FG001|Overall Study|Withdrawal by Subject|1|||
46844547|NCT03760666|83061367|FG002|Overall Study|Withdrawal by Subject|0|||
46844548|NCT03760510|83061380|FG000|Overall Study|Not ventilated for 24 hours|105|||
46844549|NCT03760510|83061381|FG001|Overall Study|Not ventilated for 24 hours|97|||
46844550|NCT00224484|83061390|FG000|Overall Study|Serious Adverse Event|1|||
46844551|NCT00224484|83061391|FG001|Overall Study|Serious Adverse Event|1|||
46844552|NCT00224484|83061392|FG002|Overall Study|Serious Adverse Event|0|||
46844553|NCT00224484|83061390|FG000|Overall Study|Non-Serious Adverse Event|5|||
46844554|NCT00224484|83061391|FG001|Overall Study|Non-Serious Adverse Event|7|||
46844555|NCT00224484|83061392|FG002|Overall Study|Non-Serious Adverse Event|3|||
46844556|NCT00224484|83061390|FG000|Overall Study|Protocol Violation|2|||
46844557|NCT00224484|83061391|FG001|Overall Study|Protocol Violation|2|||
46844558|NCT00224484|83061392|FG002|Overall Study|Protocol Violation|0|||
46844559|NCT00224484|83061390|FG000|Overall Study|Withdrawal by Subject|49|||
46844560|NCT00224484|83061391|FG001|Overall Study|Withdrawal by Subject|18|||
46844561|NCT00224484|83061392|FG002|Overall Study|Withdrawal by Subject|16|||
46844562|NCT00224484|83061390|FG000|Overall Study|Migrated/moved from study area|18|||
46844563|NCT00224484|83061391|FG001|Overall Study|Migrated/moved from study area|5|||
46844564|NCT00224484|83061392|FG002|Overall Study|Migrated/moved from study area|5|||
46844565|NCT00224484|83061390|FG000|Overall Study|Lost to Follow-up|66|||
46844566|NCT00224484|83061391|FG001|Overall Study|Lost to Follow-up|28|||
46844567|NCT00224484|83061392|FG002|Overall Study|Lost to Follow-up|36|||
46844568|NCT00224484|83061390|FG000|Overall Study|Reason not specified|5|||
46844569|NCT00224484|83061391|FG001|Overall Study|Reason not specified|4|||
46844570|NCT00224484|83061392|FG002|Overall Study|Reason not specified|2|||
46844571|NCT00254982|83061405|FG000|Overall Study|Other|2|||
46956546|NCT02925338|83197413|FG003|Overall Study|Participant's Decision|8|||
46956547|NCT02925338|83197414|FG004|Overall Study|Participant's Decision|1|||
46956548|NCT02925338|83197410|FG000|Overall Study|Treatment Discontinuation|144|||
46956549|NCT02925338|83197411|FG001|Overall Study|Treatment Discontinuation|65|||
46639526|NCT01381926|82813051|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
46844572|NCT00254982|83061406|FG001|Overall Study|Other|1|||
46844573|NCT00254982|83061405|FG000|Overall Study|Lack of Efficacy|5|||
46844574|NCT00254982|83061406|FG001|Overall Study|Lack of Efficacy|3|||
46639527|NCT01381926|82813052|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
46639528|NCT01381926|82813051|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
46639529|NCT01381926|82813052|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
46639530|NCT01395888|82813062|FG000|2-week Run-in Period|Adverse Event|2|||
46639531|NCT01395888|82813063|FG001|2-week Run-in Period|Adverse Event|0|||
46639532|NCT01395888|82813064|FG002|2-week Run-in Period|Adverse Event|0|||
46773398|NCT00717366|82991752|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
46773399|NCT00717366|82991753|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
46773400|NCT00717366|82991752|FG000|Core Study Period (20 Weeks)|Death|0|||
46844575|NCT00254982|83061405|FG000|Overall Study|Lost to Follow-up|5|||
46844576|NCT00254982|83061406|FG001|Overall Study|Lost to Follow-up|3|||
46773401|NCT00717366|82991753|FG001|Core Study Period (20 Weeks)|Death|1|||
46773402|NCT00717366|82991752|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
46844577|NCT00254982|83061405|FG000|Overall Study|Adverse Event|18|||
46844578|NCT00254982|83061406|FG001|Overall Study|Adverse Event|16|||
46844579|NCT00254982|83061405|FG000|Overall Study|Withdrawal by Subject|1|||
46844580|NCT00254982|83061406|FG001|Overall Study|Withdrawal by Subject|1|||
46844581|NCT00254982|83061405|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
46844582|NCT00254982|83061406|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
46844583|NCT00254982|83061405|FG000|Overall Study|Protocol deviation|1|||
46956550|NCT02925338|83197412|FG002|Overall Study|Treatment Discontinuation|56|||
46956551|NCT02925338|83197413|FG003|Overall Study|Treatment Discontinuation|131|||
46956552|NCT02925338|83197414|FG004|Overall Study|Treatment Discontinuation|22|||
46956553|NCT02543528|83197432|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
46956554|NCT02543528|83197433|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
46956555|NCT02543528|83197434|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
46956556|NCT02543528|83197435|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
46956557|NCT02543528|83197436|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
46956558|NCT02543528|83197432|FG000|Adaptation Period|Lens Handling Difficultes|0|||
46956559|NCT02543528|83197433|FG001|Adaptation Period|Lens Handling Difficultes|0|||
46956560|NCT02543528|83197434|FG002|Adaptation Period|Lens Handling Difficultes|0|||
46956561|NCT02543528|83197435|FG003|Adaptation Period|Lens Handling Difficultes|0|||
46956562|NCT02543528|83197436|FG004|Adaptation Period|Lens Handling Difficultes|8|||
46956563|NCT02543528|83197432|FG000|Adaptation Period|Lost to Follow-up|0|||
46956564|NCT02543528|83197433|FG001|Adaptation Period|Lost to Follow-up|0|||
46956565|NCT02543528|83197434|FG002|Adaptation Period|Lost to Follow-up|0|||
46956566|NCT02543528|83197435|FG003|Adaptation Period|Lost to Follow-up|0|||
46956567|NCT02543528|83197436|FG004|Adaptation Period|Lost to Follow-up|14|||
46956568|NCT02543528|83197432|FG000|Adaptation Period|Adverse Event|0|||
46956569|NCT02543528|83197433|FG001|Adaptation Period|Adverse Event|0|||
46956570|NCT02543528|83197434|FG002|Adaptation Period|Adverse Event|0|||
46956571|NCT02543528|83197435|FG003|Adaptation Period|Adverse Event|0|||
46956572|NCT02543528|83197436|FG004|Adaptation Period|Adverse Event|2|||
46956573|NCT02543528|83197432|FG000|Extended Wear Period|Adverse Event|17|||
46956574|NCT02543528|83197433|FG001|Extended Wear Period|Adverse Event|11|||
46773403|NCT00717366|82991753|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
46773404|NCT00717366|82991752|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
46844584|NCT00254982|83061406|FG001|Overall Study|Protocol deviation|1|||
46844585|NCT00254982|83061405|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
46773405|NCT00717366|82991753|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
46773406|NCT00717366|82991752|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
46773407|NCT00717366|82991753|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
46773408|NCT00717366|82991752|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
46773409|NCT00717366|82991753|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
46844586|NCT00254982|83061406|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
46844587|NCT00254982|83061405|FG000|Overall Study|Malignancy|0|||
46844588|NCT00254982|83061406|FG001|Overall Study|Malignancy|2|||
46844589|NCT00254982|83061405|FG000|Overall Study|Opportunistic infection|1|||
46844590|NCT00254982|83061406|FG001|Overall Study|Opportunistic infection|0|||
46844591|NCT00254982|83061405|FG000|Overall Study|Abnormal liver function tests|2|||
46844592|NCT00254982|83061406|FG001|Overall Study|Abnormal liver function tests|1|||
46844593|NCT03759340|83061412|FG000|Overall Study|Adverse Event|2|||
46844594|NCT03759340|83061412|FG000|Overall Study|Lost to Follow-up|1|||
46844595|NCT03759340|83061412|FG000|Overall Study|Withdrawal by Subject|15|||
46844596|NCT03759340|83061412|FG000|Overall Study|Study Terminated by Sponsor|38|||
46844597|NCT00224016|83061418|FG000|Titration Period|Withdrawal by Subject|0|||
46844598|NCT00224016|83061419|FG001|Titration Period|Withdrawal by Subject|1|||
46844599|NCT00224016|83061418|FG000|Titration Period|Lost to Follow-up|1|||
46844600|NCT00224016|83061419|FG001|Titration Period|Lost to Follow-up|0|||
46844601|NCT00224016|83061418|FG000|Maintenance Period|Withdrawal by Subject|2|||
46844602|NCT00224016|83061419|FG001|Maintenance Period|Withdrawal by Subject|0|||
46844603|NCT00224016|83061418|FG000|Maintenance Period|Lost to Follow-up|0|||
46844604|NCT00224016|83061419|FG001|Maintenance Period|Lost to Follow-up|1|||
46844605|NCT03757234|83061430|FG000|Overall Study|Adverse Event|0|||
46844606|NCT03757234|83061431|FG001|Overall Study|Adverse Event|0|||
46844607|NCT03757234|83061432|FG002|Overall Study|Adverse Event|0|||
46844608|NCT03757234|83061433|FG003|Overall Study|Adverse Event|0|||
46956575|NCT02543528|83197434|FG002|Extended Wear Period|Adverse Event|16|||
46956576|NCT02543528|83197435|FG003|Extended Wear Period|Adverse Event|3|||
46956577|NCT02543528|83197436|FG004|Extended Wear Period|Adverse Event|0|||
46956578|NCT02543528|83197432|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
46956579|NCT02543528|83197433|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
46956580|NCT02543528|83197434|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
46844609|NCT03757234|83061434|FG004|Overall Study|Adverse Event|1|||
46844610|NCT03757234|83061430|FG000|Overall Study|Lost to Follow-up|1|||
46844611|NCT03757234|83061431|FG001|Overall Study|Lost to Follow-up|0|||
46844612|NCT03757234|83061432|FG002|Overall Study|Lost to Follow-up|0|||
46956581|NCT02543528|83197435|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
46956582|NCT02543528|83197436|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
46956583|NCT02543528|83197432|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
46956584|NCT02543528|83197433|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
46844613|NCT03757234|83061433|FG003|Overall Study|Lost to Follow-up|0|||
46844614|NCT03757234|83061434|FG004|Overall Study|Lost to Follow-up|1|||
46844615|NCT03757234|83061430|FG000|Overall Study|Withdrawal by Subject|1|||
46844616|NCT03757234|83061431|FG001|Overall Study|Withdrawal by Subject|1|||
46844617|NCT03757234|83061432|FG002|Overall Study|Withdrawal by Subject|0|||
46844618|NCT03757234|83061433|FG003|Overall Study|Withdrawal by Subject|1|||
46844619|NCT03757234|83061434|FG004|Overall Study|Withdrawal by Subject|2|||
46844620|NCT03757234|83061430|FG000|Overall Study|Other|1|||
46844621|NCT03757234|83061431|FG001|Overall Study|Other|1|||
46844622|NCT03757234|83061432|FG002|Overall Study|Other|0|||
46639533|NCT01395888|82813062|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
46639534|NCT01395888|82813063|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
46639535|NCT01395888|82813064|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
46639536|NCT01395888|82813062|FG000|2-week Run-in Period|Lost to Follow-up|1|||
46639537|NCT01395888|82813063|FG001|2-week Run-in Period|Lost to Follow-up|0|||
46639538|NCT01395888|82813064|FG002|2-week Run-in Period|Lost to Follow-up|0|||
46639539|NCT01395888|82813062|FG000|2-week Run-in Period|Protocol Violation|2|||
46639540|NCT01395888|82813063|FG001|2-week Run-in Period|Protocol Violation|0|||
46639541|NCT01395888|82813064|FG002|2-week Run-in Period|Protocol Violation|0|||
46639542|NCT01395888|82813062|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
46639543|NCT01395888|82813063|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
46639544|NCT01395888|82813064|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
46639545|NCT01395888|82813062|FG000|Treatment Period (TP)|Adverse Event|0|||
46639546|NCT01395888|82813063|FG001|Treatment Period (TP)|Adverse Event|7|||
46639547|NCT01395888|82813064|FG002|Treatment Period (TP)|Adverse Event|6|||
46639548|NCT01395888|82813062|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
46639549|NCT01395888|82813063|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
46639550|NCT01395888|82813064|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
46639551|NCT01395888|82813062|FG000|Treatment Period (TP)|Protocol Violation|0|||
46639552|NCT01395888|82813063|FG001|Treatment Period (TP)|Protocol Violation|1|||
46639553|NCT01395888|82813064|FG002|Treatment Period (TP)|Protocol Violation|5|||
46639554|NCT01395888|82813062|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
46639555|NCT01395888|82813063|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
46639556|NCT01395888|82813064|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
46639557|NCT01395888|82813062|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
46639558|NCT01395888|82813063|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
46639559|NCT01395888|82813064|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
46639560|NCT01395810|82813074|FG000|Overall Study|Adverse Event|0|||
46639561|NCT01395810|82813075|FG001|Overall Study|Adverse Event|1|||
46639562|NCT01395810|82813076|FG002|Overall Study|Adverse Event|0|||
46639563|NCT01395810|82813077|FG003|Overall Study|Adverse Event|0|||
46639564|NCT01395810|82813074|FG000|Overall Study|Lack of Efficacy|0|||
46639565|NCT01395810|82813075|FG001|Overall Study|Lack of Efficacy|1|||
46639566|NCT01395810|82813076|FG002|Overall Study|Lack of Efficacy|0|||
46639567|NCT01395810|82813077|FG003|Overall Study|Lack of Efficacy|0|||
46639568|NCT01395810|82813074|FG000|Overall Study|Withdrawal criteria|0|||
46639569|NCT01395810|82813075|FG001|Overall Study|Withdrawal criteria|2|||
46639570|NCT01395810|82813076|FG002|Overall Study|Withdrawal criteria|0|||
46639571|NCT01395810|82813077|FG003|Overall Study|Withdrawal criteria|0|||
46639572|NCT01395810|82813074|FG000|Overall Study|Unclassified|2|||
46639573|NCT01395810|82813075|FG001|Overall Study|Unclassified|0|||
46639574|NCT01395810|82813076|FG002|Overall Study|Unclassified|0|||
46639575|NCT01395810|82813077|FG003|Overall Study|Unclassified|0|||
46639576|NCT01381692|82813090|FG000|Overall Study|Adverse Event|1|||
46639577|NCT01381692|82813091|FG001|Overall Study|Adverse Event|0|||
46639578|NCT01381692|82813092|FG002|Overall Study|Adverse Event|0|||
46639579|NCT01381692|82813093|FG003|Overall Study|Adverse Event|0|||
46639580|NCT01381692|82813094|FG004|Overall Study|Adverse Event|0|||
46639581|NCT01381692|82813095|FG005|Overall Study|Adverse Event|0|||
46639582|NCT01395030|82813103|FG000|Overall Study|Did not complete FCH PET/CT|7|||
46639583|NCT01381068|82813111|FG000|Overall Study|Death|1|||
46639584|NCT01381068|82813112|FG001|Overall Study|Death|0|||
46639585|NCT01394952|82813120|FG000|Overall Study|Lost to Follow-up|0|||
46639586|NCT01394952|82813121|FG001|Overall Study|Lost to Follow-up|5|||
46639587|NCT01394952|82813120|FG000|Overall Study|Withdrawal by Subject|10|||
46639588|NCT01394952|82813121|FG001|Overall Study|Withdrawal by Subject|5|||
46639589|NCT01394952|82813120|FG000|Overall Study|Physician Decision|2|||
46639590|NCT01394952|82813121|FG001|Overall Study|Physician Decision|0|||
46639591|NCT01394952|82813120|FG000|Overall Study|Sponsor Decision|5|||
46639592|NCT01394952|82813121|FG001|Overall Study|Sponsor Decision|7|||
46639593|NCT01394718|82813129|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
46639594|NCT01394718|82813130|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
46639595|NCT01394250|82813138|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
46639596|NCT01394250|82813139|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
46844623|NCT03757234|83061433|FG003|Overall Study|Other|0|||
46844624|NCT03757234|83061434|FG004|Overall Study|Other|0|||
46773410|NCT00723606|82991772|FG000|Overall Study|Adverse Event|2|||
46956585|NCT02543528|83197434|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
46956586|NCT02543528|83197435|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
46956587|NCT02543528|83197436|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
46956588|NCT02543528|83197432|FG000|Extended Wear Period|Lost to Follow-up|0|||
46956589|NCT02543528|83197433|FG001|Extended Wear Period|Lost to Follow-up|1|||
46956590|NCT02543528|83197434|FG002|Extended Wear Period|Lost to Follow-up|2|||
46956591|NCT02543528|83197435|FG003|Extended Wear Period|Lost to Follow-up|1|||
46956592|NCT02543528|83197436|FG004|Extended Wear Period|Lost to Follow-up|0|||
46956593|NCT02543528|83197432|FG000|Extended Wear Period|Withdrawal by Subject|10|||
46956594|NCT02543528|83197433|FG001|Extended Wear Period|Withdrawal by Subject|9|||
46956595|NCT02543528|83197434|FG002|Extended Wear Period|Withdrawal by Subject|4|||
46956596|NCT02543528|83197435|FG003|Extended Wear Period|Withdrawal by Subject|5|||
46956597|NCT02543528|83197436|FG004|Extended Wear Period|Withdrawal by Subject|0|||
46956598|NCT00156533|83197454|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
46956599|NCT00156533|83197455|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
46956600|NCT00156533|83197456|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
46956601|NCT00156533|83197457|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
46956602|NCT00156533|83197454|FG000|Overall Study|Withdrawal by Subject|1|||
46956603|NCT00156533|83197455|FG001|Overall Study|Withdrawal by Subject|0|||
46956604|NCT00156533|83197456|FG002|Overall Study|Withdrawal by Subject|0|||
46956605|NCT00156533|83197457|FG003|Overall Study|Withdrawal by Subject|1|||
46956606|NCT00156533|83197454|FG000|Overall Study|Failed Screening|1|||
46956607|NCT00156533|83197455|FG001|Overall Study|Failed Screening|0|||
47066974|NCT01449461|83350342|FG003|Overall Study|Death|0|||
47066975|NCT01449461|83350343|FG004|Overall Study|Death|7|||
47066976|NCT01449461|83350344|FG005|Overall Study|Death|1|||
46773411|NCT00723606|82991773|FG001|Overall Study|Adverse Event|5|||
46773412|NCT00723606|82991772|FG000|Overall Study|Other|2|||
46956608|NCT00156533|83197456|FG002|Overall Study|Failed Screening|1|||
46956609|NCT00156533|83197457|FG003|Overall Study|Failed Screening|1|||
46956610|NCT01660022|83197475|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
46956611|NCT01660022|83197476|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
46956612|NCT01660022|83197477|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
46956613|NCT01660022|83197478|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
46956614|NCT01660022|83197479|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
46956615|NCT01660022|83197480|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
46956616|NCT01660022|83197475|FG000|First Sequence (7 Days)|Adverse Event|0|||
46956617|NCT01660022|83197476|FG001|First Sequence (7 Days)|Adverse Event|0|||
46956618|NCT01660022|83197477|FG002|First Sequence (7 Days)|Adverse Event|0|||
46956619|NCT01660022|83197478|FG003|First Sequence (7 Days)|Adverse Event|0|||
46956620|NCT01660022|83197479|FG004|First Sequence (7 Days)|Adverse Event|1|||
46956621|NCT01660022|83197480|FG005|First Sequence (7 Days)|Adverse Event|3|||
46956622|NCT01660022|83197475|FG000|First Sequence (7 Days)|Protocol Violation|0|||
46956623|NCT01660022|83197476|FG001|First Sequence (7 Days)|Protocol Violation|0|||
46956624|NCT01660022|83197477|FG002|First Sequence (7 Days)|Protocol Violation|0|||
46956625|NCT01660022|83197478|FG003|First Sequence (7 Days)|Protocol Violation|0|||
46956626|NCT01660022|83197479|FG004|First Sequence (7 Days)|Protocol Violation|0|||
46956627|NCT01660022|83197480|FG005|First Sequence (7 Days)|Protocol Violation|1|||
46956628|NCT00156065|83197509|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
46956629|NCT00156065|83197510|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
47066977|NCT01449461|83350339|FG000|Overall Study|Physician Decision|0|||
47066978|NCT01449461|83350340|FG001|Overall Study|Physician Decision|1|||
47066979|NCT01449461|83350341|FG002|Overall Study|Physician Decision|0|||
46773413|NCT00723606|82991773|FG001|Overall Study|Other|0|||
46773414|NCT00723606|82991772|FG000|Overall Study|Withdrawal by Subject|0|||
46773415|NCT00723606|82991773|FG001|Overall Study|Withdrawal by Subject|2|||
46773416|NCT00442351|82991781|FG000|Overall Study|Administrative|6|||
46773417|NCT00442351|82991782|FG001|Overall Study|Administrative|5|||
46773418|NCT00442351|82991781|FG000|Overall Study|Did not meet protocol eligibility|1|||
46773419|NCT00442351|82991782|FG001|Overall Study|Did not meet protocol eligibility|0|||
46773420|NCT00442351|82991781|FG000|Overall Study|Other|0|||
46773421|NCT00442351|82991782|FG001|Overall Study|Other|1|||
46844625|NCT00223080|83061448|FG000|Overall Study|Withdrawal by Subject|253|||
46956630|NCT00156065|83197511|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
46956631|NCT00156065|83197509|FG000|Overall Study|Adverse Event|8|||
46956632|NCT00156065|83197510|FG001|Overall Study|Adverse Event|11|||
46956633|NCT00156065|83197511|FG002|Overall Study|Adverse Event|4|||
46956634|NCT00156065|83197509|FG000|Overall Study|Lack of Efficacy|2|||
46956635|NCT00156065|83197510|FG001|Overall Study|Lack of Efficacy|9|||
46956636|NCT00156065|83197511|FG002|Overall Study|Lack of Efficacy|3|||
46956637|NCT00156065|83197509|FG000|Overall Study|Withdrawal by Subject|13|||
46773422|NCT00436501|82991790|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
46956638|NCT00156065|83197510|FG001|Overall Study|Withdrawal by Subject|26|||
46956639|NCT00156065|83197511|FG002|Overall Study|Withdrawal by Subject|16|||
46956640|NCT00156065|83197509|FG000|Overall Study|Lost to Follow-up|5|||
46956641|NCT00156065|83197510|FG001|Overall Study|Lost to Follow-up|7|||
46956642|NCT00156065|83197511|FG002|Overall Study|Lost to Follow-up|1|||
46956643|NCT00156065|83197509|FG000|Overall Study|Other|2|||
46956644|NCT00156065|83197510|FG001|Overall Study|Other|9|||
46956645|NCT00156065|83197511|FG002|Overall Study|Other|3|||
46956646|NCT01554956|83197522|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
46956647|NCT01554956|83197523|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
46956648|NCT01554956|83197524|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
46956649|NCT01554956|83197522|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
46956650|NCT01554956|83197523|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
46956651|NCT01554956|83197524|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
46956652|NCT01554956|83197522|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
46956653|NCT01554956|83197523|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
46956654|NCT01554956|83197524|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
46956655|NCT02138786|83197545|FG000|Overall Study|Adverse Event|0|||
46956656|NCT02138786|83197546|FG001|Overall Study|Adverse Event|2|||
46956657|NCT02138786|83197547|FG002|Overall Study|Adverse Event|1|||
46956658|NCT02138786|83197545|FG000|Overall Study|Death|1|||
46956659|NCT02138786|83197546|FG001|Overall Study|Death|7|||
46956660|NCT02138786|83197547|FG002|Overall Study|Death|2|||
46956661|NCT02138786|83197545|FG000|Overall Study|Disease Progression|1|||
46956662|NCT02138786|83197546|FG001|Overall Study|Disease Progression|1|||
46956663|NCT02138786|83197547|FG002|Overall Study|Disease Progression|3|||
46956664|NCT02138786|83197545|FG000|Overall Study|Withdrawal by Subject|1|||
46956665|NCT02138786|83197546|FG001|Overall Study|Withdrawal by Subject|2|||
46956666|NCT02138786|83197547|FG002|Overall Study|Withdrawal by Subject|0|||
46956667|NCT02138786|83197545|FG000|Overall Study|Patient's Wish|0|||
46956668|NCT02138786|83197546|FG001|Overall Study|Patient's Wish|2|||
46956669|NCT02138786|83197547|FG002|Overall Study|Patient's Wish|0|||
46956670|NCT02138786|83197545|FG000|Overall Study|Sponsor Terminated Study|0|||
46956671|NCT02138786|83197546|FG001|Overall Study|Sponsor Terminated Study|1|||
46956672|NCT02138786|83197547|FG002|Overall Study|Sponsor Terminated Study|1|||
46956673|NCT02138786|83197545|FG000|Overall Study|Non-Compliance|0|||
46956674|NCT02138786|83197546|FG001|Overall Study|Non-Compliance|0|||
46956675|NCT02138786|83197547|FG002|Overall Study|Non-Compliance|1|||
46773423|NCT00436501|82991791|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
46773424|NCT00436501|82991790|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
46956676|NCT02529488|83197553|FG000|Overall Study|Adverse Event|1|||
46956677|NCT02529488|83197553|FG000|Overall Study|Death|3|||
46956678|NCT01329419|83197561|FG000|Overall Study|Protocol Violation|235|||
46956679|NCT01329341|83197566|FG000|Overall Study|Withdrawal by Subject|44|||
46956680|NCT02532764|83197580|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
46956681|NCT02532764|83197581|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
46956682|NCT02532764|83197582|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
46956683|NCT02532764|83197583|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
46956684|NCT02532764|83197584|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
46956685|NCT02532764|83197585|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
46956686|NCT02532764|83197586|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
46956687|NCT02532764|83197587|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
46956688|NCT02532764|83197588|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
46956689|NCT02532764|83197589|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
46956690|NCT02528942|83197616|FG000|Overall Study|Did not meet imaging criteria|9|||
46956691|NCT02528942|83197616|FG000|Overall Study|Lost to Follow-up|25|||
46956692|NCT02527148|83197622|FG000|Overall Study|Did not receive study intervention|1|||
46956693|NCT02527148|83197623|FG001|Overall Study|Did not receive study intervention|0|||
46956694|NCT02291614|83197642|FG000|Overall Study|Lost to Follow-up|0|||
46956695|NCT02291614|83197643|FG001|Overall Study|Lost to Follow-up|0|||
46956696|NCT02291614|83197644|FG002|Overall Study|Lost to Follow-up|0|||
46956697|NCT02291614|83197645|FG003|Overall Study|Lost to Follow-up|0|||
47066980|NCT01449461|83350342|FG003|Overall Study|Physician Decision|4|||
46639597|NCT01394250|82813138|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
46639598|NCT01394250|82813139|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
46639599|NCT01380990|82813147|FG000|Overall Study|Treatment Failure|1|||
46639600|NCT01380990|82813148|FG001|Overall Study|Treatment Failure|0|||
46773425|NCT00436501|82991791|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
46956698|NCT02291614|83197646|FG004|Overall Study|Lost to Follow-up|0|||
46956699|NCT02291614|83197647|FG005|Overall Study|Lost to Follow-up|0|||
46956700|NCT02291614|83197648|FG006|Overall Study|Lost to Follow-up|0|||
46956701|NCT02291614|83197649|FG007|Overall Study|Lost to Follow-up|1|||
46956702|NCT02291614|83197650|FG008|Overall Study|Lost to Follow-up|0|||
46956703|NCT02291614|83197651|FG009|Overall Study|Lost to Follow-up|0|||
46956704|NCT02291614|83197652|FG010|Overall Study|Lost to Follow-up|0|||
46956705|NCT02291614|83197642|FG000|Overall Study|Withdrawal by Subject|0|||
46956706|NCT02291614|83197643|FG001|Overall Study|Withdrawal by Subject|1|||
46956707|NCT02291614|83197644|FG002|Overall Study|Withdrawal by Subject|0|||
46956708|NCT02291614|83197645|FG003|Overall Study|Withdrawal by Subject|0|||
46956709|NCT02291614|83197646|FG004|Overall Study|Withdrawal by Subject|0|||
46956710|NCT02291614|83197647|FG005|Overall Study|Withdrawal by Subject|0|||
46956711|NCT02291614|83197648|FG006|Overall Study|Withdrawal by Subject|0|||
46956712|NCT02291614|83197649|FG007|Overall Study|Withdrawal by Subject|0|||
46956713|NCT02291614|83197650|FG008|Overall Study|Withdrawal by Subject|0|||
46956714|NCT02291614|83197651|FG009|Overall Study|Withdrawal by Subject|2|||
46956715|NCT02291614|83197652|FG010|Overall Study|Withdrawal by Subject|2|||
46956716|NCT02291614|83197642|FG000|Overall Study|Decision by sponsor|0|||
46956717|NCT02291614|83197643|FG001|Overall Study|Decision by sponsor|0|||
46956718|NCT02291614|83197644|FG002|Overall Study|Decision by sponsor|0|||
46956719|NCT02291614|83197645|FG003|Overall Study|Decision by sponsor|1|||
46956720|NCT02291614|83197646|FG004|Overall Study|Decision by sponsor|0|||
46956721|NCT02291614|83197647|FG005|Overall Study|Decision by sponsor|0|||
46956722|NCT02291614|83197648|FG006|Overall Study|Decision by sponsor|0|||
46639601|NCT01380990|82813147|FG000|Overall Study|Death|0|||
46639602|NCT01380990|82813148|FG001|Overall Study|Death|1|||
46639603|NCT01380834|82813160|FG000|Overall Study|Physician Decision|1|||
46639604|NCT01380834|82813161|FG001|Overall Study|Physician Decision|0|||
46639605|NCT00214422|82813170|FG000|Overall Study|Physician Decision|2|||
46639606|NCT00214422|82813171|FG001|Overall Study|Physician Decision|0|||
46773426|NCT00755846|82991804|FG000|Overall Study|Adverse Event|0|||
46773427|NCT00755846|82991805|FG001|Overall Study|Adverse Event|0|||
46956723|NCT02291614|83197649|FG007|Overall Study|Decision by sponsor|0|||
46956724|NCT02291614|83197650|FG008|Overall Study|Decision by sponsor|0|||
46956725|NCT02291614|83197651|FG009|Overall Study|Decision by sponsor|0|||
46956726|NCT02291614|83197652|FG010|Overall Study|Decision by sponsor|0|||
46956727|NCT02291614|83197642|FG000|Overall Study|Death|0|||
46956728|NCT02291614|83197643|FG001|Overall Study|Death|0|||
46956729|NCT02291614|83197644|FG002|Overall Study|Death|1|||
46956730|NCT02291614|83197645|FG003|Overall Study|Death|0|||
46956731|NCT02291614|83197646|FG004|Overall Study|Death|1|||
46956732|NCT02291614|83197647|FG005|Overall Study|Death|1|||
47066981|NCT01449461|83350343|FG004|Overall Study|Physician Decision|1|||
47066982|NCT01449461|83350344|FG005|Overall Study|Physician Decision|0|||
47066983|NCT01449461|83350339|FG000|Overall Study|Documented Progressive Disease|4|||
47066984|NCT01449461|83350340|FG001|Overall Study|Documented Progressive Disease|7|||
46773428|NCT00755846|82991806|FG002|Overall Study|Adverse Event|0|||
46773429|NCT00755846|82991807|FG003|Overall Study|Adverse Event|1|||
46773430|NCT00755846|82991808|FG004|Overall Study|Adverse Event|3|||
46773431|NCT00755846|82991809|FG005|Overall Study|Adverse Event|2|||
46773432|NCT00755846|82991804|FG000|Overall Study|Protocol Violation|1|||
46773433|NCT00755846|82991805|FG001|Overall Study|Protocol Violation|1|||
46773434|NCT00755846|82991806|FG002|Overall Study|Protocol Violation|1|||
46773435|NCT00755846|82991807|FG003|Overall Study|Protocol Violation|1|||
46773436|NCT00755846|82991808|FG004|Overall Study|Protocol Violation|1|||
46773437|NCT00755846|82991809|FG005|Overall Study|Protocol Violation|1|||
46773438|NCT00755846|82991804|FG000|Overall Study|Lost to Follow-up|0|||
46773439|NCT00755846|82991805|FG001|Overall Study|Lost to Follow-up|2|||
46773440|NCT00755846|82991806|FG002|Overall Study|Lost to Follow-up|1|||
46773441|NCT00755846|82991807|FG003|Overall Study|Lost to Follow-up|0|||
46773442|NCT00755846|82991808|FG004|Overall Study|Lost to Follow-up|4|||
46773443|NCT00755846|82991809|FG005|Overall Study|Lost to Follow-up|2|||
46773444|NCT00755846|82991804|FG000|Overall Study|Withdrawal by Subject|2|||
46773445|NCT00755846|82991805|FG001|Overall Study|Withdrawal by Subject|3|||
46773446|NCT00755846|82991806|FG002|Overall Study|Withdrawal by Subject|5|||
46773447|NCT00755846|82991807|FG003|Overall Study|Withdrawal by Subject|2|||
47066985|NCT01449461|83350341|FG002|Overall Study|Documented Progressive Disease|14|||
47066986|NCT01449461|83350342|FG003|Overall Study|Documented Progressive Disease|15|||
47066987|NCT01449461|83350343|FG004|Overall Study|Documented Progressive Disease|24|||
46773448|NCT00755846|82991808|FG004|Overall Study|Withdrawal by Subject|0|||
46773449|NCT00755846|82991809|FG005|Overall Study|Withdrawal by Subject|1|||
46773450|NCT00755846|82991804|FG000|Overall Study|Hyperglycemic Rescue|21|||
46956733|NCT02291614|83197648|FG006|Overall Study|Death|1|||
46956734|NCT02291614|83197649|FG007|Overall Study|Death|0|||
46956735|NCT02291614|83197650|FG008|Overall Study|Death|0|||
46956736|NCT02291614|83197651|FG009|Overall Study|Death|0|||
47066988|NCT01449461|83350344|FG005|Overall Study|Documented Progressive Disease|5|||
46773451|NCT00755846|82991805|FG001|Overall Study|Hyperglycemic Rescue|7|||
46773452|NCT00755846|82991806|FG002|Overall Study|Hyperglycemic Rescue|5|||
46639607|NCT00214422|82813172|FG002|Overall Study|Physician Decision|0|||
46639608|NCT00214422|82813170|FG000|Overall Study|Developed esophageal ca|1|||
46773453|NCT00755846|82991807|FG003|Overall Study|Hyperglycemic Rescue|8|||
46956737|NCT02291614|83197652|FG010|Overall Study|Death|0|||
46956738|NCT02526524|83197688|FG000|Overall Study|Withdrawal by Subject|3|||
46639609|NCT00214422|82813171|FG001|Overall Study|Developed esophageal ca|0|||
46639610|NCT00214422|82813172|FG002|Overall Study|Developed esophageal ca|0|||
46639611|NCT00214422|82813170|FG000|Overall Study|Pt taken off study|1|||
46639612|NCT00214422|82813171|FG001|Overall Study|Pt taken off study|1|||
46639613|NCT00214422|82813172|FG002|Overall Study|Pt taken off study|0|||
46639614|NCT00214422|82813170|FG000|Overall Study|Disease progression on study|1|||
46639615|NCT00214422|82813171|FG001|Overall Study|Disease progression on study|0|||
46639616|NCT00214422|82813172|FG002|Overall Study|Disease progression on study|0|||
46639617|NCT00214422|82813170|FG000|Overall Study|Unable to make a radiation treatment|0|||
46639618|NCT00214422|82813171|FG001|Overall Study|Unable to make a radiation treatment|0|||
46639619|NCT00214422|82813172|FG002|Overall Study|Unable to make a radiation treatment|1|||
46639620|NCT00218634|82813186|FG000|Overall Study|Lost to Follow-up|8|||
46639621|NCT00218634|82813187|FG001|Overall Study|Lost to Follow-up|15|||
46639622|NCT00217620|82813196|FG000|Overall Study|Adverse Event|2|||
46639623|NCT00217620|82813196|FG000|Overall Study|Progression|31|||
46639624|NCT00217620|82813196|FG000|Overall Study|Not Protocol Specified|4|||
46639625|NCT00217620|82813196|FG000|Overall Study|Ineligible|13|||
46639626|NCT00217620|82813196|FG000|Overall Study|Never received treatment|1|||
46639627|NCT00217464|82813204|FG000|Overall Study|Progression|15|||
46956739|NCT02526524|83197689|FG001|Overall Study|Withdrawal by Subject|3|||
46956740|NCT02526524|83197690|FG002|Overall Study|Withdrawal by Subject|6|||
46956741|NCT02526524|83197691|FG003|Overall Study|Withdrawal by Subject|1|||
46956742|NCT02526524|83197692|FG004|Overall Study|Withdrawal by Subject|9|||
47066989|NCT01449461|83350339|FG000|Overall Study|Clinical Progressive Disease|2|||
46773454|NCT00755846|82991808|FG004|Overall Study|Hyperglycemic Rescue|8|||
46639628|NCT00217464|82813204|FG000|Overall Study|Other|2|||
46639629|NCT00214500|82813208|FG000|Treatment Period|Adverse Event|1|||
46639630|NCT00214500|82813208|FG000|Extension Period|Withdrawal by Subject|2|||
46639631|NCT00211536|82813217|FG000|Overall Study|Withdrawal by Subject|2|||
46639632|NCT00211536|82813218|FG001|Overall Study|Withdrawal by Subject|2|||
46639633|NCT00211536|82813217|FG000|Overall Study|Physician Decision|0|||
46639634|NCT00211536|82813218|FG001|Overall Study|Physician Decision|5|||
46639635|NCT00211536|82813217|FG000|Overall Study|Adverse Event|2|||
46639636|NCT00211536|82813218|FG001|Overall Study|Adverse Event|0|||
46639637|NCT03192462|82813270|FG000|Overall Study|Death|13|||
46639638|NCT03192462|82813271|FG001|Overall Study|Death|11|||
46639639|NCT03192462|82813272|FG002|Overall Study|Death|9|||
46639640|NCT03192462|82813270|FG000|Overall Study|Lost to Follow-up|0|||
46639641|NCT03192462|82813271|FG001|Overall Study|Lost to Follow-up|1|||
46639642|NCT03192462|82813272|FG002|Overall Study|Lost to Follow-up|0|||
46639643|NCT03192462|82813270|FG000|Overall Study|On follow up|0|||
46639644|NCT03192462|82813271|FG001|Overall Study|On follow up|0|||
46639645|NCT03192462|82813272|FG002|Overall Study|On follow up|3|||
46639646|NCT03589326|82813282|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
46639647|NCT03589326|82813283|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
46639648|NCT03589326|82813282|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
46639649|NCT03589326|82813283|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
46639650|NCT03589326|82813282|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
46956743|NCT02526524|83197693|FG005|Overall Study|Withdrawal by Subject|5|||
46956744|NCT02526524|83197688|FG000|Overall Study|Adverse Event|3|||
46956745|NCT02526524|83197689|FG001|Overall Study|Adverse Event|2|||
46956746|NCT02526524|83197690|FG002|Overall Study|Adverse Event|4|||
47066990|NCT01449461|83350340|FG001|Overall Study|Clinical Progressive Disease|2|||
46639651|NCT03589326|82813283|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
46773455|NCT00755846|82991809|FG005|Overall Study|Hyperglycemic Rescue|7|||
46773456|NCT00755846|82991804|FG000|Overall Study|Physician Decision|1|||
46773457|NCT00755846|82991805|FG001|Overall Study|Physician Decision|3|||
46773458|NCT00755846|82991806|FG002|Overall Study|Physician Decision|0|||
46773459|NCT00755846|82991807|FG003|Overall Study|Physician Decision|1|||
46773460|NCT00755846|82991808|FG004|Overall Study|Physician Decision|0|||
46773461|NCT00755846|82991809|FG005|Overall Study|Physician Decision|1|||
46773462|NCT00755846|82991804|FG000|Overall Study|Administrative Error|0|||
46773463|NCT00755846|82991805|FG001|Overall Study|Administrative Error|1|||
46773464|NCT00755846|82991806|FG002|Overall Study|Administrative Error|0|||
46773465|NCT00755846|82991807|FG003|Overall Study|Administrative Error|0|||
46956747|NCT02526524|83197691|FG003|Overall Study|Adverse Event|2|||
46639652|NCT03589326|82813282|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
46639653|NCT03589326|82813283|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
46956748|NCT02526524|83197692|FG004|Overall Study|Adverse Event|6|||
47066991|NCT01449461|83350341|FG002|Overall Study|Clinical Progressive Disease|0|||
46639654|NCT03589326|82813282|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
46639655|NCT03589326|82813283|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
46639656|NCT03028740|82813304|FG000|Overall Study|Did not Receive Study Drug|4|||
46639657|NCT03028740|82813305|FG001|Overall Study|Did not Receive Study Drug|5|||
46956749|NCT02526524|83197693|FG005|Overall Study|Adverse Event|8|||
46956750|NCT02526524|83197688|FG000|Overall Study|Lost to Follow-up|2|||
46956751|NCT02526524|83197689|FG001|Overall Study|Lost to Follow-up|3|||
46956752|NCT02526524|83197690|FG002|Overall Study|Lost to Follow-up|8|||
46956753|NCT02526524|83197691|FG003|Overall Study|Lost to Follow-up|1|||
46956754|NCT02526524|83197692|FG004|Overall Study|Lost to Follow-up|2|||
46956755|NCT02526524|83197693|FG005|Overall Study|Lost to Follow-up|5|||
46956756|NCT02526524|83197688|FG000|Overall Study|Protocol Violation|3|||
46956757|NCT02526524|83197689|FG001|Overall Study|Protocol Violation|1|||
46956758|NCT02526524|83197690|FG002|Overall Study|Protocol Violation|5|||
46956759|NCT02526524|83197691|FG003|Overall Study|Protocol Violation|3|||
46956760|NCT02526524|83197692|FG004|Overall Study|Protocol Violation|4|||
46956761|NCT02526524|83197693|FG005|Overall Study|Protocol Violation|3|||
46956762|NCT02526524|83197688|FG000|Overall Study|Loss of Glucose Control|0|||
46956763|NCT02526524|83197689|FG001|Overall Study|Loss of Glucose Control|0|||
46956764|NCT02526524|83197690|FG002|Overall Study|Loss of Glucose Control|3|||
46956765|NCT02526524|83197691|FG003|Overall Study|Loss of Glucose Control|0|||
46956766|NCT02526524|83197692|FG004|Overall Study|Loss of Glucose Control|2|||
46956767|NCT02526524|83197693|FG005|Overall Study|Loss of Glucose Control|0|||
46956768|NCT02526524|83197688|FG000|Overall Study|Physician Decision|0|||
46956769|NCT02526524|83197689|FG001|Overall Study|Physician Decision|0|||
46956770|NCT02526524|83197690|FG002|Overall Study|Physician Decision|0|||
46956771|NCT02526524|83197691|FG003|Overall Study|Physician Decision|0|||
46956772|NCT02526524|83197692|FG004|Overall Study|Physician Decision|1|||
46956773|NCT02526524|83197693|FG005|Overall Study|Physician Decision|0|||
46956774|NCT02526524|83197688|FG000|Overall Study|Sponsor Decision|1|||
46956775|NCT02526524|83197689|FG001|Overall Study|Sponsor Decision|0|||
46956776|NCT02526524|83197690|FG002|Overall Study|Sponsor Decision|0|||
46956777|NCT02526524|83197691|FG003|Overall Study|Sponsor Decision|0|||
46956778|NCT02526524|83197692|FG004|Overall Study|Sponsor Decision|0|||
46956779|NCT02526524|83197693|FG005|Overall Study|Sponsor Decision|0|||
46956780|NCT02526290|83197707|FG000|Overall Study|Adverse Event|3|||
46956781|NCT02526290|83197707|FG000|Overall Study|Withdrawal by Subject|4|||
46956782|NCT02526290|83197707|FG000|Overall Study|Physician Decision|1|||
46956783|NCT02319148|83197714|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
46956784|NCT02319148|83197715|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
46956785|NCT02319148|83197716|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
46956786|NCT02319148|83197717|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
46956787|NCT02319148|83197714|FG000|Second Intervention Period|No longer willing to participate|0|||
46956788|NCT02319148|83197715|FG001|Second Intervention Period|No longer willing to participate|1|||
46956789|NCT02319148|83197716|FG002|Second Intervention Period|No longer willing to participate|0|||
46956790|NCT02319148|83197717|FG003|Second Intervention Period|No longer willing to participate|0|||
46956791|NCT02319148|83197714|FG000|Second Intervention Period|Other|0|||
46956792|NCT02319148|83197715|FG001|Second Intervention Period|Other|0|||
46956793|NCT02319148|83197716|FG002|Second Intervention Period|Other|0|||
46956794|NCT02319148|83197717|FG003|Second Intervention Period|Other|1|||
46956795|NCT02526212|83197738|FG000|Overall Study|Incarceration|1|||
46956796|NCT02526212|83197739|FG001|Overall Study|Incarceration|0|||
46956797|NCT02526212|83197738|FG000|Overall Study|Lost to Follow-up|1|||
46956798|NCT02526212|83197739|FG001|Overall Study|Lost to Follow-up|0|||
46956799|NCT02526212|83197738|FG000|Overall Study|Death|0|||
46956800|NCT02526212|83197739|FG001|Overall Study|Death|1|||
46956801|NCT02532374|83197745|FG000|Overall Study|Withdrawal by Subject|1|||
46956802|NCT02532374|83197745|FG000|Overall Study|Physician Decision|1|||
46956803|NCT05366738|83197760|FG000|Overall Study|Adverse Event|0|||
46956804|NCT05366738|83197761|FG001|Overall Study|Adverse Event|1|||
46956805|NCT05366738|83197762|FG002|Overall Study|Adverse Event|0|||
46956806|NCT02525744|83197770|FG000|Period 1|Physician Decision|0|||
46956807|NCT02525744|83197771|FG001|Period 1|Physician Decision|0|||
46956808|NCT02525744|83197772|FG002|Period 1|Physician Decision|1|||
46956809|NCT02525744|83197773|FG003|Period 1|Physician Decision|0|||
46956810|NCT02525744|83197770|FG000|Period 3|Adverse Event|0|||
46956811|NCT02525744|83197771|FG001|Period 3|Adverse Event|1|||
46956812|NCT02525744|83197772|FG002|Period 3|Adverse Event|0|||
46956813|NCT02525744|83197773|FG003|Period 3|Adverse Event|0|||
46956814|NCT02525744|83197770|FG000|Period 4|Withdrawal by Subject|1|||
46956815|NCT02525744|83197771|FG001|Period 4|Withdrawal by Subject|0|||
46956816|NCT02525744|83197772|FG002|Period 4|Withdrawal by Subject|0|||
46956817|NCT02525744|83197773|FG003|Period 4|Withdrawal by Subject|0|||
46956818|NCT02525744|83197770|FG000|Period 5|Physician Decision|1|||
46956819|NCT02525744|83197771|FG001|Period 5|Physician Decision|0|||
46956820|NCT02525744|83197772|FG002|Period 5|Physician Decision|0|||
46956821|NCT02525744|83197773|FG003|Period 5|Physician Decision|0|||
46956822|NCT00152477|83197786|FG000|Chemotherapy Period|Adverse Event|9|||
46956823|NCT00152477|83197787|FG001|Chemotherapy Period|Adverse Event|4|||
46956824|NCT00152477|83197788|FG002|Chemotherapy Period|Adverse Event|5|||
46956825|NCT00152477|83197786|FG000|Chemotherapy Period|Death|1|||
46956826|NCT00152477|83197787|FG001|Chemotherapy Period|Death|3|||
46956827|NCT00152477|83197788|FG002|Chemotherapy Period|Death|3|||
46956828|NCT00152477|83197786|FG000|Chemotherapy Period|Lack of Efficacy|4|||
46639658|NCT03028740|82813304|FG000|Overall Study|Adverse Event|8|||
46639659|NCT03028740|82813305|FG001|Overall Study|Adverse Event|26|||
46956829|NCT00152477|83197787|FG001|Chemotherapy Period|Lack of Efficacy|5|||
46956830|NCT00152477|83197788|FG002|Chemotherapy Period|Lack of Efficacy|6|||
46956831|NCT00152477|83197786|FG000|Chemotherapy Period|Lost to Follow-up|1|||
46956832|NCT00152477|83197787|FG001|Chemotherapy Period|Lost to Follow-up|0|||
46956833|NCT00152477|83197788|FG002|Chemotherapy Period|Lost to Follow-up|1|||
46956834|NCT00152477|83197786|FG000|Chemotherapy Period|Protocol Violation|1|||
46956835|NCT00152477|83197787|FG001|Chemotherapy Period|Protocol Violation|1|||
46956836|NCT00152477|83197788|FG002|Chemotherapy Period|Protocol Violation|0|||
46956837|NCT00152477|83197786|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
46956838|NCT00152477|83197787|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
46956839|NCT00152477|83197788|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
46956840|NCT00152477|83197786|FG000|Chemotherapy Period|Progression of Disease|6|||
46956841|NCT00152477|83197787|FG001|Chemotherapy Period|Progression of Disease|8|||
46956842|NCT00152477|83197788|FG002|Chemotherapy Period|Progression of Disease|4|||
46956843|NCT00152477|83197786|FG000|Chemotherapy Period|Investigator decision|0|||
46956844|NCT00152477|83197787|FG001|Chemotherapy Period|Investigator decision|0|||
46956845|NCT00152477|83197788|FG002|Chemotherapy Period|Investigator decision|1|||
46956846|NCT00152477|83197786|FG000|Chemotherapy Period|Patient condition worsened|1|||
46956847|NCT00152477|83197787|FG001|Chemotherapy Period|Patient condition worsened|0|||
46956848|NCT00152477|83197788|FG002|Chemotherapy Period|Patient condition worsened|0|||
46956849|NCT00152477|83197786|FG000|Monotherapy Period|Adverse Event|1|||
46956850|NCT00152477|83197787|FG001|Monotherapy Period|Adverse Event|0|||
46956851|NCT00152477|83197788|FG002|Monotherapy Period|Adverse Event|5|||
46956852|NCT00152477|83197786|FG000|Monotherapy Period|Death|2|||
46956853|NCT00152477|83197787|FG001|Monotherapy Period|Death|0|||
46956854|NCT00152477|83197788|FG002|Monotherapy Period|Death|1|||
46956855|NCT00152477|83197786|FG000|Monotherapy Period|Lack of Efficacy|7|||
46956856|NCT00152477|83197787|FG001|Monotherapy Period|Lack of Efficacy|16|||
46956857|NCT00152477|83197788|FG002|Monotherapy Period|Lack of Efficacy|10|||
46956858|NCT00152477|83197786|FG000|Monotherapy Period|Protocol Violation|0|||
46956859|NCT00152477|83197787|FG001|Monotherapy Period|Protocol Violation|1|||
46956860|NCT00152477|83197788|FG002|Monotherapy Period|Protocol Violation|0|||
46956861|NCT00152477|83197786|FG000|Monotherapy Period|Withdrawal by Subject|0|||
46956862|NCT00152477|83197787|FG001|Monotherapy Period|Withdrawal by Subject|0|||
46956863|NCT00152477|83197788|FG002|Monotherapy Period|Withdrawal by Subject|4|||
46956864|NCT00152477|83197786|FG000|Monotherapy Period|Progression of Disease|5|||
46956865|NCT00152477|83197787|FG001|Monotherapy Period|Progression of Disease|11|||
46956866|NCT00152477|83197788|FG002|Monotherapy Period|Progression of Disease|12|||
46956867|NCT00152477|83197786|FG000|Monotherapy Period|Patient decision|0|||
46956868|NCT00152477|83197787|FG001|Monotherapy Period|Patient decision|1|||
46956869|NCT00152477|83197788|FG002|Monotherapy Period|Patient decision|1|||
46956870|NCT00152477|83197786|FG000|Monotherapy Period|Study personel decision|0|||
46956871|NCT00152477|83197787|FG001|Monotherapy Period|Study personel decision|0|||
46956872|NCT00152477|83197788|FG002|Monotherapy Period|Study personel decision|1|||
46956873|NCT00153179|83197801|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
46956874|NCT00153179|83197802|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
46956875|NCT00153179|83197803|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
46956876|NCT00153179|83197804|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
46956877|NCT02743949|83197815|FG000|Overall Study|Adverse Event|0|||
46773466|NCT00755846|82991808|FG004|Overall Study|Administrative Error|0|||
46773467|NCT00755846|82991809|FG005|Overall Study|Administrative Error|0|||
46773468|NCT00755846|82991804|FG000|Overall Study|Participant Non-compliance|0|||
46773469|NCT00755846|82991805|FG001|Overall Study|Participant Non-compliance|0|||
46773470|NCT00755846|82991806|FG002|Overall Study|Participant Non-compliance|0|||
46773471|NCT00755846|82991807|FG003|Overall Study|Participant Non-compliance|0|||
46773472|NCT00755846|82991808|FG004|Overall Study|Participant Non-compliance|1|||
46773473|NCT00755846|82991809|FG005|Overall Study|Participant Non-compliance|0|||
46773474|NCT03850093|82991826|FG000|Overall Study|Withdrawal by Subject|1|||
46773475|NCT03850093|82991827|FG001|Overall Study|Withdrawal by Subject|0|||
46773476|NCT03850093|82991828|FG002|Overall Study|Withdrawal by Subject|2|||
46773477|NCT00442117|82991838|FG000|Overall Study|Adverse Event|3|||
46773478|NCT00442117|82991839|FG001|Overall Study|Adverse Event|2|||
46773479|NCT00442117|82991838|FG000|Overall Study|Lack of Efficacy|2|||
46773480|NCT00442117|82991839|FG001|Overall Study|Lack of Efficacy|6|||
46956878|NCT02743949|83197816|FG001|Overall Study|Adverse Event|0|||
46773481|NCT00442117|82991838|FG000|Overall Study|Lost to Follow-up|1|||
46773482|NCT00442117|82991839|FG001|Overall Study|Lost to Follow-up|2|||
46844626|NCT00223080|83061449|FG001|Overall Study|Withdrawal by Subject|232|||
46844627|NCT00223080|83061448|FG000|Overall Study|Required contraindicated med|0|||
46773483|NCT00442117|82991838|FG000|Overall Study|Withdrawal by Subject|2|||
46844628|NCT00223080|83061449|FG001|Overall Study|Required contraindicated med|1|||
46956879|NCT02743949|83197817|FG002|Overall Study|Adverse Event|2|||
46956880|NCT02743949|83197815|FG000|Overall Study|Significant Protocol Deviation|2|||
46639660|NCT03028740|82813304|FG000|Overall Study|Lack of Efficacy|0|||
46639661|NCT03028740|82813305|FG001|Overall Study|Lack of Efficacy|1|||
46639662|NCT03028740|82813304|FG000|Overall Study|Withdrawal by Subject|48|||
46639663|NCT03028740|82813305|FG001|Overall Study|Withdrawal by Subject|101|||
46639664|NCT03028740|82813304|FG000|Overall Study|Lost to Follow-up|30|||
46639665|NCT03028740|82813305|FG001|Overall Study|Lost to Follow-up|54|||
46639666|NCT03028740|82813304|FG000|Overall Study|Physician Decision|4|||
46639667|NCT03028740|82813305|FG001|Overall Study|Physician Decision|11|||
46639668|NCT03028740|82813304|FG000|Overall Study|Protocol Violation|4|||
46639669|NCT03028740|82813305|FG001|Overall Study|Protocol Violation|8|||
46639670|NCT03028740|82813304|FG000|Overall Study|Non-compliance with Study Drug|0|||
46639671|NCT03028740|82813305|FG001|Overall Study|Non-compliance with Study Drug|2|||
46639672|NCT03028740|82813304|FG000|Overall Study|Study Terminated by Sponsor|467|||
46639673|NCT03028740|82813305|FG001|Overall Study|Study Terminated by Sponsor|917|||
46639674|NCT03028740|82813304|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
46639675|NCT03028740|82813305|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
46639676|NCT03028740|82813304|FG000|Overall Study|Reason not Specified|1|||
46639677|NCT03028740|82813305|FG001|Overall Study|Reason not Specified|5|||
46639678|NCT02980692|82813328|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
46639679|NCT02980692|82813329|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
46639680|NCT02980692|82813330|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
46639681|NCT02980692|82813331|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
46639682|NCT02980692|82813332|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
46639683|NCT02980692|82813328|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
46639684|NCT02980692|82813329|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
46639685|NCT02980692|82813330|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
46639686|NCT02980692|82813331|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
46639687|NCT02980692|82813332|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
46639688|NCT02980692|82813328|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
46639689|NCT02980692|82813329|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
46639690|NCT02980692|82813330|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
46639691|NCT02980692|82813331|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
46639692|NCT02980692|82813332|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
46639693|NCT02980692|82813328|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
46639694|NCT02980692|82813329|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
46639695|NCT02980692|82813330|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
46639696|NCT02980692|82813331|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
46639697|NCT02980692|82813332|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
46639698|NCT02980692|82813328|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
46639699|NCT02980692|82813329|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
46639700|NCT02980692|82813330|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
46639701|NCT02980692|82813331|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
46639702|NCT02980692|82813332|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
46639703|NCT02980692|82813328|FG000|Double Blind Placebo Controlled Period|Other|1|||
46639704|NCT02980692|82813329|FG001|Double Blind Placebo Controlled Period|Other|0|||
46639705|NCT02980692|82813330|FG002|Double Blind Placebo Controlled Period|Other|0|||
46639706|NCT02980692|82813331|FG003|Double Blind Placebo Controlled Period|Other|0|||
46639707|NCT02980692|82813332|FG004|Double Blind Placebo Controlled Period|Other|1|||
46639708|NCT02980692|82813328|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
46639709|NCT02980692|82813329|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
46639710|NCT02980692|82813330|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
46639711|NCT02980692|82813331|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
46639712|NCT02980692|82813332|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
46639713|NCT02980692|82813328|FG000|Double-blind Follow-up Period|Adverse Event|0|||
46639714|NCT02980692|82813329|FG001|Double-blind Follow-up Period|Adverse Event|0|||
46639715|NCT02980692|82813330|FG002|Double-blind Follow-up Period|Adverse Event|0|||
46639716|NCT02980692|82813331|FG003|Double-blind Follow-up Period|Adverse Event|1|||
46639717|NCT02980692|82813332|FG004|Double-blind Follow-up Period|Adverse Event|1|||
46639718|NCT02980692|82813328|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
46639719|NCT02980692|82813329|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
46639720|NCT02980692|82813330|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
46639721|NCT02980692|82813331|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
46844629|NCT00223080|83061448|FG000|Overall Study|Non-compliant|7|||
46844630|NCT00223080|83061449|FG001|Overall Study|Non-compliant|7|||
46844631|NCT00223080|83061448|FG000|Overall Study|Moved from study area|37|||
46844632|NCT00223080|83061449|FG001|Overall Study|Moved from study area|47|||
46639722|NCT02980692|82813332|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
46639723|NCT02980692|82813328|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
46639724|NCT02980692|82813329|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
46639725|NCT02980692|82813330|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
46639726|NCT02980692|82813331|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
46639727|NCT02980692|82813332|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
46639728|NCT02980692|82813328|FG000|Double-blind Follow-up Period|Pregnancy|0|||
46639729|NCT02980692|82813329|FG001|Double-blind Follow-up Period|Pregnancy|0|||
46639730|NCT02980692|82813330|FG002|Double-blind Follow-up Period|Pregnancy|1|||
46639731|NCT02980692|82813331|FG003|Double-blind Follow-up Period|Pregnancy|1|||
46639732|NCT02980692|82813332|FG004|Double-blind Follow-up Period|Pregnancy|0|||
46639733|NCT02980692|82813328|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
46639734|NCT02980692|82813329|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
46639735|NCT02980692|82813330|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
46639736|NCT02980692|82813331|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
46639737|NCT02980692|82813332|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
46639738|NCT02980692|82813328|FG000|Double-blind Follow-up Period|Other|0|||
46639739|NCT02980692|82813329|FG001|Double-blind Follow-up Period|Other|0|||
46639740|NCT02980692|82813330|FG002|Double-blind Follow-up Period|Other|1|||
46639741|NCT02980692|82813331|FG003|Double-blind Follow-up Period|Other|1|||
46639742|NCT02980692|82813332|FG004|Double-blind Follow-up Period|Other|3|||
46639743|NCT04439279|82813574|FG000|Overall Study|Adverse Event|7|||
46639744|NCT04439279|82813574|FG000|Overall Study|Death|4|||
46639745|NCT04439279|82813574|FG000|Overall Study|Disease progression|17|||
46639746|NCT04439279|82813574|FG000|Overall Study|Complicating disease|3|||
46639747|NCT04439279|82813574|FG000|Overall Study|Withdrawal by Subject|2|||
46639748|NCT04439279|82813574|FG000|Overall Study|Ineligible|1|||
46639749|NCT04439279|82813574|FG000|Overall Study|Treatment still ongoing|1|||
46639750|NCT04123548|82813604|FG000|Overall Study|Withdrawal by Subject|1|||
46639751|NCT04123548|82813604|FG000|Overall Study|Lost to Follow-up|8|||
46639752|NCT04123548|82813604|FG000|Overall Study|Death|4|||
46639753|NCT04123548|82813604|FG000|Overall Study|Reason Not Specified|1|||
46639754|NCT04022733|82813610|FG000|Overall Study|conversion to open surgery|3|||
46639755|NCT04022733|82813611|FG001|Overall Study|conversion to open surgery|2|||
46639756|NCT04022733|82813610|FG000|Overall Study|bradycardia|0|||
46639757|NCT04022733|82813611|FG001|Overall Study|bradycardia|1|||
46639758|NCT03593915|82813640|FG000|Overall Study|Adverse Event|0|||
46639759|NCT03593915|82813641|FG001|Overall Study|Adverse Event|0|||
46639760|NCT03593915|82813642|FG002|Overall Study|Adverse Event|0|||
46639761|NCT03593915|82813643|FG003|Overall Study|Adverse Event|1|||
46639762|NCT03593915|82813644|FG004|Overall Study|Adverse Event|0|||
46639763|NCT03593915|82813645|FG005|Overall Study|Adverse Event|0|||
46639764|NCT03593915|82813640|FG000|Overall Study|Physician Decision|0|||
46639765|NCT03593915|82813641|FG001|Overall Study|Physician Decision|0|||
46639766|NCT03593915|82813642|FG002|Overall Study|Physician Decision|0|||
46639767|NCT03593915|82813643|FG003|Overall Study|Physician Decision|0|||
46639768|NCT03593915|82813644|FG004|Overall Study|Physician Decision|0|||
46639769|NCT03593915|82813645|FG005|Overall Study|Physician Decision|1|||
46639770|NCT03336333|82813672|FG000|Overall Study|Remained on study at time of data cut-off|202|||
46639771|NCT03336333|82813673|FG001|Overall Study|Remained on study at time of data cut-off|219|||
46639772|NCT03336333|82813674|FG002|Overall Study|Remained on study at time of data cut-off|102|||
46639773|NCT03336333|82813672|FG000|Overall Study|Death|14|||
46639774|NCT03336333|82813673|FG001|Overall Study|Death|16|||
46639775|NCT03336333|82813674|FG002|Overall Study|Death|8|||
46639776|NCT03336333|82813672|FG000|Overall Study|Withdrawal by Subject|16|||
46639777|NCT03336333|82813673|FG001|Overall Study|Withdrawal by Subject|5|||
46639778|NCT03336333|82813674|FG002|Overall Study|Withdrawal by Subject|1|||
46639779|NCT03336333|82813672|FG000|Overall Study|Physician Decision|5|||
46639780|NCT03336333|82813673|FG001|Overall Study|Physician Decision|1|||
46639781|NCT03336333|82813674|FG002|Overall Study|Physician Decision|0|||
46639782|NCT03336333|82813672|FG000|Overall Study|Lost to Follow-up|1|||
47066992|NCT01449461|83350342|FG003|Overall Study|Clinical Progressive Disease|3|||
47066993|NCT01449461|83350343|FG004|Overall Study|Clinical Progressive Disease|4|||
47066994|NCT01449461|83350344|FG005|Overall Study|Clinical Progressive Disease|2|||
46639783|NCT03336333|82813673|FG001|Overall Study|Lost to Follow-up|0|||
46639784|NCT03336333|82813674|FG002|Overall Study|Lost to Follow-up|0|||
46639785|NCT03240874|82813685|FG000|Overall Study|Lost to Follow-up|0|||
46639786|NCT03240874|82813686|FG001|Overall Study|Lost to Follow-up|2|||
46773484|NCT00442117|82991839|FG001|Overall Study|Withdrawal by Subject|2|||
46639787|NCT03240874|82813687|FG002|Overall Study|Lost to Follow-up|4|||
46639788|NCT03240874|82813688|FG003|Overall Study|Lost to Follow-up|1|||
46639789|NCT03083665|82813699|FG000|Double-Blind Period|Adverse Event|5|||
46639790|NCT03083665|82813700|FG001|Double-Blind Period|Adverse Event|4|||
46639791|NCT03083665|82813701|FG002|Double-Blind Period|Adverse Event|5|||
46639792|NCT03083665|82813702|FG003|Double-Blind Period|Adverse Event|0|||
46773485|NCT00442117|82991838|FG000|Overall Study|Major Deviation|25|||
46956881|NCT02743949|83197816|FG001|Overall Study|Significant Protocol Deviation|0|||
46956882|NCT02743949|83197817|FG002|Overall Study|Significant Protocol Deviation|1|||
46956883|NCT02743949|83197815|FG000|Overall Study|Voluntary Withdrawal|2|||
46956884|NCT02743949|83197816|FG001|Overall Study|Voluntary Withdrawal|1|||
46956885|NCT02743949|83197817|FG002|Overall Study|Voluntary Withdrawal|0|||
46956886|NCT02531438|83197827|FG000|Overall Study|Adverse Event|7|||
46956887|NCT02531438|83197828|FG001|Overall Study|Adverse Event|9|||
46956888|NCT02531438|83197827|FG000|Overall Study|Lost to Follow-up|0|||
46956889|NCT02531438|83197828|FG001|Overall Study|Lost to Follow-up|3|||
46956890|NCT02531438|83197827|FG000|Overall Study|Withdrawal by Subject|7|||
46956891|NCT02531438|83197828|FG001|Overall Study|Withdrawal by Subject|8|||
46956892|NCT02531438|83197827|FG000|Overall Study|Physician Decision|0|||
46956893|NCT02531438|83197828|FG001|Overall Study|Physician Decision|1|||
46956894|NCT02531438|83197827|FG000|Overall Study|Death|6|||
46956895|NCT02531438|83197828|FG001|Overall Study|Death|3|||
46956896|NCT02531438|83197827|FG000|Overall Study|Randomized, but Not Treated|4|||
46956897|NCT02531438|83197828|FG001|Overall Study|Randomized, but Not Treated|0|||
46956898|NCT02531438|83197827|FG000|Overall Study|Missed EOT/PTE Visit|5|||
46956899|NCT02531438|83197828|FG001|Overall Study|Missed EOT/PTE Visit|2|||
46956900|NCT02531438|83197827|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
46956901|NCT02531438|83197828|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
46956902|NCT02289898|83197837|FG000|Overall Study|Death|5|||
46956903|NCT02289898|83197838|FG001|Overall Study|Death|4|||
46956904|NCT02289898|83197839|FG002|Overall Study|Death|3|||
46956905|NCT02289898|83197837|FG000|Overall Study|Physician Decision|2|||
46956906|NCT02289898|83197838|FG001|Overall Study|Physician Decision|5|||
46956907|NCT02289898|83197839|FG002|Overall Study|Physician Decision|2|||
46956908|NCT02289898|83197837|FG000|Overall Study|Withdrawal by Subject|0|||
46956909|NCT02289898|83197838|FG001|Overall Study|Withdrawal by Subject|4|||
46956910|NCT02289898|83197839|FG002|Overall Study|Withdrawal by Subject|1|||
46956911|NCT02289898|83197837|FG000|Overall Study|Adverse Event|3|||
46956912|NCT02289898|83197838|FG001|Overall Study|Adverse Event|5|||
46956913|NCT02289898|83197839|FG002|Overall Study|Adverse Event|5|||
46956914|NCT02289898|83197837|FG000|Overall Study|Disease progression|34|||
46956915|NCT02289898|83197838|FG001|Overall Study|Disease progression|28|||
46956916|NCT02289898|83197839|FG002|Overall Study|Disease progression|34|||
46956917|NCT02289898|83197837|FG000|Overall Study|Use of another anticancer therapy|0|||
46956918|NCT02289898|83197838|FG001|Overall Study|Use of another anticancer therapy|0|||
46956919|NCT02289898|83197839|FG002|Overall Study|Use of another anticancer therapy|1|||
46956920|NCT02289898|83197837|FG000|Overall Study|Other|8|||
46956921|NCT02289898|83197838|FG001|Overall Study|Other|7|||
46956922|NCT02289898|83197839|FG002|Overall Study|Other|10|||
46956923|NCT01660412|83197846|FG000|Overall Study|Protocol Violation|0|||
46956924|NCT01660412|83197847|FG001|Overall Study|Protocol Violation|3|||
47066995|NCT01449461|83350339|FG000|Overall Study|Protocol Violation|0|||
47066996|NCT01449461|83350340|FG001|Overall Study|Protocol Violation|0|||
46773486|NCT00442117|82991839|FG001|Overall Study|Major Deviation|20|||
46773487|NCT00442117|82991838|FG000|Overall Study|Non compliance with protocol|3|||
46773488|NCT00442117|82991839|FG001|Overall Study|Non compliance with protocol|5|||
46773489|NCT00442117|82991838|FG000|Overall Study|Met Withdrawal Criteria|2|||
46773490|NCT00442117|82991839|FG001|Overall Study|Met Withdrawal Criteria|1|||
46773491|NCT00752726|82991847|FG000|Overall Study|Lost to Follow-up|2|||
46773492|NCT00752726|82991848|FG001|Overall Study|Lost to Follow-up|1|||
46773493|NCT00752726|82991847|FG000|Overall Study|Adverse Event|3|||
46773494|NCT00752726|82991848|FG001|Overall Study|Adverse Event|0|||
46773495|NCT00752726|82991847|FG000|Overall Study|Withdrawal by Subject|5|||
46773496|NCT00752726|82991848|FG001|Overall Study|Withdrawal by Subject|10|||
46773497|NCT00752726|82991847|FG000|Overall Study|Other Reason|1|||
46773498|NCT00752726|82991848|FG001|Overall Study|Other Reason|2|||
46773499|NCT00755222|82991856|FG000|Overall Study|Withdrawal by Subject|4|||
46773500|NCT00755222|82991857|FG001|Overall Study|Withdrawal by Subject|2|||
46844633|NCT00223080|83061448|FG000|Overall Study|Lost to Follow-up|259|||
46844634|NCT00223080|83061449|FG001|Overall Study|Lost to Follow-up|284|||
46844635|NCT00223080|83061448|FG000|Overall Study|Death|85|||
46844636|NCT00223080|83061449|FG001|Overall Study|Death|74|||
47066997|NCT01449461|83350341|FG002|Overall Study|Protocol Violation|0|||
46956925|NCT01659554|83197853|FG000|Overall Study|Study Termination|4|||
46956926|NCT01659320|83197857|FG000|Overall Study|Withdrawal by Subject|2|||
46956927|NCT01659320|83197857|FG000|Overall Study|Physician Decision|1|||
46956928|NCT01660334|83197861|FG000|Overall Study|Lost to Follow-up|1|||
47066998|NCT01449461|83350342|FG003|Overall Study|Protocol Violation|1|||
47066999|NCT01449461|83350343|FG004|Overall Study|Protocol Violation|0|||
46956929|NCT01660256|83197868|FG000|Overall Study|Adverse Event|4|||
46956930|NCT01660256|83197869|FG001|Overall Study|Adverse Event|0|||
46956931|NCT01660256|83197870|FG002|Overall Study|Adverse Event|2|||
47067000|NCT01449461|83350344|FG005|Overall Study|Protocol Violation|0|||
46773501|NCT00755222|82991856|FG000|Overall Study|Adverse Event|2|||
46773502|NCT00755222|82991857|FG001|Overall Study|Adverse Event|0|||
46956932|NCT01660256|83197868|FG000|Overall Study|Withdrawal by Subject|1|||
46844637|NCT00223080|83061448|FG000|Overall Study|Other|14|||
46639793|NCT03083665|82813703|FG004|Double-Blind Period|Adverse Event|0|||
46956933|NCT01660256|83197869|FG001|Overall Study|Withdrawal by Subject|0|||
46956934|NCT01660256|83197870|FG002|Overall Study|Withdrawal by Subject|2|||
46956935|NCT02034123|83197896|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956936|NCT02034123|83197897|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956937|NCT02034123|83197898|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956938|NCT02034123|83197899|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956939|NCT02034123|83197900|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
46956940|NCT02034123|83197901|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956941|NCT02034123|83197902|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956942|NCT02034123|83197903|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
46956943|NCT02034123|83197904|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
46956944|NCT02034123|83197905|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956945|NCT02034123|83197906|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956946|NCT02034123|83197907|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956947|NCT02034123|83197908|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956948|NCT02034123|83197909|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956949|NCT02034123|83197910|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956950|NCT02034123|83197911|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956951|NCT02034123|83197912|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956952|NCT02034123|83197913|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
46956953|NCT02034123|83197896|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956954|NCT02034123|83197897|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956955|NCT02034123|83197898|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956956|NCT02034123|83197899|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
46956957|NCT02034123|83197900|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956958|NCT02034123|83197901|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956959|NCT02034123|83197902|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956960|NCT02034123|83197903|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956961|NCT02034123|83197904|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956962|NCT02034123|83197905|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956963|NCT02034123|83197906|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956964|NCT02034123|83197907|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956965|NCT02034123|83197908|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956966|NCT02034123|83197909|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956967|NCT02034123|83197910|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956968|NCT02034123|83197911|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956969|NCT02034123|83197912|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956970|NCT02034123|83197913|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
46956971|NCT02034123|83197896|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956972|NCT02034123|83197897|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956973|NCT02034123|83197898|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956974|NCT02034123|83197899|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956975|NCT02034123|83197900|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956976|NCT02034123|83197901|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956977|NCT02034123|83197902|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956978|NCT02034123|83197903|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956979|NCT02034123|83197904|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
46639794|NCT03083665|82813704|FG005|Double-Blind Period|Adverse Event|0|||
46639795|NCT03083665|82813699|FG000|Double-Blind Period|Lack of Efficacy|0|||
46639796|NCT03083665|82813700|FG001|Double-Blind Period|Lack of Efficacy|0|||
46639797|NCT03083665|82813701|FG002|Double-Blind Period|Lack of Efficacy|1|||
46844638|NCT00223080|83061449|FG001|Overall Study|Other|11|||
46844639|NCT00223080|83061448|FG000|Overall Study|Reason not provided|141|||
46844640|NCT00223080|83061449|FG001|Overall Study|Reason not provided|140|||
46844641|NCT00223080|83061448|FG000|Overall Study|Adverse Event|0|||
46844642|NCT00223080|83061449|FG001|Overall Study|Adverse Event|1|||
46844643|NCT00220740|83061457|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
46844644|NCT00220740|83061458|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
46844645|NCT00220740|83061457|FG000|Efficacy Period|Adverse Event|1|||
46844646|NCT00220740|83061458|FG001|Efficacy Period|Adverse Event|1|||
46844647|NCT00220740|83061457|FG000|Efficacy Period|Withdrawal by Subject|1|||
46844648|NCT00220740|83061458|FG001|Efficacy Period|Withdrawal by Subject|0|||
46844649|NCT00220740|83061457|FG000|Efficacy Period|Protocol Violation|1|||
46844650|NCT00220740|83061458|FG001|Efficacy Period|Protocol Violation|0|||
46844651|NCT00220740|83061457|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
46956980|NCT02034123|83197905|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956981|NCT02034123|83197906|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956982|NCT02034123|83197907|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956983|NCT02034123|83197908|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956984|NCT02034123|83197909|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956985|NCT02034123|83197910|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956986|NCT02034123|83197911|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956987|NCT02034123|83197912|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956988|NCT02034123|83197913|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
46956989|NCT02034123|83197896|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956990|NCT02034123|83197897|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956991|NCT02034123|83197898|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956992|NCT02034123|83197899|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
46956993|NCT02034123|83197900|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
46956994|NCT02034123|83197901|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956995|NCT02034123|83197902|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956996|NCT02034123|83197903|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956997|NCT02034123|83197904|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956998|NCT02034123|83197905|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46956999|NCT02034123|83197906|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957000|NCT02034123|83197907|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957001|NCT02034123|83197908|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957002|NCT02034123|83197909|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957003|NCT02034123|83197910|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957004|NCT02034123|83197911|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957005|NCT02034123|83197912|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957006|NCT02034123|83197913|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
46957007|NCT02318602|83197959|FG000|Overall Study|Adverse Event|0|||
46957008|NCT02318602|83197960|FG001|Overall Study|Adverse Event|1|||
46957009|NCT02318602|83197961|FG002|Overall Study|Adverse Event|1|||
46957010|NCT02318602|83197959|FG000|Overall Study|Withdrawal by Subject|0|||
46957011|NCT02318602|83197960|FG001|Overall Study|Withdrawal by Subject|3|||
46957012|NCT02318602|83197961|FG002|Overall Study|Withdrawal by Subject|0|||
46957013|NCT02318602|83197959|FG000|Overall Study|Death|1|||
46957014|NCT02318602|83197960|FG001|Overall Study|Death|0|||
46957015|NCT02318602|83197961|FG002|Overall Study|Death|0|||
46957016|NCT02318602|83197959|FG000|Overall Study|Guardian decision to withdraw|0|||
46957017|NCT02318602|83197960|FG001|Overall Study|Guardian decision to withdraw|0|||
46957018|NCT02318602|83197961|FG002|Overall Study|Guardian decision to withdraw|1|||
46957019|NCT02318368|83197977|FG000|Overall Study|Withdrawal by Subject|2|||
46957020|NCT02318368|83197978|FG001|Overall Study|Withdrawal by Subject|0|||
46957021|NCT02318368|83197977|FG000|Overall Study|Study terminated by the sponsor|5|||
46957022|NCT02318368|83197978|FG001|Overall Study|Study terminated by the sponsor|2|||
46957023|NCT02318368|83197977|FG000|Overall Study|Death|0|||
46957024|NCT02318368|83197978|FG001|Overall Study|Death|1|||
46957025|NCT02318134|83197986|FG000|Overall Study|Withdrawal by Subject|2|||
46957026|NCT02318134|83197987|FG001|Overall Study|Withdrawal by Subject|1|||
46957027|NCT02317510|83197997|FG000|Overall Study|Adverse Event|0|||
46957028|NCT02317510|83197998|FG001|Overall Study|Adverse Event|1|||
46957029|NCT02317432|83198009|FG000|Overall Study|Death|4|||
46957030|NCT02317432|83198010|FG001|Overall Study|Death|1|||
46957031|NCT02317432|83198009|FG000|Overall Study|Lost to Follow-up|0|||
46957032|NCT02317432|83198010|FG001|Overall Study|Lost to Follow-up|5|||
46957033|NCT02317432|83198009|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
46957034|NCT02317432|83198010|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
46957035|NCT02289820|83198023|FG000|Overall Study|Withdrawal by Subject|2|||
46957036|NCT02289820|83198024|FG001|Overall Study|Withdrawal by Subject|1|||
46957037|NCT02289820|83198025|FG002|Overall Study|Withdrawal by Subject|2|||
46957038|NCT02289820|83198026|FG003|Overall Study|Withdrawal by Subject|1|||
46957039|NCT02289820|83198027|FG004|Overall Study|Withdrawal by Subject|0|||
46957040|NCT02289820|83198028|FG005|Overall Study|Withdrawal by Subject|0|||
46957041|NCT02289820|83198029|FG006|Overall Study|Withdrawal by Subject|1|||
46957042|NCT02289820|83198023|FG000|Overall Study|Death|0|||
46957043|NCT02289820|83198024|FG001|Overall Study|Death|0|||
46957044|NCT02289820|83198025|FG002|Overall Study|Death|1|||
46957045|NCT02289820|83198026|FG003|Overall Study|Death|0|||
47067001|NCT01449461|83350339|FG000|Overall Study|Site Terminated by Sponsor|0|||
46957046|NCT02289820|83198027|FG004|Overall Study|Death|0|||
46957047|NCT02289820|83198028|FG005|Overall Study|Death|0|||
46957048|NCT02289820|83198029|FG006|Overall Study|Death|0|||
46957049|NCT02289820|83198023|FG000|Overall Study|Lost to Follow-up|0|||
46957050|NCT02289820|83198024|FG001|Overall Study|Lost to Follow-up|0|||
46957051|NCT02289820|83198025|FG002|Overall Study|Lost to Follow-up|3|||
46957052|NCT02289820|83198026|FG003|Overall Study|Lost to Follow-up|1|||
46957053|NCT02289820|83198027|FG004|Overall Study|Lost to Follow-up|0|||
46957054|NCT02289820|83198028|FG005|Overall Study|Lost to Follow-up|1|||
46957055|NCT02289820|83198029|FG006|Overall Study|Lost to Follow-up|1|||
46957056|NCT02289820|83198023|FG000|Overall Study|withdrawal of consent|0|||
46957057|NCT02289820|83198024|FG001|Overall Study|withdrawal of consent|1|||
46957058|NCT02289820|83198025|FG002|Overall Study|withdrawal of consent|0|||
46957059|NCT02289820|83198026|FG003|Overall Study|withdrawal of consent|0|||
46957060|NCT02289820|83198027|FG004|Overall Study|withdrawal of consent|0|||
46957061|NCT02289820|83198028|FG005|Overall Study|withdrawal of consent|0|||
46957062|NCT02289820|83198029|FG006|Overall Study|withdrawal of consent|0|||
46957063|NCT02289742|83198051|FG000|First Wear Period|Adverse event prior to treatment|0|||
46957064|NCT02289742|83198052|FG001|First Wear Period|Adverse event prior to treatment|1|||
46957065|NCT02289742|83198053|FG002|First Wear Period|Adverse event prior to treatment|0|||
46957066|NCT02289742|83198054|FG003|First Wear Period|Adverse event prior to treatment|0|||
46957067|NCT02289742|83198051|FG000|First Wear Period|Adverse Event|0|||
46957068|NCT02289742|83198052|FG001|First Wear Period|Adverse Event|0|||
46957069|NCT02289742|83198053|FG002|First Wear Period|Adverse Event|1|||
46957070|NCT02289742|83198054|FG003|First Wear Period|Adverse Event|0|||
46957071|NCT02289742|83198051|FG000|First Wear Period|Other prior to treatment|0|||
46957072|NCT02289742|83198052|FG001|First Wear Period|Other prior to treatment|0|||
46957073|NCT02289742|83198053|FG002|First Wear Period|Other prior to treatment|0|||
46957074|NCT02289742|83198054|FG003|First Wear Period|Other prior to treatment|1|||
46957075|NCT02289742|83198051|FG000|Third Wear Period|Adverse Event|0|||
46957076|NCT02289742|83198052|FG001|Third Wear Period|Adverse Event|1|||
46957077|NCT02289742|83198053|FG002|Third Wear Period|Adverse Event|0|||
46957078|NCT02289742|83198054|FG003|Third Wear Period|Adverse Event|0|||
46957079|NCT02289742|83198051|FG000|Third Wear Period|Reason not given|0|||
46957080|NCT02289742|83198052|FG001|Third Wear Period|Reason not given|0|||
46957081|NCT02289742|83198053|FG002|Third Wear Period|Reason not given|0|||
46957082|NCT02289742|83198054|FG003|Third Wear Period|Reason not given|1|||
46957083|NCT02289352|83198071|FG000|Overall Study|Withdrawal by Subject|1|||
46957084|NCT02289352|83198072|FG001|Overall Study|Withdrawal by Subject|1|||
46957085|NCT02289352|83198073|FG002|Overall Study|Withdrawal by Subject|0|||
46957086|NCT02315560|83198082|FG000|Overall Study|noncompliance by subjects|3|||
46957087|NCT02522624|83198088|FG000|Overall Study|Technical failure|1|||
46957088|NCT02522624|83198089|FG001|Overall Study|Technical failure|0|||
46957089|NCT02287402|83198095|FG000|Treatment Period|Adverse Event|17|||
46957090|NCT02287402|83198095|FG000|Treatment Period|Voluntary Withdrawal|10|||
46957091|NCT02287402|83198095|FG000|Follow-up|Lost to Follow-up|1|||
46957092|NCT02287402|83198095|FG000|Follow-up|Voluntary Withdrawal|2|||
46957093|NCT02314780|83198102|FG000|Overall Study|organizational reasons|0|||
46957094|NCT02314780|83198103|FG001|Overall Study|organizational reasons|2|||
46957095|NCT02314780|83198104|FG002|Overall Study|organizational reasons|0|||
46957096|NCT02314780|83198102|FG000|Overall Study|Adverse Event|0|||
46957097|NCT02314780|83198103|FG001|Overall Study|Adverse Event|1|||
46957098|NCT02314780|83198104|FG002|Overall Study|Adverse Event|0|||
46957099|NCT02288182|83198114|FG000|Overall Study|Adverse Event|0|||
46957100|NCT02288182|83198115|FG001|Overall Study|Adverse Event|1|||
46957101|NCT02288182|83198114|FG000|Overall Study|Lost to Follow-up|0|||
46957102|NCT02288182|83198115|FG001|Overall Study|Lost to Follow-up|1|||
46957103|NCT02286466|83198125|FG000|Overall Study|Death|1|||
46957104|NCT02286466|83198126|FG001|Overall Study|Death|3|||
46957105|NCT02286466|83198125|FG000|Overall Study|Withdrawal by Subject|5|||
46957106|NCT02286466|83198126|FG001|Overall Study|Withdrawal by Subject|2|||
46957107|NCT02286466|83198125|FG000|Overall Study|Lost to Follow-up|1|||
46957108|NCT02286466|83198126|FG001|Overall Study|Lost to Follow-up|4|||
46773503|NCT00755222|82991856|FG000|Overall Study|Protocol Violation|2|||
46773504|NCT00755222|82991857|FG001|Overall Study|Protocol Violation|0|||
46773505|NCT00441727|82991866|FG000|Overall Study|Protocol Violation|19|||
46957109|NCT02286466|83198125|FG000|Overall Study|Declined Clinician Assessment|0|||
46957110|NCT02286466|83198126|FG001|Overall Study|Declined Clinician Assessment|1|||
46957111|NCT02313766|83198135|FG000|Overall Study|surgery cancelled|1|||
46773506|NCT00441727|82991867|FG001|Overall Study|Protocol Violation|28|||
46773507|NCT00441727|82991868|FG002|Overall Study|Protocol Violation|32|||
46773508|NCT00441727|82991866|FG000|Overall Study|Adverse Event|26|||
46957112|NCT02313766|83198136|FG001|Overall Study|surgery cancelled|0|||
46957113|NCT02313766|83198137|FG002|Overall Study|surgery cancelled|0|||
46957114|NCT02313766|83198135|FG000|Overall Study|Lost to Follow-up|0|||
46957115|NCT02313766|83198136|FG001|Overall Study|Lost to Follow-up|2|||
46957116|NCT02313766|83198137|FG002|Overall Study|Lost to Follow-up|0|||
46957117|NCT02313766|83198135|FG000|Overall Study|Adverse Event|0|||
46957118|NCT02313766|83198136|FG001|Overall Study|Adverse Event|1|||
46957119|NCT02313766|83198137|FG002|Overall Study|Adverse Event|0|||
46957120|NCT01646398|83198147|FG000|Overall Study|Withdrawal by Subject|1|||
46957121|NCT01646398|83198148|FG001|Overall Study|Withdrawal by Subject|0|||
46957122|NCT01646320|83198156|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
46957123|NCT01646320|83198157|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
46957124|NCT01646320|83198156|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
46957125|NCT01646320|83198157|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
46957126|NCT01646320|83198156|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
46957127|NCT01646320|83198157|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
46957128|NCT01646320|83198156|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
46957129|NCT01646320|83198157|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
46957130|NCT01646320|83198156|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
46957131|NCT01646320|83198157|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
46957132|NCT01646320|83198156|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
46957133|NCT01646320|83198157|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
46957134|NCT01646320|83198156|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
46957135|NCT01646320|83198157|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
46957136|NCT01646320|83198156|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
46957137|NCT01646320|83198157|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
46957138|NCT01646320|83198156|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
46957139|NCT01646320|83198157|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
46957140|NCT01646320|83198156|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
46957141|NCT01646320|83198157|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
46957142|NCT01646320|83198156|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
46957143|NCT01646320|83198157|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
46957144|NCT01658150|83198163|FG000|Overall Study|Withdrawal by Subject|1|||
46957145|NCT02285998|83198170|FG000|Overall Study|Adverse Event|9|||
46957146|NCT02285998|83198171|FG001|Overall Study|Adverse Event|8|||
46957147|NCT02285998|83198170|FG000|Overall Study|Physician Decision|1|||
46957148|NCT02285998|83198171|FG001|Overall Study|Physician Decision|2|||
46957149|NCT02285998|83198170|FG000|Overall Study|Lost to Follow-up|176|||
46957150|NCT02285998|83198171|FG001|Overall Study|Lost to Follow-up|172|||
46957151|NCT02285998|83198170|FG000|Overall Study|Withdrawal by Subject|53|||
46957152|NCT02285998|83198171|FG001|Overall Study|Withdrawal by Subject|61|||
46957153|NCT02285998|83198170|FG000|Overall Study|Other Reasons|7|||
46957154|NCT02285998|83198171|FG001|Overall Study|Other Reasons|10|||
46957155|NCT01658072|83198179|FG000|Overall Study|Protocol Violation|4|||
46957156|NCT01658072|83198180|FG001|Overall Study|Protocol Violation|2|||
46957157|NCT02285920|83198190|FG000|Overall Study|Kidney transplantation|2|||
46957158|NCT02285920|83198191|FG001|Overall Study|Kidney transplantation|2|||
46957159|NCT02285920|83198192|FG002|Overall Study|Kidney transplantation|2|||
46957160|NCT02285920|83198193|FG003|Overall Study|Kidney transplantation|0|||
46957161|NCT02285920|83198190|FG000|Overall Study|Change to peritoneal dialysis|0|||
46957162|NCT02285920|83198191|FG001|Overall Study|Change to peritoneal dialysis|0|||
46957163|NCT02285920|83198192|FG002|Overall Study|Change to peritoneal dialysis|1|||
47067002|NCT01449461|83350340|FG001|Overall Study|Site Terminated by Sponsor|1|||
47067003|NCT01449461|83350341|FG002|Overall Study|Site Terminated by Sponsor|2|||
46639798|NCT03083665|82813702|FG003|Double-Blind Period|Lack of Efficacy|0|||
46639799|NCT03083665|82813703|FG004|Double-Blind Period|Lack of Efficacy|0|||
46639800|NCT03083665|82813704|FG005|Double-Blind Period|Lack of Efficacy|0|||
46639801|NCT03083665|82813699|FG000|Double-Blind Period|Protocol Violation|1|||
46639802|NCT03083665|82813700|FG001|Double-Blind Period|Protocol Violation|0|||
46639803|NCT03083665|82813701|FG002|Double-Blind Period|Protocol Violation|1|||
46639804|NCT03083665|82813702|FG003|Double-Blind Period|Protocol Violation|0|||
46639805|NCT03083665|82813703|FG004|Double-Blind Period|Protocol Violation|0|||
46639806|NCT03083665|82813704|FG005|Double-Blind Period|Protocol Violation|0|||
46639807|NCT03083665|82813699|FG000|Double-Blind Period|Lost to Follow-up|1|||
46639808|NCT03083665|82813700|FG001|Double-Blind Period|Lost to Follow-up|0|||
46639809|NCT03083665|82813701|FG002|Double-Blind Period|Lost to Follow-up|1|||
46639810|NCT03083665|82813702|FG003|Double-Blind Period|Lost to Follow-up|0|||
46639811|NCT03083665|82813703|FG004|Double-Blind Period|Lost to Follow-up|0|||
46639812|NCT03083665|82813704|FG005|Double-Blind Period|Lost to Follow-up|0|||
46639813|NCT03083665|82813699|FG000|Double-Blind Period|Withdrawal by Subject|3|||
46957164|NCT02285920|83198193|FG003|Overall Study|Change to peritoneal dialysis|0|||
46639814|NCT03083665|82813700|FG001|Double-Blind Period|Withdrawal by Subject|0|||
46639815|NCT03083665|82813701|FG002|Double-Blind Period|Withdrawal by Subject|0|||
46957165|NCT02285920|83198190|FG000|Overall Study|Transfer to non-participating unit|0|||
46957166|NCT02285920|83198191|FG001|Overall Study|Transfer to non-participating unit|1|||
46957167|NCT02285920|83198192|FG002|Overall Study|Transfer to non-participating unit|0|||
46957168|NCT02285920|83198193|FG003|Overall Study|Transfer to non-participating unit|0|||
46639816|NCT03083665|82813702|FG003|Double-Blind Period|Withdrawal by Subject|0|||
46639817|NCT03083665|82813703|FG004|Double-Blind Period|Withdrawal by Subject|0|||
46639818|NCT03083665|82813704|FG005|Double-Blind Period|Withdrawal by Subject|0|||
46639819|NCT03083665|82813699|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
46639820|NCT03083665|82813700|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
46639821|NCT03083665|82813701|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
46639822|NCT03083665|82813702|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
46639823|NCT03083665|82813703|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
46957169|NCT02285920|83198190|FG000|Overall Study|Dialysis discontinuation|0|||
46957170|NCT02285920|83198191|FG001|Overall Study|Dialysis discontinuation|1|||
46957171|NCT02285920|83198192|FG002|Overall Study|Dialysis discontinuation|0|||
46957172|NCT02285920|83198193|FG003|Overall Study|Dialysis discontinuation|0|||
46957173|NCT02285920|83198190|FG000|Overall Study|Death|2|||
46957174|NCT02285920|83198191|FG001|Overall Study|Death|0|||
46957175|NCT02285920|83198192|FG002|Overall Study|Death|2|||
46957176|NCT02285920|83198193|FG003|Overall Study|Death|1|||
46957177|NCT02035137|83198206|FG000|Overall Study|Physician Decision|0|||
46957178|NCT02035137|83198207|FG001|Overall Study|Physician Decision|0|||
46957179|NCT02035137|83198208|FG002|Overall Study|Physician Decision|1|||
46957180|NCT02035137|83198206|FG000|Overall Study|Withdrawal by Subject|0|||
46957181|NCT02035137|83198207|FG001|Overall Study|Withdrawal by Subject|1|||
46957182|NCT02035137|83198208|FG002|Overall Study|Withdrawal by Subject|2|||
46957183|NCT02035137|83198206|FG000|Overall Study|Ineligible|0|||
46957184|NCT02035137|83198207|FG001|Overall Study|Ineligible|1|||
46957185|NCT02035137|83198208|FG002|Overall Study|Ineligible|2|||
46957186|NCT02035137|83198206|FG000|Overall Study|Disease progression prior to treatment start|2|||
46957187|NCT02035137|83198207|FG001|Overall Study|Disease progression prior to treatment start|0|||
46957188|NCT02035137|83198208|FG002|Overall Study|Disease progression prior to treatment start|0|||
46957189|NCT02522780|83198218|FG000|Overall Study|Consent withdrawn by subject|5|||
46957190|NCT02522780|83198219|FG001|Overall Study|Consent withdrawn by subject|7|||
46957191|NCT02522780|83198218|FG000|Overall Study|Protocol deviation|1|||
46957192|NCT02522780|83198219|FG001|Overall Study|Protocol deviation|3|||
46957193|NCT02522780|83198218|FG000|Overall Study|Subject refused endoscopic procedure|0|||
46957194|NCT02522780|83198219|FG001|Overall Study|Subject refused endoscopic procedure|1|||
46957195|NCT02522780|83198218|FG000|Overall Study|Adverse event, non-fatal|11|||
46957196|NCT02522780|83198219|FG001|Overall Study|Adverse event, non-fatal|16|||
46957197|NCT02285062|83198239|FG000|Pre-Treatment Period|Protocol Violation|0|||
46957198|NCT02285062|83198240|FG001|Pre-Treatment Period|Protocol Violation|2|||
46957199|NCT02285062|83198239|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
46957200|NCT02285062|83198240|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
46957201|NCT01352741|83198246|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
46957202|NCT01352741|83198247|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
46957203|NCT01352741|83198246|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
46957204|NCT01352741|83198247|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
46957205|NCT01352741|83198246|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
46957206|NCT01352741|83198247|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
46957207|NCT01352741|83198246|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
46957208|NCT01352741|83198247|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
46957209|NCT01352741|83198246|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
46957210|NCT01352741|83198247|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
46957211|NCT01352741|83198246|FG000|Open-label Tapentadol Titration Period|Other|4|||
46957212|NCT01352741|83198247|FG001|Open-label Tapentadol Titration Period|Other|0|||
46957213|NCT01352741|83198246|FG000|Double-blind Comparative Period|Protocol Violation|2|||
46957214|NCT01352741|83198247|FG001|Double-blind Comparative Period|Protocol Violation|0|||
46957215|NCT01352741|83198246|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
46957216|NCT01352741|83198247|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
46957217|NCT01352741|83198246|FG000|Double-blind Comparative Period|Adverse Event|16|||
46957218|NCT01352741|83198247|FG001|Double-blind Comparative Period|Adverse Event|17|||
46957219|NCT01352741|83198246|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
46957220|NCT01352741|83198247|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
46957221|NCT01352741|83198246|FG000|Double-blind Comparative Period|Death|0|||
46957222|NCT01352741|83198247|FG001|Double-blind Comparative Period|Death|1|||
46957223|NCT01352741|83198246|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
46957224|NCT01352741|83198247|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
46957225|NCT01352741|83198246|FG000|Double-blind Comparative Period|Other|1|||
46957226|NCT01352741|83198247|FG001|Double-blind Comparative Period|Other|2|||
46957227|NCT01352741|83198246|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
46957228|NCT01352741|83198247|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
46957229|NCT01352741|83198246|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
46639824|NCT03083665|82813704|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
46639825|NCT03083665|82813699|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
46957230|NCT01352741|83198247|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
46957231|NCT01352741|83198246|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
46957232|NCT01352741|83198247|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
46957233|NCT01352741|83198246|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
46957234|NCT01352741|83198247|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
46957235|NCT01657292|83198267|FG000|Overall Study|Adverse Event|6|||
46957236|NCT01657292|83198267|FG000|Overall Study|Withdrawal by Subject|2|||
46957237|NCT01657292|83198267|FG000|Overall Study|Violation of eligibility criteria|1|||
46957238|NCT01657292|83198267|FG000|Overall Study|Change of therapy|1|||
46957239|NCT00905567|83198283|FG000|Washout|Withdrawal by Subject|0|||
46957240|NCT00905567|83198284|FG001|Washout|Withdrawal by Subject|1|||
46957241|NCT02282020|83198290|FG000|Overall Study|Objective Disease Progression|128|||
46957242|NCT02282020|83198291|FG001|Overall Study|Objective Disease Progression|30|||
46957243|NCT02282020|83198290|FG000|Overall Study|Adverse Event|18|||
46957244|NCT02282020|83198291|FG001|Overall Study|Adverse Event|15|||
46957245|NCT02282020|83198290|FG000|Overall Study|Withdrawal by Subject|7|||
46957246|NCT02282020|83198291|FG001|Overall Study|Withdrawal by Subject|10|||
46957247|NCT02282020|83198290|FG000|Overall Study|Miscellaneous|5|||
46957248|NCT02282020|83198291|FG001|Overall Study|Miscellaneous|19|||
46957249|NCT02282020|83198290|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
46957250|NCT02282020|83198291|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
46957251|NCT02282020|83198290|FG000|Overall Study|Developed Discontinuation Criteria|0|||
46957252|NCT02282020|83198291|FG001|Overall Study|Developed Discontinuation Criteria|2|||
46957253|NCT02282020|83198290|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
46957254|NCT02282020|83198291|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
46957255|NCT02281552|83198307|FG000|Overall Study|Medication error|1|||
46957256|NCT02281552|83198308|FG001|Overall Study|Medication error|0|||
46957257|NCT02281552|83198307|FG000|Overall Study|Insufficient clinical response|0|||
46957258|NCT02281552|83198308|FG001|Overall Study|Insufficient clinical response|1|||
46957259|NCT02281552|83198307|FG000|Overall Study|Adverse Event|3|||
46957260|NCT02281552|83198308|FG001|Overall Study|Adverse Event|9|||
46957261|NCT00890591|83198314|FG000|Overall Study|Lack of Efficacy|20|||
46957262|NCT02284906|83198323|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
46957263|NCT02284906|83198324|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
46957264|NCT02284906|83198325|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
46957265|NCT02284906|83198323|FG000|Overall Study|Major Protocol Deviation|0|||
46957266|NCT02284906|83198324|FG001|Overall Study|Major Protocol Deviation|1|||
46957267|NCT02284906|83198325|FG002|Overall Study|Major Protocol Deviation|0|||
46957268|NCT02284906|83198323|FG000|Overall Study|Voluntary Withdrawal|2|||
46957269|NCT02284906|83198324|FG001|Overall Study|Voluntary Withdrawal|4|||
46957270|NCT02284906|83198325|FG002|Overall Study|Voluntary Withdrawal|5|||
46957271|NCT02284906|83198323|FG000|Overall Study|Study Termination|0|||
46957272|NCT02284906|83198324|FG001|Overall Study|Study Termination|11|||
46957273|NCT02284906|83198325|FG002|Overall Study|Study Termination|14|||
46957274|NCT02284906|83198323|FG000|Overall Study|Reason not Specified|1|||
46957275|NCT02284906|83198324|FG001|Overall Study|Reason not Specified|1|||
46957276|NCT02284906|83198325|FG002|Overall Study|Reason not Specified|0|||
46957277|NCT02879305|83198335|FG000|Overall Study|Investigator Site Closed|55|||
46957278|NCT02879305|83198336|FG001|Overall Study|Investigator Site Closed|57|||
46957279|NCT02879305|83198335|FG000|Overall Study|Withdrawal by Subject|44|||
46957280|NCT02879305|83198336|FG001|Overall Study|Withdrawal by Subject|42|||
46957281|NCT02879305|83198335|FG000|Overall Study|Lost to Follow-up|17|||
46957282|NCT02879305|83198336|FG001|Overall Study|Lost to Follow-up|12|||
46773509|NCT00441727|82991867|FG001|Overall Study|Adverse Event|33|||
46773510|NCT00441727|82991868|FG002|Overall Study|Adverse Event|28|||
46773511|NCT00441727|82991866|FG000|Overall Study|Lack of Efficacy|7|||
46773512|NCT00441727|82991867|FG001|Overall Study|Lack of Efficacy|8|||
46773513|NCT00441727|82991868|FG002|Overall Study|Lack of Efficacy|48|||
46773514|NCT00441727|82991866|FG000|Overall Study|Withdrawal by Subject|40|||
46773515|NCT00441727|82991867|FG001|Overall Study|Withdrawal by Subject|34|||
46773516|NCT00441727|82991868|FG002|Overall Study|Withdrawal by Subject|47|||
46773517|NCT00441727|82991866|FG000|Overall Study|Lost to Follow-up|5|||
46773518|NCT00441727|82991867|FG001|Overall Study|Lost to Follow-up|6|||
46773519|NCT00441727|82991868|FG002|Overall Study|Lost to Follow-up|5|||
46957283|NCT02879305|83198335|FG000|Overall Study|Other|1|||
46957284|NCT02879305|83198336|FG001|Overall Study|Other|0|||
46957285|NCT02281318|83198344|FG000|Overall Study|Adverse Event|2|||
46773520|NCT00441727|82991866|FG000|Overall Study|Safety Reasons|3|||
46957286|NCT02281318|83198345|FG001|Overall Study|Adverse Event|2|||
46957287|NCT02281318|83198344|FG000|Overall Study|Lack of Efficacy|2|||
46957288|NCT02281318|83198345|FG001|Overall Study|Lack of Efficacy|0|||
46957289|NCT02281318|83198344|FG000|Overall Study|Lost to Follow-up|2|||
46773521|NCT00441727|82991867|FG001|Overall Study|Safety Reasons|1|||
46773522|NCT00441727|82991868|FG002|Overall Study|Safety Reasons|3|||
46957290|NCT02281318|83198345|FG001|Overall Study|Lost to Follow-up|1|||
46957291|NCT02281318|83198344|FG000|Overall Study|Physician Decision|2|||
46957292|NCT02281318|83198345|FG001|Overall Study|Physician Decision|0|||
46957293|NCT02281318|83198344|FG000|Overall Study|Withdrawal by Subject|6|||
46957294|NCT02281318|83198345|FG001|Overall Study|Withdrawal by Subject|2|||
46957295|NCT01657760|83198353|FG000|Overall Study|Withdrawal by Subject|0|||
46957296|NCT01657760|83198354|FG001|Overall Study|Withdrawal by Subject|0|||
46957297|NCT01657760|83198355|FG002|Overall Study|Withdrawal by Subject|0|||
46957298|NCT01657760|83198356|FG003|Overall Study|Withdrawal by Subject|1|||
46957299|NCT01657760|83198353|FG000|Overall Study|Physician Decision|1|||
46957300|NCT01657760|83198354|FG001|Overall Study|Physician Decision|1|||
46957301|NCT01657760|83198355|FG002|Overall Study|Physician Decision|1|||
46957302|NCT01657760|83198356|FG003|Overall Study|Physician Decision|2|||
46957303|NCT02280304|83198383|FG000|Overall Study|Lost to Follow-up|7|||
46957304|NCT02280304|83198384|FG001|Overall Study|Lost to Follow-up|8|||
46957305|NCT02283658|83198404|FG000|Overall Study|Withdrawal by Subject|1|||
46957306|NCT02279524|83198431|FG000|Overall Study|Withdrawal by Subject|3|||
46957307|NCT02279524|83198432|FG001|Overall Study|Withdrawal by Subject|6|||
46957308|NCT02279524|83198433|FG002|Overall Study|Withdrawal by Subject|3|||
46957309|NCT02279524|83198431|FG000|Overall Study|Adverse Event|4|||
46957310|NCT02279524|83198432|FG001|Overall Study|Adverse Event|3|||
46957311|NCT02279524|83198433|FG002|Overall Study|Adverse Event|2|||
46957312|NCT02279524|83198431|FG000|Overall Study|Lost to Follow-up|1|||
46957313|NCT02279524|83198432|FG001|Overall Study|Lost to Follow-up|1|||
46957314|NCT02279524|83198433|FG002|Overall Study|Lost to Follow-up|0|||
46957315|NCT02279524|83198431|FG000|Overall Study|Disallowed medication|1|||
46957316|NCT02279524|83198432|FG001|Overall Study|Disallowed medication|1|||
46957317|NCT02279524|83198433|FG002|Overall Study|Disallowed medication|2|||
46957318|NCT02279524|83198431|FG000|Overall Study|Bariatric surgery|1|||
46957319|NCT02279524|83198432|FG001|Overall Study|Bariatric surgery|0|||
46957320|NCT02279524|83198433|FG002|Overall Study|Bariatric surgery|0|||
46957321|NCT02283268|83198441|FG000|Overall Study|Withdrawal by Subject|1|||
46957322|NCT00857285|83198455|FG000|Overall Study|Adverse Event|4|||
46957323|NCT00857285|83198456|FG001|Overall Study|Adverse Event|2|||
46957324|NCT00857285|83198455|FG000|Overall Study|Lack of Efficacy|0|||
46957325|NCT00857285|83198456|FG001|Overall Study|Lack of Efficacy|2|||
46957326|NCT00857285|83198455|FG000|Overall Study|Protocol Violation|3|||
46957327|NCT00857285|83198456|FG001|Overall Study|Protocol Violation|1|||
46957328|NCT00857285|83198455|FG000|Overall Study|Withdrawal by Subject|4|||
46957329|NCT00857285|83198456|FG001|Overall Study|Withdrawal by Subject|0|||
46957330|NCT00857285|83198455|FG000|Overall Study|Randomization criteria not met|1|||
46639826|NCT03083665|82813700|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
46639827|NCT03083665|82813701|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
46639828|NCT03083665|82813702|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
46639829|NCT03083665|82813703|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
46639830|NCT03083665|82813704|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
46639831|NCT03083665|82813699|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
46639832|NCT03083665|82813700|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
46639833|NCT03083665|82813701|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
46844652|NCT00220740|83061458|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
46844653|NCT00184002|83061466|FG000|Overall Study|Adverse Event|9|||
46844654|NCT00184002|83061466|FG000|Overall Study|Death|3|||
46844655|NCT00184002|83061466|FG000|Overall Study|Physician Decision|1|||
46844656|NCT00184002|83061466|FG000|Overall Study|Withdrawal by Subject|4|||
46844657|NCT00165672|83061472|FG000|Overall Study|Adverse Event|0|||
46844658|NCT00165672|83061473|FG001|Overall Study|Adverse Event|1|||
46844659|NCT00180414|83061481|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
46844660|NCT00180414|83061482|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
46844661|NCT00174252|83061488|FG000|Overall Study|Protocol Violation|2|||
46844662|NCT00169104|83061496|FG000|Overall Study|Withdrawal by Subject|2|||
46844663|NCT00169104|83061497|FG001|Overall Study|Withdrawal by Subject|0|||
46844664|NCT00169104|83061496|FG000|Overall Study|Protocol Violation|0|||
46844665|NCT00169104|83061497|FG001|Overall Study|Protocol Violation|1|||
46844666|NCT00169104|83061496|FG000|Overall Study|Physician Decision|0|||
46844667|NCT00169104|83061497|FG001|Overall Study|Physician Decision|1|||
46844668|NCT00163020|83061506|FG000|Overall Study|Lost to Follow-up|0|||
46844669|NCT00163020|83061507|FG001|Overall Study|Lost to Follow-up|2|||
46844670|NCT00252720|83061517|FG000|Overall Study|Withdrawal by Subject|95|||
46957331|NCT00857285|83198456|FG001|Overall Study|Randomization criteria not met|1|||
46957332|NCT02278354|83198462|FG000|Overall Study|Lost to Follow-up|2|||
46957333|NCT02278354|83198463|FG001|Overall Study|Lost to Follow-up|2|||
46957334|NCT02278354|83198462|FG000|Overall Study|Withdrawal by Subject|0|||
46957335|NCT02278354|83198463|FG001|Overall Study|Withdrawal by Subject|1|||
46957336|NCT02278354|83198462|FG000|Overall Study|<10 professional fights|2|||
46844671|NCT00252720|83061518|FG001|Overall Study|Withdrawal by Subject|97|||
46957337|NCT02278354|83198463|FG001|Overall Study|<10 professional fights|0|||
46957338|NCT01657370|83198482|FG000|Overall Study|Withdrawal by Subject|0|||
46957339|NCT01657370|83198483|FG001|Overall Study|Withdrawal by Subject|0|||
46957340|NCT01657370|83198484|FG002|Overall Study|Withdrawal by Subject|1|||
46957341|NCT01657370|83198485|FG003|Overall Study|Withdrawal by Subject|0|||
46957342|NCT01657370|83198486|FG004|Overall Study|Withdrawal by Subject|0|||
46957343|NCT01657370|83198487|FG005|Overall Study|Withdrawal by Subject|1|||
46957344|NCT01657370|83198482|FG000|Overall Study|Physician Decision|2|||
46957345|NCT01657370|83198483|FG001|Overall Study|Physician Decision|3|||
46957346|NCT01657370|83198484|FG002|Overall Study|Physician Decision|1|||
46957347|NCT01657370|83198485|FG003|Overall Study|Physician Decision|2|||
46957348|NCT01657370|83198486|FG004|Overall Study|Physician Decision|5|||
46957349|NCT01657370|83198487|FG005|Overall Study|Physician Decision|0|||
46957350|NCT01657370|83198482|FG000|Overall Study|Lack of Qualifying Event|1|||
46957351|NCT01657370|83198483|FG001|Overall Study|Lack of Qualifying Event|0|||
46957352|NCT01657370|83198484|FG002|Overall Study|Lack of Qualifying Event|3|||
46957353|NCT01657370|83198485|FG003|Overall Study|Lack of Qualifying Event|2|||
46957354|NCT01657370|83198486|FG004|Overall Study|Lack of Qualifying Event|1|||
46957355|NCT01657370|83198487|FG005|Overall Study|Lack of Qualifying Event|2|||
46957356|NCT01657370|83198482|FG000|Overall Study|Adverse Event|0|||
46957357|NCT01657370|83198483|FG001|Overall Study|Adverse Event|0|||
46957358|NCT01657370|83198484|FG002|Overall Study|Adverse Event|0|||
46957359|NCT01657370|83198485|FG003|Overall Study|Adverse Event|0|||
46957360|NCT01657370|83198486|FG004|Overall Study|Adverse Event|1|||
46957361|NCT01657370|83198487|FG005|Overall Study|Adverse Event|0|||
46957362|NCT01657370|83198482|FG000|Overall Study|Protocol Violation|1|||
46957363|NCT01657370|83198483|FG001|Overall Study|Protocol Violation|1|||
46957364|NCT01657370|83198484|FG002|Overall Study|Protocol Violation|1|||
46957365|NCT01657370|83198485|FG003|Overall Study|Protocol Violation|1|||
46957366|NCT01657370|83198486|FG004|Overall Study|Protocol Violation|0|||
46957367|NCT01657370|83198487|FG005|Overall Study|Protocol Violation|0|||
46957368|NCT01657370|83198482|FG000|Overall Study|Lost to Follow-up|2|||
46957369|NCT01657370|83198483|FG001|Overall Study|Lost to Follow-up|0|||
46957370|NCT01657370|83198484|FG002|Overall Study|Lost to Follow-up|1|||
46957371|NCT01657370|83198485|FG003|Overall Study|Lost to Follow-up|0|||
46957372|NCT01657370|83198486|FG004|Overall Study|Lost to Follow-up|0|||
46957373|NCT01657370|83198487|FG005|Overall Study|Lost to Follow-up|1|||
46957374|NCT00849797|83198529|FG000|First Intervention|bad veins|1|||
46957375|NCT00849797|83198530|FG001|First Intervention|bad veins|0|||
46957376|NCT00849797|83198529|FG000|First Intervention|Adverse Event|0|||
46957377|NCT00849797|83198530|FG001|First Intervention|Adverse Event|1|||
46957378|NCT00849797|83198529|FG000|Washout: One Week|Withdrawal by Subject|0|||
46957379|NCT00849797|83198530|FG001|Washout: One Week|Withdrawal by Subject|2|||
46957380|NCT00840203|83198560|FG000|First Intervention|Protocol Violation|1|||
46957381|NCT00840203|83198561|FG001|First Intervention|Protocol Violation|1|||
46957382|NCT00840203|83198560|FG000|Washout|Protocol Violation|1|||
46957383|NCT00840203|83198561|FG001|Washout|Protocol Violation|0|||
46957384|NCT00835991|83198567|FG000|First Intervention|Adverse Event|0|||
46957385|NCT00835991|83198568|FG001|First Intervention|Adverse Event|1|||
46957386|NCT00835991|83198567|FG000|Washout|Protocol Violation|0|||
46957387|NCT00835991|83198568|FG001|Washout|Protocol Violation|2|||
46773523|NCT00441727|82991866|FG000|Overall Study|Various reason specified|6|||
46773524|NCT00441727|82991867|FG001|Overall Study|Various reason specified|8|||
46773525|NCT00441727|82991868|FG002|Overall Study|Various reason specified|5|||
46773526|NCT00770120|82991890|FG000|Overall Study|Progression|31|||
46773527|NCT00770120|82991890|FG000|Overall Study|Adverse Event|11|||
46957388|NCT00835991|83198567|FG000|Washout|Withdrawal by Subject|3|||
46844672|NCT00252720|83061517|FG000|Overall Study|Death|7|||
46844673|NCT00252720|83061518|FG001|Overall Study|Death|8|||
46844674|NCT00252720|83061517|FG000|Overall Study|Moving|23|||
46844675|NCT00252720|83061518|FG001|Overall Study|Moving|42|||
46957389|NCT00835991|83198568|FG001|Washout|Withdrawal by Subject|1|||
46957390|NCT02276872|83198575|FG000|Overall Study|Adverse Event|1|||
46957391|NCT02276872|83198576|FG001|Overall Study|Adverse Event|0|||
46773528|NCT00770120|82991890|FG000|Overall Study|Not Protocol Specified|11|||
46773529|NCT00770120|82991890|FG000|Overall Study|Death|3|||
46773530|NCT00770120|82991890|FG000|Overall Study|Withdrawal by Subject|2|||
46773531|NCT00770120|82991890|FG000|Overall Study|Ineligible|1|||
46957392|NCT02276872|83198577|FG002|Overall Study|Adverse Event|0|||
46639834|NCT03083665|82813702|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
46639835|NCT03083665|82813703|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
46773532|NCT00770120|82991890|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
46957393|NCT00835367|83198592|FG000|Washout|Adverse Event|2|||
46957394|NCT00835367|83198593|FG001|Washout|Adverse Event|0|||
46957395|NCT00835367|83198592|FG000|Washout|Withdrawal by Subject|1|||
46773533|NCT00770120|82991890|FG000|Overall Study|Reason under Review|1|||
46773534|NCT00436345|82991897|FG000|Overall Study|ICU resident beyond follow-up period|3|||
46844676|NCT00252720|83061517|FG000|Overall Study|Mainly patients lost to follow-up|7|||
46957396|NCT00835367|83198593|FG001|Washout|Withdrawal by Subject|0|||
46957397|NCT00835367|83198592|FG000|Second Intervention|Adverse Event|1|||
46957398|NCT00835367|83198593|FG001|Second Intervention|Adverse Event|1|||
46957399|NCT02276560|83198600|FG000|Overall Study|Adverse Event|1|||
46844677|NCT00252720|83061518|FG001|Overall Study|Mainly patients lost to follow-up|18|||
46844678|NCT00167778|83061524|FG000|Overall Study|Withdrawal by Subject|1|||
46844679|NCT00167310|83061531|FG000|Overall Study|Protocol Violation|5|||
46844680|NCT00167310|83061532|FG001|Overall Study|Protocol Violation|3|||
46844681|NCT00167310|83061531|FG000|Overall Study|Withdrawal by Subject|3|||
46844682|NCT00167310|83061532|FG001|Overall Study|Withdrawal by Subject|7|||
46957400|NCT02276560|83198601|FG001|Overall Study|Adverse Event|0|||
46957401|NCT02276560|83198602|FG002|Overall Study|Adverse Event|0|||
46957402|NCT02276482|83198612|FG000|Overall Study|Adverse Event|1|||
46957403|NCT02276482|83198613|FG001|Overall Study|Adverse Event|0|||
46957404|NCT02276482|83198612|FG000|Overall Study|Withdrawal by Subject|1|||
46957405|NCT02276482|83198613|FG001|Overall Study|Withdrawal by Subject|0|||
46957406|NCT02276482|83198612|FG000|Overall Study|Gram-negative infection|1|||
46957407|NCT02276482|83198613|FG001|Overall Study|Gram-negative infection|0|||
46957408|NCT02276482|83198612|FG000|Overall Study|Reason not specified|0|||
46957409|NCT02276482|83198613|FG001|Overall Study|Reason not specified|1|||
46957410|NCT00835211|83198631|FG000|First Intervention|Withdrawal by Subject|0|||
46957411|NCT00835211|83198632|FG001|First Intervention|Withdrawal by Subject|1|||
46957412|NCT00835211|83198631|FG000|Washout: 7 Days|Adverse Event|2|||
46957413|NCT00835211|83198632|FG001|Washout: 7 Days|Adverse Event|1|||
46957414|NCT00835211|83198631|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
46957415|NCT00835211|83198632|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
46957416|NCT00834743|83198645|FG000|Second Intervention|Withdrawal by Subject|1|||
46957417|NCT00834743|83198646|FG001|Second Intervention|Withdrawal by Subject|0|||
46957418|NCT00834587|83198652|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
46957419|NCT00834587|83198653|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
46957420|NCT00834431|83198659|FG000|First Intervention|Adverse Event|0|||
46957421|NCT00834431|83198660|FG001|First Intervention|Adverse Event|1|||
46957422|NCT00834431|83198659|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
46957423|NCT00834431|83198660|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
46957424|NCT00830219|83198680|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
46957425|NCT00830219|83198681|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
46957426|NCT02274766|83198687|FG000|Overall Study|Withdrawal by Subject|3|||
46957427|NCT02274766|83198688|FG001|Overall Study|Withdrawal by Subject|6|||
46957428|NCT02274766|83198687|FG000|Overall Study|Did Not Receive Study Drug|1|||
46957429|NCT02274766|83198688|FG001|Overall Study|Did Not Receive Study Drug|1|||
46957430|NCT02274766|83198687|FG000|Overall Study|Subject Unwilling to Proceed|0|||
46957431|NCT02274766|83198688|FG001|Overall Study|Subject Unwilling to Proceed|1|||
46957432|NCT02274766|83198687|FG000|Overall Study|Adverse Event|0|||
46957433|NCT02274766|83198688|FG001|Overall Study|Adverse Event|1|||
46957434|NCT00829673|83198696|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
46957435|NCT00829673|83198697|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
46957436|NCT02370238|83198703|FG000|Overall Study|Death|42|||
46957437|NCT02370238|83198704|FG001|Overall Study|Death|35|||
46957438|NCT02370238|83198703|FG000|Overall Study|Lost to Follow-up|1|||
46957439|NCT02370238|83198704|FG001|Overall Study|Lost to Follow-up|3|||
46957440|NCT02370238|83198703|FG000|Overall Study|Withdrawal by Subject|2|||
46957441|NCT02370238|83198704|FG001|Overall Study|Withdrawal by Subject|6|||
46773535|NCT00436345|82991898|FG001|Overall Study|ICU resident beyond follow-up period|0|||
46773536|NCT00769184|82991905|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
46773537|NCT00769184|82991906|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
46773538|NCT00769184|82991905|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
46773539|NCT00769184|82991906|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
46773540|NCT00769184|82991905|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
46773541|NCT00769184|82991906|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
46773542|NCT00768560|82991920|FG000|Intervention Set 1|Adverse Event|0|||
46844683|NCT03754582|83061538|FG000|Treatment Phase|Adverse Event|0|||
46844684|NCT03754582|83061539|FG001|Treatment Phase|Adverse Event|1|||
46844685|NCT03754582|83061540|FG002|Treatment Phase|Adverse Event|0|||
46844686|NCT03754582|83061538|FG000|Follow-up Phase|Other|0|||
46957442|NCT02370238|83198703|FG000|Overall Study|Other|2|||
46957443|NCT02370238|83198704|FG001|Overall Study|Other|1|||
46957444|NCT02370160|83198714|FG000|Overall Study|Death|3|||
46957445|NCT02370160|83198715|FG001|Overall Study|Death|4|||
46957446|NCT02370160|83198716|FG002|Overall Study|Death|1|||
46957447|NCT02273908|83198731|FG000|Overall Study|Adverse Event|16|||
46957448|NCT02273908|83198732|FG001|Overall Study|Adverse Event|0|||
46957449|NCT02273908|83198731|FG000|Overall Study|Lost to Follow-up|10|||
46957450|NCT02273908|83198732|FG001|Overall Study|Lost to Follow-up|1|||
46957451|NCT02273908|83198731|FG000|Overall Study|Did not meet entrance criteria|3|||
46957452|NCT02273908|83198732|FG001|Overall Study|Did not meet entrance criteria|2|||
46957453|NCT02273908|83198731|FG000|Overall Study|Withdrawal by Subject|4|||
46844687|NCT03754582|83061539|FG001|Follow-up Phase|Other|0|||
46844688|NCT03754582|83061540|FG002|Follow-up Phase|Other|1|||
46957454|NCT02273908|83198732|FG001|Overall Study|Withdrawal by Subject|2|||
46957455|NCT02273752|83198742|FG000|Overall Study|Trial was terminated early|2|||
46957456|NCT05180630|83198746|FG000|First Intervention|Physician Decision|0|||
46639836|NCT03083665|82813704|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
46639837|NCT03083665|82813699|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
46639838|NCT03083665|82813700|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
46639839|NCT03083665|82813701|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
46957457|NCT05180630|83198747|FG001|First Intervention|Physician Decision|0|||
46957458|NCT05180630|83198748|FG002|First Intervention|Physician Decision|3|||
46957459|NCT02273596|83198757|FG000|24-Week Treatment Period|Adverse Event|3|||
46957460|NCT02273596|83198757|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
46957461|NCT02273596|83198757|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
46957462|NCT02273596|83198757|FG000|24-Week Treatment Period|Physician Decision|1|||
46957463|NCT02273596|83198757|FG000|24-Week Treatment Period|Protocol Deviation|1|||
46957464|NCT02273596|83198757|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
46957465|NCT02273596|83198757|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
46957466|NCT02273596|83198757|FG000|Extension Period|Lost to Follow-up|1|||
46957467|NCT02273596|83198757|FG000|Extension Period|Protocol Deviation|1|||
46957468|NCT01656200|83198767|FG000|Overall Study|Withdrawal by Subject|1|||
46957469|NCT02369848|83198771|FG000|Overall Study|Death|1|||
46957470|NCT02369848|83198771|FG000|Overall Study|Withdrawal by Subject|2|||
46844689|NCT00161616|83061558|FG000|Overall Study|Withdrawal by Subject|6|||
46844690|NCT00161616|83061559|FG001|Overall Study|Withdrawal by Subject|5|||
46844691|NCT00161616|83061558|FG000|Overall Study|Physician Decision|1|||
46844692|NCT00161616|83061559|FG001|Overall Study|Physician Decision|0|||
46844693|NCT00161616|83061558|FG000|Overall Study|Death|1|||
46844694|NCT00161616|83061559|FG001|Overall Study|Death|1|||
46844695|NCT00161616|83061558|FG000|Overall Study|Lost to Follow-up|17|||
46844696|NCT00161616|83061559|FG001|Overall Study|Lost to Follow-up|13|||
46844697|NCT00161616|83061558|FG000|Overall Study|Protocol deviation|1|||
46844698|NCT00161616|83061559|FG001|Overall Study|Protocol deviation|0|||
46844699|NCT00252564|83061567|FG000|Overall Study|Adverse Event|17|||
46844700|NCT00252564|83061568|FG001|Overall Study|Adverse Event|13|||
46844701|NCT00252564|83061567|FG000|Overall Study|Unrelated Complication|2|||
46844702|NCT00252564|83061568|FG001|Overall Study|Unrelated Complication|1|||
46844703|NCT00252564|83061567|FG000|Overall Study|Disease Progression|14|||
46844704|NCT00252564|83061568|FG001|Overall Study|Disease Progression|20|||
46844705|NCT00252564|83061567|FG000|Overall Study|Death|0|||
46844706|NCT00252564|83061568|FG001|Overall Study|Death|3|||
46957471|NCT02369848|83198771|FG000|Overall Study|Lost to Follow-up|1|||
46957472|NCT02368210|83198777|FG000|Overall Study|Withdrawal by Subject|1|||
46957473|NCT02368210|83198778|FG001|Overall Study|Withdrawal by Subject|0|||
46957474|NCT02368210|83198777|FG000|Overall Study|Adverse Event|0|||
46957475|NCT02368210|83198778|FG001|Overall Study|Adverse Event|1|||
46639840|NCT03083665|82813702|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
46639841|NCT03083665|82813703|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
46639842|NCT03083665|82813704|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
46639843|NCT03083665|82813699|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
46639844|NCT03083665|82813700|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
46639845|NCT03083665|82813701|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
46639846|NCT03083665|82813702|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
46639847|NCT03083665|82813703|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
46639848|NCT03083665|82813704|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
46639849|NCT03083665|82813699|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
46773543|NCT00768560|82991921|FG001|Intervention Set 1|Adverse Event|1|||
46773544|NCT00768560|82991922|FG002|Intervention Set 1|Adverse Event|0|||
46773545|NCT00768560|82991923|FG003|Intervention Set 1|Adverse Event|0|||
46773546|NCT00768560|82991924|FG004|Intervention Set 1|Adverse Event|0|||
46773547|NCT00768560|82991925|FG005|Intervention Set 1|Adverse Event|0|||
46773548|NCT00468559|82991935|FG000|Open-label Treatment Phase|Adverse Event|5|||
46773549|NCT00468559|82991936|FG001|Open-label Treatment Phase|Adverse Event|0|||
46773550|NCT00468559|82991937|FG002|Open-label Treatment Phase|Adverse Event|0|||
46773551|NCT00468559|82991935|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
46773552|NCT00468559|82991936|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
46773553|NCT00468559|82991937|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
46639850|NCT03083665|82813700|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
46773554|NCT00468559|82991935|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
46773555|NCT00468559|82991936|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
46773556|NCT00468559|82991937|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
46957476|NCT02273050|83198787|FG000|Overall Study|Adverse Event|4|||
46773557|NCT00468559|82991935|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
46844707|NCT00252564|83061567|FG000|Overall Study|Physician Decision|1|||
46844708|NCT00252564|83061568|FG001|Overall Study|Physician Decision|0|||
46844709|NCT00252564|83061567|FG000|Overall Study|Lost to Follow-up|1|||
46844710|NCT00252564|83061568|FG001|Overall Study|Lost to Follow-up|0|||
46844711|NCT00252564|83061567|FG000|Overall Study|Patient Request|4|||
46844712|NCT00252564|83061568|FG001|Overall Study|Patient Request|5|||
46844713|NCT00252564|83061567|FG000|Overall Study|Withdrawal by Subject|0|||
46844714|NCT00252564|83061568|FG001|Overall Study|Withdrawal by Subject|2|||
46844715|NCT00166296|83061576|FG000|Overall Study|Withdrawal by Subject|1|||
46844716|NCT00166296|83061577|FG001|Overall Study|Withdrawal by Subject|3|||
46844717|NCT00166296|83061576|FG000|Overall Study|Adverse Event|2|||
46957477|NCT02273050|83198788|FG001|Overall Study|Adverse Event|3|||
46957478|NCT02273050|83198789|FG002|Overall Study|Adverse Event|3|||
46957479|NCT02273050|83198787|FG000|Overall Study|Death|0|||
46957480|NCT02273050|83198788|FG001|Overall Study|Death|0|||
46957481|NCT02273050|83198789|FG002|Overall Study|Death|1|||
46957482|NCT02273050|83198787|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
46957483|NCT02273050|83198788|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
46957484|NCT02273050|83198789|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
46957485|NCT02273050|83198787|FG000|Overall Study|Lack of Efficacy|0|||
46957486|NCT02273050|83198788|FG001|Overall Study|Lack of Efficacy|1|||
46957487|NCT02273050|83198789|FG002|Overall Study|Lack of Efficacy|1|||
46957488|NCT02273050|83198787|FG000|Overall Study|Withdrawal by Subject|17|||
46957489|NCT02273050|83198788|FG001|Overall Study|Withdrawal by Subject|14|||
46957490|NCT02273050|83198789|FG002|Overall Study|Withdrawal by Subject|16|||
46957491|NCT02273050|83198787|FG000|Overall Study|Lost to Follow-up|0|||
46957492|NCT02273050|83198788|FG001|Overall Study|Lost to Follow-up|2|||
46957493|NCT02273050|83198789|FG002|Overall Study|Lost to Follow-up|3|||
46957494|NCT02273050|83198787|FG000|Overall Study|Protocol Violation|3|||
46957495|NCT02273050|83198788|FG001|Overall Study|Protocol Violation|1|||
46957496|NCT02273050|83198789|FG002|Overall Study|Protocol Violation|4|||
46957497|NCT02272816|83198797|FG000|Overall Study|Adverse Event|1|||
46957498|NCT02271880|83198803|FG000|Overall Study|Premature discontinuation of study|3|||
46957499|NCT02271880|83198804|FG001|Overall Study|Premature discontinuation of study|4|||
46957500|NCT02367352|83198812|FG000|Overall Study|Progressive disease|7|||
46844718|NCT00166296|83061577|FG001|Overall Study|Adverse Event|4|||
46844719|NCT00166296|83061576|FG000|Overall Study|Lost to Follow-up|4|||
46844720|NCT00166296|83061577|FG001|Overall Study|Lost to Follow-up|2|||
46957501|NCT02367352|83198813|FG001|Overall Study|Progressive disease|0|||
46957502|NCT02367352|83198814|FG002|Overall Study|Progressive disease|0|||
46957503|NCT02367352|83198812|FG000|Overall Study|Participant Received Alternative Therapy|1|||
46957504|NCT02367352|83198813|FG001|Overall Study|Participant Received Alternative Therapy|0|||
46957505|NCT02367352|83198814|FG002|Overall Study|Participant Received Alternative Therapy|0|||
46957506|NCT02367352|83198812|FG000|Overall Study|Adverse Event|1|||
46957507|NCT02367352|83198813|FG001|Overall Study|Adverse Event|0|||
46957508|NCT02367352|83198814|FG002|Overall Study|Adverse Event|0|||
46957509|NCT02365636|83198823|FG000|Overall Study|Adverse Event|3|||
46957510|NCT02365636|83198824|FG001|Overall Study|Adverse Event|3|||
46957511|NCT02365636|83198825|FG002|Overall Study|Adverse Event|2|||
46957512|NCT02365636|83198823|FG000|Overall Study|Protocol Violation|1|||
46957513|NCT02365636|83198824|FG001|Overall Study|Protocol Violation|4|||
46957514|NCT02365636|83198825|FG002|Overall Study|Protocol Violation|0|||
46957515|NCT02365636|83198823|FG000|Overall Study|Lost to Follow-up|0|||
46957516|NCT02365636|83198824|FG001|Overall Study|Lost to Follow-up|0|||
46957517|NCT02365636|83198825|FG002|Overall Study|Lost to Follow-up|1|||
46957518|NCT02365636|83198823|FG000|Overall Study|Other|2|||
46957519|NCT02365636|83198824|FG001|Overall Study|Other|0|||
46957520|NCT02365636|83198825|FG002|Overall Study|Other|0|||
46957521|NCT01655498|83198833|FG000|Overall Study|Unrelated health issue|2|||
46957522|NCT01655498|83198833|FG000|Overall Study|Protocol Violation|2|||
46957523|NCT01655498|83198833|FG000|Overall Study|Withdrawal by Subject|1|||
46957524|NCT02270944|83198842|FG000|Overall Study|Lost to Follow-up|9|||
46957525|NCT02270944|83198843|FG001|Overall Study|Lost to Follow-up|4|||
46957526|NCT02270944|83198842|FG000|Overall Study|Withdrawal by Subject|2|||
46957527|NCT02270944|83198843|FG001|Overall Study|Withdrawal by Subject|1|||
46957528|NCT02365558|83198850|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
46957529|NCT02365558|83198851|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
46957530|NCT02365558|83198850|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
46957531|NCT02365558|83198851|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
46639851|NCT03083665|82813701|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
46844721|NCT00252174|83061586|FG000|Overall Study|Withdrawal by Subject|0|||
46957532|NCT02365480|83198862|FG000|Overall Study|Withdrawal by Subject|2|||
46957533|NCT02365480|83198863|FG001|Overall Study|Withdrawal by Subject|0|||
46957534|NCT02270242|83198871|FG000|Overall Study|Withdrawal by Subject|18|||
46957535|NCT02270242|83198872|FG001|Overall Study|Withdrawal by Subject|25|||
46957536|NCT02270242|83198871|FG000|Overall Study|Lost to Follow-up|41|||
46957537|NCT02270242|83198872|FG001|Overall Study|Lost to Follow-up|27|||
46957538|NCT02270242|83198871|FG000|Overall Study|Physician Decision|0|||
46957539|NCT02270242|83198872|FG001|Overall Study|Physician Decision|1|||
46957540|NCT02364388|83198878|FG000|Overall Study|Protocol Violation|1|||
46957541|NCT02364388|83198878|FG000|Overall Study|Technical Failure|3|||
46957542|NCT02364388|83198878|FG000|Overall Study|No OA/US data|2|||
46957543|NCT02364388|83198878|FG000|Overall Study|No Biopsy|2|||
46957544|NCT02363686|83198882|FG000|Overall Study|Withdrawal by Subject|22|||
46957545|NCT02363686|83198882|FG000|Overall Study|incomplete FEES examinations|13|||
46844722|NCT00252174|83061587|FG001|Overall Study|Withdrawal by Subject|1|||
46844723|NCT00252174|83061588|FG002|Overall Study|Withdrawal by Subject|0|||
46844724|NCT00165984|83061596|FG000|Overall Study|Death|15|||
46844725|NCT00160524|83061603|FG000|Overall Study|Adverse Event|119|||
46957546|NCT02268916|83198888|FG000|Overall Study|Lost to Follow-up|1|||
46957547|NCT02268916|83198889|FG001|Overall Study|Lost to Follow-up|1|||
46957548|NCT02268916|83198888|FG000|Overall Study|Withdrawal by Subject|6|||
46957549|NCT02268916|83198889|FG001|Overall Study|Withdrawal by Subject|5|||
46957550|NCT02268916|83198888|FG000|Overall Study|Participant did not have diabetes|1|||
46957551|NCT02268916|83198889|FG001|Overall Study|Participant did not have diabetes|0|||
46957552|NCT02268916|83198888|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
46957553|NCT02268916|83198889|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
46957554|NCT02518490|83198896|FG000|Overall Study|Withdrawal by Subject|1|||
46957555|NCT02518490|83198897|FG001|Overall Study|Withdrawal by Subject|1|||
46844726|NCT00160524|83061603|FG000|Overall Study|Adverse Event and Other|94|||
46844727|NCT00160524|83061603|FG000|Overall Study|Protocol Violation|16|||
46844728|NCT00160524|83061603|FG000|Overall Study|Protocol Violation and Other|2|||
46844729|NCT00160524|83061603|FG000|Overall Study|Withdrawal by Subject|141|||
46844730|NCT00160524|83061603|FG000|Overall Study|Withdrawal by Subject and Other|17|||
46844731|NCT00160524|83061603|FG000|Overall Study|Physician Decision|27|||
46844732|NCT00160524|83061603|FG000|Overall Study|Physician Decision and Other|6|||
46844733|NCT00160524|83061603|FG000|Overall Study|Lost to Follow-up|13|||
46844734|NCT00160524|83061603|FG000|Overall Study|Lost to Follow-up and Other|1|||
46844735|NCT00160524|83061603|FG000|Overall Study|Lack of Efficacy|21|||
46844736|NCT00160524|83061603|FG000|Overall Study|Lack of Efficacy and Other|1|||
46844737|NCT00160524|83061603|FG000|Overall Study|Other|20|||
46844738|NCT00159822|83061607|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
46844739|NCT00159822|83061607|FG000|Voriconazole Treatment Period|Adverse Event|9|||
46844740|NCT00159822|83061607|FG000|Voriconazole Treatment Period|Death|4|||
46844741|NCT00159822|83061607|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
46844742|NCT00159822|83061607|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
46844743|NCT00159822|83061607|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
46844744|NCT00159822|83061607|FG000|Post-treatment Follow-up Period|Death|1|||
46844745|NCT00159822|83061607|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
46844746|NCT00159822|83061607|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
46844747|NCT00158262|83061613|FG000|Overall Study|Lost to Follow-up|1|||
46844748|NCT00158262|83061614|FG001|Overall Study|Lost to Follow-up|1|||
46844749|NCT00157950|83061622|FG000|Overall Study|Death|1|||
46844750|NCT00157950|83061623|FG001|Overall Study|Death|0|||
46844751|NCT03745768|83061631|FG000|Overall Study|discontinued study|2|||
46844752|NCT03745768|83061632|FG001|Overall Study|discontinued study|0|||
46844753|NCT03745222|83061641|FG000|Overall Study|Withdrawal by Subject|0|||
46844754|NCT03745222|83061642|FG001|Overall Study|Withdrawal by Subject|1|||
46844755|NCT03745222|83061643|FG002|Overall Study|Withdrawal by Subject|0|||
46844756|NCT03743038|83061651|FG000|Overall Study|Physician Decision|1|||
46844757|NCT00153816|83061663|FG000|Overall Study|Death|6|||
46844758|NCT00153816|83061664|FG001|Overall Study|Death|5|||
46844759|NCT00153816|83061665|FG002|Overall Study|Death|4|||
46844760|NCT00153816|83061666|FG003|Overall Study|Death|6|||
46844761|NCT00153816|83061667|FG004|Overall Study|Death|0|||
46844762|NCT00153816|83061668|FG005|Overall Study|Death|2|||
46957556|NCT01364870|83198907|FG000|Overall Study|Withdrawal by Subject|13|||
46957557|NCT01364870|83198908|FG001|Overall Study|Withdrawal by Subject|24|||
47067004|NCT01449461|83350342|FG003|Overall Study|Site Terminated by Sponsor|3|||
47067005|NCT01449461|83350343|FG004|Overall Study|Site Terminated by Sponsor|4|||
47067006|NCT01449461|83350344|FG005|Overall Study|Site Terminated by Sponsor|1|||
46639852|NCT03083665|82813702|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
46639853|NCT03083665|82813703|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
46639854|NCT03083665|82813704|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
46639855|NCT03083665|82813699|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
46639856|NCT03083665|82813700|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
46639857|NCT03083665|82813701|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
46844763|NCT00153816|83061663|FG000|Overall Study|Lost to Follow-up|7|||
46844764|NCT00153816|83061664|FG001|Overall Study|Lost to Follow-up|8|||
46957558|NCT01364870|83198909|FG002|Overall Study|Withdrawal by Subject|10|||
46957559|NCT01364870|83198907|FG000|Overall Study|Adverse Event|8|||
46957560|NCT01364870|83198908|FG001|Overall Study|Adverse Event|6|||
46844765|NCT00153816|83061665|FG002|Overall Study|Lost to Follow-up|5|||
46844766|NCT00153816|83061666|FG003|Overall Study|Lost to Follow-up|8|||
46844767|NCT00153816|83061667|FG004|Overall Study|Lost to Follow-up|7|||
46844768|NCT00153816|83061668|FG005|Overall Study|Lost to Follow-up|9|||
46844769|NCT00153816|83061663|FG000|Overall Study|Withdrawal by Subject|9|||
46844770|NCT00153816|83061664|FG001|Overall Study|Withdrawal by Subject|9|||
46639858|NCT03083665|82813702|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
46639859|NCT03083665|82813703|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
46639860|NCT03083665|82813704|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
46639861|NCT03083665|82813699|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
46639862|NCT03083665|82813700|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
46639863|NCT03083665|82813701|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
46639864|NCT03083665|82813702|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
46639865|NCT03083665|82813703|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
46844771|NCT00153816|83061665|FG002|Overall Study|Withdrawal by Subject|9|||
46844772|NCT00153816|83061666|FG003|Overall Study|Withdrawal by Subject|4|||
46844773|NCT00153816|83061667|FG004|Overall Study|Withdrawal by Subject|1|||
46844774|NCT00153816|83061668|FG005|Overall Study|Withdrawal by Subject|5|||
46844775|NCT00153816|83061663|FG000|Overall Study|Follow-up exam not done|8|||
46844776|NCT00153816|83061664|FG001|Overall Study|Follow-up exam not done|7|||
46844777|NCT00153816|83061665|FG002|Overall Study|Follow-up exam not done|11|||
46844778|NCT00153816|83061666|FG003|Overall Study|Follow-up exam not done|10|||
46844779|NCT00153816|83061667|FG004|Overall Study|Follow-up exam not done|8|||
46844780|NCT00153816|83061668|FG005|Overall Study|Follow-up exam not done|9|||
46844781|NCT00153816|83061663|FG000|Overall Study|Follow-up exam done, histology missing|2|||
46844782|NCT00153816|83061664|FG001|Overall Study|Follow-up exam done, histology missing|3|||
46844783|NCT00153816|83061665|FG002|Overall Study|Follow-up exam done, histology missing|3|||
46844784|NCT00153816|83061666|FG003|Overall Study|Follow-up exam done, histology missing|3|||
46844785|NCT00153816|83061667|FG004|Overall Study|Follow-up exam done, histology missing|1|||
46844786|NCT00153816|83061668|FG005|Overall Study|Follow-up exam done, histology missing|2|||
46844787|NCT00151476|83061685|FG000|FAP Identified Subjects|Protocol Violation|0|||
46844788|NCT00151476|83061686|FG001|FAP Identified Subjects|Protocol Violation|1|||
46844789|NCT00151476|83061685|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
46844790|NCT00151476|83061686|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
46844791|NCT00151476|83061685|FG000|FAP Analyzed Subjects|Other study participation|0|||
46844792|NCT00151476|83061686|FG001|FAP Analyzed Subjects|Other study participation|1|||
46844793|NCT00149994|83061695|FG000|Overall Study|Administrative problems:|1|||
46844794|NCT00149994|83061696|FG001|Overall Study|Administrative problems:|0|||
46844795|NCT00149994|83061695|FG000|Overall Study|Protocol Violation|0|||
46844796|NCT00149994|83061696|FG001|Overall Study|Protocol Violation|1|||
46844797|NCT00149214|83061704|FG000|Overall Study|Adverse Event|12|||
46844798|NCT00149214|83061705|FG001|Overall Study|Adverse Event|9|||
46957561|NCT01364870|83198909|FG002|Overall Study|Adverse Event|4|||
46957562|NCT01364870|83198907|FG000|Overall Study|Protocol Violation|1|||
46957563|NCT01364870|83198908|FG001|Overall Study|Protocol Violation|0|||
46957564|NCT01364870|83198909|FG002|Overall Study|Protocol Violation|0|||
46957565|NCT02268526|83198920|FG000|Overall Study|Adverse Event|0|||
46957566|NCT02268526|83198921|FG001|Overall Study|Adverse Event|2|||
46957567|NCT02268526|83198922|FG002|Overall Study|Adverse Event|1|||
46957568|NCT02268526|83198920|FG000|Overall Study|Death|1|||
46957569|NCT02268526|83198921|FG001|Overall Study|Death|11|||
46957570|NCT02268526|83198922|FG002|Overall Study|Death|0|||
46957571|NCT02268526|83198920|FG000|Overall Study|protocol deviation|0|||
46957572|NCT02268526|83198921|FG001|Overall Study|protocol deviation|1|||
46957573|NCT02268526|83198922|FG002|Overall Study|protocol deviation|0|||
46957574|NCT02268526|83198920|FG000|Overall Study|Physician Decision|0|||
46957575|NCT02268526|83198921|FG001|Overall Study|Physician Decision|0|||
46957576|NCT02268526|83198922|FG002|Overall Study|Physician Decision|1|||
46957577|NCT02268526|83198920|FG000|Overall Study|Subject/guardian decision|0|||
46957578|NCT02268526|83198921|FG001|Overall Study|Subject/guardian decision|7|||
46957579|NCT02268526|83198922|FG002|Overall Study|Subject/guardian decision|3|||
46957580|NCT02268214|83198935|FG000|Overall Study|Subject no longer meets study criteria|0|||
46957581|NCT02268214|83198936|FG001|Overall Study|Subject no longer meets study criteria|2|||
46957582|NCT02268214|83198937|FG002|Overall Study|Subject no longer meets study criteria|0|||
46957583|NCT02268214|83198935|FG000|Overall Study|Pregnancy|2|||
46639866|NCT03083665|82813704|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
46844799|NCT00149214|83061704|FG000|Overall Study|Withdrawal by Subject|4|||
46844800|NCT00149214|83061705|FG001|Overall Study|Withdrawal by Subject|1|||
46844801|NCT00149214|83061704|FG000|Overall Study|Physician Decision|3|||
46844802|NCT00149214|83061705|FG001|Overall Study|Physician Decision|3|||
46957584|NCT02268214|83198936|FG001|Overall Study|Pregnancy|2|||
46957585|NCT02268214|83198937|FG002|Overall Study|Pregnancy|1|||
46957586|NCT02268214|83198935|FG000|Overall Study|Lost to Follow-up|3|||
46957587|NCT02268214|83198936|FG001|Overall Study|Lost to Follow-up|3|||
46957588|NCT02268214|83198937|FG002|Overall Study|Lost to Follow-up|4|||
46957589|NCT02268214|83198935|FG000|Overall Study|Lack of Efficacy|1|||
46957590|NCT02268214|83198936|FG001|Overall Study|Lack of Efficacy|0|||
46957591|NCT02268214|83198937|FG002|Overall Study|Lack of Efficacy|2|||
46957592|NCT02268214|83198935|FG000|Overall Study|Adverse Event|11|||
46957593|NCT02268214|83198936|FG001|Overall Study|Adverse Event|14|||
46957594|NCT02268214|83198937|FG002|Overall Study|Adverse Event|9|||
46957595|NCT02268214|83198935|FG000|Overall Study|Withdrawal by Subject|4|||
46957596|NCT02268214|83198936|FG001|Overall Study|Withdrawal by Subject|5|||
46957597|NCT02268214|83198937|FG002|Overall Study|Withdrawal by Subject|10|||
46957598|NCT02268214|83198935|FG000|Overall Study|Subject request to discontinue treatment|10|||
46957599|NCT02268214|83198936|FG001|Overall Study|Subject request to discontinue treatment|8|||
46957600|NCT02268214|83198937|FG002|Overall Study|Subject request to discontinue treatment|6|||
46957601|NCT02268214|83198935|FG000|Overall Study|Poor/non-compliance|2|||
46957602|NCT02268214|83198936|FG001|Overall Study|Poor/non-compliance|1|||
46957603|NCT02268214|83198937|FG002|Overall Study|Poor/non-compliance|2|||
46957604|NCT02268214|83198935|FG000|Overall Study|Other reasons|7|||
46957605|NCT02268214|83198936|FG001|Overall Study|Other reasons|3|||
46957606|NCT02268214|83198937|FG002|Overall Study|Other reasons|3|||
46957607|NCT02268214|83198935|FG000|Overall Study|Not entering long-term period|2|||
46957608|NCT02268214|83198936|FG001|Overall Study|Not entering long-term period|3|||
46957609|NCT02268214|83198937|FG002|Overall Study|Not entering long-term period|5|||
46957610|NCT02521376|83198949|FG000|Overall Study|Enrolled, But Not Treated|1|||
46957611|NCT02521376|83198950|FG001|Overall Study|Enrolled, But Not Treated|0|||
46957612|NCT02521376|83198951|FG002|Overall Study|Enrolled, But Not Treated|0|||
46957613|NCT02521376|83198952|FG003|Overall Study|Enrolled, But Not Treated|0|||
46957614|NCT02268058|83198974|FG000|Overall Study|Protocol Violation|1|||
46957615|NCT02268058|83198975|FG001|Overall Study|Protocol Violation|0|||
46957616|NCT02268058|83198976|FG002|Overall Study|Protocol Violation|0|||
46957617|NCT02268058|83198977|FG003|Overall Study|Protocol Violation|0|||
46957618|NCT02267824|83198989|FG000|Overall Study|Pregnancy|1|||
46957619|NCT02267824|83198990|FG001|Overall Study|Pregnancy|1|||
46957620|NCT02267824|83198989|FG000|Overall Study|Lost to Follow-up|4|||
46957621|NCT02267824|83198990|FG001|Overall Study|Lost to Follow-up|0|||
46957622|NCT02267824|83198989|FG000|Overall Study|Protocol Violation|3|||
46957623|NCT02267824|83198990|FG001|Overall Study|Protocol Violation|0|||
46957624|NCT02267824|83198989|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
46957625|NCT02267824|83198990|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
46957626|NCT02267746|83198999|FG000|Overall Study|Adverse Event|0|||
46957627|NCT02267746|83199000|FG001|Overall Study|Adverse Event|2|||
46957628|NCT02267746|83199001|FG002|Overall Study|Adverse Event|1|||
46957629|NCT02267746|83198999|FG000|Overall Study|Protocol Violation|8|||
46957630|NCT02267746|83199000|FG001|Overall Study|Protocol Violation|7|||
46957631|NCT02267746|83199001|FG002|Overall Study|Protocol Violation|3|||
46957632|NCT02267746|83198999|FG000|Overall Study|Lack of Efficacy|11|||
46957633|NCT02267746|83199000|FG001|Overall Study|Lack of Efficacy|11|||
46957634|NCT02267746|83199001|FG002|Overall Study|Lack of Efficacy|15|||
46957635|NCT02267746|83198999|FG000|Overall Study|Protocol Violation|1|||
46957636|NCT02267746|83199000|FG001|Overall Study|Protocol Violation|2|||
46957637|NCT02267746|83199001|FG002|Overall Study|Protocol Violation|1|||
46957638|NCT02267746|83198999|FG000|Overall Study|Miscellaneous|1|||
46957639|NCT02267746|83199000|FG001|Overall Study|Miscellaneous|0|||
46957640|NCT02267746|83199001|FG002|Overall Study|Miscellaneous|1|||
46957641|NCT02362360|83199011|FG000|Period 1|Lack of Efficacy|1|||
46957642|NCT02362360|83199012|FG001|Period 1|Lack of Efficacy|0|||
46773558|NCT00468559|82991936|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
46773559|NCT00468559|82991937|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
46773560|NCT00468559|82991935|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
46773561|NCT00468559|82991936|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
46773562|NCT00468559|82991937|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
46773563|NCT00754442|82991947|FG000|Overall Study|Withdrawal by Subject|5|||
46773564|NCT00754442|82991948|FG001|Overall Study|Withdrawal by Subject|3|||
46773565|NCT00754052|82991957|FG000|Overall Study|Study terminated by Sponsor|5|||
46773566|NCT00754052|82991958|FG001|Overall Study|Study terminated by Sponsor|3|||
46773567|NCT00747812|82991966|FG000|Overall Study|Research Site Staff Relocation|5|||
46773568|NCT00747812|82991967|FG001|Overall Study|Research Site Staff Relocation|3|||
46773569|NCT02927067|82991975|FG000|Overall Study|Withdrawn Consent|20|||
46773570|NCT02927067|82991976|FG001|Overall Study|Withdrawn Consent|12|||
46773571|NCT02927067|82991975|FG000|Overall Study|Death|18|||
46773572|NCT02927067|82991976|FG001|Overall Study|Death|31|||
46773573|NCT02927067|82991975|FG000|Overall Study|Adverse Event|13|||
46957643|NCT02362360|83199011|FG000|Period 1|Withdrawal by Subject|2|||
46957644|NCT02362360|83199012|FG001|Period 1|Withdrawal by Subject|1|||
46957645|NCT02362282|83199020|FG000|Overall Study|Withdrawal by Subject|1|||
46957646|NCT02362282|83199021|FG001|Overall Study|Withdrawal by Subject|0|||
46957647|NCT02361580|83199029|FG000|Overall Study|Lost to Follow-up|6|||
46957648|NCT02361580|83199030|FG001|Overall Study|Lost to Follow-up|3|||
46957649|NCT02520284|83199039|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
46957650|NCT02520284|83199040|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
46957651|NCT02520284|83199041|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
46957652|NCT02520284|83199039|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
46773574|NCT02927067|82991976|FG001|Overall Study|Adverse Event|10|||
46773575|NCT02927067|82991975|FG000|Overall Study|Noncompliance|5|||
46773576|NCT02927067|82991976|FG001|Overall Study|Noncompliance|2|||
46773577|NCT02927067|82991975|FG000|Overall Study|Reason not Specified|4|||
46957653|NCT02520284|83199040|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
46957654|NCT02520284|83199041|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
46957655|NCT02520284|83199039|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
46957656|NCT02520284|83199040|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
46957657|NCT02520284|83199041|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
46957658|NCT02520284|83199039|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
46957659|NCT02520284|83199040|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
46957660|NCT02520284|83199041|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
46957661|NCT02520284|83199039|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
46957662|NCT02520284|83199040|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
46957663|NCT02520284|83199041|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
46957664|NCT02520284|83199039|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
46957665|NCT02520284|83199040|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
46957666|NCT02520284|83199041|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
46957667|NCT02520284|83199039|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
46957668|NCT02520284|83199040|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
46957669|NCT02520284|83199041|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
46957670|NCT02520284|83199039|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
46957671|NCT02520284|83199040|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
46957672|NCT02520284|83199041|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
46957673|NCT02520284|83199039|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
46773578|NCT02927067|82991976|FG001|Overall Study|Reason not Specified|6|||
46844803|NCT00149214|83061704|FG000|Overall Study|Sponsor Decision|0|||
46844804|NCT00149214|83061705|FG001|Overall Study|Sponsor Decision|1|||
46844805|NCT00149214|83061704|FG000|Overall Study|Progressive Disease|7|||
46844806|NCT00149214|83061705|FG001|Overall Study|Progressive Disease|3|||
46844807|NCT00114972|83061722|FG000|Overall Study|Withdrawal by Subject|40|||
46844808|NCT00114972|83061723|FG001|Overall Study|Withdrawal by Subject|7|||
46844809|NCT00114972|83061722|FG000|Overall Study|Lost to Follow-up|8|||
46844810|NCT00114972|83061723|FG001|Overall Study|Lost to Follow-up|5|||
46844811|NCT00129402|83061731|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
46957674|NCT02520284|83199040|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
46957675|NCT02520284|83199041|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
46957676|NCT02520284|83199039|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
46957677|NCT02520284|83199040|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
46773579|NCT01751685|82991986|FG000|6-mo Followup|Missed study visit|1|||
46773580|NCT01751685|82991987|FG001|6-mo Followup|Missed study visit|0|||
46773581|NCT01751685|82991986|FG000|6-mo Followup|Withdrawal by Subject|2|||
46773582|NCT01751685|82991987|FG001|6-mo Followup|Withdrawal by Subject|2|||
46773583|NCT01751685|82991986|FG000|6-mo Followup|Lost to Follow-up|0|||
46773584|NCT01751685|82991987|FG001|6-mo Followup|Lost to Follow-up|1|||
46773585|NCT01751685|82991986|FG000|12-mo Followup|Lost to Follow-up|5|||
46844812|NCT00129402|83061732|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
46773586|NCT01751685|82991987|FG001|12-mo Followup|Lost to Follow-up|0|||
46773587|NCT00586508|82991995|FG000|Overall Study|Progressive disease|52|||
46773588|NCT00586508|82991996|FG001|Overall Study|Progressive disease|8|||
46773589|NCT00586508|82991995|FG000|Overall Study|Death|0|||
46957678|NCT02520284|83199041|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
46957679|NCT02520284|83199039|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
46957680|NCT02520284|83199040|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
46957681|NCT02520284|83199041|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
46957682|NCT02517866|83199055|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
46957683|NCT02517866|83199056|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
46844813|NCT00129402|83061733|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
46844814|NCT00129402|83061734|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
46844815|NCT00129402|83061735|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
46844816|NCT00129402|83061736|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
46844817|NCT00129402|83061737|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
46844818|NCT00129402|83061731|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
46844819|NCT00129402|83061732|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
46844820|NCT00129402|83061733|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
46844821|NCT00129402|83061734|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
46844822|NCT00129402|83061735|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
46844823|NCT00129402|83061736|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
46844824|NCT00129402|83061737|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
46844825|NCT00129402|83061731|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
46844826|NCT00129402|83061732|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
46844827|NCT00129402|83061733|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
46844828|NCT00129402|83061734|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
46844829|NCT00129402|83061735|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
46844830|NCT00129402|83061736|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
46844831|NCT00129402|83061737|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
46957684|NCT02517866|83199057|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
46957685|NCT02517866|83199055|FG000|Overall Study|Significant Protocol Deviation|4|||
46957686|NCT02517866|83199056|FG001|Overall Study|Significant Protocol Deviation|1|||
46957687|NCT02517866|83199057|FG002|Overall Study|Significant Protocol Deviation|0|||
46957688|NCT02517866|83199055|FG000|Overall Study|Lost to Follow-up|1|||
46957689|NCT02517866|83199056|FG001|Overall Study|Lost to Follow-up|0|||
46957690|NCT02517866|83199057|FG002|Overall Study|Lost to Follow-up|0|||
46957691|NCT02517866|83199055|FG000|Overall Study|Voluntary Withdrawal|2|||
46957692|NCT02517866|83199056|FG001|Overall Study|Voluntary Withdrawal|2|||
46957693|NCT02517866|83199057|FG002|Overall Study|Voluntary Withdrawal|0|||
46957694|NCT02517866|83199055|FG000|Overall Study|Investigator Decision|2|||
46773590|NCT00586508|82991996|FG001|Overall Study|Death|1|||
46773591|NCT00586508|82991995|FG000|Overall Study|Adverse Event|12|||
46957695|NCT02517866|83199056|FG001|Overall Study|Investigator Decision|1|||
46957696|NCT02517866|83199057|FG002|Overall Study|Investigator Decision|0|||
46773592|NCT00586508|82991996|FG001|Overall Study|Adverse Event|4|||
46773593|NCT00586508|82991995|FG000|Overall Study|Withdrawal by Subject|4|||
46957697|NCT02517866|83199055|FG000|Overall Study|Reason not specified|2|||
46773594|NCT00586508|82991996|FG001|Overall Study|Withdrawal by Subject|0|||
46773595|NCT00581919|82992002|FG000|Overall Study|Adverse Event|8|||
46773596|NCT00581919|82992002|FG000|Overall Study|Death|1|||
46773597|NCT00581919|82992002|FG000|Overall Study|Disease Progression|10|||
46773598|NCT00581919|82992002|FG000|Overall Study|Physician Decision|1|||
46773599|NCT00581919|82992002|FG000|Overall Study|Other Complicating Disease|1|||
46957698|NCT02517866|83199056|FG001|Overall Study|Reason not specified|0|||
46957699|NCT02517866|83199057|FG002|Overall Study|Reason not specified|0|||
46957700|NCT02515994|83199069|FG000|Overall Study|Protocol Violation|3|||
46957701|NCT02515994|83199070|FG001|Overall Study|Protocol Violation|5|||
46957702|NCT02515994|83199069|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
46957703|NCT02515994|83199070|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
46957704|NCT02515994|83199069|FG000|Overall Study|Adverse Event|3|||
46957705|NCT02515994|83199070|FG001|Overall Study|Adverse Event|1|||
46773600|NCT00581919|82992002|FG000|Overall Study|Started Non-Protocol Therapy|2|||
46773601|NCT00581919|82992002|FG000|Overall Study|Withdrawal by Subject|1|||
46773602|NCT00723528|82992010|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
46844832|NCT00129402|83061731|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
46844833|NCT00129402|83061732|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
46844834|NCT00129402|83061733|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
46844835|NCT00129402|83061734|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
46957706|NCT02515994|83199069|FG000|Overall Study|Withdrawal by Subject|2|||
46957707|NCT02515994|83199070|FG001|Overall Study|Withdrawal by Subject|0|||
46957708|NCT02516306|83199078|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
46957709|NCT02516306|83199079|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
46957710|NCT02516228|83199085|FG000|Overall Study|Lost to Follow-up|1|||
46773603|NCT00723528|82992011|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
46957711|NCT02516228|83199085|FG000|Overall Study|Withdrawal by Subject|1|||
46773604|NCT00723528|82992012|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
46773605|NCT00723528|82992013|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
46773606|NCT00723528|82992014|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
46773607|NCT00723528|82992015|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
46844836|NCT00129402|83061735|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
46957712|NCT02516228|83199085|FG000|Overall Study|Physician Decision|1|||
46957713|NCT02519504|83199091|FG000|Overall Study|Protocol Violation|6|||
46957714|NCT02519504|83199092|FG001|Overall Study|Protocol Violation|5|||
46957715|NCT02519504|83199091|FG000|Overall Study|Ineligible for direct testing|12|||
46957716|NCT02519504|83199092|FG001|Overall Study|Ineligible for direct testing|12|||
46957717|NCT02519504|83199091|FG000|Overall Study|Did not participate in direct testing|95|||
46957718|NCT02519504|83199092|FG001|Overall Study|Did not participate in direct testing|86|||
46957719|NCT02514824|83199100|FG000|Overall Study|Withdrawal by Subject|1|||
46957720|NCT02514824|83199101|FG001|Overall Study|Withdrawal by Subject|0|||
46639867|NCT03083665|82813699|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
46639868|NCT03083665|82813700|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
46639869|NCT03083665|82813701|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
46639870|NCT03083665|82813702|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
46639871|NCT03083665|82813703|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
46639872|NCT03083665|82813704|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
46639873|NCT03045276|82813725|FG000|Intervention Phase|Withdrawal by Subject|7|||
46639874|NCT03045276|82813726|FG001|Intervention Phase|Withdrawal by Subject|2|||
46639875|NCT03045276|82813727|FG002|Intervention Phase|Withdrawal by Subject|3|||
46639876|NCT03045276|82813728|FG003|Intervention Phase|Withdrawal by Subject|7|||
46639877|NCT03045276|82813725|FG000|Intervention Phase|Developed exclusionary criteria|3|||
46639878|NCT03045276|82813726|FG001|Intervention Phase|Developed exclusionary criteria|3|||
46639879|NCT03045276|82813727|FG002|Intervention Phase|Developed exclusionary criteria|0|||
46639880|NCT03045276|82813728|FG003|Intervention Phase|Developed exclusionary criteria|0|||
46639881|NCT03045276|82813725|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
46639882|NCT03045276|82813726|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
46639883|NCT03045276|82813727|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
46639884|NCT03045276|82813728|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
46639885|NCT03045276|82813725|FG000|Follow-Up Phase|Lost to Follow-up|0|||
46773608|NCT00723528|82992016|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
46773609|NCT00723528|82992010|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
46773610|NCT00723528|82992011|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
46773611|NCT00723528|82992012|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
46773612|NCT00723528|82992013|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
46773613|NCT00723528|82992014|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
46773614|NCT00723528|82992015|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
46844837|NCT00129402|83061736|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
46844838|NCT00129402|83061737|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
46844839|NCT00129402|83061731|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
46844840|NCT00129402|83061732|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
46844841|NCT00129402|83061733|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
46844842|NCT00129402|83061734|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
46844843|NCT00129402|83061735|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
46844844|NCT00129402|83061736|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
46844845|NCT00129402|83061737|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
46844846|NCT00129402|83061731|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
46844847|NCT00129402|83061732|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
46844848|NCT00129402|83061733|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
46844849|NCT00129402|83061734|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
46844850|NCT00129402|83061735|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
46844851|NCT00129402|83061736|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
46844852|NCT00129402|83061737|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
46844853|NCT00129402|83061731|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
46844854|NCT00129402|83061732|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
46844855|NCT00129402|83061733|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
46844856|NCT00129402|83061734|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
46844857|NCT00129402|83061735|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
46844858|NCT00129402|83061736|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
46844859|NCT00129402|83061737|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
46957721|NCT02514824|83199102|FG002|Overall Study|Withdrawal by Subject|0|||
46639886|NCT03045276|82813726|FG001|Follow-Up Phase|Lost to Follow-up|1|||
46639887|NCT03045276|82813727|FG002|Follow-Up Phase|Lost to Follow-up|0|||
46639888|NCT03045276|82813728|FG003|Follow-Up Phase|Lost to Follow-up|1|||
46639889|NCT03045276|82813725|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
46639890|NCT03045276|82813726|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
46639891|NCT03045276|82813727|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
46639892|NCT03045276|82813728|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
46844860|NCT00129402|83061731|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
46639893|NCT02819518|82813760|FG000|Overall Study|Death|9|||
46639894|NCT02819518|82813761|FG001|Overall Study|Death|11|||
46639895|NCT02819518|82813762|FG002|Overall Study|Death|9|||
46639896|NCT02819518|82813763|FG003|Overall Study|Death|447|||
46639897|NCT02819518|82813764|FG004|Overall Study|Death|233|||
46639898|NCT02819518|82813760|FG000|Overall Study|Withdrawal by Subject|0|||
46639899|NCT02819518|82813761|FG001|Overall Study|Withdrawal by Subject|0|||
46639900|NCT02819518|82813762|FG002|Overall Study|Withdrawal by Subject|0|||
46639901|NCT02819518|82813763|FG003|Overall Study|Withdrawal by Subject|21|||
46639902|NCT02819518|82813764|FG004|Overall Study|Withdrawal by Subject|6|||
46639903|NCT02819518|82813760|FG000|Overall Study|Ongoing in Study|2|||
46639904|NCT02819518|82813761|FG001|Overall Study|Ongoing in Study|3|||
46639905|NCT02819518|82813762|FG002|Overall Study|Ongoing in Study|1|||
46639906|NCT02819518|82813763|FG003|Overall Study|Ongoing in Study|98|||
46639907|NCT02819518|82813764|FG004|Overall Study|Ongoing in Study|42|||
46639908|NCT02661022|82813780|FG000|Overall Study|Withdrawal by Subject|3|||
46639909|NCT02661022|82813781|FG001|Overall Study|Withdrawal by Subject|0|||
46639910|NCT02661022|82813780|FG000|Overall Study|Adverse Event|1|||
46639911|NCT02661022|82813781|FG001|Overall Study|Adverse Event|1|||
46639912|NCT02661022|82813780|FG000|Overall Study|Physician Decision|1|||
46639913|NCT02661022|82813781|FG001|Overall Study|Physician Decision|0|||
46639914|NCT02661022|82813780|FG000|Overall Study|Progressive Disease|2|||
46639915|NCT02661022|82813781|FG001|Overall Study|Progressive Disease|1|||
46773615|NCT00723528|82992016|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
46773616|NCT00723528|82992010|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
46844861|NCT00129402|83061732|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
46844862|NCT00129402|83061733|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
46844863|NCT00129402|83061734|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
46844864|NCT00129402|83061735|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
46844865|NCT00129402|83061736|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
46844866|NCT00129402|83061737|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
46844867|NCT00129402|83061731|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
46844868|NCT00129402|83061732|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
46844869|NCT00129402|83061733|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
46844870|NCT00129402|83061734|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
46844871|NCT00129402|83061735|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
46844872|NCT00129402|83061736|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
46844873|NCT00129402|83061737|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
46844874|NCT00129402|83061731|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
46844875|NCT00129402|83061732|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
46844876|NCT00129402|83061733|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
46844877|NCT00129402|83061734|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
46844878|NCT00129402|83061735|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
46844879|NCT00129402|83061736|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
46844880|NCT00129402|83061737|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
46773617|NCT00723528|82992011|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
46773618|NCT00723528|82992012|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
46773619|NCT00723528|82992013|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
46773620|NCT00723528|82992014|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
46773621|NCT00723528|82992015|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
46773622|NCT00723528|82992016|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
46773623|NCT00723528|82992010|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
46773624|NCT00723528|82992011|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
46639916|NCT01901562|82813804|FG000|Overall Study|Protocol Violation|5|||
46639917|NCT01901562|82813804|FG000|Overall Study|Excluded intraoperatively|4|||
46639918|NCT00819247|82813811|FG000|Overall Study|Adverse Event|0|||
46639919|NCT00819247|82813812|FG001|Overall Study|Adverse Event|5|||
46639920|NCT00819247|82813813|FG002|Overall Study|Adverse Event|3|||
46639921|NCT00819247|82813811|FG000|Overall Study|Insufficient testosterone response|5|||
46639922|NCT00819247|82813812|FG001|Overall Study|Insufficient testosterone response|8|||
46639923|NCT00819247|82813813|FG002|Overall Study|Insufficient testosterone response|10|||
46639924|NCT00819247|82813811|FG000|Overall Study|Withdrawal by Subject|1|||
46844881|NCT00129402|83061731|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
46844882|NCT00129402|83061732|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
46844883|NCT00129402|83061733|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
46844884|NCT00129402|83061734|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
46844885|NCT00129402|83061735|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
46844886|NCT00129402|83061736|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
46844887|NCT00129402|83061737|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
46844888|NCT00129402|83061731|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
46844889|NCT00129402|83061732|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
46844890|NCT00129402|83061733|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
46639925|NCT00819247|82813812|FG001|Overall Study|Withdrawal by Subject|0|||
46639926|NCT00819247|82813813|FG002|Overall Study|Withdrawal by Subject|0|||
46639927|NCT00819247|82813811|FG000|Overall Study|Protocol Violation|1|||
46639928|NCT00819247|82813812|FG001|Overall Study|Protocol Violation|0|||
46639929|NCT00819247|82813813|FG002|Overall Study|Protocol Violation|1|||
46639930|NCT00819247|82813811|FG000|Overall Study|Mistakenly withdrawn|0|||
46639931|NCT00819247|82813812|FG001|Overall Study|Mistakenly withdrawn|1|||
46639932|NCT00819247|82813813|FG002|Overall Study|Mistakenly withdrawn|0|||
46844891|NCT00129402|83061734|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
46844892|NCT00129402|83061735|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
46844893|NCT00129402|83061736|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
46844894|NCT00129402|83061737|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
46844895|NCT00129402|83061731|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
46844896|NCT00129402|83061732|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
46844897|NCT00129402|83061733|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
46844898|NCT00129402|83061734|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
46844899|NCT00129402|83061735|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
46844900|NCT00129402|83061736|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
46844901|NCT00129402|83061737|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
47067007|NCT01449461|83350339|FG000|Overall Study|Withdrawal by Subject|0|||
47067008|NCT01449461|83350340|FG001|Overall Study|Withdrawal by Subject|1|||
47067009|NCT01449461|83350341|FG002|Overall Study|Withdrawal by Subject|0|||
47067010|NCT01449461|83350342|FG003|Overall Study|Withdrawal by Subject|0|||
47067011|NCT01449461|83350343|FG004|Overall Study|Withdrawal by Subject|2|||
47067012|NCT01449461|83350344|FG005|Overall Study|Withdrawal by Subject|1|||
47067013|NCT01449461|83350339|FG000|Overall Study|Reason not Specified|0|||
47067014|NCT01449461|83350340|FG001|Overall Study|Reason not Specified|1|||
46639933|NCT00819247|82813811|FG000|Overall Study|Bad prostate-specific antigen response|3|||
47067015|NCT01449461|83350341|FG002|Overall Study|Reason not Specified|0|||
46639934|NCT00819247|82813812|FG001|Overall Study|Bad prostate-specific antigen response|2|||
46639935|NCT00819247|82813813|FG002|Overall Study|Bad prostate-specific antigen response|0|||
46639936|NCT00819247|82813811|FG000|Overall Study|Other|1|||
46639937|NCT00819247|82813812|FG001|Overall Study|Other|0|||
46639938|NCT00819247|82813813|FG002|Overall Study|Other|0|||
46639939|NCT00716976|82813823|FG000|Overall Study|Adverse Event|2|||
46639940|NCT00716976|82813824|FG001|Overall Study|Adverse Event|0|||
46639941|NCT00716976|82813823|FG000|Overall Study|Death|1|||
46639942|NCT00716976|82813824|FG001|Overall Study|Death|0|||
46639943|NCT00716976|82813823|FG000|Overall Study|Physician Decision|2|||
46639944|NCT00716976|82813824|FG001|Overall Study|Physician Decision|2|||
46639945|NCT00716976|82813823|FG000|Overall Study|Withdrawal by Subject|5|||
46639946|NCT00716976|82813824|FG001|Overall Study|Withdrawal by Subject|1|||
46639947|NCT00716976|82813823|FG000|Overall Study|Premature discontinuation cisplatin|5|||
46639948|NCT00716976|82813824|FG001|Overall Study|Premature discontinuation cisplatin|4|||
46639949|NCT00716976|82813823|FG000|Overall Study|Radiation during protocol|1|||
46639950|NCT00716976|82813824|FG001|Overall Study|Radiation during protocol|0|||
46773625|NCT00723528|82992012|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
46639951|NCT00716976|82813823|FG000|Overall Study|Ineligibles|4|||
46773626|NCT00723528|82992013|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
46773627|NCT00723528|82992014|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
46773628|NCT00723528|82992015|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
46773629|NCT00723528|82992016|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
46773630|NCT00723528|82992010|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
46773631|NCT00723528|82992011|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
46773632|NCT00723528|82992012|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
46773633|NCT00723528|82992013|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
47067016|NCT01449461|83350342|FG003|Overall Study|Reason not Specified|3|||
46639952|NCT00716976|82813824|FG001|Overall Study|Ineligibles|2|||
46639953|NCT00089778|82813946|FG000|Overall Study|Protocol Violation|0|||
46639954|NCT00089778|82813947|FG001|Overall Study|Protocol Violation|0|||
46639955|NCT00089778|82813948|FG002|Overall Study|Protocol Violation|1|||
46639956|NCT00089544|82813960|FG000|Overall Study|Ineligible|1|||
46639957|NCT00089544|82813961|FG001|Overall Study|Ineligible|0|||
46639958|NCT00089076|82813967|FG000|Overall Study|Alternate Therapy|1|||
46639959|NCT00089076|82813967|FG000|Overall Study|Withdrawal by Subject|2|||
46639960|NCT00089076|82813967|FG000|Overall Study|Progression|7|||
46639961|NCT00088374|82813971|FG000|Overall Study|patient did not receive any 17AAG|1|||
46639962|NCT00088374|82813971|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
46639963|NCT00087594|82813977|FG000|Overall Study|Adverse Event|2|||
46639964|NCT00087594|82813978|FG001|Overall Study|Adverse Event|3|||
46639965|NCT00087594|82813977|FG000|Overall Study|Lost to Follow-up|0|||
46844902|NCT03739528|83061747|FG000|Overall Study|Not treated|8|||
46844903|NCT03739528|83061748|FG001|Overall Study|Not treated|12|||
46844904|NCT03739528|83061747|FG000|Overall Study|Treatment and study discontinued|6|||
46844905|NCT03739528|83061748|FG001|Overall Study|Treatment and study discontinued|2|||
46844906|NCT03739528|83061747|FG000|Overall Study|Treatment discontinued + study completed|1|||
46844907|NCT03739528|83061748|FG001|Overall Study|Treatment discontinued + study completed|3|||
46844908|NCT00114738|83061757|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
46844909|NCT00114738|83061758|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
46844910|NCT00114738|83061759|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
46844911|NCT00114738|83061757|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
46844912|NCT00114738|83061758|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
46844913|NCT00114738|83061759|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
46844914|NCT00114738|83061757|FG000|Screening for Randomization|Neuropathy|17|||
46844915|NCT00114738|83061758|FG001|Screening for Randomization|Neuropathy|0|||
46844916|NCT00114738|83061759|FG002|Screening for Randomization|Neuropathy|0|||
46844917|NCT00114738|83061757|FG000|Screening for Randomization|Progressive disease|2|||
46957722|NCT02514824|83199103|FG003|Overall Study|Withdrawal by Subject|0|||
46957723|NCT02514824|83199100|FG000|Overall Study|Dose-Limiting Toxicity|0|||
46957724|NCT02514824|83199101|FG001|Overall Study|Dose-Limiting Toxicity|1|||
46957725|NCT02514824|83199102|FG002|Overall Study|Dose-Limiting Toxicity|0|||
46957726|NCT02514824|83199103|FG003|Overall Study|Dose-Limiting Toxicity|0|||
46957727|NCT02514746|83199112|FG000|Overall Study|Chronically Ill|1|||
46957728|NCT02514746|83199113|FG001|Overall Study|Chronically Ill|2|||
46957729|NCT02514746|83199112|FG000|Overall Study|Physician Decision|4|||
46957730|NCT02514746|83199113|FG001|Overall Study|Physician Decision|2|||
47067017|NCT01449461|83350343|FG004|Overall Study|Reason not Specified|2|||
46639966|NCT00087594|82813978|FG001|Overall Study|Lost to Follow-up|2|||
46639967|NCT00087594|82813977|FG000|Overall Study|Withdrawal by Subject|4|||
46639968|NCT00087594|82813978|FG001|Overall Study|Withdrawal by Subject|2|||
46639969|NCT00087594|82813977|FG000|Overall Study|Lack of Efficacy|2|||
46639970|NCT00087594|82813978|FG001|Overall Study|Lack of Efficacy|5|||
46639971|NCT00087516|82813987|FG000|Overall Study|Adverse Event|10|||
46639972|NCT00087516|82813988|FG001|Overall Study|Adverse Event|10|||
46639973|NCT00087516|82813989|FG002|Overall Study|Adverse Event|3|||
46773634|NCT00723528|82992014|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
46773635|NCT00723528|82992015|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
46773636|NCT00723528|82992016|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
46639974|NCT00087516|82813990|FG003|Overall Study|Adverse Event|6|||
46639975|NCT00087516|82813987|FG000|Overall Study|Lack of Efficacy|82|||
46639976|NCT00087516|82813988|FG001|Overall Study|Lack of Efficacy|80|||
46773637|NCT00723528|82992010|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
46773638|NCT00723528|82992011|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
46773639|NCT00723528|82992012|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
46773640|NCT00723528|82992013|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
46773641|NCT00723528|82992014|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
46773642|NCT00723528|82992015|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
46773643|NCT00723528|82992016|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
46773644|NCT00723528|82992010|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
46773645|NCT00723528|82992011|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
46773646|NCT00723528|82992012|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
46773647|NCT00723528|82992013|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
46773648|NCT00723528|82992014|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
46844918|NCT00114738|83061758|FG001|Screening for Randomization|Progressive disease|0|||
46957731|NCT02514746|83199112|FG000|Overall Study|Withdrawal by Subject|12|||
46957732|NCT02514746|83199113|FG001|Overall Study|Withdrawal by Subject|10|||
46957733|NCT02514746|83199112|FG000|Overall Study|Other|5|||
46639977|NCT00087516|82813989|FG002|Overall Study|Lack of Efficacy|39|||
46639978|NCT00087516|82813990|FG003|Overall Study|Lack of Efficacy|29|||
46639979|NCT00087516|82813987|FG000|Overall Study|Lost to Follow-up|8|||
46639980|NCT00087516|82813988|FG001|Overall Study|Lost to Follow-up|6|||
46844919|NCT00114738|83061759|FG002|Screening for Randomization|Progressive disease|0|||
46844920|NCT00114738|83061757|FG000|Screening for Randomization|CNS Hemorrhage|1|||
46844921|NCT00114738|83061758|FG001|Screening for Randomization|CNS Hemorrhage|0|||
46844922|NCT00114738|83061759|FG002|Screening for Randomization|CNS Hemorrhage|0|||
46844923|NCT00114738|83061757|FG000|Screening for Randomization|Other|1|||
46844924|NCT00114738|83061758|FG001|Screening for Randomization|Other|0|||
46844925|NCT00114738|83061759|FG002|Screening for Randomization|Other|0|||
46844926|NCT00148122|83061766|FG000|Overall Study|Withdrawal by Subject|2|||
46844927|NCT00147498|83061774|FG000|Overall Study|Adverse Event|1|||
46844928|NCT00147498|83061775|FG001|Overall Study|Adverse Event|6|||
46844929|NCT00147498|83061776|FG002|Overall Study|Adverse Event|7|||
46844930|NCT00147498|83061777|FG003|Overall Study|Adverse Event|3|||
46844931|NCT00147498|83061774|FG000|Overall Study|Lack of Efficacy|1|||
46844932|NCT00147498|83061775|FG001|Overall Study|Lack of Efficacy|1|||
46844933|NCT00147498|83061776|FG002|Overall Study|Lack of Efficacy|1|||
46844934|NCT00147498|83061777|FG003|Overall Study|Lack of Efficacy|8|||
46844935|NCT00147498|83061774|FG000|Overall Study|Laboratory abnormality|0|||
46844936|NCT00147498|83061775|FG001|Overall Study|Laboratory abnormality|0|||
46844937|NCT00147498|83061776|FG002|Overall Study|Laboratory abnormality|2|||
46844938|NCT00147498|83061777|FG003|Overall Study|Laboratory abnormality|0|||
46844939|NCT00147498|83061774|FG000|Overall Study|Participant defaulted|0|||
46844940|NCT00147498|83061775|FG001|Overall Study|Participant defaulted|1|||
46844941|NCT00147498|83061776|FG002|Overall Study|Participant defaulted|4|||
46844942|NCT00147498|83061777|FG003|Overall Study|Participant defaulted|3|||
46844943|NCT00147498|83061774|FG000|Overall Study|Other|1|||
46844944|NCT00147498|83061775|FG001|Overall Study|Other|1|||
46844945|NCT00147498|83061776|FG002|Overall Study|Other|3|||
46844946|NCT00147498|83061777|FG003|Overall Study|Other|3|||
46844947|NCT00113568|83061787|FG000|Overall Study|Adverse Event|97|||
46844948|NCT00113568|83061787|FG000|Overall Study|Death|1|||
46844949|NCT00113568|83061787|FG000|Overall Study|Lack of Efficacy|30|||
46844950|NCT00113568|83061787|FG000|Overall Study|Lost to Follow-up|156|||
46844951|NCT00113568|83061787|FG000|Overall Study|Protocol Violation|32|||
46844952|NCT00113568|83061787|FG000|Overall Study|Withdrawal by Subject|117|||
46844953|NCT00113568|83061787|FG000|Overall Study|Other|112|||
46844954|NCT00113490|83061793|FG000|Overall Study|Withdrawal by Subject|1|||
46844955|NCT00113490|83061794|FG001|Overall Study|Withdrawal by Subject|3|||
46844956|NCT00113490|83061793|FG000|Overall Study|Lost to Follow-up|1|||
46844957|NCT00113490|83061794|FG001|Overall Study|Lost to Follow-up|0|||
46844958|NCT00146640|83061802|FG000|Overall Study|Adverse Event|12|||
46844959|NCT00146640|83061803|FG001|Overall Study|Adverse Event|10|||
46844960|NCT00146640|83061802|FG000|Overall Study|Medical Reasons|3|||
46844961|NCT00146640|83061803|FG001|Overall Study|Medical Reasons|0|||
46844962|NCT00146640|83061802|FG000|Overall Study|Non-Medical Reasons|8|||
46773649|NCT00723528|82992015|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
46773650|NCT00723528|82992016|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
46773651|NCT00723528|82992010|FG000|Period 2: After Controlled Period|Other|0|||
46773652|NCT00723528|82992011|FG001|Period 2: After Controlled Period|Other|0|||
46773653|NCT00723528|82992012|FG002|Period 2: After Controlled Period|Other|0|||
46773654|NCT00723528|82992013|FG003|Period 2: After Controlled Period|Other|0|||
46773655|NCT00723528|82992014|FG004|Period 2: After Controlled Period|Other|1|||
46773656|NCT00723528|82992015|FG005|Period 2: After Controlled Period|Other|4|||
46773657|NCT00723528|82992016|FG006|Period 2: After Controlled Period|Other|0|||
46773658|NCT00723528|82992010|FG000|Period 2: After Controlled Period|Adverse Event|0|||
46773659|NCT00723528|82992011|FG001|Period 2: After Controlled Period|Adverse Event|0|||
46773660|NCT00723528|82992012|FG002|Period 2: After Controlled Period|Adverse Event|0|||
46773661|NCT00723528|82992013|FG003|Period 2: After Controlled Period|Adverse Event|0|||
46773662|NCT00723528|82992014|FG004|Period 2: After Controlled Period|Adverse Event|1|||
46773663|NCT00723528|82992015|FG005|Period 2: After Controlled Period|Adverse Event|0|||
46773664|NCT00723528|82992016|FG006|Period 2: After Controlled Period|Adverse Event|1|||
46773665|NCT00723528|82992010|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
46773666|NCT00723528|82992011|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
46844963|NCT00146640|83061803|FG001|Overall Study|Non-Medical Reasons|4|||
46844964|NCT00146328|83061821|FG000|Overall Study|Adverse Event|39|||
46844965|NCT00146328|83061822|FG001|Overall Study|Adverse Event|48|||
46844966|NCT00146328|83061823|FG002|Overall Study|Adverse Event|79|||
46844967|NCT00146328|83061821|FG000|Overall Study|Protocol Violation|11|||
46844968|NCT00146328|83061822|FG001|Overall Study|Protocol Violation|6|||
46844969|NCT00146328|83061823|FG002|Overall Study|Protocol Violation|12|||
46844970|NCT00146328|83061821|FG000|Overall Study|Lost to Follow-up|7|||
46844971|NCT00146328|83061822|FG001|Overall Study|Lost to Follow-up|4|||
46844972|NCT00146328|83061823|FG002|Overall Study|Lost to Follow-up|7|||
46844973|NCT00146328|83061821|FG000|Overall Study|Withdrawal by Subject|16|||
46844974|NCT00146328|83061822|FG001|Overall Study|Withdrawal by Subject|16|||
46844975|NCT00146328|83061823|FG002|Overall Study|Withdrawal by Subject|22|||
46844976|NCT00146328|83061821|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
46844977|NCT00146328|83061822|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
46844978|NCT00146328|83061823|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
46844979|NCT00146328|83061821|FG000|Overall Study|Trial ended/site closed|8|||
46844980|NCT00146328|83061822|FG001|Overall Study|Trial ended/site closed|2|||
46844981|NCT00146328|83061823|FG002|Overall Study|Trial ended/site closed|19|||
46844982|NCT00146328|83061821|FG000|Overall Study|Patient decision to end|0|||
46844983|NCT00146328|83061822|FG001|Overall Study|Patient decision to end|1|||
46844984|NCT00146328|83061823|FG002|Overall Study|Patient decision to end|6|||
46844985|NCT00146328|83061821|FG000|Overall Study|Enroll into other trial|2|||
46844986|NCT00146328|83061822|FG001|Overall Study|Enroll into other trial|4|||
46844987|NCT00146328|83061823|FG002|Overall Study|Enroll into other trial|2|||
46844988|NCT00146328|83061821|FG000|Overall Study|Death|0|||
46957734|NCT02514746|83199113|FG001|Overall Study|Other|1|||
46957735|NCT02483078|83199123|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
46957736|NCT02483078|83199124|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
46957737|NCT02483078|83199123|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
46957738|NCT02483078|83199124|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
46957739|NCT02483078|83199123|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
46957740|NCT02483078|83199124|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
46957741|NCT02483078|83199123|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
46957742|NCT02483078|83199124|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
46957743|NCT02483078|83199123|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
46957744|NCT02483078|83199124|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
46957745|NCT02483078|83199123|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
47067018|NCT01449461|83350344|FG005|Overall Study|Reason not Specified|1|||
47067019|NCT01572038|83350380|FG000|Overall Study|Death|648|||
46844989|NCT00146328|83061822|FG001|Overall Study|Death|1|||
46844990|NCT00146328|83061823|FG002|Overall Study|Death|1|||
46844991|NCT00146328|83061821|FG000|Overall Study|Moved|2|||
46844992|NCT00146328|83061822|FG001|Overall Study|Moved|0|||
46844993|NCT00146328|83061823|FG002|Overall Study|Moved|0|||
46844994|NCT00146328|83061821|FG000|Overall Study|Interaction with other medication|2|||
46844995|NCT00146328|83061822|FG001|Overall Study|Interaction with other medication|0|||
46844996|NCT00146328|83061823|FG002|Overall Study|Interaction with other medication|1|||
46844997|NCT03733444|83061834|FG000|Overall Study|Adverse Event|8|||
46844998|NCT03733444|83061835|FG001|Overall Study|Adverse Event|10|||
46844999|NCT03733444|83061836|FG002|Overall Study|Adverse Event|5|||
46845000|NCT03733444|83061834|FG000|Overall Study|Death|20|||
46957746|NCT02483078|83199124|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
46957747|NCT02452190|83199138|FG000|Overall Study|Withdrawal by Sponsor|1|||
46773667|NCT00723528|82992012|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
46773668|NCT00723528|82992013|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
46773669|NCT00723528|82992014|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
46773670|NCT00723528|82992015|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
46773671|NCT00723528|82992016|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
46773672|NCT00723528|82992010|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
46773673|NCT00723528|82992011|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
46773674|NCT00723528|82992012|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
46773675|NCT00723528|82992013|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
46773676|NCT00723528|82992014|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
46773677|NCT00723528|82992015|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
46773678|NCT00723528|82992016|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
46773679|NCT00751790|82992032|FG000|Overall Study|Lost to Follow-up|1|||
46773680|NCT00751790|82992032|FG000|Overall Study|Death|3|||
46773681|NCT00751790|82992032|FG000|Overall Study|Withdrawal by Subject|1|||
46773682|NCT00723450|82992038|FG000|Open-Label Phase|Adverse Event|26|||
46773683|NCT00723450|82992039|FG001|Open-Label Phase|Adverse Event|0|||
46773684|NCT00723450|82992040|FG002|Open-Label Phase|Adverse Event|0|||
46773685|NCT00723450|82992038|FG000|Open-Label Phase|Lack of Efficacy|18|||
46773686|NCT00723450|82992039|FG001|Open-Label Phase|Lack of Efficacy|0|||
46773687|NCT00723450|82992040|FG002|Open-Label Phase|Lack of Efficacy|0|||
46773688|NCT00723450|82992038|FG000|Open-Label Phase|Protocol Violation|35|||
46773689|NCT00723450|82992039|FG001|Open-Label Phase|Protocol Violation|0|||
46773690|NCT00723450|82992040|FG002|Open-Label Phase|Protocol Violation|0|||
46773691|NCT00723450|82992038|FG000|Open-Label Phase|Lost to Follow-up|7|||
46773692|NCT00723450|82992039|FG001|Open-Label Phase|Lost to Follow-up|0|||
46773693|NCT00723450|82992040|FG002|Open-Label Phase|Lost to Follow-up|0|||
46773694|NCT00723450|82992038|FG000|Open-Label Phase|Physician Decision|2|||
46773695|NCT00723450|82992039|FG001|Open-Label Phase|Physician Decision|0|||
46773696|NCT00723450|82992040|FG002|Open-Label Phase|Physician Decision|0|||
47067020|NCT01572038|83350380|FG000|Overall Study|Withdrawal by Subject|204|||
46957748|NCT02452190|83199139|FG001|Overall Study|Withdrawal by Sponsor|3|||
46957749|NCT02452190|83199138|FG000|Overall Study|Pregnancy|1|||
46957750|NCT02452190|83199139|FG001|Overall Study|Pregnancy|0|||
46957751|NCT02452190|83199138|FG000|Overall Study|Investigator's Decision|2|||
46957752|NCT02452190|83199139|FG001|Overall Study|Investigator's Decision|0|||
46957753|NCT02452190|83199138|FG000|Overall Study|Lack of Efficacy|3|||
46957754|NCT02452190|83199139|FG001|Overall Study|Lack of Efficacy|1|||
46957755|NCT02452190|83199138|FG000|Overall Study|Lost to Follow-up|4|||
46957756|NCT02452190|83199139|FG001|Overall Study|Lost to Follow-up|3|||
46957757|NCT02452190|83199138|FG000|Overall Study|Adverse Event|2|||
46957758|NCT02452190|83199139|FG001|Overall Study|Adverse Event|5|||
46957759|NCT02452190|83199138|FG000|Overall Study|Withdrawal by Subject|20|||
46957760|NCT02452190|83199139|FG001|Overall Study|Withdrawal by Subject|11|||
46957761|NCT02452190|83199138|FG000|Overall Study|Noncompliance with study drug|1|||
46957762|NCT02452190|83199139|FG001|Overall Study|Noncompliance with study drug|0|||
46957763|NCT02452190|83199138|FG000|Overall Study|Participant traveled abroad|1|||
46957764|NCT02452190|83199139|FG001|Overall Study|Participant traveled abroad|0|||
46957765|NCT02452190|83199138|FG000|Overall Study|Death|0|||
46957766|NCT02452190|83199139|FG001|Overall Study|Death|1|||
46957767|NCT02514122|83199147|FG000|Overall Study|Withdrawal by Subject|2|||
46957768|NCT02514122|83199148|FG001|Overall Study|Withdrawal by Subject|0|||
46957769|NCT00730639|83199159|FG000|Overall Study|Adverse Event|3|||
46957770|NCT00730639|83199160|FG001|Overall Study|Adverse Event|0|||
46957771|NCT00730639|83199161|FG002|Overall Study|Adverse Event|9|||
46957772|NCT00730639|83199162|FG003|Overall Study|Adverse Event|8|||
46957773|NCT00730639|83199163|FG004|Overall Study|Adverse Event|23|||
46957774|NCT00730639|83199159|FG000|Overall Study|Complete Response|0|||
46957775|NCT00730639|83199160|FG001|Overall Study|Complete Response|0|||
46957776|NCT00730639|83199161|FG002|Overall Study|Complete Response|2|||
46957777|NCT00730639|83199162|FG003|Overall Study|Complete Response|2|||
46957778|NCT00730639|83199163|FG004|Overall Study|Complete Response|1|||
46957779|NCT00730639|83199159|FG000|Overall Study|Completed Maximum Cycles|0|||
46957780|NCT00730639|83199160|FG001|Overall Study|Completed Maximum Cycles|0|||
46957781|NCT00730639|83199161|FG002|Overall Study|Completed Maximum Cycles|11|||
46957782|NCT00730639|83199162|FG003|Overall Study|Completed Maximum Cycles|3|||
46957783|NCT00730639|83199163|FG004|Overall Study|Completed Maximum Cycles|6|||
46957784|NCT00730639|83199159|FG000|Overall Study|Death|0|||
46639981|NCT00087516|82813989|FG002|Overall Study|Lost to Follow-up|5|||
46639982|NCT00087516|82813990|FG003|Overall Study|Lost to Follow-up|5|||
46773697|NCT00723450|82992038|FG000|Open-Label Phase|Withdrawal by Subject|37|||
46773698|NCT00723450|82992039|FG001|Open-Label Phase|Withdrawal by Subject|0|||
46773699|NCT00723450|82992040|FG002|Open-Label Phase|Withdrawal by Subject|0|||
46773700|NCT00723450|82992038|FG000|Randomized Phase|Adverse Event|0|||
46773701|NCT00723450|82992039|FG001|Randomized Phase|Adverse Event|26|||
46773702|NCT00723450|82992040|FG002|Randomized Phase|Adverse Event|17|||
46773703|NCT00723450|82992038|FG000|Randomized Phase|Lack of Efficacy|0|||
46773704|NCT00723450|82992039|FG001|Randomized Phase|Lack of Efficacy|11|||
46773705|NCT00723450|82992040|FG002|Randomized Phase|Lack of Efficacy|11|||
46773706|NCT00723450|82992038|FG000|Randomized Phase|Protocol Violation|0|||
46845001|NCT03733444|83061835|FG001|Overall Study|Death|19|||
46845002|NCT03733444|83061836|FG002|Overall Study|Death|11|||
46845003|NCT03733444|83061834|FG000|Overall Study|Lost to Follow-up|3|||
46845004|NCT03733444|83061835|FG001|Overall Study|Lost to Follow-up|0|||
46957785|NCT00730639|83199160|FG001|Overall Study|Death|0|||
46957786|NCT00730639|83199161|FG002|Overall Study|Death|0|||
46957787|NCT00730639|83199162|FG003|Overall Study|Death|0|||
46957788|NCT00730639|83199163|FG004|Overall Study|Death|2|||
46957789|NCT00730639|83199159|FG000|Overall Study|Disease Progression|12|||
46957790|NCT00730639|83199160|FG001|Overall Study|Disease Progression|13|||
46957791|NCT00730639|83199161|FG002|Overall Study|Disease Progression|48|||
46957792|NCT00730639|83199162|FG003|Overall Study|Disease Progression|32|||
46957793|NCT00730639|83199163|FG004|Overall Study|Disease Progression|88|||
46957794|NCT00730639|83199159|FG000|Overall Study|non-specified|0|||
46957795|NCT00730639|83199160|FG001|Overall Study|non-specified|0|||
46957796|NCT00730639|83199161|FG002|Overall Study|non-specified|4|||
46957797|NCT00730639|83199162|FG003|Overall Study|non-specified|2|||
46957798|NCT00730639|83199163|FG004|Overall Study|non-specified|3|||
46639983|NCT00087516|82813987|FG000|Overall Study|Protocol Violation|4|||
46639984|NCT00087516|82813988|FG001|Overall Study|Protocol Violation|8|||
46773707|NCT00723450|82992039|FG001|Randomized Phase|Protocol Violation|9|||
46957799|NCT00730639|83199159|FG000|Overall Study|Protocol Violation|0|||
46957800|NCT00730639|83199160|FG001|Overall Study|Protocol Violation|0|||
46957801|NCT00730639|83199161|FG002|Overall Study|Protocol Violation|1|||
46639985|NCT00087516|82813989|FG002|Overall Study|Protocol Violation|3|||
46957802|NCT00730639|83199162|FG003|Overall Study|Protocol Violation|0|||
46957803|NCT00730639|83199163|FG004|Overall Study|Protocol Violation|0|||
46957804|NCT00730639|83199159|FG000|Overall Study|Withdrawal by Subject|0|||
46957805|NCT00730639|83199160|FG001|Overall Study|Withdrawal by Subject|0|||
46957806|NCT00730639|83199161|FG002|Overall Study|Withdrawal by Subject|6|||
46957807|NCT00730639|83199162|FG003|Overall Study|Withdrawal by Subject|3|||
46957808|NCT00730639|83199163|FG004|Overall Study|Withdrawal by Subject|4|||
46957809|NCT00730639|83199159|FG000|Overall Study|Treatment on-going|2|||
46957810|NCT00730639|83199160|FG001|Overall Study|Treatment on-going|5|||
46957811|NCT00730639|83199161|FG002|Overall Study|Treatment on-going|5|||
46957812|NCT00730639|83199162|FG003|Overall Study|Treatment on-going|4|||
46957813|NCT00730639|83199163|FG004|Overall Study|Treatment on-going|4|||
46957814|NCT02536339|83199186|FG000|Overall Study|Death|20|||
46957815|NCT02536339|83199186|FG000|Overall Study|Withdrawal by Subject|3|||
46957816|NCT02536339|83199186|FG000|Overall Study|Lost to Follow-up|2|||
46957817|NCT02536339|83199186|FG000|Overall Study|Treatment discontinued|2|||
46957818|NCT02536339|83199186|FG000|Overall Study|Physician Decision|1|||
46957819|NCT02743871|83199220|FG000|Overall Study|Lost to Follow-up|0|||
46957820|NCT02743871|83199221|FG001|Overall Study|Lost to Follow-up|0|||
46957821|NCT02743871|83199222|FG002|Overall Study|Lost to Follow-up|0|||
46957822|NCT02743871|83199223|FG003|Overall Study|Lost to Follow-up|1|||
46957823|NCT02743871|83199224|FG004|Overall Study|Lost to Follow-up|0|||
46957824|NCT02743871|83199225|FG005|Overall Study|Lost to Follow-up|0|||
46957825|NCT02743871|83199226|FG006|Overall Study|Lost to Follow-up|1|||
46957826|NCT02743871|83199227|FG007|Overall Study|Lost to Follow-up|0|||
46957827|NCT02743871|83199228|FG008|Overall Study|Lost to Follow-up|0|||
46957828|NCT02743871|83199229|FG009|Overall Study|Lost to Follow-up|0|||
46957829|NCT02743871|83199230|FG010|Overall Study|Lost to Follow-up|0|||
46957830|NCT02743871|83199231|FG011|Overall Study|Lost to Follow-up|2|||
46957831|NCT02743871|83199232|FG012|Overall Study|Lost to Follow-up|0|||
46957832|NCT02743871|83199233|FG013|Overall Study|Lost to Follow-up|0|||
46957833|NCT02743871|83199220|FG000|Overall Study|Withdrawal by Subject|0|||
46957834|NCT02743871|83199221|FG001|Overall Study|Withdrawal by Subject|0|||
46957835|NCT02743871|83199222|FG002|Overall Study|Withdrawal by Subject|0|||
46957836|NCT02743871|83199223|FG003|Overall Study|Withdrawal by Subject|0|||
46957837|NCT02743871|83199224|FG004|Overall Study|Withdrawal by Subject|0|||
46957838|NCT02743871|83199225|FG005|Overall Study|Withdrawal by Subject|0|||
46957839|NCT02743871|83199226|FG006|Overall Study|Withdrawal by Subject|0|||
46957840|NCT02743871|83199227|FG007|Overall Study|Withdrawal by Subject|0|||
46957841|NCT02743871|83199228|FG008|Overall Study|Withdrawal by Subject|0|||
46957842|NCT02743871|83199229|FG009|Overall Study|Withdrawal by Subject|0|||
46957843|NCT02743871|83199230|FG010|Overall Study|Withdrawal by Subject|1|||
46957844|NCT02743871|83199231|FG011|Overall Study|Withdrawal by Subject|0|||
46957845|NCT02743871|83199232|FG012|Overall Study|Withdrawal by Subject|12|||
46957846|NCT02743871|83199233|FG013|Overall Study|Withdrawal by Subject|6|||
46957847|NCT02743871|83199220|FG000|Overall Study|Adverse Event|1|||
46957848|NCT02743871|83199221|FG001|Overall Study|Adverse Event|0|||
46957849|NCT02743871|83199222|FG002|Overall Study|Adverse Event|0|||
46957850|NCT02743871|83199223|FG003|Overall Study|Adverse Event|0|||
46957851|NCT02743871|83199224|FG004|Overall Study|Adverse Event|0|||
46957852|NCT02743871|83199225|FG005|Overall Study|Adverse Event|0|||
46957853|NCT02743871|83199226|FG006|Overall Study|Adverse Event|0|||
46957854|NCT02743871|83199227|FG007|Overall Study|Adverse Event|0|||
46957855|NCT02743871|83199228|FG008|Overall Study|Adverse Event|0|||
46957856|NCT02743871|83199229|FG009|Overall Study|Adverse Event|0|||
46957857|NCT02743871|83199230|FG010|Overall Study|Adverse Event|0|||
46957858|NCT02743871|83199231|FG011|Overall Study|Adverse Event|0|||
46957859|NCT02743871|83199232|FG012|Overall Study|Adverse Event|0|||
46957860|NCT02743871|83199233|FG013|Overall Study|Adverse Event|0|||
46957861|NCT02743871|83199220|FG000|Overall Study|Other|0|||
46957862|NCT02743871|83199221|FG001|Overall Study|Other|0|||
46957863|NCT02743871|83199222|FG002|Overall Study|Other|0|||
47067021|NCT01572038|83350380|FG000|Overall Study|Lost to Follow-up|81|||
46773708|NCT00723450|82992040|FG002|Randomized Phase|Protocol Violation|13|||
46773709|NCT00723450|82992038|FG000|Randomized Phase|Lost to Follow-up|0|||
46773710|NCT00723450|82992039|FG001|Randomized Phase|Lost to Follow-up|2|||
46957864|NCT02743871|83199223|FG003|Overall Study|Other|0|||
46773711|NCT00723450|82992040|FG002|Randomized Phase|Lost to Follow-up|3|||
46773712|NCT00723450|82992038|FG000|Randomized Phase|Physician Decision|0|||
46957865|NCT02743871|83199224|FG004|Overall Study|Other|0|||
46957866|NCT02743871|83199225|FG005|Overall Study|Other|0|||
46957867|NCT02743871|83199226|FG006|Overall Study|Other|0|||
46957868|NCT02743871|83199227|FG007|Overall Study|Other|0|||
46957869|NCT02743871|83199228|FG008|Overall Study|Other|0|||
46957870|NCT02743871|83199229|FG009|Overall Study|Other|0|||
46957871|NCT02743871|83199230|FG010|Overall Study|Other|0|||
46957872|NCT02743871|83199231|FG011|Overall Study|Other|1|||
46957873|NCT02743871|83199232|FG012|Overall Study|Other|1|||
46957874|NCT02743871|83199233|FG013|Overall Study|Other|1|||
46957875|NCT02743871|83199220|FG000|Overall Study|Protocol Violation|0|||
46957876|NCT02743871|83199221|FG001|Overall Study|Protocol Violation|0|||
46957877|NCT02743871|83199222|FG002|Overall Study|Protocol Violation|0|||
46957878|NCT02743871|83199223|FG003|Overall Study|Protocol Violation|0|||
46957879|NCT02743871|83199224|FG004|Overall Study|Protocol Violation|0|||
46957880|NCT02743871|83199225|FG005|Overall Study|Protocol Violation|0|||
46957881|NCT02743871|83199226|FG006|Overall Study|Protocol Violation|0|||
47067022|NCT01572038|83350380|FG000|Overall Study|Physician Decision|20|||
46773713|NCT00723450|82992039|FG001|Randomized Phase|Physician Decision|3|||
46773714|NCT00723450|82992040|FG002|Randomized Phase|Physician Decision|1|||
46773715|NCT00723450|82992038|FG000|Randomized Phase|Withdrawal by Subject|0|||
46773716|NCT00723450|82992039|FG001|Randomized Phase|Withdrawal by Subject|14|||
46773717|NCT00723450|82992040|FG002|Randomized Phase|Withdrawal by Subject|22|||
46773718|NCT00751400|82992049|FG000|Overall Study|Lost to Follow-up|10|||
46773719|NCT00585312|82992055|FG000|Overall Study|Adverse Event|3|||
46773720|NCT00585312|82992056|FG001|Overall Study|Adverse Event|0|||
46773721|NCT00585312|82992055|FG000|Overall Study|Lack of Efficacy|6|||
46773722|NCT00585312|82992056|FG001|Overall Study|Lack of Efficacy|11|||
46773723|NCT00585312|82992055|FG000|Overall Study|Lost to Follow-up|1|||
46773724|NCT00585312|82992056|FG001|Overall Study|Lost to Follow-up|1|||
46773725|NCT00585312|82992055|FG000|Overall Study|Reason not specified|2|||
46773726|NCT00585312|82992056|FG001|Overall Study|Reason not specified|0|||
46773727|NCT00585312|82992055|FG000|Overall Study|Withdrawal by Subject|5|||
46773728|NCT00585312|82992056|FG001|Overall Study|Withdrawal by Subject|1|||
46773729|NCT00585312|82992055|FG000|Overall Study|Study terminated by the sponsor|34|||
46773730|NCT00585312|82992056|FG001|Overall Study|Study terminated by the sponsor|31|||
46773731|NCT00753506|82992064|FG000|Overall Study|Withdrawal by Subject|4|||
46845005|NCT03733444|83061836|FG002|Overall Study|Lost to Follow-up|1|||
46845006|NCT03733444|83061834|FG000|Overall Study|Lack of Efficacy|0|||
46773732|NCT00753506|82992065|FG001|Overall Study|Withdrawal by Subject|1|||
46773733|NCT00753506|82992064|FG000|Overall Study|Lost to Follow-up|2|||
46773734|NCT00753506|82992065|FG001|Overall Study|Lost to Follow-up|0|||
46773735|NCT00753506|82992064|FG000|Overall Study|Other reason|1|||
46773736|NCT00753506|82992065|FG001|Overall Study|Other reason|1|||
46773737|NCT00720096|82992073|FG000|Overall Study|Withdrawal by Subject|0|||
46773738|NCT00720096|82992074|FG001|Overall Study|Withdrawal by Subject|2|||
46773739|NCT00723294|82992080|FG000|Overall Study|Lobular histology|2|||
46773740|NCT00723294|82992080|FG000|Overall Study|>25% intraductal component|1|||
46773741|NCT00723294|82992080|FG000|Overall Study|No MRI tumor enhancement|1|||
46773742|NCT00723294|82992080|FG000|Overall Study|1.0-Tesla MRI|1|||
46773743|NCT00723294|82992080|FG000|Overall Study|No cryoabalation|2|||
46773744|NCT00723294|82992080|FG000|Overall Study|Did not undergo surgery|1|||
46773745|NCT00723294|82992080|FG000|Overall Study|Treated prior to registration|1|||
46773746|NCT00723294|82992080|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
46773747|NCT00723294|82992080|FG000|Overall Study|Benign lesion|1|||
46773748|NCT00723294|82992080|FG000|Overall Study|Withdrawal by Subject|1|||
46773749|NCT00723294|82992080|FG000|Overall Study|No treatment due to probe failure|1|||
46773750|NCT00747344|82992086|FG000|Controlled Period|Adverse Event|3|||
46773751|NCT00747344|82992087|FG001|Controlled Period|Adverse Event|0|||
46773752|NCT00747344|82992088|FG002|Controlled Period|Adverse Event|0|||
46773753|NCT00747344|82992089|FG003|Controlled Period|Adverse Event|0|||
46773754|NCT00747344|82992086|FG000|Controlled Period|Lack of Efficacy|2|||
46773755|NCT00747344|82992087|FG001|Controlled Period|Lack of Efficacy|1|||
46773756|NCT00747344|82992088|FG002|Controlled Period|Lack of Efficacy|0|||
46773757|NCT00747344|82992089|FG003|Controlled Period|Lack of Efficacy|0|||
46773758|NCT00747344|82992086|FG000|Controlled Period|Other|0|||
46773759|NCT00747344|82992087|FG001|Controlled Period|Other|3|||
46773760|NCT00747344|82992088|FG002|Controlled Period|Other|0|||
46845007|NCT03733444|83061835|FG001|Overall Study|Lack of Efficacy|1|||
46845008|NCT03733444|83061836|FG002|Overall Study|Lack of Efficacy|1|||
46845009|NCT03733444|83061834|FG000|Overall Study|Physician Decision|2|||
46845010|NCT03733444|83061835|FG001|Overall Study|Physician Decision|1|||
46845011|NCT03733444|83061836|FG002|Overall Study|Physician Decision|0|||
46845012|NCT03733444|83061834|FG000|Overall Study|Protocol Violation|2|||
46845013|NCT03733444|83061835|FG001|Overall Study|Protocol Violation|1|||
46957882|NCT02743871|83199227|FG007|Overall Study|Protocol Violation|0|||
46957883|NCT02743871|83199228|FG008|Overall Study|Protocol Violation|0|||
46957884|NCT02743871|83199229|FG009|Overall Study|Protocol Violation|0|||
46957885|NCT02743871|83199230|FG010|Overall Study|Protocol Violation|0|||
46845014|NCT03733444|83061836|FG002|Overall Study|Protocol Violation|0|||
46957886|NCT02743871|83199231|FG011|Overall Study|Protocol Violation|0|||
46957887|NCT02743871|83199232|FG012|Overall Study|Protocol Violation|2|||
46957888|NCT02743871|83199233|FG013|Overall Study|Protocol Violation|0|||
46957889|NCT01704547|83199275|FG000|Overall Study|Physician Decision|4|||
46957890|NCT01704547|83199275|FG000|Overall Study|Withdrawal by Subject|1|||
46957891|NCT00796523|83199295|FG000|Overall Study|Lost to Follow-up|9|||
46957892|NCT00796523|83199296|FG001|Overall Study|Lost to Follow-up|7|||
46773761|NCT00747344|82992089|FG003|Controlled Period|Other|0|||
46773762|NCT00747344|82992086|FG000|After Controlled Period|Adverse Event|0|||
46773763|NCT00747344|82992087|FG001|After Controlled Period|Adverse Event|0|||
46773764|NCT00747344|82992088|FG002|After Controlled Period|Adverse Event|0|||
46773765|NCT00747344|82992089|FG003|After Controlled Period|Adverse Event|1|||
46957893|NCT01352585|83199311|FG000|Overall Study|Adverse Event|2|||
46957894|NCT01352585|83199312|FG001|Overall Study|Adverse Event|1|||
46957895|NCT01352585|83199311|FG000|Overall Study|Lost to Follow-up|1|||
46845015|NCT03733444|83061834|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
46957896|NCT01352585|83199312|FG001|Overall Study|Lost to Follow-up|0|||
46957897|NCT01352585|83199311|FG000|Overall Study|Other|5|||
46957898|NCT01352585|83199312|FG001|Overall Study|Other|2|||
46957899|NCT01352507|83199321|FG000|Treatment Period 1|Adverse Event|3|||
46957900|NCT01352507|83199322|FG001|Treatment Period 1|Adverse Event|0|||
46957901|NCT01352507|83199321|FG000|Treatment Period 1|Lost to Follow-up|3|||
46957902|NCT01352507|83199322|FG001|Treatment Period 1|Lost to Follow-up|4|||
46957903|NCT01352507|83199321|FG000|Treatment Period 1|Withdrawal by Subject|7|||
46957904|NCT01352507|83199322|FG001|Treatment Period 1|Withdrawal by Subject|5|||
46957905|NCT01352507|83199321|FG000|Treatment Period 1|Physician Decision|1|||
46957906|NCT01352507|83199322|FG001|Treatment Period 1|Physician Decision|0|||
46957907|NCT01352507|83199321|FG000|Washout Period|Withdrawal by Subject|0|||
46957908|NCT01352507|83199322|FG001|Washout Period|Withdrawal by Subject|1|||
46957909|NCT01352507|83199321|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
46957910|NCT01352507|83199322|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
46957911|NCT01352507|83199321|FG000|Treatment Period 2|Withdrawal by Subject|4|||
46957912|NCT01352507|83199322|FG001|Treatment Period 2|Withdrawal by Subject|3|||
46957913|NCT01352507|83199321|FG000|Treatment Period 2|Lack of Efficacy|1|||
46957914|NCT01352507|83199322|FG001|Treatment Period 2|Lack of Efficacy|0|||
46957915|NCT02361346|83199343|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957916|NCT02361346|83199344|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957917|NCT02361346|83199345|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957918|NCT02361346|83199346|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
46957919|NCT02361346|83199347|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957920|NCT02361346|83199348|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957921|NCT02361346|83199349|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957922|NCT02361346|83199350|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957923|NCT02361346|83199351|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
46957924|NCT02361346|83199343|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957925|NCT02361346|83199344|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957926|NCT02361346|83199345|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957927|NCT02361346|83199346|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957928|NCT02361346|83199347|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
46957929|NCT02361346|83199348|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957930|NCT02361346|83199349|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957931|NCT02361346|83199350|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957932|NCT02361346|83199351|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
46957933|NCT02361346|83199343|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
46957934|NCT02361346|83199344|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
46957935|NCT02361346|83199345|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
46957936|NCT02361346|83199346|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
46957937|NCT02361346|83199347|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
46957938|NCT02361346|83199348|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
46957939|NCT02361346|83199349|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
46957940|NCT02361346|83199350|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
46957941|NCT02361346|83199351|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
46957942|NCT02361346|83199343|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46957943|NCT02361346|83199344|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46957944|NCT02361346|83199345|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46957945|NCT02361346|83199346|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46957946|NCT02361346|83199347|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46957947|NCT02361346|83199348|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46773766|NCT00580983|82992097|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
46773767|NCT00753896|82992101|FG000|Overall Study|Adverse Event|4|||
46773768|NCT00753896|82992101|FG000|Overall Study|Death|1|||
46773769|NCT00753896|82992101|FG000|Overall Study|Lost to Follow-up|2|||
46773770|NCT00753896|82992101|FG000|Overall Study|Protocol Violation|1|||
46773771|NCT00753896|82992101|FG000|Overall Study|Withdrawal by Subject|4|||
46773772|NCT00753896|82992101|FG000|Overall Study|Entry Criteria Not Met|4|||
46773773|NCT00743444|82992105|FG000|First Intervention|Catheter placement problems|0|||
46773774|NCT00743444|82992106|FG001|First Intervention|Catheter placement problems|1|||
46957948|NCT02361346|83199349|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46957949|NCT02361346|83199350|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
46957950|NCT02361346|83199351|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
46957951|NCT02361346|83199343|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957952|NCT02361346|83199344|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957953|NCT02361346|83199345|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957954|NCT02361346|83199346|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957955|NCT02361346|83199347|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957956|NCT02361346|83199348|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957957|NCT02361346|83199349|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957958|NCT02361346|83199350|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
46957959|NCT02361346|83199351|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
46957960|NCT02361346|83199343|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957961|NCT02361346|83199344|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957962|NCT02361346|83199345|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957963|NCT02361346|83199346|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957964|NCT02361346|83199347|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957965|NCT02361346|83199348|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957966|NCT02361346|83199349|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957967|NCT02361346|83199350|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
46957968|NCT02361346|83199351|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
46957969|NCT02267278|83199393|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
46957970|NCT02267278|83199393|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
46957971|NCT02267278|83199393|FG000|Overall Study|Developed new cancer diagnoses|2|||
46957972|NCT02267278|83199393|FG000|Overall Study|prescribed prohibited medication|1|||
46957973|NCT02360098|83199399|FG000|Overall Study|Physician Decision|7|||
46957974|NCT02266888|83199410|FG000|Overall Study|Death|2|||
46957975|NCT02266888|83199411|FG001|Overall Study|Death|2|||
46957976|NCT02266888|83199412|FG002|Overall Study|Death|4|||
46957977|NCT02266888|83199413|FG003|Overall Study|Death|2|||
46957978|NCT02266888|83199410|FG000|Overall Study|Physician Decision|0|||
46957979|NCT02266888|83199411|FG001|Overall Study|Physician Decision|1|||
46957980|NCT02266888|83199412|FG002|Overall Study|Physician Decision|2|||
46957981|NCT02266888|83199413|FG003|Overall Study|Physician Decision|2|||
46957982|NCT02266888|83199410|FG000|Overall Study|Study Terminated|5|||
46957983|NCT02266888|83199411|FG001|Overall Study|Study Terminated|1|||
46957984|NCT02266888|83199412|FG002|Overall Study|Study Terminated|0|||
46957985|NCT02266888|83199413|FG003|Overall Study|Study Terminated|0|||
46957986|NCT02266888|83199410|FG000|Overall Study|No Longer Eligible|0|||
46957987|NCT02266888|83199411|FG001|Overall Study|No Longer Eligible|0|||
46957988|NCT02266888|83199412|FG002|Overall Study|No Longer Eligible|0|||
46957989|NCT02266888|83199413|FG003|Overall Study|No Longer Eligible|2|||
46957990|NCT02266888|83199410|FG000|Overall Study|Randomization Closed|0|||
46957991|NCT02266888|83199411|FG001|Overall Study|Randomization Closed|0|||
46957992|NCT02266888|83199412|FG002|Overall Study|Randomization Closed|4|||
46957993|NCT02266888|83199413|FG003|Overall Study|Randomization Closed|0|||
46957994|NCT02266888|83199410|FG000|Overall Study|Personnel unavailable at transplant|0|||
46957995|NCT02266888|83199411|FG001|Overall Study|Personnel unavailable at transplant|0|||
46957996|NCT02266888|83199412|FG002|Overall Study|Personnel unavailable at transplant|0|||
46957997|NCT02266888|83199413|FG003|Overall Study|Personnel unavailable at transplant|1|||
46957998|NCT02266888|83199410|FG000|Overall Study|Transfer of care|0|||
46957999|NCT02266888|83199411|FG001|Overall Study|Transfer of care|0|||
46958000|NCT02266888|83199412|FG002|Overall Study|Transfer of care|1|||
46958001|NCT02266888|83199413|FG003|Overall Study|Transfer of care|0|||
46958002|NCT01641952|83199421|FG000|Overall Study|Lost to Follow-up|28|||
46958003|NCT01641952|83199421|FG000|Overall Study|Adverse Event|6|||
46958004|NCT02359552|83199427|FG000|Overall Study|Lost to Follow-up|3|||
46958005|NCT02359552|83199428|FG001|Overall Study|Lost to Follow-up|4|||
46958006|NCT02743793|83199436|FG000|Overall Study|Death|1|||
46958007|NCT02743793|83199437|FG001|Overall Study|Death|1|||
46958008|NCT02743793|83199436|FG000|Overall Study|Withdrawal by Subject|0|||
46958009|NCT02743793|83199437|FG001|Overall Study|Withdrawal by Subject|1|||
46958010|NCT02743793|83199436|FG000|Overall Study|Screen Failure|4|||
46958011|NCT02743793|83199437|FG001|Overall Study|Screen Failure|0|||
46958012|NCT02743793|83199436|FG000|Overall Study|No Primary Care Physician|0|||
46958013|NCT02743793|83199437|FG001|Overall Study|No Primary Care Physician|1|||
46958014|NCT02743793|83199436|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
46958015|NCT02743793|83199437|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
46958016|NCT02743793|83199436|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
46958017|NCT02743793|83199437|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
46958018|NCT00152009|83199446|FG000|Overall Study|Adverse Event|9|||
47067023|NCT01572038|83350380|FG000|Overall Study|Patient Decision|14|||
46958019|NCT00152009|83199447|FG001|Overall Study|Adverse Event|13|||
46958020|NCT00152009|83199448|FG002|Overall Study|Adverse Event|20|||
46958021|NCT00152009|83199449|FG003|Overall Study|Adverse Event|1|||
46958022|NCT00152009|83199446|FG000|Overall Study|Protocol Violation|3|||
46958023|NCT00152009|83199447|FG001|Overall Study|Protocol Violation|0|||
46958024|NCT00152009|83199448|FG002|Overall Study|Protocol Violation|0|||
46958025|NCT00152009|83199449|FG003|Overall Study|Protocol Violation|1|||
46958026|NCT00152009|83199446|FG000|Overall Study|Withdrawal by Subject|2|||
46958027|NCT00152009|83199447|FG001|Overall Study|Withdrawal by Subject|3|||
46958028|NCT00152009|83199448|FG002|Overall Study|Withdrawal by Subject|4|||
46958029|NCT00152009|83199449|FG003|Overall Study|Withdrawal by Subject|9|||
47067024|NCT01572038|83350380|FG000|Overall Study|Progressive Disease|8|||
47067025|NCT01572038|83350380|FG000|Overall Study|Site Closed Before Completing Form|6|||
47067026|NCT01572038|83350380|FG000|Overall Study|Enrolled into Another Trial|3|||
46845016|NCT03733444|83061835|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
46845017|NCT03733444|83061836|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
46845018|NCT03733444|83061834|FG000|Overall Study|Study Terminated by Sponsor|203|||
46845019|NCT03733444|83061835|FG001|Overall Study|Study Terminated by Sponsor|209|||
46845020|NCT03733444|83061836|FG002|Overall Study|Study Terminated by Sponsor|221|||
46845021|NCT03733444|83061834|FG000|Overall Study|Withdrawal by Subject|19|||
46845022|NCT03733444|83061835|FG001|Overall Study|Withdrawal by Subject|18|||
46845023|NCT03733444|83061836|FG002|Overall Study|Withdrawal by Subject|16|||
46845024|NCT03733444|83061834|FG000|Overall Study|Miscellaneous|1|||
46845025|NCT03733444|83061835|FG001|Overall Study|Miscellaneous|0|||
46845026|NCT03733444|83061836|FG002|Overall Study|Miscellaneous|1|||
46845027|NCT03733444|83061834|FG000|Overall Study|Not Treated|1|||
46845028|NCT03733444|83061835|FG001|Overall Study|Not Treated|2|||
46845029|NCT03733444|83061836|FG002|Overall Study|Not Treated|1|||
46845030|NCT03731182|83061856|FG000|Overall Study|Lost to Follow-up|2|||
46845031|NCT03731182|83061857|FG001|Overall Study|Lost to Follow-up|0|||
46845032|NCT03731182|83061856|FG000|Overall Study|Physician Decision|1|||
46845033|NCT03731182|83061857|FG001|Overall Study|Physician Decision|0|||
46845034|NCT03731182|83061856|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
46845035|NCT03731182|83061857|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
46845036|NCT03730012|83061866|FG000|Overall Study|Adverse Event|0|||
46845037|NCT03730012|83061867|FG001|Overall Study|Adverse Event|1|||
46845038|NCT03730012|83061866|FG000|Overall Study|Lack of Efficacy|1|||
46845039|NCT03730012|83061867|FG001|Overall Study|Lack of Efficacy|5|||
46845040|NCT03730012|83061866|FG000|Overall Study|Withdrawal by Subject|0|||
46845041|NCT03730012|83061867|FG001|Overall Study|Withdrawal by Subject|1|||
46845042|NCT03730012|83061866|FG000|Overall Study|Miscellaneous|2|||
46845043|NCT03730012|83061867|FG001|Overall Study|Miscellaneous|1|||
46845044|NCT03728140|83061878|FG000|Overall Study|Abnormal embryo transfer operation|10|||
46845045|NCT03728140|83061879|FG001|Overall Study|Abnormal embryo transfer operation|7|||
46845046|NCT03725722|83061904|FG000|Overall Study|Lack of Efficacy|2|||
46845047|NCT03725722|83061905|FG001|Overall Study|Lack of Efficacy|1|||
46845048|NCT03725722|83061906|FG002|Overall Study|Lack of Efficacy|2|||
46845049|NCT03725722|83061907|FG003|Overall Study|Lack of Efficacy|0|||
46845050|NCT03725722|83061908|FG004|Overall Study|Lack of Efficacy|2|||
46845051|NCT03725722|83061904|FG000|Overall Study|Adverse Event|2|||
46845052|NCT03725722|83061905|FG001|Overall Study|Adverse Event|2|||
46845053|NCT03725722|83061906|FG002|Overall Study|Adverse Event|1|||
46845054|NCT03725722|83061907|FG003|Overall Study|Adverse Event|0|||
46845055|NCT03725722|83061908|FG004|Overall Study|Adverse Event|6|||
46845056|NCT03725722|83061904|FG000|Overall Study|Withdrawal by Subject|4|||
46845057|NCT03725722|83061905|FG001|Overall Study|Withdrawal by Subject|1|||
46845058|NCT03725722|83061906|FG002|Overall Study|Withdrawal by Subject|0|||
46845059|NCT03725722|83061907|FG003|Overall Study|Withdrawal by Subject|4|||
46845060|NCT03725722|83061908|FG004|Overall Study|Withdrawal by Subject|4|||
46845061|NCT03725722|83061904|FG000|Overall Study|Lost to Follow-up|3|||
46639986|NCT00087516|82813990|FG003|Overall Study|Protocol Violation|6|||
46773775|NCT00743444|82992105|FG000|Washout Period|Adverse Event|0|||
46773776|NCT00743444|82992106|FG001|Washout Period|Adverse Event|1|||
46773777|NCT00743366|82992112|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
46773778|NCT00743366|82992113|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
46773779|NCT00721968|82992121|FG000|Overall Study|Lost to Follow-up|2|||
46773780|NCT00721968|82992122|FG001|Overall Study|Lost to Follow-up|0|||
46773781|NCT00743288|82992128|FG000|Overall Study|Adverse Event|1|||
46773782|NCT00743288|82992129|FG001|Overall Study|Adverse Event|1|||
46773783|NCT00743288|82992130|FG002|Overall Study|Adverse Event|2|||
46773784|NCT00743288|82992131|FG003|Overall Study|Adverse Event|2|||
46773785|NCT00743288|82992132|FG004|Overall Study|Adverse Event|1|||
46773786|NCT00743288|82992133|FG005|Overall Study|Adverse Event|1|||
46773787|NCT00743288|82992134|FG006|Overall Study|Adverse Event|2|||
46773788|NCT00743288|82992128|FG000|Overall Study|Withdrawal by Subject|0|||
46773789|NCT00743288|82992129|FG001|Overall Study|Withdrawal by Subject|0|||
46773790|NCT00743288|82992130|FG002|Overall Study|Withdrawal by Subject|1|||
46773791|NCT00743288|82992131|FG003|Overall Study|Withdrawal by Subject|0|||
46773792|NCT00743288|82992132|FG004|Overall Study|Withdrawal by Subject|0|||
46773793|NCT00743288|82992133|FG005|Overall Study|Withdrawal by Subject|1|||
46773794|NCT00743288|82992134|FG006|Overall Study|Withdrawal by Subject|1|||
46773795|NCT00743288|82992128|FG000|Overall Study|Progressive disease (PD)|2|||
46773796|NCT00743288|82992129|FG001|Overall Study|Progressive disease (PD)|0|||
46773797|NCT00743288|82992130|FG002|Overall Study|Progressive disease (PD)|1|||
46845062|NCT03725722|83061905|FG001|Overall Study|Lost to Follow-up|1|||
46845063|NCT03725722|83061906|FG002|Overall Study|Lost to Follow-up|2|||
46845064|NCT03725722|83061907|FG003|Overall Study|Lost to Follow-up|2|||
46639987|NCT00087516|82813987|FG000|Overall Study|Withdrawal by Subject|16|||
46773798|NCT00743288|82992131|FG003|Overall Study|Progressive disease (PD)|4|||
46845065|NCT03725722|83061908|FG004|Overall Study|Lost to Follow-up|1|||
46639988|NCT00087516|82813988|FG001|Overall Study|Withdrawal by Subject|27|||
46845066|NCT03725722|83061904|FG000|Overall Study|Personal reasons|0|||
46958030|NCT00152009|83199446|FG000|Overall Study|Lost to Follow-up|2|||
46958031|NCT00152009|83199447|FG001|Overall Study|Lost to Follow-up|4|||
46958032|NCT00152009|83199448|FG002|Overall Study|Lost to Follow-up|3|||
46958033|NCT00152009|83199449|FG003|Overall Study|Lost to Follow-up|3|||
46958034|NCT00152009|83199446|FG000|Overall Study|Lack of Efficacy|8|||
46958035|NCT00152009|83199447|FG001|Overall Study|Lack of Efficacy|6|||
46958036|NCT00152009|83199448|FG002|Overall Study|Lack of Efficacy|7|||
46958037|NCT00152009|83199449|FG003|Overall Study|Lack of Efficacy|15|||
46958038|NCT00152009|83199446|FG000|Overall Study|ECG abnormalities|2|||
46958039|NCT00152009|83199447|FG001|Overall Study|ECG abnormalities|2|||
46958040|NCT00152009|83199448|FG002|Overall Study|ECG abnormalities|2|||
46958041|NCT00152009|83199449|FG003|Overall Study|ECG abnormalities|1|||
46958042|NCT00152009|83199446|FG000|Overall Study|Sponsor's decision|3|||
46958043|NCT00152009|83199447|FG001|Overall Study|Sponsor's decision|3|||
46958044|NCT00152009|83199448|FG002|Overall Study|Sponsor's decision|1|||
46958045|NCT00152009|83199449|FG003|Overall Study|Sponsor's decision|3|||
46958046|NCT02265952|83199459|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
46958047|NCT02265952|83199460|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
46958048|NCT02265952|83199459|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
46958049|NCT02265952|83199460|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
46958050|NCT02265796|83199468|FG000|Overall Study|Death|1|||
46958051|NCT02265796|83199469|FG001|Overall Study|Death|0|||
46958052|NCT02265796|83199468|FG000|Overall Study|started on excluded medication|1|||
46958053|NCT02265796|83199469|FG001|Overall Study|started on excluded medication|0|||
46958054|NCT02265796|83199468|FG000|Overall Study|Withdrawal by Subject|1|||
46958055|NCT02265796|83199469|FG001|Overall Study|Withdrawal by Subject|1|||
46958056|NCT02357368|83199479|FG000|Overall Study|Lost to Follow-up|0|||
46958057|NCT02357368|83199480|FG001|Overall Study|Lost to Follow-up|0|||
46958058|NCT02357368|83199481|FG002|Overall Study|Lost to Follow-up|0|||
46958059|NCT02357368|83199482|FG003|Overall Study|Lost to Follow-up|1|||
46958060|NCT02357368|83199479|FG000|Overall Study|Pregnancy|3|||
46958061|NCT02357368|83199480|FG001|Overall Study|Pregnancy|2|||
46958062|NCT02357368|83199481|FG002|Overall Study|Pregnancy|0|||
46958063|NCT02357368|83199482|FG003|Overall Study|Pregnancy|0|||
46958064|NCT02357368|83199479|FG000|Overall Study|Withdrawal by Subject|3|||
46958065|NCT02357368|83199480|FG001|Overall Study|Withdrawal by Subject|1|||
46958066|NCT02357368|83199481|FG002|Overall Study|Withdrawal by Subject|1|||
46958067|NCT02357368|83199482|FG003|Overall Study|Withdrawal by Subject|2|||
46958068|NCT03287245|83199496|FG000|Overall Study|Study terminated by sponsor|3|||
46958069|NCT03287245|83199497|FG001|Overall Study|Study terminated by sponsor|0|||
46958070|NCT03287245|83199498|FG002|Overall Study|Study terminated by sponsor|3|||
46958071|NCT03287245|83199499|FG003|Overall Study|Study terminated by sponsor|1|||
46958072|NCT03287245|83199496|FG000|Overall Study|Adverse Event|1|||
46958073|NCT03287245|83199497|FG001|Overall Study|Adverse Event|0|||
46958074|NCT03287245|83199498|FG002|Overall Study|Adverse Event|0|||
46958075|NCT03287245|83199499|FG003|Overall Study|Adverse Event|0|||
46958076|NCT03287245|83199496|FG000|Overall Study|Withdrawal by Subject|8|||
46958077|NCT03287245|83199497|FG001|Overall Study|Withdrawal by Subject|3|||
46958078|NCT03287245|83199498|FG002|Overall Study|Withdrawal by Subject|3|||
46958079|NCT03287245|83199499|FG003|Overall Study|Withdrawal by Subject|0|||
46958080|NCT03287245|83199496|FG000|Overall Study|Physician Decision|3|||
46958081|NCT03287245|83199497|FG001|Overall Study|Physician Decision|2|||
46958082|NCT03287245|83199498|FG002|Overall Study|Physician Decision|0|||
46958083|NCT03287245|83199499|FG003|Overall Study|Physician Decision|0|||
46958084|NCT04495179|83199531|FG000|Overall Study|Lost to Follow-up|0|||
46958085|NCT04495179|83199532|FG001|Overall Study|Lost to Follow-up|1|||
46958086|NCT04495179|83199531|FG000|Overall Study|Withdrawal by Subject|2|||
46958087|NCT04495179|83199532|FG001|Overall Study|Withdrawal by Subject|4|||
46958088|NCT04495179|83199531|FG000|Overall Study|Study terminated by sponsor|0|||
46958089|NCT04495179|83199532|FG001|Overall Study|Study terminated by sponsor|18|||
46958090|NCT04495179|83199531|FG000|Overall Study|Death|0|||
46958091|NCT04495179|83199532|FG001|Overall Study|Death|4|||
46958092|NCT04495179|83199531|FG000|Overall Study|Adverse Event|0|||
46958093|NCT04495179|83199532|FG001|Overall Study|Adverse Event|1|||
46958094|NCT04201262|83199557|FG000|Overall Study|Adverse Event|1|||
46958095|NCT04201262|83199558|FG001|Overall Study|Adverse Event|2|||
46958096|NCT04201262|83199557|FG000|Overall Study|Continuing in the study|57|||
46958097|NCT04201262|83199558|FG001|Overall Study|Continuing in the study|0|||
46958098|NCT04201262|83199557|FG000|Overall Study|Withdrawal by Subject|0|||
46958099|NCT04201262|83199558|FG001|Overall Study|Withdrawal by Subject|1|||
46958100|NCT03831100|83199570|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
46958101|NCT03831100|83199571|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
46958102|NCT03689244|83199590|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
46958103|NCT03689244|83199591|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
46958104|NCT03689244|83199592|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
46958105|NCT03689244|83199593|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
46958106|NCT03689244|83199590|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
46958107|NCT03689244|83199591|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
46958108|NCT03689244|83199592|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
46958109|NCT03689244|83199593|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
46958110|NCT03689244|83199590|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
46958111|NCT03689244|83199591|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
46958112|NCT03689244|83199592|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
46958113|NCT03689244|83199593|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
46958114|NCT03689244|83199590|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
46958115|NCT03689244|83199591|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
46958116|NCT03689244|83199592|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
46958117|NCT03689244|83199593|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
46958118|NCT03689244|83199590|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
46958119|NCT03689244|83199591|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
46958120|NCT03689244|83199592|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
46958121|NCT03689244|83199593|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
46958122|NCT03689244|83199590|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
46958123|NCT03689244|83199591|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
46958124|NCT03689244|83199592|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
46958125|NCT03689244|83199593|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
46958126|NCT03689244|83199590|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
46958127|NCT03689244|83199591|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
46958128|NCT03689244|83199592|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
46958129|NCT03689244|83199593|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
46958130|NCT03689244|83199590|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
46958131|NCT03689244|83199591|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
46958132|NCT03689244|83199592|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
46958133|NCT03689244|83199593|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
46958134|NCT03649074|83199603|FG000|Overall Study|Lost to Follow-up|2|||
46958135|NCT03649074|83199604|FG001|Overall Study|Lost to Follow-up|1|||
46958136|NCT03649074|83199603|FG000|Overall Study|Adverse Event|1|||
46958137|NCT03649074|83199604|FG001|Overall Study|Adverse Event|0|||
46958138|NCT03649074|83199603|FG000|Overall Study|Physician Decision|1|||
46958139|NCT03649074|83199604|FG001|Overall Study|Physician Decision|0|||
46958140|NCT03649074|83199603|FG000|Overall Study|Withdrawal by Subject|0|||
46958141|NCT03649074|83199604|FG001|Overall Study|Withdrawal by Subject|2|||
46958142|NCT03649074|83199603|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
46958143|NCT03649074|83199604|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
46958144|NCT03649074|83199603|FG000|Overall Study|Other|1|||
46958145|NCT03649074|83199604|FG001|Overall Study|Other|0|||
46958146|NCT02133573|83199621|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
46958147|NCT02133573|83199622|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
46958148|NCT02133573|83199621|FG000|Overall Study|Child Deaths|3|||
46958149|NCT02133573|83199622|FG001|Overall Study|Child Deaths|5|||
46958150|NCT02133573|83199621|FG000|Overall Study|Child Declined Follow Ups|2|||
46958151|NCT02133573|83199622|FG001|Overall Study|Child Declined Follow Ups|1|||
46958152|NCT02133573|83199621|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
46958153|NCT02133573|83199622|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
46958154|NCT00686595|83199657|FG000|Overall Study|Adverse Event|3|||
46958155|NCT00686595|83199657|FG000|Overall Study|Protocol Violation|1|||
46958156|NCT00686595|83199657|FG000|Overall Study|Lost to Follow-up|1|||
46958157|NCT00686595|83199657|FG000|Overall Study|Lack of Efficacy|1|||
46958158|NCT00686595|83199657|FG000|Overall Study|Poor Compliance|1|||
46958159|NCT00640159|83199661|FG000|Overall Study|Lost to Follow-up|2|||
46958160|NCT02262754|83199671|FG000|Overall Study|Adverse Event|3|||
46958161|NCT02262754|83199672|FG001|Overall Study|Adverse Event|4|||
46958162|NCT02262754|83199673|FG002|Overall Study|Adverse Event|0|||
46958163|NCT02262754|83199671|FG000|Overall Study|Lack of Efficacy|2|||
46958164|NCT02262754|83199672|FG001|Overall Study|Lack of Efficacy|0|||
46958165|NCT02262754|83199673|FG002|Overall Study|Lack of Efficacy|1|||
46773799|NCT00743288|82992132|FG004|Overall Study|Progressive disease (PD)|5|||
46958166|NCT02262754|83199671|FG000|Overall Study|Lost to Follow-up|0|||
46958167|NCT02262754|83199672|FG001|Overall Study|Lost to Follow-up|0|||
46958168|NCT02262754|83199673|FG002|Overall Study|Lost to Follow-up|1|||
46958169|NCT02262754|83199671|FG000|Overall Study|No longer meets eligibility criteria|0|||
46958170|NCT02262754|83199672|FG001|Overall Study|No longer meets eligibility criteria|1|||
46958171|NCT02262754|83199673|FG002|Overall Study|No longer meets eligibility criteria|0|||
46773800|NCT00743288|82992133|FG005|Overall Study|Progressive disease (PD)|3|||
46773801|NCT00743288|82992134|FG006|Overall Study|Progressive disease (PD)|6|||
46958172|NCT02262754|83199671|FG000|Overall Study|Study terminated by sponsor|5|||
46773802|NCT00743288|82992128|FG000|Overall Study|Worsening of condition (Not PD)|0|||
46958173|NCT02262754|83199672|FG001|Overall Study|Study terminated by sponsor|4|||
46958174|NCT02262754|83199673|FG002|Overall Study|Study terminated by sponsor|4|||
46958175|NCT02262754|83199671|FG000|Overall Study|Protocol Violation|1|||
46958176|NCT02262754|83199672|FG001|Overall Study|Protocol Violation|0|||
46958177|NCT02262754|83199673|FG002|Overall Study|Protocol Violation|0|||
46958178|NCT02262754|83199671|FG000|Overall Study|Withdrawal by Subject|1|||
46958179|NCT02262754|83199672|FG001|Overall Study|Withdrawal by Subject|0|||
46958180|NCT02262754|83199673|FG002|Overall Study|Withdrawal by Subject|1|||
46958181|NCT02262754|83199671|FG000|Overall Study|Other|4|||
46958182|NCT02262754|83199672|FG001|Overall Study|Other|0|||
46958183|NCT02262754|83199673|FG002|Overall Study|Other|2|||
46958184|NCT02262364|83199683|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
46958185|NCT02261974|83199689|FG000|Overall Study|Withdrawal by Subject|3|||
46958186|NCT02261974|83199690|FG001|Overall Study|Withdrawal by Subject|2|||
46958187|NCT02261974|83199689|FG000|Overall Study|Pregnancy|0|||
46958188|NCT02261974|83199690|FG001|Overall Study|Pregnancy|1|||
46958189|NCT02261974|83199689|FG000|Overall Study|Missed treatment cut-off date|6|||
46958190|NCT02261974|83199690|FG001|Overall Study|Missed treatment cut-off date|3|||
46958191|NCT02261974|83199689|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
46958192|NCT02261974|83199690|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
46958193|NCT02261974|83199689|FG000|Overall Study|Lost to Follow-up|2|||
46958194|NCT02261974|83199690|FG001|Overall Study|Lost to Follow-up|0|||
46958195|NCT02261974|83199689|FG000|Overall Study|Adverse Event|1|||
46958196|NCT02261974|83199690|FG001|Overall Study|Adverse Event|0|||
46958197|NCT02356588|83199698|FG000|Overall Study|Lack of Efficacy|4|||
46958198|NCT02356588|83199699|FG001|Overall Study|Lack of Efficacy|10|||
46958199|NCT02356588|83199698|FG000|Overall Study|Adverse Event|0|||
46958200|NCT02356588|83199699|FG001|Overall Study|Adverse Event|2|||
46958201|NCT02356588|83199698|FG000|Overall Study|Withdrawal by Subject|1|||
46958202|NCT02356588|83199699|FG001|Overall Study|Withdrawal by Subject|0|||
46958203|NCT02356588|83199698|FG000|Overall Study|Protocol Violation|0|||
46958204|NCT02356588|83199699|FG001|Overall Study|Protocol Violation|1|||
46958205|NCT02355028|83199707|FG000|Overall Study|Adverse Event|2|||
46958206|NCT02355028|83199708|FG001|Overall Study|Adverse Event|0|||
46958207|NCT02355028|83199707|FG000|Overall Study|Withdrawal by Subject|1|||
46958208|NCT02355028|83199708|FG001|Overall Study|Withdrawal by Subject|1|||
46958209|NCT02355028|83199707|FG000|Overall Study|Deemed ineligible after randomization|8|||
46958210|NCT02355028|83199708|FG001|Overall Study|Deemed ineligible after randomization|4|||
46958211|NCT01643668|83199723|FG000|Overall Study|Death|1|||
46958212|NCT02260882|83199729|FG000|Overall Study|Protocol Violation|0|||
46958213|NCT02260882|83199730|FG001|Overall Study|Protocol Violation|1|||
46958214|NCT02260804|83199739|FG000|Induction Study Period|Protocol Violation|2|||
46958215|NCT02260804|83199740|FG001|Induction Study Period|Protocol Violation|0|||
46958216|NCT02260804|83199739|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
46958217|NCT02260804|83199740|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
46958218|NCT02260804|83199739|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
46958219|NCT02260804|83199740|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
46958220|NCT02260804|83199739|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
46958221|NCT02260804|83199740|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
46958222|NCT02260804|83199739|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
46958223|NCT02260804|83199740|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
46958224|NCT02260804|83199739|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
46958225|NCT02260804|83199740|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
46958226|NCT02260804|83199739|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
46958227|NCT02260804|83199740|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
46958228|NCT02260804|83199739|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
46958229|NCT02260804|83199740|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
46958230|NCT02260804|83199739|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
46958231|NCT02260804|83199740|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
46958232|NCT02260804|83199739|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
46958233|NCT02260804|83199740|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
46958234|NCT02260804|83199739|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
46958235|NCT02260804|83199740|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
46958236|NCT02260648|83199749|FG000|Overall Study|Adverse Event|3|||
46958237|NCT02260648|83199750|FG001|Overall Study|Adverse Event|0|||
46958238|NCT02260648|83199751|FG002|Overall Study|Adverse Event|1|||
46958239|NCT02260648|83199749|FG000|Overall Study|Withdrawal by Subject|1|||
46958240|NCT02260648|83199750|FG001|Overall Study|Withdrawal by Subject|1|||
46958241|NCT02260648|83199751|FG002|Overall Study|Withdrawal by Subject|0|||
46958242|NCT02260648|83199749|FG000|Overall Study|Protocol Violation|1|||
46958243|NCT02260648|83199750|FG001|Overall Study|Protocol Violation|0|||
46958244|NCT02260648|83199751|FG002|Overall Study|Protocol Violation|0|||
46958245|NCT02260648|83199749|FG000|Overall Study|Discontinue Due to Study Termination|13|||
46958246|NCT02260648|83199750|FG001|Overall Study|Discontinue Due to Study Termination|12|||
46958247|NCT02260648|83199751|FG002|Overall Study|Discontinue Due to Study Termination|7|||
46958248|NCT02260492|83199762|FG000|Overall Study|Adverse Event|6|||
46958249|NCT02260492|83199763|FG001|Overall Study|Adverse Event|1|||
46958250|NCT02260492|83199764|FG002|Overall Study|Adverse Event|2|||
46958251|NCT02260492|83199762|FG000|Overall Study|Death|0|||
46958252|NCT02260492|83199763|FG001|Overall Study|Death|1|||
46958253|NCT02260492|83199764|FG002|Overall Study|Death|0|||
46958254|NCT02260492|83199762|FG000|Overall Study|Lost to Follow-up|12|||
46958255|NCT02260492|83199763|FG001|Overall Study|Lost to Follow-up|9|||
46958256|NCT02260492|83199764|FG002|Overall Study|Lost to Follow-up|0|||
46958257|NCT02260492|83199762|FG000|Overall Study|Physician Decision|2|||
46958258|NCT02260492|83199763|FG001|Overall Study|Physician Decision|0|||
46958259|NCT02260492|83199764|FG002|Overall Study|Physician Decision|1|||
46958260|NCT02260492|83199762|FG000|Overall Study|Withdrawal by Subject|3|||
46958261|NCT02260492|83199763|FG001|Overall Study|Withdrawal by Subject|2|||
46958262|NCT02260492|83199764|FG002|Overall Study|Withdrawal by Subject|2|||
46958263|NCT02260258|83199774|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
46958264|NCT02260258|83199775|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
46958265|NCT02260180|83199785|FG000|Overall Study|Adverse Event|2|||
46958266|NCT02260180|83199786|FG001|Overall Study|Adverse Event|0|||
46958267|NCT02260180|83199787|FG002|Overall Study|Adverse Event|1|||
46958268|NCT02353468|83199795|FG000|Overall Study|Study terminated|3|||
46958269|NCT02349412|83199801|FG000|Overall Study|Withdrawal by Subject|7|||
46958270|NCT02349412|83199802|FG001|Overall Study|Withdrawal by Subject|7|||
46958271|NCT02259400|83199810|FG000|Overall Study|Death|0|||
46958272|NCT02259400|83199811|FG001|Overall Study|Death|2|||
46958273|NCT01530997|83199817|FG000|Overall Study|Physician Decision|1|||
46958274|NCT01530997|83199817|FG000|Overall Study|Withdrawal by Subject|1|||
46958275|NCT02259088|83199830|FG000|Overall Study|Adverse Event|6|||
46958276|NCT02259088|83199831|FG001|Overall Study|Adverse Event|4|||
46958277|NCT02259088|83199830|FG000|Overall Study|Lost to Follow-up|2|||
46958278|NCT02259088|83199831|FG001|Overall Study|Lost to Follow-up|0|||
46958279|NCT02259088|83199830|FG000|Overall Study|Death|2|||
46958280|NCT02259088|83199831|FG001|Overall Study|Death|0|||
46958281|NCT02259088|83199830|FG000|Overall Study|Physician Decision|5|||
46958282|NCT02259088|83199831|FG001|Overall Study|Physician Decision|2|||
46958283|NCT02259088|83199830|FG000|Overall Study|Protocol deviation|5|||
46958284|NCT02259088|83199831|FG001|Overall Study|Protocol deviation|0|||
46958285|NCT02259088|83199830|FG000|Overall Study|Subject/guardian decision|8|||
46958286|NCT02259088|83199831|FG001|Overall Study|Subject/guardian decision|8|||
46958287|NCT02880241|83199843|FG000|Overall Study|Lack of Efficacy|1|||
46958288|NCT02880241|83199844|FG001|Overall Study|Lack of Efficacy|0|||
46958289|NCT02880241|83199845|FG002|Overall Study|Lack of Efficacy|0|||
46958290|NCT02880241|83199846|FG003|Overall Study|Lack of Efficacy|0|||
46958291|NCT02880241|83199847|FG004|Overall Study|Lack of Efficacy|0|||
46958292|NCT02880241|83199848|FG005|Overall Study|Lack of Efficacy|0|||
46958293|NCT02259010|83199864|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
46958294|NCT02021773|83199873|FG000|Overall Study|Adverse Event|1|||
46958295|NCT02021773|83199874|FG001|Overall Study|Adverse Event|4|||
46958296|NCT02021773|83199875|FG002|Overall Study|Adverse Event|3|||
46958297|NCT02021773|83199873|FG000|Overall Study|Lack of Efficacy|2|||
46958298|NCT02021773|83199874|FG001|Overall Study|Lack of Efficacy|2|||
46958299|NCT02021773|83199875|FG002|Overall Study|Lack of Efficacy|2|||
46958300|NCT02021773|83199873|FG000|Overall Study|Protocol Violation|2|||
46958301|NCT02021773|83199874|FG001|Overall Study|Protocol Violation|3|||
46958302|NCT02021773|83199875|FG002|Overall Study|Protocol Violation|1|||
46958303|NCT02021773|83199873|FG000|Overall Study|Withdrawal by Subject|3|||
46958304|NCT02021773|83199874|FG001|Overall Study|Withdrawal by Subject|4|||
46958305|NCT02021773|83199875|FG002|Overall Study|Withdrawal by Subject|5|||
46958306|NCT02021773|83199873|FG000|Overall Study|Lost to Follow-up|1|||
46958307|NCT02021773|83199874|FG001|Overall Study|Lost to Follow-up|3|||
46958308|NCT02021773|83199875|FG002|Overall Study|Lost to Follow-up|0|||
46958309|NCT02021773|83199873|FG000|Overall Study|Reason not specified|3|||
46958310|NCT02021773|83199874|FG001|Overall Study|Reason not specified|0|||
46958311|NCT02021773|83199875|FG002|Overall Study|Reason not specified|0|||
46958312|NCT00151775|83199888|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
46958313|NCT00151775|83199889|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
46958314|NCT00151775|83199890|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958315|NCT00151775|83199891|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958316|NCT00151775|83199892|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958317|NCT00151775|83199893|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958318|NCT00151775|83199894|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958319|NCT00151775|83199895|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958320|NCT00151775|83199896|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958321|NCT00151775|83199897|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958322|NCT00151775|83199898|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958323|NCT00151775|83199899|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
46958324|NCT00151775|83199888|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
46958325|NCT00151775|83199889|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958326|NCT00151775|83199890|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958327|NCT00151775|83199891|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958328|NCT00151775|83199892|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958329|NCT00151775|83199893|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958330|NCT00151775|83199894|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
46958331|NCT00151775|83199895|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958332|NCT00151775|83199896|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958333|NCT00151775|83199897|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958334|NCT00151775|83199898|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
46958335|NCT00151775|83199899|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
46958336|NCT00151775|83199888|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958337|NCT00151775|83199889|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
46958338|NCT00151775|83199890|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958339|NCT00151775|83199891|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958340|NCT00151775|83199892|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958341|NCT00151775|83199893|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958342|NCT00151775|83199894|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958343|NCT00151775|83199895|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958344|NCT00151775|83199896|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958345|NCT00151775|83199897|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958346|NCT00151775|83199898|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958347|NCT00151775|83199899|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
46958348|NCT00151775|83199888|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
46958349|NCT00151775|83199889|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
46958350|NCT00151775|83199890|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
46958351|NCT00151775|83199891|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
46958352|NCT00151775|83199892|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
46958353|NCT00151775|83199893|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
46958354|NCT00151775|83199894|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
46958355|NCT00151775|83199895|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
46958356|NCT00151775|83199896|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
46958357|NCT00151775|83199897|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
46958358|NCT00151775|83199898|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
46958359|NCT00151775|83199899|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
46958360|NCT00151775|83199888|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958361|NCT00151775|83199889|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958362|NCT00151775|83199890|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958363|NCT00151775|83199891|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958364|NCT00151775|83199892|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958365|NCT00151775|83199893|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
46958366|NCT00151775|83199894|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958367|NCT00151775|83199895|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958368|NCT00151775|83199896|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958369|NCT00151775|83199897|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958370|NCT00151775|83199898|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958371|NCT00151775|83199899|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
46958372|NCT00151775|83199888|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958373|NCT00151775|83199889|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958374|NCT00151775|83199890|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958375|NCT00151775|83199891|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958376|NCT00151775|83199892|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958377|NCT00151775|83199893|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
46958378|NCT00151775|83199894|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958379|NCT00151775|83199895|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958380|NCT00151775|83199896|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958381|NCT00151775|83199897|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958382|NCT00151775|83199898|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46958383|NCT00151775|83199899|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
46967876|NCT05091307|83210483|FG000|Overall Study|Withdrawal by Subject|16|||
46958384|NCT00151775|83199888|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958385|NCT00151775|83199889|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958386|NCT00151775|83199890|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958387|NCT00151775|83199891|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958388|NCT00151775|83199892|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958389|NCT00151775|83199893|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958390|NCT00151775|83199894|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
46958391|NCT00151775|83199895|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958392|NCT00151775|83199896|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958393|NCT00151775|83199897|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958394|NCT00151775|83199898|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958395|NCT00151775|83199899|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
46958396|NCT00151775|83199888|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958397|NCT00151775|83199889|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958398|NCT00151775|83199890|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958399|NCT00151775|83199891|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958400|NCT00151775|83199892|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958401|NCT00151775|83199893|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
46958402|NCT00151775|83199894|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958403|NCT00151775|83199895|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958404|NCT00151775|83199896|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958405|NCT00151775|83199897|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958406|NCT00151775|83199898|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958407|NCT00151775|83199899|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
46958408|NCT00151775|83199888|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
46958409|NCT00151775|83199889|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
46958410|NCT00151775|83199890|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
46958411|NCT00151775|83199891|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
46958412|NCT00151775|83199892|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
46958413|NCT00151775|83199893|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
46958414|NCT00151775|83199894|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
46958415|NCT00151775|83199895|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
46958416|NCT00151775|83199896|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
46958417|NCT00151775|83199897|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
46958418|NCT00151775|83199898|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
46958419|NCT00151775|83199899|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
46958420|NCT00151775|83199888|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958421|NCT00151775|83199889|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958422|NCT00151775|83199890|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958423|NCT00151775|83199891|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958424|NCT00151775|83199892|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958425|NCT00151775|83199893|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958426|NCT00151775|83199894|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
46958427|NCT00151775|83199895|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958428|NCT00151775|83199896|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958429|NCT00151775|83199897|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958430|NCT00151775|83199898|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958431|NCT00151775|83199899|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
46958432|NCT00151775|83199888|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958433|NCT00151775|83199889|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958434|NCT00151775|83199890|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
46958435|NCT00151775|83199891|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958436|NCT00151775|83199892|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958437|NCT00151775|83199893|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958438|NCT00151775|83199894|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958439|NCT00151775|83199895|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958440|NCT00151775|83199896|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958441|NCT00151775|83199897|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958442|NCT00151775|83199898|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958443|NCT00151775|83199899|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
46958444|NCT00151775|83199888|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
47067027|NCT01572038|83350380|FG000|Overall Study|Participated in Another Trial|3|||
46958445|NCT00151775|83199889|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
47067028|NCT01572038|83350380|FG000|Overall Study|Termination by Sponsor|2|||
47067029|NCT01572038|83350380|FG000|Overall Study|Patient Deterioration|1|||
47067030|NCT01572038|83350380|FG000|Overall Study|Sponsor Decision|1|||
46958446|NCT00151775|83199890|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
46958447|NCT00151775|83199891|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958448|NCT00151775|83199892|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958449|NCT00151775|83199893|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958450|NCT00151775|83199894|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958451|NCT00151775|83199895|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958452|NCT00151775|83199896|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958453|NCT00151775|83199897|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958454|NCT00151775|83199898|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958455|NCT00151775|83199899|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
46958456|NCT00151775|83199888|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958457|NCT00151775|83199889|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958458|NCT00151775|83199890|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958459|NCT00151775|83199891|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958460|NCT00151775|83199892|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958461|NCT00151775|83199893|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958462|NCT00151775|83199894|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958463|NCT00151775|83199895|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958464|NCT00151775|83199896|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958465|NCT00151775|83199897|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958466|NCT00151775|83199898|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
46958467|NCT00151775|83199899|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
46958468|NCT00151775|83199888|FG000|Period 4: Open Label|Increased blood pressure|0|||
46958469|NCT00151775|83199889|FG001|Period 4: Open Label|Increased blood pressure|0|||
46958470|NCT00151775|83199890|FG002|Period 4: Open Label|Increased blood pressure|0|||
46958471|NCT00151775|83199891|FG003|Period 4: Open Label|Increased blood pressure|0|||
46958472|NCT00151775|83199892|FG004|Period 4: Open Label|Increased blood pressure|1|||
46958473|NCT00151775|83199893|FG005|Period 4: Open Label|Increased blood pressure|0|||
46958474|NCT00151775|83199894|FG006|Period 4: Open Label|Increased blood pressure|0|||
46958475|NCT00151775|83199895|FG007|Period 4: Open Label|Increased blood pressure|0|||
46958476|NCT00151775|83199896|FG008|Period 4: Open Label|Increased blood pressure|0|||
46958477|NCT00151775|83199897|FG009|Period 4: Open Label|Increased blood pressure|1|||
46958478|NCT00151775|83199898|FG010|Period 4: Open Label|Increased blood pressure|0|||
46958479|NCT00151775|83199899|FG011|Period 4: Open Label|Increased blood pressure|0|||
46958480|NCT00151775|83199888|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
46958481|NCT00151775|83199889|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
46958482|NCT00151775|83199890|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
46958483|NCT00151775|83199891|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
46958484|NCT00151775|83199892|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
46958485|NCT00151775|83199893|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
46958486|NCT00151775|83199894|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
46958487|NCT00151775|83199895|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
46958488|NCT00151775|83199896|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
46958489|NCT00151775|83199897|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
46958490|NCT00151775|83199898|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
46958491|NCT00151775|83199899|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
46958492|NCT00151775|83199888|FG000|Period 4: Open Label|Adverse Event|0|||
46958493|NCT00151775|83199889|FG001|Period 4: Open Label|Adverse Event|0|||
46958494|NCT00151775|83199890|FG002|Period 4: Open Label|Adverse Event|0|||
46958495|NCT00151775|83199891|FG003|Period 4: Open Label|Adverse Event|0|||
46958496|NCT00151775|83199892|FG004|Period 4: Open Label|Adverse Event|1|||
46958497|NCT00151775|83199893|FG005|Period 4: Open Label|Adverse Event|0|||
46958498|NCT00151775|83199894|FG006|Period 4: Open Label|Adverse Event|0|||
46958499|NCT00151775|83199895|FG007|Period 4: Open Label|Adverse Event|0|||
46958500|NCT00151775|83199896|FG008|Period 4: Open Label|Adverse Event|0|||
46958501|NCT00151775|83199897|FG009|Period 4: Open Label|Adverse Event|2|||
46958502|NCT00151775|83199898|FG010|Period 4: Open Label|Adverse Event|0|||
46958503|NCT00151775|83199899|FG011|Period 4: Open Label|Adverse Event|0|||
46958504|NCT00151775|83199888|FG000|Period 4: Open Label|Lost to Follow-up|0|||
46958505|NCT00151775|83199889|FG001|Period 4: Open Label|Lost to Follow-up|0|||
46958506|NCT00151775|83199890|FG002|Period 4: Open Label|Lost to Follow-up|0|||
46958507|NCT00151775|83199891|FG003|Period 4: Open Label|Lost to Follow-up|0|||
46958508|NCT00151775|83199892|FG004|Period 4: Open Label|Lost to Follow-up|17|||
46958509|NCT00151775|83199893|FG005|Period 4: Open Label|Lost to Follow-up|0|||
46958510|NCT00151775|83199894|FG006|Period 4: Open Label|Lost to Follow-up|0|||
46958511|NCT00151775|83199895|FG007|Period 4: Open Label|Lost to Follow-up|0|||
46958512|NCT00151775|83199896|FG008|Period 4: Open Label|Lost to Follow-up|0|||
46845067|NCT03725722|83061905|FG001|Overall Study|Personal reasons|0|||
47067031|NCT01448213|83350408|FG000|Overall Study|Lost to Follow-up|12|||
47067032|NCT01448213|83350409|FG001|Overall Study|Lost to Follow-up|10|||
46958513|NCT00151775|83199897|FG009|Period 4: Open Label|Lost to Follow-up|7|||
46958514|NCT00151775|83199898|FG010|Period 4: Open Label|Lost to Follow-up|0|||
46958515|NCT00151775|83199899|FG011|Period 4: Open Label|Lost to Follow-up|0|||
46958516|NCT00151775|83199888|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
46958517|NCT00151775|83199889|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
46958518|NCT00151775|83199890|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
46958519|NCT00151775|83199891|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
46958520|NCT00151775|83199892|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
46958521|NCT00151775|83199893|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
46958522|NCT00151775|83199894|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
46958523|NCT00151775|83199895|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
46958524|NCT00151775|83199896|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
46958525|NCT00151775|83199897|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
46958526|NCT00151775|83199898|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
46958527|NCT00151775|83199899|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
46958528|NCT00151775|83199888|FG000|Period 4: Open Label|Other|0|||
46958529|NCT00151775|83199889|FG001|Period 4: Open Label|Other|0|||
46958530|NCT00151775|83199890|FG002|Period 4: Open Label|Other|0|||
46958531|NCT00151775|83199891|FG003|Period 4: Open Label|Other|0|||
46958532|NCT00151775|83199892|FG004|Period 4: Open Label|Other|1|||
46958533|NCT00151775|83199893|FG005|Period 4: Open Label|Other|0|||
46958534|NCT00151775|83199894|FG006|Period 4: Open Label|Other|0|||
46958535|NCT00151775|83199895|FG007|Period 4: Open Label|Other|0|||
46958536|NCT00151775|83199896|FG008|Period 4: Open Label|Other|0|||
46958537|NCT00151775|83199897|FG009|Period 4: Open Label|Other|3|||
46958538|NCT00151775|83199898|FG010|Period 4: Open Label|Other|0|||
46958539|NCT00151775|83199899|FG011|Period 4: Open Label|Other|0|||
46958540|NCT00151775|83199888|FG000|Period 4: Open Label|Physician Decision|0|||
46958541|NCT00151775|83199889|FG001|Period 4: Open Label|Physician Decision|0|||
46958542|NCT00151775|83199890|FG002|Period 4: Open Label|Physician Decision|0|||
46958543|NCT00151775|83199891|FG003|Period 4: Open Label|Physician Decision|0|||
46958544|NCT00151775|83199892|FG004|Period 4: Open Label|Physician Decision|0|||
46958545|NCT00151775|83199893|FG005|Period 4: Open Label|Physician Decision|0|||
46958546|NCT00151775|83199894|FG006|Period 4: Open Label|Physician Decision|0|||
46958547|NCT00151775|83199895|FG007|Period 4: Open Label|Physician Decision|0|||
46958548|NCT00151775|83199896|FG008|Period 4: Open Label|Physician Decision|0|||
46958549|NCT00151775|83199897|FG009|Period 4: Open Label|Physician Decision|2|||
46958550|NCT00151775|83199898|FG010|Period 4: Open Label|Physician Decision|0|||
46958551|NCT00151775|83199899|FG011|Period 4: Open Label|Physician Decision|0|||
46958552|NCT00151775|83199888|FG000|Period 4: Open Label|Protocol Violation|0|||
46958553|NCT00151775|83199889|FG001|Period 4: Open Label|Protocol Violation|0|||
46958554|NCT00151775|83199890|FG002|Period 4: Open Label|Protocol Violation|0|||
46958555|NCT00151775|83199891|FG003|Period 4: Open Label|Protocol Violation|0|||
46958556|NCT00151775|83199892|FG004|Period 4: Open Label|Protocol Violation|1|||
46958557|NCT00151775|83199893|FG005|Period 4: Open Label|Protocol Violation|0|||
46958558|NCT00151775|83199894|FG006|Period 4: Open Label|Protocol Violation|0|||
46958559|NCT00151775|83199895|FG007|Period 4: Open Label|Protocol Violation|0|||
46958560|NCT00151775|83199896|FG008|Period 4: Open Label|Protocol Violation|0|||
46958561|NCT00151775|83199897|FG009|Period 4: Open Label|Protocol Violation|0|||
46958562|NCT00151775|83199898|FG010|Period 4: Open Label|Protocol Violation|0|||
46958563|NCT00151775|83199899|FG011|Period 4: Open Label|Protocol Violation|0|||
46958564|NCT02258464|83199942|FG000|Overall Study|Progressive disease (PD)|9|||
46958565|NCT02258464|83199943|FG001|Overall Study|Progressive disease (PD)|17|||
46958566|NCT02258464|83199942|FG000|Overall Study|Study drug never administered|1|||
46958567|NCT02258464|83199943|FG001|Overall Study|Study drug never administered|1|||
46958568|NCT02258464|83199942|FG000|Overall Study|AE not related to clinical PD|1|||
46958569|NCT02258464|83199943|FG001|Overall Study|AE not related to clinical PD|3|||
46958570|NCT02258464|83199942|FG000|Overall Study|Withdrawal by Subject|5|||
46958571|NCT02258464|83199943|FG001|Overall Study|Withdrawal by Subject|4|||
46958572|NCT02258464|83199942|FG000|Overall Study|AE related to clinical PD|1|||
46958573|NCT02258464|83199943|FG001|Overall Study|AE related to clinical PD|0|||
46958574|NCT02682901|83199951|FG000|Overall Study|Adverse Event|10|||
46958575|NCT02682901|83199952|FG001|Overall Study|Adverse Event|3|||
46958576|NCT02682901|83199951|FG000|Overall Study|Lack of Efficacy|0|||
46958577|NCT02682901|83199952|FG001|Overall Study|Lack of Efficacy|1|||
46958578|NCT02258074|83199962|FG000|Overall Study|Withdrawal by Subject|1|||
46958579|NCT02258074|83199963|FG001|Overall Study|Withdrawal by Subject|0|||
46958580|NCT02258074|83199964|FG002|Overall Study|Withdrawal by Subject|0|||
47067033|NCT01448213|83350408|FG000|Overall Study|Adverse Event|4|||
47067034|NCT01448213|83350409|FG001|Overall Study|Adverse Event|10|||
46958581|NCT02258074|83199965|FG003|Overall Study|Withdrawal by Subject|0|||
46958582|NCT01643044|83199977|FG000|Overall Study|Lost to Follow-up|1|||
46958583|NCT01643044|83199978|FG001|Overall Study|Lost to Follow-up|1|||
46958584|NCT01643044|83199977|FG000|Overall Study|Miscarried baby|2|||
47067035|NCT01448213|83350408|FG000|Overall Study|Protocol Violation|1|||
47067036|NCT01448213|83350409|FG001|Overall Study|Protocol Violation|2|||
46958585|NCT01643044|83199978|FG001|Overall Study|Miscarried baby|2|||
46958586|NCT01643044|83199977|FG000|Overall Study|Delivered outside of hospital|1|||
46958587|NCT01643044|83199978|FG001|Overall Study|Delivered outside of hospital|2|||
46958588|NCT01642732|83199984|FG000|Overall Study|Withdrawal by Subject|1|||
46958589|NCT02257684|83199988|FG000|Overall Study|Adverse Event|2|||
46958590|NCT02257684|83199988|FG000|Overall Study|Lack of Efficacy|1|||
46958591|NCT02257684|83199988|FG000|Overall Study|Sponsor's Decision|1|||
46958592|NCT02190721|83199995|FG000|Overall Study|Patient was out of the city|0|||
46958593|NCT02190721|83199996|FG001|Overall Study|Patient was out of the city|1|||
46958594|NCT02190721|83199997|FG002|Overall Study|Patient was out of the city|0|||
46958595|NCT00581477|83200005|FG000|Overall Study|Physician Decision|2|||
46958596|NCT02348008|83200021|FG000|Overall Study|Adverse Event|2|||
46958597|NCT02348008|83200022|FG001|Overall Study|Adverse Event|3|||
46958598|NCT02348008|83200023|FG002|Overall Study|Adverse Event|3|||
46958599|NCT02348008|83200021|FG000|Overall Study|Disease Progression|1|||
46958600|NCT02348008|83200022|FG001|Overall Study|Disease Progression|5|||
46958601|NCT02348008|83200023|FG002|Overall Study|Disease Progression|16|||
46958602|NCT02348008|83200021|FG000|Overall Study|Withdrawal by Subject|0|||
46958603|NCT02348008|83200022|FG001|Overall Study|Withdrawal by Subject|1|||
46958604|NCT02348008|83200023|FG002|Overall Study|Withdrawal by Subject|0|||
46958605|NCT02348008|83200021|FG000|Overall Study|Symptomatic Deterioration|0|||
46958606|NCT02348008|83200022|FG001|Overall Study|Symptomatic Deterioration|1|||
46958607|NCT02348008|83200023|FG002|Overall Study|Symptomatic Deterioration|0|||
46958608|NCT04962022|83200029|FG000|Period 1|Withdrawal by Subject|1|||
46958609|NCT04962022|83200030|FG001|Period 1|Withdrawal by Subject|0|||
46958610|NCT04740905|83200047|FG000|Overall Study|Ongoing in the Study at the Primary Completion Date|272|||
46958611|NCT04740905|83200048|FG001|Overall Study|Ongoing in the Study at the Primary Completion Date|274|||
46958612|NCT04740905|83200047|FG000|Overall Study|Protocol Violation|0|||
46958613|NCT04740905|83200048|FG001|Overall Study|Protocol Violation|3|||
46958614|NCT04740905|83200047|FG000|Overall Study|Lost to Follow-up|2|||
46958615|NCT04740905|83200048|FG001|Overall Study|Lost to Follow-up|0|||
46958616|NCT04740905|83200047|FG000|Overall Study|Adverse Event|1|||
46958617|NCT04740905|83200048|FG001|Overall Study|Adverse Event|0|||
46958618|NCT04740905|83200047|FG000|Overall Study|Withdrawal by Subject|1|||
46958619|NCT04740905|83200048|FG001|Overall Study|Withdrawal by Subject|0|||
46958620|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
46958621|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
46958622|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
46958623|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
46958624|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
46958625|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
46958626|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
46958627|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
46958628|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
46958629|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
46958630|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
46958631|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
46958632|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
46958633|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
46958634|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
46958635|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
46958636|NCT04210843|83200107|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
46958637|NCT04210843|83200108|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
46958638|NCT04210843|83200107|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
46958639|NCT04210843|83200108|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
46958640|NCT04210843|83200107|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
46958641|NCT04210843|83200108|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
46958642|NCT04210843|83200107|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
46958643|NCT04210843|83200108|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
46958644|NCT04210843|83200107|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
46958645|NCT04210843|83200108|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
46958646|NCT04210843|83200107|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
46958647|NCT04210843|83200108|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
46958648|NCT04210843|83200107|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
46958649|NCT04210843|83200108|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
46958650|NCT04210843|83200107|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
46958651|NCT04210843|83200108|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
47067037|NCT01448057|83350426|FG000|Overall Study|Protocol Violation|3|||
47067038|NCT01448057|83350427|FG001|Overall Study|Protocol Violation|2|||
47067039|NCT01448057|83350426|FG000|Overall Study|Lost to Follow-up|3|||
47067040|NCT01448057|83350427|FG001|Overall Study|Lost to Follow-up|0|||
46958652|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
46958653|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
46958654|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
46958655|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
46958656|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
46958657|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
46958658|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
46958659|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
46958660|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
46958661|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
46958662|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
46958663|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
46958664|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
46958665|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
46958666|NCT04210843|83200107|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
46958667|NCT04210843|83200108|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
46958668|NCT02651675|83200164|FG000|Overall Study|Death|0|||
46958669|NCT02651675|83200165|FG001|Overall Study|Death|0|||
46958670|NCT02651675|83200166|FG002|Overall Study|Death|1|||
46958671|NCT02611960|83200176|FG000|Overall Study|Adverse Event|7|||
46958672|NCT02611960|83200177|FG001|Overall Study|Adverse Event|8|||
46958673|NCT02611960|83200176|FG000|Overall Study|Death|98|||
46958674|NCT02611960|83200177|FG001|Overall Study|Death|92|||
46845068|NCT03725722|83061906|FG002|Overall Study|Personal reasons|1|||
46958675|NCT02611960|83200176|FG000|Overall Study|Withdrawal by Subject|1|||
46958676|NCT02611960|83200177|FG001|Overall Study|Withdrawal by Subject|5|||
46958677|NCT02611960|83200176|FG000|Overall Study|Sponsor Decision|11|||
46958678|NCT02611960|83200177|FG001|Overall Study|Sponsor Decision|11|||
46958679|NCT01845597|83200184|FG000|Overall Study|Death|8|||
46958680|NCT01845597|83200184|FG000|Overall Study|Lost to Follow-up|22|||
46958681|NCT00713206|83200203|FG000|Overall Study|Lost to Follow-up|4|||
46958682|NCT00713206|83200204|FG001|Overall Study|Lost to Follow-up|4|||
46958683|NCT00713206|83200203|FG000|Overall Study|Death|1|||
46958684|NCT00713206|83200204|FG001|Overall Study|Death|0|||
46958685|NCT00495131|83200212|FG000|Overall Study|Adverse Event|6|||
46958686|NCT00495131|83200213|FG001|Overall Study|Adverse Event|2|||
46958687|NCT00495131|83200212|FG000|Overall Study|Lack of Efficacy|0|||
46958688|NCT00495131|83200213|FG001|Overall Study|Lack of Efficacy|2|||
46958689|NCT00495131|83200212|FG000|Overall Study|Lost to Follow-up|0|||
46958690|NCT00495131|83200213|FG001|Overall Study|Lost to Follow-up|2|||
46958691|NCT00495131|83200212|FG000|Overall Study|Withdrawal by Subject|1|||
46958692|NCT00495131|83200213|FG001|Overall Study|Withdrawal by Subject|0|||
46958693|NCT02257372|83200219|FG000|Overall Study|Adverse Event|3|||
46958694|NCT02257372|83200220|FG001|Overall Study|Adverse Event|7|||
46958695|NCT02257372|83200219|FG000|Overall Study|Lack of Efficacy|2|||
46958696|NCT02257372|83200220|FG001|Overall Study|Lack of Efficacy|1|||
46958697|NCT02257372|83200219|FG000|Overall Study|Protocol Violation|1|||
46958698|NCT02257372|83200220|FG001|Overall Study|Protocol Violation|1|||
46958699|NCT02257372|83200219|FG000|Overall Study|Lost to Follow-up|0|||
46958700|NCT02257372|83200220|FG001|Overall Study|Lost to Follow-up|1|||
46958701|NCT02257372|83200219|FG000|Overall Study|Withdrew consent|1|||
46958702|NCT02257372|83200220|FG001|Overall Study|Withdrew consent|0|||
46958703|NCT02256982|83200228|FG000|Overall Study|Disease Progression|0|||
46958704|NCT02256982|83200229|FG001|Overall Study|Disease Progression|1|||
46958705|NCT02736721|83200235|FG000|Overall Study|Adverse Event|8|||
46958706|NCT02736721|83200235|FG000|Overall Study|Lost to Follow-up|3|||
46958707|NCT02736721|83200235|FG000|Overall Study|Other|5|||
46958708|NCT04176445|83200239|FG000|Overall Study|Adverse Event|0|||
46773803|NCT00743288|82992129|FG001|Overall Study|Worsening of condition (Not PD)|2|||
46773804|NCT00743288|82992130|FG002|Overall Study|Worsening of condition (Not PD)|1|||
46958709|NCT04176445|83200240|FG001|Overall Study|Adverse Event|1|||
46639989|NCT00087516|82813989|FG002|Overall Study|Withdrawal by Subject|11|||
46773805|NCT00743288|82992131|FG003|Overall Study|Worsening of condition (Not PD)|1|||
46958710|NCT04176445|83200239|FG000|Overall Study|change plans weaning after first intervention|0|||
46773806|NCT00743288|82992132|FG004|Overall Study|Worsening of condition (Not PD)|0|||
46958711|NCT04176445|83200240|FG001|Overall Study|change plans weaning after first intervention|1|||
46958712|NCT02738203|83200248|FG000|Overall Study|Failed IUD Insertion|2|||
46958713|NCT02738203|83200249|FG001|Overall Study|Failed IUD Insertion|2|||
46958714|NCT02738203|83200248|FG000|Overall Study|Protocol Violation|0|||
46958715|NCT02738203|83200249|FG001|Overall Study|Protocol Violation|1|||
46958716|NCT02452034|83200261|FG000|Overall Study|Adverse Event|0|||
46958717|NCT02452034|83200262|FG001|Overall Study|Adverse Event|0|||
46958718|NCT02452034|83200263|FG002|Overall Study|Adverse Event|0|||
46958719|NCT02452034|83200264|FG003|Overall Study|Adverse Event|0|||
46773807|NCT00743288|82992133|FG005|Overall Study|Worsening of condition (Not PD)|0|||
46958720|NCT02452034|83200265|FG004|Overall Study|Adverse Event|0|||
46958721|NCT02452034|83200266|FG005|Overall Study|Adverse Event|1|||
46958722|NCT02452034|83200261|FG000|Overall Study|Death|0|||
46958723|NCT02452034|83200262|FG001|Overall Study|Death|0|||
46958724|NCT02452034|83200263|FG002|Overall Study|Death|0|||
46958725|NCT02452034|83200264|FG003|Overall Study|Death|0|||
46958726|NCT02452034|83200265|FG004|Overall Study|Death|1|||
46958727|NCT02452034|83200266|FG005|Overall Study|Death|1|||
46958728|NCT02452034|83200261|FG000|Overall Study|Physician Decision|0|||
46958729|NCT02452034|83200262|FG001|Overall Study|Physician Decision|1|||
46958730|NCT02452034|83200263|FG002|Overall Study|Physician Decision|1|||
46958731|NCT02452034|83200264|FG003|Overall Study|Physician Decision|0|||
46958732|NCT02452034|83200265|FG004|Overall Study|Physician Decision|0|||
46958733|NCT02452034|83200266|FG005|Overall Study|Physician Decision|0|||
46958734|NCT02452034|83200261|FG000|Overall Study|Protocol Violation|0|||
46958735|NCT02452034|83200262|FG001|Overall Study|Protocol Violation|0|||
46958736|NCT02452034|83200263|FG002|Overall Study|Protocol Violation|0|||
46958737|NCT02452034|83200264|FG003|Overall Study|Protocol Violation|0|||
46958738|NCT02452034|83200265|FG004|Overall Study|Protocol Violation|0|||
46958739|NCT02452034|83200266|FG005|Overall Study|Protocol Violation|1|||
46958740|NCT02452034|83200261|FG000|Overall Study|Screen Failure|1|||
46958741|NCT02452034|83200262|FG001|Overall Study|Screen Failure|0|||
46958742|NCT02452034|83200263|FG002|Overall Study|Screen Failure|0|||
46958743|NCT02452034|83200264|FG003|Overall Study|Screen Failure|1|||
46958744|NCT02452034|83200265|FG004|Overall Study|Screen Failure|0|||
46958745|NCT02452034|83200266|FG005|Overall Study|Screen Failure|0|||
46958746|NCT02452034|83200261|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
46958747|NCT02452034|83200262|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
46958748|NCT02452034|83200263|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
46958749|NCT02452034|83200264|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
46958750|NCT02452034|83200265|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
46958751|NCT02452034|83200266|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
46958752|NCT02482298|83200293|FG000|Overall Study|Withdrawal by Subject|2|||
46958753|NCT02482298|83200294|FG001|Overall Study|Withdrawal by Subject|1|||
46958754|NCT02482298|83200295|FG002|Overall Study|Withdrawal by Subject|2|||
46958755|NCT02482298|83200293|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
46958756|NCT02482298|83200294|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
46958757|NCT02482298|83200295|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
46958758|NCT02482298|83200293|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
46958759|NCT02482298|83200294|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
46958760|NCT02482298|83200295|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
46958761|NCT02482298|83200293|FG000|Overall Study|Lost to Follow-up|0|||
46958762|NCT02482298|83200294|FG001|Overall Study|Lost to Follow-up|1|||
46958763|NCT02482298|83200295|FG002|Overall Study|Lost to Follow-up|0|||
46958764|NCT00440531|83200306|FG000|Overall Study|Adverse Event|1|||
46958765|NCT00440531|83200307|FG001|Overall Study|Adverse Event|0|||
46958766|NCT00440531|83200308|FG002|Overall Study|Adverse Event|2|||
46958767|NCT00440531|83200306|FG000|Overall Study|Withdrawal by Subject|2|||
46958768|NCT00440531|83200307|FG001|Overall Study|Withdrawal by Subject|0|||
46958769|NCT00440531|83200308|FG002|Overall Study|Withdrawal by Subject|0|||
46958770|NCT00440531|83200306|FG000|Overall Study|Protocol Violation|1|||
46958771|NCT00440531|83200307|FG001|Overall Study|Protocol Violation|2|||
46958772|NCT00440531|83200308|FG002|Overall Study|Protocol Violation|0|||
46958773|NCT00440531|83200306|FG000|Overall Study|Lost to Follow-up|4|||
46958774|NCT00440531|83200307|FG001|Overall Study|Lost to Follow-up|3|||
46958775|NCT00440531|83200308|FG002|Overall Study|Lost to Follow-up|5|||
46958776|NCT00440531|83200306|FG000|Overall Study|see pre-assignment details|2|||
46958777|NCT00440531|83200307|FG001|Overall Study|see pre-assignment details|0|||
46958778|NCT00440531|83200308|FG002|Overall Study|see pre-assignment details|0|||
46958779|NCT02513732|83200314|FG000|Overall Study|Lost to Follow-up|11|||
47067041|NCT01448057|83350426|FG000|Overall Study|Adverse Event|0|||
47067042|NCT01448057|83350427|FG001|Overall Study|Adverse Event|2|||
46773808|NCT00743288|82992134|FG006|Overall Study|Worsening of condition (Not PD)|0|||
47067043|NCT01448057|83350426|FG000|Overall Study|Withdrawal by Subject|2|||
47067044|NCT01448057|83350427|FG001|Overall Study|Withdrawal by Subject|0|||
46958780|NCT02513732|83200314|FG000|Overall Study|Death|9|||
46958781|NCT02513732|83200314|FG000|Overall Study|Changing hospital|2|||
46958782|NCT00429923|83200321|FG000|Overall Study|Adverse Event|0|||
46773809|NCT00750308|82992145|FG000|First Treatment|Adverse Event|0|||
46958783|NCT00429923|83200322|FG001|Overall Study|Adverse Event|2|||
46958784|NCT00429923|83200323|FG002|Overall Study|Adverse Event|3|||
46958785|NCT00429923|83200321|FG000|Overall Study|Lack of Efficacy|4|||
46958786|NCT00429923|83200322|FG001|Overall Study|Lack of Efficacy|1|||
46958787|NCT00429923|83200323|FG002|Overall Study|Lack of Efficacy|33|||
46958788|NCT00429923|83200321|FG000|Overall Study|Lost to Follow-up|0|||
46958789|NCT00429923|83200322|FG001|Overall Study|Lost to Follow-up|0|||
46958790|NCT00429923|83200323|FG002|Overall Study|Lost to Follow-up|2|||
46958791|NCT00429923|83200321|FG000|Overall Study|Withdrew Consent|1|||
46958792|NCT00429923|83200322|FG001|Overall Study|Withdrew Consent|0|||
46958793|NCT00429923|83200323|FG002|Overall Study|Withdrew Consent|1|||
46958794|NCT00429923|83200321|FG000|Overall Study|Early Termination|0|||
46958795|NCT00429923|83200322|FG001|Overall Study|Early Termination|1|||
46958796|NCT00429923|83200323|FG002|Overall Study|Early Termination|0|||
46958797|NCT02256436|83200330|FG000|Overall Study|Adverse Event|9|||
46958798|NCT02256436|83200331|FG001|Overall Study|Adverse Event|14|||
46958799|NCT02256436|83200330|FG000|Overall Study|Death|216|||
46958800|NCT02256436|83200331|FG001|Overall Study|Death|208|||
46958801|NCT02256436|83200330|FG000|Overall Study|Lost to Follow-up|1|||
46958802|NCT02256436|83200331|FG001|Overall Study|Lost to Follow-up|2|||
46958803|NCT02256436|83200330|FG000|Overall Study|Physician Decision|1|||
46958804|NCT02256436|83200331|FG001|Overall Study|Physician Decision|0|||
46958805|NCT02256436|83200330|FG000|Overall Study|Protocol Violation|0|||
46958806|NCT02256436|83200331|FG001|Overall Study|Protocol Violation|1|||
46958807|NCT02256436|83200330|FG000|Overall Study|Withdrawal by Subject|26|||
46958808|NCT02256436|83200331|FG001|Overall Study|Withdrawal by Subject|10|||
46958809|NCT02256436|83200330|FG000|Overall Study|Transferred to Extension Study|11|||
46958810|NCT02256436|83200331|FG001|Overall Study|Transferred to Extension Study|23|||
46958811|NCT02256436|83200330|FG000|Overall Study|Did Not Continue on Extension Study|8|||
46958812|NCT02256436|83200331|FG001|Overall Study|Did Not Continue on Extension Study|12|||
46958813|NCT00326183|83200340|FG000|Overall Study|Lost to Follow-up|104|||
46958814|NCT00326183|83200341|FG001|Overall Study|Lost to Follow-up|56|||
46958815|NCT00326183|83200340|FG000|Overall Study|Protocol Violation|6|||
46958816|NCT00326183|83200341|FG001|Overall Study|Protocol Violation|3|||
46958817|NCT00326183|83200340|FG000|Overall Study|Withdrawal by Subject|35|||
46958818|NCT00326183|83200341|FG001|Overall Study|Withdrawal by Subject|7|||
46958819|NCT00326183|83200340|FG000|Overall Study|Subject Moved|7|||
46958820|NCT00326183|83200341|FG001|Overall Study|Subject Moved|4|||
46958821|NCT00326183|83200340|FG000|Overall Study|Other|47|||
46958822|NCT00326183|83200341|FG001|Overall Study|Other|13|||
46958823|NCT00326183|83200340|FG000|Overall Study|Adverse Event|1|||
46958824|NCT00326183|83200341|FG001|Overall Study|Adverse Event|0|||
46958825|NCT02481050|83200345|FG000|Overall Study|Adverse Event|1|||
46958826|NCT02481050|83200345|FG000|Overall Study|Disease Progression|47|||
46958827|NCT02481050|83200345|FG000|Overall Study|Withdrawal by Subject|7|||
46958828|NCT02481050|83200345|FG000|Overall Study|Other|3|||
46958829|NCT02511782|83200352|FG000|Overall Study|Withdrawal by Subject|1|||
46958830|NCT02511782|83200353|FG001|Overall Study|Withdrawal by Subject|0|||
46958831|NCT02511782|83200354|FG002|Overall Study|Withdrawal by Subject|0|||
46958832|NCT02480114|83200364|FG000|Overall Study|Not completing surveys|3|||
46958833|NCT02480114|83200365|FG001|Overall Study|Not completing surveys|2|||
46958834|NCT02480114|83200364|FG000|Overall Study|Withdrawal by Subject|2|||
46958835|NCT02480114|83200365|FG001|Overall Study|Withdrawal by Subject|4|||
46958836|NCT02480114|83200364|FG000|Overall Study|Disease progression|3|||
46958837|NCT02480114|83200365|FG001|Overall Study|Disease progression|0|||
46958838|NCT02480114|83200364|FG000|Overall Study|Improper completion of survey|1|||
46958839|NCT02480114|83200365|FG001|Overall Study|Improper completion of survey|1|||
46958840|NCT02480114|83200364|FG000|Overall Study|Not eligible|0|||
46958841|NCT02480114|83200365|FG001|Overall Study|Not eligible|1|||
46958842|NCT02479880|83200373|FG000|Overall Study|Study Terminated by Sponsor|13|||
46958843|NCT02479880|83200374|FG001|Overall Study|Study Terminated by Sponsor|12|||
46958844|NCT02479880|83200373|FG000|Overall Study|Pregnancy|0|||
46958845|NCT02479880|83200374|FG001|Overall Study|Pregnancy|1|||
46958846|NCT02479802|83200380|FG000|Overall Study|Lost to Follow-up|1|||
46958847|NCT02479802|83200380|FG000|Overall Study|Adverse Event|1|||
46958848|NCT02479412|83200393|FG000|Overall Study|Adverse Event|0|||
46958849|NCT02479412|83200394|FG001|Overall Study|Adverse Event|0|||
46958850|NCT02479412|83200395|FG002|Overall Study|Adverse Event|1|||
46958851|NCT02479412|83200396|FG003|Overall Study|Adverse Event|0|||
46958852|NCT02479412|83200397|FG004|Overall Study|Adverse Event|0|||
46958853|NCT02479412|83200398|FG005|Overall Study|Adverse Event|0|||
46958854|NCT02479412|83200399|FG006|Overall Study|Adverse Event|0|||
46958855|NCT02479412|83200400|FG007|Overall Study|Adverse Event|0|||
46958856|NCT02479412|83200401|FG008|Overall Study|Adverse Event|0|||
46958857|NCT02479412|83200393|FG000|Overall Study|Study-specific withdrawal criteria|0|||
46958858|NCT02479412|83200394|FG001|Overall Study|Study-specific withdrawal criteria|0|||
46958859|NCT02479412|83200395|FG002|Overall Study|Study-specific withdrawal criteria|1|||
46958860|NCT02479412|83200396|FG003|Overall Study|Study-specific withdrawal criteria|1|||
46958861|NCT02479412|83200397|FG004|Overall Study|Study-specific withdrawal criteria|0|||
46958862|NCT02479412|83200398|FG005|Overall Study|Study-specific withdrawal criteria|0|||
46958863|NCT02479412|83200399|FG006|Overall Study|Study-specific withdrawal criteria|0|||
46958864|NCT02479412|83200400|FG007|Overall Study|Study-specific withdrawal criteria|1|||
46958865|NCT02479412|83200401|FG008|Overall Study|Study-specific withdrawal criteria|1|||
46958866|NCT02479412|83200393|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
46958867|NCT02479412|83200394|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
46958868|NCT02479412|83200395|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
47067045|NCT01447433|83350435|FG000|Overall Study|Lost to Follow-up|0|||
46958869|NCT02479412|83200396|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
46958870|NCT02479412|83200397|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
46958871|NCT02479412|83200398|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
46958872|NCT02479412|83200399|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
46958873|NCT02479412|83200400|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
46958874|NCT02479412|83200401|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
46958875|NCT00224003|83200417|FG000|Overall Study|Adverse Event|1|||
46958876|NCT00224003|83200417|FG000|Overall Study|Protocol Violation|2|||
46958877|NCT00224003|83200417|FG000|Overall Study|Withdrawal by Subject|1|||
46958878|NCT00224003|83200417|FG000|Overall Study|unk|3|||
46958879|NCT02450552|83200423|FG000|Overall Study|Withdrawal by Subject|4|||
46958880|NCT02450552|83200424|FG001|Overall Study|Withdrawal by Subject|0|||
46958881|NCT02450552|83200425|FG002|Overall Study|Withdrawal by Subject|4|||
46958882|NCT02450552|83200423|FG000|Overall Study|Physician Decision|1|||
46958883|NCT02450552|83200424|FG001|Overall Study|Physician Decision|0|||
46958884|NCT02450552|83200425|FG002|Overall Study|Physician Decision|1|||
46958885|NCT02508428|83200435|FG000|Overall Study|Death|32|||
46958886|NCT02508428|83200436|FG001|Overall Study|Death|33|||
46958887|NCT02508428|83200435|FG000|Overall Study|Liner revised|3|||
46958888|NCT02508428|83200436|FG001|Overall Study|Liner revised|19|||
46958889|NCT02508428|83200435|FG000|Overall Study|Incomplete follow-up|17|||
46958890|NCT02508428|83200436|FG001|Overall Study|Incomplete follow-up|15|||
46958891|NCT02448680|83200444|FG000|Overall Study|Physician Decision|1|||
46958892|NCT02448680|83200445|FG001|Overall Study|Physician Decision|1|||
46958893|NCT02448680|83200444|FG000|Overall Study|Withdrawal by Subject|0|||
46958894|NCT02448680|83200445|FG001|Overall Study|Withdrawal by Subject|2|||
46958895|NCT02448446|83200455|FG000|Overall Study|Withdrawal by Subject|1|||
46958896|NCT02448446|83200456|FG001|Overall Study|Withdrawal by Subject|0|||
46845069|NCT03725722|83061907|FG003|Overall Study|Personal reasons|0|||
46845070|NCT03725722|83061908|FG004|Overall Study|Personal reasons|1|||
46845071|NCT03725722|83061904|FG000|Overall Study|COVID-19 situation|0|||
46845072|NCT03725722|83061905|FG001|Overall Study|COVID-19 situation|1|||
46845073|NCT03725722|83061906|FG002|Overall Study|COVID-19 situation|0|||
46845074|NCT03725722|83061907|FG003|Overall Study|COVID-19 situation|0|||
46845075|NCT03725722|83061908|FG004|Overall Study|COVID-19 situation|0|||
46845076|NCT02966314|83061922|FG000|Overall Study|Lost to Follow-up|1|||
46845077|NCT02966314|83061923|FG001|Overall Study|Lost to Follow-up|0|||
46845078|NCT03723070|83061929|FG000|Overall Study|Lost to Follow-up|2|||
46845079|NCT03723070|83061929|FG000|Overall Study|Physician Decision|1|||
46845080|NCT03723070|83061929|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
46845081|NCT03722524|83061937|FG000|Overall Study|Protocol Violation|86|||
46845082|NCT03722524|83061937|FG000|Overall Study|Adverse Event|7|||
46845083|NCT03722524|83061937|FG000|Overall Study|Lost to Follow-up|1|||
46845084|NCT03722524|83061937|FG000|Overall Study|Reason is not stated|1|||
46845085|NCT03722524|83061937|FG000|Overall Study|Physician Decision|1|||
46845086|NCT03722524|83061937|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
46845087|NCT03722446|83061943|FG000|Overall Study|Protocol Violation|15|||
46845088|NCT03722446|83061944|FG001|Overall Study|Protocol Violation|2|||
46845089|NCT00146172|83061958|FG000|Overall Study|Adverse Event|0|||
46845090|NCT00146172|83061959|FG001|Overall Study|Adverse Event|0|||
46845091|NCT00146172|83061960|FG002|Overall Study|Adverse Event|1|||
46845092|NCT00146172|83061961|FG003|Overall Study|Adverse Event|1|||
46845093|NCT00146172|83061962|FG004|Overall Study|Adverse Event|0|||
46845094|NCT00146172|83061963|FG005|Overall Study|Adverse Event|2|||
46845095|NCT00146172|83061964|FG006|Overall Study|Adverse Event|3|||
46845096|NCT00146172|83061965|FG007|Overall Study|Adverse Event|10|||
46845097|NCT00146172|83061958|FG000|Overall Study|Lost to Follow-up|0|||
46845098|NCT00146172|83061959|FG001|Overall Study|Lost to Follow-up|0|||
46845099|NCT00146172|83061960|FG002|Overall Study|Lost to Follow-up|0|||
46845100|NCT00146172|83061961|FG003|Overall Study|Lost to Follow-up|0|||
46845101|NCT00146172|83061962|FG004|Overall Study|Lost to Follow-up|0|||
46845102|NCT00146172|83061963|FG005|Overall Study|Lost to Follow-up|0|||
46845103|NCT00146172|83061964|FG006|Overall Study|Lost to Follow-up|0|||
46845104|NCT00146172|83061965|FG007|Overall Study|Lost to Follow-up|1|||
46845105|NCT00146172|83061958|FG000|Overall Study|Disease Progression|2|||
46845106|NCT00146172|83061959|FG001|Overall Study|Disease Progression|4|||
46845107|NCT00146172|83061960|FG002|Overall Study|Disease Progression|2|||
46845108|NCT00146172|83061961|FG003|Overall Study|Disease Progression|5|||
46958897|NCT02447744|83200464|FG000|Overall Study|Withdrawal by Subject|3|||
46958898|NCT02447744|83200465|FG001|Overall Study|Withdrawal by Subject|1|||
46845109|NCT00146172|83061962|FG004|Overall Study|Disease Progression|2|||
46845110|NCT00146172|83061963|FG005|Overall Study|Disease Progression|2|||
46845111|NCT00146172|83061964|FG006|Overall Study|Disease Progression|1|||
46845112|NCT00146172|83061965|FG007|Overall Study|Disease Progression|22|||
46845113|NCT00146172|83061958|FG000|Overall Study|Death|0|||
46958899|NCT02447744|83200464|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
46958900|NCT02447744|83200465|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
47067046|NCT01447433|83350436|FG001|Overall Study|Lost to Follow-up|2|||
46958901|NCT02478632|83200473|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
46958902|NCT02478632|83200474|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
46958903|NCT02478632|83200473|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
46958904|NCT02478632|83200474|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
46958905|NCT02478632|83200473|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
46958906|NCT02478632|83200474|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
46958907|NCT02478398|83200485|FG000|Overall Study|Adverse Event|20|||
46958908|NCT02478398|83200486|FG001|Overall Study|Adverse Event|5|||
46958909|NCT02478398|83200485|FG000|Overall Study|Lost to Follow-up|5|||
46958910|NCT02478398|83200486|FG001|Overall Study|Lost to Follow-up|4|||
46958911|NCT02478398|83200485|FG000|Overall Study|Non-Compliance With Study Drug|5|||
46958912|NCT02478398|83200486|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46958913|NCT02478398|83200485|FG000|Overall Study|Protocol Violation|3|||
46958914|NCT02478398|83200486|FG001|Overall Study|Protocol Violation|1|||
46958915|NCT02478398|83200485|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
46958916|NCT02478398|83200486|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
46958917|NCT02478398|83200485|FG000|Overall Study|Withdrawal By Participant|10|||
46958918|NCT02478398|83200486|FG001|Overall Study|Withdrawal By Participant|4|||
46958919|NCT02478164|83200493|FG000|Overall Study|Lack of Efficacy|13|||
46958920|NCT02478164|83200493|FG000|Overall Study|Adverse Event|1|||
46958921|NCT02478164|83200493|FG000|Overall Study|Withdrawal by Subject|1|||
46958922|NCT02476994|83200499|FG000|Overall Study|Based on feedback from FDA|1|||
46958923|NCT02476994|83200500|FG001|Overall Study|Based on feedback from FDA|0|||
46958924|NCT02508194|83200508|FG000|Overall Study|Death|5|||
46958925|NCT02508194|83200509|FG001|Overall Study|Death|3|||
46958926|NCT02508194|83200508|FG000|Overall Study|Lost to Follow-up|25|||
46958927|NCT02508194|83200509|FG001|Overall Study|Lost to Follow-up|18|||
46958928|NCT02508194|83200508|FG000|Overall Study|Withdrawal by Subject|20|||
46958929|NCT02508194|83200509|FG001|Overall Study|Withdrawal by Subject|18|||
46958930|NCT02508194|83200508|FG000|Overall Study|Error in Randomization|1|||
46958931|NCT02508194|83200509|FG001|Overall Study|Error in Randomization|3|||
46958932|NCT02508194|83200508|FG000|Overall Study|Principal Investigator Decision|1|||
47067047|NCT01447433|83350435|FG000|Overall Study|Withdrawal by Subject|3|||
47067048|NCT01447433|83350436|FG001|Overall Study|Withdrawal by Subject|3|||
47067049|NCT01447433|83350435|FG000|Overall Study|Protocol Violation|1|||
47067050|NCT01447433|83350436|FG001|Overall Study|Protocol Violation|1|||
46958933|NCT02508194|83200509|FG001|Overall Study|Principal Investigator Decision|2|||
46958934|NCT02508116|83200517|FG000|Overall Study|Lost to Follow-up|2|||
46958935|NCT02508116|83200518|FG001|Overall Study|Lost to Follow-up|3|||
47067051|NCT01446965|83350444|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
47067052|NCT01446965|83350445|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
47067053|NCT01446965|83350444|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
47067054|NCT01446965|83350445|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
47067055|NCT01446809|83350453|FG000|Overall Study|Adverse Event|0|||
47067056|NCT01446809|83350454|FG001|Overall Study|Adverse Event|0|||
47067057|NCT01446809|83350455|FG002|Overall Study|Adverse Event|1|||
46958936|NCT02508116|83200517|FG000|Overall Study|Withdrawal by Subject|3|||
46958937|NCT02508116|83200518|FG001|Overall Study|Withdrawal by Subject|2|||
46958938|NCT02508116|83200517|FG000|Overall Study|Protocol Violation|1|||
46958939|NCT02508116|83200518|FG001|Overall Study|Protocol Violation|2|||
46958940|NCT02508116|83200517|FG000|Overall Study|Physician Decision|2|||
46958941|NCT02508116|83200518|FG001|Overall Study|Physician Decision|0|||
46958942|NCT01653782|83200527|FG000|Overall Study|Withdrawal by Subject|9|||
46958943|NCT01653782|83200528|FG001|Overall Study|Withdrawal by Subject|15|||
46958944|NCT01653782|83200529|FG002|Overall Study|Withdrawal by Subject|4|||
46958945|NCT01653782|83200527|FG000|Overall Study|Lost to Follow-up|7|||
46958946|NCT01653782|83200528|FG001|Overall Study|Lost to Follow-up|3|||
46958947|NCT01653782|83200529|FG002|Overall Study|Lost to Follow-up|2|||
46958948|NCT02318329|83200547|FG000|Overall Study|Progressive Disease|2|||
46958949|NCT02318329|83200548|FG001|Overall Study|Progressive Disease|3|||
46958950|NCT02318329|83200549|FG002|Overall Study|Progressive Disease|2|||
47067058|NCT01446809|83350453|FG000|Overall Study|Failure to complete study procedures|0|||
47067059|NCT01446809|83350454|FG001|Overall Study|Failure to complete study procedures|0|||
46773810|NCT00750308|82992146|FG001|First Treatment|Adverse Event|1|||
46773811|NCT00750308|82992147|FG002|First Treatment|Adverse Event|0|||
47067060|NCT01446809|83350455|FG002|Overall Study|Failure to complete study procedures|1|||
46773812|NCT00750308|82992148|FG003|First Treatment|Adverse Event|0|||
46773813|NCT00750308|82992149|FG004|First Treatment|Adverse Event|0|||
46958951|NCT02318329|83200550|FG003|Overall Study|Progressive Disease|3|||
46958952|NCT02318329|83200551|FG004|Overall Study|Progressive Disease|3|||
46958953|NCT02318329|83200552|FG005|Overall Study|Progressive Disease|3|||
46958954|NCT02318329|83200553|FG006|Overall Study|Progressive Disease|1|||
46958955|NCT02318329|83200554|FG007|Overall Study|Progressive Disease|1|||
46958956|NCT02318329|83200555|FG008|Overall Study|Progressive Disease|5|||
46958957|NCT02318329|83200556|FG009|Overall Study|Progressive Disease|39|||
46958958|NCT02318329|83200547|FG000|Overall Study|Death|0|||
46958959|NCT02318329|83200548|FG001|Overall Study|Death|0|||
46958960|NCT02318329|83200549|FG002|Overall Study|Death|0|||
46958961|NCT02318329|83200550|FG003|Overall Study|Death|0|||
46958962|NCT02318329|83200551|FG004|Overall Study|Death|0|||
46958963|NCT02318329|83200552|FG005|Overall Study|Death|0|||
46958964|NCT02318329|83200553|FG006|Overall Study|Death|0|||
46958965|NCT02318329|83200554|FG007|Overall Study|Death|0|||
46958966|NCT02318329|83200555|FG008|Overall Study|Death|0|||
46958967|NCT02318329|83200556|FG009|Overall Study|Death|5|||
46958968|NCT02318329|83200547|FG000|Overall Study|Lost to Follow-up|0|||
46958969|NCT02318329|83200548|FG001|Overall Study|Lost to Follow-up|0|||
46958970|NCT02318329|83200549|FG002|Overall Study|Lost to Follow-up|0|||
46958971|NCT02318329|83200550|FG003|Overall Study|Lost to Follow-up|0|||
46958972|NCT02318329|83200551|FG004|Overall Study|Lost to Follow-up|0|||
46958973|NCT02318329|83200552|FG005|Overall Study|Lost to Follow-up|0|||
46958974|NCT02318329|83200553|FG006|Overall Study|Lost to Follow-up|0|||
46958975|NCT02318329|83200554|FG007|Overall Study|Lost to Follow-up|0|||
46958976|NCT02318329|83200555|FG008|Overall Study|Lost to Follow-up|0|||
46958977|NCT02318329|83200556|FG009|Overall Study|Lost to Follow-up|1|||
46958978|NCT02318329|83200547|FG000|Overall Study|Withdrawal by Subject|0|||
46958979|NCT02318329|83200548|FG001|Overall Study|Withdrawal by Subject|0|||
46958980|NCT02318329|83200549|FG002|Overall Study|Withdrawal by Subject|0|||
46958981|NCT02318329|83200550|FG003|Overall Study|Withdrawal by Subject|0|||
46958982|NCT02318329|83200551|FG004|Overall Study|Withdrawal by Subject|0|||
46958983|NCT02318329|83200552|FG005|Overall Study|Withdrawal by Subject|0|||
46958984|NCT02318329|83200553|FG006|Overall Study|Withdrawal by Subject|0|||
46958985|NCT02318329|83200554|FG007|Overall Study|Withdrawal by Subject|0|||
46958986|NCT02318329|83200555|FG008|Overall Study|Withdrawal by Subject|0|||
46958987|NCT02318329|83200556|FG009|Overall Study|Withdrawal by Subject|6|||
46958988|NCT02318329|83200547|FG000|Overall Study|Other|1|||
46958989|NCT02318329|83200548|FG001|Overall Study|Other|1|||
46958990|NCT02318329|83200549|FG002|Overall Study|Other|1|||
46958991|NCT02318329|83200550|FG003|Overall Study|Other|0|||
46958992|NCT02318329|83200551|FG004|Overall Study|Other|0|||
46958993|NCT02318329|83200552|FG005|Overall Study|Other|0|||
46958994|NCT02318329|83200553|FG006|Overall Study|Other|0|||
46958995|NCT02318329|83200554|FG007|Overall Study|Other|0|||
46958996|NCT02318329|83200555|FG008|Overall Study|Other|1|||
46958997|NCT02318329|83200556|FG009|Overall Study|Other|1|||
46773814|NCT00750308|82992150|FG005|First Treatment|Adverse Event|0|||
46845114|NCT00146172|83061959|FG001|Overall Study|Death|0|||
46845115|NCT00146172|83061960|FG002|Overall Study|Death|0|||
46845116|NCT00146172|83061961|FG003|Overall Study|Death|0|||
46845117|NCT00146172|83061962|FG004|Overall Study|Death|0|||
46845118|NCT00146172|83061963|FG005|Overall Study|Death|0|||
46845119|NCT00146172|83061964|FG006|Overall Study|Death|1|||
46845120|NCT00146172|83061965|FG007|Overall Study|Death|0|||
46845121|NCT00146172|83061958|FG000|Overall Study|Physician Decision|0|||
46845122|NCT00146172|83061959|FG001|Overall Study|Physician Decision|0|||
46845123|NCT00146172|83061960|FG002|Overall Study|Physician Decision|0|||
46958998|NCT02255656|83200597|FG000|Overall Study|Adverse Event|11|||
46958999|NCT02255656|83200597|FG000|Overall Study|Poor compliance to protocol|3|||
46959000|NCT02255656|83200597|FG000|Overall Study|Lost to Follow-up|30|||
46959001|NCT02255656|83200597|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
46773815|NCT00750308|82992151|FG006|First Treatment|Adverse Event|0|||
46773816|NCT00750308|82992152|FG007|First Treatment|Adverse Event|0|||
46773817|NCT00750308|82992153|FG008|First Treatment|Adverse Event|0|||
46773818|NCT00750308|82992154|FG009|First Treatment|Adverse Event|0|||
46773819|NCT00750308|82992155|FG010|First Treatment|Adverse Event|1|||
46773820|NCT00750308|82992156|FG011|First Treatment|Adverse Event|1|||
46773821|NCT00750308|82992145|FG000|First Treatment|Withdrawal by Subject|0|||
46773822|NCT00750308|82992146|FG001|First Treatment|Withdrawal by Subject|0|||
46773823|NCT00750308|82992147|FG002|First Treatment|Withdrawal by Subject|0|||
46773824|NCT00750308|82992148|FG003|First Treatment|Withdrawal by Subject|1|||
46773825|NCT00750308|82992149|FG004|First Treatment|Withdrawal by Subject|0|||
46773826|NCT00750308|82992150|FG005|First Treatment|Withdrawal by Subject|0|||
46773827|NCT00750308|82992151|FG006|First Treatment|Withdrawal by Subject|0|||
46959002|NCT02255656|83200597|FG000|Overall Study|Other|126|||
46959003|NCT02255500|83200610|FG000|Overall Study|Withdrawal by Subject|1|||
46773828|NCT00750308|82992152|FG007|First Treatment|Withdrawal by Subject|1|||
46959004|NCT02255500|83200611|FG001|Overall Study|Withdrawal by Subject|0|||
46959005|NCT02505542|83200617|FG000|Part A: Open-Label Period|Adverse Event|31|||
46845124|NCT00146172|83061961|FG003|Overall Study|Physician Decision|0|||
46845125|NCT00146172|83061962|FG004|Overall Study|Physician Decision|0|||
46959006|NCT02505542|83200618|FG001|Part A: Open-Label Period|Adverse Event|0|||
46959007|NCT02505542|83200619|FG002|Part A: Open-Label Period|Adverse Event|0|||
46959008|NCT02505542|83200620|FG003|Part A: Open-Label Period|Adverse Event|0|||
46959009|NCT02505542|83200617|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
46959010|NCT02505542|83200618|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
46959011|NCT02505542|83200619|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
46845126|NCT00146172|83061963|FG005|Overall Study|Physician Decision|0|||
46845127|NCT00146172|83061964|FG006|Overall Study|Physician Decision|0|||
46845128|NCT00146172|83061965|FG007|Overall Study|Physician Decision|1|||
46845129|NCT00146172|83061958|FG000|Overall Study|Withdrawal by Subject|0|||
46845130|NCT00146172|83061959|FG001|Overall Study|Withdrawal by Subject|0|||
46845131|NCT00146172|83061960|FG002|Overall Study|Withdrawal by Subject|0|||
46845132|NCT00146172|83061961|FG003|Overall Study|Withdrawal by Subject|0|||
46845133|NCT00146172|83061962|FG004|Overall Study|Withdrawal by Subject|0|||
46959012|NCT02505542|83200620|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
46959013|NCT02505542|83200617|FG000|Part A: Open-Label Period|Protocol Violation|1|||
46959014|NCT02505542|83200618|FG001|Part A: Open-Label Period|Protocol Violation|0|||
46959015|NCT02505542|83200619|FG002|Part A: Open-Label Period|Protocol Violation|0|||
46959016|NCT02505542|83200620|FG003|Part A: Open-Label Period|Protocol Violation|0|||
46959017|NCT02505542|83200617|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
46639990|NCT00087516|82813990|FG003|Overall Study|Withdrawal by Subject|12|||
46639991|NCT00087516|82813987|FG000|Overall Study|Site terminated|0|||
46639992|NCT00087516|82813988|FG001|Overall Study|Site terminated|2|||
46639993|NCT00087516|82813989|FG002|Overall Study|Site terminated|1|||
46639994|NCT00087516|82813990|FG003|Overall Study|Site terminated|0|||
46639995|NCT00087516|82813987|FG000|Overall Study|Protocol specified discontinuation|35|||
46639996|NCT00087516|82813988|FG001|Overall Study|Protocol specified discontinuation|33|||
46639997|NCT00087516|82813989|FG002|Overall Study|Protocol specified discontinuation|33|||
46773829|NCT00750308|82992153|FG008|First Treatment|Withdrawal by Subject|0|||
46773830|NCT00750308|82992154|FG009|First Treatment|Withdrawal by Subject|0|||
46845134|NCT00146172|83061963|FG005|Overall Study|Withdrawal by Subject|1|||
46845135|NCT00146172|83061964|FG006|Overall Study|Withdrawal by Subject|1|||
46959018|NCT02505542|83200618|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
46959019|NCT02505542|83200619|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
46959020|NCT02505542|83200620|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
46959021|NCT02505542|83200617|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
46959022|NCT02505542|83200618|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
46959023|NCT02505542|83200619|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
46959024|NCT02505542|83200620|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
46959025|NCT02505542|83200617|FG000|Part A: Open-Label Period|New medical history available|1|||
46959026|NCT02505542|83200618|FG001|Part A: Open-Label Period|New medical history available|0|||
46959027|NCT02505542|83200619|FG002|Part A: Open-Label Period|New medical history available|0|||
46959028|NCT02505542|83200620|FG003|Part A: Open-Label Period|New medical history available|0|||
46959029|NCT02505542|83200617|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
46959030|NCT02505542|83200618|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
46959031|NCT02505542|83200619|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
46959032|NCT02505542|83200620|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
46959033|NCT02505542|83200617|FG000|Part A: Open-Label Period|Pregnancy|2|||
46959034|NCT02505542|83200618|FG001|Part A: Open-Label Period|Pregnancy|0|||
46959035|NCT02505542|83200619|FG002|Part A: Open-Label Period|Pregnancy|0|||
46959036|NCT02505542|83200620|FG003|Part A: Open-Label Period|Pregnancy|0|||
46959037|NCT02505542|83200617|FG000|Part A: Open-Label Period|Sponsor directive|1|||
46845136|NCT00146172|83061965|FG007|Overall Study|Withdrawal by Subject|4|||
46959038|NCT02505542|83200618|FG001|Part A: Open-Label Period|Sponsor directive|0|||
46959039|NCT02505542|83200619|FG002|Part A: Open-Label Period|Sponsor directive|0|||
46959040|NCT02505542|83200620|FG003|Part A: Open-Label Period|Sponsor directive|0|||
46959041|NCT02505542|83200617|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
46959042|NCT02505542|83200618|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
46959043|NCT02505542|83200619|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
46959044|NCT02505542|83200620|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
46959045|NCT02505542|83200617|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
46959046|NCT02505542|83200618|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
46773831|NCT00750308|82992155|FG010|First Treatment|Withdrawal by Subject|0|||
46773832|NCT00750308|82992156|FG011|First Treatment|Withdrawal by Subject|0|||
46773833|NCT00750308|82992145|FG000|Second Treatment|Adverse Event|0|||
46773834|NCT00750308|82992146|FG001|Second Treatment|Adverse Event|0|||
46773835|NCT00750308|82992147|FG002|Second Treatment|Adverse Event|0|||
46773836|NCT00750308|82992148|FG003|Second Treatment|Adverse Event|0|||
46773837|NCT00750308|82992149|FG004|Second Treatment|Adverse Event|0|||
46773838|NCT00750308|82992150|FG005|Second Treatment|Adverse Event|1|||
46845137|NCT00146172|83061958|FG000|Overall Study|Symptomatic Deterioration|1|||
46845138|NCT00146172|83061959|FG001|Overall Study|Symptomatic Deterioration|0|||
46773839|NCT00750308|82992151|FG006|Second Treatment|Adverse Event|0|||
46845139|NCT00146172|83061960|FG002|Overall Study|Symptomatic Deterioration|1|||
46959047|NCT02505542|83200619|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
47067061|NCT01446419|83350466|FG000|Overall Study|Death|1|||
46639998|NCT00087516|82813990|FG003|Overall Study|Protocol specified discontinuation|26|||
46773840|NCT00750308|82992152|FG007|Second Treatment|Adverse Event|0|||
46959048|NCT02505542|83200620|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
46959049|NCT02505542|83200617|FG000|Part A: Open-Label Period|Non-compliance|1|||
46959050|NCT02505542|83200618|FG001|Part A: Open-Label Period|Non-compliance|0|||
46959051|NCT02505542|83200619|FG002|Part A: Open-Label Period|Non-compliance|0|||
46959052|NCT02505542|83200620|FG003|Part A: Open-Label Period|Non-compliance|0|||
46959053|NCT02505542|83200617|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
46959054|NCT02505542|83200618|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
46959055|NCT02505542|83200619|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
46959056|NCT02505542|83200620|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
46959057|NCT02505542|83200617|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
46959058|NCT02505542|83200618|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
46959059|NCT02505542|83200619|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
46959060|NCT02505542|83200620|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
46959061|NCT02505542|83200617|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
46959062|NCT02505542|83200618|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
46959063|NCT02505542|83200619|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
46959064|NCT02505542|83200620|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
46959065|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Adverse Event|0|||
46959066|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Adverse Event|0|||
46959067|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Adverse Event|1|||
46959068|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Adverse Event|3|||
46959069|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
46959070|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
46959071|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
46959072|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
46959073|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
46959074|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
46959075|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
46959076|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
46959077|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
46959078|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
46959079|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
46959080|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
46959081|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
46959082|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
46959083|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
46959084|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
46959085|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
46959086|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
46959087|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
46959088|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
46959089|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
46959090|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
46959091|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
46959092|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
46959093|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Miscalculation|0|||
46959094|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Miscalculation|1|||
46959095|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Miscalculation|0|||
46959096|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Miscalculation|0|||
46959097|NCT02505542|83200617|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
46959098|NCT02505542|83200618|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
46959099|NCT02505542|83200619|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
46959100|NCT02505542|83200620|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
46959101|NCT02475980|83200669|FG000|Overall Study|Lost to Follow-up|4|||
46959102|NCT02475980|83200669|FG000|Overall Study|Withdrawal by Subject|1|||
46959103|NCT02447432|83200675|FG000|Epoch 001|Adverse Event|1|||
46959104|NCT02447432|83200676|FG001|Epoch 001|Adverse Event|1|||
46959105|NCT02447432|83200675|FG000|Epoch 001|Withdrawal by Subject|0|||
46773841|NCT00750308|82992153|FG008|Second Treatment|Adverse Event|1|||
46959106|NCT02447432|83200676|FG001|Epoch 001|Withdrawal by Subject|4|||
46959107|NCT02447432|83200675|FG000|Epoch 001|Migrated/moved from study area|3|||
46959108|NCT02447432|83200676|FG001|Epoch 001|Migrated/moved from study area|5|||
46959109|NCT02447432|83200675|FG000|Epoch 001|Lost to Follow-up|1|||
46959110|NCT02447432|83200676|FG001|Epoch 001|Lost to Follow-up|3|||
46959111|NCT02446886|83200684|FG000|Overall Study|Adverse Event|1|||
46959112|NCT02446886|83200685|FG001|Overall Study|Adverse Event|3|||
46959113|NCT02446886|83200684|FG000|Overall Study|Withdrawal by Subject|1|||
46959114|NCT02446886|83200685|FG001|Overall Study|Withdrawal by Subject|1|||
47067062|NCT01446419|83350467|FG001|Overall Study|Death|0|||
46959115|NCT03448939|83200703|FG000|Overall Study|Adverse Event|5|||
46959116|NCT03448939|83200704|FG001|Overall Study|Adverse Event|1|||
46959117|NCT03448939|83200703|FG000|Overall Study|Lost to Follow-up|6|||
46959118|NCT03448939|83200704|FG001|Overall Study|Lost to Follow-up|6|||
46959119|NCT03448939|83200703|FG000|Overall Study|Pregnancy|1|||
46959120|NCT03448939|83200704|FG001|Overall Study|Pregnancy|1|||
46959121|NCT03448939|83200703|FG000|Overall Study|Withdrawal by Subject|9|||
46959122|NCT03448939|83200704|FG001|Overall Study|Withdrawal by Subject|3|||
46959123|NCT02504294|83200722|FG000|Overall Study|Adverse Event|15|||
46959124|NCT02504294|83200723|FG001|Overall Study|Adverse Event|12|||
46959125|NCT02504294|83200722|FG000|Overall Study|Withdrawal by Subject|7|||
46959126|NCT02504294|83200723|FG001|Overall Study|Withdrawal by Subject|1|||
46959127|NCT02504294|83200722|FG000|Overall Study|Protocol Violation|27|||
46959128|NCT02504294|83200723|FG001|Overall Study|Protocol Violation|26|||
46959129|NCT02504294|83200722|FG000|Overall Study|Physician Decision|1|||
46959130|NCT02504294|83200723|FG001|Overall Study|Physician Decision|2|||
46959131|NCT02504294|83200722|FG000|Overall Study|Lost to Follow-up|6|||
46959132|NCT02504294|83200723|FG001|Overall Study|Lost to Follow-up|7|||
46959133|NCT02446418|83200731|FG000|Overall Study|Adverse Event|4|||
46959134|NCT02446418|83200732|FG001|Overall Study|Adverse Event|8|||
46959135|NCT02446418|83200731|FG000|Overall Study|Physician Decision|5|||
46959136|NCT02446418|83200732|FG001|Overall Study|Physician Decision|1|||
46959137|NCT02446418|83200731|FG000|Overall Study|Withdrawal by Subject|3|||
46959138|NCT02446418|83200732|FG001|Overall Study|Withdrawal by Subject|3|||
46959139|NCT02446418|83200731|FG000|Overall Study|Lost to Follow-up|2|||
46959140|NCT02446418|83200732|FG001|Overall Study|Lost to Follow-up|2|||
46959141|NCT02446418|83200731|FG000|Overall Study|Protocol Violation|1|||
46959142|NCT02446418|83200732|FG001|Overall Study|Protocol Violation|2|||
46959143|NCT02446418|83200731|FG000|Overall Study|Lack of Efficacy|2|||
46959144|NCT02446418|83200732|FG001|Overall Study|Lack of Efficacy|0|||
46959145|NCT02446418|83200731|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
46959146|NCT02446418|83200732|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
46959147|NCT02445794|83200742|FG000|Overall Study|Adverse Event|0|||
46959148|NCT02445794|83200743|FG001|Overall Study|Adverse Event|0|||
46959149|NCT02445794|83200744|FG002|Overall Study|Adverse Event|2|||
46959150|NCT02445794|83200745|FG003|Overall Study|Adverse Event|0|||
46959151|NCT02475278|83200760|FG000|Overall Study|Lost to Follow-up|1|||
46959152|NCT02475278|83200760|FG000|Overall Study|Reason Not Specified|1|||
46639999|NCT00087516|82813987|FG000|Overall Study|Patient moved|3|||
46640000|NCT00087516|82813988|FG001|Overall Study|Patient moved|2|||
46845140|NCT00146172|83061961|FG003|Overall Study|Symptomatic Deterioration|0|||
46845141|NCT00146172|83061962|FG004|Overall Study|Symptomatic Deterioration|1|||
46845142|NCT00146172|83061963|FG005|Overall Study|Symptomatic Deterioration|2|||
46959153|NCT02254486|83200766|FG000|Overall Study|Adverse Event|1|||
46959154|NCT02254486|83200767|FG001|Overall Study|Adverse Event|1|||
46959155|NCT02254486|83200766|FG000|Overall Study|Lack of Efficacy|1|||
46959156|NCT02254486|83200767|FG001|Overall Study|Lack of Efficacy|0|||
46959157|NCT02254486|83200766|FG000|Overall Study|Lost to Follow-up|2|||
46959158|NCT02254486|83200767|FG001|Overall Study|Lost to Follow-up|4|||
46959159|NCT02254486|83200766|FG000|Overall Study|Protocol Violation|1|||
46959160|NCT02254486|83200767|FG001|Overall Study|Protocol Violation|2|||
46959161|NCT02254486|83200766|FG000|Overall Study|Withdrawal by Subject|17|||
46640001|NCT00087516|82813989|FG002|Overall Study|Patient moved|1|||
46773842|NCT00750308|82992154|FG009|Second Treatment|Adverse Event|0|||
46773843|NCT00750308|82992155|FG010|Second Treatment|Adverse Event|0|||
46773844|NCT00750308|82992156|FG011|Second Treatment|Adverse Event|0|||
46773845|NCT00750308|82992145|FG000|Second Treatment|Withdrawal by Subject|0|||
46773846|NCT00750308|82992146|FG001|Second Treatment|Withdrawal by Subject|0|||
46773847|NCT00750308|82992147|FG002|Second Treatment|Withdrawal by Subject|0|||
46773848|NCT00750308|82992148|FG003|Second Treatment|Withdrawal by Subject|0|||
46773849|NCT00750308|82992149|FG004|Second Treatment|Withdrawal by Subject|1|||
46773850|NCT00750308|82992150|FG005|Second Treatment|Withdrawal by Subject|0|||
46773851|NCT00750308|82992151|FG006|Second Treatment|Withdrawal by Subject|0|||
46773852|NCT00750308|82992152|FG007|Second Treatment|Withdrawal by Subject|0|||
46773853|NCT00750308|82992153|FG008|Second Treatment|Withdrawal by Subject|0|||
46773854|NCT00750308|82992154|FG009|Second Treatment|Withdrawal by Subject|0|||
46773855|NCT00750308|82992155|FG010|Second Treatment|Withdrawal by Subject|0|||
46773856|NCT00750308|82992156|FG011|Second Treatment|Withdrawal by Subject|0|||
46773857|NCT00750308|82992145|FG000|Third Treatment|Withdrawal by Subject|0|||
46773858|NCT00750308|82992146|FG001|Third Treatment|Withdrawal by Subject|1|||
46773859|NCT00750308|82992147|FG002|Third Treatment|Withdrawal by Subject|0|||
46773860|NCT00750308|82992148|FG003|Third Treatment|Withdrawal by Subject|0|||
46773861|NCT00750308|82992149|FG004|Third Treatment|Withdrawal by Subject|0|||
46773862|NCT00750308|82992150|FG005|Third Treatment|Withdrawal by Subject|0|||
46773863|NCT00750308|82992151|FG006|Third Treatment|Withdrawal by Subject|0|||
46773864|NCT00750308|82992152|FG007|Third Treatment|Withdrawal by Subject|0|||
46959162|NCT02254486|83200767|FG001|Overall Study|Withdrawal by Subject|15|||
46959163|NCT02254486|83200766|FG000|Overall Study|GFR<60mL/min|16|||
46959164|NCT02254486|83200767|FG001|Overall Study|GFR<60mL/min|21|||
46959165|NCT02254486|83200766|FG000|Overall Study|Various|12|||
46959166|NCT02254486|83200767|FG001|Overall Study|Various|12|||
46959167|NCT01641640|83200773|FG000|Overall Study|Enrolled but not treated|1|||
46959168|NCT01641640|83200773|FG000|Overall Study|Efficacy failure|29|||
46959169|NCT01641640|83200773|FG000|Overall Study|Lost to Follow-up|3|||
46959170|NCT01641640|83200773|FG000|Overall Study|Withdrawal by Subject|2|||
46959171|NCT01641640|83200773|FG000|Overall Study|Adverse Event|1|||
46959172|NCT01639144|83200779|FG000|Overall Study|Withdrawal by Subject|4|||
46959173|NCT01639144|83200780|FG001|Overall Study|Withdrawal by Subject|2|||
46959174|NCT01639144|83200779|FG000|Overall Study|Physician Decision|2|||
46959175|NCT01639144|83200780|FG001|Overall Study|Physician Decision|0|||
46959176|NCT01639144|83200779|FG000|Overall Study|Met postoperative exclusion criteria|4|||
46959177|NCT01639144|83200780|FG001|Overall Study|Met postoperative exclusion criteria|3|||
46959178|NCT01601626|83200789|FG000|Overall Study|Death|1|||
46959179|NCT01601626|83200790|FG001|Overall Study|Death|1|||
46959180|NCT01601626|83200791|FG002|Overall Study|Death|1|||
46959181|NCT01601626|83200789|FG000|Overall Study|Lost to Follow-up|1|||
46959182|NCT01601626|83200790|FG001|Overall Study|Lost to Follow-up|2|||
46959183|NCT01601626|83200791|FG002|Overall Study|Lost to Follow-up|0|||
46959184|NCT01601626|83200789|FG000|Overall Study|Unable to Get to Clinic|0|||
46959185|NCT01601626|83200790|FG001|Overall Study|Unable to Get to Clinic|1|||
46959186|NCT01601626|83200791|FG002|Overall Study|Unable to Get to Clinic|0|||
46959187|NCT01601626|83200789|FG000|Overall Study|Withdrawal by Subject|0|||
46959188|NCT01601626|83200790|FG001|Overall Study|Withdrawal by Subject|1|||
46959189|NCT01601626|83200791|FG002|Overall Study|Withdrawal by Subject|1|||
46959190|NCT01601626|83200789|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
46959191|NCT01601626|83200790|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
46959192|NCT01601626|83200791|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
46959193|NCT02737501|83200801|FG000|Randomized Phase|Died|41|||
46959194|NCT02737501|83200802|FG001|Randomized Phase|Died|29|||
46959195|NCT02737501|83200803|FG002|Randomized Phase|Died|0|||
46959196|NCT02737501|83200801|FG000|Randomized Phase|Withdrawal by Subject|16|||
46773865|NCT00750308|82992153|FG008|Third Treatment|Withdrawal by Subject|0|||
46773866|NCT00750308|82992154|FG009|Third Treatment|Withdrawal by Subject|0|||
46773867|NCT00750308|82992155|FG010|Third Treatment|Withdrawal by Subject|0|||
46773868|NCT00750308|82992156|FG011|Third Treatment|Withdrawal by Subject|0|||
46773869|NCT04942366|82992207|FG000|Overall Study|Withdrawal by Subject|5|||
46773870|NCT04942366|82992208|FG001|Overall Study|Withdrawal by Subject|5|||
46773871|NCT04840615|82992214|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
46773872|NCT04840615|82992215|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
46773873|NCT04840615|82992216|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
46773874|NCT04830215|82992221|FG000|Overall Study|Adverse Event|6|||
46773875|NCT04830215|82992221|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
46773876|NCT04830215|82992221|FG000|Overall Study|Withdrawal by Subject|3|||
46773877|NCT04830215|82992221|FG000|Overall Study|Protocol Deviation|1|||
46773878|NCT04825912|82992225|FG000|Overall Study|Death|3|||
46773879|NCT04825912|82992225|FG000|Overall Study|Withdrawal by Subject|1|||
46773880|NCT04327934|82992259|FG000|Overall Study|Did not qualify|7|||
46773881|NCT04327934|82992260|FG001|Overall Study|Did not qualify|4|||
46773882|NCT04327934|82992259|FG000|Overall Study|Physician Decision|0|||
46773883|NCT04327934|82992260|FG001|Overall Study|Physician Decision|1|||
46773884|NCT04101331|82992268|FG000|Overall Study|Adverse Event|7|||
46773885|NCT04101331|82992268|FG000|Overall Study|Disease progression|79|||
46773886|NCT04101331|82992268|FG000|Overall Study|Withdrawal by Subject|1|||
46773887|NCT04101331|82992268|FG000|Overall Study|Investigator decision|6|||
46773888|NCT04101331|82992268|FG000|Overall Study|Death|6|||
46773889|NCT04101331|82992268|FG000|Overall Study|Allogenic transplant|1|||
46773890|NCT03834519|82992278|FG000|Overall Study|Ongoing|234|||
46773891|NCT03834519|82992279|FG001|Overall Study|Ongoing|111|||
46773892|NCT03834519|82992278|FG000|Overall Study|Withdrawal by Subject|4|||
46773893|NCT03834519|82992279|FG001|Overall Study|Withdrawal by Subject|7|||
46773894|NCT03834519|82992278|FG000|Overall Study|Death|291|||
46773895|NCT03834519|82992279|FG001|Overall Study|Death|146|||
46959197|NCT02737501|83200802|FG001|Randomized Phase|Withdrawal by Subject|6|||
46959198|NCT02737501|83200803|FG002|Randomized Phase|Withdrawal by Subject|0|||
46959199|NCT02737501|83200801|FG000|Randomized Phase|Lost to Follow-up|0|||
46959200|NCT02737501|83200802|FG001|Randomized Phase|Lost to Follow-up|1|||
46959201|NCT02737501|83200803|FG002|Randomized Phase|Lost to Follow-up|0|||
46959202|NCT02737501|83200801|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
46773896|NCT03693170|82992285|FG000|Overall Study|Disease Progression|48|||
46773897|NCT03693170|82992285|FG000|Overall Study|Adverse Event|16|||
46773898|NCT03693170|82992285|FG000|Overall Study|Physician Decision|6|||
46773899|NCT03693170|82992285|FG000|Overall Study|Protocol Violation|2|||
46959203|NCT02737501|83200802|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
46959204|NCT02737501|83200803|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
46959205|NCT02737501|83200801|FG000|Randomized Phase|Reason not Specified|1|||
46959206|NCT02737501|83200802|FG001|Randomized Phase|Reason not Specified|1|||
46959207|NCT02737501|83200803|FG002|Randomized Phase|Reason not Specified|0|||
46959208|NCT02737501|83200801|FG000|Randomized Phase|Never Treated|1|||
46959209|NCT02737501|83200802|FG001|Randomized Phase|Never Treated|1|||
46959210|NCT02737501|83200803|FG002|Randomized Phase|Never Treated|0|||
46959211|NCT02737501|83200801|FG000|Crossover Phase|Died|0|||
46959212|NCT02737501|83200802|FG001|Crossover Phase|Died|0|||
46959213|NCT02737501|83200803|FG002|Crossover Phase|Died|22|||
46959214|NCT02737501|83200801|FG000|Crossover Phase|Withdrew Consent|0|||
46959215|NCT02737501|83200802|FG001|Crossover Phase|Withdrew Consent|0|||
46959216|NCT02737501|83200803|FG002|Crossover Phase|Withdrew Consent|9|||
46959217|NCT02737501|83200801|FG000|Crossover Phase|Physician Decision|0|||
46959218|NCT02737501|83200802|FG001|Crossover Phase|Physician Decision|0|||
46959219|NCT02737501|83200803|FG002|Crossover Phase|Physician Decision|1|||
46959220|NCT02737501|83200801|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
46959221|NCT02737501|83200802|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
46959222|NCT02737501|83200803|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
46959223|NCT01640314|83200813|FG000|Overall Study|Protocol Violation|0|||
46959224|NCT01640314|83200814|FG001|Overall Study|Protocol Violation|1|||
46959225|NCT02740049|83200896|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
46959226|NCT01601704|83200902|FG000|Overall Study|Randomized but not dispensed study med|1|||
46959227|NCT01601704|83200903|FG001|Overall Study|Randomized but not dispensed study med|4|||
46959228|NCT01601470|83200909|FG000|Period 2 - LCZ696|Physician Decision|1|||
46959229|NCT03248375|83200933|FG000|Overall Study|Lost to Follow-up|5|||
46959230|NCT01637272|83200937|FG000|Overall Study|Adverse Event|6|||
46959231|NCT01637272|83200937|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46959232|NCT01637272|83200937|FG000|Overall Study|Withdrawal by Subject|3|||
46959233|NCT01637272|83200937|FG000|Overall Study|Lost to Follow-up|2|||
46959234|NCT01637272|83200937|FG000|Overall Study|completed core, did not enter ext. phase|4|||
46959235|NCT01637272|83200937|FG000|Overall Study|Administrative problems|1|||
46773900|NCT03693170|82992285|FG000|Overall Study|Death|1|||
46773901|NCT03693170|82992285|FG000|Overall Study|Non compliance with study drug|1|||
46845143|NCT00146172|83061964|FG006|Overall Study|Symptomatic Deterioration|0|||
46845144|NCT00146172|83061965|FG007|Overall Study|Symptomatic Deterioration|2|||
46773902|NCT03693170|82992285|FG000|Overall Study|Withdrawal by Subject|1|||
46773903|NCT03655262|82992293|FG000|Overall Study|Withdrawal by Subject|0|||
46845145|NCT00145626|83061993|FG000|Overall Study|Did not have NK infusions|2|||
46845146|NCT00145626|83061993|FG000|Overall Study|Turned 2 years old before treatment|1|||
46845147|NCT00145626|83061993|FG000|Overall Study|Death|1|||
46845148|NCT00145626|83061993|FG000|Overall Study|Withdrawal by Subject|1|||
46845149|NCT00153062|83062017|FG000|Overall Study|Death|360|||
46845150|NCT00153062|83062018|FG001|Overall Study|Death|352|||
46845151|NCT00153062|83062019|FG002|Overall Study|Death|369|||
46845152|NCT00153062|83062020|FG003|Overall Study|Death|365|||
46845153|NCT00153062|83062017|FG000|Overall Study|Withdrawal by Subject|14|||
46845154|NCT00153062|83062018|FG001|Overall Study|Withdrawal by Subject|30|||
46959236|NCT01637272|83200937|FG000|Overall Study|Protocol Violation|2|||
46773904|NCT03655262|82992294|FG001|Overall Study|Withdrawal by Subject|0|||
46773905|NCT03655262|82992295|FG002|Overall Study|Withdrawal by Subject|1|||
46773906|NCT03580044|82992308|FG000|Overall Study|Death|2|||
46773907|NCT03580044|82992309|FG001|Overall Study|Death|1|||
46773908|NCT03580044|82992308|FG000|Overall Study|Withdrawal by Subject|1|||
46773909|NCT03580044|82992309|FG001|Overall Study|Withdrawal by Subject|1|||
46773910|NCT03520400|82992317|FG000|Overall Study|Physician Decision|15|||
46773911|NCT03520400|82992318|FG001|Overall Study|Physician Decision|7|||
46845155|NCT00153062|83062019|FG002|Overall Study|Withdrawal by Subject|27|||
46845156|NCT00153062|83062020|FG003|Overall Study|Withdrawal by Subject|28|||
46845157|NCT00153062|83062017|FG000|Overall Study|Lost to Follow-up|12|||
46959237|NCT01636960|83200956|FG000|Induction Phase|Adverse Event|2|||
46959238|NCT01636960|83200956|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
46959239|NCT01636960|83200956|FG000|Maintenance Phase|Adverse Event|3|||
46959240|NCT01636960|83200956|FG000|Maintenance Phase|Progressive disease|1|||
46959241|NCT01636258|83200962|FG000|Overall Study|Lost to Follow-up|1|||
46959242|NCT01636258|83200963|FG001|Overall Study|Lost to Follow-up|0|||
46959243|NCT02504216|83200972|FG000|Overall Study|Lost to Follow-up|3|||
46959244|NCT02504216|83200973|FG001|Overall Study|Lost to Follow-up|3|||
46959245|NCT02504216|83200972|FG000|Overall Study|Withdrawal by Subject|8|||
46959246|NCT02504216|83200973|FG001|Overall Study|Withdrawal by Subject|12|||
46959247|NCT04354870|83200981|FG000|Overall Study|Lost to Follow-up|32|||
46773912|NCT03474107|82992326|FG000|Overall Study|Adverse Event|42|||
46773913|NCT03474107|82992327|FG001|Overall Study|Adverse Event|46|||
46773914|NCT03474107|82992326|FG000|Overall Study|Death|2|||
46845158|NCT00153062|83062018|FG001|Overall Study|Lost to Follow-up|20|||
46959248|NCT04354870|83200982|FG001|Overall Study|Lost to Follow-up|12|||
46959249|NCT04354870|83200981|FG000|Overall Study|Withdrawal by Subject|10|||
46959250|NCT04354870|83200982|FG001|Overall Study|Withdrawal by Subject|16|||
46959251|NCT04354870|83200981|FG000|Overall Study|Did not complete all study visits|6|||
46959252|NCT04354870|83200982|FG001|Overall Study|Did not complete all study visits|5|||
46959253|NCT02473952|83200990|FG000|Overall Study|Adverse Event|2|||
46959254|NCT02473952|83200991|FG001|Overall Study|Adverse Event|2|||
46959255|NCT02473952|83200990|FG000|Overall Study|Withdrawal by Subject|0|||
46959256|NCT02473952|83200991|FG001|Overall Study|Withdrawal by Subject|6|||
46959257|NCT02473640|83200997|FG000|Treatment Period 1|Adverse Event|1|||
46959258|NCT01637584|83201006|FG000|Overall Study|Withdrawal by Subject|1|||
46959259|NCT01637584|83201007|FG001|Overall Study|Withdrawal by Subject|3|||
46959260|NCT03883906|83201014|FG000|Overall Study|Withdrawal by Subject|2|||
46959261|NCT03883906|83201014|FG000|Overall Study|Physician Decision|5|||
46959262|NCT02503202|83201023|FG000|Base Study: Up to Month 6|Death|1|||
46959263|NCT02503202|83201024|FG001|Base Study: Up to Month 6|Death|1|||
46959264|NCT02503202|83201025|FG002|Base Study: Up to Month 6|Death|0|||
46959265|NCT02503202|83201026|FG003|Base Study: Up to Month 6|Death|0|||
46959266|NCT02503202|83201027|FG004|Base Study: Up to Month 6|Death|0|||
46959267|NCT02503202|83201023|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
46959268|NCT02503202|83201024|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
46959269|NCT02503202|83201025|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
46959270|NCT02503202|83201026|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
46959271|NCT02503202|83201027|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
46959272|NCT02503202|83201023|FG000|Base Study: Up to Month 6|Physician Decision|0|||
46959273|NCT02503202|83201024|FG001|Base Study: Up to Month 6|Physician Decision|0|||
46959274|NCT02503202|83201025|FG002|Base Study: Up to Month 6|Physician Decision|0|||
46959275|NCT02503202|83201026|FG003|Base Study: Up to Month 6|Physician Decision|0|||
46959276|NCT02503202|83201027|FG004|Base Study: Up to Month 6|Physician Decision|1|||
46959277|NCT02503202|83201023|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
46959278|NCT02503202|83201024|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
46959279|NCT02503202|83201025|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
46959280|NCT02503202|83201026|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
46959281|NCT02503202|83201027|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
46959282|NCT02503202|83201023|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
46959283|NCT02503202|83201024|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
46959284|NCT02503202|83201025|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
46959285|NCT02503202|83201026|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
46959286|NCT02503202|83201027|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
46959287|NCT02503202|83201023|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
46959288|NCT02503202|83201024|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
46959289|NCT02503202|83201025|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
46959290|NCT02503202|83201026|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
46959291|NCT02503202|83201027|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
46959292|NCT02503202|83201023|FG000|Extension: Month 6 to 24|Death|1|||
46959293|NCT02503202|83201024|FG001|Extension: Month 6 to 24|Death|0|||
46959294|NCT02503202|83201025|FG002|Extension: Month 6 to 24|Death|0|||
46959295|NCT02503202|83201026|FG003|Extension: Month 6 to 24|Death|0|||
46959296|NCT02503202|83201027|FG004|Extension: Month 6 to 24|Death|0|||
46959297|NCT02503202|83201023|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
46959298|NCT02503202|83201024|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
46959299|NCT02503202|83201025|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
46959300|NCT02503202|83201026|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
46959301|NCT02503202|83201027|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
46959302|NCT02503202|83201023|FG000|Extension: Month 6 to 24|Physician Decision|1|||
46959303|NCT02503202|83201024|FG001|Extension: Month 6 to 24|Physician Decision|0|||
46959304|NCT02503202|83201025|FG002|Extension: Month 6 to 24|Physician Decision|1|||
46959305|NCT02503202|83201026|FG003|Extension: Month 6 to 24|Physician Decision|3|||
46959306|NCT02503202|83201027|FG004|Extension: Month 6 to 24|Physician Decision|0|||
46959307|NCT02503202|83201023|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
46959308|NCT02503202|83201024|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
46959309|NCT02503202|83201025|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
46959310|NCT02503202|83201026|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
46959311|NCT02503202|83201027|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
46959312|NCT02502734|83201039|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
46959313|NCT02502734|83201040|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
46959314|NCT02502734|83201039|FG000|Washout Period|Adverse Event|1|||
46959315|NCT02502734|83201040|FG001|Washout Period|Adverse Event|0|||
46959316|NCT02473250|83201048|FG000|Overall Study|Lost to Follow-up|10|||
46959317|NCT02473250|83201048|FG000|Overall Study|Physician Decision|5|||
46959318|NCT02473250|83201048|FG000|Overall Study|Did not tolerate medication washout|3|||
46959319|NCT02473250|83201048|FG000|Overall Study|Antidepressant effect of divalproex|2|||
46959320|NCT02706730|83201053|FG000|Overall Study|Adverse Event|3|||
46959321|NCT02706730|83201053|FG000|Overall Study|Lack of Efficacy|5|||
46959322|NCT02706730|83201053|FG000|Overall Study|Withdrawal by Subject|11|||
46959323|NCT02706730|83201053|FG000|Overall Study|Study Terminated by Sponsor|11|||
46959324|NCT02706730|83201053|FG000|Overall Study|Subject chose not to receive injection|3|||
46959325|NCT02443688|83201060|FG000|Overall Study|Adverse Event|2|||
46959326|NCT02443688|83201061|FG001|Overall Study|Adverse Event|3|||
46959327|NCT02443688|83201062|FG002|Overall Study|Adverse Event|2|||
46959328|NCT02443688|83201060|FG000|Overall Study|Lost to Follow-up|1|||
46959329|NCT02443688|83201061|FG001|Overall Study|Lost to Follow-up|0|||
46959330|NCT02443688|83201062|FG002|Overall Study|Lost to Follow-up|0|||
46959331|NCT02443688|83201060|FG000|Overall Study|Physician Decision|3|||
46959332|NCT02443688|83201061|FG001|Overall Study|Physician Decision|0|||
46959333|NCT02443688|83201062|FG002|Overall Study|Physician Decision|1|||
46959334|NCT02443688|83201060|FG000|Overall Study|Pregnancy|0|||
46959335|NCT02443688|83201061|FG001|Overall Study|Pregnancy|0|||
46959336|NCT02443688|83201062|FG002|Overall Study|Pregnancy|1|||
46959337|NCT02443688|83201060|FG000|Overall Study|Withdrawal by Subject|3|||
46959338|NCT02443688|83201061|FG001|Overall Study|Withdrawal by Subject|3|||
46959339|NCT02443688|83201062|FG002|Overall Study|Withdrawal by Subject|4|||
46959340|NCT02443688|83201060|FG000|Overall Study|Non-compliance with study drug|1|||
46959341|NCT02443688|83201061|FG001|Overall Study|Non-compliance with study drug|2|||
46959342|NCT02443688|83201062|FG002|Overall Study|Non-compliance with study drug|4|||
46959343|NCT02443688|83201060|FG000|Overall Study|Sponsor Request|2|||
46959344|NCT02443688|83201061|FG001|Overall Study|Sponsor Request|1|||
46959345|NCT02443688|83201062|FG002|Overall Study|Sponsor Request|0|||
46959346|NCT02443298|83201076|FG000|Overall Study|Adverse Event|3|||
46959347|NCT02443298|83201077|FG001|Overall Study|Adverse Event|3|||
46959348|NCT02443298|83201076|FG000|Overall Study|Withdrawal by Subject|1|||
46959349|NCT02443298|83201077|FG001|Overall Study|Withdrawal by Subject|2|||
46959350|NCT02500706|83201086|FG000|Overall Study|Adverse Event|0|||
46959351|NCT02500706|83201087|FG001|Overall Study|Adverse Event|0|||
46959352|NCT02500706|83201088|FG002|Overall Study|Adverse Event|1|||
46959353|NCT02500706|83201086|FG000|Overall Study|Lost to Follow-up|0|||
46959354|NCT02500706|83201087|FG001|Overall Study|Lost to Follow-up|1|||
46959355|NCT02500706|83201088|FG002|Overall Study|Lost to Follow-up|1|||
46959356|NCT02500706|83201086|FG000|Overall Study|Withdrawal by Subject|4|||
46959357|NCT02500706|83201087|FG001|Overall Study|Withdrawal by Subject|6|||
46959358|NCT02500706|83201088|FG002|Overall Study|Withdrawal by Subject|4|||
46959359|NCT02500706|83201086|FG000|Overall Study|Unclassified|0|||
46959360|NCT02500706|83201087|FG001|Overall Study|Unclassified|0|||
46959361|NCT02500706|83201088|FG002|Overall Study|Unclassified|1|||
46959362|NCT02442830|83201098|FG000|Overall Study|Technical Failure|0|||
46959363|NCT02442830|83201099|FG001|Overall Study|Technical Failure|1|||
46959364|NCT02471612|83201106|FG000|Overall Study|Lost to Follow-up|2|||
46959365|NCT02500550|83201123|FG000|Overall Study|Death|7|||
46959366|NCT02499770|83201129|FG000|Overall Study|Death|17|||
46959367|NCT02499770|83201130|FG001|Overall Study|Death|56|||
46959368|NCT02499770|83201129|FG000|Overall Study|Study completion|1|||
46959369|NCT02499770|83201130|FG001|Overall Study|Study completion|10|||
46959370|NCT02499770|83201129|FG000|Overall Study|Withdrawal by Subject|0|||
46959371|NCT02499770|83201130|FG001|Overall Study|Withdrawal by Subject|7|||
46959372|NCT02499770|83201129|FG000|Overall Study|Lost to Follow-up|0|||
46959373|NCT02499770|83201130|FG001|Overall Study|Lost to Follow-up|2|||
46959374|NCT02499770|83201129|FG000|Overall Study|Subject declined further treatment|1|||
46959375|NCT02499770|83201130|FG001|Overall Study|Subject declined further treatment|0|||
46959376|NCT02499770|83201129|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
46959377|NCT02499770|83201130|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
46959378|NCT02499770|83201129|FG000|Overall Study|Randomized but not enrolled|0|||
46959379|NCT02499770|83201130|FG001|Overall Study|Randomized but not enrolled|1|||
46959380|NCT02442284|83201142|FG000|Overall Study|Adverse Event|1|||
46959381|NCT02442284|83201142|FG000|Overall Study|Withdrew Consent|2|||
46959382|NCT02442284|83201142|FG000|Overall Study|Lost to Follow-up|3|||
46959383|NCT02442284|83201142|FG000|Overall Study|Other|1|||
46959384|NCT02442206|83201152|FG000|Period 1|Adverse Event|1|||
46959385|NCT02442206|83201153|FG001|Period 1|Adverse Event|1|||
46959386|NCT02442206|83201152|FG000|Period 1|withdrew consent|0|||
46959387|NCT02442206|83201153|FG001|Period 1|withdrew consent|1|||
46959388|NCT02442206|83201152|FG000|Period 1|COPD exacerbation|0|||
46959389|NCT02442206|83201153|FG001|Period 1|COPD exacerbation|1|||
46959390|NCT02442206|83201152|FG000|Period 2|Adverse Event|1|||
46959391|NCT02442206|83201153|FG001|Period 2|Adverse Event|0|||
46959392|NCT02499146|83201160|FG000|Overall Study|Lost to Follow-up|1|||
46959393|NCT02499146|83201160|FG000|Overall Study|Withdrawal by Subject|1|||
46959394|NCT02499146|83201160|FG000|Overall Study|Other|2|||
46959395|NCT02499146|83201160|FG000|Overall Study|Ongoing at date of cut-off|9|||
46959396|NCT02499146|83201160|FG000|Overall Study|Began other treatment/therapy|13|||
46959397|NCT03544138|83201164|FG000|Overall Study|Lost to Follow-up|29|||
46959398|NCT01634854|83201170|FG000|Overall Study|Cesarean delivery|2|||
46959399|NCT01634854|83201171|FG001|Overall Study|Cesarean delivery|7|||
47067063|NCT01446419|83350466|FG000|Overall Study|Withdrawal by Subject|1|||
46959400|NCT02469896|83201179|FG000|Overall Study|Withdrawal by Subject|2|||
46959401|NCT02469896|83201180|FG001|Overall Study|Withdrawal by Subject|0|||
46959402|NCT02441114|83201190|FG000|Washout2|Withdrawal by Subject|4|||
46959403|NCT02498678|83201196|FG000|Overall Study|interference from the surgical team|0|||
46959404|NCT02498678|83201197|FG001|Overall Study|interference from the surgical team|2|||
46959405|NCT02441036|83201208|FG000|Overall Study|No tissue resected|0|||
46959406|NCT02441036|83201209|FG001|Overall Study|No tissue resected|1|||
46959407|NCT02441036|83201210|FG002|Overall Study|No tissue resected|0|||
46959408|NCT02441036|83201211|FG003|Overall Study|No tissue resected|1|||
46959409|NCT02441036|83201212|FG004|Overall Study|No tissue resected|0|||
46959410|NCT02498444|83201227|FG000|Overall Study|Withdrawal by Subject|3|||
46959411|NCT02498444|83201228|FG001|Overall Study|Withdrawal by Subject|0|||
46959412|NCT02498444|83201227|FG000|Overall Study|Physician Decision|1|||
46959413|NCT02498444|83201228|FG001|Overall Study|Physician Decision|0|||
46959414|NCT02497976|83201236|FG000|Overall Study|Withdrawal by Subject|2|||
46959415|NCT02497976|83201237|FG001|Overall Study|Withdrawal by Subject|0|||
46959416|NCT02497976|83201236|FG000|Overall Study|Moved out of area|0|||
46959417|NCT02497976|83201237|FG001|Overall Study|Moved out of area|1|||
46959418|NCT03347188|83201245|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
46959419|NCT03347188|83201246|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
46959420|NCT03347188|83201245|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
46959421|NCT03347188|83201246|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
46959422|NCT03347188|83201245|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
46959423|NCT03347188|83201246|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
46959424|NCT03347188|83201245|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
46959425|NCT03347188|83201246|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
46959426|NCT03347188|83201245|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
46959427|NCT03347188|83201246|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
46959428|NCT03347188|83201245|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
46959429|NCT03347188|83201246|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
46959430|NCT03347188|83201245|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
46959431|NCT03347188|83201246|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
46959432|NCT03347188|83201245|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
46959433|NCT03347188|83201246|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
46959434|NCT02440568|83201256|FG000|Overall Study|Death|1|||
46959435|NCT02440568|83201257|FG001|Overall Study|Death|3|||
46959436|NCT02440568|83201258|FG002|Overall Study|Death|4|||
46959437|NCT02440568|83201259|FG003|Overall Study|Death|2|||
46959438|NCT02440568|83201256|FG000|Overall Study|Lack of Efficacy|2|||
46959439|NCT02440568|83201257|FG001|Overall Study|Lack of Efficacy|0|||
46959440|NCT02440568|83201258|FG002|Overall Study|Lack of Efficacy|1|||
46959441|NCT02440568|83201259|FG003|Overall Study|Lack of Efficacy|0|||
46959442|NCT02440568|83201256|FG000|Overall Study|Lost to Follow-up|1|||
46959443|NCT02440568|83201257|FG001|Overall Study|Lost to Follow-up|0|||
46959444|NCT02440568|83201258|FG002|Overall Study|Lost to Follow-up|0|||
46959445|NCT02440568|83201259|FG003|Overall Study|Lost to Follow-up|0|||
46959446|NCT03090191|83201272|FG000|Overall Study|Adverse Event|90|||
46959447|NCT03090191|83201273|FG001|Overall Study|Adverse Event|72|||
46959448|NCT03090191|83201272|FG000|Overall Study|Death|365|||
46959449|NCT03090191|83201273|FG001|Overall Study|Death|358|||
46959450|NCT03090191|83201272|FG000|Overall Study|Lost to Follow-up|382|||
46959451|NCT03090191|83201273|FG001|Overall Study|Lost to Follow-up|394|||
46959452|NCT03090191|83201272|FG000|Overall Study|Physician Decision|77|||
47067064|NCT01446419|83350467|FG001|Overall Study|Withdrawal by Subject|1|||
47067065|NCT01446419|83350466|FG000|Overall Study|Terminated per protocol|3|||
47067066|NCT01446419|83350467|FG001|Overall Study|Terminated per protocol|0|||
47067067|NCT01445951|83350476|FG000|Overall Study|Adverse Event|16|||
47067068|NCT01445951|83350477|FG001|Overall Study|Adverse Event|9|||
47067069|NCT01445951|83350478|FG002|Overall Study|Adverse Event|0|||
47067070|NCT01445951|83350476|FG000|Overall Study|Protocol Violation|2|||
47067071|NCT01445951|83350477|FG001|Overall Study|Protocol Violation|2|||
47067072|NCT01445951|83350478|FG002|Overall Study|Protocol Violation|2|||
47067073|NCT01445951|83350476|FG000|Overall Study|Withdrawal by Subject|21|||
47067074|NCT01445951|83350477|FG001|Overall Study|Withdrawal by Subject|16|||
47067075|NCT01445951|83350478|FG002|Overall Study|Withdrawal by Subject|8|||
47067076|NCT01445951|83350476|FG000|Overall Study|Physician Decision|3|||
47067077|NCT01445951|83350477|FG001|Overall Study|Physician Decision|1|||
47067078|NCT01445951|83350478|FG002|Overall Study|Physician Decision|0|||
46959453|NCT03090191|83201273|FG001|Overall Study|Physician Decision|66|||
46959454|NCT03090191|83201272|FG000|Overall Study|Protocol Violation|43|||
46959455|NCT03090191|83201273|FG001|Overall Study|Protocol Violation|52|||
47067079|NCT01445951|83350476|FG000|Overall Study|Lost to Follow-up|1|||
47067080|NCT01445951|83350477|FG001|Overall Study|Lost to Follow-up|2|||
47067081|NCT01445951|83350478|FG002|Overall Study|Lost to Follow-up|4|||
47067082|NCT01445951|83350476|FG000|Overall Study|Pregnancy|0|||
47067083|NCT01445951|83350477|FG001|Overall Study|Pregnancy|1|||
46959456|NCT03090191|83201272|FG000|Overall Study|Withdrawal by Subject|2160|||
46959457|NCT03090191|83201273|FG001|Overall Study|Withdrawal by Subject|2133|||
46959458|NCT03090191|83201272|FG000|Overall Study|Site terminated|7|||
46959459|NCT03090191|83201273|FG001|Overall Study|Site terminated|8|||
46959460|NCT03090191|83201272|FG000|Overall Study|Other|66|||
46959461|NCT03090191|83201273|FG001|Overall Study|Other|60|||
46959462|NCT03090191|83201272|FG000|Overall Study|Withdrawn before any study vaccination|43|||
46959463|NCT03090191|83201273|FG001|Overall Study|Withdrawn before any study vaccination|52|||
46959464|NCT02439320|83201295|FG000|Overall Study|Adverse Event|0|||
46959465|NCT02439320|83201296|FG001|Overall Study|Adverse Event|2|||
46959466|NCT02439320|83201297|FG002|Overall Study|Adverse Event|0|||
46959467|NCT02439320|83201295|FG000|Overall Study|Lost to Follow-up|37|||
46959468|NCT02439320|83201296|FG001|Overall Study|Lost to Follow-up|34|||
46959469|NCT02439320|83201297|FG002|Overall Study|Lost to Follow-up|42|||
46959470|NCT02439320|83201295|FG000|Overall Study|Death|0|||
46959471|NCT02439320|83201296|FG001|Overall Study|Death|1|||
46959472|NCT02439320|83201297|FG002|Overall Study|Death|0|||
46959473|NCT02439320|83201295|FG000|Overall Study|Noncompliance with Protocol|10|||
46959474|NCT02439320|83201296|FG001|Overall Study|Noncompliance with Protocol|11|||
46959475|NCT02439320|83201297|FG002|Overall Study|Noncompliance with Protocol|7|||
46959476|NCT02439320|83201295|FG000|Overall Study|Pregnancy|0|||
46959477|NCT02439320|83201296|FG001|Overall Study|Pregnancy|1|||
46959478|NCT02439320|83201297|FG002|Overall Study|Pregnancy|1|||
46959479|NCT02439320|83201295|FG000|Overall Study|Withdrawal by Subject|12|||
46959480|NCT02439320|83201296|FG001|Overall Study|Withdrawal by Subject|16|||
46959481|NCT02439320|83201297|FG002|Overall Study|Withdrawal by Subject|14|||
46959482|NCT02439320|83201295|FG000|Overall Study|Physician Decision|2|||
46959483|NCT02439320|83201296|FG001|Overall Study|Physician Decision|1|||
46959484|NCT02439320|83201297|FG002|Overall Study|Physician Decision|0|||
46959485|NCT02439320|83201295|FG000|Overall Study|Sponsor Request|0|||
46959486|NCT02439320|83201296|FG001|Overall Study|Sponsor Request|2|||
46959487|NCT02439320|83201297|FG002|Overall Study|Sponsor Request|1|||
46959488|NCT02439320|83201295|FG000|Overall Study|Randomization Failure|35|||
46959489|NCT02439320|83201296|FG001|Overall Study|Randomization Failure|46|||
46959490|NCT02439320|83201297|FG002|Overall Study|Randomization Failure|34|||
46959491|NCT02469038|83201313|FG000|Overall Study|Physician Decision|4|||
46959492|NCT02469038|83201314|FG001|Overall Study|Physician Decision|5|||
46959493|NCT02468648|83201320|FG000|Overall Study|Death|1|||
46959494|NCT02468414|83201326|FG000|Overall Study|Early Study Termination by Sponsor|1|||
46845159|NCT00153062|83062019|FG002|Overall Study|Lost to Follow-up|15|||
46845160|NCT00153062|83062020|FG003|Overall Study|Lost to Follow-up|16|||
46959495|NCT02468414|83201327|FG001|Overall Study|Early Study Termination by Sponsor|0|||
46959496|NCT02468414|83201326|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
46959497|NCT02468414|83201327|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
46959498|NCT02468414|83201326|FG000|Overall Study|Screen Failure|1|||
46959499|NCT02468414|83201327|FG001|Overall Study|Screen Failure|0|||
46959500|NCT02466386|83201333|FG000|Overall Study|Adverse Event|5|||
46959501|NCT02466386|83201333|FG000|Overall Study|Protocol Violation|2|||
46959502|NCT02466386|83201333|FG000|Overall Study|Withdrawal by Subject|14|||
46959503|NCT02466386|83201333|FG000|Overall Study|Lost to Follow-up|5|||
46959504|NCT02466386|83201333|FG000|Overall Study|Lack of Efficacy|8|||
46959505|NCT02466386|83201333|FG000|Overall Study|Other|10|||
46959506|NCT01633060|83201339|FG000|Randomization Phase|Protocol deviation|1|||
46959507|NCT01633060|83201340|FG001|Randomization Phase|Protocol deviation|2|||
46959508|NCT01633060|83201339|FG000|Randomization Phase|Technical problem|0|||
46959509|NCT01633060|83201340|FG001|Randomization Phase|Technical problem|1|||
46959510|NCT01633060|83201339|FG000|Treatment Phase|Adverse Event|24|||
46959511|NCT01633060|83201340|FG001|Treatment Phase|Adverse Event|3|||
46959512|NCT01633060|83201339|FG000|Treatment Phase|Lost to Follow-up|1|||
46959513|NCT01633060|83201340|FG001|Treatment Phase|Lost to Follow-up|0|||
46959514|NCT01633060|83201339|FG000|Treatment Phase|Physician Decision|16|||
46959515|NCT01633060|83201340|FG001|Treatment Phase|Physician Decision|7|||
46959516|NCT01633060|83201339|FG000|Treatment Phase|Progressive Disease|210|||
46959517|NCT01633060|83201340|FG001|Treatment Phase|Progressive Disease|120|||
46959518|NCT01633060|83201339|FG000|Treatment Phase|Protocol Deviation|1|||
46959519|NCT01633060|83201340|FG001|Treatment Phase|Protocol Deviation|0|||
46959520|NCT01633060|83201339|FG000|Treatment Phase|Study Terminated by sponsor|7|||
46959521|NCT01633060|83201340|FG001|Treatment Phase|Study Terminated by sponsor|3|||
47067084|NCT01445951|83350478|FG002|Overall Study|Pregnancy|4|||
46959522|NCT01633060|83201339|FG000|Treatment Phase|Subject/guardian decision|25|||
46845161|NCT00153062|83062017|FG000|Overall Study|Adverse Event|0|||
46959523|NCT01633060|83201340|FG001|Treatment Phase|Subject/guardian decision|4|||
46845162|NCT00153062|83062018|FG001|Overall Study|Adverse Event|1|||
46959524|NCT01633060|83201339|FG000|Treatment Phase|Death|4|||
46959525|NCT01633060|83201340|FG001|Treatment Phase|Death|3|||
46959526|NCT01633060|83201339|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
46959527|NCT01633060|83201340|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
47067085|NCT01445951|83350476|FG000|Overall Study|Death|0|||
47067086|NCT01445951|83350477|FG001|Overall Study|Death|0|||
46959528|NCT01633060|83201339|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
46959529|NCT01633060|83201340|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
46959530|NCT01633060|83201339|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
46959531|NCT01633060|83201340|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
46959532|NCT01633060|83201339|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
46959533|NCT01633060|83201340|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
46959534|NCT01633060|83201339|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
46959535|NCT01633060|83201340|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
46959536|NCT01633060|83201339|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
46959537|NCT01633060|83201340|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
46959538|NCT01632904|83201349|FG000|Overall Study|Adverse Event|4|||
46959539|NCT01632904|83201350|FG001|Overall Study|Adverse Event|1|||
46959540|NCT01632904|83201349|FG000|Overall Study|Physician Decision|0|||
46959541|NCT01632904|83201350|FG001|Overall Study|Physician Decision|1|||
46959542|NCT01632904|83201349|FG000|Overall Study|Subject decision|3|||
46959543|NCT01632904|83201350|FG001|Overall Study|Subject decision|2|||
46959544|NCT01632904|83201349|FG000|Overall Study|Disease Progression|0|||
46959545|NCT01632904|83201350|FG001|Overall Study|Disease Progression|1|||
46959546|NCT01632904|83201349|FG000|Overall Study|Reason for discontinuation not available|0|||
46959547|NCT01632904|83201350|FG001|Overall Study|Reason for discontinuation not available|1|||
46959548|NCT03834779|83201358|FG000|Overall Study|Death|1|||
46959549|NCT03834779|83201359|FG001|Overall Study|Death|2|||
46959550|NCT03834779|83201358|FG000|Overall Study|Lost to Follow-up|6|||
46959551|NCT03834779|83201359|FG001|Overall Study|Lost to Follow-up|4|||
46959552|NCT03726437|83201368|FG000|Overall Study|Lost to Follow-up|85|||
46959553|NCT03726437|83201369|FG001|Overall Study|Lost to Follow-up|76|||
46959554|NCT02465528|83201379|FG000|Overall Study|Progressive disease|0|||
46959555|NCT02465528|83201380|FG001|Overall Study|Progressive disease|2|||
46959556|NCT02465528|83201381|FG002|Overall Study|Progressive disease|9|||
46959557|NCT02465528|83201382|FG003|Overall Study|Progressive disease|4|||
46959558|NCT02465528|83201379|FG000|Overall Study|Study terminated by sponsor|1|||
46959559|NCT02465528|83201380|FG001|Overall Study|Study terminated by sponsor|2|||
46959560|NCT02465528|83201381|FG002|Overall Study|Study terminated by sponsor|0|||
46959561|NCT02465528|83201382|FG003|Overall Study|Study terminated by sponsor|0|||
46959562|NCT02465528|83201379|FG000|Overall Study|Withdrawal by Subject|0|||
46959563|NCT02465528|83201380|FG001|Overall Study|Withdrawal by Subject|0|||
46959564|NCT02465528|83201381|FG002|Overall Study|Withdrawal by Subject|2|||
46959565|NCT02465528|83201382|FG003|Overall Study|Withdrawal by Subject|0|||
46959566|NCT02465528|83201379|FG000|Overall Study|Adverse Event|0|||
46959567|NCT02465528|83201380|FG001|Overall Study|Adverse Event|0|||
46959568|NCT02465528|83201381|FG002|Overall Study|Adverse Event|0|||
46959569|NCT02465528|83201382|FG003|Overall Study|Adverse Event|1|||
46959570|NCT02465528|83201379|FG000|Overall Study|Physician Decision|0|||
46959571|NCT02465528|83201380|FG001|Overall Study|Physician Decision|0|||
46959572|NCT02465528|83201381|FG002|Overall Study|Physician Decision|1|||
46959573|NCT02465528|83201382|FG003|Overall Study|Physician Decision|0|||
46959574|NCT02438384|83201397|FG000|Overall Study|Lost to Follow-up|8|||
46959575|NCT02438384|83201398|FG001|Overall Study|Lost to Follow-up|6|||
46959576|NCT02438384|83201399|FG002|Overall Study|Lost to Follow-up|4|||
46959577|NCT02463032|83201409|FG000|Overall Study|Lack of Efficacy|61|||
46959578|NCT02463032|83201410|FG001|Overall Study|Lack of Efficacy|50|||
46959579|NCT02463032|83201409|FG000|Overall Study|Death|8|||
46959580|NCT02463032|83201410|FG001|Overall Study|Death|8|||
46959581|NCT02463032|83201409|FG000|Overall Study|Adverse Event|2|||
46959582|NCT02463032|83201410|FG001|Overall Study|Adverse Event|6|||
46959583|NCT02496884|83201420|FG000|Overall Study|Counted twice as enrolled|2|||
46959584|NCT02496884|83201421|FG001|Overall Study|Counted twice as enrolled|0|||
46959585|NCT02496884|83201422|FG002|Overall Study|Counted twice as enrolled|0|||
46959586|NCT02496884|83201423|FG003|Overall Study|Counted twice as enrolled|0|||
46959587|NCT02496884|83201420|FG000|Overall Study|Withdrawal by Subject|0|||
46959588|NCT02496884|83201421|FG001|Overall Study|Withdrawal by Subject|3|||
47067087|NCT01445951|83350478|FG002|Overall Study|Death|1|||
46959589|NCT02496884|83201422|FG002|Overall Study|Withdrawal by Subject|0|||
46959590|NCT02496884|83201423|FG003|Overall Study|Withdrawal by Subject|0|||
46959591|NCT02462876|83201433|FG000|Overall Study|Death|3|||
46959592|NCT02462876|83201433|FG000|Overall Study|Lost to Follow-up|7|||
46959593|NCT02462876|83201433|FG000|Overall Study|Surgical Bypass|9|||
46959594|NCT02462876|83201433|FG000|Overall Study|Amputation Above the Metatarsals|1|||
46959595|NCT02462876|83201433|FG000|Overall Study|36 months follow-up visit missed|1|||
46959596|NCT02462876|83201433|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
46959597|NCT02462876|83201433|FG000|Overall Study|Patient did not come back to the vascular department|1|||
46959598|NCT02462876|83201433|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
46959599|NCT02462876|83201433|FG000|Overall Study|Patient refused to come back|1|||
46959600|NCT02462876|83201433|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
46959601|NCT02462876|83201433|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
46959602|NCT03386721|83201452|FG000|Overall Study|Death|12|||
46959603|NCT03386721|83201453|FG001|Overall Study|Death|21|||
46959604|NCT03386721|83201454|FG002|Overall Study|Death|2|||
46959605|NCT03386721|83201455|FG003|Overall Study|Death|5|||
46959606|NCT03386721|83201456|FG004|Overall Study|Death|1|||
46959607|NCT03386721|83201457|FG005|Overall Study|Death|12|||
46959608|NCT03386721|83201458|FG006|Overall Study|Death|1|||
46959609|NCT03386721|83201459|FG007|Overall Study|Death|1|||
46959610|NCT03386721|83201460|FG008|Overall Study|Death|12|||
46959611|NCT03386721|83201461|FG009|Overall Study|Death|20|||
46959612|NCT03386721|83201462|FG010|Overall Study|Death|21|||
46959613|NCT03386721|83201463|FG011|Overall Study|Death|21|||
46959614|NCT03386721|83201464|FG012|Overall Study|Death|14|||
46959615|NCT03386721|83201465|FG013|Overall Study|Death|2|||
46959616|NCT03386721|83201466|FG014|Overall Study|Death|1|||
46959617|NCT03386721|83201452|FG000|Overall Study|Lost to Follow-up|1|||
46959618|NCT03386721|83201453|FG001|Overall Study|Lost to Follow-up|3|||
46959619|NCT03386721|83201454|FG002|Overall Study|Lost to Follow-up|0|||
46959620|NCT03386721|83201455|FG003|Overall Study|Lost to Follow-up|0|||
46959621|NCT03386721|83201456|FG004|Overall Study|Lost to Follow-up|0|||
46959622|NCT03386721|83201457|FG005|Overall Study|Lost to Follow-up|2|||
46959623|NCT03386721|83201458|FG006|Overall Study|Lost to Follow-up|1|||
46959624|NCT03386721|83201459|FG007|Overall Study|Lost to Follow-up|0|||
46959625|NCT03386721|83201460|FG008|Overall Study|Lost to Follow-up|1|||
46959626|NCT03386721|83201461|FG009|Overall Study|Lost to Follow-up|2|||
46959627|NCT03386721|83201462|FG010|Overall Study|Lost to Follow-up|1|||
46959628|NCT03386721|83201463|FG011|Overall Study|Lost to Follow-up|0|||
46959629|NCT03386721|83201464|FG012|Overall Study|Lost to Follow-up|0|||
46959630|NCT03386721|83201465|FG013|Overall Study|Lost to Follow-up|0|||
46959631|NCT03386721|83201466|FG014|Overall Study|Lost to Follow-up|0|||
46959632|NCT03386721|83201452|FG000|Overall Study|Reason not specified|3|||
46959633|NCT03386721|83201453|FG001|Overall Study|Reason not specified|0|||
46959634|NCT03386721|83201454|FG002|Overall Study|Reason not specified|0|||
46959635|NCT03386721|83201455|FG003|Overall Study|Reason not specified|0|||
46959636|NCT03386721|83201456|FG004|Overall Study|Reason not specified|0|||
46959637|NCT03386721|83201457|FG005|Overall Study|Reason not specified|3|||
46959638|NCT03386721|83201458|FG006|Overall Study|Reason not specified|1|||
46959639|NCT03386721|83201459|FG007|Overall Study|Reason not specified|0|||
46959640|NCT03386721|83201460|FG008|Overall Study|Reason not specified|0|||
46959641|NCT03386721|83201461|FG009|Overall Study|Reason not specified|1|||
46959642|NCT03386721|83201462|FG010|Overall Study|Reason not specified|2|||
46959643|NCT03386721|83201463|FG011|Overall Study|Reason not specified|6|||
46959644|NCT03386721|83201464|FG012|Overall Study|Reason not specified|1|||
46959645|NCT03386721|83201465|FG013|Overall Study|Reason not specified|0|||
46959646|NCT03386721|83201466|FG014|Overall Study|Reason not specified|0|||
46959647|NCT03386721|83201452|FG000|Overall Study|Progressive Disease|0|||
46959648|NCT03386721|83201453|FG001|Overall Study|Progressive Disease|0|||
46959649|NCT03386721|83201454|FG002|Overall Study|Progressive Disease|1|||
46959650|NCT03386721|83201455|FG003|Overall Study|Progressive Disease|0|||
46959651|NCT03386721|83201456|FG004|Overall Study|Progressive Disease|0|||
46959652|NCT03386721|83201457|FG005|Overall Study|Progressive Disease|1|||
46959653|NCT03386721|83201458|FG006|Overall Study|Progressive Disease|0|||
46959654|NCT03386721|83201459|FG007|Overall Study|Progressive Disease|0|||
46959655|NCT03386721|83201460|FG008|Overall Study|Progressive Disease|2|||
46959656|NCT03386721|83201461|FG009|Overall Study|Progressive Disease|1|||
46959657|NCT03386721|83201462|FG010|Overall Study|Progressive Disease|1|||
46959658|NCT03386721|83201463|FG011|Overall Study|Progressive Disease|0|||
46959659|NCT03386721|83201464|FG012|Overall Study|Progressive Disease|1|||
46959660|NCT03386721|83201465|FG013|Overall Study|Progressive Disease|0|||
47067088|NCT01445951|83350476|FG000|Overall Study|Non-compliance with study drug|1|||
46959661|NCT03386721|83201466|FG014|Overall Study|Progressive Disease|0|||
47067089|NCT01445951|83350477|FG001|Overall Study|Non-compliance with study drug|2|||
46959662|NCT03386721|83201452|FG000|Overall Study|Site Terminated by Sponsor|5|||
46959663|NCT03386721|83201453|FG001|Overall Study|Site Terminated by Sponsor|5|||
46959664|NCT03386721|83201454|FG002|Overall Study|Site Terminated by Sponsor|0|||
46959665|NCT03386721|83201455|FG003|Overall Study|Site Terminated by Sponsor|0|||
46959666|NCT03386721|83201456|FG004|Overall Study|Site Terminated by Sponsor|1|||
46959667|NCT03386721|83201457|FG005|Overall Study|Site Terminated by Sponsor|3|||
46959668|NCT03386721|83201458|FG006|Overall Study|Site Terminated by Sponsor|0|||
46959669|NCT03386721|83201459|FG007|Overall Study|Site Terminated by Sponsor|1|||
46959670|NCT03386721|83201460|FG008|Overall Study|Site Terminated by Sponsor|4|||
46959671|NCT03386721|83201461|FG009|Overall Study|Site Terminated by Sponsor|5|||
46959672|NCT03386721|83201462|FG010|Overall Study|Site Terminated by Sponsor|3|||
46959673|NCT03386721|83201463|FG011|Overall Study|Site Terminated by Sponsor|11|||
46959674|NCT03386721|83201464|FG012|Overall Study|Site Terminated by Sponsor|6|||
46959675|NCT03386721|83201465|FG013|Overall Study|Site Terminated by Sponsor|0|||
46959676|NCT03386721|83201466|FG014|Overall Study|Site Terminated by Sponsor|0|||
46959677|NCT03386721|83201452|FG000|Overall Study|Symptomatic Deterioration|0|||
46959678|NCT03386721|83201453|FG001|Overall Study|Symptomatic Deterioration|0|||
46959679|NCT03386721|83201454|FG002|Overall Study|Symptomatic Deterioration|0|||
46640002|NCT00087516|82813990|FG003|Overall Study|Patient moved|0|||
46640003|NCT00087516|82813987|FG000|Overall Study|Patient was non-compliant|3|||
46640004|NCT00087516|82813988|FG001|Overall Study|Patient was non-compliant|1|||
46640005|NCT00087516|82813989|FG002|Overall Study|Patient was non-compliant|0|||
46640006|NCT00087516|82813990|FG003|Overall Study|Patient was non-compliant|0|||
46640007|NCT00087516|82813987|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
46640008|NCT00087516|82813988|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
46640009|NCT00087516|82813989|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
46640010|NCT00087516|82813990|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
46959680|NCT03386721|83201455|FG003|Overall Study|Symptomatic Deterioration|0|||
46959681|NCT03386721|83201456|FG004|Overall Study|Symptomatic Deterioration|0|||
46959682|NCT03386721|83201457|FG005|Overall Study|Symptomatic Deterioration|0|||
46959683|NCT03386721|83201458|FG006|Overall Study|Symptomatic Deterioration|0|||
46959684|NCT03386721|83201459|FG007|Overall Study|Symptomatic Deterioration|0|||
46959685|NCT03386721|83201460|FG008|Overall Study|Symptomatic Deterioration|1|||
46959686|NCT03386721|83201461|FG009|Overall Study|Symptomatic Deterioration|0|||
46959687|NCT03386721|83201462|FG010|Overall Study|Symptomatic Deterioration|0|||
46959688|NCT03386721|83201463|FG011|Overall Study|Symptomatic Deterioration|1|||
46959689|NCT03386721|83201464|FG012|Overall Study|Symptomatic Deterioration|0|||
46959690|NCT03386721|83201465|FG013|Overall Study|Symptomatic Deterioration|0|||
46959691|NCT03386721|83201466|FG014|Overall Study|Symptomatic Deterioration|0|||
46959692|NCT03386721|83201452|FG000|Overall Study|Withdrawal by Subject|1|||
46959693|NCT03386721|83201453|FG001|Overall Study|Withdrawal by Subject|2|||
46959694|NCT03386721|83201454|FG002|Overall Study|Withdrawal by Subject|0|||
46959695|NCT03386721|83201455|FG003|Overall Study|Withdrawal by Subject|0|||
46959696|NCT03386721|83201456|FG004|Overall Study|Withdrawal by Subject|0|||
46959697|NCT03386721|83201457|FG005|Overall Study|Withdrawal by Subject|0|||
46959698|NCT03386721|83201458|FG006|Overall Study|Withdrawal by Subject|0|||
46959699|NCT03386721|83201459|FG007|Overall Study|Withdrawal by Subject|0|||
46959700|NCT03386721|83201460|FG008|Overall Study|Withdrawal by Subject|2|||
46959701|NCT03386721|83201461|FG009|Overall Study|Withdrawal by Subject|1|||
46959702|NCT03386721|83201462|FG010|Overall Study|Withdrawal by Subject|3|||
46959703|NCT03386721|83201463|FG011|Overall Study|Withdrawal by Subject|2|||
46959704|NCT03386721|83201464|FG012|Overall Study|Withdrawal by Subject|3|||
46959705|NCT03386721|83201465|FG013|Overall Study|Withdrawal by Subject|0|||
46959706|NCT03386721|83201466|FG014|Overall Study|Withdrawal by Subject|0|||
46959707|NCT02462720|83201498|FG000|Part 2|Withdrawal by Subject|1|||
46959708|NCT02462720|83201499|FG001|Part 2|Withdrawal by Subject|0|||
46959709|NCT02462720|83201498|FG000|Part 2|Protocol Violation|0|||
46959710|NCT02462720|83201499|FG001|Part 2|Protocol Violation|1|||
46959711|NCT02246218|83201509|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46959712|NCT02246218|83201510|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
46959713|NCT02246218|83201509|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
46959714|NCT02246218|83201510|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
46959715|NCT02246218|83201509|FG000|Overall Study|Adverse Event|1|||
46959716|NCT02246218|83201510|FG001|Overall Study|Adverse Event|1|||
46959717|NCT02246218|83201509|FG000|Overall Study|Lost to Follow-up|1|||
46959718|NCT02246218|83201510|FG001|Overall Study|Lost to Follow-up|0|||
46959719|NCT02244580|83201516|FG000|Overall Study|No cancer tissues available|241|||
46959720|NCT02244424|83201526|FG000|Overall Study|Lost to Follow-up|20|||
46959721|NCT02244424|83201527|FG001|Overall Study|Lost to Follow-up|10|||
46959722|NCT00159783|83201536|FG000|Overall Study|Adverse Event|5|||
46959723|NCT00159783|83201537|FG001|Overall Study|Adverse Event|7|||
46959724|NCT00159783|83201538|FG002|Overall Study|Adverse Event|9|||
46959725|NCT00159783|83201536|FG000|Overall Study|Lack of Efficacy|1|||
46959726|NCT00159783|83201537|FG001|Overall Study|Lack of Efficacy|2|||
46959727|NCT00159783|83201538|FG002|Overall Study|Lack of Efficacy|3|||
46959728|NCT00159783|83201536|FG000|Overall Study|Withdrawal by Subject|7|||
46959729|NCT00159783|83201537|FG001|Overall Study|Withdrawal by Subject|11|||
46959730|NCT00159783|83201538|FG002|Overall Study|Withdrawal by Subject|12|||
46959731|NCT00159783|83201536|FG000|Overall Study|Lost to Follow-up|6|||
46959732|NCT00159783|83201537|FG001|Overall Study|Lost to Follow-up|5|||
46959733|NCT00159783|83201538|FG002|Overall Study|Lost to Follow-up|11|||
46959734|NCT00159783|83201536|FG000|Overall Study|Other|0|||
46959735|NCT00159783|83201537|FG001|Overall Study|Other|2|||
46959736|NCT00159783|83201538|FG002|Overall Study|Other|4|||
46959737|NCT00646204|83201549|FG000|Overall Study|Adverse Event|3|||
46959738|NCT00646204|83201550|FG001|Overall Study|Adverse Event|0|||
46959739|NCT00646204|83201549|FG000|Overall Study|Withdrawal by Subject|1|||
46959740|NCT00646204|83201550|FG001|Overall Study|Withdrawal by Subject|0|||
46959741|NCT02936323|83201567|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
46959742|NCT02936323|83201568|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
47067090|NCT01445951|83350478|FG002|Overall Study|Non-compliance with study drug|0|||
46640011|NCT00087516|82813987|FG000|Overall Study|Other|0|||
46959743|NCT02936323|83201569|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
46959744|NCT02936323|83201570|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
46959745|NCT02936323|83201571|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
46959746|NCT02936323|83201572|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
46959747|NCT02936323|83201573|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
46959748|NCT02936323|83201574|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
46959749|NCT02936323|83201575|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
46959750|NCT02936323|83201576|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
46959751|NCT02936323|83201567|FG000|Phase 1 Dose Escalation|Death|2|||
46959752|NCT02936323|83201568|FG001|Phase 1 Dose Escalation|Death|1|||
46959753|NCT02936323|83201569|FG002|Phase 1 Dose Escalation|Death|3|||
46959754|NCT02936323|83201570|FG003|Phase 1 Dose Escalation|Death|1|||
46959755|NCT02936323|83201571|FG004|Phase 1 Dose Escalation|Death|2|||
46959756|NCT02936323|83201572|FG005|Phase 1 Dose Escalation|Death|3|||
46959757|NCT02936323|83201573|FG006|Phase 1 Dose Escalation|Death|3|||
46959758|NCT02936323|83201574|FG007|Phase 1 Dose Escalation|Death|0|||
46959759|NCT02936323|83201575|FG008|Phase 1 Dose Escalation|Death|0|||
46959760|NCT02936323|83201576|FG009|Phase 1 Dose Escalation|Death|0|||
46959761|NCT02936323|83201567|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959762|NCT02936323|83201568|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959763|NCT02936323|83201569|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959764|NCT02936323|83201570|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959765|NCT02936323|83201571|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959766|NCT02936323|83201572|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
46959767|NCT02936323|83201573|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959768|NCT02936323|83201574|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959769|NCT02936323|83201575|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959770|NCT02936323|83201576|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
46959771|NCT02936323|83201567|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
46959772|NCT02936323|83201568|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
46959773|NCT02936323|83201569|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
46959774|NCT02936323|83201570|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
46959775|NCT02936323|83201571|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
46959776|NCT02936323|83201572|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
46959777|NCT02936323|83201573|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
46959778|NCT02936323|83201574|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
46959779|NCT02936323|83201575|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
46959780|NCT02936323|83201576|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
46959781|NCT02936323|83201567|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
46959782|NCT02936323|83201568|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
46959783|NCT02936323|83201569|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
46959784|NCT02936323|83201570|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
46959785|NCT02936323|83201571|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
46959786|NCT02936323|83201572|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
46959787|NCT02936323|83201573|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
46959788|NCT02936323|83201574|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
46959789|NCT02936323|83201575|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
46959790|NCT02936323|83201576|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
46959791|NCT02936323|83201567|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959792|NCT02936323|83201568|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959793|NCT02936323|83201569|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959794|NCT02936323|83201570|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959795|NCT02936323|83201571|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959796|NCT02936323|83201572|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959797|NCT02936323|83201573|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959798|NCT02936323|83201574|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
46959799|NCT02936323|83201575|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
46959800|NCT02936323|83201576|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
46959801|NCT02936323|83201567|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959802|NCT02936323|83201568|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959803|NCT02936323|83201569|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959804|NCT02936323|83201570|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959805|NCT02936323|83201571|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959806|NCT02936323|83201572|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959807|NCT02936323|83201573|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959808|NCT02936323|83201574|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959809|NCT02936323|83201575|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
46959810|NCT02936323|83201576|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
46959811|NCT02936323|83201567|FG000|Phase 2a Dose Expansion|Death|0|||
46959812|NCT02936323|83201568|FG001|Phase 2a Dose Expansion|Death|0|||
46959813|NCT02936323|83201569|FG002|Phase 2a Dose Expansion|Death|0|||
46959814|NCT02936323|83201570|FG003|Phase 2a Dose Expansion|Death|0|||
46959815|NCT02936323|83201571|FG004|Phase 2a Dose Expansion|Death|0|||
46959816|NCT02936323|83201572|FG005|Phase 2a Dose Expansion|Death|0|||
46959817|NCT02936323|83201573|FG006|Phase 2a Dose Expansion|Death|0|||
46959818|NCT02936323|83201574|FG007|Phase 2a Dose Expansion|Death|4|||
46959819|NCT02936323|83201575|FG008|Phase 2a Dose Expansion|Death|8|||
46959820|NCT02936323|83201576|FG009|Phase 2a Dose Expansion|Death|10|||
46959821|NCT02243176|83201610|FG000|Overall Study|Other reason|1|||
46959822|NCT02243176|83201611|FG001|Overall Study|Other reason|2|||
46959823|NCT02243176|83201610|FG000|Overall Study|protocol specified withdrawal critera|1|||
46959824|NCT02243176|83201611|FG001|Overall Study|protocol specified withdrawal critera|3|||
46959825|NCT02243176|83201610|FG000|Overall Study|Protocol Violation|2|||
46959826|NCT02243176|83201611|FG001|Overall Study|Protocol Violation|1|||
46959827|NCT02243176|83201610|FG000|Overall Study|Withdrawal by Subject|8|||
46959828|NCT02243176|83201611|FG001|Overall Study|Withdrawal by Subject|7|||
46959829|NCT02243176|83201610|FG000|Overall Study|Adverse Event|2|||
46959830|NCT02243176|83201611|FG001|Overall Study|Adverse Event|2|||
46959831|NCT00002663|83201622|FG000|Overall Study|Death|4|||
46959832|NCT00002663|83201623|FG001|Overall Study|Death|1|||
46959833|NCT00002663|83201624|FG002|Overall Study|Death|1|||
46959834|NCT00002663|83201625|FG003|Overall Study|Death|0|||
46959835|NCT00002663|83201626|FG004|Overall Study|Death|0|||
46959836|NCT00002663|83201627|FG005|Overall Study|Death|13|||
46959837|NCT00002663|83201628|FG006|Overall Study|Death|0|||
46959838|NCT00002663|83201629|FG007|Overall Study|Death|1|||
46959839|NCT00002663|83201630|FG008|Overall Study|Death|1|||
46959840|NCT00002663|83201631|FG009|Overall Study|Death|1|||
46959841|NCT00002663|83201622|FG000|Overall Study|Lost to Follow-up|3|||
46959842|NCT00002663|83201623|FG001|Overall Study|Lost to Follow-up|0|||
46959843|NCT00002663|83201624|FG002|Overall Study|Lost to Follow-up|0|||
46959844|NCT00002663|83201625|FG003|Overall Study|Lost to Follow-up|1|||
46959845|NCT00002663|83201626|FG004|Overall Study|Lost to Follow-up|0|||
46959846|NCT00002663|83201627|FG005|Overall Study|Lost to Follow-up|1|||
46959847|NCT00002663|83201628|FG006|Overall Study|Lost to Follow-up|0|||
46845163|NCT00153062|83062019|FG002|Overall Study|Adverse Event|1|||
46845164|NCT00153062|83062020|FG003|Overall Study|Adverse Event|0|||
46845165|NCT00153062|83062017|FG000|Overall Study|Protocol Violation|0|||
46845166|NCT00153062|83062018|FG001|Overall Study|Protocol Violation|2|||
46845167|NCT00153062|83062019|FG002|Overall Study|Protocol Violation|1|||
46845168|NCT00153062|83062020|FG003|Overall Study|Protocol Violation|1|||
46845169|NCT00153062|83062017|FG000|Overall Study|No disposition data available|1|||
46845170|NCT00153062|83062018|FG001|Overall Study|No disposition data available|1|||
46845171|NCT00153062|83062019|FG002|Overall Study|No disposition data available|1|||
46845172|NCT00153062|83062020|FG003|Overall Study|No disposition data available|1|||
46845173|NCT00153062|83062017|FG000|Overall Study|Other|0|||
46845174|NCT00153062|83062018|FG001|Overall Study|Other|0|||
46845175|NCT00153062|83062019|FG002|Overall Study|Other|1|||
46845176|NCT00153062|83062020|FG003|Overall Study|Other|0|||
46845177|NCT00145470|83062032|FG000|Overall Study|Adverse Event|19|||
46845178|NCT00145470|83062033|FG001|Overall Study|Adverse Event|25|||
46845179|NCT00145470|83062032|FG000|Overall Study|Lack of Efficacy|27|||
46845180|NCT00145470|83062033|FG001|Overall Study|Lack of Efficacy|13|||
46845181|NCT00145470|83062032|FG000|Overall Study|Withdrawal by Subject|36|||
46959848|NCT00002663|83201629|FG007|Overall Study|Lost to Follow-up|0|||
46959849|NCT00002663|83201630|FG008|Overall Study|Lost to Follow-up|0|||
46959850|NCT00002663|83201631|FG009|Overall Study|Lost to Follow-up|0|||
46959851|NCT00002663|83201622|FG000|Overall Study|Other|0|||
46959852|NCT00002663|83201623|FG001|Overall Study|Other|1|||
46959853|NCT00002663|83201624|FG002|Overall Study|Other|0|||
46959854|NCT00002663|83201625|FG003|Overall Study|Other|0|||
46959855|NCT00002663|83201626|FG004|Overall Study|Other|0|||
46959856|NCT00002663|83201627|FG005|Overall Study|Other|1|||
46959857|NCT00002663|83201628|FG006|Overall Study|Other|1|||
46959858|NCT00002663|83201629|FG007|Overall Study|Other|0|||
46959859|NCT00002663|83201630|FG008|Overall Study|Other|0|||
46959860|NCT00002663|83201631|FG009|Overall Study|Other|0|||
46959861|NCT00002663|83201622|FG000|Overall Study|Physician Decision|0|||
46959862|NCT00002663|83201623|FG001|Overall Study|Physician Decision|0|||
46959863|NCT00002663|83201624|FG002|Overall Study|Physician Decision|0|||
46959864|NCT00002663|83201625|FG003|Overall Study|Physician Decision|0|||
46959865|NCT00002663|83201626|FG004|Overall Study|Physician Decision|1|||
46959866|NCT00002663|83201627|FG005|Overall Study|Physician Decision|0|||
46959867|NCT00002663|83201628|FG006|Overall Study|Physician Decision|0|||
46959868|NCT00002663|83201629|FG007|Overall Study|Physician Decision|0|||
46959869|NCT00002663|83201630|FG008|Overall Study|Physician Decision|1|||
46959870|NCT00002663|83201631|FG009|Overall Study|Physician Decision|1|||
46959871|NCT00002663|83201622|FG000|Overall Study|Adverse Event|0|||
46959872|NCT00002663|83201623|FG001|Overall Study|Adverse Event|0|||
46959873|NCT00002663|83201624|FG002|Overall Study|Adverse Event|0|||
46959874|NCT00002663|83201625|FG003|Overall Study|Adverse Event|1|||
46959875|NCT00002663|83201626|FG004|Overall Study|Adverse Event|0|||
46959876|NCT00002663|83201627|FG005|Overall Study|Adverse Event|0|||
46959877|NCT00002663|83201628|FG006|Overall Study|Adverse Event|0|||
46959878|NCT00002663|83201629|FG007|Overall Study|Adverse Event|1|||
46959879|NCT00002663|83201630|FG008|Overall Study|Adverse Event|0|||
46959880|NCT00002663|83201631|FG009|Overall Study|Adverse Event|0|||
46959881|NCT02240680|83201642|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
46959882|NCT02240680|83201643|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
46959883|NCT02240680|83201644|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
46959884|NCT02240680|83201645|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
46959885|NCT02240680|83201642|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
46959886|NCT02240680|83201643|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
46959887|NCT02240680|83201644|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
46959888|NCT02240680|83201645|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
46959889|NCT02240680|83201642|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
46959890|NCT02240680|83201643|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
46959891|NCT02240680|83201644|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
46959892|NCT02240680|83201645|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
46959893|NCT02240680|83201642|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
46959894|NCT02240680|83201643|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
46959895|NCT02240680|83201644|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
46959896|NCT02240680|83201645|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
46959897|NCT02240680|83201642|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
46959898|NCT02240680|83201643|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
46959899|NCT02240680|83201644|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
46959900|NCT02240680|83201645|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
46959901|NCT02240680|83201642|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
46959902|NCT02240680|83201643|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
46959903|NCT02240680|83201644|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
46959904|NCT02240680|83201645|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
46959905|NCT02240680|83201642|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
46959906|NCT02240680|83201643|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
46959907|NCT02240680|83201644|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
46959908|NCT02240680|83201645|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
46959909|NCT02240680|83201642|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
46959910|NCT02240680|83201643|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
46959911|NCT02240680|83201644|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
46959912|NCT02240680|83201645|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
46959913|NCT02240368|83201656|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
46959914|NCT02240368|83201657|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
46959915|NCT02240368|83201658|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
46959916|NCT02240368|83201656|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
46959917|NCT02240368|83201657|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
46959918|NCT02240368|83201658|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
46959919|NCT02239978|83201668|FG000|Overall Study|Withdrawal by Subject|2|||
46959920|NCT02239978|83201669|FG001|Overall Study|Withdrawal by Subject|0|||
46959921|NCT02239510|83201679|FG000|Overall Study|Lost to Follow-up|2|||
46959922|NCT02239510|83201680|FG001|Overall Study|Lost to Follow-up|1|||
46959923|NCT02462486|83201689|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
47067091|NCT01445951|83350476|FG000|Overall Study|Non-compliance with protocol|0|||
47067092|NCT01445951|83350477|FG001|Overall Study|Non-compliance with protocol|1|||
46640012|NCT00087516|82813988|FG001|Overall Study|Other|0|||
46640013|NCT00087516|82813989|FG002|Overall Study|Other|1|||
46640014|NCT00087516|82813990|FG003|Overall Study|Other|0|||
46640015|NCT00087126|82814004|FG000|Overall Study|Ineligible - second primary|1|||
46773915|NCT03474107|82992327|FG001|Overall Study|Death|2|||
46773916|NCT03474107|82992326|FG000|Overall Study|Lost to Follow-up|0|||
46959924|NCT02462486|83201690|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
46959925|NCT02462486|83201691|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
46959926|NCT02462486|83201689|FG000|Overall Study|Adverse Event|53|||
47067093|NCT01445951|83350478|FG002|Overall Study|Non-compliance with protocol|0|||
47067094|NCT01445951|83350476|FG000|Overall Study|Sponsor decision - subject travel|0|||
46640016|NCT00087126|82814004|FG000|Overall Study|Never treated|1|||
46640017|NCT03490734|82814017|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
46640018|NCT03490734|82814018|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
46773917|NCT03474107|82992327|FG001|Overall Study|Lost to Follow-up|1|||
46959927|NCT02462486|83201690|FG001|Overall Study|Adverse Event|48|||
46959928|NCT02462486|83201691|FG002|Overall Study|Adverse Event|21|||
46959929|NCT02462486|83201689|FG000|Overall Study|Lack of Efficacy|6|||
46959930|NCT02462486|83201690|FG001|Overall Study|Lack of Efficacy|12|||
46959931|NCT02462486|83201691|FG002|Overall Study|Lack of Efficacy|3|||
46959932|NCT02462486|83201689|FG000|Overall Study|Lost to Follow-up|3|||
46959933|NCT02462486|83201690|FG001|Overall Study|Lost to Follow-up|4|||
46640019|NCT03490734|82814019|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
46773918|NCT03474107|82992326|FG000|Overall Study|Progressive Disease|177|||
46773919|NCT03474107|82992327|FG001|Overall Study|Progressive Disease|180|||
46773920|NCT03474107|82992326|FG000|Overall Study|Protocol Violation|1|||
46959934|NCT02462486|83201691|FG002|Overall Study|Lost to Follow-up|2|||
46959935|NCT02462486|83201689|FG000|Overall Study|Withdrawal by Subject|25|||
46959936|NCT02462486|83201690|FG001|Overall Study|Withdrawal by Subject|22|||
46959937|NCT02462486|83201691|FG002|Overall Study|Withdrawal by Subject|19|||
46959938|NCT02462486|83201689|FG000|Overall Study|Protocol Violation|3|||
46773921|NCT03474107|82992327|FG001|Overall Study|Protocol Violation|1|||
46773922|NCT03474107|82992326|FG000|Overall Study|Withdrawal by Subject|15|||
46959939|NCT02462486|83201690|FG001|Overall Study|Protocol Violation|1|||
46959940|NCT02462486|83201691|FG002|Overall Study|Protocol Violation|1|||
46959941|NCT02462486|83201689|FG000|Overall Study|Reason not Specified|3|||
46959942|NCT02462486|83201690|FG001|Overall Study|Reason not Specified|4|||
46959943|NCT02462486|83201691|FG002|Overall Study|Reason not Specified|3|||
46959944|NCT02495948|83201699|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
46959945|NCT02495948|83201700|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
46959946|NCT02495948|83201699|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
46959947|NCT02495948|83201700|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
46959948|NCT02461628|83201709|FG000|Overall Study|Refused to complete survey|4|||
46959949|NCT02461628|83201710|FG001|Overall Study|Refused to complete survey|7|||
46959950|NCT02461160|83201729|FG000|Overall Study|Lost to Follow-up|0|||
46959951|NCT02461160|83201730|FG001|Overall Study|Lost to Follow-up|0|||
46959952|NCT02461160|83201731|FG002|Overall Study|Lost to Follow-up|0|||
46959953|NCT02461160|83201732|FG003|Overall Study|Lost to Follow-up|0|||
46959954|NCT02461160|83201733|FG004|Overall Study|Lost to Follow-up|0|||
46959955|NCT02461160|83201734|FG005|Overall Study|Lost to Follow-up|0|||
46959956|NCT02461160|83201735|FG006|Overall Study|Lost to Follow-up|0|||
46959957|NCT02461160|83201736|FG007|Overall Study|Lost to Follow-up|1|||
46959958|NCT02461160|83201737|FG008|Overall Study|Lost to Follow-up|0|||
46959959|NCT02461160|83201738|FG009|Overall Study|Lost to Follow-up|0|||
46959960|NCT02461160|83201739|FG010|Overall Study|Lost to Follow-up|0|||
46959961|NCT02461160|83201740|FG011|Overall Study|Lost to Follow-up|0|||
46959962|NCT02461160|83201741|FG012|Overall Study|Lost to Follow-up|0|||
46959963|NCT01653704|83201792|FG000|Overall Study|Technical failure during recording|1|||
46959964|NCT01653704|83201793|FG001|Overall Study|Technical failure during recording|1|||
46959965|NCT01653704|83201792|FG000|Overall Study|Performance not reflective of training|1|||
46959966|NCT01653704|83201793|FG001|Overall Study|Performance not reflective of training|0|||
46959967|NCT02495168|83201802|FG000|Overall Study|Other than Specified|18|||
46959968|NCT02495168|83201803|FG001|Overall Study|Other than Specified|22|||
46959969|NCT02495168|83201804|FG002|Overall Study|Other than Specified|5|||
46959970|NCT02495168|83201802|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
46959971|NCT02495168|83201803|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
46959972|NCT02495168|83201804|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
46959973|NCT02495168|83201802|FG000|Overall Study|Physician Decision|1|||
46959974|NCT02495168|83201803|FG001|Overall Study|Physician Decision|1|||
46959975|NCT02495168|83201804|FG002|Overall Study|Physician Decision|0|||
46773923|NCT03474107|82992327|FG001|Overall Study|Withdrawal by Subject|27|||
46773924|NCT03474107|82992326|FG000|Overall Study|Physician Decision|7|||
46773925|NCT03474107|82992327|FG001|Overall Study|Physician Decision|22|||
46773926|NCT03474107|82992326|FG000|Overall Study|Miscellaneous|1|||
46773927|NCT03474107|82992327|FG001|Overall Study|Miscellaneous|6|||
46773928|NCT03019185|82992359|FG000|Overall Study|Lost to Follow-up|3|||
46845182|NCT00145470|83062033|FG001|Overall Study|Withdrawal by Subject|34|||
46845183|NCT00145470|83062032|FG000|Overall Study|Lost to Follow-up|21|||
46845184|NCT00145470|83062033|FG001|Overall Study|Lost to Follow-up|17|||
46845185|NCT00145470|83062032|FG000|Overall Study|Reason Not Reported|9|||
46845186|NCT00145470|83062033|FG001|Overall Study|Reason Not Reported|9|||
46845187|NCT00152516|83062039|FG000|Overall Study|Adverse Event|18|||
46845188|NCT00152516|83062039|FG000|Overall Study|Lack and Loss of Efficacy|30|||
46845189|NCT00152516|83062039|FG000|Overall Study|Lost to Follow-up|5|||
46845190|NCT00152516|83062039|FG000|Overall Study|Withdrawal by Subject|8|||
46845191|NCT00152516|83062039|FG000|Overall Study|Protocol Violation|3|||
46845192|NCT00152516|83062039|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
46845193|NCT00152516|83062039|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
46959976|NCT02495168|83201802|FG000|Overall Study|Lost to Follow-up|10|||
46959977|NCT02495168|83201803|FG001|Overall Study|Lost to Follow-up|6|||
46959978|NCT02495168|83201804|FG002|Overall Study|Lost to Follow-up|1|||
46845194|NCT00152516|83062039|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
46773929|NCT03019185|82992360|FG001|Overall Study|Lost to Follow-up|0|||
46773930|NCT03019185|82992361|FG002|Overall Study|Lost to Follow-up|2|||
46773931|NCT03019185|82992359|FG000|Overall Study|Withdrawal by Subject|1|||
46959979|NCT02495168|83201802|FG000|Overall Study|Withdrawal by Subject|1|||
46959980|NCT02495168|83201803|FG001|Overall Study|Withdrawal by Subject|4|||
46959981|NCT02495168|83201804|FG002|Overall Study|Withdrawal by Subject|2|||
46959982|NCT02495168|83201802|FG000|Overall Study|Protocol Violation|0|||
46959983|NCT02495168|83201803|FG001|Overall Study|Protocol Violation|10|||
46959984|NCT02495168|83201804|FG002|Overall Study|Protocol Violation|1|||
46959985|NCT02495168|83201802|FG000|Overall Study|Adverse Event|4|||
46959986|NCT02495168|83201803|FG001|Overall Study|Adverse Event|8|||
46959987|NCT02495168|83201804|FG002|Overall Study|Adverse Event|3|||
46959988|NCT02495168|83201802|FG000|Overall Study|Lack of Efficacy|0|||
46959989|NCT02495168|83201803|FG001|Overall Study|Lack of Efficacy|0|||
46959990|NCT02495168|83201804|FG002|Overall Study|Lack of Efficacy|3|||
46959991|NCT02494778|83201812|FG000|Overall Study|Death|3|||
46959992|NCT02494778|83201812|FG000|Overall Study|Other|173|||
46959993|NCT02494778|83201812|FG000|Overall Study|Lack of Efficacy|4|||
46959994|NCT02494778|83201812|FG000|Overall Study|Adverse Event|18|||
46959995|NCT02494778|83201812|FG000|Overall Study|Withdrawal by Subject|20|||
46959996|NCT02494778|83201812|FG000|Overall Study|Lost to Follow-up|2|||
46959997|NCT02494778|83201812|FG000|Overall Study|Noncompliant with study drug admin.|1|||
46959998|NCT02493764|83201818|FG000|Overall Study|Adverse Event|2|||
46959999|NCT02493764|83201819|FG001|Overall Study|Adverse Event|2|||
46960000|NCT02493764|83201818|FG000|Overall Study|Death|44|||
46960001|NCT02493764|83201819|FG001|Overall Study|Death|58|||
46960002|NCT02493764|83201818|FG000|Overall Study|Lost to Follow-up|2|||
46960003|NCT02493764|83201819|FG001|Overall Study|Lost to Follow-up|1|||
46960004|NCT02493764|83201818|FG000|Overall Study|Protocol Violation|6|||
46960005|NCT02493764|83201819|FG001|Overall Study|Protocol Violation|7|||
46960006|NCT02493764|83201818|FG000|Overall Study|Physician Decision|1|||
46960007|NCT02493764|83201819|FG001|Overall Study|Physician Decision|1|||
46960008|NCT02493764|83201818|FG000|Overall Study|Participant moved|17|||
46960009|NCT02493764|83201819|FG001|Overall Study|Participant moved|5|||
46960010|NCT02493764|83201818|FG000|Overall Study|Withdrawal parent/guardian|0|||
46960011|NCT02493764|83201819|FG001|Overall Study|Withdrawal parent/guardian|1|||
46960012|NCT02493764|83201818|FG000|Overall Study|Withdrawal by Subject|11|||
46960013|NCT02493764|83201819|FG001|Overall Study|Withdrawal by Subject|7|||
46960014|NCT02460380|83201827|FG000|Overall Study|Withdrawal by Subject|10|||
46960015|NCT02460380|83201828|FG001|Overall Study|Withdrawal by Subject|5|||
46960016|NCT02493062|83201835|FG000|Overall Study|Physician Decision|12|||
46960017|NCT02492984|83201841|FG000|Overall Study|Adverse Event|1|||
46960018|NCT02492984|83201842|FG001|Overall Study|Adverse Event|0|||
46960019|NCT02492984|83201841|FG000|Overall Study|Protocol Violation|1|||
46960020|NCT02492984|83201842|FG001|Overall Study|Protocol Violation|0|||
46960021|NCT02492984|83201841|FG000|Overall Study|Withdrawal by Subject|1|||
46960022|NCT02492984|83201842|FG001|Overall Study|Withdrawal by Subject|0|||
46960023|NCT01680159|83201855|FG000|Screening Period|Not meet criteria for dose-up period|7|||
46960024|NCT01680159|83201855|FG000|Increased Dose Period|Adverse Event|6|||
46960025|NCT01680159|83201855|FG000|Increased Dose Period|Withdrawal by Subject|2|||
46960026|NCT02491892|83201877|FG000|Overall Study|Adverse Event|1|||
46960027|NCT02491892|83201878|FG001|Overall Study|Adverse Event|1|||
46960028|NCT02491892|83201877|FG000|Overall Study|Death|1|||
46960029|NCT02491892|83201878|FG001|Overall Study|Death|1|||
46960030|NCT02491892|83201877|FG000|Overall Study|Lack of Efficacy|37|||
46960031|NCT02491892|83201878|FG001|Overall Study|Lack of Efficacy|36|||
46960032|NCT02491892|83201877|FG000|Overall Study|Refused Treatment|1|||
46960033|NCT02491892|83201878|FG001|Overall Study|Refused Treatment|0|||
46960034|NCT02491892|83201877|FG000|Overall Study|Lost to Follow-up|1|||
46960035|NCT02491892|83201878|FG001|Overall Study|Lost to Follow-up|0|||
46960036|NCT04931888|83201888|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
46960037|NCT04931888|83201889|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
46845195|NCT00152516|83062039|FG000|Overall Study|Other: Non-Compliance|2|||
46845196|NCT00152516|83062039|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
46845197|NCT00152516|83062039|FG000|Overall Study|Other: Moved Out Of State|1|||
46845198|NCT00152516|83062039|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
46845199|NCT00152516|83062039|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
46960038|NCT04931888|83201890|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
46960039|NCT04931888|83201891|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
46960040|NCT02436356|83201920|FG000|Overall Study|Excluded by MRI Screening|0|||
46960041|NCT02436356|83201921|FG001|Overall Study|Excluded by MRI Screening|0|||
46640020|NCT03490734|82814020|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
46845200|NCT00145158|83062045|FG000|Overall Study|premature withdrawal|2|||
46845201|NCT00145158|83062046|FG001|Overall Study|premature withdrawal|3|||
46845202|NCT00150800|83062053|FG000|Overall Study|Adverse Event|89|||
46960042|NCT02436356|83201922|FG002|Overall Study|Excluded by MRI Screening|2|||
46960043|NCT02436356|83201920|FG000|Overall Study|Lost to Follow-up|0|||
46960044|NCT02436356|83201921|FG001|Overall Study|Lost to Follow-up|1|||
46960045|NCT02436356|83201922|FG002|Overall Study|Lost to Follow-up|0|||
46960046|NCT02436356|83201920|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
46960047|NCT02436356|83201921|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
46960048|NCT02436356|83201922|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
46960049|NCT02436356|83201920|FG000|Overall Study|Excluded due to other medical conditions|3|||
46960050|NCT02436356|83201921|FG001|Overall Study|Excluded due to other medical conditions|0|||
46773932|NCT03019185|82992360|FG001|Overall Study|Withdrawal by Subject|1|||
46773933|NCT03019185|82992361|FG002|Overall Study|Withdrawal by Subject|0|||
46773934|NCT03019185|82992359|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
46773935|NCT03019185|82992360|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
46960051|NCT02436356|83201922|FG002|Overall Study|Excluded due to other medical conditions|0|||
46960052|NCT02436356|83201920|FG000|Overall Study|Withdrawal by Subject|1|||
46960053|NCT02436356|83201921|FG001|Overall Study|Withdrawal by Subject|0|||
46960054|NCT02436356|83201922|FG002|Overall Study|Withdrawal by Subject|0|||
46960055|NCT02436200|83201935|FG000|Overall Study|Significant outlier|1|||
46960056|NCT01679613|83201939|FG000|Overall Study|other than stated above|0|||
46960057|NCT01679613|83201940|FG001|Overall Study|other than stated above|1|||
46960058|NCT01679613|83201941|FG002|Overall Study|other than stated above|2|||
46960059|NCT01679613|83201942|FG003|Overall Study|other than stated above|2|||
46960060|NCT02489630|83201951|FG000|Overall Study|Oversedation|1|||
46960061|NCT02489630|83201952|FG001|Overall Study|Oversedation|1|||
46960062|NCT02489630|83201951|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
46960063|NCT02489630|83201952|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
46960064|NCT02739347|83201960|FG000|Overall Study|Adverse Event|3|||
46960065|NCT02739347|83201961|FG001|Overall Study|Adverse Event|0|||
46960066|NCT02739347|83201960|FG000|Overall Study|Protocol Violation|0|||
46960067|NCT02739347|83201961|FG001|Overall Study|Protocol Violation|1|||
46960068|NCT02739347|83201960|FG000|Overall Study|Lost to Follow-up|0|||
46960069|NCT02739347|83201961|FG001|Overall Study|Lost to Follow-up|2|||
46960070|NCT02435966|83201970|FG000|Overall Study|Withdrawal by Subject|0|||
46960071|NCT02435966|83201971|FG001|Overall Study|Withdrawal by Subject|1|||
46960072|NCT02435966|83201972|FG002|Overall Study|Withdrawal by Subject|0|||
46960073|NCT01679301|83201980|FG000|Screening Period|screen failure|3|||
46960074|NCT01679301|83201981|FG001|Screening Period|screen failure|0|||
46960075|NCT01679301|83201982|FG002|Screening Period|screen failure|0|||
46960076|NCT01678911|83201988|FG000|Second Intervention|Lost to Follow-up|2|||
46960077|NCT01678911|83201989|FG001|Second Intervention|Lost to Follow-up|0|||
46960078|NCT02487446|83201995|FG000|Period 1|Physician Decision|0|||
46960079|NCT02487446|83201996|FG001|Period 1|Physician Decision|1|||
46960080|NCT02487446|83201995|FG000|Period 1|Lack of Efficacy|1|||
46960081|NCT02487446|83201996|FG001|Period 1|Lack of Efficacy|0|||
46845203|NCT00150800|83062053|FG000|Overall Study|Death|18|||
46845204|NCT00150800|83062053|FG000|Overall Study|Lack of Efficacy|166|||
46845205|NCT00150800|83062053|FG000|Overall Study|Lost to Follow-up|58|||
46845206|NCT00150800|83062053|FG000|Overall Study|Subject's choice|90|||
46845207|NCT00150800|83062053|FG000|Overall Study|No compliance|18|||
46845208|NCT00150800|83062053|FG000|Overall Study|IP misshandling|1|||
46845209|NCT00150800|83062053|FG000|Overall Study|Site closure|24|||
46845210|NCT00150800|83062053|FG000|Overall Study|Protocol non-adherence|2|||
46960082|NCT02487446|83201995|FG000|Period 1|Protocol deviation|3|||
46960083|NCT02487446|83201996|FG001|Period 1|Protocol deviation|2|||
46960084|NCT02487446|83201995|FG000|Period 1|Lost to Follow-up|2|||
46960085|NCT02487446|83201996|FG001|Period 1|Lost to Follow-up|0|||
46960086|NCT02487446|83201995|FG000|Period 1|Withdrawal by Subject|2|||
46960087|NCT02487446|83201996|FG001|Period 1|Withdrawal by Subject|0|||
46960088|NCT02487446|83201995|FG000|Period 1|Adverse Event|5|||
46960089|NCT02487446|83201996|FG001|Period 1|Adverse Event|5|||
46773936|NCT03019185|82992361|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
46773937|NCT03019185|82992359|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
46773938|NCT03019185|82992360|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
46773939|NCT03019185|82992361|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
46773940|NCT02961881|82992374|FG000|Overall Study|Adverse Event|1|||
46773941|NCT02961881|82992375|FG001|Overall Study|Adverse Event|2|||
46845211|NCT00150800|83062053|FG000|Overall Study|Nobody to accompany patient|1|||
46845212|NCT00150800|83062053|FG000|Overall Study|Distance too long for patient|1|||
46845213|NCT00150800|83062053|FG000|Overall Study|Neurosurgery|2|||
46845214|NCT00150800|83062053|FG000|Overall Study|BRV monotherapy|1|||
46960090|NCT02487446|83201995|FG000|Washout|Lost to Follow-up|0|||
46960091|NCT02487446|83201996|FG001|Washout|Lost to Follow-up|2|||
46960092|NCT02487446|83201995|FG000|Washout|Withdrawal by Subject|1|||
46960093|NCT02487446|83201996|FG001|Washout|Withdrawal by Subject|4|||
46960094|NCT02487446|83201995|FG000|Washout|Adverse Event|2|||
46960095|NCT02487446|83201996|FG001|Washout|Adverse Event|2|||
46960096|NCT02487446|83201995|FG000|Period 2|Protocol deviation|0|||
46845215|NCT00150800|83062053|FG000|Overall Study|Visit refusal|3|||
46845216|NCT00150800|83062053|FG000|Overall Study|Sponsor's request|2|||
46845217|NCT00150800|83062053|FG000|Overall Study|Generalized Epilepsy|1|||
46960097|NCT02487446|83201996|FG001|Period 2|Protocol deviation|1|||
46960098|NCT02487446|83201995|FG000|Period 2|Lost to Follow-up|1|||
46960099|NCT02487446|83201996|FG001|Period 2|Lost to Follow-up|1|||
46960100|NCT02487446|83201995|FG000|Period 2|Withdrawal by Subject|1|||
46960101|NCT02487446|83201996|FG001|Period 2|Withdrawal by Subject|1|||
46960102|NCT02487446|83201995|FG000|Period 2|Adverse Event|6|||
46960103|NCT02487446|83201996|FG001|Period 2|Adverse Event|2|||
46960104|NCT02739269|83202005|FG000|Overall Study|Protocol Violation|5|||
46960105|NCT02739269|83202006|FG001|Overall Study|Protocol Violation|0|||
46960106|NCT02739269|83202005|FG000|Overall Study|Cycle cancellation|2|||
46960107|NCT02739269|83202006|FG001|Overall Study|Cycle cancellation|2|||
46960108|NCT02739269|83202005|FG000|Overall Study|Withdrawal by Subject|0|||
46960109|NCT02739269|83202006|FG001|Overall Study|Withdrawal by Subject|2|||
46960110|NCT03318523|83202016|FG000|PC Period: Up to Year 1|Adverse Event|1|||
46960111|NCT03318523|83202017|FG001|PC Period: Up to Year 1|Adverse Event|0|||
46960112|NCT03318523|83202018|FG002|PC Period: Up to Year 1|Adverse Event|2|||
46960113|NCT03318523|83202019|FG003|PC Period: Up to Year 1|Adverse Event|0|||
46960114|NCT03318523|83202020|FG004|PC Period: Up to Year 1|Adverse Event|0|||
46960115|NCT03318523|83202021|FG005|PC Period: Up to Year 1|Adverse Event|0|||
46960116|NCT03318523|83202022|FG006|PC Period: Up to Year 1|Adverse Event|0|||
46960117|NCT03318523|83202023|FG007|PC Period: Up to Year 1|Adverse Event|0|||
46960118|NCT03318523|83202024|FG008|PC Period: Up to Year 1|Adverse Event|0|||
46960119|NCT03318523|83202025|FG009|PC Period: Up to Year 1|Adverse Event|0|||
46960120|NCT03318523|83202016|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
46960121|NCT03318523|83202017|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
46960122|NCT03318523|83202018|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
46960123|NCT03318523|83202019|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
46960124|NCT03318523|83202020|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
46960125|NCT03318523|83202021|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
46960126|NCT03318523|83202022|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
46960127|NCT03318523|83202023|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
46960128|NCT03318523|83202024|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
46960129|NCT03318523|83202025|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
46960130|NCT03318523|83202016|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
46960131|NCT03318523|83202017|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
46960132|NCT03318523|83202018|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
46960133|NCT03318523|83202019|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
46960134|NCT03318523|83202020|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
46960135|NCT03318523|83202021|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
46960136|NCT03318523|83202022|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
46960137|NCT03318523|83202023|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
46960138|NCT03318523|83202024|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
46960139|NCT03318523|83202025|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
46960140|NCT03318523|83202016|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
46960141|NCT03318523|83202017|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
46960142|NCT03318523|83202018|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
46960143|NCT03318523|83202019|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
46960144|NCT03318523|83202020|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
46960145|NCT03318523|83202021|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
46960146|NCT03318523|83202022|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
46960147|NCT03318523|83202023|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
46960148|NCT03318523|83202024|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
46960149|NCT03318523|83202025|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
46960150|NCT03318523|83202016|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960151|NCT03318523|83202017|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960152|NCT03318523|83202018|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960153|NCT03318523|83202019|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960154|NCT03318523|83202020|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960155|NCT03318523|83202021|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
46960156|NCT03318523|83202022|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960157|NCT03318523|83202023|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960158|NCT03318523|83202024|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
47067095|NCT01445951|83350477|FG001|Overall Study|Sponsor decision - subject travel|1|||
47067096|NCT01445951|83350478|FG002|Overall Study|Sponsor decision - subject travel|0|||
47067097|NCT01445951|83350476|FG000|Overall Study|Cough|0|||
47067098|NCT01445951|83350477|FG001|Overall Study|Cough|1|||
47067099|NCT01445951|83350478|FG002|Overall Study|Cough|0|||
47067100|NCT01444781|83350493|FG000|Overall Study|Lost to Follow-up|0|||
47067101|NCT01444781|83350494|FG001|Overall Study|Lost to Follow-up|3|||
47067102|NCT01444781|83350495|FG002|Overall Study|Lost to Follow-up|1|||
47067103|NCT01444781|83350493|FG000|Overall Study|Withdrawal by Subject|3|||
46960159|NCT03318523|83202025|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
46960160|NCT03318523|83202016|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960161|NCT03318523|83202017|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960162|NCT03318523|83202018|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960163|NCT03318523|83202019|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960164|NCT03318523|83202020|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960165|NCT03318523|83202021|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960166|NCT03318523|83202022|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960167|NCT03318523|83202023|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960168|NCT03318523|83202024|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
46960169|NCT03318523|83202025|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
46960170|NCT03318523|83202016|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
46960171|NCT03318523|83202017|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
46960172|NCT03318523|83202018|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
46960173|NCT03318523|83202019|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
46960174|NCT03318523|83202020|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
46960175|NCT03318523|83202021|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
46960176|NCT03318523|83202022|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
46960177|NCT03318523|83202023|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
46960178|NCT03318523|83202024|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
46960179|NCT03318523|83202025|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
46960180|NCT03318523|83202016|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
46960181|NCT03318523|83202017|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
46960182|NCT03318523|83202018|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
46960183|NCT03318523|83202019|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
46960184|NCT03318523|83202020|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
46960185|NCT03318523|83202021|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
46960186|NCT03318523|83202022|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
46960187|NCT03318523|83202023|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
46960188|NCT03318523|83202024|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
46960189|NCT03318523|83202025|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
46960190|NCT01678209|83202052|FG000|Overall Study|could not scan twice|1|||
46960191|NCT01678209|83202053|FG001|Overall Study|could not scan twice|1|||
46960192|NCT01678209|83202054|FG002|Overall Study|could not scan twice|1|||
46960193|NCT01678209|83202052|FG000|Overall Study|scheduling conflicts|0|||
46960194|NCT01678209|83202053|FG001|Overall Study|scheduling conflicts|0|||
46960195|NCT01678209|83202054|FG002|Overall Study|scheduling conflicts|1|||
46960196|NCT01678209|83202052|FG000|Overall Study|screen fail|16|||
46960197|NCT01678209|83202053|FG001|Overall Study|screen fail|17|||
46960198|NCT01678209|83202054|FG002|Overall Study|screen fail|16|||
46960199|NCT02239120|83202064|FG000|Overall Study|Death|56|||
46960200|NCT02239120|83202065|FG001|Overall Study|Death|58|||
46960201|NCT02239120|83202064|FG000|Overall Study|Lost to Follow-up|19|||
46960202|NCT02239120|83202065|FG001|Overall Study|Lost to Follow-up|14|||
46960203|NCT01603407|83202074|FG000|Overall Study|Adverse Event|1|||
46960204|NCT01603407|83202075|FG001|Overall Study|Adverse Event|1|||
46960205|NCT01603407|83202076|FG002|Overall Study|Adverse Event|1|||
46960206|NCT01603407|83202074|FG000|Overall Study|Protocol Violation|2|||
46960207|NCT01603407|83202075|FG001|Overall Study|Protocol Violation|2|||
46960208|NCT01603407|83202076|FG002|Overall Study|Protocol Violation|0|||
46960209|NCT01603407|83202074|FG000|Overall Study|Withdrawal by Subject|8|||
46960210|NCT01603407|83202075|FG001|Overall Study|Withdrawal by Subject|5|||
46960211|NCT01603407|83202076|FG002|Overall Study|Withdrawal by Subject|7|||
46960212|NCT01603407|83202074|FG000|Overall Study|Lost to Follow-up|0|||
46960213|NCT01603407|83202075|FG001|Overall Study|Lost to Follow-up|3|||
46960214|NCT01603407|83202076|FG002|Overall Study|Lost to Follow-up|2|||
46960215|NCT02235454|83202106|FG000|Overall Study|Withdrawal by Subject|2|||
46960216|NCT02235298|83202112|FG000|Overall Study|Lost to Follow-up|6|||
46960217|NCT02235298|83202113|FG001|Overall Study|Lost to Follow-up|5|||
46960218|NCT02235298|83202112|FG000|Overall Study|Adverse Event|2|||
46960219|NCT02235298|83202113|FG001|Overall Study|Adverse Event|2|||
47067104|NCT01444781|83350494|FG001|Overall Study|Withdrawal by Subject|1|||
47067105|NCT01444781|83350495|FG002|Overall Study|Withdrawal by Subject|2|||
46960220|NCT02235298|83202112|FG000|Overall Study|Withdrawal by Subject|0|||
46960221|NCT02235298|83202113|FG001|Overall Study|Withdrawal by Subject|1|||
46960222|NCT02234596|83202119|FG000|Overall Study|Participant not treated|2|||
47067106|NCT01444391|83350510|FG000|Overall Study|Death|1|||
46960223|NCT02234362|83202123|FG000|Overall Study|Not eligible after first screening visit|17|||
46960224|NCT02234362|83202123|FG000|Overall Study|Lost to Follow-up|6|||
47067107|NCT01443923|83350516|FG000|Overall Study|Adverse Event|1|||
46960225|NCT02234362|83202123|FG000|Overall Study|Withdrawal by Subject|3|||
46960226|NCT02234284|83202129|FG000|Overall Study|Death|4|||
46960227|NCT02234284|83202130|FG001|Overall Study|Death|2|||
46960228|NCT02234284|83202129|FG000|Overall Study|Withdrawal by Subject|1|||
46960229|NCT02234284|83202130|FG001|Overall Study|Withdrawal by Subject|0|||
46960230|NCT02234284|83202129|FG000|Overall Study|Lost to Follow-up|20|||
46960231|NCT02234284|83202130|FG001|Overall Study|Lost to Follow-up|7|||
46960232|NCT02232880|83202140|FG000|Overall Study|study stopped prior to randomization|1|||
46960233|NCT02896855|83202146|FG000|Overall Study|Death|50|||
46960234|NCT02896855|83202147|FG001|Overall Study|Death|40|||
46960235|NCT02896855|83202146|FG000|Overall Study|Lost to Follow-up|15|||
46960236|NCT02896855|83202147|FG001|Overall Study|Lost to Follow-up|9|||
46960237|NCT02896855|83202146|FG000|Overall Study|Withdrawal by Subject|7|||
46960238|NCT02896855|83202147|FG001|Overall Study|Withdrawal by Subject|4|||
46960239|NCT02232802|83202158|FG000|Period 1|Sponsor request|1|||
46960240|NCT02232802|83202159|FG001|Period 1|Sponsor request|0|||
46960241|NCT02232802|83202158|FG000|Period 1|Adverse Event|1|||
46960242|NCT02232802|83202159|FG001|Period 1|Adverse Event|1|||
46960243|NCT02434328|83202167|FG000|Overall Study|Adverse Event|9|||
46960244|NCT02434328|83202168|FG001|Overall Study|Adverse Event|4|||
46960245|NCT02434328|83202167|FG000|Overall Study|Lack of Efficacy|0|||
46960246|NCT02434328|83202168|FG001|Overall Study|Lack of Efficacy|2|||
46960247|NCT02434328|83202167|FG000|Overall Study|Physician Decision|0|||
46960248|NCT02434328|83202168|FG001|Overall Study|Physician Decision|1|||
46960249|NCT02434328|83202167|FG000|Overall Study|Withdrawal by Subject|12|||
46960250|NCT02434328|83202168|FG001|Overall Study|Withdrawal by Subject|21|||
46960251|NCT02434328|83202167|FG000|Overall Study|Death|4|||
46960252|NCT02434328|83202168|FG001|Overall Study|Death|7|||
46960253|NCT02434328|83202167|FG000|Overall Study|Lost to Follow-up|1|||
46960254|NCT02434328|83202168|FG001|Overall Study|Lost to Follow-up|6|||
46960255|NCT02434328|83202167|FG000|Overall Study|Other|4|||
46960256|NCT02434328|83202168|FG001|Overall Study|Other|1|||
46960257|NCT02660229|83202177|FG000|Overall Study|Adverse Event|2|||
46960258|NCT02660229|83202178|FG001|Overall Study|Adverse Event|0|||
46960259|NCT02660229|83202177|FG000|Overall Study|Withdrawal by Subject|0|||
46960260|NCT02660229|83202178|FG001|Overall Study|Withdrawal by Subject|1|||
46960261|NCT02232178|83202187|FG000|Overall Study|Lost to Follow-up|0|||
46960262|NCT02232178|83202188|FG001|Overall Study|Lost to Follow-up|1|||
46960263|NCT02232178|83202189|FG002|Overall Study|Lost to Follow-up|0|||
46960264|NCT02232178|83202187|FG000|Overall Study|ineligibility|0|||
46960265|NCT02232178|83202188|FG001|Overall Study|ineligibility|0|||
46960266|NCT02232178|83202189|FG002|Overall Study|ineligibility|1|||
46960267|NCT02232178|83202187|FG000|Overall Study|surgical complication|1|||
46960268|NCT02232178|83202188|FG001|Overall Study|surgical complication|0|||
46960269|NCT02232178|83202189|FG002|Overall Study|surgical complication|0|||
46960270|NCT01678131|83202200|FG000|Overall Study|Adverse Event|0|||
46960271|NCT01678131|83202201|FG001|Overall Study|Adverse Event|1|||
47067108|NCT01443923|83350517|FG001|Overall Study|Adverse Event|0|||
46640021|NCT03490734|82814017|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
46640022|NCT03490734|82814018|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
46640023|NCT03490734|82814019|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
46845218|NCT00150800|83062053|FG000|Overall Study|Moved from area/country|8|||
46845219|NCT00150800|83062053|FG000|Overall Study|PI retiring|2|||
46845220|NCT00150800|83062053|FG000|Overall Study|PI leaving site|2|||
46845221|NCT00150800|83062053|FG000|Overall Study|Patient insurance|1|||
46845222|NCT00150800|83062053|FG000|Overall Study|Surgical intervention|4|||
46845223|NCT00150800|83062053|FG000|Overall Study|Pregnancy planned|1|||
46845224|NCT00150800|83062053|FG000|Overall Study|PI discontinuation request|1|||
46845225|NCT00144300|83062060|FG000|Overall Study|Adverse Event|18|||
46845226|NCT00144300|83062061|FG001|Overall Study|Adverse Event|16|||
46845227|NCT00144300|83062060|FG000|Overall Study|Protocol Violation|1|||
46845228|NCT00144300|83062061|FG001|Overall Study|Protocol Violation|3|||
46845229|NCT00144300|83062060|FG000|Overall Study|Lost to Follow-up|3|||
46845230|NCT00144300|83062061|FG001|Overall Study|Lost to Follow-up|0|||
46845231|NCT00144300|83062060|FG000|Overall Study|Withdrawal by Subject|6|||
46845232|NCT00144300|83062061|FG001|Overall Study|Withdrawal by Subject|6|||
46845233|NCT00144300|83062060|FG000|Overall Study|Other reason (not specified)|1|||
46845234|NCT00144300|83062061|FG001|Overall Study|Other reason (not specified)|3|||
46845235|NCT00149630|83062069|FG000|Overall Study|Incarceration|2|||
46960272|NCT01678131|83202202|FG002|Overall Study|Adverse Event|0|||
46960273|NCT01678131|83202200|FG000|Overall Study|Withdrawal by Subject|0|||
46960274|NCT01678131|83202201|FG001|Overall Study|Withdrawal by Subject|0|||
46960275|NCT01678131|83202202|FG002|Overall Study|Withdrawal by Subject|2|||
46960276|NCT02231164|83202212|FG000|Overall Study|Adverse Event|1|||
46960277|NCT02231164|83202213|FG001|Overall Study|Adverse Event|1|||
46845236|NCT00149630|83062070|FG001|Overall Study|Incarceration|0|||
46845237|NCT00149630|83062069|FG000|Overall Study|Treatment Programs|4|||
46845238|NCT00149630|83062070|FG001|Overall Study|Treatment Programs|5|||
46960278|NCT02231164|83202212|FG000|Overall Study|Lack of Efficacy|4|||
46960279|NCT02231164|83202213|FG001|Overall Study|Lack of Efficacy|3|||
46960280|NCT02231164|83202212|FG000|Overall Study|Withdrawal by Subject|1|||
46960281|NCT02231164|83202213|FG001|Overall Study|Withdrawal by Subject|2|||
46960282|NCT02457182|83202221|FG000|Overall Study|Lost to Follow-up|1|||
46960283|NCT02457182|83202222|FG001|Overall Study|Lost to Follow-up|0|||
46960284|NCT02230384|83202230|FG000|Phase 1|Lost to Follow-up|1|||
46960285|NCT02230384|83202231|FG001|Phase 1|Lost to Follow-up|0|||
46960286|NCT02230384|83202230|FG000|Phase 1|Physician Decision|0|||
46960287|NCT02230384|83202231|FG001|Phase 1|Physician Decision|1|||
46960288|NCT02230384|83202230|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
46960289|NCT02230384|83202231|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
46960290|NCT02230384|83202230|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
46960291|NCT02230384|83202231|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
46960292|NCT02230384|83202230|FG000|Phase 2 - Switch|Adverse Event|2|||
46960293|NCT02230384|83202231|FG001|Phase 2 - Switch|Adverse Event|0|||
46960294|NCT02738801|83202247|FG000|Overall Study|Adverse Event|1|||
46960295|NCT02738801|83202248|FG001|Overall Study|Adverse Event|1|||
46640024|NCT03490734|82814020|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
46960296|NCT02738801|83202247|FG000|Overall Study|Withdrawal by Subject|0|||
46960297|NCT02738801|83202248|FG001|Overall Study|Withdrawal by Subject|1|||
46960298|NCT02230306|83202264|FG000|Overall Study|Did not receive study treatment|1|||
46960299|NCT01680861|83202270|FG000|Early Post-transplant Period|Protocol Violation|1|||
46960300|NCT01680861|83202271|FG001|Early Post-transplant Period|Protocol Violation|1|||
46960301|NCT02229214|83202281|FG000|Overall Study|Adverse Event|2|||
46960302|NCT02229214|83202282|FG001|Overall Study|Adverse Event|0|||
46960303|NCT02229214|83202281|FG000|Overall Study|Withdrawal by Subject|4|||
46960304|NCT02229214|83202282|FG001|Overall Study|Withdrawal by Subject|0|||
46960305|NCT02228980|83202294|FG000|Overall Study|Adverse Event|14|||
46960306|NCT02228980|83202295|FG001|Overall Study|Adverse Event|0|||
46960307|NCT02228980|83202296|FG002|Overall Study|Adverse Event|0|||
46960308|NCT02228980|83202297|FG003|Overall Study|Adverse Event|0|||
46960309|NCT02228980|83202294|FG000|Overall Study|Protocol Violation|7|||
46960310|NCT02228980|83202295|FG001|Overall Study|Protocol Violation|0|||
46960311|NCT02228980|83202296|FG002|Overall Study|Protocol Violation|0|||
46960312|NCT02228980|83202297|FG003|Overall Study|Protocol Violation|0|||
46960313|NCT02228980|83202294|FG000|Overall Study|Withdrawal by Subject|3|||
46960314|NCT02228980|83202295|FG001|Overall Study|Withdrawal by Subject|3|||
46960315|NCT02228980|83202296|FG002|Overall Study|Withdrawal by Subject|2|||
46960316|NCT02228980|83202297|FG003|Overall Study|Withdrawal by Subject|3|||
46960317|NCT02228590|83202311|FG000|Overall Study|Withdrawal by Subject|1|||
46960318|NCT02227108|83202316|FG000|Overall Study|Did not receive treatment|2|||
46960319|NCT02227108|83202316|FG000|Overall Study|Other|3|||
46960320|NCT02227108|83202316|FG000|Overall Study|Progressive disease|17|||
46960321|NCT02227108|83202316|FG000|Overall Study|Initiation of alternative therapy|2|||
46960322|NCT02227108|83202316|FG000|Overall Study|Investigator discretion|1|||
46960323|NCT02227108|83202316|FG000|Overall Study|Adverse Event|6|||
46960324|NCT03564145|83202320|FG000|Overall Study|Adverse Event|4|||
46960325|NCT03564145|83202320|FG000|Overall Study|Lost to Follow-up|21|||
46960326|NCT03564145|83202320|FG000|Overall Study|Protocol Violation|2|||
46960327|NCT03564145|83202320|FG000|Overall Study|Withdrawal by Subject|48|||
46960328|NCT03564145|83202320|FG000|Overall Study|Study Terminated by Sponsor|146|||
46960329|NCT03564145|83202320|FG000|Overall Study|Physician Decision|1|||
46960330|NCT03564145|83202320|FG000|Overall Study|Other Than Specified|1|||
46960331|NCT03564145|83202320|FG000|Overall Study|Pregnancy|1|||
46960332|NCT02226562|83202326|FG000|Overall Study|Lost to Follow-up|0|||
46960333|NCT02226562|83202327|FG001|Overall Study|Lost to Follow-up|1|||
46960334|NCT02456636|83202361|FG000|Overall Study|Death|0|||
46960335|NCT02456636|83202362|FG001|Overall Study|Death|3|||
46960336|NCT02456636|83202363|FG002|Overall Study|Death|0|||
46960337|NCT02456636|83202361|FG000|Overall Study|Pregnancy|1|||
46960338|NCT02456636|83202362|FG001|Overall Study|Pregnancy|3|||
46960339|NCT02456636|83202363|FG002|Overall Study|Pregnancy|5|||
46960340|NCT02456636|83202361|FG000|Overall Study|Physician Decision|4|||
46960341|NCT02456636|83202362|FG001|Overall Study|Physician Decision|5|||
46960342|NCT02456636|83202363|FG002|Overall Study|Physician Decision|4|||
46960343|NCT02456636|83202361|FG000|Overall Study|Withdrawal by Subject|13|||
46773942|NCT02961881|82992376|FG002|Overall Study|Adverse Event|2|||
46960344|NCT02456636|83202362|FG001|Overall Study|Withdrawal by Subject|14|||
46960345|NCT02456636|83202363|FG002|Overall Study|Withdrawal by Subject|16|||
46960346|NCT02456636|83202361|FG000|Overall Study|Lost to Follow-up|50|||
46960347|NCT02456636|83202362|FG001|Overall Study|Lost to Follow-up|44|||
46960348|NCT02456636|83202363|FG002|Overall Study|Lost to Follow-up|50|||
46960349|NCT02226172|83202371|FG000|Overall Study|Participant refused further follow-up|4|||
46960350|NCT02226172|83202371|FG000|Overall Study|Other|5|||
46960351|NCT02226172|83202371|FG000|Overall Study|Death|1|||
46960352|NCT02226172|83202371|FG000|Overall Study|Study terminated by sponsor|1|||
46960353|NCT02226172|83202371|FG000|Overall Study|Adverse Event|6|||
46960354|NCT01676961|83202375|FG000|Overall Study|Death|3|||
46960355|NCT01676961|83202375|FG000|Overall Study|Lost to Follow-up|1|||
46960356|NCT01676961|83202375|FG000|Overall Study|Withdrawal by Subject|1|||
46960357|NCT01676727|83202397|FG000|Overall Study|Death|18|||
46960358|NCT01676727|83202397|FG000|Overall Study|Withdrawal by Subject|6|||
46960359|NCT01676727|83202397|FG000|Overall Study|Screening failure|5|||
46960360|NCT01676727|83202397|FG000|Overall Study|Not willing to attend 1-year visit|2|||
46960361|NCT01676727|83202397|FG000|Overall Study|Valve explanted|1|||
46960362|NCT02738879|83202404|FG000|Overall Study|Adverse Event|1|||
46960363|NCT02738879|83202405|FG001|Overall Study|Adverse Event|1|||
46960364|NCT02738879|83202404|FG000|Overall Study|Death|0|||
46960365|NCT02738879|83202405|FG001|Overall Study|Death|2|||
46960366|NCT02738879|83202404|FG000|Overall Study|Lost to Follow-up|1|||
46960367|NCT02738879|83202405|FG001|Overall Study|Lost to Follow-up|5|||
46960368|NCT02738879|83202404|FG000|Overall Study|Protocol Violation|1|||
46960369|NCT02738879|83202405|FG001|Overall Study|Protocol Violation|3|||
46960370|NCT02738879|83202404|FG000|Overall Study|Physician Decision|3|||
46960371|NCT02738879|83202405|FG001|Overall Study|Physician Decision|4|||
46960372|NCT02738879|83202404|FG000|Overall Study|Pregnancy|0|||
46960373|NCT02738879|83202405|FG001|Overall Study|Pregnancy|1|||
46960374|NCT02738879|83202404|FG000|Overall Study|Screen Failure|1|||
46960375|NCT02738879|83202405|FG001|Overall Study|Screen Failure|2|||
46960376|NCT02738879|83202404|FG000|Overall Study|Site Discontinued Study Participation|1|||
46960377|NCT02738879|83202405|FG001|Overall Study|Site Discontinued Study Participation|0|||
46960378|NCT02738879|83202404|FG000|Overall Study|Withdrawal by Subject|5|||
46960379|NCT02738879|83202405|FG001|Overall Study|Withdrawal by Subject|7|||
46960380|NCT03502811|83202411|FG000|Overall Study|Death|157|||
46960381|NCT03502811|83202411|FG000|Overall Study|Withdrawal by Subject|105|||
46960382|NCT03502811|83202411|FG000|Overall Study|Lost to Follow-up|26|||
46960383|NCT03502811|83202411|FG000|Overall Study|No Visits (Missed)|31|||
46960384|NCT00515671|83202423|FG000|Overall Study|Lost to Follow-up|13|||
46960385|NCT00515671|83202424|FG001|Overall Study|Lost to Follow-up|10|||
46960386|NCT00515671|83202423|FG000|Overall Study|Withdrawal by Subject|3|||
46960387|NCT00515671|83202424|FG001|Overall Study|Withdrawal by Subject|5|||
46960388|NCT00515671|83202423|FG000|Overall Study|incarcerated|1|||
46960389|NCT00515671|83202424|FG001|Overall Study|incarcerated|2|||
46960390|NCT01677195|83202433|FG000|Overall Study|Lost to Follow-up|14|||
46960391|NCT01677195|83202434|FG001|Overall Study|Lost to Follow-up|22|||
46960392|NCT01677195|83202435|FG002|Overall Study|Lost to Follow-up|22|||
46960393|NCT01677195|83202433|FG000|Overall Study|Withdrawal by Subject|1|||
46960394|NCT01677195|83202434|FG001|Overall Study|Withdrawal by Subject|0|||
46960395|NCT01677195|83202435|FG002|Overall Study|Withdrawal by Subject|1|||
46960396|NCT01677195|83202433|FG000|Overall Study|Adverse Event|6|||
46960397|NCT01677195|83202434|FG001|Overall Study|Adverse Event|4|||
46960398|NCT01677195|83202435|FG002|Overall Study|Adverse Event|1|||
46960399|NCT01677195|83202433|FG000|Overall Study|Physician Decision|1|||
46960400|NCT01677195|83202434|FG001|Overall Study|Physician Decision|2|||
46960401|NCT01677195|83202435|FG002|Overall Study|Physician Decision|2|||
46960402|NCT01677195|83202433|FG000|Overall Study|Pregnancy|0|||
46960403|NCT01677195|83202434|FG001|Overall Study|Pregnancy|1|||
46960404|NCT01677195|83202435|FG002|Overall Study|Pregnancy|0|||
46960405|NCT01677195|83202433|FG000|Overall Study|Protocol Violation|7|||
46960406|NCT01677195|83202434|FG001|Overall Study|Protocol Violation|3|||
46960407|NCT01677195|83202435|FG002|Overall Study|Protocol Violation|4|||
46960408|NCT00928447|83202447|FG000|Overall Study|Withdrawal by Subject|1|||
46960409|NCT00928447|83202447|FG000|Overall Study|Investigator's decision|1|||
46960410|NCT02224846|83202453|FG000|Period 1 (Month 3)|Adverse Event|2|||
46960411|NCT02224846|83202454|FG001|Period 1 (Month 3)|Adverse Event|1|||
46960412|NCT02224846|83202453|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
46960413|NCT02224846|83202454|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
47067109|NCT01551212|83350529|FG000|Overall Study|Graft loss/Retransplantation|0|||
47067110|NCT01551212|83350530|FG001|Overall Study|Graft loss/Retransplantation|1|||
47067111|NCT01551212|83350529|FG000|Overall Study|Administrative problems|1|||
46960414|NCT02224846|83202453|FG000|Period 1 (Month 3)|Protocol Violation|4|||
46960415|NCT02224846|83202454|FG001|Period 1 (Month 3)|Protocol Violation|8|||
46960416|NCT02224846|83202453|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
46960417|NCT02224846|83202454|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
46960418|NCT02224846|83202453|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
46960419|NCT02224846|83202454|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
46960420|NCT02224846|83202453|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
46960421|NCT02224846|83202454|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
46960422|NCT02224846|83202453|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
46960423|NCT02224846|83202454|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
46960424|NCT02224846|83202453|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
47067112|NCT01551212|83350530|FG001|Overall Study|Administrative problems|2|||
46960425|NCT02224846|83202454|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
46960426|NCT02224846|83202453|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
46960427|NCT02224846|83202454|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
46960428|NCT02224846|83202453|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
46960429|NCT02224846|83202454|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
46960430|NCT02224846|83202453|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
46960431|NCT02224846|83202454|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
46960432|NCT02224846|83202453|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
46960433|NCT02224846|83202454|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
46960434|NCT02224846|83202453|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
46960435|NCT02224846|83202454|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
46960436|NCT02224846|83202453|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
46960437|NCT02224846|83202454|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
46960438|NCT02224846|83202453|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
46960439|NCT02224846|83202454|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
46960440|NCT02224846|83202453|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
46960441|NCT02224846|83202454|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
46960442|NCT02224846|83202453|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
46960443|NCT02224846|83202454|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
46960444|NCT01632280|83202462|FG000|Overall Study|Withdrawal by Subject|1|||
46960445|NCT01632280|83202463|FG001|Overall Study|Withdrawal by Subject|0|||
46960446|NCT02224690|83202471|FG000|Overall Study|Adverse Event|8|||
46960447|NCT02224690|83202472|FG001|Overall Study|Adverse Event|1|||
46960448|NCT02224690|83202471|FG000|Overall Study|Met Withdrawal Criteria|4|||
46960449|NCT02224690|83202472|FG001|Overall Study|Met Withdrawal Criteria|0|||
46960450|NCT02224690|83202471|FG000|Overall Study|Use of G-tube|1|||
46960451|NCT02224690|83202472|FG001|Overall Study|Use of G-tube|0|||
46960452|NCT02224690|83202471|FG000|Overall Study|Did not meet eligibility criteria|1|||
46960453|NCT02224690|83202472|FG001|Overall Study|Did not meet eligibility criteria|0|||
46960454|NCT01634152|83202481|FG000|Overall Study|Adverse Event|2|||
46960455|NCT01634152|83202482|FG001|Overall Study|Adverse Event|0|||
46960456|NCT01634152|83202483|FG002|Overall Study|Adverse Event|2|||
46960457|NCT01634152|83202481|FG000|Overall Study|Consent withdrawn not due to AE|1|||
46960458|NCT01634152|83202482|FG001|Overall Study|Consent withdrawn not due to AE|0|||
46960459|NCT01634152|83202483|FG002|Overall Study|Consent withdrawn not due to AE|1|||
46960460|NCT01634152|83202481|FG000|Overall Study|Not treated|0|||
46960461|NCT01634152|83202482|FG001|Overall Study|Not treated|1|||
46960462|NCT01634152|83202483|FG002|Overall Study|Not treated|0|||
46960463|NCT01634152|83202481|FG000|Overall Study|Other reason not defined above|1|||
46960464|NCT01634152|83202482|FG001|Overall Study|Other reason not defined above|0|||
46960465|NCT01634152|83202483|FG002|Overall Study|Other reason not defined above|1|||
46960466|NCT03862807|83202491|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
46960467|NCT04906499|83202495|FG000|Overall Study|Lack of time|1|||
46960468|NCT04757649|83202499|FG000|Overall Study|Withdrawal by Subject|1|||
46960469|NCT04757649|83202499|FG000|Overall Study|Adverse Event|1|||
46960470|NCT04393779|83202503|FG000|Overall Study|Death|1|||
46960471|NCT04393779|83202503|FG000|Overall Study|Device reintervention or explant|4|||
46960472|NCT03718884|83202507|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
46960473|NCT03718884|83202508|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
46960474|NCT03718884|83202507|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
47067113|NCT01551212|83350529|FG000|Overall Study|Lost to Follow-up|0|||
47067114|NCT01551212|83350530|FG001|Overall Study|Lost to Follow-up|1|||
47067115|NCT01551212|83350529|FG000|Overall Study|Protocol Violation|0|||
47067116|NCT01551212|83350530|FG001|Overall Study|Protocol Violation|1|||
47067117|NCT01551212|83350529|FG000|Overall Study|Withdrawal by Subject|0|||
47067118|NCT01551212|83350530|FG001|Overall Study|Withdrawal by Subject|7|||
47067119|NCT01551212|83350529|FG000|Overall Study|Death|2|||
47067120|NCT01551212|83350530|FG001|Overall Study|Death|4|||
47067121|NCT01551212|83350529|FG000|Overall Study|Never Received Study Treatment|2|||
47067122|NCT01551212|83350530|FG001|Overall Study|Never Received Study Treatment|4|||
47067123|NCT01550744|83350590|FG000|Open-Label|Lost to Follow-up|7|||
47067124|NCT01550744|83350591|FG001|Open-Label|Lost to Follow-up|0|||
47067125|NCT01550744|83350592|FG002|Open-Label|Lost to Follow-up|0|||
47067126|NCT01550744|83350590|FG000|Open-Label|Withdrawal by Subject|13|||
47067127|NCT01550744|83350591|FG001|Open-Label|Withdrawal by Subject|0|||
46960475|NCT03718884|83202508|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
46960476|NCT03509467|83202531|FG000|Overall Study|Withdrawal by Subject|5|||
46960477|NCT03509467|83202532|FG001|Overall Study|Withdrawal by Subject|1|||
46960478|NCT03509467|83202533|FG002|Overall Study|Withdrawal by Subject|6|||
46960479|NCT03509467|83202534|FG003|Overall Study|Withdrawal by Subject|7|||
46960480|NCT03509467|83202535|FG004|Overall Study|Withdrawal by Subject|10|||
47067128|NCT01550744|83350592|FG002|Open-Label|Withdrawal by Subject|0|||
47067129|NCT01550744|83350590|FG000|Open-Label|Adverse Event|11|||
47067130|NCT01550744|83350591|FG001|Open-Label|Adverse Event|0|||
47067131|NCT01550744|83350592|FG002|Open-Label|Adverse Event|0|||
46773943|NCT02961881|82992377|FG003|Overall Study|Adverse Event|0|||
46960481|NCT03509467|83202536|FG005|Overall Study|Withdrawal by Subject|10|||
46960482|NCT03509467|83202537|FG006|Overall Study|Withdrawal by Subject|10|||
46960483|NCT03509467|83202538|FG007|Overall Study|Withdrawal by Subject|10|||
46960484|NCT03509467|83202531|FG000|Overall Study|Death|0|||
46960485|NCT03509467|83202532|FG001|Overall Study|Death|0|||
46960486|NCT03509467|83202533|FG002|Overall Study|Death|2|||
46960487|NCT03509467|83202534|FG003|Overall Study|Death|2|||
46960488|NCT03509467|83202535|FG004|Overall Study|Death|1|||
46960489|NCT03509467|83202536|FG005|Overall Study|Death|0|||
46960490|NCT03509467|83202537|FG006|Overall Study|Death|1|||
46960491|NCT03509467|83202538|FG007|Overall Study|Death|0|||
46960492|NCT03509467|83202531|FG000|Overall Study|Proxy Withdrawal|0|||
46960493|NCT03509467|83202532|FG001|Overall Study|Proxy Withdrawal|0|||
46960494|NCT03509467|83202533|FG002|Overall Study|Proxy Withdrawal|0|||
46960495|NCT03509467|83202534|FG003|Overall Study|Proxy Withdrawal|0|||
46960496|NCT03509467|83202535|FG004|Overall Study|Proxy Withdrawal|0|||
46960497|NCT03509467|83202536|FG005|Overall Study|Proxy Withdrawal|0|||
46960498|NCT03509467|83202537|FG006|Overall Study|Proxy Withdrawal|0|||
46960499|NCT03509467|83202538|FG007|Overall Study|Proxy Withdrawal|1|||
46960500|NCT03406156|83202562|FG000|Overall Study|Death|6|||
46960501|NCT03406156|83202563|FG001|Overall Study|Death|2|||
46960502|NCT03406156|83202562|FG000|Overall Study|Withdrawal by Subject|0|||
46960503|NCT03406156|83202563|FG001|Overall Study|Withdrawal by Subject|2|||
46960504|NCT03406156|83202562|FG000|Overall Study|COVID-19 infection|1|||
46960505|NCT03406156|83202563|FG001|Overall Study|COVID-19 infection|0|||
46960506|NCT03406156|83202562|FG000|Overall Study|Non-compliance with study procedures|0|||
46960507|NCT03406156|83202563|FG001|Overall Study|Non-compliance with study procedures|1|||
46960508|NCT03406156|83202562|FG000|Overall Study|Other, not specified|0|||
46960509|NCT03406156|83202563|FG001|Overall Study|Other, not specified|1|||
46960510|NCT03021954|83202573|FG000|Overall Study|Lost to Follow-up|10|||
46960511|NCT03021954|83202574|FG001|Overall Study|Lost to Follow-up|43|||
46960512|NCT03021954|83202573|FG000|Overall Study|Subjects had avulsion trauma|4|||
46960513|NCT03021954|83202574|FG001|Overall Study|Subjects had avulsion trauma|1|||
46960514|NCT02994927|83202584|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46960515|NCT02994927|83202585|FG001|Overall Study|Withdrawal by parent/guardian|1|||
46960516|NCT02994927|83202584|FG000|Overall Study|Did not meet eligibility criteria|0|||
46960517|NCT02994927|83202585|FG001|Overall Study|Did not meet eligibility criteria|1|||
46960518|NCT02994927|83202584|FG000|Overall Study|Physician Decision|4|||
46960519|NCT02994927|83202585|FG001|Overall Study|Physician Decision|3|||
46960520|NCT02994927|83202584|FG000|Overall Study|Death|4|||
46960521|NCT02994927|83202585|FG001|Overall Study|Death|2|||
46960522|NCT02994927|83202584|FG000|Overall Study|Adverse Event|2|||
46960523|NCT02994927|83202585|FG001|Overall Study|Adverse Event|1|||
46960524|NCT02994927|83202584|FG000|Overall Study|Withdrawal by Subject|3|||
46960525|NCT02994927|83202585|FG001|Overall Study|Withdrawal by Subject|6|||
46960526|NCT02994927|83202584|FG000|Overall Study|Lost to Follow-up|2|||
46960527|NCT02994927|83202585|FG001|Overall Study|Lost to Follow-up|1|||
46960528|NCT02718716|83202596|FG000|Overall Study|Lack of Efficacy|1|||
46960529|NCT02718716|83202597|FG001|Overall Study|Lack of Efficacy|0|||
46960530|NCT02718716|83202598|FG002|Overall Study|Lack of Efficacy|0|||
46960531|NCT02718716|83202599|FG003|Overall Study|Lack of Efficacy|0|||
46960532|NCT02718716|83202600|FG004|Overall Study|Lack of Efficacy|0|||
46960533|NCT02032823|83202623|FG000|Overall Study|Death|75|||
46960534|NCT02032823|83202624|FG001|Overall Study|Death|109|||
47067132|NCT01550744|83350590|FG000|Open-Label|Lack of Efficacy|4|||
46640025|NCT03490734|82814017|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
46640026|NCT03490734|82814018|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
46640027|NCT03490734|82814019|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
46640028|NCT03490734|82814020|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
46640029|NCT03490734|82814017|FG000|Post-intervention Scan Visit|Adverse Event|2|||
46640030|NCT03490734|82814018|FG001|Post-intervention Scan Visit|Adverse Event|0|||
46640031|NCT03490734|82814019|FG002|Post-intervention Scan Visit|Adverse Event|0|||
47067133|NCT01550744|83350591|FG001|Open-Label|Lack of Efficacy|0|||
47067134|NCT01550744|83350592|FG002|Open-Label|Lack of Efficacy|0|||
47067135|NCT01550744|83350590|FG000|Open-Label|Protocol Violation|4|||
47067136|NCT01550744|83350591|FG001|Open-Label|Protocol Violation|0|||
47067137|NCT01550744|83350592|FG002|Open-Label|Protocol Violation|0|||
46640032|NCT03490734|82814020|FG003|Post-intervention Scan Visit|Adverse Event|0|||
46640033|NCT03490734|82814017|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
46640034|NCT03490734|82814018|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
46640035|NCT03490734|82814019|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
46640036|NCT03490734|82814020|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
46960535|NCT02032823|83202623|FG000|Overall Study|Lost to Follow-up|18|||
46960536|NCT02032823|83202624|FG001|Overall Study|Lost to Follow-up|17|||
46960537|NCT02032823|83202623|FG000|Overall Study|Withdrawal by Subject|70|||
46960538|NCT02032823|83202624|FG001|Overall Study|Withdrawal by Subject|53|||
46960539|NCT02032823|83202623|FG000|Overall Study|Ongoing study at data cut-off|755|||
47067138|NCT01550744|83350590|FG000|Open-Label|Not all 3 study drug injections received|2|||
46960540|NCT02032823|83202624|FG001|Overall Study|Ongoing study at data cut-off|731|||
46960541|NCT02032823|83202623|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
46960542|NCT02032823|83202624|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
46960543|NCT01267955|83202630|FG000|Stage 1 (6 Months)|Death|3|||
46960544|NCT01267955|83202630|FG000|Stage 2 (6 Months)|Death|5|||
46960545|NCT01267955|83202630|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
46960546|NCT00890045|83202636|FG000|Overall Study|Death|0|||
46960547|NCT00890045|83202637|FG001|Overall Study|Death|1|||
46960548|NCT00890045|83202636|FG000|Overall Study|Did not receive HeRO Graft|0|||
46960549|NCT00890045|83202637|FG001|Overall Study|Did not receive HeRO Graft|2|||
46960550|NCT00890045|83202636|FG000|Overall Study|Lost to Follow-up|5|||
46960551|NCT00890045|83202637|FG001|Overall Study|Lost to Follow-up|7|||
46960552|NCT00598481|83202650|FG000|Treatment|Physician Decision|1|||
46960553|NCT01378429|83202677|FG000|Overall Study|Noncompliance with study drug|1|||
46960554|NCT01378429|83202678|FG001|Overall Study|Noncompliance with study drug|0|||
46960555|NCT01599754|83202689|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
46960556|NCT01599754|83202690|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
46960557|NCT01599754|83202689|FG000|Overall Study|Participant noncompliance|4|||
46960558|NCT01599754|83202690|FG001|Overall Study|Participant noncompliance|4|||
46960559|NCT01599754|83202689|FG000|Overall Study|Lost to Follow-up|13|||
46960560|NCT01599754|83202690|FG001|Overall Study|Lost to Follow-up|6|||
46960561|NCT01599754|83202689|FG000|Overall Study|Death|31|||
46960562|NCT01599754|83202690|FG001|Overall Study|Death|33|||
46960563|NCT01599754|83202689|FG000|Overall Study|Adverse Event|3|||
46960564|NCT01599754|83202690|FG001|Overall Study|Adverse Event|2|||
46960565|NCT01599754|83202689|FG000|Overall Study|Investigator decision|1|||
46960566|NCT01599754|83202690|FG001|Overall Study|Investigator decision|3|||
46960567|NCT01599754|83202689|FG000|Overall Study|Withdrawal by Subject|24|||
46960568|NCT01599754|83202690|FG001|Overall Study|Withdrawal by Subject|25|||
46960569|NCT01599754|83202689|FG000|Overall Study|Study terminated by sponsor|282|||
46960570|NCT01599754|83202690|FG001|Overall Study|Study terminated by sponsor|285|||
46960571|NCT02223754|83202698|FG000|Period 1|Adverse Event|1|||
46960572|NCT02223754|83202699|FG001|Period 1|Adverse Event|0|||
46960573|NCT02223754|83202698|FG000|Period 1|Lost to Follow-up|0|||
46960574|NCT02223754|83202699|FG001|Period 1|Lost to Follow-up|1|||
46960575|NCT02223754|83202698|FG000|Period 1|Protocol Violation|2|||
46960576|NCT02223754|83202699|FG001|Period 1|Protocol Violation|4|||
46960577|NCT02223754|83202698|FG000|Period 1|Withdrawal by Subject|0|||
46960578|NCT02223754|83202699|FG001|Period 1|Withdrawal by Subject|4|||
46960579|NCT02223754|83202698|FG000|Period 1|Test Article No Longer Available|1|||
46960580|NCT02223754|83202699|FG001|Period 1|Test Article No Longer Available|5|||
46960581|NCT02223754|83202698|FG000|Period 1|Unsatisfactory Visual Response|0|||
46960582|NCT02223754|83202699|FG001|Period 1|Unsatisfactory Visual Response|1|||
46960583|NCT02223754|83202698|FG000|Period 2|Adverse Event|0|||
46960584|NCT02223754|83202699|FG001|Period 2|Adverse Event|1|||
46960585|NCT02223754|83202698|FG000|Period 2|Protocol Violation|1|||
46960586|NCT02223754|83202699|FG001|Period 2|Protocol Violation|0|||
46960587|NCT02223754|83202698|FG000|Period 2|Lens Discomfort|1|||
46960588|NCT02223754|83202699|FG001|Period 2|Lens Discomfort|1|||
46960589|NCT02223754|83202698|FG000|Period 2|Lost to Follow-up|1|||
46960590|NCT02223754|83202699|FG001|Period 2|Lost to Follow-up|0|||
46960591|NCT02223754|83202698|FG000|Period 2|Test Article No Longer Available|0|||
46960592|NCT02223754|83202699|FG001|Period 2|Test Article No Longer Available|1|||
46960593|NCT02223364|83202709|FG000|Overall Study|Protocol Violation|3|||
46960594|NCT02223364|83202710|FG001|Overall Study|Protocol Violation|0|||
46960595|NCT02223364|83202711|FG002|Overall Study|Protocol Violation|3|||
46960596|NCT02223364|83202709|FG000|Overall Study|subject expired before surgery|1|||
46960597|NCT02223364|83202710|FG001|Overall Study|subject expired before surgery|0|||
46960598|NCT02223364|83202711|FG002|Overall Study|subject expired before surgery|0|||
46960599|NCT02223364|83202709|FG000|Overall Study|Physician Decision|1|||
46960600|NCT02223364|83202710|FG001|Overall Study|Physician Decision|0|||
46960601|NCT02223364|83202711|FG002|Overall Study|Physician Decision|0|||
46960602|NCT01378975|83202721|FG000|Overall Study|Death|77|||
46960603|NCT01378975|83202722|FG001|Overall Study|Death|46|||
46960604|NCT01378975|83202721|FG000|Overall Study|Investigator Request|1|||
46960605|NCT01378975|83202722|FG001|Overall Study|Investigator Request|0|||
46960606|NCT01378975|83202721|FG000|Overall Study|Lost to Follow-up|4|||
46960607|NCT01378975|83202722|FG001|Overall Study|Lost to Follow-up|1|||
46960608|NCT01378975|83202721|FG000|Overall Study|Withdrew Consent|4|||
46960609|NCT01378975|83202722|FG001|Overall Study|Withdrew Consent|3|||
46960610|NCT02222896|83202729|FG000|Abdomen|Did not qualify|34|||
46960611|NCT02222896|83202730|FG001|Abdomen|Did not qualify|10|||
46960612|NCT02222896|83202731|FG002|Abdomen|Did not qualify|32|||
46960613|NCT02222896|83202729|FG000|Groin|Did not qualify|43|||
46960614|NCT02222896|83202730|FG001|Groin|Did not qualify|9|||
46960615|NCT02222896|83202731|FG002|Groin|Did not qualify|40|||
46960616|NCT02222818|83202744|FG000|Period 1|Eligibility criteria not met|0|||
46960617|NCT02222818|83202745|FG001|Period 1|Eligibility criteria not met|3|||
46960618|NCT01378195|83202752|FG000|Overall Study|Lost to Follow-up|29|||
46960619|NCT01378195|83202753|FG001|Overall Study|Lost to Follow-up|18|||
46960620|NCT01378117|83202762|FG000|Overall Study|withdrawal|2|||
46960621|NCT01378117|83202763|FG001|Overall Study|withdrawal|1|||
46960622|NCT01378117|83202764|FG002|Overall Study|withdrawal|2|||
46960623|NCT01378117|83202762|FG000|Overall Study|discharged before med given|2|||
46960624|NCT01378117|83202763|FG001|Overall Study|discharged before med given|0|||
46960625|NCT01378117|83202764|FG002|Overall Study|discharged before med given|1|||
46960626|NCT04254809|83202799|FG000|Overall Study|Lost to Follow-up|5|||
46960627|NCT04254809|83202800|FG001|Overall Study|Lost to Follow-up|10|||
46960628|NCT02736409|83202819|FG000|Overall Study|Withdrawal by Subject|4|||
46960629|NCT02736409|83202820|FG001|Overall Study|Withdrawal by Subject|2|||
46960630|NCT02736409|83202821|FG002|Overall Study|Withdrawal by Subject|17|||
46960631|NCT02736409|83202822|FG003|Overall Study|Withdrawal by Subject|3|||
46960632|NCT02736409|83202819|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46960633|NCT02736409|83202820|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46960634|NCT02736409|83202821|FG002|Overall Study|Non-Compliance with Study Drug|0|||
46960635|NCT02736409|83202822|FG003|Overall Study|Non-Compliance with Study Drug|1|||
46960636|NCT02736409|83202819|FG000|Overall Study|Adverse Event|0|||
46960637|NCT02736409|83202820|FG001|Overall Study|Adverse Event|1|||
46960638|NCT02736409|83202821|FG002|Overall Study|Adverse Event|5|||
46960639|NCT02736409|83202822|FG003|Overall Study|Adverse Event|4|||
46960640|NCT02736409|83202819|FG000|Overall Study|Other|0|||
46960641|NCT02736409|83202820|FG001|Overall Study|Other|0|||
46960642|NCT02736409|83202821|FG002|Overall Study|Other|1|||
46960643|NCT02736409|83202822|FG003|Overall Study|Other|1|||
46960644|NCT02736409|83202819|FG000|Overall Study|Pregnancy|0|||
46960645|NCT02736409|83202820|FG001|Overall Study|Pregnancy|0|||
46960646|NCT02736409|83202821|FG002|Overall Study|Pregnancy|1|||
46960647|NCT02736409|83202822|FG003|Overall Study|Pregnancy|0|||
46960648|NCT02736409|83202819|FG000|Overall Study|Lost to Follow-up|0|||
46960649|NCT02736409|83202820|FG001|Overall Study|Lost to Follow-up|0|||
46960650|NCT02736409|83202821|FG002|Overall Study|Lost to Follow-up|2|||
46960651|NCT02736409|83202822|FG003|Overall Study|Lost to Follow-up|1|||
46960652|NCT02736409|83202819|FG000|Overall Study|Physician Decision|0|||
46960653|NCT02736409|83202820|FG001|Overall Study|Physician Decision|0|||
46960654|NCT02736409|83202821|FG002|Overall Study|Physician Decision|0|||
46960655|NCT02736409|83202822|FG003|Overall Study|Physician Decision|2|||
46960656|NCT03099707|83202835|FG000|Overall Study|Withdrawal by Subject|0|||
46960657|NCT03099707|83202836|FG001|Overall Study|Withdrawal by Subject|3|||
46960658|NCT03099707|83202835|FG000|Overall Study|Lost to Follow-up|0|||
46773944|NCT02961881|82992378|FG004|Overall Study|Adverse Event|1|||
46773945|NCT02961881|82992374|FG000|Overall Study|Participant request|0|||
46773946|NCT02961881|82992375|FG001|Overall Study|Participant request|2|||
46773947|NCT02961881|82992376|FG002|Overall Study|Participant request|0|||
46773948|NCT02961881|82992377|FG003|Overall Study|Participant request|0|||
46773949|NCT02961881|82992378|FG004|Overall Study|Participant request|0|||
46773950|NCT02961881|82992374|FG000|Overall Study|Disease progression|1|||
46773951|NCT02961881|82992375|FG001|Overall Study|Disease progression|0|||
46773952|NCT02961881|82992376|FG002|Overall Study|Disease progression|1|||
46773953|NCT02961881|82992377|FG003|Overall Study|Disease progression|0|||
46773954|NCT02961881|82992378|FG004|Overall Study|Disease progression|0|||
46773955|NCT02891382|82992412|FG000|Overall Study|Lost to Follow-up|3|||
46773956|NCT02891382|82992413|FG001|Overall Study|Lost to Follow-up|4|||
46773957|NCT02891382|82992414|FG002|Overall Study|Lost to Follow-up|5|||
46773958|NCT02891382|82992415|FG003|Overall Study|Lost to Follow-up|3|||
46960659|NCT03099707|83202836|FG001|Overall Study|Lost to Follow-up|1|||
46960660|NCT02906033|83202844|FG000|Baseline|Protocol Violation|37|||
46960661|NCT02906033|83202845|FG001|Baseline|Protocol Violation|33|||
46960662|NCT02906033|83202844|FG000|Follow-up|Lost to Follow-up|46|||
46960663|NCT02906033|83202845|FG001|Follow-up|Lost to Follow-up|62|||
46960664|NCT02221882|83202857|FG000|Overall Study|Withdrawal by Subject|0|||
46960665|NCT02221882|83202858|FG001|Overall Study|Withdrawal by Subject|0|||
46960666|NCT02221882|83202859|FG002|Overall Study|Withdrawal by Subject|4|||
46960667|NCT02221882|83202860|FG003|Overall Study|Withdrawal by Subject|2|||
46773959|NCT02891382|82992416|FG004|Overall Study|Lost to Follow-up|4|||
46773960|NCT02860039|82992426|FG000|Overall Study|Death|4|||
46773961|NCT02860039|82992427|FG001|Overall Study|Death|0|||
46773962|NCT02860039|82992426|FG000|Overall Study|Lost to Follow-up|2|||
46773963|NCT02860039|82992427|FG001|Overall Study|Lost to Follow-up|2|||
46773964|NCT02860039|82992426|FG000|Overall Study|Protocol Violation|3|||
46960668|NCT02221882|83202861|FG004|Overall Study|Withdrawal by Subject|2|||
46960669|NCT02221882|83202862|FG005|Overall Study|Withdrawal by Subject|2|||
46960670|NCT02221882|83202857|FG000|Overall Study|Death|0|||
46960671|NCT02221882|83202858|FG001|Overall Study|Death|1|||
46960672|NCT02221882|83202859|FG002|Overall Study|Death|0|||
46960673|NCT02221882|83202860|FG003|Overall Study|Death|0|||
46960674|NCT02221882|83202861|FG004|Overall Study|Death|0|||
46960675|NCT02221882|83202862|FG005|Overall Study|Death|0|||
46960676|NCT02837783|83202883|FG000|Overall Study|Adverse Event|1|||
46960677|NCT02837783|83202884|FG001|Overall Study|Adverse Event|0|||
46960678|NCT02837783|83202883|FG000|Overall Study|Other, Not Specified|1|||
46960679|NCT02837783|83202884|FG001|Overall Study|Other, Not Specified|2|||
46960680|NCT02221648|83202892|FG000|Overall Study|Withdrawal by Subject|3|||
46960681|NCT02221648|83202893|FG001|Overall Study|Withdrawal by Subject|3|||
46960682|NCT02220712|83202903|FG000|Overall Study|Adverse Event|1|||
46960683|NCT02220712|83202903|FG000|Overall Study|Withdrawal by Subject|2|||
46960684|NCT02220712|83202903|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
46960685|NCT02219932|83202913|FG000|Overall Study|Other|5|||
46960686|NCT02219932|83202914|FG001|Overall Study|Other|11|||
46960687|NCT02219932|83202913|FG000|Overall Study|Death|1|||
46960688|NCT02219932|83202914|FG001|Overall Study|Death|1|||
46960689|NCT02219932|83202913|FG000|Overall Study|Investigator Decision|0|||
46960690|NCT02219932|83202914|FG001|Overall Study|Investigator Decision|1|||
46960691|NCT02219932|83202913|FG000|Overall Study|Consent Withdrawn|11|||
46960692|NCT02219932|83202914|FG001|Overall Study|Consent Withdrawn|7|||
46960693|NCT02219932|83202913|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
46960694|NCT02219932|83202914|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
46960695|NCT02219932|83202913|FG000|Overall Study|Protocol Violation|10|||
46960696|NCT02219932|83202914|FG001|Overall Study|Protocol Violation|6|||
46960697|NCT02219932|83202913|FG000|Overall Study|Pregnancy|1|||
46960698|NCT02219932|83202914|FG001|Overall Study|Pregnancy|0|||
46960699|NCT02219932|83202913|FG000|Overall Study|Lost to Follow-up|4|||
46960700|NCT02219932|83202914|FG001|Overall Study|Lost to Follow-up|2|||
46960701|NCT02219932|83202913|FG000|Overall Study|Adverse Event|23|||
46960702|NCT02219932|83202914|FG001|Overall Study|Adverse Event|21|||
46960703|NCT02219464|83202926|FG000|Overall Study|Withdrawal by Subject|1|||
46960704|NCT02219464|83202927|FG001|Overall Study|Withdrawal by Subject|0|||
46960705|NCT02219464|83202926|FG000|Overall Study|case cancelled|1|||
46960706|NCT02219464|83202927|FG001|Overall Study|case cancelled|0|||
46960707|NCT02219464|83202926|FG000|Overall Study|catheter malfunction|1|||
46960708|NCT02219464|83202927|FG001|Overall Study|catheter malfunction|0|||
46960709|NCT02219308|83202935|FG000|Overall Study|Withdrawal by Subject|1|||
46960710|NCT02219308|83202936|FG001|Overall Study|Withdrawal by Subject|2|||
46960711|NCT02218372|83202944|FG000|Overall Study|Adverse Event|1|||
46960712|NCT02218372|83202945|FG001|Overall Study|Adverse Event|1|||
46960713|NCT02218372|83202944|FG000|Overall Study|Miscellaneous|2|||
46960714|NCT02218372|83202945|FG001|Overall Study|Miscellaneous|1|||
46960715|NCT02218372|83202944|FG000|Overall Study|Randomized but did not receive treatment|2|||
46960716|NCT02218372|83202945|FG001|Overall Study|Randomized but did not receive treatment|3|||
46960717|NCT02218372|83202944|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46960718|NCT02218372|83202945|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
46960719|NCT02218216|83202958|FG000|Overall Study|Study terminated before completed|6|||
46960720|NCT02218216|83202959|FG001|Overall Study|Study terminated before completed|0|||
46960721|NCT02218216|83202960|FG002|Overall Study|Study terminated before completed|0|||
46960722|NCT02217982|83202970|FG000|Overall Study|Trial discontinued|1|||
46960723|NCT02217982|83202971|FG001|Overall Study|Trial discontinued|0|||
46960724|NCT02217982|83202970|FG000|Overall Study|Adverse Event|0|||
46960725|NCT02217982|83202971|FG001|Overall Study|Adverse Event|1|||
46960726|NCT02254408|83202979|FG000|Overall Study|Randomized But Not Treated|1|||
47067139|NCT01550744|83350591|FG001|Open-Label|Not all 3 study drug injections received|0|||
47067140|NCT01550744|83350592|FG002|Open-Label|Not all 3 study drug injections received|0|||
47067141|NCT01550744|83350590|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
47067142|NCT01550744|83350591|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
47067143|NCT01550744|83350592|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
47067144|NCT01550744|83350590|FG000|Open-Label|Other|1|||
47067145|NCT01550744|83350591|FG001|Open-Label|Other|0|||
47067146|NCT01550744|83350592|FG002|Open-Label|Other|0|||
47067147|NCT01550744|83350590|FG000|Double-Blind|Lost to Follow-up|0|||
47067148|NCT01550744|83350591|FG001|Double-Blind|Lost to Follow-up|6|||
47067149|NCT01550744|83350592|FG002|Double-Blind|Lost to Follow-up|12|||
47067150|NCT01550744|83350590|FG000|Double-Blind|Withdrawal by Subject|0|||
47067151|NCT01550744|83350591|FG001|Double-Blind|Withdrawal by Subject|2|||
47067152|NCT01550744|83350592|FG002|Double-Blind|Withdrawal by Subject|15|||
47067153|NCT01550744|83350590|FG000|Double-Blind|Adverse Event|0|||
46640037|NCT03490734|82814017|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
46960727|NCT02254408|83202980|FG001|Overall Study|Randomized But Not Treated|3|||
46960728|NCT02254408|83202979|FG000|Overall Study|Adverse Event|1|||
46960729|NCT02254408|83202980|FG001|Overall Study|Adverse Event|0|||
46960730|NCT02254408|83202979|FG000|Overall Study|Death|2|||
46960731|NCT02254408|83202980|FG001|Overall Study|Death|3|||
46960732|NCT02254408|83202979|FG000|Overall Study|Investigator's Discretion|0|||
46960733|NCT02254408|83202980|FG001|Overall Study|Investigator's Discretion|1|||
46960734|NCT02254408|83202979|FG000|Overall Study|Withdrawal by Subject|3|||
46960735|NCT02254408|83202980|FG001|Overall Study|Withdrawal by Subject|3|||
46960736|NCT02254408|83202979|FG000|Overall Study|Lost to Follow-up|1|||
46960737|NCT02254408|83202980|FG001|Overall Study|Lost to Follow-up|0|||
46960738|NCT02207608|83202988|FG000|Overall Study|Adverse Event|1|||
46960739|NCT02207608|83202989|FG001|Overall Study|Adverse Event|0|||
46960740|NCT03530995|83202997|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
46960741|NCT03530995|83202998|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
46960742|NCT03530995|83202997|FG000|Part 1 Period 3|Protocol Violation|1|||
46960743|NCT03530995|83202998|FG001|Part 1 Period 3|Protocol Violation|0|||
46960744|NCT03530995|83202997|FG000|Part 1 Period 4|Physician Decision|1|||
46960745|NCT03530995|83202998|FG001|Part 1 Period 4|Physician Decision|0|||
46960746|NCT03530995|83202997|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
46960747|NCT03530995|83202998|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
46960748|NCT02217436|83203022|FG000|Overall Study|Protocol Violation|1|||
46960749|NCT02217436|83203023|FG001|Overall Study|Protocol Violation|1|||
46960750|NCT02217436|83203022|FG000|Overall Study|Incomplete data|0|||
46960751|NCT02217436|83203023|FG001|Overall Study|Incomplete data|1|||
46960752|NCT02207530|83203029|FG000|Overall Study|Worsening condition under investigation|78|||
46960753|NCT02207530|83203029|FG000|Overall Study|Patient decision to stop study treatment|5|||
46960754|NCT02207530|83203029|FG000|Overall Study|Adverse Event|8|||
46960755|NCT02207374|83203036|FG000|Overall Study|Withdrawal by Subject|5|||
46960756|NCT02207374|83203037|FG001|Overall Study|Withdrawal by Subject|9|||
46960757|NCT02207374|83203038|FG002|Overall Study|Withdrawal by Subject|4|||
46960758|NCT02207374|83203036|FG000|Overall Study|Death|1|||
46960759|NCT02207374|83203037|FG001|Overall Study|Death|0|||
46960760|NCT02207374|83203038|FG002|Overall Study|Death|1|||
46960761|NCT02207374|83203036|FG000|Overall Study|Missing follow-up information|0|||
46960762|NCT02207374|83203037|FG001|Overall Study|Missing follow-up information|1|||
46960763|NCT02207374|83203038|FG002|Overall Study|Missing follow-up information|1|||
46960764|NCT02217280|83203046|FG000|Overall Study|Withdrawal by Subject|2|||
46960765|NCT02217280|83203046|FG000|Overall Study|Post-consent sceen fail|2|||
46960766|NCT02786537|83203057|FG000|As Randomized|Adverse Event|0|||
46960767|NCT02786537|83203058|FG001|As Randomized|Adverse Event|11|||
46960768|NCT02786537|83203059|FG002|As Randomized|Adverse Event|0|||
46960769|NCT02786537|83203060|FG003|As Randomized|Adverse Event|4|||
46960770|NCT02786537|83203061|FG004|As Randomized|Adverse Event|6|||
46960771|NCT02786537|83203062|FG005|As Randomized|Adverse Event|2|||
46960772|NCT02786537|83203057|FG000|As Randomized|Lack of Efficacy|0|||
46960773|NCT02786537|83203058|FG001|As Randomized|Lack of Efficacy|0|||
46960774|NCT02786537|83203059|FG002|As Randomized|Lack of Efficacy|0|||
46960775|NCT02786537|83203060|FG003|As Randomized|Lack of Efficacy|1|||
46960776|NCT02786537|83203061|FG004|As Randomized|Lack of Efficacy|0|||
46960777|NCT02786537|83203062|FG005|As Randomized|Lack of Efficacy|0|||
46960778|NCT02786537|83203057|FG000|As Randomized|Withdrawal by Subject|1|||
46960779|NCT02786537|83203058|FG001|As Randomized|Withdrawal by Subject|2|||
46960780|NCT02786537|83203059|FG002|As Randomized|Withdrawal by Subject|0|||
46960781|NCT02786537|83203060|FG003|As Randomized|Withdrawal by Subject|1|||
46960782|NCT02786537|83203061|FG004|As Randomized|Withdrawal by Subject|1|||
46960783|NCT02786537|83203062|FG005|As Randomized|Withdrawal by Subject|0|||
46960784|NCT02786537|83203057|FG000|As Randomized|Death|0|||
46960785|NCT02786537|83203058|FG001|As Randomized|Death|2|||
46960786|NCT02786537|83203059|FG002|As Randomized|Death|0|||
46960787|NCT02786537|83203060|FG003|As Randomized|Death|3|||
46960788|NCT02786537|83203061|FG004|As Randomized|Death|1|||
46960789|NCT02786537|83203062|FG005|As Randomized|Death|0|||
46960790|NCT02786537|83203057|FG000|As Randomized|Non-compliance with study drug|1|||
46960791|NCT02786537|83203058|FG001|As Randomized|Non-compliance with study drug|11|||
46960792|NCT02786537|83203059|FG002|As Randomized|Non-compliance with study drug|0|||
46960793|NCT02786537|83203060|FG003|As Randomized|Non-compliance with study drug|1|||
46960794|NCT02786537|83203061|FG004|As Randomized|Non-compliance with study drug|0|||
46960795|NCT02786537|83203062|FG005|As Randomized|Non-compliance with study drug|1|||
46960796|NCT02786537|83203057|FG000|As Randomized|Lost to treatment follow-up|4|||
47067154|NCT01550744|83350591|FG001|Double-Blind|Adverse Event|4|||
47067155|NCT01550744|83350592|FG002|Double-Blind|Adverse Event|15|||
47067156|NCT01550744|83350590|FG000|Double-Blind|Death|0|||
47067157|NCT01550744|83350591|FG001|Double-Blind|Death|1|||
47067158|NCT01550744|83350592|FG002|Double-Blind|Death|0|||
46773965|NCT02860039|82992427|FG001|Overall Study|Protocol Violation|1|||
46960797|NCT02786537|83203058|FG001|As Randomized|Lost to treatment follow-up|32|||
46960798|NCT02786537|83203059|FG002|As Randomized|Lost to treatment follow-up|0|||
46960799|NCT02786537|83203060|FG003|As Randomized|Lost to treatment follow-up|24|||
46960800|NCT02786537|83203061|FG004|As Randomized|Lost to treatment follow-up|4|||
46960801|NCT02786537|83203062|FG005|As Randomized|Lost to treatment follow-up|4|||
46960802|NCT02786537|83203057|FG000|As Randomized|Incarceration|0|||
46960803|NCT02786537|83203058|FG001|As Randomized|Incarceration|1|||
46960804|NCT02786537|83203059|FG002|As Randomized|Incarceration|0|||
46960805|NCT02786537|83203060|FG003|As Randomized|Incarceration|0|||
46960806|NCT02786537|83203061|FG004|As Randomized|Incarceration|0|||
46960807|NCT02786537|83203062|FG005|As Randomized|Incarceration|0|||
46960808|NCT02786537|83203057|FG000|As Randomized|Opiate Dependency Relapse|0|||
46960809|NCT02786537|83203058|FG001|As Randomized|Opiate Dependency Relapse|1|||
47067159|NCT01550744|83350590|FG000|Double-Blind|Lack of Efficacy|0|||
46960810|NCT02786537|83203059|FG002|As Randomized|Opiate Dependency Relapse|0|||
46960811|NCT02786537|83203060|FG003|As Randomized|Opiate Dependency Relapse|0|||
46960812|NCT02786537|83203061|FG004|As Randomized|Opiate Dependency Relapse|0|||
46960813|NCT02786537|83203062|FG005|As Randomized|Opiate Dependency Relapse|0|||
46960814|NCT02786537|83203057|FG000|As Randomized|HCV drugs stolen from pt|0|||
46960815|NCT02786537|83203058|FG001|As Randomized|HCV drugs stolen from pt|1|||
46960816|NCT02786537|83203059|FG002|As Randomized|HCV drugs stolen from pt|0|||
46960817|NCT02786537|83203060|FG003|As Randomized|HCV drugs stolen from pt|0|||
46960818|NCT02786537|83203061|FG004|As Randomized|HCV drugs stolen from pt|0|||
46960819|NCT02786537|83203062|FG005|As Randomized|HCV drugs stolen from pt|0|||
46960820|NCT02786537|83203057|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
46960821|NCT02786537|83203058|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
46960822|NCT02786537|83203059|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
46960823|NCT02786537|83203060|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
46960824|NCT02786537|83203061|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
46960825|NCT02786537|83203062|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
46960826|NCT02786537|83203057|FG000|As Randomized|Subject lost insurance|0|||
46960827|NCT02786537|83203058|FG001|As Randomized|Subject lost insurance|0|||
46960828|NCT02786537|83203059|FG002|As Randomized|Subject lost insurance|0|||
46960829|NCT02786537|83203060|FG003|As Randomized|Subject lost insurance|1|||
46960830|NCT02786537|83203061|FG004|As Randomized|Subject lost insurance|0|||
46960831|NCT02786537|83203062|FG005|As Randomized|Subject lost insurance|0|||
46960832|NCT02786537|83203057|FG000|As Treated|Adverse Event|0|||
46960833|NCT02786537|83203058|FG001|As Treated|Adverse Event|11|||
46960834|NCT02786537|83203059|FG002|As Treated|Adverse Event|0|||
46960835|NCT02786537|83203060|FG003|As Treated|Adverse Event|4|||
46960836|NCT02786537|83203061|FG004|As Treated|Adverse Event|6|||
46960837|NCT02786537|83203062|FG005|As Treated|Adverse Event|2|||
46960838|NCT02786537|83203057|FG000|As Treated|Death|0|||
46960839|NCT02786537|83203058|FG001|As Treated|Death|2|||
46960840|NCT02786537|83203059|FG002|As Treated|Death|0|||
46960841|NCT02786537|83203060|FG003|As Treated|Death|3|||
46960842|NCT02786537|83203061|FG004|As Treated|Death|1|||
46960843|NCT02786537|83203062|FG005|As Treated|Death|0|||
46960844|NCT02786537|83203057|FG000|As Treated|Lack of Efficacy|0|||
46960845|NCT02786537|83203058|FG001|As Treated|Lack of Efficacy|0|||
46960846|NCT02786537|83203059|FG002|As Treated|Lack of Efficacy|0|||
46960847|NCT02786537|83203060|FG003|As Treated|Lack of Efficacy|1|||
46960848|NCT02786537|83203061|FG004|As Treated|Lack of Efficacy|0|||
46960849|NCT02786537|83203062|FG005|As Treated|Lack of Efficacy|0|||
46960850|NCT02786537|83203057|FG000|As Treated|Lost to Follow-up|4|||
46960851|NCT02786537|83203058|FG001|As Treated|Lost to Follow-up|32|||
46960852|NCT02786537|83203059|FG002|As Treated|Lost to Follow-up|0|||
46960853|NCT02786537|83203060|FG003|As Treated|Lost to Follow-up|25|||
46960854|NCT02786537|83203061|FG004|As Treated|Lost to Follow-up|4|||
46960855|NCT02786537|83203062|FG005|As Treated|Lost to Follow-up|4|||
46960856|NCT02786537|83203057|FG000|As Treated|Non-compliance with study drug|1|||
46960857|NCT02786537|83203058|FG001|As Treated|Non-compliance with study drug|11|||
46960858|NCT02786537|83203059|FG002|As Treated|Non-compliance with study drug|0|||
46960859|NCT02786537|83203060|FG003|As Treated|Non-compliance with study drug|1|||
46960860|NCT02786537|83203061|FG004|As Treated|Non-compliance with study drug|0|||
47067160|NCT01550744|83350591|FG001|Double-Blind|Lack of Efficacy|2|||
47067161|NCT01550744|83350592|FG002|Double-Blind|Lack of Efficacy|8|||
47067162|NCT01550744|83350590|FG000|Double-Blind|Protocol Violation|0|||
47067163|NCT01550744|83350591|FG001|Double-Blind|Protocol Violation|0|||
46773966|NCT02860039|82992426|FG000|Overall Study|Withdrawal by Subject|1|||
46773967|NCT02860039|82992427|FG001|Overall Study|Withdrawal by Subject|0|||
46773968|NCT02860039|82992426|FG000|Overall Study|Not otherwise eligible|1|||
46773969|NCT02860039|82992427|FG001|Overall Study|Not otherwise eligible|1|||
46773970|NCT02807636|82992436|FG000|Overall Study|Lost to Follow-up|9|||
46773971|NCT02807636|82992437|FG001|Overall Study|Lost to Follow-up|12|||
46773972|NCT02807636|82992438|FG002|Overall Study|Lost to Follow-up|6|||
46773973|NCT02807636|82992436|FG000|Overall Study|Protocol Deviation|2|||
46773974|NCT02807636|82992437|FG001|Overall Study|Protocol Deviation|0|||
46960861|NCT02786537|83203062|FG005|As Treated|Non-compliance with study drug|1|||
46960862|NCT02786537|83203057|FG000|As Treated|Lost insurance|0|||
46960863|NCT02786537|83203058|FG001|As Treated|Lost insurance|0|||
46960864|NCT02786537|83203059|FG002|As Treated|Lost insurance|0|||
46960865|NCT02786537|83203060|FG003|As Treated|Lost insurance|1|||
46960866|NCT02786537|83203061|FG004|As Treated|Lost insurance|0|||
46960867|NCT02786537|83203062|FG005|As Treated|Lost insurance|0|||
46960868|NCT02786537|83203057|FG000|As Treated|Withdrawal by Subject|1|||
46960869|NCT02786537|83203058|FG001|As Treated|Withdrawal by Subject|2|||
46960870|NCT02786537|83203059|FG002|As Treated|Withdrawal by Subject|0|||
46960871|NCT02786537|83203060|FG003|As Treated|Withdrawal by Subject|0|||
46960872|NCT02786537|83203061|FG004|As Treated|Withdrawal by Subject|1|||
46960873|NCT02786537|83203062|FG005|As Treated|Withdrawal by Subject|0|||
46960874|NCT02786537|83203057|FG000|As Treated|Incarceration|0|||
46960875|NCT02786537|83203058|FG001|As Treated|Incarceration|1|||
46960876|NCT02786537|83203059|FG002|As Treated|Incarceration|0|||
46773975|NCT02807636|82992438|FG002|Overall Study|Protocol Deviation|0|||
46773976|NCT02807636|82992436|FG000|Overall Study|Symptomatic Deterioration|0|||
46773977|NCT02807636|82992437|FG001|Overall Study|Symptomatic Deterioration|1|||
46773978|NCT02807636|82992438|FG002|Overall Study|Symptomatic Deterioration|0|||
46773979|NCT02807636|82992436|FG000|Overall Study|Withdrawal by Subject|39|||
46773980|NCT02807636|82992437|FG001|Overall Study|Withdrawal by Subject|27|||
46773981|NCT02807636|82992438|FG002|Overall Study|Withdrawal by Subject|23|||
46773982|NCT02807636|82992436|FG000|Overall Study|Death|298|||
46960877|NCT02786537|83203060|FG003|As Treated|Incarceration|0|||
46960878|NCT02786537|83203061|FG004|As Treated|Incarceration|0|||
46960879|NCT02786537|83203062|FG005|As Treated|Incarceration|0|||
46960880|NCT02786537|83203057|FG000|As Treated|Opiate dependency relapse|0|||
46960881|NCT02786537|83203058|FG001|As Treated|Opiate dependency relapse|1|||
46960882|NCT02786537|83203059|FG002|As Treated|Opiate dependency relapse|0|||
46960883|NCT02786537|83203060|FG003|As Treated|Opiate dependency relapse|0|||
46960884|NCT02786537|83203061|FG004|As Treated|Opiate dependency relapse|0|||
46960885|NCT02786537|83203062|FG005|As Treated|Opiate dependency relapse|0|||
46960886|NCT02786537|83203057|FG000|As Treated|Drugs stolen from patient|0|||
46960887|NCT02786537|83203058|FG001|As Treated|Drugs stolen from patient|1|||
46960888|NCT02786537|83203059|FG002|As Treated|Drugs stolen from patient|0|||
46960889|NCT02786537|83203060|FG003|As Treated|Drugs stolen from patient|0|||
46960890|NCT02786537|83203061|FG004|As Treated|Drugs stolen from patient|0|||
46960891|NCT02786537|83203062|FG005|As Treated|Drugs stolen from patient|0|||
46960892|NCT02786537|83203057|FG000|As Treated|Advised to stop tx after loss of meds|0|||
46960893|NCT02786537|83203058|FG001|As Treated|Advised to stop tx after loss of meds|1|||
46960894|NCT02786537|83203059|FG002|As Treated|Advised to stop tx after loss of meds|0|||
46960895|NCT02786537|83203060|FG003|As Treated|Advised to stop tx after loss of meds|0|||
46960896|NCT02786537|83203061|FG004|As Treated|Advised to stop tx after loss of meds|0|||
46960897|NCT02786537|83203062|FG005|As Treated|Advised to stop tx after loss of meds|0|||
46960898|NCT02216812|83203170|FG000|Overall Study|Lost to Follow-up|10|||
46960899|NCT02216812|83203171|FG001|Overall Study|Lost to Follow-up|5|||
46960900|NCT02252536|83203179|FG000|Overall Study|Lost to Follow-up|5|||
46960901|NCT02252536|83203180|FG001|Overall Study|Lost to Follow-up|3|||
46960902|NCT02206828|83203186|FG000|Overall Study|Lost to Follow-up|7|||
46960903|NCT01209767|83203213|FG000|Overall Study|Withdrawal by Subject|1|||
46960904|NCT01209767|83203213|FG000|Overall Study|Lost to Follow-up|3|||
46960905|NCT02252146|83203221|FG000|Overall Study|Lack of Efficacy|4|||
46960906|NCT02252146|83203221|FG000|Overall Study|Entered hospice care|1|||
46960907|NCT02252146|83203221|FG000|Overall Study|Inability to travel to study site|1|||
46960908|NCT02251990|83203227|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
46960909|NCT02251990|83203228|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
46960910|NCT02251990|83203227|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
46960911|NCT02251990|83203228|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
46960912|NCT02251990|83203227|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
46960913|NCT02251990|83203228|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
46960914|NCT02251990|83203227|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
46960915|NCT02251990|83203228|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
46960916|NCT02251990|83203227|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
46960917|NCT02251990|83203228|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
46960918|NCT02251990|83203227|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
46960919|NCT02251990|83203228|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
46960920|NCT02251912|83203237|FG000|Overall Study|Withdrawal by Subject|2|||
46960921|NCT02251912|83203238|FG001|Overall Study|Withdrawal by Subject|3|||
46960922|NCT02251912|83203237|FG000|Overall Study|Adverse Event|0|||
46960923|NCT02251912|83203238|FG001|Overall Study|Adverse Event|2|||
46960924|NCT02206048|83203253|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
46960925|NCT02205814|83203265|FG000|Overall Study|Lost to Follow-up|0|||
46960926|NCT02205814|83203266|FG001|Overall Study|Lost to Follow-up|0|||
46960927|NCT02205814|83203267|FG002|Overall Study|Lost to Follow-up|0|||
46960928|NCT02205814|83203268|FG003|Overall Study|Lost to Follow-up|1|||
46640038|NCT03490734|82814018|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
46773983|NCT02807636|82992437|FG001|Overall Study|Death|327|||
46773984|NCT02807636|82992438|FG002|Overall Study|Death|266|||
46773985|NCT02807636|82992436|FG000|Overall Study|Ongoing in Study|52|||
46773986|NCT02807636|82992437|FG001|Overall Study|Ongoing in Study|84|||
46960929|NCT02205814|83203265|FG000|Overall Study|Lack of Efficacy|1|||
46960930|NCT02205814|83203266|FG001|Overall Study|Lack of Efficacy|0|||
46960931|NCT02205814|83203267|FG002|Overall Study|Lack of Efficacy|1|||
46960932|NCT02205814|83203268|FG003|Overall Study|Lack of Efficacy|1|||
46960933|NCT02205814|83203265|FG000|Overall Study|Physician Decision|0|||
46960934|NCT02205814|83203266|FG001|Overall Study|Physician Decision|0|||
46960935|NCT02205814|83203267|FG002|Overall Study|Physician Decision|1|||
46960936|NCT02205814|83203268|FG003|Overall Study|Physician Decision|0|||
46960937|NCT02205814|83203265|FG000|Overall Study|Protocol Violation|1|||
46960938|NCT02205814|83203266|FG001|Overall Study|Protocol Violation|0|||
46960939|NCT02205814|83203267|FG002|Overall Study|Protocol Violation|0|||
46960940|NCT02205814|83203268|FG003|Overall Study|Protocol Violation|1|||
46960941|NCT02205814|83203265|FG000|Overall Study|Withdrawal by Subject|0|||
46960942|NCT02205814|83203266|FG001|Overall Study|Withdrawal by Subject|1|||
46960943|NCT02205814|83203267|FG002|Overall Study|Withdrawal by Subject|2|||
46960944|NCT02205814|83203268|FG003|Overall Study|Withdrawal by Subject|1|||
46960945|NCT02205814|83203265|FG000|Overall Study|not compliant with study procedures|0|||
46960946|NCT02205814|83203266|FG001|Overall Study|not compliant with study procedures|0|||
46960947|NCT02205814|83203267|FG002|Overall Study|not compliant with study procedures|1|||
46960948|NCT02205814|83203268|FG003|Overall Study|not compliant with study procedures|0|||
46960949|NCT02662985|83203280|FG000|Treatment Period 1|Adverse Event|0|||
46773987|NCT02807636|82992438|FG002|Overall Study|Ongoing in Study|67|||
46773988|NCT02654587|82992449|FG000|Overall Study|patient alive at end of study|22|||
46773989|NCT02654587|82992450|FG001|Overall Study|patient alive at end of study|8|||
46773990|NCT02654587|82992449|FG000|Overall Study|Withdrawal by Subject|1|||
46773991|NCT02654587|82992450|FG001|Overall Study|Withdrawal by Subject|7|||
46773992|NCT02288247|82992462|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
46773993|NCT02288247|82992463|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
46773994|NCT02288247|82992462|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
46773995|NCT02288247|82992463|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
46773996|NCT02288247|82992462|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
46773997|NCT02288247|82992463|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
46773998|NCT02288247|82992462|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
46773999|NCT02288247|82992463|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
46774000|NCT02288247|82992462|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
46774001|NCT02288247|82992463|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
46774002|NCT02288247|82992462|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
46774003|NCT02288247|82992463|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
46774004|NCT02288247|82992462|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
46774005|NCT02288247|82992463|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
46774006|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
46774007|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
46774008|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
46774009|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
46774010|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
46774011|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
46774012|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
46774013|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
46774014|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
46774015|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
46774016|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
46774017|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
46774018|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
46774019|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
46774020|NCT02288247|82992462|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
46774021|NCT02288247|82992463|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
46774022|NCT02283177|82992473|FG000|Overall Study|Withdrawal by Subject|1|||
46774023|NCT02283177|82992474|FG001|Overall Study|Withdrawal by Subject|1|||
46774024|NCT02259231|82992488|FG000|Overall Study|Adverse Event|1|||
46774025|NCT02259231|82992489|FG001|Overall Study|Adverse Event|1|||
46774026|NCT02259231|82992490|FG002|Overall Study|Adverse Event|2|||
46774027|NCT02259231|82992491|FG003|Overall Study|Adverse Event|0|||
46774028|NCT02259231|82992492|FG004|Overall Study|Adverse Event|0|||
46774029|NCT02259231|82992493|FG005|Overall Study|Adverse Event|0|||
46774030|NCT02259231|82992494|FG006|Overall Study|Adverse Event|0|||
46774031|NCT02259231|82992488|FG000|Overall Study|Progressive Disease|4|||
46774032|NCT02259231|82992489|FG001|Overall Study|Progressive Disease|5|||
46774033|NCT02259231|82992490|FG002|Overall Study|Progressive Disease|4|||
46774034|NCT02259231|82992491|FG003|Overall Study|Progressive Disease|5|||
46774035|NCT02259231|82992492|FG004|Overall Study|Progressive Disease|4|||
46960950|NCT02662985|83203281|FG001|Treatment Period 1|Adverse Event|2|||
47067164|NCT01550744|83350592|FG002|Double-Blind|Protocol Violation|4|||
47067165|NCT01550744|83350590|FG000|Double-Blind|Pregnancy|0|||
47067166|NCT01550744|83350591|FG001|Double-Blind|Pregnancy|0|||
46774036|NCT02259231|82992493|FG005|Overall Study|Progressive Disease|5|||
46774037|NCT02259231|82992494|FG006|Overall Study|Progressive Disease|4|||
46774038|NCT02259231|82992488|FG000|Overall Study|Sponsor termination of study|1|||
46774039|NCT02259231|82992489|FG001|Overall Study|Sponsor termination of study|0|||
46960951|NCT02662985|83203280|FG000|Treatment Period 1|Protocol Violation|0|||
46960952|NCT02662985|83203281|FG001|Treatment Period 1|Protocol Violation|1|||
46960953|NCT02662985|83203280|FG000|Treatment Period 1|Physician Decision|1|||
46960954|NCT02662985|83203281|FG001|Treatment Period 1|Physician Decision|0|||
46774040|NCT02259231|82992490|FG002|Overall Study|Sponsor termination of study|0|||
46774041|NCT02259231|82992491|FG003|Overall Study|Sponsor termination of study|1|||
46774042|NCT02259231|82992492|FG004|Overall Study|Sponsor termination of study|2|||
46774043|NCT02259231|82992493|FG005|Overall Study|Sponsor termination of study|1|||
46960955|NCT02662985|83203280|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46960956|NCT02662985|83203281|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46960957|NCT02662985|83203280|FG000|Treatment Period 2|Lack of Efficacy|0|||
46960958|NCT02662985|83203281|FG001|Treatment Period 2|Lack of Efficacy|1|||
46960959|NCT02662985|83203280|FG000|Treatment Period 2|Lost to Follow-up|1|||
46960960|NCT02662985|83203281|FG001|Treatment Period 2|Lost to Follow-up|0|||
46960961|NCT02662985|83203280|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
46960962|NCT02662985|83203281|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
46960963|NCT02662985|83203280|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
46960964|NCT02662985|83203281|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
46960965|NCT02662985|83203280|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
46960966|NCT02662985|83203281|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
46960967|NCT02662985|83203280|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
46960968|NCT02662985|83203281|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
46960969|NCT02662985|83203280|FG000|Treatment Period 3 (Extension Period)|Death|0|||
46960970|NCT02662985|83203281|FG001|Treatment Period 3 (Extension Period)|Death|1|||
46960971|NCT01631812|83203287|FG000|Overall Study|Adverse Event|25|||
46960972|NCT01631812|83203287|FG000|Overall Study|Lack of Efficacy|5|||
46960973|NCT01631812|83203287|FG000|Overall Study|Withdrawal by Subject|4|||
46960974|NCT01631812|83203287|FG000|Overall Study|Physician Decision|3|||
46960975|NCT02323295|83203293|FG000|Overall Study|Adverse Event|0|||
46960976|NCT02323295|83203294|FG001|Overall Study|Adverse Event|1|||
46960977|NCT02323295|83203293|FG000|Overall Study|Withdrawal by Subject|0|||
46960978|NCT02323295|83203294|FG001|Overall Study|Withdrawal by Subject|1|||
46960979|NCT02323295|83203293|FG000|Overall Study|Patient did not have surgery as planned.|0|||
46960980|NCT02323295|83203294|FG001|Overall Study|Patient did not have surgery as planned.|1|||
46960981|NCT02215954|83203303|FG000|Overall Study|Adverse Event|0|||
46960982|NCT02215954|83203304|FG001|Overall Study|Adverse Event|0|||
46960983|NCT02215954|83203305|FG002|Overall Study|Adverse Event|1|||
46960984|NCT02215954|83203303|FG000|Overall Study|Withdrawal by Subject|0|||
46960985|NCT02215954|83203304|FG001|Overall Study|Withdrawal by Subject|0|||
46960986|NCT02215954|83203305|FG002|Overall Study|Withdrawal by Subject|2|||
46960987|NCT02215954|83203303|FG000|Overall Study|Not exposed|1|||
46960988|NCT02215954|83203304|FG001|Overall Study|Not exposed|1|||
46960989|NCT02215954|83203305|FG002|Overall Study|Not exposed|3|||
46960990|NCT01941719|83203316|FG000|Overall Study|Lost to Follow-up|20|||
46960991|NCT01941719|83203317|FG001|Overall Study|Lost to Follow-up|19|||
46774044|NCT02259231|82992494|FG006|Overall Study|Sponsor termination of study|1|||
46774045|NCT02062827|82992522|FG000|Overall Study|Death|1|||
46774046|NCT02062827|82992523|FG001|Overall Study|Death|0|||
46774047|NCT02062827|82992524|FG002|Overall Study|Death|0|||
46774048|NCT02062827|82992525|FG003|Overall Study|Death|0|||
46774049|NCT02062827|82992526|FG004|Overall Study|Death|0|||
46774050|NCT02062827|82992527|FG005|Overall Study|Death|0|||
46774051|NCT02062827|82992528|FG006|Overall Study|Death|0|||
46774052|NCT02062827|82992529|FG007|Overall Study|Death|0|||
46640039|NCT03490734|82814019|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
46960992|NCT02215252|83203327|FG000|Overall Study|Adverse Event|1|||
46640040|NCT03490734|82814020|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
46640041|NCT00086346|82814031|FG000|Randomization|Did not receive test article|4|||
46640042|NCT00086346|82814032|FG001|Randomization|Did not receive test article|4|||
46640043|NCT00086346|82814031|FG000|Patients Dosed With Test Article|Adverse Event|94|||
46640044|NCT00086346|82814032|FG001|Patients Dosed With Test Article|Adverse Event|11|||
46774053|NCT02062827|82992522|FG000|Overall Study|Withdrawal by Subject|3|||
46774054|NCT02062827|82992523|FG001|Overall Study|Withdrawal by Subject|1|||
46640045|NCT00086346|82814031|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
46774055|NCT02062827|82992524|FG002|Overall Study|Withdrawal by Subject|1|||
46774056|NCT02062827|82992525|FG003|Overall Study|Withdrawal by Subject|2|||
46774057|NCT02062827|82992526|FG004|Overall Study|Withdrawal by Subject|6|||
46774058|NCT02062827|82992527|FG005|Overall Study|Withdrawal by Subject|0|||
46774059|NCT02062827|82992528|FG006|Overall Study|Withdrawal by Subject|5|||
46774060|NCT02062827|82992529|FG007|Overall Study|Withdrawal by Subject|0|||
46774061|NCT02062827|82992522|FG000|Overall Study|Screen Fail|0|||
46774062|NCT02062827|82992523|FG001|Overall Study|Screen Fail|0|||
46960993|NCT02215252|83203328|FG001|Overall Study|Adverse Event|5|||
46960994|NCT02215252|83203329|FG002|Overall Study|Adverse Event|2|||
46960995|NCT02215252|83203327|FG000|Overall Study|Lost to Follow-up|0|||
46960996|NCT02215252|83203328|FG001|Overall Study|Lost to Follow-up|0|||
46960997|NCT02215252|83203329|FG002|Overall Study|Lost to Follow-up|1|||
46960998|NCT02215252|83203327|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
46960999|NCT02215252|83203328|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
46961000|NCT02215252|83203329|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
46961001|NCT02215252|83203327|FG000|Overall Study|Protocol Violation|0|||
46961002|NCT02215252|83203328|FG001|Overall Study|Protocol Violation|1|||
46961003|NCT02215252|83203329|FG002|Overall Study|Protocol Violation|0|||
46961004|NCT02215252|83203327|FG000|Overall Study|Withdrawal by Subject|1|||
46961005|NCT02215252|83203328|FG001|Overall Study|Withdrawal by Subject|0|||
46961006|NCT02215252|83203329|FG002|Overall Study|Withdrawal by Subject|0|||
46961007|NCT02215252|83203327|FG000|Overall Study|Other|0|||
46961008|NCT02215252|83203328|FG001|Overall Study|Other|1|||
46961009|NCT02215252|83203329|FG002|Overall Study|Other|1|||
46961010|NCT02204410|83203341|FG000|Overall Study|Lost to Follow-up|5|||
46961011|NCT02204410|83203341|FG000|Overall Study|Physician Decision|2|||
46961012|NCT02204410|83203341|FG000|Overall Study|Protocol Violation|1|||
46961013|NCT02204410|83203341|FG000|Overall Study|Withdrawal by Subject|3|||
46961014|NCT02250274|83203347|FG000|Overall Study|Insufficient blood draw amount|7|||
46961015|NCT02250274|83203348|FG001|Overall Study|Insufficient blood draw amount|6|||
46961016|NCT02213380|83203362|FG000|Underwent Randomization|Withdrawal by Subject|2|||
46961017|NCT02213380|83203363|FG001|Underwent Randomization|Withdrawal by Subject|0|||
46961018|NCT02213380|83203362|FG000|Underwent Randomization|Not treated|3|||
46961019|NCT02213380|83203363|FG001|Underwent Randomization|Not treated|3|||
46961020|NCT02213380|83203362|FG000|Per-protocol Analysis|Protocol Violation|32|||
46961021|NCT02213380|83203363|FG001|Per-protocol Analysis|Protocol Violation|36|||
46961022|NCT02202850|83203371|FG000|Overall Study|Other|2|||
46961023|NCT02202850|83203372|FG001|Overall Study|Other|2|||
46961024|NCT02202850|83203371|FG000|Overall Study|Enbrel treatment discontinued|15|||
46961025|NCT02202850|83203372|FG001|Overall Study|Enbrel treatment discontinued|3|||
46961026|NCT02202850|83203371|FG000|Overall Study|Lost to Follow-up|7|||
46961027|NCT02202850|83203372|FG001|Overall Study|Lost to Follow-up|1|||
46961028|NCT02212678|83203378|FG000|Overall Study|Adverse Event|1|||
46961029|NCT03104075|83203384|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
46961030|NCT03104075|83203385|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
46961031|NCT03038087|83203392|FG000|Overall Study|lost data|1|||
46961032|NCT02249182|83203403|FG000|Treatment Phase|Lost to Follow-up|4|||
46961033|NCT02249182|83203404|FG001|Treatment Phase|Lost to Follow-up|0|||
46961034|NCT02249182|83203405|FG002|Treatment Phase|Lost to Follow-up|0|||
46961035|NCT02249182|83203406|FG003|Treatment Phase|Lost to Follow-up|0|||
46961036|NCT02249182|83203407|FG004|Treatment Phase|Lost to Follow-up|0|||
46961037|NCT03641339|83203438|FG000|Overall Study|Physician Decision|1|||
46961038|NCT03641339|83203439|FG001|Overall Study|Physician Decision|0|||
46774063|NCT02062827|82992524|FG002|Overall Study|Screen Fail|0|||
46774064|NCT02062827|82992525|FG003|Overall Study|Screen Fail|0|||
46774065|NCT02062827|82992526|FG004|Overall Study|Screen Fail|0|||
46774066|NCT02062827|82992527|FG005|Overall Study|Screen Fail|0|||
46774067|NCT02062827|82992528|FG006|Overall Study|Screen Fail|0|||
46774068|NCT02062827|82992529|FG007|Overall Study|Screen Fail|8|||
46774069|NCT01467427|82992562|FG000|Overall Study|Withdrawal by Subject|1|||
46774070|NCT01467427|82992563|FG001|Overall Study|Withdrawal by Subject|0|||
46774071|NCT01467427|82992562|FG000|Overall Study|Entered extension phase|11|||
46774072|NCT01467427|82992563|FG001|Overall Study|Entered extension phase|11|||
46774073|NCT01467427|82992562|FG000|Overall Study|Not continuing in extension phase|0|||
46774074|NCT01467427|82992563|FG001|Overall Study|Not continuing in extension phase|2|||
46774075|NCT00750152|82992571|FG000|Overall Study|Adverse Event|2|||
46774076|NCT00750152|82992572|FG001|Overall Study|Adverse Event|1|||
46774077|NCT00750152|82992571|FG000|Overall Study|Lost to Follow-up|8|||
46774078|NCT00750152|82992572|FG001|Overall Study|Lost to Follow-up|13|||
46774079|NCT00750152|82992571|FG000|Overall Study|Withdrawal by Subject|3|||
46774080|NCT00750152|82992572|FG001|Overall Study|Withdrawal by Subject|3|||
46774081|NCT00750152|82992571|FG000|Overall Study|Physician Decision|1|||
46961039|NCT03641339|83203440|FG002|Overall Study|Physician Decision|0|||
46961040|NCT03641339|83203441|FG003|Overall Study|Physician Decision|0|||
46961041|NCT03641339|83203442|FG004|Overall Study|Physician Decision|0|||
46961042|NCT03641339|83203443|FG005|Overall Study|Physician Decision|0|||
46961043|NCT03641339|83203438|FG000|Overall Study|Withdrawal by Subject|0|||
46640046|NCT00086346|82814032|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
46640047|NCT00086346|82814031|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
46640048|NCT00086346|82814032|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
46774082|NCT00750152|82992572|FG001|Overall Study|Physician Decision|1|||
46774083|NCT00750152|82992571|FG000|Overall Study|Non-compliance|0|||
46774084|NCT00750152|82992572|FG001|Overall Study|Non-compliance|1|||
46961044|NCT03641339|83203439|FG001|Overall Study|Withdrawal by Subject|2|||
46961045|NCT03641339|83203440|FG002|Overall Study|Withdrawal by Subject|0|||
46961046|NCT03641339|83203441|FG003|Overall Study|Withdrawal by Subject|2|||
46961047|NCT03641339|83203442|FG004|Overall Study|Withdrawal by Subject|0|||
46961048|NCT03641339|83203443|FG005|Overall Study|Withdrawal by Subject|1|||
46961049|NCT02248480|83203459|FG000|Overall Study|Lack of Efficacy|4|||
46961050|NCT02248480|83203460|FG001|Overall Study|Lack of Efficacy|6|||
46961051|NCT02248480|83203459|FG000|Overall Study|Adverse Event|11|||
46961052|NCT02248480|83203460|FG001|Overall Study|Adverse Event|2|||
46961053|NCT02248480|83203459|FG000|Overall Study|Withdrawal by Subject|2|||
46961054|NCT02248480|83203460|FG001|Overall Study|Withdrawal by Subject|4|||
46961055|NCT02248480|83203459|FG000|Overall Study|Entry Criteria Not Met|0|||
46961056|NCT02248480|83203460|FG001|Overall Study|Entry Criteria Not Met|1|||
46961057|NCT02248480|83203459|FG000|Overall Study|Other:Physician Decision|0|||
46961058|NCT02248480|83203460|FG001|Overall Study|Other:Physician Decision|1|||
46961059|NCT01653158|83203467|FG000|Overall Study|Death|0|||
46961060|NCT01653158|83203468|FG001|Overall Study|Death|0|||
46961061|NCT01653158|83203469|FG002|Overall Study|Death|0|||
46961062|NCT01653158|83203470|FG003|Overall Study|Death|1|||
46961063|NCT01653158|83203471|FG004|Overall Study|Death|0|||
46961064|NCT01653158|83203472|FG005|Overall Study|Death|0|||
46961065|NCT01653158|83203473|FG006|Overall Study|Death|0|||
46961066|NCT01653158|83203474|FG007|Overall Study|Death|2|||
46961067|NCT01653158|83203467|FG000|Overall Study|Adverse Event|0|||
46961068|NCT01653158|83203468|FG001|Overall Study|Adverse Event|0|||
46961069|NCT01653158|83203469|FG002|Overall Study|Adverse Event|0|||
46961070|NCT01653158|83203470|FG003|Overall Study|Adverse Event|1|||
46961071|NCT01653158|83203471|FG004|Overall Study|Adverse Event|0|||
46961072|NCT01653158|83203472|FG005|Overall Study|Adverse Event|0|||
46961073|NCT01653158|83203473|FG006|Overall Study|Adverse Event|0|||
46961074|NCT01653158|83203474|FG007|Overall Study|Adverse Event|3|||
46961075|NCT01653158|83203467|FG000|Overall Study|Other|0|||
46961076|NCT01653158|83203468|FG001|Overall Study|Other|0|||
46961077|NCT01653158|83203469|FG002|Overall Study|Other|0|||
46961078|NCT01653158|83203470|FG003|Overall Study|Other|0|||
46961079|NCT01653158|83203471|FG004|Overall Study|Other|0|||
46961080|NCT01653158|83203472|FG005|Overall Study|Other|0|||
46961081|NCT01653158|83203473|FG006|Overall Study|Other|0|||
46961082|NCT01653158|83203474|FG007|Overall Study|Other|1|||
46961083|NCT01653158|83203467|FG000|Overall Study|Progressive disease|0|||
46961084|NCT01653158|83203468|FG001|Overall Study|Progressive disease|0|||
46961085|NCT01653158|83203469|FG002|Overall Study|Progressive disease|0|||
46961086|NCT01653158|83203470|FG003|Overall Study|Progressive disease|0|||
46961087|NCT01653158|83203471|FG004|Overall Study|Progressive disease|1|||
46961088|NCT01653158|83203472|FG005|Overall Study|Progressive disease|1|||
46961089|NCT01653158|83203473|FG006|Overall Study|Progressive disease|2|||
46961090|NCT01653158|83203474|FG007|Overall Study|Progressive disease|9|||
46961091|NCT01653158|83203467|FG000|Overall Study|Withdrawal by Subject|1|||
46961092|NCT01653158|83203468|FG001|Overall Study|Withdrawal by Subject|0|||
46961093|NCT01653158|83203469|FG002|Overall Study|Withdrawal by Subject|0|||
46961094|NCT01653158|83203470|FG003|Overall Study|Withdrawal by Subject|0|||
46961095|NCT01653158|83203471|FG004|Overall Study|Withdrawal by Subject|0|||
46961096|NCT01653158|83203472|FG005|Overall Study|Withdrawal by Subject|0|||
46961097|NCT01653158|83203473|FG006|Overall Study|Withdrawal by Subject|0|||
46774085|NCT00750152|82992571|FG000|Overall Study|Termination by sponsor|1|||
46774086|NCT00750152|82992572|FG001|Overall Study|Termination by sponsor|0|||
46774087|NCT00750152|82992571|FG000|Overall Study|Other|7|||
46774088|NCT00750152|82992572|FG001|Overall Study|Other|8|||
46774089|NCT00749996|82992580|FG000|Overall Study|Lost to Follow-up|7|||
46774090|NCT00749996|82992581|FG001|Overall Study|Lost to Follow-up|4|||
46774091|NCT00749996|82992580|FG000|Overall Study|Withdrawal by Subject|5|||
46774092|NCT00749996|82992581|FG001|Overall Study|Withdrawal by Subject|4|||
46774093|NCT00749996|82992580|FG000|Overall Study|Protocol Violation|2|||
46774094|NCT00749996|82992581|FG001|Overall Study|Protocol Violation|3|||
46774095|NCT00749996|82992580|FG000|Overall Study|Physician Decision|2|||
46774096|NCT00749996|82992581|FG001|Overall Study|Physician Decision|0|||
46774097|NCT00749996|82992580|FG000|Overall Study|Pregnancy|0|||
46774098|NCT00749996|82992581|FG001|Overall Study|Pregnancy|2|||
46774099|NCT00749996|82992580|FG000|Overall Study|Adverse Event|1|||
46774100|NCT00749996|82992581|FG001|Overall Study|Adverse Event|0|||
46961098|NCT01653158|83203474|FG007|Overall Study|Withdrawal by Subject|0|||
46961099|NCT02247466|83203499|FG000|Overall Study|Procedure changed to open surgery|0|||
46961100|NCT02247466|83203500|FG001|Overall Study|Procedure changed to open surgery|3|||
46961101|NCT03317795|83203508|FG000|Overall Study|IUD Expulsion|1|||
46961102|NCT03317795|83203509|FG001|Overall Study|IUD Expulsion|0|||
46961103|NCT03317795|83203508|FG000|Overall Study|Lost to Follow-up|1|||
46774101|NCT00749996|82992580|FG000|Overall Study|Death|1|||
46774102|NCT00749996|82992581|FG001|Overall Study|Death|0|||
46774103|NCT00749684|82992587|FG000|Overall Study|Death|1|||
46774104|NCT00749684|82992587|FG000|Overall Study|Adverse Event|27|||
46774105|NCT00749684|82992587|FG000|Overall Study|Participant's Wish|10|||
46961104|NCT03317795|83203509|FG001|Overall Study|Lost to Follow-up|3|||
46961105|NCT03317795|83203508|FG000|Overall Study|Treatment change|0|||
46961106|NCT03317795|83203509|FG001|Overall Study|Treatment change|3|||
46961107|NCT03317795|83203508|FG000|Overall Study|Intolerance of medication|0|||
46961108|NCT03317795|83203509|FG001|Overall Study|Intolerance of medication|1|||
46961109|NCT02202616|83203515|FG000|Overall Study|Screen failed|24|||
46961110|NCT02202616|83203515|FG000|Overall Study|Adverse Event|32|||
46961111|NCT02202616|83203515|FG000|Overall Study|Protocol deviation|18|||
46961112|NCT02202616|83203515|FG000|Overall Study|Patient withdrew consent|12|||
46961113|NCT02202616|83203515|FG000|Overall Study|Lost to Follow-up|6|||
46961114|NCT02202616|83203515|FG000|Overall Study|Administrative problems|6|||
46961115|NCT02202616|83203515|FG000|Overall Study|Abnormal test procedure result|1|||
46961116|NCT02202616|83203515|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46961117|NCT02455388|83203522|FG000|Overall Study|Protocol Violation|1|||
46961118|NCT02455388|83203523|FG001|Overall Study|Protocol Violation|0|||
46961119|NCT02455388|83203524|FG002|Overall Study|Protocol Violation|4|||
46961120|NCT02455388|83203522|FG000|Overall Study|Withdrawal by Subject|0|||
46961121|NCT02455388|83203523|FG001|Overall Study|Withdrawal by Subject|0|||
46961122|NCT02455388|83203524|FG002|Overall Study|Withdrawal by Subject|7|||
46961123|NCT02455076|83203537|FG000|Inpatient|Withdrawal by Subject|1|||
46961124|NCT02455076|83203538|FG001|Inpatient|Withdrawal by Subject|0|||
46961125|NCT02455076|83203539|FG002|Inpatient|Withdrawal by Subject|0|||
46961126|NCT02455076|83203540|FG003|Inpatient|Withdrawal by Subject|0|||
46961127|NCT02455076|83203541|FG004|Inpatient|Withdrawal by Subject|0|||
46961128|NCT02455076|83203537|FG000|Inpatient|Discharged <24 h after admission|0|||
46961129|NCT02455076|83203538|FG001|Inpatient|Discharged <24 h after admission|1|||
46961130|NCT02455076|83203539|FG002|Inpatient|Discharged <24 h after admission|0|||
46961131|NCT02455076|83203540|FG003|Inpatient|Discharged <24 h after admission|0|||
46961132|NCT02455076|83203541|FG004|Inpatient|Discharged <24 h after admission|0|||
46961133|NCT02455076|83203537|FG000|Inpatient|Adverse Event|3|||
46961134|NCT02455076|83203538|FG001|Inpatient|Adverse Event|0|||
46961135|NCT02455076|83203539|FG002|Inpatient|Adverse Event|0|||
46961136|NCT02455076|83203540|FG003|Inpatient|Adverse Event|0|||
46961137|NCT02455076|83203541|FG004|Inpatient|Adverse Event|0|||
46961138|NCT02455076|83203537|FG000|Outpatient|Adverse Event|0|||
46961139|NCT02455076|83203538|FG001|Outpatient|Adverse Event|0|||
46961140|NCT02455076|83203539|FG002|Outpatient|Adverse Event|0|||
46961141|NCT02455076|83203540|FG003|Outpatient|Adverse Event|5|||
46961142|NCT02455076|83203541|FG004|Outpatient|Adverse Event|0|||
46961143|NCT02455076|83203537|FG000|Outpatient|Lost to Follow-up|0|||
46961144|NCT02455076|83203538|FG001|Outpatient|Lost to Follow-up|0|||
46961145|NCT02455076|83203539|FG002|Outpatient|Lost to Follow-up|0|||
46961146|NCT02455076|83203540|FG003|Outpatient|Lost to Follow-up|1|||
46961147|NCT02455076|83203541|FG004|Outpatient|Lost to Follow-up|12|||
46961148|NCT02433080|83203555|FG000|Overall Study|Lost to Follow-up|1|||
46961149|NCT02433080|83203556|FG001|Overall Study|Lost to Follow-up|2|||
46961150|NCT02433080|83203555|FG000|Overall Study|Withdrawal by Subject|0|||
46961151|NCT02433080|83203556|FG001|Overall Study|Withdrawal by Subject|2|||
46961152|NCT03092219|83203565|FG000|Overall Study|Protocol Violation|7|||
46961153|NCT03092219|83203566|FG001|Overall Study|Protocol Violation|4|||
46961154|NCT02432846|83203581|FG000|Overall Study (4 Arms/Strata)|Death|3|||
46961155|NCT02432846|83203582|FG001|Overall Study (4 Arms/Strata)|Death|2|||
46961156|NCT02432846|83203583|FG002|Overall Study (4 Arms/Strata)|Death|4|||
46961157|NCT02432846|83203584|FG003|Overall Study (4 Arms/Strata)|Death|3|||
46961158|NCT02432846|83203585|FG004|Overall Study (4 Arms/Strata)|Death|0|||
46961159|NCT02432846|83203586|FG005|Overall Study (4 Arms/Strata)|Death|0|||
46961160|NCT02432846|83203581|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
46961161|NCT02432846|83203582|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
46961162|NCT02432846|83203583|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
46961163|NCT02432846|83203584|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
46961164|NCT02432846|83203585|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
46961165|NCT02432846|83203586|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
46961166|NCT02432846|83203581|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
46961167|NCT02432846|83203582|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
46961168|NCT02432846|83203583|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
47067167|NCT01550744|83350592|FG002|Double-Blind|Pregnancy|3|||
47067168|NCT01550744|83350590|FG000|Double-Blind|Other|0|||
47067169|NCT01550744|83350591|FG001|Double-Blind|Other|2|||
46961169|NCT02432846|83203584|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
46961170|NCT02432846|83203585|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
46961171|NCT02432846|83203586|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
46961172|NCT02432846|83203581|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
46961173|NCT02432846|83203582|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
46961174|NCT02432846|83203583|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
46961175|NCT02432846|83203584|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
46961176|NCT02432846|83203585|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
46961177|NCT02432846|83203586|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
46961178|NCT02432846|83203581|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
46961179|NCT02432846|83203582|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
46961180|NCT02432846|83203583|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
46961181|NCT02432846|83203584|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
46961182|NCT02432846|83203585|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
46961183|NCT02432846|83203586|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
46961184|NCT02432846|83203581|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
46961185|NCT02432846|83203582|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
46961186|NCT02432846|83203583|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
46961187|NCT02432846|83203584|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
46961188|NCT02432846|83203585|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
46961189|NCT02432846|83203586|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
46961190|NCT02432846|83203581|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
46961191|NCT02432846|83203582|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
46961192|NCT02432846|83203583|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
46961193|NCT02432846|83203584|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
46961194|NCT02432846|83203585|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
46961195|NCT02432846|83203586|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
46961196|NCT02432846|83203581|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
46961197|NCT02432846|83203582|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
46961198|NCT02432846|83203583|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
46961199|NCT02432846|83203584|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
46961200|NCT02432846|83203585|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
46961201|NCT02432846|83203586|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
46961202|NCT02432846|83203581|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
46961203|NCT02432846|83203582|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
46961204|NCT02432846|83203583|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
46961205|NCT02432846|83203584|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
46961206|NCT02432846|83203585|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
46961207|NCT02432846|83203586|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
46961208|NCT02432846|83203581|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
46961209|NCT02432846|83203582|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
46961210|NCT02432846|83203583|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
46961211|NCT02432846|83203584|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
46961212|NCT02432846|83203585|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
46961213|NCT02432846|83203586|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
46961214|NCT02432846|83203581|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
46961215|NCT02432846|83203582|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
46961216|NCT02432846|83203583|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
46961217|NCT02432846|83203584|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
46961218|NCT02432846|83203585|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
46961219|NCT02432846|83203586|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
46961220|NCT02432846|83203581|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
46961221|NCT02432846|83203582|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
46961222|NCT02432846|83203583|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
46961223|NCT02432846|83203584|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
46961224|NCT02432846|83203585|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
46961225|NCT02432846|83203586|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
46961226|NCT02432846|83203581|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
46961227|NCT02432846|83203582|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
46961228|NCT02432846|83203583|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
46961229|NCT02432846|83203584|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
46961230|NCT02432846|83203585|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
46961231|NCT02432846|83203586|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
46961232|NCT02432846|83203581|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
46961233|NCT02432846|83203582|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
46961234|NCT02432846|83203583|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
46961235|NCT02432846|83203584|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
46961236|NCT02432846|83203585|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
46961237|NCT02432846|83203586|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
46961238|NCT02432144|83203599|FG000|Overall Study|Participant Non-Compliance|1|||
46961239|NCT02246998|83203607|FG000|Overall Study|Adverse Event|0|||
46961240|NCT02246998|83203608|FG001|Overall Study|Adverse Event|1|||
46961241|NCT02246998|83203609|FG002|Overall Study|Adverse Event|1|||
46961242|NCT02246998|83203610|FG003|Overall Study|Adverse Event|0|||
46961243|NCT02246998|83203607|FG000|Overall Study|Lost to Follow-up|1|||
46961244|NCT02246998|83203608|FG001|Overall Study|Lost to Follow-up|0|||
46961245|NCT02246998|83203609|FG002|Overall Study|Lost to Follow-up|0|||
46961246|NCT02246998|83203610|FG003|Overall Study|Lost to Follow-up|1|||
47067170|NCT01550744|83350592|FG002|Double-Blind|Other|10|||
47067171|NCT01549964|83350653|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
46961247|NCT02246998|83203607|FG000|Overall Study|Randomized but Never Dosed|1|||
46961248|NCT02246998|83203608|FG001|Overall Study|Randomized but Never Dosed|2|||
46961249|NCT02246998|83203609|FG002|Overall Study|Randomized but Never Dosed|2|||
46961250|NCT02246998|83203610|FG003|Overall Study|Randomized but Never Dosed|1|||
46961251|NCT02486588|83203629|FG000|Overall Study|Randomized in error- ineligible|738|||
46961252|NCT02486588|83203630|FG001|Overall Study|Randomized in error- ineligible|750|||
46961253|NCT02486588|83203631|FG002|Overall Study|Randomized in error- ineligible|755|||
46961254|NCT02486588|83203632|FG003|Overall Study|Randomized in error- ineligible|738|||
46961255|NCT02486588|83203633|FG004|Overall Study|Randomized in error- ineligible|746|||
46961256|NCT02486588|83203634|FG005|Overall Study|Randomized in error- ineligible|746|||
46961257|NCT00805961|83203653|FG000|Modality Therapy|Withdrawal by Subject|1|||
46961258|NCT00805961|83203653|FG000|Modality Therapy|Adverse Event|1|||
46961259|NCT00805961|83203653|FG000|Modality Therapy|Disease Progression|2|||
46961260|NCT00805961|83203653|FG000|Treatment-Free Interval|Adverse Event|3|||
46961261|NCT00805961|83203653|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
46961262|NCT00805961|83203653|FG000|Treatment-Free Interval|Physician Decision|1|||
46961263|NCT00805961|83203653|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
46961264|NCT00805961|83203653|FG000|Maintenance Treatment|Lack of Efficacy|13|||
46961265|NCT00805961|83203653|FG000|Maintenance Treatment|Intercurrent Illness|7|||
46961266|NCT00805961|83203653|FG000|Maintenance Treatment|Adverse Event|6|||
46640049|NCT00086346|82814031|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
46640050|NCT00086346|82814032|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
46774106|NCT00749684|82992587|FG000|Overall Study|Not Documented|1|||
46774107|NCT00749684|82992587|FG000|Overall Study|Progressive Desease|31|||
46961267|NCT00805961|83203653|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
46961268|NCT00805961|83203653|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
46961269|NCT00805961|83203653|FG000|Maintenance Treatment|Withdrawn Consent|1|||
46961270|NCT02202538|83203657|FG000|Overall Study|Withdrawal by Subject|5|||
46961271|NCT02202538|83203657|FG000|Overall Study|Did not meet all inclusion criteria|2|||
46961272|NCT02202538|83203657|FG000|Overall Study|Investigator Decision|1|||
46961273|NCT02454608|83203664|FG000|Double-Blind Period|Lack of Efficacy|0|||
46961274|NCT02454608|83203665|FG001|Double-Blind Period|Lack of Efficacy|2|||
46845239|NCT00149630|83062069|FG000|Overall Study|Adverse Event|2|||
46845240|NCT00149630|83062070|FG001|Overall Study|Adverse Event|0|||
46845241|NCT00127842|83062080|FG000|Overall Study|Adverse Event|15|||
46961275|NCT02454608|83203666|FG002|Double-Blind Period|Lack of Efficacy|0|||
46961276|NCT02454608|83203664|FG000|Open Label Period|Lost to Follow-up|0|||
47067172|NCT01549964|83350654|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
47067173|NCT01549964|83350655|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
47067174|NCT01549964|83350656|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
47067175|NCT01549964|83350653|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
46774108|NCT00749684|82992587|FG000|Overall Study|Therapy according to protocol + AE|2|||
46774109|NCT00749684|82992587|FG000|Overall Study|AE+discontinuation on participants wish|1|||
46774110|NCT00749684|82992587|FG000|Overall Study|Missing|9|||
46774111|NCT00746798|82992595|FG000|Overall Study|Protocol Violation|0|||
46774112|NCT00746798|82992596|FG001|Overall Study|Protocol Violation|1|||
46774113|NCT00746798|82992597|FG002|Overall Study|Protocol Violation|0|||
46774114|NCT00746798|82992598|FG003|Overall Study|Protocol Violation|0|||
46774115|NCT00746798|82992595|FG000|Overall Study|Withdrawal by Subject|0|||
46774116|NCT00746798|82992596|FG001|Overall Study|Withdrawal by Subject|1|||
46774117|NCT00746798|82992597|FG002|Overall Study|Withdrawal by Subject|1|||
46774118|NCT00746798|82992598|FG003|Overall Study|Withdrawal by Subject|0|||
46774119|NCT00746798|82992595|FG000|Overall Study|Death|0|||
46774120|NCT00746798|82992596|FG001|Overall Study|Death|0|||
46774121|NCT00746798|82992597|FG002|Overall Study|Death|2|||
46774122|NCT00746798|82992598|FG003|Overall Study|Death|0|||
46774123|NCT00746798|82992595|FG000|Overall Study|Participant unable to return for visit|1|||
46774124|NCT00746798|82992596|FG001|Overall Study|Participant unable to return for visit|0|||
46774125|NCT00746798|82992597|FG002|Overall Study|Participant unable to return for visit|0|||
46774126|NCT00746798|82992598|FG003|Overall Study|Participant unable to return for visit|0|||
46774127|NCT00716274|82992611|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
46774128|NCT00716274|82992612|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
46774129|NCT00716274|82992613|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
46774130|NCT00716274|82992614|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
46774131|NCT00716274|82992615|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
46774132|NCT00716274|82992616|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
46774133|NCT00716274|82992611|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
46774134|NCT00716274|82992612|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
46845242|NCT00127842|83062080|FG000|Overall Study|Withdrawal by Subject|3|||
46961277|NCT02454608|83203665|FG001|Open Label Period|Lost to Follow-up|0|||
46961278|NCT02454608|83203666|FG002|Open Label Period|Lost to Follow-up|11|||
46961279|NCT02454608|83203664|FG000|Open Label Period|Withdrawal by Subject|0|||
46961280|NCT02454608|83203665|FG001|Open Label Period|Withdrawal by Subject|0|||
46961281|NCT02454608|83203666|FG002|Open Label Period|Withdrawal by Subject|8|||
46961282|NCT02246764|83203677|FG000|Overall Study|Adverse Event|15|||
46961283|NCT02246764|83203678|FG001|Overall Study|Adverse Event|29|||
46961284|NCT02246764|83203679|FG002|Overall Study|Adverse Event|1|||
46961285|NCT02246764|83203677|FG000|Overall Study|Withdrawal by Subject|0|||
46961286|NCT02246764|83203678|FG001|Overall Study|Withdrawal by Subject|0|||
46961287|NCT02246764|83203679|FG002|Overall Study|Withdrawal by Subject|1|||
46961288|NCT02246764|83203677|FG000|Overall Study|Disallowed Concomitant Medication|1|||
46961289|NCT02246764|83203678|FG001|Overall Study|Disallowed Concomitant Medication|0|||
46961290|NCT02246764|83203679|FG002|Overall Study|Disallowed Concomitant Medication|0|||
46961291|NCT02246764|83203677|FG000|Overall Study|Physician Decision|0|||
46961292|NCT02246764|83203678|FG001|Overall Study|Physician Decision|2|||
46961293|NCT02246764|83203679|FG002|Overall Study|Physician Decision|1|||
46961294|NCT02246764|83203677|FG000|Overall Study|Protocol Violation|2|||
46961295|NCT02246764|83203678|FG001|Overall Study|Protocol Violation|1|||
46961296|NCT02246764|83203679|FG002|Overall Study|Protocol Violation|1|||
46961297|NCT02454530|83203689|FG000|Overall Study|Other|8|||
46961298|NCT02454530|83203690|FG001|Overall Study|Other|13|||
46961299|NCT02454530|83203689|FG000|Overall Study|Missing information|56|||
46961300|NCT02454530|83203690|FG001|Overall Study|Missing information|69|||
46961301|NCT02454530|83203689|FG000|Overall Study|Death|2|||
46961302|NCT02454530|83203690|FG001|Overall Study|Death|41|||
46961303|NCT02454530|83203689|FG000|Overall Study|Lost to Follow-up|4|||
46961304|NCT02454530|83203690|FG001|Overall Study|Lost to Follow-up|4|||
46961305|NCT02431676|83203700|FG000|Overall Study|no lab obtained|0|||
46961306|NCT02431676|83203701|FG001|Overall Study|no lab obtained|1|||
46961307|NCT02431676|83203702|FG002|Overall Study|no lab obtained|2|||
46961308|NCT01654250|83203712|FG000|Overall Study|Lost to Follow-up|1|||
46961309|NCT01654250|83203713|FG001|Overall Study|Lost to Follow-up|0|||
46640051|NCT00086346|82814031|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
46640052|NCT00086346|82814032|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
46640053|NCT00086346|82814031|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
46640054|NCT00086346|82814032|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
46640055|NCT00085566|82814041|FG000|Overall Study|Adverse Event|0|||
46640056|NCT00085566|82814042|FG001|Overall Study|Adverse Event|0|||
46640057|NCT00085566|82814043|FG002|Overall Study|Adverse Event|10|||
46961310|NCT01652690|83203722|FG000|Overall Study|Withdrawal by Subject|16|||
46961311|NCT01652690|83203723|FG001|Overall Study|Withdrawal by Subject|4|||
46961312|NCT01652690|83203722|FG000|Overall Study|Other|8|||
46961313|NCT01652690|83203723|FG001|Overall Study|Other|9|||
46961314|NCT01652690|83203722|FG000|Overall Study|Lost to Follow-up|6|||
46961315|NCT01652690|83203723|FG001|Overall Study|Lost to Follow-up|6|||
46961316|NCT01652690|83203722|FG000|Overall Study|Death|5|||
46961317|NCT01652690|83203723|FG001|Overall Study|Death|2|||
46961318|NCT02429258|83203731|FG000|Overall Study|Withdrawal by Subject|2|||
46961319|NCT02429258|83203732|FG001|Overall Study|Withdrawal by Subject|0|||
46961320|NCT02429258|83203731|FG000|Overall Study|Protocol Violation|0|||
46961321|NCT02429258|83203732|FG001|Overall Study|Protocol Violation|1|||
46961322|NCT02201524|83203742|FG000|Overall Study|Adverse Event|0|||
46961323|NCT02201524|83203743|FG001|Overall Study|Adverse Event|2|||
46961324|NCT02201524|83203744|FG002|Overall Study|Adverse Event|1|||
46961325|NCT02201524|83203745|FG003|Overall Study|Adverse Event|0|||
46961326|NCT02201524|83203742|FG000|Overall Study|Insufficient clinical response|1|||
46961327|NCT02201524|83203743|FG001|Overall Study|Insufficient clinical response|0|||
46961328|NCT02201524|83203744|FG002|Overall Study|Insufficient clinical response|0|||
46961329|NCT02201524|83203745|FG003|Overall Study|Insufficient clinical response|0|||
46961330|NCT02201524|83203742|FG000|Overall Study|Lost to Follow-up|0|||
46961331|NCT02201524|83203743|FG001|Overall Study|Lost to Follow-up|0|||
46961332|NCT02201524|83203744|FG002|Overall Study|Lost to Follow-up|2|||
46961333|NCT02201524|83203745|FG003|Overall Study|Lost to Follow-up|0|||
46961334|NCT02201524|83203742|FG000|Overall Study|No longer meets eligibility criteria|0|||
46961335|NCT02201524|83203743|FG001|Overall Study|No longer meets eligibility criteria|0|||
46961336|NCT02201524|83203744|FG002|Overall Study|No longer meets eligibility criteria|0|||
46961337|NCT02201524|83203745|FG003|Overall Study|No longer meets eligibility criteria|2|||
46961338|NCT02201524|83203742|FG000|Overall Study|Protocol Violation|0|||
47067176|NCT01549964|83350654|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
46640058|NCT00085566|82814041|FG000|Overall Study|Patient Not treated|0|||
46961339|NCT02201524|83203743|FG001|Overall Study|Protocol Violation|0|||
46961340|NCT02201524|83203744|FG002|Overall Study|Protocol Violation|0|||
46961341|NCT02201524|83203745|FG003|Overall Study|Protocol Violation|1|||
46961342|NCT02201524|83203742|FG000|Overall Study|Withdrawal by Subject|0|||
46961343|NCT02201524|83203743|FG001|Overall Study|Withdrawal by Subject|0|||
46640059|NCT00085566|82814042|FG001|Overall Study|Patient Not treated|0|||
46961344|NCT02201524|83203744|FG002|Overall Study|Withdrawal by Subject|1|||
46961345|NCT02201524|83203745|FG003|Overall Study|Withdrawal by Subject|1|||
46961346|NCT02201524|83203742|FG000|Overall Study|Other|1|||
46961347|NCT02201524|83203743|FG001|Overall Study|Other|1|||
46961348|NCT02201524|83203744|FG002|Overall Study|Other|0|||
46961349|NCT02201524|83203745|FG003|Overall Study|Other|0|||
46961350|NCT02453048|83203760|FG000|Overall Study|Only part of initial 6 mo. study|0|||
46961351|NCT02453048|83203761|FG001|Overall Study|Only part of initial 6 mo. study|0|||
46961352|NCT02453048|83203762|FG002|Overall Study|Only part of initial 6 mo. study|0|||
46961353|NCT02453048|83203763|FG003|Overall Study|Only part of initial 6 mo. study|0|||
46961354|NCT02453048|83203764|FG004|Overall Study|Only part of initial 6 mo. study|6|||
46961355|NCT02453048|83203760|FG000|Overall Study|Lost to Follow-up|0|||
46961356|NCT02453048|83203761|FG001|Overall Study|Lost to Follow-up|1|||
46961357|NCT02453048|83203762|FG002|Overall Study|Lost to Follow-up|2|||
46961358|NCT02453048|83203763|FG003|Overall Study|Lost to Follow-up|0|||
46961359|NCT02453048|83203764|FG004|Overall Study|Lost to Follow-up|0|||
46961360|NCT02137252|83203778|FG000|Overall Study|trial terminated early|2|||
46961361|NCT02137252|83203779|FG001|Overall Study|trial terminated early|1|||
46961362|NCT02201290|83203785|FG000|Overall Study|Withdrawal by Subject|2|||
46961363|NCT02201290|83203785|FG000|Overall Study|Lack of Efficacy|2|||
46961364|NCT02201290|83203785|FG000|Overall Study|Adverse Event|1|||
46961365|NCT02200510|83203791|FG000|Overall Study|Death|1|||
46961366|NCT02200510|83203792|FG001|Overall Study|Death|1|||
46961367|NCT02200510|83203791|FG000|Overall Study|Protocol Violation|0|||
46961368|NCT02200510|83203792|FG001|Overall Study|Protocol Violation|1|||
46961369|NCT02200510|83203791|FG000|Overall Study|Lost to Follow-up|7|||
46961370|NCT02200510|83203792|FG001|Overall Study|Lost to Follow-up|1|||
46961371|NCT02200510|83203791|FG000|Overall Study|potential COI - joined study team|1|||
46961372|NCT02200510|83203792|FG001|Overall Study|potential COI - joined study team|0|||
46961373|NCT02452892|83203802|FG000|Week 1 Initial Randommization|Adverse Event|1|||
46961374|NCT02452892|83203803|FG001|Week 1 Initial Randommization|Adverse Event|0|||
46961375|NCT02452892|83203804|FG002|Week 1 Initial Randommization|Adverse Event|0|||
46961376|NCT02452892|83203805|FG003|Week 1 Initial Randommization|Adverse Event|0|||
46961377|NCT02452892|83203802|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
46961378|NCT02452892|83203803|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
46961379|NCT02452892|83203804|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
46961380|NCT02452892|83203805|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
46961381|NCT02452892|83203802|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
46961382|NCT02452892|83203803|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
46961383|NCT02452892|83203804|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
46961384|NCT02452892|83203805|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
46961385|NCT02452892|83203802|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
46961386|NCT02452892|83203803|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
46961387|NCT02452892|83203804|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
46961388|NCT02452892|83203805|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
46961389|NCT02452892|83203802|FG000|Follow-up|Withdrawal by Subject|0|||
46961390|NCT02452892|83203803|FG001|Follow-up|Withdrawal by Subject|0|||
46961391|NCT02452892|83203804|FG002|Follow-up|Withdrawal by Subject|0|||
46961392|NCT02452892|83203805|FG003|Follow-up|Withdrawal by Subject|1|||
46961393|NCT02452892|83203802|FG000|Follow-up|Subject left town on Day 42|1|||
46961394|NCT02452892|83203803|FG001|Follow-up|Subject left town on Day 42|0|||
46961395|NCT02452892|83203804|FG002|Follow-up|Subject left town on Day 42|0|||
46961396|NCT02452892|83203805|FG003|Follow-up|Subject left town on Day 42|0|||
46961397|NCT02135848|83203820|FG000|Overall Study|Adverse Event|2|||
46961398|NCT02135848|83203821|FG001|Overall Study|Adverse Event|0|||
46961399|NCT02135848|83203820|FG000|Overall Study|Withdrawal by Subject|1|||
46961400|NCT02135848|83203821|FG001|Overall Study|Withdrawal by Subject|1|||
46961401|NCT02738333|83203841|FG000|Overall Study|Death|1|||
46961402|NCT02738333|83203842|FG001|Overall Study|Death|0|||
46961403|NCT02738333|83203843|FG002|Overall Study|Death|0|||
46961404|NCT02738333|83203841|FG000|Overall Study|Lost to Follow-up|1|||
46961405|NCT02738333|83203842|FG001|Overall Study|Lost to Follow-up|0|||
47067177|NCT01549964|83350655|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
47067178|NCT01549964|83350656|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
46961406|NCT02738333|83203843|FG002|Overall Study|Lost to Follow-up|0|||
46961407|NCT02135692|83203851|FG000|Overall Study|Adverse Event|3|||
46961408|NCT02135692|83203851|FG000|Overall Study|Lack of Efficacy|2|||
46961409|NCT02135692|83203851|FG000|Overall Study|Protocol Violation|2|||
46774135|NCT00716274|82992613|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
46774136|NCT00716274|82992614|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
46961410|NCT02135692|83203851|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
46774137|NCT00716274|82992615|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
46774138|NCT00716274|82992616|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
46961411|NCT02135692|83203851|FG000|Overall Study|Product commercially available|159|||
46845243|NCT00127842|83062080|FG000|Overall Study|Lost to Follow-up|1|||
46961412|NCT02135692|83203851|FG000|Overall Study|Study closed/terminated|153|||
46961413|NCT02135692|83203851|FG000|Overall Study|Lost to Follow-up|4|||
46961414|NCT02135692|83203851|FG000|Overall Study|Withdrawal by Subject|15|||
46961415|NCT02429414|83203857|FG000|Overall Study|Physician Decision|0|||
46961416|NCT02429414|83203858|FG001|Overall Study|Physician Decision|1|||
46961417|NCT02135614|83203866|FG000|Overall Study|Randomized but Not Treated|2|||
46961418|NCT02135614|83203867|FG001|Overall Study|Randomized but Not Treated|1|||
46961419|NCT02135614|83203866|FG000|Overall Study|Adverse Event|0|||
46961420|NCT02135614|83203867|FG001|Overall Study|Adverse Event|1|||
46961421|NCT02135614|83203866|FG000|Overall Study|Death|1|||
46961422|NCT02135614|83203867|FG001|Overall Study|Death|0|||
46961423|NCT02135614|83203866|FG000|Overall Study|Investigator's Discretion|0|||
46961424|NCT02135614|83203867|FG001|Overall Study|Investigator's Discretion|1|||
46961425|NCT02135614|83203866|FG000|Overall Study|Withdrew Consent|2|||
46961426|NCT02135614|83203867|FG001|Overall Study|Withdrew Consent|2|||
46961427|NCT02135614|83203866|FG000|Overall Study|Lost to Follow-up|3|||
46961428|NCT02135614|83203867|FG001|Overall Study|Lost to Follow-up|0|||
46961429|NCT02168842|83203875|FG000|Overall Study|Withdrawal by Subject|5|||
46961430|NCT02168842|83203876|FG001|Overall Study|Withdrawal by Subject|3|||
46961431|NCT02168842|83203875|FG000|Overall Study|Lost to Follow-up|0|||
46961432|NCT02168842|83203876|FG001|Overall Study|Lost to Follow-up|2|||
46961433|NCT02168842|83203875|FG000|Overall Study|Death|2|||
46961434|NCT02168842|83203876|FG001|Overall Study|Death|1|||
46961435|NCT02168842|83203875|FG000|Overall Study|Physician Decision|1|||
46961436|NCT02168842|83203876|FG001|Overall Study|Physician Decision|2|||
46961437|NCT02200042|83203886|FG000|Overall Study|Withdrawal by Subject|0|||
46961438|NCT02200042|83203887|FG001|Overall Study|Withdrawal by Subject|1|||
46961439|NCT02199028|83203895|FG000|Week 1|Adverse Event|1|||
46961440|NCT02199028|83203896|FG001|Week 1|Adverse Event|0|||
46961441|NCT02199028|83203895|FG000|Week 3|Adverse Event|1|||
46961442|NCT02199028|83203896|FG001|Week 3|Adverse Event|0|||
46961443|NCT03347123|83203905|FG000|Overall Study|Death|1|||
46961444|NCT03347123|83203906|FG001|Overall Study|Death|2|||
46961445|NCT03347123|83203907|FG002|Overall Study|Death|0|||
46961446|NCT03347123|83203908|FG003|Overall Study|Death|0|||
46961447|NCT03347123|83203909|FG004|Overall Study|Death|0|||
46961448|NCT03347123|83203910|FG005|Overall Study|Death|0|||
46961449|NCT03347123|83203911|FG006|Overall Study|Death|0|||
46961450|NCT03347123|83203905|FG000|Overall Study|Withdrawal by Subject|1|||
46961451|NCT03347123|83203906|FG001|Overall Study|Withdrawal by Subject|0|||
46961452|NCT03347123|83203907|FG002|Overall Study|Withdrawal by Subject|0|||
46961453|NCT03347123|83203908|FG003|Overall Study|Withdrawal by Subject|0|||
46961454|NCT03347123|83203909|FG004|Overall Study|Withdrawal by Subject|0|||
46961455|NCT03347123|83203910|FG005|Overall Study|Withdrawal by Subject|0|||
46961456|NCT03347123|83203911|FG006|Overall Study|Withdrawal by Subject|0|||
46961457|NCT03347123|83203905|FG000|Overall Study|Reason not Specified|3|||
46961458|NCT03347123|83203906|FG001|Overall Study|Reason not Specified|4|||
46961459|NCT03347123|83203907|FG002|Overall Study|Reason not Specified|0|||
46961460|NCT03347123|83203908|FG003|Overall Study|Reason not Specified|0|||
46961461|NCT03347123|83203909|FG004|Overall Study|Reason not Specified|0|||
46961462|NCT03347123|83203910|FG005|Overall Study|Reason not Specified|0|||
46961463|NCT03347123|83203911|FG006|Overall Study|Reason not Specified|0|||
46961464|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
46961465|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
46961466|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
46961467|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
46961468|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
46961469|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
46961470|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
46961471|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
46961472|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
47067179|NCT01549964|83350653|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
46774139|NCT00716274|82992611|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
46774140|NCT00716274|82992612|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
46961473|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
46961474|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
46961475|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
46961476|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
46961477|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
46961478|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
46774141|NCT00716274|82992613|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
46774142|NCT00716274|82992614|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
46961479|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
46961480|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
46961481|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
46961482|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
46961483|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
46961484|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
46961485|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
46961486|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
46961487|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
46961488|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
46961489|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
46961490|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
46961491|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
46961492|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
46961493|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
46961494|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
46961495|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
46961496|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
46961497|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
46961498|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
46961499|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
46961500|NCT02198794|83203922|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
46961501|NCT02198794|83203923|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
46961502|NCT02198794|83203924|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
46961503|NCT02198794|83203925|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
46961504|NCT02198794|83203922|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
46961505|NCT02198794|83203923|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
46961506|NCT02198794|83203924|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
46961507|NCT02198794|83203925|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
46961508|NCT02198794|83203922|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
46961509|NCT02198794|83203923|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
46961510|NCT02198794|83203924|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
46961511|NCT02198794|83203925|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
46961512|NCT02198794|83203922|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
46961513|NCT02198794|83203923|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
46961514|NCT02198794|83203924|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
46961515|NCT02198794|83203925|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
46961516|NCT02198794|83203922|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
46961517|NCT02198794|83203923|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
46961518|NCT02198794|83203924|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
46961519|NCT02198794|83203925|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
46961520|NCT02198794|83203922|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
46961521|NCT02198794|83203923|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
46961522|NCT02198794|83203924|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
46961523|NCT02198794|83203925|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
46961524|NCT02133664|83203936|FG000|Overall Study|Lost to Follow-up|2|||
46961525|NCT02133664|83203937|FG001|Overall Study|Lost to Follow-up|1|||
46961526|NCT02133664|83203936|FG000|Overall Study|Adverse Event|3|||
46961527|NCT02133664|83203937|FG001|Overall Study|Adverse Event|6|||
46961528|NCT02133508|83203943|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
46961529|NCT02133508|83203943|FG000|Overall Study|Death|12|||
46961530|NCT02133508|83203943|FG000|Overall Study|Lost to Follow-up|2|||
46961531|NCT02133352|83203947|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
46961532|NCT02167594|83203954|FG000|Overall Study|Withdrawal by Subject|2|||
46961533|NCT02167594|83203955|FG001|Overall Study|Withdrawal by Subject|0|||
46961534|NCT02167594|83203956|FG002|Overall Study|Withdrawal by Subject|0|||
46961535|NCT02167594|83203954|FG000|Overall Study|Death|0|||
46961536|NCT02167594|83203955|FG001|Overall Study|Death|1|||
46961537|NCT02167594|83203956|FG002|Overall Study|Death|0|||
46961538|NCT02555657|83203967|FG000|Overall Study|Death|274|||
46961539|NCT02555657|83203968|FG001|Overall Study|Death|262|||
46961540|NCT02555657|83203967|FG000|Overall Study|Physician Decision|0|||
46961541|NCT02555657|83203968|FG001|Overall Study|Physician Decision|1|||
46961542|NCT02555657|83203967|FG000|Overall Study|Sponsor Decision|27|||
46961543|NCT02555657|83203968|FG001|Overall Study|Sponsor Decision|15|||
46961544|NCT02555657|83203967|FG000|Overall Study|Withdrawal by Subject|11|||
46961545|NCT02555657|83203968|FG001|Overall Study|Withdrawal by Subject|32|||
46961546|NCT02195518|83204000|FG000|Overall Study|Adverse Event|1|||
46961547|NCT02195518|83204000|FG000|Overall Study|Protocol Violation|4|||
46961548|NCT02195518|83204000|FG000|Overall Study|Pregnancy|2|||
46961549|NCT02195518|83204000|FG000|Overall Study|Withdrawal by Subject|1|||
46961550|NCT02195518|83204000|FG000|Overall Study|Lost to Follow-up|1|||
46961551|NCT02133742|83204030|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
46961552|NCT02133742|83204030|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
46961553|NCT02133742|83204030|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
46640060|NCT00085566|82814043|FG002|Overall Study|Patient Not treated|3|||
46774143|NCT00716274|82992615|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
46961554|NCT02133742|83204030|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
46961555|NCT02133742|83204030|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
46961556|NCT03032705|83204038|FG000|Overall Study|Lost to Follow-up|16|||
46961557|NCT03032705|83204039|FG001|Overall Study|Lost to Follow-up|17|||
46961558|NCT03032705|83204038|FG000|Overall Study|did not quality|6|||
46961559|NCT03032705|83204039|FG001|Overall Study|did not quality|6|||
46961560|NCT04476251|83204045|FG000|Overall Study|Not treated|1|||
46961561|NCT03795233|83204051|FG000|Overall Study|Withdrawal by Subject|2|||
46961562|NCT03795233|83204052|FG001|Overall Study|Withdrawal by Subject|1|||
46961563|NCT03795233|83204051|FG000|Overall Study|Lost to Follow-up|1|||
46961564|NCT03795233|83204052|FG001|Overall Study|Lost to Follow-up|0|||
46961565|NCT03795233|83204051|FG000|Overall Study|Death|1|||
46961566|NCT03795233|83204052|FG001|Overall Study|Death|0|||
46961567|NCT03564119|83204060|FG000|Overall Study|Adverse Event|4|||
46961568|NCT03564119|83204061|FG001|Overall Study|Adverse Event|0|||
46961569|NCT03564119|83204060|FG000|Overall Study|Lost to Follow-up|1|||
46961570|NCT03564119|83204061|FG001|Overall Study|Lost to Follow-up|4|||
46961571|NCT03564119|83204060|FG000|Overall Study|Protocol Violation|1|||
46961572|NCT03564119|83204061|FG001|Overall Study|Protocol Violation|0|||
46961573|NCT03564119|83204060|FG000|Overall Study|Withdrawal by Subject|9|||
46961574|NCT03564119|83204061|FG001|Overall Study|Withdrawal by Subject|4|||
46961575|NCT03564119|83204060|FG000|Overall Study|Other Than Specified|0|||
46961576|NCT03564119|83204061|FG001|Overall Study|Other Than Specified|1|||
46961577|NCT04531241|83204067|FG000|Period 1|Withdrawal by Subject|2|||
46961578|NCT04531241|83204068|FG001|Period 1|Withdrawal by Subject|0|||
46961579|NCT04531241|83204067|FG000|Period 1|Dispesed incorrect lens power|1|||
46961580|NCT04531241|83204068|FG001|Period 1|Dispesed incorrect lens power|0|||
46961581|NCT04531241|83204067|FG000|Period 1|Protocol Violation|1|||
46961582|NCT04531241|83204068|FG001|Period 1|Protocol Violation|0|||
46961583|NCT04531241|83204067|FG000|Period 1|No longer eligible|0|||
46961584|NCT04531241|83204068|FG001|Period 1|No longer eligible|1|||
46961585|NCT04531241|83204067|FG000|Period 1|Lens Discomfort|0|||
46961586|NCT04531241|83204068|FG001|Period 1|Lens Discomfort|1|||
46961587|NCT04531241|83204067|FG000|Period 2|Covid-19 Related|1|||
46961588|NCT04531241|83204068|FG001|Period 2|Covid-19 Related|1|||
46961589|NCT03181529|83204076|FG000|Overall Study|Withdrawal by Subject|1|||
46961590|NCT03181529|83204077|FG001|Overall Study|Withdrawal by Subject|1|||
46961591|NCT03181529|83204076|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
46961592|NCT03181529|83204077|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
46961593|NCT03470441|83204091|FG000|Overall Study|Death|0|||
46961594|NCT03470441|83204092|FG001|Overall Study|Death|1|||
46961595|NCT03470441|83204093|FG002|Overall Study|Death|1|||
46961596|NCT03470441|83204094|FG003|Overall Study|Death|0|||
46961597|NCT03470441|83204091|FG000|Overall Study|Adverse Event|0|||
46961598|NCT03470441|83204092|FG001|Overall Study|Adverse Event|0|||
46961599|NCT03470441|83204093|FG002|Overall Study|Adverse Event|0|||
46961600|NCT03470441|83204094|FG003|Overall Study|Adverse Event|1|||
46961601|NCT03470441|83204091|FG000|Overall Study|Withdrawal by Subject|1|||
46961602|NCT03470441|83204092|FG001|Overall Study|Withdrawal by Subject|4|||
46961603|NCT03470441|83204093|FG002|Overall Study|Withdrawal by Subject|1|||
46961604|NCT03470441|83204094|FG003|Overall Study|Withdrawal by Subject|3|||
46961605|NCT03361865|83204106|FG000|Overall Study|Death|17|||
46961606|NCT03361865|83204107|FG001|Overall Study|Death|18|||
46961607|NCT03361865|83204106|FG000|Overall Study|Physician Decision|1|||
46961608|NCT03361865|83204107|FG001|Overall Study|Physician Decision|9|||
46961609|NCT03361865|83204106|FG000|Overall Study|Withdrawal by Subject|1|||
46961610|NCT03361865|83204107|FG001|Overall Study|Withdrawal by Subject|0|||
46961611|NCT02149121|83204121|FG000|Main Study Period|Lack of Efficacy|2|||
46961612|NCT02149121|83204122|FG001|Main Study Period|Lack of Efficacy|2|||
46961613|NCT02149121|83204123|FG002|Main Study Period|Lack of Efficacy|1|||
46961614|NCT02149121|83204124|FG003|Main Study Period|Lack of Efficacy|0|||
47067180|NCT01549964|83350654|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
47067181|NCT01549964|83350655|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
47067182|NCT01549964|83350656|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
47067183|NCT01549964|83350653|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
47067184|NCT01549964|83350654|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
47067185|NCT01549964|83350655|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
47067186|NCT01549964|83350656|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
47067187|NCT01549964|83350653|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
47067188|NCT01549964|83350654|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
47067189|NCT01549964|83350655|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
47067190|NCT01549964|83350656|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
47067191|NCT01549964|83350653|FG000|24-Week Treatment Period|Other|1|||
47067192|NCT01549964|83350654|FG001|24-Week Treatment Period|Other|0|||
47067193|NCT01549964|83350655|FG002|24-Week Treatment Period|Other|1|||
46961615|NCT02149121|83204125|FG004|Main Study Period|Lack of Efficacy|0|||
46961616|NCT02149121|83204126|FG005|Main Study Period|Lack of Efficacy|0|||
46961617|NCT02149121|83204127|FG006|Main Study Period|Lack of Efficacy|0|||
46961618|NCT02149121|83204121|FG000|Main Study Period|Withdrawal by Subject|9|||
46961619|NCT02149121|83204122|FG001|Main Study Period|Withdrawal by Subject|5|||
46961620|NCT02149121|83204123|FG002|Main Study Period|Withdrawal by Subject|1|||
46961621|NCT02149121|83204124|FG003|Main Study Period|Withdrawal by Subject|0|||
46961622|NCT02149121|83204125|FG004|Main Study Period|Withdrawal by Subject|0|||
46961623|NCT02149121|83204126|FG005|Main Study Period|Withdrawal by Subject|0|||
46961624|NCT02149121|83204127|FG006|Main Study Period|Withdrawal by Subject|0|||
46961625|NCT02149121|83204121|FG000|Main Study Period|Adverse Event|2|||
46961626|NCT02149121|83204122|FG001|Main Study Period|Adverse Event|5|||
46961627|NCT02149121|83204123|FG002|Main Study Period|Adverse Event|1|||
46961628|NCT02149121|83204124|FG003|Main Study Period|Adverse Event|0|||
46961629|NCT02149121|83204125|FG004|Main Study Period|Adverse Event|0|||
46961630|NCT02149121|83204126|FG005|Main Study Period|Adverse Event|0|||
46961631|NCT02149121|83204127|FG006|Main Study Period|Adverse Event|0|||
46961632|NCT02149121|83204121|FG000|Main Study Period|Protocol Violation|2|||
46961633|NCT02149121|83204122|FG001|Main Study Period|Protocol Violation|0|||
46961634|NCT02149121|83204123|FG002|Main Study Period|Protocol Violation|0|||
46961635|NCT02149121|83204124|FG003|Main Study Period|Protocol Violation|0|||
46961636|NCT02149121|83204125|FG004|Main Study Period|Protocol Violation|0|||
46961637|NCT02149121|83204126|FG005|Main Study Period|Protocol Violation|0|||
46961638|NCT02149121|83204127|FG006|Main Study Period|Protocol Violation|0|||
46961639|NCT02149121|83204121|FG000|Main Study Period|Lost to Follow-up|2|||
46961640|NCT02149121|83204122|FG001|Main Study Period|Lost to Follow-up|1|||
46961641|NCT02149121|83204123|FG002|Main Study Period|Lost to Follow-up|0|||
46961642|NCT02149121|83204124|FG003|Main Study Period|Lost to Follow-up|0|||
46961643|NCT02149121|83204125|FG004|Main Study Period|Lost to Follow-up|0|||
46961644|NCT02149121|83204126|FG005|Main Study Period|Lost to Follow-up|0|||
46961645|NCT02149121|83204127|FG006|Main Study Period|Lost to Follow-up|0|||
46961646|NCT02149121|83204121|FG000|Main Study Period|Death|1|||
46961647|NCT02149121|83204122|FG001|Main Study Period|Death|0|||
46961648|NCT02149121|83204123|FG002|Main Study Period|Death|0|||
46961649|NCT02149121|83204124|FG003|Main Study Period|Death|0|||
46961650|NCT02149121|83204125|FG004|Main Study Period|Death|0|||
46961651|NCT02149121|83204126|FG005|Main Study Period|Death|0|||
46961652|NCT02149121|83204127|FG006|Main Study Period|Death|0|||
46961653|NCT02149121|83204121|FG000|Main Study Period|Physician Decision|1|||
46961654|NCT02149121|83204122|FG001|Main Study Period|Physician Decision|0|||
46961655|NCT02149121|83204123|FG002|Main Study Period|Physician Decision|0|||
46961656|NCT02149121|83204124|FG003|Main Study Period|Physician Decision|0|||
46961657|NCT02149121|83204125|FG004|Main Study Period|Physician Decision|0|||
46961658|NCT02149121|83204126|FG005|Main Study Period|Physician Decision|0|||
46961659|NCT02149121|83204127|FG006|Main Study Period|Physician Decision|0|||
46961660|NCT02149121|83204121|FG000|Main Study Period|Developed any malignancy|0|||
46961661|NCT02149121|83204122|FG001|Main Study Period|Developed any malignancy|1|||
46961662|NCT02149121|83204123|FG002|Main Study Period|Developed any malignancy|1|||
46961663|NCT02149121|83204124|FG003|Main Study Period|Developed any malignancy|0|||
46845244|NCT00127842|83062080|FG000|Overall Study|Lack of Efficacy|12|||
46845245|NCT00127842|83062080|FG000|Overall Study|Noncompliance|2|||
46845246|NCT00127842|83062080|FG000|Overall Study|Protocol Violation|1|||
46845247|NCT00127842|83062080|FG000|Overall Study|Other|5|||
46845248|NCT03720652|83062086|FG000|Overall Study|Withdrawal by Subject|2|||
46845249|NCT03720652|83062087|FG001|Overall Study|Withdrawal by Subject|7|||
46845250|NCT03720652|83062086|FG000|Overall Study|Lost to Follow-up|0|||
46845251|NCT03720652|83062087|FG001|Overall Study|Lost to Follow-up|4|||
46845252|NCT00112866|83062097|FG000|Overall Study|Protocol Violation|1|||
46845253|NCT00112866|83062098|FG001|Overall Study|Protocol Violation|0|||
46845254|NCT00112866|83062097|FG000|Overall Study|did not start treatment post-op|1|||
46845255|NCT00112866|83062098|FG001|Overall Study|did not start treatment post-op|2|||
46845256|NCT00127608|83062112|FG000|Overall Study|VZV DNA negative|1|||
46845257|NCT00149396|83062116|FG000|Overall Study|Death|15|||
46845258|NCT00149396|83062116|FG000|Overall Study|Withdrawal by Subject|1|||
46845259|NCT00149396|83062116|FG000|Overall Study|Subject noncompliance|2|||
46845260|NCT00149396|83062116|FG000|Overall Study|other treatment|5|||
46845261|NCT00223496|83062127|FG000|Overall Study|screen failure|9|||
46845262|NCT00223496|83062127|FG000|Overall Study|Lost to Follow-up|4|||
46845263|NCT00223496|83062127|FG000|Overall Study|Lack of Efficacy|6|||
46961664|NCT02149121|83204125|FG004|Main Study Period|Developed any malignancy|0|||
46845264|NCT00223496|83062127|FG000|Overall Study|Withdrawal by Subject|1|||
46845265|NCT00223496|83062127|FG000|Overall Study|Physician Decision|2|||
46845266|NCT00255944|83062133|FG000|Overall Study|Lost to Follow-up|797|||
46845267|NCT00255944|83062134|FG001|Overall Study|Lost to Follow-up|834|||
46961665|NCT02149121|83204126|FG005|Main Study Period|Developed any malignancy|0|||
46961666|NCT02149121|83204127|FG006|Main Study Period|Developed any malignancy|0|||
47067194|NCT01549964|83350656|FG003|24-Week Treatment Period|Other|0|||
46845268|NCT00143598|83062142|FG000|Overall Study|Lost to Follow-up|23|||
46961667|NCT02149121|83204121|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
46961668|NCT02149121|83204122|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
46961669|NCT02149121|83204123|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
46961670|NCT02149121|83204124|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
46961671|NCT02149121|83204125|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
46961672|NCT02149121|83204126|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
46961673|NCT02149121|83204127|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
46961674|NCT02149121|83204121|FG000|Main Study Period|Disease progression|0|||
46961675|NCT02149121|83204122|FG001|Main Study Period|Disease progression|1|||
46961676|NCT02149121|83204123|FG002|Main Study Period|Disease progression|0|||
46961677|NCT02149121|83204124|FG003|Main Study Period|Disease progression|0|||
46961678|NCT02149121|83204125|FG004|Main Study Period|Disease progression|0|||
46961679|NCT02149121|83204126|FG005|Main Study Period|Disease progression|0|||
46961680|NCT02149121|83204127|FG006|Main Study Period|Disease progression|0|||
46961681|NCT02149121|83204121|FG000|Extension Study Period|Withdrawal by Subject|0|||
46961682|NCT02149121|83204122|FG001|Extension Study Period|Withdrawal by Subject|0|||
46961683|NCT02149121|83204123|FG002|Extension Study Period|Withdrawal by Subject|0|||
46961684|NCT02149121|83204124|FG003|Extension Study Period|Withdrawal by Subject|1|||
46961685|NCT02149121|83204125|FG004|Extension Study Period|Withdrawal by Subject|0|||
46961686|NCT02149121|83204126|FG005|Extension Study Period|Withdrawal by Subject|2|||
46961687|NCT02149121|83204127|FG006|Extension Study Period|Withdrawal by Subject|0|||
46961688|NCT01865617|83204179|FG000|Overall Study|Death|27|||
46961689|NCT01865617|83204180|FG001|Overall Study|Death|3|||
46774144|NCT00716274|82992616|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
46774145|NCT00716274|82992611|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
46774146|NCT00716274|82992612|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
46961690|NCT01865617|83204181|FG002|Overall Study|Death|1|||
46961691|NCT01865617|83204182|FG003|Overall Study|Death|1|||
46961692|NCT01865617|83204183|FG004|Overall Study|Death|5|||
46961693|NCT01865617|83204184|FG005|Overall Study|Death|1|||
47067195|NCT01549964|83350653|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
47067196|NCT01549964|83350654|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
47067197|NCT01549964|83350655|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
47067198|NCT01549964|83350656|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
46774147|NCT00716274|82992613|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
46774148|NCT00716274|82992614|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
46774149|NCT00716274|82992615|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
46774150|NCT00716274|82992616|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
46845269|NCT00143598|83062143|FG001|Overall Study|Lost to Follow-up|21|||
46845270|NCT00143598|83062142|FG000|Overall Study|Withdrawal by Subject|33|||
46845271|NCT00143598|83062143|FG001|Overall Study|Withdrawal by Subject|37|||
46845272|NCT00143598|83062142|FG000|Overall Study|Death|36|||
46845273|NCT00143598|83062143|FG001|Overall Study|Death|36|||
46845274|NCT00126672|83062149|FG000|Overall Study|Adverse Event|4|||
46845275|NCT00126672|83062149|FG000|Overall Study|Lost to Follow-up|4|||
46845276|NCT00145574|83062156|FG000|Double Blind|Adverse Event|0|||
46845277|NCT00145574|83062157|FG001|Double Blind|Adverse Event|3|||
46845278|NCT00145574|83062158|FG002|Double Blind|Adverse Event|1|||
46845279|NCT00145574|83062156|FG000|Double Blind|Withdrawal by Subject|1|||
46845280|NCT00145574|83062157|FG001|Double Blind|Withdrawal by Subject|1|||
46845281|NCT00145574|83062158|FG002|Double Blind|Withdrawal by Subject|1|||
46845282|NCT00145574|83062156|FG000|Double Blind|required restricted medicine|0|||
46845283|NCT00145574|83062157|FG001|Double Blind|required restricted medicine|1|||
46845284|NCT00145574|83062158|FG002|Double Blind|required restricted medicine|0|||
46845285|NCT00145574|83062156|FG000|Open Label Long-term Extension|Adverse Event|0|||
46845286|NCT00145574|83062157|FG001|Open Label Long-term Extension|Adverse Event|0|||
46961694|NCT01865617|83204185|FG006|Overall Study|Death|11|||
46961695|NCT01865617|83204186|FG007|Overall Study|Death|1|||
46961696|NCT01865617|83204187|FG008|Overall Study|Death|11|||
46961697|NCT01865617|83204188|FG009|Overall Study|Death|3|||
46961698|NCT01865617|83204189|FG010|Overall Study|Death|32|||
46961699|NCT01865617|83204190|FG011|Overall Study|Death|6|||
46961700|NCT01865617|83204191|FG012|Overall Study|Death|13|||
46961701|NCT01865617|83204179|FG000|Overall Study|Lost to Follow-up|2|||
47067199|NCT01549964|83350653|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
46961702|NCT01865617|83204180|FG001|Overall Study|Lost to Follow-up|0|||
46961703|NCT01865617|83204181|FG002|Overall Study|Lost to Follow-up|0|||
46961704|NCT01865617|83204182|FG003|Overall Study|Lost to Follow-up|0|||
47067200|NCT01549964|83350654|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
46774151|NCT00716274|82992611|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
46774152|NCT00716274|82992612|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
46845287|NCT00145574|83062158|FG002|Open Label Long-term Extension|Adverse Event|5|||
46845288|NCT00145574|83062156|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
46845289|NCT00145574|83062157|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
46961705|NCT01865617|83204183|FG004|Overall Study|Lost to Follow-up|0|||
46961706|NCT01865617|83204184|FG005|Overall Study|Lost to Follow-up|0|||
46961707|NCT01865617|83204185|FG006|Overall Study|Lost to Follow-up|0|||
46961708|NCT01865617|83204186|FG007|Overall Study|Lost to Follow-up|0|||
46961709|NCT01865617|83204187|FG008|Overall Study|Lost to Follow-up|0|||
46961710|NCT01865617|83204188|FG009|Overall Study|Lost to Follow-up|0|||
46961711|NCT01865617|83204189|FG010|Overall Study|Lost to Follow-up|0|||
46961712|NCT01865617|83204190|FG011|Overall Study|Lost to Follow-up|0|||
46961713|NCT01865617|83204191|FG012|Overall Study|Lost to Follow-up|0|||
46961714|NCT01865617|83204179|FG000|Overall Study|Withdrawal by Subject|1|||
46961715|NCT01865617|83204180|FG001|Overall Study|Withdrawal by Subject|0|||
46961716|NCT01865617|83204181|FG002|Overall Study|Withdrawal by Subject|0|||
46961717|NCT01865617|83204182|FG003|Overall Study|Withdrawal by Subject|0|||
46961718|NCT01865617|83204183|FG004|Overall Study|Withdrawal by Subject|0|||
46961719|NCT01865617|83204184|FG005|Overall Study|Withdrawal by Subject|0|||
46961720|NCT01865617|83204185|FG006|Overall Study|Withdrawal by Subject|0|||
46961721|NCT01865617|83204186|FG007|Overall Study|Withdrawal by Subject|0|||
46961722|NCT01865617|83204187|FG008|Overall Study|Withdrawal by Subject|0|||
46961723|NCT01865617|83204188|FG009|Overall Study|Withdrawal by Subject|0|||
46961724|NCT01865617|83204189|FG010|Overall Study|Withdrawal by Subject|0|||
46961725|NCT01865617|83204190|FG011|Overall Study|Withdrawal by Subject|0|||
46961726|NCT01865617|83204191|FG012|Overall Study|Withdrawal by Subject|0|||
46961727|NCT01865617|83204179|FG000|Overall Study|Patient proceeded to new therapy|0|||
46961728|NCT01865617|83204180|FG001|Overall Study|Patient proceeded to new therapy|0|||
46961729|NCT01865617|83204181|FG002|Overall Study|Patient proceeded to new therapy|0|||
46961730|NCT01865617|83204182|FG003|Overall Study|Patient proceeded to new therapy|0|||
46961731|NCT01865617|83204183|FG004|Overall Study|Patient proceeded to new therapy|2|||
46961732|NCT01865617|83204184|FG005|Overall Study|Patient proceeded to new therapy|0|||
46961733|NCT01865617|83204185|FG006|Overall Study|Patient proceeded to new therapy|0|||
46961734|NCT01865617|83204186|FG007|Overall Study|Patient proceeded to new therapy|0|||
46961735|NCT01865617|83204187|FG008|Overall Study|Patient proceeded to new therapy|0|||
46961736|NCT01865617|83204188|FG009|Overall Study|Patient proceeded to new therapy|0|||
46961737|NCT01865617|83204189|FG010|Overall Study|Patient proceeded to new therapy|0|||
46961738|NCT01865617|83204190|FG011|Overall Study|Patient proceeded to new therapy|0|||
46961739|NCT01865617|83204191|FG012|Overall Study|Patient proceeded to new therapy|0|||
46961740|NCT01865617|83204179|FG000|Overall Study|Other|0|||
46961741|NCT01865617|83204180|FG001|Overall Study|Other|0|||
46961742|NCT01865617|83204181|FG002|Overall Study|Other|0|||
46961743|NCT01865617|83204182|FG003|Overall Study|Other|0|||
46961744|NCT01865617|83204183|FG004|Overall Study|Other|0|||
46961745|NCT01865617|83204184|FG005|Overall Study|Other|0|||
46961746|NCT01865617|83204185|FG006|Overall Study|Other|1|||
46961747|NCT01865617|83204186|FG007|Overall Study|Other|0|||
46961748|NCT01865617|83204187|FG008|Overall Study|Other|0|||
46961749|NCT01865617|83204188|FG009|Overall Study|Other|0|||
46961750|NCT01865617|83204189|FG010|Overall Study|Other|0|||
46961751|NCT01865617|83204190|FG011|Overall Study|Other|0|||
46961752|NCT01865617|83204191|FG012|Overall Study|Other|0|||
46961753|NCT02458313|83204224|FG000|Overall Study|Withdrawal by Subject|6|||
46961754|NCT02458313|83204225|FG001|Overall Study|Withdrawal by Subject|8|||
46961755|NCT02458313|83204224|FG000|Overall Study|Excluded for motion during MRI|1|||
46961756|NCT02458313|83204225|FG001|Overall Study|Excluded for motion during MRI|2|||
46961757|NCT01328431|83204242|FG000|Baseline|Protocol Violation|0|||
46961758|NCT01328431|83204243|FG001|Baseline|Protocol Violation|2|||
46961759|NCT01328431|83204242|FG000|1 Month (1M)|Lost to Follow-up|55|||
46961760|NCT01328431|83204243|FG001|1 Month (1M)|Lost to Follow-up|58|||
46961761|NCT01328431|83204242|FG000|3 Month (3M)|Death|2|||
46961762|NCT01328431|83204243|FG001|3 Month (3M)|Death|2|||
46961763|NCT01328431|83204242|FG000|3 Month (3M)|Lost to Follow-up|75|||
46961764|NCT01328431|83204243|FG001|3 Month (3M)|Lost to Follow-up|70|||
46961765|NCT01328431|83204242|FG000|12 Month (12M)|Death|2|||
46961766|NCT01328431|83204243|FG001|12 Month (12M)|Death|6|||
46961767|NCT01328431|83204242|FG000|12 Month (12M)|Lost to Follow-up|82|||
46961768|NCT01328431|83204243|FG001|12 Month (12M)|Lost to Follow-up|91|||
46961769|NCT00893789|83204253|FG000|Overall Study|Withdrawal by Subject|3|||
46961770|NCT00893789|83204254|FG001|Overall Study|Withdrawal by Subject|1|||
46961771|NCT00893789|83204255|FG002|Overall Study|Withdrawal by Subject|3|||
46961772|NCT00893789|83204256|FG003|Overall Study|Withdrawal by Subject|1|||
46961773|NCT00893789|83204253|FG000|Overall Study|Noncompliance With Study Drug|1|||
46961774|NCT00893789|83204254|FG001|Overall Study|Noncompliance With Study Drug|0|||
46961775|NCT00893789|83204255|FG002|Overall Study|Noncompliance With Study Drug|1|||
46961776|NCT00893789|83204256|FG003|Overall Study|Noncompliance With Study Drug|2|||
46961777|NCT00893789|83204253|FG000|Overall Study|Noncompliance With Study Procedures|1|||
46961778|NCT00893789|83204254|FG001|Overall Study|Noncompliance With Study Procedures|0|||
46961779|NCT00893789|83204255|FG002|Overall Study|Noncompliance With Study Procedures|0|||
46961780|NCT00893789|83204256|FG003|Overall Study|Noncompliance With Study Procedures|0|||
46961781|NCT00893789|83204253|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
46961782|NCT00893789|83204254|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
46961783|NCT00893789|83204255|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
46961784|NCT00893789|83204256|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
46961785|NCT00893789|83204253|FG000|Overall Study|Adverse Event|0|||
46961786|NCT00893789|83204254|FG001|Overall Study|Adverse Event|2|||
46961787|NCT00893789|83204255|FG002|Overall Study|Adverse Event|1|||
46961788|NCT00893789|83204256|FG003|Overall Study|Adverse Event|5|||
46961789|NCT00893789|83204253|FG000|Overall Study|Protocol Violation|0|||
46961790|NCT00893789|83204254|FG001|Overall Study|Protocol Violation|1|||
46961791|NCT00893789|83204255|FG002|Overall Study|Protocol Violation|1|||
46961792|NCT00893789|83204256|FG003|Overall Study|Protocol Violation|4|||
46961793|NCT00893789|83204253|FG000|Overall Study|Lost to Follow-up|0|||
46961794|NCT00893789|83204254|FG001|Overall Study|Lost to Follow-up|0|||
46961795|NCT00893789|83204255|FG002|Overall Study|Lost to Follow-up|0|||
46961796|NCT00893789|83204256|FG003|Overall Study|Lost to Follow-up|1|||
46961797|NCT02164864|83204269|FG000|Overall Study|Trial disease worsening|7|||
46961798|NCT02164864|83204270|FG001|Overall Study|Trial disease worsening|5|||
46961799|NCT02164864|83204271|FG002|Overall Study|Trial disease worsening|1|||
46961800|NCT02164864|83204269|FG000|Overall Study|Other pre-existing disease worsening|6|||
46961801|NCT02164864|83204270|FG001|Overall Study|Other pre-existing disease worsening|4|||
46961802|NCT02164864|83204271|FG002|Overall Study|Other pre-existing disease worsening|9|||
46961803|NCT02164864|83204269|FG000|Overall Study|Other Adverse Event (AE)|52|||
46961804|NCT02164864|83204270|FG001|Overall Study|Other Adverse Event (AE)|32|||
46961805|NCT02164864|83204271|FG002|Overall Study|Other Adverse Event (AE)|49|||
46774153|NCT00716274|82992613|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
46774154|NCT00716274|82992614|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
46774155|NCT00716274|82992615|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
46774156|NCT00716274|82992616|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
46774157|NCT00716274|82992611|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
46774158|NCT00716274|82992612|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
46774159|NCT00716274|82992613|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
46774160|NCT00716274|82992614|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
46774161|NCT00716274|82992615|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
46774162|NCT00716274|82992616|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
46774163|NCT00716274|82992611|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
46774164|NCT00716274|82992612|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
46774165|NCT00716274|82992613|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
46774166|NCT00716274|82992614|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
46774167|NCT00716274|82992615|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
46774168|NCT00716274|82992616|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
46774169|NCT00716274|82992611|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
46774170|NCT00716274|82992612|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
46774171|NCT00716274|82992613|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
46774172|NCT00716274|82992614|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
46845290|NCT00145574|83062158|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
46845291|NCT00145574|83062156|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
46845292|NCT00145574|83062157|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
46845293|NCT00145574|83062158|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
46774173|NCT00716274|82992615|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
46774174|NCT00716274|82992616|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
46774175|NCT00716274|82992611|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
46774176|NCT00716274|82992612|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
46774177|NCT00716274|82992613|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
46774178|NCT00716274|82992614|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
46774179|NCT00716274|82992615|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
46774180|NCT00716274|82992616|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
46774181|NCT00716274|82992611|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
46774182|NCT00716274|82992612|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
46774183|NCT00716274|82992613|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
46774184|NCT00716274|82992614|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
46845294|NCT00145574|83062156|FG000|Open Label Long-term Extension|required restricted medicine|0|||
46774185|NCT00716274|82992615|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
46845295|NCT00145574|83062157|FG001|Open Label Long-term Extension|required restricted medicine|0|||
46961806|NCT02164864|83204269|FG000|Overall Study|Protocol Violation|2|||
46961807|NCT02164864|83204270|FG001|Overall Study|Protocol Violation|4|||
46961808|NCT02164864|83204271|FG002|Overall Study|Protocol Violation|1|||
46961809|NCT02164864|83204269|FG000|Overall Study|Lost to Follow-up|4|||
46774186|NCT00716274|82992616|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
46774187|NCT00746564|82992633|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
46774188|NCT01298193|82992639|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
46774189|NCT01298193|82992639|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
46961810|NCT02164864|83204270|FG001|Overall Study|Lost to Follow-up|3|||
46961811|NCT02164864|83204271|FG002|Overall Study|Lost to Follow-up|2|||
46961812|NCT02164864|83204269|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
46961813|NCT02164864|83204270|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
46961814|NCT02164864|83204271|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
46961815|NCT02164864|83204269|FG000|Overall Study|Other than stated|3|||
46961816|NCT02164864|83204270|FG001|Overall Study|Other than stated|4|||
46961817|NCT02164864|83204271|FG002|Overall Study|Other than stated|14|||
46961818|NCT02419807|83204282|FG000|Overall Study|Withdrawal by Subject|4|||
46961819|NCT02419807|83204282|FG000|Overall Study|Physician Decision|1|||
46961820|NCT02419807|83204282|FG000|Overall Study|Protocol Violation|5|||
46961821|NCT03857867|83204286|FG000|Overall Study|Physician Decision|1|||
46961822|NCT01628926|83204294|FG000|Overall Study|Adverse Event|13|||
46961823|NCT01628926|83204295|FG001|Overall Study|Adverse Event|11|||
46961824|NCT01628926|83204296|FG002|Overall Study|Adverse Event|9|||
46961825|NCT01628926|83204294|FG000|Overall Study|Lack of Efficacy|2|||
46961826|NCT01628926|83204295|FG001|Overall Study|Lack of Efficacy|1|||
46961827|NCT01628926|83204296|FG002|Overall Study|Lack of Efficacy|5|||
46961828|NCT01628926|83204294|FG000|Overall Study|Withdrawal by Subject|6|||
46961829|NCT01628926|83204295|FG001|Overall Study|Withdrawal by Subject|4|||
46961830|NCT01628926|83204296|FG002|Overall Study|Withdrawal by Subject|2|||
46961831|NCT01628926|83204294|FG000|Overall Study|Protocol Violation|0|||
46961832|NCT01628926|83204295|FG001|Overall Study|Protocol Violation|1|||
46961833|NCT01628926|83204296|FG002|Overall Study|Protocol Violation|0|||
46961834|NCT01628926|83204294|FG000|Overall Study|Discontinuation criteria|3|||
46961835|NCT01628926|83204295|FG001|Overall Study|Discontinuation criteria|4|||
46961836|NCT01628926|83204296|FG002|Overall Study|Discontinuation criteria|0|||
46961837|NCT01628926|83204294|FG000|Overall Study|Physician Decision|2|||
46961838|NCT01628926|83204295|FG001|Overall Study|Physician Decision|2|||
46961839|NCT01628926|83204296|FG002|Overall Study|Physician Decision|1|||
46961840|NCT01628848|83204307|FG000|Overall Study|Adverse Event|9|||
46961841|NCT01628848|83204308|FG001|Overall Study|Adverse Event|7|||
46961842|NCT01628848|83204307|FG000|Overall Study|Lack of Efficacy|0|||
46961843|NCT01628848|83204308|FG001|Overall Study|Lack of Efficacy|4|||
46961844|NCT01628848|83204307|FG000|Overall Study|Withdrawal by Subject|0|||
46961845|NCT01628848|83204308|FG001|Overall Study|Withdrawal by Subject|2|||
46961846|NCT01628848|83204307|FG000|Overall Study|Physician Decision|3|||
46961847|NCT01628848|83204308|FG001|Overall Study|Physician Decision|1|||
46961848|NCT02164318|83204318|FG000|Overall Study|Withdrawal by Subject|0|||
46961849|NCT02164318|83204319|FG001|Overall Study|Withdrawal by Subject|1|||
46961850|NCT02164318|83204320|FG002|Overall Study|Withdrawal by Subject|0|||
46961851|NCT02164318|83204321|FG003|Overall Study|Withdrawal by Subject|1|||
46961852|NCT03436199|83204334|FG000|Overall Study|Adverse Event|15|||
46961853|NCT03436199|83204335|FG001|Overall Study|Adverse Event|40|||
46961854|NCT03436199|83204336|FG002|Overall Study|Adverse Event|7|||
46961855|NCT03436199|83204334|FG000|Overall Study|Withdrawal by Subject|4|||
46961856|NCT03436199|83204335|FG001|Overall Study|Withdrawal by Subject|10|||
46961857|NCT03436199|83204336|FG002|Overall Study|Withdrawal by Subject|3|||
46961858|NCT03436199|83204334|FG000|Overall Study|Lost to Follow-up|1|||
46961859|NCT03436199|83204335|FG001|Overall Study|Lost to Follow-up|0|||
46961860|NCT03436199|83204336|FG002|Overall Study|Lost to Follow-up|2|||
46961861|NCT03436199|83204334|FG000|Overall Study|Protocol Violation|1|||
46774190|NCT01298193|82992639|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
46774191|NCT01298193|82992639|FG000|Efficacy Phase (Second Cycle)|Death|1|||
46774192|NCT00719862|82992648|FG000|Overall Study|Adverse Event|1|||
46774193|NCT00719862|82992649|FG001|Overall Study|Adverse Event|2|||
46774194|NCT00719862|82992648|FG000|Overall Study|Lack of Efficacy|3|||
46774195|NCT00719862|82992649|FG001|Overall Study|Lack of Efficacy|0|||
46961862|NCT03436199|83204335|FG001|Overall Study|Protocol Violation|1|||
46961863|NCT03436199|83204336|FG002|Overall Study|Protocol Violation|0|||
46961864|NCT03436199|83204334|FG000|Overall Study|Physician Decision|0|||
47067201|NCT01549964|83350655|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
47067202|NCT01549964|83350656|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
46774196|NCT00719862|82992648|FG000|Overall Study|Non-Compliance|1|||
46774197|NCT00719862|82992649|FG001|Overall Study|Non-Compliance|0|||
46961865|NCT03436199|83204335|FG001|Overall Study|Physician Decision|1|||
46961866|NCT03436199|83204336|FG002|Overall Study|Physician Decision|0|||
46961867|NCT03436199|83204334|FG000|Overall Study|Could not return to clinic|1|||
46961868|NCT03436199|83204335|FG001|Overall Study|Could not return to clinic|0|||
46961869|NCT03436199|83204336|FG002|Overall Study|Could not return to clinic|0|||
46774198|NCT00719862|82992648|FG000|Overall Study|Withdrawal by Subject|1|||
46774199|NCT00719862|82992649|FG001|Overall Study|Withdrawal by Subject|0|||
46961870|NCT03436199|83204334|FG000|Overall Study|Withdrawn per physician|0|||
46961871|NCT03436199|83204335|FG001|Overall Study|Withdrawn per physician|1|||
46961872|NCT03436199|83204336|FG002|Overall Study|Withdrawn per physician|0|||
46961873|NCT02131636|83204346|FG000|Overall Study|Personal Reasons|4|||
46961874|NCT02131636|83204347|FG001|Overall Study|Personal Reasons|4|||
46961875|NCT02131636|83204346|FG000|Overall Study|Lost to Follow-up|4|||
46961876|NCT02131636|83204347|FG001|Overall Study|Lost to Follow-up|0|||
46961877|NCT02131636|83204346|FG000|Overall Study|Adverse Event|4|||
46961878|NCT02131636|83204347|FG001|Overall Study|Adverse Event|1|||
46961879|NCT02131324|83204355|FG000|Overall Study|Withdrawal by Subject|1|||
46961880|NCT02131324|83204356|FG001|Overall Study|Withdrawal by Subject|2|||
46961881|NCT02131324|83204355|FG000|Overall Study|Lost to Follow-up|1|||
46961882|NCT02131324|83204356|FG001|Overall Study|Lost to Follow-up|1|||
46961883|NCT02734693|83204365|FG000|Overall Study|Adverse Event|1|||
46961884|NCT02734693|83204366|FG001|Overall Study|Adverse Event|3|||
46961885|NCT02734693|83204367|FG002|Overall Study|Adverse Event|3|||
46961886|NCT02734693|83204365|FG000|Overall Study|Lack of Efficacy|1|||
46961887|NCT02734693|83204366|FG001|Overall Study|Lack of Efficacy|0|||
46961888|NCT02734693|83204367|FG002|Overall Study|Lack of Efficacy|0|||
46961889|NCT02734693|83204365|FG000|Overall Study|Lost to Follow-up|2|||
46774200|NCT00719862|82992648|FG000|Overall Study|Lost to Follow-up|0|||
46774201|NCT00719862|82992649|FG001|Overall Study|Lost to Follow-up|1|||
46774202|NCT00719862|82992648|FG000|Overall Study|Other|2|||
46774203|NCT00719862|82992649|FG001|Overall Study|Other|3|||
46774204|NCT00742508|82992657|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
46774205|NCT00742508|82992658|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
46774206|NCT00742508|82992657|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
46774207|NCT00742508|82992658|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
46774208|NCT00742508|82992657|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
46774209|NCT00742508|82992658|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
46774210|NCT00742508|82992657|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
46774211|NCT00742508|82992658|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
46774212|NCT00742508|82992657|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
46774213|NCT00742508|82992658|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
46774214|NCT00719706|82992666|FG000|Overall Study|Adverse Event|5|||
46774215|NCT00719706|82992667|FG001|Overall Study|Adverse Event|4|||
46774216|NCT00719706|82992666|FG000|Overall Study|Withdrawal by Subject|1|||
46774217|NCT00719706|82992667|FG001|Overall Study|Withdrawal by Subject|2|||
46774218|NCT00719706|82992666|FG000|Overall Study|Protocol Violation|3|||
46774219|NCT00719706|82992667|FG001|Overall Study|Protocol Violation|0|||
46774220|NCT00742274|82992675|FG000|Overall Study|Death|1|||
46774221|NCT00742274|82992676|FG001|Overall Study|Death|0|||
46774222|NCT00742274|82992675|FG000|Overall Study|Withdrawal by Subject|1|||
46774223|NCT00742274|82992676|FG001|Overall Study|Withdrawal by Subject|2|||
46774224|NCT00742274|82992675|FG000|Overall Study|Removed for medical reasons|1|||
46774225|NCT00742274|82992676|FG001|Overall Study|Removed for medical reasons|1|||
46774226|NCT00719472|82992682|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
46774227|NCT00719472|82992682|FG000|Enrolled in Study|Subject decision to withdraw|8|||
46774228|NCT00719472|82992682|FG000|Enrolled in Study|Various Reasons|17|||
46774229|NCT00719472|82992682|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
46774230|NCT00719472|82992682|FG000|Received Cycle 1 Treatment|Death|5|||
46774231|NCT00719472|82992682|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
46774232|NCT00719472|82992682|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
46774233|NCT00719472|82992682|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
46774234|NCT00719472|82992682|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
46774235|NCT00719472|82992682|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
46774236|NCT00719472|82992682|FG000|Received Cycle 2 Treatment|Death|6|||
46774237|NCT00719472|82992682|FG000|Received Cycle 2 Treatment|Disease progression|3|||
46774238|NCT00719472|82992682|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
46774239|NCT00719472|82992682|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
46774240|NCT00719472|82992682|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
46774241|NCT00719472|82992682|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
46774242|NCT00579501|82992686|FG000|Overall Study|Death|1|||
46774243|NCT00579501|82992686|FG000|Overall Study|End of neoadjuvant therapy|25|||
46774244|NCT00579501|82992686|FG000|Overall Study|toxicity|1|||
46961890|NCT02734693|83204366|FG001|Overall Study|Lost to Follow-up|0|||
46961891|NCT02734693|83204367|FG002|Overall Study|Lost to Follow-up|0|||
47067203|NCT01549964|83350653|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
47067204|NCT01549964|83350654|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
47067205|NCT01549964|83350655|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
47067206|NCT01549964|83350656|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
47067207|NCT01549964|83350653|FG000|80-Week Extension Period|Pregnancy|0|||
46774245|NCT00579501|82992686|FG000|Overall Study|Secondary lesion|1|||
46774246|NCT00579501|82992686|FG000|Overall Study|Radiation therapy before surgery|1|||
46774247|NCT00741338|82992692|FG000|Overall Study|Adverse Event|0|||
46774248|NCT00741338|82992693|FG001|Overall Study|Adverse Event|1|||
46774249|NCT00746330|82992703|FG000|Period 1|Abnormal test procedure result|0|||
46961892|NCT02734693|83204365|FG000|Overall Study|Protocol Violation|1|||
46961893|NCT02734693|83204366|FG001|Overall Study|Protocol Violation|0|||
46774250|NCT00746330|82992704|FG001|Period 1|Abnormal test procedure result|0|||
46961894|NCT02734693|83204367|FG002|Overall Study|Protocol Violation|0|||
46961895|NCT02734693|83204365|FG000|Overall Study|Withdrawal by Subject|1|||
46961896|NCT02734693|83204366|FG001|Overall Study|Withdrawal by Subject|0|||
46961897|NCT02734693|83204367|FG002|Overall Study|Withdrawal by Subject|0|||
46961898|NCT02193880|83204375|FG000|Overall Study|patients did not collect enough HPC|3|||
46961899|NCT01378325|83204381|FG000|Overall Study|Protocol Violation|0|||
46961900|NCT01378325|83204382|FG001|Overall Study|Protocol Violation|1|||
46961901|NCT01093573|83204391|FG000|Overall Study|Physician Decision|0|||
46961902|NCT01093573|83204392|FG001|Overall Study|Physician Decision|0|||
46961903|NCT01093573|83204393|FG002|Overall Study|Physician Decision|1|||
46961904|NCT01093573|83204391|FG000|Overall Study|Insurance Denied|0|||
46961905|NCT01093573|83204392|FG001|Overall Study|Insurance Denied|0|||
46961906|NCT01093573|83204393|FG002|Overall Study|Insurance Denied|1|||
46961907|NCT02733367|83204421|FG000|Overall Study|Withdrawal by Subject|6|||
46961908|NCT03688555|83204428|FG000|Treatment Period|Adverse Event|0|||
46961909|NCT03688555|83204429|FG001|Treatment Period|Adverse Event|0|||
46961910|NCT03688555|83204430|FG002|Treatment Period|Adverse Event|1|||
46961911|NCT01328951|83204472|FG000|Overall Study|Disease Progression|17|||
46961912|NCT01328951|83204473|FG001|Overall Study|Disease Progression|14|||
46961913|NCT01328951|83204472|FG000|Overall Study|Adverse Event|2|||
46961914|NCT01328951|83204473|FG001|Overall Study|Adverse Event|0|||
46961915|NCT01328951|83204472|FG000|Overall Study|Death|243|||
46961916|NCT01328951|83204473|FG001|Overall Study|Death|258|||
46961917|NCT01328951|83204472|FG000|Overall Study|Lost to Follow-up|6|||
46961918|NCT01328951|83204473|FG001|Overall Study|Lost to Follow-up|7|||
46961919|NCT01328951|83204472|FG000|Overall Study|Withdrawal by Subject|6|||
46961920|NCT01328951|83204473|FG001|Overall Study|Withdrawal by Subject|6|||
46961921|NCT01328951|83204472|FG000|Overall Study|Study Closed by the Sponsor|36|||
46961922|NCT01328951|83204473|FG001|Overall Study|Study Closed by the Sponsor|31|||
46961923|NCT01328951|83204472|FG000|Overall Study|Other|11|||
46961924|NCT01328951|83204473|FG001|Overall Study|Other|6|||
46961925|NCT02611817|83204486|FG000|Open-label Induction Phase|Reason not Specified|9|||
46961926|NCT02611817|83204487|FG001|Open-label Induction Phase|Reason not Specified|0|||
46961927|NCT02611817|83204488|FG002|Open-label Induction Phase|Reason not Specified|0|||
46961928|NCT02611817|83204486|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
46961929|NCT02611817|83204487|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
46961930|NCT02611817|83204488|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
46961931|NCT02611817|83204486|FG000|Open-label Induction Phase|Pregnancy|1|||
46961932|NCT02611817|83204487|FG001|Open-label Induction Phase|Pregnancy|0|||
46961933|NCT02611817|83204488|FG002|Open-label Induction Phase|Pregnancy|0|||
46961934|NCT02611817|83204486|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
46961935|NCT02611817|83204487|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
46961936|NCT02611817|83204488|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
46961937|NCT02611817|83204486|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
46961938|NCT02611817|83204487|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
46774251|NCT00746330|82992705|FG002|Period 1|Abnormal test procedure result|1|||
46961939|NCT02611817|83204488|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
46961940|NCT02611817|83204486|FG000|Open-label Induction Phase|Protocol Violation|5|||
46961941|NCT02611817|83204487|FG001|Open-label Induction Phase|Protocol Violation|0|||
46961942|NCT02611817|83204488|FG002|Open-label Induction Phase|Protocol Violation|0|||
46961943|NCT02611817|83204486|FG000|Open-label Induction Phase|Adverse Event|16|||
47067208|NCT01549964|83350654|FG001|80-Week Extension Period|Pregnancy|0|||
47067209|NCT01549964|83350655|FG002|80-Week Extension Period|Pregnancy|1|||
47067210|NCT01549964|83350656|FG003|80-Week Extension Period|Pregnancy|0|||
47067211|NCT01549964|83350653|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
47067212|NCT01549964|83350654|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
47067213|NCT01549964|83350655|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
47067214|NCT01549964|83350656|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
47067215|NCT01549964|83350653|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
47067216|NCT01549964|83350654|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
47067217|NCT01549964|83350655|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
46774252|NCT00746330|82992706|FG003|Period 1|Abnormal test procedure result|0|||
46774253|NCT00746252|82992719|FG000|Overall Study|weight gain >7.5 %|1|||
46774254|NCT00746252|82992720|FG001|Overall Study|weight gain >7.5 %|2|||
46961944|NCT02611817|83204487|FG001|Open-label Induction Phase|Adverse Event|0|||
46961945|NCT02611817|83204488|FG002|Open-label Induction Phase|Adverse Event|0|||
46961946|NCT02611817|83204486|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
46961947|NCT02611817|83204487|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
46961948|NCT02611817|83204488|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
46961949|NCT02611817|83204486|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
46961950|NCT02611817|83204487|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
46961951|NCT02611817|83204488|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
47067218|NCT01549964|83350656|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
47067219|NCT01549964|83350653|FG000|80-Week Extension Period|Lost to Follow-up|1|||
47067220|NCT01549964|83350654|FG001|80-Week Extension Period|Lost to Follow-up|0|||
47067221|NCT01549964|83350655|FG002|80-Week Extension Period|Lost to Follow-up|2|||
47067222|NCT01549964|83350656|FG003|80-Week Extension Period|Lost to Follow-up|1|||
47067223|NCT01549964|83350653|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
47067224|NCT01549964|83350654|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
47067225|NCT01549964|83350655|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
47067226|NCT01549964|83350656|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
47067227|NCT01570244|83350738|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
47067228|NCT01535222|83350773|FG000|Overall Study|Inclusion/exclusion|0|||
47067229|NCT01535222|83350774|FG001|Overall Study|Inclusion/exclusion|0|||
47067230|NCT01535222|83350775|FG002|Overall Study|Inclusion/exclusion|1|||
47067231|NCT01535222|83350776|FG003|Overall Study|Inclusion/exclusion|0|||
46774255|NCT00718770|82992726|FG000|Overall Study|Adverse Event|1|||
46774256|NCT00718770|82992726|FG000|Overall Study|Lack of Efficacy|1|||
46774257|NCT00718770|82992726|FG000|Overall Study|Lack of Efficacy|1|||
46774258|NCT00718770|82992726|FG000|Overall Study|Adverse Event|1|||
46774259|NCT00718770|82992726|FG000|Overall Study|Lack of Efficacy|1|||
46961952|NCT02611817|83204486|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
46961953|NCT02611817|83204487|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
46961954|NCT02611817|83204488|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
46774260|NCT00718770|82992726|FG000|Overall Study|Adverse Event|1|||
46961955|NCT02611817|83204486|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
46961956|NCT02611817|83204487|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
46961957|NCT02611817|83204488|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
47067232|NCT01535222|83350777|FG004|Overall Study|Inclusion/exclusion|0|||
47067233|NCT01535222|83350778|FG005|Overall Study|Inclusion/exclusion|0|||
47067234|NCT01549886|83350794|FG000|Overall Study|Sponsor's decision|2|||
46774261|NCT00718770|82992726|FG000|Overall Study|Lack of Efficacy|1|||
46845296|NCT00145574|83062158|FG002|Open Label Long-term Extension|required restricted medicine|1|||
46845297|NCT00145496|83062173|FG000|Overall Study|Adverse Event|42|||
46845298|NCT00145496|83062174|FG001|Overall Study|Adverse Event|30|||
46845299|NCT00145496|83062173|FG000|Overall Study|Lack of Efficacy|12|||
46845300|NCT00145496|83062174|FG001|Overall Study|Lack of Efficacy|7|||
46845301|NCT00145496|83062173|FG000|Overall Study|Withdrawal by Subject|32|||
46845302|NCT00145496|83062174|FG001|Overall Study|Withdrawal by Subject|26|||
46845303|NCT00145496|83062173|FG000|Overall Study|Lost to Follow-up|12|||
46845304|NCT00145496|83062174|FG001|Overall Study|Lost to Follow-up|5|||
46845305|NCT00145496|83062173|FG000|Overall Study|Other|25|||
46845306|NCT00145496|83062174|FG001|Overall Study|Other|13|||
46845307|NCT00255164|83062183|FG000|Overall Study|Adverse Event|10|||
46845308|NCT00255164|83062184|FG001|Overall Study|Adverse Event|6|||
46845309|NCT00255164|83062185|FG002|Overall Study|Adverse Event|9|||
46845310|NCT00255164|83062183|FG000|Overall Study|Lost to Follow-up|4|||
46845311|NCT00255164|83062184|FG001|Overall Study|Lost to Follow-up|3|||
46845312|NCT00255164|83062185|FG002|Overall Study|Lost to Follow-up|4|||
46845313|NCT00255164|83062183|FG000|Overall Study|Withdrawal by Subject|18|||
46845314|NCT00255164|83062184|FG001|Overall Study|Withdrawal by Subject|17|||
46845315|NCT00255164|83062185|FG002|Overall Study|Withdrawal by Subject|8|||
46845316|NCT00255164|83062183|FG000|Overall Study|Noncompliance|0|||
46845317|NCT00255164|83062184|FG001|Overall Study|Noncompliance|1|||
46845318|NCT00255164|83062185|FG002|Overall Study|Noncompliance|2|||
46845319|NCT00255164|83062183|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
46845320|NCT00255164|83062184|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
46845321|NCT00255164|83062185|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
46845322|NCT00255164|83062183|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
46845323|NCT00255164|83062184|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
46845324|NCT00255164|83062185|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
46845325|NCT00255164|83062183|FG000|Overall Study|Possible Barrett's Esophagus|1|||
46845326|NCT00255164|83062184|FG001|Overall Study|Possible Barrett's Esophagus|3|||
47067235|NCT01549886|83350795|FG001|Overall Study|Sponsor's decision|3|||
46774262|NCT00718770|82992726|FG000|Overall Study|Adverse Event|1|||
46774263|NCT00746096|82992732|FG000|Overall Study|Adverse Event|1|||
46845327|NCT00255164|83062185|FG002|Overall Study|Possible Barrett's Esophagus|8|||
46961958|NCT02611817|83204486|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
46961959|NCT02611817|83204487|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
47067236|NCT01443845|83350824|FG000|Overall Study|Protocol Violation|43|||
46774264|NCT00746096|82992733|FG001|Overall Study|Adverse Event|0|||
46774265|NCT00746096|82992732|FG000|Overall Study|Withdrawal by Subject|5|||
46845328|NCT00255164|83062183|FG000|Overall Study|Esophageal Stricture|0|||
46845329|NCT00255164|83062184|FG001|Overall Study|Esophageal Stricture|0|||
46845330|NCT00255164|83062185|FG002|Overall Study|Esophageal Stricture|1|||
46845331|NCT00255164|83062183|FG000|Overall Study|Therapeutic Failure|11|||
46845332|NCT00255164|83062184|FG001|Overall Study|Therapeutic Failure|2|||
46845333|NCT00255164|83062185|FG002|Overall Study|Therapeutic Failure|3|||
46961960|NCT02611817|83204488|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
46961961|NCT02611817|83204486|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
46961962|NCT02611817|83204487|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
46961963|NCT02611817|83204488|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
46961964|NCT02611817|83204486|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
46961965|NCT02611817|83204487|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
46961966|NCT02611817|83204488|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
46961967|NCT02735915|83204495|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
46961968|NCT02735915|83204495|FG000|Overall Study|Withdrawal following SAE|2|||
46961969|NCT02735915|83204495|FG000|Overall Study|Withdrawal by Subject|1|||
46961970|NCT02557139|83204504|FG000|Overall Study|Significant liver elevation|1|||
46961971|NCT02557139|83204505|FG001|Overall Study|Significant liver elevation|0|||
46961972|NCT02557139|83204506|FG002|Overall Study|Significant liver elevation|1|||
46961973|NCT02557139|83204504|FG000|Overall Study|Withdrawal by Subject|1|||
46961974|NCT02557139|83204505|FG001|Overall Study|Withdrawal by Subject|0|||
46961975|NCT02557139|83204506|FG002|Overall Study|Withdrawal by Subject|0|||
46961976|NCT02557139|83204504|FG000|Overall Study|Illness of prohibited medication|0|||
46961977|NCT02557139|83204505|FG001|Overall Study|Illness of prohibited medication|0|||
46961978|NCT02557139|83204506|FG002|Overall Study|Illness of prohibited medication|1|||
46961979|NCT01328717|83204523|FG000|Overall Study|Adverse Event|1|||
46961980|NCT01677741|83204535|FG000|Overall Study|Death|0|||
46961981|NCT01677741|83204536|FG001|Overall Study|Death|0|||
46961982|NCT01677741|83204537|FG002|Overall Study|Death|0|||
46961983|NCT01677741|83204538|FG003|Overall Study|Death|1|||
46961984|NCT01677741|83204539|FG004|Overall Study|Death|0|||
46961985|NCT01677741|83204540|FG005|Overall Study|Death|1|||
46961986|NCT01677741|83204541|FG006|Overall Study|Death|0|||
46961987|NCT01677741|83204542|FG007|Overall Study|Death|0|||
46961988|NCT01677741|83204535|FG000|Overall Study|Withdrawal by Subject|2|||
46961989|NCT01677741|83204536|FG001|Overall Study|Withdrawal by Subject|7|||
46961990|NCT01677741|83204537|FG002|Overall Study|Withdrawal by Subject|5|||
46961991|NCT01677741|83204538|FG003|Overall Study|Withdrawal by Subject|4|||
46961992|NCT01677741|83204539|FG004|Overall Study|Withdrawal by Subject|11|||
46961993|NCT01677741|83204540|FG005|Overall Study|Withdrawal by Subject|20|||
46961994|NCT01677741|83204541|FG006|Overall Study|Withdrawal by Subject|4|||
46961995|NCT01677741|83204542|FG007|Overall Study|Withdrawal by Subject|2|||
46961996|NCT01677741|83204535|FG000|Overall Study|Enrolled in a rollover study|0|||
46961997|NCT01677741|83204536|FG001|Overall Study|Enrolled in a rollover study|3|||
46961998|NCT01677741|83204537|FG002|Overall Study|Enrolled in a rollover study|2|||
46961999|NCT01677741|83204538|FG003|Overall Study|Enrolled in a rollover study|1|||
46962000|NCT01677741|83204539|FG004|Overall Study|Enrolled in a rollover study|6|||
46962001|NCT01677741|83204540|FG005|Overall Study|Enrolled in a rollover study|6|||
46962002|NCT01677741|83204541|FG006|Overall Study|Enrolled in a rollover study|7|||
46962003|NCT01677741|83204542|FG007|Overall Study|Enrolled in a rollover study|0|||
46962004|NCT01677741|83204535|FG000|Overall Study|Progressive disease|1|||
46962005|NCT01677741|83204536|FG001|Overall Study|Progressive disease|0|||
46962006|NCT01677741|83204537|FG002|Overall Study|Progressive disease|1|||
46962007|NCT01677741|83204538|FG003|Overall Study|Progressive disease|0|||
46962008|NCT01677741|83204539|FG004|Overall Study|Progressive disease|0|||
46962009|NCT01677741|83204540|FG005|Overall Study|Progressive disease|1|||
46962010|NCT01677741|83204541|FG006|Overall Study|Progressive disease|0|||
46962011|NCT01677741|83204542|FG007|Overall Study|Progressive disease|0|||
46962012|NCT01677507|83204594|FG000|Initial Assignment|Adverse Event|0|||
46962013|NCT01677507|83204595|FG001|Initial Assignment|Adverse Event|1|||
46962014|NCT01677507|83204594|FG000|Initial Assignment|Protocol Violation|0|||
46962015|NCT01677507|83204595|FG001|Initial Assignment|Protocol Violation|1|||
46962016|NCT01677507|83204594|FG000|Second Assigment|Withdrawal by Subject|2|||
46774266|NCT00746096|82992733|FG001|Overall Study|Withdrawal by Subject|1|||
46774267|NCT00746096|82992732|FG000|Overall Study|Lost to Follow-up|2|||
46774268|NCT00746096|82992733|FG001|Overall Study|Lost to Follow-up|1|||
46774269|NCT00746096|82992732|FG000|Overall Study|Protocol Violation|1|||
46774270|NCT00746096|82992733|FG001|Overall Study|Protocol Violation|0|||
46774271|NCT00746096|82992732|FG000|Overall Study|No study drug treatment|1|||
46962017|NCT01677507|83204595|FG001|Second Assigment|Withdrawal by Subject|2|||
46962018|NCT01677507|83204594|FG000|Second Assigment|Adverse Event|1|||
46962019|NCT01677507|83204595|FG001|Second Assigment|Adverse Event|3|||
46962020|NCT02732951|83204614|FG000|Overall Study|Other than listed|1|||
46962021|NCT02732951|83204615|FG001|Overall Study|Other than listed|0|||
46962022|NCT02732951|83204614|FG000|Overall Study|Lost to Follow-up|0|||
46962023|NCT02732951|83204615|FG001|Overall Study|Lost to Follow-up|1|||
46962024|NCT02732951|83204614|FG000|Overall Study|Adverse Event|4|||
46962025|NCT02732951|83204615|FG001|Overall Study|Adverse Event|4|||
46962026|NCT02732951|83204614|FG000|Overall Study|Protocol Violation|0|||
46962027|NCT02732951|83204615|FG001|Overall Study|Protocol Violation|1|||
46774272|NCT00746096|82992733|FG001|Overall Study|No study drug treatment|1|||
46962028|NCT01377233|83204626|FG000|Open-label|Adverse Event|1|||
46962029|NCT01377233|83204627|FG001|Open-label|Adverse Event|0|||
46962030|NCT01377233|83204628|FG002|Open-label|Adverse Event|0|||
46962031|NCT01377233|83204629|FG003|Open-label|Adverse Event|0|||
46962032|NCT01377233|83204630|FG004|Open-label|Adverse Event|0|||
46962033|NCT01377233|83204626|FG000|Open-label|Withdrawal by Subject|3|||
46962034|NCT01377233|83204627|FG001|Open-label|Withdrawal by Subject|0|||
46962035|NCT01377233|83204628|FG002|Open-label|Withdrawal by Subject|0|||
46962036|NCT01377233|83204629|FG003|Open-label|Withdrawal by Subject|0|||
46962037|NCT01377233|83204630|FG004|Open-label|Withdrawal by Subject|0|||
46962038|NCT01377233|83204626|FG000|Double-blind|Adverse Event|0|||
46962039|NCT01377233|83204627|FG001|Double-blind|Adverse Event|1|||
46962040|NCT01377233|83204628|FG002|Double-blind|Adverse Event|2|||
46962041|NCT01377233|83204629|FG003|Double-blind|Adverse Event|2|||
46962042|NCT01377233|83204630|FG004|Double-blind|Adverse Event|0|||
46962043|NCT01377233|83204626|FG000|Double-blind|Protocol Violation|0|||
46962044|NCT01377233|83204627|FG001|Double-blind|Protocol Violation|0|||
46962045|NCT01377233|83204628|FG002|Double-blind|Protocol Violation|0|||
46962046|NCT01377233|83204629|FG003|Double-blind|Protocol Violation|0|||
46962047|NCT01377233|83204630|FG004|Double-blind|Protocol Violation|1|||
46962048|NCT01377233|83204626|FG000|Double-blind|Withdrawal by Subject|0|||
46962049|NCT01377233|83204627|FG001|Double-blind|Withdrawal by Subject|0|||
46962050|NCT01377233|83204628|FG002|Double-blind|Withdrawal by Subject|0|||
46962051|NCT01377233|83204629|FG003|Double-blind|Withdrawal by Subject|1|||
46962052|NCT01377233|83204630|FG004|Double-blind|Withdrawal by Subject|0|||
46962053|NCT01377233|83204626|FG000|Double-blind|Administrative or other|0|||
46962054|NCT01377233|83204627|FG001|Double-blind|Administrative or other|0|||
46962055|NCT01377233|83204628|FG002|Double-blind|Administrative or other|0|||
46962056|NCT01377233|83204629|FG003|Double-blind|Administrative or other|1|||
46962057|NCT01377233|83204630|FG004|Double-blind|Administrative or other|1|||
46962058|NCT03248531|83204649|FG000|Overall Study|Adverse Event|0|||
46962059|NCT03248531|83204650|FG001|Overall Study|Adverse Event|0|||
46962060|NCT03248531|83204651|FG002|Overall Study|Adverse Event|1|||
46962061|NCT03248531|83204649|FG000|Overall Study|Lost to Follow-up|1|||
46962062|NCT03248531|83204650|FG001|Overall Study|Lost to Follow-up|0|||
46962063|NCT03248531|83204651|FG002|Overall Study|Lost to Follow-up|5|||
46962064|NCT03248531|83204649|FG000|Overall Study|Withdrawal by Subject|3|||
46962065|NCT03248531|83204650|FG001|Overall Study|Withdrawal by Subject|3|||
46962066|NCT03248531|83204651|FG002|Overall Study|Withdrawal by Subject|2|||
46962067|NCT03248531|83204649|FG000|Overall Study|Sponsor Request|0|||
46962068|NCT03248531|83204650|FG001|Overall Study|Sponsor Request|2|||
46962069|NCT03248531|83204651|FG002|Overall Study|Sponsor Request|0|||
46962070|NCT02656329|83204668|FG000|Overall Study|Lost to Follow-up|2|||
46962071|NCT02656329|83204669|FG001|Overall Study|Lost to Follow-up|3|||
46962072|NCT02656329|83204668|FG000|Overall Study|Withdrawal by Subject|7|||
46962073|NCT02656329|83204669|FG001|Overall Study|Withdrawal by Subject|6|||
46962074|NCT02656329|83204668|FG000|Overall Study|Study termination by Sponsor|150|||
46962075|NCT02656329|83204669|FG001|Overall Study|Study termination by Sponsor|142|||
46962076|NCT02656329|83204668|FG000|Overall Study|Other than specified above|5|||
46962077|NCT02656329|83204669|FG001|Overall Study|Other than specified above|6|||
46962078|NCT02712905|83204694|FG000|Monotherapy|Death|2|||
46962079|NCT02712905|83204695|FG001|Monotherapy|Death|5|||
46962080|NCT02712905|83204696|FG002|Monotherapy|Death|0|||
46962081|NCT02712905|83204697|FG003|Monotherapy|Death|3|||
46962082|NCT02712905|83204698|FG004|Monotherapy|Death|15|||
46962083|NCT02712905|83204699|FG005|Monotherapy|Death|1|||
46962084|NCT02712905|83204700|FG006|Monotherapy|Death|3|||
46962085|NCT02712905|83204701|FG007|Monotherapy|Death|3|||
46962086|NCT02712905|83204702|FG008|Monotherapy|Death|0|||
46962087|NCT02712905|83204703|FG009|Monotherapy|Death|27|||
46962088|NCT02712905|83204704|FG010|Monotherapy|Death|2|||
46962089|NCT02712905|83204705|FG011|Monotherapy|Death|5|||
46962090|NCT02712905|83204706|FG012|Monotherapy|Death|0|||
46962091|NCT02712905|83204707|FG013|Monotherapy|Death|0|||
46962092|NCT02712905|83204708|FG014|Monotherapy|Death|0|||
46962093|NCT02712905|83204709|FG015|Monotherapy|Death|0|||
46774273|NCT00715026|82992739|FG000|Overall Study|Withdrawal by Subject|5|||
46774274|NCT00715026|82992739|FG000|Overall Study|Lost to Follow-up|3|||
46962094|NCT02712905|83204710|FG016|Monotherapy|Death|0|||
46962095|NCT02712905|83204711|FG017|Monotherapy|Death|0|||
46962096|NCT02712905|83204694|FG000|Monotherapy|Lost to Follow-up|0|||
46962097|NCT02712905|83204695|FG001|Monotherapy|Lost to Follow-up|1|||
46962098|NCT02712905|83204696|FG002|Monotherapy|Lost to Follow-up|0|||
46774275|NCT00715026|82992739|FG000|Overall Study|Protocol Violation|1|||
46962099|NCT02712905|83204697|FG003|Monotherapy|Lost to Follow-up|1|||
46962100|NCT02712905|83204698|FG004|Monotherapy|Lost to Follow-up|0|||
46962101|NCT02712905|83204699|FG005|Monotherapy|Lost to Follow-up|0|||
46962102|NCT02712905|83204700|FG006|Monotherapy|Lost to Follow-up|0|||
46962103|NCT02712905|83204701|FG007|Monotherapy|Lost to Follow-up|0|||
46962104|NCT02712905|83204702|FG008|Monotherapy|Lost to Follow-up|0|||
46962105|NCT02712905|83204703|FG009|Monotherapy|Lost to Follow-up|2|||
46962106|NCT02712905|83204704|FG010|Monotherapy|Lost to Follow-up|0|||
46962107|NCT02712905|83204705|FG011|Monotherapy|Lost to Follow-up|0|||
46962108|NCT02712905|83204706|FG012|Monotherapy|Lost to Follow-up|0|||
46962109|NCT02712905|83204707|FG013|Monotherapy|Lost to Follow-up|0|||
46962110|NCT02712905|83204708|FG014|Monotherapy|Lost to Follow-up|0|||
46962111|NCT02712905|83204709|FG015|Monotherapy|Lost to Follow-up|0|||
46962112|NCT02712905|83204710|FG016|Monotherapy|Lost to Follow-up|0|||
46962113|NCT02712905|83204711|FG017|Monotherapy|Lost to Follow-up|0|||
46962114|NCT02712905|83204694|FG000|Monotherapy|Physician Decision|1|||
46962115|NCT02712905|83204695|FG001|Monotherapy|Physician Decision|0|||
46962116|NCT02712905|83204696|FG002|Monotherapy|Physician Decision|0|||
46962117|NCT02712905|83204697|FG003|Monotherapy|Physician Decision|1|||
46962118|NCT02712905|83204698|FG004|Monotherapy|Physician Decision|0|||
46962119|NCT02712905|83204699|FG005|Monotherapy|Physician Decision|0|||
46962120|NCT02712905|83204700|FG006|Monotherapy|Physician Decision|0|||
46962121|NCT02712905|83204701|FG007|Monotherapy|Physician Decision|0|||
46962122|NCT02712905|83204702|FG008|Monotherapy|Physician Decision|0|||
46962123|NCT02712905|83204703|FG009|Monotherapy|Physician Decision|1|||
46962124|NCT02712905|83204704|FG010|Monotherapy|Physician Decision|0|||
46962125|NCT02712905|83204705|FG011|Monotherapy|Physician Decision|0|||
46962126|NCT02712905|83204706|FG012|Monotherapy|Physician Decision|0|||
46962127|NCT02712905|83204707|FG013|Monotherapy|Physician Decision|0|||
46962128|NCT02712905|83204708|FG014|Monotherapy|Physician Decision|0|||
46962129|NCT02712905|83204709|FG015|Monotherapy|Physician Decision|0|||
46962130|NCT02712905|83204710|FG016|Monotherapy|Physician Decision|0|||
46962131|NCT02712905|83204711|FG017|Monotherapy|Physician Decision|0|||
46962132|NCT02712905|83204694|FG000|Monotherapy|Study Terminated by Sponsor|0|||
46962133|NCT02712905|83204695|FG001|Monotherapy|Study Terminated by Sponsor|0|||
46962134|NCT02712905|83204696|FG002|Monotherapy|Study Terminated by Sponsor|0|||
46962135|NCT02712905|83204697|FG003|Monotherapy|Study Terminated by Sponsor|0|||
46962136|NCT02712905|83204698|FG004|Monotherapy|Study Terminated by Sponsor|1|||
46962137|NCT02712905|83204699|FG005|Monotherapy|Study Terminated by Sponsor|0|||
46962138|NCT02712905|83204700|FG006|Monotherapy|Study Terminated by Sponsor|0|||
46962139|NCT02712905|83204701|FG007|Monotherapy|Study Terminated by Sponsor|0|||
46962140|NCT02712905|83204702|FG008|Monotherapy|Study Terminated by Sponsor|0|||
46962141|NCT02712905|83204703|FG009|Monotherapy|Study Terminated by Sponsor|2|||
46962142|NCT02712905|83204704|FG010|Monotherapy|Study Terminated by Sponsor|0|||
46962143|NCT02712905|83204705|FG011|Monotherapy|Study Terminated by Sponsor|0|||
46962144|NCT02712905|83204706|FG012|Monotherapy|Study Terminated by Sponsor|0|||
46962145|NCT02712905|83204707|FG013|Monotherapy|Study Terminated by Sponsor|0|||
46962146|NCT02712905|83204708|FG014|Monotherapy|Study Terminated by Sponsor|0|||
46962147|NCT02712905|83204709|FG015|Monotherapy|Study Terminated by Sponsor|0|||
46962148|NCT02712905|83204710|FG016|Monotherapy|Study Terminated by Sponsor|0|||
46962149|NCT02712905|83204711|FG017|Monotherapy|Study Terminated by Sponsor|0|||
46962150|NCT02712905|83204694|FG000|Monotherapy|Withdrawal by Subject|0|||
46962151|NCT02712905|83204695|FG001|Monotherapy|Withdrawal by Subject|0|||
46962152|NCT02712905|83204696|FG002|Monotherapy|Withdrawal by Subject|1|||
46962153|NCT02712905|83204697|FG003|Monotherapy|Withdrawal by Subject|0|||
46962154|NCT02712905|83204698|FG004|Monotherapy|Withdrawal by Subject|2|||
46962155|NCT02712905|83204699|FG005|Monotherapy|Withdrawal by Subject|0|||
46962156|NCT02712905|83204700|FG006|Monotherapy|Withdrawal by Subject|0|||
46962157|NCT02712905|83204701|FG007|Monotherapy|Withdrawal by Subject|0|||
46962158|NCT02712905|83204702|FG008|Monotherapy|Withdrawal by Subject|0|||
46962159|NCT02712905|83204703|FG009|Monotherapy|Withdrawal by Subject|4|||
46962160|NCT02712905|83204704|FG010|Monotherapy|Withdrawal by Subject|1|||
46962161|NCT02712905|83204705|FG011|Monotherapy|Withdrawal by Subject|2|||
46962162|NCT02712905|83204706|FG012|Monotherapy|Withdrawal by Subject|0|||
46962163|NCT02712905|83204707|FG013|Monotherapy|Withdrawal by Subject|0|||
46962164|NCT02712905|83204708|FG014|Monotherapy|Withdrawal by Subject|0|||
46962165|NCT02712905|83204709|FG015|Monotherapy|Withdrawal by Subject|0|||
46962166|NCT02712905|83204710|FG016|Monotherapy|Withdrawal by Subject|0|||
46962167|NCT02712905|83204711|FG017|Monotherapy|Withdrawal by Subject|0|||
46962168|NCT02712905|83204694|FG000|Monotherapy|Started New Cancer Drug|0|||
46962169|NCT02712905|83204695|FG001|Monotherapy|Started New Cancer Drug|0|||
46962170|NCT02712905|83204696|FG002|Monotherapy|Started New Cancer Drug|0|||
46962171|NCT02712905|83204697|FG003|Monotherapy|Started New Cancer Drug|0|||
46962172|NCT02712905|83204698|FG004|Monotherapy|Started New Cancer Drug|0|||
46962173|NCT02712905|83204699|FG005|Monotherapy|Started New Cancer Drug|1|||
46962174|NCT02712905|83204700|FG006|Monotherapy|Started New Cancer Drug|0|||
46962175|NCT02712905|83204701|FG007|Monotherapy|Started New Cancer Drug|0|||
46962176|NCT02712905|83204702|FG008|Monotherapy|Started New Cancer Drug|0|||
46962177|NCT02712905|83204703|FG009|Monotherapy|Started New Cancer Drug|0|||
46962178|NCT02712905|83204704|FG010|Monotherapy|Started New Cancer Drug|0|||
46962179|NCT02712905|83204705|FG011|Monotherapy|Started New Cancer Drug|0|||
46962180|NCT02712905|83204706|FG012|Monotherapy|Started New Cancer Drug|0|||
47067237|NCT01443845|83350825|FG001|Overall Study|Protocol Violation|45|||
46962181|NCT02712905|83204707|FG013|Monotherapy|Started New Cancer Drug|0|||
46962182|NCT02712905|83204708|FG014|Monotherapy|Started New Cancer Drug|0|||
46962183|NCT02712905|83204709|FG015|Monotherapy|Started New Cancer Drug|0|||
46962184|NCT02712905|83204710|FG016|Monotherapy|Started New Cancer Drug|0|||
46962185|NCT02712905|83204711|FG017|Monotherapy|Started New Cancer Drug|0|||
46962186|NCT02712905|83204694|FG000|Monotherapy|Adverse Event|0|||
46962187|NCT02712905|83204695|FG001|Monotherapy|Adverse Event|0|||
46962188|NCT02712905|83204696|FG002|Monotherapy|Adverse Event|0|||
46962189|NCT02712905|83204697|FG003|Monotherapy|Adverse Event|0|||
46962190|NCT02712905|83204698|FG004|Monotherapy|Adverse Event|0|||
46962191|NCT02712905|83204699|FG005|Monotherapy|Adverse Event|0|||
46962192|NCT02712905|83204700|FG006|Monotherapy|Adverse Event|0|||
46962193|NCT02712905|83204701|FG007|Monotherapy|Adverse Event|0|||
46962194|NCT02712905|83204702|FG008|Monotherapy|Adverse Event|1|||
46962195|NCT02712905|83204703|FG009|Monotherapy|Adverse Event|0|||
46962196|NCT02712905|83204704|FG010|Monotherapy|Adverse Event|0|||
46962197|NCT02712905|83204705|FG011|Monotherapy|Adverse Event|0|||
46962198|NCT02712905|83204706|FG012|Monotherapy|Adverse Event|0|||
46962199|NCT02712905|83204707|FG013|Monotherapy|Adverse Event|0|||
46962200|NCT02712905|83204708|FG014|Monotherapy|Adverse Event|0|||
46962201|NCT02712905|83204709|FG015|Monotherapy|Adverse Event|0|||
46962202|NCT02712905|83204710|FG016|Monotherapy|Adverse Event|0|||
46962203|NCT02712905|83204711|FG017|Monotherapy|Adverse Event|0|||
46962204|NCT02712905|83204694|FG000|Combination Therapy|Death|0|||
46962205|NCT02712905|83204695|FG001|Combination Therapy|Death|0|||
46962206|NCT02712905|83204696|FG002|Combination Therapy|Death|0|||
46962207|NCT02712905|83204697|FG003|Combination Therapy|Death|0|||
46962208|NCT02712905|83204698|FG004|Combination Therapy|Death|0|||
46962209|NCT02712905|83204699|FG005|Combination Therapy|Death|0|||
46962210|NCT02712905|83204700|FG006|Combination Therapy|Death|0|||
46962211|NCT02712905|83204701|FG007|Combination Therapy|Death|0|||
46962212|NCT02712905|83204702|FG008|Combination Therapy|Death|0|||
46962213|NCT02712905|83204703|FG009|Combination Therapy|Death|0|||
46962214|NCT02712905|83204704|FG010|Combination Therapy|Death|0|||
46962215|NCT02712905|83204705|FG011|Combination Therapy|Death|0|||
46962216|NCT02712905|83204706|FG012|Combination Therapy|Death|5|||
46962217|NCT02712905|83204707|FG013|Combination Therapy|Death|6|||
46962218|NCT02712905|83204708|FG014|Combination Therapy|Death|1|||
46962219|NCT02712905|83204709|FG015|Combination Therapy|Death|3|||
46962220|NCT02712905|83204710|FG016|Combination Therapy|Death|1|||
46962221|NCT02712905|83204711|FG017|Combination Therapy|Death|3|||
46962222|NCT02712905|83204694|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
46962223|NCT02712905|83204695|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
46962224|NCT02712905|83204696|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
46962225|NCT02712905|83204697|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
46962226|NCT02712905|83204698|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
46962227|NCT02712905|83204699|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
46962228|NCT02712905|83204700|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
46962229|NCT02712905|83204701|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
46962230|NCT02712905|83204702|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
46962231|NCT02712905|83204703|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
46962232|NCT02712905|83204704|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
46962233|NCT02712905|83204705|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
46962234|NCT02712905|83204706|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
46962235|NCT02712905|83204707|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
46962236|NCT02712905|83204708|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
46962237|NCT02712905|83204709|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
46962238|NCT02712905|83204710|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
46962239|NCT02712905|83204711|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
46962240|NCT02712905|83204694|FG000|Combination Therapy|Withdrawal by Subject|0|||
46962241|NCT02712905|83204695|FG001|Combination Therapy|Withdrawal by Subject|0|||
46962242|NCT02712905|83204696|FG002|Combination Therapy|Withdrawal by Subject|0|||
46962243|NCT02712905|83204697|FG003|Combination Therapy|Withdrawal by Subject|0|||
46962244|NCT02712905|83204698|FG004|Combination Therapy|Withdrawal by Subject|0|||
46962245|NCT02712905|83204699|FG005|Combination Therapy|Withdrawal by Subject|0|||
46962246|NCT02712905|83204700|FG006|Combination Therapy|Withdrawal by Subject|0|||
46962247|NCT02712905|83204701|FG007|Combination Therapy|Withdrawal by Subject|0|||
46962248|NCT02712905|83204702|FG008|Combination Therapy|Withdrawal by Subject|0|||
46962249|NCT02712905|83204703|FG009|Combination Therapy|Withdrawal by Subject|0|||
46962250|NCT02712905|83204704|FG010|Combination Therapy|Withdrawal by Subject|0|||
46962251|NCT02712905|83204705|FG011|Combination Therapy|Withdrawal by Subject|0|||
46962252|NCT02712905|83204706|FG012|Combination Therapy|Withdrawal by Subject|0|||
46962253|NCT02712905|83204707|FG013|Combination Therapy|Withdrawal by Subject|0|||
46962254|NCT02712905|83204708|FG014|Combination Therapy|Withdrawal by Subject|0|||
46962255|NCT02712905|83204709|FG015|Combination Therapy|Withdrawal by Subject|1|||
46962256|NCT02712905|83204710|FG016|Combination Therapy|Withdrawal by Subject|0|||
46962257|NCT02712905|83204711|FG017|Combination Therapy|Withdrawal by Subject|2|||
46962258|NCT02712905|83204694|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962259|NCT02712905|83204695|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962260|NCT02712905|83204696|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962261|NCT02712905|83204697|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46967877|NCT05091307|83210484|FG001|Overall Study|Withdrawal by Subject|16|||
46962262|NCT02712905|83204698|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962263|NCT02712905|83204699|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962264|NCT02712905|83204700|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962265|NCT02712905|83204701|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962266|NCT02712905|83204702|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962267|NCT02712905|83204703|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962268|NCT02712905|83204704|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962269|NCT02712905|83204705|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962270|NCT02712905|83204706|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962271|NCT02712905|83204707|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962272|NCT02712905|83204708|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962273|NCT02712905|83204709|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
46962274|NCT02712905|83204710|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962275|NCT02712905|83204711|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
46962276|NCT03776357|83204749|FG000|Overall Study|Lost to Follow-up|3|||
46962277|NCT04520997|83204755|FG000|Overall Study|Lost to Follow-up|1|||
46962278|NCT04520997|83204756|FG001|Overall Study|Lost to Follow-up|1|||
46962279|NCT04520997|83204755|FG000|Overall Study|Withdrawal by Subject|1|||
46962280|NCT04520997|83204756|FG001|Overall Study|Withdrawal by Subject|0|||
46962281|NCT04520997|83204755|FG000|Overall Study|Not Treated|0|||
46962282|NCT04520997|83204756|FG001|Overall Study|Not Treated|1|||
46962283|NCT02734433|83204767|FG000|Overall Study|Disease progression|1|||
46962284|NCT02734433|83204768|FG001|Overall Study|Disease progression|5|||
46962285|NCT02734433|83204767|FG000|Overall Study|Clinical progression|0|||
46962286|NCT02734433|83204768|FG001|Overall Study|Clinical progression|1|||
46962287|NCT02734433|83204767|FG000|Overall Study|Withdrawal by Subject|1|||
46962288|NCT02734433|83204768|FG001|Overall Study|Withdrawal by Subject|2|||
46962289|NCT02452424|83204794|FG000|Overall Study|Death|2|||
46962290|NCT02452424|83204795|FG001|Overall Study|Death|2|||
46962291|NCT02452424|83204796|FG002|Overall Study|Death|2|||
46962292|NCT02452424|83204797|FG003|Overall Study|Death|6|||
46962293|NCT02452424|83204798|FG004|Overall Study|Death|2|||
46962294|NCT02452424|83204799|FG005|Overall Study|Death|0|||
46962295|NCT02452424|83204800|FG006|Overall Study|Death|5|||
46962296|NCT02452424|83204801|FG007|Overall Study|Death|1|||
46962297|NCT02452424|83204802|FG008|Overall Study|Death|3|||
46962298|NCT02452424|83204803|FG009|Overall Study|Death|1|||
46962299|NCT02452424|83204804|FG010|Overall Study|Death|0|||
46962300|NCT02452424|83204794|FG000|Overall Study|Lost to Follow-up|0|||
46962301|NCT02452424|83204795|FG001|Overall Study|Lost to Follow-up|1|||
46962302|NCT02452424|83204796|FG002|Overall Study|Lost to Follow-up|1|||
46962303|NCT02452424|83204797|FG003|Overall Study|Lost to Follow-up|0|||
46962304|NCT02452424|83204798|FG004|Overall Study|Lost to Follow-up|0|||
46962305|NCT02452424|83204799|FG005|Overall Study|Lost to Follow-up|0|||
46962306|NCT02452424|83204800|FG006|Overall Study|Lost to Follow-up|0|||
46962307|NCT02452424|83204801|FG007|Overall Study|Lost to Follow-up|0|||
46962308|NCT02452424|83204802|FG008|Overall Study|Lost to Follow-up|0|||
46962309|NCT02452424|83204803|FG009|Overall Study|Lost to Follow-up|0|||
46962310|NCT02452424|83204804|FG010|Overall Study|Lost to Follow-up|0|||
46962311|NCT02452424|83204794|FG000|Overall Study|Withdrawal by Subject|0|||
46962312|NCT02452424|83204795|FG001|Overall Study|Withdrawal by Subject|0|||
46962313|NCT02452424|83204796|FG002|Overall Study|Withdrawal by Subject|3|||
46962314|NCT02452424|83204797|FG003|Overall Study|Withdrawal by Subject|2|||
46962315|NCT02452424|83204798|FG004|Overall Study|Withdrawal by Subject|0|||
46962316|NCT02452424|83204799|FG005|Overall Study|Withdrawal by Subject|0|||
46962317|NCT02452424|83204800|FG006|Overall Study|Withdrawal by Subject|1|||
46962318|NCT02452424|83204801|FG007|Overall Study|Withdrawal by Subject|0|||
46962319|NCT02452424|83204802|FG008|Overall Study|Withdrawal by Subject|1|||
46962320|NCT02452424|83204803|FG009|Overall Study|Withdrawal by Subject|1|||
46962321|NCT02452424|83204804|FG010|Overall Study|Withdrawal by Subject|0|||
47067238|NCT01443845|83350824|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
47067239|NCT01443845|83350825|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
47067240|NCT01443845|83350824|FG000|Overall Study|Deterioration in pulmonary function|1|||
47067241|NCT01443845|83350825|FG001|Overall Study|Deterioration in pulmonary function|4|||
47067242|NCT01443845|83350824|FG000|Overall Study|Lack of Efficacy|10|||
47067243|NCT01443845|83350825|FG001|Overall Study|Lack of Efficacy|5|||
47067244|NCT01443845|83350824|FG000|Overall Study|Adverse Event|64|||
46962322|NCT02452424|83204794|FG000|Overall Study|Other|0|||
46962323|NCT02452424|83204795|FG001|Overall Study|Other|0|||
46962324|NCT02452424|83204796|FG002|Overall Study|Other|1|||
47067245|NCT01443845|83350825|FG001|Overall Study|Adverse Event|138|||
46962325|NCT02452424|83204797|FG003|Overall Study|Other|0|||
46962326|NCT02452424|83204798|FG004|Overall Study|Other|0|||
46962327|NCT02452424|83204799|FG005|Overall Study|Other|1|||
46962328|NCT02452424|83204800|FG006|Overall Study|Other|4|||
46962329|NCT02452424|83204801|FG007|Overall Study|Other|3|||
46962330|NCT02452424|83204802|FG008|Overall Study|Other|0|||
46962331|NCT02452424|83204803|FG009|Overall Study|Other|0|||
46962332|NCT02452424|83204804|FG010|Overall Study|Other|1|||
46962333|NCT02452424|83204794|FG000|Overall Study|Progressive disease (per RECIST)|0|||
46962334|NCT02452424|83204795|FG001|Overall Study|Progressive disease (per RECIST)|0|||
46962335|NCT02452424|83204796|FG002|Overall Study|Progressive disease (per RECIST)|0|||
46962336|NCT02452424|83204797|FG003|Overall Study|Progressive disease (per RECIST)|0|||
46962337|NCT02452424|83204798|FG004|Overall Study|Progressive disease (per RECIST)|0|||
46962338|NCT02452424|83204799|FG005|Overall Study|Progressive disease (per RECIST)|0|||
46962339|NCT02452424|83204800|FG006|Overall Study|Progressive disease (per RECIST)|0|||
46962340|NCT02452424|83204801|FG007|Overall Study|Progressive disease (per RECIST)|0|||
46962341|NCT02452424|83204802|FG008|Overall Study|Progressive disease (per RECIST)|2|||
46962342|NCT02452424|83204803|FG009|Overall Study|Progressive disease (per RECIST)|0|||
46962343|NCT02452424|83204804|FG010|Overall Study|Progressive disease (per RECIST)|0|||
46962344|NCT02452424|83204794|FG000|Overall Study|Adverse Event|0|||
46962345|NCT02452424|83204795|FG001|Overall Study|Adverse Event|0|||
46962346|NCT02452424|83204796|FG002|Overall Study|Adverse Event|0|||
46962347|NCT02452424|83204797|FG003|Overall Study|Adverse Event|0|||
46962348|NCT02452424|83204798|FG004|Overall Study|Adverse Event|0|||
46962349|NCT02452424|83204799|FG005|Overall Study|Adverse Event|0|||
46962350|NCT02452424|83204800|FG006|Overall Study|Adverse Event|0|||
46640061|NCT00085566|82814041|FG000|Overall Study|Clinical progression|0|||
46640062|NCT00085566|82814042|FG001|Overall Study|Clinical progression|0|||
46640063|NCT00085566|82814043|FG002|Overall Study|Clinical progression|1|||
46640064|NCT00085098|82814053|FG000|Overall Study|Withdrawal by Subject|0|||
46845334|NCT00126594|83062195|FG000|Overall Study|Ineligible|2|||
46845335|NCT00126594|83062196|FG001|Overall Study|Ineligible|0|||
46845336|NCT00126594|83062195|FG000|Overall Study|Withdrawal by Subject|0|||
46845337|NCT00126594|83062196|FG001|Overall Study|Withdrawal by Subject|4|||
46845338|NCT00126594|83062195|FG000|Overall Study|Physician Decision|1|||
46845339|NCT00126594|83062196|FG001|Overall Study|Physician Decision|3|||
46845340|NCT00126594|83062195|FG000|Overall Study|Adverse Event|7|||
46845341|NCT00126594|83062196|FG001|Overall Study|Adverse Event|5|||
46845342|NCT00126594|83062195|FG000|Overall Study|Non-compliance|0|||
46962351|NCT02452424|83204801|FG007|Overall Study|Adverse Event|0|||
46962352|NCT02452424|83204802|FG008|Overall Study|Adverse Event|0|||
46962353|NCT02452424|83204803|FG009|Overall Study|Adverse Event|0|||
46962354|NCT02452424|83204804|FG010|Overall Study|Adverse Event|1|||
46962355|NCT02419508|83204832|FG000|Overall Study|Adverse Event|9|||
46962356|NCT02419508|83204833|FG001|Overall Study|Adverse Event|3|||
46640065|NCT00085098|82814054|FG001|Overall Study|Withdrawal by Subject|1|||
46640066|NCT00085098|82814053|FG000|Overall Study|Ineligible|1|||
46640067|NCT00085098|82814054|FG001|Overall Study|Ineligible|1|||
46640068|NCT00084864|82814067|FG000|Overall Study|Adverse Event|1|||
46640069|NCT00084864|82814068|FG001|Overall Study|Adverse Event|0|||
46640070|NCT00084864|82814069|FG002|Overall Study|Adverse Event|0|||
46640071|NCT00084864|82814070|FG003|Overall Study|Adverse Event|0|||
46640072|NCT00084318|82814082|FG000|Overall Study|Withdrawal by Subject|5|||
46640073|NCT00084318|82814083|FG001|Overall Study|Withdrawal by Subject|2|||
46640074|NCT00084318|82814082|FG000|Overall Study|Protocol Violation|15|||
46640075|NCT00084318|82814083|FG001|Overall Study|Protocol Violation|11|||
46774276|NCT00715026|82992739|FG000|Overall Study|Surgery done on non-study consented hip|1|||
46774277|NCT00714948|82992743|FG000|Overall Study|Adverse Event|2|||
46774278|NCT00714870|82992749|FG000|Overall Study|Lost to Follow-up|22|||
46774279|NCT00714870|82992750|FG001|Overall Study|Lost to Follow-up|5|||
46774280|NCT00714870|82992749|FG000|Overall Study|patient unable to come b/c back pain|1|||
46774281|NCT00714870|82992750|FG001|Overall Study|patient unable to come b/c back pain|0|||
46774282|NCT00714870|82992749|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
46774283|NCT00714870|82992750|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
46774284|NCT00714714|82992756|FG000|Overall Study|Adverse Event|1|||
46774285|NCT00441337|82992766|FG000|Overall Study|Disease Progression|6|||
46774286|NCT00441337|82992767|FG001|Overall Study|Disease Progression|6|||
46845343|NCT00126594|83062196|FG001|Overall Study|Non-compliance|1|||
46962357|NCT02419508|83204832|FG000|Overall Study|Withdrawal by Subject|1|||
46962358|NCT02419508|83204833|FG001|Overall Study|Withdrawal by Subject|0|||
46962359|NCT02419508|83204832|FG000|Overall Study|Other - Reason not specified|0|||
46962360|NCT02419508|83204833|FG001|Overall Study|Other - Reason not specified|1|||
46962361|NCT01328249|83204841|FG000|Overall Study|Adverse Event|3|||
46640076|NCT00084318|82814082|FG000|Overall Study|No protocol treatment|2|||
46640077|NCT00084318|82814083|FG001|Overall Study|No protocol treatment|0|||
46640078|NCT00084084|82814091|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
46640079|NCT00084084|82814091|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
46962362|NCT01328249|83204842|FG001|Overall Study|Adverse Event|0|||
46962363|NCT01328249|83204841|FG000|Overall Study|Disease progression|1|||
46962364|NCT01328249|83204842|FG001|Overall Study|Disease progression|0|||
46962365|NCT01328249|83204841|FG000|Overall Study|Withdrawal by Subject|1|||
46962366|NCT01328249|83204842|FG001|Overall Study|Withdrawal by Subject|1|||
46962367|NCT01328249|83204841|FG000|Overall Study|Moved before end of treatment visit|1|||
46962368|NCT01328249|83204842|FG001|Overall Study|Moved before end of treatment visit|0|||
46962369|NCT01328249|83204841|FG000|Overall Study|Subject choice|1|||
46962370|NCT01328249|83204842|FG001|Overall Study|Subject choice|1|||
46962371|NCT01328249|83204841|FG000|Overall Study|Protocol Violation|0|||
46962372|NCT01328249|83204842|FG001|Overall Study|Protocol Violation|1|||
46962373|NCT01651052|83204850|FG000|Overall Study|Death|21|||
46962374|NCT01651052|83204850|FG000|Overall Study|Explant|1|||
46962375|NCT01651052|83204850|FG000|Overall Study|Withdrawal by Subject|1|||
46962376|NCT01651052|83204850|FG000|Overall Study|Lost to Follow-up|3|||
46962377|NCT02388074|83204854|FG000|Overall Study|Lost in Transit|2|||
46962378|NCT02388074|83204854|FG000|Overall Study|Sample Not Returned|1|||
46962379|NCT01602549|83204860|FG000|Overall Study|Protocol Violation|0|||
46962380|NCT01602549|83204861|FG001|Overall Study|Protocol Violation|1|||
46962381|NCT01602549|83204860|FG000|Overall Study|Withdrawal by Subject|1|||
46845344|NCT00126594|83062195|FG000|Overall Study|Disease Progression|29|||
46845345|NCT00126594|83062196|FG001|Overall Study|Disease Progression|24|||
46962382|NCT01602549|83204861|FG001|Overall Study|Withdrawal by Subject|0|||
46962383|NCT02427464|83204871|FG000|Overall Study|Adverse Event|6|||
46962384|NCT02427464|83204872|FG001|Overall Study|Adverse Event|1|||
46962385|NCT02427464|83204871|FG000|Overall Study|Lost to Follow-up|16|||
46962386|NCT02427464|83204872|FG001|Overall Study|Lost to Follow-up|5|||
46962387|NCT02427464|83204871|FG000|Overall Study|Physician Decision|2|||
46962388|NCT02427464|83204872|FG001|Overall Study|Physician Decision|0|||
46962389|NCT02427464|83204871|FG000|Overall Study|Withdrawal by Subject|10|||
46962390|NCT02427464|83204872|FG001|Overall Study|Withdrawal by Subject|8|||
46962391|NCT02427464|83204871|FG000|Overall Study|Noncompliance|16|||
46962392|NCT02427464|83204872|FG001|Overall Study|Noncompliance|10|||
46962393|NCT02426918|83204881|FG000|Overall Study|Adverse Event|2|||
46962394|NCT02426918|83204882|FG001|Overall Study|Adverse Event|2|||
46962395|NCT02426918|83204883|FG002|Overall Study|Adverse Event|0|||
46962396|NCT02426918|83204881|FG000|Overall Study|Physician Decision|1|||
46962397|NCT02426918|83204882|FG001|Overall Study|Physician Decision|1|||
46962398|NCT02426918|83204883|FG002|Overall Study|Physician Decision|1|||
46962399|NCT02426918|83204881|FG000|Overall Study|Withdrawal by Subject|5|||
46962400|NCT02426918|83204882|FG001|Overall Study|Withdrawal by Subject|5|||
46962401|NCT02426918|83204883|FG002|Overall Study|Withdrawal by Subject|4|||
46962402|NCT02426918|83204881|FG000|Overall Study|Other|9|||
46962403|NCT02426918|83204882|FG001|Overall Study|Other|11|||
46962404|NCT02426918|83204883|FG002|Overall Study|Other|9|||
46962405|NCT02387840|83204897|FG000|Overall Study|Death|0|||
46962406|NCT02387840|83204898|FG001|Overall Study|Death|0|||
46962407|NCT02387840|83204899|FG002|Overall Study|Death|0|||
46962408|NCT02387840|83204900|FG003|Overall Study|Death|0|||
46962409|NCT02387840|83204901|FG004|Overall Study|Death|0|||
46962410|NCT02387840|83204902|FG005|Overall Study|Death|1|||
46962411|NCT02387762|83204924|FG000|Overall Study|Withdrawal by Subject|1|||
46962412|NCT02387762|83204925|FG001|Overall Study|Withdrawal by Subject|0|||
46962413|NCT02418182|83204933|FG000|Overall Study|Unable to re-consent|18|||
46962414|NCT02418182|83204934|FG001|Overall Study|Unable to re-consent|15|||
47067246|NCT01443845|83350824|FG000|Overall Study|Withdrawal by Subject|63|||
46845346|NCT00126438|83062205|FG000|Overall Study|Withdrawal due to adverse event|1|||
46845347|NCT00126438|83062206|FG001|Overall Study|Withdrawal due to adverse event|0|||
46845348|NCT00126438|83062205|FG000|Overall Study|Lost to Follow-up|22|||
46845349|NCT00126438|83062206|FG001|Overall Study|Lost to Follow-up|0|||
46845350|NCT00126438|83062205|FG000|Overall Study|Protocol Violation|8|||
46845351|NCT00126438|83062206|FG001|Overall Study|Protocol Violation|8|||
46845352|NCT00126438|83062205|FG000|Overall Study|Withdrawal by Subject|3|||
46845353|NCT00126438|83062206|FG001|Overall Study|Withdrawal by Subject|2|||
46845354|NCT00142584|83062214|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
46845355|NCT00142584|83062215|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
47067247|NCT01443845|83350825|FG001|Overall Study|Withdrawal by Subject|67|||
46845356|NCT00142584|83062214|FG000|Overall Study|Withdrawal by Subject|30|||
46962415|NCT02418182|83204933|FG000|Overall Study|Lost to Follow-up|0|||
46962416|NCT02418182|83204934|FG001|Overall Study|Lost to Follow-up|2|||
46962417|NCT02387372|83204955|FG000|Overall Study|Not Treated|1|||
46962418|NCT02387372|83204956|FG001|Overall Study|Not Treated|0|||
46962419|NCT02426138|83204972|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
46962420|NCT02426138|83204973|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
46962421|NCT02426684|83204986|FG000|Overall Study|Physician Decision|1|||
46962422|NCT02656173|83204992|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
46962423|NCT02656173|83204993|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
46962424|NCT02656173|83204992|FG000|Overall Study|Adverse Event|7|||
46962425|NCT02656173|83204993|FG001|Overall Study|Adverse Event|5|||
46962426|NCT02656173|83204992|FG000|Overall Study|Withdrawal by Subject|1|||
46962427|NCT02656173|83204993|FG001|Overall Study|Withdrawal by Subject|3|||
46962428|NCT02656173|83204992|FG000|Overall Study|Protocol Violation|0|||
46962429|NCT02656173|83204993|FG001|Overall Study|Protocol Violation|1|||
46962430|NCT02656173|83204992|FG000|Overall Study|Miscellaneous|2|||
46962431|NCT02656173|83204993|FG001|Overall Study|Miscellaneous|0|||
46962432|NCT02656017|83205003|FG000|Overall Study|Study burden|3|||
46962433|NCT02656017|83205004|FG001|Overall Study|Study burden|3|||
46962434|NCT02656017|83205003|FG000|Overall Study|Adverse Event|2|||
46962435|NCT02656017|83205004|FG001|Overall Study|Adverse Event|1|||
46962436|NCT02656017|83205003|FG000|Overall Study|Unable/unwilling to take study medication|2|||
46962437|NCT02656017|83205004|FG001|Overall Study|Unable/unwilling to take study medication|1|||
46962438|NCT02656017|83205003|FG000|Overall Study|Began Tolvaptan|1|||
46962439|NCT02656017|83205004|FG001|Overall Study|Began Tolvaptan|1|||
46962440|NCT02656017|83205003|FG000|Overall Study|Withdrawal by Subject|1|||
46962441|NCT02656017|83205004|FG001|Overall Study|Withdrawal by Subject|0|||
46962442|NCT02657343|83205016|FG000|Overall Study|Death|0|||
46962443|NCT02657343|83205017|FG001|Overall Study|Death|2|||
46962444|NCT02657343|83205018|FG002|Overall Study|Death|0|||
46962445|NCT02657343|83205019|FG003|Overall Study|Death|0|||
46962446|NCT02657343|83205020|FG004|Overall Study|Death|0|||
46962447|NCT02657343|83205021|FG005|Overall Study|Death|0|||
46962448|NCT02657343|83205016|FG000|Overall Study|Patient went to hospice|1|||
46962449|NCT02657343|83205017|FG001|Overall Study|Patient went to hospice|0|||
46962450|NCT02657343|83205018|FG002|Overall Study|Patient went to hospice|0|||
46962451|NCT02657343|83205019|FG003|Overall Study|Patient went to hospice|0|||
46962452|NCT02657343|83205020|FG004|Overall Study|Patient went to hospice|0|||
46962453|NCT02657343|83205021|FG005|Overall Study|Patient went to hospice|0|||
46962454|NCT02657343|83205016|FG000|Overall Study|Withdrawal by Subject|0|||
46962455|NCT02657343|83205017|FG001|Overall Study|Withdrawal by Subject|0|||
46962456|NCT02657343|83205018|FG002|Overall Study|Withdrawal by Subject|0|||
46962457|NCT02657343|83205019|FG003|Overall Study|Withdrawal by Subject|0|||
46962458|NCT02657343|83205020|FG004|Overall Study|Withdrawal by Subject|1|||
46962459|NCT02657343|83205021|FG005|Overall Study|Withdrawal by Subject|0|||
46962460|NCT02655237|83205037|FG000|Overall Study|Adverse Event|10|||
46962461|NCT02655237|83205038|FG001|Overall Study|Adverse Event|7|||
46962462|NCT02655237|83205037|FG000|Overall Study|Protocol Deviation|2|||
46962463|NCT02655237|83205038|FG001|Overall Study|Protocol Deviation|0|||
46962464|NCT02655237|83205037|FG000|Overall Study|Withdrawal by Participant|1|||
46962465|NCT02655237|83205038|FG001|Overall Study|Withdrawal by Participant|2|||
46962466|NCT02655237|83205037|FG000|Overall Study|Lack of Efficacy|0|||
46962467|NCT02655237|83205038|FG001|Overall Study|Lack of Efficacy|1|||
46962468|NCT02655237|83205037|FG000|Overall Study|Recovery Leading to Surgery|2|||
46962469|NCT02655237|83205038|FG001|Overall Study|Recovery Leading to Surgery|1|||
46962470|NCT02655237|83205037|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
46962471|NCT02655237|83205038|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
46962472|NCT02655237|83205037|FG000|Overall Study|Randomized but Not Treated|1|||
46962473|NCT02655237|83205038|FG001|Overall Study|Randomized but Not Treated|0|||
46962474|NCT02657031|83205046|FG000|Overall Study|Adverse Event|1|||
46962475|NCT02657031|83205047|FG001|Overall Study|Adverse Event|2|||
46962476|NCT04375397|83205075|FG000|Overall Study|Death|1|||
46962477|NCT04375397|83205076|FG001|Overall Study|Death|1|||
46962478|NCT04375397|83205075|FG000|Overall Study|Withdrew consent|2|||
46962479|NCT04375397|83205076|FG001|Overall Study|Withdrew consent|0|||
46962480|NCT04375397|83205075|FG000|Overall Study|Lost to Follow-up|6|||
46962481|NCT04375397|83205076|FG001|Overall Study|Lost to Follow-up|4|||
46962482|NCT04375397|83205075|FG000|Overall Study|Other, not specified|0|||
46845357|NCT00142584|83062215|FG001|Overall Study|Withdrawal by Subject|16|||
46845358|NCT00142584|83062214|FG000|Overall Study|Lost to Follow-up|22|||
46845359|NCT00142584|83062215|FG001|Overall Study|Lost to Follow-up|12|||
46845360|NCT00142584|83062214|FG000|Overall Study|Adverse Event|14|||
46845361|NCT00142584|83062215|FG001|Overall Study|Adverse Event|5|||
46845362|NCT00142584|83062214|FG000|Overall Study|Protocol Violation|4|||
46845363|NCT00142584|83062215|FG001|Overall Study|Protocol Violation|7|||
47067248|NCT01443845|83350824|FG000|Overall Study|Military Conflict - Site Terminated|20|||
47067249|NCT01443845|83350825|FG001|Overall Study|Military Conflict - Site Terminated|21|||
46845364|NCT00142584|83062214|FG000|Overall Study|Treatment Failure|2|||
46962483|NCT04375397|83205076|FG001|Overall Study|Other, not specified|1|||
46962484|NCT02387216|83205084|FG000|Overall Study|Progressive disease|2|||
46962485|NCT02387216|83205085|FG001|Overall Study|Progressive disease|0|||
46962486|NCT02387216|83205084|FG000|Overall Study|Withdrawal by Subject|3|||
46962487|NCT02387216|83205085|FG001|Overall Study|Withdrawal by Subject|5|||
46962488|NCT02387216|83205084|FG000|Overall Study|Physician Decision|2|||
46962489|NCT02387216|83205085|FG001|Overall Study|Physician Decision|0|||
46962490|NCT02387216|83205084|FG000|Overall Study|Sponsor Decision|28|||
46962491|NCT02387216|83205085|FG001|Overall Study|Sponsor Decision|12|||
46962492|NCT02387216|83205084|FG000|Overall Study|Death|60|||
46845365|NCT00142584|83062215|FG001|Overall Study|Treatment Failure|0|||
46962493|NCT02387216|83205085|FG001|Overall Study|Death|23|||
46962494|NCT02387216|83205084|FG000|Overall Study|Other|5|||
46962495|NCT02387216|83205085|FG001|Overall Study|Other|4|||
46962496|NCT02387216|83205084|FG000|Overall Study|Lost to Follow-up|0|||
46962497|NCT02387216|83205085|FG001|Overall Study|Lost to Follow-up|3|||
46962498|NCT02417246|83205093|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
46962499|NCT02417246|83205094|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
46962500|NCT02417246|83205093|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
46962501|NCT02417246|83205094|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
46962502|NCT02417246|83205093|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
46962503|NCT02417246|83205094|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
46962504|NCT02417246|83205093|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
46962505|NCT02417246|83205094|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
46962506|NCT02424734|83205105|FG000|Overall Study|Treatment stopped to be discharged home|2|||
46962507|NCT02424734|83205106|FG001|Overall Study|Treatment stopped to be discharged home|2|||
46962508|NCT02424734|83205107|FG002|Overall Study|Treatment stopped to be discharged home|0|||
46962509|NCT02424578|83205118|FG000|Overall Study|Withdrawal by Subject|0|||
46962510|NCT02424578|83205119|FG001|Overall Study|Withdrawal by Subject|1|||
46962511|NCT02416934|83205127|FG000|Overall Study|given steroids|1|||
46962512|NCT02416934|83205128|FG001|Overall Study|given steroids|2|||
46962513|NCT02416934|83205127|FG000|Overall Study|Lost to Follow-up|0|||
46962514|NCT02416934|83205128|FG001|Overall Study|Lost to Follow-up|2|||
46962515|NCT02416934|83205127|FG000|Overall Study|Withdrawal by Subject|1|||
46962516|NCT02416934|83205128|FG001|Overall Study|Withdrawal by Subject|0|||
46962517|NCT02416934|83205127|FG000|Overall Study|recruited during continuing renewal proc|0|||
46962518|NCT02416934|83205128|FG001|Overall Study|recruited during continuing renewal proc|1|||
46962519|NCT02416934|83205127|FG000|Overall Study|Protocol Violation|0|||
46962520|NCT02416934|83205128|FG001|Overall Study|Protocol Violation|1|||
46962521|NCT02416934|83205127|FG000|Overall Study|surgery started late|0|||
46962522|NCT02416934|83205128|FG001|Overall Study|surgery started late|1|||
46962523|NCT02416934|83205127|FG000|Overall Study|re-operation|1|||
46962524|NCT02416934|83205128|FG001|Overall Study|re-operation|0|||
46962525|NCT02819635|83205148|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
46962526|NCT02819635|83205149|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
46962527|NCT02819635|83205150|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
46962528|NCT02819635|83205151|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
46962529|NCT02819635|83205152|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
46962530|NCT02819635|83205153|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
46962531|NCT02819635|83205154|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
46962532|NCT02819635|83205155|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
46962533|NCT02819635|83205156|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
46962534|NCT02819635|83205157|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
46962535|NCT02819635|83205158|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
46962536|NCT02819635|83205159|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
46962537|NCT02819635|83205148|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962538|NCT02819635|83205149|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962539|NCT02819635|83205150|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962540|NCT02819635|83205151|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962541|NCT02819635|83205152|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
46962542|NCT02819635|83205153|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
46962543|NCT02819635|83205154|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
46962544|NCT02819635|83205155|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962545|NCT02819635|83205156|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962546|NCT02819635|83205157|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962547|NCT02819635|83205158|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962548|NCT02819635|83205159|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
46962549|NCT02819635|83205148|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962550|NCT02819635|83205149|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962551|NCT02819635|83205150|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
47067250|NCT01443845|83350824|FG000|Overall Study|Lost to Follow-up|9|||
47067251|NCT01443845|83350825|FG001|Overall Study|Lost to Follow-up|13|||
47067252|NCT01549652|83350834|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
47067253|NCT01549652|83350835|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
47067254|NCT01549652|83350836|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
46962552|NCT02819635|83205151|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
47067255|NCT01549652|83350837|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
46962553|NCT02819635|83205152|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962554|NCT02819635|83205153|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
46962555|NCT02819635|83205154|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
46962556|NCT02819635|83205155|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962557|NCT02819635|83205156|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962558|NCT02819635|83205157|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962559|NCT02819635|83205158|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962560|NCT02819635|83205159|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
46962561|NCT02819635|83205148|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962562|NCT02819635|83205149|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962563|NCT02819635|83205150|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962564|NCT02819635|83205151|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962565|NCT02819635|83205152|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962566|NCT02819635|83205153|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962567|NCT02819635|83205154|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
46962568|NCT02819635|83205155|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962569|NCT02819635|83205156|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962570|NCT02819635|83205157|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962571|NCT02819635|83205158|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962572|NCT02819635|83205159|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
46962573|NCT02819635|83205148|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
46962574|NCT02819635|83205149|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
46962575|NCT02819635|83205150|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
46962576|NCT02819635|83205151|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
46962577|NCT02819635|83205152|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
46962578|NCT02819635|83205153|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
46962579|NCT02819635|83205154|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
46962580|NCT02819635|83205155|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
46962581|NCT02819635|83205156|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
46962582|NCT02819635|83205157|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
46962583|NCT02819635|83205158|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
46962584|NCT02819635|83205159|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
46962585|NCT02819635|83205148|FG000|Substudy 2, Part 2|Adverse Event|0|||
46962586|NCT02819635|83205149|FG001|Substudy 2, Part 2|Adverse Event|0|||
46962587|NCT02819635|83205150|FG002|Substudy 2, Part 2|Adverse Event|0|||
46962588|NCT02819635|83205151|FG003|Substudy 2, Part 2|Adverse Event|0|||
46962589|NCT02819635|83205152|FG004|Substudy 2, Part 2|Adverse Event|0|||
46962590|NCT02819635|83205153|FG005|Substudy 2, Part 2|Adverse Event|4|||
46962591|NCT02819635|83205154|FG006|Substudy 2, Part 2|Adverse Event|0|||
46962592|NCT02819635|83205155|FG007|Substudy 2, Part 2|Adverse Event|0|||
46962593|NCT02819635|83205156|FG008|Substudy 2, Part 2|Adverse Event|0|||
46962594|NCT02819635|83205157|FG009|Substudy 2, Part 2|Adverse Event|0|||
46962595|NCT02819635|83205158|FG010|Substudy 2, Part 2|Adverse Event|0|||
46962596|NCT02819635|83205159|FG011|Substudy 2, Part 2|Adverse Event|0|||
46962597|NCT02819635|83205148|FG000|Substudy 2, Part 2|Withdrew consent|0|||
46962598|NCT02819635|83205149|FG001|Substudy 2, Part 2|Withdrew consent|0|||
46962599|NCT02819635|83205150|FG002|Substudy 2, Part 2|Withdrew consent|0|||
46962600|NCT02819635|83205151|FG003|Substudy 2, Part 2|Withdrew consent|0|||
46962601|NCT02819635|83205152|FG004|Substudy 2, Part 2|Withdrew consent|0|||
46962602|NCT02819635|83205153|FG005|Substudy 2, Part 2|Withdrew consent|3|||
46962603|NCT02819635|83205154|FG006|Substudy 2, Part 2|Withdrew consent|1|||
46962604|NCT02819635|83205155|FG007|Substudy 2, Part 2|Withdrew consent|0|||
46962605|NCT02819635|83205156|FG008|Substudy 2, Part 2|Withdrew consent|0|||
46962606|NCT02819635|83205157|FG009|Substudy 2, Part 2|Withdrew consent|0|||
46640080|NCT00083616|82814096|FG000|Overall Study|Disease Progression|16|||
46640081|NCT00083616|82814096|FG000|Overall Study|Lost to Follow-up|1|||
46640082|NCT00083616|82814096|FG000|Overall Study|Physician Decision|2|||
46640083|NCT00083616|82814096|FG000|Overall Study|Withdrawal by Subject|3|||
46640084|NCT00083616|82814096|FG000|Overall Study|Ineligibility determined|2|||
46640085|NCT00083616|82814096|FG000|Overall Study|Non-compliance|1|||
46962607|NCT02819635|83205158|FG010|Substudy 2, Part 2|Withdrew consent|0|||
46962608|NCT02819635|83205159|FG011|Substudy 2, Part 2|Withdrew consent|0|||
46962609|NCT02819635|83205148|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
46962610|NCT02819635|83205149|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
46962611|NCT02819635|83205150|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
46962612|NCT02819635|83205151|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
46962613|NCT02819635|83205152|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
46962614|NCT02819635|83205153|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
46962615|NCT02819635|83205154|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
46962616|NCT02819635|83205155|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
46962617|NCT02819635|83205156|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
46962618|NCT02819635|83205157|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
46640086|NCT00083616|82814096|FG000|Overall Study|Other|6|||
46640087|NCT00083226|82814100|FG000|Overall Study|Lack of Efficacy|19|||
46640088|NCT00083226|82814100|FG000|Overall Study|Adverse Event|9|||
46962619|NCT02819635|83205158|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
46962620|NCT02819635|83205159|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
46962621|NCT02819635|83205148|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962622|NCT02819635|83205149|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962623|NCT02819635|83205150|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962624|NCT02819635|83205151|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962625|NCT02819635|83205152|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962626|NCT02819635|83205153|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962627|NCT02819635|83205154|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
46962628|NCT02819635|83205155|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962629|NCT02819635|83205156|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962630|NCT02819635|83205157|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962631|NCT02819635|83205158|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962632|NCT02819635|83205159|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
46962633|NCT02819635|83205148|FG000|Substudy 2, Part 2|Other, not specified|0|||
46962634|NCT02819635|83205149|FG001|Substudy 2, Part 2|Other, not specified|0|||
46962635|NCT02819635|83205150|FG002|Substudy 2, Part 2|Other, not specified|0|||
46962636|NCT02819635|83205151|FG003|Substudy 2, Part 2|Other, not specified|0|||
46962637|NCT02819635|83205152|FG004|Substudy 2, Part 2|Other, not specified|0|||
46962638|NCT02819635|83205153|FG005|Substudy 2, Part 2|Other, not specified|4|||
46962639|NCT02819635|83205154|FG006|Substudy 2, Part 2|Other, not specified|8|||
46962640|NCT02819635|83205155|FG007|Substudy 2, Part 2|Other, not specified|0|||
46962641|NCT02819635|83205156|FG008|Substudy 2, Part 2|Other, not specified|0|||
46962642|NCT02819635|83205157|FG009|Substudy 2, Part 2|Other, not specified|0|||
46962643|NCT02819635|83205158|FG010|Substudy 2, Part 2|Other, not specified|0|||
46962644|NCT02819635|83205159|FG011|Substudy 2, Part 2|Other, not specified|0|||
46962645|NCT02819635|83205148|FG000|Substudy 3|Adverse Event|0|||
46962646|NCT02819635|83205149|FG001|Substudy 3|Adverse Event|0|||
46962647|NCT02819635|83205150|FG002|Substudy 3|Adverse Event|0|||
46962648|NCT02819635|83205151|FG003|Substudy 3|Adverse Event|0|||
46962649|NCT02819635|83205152|FG004|Substudy 3|Adverse Event|0|||
46962650|NCT02819635|83205153|FG005|Substudy 3|Adverse Event|0|||
46962651|NCT02819635|83205154|FG006|Substudy 3|Adverse Event|0|||
46962652|NCT02819635|83205155|FG007|Substudy 3|Adverse Event|0|||
46962653|NCT02819635|83205156|FG008|Substudy 3|Adverse Event|32|||
46962654|NCT02819635|83205157|FG009|Substudy 3|Adverse Event|3|||
46962655|NCT02819635|83205158|FG010|Substudy 3|Adverse Event|12|||
46962656|NCT02819635|83205159|FG011|Substudy 3|Adverse Event|18|||
46962657|NCT02819635|83205148|FG000|Substudy 3|Withdrew consent|0|||
46962658|NCT02819635|83205149|FG001|Substudy 3|Withdrew consent|0|||
46962659|NCT02819635|83205150|FG002|Substudy 3|Withdrew consent|0|||
46962660|NCT02819635|83205151|FG003|Substudy 3|Withdrew consent|0|||
46962661|NCT02819635|83205152|FG004|Substudy 3|Withdrew consent|0|||
46962662|NCT02819635|83205153|FG005|Substudy 3|Withdrew consent|0|||
46962663|NCT02819635|83205154|FG006|Substudy 3|Withdrew consent|0|||
46962664|NCT02819635|83205155|FG007|Substudy 3|Withdrew consent|0|||
46962665|NCT02819635|83205156|FG008|Substudy 3|Withdrew consent|11|||
46962666|NCT02819635|83205157|FG009|Substudy 3|Withdrew consent|1|||
46962667|NCT02819635|83205158|FG010|Substudy 3|Withdrew consent|4|||
46962668|NCT02819635|83205159|FG011|Substudy 3|Withdrew consent|9|||
46962669|NCT02819635|83205148|FG000|Substudy 3|Lost to Follow-up|0|||
46962670|NCT02819635|83205149|FG001|Substudy 3|Lost to Follow-up|0|||
46962671|NCT02819635|83205150|FG002|Substudy 3|Lost to Follow-up|0|||
46962672|NCT02819635|83205151|FG003|Substudy 3|Lost to Follow-up|0|||
46962673|NCT02819635|83205152|FG004|Substudy 3|Lost to Follow-up|0|||
46962674|NCT02819635|83205153|FG005|Substudy 3|Lost to Follow-up|0|||
46962675|NCT02819635|83205154|FG006|Substudy 3|Lost to Follow-up|0|||
46962676|NCT02819635|83205155|FG007|Substudy 3|Lost to Follow-up|0|||
46962677|NCT02819635|83205156|FG008|Substudy 3|Lost to Follow-up|1|||
46962678|NCT02819635|83205157|FG009|Substudy 3|Lost to Follow-up|0|||
46962679|NCT02819635|83205158|FG010|Substudy 3|Lost to Follow-up|1|||
47067256|NCT01549652|83350834|FG000|Overall Study|Study Drug Titration Failure|5|||
46962680|NCT02819635|83205159|FG011|Substudy 3|Lost to Follow-up|1|||
46774287|NCT00441337|82992768|FG002|Overall Study|Disease Progression|4|||
46962681|NCT02819635|83205148|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
46774288|NCT00441337|82992769|FG003|Overall Study|Disease Progression|18|||
46962682|NCT02819635|83205149|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962683|NCT02819635|83205150|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962684|NCT02819635|83205151|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962685|NCT02819635|83205152|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962686|NCT02819635|83205153|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962687|NCT02819635|83205154|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962688|NCT02819635|83205155|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
46774289|NCT00441337|82992766|FG000|Overall Study|Lost to Follow-up|0|||
46774290|NCT00441337|82992767|FG001|Overall Study|Lost to Follow-up|0|||
46962689|NCT02819635|83205156|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962690|NCT02819635|83205157|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962691|NCT02819635|83205158|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
46962692|NCT02819635|83205159|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
46962693|NCT02819635|83205148|FG000|Substudy 3|Other, not specified|0|||
46962694|NCT02819635|83205149|FG001|Substudy 3|Other, not specified|0|||
46962695|NCT02819635|83205150|FG002|Substudy 3|Other, not specified|0|||
46962696|NCT02819635|83205151|FG003|Substudy 3|Other, not specified|0|||
46962697|NCT02819635|83205152|FG004|Substudy 3|Other, not specified|0|||
46962698|NCT02819635|83205153|FG005|Substudy 3|Other, not specified|0|||
46962699|NCT02819635|83205154|FG006|Substudy 3|Other, not specified|0|||
46962700|NCT02819635|83205155|FG007|Substudy 3|Other, not specified|0|||
46962701|NCT02819635|83205156|FG008|Substudy 3|Other, not specified|202|||
46962702|NCT02819635|83205157|FG009|Substudy 3|Other, not specified|5|||
46962703|NCT02819635|83205158|FG010|Substudy 3|Other, not specified|89|||
46962704|NCT02819635|83205159|FG011|Substudy 3|Other, not specified|39|||
46962705|NCT02424344|83205194|FG000|Overall Study|Lack of Efficacy|0|||
46962706|NCT02424344|83205195|FG001|Overall Study|Lack of Efficacy|1|||
46962707|NCT02424344|83205194|FG000|Overall Study|Withdrawal by Subject|2|||
46962708|NCT02424344|83205195|FG001|Overall Study|Withdrawal by Subject|1|||
46962709|NCT02424344|83205194|FG000|Overall Study|Lost to Follow-up|1|||
46962710|NCT02424344|83205195|FG001|Overall Study|Lost to Follow-up|0|||
46962711|NCT02424344|83205194|FG000|Overall Study|Adverse Event|4|||
46962712|NCT02424344|83205195|FG001|Overall Study|Adverse Event|8|||
46962713|NCT02423798|83205201|FG000|Overall Study|Withdrawal by Subject|3|||
46962714|NCT02383940|83205224|FG000|Overall Study|Adverse Event|1|||
46962715|NCT02383940|83205225|FG001|Overall Study|Adverse Event|0|||
46962716|NCT02383940|83205224|FG000|Overall Study|Lost to Follow-up|2|||
46962717|NCT02383940|83205225|FG001|Overall Study|Lost to Follow-up|2|||
46962718|NCT02383940|83205224|FG000|Overall Study|Physician Decision|2|||
46962719|NCT02383940|83205225|FG001|Overall Study|Physician Decision|0|||
46962720|NCT02383940|83205224|FG000|Overall Study|Withdrawal by Subject|1|||
46962721|NCT02383940|83205225|FG001|Overall Study|Withdrawal by Subject|1|||
46962722|NCT02383940|83205224|FG000|Overall Study|Randomized but not treated|2|||
46962723|NCT02383940|83205225|FG001|Overall Study|Randomized but not treated|0|||
46962724|NCT02383940|83205224|FG000|Overall Study|Other than specified above|1|||
46962725|NCT02383940|83205225|FG001|Overall Study|Other than specified above|0|||
46962726|NCT02383862|83205233|FG000|3 Month Follow up|Lost to Follow-up|23|||
46962727|NCT02383862|83205234|FG001|3 Month Follow up|Lost to Follow-up|21|||
46962728|NCT02383472|83205249|FG000|Overall Study|Withdrawal by Subject|1|||
46962729|NCT02383472|83205250|FG001|Overall Study|Withdrawal by Subject|1|||
46962730|NCT02234323|83205258|FG000|All Enrolled|Not Treated: Completed study in database|2|||
46962731|NCT02234323|83205258|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
46962732|NCT02234323|83205258|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
46962733|NCT02234323|83205258|FG000|All Treated|Death|1|||
46962734|NCT02234323|83205258|FG000|All Treated|Physician Decision|5|||
46962735|NCT02234323|83205258|FG000|All Treated|Lack of Efficacy|3|||
46962736|NCT02234323|83205258|FG000|All Treated|Exceeded lab value limit|2|||
46962737|NCT02234323|83205258|FG000|All Treated|Other|7|||
46962738|NCT02414828|83205268|FG000|Overall Study|Lost to Follow-up|0|||
46962739|NCT02414828|83205269|FG001|Overall Study|Lost to Follow-up|1|||
46962740|NCT02414828|83205270|FG002|Overall Study|Lost to Follow-up|1|||
46962741|NCT02414828|83205271|FG003|Overall Study|Lost to Follow-up|2|||
46962742|NCT02413346|83205284|FG000|Overall Study|Adverse Event|6|||
46962743|NCT02413346|83205285|FG001|Overall Study|Adverse Event|6|||
46962744|NCT02413346|83205284|FG000|Overall Study|Withdrawal by Subject|30|||
46962745|NCT02413346|83205285|FG001|Overall Study|Withdrawal by Subject|40|||
46962746|NCT02413346|83205284|FG000|Overall Study|Lost to Follow-up|17|||
46962747|NCT02413346|83205285|FG001|Overall Study|Lost to Follow-up|21|||
46962748|NCT02413346|83205284|FG000|Overall Study|Protocol Violation|2|||
46845366|NCT00126126|83062225|FG000|Overall Study|Lost to Follow-up|0|||
46845367|NCT00126126|83062226|FG001|Overall Study|Lost to Follow-up|2|||
46640089|NCT00083226|82814100|FG000|Overall Study|Death|4|||
46845368|NCT00125268|83062234|FG000|Overall Study|Withdrawal by Subject|1|||
46845369|NCT00125268|83062235|FG001|Overall Study|Withdrawal by Subject|1|||
46845370|NCT00125190|83062241|FG000|Overall Study|Subject/Parent Decision|7|||
46962749|NCT02413346|83205285|FG001|Overall Study|Protocol Violation|0|||
46962750|NCT02413346|83205284|FG000|Overall Study|Other Miscellaneous Reasons|4|||
46962751|NCT02413346|83205285|FG001|Overall Study|Other Miscellaneous Reasons|3|||
46962752|NCT03390101|83205298|FG000|Weeks 0-12|Withdrawal by Subject|0|||
46962753|NCT03390101|83205299|FG001|Weeks 0-12|Withdrawal by Subject|1|||
46962754|NCT03390101|83205300|FG002|Weeks 0-12|Withdrawal by Subject|1|||
46962755|NCT03390101|83205298|FG000|Weeks 0-12|Lost to Follow-up|0|||
46962756|NCT03390101|83205299|FG001|Weeks 0-12|Lost to Follow-up|1|||
46962757|NCT03390101|83205300|FG002|Weeks 0-12|Lost to Follow-up|0|||
46962758|NCT03390101|83205298|FG000|Weeks 12-54|Withdrawal by Subject|0|||
46962759|NCT03390101|83205299|FG001|Weeks 12-54|Withdrawal by Subject|3|||
46640090|NCT00083226|82814100|FG000|Overall Study|Withdrawal by Subject|4|||
46962760|NCT03390101|83205300|FG002|Weeks 12-54|Withdrawal by Subject|1|||
46962761|NCT03390101|83205298|FG000|Weeks 12-54|Pregnancy|1|||
46962762|NCT03390101|83205299|FG001|Weeks 12-54|Pregnancy|0|||
46962763|NCT03390101|83205300|FG002|Weeks 12-54|Pregnancy|0|||
46962764|NCT03390101|83205298|FG000|Weeks 12-54|Adverse Event|2|||
46962765|NCT03390101|83205299|FG001|Weeks 12-54|Adverse Event|1|||
46962766|NCT03390101|83205300|FG002|Weeks 12-54|Adverse Event|1|||
46962767|NCT02732639|83205308|FG000|Overall Study|Lost to Follow-up|1|||
47067257|NCT01549652|83350835|FG001|Overall Study|Study Drug Titration Failure|6|||
47067258|NCT01549652|83350836|FG002|Overall Study|Study Drug Titration Failure|0|||
47067259|NCT01549652|83350837|FG003|Overall Study|Study Drug Titration Failure|0|||
46845371|NCT00125190|83062241|FG000|Overall Study|Non-compliance|2|||
46845372|NCT00125190|83062241|FG000|Overall Study|Adverse Event|1|||
46845373|NCT00125190|83062241|FG000|Overall Study|Other|1|||
46845374|NCT00125190|83062241|FG000|Overall Study|Lost to Follow-up|4|||
46845375|NCT00141726|83062246|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
46845376|NCT00111228|83062253|FG000|Overall Study|Withdrawal by Subject|5|||
46845377|NCT00111228|83062254|FG001|Overall Study|Withdrawal by Subject|1|||
46845378|NCT00111228|83062255|FG002|Overall Study|Withdrawal by Subject|0|||
46845379|NCT00110994|83062265|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
46845380|NCT00110994|83062266|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
46845381|NCT00110994|83062265|FG000|Double-blind (DB) Treatment|Death|1|||
46845382|NCT00110994|83062266|FG001|Double-blind (DB) Treatment|Death|0|||
46845383|NCT00110994|83062265|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
46845384|NCT00110994|83062266|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
46845385|NCT00110994|83062265|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
46845386|NCT00110994|83062266|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
46845387|NCT00110994|83062265|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
46845388|NCT00110994|83062266|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
46845389|NCT00110994|83062265|FG000|Double-blind (DB) Treatment|other reasons|2|||
46845390|NCT00110994|83062266|FG001|Double-blind (DB) Treatment|other reasons|3|||
46845391|NCT00110994|83062265|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
46845392|NCT00110994|83062266|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
46845393|NCT00110994|83062265|FG000|Active Follow-up|Other reasons|0|||
46845394|NCT00110994|83062266|FG001|Active Follow-up|Other reasons|2|||
46845395|NCT00110994|83062265|FG000|Long Term Follow-up|Death|19|||
46845396|NCT00110994|83062266|FG001|Long Term Follow-up|Death|17|||
46845397|NCT00144170|83062274|FG000|Overall Study|Adverse Event|84|||
46845398|NCT00144170|83062275|FG001|Overall Study|Adverse Event|41|||
46845399|NCT00144170|83062274|FG000|Overall Study|Protocol Violation|23|||
46845400|NCT00144170|83062275|FG001|Overall Study|Protocol Violation|16|||
46845401|NCT00144170|83062274|FG000|Overall Study|Lost to Follow-up|5|||
46845402|NCT00144170|83062275|FG001|Overall Study|Lost to Follow-up|10|||
46845403|NCT00144170|83062274|FG000|Overall Study|Withdrawal by Subject|29|||
46845404|NCT00144170|83062275|FG001|Overall Study|Withdrawal by Subject|13|||
46845405|NCT00144170|83062274|FG000|Overall Study|Other reason not defined above|211|||
46845406|NCT00144170|83062275|FG001|Overall Study|Other reason not defined above|316|||
46845407|NCT00255086|83062283|FG000|Overall Study|Adverse Event|1|||
46845408|NCT00255086|83062284|FG001|Overall Study|Adverse Event|1|||
46845409|NCT00255086|83062283|FG000|Overall Study|Protocol Violation|1|||
46845410|NCT00255086|83062284|FG001|Overall Study|Protocol Violation|1|||
46845411|NCT00110214|83062293|FG000|Overall Study|Never started treatment|21|||
46845412|NCT00110214|83062294|FG001|Overall Study|Never started treatment|20|||
46845413|NCT00110214|83062293|FG000|Overall Study|Disease progression or death|260|||
46845414|NCT00110214|83062294|FG001|Overall Study|Disease progression or death|151|||
46845415|NCT00110214|83062293|FG000|Overall Study|Adverse Event|115|||
46845416|NCT00110214|83062294|FG001|Overall Study|Adverse Event|192|||
46845417|NCT00110214|83062293|FG000|Overall Study|Refused further treatment|52|||
46845418|NCT00110214|83062294|FG001|Overall Study|Refused further treatment|65|||
46845419|NCT00110214|83062293|FG000|Overall Study|Other (not specified)|61|||
46845420|NCT00110214|83062294|FG001|Overall Study|Other (not specified)|75|||
46845421|NCT00124020|83062302|FG000|Overall Study|Death|67|||
46845422|NCT00124020|83062303|FG001|Overall Study|Death|71|||
46845423|NCT00124020|83062302|FG000|Overall Study|Withdrawal by Subject|13|||
46845424|NCT00124020|83062303|FG001|Overall Study|Withdrawal by Subject|11|||
46845425|NCT00124020|83062302|FG000|Overall Study|Lost to Follow-up|5|||
46962768|NCT02732561|83205314|FG000|Overall Study|Lost to Follow-up|1|||
46845426|NCT00124020|83062303|FG001|Overall Study|Lost to Follow-up|8|||
46845427|NCT00124020|83062302|FG000|Overall Study|Other|1|||
46845428|NCT00124020|83062303|FG001|Overall Study|Other|1|||
46845429|NCT00124020|83062302|FG000|Overall Study|Transfer to another hospital|2|||
46845430|NCT00124020|83062303|FG001|Overall Study|Transfer to another hospital|0|||
46845431|NCT00215540|83062312|FG000|Overall Study|Withdrew from study medication|1|||
46845432|NCT00215540|83062313|FG001|Overall Study|Withdrew from study medication|0|||
46962769|NCT02732561|83205315|FG001|Overall Study|Lost to Follow-up|1|||
46962770|NCT02732561|83205314|FG000|Overall Study|Withdrawal by Subject|1|||
47067260|NCT01549652|83350834|FG000|Overall Study|Withdrawal Effect|0|||
46845433|NCT00215540|83062314|FG002|Overall Study|Withdrew from study medication|0|||
46845434|NCT00143390|83062324|FG000|Overall Study|Death|2|||
46845435|NCT00143390|83062325|FG001|Overall Study|Death|0|||
46845436|NCT00143390|83062324|FG000|Overall Study|Not meeting entry criteria|2|||
46845437|NCT00143390|83062325|FG001|Overall Study|Not meeting entry criteria|5|||
46845438|NCT00143390|83062324|FG000|Overall Study|Withdrawal by Subject|4|||
46845439|NCT00143390|83062325|FG001|Overall Study|Withdrawal by Subject|4|||
46845440|NCT00143390|83062324|FG000|Overall Study|Progressive disease|119|||
46845441|NCT00143390|83062325|FG001|Overall Study|Progressive disease|115|||
46845442|NCT00143390|83062324|FG000|Overall Study|Protocol Violation|2|||
46845443|NCT00143390|83062325|FG001|Overall Study|Protocol Violation|0|||
46845444|NCT00143390|83062324|FG000|Overall Study|Study termination|10|||
46845445|NCT00143390|83062325|FG001|Overall Study|Study termination|15|||
46845446|NCT00143390|83062324|FG000|Overall Study|Adverse Event|9|||
46845447|NCT00143390|83062325|FG001|Overall Study|Adverse Event|8|||
46845448|NCT00143390|83062324|FG000|Overall Study|Other|1|||
46845449|NCT00143390|83062325|FG001|Overall Study|Other|2|||
46845450|NCT00141102|83062333|FG000|Overall Study|Adverse Event|233|||
46845451|NCT00141102|83062334|FG001|Overall Study|Adverse Event|305|||
46845452|NCT00141102|83062333|FG000|Overall Study|Laboratory Abnormality|9|||
46845453|NCT00141102|83062334|FG001|Overall Study|Laboratory Abnormality|33|||
46845454|NCT00141102|83062333|FG000|Overall Study|Lack of Efficacy|21|||
46845455|NCT00141102|83062334|FG001|Overall Study|Lack of Efficacy|26|||
46845456|NCT00141102|83062333|FG000|Overall Study|Lost to Follow-up|29|||
46845457|NCT00141102|83062334|FG001|Overall Study|Lost to Follow-up|32|||
46845458|NCT00141102|83062333|FG000|Overall Study|Other|87|||
46845459|NCT00141102|83062334|FG001|Overall Study|Other|76|||
46845460|NCT00141102|83062333|FG000|Overall Study|Withdrawal by Subject|112|||
46845461|NCT00141102|83062334|FG001|Overall Study|Withdrawal by Subject|142|||
46845462|NCT00141102|83062333|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
46845463|NCT00141102|83062334|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
46845464|NCT00141102|83062333|FG000|Overall Study|Death|2|||
46845465|NCT00141102|83062334|FG001|Overall Study|Death|2|||
46845466|NCT00255008|83062345|FG000|Overall Study|Adverse Event|1|||
46845467|NCT00255008|83062346|FG001|Overall Study|Adverse Event|1|||
46845468|NCT00255008|83062347|FG002|Overall Study|Adverse Event|2|||
46845469|NCT00255008|83062348|FG003|Overall Study|Adverse Event|0|||
46845470|NCT00255008|83062345|FG000|Overall Study|Lost to Follow-up|1|||
46845471|NCT00255008|83062346|FG001|Overall Study|Lost to Follow-up|0|||
46845472|NCT00255008|83062347|FG002|Overall Study|Lost to Follow-up|1|||
46962771|NCT02732561|83205315|FG001|Overall Study|Withdrawal by Subject|0|||
46962772|NCT02412878|83205323|FG000|Overall Study|Withdrawal by Subject|19|||
46962773|NCT02412878|83205324|FG001|Overall Study|Withdrawal by Subject|10|||
46962774|NCT02412878|83205323|FG000|Overall Study|Lost to Follow-up|2|||
46962775|NCT02412878|83205324|FG001|Overall Study|Lost to Follow-up|3|||
46962776|NCT02380742|83205332|FG000|Overall Study|Withdrawal by Subject|1|||
46962777|NCT02380742|83205333|FG001|Overall Study|Withdrawal by Subject|0|||
46962778|NCT02922725|83205342|FG000|Overall Study|Withdrawal by Subject|1|||
46962779|NCT02922725|83205343|FG001|Overall Study|Withdrawal by Subject|0|||
46962780|NCT02922725|83205344|FG002|Overall Study|Withdrawal by Subject|0|||
46962781|NCT02805257|83205353|FG000|Overall Study|Lost to Follow-up|7|||
46962782|NCT02805257|83205354|FG001|Overall Study|Lost to Follow-up|6|||
46962783|NCT02805257|83205353|FG000|Overall Study|Death|0|||
46962784|NCT02805257|83205354|FG001|Overall Study|Death|1|||
46962785|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
46962786|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
46962787|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
46962788|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
46962789|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
46962790|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
46962791|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
46962792|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
46962793|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
46962794|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
46962795|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
46962796|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
46845473|NCT00255008|83062348|FG003|Overall Study|Lost to Follow-up|2|||
46845474|NCT00255008|83062345|FG000|Overall Study|Did not meet viral reduction criteria|4|||
46845475|NCT00255008|83062346|FG001|Overall Study|Did not meet viral reduction criteria|5|||
46845476|NCT00255008|83062347|FG002|Overall Study|Did not meet viral reduction criteria|0|||
46845477|NCT00255008|83062348|FG003|Overall Study|Did not meet viral reduction criteria|1|||
46845478|NCT00255008|83062345|FG000|Overall Study|Withdrew consent|0|||
46845479|NCT00255008|83062346|FG001|Overall Study|Withdrew consent|0|||
46845480|NCT00255008|83062347|FG002|Overall Study|Withdrew consent|2|||
46962797|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
46640091|NCT00083226|82814100|FG000|Overall Study|Other|2|||
46845481|NCT00255008|83062348|FG003|Overall Study|Withdrew consent|0|||
46962798|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
46962799|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
46962800|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
46962801|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
46962802|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
46962803|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
46962804|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
46962805|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
46962806|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
46962807|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
46962808|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
46962809|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
46962810|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
46962811|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
46962812|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
46962813|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
46962814|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
46962815|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
46962816|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
46962817|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
46962818|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
46962819|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
46962820|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
46962821|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
46962822|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
46962823|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
46962824|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
46962825|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
46962826|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
46962827|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
46962828|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
46962829|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
46962830|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
46962831|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
46962832|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
46962833|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
46962834|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
46962835|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
46962836|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
46962837|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
46962838|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
46962839|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
46962840|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
46962841|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
46962842|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
46962843|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
46962844|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
46962845|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
46962846|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
46962847|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
46962848|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
46962849|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
46774291|NCT00441337|82992768|FG002|Overall Study|Lost to Follow-up|0|||
46774292|NCT00441337|82992769|FG003|Overall Study|Lost to Follow-up|1|||
46774293|NCT00441337|82992766|FG000|Overall Study|Sponsor Decision|0|||
46774294|NCT00441337|82992767|FG001|Overall Study|Sponsor Decision|0|||
46774295|NCT00441337|82992768|FG002|Overall Study|Sponsor Decision|1|||
46774296|NCT00441337|82992769|FG003|Overall Study|Sponsor Decision|2|||
46774297|NCT00441337|82992766|FG000|Overall Study|Did not meet inclusion criteria|0|||
46774298|NCT00441337|82992767|FG001|Overall Study|Did not meet inclusion criteria|0|||
46774299|NCT00441337|82992768|FG002|Overall Study|Did not meet inclusion criteria|1|||
46774300|NCT00441337|82992769|FG003|Overall Study|Did not meet inclusion criteria|0|||
46774301|NCT00578877|82992789|FG000|Overall Study|Lost to Follow-up|8|||
46774302|NCT00578877|82992790|FG001|Overall Study|Lost to Follow-up|10|||
46774303|NCT00578877|82992789|FG000|Overall Study|early discontinue|61|||
46774304|NCT00578877|82992790|FG001|Overall Study|early discontinue|101|||
46962850|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
46962851|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
46962852|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
46962853|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
46962854|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
46962855|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
46962856|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
46962857|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
46962858|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
46962859|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
46962860|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
46962861|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
46962862|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
46962863|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
46962864|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
46962865|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
46962866|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
46962867|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
46962868|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
46962869|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
46962870|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
46962871|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
46962872|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
46962873|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
46962874|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
46962875|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
46962876|NCT01791595|83205367|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
46962877|NCT01791595|83205368|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
46962878|NCT01791595|83205369|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
46962879|NCT01791595|83205370|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
46962880|NCT01791595|83205371|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
46962881|NCT01791595|83205372|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
47067261|NCT01549652|83350835|FG001|Overall Study|Withdrawal Effect|2|||
47067262|NCT01549652|83350836|FG002|Overall Study|Withdrawal Effect|0|||
47067263|NCT01549652|83350837|FG003|Overall Study|Withdrawal Effect|0|||
47067264|NCT01549652|83350834|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
46640092|NCT00083226|82814100|FG000|Overall Study|ineligible or not receiving treatment|4|||
46640093|NCT00082758|82814107|FG000|Overall Study|Adverse Event|0|||
46640094|NCT00082758|82814108|FG001|Overall Study|Adverse Event|2|||
46640095|NCT00082758|82814109|FG002|Overall Study|Adverse Event|0|||
46640096|NCT00082758|82814107|FG000|Overall Study|Lack of Efficacy|12|||
46774305|NCT00578877|82992789|FG000|Overall Study|did not provide follow-up data|12|||
46774306|NCT00578877|82992790|FG001|Overall Study|did not provide follow-up data|17|||
46774307|NCT00468481|82992798|FG000|Overall Study|Adverse Event|13|||
46774308|NCT00468481|82992799|FG001|Overall Study|Adverse Event|3|||
46774309|NCT00468481|82992798|FG000|Overall Study|Lost to Follow-up|25|||
46774310|NCT00468481|82992799|FG001|Overall Study|Lost to Follow-up|8|||
46774311|NCT00468481|82992798|FG000|Overall Study|Pregnancy|2|||
46774312|NCT00468481|82992799|FG001|Overall Study|Pregnancy|0|||
46774313|NCT00468481|82992798|FG000|Overall Study|Protocol Violation|18|||
46774314|NCT00468481|82992799|FG001|Overall Study|Protocol Violation|8|||
46774315|NCT00468481|82992798|FG000|Overall Study|Withdrawal by Subject|12|||
46774316|NCT00468481|82992799|FG001|Overall Study|Withdrawal by Subject|3|||
46774317|NCT00468481|82992798|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
46774318|NCT00468481|82992799|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
46774319|NCT00468481|82992798|FG000|Overall Study|Prohibited Medication|1|||
46774320|NCT00468481|82992799|FG001|Overall Study|Prohibited Medication|1|||
46774321|NCT00468481|82992798|FG000|Overall Study|Egg Donor|1|||
46774322|NCT00468481|82992799|FG001|Overall Study|Egg Donor|0|||
46774323|NCT00468481|82992798|FG000|Overall Study|Moved out of area|4|||
46774324|NCT00468481|82992799|FG001|Overall Study|Moved out of area|1|||
46774325|NCT00468481|82992798|FG000|Overall Study|Non-Compliance|5|||
47067265|NCT01549652|83350835|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
46774326|NCT00468481|82992799|FG001|Overall Study|Non-Compliance|0|||
47067266|NCT01549652|83350836|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
46774327|NCT00468481|82992798|FG000|Overall Study|Other|6|||
46774328|NCT00468481|82992799|FG001|Overall Study|Other|0|||
46774329|NCT00714168|82992807|FG000|Overall Study|Pregnancy|5|||
46774330|NCT00714168|82992808|FG001|Overall Study|Pregnancy|4|||
46774331|NCT00714168|82992807|FG000|Overall Study|Lost to Follow-up|32|||
46640097|NCT00082758|82814108|FG001|Overall Study|Lack of Efficacy|13|||
46640098|NCT00082758|82814109|FG002|Overall Study|Lack of Efficacy|0|||
46640099|NCT00082758|82814107|FG000|Overall Study|Physician Decision|0|||
46962882|NCT01791595|83205373|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
46962883|NCT01791595|83205367|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
46962884|NCT01791595|83205368|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
46962885|NCT01791595|83205369|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
46962886|NCT01791595|83205370|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
46962887|NCT01791595|83205371|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
46962888|NCT01791595|83205372|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
46962889|NCT01791595|83205373|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
46962890|NCT01791595|83205367|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
46962891|NCT01791595|83205368|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
46962892|NCT01791595|83205369|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
46962893|NCT01791595|83205370|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
46962894|NCT01791595|83205371|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
46962895|NCT01791595|83205372|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
46962896|NCT01791595|83205373|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
46962897|NCT01791595|83205367|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
46962898|NCT01791595|83205368|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
46962899|NCT01791595|83205369|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
46962900|NCT01791595|83205370|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
46962901|NCT01791595|83205371|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
46962902|NCT01791595|83205372|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
46962903|NCT01791595|83205373|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
46962904|NCT01791595|83205367|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
46962905|NCT01791595|83205368|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
46962906|NCT01791595|83205369|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
46962907|NCT01791595|83205370|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
46962908|NCT01791595|83205371|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
46640100|NCT00082758|82814108|FG001|Overall Study|Physician Decision|1|||
46640101|NCT00082758|82814109|FG002|Overall Study|Physician Decision|0|||
46640102|NCT00082758|82814107|FG000|Overall Study|Withdrawal by Subject|3|||
46962909|NCT01791595|83205372|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
46962910|NCT01791595|83205373|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
46962911|NCT01559363|83205426|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
46962912|NCT01559363|83205427|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
46962913|NCT01559363|83205428|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
46962914|NCT01559363|83205429|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
46962915|NCT01559363|83205430|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
46962916|NCT01559363|83205431|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
46962917|NCT01559363|83205426|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
46962918|NCT01559363|83205427|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
46962919|NCT01559363|83205428|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
46962920|NCT01559363|83205429|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
46962921|NCT01559363|83205430|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
46962922|NCT01559363|83205431|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
46962923|NCT01559363|83205426|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
46962924|NCT01559363|83205427|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
46962925|NCT01559363|83205428|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
46962926|NCT01559363|83205429|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
46962927|NCT01559363|83205430|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
46962928|NCT01559363|83205431|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
47067267|NCT01549652|83350837|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
47067268|NCT01549652|83350834|FG000|Overall Study|Problem with Infusion|1|||
47067269|NCT01549652|83350835|FG001|Overall Study|Problem with Infusion|0|||
47067270|NCT01549652|83350836|FG002|Overall Study|Problem with Infusion|0|||
47067271|NCT01549652|83350837|FG003|Overall Study|Problem with Infusion|0|||
47067272|NCT01549652|83350834|FG000|Overall Study|Titration Non-Compliance|1|||
47067273|NCT01549652|83350835|FG001|Overall Study|Titration Non-Compliance|3|||
47067274|NCT01549652|83350836|FG002|Overall Study|Titration Non-Compliance|4|||
47067275|NCT01549652|83350837|FG003|Overall Study|Titration Non-Compliance|5|||
47067276|NCT01549652|83350834|FG000|Overall Study|Titration Side Effects|0|||
47067277|NCT01549652|83350835|FG001|Overall Study|Titration Side Effects|0|||
47067278|NCT01549652|83350836|FG002|Overall Study|Titration Side Effects|6|||
47067279|NCT01549652|83350837|FG003|Overall Study|Titration Side Effects|3|||
47067280|NCT01549652|83350834|FG000|Overall Study|Withdrawal by Subject|0|||
46640103|NCT00082758|82814108|FG001|Overall Study|Withdrawal by Subject|0|||
46640104|NCT00082758|82814109|FG002|Overall Study|Withdrawal by Subject|0|||
46640105|NCT00082758|82814107|FG000|Overall Study|Protocol Violation|0|||
46962929|NCT01559363|83205426|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
46962930|NCT01559363|83205427|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
46962931|NCT01559363|83205428|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
46962932|NCT01559363|83205429|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
46962933|NCT01559363|83205430|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
46962934|NCT01559363|83205431|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
46962935|NCT01559363|83205426|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
46962936|NCT01559363|83205427|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
46962937|NCT01559363|83205428|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
46962938|NCT01559363|83205429|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
46962939|NCT01559363|83205430|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
46962940|NCT01559363|83205431|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
46962941|NCT01559363|83205426|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
46962942|NCT01559363|83205427|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
46962943|NCT01559363|83205428|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
46962944|NCT01559363|83205429|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
46962945|NCT01559363|83205430|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
46962946|NCT01559363|83205431|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
46962947|NCT01559363|83205426|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
46962948|NCT01559363|83205427|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
46962949|NCT01559363|83205428|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
46962950|NCT01559363|83205429|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
46962951|NCT01559363|83205430|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
46962952|NCT01559363|83205431|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
46962953|NCT02732327|83205453|FG000|Overall Study|Protocol Violation|0|||
46962954|NCT02732327|83205454|FG001|Overall Study|Protocol Violation|1|||
46962955|NCT02412722|83205466|FG000|Overall Study|Adverse Event|0|||
46962956|NCT02412722|83205467|FG001|Overall Study|Adverse Event|2|||
46962957|NCT02412722|83205468|FG002|Overall Study|Adverse Event|0|||
46962958|NCT02412722|83205469|FG003|Overall Study|Adverse Event|3|||
46962959|NCT02412722|83205470|FG004|Overall Study|Adverse Event|0|||
46962960|NCT02412722|83205471|FG005|Overall Study|Adverse Event|3|||
46962961|NCT02412722|83205466|FG000|Overall Study|Progressive Disease|6|||
46962962|NCT02412722|83205467|FG001|Overall Study|Progressive Disease|4|||
46962963|NCT02412722|83205468|FG002|Overall Study|Progressive Disease|4|||
46962964|NCT02412722|83205469|FG003|Overall Study|Progressive Disease|9|||
46962965|NCT02412722|83205470|FG004|Overall Study|Progressive Disease|3|||
46962966|NCT02412722|83205471|FG005|Overall Study|Progressive Disease|3|||
46962967|NCT02412722|83205466|FG000|Overall Study|Withdrawal by Subject|2|||
46962968|NCT02412722|83205467|FG001|Overall Study|Withdrawal by Subject|0|||
46962969|NCT02412722|83205468|FG002|Overall Study|Withdrawal by Subject|1|||
46962970|NCT02412722|83205469|FG003|Overall Study|Withdrawal by Subject|2|||
46962971|NCT02412722|83205470|FG004|Overall Study|Withdrawal by Subject|1|||
46962972|NCT02412722|83205471|FG005|Overall Study|Withdrawal by Subject|1|||
46962973|NCT02412722|83205466|FG000|Overall Study|Lost to Follow-up|0|||
46962974|NCT02412722|83205467|FG001|Overall Study|Lost to Follow-up|0|||
46962975|NCT02412722|83205468|FG002|Overall Study|Lost to Follow-up|0|||
46962976|NCT02412722|83205469|FG003|Overall Study|Lost to Follow-up|0|||
46962977|NCT02412722|83205470|FG004|Overall Study|Lost to Follow-up|1|||
46962978|NCT02412722|83205471|FG005|Overall Study|Lost to Follow-up|0|||
46962979|NCT02412722|83205466|FG000|Overall Study|Received drug in run-in and discontinued|0|||
46962980|NCT02412722|83205467|FG001|Overall Study|Received drug in run-in and discontinued|2|||
46962981|NCT02412722|83205468|FG002|Overall Study|Received drug in run-in and discontinued|0|||
46962982|NCT02412722|83205469|FG003|Overall Study|Received drug in run-in and discontinued|0|||
47067281|NCT01549652|83350835|FG001|Overall Study|Withdrawal by Subject|0|||
47067282|NCT01549652|83350836|FG002|Overall Study|Withdrawal by Subject|5|||
47067283|NCT01549652|83350837|FG003|Overall Study|Withdrawal by Subject|3|||
47067284|NCT01569464|83350845|FG000|Overall Study|Adverse Event|4|||
47067285|NCT01569464|83350846|FG001|Overall Study|Adverse Event|0|||
47067286|NCT01569464|83350845|FG000|Overall Study|Lack of Efficacy|1|||
47067287|NCT01569464|83350846|FG001|Overall Study|Lack of Efficacy|0|||
47067288|NCT01569464|83350845|FG000|Overall Study|Protocol Violation|1|||
46962983|NCT02412722|83205470|FG004|Overall Study|Received drug in run-in and discontinued|0|||
46962984|NCT02412722|83205471|FG005|Overall Study|Received drug in run-in and discontinued|0|||
46962985|NCT02412722|83205466|FG000|Overall Study|Reason not Specified|3|||
46962986|NCT02412722|83205467|FG001|Overall Study|Reason not Specified|0|||
46962987|NCT02412722|83205468|FG002|Overall Study|Reason not Specified|2|||
46962988|NCT02412722|83205469|FG003|Overall Study|Reason not Specified|1|||
46962989|NCT02412722|83205470|FG004|Overall Study|Reason not Specified|2|||
46962990|NCT02412722|83205471|FG005|Overall Study|Reason not Specified|6|||
46962991|NCT03074695|83205507|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
47067289|NCT01569464|83350846|FG001|Overall Study|Protocol Violation|0|||
46962992|NCT03074695|83205508|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
46962993|NCT03074695|83205507|FG000|Overall Study|Research staff not available|1|||
46962994|NCT03074695|83205508|FG001|Overall Study|Research staff not available|2|||
46962995|NCT03074695|83205507|FG000|Overall Study|Did not receive neuraxial block|2|||
46962996|NCT03074695|83205508|FG001|Overall Study|Did not receive neuraxial block|2|||
46962997|NCT03469999|83205514|FG000|Overall Study|Lost to Follow-up|2|||
46962998|NCT02379728|83205521|FG000|Overall Study|Lost to Follow-up|1|||
46962999|NCT02379728|83205522|FG001|Overall Study|Lost to Follow-up|0|||
46963000|NCT02379728|83205523|FG002|Overall Study|Lost to Follow-up|3|||
46963001|NCT02379728|83205524|FG003|Overall Study|Lost to Follow-up|0|||
46963002|NCT02379728|83205521|FG000|Overall Study|Withdrawal by Subject|5|||
46963003|NCT02379728|83205522|FG001|Overall Study|Withdrawal by Subject|0|||
46963004|NCT02379728|83205523|FG002|Overall Study|Withdrawal by Subject|5|||
46963005|NCT02379728|83205524|FG003|Overall Study|Withdrawal by Subject|3|||
46963006|NCT02379728|83205521|FG000|Overall Study|Protocol Violation|0|||
46963007|NCT02379728|83205522|FG001|Overall Study|Protocol Violation|0|||
46963008|NCT02379728|83205523|FG002|Overall Study|Protocol Violation|2|||
46963009|NCT02379728|83205524|FG003|Overall Study|Protocol Violation|0|||
46963010|NCT03463993|83205535|FG000|Overall Study|Lost to Follow-up|7|||
46963011|NCT03463993|83205536|FG001|Overall Study|Lost to Follow-up|8|||
46963012|NCT03463993|83205535|FG000|Overall Study|Withdrawal by Subject|2|||
46963013|NCT03463993|83205536|FG001|Overall Study|Withdrawal by Subject|0|||
46963014|NCT03463993|83205535|FG000|Overall Study|Protocol Violation|4|||
46963015|NCT03463993|83205536|FG001|Overall Study|Protocol Violation|1|||
46963016|NCT03463993|83205535|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
46963017|NCT03463993|83205536|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
46963018|NCT03463993|83205535|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
46963019|NCT03463993|83205536|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
46963020|NCT02412488|83205551|FG000|Overall Study|Lost to Follow-up|10|||
46963021|NCT02412488|83205551|FG000|Overall Study|Withdrawal by Subject|5|||
46963022|NCT02412488|83205551|FG000|Overall Study|Physician Decision|1|||
46963023|NCT02412488|83205551|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
46963024|NCT02412488|83205551|FG000|Overall Study|Reveal LINQ explant|1|||
46963025|NCT02378480|83205557|FG000|Overall Study|Physician Decision|1|||
46963026|NCT02378480|83205558|FG001|Overall Study|Physician Decision|1|||
46963027|NCT02378480|83205557|FG000|Overall Study|Death|1|||
46963028|NCT02378480|83205558|FG001|Overall Study|Death|2|||
46963029|NCT02378480|83205557|FG000|Overall Study|Randomized, but Not Treated|6|||
46963030|NCT02378480|83205558|FG001|Overall Study|Randomized, but Not Treated|4|||
46963031|NCT02378480|83205557|FG000|Overall Study|Adverse Event|0|||
46963032|NCT02378480|83205558|FG001|Overall Study|Adverse Event|1|||
46963033|NCT02378480|83205557|FG000|Overall Study|Missed EOT/PTE Visit|1|||
46963034|NCT02378480|83205558|FG001|Overall Study|Missed EOT/PTE Visit|2|||
46963035|NCT02378480|83205557|FG000|Overall Study|Withdrawal by Subject|9|||
46963036|NCT02378480|83205558|FG001|Overall Study|Withdrawal by Subject|4|||
46963037|NCT02378480|83205557|FG000|Overall Study|Lost to Follow-up|10|||
46963038|NCT02378480|83205558|FG001|Overall Study|Lost to Follow-up|18|||
46963039|NCT02411396|83205564|FG000|Overall Study|Lost to Follow-up|31|||
46963040|NCT02411396|83205564|FG000|Overall Study|Death|10|||
46963041|NCT02345252|83205585|FG000|Double-Blind Phase|Adverse Event|2|||
46963042|NCT02345252|83205586|FG001|Double-Blind Phase|Adverse Event|3|||
46963043|NCT02345252|83205585|FG000|Double-Blind Phase|Death|1|||
46963044|NCT02345252|83205586|FG001|Double-Blind Phase|Death|2|||
46963045|NCT02345252|83205585|FG000|Double-Blind Phase|Lack of Efficacy|1|||
46963046|NCT02345252|83205586|FG001|Double-Blind Phase|Lack of Efficacy|0|||
46963047|NCT02345252|83205585|FG000|Double-Blind Phase|Investigator's Discretion|4|||
46963048|NCT02345252|83205586|FG001|Double-Blind Phase|Investigator's Discretion|6|||
46963049|NCT02345252|83205585|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
46963050|NCT02345252|83205586|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
46963051|NCT02345252|83205585|FG000|Double-Blind Phase|Protocol Violation|2|||
46963052|NCT02345252|83205586|FG001|Double-Blind Phase|Protocol Violation|1|||
46963053|NCT02345252|83205585|FG000|Double-Blind Phase|Withdrew Consent|21|||
46963054|NCT02345252|83205586|FG001|Double-Blind Phase|Withdrew Consent|23|||
46963055|NCT02345252|83205585|FG000|Double-Blind Phase|Lost to Follow-up|8|||
46963056|NCT02345252|83205586|FG001|Double-Blind Phase|Lost to Follow-up|10|||
46963057|NCT02345252|83205585|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
46963058|NCT02345252|83205586|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
46963059|NCT01239797|83205596|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
46963060|NCT01239797|83205597|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
46963061|NCT01239797|83205596|FG000|Randomized Participants|Participant withdrew consent|1|||
46963062|NCT01239797|83205597|FG001|Randomized Participants|Participant withdrew consent|7|||
46963063|NCT01239797|83205596|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
46963064|NCT01239797|83205597|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
46963065|NCT01239797|83205596|FG000|Treated Participants|Disease progression|185|||
46963066|NCT01239797|83205597|FG001|Treated Participants|Disease progression|185|||
46963067|NCT01239797|83205596|FG000|Treated Participants|Study drug toxicity|39|||
46963068|NCT01239797|83205597|FG001|Treated Participants|Study drug toxicity|45|||
46963069|NCT01239797|83205596|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
46963070|NCT01239797|83205597|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
46963071|NCT01239797|83205596|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
46963072|NCT01239797|83205597|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
46963073|NCT01239797|83205596|FG000|Treated Participants|Administrative reason by sponsor|13|||
46963074|NCT01239797|83205597|FG001|Treated Participants|Administrative reason by sponsor|4|||
46963075|NCT01239797|83205596|FG000|Treated Participants|Other reasons|14|||
46963076|NCT01239797|83205597|FG001|Treated Participants|Other reasons|14|||
46963077|NCT01239797|83205596|FG000|Treated Participants|Participant withdrew consent|6|||
46963078|NCT01239797|83205597|FG001|Treated Participants|Participant withdrew consent|11|||
46963079|NCT01239797|83205596|FG000|Treated Participants|Death|1|||
46963080|NCT01239797|83205597|FG001|Treated Participants|Death|1|||
46963081|NCT01239797|83205596|FG000|Treated Participants|Participant no longer meets study criteria|1|||
46963082|NCT01239797|83205597|FG001|Treated Participants|Participant no longer meets study criteria|1|||
46963083|NCT01239797|83205596|FG000|Treated Participants|Poor/non-compliance|0|||
46963084|NCT01239797|83205597|FG001|Treated Participants|Poor/non-compliance|1|||
46963085|NCT01092143|83205608|FG000|Overall Study|Adverse Event|10|||
46963086|NCT01092143|83205609|FG001|Overall Study|Adverse Event|5|||
46963087|NCT01092143|83205610|FG002|Overall Study|Adverse Event|1|||
46963088|NCT01092143|83205611|FG003|Overall Study|Adverse Event|4|||
46963089|NCT01092143|83205612|FG004|Overall Study|Adverse Event|3|||
46774332|NCT00714168|82992808|FG001|Overall Study|Lost to Follow-up|50|||
46774333|NCT00714168|82992807|FG000|Overall Study|Relocation|4|||
46963090|NCT01092143|83205608|FG000|Overall Study|Lost to Follow-up|1|||
46963091|NCT01092143|83205609|FG001|Overall Study|Lost to Follow-up|0|||
46963092|NCT01092143|83205610|FG002|Overall Study|Lost to Follow-up|1|||
46963093|NCT01092143|83205611|FG003|Overall Study|Lost to Follow-up|0|||
46963094|NCT01092143|83205612|FG004|Overall Study|Lost to Follow-up|0|||
46963095|NCT01092143|83205608|FG000|Overall Study|Consent withdrawn|2|||
46963096|NCT01092143|83205609|FG001|Overall Study|Consent withdrawn|1|||
46963097|NCT01092143|83205610|FG002|Overall Study|Consent withdrawn|0|||
46963098|NCT01092143|83205611|FG003|Overall Study|Consent withdrawn|1|||
46963099|NCT01092143|83205612|FG004|Overall Study|Consent withdrawn|3|||
46963100|NCT01092143|83205608|FG000|Overall Study|Not treated|0|||
46963101|NCT01092143|83205609|FG001|Overall Study|Not treated|0|||
46963102|NCT01092143|83205610|FG002|Overall Study|Not treated|1|||
46963103|NCT01092143|83205611|FG003|Overall Study|Not treated|0|||
46963104|NCT01092143|83205612|FG004|Overall Study|Not treated|0|||
46963105|NCT01092143|83205608|FG000|Overall Study|did not reversibility criteria|0|||
46963106|NCT01092143|83205609|FG001|Overall Study|did not reversibility criteria|0|||
46963107|NCT01092143|83205610|FG002|Overall Study|did not reversibility criteria|1|||
46963108|NCT01092143|83205611|FG003|Overall Study|did not reversibility criteria|0|||
46963109|NCT01092143|83205612|FG004|Overall Study|did not reversibility criteria|0|||
46963110|NCT01092143|83205608|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
46963111|NCT01092143|83205609|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
46963112|NCT01092143|83205610|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
46963113|NCT01092143|83205611|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
46963114|NCT01092143|83205612|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
46963115|NCT01092143|83205608|FG000|Overall Study|Ineligible patient|1|||
46963116|NCT01092143|83205609|FG001|Overall Study|Ineligible patient|0|||
46963117|NCT01092143|83205610|FG002|Overall Study|Ineligible patient|0|||
46963118|NCT01092143|83205611|FG003|Overall Study|Ineligible patient|0|||
46963119|NCT01092143|83205612|FG004|Overall Study|Ineligible patient|0|||
46963120|NCT01092143|83205608|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
46963121|NCT01092143|83205609|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
46963122|NCT01092143|83205610|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
46963123|NCT01092143|83205611|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
46963124|NCT01092143|83205612|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
46963125|NCT01092143|83205608|FG000|Overall Study|Patient travel|0|||
46963126|NCT01092143|83205609|FG001|Overall Study|Patient travel|0|||
46963127|NCT01092143|83205610|FG002|Overall Study|Patient travel|0|||
46963128|NCT01092143|83205611|FG003|Overall Study|Patient travel|0|||
46963129|NCT01092143|83205612|FG004|Overall Study|Patient travel|1|||
46963130|NCT01092143|83205608|FG000|Overall Study|Non compliance with study medication|0|||
46963131|NCT01092143|83205609|FG001|Overall Study|Non compliance with study medication|0|||
46963132|NCT01092143|83205610|FG002|Overall Study|Non compliance with study medication|0|||
46963133|NCT01092143|83205611|FG003|Overall Study|Non compliance with study medication|0|||
46963134|NCT01092143|83205612|FG004|Overall Study|Non compliance with study medication|1|||
46963135|NCT01092143|83205608|FG000|Overall Study|Randomized by mistake|0|||
46963136|NCT01092143|83205609|FG001|Overall Study|Randomized by mistake|0|||
46963137|NCT01092143|83205610|FG002|Overall Study|Randomized by mistake|0|||
46774334|NCT00714168|82992808|FG001|Overall Study|Relocation|3|||
46963138|NCT01092143|83205611|FG003|Overall Study|Randomized by mistake|1|||
46963139|NCT01092143|83205612|FG004|Overall Study|Randomized by mistake|0|||
46963140|NCT01092143|83205608|FG000|Overall Study|Pregnancy|0|||
46963141|NCT01092143|83205609|FG001|Overall Study|Pregnancy|0|||
46963142|NCT01092143|83205610|FG002|Overall Study|Pregnancy|0|||
46963143|NCT01092143|83205611|FG003|Overall Study|Pregnancy|1|||
46963144|NCT01092143|83205612|FG004|Overall Study|Pregnancy|0|||
46963145|NCT02377466|83205626|FG000|Overall Study|Other: Randomized and not treated|0|||
46963146|NCT02377466|83205627|FG001|Overall Study|Other: Randomized and not treated|2|||
46963147|NCT00950989|83205644|FG000|Overall Study|Death|0|||
46963148|NCT00950989|83205645|FG001|Overall Study|Death|0|||
46963149|NCT00950989|83205646|FG002|Overall Study|Death|1|||
46963150|NCT00950989|83205647|FG003|Overall Study|Death|0|||
46963151|NCT00950989|83205644|FG000|Overall Study|Administrative Decision|0|||
46963152|NCT00950989|83205645|FG001|Overall Study|Administrative Decision|1|||
46963153|NCT00950989|83205646|FG002|Overall Study|Administrative Decision|0|||
46963154|NCT00950989|83205647|FG003|Overall Study|Administrative Decision|0|||
46963155|NCT00950989|83205644|FG000|Overall Study|Disease Progression|0|||
46963156|NCT00950989|83205645|FG001|Overall Study|Disease Progression|0|||
46963157|NCT00950989|83205646|FG002|Overall Study|Disease Progression|1|||
46963158|NCT00950989|83205647|FG003|Overall Study|Disease Progression|0|||
46963159|NCT00950989|83205644|FG000|Overall Study|Withdrawal by Subject|2|||
46963160|NCT00950989|83205645|FG001|Overall Study|Withdrawal by Subject|1|||
46963161|NCT00950989|83205646|FG002|Overall Study|Withdrawal by Subject|0|||
46963162|NCT00950989|83205647|FG003|Overall Study|Withdrawal by Subject|0|||
46963163|NCT00950989|83205644|FG000|Overall Study|Adverse Event|2|||
46963164|NCT00950989|83205645|FG001|Overall Study|Adverse Event|1|||
46963165|NCT00950989|83205646|FG002|Overall Study|Adverse Event|1|||
46963166|NCT00950989|83205647|FG003|Overall Study|Adverse Event|0|||
46963167|NCT00593567|83205662|FG000|Overall Study|Adverse Event|2|||
46963168|NCT00593567|83205663|FG001|Overall Study|Adverse Event|0|||
46963169|NCT00593567|83205662|FG000|Overall Study|Physician Decision|2|||
46963170|NCT00593567|83205663|FG001|Overall Study|Physician Decision|0|||
46963171|NCT00593567|83205662|FG000|Overall Study|Protocol Violation|13|||
46963172|NCT00593567|83205663|FG001|Overall Study|Protocol Violation|7|||
46963173|NCT00593567|83205662|FG000|Overall Study|Lack of Efficacy|2|||
46963174|NCT00593567|83205663|FG001|Overall Study|Lack of Efficacy|1|||
46963175|NCT00593567|83205662|FG000|Overall Study|Withdrawal by Subject|1|||
46963176|NCT00593567|83205663|FG001|Overall Study|Withdrawal by Subject|2|||
46963177|NCT02411084|83205671|FG000|Overall Study|Lack of Efficacy|6|||
46963178|NCT02411084|83205672|FG001|Overall Study|Lack of Efficacy|3|||
46963179|NCT02411084|83205671|FG000|Overall Study|Death|5|||
46963180|NCT02411084|83205672|FG001|Overall Study|Death|4|||
46963181|NCT02411084|83205671|FG000|Overall Study|Adverse Event|2|||
46963182|NCT02411084|83205672|FG001|Overall Study|Adverse Event|1|||
46963183|NCT02411084|83205671|FG000|Overall Study|Other reasons|0|||
46963184|NCT02411084|83205672|FG001|Overall Study|Other reasons|5|||
46963185|NCT01602315|83205685|FG000|Overall Study|Protocol Violation|0|||
46963186|NCT01602315|83205686|FG001|Overall Study|Protocol Violation|0|||
46963187|NCT01602315|83205687|FG002|Overall Study|Protocol Violation|0|||
46963188|NCT01602315|83205688|FG003|Overall Study|Protocol Violation|0|||
46963189|NCT01602315|83205689|FG004|Overall Study|Protocol Violation|0|||
46963190|NCT01602315|83205690|FG005|Overall Study|Protocol Violation|1|||
46963191|NCT01602315|83205691|FG006|Overall Study|Protocol Violation|0|||
46963192|NCT01602315|83205685|FG000|Overall Study|Physician Decision|2|||
46963193|NCT01602315|83205686|FG001|Overall Study|Physician Decision|0|||
46963194|NCT01602315|83205687|FG002|Overall Study|Physician Decision|0|||
46963195|NCT01602315|83205688|FG003|Overall Study|Physician Decision|0|||
46963196|NCT01602315|83205689|FG004|Overall Study|Physician Decision|2|||
46963197|NCT01602315|83205690|FG005|Overall Study|Physician Decision|1|||
46774335|NCT00714168|82992807|FG000|Overall Study|Non-study medical condition|3|||
46963198|NCT01602315|83205691|FG006|Overall Study|Physician Decision|1|||
46963199|NCT01602315|83205685|FG000|Overall Study|Disease progression|6|||
46963200|NCT01602315|83205686|FG001|Overall Study|Disease progression|3|||
46963201|NCT01602315|83205687|FG002|Overall Study|Disease progression|10|||
46963202|NCT01602315|83205688|FG003|Overall Study|Disease progression|1|||
46963203|NCT01602315|83205689|FG004|Overall Study|Disease progression|41|||
46963204|NCT01602315|83205690|FG005|Overall Study|Disease progression|12|||
46963205|NCT01602315|83205691|FG006|Overall Study|Disease progression|15|||
46963206|NCT01602315|83205685|FG000|Overall Study|Death|1|||
46963207|NCT01602315|83205686|FG001|Overall Study|Death|1|||
46963208|NCT01602315|83205687|FG002|Overall Study|Death|1|||
46963209|NCT01602315|83205688|FG003|Overall Study|Death|1|||
46963210|NCT01602315|83205689|FG004|Overall Study|Death|7|||
46963211|NCT01602315|83205690|FG005|Overall Study|Death|2|||
46963212|NCT01602315|83205691|FG006|Overall Study|Death|2|||
46845482|NCT00255008|83062345|FG000|Overall Study|Sponsor request|18|||
46963213|NCT01602315|83205685|FG000|Overall Study|Withdrawal by Subject|2|||
46963214|NCT01602315|83205686|FG001|Overall Study|Withdrawal by Subject|0|||
46963215|NCT01602315|83205687|FG002|Overall Study|Withdrawal by Subject|2|||
46963216|NCT01602315|83205688|FG003|Overall Study|Withdrawal by Subject|0|||
46963217|NCT01602315|83205689|FG004|Overall Study|Withdrawal by Subject|6|||
46774336|NCT00714168|82992808|FG001|Overall Study|Non-study medical condition|2|||
46774337|NCT00713700|82992814|FG000|Overall Study|Lost to Follow-up|3|||
46845483|NCT00255008|83062346|FG001|Overall Study|Sponsor request|3|||
46845484|NCT00255008|83062347|FG002|Overall Study|Sponsor request|8|||
46845485|NCT00255008|83062348|FG003|Overall Study|Sponsor request|17|||
46845486|NCT00255008|83062345|FG000|Overall Study|Adverse lab experience|1|||
46845487|NCT00255008|83062346|FG001|Overall Study|Adverse lab experience|0|||
46845488|NCT00255008|83062347|FG002|Overall Study|Adverse lab experience|0|||
46845489|NCT00255008|83062348|FG003|Overall Study|Adverse lab experience|0|||
46845490|NCT00255008|83062345|FG000|Overall Study|Other|7|||
46845491|NCT00255008|83062346|FG001|Overall Study|Other|0|||
46845492|NCT00255008|83062347|FG002|Overall Study|Other|3|||
46774338|NCT00713700|82992814|FG000|Overall Study|Withdrawal by Subject|1|||
46774339|NCT00468169|82992820|FG000|Overall Study|Withdrawal by Subject|1|||
46774340|NCT00468169|82992821|FG001|Overall Study|Withdrawal by Subject|0|||
46774341|NCT00435487|82992831|FG000|Overall Study|Death|3|||
46774342|NCT00435487|82992832|FG001|Overall Study|Death|4|||
46774343|NCT00435487|82992831|FG000|Overall Study|Adverse Event|0|||
46774344|NCT00435487|82992832|FG001|Overall Study|Adverse Event|3|||
46774345|NCT00435487|82992831|FG000|Overall Study|Lost to Follow-up|2|||
46774346|NCT00435487|82992832|FG001|Overall Study|Lost to Follow-up|2|||
46845493|NCT00255008|83062348|FG003|Overall Study|Other|2|||
46845494|NCT03714022|83062360|FG000|Overall Study|Adverse Event|1|||
46845495|NCT03714022|83062361|FG001|Overall Study|Adverse Event|0|||
46845496|NCT03714022|83062360|FG000|Overall Study|Consent withdrawal|0|||
46774347|NCT00435487|82992831|FG000|Overall Study|Other|5|||
46845497|NCT03714022|83062361|FG001|Overall Study|Consent withdrawal|1|||
46845498|NCT03714022|83062360|FG000|Overall Study|Lost to Follow-up|3|||
46774348|NCT00435487|82992832|FG001|Overall Study|Other|2|||
46774349|NCT00435487|82992831|FG000|Overall Study|Withdrawal by Subject|2|||
46774350|NCT00435487|82992832|FG001|Overall Study|Withdrawal by Subject|1|||
46774351|NCT00435487|82992831|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
46774352|NCT00435487|82992832|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
46774353|NCT00435487|82992831|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
46774354|NCT00435487|82992832|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
46774355|NCT00579345|82992846|FG000|Overall Study|Withdrawal by Subject|2|||
46845499|NCT03714022|83062361|FG001|Overall Study|Lost to Follow-up|2|||
46845500|NCT00143312|83062367|FG000|Overall Study|Death|11|||
46845501|NCT00143312|83062367|FG000|Overall Study|Adverse Event|2|||
46845502|NCT00143312|83062367|FG000|Overall Study|Lost to Follow-up|1|||
46845503|NCT00143312|83062367|FG000|Overall Study|Other|1|||
46845504|NCT00143312|83062367|FG000|Overall Study|Withdrawal by Subject|1|||
46845505|NCT00254540|83062373|FG000|Overall Study|Adverse Event|6|||
46845506|NCT00254540|83062374|FG001|Overall Study|Adverse Event|7|||
46845507|NCT00254540|83062373|FG000|Overall Study|Lack of Efficacy|13|||
46845508|NCT00254540|83062374|FG001|Overall Study|Lack of Efficacy|13|||
46845509|NCT00254540|83062373|FG000|Overall Study|Death|0|||
46774356|NCT00579345|82992847|FG001|Overall Study|Withdrawal by Subject|0|||
46774357|NCT00579345|82992848|FG002|Overall Study|Withdrawal by Subject|0|||
46845510|NCT00254540|83062374|FG001|Overall Study|Death|1|||
46845511|NCT00254540|83062373|FG000|Overall Study|Laboratory Test Abnormality|0|||
46845512|NCT00254540|83062374|FG001|Overall Study|Laboratory Test Abnormality|1|||
46845513|NCT00139776|83062400|FG000|Period I|Did not enter Period II|575|||
46845514|NCT00139776|83062401|FG001|Period I|Did not enter Period II|0|||
46845515|NCT00139776|83062402|FG002|Period I|Did not enter Period II|0|||
46845516|NCT00139776|83062403|FG003|Period I|Did not enter Period II|0|||
46963218|NCT01602315|83205690|FG005|Overall Study|Withdrawal by Subject|0|||
46963219|NCT01602315|83205691|FG006|Overall Study|Withdrawal by Subject|1|||
46963220|NCT01602315|83205685|FG000|Overall Study|Adverse Event|5|||
46963221|NCT01602315|83205686|FG001|Overall Study|Adverse Event|1|||
46845517|NCT00139776|83062400|FG000|Period II|Not Randomized into Period III|0|||
46845518|NCT00139776|83062401|FG001|Period II|Not Randomized into Period III|322|||
46845519|NCT00139776|83062402|FG002|Period II|Not Randomized into Period III|0|||
46963222|NCT01602315|83205687|FG002|Overall Study|Adverse Event|5|||
46845520|NCT00139776|83062403|FG003|Period II|Not Randomized into Period III|0|||
46845521|NCT00139776|83062400|FG000|Period III|Adverse Event|0|||
46845522|NCT00139776|83062401|FG001|Period III|Adverse Event|0|||
46845523|NCT00139776|83062402|FG002|Period III|Adverse Event|22|||
46845524|NCT00139776|83062403|FG003|Period III|Adverse Event|23|||
46845525|NCT00139776|83062400|FG000|Period III|Other|0|||
47067290|NCT01569464|83350845|FG000|Overall Study|Lost to Follow-up|2|||
46774358|NCT00579345|82992849|FG003|Overall Study|Withdrawal by Subject|0|||
46774359|NCT00579345|82992850|FG004|Overall Study|Withdrawal by Subject|0|||
46774360|NCT00579345|82992851|FG005|Overall Study|Withdrawal by Subject|0|||
46845526|NCT00139776|83062401|FG001|Period III|Other|0|||
46963223|NCT01602315|83205688|FG003|Overall Study|Adverse Event|4|||
46845527|NCT00139776|83062402|FG002|Period III|Other|23|||
46845528|NCT00139776|83062403|FG003|Period III|Other|34|||
46963224|NCT01602315|83205689|FG004|Overall Study|Adverse Event|15|||
46963225|NCT01602315|83205690|FG005|Overall Study|Adverse Event|3|||
46963226|NCT01602315|83205691|FG006|Overall Study|Adverse Event|9|||
46963227|NCT01602315|83205685|FG000|Overall Study|Subject/guardian decision|0|||
46963228|NCT01602315|83205686|FG001|Overall Study|Subject/guardian decision|0|||
46963229|NCT01602315|83205687|FG002|Overall Study|Subject/guardian decision|0|||
46963230|NCT01602315|83205688|FG003|Overall Study|Subject/guardian decision|0|||
46963231|NCT01602315|83205689|FG004|Overall Study|Subject/guardian decision|0|||
46963232|NCT01602315|83205690|FG005|Overall Study|Subject/guardian decision|0|||
46963233|NCT01602315|83205691|FG006|Overall Study|Subject/guardian decision|1|||
46963234|NCT01602315|83205685|FG000|Overall Study|Cross-over patients to combo treatment|0|||
46963235|NCT01602315|83205686|FG001|Overall Study|Cross-over patients to combo treatment|0|||
46963236|NCT01602315|83205687|FG002|Overall Study|Cross-over patients to combo treatment|0|||
46963237|NCT01602315|83205688|FG003|Overall Study|Cross-over patients to combo treatment|0|||
46963238|NCT01602315|83205689|FG004|Overall Study|Cross-over patients to combo treatment|0|||
46963239|NCT01602315|83205690|FG005|Overall Study|Cross-over patients to combo treatment|16|||
46963240|NCT01602315|83205691|FG006|Overall Study|Cross-over patients to combo treatment|0|||
46963241|NCT02344004|83205738|FG000|Overall Study|Adverse Event|11|||
46963242|NCT02344004|83205739|FG001|Overall Study|Adverse Event|1|||
46963243|NCT02344004|83205738|FG000|Overall Study|Death|9|||
46963244|NCT02344004|83205739|FG001|Overall Study|Death|7|||
46963245|NCT02344004|83205738|FG000|Overall Study|Physician Decision|4|||
46963246|NCT02344004|83205739|FG001|Overall Study|Physician Decision|1|||
46963247|NCT02344004|83205738|FG000|Overall Study|Withdrawal by Subject|22|||
46963248|NCT02344004|83205739|FG001|Overall Study|Withdrawal by Subject|5|||
46963249|NCT02344004|83205738|FG000|Overall Study|Rescue Medication|2|||
46963250|NCT02344004|83205739|FG001|Overall Study|Rescue Medication|0|||
46963251|NCT02344004|83205738|FG000|Overall Study|Other Not Specified|12|||
46963252|NCT02344004|83205739|FG001|Overall Study|Other Not Specified|0|||
46963253|NCT02344004|83205738|FG000|Overall Study|Protocol Violation|1|||
46963254|NCT02344004|83205739|FG001|Overall Study|Protocol Violation|0|||
46963255|NCT01328093|83205748|FG000|Double-Blind Phase|Adverse Event|78|||
46963256|NCT01328093|83205749|FG001|Double-Blind Phase|Adverse Event|15|||
46963257|NCT01328093|83205748|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
46963258|NCT01328093|83205749|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
46963259|NCT01328093|83205748|FG000|Double-Blind Phase|Lost to Follow-up|39|||
46963260|NCT01328093|83205749|FG001|Double-Blind Phase|Lost to Follow-up|14|||
46963261|NCT01328093|83205748|FG000|Double-Blind Phase|Protocol Violation|30|||
46963262|NCT01328093|83205749|FG001|Double-Blind Phase|Protocol Violation|10|||
46963263|NCT01328093|83205748|FG000|Double-Blind Phase|Lack of Efficacy|55|||
46963264|NCT01328093|83205749|FG001|Double-Blind Phase|Lack of Efficacy|13|||
46963265|NCT01328093|83205748|FG000|Double-Blind Phase|Sponsor Decision|17|||
46963266|NCT01328093|83205749|FG001|Double-Blind Phase|Sponsor Decision|3|||
46963267|NCT01328093|83205748|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
46963268|NCT01328093|83205749|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
46963269|NCT01328093|83205748|FG000|Double-Blind Phase|Scheduling conflict|8|||
46963270|NCT01328093|83205749|FG001|Double-Blind Phase|Scheduling conflict|3|||
46963271|NCT01328093|83205748|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
46963272|NCT01328093|83205749|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
46963273|NCT01328093|83205748|FG000|Double-Blind Phase|Death|1|||
46963274|NCT01328093|83205749|FG001|Double-Blind Phase|Death|0|||
46963275|NCT01328093|83205748|FG000|Open-Label Phase|Sponsor Decision|98|||
47067291|NCT01569464|83350846|FG001|Overall Study|Lost to Follow-up|3|||
46845529|NCT00139776|83062400|FG000|Period III|Lack of Efficacy|0|||
46963276|NCT01328093|83205749|FG001|Open-Label Phase|Sponsor Decision|34|||
46963277|NCT01328093|83205748|FG000|Open-Label Phase|Protocol Violation|8|||
46963278|NCT01328093|83205749|FG001|Open-Label Phase|Protocol Violation|3|||
46963279|NCT01328093|83205748|FG000|Open-Label Phase|Lost to Follow-up|10|||
46963280|NCT01328093|83205749|FG001|Open-Label Phase|Lost to Follow-up|1|||
46963281|NCT01328093|83205748|FG000|Open-Label Phase|Adverse Event|10|||
46963282|NCT01328093|83205749|FG001|Open-Label Phase|Adverse Event|4|||
46963283|NCT01328093|83205748|FG000|Open-Label Phase|Lack of Efficacy|5|||
46963284|NCT01328093|83205749|FG001|Open-Label Phase|Lack of Efficacy|6|||
46963285|NCT01328093|83205748|FG000|Open-Label Phase|Withdrawal by Subject|4|||
46963286|NCT01328093|83205749|FG001|Open-Label Phase|Withdrawal by Subject|1|||
46963287|NCT01328093|83205748|FG000|Open-Label Phase|Scheduling conflict|2|||
46963288|NCT01328093|83205749|FG001|Open-Label Phase|Scheduling conflict|1|||
46963289|NCT01328093|83205748|FG000|Open-Label Phase|Subject is moving or has moved|2|||
46963290|NCT01328093|83205749|FG001|Open-Label Phase|Subject is moving or has moved|0|||
46963291|NCT01328093|83205748|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
46963292|NCT01328093|83205749|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
46963293|NCT02654145|83205756|FG000|Overall Study|Lack of Efficacy|1|||
46963294|NCT02654145|83205756|FG000|Overall Study|Protocol Violation|1|||
46963295|NCT02654145|83205756|FG000|Overall Study|Withdrawal by Subject|5|||
46963296|NCT01111565|83205760|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
46963297|NCT01111565|83205761|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
46963298|NCT01111565|83205762|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
46963299|NCT01111565|83205763|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
46963300|NCT01111565|83205764|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
46963301|NCT01111565|83205760|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
46963302|NCT01111565|83205761|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
46963303|NCT01111565|83205762|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
46963304|NCT01111565|83205763|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
46963305|NCT01111565|83205764|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
46963306|NCT01111565|83205760|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
46963307|NCT01111565|83205761|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
46963308|NCT01111565|83205762|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
46963309|NCT01111565|83205763|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
46963310|NCT01111565|83205764|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
46963311|NCT01111565|83205760|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
46963312|NCT01111565|83205761|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
46963313|NCT01111565|83205762|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
46963314|NCT01111565|83205763|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
46963315|NCT01111565|83205764|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
46963316|NCT01111565|83205760|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
46963317|NCT01111565|83205761|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
46963318|NCT01111565|83205762|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
46963319|NCT01111565|83205763|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
46963320|NCT01111565|83205764|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
46963321|NCT01111565|83205760|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
46963322|NCT01111565|83205761|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
46963323|NCT01111565|83205762|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
46963324|NCT01111565|83205763|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
46963325|NCT01111565|83205764|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
46963326|NCT01111565|83205760|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
46963327|NCT01111565|83205761|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
46963328|NCT01111565|83205762|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
46963329|NCT01111565|83205763|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
46963330|NCT01111565|83205764|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
46963331|NCT01111565|83205760|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
46963332|NCT01111565|83205761|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
46963333|NCT01111565|83205762|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
46963334|NCT01111565|83205763|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
46963335|NCT01111565|83205764|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
46963336|NCT01111565|83205760|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46963337|NCT01111565|83205761|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46963338|NCT01111565|83205762|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
46963339|NCT01111565|83205763|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46963340|NCT01111565|83205764|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46774361|NCT00579345|82992852|FG006|Overall Study|Withdrawal by Subject|0|||
46774362|NCT00579345|82992853|FG007|Overall Study|Withdrawal by Subject|1|||
46774363|NCT00579345|82992846|FG000|Overall Study|Lost to Follow-up|1|||
46774364|NCT00579345|82992847|FG001|Overall Study|Lost to Follow-up|0|||
46774365|NCT00579345|82992848|FG002|Overall Study|Lost to Follow-up|0|||
46774366|NCT00579345|82992849|FG003|Overall Study|Lost to Follow-up|0|||
46774367|NCT00579345|82992850|FG004|Overall Study|Lost to Follow-up|0|||
46774368|NCT00579345|82992851|FG005|Overall Study|Lost to Follow-up|0|||
46774369|NCT00579345|82992852|FG006|Overall Study|Lost to Follow-up|0|||
46774370|NCT00579345|82992853|FG007|Overall Study|Lost to Follow-up|0|||
46774371|NCT00579345|82992846|FG000|Overall Study|Adverse Event|0|||
46963341|NCT01111565|83205760|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
46963342|NCT01111565|83205761|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
46963343|NCT01111565|83205762|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
46963344|NCT01111565|83205763|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
46963345|NCT01111565|83205764|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
46963346|NCT01111565|83205760|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
46774372|NCT00579345|82992847|FG001|Overall Study|Adverse Event|0|||
46774373|NCT00579345|82992848|FG002|Overall Study|Adverse Event|1|||
46774374|NCT00579345|82992849|FG003|Overall Study|Adverse Event|0|||
46774375|NCT00579345|82992850|FG004|Overall Study|Adverse Event|0|||
46963347|NCT01111565|83205761|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
46963348|NCT01111565|83205762|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
46963349|NCT01111565|83205763|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
46963350|NCT01111565|83205764|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
46963351|NCT01111565|83205760|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
46963352|NCT01111565|83205761|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
46963353|NCT01111565|83205762|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
46963354|NCT01111565|83205763|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
46963355|NCT01111565|83205764|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
46963356|NCT02343458|83205778|FG000|Overall Study|Adverse Event|15|||
46963357|NCT02343458|83205779|FG001|Overall Study|Adverse Event|14|||
46963358|NCT02343458|83205780|FG002|Overall Study|Adverse Event|15|||
46963359|NCT02343458|83205781|FG003|Overall Study|Adverse Event|3|||
46963360|NCT02343458|83205778|FG000|Overall Study|Lack of Efficacy|3|||
46963361|NCT02343458|83205779|FG001|Overall Study|Lack of Efficacy|8|||
46963362|NCT02343458|83205780|FG002|Overall Study|Lack of Efficacy|4|||
46963363|NCT02343458|83205781|FG003|Overall Study|Lack of Efficacy|8|||
46963364|NCT02343458|83205778|FG000|Overall Study|Withdrawal by Subject|18|||
46963365|NCT02343458|83205779|FG001|Overall Study|Withdrawal by Subject|17|||
46963366|NCT02343458|83205780|FG002|Overall Study|Withdrawal by Subject|23|||
46963367|NCT02343458|83205781|FG003|Overall Study|Withdrawal by Subject|14|||
46963368|NCT02343458|83205778|FG000|Overall Study|Physician Decision|1|||
46963369|NCT02343458|83205779|FG001|Overall Study|Physician Decision|4|||
46963370|NCT02343458|83205780|FG002|Overall Study|Physician Decision|2|||
46963371|NCT02343458|83205781|FG003|Overall Study|Physician Decision|2|||
46963372|NCT02343458|83205778|FG000|Overall Study|Lost to Follow-up|5|||
46963373|NCT02343458|83205779|FG001|Overall Study|Lost to Follow-up|5|||
46963374|NCT02343458|83205780|FG002|Overall Study|Lost to Follow-up|3|||
46963375|NCT02343458|83205781|FG003|Overall Study|Lost to Follow-up|1|||
46963376|NCT02343458|83205778|FG000|Overall Study|Protocol Violation|2|||
46963377|NCT02343458|83205779|FG001|Overall Study|Protocol Violation|5|||
46963378|NCT02343458|83205780|FG002|Overall Study|Protocol Violation|2|||
46963379|NCT02343458|83205781|FG003|Overall Study|Protocol Violation|2|||
46963380|NCT02343458|83205778|FG000|Overall Study|Protocol Specified Criteria|17|||
46963381|NCT02343458|83205779|FG001|Overall Study|Protocol Specified Criteria|13|||
46963382|NCT02343458|83205780|FG002|Overall Study|Protocol Specified Criteria|14|||
46963383|NCT02343458|83205781|FG003|Overall Study|Protocol Specified Criteria|8|||
46963384|NCT01328041|83205804|FG000|Overall Study|Adverse Event|7|||
46963385|NCT01328041|83205804|FG000|Overall Study|Lack of Efficacy|27|||
46963386|NCT01328041|83205804|FG000|Overall Study|Protocol Violation|7|||
46963387|NCT01328041|83205804|FG000|Overall Study|Lost to Follow-up|7|||
46963388|NCT01328041|83205804|FG000|Overall Study|Physician Decision|2|||
46963389|NCT01328041|83205804|FG000|Overall Study|Withdrawal by Subject|7|||
46963390|NCT02410772|83205811|FG000|Overall Study|Death|3|||
46963391|NCT02410772|83205812|FG001|Overall Study|Death|4|||
46963392|NCT02410772|83205813|FG002|Overall Study|Death|8|||
46963393|NCT02410772|83205811|FG000|Overall Study|Lost to Follow-up|31|||
46963394|NCT02410772|83205812|FG001|Overall Study|Lost to Follow-up|23|||
46963395|NCT02410772|83205813|FG002|Overall Study|Lost to Follow-up|22|||
46963396|NCT02410772|83205811|FG000|Overall Study|Pregnancy|8|||
46963397|NCT02410772|83205812|FG001|Overall Study|Pregnancy|4|||
46963398|NCT02410772|83205813|FG002|Overall Study|Pregnancy|5|||
46963399|NCT02410772|83205811|FG000|Overall Study|Protocol Violation|8|||
46963400|NCT02410772|83205812|FG001|Overall Study|Protocol Violation|8|||
46963401|NCT02410772|83205813|FG002|Overall Study|Protocol Violation|4|||
46963402|NCT02410772|83205811|FG000|Overall Study|Baseline Drug Resistance|49|||
46963403|NCT02410772|83205812|FG001|Overall Study|Baseline Drug Resistance|40|||
46963404|NCT02410772|83205813|FG002|Overall Study|Baseline Drug Resistance|51|||
46963405|NCT02410772|83205811|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
46963406|NCT02410772|83205812|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
46963407|NCT02410772|83205813|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
46963408|NCT02410772|83205811|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
46963409|NCT02410772|83205812|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
46963410|NCT02410772|83205813|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
46963411|NCT01648790|83205830|FG000|Treatment 3|Withdrawal by Subject|0|||
46963412|NCT01648790|83205831|FG001|Treatment 3|Withdrawal by Subject|0|||
46963413|NCT01648790|83205832|FG002|Treatment 3|Withdrawal by Subject|0|||
46963414|NCT01648790|83205833|FG003|Treatment 3|Withdrawal by Subject|1|||
46963415|NCT01648790|83205834|FG004|Treatment 3|Withdrawal by Subject|0|||
46963416|NCT01936857|83205857|FG000|Overall Study|Sent to prison or 06 center|11|||
46963417|NCT01936857|83205858|FG001|Overall Study|Sent to prison or 06 center|12|||
46963418|NCT01936857|83205857|FG000|Overall Study|Lost to Follow-up|10|||
46963419|NCT01936857|83205858|FG001|Overall Study|Lost to Follow-up|7|||
47067292|NCT01569464|83350845|FG000|Overall Study|Withdrawal by Subject|1|||
46640106|NCT00082758|82814108|FG001|Overall Study|Protocol Violation|1|||
46963420|NCT01936857|83205857|FG000|Overall Study|Death|7|||
46963421|NCT01936857|83205858|FG001|Overall Study|Death|3|||
47067293|NCT01569464|83350846|FG001|Overall Study|Withdrawal by Subject|1|||
46963422|NCT01936857|83205857|FG000|Overall Study|Moved|2|||
46963423|NCT01936857|83205858|FG001|Overall Study|Moved|1|||
46963424|NCT01936857|83205857|FG000|Overall Study|Withdrawal by Subject|1|||
46963425|NCT01936857|83205858|FG001|Overall Study|Withdrawal by Subject|0|||
46963426|NCT01936857|83205857|FG000|Overall Study|Side effect of medication|1|||
46963427|NCT01936857|83205858|FG001|Overall Study|Side effect of medication|0|||
46963428|NCT01936857|83205857|FG000|Overall Study|Other|2|||
46963429|NCT01936857|83205858|FG001|Overall Study|Other|2|||
46963430|NCT01602224|83205867|FG000|Overall Study|Adverse Event|0|||
46963431|NCT01602224|83205868|FG001|Overall Study|Adverse Event|1|||
46963432|NCT01602224|83205869|FG002|Overall Study|Adverse Event|0|||
46963433|NCT01602224|83205867|FG000|Overall Study|Investigator Decison|1|||
46963434|NCT01602224|83205868|FG001|Overall Study|Investigator Decison|0|||
46963435|NCT01602224|83205869|FG002|Overall Study|Investigator Decison|0|||
46963436|NCT01602224|83205867|FG000|Overall Study|Lost to Follow-up|0|||
46963437|NCT01602224|83205868|FG001|Overall Study|Lost to Follow-up|0|||
46963438|NCT01602224|83205869|FG002|Overall Study|Lost to Follow-up|1|||
46963439|NCT01602224|83205867|FG000|Overall Study|Protocol Violation|0|||
46963440|NCT01602224|83205868|FG001|Overall Study|Protocol Violation|1|||
46963441|NCT01602224|83205869|FG002|Overall Study|Protocol Violation|0|||
46963442|NCT01602224|83205867|FG000|Overall Study|Sponsor Decision|2|||
46963443|NCT01602224|83205868|FG001|Overall Study|Sponsor Decision|3|||
46963444|NCT01602224|83205869|FG002|Overall Study|Sponsor Decision|2|||
46963445|NCT01602224|83205867|FG000|Overall Study|Withdrawal by Subject|5|||
46963446|NCT01602224|83205868|FG001|Overall Study|Withdrawal by Subject|3|||
46963447|NCT01602224|83205869|FG002|Overall Study|Withdrawal by Subject|3|||
46963448|NCT04498247|83205887|FG000|Overall Study|Lost to Follow-up|0|||
46963449|NCT04498247|83205888|FG001|Overall Study|Lost to Follow-up|0|||
46963450|NCT04498247|83205889|FG002|Overall Study|Lost to Follow-up|0|||
46963451|NCT04498247|83205890|FG003|Overall Study|Lost to Follow-up|1|||
46963452|NCT04498247|83205891|FG004|Overall Study|Lost to Follow-up|0|||
46963453|NCT04498247|83205892|FG005|Overall Study|Lost to Follow-up|0|||
46963454|NCT04498247|83205893|FG006|Overall Study|Lost to Follow-up|0|||
46963455|NCT04498247|83205894|FG007|Overall Study|Lost to Follow-up|0|||
46963456|NCT04498247|83205887|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
46963457|NCT04498247|83205888|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
46963458|NCT04498247|83205889|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
46963459|NCT04498247|83205890|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
46963460|NCT04498247|83205891|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
46963461|NCT04498247|83205892|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
46963462|NCT04498247|83205893|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
46963463|NCT04498247|83205894|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
46963464|NCT04498247|83205887|FG000|Overall Study|Withdrawal by Subject|0|||
46963465|NCT04498247|83205888|FG001|Overall Study|Withdrawal by Subject|8|||
46963466|NCT04498247|83205889|FG002|Overall Study|Withdrawal by Subject|0|||
46963467|NCT04498247|83205890|FG003|Overall Study|Withdrawal by Subject|7|||
46963468|NCT04498247|83205891|FG004|Overall Study|Withdrawal by Subject|0|||
46963469|NCT04498247|83205892|FG005|Overall Study|Withdrawal by Subject|0|||
46963470|NCT04498247|83205893|FG006|Overall Study|Withdrawal by Subject|1|||
46963471|NCT04498247|83205894|FG007|Overall Study|Withdrawal by Subject|0|||
46963472|NCT04498247|83205887|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
46963473|NCT04498247|83205888|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
46963474|NCT04498247|83205889|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
46963475|NCT04498247|83205890|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
46963476|NCT04498247|83205891|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
46963477|NCT04498247|83205892|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
46963478|NCT04498247|83205893|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
46963479|NCT04498247|83205894|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
46640107|NCT00082758|82814109|FG002|Overall Study|Protocol Violation|0|||
46640108|NCT00088452|82814120|FG000|Overall Study|Did not receive intervention|1|||
46640109|NCT00088452|82814121|FG001|Overall Study|Did not receive intervention|0|||
46963480|NCT03887117|83205922|FG000|Overall Study|Discontinued prematurely|0|||
46963481|NCT03887117|83205923|FG001|Overall Study|Discontinued prematurely|1|||
46963482|NCT03887117|83205924|FG002|Overall Study|Discontinued prematurely|1|||
46963483|NCT03887117|83205925|FG003|Overall Study|Discontinued prematurely|2|||
46963484|NCT04038385|83205946|FG000|Overall Study|Completed baseline assessment only|7|||
46963485|NCT04038385|83205947|FG001|Overall Study|Completed baseline assessment only|4|||
46963486|NCT04038385|83205946|FG000|Overall Study|Moved out of area|4|||
46963487|NCT04038385|83205947|FG001|Overall Study|Moved out of area|2|||
46963488|NCT04038385|83205946|FG000|Overall Study|Discontinued study involvement|6|||
46963489|NCT04038385|83205947|FG001|Overall Study|Discontinued study involvement|1|||
46640110|NCT00088452|82814122|FG002|Overall Study|Did not receive intervention|1|||
46640111|NCT03406104|82814150|FG000|Overall Study|Lost to Follow-up|2|||
46640112|NCT03406104|82814150|FG000|Overall Study|Withdrawal by Subject|2|||
46640113|NCT03406104|82814150|FG000|Overall Study|due to Covid patient did not want to travel|1|||
46640114|NCT03406104|82814150|FG000|Overall Study|Death|2|||
46640115|NCT04686084|82814219|FG000|Overall Study|Lost to Follow-up|1|||
46640116|NCT04685538|82814226|FG000|Overall Study|Adverse Event|0|||
46963490|NCT00783263|83205957|FG000|Overall Study|Adverse Event|3|||
46640117|NCT04685538|82814227|FG001|Overall Study|Adverse Event|1|||
46963491|NCT00783263|83205958|FG001|Overall Study|Adverse Event|0|||
46963492|NCT00783263|83205959|FG002|Overall Study|Adverse Event|2|||
46963493|NCT00783263|83205960|FG003|Overall Study|Adverse Event|1|||
46963494|NCT00783263|83205957|FG000|Overall Study|Lost to Follow-up|1|||
46963495|NCT00783263|83205958|FG001|Overall Study|Lost to Follow-up|1|||
46963496|NCT00783263|83205959|FG002|Overall Study|Lost to Follow-up|0|||
46963497|NCT00783263|83205960|FG003|Overall Study|Lost to Follow-up|0|||
46963498|NCT00783263|83205957|FG000|Overall Study|Withdrawal by Subject|0|||
46963499|NCT00783263|83205958|FG001|Overall Study|Withdrawal by Subject|1|||
46963500|NCT00783263|83205959|FG002|Overall Study|Withdrawal by Subject|1|||
46963501|NCT00783263|83205960|FG003|Overall Study|Withdrawal by Subject|2|||
46963502|NCT03987919|83205987|FG000|Overall Study|Adverse Event|1|||
46963503|NCT03987919|83205988|FG001|Overall Study|Adverse Event|4|||
46963504|NCT03987919|83205989|FG002|Overall Study|Adverse Event|1|||
46963505|NCT03987919|83205990|FG003|Overall Study|Adverse Event|3|||
46963506|NCT03987919|83205987|FG000|Overall Study|Death|4|||
46963507|NCT03987919|83205988|FG001|Overall Study|Death|4|||
46963508|NCT03987919|83205989|FG002|Overall Study|Death|4|||
46963509|NCT03987919|83205990|FG003|Overall Study|Death|1|||
46963510|NCT03987919|83205987|FG000|Overall Study|Lost to Follow-up|5|||
46963511|NCT03987919|83205988|FG001|Overall Study|Lost to Follow-up|6|||
46963512|NCT03987919|83205989|FG002|Overall Study|Lost to Follow-up|8|||
46963513|NCT03987919|83205990|FG003|Overall Study|Lost to Follow-up|12|||
46963514|NCT03987919|83205987|FG000|Overall Study|Physician Decision|0|||
46963515|NCT03987919|83205988|FG001|Overall Study|Physician Decision|2|||
46963516|NCT03987919|83205989|FG002|Overall Study|Physician Decision|0|||
46963517|NCT03987919|83205990|FG003|Overall Study|Physician Decision|4|||
46963518|NCT03987919|83205987|FG000|Overall Study|Pregnancy|1|||
46963519|NCT03987919|83205988|FG001|Overall Study|Pregnancy|0|||
46963520|NCT03987919|83205989|FG002|Overall Study|Pregnancy|1|||
46963521|NCT03987919|83205990|FG003|Overall Study|Pregnancy|1|||
46963522|NCT03987919|83205987|FG000|Overall Study|Protocol Violation|0|||
46963523|NCT03987919|83205988|FG001|Overall Study|Protocol Violation|1|||
46963524|NCT03987919|83205989|FG002|Overall Study|Protocol Violation|0|||
46963525|NCT03987919|83205990|FG003|Overall Study|Protocol Violation|0|||
46963526|NCT03987919|83205987|FG000|Overall Study|Site terminated by Sponsor|0|||
46963527|NCT03987919|83205988|FG001|Overall Study|Site terminated by Sponsor|0|||
46963528|NCT03987919|83205989|FG002|Overall Study|Site terminated by Sponsor|0|||
46963529|NCT03987919|83205990|FG003|Overall Study|Site terminated by Sponsor|1|||
46963530|NCT03987919|83205987|FG000|Overall Study|Withdrawal by Subject|7|||
46963531|NCT03987919|83205988|FG001|Overall Study|Withdrawal by Subject|7|||
46963532|NCT03987919|83205989|FG002|Overall Study|Withdrawal by Subject|8|||
46963533|NCT03987919|83205990|FG003|Overall Study|Withdrawal by Subject|4|||
46963534|NCT03987919|83205987|FG000|Overall Study|Other - as reported by the investigator|1|||
46963535|NCT03987919|83205988|FG001|Overall Study|Other - as reported by the investigator|3|||
46963536|NCT03987919|83205989|FG002|Overall Study|Other - as reported by the investigator|2|||
46963537|NCT03987919|83205990|FG003|Overall Study|Other - as reported by the investigator|0|||
46963538|NCT00535405|83206010|FG000|Overall Study|Adverse Event|6|||
46963539|NCT00535405|83206011|FG001|Overall Study|Adverse Event|8|||
46963540|NCT00535405|83206012|FG002|Overall Study|Adverse Event|3|||
46963541|NCT00535405|83206013|FG003|Overall Study|Adverse Event|8|||
46963542|NCT00535405|83206014|FG004|Overall Study|Adverse Event|6|||
46963543|NCT00535405|83206010|FG000|Overall Study|Lost to Follow-up|1|||
46963544|NCT00535405|83206011|FG001|Overall Study|Lost to Follow-up|3|||
46963545|NCT00535405|83206012|FG002|Overall Study|Lost to Follow-up|3|||
46963546|NCT00535405|83206013|FG003|Overall Study|Lost to Follow-up|2|||
46963547|NCT00535405|83206014|FG004|Overall Study|Lost to Follow-up|1|||
46963548|NCT00535405|83206010|FG000|Overall Study|Physician Decision|3|||
46963549|NCT00535405|83206011|FG001|Overall Study|Physician Decision|2|||
46963550|NCT00535405|83206012|FG002|Overall Study|Physician Decision|0|||
46963551|NCT00535405|83206013|FG003|Overall Study|Physician Decision|1|||
46963552|NCT00535405|83206014|FG004|Overall Study|Physician Decision|1|||
46963553|NCT00535405|83206010|FG000|Overall Study|Protocol Violation|2|||
46963554|NCT00535405|83206011|FG001|Overall Study|Protocol Violation|2|||
46963555|NCT00535405|83206012|FG002|Overall Study|Protocol Violation|2|||
47067294|NCT01569464|83350845|FG000|Overall Study|Other|1|||
46963556|NCT00535405|83206013|FG003|Overall Study|Protocol Violation|1|||
46963557|NCT00535405|83206014|FG004|Overall Study|Protocol Violation|0|||
46963558|NCT00535405|83206010|FG000|Overall Study|Withdrawal by Subject|5|||
46963559|NCT00535405|83206011|FG001|Overall Study|Withdrawal by Subject|11|||
46963560|NCT00535405|83206012|FG002|Overall Study|Withdrawal by Subject|10|||
46963561|NCT00535405|83206013|FG003|Overall Study|Withdrawal by Subject|10|||
46963562|NCT00535405|83206014|FG004|Overall Study|Withdrawal by Subject|8|||
47067295|NCT01569464|83350846|FG001|Overall Study|Other|1|||
47067296|NCT01534676|83350856|FG000|Overall Study|Study closed due to poor enrollment|2|||
47067297|NCT01534676|83350857|FG001|Overall Study|Study closed due to poor enrollment|1|||
47067298|NCT01442675|83350863|FG000|Overall Study|Protocol Violation|6|||
46963563|NCT00271817|83206029|FG000|Part 1|Adverse Event|68|||
46963564|NCT00271817|83206030|FG001|Part 1|Adverse Event|25|||
46963565|NCT00271817|83206031|FG002|Part 1|Adverse Event|156|||
46963566|NCT00271817|83206029|FG000|Part 1|Lost to Follow-up|6|||
46963567|NCT00271817|83206030|FG001|Part 1|Lost to Follow-up|8|||
46963568|NCT00271817|83206031|FG002|Part 1|Lost to Follow-up|24|||
46963569|NCT00271817|83206029|FG000|Part 1|Protocol Violation|5|||
46963570|NCT00271817|83206030|FG001|Part 1|Protocol Violation|4|||
46963571|NCT00271817|83206031|FG002|Part 1|Protocol Violation|7|||
46963572|NCT00271817|83206029|FG000|Part 1|Patient Moved|3|||
46963573|NCT00271817|83206030|FG001|Part 1|Patient Moved|1|||
46963574|NCT00271817|83206031|FG002|Part 1|Patient Moved|5|||
46963575|NCT00271817|83206029|FG000|Part 1|Withdrawal by Subject|23|||
46963576|NCT00271817|83206030|FG001|Part 1|Withdrawal by Subject|17|||
46963577|NCT00271817|83206031|FG002|Part 1|Withdrawal by Subject|45|||
46963578|NCT00271817|83206029|FG000|Part 1|LDL < 50 mg/dL|1|||
46963579|NCT00271817|83206030|FG001|Part 1|LDL < 50 mg/dL|4|||
46963580|NCT00271817|83206031|FG002|Part 1|LDL < 50 mg/dL|48|||
46963581|NCT00271817|83206029|FG000|Part 2|Adverse Event|0|||
46963582|NCT00271817|83206030|FG001|Part 2|Adverse Event|17|||
46774376|NCT00579345|82992851|FG005|Overall Study|Adverse Event|0|||
46774377|NCT00579345|82992852|FG006|Overall Study|Adverse Event|0|||
46774378|NCT00579345|82992853|FG007|Overall Study|Adverse Event|0|||
46774379|NCT00579345|82992846|FG000|Overall Study|Protocol Violation|1|||
46774380|NCT00579345|82992847|FG001|Overall Study|Protocol Violation|0|||
46845530|NCT00139776|83062401|FG001|Period III|Lack of Efficacy|0|||
46845531|NCT00139776|83062402|FG002|Period III|Lack of Efficacy|10|||
46845532|NCT00139776|83062403|FG003|Period III|Lack of Efficacy|24|||
46845533|NCT00139776|83062400|FG000|Period III|Lost to Follow-up|0|||
46845534|NCT00139776|83062401|FG001|Period III|Lost to Follow-up|0|||
46845535|NCT00139776|83062402|FG002|Period III|Lost to Follow-up|5|||
46845536|NCT00139776|83062403|FG003|Period III|Lost to Follow-up|4|||
46845537|NCT00139776|83062400|FG000|Period III|Withdrawal by Subject|0|||
46845538|NCT00139776|83062401|FG001|Period III|Withdrawal by Subject|0|||
46845539|NCT00139776|83062402|FG002|Period III|Withdrawal by Subject|16|||
46845540|NCT00139776|83062403|FG003|Period III|Withdrawal by Subject|21|||
46845541|NCT00413699|83062412|FG000|Initial Period|Death|25|||
46845542|NCT00413699|83062413|FG001|Initial Period|Death|30|||
46963583|NCT00271817|83206031|FG002|Part 2|Adverse Event|33|||
46963584|NCT00271817|83206029|FG000|Part 2|Lack of Efficacy|0|||
46774381|NCT00579345|82992848|FG002|Overall Study|Protocol Violation|0|||
46774382|NCT00579345|82992849|FG003|Overall Study|Protocol Violation|0|||
46774383|NCT00579345|82992850|FG004|Overall Study|Protocol Violation|0|||
46774384|NCT00579345|82992851|FG005|Overall Study|Protocol Violation|0|||
46774385|NCT00579345|82992852|FG006|Overall Study|Protocol Violation|0|||
46774386|NCT00579345|82992853|FG007|Overall Study|Protocol Violation|1|||
46774387|NCT00579345|82992846|FG000|Overall Study|Death|1|||
46774388|NCT00579345|82992847|FG001|Overall Study|Death|1|||
46774389|NCT00579345|82992848|FG002|Overall Study|Death|1|||
46774390|NCT00579345|82992849|FG003|Overall Study|Death|1|||
46774391|NCT00579345|82992850|FG004|Overall Study|Death|0|||
46774392|NCT00579345|82992851|FG005|Overall Study|Death|0|||
46774393|NCT00579345|82992852|FG006|Overall Study|Death|0|||
46774394|NCT00579345|82992853|FG007|Overall Study|Death|0|||
46774395|NCT00795821|82992901|FG000|Acute Treatment Phase|Adverse Event|23|||
46774396|NCT00795821|82992902|FG001|Acute Treatment Phase|Adverse Event|4|||
46774397|NCT00795821|82992901|FG000|Acute Treatment Phase|Death|1|||
46774398|NCT00795821|82992902|FG001|Acute Treatment Phase|Death|0|||
46774399|NCT00795821|82992901|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
46774400|NCT00795821|82992902|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
46774401|NCT00795821|82992901|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
46774402|NCT00795821|82992902|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
46774403|NCT00795821|82992901|FG000|Acute Treatment Phase|Physician Decision|1|||
46774404|NCT00795821|82992902|FG001|Acute Treatment Phase|Physician Decision|1|||
46774405|NCT00795821|82992901|FG000|Acute Treatment Phase|Protocol Violation|1|||
46774406|NCT00795821|82992902|FG001|Acute Treatment Phase|Protocol Violation|2|||
46774407|NCT00795821|82992901|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
46845543|NCT00413699|83062414|FG002|Initial Period|Death|0|||
46845544|NCT00413699|83062412|FG000|Initial Period|Lack of Efficacy|59|||
46845545|NCT00413699|83062413|FG001|Initial Period|Lack of Efficacy|115|||
46845546|NCT00413699|83062414|FG002|Initial Period|Lack of Efficacy|0|||
46963585|NCT00271817|83206030|FG001|Part 2|Lack of Efficacy|1|||
46845547|NCT00413699|83062412|FG000|Initial Period|Lost to Follow-up|31|||
46845548|NCT00413699|83062413|FG001|Initial Period|Lost to Follow-up|101|||
46963586|NCT00271817|83206031|FG002|Part 2|Lack of Efficacy|6|||
46774408|NCT00795821|82992902|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
46774409|NCT00795821|82992901|FG000|Long-term Extension Phase|Adverse Event|25|||
46963587|NCT00271817|83206029|FG000|Part 2|Lost to Follow-up|0|||
46963588|NCT00271817|83206030|FG001|Part 2|Lost to Follow-up|6|||
46963589|NCT00271817|83206031|FG002|Part 2|Lost to Follow-up|18|||
46963590|NCT00271817|83206029|FG000|Part 2|Protocol Violation|0|||
46774410|NCT00795821|82992902|FG001|Long-term Extension Phase|Adverse Event|32|||
46774411|NCT00795821|82992901|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
46845549|NCT00413699|83062414|FG002|Initial Period|Lost to Follow-up|0|||
46963591|NCT00271817|83206030|FG001|Part 2|Protocol Violation|3|||
46963592|NCT00271817|83206031|FG002|Part 2|Protocol Violation|5|||
46963593|NCT00271817|83206029|FG000|Part 2|Patient Moved|0|||
46963594|NCT00271817|83206030|FG001|Part 2|Patient Moved|0|||
46963595|NCT00271817|83206031|FG002|Part 2|Patient Moved|5|||
46963596|NCT00271817|83206029|FG000|Part 2|Withdrawal by Subject|0|||
46963597|NCT00271817|83206030|FG001|Part 2|Withdrawal by Subject|2|||
46963598|NCT00271817|83206031|FG002|Part 2|Withdrawal by Subject|13|||
46963599|NCT00271817|83206029|FG000|Part 2|LDL < 50 mg/dL|0|||
46963600|NCT00271817|83206030|FG001|Part 2|LDL < 50 mg/dL|3|||
46963601|NCT00271817|83206031|FG002|Part 2|LDL < 50 mg/dL|4|||
46963602|NCT02731157|83206043|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
46963603|NCT03268811|83206051|FG000|Overall Study|Adverse Event|0|||
46963604|NCT03268811|83206052|FG001|Overall Study|Adverse Event|1|||
46963605|NCT02732015|83206061|FG000|Overall Study|Lost to Follow-up|0|||
46963606|NCT02732015|83206062|FG001|Overall Study|Lost to Follow-up|1|||
46963607|NCT01441115|83206082|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
46963608|NCT02006147|83206093|FG000|Overall Study|Protocol Violation|1|||
46963609|NCT02006147|83206094|FG001|Overall Study|Protocol Violation|1|||
46963610|NCT02006147|83206095|FG002|Overall Study|Protocol Violation|0|||
46963611|NCT02006147|83206096|FG003|Overall Study|Protocol Violation|0|||
46963612|NCT02006147|83206093|FG000|Overall Study|Withdrawal by Subject|0|||
46963613|NCT02006147|83206094|FG001|Overall Study|Withdrawal by Subject|1|||
46963614|NCT02006147|83206095|FG002|Overall Study|Withdrawal by Subject|0|||
46963615|NCT02006147|83206096|FG003|Overall Study|Withdrawal by Subject|0|||
46963616|NCT02006147|83206093|FG000|Overall Study|Withdrawal by Sponsor|1|||
46963617|NCT02006147|83206094|FG001|Overall Study|Withdrawal by Sponsor|0|||
46963618|NCT02006147|83206095|FG002|Overall Study|Withdrawal by Sponsor|0|||
46963619|NCT02006147|83206096|FG003|Overall Study|Withdrawal by Sponsor|0|||
46963620|NCT02732119|83206107|FG000|Phase I|Adverse Event|1|||
46963621|NCT02732119|83206108|FG001|Phase I|Adverse Event|3|||
46963622|NCT02732119|83206109|FG002|Phase I|Adverse Event|1|||
46963623|NCT02732119|83206110|FG003|Phase I|Adverse Event|0|||
46963624|NCT02732119|83206111|FG004|Phase I|Adverse Event|0|||
46963625|NCT02732119|83206107|FG000|Phase I|Progressive disease|7|||
46963626|NCT02732119|83206108|FG001|Phase I|Progressive disease|3|||
46963627|NCT02732119|83206109|FG002|Phase I|Progressive disease|2|||
46963628|NCT02732119|83206110|FG003|Phase I|Progressive disease|0|||
46963629|NCT02732119|83206111|FG004|Phase I|Progressive disease|0|||
46963630|NCT02732119|83206107|FG000|Phase I|Protocol deviation|0|||
46963631|NCT02732119|83206108|FG001|Phase I|Protocol deviation|1|||
46963632|NCT02732119|83206109|FG002|Phase I|Protocol deviation|0|||
46963633|NCT02732119|83206110|FG003|Phase I|Protocol deviation|0|||
46963634|NCT02732119|83206111|FG004|Phase I|Protocol deviation|0|||
46963635|NCT02732119|83206107|FG000|Phase I|Physician Decision|0|||
46963636|NCT02732119|83206108|FG001|Phase I|Physician Decision|3|||
46963637|NCT02732119|83206109|FG002|Phase I|Physician Decision|4|||
46963638|NCT02732119|83206110|FG003|Phase I|Physician Decision|0|||
46963639|NCT02732119|83206111|FG004|Phase I|Physician Decision|0|||
46963640|NCT02732119|83206107|FG000|Phase II|Adverse Event|0|||
46963641|NCT02732119|83206108|FG001|Phase II|Adverse Event|0|||
46963642|NCT02732119|83206109|FG002|Phase II|Adverse Event|0|||
46963643|NCT02732119|83206110|FG003|Phase II|Adverse Event|3|||
46963644|NCT02732119|83206111|FG004|Phase II|Adverse Event|3|||
46963645|NCT02732119|83206107|FG000|Phase II|Death|0|||
46963646|NCT02732119|83206108|FG001|Phase II|Death|0|||
46963647|NCT02732119|83206109|FG002|Phase II|Death|0|||
46963648|NCT02732119|83206110|FG003|Phase II|Death|1|||
46963649|NCT02732119|83206111|FG004|Phase II|Death|0|||
46963650|NCT02732119|83206107|FG000|Phase II|Progressive dissease|0|||
46963651|NCT02732119|83206108|FG001|Phase II|Progressive dissease|0|||
46640118|NCT04685538|82814226|FG000|Overall Study|Lost to Follow-up|0|||
46640119|NCT04685538|82814227|FG001|Overall Study|Lost to Follow-up|2|||
46640120|NCT04213326|82814239|FG000|Overall Study|Consent withdrawn|51|||
46845550|NCT00413699|83062412|FG000|Initial Period|Protocol Violation|38|||
46963652|NCT02732119|83206109|FG002|Phase II|Progressive dissease|0|||
46963653|NCT02732119|83206110|FG003|Phase II|Progressive dissease|30|||
46963654|NCT02732119|83206111|FG004|Phase II|Progressive dissease|23|||
46963655|NCT02732119|83206107|FG000|Phase II|Study terminated by sponsor|0|||
46963656|NCT02732119|83206108|FG001|Phase II|Study terminated by sponsor|0|||
46963657|NCT02732119|83206109|FG002|Phase II|Study terminated by sponsor|0|||
46963658|NCT02732119|83206110|FG003|Phase II|Study terminated by sponsor|2|||
46640121|NCT04213326|82814240|FG001|Overall Study|Consent withdrawn|241|||
46963659|NCT02732119|83206111|FG004|Phase II|Study terminated by sponsor|2|||
46963660|NCT02732119|83206107|FG000|Phase II|Other|0|||
46963661|NCT02732119|83206108|FG001|Phase II|Other|0|||
46963662|NCT02732119|83206109|FG002|Phase II|Other|0|||
46963663|NCT02732119|83206110|FG003|Phase II|Other|2|||
46963664|NCT02732119|83206111|FG004|Phase II|Other|0|||
46963665|NCT02732119|83206107|FG000|Phase II|Physician Decision|0|||
46963666|NCT02732119|83206108|FG001|Phase II|Physician Decision|0|||
46963667|NCT02732119|83206109|FG002|Phase II|Physician Decision|0|||
46963668|NCT02732119|83206110|FG003|Phase II|Physician Decision|8|||
46963669|NCT02732119|83206111|FG004|Phase II|Physician Decision|5|||
46963670|NCT03252925|83206134|FG000|Overall Study|Withdrawal by Subject|1|||
46963671|NCT03252925|83206135|FG001|Overall Study|Withdrawal by Subject|0|||
46963672|NCT03252925|83206134|FG000|Overall Study|Protocol Violation|6|||
46963673|NCT03252925|83206135|FG001|Overall Study|Protocol Violation|0|||
46963674|NCT03252925|83206134|FG000|Overall Study|Adverse Event|1|||
46963675|NCT03252925|83206135|FG001|Overall Study|Adverse Event|0|||
46963676|NCT03252925|83206134|FG000|Overall Study|Lost to Follow-up|6|||
46963677|NCT03252925|83206135|FG001|Overall Study|Lost to Follow-up|6|||
46963678|NCT01327885|83206143|FG000|Overall Study|Disease progression-according to RECIST|173|||
46963679|NCT01327885|83206144|FG001|Overall Study|Disease progression-according to RECIST|165|||
46963680|NCT01327885|83206143|FG000|Overall Study|Clinical progression|24|||
46963681|NCT01327885|83206144|FG001|Overall Study|Clinical progression|27|||
46963682|NCT01327885|83206143|FG000|Overall Study|Adverse Event|14|||
46963683|NCT01327885|83206144|FG001|Overall Study|Adverse Event|10|||
46963684|NCT01327885|83206143|FG000|Overall Study|Subject choice|5|||
46963685|NCT01327885|83206144|FG001|Overall Study|Subject choice|10|||
46963686|NCT01327885|83206143|FG000|Overall Study|Other|8|||
46963687|NCT01327885|83206144|FG001|Overall Study|Other|6|||
46963688|NCT01327885|83206143|FG000|Overall Study|Withdrawal of consent from study|3|||
46963689|NCT01327885|83206144|FG001|Overall Study|Withdrawal of consent from study|4|||
46963690|NCT01327885|83206143|FG000|Overall Study|Not treated|1|||
46963691|NCT01327885|83206144|FG001|Overall Study|Not treated|1|||
46963692|NCT01327885|83206143|FG000|Overall Study|Administrative decision|0|||
46963693|NCT01327885|83206144|FG001|Overall Study|Administrative decision|1|||
46963694|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
46963695|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
46963696|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
46963697|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
46963698|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
46963699|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
46963700|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
46963701|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
46963702|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
46963703|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
46963704|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
46963705|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
46963706|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
46963707|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
46963708|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
46963709|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
46963710|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
46963711|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
46963712|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
46963713|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
46963714|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Death|2|||
46963715|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Death|2|||
46963716|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Death|0|||
46963717|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Death|0|||
46963718|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Death|0|||
46963719|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
46963720|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
46963721|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
46963722|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
46963723|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
46963724|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
46963725|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
46963726|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
46963727|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
46963728|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
46963729|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
46640122|NCT04213326|82814239|FG000|Overall Study|Lost to Follow-up|50|||
46774412|NCT00795821|82992902|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
46774413|NCT00795821|82992901|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
46774414|NCT00795821|82992902|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
46774415|NCT00795821|82992901|FG000|Long-term Extension Phase|Physician Decision|1|||
46774416|NCT00795821|82992902|FG001|Long-term Extension Phase|Physician Decision|2|||
46963730|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
46963731|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
46963732|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
46640123|NCT04213326|82814240|FG001|Overall Study|Lost to Follow-up|902|||
46640124|NCT04213326|82814239|FG000|Overall Study|Protocol Violation|3|||
46845551|NCT00413699|83062413|FG001|Initial Period|Protocol Violation|89|||
46963733|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
46845552|NCT00413699|83062414|FG002|Initial Period|Protocol Violation|0|||
46963734|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
46963735|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
46963736|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
46963737|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
46963738|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
46963739|NCT03420781|83206162|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
46963740|NCT03420781|83206163|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
46963741|NCT03420781|83206164|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
46963742|NCT03420781|83206165|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
46963743|NCT03420781|83206166|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
46963744|NCT03420781|83206162|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
46963745|NCT03420781|83206163|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
46963746|NCT03420781|83206164|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
46963747|NCT03420781|83206165|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
46963748|NCT03420781|83206166|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
46963749|NCT03420781|83206162|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
46963750|NCT03420781|83206163|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
46963751|NCT03420781|83206164|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
46963752|NCT03420781|83206165|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
46963753|NCT03420781|83206166|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
46963754|NCT03420781|83206162|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
46963755|NCT03420781|83206163|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
46963756|NCT03420781|83206164|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
46963757|NCT03420781|83206165|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
46963758|NCT03420781|83206166|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
46963759|NCT03269695|83206184|FG000|Overall Study|Adverse Event|2|||
46963760|NCT03269695|83206185|FG001|Overall Study|Adverse Event|1|||
46963761|NCT03269695|83206184|FG000|Overall Study|Lack of Efficacy|0|||
46963762|NCT03269695|83206185|FG001|Overall Study|Lack of Efficacy|1|||
46963763|NCT03269695|83206184|FG000|Overall Study|Withdrawal by Subject|0|||
46963764|NCT03269695|83206185|FG001|Overall Study|Withdrawal by Subject|1|||
46963765|NCT00462943|83206195|FG000|Overall Study|Failure to achieve a response|5|||
46963766|NCT00462943|83206196|FG001|Overall Study|Failure to achieve a response|5|||
46963767|NCT00462943|83206197|FG002|Overall Study|Failure to achieve a response|1|||
46963768|NCT00462943|83206195|FG000|Overall Study|Adverse Event|6|||
46963769|NCT00462943|83206196|FG001|Overall Study|Adverse Event|4|||
46963770|NCT00462943|83206197|FG002|Overall Study|Adverse Event|1|||
46963771|NCT00462943|83206195|FG000|Overall Study|Protocol Violation|1|||
46963772|NCT00462943|83206196|FG001|Overall Study|Protocol Violation|0|||
46963773|NCT00462943|83206197|FG002|Overall Study|Protocol Violation|0|||
46963774|NCT00462943|83206195|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
46963775|NCT00462943|83206196|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
46963776|NCT00462943|83206197|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
46963777|NCT00462943|83206195|FG000|Overall Study|Disease Progression|15|||
46963778|NCT00462943|83206196|FG001|Overall Study|Disease Progression|15|||
46963779|NCT00462943|83206197|FG002|Overall Study|Disease Progression|9|||
46963780|NCT00462943|83206195|FG000|Overall Study|Death|5|||
46963781|NCT00462943|83206196|FG001|Overall Study|Death|2|||
46963782|NCT00462943|83206197|FG002|Overall Study|Death|7|||
46963783|NCT00462943|83206195|FG000|Overall Study|Stem Cell Transplant|1|||
46963784|NCT00462943|83206196|FG001|Overall Study|Stem Cell Transplant|1|||
46963785|NCT00462943|83206197|FG002|Overall Study|Stem Cell Transplant|0|||
46963786|NCT00462943|83206195|FG000|Overall Study|Bone Marrow Transplant|1|||
46963787|NCT00462943|83206196|FG001|Overall Study|Bone Marrow Transplant|0|||
46963788|NCT00462943|83206197|FG002|Overall Study|Bone Marrow Transplant|0|||
47067299|NCT01442675|83350863|FG000|Overall Study|Lost to Follow-up|2|||
47067300|NCT01442675|83350863|FG000|Overall Study|Withdrawal by Subject|4|||
47067301|NCT01534520|83350870|FG000|Overall Study|Adverse Event|0|||
47067302|NCT01534520|83350871|FG001|Overall Study|Adverse Event|1|||
46774417|NCT00795821|82992901|FG000|Long-term Extension Phase|Protocol Violation|3|||
46774418|NCT00795821|82992902|FG001|Long-term Extension Phase|Protocol Violation|5|||
46774419|NCT00795821|82992901|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
46774420|NCT00795821|82992902|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
46774421|NCT00795821|82992901|FG000|Taper Phase|Adverse Event|2|||
46774422|NCT00795821|82992902|FG001|Taper Phase|Adverse Event|0|||
46774423|NCT00795821|82992901|FG000|Taper Phase|Lost to Follow-up|1|||
46845553|NCT00413699|83062412|FG000|Initial Period|Pregnancy|10|||
46845554|NCT00413699|83062413|FG001|Initial Period|Pregnancy|8|||
46774424|NCT00795821|82992902|FG001|Taper Phase|Lost to Follow-up|0|||
46774425|NCT00795821|82992901|FG000|Taper Phase|Physician Decision|2|||
46774426|NCT00795821|82992902|FG001|Taper Phase|Physician Decision|0|||
46963789|NCT00462943|83206195|FG000|Overall Study|Required Lymphocyte Infusion|1|||
46963790|NCT00462943|83206196|FG001|Overall Study|Required Lymphocyte Infusion|0|||
46963791|NCT00462943|83206197|FG002|Overall Study|Required Lymphocyte Infusion|0|||
46963792|NCT00462943|83206195|FG000|Overall Study|Transplant - not specified|1|||
46963793|NCT00462943|83206196|FG001|Overall Study|Transplant - not specified|0|||
46963794|NCT00462943|83206197|FG002|Overall Study|Transplant - not specified|1|||
46963795|NCT00462943|83206195|FG000|Overall Study|Physician Decision|1|||
46963796|NCT00462943|83206196|FG001|Overall Study|Physician Decision|0|||
46963797|NCT00462943|83206197|FG002|Overall Study|Physician Decision|0|||
46963798|NCT00462943|83206195|FG000|Overall Study|Withdrawal by Subject|0|||
46963799|NCT00462943|83206196|FG001|Overall Study|Withdrawal by Subject|1|||
46963800|NCT00462943|83206197|FG002|Overall Study|Withdrawal by Subject|0|||
46963801|NCT02730793|83206221|FG000|Overall Study|Physician Decision|0|||
46963802|NCT02730793|83206222|FG001|Overall Study|Physician Decision|1|||
46963803|NCT02730793|83206221|FG000|Overall Study|Withdrawal by Subject|0|||
46963804|NCT02730793|83206222|FG001|Overall Study|Withdrawal by Subject|1|||
46963805|NCT02855125|83206230|FG000|Overall Study|Withdrawal by Subject|2|||
46963806|NCT02855125|83206231|FG001|Overall Study|Withdrawal by Subject|2|||
46963807|NCT02855125|83206230|FG000|Overall Study|Clinical Disease Progression|5|||
46963808|NCT02855125|83206231|FG001|Overall Study|Clinical Disease Progression|4|||
46963809|NCT02855125|83206230|FG000|Overall Study|Radiologic Disease Progression|36|||
46963810|NCT02855125|83206231|FG001|Overall Study|Radiologic Disease Progression|39|||
46963811|NCT02855125|83206230|FG000|Overall Study|Adverse Event|11|||
46963812|NCT02855125|83206231|FG001|Overall Study|Adverse Event|7|||
46963813|NCT02855125|83206230|FG000|Overall Study|Physician Decision|1|||
46963814|NCT02855125|83206231|FG001|Overall Study|Physician Decision|0|||
46963815|NCT02855125|83206230|FG000|Overall Study|On Treatment|9|||
46963816|NCT02855125|83206231|FG001|Overall Study|On Treatment|11|||
46963817|NCT02855125|83206230|FG000|Overall Study|Randomized but not treated|0|||
46963818|NCT02855125|83206231|FG001|Overall Study|Randomized but not treated|1|||
46963819|NCT02730871|83206254|FG000|Overall Study|Adverse Event|6|||
46963820|NCT02730871|83206255|FG001|Overall Study|Adverse Event|0|||
46963821|NCT03376789|83206263|FG000|Overall Study|Withdrawal by Subject|3|||
46963822|NCT03376789|83206264|FG001|Overall Study|Withdrawal by Subject|5|||
46963823|NCT03376789|83206263|FG000|Overall Study|Protocol Violation|0|||
46963824|NCT03376789|83206264|FG001|Overall Study|Protocol Violation|1|||
46963825|NCT03376789|83206263|FG000|Overall Study|Adverse Event|0|||
46963826|NCT03376789|83206264|FG001|Overall Study|Adverse Event|1|||
46963827|NCT03376789|83206263|FG000|Overall Study|Lost to Follow-up|1|||
46963828|NCT03376789|83206264|FG001|Overall Study|Lost to Follow-up|1|||
46963829|NCT03376789|83206263|FG000|Overall Study|Per sponsor due to noncompliance|1|||
46963830|NCT03376789|83206264|FG001|Overall Study|Per sponsor due to noncompliance|0|||
46963831|NCT03376789|83206263|FG000|Overall Study|Subject off study medication|0|||
46963832|NCT03376789|83206264|FG001|Overall Study|Subject off study medication|1|||
46963833|NCT04032093|83206280|FG000|Overall Study|Lost to Follow-up|7|||
46963834|NCT04032093|83206281|FG001|Overall Study|Lost to Follow-up|7|||
46963835|NCT04032093|83206282|FG002|Overall Study|Lost to Follow-up|6|||
46963836|NCT04032093|83206283|FG003|Overall Study|Lost to Follow-up|10|||
46963837|NCT04032093|83206284|FG004|Overall Study|Lost to Follow-up|13|||
46963838|NCT04032093|83206285|FG005|Overall Study|Lost to Follow-up|7|||
46963839|NCT04032093|83206286|FG006|Overall Study|Lost to Follow-up|7|||
46963840|NCT04032093|83206287|FG007|Overall Study|Lost to Follow-up|5|||
46963841|NCT04032093|83206288|FG008|Overall Study|Lost to Follow-up|9|||
46963842|NCT04032093|83206289|FG009|Overall Study|Lost to Follow-up|12|||
46963843|NCT04032093|83206280|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
46963844|NCT04032093|83206281|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46963845|NCT04032093|83206282|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
46963846|NCT04032093|83206283|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
46963847|NCT04032093|83206284|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
46963848|NCT04032093|83206285|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
46963849|NCT04032093|83206286|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
46963850|NCT04032093|83206287|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
46963851|NCT04032093|83206288|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
46963852|NCT04032093|83206289|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
46963853|NCT04032093|83206280|FG000|Overall Study|Other|1|||
46963854|NCT04032093|83206281|FG001|Overall Study|Other|0|||
46963855|NCT04032093|83206282|FG002|Overall Study|Other|0|||
46963856|NCT04032093|83206283|FG003|Overall Study|Other|1|||
46774427|NCT00795821|82992901|FG000|Taper Phase|Withdrawal by Subject|4|||
46963857|NCT04032093|83206284|FG004|Overall Study|Other|1|||
46963858|NCT04032093|83206285|FG005|Overall Study|Other|0|||
46774428|NCT00795821|82992902|FG001|Taper Phase|Withdrawal by Subject|0|||
46774429|NCT00578643|82992918|FG000|Overall Study|Death|1|||
46963859|NCT04032093|83206286|FG006|Overall Study|Other|0|||
46963860|NCT04032093|83206287|FG007|Overall Study|Other|0|||
46963861|NCT04032093|83206288|FG008|Overall Study|Other|0|||
46963862|NCT04032093|83206289|FG009|Overall Study|Other|1|||
46963863|NCT04032093|83206280|FG000|Overall Study|Withdrawal by Subject|1|||
46963864|NCT04032093|83206281|FG001|Overall Study|Withdrawal by Subject|3|||
46963865|NCT04032093|83206282|FG002|Overall Study|Withdrawal by Subject|2|||
46963866|NCT04032093|83206283|FG003|Overall Study|Withdrawal by Subject|2|||
46963867|NCT04032093|83206284|FG004|Overall Study|Withdrawal by Subject|3|||
46963868|NCT04032093|83206285|FG005|Overall Study|Withdrawal by Subject|0|||
46963869|NCT04032093|83206286|FG006|Overall Study|Withdrawal by Subject|0|||
46963870|NCT04032093|83206287|FG007|Overall Study|Withdrawal by Subject|0|||
46963871|NCT04032093|83206288|FG008|Overall Study|Withdrawal by Subject|0|||
46963872|NCT04032093|83206289|FG009|Overall Study|Withdrawal by Subject|0|||
46963873|NCT04032093|83206280|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46963874|NCT04032093|83206281|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46963875|NCT04032093|83206282|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
46963876|NCT04032093|83206283|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
46963877|NCT04032093|83206284|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
46963878|NCT04032093|83206285|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
46963879|NCT04032093|83206286|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
46963880|NCT04032093|83206287|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
46963881|NCT04032093|83206288|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
46963882|NCT04032093|83206289|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
46963883|NCT04032093|83206280|FG000|Overall Study|Adverse Event|0|||
46963884|NCT04032093|83206281|FG001|Overall Study|Adverse Event|0|||
46963885|NCT04032093|83206282|FG002|Overall Study|Adverse Event|0|||
46963886|NCT04032093|83206283|FG003|Overall Study|Adverse Event|0|||
46963887|NCT04032093|83206284|FG004|Overall Study|Adverse Event|0|||
46963888|NCT04032093|83206285|FG005|Overall Study|Adverse Event|0|||
46963889|NCT04032093|83206286|FG006|Overall Study|Adverse Event|0|||
46963890|NCT04032093|83206287|FG007|Overall Study|Adverse Event|0|||
46963891|NCT04032093|83206288|FG008|Overall Study|Adverse Event|0|||
46963892|NCT04032093|83206289|FG009|Overall Study|Adverse Event|1|||
46963893|NCT04032093|83206280|FG000|Overall Study|Physician Decision|0|||
46963894|NCT04032093|83206281|FG001|Overall Study|Physician Decision|0|||
46963895|NCT04032093|83206282|FG002|Overall Study|Physician Decision|0|||
46963896|NCT04032093|83206283|FG003|Overall Study|Physician Decision|0|||
46963897|NCT04032093|83206284|FG004|Overall Study|Physician Decision|0|||
46963898|NCT04032093|83206285|FG005|Overall Study|Physician Decision|1|||
46963899|NCT04032093|83206286|FG006|Overall Study|Physician Decision|0|||
46963900|NCT04032093|83206287|FG007|Overall Study|Physician Decision|0|||
46963901|NCT04032093|83206288|FG008|Overall Study|Physician Decision|0|||
46963902|NCT04032093|83206289|FG009|Overall Study|Physician Decision|0|||
46963903|NCT01675167|83206313|FG000|Open-label Titration Phase|Adverse Event|81|||
46963904|NCT01675167|83206314|FG001|Open-label Titration Phase|Adverse Event|0|||
46963905|NCT01675167|83206315|FG002|Open-label Titration Phase|Adverse Event|0|||
46963906|NCT01675167|83206313|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
46963907|NCT01675167|83206314|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
46963908|NCT01675167|83206315|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
46963909|NCT01675167|83206313|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
46963910|NCT01675167|83206314|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
46963911|NCT01675167|83206315|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
46963912|NCT01675167|83206313|FG000|Open-label Titration Phase|Protocol Violation|43|||
46963913|NCT01675167|83206314|FG001|Open-label Titration Phase|Protocol Violation|0|||
46963914|NCT01675167|83206315|FG002|Open-label Titration Phase|Protocol Violation|0|||
46963915|NCT01675167|83206313|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
46774430|NCT00578643|82992918|FG000|Overall Study|Lost to Follow-up|1|||
46774431|NCT00578565|82992922|FG000|Overall Study|Adverse Event|3|||
46774432|NCT00741260|82992934|FG000|Overall Study|Disease Progression|3|||
46774433|NCT00741260|82992935|FG001|Overall Study|Disease Progression|5|||
46963916|NCT01675167|83206314|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
46963917|NCT01675167|83206315|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
46963918|NCT01675167|83206313|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
46963919|NCT01675167|83206314|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
46774434|NCT00741260|82992936|FG002|Overall Study|Disease Progression|3|||
46774435|NCT00741260|82992937|FG003|Overall Study|Disease Progression|3|||
46963920|NCT01675167|83206315|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
46963921|NCT01675167|83206313|FG000|Open-label Titration Phase|Other|55|||
46963922|NCT01675167|83206314|FG001|Open-label Titration Phase|Other|0|||
46963923|NCT01675167|83206315|FG002|Open-label Titration Phase|Other|0|||
46963924|NCT01675167|83206313|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
46963925|NCT01675167|83206314|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
46963926|NCT01675167|83206315|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
46774436|NCT00741260|82992938|FG004|Overall Study|Disease Progression|5|||
46774437|NCT00741260|82992939|FG005|Overall Study|Disease Progression|37|||
46963927|NCT01675167|83206313|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46963928|NCT01675167|83206314|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
46963929|NCT01675167|83206315|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
46963930|NCT01675167|83206313|FG000|Double-blind Treatment Phase|Adverse Event|0|||
46963931|NCT01675167|83206314|FG001|Double-blind Treatment Phase|Adverse Event|5|||
46963932|NCT01675167|83206315|FG002|Double-blind Treatment Phase|Adverse Event|13|||
46963933|NCT01675167|83206313|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
46963934|NCT01675167|83206314|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
46963935|NCT01675167|83206315|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
46963936|NCT01675167|83206313|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
46963937|NCT01675167|83206314|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
46963938|NCT01675167|83206315|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
46963939|NCT01675167|83206313|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
46963940|NCT01675167|83206314|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
46963941|NCT01675167|83206315|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
46963942|NCT01675167|83206313|FG000|Double-blind Treatment Phase|Other|0|||
46963943|NCT01675167|83206314|FG001|Double-blind Treatment Phase|Other|7|||
46963944|NCT01675167|83206315|FG002|Double-blind Treatment Phase|Other|5|||
46963945|NCT01675011|83206325|FG000|Overall Study|Trial terminated by Sponsor|3|||
46963946|NCT01675011|83206326|FG001|Overall Study|Trial terminated by Sponsor|1|||
46963947|NCT04109547|83206354|FG000|Overall Study|Withdrawal by Subject|3|||
46963948|NCT04109547|83206355|FG001|Overall Study|Withdrawal by Subject|2|||
46963949|NCT04109547|83206356|FG002|Overall Study|Withdrawal by Subject|6|||
46963950|NCT04109547|83206357|FG003|Overall Study|Withdrawal by Subject|6|||
46963951|NCT04109547|83206354|FG000|Overall Study|Lost to Follow-up|0|||
46963952|NCT04109547|83206355|FG001|Overall Study|Lost to Follow-up|0|||
46963953|NCT04109547|83206356|FG002|Overall Study|Lost to Follow-up|0|||
46963954|NCT04109547|83206357|FG003|Overall Study|Lost to Follow-up|1|||
46963955|NCT04109547|83206354|FG000|Overall Study|Physician Decision|1|||
46963956|NCT04109547|83206355|FG001|Overall Study|Physician Decision|2|||
46963957|NCT04109547|83206356|FG002|Overall Study|Physician Decision|0|||
46963958|NCT04109547|83206357|FG003|Overall Study|Physician Decision|0|||
46963959|NCT02649231|83206380|FG000|Overall Study|Adverse Event|0|||
46963960|NCT02649231|83206381|FG001|Overall Study|Adverse Event|0|||
46963961|NCT02649231|83206382|FG002|Overall Study|Adverse Event|0|||
46963962|NCT02649231|83206383|FG003|Overall Study|Adverse Event|1|||
46963963|NCT02649231|83206380|FG000|Overall Study|Lost to Follow-up|2|||
46963964|NCT02649231|83206381|FG001|Overall Study|Lost to Follow-up|1|||
46963965|NCT02649231|83206382|FG002|Overall Study|Lost to Follow-up|1|||
46963966|NCT02649231|83206383|FG003|Overall Study|Lost to Follow-up|0|||
46963967|NCT02649231|83206380|FG000|Overall Study|Withdrawal by Subject|0|||
46963968|NCT02649231|83206381|FG001|Overall Study|Withdrawal by Subject|1|||
46963969|NCT02649231|83206382|FG002|Overall Study|Withdrawal by Subject|0|||
46963970|NCT02649231|83206383|FG003|Overall Study|Withdrawal by Subject|1|||
46963971|NCT02649231|83206380|FG000|Overall Study|Protocol Violation|2|||
46963972|NCT02649231|83206381|FG001|Overall Study|Protocol Violation|1|||
46963973|NCT02649231|83206382|FG002|Overall Study|Protocol Violation|1|||
46963974|NCT02649231|83206383|FG003|Overall Study|Protocol Violation|0|||
46963975|NCT01376245|83206397|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
46963976|NCT01376245|83206398|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
46963977|NCT01376245|83206399|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
46963978|NCT01376245|83206400|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
46963979|NCT01376245|83206401|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
46963980|NCT01376245|83206397|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
46963981|NCT01376245|83206398|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
46963982|NCT01376245|83206399|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
46963983|NCT01376245|83206400|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
46963984|NCT01376245|83206401|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
46963985|NCT01376245|83206397|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
46963986|NCT01376245|83206398|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
46963987|NCT01376245|83206399|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
46963988|NCT01376245|83206400|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
46963989|NCT01376245|83206401|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
46963990|NCT01376245|83206397|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
46963991|NCT01376245|83206398|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
46963992|NCT01376245|83206399|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
46963993|NCT01376245|83206400|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
46963994|NCT01376245|83206401|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
46963995|NCT01376245|83206397|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
46963996|NCT01376245|83206398|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
46963997|NCT01376245|83206399|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
46963998|NCT01376245|83206400|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
46963999|NCT01376245|83206401|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
46964000|NCT01376245|83206397|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
46964001|NCT01376245|83206398|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
46964002|NCT01376245|83206399|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
46964003|NCT01376245|83206400|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
46964004|NCT01376245|83206401|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
46964005|NCT01376245|83206397|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
46964006|NCT01376245|83206398|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
46964007|NCT01376245|83206399|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
46964008|NCT01376245|83206400|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
46964009|NCT01376245|83206401|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
46964010|NCT01376245|83206397|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
46964011|NCT01376245|83206398|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
46964012|NCT01376245|83206399|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
46964013|NCT01376245|83206400|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
46964014|NCT01376245|83206401|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
46964015|NCT01376245|83206397|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
46964016|NCT01376245|83206398|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
46964017|NCT01376245|83206399|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
46964018|NCT01376245|83206400|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
46964019|NCT01376245|83206401|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
46964020|NCT01376245|83206397|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46964021|NCT01376245|83206398|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
46964022|NCT01376245|83206399|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46964023|NCT01376245|83206400|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
46964024|NCT01376245|83206401|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
46964025|NCT01376245|83206397|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
46964026|NCT01376245|83206398|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
46964027|NCT01376245|83206399|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
46964028|NCT01376245|83206400|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
46964029|NCT01376245|83206401|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
46964030|NCT01376245|83206397|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
46964031|NCT01376245|83206398|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
46964032|NCT01376245|83206399|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
46964033|NCT01376245|83206400|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
46964034|NCT01376245|83206401|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
46964035|NCT01674621|83206416|FG000|Overall Study|Adverse Event|3|||
46964036|NCT01674621|83206417|FG001|Overall Study|Adverse Event|2|||
46964037|NCT01674621|83206418|FG002|Overall Study|Adverse Event|5|||
46964038|NCT01674621|83206419|FG003|Overall Study|Adverse Event|5|||
46964039|NCT01674621|83206420|FG004|Overall Study|Adverse Event|1|||
46964040|NCT01674621|83206416|FG000|Overall Study|Inability to Complete Study Procedures|0|||
46964041|NCT01674621|83206417|FG001|Overall Study|Inability to Complete Study Procedures|0|||
46964042|NCT01674621|83206418|FG002|Overall Study|Inability to Complete Study Procedures|0|||
46964043|NCT01674621|83206419|FG003|Overall Study|Inability to Complete Study Procedures|0|||
46964044|NCT01674621|83206420|FG004|Overall Study|Inability to Complete Study Procedures|2|||
46964045|NCT01674621|83206416|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
46964046|NCT01674621|83206417|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
46964047|NCT01674621|83206418|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
46964048|NCT01674621|83206419|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
46964049|NCT01674621|83206420|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
46964050|NCT01674621|83206416|FG000|Overall Study|Withdrawal by Subject|2|||
46964051|NCT01674621|83206417|FG001|Overall Study|Withdrawal by Subject|5|||
46964052|NCT01674621|83206418|FG002|Overall Study|Withdrawal by Subject|2|||
47067303|NCT01534208|83350901|FG000|Overall Study|Lost to Follow-up|19|||
47067304|NCT01534208|83350902|FG001|Overall Study|Lost to Follow-up|14|||
47067305|NCT01534208|83350901|FG000|Overall Study|Withdrawal by Subject|6|||
47067306|NCT01534208|83350902|FG001|Overall Study|Withdrawal by Subject|20|||
46774438|NCT00741260|82992940|FG006|Overall Study|Disease Progression|4|||
46964053|NCT01674621|83206419|FG003|Overall Study|Withdrawal by Subject|0|||
46964054|NCT01674621|83206420|FG004|Overall Study|Withdrawal by Subject|1|||
46964055|NCT01674621|83206416|FG000|Overall Study|Other than specified|0|||
47067307|NCT01534208|83350901|FG000|Overall Study|Adverse Event|15|||
46774439|NCT00741260|82992934|FG000|Overall Study|Death|0|||
47067308|NCT01534208|83350902|FG001|Overall Study|Adverse Event|8|||
47067309|NCT01534208|83350901|FG000|Overall Study|Physician Decision|2|||
46774440|NCT00741260|82992935|FG001|Overall Study|Death|1|||
46774441|NCT00741260|82992936|FG002|Overall Study|Death|0|||
46964056|NCT01674621|83206417|FG001|Overall Study|Other than specified|1|||
46964057|NCT01674621|83206418|FG002|Overall Study|Other than specified|0|||
46964058|NCT01674621|83206419|FG003|Overall Study|Other than specified|0|||
46964059|NCT01674621|83206420|FG004|Overall Study|Other than specified|2|||
46964060|NCT02730169|83206437|FG000|Overall Study|Protocol Violation|1|||
46964061|NCT02730169|83206438|FG001|Overall Study|Protocol Violation|0|||
46964062|NCT02730169|83206439|FG002|Overall Study|Protocol Violation|0|||
46964063|NCT02730169|83206440|FG003|Overall Study|Protocol Violation|1|||
46964064|NCT02730169|83206437|FG000|Overall Study|Adverse Event|2|||
46964065|NCT02730169|83206438|FG001|Overall Study|Adverse Event|3|||
46964066|NCT02730169|83206439|FG002|Overall Study|Adverse Event|3|||
46964067|NCT02730169|83206440|FG003|Overall Study|Adverse Event|0|||
46964068|NCT02730169|83206437|FG000|Overall Study|Adverse Event of Special Interest|0|||
46964069|NCT02730169|83206438|FG001|Overall Study|Adverse Event of Special Interest|1|||
46964070|NCT02730169|83206439|FG002|Overall Study|Adverse Event of Special Interest|2|||
46964071|NCT02730169|83206440|FG003|Overall Study|Adverse Event of Special Interest|0|||
46964072|NCT02730169|83206437|FG000|Overall Study|Withdrawal by Subject|6|||
46964073|NCT02730169|83206438|FG001|Overall Study|Withdrawal by Subject|11|||
46964074|NCT02730169|83206439|FG002|Overall Study|Withdrawal by Subject|6|||
46964075|NCT02730169|83206440|FG003|Overall Study|Withdrawal by Subject|8|||
46964076|NCT02730169|83206437|FG000|Overall Study|Lost to Follow-up|5|||
46964077|NCT02730169|83206438|FG001|Overall Study|Lost to Follow-up|6|||
46964078|NCT02730169|83206439|FG002|Overall Study|Lost to Follow-up|5|||
46964079|NCT02730169|83206440|FG003|Overall Study|Lost to Follow-up|6|||
46964080|NCT02730169|83206437|FG000|Overall Study|Other|0|||
46964081|NCT02730169|83206438|FG001|Overall Study|Other|0|||
46964082|NCT02730169|83206439|FG002|Overall Study|Other|1|||
46964083|NCT02730169|83206440|FG003|Overall Study|Other|1|||
46964084|NCT02648217|83206452|FG000|Overall Study|Adverse Event|0|||
46964085|NCT02648217|83206453|FG001|Overall Study|Adverse Event|1|||
46964086|NCT02648217|83206452|FG000|Overall Study|Lost to Follow-up|1|||
46964087|NCT02648217|83206453|FG001|Overall Study|Lost to Follow-up|1|||
46964088|NCT02648217|83206452|FG000|Overall Study|Withdrawal by Subject|4|||
46964089|NCT02648217|83206453|FG001|Overall Study|Withdrawal by Subject|3|||
46964090|NCT02648217|83206452|FG000|Overall Study|Unclassified|5|||
46964091|NCT02648217|83206453|FG001|Overall Study|Unclassified|0|||
46964092|NCT00709735|83206461|FG000|Overall Study|Lost to Follow-up|1|||
46964093|NCT00709735|83206462|FG001|Overall Study|Lost to Follow-up|1|||
46964094|NCT00709735|83206461|FG000|Overall Study|Relapse into Opioid Abuse|0|||
46964095|NCT00709735|83206462|FG001|Overall Study|Relapse into Opioid Abuse|1|||
46964096|NCT00709735|83206461|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
46964097|NCT00709735|83206462|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
46964098|NCT02647905|83206468|FG000|Overall Study|Lost to Follow-up|1|||
46964099|NCT02647905|83206468|FG000|Overall Study|Withdrawal by Subject|2|||
46964100|NCT04185909|83206481|FG000|Overall Study|Lost to Follow-up|1|||
46964101|NCT04076943|83206485|FG000|Overall Study|Withdrawal by Subject|12|||
46964102|NCT04076943|83206485|FG000|Overall Study|Adverse Event|1|||
46964103|NCT04076943|83206485|FG000|Overall Study|Progressive Disease|2|||
46964104|NCT04076943|83206485|FG000|Overall Study|Death|13|||
46964105|NCT04076943|83206485|FG000|Overall Study|Other than specified|6|||
46964106|NCT00708643|83206491|FG000|Overall Study|Adverse Event|0|||
46964107|NCT00708643|83206492|FG001|Overall Study|Adverse Event|1|||
46964108|NCT05425563|83206545|FG000|Overall Study|Withdrawal by Subject|17|||
46964109|NCT05097963|83206555|FG000|Overall Study|Protocol Violation|13|||
46964110|NCT05097963|83206555|FG000|Overall Study|Withdrawal by Subject|21|||
46964111|NCT04529096|83206570|FG000|Overall Study|Adverse Event|6|||
46964112|NCT04529096|83206571|FG001|Overall Study|Adverse Event|1|||
46964113|NCT04529096|83206570|FG000|Overall Study|Lack of Efficacy|1|||
46964114|NCT04529096|83206571|FG001|Overall Study|Lack of Efficacy|0|||
46964115|NCT04529096|83206570|FG000|Overall Study|Lost to Follow-up|1|||
46964116|NCT04529096|83206571|FG001|Overall Study|Lost to Follow-up|1|||
46964117|NCT04529096|83206570|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46964118|NCT04529096|83206571|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46964119|NCT04529096|83206570|FG000|Overall Study|Physician Decision|1|||
46964120|NCT04529096|83206571|FG001|Overall Study|Physician Decision|3|||
47067310|NCT01534208|83350902|FG001|Overall Study|Physician Decision|0|||
46964121|NCT04529096|83206570|FG000|Overall Study|Withdrawal by Subject|5|||
46964122|NCT04529096|83206571|FG001|Overall Study|Withdrawal by Subject|0|||
46964123|NCT04442503|83206579|FG000|Overall Study|Adverse Event|1|||
46964124|NCT04442503|83206580|FG001|Overall Study|Adverse Event|1|||
46964125|NCT04442503|83206579|FG000|Overall Study|Lost to Follow-up|8|||
46964126|NCT04442503|83206580|FG001|Overall Study|Lost to Follow-up|6|||
46964127|NCT04442503|83206579|FG000|Overall Study|Physician Decision|0|||
46964128|NCT04442503|83206580|FG001|Overall Study|Physician Decision|2|||
46964129|NCT04442503|83206579|FG000|Overall Study|Withdrawal by Subject|3|||
46964130|NCT04442503|83206580|FG001|Overall Study|Withdrawal by Subject|4|||
46964131|NCT04442503|83206579|FG000|Overall Study|Reason not Specified|0|||
46964132|NCT04442503|83206580|FG001|Overall Study|Reason not Specified|1|||
46964133|NCT04442503|83206579|FG000|Overall Study|Randomized but not Treated|3|||
46964134|NCT04442503|83206580|FG001|Overall Study|Randomized but not Treated|1|||
46964135|NCT04109976|83206593|FG000|Overall Study|Withdrawal by Subject|1|||
46964136|NCT04109976|83206594|FG001|Overall Study|Withdrawal by Subject|0|||
46964137|NCT04068519|83206600|FG000|Dose Verification|Death|15|||
46964138|NCT04068519|83206600|FG000|Dose Verification|Withdrawal by Subject|1|||
46964139|NCT04068519|83206600|FG000|Pharmacokinetic Sub-study|Death|35|||
46964140|NCT04068519|83206600|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
46964141|NCT04068519|83206600|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
46964142|NCT04068519|83206600|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
46964143|NCT04068519|83206600|FG000|Indication Expansion|Death|152|||
46964144|NCT04068519|83206600|FG000|Indication Expansion|Withdrawal by Subject|10|||
46964145|NCT04068519|83206600|FG000|Indication Expansion|Lost to Follow-up|7|||
46964146|NCT03810365|83206627|FG000|Overall Study|Lost to Follow-up|2|||
46964147|NCT03810365|83206628|FG001|Overall Study|Lost to Follow-up|1|||
46964148|NCT03810365|83206627|FG000|Overall Study|Withdrawal by Subject|4|||
46964149|NCT03810365|83206628|FG001|Overall Study|Withdrawal by Subject|3|||
46964150|NCT03810365|83206627|FG000|Overall Study|referred for Sleep apnea|0|||
46964151|NCT03810365|83206628|FG001|Overall Study|referred for Sleep apnea|3|||
46964152|NCT03605758|83206636|FG000|Overall Study|Lost to Follow-up|2|||
46964153|NCT03605758|83206637|FG001|Overall Study|Lost to Follow-up|1|||
46964154|NCT03605758|83206636|FG000|Overall Study|Illness|0|||
46964155|NCT03605758|83206637|FG001|Overall Study|Illness|1|||
46964156|NCT03605758|83206636|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
46964157|NCT03605758|83206637|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
46964158|NCT03016975|83206651|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
46964159|NCT03016975|83206652|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
46964160|NCT03016975|83206653|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
46774442|NCT00741260|82992937|FG003|Overall Study|Death|1|||
46774443|NCT00741260|82992938|FG004|Overall Study|Death|2|||
46774444|NCT00741260|82992939|FG005|Overall Study|Death|2|||
46774445|NCT00741260|82992940|FG006|Overall Study|Death|1|||
46774446|NCT00741260|82992934|FG000|Overall Study|Withdrawal by Subject|0|||
46774447|NCT00741260|82992935|FG001|Overall Study|Withdrawal by Subject|0|||
46774448|NCT00741260|82992936|FG002|Overall Study|Withdrawal by Subject|0|||
46845555|NCT00413699|83062414|FG002|Initial Period|Pregnancy|0|||
46845556|NCT00413699|83062412|FG000|Initial Period|Did not meet entrance criteria|2|||
46845557|NCT00413699|83062413|FG001|Initial Period|Did not meet entrance criteria|2|||
46845558|NCT00413699|83062414|FG002|Initial Period|Did not meet entrance criteria|0|||
46845559|NCT00413699|83062412|FG000|Initial Period|Medication error without adverse event|0|||
46845560|NCT00413699|83062413|FG001|Initial Period|Medication error without adverse event|1|||
46845561|NCT00413699|83062414|FG002|Initial Period|Medication error without adverse event|0|||
46845562|NCT00413699|83062412|FG000|Initial Period|Study terminated by Sponsor|0|||
46845563|NCT00413699|83062413|FG001|Initial Period|Study terminated by Sponsor|1|||
46845564|NCT00413699|83062414|FG002|Initial Period|Study terminated by Sponsor|0|||
46845565|NCT00413699|83062412|FG000|Initial Period|Other|67|||
46845566|NCT00413699|83062413|FG001|Initial Period|Other|211|||
46845567|NCT00413699|83062414|FG002|Initial Period|Other|0|||
46845568|NCT00413699|83062412|FG000|Initial Period|Adverse event related to study drug|178|||
46845569|NCT00413699|83062413|FG001|Initial Period|Adverse event related to study drug|527|||
46845570|NCT00413699|83062414|FG002|Initial Period|Adverse event related to study drug|0|||
46845571|NCT00413699|83062412|FG000|Initial Period|Adverse event not related to study drug|113|||
46845572|NCT00413699|83062413|FG001|Initial Period|Adverse event not related to study drug|248|||
46845573|NCT00413699|83062414|FG002|Initial Period|Adverse event not related to study drug|0|||
46845574|NCT00413699|83062412|FG000|Initial Period|Missing end of study page|0|||
46845575|NCT00413699|83062413|FG001|Initial Period|Missing end of study page|4|||
47067311|NCT01534208|83350901|FG000|Overall Study|Lack of Efficacy|0|||
46774449|NCT00741260|82992937|FG003|Overall Study|Withdrawal by Subject|0|||
46774450|NCT00741260|82992938|FG004|Overall Study|Withdrawal by Subject|1|||
46774451|NCT00741260|82992939|FG005|Overall Study|Withdrawal by Subject|3|||
46774452|NCT00741260|82992940|FG006|Overall Study|Withdrawal by Subject|1|||
46774453|NCT00741260|82992934|FG000|Overall Study|Physician Decision|1|||
46845576|NCT00413699|83062414|FG002|Initial Period|Missing end of study page|0|||
46845577|NCT00413699|83062412|FG000|Initial Period|No longer willing to participate|116|||
46964161|NCT03016975|83206651|FG000|At 6 Months Follow-up|Death|2|||
46964162|NCT03016975|83206652|FG001|At 6 Months Follow-up|Death|0|||
46964163|NCT03016975|83206653|FG002|At 6 Months Follow-up|Death|0|||
46964164|NCT03016975|83206651|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
46774454|NCT00741260|82992935|FG001|Overall Study|Physician Decision|1|||
46964165|NCT03016975|83206652|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
46774455|NCT00741260|82992936|FG002|Overall Study|Physician Decision|0|||
46774456|NCT00741260|82992937|FG003|Overall Study|Physician Decision|0|||
46774457|NCT00741260|82992938|FG004|Overall Study|Physician Decision|0|||
46964166|NCT03016975|83206653|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
47067312|NCT01534208|83350902|FG001|Overall Study|Lack of Efficacy|3|||
46774458|NCT00741260|82992939|FG005|Overall Study|Physician Decision|0|||
46774459|NCT00741260|82992940|FG006|Overall Study|Physician Decision|0|||
46774460|NCT00741260|82992934|FG000|Overall Study|Other|2|||
46774461|NCT00741260|82992935|FG001|Overall Study|Other|1|||
46774462|NCT00741260|82992936|FG002|Overall Study|Other|1|||
46774463|NCT00741260|82992937|FG003|Overall Study|Other|2|||
46774464|NCT00741260|82992938|FG004|Overall Study|Other|1|||
46774465|NCT00741260|82992939|FG005|Overall Study|Other|3|||
46774466|NCT00741260|82992940|FG006|Overall Study|Other|1|||
46845578|NCT00413699|83062413|FG001|Initial Period|No longer willing to participate|368|||
46845579|NCT00413699|83062414|FG002|Initial Period|No longer willing to participate|0|||
46845580|NCT00413699|83062412|FG000|Extension Period|No Longer Willing to Participate|0|||
46845581|NCT00413699|83062413|FG001|Extension Period|No Longer Willing to Participate|0|||
46845582|NCT00413699|83062414|FG002|Extension Period|No Longer Willing to Participate|2|||
46845583|NCT00413699|83062412|FG000|Extension Period|Protocol Violation|0|||
46845584|NCT00413699|83062413|FG001|Extension Period|Protocol Violation|0|||
46845585|NCT00413699|83062414|FG002|Extension Period|Protocol Violation|1|||
46845586|NCT00413699|83062412|FG000|Extension Period|Adverse Event|0|||
46845587|NCT00413699|83062413|FG001|Extension Period|Adverse Event|0|||
46845588|NCT00413699|83062414|FG002|Extension Period|Adverse Event|2|||
46845589|NCT03713320|83062442|FG000|Randomized Period|Adverse Event|1|||
46845590|NCT03713320|83062443|FG001|Randomized Period|Adverse Event|5|||
46845591|NCT03713320|83062444|FG002|Randomized Period|Adverse Event|0|||
46845592|NCT03713320|83062442|FG000|Randomized Period|Physician Decision|1|||
46845593|NCT03713320|83062443|FG001|Randomized Period|Physician Decision|1|||
46845594|NCT03713320|83062444|FG002|Randomized Period|Physician Decision|0|||
46845595|NCT03713320|83062442|FG000|Randomized Period|Withdrawal by Subject|4|||
46845596|NCT03713320|83062443|FG001|Randomized Period|Withdrawal by Subject|0|||
46845597|NCT03713320|83062444|FG002|Randomized Period|Withdrawal by Subject|0|||
46845598|NCT03713320|83062442|FG000|Randomized Period|Participant decision|3|||
46845599|NCT03713320|83062443|FG001|Randomized Period|Participant decision|1|||
46845600|NCT03713320|83062444|FG002|Randomized Period|Participant decision|0|||
46845601|NCT03713320|83062442|FG000|Randomized Period|Study terminated by sponsor|6|||
46845602|NCT03713320|83062443|FG001|Randomized Period|Study terminated by sponsor|3|||
46845603|NCT03713320|83062444|FG002|Randomized Period|Study terminated by sponsor|0|||
46845604|NCT03713320|83062442|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
46845605|NCT03713320|83062443|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
46774467|NCT00740792|82992965|FG000|Overall Study|Adverse Event|3|||
46774468|NCT00740792|82992966|FG001|Overall Study|Adverse Event|1|||
46774469|NCT00740792|82992967|FG002|Overall Study|Adverse Event|1|||
46774470|NCT00740792|82992968|FG003|Overall Study|Adverse Event|3|||
46774471|NCT00740792|82992965|FG000|Overall Study|Lack of Efficacy|1|||
46774472|NCT00740792|82992966|FG001|Overall Study|Lack of Efficacy|1|||
46774473|NCT00740792|82992967|FG002|Overall Study|Lack of Efficacy|0|||
46845606|NCT03713320|83062444|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
46845607|NCT03713320|83062442|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
46845608|NCT03713320|83062443|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
46845609|NCT03713320|83062444|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
46845610|NCT03712930|83062451|FG000|Overall Study|Death|7|||
46845611|NCT03712930|83062451|FG000|Overall Study|Physician Decision|1|||
46845612|NCT03712930|83062451|FG000|Overall Study|Study Terminated by Sponsor|3|||
46845613|NCT03712930|83062451|FG000|Overall Study|Progressive Disease|2|||
46845614|NCT00420407|83062457|FG000|Overall Study|Lost to Follow-up|0|||
46845615|NCT00420407|83062458|FG001|Overall Study|Lost to Follow-up|3|||
46640125|NCT04213326|82814240|FG001|Overall Study|Protocol Violation|25|||
46640126|NCT04213326|82814239|FG000|Overall Study|Participant eligibility changed|106|||
46845616|NCT00420407|83062457|FG000|Overall Study|Physician Decision|2|||
46640127|NCT04213326|82814240|FG001|Overall Study|Participant eligibility changed|19|||
46640128|NCT04213326|82814239|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
46640129|NCT04213326|82814240|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
46774474|NCT00740792|82992968|FG003|Overall Study|Lack of Efficacy|3|||
46774475|NCT00740792|82992965|FG000|Overall Study|Lost to Follow-up|2|||
46774476|NCT00740792|82992966|FG001|Overall Study|Lost to Follow-up|1|||
46774477|NCT00740792|82992967|FG002|Overall Study|Lost to Follow-up|0|||
46774478|NCT00740792|82992968|FG003|Overall Study|Lost to Follow-up|0|||
46774479|NCT00740792|82992965|FG000|Overall Study|Protocol Violation|0|||
46774480|NCT00740792|82992966|FG001|Overall Study|Protocol Violation|1|||
46774481|NCT00740792|82992967|FG002|Overall Study|Protocol Violation|0|||
46845617|NCT00420407|83062458|FG001|Overall Study|Physician Decision|1|||
46845618|NCT00420407|83062457|FG000|Overall Study|subject identified as detainee|1|||
46774482|NCT00740792|82992968|FG003|Overall Study|Protocol Violation|2|||
46774483|NCT00740792|82992965|FG000|Overall Study|Withdrawal by Subject|1|||
46845619|NCT00420407|83062458|FG001|Overall Study|subject identified as detainee|0|||
46845620|NCT00420407|83062457|FG000|Overall Study|subject identified as Jehovah's witness|1|||
46845621|NCT00420407|83062458|FG001|Overall Study|subject identified as Jehovah's witness|0|||
46640130|NCT04213326|82814239|FG000|Overall Study|Incomplete study visit|0|||
46964167|NCT03016975|83206651|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
46964168|NCT03016975|83206652|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
46964169|NCT03016975|83206653|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
46964170|NCT03016975|83206651|FG000|At 6 Months Follow-up|Aborted implant|1|||
46964171|NCT03016975|83206652|FG001|At 6 Months Follow-up|Aborted implant|0|||
46964172|NCT03016975|83206653|FG002|At 6 Months Follow-up|Aborted implant|0|||
46964173|NCT03016975|83206651|FG000|At 2 Year Follow-up|Death|1|||
46964174|NCT03016975|83206652|FG001|At 2 Year Follow-up|Death|0|||
46964175|NCT03016975|83206653|FG002|At 2 Year Follow-up|Death|0|||
46964176|NCT03016975|83206651|FG000|At 3 Year Follow-up|Death|1|||
46964177|NCT03016975|83206652|FG001|At 3 Year Follow-up|Death|0|||
46964178|NCT03016975|83206653|FG002|At 3 Year Follow-up|Death|0|||
46964179|NCT03016975|83206651|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
46964180|NCT03016975|83206652|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
46964181|NCT03016975|83206653|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
46964182|NCT03016975|83206651|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
46964183|NCT03016975|83206652|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
46964184|NCT03016975|83206653|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
46964185|NCT02911792|83206676|FG000|Overall Study|Lost to Follow-up|3|||
46964186|NCT02911792|83206677|FG001|Overall Study|Lost to Follow-up|3|||
46964187|NCT02911792|83206678|FG002|Overall Study|Lost to Follow-up|3|||
46964188|NCT02911792|83206679|FG003|Overall Study|Lost to Follow-up|3|||
46964189|NCT01867606|83206729|FG000|Overall Study|Withdrawal by Subject|10|||
46964190|NCT01867606|83206730|FG001|Overall Study|Withdrawal by Subject|14|||
46964191|NCT01867606|83206729|FG000|Overall Study|Protocol Violation|0|||
46964192|NCT01867606|83206730|FG001|Overall Study|Protocol Violation|1|||
46964193|NCT01828112|83206744|FG000|Overall Study|Adverse Event|6|||
46964194|NCT01828112|83206745|FG001|Overall Study|Adverse Event|8|||
46964195|NCT01828112|83206744|FG000|Overall Study|Death|9|||
46964196|NCT01828112|83206745|FG001|Overall Study|Death|5|||
46964197|NCT01828112|83206744|FG000|Overall Study|Physician Decision|5|||
46964198|NCT01828112|83206745|FG001|Overall Study|Physician Decision|5|||
46964199|NCT01828112|83206744|FG000|Overall Study|Progressive disease|56|||
46964200|NCT01828112|83206745|FG001|Overall Study|Progressive disease|82|||
46964201|NCT01828112|83206744|FG000|Overall Study|Subject/guardian decision|6|||
46964202|NCT01828112|83206745|FG001|Overall Study|Subject/guardian decision|8|||
46964203|NCT01740427|83206753|FG000|Overall Study|Ongoing|45|||
46964204|NCT01740427|83206754|FG001|Overall Study|Ongoing|5|||
46964205|NCT01740427|83206753|FG000|Overall Study|Objective Progression or Relapse|281|||
46964206|NCT01740427|83206754|FG001|Overall Study|Objective Progression or Relapse|171|||
46964207|NCT01740427|83206753|FG000|Overall Study|Adverse Event|31|||
46964208|NCT01740427|83206754|FG001|Overall Study|Adverse Event|9|||
46964209|NCT01740427|83206753|FG000|Overall Study|Global Deterioration of Health Status|28|||
46964210|NCT01740427|83206754|FG001|Overall Study|Global Deterioration of Health Status|12|||
46964211|NCT01740427|83206753|FG000|Overall Study|Participant Refused Continued Treatment|26|||
46964212|NCT01740427|83206754|FG001|Overall Study|Participant Refused Continued Treatment|15|||
46964213|NCT01740427|83206753|FG000|Overall Study|Unspecified reasons|15|||
46964214|NCT01740427|83206754|FG001|Overall Study|Unspecified reasons|4|||
46964215|NCT01740427|83206753|FG000|Overall Study|Death|10|||
46964216|NCT01740427|83206754|FG001|Overall Study|Death|3|||
46964217|NCT01740427|83206753|FG000|Overall Study|Protocol Violation|5|||
46964218|NCT01740427|83206754|FG001|Overall Study|Protocol Violation|3|||
46964219|NCT01740427|83206753|FG000|Overall Study|Lost to Follow-up|2|||
46964220|NCT01740427|83206754|FG001|Overall Study|Lost to Follow-up|0|||
46964221|NCT01740427|83206753|FG000|Overall Study|Site Terminated by Sponsor|1|||
46964222|NCT01740427|83206754|FG001|Overall Study|Site Terminated by Sponsor|0|||
46964223|NCT01657682|83206763|FG000|Overall Study|Lost to Follow-up|1|||
46964224|NCT01657682|83206764|FG001|Overall Study|Lost to Follow-up|0|||
47067313|NCT01534208|83350901|FG000|Overall Study|Protocol Violation|2|||
47067314|NCT01534208|83350902|FG001|Overall Study|Protocol Violation|2|||
47067315|NCT01534208|83350901|FG000|Overall Study|Sponsor decision|4|||
47067316|NCT01534208|83350902|FG001|Overall Study|Sponsor decision|1|||
46964225|NCT01657682|83206765|FG002|Overall Study|Lost to Follow-up|0|||
46964226|NCT01657682|83206763|FG000|Overall Study|Withdrawal by Subject|0|||
46964227|NCT01657682|83206764|FG001|Overall Study|Withdrawal by Subject|1|||
46964228|NCT01657682|83206765|FG002|Overall Study|Withdrawal by Subject|1|||
46964229|NCT01657682|83206763|FG000|Overall Study|Adverse Event|0|||
46964230|NCT01657682|83206764|FG001|Overall Study|Adverse Event|1|||
46964231|NCT01657682|83206765|FG002|Overall Study|Adverse Event|0|||
46964232|NCT01556243|83206785|FG000|Overall Study|Ineligible|34|||
46964233|NCT01556243|83206785|FG000|Overall Study|Converted to mastectomy|14|||
46964234|NCT01556243|83206785|FG000|Overall Study|Unable to achieve negative margins|2|||
46964235|NCT01556243|83206785|FG000|Overall Study|Withdrawal by Subject|16|||
47067317|NCT01534208|83350901|FG000|Overall Study|Subject relocation|2|||
46964236|NCT00819156|83206830|FG000|Overall Study|Adverse Event|1|||
46964237|NCT00819156|83206831|FG001|Overall Study|Adverse Event|4|||
46964238|NCT00819156|83206832|FG002|Overall Study|Adverse Event|2|||
46964239|NCT00819156|83206833|FG003|Overall Study|Adverse Event|1|||
46964240|NCT00819156|83206834|FG004|Overall Study|Adverse Event|2|||
46964241|NCT00819156|83206835|FG005|Overall Study|Adverse Event|3|||
46964242|NCT00819156|83206830|FG000|Overall Study|Withdrawal by Subject|0|||
46964243|NCT00819156|83206831|FG001|Overall Study|Withdrawal by Subject|3|||
46964244|NCT00819156|83206832|FG002|Overall Study|Withdrawal by Subject|2|||
46964245|NCT00819156|83206833|FG003|Overall Study|Withdrawal by Subject|0|||
46964246|NCT00819156|83206834|FG004|Overall Study|Withdrawal by Subject|1|||
46964247|NCT00819156|83206835|FG005|Overall Study|Withdrawal by Subject|0|||
46964248|NCT00819156|83206830|FG000|Overall Study|Protocol Violation|1|||
46964249|NCT00819156|83206831|FG001|Overall Study|Protocol Violation|0|||
46964250|NCT00819156|83206832|FG002|Overall Study|Protocol Violation|1|||
46964251|NCT00819156|83206833|FG003|Overall Study|Protocol Violation|0|||
46964252|NCT00819156|83206834|FG004|Overall Study|Protocol Violation|0|||
46964253|NCT00819156|83206835|FG005|Overall Study|Protocol Violation|1|||
46845622|NCT00420407|83062457|FG000|Overall Study|Withdrawal by Subject|0|||
46845623|NCT00420407|83062458|FG001|Overall Study|Withdrawal by Subject|2|||
46964254|NCT00819156|83206830|FG000|Overall Study|Lost to Follow-up|0|||
46964255|NCT00819156|83206831|FG001|Overall Study|Lost to Follow-up|1|||
46964256|NCT00819156|83206832|FG002|Overall Study|Lost to Follow-up|0|||
46964257|NCT00819156|83206833|FG003|Overall Study|Lost to Follow-up|0|||
46964258|NCT00819156|83206834|FG004|Overall Study|Lost to Follow-up|0|||
46964259|NCT00819156|83206835|FG005|Overall Study|Lost to Follow-up|2|||
46964260|NCT00819156|83206830|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
46964261|NCT00819156|83206831|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
46964262|NCT00819156|83206832|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
46964263|NCT00819156|83206833|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
46964264|NCT00819156|83206834|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
46964265|NCT00819156|83206835|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
46964266|NCT00819156|83206830|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
46964267|NCT00819156|83206831|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
46964268|NCT00819156|83206832|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
46964269|NCT00819156|83206833|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
46845624|NCT00420095|83062467|FG000|Overall Study|Adverse Event|1|||
46845625|NCT00420095|83062468|FG001|Overall Study|Adverse Event|0|||
46845626|NCT00420095|83062467|FG000|Overall Study|Protocol Violation|1|||
46845627|NCT00420095|83062468|FG001|Overall Study|Protocol Violation|1|||
46845628|NCT00420095|83062467|FG000|Overall Study|Lost to Follow-up|1|||
46845629|NCT00420095|83062468|FG001|Overall Study|Lost to Follow-up|0|||
46845630|NCT00419393|83062474|FG000|Overall Study|Adverse Event|5|||
46845631|NCT00419393|83062474|FG000|Overall Study|Protocol Violation|5|||
46845632|NCT00419393|83062474|FG000|Overall Study|Withdrawal by Subject|7|||
46845633|NCT00419393|83062474|FG000|Overall Study|Other: Sponsor request|3|||
46845634|NCT00419393|83062474|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
46845635|NCT00419393|83062474|FG000|Overall Study|Other: Site closure|1|||
46845636|NCT00419393|83062474|FG000|Overall Study|Other: Other health problems|1|||
46845637|NCT00419393|83062474|FG000|Overall Study|Other: Investigator decision|1|||
46845638|NCT00419159|83062480|FG000|Overall Study|Adverse Event|7|||
46845639|NCT00419159|83062481|FG001|Overall Study|Adverse Event|15|||
46845640|NCT00419159|83062480|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46845641|NCT00419159|83062481|FG001|Overall Study|Abnormal laboratory value(s)|2|||
46845642|NCT00419159|83062480|FG000|Overall Study|Subject's no longer requires study drug|0|||
46845643|NCT00419159|83062481|FG001|Overall Study|Subject's no longer requires study drug|1|||
46845644|NCT00419159|83062480|FG000|Overall Study|Protocol Violation|1|||
46845645|NCT00419159|83062481|FG001|Overall Study|Protocol Violation|0|||
46845646|NCT00419159|83062480|FG000|Overall Study|Withdrawal by Subject|10|||
46845647|NCT00419159|83062481|FG001|Overall Study|Withdrawal by Subject|3|||
46845648|NCT00419159|83062480|FG000|Overall Study|Lost to Follow-up|0|||
46845649|NCT00419159|83062481|FG001|Overall Study|Lost to Follow-up|1|||
46964270|NCT00819156|83206834|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
46964271|NCT00819156|83206835|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
46964272|NCT00819156|83206830|FG000|Overall Study|Prostate-specific antigen progression|0|||
46964273|NCT00819156|83206831|FG001|Overall Study|Prostate-specific antigen progression|0|||
46964274|NCT00819156|83206832|FG002|Overall Study|Prostate-specific antigen progression|0|||
46964275|NCT00819156|83206833|FG003|Overall Study|Prostate-specific antigen progression|0|||
46964276|NCT00819156|83206834|FG004|Overall Study|Prostate-specific antigen progression|1|||
46640131|NCT04213326|82814240|FG001|Overall Study|Incomplete study visit|367|||
46964277|NCT00819156|83206835|FG005|Overall Study|Prostate-specific antigen progression|0|||
46964278|NCT00818623|83206865|FG000|Overall Study|Adverse Event|1|||
46964279|NCT00818623|83206866|FG001|Overall Study|Adverse Event|0|||
46964280|NCT00818623|83206867|FG002|Overall Study|Adverse Event|1|||
46964281|NCT00818623|83206868|FG003|Overall Study|Adverse Event|0|||
46964282|NCT00818623|83206869|FG004|Overall Study|Adverse Event|0|||
46845650|NCT00419159|83062480|FG000|Overall Study|Death|2|||
46845651|NCT00419159|83062481|FG001|Overall Study|Death|2|||
46845652|NCT00419159|83062480|FG000|Overall Study|Disease progression|79|||
46845653|NCT00419159|83062481|FG001|Overall Study|Disease progression|76|||
46964283|NCT00818623|83206870|FG005|Overall Study|Adverse Event|1|||
46964284|NCT00818623|83206871|FG006|Overall Study|Adverse Event|0|||
46964285|NCT00818623|83206872|FG007|Overall Study|Adverse Event|0|||
46964286|NCT00818623|83206865|FG000|Overall Study|Bad prostate specific antigen response|0|||
46964287|NCT00818623|83206866|FG001|Overall Study|Bad prostate specific antigen response|3|||
46964288|NCT00818623|83206867|FG002|Overall Study|Bad prostate specific antigen response|2|||
46964289|NCT00818623|83206868|FG003|Overall Study|Bad prostate specific antigen response|5|||
46964290|NCT00818623|83206869|FG004|Overall Study|Bad prostate specific antigen response|0|||
46964291|NCT00818623|83206870|FG005|Overall Study|Bad prostate specific antigen response|1|||
46964292|NCT00818623|83206871|FG006|Overall Study|Bad prostate specific antigen response|0|||
46964293|NCT00818623|83206872|FG007|Overall Study|Bad prostate specific antigen response|0|||
46964294|NCT00818623|83206865|FG000|Overall Study|Withdrawal by Subject|0|||
46964295|NCT00818623|83206866|FG001|Overall Study|Withdrawal by Subject|1|||
46964296|NCT00818623|83206867|FG002|Overall Study|Withdrawal by Subject|1|||
46964297|NCT00818623|83206868|FG003|Overall Study|Withdrawal by Subject|0|||
46964298|NCT00818623|83206869|FG004|Overall Study|Withdrawal by Subject|0|||
46964299|NCT00818623|83206870|FG005|Overall Study|Withdrawal by Subject|1|||
46964300|NCT00818623|83206871|FG006|Overall Study|Withdrawal by Subject|1|||
46964301|NCT00818623|83206872|FG007|Overall Study|Withdrawal by Subject|1|||
46964302|NCT00818623|83206865|FG000|Overall Study|Protocol Violation|1|||
46964303|NCT00818623|83206866|FG001|Overall Study|Protocol Violation|0|||
46964304|NCT00818623|83206867|FG002|Overall Study|Protocol Violation|0|||
46964305|NCT00818623|83206868|FG003|Overall Study|Protocol Violation|0|||
46964306|NCT00818623|83206869|FG004|Overall Study|Protocol Violation|1|||
46964307|NCT00818623|83206870|FG005|Overall Study|Protocol Violation|0|||
46964308|NCT00818623|83206871|FG006|Overall Study|Protocol Violation|1|||
46964309|NCT00818623|83206872|FG007|Overall Study|Protocol Violation|0|||
46964310|NCT00818623|83206865|FG000|Overall Study|Need of additional treatment|0|||
46964311|NCT00818623|83206866|FG001|Overall Study|Need of additional treatment|0|||
46964312|NCT00818623|83206867|FG002|Overall Study|Need of additional treatment|0|||
46964313|NCT00818623|83206868|FG003|Overall Study|Need of additional treatment|0|||
46964314|NCT00818623|83206869|FG004|Overall Study|Need of additional treatment|1|||
46964315|NCT00818623|83206870|FG005|Overall Study|Need of additional treatment|0|||
46964316|NCT00818623|83206871|FG006|Overall Study|Need of additional treatment|0|||
46964317|NCT00818623|83206872|FG007|Overall Study|Need of additional treatment|0|||
46964318|NCT00818623|83206865|FG000|Overall Study|Lack of trial drug at site|0|||
46964319|NCT00818623|83206866|FG001|Overall Study|Lack of trial drug at site|0|||
46964320|NCT00818623|83206867|FG002|Overall Study|Lack of trial drug at site|0|||
46964321|NCT00818623|83206868|FG003|Overall Study|Lack of trial drug at site|0|||
46964322|NCT00818623|83206869|FG004|Overall Study|Lack of trial drug at site|2|||
46964323|NCT00818623|83206870|FG005|Overall Study|Lack of trial drug at site|0|||
46964324|NCT00818623|83206871|FG006|Overall Study|Lack of trial drug at site|1|||
46964325|NCT00818623|83206872|FG007|Overall Study|Lack of trial drug at site|0|||
46964326|NCT00818623|83206865|FG000|Overall Study|Disease progression|0|||
46964327|NCT00818623|83206866|FG001|Overall Study|Disease progression|0|||
46964328|NCT00818623|83206867|FG002|Overall Study|Disease progression|0|||
46964329|NCT00818623|83206868|FG003|Overall Study|Disease progression|0|||
46964330|NCT00818623|83206869|FG004|Overall Study|Disease progression|0|||
46964331|NCT00818623|83206870|FG005|Overall Study|Disease progression|0|||
46964332|NCT00818623|83206871|FG006|Overall Study|Disease progression|1|||
46964333|NCT00818623|83206872|FG007|Overall Study|Disease progression|0|||
46964334|NCT01285557|83206900|FG000|Overall Study|Death|173|||
46964335|NCT01285557|83206901|FG001|Overall Study|Death|90|||
46964336|NCT01285557|83206900|FG000|Overall Study|Lost to Follow-up|6|||
46964337|NCT01285557|83206901|FG001|Overall Study|Lost to Follow-up|2|||
46964338|NCT01285557|83206900|FG000|Overall Study|Withdrew Consent|6|||
46964339|NCT01285557|83206901|FG001|Overall Study|Withdrew Consent|1|||
47067318|NCT01534208|83350902|FG001|Overall Study|Subject relocation|0|||
47067319|NCT01534208|83350901|FG000|Overall Study|Lab assessment|2|||
46845654|NCT03717064|83062495|FG000|Period 2|Adverse Event|1|||
46845655|NCT03716050|83062507|FG000|Overall Study|Lost to Follow-up|0|||
46845656|NCT03716050|83062508|FG001|Overall Study|Lost to Follow-up|0|||
46964340|NCT01285557|83206900|FG000|Overall Study|Sponsor Study Termination|23|||
46964341|NCT01285557|83206901|FG001|Overall Study|Sponsor Study Termination|13|||
46964342|NCT01285557|83206900|FG000|Overall Study|Randomized but not treated|1|||
46964343|NCT01285557|83206901|FG001|Overall Study|Randomized but not treated|1|||
46964344|NCT01285557|83206900|FG000|Overall Study|Study follow-up ongoing|28|||
46964345|NCT01285557|83206901|FG001|Overall Study|Study follow-up ongoing|14|||
46964346|NCT01285557|83206900|FG000|Overall Study|Sponsor Decision|2|||
46964347|NCT01285557|83206901|FG001|Overall Study|Sponsor Decision|1|||
46964348|NCT01376167|83206954|FG000|Overall Study|Lost to Follow-up|2|||
46964349|NCT01376167|83206955|FG001|Overall Study|Lost to Follow-up|4|||
47067320|NCT01534208|83350902|FG001|Overall Study|Lab assessment|1|||
46964350|NCT01376167|83206956|FG002|Overall Study|Lost to Follow-up|2|||
47067321|NCT01534208|83350901|FG000|Overall Study|Eligibility error|3|||
46845657|NCT03716050|83062509|FG002|Overall Study|Lost to Follow-up|1|||
47067322|NCT01534208|83350902|FG001|Overall Study|Eligibility error|0|||
46774484|NCT00740792|82992966|FG001|Overall Study|Withdrawal by Subject|1|||
46774485|NCT00740792|82992967|FG002|Overall Study|Withdrawal by Subject|0|||
46774486|NCT00740792|82992968|FG003|Overall Study|Withdrawal by Subject|0|||
46774487|NCT00740792|82992965|FG000|Overall Study|administrative|3|||
46774488|NCT00740792|82992966|FG001|Overall Study|administrative|3|||
46774489|NCT00740792|82992967|FG002|Overall Study|administrative|8|||
46774490|NCT00740792|82992968|FG003|Overall Study|administrative|2|||
46774491|NCT00740714|82992981|FG000|Overall Study|Withdrawal by Subject|17|||
46774492|NCT00740714|82992982|FG001|Overall Study|Withdrawal by Subject|19|||
46774493|NCT00740714|82992983|FG002|Overall Study|Withdrawal by Subject|29|||
46774494|NCT00788957|82992995|FG000|Part 1|Death|8|||
46774495|NCT00788957|82992996|FG001|Part 1|Death|0|||
46774496|NCT00788957|82992997|FG002|Part 1|Death|0|||
46774497|NCT00788957|82992998|FG003|Part 1|Death|0|||
46774498|NCT00788957|82992999|FG004|Part 1|Death|0|||
46774499|NCT00788957|82993000|FG005|Part 1|Death|0|||
46774500|NCT00788957|82992995|FG000|Part 1|Lost to Follow-up|1|||
46774501|NCT00788957|82992996|FG001|Part 1|Lost to Follow-up|0|||
46774502|NCT00788957|82992997|FG002|Part 1|Lost to Follow-up|0|||
46774503|NCT00788957|82992998|FG003|Part 1|Lost to Follow-up|0|||
46774504|NCT00788957|82992999|FG004|Part 1|Lost to Follow-up|0|||
46774505|NCT00788957|82993000|FG005|Part 1|Lost to Follow-up|0|||
46774506|NCT00788957|82992995|FG000|Part 2|Withdrawal by Subject|0|||
46774507|NCT00788957|82992996|FG001|Part 2|Withdrawal by Subject|9|||
46774508|NCT00788957|82992997|FG002|Part 2|Withdrawal by Subject|5|||
46774509|NCT00788957|82992998|FG003|Part 2|Withdrawal by Subject|3|||
46774510|NCT00788957|82992999|FG004|Part 2|Withdrawal by Subject|0|||
46774511|NCT00788957|82993000|FG005|Part 2|Withdrawal by Subject|0|||
46774512|NCT00788957|82992995|FG000|Part 2|Death|0|||
46774513|NCT00788957|82992996|FG001|Part 2|Death|32|||
46774514|NCT00788957|82992997|FG002|Part 2|Death|35|||
46774515|NCT00788957|82992998|FG003|Part 2|Death|37|||
46774516|NCT00788957|82992999|FG004|Part 2|Death|0|||
46774517|NCT00788957|82993000|FG005|Part 2|Death|0|||
46774518|NCT00788957|82992995|FG000|Part 2|Lost to Follow-up|0|||
46774519|NCT00788957|82992996|FG001|Part 2|Lost to Follow-up|0|||
46774520|NCT00788957|82992997|FG002|Part 2|Lost to Follow-up|3|||
46774521|NCT00788957|82992998|FG003|Part 2|Lost to Follow-up|0|||
46774522|NCT00788957|82992999|FG004|Part 2|Lost to Follow-up|0|||
46774523|NCT00788957|82993000|FG005|Part 2|Lost to Follow-up|0|||
46774524|NCT00788957|82992995|FG000|Part 2|On-study at time of data cut-off|0|||
46774525|NCT00788957|82992996|FG001|Part 2|On-study at time of data cut-off|1|||
46774526|NCT00788957|82992997|FG002|Part 2|On-study at time of data cut-off|1|||
46774527|NCT00788957|82992998|FG003|Part 2|On-study at time of data cut-off|1|||
46774528|NCT00788957|82992999|FG004|Part 2|On-study at time of data cut-off|0|||
46774529|NCT00788957|82993000|FG005|Part 2|On-study at time of data cut-off|0|||
46774530|NCT00788957|82992995|FG000|Part 3|Withdrawal by Subject|0|||
46774531|NCT00788957|82992996|FG001|Part 3|Withdrawal by Subject|0|||
46774532|NCT00788957|82992997|FG002|Part 3|Withdrawal by Subject|0|||
46774533|NCT00788957|82992998|FG003|Part 3|Withdrawal by Subject|0|||
46774534|NCT00788957|82992999|FG004|Part 3|Withdrawal by Subject|0|||
46774535|NCT00788957|82993000|FG005|Part 3|Withdrawal by Subject|2|||
46845658|NCT03716050|83062510|FG003|Overall Study|Lost to Follow-up|0|||
47067323|NCT01534208|83350901|FG000|Overall Study|PCP decision|1|||
47067324|NCT01534208|83350902|FG001|Overall Study|PCP decision|0|||
47067325|NCT01534208|83350901|FG000|Overall Study|Needed prohibited meds|1|||
47067326|NCT01534208|83350902|FG001|Overall Study|Needed prohibited meds|0|||
47067327|NCT01548638|83350908|FG000|Overall Study|Protocol Violation|3|||
47067328|NCT01548638|83350908|FG000|Overall Study|Withdrawal by Subject|1|||
47067329|NCT01533428|83350932|FG000|Overall Study|Adverse Event|0|||
47067330|NCT01533428|83350933|FG001|Overall Study|Adverse Event|1|||
47067331|NCT01533428|83350932|FG000|Overall Study|Lost to Follow-up|2|||
47067332|NCT01533428|83350933|FG001|Overall Study|Lost to Follow-up|1|||
47067333|NCT01533428|83350932|FG000|Overall Study|Withdrawal by Subject|7|||
47067334|NCT01533428|83350933|FG001|Overall Study|Withdrawal by Subject|6|||
47067335|NCT01517984|83350942|FG000|Overall Study|Lost to Follow-up|0|||
47067336|NCT01517984|83350943|FG001|Overall Study|Lost to Follow-up|1|||
47067337|NCT01517984|83350944|FG002|Overall Study|Lost to Follow-up|0|||
47067338|NCT01517984|83350945|FG003|Overall Study|Lost to Follow-up|0|||
46640132|NCT01625286|82814253|FG000|Overall Study|Adverse Event|0|||
46774536|NCT00788957|82992995|FG000|Part 3|Death|0|||
46774537|NCT00788957|82992996|FG001|Part 3|Death|0|||
46774538|NCT00788957|82992997|FG002|Part 3|Death|0|||
46774539|NCT00788957|82992998|FG003|Part 3|Death|0|||
46774540|NCT00788957|82992999|FG004|Part 3|Death|8|||
46774541|NCT00788957|82993000|FG005|Part 3|Death|9|||
46774542|NCT00788957|82992995|FG000|Part 3|On-study at time of data cut-off|0|||
46774543|NCT00788957|82992996|FG001|Part 3|On-study at time of data cut-off|0|||
46774544|NCT00788957|82992997|FG002|Part 3|On-study at time of data cut-off|0|||
47067339|NCT01517984|83350942|FG000|Overall Study|Withdrawal by Subject|1|||
47067340|NCT01517984|83350943|FG001|Overall Study|Withdrawal by Subject|8|||
47067341|NCT01517984|83350944|FG002|Overall Study|Withdrawal by Subject|4|||
47067342|NCT01517984|83350945|FG003|Overall Study|Withdrawal by Subject|1|||
47067343|NCT01517984|83350942|FG000|Overall Study|Screen Failure|4|||
47067344|NCT01517984|83350943|FG001|Overall Study|Screen Failure|0|||
47067345|NCT01517984|83350944|FG002|Overall Study|Screen Failure|0|||
46964351|NCT01376167|83206954|FG000|Overall Study|Physician Decision|1|||
46964352|NCT01376167|83206955|FG001|Overall Study|Physician Decision|1|||
46964353|NCT01376167|83206956|FG002|Overall Study|Physician Decision|0|||
46964354|NCT01376167|83206954|FG000|Overall Study|Withdrawal by Subject|1|||
46964355|NCT01376167|83206955|FG001|Overall Study|Withdrawal by Subject|5|||
46964356|NCT01376167|83206956|FG002|Overall Study|Withdrawal by Subject|4|||
46964357|NCT02647281|83206976|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964358|NCT02647281|83206977|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964359|NCT02647281|83206978|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964360|NCT02647281|83206979|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964361|NCT02647281|83206980|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964362|NCT02647281|83206981|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964363|NCT02647281|83206982|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964364|NCT02647281|83206983|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
46964365|NCT02647281|83206984|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
46964366|NCT02729545|83207015|FG000|Overall Study|Pregnancy|1|||
46964367|NCT02729545|83207016|FG001|Overall Study|Pregnancy|1|||
46964368|NCT02729545|83207015|FG000|Overall Study|Lost to Follow-up|0|||
46964369|NCT02729545|83207016|FG001|Overall Study|Lost to Follow-up|1|||
46964370|NCT02729545|83207015|FG000|Overall Study|Withdrawal by Subject|2|||
46964371|NCT02729545|83207016|FG001|Overall Study|Withdrawal by Subject|3|||
46964372|NCT01376089|83207024|FG000|Overall Study|Patient received no contrast media|3|||
46964373|NCT01376089|83207025|FG001|Overall Study|Patient received no contrast media|4|||
46964374|NCT00706849|83207037|FG000|Treatment Period|Adverse Event|0|||
46964375|NCT00706849|83207038|FG001|Treatment Period|Adverse Event|9|||
46964376|NCT00706849|83207037|FG000|Treatment Period|Other|0|||
46964377|NCT00706849|83207038|FG001|Treatment Period|Other|1|||
46964378|NCT00706849|83207037|FG000|Follow-up Period|Withdrawal by Subject|0|||
46964379|NCT00706849|83207038|FG001|Follow-up Period|Withdrawal by Subject|2|||
46964380|NCT00706849|83207037|FG000|Follow-up Period|Protocol non-compliance|0|||
46964381|NCT00706849|83207038|FG001|Follow-up Period|Protocol non-compliance|1|||
46964382|NCT00707161|83207044|FG000|Overall Study|Physician Decision|6|||
46964383|NCT02130466|83207062|FG000|Overall Study|Death|4|||
46964384|NCT02130466|83207063|FG001|Overall Study|Death|1|||
46964385|NCT02130466|83207064|FG002|Overall Study|Death|1|||
46964386|NCT02130466|83207065|FG003|Overall Study|Death|3|||
46964387|NCT02130466|83207066|FG004|Overall Study|Death|2|||
47067346|NCT01517984|83350945|FG003|Overall Study|Screen Failure|0|||
47067347|NCT01517984|83350942|FG000|Overall Study|Ineligible for randomization|0|||
47067348|NCT01517984|83350943|FG001|Overall Study|Ineligible for randomization|14|||
47067349|NCT01517984|83350944|FG002|Overall Study|Ineligible for randomization|0|||
47067350|NCT01517984|83350945|FG003|Overall Study|Ineligible for randomization|0|||
47067351|NCT01517750|83350973|FG000|Overall Study|Lost to Follow-up|1|||
47067352|NCT01517750|83350974|FG001|Overall Study|Lost to Follow-up|2|||
47067353|NCT01517750|83350975|FG002|Overall Study|Lost to Follow-up|4|||
47067354|NCT01517750|83350976|FG003|Overall Study|Lost to Follow-up|1|||
47067355|NCT01548404|83351001|FG000|Overall Study|Adverse Event|3|||
47067356|NCT01548404|83351002|FG001|Overall Study|Adverse Event|1|||
47067357|NCT01548404|83351001|FG000|Overall Study|Physician Decision|2|||
47067358|NCT01548404|83351002|FG001|Overall Study|Physician Decision|1|||
47067359|NCT01548404|83351001|FG000|Overall Study|Inadequate response to study treatment|23|||
47067360|NCT01548404|83351002|FG001|Overall Study|Inadequate response to study treatment|7|||
47067361|NCT01548404|83351001|FG000|Overall Study|Lost to Follow-up|2|||
47067362|NCT01548404|83351002|FG001|Overall Study|Lost to Follow-up|0|||
47067363|NCT01548404|83351001|FG000|Overall Study|Withdrawal by Subject|0|||
47067364|NCT01548404|83351002|FG001|Overall Study|Withdrawal by Subject|3|||
47067365|NCT01548404|83351001|FG000|Overall Study|Other than specified above|0|||
47067366|NCT01548404|83351002|FG001|Overall Study|Other than specified above|2|||
47067367|NCT01547780|83351016|FG000|Baseline PET Scan|Physician Decision|1|||
47067368|NCT01547780|83351017|FG001|Baseline PET Scan|Physician Decision|0|||
46964388|NCT02130466|83207067|FG005|Overall Study|Death|30|||
46964389|NCT02130466|83207068|FG006|Overall Study|Death|45|||
46964390|NCT02130466|83207069|FG007|Overall Study|Death|2|||
46964391|NCT02130466|83207070|FG008|Overall Study|Death|3|||
46964392|NCT02130466|83207071|FG009|Overall Study|Death|4|||
46964393|NCT02130466|83207072|FG010|Overall Study|Death|5|||
46964394|NCT02130466|83207073|FG011|Overall Study|Death|3|||
46964395|NCT02130466|83207074|FG012|Overall Study|Death|11|||
47067369|NCT01547780|83351018|FG002|Baseline PET Scan|Physician Decision|1|||
47067370|NCT01547780|83351019|FG003|Baseline PET Scan|Physician Decision|0|||
47067371|NCT01547780|83351016|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
47067372|NCT01547780|83351017|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
47067373|NCT01547780|83351018|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
46964396|NCT02130466|83207075|FG013|Overall Study|Death|7|||
46964397|NCT02130466|83207062|FG000|Overall Study|Lost to Follow-up|1|||
46964398|NCT02130466|83207063|FG001|Overall Study|Lost to Follow-up|0|||
46964399|NCT02130466|83207064|FG002|Overall Study|Lost to Follow-up|0|||
46964400|NCT02130466|83207065|FG003|Overall Study|Lost to Follow-up|0|||
46964401|NCT02130466|83207066|FG004|Overall Study|Lost to Follow-up|0|||
46964402|NCT02130466|83207067|FG005|Overall Study|Lost to Follow-up|1|||
46964403|NCT02130466|83207068|FG006|Overall Study|Lost to Follow-up|0|||
46964404|NCT02130466|83207069|FG007|Overall Study|Lost to Follow-up|0|||
46964405|NCT02130466|83207070|FG008|Overall Study|Lost to Follow-up|0|||
46964406|NCT02130466|83207071|FG009|Overall Study|Lost to Follow-up|0|||
46964407|NCT02130466|83207072|FG010|Overall Study|Lost to Follow-up|0|||
46964408|NCT02130466|83207073|FG011|Overall Study|Lost to Follow-up|0|||
46964409|NCT02130466|83207074|FG012|Overall Study|Lost to Follow-up|1|||
46964410|NCT02130466|83207075|FG013|Overall Study|Lost to Follow-up|0|||
46964411|NCT02130466|83207062|FG000|Overall Study|Physician Decision|0|||
46964412|NCT02130466|83207063|FG001|Overall Study|Physician Decision|0|||
46964413|NCT02130466|83207064|FG002|Overall Study|Physician Decision|0|||
46964414|NCT02130466|83207065|FG003|Overall Study|Physician Decision|0|||
46964415|NCT02130466|83207066|FG004|Overall Study|Physician Decision|0|||
46964416|NCT02130466|83207067|FG005|Overall Study|Physician Decision|1|||
46964417|NCT02130466|83207068|FG006|Overall Study|Physician Decision|1|||
46964418|NCT02130466|83207069|FG007|Overall Study|Physician Decision|0|||
46964419|NCT02130466|83207070|FG008|Overall Study|Physician Decision|0|||
46964420|NCT02130466|83207071|FG009|Overall Study|Physician Decision|0|||
46964421|NCT02130466|83207072|FG010|Overall Study|Physician Decision|0|||
46964422|NCT02130466|83207073|FG011|Overall Study|Physician Decision|0|||
46964423|NCT02130466|83207074|FG012|Overall Study|Physician Decision|0|||
46964424|NCT02130466|83207075|FG013|Overall Study|Physician Decision|0|||
46964425|NCT02130466|83207062|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
46964426|NCT02130466|83207063|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
46964427|NCT02130466|83207064|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
46964428|NCT02130466|83207065|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
46964429|NCT02130466|83207066|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
46964430|NCT02130466|83207067|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
46964431|NCT02130466|83207068|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
46964432|NCT02130466|83207069|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
46964433|NCT02130466|83207070|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
46964434|NCT02130466|83207071|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
46964435|NCT02130466|83207072|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
46964436|NCT02130466|83207073|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
46964437|NCT02130466|83207074|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
46964438|NCT02130466|83207075|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
46964439|NCT02130466|83207062|FG000|Overall Study|Withdrawal by Subject|1|||
46964440|NCT02130466|83207063|FG001|Overall Study|Withdrawal by Subject|0|||
46964441|NCT02130466|83207064|FG002|Overall Study|Withdrawal by Subject|0|||
46964442|NCT02130466|83207065|FG003|Overall Study|Withdrawal by Subject|0|||
46964443|NCT02130466|83207066|FG004|Overall Study|Withdrawal by Subject|0|||
46964444|NCT02130466|83207067|FG005|Overall Study|Withdrawal by Subject|1|||
46964445|NCT02130466|83207068|FG006|Overall Study|Withdrawal by Subject|0|||
46774545|NCT00788957|82992998|FG003|Part 3|On-study at time of data cut-off|0|||
46774546|NCT00788957|82992999|FG004|Part 3|On-study at time of data cut-off|1|||
46774547|NCT00788957|82993000|FG005|Part 3|On-study at time of data cut-off|0|||
46774548|NCT00740636|82993019|FG000|Overall Study|Adverse Event|0|||
46774549|NCT00740636|82993020|FG001|Overall Study|Adverse Event|2|||
46845659|NCT03716050|83062511|FG004|Overall Study|Lost to Follow-up|0|||
46774550|NCT00740636|82993019|FG000|Overall Study|Patient Ineligible|0|||
46774551|NCT00740636|82993020|FG001|Overall Study|Patient Ineligible|1|||
46774552|NCT00740636|82993019|FG000|Overall Study|Patient Not Treated|0|||
46774553|NCT00740636|82993020|FG001|Overall Study|Patient Not Treated|1|||
46774554|NCT00740636|82993019|FG000|Overall Study|Progressive Disease|1|||
46774555|NCT00740636|82993020|FG001|Overall Study|Progressive Disease|0|||
46774556|NCT00740636|82993019|FG000|Overall Study|Death|1|||
46845660|NCT03716050|83062512|FG005|Overall Study|Lost to Follow-up|0|||
46964446|NCT02130466|83207069|FG007|Overall Study|Withdrawal by Subject|0|||
46964447|NCT02130466|83207070|FG008|Overall Study|Withdrawal by Subject|1|||
46964448|NCT02130466|83207071|FG009|Overall Study|Withdrawal by Subject|0|||
46964449|NCT02130466|83207072|FG010|Overall Study|Withdrawal by Subject|0|||
46964450|NCT02130466|83207073|FG011|Overall Study|Withdrawal by Subject|0|||
46964451|NCT02130466|83207074|FG012|Overall Study|Withdrawal by Subject|0|||
46774557|NCT00740636|82993020|FG001|Overall Study|Death|0|||
46774558|NCT00735254|82993030|FG000|Overall Study|Protocol Violation|1|||
46964452|NCT02130466|83207075|FG013|Overall Study|Withdrawal by Subject|0|||
46964453|NCT02163538|83207124|FG000|Overall Study|Protocol Violation|1|||
46774559|NCT00735254|82993031|FG001|Overall Study|Protocol Violation|1|||
46964454|NCT02163538|83207125|FG001|Overall Study|Protocol Violation|0|||
46964455|NCT02163538|83207124|FG000|Overall Study|Physician Decision|0|||
46964456|NCT02163538|83207125|FG001|Overall Study|Physician Decision|1|||
46964457|NCT02163226|83207133|FG000|Overall Study|Death|2|||
46964458|NCT02163226|83207134|FG001|Overall Study|Death|1|||
46964459|NCT02163226|83207133|FG000|Overall Study|Withdrawal by Subject|5|||
46964460|NCT02163226|83207134|FG001|Overall Study|Withdrawal by Subject|2|||
46964461|NCT02163226|83207133|FG000|Overall Study|Returned home, local radiotherapy|3|||
46964462|NCT02163226|83207134|FG001|Overall Study|Returned home, local radiotherapy|0|||
46964463|NCT02163226|83207133|FG000|Overall Study|Repeat imaging showed no disease|2|||
46964464|NCT02163226|83207134|FG001|Overall Study|Repeat imaging showed no disease|0|||
47067374|NCT01547780|83351019|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
47067375|NCT01547390|83351041|FG000|Overall Study|Withdrawal by Subject|10|||
47067376|NCT01547390|83351042|FG001|Overall Study|Withdrawal by Subject|7|||
47067377|NCT01547390|83351041|FG000|Overall Study|termination of pregnancy|0|||
47067378|NCT01547390|83351042|FG001|Overall Study|termination of pregnancy|1|||
47067379|NCT01547390|83351041|FG000|Overall Study|Lost to Follow-up|0|||
47067380|NCT01547390|83351042|FG001|Overall Study|Lost to Follow-up|2|||
47067381|NCT01547390|83351041|FG000|Overall Study|Adverse Event|3|||
46845661|NCT03716050|83062513|FG006|Overall Study|Lost to Follow-up|0|||
46845662|NCT03716050|83062514|FG007|Overall Study|Lost to Follow-up|0|||
46845663|NCT03716050|83062507|FG000|Overall Study|Physician Decision|0|||
46845664|NCT03716050|83062508|FG001|Overall Study|Physician Decision|0|||
46845665|NCT03716050|83062509|FG002|Overall Study|Physician Decision|0|||
46845666|NCT03716050|83062510|FG003|Overall Study|Physician Decision|1|||
46845667|NCT03716050|83062511|FG004|Overall Study|Physician Decision|0|||
46845668|NCT03716050|83062512|FG005|Overall Study|Physician Decision|0|||
46845669|NCT03716050|83062513|FG006|Overall Study|Physician Decision|0|||
46845670|NCT03716050|83062514|FG007|Overall Study|Physician Decision|0|||
46845671|NCT03716050|83062507|FG000|Overall Study|Protocol Violation|0|||
46845672|NCT03716050|83062508|FG001|Overall Study|Protocol Violation|0|||
46845673|NCT03716050|83062509|FG002|Overall Study|Protocol Violation|0|||
46845674|NCT03716050|83062510|FG003|Overall Study|Protocol Violation|1|||
46845675|NCT03716050|83062511|FG004|Overall Study|Protocol Violation|0|||
46845676|NCT03716050|83062512|FG005|Overall Study|Protocol Violation|0|||
46845677|NCT03716050|83062513|FG006|Overall Study|Protocol Violation|0|||
46845678|NCT03716050|83062514|FG007|Overall Study|Protocol Violation|2|||
46845679|NCT00413231|83062531|FG000|0 to 30-day Post Treatment|Death|5|||
46845680|NCT00413231|83062531|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
46845681|NCT00413231|83062531|FG000|30-day to 365-day Post Treatment|Death|13|||
46845682|NCT00413231|83062531|FG000|365-day to 60-month Post Treatment|Death|36|||
46845683|NCT00413231|83062531|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
46845684|NCT00413231|83062531|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
46845685|NCT00413231|83062531|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
46845686|NCT00413153|83062551|FG000|Overall Study|Withdrawal by Subject|1|||
46845687|NCT00413153|83062552|FG001|Overall Study|Withdrawal by Subject|1|||
46845688|NCT00413153|83062551|FG000|Overall Study|Adverse Event|1|||
46845689|NCT00413153|83062552|FG001|Overall Study|Adverse Event|0|||
46845690|NCT00412607|83062558|FG000|Overall Study|Withdrawal by Subject|9|||
46845691|NCT00412607|83062558|FG000|Overall Study|Lost to Follow-up|19|||
46845692|NCT00412607|83062558|FG000|Overall Study|Death|61|||
46845693|NCT00412607|83062558|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
46845694|NCT00419003|83062567|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
46845695|NCT00419003|83062568|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
46845696|NCT00419003|83062567|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
46845697|NCT00419003|83062568|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
46845698|NCT00418691|83062580|FG000|Overall Study|Lost to Follow-up|1|||
46845699|NCT00418691|83062581|FG001|Overall Study|Lost to Follow-up|2|||
46845700|NCT00418691|83062582|FG002|Overall Study|Lost to Follow-up|3|||
46845701|NCT00418691|83062580|FG000|Overall Study|Started new medication voiding entry|0|||
46845702|NCT00418691|83062581|FG001|Overall Study|Started new medication voiding entry|0|||
46845703|NCT00418691|83062582|FG002|Overall Study|Started new medication voiding entry|1|||
46845704|NCT00418691|83062580|FG000|Overall Study|Progressive Disease|1|||
46845705|NCT00418691|83062581|FG001|Overall Study|Progressive Disease|0|||
46845706|NCT00418691|83062582|FG002|Overall Study|Progressive Disease|1|||
46845707|NCT00412373|83062592|FG000|Overall Study|Adverse Event|8|||
46845708|NCT00412373|83062593|FG001|Overall Study|Adverse Event|13|||
46845709|NCT00412373|83062592|FG000|Overall Study|Lack of Efficacy|16|||
46845710|NCT00412373|83062593|FG001|Overall Study|Lack of Efficacy|22|||
46845711|NCT00412373|83062592|FG000|Overall Study|Lost to Follow-up|7|||
46845712|NCT00412373|83062593|FG001|Overall Study|Lost to Follow-up|13|||
46845713|NCT00412373|83062592|FG000|Overall Study|Withdrawal by Subject|8|||
46845714|NCT00412373|83062593|FG001|Overall Study|Withdrawal by Subject|27|||
46845715|NCT00412373|83062592|FG000|Overall Study|Other|2|||
46845716|NCT00412373|83062593|FG001|Overall Study|Other|2|||
46845717|NCT00418379|83062602|FG000|Year 1|Adverse Event|9|||
46845718|NCT00418379|83062603|FG001|Year 1|Adverse Event|15|||
46964465|NCT02163226|83207133|FG000|Overall Study|Incomplete radiotherapy|3|||
46964466|NCT02163226|83207134|FG001|Overall Study|Incomplete radiotherapy|0|||
46964467|NCT02163226|83207133|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
46964468|NCT02163226|83207134|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
46964469|NCT02163226|83207133|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
46964470|NCT02163226|83207134|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
46964471|NCT02163226|83207133|FG000|Overall Study|ineligible|0|||
46964472|NCT02163226|83207134|FG001|Overall Study|ineligible|3|||
46964473|NCT02193178|83207140|FG000|Overall Study|Lost to Follow-up|1|||
46964474|NCT02193178|83207140|FG000|Overall Study|Dry eyes|1|||
46964475|NCT02129608|83207161|FG000|Overall Study|Lost to Follow-up|0|||
46964476|NCT02129608|83207162|FG001|Overall Study|Lost to Follow-up|1|||
46964477|NCT02129608|83207163|FG002|Overall Study|Lost to Follow-up|1|||
46964478|NCT02129608|83207161|FG000|Overall Study|Withdrawal by Subject|0|||
46964479|NCT02129608|83207162|FG001|Overall Study|Withdrawal by Subject|0|||
46964480|NCT02129608|83207163|FG002|Overall Study|Withdrawal by Subject|2|||
46964481|NCT01631188|83207171|FG000|Overall Study|Physician Decision|75|||
46964482|NCT02129062|83207175|FG000|Overall Study|Death|1|||
46964483|NCT02129062|83207175|FG000|Overall Study|Disease Progression|2|||
46964484|NCT02162758|83207181|FG000|Overall Study|Study termination|0|||
46964485|NCT02162758|83207182|FG001|Overall Study|Study termination|1|||
46964486|NCT02192164|83207188|FG000|Overall Study|Other|8|||
46964487|NCT02192164|83207188|FG000|Overall Study|Withdrawal by Subject|1|||
46964488|NCT02192164|83207188|FG000|Overall Study|Physician Decision|4|||
46964489|NCT02192164|83207188|FG000|Overall Study|Did not meet the exclusion criteria|1|||
46964490|NCT02191618|83207195|FG000|Overall Study|Withdrawal by Subject|3|||
46964491|NCT02191618|83207195|FG000|Overall Study|Missed Visit|4|||
46964492|NCT02646891|83207209|FG000|Overall Study|Adverse Event|0|||
46964493|NCT02646891|83207210|FG001|Overall Study|Adverse Event|1|||
46964494|NCT02646891|83207211|FG002|Overall Study|Adverse Event|0|||
46964495|NCT02646891|83207212|FG003|Overall Study|Adverse Event|0|||
46964496|NCT02646891|83207213|FG004|Overall Study|Adverse Event|0|||
46964497|NCT02646891|83207214|FG005|Overall Study|Adverse Event|0|||
46964498|NCT02646891|83207215|FG006|Overall Study|Adverse Event|0|||
46964499|NCT02646891|83207216|FG007|Overall Study|Adverse Event|0|||
46964500|NCT02646891|83207217|FG008|Overall Study|Adverse Event|0|||
46964501|NCT02646891|83207218|FG009|Overall Study|Adverse Event|0|||
46964502|NCT02646891|83207209|FG000|Overall Study|Lost to Follow-up|0|||
46964503|NCT02646891|83207210|FG001|Overall Study|Lost to Follow-up|0|||
46964504|NCT02646891|83207211|FG002|Overall Study|Lost to Follow-up|0|||
46964505|NCT02646891|83207212|FG003|Overall Study|Lost to Follow-up|0|||
46964506|NCT02646891|83207213|FG004|Overall Study|Lost to Follow-up|0|||
46964507|NCT02646891|83207214|FG005|Overall Study|Lost to Follow-up|0|||
46964508|NCT02646891|83207215|FG006|Overall Study|Lost to Follow-up|2|||
46964509|NCT02646891|83207216|FG007|Overall Study|Lost to Follow-up|2|||
46964510|NCT02646891|83207217|FG008|Overall Study|Lost to Follow-up|2|||
46964511|NCT02646891|83207218|FG009|Overall Study|Lost to Follow-up|2|||
46964512|NCT02646891|83207209|FG000|Overall Study|Protocol Violation|0|||
46964513|NCT02646891|83207210|FG001|Overall Study|Protocol Violation|0|||
46964514|NCT02646891|83207211|FG002|Overall Study|Protocol Violation|0|||
46964515|NCT02646891|83207212|FG003|Overall Study|Protocol Violation|0|||
46964516|NCT02646891|83207213|FG004|Overall Study|Protocol Violation|0|||
46964517|NCT02646891|83207214|FG005|Overall Study|Protocol Violation|0|||
46964518|NCT02646891|83207215|FG006|Overall Study|Protocol Violation|1|||
46964519|NCT02646891|83207216|FG007|Overall Study|Protocol Violation|1|||
46964520|NCT02646891|83207217|FG008|Overall Study|Protocol Violation|0|||
46964521|NCT02646891|83207218|FG009|Overall Study|Protocol Violation|0|||
46964522|NCT02646891|83207209|FG000|Overall Study|Withdrawal by Subject|2|||
46964523|NCT02646891|83207210|FG001|Overall Study|Withdrawal by Subject|0|||
46964524|NCT02646891|83207211|FG002|Overall Study|Withdrawal by Subject|1|||
46964525|NCT02646891|83207212|FG003|Overall Study|Withdrawal by Subject|0|||
46845719|NCT00418379|83062604|FG002|Year 1|Adverse Event|3|||
46964526|NCT02646891|83207213|FG004|Overall Study|Withdrawal by Subject|0|||
46964527|NCT02646891|83207214|FG005|Overall Study|Withdrawal by Subject|0|||
46964528|NCT02646891|83207215|FG006|Overall Study|Withdrawal by Subject|5|||
46845720|NCT00418379|83062602|FG000|Year 1|Withdrawal by Subject|7|||
46845721|NCT00418379|83062603|FG001|Year 1|Withdrawal by Subject|8|||
46845722|NCT00418379|83062604|FG002|Year 1|Withdrawal by Subject|5|||
46845723|NCT00418379|83062602|FG000|Year 1|Any other reason not above-mentioned|2|||
46845724|NCT00418379|83062603|FG001|Year 1|Any other reason not above-mentioned|5|||
46845725|NCT00418379|83062604|FG002|Year 1|Any other reason not above-mentioned|7|||
46845726|NCT00418379|83062602|FG000|Year 2|Adverse Event|5|||
46845727|NCT00418379|83062603|FG001|Year 2|Adverse Event|2|||
46845728|NCT00418379|83062604|FG002|Year 2|Adverse Event|1|||
46845729|NCT00418379|83062602|FG000|Year 2|Withdrawal by Subject|1|||
46845730|NCT00418379|83062603|FG001|Year 2|Withdrawal by Subject|1|||
46845731|NCT00418379|83062604|FG002|Year 2|Withdrawal by Subject|3|||
46845732|NCT00418379|83062602|FG000|Year 2|Any other reason not above-mentioned|2|||
46845733|NCT00418379|83062603|FG001|Year 2|Any other reason not above-mentioned|1|||
46964529|NCT02646891|83207216|FG007|Overall Study|Withdrawal by Subject|9|||
46964530|NCT02646891|83207217|FG008|Overall Study|Withdrawal by Subject|7|||
46964531|NCT02646891|83207218|FG009|Overall Study|Withdrawal by Subject|3|||
46964532|NCT02646891|83207209|FG000|Overall Study|Death|0|||
46964533|NCT02646891|83207210|FG001|Overall Study|Death|0|||
46964534|NCT02646891|83207211|FG002|Overall Study|Death|0|||
46964535|NCT02646891|83207212|FG003|Overall Study|Death|0|||
46964536|NCT02646891|83207213|FG004|Overall Study|Death|0|||
46964537|NCT02646891|83207214|FG005|Overall Study|Death|0|||
46964538|NCT02646891|83207215|FG006|Overall Study|Death|1|||
46964539|NCT02646891|83207216|FG007|Overall Study|Death|1|||
46964540|NCT02646891|83207217|FG008|Overall Study|Death|1|||
46964541|NCT02646891|83207218|FG009|Overall Study|Death|0|||
46964542|NCT02646423|83207254|FG000|Overall Study|Adverse Event|5|||
46964543|NCT02646423|83207255|FG001|Overall Study|Adverse Event|7|||
46964544|NCT02646423|83207254|FG000|Overall Study|Ineligible|2|||
46964545|NCT02646423|83207255|FG001|Overall Study|Ineligible|1|||
46964546|NCT02647359|83207291|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
46964547|NCT02647359|83207292|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
46964548|NCT02647359|83207291|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
46964549|NCT02647359|83207292|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
46964550|NCT02647359|83207291|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
46964551|NCT02647359|83207292|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
46964552|NCT02647359|83207291|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
46964553|NCT02647359|83207292|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
46964554|NCT02647359|83207291|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
46964555|NCT02647359|83207292|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
46964556|NCT02647359|83207291|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
46964557|NCT02647359|83207292|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
46964558|NCT02645409|83207304|FG000|Overall Study|Withdrawal by Subject|3|||
46964559|NCT02645409|83207305|FG001|Overall Study|Withdrawal by Subject|0|||
46964560|NCT02645409|83207304|FG000|Overall Study|Physician Decision|1|||
46964561|NCT02645409|83207305|FG001|Overall Study|Physician Decision|0|||
46964562|NCT01597479|83207312|FG000|Overall Study|Protocol Violation|1|||
46964563|NCT01597479|83207313|FG001|Overall Study|Protocol Violation|0|||
46964564|NCT01597479|83207312|FG000|Overall Study|Lost to Follow-up|1|||
46964565|NCT01597479|83207313|FG001|Overall Study|Lost to Follow-up|0|||
46964566|NCT04248465|83207322|FG000|Randomized-Controlled Period|Death|12|||
46964567|NCT04248465|83207323|FG001|Randomized-Controlled Period|Death|5|||
46964568|NCT04248465|83207322|FG000|Randomized-Controlled Period|Adverse Event|2|||
46964569|NCT04248465|83207323|FG001|Randomized-Controlled Period|Adverse Event|0|||
46964570|NCT04248465|83207322|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
46964571|NCT04248465|83207323|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
46964572|NCT04248465|83207322|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
46964573|NCT04248465|83207323|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
46964574|NCT04248465|83207322|FG000|Randomized-Controlled Period|Physician Decision|1|||
46964575|NCT04248465|83207323|FG001|Randomized-Controlled Period|Physician Decision|1|||
46964576|NCT04248465|83207322|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
46964577|NCT04248465|83207323|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
46964578|NCT04248465|83207322|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
46964579|NCT04248465|83207323|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
46845734|NCT00418379|83062604|FG002|Year 2|Any other reason not above-mentioned|6|||
46845735|NCT00418379|83062602|FG000|Year 3|Withdrawal by Subject|1|||
46845736|NCT00418379|83062603|FG001|Year 3|Withdrawal by Subject|1|||
46845737|NCT00418379|83062604|FG002|Year 3|Withdrawal by Subject|2|||
46845738|NCT00418379|83062602|FG000|Year 3|Any other reason not above-mentioned|2|||
46845739|NCT00418379|83062603|FG001|Year 3|Any other reason not above-mentioned|1|||
46845740|NCT00418379|83062604|FG002|Year 3|Any other reason not above-mentioned|1|||
46845741|NCT00418379|83062602|FG000|Year 4|Adverse Event|0|||
46845742|NCT00418379|83062603|FG001|Year 4|Adverse Event|1|||
46845743|NCT00418379|83062604|FG002|Year 4|Adverse Event|0|||
46845744|NCT00418379|83062602|FG000|Year 4|Withdrawal by Subject|2|||
46845745|NCT00418379|83062603|FG001|Year 4|Withdrawal by Subject|3|||
46845746|NCT00418379|83062604|FG002|Year 4|Withdrawal by Subject|2|||
46845747|NCT00418379|83062602|FG000|Year 4|Any other reason not above-mentioned|1|||
46845748|NCT00418379|83062603|FG001|Year 4|Any other reason not above-mentioned|1|||
46845749|NCT00418379|83062604|FG002|Year 4|Any other reason not above-mentioned|0|||
46845750|NCT00418379|83062602|FG000|Year 5|Adverse Event|0|||
46845751|NCT00418379|83062603|FG001|Year 5|Adverse Event|1|||
46845752|NCT00418379|83062604|FG002|Year 5|Adverse Event|0|||
46845753|NCT00418379|83062602|FG000|Year 5|Any other reason not above-mentioned|2|||
46845754|NCT00418379|83062603|FG001|Year 5|Any other reason not above-mentioned|4|||
46964580|NCT04248465|83207322|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
46964581|NCT04248465|83207323|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
46964582|NCT02643693|83207331|FG000|Overall Study|Physician Decision|0|||
46964583|NCT02643693|83207332|FG001|Overall Study|Physician Decision|1|||
46964584|NCT02643693|83207333|FG002|Overall Study|Physician Decision|0|||
46964585|NCT02643693|83207334|FG003|Overall Study|Physician Decision|0|||
46964586|NCT02643693|83207335|FG004|Overall Study|Physician Decision|0|||
46964587|NCT02643693|83207336|FG005|Overall Study|Physician Decision|0|||
46964588|NCT02643693|83207331|FG000|Overall Study|Withdrawal by Subject|0|||
46774560|NCT00735254|82993032|FG002|Overall Study|Protocol Violation|1|||
46774561|NCT00735254|82993033|FG003|Overall Study|Protocol Violation|0|||
46774562|NCT00795509|82993043|FG000|Overall Study|Protocol Violation|31|||
46774563|NCT00787787|82993047|FG000|Overall Study|Lack of Efficacy|4|||
46774564|NCT00787787|82993047|FG000|Overall Study|Adverse Event|3|||
46774565|NCT00787319|82993051|FG000|Overall Study|Lost to Follow-up|2|||
46774566|NCT00787319|82993051|FG000|Overall Study|Withdrawal by Subject|15|||
46774567|NCT00787319|82993051|FG000|Overall Study|Adverse Event|3|||
46774568|NCT00787319|82993051|FG000|Overall Study|Objective progression or relapse|30|||
46774569|NCT00787319|82993051|FG000|Overall Study|Lack of Efficacy|1|||
46774570|NCT00787319|82993051|FG000|Overall Study|Budget exhausted/exceeded|1|||
46774571|NCT00787319|82993051|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
46774572|NCT00787319|82993051|FG000|Overall Study|No health insurance reimbursement|2|||
46774573|NCT00787319|82993051|FG000|Overall Study|Stabilized disease findings|3|||
46774574|NCT00787319|82993051|FG000|Overall Study|Inactive disease|5|||
46774575|NCT00794963|82993057|FG000|Overall Study|Withdrawal by Subject|1|||
46774576|NCT00794963|82993058|FG001|Overall Study|Withdrawal by Subject|4|||
46774577|NCT00794573|82993066|FG000|Overall Study|Death|3|||
46774578|NCT00794573|82993067|FG001|Overall Study|Death|0|||
46774579|NCT00794573|82993066|FG000|Overall Study|Withdrawal by Subject|9|||
46774580|NCT00794573|82993067|FG001|Overall Study|Withdrawal by Subject|12|||
46774581|NCT00794573|82993066|FG000|Overall Study|Lost to Follow-up|26|||
46774582|NCT00794573|82993067|FG001|Overall Study|Lost to Follow-up|33|||
46774583|NCT00584844|82993073|FG000|Overall Study|Withdrawal by Subject|59|||
46774584|NCT00584844|82993073|FG000|Overall Study|Screen Failure|20|||
46845755|NCT00418379|83062604|FG002|Year 5|Any other reason not above-mentioned|3|||
46845756|NCT00418145|83062612|FG000|Overall Study|study terminated|6|||
46845757|NCT00417989|83062620|FG000|Overall Study|Withdrawal by Subject|13|||
46845758|NCT00417989|83062621|FG001|Overall Study|Withdrawal by Subject|13|||
46774585|NCT00739934|82993081|FG000|Voriconazole IV|Adverse Event|6|||
46774586|NCT00739934|82993081|FG000|Voriconazole Oral|Other|3|||
46845759|NCT00417989|83062620|FG000|Overall Study|Lost to Follow-up|1|||
46845760|NCT00417989|83062621|FG001|Overall Study|Lost to Follow-up|6|||
46845761|NCT00417989|83062620|FG000|Overall Study|Protocol Violation|1|||
46845762|NCT00417989|83062621|FG001|Overall Study|Protocol Violation|0|||
46845763|NCT00417989|83062620|FG000|Overall Study|Death|0|||
46845764|NCT00417989|83062621|FG001|Overall Study|Death|1|||
46845765|NCT00417989|83062620|FG000|Overall Study|Physician Decision|5|||
46845766|NCT00417989|83062621|FG001|Overall Study|Physician Decision|2|||
46845767|NCT00412217|83062631|FG000|Overall Study|Insufficient Data Available|8|||
46845768|NCT00412217|83062632|FG001|Overall Study|Insufficient Data Available|3|||
46845769|NCT00412217|83062631|FG000|Overall Study|Death|5|||
46845770|NCT00412217|83062632|FG001|Overall Study|Death|4|||
46845771|NCT00412217|83062631|FG000|Overall Study|Disease Progression|2|||
46845772|NCT00412217|83062632|FG001|Overall Study|Disease Progression|3|||
46845773|NCT00412217|83062631|FG000|Overall Study|Investigator Decision|1|||
46845774|NCT00412217|83062632|FG001|Overall Study|Investigator Decision|0|||
46845775|NCT00412217|83062631|FG000|Overall Study|Withdrawal by Subject|2|||
46845776|NCT00412217|83062632|FG001|Overall Study|Withdrawal by Subject|0|||
46845777|NCT00412217|83062631|FG000|Overall Study|Lost to Follow-up|1|||
46845778|NCT00412217|83062632|FG001|Overall Study|Lost to Follow-up|4|||
46845779|NCT00412217|83062631|FG000|Overall Study|Study Terminated by Sponsor|26|||
46845780|NCT00412217|83062632|FG001|Overall Study|Study Terminated by Sponsor|33|||
46845781|NCT00412217|83062631|FG000|Overall Study|Other|1|||
46845782|NCT00412217|83062632|FG001|Overall Study|Other|1|||
46845783|NCT05000164|83062638|FG000|Overall Study|Adverse Event|1|||
46845784|NCT05000164|83062638|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
46845785|NCT05000164|83062638|FG000|Overall Study|Lens Discomfort|3|||
46845786|NCT05000164|83062638|FG000|Overall Study|Withdrew Consent during Study|2|||
46845787|NCT05000164|83062638|FG000|Overall Study|Subject Withdrawn by PI|2|||
46845788|NCT05000164|83062638|FG000|Overall Study|Other Fractured Test Article|1|||
46845789|NCT00123474|83062646|FG000|Randomized to Treatment|Randomized, never treated|1|||
46845790|NCT00123474|83062647|FG001|Randomized to Treatment|Randomized, never treated|4|||
46845791|NCT00123474|83062648|FG002|Randomized to Treatment|Randomized, never treated|2|||
46845792|NCT00123474|83062649|FG003|Randomized to Treatment|Randomized, never treated|1|||
46845793|NCT00123474|83062646|FG000|As Treated at Study Closure|not reported when site closed|1|||
46845794|NCT00123474|83062647|FG001|As Treated at Study Closure|not reported when site closed|0|||
46845795|NCT00123474|83062648|FG002|As Treated at Study Closure|not reported when site closed|1|||
46845796|NCT00123474|83062649|FG003|As Treated at Study Closure|not reported when site closed|0|||
46845797|NCT00123474|83062646|FG000|As Treated at Study Closure|Adverse Event|10|||
46845798|NCT00123474|83062647|FG001|As Treated at Study Closure|Adverse Event|4|||
46845799|NCT00123474|83062648|FG002|As Treated at Study Closure|Adverse Event|10|||
46845800|NCT00123474|83062649|FG003|As Treated at Study Closure|Adverse Event|8|||
46964589|NCT02643693|83207332|FG001|Overall Study|Withdrawal by Subject|1|||
46964590|NCT02643693|83207333|FG002|Overall Study|Withdrawal by Subject|0|||
46964591|NCT02643693|83207334|FG003|Overall Study|Withdrawal by Subject|0|||
46964592|NCT02643693|83207335|FG004|Overall Study|Withdrawal by Subject|0|||
46964593|NCT02643693|83207336|FG005|Overall Study|Withdrawal by Subject|0|||
46964594|NCT02643693|83207331|FG000|Overall Study|Protocol Adherence Issues|2|||
46964595|NCT02643693|83207332|FG001|Overall Study|Protocol Adherence Issues|0|||
46964596|NCT02643693|83207333|FG002|Overall Study|Protocol Adherence Issues|1|||
46964597|NCT02643693|83207334|FG003|Overall Study|Protocol Adherence Issues|0|||
46964598|NCT02643693|83207335|FG004|Overall Study|Protocol Adherence Issues|0|||
46964599|NCT02643693|83207336|FG005|Overall Study|Protocol Adherence Issues|1|||
46964600|NCT02726113|83207346|FG000|Total Enrollment|Physician Decision|0|||
46774587|NCT00739310|82993090|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
46845801|NCT00123474|83062646|FG000|As Treated at Study Closure|Disease Progression|35|||
46845802|NCT00123474|83062647|FG001|As Treated at Study Closure|Disease Progression|42|||
46845803|NCT00123474|83062648|FG002|As Treated at Study Closure|Disease Progression|29|||
46845804|NCT00123474|83062649|FG003|As Treated at Study Closure|Disease Progression|27|||
46845805|NCT00123474|83062646|FG000|As Treated at Study Closure|Investigator Request|12|||
46845806|NCT00123474|83062647|FG001|As Treated at Study Closure|Investigator Request|6|||
46845807|NCT00123474|83062648|FG002|As Treated at Study Closure|Investigator Request|7|||
46845808|NCT00123474|83062649|FG003|As Treated at Study Closure|Investigator Request|5|||
46845809|NCT00123474|83062646|FG000|As Treated at Study Closure|non-specified|54|||
46845810|NCT00123474|83062647|FG001|As Treated at Study Closure|non-specified|47|||
46845811|NCT00123474|83062648|FG002|As Treated at Study Closure|non-specified|57|||
46845812|NCT00123474|83062649|FG003|As Treated at Study Closure|non-specified|60|||
46845813|NCT00123474|83062646|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
46845814|NCT00123474|83062647|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
46845815|NCT00123474|83062648|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
46845816|NCT00123474|83062649|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
46845817|NCT00123474|83062646|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
46845818|NCT00123474|83062647|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
46845819|NCT00123474|83062648|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
46845820|NCT00123474|83062649|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
46845821|NCT00142298|83062690|FG000|Overall Study|Adverse Event|10|||
46845822|NCT00142298|83062691|FG001|Overall Study|Adverse Event|10|||
46845823|NCT00142298|83062692|FG002|Overall Study|Adverse Event|1|||
46845824|NCT00142298|83062693|FG003|Overall Study|Adverse Event|5|||
46964601|NCT02726113|83207347|FG001|Total Enrollment|Physician Decision|1|||
47067382|NCT01547390|83351042|FG001|Overall Study|Adverse Event|0|||
46774588|NCT00739310|82993090|FG000|Overall Study|Withdrawal by Subject|1|||
46774589|NCT00739310|82993090|FG000|Overall Study|Lost to Follow-up|2|||
46774590|NCT00734630|82993097|FG000|Overall Study|Lack of Efficacy|4|||
46774591|NCT00734630|82993098|FG001|Overall Study|Lack of Efficacy|4|||
46774592|NCT00734630|82993097|FG000|Overall Study|Withdrawal by Subject|7|||
46774593|NCT00734630|82993098|FG001|Overall Study|Withdrawal by Subject|9|||
46774594|NCT00734630|82993097|FG000|Overall Study|Lost to Follow-up|13|||
46774595|NCT00734630|82993098|FG001|Overall Study|Lost to Follow-up|7|||
46774596|NCT00734630|82993097|FG000|Overall Study|Protocol Violation|0|||
46774597|NCT00734630|82993098|FG001|Overall Study|Protocol Violation|3|||
46774598|NCT00734630|82993097|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
46774599|NCT00734630|82993098|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
46774600|NCT00734630|82993097|FG000|Overall Study|Adverse Event|3|||
46774601|NCT00734630|82993098|FG001|Overall Study|Adverse Event|6|||
46774602|NCT00734630|82993097|FG000|Overall Study|Randomized in Error|0|||
46964602|NCT02726113|83207346|FG000|Total Enrollment|Protocol Violation|1|||
46964603|NCT02726113|83207347|FG001|Total Enrollment|Protocol Violation|0|||
47067383|NCT01546922|83351048|FG000|First Period of 10 Weeks|Protocol Violation|3|||
46640133|NCT01625286|82814254|FG001|Overall Study|Adverse Event|0|||
46774603|NCT00734630|82993098|FG001|Overall Study|Randomized in Error|1|||
46845825|NCT00142298|83062694|FG004|Overall Study|Adverse Event|2|||
46845826|NCT00142298|83062695|FG005|Overall Study|Adverse Event|2|||
46845827|NCT00142298|83062696|FG006|Overall Study|Adverse Event|0|||
46845828|NCT00142298|83062697|FG007|Overall Study|Adverse Event|0|||
46845829|NCT00142298|83062698|FG008|Overall Study|Adverse Event|0|||
46845830|NCT00142298|83062699|FG009|Overall Study|Adverse Event|0|||
46845831|NCT00142298|83062690|FG000|Overall Study|Clinical disease progression|1|||
46845832|NCT00142298|83062691|FG001|Overall Study|Clinical disease progression|0|||
46774604|NCT00734630|82993097|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
46774605|NCT00734630|82993098|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
46964604|NCT02726113|83207346|FG000|Total Enrollment|Withdrawal by Subject|2|||
46964605|NCT02726113|83207347|FG001|Total Enrollment|Withdrawal by Subject|1|||
46964606|NCT02726113|83207346|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
46964607|NCT02726113|83207347|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
46964608|NCT02726113|83207346|FG000|Genomic Analysis|Protocol Violation|1|||
46964609|NCT02726113|83207347|FG001|Genomic Analysis|Protocol Violation|0|||
46964610|NCT02726113|83207346|FG000|Genomic Analysis|Withdrawal by Subject|2|||
46964611|NCT02726113|83207347|FG001|Genomic Analysis|Withdrawal by Subject|1|||
46964612|NCT02726113|83207346|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
46964613|NCT02726113|83207347|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
46964614|NCT01361919|83207365|FG000|Overall Study|technical issues|10|||
46964615|NCT01361919|83207366|FG001|Overall Study|technical issues|12|||
46964616|NCT01361919|83207367|FG002|Overall Study|technical issues|10|||
46964617|NCT02642679|83207375|FG000|Overall Study|Withdrawal by Subject|1|||
46964618|NCT02642679|83207375|FG000|Overall Study|Physician Decision|1|||
46964619|NCT02642679|83207375|FG000|Overall Study|Physician Decision|1|||
46964620|NCT00705523|83207381|FG000|Overall Study|Lost to Follow-up|2|||
46964621|NCT00705523|83207382|FG001|Overall Study|Lost to Follow-up|3|||
46845833|NCT00142298|83062692|FG002|Overall Study|Clinical disease progression|0|||
46845834|NCT00142298|83062693|FG003|Overall Study|Clinical disease progression|0|||
46845835|NCT00142298|83062694|FG004|Overall Study|Clinical disease progression|0|||
46845836|NCT00142298|83062695|FG005|Overall Study|Clinical disease progression|0|||
46845837|NCT00142298|83062696|FG006|Overall Study|Clinical disease progression|0|||
46845838|NCT00142298|83062697|FG007|Overall Study|Clinical disease progression|0|||
46845839|NCT00142298|83062698|FG008|Overall Study|Clinical disease progression|0|||
46845840|NCT00142298|83062699|FG009|Overall Study|Clinical disease progression|0|||
46845841|NCT00142298|83062690|FG000|Overall Study|Death|1|||
46845842|NCT00142298|83062691|FG001|Overall Study|Death|1|||
46845843|NCT00142298|83062692|FG002|Overall Study|Death|1|||
46845844|NCT00142298|83062693|FG003|Overall Study|Death|0|||
46845845|NCT00142298|83062694|FG004|Overall Study|Death|0|||
46964622|NCT02725411|83207391|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
46964623|NCT02725411|83207392|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
46964624|NCT02725411|83207393|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
46964625|NCT02725411|83207391|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
46964626|NCT02725411|83207392|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
46964627|NCT02725411|83207393|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
46964628|NCT02725411|83207391|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
46964629|NCT02725411|83207392|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
46964630|NCT02725411|83207393|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
46964631|NCT02725411|83207391|FG000|Treatment Period (56 Weeks)|Other|1|||
46964632|NCT02725411|83207392|FG001|Treatment Period (56 Weeks)|Other|4|||
46964633|NCT02725411|83207393|FG002|Treatment Period (56 Weeks)|Other|5|||
46964634|NCT02725411|83207391|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
46964635|NCT02725411|83207392|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
46964636|NCT02725411|83207393|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
46964637|NCT02725411|83207391|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
46964638|NCT02725411|83207392|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
46964639|NCT02725411|83207393|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
46964640|NCT02725411|83207391|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
47067384|NCT01546922|83351049|FG001|First Period of 10 Weeks|Protocol Violation|1|||
46774606|NCT00734630|82993097|FG000|Overall Study|Poor Compliance|1|||
46774607|NCT00734630|82993098|FG001|Overall Study|Poor Compliance|1|||
46774608|NCT00584454|82993104|FG000|Overall Study|Adverse Event|1|||
46774609|NCT00584454|82993104|FG000|Overall Study|Relocation|1|||
46774610|NCT00584454|82993104|FG000|Overall Study|Clinical Hold|2|||
46774611|NCT00578175|82993111|FG000|Overall Study|Adverse Event|0|||
46774612|NCT00578175|82993112|FG001|Overall Study|Adverse Event|1|||
46845846|NCT00142298|83062695|FG005|Overall Study|Death|6|||
46845847|NCT00142298|83062696|FG006|Overall Study|Death|0|||
46845848|NCT00142298|83062697|FG007|Overall Study|Death|0|||
46845849|NCT00142298|83062698|FG008|Overall Study|Death|0|||
46845850|NCT00142298|83062699|FG009|Overall Study|Death|0|||
46845851|NCT00142298|83062690|FG000|Overall Study|Lack of Efficacy|44|||
46845852|NCT00142298|83062691|FG001|Overall Study|Lack of Efficacy|62|||
46964641|NCT02725411|83207392|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
47067385|NCT01546922|83351048|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
46964642|NCT02725411|83207393|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
47067386|NCT01546922|83351049|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
46774613|NCT00578175|82993113|FG002|Overall Study|Adverse Event|1|||
46774614|NCT00578175|82993111|FG000|Overall Study|Other reasons|70|||
46774615|NCT00578175|82993112|FG001|Overall Study|Other reasons|42|||
46845853|NCT00142298|83062692|FG002|Overall Study|Lack of Efficacy|9|||
46964643|NCT02725411|83207391|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
46964644|NCT02725411|83207392|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
46774616|NCT00578175|82993113|FG002|Overall Study|Other reasons|23|||
46774617|NCT00435409|82993125|FG000|Overall Study|Protocol Violation|1|||
46774618|NCT00435409|82993126|FG001|Overall Study|Protocol Violation|2|||
46774619|NCT00435409|82993127|FG002|Overall Study|Protocol Violation|0|||
46774620|NCT00435409|82993125|FG000|Overall Study|Lost to Follow-up|1|||
46774621|NCT00435409|82993126|FG001|Overall Study|Lost to Follow-up|2|||
46774622|NCT00435409|82993127|FG002|Overall Study|Lost to Follow-up|0|||
46774623|NCT00435409|82993125|FG000|Overall Study|Death|8|||
46774624|NCT00435409|82993126|FG001|Overall Study|Death|6|||
46774625|NCT00435409|82993127|FG002|Overall Study|Death|6|||
46964645|NCT02725411|83207393|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
46964646|NCT02725411|83207391|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
46964647|NCT02725411|83207392|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
46964648|NCT02725411|83207393|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
46964649|NCT02725411|83207391|FG000|Follow-up Period (24 Weeks)|Other|1|||
46774626|NCT00435409|82993125|FG000|Overall Study|Objective progression or relapse|158|||
46774627|NCT00435409|82993126|FG001|Overall Study|Objective progression or relapse|93|||
46774628|NCT00435409|82993127|FG002|Overall Study|Objective progression or relapse|58|||
46774629|NCT00435409|82993125|FG000|Overall Study|Global deterioration of health status|0|||
46774630|NCT00435409|82993126|FG001|Overall Study|Global deterioration of health status|0|||
46774631|NCT00435409|82993127|FG002|Overall Study|Global deterioration of health status|4|||
46774632|NCT00435409|82993125|FG000|Overall Study|Withdrawal by Subject|8|||
46774633|NCT00435409|82993126|FG001|Overall Study|Withdrawal by Subject|7|||
46774634|NCT00435409|82993127|FG002|Overall Study|Withdrawal by Subject|1|||
46774635|NCT00435409|82993125|FG000|Overall Study|Other|45|||
46774636|NCT00435409|82993126|FG001|Overall Study|Other|30|||
46774637|NCT00435409|82993127|FG002|Overall Study|Other|1|||
46774638|NCT00435409|82993125|FG000|Overall Study|Adverse Event|0|||
46774639|NCT00435409|82993126|FG001|Overall Study|Adverse Event|0|||
46774640|NCT00435409|82993127|FG002|Overall Study|Adverse Event|8|||
46774641|NCT00435409|82993125|FG000|Overall Study|Sponsor decision|0|||
46774642|NCT00435409|82993126|FG001|Overall Study|Sponsor decision|3|||
46774643|NCT00435409|82993127|FG002|Overall Study|Sponsor decision|0|||
46774644|NCT00467857|82993144|FG000|Overall Study|Adverse Event|1|||
46774645|NCT00467857|82993145|FG001|Overall Study|Adverse Event|0|||
46774646|NCT00467857|82993144|FG000|Overall Study|Withdrew consent|2|||
46774647|NCT00467857|82993145|FG001|Overall Study|Withdrew consent|0|||
46774648|NCT00467857|82993144|FG000|Overall Study|Death|0|||
46774649|NCT00467857|82993145|FG001|Overall Study|Death|1|||
46774650|NCT00467857|82993144|FG000|Overall Study|Discharged from court service|0|||
46774651|NCT00467857|82993145|FG001|Overall Study|Discharged from court service|1|||
46774652|NCT00467857|82993144|FG000|Overall Study|Emergency care required|0|||
46774653|NCT00467857|82993145|FG001|Overall Study|Emergency care required|1|||
46774654|NCT00467857|82993144|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
46774655|NCT00467857|82993145|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
46774656|NCT00467857|82993144|FG000|Overall Study|Discontinuation reason missing|0|||
46774657|NCT00467857|82993145|FG001|Overall Study|Discontinuation reason missing|3|||
46774658|NCT00435019|82993153|FG000|Overall Study|Adverse Event|1|||
46774659|NCT00435019|82993154|FG001|Overall Study|Adverse Event|0|||
46774660|NCT00435019|82993153|FG000|Overall Study|Lack of Efficacy|1|||
46774661|NCT00435019|82993154|FG001|Overall Study|Lack of Efficacy|2|||
46774662|NCT00435019|82993153|FG000|Overall Study|Protocol Violation|3|||
46774663|NCT00435019|82993154|FG001|Overall Study|Protocol Violation|1|||
46774664|NCT00435019|82993153|FG000|Overall Study|Personal reasons for withdrawal|8|||
46774665|NCT00435019|82993154|FG001|Overall Study|Personal reasons for withdrawal|7|||
46774666|NCT00577863|82993162|FG000|Overall Study|Adverse Event|4|||
46774667|NCT00577863|82993163|FG001|Overall Study|Adverse Event|2|||
46774668|NCT00577863|82993162|FG000|Overall Study|Death|1|||
46774669|NCT00577863|82993163|FG001|Overall Study|Death|0|||
46774670|NCT00577863|82993162|FG000|Overall Study|Lost to Follow-up|2|||
46774671|NCT00577863|82993163|FG001|Overall Study|Lost to Follow-up|2|||
46774672|NCT00577863|82993162|FG000|Overall Study|Entry Criteria Exclusion|1|||
46964650|NCT02725411|83207392|FG001|Follow-up Period (24 Weeks)|Other|4|||
46774673|NCT00577863|82993163|FG001|Overall Study|Entry Criteria Exclusion|0|||
46774674|NCT00577863|82993162|FG000|Overall Study|Withdrawal by Subject|0|||
46774675|NCT00577863|82993163|FG001|Overall Study|Withdrawal by Subject|2|||
46774676|NCT00577863|82993162|FG000|Overall Study|Sponsor Decision|2|||
46774677|NCT00577863|82993163|FG001|Overall Study|Sponsor Decision|7|||
46774678|NCT00577863|82993162|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
46774679|NCT00577863|82993163|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
46774680|NCT00794417|82993173|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
46774681|NCT00794417|82993174|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
46774682|NCT00794417|82993175|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
46964651|NCT02725411|83207393|FG002|Follow-up Period (24 Weeks)|Other|2|||
46774683|NCT00794417|82993176|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
46774684|NCT00794417|82993173|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
46774685|NCT00794417|82993174|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
46774686|NCT00794417|82993175|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
46774687|NCT00794417|82993176|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
46774688|NCT00794417|82993173|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
46774689|NCT00794417|82993174|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
46774690|NCT00794417|82993175|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
46774691|NCT00794417|82993176|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
46774692|NCT00794417|82993173|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
46774693|NCT00794417|82993174|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
46774694|NCT00794417|82993175|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
46774695|NCT00794417|82993176|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
46774696|NCT00794417|82993173|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
46774697|NCT00794417|82993174|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
46774698|NCT00794417|82993175|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
46774699|NCT00794417|82993176|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
46774700|NCT00794417|82993173|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
46774701|NCT00794417|82993174|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
46774702|NCT00794417|82993175|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
46774703|NCT00794417|82993176|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
46774704|NCT00790907|82993191|FG000|Overall Study|Adverse Event|9|||
46774705|NCT00790907|82993192|FG001|Overall Study|Adverse Event|7|||
46774706|NCT00790907|82993193|FG002|Overall Study|Adverse Event|6|||
46774707|NCT00790907|82993191|FG000|Overall Study|Physician Decision|304|||
46774708|NCT00790907|82993192|FG001|Overall Study|Physician Decision|271|||
46774709|NCT00790907|82993193|FG002|Overall Study|Physician Decision|255|||
46774710|NCT00790907|82993191|FG000|Overall Study|Withdrawal by Subject|1|||
46774711|NCT00790907|82993192|FG001|Overall Study|Withdrawal by Subject|7|||
46774712|NCT00790907|82993193|FG002|Overall Study|Withdrawal by Subject|5|||
46845854|NCT00142298|83062693|FG003|Overall Study|Lack of Efficacy|12|||
46845855|NCT00142298|83062694|FG004|Overall Study|Lack of Efficacy|1|||
46845856|NCT00142298|83062695|FG005|Overall Study|Lack of Efficacy|0|||
46845857|NCT00142298|83062696|FG006|Overall Study|Lack of Efficacy|0|||
46845858|NCT00142298|83062697|FG007|Overall Study|Lack of Efficacy|1|||
46845859|NCT00142298|83062698|FG008|Overall Study|Lack of Efficacy|0|||
46845860|NCT00142298|83062699|FG009|Overall Study|Lack of Efficacy|0|||
46845861|NCT00142298|83062690|FG000|Overall Study|Non-compliance|15|||
46845862|NCT00142298|83062691|FG001|Overall Study|Non-compliance|13|||
46845863|NCT00142298|83062692|FG002|Overall Study|Non-compliance|0|||
46845864|NCT00142298|83062693|FG003|Overall Study|Non-compliance|6|||
46845865|NCT00142298|83062694|FG004|Overall Study|Non-compliance|1|||
46964652|NCT02725411|83207391|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
46964653|NCT02725411|83207392|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
46964654|NCT02725411|83207393|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
46964655|NCT02190604|83207429|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964656|NCT02190604|83207430|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964657|NCT02190604|83207431|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964658|NCT02190604|83207432|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964659|NCT02190604|83207433|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964660|NCT02190604|83207434|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964661|NCT02190604|83207435|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964662|NCT02190604|83207436|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964663|NCT02190604|83207437|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
47067387|NCT01546922|83351048|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
47067388|NCT01546922|83351049|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
46774713|NCT00790907|82993191|FG000|Overall Study|Bleeding Event|11|||
46774714|NCT00790907|82993192|FG001|Overall Study|Bleeding Event|16|||
46774715|NCT00790907|82993193|FG002|Overall Study|Bleeding Event|21|||
46774716|NCT00790907|82993191|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
46845866|NCT00142298|83062695|FG005|Overall Study|Non-compliance|0|||
46774717|NCT00790907|82993192|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
46774718|NCT00790907|82993193|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
46774719|NCT00790907|82993191|FG000|Overall Study|Qualifying Condition Not Present|29|||
46845867|NCT00142298|83062696|FG006|Overall Study|Non-compliance|0|||
46845868|NCT00142298|83062697|FG007|Overall Study|Non-compliance|3|||
46845869|NCT00142298|83062698|FG008|Overall Study|Non-compliance|3|||
46845870|NCT00142298|83062699|FG009|Overall Study|Non-compliance|0|||
46845871|NCT00142298|83062690|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
46845872|NCT00142298|83062691|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
46845873|NCT00142298|83062692|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
46964664|NCT02190604|83207438|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964665|NCT02190604|83207439|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964666|NCT02190604|83207440|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964667|NCT02190604|83207441|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964668|NCT02190604|83207442|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964669|NCT02190604|83207443|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
46964670|NCT02190604|83207444|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964671|NCT02190604|83207445|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964672|NCT02190604|83207446|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964673|NCT02190604|83207447|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
46964674|NCT02190604|83207429|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964675|NCT02190604|83207430|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964676|NCT02190604|83207431|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964677|NCT02190604|83207432|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964678|NCT02190604|83207433|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964679|NCT02190604|83207434|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964680|NCT02190604|83207435|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964681|NCT02190604|83207436|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964682|NCT02190604|83207437|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964683|NCT02190604|83207438|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964684|NCT02190604|83207439|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964685|NCT02190604|83207440|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964686|NCT02190604|83207441|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964687|NCT02190604|83207442|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
46964688|NCT02190604|83207443|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964689|NCT02190604|83207444|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964690|NCT02190604|83207445|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964691|NCT02190604|83207446|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964692|NCT02190604|83207447|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
46964693|NCT02127970|83207506|FG000|Overall Study|Adverse Event|2|||
46964694|NCT02127970|83207507|FG001|Overall Study|Adverse Event|1|||
46964695|NCT02127970|83207506|FG000|Overall Study|Death|1|||
46964696|NCT02127970|83207507|FG001|Overall Study|Death|1|||
46964697|NCT02127970|83207506|FG000|Overall Study|Lost to Follow-up|14|||
46964698|NCT02127970|83207507|FG001|Overall Study|Lost to Follow-up|14|||
46964699|NCT02127970|83207506|FG000|Overall Study|Reason not Specified|4|||
46964700|NCT02127970|83207507|FG001|Overall Study|Reason not Specified|7|||
46964701|NCT02127970|83207506|FG000|Overall Study|Pregnancy|0|||
46964702|NCT02127970|83207507|FG001|Overall Study|Pregnancy|1|||
46964703|NCT02127970|83207506|FG000|Overall Study|Subject Withdrew Consent|5|||
46964704|NCT02127970|83207507|FG001|Overall Study|Subject Withdrew Consent|3|||
46964705|NCT03549871|83207515|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
46964706|NCT03549871|83207516|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
46964707|NCT03549871|83207515|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
46964708|NCT03549871|83207516|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
46964709|NCT03549871|83207515|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
46964710|NCT03549871|83207516|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
46964711|NCT03549871|83207515|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
46964712|NCT03549871|83207516|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
46964713|NCT03549871|83207515|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
46964714|NCT03549871|83207516|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
46964715|NCT03549871|83207515|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
46964716|NCT03549871|83207516|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
46964717|NCT03549871|83207515|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
46964718|NCT03549871|83207516|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
46964719|NCT03549871|83207515|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
46964720|NCT03549871|83207516|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
46964721|NCT03549871|83207515|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
46964722|NCT03549871|83207516|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
46964723|NCT03549871|83207515|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
46964724|NCT03549871|83207516|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
47067389|NCT01546922|83351048|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
47067390|NCT01546922|83351049|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
47067391|NCT01546922|83351048|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
47067392|NCT01546922|83351049|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
47067393|NCT01532648|83351066|FG000|Overall Study|Lost to Follow-up|3|||
47067394|NCT01532648|83351067|FG001|Overall Study|Lost to Follow-up|4|||
47067395|NCT01532648|83351066|FG000|Overall Study|Lack of Efficacy|4|||
46964725|NCT03549871|83207515|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
46964726|NCT03549871|83207516|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
46964727|NCT00705367|83207539|FG000|Long-term Extension Period|Adverse Event|2|||
46964728|NCT00705367|83207540|FG001|Long-term Extension Period|Adverse Event|0|||
46964729|NCT00705367|83207539|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
46964730|NCT00705367|83207540|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
46964731|NCT00705367|83207539|FG000|Long-term Extension Period|Lack of Efficacy|1|||
46964732|NCT00705367|83207540|FG001|Long-term Extension Period|Lack of Efficacy|0|||
46964733|NCT00705367|83207539|FG000|Long-term Extension Period|No longer met study criteria|1|||
46964734|NCT00705367|83207540|FG001|Long-term Extension Period|No longer met study criteria|0|||
46964735|NCT00705367|83207539|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
46964736|NCT00705367|83207540|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
46964737|NCT00705289|83207548|FG000|Overall Study|Subject or treating physician's choice|131|||
46964738|NCT00703963|83207571|FG000|Overall Study|Withdrawal by Subject|7|||
46964739|NCT00703963|83207572|FG001|Overall Study|Withdrawal by Subject|13|||
46964740|NCT00703963|83207571|FG000|Overall Study|Physician Decision|0|||
46964741|NCT00703963|83207572|FG001|Overall Study|Physician Decision|1|||
46964742|NCT02721355|83207580|FG000|Overall Study|Lost to Follow-up|6|||
46964743|NCT02721355|83207581|FG001|Overall Study|Lost to Follow-up|1|||
46964744|NCT02733991|83207589|FG000|Overall Study|Adverse Event|1|||
46964745|NCT02733991|83207590|FG001|Overall Study|Adverse Event|0|||
46964746|NCT02733991|83207589|FG000|Overall Study|Withdrawal by Subject|0|||
46964747|NCT02733991|83207590|FG001|Overall Study|Withdrawal by Subject|5|||
46964748|NCT00702949|83207599|FG000|Overall Study|Refusal|3|||
46964749|NCT00702949|83207600|FG001|Overall Study|Refusal|2|||
46964750|NCT00702949|83207601|FG002|Overall Study|Refusal|2|||
46964751|NCT00702949|83207599|FG000|Overall Study|Adverse Event|1|||
46964752|NCT00702949|83207600|FG001|Overall Study|Adverse Event|6|||
46964753|NCT00702949|83207601|FG002|Overall Study|Adverse Event|3|||
46964754|NCT00702949|83207599|FG000|Overall Study|Other Medical Reason/unknown|1|||
46964755|NCT00702949|83207600|FG001|Overall Study|Other Medical Reason/unknown|1|||
46640134|NCT01625286|82814255|FG002|Overall Study|Adverse Event|0|||
46640135|NCT01625286|82814256|FG003|Overall Study|Adverse Event|0|||
46640136|NCT01625286|82814257|FG004|Overall Study|Adverse Event|1|||
46640137|NCT01625286|82814258|FG005|Overall Study|Adverse Event|2|||
46640138|NCT01625286|82814259|FG006|Overall Study|Adverse Event|1|||
46640139|NCT01625286|82814253|FG000|Overall Study|Death|0|||
46640140|NCT01625286|82814254|FG001|Overall Study|Death|0|||
46640141|NCT01625286|82814255|FG002|Overall Study|Death|1|||
46640142|NCT01625286|82814256|FG003|Overall Study|Death|1|||
46640143|NCT01625286|82814257|FG004|Overall Study|Death|0|||
46640144|NCT01625286|82814258|FG005|Overall Study|Death|11|||
46640145|NCT01625286|82814259|FG006|Overall Study|Death|16|||
46640146|NCT01625286|82814253|FG000|Overall Study|Withdrawal by Subject|0|||
46640147|NCT01625286|82814254|FG001|Overall Study|Withdrawal by Subject|1|||
46640148|NCT01625286|82814255|FG002|Overall Study|Withdrawal by Subject|0|||
46640149|NCT01625286|82814256|FG003|Overall Study|Withdrawal by Subject|1|||
46640150|NCT01625286|82814257|FG004|Overall Study|Withdrawal by Subject|0|||
46640151|NCT01625286|82814258|FG005|Overall Study|Withdrawal by Subject|0|||
46640152|NCT01625286|82814259|FG006|Overall Study|Withdrawal by Subject|1|||
46640153|NCT01625286|82814253|FG000|Overall Study|Any reason not specifically recorded|0|||
46640154|NCT01625286|82814254|FG001|Overall Study|Any reason not specifically recorded|0|||
46640155|NCT01625286|82814255|FG002|Overall Study|Any reason not specifically recorded|0|||
46640156|NCT01625286|82814256|FG003|Overall Study|Any reason not specifically recorded|0|||
46640157|NCT01625286|82814257|FG004|Overall Study|Any reason not specifically recorded|0|||
46640158|NCT01625286|82814258|FG005|Overall Study|Any reason not specifically recorded|1|||
46640159|NCT01625286|82814259|FG006|Overall Study|Any reason not specifically recorded|0|||
46964756|NCT00702949|83207601|FG002|Overall Study|Other Medical Reason/unknown|3|||
46964757|NCT00702715|83207613|FG000|Overall Study|Lost to Follow-up|1|||
46964758|NCT00702715|83207614|FG001|Overall Study|Lost to Follow-up|0|||
46964759|NCT00702403|83207620|FG000|From Consent to Engraftment|Progressive leukemia|6|||
46964760|NCT00702403|83207620|FG000|From Consent to Engraftment|Critically ill|2|||
46640160|NCT01625286|82814253|FG000|Overall Study|Progressive disease|6|||
46964761|NCT00702403|83207620|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
46964762|NCT00702403|83207620|FG000|From Consent to Engraftment|Myocardial infarction|1|||
46964763|NCT00702403|83207620|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
46964764|NCT00702403|83207620|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
46964765|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
46640161|NCT01625286|82814254|FG001|Overall Study|Progressive disease|3|||
46640162|NCT01625286|82814255|FG002|Overall Study|Progressive disease|4|||
46640163|NCT01625286|82814256|FG003|Overall Study|Progressive disease|5|||
46640164|NCT01625286|82814257|FG004|Overall Study|Progressive disease|5|||
46640165|NCT01625286|82814258|FG005|Overall Study|Progressive disease|0|||
46640166|NCT01625286|82814259|FG006|Overall Study|Progressive disease|0|||
46964766|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
46964767|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Non-compliance|2|||
46964768|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
46964769|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
46964770|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Suicide|1|||
46964771|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
46964772|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
46964773|NCT00702403|83207620|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
46964774|NCT00702325|83207629|FG000|Overall Study|Adverse Event|1|||
46964775|NCT00702325|83207630|FG001|Overall Study|Adverse Event|0|||
46964776|NCT00702325|83207629|FG000|Overall Study|Withdrawal by Subject|7|||
46964777|NCT00702325|83207630|FG001|Overall Study|Withdrawal by Subject|7|||
46964778|NCT00702325|83207629|FG000|Overall Study|Lost to Follow-up|3|||
46964779|NCT00702325|83207630|FG001|Overall Study|Lost to Follow-up|4|||
46964780|NCT00702325|83207629|FG000|Overall Study|Incorrect enrollment|5|||
46964781|NCT00702325|83207630|FG001|Overall Study|Incorrect enrollment|7|||
46964782|NCT00702325|83207629|FG000|Overall Study|Developed study discontinuation criteria|18|||
46964783|NCT00702325|83207630|FG001|Overall Study|Developed study discontinuation criteria|28|||
46964784|NCT00702325|83207629|FG000|Overall Study|Severe noncompliance to protocol|3|||
46964785|NCT00702325|83207630|FG001|Overall Study|Severe noncompliance to protocol|3|||
46964786|NCT00702325|83207629|FG000|Overall Study|Termination due to lab results|1|||
46964787|NCT00702325|83207630|FG001|Overall Study|Termination due to lab results|0|||
46964788|NCT00702325|83207629|FG000|Overall Study|Didn't follow study medication dosage|0|||
46964789|NCT00702325|83207630|FG001|Overall Study|Didn't follow study medication dosage|2|||
46964790|NCT00702325|83207629|FG000|Overall Study|Withdrew consent|0|||
46964791|NCT00702325|83207630|FG001|Overall Study|Withdrew consent|1|||
46964792|NCT00702325|83207629|FG000|Overall Study|Incorrectly Discontinued|0|||
46964793|NCT00702325|83207630|FG001|Overall Study|Incorrectly Discontinued|1|||
46964794|NCT02719171|83207641|FG000|Overall Study|Adverse Event|1|||
46964795|NCT02719171|83207642|FG001|Overall Study|Adverse Event|2|||
46964796|NCT02719171|83207643|FG002|Overall Study|Adverse Event|0|||
46964797|NCT02719171|83207644|FG003|Overall Study|Adverse Event|0|||
46964798|NCT02719171|83207645|FG004|Overall Study|Adverse Event|2|||
46964799|NCT02719171|83207641|FG000|Overall Study|Lost to Follow-up|0|||
46964800|NCT02719171|83207642|FG001|Overall Study|Lost to Follow-up|0|||
46964801|NCT02719171|83207643|FG002|Overall Study|Lost to Follow-up|1|||
46964802|NCT02719171|83207644|FG003|Overall Study|Lost to Follow-up|0|||
46964803|NCT02719171|83207645|FG004|Overall Study|Lost to Follow-up|0|||
46964804|NCT02719171|83207641|FG000|Overall Study|Subject Withdrawal|0|||
46964805|NCT02719171|83207642|FG001|Overall Study|Subject Withdrawal|2|||
46964806|NCT02719171|83207643|FG002|Overall Study|Subject Withdrawal|2|||
46964807|NCT02719171|83207644|FG003|Overall Study|Subject Withdrawal|1|||
46964808|NCT02719171|83207645|FG004|Overall Study|Subject Withdrawal|0|||
46964809|NCT02719171|83207641|FG000|Overall Study|Other|0|||
46964810|NCT02719171|83207642|FG001|Overall Study|Other|0|||
46964811|NCT02719171|83207643|FG002|Overall Study|Other|0|||
46964812|NCT02719171|83207644|FG003|Overall Study|Other|1|||
46964813|NCT02719171|83207645|FG004|Overall Study|Other|0|||
46964814|NCT02718625|83207662|FG000|Overall Study|Adverse Event|0|||
46964815|NCT02718625|83207663|FG001|Overall Study|Adverse Event|1|||
46964816|NCT02718625|83207662|FG000|Overall Study|Termination of Study by Sponsor|0|||
46964817|NCT02718625|83207663|FG001|Overall Study|Termination of Study by Sponsor|1|||
46964818|NCT02716987|83207675|FG000|Overall Study|Ligand synthesis failure|0|||
46964819|NCT02716987|83207676|FG001|Overall Study|Ligand synthesis failure|0|||
46964820|NCT02716987|83207677|FG002|Overall Study|Ligand synthesis failure|1|||
46964821|NCT02716987|83207678|FG003|Overall Study|Ligand synthesis failure|0|||
46964822|NCT02716987|83207679|FG004|Overall Study|Ligand synthesis failure|0|||
46964823|NCT02716987|83207680|FG005|Overall Study|Ligand synthesis failure|0|||
46964824|NCT02716987|83207675|FG000|Overall Study|Withdrawal by Subject|0|||
46964825|NCT02716987|83207676|FG001|Overall Study|Withdrawal by Subject|0|||
46964826|NCT02716987|83207677|FG002|Overall Study|Withdrawal by Subject|0|||
46640167|NCT01625286|82814253|FG000|Overall Study|Lost to Follow-up|0|||
46640168|NCT01625286|82814254|FG001|Overall Study|Lost to Follow-up|0|||
46640169|NCT01625286|82814255|FG002|Overall Study|Lost to Follow-up|0|||
46640170|NCT01625286|82814256|FG003|Overall Study|Lost to Follow-up|0|||
46640171|NCT01625286|82814257|FG004|Overall Study|Lost to Follow-up|0|||
46640172|NCT01625286|82814258|FG005|Overall Study|Lost to Follow-up|0|||
46640173|NCT01625286|82814259|FG006|Overall Study|Lost to Follow-up|1|||
46964827|NCT02716987|83207678|FG003|Overall Study|Withdrawal by Subject|0|||
46964828|NCT02716987|83207679|FG004|Overall Study|Withdrawal by Subject|1|||
46964829|NCT02716987|83207680|FG005|Overall Study|Withdrawal by Subject|1|||
46964830|NCT00701779|83207705|FG000|Overall Study|Adverse Event|6|||
46640174|NCT04083222|82814304|FG000|Overall Study|Voluntary Withdrawal|0|||
46640175|NCT04083222|82814305|FG001|Overall Study|Voluntary Withdrawal|1|||
46640176|NCT04083222|82814304|FG000|Overall Study|Reason not Specified|0|||
46964831|NCT00701779|83207705|FG000|Overall Study|Lost to Follow-up|1|||
46845874|NCT00142298|83062693|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
46845875|NCT00142298|83062694|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
46845876|NCT00142298|83062695|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
46845877|NCT00142298|83062696|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
46845878|NCT00142298|83062697|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
46845879|NCT00142298|83062698|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
46845880|NCT00142298|83062699|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
46845881|NCT00142298|83062690|FG000|Overall Study|Pregnancy|4|||
46845882|NCT00142298|83062691|FG001|Overall Study|Pregnancy|4|||
46845883|NCT00142298|83062692|FG002|Overall Study|Pregnancy|2|||
46845884|NCT00142298|83062693|FG003|Overall Study|Pregnancy|3|||
46845885|NCT00142298|83062694|FG004|Overall Study|Pregnancy|0|||
46845886|NCT00142298|83062695|FG005|Overall Study|Pregnancy|0|||
46845887|NCT00142298|83062696|FG006|Overall Study|Pregnancy|0|||
46845888|NCT00142298|83062697|FG007|Overall Study|Pregnancy|0|||
46845889|NCT00142298|83062698|FG008|Overall Study|Pregnancy|1|||
46845890|NCT00142298|83062699|FG009|Overall Study|Pregnancy|0|||
46845891|NCT00142298|83062690|FG000|Overall Study|Virologic breakthrough|19|||
46845892|NCT00142298|83062691|FG001|Overall Study|Virologic breakthrough|23|||
46845893|NCT00142298|83062692|FG002|Overall Study|Virologic breakthrough|9|||
46845894|NCT00142298|83062693|FG003|Overall Study|Virologic breakthrough|7|||
46845895|NCT00142298|83062694|FG004|Overall Study|Virologic breakthrough|2|||
46845896|NCT00142298|83062695|FG005|Overall Study|Virologic breakthrough|3|||
46845897|NCT00142298|83062696|FG006|Overall Study|Virologic breakthrough|3|||
46845898|NCT00142298|83062697|FG007|Overall Study|Virologic breakthrough|0|||
46845899|NCT00142298|83062698|FG008|Overall Study|Virologic breakthrough|0|||
46845900|NCT00142298|83062699|FG009|Overall Study|Virologic breakthrough|0|||
46845901|NCT00142298|83062690|FG000|Overall Study|Other- not specified|0|||
46845902|NCT00142298|83062691|FG001|Overall Study|Other- not specified|3|||
46845903|NCT00142298|83062692|FG002|Overall Study|Other- not specified|0|||
46845904|NCT00142298|83062693|FG003|Overall Study|Other- not specified|1|||
46845905|NCT00142298|83062694|FG004|Overall Study|Other- not specified|0|||
46845906|NCT00142298|83062695|FG005|Overall Study|Other- not specified|0|||
46845907|NCT00142298|83062696|FG006|Overall Study|Other- not specified|0|||
46845908|NCT00142298|83062697|FG007|Overall Study|Other- not specified|0|||
46845909|NCT00142298|83062698|FG008|Overall Study|Other- not specified|0|||
46845910|NCT00142298|83062699|FG009|Overall Study|Other- not specified|0|||
46845911|NCT00142298|83062690|FG000|Overall Study|Lost to Follow-up|0|||
46845912|NCT00142298|83062691|FG001|Overall Study|Lost to Follow-up|0|||
46845913|NCT00142298|83062692|FG002|Overall Study|Lost to Follow-up|0|||
46845914|NCT00142298|83062693|FG003|Overall Study|Lost to Follow-up|0|||
46845915|NCT00142298|83062694|FG004|Overall Study|Lost to Follow-up|0|||
46845916|NCT00142298|83062695|FG005|Overall Study|Lost to Follow-up|0|||
46845917|NCT00142298|83062696|FG006|Overall Study|Lost to Follow-up|2|||
46845918|NCT00142298|83062697|FG007|Overall Study|Lost to Follow-up|0|||
46845919|NCT00142298|83062698|FG008|Overall Study|Lost to Follow-up|0|||
46845920|NCT00142298|83062699|FG009|Overall Study|Lost to Follow-up|0|||
46845921|NCT00142298|83062690|FG000|Overall Study|Treatment Failure|0|||
46845922|NCT00142298|83062691|FG001|Overall Study|Treatment Failure|0|||
46964832|NCT00701779|83207705|FG000|Overall Study|Withdrawal by Subject|2|||
46964833|NCT03707977|83207728|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
46964834|NCT03707977|83207729|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
46964835|NCT03707977|83207730|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
46774720|NCT00790907|82993192|FG001|Overall Study|Qualifying Condition Not Present|14|||
46774721|NCT00790907|82993193|FG002|Overall Study|Qualifying Condition Not Present|16|||
46774722|NCT00790907|82993191|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
46774723|NCT00790907|82993192|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
46774724|NCT00790907|82993193|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
46774725|NCT00790907|82993191|FG000|Overall Study|Did Not Receive Study Drug|10|||
46774726|NCT00790907|82993192|FG001|Overall Study|Did Not Receive Study Drug|0|||
46774727|NCT00790907|82993193|FG002|Overall Study|Did Not Receive Study Drug|0|||
46774728|NCT00793871|82993211|FG000|Overall Study|Death|50|||
46845923|NCT00142298|83062692|FG002|Overall Study|Treatment Failure|0|||
46845924|NCT00142298|83062693|FG003|Overall Study|Treatment Failure|0|||
46845925|NCT00142298|83062694|FG004|Overall Study|Treatment Failure|0|||
46845926|NCT00142298|83062695|FG005|Overall Study|Treatment Failure|2|||
46845927|NCT00142298|83062696|FG006|Overall Study|Treatment Failure|2|||
46845928|NCT00142298|83062697|FG007|Overall Study|Treatment Failure|0|||
46845929|NCT00142298|83062698|FG008|Overall Study|Treatment Failure|0|||
46845930|NCT00142298|83062699|FG009|Overall Study|Treatment Failure|0|||
46967878|NCT05091307|83210485|FG002|Overall Study|Withdrawal by Subject|0|||
46774729|NCT00793871|82993211|FG000|Overall Study|Lost to Follow-up|3|||
46845931|NCT03709654|83062723|FG000|Overall Study|Lost to Follow-up|1|||
46845932|NCT03709654|83062724|FG001|Overall Study|Lost to Follow-up|1|||
46845933|NCT03709654|83062723|FG000|Overall Study|Withdrawal by Subject|1|||
46964836|NCT03707977|83207728|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
46964837|NCT03707977|83207729|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
46964838|NCT03707977|83207730|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
46964839|NCT03332095|83207746|FG000|Overall Study|Lost to Follow-up|1|||
46964840|NCT03332095|83207747|FG001|Overall Study|Lost to Follow-up|0|||
46964841|NCT03332095|83207746|FG000|Overall Study|Pregnancy|0|||
46964842|NCT03332095|83207747|FG001|Overall Study|Pregnancy|1|||
46964843|NCT02764489|83207754|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
46964844|NCT02764489|83207755|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
46964845|NCT02764489|83207754|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
46964846|NCT02764489|83207755|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
46964847|NCT02764489|83207754|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
46964848|NCT02764489|83207755|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
46964849|NCT02764489|83207754|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
46964850|NCT02764489|83207755|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
46964851|NCT02001623|83207780|FG000|Overall Study|Disease Progression|2|||
46964852|NCT02001623|83207781|FG001|Overall Study|Disease Progression|2|||
46964853|NCT02001623|83207782|FG002|Overall Study|Disease Progression|3|||
46964854|NCT02001623|83207783|FG003|Overall Study|Disease Progression|2|||
46964855|NCT02001623|83207784|FG004|Overall Study|Disease Progression|3|||
46964856|NCT02001623|83207785|FG005|Overall Study|Disease Progression|2|||
46964857|NCT02001623|83207786|FG006|Overall Study|Disease Progression|3|||
46964858|NCT02001623|83207787|FG007|Overall Study|Disease Progression|3|||
46964859|NCT02001623|83207788|FG008|Overall Study|Disease Progression|7|||
46964860|NCT02001623|83207789|FG009|Overall Study|Disease Progression|40|||
46964861|NCT02001623|83207790|FG010|Overall Study|Disease Progression|5|||
46964862|NCT02001623|83207791|FG011|Overall Study|Disease Progression|9|||
46964863|NCT02001623|83207792|FG012|Overall Study|Disease Progression|9|||
46964864|NCT02001623|83207793|FG013|Overall Study|Disease Progression|20|||
46964865|NCT02001623|83207794|FG014|Overall Study|Disease Progression|9|||
46964866|NCT02001623|83207780|FG000|Overall Study|Physician Decision|0|||
46964867|NCT02001623|83207781|FG001|Overall Study|Physician Decision|0|||
46964868|NCT02001623|83207782|FG002|Overall Study|Physician Decision|0|||
46964869|NCT02001623|83207783|FG003|Overall Study|Physician Decision|0|||
46964870|NCT02001623|83207784|FG004|Overall Study|Physician Decision|0|||
46964871|NCT02001623|83207785|FG005|Overall Study|Physician Decision|0|||
46964872|NCT02001623|83207786|FG006|Overall Study|Physician Decision|0|||
46964873|NCT02001623|83207787|FG007|Overall Study|Physician Decision|0|||
46964874|NCT02001623|83207788|FG008|Overall Study|Physician Decision|3|||
46964875|NCT02001623|83207789|FG009|Overall Study|Physician Decision|2|||
46964876|NCT02001623|83207790|FG010|Overall Study|Physician Decision|3|||
46964877|NCT02001623|83207791|FG011|Overall Study|Physician Decision|3|||
46964878|NCT02001623|83207792|FG012|Overall Study|Physician Decision|1|||
46964879|NCT02001623|83207793|FG013|Overall Study|Physician Decision|2|||
46964880|NCT02001623|83207794|FG014|Overall Study|Physician Decision|1|||
46964881|NCT02001623|83207780|FG000|Overall Study|Death|0|||
46964882|NCT02001623|83207781|FG001|Overall Study|Death|1|||
46964883|NCT02001623|83207782|FG002|Overall Study|Death|0|||
46964884|NCT02001623|83207783|FG003|Overall Study|Death|0|||
46964885|NCT02001623|83207784|FG004|Overall Study|Death|0|||
46964886|NCT02001623|83207785|FG005|Overall Study|Death|0|||
46964887|NCT02001623|83207786|FG006|Overall Study|Death|0|||
46964888|NCT02001623|83207787|FG007|Overall Study|Death|0|||
46964889|NCT02001623|83207788|FG008|Overall Study|Death|0|||
46774730|NCT00793871|82993211|FG000|Overall Study|Study terminated by the Sponsor|7|||
46964890|NCT02001623|83207789|FG009|Overall Study|Death|0|||
46964891|NCT02001623|83207790|FG010|Overall Study|Death|0|||
46774731|NCT00577707|82993219|FG000|Overall Study|Withdrawal by Subject|3|||
46774732|NCT00713349|82993223|FG000|Overall Study|Protocol Violation|1|||
46964892|NCT02001623|83207791|FG011|Overall Study|Death|0|||
46964893|NCT02001623|83207792|FG012|Overall Study|Death|0|||
46964894|NCT02001623|83207793|FG013|Overall Study|Death|0|||
46964895|NCT02001623|83207794|FG014|Overall Study|Death|0|||
46964896|NCT02001623|83207780|FG000|Overall Study|Adverse Event|0|||
46964897|NCT02001623|83207781|FG001|Overall Study|Adverse Event|0|||
46964898|NCT02001623|83207782|FG002|Overall Study|Adverse Event|0|||
46964899|NCT02001623|83207783|FG003|Overall Study|Adverse Event|0|||
46964900|NCT02001623|83207784|FG004|Overall Study|Adverse Event|0|||
46964901|NCT02001623|83207785|FG005|Overall Study|Adverse Event|1|||
46964902|NCT02001623|83207786|FG006|Overall Study|Adverse Event|0|||
46964903|NCT02001623|83207787|FG007|Overall Study|Adverse Event|3|||
46964904|NCT02001623|83207788|FG008|Overall Study|Adverse Event|4|||
46964905|NCT02001623|83207789|FG009|Overall Study|Adverse Event|6|||
46964906|NCT02001623|83207790|FG010|Overall Study|Adverse Event|4|||
46964907|NCT02001623|83207791|FG011|Overall Study|Adverse Event|0|||
46964908|NCT02001623|83207792|FG012|Overall Study|Adverse Event|3|||
46964909|NCT02001623|83207793|FG013|Overall Study|Adverse Event|5|||
46964910|NCT02001623|83207794|FG014|Overall Study|Adverse Event|6|||
46964911|NCT02001623|83207780|FG000|Overall Study|Other - Miscellaneous|0|||
46964912|NCT02001623|83207781|FG001|Overall Study|Other - Miscellaneous|0|||
46964913|NCT02001623|83207782|FG002|Overall Study|Other - Miscellaneous|0|||
46964914|NCT02001623|83207783|FG003|Overall Study|Other - Miscellaneous|0|||
46964915|NCT02001623|83207784|FG004|Overall Study|Other - Miscellaneous|0|||
46964916|NCT02001623|83207785|FG005|Overall Study|Other - Miscellaneous|0|||
46964917|NCT02001623|83207786|FG006|Overall Study|Other - Miscellaneous|0|||
46964918|NCT02001623|83207787|FG007|Overall Study|Other - Miscellaneous|0|||
46964919|NCT02001623|83207788|FG008|Overall Study|Other - Miscellaneous|0|||
46964920|NCT02001623|83207789|FG009|Overall Study|Other - Miscellaneous|1|||
46964921|NCT02001623|83207790|FG010|Overall Study|Other - Miscellaneous|0|||
46964922|NCT02001623|83207791|FG011|Overall Study|Other - Miscellaneous|0|||
46964923|NCT02001623|83207792|FG012|Overall Study|Other - Miscellaneous|0|||
46964924|NCT02001623|83207793|FG013|Overall Study|Other - Miscellaneous|1|||
46964925|NCT02001623|83207794|FG014|Overall Study|Other - Miscellaneous|0|||
46964926|NCT02001623|83207780|FG000|Overall Study|Withdrawal by Subject|1|||
46964927|NCT02001623|83207781|FG001|Overall Study|Withdrawal by Subject|0|||
46964928|NCT02001623|83207782|FG002|Overall Study|Withdrawal by Subject|0|||
46964929|NCT02001623|83207783|FG003|Overall Study|Withdrawal by Subject|0|||
46964930|NCT02001623|83207784|FG004|Overall Study|Withdrawal by Subject|0|||
46964931|NCT02001623|83207785|FG005|Overall Study|Withdrawal by Subject|0|||
46964932|NCT02001623|83207786|FG006|Overall Study|Withdrawal by Subject|0|||
46964933|NCT02001623|83207787|FG007|Overall Study|Withdrawal by Subject|0|||
46964934|NCT02001623|83207788|FG008|Overall Study|Withdrawal by Subject|1|||
46964935|NCT02001623|83207789|FG009|Overall Study|Withdrawal by Subject|3|||
46964936|NCT02001623|83207790|FG010|Overall Study|Withdrawal by Subject|2|||
46964937|NCT02001623|83207791|FG011|Overall Study|Withdrawal by Subject|2|||
46964938|NCT02001623|83207792|FG012|Overall Study|Withdrawal by Subject|1|||
46964939|NCT02001623|83207793|FG013|Overall Study|Withdrawal by Subject|5|||
46964940|NCT02001623|83207794|FG014|Overall Study|Withdrawal by Subject|2|||
46964941|NCT02001623|83207780|FG000|Overall Study|Lost to Follow-up|0|||
46964942|NCT02001623|83207781|FG001|Overall Study|Lost to Follow-up|0|||
46964943|NCT02001623|83207782|FG002|Overall Study|Lost to Follow-up|0|||
46964944|NCT02001623|83207783|FG003|Overall Study|Lost to Follow-up|0|||
46964945|NCT02001623|83207784|FG004|Overall Study|Lost to Follow-up|0|||
46964946|NCT02001623|83207785|FG005|Overall Study|Lost to Follow-up|0|||
46964947|NCT02001623|83207786|FG006|Overall Study|Lost to Follow-up|0|||
46964948|NCT02001623|83207787|FG007|Overall Study|Lost to Follow-up|0|||
46964949|NCT02001623|83207788|FG008|Overall Study|Lost to Follow-up|0|||
46964950|NCT02001623|83207789|FG009|Overall Study|Lost to Follow-up|1|||
46964951|NCT02001623|83207790|FG010|Overall Study|Lost to Follow-up|0|||
46964952|NCT02001623|83207791|FG011|Overall Study|Lost to Follow-up|0|||
46964953|NCT02001623|83207792|FG012|Overall Study|Lost to Follow-up|0|||
46964954|NCT02001623|83207793|FG013|Overall Study|Lost to Follow-up|0|||
46964955|NCT02001623|83207794|FG014|Overall Study|Lost to Follow-up|0|||
46964956|NCT02001623|83207780|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
46964957|NCT02001623|83207781|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
46964958|NCT02001623|83207782|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
46964959|NCT02001623|83207783|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
46964960|NCT02001623|83207784|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
46964961|NCT02001623|83207785|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
46964962|NCT02001623|83207786|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
46964963|NCT02001623|83207787|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
46964964|NCT02001623|83207788|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
46964965|NCT02001623|83207789|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
46964966|NCT02001623|83207790|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
46964967|NCT02001623|83207791|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
46964968|NCT02001623|83207792|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
46964969|NCT02001623|83207793|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
46964970|NCT02001623|83207794|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
46964971|NCT02001623|83207780|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
46964972|NCT02001623|83207781|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
46964973|NCT02001623|83207782|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
46964974|NCT02001623|83207783|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
46964975|NCT02001623|83207784|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
46964976|NCT02001623|83207785|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
46964977|NCT02001623|83207786|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
46964978|NCT02001623|83207787|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
46964979|NCT02001623|83207788|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
46964980|NCT02001623|83207789|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
46964981|NCT02001623|83207790|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
46964982|NCT02001623|83207791|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
46964983|NCT02001623|83207792|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
46964984|NCT02001623|83207793|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
46964985|NCT02001623|83207794|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
46964986|NCT02713867|83207845|FG000|Randomization|Other Reason|2|||
46964987|NCT02713867|83207846|FG001|Randomization|Other Reason|1|||
46964988|NCT02713867|83207845|FG000|Randomization|Participant Withdrew consent|0|||
46964989|NCT02713867|83207846|FG001|Randomization|Participant Withdrew consent|2|||
46964990|NCT02713867|83207845|FG000|Treatment Period|Other Reasons|22|||
46964991|NCT02713867|83207846|FG001|Treatment Period|Other Reasons|28|||
46964992|NCT02713867|83207845|FG000|Treatment Period|Administrative reason by sponsor|21|||
46964993|NCT02713867|83207846|FG001|Treatment Period|Administrative reason by sponsor|16|||
46964994|NCT02713867|83207845|FG000|Treatment Period|No longer meets study criteria|2|||
46964995|NCT02713867|83207846|FG001|Treatment Period|No longer meets study criteria|1|||
46964996|NCT02713867|83207845|FG000|Treatment Period|Poor/Non Compliance|1|||
46964997|NCT02713867|83207846|FG001|Treatment Period|Poor/Non Compliance|0|||
46964998|NCT02713867|83207845|FG000|Treatment Period|Maximum Clinical Benefit|5|||
46964999|NCT02713867|83207846|FG001|Treatment Period|Maximum Clinical Benefit|6|||
46965000|NCT02713867|83207845|FG000|Treatment Period|Withdrew consent|3|||
46965001|NCT02713867|83207846|FG001|Treatment Period|Withdrew consent|6|||
46965002|NCT02713867|83207845|FG000|Treatment Period|Requested to Discontinue|8|||
46965003|NCT02713867|83207846|FG001|Treatment Period|Requested to Discontinue|8|||
46965004|NCT02713867|83207845|FG000|Treatment Period|AE unrelated to Study Drug|11|||
46965005|NCT02713867|83207846|FG001|Treatment Period|AE unrelated to Study Drug|10|||
46965006|NCT02713867|83207845|FG000|Treatment Period|Death|7|||
46965007|NCT02713867|83207846|FG001|Treatment Period|Death|3|||
46965008|NCT02713867|83207845|FG000|Treatment Period|Study Drug Toxicity|16|||
46965009|NCT02713867|83207846|FG001|Treatment Period|Study Drug Toxicity|19|||
46965010|NCT02713867|83207845|FG000|Treatment Period|Disease Progression|82|||
46965011|NCT02713867|83207846|FG001|Treatment Period|Disease Progression|83|||
46965012|NCT02730455|83207855|FG000|Overall Study|Death|5|||
46965013|NCT02730455|83207856|FG001|Overall Study|Death|6|||
46965014|NCT02730455|83207857|FG002|Overall Study|Death|4|||
46965015|NCT02730455|83207855|FG000|Overall Study|Consent withdrawn|2|||
46965016|NCT02730455|83207856|FG001|Overall Study|Consent withdrawn|4|||
46965017|NCT02730455|83207857|FG002|Overall Study|Consent withdrawn|1|||
46965018|NCT02730455|83207855|FG000|Overall Study|Lost to Follow-up|3|||
46965019|NCT02730455|83207856|FG001|Overall Study|Lost to Follow-up|1|||
46965020|NCT02730455|83207857|FG002|Overall Study|Lost to Follow-up|4|||
46965021|NCT02730455|83207855|FG000|Overall Study|Other|1|||
46965022|NCT02730455|83207856|FG001|Overall Study|Other|1|||
46965023|NCT02730455|83207857|FG002|Overall Study|Other|2|||
46965024|NCT02730455|83207855|FG000|Overall Study|Other|2|||
46965025|NCT02730455|83207856|FG001|Overall Study|Other|2|||
46965026|NCT02730455|83207857|FG002|Overall Study|Other|0|||
46965027|NCT04440449|83207867|FG000|Overall Study|Lost to Follow-up|2|||
46845934|NCT03709654|83062724|FG001|Overall Study|Withdrawal by Subject|1|||
46845935|NCT03709654|83062723|FG000|Overall Study|Adverse Event|1|||
46845936|NCT03709654|83062724|FG001|Overall Study|Adverse Event|0|||
46845937|NCT00412061|83062732|FG000|Double Blind Phase|Disease Progression|101|||
46845938|NCT00412061|83062733|FG001|Double Blind Phase|Disease Progression|154|||
46845939|NCT00412061|83062732|FG000|Double Blind Phase|Adverse Event|61|||
46845940|NCT00412061|83062733|FG001|Double Blind Phase|Adverse Event|16|||
46845941|NCT00412061|83062732|FG000|Double Blind Phase|Final Primary Analysis|26|||
46845942|NCT00412061|83062733|FG001|Double Blind Phase|Final Primary Analysis|14|||
46845943|NCT00412061|83062732|FG000|Double Blind Phase|Withdrawal by Subject|18|||
46845944|NCT00412061|83062733|FG001|Double Blind Phase|Withdrawal by Subject|20|||
46845945|NCT00412061|83062732|FG000|Double Blind Phase|Death|6|||
46845946|NCT00412061|83062733|FG001|Double Blind Phase|Death|3|||
46845947|NCT00412061|83062732|FG000|Double Blind Phase|Protocol Violation|3|||
46845948|NCT00412061|83062733|FG001|Double Blind Phase|Protocol Violation|4|||
46845949|NCT00412061|83062732|FG000|Double Blind Phase|New Cander Therapy|1|||
46845950|NCT00412061|83062733|FG001|Double Blind Phase|New Cander Therapy|1|||
46845951|NCT00412061|83062732|FG000|Double Blind Phase|Lost to Follow-up|0|||
46965028|NCT04440449|83207868|FG001|Overall Study|Lost to Follow-up|0|||
46965029|NCT00701311|83207875|FG000|Overall Study|Lack of Efficacy|3|||
46965030|NCT00701311|83207875|FG000|Overall Study|Adverse Event|3|||
46965031|NCT00701311|83207875|FG000|Overall Study|Withdrawal by Subject|2|||
46965032|NCT02730377|83207881|FG000|Overall Study|Other|5|||
46965033|NCT02730377|83207882|FG001|Overall Study|Other|4|||
46965034|NCT02730377|83207881|FG000|Overall Study|Death|1|||
46965035|NCT02730377|83207882|FG001|Overall Study|Death|8|||
46965036|NCT02730377|83207881|FG000|Overall Study|Inadequate glycaemic control|368|||
46965037|NCT02730377|83207882|FG001|Overall Study|Inadequate glycaemic control|473|||
46965038|NCT02730377|83207881|FG000|Overall Study|Adverse Event|79|||
46965039|NCT02730377|83207882|FG001|Overall Study|Adverse Event|41|||
46965040|NCT02730377|83207881|FG000|Overall Study|Protocol Violation|23|||
46965041|NCT02730377|83207882|FG001|Overall Study|Protocol Violation|30|||
46965042|NCT02730377|83207881|FG000|Overall Study|Lack of Efficacy|4|||
46965043|NCT02730377|83207882|FG001|Overall Study|Lack of Efficacy|13|||
46965044|NCT02730377|83207881|FG000|Overall Study|Pregnancy|0|||
46965045|NCT02730377|83207882|FG001|Overall Study|Pregnancy|1|||
46965046|NCT02730377|83207881|FG000|Overall Study|Withdrawal by Subject|45|||
46965047|NCT02730377|83207882|FG001|Overall Study|Withdrawal by Subject|42|||
46965048|NCT02730377|83207881|FG000|Overall Study|Lost to Follow-up|25|||
46965049|NCT02730377|83207882|FG001|Overall Study|Lost to Follow-up|21|||
46965050|NCT02714569|83207899|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
46965051|NCT02714569|83207900|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
46965052|NCT02714569|83207901|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
46965053|NCT02714569|83207902|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
46965054|NCT02714569|83207903|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
46965055|NCT02714569|83207904|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
46965056|NCT02714569|83207905|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
46965057|NCT02714569|83207906|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
46965058|NCT02714569|83207907|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
46965059|NCT02714569|83207908|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
46965060|NCT02714569|83207909|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
46965061|NCT02714569|83207899|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965062|NCT02714569|83207900|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965063|NCT02714569|83207901|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965064|NCT02714569|83207902|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
46965065|NCT02714569|83207903|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965066|NCT02714569|83207904|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965067|NCT02714569|83207905|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965068|NCT02714569|83207906|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965069|NCT02714569|83207907|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965070|NCT02714569|83207908|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965071|NCT02714569|83207909|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
46965072|NCT02714569|83207899|FG000|Part A Third Intervention|Adverse Event|0|||
46965073|NCT02714569|83207900|FG001|Part A Third Intervention|Adverse Event|0|||
46965074|NCT02714569|83207901|FG002|Part A Third Intervention|Adverse Event|1|||
46965075|NCT02714569|83207902|FG003|Part A Third Intervention|Adverse Event|0|||
46965076|NCT02714569|83207903|FG004|Part A Third Intervention|Adverse Event|0|||
46965077|NCT02714569|83207904|FG005|Part A Third Intervention|Adverse Event|0|||
46965078|NCT02714569|83207905|FG006|Part A Third Intervention|Adverse Event|0|||
46965079|NCT02714569|83207906|FG007|Part A Third Intervention|Adverse Event|0|||
46965080|NCT02714569|83207907|FG008|Part A Third Intervention|Adverse Event|0|||
46965081|NCT02714569|83207908|FG009|Part A Third Intervention|Adverse Event|0|||
46965082|NCT02714569|83207909|FG010|Part A Third Intervention|Adverse Event|0|||
46965083|NCT02714569|83207899|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
46965084|NCT02714569|83207900|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965085|NCT02714569|83207901|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965086|NCT02714569|83207902|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965087|NCT02714569|83207903|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965088|NCT02714569|83207904|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
46965089|NCT02714569|83207905|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965090|NCT02714569|83207906|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965091|NCT02714569|83207907|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965092|NCT02714569|83207908|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965093|NCT02714569|83207909|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
46965094|NCT02714569|83207899|FG000|Part B (Overall)|Lost to Follow-up|0|||
46965095|NCT02714569|83207900|FG001|Part B (Overall)|Lost to Follow-up|0|||
46965096|NCT02714569|83207901|FG002|Part B (Overall)|Lost to Follow-up|0|||
46965097|NCT02714569|83207902|FG003|Part B (Overall)|Lost to Follow-up|0|||
46965098|NCT02714569|83207903|FG004|Part B (Overall)|Lost to Follow-up|0|||
46965099|NCT02714569|83207904|FG005|Part B (Overall)|Lost to Follow-up|0|||
46965100|NCT02714569|83207905|FG006|Part B (Overall)|Lost to Follow-up|1|||
47067396|NCT01532648|83351067|FG001|Overall Study|Lack of Efficacy|1|||
47067397|NCT01532648|83351066|FG000|Overall Study|Protocol Violation|1|||
47067398|NCT01532648|83351067|FG001|Overall Study|Protocol Violation|1|||
47067399|NCT01532648|83351066|FG000|Overall Study|Adverse Event|12|||
46965101|NCT02714569|83207906|FG007|Part B (Overall)|Lost to Follow-up|0|||
46965102|NCT02714569|83207907|FG008|Part B (Overall)|Lost to Follow-up|0|||
46965103|NCT02714569|83207908|FG009|Part B (Overall)|Lost to Follow-up|0|||
46965104|NCT02714569|83207909|FG010|Part B (Overall)|Lost to Follow-up|0|||
46965105|NCT02714569|83207899|FG000|Part B (Overall)|Withdrawal by Subject|0|||
46965106|NCT02714569|83207900|FG001|Part B (Overall)|Withdrawal by Subject|0|||
46965107|NCT02714569|83207901|FG002|Part B (Overall)|Withdrawal by Subject|0|||
46965108|NCT02714569|83207902|FG003|Part B (Overall)|Withdrawal by Subject|0|||
46965109|NCT02714569|83207903|FG004|Part B (Overall)|Withdrawal by Subject|0|||
46965110|NCT02714569|83207904|FG005|Part B (Overall)|Withdrawal by Subject|0|||
46965111|NCT02714569|83207905|FG006|Part B (Overall)|Withdrawal by Subject|0|||
46965112|NCT02714569|83207906|FG007|Part B (Overall)|Withdrawal by Subject|1|||
46965113|NCT02714569|83207907|FG008|Part B (Overall)|Withdrawal by Subject|0|||
46965114|NCT02714569|83207908|FG009|Part B (Overall)|Withdrawal by Subject|1|||
46965115|NCT02714569|83207909|FG010|Part B (Overall)|Withdrawal by Subject|0|||
46965116|NCT02714569|83207899|FG000|Part B (Overall)|Adverse Event|0|||
46965117|NCT02714569|83207900|FG001|Part B (Overall)|Adverse Event|0|||
46965118|NCT02714569|83207901|FG002|Part B (Overall)|Adverse Event|0|||
46965119|NCT02714569|83207902|FG003|Part B (Overall)|Adverse Event|0|||
46965120|NCT02714569|83207903|FG004|Part B (Overall)|Adverse Event|0|||
46965121|NCT02714569|83207904|FG005|Part B (Overall)|Adverse Event|0|||
46965122|NCT02714569|83207905|FG006|Part B (Overall)|Adverse Event|0|||
46965123|NCT02714569|83207906|FG007|Part B (Overall)|Adverse Event|0|||
46965124|NCT02714569|83207907|FG008|Part B (Overall)|Adverse Event|0|||
46965125|NCT02714569|83207908|FG009|Part B (Overall)|Adverse Event|1|||
46965126|NCT02714569|83207909|FG010|Part B (Overall)|Adverse Event|0|||
46965127|NCT02713789|83207972|FG000|Overall Study|Lost to Follow-up|0|||
46965128|NCT02713789|83207973|FG001|Overall Study|Lost to Follow-up|1|||
46965129|NCT02713789|83207974|FG002|Overall Study|Lost to Follow-up|1|||
46965130|NCT04445051|83207984|FG000|Overall Study|Adverse Event|0|||
46965131|NCT04445051|83207985|FG001|Overall Study|Adverse Event|0|||
46965132|NCT04445051|83207986|FG002|Overall Study|Adverse Event|1|||
46965133|NCT04445051|83207987|FG003|Overall Study|Adverse Event|0|||
46965134|NCT04445051|83207988|FG004|Overall Study|Adverse Event|0|||
46965135|NCT04445051|83207989|FG005|Overall Study|Adverse Event|0|||
46965136|NCT04086121|83208003|FG000|Overall Study|Other than listed|8|||
46965137|NCT04086121|83208003|FG000|Overall Study|Withdrawal by Subject|3|||
46965138|NCT04086121|83208003|FG000|Overall Study|Lost to Follow-up|2|||
46965139|NCT04086121|83208003|FG000|Overall Study|Adverse Event|1|||
46965140|NCT02729909|83208010|FG000|Overall Study|Lost to Follow-up|0|||
46965141|NCT02729909|83208011|FG001|Overall Study|Lost to Follow-up|1|||
46965142|NCT02729909|83208010|FG000|Overall Study|Lack of Efficacy|0|||
46965143|NCT02729909|83208011|FG001|Overall Study|Lack of Efficacy|2|||
46965144|NCT02729909|83208010|FG000|Overall Study|Significant Protocol Deviation|0|||
46965145|NCT02729909|83208011|FG001|Overall Study|Significant Protocol Deviation|2|||
46965146|NCT02729909|83208010|FG000|Overall Study|Voluntary Withdrawal|1|||
46965147|NCT02729909|83208011|FG001|Overall Study|Voluntary Withdrawal|0|||
46965148|NCT02713243|83208019|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
46965149|NCT02713243|83208020|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
46965150|NCT02713243|83208019|FG000|Overall Study|Administrative problems|0|||
46965151|NCT02713243|83208020|FG001|Overall Study|Administrative problems|1|||
46965152|NCT02713243|83208019|FG000|Overall Study|Protocol deviation|0|||
46965153|NCT02713243|83208020|FG001|Overall Study|Protocol deviation|1|||
46965154|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
46965155|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
46965156|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
46640177|NCT04083222|82814305|FG001|Overall Study|Reason not Specified|1|||
46640178|NCT03286842|82814311|FG000|Overall Study|Patients rolled over to another study|80|||
46640179|NCT03037476|82814319|FG000|Overall Study|Lost to Follow-up|63|||
46774733|NCT00712959|82993231|FG000|Overall Study|Protocol Violation|3|||
46965157|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
46640180|NCT03037476|82814320|FG001|Overall Study|Lost to Follow-up|46|||
46640181|NCT00639678|82814335|FG000|Overall Study|Withdrawal by Subject|3|||
46774734|NCT00712959|82993232|FG001|Overall Study|Protocol Violation|1|||
46965158|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
46965159|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
46965160|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
46965161|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
46640182|NCT00639678|82814336|FG001|Overall Study|Withdrawal by Subject|0|||
46965162|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
46965163|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
46965164|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
46965165|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
46965166|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
46965167|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
46965168|NCT03434041|83208028|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
46965169|NCT03434041|83208029|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
46965170|NCT03434041|83208028|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
46965171|NCT03434041|83208029|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
46965172|NCT03434041|83208028|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
46965173|NCT03434041|83208029|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
46965174|NCT03434041|83208028|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
46965175|NCT03434041|83208029|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
46965176|NCT00708461|83208044|FG000|Overall Study|Lost to Follow-up|18|||
46965177|NCT00708461|83208045|FG001|Overall Study|Lost to Follow-up|11|||
46965178|NCT00708461|83208044|FG000|Overall Study|Withdrawal by Subject|8|||
46965179|NCT00708461|83208045|FG001|Overall Study|Withdrawal by Subject|9|||
46965180|NCT00708461|83208044|FG000|Overall Study|left workforce|115|||
46965181|NCT00708461|83208045|FG001|Overall Study|left workforce|180|||
46965182|NCT00700999|83208053|FG000|Overall Study|Lost to Follow-up|7|||
46965183|NCT00700999|83208054|FG001|Overall Study|Lost to Follow-up|7|||
46965184|NCT00700999|83208053|FG000|Overall Study|Excluded - did not meet study criteria|0|||
46965185|NCT00700999|83208054|FG001|Overall Study|Excluded - did not meet study criteria|1|||
46965186|NCT00700999|83208053|FG000|Overall Study|Withdrawal by Subject|8|||
46965187|NCT00700999|83208054|FG001|Overall Study|Withdrawal by Subject|1|||
46965188|NCT02729831|83208064|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
46965189|NCT02729831|83208065|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
46965190|NCT02729831|83208066|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
46965191|NCT02729831|83208067|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
46965192|NCT02729831|83208064|FG000|1 Week Post-visit|Lost to Follow-up|43|||
46965193|NCT02729831|83208065|FG001|1 Week Post-visit|Lost to Follow-up|40|||
46965194|NCT02729831|83208066|FG002|1 Week Post-visit|Lost to Follow-up|38|||
46965195|NCT02729831|83208067|FG003|1 Week Post-visit|Lost to Follow-up|36|||
46965196|NCT02729831|83208064|FG000|6 Month Follow-up|Lost to Follow-up|54|||
46965197|NCT02729831|83208065|FG001|6 Month Follow-up|Lost to Follow-up|51|||
46965198|NCT02729831|83208066|FG002|6 Month Follow-up|Lost to Follow-up|48|||
46965199|NCT02729831|83208067|FG003|6 Month Follow-up|Lost to Follow-up|42|||
46965200|NCT02729831|83208064|FG000|6 Month Follow-up|Death|1|||
46965201|NCT02729831|83208065|FG001|6 Month Follow-up|Death|3|||
46965202|NCT02729831|83208066|FG002|6 Month Follow-up|Death|0|||
46965203|NCT02729831|83208067|FG003|6 Month Follow-up|Death|1|||
46965204|NCT02729753|83208079|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
46965205|NCT02729753|83208080|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
46965206|NCT00709319|83208089|FG000|Overall Study|Death|4|||
46965207|NCT00709319|83208089|FG000|Overall Study|Withdrawal by Subject|2|||
46965208|NCT02729051|83208134|FG000|Overall Study|Adverse Event|21|||
46965209|NCT02729051|83208135|FG001|Overall Study|Adverse Event|11|||
46965210|NCT02729051|83208134|FG000|Overall Study|Lack of Efficacy|1|||
46965211|NCT02729051|83208135|FG001|Overall Study|Lack of Efficacy|1|||
46965212|NCT02729051|83208134|FG000|Overall Study|Lost to Follow-up|1|||
46965213|NCT02729051|83208135|FG001|Overall Study|Lost to Follow-up|2|||
47067400|NCT01532648|83351067|FG001|Overall Study|Adverse Event|9|||
47067401|NCT01532648|83351066|FG000|Overall Study|Withdrawal by Subject|16|||
47067402|NCT01532648|83351067|FG001|Overall Study|Withdrawal by Subject|2|||
47067403|NCT01532570|83351097|FG000|Overall Study|Lack of Efficacy|1|||
47067404|NCT01532570|83351098|FG001|Overall Study|Lack of Efficacy|0|||
47067405|NCT01532570|83351099|FG002|Overall Study|Lack of Efficacy|0|||
47067406|NCT01532570|83351100|FG003|Overall Study|Lack of Efficacy|0|||
47067407|NCT01532570|83351097|FG000|Overall Study|Withdrawal by Subject|0|||
46640183|NCT00639678|82814337|FG002|Overall Study|Withdrawal by Subject|4|||
46845952|NCT00412061|83062733|FG001|Double Blind Phase|Lost to Follow-up|1|||
46845953|NCT00412061|83062732|FG000|Open Label Phase|Disease Progression|0|||
46965214|NCT02729051|83208134|FG000|Overall Study|Physician Decision|1|||
46965215|NCT02729051|83208135|FG001|Overall Study|Physician Decision|1|||
46965216|NCT02729051|83208134|FG000|Overall Study|Withdrawal by Subject|6|||
46965217|NCT02729051|83208135|FG001|Overall Study|Withdrawal by Subject|17|||
46965218|NCT00707993|83208143|FG000|Overall Study|Adverse Event|16|||
46965219|NCT00707993|83208144|FG001|Overall Study|Adverse Event|20|||
46965220|NCT00707993|83208143|FG000|Overall Study|Protocol Violation|4|||
46774735|NCT00712959|82993231|FG000|Overall Study|Lost to Follow-up|13|||
47067408|NCT01532570|83351098|FG001|Overall Study|Withdrawal by Subject|1|||
47067409|NCT01532570|83351099|FG002|Overall Study|Withdrawal by Subject|0|||
46965221|NCT00707993|83208144|FG001|Overall Study|Protocol Violation|7|||
46965222|NCT00707993|83208143|FG000|Overall Study|Lost to Follow-up|0|||
46965223|NCT00707993|83208144|FG001|Overall Study|Lost to Follow-up|4|||
46965224|NCT00707993|83208143|FG000|Overall Study|Withdrawal by Subject|12|||
46965225|NCT00707993|83208144|FG001|Overall Study|Withdrawal by Subject|16|||
46965226|NCT00707993|83208143|FG000|Overall Study|Hyperglycemic Rescue|55|||
46965227|NCT00707993|83208144|FG001|Overall Study|Hyperglycemic Rescue|47|||
46965228|NCT00707993|83208143|FG000|Overall Study|Other|2|||
46965229|NCT00707993|83208144|FG001|Overall Study|Other|0|||
46965230|NCT00708227|83208154|FG000|Overall Study|Physician Decision|0|||
46965231|NCT00708227|83208155|FG001|Overall Study|Physician Decision|3|||
46965232|NCT00708227|83208156|FG002|Overall Study|Physician Decision|1|||
46965233|NCT00708227|83208157|FG003|Overall Study|Physician Decision|2|||
46965234|NCT00708227|83208154|FG000|Overall Study|Withdrawal by Subject|1|||
46965235|NCT00708227|83208155|FG001|Overall Study|Withdrawal by Subject|2|||
46965236|NCT00708227|83208156|FG002|Overall Study|Withdrawal by Subject|0|||
46965237|NCT00708227|83208157|FG003|Overall Study|Withdrawal by Subject|1|||
46965238|NCT02425891|83208189|FG000|Overall Study|Death|333|||
46965239|NCT02425891|83208190|FG001|Overall Study|Death|314|||
46965240|NCT02425891|83208189|FG000|Overall Study|Lost to Follow-up|4|||
46965241|NCT02425891|83208190|FG001|Overall Study|Lost to Follow-up|6|||
46965242|NCT02425891|83208189|FG000|Overall Study|Non-Compliance|1|||
46965243|NCT02425891|83208190|FG001|Overall Study|Non-Compliance|1|||
46965244|NCT02425891|83208189|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
46965245|NCT02425891|83208190|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
46965246|NCT02425891|83208189|FG000|Overall Study|Physician Decision|0|||
46965247|NCT02425891|83208190|FG001|Overall Study|Physician Decision|1|||
46965248|NCT02425891|83208189|FG000|Overall Study|Protocol Violation|1|||
46965249|NCT02425891|83208190|FG001|Overall Study|Protocol Violation|1|||
46965250|NCT02425891|83208189|FG000|Overall Study|Study Terminated By Sponsor|85|||
46965251|NCT02425891|83208190|FG001|Overall Study|Study Terminated By Sponsor|95|||
46965252|NCT02425891|83208189|FG000|Overall Study|Withdrawal by Subject|27|||
46965253|NCT02425891|83208190|FG001|Overall Study|Withdrawal by Subject|32|||
46965254|NCT03241225|83208200|FG000|Overall Study|Lost to Follow-up|2|||
46965255|NCT03241225|83208201|FG001|Overall Study|Lost to Follow-up|1|||
46965256|NCT03241225|83208200|FG000|Overall Study|Protocol Violation|4|||
46965257|NCT03241225|83208201|FG001|Overall Study|Protocol Violation|1|||
46965258|NCT03241225|83208200|FG000|Overall Study|Withdrawal by Subject|1|||
46965259|NCT03241225|83208201|FG001|Overall Study|Withdrawal by Subject|0|||
46965260|NCT01597245|83208211|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
46965261|NCT01597245|83208212|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
46965262|NCT01597245|83208213|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
46965263|NCT01597245|83208214|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
46965264|NCT01597245|83208215|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965265|NCT01597245|83208216|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965266|NCT01597245|83208217|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965267|NCT01597245|83208218|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965268|NCT01597245|83208219|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965269|NCT01597245|83208220|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965270|NCT01597245|83208221|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965271|NCT01597245|83208222|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965272|NCT01597245|83208223|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965273|NCT01597245|83208224|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965274|NCT01597245|83208225|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965275|NCT01597245|83208226|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965276|NCT01597245|83208227|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965277|NCT01597245|83208228|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965278|NCT01597245|83208229|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965279|NCT01597245|83208230|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965280|NCT01597245|83208231|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
46965281|NCT01597245|83208211|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
46965282|NCT01597245|83208212|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
46965283|NCT01597245|83208213|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
46965284|NCT01597245|83208214|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
46965285|NCT01597245|83208215|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965286|NCT01597245|83208216|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965287|NCT01597245|83208217|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965288|NCT01597245|83208218|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965289|NCT01597245|83208219|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965290|NCT01597245|83208220|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965291|NCT01597245|83208221|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965292|NCT01597245|83208222|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46640184|NCT00639678|82814338|FG003|Overall Study|Withdrawal by Subject|0|||
46965293|NCT01597245|83208223|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965294|NCT01597245|83208224|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965295|NCT01597245|83208225|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965296|NCT01597245|83208226|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965297|NCT01597245|83208227|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965298|NCT01597245|83208228|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965299|NCT01597245|83208229|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965300|NCT01597245|83208230|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965301|NCT01597245|83208231|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
46965302|NCT01597245|83208211|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
46965303|NCT01597245|83208212|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
46965304|NCT01597245|83208213|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
46965305|NCT01597245|83208214|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
46965306|NCT01597245|83208215|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965307|NCT01597245|83208216|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965308|NCT01597245|83208217|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965309|NCT01597245|83208218|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965310|NCT01597245|83208219|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965311|NCT01597245|83208220|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965312|NCT01597245|83208221|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965313|NCT01597245|83208222|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965314|NCT01597245|83208223|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965315|NCT01597245|83208224|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965316|NCT01597245|83208225|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965317|NCT01597245|83208226|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965318|NCT01597245|83208227|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965319|NCT01597245|83208228|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965320|NCT01597245|83208229|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965321|NCT01597245|83208230|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965322|NCT01597245|83208231|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
46965323|NCT01597245|83208211|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
46965324|NCT01597245|83208212|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
46965325|NCT01597245|83208213|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
46965326|NCT01597245|83208214|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965327|NCT01597245|83208215|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965328|NCT01597245|83208216|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965329|NCT01597245|83208217|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965330|NCT01597245|83208218|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965331|NCT01597245|83208219|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965332|NCT01597245|83208220|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965333|NCT01597245|83208221|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965334|NCT01597245|83208222|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965335|NCT01597245|83208223|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965336|NCT01597245|83208224|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965337|NCT01597245|83208225|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965338|NCT01597245|83208226|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965339|NCT01597245|83208227|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965340|NCT01597245|83208228|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965341|NCT01597245|83208229|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965342|NCT01597245|83208230|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965343|NCT01597245|83208231|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
46965344|NCT01597245|83208211|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
46965345|NCT01597245|83208212|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965346|NCT01597245|83208213|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965347|NCT01597245|83208214|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
46965348|NCT01597245|83208215|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965349|NCT01597245|83208216|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965350|NCT01597245|83208217|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965351|NCT01597245|83208218|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46640185|NCT00639678|82814335|FG000|Overall Study|Lost to Follow-up|1|||
46774736|NCT00712959|82993232|FG001|Overall Study|Lost to Follow-up|2|||
46774737|NCT00712959|82993231|FG000|Overall Study|Withdrawal by Subject|3|||
46774738|NCT00712959|82993232|FG001|Overall Study|Withdrawal by Subject|0|||
46774739|NCT00712725|82993246|FG000|Overall Study|Adverse Event|1|||
46774740|NCT00712725|82993247|FG001|Overall Study|Adverse Event|0|||
46774741|NCT00712725|82993248|FG002|Overall Study|Adverse Event|0|||
46965352|NCT01597245|83208219|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965353|NCT01597245|83208220|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965354|NCT01597245|83208221|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965355|NCT01597245|83208222|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965356|NCT01597245|83208223|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965357|NCT01597245|83208224|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965358|NCT01597245|83208225|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965359|NCT01597245|83208226|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965360|NCT01597245|83208227|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965361|NCT01597245|83208228|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965362|NCT01597245|83208229|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965363|NCT01597245|83208230|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965364|NCT01597245|83208231|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
46965365|NCT01597245|83208211|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
46965366|NCT01597245|83208212|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
46965367|NCT01597245|83208213|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
46965368|NCT01597245|83208214|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965369|NCT01597245|83208215|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965370|NCT01597245|83208216|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965371|NCT01597245|83208217|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965372|NCT01597245|83208218|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965373|NCT01597245|83208219|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965374|NCT01597245|83208220|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965375|NCT01597245|83208221|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965376|NCT01597245|83208222|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965377|NCT01597245|83208223|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965378|NCT01597245|83208224|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965379|NCT01597245|83208225|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965380|NCT01597245|83208226|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965381|NCT01597245|83208227|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965382|NCT01597245|83208228|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965383|NCT01597245|83208229|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965384|NCT01597245|83208230|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965385|NCT01597245|83208231|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
46965386|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965387|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965388|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965389|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965390|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965391|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
46965392|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
46965393|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965394|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965395|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965396|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965397|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965398|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965399|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965400|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965401|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965402|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965403|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965404|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965405|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965406|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
46965407|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965408|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965409|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965410|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965411|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
46965412|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
46640186|NCT00639678|82814336|FG001|Overall Study|Lost to Follow-up|0|||
46640187|NCT00639678|82814337|FG002|Overall Study|Lost to Follow-up|6|||
46640188|NCT00639678|82814338|FG003|Overall Study|Lost to Follow-up|0|||
46640189|NCT00639678|82814335|FG000|Overall Study|Adverse Event|0|||
46965413|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
46965414|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
46965415|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965416|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
46965417|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965418|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965419|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965420|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965421|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965422|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965423|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965424|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965425|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965426|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965427|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
46965428|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965429|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965430|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
47067410|NCT01532570|83351100|FG003|Overall Study|Withdrawal by Subject|0|||
46965431|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
47067411|NCT01532414|83351133|FG000|Overall Study|Lost to Follow-up|3|||
47067412|NCT01532414|83351134|FG001|Overall Study|Lost to Follow-up|0|||
47067413|NCT01532414|83351135|FG002|Overall Study|Lost to Follow-up|1|||
47067414|NCT01532414|83351133|FG000|Overall Study|Withdrawal by Subject|3|||
47067415|NCT01532414|83351134|FG001|Overall Study|Withdrawal by Subject|0|||
47067416|NCT01532414|83351135|FG002|Overall Study|Withdrawal by Subject|0|||
47067417|NCT01532414|83351133|FG000|Overall Study|No V6 semen sample|0|||
47067418|NCT01532414|83351134|FG001|Overall Study|No V6 semen sample|1|||
47067419|NCT01532414|83351135|FG002|Overall Study|No V6 semen sample|0|||
47067420|NCT01532414|83351133|FG000|Overall Study|Adverse Event|0|||
47067421|NCT01532414|83351134|FG001|Overall Study|Adverse Event|1|||
47067422|NCT01532414|83351135|FG002|Overall Study|Adverse Event|1|||
46965432|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965433|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
47067423|NCT01532414|83351133|FG000|Overall Study|Unable to complete 24 hour PK|0|||
46965434|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965435|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965436|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
46965437|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965438|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
46965439|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
46965440|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
46965441|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965442|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46640190|NCT00639678|82814336|FG001|Overall Study|Adverse Event|1|||
46965443|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965444|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965445|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965446|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965447|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965448|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
46965449|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965450|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965451|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965452|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965453|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
46965454|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
46965455|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
46965456|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
46965457|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
46965458|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
46965459|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
46965460|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
46965461|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
46965462|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965463|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965464|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965465|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965466|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965467|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965468|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965469|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
46965470|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965471|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965472|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965473|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965474|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
46965475|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
46965476|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
46965477|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965478|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
46965479|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
46965480|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
46965481|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
46965482|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
46965483|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965484|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965485|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965486|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965487|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965488|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965489|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965490|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
46965491|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965492|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46845954|NCT00412061|83062733|FG001|Open Label Phase|Disease Progression|86|||
46965493|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46845955|NCT00412061|83062732|FG000|Open Label Phase|Adverse Event|0|||
46640191|NCT00639678|82814337|FG002|Overall Study|Adverse Event|0|||
46965494|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965495|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
46965496|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965497|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965498|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965499|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
46965500|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
46965501|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
46965502|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965503|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
46965504|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965505|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46640192|NCT00639678|82814338|FG003|Overall Study|Adverse Event|0|||
46640193|NCT00639678|82814335|FG000|Overall Study|Lack of Compliance|0|||
46640194|NCT00639678|82814336|FG001|Overall Study|Lack of Compliance|0|||
46640195|NCT00639678|82814337|FG002|Overall Study|Lack of Compliance|1|||
46640196|NCT00639678|82814338|FG003|Overall Study|Lack of Compliance|0|||
46965506|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965507|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965508|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965509|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965510|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965511|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
46965512|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965513|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965514|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965515|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46640197|NCT00638508|82814363|FG000|Overall Study|Physician Decision|5|||
46640198|NCT00638508|82814364|FG001|Overall Study|Physician Decision|2|||
46640199|NCT00637806|82814377|FG000|Double-blind Phase|Study Discontinued|2|||
46640200|NCT00637806|82814378|FG001|Double-blind Phase|Study Discontinued|0|||
46640201|NCT00637806|82814379|FG002|Double-blind Phase|Study Discontinued|1|||
46640202|NCT00637806|82814380|FG003|Double-blind Phase|Study Discontinued|0|||
46640203|NCT00637806|82814377|FG000|Extension Phase|Study Discontinued|0|||
46640204|NCT00637806|82814378|FG001|Extension Phase|Study Discontinued|0|||
46640205|NCT00637806|82814379|FG002|Extension Phase|Study Discontinued|0|||
46640206|NCT00637806|82814380|FG003|Extension Phase|Study Discontinued|1|||
46965516|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
46965517|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
46965518|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
46965519|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965520|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
46965521|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
46965522|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
46965523|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
46965524|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
46965525|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965526|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965527|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965528|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46640207|NCT00637728|82814391|FG000|Double-blind Phase|Adverse Event|1|||
46640208|NCT00637728|82814392|FG001|Double-blind Phase|Adverse Event|0|||
46640209|NCT00637728|82814393|FG002|Double-blind Phase|Adverse Event|0|||
46640210|NCT00637728|82814391|FG000|Double-blind Phase|Non-compliance|2|||
46640211|NCT00637728|82814392|FG001|Double-blind Phase|Non-compliance|0|||
46640212|NCT00637728|82814393|FG002|Double-blind Phase|Non-compliance|0|||
46640213|NCT00637728|82814391|FG000|Double-blind Phase|Study Discontinued|1|||
46640214|NCT00637728|82814392|FG001|Double-blind Phase|Study Discontinued|1|||
46640215|NCT00637728|82814393|FG002|Double-blind Phase|Study Discontinued|0|||
46640216|NCT00637572|82814402|FG000|Overall Study|Adverse Event|1|||
46774742|NCT00712725|82993249|FG003|Overall Study|Adverse Event|1|||
46774743|NCT00712725|82993250|FG004|Overall Study|Adverse Event|0|||
46774744|NCT00712725|82993251|FG005|Overall Study|Adverse Event|0|||
46965529|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46640217|NCT00637572|82814403|FG001|Overall Study|Adverse Event|2|||
46640218|NCT00637572|82814402|FG000|Overall Study|Death|0|||
46640219|NCT00637572|82814403|FG001|Overall Study|Death|1|||
46640220|NCT00637572|82814402|FG000|Overall Study|Lost to Follow-up|0|||
46640221|NCT00637572|82814403|FG001|Overall Study|Lost to Follow-up|1|||
46640222|NCT00637572|82814402|FG000|Overall Study|Physician Decision|1|||
46640223|NCT00637572|82814403|FG001|Overall Study|Physician Decision|1|||
46640224|NCT00637572|82814402|FG000|Overall Study|Withdrawal by Subject|0|||
46640225|NCT00637572|82814403|FG001|Overall Study|Withdrawal by Subject|2|||
46640226|NCT00637572|82814402|FG000|Overall Study|Illicit Drug Use|1|||
46640227|NCT00637572|82814403|FG001|Overall Study|Illicit Drug Use|0|||
46640228|NCT00637416|82814411|FG000|Overall Study|Lost to Follow-up|1|||
46640229|NCT00637416|82814412|FG001|Overall Study|Lost to Follow-up|1|||
46640230|NCT00637416|82814411|FG000|Overall Study|Unable to take study drug|0|||
46640231|NCT00637416|82814412|FG001|Overall Study|Unable to take study drug|1|||
46640232|NCT00636792|82814418|FG000|Overall Study|Adverse Event|16|||
46640233|NCT00636792|82814418|FG000|Overall Study|Physician Decision|7|||
46640234|NCT00636792|82814418|FG000|Overall Study|Progressive Disease|4|||
46640235|NCT00636792|82814418|FG000|Overall Study|Withdrawal by Subject|3|||
46640236|NCT00636792|82814418|FG000|Overall Study|Other|3|||
46640237|NCT00636636|82814450|FG000|Overall Study|Other reason|4|||
46640238|NCT00636636|82814451|FG001|Overall Study|Other reason|6|||
46640239|NCT00636636|82814450|FG000|Overall Study|Adverse Event|19|||
46640240|NCT00636636|82814451|FG001|Overall Study|Adverse Event|8|||
46640241|NCT00636636|82814450|FG000|Overall Study|Lack of Efficacy|7|||
46640242|NCT00636636|82814451|FG001|Overall Study|Lack of Efficacy|12|||
46640243|NCT00636636|82814450|FG000|Overall Study|Protocol Violation|2|||
46640244|NCT00636636|82814451|FG001|Overall Study|Protocol Violation|2|||
46640245|NCT00636636|82814450|FG000|Overall Study|Lost to Follow-up|0|||
46640246|NCT00636636|82814451|FG001|Overall Study|Lost to Follow-up|1|||
46640247|NCT00636636|82814450|FG000|Overall Study|Death|0|||
46640248|NCT00636636|82814451|FG001|Overall Study|Death|1|||
46640249|NCT00636636|82814450|FG000|Overall Study|Withdrawal by Subject|4|||
46640250|NCT00636636|82814451|FG001|Overall Study|Withdrawal by Subject|9|||
46640251|NCT00635778|82814464|FG000|Overall Study|Adverse Event|1|||
46640252|NCT00635778|82814465|FG001|Overall Study|Adverse Event|0|||
46640253|NCT00635778|82814466|FG002|Overall Study|Adverse Event|0|||
46640254|NCT00635778|82814467|FG003|Overall Study|Adverse Event|3|||
46640255|NCT00635778|82814468|FG004|Overall Study|Adverse Event|3|||
46640256|NCT00635778|82814469|FG005|Overall Study|Adverse Event|6|||
46640257|NCT00635778|82814470|FG006|Overall Study|Adverse Event|1|||
46774745|NCT00712725|82993252|FG006|Overall Study|Adverse Event|0|||
46774746|NCT00712725|82993253|FG007|Overall Study|Adverse Event|0|||
46845956|NCT00412061|83062733|FG001|Open Label Phase|Adverse Event|46|||
46845957|NCT00412061|83062732|FG000|Open Label Phase|Withdrawal by Subject|0|||
46845958|NCT00412061|83062733|FG001|Open Label Phase|Withdrawal by Subject|15|||
46845959|NCT00412061|83062732|FG000|Open Label Phase|Administrative Problems|0|||
46845960|NCT00412061|83062733|FG001|Open Label Phase|Administrative Problems|13|||
46845961|NCT00412061|83062732|FG000|Open Label Phase|Death|0|||
46845962|NCT00412061|83062733|FG001|Open Label Phase|Death|7|||
46845963|NCT00412061|83062732|FG000|Open Label Phase|Lost to Follow-up|0|||
46845964|NCT00412061|83062733|FG001|Open Label Phase|Lost to Follow-up|2|||
46845965|NCT00412061|83062732|FG000|Open Label Phase|New Cancer Therapy|0|||
46845966|NCT00412061|83062733|FG001|Open Label Phase|New Cancer Therapy|1|||
46845967|NCT00411671|83062751|FG000|Overall Study|Adverse Event|15|||
46845968|NCT00411671|83062751|FG000|Overall Study|Death|2|||
46845969|NCT00411671|83062751|FG000|Overall Study|Lost to Follow-up|3|||
46845970|NCT03835481|83062760|FG000|Double-blind Period|Other not stated below|0|||
46845971|NCT03835481|83062761|FG001|Double-blind Period|Other not stated below|0|||
47067424|NCT01532414|83351134|FG001|Overall Study|Unable to complete 24 hour PK|0|||
47067425|NCT01532414|83351135|FG002|Overall Study|Unable to complete 24 hour PK|1|||
47067426|NCT01532414|83351133|FG000|Overall Study|Withdrawn by sponsor|1|||
46640258|NCT00635778|82814464|FG000|Overall Study|Withdrawal by Subject|0|||
46774747|NCT00712725|82993246|FG000|Overall Study|Lost to Follow-up|3|||
46774748|NCT00712725|82993247|FG001|Overall Study|Lost to Follow-up|2|||
46774749|NCT00712725|82993248|FG002|Overall Study|Lost to Follow-up|1|||
46774750|NCT00712725|82993249|FG003|Overall Study|Lost to Follow-up|1|||
46774751|NCT00712725|82993250|FG004|Overall Study|Lost to Follow-up|2|||
46774752|NCT00712725|82993251|FG005|Overall Study|Lost to Follow-up|2|||
46774753|NCT00712725|82993252|FG006|Overall Study|Lost to Follow-up|3|||
46774754|NCT00712725|82993253|FG007|Overall Study|Lost to Follow-up|1|||
46774755|NCT00712725|82993246|FG000|Overall Study|Physician Decision|2|||
46640259|NCT00635778|82814465|FG001|Overall Study|Withdrawal by Subject|0|||
46640260|NCT00635778|82814466|FG002|Overall Study|Withdrawal by Subject|0|||
46640261|NCT00635778|82814467|FG003|Overall Study|Withdrawal by Subject|1|||
46640262|NCT00635778|82814468|FG004|Overall Study|Withdrawal by Subject|0|||
46640263|NCT00635778|82814469|FG005|Overall Study|Withdrawal by Subject|1|||
46640264|NCT00635778|82814470|FG006|Overall Study|Withdrawal by Subject|1|||
46640265|NCT00635778|82814464|FG000|Overall Study|Progressive disease|0|||
46640266|NCT00635778|82814465|FG001|Overall Study|Progressive disease|3|||
46640267|NCT00635778|82814466|FG002|Overall Study|Progressive disease|3|||
46640268|NCT00635778|82814467|FG003|Overall Study|Progressive disease|4|||
46640269|NCT00635778|82814468|FG004|Overall Study|Progressive disease|5|||
46845972|NCT03835481|83062762|FG002|Double-blind Period|Other not stated below|0|||
47067427|NCT01532414|83351134|FG001|Overall Study|Withdrawn by sponsor|0|||
46640270|NCT00635778|82814469|FG005|Overall Study|Progressive disease|14|||
46640271|NCT00635778|82814470|FG006|Overall Study|Progressive disease|4|||
46640272|NCT00634920|82814490|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
46640273|NCT00634920|82814491|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
46640274|NCT00634920|82814492|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
46640275|NCT00634920|82814490|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
46640276|NCT00634920|82814491|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
46640277|NCT00634920|82814492|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
46640278|NCT00634920|82814490|FG000|Period 1 - Pre-Randomization|Rejections|0|||
46640279|NCT00634920|82814491|FG001|Period 1 - Pre-Randomization|Rejections|0|||
46640280|NCT00634920|82814492|FG002|Period 1 - Pre-Randomization|Rejections|55|||
46640281|NCT00634920|82814490|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
46640282|NCT00634920|82814491|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
46640283|NCT00634920|82814492|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
46640284|NCT00634920|82814490|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
46640285|NCT00634920|82814491|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
46640286|NCT00634920|82814492|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
46640287|NCT00634920|82814490|FG000|Period 1 - Pre-Randomization|Other issues|0|||
46640288|NCT00634920|82814491|FG001|Period 1 - Pre-Randomization|Other issues|0|||
46640289|NCT00634920|82814492|FG002|Period 1 - Pre-Randomization|Other issues|6|||
46640290|NCT00634920|82814490|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
46640291|NCT00634920|82814491|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
46640292|NCT00634920|82814492|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
46640293|NCT00634920|82814490|FG000|Period 2 - Post-Randomization|Rejection|11|||
46640294|NCT00634920|82814491|FG001|Period 2 - Post-Randomization|Rejection|5|||
46640295|NCT00634920|82814492|FG002|Period 2 - Post-Randomization|Rejection|0|||
46640296|NCT00634920|82814490|FG000|Period 2 - Post-Randomization|Death|2|||
46965530|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965531|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965532|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
46965533|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965534|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965535|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965536|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965537|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965538|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
46965539|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965540|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965541|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
46965542|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
46965543|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
46965544|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
46965545|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
47067428|NCT01532414|83351135|FG002|Overall Study|Withdrawn by sponsor|0|||
46640297|NCT00634920|82814491|FG001|Period 2 - Post-Randomization|Death|5|||
46640298|NCT00634920|82814492|FG002|Period 2 - Post-Randomization|Death|0|||
46640299|NCT00634920|82814490|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
46640300|NCT00634920|82814491|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
46640301|NCT00634920|82814492|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
46640302|NCT00634920|82814490|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
46640303|NCT00634920|82814491|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
46640304|NCT00634920|82814492|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
46640305|NCT00634842|82814500|FG000|Overall Study|Adverse Event|2|||
46640306|NCT00634842|82814501|FG001|Overall Study|Adverse Event|3|||
46640307|NCT00634842|82814500|FG000|Overall Study|Protocol Violation|8|||
46640308|NCT00634842|82814501|FG001|Overall Study|Protocol Violation|4|||
46640309|NCT00634842|82814500|FG000|Overall Study|Move to another state|1|||
46640310|NCT00634842|82814501|FG001|Overall Study|Move to another state|0|||
47067429|NCT01441973|83351145|FG000|Overall Study|Disease progression|8|||
47067430|NCT01441973|83351146|FG001|Overall Study|Disease progression|6|||
47067431|NCT01441973|83351145|FG000|Overall Study|Adverse event unrelated to study drug|3|||
46640311|NCT00634842|82814500|FG000|Overall Study|Inclusion criteria were not met|1|||
46640312|NCT00634842|82814501|FG001|Overall Study|Inclusion criteria were not met|0|||
46640313|NCT00634842|82814500|FG000|Overall Study|Lost to Follow-up|1|||
46640314|NCT00634842|82814501|FG001|Overall Study|Lost to Follow-up|2|||
46845973|NCT03835481|83062763|FG003|Double-blind Period|Other not stated below|1|||
46640315|NCT00634842|82814500|FG000|Overall Study|Physician Decision|1|||
46640316|NCT00634842|82814501|FG001|Overall Study|Physician Decision|0|||
46640317|NCT00634842|82814500|FG000|Overall Study|Withdrawal by Subject|1|||
46640318|NCT00634842|82814501|FG001|Overall Study|Withdrawal by Subject|3|||
46640319|NCT00634842|82814500|FG000|Overall Study|Lack of time and intolerance to drug|0|||
46640320|NCT00634842|82814501|FG001|Overall Study|Lack of time and intolerance to drug|1|||
46640321|NCT00634842|82814500|FG000|Overall Study|Discontinued due to injection|0|||
46640322|NCT00634842|82814501|FG001|Overall Study|Discontinued due to injection|2|||
46965546|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965547|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965548|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46640323|NCT00634842|82814500|FG000|Overall Study|No need of study drug to treat diabetes|0|||
46640324|NCT00634842|82814501|FG001|Overall Study|No need of study drug to treat diabetes|1|||
46640325|NCT00634842|82814500|FG000|Overall Study|No wish to keep taking Avandia|0|||
46640326|NCT00634842|82814501|FG001|Overall Study|No wish to keep taking Avandia|1|||
46640327|NCT00634842|82814500|FG000|Overall Study|Subject off study drug for too long|0|||
46640328|NCT00634842|82814501|FG001|Overall Study|Subject off study drug for too long|1|||
46640329|NCT00633984|82814509|FG000|Overall Study|Lost to Follow-up|0|||
46640330|NCT00633984|82814510|FG001|Overall Study|Lost to Follow-up|6|||
46640331|NCT00633984|82814509|FG000|Overall Study|Withdrawal by Subject|8|||
46640332|NCT00633984|82814510|FG001|Overall Study|Withdrawal by Subject|7|||
46640333|NCT00633984|82814509|FG000|Overall Study|Hospitalized|1|||
46640334|NCT00633984|82814510|FG001|Overall Study|Hospitalized|0|||
46640335|NCT01921218|82814538|FG000|Overall Study|Death|2|||
46640336|NCT01921218|82814539|FG001|Overall Study|Death|1|||
46640337|NCT01921218|82814538|FG000|Overall Study|Withdrawal by Subject|0|||
46640338|NCT01921218|82814539|FG001|Overall Study|Withdrawal by Subject|2|||
46640339|NCT01921218|82814538|FG000|Overall Study|Kidney transplant|1|||
46640340|NCT01921218|82814539|FG001|Overall Study|Kidney transplant|1|||
46640341|NCT00633750|82814545|FG000|Overall Study|Adverse Event|2|||
46640342|NCT00633750|82814545|FG000|Overall Study|Withdrawal by Subject|3|||
46640343|NCT00633360|82814553|FG000|Overall Study|Lost to Follow-up|1|||
46640344|NCT00633360|82814554|FG001|Overall Study|Lost to Follow-up|1|||
46640345|NCT00633360|82814553|FG000|Overall Study|Adverse Event|3|||
46640346|NCT00633360|82814554|FG001|Overall Study|Adverse Event|1|||
46640347|NCT00633360|82814553|FG000|Overall Study|Protocol Violation|0|||
46640348|NCT00633360|82814554|FG001|Overall Study|Protocol Violation|1|||
46640349|NCT00633126|82814562|FG000|Overall Study|Did not receive full dose|1|||
46640350|NCT00989664|82814566|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
46640351|NCT00989664|82814566|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
46640352|NCT00989664|82814566|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
46640353|NCT00989664|82814566|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
46640354|NCT00989664|82814566|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
46640355|NCT00989664|82814566|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
46640356|NCT00989664|82814566|FG000|Long-Term Follow-Up|Death|3|||
46640357|NCT00632736|82814572|FG000|Overall Study|Adverse Event|104|||
46640358|NCT00632736|82814572|FG000|Overall Study|Lost to Follow-up|15|||
46640359|NCT00632736|82814572|FG000|Overall Study|Protocol Violation|14|||
46640360|NCT00632736|82814572|FG000|Overall Study|Withdrawal by Subject|99|||
46640361|NCT00632736|82814572|FG000|Overall Study|Lack of Efficacy|5|||
46640362|NCT00632736|82814572|FG000|Overall Study|Sponsor terminated study|5|||
46640363|NCT00632736|82814572|FG000|Overall Study|Non-compliance|10|||
46640364|NCT00632736|82814572|FG000|Overall Study|Other|16|||
46640365|NCT00989196|82814576|FG000|Treatment Period|Lost to Follow-up|1|||
46640366|NCT00989196|82814577|FG001|Treatment Period|Lost to Follow-up|0|||
46640367|NCT00632502|82814585|FG000|Overall Study|Adverse Event|0|||
46640368|NCT00632502|82814586|FG001|Overall Study|Adverse Event|1|||
46640369|NCT00632502|82814585|FG000|Overall Study|Randomized not treated|3|||
46640370|NCT00632502|82814586|FG001|Overall Study|Randomized not treated|0|||
46640371|NCT00632424|82814596|FG000|Overall Study|Disease Progression|17|||
46640372|NCT00632424|82814596|FG000|Overall Study|Study Drug Toxicity|1|||
46640373|NCT00631488|82814613|FG000|Overall Study|Adverse Event|1|||
46640374|NCT00631488|82814614|FG001|Overall Study|Adverse Event|0|||
46640375|NCT00631488|82814615|FG002|Overall Study|Adverse Event|0|||
46640376|NCT00631488|82814613|FG000|Overall Study|Lost to Follow-up|2|||
46640377|NCT00631488|82814614|FG001|Overall Study|Lost to Follow-up|2|||
46640378|NCT00631488|82814615|FG002|Overall Study|Lost to Follow-up|0|||
46640379|NCT00631488|82814613|FG000|Overall Study|Physician Decision|1|||
46640380|NCT00631488|82814614|FG001|Overall Study|Physician Decision|0|||
46640381|NCT00631488|82814615|FG002|Overall Study|Physician Decision|1|||
46640382|NCT00631488|82814613|FG000|Overall Study|Protocol Violation|0|||
46640383|NCT00631488|82814614|FG001|Overall Study|Protocol Violation|0|||
46640384|NCT00631488|82814615|FG002|Overall Study|Protocol Violation|1|||
46640385|NCT00988884|82814625|FG000|Overall Study|Adverse Event|0|||
46640386|NCT00988884|82814626|FG001|Overall Study|Adverse Event|1|||
46640387|NCT00988884|82814625|FG000|Overall Study|Lost to Follow-up|20|||
46640388|NCT00988884|82814626|FG001|Overall Study|Lost to Follow-up|16|||
46640389|NCT00988884|82814625|FG000|Overall Study|Protocol Violation|0|||
46640390|NCT00988884|82814626|FG001|Overall Study|Protocol Violation|1|||
46640391|NCT00988884|82814625|FG000|Overall Study|Withdrawal by Subject|15|||
46640392|NCT00988884|82814626|FG001|Overall Study|Withdrawal by Subject|18|||
46640393|NCT00631020|82814632|FG000|Overall Study|Lost to Follow-up|7|||
46640394|NCT00631020|82814632|FG000|Overall Study|Incarcerated|1|||
46640395|NCT00987402|82814638|FG000|Overall Study|Insufficient data entry|86|||
46640396|NCT00987402|82814639|FG001|Overall Study|Insufficient data entry|98|||
46640397|NCT00630864|82814645|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
46640398|NCT00630864|82814645|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
46640399|NCT00630786|82814652|FG000|Overall Study|Physician Decision|0|||
46640400|NCT00630786|82814653|FG001|Overall Study|Physician Decision|0|||
46640401|NCT00630786|82814654|FG002|Overall Study|Physician Decision|1|||
46640402|NCT00630786|82814652|FG000|Overall Study|Withdrawal by Subject|0|||
46640403|NCT00630786|82814653|FG001|Overall Study|Withdrawal by Subject|1|||
46640404|NCT00630786|82814654|FG002|Overall Study|Withdrawal by Subject|1|||
46640405|NCT00630786|82814652|FG000|Overall Study|Lost to Follow-up|0|||
46640406|NCT00630786|82814653|FG001|Overall Study|Lost to Follow-up|1|||
46640407|NCT00630786|82814654|FG002|Overall Study|Lost to Follow-up|0|||
46774756|NCT00712725|82993247|FG001|Overall Study|Physician Decision|0|||
46774757|NCT00712725|82993248|FG002|Overall Study|Physician Decision|0|||
46774758|NCT00712725|82993249|FG003|Overall Study|Physician Decision|0|||
46965549|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965550|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965551|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965552|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965553|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
46965554|NCT01597245|83208211|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965555|NCT01597245|83208212|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965556|NCT01597245|83208213|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965557|NCT01597245|83208214|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965558|NCT01597245|83208215|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965559|NCT01597245|83208216|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965560|NCT01597245|83208217|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965561|NCT01597245|83208218|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965562|NCT01597245|83208219|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965563|NCT01597245|83208220|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965564|NCT01597245|83208221|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
46965565|NCT01597245|83208222|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965566|NCT01597245|83208223|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965567|NCT01597245|83208224|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965568|NCT01597245|83208225|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965569|NCT01597245|83208226|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965570|NCT01597245|83208227|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965571|NCT01597245|83208228|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
47067432|NCT01441973|83351146|FG001|Overall Study|Adverse event unrelated to study drug|2|||
47067433|NCT01441973|83351145|FG000|Overall Study|Participant request to discontinue|1|||
46774759|NCT00712725|82993250|FG004|Overall Study|Physician Decision|1|||
46774760|NCT00712725|82993251|FG005|Overall Study|Physician Decision|0|||
46774761|NCT00712725|82993252|FG006|Overall Study|Physician Decision|2|||
46774762|NCT00712725|82993253|FG007|Overall Study|Physician Decision|0|||
46774763|NCT00712725|82993246|FG000|Overall Study|Pregnancy|0|||
46774764|NCT00712725|82993247|FG001|Overall Study|Pregnancy|1|||
46774765|NCT00712725|82993248|FG002|Overall Study|Pregnancy|0|||
46774766|NCT00712725|82993249|FG003|Overall Study|Pregnancy|0|||
46774767|NCT00712725|82993250|FG004|Overall Study|Pregnancy|1|||
46774768|NCT00712725|82993251|FG005|Overall Study|Pregnancy|0|||
46774769|NCT00712725|82993252|FG006|Overall Study|Pregnancy|2|||
46965572|NCT01597245|83208229|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965573|NCT01597245|83208230|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
46965574|NCT01597245|83208231|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
47067434|NCT01441973|83351146|FG001|Overall Study|Participant request to discontinue|1|||
47067435|NCT01441973|83351145|FG000|Overall Study|Poor compliance/noncompliance|0|||
47067436|NCT01441973|83351146|FG001|Overall Study|Poor compliance/noncompliance|1|||
46640408|NCT00630786|82814652|FG000|Overall Study|Other|1|||
46640409|NCT00630786|82814653|FG001|Overall Study|Other|0|||
46774770|NCT00712725|82993253|FG007|Overall Study|Pregnancy|0|||
46845974|NCT03835481|83062764|FG004|Double-blind Period|Other not stated below|1|||
46640410|NCT00630786|82814654|FG002|Overall Study|Other|0|||
46640411|NCT00630396|82814660|FG000|Overall Study|Death|4|||
46774771|NCT00712725|82993246|FG000|Overall Study|Protocol Violation|2|||
46774772|NCT00712725|82993247|FG001|Overall Study|Protocol Violation|0|||
46774773|NCT00712725|82993248|FG002|Overall Study|Protocol Violation|1|||
46774774|NCT00712725|82993249|FG003|Overall Study|Protocol Violation|3|||
46774775|NCT00712725|82993250|FG004|Overall Study|Protocol Violation|2|||
46965575|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965576|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965577|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965578|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965579|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965580|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965581|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965582|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965583|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965584|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965585|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965586|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965587|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965588|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
46965589|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
46965590|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
46640412|NCT00630396|82814660|FG000|Overall Study|Lost to Follow-up|3|||
46640413|NCT00985686|82814668|FG000|Overall Study|Lost to Follow-up|1|||
46640414|NCT00985686|82814669|FG001|Overall Study|Lost to Follow-up|1|||
46965591|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965592|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965593|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965594|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965595|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
46965596|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965597|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965598|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965599|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
47067437|NCT01441973|83351145|FG000|Overall Study|Administrative reason by sponsor|3|||
47067438|NCT01441973|83351146|FG001|Overall Study|Administrative reason by sponsor|5|||
47067439|NCT01441973|83351145|FG000|Overall Study|Participant withdrew consent|0|||
47067440|NCT01441973|83351146|FG001|Overall Study|Participant withdrew consent|1|||
47067441|NCT01575899|83351165|FG000|Overall Study|Lost to Follow-up|3|||
47067442|NCT01575899|83351166|FG001|Overall Study|Lost to Follow-up|4|||
46640415|NCT00985686|82814670|FG002|Overall Study|Lost to Follow-up|0|||
46640416|NCT00985686|82814671|FG003|Overall Study|Lost to Follow-up|2|||
46640417|NCT03098394|82814681|FG000|Overall Study|Pregnancy|0|||
46774776|NCT00712725|82993251|FG005|Overall Study|Protocol Violation|0|||
46774777|NCT00712725|82993252|FG006|Overall Study|Protocol Violation|1|||
46774778|NCT00712725|82993253|FG007|Overall Study|Protocol Violation|1|||
46774779|NCT00712725|82993246|FG000|Overall Study|Withdrawal by Subject|2|||
46774780|NCT00712725|82993247|FG001|Overall Study|Withdrawal by Subject|1|||
46774781|NCT00712725|82993248|FG002|Overall Study|Withdrawal by Subject|1|||
46774782|NCT00712725|82993249|FG003|Overall Study|Withdrawal by Subject|2|||
46774783|NCT00712725|82993250|FG004|Overall Study|Withdrawal by Subject|1|||
46774784|NCT00712725|82993251|FG005|Overall Study|Withdrawal by Subject|1|||
46774785|NCT00712725|82993252|FG006|Overall Study|Withdrawal by Subject|1|||
46845975|NCT03835481|83062760|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
46845976|NCT03835481|83062761|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
46845977|NCT03835481|83062762|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
46845978|NCT03835481|83062763|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
46845979|NCT03835481|83062764|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
46845980|NCT03835481|83062760|FG000|Double-blind Period|Withdrawal by Subject|0|||
46845981|NCT03835481|83062761|FG001|Double-blind Period|Withdrawal by Subject|0|||
46845982|NCT03835481|83062762|FG002|Double-blind Period|Withdrawal by Subject|1|||
46965600|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965601|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965602|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965603|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965604|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965605|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965606|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
47067443|NCT01575899|83351167|FG002|Overall Study|Lost to Follow-up|2|||
47067444|NCT01575899|83351165|FG000|Overall Study|Protocol Violation|2|||
47067445|NCT01575899|83351166|FG001|Overall Study|Protocol Violation|1|||
46640418|NCT03098394|82814682|FG001|Overall Study|Pregnancy|1|||
46640419|NCT00984594|82814693|FG000|Overall Study|Lost to Follow-up|1|||
46640420|NCT00984594|82814694|FG001|Overall Study|Lost to Follow-up|0|||
46774786|NCT00712725|82993253|FG007|Overall Study|Withdrawal by Subject|2|||
46774787|NCT00712725|82993246|FG000|Overall Study|Lack of Qualifying Event|16|||
46965607|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965608|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965609|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
46965610|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
46965611|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
46965612|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965613|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965614|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965615|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965616|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
46965617|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965618|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965619|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965620|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965621|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965622|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965623|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965624|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965625|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965626|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965627|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46640421|NCT00984594|82814693|FG000|Overall Study|Withdrawal by Subject|0|||
46640422|NCT00984594|82814694|FG001|Overall Study|Withdrawal by Subject|1|||
46640423|NCT00984204|82814702|FG000|Overall Study|Death|1|||
46640424|NCT00984204|82814702|FG000|Overall Study|Lost to Follow-up|4|||
46640425|NCT00984204|82814702|FG000|Overall Study|Lack of Efficacy|10|||
46640426|NCT00983892|82814708|FG000|Overall Study|Withdrawal by Subject|10|||
46640427|NCT00983892|82814709|FG001|Overall Study|Withdrawal by Subject|12|||
46640428|NCT00983580|82814717|FG000|Overall Study|Cancel Prior to treatment|1|||
46640429|NCT00983580|82814718|FG001|Overall Study|Cancel Prior to treatment|3|||
46640430|NCT00983580|82814717|FG000|Overall Study|Protocol Violation|1|||
46640431|NCT00983580|82814718|FG001|Overall Study|Protocol Violation|1|||
46640432|NCT00983580|82814717|FG000|Overall Study|Ineligible|3|||
46965628|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965629|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965630|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965631|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
46965632|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
46640433|NCT00983580|82814718|FG001|Overall Study|Ineligible|0|||
46640434|NCT00982878|82814725|FG000|Overall Study|Physician Decision|1|||
46640435|NCT00982488|82814734|FG000|Overall Study|Administrative reason by sponsor|81|||
46640436|NCT00982488|82814735|FG001|Overall Study|Administrative reason by sponsor|3|||
46640437|NCT00982488|82814736|FG002|Overall Study|Administrative reason by sponsor|11|||
46640438|NCT00982488|82814737|FG003|Overall Study|Administrative reason by sponsor|0|||
46640439|NCT00982488|82814738|FG004|Overall Study|Administrative reason by sponsor|0|||
46640440|NCT00982488|82814734|FG000|Overall Study|Adverse event unrelated to study drug|5|||
46640441|NCT00982488|82814735|FG001|Overall Study|Adverse event unrelated to study drug|1|||
46640442|NCT00982488|82814736|FG002|Overall Study|Adverse event unrelated to study drug|0|||
46640443|NCT00982488|82814737|FG003|Overall Study|Adverse event unrelated to study drug|0|||
46774788|NCT00712725|82993247|FG001|Overall Study|Lack of Qualifying Event|2|||
46965633|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965634|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
47067446|NCT01575899|83351167|FG002|Overall Study|Protocol Violation|0|||
47067447|NCT01440881|83351179|FG000|Overall Study|Death|0|||
47067448|NCT01440881|83351180|FG001|Overall Study|Death|1|||
47067449|NCT01575197|83351195|FG000|Overall Study|Migration out of study area|1|||
47067450|NCT01575197|83351196|FG001|Overall Study|Migration out of study area|5|||
47067451|NCT01575197|83351197|FG002|Overall Study|Migration out of study area|4|||
47067452|NCT01575197|83351195|FG000|Overall Study|SAE|0|||
47067453|NCT01575197|83351196|FG001|Overall Study|SAE|1|||
46640444|NCT00982488|82814738|FG004|Overall Study|Adverse event unrelated to study drug|0|||
46640445|NCT00982488|82814734|FG000|Overall Study|Death|11|||
46640446|NCT00982488|82814735|FG001|Overall Study|Death|0|||
47067454|NCT01575197|83351197|FG002|Overall Study|SAE|0|||
47067455|NCT01575197|83351195|FG000|Overall Study|Lost to Follow-up|0|||
46640447|NCT00982488|82814736|FG002|Overall Study|Death|2|||
46640448|NCT00982488|82814737|FG003|Overall Study|Death|0|||
46640449|NCT00982488|82814738|FG004|Overall Study|Death|0|||
46640450|NCT00982488|82814734|FG000|Overall Study|Disease progression|30|||
47067456|NCT01575197|83351196|FG001|Overall Study|Lost to Follow-up|1|||
46640451|NCT00982488|82814735|FG001|Overall Study|Disease progression|5|||
46774789|NCT00712725|82993248|FG002|Overall Study|Lack of Qualifying Event|6|||
46774790|NCT00712725|82993249|FG003|Overall Study|Lack of Qualifying Event|8|||
46774791|NCT00712725|82993250|FG004|Overall Study|Lack of Qualifying Event|11|||
46774792|NCT00712725|82993251|FG005|Overall Study|Lack of Qualifying Event|13|||
46845983|NCT03835481|83062763|FG003|Double-blind Period|Withdrawal by Subject|0|||
46640452|NCT00982488|82814736|FG002|Overall Study|Disease progression|10|||
46640453|NCT00982488|82814737|FG003|Overall Study|Disease progression|1|||
46640454|NCT00982488|82814738|FG004|Overall Study|Disease progression|1|||
46640455|NCT00982488|82814734|FG000|Overall Study|Lost to Follow-up|1|||
46640456|NCT00982488|82814735|FG001|Overall Study|Lost to Follow-up|0|||
46640457|NCT00982488|82814736|FG002|Overall Study|Lost to Follow-up|0|||
46640458|NCT00982488|82814737|FG003|Overall Study|Lost to Follow-up|0|||
46640459|NCT00982488|82814738|FG004|Overall Study|Lost to Follow-up|0|||
46640460|NCT00982488|82814734|FG000|Overall Study|Maximum clinical benefit|1|||
46640461|NCT00982488|82814735|FG001|Overall Study|Maximum clinical benefit|1|||
46640462|NCT00982488|82814736|FG002|Overall Study|Maximum clinical benefit|1|||
46640463|NCT00982488|82814737|FG003|Overall Study|Maximum clinical benefit|0|||
46640464|NCT00982488|82814738|FG004|Overall Study|Maximum clinical benefit|0|||
46774793|NCT00712725|82993252|FG006|Overall Study|Lack of Qualifying Event|11|||
46774794|NCT00712725|82993253|FG007|Overall Study|Lack of Qualifying Event|6|||
46774795|NCT00712725|82993246|FG000|Overall Study|Protocol Specified Criteria|3|||
46774796|NCT00712725|82993247|FG001|Overall Study|Protocol Specified Criteria|0|||
46774797|NCT00712725|82993248|FG002|Overall Study|Protocol Specified Criteria|1|||
46774798|NCT00712725|82993249|FG003|Overall Study|Protocol Specified Criteria|2|||
46845984|NCT03835481|83062764|FG004|Double-blind Period|Withdrawal by Subject|5|||
46845985|NCT03835481|83062760|FG000|Double-blind Period|Lost to Follow-up|0|||
46845986|NCT03835481|83062761|FG001|Double-blind Period|Lost to Follow-up|0|||
46845987|NCT03835481|83062762|FG002|Double-blind Period|Lost to Follow-up|0|||
46845988|NCT03835481|83062763|FG003|Double-blind Period|Lost to Follow-up|1|||
46845989|NCT03835481|83062764|FG004|Double-blind Period|Lost to Follow-up|0|||
46845990|NCT03835481|83062760|FG000|Double-blind Period|Protocol Violation|0|||
46845991|NCT03835481|83062761|FG001|Double-blind Period|Protocol Violation|2|||
46845992|NCT03835481|83062762|FG002|Double-blind Period|Protocol Violation|0|||
46845993|NCT03835481|83062763|FG003|Double-blind Period|Protocol Violation|1|||
47067457|NCT01575197|83351197|FG002|Overall Study|Lost to Follow-up|0|||
47067458|NCT01575197|83351195|FG000|Overall Study|Withdrawal by Subject|0|||
46845994|NCT03835481|83062764|FG004|Double-blind Period|Protocol Violation|0|||
46845995|NCT03835481|83062760|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
46845996|NCT03835481|83062761|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
46845997|NCT03835481|83062762|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
46845998|NCT03835481|83062763|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
46845999|NCT03835481|83062764|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
46846000|NCT03835481|83062760|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
46846001|NCT03835481|83062761|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
46846002|NCT03835481|83062762|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
46774799|NCT00712725|82993250|FG004|Overall Study|Protocol Specified Criteria|1|||
46774800|NCT00712725|82993251|FG005|Overall Study|Protocol Specified Criteria|0|||
46774801|NCT00712725|82993252|FG006|Overall Study|Protocol Specified Criteria|2|||
46774802|NCT00712725|82993253|FG007|Overall Study|Protocol Specified Criteria|1|||
46774803|NCT00712335|82993276|FG000|Overall Study|Withdrawal by Subject|0|||
46774804|NCT00712335|82993277|FG001|Overall Study|Withdrawal by Subject|7|||
47067459|NCT01575197|83351196|FG001|Overall Study|Withdrawal by Subject|1|||
47067460|NCT01575197|83351197|FG002|Overall Study|Withdrawal by Subject|1|||
47067461|NCT01575197|83351195|FG000|Overall Study|Protocol Violation|2|||
47067462|NCT01575197|83351196|FG001|Overall Study|Protocol Violation|1|||
47067463|NCT01575197|83351197|FG002|Overall Study|Protocol Violation|1|||
47067464|NCT01574651|83351228|FG000|Overall Study|Lost to Follow-up|2|||
46640465|NCT00982488|82814734|FG000|Overall Study|Other|15|||
46774805|NCT00712335|82993278|FG002|Overall Study|Withdrawal by Subject|2|||
46774806|NCT00712335|82993279|FG003|Overall Study|Withdrawal by Subject|3|||
47067465|NCT01574651|83351229|FG001|Overall Study|Lost to Follow-up|4|||
46640466|NCT00982488|82814735|FG001|Overall Study|Other|1|||
46640467|NCT00982488|82814736|FG002|Overall Study|Other|3|||
46640468|NCT00982488|82814737|FG003|Overall Study|Other|1|||
46640469|NCT00982488|82814738|FG004|Overall Study|Other|0|||
46640470|NCT00982488|82814734|FG000|Overall Study|Poor compliance/noncompliance|0|||
46965635|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965636|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965637|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
46965638|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965639|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965640|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965641|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965642|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965643|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965644|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965645|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965646|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965647|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46640471|NCT00982488|82814735|FG001|Overall Study|Poor compliance/noncompliance|1|||
46640472|NCT00982488|82814736|FG002|Overall Study|Poor compliance/noncompliance|0|||
46640473|NCT00982488|82814737|FG003|Overall Study|Poor compliance/noncompliance|0|||
46640474|NCT00982488|82814738|FG004|Overall Study|Poor compliance/noncompliance|0|||
46640475|NCT00982488|82814734|FG000|Overall Study|Stem cell transplant|2|||
46640476|NCT00982488|82814735|FG001|Overall Study|Stem cell transplant|0|||
46640477|NCT00982488|82814736|FG002|Overall Study|Stem cell transplant|0|||
46640478|NCT00982488|82814737|FG003|Overall Study|Stem cell transplant|1|||
46640479|NCT00982488|82814738|FG004|Overall Study|Stem cell transplant|0|||
46640480|NCT00982488|82814734|FG000|Overall Study|Study drug toxicity|34|||
46640481|NCT00982488|82814735|FG001|Overall Study|Study drug toxicity|1|||
46640482|NCT00982488|82814736|FG002|Overall Study|Study drug toxicity|6|||
46640483|NCT00982488|82814737|FG003|Overall Study|Study drug toxicity|0|||
46640484|NCT00982488|82814738|FG004|Overall Study|Study drug toxicity|0|||
46640485|NCT00982488|82814734|FG000|Overall Study|Withdrawal by Subject|5|||
46640486|NCT00982488|82814735|FG001|Overall Study|Withdrawal by Subject|1|||
46640487|NCT00982488|82814736|FG002|Overall Study|Withdrawal by Subject|1|||
46640488|NCT00982488|82814737|FG003|Overall Study|Withdrawal by Subject|0|||
46640489|NCT00982488|82814738|FG004|Overall Study|Withdrawal by Subject|0|||
46640490|NCT00982410|82814752|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
46640491|NCT00982410|82814753|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
46965648|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965649|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965650|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965651|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965652|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
46965653|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
46965654|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965655|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
47067466|NCT01574651|83351228|FG000|Overall Study|Administrative problems|0|||
47067467|NCT01574651|83351229|FG001|Overall Study|Administrative problems|1|||
47067468|NCT01574651|83351228|FG000|Overall Study|Death|3|||
47067469|NCT01574651|83351229|FG001|Overall Study|Death|3|||
47067470|NCT01574651|83351228|FG000|Overall Study|Patient's inability to use the device|0|||
47067471|NCT01574651|83351229|FG001|Overall Study|Patient's inability to use the device|1|||
47067472|NCT01574651|83351228|FG000|Overall Study|Adverse Event|36|||
46640492|NCT00982410|82814752|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
46640493|NCT00982410|82814753|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
46640494|NCT00982410|82814752|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
46774807|NCT00712335|82993280|FG004|Overall Study|Withdrawal by Subject|0|||
46965656|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965657|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
46965658|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
47067473|NCT01574651|83351229|FG001|Overall Study|Adverse Event|27|||
47067474|NCT01574651|83351228|FG000|Overall Study|Abnormal laboratory value(s)|1|||
47067475|NCT01574651|83351229|FG001|Overall Study|Abnormal laboratory value(s)|0|||
47067476|NCT01574651|83351228|FG000|Overall Study|Abnormal test procedure result(s)|1|||
47067477|NCT01574651|83351229|FG001|Overall Study|Abnormal test procedure result(s)|1|||
47067478|NCT01574651|83351228|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
47067479|NCT01574651|83351229|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46965659|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965660|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965661|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965662|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965663|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965664|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965665|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965666|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965667|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965668|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965669|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965670|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965671|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46774808|NCT00712335|82993276|FG000|Overall Study|Lost to Follow-up|2|||
46774809|NCT00712335|82993277|FG001|Overall Study|Lost to Follow-up|5|||
46774810|NCT00712335|82993278|FG002|Overall Study|Lost to Follow-up|0|||
46774811|NCT00712335|82993279|FG003|Overall Study|Lost to Follow-up|1|||
46774812|NCT00712335|82993280|FG004|Overall Study|Lost to Follow-up|0|||
46774813|NCT00712335|82993276|FG000|Overall Study|Protocol Violation|1|||
46774814|NCT00712335|82993277|FG001|Overall Study|Protocol Violation|2|||
46774815|NCT00712335|82993278|FG002|Overall Study|Protocol Violation|1|||
46774816|NCT00712335|82993279|FG003|Overall Study|Protocol Violation|0|||
46774817|NCT00712335|82993280|FG004|Overall Study|Protocol Violation|0|||
46774818|NCT00712335|82993276|FG000|Overall Study|Lack of Efficacy|0|||
46774819|NCT00712335|82993277|FG001|Overall Study|Lack of Efficacy|0|||
46774820|NCT00712335|82993278|FG002|Overall Study|Lack of Efficacy|1|||
46774821|NCT00712335|82993279|FG003|Overall Study|Lack of Efficacy|1|||
46774822|NCT00712335|82993280|FG004|Overall Study|Lack of Efficacy|0|||
46774823|NCT00712335|82993276|FG000|Overall Study|Other Reason|0|||
46774824|NCT00712335|82993277|FG001|Overall Study|Other Reason|3|||
46774825|NCT00712335|82993278|FG002|Overall Study|Other Reason|1|||
46774826|NCT00712335|82993279|FG003|Overall Study|Other Reason|0|||
46774827|NCT00712335|82993280|FG004|Overall Study|Other Reason|0|||
46640495|NCT00982410|82814753|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
46640496|NCT00982410|82814752|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
46640497|NCT00982410|82814753|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
46640498|NCT00982410|82814752|FG000|6-month Follow-up Assessment|participant no transportation|1|||
46640499|NCT00982410|82814753|FG001|6-month Follow-up Assessment|participant no transportation|0|||
46774828|NCT00577629|82993292|FG000|Treatment Period|Death|1|||
46846003|NCT03835481|83062763|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
46774829|NCT00577629|82993292|FG000|Long Term Follow-Up|Death|15|||
46774830|NCT00577629|82993292|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
46774831|NCT00577629|82993292|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
46846004|NCT03835481|83062764|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
46640500|NCT00982410|82814752|FG000|6-month Follow-up Assessment|incarceration|0|||
46774832|NCT00577629|82993292|FG000|Long Term Follow-Up|Physician Decision|1|||
46774833|NCT00710385|82993298|FG000|Overall Study|Did not qualify|1|||
46774834|NCT00710385|82993298|FG000|Overall Study|Withdrawal by Subject|1|||
46774835|NCT00710385|82993298|FG000|Overall Study|Undisclosed back pain|1|||
46774836|NCT00710385|82993298|FG000|Overall Study|Physician Decision|1|||
46774837|NCT00710385|82993298|FG000|Overall Study|Undisclosed excessive methadone use|1|||
46774838|NCT00701415|82993310|FG000|Overall Study|Adverse Event|0|||
46640501|NCT00982410|82814753|FG001|6-month Follow-up Assessment|incarceration|2|||
46640502|NCT00982410|82814752|FG000|6-month Follow-up Assessment|patent surgery|0|||
46640503|NCT00982410|82814753|FG001|6-month Follow-up Assessment|patent surgery|1|||
46640504|NCT00982410|82814752|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
46640505|NCT00982410|82814753|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
46640506|NCT00982410|82814752|FG000|12-month Follow-up Assessment|Death|0|||
46640507|NCT00982410|82814753|FG001|12-month Follow-up Assessment|Death|2|||
46640508|NCT00982410|82814752|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
46640509|NCT00982410|82814753|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
46640510|NCT00982410|82814752|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
46640511|NCT00982410|82814753|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
46640512|NCT00982410|82814752|FG000|12-month Follow-up Assessment|incarceration|2|||
46640513|NCT00982410|82814753|FG001|12-month Follow-up Assessment|incarceration|1|||
46640514|NCT00982410|82814752|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
46640515|NCT00982410|82814753|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
46640516|NCT00982020|82814762|FG000|Overall Study|Adverse Event|19|||
46640517|NCT00982020|82814763|FG001|Overall Study|Adverse Event|15|||
46640518|NCT00982020|82814762|FG000|Overall Study|Withdrawal by Subject|11|||
46640519|NCT00982020|82814763|FG001|Overall Study|Withdrawal by Subject|14|||
46640520|NCT00982020|82814762|FG000|Overall Study|Lost to Follow-up|5|||
46640521|NCT00982020|82814763|FG001|Overall Study|Lost to Follow-up|11|||
46640522|NCT00982020|82814762|FG000|Overall Study|Lack of Efficacy|10|||
46640523|NCT00982020|82814763|FG001|Overall Study|Lack of Efficacy|4|||
46640524|NCT00982020|82814762|FG000|Overall Study|Parent/Caregiver Decision|5|||
46640525|NCT00982020|82814763|FG001|Overall Study|Parent/Caregiver Decision|5|||
46640526|NCT00982020|82814762|FG000|Overall Study|Treatment Non-compliance|3|||
46640527|NCT00982020|82814763|FG001|Overall Study|Treatment Non-compliance|6|||
46640528|NCT00982020|82814762|FG000|Overall Study|Physician Decision|2|||
46640529|NCT00982020|82814763|FG001|Overall Study|Physician Decision|5|||
46640530|NCT00982020|82814762|FG000|Overall Study|Entry Criteria Not Met|2|||
46640531|NCT00982020|82814763|FG001|Overall Study|Entry Criteria Not Met|1|||
46640532|NCT00982020|82814762|FG000|Overall Study|Protocol Violation|0|||
46640533|NCT00982020|82814763|FG001|Overall Study|Protocol Violation|2|||
46640534|NCT00982020|82814762|FG000|Overall Study|Clinical Relapse|0|||
46640535|NCT00982020|82814763|FG001|Overall Study|Clinical Relapse|1|||
46640536|NCT00981084|82814776|FG000|Post Intervention (Data Analysis)|poor effort|1|||
46640537|NCT00981084|82814777|FG001|Post Intervention (Data Analysis)|poor effort|1|||
46640538|NCT00981084|82814776|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
46640539|NCT00981084|82814777|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
46640540|NCT00980148|82814787|FG000|Overall Study|Discharged from facility|89|||
46640541|NCT00980148|82814788|FG001|Overall Study|Discharged from facility|96|||
46640542|NCT00980148|82814787|FG000|Overall Study|Received other antichlamydia treatment|20|||
46640543|NCT00980148|82814788|FG001|Overall Study|Received other antichlamydia treatment|14|||
46640544|NCT00980148|82814787|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
46640545|NCT00980148|82814788|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
46640546|NCT00980148|82814787|FG000|Overall Study|Various other reasons|8|||
46640547|NCT00980148|82814788|FG001|Overall Study|Various other reasons|9|||
46640548|NCT04553406|82814825|FG000|Overall Study|Study Discontinuation|0|||
46640549|NCT04553406|82814826|FG001|Overall Study|Study Discontinuation|1|||
46640550|NCT04129944|82814836|FG000|Overall Study|Death|0|||
46640551|NCT04129944|82814837|FG001|Overall Study|Death|0|||
46640552|NCT04129944|82814838|FG002|Overall Study|Death|0|||
46640553|NCT04129944|82814839|FG003|Overall Study|Death|1|||
46640554|NCT04129944|82814836|FG000|Overall Study|Lost to Follow-up|1|||
46640555|NCT04129944|82814837|FG001|Overall Study|Lost to Follow-up|0|||
46640556|NCT04129944|82814838|FG002|Overall Study|Lost to Follow-up|0|||
46774839|NCT00701415|82993311|FG001|Overall Study|Adverse Event|1|||
46774840|NCT00701415|82993310|FG000|Overall Study|Social/family issues and needle phobia|1|||
46774841|NCT00701415|82993311|FG001|Overall Study|Social/family issues and needle phobia|0|||
46774842|NCT00700011|82993319|FG000|Overall Study|Death|0|||
46774843|NCT00700011|82993320|FG001|Overall Study|Death|1|||
46774844|NCT00707031|82993328|FG000|Overall Study|Adverse Event|45|||
46774845|NCT00707031|82993329|FG001|Overall Study|Adverse Event|45|||
46846005|NCT03835481|83062760|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
46846006|NCT03835481|83062761|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
46640557|NCT04129944|82814839|FG003|Overall Study|Lost to Follow-up|0|||
46640558|NCT04129944|82814836|FG000|Overall Study|Withdrawal by Subject|1|||
46774846|NCT00707031|82993328|FG000|Overall Study|Lack of Efficacy|19|||
46846007|NCT03835481|83062762|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
46640559|NCT04129944|82814837|FG001|Overall Study|Withdrawal by Subject|0|||
46774847|NCT00707031|82993329|FG001|Overall Study|Lack of Efficacy|6|||
46774848|NCT00707031|82993328|FG000|Overall Study|Lost to Follow-up|2|||
47067480|NCT01574651|83351228|FG000|Overall Study|Protocol Violation|3|||
46774849|NCT00707031|82993329|FG001|Overall Study|Lost to Follow-up|1|||
46774850|NCT00707031|82993328|FG000|Overall Study|Protocol Violation|1|||
46640560|NCT04129944|82814838|FG002|Overall Study|Withdrawal by Subject|1|||
46640561|NCT04129944|82814839|FG003|Overall Study|Withdrawal by Subject|2|||
46640562|NCT02884908|82814913|FG000|Overall Study|Lost to Follow-up|13|||
46640563|NCT02884908|82814914|FG001|Overall Study|Lost to Follow-up|18|||
46640564|NCT01899144|82816491|FG000|Treatment Period 2|Other|1|||
46640565|NCT01899144|82816491|FG000|Treatment Period 3|Other|2|||
46640566|NCT01899144|82816491|FG000|Treatment Period 5|Other|1|||
46640567|NCT03821844|82817081|FG000|Overall Study|Death|37|||
46640568|NCT03821844|82817082|FG001|Overall Study|Death|31|||
46640569|NCT03821844|82817081|FG000|Overall Study|Discharged|10|||
46640570|NCT03821844|82817082|FG001|Overall Study|Discharged|14|||
46640571|NCT03821844|82817081|FG000|Overall Study|Not present in facility at followup|2|||
46640572|NCT03821844|82817082|FG001|Overall Study|Not present in facility at followup|3|||
46640573|NCT01796106|82818533|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
46640574|NCT01796106|82818534|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
46640575|NCT04985682|82819198|FG000|Overall Study|Withdrawal by Subject|1|||
46640576|NCT04913675|82819232|FG000|Main Study (Up to Week 36)|Death|0|||
46640577|NCT04913675|82819233|FG001|Main Study (Up to Week 36)|Death|2|||
46640578|NCT04913675|82819234|FG002|Main Study (Up to Week 36)|Death|2|||
46640579|NCT04913675|82819235|FG003|Main Study (Up to Week 36)|Death|0|||
46640580|NCT04913675|82819232|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
46640581|NCT04913675|82819233|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
46640582|NCT04913675|82819234|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
46640583|NCT04913675|82819235|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
46640584|NCT04913675|82819232|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
46640585|NCT04913675|82819233|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
46640586|NCT04913675|82819234|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
46640587|NCT04913675|82819235|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
46640588|NCT04913675|82819232|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
46640589|NCT04913675|82819233|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
46640590|NCT04913675|82819234|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
46640591|NCT04913675|82819235|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
46640592|NCT04913675|82819232|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
46640593|NCT04913675|82819233|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
46640594|NCT04913675|82819234|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
46640595|NCT04913675|82819235|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
46640596|NCT04277507|82819274|FG000|Overall Study|Lost to Follow-up|17|||
46640597|NCT04277507|82819274|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
46640598|NCT04277507|82819274|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
46640599|NCT04277507|82819274|FG000|Overall Study|Withdrawal by Subject|3|||
46640600|NCT04277507|82819274|FG000|Overall Study|Death due to COVID-19|1|||
46640601|NCT04277507|82819274|FG000|Overall Study|Data missing for full evaluation|5|||
46640602|NCT04214288|82819286|FG000|Overall Study|Ongoing in the study|41|||
46774851|NCT00707031|82993329|FG001|Overall Study|Protocol Violation|0|||
46774852|NCT00707031|82993328|FG000|Overall Study|Withdrawal by Subject|7|||
46640603|NCT04214288|82819287|FG001|Overall Study|Ongoing in the study|51|||
46640604|NCT04214288|82819288|FG002|Overall Study|Ongoing in the study|12|||
46640605|NCT04214288|82819289|FG003|Overall Study|Ongoing in the study|39|||
46640606|NCT04214288|82819286|FG000|Overall Study|Adverse Event|1|||
46640607|NCT04214288|82819287|FG001|Overall Study|Adverse Event|0|||
46640608|NCT04214288|82819288|FG002|Overall Study|Adverse Event|0|||
46640609|NCT04214288|82819289|FG003|Overall Study|Adverse Event|0|||
46640610|NCT04214288|82819286|FG000|Overall Study|Death|22|||
46640611|NCT04214288|82819287|FG001|Overall Study|Death|13|||
46640612|NCT04214288|82819288|FG002|Overall Study|Death|7|||
46640613|NCT04214288|82819289|FG003|Overall Study|Death|19|||
46640614|NCT04214288|82819286|FG000|Overall Study|Lost to Follow-up|1|||
46640615|NCT04214288|82819287|FG001|Overall Study|Lost to Follow-up|2|||
46640616|NCT04214288|82819288|FG002|Overall Study|Lost to Follow-up|1|||
46640617|NCT04214288|82819289|FG003|Overall Study|Lost to Follow-up|0|||
46640618|NCT04214288|82819286|FG000|Overall Study|Other|1|||
46640619|NCT04214288|82819287|FG001|Overall Study|Other|2|||
46640620|NCT04214288|82819288|FG002|Overall Study|Other|0|||
46640621|NCT04214288|82819289|FG003|Overall Study|Other|6|||
46640622|NCT04214288|82819286|FG000|Overall Study|Protocol Violation|0|||
46640623|NCT04214288|82819287|FG001|Overall Study|Protocol Violation|1|||
46640624|NCT04214288|82819288|FG002|Overall Study|Protocol Violation|0|||
46640625|NCT04214288|82819289|FG003|Overall Study|Protocol Violation|0|||
46640626|NCT04214288|82819286|FG000|Overall Study|Withdrawal by Subject|8|||
46640627|NCT04214288|82819287|FG001|Overall Study|Withdrawal by Subject|4|||
46640628|NCT04214288|82819288|FG002|Overall Study|Withdrawal by Subject|0|||
46640629|NCT04214288|82819289|FG003|Overall Study|Withdrawal by Subject|9|||
46640630|NCT04144140|82819305|FG000|Overall Study|Other|0|||
46640631|NCT04144140|82819306|FG001|Overall Study|Other|0|||
46640632|NCT04144140|82819307|FG002|Overall Study|Other|0|||
46640633|NCT04144140|82819308|FG003|Overall Study|Other|0|||
46640634|NCT04144140|82819309|FG004|Overall Study|Other|0|||
46640635|NCT04144140|82819310|FG005|Overall Study|Other|1|||
46640636|NCT04144140|82819311|FG006|Overall Study|Other|0|||
46640637|NCT04085523|82819343|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
46640638|NCT04085523|82819344|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
46640639|NCT04085523|82819345|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
46640640|NCT04085523|82819346|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
46640641|NCT04085523|82819347|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
46640642|NCT04085523|82819348|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
46640643|NCT03991988|82819362|FG000|Overall Study|Withdrawal by Subject|2|||
46640644|NCT03991988|82819363|FG001|Overall Study|Withdrawal by Subject|2|||
46640645|NCT03945591|82819386|FG000|Overall Study|Participant not transplanted|1|||
46640646|NCT03945591|82819386|FG000|Overall Study|Change in treatment plan|3|||
46640647|NCT03945591|82819386|FG000|Overall Study|Adverse Event|1|||
46640648|NCT03612856|82819393|FG000|Pre-dose Period|Physician Decision|0|||
46640649|NCT03612856|82819394|FG001|Pre-dose Period|Physician Decision|1|||
46640650|NCT03612856|82819395|FG002|Pre-dose Period|Physician Decision|1|||
46640651|NCT03612856|82819393|FG000|Pre-dose Period|Withdrawal by Subject|0|||
46640652|NCT03612856|82819394|FG001|Pre-dose Period|Withdrawal by Subject|1|||
46640653|NCT03612856|82819395|FG002|Pre-dose Period|Withdrawal by Subject|0|||
46640654|NCT03594110|82819405|FG000|Overall Study|Participant concerned about study treatment|23|||
46640655|NCT03594110|82819406|FG001|Overall Study|Participant concerned about study treatment|28|||
46640656|NCT03594110|82819405|FG000|Overall Study|Doctor advice|38|||
46640657|NCT03594110|82819406|FG001|Overall Study|Doctor advice|40|||
46640658|NCT03594110|82819405|FG000|Overall Study|Participants' wish|89|||
46640659|NCT03594110|82819406|FG001|Overall Study|Participants' wish|68|||
46640660|NCT03594110|82819405|FG000|Overall Study|Adverse Event|119|||
46640661|NCT03594110|82819406|FG001|Overall Study|Adverse Event|116|||
46640662|NCT03594110|82819405|FG000|Overall Study|Study drug stopped, reason missing|337|||
46640663|NCT03594110|82819406|FG001|Overall Study|Study drug stopped, reason missing|295|||
46640664|NCT03594110|82819405|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
46640665|NCT03594110|82819406|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
46640666|NCT03594110|82819405|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
46640667|NCT03594110|82819406|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
46640668|NCT03594110|82819405|FG000|Overall Study|Contraindicated drug started|32|||
46640669|NCT03594110|82819406|FG001|Overall Study|Contraindicated drug started|18|||
46640670|NCT03594110|82819405|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
46640671|NCT03594110|82819406|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
46640672|NCT03594110|82819405|FG000|Overall Study|Death|129|||
46640673|NCT03594110|82819406|FG001|Overall Study|Death|120|||
46640674|NCT03391466|82819414|FG000|Overall Study|Death|82|||
46640675|NCT03391466|82819415|FG001|Overall Study|Death|85|||
46640676|NCT03391466|82819414|FG000|Overall Study|Still on study|93|||
46640677|NCT03391466|82819415|FG001|Overall Study|Still on study|74|||
46640678|NCT03391466|82819414|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
46640679|NCT03391466|82819415|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
46640680|NCT03391466|82819414|FG000|Overall Study|Lost to Follow-up|5|||
46640681|NCT03391466|82819415|FG001|Overall Study|Lost to Follow-up|5|||
46640682|NCT03391466|82819414|FG000|Overall Study|Investigator decision|0|||
46640683|NCT03391466|82819415|FG001|Overall Study|Investigator decision|1|||
46640684|NCT03391466|82819414|FG000|Overall Study|Other|0|||
46640685|NCT03391466|82819415|FG001|Overall Study|Other|1|||
46640686|NCT03334539|82819443|FG000|Overall Study|Adverse Event|3|||
46640687|NCT03334539|82819444|FG001|Overall Study|Adverse Event|5|||
46640688|NCT03334539|82819445|FG002|Overall Study|Adverse Event|0|||
46640689|NCT03334539|82819443|FG000|Overall Study|Withdrawal by Subject|0|||
46640690|NCT03334539|82819444|FG001|Overall Study|Withdrawal by Subject|1|||
46640691|NCT03334539|82819445|FG002|Overall Study|Withdrawal by Subject|1|||
46640692|NCT03334539|82819443|FG000|Overall Study|Administrative Reasons|1|||
46965672|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
46965673|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
46965674|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
46965675|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965676|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965677|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965678|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965679|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
46965680|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965681|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965682|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965683|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965684|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965685|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965686|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965687|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965688|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965689|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965690|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965691|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965692|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965693|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965694|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
46965695|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
46965696|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965697|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965698|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965699|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965700|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
46965701|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965702|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965703|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965704|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965705|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965706|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965707|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965708|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965709|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965710|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965711|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965712|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965713|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965714|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
47067481|NCT01574651|83351229|FG001|Overall Study|Protocol Violation|5|||
47067482|NCT01574651|83351228|FG000|Overall Study|Withdrawal by Subject|9|||
47067483|NCT01574651|83351229|FG001|Overall Study|Withdrawal by Subject|10|||
47067484|NCT01440803|83351241|FG000|Overall Study|Met study stopping rule|2|||
47067485|NCT01440803|83351242|FG001|Overall Study|Met study stopping rule|1|||
47067486|NCT01440803|83351241|FG000|Overall Study|Lost to Follow-up|0|||
47067487|NCT01440803|83351242|FG001|Overall Study|Lost to Follow-up|2|||
47067488|NCT01440803|83351241|FG000|Overall Study|Withdrawal by Subject|0|||
47067489|NCT01440803|83351242|FG001|Overall Study|Withdrawal by Subject|1|||
46640693|NCT03334539|82819444|FG001|Overall Study|Administrative Reasons|0|||
46640694|NCT03334539|82819445|FG002|Overall Study|Administrative Reasons|0|||
46640695|NCT03334539|82819443|FG000|Overall Study|Hypertension Not Controlled|0|||
46774853|NCT00707031|82993329|FG001|Overall Study|Withdrawal by Subject|8|||
46774854|NCT00707031|82993328|FG000|Overall Study|Poor Compliance to Protocol|7|||
46774855|NCT00707031|82993329|FG001|Overall Study|Poor Compliance to Protocol|13|||
47067490|NCT01517282|83351253|FG000|Overall Study|Consent withdrawn|0|||
47067491|NCT01517282|83351254|FG001|Overall Study|Consent withdrawn|1|||
46965715|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
46965716|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
46965717|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965718|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965719|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965720|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965721|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
46965722|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965723|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965724|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965725|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965726|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965727|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965728|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965729|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965730|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965731|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965732|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965733|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965734|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965735|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965736|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
46965737|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
46965738|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965739|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965740|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965741|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965742|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
46965743|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965744|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965745|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965746|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965747|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965748|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965749|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965750|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965751|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965752|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965753|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965754|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965755|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965756|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965757|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
46965758|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
46965759|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965760|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965761|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965762|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965763|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
46965764|NCT01597245|83208211|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965765|NCT01597245|83208212|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46640696|NCT03334539|82819444|FG001|Overall Study|Hypertension Not Controlled|1|||
46640697|NCT03334539|82819445|FG002|Overall Study|Hypertension Not Controlled|0|||
46640698|NCT03321981|82819461|FG000|Overall Study|Progressive Disease (PD)|15|||
46640699|NCT03321981|82819462|FG001|Overall Study|Progressive Disease (PD)|30|||
46640700|NCT03321981|82819463|FG002|Overall Study|Progressive Disease (PD)|47|||
46640701|NCT03321981|82819461|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
46640702|NCT03321981|82819462|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
46640703|NCT03321981|82819463|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
46640704|NCT03321981|82819461|FG000|Overall Study|Adverse Event|0|||
46640705|NCT03321981|82819462|FG001|Overall Study|Adverse Event|0|||
46640706|NCT03321981|82819463|FG002|Overall Study|Adverse Event|2|||
46640707|NCT03321981|82819461|FG000|Overall Study|symptomatic deterioration|0|||
47067492|NCT01517282|83351255|FG002|Overall Study|Consent withdrawn|1|||
46640708|NCT03321981|82819462|FG001|Overall Study|symptomatic deterioration|1|||
46640709|NCT03321981|82819463|FG002|Overall Study|symptomatic deterioration|1|||
46640710|NCT03321981|82819461|FG000|Overall Study|Lack of compliance|0|||
46640711|NCT03321981|82819462|FG001|Overall Study|Lack of compliance|1|||
46640712|NCT03321981|82819463|FG002|Overall Study|Lack of compliance|0|||
46640713|NCT03321981|82819461|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
46640714|NCT03321981|82819462|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
46640715|NCT03321981|82819463|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
46640716|NCT03321981|82819461|FG000|Overall Study|Death|0|||
46640717|NCT03321981|82819462|FG001|Overall Study|Death|1|||
46640718|NCT03321981|82819463|FG002|Overall Study|Death|0|||
46640719|NCT03321981|82819461|FG000|Overall Study|Subject withdrawal of investigational product|0|||
46640720|NCT03321981|82819462|FG001|Overall Study|Subject withdrawal of investigational product|1|||
46640721|NCT03321981|82819463|FG002|Overall Study|Subject withdrawal of investigational product|0|||
46640722|NCT03321981|82819461|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
46640723|NCT03321981|82819462|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
46640724|NCT03321981|82819463|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
46640725|NCT03321981|82819461|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
46640726|NCT03321981|82819462|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
46640727|NCT03321981|82819463|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
46640728|NCT03207009|82819471|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
46640729|NCT03201458|82819477|FG000|Overall Study|No longer eligible|2|||
46640730|NCT03201458|82819478|FG001|Overall Study|No longer eligible|5|||
46640731|NCT03201458|82819477|FG000|Overall Study|Health event before starting|1|||
46640732|NCT03201458|82819478|FG001|Overall Study|Health event before starting|0|||
46640733|NCT03201458|82819477|FG000|Overall Study|Physician Decision|1|||
46640734|NCT03201458|82819478|FG001|Overall Study|Physician Decision|0|||
46640735|NCT03179605|82819484|FG000|Overall Study|Withdrawal by Subject|1|||
46640736|NCT02963441|82819495|FG000|Overall Study|Protocol violation or withdrawn|8|||
46640737|NCT02963441|82819495|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
46640738|NCT02963441|82819495|FG000|Overall Study|IDx-DR insufficient quality|33|||
46640739|NCT02853331|82819502|FG000|Overall Study|Death|59|||
46640740|NCT02853331|82819503|FG001|Overall Study|Death|95|||
46640741|NCT02853331|82819502|FG000|Overall Study|Withdrawal by Subject|5|||
46640742|NCT02853331|82819503|FG001|Overall Study|Withdrawal by Subject|9|||
46640743|NCT02853331|82819502|FG000|Overall Study|Ongoing in study|368|||
46640744|NCT02853331|82819503|FG001|Overall Study|Ongoing in study|325|||
46640745|NCT02749799|82819509|FG000|Overall Study|Adverse Event|2|||
46640746|NCT02749799|82819509|FG000|Overall Study|Lost to Follow-up|4|||
46965766|NCT01597245|83208213|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965767|NCT01597245|83208214|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965768|NCT01597245|83208215|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965769|NCT01597245|83208216|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
47067493|NCT01517282|83351256|FG003|Overall Study|Consent withdrawn|1|||
47067494|NCT01517282|83351253|FG000|Overall Study|Physician Decision|1|||
47067495|NCT01517282|83351254|FG001|Overall Study|Physician Decision|0|||
46640747|NCT02749799|82819509|FG000|Overall Study|Protocol Violation|1|||
46640748|NCT02749799|82819509|FG000|Overall Study|Withdrawal by Subject|1|||
46640749|NCT02527421|82819528|FG000|Overall Study|Withdrawal by Subject|1|||
46640750|NCT02527421|82819529|FG001|Overall Study|Withdrawal by Subject|0|||
46640751|NCT02070965|82819549|FG000|Overall Study|Lost to Follow-up|0|||
46640752|NCT02070965|82819550|FG001|Overall Study|Lost to Follow-up|1|||
46640753|NCT02070965|82819551|FG002|Overall Study|Lost to Follow-up|0|||
46640754|NCT02070965|82819549|FG000|Overall Study|Withdrawal by Subject|1|||
46640755|NCT02070965|82819550|FG001|Overall Study|Withdrawal by Subject|1|||
46640756|NCT02070965|82819551|FG002|Overall Study|Withdrawal by Subject|1|||
46640757|NCT02070965|82819549|FG000|Overall Study|Subject moved|1|||
46640758|NCT02070965|82819550|FG001|Overall Study|Subject moved|0|||
46640759|NCT02070965|82819551|FG002|Overall Study|Subject moved|0|||
46640760|NCT01967069|82819561|FG000|Overall Study|Adverse Event|2|||
46640761|NCT01967069|82819562|FG001|Overall Study|Adverse Event|2|||
46640762|NCT01967069|82819561|FG000|Overall Study|Lost to Follow-up|5|||
46640763|NCT01967069|82819562|FG001|Overall Study|Lost to Follow-up|2|||
46640764|NCT01967069|82819561|FG000|Overall Study|Withdrawal by Subject|1|||
46640765|NCT01967069|82819562|FG001|Overall Study|Withdrawal by Subject|3|||
46640766|NCT01967069|82819561|FG000|Overall Study|Lack of Efficacy|0|||
46640767|NCT01967069|82819562|FG001|Overall Study|Lack of Efficacy|1|||
46640768|NCT01947491|82819572|FG000|Overall Study|Lost to Follow-up|5|||
46640769|NCT01947491|82819573|FG001|Overall Study|Lost to Follow-up|3|||
46640770|NCT01947491|82819574|FG002|Overall Study|Lost to Follow-up|1|||
46640771|NCT01947491|82819575|FG003|Overall Study|Lost to Follow-up|2|||
46640772|NCT01947491|82819572|FG000|Overall Study|Lack of Efficacy|1|||
47067496|NCT01517282|83351255|FG002|Overall Study|Physician Decision|0|||
47067497|NCT01517282|83351256|FG003|Overall Study|Physician Decision|0|||
46640773|NCT01947491|82819573|FG001|Overall Study|Lack of Efficacy|0|||
46640774|NCT01947491|82819574|FG002|Overall Study|Lack of Efficacy|0|||
46640775|NCT01947491|82819575|FG003|Overall Study|Lack of Efficacy|1|||
46640776|NCT01947491|82819572|FG000|Overall Study|Protocol Violation|1|||
46640777|NCT01947491|82819573|FG001|Overall Study|Protocol Violation|0|||
46640778|NCT01947491|82819574|FG002|Overall Study|Protocol Violation|0|||
46640779|NCT01947491|82819575|FG003|Overall Study|Protocol Violation|0|||
46640780|NCT01947491|82819572|FG000|Overall Study|Withdrawal by Subject|1|||
46640781|NCT01947491|82819573|FG001|Overall Study|Withdrawal by Subject|1|||
46640782|NCT01947491|82819574|FG002|Overall Study|Withdrawal by Subject|1|||
46640783|NCT01947491|82819575|FG003|Overall Study|Withdrawal by Subject|0|||
46640784|NCT01947491|82819572|FG000|Overall Study|Worsening of condition|0|||
46640785|NCT01947491|82819573|FG001|Overall Study|Worsening of condition|1|||
46640786|NCT01947491|82819574|FG002|Overall Study|Worsening of condition|0|||
46640787|NCT01947491|82819575|FG003|Overall Study|Worsening of condition|0|||
46640788|NCT01947491|82819572|FG000|Overall Study|Adverse Event|0|||
46640789|NCT01947491|82819573|FG001|Overall Study|Adverse Event|1|||
46640790|NCT01947491|82819574|FG002|Overall Study|Adverse Event|0|||
46640791|NCT01947491|82819575|FG003|Overall Study|Adverse Event|2|||
46640792|NCT01627574|82819587|FG000|Overall Study|Withdrawal by Subject|8|||
46640793|NCT01627574|82819588|FG001|Overall Study|Withdrawal by Subject|5|||
46640794|NCT01627574|82819587|FG000|Overall Study|Lost to Follow-up|13|||
46640795|NCT01627574|82819588|FG001|Overall Study|Lost to Follow-up|13|||
46640796|NCT01546545|82819594|FG000|Overall Study|Withdrawal by Subject|1|||
46640797|NCT01317160|82819603|FG000|Overall Study|Incorrect inclusion|1|||
46640798|NCT01317160|82819604|FG001|Overall Study|Incorrect inclusion|1|||
46965770|NCT01597245|83208217|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965771|NCT01597245|83208218|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46640799|NCT01317160|82819603|FG000|Overall Study|Lost to Follow-up|3|||
46640800|NCT01317160|82819604|FG001|Overall Study|Lost to Follow-up|3|||
46640801|NCT01317160|82819603|FG000|Overall Study|Withdrawal by Subject|0|||
46640802|NCT01317160|82819604|FG001|Overall Study|Withdrawal by Subject|2|||
46640803|NCT01168219|82820170|FG000|Overall Study|off study before starting treatment|2|||
46640804|NCT01168219|82820170|FG000|Overall Study|withdrew before transplant|1|||
46640805|NCT01168219|82820170|FG000|Overall Study|ineligible due to CML|2|||
46640806|NCT01115803|82820181|FG000|Overall Study|Withdrawal by Subject|0|||
46640807|NCT01115803|82820182|FG001|Overall Study|Withdrawal by Subject|0|||
46640808|NCT01115803|82820183|FG002|Overall Study|Withdrawal by Subject|0|||
46965772|NCT01597245|83208219|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965773|NCT01597245|83208220|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965774|NCT01597245|83208221|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965775|NCT01597245|83208222|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965776|NCT01597245|83208223|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965777|NCT01597245|83208224|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
46640809|NCT01115803|82820184|FG003|Overall Study|Withdrawal by Subject|0|||
46640810|NCT01115803|82820185|FG004|Overall Study|Withdrawal by Subject|0|||
46640811|NCT01115803|82820186|FG005|Overall Study|Withdrawal by Subject|0|||
46640812|NCT01115803|82820187|FG006|Overall Study|Withdrawal by Subject|1|||
46965778|NCT01597245|83208225|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965779|NCT01597245|83208226|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965780|NCT01597245|83208227|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965781|NCT01597245|83208228|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965782|NCT01597245|83208229|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965783|NCT01597245|83208230|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965784|NCT01597245|83208231|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
46965785|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965786|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965787|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46640813|NCT01115803|82820181|FG000|Overall Study|Lost to Follow-up|0|||
46640814|NCT01115803|82820182|FG001|Overall Study|Lost to Follow-up|0|||
46640815|NCT01115803|82820183|FG002|Overall Study|Lost to Follow-up|1|||
46640816|NCT01115803|82820184|FG003|Overall Study|Lost to Follow-up|0|||
46640817|NCT01115803|82820185|FG004|Overall Study|Lost to Follow-up|0|||
46640818|NCT01115803|82820186|FG005|Overall Study|Lost to Follow-up|0|||
46640819|NCT01115803|82820187|FG006|Overall Study|Lost to Follow-up|0|||
46640820|NCT01115803|82820181|FG000|Overall Study|Progressive Disease during Cycle1|0|||
46640821|NCT01115803|82820182|FG001|Overall Study|Progressive Disease during Cycle1|0|||
46774856|NCT00707031|82993328|FG000|Overall Study|Familial or Personal Reasons|12|||
46774857|NCT00707031|82993329|FG001|Overall Study|Familial or Personal Reasons|15|||
46774858|NCT00707031|82993328|FG000|Overall Study|Serious Noncompliance|2|||
46774859|NCT00707031|82993329|FG001|Overall Study|Serious Noncompliance|3|||
46774860|NCT00707031|82993328|FG000|Overall Study|Sponsor Decision|9|||
46774861|NCT00707031|82993329|FG001|Overall Study|Sponsor Decision|8|||
46640822|NCT01115803|82820183|FG002|Overall Study|Progressive Disease during Cycle1|0|||
46846008|NCT03835481|83062763|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
46846009|NCT03835481|83062764|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
46846010|NCT03835481|83062760|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
46846011|NCT03835481|83062761|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
46846012|NCT03835481|83062762|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
46846013|NCT03835481|83062763|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
46846014|NCT03835481|83062764|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
46846015|NCT03835481|83062760|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
46846016|NCT03835481|83062761|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
46846017|NCT03835481|83062762|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
46846018|NCT03835481|83062763|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
46846019|NCT03835481|83062764|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
46640823|NCT01115803|82820184|FG003|Overall Study|Progressive Disease during Cycle1|0|||
46640824|NCT01115803|82820185|FG004|Overall Study|Progressive Disease during Cycle1|0|||
46640825|NCT01115803|82820186|FG005|Overall Study|Progressive Disease during Cycle1|0|||
46640826|NCT01115803|82820187|FG006|Overall Study|Progressive Disease during Cycle1|1|||
46640827|NCT01115569|82820208|FG000|Conversion/Titration Phase|Adverse Event|59|||
46640828|NCT01115569|82820209|FG001|Conversion/Titration Phase|Adverse Event|0|||
46640829|NCT01115569|82820208|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
46640830|NCT01115569|82820209|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
46640831|NCT01115569|82820208|FG000|Conversion/Titration Phase|Physician Decision|5|||
46640832|NCT01115569|82820209|FG001|Conversion/Titration Phase|Physician Decision|0|||
46640833|NCT01115569|82820208|FG000|Conversion/Titration Phase|Protocol Violation|68|||
46640834|NCT01115569|82820209|FG001|Conversion/Titration Phase|Protocol Violation|0|||
46640835|NCT01115569|82820208|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
46640836|NCT01115569|82820209|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
46640837|NCT01115569|82820208|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
46640838|NCT01115569|82820209|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
46640839|NCT01115569|82820208|FG000|Maintenance Phase|Adverse Event|0|||
46640840|NCT01115569|82820209|FG001|Maintenance Phase|Adverse Event|43|||
46640841|NCT01115569|82820208|FG000|Maintenance Phase|Lost to Follow-up|0|||
46640842|NCT01115569|82820209|FG001|Maintenance Phase|Lost to Follow-up|8|||
46640843|NCT01115569|82820208|FG000|Maintenance Phase|Physician Decision|0|||
46640844|NCT01115569|82820209|FG001|Maintenance Phase|Physician Decision|3|||
46640845|NCT01115569|82820208|FG000|Maintenance Phase|Protocol Violation|0|||
46640846|NCT01115569|82820209|FG001|Maintenance Phase|Protocol Violation|9|||
46640847|NCT01115569|82820208|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46640848|NCT01115569|82820209|FG001|Maintenance Phase|Withdrawal by Subject|27|||
46640849|NCT01115569|82820208|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
46640850|NCT01115569|82820209|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
46640851|NCT01115569|82820208|FG000|Maintenance Phase|Administrative|0|||
46640852|NCT01115569|82820209|FG001|Maintenance Phase|Administrative|1|||
46640853|NCT01107886|82820216|FG000|Overall Study|Lost to Follow-up|15|||
46640854|NCT01107886|82820217|FG001|Overall Study|Lost to Follow-up|13|||
46640855|NCT01107886|82820216|FG000|Overall Study|Withdrawal by Subject|180|||
46640856|NCT01107886|82820217|FG001|Overall Study|Withdrawal by Subject|196|||
46640857|NCT01107886|82820216|FG000|Overall Study|Administrative withdrawal of consent|7|||
46640858|NCT01107886|82820217|FG001|Overall Study|Administrative withdrawal of consent|5|||
46640859|NCT01107457|82820228|FG000|Part A|Adverse Event|1|||
46640860|NCT01107457|82820229|FG001|Part A|Adverse Event|2|||
46640861|NCT01107457|82820230|FG002|Part A|Adverse Event|1|||
46640862|NCT01107457|82820231|FG003|Part A|Adverse Event|0|||
46640863|NCT01107457|82820232|FG004|Part A|Adverse Event|0|||
46640864|NCT01107457|82820233|FG005|Part A|Adverse Event|0|||
46640865|NCT01107457|82820228|FG000|Part A|Withdrawal by Subject|3|||
46640866|NCT01107457|82820229|FG001|Part A|Withdrawal by Subject|3|||
46640867|NCT01107457|82820230|FG002|Part A|Withdrawal by Subject|0|||
46640868|NCT01107457|82820231|FG003|Part A|Withdrawal by Subject|3|||
46640869|NCT01107457|82820232|FG004|Part A|Withdrawal by Subject|1|||
47067498|NCT01440647|83351277|FG000|Overall Study|Death|2|||
46640870|NCT01107457|82820233|FG005|Part A|Withdrawal by Subject|0|||
46640871|NCT01107457|82820228|FG000|Part A|Lost to Follow-up|0|||
46640872|NCT01107457|82820229|FG001|Part A|Lost to Follow-up|1|||
46640873|NCT01107457|82820230|FG002|Part A|Lost to Follow-up|0|||
46640874|NCT01107457|82820231|FG003|Part A|Lost to Follow-up|0|||
46640875|NCT01107457|82820232|FG004|Part A|Lost to Follow-up|0|||
46640876|NCT01107457|82820233|FG005|Part A|Lost to Follow-up|0|||
46640877|NCT01107457|82820228|FG000|Part A|Lack of Efficacy|1|||
46640878|NCT01107457|82820229|FG001|Part A|Lack of Efficacy|0|||
46640879|NCT01107457|82820230|FG002|Part A|Lack of Efficacy|0|||
46640880|NCT01107457|82820231|FG003|Part A|Lack of Efficacy|0|||
46640881|NCT01107457|82820232|FG004|Part A|Lack of Efficacy|0|||
46640882|NCT01107457|82820233|FG005|Part A|Lack of Efficacy|0|||
46640883|NCT01107457|82820228|FG000|Part A|Protocol Violation|0|||
46640884|NCT01107457|82820229|FG001|Part A|Protocol Violation|1|||
46640885|NCT01107457|82820230|FG002|Part A|Protocol Violation|0|||
46640886|NCT01107457|82820231|FG003|Part A|Protocol Violation|0|||
46640887|NCT01107457|82820232|FG004|Part A|Protocol Violation|0|||
46640888|NCT01107457|82820233|FG005|Part A|Protocol Violation|0|||
46640889|NCT01107457|82820228|FG000|Part B and C|Adverse Event|0|||
46640890|NCT01107457|82820229|FG001|Part B and C|Adverse Event|0|||
46640891|NCT01107457|82820230|FG002|Part B and C|Adverse Event|0|||
46640892|NCT01107457|82820231|FG003|Part B and C|Adverse Event|0|||
46640893|NCT01107457|82820232|FG004|Part B and C|Adverse Event|0|||
46640894|NCT01107457|82820233|FG005|Part B and C|Adverse Event|12|||
46640895|NCT01107457|82820228|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
46640896|NCT01107457|82820229|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
46640897|NCT01107457|82820230|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
46640898|NCT01107457|82820231|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
46640899|NCT01107457|82820232|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
46640900|NCT01107457|82820233|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
46640901|NCT01107457|82820228|FG000|Part B and C|Physician Decision|0|||
46640902|NCT01107457|82820229|FG001|Part B and C|Physician Decision|0|||
46640903|NCT01107457|82820230|FG002|Part B and C|Physician Decision|0|||
46640904|NCT01107457|82820231|FG003|Part B and C|Physician Decision|0|||
46640905|NCT01107457|82820232|FG004|Part B and C|Physician Decision|0|||
46640906|NCT01107457|82820233|FG005|Part B and C|Physician Decision|3|||
46640907|NCT01107457|82820228|FG000|Part B and C|Lack of Efficacy|0|||
46640908|NCT01107457|82820229|FG001|Part B and C|Lack of Efficacy|0|||
46640909|NCT01107457|82820230|FG002|Part B and C|Lack of Efficacy|0|||
46640910|NCT01107457|82820231|FG003|Part B and C|Lack of Efficacy|0|||
46640911|NCT01107457|82820232|FG004|Part B and C|Lack of Efficacy|0|||
46640912|NCT01107457|82820233|FG005|Part B and C|Lack of Efficacy|7|||
46640913|NCT01107457|82820228|FG000|Part B and C|Lost to Follow-up|0|||
46846020|NCT03835481|83062760|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
46846021|NCT03835481|83062761|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
46965788|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965789|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965790|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965791|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965792|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965793|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965794|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965795|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965796|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965797|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965798|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965799|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965800|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
46965801|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
46965802|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
46965803|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
46965804|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
46965805|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
46965806|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965807|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965808|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965809|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965810|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965811|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965812|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965813|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965814|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
47067499|NCT01440647|83351278|FG001|Overall Study|Death|3|||
47067500|NCT01516970|83351286|FG000|Overall Study|Lost to Follow-up|7|||
47067501|NCT01516970|83351287|FG001|Overall Study|Lost to Follow-up|8|||
46640914|NCT01107457|82820229|FG001|Part B and C|Lost to Follow-up|0|||
46640915|NCT01107457|82820230|FG002|Part B and C|Lost to Follow-up|0|||
46640916|NCT01107457|82820231|FG003|Part B and C|Lost to Follow-up|0|||
46640917|NCT01107457|82820232|FG004|Part B and C|Lost to Follow-up|0|||
46640918|NCT01107457|82820233|FG005|Part B and C|Lost to Follow-up|10|||
46640919|NCT01107457|82820228|FG000|Part B and C|Protocol Violation|0|||
46640920|NCT01107457|82820229|FG001|Part B and C|Protocol Violation|0|||
46640921|NCT01107457|82820230|FG002|Part B and C|Protocol Violation|0|||
46640922|NCT01107457|82820231|FG003|Part B and C|Protocol Violation|0|||
46640923|NCT01107457|82820232|FG004|Part B and C|Protocol Violation|0|||
46640924|NCT01107457|82820233|FG005|Part B and C|Protocol Violation|1|||
46965815|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965816|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965817|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965818|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965819|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965820|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965821|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965822|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
46965823|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
46965824|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
46965825|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
46965826|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
46965827|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965828|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965829|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965830|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965831|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965832|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965833|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965834|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965835|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965836|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965837|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965838|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965839|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965840|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965841|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965842|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965843|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
46965844|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965845|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
46965846|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
46965847|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
46965848|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965849|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965850|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965851|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965852|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965853|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965854|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965855|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965856|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965857|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965858|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965859|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965860|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965861|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965862|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965863|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965864|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965865|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
46965866|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
46965867|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
46965868|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
46965869|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
47067502|NCT01516970|83351286|FG000|Overall Study|Adverse Event|1|||
47067503|NCT01516970|83351287|FG001|Overall Study|Adverse Event|5|||
47067504|NCT01516970|83351286|FG000|Overall Study|Withdrawal by Subject|1|||
47067505|NCT01516970|83351287|FG001|Overall Study|Withdrawal by Subject|1|||
47067506|NCT01516970|83351286|FG000|Overall Study|Other|9|||
47067507|NCT01516970|83351287|FG001|Overall Study|Other|7|||
46965870|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965871|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
47067508|NCT01516892|83351308|FG000|Overall Study|Adverse Event|25|||
47067509|NCT01516892|83351308|FG000|Overall Study|Lack of Efficacy|35|||
46965872|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965873|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965874|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965875|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965876|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965877|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965878|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965879|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965880|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965881|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965882|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965883|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965884|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965885|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
46965886|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965887|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
46965888|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
46965889|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
46965890|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965891|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965892|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965893|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965894|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965895|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965896|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965897|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965898|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965899|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965900|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965901|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965902|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965903|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965904|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965905|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965906|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
46965907|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965908|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
46965909|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
46965910|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
46965911|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965912|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965913|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965914|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965915|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965916|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965917|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965918|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965919|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965920|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965921|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965922|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965923|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965924|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965925|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965926|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
47067510|NCT01516892|83351308|FG000|Overall Study|Pregnancy|5|||
47067511|NCT01516892|83351308|FG000|Overall Study|Lost to Follow-up|82|||
46774862|NCT00711477|82993338|FG000|Overall Study|Adverse Event|3|||
46774863|NCT00711477|82993339|FG001|Overall Study|Adverse Event|1|||
46965927|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
46965928|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965929|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
47067512|NCT01516892|83351308|FG000|Overall Study|Subject Withdrew Consent|92|||
46965930|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
46965931|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
46965932|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965933|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965934|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965935|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965936|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965937|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965938|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965939|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965940|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965941|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965942|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46774864|NCT00711477|82993338|FG000|Overall Study|Lost to Follow-up|0|||
46774865|NCT00711477|82993339|FG001|Overall Study|Lost to Follow-up|1|||
46774866|NCT00711477|82993338|FG000|Overall Study|Noncompliance|0|||
46774867|NCT00711477|82993339|FG001|Overall Study|Noncompliance|1|||
46774868|NCT00699699|82993347|FG000|Overall Study|Adverse Event|36|||
46774869|NCT00699699|82993347|FG000|Overall Study|Individual different reasons|21|||
46774870|NCT00734474|82993360|FG000|Overall Study|Entry Criteria Not Met|0|||
46774871|NCT00734474|82993361|FG001|Overall Study|Entry Criteria Not Met|0|||
46774872|NCT00734474|82993362|FG002|Overall Study|Entry Criteria Not Met|5|||
46774873|NCT00734474|82993363|FG003|Overall Study|Entry Criteria Not Met|0|||
46774874|NCT00734474|82993364|FG004|Overall Study|Entry Criteria Not Met|3|||
46774875|NCT00734474|82993365|FG005|Overall Study|Entry Criteria Not Met|1|||
46774876|NCT00734474|82993366|FG006|Overall Study|Entry Criteria Not Met|0|||
46774877|NCT00734474|82993367|FG007|Overall Study|Entry Criteria Not Met|1|||
46774878|NCT00734474|82993368|FG008|Overall Study|Entry Criteria Not Met|1|||
46774879|NCT00734474|82993360|FG000|Overall Study|Lost to Follow-up|1|||
46774880|NCT00734474|82993361|FG001|Overall Study|Lost to Follow-up|0|||
46774881|NCT00734474|82993362|FG002|Overall Study|Lost to Follow-up|13|||
46774882|NCT00734474|82993363|FG003|Overall Study|Lost to Follow-up|0|||
46774883|NCT00734474|82993364|FG004|Overall Study|Lost to Follow-up|11|||
46774884|NCT00734474|82993365|FG005|Overall Study|Lost to Follow-up|1|||
46774885|NCT00734474|82993366|FG006|Overall Study|Lost to Follow-up|0|||
46774886|NCT00734474|82993367|FG007|Overall Study|Lost to Follow-up|9|||
46774887|NCT00734474|82993368|FG008|Overall Study|Lost to Follow-up|4|||
46774888|NCT00734474|82993360|FG000|Overall Study|Withdrawal by Subject|2|||
46774889|NCT00734474|82993361|FG001|Overall Study|Withdrawal by Subject|1|||
46774890|NCT00734474|82993362|FG002|Overall Study|Withdrawal by Subject|18|||
46774891|NCT00734474|82993363|FG003|Overall Study|Withdrawal by Subject|0|||
46774892|NCT00734474|82993364|FG004|Overall Study|Withdrawal by Subject|24|||
46774893|NCT00734474|82993365|FG005|Overall Study|Withdrawal by Subject|2|||
46774894|NCT00734474|82993366|FG006|Overall Study|Withdrawal by Subject|0|||
46774895|NCT00734474|82993367|FG007|Overall Study|Withdrawal by Subject|36|||
46774896|NCT00734474|82993368|FG008|Overall Study|Withdrawal by Subject|21|||
46774897|NCT00734474|82993360|FG000|Overall Study|Physician Decision|0|||
46774898|NCT00734474|82993361|FG001|Overall Study|Physician Decision|0|||
46774899|NCT00734474|82993362|FG002|Overall Study|Physician Decision|4|||
46774900|NCT00734474|82993363|FG003|Overall Study|Physician Decision|1|||
46774901|NCT00734474|82993364|FG004|Overall Study|Physician Decision|11|||
46774902|NCT00734474|82993365|FG005|Overall Study|Physician Decision|0|||
46774903|NCT00734474|82993366|FG006|Overall Study|Physician Decision|0|||
46774904|NCT00734474|82993367|FG007|Overall Study|Physician Decision|9|||
46846022|NCT03835481|83062762|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
46846023|NCT03835481|83062763|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
46774905|NCT00734474|82993368|FG008|Overall Study|Physician Decision|9|||
46774906|NCT00734474|82993360|FG000|Overall Study|Adverse Event|4|||
46774907|NCT00734474|82993361|FG001|Overall Study|Adverse Event|4|||
46774908|NCT00734474|82993362|FG002|Overall Study|Adverse Event|63|||
46774909|NCT00734474|82993363|FG003|Overall Study|Adverse Event|1|||
46774910|NCT00734474|82993364|FG004|Overall Study|Adverse Event|64|||
46774911|NCT00734474|82993365|FG005|Overall Study|Adverse Event|0|||
46774912|NCT00734474|82993366|FG006|Overall Study|Adverse Event|1|||
46774913|NCT00734474|82993367|FG007|Overall Study|Adverse Event|65|||
46774914|NCT00734474|82993368|FG008|Overall Study|Adverse Event|39|||
46846024|NCT03835481|83062764|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
46774915|NCT00734474|82993360|FG000|Overall Study|Protocol Violation|0|||
46774916|NCT00734474|82993361|FG001|Overall Study|Protocol Violation|0|||
46774917|NCT00734474|82993362|FG002|Overall Study|Protocol Violation|4|||
46774918|NCT00734474|82993363|FG003|Overall Study|Protocol Violation|0|||
46774919|NCT00734474|82993364|FG004|Overall Study|Protocol Violation|3|||
46774920|NCT00734474|82993365|FG005|Overall Study|Protocol Violation|0|||
46965943|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46774921|NCT00734474|82993366|FG006|Overall Study|Protocol Violation|0|||
46965944|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965945|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965946|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965947|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965948|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
46640925|NCT01107457|82820228|FG000|Part B and C|Sponsor Decision|0|||
46965949|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965950|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965951|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
46965952|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
46965953|NCT01597245|83208211|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965954|NCT01597245|83208212|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965955|NCT01597245|83208213|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965956|NCT01597245|83208214|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965957|NCT01597245|83208215|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965958|NCT01597245|83208216|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965959|NCT01597245|83208217|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965960|NCT01597245|83208218|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965961|NCT01597245|83208219|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965962|NCT01597245|83208220|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965963|NCT01597245|83208221|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965964|NCT01597245|83208222|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965965|NCT01597245|83208223|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965966|NCT01597245|83208224|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965967|NCT01597245|83208225|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965968|NCT01597245|83208226|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965969|NCT01597245|83208227|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965970|NCT01597245|83208228|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965971|NCT01597245|83208229|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965972|NCT01597245|83208230|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
46965973|NCT01597245|83208231|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
46965974|NCT00707057|83208266|FG000|Overall Study|Withdrawal by Subject|8|||
46965975|NCT00707057|83208267|FG001|Overall Study|Withdrawal by Subject|3|||
46965976|NCT00707057|83208266|FG000|Overall Study|Dosed incorrectly|0|||
46965977|NCT00707057|83208267|FG001|Overall Study|Dosed incorrectly|1|||
46965978|NCT02639247|83208275|FG000|Overall Study|Lost to Follow-up|2|||
46965979|NCT02639247|83208276|FG001|Overall Study|Lost to Follow-up|1|||
46965980|NCT02639247|83208275|FG000|Overall Study|Death|2|||
46965981|NCT02639247|83208276|FG001|Overall Study|Death|0|||
46965982|NCT02639247|83208275|FG000|Overall Study|Withdrew Consent|0|||
46965983|NCT02639247|83208276|FG001|Overall Study|Withdrew Consent|1|||
46965984|NCT02639247|83208275|FG000|Overall Study|Protocol Violation|1|||
46965985|NCT02639247|83208276|FG001|Overall Study|Protocol Violation|0|||
46965986|NCT00706901|83208285|FG000|Overall Study|Lost to Follow-up|2|||
46965987|NCT00706901|83208286|FG001|Overall Study|Lost to Follow-up|3|||
46965988|NCT00706901|83208287|FG002|Overall Study|Lost to Follow-up|2|||
46965989|NCT00706901|83208285|FG000|Overall Study|Withdrawal by Subject|4|||
46965990|NCT00706901|83208286|FG001|Overall Study|Withdrawal by Subject|2|||
46965991|NCT00706901|83208287|FG002|Overall Study|Withdrawal by Subject|5|||
46965992|NCT00706901|83208285|FG000|Overall Study|In Jail|1|||
46965993|NCT00706901|83208286|FG001|Overall Study|In Jail|0|||
46965994|NCT00706901|83208287|FG002|Overall Study|In Jail|1|||
46965995|NCT00706901|83208285|FG000|Overall Study|Death|1|||
46965996|NCT00706901|83208286|FG001|Overall Study|Death|0|||
46965997|NCT00706901|83208287|FG002|Overall Study|Death|0|||
46965998|NCT05274217|83208298|FG000|Overall Study|Study terminated.|11|||
46965999|NCT05274217|83208299|FG001|Overall Study|Study terminated.|0|||
46966000|NCT05070546|83208311|FG000|Overall Study|Death|0|||
46966001|NCT05070546|83208312|FG001|Overall Study|Death|0|||
46966002|NCT05070546|83208313|FG002|Overall Study|Death|0|||
46966003|NCT05070546|83208314|FG003|Overall Study|Death|0|||
46774922|NCT00734474|82993367|FG007|Overall Study|Protocol Violation|3|||
46774923|NCT00734474|82993368|FG008|Overall Study|Protocol Violation|1|||
46966004|NCT05070546|83208315|FG004|Overall Study|Death|0|||
46966005|NCT05070546|83208316|FG005|Overall Study|Death|1|||
46966006|NCT05070546|83208311|FG000|Overall Study|Lost to Follow-up|8|||
46966007|NCT05070546|83208312|FG001|Overall Study|Lost to Follow-up|2|||
46966008|NCT05070546|83208313|FG002|Overall Study|Lost to Follow-up|7|||
46966009|NCT05070546|83208314|FG003|Overall Study|Lost to Follow-up|1|||
46966010|NCT05070546|83208315|FG004|Overall Study|Lost to Follow-up|2|||
46774924|NCT00734474|82993360|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
47067513|NCT01516892|83351308|FG000|Overall Study|Protocol Violation|60|||
46966011|NCT05070546|83208316|FG005|Overall Study|Lost to Follow-up|0|||
47067514|NCT01516892|83351308|FG000|Overall Study|Other Miscellaneous Reasons|43|||
47067515|NCT01516892|83351308|FG000|Overall Study|Missing|1|||
46966012|NCT05070546|83208311|FG000|Overall Study|Withdrawal by Subject|1|||
46966013|NCT05070546|83208312|FG001|Overall Study|Withdrawal by Subject|1|||
46966014|NCT05070546|83208313|FG002|Overall Study|Withdrawal by Subject|3|||
46966015|NCT05070546|83208314|FG003|Overall Study|Withdrawal by Subject|0|||
46966016|NCT05070546|83208315|FG004|Overall Study|Withdrawal by Subject|0|||
46966017|NCT05070546|83208316|FG005|Overall Study|Withdrawal by Subject|0|||
46966018|NCT05070546|83208311|FG000|Overall Study|Other|0|||
46966019|NCT05070546|83208312|FG001|Overall Study|Other|0|||
46966020|NCT05070546|83208313|FG002|Overall Study|Other|0|||
46966021|NCT05070546|83208314|FG003|Overall Study|Other|0|||
46966022|NCT05070546|83208315|FG004|Overall Study|Other|3|||
46966023|NCT05070546|83208316|FG005|Overall Study|Other|0|||
46966024|NCT05070546|83208311|FG000|Overall Study|Randomized but not vaccinated|1|||
46966025|NCT05070546|83208312|FG001|Overall Study|Randomized but not vaccinated|0|||
46966026|NCT05070546|83208313|FG002|Overall Study|Randomized but not vaccinated|1|||
46966027|NCT05070546|83208314|FG003|Overall Study|Randomized but not vaccinated|1|||
46966028|NCT05070546|83208315|FG004|Overall Study|Randomized but not vaccinated|3|||
46966029|NCT05070546|83208316|FG005|Overall Study|Randomized but not vaccinated|0|||
46966030|NCT05032950|83208335|FG000|Overall Study|Adverse Event|0|||
46966031|NCT05032950|83208336|FG001|Overall Study|Adverse Event|0|||
46966032|NCT05032950|83208337|FG002|Overall Study|Adverse Event|1|||
46966033|NCT05032950|83208338|FG003|Overall Study|Adverse Event|1|||
46774925|NCT00734474|82993361|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
46774926|NCT00734474|82993362|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
46774927|NCT00734474|82993363|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
46774928|NCT00734474|82993364|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
46774929|NCT00734474|82993365|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
46774930|NCT00734474|82993366|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
46774931|NCT00734474|82993367|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
46846025|NCT03709576|83062811|FG000|Overall Study|progression prior to enrollment|1|||
46846026|NCT00122460|83062818|FG000|Overall Study|investigational study phase ongoing|7|||
46846027|NCT00122460|83062819|FG001|Overall Study|investigational study phase ongoing|1|||
46846028|NCT00137436|83062825|FG000|Overall Study|Adverse Event|13|||
46846029|NCT00137436|83062825|FG000|Overall Study|Death|2|||
46846030|NCT00137436|83062825|FG000|Overall Study|Lack of Efficacy|17|||
46846031|NCT00137436|83062825|FG000|Overall Study|Withdrawal by Subject|6|||
46846032|NCT00137436|83062825|FG000|Overall Study|Other|5|||
46846033|NCT03834623|83062831|FG000|Overall Study|Progression|0|||
46846034|NCT03834623|83062832|FG001|Overall Study|Progression|1|||
46846035|NCT00410813|83062840|FG000|Overall Study|Adverse Event|6|||
46846036|NCT00410813|83062841|FG001|Overall Study|Adverse Event|11|||
46846037|NCT00410813|83062840|FG000|Overall Study|Progression|32|||
46846038|NCT00410813|83062841|FG001|Overall Study|Progression|21|||
46846039|NCT00410813|83062840|FG000|Overall Study|Not protocol specified|3|||
46846040|NCT00410813|83062841|FG001|Overall Study|Not protocol specified|4|||
46846041|NCT00410813|83062840|FG000|Overall Study|Ineligible|2|||
46846042|NCT00410813|83062841|FG001|Overall Study|Ineligible|4|||
46846043|NCT00410813|83062840|FG000|Overall Study|Death|0|||
46846044|NCT00410813|83062841|FG001|Overall Study|Death|2|||
46846045|NCT00405821|83062872|FG000|Overall Study|Death|5|||
46846046|NCT00405821|83062873|FG001|Overall Study|Death|7|||
46846047|NCT00405821|83062872|FG000|Overall Study|Lost to Follow-up|7|||
46846048|NCT00405821|83062873|FG001|Overall Study|Lost to Follow-up|7|||
46846049|NCT00405821|83062872|FG000|Overall Study|Protocol Violation|1|||
46846050|NCT00405821|83062873|FG001|Overall Study|Protocol Violation|0|||
46846051|NCT00405821|83062872|FG000|Overall Study|initiated ART|9|||
46846052|NCT00405821|83062873|FG001|Overall Study|initiated ART|8|||
46846053|NCT01446016|83062879|FG000|Overall Study|Lost to Follow-up|3|||
46846054|NCT01446016|83062879|FG000|Overall Study|Withdrawal by Subject|1|||
46846055|NCT01446016|83062879|FG000|Overall Study|Toxicity|3|||
46774932|NCT00734474|82993368|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
46774933|NCT00734474|82993360|FG000|Overall Study|Sponsor Decision|0|||
46774934|NCT00734474|82993361|FG001|Overall Study|Sponsor Decision|0|||
46774935|NCT00734474|82993362|FG002|Overall Study|Sponsor Decision|0|||
46774936|NCT00734474|82993363|FG003|Overall Study|Sponsor Decision|0|||
46774937|NCT00734474|82993364|FG004|Overall Study|Sponsor Decision|2|||
46774938|NCT00734474|82993365|FG005|Overall Study|Sponsor Decision|0|||
46774939|NCT00734474|82993366|FG006|Overall Study|Sponsor Decision|0|||
46846056|NCT00137046|83062885|FG000|Overall Study|Death|2|||
46846057|NCT00137046|83062886|FG001|Overall Study|Death|1|||
46846058|NCT00137046|83062885|FG000|Overall Study|Adverse Event|16|||
46846059|NCT00137046|83062886|FG001|Overall Study|Adverse Event|5|||
46966034|NCT05032950|83208339|FG004|Overall Study|Adverse Event|0|||
46966035|NCT05032950|83208340|FG005|Overall Study|Adverse Event|0|||
46966036|NCT04776161|83208360|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
46966037|NCT04776161|83208361|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
46774940|NCT00734474|82993367|FG007|Overall Study|Sponsor Decision|0|||
46846060|NCT00137046|83062885|FG000|Overall Study|Laboratory Abnormality|2|||
46846061|NCT00137046|83062886|FG001|Overall Study|Laboratory Abnormality|0|||
46846062|NCT00137046|83062885|FG000|Overall Study|Lack of Efficacy|13|||
46846063|NCT00137046|83062886|FG001|Overall Study|Lack of Efficacy|1|||
46846064|NCT00137046|83062885|FG000|Overall Study|Lost to Follow-up|8|||
46846065|NCT00137046|83062886|FG001|Overall Study|Lost to Follow-up|24|||
46846066|NCT00137046|83062885|FG000|Overall Study|Other|23|||
46846067|NCT00137046|83062886|FG001|Overall Study|Other|19|||
46846068|NCT00137046|83062885|FG000|Overall Study|Withdrawal by Subject|33|||
46846069|NCT00137046|83062886|FG001|Overall Study|Withdrawal by Subject|42|||
46846070|NCT00137046|83062885|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
46966038|NCT04776161|83208362|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
46966039|NCT04776161|83208360|FG000|Overall Study|Withdrawal by Subject|1|||
46966040|NCT04776161|83208361|FG001|Overall Study|Withdrawal by Subject|0|||
46966041|NCT04776161|83208362|FG002|Overall Study|Withdrawal by Subject|1|||
46966042|NCT04776161|83208360|FG000|Overall Study|Adverse Event|0|||
46966043|NCT04776161|83208361|FG001|Overall Study|Adverse Event|1|||
46966044|NCT04776161|83208362|FG002|Overall Study|Adverse Event|1|||
46966045|NCT04268823|83208376|FG000|Overall Study|Adverse Event|1|||
46966046|NCT04268823|83208377|FG001|Overall Study|Adverse Event|0|||
46966047|NCT04268823|83208376|FG000|Overall Study|Participant Decision|1|||
46966048|NCT04268823|83208377|FG001|Overall Study|Participant Decision|0|||
46966049|NCT04226495|83208386|FG000|Overall Study|Withdrawal by Subject|3|||
46966050|NCT04226495|83208387|FG001|Overall Study|Withdrawal by Subject|3|||
46966051|NCT04226495|83208386|FG000|Overall Study|PI discretion|2|||
46966052|NCT04226495|83208387|FG001|Overall Study|PI discretion|4|||
46966053|NCT05109117|83208397|FG000|Overall Study|Lost to Follow-up|1|||
46966054|NCT05109117|83208397|FG000|Overall Study|Discontinued for non-compliance|1|||
46966055|NCT05064800|83208402|FG000|Period 3|Withdrawal by Subject|0|||
46966056|NCT05064800|83208403|FG001|Period 3|Withdrawal by Subject|0|||
46966057|NCT05064800|83208404|FG002|Period 3|Withdrawal by Subject|0|||
47067516|NCT01516736|83351333|FG000|Overall Study|Withdrawal by Subject|10|||
47067517|NCT01516736|83351334|FG001|Overall Study|Withdrawal by Subject|4|||
47067518|NCT01516736|83351333|FG000|Overall Study|Adverse Event|4|||
47067519|NCT01516736|83351334|FG001|Overall Study|Adverse Event|5|||
47067520|NCT01516736|83351333|FG000|Overall Study|Death|3|||
46774941|NCT00734474|82993368|FG008|Overall Study|Sponsor Decision|0|||
46774942|NCT00734474|82993360|FG000|Overall Study|Death|0|||
46774943|NCT00734474|82993361|FG001|Overall Study|Death|0|||
46774944|NCT00734474|82993362|FG002|Overall Study|Death|1|||
47067521|NCT01516736|83351334|FG001|Overall Study|Death|1|||
47067522|NCT01516736|83351333|FG000|Overall Study|Physician Decision|2|||
47067523|NCT01516736|83351334|FG001|Overall Study|Physician Decision|1|||
47067524|NCT01516736|83351333|FG000|Overall Study|Lack of Efficacy|1|||
47067525|NCT01516736|83351334|FG001|Overall Study|Lack of Efficacy|0|||
47067526|NCT01516736|83351333|FG000|Overall Study|Protocol Violation|0|||
47067527|NCT01516736|83351334|FG001|Overall Study|Protocol Violation|1|||
47067528|NCT01516736|83351333|FG000|Overall Study|Other (not specified)|0|||
47067529|NCT01516736|83351334|FG001|Overall Study|Other (not specified)|1|||
47067530|NCT01546688|83351346|FG000|Overall Study|Adverse Event|0|||
47067531|NCT01546688|83351347|FG001|Overall Study|Adverse Event|4|||
47067532|NCT01546688|83351346|FG000|Overall Study|Withdrawal by Subject|2|||
47067533|NCT01546688|83351347|FG001|Overall Study|Withdrawal by Subject|1|||
47067534|NCT01546688|83351346|FG000|Overall Study|Lack of Efficacy|1|||
47067535|NCT01546688|83351347|FG001|Overall Study|Lack of Efficacy|0|||
47067536|NCT01516034|83351353|FG000|Overall Study|Physician Decision|1|||
47067537|NCT01516034|83351353|FG000|Overall Study|Lack of Efficacy|7|||
46774945|NCT00734474|82993363|FG003|Overall Study|Death|0|||
46774946|NCT00734474|82993364|FG004|Overall Study|Death|0|||
46774947|NCT00734474|82993365|FG005|Overall Study|Death|0|||
47067538|NCT01440569|83351364|FG000|Main Study|Enrolled but not treated|1|||
47067539|NCT01440569|83351365|FG001|Main Study|Enrolled but not treated|0|||
47067540|NCT01440569|83351364|FG000|Main Study|Adverse Event|9|||
47067541|NCT01440569|83351365|FG001|Main Study|Adverse Event|0|||
47067542|NCT01440569|83351364|FG000|Main Study|Pregnancy|1|||
47067543|NCT01440569|83351365|FG001|Main Study|Pregnancy|0|||
47067544|NCT01440569|83351364|FG000|Main Study|Investigator's Discretion|1|||
46774948|NCT00734474|82993366|FG006|Overall Study|Death|0|||
46774949|NCT00734474|82993367|FG007|Overall Study|Death|2|||
46774950|NCT00734474|82993368|FG008|Overall Study|Death|1|||
46774951|NCT00734474|82993360|FG000|Overall Study|Lack of Efficacy|0|||
46774952|NCT00734474|82993361|FG001|Overall Study|Lack of Efficacy|0|||
46846071|NCT00137046|83062886|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
47067545|NCT01440569|83351365|FG001|Main Study|Investigator's Discretion|1|||
46966058|NCT05064800|83208405|FG003|Period 3|Withdrawal by Subject|0|||
47067546|NCT01440569|83351364|FG000|Main Study|Withdrew Consent|7|||
47067547|NCT01440569|83351365|FG001|Main Study|Withdrew Consent|1|||
47067548|NCT01440569|83351364|FG000|Main Study|Lost to Follow-up|13|||
46774953|NCT00734474|82993362|FG002|Overall Study|Lack of Efficacy|4|||
46774954|NCT00734474|82993363|FG003|Overall Study|Lack of Efficacy|0|||
46966059|NCT05064800|83208406|FG004|Period 3|Withdrawal by Subject|1|||
46966060|NCT05064800|83208407|FG005|Period 3|Withdrawal by Subject|0|||
46966061|NCT04743999|83208428|FG000|3-month Questionnaire|Death|1|||
46966062|NCT04743999|83208428|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
46966063|NCT04743999|83208428|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
46966064|NCT04743999|83208428|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
46966065|NCT04651777|83208460|FG000|Overall Study|Adverse Event|1|||
47067549|NCT01440569|83351365|FG001|Main Study|Lost to Follow-up|2|||
46966066|NCT04651777|83208460|FG000|Overall Study|Withdrawal by Subject|2|||
46966067|NCT04577651|83208468|FG000|Overall Study|Screen Failure|7|||
46966068|NCT04577651|83208468|FG000|Overall Study|Adverse Event|1|||
46966069|NCT04577651|83208468|FG000|Overall Study|Death|1|||
46966070|NCT04577651|83208468|FG000|Overall Study|Physician Decision|1|||
46966071|NCT04577651|83208468|FG000|Overall Study|Withdrawal by Subject|3|||
46966072|NCT04338269|83208474|FG000|Overall Study|Death|86|||
46966073|NCT04338269|83208475|FG001|Overall Study|Death|89|||
46966074|NCT04338269|83208474|FG000|Overall Study|Lost to Follow-up|1|||
46966075|NCT04338269|83208475|FG001|Overall Study|Lost to Follow-up|2|||
46966076|NCT04338269|83208474|FG000|Overall Study|Physician Decision|1|||
46966077|NCT04338269|83208475|FG001|Overall Study|Physician Decision|0|||
46966078|NCT04338269|83208474|FG000|Overall Study|Withdrawal by Subject|14|||
46966079|NCT04338269|83208475|FG001|Overall Study|Withdrawal by Subject|11|||
46966080|NCT04083235|83208487|FG000|Overall Study|Death|252|||
46966081|NCT04083235|83208488|FG001|Overall Study|Death|277|||
46966082|NCT04083235|83208487|FG000|Overall Study|Withdrawal by Subject|13|||
46966083|NCT04083235|83208488|FG001|Overall Study|Withdrawal by Subject|17|||
46966084|NCT04083235|83208487|FG000|Overall Study|Lost to Follow-up|1|||
47067550|NCT01440569|83351364|FG000|Main Study|Subject Non-Compliance|3|||
47067551|NCT01440569|83351365|FG001|Main Study|Subject Non-Compliance|0|||
47067552|NCT01440569|83351364|FG000|Main Study|Protocol Violation|1|||
47067553|NCT01440569|83351365|FG001|Main Study|Protocol Violation|0|||
47067554|NCT01440569|83351364|FG000|Open-Label Rollover Phase|Adverse Event|3|||
47067555|NCT01440569|83351365|FG001|Open-Label Rollover Phase|Adverse Event|0|||
47067556|NCT01440569|83351364|FG000|Open-Label Rollover Phase|Pregnancy|1|||
47067557|NCT01440569|83351365|FG001|Open-Label Rollover Phase|Pregnancy|0|||
47067558|NCT01440569|83351364|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
47067559|NCT01440569|83351365|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
47067560|NCT01440569|83351364|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
47067561|NCT01440569|83351365|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
47067562|NCT01440569|83351364|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
47067563|NCT01440569|83351365|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
47067564|NCT01440569|83351364|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
47067565|NCT01440569|83351365|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
47067566|NCT01440569|83351364|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
47067567|NCT01440569|83351365|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
47067568|NCT01546142|83351388|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
47067569|NCT01546142|83351389|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
47067570|NCT01546142|83351388|FG000|Overall Study|Subject Noncompliance|1|||
47067571|NCT01546142|83351389|FG001|Overall Study|Subject Noncompliance|1|||
47067572|NCT01546142|83351388|FG000|Overall Study|Adverse Event|6|||
47067573|NCT01546142|83351389|FG001|Overall Study|Adverse Event|3|||
47067574|NCT01546142|83351388|FG000|Overall Study|Lost to Follow-up|20|||
47067575|NCT01546142|83351389|FG001|Overall Study|Lost to Follow-up|15|||
47067576|NCT01546142|83351388|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
47067577|NCT01546142|83351389|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
47067578|NCT01546142|83351388|FG000|Overall Study|Subject Randomized but Not Treated|1|||
46966085|NCT04083235|83208488|FG001|Overall Study|Lost to Follow-up|1|||
47067579|NCT01546142|83351389|FG001|Overall Study|Subject Randomized but Not Treated|0|||
47067580|NCT01440101|83351423|FG000|Overall Study|Adverse Event|2|||
47067581|NCT01440101|83351424|FG001|Overall Study|Adverse Event|0|||
47067582|NCT01440101|83351425|FG002|Overall Study|Adverse Event|0|||
47067583|NCT01440101|83351423|FG000|Overall Study|Withdrawal by Subject|0|||
47067584|NCT01440101|83351424|FG001|Overall Study|Withdrawal by Subject|3|||
47067585|NCT01440101|83351425|FG002|Overall Study|Withdrawal by Subject|1|||
47067586|NCT01440101|83351423|FG000|Overall Study|Other|0|||
47067587|NCT01440101|83351424|FG001|Overall Study|Other|1|||
47067588|NCT01440101|83351425|FG002|Overall Study|Other|0|||
47067589|NCT01530464|83351436|FG000|Washout (24h)|Withdrawal by Subject|1|||
47067590|NCT01530464|83351437|FG001|Washout (24h)|Withdrawal by Subject|0|||
46966086|NCT04083235|83208487|FG000|Overall Study|Does not meet entry criteria|1|||
46966087|NCT04083235|83208488|FG001|Overall Study|Does not meet entry criteria|0|||
46966088|NCT04083235|83208487|FG000|Overall Study|Did not receive treatment|13|||
46966089|NCT04083235|83208488|FG001|Overall Study|Did not receive treatment|8|||
46966090|NCT04083235|83208487|FG000|Overall Study|Ongoing at the time of DCO|44|||
46966091|NCT04083235|83208488|FG001|Overall Study|Ongoing at the time of DCO|7|||
46966092|NCT03575325|83208521|FG000|Overall Study|Death|1|||
46966093|NCT03532932|83208529|FG000|Overall Study|Protocol Deviation|33|||
46966094|NCT03532932|83208530|FG001|Overall Study|Protocol Deviation|31|||
46966095|NCT03532932|83208529|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
46966096|NCT03532932|83208530|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
46966097|NCT03532932|83208529|FG000|Overall Study|Withdrawal by Subject|2|||
46966098|NCT03532932|83208530|FG001|Overall Study|Withdrawal by Subject|0|||
46966099|NCT03532932|83208529|FG000|Overall Study|Lost to Follow-up|15|||
46966100|NCT03532932|83208530|FG001|Overall Study|Lost to Follow-up|9|||
46966101|NCT03532932|83208529|FG000|Overall Study|Adverse Event|4|||
46966102|NCT03532932|83208530|FG001|Overall Study|Adverse Event|3|||
46966103|NCT03532932|83208529|FG000|Overall Study|Death|0|||
46966104|NCT03532932|83208530|FG001|Overall Study|Death|2|||
46966105|NCT03532932|83208529|FG000|Overall Study|Other|11|||
46966106|NCT03532932|83208530|FG001|Overall Study|Other|16|||
46966107|NCT03450057|83208537|FG000|Overall Study|Death|17|||
46966108|NCT03450057|83208537|FG000|Overall Study|ICF withdrawal|4|||
46966109|NCT03450057|83208537|FG000|Overall Study|Lost to Follow-up|2|||
46966110|NCT02964208|83208541|FG000|Overall Study|Death|103|||
46966111|NCT02964208|83208541|FG000|Overall Study|Withdrawal by Subject|6|||
46966112|NCT02964208|83208541|FG000|Overall Study|Lost to Follow-up|6|||
46966113|NCT02964208|83208541|FG000|Overall Study|Unsuccessful Procedure|5|||
46966114|NCT02964208|83208541|FG000|Overall Study|Device Explant|1|||
46966115|NCT02964208|83208541|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
46966116|NCT02516241|83208571|FG000|Overall Study|Death|255|||
46966117|NCT02516241|83208572|FG001|Overall Study|Death|262|||
46966118|NCT02516241|83208573|FG002|Overall Study|Death|270|||
46966119|NCT02516241|83208571|FG000|Overall Study|Lost to Follow-up|1|||
46966120|NCT02516241|83208572|FG001|Overall Study|Lost to Follow-up|1|||
46966121|NCT02516241|83208573|FG002|Overall Study|Lost to Follow-up|3|||
46966122|NCT02516241|83208571|FG000|Overall Study|Withdrawal by Subject|2|||
46966123|NCT02516241|83208572|FG001|Overall Study|Withdrawal by Subject|7|||
46966124|NCT02516241|83208573|FG002|Overall Study|Withdrawal by Subject|12|||
46966125|NCT02516241|83208571|FG000|Overall Study|participants ongoing at data cut-off|84|||
46966126|NCT02516241|83208572|FG001|Overall Study|participants ongoing at data cut-off|76|||
46966127|NCT02516241|83208573|FG002|Overall Study|participants ongoing at data cut-off|59|||
46774955|NCT00734474|82993364|FG004|Overall Study|Lack of Efficacy|0|||
46774956|NCT00734474|82993365|FG005|Overall Study|Lack of Efficacy|0|||
46774957|NCT00734474|82993366|FG006|Overall Study|Lack of Efficacy|0|||
46774958|NCT00734474|82993367|FG007|Overall Study|Lack of Efficacy|4|||
46774959|NCT00734474|82993368|FG008|Overall Study|Lack of Efficacy|6|||
46774960|NCT00583362|82993394|FG000|Overall Study|Adverse Event|44|||
46774961|NCT00583362|82993394|FG000|Overall Study|Lack of Efficacy|22|||
46774962|NCT00583362|82993394|FG000|Overall Study|Lost to Follow-up|4|||
46846072|NCT00137046|83062885|FG000|Overall Study|Withdrew prior to study treatment|1|||
46846073|NCT00137046|83062886|FG001|Overall Study|Withdrew prior to study treatment|1|||
46774963|NCT00583362|82993394|FG000|Overall Study|Non-compliance with study drug|28|||
46846074|NCT00122382|83062898|FG000|Double-Blind Study|Adverse Event|9|||
46846075|NCT00122382|83062899|FG001|Double-Blind Study|Adverse Event|11|||
46846076|NCT00122382|83062900|FG002|Double-Blind Study|Adverse Event|0|||
46846077|NCT00122382|83062898|FG000|Double-Blind Study|Death|2|||
46846078|NCT00122382|83062899|FG001|Double-Blind Study|Death|2|||
46846079|NCT00122382|83062900|FG002|Double-Blind Study|Death|0|||
46846080|NCT00122382|83062898|FG000|Double-Blind Study|Lack of Efficacy|0|||
46846081|NCT00122382|83062899|FG001|Double-Blind Study|Lack of Efficacy|8|||
46846082|NCT00122382|83062900|FG002|Double-Blind Study|Lack of Efficacy|0|||
46846083|NCT00122382|83062898|FG000|Double-Blind Study|Lost to Follow-up|2|||
46774964|NCT00583362|82993394|FG000|Overall Study|Pregnancy|7|||
46774965|NCT00583362|82993394|FG000|Overall Study|Miscommunication of visit window|5|||
46774966|NCT00583362|82993394|FG000|Overall Study|Current site closed|7|||
46774967|NCT00583362|82993394|FG000|Overall Study|Subject not dosed in LBSL99|1|||
46774968|NCT00583362|82993394|FG000|Overall Study|Subject moved out of the country/state|2|||
46774969|NCT00583362|82993394|FG000|Overall Study|Missed visits due to staff changes|1|||
46774970|NCT00583362|82993394|FG000|Overall Study|Misunderstanding of protocol|1|||
46846084|NCT00122382|83062899|FG001|Double-Blind Study|Lost to Follow-up|1|||
46846085|NCT00122382|83062900|FG002|Double-Blind Study|Lost to Follow-up|0|||
46966128|NCT02003963|83208615|FG000|Overall Study|Lost to Follow-up|2|||
46966129|NCT02003963|83208616|FG001|Overall Study|Lost to Follow-up|1|||
46966130|NCT02003209|83208626|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
46966131|NCT02003209|83208627|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
46966132|NCT01761240|83208638|FG000|Overall Study|Progressive disease:radiology assessment|3|||
46966133|NCT01761240|83208639|FG001|Overall Study|Progressive disease:radiology assessment|3|||
46966134|NCT01761240|83208640|FG002|Overall Study|Progressive disease:radiology assessment|0|||
46966135|NCT01761240|83208641|FG003|Overall Study|Progressive disease:radiology assessment|0|||
46966136|NCT01761240|83208642|FG004|Overall Study|Progressive disease:radiology assessment|0|||
46966137|NCT01761240|83208638|FG000|Overall Study|Progressive disease:clinical assessment|0|||
46966138|NCT01761240|83208639|FG001|Overall Study|Progressive disease:clinical assessment|0|||
46966139|NCT01761240|83208640|FG002|Overall Study|Progressive disease:clinical assessment|3|||
46966140|NCT01761240|83208641|FG003|Overall Study|Progressive disease:clinical assessment|1|||
46966141|NCT01761240|83208642|FG004|Overall Study|Progressive disease:clinical assessment|0|||
46966142|NCT01761240|83208638|FG000|Overall Study|Withdrawal by Subject|0|||
46966143|NCT01761240|83208639|FG001|Overall Study|Withdrawal by Subject|0|||
46966144|NCT01761240|83208640|FG002|Overall Study|Withdrawal by Subject|0|||
46966145|NCT01761240|83208641|FG003|Overall Study|Withdrawal by Subject|3|||
46966146|NCT01761240|83208642|FG004|Overall Study|Withdrawal by Subject|1|||
46966147|NCT01761240|83208638|FG000|Overall Study|Adverse Event|0|||
46966148|NCT01761240|83208639|FG001|Overall Study|Adverse Event|0|||
46966149|NCT01761240|83208640|FG002|Overall Study|Adverse Event|0|||
46966150|NCT01761240|83208641|FG003|Overall Study|Adverse Event|1|||
46966151|NCT01761240|83208642|FG004|Overall Study|Adverse Event|6|||
46966152|NCT01761240|83208638|FG000|Overall Study|Death|0|||
46966153|NCT01761240|83208639|FG001|Overall Study|Death|1|||
46966154|NCT01761240|83208640|FG002|Overall Study|Death|1|||
46966155|NCT01761240|83208641|FG003|Overall Study|Death|2|||
46966156|NCT01761240|83208642|FG004|Overall Study|Death|1|||
46846086|NCT00122382|83062898|FG000|Double-Blind Study|Pregnancy|2|||
46846087|NCT00122382|83062899|FG001|Double-Blind Study|Pregnancy|0|||
46846088|NCT00122382|83062900|FG002|Double-Blind Study|Pregnancy|0|||
46846089|NCT00122382|83062898|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
46846090|NCT00122382|83062899|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
46846091|NCT00122382|83062900|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
46846092|NCT00122382|83062898|FG000|Double-Blind Study|Withdrawal of Consent|7|||
46846093|NCT00122382|83062899|FG001|Double-Blind Study|Withdrawal of Consent|3|||
46846094|NCT00122382|83062900|FG002|Double-Blind Study|Withdrawal of Consent|0|||
46966157|NCT01761240|83208638|FG000|Overall Study|Non-compliance|0|||
46966158|NCT01761240|83208639|FG001|Overall Study|Non-compliance|0|||
46966159|NCT01761240|83208640|FG002|Overall Study|Non-compliance|1|||
46966160|NCT01761240|83208641|FG003|Overall Study|Non-compliance|0|||
46966161|NCT01761240|83208642|FG004|Overall Study|Non-compliance|0|||
46966162|NCT00788671|83208659|FG000|Overall Study|Death|2|||
46966163|NCT00788671|83208659|FG000|Overall Study|Unable to biopsy|1|||
46966164|NCT00788671|83208659|FG000|Overall Study|Withdrawal by Subject|4|||
46966165|NCT00788671|83208659|FG000|Overall Study|IUD expulsed|1|||
46966166|NCT00788671|83208659|FG000|Overall Study|Lost to follow up|2|||
46966167|NCT00152451|83208663|FG000|Overall Study|Adverse Event|4|||
46967879|NCT05091307|83210486|FG003|Overall Study|Withdrawal by Subject|1|||
46967880|NCT05091307|83210483|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
46967881|NCT05091307|83210484|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
46967882|NCT05091307|83210485|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
46967883|NCT05091307|83210486|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
46967884|NCT05091307|83210483|FG000|Overall Study|Initiated Prohibited Medication|1|||
46967885|NCT05091307|83210484|FG001|Overall Study|Initiated Prohibited Medication|0|||
46967886|NCT05091307|83210485|FG002|Overall Study|Initiated Prohibited Medication|0|||
46967887|NCT05091307|83210486|FG003|Overall Study|Initiated Prohibited Medication|0|||
46967888|NCT05091307|83210483|FG000|Overall Study|Other|4|||
46967889|NCT05091307|83210484|FG001|Overall Study|Other|4|||
46967890|NCT05091307|83210485|FG002|Overall Study|Other|0|||
46967891|NCT05091307|83210486|FG003|Overall Study|Other|0|||
46967892|NCT05091307|83210483|FG000|Overall Study|Randomized but not vaccinated|0|||
46967893|NCT05091307|83210484|FG001|Overall Study|Randomized but not vaccinated|2|||
46967894|NCT05091307|83210485|FG002|Overall Study|Randomized but not vaccinated|0|||
46967895|NCT05091307|83210486|FG003|Overall Study|Randomized but not vaccinated|0|||
46967896|NCT04930965|83210518|FG000|Overall Study|Lost to Follow-up|7|||
46967897|NCT04930965|83210519|FG001|Overall Study|Lost to Follow-up|5|||
46967898|NCT04806334|83210525|FG000|Overall Study|Withdrawal by Subject|1|||
46967899|NCT04740931|83210544|FG000|Overall Study|Ongoing in the Study at the Primary Completion Date|360|||
46967900|NCT04740931|83210545|FG001|Overall Study|Ongoing in the Study at the Primary Completion Date|353|||
46967901|NCT04740931|83210544|FG000|Overall Study|Withdrawal by Subject|0|||
46967902|NCT04740931|83210545|FG001|Overall Study|Withdrawal by Subject|4|||
46967903|NCT04740931|83210544|FG000|Overall Study|Death|1|||
46967904|NCT04740931|83210545|FG001|Overall Study|Death|2|||
46846095|NCT00122382|83062898|FG000|Double-Blind Study|Protocol Violation|1|||
46967905|NCT04740931|83210544|FG000|Overall Study|Noncompliance with study drug|2|||
46967906|NCT04740931|83210545|FG001|Overall Study|Noncompliance with study drug|0|||
46967907|NCT04740931|83210544|FG000|Overall Study|Reason Not Specified|2|||
46967908|NCT04740931|83210545|FG001|Overall Study|Reason Not Specified|0|||
46967909|NCT04740931|83210544|FG000|Overall Study|Adverse Event|1|||
46967910|NCT04740931|83210545|FG001|Overall Study|Adverse Event|1|||
46967911|NCT04740931|83210544|FG000|Overall Study|Protocol Violation|0|||
46967912|NCT04740931|83210545|FG001|Overall Study|Protocol Violation|1|||
46967913|NCT04740931|83210544|FG000|Overall Study|Physician Decision|0|||
46967914|NCT04740931|83210545|FG001|Overall Study|Physician Decision|1|||
46967915|NCT04740931|83210544|FG000|Overall Study|Lost to Follow-up|0|||
46967916|NCT04740931|83210545|FG001|Overall Study|Lost to Follow-up|1|||
46967917|NCT04681352|83210551|FG000|Overall Study|Lost to Follow-up|2|||
46966168|NCT04060212|83208667|FG000|Overall Study|Withdrawal by Subject|7|||
46966169|NCT04007991|83208673|FG000|Overall Study|Withdrawal by Subject|1|||
46966170|NCT04007991|83208674|FG001|Overall Study|Withdrawal by Subject|1|||
46966171|NCT04007991|83208673|FG000|Overall Study|Physician Decision|1|||
46966172|NCT04007991|83208674|FG001|Overall Study|Physician Decision|1|||
46966173|NCT04007991|83208673|FG000|Overall Study|Non-compliance with Study Drug|0|||
46966174|NCT04007991|83208674|FG001|Overall Study|Non-compliance with Study Drug|1|||
46966175|NCT04007991|83208673|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
46966176|NCT04007991|83208674|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
46966177|NCT04007991|83208673|FG000|Overall Study|Adverse event, non-fatal|5|||
46966178|NCT04007991|83208674|FG001|Overall Study|Adverse event, non-fatal|0|||
46966179|NCT04007991|83208673|FG000|Overall Study|Lost to Follow-up|2|||
46966180|NCT04007991|83208674|FG001|Overall Study|Lost to Follow-up|1|||
46966181|NCT03935217|83208695|FG000|Overall Study|Adverse Event|1|||
46966182|NCT03935217|83208696|FG001|Overall Study|Adverse Event|0|||
46966183|NCT03935217|83208695|FG000|Overall Study|Lost to Follow-up|0|||
46966184|NCT03935217|83208696|FG001|Overall Study|Lost to Follow-up|1|||
46966185|NCT03935217|83208695|FG000|Overall Study|Withdrawal by Subject|0|||
46966186|NCT03935217|83208696|FG001|Overall Study|Withdrawal by Subject|2|||
46966187|NCT03806933|83208710|FG000|Main Period|Physician Decision|0|||
46966188|NCT03806933|83208711|FG001|Main Period|Physician Decision|0|||
46966189|NCT03806933|83208712|FG002|Main Period|Physician Decision|0|||
46966190|NCT03806933|83208713|FG003|Main Period|Physician Decision|1|||
46966191|NCT03806933|83208710|FG000|Main Period|Pregnancy|0|||
46966192|NCT03806933|83208711|FG001|Main Period|Pregnancy|0|||
46966193|NCT03806933|83208712|FG002|Main Period|Pregnancy|1|||
46966194|NCT03806933|83208713|FG003|Main Period|Pregnancy|0|||
46966195|NCT03806933|83208710|FG000|Main Period|Withdrawal by Subject|2|||
46966196|NCT03806933|83208711|FG001|Main Period|Withdrawal by Subject|1|||
46966197|NCT03806933|83208712|FG002|Main Period|Withdrawal by Subject|1|||
46966198|NCT03806933|83208713|FG003|Main Period|Withdrawal by Subject|2|||
46966199|NCT03806933|83208710|FG000|Main Period|Lost to Follow-up|2|||
46966200|NCT03806933|83208711|FG001|Main Period|Lost to Follow-up|2|||
46966201|NCT03806933|83208712|FG002|Main Period|Lost to Follow-up|0|||
46966202|NCT03806933|83208713|FG003|Main Period|Lost to Follow-up|0|||
46966203|NCT03806933|83208710|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
46966204|NCT03806933|83208711|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
46966205|NCT03806933|83208712|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
46966206|NCT03806933|83208713|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
46966207|NCT03590613|83208744|FG000|Period 2, 4 Days|Physician Decision|0|||
46966208|NCT03590613|83208745|FG001|Period 2, 4 Days|Physician Decision|0|||
46966209|NCT03590613|83208746|FG002|Period 2, 4 Days|Physician Decision|0|||
47067591|NCT01530464|83351436|FG000|Washout (24h)|Withdrawal by Subject|0|||
46640926|NCT01107457|82820229|FG001|Part B and C|Sponsor Decision|0|||
46640927|NCT01107457|82820230|FG002|Part B and C|Sponsor Decision|0|||
46640928|NCT01107457|82820231|FG003|Part B and C|Sponsor Decision|0|||
46640929|NCT01107457|82820232|FG004|Part B and C|Sponsor Decision|0|||
46640930|NCT01107457|82820233|FG005|Part B and C|Sponsor Decision|66|||
46640931|NCT01107457|82820228|FG000|Part B and C|Withdrawal by Subject|0|||
46640932|NCT01107457|82820229|FG001|Part B and C|Withdrawal by Subject|0|||
46640933|NCT01107457|82820230|FG002|Part B and C|Withdrawal by Subject|0|||
46640934|NCT01107457|82820231|FG003|Part B and C|Withdrawal by Subject|0|||
46640935|NCT01107457|82820232|FG004|Part B and C|Withdrawal by Subject|0|||
46640936|NCT01107457|82820233|FG005|Part B and C|Withdrawal by Subject|16|||
46640937|NCT01107457|82820228|FG000|Part B and C|Clinical Relapse|0|||
46640938|NCT01107457|82820229|FG001|Part B and C|Clinical Relapse|0|||
46640939|NCT01107457|82820230|FG002|Part B and C|Clinical Relapse|0|||
46640940|NCT01107457|82820231|FG003|Part B and C|Clinical Relapse|0|||
46640941|NCT01107457|82820232|FG004|Part B and C|Clinical Relapse|0|||
46640942|NCT01107457|82820233|FG005|Part B and C|Clinical Relapse|4|||
46640943|NCT04545385|82820263|FG000|Overall Study|Withdrawal by Subject|2|||
47067592|NCT01530464|83351437|FG001|Washout (24h)|Withdrawal by Subject|1|||
46640944|NCT04545385|82820264|FG001|Overall Study|Withdrawal by Subject|0|||
46640945|NCT04545385|82820263|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
46640946|NCT04545385|82820264|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
46640947|NCT04545385|82820263|FG000|Overall Study|Study termination|10|||
46774971|NCT00583362|82993394|FG000|Overall Study|Behavioral problems and non-compliance|1|||
46966210|NCT03590613|83208747|FG003|Period 2, 4 Days|Physician Decision|1|||
46966211|NCT02689258|83208788|FG000|Overall Study|Subject Non-Compliance|0|||
46966212|NCT02689258|83208789|FG001|Overall Study|Subject Non-Compliance|1|||
46966213|NCT02689258|83208790|FG002|Overall Study|Subject Non-Compliance|0|||
46966214|NCT02689258|83208791|FG003|Overall Study|Subject Non-Compliance|0|||
46966215|NCT02689258|83208792|FG004|Overall Study|Subject Non-Compliance|0|||
46966216|NCT02689258|83208793|FG005|Overall Study|Subject Non-Compliance|0|||
46640948|NCT04545385|82820264|FG001|Overall Study|Study termination|10|||
46640949|NCT04545385|82820263|FG000|Overall Study|Sponsor decision|2|||
46640950|NCT04545385|82820264|FG001|Overall Study|Sponsor decision|2|||
46640951|NCT04545385|82820263|FG000|Overall Study|Other than specified|1|||
46640952|NCT04545385|82820264|FG001|Overall Study|Other than specified|0|||
46640953|NCT03783026|82820279|FG000|Treatment Phase|Adverse Event|15|||
46640954|NCT03783026|82820279|FG000|Treatment Phase|Lack of Efficacy|11|||
46640955|NCT03783026|82820279|FG000|Treatment Phase|Withdrawal by Subject|6|||
46640956|NCT03783026|82820279|FG000|Treatment Phase|Lost to Follow-up|2|||
46640957|NCT03783026|82820279|FG000|Treatment Phase|Protocol Deviation|8|||
46966217|NCT02689258|83208794|FG006|Overall Study|Subject Non-Compliance|0|||
46966218|NCT02689258|83208795|FG007|Overall Study|Subject Non-Compliance|0|||
47067593|NCT01439945|83351504|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
47067594|NCT01439945|83351505|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
47067595|NCT01439945|83351506|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
46966219|NCT02689258|83208796|FG008|Overall Study|Subject Non-Compliance|0|||
46966220|NCT02689258|83208797|FG009|Overall Study|Subject Non-Compliance|0|||
46966221|NCT02689258|83208798|FG010|Overall Study|Subject Non-Compliance|0|||
46966222|NCT02689258|83208799|FG011|Overall Study|Subject Non-Compliance|0|||
46966223|NCT02689258|83208788|FG000|Overall Study|Subject Refusal to Continue|0|||
46966224|NCT02689258|83208789|FG001|Overall Study|Subject Refusal to Continue|1|||
46966225|NCT02689258|83208790|FG002|Overall Study|Subject Refusal to Continue|0|||
46966226|NCT02689258|83208791|FG003|Overall Study|Subject Refusal to Continue|0|||
46966227|NCT02689258|83208792|FG004|Overall Study|Subject Refusal to Continue|0|||
46966228|NCT02689258|83208793|FG005|Overall Study|Subject Refusal to Continue|0|||
46966229|NCT02689258|83208794|FG006|Overall Study|Subject Refusal to Continue|0|||
46966230|NCT02689258|83208795|FG007|Overall Study|Subject Refusal to Continue|0|||
46966231|NCT02689258|83208796|FG008|Overall Study|Subject Refusal to Continue|1|||
46966232|NCT02689258|83208797|FG009|Overall Study|Subject Refusal to Continue|0|||
46966233|NCT02689258|83208798|FG010|Overall Study|Subject Refusal to Continue|0|||
46966234|NCT02689258|83208799|FG011|Overall Study|Subject Refusal to Continue|1|||
46966235|NCT02689258|83208788|FG000|Overall Study|Other|0|||
46966236|NCT02689258|83208789|FG001|Overall Study|Other|2|||
46966237|NCT02689258|83208790|FG002|Overall Study|Other|0|||
46966238|NCT02689258|83208791|FG003|Overall Study|Other|0|||
46966239|NCT02689258|83208792|FG004|Overall Study|Other|1|||
46966240|NCT02689258|83208793|FG005|Overall Study|Other|0|||
46966241|NCT02689258|83208794|FG006|Overall Study|Other|0|||
46966242|NCT02689258|83208795|FG007|Overall Study|Other|0|||
46966243|NCT02689258|83208796|FG008|Overall Study|Other|1|||
46966244|NCT02689258|83208797|FG009|Overall Study|Other|0|||
46966245|NCT02689258|83208798|FG010|Overall Study|Other|0|||
46966246|NCT02689258|83208799|FG011|Overall Study|Other|0|||
46966247|NCT02685735|83208822|FG000|Overall Study|Missing construct or pain data|23|||
46966248|NCT02685735|83208823|FG001|Overall Study|Missing construct or pain data|22|||
46966249|NCT02606136|83208848|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
46966250|NCT02606136|83208848|FG000|Overall Study|Withdrawal by Subject|1|||
46966251|NCT02292706|83208874|FG000|Overall Study|Lost to Follow-up|20|||
46966252|NCT02292706|83208875|FG001|Overall Study|Lost to Follow-up|44|||
46966253|NCT02292706|83208876|FG002|Overall Study|Lost to Follow-up|24|||
46966254|NCT02292706|83208877|FG003|Overall Study|Lost to Follow-up|61|||
46966255|NCT02292706|83208878|FG004|Overall Study|Lost to Follow-up|21|||
46966256|NCT02292706|83208879|FG005|Overall Study|Lost to Follow-up|52|||
46966257|NCT02292706|83208880|FG006|Overall Study|Lost to Follow-up|25|||
47067596|NCT01439945|83351507|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
47067597|NCT01439945|83351504|FG000|Double-Blind Treatment Phase|Ineligible|1|||
47067598|NCT01439945|83351505|FG001|Double-Blind Treatment Phase|Ineligible|2|||
47067599|NCT01439945|83351506|FG002|Double-Blind Treatment Phase|Ineligible|0|||
47067600|NCT01439945|83351507|FG003|Double-Blind Treatment Phase|Ineligible|1|||
47067601|NCT01420081|83351612|FG000|Overall Study|Death|1|||
47067602|NCT01420081|83351613|FG001|Overall Study|Death|0|||
47067603|NCT01420081|83351614|FG002|Overall Study|Death|8|||
46966258|NCT02292706|83208881|FG007|Overall Study|Lost to Follow-up|0|||
47067604|NCT01420081|83351615|FG003|Overall Study|Death|0|||
47067605|NCT01420081|83351616|FG004|Overall Study|Death|7|||
46640958|NCT03783026|82820279|FG000|Treatment Phase|Did Not Receive Treatment|1|||
46966259|NCT02292706|83208874|FG000|Overall Study|Withdrew consent|15|||
46966260|NCT02292706|83208875|FG001|Overall Study|Withdrew consent|56|||
46966261|NCT02292706|83208876|FG002|Overall Study|Withdrew consent|43|||
46640959|NCT03783026|82820279|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
46774972|NCT00583362|82993394|FG000|Overall Study|Sponsor request due to missed doses|1|||
46774973|NCT00583362|82993394|FG000|Overall Study|Physician Decision|19|||
46774974|NCT00583362|82993394|FG000|Overall Study|Protocol Violation|2|||
46774975|NCT00583362|82993394|FG000|Overall Study|Withdrawal by Subject|57|||
46774976|NCT00577473|82993400|FG000|Overall Study|Protocol Violation|1|||
46774977|NCT00577473|82993401|FG001|Overall Study|Protocol Violation|4|||
46774978|NCT00577473|82993400|FG000|Overall Study|Adverse Event|8|||
47067606|NCT01420081|83351617|FG005|Overall Study|Death|12|||
47067607|NCT01420081|83351618|FG006|Overall Study|Death|0|||
46966262|NCT02292706|83208877|FG003|Overall Study|Withdrew consent|36|||
46966263|NCT02292706|83208878|FG004|Overall Study|Withdrew consent|13|||
46966264|NCT02292706|83208879|FG005|Overall Study|Withdrew consent|51|||
46966265|NCT02292706|83208880|FG006|Overall Study|Withdrew consent|20|||
46966266|NCT02292706|83208881|FG007|Overall Study|Withdrew consent|0|||
46966267|NCT02292706|83208874|FG000|Overall Study|Death|3|||
46966268|NCT02292706|83208875|FG001|Overall Study|Death|11|||
46966269|NCT02292706|83208876|FG002|Overall Study|Death|16|||
46966270|NCT02292706|83208877|FG003|Overall Study|Death|22|||
46966271|NCT02292706|83208878|FG004|Overall Study|Death|8|||
46966272|NCT02292706|83208879|FG005|Overall Study|Death|17|||
46966273|NCT02292706|83208880|FG006|Overall Study|Death|3|||
46966274|NCT02292706|83208881|FG007|Overall Study|Death|0|||
46966275|NCT02292706|83208874|FG000|Overall Study|Study terminated by sponsor|0|||
46966276|NCT02292706|83208875|FG001|Overall Study|Study terminated by sponsor|9|||
46966277|NCT02292706|83208876|FG002|Overall Study|Study terminated by sponsor|4|||
46966278|NCT02292706|83208877|FG003|Overall Study|Study terminated by sponsor|21|||
46966279|NCT02292706|83208878|FG004|Overall Study|Study terminated by sponsor|11|||
46966280|NCT02292706|83208879|FG005|Overall Study|Study terminated by sponsor|13|||
46966281|NCT02292706|83208880|FG006|Overall Study|Study terminated by sponsor|3|||
46966282|NCT02292706|83208881|FG007|Overall Study|Study terminated by sponsor|0|||
46966283|NCT02292706|83208874|FG000|Overall Study|Investigator's discretion|4|||
46966284|NCT02292706|83208875|FG001|Overall Study|Investigator's discretion|9|||
46966285|NCT02292706|83208876|FG002|Overall Study|Investigator's discretion|7|||
46966286|NCT02292706|83208877|FG003|Overall Study|Investigator's discretion|11|||
46966287|NCT02292706|83208878|FG004|Overall Study|Investigator's discretion|4|||
46966288|NCT02292706|83208879|FG005|Overall Study|Investigator's discretion|10|||
46966289|NCT02292706|83208880|FG006|Overall Study|Investigator's discretion|1|||
46966290|NCT02292706|83208881|FG007|Overall Study|Investigator's discretion|0|||
46966291|NCT02292706|83208874|FG000|Overall Study|Liver transplant|1|||
46966292|NCT02292706|83208875|FG001|Overall Study|Liver transplant|1|||
46966293|NCT02292706|83208876|FG002|Overall Study|Liver transplant|11|||
46966294|NCT02292706|83208877|FG003|Overall Study|Liver transplant|16|||
46966295|NCT02292706|83208878|FG004|Overall Study|Liver transplant|5|||
46966296|NCT02292706|83208879|FG005|Overall Study|Liver transplant|6|||
46966297|NCT02292706|83208880|FG006|Overall Study|Liver transplant|5|||
46966298|NCT02292706|83208881|FG007|Overall Study|Liver transplant|0|||
46966299|NCT02292706|83208874|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
46966300|NCT02292706|83208875|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
46966301|NCT02292706|83208876|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
46966302|NCT02292706|83208877|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
46966303|NCT02292706|83208878|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
46966304|NCT02292706|83208879|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
46966305|NCT02292706|83208880|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
46966306|NCT02292706|83208881|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
46966307|NCT02292706|83208874|FG000|Overall Study|Subject terminated by sponsor|1|||
46966308|NCT02292706|83208875|FG001|Overall Study|Subject terminated by sponsor|0|||
46966309|NCT02292706|83208876|FG002|Overall Study|Subject terminated by sponsor|0|||
46966310|NCT02292706|83208877|FG003|Overall Study|Subject terminated by sponsor|2|||
46966311|NCT02292706|83208878|FG004|Overall Study|Subject terminated by sponsor|1|||
46966312|NCT02292706|83208879|FG005|Overall Study|Subject terminated by sponsor|0|||
46966313|NCT02292706|83208880|FG006|Overall Study|Subject terminated by sponsor|0|||
46966314|NCT02292706|83208881|FG007|Overall Study|Subject terminated by sponsor|0|||
46966315|NCT02292706|83208874|FG000|Overall Study|Missing|0|||
46966316|NCT02292706|83208875|FG001|Overall Study|Missing|0|||
46966317|NCT02292706|83208876|FG002|Overall Study|Missing|1|||
46966318|NCT02292706|83208877|FG003|Overall Study|Missing|1|||
46966319|NCT02292706|83208878|FG004|Overall Study|Missing|0|||
46966320|NCT02292706|83208879|FG005|Overall Study|Missing|1|||
46966321|NCT02292706|83208880|FG006|Overall Study|Missing|0|||
46966322|NCT02292706|83208881|FG007|Overall Study|Missing|0|||
46966323|NCT02292706|83208874|FG000|Overall Study|Virologic relapse or reinfection|1|||
46966324|NCT02292706|83208875|FG001|Overall Study|Virologic relapse or reinfection|0|||
46966325|NCT02292706|83208876|FG002|Overall Study|Virologic relapse or reinfection|0|||
46966326|NCT02292706|83208877|FG003|Overall Study|Virologic relapse or reinfection|1|||
46966327|NCT02292706|83208878|FG004|Overall Study|Virologic relapse or reinfection|0|||
46966328|NCT02292706|83208879|FG005|Overall Study|Virologic relapse or reinfection|1|||
46966329|NCT02292706|83208880|FG006|Overall Study|Virologic relapse or reinfection|0|||
46966330|NCT02292706|83208881|FG007|Overall Study|Virologic relapse or reinfection|0|||
46966331|NCT01930539|83208905|FG000|Overall Study|Withdrawal by Subject|2|||
46966332|NCT01930539|83208906|FG001|Overall Study|Withdrawal by Subject|2|||
46966333|NCT01459068|83208914|FG000|Overall Study|Withdrawal by Subject|8|||
46966334|NCT01459068|83208915|FG001|Overall Study|Withdrawal by Subject|18|||
46966335|NCT01459068|83208914|FG000|Overall Study|Lost to Follow-up|31|||
46966336|NCT01459068|83208915|FG001|Overall Study|Lost to Follow-up|15|||
46966337|NCT01459068|83208914|FG000|Overall Study|Death|0|||
46966338|NCT01459068|83208915|FG001|Overall Study|Death|1|||
46966339|NCT01216202|83208923|FG000|Overall Study|Withdrawal by Subject|8|||
46966340|NCT01216202|83208924|FG001|Overall Study|Withdrawal by Subject|0|||
46966341|NCT01216202|83208923|FG000|Overall Study|Death|0|||
46966342|NCT01216202|83208924|FG001|Overall Study|Death|2|||
46966343|NCT01216202|83208923|FG000|Overall Study|Lost to Follow-up|14|||
46966344|NCT01216202|83208924|FG001|Overall Study|Lost to Follow-up|0|||
46966345|NCT01186016|83208934|FG000|Overall Study|Withdrawal by Subject|46|||
46966346|NCT01186016|83208935|FG001|Overall Study|Withdrawal by Subject|29|||
46966347|NCT01113749|83208943|FG000|Overall Study|Lost to Follow-up|1|||
46966348|NCT01113749|83208944|FG001|Overall Study|Lost to Follow-up|2|||
46966349|NCT01060384|83208950|FG000|Overall Study|Withdrawal by Subject|0|||
46966350|NCT01060384|83208951|FG001|Overall Study|Withdrawal by Subject|1|||
46966351|NCT01060384|83208952|FG002|Overall Study|Withdrawal by Subject|0|||
46966352|NCT01060384|83208953|FG003|Overall Study|Withdrawal by Subject|0|||
46966353|NCT01060384|83208954|FG004|Overall Study|Withdrawal by Subject|0|||
46966354|NCT01060384|83208950|FG000|Overall Study|Death|0|||
46966355|NCT01060384|83208951|FG001|Overall Study|Death|0|||
46966356|NCT01060384|83208952|FG002|Overall Study|Death|0|||
46966357|NCT01060384|83208953|FG003|Overall Study|Death|0|||
46966358|NCT01060384|83208954|FG004|Overall Study|Death|1|||
46966359|NCT01060384|83208950|FG000|Overall Study|Intercurrent illness|0|||
46966360|NCT01060384|83208951|FG001|Overall Study|Intercurrent illness|0|||
46966361|NCT01060384|83208952|FG002|Overall Study|Intercurrent illness|0|||
46966362|NCT01060384|83208953|FG003|Overall Study|Intercurrent illness|0|||
46966363|NCT01060384|83208954|FG004|Overall Study|Intercurrent illness|1|||
46966364|NCT00580047|83208966|FG000|Overall Study|Lost to Follow-up|1|||
46966365|NCT00580047|83208967|FG001|Overall Study|Lost to Follow-up|1|||
46966366|NCT00580047|83208968|FG002|Overall Study|Lost to Follow-up|0|||
46966367|NCT00580047|83208966|FG000|Overall Study|Withdrawal by Subject|1|||
46966368|NCT00580047|83208967|FG001|Overall Study|Withdrawal by Subject|1|||
46966369|NCT00580047|83208968|FG002|Overall Study|Withdrawal by Subject|2|||
46966370|NCT00580047|83208966|FG000|Overall Study|Withdrawal by Subject|1|||
46966371|NCT00580047|83208967|FG001|Overall Study|Withdrawal by Subject|0|||
46966372|NCT00580047|83208968|FG002|Overall Study|Withdrawal by Subject|0|||
46966373|NCT00561340|83208981|FG000|Overall Study|refused to drink pediasure|6|||
46966374|NCT00561340|83208982|FG001|Overall Study|refused to drink pediasure|0|||
46966375|NCT00292045|83208988|FG000|Core Study (Through Week 13)|Adverse Event|1|||
46966376|NCT00292045|83208988|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
46966377|NCT00084799|83208994|FG000|Overall Study|Disease Progression|1|||
46966378|NCT00084799|83208995|FG001|Overall Study|Disease Progression|0|||
46966379|NCT00072410|83209003|FG000|Overall Study|Progressive disease|0|||
46966380|NCT00072410|83209004|FG001|Overall Study|Progressive disease|3|||
46966381|NCT00066729|83209010|FG000|Overall Study|Lost to Follow-up|1|||
46966382|NCT00066729|83209010|FG000|Overall Study|Disease progression|1|||
46966383|NCT00006046|83209028|FG000|Overall Study|Adverse Event|3|||
46966384|NCT00006046|83209029|FG001|Overall Study|Adverse Event|0|||
46966385|NCT00006046|83209030|FG002|Overall Study|Adverse Event|0|||
46966386|NCT00006046|83209031|FG003|Overall Study|Adverse Event|0|||
46966387|NCT00006046|83209032|FG004|Overall Study|Adverse Event|0|||
46966388|NCT00006046|83209028|FG000|Overall Study|Disease Progression|2|||
46966389|NCT00006046|83209029|FG001|Overall Study|Disease Progression|0|||
46966390|NCT00006046|83209030|FG002|Overall Study|Disease Progression|0|||
46966391|NCT00006046|83209031|FG003|Overall Study|Disease Progression|0|||
46966392|NCT00006046|83209032|FG004|Overall Study|Disease Progression|0|||
46966393|NCT00003102|83209047|FG000|Overall Study|Physician Decision|1|||
46966394|NCT00003102|83209048|FG001|Overall Study|Physician Decision|1|||
46966395|NCT00003102|83209049|FG002|Overall Study|Physician Decision|0|||
46966396|NCT00003102|83209047|FG000|Overall Study|Progressive Disease|0|||
46966397|NCT00003102|83209048|FG001|Overall Study|Progressive Disease|1|||
46966398|NCT00003102|83209049|FG002|Overall Study|Progressive Disease|0|||
46966399|NCT00003102|83209047|FG000|Overall Study|Adverse Event|0|||
46966400|NCT00003102|83209048|FG001|Overall Study|Adverse Event|1|||
46966401|NCT00003102|83209049|FG002|Overall Study|Adverse Event|1|||
46966402|NCT00003102|83209047|FG000|Overall Study|Death|0|||
46966403|NCT00003102|83209048|FG001|Overall Study|Death|0|||
46966404|NCT00003102|83209049|FG002|Overall Study|Death|1|||
46966405|NCT01673373|83209057|FG000|Overall Study|Death|2|||
46966406|NCT01236547|83209066|FG000|Overall Study|Protocol Violation|0|||
46966407|NCT01236547|83209067|FG001|Overall Study|Protocol Violation|1|||
46966408|NCT01236547|83209068|FG002|Overall Study|Protocol Violation|1|||
46774979|NCT00577473|82993401|FG001|Overall Study|Adverse Event|5|||
46774980|NCT00577473|82993400|FG000|Overall Study|Withdrawal by Subject|2|||
46774981|NCT00577473|82993401|FG001|Overall Study|Withdrawal by Subject|6|||
46774982|NCT00577473|82993400|FG000|Overall Study|Physician Decision|2|||
46966409|NCT01236547|83209069|FG003|Overall Study|Protocol Violation|6|||
46966410|NCT01236547|83209070|FG004|Overall Study|Protocol Violation|12|||
46966411|NCT02167945|83209083|FG000|Overall Study|Adverse Event|16|||
46966412|NCT02167945|83209083|FG000|Overall Study|Withdrew Consent|42|||
46640960|NCT03635112|82820286|FG000|Overall Study|Adverse Event|5|||
46774983|NCT00577473|82993401|FG001|Overall Study|Physician Decision|2|||
46966413|NCT02167945|83209083|FG000|Overall Study|Lost to Follow-up|122|||
46966414|NCT02167945|83209083|FG000|Overall Study|COVID-19 logistical restrictions|6|||
46966415|NCT02167945|83209083|FG000|Overall Study|Other, not specified|63|||
46966416|NCT01375075|83209101|FG000|Overall Study|Adverse Event|0|||
46966417|NCT01375075|83209102|FG001|Overall Study|Adverse Event|0|||
46966418|NCT01375075|83209103|FG002|Overall Study|Adverse Event|3|||
46966419|NCT01375075|83209104|FG003|Overall Study|Adverse Event|1|||
46966420|NCT01375075|83209105|FG004|Overall Study|Adverse Event|0|||
46966421|NCT01375075|83209106|FG005|Overall Study|Adverse Event|1|||
46966422|NCT01375075|83209101|FG000|Overall Study|Entry Criterion Not Met|1|||
46966423|NCT01375075|83209102|FG001|Overall Study|Entry Criterion Not Met|0|||
46966424|NCT01375075|83209103|FG002|Overall Study|Entry Criterion Not Met|0|||
46966425|NCT01375075|83209104|FG003|Overall Study|Entry Criterion Not Met|0|||
46966426|NCT01375075|83209105|FG004|Overall Study|Entry Criterion Not Met|0|||
46966427|NCT01375075|83209106|FG005|Overall Study|Entry Criterion Not Met|1|||
46966428|NCT01375075|83209101|FG000|Overall Study|Withdrawal by Subject|0|||
46966429|NCT01375075|83209102|FG001|Overall Study|Withdrawal by Subject|1|||
46966430|NCT01375075|83209103|FG002|Overall Study|Withdrawal by Subject|0|||
46966431|NCT01375075|83209104|FG003|Overall Study|Withdrawal by Subject|0|||
46966432|NCT01375075|83209105|FG004|Overall Study|Withdrawal by Subject|0|||
46966433|NCT01375075|83209106|FG005|Overall Study|Withdrawal by Subject|1|||
46966434|NCT00706433|83209128|FG000|Overall Study|Lost to Follow-up|3|||
46966435|NCT00706433|83209129|FG001|Overall Study|Lost to Follow-up|1|||
46966436|NCT00706433|83209130|FG002|Overall Study|Lost to Follow-up|6|||
46966437|NCT00706433|83209131|FG003|Overall Study|Lost to Follow-up|0|||
46966438|NCT00706433|83209128|FG000|Overall Study|Withdrawal by Subject|1|||
46966439|NCT00706433|83209129|FG001|Overall Study|Withdrawal by Subject|2|||
46966440|NCT00706433|83209130|FG002|Overall Study|Withdrawal by Subject|3|||
46966441|NCT00706433|83209131|FG003|Overall Study|Withdrawal by Subject|1|||
46966442|NCT00706433|83209128|FG000|Overall Study|Adverse Event|0|||
46966443|NCT00706433|83209129|FG001|Overall Study|Adverse Event|0|||
46966444|NCT00706433|83209130|FG002|Overall Study|Adverse Event|1|||
46966445|NCT00706433|83209131|FG003|Overall Study|Adverse Event|0|||
46966446|NCT00706433|83209128|FG000|Overall Study|Protocol Violation|1|||
46966447|NCT00706433|83209129|FG001|Overall Study|Protocol Violation|0|||
46966448|NCT00706433|83209130|FG002|Overall Study|Protocol Violation|0|||
46966449|NCT00706433|83209131|FG003|Overall Study|Protocol Violation|0|||
46966450|NCT00706433|83209128|FG000|Overall Study|new job|0|||
46966451|NCT00706433|83209129|FG001|Overall Study|new job|0|||
46966452|NCT00706433|83209130|FG002|Overall Study|new job|0|||
46966453|NCT00706433|83209131|FG003|Overall Study|new job|1|||
46966454|NCT02638623|83209143|FG000|Overall Study|Surgery timing|5|||
46966455|NCT02638623|83209144|FG001|Overall Study|Surgery timing|6|||
46966456|NCT02638623|83209143|FG000|Overall Study|Not given intervention|2|||
46966457|NCT02638623|83209144|FG001|Overall Study|Not given intervention|0|||
46966458|NCT02637141|83209153|FG000|Overall Study|Adverse Event|1|||
46966459|NCT02637141|83209154|FG001|Overall Study|Adverse Event|1|||
46966460|NCT02637141|83209155|FG002|Overall Study|Adverse Event|0|||
46966461|NCT02637141|83209153|FG000|Overall Study|Withdrawal by Subject|1|||
46966462|NCT02637141|83209154|FG001|Overall Study|Withdrawal by Subject|1|||
46966463|NCT02637141|83209155|FG002|Overall Study|Withdrawal by Subject|1|||
46966464|NCT02637063|83209166|FG000|Overall Study|Lost to Follow-up|3|||
46966465|NCT02637063|83209167|FG001|Overall Study|Lost to Follow-up|2|||
46966466|NCT02637063|83209168|FG002|Overall Study|Lost to Follow-up|3|||
46966467|NCT02637063|83209166|FG000|Overall Study|Withdrawal by Subject|2|||
46966468|NCT02637063|83209167|FG001|Overall Study|Withdrawal by Subject|2|||
46966469|NCT02637063|83209168|FG002|Overall Study|Withdrawal by Subject|3|||
46966470|NCT02635737|83209176|FG000|Overall Study|Protocol Violation|1|||
46966471|NCT02636907|83209180|FG000|Autoinjector Assessment Period|Adverse Event|2|||
46966472|NCT02636907|83209180|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
46966473|NCT02636907|83209180|FG000|Extension Phase|Adverse Event|2|||
46966474|NCT02636907|83209180|FG000|Extension Phase|Withdrawal by Subject|4|||
46966475|NCT02636907|83209180|FG000|Extension Phase|Physician Decision|1|||
46966476|NCT02636907|83209180|FG000|Extension Phase|Lost to Follow-up|2|||
46966477|NCT02636907|83209180|FG000|Extension Phase|Lack of Efficacy|1|||
46966478|NCT01374919|83209184|FG000|Overall Study|Withdrawal by Subject|2|||
46966479|NCT02726945|83209195|FG000|Overall Study|Withdrawal by Subject|0|||
47067608|NCT01420081|83351619|FG007|Overall Study|Death|1|||
47067609|NCT01420081|83351620|FG008|Overall Study|Death|1|||
46774984|NCT00577473|82993400|FG000|Overall Study|Lack of Efficacy|8|||
46966480|NCT02726945|83209196|FG001|Overall Study|Withdrawal by Subject|0|||
46966481|NCT02726945|83209197|FG002|Overall Study|Withdrawal by Subject|1|||
46966482|NCT02726945|83209195|FG000|Overall Study|Elected to have total knee replacement|0|||
46966483|NCT02726945|83209196|FG001|Overall Study|Elected to have total knee replacement|1|||
46966484|NCT02726945|83209197|FG002|Overall Study|Elected to have total knee replacement|0|||
46966485|NCT02635347|83209207|FG000|Overall Study|Failed screening|20|||
46966486|NCT02635347|83209208|FG001|Overall Study|Failed screening|7|||
47067610|NCT01420081|83351612|FG000|Overall Study|Lost to Follow-up|0|||
46774985|NCT00577473|82993401|FG001|Overall Study|Lack of Efficacy|7|||
46966487|NCT02726399|83209215|FG000|Overall Study|Participant Non-Compliance|1|||
46966488|NCT02726399|83209215|FG000|Overall Study|Adverse Event|2|||
46966489|NCT02726399|83209215|FG000|Overall Study|Progression of disease|4|||
46966490|NCT02634801|83209222|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
46966491|NCT02634801|83209223|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
46966492|NCT02634801|83209224|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
46966493|NCT02634801|83209222|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
46966494|NCT02634801|83209223|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
46966495|NCT02634801|83209224|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
46966496|NCT02634801|83209222|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
46966497|NCT02634801|83209223|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
46966498|NCT02634801|83209224|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
46966499|NCT02634801|83209222|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
46966500|NCT02634801|83209223|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
46966501|NCT02634801|83209224|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
46966502|NCT02634801|83209222|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
46966503|NCT02634801|83209223|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
46966504|NCT02634801|83209224|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
46966505|NCT02634801|83209222|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
46966506|NCT02634801|83209223|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
46966507|NCT02634801|83209224|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
46966508|NCT02634801|83209222|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
46966509|NCT02634801|83209223|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
46966510|NCT02634801|83209224|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
46966511|NCT02634801|83209222|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
46966512|NCT02634801|83209223|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
46966513|NCT02634801|83209224|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
46966514|NCT02634801|83209222|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
46966515|NCT02634801|83209223|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
46966516|NCT02634801|83209224|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
46966517|NCT02634801|83209222|FG000|Follow-up Period|Lost to Follow-up|3|||
46966518|NCT02634801|83209223|FG001|Follow-up Period|Lost to Follow-up|1|||
46966519|NCT02634801|83209224|FG002|Follow-up Period|Lost to Follow-up|2|||
46966520|NCT02634801|83209222|FG000|Follow-up Period|Physician Decision|0|||
46966521|NCT02634801|83209223|FG001|Follow-up Period|Physician Decision|0|||
46966522|NCT02634801|83209224|FG002|Follow-up Period|Physician Decision|1|||
46966523|NCT02634801|83209222|FG000|Follow-up Period|Withdrawal by Subject|1|||
46966524|NCT02634801|83209223|FG001|Follow-up Period|Withdrawal by Subject|2|||
46966525|NCT02634801|83209224|FG002|Follow-up Period|Withdrawal by Subject|5|||
46966526|NCT02634801|83209222|FG000|Follow-up Period|Adverse Event|1|||
46966527|NCT02634801|83209223|FG001|Follow-up Period|Adverse Event|5|||
46966528|NCT02634801|83209224|FG002|Follow-up Period|Adverse Event|0|||
46966529|NCT02724839|83209239|FG000|Overall Study|Withdrawal by Subject|1|||
46966530|NCT02724839|83209240|FG001|Overall Study|Withdrawal by Subject|1|||
46966531|NCT02724839|83209241|FG002|Overall Study|Withdrawal by Subject|0|||
46966532|NCT02724839|83209239|FG000|Overall Study|Lost to Follow-up|0|||
46966533|NCT02724839|83209240|FG001|Overall Study|Lost to Follow-up|3|||
46966534|NCT02724839|83209241|FG002|Overall Study|Lost to Follow-up|2|||
46966535|NCT02724839|83209239|FG000|Overall Study|Physician Decision|0|||
46966536|NCT02724839|83209240|FG001|Overall Study|Physician Decision|0|||
46966537|NCT02724839|83209241|FG002|Overall Study|Physician Decision|3|||
46966538|NCT01375751|83209259|FG000|Overall Study|Other|0|||
46966539|NCT01375751|83209260|FG001|Overall Study|Other|1|||
46966540|NCT01375751|83209261|FG002|Overall Study|Other|0|||
46640961|NCT03635112|82820287|FG001|Overall Study|Adverse Event|9|||
46774986|NCT00785291|82993410|FG000|Overall Study|Never began treatment|8|||
46774987|NCT00785291|82993411|FG001|Overall Study|Never began treatment|4|||
46774988|NCT00785291|82993412|FG002|Overall Study|Never began treatment|4|||
46966541|NCT00705575|83209271|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46966542|NCT00705575|83209272|FG001|Overall Study|Abnormal laboratory value(s)|3|||
46966543|NCT00705575|83209271|FG000|Overall Study|Abnormal test procedure result(s)|2|||
46966544|NCT00705575|83209272|FG001|Overall Study|Abnormal test procedure result(s)|12|||
46966545|NCT00705575|83209271|FG000|Overall Study|Adverse Event|11|||
46966546|NCT00705575|83209272|FG001|Overall Study|Adverse Event|15|||
46966547|NCT00705575|83209271|FG000|Overall Study|Lost to Follow-up|3|||
46966548|NCT00705575|83209272|FG001|Overall Study|Lost to Follow-up|4|||
46966549|NCT00705575|83209271|FG000|Overall Study|Protocol Violation|2|||
46966550|NCT00705575|83209272|FG001|Overall Study|Protocol Violation|2|||
46966551|NCT00705575|83209271|FG000|Overall Study|Withdrawal by Subject|5|||
46966552|NCT00705575|83209272|FG001|Overall Study|Withdrawal by Subject|10|||
46640962|NCT03635112|82820288|FG002|Overall Study|Adverse Event|14|||
46966553|NCT02636595|83209278|FG000|Overall Study|Lost to Follow-up|1|||
46966554|NCT02636595|83209278|FG000|Overall Study|Other|1|||
46966555|NCT02636361|83209282|FG000|Period 4|Physician Decision|0|||
46966556|NCT02636361|83209283|FG001|Period 4|Physician Decision|0|||
46966557|NCT02636361|83209284|FG002|Period 4|Physician Decision|0|||
46966558|NCT02636361|83209285|FG003|Period 4|Physician Decision|1|||
46966559|NCT02636361|83209286|FG004|Period 4|Physician Decision|0|||
46966560|NCT02636283|83209302|FG000|Overall Study|Adverse Event|2|||
46966561|NCT02636283|83209303|FG001|Overall Study|Adverse Event|0|||
46966562|NCT02636283|83209302|FG000|Overall Study|Trial Terminated Prematurely|0|||
46966563|NCT02636283|83209303|FG001|Overall Study|Trial Terminated Prematurely|3|||
46966564|NCT04430855|83209311|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
46966565|NCT04430855|83209312|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
46966566|NCT04430855|83209311|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
46966567|NCT04430855|83209312|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
46966568|NCT04430855|83209311|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
46966569|NCT04430855|83209312|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
46966570|NCT04430855|83209311|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
46966571|NCT04430855|83209312|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
46966572|NCT04430855|83209311|FG000|Period 1 (Weeks 1-12)|Other|0|||
46966573|NCT04430855|83209312|FG001|Period 1 (Weeks 1-12)|Other|1|||
46966574|NCT04430855|83209311|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
46966575|NCT04430855|83209312|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
46966576|NCT04430855|83209311|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
46966577|NCT04430855|83209312|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
46966578|NCT04430855|83209311|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
46966579|NCT04430855|83209312|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
46966580|NCT01375673|83209322|FG000|Overall Study|Withdrawal by Subject|0|||
46966581|NCT01375673|83209323|FG001|Overall Study|Withdrawal by Subject|1|||
46966582|NCT02723591|83209331|FG000|Overall Study|Adverse Event|48|||
46966583|NCT02723591|83209332|FG001|Overall Study|Adverse Event|40|||
46966584|NCT02723591|83209331|FG000|Overall Study|Death|2|||
46966585|NCT02723591|83209332|FG001|Overall Study|Death|2|||
46966586|NCT02723591|83209331|FG000|Overall Study|Lack of Efficacy|4|||
46966587|NCT02723591|83209332|FG001|Overall Study|Lack of Efficacy|3|||
46966588|NCT02723591|83209331|FG000|Overall Study|Lost to Follow-up|1|||
46966589|NCT02723591|83209332|FG001|Overall Study|Lost to Follow-up|7|||
46966590|NCT02723591|83209331|FG000|Overall Study|Protocol Violation|20|||
46966591|NCT02723591|83209332|FG001|Overall Study|Protocol Violation|23|||
46966592|NCT02723591|83209331|FG000|Overall Study|Withdrawal by Subject|4|||
46966593|NCT02723591|83209332|FG001|Overall Study|Withdrawal by Subject|8|||
46966594|NCT02723591|83209331|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
46966595|NCT02723591|83209332|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
46966596|NCT02723591|83209331|FG000|Overall Study|Miscellaneous|5|||
46966597|NCT02723591|83209332|FG001|Overall Study|Miscellaneous|6|||
46966598|NCT00705341|83209340|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
46966599|NCT00705341|83209341|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
46966600|NCT00705341|83209342|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
46966601|NCT00705341|83209343|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
46966602|NCT00705341|83209340|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
46966603|NCT00705341|83209341|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
46966604|NCT00705341|83209342|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
46966605|NCT00705341|83209343|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
46966606|NCT02723201|83209354|FG000|Second Intervention Period|Protocol Violation|1|||
46966607|NCT02723201|83209355|FG001|Second Intervention Period|Protocol Violation|0|||
47067611|NCT01420081|83351613|FG001|Overall Study|Lost to Follow-up|0|||
47067612|NCT01420081|83351614|FG002|Overall Study|Lost to Follow-up|0|||
47067613|NCT01420081|83351615|FG003|Overall Study|Lost to Follow-up|0|||
46966608|NCT02723201|83209356|FG002|Second Intervention Period|Protocol Violation|0|||
46966609|NCT02723201|83209354|FG000|Second Intervention Period|Adverse Event|1|||
46966610|NCT02723201|83209355|FG001|Second Intervention Period|Adverse Event|0|||
46966611|NCT02723201|83209356|FG002|Second Intervention Period|Adverse Event|0|||
46966612|NCT03846479|83209370|FG000|Overall Study|Death|8|||
46966613|NCT03846479|83209370|FG000|Overall Study|Lost to Follow-up|1|||
46966614|NCT00705263|83209374|FG000|Overall Study|Withdrawal by Subject|2|||
46966615|NCT00704405|83209392|FG000|Overall Study (NC Population)|Adverse Event|1|||
46966616|NCT00704405|83209393|FG001|Overall Study (NC Population)|Adverse Event|0|||
46966617|NCT00704405|83209394|FG002|Overall Study (NC Population)|Adverse Event|0|||
46966618|NCT00704405|83209395|FG003|Overall Study (NC Population)|Adverse Event|0|||
46966619|NCT00704405|83209396|FG004|Overall Study (NC Population)|Adverse Event|0|||
46966620|NCT00704405|83209392|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
46966621|NCT00704405|83209393|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
46966622|NCT00704405|83209394|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
46774989|NCT00785291|82993410|FG000|Overall Study|Adverse Event|39|||
46966623|NCT00704405|83209395|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
46966624|NCT00704405|83209396|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
46966625|NCT00704405|83209392|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
46966626|NCT00704405|83209393|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
46966627|NCT00704405|83209394|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
46966628|NCT00704405|83209395|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
46966629|NCT00704405|83209396|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
46966630|NCT00704405|83209392|FG000|Overall Study (NC Population)|Other|0|||
46966631|NCT00704405|83209393|FG001|Overall Study (NC Population)|Other|0|||
46966632|NCT00704405|83209394|FG002|Overall Study (NC Population)|Other|0|||
46966633|NCT00704405|83209395|FG003|Overall Study (NC Population)|Other|0|||
46966634|NCT00704405|83209396|FG004|Overall Study (NC Population)|Other|1|||
46966635|NCT00704405|83209392|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
46966636|NCT00704405|83209393|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
46966637|NCT00704405|83209394|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
46966638|NCT00704405|83209395|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
46966639|NCT00704405|83209396|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
46966640|NCT00704405|83209392|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
46966641|NCT00704405|83209393|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
46966642|NCT00704405|83209394|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
46966643|NCT00704405|83209395|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
46966644|NCT00704405|83209396|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
46966645|NCT01534481|83209416|FG000|Overall Study|Lost to Follow-up|29|||
46966646|NCT01534481|83209417|FG001|Overall Study|Lost to Follow-up|24|||
46966647|NCT01534481|83209416|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
46966648|NCT01534481|83209417|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
46966649|NCT00704171|83209425|FG000|Overall Study|Withdrawal by Subject|1|||
46966650|NCT00704171|83209426|FG001|Overall Study|Withdrawal by Subject|0|||
46966651|NCT00703781|83209434|FG000|Overall Study|Withdrawal by Subject|1|||
46966652|NCT00703781|83209435|FG001|Overall Study|Withdrawal by Subject|2|||
46966653|NCT00703781|83209434|FG000|Overall Study|Cancelled surgery|1|||
46966654|NCT00703781|83209435|FG001|Overall Study|Cancelled surgery|0|||
46966655|NCT00703157|83209443|FG000|Overall Study|Lost to Follow-up|0|||
46966656|NCT00703157|83209444|FG001|Overall Study|Lost to Follow-up|1|||
46966657|NCT00703157|83209443|FG000|Overall Study|source data permanently lost/ other|4|||
46966658|NCT00703157|83209444|FG001|Overall Study|source data permanently lost/ other|1|||
46966659|NCT02722967|83209455|FG000|Overall Study|Adverse Event|1|||
46966660|NCT02722967|83209456|FG001|Overall Study|Adverse Event|0|||
46966661|NCT02722967|83209457|FG002|Overall Study|Adverse Event|0|||
46966662|NCT02722967|83209455|FG000|Overall Study|Lost to Follow-up|0|||
46966663|NCT02722967|83209456|FG001|Overall Study|Lost to Follow-up|1|||
46966664|NCT02722967|83209457|FG002|Overall Study|Lost to Follow-up|0|||
46966665|NCT02722967|83209455|FG000|Overall Study|Non-compliance with patch wearing|2|||
46966666|NCT02722967|83209456|FG001|Overall Study|Non-compliance with patch wearing|1|||
46966667|NCT02722967|83209457|FG002|Overall Study|Non-compliance with patch wearing|1|||
46966668|NCT02722967|83209455|FG000|Overall Study|Withdrawal by Subject|1|||
46966669|NCT02722967|83209456|FG001|Overall Study|Withdrawal by Subject|0|||
46966670|NCT02722967|83209457|FG002|Overall Study|Withdrawal by Subject|1|||
46966671|NCT02722967|83209455|FG000|Overall Study|Physician Decision|1|||
47067614|NCT01420081|83351616|FG004|Overall Study|Lost to Follow-up|1|||
47067615|NCT01420081|83351617|FG005|Overall Study|Lost to Follow-up|1|||
47067616|NCT01420081|83351618|FG006|Overall Study|Lost to Follow-up|0|||
47067617|NCT01420081|83351619|FG007|Overall Study|Lost to Follow-up|0|||
46640963|NCT03635112|82820286|FG000|Overall Study|Lost to Follow-up|1|||
46640964|NCT03635112|82820287|FG001|Overall Study|Lost to Follow-up|0|||
46966672|NCT02722967|83209456|FG001|Overall Study|Physician Decision|0|||
46966673|NCT02722967|83209457|FG002|Overall Study|Physician Decision|0|||
46966674|NCT02722967|83209455|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
46966675|NCT02722967|83209456|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
46966676|NCT02722967|83209457|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
46966677|NCT02722499|83209468|FG000|Overall Study|Lost to Follow-up|2|||
46966678|NCT02722499|83209469|FG001|Overall Study|Lost to Follow-up|0|||
46966679|NCT02722499|83209470|FG002|Overall Study|Lost to Follow-up|1|||
46966680|NCT02721875|83209480|FG000|Overall Study|Progressive disease/relapse|1|||
46966681|NCT02721875|83209481|FG001|Overall Study|Progressive disease/relapse|0|||
46966682|NCT02721251|83209490|FG000|Overall Study|Withdrawal by Subject|8|||
46966683|NCT02721251|83209491|FG001|Overall Study|Withdrawal by Subject|7|||
46966684|NCT02721251|83209492|FG002|Overall Study|Withdrawal by Subject|9|||
46966685|NCT02721251|83209490|FG000|Overall Study|poor adherence|2|||
46966686|NCT02721251|83209491|FG001|Overall Study|poor adherence|2|||
46966687|NCT02721251|83209492|FG002|Overall Study|poor adherence|2|||
46966688|NCT00702221|83209503|FG000|Overall Study|Adverse Event|4|||
46966689|NCT00702221|83209504|FG001|Overall Study|Adverse Event|3|||
47067618|NCT01420081|83351620|FG008|Overall Study|Lost to Follow-up|0|||
46640965|NCT03635112|82820288|FG002|Overall Study|Lost to Follow-up|1|||
46966690|NCT00702143|83209513|FG000|Overall Study|Lost to Follow-up|0|||
46966691|NCT00702143|83209514|FG001|Overall Study|Lost to Follow-up|0|||
46966692|NCT00702143|83209515|FG002|Overall Study|Lost to Follow-up|1|||
46966693|NCT00702923|83209521|FG000|Overall Study|Adverse Event|1|||
46966694|NCT02633787|83209526|FG000|Overall Study|Withdrawal by Subject|1|||
46966695|NCT02719691|83209537|FG000|Overall Study|Physician Decision|0|||
46966696|NCT02719691|83209538|FG001|Overall Study|Physician Decision|0|||
46966697|NCT02719691|83209539|FG002|Overall Study|Physician Decision|1|||
46966698|NCT02719691|83209540|FG003|Overall Study|Physician Decision|0|||
46966699|NCT02719691|83209541|FG004|Overall Study|Physician Decision|0|||
46966700|NCT02719691|83209542|FG005|Overall Study|Physician Decision|0|||
46966701|NCT02719691|83209543|FG006|Overall Study|Physician Decision|0|||
46966702|NCT02719691|83209537|FG000|Overall Study|Withdrawal by Subject|0|||
46966703|NCT02719691|83209538|FG001|Overall Study|Withdrawal by Subject|0|||
46966704|NCT02719691|83209539|FG002|Overall Study|Withdrawal by Subject|0|||
46966705|NCT02719691|83209540|FG003|Overall Study|Withdrawal by Subject|0|||
46966706|NCT02719691|83209541|FG004|Overall Study|Withdrawal by Subject|0|||
46966707|NCT02719691|83209542|FG005|Overall Study|Withdrawal by Subject|1|||
46966708|NCT02719691|83209543|FG006|Overall Study|Withdrawal by Subject|0|||
46966709|NCT02720081|83209562|FG000|Overall Study|Adverse Event|0|||
46966710|NCT02720081|83209563|FG001|Overall Study|Adverse Event|3|||
46966711|NCT02720081|83209562|FG000|Overall Study|Protocol Violation|4|||
46966712|NCT02720081|83209563|FG001|Overall Study|Protocol Violation|1|||
46966713|NCT04248933|83209569|FG000|Overall Study|Lost to Follow-up|9|||
46966714|NCT04248933|83209569|FG000|Overall Study|Withdrawal by Subject|2|||
46966715|NCT02718131|83209575|FG000|Overall Study|Withdrawal by Subject|1|||
46966716|NCT02718131|83209576|FG001|Overall Study|Withdrawal by Subject|0|||
46966717|NCT02718131|83209575|FG000|Overall Study|Adverse Event|1|||
46966718|NCT02718131|83209576|FG001|Overall Study|Adverse Event|0|||
46966719|NCT02718131|83209575|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
46966720|NCT02718131|83209576|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
46966721|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
46774990|NCT00785291|82993411|FG001|Overall Study|Adverse Event|70|||
46774991|NCT00785291|82993412|FG002|Overall Study|Adverse Event|56|||
46966722|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
46966723|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
46966724|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
46966725|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
46966726|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
46966727|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
46966728|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
46966729|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
46966730|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
46966731|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
46966732|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
46966733|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
46966734|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
46966735|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
46966736|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
46966737|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
46966738|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
46966739|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
46966740|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
46966741|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
46966742|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
46966743|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
46966744|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
46966745|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
46966746|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
46966747|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
46966748|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
46774992|NCT00785291|82993410|FG000|Overall Study|Death|7|||
46966749|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
46966750|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
46966751|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
46966752|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
46966753|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
46966754|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
46640966|NCT03635112|82820286|FG000|Overall Study|Physician Decision|5|||
46640967|NCT03635112|82820287|FG001|Overall Study|Physician Decision|7|||
46640968|NCT03635112|82820288|FG002|Overall Study|Physician Decision|5|||
46640969|NCT03635112|82820286|FG000|Overall Study|Protocol Violation|0|||
46640970|NCT03635112|82820287|FG001|Overall Study|Protocol Violation|0|||
46640971|NCT03635112|82820288|FG002|Overall Study|Protocol Violation|1|||
46640972|NCT03635112|82820286|FG000|Overall Study|Study Terminated by Sponsor|11|||
46640973|NCT03635112|82820287|FG001|Overall Study|Study Terminated by Sponsor|17|||
46640974|NCT03635112|82820288|FG002|Overall Study|Study Terminated by Sponsor|21|||
46640975|NCT03635112|82820286|FG000|Overall Study|Withdrawal by Subject|4|||
46640976|NCT03635112|82820287|FG001|Overall Study|Withdrawal by Subject|9|||
46640977|NCT03635112|82820288|FG002|Overall Study|Withdrawal by Subject|7|||
46640978|NCT03635112|82820286|FG000|Overall Study|Miscellaneous|0|||
46640979|NCT03635112|82820287|FG001|Overall Study|Miscellaneous|0|||
46966755|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
46966756|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
46966757|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
46966758|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
46966759|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
46966760|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
46966761|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
46966762|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
46966763|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
46966764|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
46966765|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
46966766|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
46966767|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
46966768|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
46966769|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
46966770|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
46966771|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
46966772|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
46966773|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
46966774|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
46966775|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
46966776|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
46966777|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
46966778|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
46966779|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
46966780|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
46966781|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
46966782|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
46966783|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
46966784|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
46966785|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
46966786|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
46966787|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
46966788|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
46966789|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
46966790|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
46966791|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
46966792|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
46966793|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
46966794|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
46966795|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
46966796|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
46640980|NCT03635112|82820288|FG002|Overall Study|Miscellaneous|1|||
46640981|NCT03588728|82820301|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
46640982|NCT03588728|82820302|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
46640983|NCT03588728|82820303|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
46966797|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
46966798|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
46966799|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
46966800|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
46966801|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
46966802|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
46966803|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
46966804|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
46966805|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
46966806|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
46966807|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
46966808|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
46966809|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
46966810|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
46966811|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
46966812|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
46966813|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
46966814|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
46966815|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
46966816|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
46966817|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
46966818|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
46966819|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
46966820|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
46966821|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
46966822|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
46966823|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
46966824|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
46966825|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
46966826|NCT02717195|83209611|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
46966827|NCT02717195|83209612|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
46966828|NCT02717195|83209613|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
46966829|NCT02717195|83209614|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
46966830|NCT02717195|83209615|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
46966831|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
46966832|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
46966833|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
46966834|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
46966835|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
46966836|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
46966837|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
46966838|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
46966839|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
46966840|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
46966841|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
46966842|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
46966843|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
46966844|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
46966845|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
46966846|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
46966847|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
46966848|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
46966849|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
46966850|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
46966851|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
46966852|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
47067619|NCT01420081|83351612|FG000|Overall Study|Study Terminated by Sponsor|2|||
47067620|NCT01420081|83351613|FG001|Overall Study|Study Terminated by Sponsor|1|||
46966853|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
46966854|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
46966855|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
47067621|NCT01420081|83351614|FG002|Overall Study|Study Terminated by Sponsor|1|||
46774993|NCT00785291|82993411|FG001|Overall Study|Death|4|||
46774994|NCT00785291|82993412|FG002|Overall Study|Death|3|||
46966856|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
46966857|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
46966858|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
46966859|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
46966860|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
46966861|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
46966862|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
46966863|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
46966864|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
46966865|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
46966866|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
46966867|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
46966868|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
46966869|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
46966870|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
46966871|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
47067622|NCT01420081|83351615|FG003|Overall Study|Study Terminated by Sponsor|3|||
47067623|NCT01420081|83351616|FG004|Overall Study|Study Terminated by Sponsor|11|||
47067624|NCT01420081|83351617|FG005|Overall Study|Study Terminated by Sponsor|7|||
47067625|NCT01420081|83351618|FG006|Overall Study|Study Terminated by Sponsor|3|||
47067626|NCT01420081|83351619|FG007|Overall Study|Study Terminated by Sponsor|2|||
47067627|NCT01420081|83351620|FG008|Overall Study|Study Terminated by Sponsor|2|||
47067628|NCT01420081|83351612|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
47067629|NCT01420081|83351613|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
47067630|NCT01420081|83351614|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
47067631|NCT01420081|83351615|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
47067632|NCT01420081|83351616|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
47067633|NCT01420081|83351617|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
47067634|NCT01420081|83351618|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
47067635|NCT01420081|83351619|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
47067636|NCT01420081|83351620|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
47067637|NCT01420081|83351612|FG000|Overall Study|Other Reasons|0|||
47067638|NCT01420081|83351613|FG001|Overall Study|Other Reasons|0|||
46774995|NCT00785291|82993410|FG000|Overall Study|Withdrawal by Subject|35|||
46966872|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
46966873|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
46966874|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
46966875|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
46966876|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
46966877|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
46966878|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
46966879|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
46966880|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
46966881|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
46966882|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
46966883|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
46966884|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
46966885|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
46966886|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
47067639|NCT01420081|83351614|FG002|Overall Study|Other Reasons|1|||
47067640|NCT01420081|83351615|FG003|Overall Study|Other Reasons|0|||
47067641|NCT01420081|83351616|FG004|Overall Study|Other Reasons|0|||
46774996|NCT00785291|82993411|FG001|Overall Study|Withdrawal by Subject|36|||
46774997|NCT00785291|82993412|FG002|Overall Study|Withdrawal by Subject|17|||
46774998|NCT00785291|82993410|FG000|Overall Study|Alternative Therapy|12|||
46774999|NCT00785291|82993411|FG001|Overall Study|Alternative Therapy|6|||
46775000|NCT00785291|82993412|FG002|Overall Study|Alternative Therapy|7|||
46775001|NCT00785291|82993410|FG000|Overall Study|Complicating illness|6|||
46775002|NCT00785291|82993411|FG001|Overall Study|Complicating illness|4|||
46775003|NCT00785291|82993412|FG002|Overall Study|Complicating illness|4|||
46775004|NCT00785291|82993410|FG000|Overall Study|Other Medical Reasons|29|||
46775005|NCT00785291|82993411|FG001|Overall Study|Other Medical Reasons|25|||
46775006|NCT00785291|82993412|FG002|Overall Study|Other Medical Reasons|15|||
46775007|NCT00705939|82993423|FG000|Overall Study|Protocol Violation|0|||
46775008|NCT00705939|82993424|FG001|Overall Study|Protocol Violation|0|||
46775009|NCT00705939|82993425|FG002|Overall Study|Protocol Violation|1|||
46775010|NCT00705939|82993423|FG000|Overall Study|Withdrawal by Subject|0|||
47067642|NCT01420081|83351617|FG005|Overall Study|Other Reasons|0|||
46966887|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
46966888|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
46966889|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
46966890|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
46966891|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
46966892|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
46966893|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
46966894|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
46966895|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
46966896|NCT02717195|83209611|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
46966897|NCT02717195|83209612|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
46966898|NCT02717195|83209613|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
46966899|NCT02717195|83209614|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
46966900|NCT02717195|83209615|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
46966901|NCT00701441|83209630|FG000|Overall Study|failure in cpap compliance|0|||
46966902|NCT00701441|83209631|FG001|Overall Study|failure in cpap compliance|4|||
46966903|NCT02628873|83209643|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
46966904|NCT02628873|83209644|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
46775011|NCT00705939|82993424|FG001|Overall Study|Withdrawal by Subject|1|||
46846096|NCT00122382|83062899|FG001|Double-Blind Study|Protocol Violation|0|||
46846097|NCT00122382|83062900|FG002|Double-Blind Study|Protocol Violation|0|||
46846098|NCT00122382|83062898|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
46846099|NCT00122382|83062899|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
46846100|NCT00122382|83062900|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
46846101|NCT00122382|83062898|FG000|Double-Blind Study|Randomized but not treated|0|||
46846102|NCT00122382|83062899|FG001|Double-Blind Study|Randomized but not treated|2|||
46846103|NCT00122382|83062900|FG002|Double-Blind Study|Randomized but not treated|0|||
46846104|NCT00122382|83062898|FG000|Open-Label Study|Adverse Event|0|||
46846105|NCT00122382|83062899|FG001|Open-Label Study|Adverse Event|0|||
46846106|NCT00122382|83062900|FG002|Open-Label Study|Adverse Event|11|||
46846107|NCT00122382|83062898|FG000|Open-Label Study|Death|0|||
46846108|NCT00122382|83062899|FG001|Open-Label Study|Death|0|||
46846109|NCT00122382|83062900|FG002|Open-Label Study|Death|2|||
46846110|NCT00122382|83062898|FG000|Open-Label Study|Lack of Efficacy|0|||
46846111|NCT00122382|83062899|FG001|Open-Label Study|Lack of Efficacy|0|||
46846112|NCT00122382|83062900|FG002|Open-Label Study|Lack of Efficacy|3|||
46846113|NCT00122382|83062898|FG000|Open-Label Study|Lost to Follow-up|0|||
46846114|NCT00122382|83062899|FG001|Open-Label Study|Lost to Follow-up|0|||
46846115|NCT00122382|83062900|FG002|Open-Label Study|Lost to Follow-up|3|||
46846116|NCT00122382|83062898|FG000|Open-Label Study|Pregnancy|0|||
46846117|NCT00122382|83062899|FG001|Open-Label Study|Pregnancy|0|||
46846118|NCT00122382|83062900|FG002|Open-Label Study|Pregnancy|2|||
46846119|NCT00122382|83062898|FG000|Open-Label Study|Poor/Non-Compliance|0|||
46846120|NCT00122382|83062899|FG001|Open-Label Study|Poor/Non-Compliance|0|||
46846121|NCT00122382|83062900|FG002|Open-Label Study|Poor/Non-Compliance|1|||
46846122|NCT00122382|83062898|FG000|Open-Label Study|Withdrawal of Consent|0|||
46846123|NCT00122382|83062899|FG001|Open-Label Study|Withdrawal of Consent|0|||
46846124|NCT00122382|83062900|FG002|Open-Label Study|Withdrawal of Consent|4|||
46846125|NCT01028716|83062918|FG000|Overall Study|Physician Decision|1|||
46846126|NCT00106704|83062925|FG000|Overall Study|Adverse Event|10|||
46846127|NCT00106704|83062926|FG001|Overall Study|Adverse Event|7|||
46846128|NCT00106704|83062925|FG000|Overall Study|Death|2|||
46846129|NCT00106704|83062926|FG001|Overall Study|Death|1|||
46846130|NCT00106704|83062925|FG000|Overall Study|Lack of Efficacy|67|||
46846131|NCT00106704|83062926|FG001|Overall Study|Lack of Efficacy|69|||
46846132|NCT00106704|83062925|FG000|Overall Study|Lost to Follow-up|7|||
46846133|NCT00106704|83062926|FG001|Overall Study|Lost to Follow-up|3|||
46846134|NCT00106704|83062925|FG000|Overall Study|Pregnancy|1|||
46775012|NCT00705939|82993425|FG002|Overall Study|Withdrawal by Subject|3|||
46775013|NCT00705939|82993423|FG000|Overall Study|Physician Decision|0|||
46775014|NCT00705939|82993424|FG001|Overall Study|Physician Decision|1|||
46775015|NCT00705939|82993425|FG002|Overall Study|Physician Decision|0|||
46775016|NCT00785213|82993434|FG000|Quinine Sulfate Alone|Adverse Event|4|||
46775017|NCT00785213|82993434|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
46775018|NCT00577317|82993443|FG000|Overall Study|Study Terminated|0|||
46775019|NCT00577317|82993444|FG001|Overall Study|Study Terminated|2|||
46775020|NCT00734162|82993454|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
46775021|NCT00734162|82993455|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
46846135|NCT00106704|83062926|FG001|Overall Study|Pregnancy|0|||
46846136|NCT00106704|83062925|FG000|Overall Study|Protocol Violation|4|||
46846137|NCT00106704|83062926|FG001|Overall Study|Protocol Violation|7|||
46846138|NCT00106704|83062925|FG000|Overall Study|Withdrawal by Subject|14|||
46846139|NCT00106704|83062926|FG001|Overall Study|Withdrawal by Subject|21|||
46846140|NCT00106704|83062925|FG000|Overall Study|Patient moved|1|||
46846141|NCT00106704|83062926|FG001|Overall Study|Patient moved|0|||
46846142|NCT00106704|83062925|FG000|Overall Study|Site terminated|0|||
46846143|NCT00106704|83062926|FG001|Overall Study|Site terminated|1|||
46846144|NCT00106704|83062925|FG000|Overall Study|Planned major surgery|1|||
46846145|NCT00106704|83062926|FG001|Overall Study|Planned major surgery|0|||
46846146|NCT00106704|83062925|FG000|Overall Study|Patient Received Glycemic Medication|22|||
46846147|NCT00106704|83062926|FG001|Overall Study|Patient Received Glycemic Medication|41|||
46846148|NCT00106704|83062925|FG000|Overall Study|Unable to re-enter US|1|||
46846149|NCT00106704|83062926|FG001|Overall Study|Unable to re-enter US|0|||
46846150|NCT00106704|83062925|FG000|Overall Study|Laboratory test|1|||
46966905|NCT02628873|83209643|FG000|Second Test (1 Hour)|Physician Decision|1|||
46966906|NCT02628873|83209644|FG001|Second Test (1 Hour)|Physician Decision|0|||
46966907|NCT02629965|83209654|FG000|Period 1|Adverse Event|1|||
46966908|NCT02629965|83209655|FG001|Period 1|Adverse Event|0|||
46966909|NCT02629965|83209654|FG000|Period 1|Unexpected worsening of disease|2|||
46966910|NCT02629965|83209655|FG001|Period 1|Unexpected worsening of disease|0|||
46966911|NCT02629965|83209654|FG000|Period 1|Other than listed above|1|||
46966912|NCT02629965|83209655|FG001|Period 1|Other than listed above|2|||
46966913|NCT02629965|83209654|FG000|Period 2|Adverse Event|1|||
46966914|NCT02629965|83209655|FG001|Period 2|Adverse Event|0|||
46966915|NCT01671111|83209661|FG000|Overall Study|Adverse Event|2|||
46966916|NCT01671111|83209661|FG000|Overall Study|Lack of Efficacy|1|||
46966917|NCT01671111|83209661|FG000|Overall Study|Withdrawal by Subject|2|||
46966918|NCT01671111|83209661|FG000|Overall Study|Physician Decision|1|||
46966919|NCT01671111|83209661|FG000|Overall Study|Other|24|||
46966920|NCT01671345|83209667|FG000|Overall Study|Lost to Follow-up|10|||
46966921|NCT01671345|83209668|FG001|Overall Study|Lost to Follow-up|6|||
46966922|NCT01671345|83209667|FG000|Overall Study|visit with non-participating physician|3|||
46966923|NCT01671345|83209668|FG001|Overall Study|visit with non-participating physician|3|||
46966924|NCT03855137|83209685|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
46966925|NCT03855137|83209686|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
46966926|NCT03855137|83209687|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
46966927|NCT03855137|83209685|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
46966928|NCT03855137|83209686|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
46966929|NCT03855137|83209687|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
46966930|NCT03855137|83209685|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
46966931|NCT03855137|83209686|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
46966932|NCT03855137|83209687|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
46966933|NCT03855137|83209685|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
46966934|NCT03855137|83209686|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
46966935|NCT03855137|83209687|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
46966936|NCT03855137|83209685|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
46966937|NCT03855137|83209686|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
47067643|NCT01420081|83351618|FG006|Overall Study|Other Reasons|0|||
47067644|NCT01420081|83351619|FG007|Overall Study|Other Reasons|0|||
47067645|NCT01420081|83351620|FG008|Overall Study|Other Reasons|0|||
47067646|NCT01439867|83351638|FG000|Overall Study|Non-compliance|0|||
47067647|NCT01439867|83351639|FG001|Overall Study|Non-compliance|1|||
47067648|NCT01439867|83351638|FG000|Overall Study|Withdrawal by Subject|1|||
47067649|NCT01439867|83351639|FG001|Overall Study|Withdrawal by Subject|2|||
47067650|NCT01439867|83351638|FG000|Overall Study|Administrative Decision|4|||
47067651|NCT01439867|83351639|FG001|Overall Study|Administrative Decision|5|||
47067652|NCT01439867|83351638|FG000|Overall Study|Protocol-specified Criteria|1|||
47067653|NCT01439867|83351639|FG001|Overall Study|Protocol-specified Criteria|0|||
47067654|NCT01439711|83351656|FG000|Overall Study|Ineligible|13|||
47067655|NCT01439711|83351656|FG000|Overall Study|Cancel|3|||
47067656|NCT01439711|83351656|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
47067657|NCT01439711|83351656|FG000|Overall Study|Adverse Event|5|||
47067658|NCT01439711|83351656|FG000|Overall Study|Withdrawal by Subject|3|||
46640984|NCT03588728|82820304|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
46640985|NCT03588728|82820301|FG000|Overall Study|Lab shut down due to COVID-19|0|||
46640986|NCT03588728|82820302|FG001|Overall Study|Lab shut down due to COVID-19|0|||
47067659|NCT01439711|83351656|FG000|Overall Study|Progression During Active Tx|3|||
47067660|NCT01439711|83351656|FG000|Overall Study|Noncompliance|3|||
46640987|NCT03588728|82820303|FG002|Overall Study|Lab shut down due to COVID-19|0|||
46846151|NCT00106704|83062926|FG001|Overall Study|Laboratory test|1|||
46966938|NCT03855137|83209687|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
46966939|NCT03855137|83209685|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
46966940|NCT03855137|83209686|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
46966941|NCT03855137|83209687|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
46966942|NCT03855137|83209685|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
46966943|NCT03855137|83209686|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
46966944|NCT03855137|83209687|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
46966945|NCT03855137|83209685|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
46966946|NCT03855137|83209686|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
46966947|NCT03855137|83209687|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
46966948|NCT03855137|83209685|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
46966949|NCT03855137|83209686|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
46966950|NCT03855137|83209687|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
46966951|NCT03855137|83209685|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
46966952|NCT03855137|83209686|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
46966953|NCT03855137|83209687|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
46966954|NCT00701363|83209709|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
46966955|NCT00701363|83209710|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
46966956|NCT00701363|83209711|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
46966957|NCT00701363|83209712|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
46966958|NCT00701363|83209709|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
46966959|NCT00701363|83209710|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
46966960|NCT00701363|83209711|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
46966961|NCT00701363|83209712|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
46966962|NCT00701363|83209709|FG000|Treatment Phase 1|Adverse Event|7|||
46966963|NCT00701363|83209710|FG001|Treatment Phase 1|Adverse Event|0|||
46966964|NCT00701363|83209711|FG002|Treatment Phase 1|Adverse Event|0|||
46966965|NCT00701363|83209712|FG003|Treatment Phase 1|Adverse Event|0|||
46966966|NCT00701363|83209709|FG000|Treatment Phase 1|Protocol Violation|1|||
46966967|NCT00701363|83209710|FG001|Treatment Phase 1|Protocol Violation|0|||
46966968|NCT00701363|83209711|FG002|Treatment Phase 1|Protocol Violation|0|||
46966969|NCT00701363|83209712|FG003|Treatment Phase 1|Protocol Violation|0|||
46966970|NCT00701363|83209709|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
46966971|NCT00701363|83209710|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
46966972|NCT00701363|83209711|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
46966973|NCT00701363|83209712|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
46966974|NCT00701363|83209709|FG000|Treatment Phase 1|Lack of Efficacy|1|||
46966975|NCT00701363|83209710|FG001|Treatment Phase 1|Lack of Efficacy|0|||
46966976|NCT00701363|83209711|FG002|Treatment Phase 1|Lack of Efficacy|0|||
46966977|NCT00701363|83209712|FG003|Treatment Phase 1|Lack of Efficacy|0|||
46966978|NCT00701363|83209709|FG000|Treatment Phase 2|Adverse Event|0|||
46966979|NCT00701363|83209710|FG001|Treatment Phase 2|Adverse Event|0|||
47067661|NCT01439711|83351656|FG000|Overall Study|No MRI|9|||
47067662|NCT01439555|83351660|FG000|Overall Study|Protocol Violation|1|||
46640988|NCT03588728|82820304|FG003|Overall Study|Lab shut down due to COVID-19|1|||
46640989|NCT03588728|82820301|FG000|Overall Study|multiple technical issues|1|||
46640990|NCT03588728|82820302|FG001|Overall Study|multiple technical issues|0|||
46846152|NCT00105066|83062934|FG000|Overall Study|Adverse Event|2|||
47067663|NCT01544582|83351680|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
47067664|NCT01544582|83351681|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
47067665|NCT01544582|83351682|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
46846153|NCT00105066|83062935|FG001|Overall Study|Adverse Event|5|||
46846154|NCT00104520|83062943|FG000|Overall Study|Unrelated adverse event|34|||
46846155|NCT00104520|83062944|FG001|Overall Study|Unrelated adverse event|47|||
46846156|NCT00104520|83062943|FG000|Overall Study|Study drug intolerance|0|||
46846157|NCT00104520|83062944|FG001|Overall Study|Study drug intolerance|1|||
46846158|NCT00104520|83062943|FG000|Overall Study|Related adverse event|13|||
46846159|NCT00104520|83062944|FG001|Overall Study|Related adverse event|15|||
46846160|NCT00104520|83062943|FG000|Overall Study|Lost to Follow-up|1|||
46846161|NCT00104520|83062944|FG001|Overall Study|Lost to Follow-up|0|||
46846162|NCT00104520|83062943|FG000|Overall Study|Noncompliance|0|||
46846163|NCT00104520|83062944|FG001|Overall Study|Noncompliance|2|||
46846164|NCT00104520|83062943|FG000|Overall Study|Personal/administrative|1|||
46846165|NCT00104520|83062944|FG001|Overall Study|Personal/administrative|1|||
46846166|NCT00104520|83062943|FG000|Overall Study|Other|1|||
46846167|NCT00104520|83062944|FG001|Overall Study|Other|5|||
46846168|NCT00135330|83062953|FG000|Overall Study|Adverse Event|2|||
46846169|NCT00135330|83062954|FG001|Overall Study|Adverse Event|5|||
46846170|NCT00135330|83062955|FG002|Overall Study|Adverse Event|1|||
46846171|NCT00135330|83062953|FG000|Overall Study|Lost to Follow-up|0|||
46846172|NCT00135330|83062954|FG001|Overall Study|Lost to Follow-up|2|||
46846173|NCT00135330|83062955|FG002|Overall Study|Lost to Follow-up|3|||
46846174|NCT00135330|83062953|FG000|Overall Study|Physician Decision|1|||
46846175|NCT00135330|83062954|FG001|Overall Study|Physician Decision|1|||
46966980|NCT00701363|83209711|FG002|Treatment Phase 2|Adverse Event|1|||
46966981|NCT00701363|83209712|FG003|Treatment Phase 2|Adverse Event|0|||
46966982|NCT00701363|83209709|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
46966983|NCT00701363|83209710|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
46966984|NCT00701363|83209711|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
46966985|NCT00701363|83209712|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
46966986|NCT01670877|83209736|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
46966987|NCT01670877|83209737|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
46966988|NCT01670877|83209738|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
46966989|NCT01670877|83209739|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
46966990|NCT01670877|83209740|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
46966991|NCT01670877|83209741|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
46966992|NCT01670877|83209736|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
46966993|NCT01670877|83209737|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
46966994|NCT01670877|83209738|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
46966995|NCT01670877|83209739|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
46966996|NCT01670877|83209740|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
46966997|NCT01670877|83209741|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
46966998|NCT01670877|83209736|FG000|Part I and Part 2|Grade 2 vomiting|0|||
46966999|NCT01670877|83209737|FG001|Part I and Part 2|Grade 2 vomiting|0|||
46967000|NCT01670877|83209738|FG002|Part I and Part 2|Grade 2 vomiting|0|||
46967001|NCT01670877|83209739|FG003|Part I and Part 2|Grade 2 vomiting|1|||
46967002|NCT01670877|83209740|FG004|Part I and Part 2|Grade 2 vomiting|0|||
46967003|NCT01670877|83209741|FG005|Part I and Part 2|Grade 2 vomiting|0|||
46967004|NCT01670877|83209736|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
46967005|NCT01670877|83209737|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
46967006|NCT01670877|83209738|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
46967007|NCT01670877|83209739|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
46967008|NCT01670877|83209740|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
46967009|NCT01670877|83209741|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
46967010|NCT01670877|83209736|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
46967011|NCT01670877|83209737|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
46967012|NCT01670877|83209738|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
46967013|NCT01670877|83209739|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
46967014|NCT01670877|83209740|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
46967015|NCT01670877|83209741|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
46967016|NCT00701129|83209755|FG000|Overall Study|Death|2|||
46967017|NCT01670721|83209759|FG000|Overall Study|Participant's decision|15|||
46967018|NCT01670721|83209759|FG000|Overall Study|Other than specified above|38|||
46967019|NCT02711137|83209778|FG000|Overall Study|Death|1|||
46967020|NCT02711137|83209779|FG001|Overall Study|Death|4|||
46967021|NCT02711137|83209780|FG002|Overall Study|Death|5|||
46967022|NCT02711137|83209781|FG003|Overall Study|Death|5|||
46967023|NCT02711137|83209782|FG004|Overall Study|Death|3|||
46967024|NCT02711137|83209783|FG005|Overall Study|Death|1|||
46967025|NCT02711137|83209784|FG006|Overall Study|Death|61|||
46967026|NCT02711137|83209785|FG007|Overall Study|Death|3|||
46967027|NCT02711137|83209786|FG008|Overall Study|Death|0|||
46967028|NCT02711137|83209787|FG009|Overall Study|Death|1|||
46967029|NCT02711137|83209788|FG010|Overall Study|Death|1|||
46967030|NCT02711137|83209789|FG011|Overall Study|Death|1|||
46967031|NCT02711137|83209790|FG012|Overall Study|Death|0|||
46967032|NCT02711137|83209791|FG013|Overall Study|Death|0|||
46967033|NCT02711137|83209792|FG014|Overall Study|Death|0|||
46967034|NCT02711137|83209778|FG000|Overall Study|Study Terminated by Sponsor|0|||
46967035|NCT02711137|83209779|FG001|Overall Study|Study Terminated by Sponsor|0|||
46967036|NCT02711137|83209780|FG002|Overall Study|Study Terminated by Sponsor|1|||
46967037|NCT02711137|83209781|FG003|Overall Study|Study Terminated by Sponsor|0|||
46967038|NCT02711137|83209782|FG004|Overall Study|Study Terminated by Sponsor|0|||
46967039|NCT02711137|83209783|FG005|Overall Study|Study Terminated by Sponsor|0|||
46967040|NCT02711137|83209784|FG006|Overall Study|Study Terminated by Sponsor|1|||
46967041|NCT02711137|83209785|FG007|Overall Study|Study Terminated by Sponsor|0|||
46967042|NCT02711137|83209786|FG008|Overall Study|Study Terminated by Sponsor|0|||
46967043|NCT02711137|83209787|FG009|Overall Study|Study Terminated by Sponsor|0|||
46967044|NCT02711137|83209788|FG010|Overall Study|Study Terminated by Sponsor|0|||
46967045|NCT02711137|83209789|FG011|Overall Study|Study Terminated by Sponsor|0|||
46967046|NCT02711137|83209790|FG012|Overall Study|Study Terminated by Sponsor|0|||
46967047|NCT02711137|83209791|FG013|Overall Study|Study Terminated by Sponsor|0|||
46967048|NCT02711137|83209792|FG014|Overall Study|Study Terminated by Sponsor|0|||
46967049|NCT02711137|83209778|FG000|Overall Study|Physician Decision|1|||
46967050|NCT02711137|83209779|FG001|Overall Study|Physician Decision|0|||
46967051|NCT02711137|83209780|FG002|Overall Study|Physician Decision|2|||
46967052|NCT02711137|83209781|FG003|Overall Study|Physician Decision|1|||
46775022|NCT00734162|82993456|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
46967053|NCT02711137|83209782|FG004|Overall Study|Physician Decision|1|||
46967054|NCT02711137|83209783|FG005|Overall Study|Physician Decision|0|||
46967055|NCT02711137|83209784|FG006|Overall Study|Physician Decision|12|||
46846176|NCT00135330|83062955|FG002|Overall Study|Physician Decision|0|||
46967056|NCT02711137|83209785|FG007|Overall Study|Physician Decision|2|||
46967057|NCT02711137|83209786|FG008|Overall Study|Physician Decision|1|||
46967058|NCT02711137|83209787|FG009|Overall Study|Physician Decision|1|||
46967059|NCT02711137|83209788|FG010|Overall Study|Physician Decision|3|||
46967060|NCT02711137|83209789|FG011|Overall Study|Physician Decision|2|||
46967061|NCT02711137|83209790|FG012|Overall Study|Physician Decision|1|||
46967062|NCT02711137|83209791|FG013|Overall Study|Physician Decision|1|||
46967063|NCT02711137|83209792|FG014|Overall Study|Physician Decision|2|||
46967064|NCT02711137|83209778|FG000|Overall Study|Other|0|||
46967065|NCT02711137|83209779|FG001|Overall Study|Other|1|||
46967066|NCT02711137|83209780|FG002|Overall Study|Other|0|||
46967067|NCT02711137|83209781|FG003|Overall Study|Other|0|||
46967068|NCT02711137|83209782|FG004|Overall Study|Other|0|||
47067666|NCT01544582|83351683|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
47067667|NCT01544582|83351680|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
47067668|NCT01544582|83351681|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
47067669|NCT01544582|83351682|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
46846177|NCT00135330|83062953|FG000|Overall Study|Protocol Violation|4|||
46846178|NCT00135330|83062954|FG001|Overall Study|Protocol Violation|3|||
46846179|NCT00135330|83062955|FG002|Overall Study|Protocol Violation|3|||
46846180|NCT00135330|83062953|FG000|Overall Study|Patient Decision|5|||
47067670|NCT01544582|83351683|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
47067671|NCT01544582|83351680|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
47067672|NCT01544582|83351681|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
47067673|NCT01544582|83351682|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
47067674|NCT01544582|83351683|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
47067675|NCT01544582|83351680|FG000|Analysis Population|Physician Decision|0|||
47067676|NCT01544582|83351681|FG001|Analysis Population|Physician Decision|13|||
47067677|NCT01544582|83351682|FG002|Analysis Population|Physician Decision|10|||
47067678|NCT01544582|83351683|FG003|Analysis Population|Physician Decision|9|||
47067679|NCT01544582|83351680|FG000|Analysis Population|Safety Reason|0|||
47067680|NCT01544582|83351681|FG001|Analysis Population|Safety Reason|33|||
47067681|NCT01544582|83351682|FG002|Analysis Population|Safety Reason|31|||
47067682|NCT01544582|83351683|FG003|Analysis Population|Safety Reason|8|||
47067683|NCT01544582|83351680|FG000|Analysis Population|Effectiveness Reason|0|||
47067684|NCT01544582|83351681|FG001|Analysis Population|Effectiveness Reason|48|||
47067685|NCT01544582|83351682|FG002|Analysis Population|Effectiveness Reason|29|||
47067686|NCT01544582|83351683|FG003|Analysis Population|Effectiveness Reason|12|||
47067687|NCT01544582|83351680|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
47067688|NCT01544582|83351681|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
47067689|NCT01544582|83351682|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
47067690|NCT01544582|83351683|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
47067691|NCT01544582|83351680|FG000|Analysis Population|Lost to Follow-up|0|||
46846181|NCT00135330|83062954|FG001|Overall Study|Patient Decision|1|||
46846182|NCT00135330|83062955|FG002|Overall Study|Patient Decision|4|||
46846183|NCT00135330|83062953|FG000|Overall Study|Sponsor Decision|0|||
46846184|NCT00135330|83062954|FG001|Overall Study|Sponsor Decision|1|||
46846185|NCT00135330|83062955|FG002|Overall Study|Sponsor Decision|0|||
46846186|NCT00134784|83062967|FG000|Overall Study|Withdrawal by Subject|2|||
46846187|NCT00134784|83062968|FG001|Overall Study|Withdrawal by Subject|2|||
46846188|NCT00134784|83062969|FG002|Overall Study|Withdrawal by Subject|2|||
46846189|NCT00134784|83062970|FG003|Overall Study|Withdrawal by Subject|1|||
46967069|NCT02711137|83209783|FG005|Overall Study|Other|0|||
47067692|NCT01544582|83351681|FG001|Analysis Population|Lost to Follow-up|6|||
47067693|NCT01544582|83351682|FG002|Analysis Population|Lost to Follow-up|6|||
47067694|NCT01544582|83351683|FG003|Analysis Population|Lost to Follow-up|5|||
47067695|NCT01544582|83351680|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
47067696|NCT01544582|83351681|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
47067697|NCT01544582|83351682|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
46846190|NCT00134082|83062977|FG000|Overall Study|Adverse Event|2|||
46846191|NCT00134082|83062977|FG000|Overall Study|Death|1|||
46846192|NCT03703336|83062983|FG000|Overall Study|Parent withdrew consent|29|||
46846193|NCT03703336|83062984|FG001|Overall Study|Parent withdrew consent|8|||
46967070|NCT02711137|83209784|FG006|Overall Study|Other|3|||
46967071|NCT02711137|83209785|FG007|Overall Study|Other|0|||
47067698|NCT01544582|83351683|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
47067699|NCT01544582|83351680|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
47067700|NCT01544582|83351681|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
46967072|NCT02711137|83209786|FG008|Overall Study|Other|0|||
46967073|NCT02711137|83209787|FG009|Overall Study|Other|0|||
46846194|NCT03703336|83062983|FG000|Overall Study|Migration|3|||
46846195|NCT03703336|83062984|FG001|Overall Study|Migration|3|||
46967074|NCT02711137|83209788|FG010|Overall Study|Other|0|||
46967075|NCT02711137|83209789|FG011|Overall Study|Other|0|||
46967076|NCT02711137|83209790|FG012|Overall Study|Other|0|||
46967077|NCT02711137|83209791|FG013|Overall Study|Other|0|||
46967078|NCT02711137|83209792|FG014|Overall Study|Other|1|||
46967079|NCT02711137|83209778|FG000|Overall Study|Withdrawal by Subject|1|||
46967080|NCT02711137|83209779|FG001|Overall Study|Withdrawal by Subject|0|||
46967081|NCT02711137|83209780|FG002|Overall Study|Withdrawal by Subject|0|||
46967082|NCT02711137|83209781|FG003|Overall Study|Withdrawal by Subject|1|||
46967083|NCT02711137|83209782|FG004|Overall Study|Withdrawal by Subject|1|||
46967084|NCT02711137|83209783|FG005|Overall Study|Withdrawal by Subject|0|||
46967085|NCT02711137|83209784|FG006|Overall Study|Withdrawal by Subject|7|||
46967086|NCT02711137|83209785|FG007|Overall Study|Withdrawal by Subject|0|||
46967087|NCT02711137|83209786|FG008|Overall Study|Withdrawal by Subject|0|||
46967088|NCT02711137|83209787|FG009|Overall Study|Withdrawal by Subject|0|||
46967089|NCT02711137|83209788|FG010|Overall Study|Withdrawal by Subject|0|||
46967090|NCT02711137|83209789|FG011|Overall Study|Withdrawal by Subject|0|||
46967091|NCT02711137|83209790|FG012|Overall Study|Withdrawal by Subject|0|||
46967092|NCT02711137|83209791|FG013|Overall Study|Withdrawal by Subject|1|||
46967093|NCT02711137|83209792|FG014|Overall Study|Withdrawal by Subject|0|||
46967094|NCT02711137|83209778|FG000|Overall Study|Lost to Follow-up|1|||
46967095|NCT02711137|83209779|FG001|Overall Study|Lost to Follow-up|0|||
46967096|NCT02711137|83209780|FG002|Overall Study|Lost to Follow-up|0|||
46967097|NCT02711137|83209781|FG003|Overall Study|Lost to Follow-up|0|||
46967098|NCT02711137|83209782|FG004|Overall Study|Lost to Follow-up|0|||
46967099|NCT02711137|83209783|FG005|Overall Study|Lost to Follow-up|0|||
46967100|NCT02711137|83209784|FG006|Overall Study|Lost to Follow-up|2|||
46967101|NCT02711137|83209785|FG007|Overall Study|Lost to Follow-up|0|||
46967102|NCT02711137|83209786|FG008|Overall Study|Lost to Follow-up|0|||
46967103|NCT02711137|83209787|FG009|Overall Study|Lost to Follow-up|0|||
46967104|NCT02711137|83209788|FG010|Overall Study|Lost to Follow-up|0|||
46967105|NCT02711137|83209789|FG011|Overall Study|Lost to Follow-up|0|||
46967106|NCT02711137|83209790|FG012|Overall Study|Lost to Follow-up|0|||
46967107|NCT02711137|83209791|FG013|Overall Study|Lost to Follow-up|0|||
46967108|NCT02711137|83209792|FG014|Overall Study|Lost to Follow-up|0|||
46967109|NCT02710045|83209832|FG000|Overall Study|Death|1|||
46967110|NCT02710045|83209833|FG001|Overall Study|Death|2|||
46967111|NCT02710045|83209834|FG002|Overall Study|Death|0|||
46967112|NCT02710045|83209832|FG000|Overall Study|Withdrawal by Subject|6|||
46967113|NCT02710045|83209833|FG001|Overall Study|Withdrawal by Subject|6|||
46967114|NCT02710045|83209834|FG002|Overall Study|Withdrawal by Subject|2|||
46967115|NCT02710045|83209832|FG000|Overall Study|Protocol Violation|1|||
46967116|NCT02710045|83209833|FG001|Overall Study|Protocol Violation|2|||
46967117|NCT02710045|83209834|FG002|Overall Study|Protocol Violation|3|||
46967118|NCT02710045|83209832|FG000|Overall Study|Lost to Follow-up|3|||
46967119|NCT02710045|83209833|FG001|Overall Study|Lost to Follow-up|6|||
46967120|NCT02710045|83209834|FG002|Overall Study|Lost to Follow-up|7|||
46967121|NCT02710045|83209832|FG000|Overall Study|Physician Decision|0|||
47067701|NCT01544582|83351682|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
47067702|NCT01544582|83351683|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
47067703|NCT01544582|83351680|FG000|Analysis Population|Intolerance|0|||
47067704|NCT01544582|83351681|FG001|Analysis Population|Intolerance|1|||
47067705|NCT01544582|83351682|FG002|Analysis Population|Intolerance|0|||
47067706|NCT01544582|83351683|FG003|Analysis Population|Intolerance|0|||
47067707|NCT01544582|83351680|FG000|Analysis Population|Liver Transplantation|0|||
47067708|NCT01544582|83351681|FG001|Analysis Population|Liver Transplantation|0|||
47067709|NCT01544582|83351682|FG002|Analysis Population|Liver Transplantation|1|||
47067710|NCT01544582|83351683|FG003|Analysis Population|Liver Transplantation|0|||
47067711|NCT01544582|83351680|FG000|Analysis Population|No Social Insurance|0|||
47067712|NCT01544582|83351681|FG001|Analysis Population|No Social Insurance|0|||
47067713|NCT01544582|83351682|FG002|Analysis Population|No Social Insurance|1|||
47067714|NCT01544582|83351683|FG003|Analysis Population|No Social Insurance|0|||
47067715|NCT01544582|83351680|FG000|Analysis Population|Poor Adherence|0|||
47067716|NCT01544582|83351681|FG001|Analysis Population|Poor Adherence|0|||
47067717|NCT01544582|83351682|FG002|Analysis Population|Poor Adherence|1|||
47067718|NCT01544582|83351683|FG003|Analysis Population|Poor Adherence|0|||
46640991|NCT03588728|82820303|FG002|Overall Study|multiple technical issues|0|||
46640992|NCT03588728|82820304|FG003|Overall Study|multiple technical issues|0|||
46967122|NCT02710045|83209833|FG001|Overall Study|Physician Decision|0|||
46967123|NCT02710045|83209834|FG002|Overall Study|Physician Decision|1|||
46967124|NCT02710045|83209832|FG000|Overall Study|Poor Attendance|0|||
47067719|NCT01544582|83351680|FG000|Analysis Population|Poor Participant Compliance|0|||
47067720|NCT01544582|83351681|FG001|Analysis Population|Poor Participant Compliance|1|||
47067721|NCT01544582|83351682|FG002|Analysis Population|Poor Participant Compliance|0|||
46640993|NCT03588728|82820301|FG000|Overall Study|Hospitalized for COVID|1|||
46967125|NCT02710045|83209833|FG001|Overall Study|Poor Attendance|1|||
46967126|NCT02710045|83209834|FG002|Overall Study|Poor Attendance|0|||
46967127|NCT02714153|83209842|FG000|Overall Study|Death|1|||
46967128|NCT04369469|83209848|FG000|Overall Study|Lost to Follow-up|2|||
46967129|NCT04369469|83209849|FG001|Overall Study|Lost to Follow-up|4|||
46967130|NCT04369469|83209848|FG000|Overall Study|Physician Decision|2|||
47067722|NCT01544582|83351683|FG003|Analysis Population|Poor Participant Compliance|0|||
47067723|NCT01544582|83351680|FG000|Analysis Population|Programmed Surgery|0|||
47067724|NCT01544582|83351681|FG001|Analysis Population|Programmed Surgery|1|||
47067725|NCT01544582|83351682|FG002|Analysis Population|Programmed Surgery|0|||
47067726|NCT01544582|83351683|FG003|Analysis Population|Programmed Surgery|0|||
47067727|NCT01544582|83351680|FG000|Analysis Population|Participant in Jail|0|||
47067728|NCT01544582|83351681|FG001|Analysis Population|Participant in Jail|0|||
47067729|NCT01544582|83351682|FG002|Analysis Population|Participant in Jail|1|||
47067730|NCT01544582|83351683|FG003|Analysis Population|Participant in Jail|0|||
47067731|NCT01439165|83351711|FG000|Overall Study|Protocol Violation|3|||
47067732|NCT01439165|83351712|FG001|Overall Study|Protocol Violation|0|||
47067733|NCT01439165|83351711|FG000|Overall Study|Lost to Follow-up|11|||
47067734|NCT01439165|83351712|FG001|Overall Study|Lost to Follow-up|1|||
47067735|NCT01439165|83351711|FG000|Overall Study|Withdrawal by Subject|7|||
47067736|NCT01439165|83351712|FG001|Overall Study|Withdrawal by Subject|1|||
47067737|NCT01529606|83351726|FG000|Overall Study|Lost to Follow-up|21|||
47067738|NCT01529606|83351727|FG001|Overall Study|Lost to Follow-up|18|||
47067739|NCT01439009|83351744|FG000|Overall Study|Physician Decision|5|||
47067740|NCT01439009|83351745|FG001|Overall Study|Physician Decision|3|||
47067741|NCT01439009|83351744|FG000|Overall Study|Protocol Violation|2|||
47067742|NCT01439009|83351745|FG001|Overall Study|Protocol Violation|0|||
47067743|NCT01439009|83351744|FG000|Overall Study|Deviation of exclusion criteria|1|||
47067744|NCT01439009|83351745|FG001|Overall Study|Deviation of exclusion criteria|0|||
47067745|NCT01572389|83351764|FG000|Overall Study|Death|1|||
47067746|NCT01572389|83351765|FG001|Overall Study|Death|3|||
47067747|NCT01572389|83351764|FG000|Overall Study|Withdrawal by Subject|14|||
47067748|NCT01572389|83351765|FG001|Overall Study|Withdrawal by Subject|2|||
47067749|NCT01572389|83351764|FG000|Overall Study|Lost to Follow-up|25|||
47067750|NCT01572389|83351765|FG001|Overall Study|Lost to Follow-up|14|||
47067751|NCT01572389|83351764|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
47067752|NCT01572389|83351765|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
47067753|NCT01571453|83351777|FG000|Overall Study|Adverse Event|14|||
47067754|NCT01571453|83351778|FG001|Overall Study|Adverse Event|32|||
47067755|NCT01571453|83351777|FG000|Overall Study|Lack of Efficacy|8|||
47067756|NCT01571453|83351778|FG001|Overall Study|Lack of Efficacy|3|||
47067757|NCT01571453|83351777|FG000|Overall Study|Non-compliance|2|||
47067758|NCT01571453|83351778|FG001|Overall Study|Non-compliance|4|||
47067759|NCT01571453|83351777|FG000|Overall Study|Protocol Violation|1|||
47067760|NCT01571453|83351778|FG001|Overall Study|Protocol Violation|5|||
47067761|NCT01571453|83351777|FG000|Overall Study|Withdrawal of consent|5|||
47067762|NCT01571453|83351778|FG001|Overall Study|Withdrawal of consent|13|||
47067763|NCT01571453|83351777|FG000|Overall Study|Lost to Follow-up|4|||
47067764|NCT01571453|83351778|FG001|Overall Study|Lost to Follow-up|2|||
47067765|NCT01571453|83351777|FG000|Overall Study|Administrative or other reason(s)|4|||
47067766|NCT01571453|83351778|FG001|Overall Study|Administrative or other reason(s)|3|||
47067767|NCT01446289|83351788|FG000|Overall Study|Withdrawal by Subject|1|||
47067768|NCT01446289|83351789|FG001|Overall Study|Withdrawal by Subject|0|||
47067769|NCT01446289|83351790|FG002|Overall Study|Withdrawal by Subject|1|||
47067770|NCT01446289|83351791|FG003|Overall Study|Withdrawal by Subject|0|||
47067771|NCT01438541|83351803|FG000|Overall Study|Physician Decision|1|||
47067772|NCT01438541|83351803|FG000|Overall Study|Withdrawal by Subject|1|||
47067773|NCT01438541|83351803|FG000|Overall Study|discharge from the hospital|5|||
46640994|NCT03588728|82820302|FG001|Overall Study|Hospitalized for COVID|0|||
47067774|NCT01419769|83351807|FG000|Overall Study|Did not receive the AXIOS stent|3|||
47067775|NCT01419769|83351807|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
47067776|NCT01438307|83351813|FG000|Overall Study|Death|1|||
47067777|NCT01438307|83351814|FG001|Overall Study|Death|1|||
47067778|NCT01444651|83351822|FG000|Overall Study|Adverse Event|3|||
47067779|NCT01444651|83351823|FG001|Overall Study|Adverse Event|2|||
47067780|NCT01444651|83351822|FG000|Overall Study|Lost to Follow-up|5|||
47067781|NCT01444651|83351823|FG001|Overall Study|Lost to Follow-up|5|||
47067782|NCT01444651|83351822|FG000|Overall Study|Non-fasting|2|||
47067783|NCT01444651|83351823|FG001|Overall Study|Non-fasting|1|||
47067784|NCT01444651|83351822|FG000|Overall Study|Missing data|1|||
47067785|NCT01444651|83351823|FG001|Overall Study|Missing data|1|||
47067786|NCT01570751|83351831|FG000|Period A (16 Weeks)|Protocol Violation|1|||
47067787|NCT01570751|83351832|FG001|Period A (16 Weeks)|Protocol Violation|1|||
47067788|NCT01570751|83351831|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
46775023|NCT00734162|82993457|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
47067789|NCT01570751|83351832|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
47067790|NCT01570751|83351831|FG000|Period A (16 Weeks)|Unclassified|2|||
47067791|NCT01570751|83351832|FG001|Period A (16 Weeks)|Unclassified|3|||
47067792|NCT01570751|83351831|FG000|Period B (16 Weeks)|Adverse Event|1|||
46640995|NCT03588728|82820303|FG002|Overall Study|Hospitalized for COVID|0|||
47067793|NCT01570751|83351832|FG001|Period B (16 Weeks)|Adverse Event|0|||
47067794|NCT01570751|83351831|FG000|Period B (16 Weeks)|Protocol Violation|0|||
47067795|NCT01570751|83351832|FG001|Period B (16 Weeks)|Protocol Violation|1|||
47067796|NCT01419535|83351842|FG000|Overall Study|could not maintain iv line|1|||
47067797|NCT01419535|83351843|FG001|Overall Study|could not maintain iv line|1|||
47067798|NCT01419535|83351842|FG000|Overall Study|Withdrawal by Subject|0|||
47067799|NCT01419535|83351843|FG001|Overall Study|Withdrawal by Subject|1|||
47067800|NCT01438151|83351849|FG000|Overall Study|study terminated|8|||
47067801|NCT01418365|83351875|FG000|First Intervention|Withdrawal by Subject|0|||
47067802|NCT01418365|83351876|FG001|First Intervention|Withdrawal by Subject|1|||
47067803|NCT01418365|83351875|FG000|First Intervention|Non-compliance|1|||
47067804|NCT01418365|83351876|FG001|First Intervention|Non-compliance|0|||
47067805|NCT01418365|83351875|FG000|Second Intervention|Withdrawal by Subject|0|||
47067806|NCT01418365|83351876|FG001|Second Intervention|Withdrawal by Subject|1|||
47067807|NCT01437995|83351911|FG000|Overall Study|Lost to Follow-up|11|||
47067808|NCT01437995|83351912|FG001|Overall Study|Lost to Follow-up|18|||
47067809|NCT01437995|83351913|FG002|Overall Study|Lost to Follow-up|20|||
47067810|NCT01439347|83351962|FG000|Overall Study|Death|10|||
47067811|NCT01439347|83351963|FG001|Overall Study|Death|9|||
47067812|NCT01439347|83351962|FG000|Overall Study|Withdrawal by Subject|0|||
47067813|NCT01439347|83351963|FG001|Overall Study|Withdrawal by Subject|1|||
47067814|NCT01439347|83351962|FG000|Overall Study|Physician Decision|1|||
47067815|NCT01439347|83351963|FG001|Overall Study|Physician Decision|0|||
47067816|NCT01439347|83351962|FG000|Overall Study|Sponsor Terminated Study|2|||
47067817|NCT01439347|83351963|FG001|Overall Study|Sponsor Terminated Study|3|||
47067818|NCT01438957|83352010|FG000|Overall Study|Physician Decision|1|||
47067819|NCT01438957|83352011|FG001|Overall Study|Physician Decision|1|||
47067820|NCT01438957|83352012|FG002|Overall Study|Physician Decision|0|||
47067821|NCT01438957|83352013|FG003|Overall Study|Physician Decision|1|||
47067822|NCT01438957|83352014|FG004|Overall Study|Physician Decision|0|||
47067823|NCT01444417|83352063|FG000|Overall Study|Ineligibility Determined|0|||
47067824|NCT01444417|83352064|FG001|Overall Study|Ineligibility Determined|1|||
47067825|NCT01444417|83352063|FG000|Overall Study|Withdrawal by Subject|2|||
47067826|NCT01444417|83352064|FG001|Overall Study|Withdrawal by Subject|0|||
47067827|NCT01444027|83352091|FG000|Overall Study|Withdrawal by Subject|4|||
47067828|NCT01444027|83352092|FG001|Overall Study|Withdrawal by Subject|10|||
47067829|NCT01444027|83352093|FG002|Overall Study|Withdrawal by Subject|24|||
47067830|NCT01444027|83352091|FG000|Overall Study|Lost to Follow-up|26|||
47067831|NCT01444027|83352092|FG001|Overall Study|Lost to Follow-up|20|||
47067832|NCT01444027|83352093|FG002|Overall Study|Lost to Follow-up|14|||
47067833|NCT01438489|83352135|FG000|Overall Study|Lost to Follow-up|4|||
47067834|NCT01438489|83352136|FG001|Overall Study|Lost to Follow-up|2|||
47067835|NCT01438489|83352137|FG002|Overall Study|Lost to Follow-up|2|||
47067836|NCT01438489|83352135|FG000|Overall Study|Withdrawal by Subject|11|||
47067837|NCT01438489|83352136|FG001|Overall Study|Withdrawal by Subject|3|||
47067838|NCT01438489|83352137|FG002|Overall Study|Withdrawal by Subject|8|||
47067839|NCT01438489|83352135|FG000|Overall Study|Death|0|||
47067840|NCT01438489|83352136|FG001|Overall Study|Death|0|||
47067841|NCT01438489|83352137|FG002|Overall Study|Death|1|||
47067842|NCT01438489|83352135|FG000|Overall Study|Sponsor decision|4|||
47067843|NCT01438489|83352136|FG001|Overall Study|Sponsor decision|1|||
47067844|NCT01438489|83352137|FG002|Overall Study|Sponsor decision|4|||
47067845|NCT01438489|83352135|FG000|Overall Study|Subject choice/Subject moved|2|||
47067846|NCT01438489|83352136|FG001|Overall Study|Subject choice/Subject moved|1|||
47067847|NCT01438489|83352137|FG002|Overall Study|Subject choice/Subject moved|1|||
47067848|NCT01438489|83352135|FG000|Overall Study|Investigator decision|0|||
47067849|NCT01438489|83352136|FG001|Overall Study|Investigator decision|1|||
47067850|NCT01438489|83352137|FG002|Overall Study|Investigator decision|0|||
47067851|NCT01438489|83352135|FG000|Overall Study|AE/SAEs|2|||
47067852|NCT01438489|83352136|FG001|Overall Study|AE/SAEs|1|||
47067853|NCT01438489|83352137|FG002|Overall Study|AE/SAEs|1|||
47067854|NCT01438489|83352135|FG000|Overall Study|Received prohibited medication|1|||
47067855|NCT01438489|83352136|FG001|Overall Study|Received prohibited medication|0|||
47067856|NCT01438489|83352137|FG002|Overall Study|Received prohibited medication|0|||
47067857|NCT01438489|83352135|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
46846196|NCT03703336|83062983|FG000|Overall Study|Protocol Violation|3|||
47067858|NCT01438489|83352136|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
47067859|NCT01438489|83352137|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
47067860|NCT01438489|83352135|FG000|Overall Study|Inadequate venous access|0|||
47067861|NCT01438489|83352136|FG001|Overall Study|Inadequate venous access|2|||
47067862|NCT01438489|83352137|FG002|Overall Study|Inadequate venous access|0|||
47067863|NCT01418209|83352163|FG000|Overall Study|Withdrawal by Subject|1|||
46846197|NCT03703336|83062984|FG001|Overall Study|Protocol Violation|1|||
47067864|NCT01418209|83352164|FG001|Overall Study|Withdrawal by Subject|0|||
47067865|NCT01418209|83352165|FG002|Overall Study|Withdrawal by Subject|1|||
47067866|NCT01418209|83352163|FG000|Overall Study|Did not provide hot flash diary data|1|||
47067867|NCT01418209|83352164|FG001|Overall Study|Did not provide hot flash diary data|3|||
47067868|NCT01418209|83352165|FG002|Overall Study|Did not provide hot flash diary data|3|||
47067869|NCT01570361|83352184|FG000|Overall Study|Subject discontinued|1|||
47067870|NCT01570361|83352185|FG001|Overall Study|Subject discontinued|2|||
47067871|NCT01570361|83352184|FG000|Overall Study|Sponsor closing the study|51|||
47067872|NCT01570361|83352185|FG001|Overall Study|Sponsor closing the study|50|||
47067873|NCT01570361|83352184|FG000|Overall Study|Subject excluded|5|||
47067874|NCT01570361|83352185|FG001|Overall Study|Subject excluded|3|||
47067875|NCT01570361|83352184|FG000|Overall Study|Subject withdrew consent|14|||
47067876|NCT01570361|83352185|FG001|Overall Study|Subject withdrew consent|9|||
47067877|NCT01570361|83352184|FG000|Overall Study|Adverse Event|2|||
47067878|NCT01570361|83352185|FG001|Overall Study|Adverse Event|1|||
47067879|NCT01570361|83352184|FG000|Overall Study|Lost to Follow-up|4|||
47067880|NCT01570361|83352185|FG001|Overall Study|Lost to Follow-up|4|||
47067881|NCT01570361|83352184|FG000|Overall Study|Death|5|||
47067882|NCT01570361|83352185|FG001|Overall Study|Death|4|||
47067883|NCT01570361|83352184|FG000|Overall Study|Other|0|||
47067884|NCT01570361|83352185|FG001|Overall Study|Other|2|||
47067885|NCT01417195|83352196|FG000|Overall Study|Stimulation failure|1|||
47067886|NCT01417195|83352197|FG001|Overall Study|Stimulation failure|0|||
47067887|NCT01417195|83352196|FG000|Overall Study|No embryos for transfer|0|||
47067888|NCT01417195|83352197|FG001|Overall Study|No embryos for transfer|1|||
47067889|NCT01417195|83352196|FG000|Overall Study|No transfer due to risk of OHSS|1|||
47067890|NCT01417195|83352197|FG001|Overall Study|No transfer due to risk of OHSS|0|||
47067891|NCT01417195|83352196|FG000|Overall Study|No transfer due to elevated progesterone|1|||
47067892|NCT01417195|83352197|FG001|Overall Study|No transfer due to elevated progesterone|0|||
47067893|NCT01443403|83352230|FG000|Overall Study|Adverse Event|1|||
47067894|NCT01443403|83352231|FG001|Overall Study|Adverse Event|1|||
47067895|NCT01443403|83352232|FG002|Overall Study|Adverse Event|4|||
47067896|NCT01443403|83352233|FG003|Overall Study|Adverse Event|5|||
47067897|NCT01443403|83352230|FG000|Overall Study|Withdrawal by Subject|0|||
47067898|NCT01443403|83352231|FG001|Overall Study|Withdrawal by Subject|1|||
47067899|NCT01443403|83352232|FG002|Overall Study|Withdrawal by Subject|2|||
47067900|NCT01443403|83352233|FG003|Overall Study|Withdrawal by Subject|1|||
47067901|NCT01443403|83352230|FG000|Overall Study|Lost to Follow-up|0|||
47067902|NCT01443403|83352231|FG001|Overall Study|Lost to Follow-up|0|||
47067903|NCT01443403|83352232|FG002|Overall Study|Lost to Follow-up|0|||
47067904|NCT01443403|83352233|FG003|Overall Study|Lost to Follow-up|1|||
47067905|NCT01443403|83352230|FG000|Overall Study|Protocol Violation|2|||
47067906|NCT01443403|83352231|FG001|Overall Study|Protocol Violation|1|||
47067907|NCT01443403|83352232|FG002|Overall Study|Protocol Violation|1|||
47067908|NCT01443403|83352233|FG003|Overall Study|Protocol Violation|1|||
47067909|NCT01443403|83352230|FG000|Overall Study|Use of Prohibited Treatment|2|||
47067910|NCT01443403|83352231|FG001|Overall Study|Use of Prohibited Treatment|3|||
47067911|NCT01443403|83352232|FG002|Overall Study|Use of Prohibited Treatment|0|||
47067912|NCT01443403|83352233|FG003|Overall Study|Use of Prohibited Treatment|0|||
47067913|NCT01443403|83352230|FG000|Overall Study|Other - Miscellaneous|1|||
47067914|NCT01443403|83352231|FG001|Overall Study|Other - Miscellaneous|0|||
47067915|NCT01443403|83352232|FG002|Overall Study|Other - Miscellaneous|0|||
47067916|NCT01443403|83352233|FG003|Overall Study|Other - Miscellaneous|1|||
47067917|NCT01438177|83352246|FG000|Overall Study|Withdrawal by Subject|1|||
47067918|NCT01438177|83352246|FG000|Overall Study|Initiation of new therapy|1|||
47067919|NCT01442779|83352250|FG000|Overall Study|Withdrawal by Subject|3|||
47067920|NCT01442779|83352250|FG000|Overall Study|Death|3|||
47067921|NCT01442779|83352250|FG000|Overall Study|Non-compliance|1|||
47067922|NCT01416805|83352256|FG000|Overall Study|Lost to Follow-up|4|||
47067923|NCT01416805|83352257|FG001|Overall Study|Lost to Follow-up|4|||
47067924|NCT01437943|83352265|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
47067925|NCT01437943|83352266|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
47067926|NCT01437943|83352265|FG000|Overall Study|Subject expressed pregnancy plans|1|||
47067927|NCT01437943|83352266|FG001|Overall Study|Subject expressed pregnancy plans|0|||
47067928|NCT01437943|83352265|FG000|Overall Study|Adverse Event|2|||
47067929|NCT01437943|83352266|FG001|Overall Study|Adverse Event|0|||
47067930|NCT01570283|83352275|FG000|Cohort 1: Dose Level 1|Death|0|||
47067931|NCT01570283|83352276|FG001|Cohort 1: Dose Level 1|Death|1|||
47067932|NCT01570283|83352277|FG002|Cohort 1: Dose Level 1|Death|0|||
47067933|NCT01570283|83352278|FG003|Cohort 1: Dose Level 1|Death|0|||
46640996|NCT03588728|82820304|FG003|Overall Study|Hospitalized for COVID|0|||
47067934|NCT01570283|83352279|FG004|Cohort 1: Dose Level 1|Death|0|||
47067935|NCT01570283|83352280|FG005|Cohort 1: Dose Level 1|Death|0|||
47067936|NCT01570283|83352275|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
47067937|NCT01570283|83352276|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
47067938|NCT01570283|83352277|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
47067939|NCT01570283|83352278|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
47067940|NCT01570283|83352279|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
47067941|NCT01570283|83352280|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
47067942|NCT01570283|83352275|FG000|Cohort 2: Dose Level 2|Death|0|||
47067943|NCT01570283|83352276|FG001|Cohort 2: Dose Level 2|Death|0|||
47067944|NCT01570283|83352277|FG002|Cohort 2: Dose Level 2|Death|1|||
47067945|NCT01570283|83352278|FG003|Cohort 2: Dose Level 2|Death|0|||
47067946|NCT01570283|83352279|FG004|Cohort 2: Dose Level 2|Death|0|||
47067947|NCT01570283|83352280|FG005|Cohort 2: Dose Level 2|Death|0|||
47067948|NCT01570283|83352275|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
47067949|NCT01570283|83352276|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
47067950|NCT01570283|83352277|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
47067951|NCT01570283|83352278|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
47067952|NCT01570283|83352279|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
47067953|NCT01570283|83352280|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
47067954|NCT01570283|83352275|FG000|Cohort 3: Dose Level 3|Death|0|||
47067955|NCT01570283|83352276|FG001|Cohort 3: Dose Level 3|Death|0|||
47067956|NCT01570283|83352277|FG002|Cohort 3: Dose Level 3|Death|0|||
47067957|NCT01570283|83352278|FG003|Cohort 3: Dose Level 3|Death|0|||
47067958|NCT01570283|83352279|FG004|Cohort 3: Dose Level 3|Death|0|||
47067959|NCT01570283|83352280|FG005|Cohort 3: Dose Level 3|Death|1|||
47067960|NCT01570283|83352275|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
47067961|NCT01570283|83352276|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
47067962|NCT01570283|83352277|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
47067963|NCT01570283|83352278|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
47067964|NCT01570283|83352279|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
47067965|NCT01570283|83352280|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
47067966|NCT01436357|83352296|FG000|Overall Study|Death|5|||
47067967|NCT01436357|83352297|FG001|Overall Study|Death|1|||
47067968|NCT01436357|83352296|FG000|Overall Study|Enrolled but not vaccinated|1|||
47067969|NCT01436357|83352297|FG001|Overall Study|Enrolled but not vaccinated|1|||
47067970|NCT01436357|83352296|FG000|Overall Study|Incarceration|18|||
47067971|NCT01436357|83352297|FG001|Overall Study|Incarceration|20|||
47067972|NCT01436357|83352296|FG000|Overall Study|Lost to Follow-up|67|||
47067973|NCT01436357|83352297|FG001|Overall Study|Lost to Follow-up|61|||
47067974|NCT01436357|83352296|FG000|Overall Study|Protocol Violation|1|||
47067975|NCT01436357|83352297|FG001|Overall Study|Protocol Violation|0|||
47067976|NCT01436357|83352296|FG000|Overall Study|Withdrawal by Subject|26|||
47067977|NCT01436357|83352297|FG001|Overall Study|Withdrawal by Subject|38|||
47067978|NCT01436357|83352296|FG000|Overall Study|Physician Decision|3|||
47067979|NCT01436357|83352297|FG001|Overall Study|Physician Decision|4|||
47067980|NCT01436357|83352296|FG000|Overall Study|Moved out of area|1|||
47067981|NCT01436357|83352297|FG001|Overall Study|Moved out of area|2|||
47067982|NCT01436357|83352296|FG000|Overall Study|Subject in rehab|0|||
47067983|NCT01436357|83352297|FG001|Overall Study|Subject in rehab|1|||
47067984|NCT01436201|83352303|FG000|Overall Study|Adverse Event|2|||
47067985|NCT01436201|83352303|FG000|Overall Study|Withdrawal by Subject|1|||
47067986|NCT01436201|83352303|FG000|Overall Study|Protocol Violation|1|||
47067987|NCT01437397|83352314|FG000|Overall Study|Lost to Follow-up|9|||
47067988|NCT01437397|83352315|FG001|Overall Study|Lost to Follow-up|4|||
47067989|NCT01437397|83352316|FG002|Overall Study|Lost to Follow-up|2|||
47067990|NCT01437397|83352317|FG003|Overall Study|Lost to Follow-up|4|||
47067991|NCT01437397|83352318|FG004|Overall Study|Lost to Follow-up|5|||
46846198|NCT03703336|83062983|FG000|Overall Study|Physician Decision|2|||
47067992|NCT01437397|83352314|FG000|Overall Study|Withdrawal by Subject|11|||
47067993|NCT01437397|83352315|FG001|Overall Study|Withdrawal by Subject|12|||
47067994|NCT01437397|83352316|FG002|Overall Study|Withdrawal by Subject|24|||
47067995|NCT01437397|83352317|FG003|Overall Study|Withdrawal by Subject|11|||
47067996|NCT01437397|83352318|FG004|Overall Study|Withdrawal by Subject|22|||
47067997|NCT01437397|83352314|FG000|Overall Study|Protocol Violation|10|||
47067998|NCT01437397|83352315|FG001|Overall Study|Protocol Violation|12|||
47067999|NCT01437397|83352316|FG002|Overall Study|Protocol Violation|13|||
47068000|NCT01437397|83352317|FG003|Overall Study|Protocol Violation|21|||
47068001|NCT01437397|83352318|FG004|Overall Study|Protocol Violation|19|||
47068002|NCT01437397|83352314|FG000|Overall Study|Lack of Efficacy|5|||
47068003|NCT01437397|83352315|FG001|Overall Study|Lack of Efficacy|4|||
47068004|NCT01437397|83352316|FG002|Overall Study|Lack of Efficacy|8|||
47068005|NCT01437397|83352317|FG003|Overall Study|Lack of Efficacy|10|||
46846199|NCT03703336|83062984|FG001|Overall Study|Physician Decision|0|||
47068006|NCT01437397|83352318|FG004|Overall Study|Lack of Efficacy|20|||
47068007|NCT01437397|83352314|FG000|Overall Study|Adverse Event|21|||
47068008|NCT01437397|83352315|FG001|Overall Study|Adverse Event|22|||
47068009|NCT01437397|83352316|FG002|Overall Study|Adverse Event|16|||
46846200|NCT03703336|83062983|FG000|Overall Study|Adverse Event|0|||
47068010|NCT01437397|83352317|FG003|Overall Study|Adverse Event|14|||
47068011|NCT01437397|83352318|FG004|Overall Study|Adverse Event|21|||
47068012|NCT01437397|83352314|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
47068013|NCT01437397|83352315|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
47068014|NCT01437397|83352316|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
47068015|NCT01437397|83352317|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
47068016|NCT01437397|83352318|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
47068017|NCT01437319|83352330|FG000|Phase I|Lost to Follow-up|2|||
47068018|NCT01437319|83352331|FG001|Phase I|Lost to Follow-up|0|||
47068019|NCT01437319|83352332|FG002|Phase I|Lost to Follow-up|0|||
47068020|NCT01437319|83352330|FG000|Phase I|Protocol Violation|1|||
47068021|NCT01437319|83352331|FG001|Phase I|Protocol Violation|0|||
47068022|NCT01437319|83352332|FG002|Phase I|Protocol Violation|0|||
47068023|NCT01437319|83352330|FG000|Phase I|Study related symptoms/complaints|27|||
47068024|NCT01437319|83352331|FG001|Phase I|Study related symptoms/complaints|0|||
47068025|NCT01437319|83352332|FG002|Phase I|Study related symptoms/complaints|0|||
47068026|NCT01437319|83352330|FG000|Phase I|Withdrawal by Subject|25|||
47068027|NCT01437319|83352331|FG001|Phase I|Withdrawal by Subject|0|||
47068028|NCT01437319|83352332|FG002|Phase I|Withdrawal by Subject|0|||
47068029|NCT01437319|83352330|FG000|Phase II|Withdrawal by Subject|0|||
47068030|NCT01437319|83352331|FG001|Phase II|Withdrawal by Subject|8|||
47068031|NCT01437319|83352332|FG002|Phase II|Withdrawal by Subject|16|||
47068032|NCT01437319|83352330|FG000|Phase II|Lost to Follow-up|0|||
47068033|NCT01437319|83352331|FG001|Phase II|Lost to Follow-up|7|||
47068034|NCT01437319|83352332|FG002|Phase II|Lost to Follow-up|2|||
47068035|NCT01437319|83352330|FG000|Phase II|Study related symptoms/complaints|0|||
47068036|NCT01437319|83352331|FG001|Phase II|Study related symptoms/complaints|28|||
47068037|NCT01437319|83352332|FG002|Phase II|Study related symptoms/complaints|19|||
47068038|NCT01437319|83352330|FG000|Phase II|Protocol Violation|0|||
47068039|NCT01437319|83352331|FG001|Phase II|Protocol Violation|1|||
47068040|NCT01437319|83352332|FG002|Phase II|Protocol Violation|0|||
47068041|NCT01416571|83352341|FG000|Overall Study|Lost to Follow-up|2|||
47068042|NCT01442155|83352362|FG000|Overall Study|Complete remission|35|||
47068043|NCT01442155|83352362|FG000|Overall Study|Recurrence|26|||
47068044|NCT01442155|83352362|FG000|Overall Study|Adverse Event|2|||
47068045|NCT01442155|83352362|FG000|Overall Study|Lost to Follow-up|2|||
47068046|NCT01416181|83352368|FG000|Part 1|Other|10|||
47068047|NCT01416181|83352369|FG001|Part 1|Other|24|||
47068048|NCT01416181|83352368|FG000|Part 1|Death|0|||
47068049|NCT01416181|83352369|FG001|Part 1|Death|1|||
47068050|NCT01416181|83352368|FG000|Part 1|Investigator Decision|7|||
47068051|NCT01416181|83352369|FG001|Part 1|Investigator Decision|6|||
47068052|NCT01416181|83352368|FG000|Part 1|Withdrawal by Subject|74|||
47068053|NCT01416181|83352369|FG001|Part 1|Withdrawal by Subject|48|||
47068054|NCT01416181|83352368|FG000|Part 1|Lack of Efficacy|16|||
47068055|NCT01416181|83352369|FG001|Part 1|Lack of Efficacy|8|||
47068056|NCT01416181|83352368|FG000|Part 1|Lost to Follow-up|1|||
47068057|NCT01416181|83352369|FG001|Part 1|Lost to Follow-up|1|||
47068058|NCT01416181|83352368|FG000|Part 1|Adverse Event|15|||
47068059|NCT01416181|83352369|FG001|Part 1|Adverse Event|18|||
47068060|NCT01416181|83352368|FG000|Part 1|Ongoing in Follow-Up|14|||
47068061|NCT01416181|83352369|FG001|Part 1|Ongoing in Follow-Up|8|||
47068062|NCT01416181|83352368|FG000|Part 2|Adverse Event|11|||
47068063|NCT01416181|83352369|FG001|Part 2|Adverse Event|4|||
47068064|NCT01416181|83352368|FG000|Part 2|Other|234|||
47068065|NCT01416181|83352369|FG001|Part 2|Other|267|||
47068066|NCT01416181|83352368|FG000|Part 2|Investigator Decision|6|||
47068067|NCT01416181|83352369|FG001|Part 2|Investigator Decision|7|||
47068068|NCT01416181|83352368|FG000|Part 2|Withdrawal by Subject|14|||
46640997|NCT03588728|82820301|FG000|Overall Study|Schedule change unable to attend sessions|1|||
47068069|NCT01416181|83352369|FG001|Part 2|Withdrawal by Subject|5|||
47068070|NCT01416181|83352368|FG000|Part 2|Lack of Efficacy|4|||
47068071|NCT01416181|83352369|FG001|Part 2|Lack of Efficacy|1|||
47068072|NCT01416181|83352368|FG000|Part 2|Lost to Follow-up|2|||
47068073|NCT01416181|83352369|FG001|Part 2|Lost to Follow-up|2|||
47068074|NCT01441765|83352377|FG000|Overall Study|Death|1|||
47068075|NCT01441765|83352378|FG001|Overall Study|Death|0|||
47068076|NCT01419665|83352386|FG000|Combination Treatment|Adverse Event|7|||
47068077|NCT01419665|83352387|FG001|Combination Treatment|Adverse Event|10|||
47068078|NCT01419665|83352386|FG000|Combination Treatment|Physician Decision|5|||
47068079|NCT01419665|83352387|FG001|Combination Treatment|Physician Decision|8|||
47068080|NCT01419665|83352386|FG000|Combination Treatment|Protocol Violation|6|||
47068081|NCT01419665|83352387|FG001|Combination Treatment|Protocol Violation|2|||
46640998|NCT03588728|82820302|FG001|Overall Study|Schedule change unable to attend sessions|0|||
46846201|NCT03703336|83062984|FG001|Overall Study|Adverse Event|2|||
47068082|NCT01419665|83352386|FG000|Combination Treatment|disease progression|10|||
47068083|NCT01419665|83352387|FG001|Combination Treatment|disease progression|9|||
47068084|NCT01419665|83352386|FG000|Combination Treatment|Death|5|||
47068085|NCT01419665|83352387|FG001|Combination Treatment|Death|7|||
47068086|NCT01419665|83352386|FG000|Combination Treatment|administrative problems|0|||
47068087|NCT01419665|83352387|FG001|Combination Treatment|administrative problems|1|||
47068088|NCT01419665|83352386|FG000|Combination Treatment|Withdrawal by Subject|5|||
47068089|NCT01419665|83352387|FG001|Combination Treatment|Withdrawal by Subject|4|||
47068090|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
47068091|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
47068092|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
47068093|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
47068094|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
47068095|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
47068096|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
47068097|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
47068098|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
47068099|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
47068100|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
47068101|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
47068102|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|Death|1|||
47068103|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|Death|2|||
47068104|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
47068105|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
47068106|NCT01419665|83352386|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
47068107|NCT01419665|83352387|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
47068108|NCT01419665|83352386|FG000|Open Label Phase|Death|1|||
47068109|NCT01419665|83352387|FG001|Open Label Phase|Death|0|||
47068110|NCT01419665|83352386|FG000|Open Label Phase|disease progression|0|||
47068111|NCT01419665|83352387|FG001|Open Label Phase|disease progression|1|||
47068112|NCT01436305|83352398|FG000|Overall Study|Death|1|||
47068113|NCT01436305|83352399|FG001|Overall Study|Death|0|||
47068114|NCT01436305|83352400|FG002|Overall Study|Death|0|||
47068115|NCT01436305|83352398|FG000|Overall Study|Lost to Follow-up|0|||
47068116|NCT01436305|83352399|FG001|Overall Study|Lost to Follow-up|1|||
47068117|NCT01436305|83352400|FG002|Overall Study|Lost to Follow-up|0|||
47068118|NCT01436305|83352398|FG000|Overall Study|Withdrawal by Subject|1|||
47068119|NCT01436305|83352399|FG001|Overall Study|Withdrawal by Subject|3|||
47068120|NCT01436305|83352400|FG002|Overall Study|Withdrawal by Subject|0|||
47068121|NCT01436149|83352410|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
47068122|NCT01436149|83352411|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
47068123|NCT01436149|83352412|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
47068124|NCT01436149|83352410|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
47068125|NCT01436149|83352411|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
47068126|NCT01436149|83352412|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
47068127|NCT01436149|83352410|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
47068128|NCT01436149|83352411|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
47068129|NCT01436149|83352412|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
47068130|NCT01436149|83352410|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
47068131|NCT01436149|83352411|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
47068132|NCT01436149|83352412|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
47068133|NCT01436149|83352410|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
47068134|NCT01436149|83352411|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
47068135|NCT01436149|83352412|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
47068136|NCT01436149|83352410|FG000|Antidepressant Lead-in Phase|Other|119|||
47068137|NCT01436149|83352411|FG001|Antidepressant Lead-in Phase|Other|0|||
46846202|NCT03703336|83062983|FG000|Overall Study|Lost to Follow-up|1|||
46846203|NCT03703336|83062984|FG001|Overall Study|Lost to Follow-up|0|||
46846204|NCT03702166|83062990|FG000|Overall Study|Lost to Follow-up|1|||
46846205|NCT03702166|83062990|FG000|Overall Study|Withdrawal by Subject|1|||
46846206|NCT00132678|83062997|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
47068138|NCT01436149|83352412|FG002|Antidepressant Lead-in Phase|Other|0|||
47068139|NCT01436149|83352410|FG000|Randomized Phase|Adverse Event|9|||
47068140|NCT01436149|83352411|FG001|Randomized Phase|Adverse Event|10|||
47068141|NCT01436149|83352412|FG002|Randomized Phase|Adverse Event|11|||
46775024|NCT00734162|82993454|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
46775025|NCT00734162|82993455|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
46775026|NCT00734162|82993456|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
46775027|NCT00734162|82993457|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
46775028|NCT00734162|82993454|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
46775029|NCT00734162|82993455|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
46775030|NCT00734162|82993456|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
46775031|NCT00734162|82993457|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
46775032|NCT00734162|82993454|FG000|Open-Label Phase|Withdrew Consent|1|||
46775033|NCT00734162|82993455|FG001|Open-Label Phase|Withdrew Consent|0|||
46775034|NCT00734162|82993456|FG002|Open-Label Phase|Withdrew Consent|1|||
46775035|NCT00734162|82993457|FG003|Open-Label Phase|Withdrew Consent|1|||
46775036|NCT00734162|82993454|FG000|Open-Label Phase|Lost to Follow-up|1|||
46775037|NCT00734162|82993455|FG001|Open-Label Phase|Lost to Follow-up|2|||
46846207|NCT00132678|83062998|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
46846208|NCT00132678|83062999|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
46846209|NCT00132678|83062997|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
47068142|NCT01436149|83352410|FG000|Randomized Phase|Protocol Violation|4|||
47068143|NCT01436149|83352411|FG001|Randomized Phase|Protocol Violation|5|||
47068144|NCT01436149|83352412|FG002|Randomized Phase|Protocol Violation|0|||
47068145|NCT01436149|83352410|FG000|Randomized Phase|Withdrawal by Subject|16|||
47068146|NCT01436149|83352411|FG001|Randomized Phase|Withdrawal by Subject|10|||
47068147|NCT01436149|83352412|FG002|Randomized Phase|Withdrawal by Subject|10|||
47068148|NCT01436149|83352410|FG000|Randomized Phase|Lost to Follow-up|34|||
47068149|NCT01436149|83352411|FG001|Randomized Phase|Lost to Follow-up|5|||
47068150|NCT01436149|83352412|FG002|Randomized Phase|Lost to Follow-up|6|||
47068151|NCT01436149|83352410|FG000|Randomized Phase|Lack of Efficacy|0|||
47068152|NCT01436149|83352411|FG001|Randomized Phase|Lack of Efficacy|0|||
47068153|NCT01436149|83352412|FG002|Randomized Phase|Lack of Efficacy|1|||
47068154|NCT01436149|83352410|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
47068155|NCT01436149|83352411|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
47068156|NCT01436149|83352412|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
47068157|NCT01436149|83352410|FG000|Randomized Phase|Other|12|||
47068158|NCT01436149|83352411|FG001|Randomized Phase|Other|5|||
47068159|NCT01436149|83352412|FG002|Randomized Phase|Other|11|||
47068160|NCT01415401|83352418|FG000|Overall Study|Adverse Event|5|||
47068161|NCT01415401|83352418|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
47068162|NCT01415401|83352418|FG000|Overall Study|Terminated by Sponsor|1|||
47068163|NCT01414855|83352422|FG000|Overall Study|Death|17|||
47068164|NCT01414855|83352422|FG000|Overall Study|Lost to Follow-up|5|||
47068165|NCT01414855|83352422|FG000|Overall Study|Withdrawal by Subject|7|||
47068166|NCT01527500|83352430|FG000|Part A|Administrative|11|||
47068167|NCT01527500|83352431|FG001|Part A|Administrative|7|||
47068168|NCT01527500|83352430|FG000|Part A|Adverse Event|4|||
47068169|NCT01527500|83352431|FG001|Part A|Adverse Event|2|||
47068170|NCT01527500|83352430|FG000|Part A|Death|4|||
47068171|NCT01527500|83352431|FG001|Part A|Death|1|||
47068172|NCT01527500|83352430|FG000|Part A|Lost to Follow-up|0|||
47068173|NCT01527500|83352431|FG001|Part A|Lost to Follow-up|1|||
47068174|NCT01527500|83352430|FG000|Part A|Protocol Deviation|9|||
47068175|NCT01527500|83352431|FG001|Part A|Protocol Deviation|2|||
47068176|NCT01527500|83352430|FG000|Part A|Withdrawal by Subject|2|||
47068177|NCT01527500|83352431|FG001|Part A|Withdrawal by Subject|0|||
47068178|NCT01527500|83352430|FG000|Part B|Adverse Event|1|||
47068179|NCT01527500|83352431|FG001|Part B|Adverse Event|0|||
47068180|NCT01527110|83352456|FG000|Overall Study|Adverse Event|1|||
47068181|NCT01441063|83352460|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
47068182|NCT01441063|83352460|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
47068183|NCT01436071|83352469|FG000|Overall Study|Adverse Event|1|||
47068184|NCT01436071|83352470|FG001|Overall Study|Adverse Event|0|||
47068185|NCT01436071|83352469|FG000|Overall Study|Lack of Efficacy|16|||
47068186|NCT01436071|83352470|FG001|Overall Study|Lack of Efficacy|7|||
47068187|NCT01436071|83352469|FG000|Overall Study|Protocol Violation|0|||
47068188|NCT01436071|83352470|FG001|Overall Study|Protocol Violation|1|||
47068189|NCT01436071|83352469|FG000|Overall Study|Lost to Follow-up|3|||
47068190|NCT01436071|83352470|FG001|Overall Study|Lost to Follow-up|1|||
47068191|NCT01436071|83352469|FG000|Overall Study|Physician Decision|1|||
47068192|NCT01436071|83352470|FG001|Overall Study|Physician Decision|0|||
47068193|NCT01436071|83352469|FG000|Overall Study|Withdrawal by Subject|2|||
47068194|NCT01436071|83352470|FG001|Overall Study|Withdrawal by Subject|2|||
47068195|NCT01436071|83352469|FG000|Overall Study|Did Not Receive Trial Medication|3|||
47068196|NCT01436071|83352470|FG001|Overall Study|Did Not Receive Trial Medication|3|||
47068197|NCT01514240|83352478|FG000|Overall Study|Adverse Event|4|||
47068198|NCT01514240|83352479|FG001|Overall Study|Adverse Event|4|||
46967131|NCT04369469|83209849|FG001|Overall Study|Physician Decision|1|||
46967132|NCT04369469|83209848|FG000|Overall Study|Withdrawal by Subject|2|||
46967133|NCT04369469|83209849|FG001|Overall Study|Withdrawal by Subject|3|||
47068199|NCT01514240|83352478|FG000|Overall Study|Subject Decision|2|||
47068200|NCT01514240|83352479|FG001|Overall Study|Subject Decision|7|||
47068201|NCT01435759|83352490|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
47068202|NCT01435759|83352491|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
47068203|NCT01435759|83352492|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
46775038|NCT00734162|82993456|FG002|Open-Label Phase|Lost to Follow-up|0|||
47068204|NCT01435759|83352493|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
47068205|NCT01435759|83352494|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
47068206|NCT01435759|83352495|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
47068207|NCT01435759|83352490|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
47068208|NCT01435759|83352491|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
47068209|NCT01435759|83352492|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
47068210|NCT01435759|83352493|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
47068211|NCT01435759|83352494|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
47068212|NCT01435759|83352495|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
46967134|NCT04369469|83209848|FG000|Overall Study|Adverse Event|1|||
46967135|NCT04369469|83209849|FG001|Overall Study|Adverse Event|0|||
47068213|NCT01435759|83352490|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
47068214|NCT01435759|83352491|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
47068215|NCT01435759|83352492|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
47068216|NCT01435759|83352493|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
47068217|NCT01435759|83352494|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
47068218|NCT01435759|83352495|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
47068219|NCT01435759|83352490|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
47068220|NCT01435759|83352491|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
47068221|NCT01435759|83352492|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
47068222|NCT01435759|83352493|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
47068223|NCT01435759|83352494|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
47068224|NCT01435759|83352495|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
47068225|NCT01435759|83352490|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
47068226|NCT01435759|83352491|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068227|NCT01435759|83352492|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068228|NCT01435759|83352493|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068229|NCT01435759|83352494|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068230|NCT01435759|83352495|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068231|NCT01435759|83352490|FG000|Antidepressant Lead-in Phase|Other|119|||
47068232|NCT01435759|83352491|FG001|Antidepressant Lead-in Phase|Other|0|||
47068233|NCT01435759|83352492|FG002|Antidepressant Lead-in Phase|Other|0|||
47068234|NCT01435759|83352493|FG003|Antidepressant Lead-in Phase|Other|0|||
47068235|NCT01435759|83352494|FG004|Antidepressant Lead-in Phase|Other|0|||
47068236|NCT01435759|83352495|FG005|Antidepressant Lead-in Phase|Other|0|||
47068237|NCT01435759|83352490|FG000|Double-blind Phase|Adverse Event|7|||
47068238|NCT01435759|83352491|FG001|Double-blind Phase|Adverse Event|0|||
47068239|NCT01435759|83352492|FG002|Double-blind Phase|Adverse Event|1|||
47068240|NCT01435759|83352493|FG003|Double-blind Phase|Adverse Event|1|||
47068241|NCT01435759|83352494|FG004|Double-blind Phase|Adverse Event|1|||
47068242|NCT01435759|83352495|FG005|Double-blind Phase|Adverse Event|3|||
47068243|NCT01435759|83352490|FG000|Double-blind Phase|Protocol Violation|2|||
47068244|NCT01435759|83352491|FG001|Double-blind Phase|Protocol Violation|0|||
47068245|NCT01435759|83352492|FG002|Double-blind Phase|Protocol Violation|1|||
47068246|NCT01435759|83352493|FG003|Double-blind Phase|Protocol Violation|2|||
47068247|NCT01435759|83352494|FG004|Double-blind Phase|Protocol Violation|0|||
47068248|NCT01435759|83352495|FG005|Double-blind Phase|Protocol Violation|1|||
47068249|NCT01435759|83352490|FG000|Double-blind Phase|Withdrawal by Subject|17|||
47068250|NCT01435759|83352491|FG001|Double-blind Phase|Withdrawal by Subject|4|||
47068251|NCT01435759|83352492|FG002|Double-blind Phase|Withdrawal by Subject|3|||
47068252|NCT01435759|83352493|FG003|Double-blind Phase|Withdrawal by Subject|4|||
47068253|NCT01435759|83352494|FG004|Double-blind Phase|Withdrawal by Subject|2|||
47068254|NCT01435759|83352495|FG005|Double-blind Phase|Withdrawal by Subject|2|||
47068255|NCT01435759|83352490|FG000|Double-blind Phase|Lost to Follow-up|31|||
47068256|NCT01435759|83352491|FG001|Double-blind Phase|Lost to Follow-up|1|||
47068257|NCT01435759|83352492|FG002|Double-blind Phase|Lost to Follow-up|2|||
47068258|NCT01435759|83352493|FG003|Double-blind Phase|Lost to Follow-up|0|||
47068259|NCT01435759|83352494|FG004|Double-blind Phase|Lost to Follow-up|3|||
47068260|NCT01435759|83352495|FG005|Double-blind Phase|Lost to Follow-up|3|||
47068261|NCT01435759|83352490|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
47068262|NCT01435759|83352491|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
46640999|NCT03588728|82820303|FG002|Overall Study|Schedule change unable to attend sessions|0|||
46641000|NCT03588728|82820304|FG003|Overall Study|Schedule change unable to attend sessions|0|||
46641001|NCT02987543|82820326|FG000|Overall Study|Ongoing study at data cut off|49|||
46641002|NCT02987543|82820327|FG001|Overall Study|Ongoing study at data cut off|21|||
46641003|NCT02987543|82820328|FG002|Overall Study|Ongoing study at data cut off|19|||
47068263|NCT01435759|83352492|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068264|NCT01435759|83352493|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068265|NCT01435759|83352494|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
47068266|NCT01435759|83352495|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
47068267|NCT01435759|83352490|FG000|Double-blind Phase|Other|8|||
47068268|NCT01435759|83352491|FG001|Double-blind Phase|Other|2|||
47068269|NCT01435759|83352492|FG002|Double-blind Phase|Other|0|||
47068270|NCT01435759|83352493|FG003|Double-blind Phase|Other|2|||
47068271|NCT01435759|83352494|FG004|Double-blind Phase|Other|0|||
47068272|NCT01435759|83352495|FG005|Double-blind Phase|Other|0|||
47068273|NCT01393405|83352507|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
47068274|NCT01393405|83352508|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
46641004|NCT02987543|82820329|FG003|Overall Study|Ongoing study at data cut off|12|||
46641005|NCT02987543|82820326|FG000|Overall Study|Death|88|||
47068275|NCT01393405|83352509|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
46641006|NCT02987543|82820327|FG001|Overall Study|Death|54|||
46641007|NCT02987543|82820328|FG002|Overall Study|Death|67|||
47068276|NCT01393405|83352507|FG000|Induction Period (week1-16)|Adverse Event|16|||
47068277|NCT01393405|83352508|FG001|Induction Period (week1-16)|Adverse Event|0|||
47068278|NCT01393405|83352509|FG002|Induction Period (week1-16)|Adverse Event|0|||
47068279|NCT01393405|83352507|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
47068280|NCT01393405|83352508|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
47068281|NCT01393405|83352509|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
47068282|NCT01393405|83352507|FG000|Maintenance Period Week|Lack of Efficacy|0|||
47068283|NCT01393405|83352508|FG001|Maintenance Period Week|Lack of Efficacy|22|||
47068284|NCT01393405|83352509|FG002|Maintenance Period Week|Lack of Efficacy|22|||
47068285|NCT01393405|83352507|FG000|Maintenance Period Week|Adverse Event|0|||
47068286|NCT01393405|83352508|FG001|Maintenance Period Week|Adverse Event|5|||
47068287|NCT01393405|83352509|FG002|Maintenance Period Week|Adverse Event|2|||
47068288|NCT01393405|83352507|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
47068289|NCT01393405|83352508|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
47068290|NCT01393405|83352509|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
47068291|NCT01393405|83352507|FG000|Maintenance Period Week|Lost to Follow-up|0|||
47068292|NCT01393405|83352508|FG001|Maintenance Period Week|Lost to Follow-up|1|||
47068293|NCT01393405|83352509|FG002|Maintenance Period Week|Lost to Follow-up|0|||
47068294|NCT01419197|83352521|FG000|Overall Study|Death|247|||
47068295|NCT01419197|83352522|FG001|Overall Study|Death|122|||
47068296|NCT01419197|83352521|FG000|Overall Study|Physician Decision|4|||
47068297|NCT01419197|83352522|FG001|Overall Study|Physician Decision|4|||
47068298|NCT01419197|83352521|FG000|Overall Study|Non-compliance|3|||
47068299|NCT01419197|83352522|FG001|Overall Study|Non-compliance|1|||
47068300|NCT01419197|83352521|FG000|Overall Study|Withdrawal by Subject|33|||
47068301|NCT01419197|83352522|FG001|Overall Study|Withdrawal by Subject|32|||
47068302|NCT01419197|83352521|FG000|Overall Study|Study Completed by Sponsor|103|||
47068303|NCT01419197|83352522|FG001|Overall Study|Study Completed by Sponsor|34|||
47068304|NCT01419197|83352521|FG000|Overall Study|Reason Not Specified|0|||
47068305|NCT01419197|83352522|FG001|Overall Study|Reason Not Specified|1|||
47068306|NCT01419197|83352521|FG000|Overall Study|Lost to Follow-up|14|||
47068307|NCT01419197|83352522|FG001|Overall Study|Lost to Follow-up|4|||
47068308|NCT01414075|83352533|FG000|Overall Study|Adverse Event|1|||
47068309|NCT01414075|83352534|FG001|Overall Study|Adverse Event|0|||
47068310|NCT01414075|83352535|FG002|Overall Study|Adverse Event|1|||
47068311|NCT01414075|83352536|FG003|Overall Study|Adverse Event|0|||
47068312|NCT01414075|83352533|FG000|Overall Study|Death|1|||
47068313|NCT01414075|83352534|FG001|Overall Study|Death|0|||
47068314|NCT01414075|83352535|FG002|Overall Study|Death|0|||
47068315|NCT01414075|83352536|FG003|Overall Study|Death|1|||
47068316|NCT01414075|83352533|FG000|Overall Study|Withdrawal by Subject|0|||
47068317|NCT01414075|83352534|FG001|Overall Study|Withdrawal by Subject|0|||
47068318|NCT01414075|83352535|FG002|Overall Study|Withdrawal by Subject|0|||
47068319|NCT01414075|83352536|FG003|Overall Study|Withdrawal by Subject|1|||
47068320|NCT01414075|83352533|FG000|Overall Study|Other than specified|1|||
47068321|NCT01414075|83352534|FG001|Overall Study|Other than specified|0|||
47068322|NCT01414075|83352535|FG002|Overall Study|Other than specified|1|||
47068323|NCT01414075|83352536|FG003|Overall Study|Other than specified|0|||
47068324|NCT01434823|83352548|FG000|Overall Study|Incomplete data in medical record|4|||
47068325|NCT01434823|83352549|FG001|Overall Study|Incomplete data in medical record|7|||
47068326|NCT01513460|83352559|FG000|Overall Study|Death|0|||
47068327|NCT01513460|83352560|FG001|Overall Study|Death|0|||
47068328|NCT01513460|83352561|FG002|Overall Study|Death|1|||
47068329|NCT01513460|83352559|FG000|Overall Study|Lost to Follow-up|0|||
47068330|NCT01513460|83352560|FG001|Overall Study|Lost to Follow-up|0|||
47068331|NCT01513460|83352561|FG002|Overall Study|Lost to Follow-up|2|||
47068332|NCT01513460|83352559|FG000|Overall Study|Abnormal laboratory value|1|||
47068333|NCT01513460|83352560|FG001|Overall Study|Abnormal laboratory value|0|||
47068334|NCT01513460|83352561|FG002|Overall Study|Abnormal laboratory value|1|||
47068335|NCT01513460|83352559|FG000|Overall Study|Lack of Efficacy|1|||
47068336|NCT01513460|83352560|FG001|Overall Study|Lack of Efficacy|2|||
47068337|NCT01513460|83352561|FG002|Overall Study|Lack of Efficacy|5|||
47068338|NCT01513460|83352559|FG000|Overall Study|Protocol deviations|3|||
47068339|NCT01513460|83352560|FG001|Overall Study|Protocol deviations|4|||
47068340|NCT01513460|83352561|FG002|Overall Study|Protocol deviations|3|||
47068341|NCT01513460|83352559|FG000|Overall Study|Withdrawal by Subject|7|||
47068342|NCT01513460|83352560|FG001|Overall Study|Withdrawal by Subject|8|||
47068343|NCT01513460|83352561|FG002|Overall Study|Withdrawal by Subject|21|||
47068344|NCT01513460|83352559|FG000|Overall Study|Adverse Event|16|||
47068345|NCT01513460|83352560|FG001|Overall Study|Adverse Event|18|||
47068346|NCT01513460|83352561|FG002|Overall Study|Adverse Event|23|||
47068347|NCT01513460|83352559|FG000|Overall Study|Abnormal test procedure|1|||
47068348|NCT01513460|83352560|FG001|Overall Study|Abnormal test procedure|0|||
47068349|NCT01513460|83352561|FG002|Overall Study|Abnormal test procedure|0|||
47068350|NCT01392547|83352571|FG000|Overall Study|Adverse Event|2|||
47068351|NCT01392547|83352571|FG000|Overall Study|Non-compliance|2|||
47068352|NCT01392547|83352571|FG000|Overall Study|Withdrawal criteria|3|||
47068353|NCT01392547|83352571|FG000|Overall Study|Unclassified|1|||
47068354|NCT01435655|83352577|FG000|Overall Study|Death|2|||
47068355|NCT01435655|83352577|FG000|Overall Study|Other|1|||
47068356|NCT01434667|83352583|FG000|Overall Study|Lost to Follow-up|5|||
47068357|NCT01434667|83352584|FG001|Overall Study|Lost to Follow-up|10|||
47068358|NCT01513148|83352592|FG000|Overall Study|Protocol Violation|2|||
47068359|NCT01513148|83352593|FG001|Overall Study|Protocol Violation|2|||
47068360|NCT01418339|83352641|FG000|Overall Study|Adverse Event|5|||
47068361|NCT01418339|83352642|FG001|Overall Study|Adverse Event|2|||
47068362|NCT01418339|83352641|FG000|Overall Study|Subject Withdrew Consent|1|||
47068363|NCT01418339|83352642|FG001|Overall Study|Subject Withdrew Consent|2|||
47068364|NCT01418339|83352641|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
47068365|NCT01418339|83352642|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
47068366|NCT01512368|83352648|FG000|Overall Study|Protocol Violation|3|||
47068367|NCT01412983|83352652|FG000|1st Period|Ineligible|0|||
47068368|NCT01412983|83352653|FG001|1st Period|Ineligible|1|||
47068369|NCT01412983|83352652|FG000|1st Period|Positive slit lamp finding|0|||
47068370|NCT01412983|83352653|FG001|1st Period|Positive slit lamp finding|1|||
47068371|NCT01412983|83352652|FG000|1st Period|Unacceptable lens movement|0|||
47068372|NCT01412983|83352653|FG001|1st Period|Unacceptable lens movement|1|||
47068373|NCT01412983|83352652|FG000|1st Period|Inability to maintain wear|0|||
47068374|NCT01412983|83352653|FG001|1st Period|Inability to maintain wear|1|||
47068375|NCT01417481|83352662|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
47068376|NCT01417481|83352663|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
47068377|NCT01392469|83352669|FG000|Overall Study|Adverse Event|2|||
47068378|NCT01392469|83352669|FG000|Overall Study|Withdrawal by Subject|1|||
47068379|NCT01392469|83352669|FG000|Overall Study|Protocol Violation|1|||
47068380|NCT01435577|83352686|FG000|Overall Study|Adverse Event|10|||
47068381|NCT01435577|83352687|FG001|Overall Study|Adverse Event|0|||
47068382|NCT01435577|83352686|FG000|Overall Study|Lack of Efficacy|7|||
47068383|NCT01435577|83352687|FG001|Overall Study|Lack of Efficacy|51|||
47068384|NCT01435577|83352686|FG000|Overall Study|Alternative treatment started|0|||
46967136|NCT04369469|83209848|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
46967137|NCT04369469|83209849|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
47068385|NCT01435577|83352687|FG001|Overall Study|Alternative treatment started|1|||
46846210|NCT00132678|83062998|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
46846211|NCT00132678|83062999|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
46846212|NCT00132678|83062997|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
46846213|NCT00132678|83062998|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
46846214|NCT00132678|83062999|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
46846215|NCT00132678|83062997|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
46846216|NCT00132678|83062998|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
46846217|NCT00132678|83062999|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
46846218|NCT00132678|83062997|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
46846219|NCT00132678|83062998|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
46846220|NCT00132678|83062999|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
46846221|NCT00132678|83062997|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
46846222|NCT00132678|83062998|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
46846223|NCT00132678|83062999|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
46846224|NCT00132678|83062997|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
46846225|NCT00132678|83062998|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
46846226|NCT00132678|83062999|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
46846227|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Death|2|||
46846228|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Death|0|||
46846229|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Death|0|||
46967138|NCT04369469|83209848|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
47068386|NCT01411891|83352699|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
47068387|NCT01411891|83352700|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
47068388|NCT01416389|83352708|FG000|Overall Study|Lost to Follow-up|1|||
46775039|NCT00734162|82993457|FG003|Open-Label Phase|Lost to Follow-up|1|||
46775040|NCT00734162|82993454|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
46775041|NCT00734162|82993455|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
46775042|NCT00734162|82993456|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
46775043|NCT00734162|82993457|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
46775044|NCT00790751|82993475|FG000|Overall Study|Protocol non-compliance|16|||
46775045|NCT00790751|82993476|FG001|Overall Study|Protocol non-compliance|16|||
47068389|NCT01416389|83352709|FG001|Overall Study|Lost to Follow-up|0|||
47068390|NCT01416389|83352708|FG000|Overall Study|Started New Therapy|2|||
47068391|NCT01416389|83352709|FG001|Overall Study|Started New Therapy|0|||
47068392|NCT01544348|83352725|FG000|Overall Study|Lost to Follow-up|1|||
47068393|NCT01544348|83352726|FG001|Overall Study|Lost to Follow-up|0|||
46775046|NCT00790751|82993477|FG002|Overall Study|Protocol non-compliance|10|||
46775047|NCT00790751|82993478|FG003|Overall Study|Protocol non-compliance|11|||
47068394|NCT01544348|83352727|FG002|Overall Study|Lost to Follow-up|0|||
47068395|NCT01544348|83352728|FG003|Overall Study|Lost to Follow-up|0|||
47068396|NCT01544348|83352729|FG004|Overall Study|Lost to Follow-up|0|||
47068397|NCT01544348|83352730|FG005|Overall Study|Lost to Follow-up|0|||
47068398|NCT01544348|83352731|FG006|Overall Study|Lost to Follow-up|1|||
47068399|NCT01544348|83352732|FG007|Overall Study|Lost to Follow-up|0|||
47068400|NCT01544348|83352725|FG000|Overall Study|Withdrawal by Subject|1|||
47068401|NCT01544348|83352726|FG001|Overall Study|Withdrawal by Subject|0|||
47068402|NCT01544348|83352727|FG002|Overall Study|Withdrawal by Subject|0|||
47068403|NCT01544348|83352728|FG003|Overall Study|Withdrawal by Subject|0|||
47068404|NCT01544348|83352729|FG004|Overall Study|Withdrawal by Subject|1|||
47068405|NCT01544348|83352730|FG005|Overall Study|Withdrawal by Subject|2|||
47068406|NCT01544348|83352731|FG006|Overall Study|Withdrawal by Subject|1|||
47068407|NCT01544348|83352732|FG007|Overall Study|Withdrawal by Subject|0|||
47068408|NCT01544348|83352725|FG000|Overall Study|Physician Decision|0|||
47068409|NCT01544348|83352726|FG001|Overall Study|Physician Decision|0|||
47068410|NCT01544348|83352727|FG002|Overall Study|Physician Decision|0|||
47068411|NCT01544348|83352728|FG003|Overall Study|Physician Decision|0|||
47068412|NCT01544348|83352729|FG004|Overall Study|Physician Decision|0|||
47068413|NCT01544348|83352730|FG005|Overall Study|Physician Decision|1|||
47068414|NCT01544348|83352731|FG006|Overall Study|Physician Decision|0|||
47068415|NCT01544348|83352732|FG007|Overall Study|Physician Decision|0|||
47068416|NCT01416155|83352757|FG000|Overall Study|Adverse Event|8|||
47068417|NCT01416155|83352757|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
47068418|NCT01416155|83352757|FG000|Overall Study|Withdrawal by Subject|33|||
47068419|NCT01416155|83352757|FG000|Overall Study|Investigator decision|8|||
47068420|NCT01416155|83352757|FG000|Overall Study|Other|7|||
47068421|NCT01415921|83352763|FG000|Overall Study|Adverse Event|0|||
47068422|NCT01415921|83352764|FG001|Overall Study|Adverse Event|1|||
47068423|NCT01415921|83352763|FG000|Overall Study|Physician Decision|1|||
47068424|NCT01415921|83352764|FG001|Overall Study|Physician Decision|1|||
47068425|NCT01415921|83352763|FG000|Overall Study|Withdrawal by Subject|0|||
47068426|NCT01415921|83352764|FG001|Overall Study|Withdrawal by Subject|1|||
47068427|NCT01415921|83352763|FG000|Overall Study|Other|2|||
47068428|NCT01415921|83352764|FG001|Overall Study|Other|0|||
47068429|NCT01415531|83352772|FG000|Overall Study|Adverse Event|7|||
47068430|NCT01415531|83352773|FG001|Overall Study|Adverse Event|10|||
47068431|NCT01415531|83352772|FG000|Overall Study|Lack of Efficacy|3|||
47068432|NCT01415531|83352773|FG001|Overall Study|Lack of Efficacy|2|||
47068433|NCT01415531|83352772|FG000|Overall Study|Protocol Violation|0|||
47068434|NCT01415531|83352773|FG001|Overall Study|Protocol Violation|1|||
47068435|NCT01415531|83352772|FG000|Overall Study|Withdrawal by Subject|5|||
47068436|NCT01415531|83352773|FG001|Overall Study|Withdrawal by Subject|4|||
47068437|NCT01415531|83352772|FG000|Overall Study|Lost to Follow-up|6|||
47068438|NCT01415531|83352773|FG001|Overall Study|Lost to Follow-up|14|||
47068439|NCT01415531|83352772|FG000|Overall Study|Lack of Compliance|1|||
47068440|NCT01415531|83352773|FG001|Overall Study|Lack of Compliance|4|||
47068441|NCT01415531|83352772|FG000|Overall Study|Other Reasons|3|||
47068442|NCT01415531|83352773|FG001|Overall Study|Other Reasons|2|||
47068443|NCT01544114|83352782|FG000|Overall Study|Withdrawal by Subject|0|||
47068444|NCT01544114|83352783|FG001|Overall Study|Withdrawal by Subject|0|||
47068445|NCT01544114|83352784|FG002|Overall Study|Withdrawal by Subject|3|||
47068446|NCT01544114|83352782|FG000|Overall Study|Lost to Follow-up|0|||
47068447|NCT01544114|83352783|FG001|Overall Study|Lost to Follow-up|2|||
47068448|NCT01544114|83352784|FG002|Overall Study|Lost to Follow-up|0|||
47068449|NCT01544114|83352782|FG000|Overall Study|Adverse Event|1|||
47068450|NCT01544114|83352783|FG001|Overall Study|Adverse Event|1|||
47068451|NCT01544114|83352784|FG002|Overall Study|Adverse Event|2|||
47068452|NCT01544114|83352782|FG000|Overall Study|Protocol Violation|0|||
46641008|NCT02987543|82820329|FG003|Overall Study|Death|28|||
46846230|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
46846231|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
46846232|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
47068453|NCT01544114|83352783|FG001|Overall Study|Protocol Violation|1|||
47068454|NCT01544114|83352784|FG002|Overall Study|Protocol Violation|0|||
47068455|NCT01435265|83352796|FG000|Overall Study|Lost to Follow-up|0|||
47068456|NCT01435265|83352797|FG001|Overall Study|Lost to Follow-up|1|||
47068457|NCT01433263|83352805|FG000|Overall Study|Adverse Event|3|||
47068458|NCT01433263|83352806|FG001|Overall Study|Adverse Event|1|||
47068459|NCT01433263|83352805|FG000|Overall Study|Death|5|||
47068460|NCT01433263|83352806|FG001|Overall Study|Death|3|||
47068461|NCT01433263|83352805|FG000|Overall Study|Lost to Follow-up|0|||
47068462|NCT01433263|83352806|FG001|Overall Study|Lost to Follow-up|1|||
47068463|NCT01433263|83352805|FG000|Overall Study|Protocol Deviation|1|||
47068464|NCT01433263|83352806|FG001|Overall Study|Protocol Deviation|0|||
47068465|NCT01433263|83352805|FG000|Overall Study|Withdrawal by Subject|10|||
47068466|NCT01433263|83352806|FG001|Overall Study|Withdrawal by Subject|7|||
47068467|NCT01432951|83352815|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
47068468|NCT01432327|83352824|FG000|Posttest 3 Months|depression|3|||
47068469|NCT01432327|83352825|FG001|Posttest 3 Months|depression|0|||
47068470|NCT01432327|83352826|FG002|Posttest 3 Months|depression|0|||
47068471|NCT01432327|83352827|FG003|Posttest 3 Months|depression|0|||
47068472|NCT01432327|83352824|FG000|Posttest 3 Months|Lost to Follow-up|1|||
47068473|NCT01432327|83352825|FG001|Posttest 3 Months|Lost to Follow-up|0|||
47068474|NCT01432327|83352826|FG002|Posttest 3 Months|Lost to Follow-up|2|||
47068475|NCT01432327|83352827|FG003|Posttest 3 Months|Lost to Follow-up|1|||
47068476|NCT01432327|83352824|FG000|Posttest 3 Months|Allergic reaction|0|||
47068477|NCT01432327|83352825|FG001|Posttest 3 Months|Allergic reaction|2|||
47068478|NCT01432327|83352826|FG002|Posttest 3 Months|Allergic reaction|0|||
46846233|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
47068479|NCT01432327|83352827|FG003|Posttest 3 Months|Allergic reaction|0|||
47068480|NCT01432327|83352824|FG000|Posttest 6 Months|Lost to Follow-up|0|||
47068481|NCT01432327|83352825|FG001|Posttest 6 Months|Lost to Follow-up|0|||
47068482|NCT01432327|83352826|FG002|Posttest 6 Months|Lost to Follow-up|3|||
47068483|NCT01432327|83352827|FG003|Posttest 6 Months|Lost to Follow-up|2|||
47068484|NCT01432327|83352824|FG000|Posttest 6 Months|Allergic reaction|0|||
47068485|NCT01432327|83352825|FG001|Posttest 6 Months|Allergic reaction|0|||
47068486|NCT01432327|83352826|FG002|Posttest 6 Months|Allergic reaction|1|||
47068487|NCT01432327|83352827|FG003|Posttest 6 Months|Allergic reaction|0|||
47068488|NCT01432327|83352824|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
47068489|NCT01432327|83352825|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
47068490|NCT01432327|83352826|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
47068491|NCT01432327|83352827|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
47068492|NCT01432327|83352824|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
47068493|NCT01432327|83352825|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
47068494|NCT01432327|83352826|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
47068495|NCT01432327|83352827|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
47068496|NCT01432327|83352824|FG000|Posttest 1 Year|Lost to Follow-up|0|||
47068497|NCT01432327|83352825|FG001|Posttest 1 Year|Lost to Follow-up|0|||
47068498|NCT01432327|83352826|FG002|Posttest 1 Year|Lost to Follow-up|4|||
47068499|NCT01432327|83352827|FG003|Posttest 1 Year|Lost to Follow-up|2|||
47068500|NCT01432327|83352824|FG000|Posttest 1 Year|Allergic reaction|0|||
47068501|NCT01432327|83352825|FG001|Posttest 1 Year|Allergic reaction|0|||
47068502|NCT01432327|83352826|FG002|Posttest 1 Year|Allergic reaction|1|||
47068503|NCT01432327|83352827|FG003|Posttest 1 Year|Allergic reaction|1|||
47068504|NCT01410799|83352837|FG000|Overall Study|PI decision|13|||
47068505|NCT01432171|83352843|FG000|Overall Study|Death|1|||
47068506|NCT01432171|83352844|FG001|Overall Study|Death|2|||
47068507|NCT01432171|83352843|FG000|Overall Study|Lost to Follow-up|6|||
47068508|NCT01432171|83352844|FG001|Overall Study|Lost to Follow-up|5|||
47068509|NCT01432171|83352843|FG000|Overall Study|Withdrawal by Subject|3|||
47068510|NCT01432171|83352844|FG001|Overall Study|Withdrawal by Subject|1|||
47068511|NCT01432171|83352843|FG000|Overall Study|Noncompliance|2|||
47068512|NCT01432171|83352844|FG001|Overall Study|Noncompliance|3|||
47068513|NCT01432171|83352843|FG000|Overall Study|Insurance denial trial coverage|1|||
47068514|NCT01432171|83352844|FG001|Overall Study|Insurance denial trial coverage|0|||
47068515|NCT01432171|83352843|FG000|Overall Study|Patient moved to palliative care|1|||
47068516|NCT01432171|83352844|FG001|Overall Study|Patient moved to palliative care|0|||
47068517|NCT01435031|83352854|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
47068518|NCT01435031|83352854|FG000|ITT at 1 Month|Death|1|||
47068519|NCT01435031|83352854|FG000|ITT at 1 Month|Lost to Follow-up|4|||
47068520|NCT01435031|83352854|FG000|ITT at 6 Months|Death|2|||
47068521|NCT01435031|83352854|FG000|ITT at 6 Months|Lost to Follow-up|3|||
47068522|NCT01435031|83352854|FG000|ITT at 1 Year|Death|1|||
47068523|NCT01435031|83352854|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
47068524|NCT01435031|83352854|FG000|ITT at 1 Year|Lost to Follow-up|6|||
47068525|NCT01435031|83352854|FG000|ITT at 2 Years|Death|7|||
47068526|NCT01435031|83352854|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
47068527|NCT01435031|83352854|FG000|ITT at 2 Years|Lost to Follow-up|4|||
47068528|NCT01435031|83352854|FG000|ITT at 3 Years|Death|5|||
47068529|NCT01435031|83352854|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
47068530|NCT01435031|83352854|FG000|ITT at 3 Years|Lost to Follow-up|4|||
47068531|NCT01435031|83352854|FG000|ITT at 4 Years|Death|4|||
47068532|NCT01435031|83352854|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
47068533|NCT01435031|83352854|FG000|ITT at 4 Years|Lost to Follow-up|1|||
47068534|NCT01433549|83352858|FG000|Phase 2: Second Study Product|Adverse Event|0|||
46846234|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
46846235|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
46641009|NCT02987543|82820326|FG000|Overall Study|Lost to Follow-up|3|||
47068535|NCT01433549|83352859|FG001|Phase 2: Second Study Product|Adverse Event|1|||
47068536|NCT01414205|83352867|FG000|Overall Study|Death|5|||
47068537|NCT01414205|83352868|FG001|Overall Study|Death|1|||
47068538|NCT01414205|83352867|FG000|Overall Study|Lost to Follow-up|1|||
47068539|NCT01414205|83352868|FG001|Overall Study|Lost to Follow-up|4|||
47068540|NCT01414205|83352867|FG000|Overall Study|Physician Decision|0|||
47068541|NCT01414205|83352868|FG001|Overall Study|Physician Decision|1|||
47068542|NCT01414205|83352867|FG000|Overall Study|Randomized but not Treated|1|||
47068543|NCT01414205|83352868|FG001|Overall Study|Randomized but not Treated|1|||
47068544|NCT01433471|83352876|FG000|Overall Study|Withdrawal by Subject|0|||
47068545|NCT01433471|83352877|FG001|Overall Study|Withdrawal by Subject|1|||
47068546|NCT01433159|83352887|FG000|Overall Study|Adverse Event|1|||
47068547|NCT01433159|83352888|FG001|Overall Study|Adverse Event|0|||
47068548|NCT01433159|83352887|FG000|Overall Study|Physician Decision|1|||
47068549|NCT01433159|83352888|FG001|Overall Study|Physician Decision|0|||
47068550|NCT01433159|83352887|FG000|Overall Study|Protocol Violation|0|||
47068551|NCT01433159|83352888|FG001|Overall Study|Protocol Violation|1|||
47068552|NCT01413503|83352903|FG000|Overall Study|Lost to Follow-up|1|||
47068553|NCT01413191|83352907|FG000|Overall Study|Lost to Follow-up|5|||
47068554|NCT01413191|83352907|FG000|Overall Study|Disease Progression|5|||
47068555|NCT01413191|83352907|FG000|Overall Study|Death|1|||
47068556|NCT01412957|83352913|FG000|Overall Study|Withdrawal by Subject|6|||
47068557|NCT01412957|83352914|FG001|Overall Study|Withdrawal by Subject|22|||
47068558|NCT01412957|83352913|FG000|Overall Study|Lost to Follow-up|7|||
47068559|NCT01412957|83352914|FG001|Overall Study|Lost to Follow-up|2|||
47068560|NCT01412957|83352913|FG000|Overall Study|Death|136|||
47068561|NCT01412957|83352914|FG001|Overall Study|Death|133|||
47068562|NCT01432457|83352927|FG000|Overall Study|Adverse Event|7|||
47068563|NCT01432457|83352928|FG001|Overall Study|Adverse Event|10|||
47068564|NCT01432457|83352929|FG002|Overall Study|Adverse Event|16|||
47068565|NCT01432457|83352927|FG000|Overall Study|Lack of Efficacy|2|||
47068566|NCT01432457|83352928|FG001|Overall Study|Lack of Efficacy|1|||
47068567|NCT01432457|83352929|FG002|Overall Study|Lack of Efficacy|1|||
47068568|NCT01432457|83352927|FG000|Overall Study|Lost to Follow-up|11|||
47068569|NCT01432457|83352928|FG001|Overall Study|Lost to Follow-up|15|||
47068570|NCT01432457|83352929|FG002|Overall Study|Lost to Follow-up|20|||
47068571|NCT01432457|83352927|FG000|Overall Study|Protocol Violation|3|||
47068572|NCT01432457|83352928|FG001|Overall Study|Protocol Violation|2|||
47068573|NCT01432457|83352929|FG002|Overall Study|Protocol Violation|6|||
47068574|NCT01432457|83352927|FG000|Overall Study|Withdrawal by Subject|6|||
47068575|NCT01432457|83352928|FG001|Overall Study|Withdrawal by Subject|11|||
47068576|NCT01432457|83352929|FG002|Overall Study|Withdrawal by Subject|9|||
47068577|NCT01432457|83352927|FG000|Overall Study|Reasons not defined|2|||
47068578|NCT01432457|83352928|FG001|Overall Study|Reasons not defined|3|||
47068579|NCT01432457|83352929|FG002|Overall Study|Reasons not defined|4|||
47068580|NCT01432457|83352927|FG000|Overall Study|Did not take study drug|6|||
47068581|NCT01432457|83352928|FG001|Overall Study|Did not take study drug|6|||
47068582|NCT01432457|83352929|FG002|Overall Study|Did not take study drug|3|||
47068583|NCT01390441|83352951|FG000|Treatment Period|Protocol Violation|0|||
47068584|NCT01390441|83352952|FG001|Treatment Period|Protocol Violation|1|||
47068585|NCT01390441|83352953|FG002|Treatment Period|Protocol Violation|0|||
47068586|NCT01390441|83352954|FG003|Treatment Period|Protocol Violation|0|||
47068587|NCT01390441|83352955|FG004|Treatment Period|Protocol Violation|0|||
47068588|NCT01390441|83352951|FG000|Treatment Period|Physician Decision|0|||
47068589|NCT01390441|83352952|FG001|Treatment Period|Physician Decision|0|||
47068590|NCT01390441|83352953|FG002|Treatment Period|Physician Decision|0|||
47068591|NCT01390441|83352954|FG003|Treatment Period|Physician Decision|1|||
47068592|NCT01390441|83352955|FG004|Treatment Period|Physician Decision|0|||
47068593|NCT01390441|83352951|FG000|Treatment Period|Lack of Efficacy|0|||
47068594|NCT01390441|83352952|FG001|Treatment Period|Lack of Efficacy|0|||
47068595|NCT01390441|83352953|FG002|Treatment Period|Lack of Efficacy|0|||
47068596|NCT01390441|83352954|FG003|Treatment Period|Lack of Efficacy|0|||
47068597|NCT01390441|83352955|FG004|Treatment Period|Lack of Efficacy|1|||
47068598|NCT01390441|83352951|FG000|Treatment Period|Unknown due to early stopping of study|0|||
47068599|NCT01390441|83352952|FG001|Treatment Period|Unknown due to early stopping of study|0|||
47068600|NCT01390441|83352953|FG002|Treatment Period|Unknown due to early stopping of study|8|||
47068601|NCT01390441|83352954|FG003|Treatment Period|Unknown due to early stopping of study|11|||
47068602|NCT01390441|83352955|FG004|Treatment Period|Unknown due to early stopping of study|7|||
47068603|NCT01390441|83352951|FG000|Treatment Period|Adverse Event|0|||
47068604|NCT01390441|83352952|FG001|Treatment Period|Adverse Event|0|||
47068605|NCT01390441|83352953|FG002|Treatment Period|Adverse Event|1|||
47068606|NCT01390441|83352954|FG003|Treatment Period|Adverse Event|1|||
47068607|NCT01390441|83352955|FG004|Treatment Period|Adverse Event|2|||
47068608|NCT01390441|83352951|FG000|Treatment Period|Withdrawal by Subject|0|||
47068609|NCT01390441|83352952|FG001|Treatment Period|Withdrawal by Subject|0|||
47068610|NCT01390441|83352953|FG002|Treatment Period|Withdrawal by Subject|1|||
47068611|NCT01390441|83352954|FG003|Treatment Period|Withdrawal by Subject|0|||
47068612|NCT01390441|83352955|FG004|Treatment Period|Withdrawal by Subject|1|||
47068613|NCT01390441|83352951|FG000|Treatment Period|Lost to Follow-up|1|||
47068614|NCT01390441|83352952|FG001|Treatment Period|Lost to Follow-up|0|||
47068615|NCT01390441|83352953|FG002|Treatment Period|Lost to Follow-up|0|||
47068616|NCT01390441|83352954|FG003|Treatment Period|Lost to Follow-up|0|||
47068617|NCT01390441|83352955|FG004|Treatment Period|Lost to Follow-up|0|||
47068618|NCT01390441|83352951|FG000|Extension Period|Protocol Violation|3|||
47068619|NCT01390441|83352952|FG001|Extension Period|Protocol Violation|1|||
47068620|NCT01390441|83352953|FG002|Extension Period|Protocol Violation|0|||
47068621|NCT01390441|83352954|FG003|Extension Period|Protocol Violation|1|||
47068622|NCT01390441|83352955|FG004|Extension Period|Protocol Violation|0|||
47068623|NCT01412879|83353004|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
47068624|NCT01412879|83353005|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
47068625|NCT01412879|83353006|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
47068626|NCT01412879|83353004|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
47068627|NCT01412879|83353005|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
47068628|NCT01412879|83353006|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
47068629|NCT01412879|83353004|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
47068630|NCT01412879|83353005|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
47068631|NCT01412879|83353006|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
47068632|NCT01412879|83353004|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
47068633|NCT01412879|83353005|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
47068634|NCT01412879|83353006|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
47068635|NCT01412879|83353004|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
47068636|NCT01412879|83353005|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
47068637|NCT01412879|83353006|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
47068638|NCT01431079|83353018|FG000|Overall Study|Lost to Follow-up|35|||
47068639|NCT01431079|83353019|FG001|Overall Study|Lost to Follow-up|39|||
47068640|NCT01430611|83353051|FG000|Overall Study|Adverse Event|0|||
47068641|NCT01430611|83353052|FG001|Overall Study|Adverse Event|1|||
47068642|NCT01430611|83353051|FG000|Overall Study|Protocol Violation|1|||
47068643|NCT01430611|83353052|FG001|Overall Study|Protocol Violation|0|||
47068644|NCT01430611|83353051|FG000|Overall Study|Lost to Follow-up|1|||
47068645|NCT01430611|83353052|FG001|Overall Study|Lost to Follow-up|0|||
47068646|NCT01430611|83353051|FG000|Overall Study|Withdrawal by Subject|15|||
47068647|NCT01430611|83353052|FG001|Overall Study|Withdrawal by Subject|14|||
47068648|NCT01409707|83353061|FG000|Overall Study|Withdrawal by Subject|5|||
47068649|NCT01409707|83353062|FG001|Overall Study|Withdrawal by Subject|17|||
47068650|NCT01409707|83353063|FG002|Overall Study|Withdrawal by Subject|16|||
47068651|NCT01389973|83353070|FG000|Overall Study|Lost to Follow-up|1|||
47068652|NCT01389973|83353070|FG000|Overall Study|Trial Stopped by Sponsor|9|||
47068653|NCT01389973|83353070|FG000|Overall Study|Other|10|||
47068654|NCT01389817|83353090|FG000|Overall Study|Physician Decision|1|||
47068655|NCT01389817|83353091|FG001|Overall Study|Physician Decision|0|||
47068656|NCT01389817|83353090|FG000|Overall Study|Lost to Follow-up|1|||
47068657|NCT01389817|83353091|FG001|Overall Study|Lost to Follow-up|0|||
47068658|NCT01389817|83353090|FG000|Overall Study|Withdrawal by Subject|2|||
47068659|NCT01389817|83353091|FG001|Overall Study|Withdrawal by Subject|0|||
47068660|NCT01430455|83353106|FG000|Overall Study|Withdrawal by Subject|1|||
47068661|NCT01430455|83353106|FG000|Overall Study|Switched to follow-up phase|1|||
47068662|NCT01429441|83353134|FG000|Overall Study|Adverse Event|5|||
47068663|NCT01429441|83353135|FG001|Overall Study|Adverse Event|1|||
47068664|NCT01429441|83353134|FG000|Overall Study|Death|0|||
47068665|NCT01429441|83353135|FG001|Overall Study|Death|2|||
47068666|NCT01429441|83353134|FG000|Overall Study|Lost to Follow-up|5|||
47068667|NCT01429441|83353135|FG001|Overall Study|Lost to Follow-up|2|||
47068668|NCT01429441|83353134|FG000|Overall Study|Physician Decision|1|||
47068669|NCT01429441|83353135|FG001|Overall Study|Physician Decision|0|||
47068670|NCT01429441|83353134|FG000|Overall Study|Withdrawal by Subject|27|||
47068671|NCT01429441|83353135|FG001|Overall Study|Withdrawal by Subject|18|||
47068672|NCT01429285|83353170|FG000|Overall Study|Protocol Violation|9|||
47068673|NCT01429285|83353171|FG001|Overall Study|Protocol Violation|4|||
47068674|NCT01429285|83353170|FG000|Overall Study|Missing Data|5|||
47068675|NCT01429285|83353171|FG001|Overall Study|Missing Data|3|||
47068676|NCT01429285|83353170|FG000|Overall Study|Erroneously Enrolled Twice|8|||
47068677|NCT01429285|83353171|FG001|Overall Study|Erroneously Enrolled Twice|2|||
47068678|NCT01429051|83353248|FG000|Titration Phase|Death|1|||
47068679|NCT01429051|83353248|FG000|Titration Phase|Withdrawal by Subject|7|||
46846236|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
47068680|NCT01429051|83353248|FG000|Titration Phase|Physician Decision|1|||
47068681|NCT01429051|83353248|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
47068682|NCT01429051|83353248|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
47068683|NCT01429051|83353248|FG000|Efficacy Phase|Adverse Event|1|||
47068684|NCT01429051|83353248|FG000|Efficacy Phase|Death|1|||
47068685|NCT01429051|83353248|FG000|Tolerability Phase|Death|5|||
47068686|NCT01429051|83353248|FG000|Tolerability Phase|Adverse Event|2|||
47068687|NCT01429051|83353248|FG000|Tolerability Phase|Withdrawal by Subject|5|||
47068688|NCT01429051|83353248|FG000|Tolerability Phase|Physician Decision|1|||
47068689|NCT01429051|83353248|FG000|Tolerability Phase|Other|2|||
47068690|NCT01428661|83353281|FG000|Double-Masked Phase|Protocol Violation|9|||
47068691|NCT01428661|83353282|FG001|Double-Masked Phase|Protocol Violation|4|||
47068692|NCT01428661|83353283|FG002|Double-Masked Phase|Protocol Violation|0|||
47068693|NCT01428661|83353281|FG000|Double-Masked Phase|Adverse Event|13|||
47068694|NCT01428661|83353282|FG001|Double-Masked Phase|Adverse Event|4|||
47068695|NCT01428661|83353283|FG002|Double-Masked Phase|Adverse Event|0|||
47068696|NCT01428661|83353281|FG000|Double-Masked Phase|Lost to Follow-up|14|||
47068697|NCT01428661|83353282|FG001|Double-Masked Phase|Lost to Follow-up|14|||
47068698|NCT01428661|83353283|FG002|Double-Masked Phase|Lost to Follow-up|0|||
47068699|NCT01428661|83353281|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
47068700|NCT01428661|83353282|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
47068701|NCT01428661|83353283|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
47068702|NCT01428661|83353281|FG000|Double-Masked Phase|Lack of Efficacy|2|||
47068703|NCT01428661|83353282|FG001|Double-Masked Phase|Lack of Efficacy|1|||
47068704|NCT01428661|83353283|FG002|Double-Masked Phase|Lack of Efficacy|0|||
47068705|NCT01428661|83353281|FG000|Double-Masked Phase|*Various|1|||
47068706|NCT01428661|83353282|FG001|Double-Masked Phase|*Various|6|||
47068707|NCT01428661|83353283|FG002|Double-Masked Phase|*Various|0|||
47068708|NCT01428661|83353281|FG000|Open Label Extension|Protocol Violation|0|||
47068709|NCT01428661|83353282|FG001|Open Label Extension|Protocol Violation|0|||
47068710|NCT01428661|83353283|FG002|Open Label Extension|Protocol Violation|9|||
47068711|NCT01428661|83353281|FG000|Open Label Extension|Adverse Event|0|||
47068712|NCT01428661|83353282|FG001|Open Label Extension|Adverse Event|0|||
47068713|NCT01428661|83353283|FG002|Open Label Extension|Adverse Event|15|||
47068714|NCT01428661|83353281|FG000|Open Label Extension|Lost to Follow-up|0|||
47068715|NCT01428661|83353282|FG001|Open Label Extension|Lost to Follow-up|0|||
47068716|NCT01428661|83353283|FG002|Open Label Extension|Lost to Follow-up|38|||
47068717|NCT01428661|83353281|FG000|Open Label Extension|Withdrawal by Subject|0|||
47068718|NCT01428661|83353282|FG001|Open Label Extension|Withdrawal by Subject|0|||
47068719|NCT01428661|83353283|FG002|Open Label Extension|Withdrawal by Subject|49|||
47068720|NCT01428661|83353281|FG000|Open Label Extension|Lack of Efficacy|0|||
47068721|NCT01428661|83353282|FG001|Open Label Extension|Lack of Efficacy|0|||
46775048|NCT00790751|82993475|FG000|Overall Study|Lost to Follow-up|4|||
46775049|NCT00790751|82993476|FG001|Overall Study|Lost to Follow-up|9|||
46967139|NCT04369469|83209849|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
46967140|NCT04369469|83209848|FG000|Overall Study|Unable to Provide Consent|0|||
46967141|NCT04369469|83209849|FG001|Overall Study|Unable to Provide Consent|1|||
46967142|NCT04647383|83209872|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
46967143|NCT04647383|83209873|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
46967144|NCT04647383|83209874|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
46967145|NCT04647383|83209875|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
46967146|NCT01670097|83209887|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
46967147|NCT01670097|83209888|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
46967148|NCT01670097|83209887|FG000|Overall Study|Study burden|1|||
46967149|NCT01670097|83209888|FG001|Overall Study|Study burden|0|||
46967150|NCT01670097|83209887|FG000|Overall Study|COPD exacerbation|0|||
46967151|NCT01670097|83209888|FG001|Overall Study|COPD exacerbation|1|||
46967152|NCT01670097|83209887|FG000|Overall Study|Neutropenia|0|||
46967153|NCT01670097|83209888|FG001|Overall Study|Neutropenia|1|||
46967154|NCT01670097|83209887|FG000|Overall Study|Clinical deterioration|0|||
46967155|NCT01670097|83209888|FG001|Overall Study|Clinical deterioration|1|||
46967156|NCT01670097|83209887|FG000|Overall Study|Disease progression|0|||
46967157|NCT01670097|83209888|FG001|Overall Study|Disease progression|1|||
46967158|NCT01670019|83209896|FG000|Overall Study|Adverse Event|3|||
46967159|NCT01670019|83209897|FG001|Overall Study|Adverse Event|0|||
46967160|NCT01670019|83209896|FG000|Overall Study|Withdrawal by Subject|6|||
46967161|NCT01670019|83209897|FG001|Overall Study|Withdrawal by Subject|0|||
46967162|NCT01669629|83209903|FG000|Period 1|protocol deviation|1|||
46967163|NCT01669629|83209904|FG001|Period 1|protocol deviation|2|||
47068722|NCT01428661|83353283|FG002|Open Label Extension|Lack of Efficacy|24|||
47068723|NCT01428661|83353281|FG000|Open Label Extension|**Various|0|||
47068724|NCT01428661|83353282|FG001|Open Label Extension|**Various|0|||
47068725|NCT01428661|83353283|FG002|Open Label Extension|**Various|185|||
46775050|NCT00790751|82993477|FG002|Overall Study|Lost to Follow-up|4|||
46775051|NCT00790751|82993478|FG003|Overall Study|Lost to Follow-up|5|||
47068726|NCT01428583|83353291|FG000|Overall Study|Adverse Event|75|||
46775052|NCT00790751|82993475|FG000|Overall Study|Adverse Event|5|||
46775053|NCT00790751|82993476|FG001|Overall Study|Adverse Event|3|||
46775054|NCT00790751|82993477|FG002|Overall Study|Adverse Event|5|||
46775055|NCT00790751|82993478|FG003|Overall Study|Adverse Event|4|||
46775056|NCT00790751|82993475|FG000|Overall Study|Requirement for restricted medication|0|||
46775057|NCT00790751|82993476|FG001|Overall Study|Requirement for restricted medication|2|||
46967164|NCT00701051|83209912|FG000|Screening|Failed Screening|40|||
46967165|NCT00701051|83209913|FG001|Screening|Failed Screening|0|||
46967166|NCT00701051|83209914|FG002|Screening|Failed Screening|0|||
46967167|NCT00701051|83209912|FG000|Screening|Time conflicts|19|||
47068727|NCT01428583|83353291|FG000|Overall Study|Withdrawal by Subject|51|||
47068728|NCT01428583|83353291|FG000|Overall Study|Lack of Efficacy|37|||
47068729|NCT01428583|83353291|FG000|Overall Study|Lost to Follow-up|17|||
47068730|NCT01428583|83353291|FG000|Overall Study|Death|1|||
47068731|NCT01428583|83353291|FG000|Overall Study|Pregnancy|1|||
47068732|NCT01428583|83353291|FG000|Overall Study|Protocol Violation|1|||
47068733|NCT01428583|83353291|FG000|Overall Study|Physician Decision|12|||
47068734|NCT01428583|83353291|FG000|Overall Study|Non-compliant|25|||
47068735|NCT01428583|83353291|FG000|Overall Study|Confirmed positive urine drug test|8|||
47068736|NCT01428583|83353291|FG000|Overall Study|Sponsor's request|3|||
47068737|NCT01428583|83353291|FG000|Overall Study|Other|6|||
47068738|NCT01428193|83353308|FG000|Overall Study|Physician Decision|1|||
47068739|NCT01428193|83353308|FG000|Overall Study|Elevated screening liver enzymes|1|||
47068740|NCT01428115|83353312|FG000|Overall Study|Lack of Efficacy|3|||
47068741|NCT01428115|83353312|FG000|Overall Study|Lost to Follow-up|10|||
47068742|NCT01428115|83353312|FG000|Overall Study|Pregnancy|1|||
47068743|NCT01428115|83353312|FG000|Overall Study|Protocol Violation|3|||
47068744|NCT01428115|83353312|FG000|Overall Study|Withdrawal by Subject|4|||
47068745|NCT01427803|83353319|FG000|Overall Study|Lost to Follow-up|32|||
47068746|NCT01427803|83353320|FG001|Overall Study|Lost to Follow-up|26|||
47068747|NCT01427803|83353319|FG000|Overall Study|Withdrawal by Subject|20|||
47068748|NCT01427803|83353320|FG001|Overall Study|Withdrawal by Subject|0|||
47068749|NCT01427803|83353319|FG000|Overall Study|Unable to complete full treatment period|6|||
47068750|NCT01427803|83353320|FG001|Overall Study|Unable to complete full treatment period|0|||
47068751|NCT01427803|83353319|FG000|Overall Study|Protocol Violation|1|||
47068752|NCT01427803|83353320|FG001|Overall Study|Protocol Violation|0|||
47068753|NCT01427803|83353319|FG000|Overall Study|Physician Decision|3|||
47068754|NCT01427803|83353320|FG001|Overall Study|Physician Decision|0|||
47068755|NCT01427803|83353319|FG000|Overall Study|did not take product|1|||
47068756|NCT01427803|83353320|FG001|Overall Study|did not take product|0|||
47068757|NCT01408537|83353324|FG000|Overall Study|Withdrawal by Subject|2|||
47068758|NCT01408537|83353324|FG000|Overall Study|Protocol Violation|3|||
47068759|NCT01408537|83353324|FG000|Overall Study|Lost to Follow-up|3|||
47068760|NCT01408459|83353357|FG000|Overall Study|Withdrawal by Subject|1|||
47068761|NCT01408459|83353358|FG001|Overall Study|Withdrawal by Subject|1|||
47068762|NCT01408303|83353377|FG000|Overall Study|Adverse Event|3|||
47068763|NCT01408303|83353378|FG001|Overall Study|Adverse Event|7|||
47068764|NCT01408303|83353379|FG002|Overall Study|Adverse Event|2|||
47068765|NCT01408303|83353377|FG000|Overall Study|Lost to Follow-up|0|||
47068766|NCT01408303|83353378|FG001|Overall Study|Lost to Follow-up|1|||
47068767|NCT01408303|83353379|FG002|Overall Study|Lost to Follow-up|2|||
47068768|NCT01408303|83353377|FG000|Overall Study|Withdrawal by Subject|2|||
47068769|NCT01408303|83353378|FG001|Overall Study|Withdrawal by Subject|3|||
47068770|NCT01408303|83353379|FG002|Overall Study|Withdrawal by Subject|1|||
47068771|NCT01408303|83353377|FG000|Overall Study|Protocol Violation|0|||
47068772|NCT01408303|83353378|FG001|Overall Study|Protocol Violation|1|||
47068773|NCT01408303|83353379|FG002|Overall Study|Protocol Violation|0|||
47068774|NCT01408303|83353377|FG000|Overall Study|Noncompliance|1|||
47068775|NCT01408303|83353378|FG001|Overall Study|Noncompliance|0|||
47068776|NCT01408303|83353379|FG002|Overall Study|Noncompliance|1|||
47068777|NCT01408147|83353400|FG000|Overall Study|Withdrawal by Subject|0|||
47068778|NCT01408147|83353401|FG001|Overall Study|Withdrawal by Subject|1|||
47068779|NCT01407367|83353409|FG000|Overall Study|Death|24|||
47068780|NCT01407367|83353410|FG001|Overall Study|Death|32|||
47068781|NCT01407367|83353409|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
47068782|NCT01407367|83353410|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
47068783|NCT01407367|83353409|FG000|Overall Study|Withdrawal by Subject|4|||
47068784|NCT01407367|83353410|FG001|Overall Study|Withdrawal by Subject|15|||
47068785|NCT01407367|83353409|FG000|Overall Study|Lost to Follow-up|0|||
47068786|NCT01407367|83353410|FG001|Overall Study|Lost to Follow-up|2|||
47068787|NCT01405027|83353446|FG000|Overall Study|Withdrawn consent|3|||
47068788|NCT01405027|83353447|FG001|Overall Study|Withdrawn consent|0|||
47068789|NCT01405027|83353446|FG000|Overall Study|Lost to Follow-up|16|||
46775058|NCT00790751|82993477|FG002|Overall Study|Requirement for restricted medication|0|||
46775059|NCT00790751|82993478|FG003|Overall Study|Requirement for restricted medication|0|||
46775060|NCT00790751|82993475|FG000|Overall Study|Death|0|||
46775061|NCT00790751|82993476|FG001|Overall Study|Death|0|||
46775062|NCT00790751|82993477|FG002|Overall Study|Death|1|||
46775063|NCT00790751|82993478|FG003|Overall Study|Death|0|||
46775064|NCT00790751|82993475|FG000|Overall Study|Physician Decision|0|||
46775065|NCT00790751|82993476|FG001|Overall Study|Physician Decision|0|||
47068790|NCT01405027|83353447|FG001|Overall Study|Lost to Follow-up|24|||
47068791|NCT01405027|83353446|FG000|Overall Study|Investigator judgement|0|||
47068792|NCT01405027|83353447|FG001|Overall Study|Investigator judgement|2|||
46775066|NCT00790751|82993477|FG002|Overall Study|Physician Decision|0|||
47068793|NCT01405027|83353446|FG000|Overall Study|Death|1|||
46775067|NCT00790751|82993478|FG003|Overall Study|Physician Decision|1|||
46775068|NCT00784979|82993488|FG000|Overall Study|incomplete data|6|||
46775069|NCT00738920|82993495|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
47068794|NCT01405027|83353447|FG001|Overall Study|Death|0|||
47068795|NCT01405027|83353446|FG000|Overall Study|Other or Unknown|12|||
46775070|NCT00738920|82993496|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
47068796|NCT01405027|83353447|FG001|Overall Study|Other or Unknown|25|||
47068797|NCT01412801|83353468|FG000|Overall Study|Death|0|||
47068798|NCT01412801|83353469|FG001|Overall Study|Death|1|||
47068799|NCT01412801|83353470|FG002|Overall Study|Death|0|||
47068800|NCT01412801|83353471|FG003|Overall Study|Death|4|||
47068801|NCT01412801|83353472|FG004|Overall Study|Death|2|||
47068802|NCT01412801|83353473|FG005|Overall Study|Death|2|||
47068803|NCT01412801|83353468|FG000|Overall Study|Lost to Follow-up|1|||
47068804|NCT01412801|83353469|FG001|Overall Study|Lost to Follow-up|2|||
47068805|NCT01412801|83353470|FG002|Overall Study|Lost to Follow-up|4|||
47068806|NCT01412801|83353471|FG003|Overall Study|Lost to Follow-up|0|||
47068807|NCT01412801|83353472|FG004|Overall Study|Lost to Follow-up|1|||
47068808|NCT01412801|83353473|FG005|Overall Study|Lost to Follow-up|1|||
47068809|NCT01412801|83353468|FG000|Overall Study|Withdrawal by Subject|3|||
47068810|NCT01412801|83353469|FG001|Overall Study|Withdrawal by Subject|2|||
47068811|NCT01412801|83353470|FG002|Overall Study|Withdrawal by Subject|1|||
47068812|NCT01412801|83353471|FG003|Overall Study|Withdrawal by Subject|0|||
47068813|NCT01412801|83353472|FG004|Overall Study|Withdrawal by Subject|0|||
47068814|NCT01412801|83353473|FG005|Overall Study|Withdrawal by Subject|0|||
47068815|NCT01412801|83353468|FG000|Overall Study|Relocated to another area|0|||
47068816|NCT01412801|83353469|FG001|Overall Study|Relocated to another area|0|||
47068817|NCT01412801|83353470|FG002|Overall Study|Relocated to another area|2|||
47068818|NCT01412801|83353471|FG003|Overall Study|Relocated to another area|0|||
47068819|NCT01412801|83353472|FG004|Overall Study|Relocated to another area|0|||
47068820|NCT01412801|83353473|FG005|Overall Study|Relocated to another area|0|||
47068821|NCT01525628|83353521|FG000|Overall Study|Adverse Event|1|||
47068822|NCT01525628|83353522|FG001|Overall Study|Adverse Event|1|||
47068823|NCT01525628|83353523|FG002|Overall Study|Adverse Event|2|||
47068824|NCT01525628|83353524|FG003|Overall Study|Adverse Event|0|||
47068825|NCT01525628|83353525|FG004|Overall Study|Adverse Event|1|||
47068826|NCT01525628|83353521|FG000|Overall Study|Lack of Efficacy|0|||
47068827|NCT01525628|83353522|FG001|Overall Study|Lack of Efficacy|2|||
47068828|NCT01525628|83353523|FG002|Overall Study|Lack of Efficacy|2|||
47068829|NCT01525628|83353524|FG003|Overall Study|Lack of Efficacy|1|||
47068830|NCT01525628|83353525|FG004|Overall Study|Lack of Efficacy|2|||
47068831|NCT01525628|83353521|FG000|Overall Study|Protocol Violation|0|||
47068832|NCT01525628|83353522|FG001|Overall Study|Protocol Violation|0|||
47068833|NCT01525628|83353523|FG002|Overall Study|Protocol Violation|1|||
47068834|NCT01525628|83353524|FG003|Overall Study|Protocol Violation|0|||
47068835|NCT01525628|83353525|FG004|Overall Study|Protocol Violation|0|||
47068836|NCT01525628|83353521|FG000|Overall Study|Lost to Follow-up|1|||
47068837|NCT01525628|83353522|FG001|Overall Study|Lost to Follow-up|1|||
47068838|NCT01525628|83353523|FG002|Overall Study|Lost to Follow-up|0|||
47068839|NCT01525628|83353524|FG003|Overall Study|Lost to Follow-up|0|||
46775071|NCT00738920|82993497|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
46775072|NCT00738920|82993495|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
46775073|NCT00738920|82993496|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
46775074|NCT00738920|82993497|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
46775075|NCT00738920|82993495|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
46775076|NCT00738920|82993496|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
46775077|NCT00738920|82993497|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
46846237|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
46846238|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
46846239|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
46846240|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
46846241|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
46846242|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
46846243|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
46775078|NCT00738920|82993495|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
46775079|NCT00738920|82993496|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
46775080|NCT00738920|82993497|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
46846244|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
46846245|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
46846246|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
46846247|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
46967168|NCT00701051|83209913|FG001|Screening|Time conflicts|0|||
46967169|NCT00701051|83209914|FG002|Screening|Time conflicts|0|||
47068840|NCT01525628|83353525|FG004|Overall Study|Lost to Follow-up|0|||
47068841|NCT01525628|83353521|FG000|Overall Study|Withdrawal by Subject|0|||
47068842|NCT01525628|83353522|FG001|Overall Study|Withdrawal by Subject|1|||
47068843|NCT01525628|83353523|FG002|Overall Study|Withdrawal by Subject|0|||
47068844|NCT01525628|83353524|FG003|Overall Study|Withdrawal by Subject|0|||
47068845|NCT01525628|83353525|FG004|Overall Study|Withdrawal by Subject|0|||
47068846|NCT01525628|83353521|FG000|Overall Study|Other reason not defined above|0|||
47068847|NCT01525628|83353522|FG001|Overall Study|Other reason not defined above|0|||
46846248|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
46846249|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
46846250|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
46846251|NCT00132678|83062997|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
46846252|NCT00132678|83062998|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
46846253|NCT00132678|83062999|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
46846254|NCT00132678|83062997|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
46846255|NCT00132678|83062998|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
46846256|NCT00132678|83062999|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
46846257|NCT00132678|83062997|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
46846258|NCT00132678|83062998|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
46846259|NCT00132678|83062999|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
46846260|NCT00132678|83062997|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
46846261|NCT00132678|83062998|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
46846262|NCT00132678|83062999|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
46846263|NCT00132678|83062997|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
46846264|NCT00132678|83062998|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
47068848|NCT01525628|83353523|FG002|Overall Study|Other reason not defined above|0|||
47068849|NCT01525628|83353524|FG003|Overall Study|Other reason not defined above|3|||
47068850|NCT01525628|83353525|FG004|Overall Study|Other reason not defined above|0|||
47068851|NCT01412021|83353539|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
47068852|NCT01412021|83353539|FG000|Overall Study|Treatment Prior to Approval|3|||
47068853|NCT01412021|83353539|FG000|Overall Study|Transferred to Other Hospital|9|||
47068854|NCT01426789|83353545|FG000|Part 1|Protocol deviation|0|||
47068855|NCT01426789|83353546|FG001|Part 1|Protocol deviation|1|||
47068856|NCT01426789|83353547|FG002|Part 1|Protocol deviation|0|||
47068857|NCT01426789|83353548|FG003|Part 1|Protocol deviation|0|||
47068858|NCT01426789|83353549|FG004|Part 1|Protocol deviation|0|||
47068859|NCT01426789|83353550|FG005|Part 1|Protocol deviation|0|||
47068860|NCT01426789|83353545|FG000|Part 1|Lost to Follow-up|1|||
47068861|NCT01426789|83353546|FG001|Part 1|Lost to Follow-up|2|||
47068862|NCT01426789|83353547|FG002|Part 1|Lost to Follow-up|0|||
47068863|NCT01426789|83353548|FG003|Part 1|Lost to Follow-up|0|||
47068864|NCT01426789|83353549|FG004|Part 1|Lost to Follow-up|0|||
47068865|NCT01426789|83353550|FG005|Part 1|Lost to Follow-up|0|||
47068866|NCT01426789|83353545|FG000|Part 1|Lack of Efficacy|2|||
47068867|NCT01426789|83353546|FG001|Part 1|Lack of Efficacy|1|||
47068868|NCT01426789|83353547|FG002|Part 1|Lack of Efficacy|0|||
47068869|NCT01426789|83353548|FG003|Part 1|Lack of Efficacy|0|||
47068870|NCT01426789|83353549|FG004|Part 1|Lack of Efficacy|0|||
47068871|NCT01426789|83353550|FG005|Part 1|Lack of Efficacy|0|||
47068872|NCT01426789|83353545|FG000|Part 1|Adverse Event|3|||
47068873|NCT01426789|83353546|FG001|Part 1|Adverse Event|0|||
47068874|NCT01426789|83353547|FG002|Part 1|Adverse Event|0|||
47068875|NCT01426789|83353548|FG003|Part 1|Adverse Event|0|||
47068876|NCT01426789|83353549|FG004|Part 1|Adverse Event|0|||
47068877|NCT01426789|83353550|FG005|Part 1|Adverse Event|0|||
47068878|NCT01426789|83353545|FG000|Part 2|Protocol deviation|0|||
47068879|NCT01426789|83353546|FG001|Part 2|Protocol deviation|0|||
47068880|NCT01426789|83353547|FG002|Part 2|Protocol deviation|1|||
47068881|NCT01426789|83353548|FG003|Part 2|Protocol deviation|0|||
47068882|NCT01426789|83353549|FG004|Part 2|Protocol deviation|0|||
46775081|NCT00738920|82993495|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
46775082|NCT00738920|82993496|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
46775083|NCT00738920|82993497|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
46775084|NCT00738920|82993495|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
46775085|NCT00738920|82993496|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
46775086|NCT00738920|82993497|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
46775087|NCT00738920|82993495|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
46775088|NCT00738920|82993496|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
46775089|NCT00738920|82993497|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
46775090|NCT00738920|82993495|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
46775091|NCT00738920|82993496|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
46967170|NCT00701051|83209912|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
46846265|NCT00132678|83062999|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
47068883|NCT01426789|83353550|FG005|Part 2|Protocol deviation|0|||
47068884|NCT01426789|83353545|FG000|Part 2|Death|0|||
47068885|NCT01426789|83353546|FG001|Part 2|Death|0|||
47068886|NCT01426789|83353547|FG002|Part 2|Death|1|||
47068887|NCT01426789|83353548|FG003|Part 2|Death|0|||
47068888|NCT01426789|83353549|FG004|Part 2|Death|1|||
47068889|NCT01426789|83353550|FG005|Part 2|Death|0|||
47068890|NCT01426789|83353545|FG000|Part 2|Administrative problems|0|||
47068891|NCT01426789|83353546|FG001|Part 2|Administrative problems|0|||
47068892|NCT01426789|83353547|FG002|Part 2|Administrative problems|2|||
47068893|NCT01426789|83353548|FG003|Part 2|Administrative problems|0|||
47068894|NCT01426789|83353549|FG004|Part 2|Administrative problems|1|||
47068895|NCT01426789|83353550|FG005|Part 2|Administrative problems|0|||
47068896|NCT01426789|83353545|FG000|Part 2|Lost to Follow-up|0|||
47068897|NCT01426789|83353546|FG001|Part 2|Lost to Follow-up|0|||
47068898|NCT01426789|83353547|FG002|Part 2|Lost to Follow-up|4|||
47068899|NCT01426789|83353548|FG003|Part 2|Lost to Follow-up|0|||
47068900|NCT01426789|83353549|FG004|Part 2|Lost to Follow-up|1|||
47068901|NCT01426789|83353550|FG005|Part 2|Lost to Follow-up|0|||
47068902|NCT01426789|83353545|FG000|Part 2|Withdrawal by Subject|0|||
47068903|NCT01426789|83353546|FG001|Part 2|Withdrawal by Subject|0|||
47068904|NCT01426789|83353547|FG002|Part 2|Withdrawal by Subject|0|||
47068905|NCT01426789|83353548|FG003|Part 2|Withdrawal by Subject|1|||
47068906|NCT01426789|83353549|FG004|Part 2|Withdrawal by Subject|2|||
47068907|NCT01426789|83353550|FG005|Part 2|Withdrawal by Subject|0|||
47068908|NCT01426789|83353545|FG000|Part 2|Lack of Efficacy|0|||
47068909|NCT01426789|83353546|FG001|Part 2|Lack of Efficacy|0|||
47068910|NCT01426789|83353547|FG002|Part 2|Lack of Efficacy|5|||
47068911|NCT01426789|83353548|FG003|Part 2|Lack of Efficacy|0|||
47068912|NCT01426789|83353549|FG004|Part 2|Lack of Efficacy|2|||
47068913|NCT01426789|83353550|FG005|Part 2|Lack of Efficacy|0|||
47068914|NCT01426789|83353545|FG000|Part 2|Adverse Event|0|||
47068915|NCT01426789|83353546|FG001|Part 2|Adverse Event|0|||
47068916|NCT01426789|83353547|FG002|Part 2|Adverse Event|2|||
47068917|NCT01426789|83353548|FG003|Part 2|Adverse Event|0|||
47068918|NCT01426789|83353549|FG004|Part 2|Adverse Event|1|||
47068919|NCT01426789|83353550|FG005|Part 2|Adverse Event|0|||
47068920|NCT01426009|83353571|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
47068921|NCT01426009|83353571|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
47068922|NCT01426009|83353571|FG000|Washout 1|Withdrawal by Subject|1|||
47068923|NCT01426009|83353571|FG000|Washout 1|Personal Reasons|1|||
47068924|NCT01426009|83353571|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
47068925|NCT01426009|83353571|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
47068926|NCT01426009|83353571|FG000|Washout 2|electrive surgery|1|||
47068927|NCT01426009|83353571|FG000|Washout 3|personal reasons|1|||
47068928|NCT01426009|83353571|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
47068929|NCT01426009|83353571|FG000|Washout 4|Lost to Follow-up|1|||
47068930|NCT01411319|83353600|FG000|Overall Study|Lost to Follow-up|1|||
47068931|NCT01543958|83353604|FG000|Overall Study|Loss to follow-up|3|||
47068932|NCT01543958|83353604|FG000|Overall Study|ART initiation|1|||
47068933|NCT01411085|83353608|FG000|Overall Study|Physician Decision|1|||
47068934|NCT01411085|83353608|FG000|Overall Study|Protocol Violation|1|||
47068935|NCT01411085|83353608|FG000|Overall Study|Adverse Event|1|||
47068936|NCT01543490|83353614|FG000|Overall Study|Adverse Event|4|||
47068937|NCT01543490|83353615|FG001|Overall Study|Adverse Event|0|||
47068938|NCT01543490|83353614|FG000|Overall Study|Physician Decision|1|||
47068939|NCT01543490|83353615|FG001|Overall Study|Physician Decision|0|||
47068940|NCT01543490|83353614|FG000|Overall Study|Lack of Efficacy|3|||
47068941|NCT01543490|83353615|FG001|Overall Study|Lack of Efficacy|3|||
47068942|NCT01543490|83353614|FG000|Overall Study|Lost to Follow-up|5|||
47068943|NCT01543490|83353615|FG001|Overall Study|Lost to Follow-up|0|||
47068944|NCT01543490|83353614|FG000|Overall Study|Withdrawal by Subject|2|||
47068945|NCT01543490|83353615|FG001|Overall Study|Withdrawal by Subject|0|||
47068946|NCT01543490|83353614|FG000|Overall Study|Other-Various Administrative Reasons|1|||
47068947|NCT01543490|83353615|FG001|Overall Study|Other-Various Administrative Reasons|2|||
47068948|NCT01404949|83353621|FG000|Overall Study|Not Treated|1|||
47068949|NCT01431521|83353629|FG000|Overall Study|Withdrawal by Subject|0|||
47068950|NCT01431521|83353630|FG001|Overall Study|Withdrawal by Subject|0|||
47068951|NCT01431521|83353631|FG002|Overall Study|Withdrawal by Subject|1|||
47068952|NCT01431521|83353632|FG003|Overall Study|Withdrawal by Subject|0|||
47068953|NCT01404325|83353708|FG000|Overall Study|Lost to Follow-up|1|||
46846266|NCT00132678|83062997|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
46846267|NCT00132678|83062998|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
46846268|NCT00132678|83062999|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
47068954|NCT01404325|83353709|FG001|Overall Study|Lost to Follow-up|0|||
47068955|NCT01404325|83353708|FG000|Overall Study|Death|2|||
47068956|NCT01404325|83353709|FG001|Overall Study|Death|0|||
47068957|NCT01404325|83353708|FG000|Overall Study|Graft loss/Retransplantation|1|||
47068958|NCT01404325|83353709|FG001|Overall Study|Graft loss/Retransplantation|0|||
47068959|NCT01404325|83353708|FG000|Overall Study|non-specified reason|0|||
47068960|NCT01404325|83353709|FG001|Overall Study|non-specified reason|2|||
47068961|NCT01425463|83353730|FG000|Overall Study|Adverse Event|5|||
47068962|NCT01425463|83353731|FG001|Overall Study|Adverse Event|7|||
47068963|NCT01425463|83353730|FG000|Overall Study|Lack of Efficacy|1|||
47068964|NCT01425463|83353731|FG001|Overall Study|Lack of Efficacy|1|||
47068965|NCT01425463|83353730|FG000|Overall Study|Protocol Violation|2|||
47068966|NCT01425463|83353731|FG001|Overall Study|Protocol Violation|2|||
47068967|NCT01425463|83353730|FG000|Overall Study|Lost to Follow-up|5|||
47068968|NCT01425463|83353731|FG001|Overall Study|Lost to Follow-up|2|||
47068969|NCT01425463|83353730|FG000|Overall Study|Withdrawal by Subject|7|||
47068970|NCT01425463|83353731|FG001|Overall Study|Withdrawal by Subject|5|||
47068971|NCT01425463|83353730|FG000|Overall Study|Unknown Reason|4|||
47068972|NCT01425463|83353731|FG001|Overall Study|Unknown Reason|7|||
47068973|NCT04655586|83353753|FG000|Overall Study|Physician Decision|1|||
46775092|NCT00738920|82993497|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
46775093|NCT00738920|82993495|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
46775094|NCT00738920|82993496|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
46967171|NCT00701051|83209913|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
46967172|NCT00701051|83209914|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
46967173|NCT00700817|83209925|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
46967174|NCT00700817|83209926|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
46967175|NCT00700817|83209927|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
46967176|NCT00700817|83209928|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
46967177|NCT00700817|83209929|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
46967178|NCT00700817|83209925|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
46967179|NCT00700817|83209926|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
46967180|NCT00700817|83209927|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
46967181|NCT00700817|83209928|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
46967182|NCT00700817|83209929|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
46775095|NCT00738920|82993497|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
46775096|NCT00738920|82993495|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
46775097|NCT00738920|82993496|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
46775098|NCT00738920|82993497|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
46775099|NCT00582972|82993505|FG000|Overall Study|Protocol Violation|2|||
46775100|NCT04319718|82993512|FG000|Overall Study|Adverse Event|0|||
46775101|NCT04319718|82993513|FG001|Overall Study|Adverse Event|2|||
46775102|NCT04319718|82993512|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
46775103|NCT04319718|82993513|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
46775104|NCT04372602|82993521|FG000|Overall Study|Withdrawal by Subject|1|||
46775105|NCT04372602|82993522|FG001|Overall Study|Withdrawal by Subject|1|||
46775106|NCT04372602|82993521|FG000|Overall Study|Adverse Event|0|||
46775107|NCT04372602|82993522|FG001|Overall Study|Adverse Event|1|||
46775108|NCT04372602|82993521|FG000|Overall Study|Transitioned to comfort care|0|||
46775109|NCT04372602|82993522|FG001|Overall Study|Transitioned to comfort care|1|||
46775110|NCT00733304|82993531|FG000|Overall Study|Adverse Event|3|||
46775111|NCT00733304|82993532|FG001|Overall Study|Adverse Event|0|||
46775112|NCT00733304|82993533|FG002|Overall Study|Adverse Event|0|||
46775113|NCT00733304|82993531|FG000|Overall Study|Lack of Efficacy|0|||
46775114|NCT00733304|82993532|FG001|Overall Study|Lack of Efficacy|0|||
46775115|NCT00733304|82993533|FG002|Overall Study|Lack of Efficacy|2|||
46775116|NCT00733304|82993531|FG000|Overall Study|Lost to Follow-up|0|||
46775117|NCT00733304|82993532|FG001|Overall Study|Lost to Follow-up|1|||
46775118|NCT00733304|82993533|FG002|Overall Study|Lost to Follow-up|0|||
46775119|NCT00733304|82993531|FG000|Overall Study|Physician Decision|3|||
46775120|NCT00733304|82993532|FG001|Overall Study|Physician Decision|1|||
46775121|NCT00733304|82993533|FG002|Overall Study|Physician Decision|3|||
46775122|NCT00733304|82993531|FG000|Overall Study|Withdrawal by Subject|1|||
46775123|NCT00733304|82993532|FG001|Overall Study|Withdrawal by Subject|1|||
46775124|NCT00733304|82993533|FG002|Overall Study|Withdrawal by Subject|0|||
46775125|NCT00711243|82993547|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
46775126|NCT00711243|82993548|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
46775127|NCT00711243|82993549|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
46775128|NCT00711243|82993550|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
46775129|NCT00711243|82993551|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
46775130|NCT00711243|82993552|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
46775131|NCT00711243|82993547|FG000|Reached First Response/4 Cycles|Death|0|||
46775132|NCT00711243|82993548|FG001|Reached First Response/4 Cycles|Death|0|||
46967183|NCT00700817|83209925|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
46967184|NCT00700817|83209926|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
46967185|NCT00700817|83209927|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
46967186|NCT00700817|83209928|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
46775133|NCT00711243|82993549|FG002|Reached First Response/4 Cycles|Death|0|||
46641010|NCT02987543|82820327|FG001|Overall Study|Lost to Follow-up|0|||
46775134|NCT00711243|82993550|FG003|Reached First Response/4 Cycles|Death|0|||
46775135|NCT00711243|82993551|FG004|Reached First Response/4 Cycles|Death|0|||
46846269|NCT00132678|83062997|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
46846270|NCT00132678|83062998|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
46967187|NCT00700817|83209929|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
46967188|NCT00700817|83209925|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
46775136|NCT00711243|82993552|FG005|Reached First Response/4 Cycles|Death|2|||
46775137|NCT00711243|82993547|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
46775138|NCT00711243|82993548|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
46846271|NCT00132678|83062999|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
46846272|NCT00132678|83062997|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
47068974|NCT04655586|83353754|FG001|Overall Study|Physician Decision|3|||
47068975|NCT04655586|83353755|FG002|Overall Study|Physician Decision|4|||
47068976|NCT04655586|83353753|FG000|Overall Study|Withdrawal by Subject|1|||
47068977|NCT04655586|83353754|FG001|Overall Study|Withdrawal by Subject|3|||
47068978|NCT04655586|83353755|FG002|Overall Study|Withdrawal by Subject|1|||
47068979|NCT01388647|83353783|FG000|Overall Study|Adverse Event|1|||
46846273|NCT00132678|83062998|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
46846274|NCT00132678|83062999|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
46846275|NCT00101868|83063009|FG000|Overall Study|Death|10|||
46846276|NCT00101868|83063010|FG001|Overall Study|Death|10|||
46846277|NCT00101868|83063009|FG000|Overall Study|Withdrawal by Subject|8|||
46846278|NCT00101868|83063010|FG001|Overall Study|Withdrawal by Subject|9|||
46846279|NCT00101868|83063009|FG000|Overall Study|Protocol Violation|3|||
46846280|NCT00101868|83063010|FG001|Overall Study|Protocol Violation|0|||
46846281|NCT00101868|83063009|FG000|Overall Study|Lost to Follow-up|8|||
46846282|NCT00101868|83063010|FG001|Overall Study|Lost to Follow-up|13|||
46846283|NCT00101400|83063018|FG000|Survival Follow-Up|Alive|7|||
46846284|NCT03821064|83063022|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
46846285|NCT00141518|83063029|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
46846286|NCT00141518|83063030|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
46846287|NCT00141518|83063031|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
46846288|NCT00141518|83063029|FG000|Overall Study|Adverse Event|7|||
46846289|NCT00141518|83063030|FG001|Overall Study|Adverse Event|5|||
46846290|NCT00141518|83063031|FG002|Overall Study|Adverse Event|2|||
46846291|NCT00141518|83063029|FG000|Overall Study|Withdrawal by Subject|2|||
46846292|NCT00141518|83063030|FG001|Overall Study|Withdrawal by Subject|0|||
46846293|NCT00141518|83063031|FG002|Overall Study|Withdrawal by Subject|2|||
46846294|NCT00141518|83063029|FG000|Overall Study|Protocol Violation|1|||
47068980|NCT01388647|83353784|FG001|Overall Study|Adverse Event|2|||
47068981|NCT01402063|83353859|FG000|Overall Study|Withdrawal by Subject|3|||
47068982|NCT01402063|83353860|FG001|Overall Study|Withdrawal by Subject|3|||
47068983|NCT01796301|83353868|FG000|Overall Study|Withdrawal by Subject|15|||
47068984|NCT01796301|83353869|FG001|Overall Study|Withdrawal by Subject|15|||
47068985|NCT01796301|83353868|FG000|Overall Study|Lost to Follow-up|3|||
47068986|NCT01796301|83353869|FG001|Overall Study|Lost to Follow-up|3|||
47068987|NCT01796301|83353868|FG000|Overall Study|Death|0|||
47068988|NCT01796301|83353869|FG001|Overall Study|Death|1|||
47068989|NCT01796301|83353868|FG000|Overall Study|Decision by Sponsor|0|||
47068990|NCT01796301|83353869|FG001|Overall Study|Decision by Sponsor|1|||
47068991|NCT01388335|83353888|FG000|Period 1|Progressive Disease|1|||
47068992|NCT01388335|83353888|FG000|Period 2|Progressive Disease|2|||
46775139|NCT00711243|82993549|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
46775140|NCT00711243|82993550|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
46775141|NCT00711243|82993551|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
46775142|NCT00711243|82993552|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
46775143|NCT00711243|82993547|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
46775144|NCT00711243|82993548|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
46775145|NCT00711243|82993549|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
46775146|NCT00711243|82993550|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
46775147|NCT00711243|82993551|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
46775148|NCT00711243|82993552|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
46775149|NCT00711243|82993547|FG000|Treated Cycle 5 After First Response|Death|0|||
46775150|NCT00711243|82993548|FG001|Treated Cycle 5 After First Response|Death|0|||
46775151|NCT00711243|82993549|FG002|Treated Cycle 5 After First Response|Death|0|||
46775152|NCT00711243|82993550|FG003|Treated Cycle 5 After First Response|Death|0|||
46775153|NCT00711243|82993551|FG004|Treated Cycle 5 After First Response|Death|0|||
46775154|NCT00711243|82993552|FG005|Treated Cycle 5 After First Response|Death|2|||
46846295|NCT00141518|83063030|FG001|Overall Study|Protocol Violation|1|||
47068993|NCT01388335|83353888|FG000|Period 2|Sponsor Decision|1|||
47068994|NCT01388335|83353888|FG000|Safety Extension|Progressive Disease|7|||
47068995|NCT01401361|83353935|FG000|Overall Study|Withdrawal by Subject|16|||
46846296|NCT00141518|83063031|FG002|Overall Study|Protocol Violation|2|||
46846297|NCT00141518|83063029|FG000|Overall Study|Lack of Efficacy|5|||
46846298|NCT00141518|83063030|FG001|Overall Study|Lack of Efficacy|0|||
46846299|NCT00141518|83063031|FG002|Overall Study|Lack of Efficacy|0|||
47068996|NCT01401361|83353935|FG000|Overall Study|Lack of Efficacy|6|||
46775155|NCT00711243|82993547|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
46775156|NCT00711243|82993548|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
46775157|NCT00711243|82993549|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
46846300|NCT00253448|83063041|FG000|Overall Study|Withdrawal by Subject|1|||
46775158|NCT00711243|82993550|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
46775159|NCT00711243|82993551|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
47068997|NCT01401361|83353935|FG000|Overall Study|Physician Decision|1|||
47068998|NCT01401361|83353935|FG000|Overall Study|Lost to Follow-up|3|||
47068999|NCT01401361|83353935|FG000|Overall Study|Subject/family decision post procedure|2|||
47069000|NCT01401283|83353941|FG000|Overall Study|surgery cancelled|5|||
47069001|NCT01401283|83353942|FG001|Overall Study|surgery cancelled|8|||
47069002|NCT01401283|83353941|FG000|Overall Study|preoperative arrhythmia|5|||
47069003|NCT01401283|83353942|FG001|Overall Study|preoperative arrhythmia|0|||
47069004|NCT01401283|83353941|FG000|Overall Study|no central venous access|0|||
47069005|NCT01401283|83353942|FG001|Overall Study|no central venous access|1|||
47069006|NCT01401283|83353941|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
47069007|NCT01401283|83353942|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
47069008|NCT01422889|83353965|FG000|Overall Study|No Data Entered for Study Stent|9|||
47069009|NCT01400971|83353969|FG000|Overall Study|Death|82|||
47069010|NCT01400971|83353969|FG000|Overall Study|Lost to Follow-up|196|||
47069011|NCT01400971|83353969|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
47069012|NCT01400971|83353969|FG000|Overall Study|Physician Decision|57|||
47069013|NCT01400971|83353969|FG000|Overall Study|Withdrawal by Subject|158|||
47069014|NCT01400971|83353969|FG000|Overall Study|Other|422|||
47069015|NCT01387789|83353973|FG000|Overall Study|Adverse Event|5|||
47069016|NCT01387789|83353973|FG000|Overall Study|Lack of Efficacy|2|||
47069017|NCT01387789|83353973|FG000|Overall Study|Lost to Follow-up|1|||
47069018|NCT01400893|83353984|FG000|Overall Study|Death|27|||
47069019|NCT01400893|83353985|FG001|Overall Study|Death|21|||
47069020|NCT01400893|83353984|FG000|Overall Study|Lost to Follow-up|0|||
47069021|NCT01400893|83353985|FG001|Overall Study|Lost to Follow-up|6|||
47069022|NCT01400815|83354025|FG000|Overall Study|Adverse Event|3|||
47069023|NCT01400815|83354026|FG001|Overall Study|Adverse Event|0|||
47069024|NCT01400815|83354025|FG000|Overall Study|Death|0|||
47069025|NCT01400815|83354026|FG001|Overall Study|Death|1|||
47069026|NCT01400815|83354025|FG000|Overall Study|Lost to Follow-up|18|||
47069027|NCT01400815|83354026|FG001|Overall Study|Lost to Follow-up|11|||
47069028|NCT01400815|83354025|FG000|Overall Study|Protocol Violation|0|||
47069029|NCT01400815|83354026|FG001|Overall Study|Protocol Violation|1|||
47069030|NCT01400815|83354025|FG000|Overall Study|Physician Decision|1|||
47069031|NCT01400815|83354026|FG001|Overall Study|Physician Decision|0|||
47069032|NCT01400815|83354025|FG000|Overall Study|Withdrawal by Subject|15|||
47069033|NCT01400815|83354026|FG001|Overall Study|Withdrawal by Subject|8|||
47069034|NCT01400815|83354025|FG000|Overall Study|Subject in jail|1|||
47069035|NCT01400815|83354026|FG001|Overall Study|Subject in jail|0|||
47069036|NCT01400503|83354080|FG000|Overall Study|Withdrawal by Subject|1|||
47069037|NCT01400503|83354080|FG000|Overall Study|Study Terminated by Sponsor|58|||
47069038|NCT01400503|83354080|FG000|Overall Study|Other|1|||
47069039|NCT01400425|83354096|FG000|Overall Study|Withdrawal by Subject|10|||
47069040|NCT01421719|83354102|FG000|Overall Study|Withdrawal by Subject|4|||
47069041|NCT01421641|83354109|FG000|Overall Study|Protocol Violation|2|||
47069042|NCT01421641|83354110|FG001|Overall Study|Protocol Violation|2|||
47069043|NCT01385995|83354118|FG000|Period 1, 2 Months|Physician Decision|1|||
47069044|NCT01385995|83354119|FG001|Period 1, 2 Months|Physician Decision|0|||
47069045|NCT01421017|83354130|FG000|Overall Study|Withdrawal by Subject|2|||
47069046|NCT01421017|83354131|FG001|Overall Study|Withdrawal by Subject|0|||
47069047|NCT01421017|83354132|FG002|Overall Study|Withdrawal by Subject|0|||
47069048|NCT01421017|83354130|FG000|Overall Study|POD|0|||
47069049|NCT01421017|83354131|FG001|Overall Study|POD|6|||
47069050|NCT01421017|83354132|FG002|Overall Study|POD|3|||
47069051|NCT01420627|83354179|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
47069052|NCT01400113|83354189|FG000|Overall Study|Withdrawal by Subject|1|||
46775160|NCT00711243|82993552|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
46775161|NCT00711243|82993547|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
47069053|NCT01400113|83354190|FG001|Overall Study|Withdrawal by Subject|1|||
47069054|NCT01399723|83354198|FG000|Overall Study|Lost to Follow-up|0|||
47069055|NCT01399723|83354199|FG001|Overall Study|Lost to Follow-up|1|||
47069056|NCT01385371|83354208|FG000|Overall Study|Adverse Event|54|||
47069057|NCT01385371|83354209|FG001|Overall Study|Adverse Event|19|||
47069058|NCT01385371|83354208|FG000|Overall Study|Lost to Follow-up|16|||
46775162|NCT00711243|82993548|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
46775163|NCT00711243|82993549|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
47069059|NCT01385371|83354209|FG001|Overall Study|Lost to Follow-up|16|||
46775164|NCT00711243|82993550|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
46775165|NCT00711243|82993551|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
47069060|NCT01385371|83354208|FG000|Overall Study|Withdrawal by Subject|52|||
47069061|NCT01385371|83354209|FG001|Overall Study|Withdrawal by Subject|39|||
47069062|NCT01385371|83354208|FG000|Overall Study|Protocol Violation|25|||
47069063|NCT01385371|83354209|FG001|Overall Study|Protocol Violation|21|||
47069064|NCT01385371|83354208|FG000|Overall Study|Administrative|2|||
47069065|NCT01385371|83354209|FG001|Overall Study|Administrative|2|||
47069066|NCT01399099|83354215|FG000|Overall Study|Lost to Follow-up|11|||
47069067|NCT01399099|83354215|FG000|Overall Study|Physician Decision|1|||
47069068|NCT01399099|83354215|FG000|Overall Study|Protocol Violation|1|||
47069069|NCT01399099|83354215|FG000|Overall Study|Skin Irritation|13|||
47069070|NCT01399099|83354215|FG000|Overall Study|Infection|1|||
47069071|NCT01399099|83354215|FG000|Overall Study|Miscellaneous|4|||
47069072|NCT01398787|83354220|FG000|Overall Study|Adverse Event|1|||
47069073|NCT01383499|83354226|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
47069074|NCT01383499|83354227|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
47069075|NCT01383499|83354228|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
46641011|NCT02987543|82820328|FG002|Overall Study|Lost to Follow-up|1|||
46775166|NCT00711243|82993552|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
46775167|NCT00733226|82993570|FG000|Overall Study|Withdrawal by Subject|1|||
46775168|NCT00733226|82993571|FG001|Overall Study|Withdrawal by Subject|0|||
46846301|NCT00098748|83063048|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
46846302|NCT00098748|83063049|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
46775169|NCT00733226|82993570|FG000|Overall Study|Lost to Follow-up|2|||
46775170|NCT00733226|82993571|FG001|Overall Study|Lost to Follow-up|0|||
46775171|NCT00733226|82993570|FG000|Overall Study|moved to another place|2|||
46775172|NCT00733226|82993571|FG001|Overall Study|moved to another place|0|||
46846303|NCT00098748|83063050|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
46846304|NCT00098748|83063048|FG000|Received Study Treatment|Death|2|||
46846305|NCT00098748|83063049|FG001|Received Study Treatment|Death|1|||
46846306|NCT00098748|83063050|FG002|Received Study Treatment|Death|2|||
46846307|NCT00098748|83063048|FG000|Received Study Treatment|Adverse Event|1|||
46846308|NCT00098748|83063049|FG001|Received Study Treatment|Adverse Event|2|||
46846309|NCT00098748|83063050|FG002|Received Study Treatment|Adverse Event|5|||
46846310|NCT00098748|83063048|FG000|Received Study Treatment|Lack of Efficacy|40|||
46846311|NCT00098748|83063049|FG001|Received Study Treatment|Lack of Efficacy|27|||
46846312|NCT00098748|83063050|FG002|Received Study Treatment|Lack of Efficacy|27|||
46846313|NCT00098748|83063048|FG000|Received Study Treatment|Other|2|||
46846314|NCT00098748|83063049|FG001|Received Study Treatment|Other|2|||
46846315|NCT00098748|83063050|FG002|Received Study Treatment|Other|6|||
46967189|NCT00700817|83209926|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
46967190|NCT00700817|83209927|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
46967191|NCT00700817|83209928|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
46967192|NCT00700817|83209929|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
46967193|NCT00700817|83209925|FG000|Week 0-26 (Main Period)|Unclassified|14|||
46967194|NCT00700817|83209926|FG001|Week 0-26 (Main Period)|Unclassified|4|||
46967195|NCT00700817|83209927|FG002|Week 0-26 (Main Period)|Unclassified|8|||
46967196|NCT00700817|83209928|FG003|Week 0-26 (Main Period)|Unclassified|0|||
46967197|NCT00700817|83209929|FG004|Week 0-26 (Main Period)|Unclassified|0|||
46967198|NCT00700817|83209925|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
46967199|NCT00700817|83209926|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
46967200|NCT00700817|83209927|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
46967201|NCT00700817|83209928|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
46967202|NCT00700817|83209929|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
46967203|NCT00700817|83209925|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
46967204|NCT00700817|83209926|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
46967205|NCT00700817|83209927|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
46967206|NCT00700817|83209928|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
46967207|NCT00700817|83209929|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
46967208|NCT00700817|83209925|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
46967209|NCT00700817|83209926|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
46967210|NCT00700817|83209927|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
46967211|NCT00700817|83209928|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
46967212|NCT00700817|83209929|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
46967213|NCT00700817|83209925|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
46967214|NCT00700817|83209926|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
46967215|NCT00700817|83209927|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
46967216|NCT00700817|83209928|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
46967217|NCT00700817|83209929|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
46967218|NCT00700817|83209925|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
47069076|NCT01383499|83354229|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
47069077|NCT01397461|83354245|FG000|Overall Study|Withdrawal by Subject|2|||
46641012|NCT02987543|82820329|FG003|Overall Study|Lost to Follow-up|0|||
46775173|NCT00732992|82993579|FG000|Overall Study|Adverse Event|1|||
46846316|NCT00098748|83063048|FG000|Received Study Treatment|Subject defaulted|3|||
46846317|NCT00098748|83063049|FG001|Received Study Treatment|Subject defaulted|4|||
46775174|NCT00732992|82993580|FG001|Overall Study|Adverse Event|1|||
46775175|NCT00732992|82993579|FG000|Overall Study|Objective Progression or Relapse|3|||
46846318|NCT00098748|83063050|FG002|Received Study Treatment|Subject defaulted|4|||
46846319|NCT00098748|83063048|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
46846320|NCT00098748|83063049|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
47069078|NCT01397461|83354246|FG001|Overall Study|Withdrawal by Subject|1|||
47069079|NCT01397461|83354247|FG002|Overall Study|Withdrawal by Subject|0|||
47069080|NCT01397461|83354245|FG000|Overall Study|Lost to Follow-up|0|||
47069081|NCT01397461|83354246|FG001|Overall Study|Lost to Follow-up|2|||
47069082|NCT01397461|83354247|FG002|Overall Study|Lost to Follow-up|1|||
47069083|NCT01397461|83354245|FG000|Overall Study|Lack of Efficacy|0|||
47069084|NCT01397461|83354246|FG001|Overall Study|Lack of Efficacy|3|||
47069085|NCT01397461|83354247|FG002|Overall Study|Lack of Efficacy|0|||
47069086|NCT01397461|83354245|FG000|Overall Study|Not treated|0|||
46775176|NCT00732992|82993580|FG001|Overall Study|Objective Progression or Relapse|5|||
46775177|NCT00732992|82993579|FG000|Overall Study|Global Deterioration of Health Status|1|||
46775178|NCT00732992|82993580|FG001|Overall Study|Global Deterioration of Health Status|0|||
46775179|NCT00732992|82993579|FG000|Overall Study|Withdrawal by Subject|1|||
47069087|NCT01397461|83354246|FG001|Overall Study|Not treated|0|||
47069088|NCT01397461|83354247|FG002|Overall Study|Not treated|1|||
47069089|NCT01382251|83354257|FG000|Overall Study|Surgeries cancelled or delayed|16|||
47069090|NCT01382251|83354258|FG001|Overall Study|Surgeries cancelled or delayed|16|||
47069091|NCT01382251|83354257|FG000|Overall Study|Lost to Follow-up|4|||
47069092|NCT01382251|83354258|FG001|Overall Study|Lost to Follow-up|4|||
47069093|NCT01382251|83354257|FG000|Overall Study|Contacted after study closed|1|||
47069094|NCT01382251|83354258|FG001|Overall Study|Contacted after study closed|1|||
47069095|NCT01396525|83354263|FG000|Overall Study|Withdrawal by Subject|8|||
47069096|NCT01396525|83354263|FG000|Overall Study|Death|14|||
47069097|NCT01396525|83354263|FG000|Overall Study|Lost to Follow-up|4|||
47069098|NCT02849652|83354275|FG000|Overall Study|Lost to Follow-up|104|||
47069099|NCT02849652|83354276|FG001|Overall Study|Lost to Follow-up|35|||
47069100|NCT02849652|83354277|FG002|Overall Study|Lost to Follow-up|116|||
47069101|NCT02849652|83354278|FG003|Overall Study|Lost to Follow-up|22|||
47069102|NCT02849652|83354275|FG000|Overall Study|Withdrawal by Subject|10|||
47069103|NCT02849652|83354276|FG001|Overall Study|Withdrawal by Subject|2|||
47069104|NCT02849652|83354277|FG002|Overall Study|Withdrawal by Subject|8|||
47069105|NCT02849652|83354278|FG003|Overall Study|Withdrawal by Subject|4|||
47069106|NCT01396447|83354290|FG000|Overall Study|Did Not Receive Treatment|3|||
47069107|NCT01396447|83354291|FG001|Overall Study|Did Not Receive Treatment|2|||
47069108|NCT01396447|83354292|FG002|Overall Study|Did Not Receive Treatment|1|||
47069109|NCT01396447|83354293|FG003|Overall Study|Did Not Receive Treatment|0|||
47069110|NCT01396447|83354290|FG000|Overall Study|Adverse Event|15|||
47069111|NCT01396447|83354291|FG001|Overall Study|Adverse Event|12|||
47069112|NCT01396447|83354292|FG002|Overall Study|Adverse Event|12|||
47069113|NCT01396447|83354293|FG003|Overall Study|Adverse Event|17|||
47069114|NCT01396447|83354290|FG000|Overall Study|Insufficient Therapeutic Response|5|||
47069115|NCT01396447|83354291|FG001|Overall Study|Insufficient Therapeutic Response|5|||
47069116|NCT01396447|83354292|FG002|Overall Study|Insufficient Therapeutic Response|2|||
47069117|NCT01396447|83354293|FG003|Overall Study|Insufficient Therapeutic Response|4|||
47069118|NCT01396447|83354290|FG000|Overall Study|Protocol Violation|5|||
47069119|NCT01396447|83354291|FG001|Overall Study|Protocol Violation|2|||
47069120|NCT01396447|83354292|FG002|Overall Study|Protocol Violation|3|||
47069121|NCT01396447|83354293|FG003|Overall Study|Protocol Violation|7|||
47069122|NCT01396447|83354290|FG000|Overall Study|Withdrawal of Consent|11|||
47069123|NCT01396447|83354291|FG001|Overall Study|Withdrawal of Consent|9|||
47069124|NCT01396447|83354292|FG002|Overall Study|Withdrawal of Consent|4|||
47069125|NCT01396447|83354293|FG003|Overall Study|Withdrawal of Consent|15|||
47069126|NCT01396447|83354290|FG000|Overall Study|Lost to Follow-up|4|||
47069127|NCT01396447|83354291|FG001|Overall Study|Lost to Follow-up|8|||
47069128|NCT01396447|83354292|FG002|Overall Study|Lost to Follow-up|7|||
47069129|NCT01396447|83354293|FG003|Overall Study|Lost to Follow-up|9|||
47069130|NCT01396447|83354290|FG000|Overall Study|Other Miscellaneous Reasons|0|||
47069131|NCT01396447|83354291|FG001|Overall Study|Other Miscellaneous Reasons|2|||
47069132|NCT01396447|83354292|FG002|Overall Study|Other Miscellaneous Reasons|1|||
47069133|NCT01396447|83354293|FG003|Overall Study|Other Miscellaneous Reasons|0|||
47069134|NCT01678560|83354366|FG000|Overall Study|Physician Decision|4|||
47069135|NCT01678560|83354367|FG001|Overall Study|Physician Decision|4|||
47069136|NCT01678560|83354366|FG000|Overall Study|Death|0|||
47069137|NCT01678560|83354367|FG001|Overall Study|Death|1|||
47069138|NCT01678560|83354366|FG000|Overall Study|Withdrawal by Subject|0|||
47069139|NCT01678560|83354367|FG001|Overall Study|Withdrawal by Subject|1|||
47069140|NCT01381549|83354406|FG000|Overall Study|Ineligible: No organisms isolated|0|||
47069141|NCT01381549|83354407|FG001|Overall Study|Ineligible: No organisms isolated|0|||
47069142|NCT01381549|83354408|FG002|Overall Study|Ineligible: No organisms isolated|1|||
46775180|NCT00732992|82993580|FG001|Overall Study|Withdrawal by Subject|0|||
47069143|NCT00159432|83354417|FG000|Overall Study|Adverse Event|1|||
47069144|NCT00159432|83354417|FG000|Overall Study|Death|1|||
46775181|NCT00732758|82993589|FG000|Overall Study|Lost to Follow-up|8|||
47069145|NCT00159432|83354417|FG000|Overall Study|Lack of Efficacy|8|||
47069146|NCT01396057|83354423|FG000|Overall Study|Adverse Event|2|||
46775182|NCT00732758|82993590|FG001|Overall Study|Lost to Follow-up|16|||
46775183|NCT00699153|82993598|FG000|Overall Study|Lost to Follow-up|1|||
46775184|NCT00699153|82993599|FG001|Overall Study|Lost to Follow-up|0|||
47069147|NCT01396057|83354424|FG001|Overall Study|Adverse Event|6|||
47069148|NCT01396057|83354423|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
47069149|NCT01396057|83354424|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
47069150|NCT01396057|83354423|FG000|Overall Study|Protocol deviation|4|||
47069151|NCT01396057|83354424|FG001|Overall Study|Protocol deviation|4|||
47069152|NCT01396057|83354423|FG000|Overall Study|Consent withdrawn|3|||
47069153|NCT01396057|83354424|FG001|Overall Study|Consent withdrawn|2|||
47069154|NCT01380769|83354441|FG000|Overall Study|Withdrawal by Subject|7|||
47069155|NCT01380769|83354442|FG001|Overall Study|Withdrawal by Subject|11|||
47069156|NCT01380769|83354441|FG000|Overall Study|Physician Decision|1|||
47069157|NCT01380769|83354442|FG001|Overall Study|Physician Decision|1|||
47069158|NCT01380769|83354441|FG000|Overall Study|Adverse Event|1|||
47069159|NCT01380769|83354442|FG001|Overall Study|Adverse Event|1|||
47069160|NCT01380769|83354441|FG000|Overall Study|Protocol Violation|0|||
47069161|NCT01380769|83354442|FG001|Overall Study|Protocol Violation|1|||
47069162|NCT01395901|83354450|FG000|Overall Study|Lost to Follow-up|4|||
47069163|NCT01395901|83354451|FG001|Overall Study|Lost to Follow-up|0|||
47069164|NCT01395901|83354450|FG000|Overall Study|Randomized but not received study drug|5|||
47069165|NCT01395901|83354451|FG001|Overall Study|Randomized but not received study drug|4|||
47069166|NCT01395901|83354450|FG000|Overall Study|Adverse Event|0|||
47069167|NCT01395901|83354451|FG001|Overall Study|Adverse Event|1|||
47069168|NCT01395901|83354450|FG000|Overall Study|Withdrawal of consent|1|||
47069169|NCT01395901|83354451|FG001|Overall Study|Withdrawal of consent|0|||
47069170|NCT01395823|83354459|FG000|Overall Study|Death|4|||
47069171|NCT01395823|83354460|FG001|Overall Study|Death|4|||
47069172|NCT01395823|83354459|FG000|Overall Study|Physician Decision|3|||
47069173|NCT01395823|83354460|FG001|Overall Study|Physician Decision|1|||
47069174|NCT01395823|83354459|FG000|Overall Study|Lost to Follow-up|1|||
47069175|NCT01395823|83354460|FG001|Overall Study|Lost to Follow-up|0|||
47069176|NCT01395823|83354459|FG000|Overall Study|Transplant|1|||
47069177|NCT01395823|83354460|FG001|Overall Study|Transplant|0|||
47069178|NCT01395823|83354459|FG000|Overall Study|GI symptoms|1|||
47069179|NCT01395823|83354460|FG001|Overall Study|GI symptoms|0|||
47069180|NCT01395823|83354459|FG000|Overall Study|Withdrawal by Subject|5|||
47069181|NCT01395823|83354460|FG001|Overall Study|Withdrawal by Subject|4|||
47069182|NCT00158184|83354468|FG000|Overall Study|personal issues|3|||
47069183|NCT00158184|83354469|FG001|Overall Study|personal issues|1|||
47069184|NCT00158184|83354468|FG000|Overall Study|failed for follow unit/study rules|2|||
47069185|NCT00158184|83354469|FG001|Overall Study|failed for follow unit/study rules|0|||
47069186|NCT00158184|83354468|FG000|Overall Study|Adverse Event|1|||
47069187|NCT00158184|83354469|FG001|Overall Study|Adverse Event|1|||
47069188|NCT01380691|83354477|FG000|Washout (7 Days)|Protocol Violation|0|||
46641013|NCT02987543|82820326|FG000|Overall Study|Screen failure|0|||
46775185|NCT00699153|82993598|FG000|Overall Study|Adverse Event|0|||
46775186|NCT00699153|82993599|FG001|Overall Study|Adverse Event|2|||
46775187|NCT00699153|82993598|FG000|Overall Study|Protocol Violation|1|||
46775188|NCT00699153|82993599|FG001|Overall Study|Protocol Violation|0|||
46775189|NCT00699153|82993598|FG000|Overall Study|Travel Problem|1|||
46775190|NCT00699153|82993599|FG001|Overall Study|Travel Problem|0|||
46775191|NCT00698997|82993607|FG000|Overall Study|Lost to Follow-up|3|||
46775192|NCT00698997|82993608|FG001|Overall Study|Lost to Follow-up|0|||
46775193|NCT00698997|82993607|FG000|Overall Study|Withdrawal by Subject|7|||
46775194|NCT00698997|82993608|FG001|Overall Study|Withdrawal by Subject|27|||
46775195|NCT00711087|82993617|FG000|Overall Study|Lost to Follow-up|1|||
46775196|NCT00711087|82993618|FG001|Overall Study|Lost to Follow-up|0|||
46775197|NCT00738530|82993626|FG000|Overall Study|Death|220|||
46775198|NCT00738530|82993627|FG001|Overall Study|Death|224|||
46775199|NCT00738530|82993626|FG000|Overall Study|Lost to Follow-up|8|||
46846321|NCT00098748|83063050|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
46775200|NCT00738530|82993627|FG001|Overall Study|Lost to Follow-up|6|||
46775201|NCT00738530|82993626|FG000|Overall Study|Withdrawal by Subject|6|||
46967219|NCT00700817|83209926|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
46775202|NCT00738530|82993627|FG001|Overall Study|Withdrawal by Subject|8|||
47069189|NCT01380691|83354478|FG001|Washout (7 Days)|Protocol Violation|0|||
47069190|NCT01380691|83354479|FG002|Washout (7 Days)|Protocol Violation|0|||
47069191|NCT01380691|83354480|FG003|Washout (7 Days)|Protocol Violation|1|||
47069192|NCT01380691|83354477|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
47069193|NCT01380691|83354478|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
47069194|NCT01380691|83354479|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
46775203|NCT00711009|82993635|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
47069195|NCT01380691|83354480|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
47069196|NCT01380535|83354506|FG000|Overall Study|Adverse Event|3|||
46775204|NCT00711009|82993636|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
47069197|NCT01380535|83354507|FG001|Overall Study|Adverse Event|3|||
47069198|NCT01380535|83354506|FG000|Overall Study|Death|3|||
47069199|NCT01380535|83354507|FG001|Overall Study|Death|0|||
47069200|NCT01380535|83354506|FG000|Overall Study|Study site closed|0|||
47069201|NCT01380535|83354507|FG001|Overall Study|Study site closed|5|||
47069202|NCT01380535|83354506|FG000|Overall Study|Withdrawal by Subject|1|||
47069203|NCT01380535|83354507|FG001|Overall Study|Withdrawal by Subject|2|||
47069204|NCT01380535|83354506|FG000|Overall Study|Protocol Violation|0|||
47069205|NCT01380535|83354507|FG001|Overall Study|Protocol Violation|2|||
47069206|NCT01380535|83354506|FG000|Overall Study|Lack of Efficacy|0|||
47069207|NCT01380535|83354507|FG001|Overall Study|Lack of Efficacy|3|||
47069208|NCT01380379|83354517|FG000|Overall Study|Pregnancy|1|||
47069209|NCT01380145|83354521|FG000|Overall Study|Progressive disease|4|||
47069210|NCT03420222|83354547|FG000|Overall Study|Withdrawal by Subject|5|||
47069211|NCT03420222|83354548|FG001|Overall Study|Withdrawal by Subject|0|||
47069212|NCT03420222|83354547|FG000|Overall Study|Physician Decision|0|||
47069213|NCT03420222|83354548|FG001|Overall Study|Physician Decision|1|||
47069214|NCT01394185|83354554|FG000|Overall Study|Withdrawal by Subject|2|||
47069215|NCT01394185|83354555|FG001|Overall Study|Withdrawal by Subject|0|||
47069216|NCT01394185|83354556|FG002|Overall Study|Withdrawal by Subject|0|||
47069217|NCT01394185|83354557|FG003|Overall Study|Withdrawal by Subject|0|||
47069218|NCT01394185|83354558|FG004|Overall Study|Withdrawal by Subject|1|||
47069219|NCT01394185|83354559|FG005|Overall Study|Withdrawal by Subject|0|||
47069220|NCT01394185|83354554|FG000|Overall Study|Change in protocol|3|||
47069221|NCT01394185|83354555|FG001|Overall Study|Change in protocol|0|||
47069222|NCT01394185|83354556|FG002|Overall Study|Change in protocol|0|||
47069223|NCT01394185|83354557|FG003|Overall Study|Change in protocol|0|||
47069224|NCT01394185|83354558|FG004|Overall Study|Change in protocol|3|||
47069225|NCT01394185|83354559|FG005|Overall Study|Change in protocol|0|||
47069226|NCT01394185|83354554|FG000|Overall Study|Protocol Violation|1|||
47069227|NCT01394185|83354555|FG001|Overall Study|Protocol Violation|0|||
47069228|NCT01394185|83354556|FG002|Overall Study|Protocol Violation|0|||
47069229|NCT01394185|83354557|FG003|Overall Study|Protocol Violation|1|||
47069230|NCT01394185|83354558|FG004|Overall Study|Protocol Violation|0|||
47069231|NCT01394185|83354559|FG005|Overall Study|Protocol Violation|1|||
47069232|NCT01677936|83354592|FG000|Overall Study|Lost to Follow-up|4|||
47069233|NCT01677936|83354593|FG001|Overall Study|Lost to Follow-up|1|||
47069234|NCT01677936|83354592|FG000|Overall Study|Protocol Violation|3|||
47069235|NCT01677936|83354593|FG001|Overall Study|Protocol Violation|0|||
47069236|NCT01677936|83354592|FG000|Overall Study|Adverse Event|1|||
47069237|NCT01677936|83354593|FG001|Overall Study|Adverse Event|0|||
47069238|NCT01677936|83354592|FG000|Overall Study|Lost to Follow-up|1|||
47069239|NCT01677936|83354593|FG001|Overall Study|Lost to Follow-up|0|||
47069240|NCT01677936|83354592|FG000|Overall Study|Protocol Violation|0|||
47069241|NCT01677936|83354593|FG001|Overall Study|Protocol Violation|4|||
47069242|NCT01525550|83354624|FG000|Overall Study|Lost to Follow-up|8|||
47069243|NCT01525550|83354625|FG001|Overall Study|Lost to Follow-up|2|||
47069244|NCT01525550|83354624|FG000|Overall Study|Death|19|||
46641014|NCT02987543|82820327|FG001|Overall Study|Screen failure|0|||
46641015|NCT02987543|82820328|FG002|Overall Study|Screen failure|0|||
46641016|NCT02987543|82820329|FG003|Overall Study|Screen failure|1|||
46775205|NCT00711009|82993635|FG000|Overall Study|Withdrawal by Subject|4|||
46775206|NCT00711009|82993636|FG001|Overall Study|Withdrawal by Subject|2|||
47069245|NCT01525550|83354625|FG001|Overall Study|Death|28|||
47069246|NCT01525550|83354624|FG000|Overall Study|Other|0|||
47069247|NCT01525550|83354625|FG001|Overall Study|Other|4|||
47069248|NCT01525550|83354624|FG000|Overall Study|Sponsor's Decision|30|||
47069249|NCT01525550|83354625|FG001|Overall Study|Sponsor's Decision|11|||
47069250|NCT01525550|83354624|FG000|Overall Study|Withdrawal by Subject|4|||
47069251|NCT01525550|83354625|FG001|Overall Study|Withdrawal by Subject|0|||
47069252|NCT00211237|83354646|FG000|Baseline|Withdrew|1|||
47069253|NCT00211237|83354647|FG001|Baseline|Withdrew|3|||
46641017|NCT02987543|82820326|FG000|Overall Study|Withdrawal by Subject|21|||
46775207|NCT00711009|82993635|FG000|Overall Study|Lost to Follow-up|3|||
46775208|NCT00711009|82993636|FG001|Overall Study|Lost to Follow-up|9|||
46775209|NCT00711009|82993635|FG000|Overall Study|Participant Noncompliant|0|||
46775210|NCT00711009|82993636|FG001|Overall Study|Participant Noncompliant|1|||
46775211|NCT00711009|82993635|FG000|Overall Study|Virologic Failure|2|||
47069254|NCT00211237|83354648|FG002|Baseline|Withdrew|0|||
47069255|NCT00211237|83354646|FG000|Baseline|Refused random assignment|1|||
47069256|NCT00211237|83354647|FG001|Baseline|Refused random assignment|0|||
47069257|NCT00211237|83354648|FG002|Baseline|Refused random assignment|0|||
47069258|NCT00211237|83354646|FG000|1 Month|Death|2|||
47069259|NCT00211237|83354647|FG001|1 Month|Death|1|||
46641018|NCT02987543|82820327|FG001|Overall Study|Withdrawal by Subject|7|||
46775212|NCT00711009|82993636|FG001|Overall Study|Virologic Failure|1|||
47069260|NCT00211237|83354648|FG002|1 Month|Death|0|||
47069261|NCT00211237|83354646|FG000|1 Month|Lost to Follow-up|0|||
47069262|NCT00211237|83354647|FG001|1 Month|Lost to Follow-up|2|||
47069263|NCT00211237|83354648|FG002|1 Month|Lost to Follow-up|0|||
47069264|NCT00211237|83354646|FG000|1 Month|Withdrew|0|||
47069265|NCT00211237|83354647|FG001|1 Month|Withdrew|4|||
47069266|NCT00211237|83354648|FG002|1 Month|Withdrew|0|||
47069267|NCT00211237|83354646|FG000|1 Month|Additional surgery needed|1|||
47069268|NCT00211237|83354647|FG001|1 Month|Additional surgery needed|0|||
47069269|NCT00211237|83354648|FG002|1 Month|Additional surgery needed|0|||
47069270|NCT00211237|83354646|FG000|1 Month|Non-medical problem|0|||
47069271|NCT00211237|83354647|FG001|1 Month|Non-medical problem|2|||
47069272|NCT00211237|83354648|FG002|1 Month|Non-medical problem|0|||
47069273|NCT00211237|83354646|FG000|3 Months|Death|7|||
47069274|NCT00211237|83354647|FG001|3 Months|Death|3|||
47069275|NCT00211237|83354648|FG002|3 Months|Death|0|||
47069276|NCT00211237|83354646|FG000|3 Months|Could not comply with protocol|1|||
47069277|NCT00211237|83354647|FG001|3 Months|Could not comply with protocol|0|||
47069278|NCT00211237|83354648|FG002|3 Months|Could not comply with protocol|0|||
47069279|NCT00211237|83354646|FG000|3 Months|Withdrew|0|||
47069280|NCT00211237|83354647|FG001|3 Months|Withdrew|1|||
47069281|NCT00211237|83354648|FG002|3 Months|Withdrew|0|||
47069282|NCT00211237|83354646|FG000|3 Months|Non-medical problem|0|||
47069283|NCT00211237|83354647|FG001|3 Months|Non-medical problem|0|||
47069284|NCT00211237|83354648|FG002|3 Months|Non-medical problem|1|||
47069285|NCT00211237|83354646|FG000|6 Months|Death|6|||
47069286|NCT00211237|83354647|FG001|6 Months|Death|0|||
47069287|NCT00211237|83354648|FG002|6 Months|Death|3|||
47069288|NCT00211237|83354646|FG000|6 Months|Lost to Follow-up|2|||
47069289|NCT00211237|83354647|FG001|6 Months|Lost to Follow-up|0|||
47069290|NCT00211237|83354648|FG002|6 Months|Lost to Follow-up|0|||
47069291|NCT00211237|83354646|FG000|6 Months|Could not comply with protocol|0|||
47069292|NCT00211237|83354647|FG001|6 Months|Could not comply with protocol|2|||
47069293|NCT00211237|83354648|FG002|6 Months|Could not comply with protocol|0|||
47069294|NCT00211237|83354646|FG000|12 Months|Death|8|||
47069295|NCT00211237|83354647|FG001|12 Months|Death|2|||
47069296|NCT00211237|83354648|FG002|12 Months|Death|3|||
47069297|NCT00211237|83354646|FG000|12 Months|Lost to Follow-up|1|||
47069298|NCT00211237|83354647|FG001|12 Months|Lost to Follow-up|0|||
47069299|NCT00211237|83354648|FG002|12 Months|Lost to Follow-up|1|||
47069300|NCT00211237|83354646|FG000|12 Months|Withdrew|0|||
47069301|NCT00211237|83354647|FG001|12 Months|Withdrew|0|||
47069302|NCT00211237|83354648|FG002|12 Months|Withdrew|1|||
47069303|NCT00211237|83354646|FG000|12 Months|unrelated medical problem|0|||
47069304|NCT00211237|83354647|FG001|12 Months|unrelated medical problem|0|||
47069305|NCT00211237|83354648|FG002|12 Months|unrelated medical problem|1|||
47069306|NCT01489358|83354668|FG000|Overall Study|Lost to Follow-up|0|||
47069307|NCT01489358|83354669|FG001|Overall Study|Lost to Follow-up|0|||
47069308|NCT01489358|83354670|FG002|Overall Study|Lost to Follow-up|2|||
47069309|NCT01525238|83354681|FG000|Overall Study|Withdrawal by Subject|1|||
47069310|NCT01525238|83354682|FG001|Overall Study|Withdrawal by Subject|0|||
47069311|NCT01525238|83354683|FG002|Overall Study|Withdrawal by Subject|0|||
47069312|NCT01488578|83354704|FG000|Overall Study|Protocol Violation|1836|||
47069313|NCT01524770|83354745|FG000|First Intervention|Withdrawal by Subject|1|||
47069314|NCT01524770|83354746|FG001|First Intervention|Withdrawal by Subject|0|||
47069315|NCT01524770|83354745|FG000|First Intervention|Adverse Event|1|||
47069316|NCT01524770|83354746|FG001|First Intervention|Adverse Event|1|||
47069317|NCT01524770|83354745|FG000|First Intervention|Protocol Violation|1|||
47069318|NCT01524770|83354746|FG001|First Intervention|Protocol Violation|0|||
47069319|NCT05166876|83354770|FG000|Overall Study|Withdrawal by Subject|1|||
47069320|NCT05166876|83354771|FG001|Overall Study|Withdrawal by Subject|0|||
47069321|NCT05166876|83354772|FG002|Overall Study|Withdrawal by Subject|0|||
47069322|NCT05065619|83354786|FG000|Up to Day 42|Lost to Follow-up|1|||
47069323|NCT05065619|83354787|FG001|Up to Day 42|Lost to Follow-up|0|||
47069324|NCT05065619|83354786|FG000|Up to Day 42|Withdrawal by Subject|1|||
47069325|NCT05065619|83354787|FG001|Up to Day 42|Withdrawal by Subject|0|||
47069326|NCT05065619|83354786|FG000|After Day 43|Lost to Follow-up|1|||
47069327|NCT05065619|83354787|FG001|After Day 43|Lost to Follow-up|0|||
47069328|NCT05065619|83354786|FG000|After Day 43|Physician Decision|3|||
47069329|NCT05065619|83354787|FG001|After Day 43|Physician Decision|0|||
47069330|NCT05065619|83354786|FG000|After Day 43|Withdrawal by Subject|1|||
47069331|NCT05065619|83354787|FG001|After Day 43|Withdrawal by Subject|2|||
47069332|NCT05065619|83354786|FG000|After Day 43|Public vaccination|6|||
47069333|NCT05065619|83354787|FG001|After Day 43|Public vaccination|8|||
47069334|NCT05065619|83354786|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
47069335|NCT05065619|83354787|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
47069336|NCT05065619|83354786|FG000|After Day 43|Study Terminated by Sponsor|88|||
47069337|NCT05065619|83354787|FG001|After Day 43|Study Terminated by Sponsor|16|||
47069338|NCT04581200|83354813|FG000|Overall Study|Lost to Follow-up|6|||
47069339|NCT04581200|83354814|FG001|Overall Study|Lost to Follow-up|5|||
47069340|NCT04481243|83354821|FG000|Overall Study|Withdrawal by Subject|4|||
47069341|NCT04468230|83354825|FG000|Overall Study|Adverse Event|2|||
47069342|NCT04439175|83354842|FG000|Overall Study|Never started treatment|4|||
47069343|NCT04439175|83354842|FG000|Overall Study|Ineligible|5|||
47069344|NCT04439175|83354842|FG000|Overall Study|Adverse Event|6|||
47069345|NCT04439175|83354842|FG000|Overall Study|Death|4|||
47069346|NCT04439175|83354842|FG000|Overall Study|Disease progression|44|||
47069347|NCT04439175|83354842|FG000|Overall Study|Withdrawal by Subject|4|||
47069348|NCT04439175|83354842|FG000|Overall Study|Alternative Therapy|1|||
47069349|NCT04439175|83354842|FG000|Overall Study|Other|2|||
47069350|NCT04439136|83354846|FG000|Overall Study|Ineligible|1|||
47069351|NCT04439136|83354846|FG000|Overall Study|Never Started Treatment|2|||
47069352|NCT04439136|83354846|FG000|Overall Study|Adverse Event|4|||
47069353|NCT04439136|83354846|FG000|Overall Study|Death|3|||
47069354|NCT04439136|83354846|FG000|Overall Study|Disease Progression|27|||
47069355|NCT04439136|83354846|FG000|Overall Study|Alternative Therapy|1|||
47069356|NCT04439136|83354846|FG000|Overall Study|Increased Tumor Burden|1|||
47069357|NCT04439136|83354846|FG000|Overall Study|Symptomatic Detrioration|1|||
47069358|NCT04204902|83354879|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
47069359|NCT04204902|83354880|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
47069360|NCT04166383|83354886|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
47069361|NCT04166383|83354886|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
47069362|NCT04166383|83354886|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
47069363|NCT04163458|83354907|FG000|Overall Study|Protocol Deviation|7|||
47069364|NCT04163458|83354908|FG001|Overall Study|Protocol Deviation|13|||
47069365|NCT04163458|83354907|FG000|Overall Study|Adverse Event|5|||
47069366|NCT04163458|83354908|FG001|Overall Study|Adverse Event|8|||
47069367|NCT04163458|83354907|FG000|Overall Study|Due to COVID-19 pandemic|4|||
47069368|NCT04163458|83354908|FG001|Overall Study|Due to COVID-19 pandemic|2|||
47069369|NCT04163458|83354907|FG000|Overall Study|Participant withdrew consent|2|||
47069370|NCT04163458|83354908|FG001|Overall Study|Participant withdrew consent|3|||
47069371|NCT04163458|83354907|FG000|Overall Study|Randomization failure|2|||
47069372|NCT04163458|83354908|FG001|Overall Study|Randomization failure|2|||
47069373|NCT04163458|83354907|FG000|Overall Study|Other|4|||
47069374|NCT04163458|83354908|FG001|Overall Study|Other|2|||
47069375|NCT03783442|83354961|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
47069376|NCT03783442|83354962|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
47069377|NCT03783442|83354961|FG000|Overall Study|Death|196|||
47069378|NCT03783442|83354962|FG001|Overall Study|Death|226|||
47069379|NCT03783442|83354961|FG000|Overall Study|Withdrawal by Subject|14|||
47069380|NCT03783442|83354962|FG001|Overall Study|Withdrawal by Subject|17|||
47069381|NCT03783442|83354961|FG000|Overall Study|Lost to Follow-up|2|||
47069382|NCT03783442|83354962|FG001|Overall Study|Lost to Follow-up|3|||
47069383|NCT03734016|83354970|FG000|Overall Study|Participants Remaining in the Study|260|||
47069384|NCT03734016|83354971|FG001|Overall Study|Participants Remaining in the Study|240|||
47069385|NCT03734016|83354970|FG000|Overall Study|Death|48|||
47069386|NCT03734016|83354971|FG001|Overall Study|Death|60|||
47069387|NCT03734016|83354970|FG000|Overall Study|Withdrawal by Subject|14|||
47069388|NCT03734016|83354971|FG001|Overall Study|Withdrawal by Subject|16|||
47069389|NCT03734016|83354970|FG000|Overall Study|Physician Decision|0|||
47069390|NCT03734016|83354971|FG001|Overall Study|Physician Decision|7|||
47069391|NCT03734016|83354970|FG000|Overall Study|Lost to Follow-up|3|||
47069392|NCT03734016|83354971|FG001|Overall Study|Lost to Follow-up|1|||
47069393|NCT03734016|83354970|FG000|Overall Study|Adverse Event|2|||
47069394|NCT03734016|83354971|FG001|Overall Study|Adverse Event|1|||
47069395|NCT03693300|83354980|FG000|Overall Study|Patients ongoing study|43|||
47069396|NCT03693300|83354981|FG001|Overall Study|Patients ongoing study|1|||
47069397|NCT03671564|83354992|FG000|Overall Study|Progressive Disease|3|||
47069398|NCT03671564|83354993|FG001|Overall Study|Progressive Disease|5|||
47069399|NCT03671564|83354994|FG002|Overall Study|Progressive Disease|3|||
47069400|NCT03671564|83354992|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
47069401|NCT03671564|83354993|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
47069402|NCT03671564|83354994|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
47069403|NCT03671564|83354992|FG000|Overall Study|Withdrawal by Subject|1|||
47069404|NCT03671564|83354993|FG001|Overall Study|Withdrawal by Subject|1|||
47069405|NCT03671564|83354994|FG002|Overall Study|Withdrawal by Subject|0|||
47069406|NCT03632720|83355014|FG000|Overall Study|Adverse Event|2|||
47069407|NCT03632720|83355015|FG001|Overall Study|Adverse Event|0|||
47069408|NCT03632720|83355016|FG002|Overall Study|Adverse Event|0|||
47069409|NCT03632720|83355014|FG000|Overall Study|Lost to Follow-up|0|||
47069410|NCT03632720|83355015|FG001|Overall Study|Lost to Follow-up|1|||
47069411|NCT03632720|83355016|FG002|Overall Study|Lost to Follow-up|0|||
47069412|NCT03632720|83355014|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
47069413|NCT03632720|83355015|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
47069414|NCT03632720|83355016|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
47069415|NCT03632720|83355014|FG000|Overall Study|Screen failure|0|||
47069416|NCT03632720|83355015|FG001|Overall Study|Screen failure|1|||
47069417|NCT03632720|83355016|FG002|Overall Study|Screen failure|0|||
47069418|NCT03606512|83355028|FG000|Overall Study|Lost to Follow-up|0|||
47069419|NCT03606512|83355029|FG001|Overall Study|Lost to Follow-up|1|||
47069420|NCT03606512|83355028|FG000|Overall Study|'moved from study area|0|||
47069421|NCT03606512|83355029|FG001|Overall Study|'moved from study area|1|||
47069422|NCT03323099|83355052|FG000|Overall Study|Withdrawal by Subject|6|||
47069423|NCT03323099|83355053|FG001|Overall Study|Withdrawal by Subject|12|||
47069424|NCT03323099|83355052|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
47069425|NCT03323099|83355053|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
47069426|NCT03323034|83355064|FG000|Overall Study|Lack of Efficacy|5|||
47069427|NCT03323034|83355065|FG001|Overall Study|Lack of Efficacy|5|||
47069428|NCT03323034|83355066|FG002|Overall Study|Lack of Efficacy|6|||
47069429|NCT03323034|83355067|FG003|Overall Study|Lack of Efficacy|5|||
47069430|NCT03323034|83355068|FG004|Overall Study|Lack of Efficacy|5|||
47069431|NCT03323034|83355064|FG000|Overall Study|Physician Decision|0|||
47069432|NCT03323034|83355065|FG001|Overall Study|Physician Decision|0|||
47069433|NCT03323034|83355066|FG002|Overall Study|Physician Decision|0|||
47069434|NCT03323034|83355067|FG003|Overall Study|Physician Decision|0|||
47069435|NCT03323034|83355068|FG004|Overall Study|Physician Decision|1|||
47069436|NCT03323034|83355064|FG000|Overall Study|Withdrawal by Subject|1|||
47069437|NCT03323034|83355065|FG001|Overall Study|Withdrawal by Subject|1|||
47069438|NCT03323034|83355066|FG002|Overall Study|Withdrawal by Subject|0|||
47069439|NCT03323034|83355067|FG003|Overall Study|Withdrawal by Subject|1|||
47069440|NCT03323034|83355068|FG004|Overall Study|Withdrawal by Subject|0|||
47069441|NCT03307252|83355092|FG000|Part 2, Period 1|Treatment not received|0|||
47069442|NCT03307252|83355093|FG001|Part 2, Period 1|Treatment not received|0|||
47069443|NCT03307252|83355094|FG002|Part 2, Period 1|Treatment not received|0|||
47069444|NCT03307252|83355095|FG003|Part 2, Period 1|Treatment not received|0|||
47069445|NCT03307252|83355096|FG004|Part 2, Period 1|Treatment not received|0|||
47069446|NCT03307252|83355097|FG005|Part 2, Period 1|Treatment not received|1|||
47069447|NCT03307252|83355098|FG006|Part 2, Period 1|Treatment not received|0|||
47069448|NCT03307252|83355099|FG007|Part 2, Period 1|Treatment not received|0|||
47069449|NCT03307252|83355100|FG008|Part 2, Period 1|Treatment not received|0|||
47069450|NCT03307252|83355101|FG009|Part 2, Period 1|Treatment not received|0|||
47069451|NCT03307252|83355102|FG010|Part 2, Period 1|Treatment not received|0|||
47069452|NCT03307252|83355092|FG000|Part 2, Period 3|Other than listed|0|||
47069453|NCT03307252|83355093|FG001|Part 2, Period 3|Other than listed|0|||
47069454|NCT03307252|83355094|FG002|Part 2, Period 3|Other than listed|0|||
47069455|NCT03307252|83355095|FG003|Part 2, Period 3|Other than listed|0|||
47069456|NCT03307252|83355096|FG004|Part 2, Period 3|Other than listed|1|||
47069457|NCT03307252|83355097|FG005|Part 2, Period 3|Other than listed|0|||
47069458|NCT03307252|83355098|FG006|Part 2, Period 3|Other than listed|0|||
47069459|NCT03307252|83355099|FG007|Part 2, Period 3|Other than listed|0|||
47069460|NCT03307252|83355100|FG008|Part 2, Period 3|Other than listed|0|||
47069461|NCT03307252|83355101|FG009|Part 2, Period 3|Other than listed|0|||
47069462|NCT03307252|83355102|FG010|Part 2, Period 3|Other than listed|0|||
47069463|NCT03307252|83355092|FG000|Part 2, Period 4|Other than listed|0|||
47069464|NCT03307252|83355093|FG001|Part 2, Period 4|Other than listed|0|||
47069465|NCT03307252|83355094|FG002|Part 2, Period 4|Other than listed|0|||
47069466|NCT03307252|83355095|FG003|Part 2, Period 4|Other than listed|0|||
47069467|NCT03307252|83355096|FG004|Part 2, Period 4|Other than listed|0|||
47069468|NCT03307252|83355097|FG005|Part 2, Period 4|Other than listed|0|||
47069469|NCT03307252|83355098|FG006|Part 2, Period 4|Other than listed|1|||
47069470|NCT03307252|83355099|FG007|Part 2, Period 4|Other than listed|0|||
47069471|NCT03307252|83355100|FG008|Part 2, Period 4|Other than listed|0|||
47069472|NCT03307252|83355101|FG009|Part 2, Period 4|Other than listed|0|||
47069473|NCT03307252|83355102|FG010|Part 2, Period 4|Other than listed|0|||
47069474|NCT03307252|83355092|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
46641019|NCT02987543|82820328|FG002|Overall Study|Withdrawal by Subject|7|||
46641020|NCT02987543|82820329|FG003|Overall Study|Withdrawal by Subject|6|||
46641021|NCT02987543|82820326|FG000|Overall Study|Study terminated by sponsor|1|||
46775213|NCT00711009|82993635|FG000|Overall Study|Pregnancy|1|||
46775214|NCT00711009|82993636|FG001|Overall Study|Pregnancy|0|||
46775215|NCT00711009|82993635|FG000|Overall Study|Site closing|0|||
46775216|NCT00711009|82993636|FG001|Overall Study|Site closing|1|||
46775217|NCT00711009|82993635|FG000|Overall Study|Dose adjustment|1|||
47069475|NCT03307252|83355093|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069476|NCT03307252|83355094|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069477|NCT03307252|83355095|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069478|NCT03307252|83355096|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
46641022|NCT02987543|82820327|FG001|Overall Study|Study terminated by sponsor|0|||
46775218|NCT00711009|82993636|FG001|Overall Study|Dose adjustment|0|||
46967220|NCT00700817|83209927|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
47069479|NCT03307252|83355097|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069480|NCT03307252|83355098|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069481|NCT03307252|83355099|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069482|NCT03307252|83355100|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069483|NCT03307252|83355101|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
47069484|NCT03307252|83355102|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
47069485|NCT03286504|83355120|FG000|Overall Study|Lost to Follow-up|19|||
47069486|NCT03286504|83355121|FG001|Overall Study|Lost to Follow-up|16|||
47069487|NCT03191786|83355138|FG000|Overall Study|Death|236|||
47069488|NCT03191786|83355139|FG001|Overall Study|Death|127|||
47069489|NCT03191786|83355138|FG000|Overall Study|Lost to Follow-up|9|||
47069490|NCT03191786|83355139|FG001|Overall Study|Lost to Follow-up|3|||
47069491|NCT03191786|83355138|FG000|Overall Study|Physician Decision|1|||
47069492|NCT03191786|83355139|FG001|Overall Study|Physician Decision|0|||
47069493|NCT03191786|83355138|FG000|Overall Study|Study Terminated By Sponsor|15|||
47069494|NCT03191786|83355139|FG001|Overall Study|Study Terminated By Sponsor|5|||
47069495|NCT03191786|83355138|FG000|Overall Study|Withdrawal by Subject|26|||
47069496|NCT03191786|83355139|FG001|Overall Study|Withdrawal by Subject|16|||
47069497|NCT03138733|83355147|FG000|Overall Study|Death|17|||
47069498|NCT03138733|83355148|FG001|Overall Study|Death|18|||
47069499|NCT03138733|83355147|FG000|Overall Study|Withdrawal by Subject|11|||
47069500|NCT03138733|83355148|FG001|Overall Study|Withdrawal by Subject|6|||
47069501|NCT03138733|83355147|FG000|Overall Study|Lost to Follow-up|3|||
47069502|NCT03138733|83355148|FG001|Overall Study|Lost to Follow-up|2|||
47069503|NCT03138733|83355147|FG000|Overall Study|Adverse Event|1|||
47069504|NCT03138733|83355148|FG001|Overall Study|Adverse Event|0|||
47069505|NCT03138733|83355147|FG000|Overall Study|Protocol Violation|1|||
47069506|NCT03138733|83355148|FG001|Overall Study|Protocol Violation|3|||
47069507|NCT03138733|83355147|FG000|Overall Study|Administrative or logistical reason|1|||
47069508|NCT03138733|83355148|FG001|Overall Study|Administrative or logistical reason|0|||
47069509|NCT03138733|83355147|FG000|Overall Study|The patient was transferred to another hospital|1|||
47069510|NCT03138733|83355148|FG001|Overall Study|The patient was transferred to another hospital|0|||
46775219|NCT00577005|82993644|FG000|Overall Study|Lost to Follow-up|3|||
46775220|NCT00577005|82993645|FG001|Overall Study|Lost to Follow-up|2|||
46775221|NCT00577005|82993644|FG000|Overall Study|Withdrawal by Subject|2|||
47069511|NCT03057054|83355156|FG000|Overall Study|Death|4|||
47069512|NCT03057054|83355157|FG001|Overall Study|Death|4|||
47069513|NCT03057054|83355156|FG000|Overall Study|Withdrawal by Subject|6|||
47069514|NCT03057054|83355157|FG001|Overall Study|Withdrawal by Subject|3|||
47069515|NCT03057054|83355156|FG000|Overall Study|Ineligible|1|||
47069516|NCT03057054|83355157|FG001|Overall Study|Ineligible|1|||
47069517|NCT02854527|83355234|FG000|Overall Study|Adverse Event|0|||
47069518|NCT02854527|83355235|FG001|Overall Study|Adverse Event|0|||
47069519|NCT02854527|83355236|FG002|Overall Study|Adverse Event|0|||
46775222|NCT00577005|82993645|FG001|Overall Study|Withdrawal by Subject|1|||
46775223|NCT00576927|82993656|FG000|Clinical Assessment|Lack of Efficacy|24|||
46967221|NCT00700817|83209928|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
46967222|NCT00700817|83209929|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
47069520|NCT02854527|83355237|FG003|Overall Study|Adverse Event|0|||
47069521|NCT02854527|83355238|FG004|Overall Study|Adverse Event|1|||
47069522|NCT02854527|83355239|FG005|Overall Study|Adverse Event|0|||
47069523|NCT02854527|83355240|FG006|Overall Study|Adverse Event|0|||
47069524|NCT02854527|83355241|FG007|Overall Study|Adverse Event|0|||
47069525|NCT02854527|83355242|FG008|Overall Study|Adverse Event|0|||
47069526|NCT02854527|83355243|FG009|Overall Study|Adverse Event|0|||
47069527|NCT02854527|83355234|FG000|Overall Study|Lost to Follow-up|0|||
47069528|NCT02854527|83355235|FG001|Overall Study|Lost to Follow-up|0|||
47069529|NCT02854527|83355236|FG002|Overall Study|Lost to Follow-up|0|||
47069530|NCT02854527|83355237|FG003|Overall Study|Lost to Follow-up|1|||
47069531|NCT02854527|83355238|FG004|Overall Study|Lost to Follow-up|0|||
47069532|NCT02854527|83355239|FG005|Overall Study|Lost to Follow-up|0|||
47069533|NCT02854527|83355240|FG006|Overall Study|Lost to Follow-up|0|||
47069534|NCT02854527|83355241|FG007|Overall Study|Lost to Follow-up|0|||
47069535|NCT02854527|83355242|FG008|Overall Study|Lost to Follow-up|0|||
47069536|NCT02854527|83355243|FG009|Overall Study|Lost to Follow-up|0|||
47069537|NCT02772081|83355257|FG000|Overall Study|Physician Decision|1|||
47069538|NCT02772081|83355258|FG001|Overall Study|Physician Decision|1|||
47069539|NCT02772081|83355257|FG000|Overall Study|Death|1|||
47069540|NCT02772081|83355258|FG001|Overall Study|Death|1|||
47069541|NCT02639559|83355266|FG000|Overall Study|Mobilization failure|0|||
47069542|NCT02639559|83355267|FG001|Overall Study|Mobilization failure|3|||
47069543|NCT02639559|83355266|FG000|Overall Study|Issues with vascular acess|1|||
47069544|NCT02639559|83355267|FG001|Overall Study|Issues with vascular acess|0|||
47069545|NCT02581891|83355275|FG000|Overall Study|Adverse Event|4|||
46967223|NCT00700817|83209925|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
47069546|NCT02581891|83355276|FG001|Overall Study|Adverse Event|6|||
47069547|NCT02581891|83355275|FG000|Overall Study|Death|3|||
47069548|NCT02581891|83355276|FG001|Overall Study|Death|4|||
47069549|NCT02581891|83355275|FG000|Overall Study|Lost to Follow-up|1|||
46967224|NCT00700817|83209926|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
46967225|NCT00700817|83209927|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
47069550|NCT02581891|83355276|FG001|Overall Study|Lost to Follow-up|2|||
47069551|NCT02581891|83355275|FG000|Overall Study|Physician Decision|0|||
46775224|NCT00576927|82993656|FG000|Clinical Assessment|Death|1|||
46775225|NCT00576927|82993656|FG000|Clinical Assessment|Withdrawal by Subject|10|||
46775226|NCT00576927|82993656|FG000|Clinical Assessment|Physician Decision|1|||
46775227|NCT00576927|82993656|FG000|Baseline|Physician Decision|9|||
46775228|NCT00576927|82993656|FG000|Baseline|Medication Change by PCP of subject|1|||
47069552|NCT02581891|83355276|FG001|Overall Study|Physician Decision|1|||
47069553|NCT02581891|83355275|FG000|Overall Study|Withdrawal by Subject|4|||
47069554|NCT02581891|83355276|FG001|Overall Study|Withdrawal by Subject|5|||
47069555|NCT02581891|83355275|FG000|Overall Study|Other Reasons|3|||
47069556|NCT02581891|83355276|FG001|Overall Study|Other Reasons|1|||
47069557|NCT02581891|83355275|FG000|Overall Study|Discontinued during followup|1|||
47069558|NCT02581891|83355276|FG001|Overall Study|Discontinued during followup|0|||
47069559|NCT02576535|83355283|FG000|Overall Study|Withdrawal by Subject|2|||
47069560|NCT02574845|83355293|FG000|Overall Study|Consent withdrawn further participation|0|||
47069561|NCT02574845|83355294|FG001|Overall Study|Consent withdrawn further participation|0|||
47069562|NCT02574845|83355295|FG002|Overall Study|Consent withdrawn further participation|0|||
47069563|NCT02574845|83355296|FG003|Overall Study|Consent withdrawn further participation|0|||
46775229|NCT00576927|82993656|FG000|Baseline|Withdrawal by Subject|3|||
46775230|NCT00576927|82993656|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
46967226|NCT00700817|83209928|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
47069564|NCT02574845|83355297|FG004|Overall Study|Consent withdrawn further participation|1|||
47069565|NCT02574845|83355298|FG005|Overall Study|Consent withdrawn further participation|0|||
47069566|NCT02574845|83355293|FG000|Overall Study|Adverse Event|0|||
47069567|NCT02574845|83355294|FG001|Overall Study|Adverse Event|1|||
46967227|NCT00700817|83209929|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
46967228|NCT00700817|83209925|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
47069568|NCT02574845|83355295|FG002|Overall Study|Adverse Event|0|||
47069569|NCT02574845|83355296|FG003|Overall Study|Adverse Event|0|||
47069570|NCT02574845|83355297|FG004|Overall Study|Adverse Event|0|||
47069571|NCT02574845|83355298|FG005|Overall Study|Adverse Event|1|||
47069572|NCT01946139|83355370|FG000|Overall Study|Withdrawal by Subject|8|||
47069573|NCT01946139|83355370|FG000|Overall Study|ineligible|8|||
47069574|NCT01946139|83355370|FG000|Overall Study|Specimens not available|4|||
47069575|NCT01685008|83355378|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
47069576|NCT01685008|83355379|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
46967229|NCT00700817|83209926|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
46967230|NCT00700817|83209927|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
46967231|NCT00700817|83209928|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
46967232|NCT00700817|83209929|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
46967233|NCT00700817|83209925|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
46967234|NCT00700817|83209926|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
46967235|NCT00700817|83209927|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
46967236|NCT00700817|83209928|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
46967237|NCT00700817|83209929|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
46967238|NCT00700817|83209925|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
46967239|NCT00700817|83209926|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
46967240|NCT00700817|83209927|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
46967241|NCT00700817|83209928|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
46967242|NCT00700817|83209929|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
46967243|NCT00700817|83209925|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
46967244|NCT00700817|83209926|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
46967245|NCT00700817|83209927|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
46967246|NCT00700817|83209928|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
46967247|NCT00700817|83209929|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
46967248|NCT02625909|83209941|FG000|Overall Study|Death|2|||
47069577|NCT01685008|83355380|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
47069578|NCT01685008|83355381|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
47069579|NCT01685008|83355378|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
47069580|NCT01685008|83355379|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
47069581|NCT01685008|83355380|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
47069582|NCT01685008|83355381|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
47069583|NCT01685008|83355378|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
47069584|NCT01685008|83355379|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
47069585|NCT01685008|83355380|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
47069586|NCT01685008|83355381|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
47069587|NCT01685008|83355378|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
47069588|NCT01685008|83355379|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
46967249|NCT02625909|83209942|FG001|Overall Study|Death|0|||
46967250|NCT02625909|83209941|FG000|Overall Study|Lost to Follow-up|3|||
46967251|NCT02625909|83209942|FG001|Overall Study|Lost to Follow-up|5|||
46967252|NCT02625909|83209941|FG000|Overall Study|Lack of Efficacy|9|||
47069589|NCT01685008|83355380|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
47069590|NCT01685008|83355381|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
47069591|NCT01685008|83355378|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
47069592|NCT01685008|83355379|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
47069593|NCT01685008|83355380|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
47069594|NCT01685008|83355381|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
47069595|NCT01556490|83355397|FG000|Randomized Patients Summary|Protocol Violation|22|||
47069596|NCT01556490|83355398|FG001|Randomized Patients Summary|Protocol Violation|23|||
47069597|NCT01556490|83355397|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
47069598|NCT01556490|83355398|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
47069599|NCT01133990|83355417|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
47069600|NCT01133990|83355418|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
46641023|NCT02987543|82820328|FG002|Overall Study|Study terminated by sponsor|0|||
46641024|NCT02987543|82820329|FG003|Overall Study|Study terminated by sponsor|0|||
46641025|NCT02987543|82820326|FG000|Overall Study|Investigator decision|0|||
46641026|NCT02987543|82820327|FG001|Overall Study|Investigator decision|1|||
46641027|NCT02987543|82820328|FG002|Overall Study|Investigator decision|0|||
46641028|NCT02987543|82820329|FG003|Overall Study|Investigator decision|0|||
46641029|NCT02987543|82820326|FG000|Overall Study|Disease progression|0|||
46641030|NCT02987543|82820327|FG001|Overall Study|Disease progression|0|||
47069601|NCT01133990|83355419|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
47069602|NCT01133990|83355420|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
47069603|NCT01133990|83355421|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
47069604|NCT01133990|83355422|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
47069605|NCT01133990|83355417|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
47069606|NCT01133990|83355418|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
47069607|NCT01133990|83355419|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
47069608|NCT01133990|83355420|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
47069609|NCT01133990|83355421|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
46775231|NCT00576927|82993656|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
47069610|NCT01133990|83355422|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
47069611|NCT01133990|83355417|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
47069612|NCT01133990|83355418|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
47069613|NCT01133990|83355419|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
47069614|NCT01133990|83355420|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
47069615|NCT01133990|83355421|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
47069616|NCT01133990|83355422|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
47069617|NCT01133990|83355417|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
47069618|NCT01133990|83355418|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
47069619|NCT01133990|83355419|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
47069620|NCT01133990|83355420|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
47069621|NCT01133990|83355421|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
47069622|NCT01133990|83355422|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
47069623|NCT00910429|83355431|FG000|Overall Study|Death|18|||
47069624|NCT00910429|83355432|FG001|Overall Study|Death|12|||
47069625|NCT00910429|83355431|FG000|Overall Study|Withdrawal by Subject|3|||
47069626|NCT00910429|83355432|FG001|Overall Study|Withdrawal by Subject|2|||
47069627|NCT00910429|83355431|FG000|Overall Study|Protocol Violation|1|||
47069628|NCT00910429|83355432|FG001|Overall Study|Protocol Violation|0|||
47069629|NCT00910429|83355431|FG000|Overall Study|Lost to Follow-up|2|||
47069630|NCT00910429|83355432|FG001|Overall Study|Lost to Follow-up|1|||
47069631|NCT00910429|83355431|FG000|Overall Study|Adverse Event|10|||
47069632|NCT00910429|83355432|FG001|Overall Study|Adverse Event|5|||
47069633|NCT00910429|83355431|FG000|Overall Study|Drug non-compliance|1|||
47069634|NCT00910429|83355432|FG001|Overall Study|Drug non-compliance|0|||
47069635|NCT00910429|83355431|FG000|Overall Study|Lack of Efficacy|4|||
47069636|NCT00910429|83355432|FG001|Overall Study|Lack of Efficacy|1|||
47069637|NCT00863681|83355441|FG000|Overall Study|Other|2|||
47069638|NCT00863681|83355442|FG001|Overall Study|Other|0|||
47069639|NCT00863681|83355443|FG002|Overall Study|Other|0|||
47069640|NCT00863681|83355441|FG000|Overall Study|Missing|1|||
47069641|NCT00863681|83355442|FG001|Overall Study|Missing|0|||
47069642|NCT00863681|83355443|FG002|Overall Study|Missing|0|||
47069643|NCT00863681|83355441|FG000|Overall Study|Death|40|||
47069644|NCT00863681|83355442|FG001|Overall Study|Death|23|||
47069645|NCT00863681|83355443|FG002|Overall Study|Death|6|||
47069646|NCT00863681|83355441|FG000|Overall Study|Withdrawal by Subject|12|||
47069647|NCT00863681|83355442|FG001|Overall Study|Withdrawal by Subject|5|||
47069648|NCT00863681|83355443|FG002|Overall Study|Withdrawal by Subject|2|||
47069649|NCT00863681|83355441|FG000|Overall Study|Protocol Violation|2|||
47069650|NCT00863681|83355442|FG001|Overall Study|Protocol Violation|0|||
47069651|NCT00863681|83355443|FG002|Overall Study|Protocol Violation|0|||
47069652|NCT00863681|83355441|FG000|Overall Study|Lost to Follow-up|3|||
47069653|NCT00863681|83355442|FG001|Overall Study|Lost to Follow-up|0|||
47069654|NCT00863681|83355443|FG002|Overall Study|Lost to Follow-up|3|||
47069655|NCT00863681|83355441|FG000|Overall Study|Adverse Event|28|||
47069656|NCT00863681|83355442|FG001|Overall Study|Adverse Event|10|||
47069657|NCT00863681|83355443|FG002|Overall Study|Adverse Event|6|||
47069658|NCT00863681|83355441|FG000|Overall Study|Lack of Efficacy|2|||
47069659|NCT00863681|83355442|FG001|Overall Study|Lack of Efficacy|2|||
47069660|NCT00863681|83355443|FG002|Overall Study|Lack of Efficacy|1|||
47069661|NCT00863681|83355441|FG000|Overall Study|Non-compliance with study drug|1|||
47069662|NCT00863681|83355442|FG001|Overall Study|Non-compliance with study drug|3|||
47069663|NCT00863681|83355443|FG002|Overall Study|Non-compliance with study drug|0|||
47069664|NCT00846742|83355451|FG000|Overall Study|Withdrawal by Subject|1|||
47069665|NCT00734149|83355456|FG000|Overall Study|Withdrawal by Subject|1|||
47069666|NCT00587431|83355464|FG000|Overall Study|Adverse Event|1|||
47069667|NCT00587431|83355465|FG001|Overall Study|Adverse Event|0|||
47069668|NCT00587431|83355464|FG000|Overall Study|Withdrawal by Subject|0|||
47069669|NCT00587431|83355465|FG001|Overall Study|Withdrawal by Subject|1|||
47069670|NCT00097786|83355487|FG000|Overall Study|lost to follow-up for all-cause death|296|||
47069671|NCT00097786|83355488|FG001|Overall Study|lost to follow-up for all-cause death|292|||
47069672|NCT00097786|83355489|FG002|Overall Study|lost to follow-up for all-cause death|313|||
47069673|NCT00097786|83355490|FG003|Overall Study|lost to follow-up for all-cause death|310|||
47069674|NCT01524692|83355500|FG000|Overall Study|Withdrawal by Subject|3|||
47069675|NCT01431287|83355519|FG000|Overall Study|not treated|0|||
47069676|NCT01431287|83355520|FG001|Overall Study|not treated|0|||
47069677|NCT01431287|83355521|FG002|Overall Study|not treated|1|||
47069678|NCT01431287|83355522|FG003|Overall Study|not treated|0|||
46967253|NCT02625909|83209942|FG001|Overall Study|Lack of Efficacy|2|||
47069679|NCT01431287|83355523|FG004|Overall Study|not treated|0|||
47069680|NCT01431287|83355519|FG000|Overall Study|Adverse Event|59|||
47069681|NCT01431287|83355520|FG001|Overall Study|Adverse Event|57|||
47069682|NCT01431287|83355521|FG002|Overall Study|Adverse Event|53|||
47069683|NCT01431287|83355522|FG003|Overall Study|Adverse Event|33|||
47069684|NCT01431287|83355523|FG004|Overall Study|Adverse Event|41|||
47069685|NCT01431287|83355519|FG000|Overall Study|Non compliant with protocol|6|||
47069686|NCT01431287|83355520|FG001|Overall Study|Non compliant with protocol|6|||
47069687|NCT01431287|83355521|FG002|Overall Study|Non compliant with protocol|5|||
47069688|NCT01431287|83355522|FG003|Overall Study|Non compliant with protocol|6|||
47069689|NCT01431287|83355523|FG004|Overall Study|Non compliant with protocol|5|||
47069690|NCT01431287|83355519|FG000|Overall Study|Lost to Follow-up|0|||
47069691|NCT01431287|83355520|FG001|Overall Study|Lost to Follow-up|3|||
47069692|NCT01431287|83355521|FG002|Overall Study|Lost to Follow-up|2|||
47069693|NCT01431287|83355522|FG003|Overall Study|Lost to Follow-up|3|||
47069694|NCT01431287|83355523|FG004|Overall Study|Lost to Follow-up|1|||
47069695|NCT01431287|83355519|FG000|Overall Study|Consent withdrawn not due to AE|29|||
47069696|NCT01431287|83355520|FG001|Overall Study|Consent withdrawn not due to AE|30|||
47069697|NCT01431287|83355521|FG002|Overall Study|Consent withdrawn not due to AE|34|||
47069698|NCT01431287|83355522|FG003|Overall Study|Consent withdrawn not due to AE|19|||
46775232|NCT00576927|82993656|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
46775233|NCT00576927|82993656|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
46775234|NCT00576927|82993656|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
46967254|NCT02625909|83209941|FG000|Overall Study|Reinfection|3|||
47069699|NCT01431287|83355523|FG004|Overall Study|Consent withdrawn not due to AE|29|||
47069700|NCT01431287|83355519|FG000|Overall Study|not stated above|4|||
47069701|NCT01431287|83355520|FG001|Overall Study|not stated above|2|||
47069702|NCT01431287|83355521|FG002|Overall Study|not stated above|2|||
47069703|NCT01431287|83355522|FG003|Overall Study|not stated above|2|||
47069704|NCT01431287|83355523|FG004|Overall Study|not stated above|1|||
47069705|NCT01274715|83355569|FG000|Overall Study|Lost to Follow-up|1|||
47069706|NCT01274715|83355569|FG000|Overall Study|After consent, met exclusion criteria.|1|||
47069707|NCT01274715|83355569|FG000|Overall Study|After consent, met exclusion criteria.|1|||
47069708|NCT01274715|83355569|FG000|Overall Study|After consent, met exclusion criteria.|1|||
47069709|NCT01410227|83355573|FG000|Overall Study|Adverse Event|1|||
47069710|NCT01410227|83355574|FG001|Overall Study|Adverse Event|0|||
47069711|NCT01410227|83355575|FG002|Overall Study|Adverse Event|0|||
47069712|NCT01410227|83355576|FG003|Overall Study|Adverse Event|0|||
47069713|NCT01410227|83355573|FG000|Overall Study|Withdrawal by Subject|3|||
47069714|NCT01410227|83355574|FG001|Overall Study|Withdrawal by Subject|0|||
47069715|NCT01410227|83355575|FG002|Overall Study|Withdrawal by Subject|1|||
47069716|NCT01410227|83355576|FG003|Overall Study|Withdrawal by Subject|0|||
47069717|NCT01410227|83355573|FG000|Overall Study|Pregnancy|0|||
47069718|NCT01410227|83355574|FG001|Overall Study|Pregnancy|0|||
47069719|NCT01410227|83355575|FG002|Overall Study|Pregnancy|0|||
47069720|NCT01410227|83355576|FG003|Overall Study|Pregnancy|1|||
47069721|NCT01410227|83355573|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
47069722|NCT01410227|83355574|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
47069723|NCT01410227|83355575|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
47069724|NCT01410227|83355576|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
47069725|NCT01274559|83355588|FG000|Overall Study|Adverse Event|57|||
47069726|NCT01274559|83355589|FG001|Overall Study|Adverse Event|13|||
47069727|NCT01274559|83355588|FG000|Overall Study|Death|1|||
47069728|NCT01274559|83355589|FG001|Overall Study|Death|1|||
47069729|NCT01274559|83355588|FG000|Overall Study|Lost to Follow-up|3|||
47069730|NCT01274559|83355589|FG001|Overall Study|Lost to Follow-up|3|||
47069731|NCT01274559|83355588|FG000|Overall Study|Non-compliance with Study Drug|2|||
47069732|NCT01274559|83355589|FG001|Overall Study|Non-compliance with Study Drug|4|||
47069733|NCT01274559|83355588|FG000|Overall Study|Physician Decision|2|||
47069734|NCT01274559|83355589|FG001|Overall Study|Physician Decision|1|||
47069735|NCT01274559|83355588|FG000|Overall Study|Protocol Violation|28|||
47069736|NCT01274559|83355589|FG001|Overall Study|Protocol Violation|23|||
47069737|NCT01274559|83355588|FG000|Overall Study|Study Terminated by Sponsor|79|||
47069738|NCT01274559|83355589|FG001|Overall Study|Study Terminated by Sponsor|87|||
47069739|NCT01274559|83355588|FG000|Overall Study|Withdrawal by Subject|25|||
47069740|NCT01274559|83355589|FG001|Overall Study|Withdrawal by Subject|13|||
47069741|NCT01409993|83355597|FG000|Overall Study|Adverse Event|4|||
47069742|NCT01409993|83355598|FG001|Overall Study|Adverse Event|4|||
47069743|NCT01409993|83355599|FG002|Overall Study|Adverse Event|3|||
47069744|NCT01409993|83355600|FG003|Overall Study|Adverse Event|1|||
47069745|NCT01409993|83355597|FG000|Overall Study|Withdrawal by Subject|0|||
47069746|NCT01409993|83355598|FG001|Overall Study|Withdrawal by Subject|0|||
47069747|NCT01409993|83355599|FG002|Overall Study|Withdrawal by Subject|0|||
47069748|NCT01409993|83355600|FG003|Overall Study|Withdrawal by Subject|4|||
47069749|NCT01409993|83355597|FG000|Overall Study|Lost to Follow-up|0|||
47069750|NCT01409993|83355598|FG001|Overall Study|Lost to Follow-up|1|||
47069751|NCT01409993|83355599|FG002|Overall Study|Lost to Follow-up|0|||
46967255|NCT02625909|83209942|FG001|Overall Study|Reinfection|2|||
47069752|NCT01409993|83355600|FG003|Overall Study|Lost to Follow-up|0|||
47069753|NCT01273623|83355614|FG000|Overall Study|did not meet IVUS criteria|29|||
47069754|NCT01409915|83355622|FG000|Overall Study|Adverse Event|0|||
47069755|NCT01409915|83355623|FG001|Overall Study|Adverse Event|2|||
47069756|NCT01409915|83355622|FG000|Overall Study|Withdrawal by Subject|0|||
47069757|NCT01409915|83355623|FG001|Overall Study|Withdrawal by Subject|1|||
47069758|NCT01409915|83355622|FG000|Overall Study|Protocol Violation|1|||
47069759|NCT01409915|83355623|FG001|Overall Study|Protocol Violation|0|||
47069760|NCT01272921|83355631|FG000|Overall Study|Protocol Violation|2|||
47069761|NCT01272921|83355632|FG001|Overall Study|Protocol Violation|1|||
47069762|NCT01409837|83355642|FG000|Overall Study|Withdrawal by Subject|2|||
47069763|NCT01409837|83355643|FG001|Overall Study|Withdrawal by Subject|1|||
47069764|NCT01409837|83355642|FG000|Overall Study|Lost to Follow-up|1|||
47069765|NCT01409837|83355643|FG001|Overall Study|Lost to Follow-up|0|||
47069766|NCT01409837|83355642|FG000|Overall Study|Physician Decision|0|||
47069767|NCT01409837|83355643|FG001|Overall Study|Physician Decision|1|||
47069768|NCT01430585|83355662|FG000|Overall Study|Death|1|||
47069769|NCT01430585|83355662|FG000|Overall Study|Objective Progression or Relapse|3|||
47069770|NCT01430585|83355662|FG000|Overall Study|Study Terminated by Sponsor|3|||
47069771|NCT01430585|83355662|FG000|Overall Study|Other|7|||
47069772|NCT01408901|83355685|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
47069773|NCT01408901|83355686|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
47069774|NCT01408901|83355687|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
47069775|NCT01408901|83355688|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
47069776|NCT01408901|83355685|FG000|6-Week Follow-Up|Death|1|||
47069777|NCT01408901|83355686|FG001|6-Week Follow-Up|Death|0|||
47069778|NCT01408901|83355687|FG002|6-Week Follow-Up|Death|0|||
47069779|NCT01408901|83355688|FG003|6-Week Follow-Up|Death|0|||
47069780|NCT01408901|83355685|FG000|6-Week Follow-Up|Cancelled visit|0|||
47069781|NCT01408901|83355686|FG001|6-Week Follow-Up|Cancelled visit|1|||
47069782|NCT01408901|83355687|FG002|6-Week Follow-Up|Cancelled visit|0|||
47069783|NCT01408901|83355688|FG003|6-Week Follow-Up|Cancelled visit|2|||
47069784|NCT01408901|83355685|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
47069785|NCT01408901|83355686|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
47069786|NCT01408901|83355687|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
47069787|NCT01408901|83355688|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
47069788|NCT01408901|83355685|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
47069789|NCT01408901|83355686|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
47069790|NCT01408901|83355687|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
47069791|NCT01408901|83355688|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
47069792|NCT01408901|83355685|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
47069793|NCT01408901|83355686|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
47069794|NCT01408901|83355687|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
47069795|NCT01408901|83355688|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
47069796|NCT01408901|83355685|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
47069797|NCT01408901|83355686|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
47069798|NCT01408901|83355687|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
47069799|NCT01408901|83355688|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
47069800|NCT01408901|83355685|FG000|26-Week Follow-Up|Death|0|||
47069801|NCT01408901|83355686|FG001|26-Week Follow-Up|Death|1|||
47069802|NCT01408901|83355687|FG002|26-Week Follow-Up|Death|0|||
47069803|NCT01408901|83355688|FG003|26-Week Follow-Up|Death|0|||
47069804|NCT01428713|83355704|FG000|Overall Study|Non-compliance|2|||
47069805|NCT01428713|83355705|FG001|Overall Study|Non-compliance|2|||
47069806|NCT01428713|83355704|FG000|Overall Study|Withdrawal by Subject|1|||
47069807|NCT01428713|83355705|FG001|Overall Study|Withdrawal by Subject|1|||
47069808|NCT01428713|83355704|FG000|Overall Study|Adverse Event|0|||
47069809|NCT01428713|83355705|FG001|Overall Study|Adverse Event|2|||
47069810|NCT01408277|83355713|FG000|Overall Study|Adverse Event|3|||
46967256|NCT02623959|83209950|FG000|Overall Study|Progression|0|||
47069811|NCT01408277|83355714|FG001|Overall Study|Adverse Event|4|||
47069812|NCT01408277|83355713|FG000|Overall Study|Lost to Follow-up|1|||
47069813|NCT01408277|83355714|FG001|Overall Study|Lost to Follow-up|0|||
47069814|NCT01408277|83355713|FG000|Overall Study|Withdrawal by Subject|2|||
47069815|NCT01408277|83355714|FG001|Overall Study|Withdrawal by Subject|0|||
47069816|NCT01408277|83355713|FG000|Overall Study|Protocol Violation|2|||
47069817|NCT01408277|83355714|FG001|Overall Study|Protocol Violation|0|||
47069818|NCT01408043|83355720|FG000|Overall Study|unable to collect cells|1|||
46775235|NCT00698841|82993662|FG000|Overall Study|Withdrawal by Subject|2|||
47069819|NCT01524224|83355732|FG000|Overall Study|Progressive Disease|1|||
47069820|NCT01524224|83355733|FG001|Overall Study|Progressive Disease|0|||
47069821|NCT01524224|83355734|FG002|Overall Study|Progressive Disease|2|||
47069822|NCT01524224|83355735|FG003|Overall Study|Progressive Disease|1|||
47069823|NCT01524224|83355736|FG004|Overall Study|Progressive Disease|2|||
47069824|NCT01524224|83355737|FG005|Overall Study|Progressive Disease|1|||
47069825|NCT01524224|83355738|FG006|Overall Study|Progressive Disease|1|||
46775236|NCT00698841|82993662|FG000|Overall Study|Adverse Event|3|||
46775237|NCT00698841|82993662|FG000|Overall Study|Disease progression|7|||
46775238|NCT00698841|82993662|FG000|Overall Study|Failure to meet eligibility criteria|2|||
46775239|NCT00698841|82993662|FG000|Overall Study|Study drug toxicity|2|||
47069826|NCT01524224|83355739|FG007|Overall Study|Progressive Disease|5|||
47069827|NCT01524224|83355732|FG000|Overall Study|Withdrawal by Subject|2|||
47069828|NCT01524224|83355733|FG001|Overall Study|Withdrawal by Subject|0|||
47069829|NCT01524224|83355734|FG002|Overall Study|Withdrawal by Subject|0|||
47069830|NCT01524224|83355735|FG003|Overall Study|Withdrawal by Subject|0|||
47069831|NCT01524224|83355736|FG004|Overall Study|Withdrawal by Subject|0|||
47069832|NCT01524224|83355737|FG005|Overall Study|Withdrawal by Subject|0|||
47069833|NCT01524224|83355738|FG006|Overall Study|Withdrawal by Subject|2|||
47069834|NCT01524224|83355739|FG007|Overall Study|Withdrawal by Subject|0|||
47069835|NCT01524224|83355732|FG000|Overall Study|Adverse Event|0|||
47069836|NCT01524224|83355733|FG001|Overall Study|Adverse Event|1|||
47069837|NCT01524224|83355734|FG002|Overall Study|Adverse Event|0|||
47069838|NCT01524224|83355735|FG003|Overall Study|Adverse Event|0|||
47069839|NCT01524224|83355736|FG004|Overall Study|Adverse Event|0|||
47069840|NCT01524224|83355737|FG005|Overall Study|Adverse Event|1|||
47069841|NCT01524224|83355738|FG006|Overall Study|Adverse Event|0|||
47069842|NCT01524224|83355739|FG007|Overall Study|Adverse Event|0|||
47069843|NCT01524224|83355732|FG000|Overall Study|Physician Decision|0|||
47069844|NCT01524224|83355733|FG001|Overall Study|Physician Decision|0|||
47069845|NCT01524224|83355734|FG002|Overall Study|Physician Decision|0|||
47069846|NCT01524224|83355735|FG003|Overall Study|Physician Decision|1|||
47069847|NCT01524224|83355736|FG004|Overall Study|Physician Decision|1|||
47069848|NCT01524224|83355737|FG005|Overall Study|Physician Decision|0|||
47069849|NCT01524224|83355738|FG006|Overall Study|Physician Decision|0|||
47069850|NCT01524224|83355739|FG007|Overall Study|Physician Decision|1|||
47069851|NCT01524224|83355732|FG000|Overall Study|Sponsor Decision|0|||
47069852|NCT01524224|83355733|FG001|Overall Study|Sponsor Decision|0|||
47069853|NCT01524224|83355734|FG002|Overall Study|Sponsor Decision|0|||
47069854|NCT01524224|83355735|FG003|Overall Study|Sponsor Decision|0|||
47069855|NCT01524224|83355736|FG004|Overall Study|Sponsor Decision|1|||
47069856|NCT01524224|83355737|FG005|Overall Study|Sponsor Decision|0|||
47069857|NCT01524224|83355738|FG006|Overall Study|Sponsor Decision|0|||
47069858|NCT01524224|83355739|FG007|Overall Study|Sponsor Decision|0|||
47069859|NCT00219349|83355757|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
47069860|NCT00219349|83355757|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
47069861|NCT00219349|83355757|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
47069862|NCT00219349|83355757|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
47069863|NCT01523756|83355761|FG000|Baseline Period|Adverse Event|0|||
47069864|NCT01523756|83355762|FG001|Baseline Period|Adverse Event|1|||
47069865|NCT01523756|83355761|FG000|Test Period 1|Adverse Event|1|||
47069866|NCT01523756|83355762|FG001|Test Period 1|Adverse Event|0|||
47069867|NCT01523756|83355761|FG000|Test Period 2|Withdrawal by Subject|0|||
47069868|NCT01523756|83355762|FG001|Test Period 2|Withdrawal by Subject|1|||
47069869|NCT00218257|83355770|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
47069870|NCT00218257|83355771|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
47069871|NCT01523366|83355782|FG000|Treatment Period 1|Withdrawal by Subject|1|||
47069872|NCT01523366|83355783|FG001|Treatment Period 1|Withdrawal by Subject|0|||
47069873|NCT01523366|83355782|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
47069874|NCT01523366|83355783|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
47069875|NCT01427933|83355793|FG000|Overall Study|Withdrawal by Subject|5|||
47069876|NCT01427933|83355794|FG001|Overall Study|Withdrawal by Subject|8|||
47069877|NCT01427933|83355793|FG000|Overall Study|Lost to Follow-up|1|||
47069878|NCT01427933|83355794|FG001|Overall Study|Lost to Follow-up|5|||
47069879|NCT01427933|83355793|FG000|Overall Study|Other|1|||
47069880|NCT01427933|83355794|FG001|Overall Study|Other|0|||
47069881|NCT01427933|83355793|FG000|Overall Study|Investigator's Decision|1|||
47069882|NCT01427933|83355794|FG001|Overall Study|Investigator's Decision|0|||
47069883|NCT00217087|83355803|FG000|Overall Study|decided to have esophagectomy|1|||
47069884|NCT00217087|83355804|FG001|Overall Study|decided to have esophagectomy|2|||
47069885|NCT00217087|83355803|FG000|Overall Study|completed less than 12 months return|10|||
47069886|NCT00217087|83355804|FG001|Overall Study|completed less than 12 months return|18|||
47069887|NCT01406873|83355818|FG000|Overall Study|Withdrawal by Subject|1|||
47069888|NCT01406873|83355819|FG001|Overall Study|Withdrawal by Subject|1|||
47069889|NCT01406795|83355835|FG000|Overall Study|Withdrawal by Subject|1|||
47069890|NCT01406717|83355841|FG000|Overall Study|Subject non-compliance|4|||
47069891|NCT01406717|83355842|FG001|Overall Study|Subject non-compliance|3|||
47069892|NCT01406717|83355841|FG000|Overall Study|Protocol Violation|5|||
47069893|NCT01406717|83355842|FG001|Overall Study|Protocol Violation|1|||
46775240|NCT00698841|82993662|FG000|Overall Study|Other|2|||
46775241|NCT00577395|82993668|FG000|Overall Study|Study was terminated early by Sponsor|7|||
46775242|NCT00577395|82993669|FG001|Overall Study|Study was terminated early by Sponsor|6|||
46775243|NCT00738374|82993678|FG000|Induction Treatment Phase|Adverse Event|14|||
47069894|NCT01406717|83355841|FG000|Overall Study|Lost to Follow-up|14|||
47069895|NCT01406717|83355842|FG001|Overall Study|Lost to Follow-up|8|||
47069896|NCT01406717|83355841|FG000|Overall Study|Withdrawal by Subject|19|||
47069897|NCT01406717|83355842|FG001|Overall Study|Withdrawal by Subject|15|||
47069898|NCT01406717|83355841|FG000|Overall Study|Adverse Event|1|||
47069899|NCT01406717|83355842|FG001|Overall Study|Adverse Event|2|||
47069900|NCT01406717|83355841|FG000|Overall Study|Lack of Efficacy|0|||
47069901|NCT01406717|83355842|FG001|Overall Study|Lack of Efficacy|1|||
47069902|NCT01406717|83355841|FG000|Overall Study|Non-completion of visit activity|0|||
47069903|NCT01406717|83355842|FG001|Overall Study|Non-completion of visit activity|1|||
47069904|NCT01406015|83355860|FG000|Overall Study|Withdrawal by Subject|3|||
47069905|NCT01406015|83355861|FG001|Overall Study|Withdrawal by Subject|3|||
47069906|NCT00215683|83355870|FG000|Overall Study|Adverse Event|15|||
47069907|NCT00215683|83355871|FG001|Overall Study|Adverse Event|16|||
47069908|NCT00215683|83355872|FG002|Overall Study|Adverse Event|15|||
47069909|NCT00215683|83355870|FG000|Overall Study|Lack of Efficacy|5|||
47069910|NCT00215683|83355871|FG001|Overall Study|Lack of Efficacy|1|||
47069911|NCT00215683|83355872|FG002|Overall Study|Lack of Efficacy|2|||
47069912|NCT00215683|83355870|FG000|Overall Study|Lost to Follow-up|0|||
47069913|NCT00215683|83355871|FG001|Overall Study|Lost to Follow-up|2|||
46775244|NCT00738374|82993679|FG001|Induction Treatment Phase|Adverse Event|0|||
46775245|NCT00738374|82993680|FG002|Induction Treatment Phase|Adverse Event|0|||
46775246|NCT00738374|82993681|FG003|Induction Treatment Phase|Adverse Event|0|||
46775247|NCT00738374|82993678|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
46775248|NCT00738374|82993679|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
46775249|NCT00738374|82993680|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
46775250|NCT00738374|82993681|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
46775251|NCT00738374|82993678|FG000|Induction Treatment Phase|Physician Decision|2|||
46775252|NCT00738374|82993679|FG001|Induction Treatment Phase|Physician Decision|0|||
46775253|NCT00738374|82993680|FG002|Induction Treatment Phase|Physician Decision|0|||
46775254|NCT00738374|82993681|FG003|Induction Treatment Phase|Physician Decision|0|||
46775255|NCT00738374|82993678|FG000|Induction Treatment Phase|Protocol Violation|2|||
46775256|NCT00738374|82993679|FG001|Induction Treatment Phase|Protocol Violation|0|||
46775257|NCT00738374|82993680|FG002|Induction Treatment Phase|Protocol Violation|0|||
46775258|NCT00738374|82993681|FG003|Induction Treatment Phase|Protocol Violation|0|||
46775259|NCT00738374|82993678|FG000|Induction Treatment Phase|Non-compliance|1|||
46775260|NCT00738374|82993679|FG001|Induction Treatment Phase|Non-compliance|0|||
46775261|NCT00738374|82993680|FG002|Induction Treatment Phase|Non-compliance|0|||
46846322|NCT00098748|83063048|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
46846323|NCT00098748|83063049|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
46846324|NCT00098748|83063050|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
46846325|NCT00098748|83063048|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
46846326|NCT00098748|83063049|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
46846327|NCT00098748|83063050|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
46846328|NCT00098748|83063048|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
46846329|NCT00098748|83063049|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
46967257|NCT02623959|83209951|FG001|Overall Study|Progression|1|||
46967258|NCT00700739|83209961|FG000|Overall Study|Lost to Follow-up|4|||
46967259|NCT00700739|83209962|FG001|Overall Study|Lost to Follow-up|4|||
46967260|NCT02623335|83209971|FG000|Overall Study|Death|8|||
46967261|NCT02623335|83209972|FG001|Overall Study|Death|7|||
46967262|NCT02623335|83209971|FG000|Overall Study|Lost to Follow-up|15|||
46967263|NCT02623335|83209972|FG001|Overall Study|Lost to Follow-up|23|||
46967264|NCT02623335|83209971|FG000|Overall Study|Withdrawal by Subject|2|||
46967265|NCT02623335|83209972|FG001|Overall Study|Withdrawal by Subject|5|||
46967266|NCT02623335|83209971|FG000|Overall Study|Protocol Violation|2|||
47069914|NCT00215683|83355872|FG002|Overall Study|Lost to Follow-up|1|||
47069915|NCT00215683|83355870|FG000|Overall Study|Withdrawal by Subject|9|||
47069916|NCT00215683|83355871|FG001|Overall Study|Withdrawal by Subject|4|||
47069917|NCT00215683|83355872|FG002|Overall Study|Withdrawal by Subject|13|||
47069918|NCT00215683|83355870|FG000|Overall Study|Physician Decision|0|||
47069919|NCT00215683|83355871|FG001|Overall Study|Physician Decision|0|||
47069920|NCT00215683|83355872|FG002|Overall Study|Physician Decision|1|||
47069921|NCT00215683|83355870|FG000|Overall Study|Difficult to attend visits|0|||
47069922|NCT00215683|83355871|FG001|Overall Study|Difficult to attend visits|1|||
47069923|NCT00215683|83355872|FG002|Overall Study|Difficult to attend visits|0|||
47069924|NCT00215683|83355870|FG000|Overall Study|No study drug available|0|||
46641031|NCT02987543|82820328|FG002|Overall Study|Disease progression|0|||
46641032|NCT02987543|82820329|FG003|Overall Study|Disease progression|1|||
46967267|NCT02623335|83209972|FG001|Overall Study|Protocol Violation|1|||
46641033|NCT02983045|82820345|FG000|Overall Study|Withdrawal by Subject|0|||
46967268|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
47069925|NCT00215683|83355871|FG001|Overall Study|No study drug available|1|||
47069926|NCT00215683|83355872|FG002|Overall Study|No study drug available|0|||
47069927|NCT00215683|83355870|FG000|Overall Study|Intermittent therapy required|0|||
47069928|NCT00215683|83355871|FG001|Overall Study|Intermittent therapy required|1|||
46641034|NCT02983045|82820346|FG001|Overall Study|Withdrawal by Subject|1|||
47069929|NCT00215683|83355872|FG002|Overall Study|Intermittent therapy required|0|||
47069930|NCT00215137|83355880|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
47069931|NCT00215137|83355881|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
47069932|NCT00215137|83355882|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
47069933|NCT00215137|83355880|FG000|Randomization Period|Lost to Follow-up|0|||
47069934|NCT00215137|83355881|FG001|Randomization Period|Lost to Follow-up|1|||
47069935|NCT00215137|83355882|FG002|Randomization Period|Lost to Follow-up|0|||
47069936|NCT00215137|83355880|FG000|Randomization Period|Withdrawal by Subject|0|||
47069937|NCT00215137|83355881|FG001|Randomization Period|Withdrawal by Subject|1|||
47069938|NCT00215137|83355882|FG002|Randomization Period|Withdrawal by Subject|0|||
47069939|NCT00214201|83355892|FG000|Overall Study|Withdrawal by Subject|2|||
47069940|NCT00214201|83355893|FG001|Overall Study|Withdrawal by Subject|0|||
47069941|NCT00214201|83355892|FG000|Overall Study|Death|0|||
47069942|NCT00214201|83355893|FG001|Overall Study|Death|2|||
47069943|NCT01486784|83355906|FG000|Overall Study|Withdrawal by Subject|0|||
47069944|NCT01486784|83355907|FG001|Overall Study|Withdrawal by Subject|0|||
47069945|NCT01486784|83355908|FG002|Overall Study|Withdrawal by Subject|1|||
47069946|NCT01486784|83355909|FG003|Overall Study|Withdrawal by Subject|0|||
47069947|NCT01486784|83355910|FG004|Overall Study|Withdrawal by Subject|1|||
47069948|NCT01486784|83355911|FG005|Overall Study|Withdrawal by Subject|2|||
47069949|NCT01486784|83355906|FG000|Overall Study|Subject did not meet entry criteria|0|||
47069950|NCT01486784|83355907|FG001|Overall Study|Subject did not meet entry criteria|0|||
47069951|NCT01486784|83355908|FG002|Overall Study|Subject did not meet entry criteria|0|||
47069952|NCT01486784|83355909|FG003|Overall Study|Subject did not meet entry criteria|0|||
47069953|NCT01486784|83355910|FG004|Overall Study|Subject did not meet entry criteria|1|||
47069954|NCT01486784|83355911|FG005|Overall Study|Subject did not meet entry criteria|0|||
47069955|NCT01486784|83355906|FG000|Overall Study|Death|0|||
47069956|NCT01486784|83355907|FG001|Overall Study|Death|0|||
47069957|NCT01486784|83355908|FG002|Overall Study|Death|0|||
47069958|NCT01486784|83355909|FG003|Overall Study|Death|0|||
47069959|NCT01486784|83355910|FG004|Overall Study|Death|0|||
47069960|NCT01486784|83355911|FG005|Overall Study|Death|1|||
47069961|NCT01521884|83355925|FG000|Overall Study|Non Responders|10|||
47069962|NCT01521884|83355925|FG000|Overall Study|Adverse Event|5|||
47069963|NCT01521884|83355925|FG000|Overall Study|Pregnancy|1|||
47069964|NCT01521884|83355925|FG000|Overall Study|Withdrawal by Subject|1|||
47069965|NCT01521884|83355925|FG000|Overall Study|Physician Decision|2|||
47069966|NCT01521884|83355925|FG000|Overall Study|Protocol Violation|3|||
47069967|NCT01521884|83355925|FG000|Overall Study|Participant non-eligible|1|||
47069968|NCT01521884|83355925|FG000|Overall Study|Lost to Follow-up|4|||
47069969|NCT01677858|83355934|FG000|Overall Study|Adverse Event|0|||
47069970|NCT01677858|83355935|FG001|Overall Study|Adverse Event|0|||
47069971|NCT01677858|83355936|FG002|Overall Study|Adverse Event|2|||
47069972|NCT01677858|83355937|FG003|Overall Study|Adverse Event|3|||
47069973|NCT01677858|83355938|FG004|Overall Study|Adverse Event|13|||
47069974|NCT01677858|83355934|FG000|Overall Study|Death|0|||
47069975|NCT01677858|83355935|FG001|Overall Study|Death|0|||
47069976|NCT01677858|83355936|FG002|Overall Study|Death|0|||
47069977|NCT01677858|83355937|FG003|Overall Study|Death|0|||
47069978|NCT01677858|83355938|FG004|Overall Study|Death|1|||
47069979|NCT01677858|83355934|FG000|Overall Study|Physician Decision|1|||
47069980|NCT01677858|83355935|FG001|Overall Study|Physician Decision|0|||
47069981|NCT01677858|83355936|FG002|Overall Study|Physician Decision|2|||
47069982|NCT01677858|83355937|FG003|Overall Study|Physician Decision|0|||
47069983|NCT01677858|83355938|FG004|Overall Study|Physician Decision|12|||
47069984|NCT01677858|83355934|FG000|Overall Study|Progressive Disease|2|||
47069985|NCT01677858|83355935|FG001|Overall Study|Progressive Disease|1|||
47069986|NCT01677858|83355936|FG002|Overall Study|Progressive Disease|9|||
47069987|NCT01677858|83355937|FG003|Overall Study|Progressive Disease|3|||
47069988|NCT01677858|83355938|FG004|Overall Study|Progressive Disease|43|||
47069989|NCT01677858|83355934|FG000|Overall Study|Withdrawal by Subject|0|||
47069990|NCT01677858|83355935|FG001|Overall Study|Withdrawal by Subject|1|||
47069991|NCT01677858|83355936|FG002|Overall Study|Withdrawal by Subject|1|||
47069992|NCT01677858|83355937|FG003|Overall Study|Withdrawal by Subject|0|||
46967269|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
47069993|NCT01677858|83355938|FG004|Overall Study|Withdrawal by Subject|15|||
47069994|NCT01677858|83355934|FG000|Overall Study|Lost to Follow-up|0|||
47069995|NCT01677858|83355935|FG001|Overall Study|Lost to Follow-up|0|||
47069996|NCT01677858|83355936|FG002|Overall Study|Lost to Follow-up|0|||
47069997|NCT01677858|83355937|FG003|Overall Study|Lost to Follow-up|0|||
47069998|NCT01677858|83355938|FG004|Overall Study|Lost to Follow-up|1|||
47069999|NCT01486316|83355958|FG000|Overall Study|Device explanted with/without re-implant|3|||
47070000|NCT01486316|83355959|FG001|Overall Study|Device explanted with/without re-implant|2|||
47070001|NCT01486316|83355960|FG002|Overall Study|Device explanted with/without re-implant|0|||
47070002|NCT01486316|83355961|FG003|Overall Study|Device explanted with/without re-implant|2|||
47070003|NCT01486316|83355958|FG000|Overall Study|Not meeting eligibility criteria|0|||
47070004|NCT01486316|83355959|FG001|Overall Study|Not meeting eligibility criteria|0|||
47070005|NCT01486316|83355960|FG002|Overall Study|Not meeting eligibility criteria|1|||
47070006|NCT01486316|83355961|FG003|Overall Study|Not meeting eligibility criteria|0|||
47070007|NCT01486316|83355958|FG000|Overall Study|Withdrawal by Subject|1|||
47070008|NCT01486316|83355959|FG001|Overall Study|Withdrawal by Subject|0|||
47070009|NCT01486316|83355960|FG002|Overall Study|Withdrawal by Subject|3|||
47070010|NCT01486316|83355961|FG003|Overall Study|Withdrawal by Subject|0|||
47070011|NCT01486316|83355958|FG000|Overall Study|Physician Decision|0|||
47070012|NCT01486316|83355959|FG001|Overall Study|Physician Decision|0|||
47070013|NCT01486316|83355960|FG002|Overall Study|Physician Decision|1|||
47070014|NCT01486316|83355961|FG003|Overall Study|Physician Decision|0|||
47070015|NCT01486316|83355958|FG000|Overall Study|Death|0|||
47070016|NCT01486316|83355959|FG001|Overall Study|Death|1|||
47070017|NCT01486316|83355960|FG002|Overall Study|Death|0|||
47070018|NCT01486316|83355961|FG003|Overall Study|Death|0|||
47070019|NCT01486238|83355972|FG000|Overall Study|Death|0|||
47070020|NCT01486238|83355973|FG001|Overall Study|Death|2|||
47070021|NCT01486238|83355972|FG000|Overall Study|Withdrawal by Subject|2|||
47070022|NCT01486238|83355973|FG001|Overall Study|Withdrawal by Subject|1|||
47070023|NCT01486238|83355972|FG000|Overall Study|Lost to Follow-up|0|||
47070024|NCT01486238|83355973|FG001|Overall Study|Lost to Follow-up|3|||
47070025|NCT01602744|83355981|FG000|Overall Study|Death|17|||
47070026|NCT01602744|83355982|FG001|Overall Study|Death|15|||
47070027|NCT01602744|83355981|FG000|Overall Study|Lost to Follow-up|13|||
47070028|NCT01602744|83355982|FG001|Overall Study|Lost to Follow-up|8|||
47070029|NCT03598777|83355993|FG000|Overall Study|Study Terminated by Sponsor|3|||
47070030|NCT03598777|83355994|FG001|Overall Study|Study Terminated by Sponsor|0|||
47070031|NCT03598777|83355995|FG002|Overall Study|Study Terminated by Sponsor|0|||
47070032|NCT03598777|83355996|FG003|Overall Study|Study Terminated by Sponsor|0|||
47070033|NCT03598777|83355997|FG004|Overall Study|Study Terminated by Sponsor|15|||
47070034|NCT03598777|83355993|FG000|Overall Study|Withdrawal by Subject|1|||
47070035|NCT03598777|83355994|FG001|Overall Study|Withdrawal by Subject|1|||
47070036|NCT03598777|83355995|FG002|Overall Study|Withdrawal by Subject|0|||
47070037|NCT03598777|83355996|FG003|Overall Study|Withdrawal by Subject|0|||
47070038|NCT03598777|83355997|FG004|Overall Study|Withdrawal by Subject|0|||
47070039|NCT03598777|83355993|FG000|Overall Study|Adverse Event|1|||
47070040|NCT03598777|83355994|FG001|Overall Study|Adverse Event|0|||
47070041|NCT03598777|83355995|FG002|Overall Study|Adverse Event|0|||
47070042|NCT03598777|83355996|FG003|Overall Study|Adverse Event|0|||
47070043|NCT03598777|83355997|FG004|Overall Study|Adverse Event|0|||
47070044|NCT03598777|83355993|FG000|Overall Study|Lost to Follow-up|1|||
47070045|NCT03598777|83355994|FG001|Overall Study|Lost to Follow-up|0|||
47070046|NCT03598777|83355995|FG002|Overall Study|Lost to Follow-up|0|||
47070047|NCT03598777|83355996|FG003|Overall Study|Lost to Follow-up|0|||
47070048|NCT03598777|83355997|FG004|Overall Study|Lost to Follow-up|0|||
47070049|NCT04348591|83356052|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
47070050|NCT04348591|83356053|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
47070051|NCT04348591|83356052|FG000|Imaging Session (120 Min)|Physician Decision|0|||
47070052|NCT04348591|83356053|FG001|Imaging Session (120 Min)|Physician Decision|1|||
47070053|NCT04348591|83356052|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
47070054|NCT04348591|83356053|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
47070055|NCT04046250|83356072|FG000|Overall Study|Death|0|||
47070056|NCT04046250|83356073|FG001|Overall Study|Death|1|||
47070057|NCT04046250|83356072|FG000|Overall Study|Withdrawal by Subject|3|||
47070058|NCT04046250|83356073|FG001|Overall Study|Withdrawal by Subject|3|||
47070059|NCT03841526|83356081|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
47070060|NCT03841526|83356082|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
47070061|NCT03841526|83356083|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
47070062|NCT03841526|83356084|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
47070063|NCT03841526|83356085|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
47070064|NCT03841526|83356086|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
46641035|NCT02983045|82820347|FG002|Overall Study|Withdrawal by Subject|0|||
46641036|NCT02983045|82820348|FG003|Overall Study|Withdrawal by Subject|5|||
46641037|NCT02983045|82820349|FG004|Overall Study|Withdrawal by Subject|0|||
47070065|NCT03841526|83356081|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
47070066|NCT03841526|83356082|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
47070067|NCT03841526|83356083|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
47070068|NCT03841526|83356084|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
46641038|NCT02983045|82820350|FG005|Overall Study|Withdrawal by Subject|72|||
47070069|NCT03841526|83356085|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
47070070|NCT03841526|83356086|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
47070071|NCT03841526|83356081|FG000|Outpatient Phase Treatment|Physician Decision|0|||
47070072|NCT03841526|83356082|FG001|Outpatient Phase Treatment|Physician Decision|1|||
47070073|NCT03841526|83356083|FG002|Outpatient Phase Treatment|Physician Decision|0|||
47070074|NCT03841526|83356084|FG003|Outpatient Phase Treatment|Physician Decision|0|||
47070075|NCT03841526|83356085|FG004|Outpatient Phase Treatment|Physician Decision|0|||
46641039|NCT02983045|82820351|FG006|Overall Study|Withdrawal by Subject|0|||
47070076|NCT03841526|83356086|FG005|Outpatient Phase Treatment|Physician Decision|0|||
47070077|NCT03841526|83356081|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
47070078|NCT03841526|83356082|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
47070079|NCT03841526|83356083|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
47070080|NCT03841526|83356084|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
47070081|NCT03841526|83356085|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
47070082|NCT03841526|83356086|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
47070083|NCT03834506|83356109|FG000|Overall Study|Death|268|||
47070084|NCT03834506|83356110|FG001|Overall Study|Death|285|||
47070085|NCT03834506|83356109|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
47070086|NCT03834506|83356110|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
47070087|NCT03834506|83356109|FG000|Overall Study|Withdrawal by Subject|12|||
47070088|NCT03834506|83356110|FG001|Overall Study|Withdrawal by Subject|8|||
47070089|NCT03834506|83356109|FG000|Overall Study|Participants ongoing in the study|234|||
47070090|NCT03834506|83356110|FG001|Overall Study|Participants ongoing in the study|221|||
47070091|NCT03535740|83356116|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
47070092|NCT03535740|83356116|FG000|Overall Study|Death|34|||
47070093|NCT03535740|83356116|FG000|Overall Study|Lost to Follow-up|1|||
47070094|NCT03535740|83356116|FG000|Overall Study|Withdrawal by Subject|13|||
47070095|NCT03351049|83356127|FG000|Overall Study|Withdrawal|26|||
47070096|NCT03351049|83356128|FG001|Overall Study|Withdrawal|22|||
47070097|NCT03288506|83356149|FG000|Overall Study|Withdrawal by Subject|52|||
47070098|NCT03180684|83356157|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
47070099|NCT03180684|83356158|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
47070100|NCT03180684|83356157|FG000|Overall Study|Physician Decision|1|||
47070101|NCT03180684|83356158|FG001|Overall Study|Physician Decision|0|||
47070102|NCT03180684|83356157|FG000|Overall Study|Lost to Follow-up|1|||
47070103|NCT03180684|83356158|FG001|Overall Study|Lost to Follow-up|0|||
47070104|NCT03180684|83356157|FG000|Overall Study|Progressive Disease|1|||
47070105|NCT03180684|83356158|FG001|Overall Study|Progressive Disease|0|||
47070106|NCT02515227|83356206|FG000|Overall Study|Adverse Event|0|||
47070107|NCT02515227|83356207|FG001|Overall Study|Adverse Event|2|||
47070108|NCT02515227|83356206|FG000|Overall Study|Progressive disease|2|||
47070109|NCT02515227|83356207|FG001|Overall Study|Progressive disease|9|||
47070110|NCT02369458|83356217|FG000|Overall Study|Determined to be not eligible|1|||
47070111|NCT02369458|83356218|FG001|Overall Study|Determined to be not eligible|0|||
47070112|NCT00066573|83356255|FG000|Overall Study|Did not received protocol treatment|28|||
47070113|NCT00066573|83356256|FG001|Overall Study|Did not received protocol treatment|28|||
47070114|NCT03594955|83356262|FG000|Overall Study|Adverse Event|1|||
47070115|NCT03594955|83356262|FG000|Overall Study|Progressive disease|5|||
47070116|NCT03594955|83356262|FG000|Overall Study|Sponsor's decision|1|||
47070117|NCT01677624|83356290|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
47070118|NCT01272219|83356311|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
47070119|NCT01272219|83356312|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
47070120|NCT01272219|83356313|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
47070121|NCT01272219|83356314|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
47070122|NCT01272219|83356315|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
47070123|NCT01272219|83356316|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
47070124|NCT01272219|83356311|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
47070125|NCT01272219|83356312|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
47070126|NCT01272219|83356313|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
47070127|NCT01272219|83356314|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
47070128|NCT01272219|83356315|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
47070129|NCT01272219|83356316|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
47070130|NCT01272219|83356311|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
47070131|NCT01272219|83356312|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
47070132|NCT01272219|83356313|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
46967270|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
46967271|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
46967272|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
46967273|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
46967274|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
47070133|NCT01272219|83356314|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
47070134|NCT01272219|83356315|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
47070135|NCT01272219|83356316|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
47070136|NCT01272219|83356311|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
47070137|NCT01272219|83356312|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
47070138|NCT01272219|83356313|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
47070139|NCT01272219|83356314|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
46775262|NCT00738374|82993681|FG003|Induction Treatment Phase|Non-compliance|0|||
47070140|NCT01272219|83356315|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
46641040|NCT02983045|82820352|FG007|Overall Study|Withdrawal by Subject|0|||
47070141|NCT01272219|83356316|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
47070142|NCT01272219|83356311|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
47070143|NCT01272219|83356312|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
47070144|NCT01272219|83356313|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
47070145|NCT01272219|83356314|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
47070146|NCT01272219|83356315|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
47070147|NCT01272219|83356316|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
47070148|NCT01272219|83356311|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
47070149|NCT01272219|83356312|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
47070150|NCT01272219|83356313|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
47070151|NCT01272219|83356314|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
47070152|NCT01272219|83356315|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
47070153|NCT01272219|83356316|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
47070154|NCT01272219|83356311|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
47070155|NCT01272219|83356312|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
47070156|NCT01272219|83356313|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
47070157|NCT01272219|83356314|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
47070158|NCT01272219|83356315|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
47070159|NCT01272219|83356316|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
47070160|NCT01272219|83356311|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
47070161|NCT01272219|83356312|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
47070162|NCT01272219|83356313|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
47070163|NCT01272219|83356314|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
47070164|NCT01272219|83356315|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
47070165|NCT01272219|83356316|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
47070166|NCT01272219|83356311|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
47070167|NCT01272219|83356312|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
47070168|NCT01272219|83356313|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
47070169|NCT01272219|83356314|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
47070170|NCT01272219|83356315|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
47070171|NCT01272219|83356316|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
47070172|NCT01272219|83356311|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
47070173|NCT01272219|83356312|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
47070174|NCT01272219|83356313|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
47070175|NCT01272219|83356314|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
47070176|NCT01272219|83356315|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
47070177|NCT01272219|83356316|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
47070178|NCT01272219|83356311|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
47070179|NCT01272219|83356312|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
47070180|NCT01272219|83356313|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
47070181|NCT01272219|83356314|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
47070182|NCT01272219|83356315|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
47070183|NCT01272219|83356316|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
47070184|NCT01272219|83356311|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
47070185|NCT01272219|83356312|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
47070186|NCT01272219|83356313|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
47070187|NCT01272219|83356314|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
47070188|NCT01272219|83356315|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
47070189|NCT01272219|83356316|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
47070190|NCT01272219|83356311|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
47070191|NCT01272219|83356312|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
47070192|NCT01272219|83356313|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
47070193|NCT01272219|83356314|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
47070194|NCT01272219|83356315|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
46775263|NCT00738374|82993678|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
46775264|NCT00738374|82993679|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
46775265|NCT00738374|82993680|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
46775266|NCT00738374|82993681|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
46775267|NCT00738374|82993678|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
46775268|NCT00738374|82993679|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
47070195|NCT01272219|83356316|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
46775269|NCT00738374|82993680|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
46775270|NCT00738374|82993681|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
47070196|NCT01272219|83356311|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
47070197|NCT01272219|83356312|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
47070198|NCT01272219|83356313|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
47070199|NCT01272219|83356314|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
47070200|NCT01272219|83356315|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
47070201|NCT01272219|83356316|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
47070202|NCT01272219|83356311|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
47070203|NCT01272219|83356312|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
47070204|NCT01272219|83356313|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
47070205|NCT01272219|83356314|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
47070206|NCT01272219|83356315|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
47070207|NCT01272219|83356316|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
47070208|NCT01272219|83356311|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
47070209|NCT01272219|83356312|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
47070210|NCT01272219|83356313|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
47070211|NCT01272219|83356314|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
47070212|NCT01272219|83356315|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
47070213|NCT01272219|83356316|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
47070214|NCT01510028|83356333|FG000|Overall Study|Lack of Efficacy|1|||
47070215|NCT01510028|83356334|FG001|Overall Study|Lack of Efficacy|0|||
47070216|NCT01510028|83356335|FG002|Overall Study|Lack of Efficacy|0|||
47070217|NCT01510028|83356336|FG003|Overall Study|Lack of Efficacy|0|||
47070218|NCT01521494|83356357|FG000|Overall Study|Adverse Event|1|||
47070219|NCT01521494|83356358|FG001|Overall Study|Adverse Event|2|||
47070220|NCT01521494|83356359|FG002|Overall Study|Adverse Event|9|||
47070221|NCT01521494|83356360|FG003|Overall Study|Adverse Event|6|||
47070222|NCT01521494|83356361|FG004|Overall Study|Adverse Event|2|||
47070223|NCT01521494|83356357|FG000|Overall Study|Lack of Efficacy|0|||
47070224|NCT01521494|83356358|FG001|Overall Study|Lack of Efficacy|0|||
47070225|NCT01521494|83356359|FG002|Overall Study|Lack of Efficacy|0|||
47070226|NCT01521494|83356360|FG003|Overall Study|Lack of Efficacy|0|||
47070227|NCT01521494|83356361|FG004|Overall Study|Lack of Efficacy|2|||
47070228|NCT01521494|83356357|FG000|Overall Study|Withdrawal by Subject|1|||
47070229|NCT01521494|83356358|FG001|Overall Study|Withdrawal by Subject|1|||
47070230|NCT01521494|83356359|FG002|Overall Study|Withdrawal by Subject|0|||
47070231|NCT01521494|83356360|FG003|Overall Study|Withdrawal by Subject|2|||
47070232|NCT01521494|83356361|FG004|Overall Study|Withdrawal by Subject|0|||
47070233|NCT01521494|83356357|FG000|Overall Study|Decrease in serum phosphate|0|||
47070234|NCT01521494|83356358|FG001|Overall Study|Decrease in serum phosphate|2|||
47070235|NCT01521494|83356359|FG002|Overall Study|Decrease in serum phosphate|3|||
47070236|NCT01521494|83356360|FG003|Overall Study|Decrease in serum phosphate|12|||
47070237|NCT01521494|83356361|FG004|Overall Study|Decrease in serum phosphate|0|||
47070238|NCT01521494|83356357|FG000|Overall Study|Decrease in serum calcium|0|||
47070239|NCT01521494|83356358|FG001|Overall Study|Decrease in serum calcium|0|||
47070240|NCT01521494|83356359|FG002|Overall Study|Decrease in serum calcium|0|||
47070241|NCT01521494|83356360|FG003|Overall Study|Decrease in serum calcium|1|||
47070242|NCT01521494|83356361|FG004|Overall Study|Decrease in serum calcium|1|||
47070243|NCT01521494|83356357|FG000|Overall Study|Physician Decision|0|||
47070244|NCT01521494|83356358|FG001|Overall Study|Physician Decision|0|||
47070245|NCT01521494|83356359|FG002|Overall Study|Physician Decision|0|||
47070246|NCT01521494|83356360|FG003|Overall Study|Physician Decision|0|||
47070247|NCT01521494|83356361|FG004|Overall Study|Physician Decision|2|||
47070248|NCT01270971|83356375|FG000|Overall Study|Withdrawal by Subject|24|||
47070249|NCT01270971|83356376|FG001|Overall Study|Withdrawal by Subject|11|||
47070250|NCT01270971|83356375|FG000|Overall Study|Lost to Follow-up|18|||
47070251|NCT01270971|83356376|FG001|Overall Study|Lost to Follow-up|5|||
47070252|NCT01270971|83356375|FG000|Overall Study|Adverse Event|1|||
47070253|NCT01270971|83356376|FG001|Overall Study|Adverse Event|2|||
47070254|NCT01270971|83356375|FG000|Overall Study|Non compliance|2|||
47070255|NCT01270971|83356376|FG001|Overall Study|Non compliance|2|||
47070256|NCT01270971|83356375|FG000|Overall Study|Non-specific|7|||
47070257|NCT01270971|83356376|FG001|Overall Study|Non-specific|3|||
47070258|NCT01270503|83356403|FG000|Overall Study|Lost to Follow-up|1|||
47070259|NCT01277211|83356420|FG000|Overall Study|Adverse Event|60|||
47070260|NCT01277211|83356421|FG001|Overall Study|Adverse Event|22|||
47070261|NCT01277211|83356420|FG000|Overall Study|Pregnancy|9|||
47070262|NCT01277211|83356421|FG001|Overall Study|Pregnancy|4|||
47070263|NCT01277211|83356420|FG000|Overall Study|Lost to Follow-up|14|||
47070264|NCT01277211|83356421|FG001|Overall Study|Lost to Follow-up|9|||
47070265|NCT01277211|83356420|FG000|Overall Study|Did not wish to continue|17|||
47070266|NCT01277211|83356421|FG001|Overall Study|Did not wish to continue|0|||
47070267|NCT01277211|83356420|FG000|Overall Study|Withdrew Consent|9|||
47070268|NCT01277211|83356421|FG001|Overall Study|Withdrew Consent|9|||
47070269|NCT01277211|83356420|FG000|Overall Study|Non-compliance with protocol|13|||
47070270|NCT01277211|83356421|FG001|Overall Study|Non-compliance with protocol|4|||
47070271|NCT01277211|83356420|FG000|Overall Study|Did not meet protocol eligibility|1|||
47070272|NCT01277211|83356421|FG001|Overall Study|Did not meet protocol eligibility|0|||
47070273|NCT01277211|83356420|FG000|Overall Study|Administrative|3|||
47070274|NCT01277211|83356421|FG001|Overall Study|Administrative|0|||
47070275|NCT01277211|83356420|FG000|Overall Study|Pregnancy wish|0|||
47070276|NCT01277211|83356421|FG001|Overall Study|Pregnancy wish|2|||
47070277|NCT01277211|83356420|FG000|Overall Study|Discontinued prior to treatment|24|||
47070278|NCT01277211|83356421|FG001|Overall Study|Discontinued prior to treatment|13|||
47070279|NCT01676220|83356429|FG000|Overall Study|Randomized But Not Treated|4|||
47070280|NCT01676220|83356430|FG001|Overall Study|Randomized But Not Treated|1|||
47070281|NCT01676220|83356429|FG000|Overall Study|Adverse Event|10|||
47070282|NCT01676220|83356430|FG001|Overall Study|Adverse Event|8|||
47070283|NCT01676220|83356429|FG000|Overall Study|Lack of Efficacy|2|||
47070284|NCT01676220|83356430|FG001|Overall Study|Lack of Efficacy|5|||
47070285|NCT01676220|83356429|FG000|Overall Study|Protocol Violation|11|||
47070286|NCT01676220|83356430|FG001|Overall Study|Protocol Violation|12|||
47070287|NCT01676220|83356429|FG000|Overall Study|Received Rescue Therapy|14|||
47070288|NCT01676220|83356430|FG001|Overall Study|Received Rescue Therapy|22|||
47070289|NCT01676220|83356429|FG000|Overall Study|Personal Reason|34|||
47070290|NCT01676220|83356430|FG001|Overall Study|Personal Reason|45|||
47070291|NCT01676220|83356429|FG000|Overall Study|Lost to Follow-up|11|||
47070292|NCT01676220|83356430|FG001|Overall Study|Lost to Follow-up|18|||
47070293|NCT01676220|83356429|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
47070294|NCT01676220|83356430|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
47070295|NCT01676220|83356429|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
47070296|NCT01676220|83356430|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
47070297|NCT01676220|83356429|FG000|Overall Study|Perceived Lack of Efficacy|3|||
47070298|NCT01676220|83356430|FG001|Overall Study|Perceived Lack of Efficacy|1|||
47070299|NCT01676220|83356429|FG000|Overall Study|Non Serious Hypoglycemia|2|||
47070300|NCT01676220|83356430|FG001|Overall Study|Non Serious Hypoglycemia|0|||
47070301|NCT01676220|83356429|FG000|Overall Study|No More Need of Insulin|1|||
47070302|NCT01676220|83356430|FG001|Overall Study|No More Need of Insulin|0|||
47070303|NCT04007094|83356456|FG000|Overall Study|Lost to Follow-up|1|||
47070304|NCT04007094|83356457|FG001|Overall Study|Lost to Follow-up|1|||
47070305|NCT01485614|83356478|FG000|Randomization|Not Treated|1|||
47070306|NCT01485614|83356479|FG001|Randomization|Not Treated|0|||
47070307|NCT01485614|83356480|FG002|Randomization|Not Treated|0|||
47070308|NCT01485614|83356481|FG003|Randomization|Not Treated|0|||
47070309|NCT01485614|83356478|FG000|Weeks 0-20|Lost to Follow-up|2|||
47070310|NCT01485614|83356479|FG001|Weeks 0-20|Lost to Follow-up|0|||
47070311|NCT01485614|83356480|FG002|Weeks 0-20|Lost to Follow-up|0|||
47070312|NCT01485614|83356481|FG003|Weeks 0-20|Lost to Follow-up|0|||
47070313|NCT01485614|83356478|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
47070314|NCT01485614|83356479|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
47070315|NCT01485614|83356480|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
47070316|NCT01485614|83356481|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
47070317|NCT01485614|83356478|FG000|Weeks 0-20|Withdrawal by Subject|3|||
47070318|NCT01485614|83356479|FG001|Weeks 0-20|Withdrawal by Subject|2|||
47070319|NCT01485614|83356480|FG002|Weeks 0-20|Withdrawal by Subject|1|||
47070320|NCT01485614|83356481|FG003|Weeks 0-20|Withdrawal by Subject|0|||
47070321|NCT01485614|83356478|FG000|Weeks 20-54|Lost to Follow-up|4|||
47070322|NCT01485614|83356479|FG001|Weeks 20-54|Lost to Follow-up|3|||
47070323|NCT01485614|83356480|FG002|Weeks 20-54|Lost to Follow-up|1|||
47070324|NCT01485614|83356481|FG003|Weeks 20-54|Lost to Follow-up|0|||
47070325|NCT01485614|83356478|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
47070326|NCT01485614|83356479|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
47070327|NCT01485614|83356480|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
47070328|NCT01485614|83356481|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
47070329|NCT01485614|83356478|FG000|Weeks 20-54|Withdrawal by Subject|5|||
47070330|NCT01485614|83356479|FG001|Weeks 20-54|Withdrawal by Subject|3|||
47070331|NCT01485614|83356480|FG002|Weeks 20-54|Withdrawal by Subject|0|||
46641041|NCT02983045|82820353|FG008|Overall Study|Withdrawal by Subject|0|||
46641042|NCT02983045|82820354|FG009|Overall Study|Withdrawal by Subject|2|||
46775271|NCT00738374|82993678|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
46775272|NCT00738374|82993679|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
47070332|NCT01485614|83356481|FG003|Weeks 20-54|Withdrawal by Subject|0|||
47070333|NCT01485536|83356531|FG000|Overall Study|Withdrawal by Subject|3|||
47070334|NCT01485536|83356531|FG000|Overall Study|Adverse Event|1|||
47070335|NCT02658630|83356535|FG000|Overall Study|Withdrawal by Subject|4|||
47070336|NCT01484912|83356541|FG000|Overall Study|Withdrawal by Subject|1|||
47070337|NCT01484912|83356542|FG001|Overall Study|Withdrawal by Subject|0|||
47070338|NCT01484912|83356541|FG000|Overall Study|Physician Decision|0|||
47070339|NCT01484912|83356542|FG001|Overall Study|Physician Decision|1|||
47070340|NCT01520870|83356548|FG000|Overall Study|Withdrawal by Subject|2|||
47070341|NCT01520714|83356554|FG000|Overall Study|Protocol Violation|0|||
47070342|NCT01520714|83356555|FG001|Overall Study|Protocol Violation|3|||
47070343|NCT01520714|83356554|FG000|Overall Study|Adverse Event|0|||
47070344|NCT01520714|83356555|FG001|Overall Study|Adverse Event|2|||
47070345|NCT01520714|83356554|FG000|Overall Study|Lack of Efficacy|0|||
47070346|NCT01520714|83356555|FG001|Overall Study|Lack of Efficacy|1|||
47070347|NCT02659098|83356574|FG000|Overall Study|Withdrawal by Subject|7|||
47070348|NCT01508936|83356585|FG000|Overall Study|Adverse Event|11|||
47070349|NCT01508936|83356586|FG001|Overall Study|Adverse Event|32|||
47070350|NCT01508936|83356585|FG000|Overall Study|Lack of Efficacy|0|||
47070351|NCT01508936|83356586|FG001|Overall Study|Lack of Efficacy|1|||
47070352|NCT01508936|83356585|FG000|Overall Study|Withdrawal by Subject|4|||
47070353|NCT01508936|83356586|FG001|Overall Study|Withdrawal by Subject|18|||
47070354|NCT01508936|83356585|FG000|Overall Study|Protocol Violation|2|||
47070355|NCT01508936|83356586|FG001|Overall Study|Protocol Violation|3|||
47070356|NCT01508936|83356585|FG000|Overall Study|Lost to Follow-up|2|||
47070357|NCT01508936|83356586|FG001|Overall Study|Lost to Follow-up|9|||
47070358|NCT01508936|83356585|FG000|Overall Study|Other|0|||
47070359|NCT01508936|83356586|FG001|Overall Study|Other|5|||
47070360|NCT01508936|83356585|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
47070361|NCT01508936|83356586|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
47070362|NCT01508702|83356607|FG000|Overall Study|Adverse Event|7|||
47070363|NCT01508702|83356608|FG001|Overall Study|Adverse Event|3|||
47070364|NCT01508702|83356607|FG000|Overall Study|Gout flare|2|||
47070365|NCT01508702|83356608|FG001|Overall Study|Gout flare|0|||
47070366|NCT01508702|83356607|FG000|Overall Study|Protocol Violation|2|||
47070367|NCT01508702|83356608|FG001|Overall Study|Protocol Violation|1|||
47070368|NCT01508702|83356607|FG000|Overall Study|Lost to Follow-up|1|||
47070369|NCT01508702|83356608|FG001|Overall Study|Lost to Follow-up|2|||
47070370|NCT01508702|83356607|FG000|Overall Study|Withdrawal by Subject|11|||
47070371|NCT01508702|83356608|FG001|Overall Study|Withdrawal by Subject|7|||
47070372|NCT01484834|83356622|FG000|Overall Study|Lost to Follow-up|5|||
47070373|NCT01484834|83356623|FG001|Overall Study|Lost to Follow-up|8|||
47070374|NCT01484834|83356624|FG002|Overall Study|Lost to Follow-up|1|||
47070375|NCT01484834|83356625|FG003|Overall Study|Lost to Follow-up|4|||
47070376|NCT01484132|83356635|FG000|Overall Study|Lost to Follow-up|8|||
47070377|NCT01484132|83356635|FG000|Overall Study|Difficulty with time commitment|2|||
47070378|NCT01484132|83356635|FG000|Overall Study|Ineligible|1|||
47070379|NCT01484132|83356635|FG000|Overall Study|No pre-treatment urine sample collected|1|||
47070380|NCT01484132|83356635|FG000|Overall Study|No post-treatment urine sample collected|10|||
47070381|NCT01276041|83356639|FG000|Overall Study|Adverse Event|2|||
47070382|NCT01276041|83356639|FG000|Overall Study|Protocol Violation|1|||
47070383|NCT01275339|83356647|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
47070384|NCT01275339|83356648|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
47070385|NCT01275339|83356649|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
47070386|NCT01275339|83356650|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
47070387|NCT01275339|83356647|FG000|Overall Study|Withdrawal by Subject|0|||
47070388|NCT01275339|83356648|FG001|Overall Study|Withdrawal by Subject|0|||
47070389|NCT01275339|83356649|FG002|Overall Study|Withdrawal by Subject|1|||
47070390|NCT01275339|83356650|FG003|Overall Study|Withdrawal by Subject|0|||
47070391|NCT01520402|83356660|FG000|Overall Study|Withdrawal by Subject|2|||
47070392|NCT01520402|83356660|FG000|Overall Study|Physician Decision|3|||
47070393|NCT01520324|83356675|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
47070394|NCT01519934|83356679|FG000|Overall Study|Lost to Follow-up|3|||
47070395|NCT01484054|83356683|FG000|Period 1|Withdrawal by Subject|0|||
47070396|NCT01484054|83356684|FG001|Period 1|Withdrawal by Subject|1|||
47070397|NCT01507298|83356702|FG000|Overall Study|Protocol Violation|0|||
47070398|NCT01507298|83356703|FG001|Overall Study|Protocol Violation|6|||
47070399|NCT01483118|83356712|FG000|Overall Study|Lost to Follow-up|12|||
47070400|NCT01483118|83356713|FG001|Overall Study|Lost to Follow-up|16|||
47070401|NCT01506908|83356723|FG000|Overall Study|Adverse Event|1|||
47070402|NCT01506908|83356724|FG001|Overall Study|Adverse Event|0|||
47070403|NCT01519778|83356732|FG000|Overall Study|Withdrawal by Subject|3|||
47070404|NCT01519778|83356732|FG000|Overall Study|Lost to Follow-up|10|||
47070405|NCT01519778|83356732|FG000|Overall Study|Physician Decision|1|||
46846330|NCT00098748|83063050|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
46846331|NCT00098748|83063048|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
46967275|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
46967276|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
47070406|NCT01519700|83356740|FG000|Overall Study|Death|1|||
47070407|NCT01519700|83356741|FG001|Overall Study|Death|0|||
47070408|NCT01519700|83356742|FG002|Overall Study|Death|0|||
47070409|NCT01519700|83356743|FG003|Overall Study|Death|0|||
47070410|NCT01519700|83356740|FG000|Overall Study|Lost to Follow-up|0|||
47070411|NCT01519700|83356741|FG001|Overall Study|Lost to Follow-up|0|||
47070412|NCT01519700|83356742|FG002|Overall Study|Lost to Follow-up|1|||
47070413|NCT01519700|83356743|FG003|Overall Study|Lost to Follow-up|1|||
47070414|NCT01519700|83356740|FG000|Overall Study|Physician Decision|1|||
47070415|NCT01519700|83356741|FG001|Overall Study|Physician Decision|1|||
47070416|NCT01519700|83356742|FG002|Overall Study|Physician Decision|3|||
47070417|NCT01519700|83356743|FG003|Overall Study|Physician Decision|0|||
47070418|NCT01519700|83356740|FG000|Overall Study|Withdrawal by Subject|5|||
47070419|NCT01519700|83356741|FG001|Overall Study|Withdrawal by Subject|3|||
47070420|NCT01519700|83356742|FG002|Overall Study|Withdrawal by Subject|3|||
47070421|NCT01519700|83356743|FG003|Overall Study|Withdrawal by Subject|2|||
47070422|NCT01519700|83356740|FG000|Overall Study|Other Reason|2|||
47070423|NCT01519700|83356741|FG001|Overall Study|Other Reason|2|||
47070424|NCT01519700|83356742|FG002|Overall Study|Other Reason|0|||
47070425|NCT01519700|83356743|FG003|Overall Study|Other Reason|4|||
47070426|NCT02658084|83356787|FG000|Overall Study|Withdrawal by Subject|1|||
47070427|NCT02658084|83356788|FG001|Overall Study|Withdrawal by Subject|0|||
47070428|NCT02658084|83356787|FG000|Overall Study|Study Termination|1|||
47070429|NCT02658084|83356788|FG001|Overall Study|Study Termination|0|||
47070430|NCT01482962|83356804|FG000|Overall Study|Progressive Disease|65|||
47070431|NCT01482962|83356805|FG001|Overall Study|Progressive Disease|53|||
47070432|NCT01482962|83356804|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
47070433|NCT01482962|83356805|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
47070434|NCT01482962|83356804|FG000|Overall Study|Adverse Event|18|||
47070435|NCT01482962|83356805|FG001|Overall Study|Adverse Event|22|||
47070436|NCT01482962|83356804|FG000|Overall Study|Withdrawal by Participant|8|||
47070437|NCT01482962|83356805|FG001|Overall Study|Withdrawal by Participant|13|||
47070438|NCT01482962|83356804|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
47070439|NCT01482962|83356805|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
47070440|NCT01482962|83356804|FG000|Overall Study|Other Reason|1|||
47070441|NCT01482962|83356805|FG001|Overall Study|Other Reason|5|||
47070442|NCT01482962|83356804|FG000|Overall Study|Study Terminated by Sponsor|5|||
47070443|NCT01482962|83356805|FG001|Overall Study|Study Terminated by Sponsor|2|||
47070444|NCT01482962|83356804|FG000|Overall Study|Did not Receive Study Drug|1|||
47070445|NCT01482962|83356805|FG001|Overall Study|Did not Receive Study Drug|6|||
47070446|NCT02655666|83356813|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
47070447|NCT01506596|83356817|FG000|Overall Study|ineligible pathology|1|||
47070448|NCT01482884|83356836|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
47070449|NCT01482884|83356837|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
47070450|NCT01482884|83356836|FG000|Overall Study|Protocol Violation|1|||
47070451|NCT01482884|83356837|FG001|Overall Study|Protocol Violation|0|||
47070452|NCT01482884|83356836|FG000|Overall Study|Lost to Follow-up|2|||
47070453|NCT01482884|83356837|FG001|Overall Study|Lost to Follow-up|2|||
47070454|NCT01482884|83356836|FG000|Overall Study|Lack of Efficacy|0|||
47070455|NCT01482884|83356837|FG001|Overall Study|Lack of Efficacy|1|||
47070456|NCT01482884|83356836|FG000|Overall Study|Adverse Event|2|||
47070457|NCT01482884|83356837|FG001|Overall Study|Adverse Event|1|||
47070458|NCT01482884|83356836|FG000|Overall Study|Withdrawal by Subject|8|||
47070459|NCT01482884|83356837|FG001|Overall Study|Withdrawal by Subject|13|||
47070460|NCT01518374|83356843|FG000|Overall Study|Withdrawal by Subject|2|||
47070461|NCT01518374|83356843|FG000|Overall Study|Protocol Violation|3|||
47070462|NCT01518374|83356843|FG000|Overall Study|Lost to Follow-up|2|||
47070463|NCT01481324|83356850|FG000|Overall Study|Missing Data|0|||
47070464|NCT01481324|83356851|FG001|Overall Study|Missing Data|2|||
47070465|NCT01481324|83356852|FG002|Overall Study|Missing Data|2|||
47070466|NCT04591626|83356862|FG000|Overall Study|Adverse Event|4|||
47070467|NCT04591626|83356863|FG001|Overall Study|Adverse Event|0|||
47070468|NCT04591626|83356862|FG000|Overall Study|Withdrawal by Subject|5|||
47070469|NCT04591626|83356863|FG001|Overall Study|Withdrawal by Subject|3|||
47070470|NCT04591626|83356862|FG000|Overall Study|Physician Decision|0|||
47070471|NCT04591626|83356863|FG001|Overall Study|Physician Decision|1|||
47070472|NCT04591626|83356862|FG000|Overall Study|Death|0|||
47070473|NCT04591626|83356863|FG001|Overall Study|Death|1|||
47070474|NCT04591626|83356862|FG000|Overall Study|Non-Compliance with Study Drug|1|||
47070475|NCT04591626|83356863|FG001|Overall Study|Non-Compliance with Study Drug|0|||
47070476|NCT03583333|83356871|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
47070477|NCT03583333|83356872|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
47070478|NCT03583333|83356871|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
47070479|NCT03583333|83356872|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
47070480|NCT03583333|83356871|FG000|Overall Study|Withdrawal by Subject|9|||
47070481|NCT03583333|83356872|FG001|Overall Study|Withdrawal by Subject|5|||
47070482|NCT03583333|83356871|FG000|Overall Study|Physician Decision|3|||
47070483|NCT03583333|83356872|FG001|Overall Study|Physician Decision|2|||
47070484|NCT03583333|83356871|FG000|Overall Study|Death|12|||
47070485|NCT03583333|83356872|FG001|Overall Study|Death|7|||
47070486|NCT01602510|83356878|FG000|Open Label Phase|Adverse Event|46|||
47070487|NCT01602510|83356879|FG001|Open Label Phase|Adverse Event|0|||
47070488|NCT01602510|83356880|FG002|Open Label Phase|Adverse Event|0|||
47070489|NCT01602510|83356878|FG000|Open Label Phase|Lack of Efficacy|22|||
47070490|NCT01602510|83356879|FG001|Open Label Phase|Lack of Efficacy|0|||
47070491|NCT01602510|83356880|FG002|Open Label Phase|Lack of Efficacy|0|||
47070492|NCT01602510|83356878|FG000|Open Label Phase|Protocol Violation|15|||
47070493|NCT01602510|83356879|FG001|Open Label Phase|Protocol Violation|0|||
47070494|NCT01602510|83356880|FG002|Open Label Phase|Protocol Violation|0|||
47070495|NCT01602510|83356878|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
47070496|NCT01602510|83356879|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
47070497|NCT01602510|83356880|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
47070498|NCT01602510|83356878|FG000|Open Label Phase|Lost to Follow-up|22|||
47070499|NCT01602510|83356879|FG001|Open Label Phase|Lost to Follow-up|0|||
47070500|NCT01602510|83356880|FG002|Open Label Phase|Lost to Follow-up|0|||
47070501|NCT01602510|83356878|FG000|Open Label Phase|Physician Decision|19|||
47070502|NCT01602510|83356879|FG001|Open Label Phase|Physician Decision|0|||
47070503|NCT01602510|83356880|FG002|Open Label Phase|Physician Decision|0|||
47070504|NCT01602510|83356878|FG000|Open Label Phase|Withdrawal by Subject|57|||
47070505|NCT01602510|83356879|FG001|Open Label Phase|Withdrawal by Subject|0|||
47070506|NCT01602510|83356880|FG002|Open Label Phase|Withdrawal by Subject|0|||
47070507|NCT01602510|83356878|FG000|Randomized Phase|Adverse Event|0|||
47070508|NCT01602510|83356879|FG001|Randomized Phase|Adverse Event|2|||
47070509|NCT01602510|83356880|FG002|Randomized Phase|Adverse Event|6|||
47070510|NCT01602510|83356878|FG000|Randomized Phase|Lack of Efficacy|0|||
47070511|NCT01602510|83356879|FG001|Randomized Phase|Lack of Efficacy|4|||
47070512|NCT01602510|83356880|FG002|Randomized Phase|Lack of Efficacy|4|||
47070513|NCT01602510|83356878|FG000|Randomized Phase|Protocol Violation|0|||
47070514|NCT01602510|83356879|FG001|Randomized Phase|Protocol Violation|3|||
47070515|NCT01602510|83356880|FG002|Randomized Phase|Protocol Violation|3|||
47070516|NCT01602510|83356878|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
47070517|NCT01602510|83356879|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
47070518|NCT01602510|83356880|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
47070519|NCT01602510|83356878|FG000|Randomized Phase|Lost to Follow-up|0|||
47070520|NCT01602510|83356879|FG001|Randomized Phase|Lost to Follow-up|1|||
47070521|NCT01602510|83356880|FG002|Randomized Phase|Lost to Follow-up|3|||
47070522|NCT01602510|83356878|FG000|Randomized Phase|Physician Decision|0|||
47070523|NCT01602510|83356879|FG001|Randomized Phase|Physician Decision|0|||
47070524|NCT01602510|83356880|FG002|Randomized Phase|Physician Decision|2|||
47070525|NCT01602510|83356878|FG000|Randomized Phase|Withdrawal by Subject|0|||
47070526|NCT01602510|83356879|FG001|Randomized Phase|Withdrawal by Subject|6|||
47070527|NCT01602510|83356880|FG002|Randomized Phase|Withdrawal by Subject|7|||
47070528|NCT01675596|83356895|FG000|Overall Study|Death|6|||
46967277|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
46967278|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
46967279|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
46967280|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
46967281|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
46967282|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
46967283|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
46967284|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
46967285|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
46967286|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
46967287|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
46967288|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
46967289|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
47070529|NCT01675596|83356895|FG000|Overall Study|Exit with other reason|1|||
47070530|NCT01675596|83356895|FG000|Overall Study|Missed Visit|1|||
47070531|NCT02653326|83356905|FG000|Overall Study|Lost to Follow-up|10|||
47070532|NCT02653326|83356906|FG001|Overall Study|Lost to Follow-up|7|||
47070533|NCT02653170|83356915|FG000|Overall Study|Withdrawal by Subject|3|||
47070534|NCT02653170|83356916|FG001|Overall Study|Withdrawal by Subject|8|||
46775273|NCT00738374|82993680|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
46775274|NCT00738374|82993681|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
47070535|NCT02653170|83356917|FG002|Overall Study|Withdrawal by Subject|3|||
47070536|NCT02653170|83356915|FG000|Overall Study|withdrawn by study team|2|||
46641043|NCT02983045|82820345|FG000|Overall Study|Lost to Follow-up|0|||
46641044|NCT02983045|82820346|FG001|Overall Study|Lost to Follow-up|0|||
46775275|NCT00738374|82993678|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
46775276|NCT00738374|82993679|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
46641045|NCT02983045|82820347|FG002|Overall Study|Lost to Follow-up|0|||
47070537|NCT02653170|83356916|FG001|Overall Study|withdrawn by study team|4|||
47070538|NCT02653170|83356917|FG002|Overall Study|withdrawn by study team|5|||
47070539|NCT02653170|83356915|FG000|Overall Study|Lost to Follow-up|12|||
47070540|NCT02653170|83356916|FG001|Overall Study|Lost to Follow-up|4|||
47070541|NCT02653170|83356917|FG002|Overall Study|Lost to Follow-up|10|||
47070542|NCT01463696|83356937|FG000|Overall Study|Adverse Event|0|||
47070543|NCT01463696|83356938|FG001|Overall Study|Adverse Event|1|||
47070544|NCT01463696|83356939|FG002|Overall Study|Adverse Event|0|||
47070545|NCT01463696|83356940|FG003|Overall Study|Adverse Event|2|||
46846332|NCT00098748|83063049|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
47070546|NCT01463696|83356941|FG004|Overall Study|Adverse Event|0|||
47070547|NCT01463696|83356942|FG005|Overall Study|Adverse Event|1|||
47070548|NCT01463696|83356943|FG006|Overall Study|Adverse Event|3|||
47070549|NCT01463696|83356944|FG007|Overall Study|Adverse Event|2|||
47070550|NCT01463696|83356937|FG000|Overall Study|Lost to Follow-up|0|||
47070551|NCT01463696|83356938|FG001|Overall Study|Lost to Follow-up|0|||
47070552|NCT01463696|83356939|FG002|Overall Study|Lost to Follow-up|1|||
47070553|NCT01463696|83356940|FG003|Overall Study|Lost to Follow-up|0|||
47070554|NCT01463696|83356941|FG004|Overall Study|Lost to Follow-up|0|||
47070555|NCT01463696|83356942|FG005|Overall Study|Lost to Follow-up|0|||
47070556|NCT01463696|83356943|FG006|Overall Study|Lost to Follow-up|0|||
47070557|NCT01463696|83356944|FG007|Overall Study|Lost to Follow-up|0|||
47070558|NCT01463696|83356937|FG000|Overall Study|Progressive Disease|0|||
47070559|NCT01463696|83356938|FG001|Overall Study|Progressive Disease|1|||
46775277|NCT00738374|82993680|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
46775278|NCT00738374|82993681|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
46775279|NCT00738374|82993678|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
46775280|NCT00738374|82993679|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
46775281|NCT00738374|82993680|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
46775282|NCT00738374|82993681|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
47070560|NCT01463696|83356939|FG002|Overall Study|Progressive Disease|0|||
47070561|NCT01463696|83356940|FG003|Overall Study|Progressive Disease|1|||
47070562|NCT01463696|83356941|FG004|Overall Study|Progressive Disease|0|||
47070563|NCT01463696|83356942|FG005|Overall Study|Progressive Disease|1|||
47070564|NCT01463696|83356943|FG006|Overall Study|Progressive Disease|4|||
47070565|NCT01463696|83356944|FG007|Overall Study|Progressive Disease|2|||
47070566|NCT01463696|83356937|FG000|Overall Study|Withdrawal by Subject|0|||
47070567|NCT01463696|83356938|FG001|Overall Study|Withdrawal by Subject|0|||
47070568|NCT01463696|83356939|FG002|Overall Study|Withdrawal by Subject|0|||
47070569|NCT01463696|83356940|FG003|Overall Study|Withdrawal by Subject|1|||
47070570|NCT01463696|83356941|FG004|Overall Study|Withdrawal by Subject|1|||
47070571|NCT01463696|83356942|FG005|Overall Study|Withdrawal by Subject|1|||
47070572|NCT01463696|83356943|FG006|Overall Study|Withdrawal by Subject|2|||
47070573|NCT01463696|83356944|FG007|Overall Study|Withdrawal by Subject|0|||
47070574|NCT01463696|83356937|FG000|Overall Study|Not Treated|0|||
47070575|NCT01463696|83356938|FG001|Overall Study|Not Treated|0|||
47070576|NCT01463696|83356939|FG002|Overall Study|Not Treated|0|||
47070577|NCT01463696|83356940|FG003|Overall Study|Not Treated|0|||
47070578|NCT01463696|83356941|FG004|Overall Study|Not Treated|0|||
47070579|NCT01463696|83356942|FG005|Overall Study|Not Treated|0|||
47070580|NCT01463696|83356943|FG006|Overall Study|Not Treated|1|||
47070581|NCT01463696|83356944|FG007|Overall Study|Not Treated|0|||
47070582|NCT02653482|83356968|FG000|Overall Study|Death|1|||
47070583|NCT02653482|83356969|FG001|Overall Study|Death|1|||
47070584|NCT01362348|83356975|FG000|Overall Study|Protocol-defined stopping criteria|9|||
47070585|NCT01362348|83356975|FG000|Overall Study|Study closed/terminated|5|||
47070586|NCT01675128|83357045|FG000|Overall Study|Disease progression on study|1|||
47070587|NCT01675128|83357046|FG001|Overall Study|Disease progression on study|1|||
47070588|NCT01675128|83357047|FG002|Overall Study|Disease progression on study|1|||
47070589|NCT01675128|83357045|FG000|Overall Study|Refused further treatment|1|||
47070590|NCT01675128|83357046|FG001|Overall Study|Refused further treatment|0|||
47070591|NCT01675128|83357047|FG002|Overall Study|Refused further treatment|0|||
47070592|NCT01675128|83357045|FG000|Overall Study|Pulmonary complication; off study|0|||
47070593|NCT01675128|83357046|FG001|Overall Study|Pulmonary complication; off study|1|||
46775283|NCT00738374|82993678|FG000|Maintenance Treatment/Observation Phase|Other|0|||
46775284|NCT00738374|82993679|FG001|Maintenance Treatment/Observation Phase|Other|1|||
46846333|NCT00098748|83063050|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
47070594|NCT01675128|83357047|FG002|Overall Study|Pulmonary complication; off study|0|||
47070595|NCT01427309|83357093|FG000|Overall Study|Lost to Follow-up|130|||
47070596|NCT01427309|83357094|FG001|Overall Study|Lost to Follow-up|145|||
47070597|NCT01427309|83357095|FG002|Overall Study|Lost to Follow-up|122|||
47070598|NCT01427309|83357096|FG003|Overall Study|Lost to Follow-up|135|||
47070599|NCT01427309|83357093|FG000|Overall Study|Protocol Violation|42|||
46846334|NCT00130520|83063058|FG000|Overall Study|Adverse Event|11|||
47070600|NCT01427309|83357094|FG001|Overall Study|Protocol Violation|69|||
47070601|NCT01427309|83357095|FG002|Overall Study|Protocol Violation|125|||
47070602|NCT01427309|83357096|FG003|Overall Study|Protocol Violation|124|||
47070603|NCT01427309|83357093|FG000|Overall Study|Adverse Event|0|||
47070604|NCT01427309|83357094|FG001|Overall Study|Adverse Event|0|||
47070605|NCT01427309|83357095|FG002|Overall Study|Adverse Event|3|||
47070606|NCT01427309|83357096|FG003|Overall Study|Adverse Event|1|||
47070607|NCT01427309|83357093|FG000|Overall Study|Serious adverse event|52|||
47070608|NCT01427309|83357094|FG001|Overall Study|Serious adverse event|45|||
47070609|NCT01427309|83357095|FG002|Overall Study|Serious adverse event|50|||
47070610|NCT01427309|83357096|FG003|Overall Study|Serious adverse event|61|||
47070611|NCT01427309|83357093|FG000|Overall Study|Withdrawal by Subject|148|||
47070612|NCT01427309|83357094|FG001|Overall Study|Withdrawal by Subject|148|||
47070613|NCT01427309|83357095|FG002|Overall Study|Withdrawal by Subject|61|||
47070614|NCT01427309|83357096|FG003|Overall Study|Withdrawal by Subject|55|||
47070615|NCT01426373|83357106|FG000|Overall Study|Adverse Event|6|||
47070616|NCT01426373|83357106|FG000|Overall Study|Lost to Follow-up|14|||
47070617|NCT01426373|83357106|FG000|Overall Study|Participant Convenience|10|||
47070618|NCT01426373|83357106|FG000|Overall Study|Miscellaneous Reasons|4|||
47070619|NCT01426217|83357114|FG000|Overall Study|lost sample|8|||
47070620|NCT01426217|83357115|FG001|Overall Study|lost sample|14|||
47070621|NCT01425749|83357123|FG000|Overall Study|progression of melanoma|0|||
47070622|NCT01425749|83357124|FG001|Overall Study|progression of melanoma|1|||
47070623|NCT01403987|83357140|FG000|Overall Study|Residents forgot their secret PIN|18|||
47070624|NCT01403987|83357141|FG001|Overall Study|Residents forgot their secret PIN|17|||
47070625|NCT01403987|83357142|FG002|Overall Study|Residents forgot their secret PIN|18|||
47070626|NCT01425359|83357152|FG000|Overall Study|Randomized but Not Treated|2|||
47070627|NCT01425359|83357153|FG001|Overall Study|Randomized but Not Treated|3|||
47070628|NCT01425359|83357152|FG000|Overall Study|Adverse Event|9|||
47070629|NCT01425359|83357153|FG001|Overall Study|Adverse Event|8|||
47070630|NCT01425359|83357152|FG000|Overall Study|Revascularization|0|||
47070631|NCT01425359|83357153|FG001|Overall Study|Revascularization|1|||
47070632|NCT01425359|83357152|FG000|Overall Study|Death|0|||
47070633|NCT01425359|83357153|FG001|Overall Study|Death|1|||
47070634|NCT01425359|83357152|FG000|Overall Study|Unsatisfactory Response|1|||
47070635|NCT01425359|83357153|FG001|Overall Study|Unsatisfactory Response|0|||
47070636|NCT01425359|83357152|FG000|Overall Study|Protocol Violation|1|||
47070637|NCT01425359|83357153|FG001|Overall Study|Protocol Violation|2|||
47070638|NCT01425359|83357152|FG000|Overall Study|Subject Withdrew Consent|1|||
47070639|NCT01425359|83357153|FG001|Overall Study|Subject Withdrew Consent|2|||
47070640|NCT01425359|83357152|FG000|Overall Study|Investigator's Discretion|2|||
47070641|NCT01425359|83357153|FG001|Overall Study|Investigator's Discretion|0|||
47070642|NCT01425359|83357152|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
47070643|NCT01425359|83357153|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
47070644|NCT01403051|83357173|FG000|Overall Study|Protocol Violation|2|||
47070645|NCT01403051|83357174|FG001|Overall Study|Protocol Violation|0|||
47070646|NCT01403051|83357173|FG000|Overall Study|Death|1|||
47070647|NCT01403051|83357174|FG001|Overall Study|Death|0|||
47070648|NCT01403051|83357173|FG000|Overall Study|Withdrawal by Subject|2|||
47070649|NCT01403051|83357174|FG001|Overall Study|Withdrawal by Subject|1|||
47070650|NCT01403051|83357173|FG000|Overall Study|Lost to Follow-up|5|||
47070651|NCT01403051|83357174|FG001|Overall Study|Lost to Follow-up|5|||
47070652|NCT04115748|83357189|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
47070653|NCT04115748|83357190|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
47070654|NCT04115748|83357191|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
47070655|NCT04115748|83357192|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
47070656|NCT04115748|83357193|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
47070657|NCT04115748|83357194|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
47070658|NCT04115748|83357195|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
47070659|NCT04115748|83357196|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
47070660|NCT04115748|83357197|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
47070661|NCT04115748|83357198|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
47070662|NCT04115748|83357189|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070663|NCT04115748|83357190|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070664|NCT04115748|83357191|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070665|NCT04115748|83357192|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
47070666|NCT04115748|83357193|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070667|NCT04115748|83357194|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
46775285|NCT00738374|82993680|FG002|Maintenance Treatment/Observation Phase|Other|0|||
46775286|NCT00738374|82993681|FG003|Maintenance Treatment/Observation Phase|Other|0|||
46775287|NCT00697593|82993690|FG000|Overall Study|Adverse Event|3|||
47070668|NCT04115748|83357195|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070669|NCT04115748|83357196|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070670|NCT04115748|83357197|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070671|NCT04115748|83357198|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
47070672|NCT04115748|83357189|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
47070673|NCT04115748|83357190|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
47070674|NCT04115748|83357191|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
47070675|NCT04115748|83357192|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
47070676|NCT04115748|83357193|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
47070677|NCT04115748|83357194|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
47070678|NCT04115748|83357195|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
47070679|NCT04115748|83357196|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
47070680|NCT04115748|83357197|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
47070681|NCT04115748|83357198|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
47070682|NCT04115748|83357189|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070683|NCT04115748|83357190|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070684|NCT04115748|83357191|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070685|NCT04115748|83357192|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070686|NCT04115748|83357193|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070687|NCT04115748|83357194|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070688|NCT04115748|83357195|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070689|NCT04115748|83357196|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070690|NCT04115748|83357197|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
47070691|NCT04115748|83357198|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
47070692|NCT02652624|83357255|FG000|Randomized Phase|Pregnancy|3|||
47070693|NCT02652624|83357256|FG001|Randomized Phase|Pregnancy|1|||
47070694|NCT02652624|83357255|FG000|Randomized Phase|Investigator's Discretion|0|||
47070695|NCT02652624|83357256|FG001|Randomized Phase|Investigator's Discretion|2|||
47070696|NCT02652624|83357255|FG000|Randomized Phase|Death|0|||
47070697|NCT02652624|83357256|FG001|Randomized Phase|Death|1|||
47070698|NCT02652624|83357255|FG000|Randomized Phase|Lost to Follow-up|0|||
47070699|NCT02652624|83357256|FG001|Randomized Phase|Lost to Follow-up|1|||
47070700|NCT02652624|83357255|FG000|Extension Phase|Lost to Follow-up|3|||
47070701|NCT02652624|83357256|FG001|Extension Phase|Lost to Follow-up|1|||
47070702|NCT02652624|83357255|FG000|Extension Phase|Pregnancy|1|||
47070703|NCT02652624|83357256|FG001|Extension Phase|Pregnancy|1|||
47070704|NCT02652624|83357255|FG000|Extension Phase|Adverse Event|0|||
47070705|NCT02652624|83357256|FG001|Extension Phase|Adverse Event|1|||
47070706|NCT02652624|83357255|FG000|Extension Phase|Withdrew Consent|0|||
47070707|NCT02652624|83357256|FG001|Extension Phase|Withdrew Consent|1|||
47070708|NCT00249795|83357266|FG000|Overall Study|Not treated|16|||
47070709|NCT00249795|83357267|FG001|Overall Study|Not treated|14|||
47070710|NCT00249795|83357266|FG000|Overall Study|Symptomatic hypotension|127|||
47070711|NCT00249795|83357267|FG001|Overall Study|Symptomatic hypotension|64|||
47070712|NCT00249795|83357266|FG000|Overall Study|Other Serious Adverse Event|84|||
47070713|NCT00249795|83357267|FG001|Overall Study|Other Serious Adverse Event|93|||
47070714|NCT00249795|83357266|FG000|Overall Study|Qualifying condition not present|26|||
47070715|NCT00249795|83357267|FG001|Overall Study|Qualifying condition not present|29|||
47070716|NCT00249795|83357266|FG000|Overall Study|Withdrawal by Subject|678|||
47070717|NCT00249795|83357267|FG001|Overall Study|Withdrawal by Subject|742|||
47070718|NCT00249795|83357266|FG000|Overall Study|Thromboembolic / outcome event|39|||
47070719|NCT00249795|83357267|FG001|Overall Study|Thromboembolic / outcome event|45|||
47070720|NCT00249795|83357266|FG000|Overall Study|Oral anticoagulant required|2|||
47070721|NCT00249795|83357267|FG001|Overall Study|Oral anticoagulant required|0|||
47070722|NCT00249795|83357266|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
47070723|NCT00249795|83357267|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
47070724|NCT00249795|83357266|FG000|Overall Study|Non-compliance|71|||
47070725|NCT00249795|83357267|FG001|Overall Study|Non-compliance|69|||
47070726|NCT00249795|83357266|FG000|Overall Study|Study drug intolerance|3|||
47070727|NCT00249795|83357267|FG001|Overall Study|Study drug intolerance|3|||
47070728|NCT00249795|83357266|FG000|Overall Study|Other adverse events (non-serious)|188|||
47070729|NCT00249795|83357267|FG001|Overall Study|Other adverse events (non-serious)|159|||
47070730|NCT00249795|83357266|FG000|Overall Study|Physician withdrew consent|71|||
47070731|NCT00249795|83357267|FG001|Overall Study|Physician withdrew consent|63|||
47070732|NCT00249795|83357266|FG000|Overall Study|Surgery / procedure|4|||
47070733|NCT00249795|83357267|FG001|Overall Study|Surgery / procedure|5|||
47070734|NCT00249795|83357266|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
47070735|NCT00249795|83357267|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
46775288|NCT00697593|82993690|FG000|Overall Study|Protocol Violation|1|||
46775289|NCT00697593|82993690|FG000|Overall Study|Lack of Efficacy|3|||
47070736|NCT00249795|83357266|FG000|Overall Study|Lightheadedness / dizziness|15|||
47070737|NCT00249795|83357267|FG001|Overall Study|Lightheadedness / dizziness|11|||
47070738|NCT00249795|83357266|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
47070739|NCT00249795|83357267|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
47070740|NCT00249795|83357266|FG000|Overall Study|Other contraindicated medication|1|||
47070741|NCT00249795|83357267|FG001|Overall Study|Other contraindicated medication|1|||
47070742|NCT00249795|83357266|FG000|Overall Study|Event related to cardiac condition|17|||
47070743|NCT00249795|83357267|FG001|Overall Study|Event related to cardiac condition|16|||
47070744|NCT00249795|83357266|FG000|Overall Study|Patient not wish to continue after May08|4|||
47070745|NCT00249795|83357267|FG001|Overall Study|Patient not wish to continue after May08|6|||
47070746|NCT00249795|83357266|FG000|Overall Study|Site not agree to continue after May08|1|||
47070747|NCT00249795|83357267|FG001|Overall Study|Site not agree to continue after May08|1|||
47070748|NCT00249795|83357266|FG000|Overall Study|Lost to Follow-up|0|||
47070749|NCT00249795|83357267|FG001|Overall Study|Lost to Follow-up|2|||
47070750|NCT00249795|83357266|FG000|Overall Study|Missing|0|||
47070751|NCT00249795|83357267|FG001|Overall Study|Missing|1|||
47070752|NCT02651220|83357276|FG000|Overall Study|Adverse Event|1|||
47070753|NCT02651220|83357277|FG001|Overall Study|Adverse Event|5|||
47070754|NCT02651220|83357278|FG002|Overall Study|Adverse Event|1|||
47070755|NCT02651220|83357276|FG000|Overall Study|Lost to Follow-up|8|||
47070756|NCT02651220|83357277|FG001|Overall Study|Lost to Follow-up|14|||
47070757|NCT02651220|83357278|FG002|Overall Study|Lost to Follow-up|14|||
47070758|NCT02651220|83357276|FG000|Overall Study|Non-Compliance with Study Drug|4|||
47070759|NCT02651220|83357277|FG001|Overall Study|Non-Compliance with Study Drug|0|||
47070760|NCT02651220|83357278|FG002|Overall Study|Non-Compliance with Study Drug|1|||
47070761|NCT02651220|83357276|FG000|Overall Study|Pregnancy|1|||
47070762|NCT02651220|83357277|FG001|Overall Study|Pregnancy|0|||
47070763|NCT02651220|83357278|FG002|Overall Study|Pregnancy|1|||
47070764|NCT02651220|83357276|FG000|Overall Study|Protocol Violation|0|||
47070765|NCT02651220|83357277|FG001|Overall Study|Protocol Violation|0|||
47070766|NCT02651220|83357278|FG002|Overall Study|Protocol Violation|1|||
47070767|NCT02651220|83357276|FG000|Overall Study|Withdrawal by Subject|5|||
47070768|NCT02651220|83357277|FG001|Overall Study|Withdrawal by Subject|6|||
47070769|NCT02651220|83357278|FG002|Overall Study|Withdrawal by Subject|8|||
47070770|NCT02651220|83357276|FG000|Overall Study|Miscellaneous|4|||
47070771|NCT02651220|83357277|FG001|Overall Study|Miscellaneous|1|||
47070772|NCT02651220|83357278|FG002|Overall Study|Miscellaneous|2|||
47070773|NCT02651220|83357276|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46641046|NCT02983045|82820348|FG003|Overall Study|Lost to Follow-up|0|||
46641047|NCT02983045|82820349|FG004|Overall Study|Lost to Follow-up|0|||
46641048|NCT02983045|82820350|FG005|Overall Study|Lost to Follow-up|10|||
46641049|NCT02983045|82820351|FG006|Overall Study|Lost to Follow-up|0|||
46641050|NCT02983045|82820352|FG007|Overall Study|Lost to Follow-up|0|||
46641051|NCT02983045|82820353|FG008|Overall Study|Lost to Follow-up|0|||
46641052|NCT02983045|82820354|FG009|Overall Study|Lost to Follow-up|0|||
46641053|NCT02564263|82820378|FG000|Overall Study|Adverse Event|31|||
46641054|NCT02564263|82820379|FG001|Overall Study|Adverse Event|29|||
46641055|NCT02564263|82820378|FG000|Overall Study|Death|270|||
46641056|NCT02564263|82820379|FG001|Overall Study|Death|262|||
46641057|NCT02564263|82820378|FG000|Overall Study|Withdrawal by Subject|4|||
46641058|NCT02564263|82820379|FG001|Overall Study|Withdrawal by Subject|19|||
46846335|NCT00130520|83063058|FG000|Overall Study|Death|1|||
46846336|NCT00130520|83063058|FG000|Overall Study|Physician Decision|1|||
46967290|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
46967291|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
47070774|NCT02651220|83357277|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
47070775|NCT02651220|83357278|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
47070776|NCT00247611|83357326|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
47070777|NCT00247611|83357327|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
47070778|NCT00247611|83357326|FG000|Baselined|Completed baseline only|9|||
46641059|NCT02564263|82820378|FG000|Overall Study|Sponsor's decision|9|||
46641060|NCT02564263|82820379|FG001|Overall Study|Sponsor's decision|4|||
46641061|NCT02379819|82820386|FG000|Overall Study|Withdrawal by Subject|10|||
46641062|NCT02379819|82820386|FG000|Overall Study|Death|2|||
46641063|NCT02379819|82820386|FG000|Overall Study|Lack of Efficacy|1|||
46846337|NCT00130520|83063058|FG000|Overall Study|Withdrawal by Subject|1|||
47070779|NCT00247611|83357327|FG001|Baselined|Completed baseline only|8|||
47070780|NCT00246753|83357350|FG000|Overall Study|Withdrawal by Subject|2|||
47070781|NCT00246753|83357350|FG000|Overall Study|Physician Decision|2|||
46641064|NCT02379819|82820386|FG000|Overall Study|Lost to Follow-up|1|||
46641065|NCT02368886|82820394|FG000|Overall Study|Cancel|1|||
46641066|NCT02368886|82820395|FG001|Overall Study|Cancel|1|||
46641067|NCT02368886|82820396|FG002|Overall Study|Cancel|1|||
46641068|NCT02368886|82820397|FG003|Overall Study|Cancel|3|||
46641069|NCT02368886|82820394|FG000|Overall Study|Ineligible|0|||
46641070|NCT02368886|82820395|FG001|Overall Study|Ineligible|0|||
46641071|NCT02368886|82820396|FG002|Overall Study|Ineligible|0|||
46641072|NCT02368886|82820397|FG003|Overall Study|Ineligible|1|||
46641073|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
46641074|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
46641075|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
46641076|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
46641077|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
46641078|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
46641079|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
46641080|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
46641081|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
46641082|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
46641083|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
46641084|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
46641085|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
46641086|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
46641087|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
46641088|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
46641089|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
46641090|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
46641091|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
46641092|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
46641093|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
46641094|NCT02227238|82820411|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
46641095|NCT02227238|82820412|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
46641096|NCT02227238|82820413|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
46641097|NCT02227238|82820411|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
46641098|NCT02227238|82820412|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
46641099|NCT02227238|82820413|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
46641100|NCT02227238|82820411|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
46641101|NCT02227238|82820412|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
46641102|NCT02227238|82820413|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
46641103|NCT02227238|82820411|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
46641104|NCT02227238|82820412|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
46641105|NCT02227238|82820413|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
46641106|NCT02227238|82820411|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
46641107|NCT02227238|82820412|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
46641108|NCT02227238|82820413|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
46641109|NCT02227238|82820411|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
46641110|NCT02227238|82820412|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
46641111|NCT02227238|82820413|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
46641112|NCT02227238|82820411|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
46641113|NCT02227238|82820412|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
46641114|NCT02227238|82820413|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
46641115|NCT02126969|82820434|FG000|Overall Study|Withdrawal by Subject|1|||
46641116|NCT02126969|82820435|FG001|Overall Study|Withdrawal by Subject|2|||
46641117|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
46641118|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
46967292|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
47070782|NCT00246753|83357350|FG000|Overall Study|Adverse Event|2|||
47070783|NCT00246753|83357350|FG000|Overall Study|Unacceptable toxicity|2|||
47070784|NCT00246129|83357367|FG000|Overall Study|Lost to Follow-up|1|||
47070785|NCT00246129|83357368|FG001|Overall Study|Lost to Follow-up|0|||
47070786|NCT00246129|83357367|FG000|Overall Study|Death|2|||
47070787|NCT00246129|83357368|FG001|Overall Study|Death|1|||
47070788|NCT00246129|83357367|FG000|Overall Study|suffered primary non-function|1|||
47070789|NCT00246129|83357368|FG001|Overall Study|suffered primary non-function|0|||
46641119|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
46967293|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
46967294|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
46967295|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
47070790|NCT00246129|83357367|FG000|Overall Study|grafts failed|3|||
46775290|NCT00697593|82993690|FG000|Overall Study|Suspension of the study by sponsor|12|||
46775291|NCT00697515|82993694|FG000|Dose Optimization Period|Adverse Event|4|||
46967296|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
46967297|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
46967298|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
46967299|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
46967300|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
46775292|NCT00697515|82993695|FG001|Dose Optimization Period|Adverse Event|0|||
46967301|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
46967302|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
46967303|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
46967304|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
46967305|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
46967306|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
46967307|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
46967308|NCT00700427|83209982|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
46967309|NCT00700427|83209983|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
47070791|NCT00246129|83357368|FG001|Overall Study|grafts failed|1|||
46775293|NCT00697515|82993694|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
46775294|NCT00697515|82993695|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
46846338|NCT00130520|83063058|FG000|Overall Study|Disease Progression|23|||
46846339|NCT00130520|83063058|FG000|Overall Study|Protocol non-compliance|1|||
46846340|NCT00130520|83063058|FG000|Overall Study|Did not meet re-treatment criteria|1|||
46846341|NCT00132132|83063064|FG000|Overall Study|Lost to Follow-up|7|||
46846342|NCT00132132|83063065|FG001|Overall Study|Lost to Follow-up|2|||
46846343|NCT00130442|83063073|FG000|Overall Study|Withdrawal by Subject|0|||
46846344|NCT00130442|83063074|FG001|Overall Study|Withdrawal by Subject|1|||
46846345|NCT00130442|83063073|FG000|Overall Study|did not meet criteria|1|||
46846346|NCT00130442|83063074|FG001|Overall Study|did not meet criteria|1|||
46846347|NCT00130208|83063084|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
46846348|NCT00130208|83063085|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
46846349|NCT00130208|83063084|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
46846350|NCT00130208|83063085|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
47070792|NCT03182868|83357391|FG000|Overall Study|Protocol Violation|3|||
47070793|NCT03182868|83357392|FG001|Overall Study|Protocol Violation|0|||
47070794|NCT03182868|83357393|FG002|Overall Study|Protocol Violation|4|||
47070795|NCT03182868|83357394|FG003|Overall Study|Protocol Violation|1|||
46775295|NCT00697515|82993694|FG000|Dose Optimization Period|Lost to Follow-up|2|||
46775296|NCT00697515|82993695|FG001|Dose Optimization Period|Lost to Follow-up|0|||
46775297|NCT00697515|82993694|FG000|Dose Optimization Period|sponsor request|2|||
46775298|NCT00697515|82993695|FG001|Dose Optimization Period|sponsor request|0|||
46775299|NCT00697515|82993694|FG000|Dose Optimization Period|called to active duty|1|||
46775300|NCT00697515|82993695|FG001|Dose Optimization Period|called to active duty|0|||
46775301|NCT00697515|82993694|FG000|Dose Optimization Period|elevated QTc|1|||
46775302|NCT00697515|82993695|FG001|Dose Optimization Period|elevated QTc|0|||
46775303|NCT00697515|82993694|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
46775304|NCT00697515|82993695|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
46775305|NCT00697515|82993694|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
46775306|NCT00697515|82993695|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
46775307|NCT00697515|82993694|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
46775308|NCT00697515|82993695|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
46775309|NCT00697515|82993694|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
46775310|NCT00697515|82993695|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
47070796|NCT03182868|83357395|FG004|Overall Study|Protocol Violation|8|||
46775311|NCT00738062|82993704|FG000|Open Label Treatment|Lack of Efficacy|5|||
46775312|NCT00738062|82993705|FG001|Open Label Treatment|Lack of Efficacy|0|||
46775313|NCT00738062|82993706|FG002|Open Label Treatment|Lack of Efficacy|0|||
46775314|NCT00738062|82993704|FG000|Open Label Treatment|Adverse Event|11|||
46775315|NCT00738062|82993705|FG001|Open Label Treatment|Adverse Event|0|||
47070797|NCT00245583|83357419|FG000|Overall Study|Lost to Follow-up|1|||
47070798|NCT00245583|83357420|FG001|Overall Study|Lost to Follow-up|5|||
47070799|NCT00245583|83357419|FG000|Overall Study|Adverse Event|2|||
47070800|NCT00245583|83357420|FG001|Overall Study|Adverse Event|1|||
46775316|NCT00738062|82993706|FG002|Open Label Treatment|Adverse Event|0|||
46775317|NCT00738062|82993704|FG000|Open Label Treatment|Protocol Violation|2|||
46775318|NCT00738062|82993705|FG001|Open Label Treatment|Protocol Violation|0|||
46846351|NCT00130208|83063084|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
46775319|NCT00738062|82993706|FG002|Open Label Treatment|Protocol Violation|0|||
46846352|NCT00130208|83063085|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
46846353|NCT00130208|83063084|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
47070801|NCT00245583|83357419|FG000|Overall Study|Lack of Efficacy|1|||
47070802|NCT00245583|83357420|FG001|Overall Study|Lack of Efficacy|0|||
47070803|NCT00245583|83357419|FG000|Overall Study|Withdrawal by Subject|2|||
47070804|NCT00245583|83357420|FG001|Overall Study|Withdrawal by Subject|3|||
47070805|NCT02652156|83357429|FG000|Overall Study|Physician Decision|1|||
47070806|NCT02652156|83357430|FG001|Overall Study|Physician Decision|0|||
47070807|NCT02652156|83357431|FG002|Overall Study|Physician Decision|0|||
47070808|NCT01675050|83357478|FG000|Period One Treatment|Withdrawal by Subject|1|||
47070809|NCT01675050|83357479|FG001|Period One Treatment|Withdrawal by Subject|0|||
47070810|NCT00244881|83357498|FG000|Overall Study|Withdrawal by Subject|3|||
47070811|NCT00244725|83357529|FG000|Overall Study|Lost to Follow-up|3|||
47070812|NCT00244725|83357530|FG001|Overall Study|Lost to Follow-up|4|||
47070813|NCT00244725|83357531|FG002|Overall Study|Lost to Follow-up|9|||
47070814|NCT00244725|83357532|FG003|Overall Study|Lost to Follow-up|2|||
47070815|NCT00244725|83357529|FG000|Overall Study|Withdrawal by Subject|9|||
47070816|NCT00244725|83357530|FG001|Overall Study|Withdrawal by Subject|7|||
47070817|NCT00244725|83357531|FG002|Overall Study|Withdrawal by Subject|7|||
47070818|NCT00244725|83357532|FG003|Overall Study|Withdrawal by Subject|8|||
47070819|NCT00244725|83357529|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
47070820|NCT00244725|83357530|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
47070821|NCT00244725|83357531|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
47070822|NCT00244725|83357532|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
47070823|NCT00244725|83357529|FG000|Overall Study|Physician Decision|3|||
47070824|NCT00244725|83357530|FG001|Overall Study|Physician Decision|0|||
47070825|NCT00244725|83357531|FG002|Overall Study|Physician Decision|1|||
47070826|NCT00244725|83357532|FG003|Overall Study|Physician Decision|2|||
47070827|NCT00244725|83357529|FG000|Overall Study|Adverse Events|3|||
47070828|NCT00244725|83357530|FG001|Overall Study|Adverse Events|1|||
47070829|NCT00244725|83357531|FG002|Overall Study|Adverse Events|4|||
47070830|NCT00244725|83357532|FG003|Overall Study|Adverse Events|4|||
47070831|NCT00244725|83357529|FG000|Overall Study|Withdrwal by participant|1|||
47070832|NCT00244725|83357530|FG001|Overall Study|Withdrwal by participant|0|||
47070833|NCT00244725|83357531|FG002|Overall Study|Withdrwal by participant|0|||
47070834|NCT00244725|83357532|FG003|Overall Study|Withdrwal by participant|1|||
47070835|NCT00244725|83357529|FG000|Overall Study|Liver function test abnormality|2|||
47070836|NCT00244725|83357530|FG001|Overall Study|Liver function test abnormality|0|||
47070837|NCT00244725|83357531|FG002|Overall Study|Liver function test abnormality|0|||
47070838|NCT00244725|83357532|FG003|Overall Study|Liver function test abnormality|1|||
47070839|NCT00244725|83357529|FG000|Overall Study|Sponsor withdrew the participant|1|||
47070840|NCT00244725|83357530|FG001|Overall Study|Sponsor withdrew the participant|0|||
47070841|NCT00244725|83357531|FG002|Overall Study|Sponsor withdrew the participant|0|||
47070842|NCT00244725|83357532|FG003|Overall Study|Sponsor withdrew the participant|1|||
47070843|NCT00244725|83357529|FG000|Overall Study|Mediciation Error|0|||
47070844|NCT00244725|83357530|FG001|Overall Study|Mediciation Error|1|||
47070845|NCT00244725|83357531|FG002|Overall Study|Mediciation Error|0|||
47070846|NCT00244725|83357532|FG003|Overall Study|Mediciation Error|0|||
47070847|NCT00244725|83357529|FG000|Overall Study|Rehab Refused to allow participantion|0|||
47070848|NCT00244725|83357530|FG001|Overall Study|Rehab Refused to allow participantion|1|||
47070849|NCT00244725|83357531|FG002|Overall Study|Rehab Refused to allow participantion|0|||
47070850|NCT00244725|83357532|FG003|Overall Study|Rehab Refused to allow participantion|0|||
47070851|NCT00244725|83357529|FG000|Overall Study|Headache|0|||
47070852|NCT00244725|83357530|FG001|Overall Study|Headache|1|||
47070853|NCT00244725|83357531|FG002|Overall Study|Headache|0|||
47070854|NCT00244725|83357532|FG003|Overall Study|Headache|0|||
46775320|NCT00738062|82993704|FG000|Open Label Treatment|Withdrawal by Subject|9|||
46775321|NCT00738062|82993705|FG001|Open Label Treatment|Withdrawal by Subject|0|||
46775322|NCT00738062|82993706|FG002|Open Label Treatment|Withdrawal by Subject|0|||
46775323|NCT00738062|82993704|FG000|Open Label Treatment|Investigator Decision|1|||
46775324|NCT00738062|82993705|FG001|Open Label Treatment|Investigator Decision|0|||
46775325|NCT00738062|82993706|FG002|Open Label Treatment|Investigator Decision|0|||
46775326|NCT00738062|82993704|FG000|Open-Label Extension|Adverse Event|5|||
46775327|NCT00738062|82993705|FG001|Open-Label Extension|Adverse Event|0|||
46775328|NCT00738062|82993706|FG002|Open-Label Extension|Adverse Event|0|||
46775329|NCT00738062|82993704|FG000|Open-Label Extension|Physician Decision|1|||
46775330|NCT00738062|82993705|FG001|Open-Label Extension|Physician Decision|0|||
46775331|NCT00738062|82993706|FG002|Open-Label Extension|Physician Decision|0|||
46846354|NCT00130208|83063085|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
47070855|NCT00244725|83357529|FG000|Overall Study|Received prohibited medication|0|||
47070856|NCT00244725|83357530|FG001|Overall Study|Received prohibited medication|1|||
47070857|NCT00244725|83357531|FG002|Overall Study|Received prohibited medication|0|||
47070858|NCT00244725|83357532|FG003|Overall Study|Received prohibited medication|1|||
47070859|NCT00244725|83357529|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
47070860|NCT00244725|83357530|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
47070861|NCT00244725|83357531|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
47070862|NCT00244725|83357532|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
47070863|NCT00244725|83357529|FG000|Overall Study|Administrative reason|0|||
47070864|NCT00244725|83357530|FG001|Overall Study|Administrative reason|0|||
47070865|NCT00244725|83357531|FG002|Overall Study|Administrative reason|1|||
47070866|NCT00244725|83357532|FG003|Overall Study|Administrative reason|0|||
47070867|NCT00244725|83357529|FG000|Overall Study|Vomit|0|||
47070868|NCT00244725|83357530|FG001|Overall Study|Vomit|0|||
47070869|NCT00244725|83357531|FG002|Overall Study|Vomit|1|||
47070870|NCT00244725|83357532|FG003|Overall Study|Vomit|0|||
47070871|NCT00244725|83357529|FG000|Overall Study|Failed to follow-up|0|||
47070872|NCT00244725|83357530|FG001|Overall Study|Failed to follow-up|0|||
47070873|NCT00244725|83357531|FG002|Overall Study|Failed to follow-up|1|||
47070874|NCT00244725|83357532|FG003|Overall Study|Failed to follow-up|1|||
47070875|NCT02649894|83357544|FG000|Overall Study|Adverse Event|1|||
47070876|NCT02649894|83357545|FG001|Overall Study|Adverse Event|0|||
47070877|NCT02649894|83357544|FG000|Overall Study|Physician Decision|0|||
47070878|NCT02649894|83357545|FG001|Overall Study|Physician Decision|1|||
47070879|NCT02649894|83357544|FG000|Overall Study|Withdrawal by Subject|5|||
47070880|NCT02649894|83357545|FG001|Overall Study|Withdrawal by Subject|2|||
47070881|NCT02649894|83357544|FG000|Overall Study|Lost to Follow-up|2|||
47070882|NCT02649894|83357545|FG001|Overall Study|Lost to Follow-up|1|||
47070883|NCT02649894|83357544|FG000|Overall Study|Death|30|||
47070884|NCT02649894|83357545|FG001|Overall Study|Death|7|||
47070885|NCT02649894|83357544|FG000|Overall Study|Other, not specified|6|||
47070886|NCT02649894|83357545|FG001|Overall Study|Other, not specified|0|||
47070887|NCT01278615|83357551|FG000|Overall Study|Withdrawal by Subject|2|||
47070888|NCT01505114|83357577|FG000|Overall Study|Withdrawal by Subject|5|||
46775332|NCT00738062|82993704|FG000|Open-Label Extension|Lack of Efficacy|2|||
46775333|NCT00738062|82993705|FG001|Open-Label Extension|Lack of Efficacy|0|||
46775334|NCT00738062|82993706|FG002|Open-Label Extension|Lack of Efficacy|0|||
46775335|NCT00738062|82993704|FG000|Open-Label Extension|Withdrawal by Subject|6|||
46967310|NCT00700427|83209984|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
46967311|NCT00700427|83209985|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
46967312|NCT00700427|83209986|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
46967313|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
46775336|NCT00738062|82993705|FG001|Open-Label Extension|Withdrawal by Subject|0|||
46775337|NCT00738062|82993706|FG002|Open-Label Extension|Withdrawal by Subject|0|||
46775338|NCT00738062|82993704|FG000|Open-Label Extension|Protocol Violation|1|||
46775339|NCT00738062|82993705|FG001|Open-Label Extension|Protocol Violation|0|||
46775340|NCT00738062|82993706|FG002|Open-Label Extension|Protocol Violation|0|||
46775341|NCT00738062|82993704|FG000|Open-Label Extension|Study Terminated|2|||
46775342|NCT00738062|82993705|FG001|Open-Label Extension|Study Terminated|0|||
46775343|NCT00738062|82993706|FG002|Open-Label Extension|Study Terminated|0|||
46775344|NCT04245345|82993715|FG000|Overall Study|Death|1|||
46775345|NCT04245345|82993715|FG000|Overall Study|Exited prior to implant|5|||
46775346|NCT04245345|82993715|FG000|Overall Study|Exited prior to 1-month|9|||
46775347|NCT04245345|82993715|FG000|Overall Study|Missed 1-month visit|3|||
46775348|NCT04245345|82993715|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
46775349|NCT04245345|82993715|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
46775350|NCT00698685|82993721|FG000|Overall Study|Sister withdrew as donor|1|||
46775351|NCT00698685|82993721|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
46775352|NCT00737672|82993727|FG000|Overall Study|Graft Abandonment|48|||
46775353|NCT00737672|82993728|FG001|Overall Study|Graft Abandonment|56|||
46775354|NCT00737672|82993727|FG000|Overall Study|Death|23|||
46775355|NCT00737672|82993728|FG001|Overall Study|Death|22|||
46775356|NCT00737672|82993727|FG000|Overall Study|Withdrawal by Subject|1|||
46775357|NCT00737672|82993728|FG001|Overall Study|Withdrawal by Subject|2|||
46775358|NCT00737672|82993727|FG000|Overall Study|Lost to Follow-up|1|||
46775359|NCT00737672|82993728|FG001|Overall Study|Lost to Follow-up|0|||
46775360|NCT00737672|82993727|FG000|Overall Study|Miscellaneous|7|||
46775361|NCT00737672|82993728|FG001|Overall Study|Miscellaneous|1|||
46775362|NCT00737672|82993727|FG000|Overall Study|Physician Decision|0|||
46967314|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
46967315|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
47070889|NCT01505114|83357578|FG001|Overall Study|Withdrawal by Subject|4|||
47070890|NCT01505114|83357579|FG002|Overall Study|Withdrawal by Subject|4|||
47070891|NCT01505114|83357580|FG003|Overall Study|Withdrawal by Subject|7|||
47070892|NCT01505114|83357577|FG000|Overall Study|Death|1|||
47070893|NCT01505114|83357578|FG001|Overall Study|Death|0|||
47070894|NCT01505114|83357579|FG002|Overall Study|Death|0|||
47070895|NCT01505114|83357580|FG003|Overall Study|Death|1|||
46641120|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
46641121|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
46641122|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
46641123|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
46641124|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
46641125|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
46641126|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
47070896|NCT01505114|83357577|FG000|Overall Study|unable to adhere to visit schedule|3|||
47070897|NCT01505114|83357578|FG001|Overall Study|unable to adhere to visit schedule|2|||
47070898|NCT01505114|83357579|FG002|Overall Study|unable to adhere to visit schedule|3|||
47070899|NCT01505114|83357580|FG003|Overall Study|unable to adhere to visit schedule|3|||
47070900|NCT01505114|83357577|FG000|Overall Study|Lost to Follow-up|11|||
47070901|NCT01505114|83357578|FG001|Overall Study|Lost to Follow-up|5|||
47070902|NCT01505114|83357579|FG002|Overall Study|Lost to Follow-up|8|||
47070903|NCT01505114|83357580|FG003|Overall Study|Lost to Follow-up|7|||
47070904|NCT01505114|83357577|FG000|Overall Study|relocated|4|||
47070905|NCT01505114|83357578|FG001|Overall Study|relocated|2|||
47070906|NCT01505114|83357579|FG002|Overall Study|relocated|2|||
47070907|NCT01505114|83357580|FG003|Overall Study|relocated|3|||
47070908|NCT01505114|83357577|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
47070909|NCT01505114|83357578|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
47070910|NCT01505114|83357579|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
47070911|NCT01505114|83357580|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
47070912|NCT01505114|83357577|FG000|Overall Study|staff safety concerns|0|||
46775363|NCT00737672|82993728|FG001|Overall Study|Physician Decision|2|||
46775364|NCT00737438|82993734|FG000|Overall Study|Withdrawal by Subject|2|||
46775365|NCT00737438|82993734|FG000|Overall Study|Patient ineligible|1|||
46775366|NCT00737282|82993740|FG000|Overall Study|Study prematurely terminated|175|||
46775367|NCT03884478|82993749|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
46775368|NCT03884478|82993750|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
46775369|NCT03884478|82993751|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
46775370|NCT03884478|82993749|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
46775371|NCT03884478|82993750|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
46775372|NCT03884478|82993751|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
46775373|NCT03884478|82993749|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
46775374|NCT03884478|82993750|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
46775375|NCT03884478|82993751|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
46775376|NCT03884478|82993749|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
46775377|NCT03884478|82993750|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
46775378|NCT03884478|82993751|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
46775379|NCT00582816|82993772|FG000|Overall Study|Engraftment Failure|3|||
46967316|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
47070913|NCT01505114|83357578|FG001|Overall Study|staff safety concerns|0|||
47070914|NCT01505114|83357579|FG002|Overall Study|staff safety concerns|0|||
46641127|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
46641128|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
46641129|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
46641130|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
46641131|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
46641132|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
46641133|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
46775380|NCT00737048|82993779|FG000|Overall Study|Physician Decision|0|||
46846355|NCT00130208|83063084|FG000|Maintenance Period (26 Weeks)|Other|1|||
47070915|NCT01505114|83357580|FG003|Overall Study|staff safety concerns|1|||
47070916|NCT01505114|83357577|FG000|Overall Study|investigator decision|1|||
47070917|NCT01505114|83357578|FG001|Overall Study|investigator decision|0|||
47070918|NCT01505114|83357579|FG002|Overall Study|investigator decision|1|||
47070919|NCT01505114|83357580|FG003|Overall Study|investigator decision|0|||
47070920|NCT02651922|83357612|FG000|Overall Study|due to exclusion criteria|2|||
47070921|NCT01277757|83357616|FG000|Overall Study|Disease Progression|1|||
47070922|NCT01277757|83357616|FG000|Overall Study|Withdrawal by Subject|1|||
47070923|NCT01276821|83357622|FG000|Overall Study|Protocol Violation|0|||
47070924|NCT01276821|83357623|FG001|Overall Study|Protocol Violation|1|||
47070925|NCT00245037|83357629|FG000|Overall Study|Death|17|||
47070926|NCT00241839|83357635|FG000|Overall Study|Withdrawal by Subject|18|||
47070927|NCT00241839|83357636|FG001|Overall Study|Withdrawal by Subject|17|||
47070928|NCT00241839|83357635|FG000|Overall Study|Adverse Event|1|||
47070929|NCT00241839|83357636|FG001|Overall Study|Adverse Event|1|||
47070930|NCT02651688|83357645|FG000|Overall Study|Non-compliance|0|||
47070931|NCT02651688|83357646|FG001|Overall Study|Non-compliance|0|||
47070932|NCT02651688|83357647|FG002|Overall Study|Non-compliance|1|||
47070933|NCT02651688|83357645|FG000|Overall Study|Principal Investigator (PI) decision|0|||
47070934|NCT02651688|83357646|FG001|Overall Study|Principal Investigator (PI) decision|2|||
47070935|NCT02651688|83357647|FG002|Overall Study|Principal Investigator (PI) decision|0|||
47070936|NCT02651688|83357645|FG000|Overall Study|Lost to Follow-up|1|||
47070937|NCT02651688|83357646|FG001|Overall Study|Lost to Follow-up|3|||
47070938|NCT02651688|83357647|FG002|Overall Study|Lost to Follow-up|0|||
47070939|NCT02651688|83357645|FG000|Overall Study|Withdrawal by Subject|1|||
47070940|NCT02651688|83357646|FG001|Overall Study|Withdrawal by Subject|0|||
47070941|NCT02651688|83357647|FG002|Overall Study|Withdrawal by Subject|2|||
47070942|NCT01276353|83357657|FG000|Double-blind|Adverse Event|2|||
47070943|NCT01276353|83357658|FG001|Double-blind|Adverse Event|0|||
47070944|NCT01276353|83357657|FG000|Double-blind|Withdrawal by Subject|1|||
47070945|NCT01276353|83357658|FG001|Double-blind|Withdrawal by Subject|0|||
47070946|NCT01276353|83357657|FG000|Extension|Adverse Event|2|||
47070947|NCT01276353|83357658|FG001|Extension|Adverse Event|5|||
47070948|NCT01276353|83357657|FG000|Extension|Withdrawal by Subject|1|||
47070949|NCT01276353|83357658|FG001|Extension|Withdrawal by Subject|2|||
47070950|NCT01276353|83357657|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
47070951|NCT01276353|83357658|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
47070952|NCT01276353|83357657|FG000|Extension|Physician Decision|1|||
47070953|NCT01276353|83357658|FG001|Extension|Physician Decision|0|||
47070954|NCT01276353|83357657|FG000|Extension|Prohibited concomitant medications|0|||
47070955|NCT01276353|83357658|FG001|Extension|Prohibited concomitant medications|1|||
47070956|NCT02536794|83357693|FG000|Reached 1st Response Assessment|Adverse Event|2|||
47070957|NCT02536794|83357693|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
47070958|NCT02536794|83357693|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
47070959|NCT02536794|83357693|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
47070960|NCT02536794|83357693|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
47070961|NCT02536794|83357693|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
47070962|NCT01480076|83357763|FG000|Overall Study|Run-in Failure|52|||
47070963|NCT01480076|83357763|FG000|Overall Study|Adverse Event|39|||
47070964|NCT01480076|83357763|FG000|Overall Study|Death|2|||
47070965|NCT01480076|83357763|FG000|Overall Study|Disease Progression|5|||
47070966|NCT01480076|83357763|FG000|Overall Study|Non-compliance With Study Protocol|15|||
47070967|NCT01480076|83357763|FG000|Overall Study|Withdrawal by Subject|105|||
47070968|NCT01480076|83357763|FG000|Overall Study|Lost to Follow-up|7|||
47070969|NCT01480076|83357763|FG000|Overall Study|Investigator Decision|13|||
47070970|NCT01480076|83357763|FG000|Overall Study|Other|52|||
47070971|NCT02650128|83357851|FG000|Overall Study|Death|2|||
47070972|NCT01362270|83357866|FG000|Overall Study|Withdrawal by Subject|1|||
47070973|NCT01362270|83357867|FG001|Overall Study|Withdrawal by Subject|0|||
47070974|NCT01362270|83357866|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
46775381|NCT00737048|82993780|FG001|Overall Study|Physician Decision|0|||
46775382|NCT00737048|82993781|FG002|Overall Study|Physician Decision|1|||
46641134|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
46775383|NCT00737048|82993779|FG000|Overall Study|Adverse Event|0|||
46775384|NCT00737048|82993780|FG001|Overall Study|Adverse Event|1|||
46775385|NCT00737048|82993781|FG002|Overall Study|Adverse Event|0|||
47070975|NCT01362270|83357867|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
47070976|NCT01362270|83357866|FG000|Overall Study|Met excl. criteria before 1st session|1|||
47070977|NCT01362270|83357867|FG001|Overall Study|Met excl. criteria before 1st session|1|||
47070978|NCT00089479|83357888|FG000|Overall Study|Death|108|||
47070979|NCT00089479|83357889|FG001|Overall Study|Death|75|||
47070980|NCT00089479|83357888|FG000|Overall Study|Withdrawal by Subject|86|||
47070981|NCT00089479|83357889|FG001|Overall Study|Withdrawal by Subject|107|||
47070982|NCT00089479|83357888|FG000|Overall Study|Lost to Follow-up|137|||
47070983|NCT00089479|83357889|FG001|Overall Study|Lost to Follow-up|107|||
47070984|NCT01463306|83357898|FG000|Overall Study|Adverse Event|6|||
47070985|NCT01463306|83357899|FG001|Overall Study|Adverse Event|9|||
47070986|NCT01463306|83357900|FG002|Overall Study|Adverse Event|3|||
47070987|NCT01463306|83357898|FG000|Overall Study|Death|3|||
47070988|NCT01463306|83357899|FG001|Overall Study|Death|3|||
47070989|NCT01463306|83357900|FG002|Overall Study|Death|0|||
47070990|NCT01463306|83357898|FG000|Overall Study|Lack of Efficacy|22|||
47070991|NCT01463306|83357899|FG001|Overall Study|Lack of Efficacy|16|||
47070992|NCT01463306|83357900|FG002|Overall Study|Lack of Efficacy|1|||
47070993|NCT01463306|83357898|FG000|Overall Study|Lost to Follow-up|5|||
47070994|NCT01463306|83357899|FG001|Overall Study|Lost to Follow-up|2|||
47070995|NCT01463306|83357900|FG002|Overall Study|Lost to Follow-up|0|||
47070996|NCT01463306|83357898|FG000|Overall Study|Protocol Violation|4|||
47070997|NCT01463306|83357899|FG001|Overall Study|Protocol Violation|0|||
47070998|NCT01463306|83357900|FG002|Overall Study|Protocol Violation|0|||
47070999|NCT01463306|83357898|FG000|Overall Study|Withdrawal by Subject|19|||
47071000|NCT01463306|83357899|FG001|Overall Study|Withdrawal by Subject|9|||
47071001|NCT01463306|83357900|FG002|Overall Study|Withdrawal by Subject|1|||
47071002|NCT01463306|83357898|FG000|Overall Study|Other|26|||
47071003|NCT01463306|83357899|FG001|Overall Study|Other|13|||
47071004|NCT01463306|83357900|FG002|Overall Study|Other|0|||
47071005|NCT01463306|83357898|FG000|Overall Study|Approval expiry at site|1|||
47071006|NCT01463306|83357899|FG001|Overall Study|Approval expiry at site|0|||
47071007|NCT01463306|83357900|FG002|Overall Study|Approval expiry at site|0|||
47071008|NCT01504412|83357929|FG000|Overall Study|Adverse Event|1|||
47071009|NCT01504412|83357930|FG001|Overall Study|Adverse Event|8|||
47071010|NCT01504412|83357931|FG002|Overall Study|Adverse Event|1|||
47071011|NCT01504412|83357932|FG003|Overall Study|Adverse Event|7|||
47071012|NCT01504412|83357933|FG004|Overall Study|Adverse Event|10|||
47071013|NCT01504412|83357929|FG000|Overall Study|Withdrawal by Subject|2|||
47071014|NCT01504412|83357930|FG001|Overall Study|Withdrawal by Subject|1|||
47071015|NCT01504412|83357931|FG002|Overall Study|Withdrawal by Subject|1|||
47071016|NCT01504412|83357932|FG003|Overall Study|Withdrawal by Subject|5|||
47071017|NCT01504412|83357933|FG004|Overall Study|Withdrawal by Subject|1|||
47071018|NCT01504412|83357929|FG000|Overall Study|Other|2|||
47071019|NCT01504412|83357930|FG001|Overall Study|Other|1|||
47071020|NCT01504412|83357931|FG002|Overall Study|Other|1|||
47071021|NCT01504412|83357932|FG003|Overall Study|Other|6|||
47071022|NCT01504412|83357933|FG004|Overall Study|Other|1|||
47071023|NCT01504412|83357929|FG000|Overall Study|Lost to Follow-up|0|||
47071024|NCT01504412|83357930|FG001|Overall Study|Lost to Follow-up|2|||
47071025|NCT01504412|83357931|FG002|Overall Study|Lost to Follow-up|0|||
47071026|NCT01504412|83357932|FG003|Overall Study|Lost to Follow-up|0|||
47071027|NCT01504412|83357933|FG004|Overall Study|Lost to Follow-up|0|||
47071028|NCT01504412|83357929|FG000|Overall Study|Lack of Efficacy|0|||
47071029|NCT01504412|83357930|FG001|Overall Study|Lack of Efficacy|0|||
47071030|NCT01504412|83357931|FG002|Overall Study|Lack of Efficacy|1|||
47071031|NCT01504412|83357932|FG003|Overall Study|Lack of Efficacy|0|||
47071032|NCT01504412|83357933|FG004|Overall Study|Lack of Efficacy|1|||
47071033|NCT01504412|83357929|FG000|Overall Study|Death|0|||
47071034|NCT01504412|83357930|FG001|Overall Study|Death|0|||
47071035|NCT01504412|83357931|FG002|Overall Study|Death|0|||
47071036|NCT01504412|83357932|FG003|Overall Study|Death|1|||
47071037|NCT01504412|83357933|FG004|Overall Study|Death|0|||
47071038|NCT01503164|83357963|FG000|Overall Study|Withdrawal by Subject|2|||
47071039|NCT01503164|83357964|FG001|Overall Study|Withdrawal by Subject|1|||
47071040|NCT00088465|83357970|FG000|Overall Study|Withdrawal by Subject|290|||
46775386|NCT00737048|82993779|FG000|Overall Study|Worsening of the symptoms|3|||
46775387|NCT00737048|82993780|FG001|Overall Study|Worsening of the symptoms|5|||
46775388|NCT00737048|82993781|FG002|Overall Study|Worsening of the symptoms|3|||
46775389|NCT00731822|82993791|FG000|Overall Study|Adverse Event|2|||
47071041|NCT00088465|83357970|FG000|Overall Study|Adverse Event|77|||
47071042|NCT00088465|83357970|FG000|Overall Study|Lost to Follow-up|57|||
47071043|NCT00088465|83357970|FG000|Overall Study|Physician Decision|45|||
47071044|NCT00088465|83357970|FG000|Overall Study|Sponsor Decision|37|||
47071045|NCT00088465|83357970|FG000|Overall Study|Lack of Efficacy|27|||
47071046|NCT00088465|83357970|FG000|Overall Study|Protocol Violation|17|||
46967317|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
46967318|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
47071047|NCT00088465|83357970|FG000|Overall Study|Death|11|||
46775390|NCT00731822|82993792|FG001|Overall Study|Adverse Event|1|||
47071048|NCT00088153|83357998|FG000|Overall Study|Physician Decision|3|||
47071049|NCT00088153|83357999|FG001|Overall Study|Physician Decision|3|||
47071050|NCT00088153|83357998|FG000|Overall Study|Withdrawal by Subject|10|||
47071051|NCT00088153|83357999|FG001|Overall Study|Withdrawal by Subject|10|||
47071052|NCT00088153|83357998|FG000|Overall Study|Lost to Follow-up|11|||
47071053|NCT00088153|83357999|FG001|Overall Study|Lost to Follow-up|12|||
47071054|NCT01502228|83358018|FG000|Overall Study|Death|1|||
47071055|NCT01502072|83358025|FG000|Overall Study|Withdrawal by Subject|1|||
47071056|NCT01502072|83358026|FG001|Overall Study|Withdrawal by Subject|0|||
46775391|NCT00731822|82993791|FG000|Overall Study|Protocol Violation|1|||
46775392|NCT00731822|82993792|FG001|Overall Study|Protocol Violation|0|||
46775393|NCT00731822|82993791|FG000|Overall Study|Lost to Follow-up|1|||
47071057|NCT01502072|83358027|FG002|Overall Study|Withdrawal by Subject|0|||
47071058|NCT01502072|83358025|FG000|Overall Study|Death|0|||
47071059|NCT01502072|83358026|FG001|Overall Study|Death|1|||
47071060|NCT01502072|83358027|FG002|Overall Study|Death|0|||
47071061|NCT01462370|83358035|FG000|Overall Study|Lack of Qualifying Event|1|||
47071062|NCT01462370|83358036|FG001|Overall Study|Lack of Qualifying Event|1|||
47071063|NCT01462370|83358035|FG000|Overall Study|Physician Decision|0|||
47071064|NCT01462370|83358036|FG001|Overall Study|Physician Decision|1|||
47071065|NCT01462370|83358035|FG000|Overall Study|Withdrawal by Subject|0|||
47071066|NCT01462370|83358036|FG001|Overall Study|Withdrawal by Subject|3|||
47071067|NCT01479764|83358044|FG000|Randomized|Adverse Event|1|||
47071068|NCT01479764|83358045|FG001|Randomized|Adverse Event|1|||
47071069|NCT01479764|83358044|FG000|Randomized|Withdrawal by Subject|1|||
47071070|NCT01479764|83358045|FG001|Randomized|Withdrawal by Subject|0|||
47071071|NCT01479764|83358044|FG000|Treated|Lost to Follow-up|0|||
47071072|NCT01479764|83358045|FG001|Treated|Lost to Follow-up|2|||
47071073|NCT01479530|83358053|FG000|Overall Study|Adverse Event|5|||
47071074|NCT01479530|83358054|FG001|Overall Study|Adverse Event|6|||
47071075|NCT01479530|83358053|FG000|Overall Study|Lack of Efficacy|0|||
47071076|NCT01479530|83358054|FG001|Overall Study|Lack of Efficacy|1|||
47071077|NCT01479530|83358053|FG000|Overall Study|Protocol Violation|2|||
47071078|NCT01479530|83358054|FG001|Overall Study|Protocol Violation|3|||
47071079|NCT01479530|83358053|FG000|Overall Study|Withdrawal of Consent|3|||
47071080|NCT01479530|83358054|FG001|Overall Study|Withdrawal of Consent|2|||
47071081|NCT01479374|83358063|FG000|Overall Study|Adverse Event|2|||
47071082|NCT01479374|83358064|FG001|Overall Study|Adverse Event|1|||
47071083|NCT01479374|83358065|FG002|Overall Study|Adverse Event|0|||
47071084|NCT01479374|83358063|FG000|Overall Study|Lost to Follow-up|1|||
47071085|NCT01479374|83358064|FG001|Overall Study|Lost to Follow-up|2|||
47071086|NCT01479374|83358065|FG002|Overall Study|Lost to Follow-up|0|||
47071087|NCT01479374|83358063|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
47071088|NCT01479374|83358064|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
47071089|NCT01479374|83358065|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
47071090|NCT01479374|83358063|FG000|Overall Study|Other|0|||
47071091|NCT01479374|83358064|FG001|Overall Study|Other|4|||
47071092|NCT01479374|83358065|FG002|Overall Study|Other|5|||
47071093|NCT00087529|83358075|FG000|Overall Study|Death|1|||
47071094|NCT00087529|83358076|FG001|Overall Study|Death|0|||
47071095|NCT00087529|83358075|FG000|Overall Study|Adverse Event|0|||
47071096|NCT00087529|83358076|FG001|Overall Study|Adverse Event|8|||
47071097|NCT00087529|83358075|FG000|Overall Study|Pregnancy|0|||
47071098|NCT00087529|83358076|FG001|Overall Study|Pregnancy|1|||
47071099|NCT00087529|83358075|FG000|Overall Study|Lost to Follow-up|2|||
47071100|NCT00087529|83358076|FG001|Overall Study|Lost to Follow-up|3|||
47071101|NCT00087529|83358075|FG000|Overall Study|Participant Decision|14|||
47071102|NCT00087529|83358076|FG001|Overall Study|Participant Decision|37|||
47071103|NCT00087529|83358075|FG000|Overall Study|Physician Decision|4|||
47071104|NCT00087529|83358076|FG001|Overall Study|Physician Decision|8|||
47071105|NCT00087529|83358075|FG000|Overall Study|Initiation of Excluded Therapy|0|||
47071106|NCT00087529|83358076|FG001|Overall Study|Initiation of Excluded Therapy|1|||
47071107|NCT00087529|83358075|FG000|Overall Study|Participant Noncompliance|0|||
46775394|NCT00731822|82993792|FG001|Overall Study|Lost to Follow-up|0|||
46775395|NCT00731666|82993798|FG000|Overall Study|Adverse Event|2|||
46775396|NCT00731666|82993798|FG000|Overall Study|Lost to Follow-up|8|||
46775397|NCT00731666|82993798|FG000|Overall Study|Withdrawal by Subject|2|||
46775398|NCT00731120|82993805|FG000|Overall Study|Adverse Event|7|||
46775399|NCT00731120|82993806|FG001|Overall Study|Adverse Event|6|||
46775400|NCT00731120|82993807|FG002|Overall Study|Adverse Event|8|||
46775401|NCT00731120|82993805|FG000|Overall Study|Lack of Efficacy|4|||
46775402|NCT00731120|82993806|FG001|Overall Study|Lack of Efficacy|5|||
46775403|NCT00731120|82993807|FG002|Overall Study|Lack of Efficacy|4|||
46775404|NCT00731120|82993805|FG000|Overall Study|Noncompliance with Study Drug|3|||
46775405|NCT00731120|82993806|FG001|Overall Study|Noncompliance with Study Drug|3|||
46967319|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
46967320|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
47071108|NCT00087529|83358076|FG001|Overall Study|Participant Noncompliance|1|||
46775406|NCT00731120|82993807|FG002|Overall Study|Noncompliance with Study Drug|1|||
46775407|NCT00731120|82993805|FG000|Overall Study|Protocol Deviations|1|||
46775408|NCT00731120|82993806|FG001|Overall Study|Protocol Deviations|6|||
46775409|NCT00731120|82993807|FG002|Overall Study|Protocol Deviations|1|||
46775410|NCT00731120|82993805|FG000|Overall Study|Withdrawal of Consent|13|||
47071109|NCT00087529|83358075|FG000|Overall Study|Disease Progression|5|||
47071110|NCT00087529|83358076|FG001|Overall Study|Disease Progression|4|||
47071111|NCT00087529|83358075|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
47071112|NCT00087529|83358076|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
47071113|NCT01500434|83358099|FG000|Overall Study|Death|1|||
47071114|NCT01500434|83358099|FG000|Overall Study|Withdrawal by Subject|1|||
47071115|NCT01500434|83358099|FG000|Overall Study|Missed 12-month follow-up|5|||
47071116|NCT00087139|83358106|FG000|Overall Study|Adverse Event|18|||
47071117|NCT00087139|83358107|FG001|Overall Study|Adverse Event|17|||
47071118|NCT00087139|83358108|FG002|Overall Study|Adverse Event|13|||
47071119|NCT00087139|83358106|FG000|Overall Study|Death|2|||
47071120|NCT00087139|83358107|FG001|Overall Study|Death|1|||
47071121|NCT00087139|83358108|FG002|Overall Study|Death|0|||
47071122|NCT00087139|83358106|FG000|Overall Study|Withdrawal by Subject|3|||
47071123|NCT00087139|83358107|FG001|Overall Study|Withdrawal by Subject|2|||
47071124|NCT00087139|83358108|FG002|Overall Study|Withdrawal by Subject|2|||
47071125|NCT00087139|83358106|FG000|Overall Study|Physician Decision|1|||
47071126|NCT00087139|83358107|FG001|Overall Study|Physician Decision|1|||
47071127|NCT00087139|83358108|FG002|Overall Study|Physician Decision|1|||
47071128|NCT00087139|83358106|FG000|Overall Study|Disease progression|9|||
47071129|NCT00087139|83358107|FG001|Overall Study|Disease progression|19|||
47071130|NCT00087139|83358108|FG002|Overall Study|Disease progression|12|||
47071131|NCT00087139|83358106|FG000|Overall Study|Ineligible|4|||
47071132|NCT00087139|83358107|FG001|Overall Study|Ineligible|7|||
47071133|NCT00087139|83358108|FG002|Overall Study|Ineligible|4|||
47071134|NCT00087139|83358106|FG000|Overall Study|Symptomatic deterioration|1|||
47071135|NCT00087139|83358107|FG001|Overall Study|Symptomatic deterioration|1|||
47071136|NCT00087139|83358108|FG002|Overall Study|Symptomatic deterioration|3|||
47071137|NCT00087139|83358106|FG000|Overall Study|Use of coumadin|1|||
47071138|NCT00087139|83358107|FG001|Overall Study|Use of coumadin|0|||
47071139|NCT00087139|83358108|FG002|Overall Study|Use of coumadin|0|||
47071140|NCT00087139|83358106|FG000|Overall Study|Response achieved|0|||
47071141|NCT00087139|83358107|FG001|Overall Study|Response achieved|1|||
47071142|NCT00087139|83358108|FG002|Overall Study|Response achieved|0|||
47071143|NCT00087139|83358106|FG000|Overall Study|Extradural disease|0|||
47071144|NCT00087139|83358107|FG001|Overall Study|Extradural disease|0|||
47071145|NCT00087139|83358108|FG002|Overall Study|Extradural disease|1|||
47071146|NCT01500278|83358160|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
47071147|NCT01500278|83358161|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
47071148|NCT01500278|83358160|FG000|Week 0 - Week 12|Protocol Violation|10|||
47071149|NCT01500278|83358161|FG001|Week 0 - Week 12|Protocol Violation|16|||
47071150|NCT01500278|83358160|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
47071151|NCT01500278|83358161|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
47071152|NCT01500278|83358160|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
47071153|NCT01500278|83358161|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
47071154|NCT01500278|83358160|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
47071155|NCT01500278|83358161|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
47071156|NCT01500278|83358160|FG000|Week 0 - Week 12|Patient decision|1|||
47071157|NCT01500278|83358161|FG001|Week 0 - Week 12|Patient decision|0|||
47071158|NCT01500278|83358160|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
47071159|NCT01500278|83358161|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
47071160|NCT01500278|83358160|FG000|Week 0 - Week 12|Investigator decision|1|||
47071161|NCT01500278|83358161|FG001|Week 0 - Week 12|Investigator decision|0|||
47071162|NCT01500278|83358160|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
47071163|NCT01500278|83358161|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
47071164|NCT01500278|83358160|FG000|Week 0 - Week 12|Sponsor decision|1|||
47071165|NCT01500278|83358161|FG001|Week 0 - Week 12|Sponsor decision|0|||
47071166|NCT01500278|83358160|FG000|Week 0 - Week 12|Personal reason|0|||
47071167|NCT01500278|83358161|FG001|Week 0 - Week 12|Personal reason|1|||
47071168|NCT01500278|83358160|FG000|Week 0 - Week 12|Other serious disease|0|||
47071169|NCT01500278|83358161|FG001|Week 0 - Week 12|Other serious disease|1|||
47071170|NCT01500278|83358160|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
47071171|NCT01500278|83358161|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
47071172|NCT01500278|83358160|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
46641135|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
46641136|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
46641137|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
46967321|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
46967322|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
47071173|NCT01500278|83358161|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
47071174|NCT01500278|83358160|FG000|Week 13 - Week 104|Protocol Violation|6|||
47071175|NCT01500278|83358161|FG001|Week 13 - Week 104|Protocol Violation|6|||
47071176|NCT01500278|83358160|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
47071177|NCT01500278|83358161|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
47071178|NCT01500278|83358160|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
47071179|NCT01500278|83358161|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
47071180|NCT01500278|83358160|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
47071181|NCT01500278|83358161|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
47071182|NCT01500278|83358160|FG000|Week 13 - Week 104|Non/bad compliance|7|||
47071183|NCT01500278|83358161|FG001|Week 13 - Week 104|Non/bad compliance|5|||
47071184|NCT01500278|83358160|FG000|Week 13 - Week 104|Recurrent infections|1|||
47071185|NCT01500278|83358161|FG001|Week 13 - Week 104|Recurrent infections|0|||
47071186|NCT01500278|83358160|FG000|Week 13 - Week 104|False positive test|1|||
47071187|NCT01500278|83358161|FG001|Week 13 - Week 104|False positive test|2|||
47071188|NCT01500278|83358160|FG000|Week 13 - Week 104|Sponsor request|4|||
47071189|NCT01500278|83358161|FG001|Week 13 - Week 104|Sponsor request|0|||
47071190|NCT01500278|83358160|FG000|Week 13 - Week 104|Withdrawn in error|1|||
47071191|NCT01500278|83358161|FG001|Week 13 - Week 104|Withdrawn in error|0|||
47071192|NCT01500278|83358160|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
47071193|NCT01500278|83358161|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
47071194|NCT01500278|83358160|FG000|Week 13 - Week 104|Protocol deviation|1|||
47071195|NCT01500278|83358161|FG001|Week 13 - Week 104|Protocol deviation|0|||
47071196|NCT01500278|83358160|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
47071197|NCT01500278|83358161|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
47071198|NCT01500278|83358160|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
47071199|NCT01500278|83358161|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
47071200|NCT01500278|83358160|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
47071201|NCT01500278|83358161|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
47071202|NCT01500278|83358160|FG000|Week 13 - Week 104|Relocation|0|||
47071203|NCT01500278|83358161|FG001|Week 13 - Week 104|Relocation|1|||
47071204|NCT01500278|83358160|FG000|Week 13 - Week 104|Sponsor decision|0|||
47071205|NCT01500278|83358161|FG001|Week 13 - Week 104|Sponsor decision|2|||
47071206|NCT01500278|83358160|FG000|Week 13 - Week 104|Medical monitor decision|0|||
47071207|NCT01500278|83358161|FG001|Week 13 - Week 104|Medical monitor decision|2|||
47071208|NCT01500278|83358160|FG000|Week 13 - Week 104|Personal reason|0|||
47071209|NCT01500278|83358161|FG001|Week 13 - Week 104|Personal reason|1|||
47071210|NCT01500278|83358160|FG000|Week 13 - Week 104|Not completed|0|||
47071211|NCT01500278|83358161|FG001|Week 13 - Week 104|Not completed|1|||
47071212|NCT01500278|83358160|FG000|Week 13 - Week 104|Death|2|||
47071213|NCT01500278|83358161|FG001|Week 13 - Week 104|Death|4|||
47071214|NCT01500278|83358160|FG000|Week 13 - Week 104|Adverse Event|54|||
47071215|NCT01500278|83358161|FG001|Week 13 - Week 104|Adverse Event|54|||
47071216|NCT00086281|83358184|FG000|Phase 1|Adverse Event|0|||
47071217|NCT00086281|83358185|FG001|Phase 1|Adverse Event|0|||
47071218|NCT00086281|83358186|FG002|Phase 1|Adverse Event|0|||
46641138|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
47071219|NCT00086281|83358187|FG003|Phase 1|Adverse Event|0|||
47071220|NCT00086281|83358188|FG004|Phase 1|Adverse Event|0|||
46846356|NCT00130208|83063085|FG001|Maintenance Period (26 Weeks)|Other|1|||
46967323|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
47071221|NCT00086281|83358189|FG005|Phase 1|Adverse Event|0|||
47071222|NCT00086281|83358190|FG006|Phase 1|Adverse Event|0|||
47071223|NCT00086281|83358191|FG007|Phase 1|Adverse Event|0|||
47071224|NCT00086281|83358192|FG008|Phase 1|Adverse Event|0|||
47071225|NCT00086281|83358193|FG009|Phase 1|Adverse Event|1|||
47071226|NCT00086281|83358194|FG010|Phase 1|Adverse Event|2|||
47071227|NCT00086281|83358195|FG011|Phase 1|Adverse Event|1|||
47071228|NCT00086281|83358196|FG012|Phase 1|Adverse Event|1|||
47071229|NCT00086281|83358197|FG013|Phase 1|Adverse Event|1|||
47071230|NCT00086281|83358198|FG014|Phase 1|Adverse Event|2|||
47071231|NCT00086281|83358184|FG000|Phase 1|Protocol Violation|0|||
47071232|NCT00086281|83358185|FG001|Phase 1|Protocol Violation|0|||
47071233|NCT00086281|83358186|FG002|Phase 1|Protocol Violation|0|||
47071234|NCT00086281|83358187|FG003|Phase 1|Protocol Violation|0|||
47071235|NCT00086281|83358188|FG004|Phase 1|Protocol Violation|0|||
47071236|NCT00086281|83358189|FG005|Phase 1|Protocol Violation|0|||
47071237|NCT00086281|83358190|FG006|Phase 1|Protocol Violation|0|||
47071238|NCT00086281|83358191|FG007|Phase 1|Protocol Violation|0|||
47071239|NCT00086281|83358192|FG008|Phase 1|Protocol Violation|0|||
47071240|NCT00086281|83358193|FG009|Phase 1|Protocol Violation|0|||
47071241|NCT00086281|83358194|FG010|Phase 1|Protocol Violation|1|||
47071242|NCT00086281|83358195|FG011|Phase 1|Protocol Violation|0|||
47071243|NCT00086281|83358196|FG012|Phase 1|Protocol Violation|0|||
47071244|NCT00086281|83358197|FG013|Phase 1|Protocol Violation|0|||
47071245|NCT00086281|83358198|FG014|Phase 1|Protocol Violation|0|||
47071246|NCT00086281|83358184|FG000|Phase 1|Serious Adverse Event|0|||
47071247|NCT00086281|83358185|FG001|Phase 1|Serious Adverse Event|0|||
47071248|NCT00086281|83358186|FG002|Phase 1|Serious Adverse Event|0|||
47071249|NCT00086281|83358187|FG003|Phase 1|Serious Adverse Event|0|||
47071250|NCT00086281|83358188|FG004|Phase 1|Serious Adverse Event|0|||
47071251|NCT00086281|83358189|FG005|Phase 1|Serious Adverse Event|0|||
47071252|NCT00086281|83358190|FG006|Phase 1|Serious Adverse Event|0|||
47071253|NCT00086281|83358191|FG007|Phase 1|Serious Adverse Event|0|||
47071254|NCT00086281|83358192|FG008|Phase 1|Serious Adverse Event|0|||
47071255|NCT00086281|83358193|FG009|Phase 1|Serious Adverse Event|0|||
47071256|NCT00086281|83358194|FG010|Phase 1|Serious Adverse Event|0|||
47071257|NCT00086281|83358195|FG011|Phase 1|Serious Adverse Event|0|||
47071258|NCT00086281|83358196|FG012|Phase 1|Serious Adverse Event|0|||
47071259|NCT00086281|83358197|FG013|Phase 1|Serious Adverse Event|0|||
47071260|NCT00086281|83358198|FG014|Phase 1|Serious Adverse Event|1|||
47071261|NCT00086281|83358184|FG000|Phase 2|Adverse Event|0|||
47071262|NCT00086281|83358185|FG001|Phase 2|Adverse Event|0|||
47071263|NCT00086281|83358186|FG002|Phase 2|Adverse Event|0|||
47071264|NCT00086281|83358187|FG003|Phase 2|Adverse Event|0|||
47071265|NCT00086281|83358188|FG004|Phase 2|Adverse Event|0|||
47071266|NCT00086281|83358189|FG005|Phase 2|Adverse Event|0|||
47071267|NCT00086281|83358190|FG006|Phase 2|Adverse Event|0|||
47071268|NCT00086281|83358191|FG007|Phase 2|Adverse Event|0|||
47071269|NCT00086281|83358192|FG008|Phase 2|Adverse Event|0|||
47071270|NCT00086281|83358193|FG009|Phase 2|Adverse Event|0|||
47071271|NCT00086281|83358194|FG010|Phase 2|Adverse Event|0|||
47071272|NCT00086281|83358195|FG011|Phase 2|Adverse Event|0|||
47071273|NCT00086281|83358196|FG012|Phase 2|Adverse Event|1|||
47071274|NCT00086281|83358197|FG013|Phase 2|Adverse Event|1|||
47071275|NCT00086281|83358198|FG014|Phase 2|Adverse Event|0|||
47071276|NCT00086047|83358210|FG000|Overall Study|Lost to Follow-up|7|||
47071277|NCT00086047|83358211|FG001|Overall Study|Lost to Follow-up|6|||
47071278|NCT00086047|83358210|FG000|Overall Study|Physician Decision|0|||
47071279|NCT00086047|83358211|FG001|Overall Study|Physician Decision|1|||
47071280|NCT01478828|83358223|FG000|Overall Study|Adverse Event|1|||
47071281|NCT00085423|83358228|FG000|Overall Study|Withdrawal by Subject|1|||
47071282|NCT00085423|83358228|FG000|Overall Study|screen failure|1|||
47071283|NCT00084487|83358232|FG000|Overall Study|Death|1|||
47071284|NCT01425281|83358272|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
47071285|NCT01425281|83358273|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
47071286|NCT01425281|83358272|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
47071287|NCT01425281|83358273|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
46967324|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
47071288|NCT01425281|83358272|FG000|At 180-day Clinical Follow-up|Death|0|||
47071289|NCT01425281|83358273|FG001|At 180-day Clinical Follow-up|Death|1|||
47071290|NCT01425281|83358272|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
47071291|NCT01425281|83358273|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
47071292|NCT01425281|83358272|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
47071293|NCT01425281|83358273|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
47071294|NCT01425281|83358272|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
47071295|NCT01425281|83358273|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
47071296|NCT01425281|83358272|FG000|At 2-year Clinical Follow-up|Death|2|||
47071297|NCT01425281|83358273|FG001|At 2-year Clinical Follow-up|Death|0|||
47071298|NCT01425281|83358272|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
47071299|NCT01425281|83358273|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
47071300|NCT01425281|83358272|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
47071301|NCT01425281|83358273|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
47071302|NCT01425281|83358272|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
47071303|NCT01425281|83358273|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
47071304|NCT01425281|83358272|FG000|At 3-year Clinical Follow-up|Death|2|||
47071305|NCT01425281|83358273|FG001|At 3-year Clinical Follow-up|Death|3|||
47071306|NCT01425281|83358272|FG000|At 4-year Clinical Follow-up|Death|7|||
47071307|NCT01425281|83358273|FG001|At 4-year Clinical Follow-up|Death|3|||
47071308|NCT01425281|83358272|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
47071309|NCT01425281|83358273|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
47071310|NCT01425281|83358272|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
47071311|NCT01425281|83358273|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
47071312|NCT01425281|83358272|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
47071313|NCT01425281|83358273|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
47071314|NCT01425281|83358272|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
47071315|NCT01425281|83358273|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
47071316|NCT01425281|83358272|FG000|At 5-year Clinical Follow-up|Death|2|||
47071317|NCT01425281|83358273|FG001|At 5-year Clinical Follow-up|Death|0|||
47071318|NCT01425281|83358272|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
47071319|NCT01425281|83358273|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
47071320|NCT01425281|83358272|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
47071321|NCT01425281|83358273|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
47071322|NCT01425281|83358272|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
47071323|NCT01425281|83358273|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
47071324|NCT02648724|83358301|FG000|Overall Study|Withdrawal by Subject|0|||
47071325|NCT02648724|83358302|FG001|Overall Study|Withdrawal by Subject|1|||
47071326|NCT02648724|83358303|FG002|Overall Study|Withdrawal by Subject|1|||
47071327|NCT02648724|83358304|FG003|Overall Study|Withdrawal by Subject|0|||
47071328|NCT02648724|83358305|FG004|Overall Study|Withdrawal by Subject|1|||
47071329|NCT02648724|83358306|FG005|Overall Study|Withdrawal by Subject|0|||
47071330|NCT02648724|83358307|FG006|Overall Study|Withdrawal by Subject|0|||
47071331|NCT02648724|83358301|FG000|Overall Study|Progressive disease|2|||
47071332|NCT02648724|83358302|FG001|Overall Study|Progressive disease|2|||
47071333|NCT02648724|83358303|FG002|Overall Study|Progressive disease|2|||
47071334|NCT02648724|83358304|FG003|Overall Study|Progressive disease|3|||
47071335|NCT02648724|83358305|FG004|Overall Study|Progressive disease|22|||
47071336|NCT02648724|83358306|FG005|Overall Study|Progressive disease|7|||
47071337|NCT02648724|83358307|FG006|Overall Study|Progressive disease|8|||
47071338|NCT02648724|83358301|FG000|Overall Study|Other reason (unknown)|1|||
47071339|NCT02648724|83358302|FG001|Overall Study|Other reason (unknown)|0|||
47071340|NCT02648724|83358303|FG002|Overall Study|Other reason (unknown)|0|||
47071341|NCT02648724|83358304|FG003|Overall Study|Other reason (unknown)|0|||
47071342|NCT02648724|83358305|FG004|Overall Study|Other reason (unknown)|0|||
47071343|NCT02648724|83358306|FG005|Overall Study|Other reason (unknown)|0|||
47071344|NCT02648724|83358307|FG006|Overall Study|Other reason (unknown)|0|||
47071345|NCT02648724|83358301|FG000|Overall Study|Protocol Violation|0|||
47071346|NCT02648724|83358302|FG001|Overall Study|Protocol Violation|0|||
47071347|NCT02648724|83358303|FG002|Overall Study|Protocol Violation|0|||
47071348|NCT02648724|83358304|FG003|Overall Study|Protocol Violation|0|||
47071349|NCT02648724|83358305|FG004|Overall Study|Protocol Violation|1|||
47071350|NCT02648724|83358306|FG005|Overall Study|Protocol Violation|0|||
47071351|NCT02648724|83358307|FG006|Overall Study|Protocol Violation|0|||
47071352|NCT02648724|83358301|FG000|Overall Study|Death|0|||
47071353|NCT02648724|83358302|FG001|Overall Study|Death|0|||
47071354|NCT02648724|83358303|FG002|Overall Study|Death|0|||
47071355|NCT02648724|83358304|FG003|Overall Study|Death|0|||
47071356|NCT02648724|83358305|FG004|Overall Study|Death|0|||
47071357|NCT02648724|83358306|FG005|Overall Study|Death|0|||
47071358|NCT02648724|83358307|FG006|Overall Study|Death|3|||
47071359|NCT02648724|83358301|FG000|Overall Study|Physician Decision|0|||
47071360|NCT02648724|83358302|FG001|Overall Study|Physician Decision|0|||
47071361|NCT02648724|83358303|FG002|Overall Study|Physician Decision|0|||
47071362|NCT02648724|83358304|FG003|Overall Study|Physician Decision|0|||
47071363|NCT02648724|83358305|FG004|Overall Study|Physician Decision|1|||
47071364|NCT02648724|83358306|FG005|Overall Study|Physician Decision|0|||
46775411|NCT00731120|82993806|FG001|Overall Study|Withdrawal of Consent|8|||
46775412|NCT00731120|82993807|FG002|Overall Study|Withdrawal of Consent|4|||
46775413|NCT00731120|82993805|FG000|Overall Study|Lost to Follow-up|10|||
47071365|NCT02648724|83358307|FG006|Overall Study|Physician Decision|1|||
47071366|NCT02648724|83358301|FG000|Overall Study|Transferred to named patient program|0|||
47071367|NCT02648724|83358302|FG001|Overall Study|Transferred to named patient program|0|||
47071368|NCT02648724|83358303|FG002|Overall Study|Transferred to named patient program|0|||
47071369|NCT02648724|83358304|FG003|Overall Study|Transferred to named patient program|0|||
47071370|NCT02648724|83358305|FG004|Overall Study|Transferred to named patient program|0|||
47071371|NCT02648724|83358306|FG005|Overall Study|Transferred to named patient program|1|||
47071372|NCT02648724|83358307|FG006|Overall Study|Transferred to named patient program|0|||
47071373|NCT01402817|83358339|FG000|Overall Study|Withdrawal by Subject|3|||
47071374|NCT01402817|83358339|FG000|Overall Study|Study Suspended by FDA|8|||
47071375|NCT01425203|83358346|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
47071376|NCT01425203|83358347|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
47071377|NCT01425203|83358348|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
47071378|NCT01425203|83358346|FG000|Treatment Phase|Failure at futility timepoint|8|||
46967325|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
46967326|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
46967327|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
46967328|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
46967329|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
46967330|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
46967331|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
47071379|NCT01425203|83358347|FG001|Treatment Phase|Failure at futility timepoint|27|||
47071380|NCT01425203|83358348|FG002|Treatment Phase|Failure at futility timepoint|0|||
47071381|NCT01425203|83358346|FG000|Treatment Phase|Other virologic failure criteria|5|||
47071382|NCT01425203|83358347|FG001|Treatment Phase|Other virologic failure criteria|3|||
47071383|NCT01425203|83358348|FG002|Treatment Phase|Other virologic failure criteria|0|||
47071384|NCT01425203|83358346|FG000|Treatment Phase|Unidentified reasons|11|||
47071385|NCT01425203|83358347|FG001|Treatment Phase|Unidentified reasons|5|||
47071386|NCT01425203|83358348|FG002|Treatment Phase|Unidentified reasons|0|||
47071387|NCT01425203|83358346|FG000|Treatment Phase|Did not receive treatment|0|||
47071388|NCT01425203|83358347|FG001|Treatment Phase|Did not receive treatment|1|||
47071389|NCT01425203|83358348|FG002|Treatment Phase|Did not receive treatment|0|||
47071390|NCT01425203|83358346|FG000|Crossover Phase|Failure at futility timepoint|0|||
47071391|NCT01425203|83358347|FG001|Crossover Phase|Failure at futility timepoint|0|||
47071392|NCT01425203|83358348|FG002|Crossover Phase|Failure at futility timepoint|3|||
47071393|NCT01425203|83358346|FG000|Crossover Phase|Other virologic failure criteria|0|||
47071394|NCT01425203|83358347|FG001|Crossover Phase|Other virologic failure criteria|0|||
47071395|NCT01425203|83358348|FG002|Crossover Phase|Other virologic failure criteria|3|||
47071396|NCT00081289|83358358|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
47071397|NCT00081289|83358359|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
47071398|NCT00081289|83358358|FG000|Overall Study|Ineligible / no protocol treatment|3|||
47071399|NCT00081289|83358359|FG001|Overall Study|Ineligible / no protocol treatment|4|||
47071400|NCT01478594|83358368|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
47071401|NCT01478594|83358369|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
47071402|NCT01478594|83358368|FG000|Overall Study|Death|45|||
47071403|NCT01478594|83358369|FG001|Overall Study|Death|18|||
47071404|NCT01478594|83358368|FG000|Overall Study|Lost to Follow-up|3|||
47071405|NCT01478594|83358369|FG001|Overall Study|Lost to Follow-up|1|||
47071406|NCT01478594|83358368|FG000|Overall Study|Withdrawal by Subject|9|||
47071407|NCT01478594|83358369|FG001|Overall Study|Withdrawal by Subject|3|||
47071408|NCT01478594|83358368|FG000|Overall Study|Study Closed by Sponsor|8|||
47071409|NCT01478594|83358369|FG001|Overall Study|Study Closed by Sponsor|5|||
47071410|NCT01424813|83358430|FG000|Overall Study|Withdrawal by Subject|3|||
47071411|NCT01424813|83358431|FG001|Overall Study|Withdrawal by Subject|0|||
47071412|NCT01424813|83358430|FG000|Overall Study|Protocol Violation|1|||
47071413|NCT01424813|83358431|FG001|Overall Study|Protocol Violation|0|||
47071414|NCT01424813|83358430|FG000|Overall Study|Other|1|||
47071415|NCT01424813|83358431|FG001|Overall Study|Other|2|||
47071416|NCT00080899|83358437|FG000|Overall Study|Adverse Event|1|||
47071417|NCT00089635|83358441|FG000|Overall Study|Adverse Event|2|||
47071418|NCT00089635|83358441|FG000|Overall Study|Death|17|||
47071419|NCT00089635|83358441|FG000|Overall Study|Disease Progression|12|||
47071420|NCT00089635|83358441|FG000|Overall Study|Lost to Follow-up|3|||
47071421|NCT00089635|83358441|FG000|Overall Study|Withdrawal by Subject|6|||
47071422|NCT00089635|83358441|FG000|Overall Study|Ineligibility determined|1|||
47071423|NCT00089635|83358441|FG000|Overall Study|Other|2|||
47071424|NCT01500200|83358455|FG000|Stage 1|Adverse Event|1|||
47071425|NCT01500200|83358456|FG001|Stage 1|Adverse Event|4|||
46775414|NCT00731120|82993806|FG001|Overall Study|Lost to Follow-up|15|||
46775415|NCT00731120|82993807|FG002|Overall Study|Lost to Follow-up|17|||
46775416|NCT00731120|82993805|FG000|Overall Study|Other|4|||
47071426|NCT01500200|83358457|FG002|Stage 1|Adverse Event|5|||
47071427|NCT01500200|83358458|FG003|Stage 1|Adverse Event|0|||
47071428|NCT01500200|83358459|FG004|Stage 1|Adverse Event|0|||
47071429|NCT01500200|83358460|FG005|Stage 1|Adverse Event|0|||
47071430|NCT01500200|83358455|FG000|Stage 1|Lost to Follow-up|2|||
47071431|NCT01500200|83358456|FG001|Stage 1|Lost to Follow-up|2|||
46775417|NCT00731120|82993806|FG001|Overall Study|Other|0|||
47071432|NCT01500200|83358457|FG002|Stage 1|Lost to Follow-up|1|||
47071433|NCT01500200|83358458|FG003|Stage 1|Lost to Follow-up|0|||
47071434|NCT01500200|83358459|FG004|Stage 1|Lost to Follow-up|0|||
47071435|NCT01500200|83358460|FG005|Stage 1|Lost to Follow-up|0|||
46641139|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
46775418|NCT00731120|82993807|FG002|Overall Study|Other|1|||
47071436|NCT01500200|83358455|FG000|Stage 1|Withdrawal by Subject|3|||
47071437|NCT01500200|83358456|FG001|Stage 1|Withdrawal by Subject|0|||
47071438|NCT01500200|83358457|FG002|Stage 1|Withdrawal by Subject|0|||
47071439|NCT01500200|83358458|FG003|Stage 1|Withdrawal by Subject|0|||
47071440|NCT01500200|83358459|FG004|Stage 1|Withdrawal by Subject|0|||
47071441|NCT01500200|83358460|FG005|Stage 1|Withdrawal by Subject|0|||
47071442|NCT01500200|83358455|FG000|Stage 1|Noncompliance with Study Drug|1|||
47071443|NCT01500200|83358456|FG001|Stage 1|Noncompliance with Study Drug|0|||
47071444|NCT01500200|83358457|FG002|Stage 1|Noncompliance with Study Drug|0|||
47071445|NCT01500200|83358458|FG003|Stage 1|Noncompliance with Study Drug|0|||
47071446|NCT01500200|83358459|FG004|Stage 1|Noncompliance with Study Drug|0|||
47071447|NCT01500200|83358460|FG005|Stage 1|Noncompliance with Study Drug|0|||
47071448|NCT01500200|83358455|FG000|Stage 1|Physician Decision|1|||
47071449|NCT01500200|83358456|FG001|Stage 1|Physician Decision|0|||
47071450|NCT01500200|83358457|FG002|Stage 1|Physician Decision|0|||
47071451|NCT01500200|83358458|FG003|Stage 1|Physician Decision|0|||
47071452|NCT01500200|83358459|FG004|Stage 1|Physician Decision|0|||
47071453|NCT01500200|83358460|FG005|Stage 1|Physician Decision|0|||
47071454|NCT01500200|83358455|FG000|Stage 2|Adverse Event|0|||
47071455|NCT01500200|83358456|FG001|Stage 2|Adverse Event|0|||
47071456|NCT01500200|83358457|FG002|Stage 2|Adverse Event|0|||
47071457|NCT01500200|83358458|FG003|Stage 2|Adverse Event|0|||
47071458|NCT01500200|83358459|FG004|Stage 2|Adverse Event|5|||
47071459|NCT01500200|83358460|FG005|Stage 2|Adverse Event|4|||
47071460|NCT01478360|83358476|FG000|Overall Study|Lost to Follow-up|1|||
47071461|NCT01478360|83358477|FG001|Overall Study|Lost to Follow-up|0|||
47071462|NCT01478360|83358476|FG000|Overall Study|Adverse Event|0|||
47071463|NCT01478360|83358477|FG001|Overall Study|Adverse Event|1|||
47071464|NCT01478360|83358476|FG000|Overall Study|Administrative problems|1|||
47071465|NCT01478360|83358477|FG001|Overall Study|Administrative problems|2|||
47071466|NCT01461980|83358495|FG000|Overall Study|Other|9|||
47071467|NCT01461980|83358496|FG001|Overall Study|Other|8|||
47071468|NCT01461980|83358497|FG002|Overall Study|Other|6|||
47071469|NCT01461980|83358495|FG000|Overall Study|Medication error|7|||
47071470|NCT01461980|83358496|FG001|Overall Study|Medication error|5|||
47071471|NCT01461980|83358497|FG002|Overall Study|Medication error|6|||
47071472|NCT01461980|83358495|FG000|Overall Study|Adverse Event|12|||
47071473|NCT01461980|83358496|FG001|Overall Study|Adverse Event|5|||
47071474|NCT01461980|83358497|FG002|Overall Study|Adverse Event|6|||
47071475|NCT01461980|83358495|FG000|Overall Study|Protocol Violation|12|||
47071476|NCT01461980|83358496|FG001|Overall Study|Protocol Violation|19|||
47071477|NCT01461980|83358497|FG002|Overall Study|Protocol Violation|16|||
47071478|NCT01461980|83358495|FG000|Overall Study|No longer meets eligibility criteria|18|||
47071479|NCT01461980|83358496|FG001|Overall Study|No longer meets eligibility criteria|9|||
47071480|NCT01461980|83358497|FG002|Overall Study|No longer meets eligibility criteria|19|||
47071481|NCT01461980|83358495|FG000|Overall Study|Lost to Follow-up|52|||
47071482|NCT01461980|83358496|FG001|Overall Study|Lost to Follow-up|53|||
47071483|NCT01461980|83358497|FG002|Overall Study|Lost to Follow-up|51|||
47071484|NCT01461980|83358495|FG000|Overall Study|No longer willing to participate|52|||
47071485|NCT01461980|83358496|FG001|Overall Study|No longer willing to participate|38|||
47071486|NCT01461980|83358497|FG002|Overall Study|No longer willing to participate|54|||
47071487|NCT01461980|83358495|FG000|Overall Study|Randomized but not vaccinated|4|||
47071488|NCT01461980|83358496|FG001|Overall Study|Randomized but not vaccinated|8|||
47071489|NCT01461980|83358497|FG002|Overall Study|Randomized but not vaccinated|7|||
47071490|NCT01424501|83358512|FG000|Overall Study|Withdrawal by Subject|1|||
47071491|NCT01424501|83358513|FG001|Overall Study|Withdrawal by Subject|0|||
47071492|NCT01424501|83358514|FG002|Overall Study|Withdrawal by Subject|1|||
47071493|NCT01424501|83358515|FG003|Overall Study|Withdrawal by Subject|0|||
47071494|NCT01424501|83358516|FG004|Overall Study|Withdrawal by Subject|0|||
47071495|NCT01424501|83358517|FG005|Overall Study|Withdrawal by Subject|0|||
47071496|NCT01424501|83358512|FG000|Overall Study|Lost to Follow-up|0|||
47071497|NCT01424501|83358513|FG001|Overall Study|Lost to Follow-up|1|||
47071498|NCT01424501|83358514|FG002|Overall Study|Lost to Follow-up|1|||
47071499|NCT01424501|83358515|FG003|Overall Study|Lost to Follow-up|0|||
47071500|NCT01424501|83358516|FG004|Overall Study|Lost to Follow-up|0|||
46775419|NCT00731042|82993817|FG000|Second Intervention|Did not meet inclusion criteria|0|||
46846357|NCT00130208|83063084|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
47071501|NCT01424501|83358517|FG005|Overall Study|Lost to Follow-up|0|||
47071502|NCT01401959|83358598|FG000|Enrolled|Withdrawal by Subject|1|||
47071503|NCT01401959|83358599|FG001|Enrolled|Withdrawal by Subject|0|||
47071504|NCT01401959|83358600|FG002|Enrolled|Withdrawal by Subject|0|||
47071505|NCT01401959|83358598|FG000|Treated|Disease Progression|2|||
47071506|NCT01401959|83358599|FG001|Treated|Disease Progression|2|||
47071507|NCT01401959|83358600|FG002|Treated|Disease Progression|1|||
47071508|NCT01401959|83358598|FG000|Treated|Adverse Event|4|||
47071509|NCT01401959|83358599|FG001|Treated|Adverse Event|3|||
47071510|NCT01401959|83358600|FG002|Treated|Adverse Event|2|||
47071511|NCT01401959|83358598|FG000|Treated|Withdrawal by Subject|1|||
47071512|NCT01401959|83358599|FG001|Treated|Withdrawal by Subject|2|||
47071513|NCT01401959|83358600|FG002|Treated|Withdrawal by Subject|2|||
47071514|NCT01401959|83358598|FG000|Treated|Protocol Violation|0|||
47071515|NCT01401959|83358599|FG001|Treated|Protocol Violation|1|||
47071516|NCT01401959|83358600|FG002|Treated|Protocol Violation|0|||
47071517|NCT01478048|83358630|FG000|Overall Study|Disease Progression|52|||
47071518|NCT01478048|83358631|FG001|Overall Study|Disease Progression|35|||
47071519|NCT01478048|83358630|FG000|Overall Study|study drug toxicity|11|||
47071520|NCT01478048|83358631|FG001|Overall Study|study drug toxicity|14|||
47071521|NCT01478048|83358630|FG000|Overall Study|Adverse Event|2|||
47071522|NCT01478048|83358631|FG001|Overall Study|Adverse Event|11|||
47071523|NCT01478048|83358630|FG000|Overall Study|subject request to discontinue treatment|3|||
47071524|NCT01478048|83358631|FG001|Overall Study|subject request to discontinue treatment|5|||
47071525|NCT01478048|83358630|FG000|Overall Study|Withdrawal by Subject|2|||
47071526|NCT01478048|83358631|FG001|Overall Study|Withdrawal by Subject|5|||
47071527|NCT01478048|83358630|FG000|Overall Study|non-specified|6|||
47071528|NCT01478048|83358631|FG001|Overall Study|non-specified|4|||
47071529|NCT01478048|83358630|FG000|Overall Study|poor/non-compliance|0|||
47071530|NCT01478048|83358631|FG001|Overall Study|poor/non-compliance|1|||
47071531|NCT01478048|83358630|FG000|Overall Study|no longer meets study criteria|1|||
47071532|NCT01478048|83358631|FG001|Overall Study|no longer meets study criteria|0|||
47071533|NCT01424189|83358639|FG000|Overall Study|Adverse Event|1|||
47071534|NCT01424189|83358640|FG001|Overall Study|Adverse Event|0|||
47071535|NCT01424189|83358639|FG000|Overall Study|Lost to Follow-up|4|||
47071536|NCT01424189|83358640|FG001|Overall Study|Lost to Follow-up|1|||
47071537|NCT01424189|83358639|FG000|Overall Study|Withdrawal by Subject|4|||
47071538|NCT01424189|83358640|FG001|Overall Study|Withdrawal by Subject|4|||
47071539|NCT01424189|83358639|FG000|Overall Study|Subject moved|1|||
47071540|NCT01424189|83358640|FG001|Overall Study|Subject moved|0|||
47071541|NCT01424189|83358639|FG000|Overall Study|Death|3|||
47071542|NCT01424189|83358640|FG001|Overall Study|Death|1|||
47071543|NCT01401647|83358653|FG000|Overall Study|Withdrawal by Subject|1|||
47071544|NCT01401647|83358654|FG001|Overall Study|Withdrawal by Subject|5|||
47071545|NCT01401647|83358655|FG002|Overall Study|Withdrawal by Subject|2|||
47071546|NCT01401647|83358653|FG000|Overall Study|Lost to Follow-up|3|||
47071547|NCT01401647|83358654|FG001|Overall Study|Lost to Follow-up|3|||
47071548|NCT01401647|83358655|FG002|Overall Study|Lost to Follow-up|1|||
47071549|NCT01499810|83358663|FG000|Overall Study|Lost to Follow-up|10|||
47071550|NCT01499810|83358663|FG000|Overall Study|Protocol Violation|1|||
47071551|NCT01499810|83358663|FG000|Overall Study|Withdrawal by Subject|1|||
47071552|NCT01423253|83358668|FG000|Overall Study|Adverse Event|2|||
47071553|NCT01423253|83358668|FG000|Overall Study|Lack of Efficacy|2|||
47071554|NCT01423253|83358668|FG000|Overall Study|Lost to Follow-up|1|||
47071555|NCT01423253|83358668|FG000|Overall Study|Protocol Violation|2|||
47071556|NCT01423253|83358668|FG000|Overall Study|Withdrawal by Subject|2|||
47071557|NCT01477892|83358674|FG000|Overall Study|Withdrawal by Subject|0|||
47071558|NCT01477892|83358675|FG001|Overall Study|Withdrawal by Subject|2|||
47071559|NCT01422239|83358688|FG000|Overall Study|Lost to Follow-up|4|||
47071560|NCT01422239|83358689|FG001|Overall Study|Lost to Follow-up|3|||
47071561|NCT01499576|83358695|FG000|Overall Study|Physician Decision|12|||
47071562|NCT01499576|83358695|FG000|Overall Study|Withdrawal by Subject|9|||
47071563|NCT01476722|83358709|FG000|Overall Study|Adverse Event|1|||
46775420|NCT00731042|82993818|FG001|Second Intervention|Did not meet inclusion criteria|2|||
46775421|NCT00726986|82993824|FG000|Induction Phase|Adverse Event|4|||
46775422|NCT00726986|82993824|FG000|Induction Phase|Withdrawal by Subject|2|||
46775423|NCT00726986|82993824|FG000|Induction Phase|Death|2|||
46775424|NCT00726986|82993824|FG000|Induction Phase|Lack of Efficacy|5|||
47071564|NCT01476644|83358722|FG000|Overall Study|Death|5|||
47071565|NCT01476644|83358722|FG000|Overall Study|moved to another state|2|||
47071566|NCT01476644|83358722|FG000|Overall Study|Lost to Follow-up|19|||
47071567|NCT01476644|83358722|FG000|Overall Study|Withdrawal by Subject|13|||
47071568|NCT01421459|83358746|FG000|Overall Study|Adverse Event|6|||
47071569|NCT01421459|83358747|FG001|Overall Study|Adverse Event|10|||
47071570|NCT01421459|83358746|FG000|Overall Study|Death|1|||
47071571|NCT01421459|83358747|FG001|Overall Study|Death|1|||
47071572|NCT01421459|83358746|FG000|Overall Study|Lack of Efficacy|1|||
47071573|NCT01421459|83358747|FG001|Overall Study|Lack of Efficacy|2|||
46641140|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
47071574|NCT01421459|83358746|FG000|Overall Study|Lost to Follow-up|8|||
47071575|NCT01421459|83358747|FG001|Overall Study|Lost to Follow-up|9|||
47071576|NCT01421459|83358746|FG000|Overall Study|Physician Decision|9|||
47071577|NCT01421459|83358747|FG001|Overall Study|Physician Decision|9|||
46641141|NCT01715285|82820443|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
46641142|NCT01715285|82820444|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
46775425|NCT00726986|82993824|FG000|Induction Phase|Secondary Disease|2|||
46775426|NCT00726986|82993824|FG000|Maintenance Phase|Adverse Event|1|||
47071578|NCT01421459|83358746|FG000|Overall Study|Protocol Violation|8|||
47071579|NCT01421459|83358747|FG001|Overall Study|Protocol Violation|5|||
47071580|NCT01421459|83358746|FG000|Overall Study|Withdrawal by Subject|12|||
47071581|NCT01421459|83358747|FG001|Overall Study|Withdrawal by Subject|16|||
47071582|NCT01498952|83358755|FG000|Overall Study|Death|2|||
47071583|NCT01498952|83358756|FG001|Overall Study|Death|2|||
47071584|NCT01498952|83358757|FG002|Overall Study|Death|0|||
47071585|NCT01498952|83358758|FG003|Overall Study|Death|0|||
47071586|NCT01498952|83358759|FG004|Overall Study|Death|0|||
47071587|NCT01461044|83358791|FG000|Overall Study|Death|58|||
47071588|NCT01461044|83358792|FG001|Overall Study|Death|35|||
47071589|NCT01461044|83358791|FG000|Overall Study|Lost to Follow-up|12|||
47071590|NCT01461044|83358792|FG001|Overall Study|Lost to Follow-up|5|||
47071591|NCT01421303|83358825|FG000|Overall Study|Lost to Follow-up|13|||
47071592|NCT01421303|83358825|FG000|Overall Study|Non compliance with study procedure|1|||
47071593|NCT01421303|83358825|FG000|Overall Study|Other|7|||
47071594|NCT01421303|83358825|FG000|Overall Study|Withdrawal by Subject|1|||
47071595|NCT01475474|83358829|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
47071596|NCT01475474|83358829|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
47071597|NCT01400243|83358836|FG000|Overall Study|Protocol Violation|8|||
47071598|NCT01400243|83358837|FG001|Overall Study|Protocol Violation|11|||
47071599|NCT01475162|83358854|FG000|Overall Study|Physician Decision|1|||
47071600|NCT01475162|83358854|FG000|Overall Study|Death|10|||
47071601|NCT01475162|83358854|FG000|Overall Study|Study closed for safety|3|||
47071602|NCT01421225|83358861|FG000|Overall Study|Withdrawal by Subject|0|||
47071603|NCT01421225|83358862|FG001|Overall Study|Withdrawal by Subject|1|||
47071604|NCT01498640|83358878|FG000|Overall Study|Lost to Follow-up|1|||
47071605|NCT01498640|83358878|FG000|Overall Study|Death|1|||
47071606|NCT01498640|83358878|FG000|Overall Study|Other|3|||
47071607|NCT01498484|83358890|FG000|Overall Study|Death|6|||
47071608|NCT01498484|83358891|FG001|Overall Study|Death|3|||
47071609|NCT01498484|83358892|FG002|Overall Study|Death|1|||
47071610|NCT01498484|83358893|FG003|Overall Study|Death|1|||
47071611|NCT01498484|83358894|FG004|Overall Study|Death|0|||
47071612|NCT01498484|83358895|FG005|Overall Study|Death|0|||
47071613|NCT01498484|83358896|FG006|Overall Study|Death|10|||
47071614|NCT01498484|83358897|FG007|Overall Study|Death|1|||
47071615|NCT01498484|83358898|FG008|Overall Study|Death|0|||
47071616|NCT01498484|83358890|FG000|Overall Study|Physician Decision|3|||
47071617|NCT01498484|83358891|FG001|Overall Study|Physician Decision|2|||
47071618|NCT01498484|83358892|FG002|Overall Study|Physician Decision|1|||
47071619|NCT01498484|83358893|FG003|Overall Study|Physician Decision|1|||
47071620|NCT01498484|83358894|FG004|Overall Study|Physician Decision|0|||
47071621|NCT01498484|83358895|FG005|Overall Study|Physician Decision|0|||
47071622|NCT01498484|83358896|FG006|Overall Study|Physician Decision|8|||
47071623|NCT01498484|83358897|FG007|Overall Study|Physician Decision|13|||
47071624|NCT01498484|83358898|FG008|Overall Study|Physician Decision|1|||
47071625|NCT01498484|83358890|FG000|Overall Study|Adverse Event|0|||
47071626|NCT01498484|83358891|FG001|Overall Study|Adverse Event|0|||
47071627|NCT01498484|83358892|FG002|Overall Study|Adverse Event|0|||
47071628|NCT01498484|83358893|FG003|Overall Study|Adverse Event|0|||
47071629|NCT01498484|83358894|FG004|Overall Study|Adverse Event|0|||
47071630|NCT01498484|83358895|FG005|Overall Study|Adverse Event|1|||
47071631|NCT01498484|83358896|FG006|Overall Study|Adverse Event|0|||
47071632|NCT01498484|83358897|FG007|Overall Study|Adverse Event|0|||
47071633|NCT01498484|83358898|FG008|Overall Study|Adverse Event|0|||
46967332|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
47071634|NCT01498484|83358890|FG000|Overall Study|Withdrawal by Subject|0|||
47071635|NCT01498484|83358891|FG001|Overall Study|Withdrawal by Subject|0|||
47071636|NCT01498484|83358892|FG002|Overall Study|Withdrawal by Subject|0|||
47071637|NCT01498484|83358893|FG003|Overall Study|Withdrawal by Subject|1|||
47071638|NCT01498484|83358894|FG004|Overall Study|Withdrawal by Subject|0|||
47071639|NCT01498484|83358895|FG005|Overall Study|Withdrawal by Subject|0|||
47071640|NCT01498484|83358896|FG006|Overall Study|Withdrawal by Subject|1|||
47071641|NCT01498484|83358897|FG007|Overall Study|Withdrawal by Subject|0|||
47071642|NCT01498484|83358898|FG008|Overall Study|Withdrawal by Subject|0|||
46967333|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
47071643|NCT01498484|83358890|FG000|Overall Study|Other|5|||
47071644|NCT01498484|83358891|FG001|Overall Study|Other|2|||
47071645|NCT01498484|83358892|FG002|Overall Study|Other|0|||
47071646|NCT01498484|83358893|FG003|Overall Study|Other|0|||
47071647|NCT01498484|83358894|FG004|Overall Study|Other|1|||
47071648|NCT01498484|83358895|FG005|Overall Study|Other|0|||
47071649|NCT01498484|83358896|FG006|Overall Study|Other|3|||
47071650|NCT01498484|83358897|FG007|Overall Study|Other|0|||
47071651|NCT01498484|83358898|FG008|Overall Study|Other|1|||
46775427|NCT00726986|82993824|FG000|Maintenance Phase|Lack of Efficacy|2|||
46775428|NCT00696657|82993837|FG000|Overall Study|Protocol Violation|0|||
47071652|NCT01474772|83358907|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
47071653|NCT01474772|83358908|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
47071654|NCT01474772|83358907|FG000|Period 1|AE not Related to Study Drug|1|||
47071655|NCT01474772|83358908|FG001|Period 1|AE not Related to Study Drug|0|||
47071656|NCT01474772|83358907|FG000|Period 1|Withdrawal by Subject|3|||
47071657|NCT01474772|83358908|FG001|Period 1|Withdrawal by Subject|1|||
47071658|NCT01474772|83358907|FG000|Period 1|Lost to Follow-up|1|||
47071659|NCT01474772|83358908|FG001|Period 1|Lost to Follow-up|0|||
47071660|NCT01474772|83358907|FG000|Period 1|Reason not Specified|1|||
47071661|NCT01474772|83358908|FG001|Period 1|Reason not Specified|1|||
47071662|NCT01474772|83358907|FG000|Washout|AE not Related to Study Drug|2|||
47071663|NCT01474772|83358908|FG001|Washout|AE not Related to Study Drug|0|||
47071664|NCT01474772|83358907|FG000|Washout|Withdrawal by Subject|1|||
47071665|NCT01474772|83358908|FG001|Washout|Withdrawal by Subject|0|||
47071666|NCT01474772|83358907|FG000|Washout|Lost to Follow-up|0|||
47071667|NCT01474772|83358908|FG001|Washout|Lost to Follow-up|1|||
47071668|NCT01474772|83358907|FG000|Washout|Reason not Specified|0|||
47071669|NCT01474772|83358908|FG001|Washout|Reason not Specified|1|||
47071670|NCT01474772|83358907|FG000|Period 2|Death|0|||
47071671|NCT01474772|83358908|FG001|Period 2|Death|1|||
47071672|NCT01474772|83358907|FG000|Period 2|AE Related to Study Drug|0|||
47071673|NCT01474772|83358908|FG001|Period 2|AE Related to Study Drug|1|||
47071674|NCT01474772|83358907|FG000|Period 2|AE not Related to Study Drug|4|||
47071675|NCT01474772|83358908|FG001|Period 2|AE not Related to Study Drug|1|||
47071676|NCT01474772|83358907|FG000|Period 2|Lack of Efficacy|1|||
47071677|NCT01474772|83358908|FG001|Period 2|Lack of Efficacy|0|||
47071678|NCT01474772|83358907|FG000|Period 2|Withdrawal by Subject|3|||
47071679|NCT01474772|83358908|FG001|Period 2|Withdrawal by Subject|4|||
47071680|NCT01474772|83358907|FG000|Period 2|Lost to Follow-up|1|||
47071681|NCT01474772|83358908|FG001|Period 2|Lost to Follow-up|1|||
47071682|NCT01474772|83358907|FG000|Period 2|Reason not Specified|0|||
47071683|NCT01474772|83358908|FG001|Period 2|Reason not Specified|2|||
47071684|NCT01474772|83358907|FG000|Follow-up|AE not Related to Study Drug|0|||
47071685|NCT01474772|83358908|FG001|Follow-up|AE not Related to Study Drug|1|||
47071686|NCT01421147|83358916|FG000|Treatment Period|Adverse Event|2|||
47071687|NCT01421147|83358917|FG001|Treatment Period|Adverse Event|3|||
47071688|NCT01421147|83358916|FG000|Treatment Period|Lost to Follow-up|2|||
47071689|NCT01421147|83358917|FG001|Treatment Period|Lost to Follow-up|1|||
47071690|NCT01421147|83358916|FG000|Treatment Period|Physician Decision|2|||
47071691|NCT01421147|83358917|FG001|Treatment Period|Physician Decision|2|||
47071692|NCT01421147|83358916|FG000|Treatment Period|Withdrawal by Subject|10|||
47071693|NCT01421147|83358917|FG001|Treatment Period|Withdrawal by Subject|5|||
47071694|NCT01421147|83358916|FG000|Extension Period|Adverse Event|0|||
47071695|NCT01421147|83358917|FG001|Extension Period|Adverse Event|2|||
47071696|NCT01421147|83358916|FG000|Extension Period|Death|0|||
47071697|NCT01421147|83358917|FG001|Extension Period|Death|1|||
47071698|NCT01421147|83358916|FG000|Extension Period|Lost to Follow-up|2|||
47071699|NCT01421147|83358917|FG001|Extension Period|Lost to Follow-up|5|||
47071700|NCT01421147|83358916|FG000|Extension Period|Physician Decision|1|||
47071701|NCT01421147|83358917|FG001|Extension Period|Physician Decision|0|||
47071702|NCT01421147|83358916|FG000|Extension Period|Withdrawal by Subject|5|||
47071703|NCT01421147|83358917|FG001|Extension Period|Withdrawal by Subject|3|||
47071704|NCT01497938|83358934|FG000|Overall Study|Adverse Event|0|||
47071705|NCT01497938|83358935|FG001|Overall Study|Adverse Event|1|||
47071706|NCT01497938|83358934|FG000|Overall Study|Physician Decision|0|||
47071707|NCT01497938|83358935|FG001|Overall Study|Physician Decision|1|||
47071708|NCT01497938|83358934|FG000|Overall Study|Withdrawal by Subject|4|||
47071709|NCT01497938|83358935|FG001|Overall Study|Withdrawal by Subject|0|||
47071710|NCT01497938|83358934|FG000|Overall Study|Device Violation|1|||
47071711|NCT01497938|83358935|FG001|Overall Study|Device Violation|0|||
47071712|NCT01460342|83358985|FG000|Overall Study|Adverse Event|5|||
47071713|NCT01460342|83358986|FG001|Overall Study|Adverse Event|4|||
47071714|NCT01460342|83358985|FG000|Overall Study|Lost to Follow-up|1|||
47071715|NCT01460342|83358986|FG001|Overall Study|Lost to Follow-up|2|||
47071716|NCT01460342|83358985|FG000|Overall Study|Protocol Violation|0|||
47071717|NCT01460342|83358986|FG001|Overall Study|Protocol Violation|1|||
46641143|NCT01715285|82820445|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
46641144|NCT01715285|82820443|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
46641145|NCT01715285|82820444|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
47071718|NCT01460342|83358985|FG000|Overall Study|Withdrawal by Subject|3|||
47071719|NCT01460342|83358986|FG001|Overall Study|Withdrawal by Subject|4|||
47071720|NCT01460342|83358985|FG000|Overall Study|Physician Decision|1|||
47071721|NCT01460342|83358986|FG001|Overall Study|Physician Decision|3|||
47071722|NCT01460342|83358985|FG000|Overall Study|Lack of Efficacy|1|||
47071723|NCT01460342|83358986|FG001|Overall Study|Lack of Efficacy|0|||
47071724|NCT01459796|83359018|FG000|Overall Study|Non compliance with protocol|2|||
47071725|NCT01459796|83359019|FG001|Overall Study|Non compliance with protocol|4|||
47071726|NCT01459796|83359018|FG000|Overall Study|Adverse Event|5|||
47071727|NCT01459796|83359019|FG001|Overall Study|Adverse Event|5|||
47071728|NCT01459796|83359018|FG000|Overall Study|Withdrawal by Subject|6|||
47071729|NCT01459796|83359019|FG001|Overall Study|Withdrawal by Subject|3|||
47071730|NCT01459796|83359018|FG000|Overall Study|Lost to Follow-up|5|||
47071731|NCT01459796|83359019|FG001|Overall Study|Lost to Follow-up|4|||
47071732|NCT01459796|83359018|FG000|Overall Study|Reason unspecified|1|||
47071733|NCT01459796|83359019|FG001|Overall Study|Reason unspecified|2|||
47071734|NCT01459796|83359018|FG000|Overall Study|Decision by the sponsor|75|||
47071735|NCT01459796|83359019|FG001|Overall Study|Decision by the sponsor|108|||
47071736|NCT01459718|83359029|FG000|Overall Study|Physician Decision|1|||
47071737|NCT01459718|83359029|FG000|Overall Study|Lost to Follow-up|1|||
47071738|NCT01459718|83359029|FG000|Overall Study|Adverse Event|1|||
47071739|NCT04008069|83359033|FG000|Open-Label Period|Adverse Event|1|||
47071740|NCT04008069|83359034|FG001|Open-Label Period|Adverse Event|0|||
47071741|NCT04008069|83359035|FG002|Open-Label Period|Adverse Event|0|||
47071742|NCT04008069|83359033|FG000|Open-Label Period|Lack of Efficacy|4|||
47071743|NCT04008069|83359034|FG001|Open-Label Period|Lack of Efficacy|0|||
47071744|NCT04008069|83359035|FG002|Open-Label Period|Lack of Efficacy|0|||
47071745|NCT04008069|83359033|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
47071746|NCT04008069|83359034|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
47071747|NCT04008069|83359035|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
47071748|NCT04008069|83359033|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
47071749|NCT04008069|83359034|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
47071750|NCT04008069|83359035|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
47071751|NCT01474538|83359051|FG000|Treatment Period 1|Death|1|||
47071752|NCT01474538|83359052|FG001|Treatment Period 1|Death|0|||
47071753|NCT01474538|83359051|FG000|Treatment Period 1|Physician Decision|1|||
47071754|NCT01474538|83359052|FG001|Treatment Period 1|Physician Decision|0|||
47071755|NCT01474538|83359051|FG000|Treatment Period 1|Withdrawal by Subject|1|||
47071756|NCT01474538|83359052|FG001|Treatment Period 1|Withdrawal by Subject|3|||
47071757|NCT01474538|83359051|FG000|Treatment Period 1|Protocol Violation|0|||
47071758|NCT01474538|83359052|FG001|Treatment Period 1|Protocol Violation|1|||
47071759|NCT01474538|83359051|FG000|Treatment Period 2|Death|1|||
47071760|NCT01474538|83359052|FG001|Treatment Period 2|Death|0|||
47071761|NCT01474538|83359051|FG000|Treatment Period 2|Adverse Event|1|||
47071762|NCT01474538|83359052|FG001|Treatment Period 2|Adverse Event|1|||
47071763|NCT01474538|83359051|FG000|Treatment Period 2|Withdrawal by Subject|2|||
47071764|NCT01474538|83359052|FG001|Treatment Period 2|Withdrawal by Subject|0|||
47071765|NCT01474538|83359051|FG000|Treatment Period 2|Sponsor decision|1|||
47071766|NCT01474538|83359052|FG001|Treatment Period 2|Sponsor decision|0|||
47071767|NCT01474538|83359051|FG000|Treatment Period 2|Physician Decision|0|||
47071768|NCT01474538|83359052|FG001|Treatment Period 2|Physician Decision|1|||
47071769|NCT01474538|83359051|FG000|Treatment Period 2|Protocol Violation|1|||
47071770|NCT01474538|83359052|FG001|Treatment Period 2|Protocol Violation|0|||
47071771|NCT02647788|83359060|FG000|Overall Study|Lost to Follow-up|13|||
47071772|NCT02647788|83359061|FG001|Overall Study|Lost to Follow-up|11|||
47071773|NCT02647788|83359060|FG000|Overall Study|Did not want opiate|0|||
47071774|NCT02647788|83359061|FG001|Overall Study|Did not want opiate|1|||
47071775|NCT02647788|83359060|FG000|Overall Study|Withdrawal by Subject|1|||
47071776|NCT02647788|83359061|FG001|Overall Study|Withdrawal by Subject|0|||
47071777|NCT02647788|83359060|FG000|Overall Study|Felt itchy with assigned medication|1|||
47071778|NCT02647788|83359061|FG001|Overall Study|Felt itchy with assigned medication|0|||
47071779|NCT02647788|83359060|FG000|Overall Study|Felt nauseous with assigned medication|1|||
47071780|NCT02647788|83359061|FG001|Overall Study|Felt nauseous with assigned medication|1|||
47071781|NCT01459016|83359067|FG000|Overall Study|Withdrawal by Subject|11|||
47071782|NCT01459016|83359067|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
47071783|NCT01458392|83359109|FG000|Overall Study|Death|2|||
47071784|NCT01458392|83359110|FG001|Overall Study|Death|11|||
47071785|NCT01458392|83359111|FG002|Overall Study|Death|22|||
47071786|NCT01458392|83359109|FG000|Overall Study|At the discretion of the sponsor|0|||
47071787|NCT01458392|83359110|FG001|Overall Study|At the discretion of the sponsor|2|||
47071788|NCT01458392|83359111|FG002|Overall Study|At the discretion of the sponsor|7|||
47071789|NCT01458392|83359109|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
47071790|NCT01458392|83359110|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
46967334|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
46967335|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
47071791|NCT01458392|83359111|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
47071792|NCT01421069|83359123|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
47071793|NCT01421069|83359123|FG000|Parent Study|Failed to return|3|||
47071794|NCT01421069|83359123|FG000|Parent Study|Withdrawal by Subject|1|||
47071795|NCT01421069|83359123|FG000|Parent Study|Lost to Follow-up|2|||
47071796|NCT01421069|83359123|FG000|Parent Study|Lack of Efficacy|1|||
47071797|NCT01421069|83359123|FG000|Overall Period for Extension Study|Other|2|||
47071798|NCT01421069|83359123|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
47071799|NCT01421069|83359123|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
47071800|NCT01421069|83359123|FG000|Overall Period for Extension Study|Pregnancy|1|||
47071801|NCT01421069|83359123|FG000|Overall Period for Extension Study|Adverse Event|1|||
47071802|NCT01421069|83359123|FG000|Overall Period for Extension Study|Protocol Violation|1|||
47071803|NCT01421069|83359123|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
47071804|NCT01421069|83359123|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
47071805|NCT01421069|83359123|FG000|Active Treatment Period|Other|1|||
46775429|NCT00696657|82993838|FG001|Overall Study|Protocol Violation|0|||
47071806|NCT01421069|83359123|FG000|Active Treatment Period|No longer willing to participate in study|8|||
47071807|NCT01421069|83359123|FG000|Active Treatment Period|Insufficient clinical response|1|||
47071808|NCT01421069|83359123|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
47071809|NCT01421069|83359123|FG000|Active Treatment Period|Pregnancy|1|||
47071810|NCT01421069|83359123|FG000|Active Treatment Period|Adverse Event|1|||
47071811|NCT01421069|83359123|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
47071812|NCT01421069|83359123|FG000|Active Treatment Period|Enrolled in observational period|29|||
47071813|NCT01421069|83359123|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
47071814|NCT01421069|83359123|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
47071815|NCT01421069|83359123|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
47071816|NCT01421069|83359123|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
47071817|NCT01421069|83359123|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
47071818|NCT01421069|83359123|FG000|2b. Retreatment Period|Protocol Violation|1|||
47071819|NCT01421069|83359123|FG000|Observational Period|Other|1|||
47071820|NCT01421069|83359123|FG000|Observational Period|No longer willing to participate in study|4|||
47071821|NCT01421069|83359123|FG000|Observational Period|Lost to Follow-up|3|||
47071822|NCT01473836|83359155|FG000|Overall Study|Adverse Event|4|||
47071823|NCT01473836|83359155|FG000|Overall Study|Lack of Efficacy|1|||
47071824|NCT01473836|83359155|FG000|Overall Study|Does not meet entrance criteria|1|||
47071825|NCT01473758|83359180|FG000|Cycle 1|Adverse Event|10|||
47071826|NCT01473758|83359181|FG001|Cycle 1|Adverse Event|2|||
47071827|NCT01473758|83359182|FG002|Cycle 1|Adverse Event|0|||
47071828|NCT01473758|83359183|FG003|Cycle 1|Adverse Event|0|||
47071829|NCT01473758|83359180|FG000|Cycle 1|Withdrawal by Subject|1|||
47071830|NCT01473758|83359181|FG001|Cycle 1|Withdrawal by Subject|1|||
47071831|NCT01473758|83359182|FG002|Cycle 1|Withdrawal by Subject|0|||
47071832|NCT01473758|83359183|FG003|Cycle 1|Withdrawal by Subject|0|||
47071833|NCT01473758|83359180|FG000|Cycle 2|Adverse Event|0|||
47071834|NCT01473758|83359181|FG001|Cycle 2|Adverse Event|0|||
47071835|NCT01473758|83359182|FG002|Cycle 2|Adverse Event|5|||
47071836|NCT01473758|83359183|FG003|Cycle 2|Adverse Event|0|||
47071837|NCT01420679|83359193|FG000|Overall Study|Disease Progression|3|||
47071838|NCT01420679|83359194|FG001|Overall Study|Disease Progression|2|||
47071839|NCT01420679|83359193|FG000|Overall Study|Adverse Event|4|||
47071840|NCT01420679|83359194|FG001|Overall Study|Adverse Event|0|||
47071841|NCT01420679|83359193|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
47071842|NCT01420679|83359194|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
47071843|NCT01420679|83359193|FG000|Overall Study|Patient Decision|1|||
47071844|NCT01420679|83359194|FG001|Overall Study|Patient Decision|0|||
47071845|NCT01420679|83359193|FG000|Overall Study|Investigator Decision|1|||
47071846|NCT01420679|83359194|FG001|Overall Study|Investigator Decision|2|||
47071847|NCT01420679|83359193|FG000|Overall Study|Sponsor Decision|3|||
47071848|NCT01420679|83359194|FG001|Overall Study|Sponsor Decision|3|||
47071849|NCT01420679|83359193|FG000|Overall Study|Other|1|||
47071850|NCT01420679|83359194|FG001|Overall Study|Other|0|||
47071851|NCT01496846|83359211|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
47071852|NCT01496846|83359212|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
47071853|NCT01496846|83359213|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
47071854|NCT01496846|83359214|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
47071855|NCT01496846|83359215|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
47071856|NCT01496846|83359216|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
47071857|NCT00964002|83359227|FG000|Overall Study|Protocol Violation|8|||
47071858|NCT01399697|83359239|FG000|Overall Study|Adverse Event|13|||
47071859|NCT01399697|83359240|FG001|Overall Study|Adverse Event|3|||
47071860|NCT01399697|83359241|FG002|Overall Study|Adverse Event|1|||
47071861|NCT01399697|83359239|FG000|Overall Study|Lost to Follow-up|2|||
47071862|NCT01399697|83359240|FG001|Overall Study|Lost to Follow-up|0|||
47071863|NCT01399697|83359241|FG002|Overall Study|Lost to Follow-up|0|||
47071864|NCT01399697|83359239|FG000|Overall Study|Withdrawal by Subject|8|||
47071865|NCT01399697|83359240|FG001|Overall Study|Withdrawal by Subject|0|||
47071866|NCT01399697|83359241|FG002|Overall Study|Withdrawal by Subject|0|||
47071867|NCT01399697|83359239|FG000|Overall Study|Investigator Decisión|1|||
47071868|NCT01399697|83359240|FG001|Overall Study|Investigator Decisión|0|||
46641146|NCT01715285|82820445|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
47071869|NCT01399697|83359241|FG002|Overall Study|Investigator Decisión|2|||
47071870|NCT01399697|83359239|FG000|Overall Study|Lack of Efficacy|9|||
47071871|NCT01399697|83359240|FG001|Overall Study|Lack of Efficacy|0|||
47071872|NCT01399697|83359241|FG002|Overall Study|Lack of Efficacy|1|||
47071873|NCT01399697|83359239|FG000|Overall Study|Protocol Violation|2|||
47071874|NCT01399697|83359240|FG001|Overall Study|Protocol Violation|0|||
47071875|NCT01399697|83359241|FG002|Overall Study|Protocol Violation|0|||
47071876|NCT01399697|83359239|FG000|Overall Study|Non-Compliant|1|||
47071877|NCT01399697|83359240|FG001|Overall Study|Non-Compliant|0|||
47071878|NCT01399697|83359241|FG002|Overall Study|Non-Compliant|0|||
47071879|NCT01399697|83359239|FG000|Overall Study|Inclusion Error|2|||
47071880|NCT01399697|83359240|FG001|Overall Study|Inclusion Error|0|||
47071881|NCT01399697|83359241|FG002|Overall Study|Inclusion Error|0|||
47071882|NCT01399697|83359239|FG000|Overall Study|Positive result for hepatitis B|1|||
47071883|NCT01399697|83359240|FG001|Overall Study|Positive result for hepatitis B|0|||
47071884|NCT01399697|83359241|FG002|Overall Study|Positive result for hepatitis B|0|||
47071885|NCT01399697|83359239|FG000|Overall Study|Clinical RA remission|1|||
47071886|NCT01399697|83359240|FG001|Overall Study|Clinical RA remission|0|||
47071887|NCT01399697|83359241|FG002|Overall Study|Clinical RA remission|0|||
47071888|NCT01399697|83359239|FG000|Overall Study|Sponsor Decision|1|||
47071889|NCT01399697|83359240|FG001|Overall Study|Sponsor Decision|0|||
47071890|NCT01399697|83359241|FG002|Overall Study|Sponsor Decision|0|||
47071891|NCT01473602|83359275|FG000|Overall Study|Adverse Event|1|||
47071892|NCT01473602|83359276|FG001|Overall Study|Adverse Event|2|||
47071893|NCT01473602|83359275|FG000|Overall Study|Death|0|||
47071894|NCT01473602|83359276|FG001|Overall Study|Death|1|||
47071895|NCT01473602|83359275|FG000|Overall Study|Lost to Follow-up|1|||
47071896|NCT01473602|83359276|FG001|Overall Study|Lost to Follow-up|1|||
47071897|NCT01473602|83359275|FG000|Overall Study|Withdrawal by Subject|5|||
47071898|NCT01473602|83359276|FG001|Overall Study|Withdrawal by Subject|4|||
47071899|NCT01473602|83359275|FG000|Overall Study|Physician Decision|1|||
47071900|NCT01473602|83359276|FG001|Overall Study|Physician Decision|0|||
47071901|NCT01496612|83359284|FG000|1st Intervention|Adverse Event|1|||
47071902|NCT01496612|83359285|FG001|1st Intervention|Adverse Event|0|||
47071903|NCT01496612|83359284|FG000|1st Intervention|Withdrawal by Subject|1|||
47071904|NCT01496612|83359285|FG001|1st Intervention|Withdrawal by Subject|0|||
47071905|NCT00790218|83359302|FG000|Overall Study|Death|1|||
47071906|NCT00790218|83359303|FG001|Overall Study|Death|0|||
47071907|NCT00790218|83359304|FG002|Overall Study|Death|0|||
47071908|NCT01457924|83359330|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
47071909|NCT01457924|83359331|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
47071910|NCT01457924|83359332|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
47071911|NCT01457924|83359333|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
47071912|NCT01457924|83359334|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
47071913|NCT01457924|83359330|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
47071914|NCT01457924|83359331|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
47071915|NCT01457924|83359332|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
47071916|NCT01457924|83359333|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
47071917|NCT01457924|83359334|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
47071918|NCT01457924|83359330|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
47071919|NCT01457924|83359331|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
47071920|NCT01457924|83359332|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
47071921|NCT01457924|83359333|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
47071922|NCT01457924|83359334|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
47071923|NCT01457924|83359330|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
47071924|NCT01457924|83359331|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
47071925|NCT01457924|83359332|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
47071926|NCT01457924|83359333|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
47071927|NCT01457924|83359334|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
47071928|NCT01457924|83359330|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
47071929|NCT01457924|83359331|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
47071930|NCT01457924|83359332|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
47071931|NCT01457924|83359333|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
47071932|NCT01457924|83359334|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
47071933|NCT01457924|83359330|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
47071934|NCT01457924|83359331|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
47071935|NCT01457924|83359332|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
47071936|NCT01457924|83359333|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
47071937|NCT01457924|83359334|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
47071938|NCT01457924|83359330|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
46775430|NCT00696657|82993839|FG002|Overall Study|Protocol Violation|0|||
46775431|NCT00696657|82993840|FG003|Overall Study|Protocol Violation|0|||
46775432|NCT00696657|82993841|FG004|Overall Study|Protocol Violation|0|||
47071939|NCT01457924|83359331|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
47071940|NCT01457924|83359332|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
47071941|NCT01457924|83359333|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
46775433|NCT00696657|82993842|FG005|Overall Study|Protocol Violation|1|||
46846358|NCT00130208|83063085|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
47071942|NCT01457924|83359334|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
47071943|NCT01457924|83359330|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
47071944|NCT01457924|83359331|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
47071945|NCT01457924|83359332|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
47071946|NCT01457924|83359333|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
47071947|NCT01457924|83359334|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
46775434|NCT00696657|82993843|FG006|Overall Study|Protocol Violation|0|||
47071948|NCT01457924|83359330|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
47071949|NCT01457924|83359331|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
47071950|NCT01457924|83359332|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
47071951|NCT01457924|83359333|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
47071952|NCT01457924|83359334|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
47071953|NCT01457924|83359330|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
47071954|NCT01457924|83359331|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
47071955|NCT01457924|83359332|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
47071956|NCT01457924|83359333|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
47071957|NCT01457924|83359334|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
47071958|NCT01457924|83359330|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
47071959|NCT01457924|83359331|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
47071960|NCT01457924|83359332|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
47071961|NCT01457924|83359333|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
46775435|NCT00696657|82993844|FG007|Overall Study|Protocol Violation|0|||
46775436|NCT00696657|82993845|FG008|Overall Study|Protocol Violation|1|||
47071962|NCT01457924|83359334|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
47071963|NCT01457924|83359330|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
47071964|NCT01457924|83359331|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
47071965|NCT01457924|83359332|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
47071966|NCT01457924|83359333|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
47071967|NCT01457924|83359334|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
47071968|NCT01457924|83359330|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
47071969|NCT01457924|83359331|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
46775437|NCT00696657|82993837|FG000|Overall Study|Lack of Efficacy|0|||
46775438|NCT00696657|82993838|FG001|Overall Study|Lack of Efficacy|1|||
46775439|NCT00696657|82993839|FG002|Overall Study|Lack of Efficacy|0|||
46775440|NCT00696657|82993840|FG003|Overall Study|Lack of Efficacy|0|||
46775441|NCT00696657|82993841|FG004|Overall Study|Lack of Efficacy|0|||
46775442|NCT00696657|82993842|FG005|Overall Study|Lack of Efficacy|0|||
46775443|NCT00696657|82993843|FG006|Overall Study|Lack of Efficacy|0|||
46775444|NCT00696657|82993844|FG007|Overall Study|Lack of Efficacy|0|||
46775445|NCT00696657|82993845|FG008|Overall Study|Lack of Efficacy|0|||
46775446|NCT00696657|82993837|FG000|Overall Study|Withdrawal criteria|1|||
46775447|NCT00696657|82993838|FG001|Overall Study|Withdrawal criteria|3|||
46775448|NCT00696657|82993839|FG002|Overall Study|Withdrawal criteria|2|||
46775449|NCT00696657|82993840|FG003|Overall Study|Withdrawal criteria|2|||
46775450|NCT00696657|82993841|FG004|Overall Study|Withdrawal criteria|0|||
46775451|NCT00696657|82993842|FG005|Overall Study|Withdrawal criteria|0|||
46775452|NCT00696657|82993843|FG006|Overall Study|Withdrawal criteria|1|||
46775453|NCT00696657|82993844|FG007|Overall Study|Withdrawal criteria|1|||
46775454|NCT00696657|82993845|FG008|Overall Study|Withdrawal criteria|2|||
46775455|NCT00696657|82993837|FG000|Overall Study|Unclassified|0|||
46775456|NCT00696657|82993838|FG001|Overall Study|Unclassified|1|||
46775457|NCT00696657|82993839|FG002|Overall Study|Unclassified|3|||
46775458|NCT00696657|82993840|FG003|Overall Study|Unclassified|2|||
46775459|NCT00696657|82993841|FG004|Overall Study|Unclassified|4|||
46775460|NCT00696657|82993842|FG005|Overall Study|Unclassified|2|||
46775461|NCT00696657|82993843|FG006|Overall Study|Unclassified|0|||
46775462|NCT00696657|82993844|FG007|Overall Study|Unclassified|0|||
46775463|NCT00696657|82993845|FG008|Overall Study|Unclassified|1|||
46775464|NCT00696657|82993837|FG000|Overall Study|Adverse Event|0|||
46775465|NCT00696657|82993838|FG001|Overall Study|Adverse Event|0|||
47071970|NCT01457924|83359332|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
47071971|NCT01457924|83359333|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
47071972|NCT01457924|83359334|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
47071973|NCT01399619|83359355|FG000|Overall Study|Adverse Event|10|||
47071974|NCT01399619|83359356|FG001|Overall Study|Adverse Event|0|||
47071975|NCT01399619|83359357|FG002|Overall Study|Adverse Event|4|||
47071976|NCT01399619|83359358|FG003|Overall Study|Adverse Event|10|||
47071977|NCT01399619|83359355|FG000|Overall Study|Lack of Efficacy|9|||
46775466|NCT00696657|82993839|FG002|Overall Study|Adverse Event|3|||
46775467|NCT00696657|82993840|FG003|Overall Study|Adverse Event|7|||
46775468|NCT00696657|82993841|FG004|Overall Study|Adverse Event|6|||
46775469|NCT00696657|82993842|FG005|Overall Study|Adverse Event|9|||
46775470|NCT00696657|82993843|FG006|Overall Study|Adverse Event|14|||
46775471|NCT00696657|82993844|FG007|Overall Study|Adverse Event|2|||
46775472|NCT00696657|82993845|FG008|Overall Study|Adverse Event|5|||
47071978|NCT01399619|83359356|FG001|Overall Study|Lack of Efficacy|0|||
46775473|NCT00730886|82993867|FG000|Overall Study|Lost to Follow-up|1|||
46775474|NCT00730886|82993868|FG001|Overall Study|Lost to Follow-up|0|||
47071979|NCT01399619|83359357|FG002|Overall Study|Lack of Efficacy|5|||
46775475|NCT00730886|82993867|FG000|Overall Study|Physician Decision|1|||
46775476|NCT00730886|82993868|FG001|Overall Study|Physician Decision|0|||
46775477|NCT00726752|82993874|FG000|Overall Study|Lack of Efficacy|6|||
46775478|NCT00730028|82993892|FG000|Overall Study|Adverse Event|23|||
47071980|NCT01399619|83359358|FG003|Overall Study|Lack of Efficacy|0|||
47071981|NCT01399619|83359355|FG000|Overall Study|Withdrawal by Subject|6|||
47071982|NCT01399619|83359356|FG001|Overall Study|Withdrawal by Subject|0|||
47071983|NCT01399619|83359357|FG002|Overall Study|Withdrawal by Subject|3|||
47071984|NCT01399619|83359358|FG003|Overall Study|Withdrawal by Subject|4|||
47071985|NCT01399619|83359355|FG000|Overall Study|Protocol Violation|0|||
47071986|NCT01399619|83359356|FG001|Overall Study|Protocol Violation|0|||
47071987|NCT01399619|83359357|FG002|Overall Study|Protocol Violation|0|||
47071988|NCT01399619|83359358|FG003|Overall Study|Protocol Violation|1|||
47071989|NCT01399619|83359355|FG000|Overall Study|Not treated|0|||
47071990|NCT01399619|83359356|FG001|Overall Study|Not treated|0|||
47071991|NCT01399619|83359357|FG002|Overall Study|Not treated|0|||
47071992|NCT01399619|83359358|FG003|Overall Study|Not treated|2|||
47071993|NCT01496456|83359373|FG000|Overall Study|Protocol Violation|1|||
47071994|NCT01496456|83359373|FG000|Overall Study|Lost to Follow-up|7|||
47071995|NCT01673646|83359573|FG000|Overall Study|Adverse Event|2|||
47071996|NCT01673646|83359574|FG001|Overall Study|Adverse Event|1|||
47071997|NCT01673646|83359575|FG002|Overall Study|Adverse Event|1|||
47071998|NCT01673646|83359573|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
47071999|NCT01673646|83359574|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
47072000|NCT01673646|83359575|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
47072001|NCT01673646|83359573|FG000|Overall Study|Condition no longer requires study drug|0|||
47072002|NCT01673646|83359574|FG001|Overall Study|Condition no longer requires study drug|1|||
47072003|NCT01673646|83359575|FG002|Overall Study|Condition no longer requires study drug|0|||
47072004|NCT01673646|83359573|FG000|Overall Study|Withdrawal by Subject|0|||
47072005|NCT01673646|83359574|FG001|Overall Study|Withdrawal by Subject|2|||
47072006|NCT01673646|83359575|FG002|Overall Study|Withdrawal by Subject|2|||
47072007|NCT01673646|83359573|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
47072008|NCT01673646|83359574|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
47072009|NCT01673646|83359575|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
47072010|NCT02647944|83359615|FG000|Overall Study|Withdrawal by Subject|0|||
47072011|NCT02647944|83359616|FG001|Overall Study|Withdrawal by Subject|3|||
47072012|NCT02647944|83359615|FG000|Overall Study|Adverse Event|2|||
47072013|NCT02647944|83359616|FG001|Overall Study|Adverse Event|0|||
47072014|NCT01397825|83359671|FG000|Overall Study|Progressive Disease|10|||
47072015|NCT01397825|83359672|FG001|Overall Study|Progressive Disease|3|||
47072016|NCT01397825|83359673|FG002|Overall Study|Progressive Disease|11|||
47072017|NCT01397825|83359674|FG003|Overall Study|Progressive Disease|1|||
47072018|NCT01397825|83359675|FG004|Overall Study|Progressive Disease|0|||
47072019|NCT01397825|83359671|FG000|Overall Study|Symptomatic Deterioration|2|||
47072020|NCT01397825|83359672|FG001|Overall Study|Symptomatic Deterioration|0|||
47072021|NCT01397825|83359673|FG002|Overall Study|Symptomatic Deterioration|4|||
47072022|NCT01397825|83359674|FG003|Overall Study|Symptomatic Deterioration|0|||
47072023|NCT01397825|83359675|FG004|Overall Study|Symptomatic Deterioration|0|||
47072024|NCT01397825|83359671|FG000|Overall Study|Adverse Event|0|||
47072025|NCT01397825|83359672|FG001|Overall Study|Adverse Event|1|||
47072026|NCT01397825|83359673|FG002|Overall Study|Adverse Event|5|||
47072027|NCT01397825|83359674|FG003|Overall Study|Adverse Event|1|||
47072028|NCT01397825|83359675|FG004|Overall Study|Adverse Event|0|||
47072029|NCT01397825|83359671|FG000|Overall Study|Withdrawal by Subject|1|||
47072030|NCT01397825|83359672|FG001|Overall Study|Withdrawal by Subject|0|||
47072031|NCT01397825|83359673|FG002|Overall Study|Withdrawal by Subject|5|||
47072032|NCT01397825|83359674|FG003|Overall Study|Withdrawal by Subject|1|||
47072033|NCT01397825|83359675|FG004|Overall Study|Withdrawal by Subject|0|||
47072034|NCT01397747|83359698|FG000|Overall Study|Multitarget DNA test excluded|689|||
47072035|NCT01397747|83359698|FG000|Overall Study|Colonoscopy excluded|304|||
47072036|NCT01397747|83359698|FG000|Overall Study|FIT excluded|34|||
47072037|NCT01397201|83359736|FG000|Overall Study|Not treated|0|||
47072038|NCT01397201|83359737|FG001|Overall Study|Not treated|0|||
47072039|NCT01397201|83359738|FG002|Overall Study|Not treated|1|||
47072040|NCT01397201|83359739|FG003|Overall Study|Not treated|0|||
47072041|NCT01397201|83359740|FG004|Overall Study|Not treated|0|||
47072042|NCT01397201|83359736|FG000|Overall Study|Not yet defined|3|||
47072043|NCT01397201|83359737|FG001|Overall Study|Not yet defined|6|||
47072044|NCT01397201|83359738|FG002|Overall Study|Not yet defined|5|||
47072045|NCT01397201|83359739|FG003|Overall Study|Not yet defined|5|||
47072046|NCT01397201|83359740|FG004|Overall Study|Not yet defined|4|||
47072047|NCT01397201|83359736|FG000|Overall Study|Adverse Event|2|||
47072048|NCT01397201|83359737|FG001|Overall Study|Adverse Event|0|||
47072049|NCT01397201|83359738|FG002|Overall Study|Adverse Event|0|||
47072050|NCT01397201|83359739|FG003|Overall Study|Adverse Event|0|||
47072051|NCT01397201|83359740|FG004|Overall Study|Adverse Event|0|||
47072052|NCT01393613|83359774|FG000|Overall Study|Adverse Event|11|||
47072053|NCT01393613|83359775|FG001|Overall Study|Adverse Event|11|||
47072054|NCT01393613|83359776|FG002|Overall Study|Adverse Event|13|||
47072055|NCT01393613|83359777|FG003|Overall Study|Adverse Event|22|||
47072056|NCT01393613|83359774|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
47072057|NCT01393613|83359775|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
47072058|NCT01393613|83359776|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
47072059|NCT01393613|83359777|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
47072060|NCT01393613|83359774|FG000|Overall Study|Physician Decision|2|||
47072061|NCT01393613|83359775|FG001|Overall Study|Physician Decision|0|||
47072062|NCT01393613|83359776|FG002|Overall Study|Physician Decision|0|||
47072063|NCT01393613|83359777|FG003|Overall Study|Physician Decision|1|||
47072064|NCT01393613|83359774|FG000|Overall Study|Withdrawal by Subject|15|||
47072065|NCT01393613|83359775|FG001|Overall Study|Withdrawal by Subject|25|||
47072066|NCT01393613|83359776|FG002|Overall Study|Withdrawal by Subject|23|||
47072067|NCT01393613|83359777|FG003|Overall Study|Withdrawal by Subject|21|||
47072068|NCT01393613|83359774|FG000|Overall Study|Protocol Deviation|2|||
47072069|NCT01393613|83359775|FG001|Overall Study|Protocol Deviation|1|||
47072070|NCT01393613|83359776|FG002|Overall Study|Protocol Deviation|0|||
47072071|NCT01393613|83359777|FG003|Overall Study|Protocol Deviation|0|||
47072072|NCT01393613|83359774|FG000|Overall Study|Lack of Efficacy|9|||
47072073|NCT01393613|83359775|FG001|Overall Study|Lack of Efficacy|20|||
47072074|NCT01393613|83359776|FG002|Overall Study|Lack of Efficacy|16|||
47072075|NCT01393613|83359777|FG003|Overall Study|Lack of Efficacy|21|||
47072076|NCT01396421|83359827|FG000|Overall Study|Lost to Follow-up|0|||
47072077|NCT01396421|83359828|FG001|Overall Study|Lost to Follow-up|0|||
47072078|NCT01396421|83359829|FG002|Overall Study|Lost to Follow-up|0|||
47072079|NCT01396421|83359830|FG003|Overall Study|Lost to Follow-up|1|||
47072080|NCT01396421|83359827|FG000|Overall Study|Adverse Event|17|||
47072081|NCT01396421|83359828|FG001|Overall Study|Adverse Event|15|||
47072082|NCT01396421|83359829|FG002|Overall Study|Adverse Event|12|||
47072083|NCT01396421|83359830|FG003|Overall Study|Adverse Event|32|||
47072084|NCT01396421|83359827|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
47072085|NCT01396421|83359828|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
47072086|NCT01396421|83359829|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
47072087|NCT01396421|83359830|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
47072088|NCT01396421|83359827|FG000|Overall Study|Physician Decision|1|||
47072089|NCT01396421|83359828|FG001|Overall Study|Physician Decision|1|||
47072090|NCT01396421|83359829|FG002|Overall Study|Physician Decision|0|||
47072091|NCT01396421|83359830|FG003|Overall Study|Physician Decision|3|||
47072092|NCT01396421|83359827|FG000|Overall Study|Withdrawal by Subject|31|||
47072093|NCT01396421|83359828|FG001|Overall Study|Withdrawal by Subject|24|||
47072094|NCT01396421|83359829|FG002|Overall Study|Withdrawal by Subject|13|||
47072095|NCT01396421|83359830|FG003|Overall Study|Withdrawal by Subject|21|||
47072096|NCT01396421|83359827|FG000|Overall Study|Protocol Deviation|2|||
47072097|NCT01396421|83359828|FG001|Overall Study|Protocol Deviation|1|||
47072098|NCT01396421|83359829|FG002|Overall Study|Protocol Deviation|1|||
47072099|NCT01396421|83359830|FG003|Overall Study|Protocol Deviation|0|||
47072100|NCT01396421|83359827|FG000|Overall Study|Lack of Efficacy|7|||
47072101|NCT01396421|83359828|FG001|Overall Study|Lack of Efficacy|17|||
47072102|NCT01396421|83359829|FG002|Overall Study|Lack of Efficacy|7|||
47072103|NCT01396421|83359830|FG003|Overall Study|Lack of Efficacy|18|||
47072104|NCT01396265|83359888|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
47072105|NCT02647866|83359933|FG000|Overall Study|Adverse Event|0|||
47072106|NCT02647866|83359934|FG001|Overall Study|Adverse Event|0|||
47072107|NCT02647866|83359935|FG002|Overall Study|Adverse Event|2|||
47072108|NCT02647866|83359936|FG003|Overall Study|Adverse Event|2|||
47072109|NCT02647866|83359937|FG004|Overall Study|Adverse Event|1|||
47072110|NCT02647866|83359933|FG000|Overall Study|Disease Worsening|3|||
47072111|NCT02647866|83359934|FG001|Overall Study|Disease Worsening|1|||
47072112|NCT02647866|83359935|FG002|Overall Study|Disease Worsening|0|||
47072113|NCT02647866|83359936|FG003|Overall Study|Disease Worsening|0|||
47072114|NCT02647866|83359937|FG004|Overall Study|Disease Worsening|1|||
47072115|NCT02647866|83359933|FG000|Overall Study|Withdrawal by Subject|1|||
47072116|NCT02647866|83359934|FG001|Overall Study|Withdrawal by Subject|1|||
47072117|NCT02647866|83359935|FG002|Overall Study|Withdrawal by Subject|2|||
47072118|NCT02647866|83359936|FG003|Overall Study|Withdrawal by Subject|4|||
47072119|NCT02647866|83359937|FG004|Overall Study|Withdrawal by Subject|4|||
47072120|NCT02647866|83359933|FG000|Overall Study|Physician Decision|0|||
47072121|NCT02647866|83359934|FG001|Overall Study|Physician Decision|1|||
47072122|NCT02647866|83359935|FG002|Overall Study|Physician Decision|1|||
47072123|NCT02647866|83359936|FG003|Overall Study|Physician Decision|0|||
47072124|NCT02647866|83359937|FG004|Overall Study|Physician Decision|2|||
47072125|NCT02647866|83359933|FG000|Overall Study|Death|0|||
47072126|NCT02647866|83359934|FG001|Overall Study|Death|1|||
47072127|NCT02647866|83359935|FG002|Overall Study|Death|0|||
47072128|NCT02647866|83359936|FG003|Overall Study|Death|0|||
47072129|NCT02647866|83359937|FG004|Overall Study|Death|0|||
47072130|NCT02647866|83359933|FG000|Overall Study|Subject moved to different country|1|||
47072131|NCT02647866|83359934|FG001|Overall Study|Subject moved to different country|0|||
47072132|NCT02647866|83359935|FG002|Overall Study|Subject moved to different country|0|||
47072133|NCT02647866|83359936|FG003|Overall Study|Subject moved to different country|0|||
47072134|NCT02647866|83359937|FG004|Overall Study|Subject moved to different country|0|||
47072135|NCT01396187|83359997|FG000|Overall Study|Adverse Event|0|||
47072136|NCT01396187|83359998|FG001|Overall Study|Adverse Event|1|||
47072137|NCT01396187|83359999|FG002|Overall Study|Adverse Event|0|||
47072138|NCT01396187|83360000|FG003|Overall Study|Adverse Event|0|||
47072139|NCT01396187|83360001|FG004|Overall Study|Adverse Event|0|||
47072140|NCT01396187|83359997|FG000|Overall Study|Withdrawal by Subject|0|||
47072141|NCT01396187|83359998|FG001|Overall Study|Withdrawal by Subject|1|||
47072142|NCT01396187|83359999|FG002|Overall Study|Withdrawal by Subject|1|||
47072143|NCT01396187|83360000|FG003|Overall Study|Withdrawal by Subject|0|||
47072144|NCT01396187|83360001|FG004|Overall Study|Withdrawal by Subject|0|||
47072145|NCT01396187|83359997|FG000|Overall Study|Other|1|||
47072146|NCT01396187|83359998|FG001|Overall Study|Other|1|||
47072147|NCT01396187|83359999|FG002|Overall Study|Other|0|||
47072148|NCT01396187|83360000|FG003|Overall Study|Other|0|||
47072149|NCT01396187|83360001|FG004|Overall Study|Other|1|||
47072150|NCT01392677|83360048|FG000|Overall Study|Adverse Event|3|||
47072151|NCT01392677|83360049|FG001|Overall Study|Adverse Event|1|||
47072152|NCT01392677|83360048|FG000|Overall Study|Withdrawal by Subject|0|||
47072153|NCT01392677|83360049|FG001|Overall Study|Withdrawal by Subject|2|||
47072154|NCT01392677|83360048|FG000|Overall Study|Incorrect enrollment|2|||
47072155|NCT01392677|83360049|FG001|Overall Study|Incorrect enrollment|3|||
47072156|NCT01392677|83360048|FG000|Overall Study|Other reason|3|||
47072157|NCT01392677|83360049|FG001|Overall Study|Other reason|2|||
47072158|NCT01392443|83360098|FG000|Overall Study|Disease progression|30|||
47072159|NCT01392443|83360098|FG000|Overall Study|Adverse Event|24|||
47072160|NCT01392443|83360098|FG000|Overall Study|Death|7|||
47072161|NCT01392443|83360098|FG000|Overall Study|Withdrawal by Subject|5|||
47072162|NCT01392443|83360098|FG000|Overall Study|Lost to Follow-up|1|||
47072163|NCT01392443|83360098|FG000|Overall Study|Protocol Violation|1|||
47072164|NCT01391819|83360102|FG000|Overall Study|Withdrawal by Subject|56|||
47072165|NCT01391819|83360102|FG000|Overall Study|Migrated/moved from study area|82|||
47072166|NCT01391819|83360102|FG000|Overall Study|Lost to Follow-up|252|||
47072167|NCT01391819|83360102|FG000|Overall Study|Death|3|||
47072168|NCT01391819|83360102|FG000|Overall Study|Other|9|||
47072169|NCT03845023|83360113|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
47072170|NCT03845023|83360114|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
47072171|NCT03845023|83360115|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
47072172|NCT03845023|83360116|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
47072173|NCT03845023|83360113|FG000|Follow-Up (14 Days)|Adverse Event|0|||
47072174|NCT03845023|83360114|FG001|Follow-Up (14 Days)|Adverse Event|0|||
47072175|NCT03845023|83360115|FG002|Follow-Up (14 Days)|Adverse Event|1|||
47072176|NCT03845023|83360116|FG003|Follow-Up (14 Days)|Adverse Event|1|||
47072177|NCT01395017|83360178|FG000|Overall Study|Lost to Follow-up|1|||
47072178|NCT01395017|83360179|FG001|Overall Study|Lost to Follow-up|0|||
47072179|NCT01395017|83360178|FG000|Overall Study|Adverse Event|26|||
47072180|NCT01395017|83360179|FG001|Overall Study|Adverse Event|12|||
47072181|NCT01395017|83360178|FG000|Overall Study|Physician Decision|11|||
47072182|NCT01395017|83360179|FG001|Overall Study|Physician Decision|15|||
47072183|NCT01395017|83360178|FG000|Overall Study|Withdrawal by Subject|14|||
47072184|NCT01395017|83360179|FG001|Overall Study|Withdrawal by Subject|8|||
47072185|NCT01395017|83360178|FG000|Overall Study|Protocol deviation|1|||
47072186|NCT01395017|83360179|FG001|Overall Study|Protocol deviation|2|||
47072187|NCT01395017|83360178|FG000|Overall Study|Death|4|||
47072188|NCT01395017|83360179|FG001|Overall Study|Death|3|||
47072189|NCT01395017|83360178|FG000|Overall Study|Disease progression|42|||
47072190|NCT01395017|83360179|FG001|Overall Study|Disease progression|58|||
47072191|NCT01395017|83360178|FG000|Overall Study|Sponsor discontinued study|1|||
47072192|NCT01395017|83360179|FG001|Overall Study|Sponsor discontinued study|4|||
47072193|NCT02647320|83360208|FG000|Overall Study|Adverse Event|0|||
47072194|NCT02647320|83360209|FG001|Overall Study|Adverse Event|1|||
47072195|NCT02647320|83360210|FG002|Overall Study|Adverse Event|3|||
47072196|NCT02647320|83360211|FG003|Overall Study|Adverse Event|2|||
47072197|NCT02647320|83360212|FG004|Overall Study|Adverse Event|1|||
47072198|NCT02647320|83360208|FG000|Overall Study|Protocol Violation|0|||
47072199|NCT02647320|83360209|FG001|Overall Study|Protocol Violation|0|||
47072200|NCT02647320|83360210|FG002|Overall Study|Protocol Violation|3|||
46967336|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
47072201|NCT02647320|83360211|FG003|Overall Study|Protocol Violation|0|||
47072202|NCT02647320|83360212|FG004|Overall Study|Protocol Violation|0|||
47072203|NCT02647320|83360208|FG000|Overall Study|Withdrawal by Subject|7|||
47072204|NCT02647320|83360209|FG001|Overall Study|Withdrawal by Subject|4|||
47072205|NCT02647320|83360210|FG002|Overall Study|Withdrawal by Subject|2|||
47072206|NCT02647320|83360211|FG003|Overall Study|Withdrawal by Subject|2|||
47072207|NCT02647320|83360212|FG004|Overall Study|Withdrawal by Subject|7|||
47072208|NCT02647320|83360208|FG000|Overall Study|Persistent hyperglycemia|0|||
47072209|NCT02647320|83360209|FG001|Overall Study|Persistent hyperglycemia|1|||
47072210|NCT02647320|83360210|FG002|Overall Study|Persistent hyperglycemia|1|||
47072211|NCT02647320|83360211|FG003|Overall Study|Persistent hyperglycemia|1|||
47072212|NCT02647320|83360212|FG004|Overall Study|Persistent hyperglycemia|1|||
47072213|NCT02647320|83360208|FG000|Overall Study|Study terminated by sponsor|1|||
47072214|NCT02647320|83360209|FG001|Overall Study|Study terminated by sponsor|1|||
47072215|NCT02647320|83360210|FG002|Overall Study|Study terminated by sponsor|1|||
47072216|NCT02647320|83360211|FG003|Overall Study|Study terminated by sponsor|1|||
47072217|NCT02647320|83360212|FG004|Overall Study|Study terminated by sponsor|2|||
46775479|NCT00730028|82993893|FG001|Overall Study|Adverse Event|26|||
46775480|NCT00730028|82993894|FG002|Overall Study|Adverse Event|16|||
46775481|NCT00730028|82993895|FG003|Overall Study|Adverse Event|20|||
46641147|NCT01715285|82820443|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
46641148|NCT01715285|82820444|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
46641149|NCT01715285|82820445|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
46641150|NCT01715285|82820443|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
46641151|NCT01715285|82820444|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
46641152|NCT01715285|82820445|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
46775482|NCT00730028|82993896|FG004|Overall Study|Adverse Event|43|||
46967337|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
46967338|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
47072218|NCT02647320|83360208|FG000|Overall Study|Reason not provided|0|||
46775483|NCT00730028|82993892|FG000|Overall Study|Lost to Follow-up|13|||
46775484|NCT00730028|82993893|FG001|Overall Study|Lost to Follow-up|26|||
46775485|NCT00730028|82993894|FG002|Overall Study|Lost to Follow-up|22|||
46775486|NCT00730028|82993895|FG003|Overall Study|Lost to Follow-up|26|||
46775487|NCT00730028|82993896|FG004|Overall Study|Lost to Follow-up|25|||
46775488|NCT00730028|82993892|FG000|Overall Study|Protocol Violation|6|||
46775489|NCT00730028|82993893|FG001|Overall Study|Protocol Violation|1|||
46775490|NCT00730028|82993894|FG002|Overall Study|Protocol Violation|1|||
47072219|NCT02647320|83360209|FG001|Overall Study|Reason not provided|0|||
47072220|NCT02647320|83360210|FG002|Overall Study|Reason not provided|1|||
47072221|NCT02647320|83360211|FG003|Overall Study|Reason not provided|0|||
47072222|NCT02647320|83360212|FG004|Overall Study|Reason not provided|2|||
47072223|NCT02647320|83360208|FG000|Overall Study|Lost to Follow-up|1|||
47072224|NCT02647320|83360209|FG001|Overall Study|Lost to Follow-up|1|||
47072225|NCT02647320|83360210|FG002|Overall Study|Lost to Follow-up|0|||
47072226|NCT02647320|83360211|FG003|Overall Study|Lost to Follow-up|0|||
47072227|NCT02647320|83360212|FG004|Overall Study|Lost to Follow-up|0|||
47072228|NCT02647320|83360208|FG000|Overall Study|Develop anemia|1|||
47072229|NCT02647320|83360209|FG001|Overall Study|Develop anemia|0|||
47072230|NCT02647320|83360210|FG002|Overall Study|Develop anemia|0|||
47072231|NCT02647320|83360211|FG003|Overall Study|Develop anemia|0|||
47072232|NCT02647320|83360212|FG004|Overall Study|Develop anemia|0|||
47072233|NCT02647320|83360208|FG000|Overall Study|Lack of Efficacy|0|||
47072234|NCT02647320|83360209|FG001|Overall Study|Lack of Efficacy|0|||
47072235|NCT02647320|83360210|FG002|Overall Study|Lack of Efficacy|0|||
47072236|NCT02647320|83360211|FG003|Overall Study|Lack of Efficacy|1|||
47072237|NCT02647320|83360212|FG004|Overall Study|Lack of Efficacy|0|||
47072238|NCT02647320|83360208|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
47072239|NCT02647320|83360209|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
47072240|NCT02647320|83360210|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
47072241|NCT02647320|83360211|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
47072242|NCT02647320|83360212|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
47072243|NCT03458325|83360235|FG000|Overall Study|Withdrawal by Subject|1|||
47072244|NCT02644122|83360270|FG000|Overall Study|Withdrawal by Subject|1|||
47072245|NCT01394939|83360296|FG000|Overall Study|Adverse Event|1|||
47072246|NCT01394939|83360297|FG001|Overall Study|Adverse Event|3|||
47072247|NCT01394939|83360298|FG002|Overall Study|Adverse Event|0|||
47072248|NCT01394939|83360299|FG003|Overall Study|Adverse Event|2|||
47072249|NCT01394939|83360296|FG000|Overall Study|Death|0|||
47072250|NCT01394939|83360297|FG001|Overall Study|Death|2|||
47072251|NCT01394939|83360298|FG002|Overall Study|Death|0|||
47072252|NCT01394939|83360299|FG003|Overall Study|Death|0|||
46775491|NCT00730028|82993895|FG003|Overall Study|Protocol Violation|2|||
46967339|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
46641153|NCT01715285|82820443|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
46967340|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
47072253|NCT01394939|83360296|FG000|Overall Study|Physician Decision|0|||
46641154|NCT01715285|82820444|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
46641155|NCT01715285|82820445|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
46775492|NCT00730028|82993896|FG004|Overall Study|Protocol Violation|0|||
46775493|NCT00730028|82993892|FG000|Overall Study|Withdrawal by Subject|9|||
46775494|NCT00730028|82993893|FG001|Overall Study|Withdrawal by Subject|5|||
47072254|NCT01394939|83360297|FG001|Overall Study|Physician Decision|1|||
47072255|NCT01394939|83360298|FG002|Overall Study|Physician Decision|0|||
47072256|NCT01394939|83360299|FG003|Overall Study|Physician Decision|0|||
47072257|NCT01394939|83360296|FG000|Overall Study|Withdrawal by Subject|0|||
47072258|NCT01394939|83360297|FG001|Overall Study|Withdrawal by Subject|2|||
46775495|NCT00730028|82993894|FG002|Overall Study|Withdrawal by Subject|4|||
47072259|NCT01394939|83360298|FG002|Overall Study|Withdrawal by Subject|0|||
47072260|NCT01394939|83360299|FG003|Overall Study|Withdrawal by Subject|2|||
47072261|NCT01394939|83360296|FG000|Overall Study|Others|0|||
47072262|NCT01394939|83360297|FG001|Overall Study|Others|2|||
47072263|NCT01394939|83360298|FG002|Overall Study|Others|0|||
47072264|NCT01394939|83360299|FG003|Overall Study|Others|3|||
47072265|NCT01394627|83360317|FG000|First Intervention (1 Day)|poor intravenous access|0|||
47072266|NCT01394627|83360318|FG001|First Intervention (1 Day)|poor intravenous access|1|||
47072267|NCT01394627|83360317|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
47072268|NCT01394627|83360318|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
47072269|NCT01391663|83360337|FG000|Overall Study|Withdrawal by Subject|0|||
47072270|NCT01391663|83360338|FG001|Overall Study|Withdrawal by Subject|0|||
47072271|NCT01391663|83360339|FG002|Overall Study|Withdrawal by Subject|1|||
47072272|NCT01391663|83360340|FG003|Overall Study|Withdrawal by Subject|0|||
46846359|NCT00130208|83063084|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
46846360|NCT00130208|83063085|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
46846361|NCT00130208|83063084|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
46846362|NCT00130208|83063085|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
46846363|NCT00130208|83063084|FG000|Washout Period (8 Weeks)|Other|1|||
46846364|NCT00130208|83063085|FG001|Washout Period (8 Weeks)|Other|1|||
46846365|NCT00253370|83063091|FG000|Overall Study|Adverse Event|18|||
46846366|NCT00253370|83063091|FG000|Overall Study|Disease progression|13|||
46846367|NCT00253370|83063091|FG000|Overall Study|Death|2|||
46846368|NCT00253370|83063091|FG000|Overall Study|Withdrawal by Subject|6|||
47072273|NCT02641392|83360361|FG000|Overall Study|Lost to Follow-up|0|||
47072274|NCT02641392|83360362|FG001|Overall Study|Lost to Follow-up|0|||
47072275|NCT02641392|83360363|FG002|Overall Study|Lost to Follow-up|2|||
47072276|NCT02641392|83360361|FG000|Overall Study|Withdrawal by Subject|0|||
47072277|NCT02641392|83360362|FG001|Overall Study|Withdrawal by Subject|0|||
47072278|NCT02641392|83360363|FG002|Overall Study|Withdrawal by Subject|17|||
47072279|NCT02641392|83360361|FG000|Overall Study|Adverse Event|0|||
47072280|NCT02641392|83360362|FG001|Overall Study|Adverse Event|1|||
47072281|NCT02641392|83360363|FG002|Overall Study|Adverse Event|25|||
47072282|NCT02641392|83360361|FG000|Overall Study|Study Terminated by Sponsor|4|||
47072283|NCT02641392|83360362|FG001|Overall Study|Study Terminated by Sponsor|12|||
47072284|NCT02641392|83360363|FG002|Overall Study|Study Terminated by Sponsor|144|||
47072285|NCT02641392|83360361|FG000|Overall Study|Lack of Efficacy|0|||
47072286|NCT02641392|83360362|FG001|Overall Study|Lack of Efficacy|0|||
47072287|NCT02641392|83360363|FG002|Overall Study|Lack of Efficacy|101|||
47072288|NCT02641392|83360361|FG000|Overall Study|Miscellaneous|0|||
47072289|NCT02641392|83360362|FG001|Overall Study|Miscellaneous|0|||
47072290|NCT02641392|83360363|FG002|Overall Study|Miscellaneous|3|||
47072291|NCT02641392|83360361|FG000|Overall Study|Death|0|||
47072292|NCT02641392|83360362|FG001|Overall Study|Death|0|||
47072293|NCT02641392|83360363|FG002|Overall Study|Death|1|||
47072294|NCT04440007|83360373|FG000|Overall Study|Adverse Event|0|||
47072295|NCT04440007|83360374|FG001|Overall Study|Adverse Event|1|||
47072296|NCT04440007|83360373|FG000|Overall Study|Lost to Follow-up|1|||
47072297|NCT04440007|83360374|FG001|Overall Study|Lost to Follow-up|3|||
47072298|NCT04440007|83360373|FG000|Overall Study|Death|7|||
47072299|NCT04440007|83360374|FG001|Overall Study|Death|2|||
47072300|NCT04440007|83360373|FG000|Overall Study|Physician Decision|1|||
47072301|NCT04440007|83360374|FG001|Overall Study|Physician Decision|1|||
47072302|NCT04440007|83360373|FG000|Overall Study|Withdrawal by Subject|2|||
47072303|NCT04440007|83360374|FG001|Overall Study|Withdrawal by Subject|1|||
47072304|NCT04440007|83360373|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
47072305|NCT04440007|83360374|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
47072306|NCT04440007|83360373|FG000|Overall Study|Discontinued prior to dosing|0|||
47072307|NCT04440007|83360374|FG001|Overall Study|Discontinued prior to dosing|2|||
47072308|NCT01391507|83360384|FG000|Overall Study|Death|0|||
47072309|NCT01391507|83360385|FG001|Overall Study|Death|0|||
47072310|NCT01391507|83360386|FG002|Overall Study|Death|0|||
47072311|NCT01391507|83360387|FG003|Overall Study|Death|1|||
47072312|NCT01391507|83360384|FG000|Overall Study|Adverse Event|1|||
47072313|NCT01391507|83360385|FG001|Overall Study|Adverse Event|1|||
46641156|NCT01715285|82820443|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
46641157|NCT01715285|82820444|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
46846369|NCT00253370|83063091|FG000|Overall Study|Non-protocol therapy|1|||
47072314|NCT01391507|83360386|FG002|Overall Study|Adverse Event|2|||
47072315|NCT01391507|83360387|FG003|Overall Study|Adverse Event|2|||
47072316|NCT01391507|83360384|FG000|Overall Study|Withdrawal by Subject|1|||
47072317|NCT01391507|83360385|FG001|Overall Study|Withdrawal by Subject|2|||
47072318|NCT01391507|83360386|FG002|Overall Study|Withdrawal by Subject|1|||
47072319|NCT01391507|83360387|FG003|Overall Study|Withdrawal by Subject|1|||
46641158|NCT01715285|82820445|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
47072320|NCT01391507|83360384|FG000|Overall Study|Lack of Efficacy|0|||
47072321|NCT01391507|83360385|FG001|Overall Study|Lack of Efficacy|0|||
47072322|NCT01391507|83360386|FG002|Overall Study|Lack of Efficacy|0|||
47072323|NCT01391507|83360387|FG003|Overall Study|Lack of Efficacy|1|||
47072324|NCT01391507|83360384|FG000|Overall Study|Protocol Violation|2|||
47072325|NCT01391507|83360385|FG001|Overall Study|Protocol Violation|1|||
47072326|NCT01391507|83360386|FG002|Overall Study|Protocol Violation|1|||
47072327|NCT01391507|83360387|FG003|Overall Study|Protocol Violation|2|||
47072328|NCT01473524|83360409|FG000|DB Phase|Adverse Event|4|||
47072329|NCT01473524|83360410|FG001|DB Phase|Adverse Event|8|||
47072330|NCT01473524|83360411|FG002|DB Phase|Adverse Event|2|||
47072331|NCT01473524|83360412|FG003|DB Phase|Adverse Event|0|||
47072332|NCT01473524|83360413|FG004|DB Phase|Adverse Event|0|||
47072333|NCT01473524|83360414|FG005|DB Phase|Adverse Event|0|||
47072334|NCT01473524|83360409|FG000|DB Phase|Death|1|||
47072335|NCT01473524|83360410|FG001|DB Phase|Death|0|||
47072336|NCT01473524|83360411|FG002|DB Phase|Death|0|||
47072337|NCT01473524|83360412|FG003|DB Phase|Death|0|||
47072338|NCT01473524|83360413|FG004|DB Phase|Death|0|||
47072339|NCT01473524|83360414|FG005|DB Phase|Death|0|||
47072340|NCT01473524|83360409|FG000|DB Phase|Withdrawal by Subject|2|||
47072341|NCT01473524|83360410|FG001|DB Phase|Withdrawal by Subject|1|||
47072342|NCT01473524|83360411|FG002|DB Phase|Withdrawal by Subject|1|||
47072343|NCT01473524|83360412|FG003|DB Phase|Withdrawal by Subject|0|||
47072344|NCT01473524|83360413|FG004|DB Phase|Withdrawal by Subject|0|||
47072345|NCT01473524|83360414|FG005|DB Phase|Withdrawal by Subject|0|||
47072346|NCT01473524|83360409|FG000|LTSE Phase|Withdrawal by Subject|0|||
47072347|NCT01473524|83360410|FG001|LTSE Phase|Withdrawal by Subject|0|||
47072348|NCT01473524|83360411|FG002|LTSE Phase|Withdrawal by Subject|0|||
47072349|NCT01473524|83360412|FG003|LTSE Phase|Withdrawal by Subject|3|||
47072350|NCT01473524|83360413|FG004|LTSE Phase|Withdrawal by Subject|3|||
47072351|NCT01473524|83360414|FG005|LTSE Phase|Withdrawal by Subject|6|||
47072352|NCT01473524|83360409|FG000|LTSE Phase|Death|0|||
47072353|NCT01473524|83360410|FG001|LTSE Phase|Death|0|||
47072354|NCT01473524|83360411|FG002|LTSE Phase|Death|0|||
47072355|NCT01473524|83360412|FG003|LTSE Phase|Death|0|||
47072356|NCT01473524|83360413|FG004|LTSE Phase|Death|1|||
47072357|NCT01473524|83360414|FG005|LTSE Phase|Death|0|||
47072358|NCT01473524|83360409|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
47072359|NCT01473524|83360410|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
47072360|NCT01473524|83360411|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
47072361|NCT01473524|83360412|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
47072362|NCT01473524|83360413|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
47072363|NCT01473524|83360414|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
47072364|NCT01473524|83360409|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
47072365|NCT01473524|83360410|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
47072366|NCT01473524|83360411|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
47072367|NCT01473524|83360412|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
47072368|NCT01473524|83360413|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
47072369|NCT01473524|83360414|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
47072370|NCT01473524|83360409|FG000|LTSE Phase|Lost to Follow-up|0|||
47072371|NCT01473524|83360410|FG001|LTSE Phase|Lost to Follow-up|0|||
47072372|NCT01473524|83360411|FG002|LTSE Phase|Lost to Follow-up|0|||
47072373|NCT01473524|83360412|FG003|LTSE Phase|Lost to Follow-up|1|||
47072374|NCT01473524|83360413|FG004|LTSE Phase|Lost to Follow-up|3|||
47072375|NCT01473524|83360414|FG005|LTSE Phase|Lost to Follow-up|2|||
47072376|NCT01473524|83360409|FG000|LTSE Phase|Principal Investigator Decision|0|||
47072377|NCT01473524|83360410|FG001|LTSE Phase|Principal Investigator Decision|0|||
47072378|NCT01473524|83360411|FG002|LTSE Phase|Principal Investigator Decision|0|||
47072379|NCT01473524|83360412|FG003|LTSE Phase|Principal Investigator Decision|1|||
47072380|NCT01473524|83360413|FG004|LTSE Phase|Principal Investigator Decision|1|||
47072381|NCT01473524|83360414|FG005|LTSE Phase|Principal Investigator Decision|3|||
47072382|NCT01473524|83360409|FG000|LTSE Phase|Liver Transplantation|0|||
47072383|NCT01473524|83360410|FG001|LTSE Phase|Liver Transplantation|0|||
47072384|NCT01473524|83360411|FG002|LTSE Phase|Liver Transplantation|0|||
47072385|NCT01473524|83360412|FG003|LTSE Phase|Liver Transplantation|0|||
47072386|NCT01473524|83360413|FG004|LTSE Phase|Liver Transplantation|0|||
47072387|NCT01473524|83360414|FG005|LTSE Phase|Liver Transplantation|1|||
47072388|NCT01473524|83360409|FG000|LTSE Phase|Pregnancy|0|||
46641159|NCT01250496|82820454|FG000|Overall Study|Study terminated|124|||
47072389|NCT01473524|83360410|FG001|LTSE Phase|Pregnancy|0|||
47072390|NCT01473524|83360411|FG002|LTSE Phase|Pregnancy|0|||
47072391|NCT01473524|83360412|FG003|LTSE Phase|Pregnancy|1|||
47072392|NCT01473524|83360413|FG004|LTSE Phase|Pregnancy|0|||
47072393|NCT01473524|83360414|FG005|LTSE Phase|Pregnancy|0|||
47072394|NCT01473524|83360409|FG000|LTSE Phase|Protocol Violation|0|||
47072395|NCT01473524|83360410|FG001|LTSE Phase|Protocol Violation|0|||
47072396|NCT01473524|83360411|FG002|LTSE Phase|Protocol Violation|0|||
47072397|NCT01473524|83360412|FG003|LTSE Phase|Protocol Violation|0|||
47072398|NCT01473524|83360413|FG004|LTSE Phase|Protocol Violation|0|||
47072399|NCT01473524|83360414|FG005|LTSE Phase|Protocol Violation|1|||
47072400|NCT01390649|83360445|FG000|Overall Study|Physician Decision|1|||
47072401|NCT01390181|83360449|FG000|Overall Study|Lost to Follow-up|1|||
47072402|NCT01390181|83360449|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
47072403|NCT02641080|83360455|FG000|Overall Study|Physician Decision|2|||
47072404|NCT02641080|83360456|FG001|Overall Study|Physician Decision|0|||
47072405|NCT02641080|83360455|FG000|Overall Study|Withdrawal by Subject|0|||
47072406|NCT02641080|83360456|FG001|Overall Study|Withdrawal by Subject|1|||
47072407|NCT02641080|83360455|FG000|Overall Study|Rehab Center denied use of pumps|0|||
47072408|NCT02641080|83360456|FG001|Overall Study|Rehab Center denied use of pumps|3|||
47072409|NCT02641080|83360455|FG000|Overall Study|Lost to Follow-up|0|||
47072410|NCT02641080|83360456|FG001|Overall Study|Lost to Follow-up|3|||
47072411|NCT01457846|83360464|FG000|Overall Study|Death before treatment|1|||
47072412|NCT01457846|83360465|FG001|Overall Study|Death before treatment|2|||
47072413|NCT01457846|83360464|FG000|Overall Study|Did not receive treatment|0|||
47072414|NCT01457846|83360465|FG001|Overall Study|Did not receive treatment|1|||
47072415|NCT01457846|83360464|FG000|Overall Study|Death|27|||
47072416|NCT01457846|83360465|FG001|Overall Study|Death|16|||
47072417|NCT01457846|83360464|FG000|Overall Study|Unclassified reason for not completed|11|||
47072418|NCT01457846|83360465|FG001|Overall Study|Unclassified reason for not completed|10|||
47072419|NCT01457846|83360464|FG000|Overall Study|Withdrawal by Subject|1|||
47072420|NCT01457846|83360465|FG001|Overall Study|Withdrawal by Subject|1|||
47072421|NCT01457846|83360464|FG000|Overall Study|Lost to Follow-up|1|||
46846370|NCT00253370|83063091|FG000|Overall Study|Physician Decision|1|||
46846371|NCT00253370|83063091|FG000|Overall Study|Protocol Violation|1|||
46846372|NCT00253370|83063091|FG000|Overall Study|Abdominal pain due to disease|1|||
46846373|NCT00140426|83063098|FG000|Overall Study|Withdrawal by Subject|0|||
46846374|NCT00140426|83063099|FG001|Overall Study|Withdrawal by Subject|3|||
46846375|NCT00121134|83063114|FG000|Overall Study|Progression of Disease|5|||
46846376|NCT00121134|83063115|FG001|Overall Study|Progression of Disease|3|||
46846377|NCT00121134|83063116|FG002|Overall Study|Progression of Disease|4|||
46846378|NCT00121134|83063117|FG003|Overall Study|Progression of Disease|2|||
46846379|NCT00121134|83063114|FG000|Overall Study|Toxicity|4|||
46846380|NCT00121134|83063115|FG001|Overall Study|Toxicity|7|||
46846381|NCT00121134|83063116|FG002|Overall Study|Toxicity|13|||
46846382|NCT00121134|83063117|FG003|Overall Study|Toxicity|5|||
46846383|NCT00121134|83063114|FG000|Overall Study|Physician Decision|6|||
46846384|NCT00121134|83063115|FG001|Overall Study|Physician Decision|4|||
46846385|NCT00121134|83063116|FG002|Overall Study|Physician Decision|4|||
46846386|NCT00121134|83063117|FG003|Overall Study|Physician Decision|1|||
46846387|NCT00121134|83063114|FG000|Overall Study|Treatment Delay|1|||
46846388|NCT00121134|83063115|FG001|Overall Study|Treatment Delay|0|||
46846389|NCT00121134|83063116|FG002|Overall Study|Treatment Delay|0|||
46846390|NCT00121134|83063117|FG003|Overall Study|Treatment Delay|0|||
46846391|NCT00121134|83063114|FG000|Overall Study|Intercurrent Illness|0|||
46846392|NCT00121134|83063115|FG001|Overall Study|Intercurrent Illness|0|||
46846393|NCT00121134|83063116|FG002|Overall Study|Intercurrent Illness|0|||
46846394|NCT00121134|83063117|FG003|Overall Study|Intercurrent Illness|1|||
46846395|NCT00121134|83063114|FG000|Overall Study|Patient Personal Reasons|0|||
47072422|NCT01457846|83360465|FG001|Overall Study|Lost to Follow-up|0|||
46641160|NCT01250496|82820455|FG001|Overall Study|Study terminated|124|||
46775496|NCT00730028|82993895|FG003|Overall Study|Withdrawal by Subject|5|||
47072423|NCT01496066|83360477|FG000|Overall Study|Lost to Follow-up|8|||
47072424|NCT01496066|83360478|FG001|Overall Study|Lost to Follow-up|5|||
46775497|NCT00730028|82993896|FG004|Overall Study|Withdrawal by Subject|9|||
47072425|NCT01496066|83360477|FG000|Overall Study|Explant|3|||
46775498|NCT00730028|82993892|FG000|Overall Study|Physician Decision|3|||
46775499|NCT00730028|82993893|FG001|Overall Study|Physician Decision|3|||
46775500|NCT00730028|82993894|FG002|Overall Study|Physician Decision|2|||
46775501|NCT00730028|82993895|FG003|Overall Study|Physician Decision|3|||
46775502|NCT00730028|82993896|FG004|Overall Study|Physician Decision|2|||
46775503|NCT00730028|82993892|FG000|Overall Study|Treatment Failure|5|||
46775504|NCT00730028|82993893|FG001|Overall Study|Treatment Failure|5|||
46846396|NCT00121134|83063115|FG001|Overall Study|Patient Personal Reasons|1|||
46846397|NCT00121134|83063116|FG002|Overall Study|Patient Personal Reasons|0|||
46846398|NCT00121134|83063117|FG003|Overall Study|Patient Personal Reasons|0|||
46846399|NCT00119262|83063129|FG000|Overall Study|Lack of Efficacy|0|||
46846400|NCT00119262|83063130|FG001|Overall Study|Lack of Efficacy|3|||
46846401|NCT00119262|83063129|FG000|Overall Study|Withdrawal by Subject|12|||
46846402|NCT00119262|83063130|FG001|Overall Study|Withdrawal by Subject|11|||
46846403|NCT00119262|83063129|FG000|Overall Study|Adverse Event|33|||
47072426|NCT01496066|83360478|FG001|Overall Study|Explant|0|||
47072427|NCT01496066|83360477|FG000|Overall Study|Death|1|||
47072428|NCT01496066|83360478|FG001|Overall Study|Death|4|||
47072429|NCT01389323|83360491|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
47072430|NCT01389323|83360491|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
47072431|NCT01389323|83360491|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
47072432|NCT01389323|83360491|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
47072433|NCT01389323|83360491|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
47072434|NCT01389323|83360491|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
47072435|NCT01389323|83360491|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
47072436|NCT01389323|83360491|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
47072437|NCT01389323|83360491|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
47072438|NCT01389323|83360491|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
47072439|NCT01389323|83360491|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
47072440|NCT01389245|83360502|FG000|Overall Study|Protocol Violation|10|||
47072441|NCT01389245|83360502|FG000|Overall Study|Lost to Follow-up|3|||
47072442|NCT01389245|83360502|FG000|Overall Study|Withdrawal by Subject|2|||
47072443|NCT01494818|83360508|FG000|Overall Study|Relocation|1|||
47072444|NCT01494818|83360509|FG001|Overall Study|Relocation|2|||
47072445|NCT01494818|83360508|FG000|Overall Study|Lost to Follow-up|1|||
47072446|NCT01494818|83360509|FG001|Overall Study|Lost to Follow-up|0|||
47072447|NCT01494584|83360515|FG000|Overall Study|Study Closed/Terminated|1|||
47072448|NCT01388543|83360540|FG000|Day 14|Adverse Event|1|||
47072449|NCT01388543|83360541|FG001|Day 14|Adverse Event|4|||
47072450|NCT00512317|83360560|FG000|Overall Study|Insufficient clinical response|36|||
47072451|NCT00512317|83360560|FG000|Overall Study|Withdrawal by Subject|23|||
47072452|NCT00512317|83360560|FG000|Overall Study|Sponsor closure of study|21|||
47072453|NCT00512317|83360560|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
47072454|NCT00512317|83360560|FG000|Overall Study|Adverse Event|13|||
47072455|NCT00512317|83360560|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
47072456|NCT00512317|83360560|FG000|Overall Study|Lost to Follow-up|2|||
47072457|NCT00512317|83360560|FG000|Overall Study|Other|2|||
47072458|NCT01494506|83360576|FG000|Overall Study|Lack of Efficacy|77|||
47072459|NCT01494506|83360577|FG001|Overall Study|Lack of Efficacy|83|||
47072460|NCT01494506|83360578|FG002|Overall Study|Lack of Efficacy|57|||
47072461|NCT01494506|83360576|FG000|Overall Study|Adverse Event|17|||
47072462|NCT01494506|83360577|FG001|Overall Study|Adverse Event|10|||
47072463|NCT01494506|83360578|FG002|Overall Study|Adverse Event|11|||
47072464|NCT01494506|83360576|FG000|Overall Study|Death|9|||
47072465|NCT01494506|83360577|FG001|Overall Study|Death|5|||
46846404|NCT00119262|83063130|FG001|Overall Study|Adverse Event|35|||
46846405|NCT00119262|83063129|FG000|Overall Study|other disease|0|||
46846406|NCT00119262|83063130|FG001|Overall Study|other disease|2|||
46846407|NCT00119262|83063129|FG000|Overall Study|ineligble|1|||
46967341|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
46967342|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
46967343|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
46967344|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
46967345|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
46967346|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
46967347|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
46967348|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
46967349|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
46967350|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
46967351|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
46967352|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
46846408|NCT00119262|83063130|FG001|Overall Study|ineligble|2|||
46846409|NCT00119262|83063129|FG000|Overall Study|others|0|||
46846410|NCT00119262|83063130|FG001|Overall Study|others|5|||
47072466|NCT01494506|83360578|FG002|Overall Study|Death|2|||
47072467|NCT01494506|83360576|FG000|Overall Study|Physician Decision|7|||
47072468|NCT01494506|83360577|FG001|Overall Study|Physician Decision|5|||
47072469|NCT01494506|83360578|FG002|Overall Study|Physician Decision|4|||
47072470|NCT01494506|83360576|FG000|Overall Study|Withdrawal by Subject|17|||
46846411|NCT03703882|83063138|FG000|Overall Study|Adverse Event|1|||
46846412|NCT03703882|83063139|FG001|Overall Study|Adverse Event|0|||
46846413|NCT03703882|83063138|FG000|Overall Study|Lost to Follow-up|0|||
47072471|NCT01494506|83360577|FG001|Overall Study|Withdrawal by Subject|20|||
46967353|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
46967354|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
46967355|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
46967356|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
46967357|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
46967358|NCT00700427|83209982|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
46967359|NCT00700427|83209983|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
46967360|NCT00700427|83209984|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
46967361|NCT00700427|83209985|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
46967362|NCT00700427|83209986|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
46967363|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
46967364|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
46967365|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
46967366|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
46775505|NCT00730028|82993894|FG002|Overall Study|Treatment Failure|0|||
46775506|NCT00730028|82993895|FG003|Overall Study|Treatment Failure|0|||
46846414|NCT03703882|83063139|FG001|Overall Study|Lost to Follow-up|2|||
46846415|NCT03703882|83063138|FG000|Overall Study|Non-compliance with study drug|0|||
46846416|NCT03703882|83063139|FG001|Overall Study|Non-compliance with study drug|1|||
46846417|NCT03703882|83063138|FG000|Overall Study|Physician Decision|0|||
46846418|NCT03703882|83063139|FG001|Overall Study|Physician Decision|1|||
46846419|NCT03703882|83063138|FG000|Overall Study|Progressive disease|1|||
47072472|NCT01494506|83360578|FG002|Overall Study|Withdrawal by Subject|14|||
47072473|NCT01494506|83360576|FG000|Overall Study|Clinical Deterioration|21|||
47072474|NCT01494506|83360577|FG001|Overall Study|Clinical Deterioration|17|||
47072475|NCT01494506|83360578|FG002|Overall Study|Clinical Deterioration|13|||
47072476|NCT01494506|83360576|FG000|Overall Study|Sponsor Decision|0|||
47072477|NCT01494506|83360577|FG001|Overall Study|Sponsor Decision|0|||
47072478|NCT01494506|83360578|FG002|Overall Study|Sponsor Decision|1|||
47072479|NCT01494506|83360576|FG000|Overall Study|Other|0|||
47072480|NCT01494506|83360577|FG001|Overall Study|Other|3|||
47072481|NCT01494506|83360578|FG002|Overall Study|Other|1|||
47072482|NCT02643420|83360590|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
47072483|NCT02643420|83360591|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
47072484|NCT02643420|83360590|FG000|Overall Study|Withdrawal by Subject|25|||
47072485|NCT02643420|83360591|FG001|Overall Study|Withdrawal by Subject|19|||
47072486|NCT02643420|83360590|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
47072487|NCT02643420|83360591|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
46967367|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
46967368|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
47072488|NCT02643420|83360590|FG000|Overall Study|Lost to Follow-up|6|||
47072489|NCT02643420|83360591|FG001|Overall Study|Lost to Follow-up|10|||
46641161|NCT01105975|82820471|FG000|Overall Study|Adverse Event|2|||
46641162|NCT01105975|82820472|FG001|Overall Study|Adverse Event|1|||
46641163|NCT01105975|82820473|FG002|Overall Study|Adverse Event|5|||
46775507|NCT00730028|82993896|FG004|Overall Study|Treatment Failure|1|||
46775508|NCT00730028|82993892|FG000|Overall Study|Randomization Error|1|||
46775509|NCT00730028|82993893|FG001|Overall Study|Randomization Error|0|||
46775510|NCT00730028|82993894|FG002|Overall Study|Randomization Error|0|||
46775511|NCT00730028|82993895|FG003|Overall Study|Randomization Error|0|||
46775512|NCT00730028|82993896|FG004|Overall Study|Randomization Error|2|||
46775513|NCT00736502|82993908|FG000|Overall Study|Adverse Event|22|||
46775514|NCT00736502|82993908|FG000|Overall Study|Lack of Efficacy|16|||
46775515|NCT00736502|82993908|FG000|Overall Study|Lost to Follow-up|27|||
46846420|NCT03703882|83063139|FG001|Overall Study|Progressive disease|0|||
46846421|NCT03703882|83063138|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46846422|NCT03703882|83063139|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46846423|NCT03703882|83063138|FG000|Overall Study|Starting another treatment|0|||
46846424|NCT03703882|83063139|FG001|Overall Study|Starting another treatment|1|||
46846425|NCT03703882|83063138|FG000|Overall Study|noncompliance with study procedures|0|||
46846426|NCT03703882|83063139|FG001|Overall Study|noncompliance with study procedures|1|||
46846427|NCT00131664|83063148|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
46846428|NCT00131664|83063149|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
46846429|NCT00131664|83063150|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
46846430|NCT00131664|83063151|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
46846431|NCT00131664|83063152|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
47072490|NCT02643420|83360590|FG000|Overall Study|Investigator Decision|2|||
47072491|NCT02643420|83360591|FG001|Overall Study|Investigator Decision|4|||
47072492|NCT02643420|83360590|FG000|Overall Study|Sponsor decision|1|||
47072493|NCT02643420|83360591|FG001|Overall Study|Sponsor decision|1|||
46846432|NCT00131664|83063153|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
46846433|NCT00131664|83063148|FG000|First Period (First 6 Months)|Death|0|||
47072494|NCT02643420|83360590|FG000|Overall Study|Death|0|||
47072495|NCT02643420|83360591|FG001|Overall Study|Death|2|||
47072496|NCT02643420|83360590|FG000|Overall Study|Reason not Specified|8|||
47072497|NCT02643420|83360591|FG001|Overall Study|Reason not Specified|7|||
47072498|NCT01456130|83360614|FG000|Overall Study|Adverse Event|4|||
47072499|NCT01456130|83360614|FG000|Overall Study|Voluntary Withdrawal|1|||
47072500|NCT01456130|83360614|FG000|Overall Study|Lack of Efficacy|4|||
47072501|NCT01456130|83360614|FG000|Overall Study|Other|1|||
47072502|NCT01456052|83360621|FG000|Overall Study|Adverse Event|1|||
47072503|NCT01456052|83360622|FG001|Overall Study|Adverse Event|1|||
47072504|NCT01456052|83360623|FG002|Overall Study|Adverse Event|2|||
47072505|NCT01456052|83360621|FG000|Overall Study|Consent withdrawn|0|||
47072506|NCT01456052|83360622|FG001|Overall Study|Consent withdrawn|2|||
47072507|NCT01456052|83360623|FG002|Overall Study|Consent withdrawn|1|||
47072508|NCT01456052|83360621|FG000|Overall Study|Protocol Violation|0|||
47072509|NCT01456052|83360622|FG001|Overall Study|Protocol Violation|1|||
47072510|NCT01456052|83360623|FG002|Overall Study|Protocol Violation|0|||
47072511|NCT01456052|83360621|FG000|Overall Study|Physician Decision|1|||
47072512|NCT01456052|83360622|FG001|Overall Study|Physician Decision|0|||
47072513|NCT01456052|83360623|FG002|Overall Study|Physician Decision|1|||
47072514|NCT01456052|83360621|FG000|Overall Study|Treatment Failure|0|||
47072515|NCT01456052|83360622|FG001|Overall Study|Treatment Failure|1|||
47072516|NCT01456052|83360623|FG002|Overall Study|Treatment Failure|1|||
47072517|NCT01387607|83360634|FG000|Overall Study|Adverse Event|23|||
47072518|NCT01387607|83360635|FG001|Overall Study|Adverse Event|11|||
47072519|NCT01387607|83360634|FG000|Overall Study|Lack of Efficacy|8|||
47072520|NCT01387607|83360635|FG001|Overall Study|Lack of Efficacy|6|||
47072521|NCT01387607|83360634|FG000|Overall Study|Lost to Follow-up|2|||
47072522|NCT01387607|83360635|FG001|Overall Study|Lost to Follow-up|1|||
47072523|NCT01387607|83360634|FG000|Overall Study|No longer meets eligibility criteria|0|||
47072524|NCT01387607|83360635|FG001|Overall Study|No longer meets eligibility criteria|1|||
47072525|NCT01387607|83360634|FG000|Overall Study|Protocol Violation|1|||
46775516|NCT00729560|82993912|FG000|Overall Study|Withdrawal by Subject|3|||
46775517|NCT00736190|82993916|FG000|Overall Study|Pregnancy|1|||
46775518|NCT00736190|82993916|FG000|Overall Study|Withdrawal by Subject|1|||
47072526|NCT01387607|83360635|FG001|Overall Study|Protocol Violation|5|||
47072527|NCT01387607|83360634|FG000|Overall Study|Withdrawal by Subject|13|||
47072528|NCT01387607|83360635|FG001|Overall Study|Withdrawal by Subject|14|||
47072529|NCT01387607|83360634|FG000|Overall Study|Other|1|||
47072530|NCT01387607|83360635|FG001|Overall Study|Other|1|||
47072531|NCT01387607|83360634|FG000|Overall Study|Randomized, not treated|3|||
47072532|NCT01387607|83360635|FG001|Overall Study|Randomized, not treated|6|||
47072533|NCT03451045|83360644|FG000|Overall Study|Lack of Efficacy|3|||
47072534|NCT03451045|83360645|FG001|Overall Study|Lack of Efficacy|2|||
47072535|NCT03451045|83360646|FG002|Overall Study|Lack of Efficacy|2|||
47072536|NCT03451045|83360644|FG000|Overall Study|Physician Decision|1|||
47072537|NCT03451045|83360645|FG001|Overall Study|Physician Decision|1|||
47072538|NCT03451045|83360646|FG002|Overall Study|Physician Decision|1|||
47072539|NCT03451045|83360644|FG000|Overall Study|Withdrawal by Subject|4|||
47072540|NCT03451045|83360645|FG001|Overall Study|Withdrawal by Subject|0|||
47072541|NCT03451045|83360646|FG002|Overall Study|Withdrawal by Subject|5|||
47072542|NCT03451045|83360644|FG000|Overall Study|Pregnancy|0|||
47072543|NCT03451045|83360645|FG001|Overall Study|Pregnancy|0|||
47072544|NCT03451045|83360646|FG002|Overall Study|Pregnancy|2|||
47072545|NCT03451045|83360644|FG000|Overall Study|Adverse Event|7|||
47072546|NCT03451045|83360645|FG001|Overall Study|Adverse Event|1|||
47072547|NCT03451045|83360646|FG002|Overall Study|Adverse Event|3|||
47072548|NCT03451045|83360644|FG000|Overall Study|Non-compliance with study|2|||
47072549|NCT03451045|83360645|FG001|Overall Study|Non-compliance with study|0|||
47072550|NCT03451045|83360646|FG002|Overall Study|Non-compliance with study|1|||
47072551|NCT03451045|83360644|FG000|Overall Study|any other reason|10|||
47072552|NCT03451045|83360645|FG001|Overall Study|any other reason|2|||
47072553|NCT03451045|83360646|FG002|Overall Study|any other reason|13|||
47072554|NCT03219567|83360657|FG000|Overall Study|Withdrawal by Subject|0|||
46641164|NCT01105975|82820474|FG003|Overall Study|Adverse Event|1|||
47072555|NCT03219567|83360658|FG001|Overall Study|Withdrawal by Subject|1|||
47072556|NCT01386125|83360667|FG000|Overall Study|Lost to Follow-up|3|||
47072557|NCT01386125|83360668|FG001|Overall Study|Lost to Follow-up|9|||
47072558|NCT01386125|83360667|FG000|Overall Study|Physician Decision|0|||
47072559|NCT01386125|83360668|FG001|Overall Study|Physician Decision|1|||
47072560|NCT01386125|83360667|FG000|Overall Study|Protocol Violation|5|||
46775519|NCT00736190|82993916|FG000|Overall Study|Adverse Event|1|||
46967369|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
47072561|NCT01386125|83360668|FG001|Overall Study|Protocol Violation|7|||
47072562|NCT01386125|83360667|FG000|Overall Study|Disease Progress|1|||
47072563|NCT01386125|83360668|FG001|Overall Study|Disease Progress|2|||
47072564|NCT01386125|83360667|FG000|Overall Study|Withdrawal by Subject|13|||
47072565|NCT01386125|83360668|FG001|Overall Study|Withdrawal by Subject|12|||
47072566|NCT01386125|83360667|FG000|Overall Study|Adverse Event|2|||
46641165|NCT01105975|82820475|FG004|Overall Study|Adverse Event|0|||
47072567|NCT01386125|83360668|FG001|Overall Study|Adverse Event|5|||
47072568|NCT01386125|83360667|FG000|Overall Study|Lack of Efficacy|0|||
47072569|NCT01386125|83360668|FG001|Overall Study|Lack of Efficacy|1|||
47072570|NCT01386125|83360667|FG000|Overall Study|Participant Leaving Country|1|||
47072571|NCT01386125|83360668|FG001|Overall Study|Participant Leaving Country|0|||
47072572|NCT01384877|83360676|FG000|Treatment 2|Lost to Follow-up|2|||
47072573|NCT01384877|83360677|FG001|Treatment 2|Lost to Follow-up|2|||
47072574|NCT00114517|83360687|FG000|Overall Study|Adverse Event|6|||
47072575|NCT00114517|83360688|FG001|Overall Study|Adverse Event|1|||
47072576|NCT00114517|83360689|FG002|Overall Study|Adverse Event|6|||
47072577|NCT00114517|83360690|FG003|Overall Study|Adverse Event|3|||
47072578|NCT00114517|83360687|FG000|Overall Study|Lost to Follow-up|2|||
47072579|NCT00114517|83360688|FG001|Overall Study|Lost to Follow-up|2|||
47072580|NCT00114517|83360689|FG002|Overall Study|Lost to Follow-up|2|||
47072581|NCT00114517|83360690|FG003|Overall Study|Lost to Follow-up|1|||
47072582|NCT00114517|83360687|FG000|Overall Study|Too busy|3|||
47072583|NCT00114517|83360688|FG001|Overall Study|Too busy|1|||
47072584|NCT00114517|83360689|FG002|Overall Study|Too busy|1|||
47072585|NCT00114517|83360690|FG003|Overall Study|Too busy|2|||
47072586|NCT00114517|83360687|FG000|Overall Study|Moved from area|0|||
47072587|NCT00114517|83360688|FG001|Overall Study|Moved from area|3|||
47072588|NCT00114517|83360689|FG002|Overall Study|Moved from area|2|||
47072589|NCT00114517|83360690|FG003|Overall Study|Moved from area|1|||
47072590|NCT00114517|83360687|FG000|Overall Study|Did not want estradiol|1|||
47072591|NCT00114517|83360688|FG001|Overall Study|Did not want estradiol|1|||
47072592|NCT00114517|83360689|FG002|Overall Study|Did not want estradiol|0|||
47072593|NCT00114517|83360690|FG003|Overall Study|Did not want estradiol|0|||
47072594|NCT00114517|83360687|FG000|Overall Study|Armed-services duty|0|||
47072595|NCT00114517|83360688|FG001|Overall Study|Armed-services duty|1|||
47072596|NCT00114517|83360689|FG002|Overall Study|Armed-services duty|0|||
47072597|NCT00114517|83360690|FG003|Overall Study|Armed-services duty|1|||
47072598|NCT00114517|83360687|FG000|Overall Study|Competing family issue|0|||
47072599|NCT00114517|83360688|FG001|Overall Study|Competing family issue|1|||
47072600|NCT00114517|83360689|FG002|Overall Study|Competing family issue|0|||
47072601|NCT00114517|83360690|FG003|Overall Study|Competing family issue|1|||
47072602|NCT00114517|83360687|FG000|Overall Study|Physician Decision|0|||
47072603|NCT00114517|83360688|FG001|Overall Study|Physician Decision|1|||
47072604|NCT00114517|83360689|FG002|Overall Study|Physician Decision|0|||
47072605|NCT00114517|83360690|FG003|Overall Study|Physician Decision|0|||
47072606|NCT00114517|83360687|FG000|Overall Study|Lost interest|0|||
47072607|NCT00114517|83360688|FG001|Overall Study|Lost interest|0|||
47072608|NCT00114517|83360689|FG002|Overall Study|Lost interest|1|||
47072609|NCT00114517|83360690|FG003|Overall Study|Lost interest|0|||
47072610|NCT00114517|83360687|FG000|Overall Study|Weight increase|0|||
47072611|NCT00114517|83360688|FG001|Overall Study|Weight increase|0|||
47072612|NCT00114517|83360689|FG002|Overall Study|Weight increase|1|||
47072613|NCT00114517|83360690|FG003|Overall Study|Weight increase|0|||
47072614|NCT00114517|83360687|FG000|Overall Study|Concern about blood clots|0|||
47072615|NCT00114517|83360688|FG001|Overall Study|Concern about blood clots|0|||
47072616|NCT00114517|83360689|FG002|Overall Study|Concern about blood clots|1|||
47072617|NCT00114517|83360690|FG003|Overall Study|Concern about blood clots|0|||
47072618|NCT00114517|83360687|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
47072619|NCT00114517|83360688|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
47072620|NCT00114517|83360689|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
47072621|NCT00114517|83360690|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
47072622|NCT01384019|83360743|FG000|Overall Study|Withdrawal by Subject|3|||
47072623|NCT01384019|83360744|FG001|Overall Study|Withdrawal by Subject|0|||
47072624|NCT01384019|83360743|FG000|Overall Study|Death|1|||
47072625|NCT01384019|83360744|FG001|Overall Study|Death|0|||
47072626|NCT01384019|83360743|FG000|Overall Study|MRI refusal|6|||
47072627|NCT01384019|83360744|FG001|Overall Study|MRI refusal|6|||
47072628|NCT00033631|83360752|FG000|Overall Study|Protocol Violation|14|||
47072629|NCT00033631|83360753|FG001|Overall Study|Protocol Violation|11|||
46967370|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
46967371|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
46967372|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
47072630|NCT00033631|83360752|FG000|Overall Study|Withdrawal by Subject|4|||
47072631|NCT00033631|83360753|FG001|Overall Study|Withdrawal by Subject|4|||
47072632|NCT01471574|83360764|FG000|Treatment Period|Lack of Efficacy|12|||
47072633|NCT01471574|83360765|FG001|Treatment Period|Lack of Efficacy|4|||
47072634|NCT01471574|83360766|FG002|Treatment Period|Lack of Efficacy|14|||
47072635|NCT01471574|83360767|FG003|Treatment Period|Lack of Efficacy|1|||
47072636|NCT01471574|83360764|FG000|Treatment Period|Adverse Event|7|||
47072637|NCT01471574|83360765|FG001|Treatment Period|Adverse Event|3|||
47072638|NCT01471574|83360766|FG002|Treatment Period|Adverse Event|6|||
47072639|NCT01471574|83360767|FG003|Treatment Period|Adverse Event|1|||
47072640|NCT01471574|83360764|FG000|Treatment Period|Withdrawal by Subject|5|||
47072641|NCT01471574|83360765|FG001|Treatment Period|Withdrawal by Subject|1|||
47072642|NCT01471574|83360766|FG002|Treatment Period|Withdrawal by Subject|1|||
47072643|NCT01471574|83360767|FG003|Treatment Period|Withdrawal by Subject|0|||
47072644|NCT01471574|83360764|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
47072645|NCT01471574|83360765|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
47072646|NCT01471574|83360766|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
47072647|NCT01471574|83360767|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
47072648|NCT01471574|83360764|FG000|Treatment Period|Lost to Follow-up|1|||
47072649|NCT01471574|83360765|FG001|Treatment Period|Lost to Follow-up|2|||
47072650|NCT01471574|83360766|FG002|Treatment Period|Lost to Follow-up|2|||
47072651|NCT01471574|83360767|FG003|Treatment Period|Lost to Follow-up|0|||
47072652|NCT01471574|83360764|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
47072653|NCT01471574|83360765|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
47072654|NCT01471574|83360766|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
47072655|NCT01471574|83360767|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
47072656|NCT01471574|83360764|FG000|Treatment Period|Other|1|||
47072657|NCT01471574|83360765|FG001|Treatment Period|Other|0|||
47072658|NCT01471574|83360766|FG002|Treatment Period|Other|0|||
47072659|NCT01471574|83360767|FG003|Treatment Period|Other|0|||
47072660|NCT01471574|83360764|FG000|Follow-up Period|Withdrawal by Subject|3|||
47072661|NCT01471574|83360765|FG001|Follow-up Period|Withdrawal by Subject|0|||
47072662|NCT01471574|83360766|FG002|Follow-up Period|Withdrawal by Subject|3|||
47072663|NCT01471574|83360767|FG003|Follow-up Period|Withdrawal by Subject|1|||
47072664|NCT01471574|83360764|FG000|Follow-up Period|Lost to Follow-up|4|||
47072665|NCT01471574|83360765|FG001|Follow-up Period|Lost to Follow-up|1|||
47072666|NCT01471574|83360766|FG002|Follow-up Period|Lost to Follow-up|3|||
47072667|NCT01471574|83360767|FG003|Follow-up Period|Lost to Follow-up|2|||
47072668|NCT01471574|83360764|FG000|Follow-up Period|Death|0|||
47072669|NCT01471574|83360765|FG001|Follow-up Period|Death|0|||
47072670|NCT01471574|83360766|FG002|Follow-up Period|Death|1|||
47072671|NCT01471574|83360767|FG003|Follow-up Period|Death|0|||
47072672|NCT01471574|83360764|FG000|Follow-up Period|Follow-up no longer required|0|||
47072673|NCT01471574|83360765|FG001|Follow-up Period|Follow-up no longer required|1|||
47072674|NCT01471574|83360766|FG002|Follow-up Period|Follow-up no longer required|0|||
47072675|NCT01471574|83360767|FG003|Follow-up Period|Follow-up no longer required|0|||
47072676|NCT01383707|83360783|FG000|Overall Study|Consent withdrawal|6|||
47072677|NCT01383707|83360783|FG000|Overall Study|Death|19|||
47072678|NCT01383707|83360783|FG000|Overall Study|Other|8|||
47072679|NCT01383707|83360783|FG000|Overall Study|Sponsor's decision|2|||
47072680|NCT01383707|83360783|FG000|Overall Study|Adverse Event|14|||
47072681|NCT01383707|83360783|FG000|Overall Study|Progressive disease|23|||
47072682|NCT01383317|83360789|FG000|Overall Study|Lost to Follow-up|2|||
47072683|NCT01383317|83360790|FG001|Overall Study|Lost to Follow-up|1|||
47072684|NCT01383317|83360789|FG000|Overall Study|Death|1|||
47072685|NCT01383317|83360790|FG001|Overall Study|Death|0|||
47072686|NCT01383317|83360789|FG000|Overall Study|Adverse Event|0|||
47072687|NCT01383317|83360790|FG001|Overall Study|Adverse Event|1|||
47072688|NCT01455428|83360798|FG000|Overall Study|Protocol Violation|2|||
47072689|NCT01455428|83360799|FG001|Overall Study|Protocol Violation|1|||
46775520|NCT00729326|82993922|FG000|Overall Study|Lost to Follow-up|2|||
46775521|NCT00729326|82993923|FG001|Overall Study|Lost to Follow-up|0|||
46775522|NCT00729326|82993922|FG000|Overall Study|Physician Decision|0|||
46775523|NCT00729326|82993923|FG001|Overall Study|Physician Decision|1|||
46775524|NCT00729326|82993922|FG000|Overall Study|Protocol Violation|3|||
46775525|NCT00729326|82993923|FG001|Overall Study|Protocol Violation|2|||
46775526|NCT00729326|82993922|FG000|Overall Study|Subject Decision|4|||
46775527|NCT00729326|82993923|FG001|Overall Study|Subject Decision|4|||
46775528|NCT00729326|82993922|FG000|Overall Study|Sponsor Decision|1|||
46775529|NCT00729326|82993923|FG001|Overall Study|Sponsor Decision|2|||
46775530|NCT00729248|82993929|FG000|Overall Study|Physician Decision|2|||
46775531|NCT00696423|82993936|FG000|Overall Study|Lost to Follow-up|0|||
46775532|NCT00696423|82993937|FG001|Overall Study|Lost to Follow-up|5|||
46775533|NCT00736034|82993943|FG000|Overall Study|Adverse Event|2|||
46775534|NCT00576693|82993949|FG000|Overall Study|Lost to Follow-up|7|||
46775535|NCT00576693|82993950|FG001|Overall Study|Lost to Follow-up|11|||
46775536|NCT00576693|82993949|FG000|Overall Study|Withdrawal by Subject|3|||
46775537|NCT00576693|82993950|FG001|Overall Study|Withdrawal by Subject|13|||
46775538|NCT00698451|82993956|FG000|Overall Study|Adverse Event|22|||
46775539|NCT00698451|82993956|FG000|Overall Study|Physician Decision|2|||
46775540|NCT00698451|82993956|FG000|Overall Study|Protocol Violation|6|||
47072690|NCT01455428|83360798|FG000|Overall Study|Adverse Event|6|||
47072691|NCT01455428|83360799|FG001|Overall Study|Adverse Event|2|||
47072692|NCT01455428|83360798|FG000|Overall Study|Lost to Follow-up|1|||
47072693|NCT01455428|83360799|FG001|Overall Study|Lost to Follow-up|1|||
46775541|NCT00698451|82993956|FG000|Overall Study|Withdrawal by Subject|6|||
46775542|NCT00698451|82993956|FG000|Overall Study|Disease progression|3|||
46775543|NCT00697827|82993962|FG000|Overall Study|enrolled but not treated|2|||
47072694|NCT01455428|83360798|FG000|Overall Study|Withdrawal by Subject|2|||
47072695|NCT01455428|83360799|FG001|Overall Study|Withdrawal by Subject|5|||
46775544|NCT00697827|82993963|FG001|Overall Study|enrolled but not treated|1|||
46775545|NCT00728936|82993976|FG000|Overall Study|Withdrawal by Subject|0|||
46775546|NCT00728936|82993977|FG001|Overall Study|Withdrawal by Subject|0|||
46775547|NCT00728936|82993978|FG002|Overall Study|Withdrawal by Subject|0|||
46775548|NCT00728936|82993979|FG003|Overall Study|Withdrawal by Subject|0|||
46775549|NCT00728936|82993980|FG004|Overall Study|Withdrawal by Subject|0|||
46775550|NCT00728936|82993981|FG005|Overall Study|Withdrawal by Subject|1|||
46775551|NCT00728936|82993982|FG006|Overall Study|Withdrawal by Subject|0|||
46775552|NCT00693693|82994001|FG000|Overall Study|Lost to Follow-up|1|||
46775553|NCT00693693|82994002|FG001|Overall Study|Lost to Follow-up|1|||
46775554|NCT00693693|82994003|FG002|Overall Study|Lost to Follow-up|2|||
46967373|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
47072696|NCT01455428|83360798|FG000|Overall Study|Did not meet entrance criteria|0|||
47072697|NCT01455428|83360799|FG001|Overall Study|Did not meet entrance criteria|2|||
47072698|NCT01455428|83360798|FG000|Overall Study|Insufficient clinical response|0|||
47072699|NCT01455428|83360799|FG001|Overall Study|Insufficient clinical response|2|||
47072700|NCT01455428|83360798|FG000|Overall Study|Did not receive treatment|1|||
47072701|NCT01455428|83360799|FG001|Overall Study|Did not receive treatment|1|||
47072702|NCT01455428|83360798|FG000|Overall Study|Other|2|||
47072703|NCT01455428|83360799|FG001|Overall Study|Other|4|||
47072704|NCT01383161|83360807|FG000|Overall Study|Adverse Event|5|||
47072705|NCT01383161|83360808|FG001|Overall Study|Adverse Event|1|||
47072706|NCT01383161|83360807|FG000|Overall Study|Withdrawal by Subject|0|||
47072707|NCT01383161|83360808|FG001|Overall Study|Withdrawal by Subject|2|||
47072708|NCT01383161|83360807|FG000|Overall Study|Lack of Efficacy|0|||
47072709|NCT01383161|83360808|FG001|Overall Study|Lack of Efficacy|1|||
47072710|NCT01382225|83360834|FG000|Overall Study|Adverse Event|3|||
47072711|NCT01382225|83360835|FG001|Overall Study|Adverse Event|2|||
47072712|NCT01382225|83360834|FG000|Overall Study|Protocol Violation|2|||
47072713|NCT01382225|83360835|FG001|Overall Study|Protocol Violation|1|||
47072714|NCT01382225|83360834|FG000|Overall Study|Subject Withdrew Consent|5|||
47072715|NCT01382225|83360835|FG001|Overall Study|Subject Withdrew Consent|2|||
47072716|NCT01382225|83360834|FG000|Overall Study|Other|4|||
47072717|NCT01382225|83360835|FG001|Overall Study|Other|2|||
47072718|NCT01381679|83360841|FG000|Overall Study|Adverse Event|3|||
47072719|NCT01381679|83360841|FG000|Overall Study|Lost to Follow-up|885|||
47072720|NCT01455194|83360848|FG000|Overall Study|Screen Failure|20|||
47072721|NCT01455194|83360849|FG001|Overall Study|Screen Failure|0|||
47072722|NCT01455194|83360850|FG002|Overall Study|Screen Failure|0|||
47072723|NCT01455194|83360851|FG003|Overall Study|Screen Failure|0|||
47072724|NCT01455194|83360848|FG000|Overall Study|Randomisation Failure|90|||
47072725|NCT01455194|83360849|FG001|Overall Study|Randomisation Failure|0|||
47072726|NCT01455194|83360850|FG002|Overall Study|Randomisation Failure|0|||
47072727|NCT01455194|83360851|FG003|Overall Study|Randomisation Failure|0|||
47072728|NCT01455194|83360848|FG000|Overall Study|Deterioration in asthma|12|||
47072729|NCT01455194|83360849|FG001|Overall Study|Deterioration in asthma|6|||
47072730|NCT01455194|83360850|FG002|Overall Study|Deterioration in asthma|14|||
46775555|NCT00728468|82994011|FG000|Overall Study|Enrolled but not treated|1|||
46775556|NCT00728468|82994011|FG000|Overall Study|Death|1|||
46846434|NCT00131664|83063149|FG001|First Period (First 6 Months)|Death|1|||
47072731|NCT01455194|83360851|FG003|Overall Study|Deterioration in asthma|9|||
47072732|NCT01455194|83360848|FG000|Overall Study|Adverse Event|1|||
47072733|NCT01455194|83360849|FG001|Overall Study|Adverse Event|1|||
47072734|NCT01455194|83360850|FG002|Overall Study|Adverse Event|1|||
47072735|NCT01455194|83360851|FG003|Overall Study|Adverse Event|3|||
46775557|NCT00728468|82994011|FG000|Overall Study|Protocol Violation|4|||
47072736|NCT01455194|83360848|FG000|Overall Study|Withdrawal by Subject|21|||
47072737|NCT01455194|83360849|FG001|Overall Study|Withdrawal by Subject|16|||
47072738|NCT01455194|83360850|FG002|Overall Study|Withdrawal by Subject|12|||
47072739|NCT01455194|83360851|FG003|Overall Study|Withdrawal by Subject|9|||
47072740|NCT01455194|83360848|FG000|Overall Study|Lost to Follow-up|2|||
47072741|NCT01455194|83360849|FG001|Overall Study|Lost to Follow-up|0|||
47072742|NCT01455194|83360850|FG002|Overall Study|Lost to Follow-up|1|||
47072743|NCT01455194|83360851|FG003|Overall Study|Lost to Follow-up|1|||
47072744|NCT01455194|83360848|FG000|Overall Study|Pregnancy|0|||
47072745|NCT01455194|83360849|FG001|Overall Study|Pregnancy|1|||
47072746|NCT01455194|83360850|FG002|Overall Study|Pregnancy|1|||
47072747|NCT01455194|83360851|FG003|Overall Study|Pregnancy|0|||
47072748|NCT01455194|83360848|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
47072749|NCT01455194|83360849|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
47072750|NCT01455194|83360850|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
46775558|NCT00728468|82994011|FG000|Overall Study|Objective progression or relapse|9|||
46775559|NCT00728468|82994011|FG000|Overall Study|Study terminated by sponsor|1|||
47072751|NCT01455194|83360851|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
47072752|NCT01455194|83360848|FG000|Overall Study|Miscellaneous|4|||
47072753|NCT01455194|83360849|FG001|Overall Study|Miscellaneous|5|||
47072754|NCT01455194|83360850|FG002|Overall Study|Miscellaneous|1|||
46775560|NCT00727844|82994017|FG000|Initial Randomization|Physician Decision|2|||
46775561|NCT00727844|82994018|FG001|Initial Randomization|Physician Decision|0|||
47072755|NCT01455194|83360851|FG003|Overall Study|Miscellaneous|4|||
47072756|NCT01454726|83360875|FG000|Overall Study|Withdrawal by Subject|0|||
47072757|NCT01454726|83360876|FG001|Overall Study|Withdrawal by Subject|1|||
47072758|NCT01361568|83360888|FG000|Overall Study|Adverse Event|0|||
46775562|NCT00727844|82994019|FG002|Initial Randomization|Physician Decision|0|||
46775563|NCT00727844|82994020|FG003|Initial Randomization|Physician Decision|0|||
46775564|NCT00735878|82994028|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
46775565|NCT00735878|82994029|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
46775566|NCT00735878|82994030|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
46775567|NCT00695955|82994041|FG000|Cohort 1|Adverse Event|26|||
46775568|NCT00695955|82994041|FG000|Cohort 1|Protocol Violation|2|||
46775569|NCT00695955|82994041|FG000|Cohort 1|Lost to Follow-up|30|||
47072759|NCT01361568|83360889|FG001|Overall Study|Adverse Event|0|||
47072760|NCT01361568|83360890|FG002|Overall Study|Adverse Event|0|||
47072761|NCT01361568|83360891|FG003|Overall Study|Adverse Event|0|||
47072762|NCT01361568|83360892|FG004|Overall Study|Adverse Event|1|||
47072763|NCT01361568|83360893|FG005|Overall Study|Adverse Event|0|||
47072764|NCT01361568|83360888|FG000|Overall Study|Physician Decision|0|||
47072765|NCT01361568|83360889|FG001|Overall Study|Physician Decision|0|||
47072766|NCT01361568|83360890|FG002|Overall Study|Physician Decision|0|||
47072767|NCT01361568|83360891|FG003|Overall Study|Physician Decision|0|||
47072768|NCT01361568|83360892|FG004|Overall Study|Physician Decision|0|||
47072769|NCT01361568|83360893|FG005|Overall Study|Physician Decision|1|||
47072770|NCT01361568|83360888|FG000|Overall Study|Withdrawal by Subject|2|||
47072771|NCT01361568|83360889|FG001|Overall Study|Withdrawal by Subject|1|||
47072772|NCT01361568|83360890|FG002|Overall Study|Withdrawal by Subject|0|||
47072773|NCT01361568|83360891|FG003|Overall Study|Withdrawal by Subject|0|||
47072774|NCT01361568|83360892|FG004|Overall Study|Withdrawal by Subject|0|||
47072775|NCT01361568|83360893|FG005|Overall Study|Withdrawal by Subject|1|||
47072776|NCT03084367|83360908|FG000|Overall Study|Lost to Follow-up|32|||
47072777|NCT03084367|83360908|FG000|Overall Study|Withdrawal by Subject|4|||
47072778|NCT03084367|83360908|FG000|Overall Study|Other|1|||
47072779|NCT01454570|83360921|FG000|Overall Study|Withdrawal by Subject|2|||
47072780|NCT01454570|83360921|FG000|Overall Study|Screen Failure|7|||
47072781|NCT01494350|83360934|FG000|Overall Study|Worsening of lesion|1|||
46775570|NCT00695955|82994041|FG000|Cohort 1|Withdrawal by Subject|25|||
47072782|NCT03281629|83360944|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
47072783|NCT03281629|83360945|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
47072784|NCT03281629|83360944|FG000|Overall Study|Death|0|||
47072785|NCT03281629|83360945|FG001|Overall Study|Death|1|||
47072786|NCT03281629|83360944|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
47072787|NCT03281629|83360945|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
47072788|NCT00218543|83360951|FG000|Overall Study|Lost to Follow-up|8|||
47072789|NCT00218543|83360951|FG000|Overall Study|relocated|1|||
47072790|NCT00218543|83360951|FG000|Overall Study|Withdrawal by Subject|1|||
47072791|NCT00218543|83360951|FG000|Overall Study|Physician Decision|3|||
47072792|NCT00218543|83360951|FG000|Overall Study|Adverse Event|2|||
47072793|NCT00216671|83360966|FG000|Overall Study|Adverse Event|4|||
47072794|NCT00216671|83360967|FG001|Overall Study|Adverse Event|9|||
47072795|NCT00216671|83360966|FG000|Overall Study|Pregnancy|0|||
47072796|NCT00216671|83360967|FG001|Overall Study|Pregnancy|1|||
47072797|NCT00216671|83360966|FG000|Overall Study|Withdrawal by Subject|4|||
46775571|NCT00695955|82994041|FG000|Cohort 1|Lack of Efficacy|3|||
46775572|NCT00695955|82994041|FG000|Cohort 1|Other|16|||
46641166|NCT01105975|82820476|FG005|Overall Study|Adverse Event|1|||
47072798|NCT00216671|83360967|FG001|Overall Study|Withdrawal by Subject|2|||
46775573|NCT00695955|82994041|FG000|Cohort 2|Adverse Event|24|||
47072799|NCT00216671|83360966|FG000|Overall Study|Refused Injections|3|||
47072800|NCT00216671|83360967|FG001|Overall Study|Refused Injections|13|||
47072801|NCT00216671|83360966|FG000|Overall Study|No Need to Continue Medication|1|||
47072802|NCT00216671|83360967|FG001|Overall Study|No Need to Continue Medication|1|||
47072803|NCT00216671|83360966|FG000|Overall Study|Insufficient Response|9|||
47072804|NCT00216671|83360967|FG001|Overall Study|Insufficient Response|4|||
46641167|NCT01105975|82820477|FG006|Overall Study|Adverse Event|2|||
46641168|NCT01105975|82820478|FG007|Overall Study|Adverse Event|4|||
46641169|NCT01105975|82820479|FG008|Overall Study|Adverse Event|1|||
46641170|NCT01105975|82820480|FG009|Overall Study|Adverse Event|4|||
46641171|NCT01105975|82820471|FG000|Overall Study|Withdrawal by Subject|2|||
46641172|NCT01105975|82820472|FG001|Overall Study|Withdrawal by Subject|2|||
46641173|NCT01105975|82820473|FG002|Overall Study|Withdrawal by Subject|2|||
46641174|NCT01105975|82820474|FG003|Overall Study|Withdrawal by Subject|0|||
46641175|NCT01105975|82820475|FG004|Overall Study|Withdrawal by Subject|4|||
46641176|NCT01105975|82820476|FG005|Overall Study|Withdrawal by Subject|1|||
46641177|NCT01105975|82820477|FG006|Overall Study|Withdrawal by Subject|2|||
46641178|NCT01105975|82820478|FG007|Overall Study|Withdrawal by Subject|1|||
46641179|NCT01105975|82820479|FG008|Overall Study|Withdrawal by Subject|0|||
46641180|NCT01105975|82820480|FG009|Overall Study|Withdrawal by Subject|3|||
46641181|NCT01105975|82820471|FG000|Overall Study|Lost to Follow-up|1|||
46641182|NCT01105975|82820472|FG001|Overall Study|Lost to Follow-up|0|||
46641183|NCT01105975|82820473|FG002|Overall Study|Lost to Follow-up|0|||
46641184|NCT01105975|82820474|FG003|Overall Study|Lost to Follow-up|1|||
46641185|NCT01105975|82820475|FG004|Overall Study|Lost to Follow-up|1|||
46641186|NCT01105975|82820476|FG005|Overall Study|Lost to Follow-up|0|||
46641187|NCT01105975|82820477|FG006|Overall Study|Lost to Follow-up|0|||
46641188|NCT01105975|82820478|FG007|Overall Study|Lost to Follow-up|0|||
46641189|NCT01105975|82820479|FG008|Overall Study|Lost to Follow-up|1|||
46641190|NCT01105975|82820480|FG009|Overall Study|Lost to Follow-up|0|||
46641191|NCT01105975|82820471|FG000|Overall Study|Physician Decision|0|||
46775574|NCT00695955|82994041|FG000|Cohort 2|Protocol Violation|5|||
47072805|NCT00216671|83360966|FG000|Overall Study|Lost to Follow-up|3|||
47072806|NCT00216671|83360967|FG001|Overall Study|Lost to Follow-up|5|||
47072807|NCT00216671|83360966|FG000|Overall Study|Non compliant|2|||
47072808|NCT00216671|83360967|FG001|Overall Study|Non compliant|2|||
46641192|NCT01105975|82820472|FG001|Overall Study|Physician Decision|0|||
46775575|NCT00695955|82994041|FG000|Cohort 2|Lost to Follow-up|38|||
46775576|NCT00695955|82994041|FG000|Cohort 2|Withdrawal by Subject|28|||
46967374|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
47072809|NCT00216671|83360966|FG000|Overall Study|Ineligible|0|||
46641193|NCT01105975|82820473|FG002|Overall Study|Physician Decision|0|||
46641194|NCT01105975|82820474|FG003|Overall Study|Physician Decision|0|||
47072810|NCT00216671|83360967|FG001|Overall Study|Ineligible|2|||
46641195|NCT01105975|82820475|FG004|Overall Study|Physician Decision|0|||
46641196|NCT01105975|82820476|FG005|Overall Study|Physician Decision|0|||
46641197|NCT01105975|82820477|FG006|Overall Study|Physician Decision|2|||
46641198|NCT01105975|82820478|FG007|Overall Study|Physician Decision|0|||
46775577|NCT00695955|82994041|FG000|Cohort 2|Lack of Efficacy|4|||
46775578|NCT00695955|82994041|FG000|Cohort 2|Other|5|||
46775579|NCT00693225|82994049|FG000|Overall Study|Lost to Follow-up|1|||
46775580|NCT00693225|82994050|FG001|Overall Study|Lost to Follow-up|2|||
46775581|NCT00693225|82994049|FG000|Overall Study|Adverse Event|1|||
46775582|NCT00693225|82994050|FG001|Overall Study|Adverse Event|3|||
46775583|NCT00735644|82994061|FG000|Overall Study|Did not receive study vaccine|0|||
46775584|NCT00735644|82994062|FG001|Overall Study|Did not receive study vaccine|1|||
46775585|NCT00735644|82994063|FG002|Overall Study|Did not receive study vaccine|0|||
46775586|NCT00735644|82994064|FG003|Overall Study|Did not receive study vaccine|0|||
46775587|NCT00735644|82994065|FG004|Overall Study|Did not receive study vaccine|0|||
46775588|NCT00735644|82994061|FG000|Overall Study|Withdrawal by Subject|0|||
46775589|NCT00735644|82994062|FG001|Overall Study|Withdrawal by Subject|1|||
46775590|NCT00735644|82994063|FG002|Overall Study|Withdrawal by Subject|1|||
46775591|NCT00735644|82994064|FG003|Overall Study|Withdrawal by Subject|1|||
46775592|NCT00735644|82994065|FG004|Overall Study|Withdrawal by Subject|0|||
46775593|NCT03718299|82994084|FG000|Overall Study|Adverse Event|1|||
46775594|NCT03718299|82994084|FG000|Overall Study|Withdrawal by Subject|6|||
46775595|NCT03718299|82994084|FG000|Overall Study|Physician Decision|2|||
46775596|NCT03718299|82994084|FG000|Overall Study|Lost to Follow-up|1|||
46775597|NCT00724958|82994088|FG000|Overall Study|Adverse Event|28|||
46775598|NCT00724958|82994088|FG000|Overall Study|Loss of Response|40|||
46775599|NCT00724958|82994088|FG000|Overall Study|No Response|18|||
46775600|NCT00724958|82994088|FG000|Overall Study|Remission|7|||
46775601|NCT00724958|82994088|FG000|Overall Study|Other Reason|76|||
46775602|NCT00724958|82994088|FG000|Overall Study|No documentation for end of therapy|13|||
46775603|NCT00695565|82994094|FG000|Overall Study|Lost to Follow-up|4|||
46775604|NCT00695565|82994095|FG001|Overall Study|Lost to Follow-up|4|||
46775605|NCT00695565|82994094|FG000|Overall Study|Adverse Event|3|||
46775606|NCT00695565|82994095|FG001|Overall Study|Adverse Event|1|||
46775607|NCT00695565|82994094|FG000|Overall Study|Protocol Violation|3|||
46775608|NCT00695565|82994095|FG001|Overall Study|Protocol Violation|1|||
46775609|NCT00695565|82994094|FG000|Overall Study|Withdrawal by Subject|1|||
46775610|NCT00695565|82994095|FG001|Overall Study|Withdrawal by Subject|1|||
46775611|NCT00695565|82994094|FG000|Overall Study|Lack of Efficacy|1|||
46775612|NCT00695565|82994095|FG001|Overall Study|Lack of Efficacy|1|||
46775613|NCT00695565|82994094|FG000|Overall Study|Subject did not follow instructions|1|||
46775614|NCT00695565|82994095|FG001|Overall Study|Subject did not follow instructions|1|||
46775615|NCT00727532|82994101|FG000|Overall Study|Adverse Event|1|||
46775616|NCT00727532|82994101|FG000|Overall Study|Withdrawal by Subject|1|||
46775617|NCT00721214|82994105|FG000|Overall Study|Chose another center for transplant|1|||
46775618|NCT00721214|82994105|FG000|Overall Study|Death|3|||
46775619|NCT00720902|82994111|FG000|Overall Study|Withdrawal by Subject|1|||
46775620|NCT00720902|82994112|FG001|Overall Study|Withdrawal by Subject|0|||
46967375|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
46967376|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
46967377|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
46775621|NCT00720902|82994111|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
46775622|NCT00720902|82994112|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
46775623|NCT00695019|82994121|FG000|Overall Study|Withdrawal by Subject|8|||
46775624|NCT00695019|82994122|FG001|Overall Study|Withdrawal by Subject|6|||
46775625|NCT00695019|82994123|FG002|Overall Study|Withdrawal by Subject|4|||
46775626|NCT00695019|82994121|FG000|Overall Study|Protocol Violation|1|||
46846435|NCT00131664|83063150|FG002|First Period (First 6 Months)|Death|0|||
46846436|NCT00131664|83063151|FG003|First Period (First 6 Months)|Death|0|||
46775627|NCT00695019|82994122|FG001|Overall Study|Protocol Violation|3|||
46775628|NCT00695019|82994123|FG002|Overall Study|Protocol Violation|1|||
47072811|NCT00216671|83360966|FG000|Overall Study|Physician Decision|1|||
46775629|NCT00695019|82994121|FG000|Overall Study|Lack of Efficacy|0|||
46775630|NCT00695019|82994122|FG001|Overall Study|Lack of Efficacy|0|||
46775631|NCT00695019|82994123|FG002|Overall Study|Lack of Efficacy|1|||
46775632|NCT00695019|82994121|FG000|Overall Study|Various|4|||
46846437|NCT00131664|83063152|FG004|First Period (First 6 Months)|Death|0|||
47072812|NCT00216671|83360967|FG001|Overall Study|Physician Decision|1|||
47072813|NCT00216671|83360966|FG000|Overall Study|Protocol Violation|3|||
46775633|NCT00695019|82994122|FG001|Overall Study|Various|5|||
46846438|NCT00131664|83063153|FG005|First Period (First 6 Months)|Death|0|||
47072814|NCT00216671|83360967|FG001|Overall Study|Protocol Violation|5|||
46775634|NCT00695019|82994123|FG002|Overall Study|Various|4|||
46775635|NCT00694707|82994136|FG000|Overall Study|Did Not Receive Treatment|0|||
46775636|NCT00694707|82994137|FG001|Overall Study|Did Not Receive Treatment|0|||
46775637|NCT00694707|82994138|FG002|Overall Study|Did Not Receive Treatment|1|||
46775638|NCT00694707|82994139|FG003|Overall Study|Did Not Receive Treatment|1|||
46775639|NCT00694707|82994140|FG004|Overall Study|Did Not Receive Treatment|1|||
46775640|NCT00694707|82994136|FG000|Overall Study|Adverse Event|22|||
46775641|NCT00694707|82994137|FG001|Overall Study|Adverse Event|14|||
46775642|NCT00694707|82994138|FG002|Overall Study|Adverse Event|8|||
46775643|NCT00694707|82994139|FG003|Overall Study|Adverse Event|12|||
46775644|NCT00694707|82994140|FG004|Overall Study|Adverse Event|13|||
47072815|NCT00216671|83360966|FG000|Overall Study|Relapse|1|||
47072816|NCT00216671|83360967|FG001|Overall Study|Relapse|0|||
47072817|NCT00216671|83360966|FG000|Overall Study|Investigator Illness|0|||
47072818|NCT00216671|83360967|FG001|Overall Study|Investigator Illness|1|||
47072819|NCT00216671|83360966|FG000|Overall Study|Patient Moved|0|||
47072820|NCT00216671|83360967|FG001|Overall Study|Patient Moved|1|||
47072821|NCT00216671|83360966|FG000|Overall Study|Ineligible, no efficacy data|2|||
47072822|NCT00216671|83360967|FG001|Overall Study|Ineligible, no efficacy data|2|||
47072823|NCT00216671|83360966|FG000|Overall Study|Insufficient Response Adverse Event|2|||
47072824|NCT00216671|83360967|FG001|Overall Study|Insufficient Response Adverse Event|1|||
47072825|NCT00216203|83360973|FG000|Overall Study|Withdrawal by Subject|2|||
47072826|NCT02644668|83361008|FG000|Overall Study|Adverse Event|2|||
47072827|NCT02644668|83361009|FG001|Overall Study|Adverse Event|0|||
47072828|NCT02644668|83361010|FG002|Overall Study|Adverse Event|1|||
47072829|NCT02644668|83361008|FG000|Overall Study|Protocol Violation|0|||
47072830|NCT02644668|83361009|FG001|Overall Study|Protocol Violation|0|||
47072831|NCT02644668|83361010|FG002|Overall Study|Protocol Violation|1|||
47072832|NCT02644668|83361008|FG000|Overall Study|Withdrawal by Subject|0|||
47072833|NCT02644668|83361009|FG001|Overall Study|Withdrawal by Subject|0|||
47072834|NCT02644668|83361010|FG002|Overall Study|Withdrawal by Subject|1|||
46967378|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
46967379|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
46967380|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
46967381|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
46967382|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
46846439|NCT00131664|83063148|FG000|First Period (First 6 Months)|Protocol Violation|2|||
46967383|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
46967384|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
46967385|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
46967386|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
46967387|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
46967388|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
46967389|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
46967390|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
46967391|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
47072835|NCT02644356|83361029|FG000|Overall Study|Withdrawal by Subject|2|||
47072836|NCT01494038|83361061|FG000|Overall Study|Protocol Violation|1|||
47072837|NCT01494038|83361062|FG001|Overall Study|Protocol Violation|1|||
47072838|NCT01494038|83361061|FG000|Overall Study|Lost to Follow-up|18|||
47072839|NCT01494038|83361062|FG001|Overall Study|Lost to Follow-up|20|||
47072840|NCT01494038|83361061|FG000|Overall Study|Withdrawal by Subject|44|||
47072841|NCT01494038|83361062|FG001|Overall Study|Withdrawal by Subject|34|||
47072842|NCT01494038|83361061|FG000|Overall Study|Not able to get to clinic|21|||
47072843|NCT01494038|83361062|FG001|Overall Study|Not able to get to clinic|15|||
47072844|NCT01494038|83361061|FG000|Overall Study|Not willing to adhere to reqs|2|||
47072845|NCT01494038|83361062|FG001|Overall Study|Not willing to adhere to reqs|9|||
47072846|NCT01494038|83361061|FG000|Overall Study|Death|2|||
47072847|NCT01494038|83361062|FG001|Overall Study|Death|4|||
46967392|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
46967393|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
46967394|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
46967395|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
46967396|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
47072848|NCT02640612|83361099|FG000|Overall Study|Adverse Event|6|||
47072849|NCT02640612|83361100|FG001|Overall Study|Adverse Event|7|||
47072850|NCT02640612|83361101|FG002|Overall Study|Adverse Event|2|||
47072851|NCT02640612|83361099|FG000|Overall Study|Death|1|||
47072852|NCT02640612|83361100|FG001|Overall Study|Death|0|||
47072853|NCT02640612|83361101|FG002|Overall Study|Death|0|||
47072854|NCT02640612|83361099|FG000|Overall Study|Withdrawal by Subject|10|||
47072855|NCT02640612|83361100|FG001|Overall Study|Withdrawal by Subject|3|||
47072856|NCT02640612|83361101|FG002|Overall Study|Withdrawal by Subject|3|||
47072857|NCT02640612|83361099|FG000|Overall Study|Lost to Follow-up|4|||
47072858|NCT02640612|83361100|FG001|Overall Study|Lost to Follow-up|1|||
47072859|NCT02640612|83361101|FG002|Overall Study|Lost to Follow-up|1|||
47072860|NCT02640612|83361099|FG000|Overall Study|Protocol Violation|0|||
47072861|NCT02640612|83361100|FG001|Overall Study|Protocol Violation|2|||
47072862|NCT02640612|83361101|FG002|Overall Study|Protocol Violation|0|||
47072863|NCT02640612|83361099|FG000|Overall Study|Lack of Efficacy|1|||
47072864|NCT02640612|83361100|FG001|Overall Study|Lack of Efficacy|1|||
47072865|NCT02640612|83361101|FG002|Overall Study|Lack of Efficacy|0|||
47072866|NCT00639769|83361109|FG000|Overall Study|Death|2|||
47072867|NCT00639769|83361109|FG000|Overall Study|Adverse Event|7|||
46967397|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
47072868|NCT00639769|83361109|FG000|Overall Study|Lack of Efficacy|1|||
47072869|NCT00639769|83361109|FG000|Overall Study|Disease progression|26|||
47072870|NCT00639769|83361109|FG000|Overall Study|Withdrawal by Subject|4|||
46641199|NCT01105975|82820479|FG008|Overall Study|Physician Decision|0|||
46641200|NCT01105975|82820480|FG009|Overall Study|Physician Decision|0|||
46641201|NCT01105975|82820471|FG000|Overall Study|Protocol Violation|0|||
46641202|NCT01105975|82820472|FG001|Overall Study|Protocol Violation|2|||
46967398|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
46967399|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
46641203|NCT01105975|82820473|FG002|Overall Study|Protocol Violation|2|||
46641204|NCT01105975|82820474|FG003|Overall Study|Protocol Violation|0|||
46641205|NCT01105975|82820475|FG004|Overall Study|Protocol Violation|1|||
46967400|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
46967401|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
46641206|NCT01105975|82820476|FG005|Overall Study|Protocol Violation|1|||
46641207|NCT01105975|82820477|FG006|Overall Study|Protocol Violation|1|||
46641208|NCT01105975|82820478|FG007|Overall Study|Protocol Violation|1|||
46641209|NCT01105975|82820479|FG008|Overall Study|Protocol Violation|2|||
46641210|NCT01105975|82820480|FG009|Overall Study|Protocol Violation|2|||
46967402|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
47072871|NCT00639457|83361115|FG000|Overall Study|Withdrawal by Subject|2|||
47072872|NCT00639457|83361116|FG001|Overall Study|Withdrawal by Subject|3|||
47072873|NCT00639379|83361122|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
47072874|NCT00639379|83361123|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
47072875|NCT00639379|83361122|FG000|Period 1 - 2 Weeks|lens issue|3|||
47072876|NCT00639379|83361123|FG001|Period 1 - 2 Weeks|lens issue|0|||
47072877|NCT00639223|83361131|FG000|Overall Study|Lost to Follow-up|0|||
47072878|NCT00639223|83361132|FG001|Overall Study|Lost to Follow-up|2|||
47072879|NCT00638989|83361141|FG000|Overall Study|Lost to Follow-up|0|||
47072880|NCT00638989|83361142|FG001|Overall Study|Lost to Follow-up|0|||
47072881|NCT00638989|83361143|FG002|Overall Study|Lost to Follow-up|1|||
47072882|NCT00637273|83361164|FG000|Overall Study|Adverse Event|11|||
46641211|NCT01105975|82820471|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
46641212|NCT01105975|82820472|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
46967403|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
46641213|NCT01105975|82820473|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
46967404|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
46967405|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
47072883|NCT00637273|83361165|FG001|Overall Study|Adverse Event|5|||
47072884|NCT00637273|83361166|FG002|Overall Study|Adverse Event|7|||
47072885|NCT00637273|83361164|FG000|Overall Study|Lost to Follow-up|8|||
47072886|NCT00637273|83361165|FG001|Overall Study|Lost to Follow-up|9|||
46641214|NCT01105975|82820474|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
46775645|NCT00694707|82994136|FG000|Overall Study|Insufficient Therapeutic Response|33|||
46775646|NCT00694707|82994137|FG001|Overall Study|Insufficient Therapeutic Response|18|||
46775647|NCT00694707|82994138|FG002|Overall Study|Insufficient Therapeutic Response|17|||
46967406|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
46967407|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
46967408|NCT00700427|83209982|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
46967409|NCT00700427|83209983|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
46967410|NCT00700427|83209984|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
46967411|NCT00700427|83209985|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
46967412|NCT00700427|83209986|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
46967413|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
46967414|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
47072887|NCT00637273|83361166|FG002|Overall Study|Lost to Follow-up|13|||
47072888|NCT00637273|83361164|FG000|Overall Study|Protocol Violation|2|||
47072889|NCT00637273|83361165|FG001|Overall Study|Protocol Violation|4|||
47072890|NCT00637273|83361166|FG002|Overall Study|Protocol Violation|1|||
47072891|NCT00637273|83361164|FG000|Overall Study|Withdrawal of Consent|18|||
47072892|NCT00637273|83361165|FG001|Overall Study|Withdrawal of Consent|6|||
47072893|NCT00637273|83361166|FG002|Overall Study|Withdrawal of Consent|18|||
47072894|NCT00637273|83361164|FG000|Overall Study|Investigator Decision|1|||
47072895|NCT00637273|83361165|FG001|Overall Study|Investigator Decision|3|||
47072896|NCT00637273|83361166|FG002|Overall Study|Investigator Decision|1|||
47072897|NCT00637273|83361164|FG000|Overall Study|Administrative|2|||
47072898|NCT00637273|83361165|FG001|Overall Study|Administrative|0|||
47072899|NCT00637273|83361166|FG002|Overall Study|Administrative|0|||
47072900|NCT00637273|83361164|FG000|Overall Study|Loss of Glucose Control|1|||
47072901|NCT00637273|83361165|FG001|Overall Study|Loss of Glucose Control|1|||
47072902|NCT00637273|83361166|FG002|Overall Study|Loss of Glucose Control|1|||
46775648|NCT00694707|82994139|FG003|Overall Study|Insufficient Therapeutic Response|15|||
46775649|NCT00694707|82994140|FG004|Overall Study|Insufficient Therapeutic Response|10|||
46967415|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
47072903|NCT00988351|83361176|FG000|Overall Study|Withdrawal by Subject|8|||
47072904|NCT00988351|83361177|FG001|Overall Study|Withdrawal by Subject|0|||
47072905|NCT00988351|83361176|FG000|Overall Study|Lost to Follow-up|6|||
47072906|NCT00988351|83361177|FG001|Overall Study|Lost to Follow-up|9|||
47072907|NCT00988351|83361176|FG000|Overall Study|not using CPAP|5|||
47072908|NCT00988351|83361177|FG001|Overall Study|not using CPAP|3|||
47072909|NCT00988117|83361183|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
47072910|NCT00988117|83361183|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
47072911|NCT00637195|83361190|FG000|Overall Study|Lost to Follow-up|1|||
47072912|NCT00637195|83361191|FG001|Overall Study|Lost to Follow-up|0|||
47072913|NCT00637195|83361190|FG000|Overall Study|Other|2|||
47072914|NCT00637195|83361191|FG001|Overall Study|Other|0|||
47072915|NCT00637195|83361190|FG000|Overall Study|Withdrawal by Subject|0|||
47072916|NCT00637195|83361191|FG001|Overall Study|Withdrawal by Subject|1|||
47072917|NCT00636961|83361209|FG000|Period 1|Administrative problems|1|||
47072918|NCT00636961|83361210|FG001|Period 1|Administrative problems|1|||
47072919|NCT00636961|83361209|FG000|Period 2|Adverse Event|1|||
47072920|NCT00636961|83361210|FG001|Period 2|Adverse Event|0|||
47072921|NCT00635089|83361225|FG000|Overall Study|Adverse Event|7|||
47072922|NCT00635089|83361225|FG000|Overall Study|Lack of Efficacy|28|||
47072923|NCT00635089|83361225|FG000|Overall Study|Protocol Deviation|4|||
47072924|NCT00635089|83361225|FG000|Overall Study|Lost to Follow-up|8|||
47072925|NCT00635089|83361225|FG000|Overall Study|Other|31|||
47072926|NCT01493414|83361242|FG000|Overall Study|Adverse Event|405|||
47072927|NCT01493414|83361242|FG000|Overall Study|Disease progression|204|||
47072928|NCT01493414|83361242|FG000|Overall Study|Death|101|||
47072929|NCT01493414|83361242|FG000|Overall Study|Physician Decision|93|||
47072930|NCT01493414|83361242|FG000|Overall Study|Withdrawal by Subject|79|||
47072931|NCT01493414|83361242|FG000|Overall Study|Protocol deviation|27|||
47072932|NCT01493414|83361242|FG000|Overall Study|Administrative problems|25|||
47072933|NCT01493414|83361242|FG000|Overall Study|Lost to Follow-up|16|||
47072934|NCT00634543|83361252|FG000|Overall Study|Other|1|||
46775650|NCT00694707|82994136|FG000|Overall Study|Protocol Violation|1|||
46775651|NCT00694707|82994137|FG001|Overall Study|Protocol Violation|2|||
46641215|NCT01105975|82820475|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
47072935|NCT00634543|83361253|FG001|Overall Study|Other|2|||
47072936|NCT00634543|83361252|FG000|Overall Study|Protocol Violation|3|||
47072937|NCT00634543|83361253|FG001|Overall Study|Protocol Violation|3|||
47072938|NCT00634543|83361252|FG000|Overall Study|Adverse Event|11|||
47072939|NCT00634543|83361253|FG001|Overall Study|Adverse Event|11|||
47072940|NCT00634543|83361252|FG000|Overall Study|Withdrawal by Subject|4|||
47072941|NCT00634543|83361253|FG001|Overall Study|Withdrawal by Subject|4|||
47072942|NCT00634543|83361252|FG000|Overall Study|Lost to Follow-up|0|||
47072943|NCT00634543|83361253|FG001|Overall Study|Lost to Follow-up|1|||
47072944|NCT00985465|83361261|FG000|Overall Study|Withdrawal by Subject|1|||
47072945|NCT00985465|83361262|FG001|Overall Study|Withdrawal by Subject|2|||
47072946|NCT00985465|83361261|FG000|Overall Study|Considered to be part of the other group|0|||
47072947|NCT00985465|83361262|FG001|Overall Study|Considered to be part of the other group|1|||
47072948|NCT01049919|83361271|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
47072949|NCT01049919|83361272|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
47072950|NCT01049919|83361271|FG000|Overall Study|Withdrawal by Subject|5|||
47072951|NCT01049919|83361272|FG001|Overall Study|Withdrawal by Subject|0|||
47072952|NCT01049919|83361271|FG000|Overall Study|Lost to Follow-up|6|||
47072953|NCT01049919|83361272|FG001|Overall Study|Lost to Follow-up|1|||
47072954|NCT01049919|83361271|FG000|Overall Study|Physician Decision|2|||
47072955|NCT01049919|83361272|FG001|Overall Study|Physician Decision|0|||
47072956|NCT01049919|83361271|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
47072957|NCT01049919|83361272|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
47072958|NCT01049919|83361271|FG000|Overall Study|Early study termination by sponsor.|2|||
47072959|NCT01049919|83361272|FG001|Overall Study|Early study termination by sponsor.|0|||
47072960|NCT01049373|83361280|FG000|Overall Study|Protocol Violation|9|||
47072961|NCT01049373|83361281|FG001|Overall Study|Protocol Violation|9|||
47072962|NCT01049373|83361280|FG000|Overall Study|Withdrawal by Subject|8|||
47072963|NCT01049373|83361281|FG001|Overall Study|Withdrawal by Subject|5|||
47072964|NCT01049373|83361280|FG000|Overall Study|Adverse Event|3|||
47072965|NCT01049373|83361281|FG001|Overall Study|Adverse Event|3|||
47072966|NCT01049373|83361280|FG000|Overall Study|Lost to Follow-up|9|||
47072967|NCT01049373|83361281|FG001|Overall Study|Lost to Follow-up|4|||
47072968|NCT01049373|83361280|FG000|Overall Study|no evaluable study values|9|||
47072969|NCT01049373|83361281|FG001|Overall Study|no evaluable study values|21|||
47072970|NCT01049373|83361280|FG000|Overall Study|Other|1|||
47072971|NCT01049373|83361281|FG001|Overall Study|Other|1|||
47072972|NCT01049373|83361280|FG000|Overall Study|Non-cooperation|0|||
47072973|NCT01049373|83361281|FG001|Overall Study|Non-cooperation|1|||
47072974|NCT00985231|83361291|FG000|Overall Study|ineligible|1|||
47072975|NCT00985231|83361292|FG001|Overall Study|ineligible|0|||
47072976|NCT00985231|83361291|FG000|Overall Study|Protocol Violation|1|||
47072977|NCT00985231|83361292|FG001|Overall Study|Protocol Violation|0|||
47072978|NCT00985231|83361291|FG000|Overall Study|Withdrawal by Subject|1|||
47072979|NCT00985231|83361292|FG001|Overall Study|Withdrawal by Subject|0|||
47072980|NCT00985231|83361291|FG000|Overall Study|Lost to Follow-up|0|||
47072981|NCT00985231|83361292|FG001|Overall Study|Lost to Follow-up|1|||
47072982|NCT00985231|83361291|FG000|Overall Study|Study related symptoms & complaints|0|||
47072983|NCT00985231|83361292|FG001|Overall Study|Study related symptoms & complaints|2|||
47072984|NCT01048671|83361312|FG000|Overall Study|Protocol Violation|0|||
47072985|NCT01048671|83361313|FG001|Overall Study|Protocol Violation|1|||
47072986|NCT01048671|83361314|FG002|Overall Study|Protocol Violation|1|||
47072987|NCT01360866|83361326|FG000|Overall Study|Lost to Follow-up|11|||
47072988|NCT01360866|83361327|FG001|Overall Study|Lost to Follow-up|28|||
47072989|NCT01360866|83361328|FG002|Overall Study|Lost to Follow-up|41|||
47072990|NCT01360866|83361329|FG003|Overall Study|Lost to Follow-up|0|||
47072991|NCT01360866|83361326|FG000|Overall Study|Adverse Event|56|||
47072992|NCT01360866|83361327|FG001|Overall Study|Adverse Event|61|||
47072993|NCT01360866|83361328|FG002|Overall Study|Adverse Event|134|||
47072994|NCT01360866|83361329|FG003|Overall Study|Adverse Event|6|||
47072995|NCT01360866|83361326|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
47072996|NCT01360866|83361327|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
47072997|NCT01360866|83361328|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
47072998|NCT01360866|83361329|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
47072999|NCT01360866|83361326|FG000|Overall Study|Withdrawn by Investigator|9|||
47073000|NCT01360866|83361327|FG001|Overall Study|Withdrawn by Investigator|8|||
47073001|NCT01360866|83361328|FG002|Overall Study|Withdrawn by Investigator|31|||
47073002|NCT01360866|83361329|FG003|Overall Study|Withdrawn by Investigator|2|||
47073003|NCT01360866|83361326|FG000|Overall Study|Withdrawal by participant|79|||
47073004|NCT01360866|83361327|FG001|Overall Study|Withdrawal by participant|89|||
47073005|NCT01360866|83361328|FG002|Overall Study|Withdrawal by participant|168|||
47073006|NCT01360866|83361329|FG003|Overall Study|Withdrawal by participant|8|||
47073007|NCT01360866|83361326|FG000|Overall Study|Protocol Deviation|25|||
47073008|NCT01360866|83361327|FG001|Overall Study|Protocol Deviation|33|||
47073009|NCT01360866|83361328|FG002|Overall Study|Protocol Deviation|61|||
47073010|NCT01360866|83361329|FG003|Overall Study|Protocol Deviation|2|||
47073011|NCT01360866|83361326|FG000|Overall Study|Lack of Efficacy|30|||
47073012|NCT01360866|83361327|FG001|Overall Study|Lack of Efficacy|40|||
47073013|NCT01360866|83361328|FG002|Overall Study|Lack of Efficacy|30|||
47073014|NCT01360866|83361329|FG003|Overall Study|Lack of Efficacy|4|||
46775652|NCT00694707|82994138|FG002|Overall Study|Protocol Violation|1|||
46775653|NCT00694707|82994139|FG003|Overall Study|Protocol Violation|3|||
47073015|NCT00985153|83361343|FG000|Overall Study|Lost to Follow-up|16|||
47073016|NCT00985153|83361344|FG001|Overall Study|Lost to Follow-up|19|||
47073017|NCT00985153|83361345|FG002|Overall Study|Lost to Follow-up|17|||
47073018|NCT00985153|83361346|FG003|Overall Study|Lost to Follow-up|20|||
47073019|NCT00985153|83361343|FG000|Overall Study|Protocol Violation|3|||
47073020|NCT00985153|83361344|FG001|Overall Study|Protocol Violation|2|||
47073021|NCT00985153|83361345|FG002|Overall Study|Protocol Violation|4|||
47073022|NCT00985153|83361346|FG003|Overall Study|Protocol Violation|3|||
47073023|NCT00985153|83361343|FG000|Overall Study|Withdrawal by Subject|6|||
47073024|NCT00985153|83361344|FG001|Overall Study|Withdrawal by Subject|11|||
47073025|NCT00985153|83361345|FG002|Overall Study|Withdrawal by Subject|11|||
47073026|NCT00985153|83361346|FG003|Overall Study|Withdrawal by Subject|10|||
47073027|NCT00985153|83361343|FG000|Overall Study|Missed One or More Bleeds|7|||
47073028|NCT00985153|83361344|FG001|Overall Study|Missed One or More Bleeds|7|||
47073029|NCT00985153|83361345|FG002|Overall Study|Missed One or More Bleeds|8|||
47073030|NCT00985153|83361346|FG003|Overall Study|Missed One or More Bleeds|10|||
47073031|NCT00985153|83361343|FG000|Overall Study|Incomplete Safety Follow-up|3|||
47073032|NCT00985153|83361344|FG001|Overall Study|Incomplete Safety Follow-up|5|||
47073033|NCT00985153|83361345|FG002|Overall Study|Incomplete Safety Follow-up|4|||
47073034|NCT00985153|83361346|FG003|Overall Study|Incomplete Safety Follow-up|4|||
47073035|NCT01047345|83361358|FG000|Base Study|Adverse Event|3|||
47073036|NCT01047345|83361359|FG001|Base Study|Adverse Event|0|||
47073037|NCT01047345|83361360|FG002|Base Study|Adverse Event|0|||
47073038|NCT01047345|83361358|FG000|Base Study|Lost to Follow-up|4|||
46641216|NCT01105975|82820476|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
46775654|NCT00694707|82994140|FG004|Overall Study|Protocol Violation|1|||
46775655|NCT00694707|82994136|FG000|Overall Study|Withdrawal of Consent|14|||
46775656|NCT00694707|82994137|FG001|Overall Study|Withdrawal of Consent|18|||
46775657|NCT00694707|82994138|FG002|Overall Study|Withdrawal of Consent|22|||
46775658|NCT00694707|82994139|FG003|Overall Study|Withdrawal of Consent|16|||
46775659|NCT00694707|82994140|FG004|Overall Study|Withdrawal of Consent|15|||
46775660|NCT00694707|82994136|FG000|Overall Study|Lost to Follow-up|0|||
46775661|NCT00694707|82994137|FG001|Overall Study|Lost to Follow-up|1|||
46775662|NCT00694707|82994138|FG002|Overall Study|Lost to Follow-up|2|||
46775663|NCT00694707|82994139|FG003|Overall Study|Lost to Follow-up|0|||
46775664|NCT00694707|82994140|FG004|Overall Study|Lost to Follow-up|0|||
46775665|NCT00694707|82994136|FG000|Overall Study|Jeopardizing Parole Status|1|||
46846440|NCT00131664|83063149|FG001|First Period (First 6 Months)|Protocol Violation|2|||
46846441|NCT00131664|83063150|FG002|First Period (First 6 Months)|Protocol Violation|1|||
46846442|NCT00131664|83063151|FG003|First Period (First 6 Months)|Protocol Violation|0|||
46846443|NCT00131664|83063152|FG004|First Period (First 6 Months)|Protocol Violation|0|||
46846444|NCT00131664|83063153|FG005|First Period (First 6 Months)|Protocol Violation|0|||
46967416|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
46967417|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
46967418|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
47073039|NCT01047345|83361359|FG001|Base Study|Lost to Follow-up|1|||
47073040|NCT01047345|83361360|FG002|Base Study|Lost to Follow-up|0|||
46846445|NCT00131664|83063148|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
46846446|NCT00131664|83063149|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
46846447|NCT00131664|83063150|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
46846448|NCT00131664|83063151|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
46846449|NCT00131664|83063152|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
46846450|NCT00131664|83063153|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
46846451|NCT00131664|83063148|FG000|First Period (First 6 Months)|Adverse Event|9|||
46967419|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
46967420|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
46967421|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
46967422|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
47073041|NCT01047345|83361358|FG000|Base Study|Protocol Violation|3|||
47073042|NCT01047345|83361359|FG001|Base Study|Protocol Violation|1|||
47073043|NCT01047345|83361360|FG002|Base Study|Protocol Violation|0|||
47073044|NCT01047345|83361358|FG000|Base Study|Withdrawal by Subject|12|||
47073045|NCT01047345|83361359|FG001|Base Study|Withdrawal by Subject|4|||
47073046|NCT01047345|83361360|FG002|Base Study|Withdrawal by Subject|0|||
47073047|NCT01047345|83361358|FG000|Extension|Withdrawal by Subject|0|||
47073048|NCT01047345|83361359|FG001|Extension|Withdrawal by Subject|0|||
47073049|NCT01047345|83361360|FG002|Extension|Withdrawal by Subject|1|||
47073050|NCT01047345|83361358|FG000|Extension|Lost to Follow-up|0|||
47073051|NCT01047345|83361359|FG001|Extension|Lost to Follow-up|0|||
47073052|NCT01047345|83361360|FG002|Extension|Lost to Follow-up|5|||
47073053|NCT01046877|83361368|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
47073054|NCT01046877|83361368|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
47073055|NCT00984061|83361372|FG000|Clarithromycin Alone|Protocol Violation|1|||
46775666|NCT00694707|82994137|FG001|Overall Study|Jeopardizing Parole Status|0|||
46775667|NCT00694707|82994138|FG002|Overall Study|Jeopardizing Parole Status|0|||
46775668|NCT00694707|82994139|FG003|Overall Study|Jeopardizing Parole Status|0|||
46846452|NCT00131664|83063149|FG001|First Period (First 6 Months)|Adverse Event|4|||
46967423|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
47073056|NCT01046643|83361381|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
46775669|NCT00694707|82994140|FG004|Overall Study|Jeopardizing Parole Status|0|||
47073057|NCT01046643|83361382|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
47073058|NCT01046643|83361383|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
47073059|NCT01046643|83361384|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
47073060|NCT00983905|83361394|FG000|Theophylline Alone|Adverse Event|1|||
47073061|NCT00983905|83361394|FG000|Colchicine Alone|Adverse Event|2|||
47073062|NCT01046565|83361401|FG000|Overall Study|Adverse Event|2|||
47073063|NCT01046565|83361401|FG000|Overall Study|Withdrawal by Subject|7|||
47073064|NCT00983827|83361410|FG000|Overall Study|Withdrawal by Subject|1|||
47073065|NCT00983749|83361416|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
46967424|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
46967425|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
46967426|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
46967427|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
46967428|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
46967429|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
46967430|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
47073066|NCT00983749|83361417|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
47073067|NCT01046253|83361425|FG000|Second Intervention|Adverse Event|0|||
47073068|NCT01046253|83361426|FG001|Second Intervention|Adverse Event|1|||
47073069|NCT01046253|83361425|FG000|Second Intervention|Protocol Violation|0|||
47073070|NCT01046253|83361426|FG001|Second Intervention|Protocol Violation|1|||
47073071|NCT00983515|83361432|FG000|Ritonavir Alone|liver panel out of range|6|||
46967431|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
46967432|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
46967433|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
47073072|NCT00983515|83361432|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
47073073|NCT00982735|83361439|FG000|Overall Study|Lost to Follow-up|6|||
47073074|NCT00982735|83361439|FG000|Overall Study|Patient ineligible for trial|224|||
47073075|NCT01361178|83361445|FG000|Overall Study|Death|13|||
47073076|NCT01361178|83361446|FG001|Overall Study|Death|0|||
47073077|NCT00981799|83361456|FG000|Overall Study|Adverse Event|1|||
47073078|NCT00981799|83361457|FG001|Overall Study|Adverse Event|1|||
47073079|NCT00981799|83361458|FG002|Overall Study|Adverse Event|0|||
47073080|NCT00981799|83361459|FG003|Overall Study|Adverse Event|0|||
47073081|NCT00981175|83361473|FG000|Primary Dose Vaccination|Adverse Event|1|||
47073082|NCT00981175|83361474|FG001|Primary Dose Vaccination|Adverse Event|0|||
47073083|NCT00981175|83361473|FG000|Primary Dose Vaccination|Protocol Violation|0|||
47073084|NCT00981175|83361474|FG001|Primary Dose Vaccination|Protocol Violation|1|||
47073085|NCT00981175|83361473|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
47073086|NCT00981175|83361474|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
47073087|NCT00981175|83361473|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
47073088|NCT00981175|83361474|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
47073089|NCT00981019|83361487|FG000|Overall Study|Did not respond|65|||
47073090|NCT00981019|83361487|FG000|Overall Study|Did not match target population|94|||
47073091|NCT00981019|83361487|FG000|Overall Study|Inadvertent exclusion|239|||
47073092|NCT00981019|83361487|FG000|Overall Study|Hit the survey after closure|79|||
47073093|NCT01045161|83361494|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
47073094|NCT01045161|83361495|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
46641217|NCT01105975|82820477|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
46967434|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
46967435|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
46967436|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
47073095|NCT01045161|83361496|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
47073096|NCT01045161|83361494|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
47073097|NCT01045161|83361495|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
47073098|NCT01045161|83361496|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
47073099|NCT01045161|83361494|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
47073100|NCT01045161|83361495|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
47073101|NCT01045161|83361496|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
47073102|NCT01045161|83361494|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
47073103|NCT01045161|83361495|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
47073104|NCT01045161|83361496|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
47073105|NCT01045161|83361494|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
46641218|NCT01105975|82820478|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
46967437|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
46967438|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
46967439|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
46967440|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
46775670|NCT00694707|82994136|FG000|Overall Study|Death in the Family|1|||
46967441|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
46967442|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
46967443|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
46967444|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
46967445|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
46967446|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
46967447|NCT00700427|83209986|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
46967448|NCT00700427|83209982|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
46967449|NCT00700427|83209983|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
46967450|NCT00700427|83209984|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
46967451|NCT00700427|83209985|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
46641219|NCT01105975|82820479|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
46775671|NCT00694707|82994137|FG001|Overall Study|Death in the Family|0|||
46775672|NCT00694707|82994138|FG002|Overall Study|Death in the Family|0|||
47073106|NCT01045161|83361495|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
47073107|NCT01045161|83361496|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
47073108|NCT01045161|83361494|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
46775673|NCT00694707|82994139|FG003|Overall Study|Death in the Family|0|||
46641317|NCT02929108|82825697|FG004|Overall Study|Hospice patient death|55|||
46641318|NCT02929108|82825698|FG005|Overall Study|Hospice patient death|28|||
46641319|NCT02929108|82825699|FG006|Overall Study|Hospice patient death|78|||
46641320|NCT02661295|82825707|FG000|Overall Study|Death|1|||
46641321|NCT02661295|82825707|FG000|Overall Study|Transferred Out|1|||
46641322|NCT02661295|82825707|FG000|Overall Study|Kidney Transplant|1|||
46641323|NCT02661295|82825707|FG000|Overall Study|Withdrawn due to side effects|8|||
46641324|NCT02661295|82825707|FG000|Overall Study|Withdrawn due to access type|1|||
46846489|NCT00131664|83063150|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
46846490|NCT00131664|83063151|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
46846491|NCT00131664|83063152|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
46846492|NCT00131664|83063153|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
46846493|NCT00131664|83063148|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
46641325|NCT02661295|82825707|FG000|Overall Study|Withdrawn due to allergies|1|||
46641326|NCT02661295|82825707|FG000|Overall Study|Withdrawn due to non-compliance|1|||
46641327|NCT02661295|82825707|FG000|Overall Study|Withdrawal by Subject|3|||
46641328|NCT02661295|82825707|FG000|Overall Study|Failed screening|2|||
46641329|NCT02412748|82825713|FG000|Overall Study|Lost to Follow-up|38|||
46846494|NCT00131664|83063149|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
46846495|NCT00131664|83063150|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
46846496|NCT00131664|83063151|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
46846497|NCT00131664|83063152|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
46846498|NCT00131664|83063153|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
46846499|NCT00131664|83063148|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
46846500|NCT00131664|83063149|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
46641330|NCT02412748|82825714|FG001|Overall Study|Lost to Follow-up|39|||
46641331|NCT01844726|82825739|FG000|Overall Study|Withdrawal by Subject|0|||
46641332|NCT01844726|82825740|FG001|Overall Study|Withdrawal by Subject|1|||
46641333|NCT01844726|82825739|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
46641334|NCT01844726|82825740|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
46641335|NCT04980391|82828959|FG000|Overall Study|Death|0|||
46641336|NCT04980391|82828960|FG001|Overall Study|Death|0|||
46641337|NCT04980391|82828961|FG002|Overall Study|Death|1|||
46641338|NCT04980391|82828962|FG003|Overall Study|Death|1|||
46641339|NCT04980391|82828959|FG000|Overall Study|Lost to Follow-up|3|||
46641340|NCT04980391|82828960|FG001|Overall Study|Lost to Follow-up|3|||
46641341|NCT04980391|82828961|FG002|Overall Study|Lost to Follow-up|2|||
46641342|NCT04980391|82828962|FG003|Overall Study|Lost to Follow-up|3|||
46641343|NCT04980391|82828959|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
46641344|NCT04980391|82828960|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
46641345|NCT04980391|82828961|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
46641346|NCT04980391|82828962|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
46641347|NCT04980391|82828959|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46641348|NCT04980391|82828960|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46641349|NCT04980391|82828961|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
46641350|NCT04980391|82828962|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46641351|NCT04980391|82828959|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
46641352|NCT04980391|82828960|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
46641353|NCT04980391|82828961|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
46641354|NCT04980391|82828962|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
46641355|NCT04939428|82828977|FG000|Overall Study|Death|0|||
46641356|NCT04939428|82828978|FG001|Overall Study|Death|1|||
46641357|NCT04939428|82828979|FG002|Overall Study|Death|0|||
46641358|NCT04939428|82828977|FG000|Overall Study|Lost to Follow-up|0|||
46641359|NCT04939428|82828978|FG001|Overall Study|Lost to Follow-up|5|||
46641360|NCT04939428|82828979|FG002|Overall Study|Lost to Follow-up|0|||
46641361|NCT04939428|82828977|FG000|Overall Study|Physician Decision|1|||
46641362|NCT04939428|82828978|FG001|Overall Study|Physician Decision|0|||
46641363|NCT04939428|82828979|FG002|Overall Study|Physician Decision|0|||
46641364|NCT04939428|82828977|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
46641365|NCT04939428|82828978|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46641366|NCT04939428|82828979|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
46641367|NCT04939428|82828977|FG000|Overall Study|Withdrawal by Subject|10|||
46641368|NCT04939428|82828978|FG001|Overall Study|Withdrawal by Subject|11|||
46641369|NCT04939428|82828979|FG002|Overall Study|Withdrawal by Subject|0|||
46641370|NCT04939428|82828977|FG000|Overall Study|Unkown|6|||
46641371|NCT04939428|82828978|FG001|Overall Study|Unkown|3|||
46641372|NCT04939428|82828979|FG002|Overall Study|Unkown|0|||
46641373|NCT04939428|82828977|FG000|Overall Study|Discotinued per protocol|0|||
46641374|NCT04939428|82828978|FG001|Overall Study|Discotinued per protocol|0|||
46641375|NCT04939428|82828979|FG002|Overall Study|Discotinued per protocol|902|||
46846501|NCT00131664|83063150|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
46846502|NCT00131664|83063151|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
46641376|NCT04805671|82828987|FG000|Overall Study|Death|2|||
46846503|NCT00131664|83063152|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
46846504|NCT00131664|83063153|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
46846505|NCT00131508|83063166|FG000|Overall Study|Disease progression|0|||
46846506|NCT00131508|83063167|FG001|Overall Study|Disease progression|2|||
46846507|NCT00131508|83063166|FG000|Overall Study|Non-Compliance|2|||
46846508|NCT00131508|83063167|FG001|Overall Study|Non-Compliance|4|||
46846509|NCT00131508|83063166|FG000|Overall Study|Withdrawal by Subject|1|||
46846510|NCT00131508|83063167|FG001|Overall Study|Withdrawal by Subject|2|||
46846511|NCT05050318|83063176|FG000|Overall Study|Protocol Deviation|1|||
46846512|NCT05050318|83063177|FG001|Overall Study|Protocol Deviation|0|||
46846513|NCT05050318|83063178|FG002|Overall Study|Protocol Deviation|0|||
46846514|NCT03699124|83063189|FG000|Overall Study|Adverse Event|6|||
46846515|NCT03699124|83063190|FG001|Overall Study|Adverse Event|5|||
46846516|NCT03699124|83063191|FG002|Overall Study|Adverse Event|2|||
46846517|NCT03699124|83063189|FG000|Overall Study|Death|0|||
46846518|NCT03699124|83063190|FG001|Overall Study|Death|2|||
46846519|NCT03699124|83063191|FG002|Overall Study|Death|0|||
46846520|NCT03699124|83063189|FG000|Overall Study|Lost to Follow-up|20|||
46846521|NCT03699124|83063190|FG001|Overall Study|Lost to Follow-up|16|||
46846522|NCT03699124|83063191|FG002|Overall Study|Lost to Follow-up|15|||
46846523|NCT03699124|83063189|FG000|Overall Study|Protocol Violation|1|||
46846524|NCT03699124|83063190|FG001|Overall Study|Protocol Violation|0|||
46846525|NCT03699124|83063191|FG002|Overall Study|Protocol Violation|0|||
46846526|NCT03699124|83063189|FG000|Overall Study|Withdrawal by Subject|13|||
46846527|NCT03699124|83063190|FG001|Overall Study|Withdrawal by Subject|14|||
46846528|NCT03699124|83063191|FG002|Overall Study|Withdrawal by Subject|13|||
46846529|NCT03699124|83063189|FG000|Overall Study|Other reasons|5|||
46846530|NCT03699124|83063190|FG001|Overall Study|Other reasons|3|||
46846531|NCT03699124|83063191|FG002|Overall Study|Other reasons|10|||
46846532|NCT05002972|83063199|FG000|Overall Study|Withdrawal by Subject|2|||
46846533|NCT04651114|83063203|FG000|Overall Study|Withdrawal by Subject|8|||
46846534|NCT04980040|83063207|FG000|Overall Study|Violated the Inclusion Criteria|260|||
46846535|NCT04980040|83063207|FG000|Overall Study|Violated the Administration & Dosage|225|||
46846536|NCT04980040|83063207|FG000|Overall Study|Lost to Safety-Follow-up|4|||
46846537|NCT04980040|83063207|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
46846538|NCT00131352|83063213|FG000|Initial Treatment Period|Adverse Event|1|||
46846539|NCT00131352|83063214|FG001|Initial Treatment Period|Adverse Event|3|||
46641377|NCT04805671|82828988|FG001|Overall Study|Death|7|||
46641378|NCT04805671|82828987|FG000|Overall Study|Lost to Follow-up|1|||
46641379|NCT04805671|82828988|FG001|Overall Study|Lost to Follow-up|0|||
46641380|NCT04805671|82828987|FG000|Overall Study|Withdrawal by Subject|9|||
46641381|NCT04805671|82828988|FG001|Overall Study|Withdrawal by Subject|7|||
46641382|NCT04805671|82828987|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
46641383|NCT04805671|82828988|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
46641384|NCT04779489|82828994|FG000|Overall Study|Physician Decision|1|||
46641385|NCT04533438|82829012|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
46641386|NCT04533438|82829013|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
46641387|NCT04469465|82829023|FG000|Overall Study|Adverse Event|2|||
46641388|NCT04469465|82829024|FG001|Overall Study|Adverse Event|1|||
46641389|NCT04469465|82829023|FG000|Overall Study|Ongoing treatment|7|||
46641390|NCT04469465|82829024|FG001|Overall Study|Ongoing treatment|4|||
46641391|NCT04469465|82829023|FG000|Overall Study|Withdrawal by Subject|0|||
46641392|NCT04469465|82829024|FG001|Overall Study|Withdrawal by Subject|1|||
46641393|NCT04431453|82829038|FG000|Overall Study|Withdrew Consent|0|||
46641394|NCT04431453|82829039|FG001|Overall Study|Withdrew Consent|1|||
46846540|NCT00131352|83063213|FG000|Initial Treatment Period|Non-compliant|1|||
46846541|NCT00131352|83063214|FG001|Initial Treatment Period|Non-compliant|2|||
46846542|NCT00131352|83063213|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
46846543|NCT00131352|83063214|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
46846544|NCT00131352|83063213|FG000|Initial Treatment Period|Lack of Efficacy|6|||
46846545|NCT00131352|83063214|FG001|Initial Treatment Period|Lack of Efficacy|4|||
46846546|NCT00131352|83063213|FG000|Initial Treatment Period|Other|0|||
46846547|NCT00131352|83063214|FG001|Initial Treatment Period|Other|2|||
46846548|NCT00131352|83063213|FG000|Repeat Treatment Period|Adverse Event|1|||
46846549|NCT00131352|83063214|FG001|Repeat Treatment Period|Adverse Event|0|||
46846550|NCT00131352|83063213|FG000|Repeat Treatment Period|Other|1|||
46846551|NCT00131352|83063214|FG001|Repeat Treatment Period|Other|0|||
46846552|NCT04633642|83063224|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
46846553|NCT04633642|83063225|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
46846554|NCT00136916|83063233|FG000|Overall Study|Never received study treatment|3|||
46846555|NCT00136916|83063234|FG001|Overall Study|Never received study treatment|5|||
46846556|NCT00136916|83063233|FG000|Overall Study|Death|1|||
46846557|NCT00136916|83063234|FG001|Overall Study|Death|3|||
46846558|NCT00136916|83063233|FG000|Overall Study|Adverse Event|27|||
46846559|NCT00136916|83063234|FG001|Overall Study|Adverse Event|8|||
46846560|NCT00136916|83063233|FG000|Overall Study|Laboratory abnormality|0|||
46846561|NCT00136916|83063234|FG001|Overall Study|Laboratory abnormality|1|||
46846562|NCT00136916|83063233|FG000|Overall Study|Lack of Efficacy|13|||
46846563|NCT00136916|83063234|FG001|Overall Study|Lack of Efficacy|3|||
46846564|NCT00136916|83063233|FG000|Overall Study|Lost to Follow-up|12|||
46846565|NCT00136916|83063234|FG001|Overall Study|Lost to Follow-up|14|||
46846566|NCT00136916|83063233|FG000|Overall Study|Withdrawal by Subject|44|||
46846567|NCT00136916|83063234|FG001|Overall Study|Withdrawal by Subject|46|||
46846568|NCT00136916|83063233|FG000|Overall Study|Other|22|||
46846569|NCT00136916|83063234|FG001|Overall Study|Other|24|||
46846570|NCT00136916|83063233|FG000|Overall Study|Discontinued in follow up period|3|||
46846571|NCT00136916|83063234|FG001|Overall Study|Discontinued in follow up period|0|||
46846572|NCT04633564|83063244|FG000|Period 1|Adverse Event|28|||
46846573|NCT04633564|83063245|FG001|Period 1|Adverse Event|19|||
46846574|NCT04633564|83063244|FG000|Period 1|Death|8|||
46846575|NCT04633564|83063245|FG001|Period 1|Death|7|||
46846576|NCT04633564|83063244|FG000|Period 1|Lost to Follow-up|3|||
46846577|NCT04633564|83063245|FG001|Period 1|Lost to Follow-up|5|||
46846578|NCT04633564|83063244|FG000|Period 1|Physician Decision|4|||
46846579|NCT04633564|83063245|FG001|Period 1|Physician Decision|12|||
46846580|NCT04633564|83063244|FG000|Period 1|Protocol Violation|0|||
46846581|NCT04633564|83063245|FG001|Period 1|Protocol Violation|1|||
46846582|NCT04633564|83063244|FG000|Period 1|Withdrawal by Subject|10|||
46846583|NCT04633564|83063245|FG001|Period 1|Withdrawal by Subject|8|||
46846584|NCT04633564|83063244|FG000|Period 1|Progressive disease|47|||
46846585|NCT04633564|83063245|FG001|Period 1|Progressive disease|51|||
46846586|NCT04633564|83063244|FG000|Period 1|Terminated by Sponsor|8|||
46846587|NCT04633564|83063245|FG001|Period 1|Terminated by Sponsor|6|||
46846588|NCT04633564|83063244|FG000|Period 2|Adverse Event|3|||
46846589|NCT04633564|83063245|FG001|Period 2|Adverse Event|4|||
46846590|NCT04633564|83063244|FG000|Period 2|Death|0|||
46846591|NCT04633564|83063245|FG001|Period 2|Death|2|||
46846592|NCT04633564|83063244|FG000|Period 2|Lost to Follow-up|0|||
46846593|NCT04633564|83063245|FG001|Period 2|Lost to Follow-up|1|||
46641395|NCT04431453|82829040|FG002|Overall Study|Withdrew Consent|0|||
46641396|NCT04431453|82829041|FG003|Overall Study|Withdrew Consent|2|||
46641397|NCT04431453|82829042|FG004|Overall Study|Withdrew Consent|0|||
46846594|NCT04633564|83063244|FG000|Period 2|Physician Decision|2|||
46846595|NCT04633564|83063245|FG001|Period 2|Physician Decision|4|||
46846596|NCT04633564|83063244|FG000|Period 2|Withdrawal by Subject|5|||
46641398|NCT04431453|82829043|FG005|Overall Study|Withdrew Consent|0|||
46641399|NCT04431453|82829044|FG006|Overall Study|Withdrew Consent|0|||
46641400|NCT04431453|82829045|FG007|Overall Study|Withdrew Consent|0|||
46846597|NCT04633564|83063245|FG001|Period 2|Withdrawal by Subject|1|||
46846598|NCT04633564|83063244|FG000|Period 2|Progressive Disease|74|||
46846599|NCT04633564|83063245|FG001|Period 2|Progressive Disease|82|||
46846600|NCT04633564|83063244|FG000|Period 2|Terminated by Sponsor|9|||
46846601|NCT04633564|83063245|FG001|Period 2|Terminated by Sponsor|3|||
47073143|NCT00633217|83361515|FG000|Overall Study|Investigator Discretion|2|||
46846602|NCT04960228|83063253|FG000|Overall Study|Withdrawal by Subject|216|||
46846603|NCT04960228|83063254|FG001|Overall Study|Withdrawal by Subject|35|||
46846604|NCT04960228|83063253|FG000|Overall Study|Failed attention check|69|||
47073144|NCT00633217|83361516|FG001|Overall Study|Investigator Discretion|0|||
47073145|NCT00633217|83361515|FG000|Overall Study|Withdrew Consent|3|||
47073146|NCT00633217|83361516|FG001|Overall Study|Withdrew Consent|3|||
46641401|NCT04431453|82829038|FG000|Overall Study|Death|1|||
46641402|NCT04431453|82829039|FG001|Overall Study|Death|0|||
46641403|NCT04431453|82829040|FG002|Overall Study|Death|0|||
46641404|NCT04431453|82829041|FG003|Overall Study|Death|0|||
46641405|NCT04431453|82829042|FG004|Overall Study|Death|0|||
46846605|NCT04960228|83063254|FG001|Overall Study|Failed attention check|148|||
46846606|NCT04960228|83063253|FG000|Overall Study|Flagged for response quality by Dynata|3|||
46846607|NCT04960228|83063254|FG001|Overall Study|Flagged for response quality by Dynata|3|||
46846608|NCT04619992|83063262|FG000|Overall Study|Withdrawal by Subject|1|||
46846609|NCT04619992|83063263|FG001|Overall Study|Withdrawal by Subject|0|||
46846610|NCT00136604|83063274|FG000|Overall Study|Lost to Follow-up|1|||
46846611|NCT00136604|83063275|FG001|Overall Study|Lost to Follow-up|0|||
46846612|NCT00136604|83063276|FG002|Overall Study|Lost to Follow-up|0|||
46846613|NCT00136604|83063277|FG003|Overall Study|Lost to Follow-up|0|||
46846614|NCT00136604|83063278|FG004|Overall Study|Lost to Follow-up|1|||
46846615|NCT00136604|83063274|FG000|Overall Study|Migrated/moved from study area|0|||
47073147|NCT01673490|83361522|FG000|Overall Study|Lost to Follow-up|1|||
46846616|NCT00136604|83063275|FG001|Overall Study|Migrated/moved from study area|1|||
46846617|NCT00136604|83063276|FG002|Overall Study|Migrated/moved from study area|0|||
46846618|NCT00136604|83063277|FG003|Overall Study|Migrated/moved from study area|0|||
46846619|NCT00136604|83063278|FG004|Overall Study|Migrated/moved from study area|0|||
46846620|NCT00135512|83063294|FG000|Overall Study|Adverse Event|56|||
46846621|NCT00135512|83063294|FG000|Overall Study|Lack of Efficacy|25|||
46846622|NCT00135512|83063294|FG000|Overall Study|Other|42|||
46846623|NCT00130728|83063300|FG000|Overall Study|Death|258|||
46846624|NCT00130728|83063301|FG001|Overall Study|Death|258|||
46846625|NCT00130728|83063300|FG000|Overall Study|Lost to Follow-up|4|||
46846626|NCT00130728|83063301|FG001|Overall Study|Lost to Follow-up|0|||
46846627|NCT00130728|83063300|FG000|Overall Study|Withdrawal by Subject|0|||
46846628|NCT00130728|83063301|FG001|Overall Study|Withdrawal by Subject|2|||
46846629|NCT00129974|83063307|FG000|Overall Study|Other|1|||
46846630|NCT04947436|83063314|FG000|Overall Study|Lost to Follow-up|3|||
46846631|NCT04947436|83063315|FG001|Overall Study|Lost to Follow-up|7|||
46846632|NCT04947436|83063316|FG002|Overall Study|Lost to Follow-up|5|||
46846633|NCT04947436|83063314|FG000|Overall Study|Death|1|||
46846634|NCT04947436|83063315|FG001|Overall Study|Death|1|||
46846635|NCT04947436|83063316|FG002|Overall Study|Death|1|||
46846636|NCT00119106|83063326|FG000|Overall Study|HIV infected at baseline|179|||
46641406|NCT04431453|82829043|FG005|Overall Study|Death|0|||
46775776|NCT00793793|82994209|FG005|Overall Study|reason not specified|1|||
46775777|NCT00793793|82994210|FG006|Overall Study|reason not specified|2|||
46846637|NCT00119106|83063327|FG001|Overall Study|HIV infected at baseline|178|||
46846638|NCT00135356|83063343|FG000|Overall Study|Adverse Event|6|||
46846639|NCT00135356|83063344|FG001|Overall Study|Adverse Event|2|||
46846640|NCT00135356|83063343|FG000|Overall Study|Lack of Efficacy|2|||
46846641|NCT00135356|83063344|FG001|Overall Study|Lack of Efficacy|0|||
46846642|NCT00135356|83063343|FG000|Overall Study|Lost to Follow-up|3|||
46846643|NCT00135356|83063344|FG001|Overall Study|Lost to Follow-up|1|||
46846644|NCT00135356|83063343|FG000|Overall Study|Surgery for abdominal fat|1|||
46846645|NCT00135356|83063344|FG001|Overall Study|Surgery for abdominal fat|0|||
46846646|NCT00135356|83063343|FG000|Overall Study|Change in antiviral regimen|0|||
46846647|NCT00135356|83063344|FG001|Overall Study|Change in antiviral regimen|1|||
46846648|NCT00135356|83063343|FG000|Overall Study|Poor/noncompliance|1|||
46846649|NCT00135356|83063344|FG001|Overall Study|Poor/noncompliance|1|||
46846650|NCT00135356|83063343|FG000|Overall Study|No longer meets study criteria|2|||
46846651|NCT00135356|83063344|FG001|Overall Study|No longer meets study criteria|0|||
46846652|NCT00135356|83063343|FG000|Overall Study|Withdrawal by Subject|2|||
46846653|NCT00135356|83063344|FG001|Overall Study|Withdrawal by Subject|4|||
46641407|NCT04431453|82829044|FG006|Overall Study|Death|0|||
46775778|NCT00793793|82994211|FG007|Overall Study|reason not specified|0|||
46775779|NCT00793793|82994212|FG008|Overall Study|reason not specified|7|||
46775780|NCT00793793|82994213|FG009|Overall Study|reason not specified|6|||
46775781|NCT00793793|82994214|FG010|Overall Study|reason not specified|2|||
46775782|NCT00793793|82994215|FG011|Overall Study|reason not specified|4|||
46775783|NCT00776789|82994263|FG000|Overall Study|Consent refusal|2|||
46641408|NCT04431453|82829045|FG007|Overall Study|Death|1|||
46641409|NCT04431453|82829038|FG000|Overall Study|Lost to Follow-up|0|||
46641410|NCT04431453|82829039|FG001|Overall Study|Lost to Follow-up|0|||
46641411|NCT04431453|82829040|FG002|Overall Study|Lost to Follow-up|1|||
46641412|NCT04431453|82829041|FG003|Overall Study|Lost to Follow-up|1|||
46641413|NCT04431453|82829042|FG004|Overall Study|Lost to Follow-up|0|||
46641414|NCT04431453|82829043|FG005|Overall Study|Lost to Follow-up|0|||
46641415|NCT04431453|82829044|FG006|Overall Study|Lost to Follow-up|0|||
46641416|NCT04431453|82829045|FG007|Overall Study|Lost to Follow-up|0|||
46641417|NCT04431453|82829038|FG000|Overall Study|Enrolled but Never Treated|0|||
46641418|NCT04431453|82829039|FG001|Overall Study|Enrolled but Never Treated|0|||
46641419|NCT04431453|82829040|FG002|Overall Study|Enrolled but Never Treated|0|||
46641420|NCT04431453|82829041|FG003|Overall Study|Enrolled but Never Treated|0|||
46641421|NCT04431453|82829042|FG004|Overall Study|Enrolled but Never Treated|1|||
46641422|NCT04431453|82829043|FG005|Overall Study|Enrolled but Never Treated|0|||
46641423|NCT04431453|82829044|FG006|Overall Study|Enrolled but Never Treated|0|||
46775784|NCT00776789|82994264|FG001|Overall Study|Consent refusal|2|||
46775785|NCT00776789|82994263|FG000|Overall Study|Poor quality video|1|||
46775786|NCT00776789|82994264|FG001|Overall Study|Poor quality video|1|||
46775787|NCT00776555|82994274|FG000|Overall Study|Study terminated|3|||
46846654|NCT00118716|83063352|FG000|Overall Study|Adverse Event|2|||
46775788|NCT00776555|82994275|FG001|Overall Study|Study terminated|0|||
46775789|NCT00720434|82994285|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
46846655|NCT00118716|83063353|FG001|Overall Study|Adverse Event|7|||
46846656|NCT00118716|83063352|FG000|Overall Study|Protocol Violation|5|||
46846657|NCT00118716|83063353|FG001|Overall Study|Protocol Violation|4|||
46846658|NCT00118716|83063352|FG000|Overall Study|Withdrawal by Subject|0|||
46846659|NCT00118716|83063353|FG001|Overall Study|Withdrawal by Subject|1|||
46846660|NCT00118716|83063352|FG000|Overall Study|Exacerbation|2|||
46846661|NCT00118716|83063353|FG001|Overall Study|Exacerbation|2|||
46846662|NCT00118716|83063352|FG000|Overall Study|Discontinued by sponsor|1|||
46775790|NCT00720434|82994286|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
46775791|NCT00720434|82994287|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
46775792|NCT00720434|82994288|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
46641424|NCT04431453|82829045|FG007|Overall Study|Enrolled but Never Treated|0|||
46641425|NCT04403763|82829076|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
46641426|NCT04403763|82829077|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
46641427|NCT04403763|82829078|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
46641428|NCT04403763|82829079|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
46641429|NCT04403763|82829080|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
46641430|NCT04403763|82829081|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
46641431|NCT04403763|82829082|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
46641432|NCT04403763|82829076|FG000|Stage 1|Early termination due to PK tube failure|0|||
46641433|NCT04403763|82829077|FG001|Stage 1|Early termination due to PK tube failure|0|||
46641434|NCT04403763|82829078|FG002|Stage 1|Early termination due to PK tube failure|1|||
46641435|NCT04403763|82829079|FG003|Stage 1|Early termination due to PK tube failure|0|||
46641436|NCT04403763|82829080|FG004|Stage 1|Early termination due to PK tube failure|0|||
46641437|NCT04403763|82829081|FG005|Stage 1|Early termination due to PK tube failure|0|||
46775793|NCT00720434|82994285|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
46775794|NCT00720434|82994286|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
46846663|NCT00118716|83063353|FG001|Overall Study|Discontinued by sponsor|1|||
46846664|NCT00118716|83063352|FG000|Overall Study|Non-compliance|1|||
46846665|NCT00118716|83063353|FG001|Overall Study|Non-compliance|3|||
46846666|NCT00118716|83063352|FG000|Overall Study|misrandomized|1|||
46846667|NCT00118716|83063353|FG001|Overall Study|misrandomized|1|||
46846668|NCT00118716|83063352|FG000|Overall Study|Expired drug use|1|||
46846669|NCT00118716|83063353|FG001|Overall Study|Expired drug use|2|||
46846670|NCT00118716|83063352|FG000|Overall Study|Investigator discretion|0|||
46846671|NCT00118716|83063353|FG001|Overall Study|Investigator discretion|1|||
46846672|NCT04584346|83063361|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
46846673|NCT04584346|83063362|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
46846674|NCT00118482|83063372|FG000|Overall Study|Lost to Follow-up|7|||
46846675|NCT00118482|83063373|FG001|Overall Study|Lost to Follow-up|7|||
46775795|NCT00720434|82994287|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
46775796|NCT00720434|82994288|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
46775797|NCT00720434|82994285|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
46775798|NCT00720434|82994286|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
46775799|NCT00720434|82994287|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
46775800|NCT00720434|82994288|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
46846676|NCT00118482|83063372|FG000|Overall Study|Withdrawal by Subject|23|||
46846677|NCT00118482|83063373|FG001|Overall Study|Withdrawal by Subject|22|||
46846678|NCT00129272|83063381|FG000|Overall Study|Lost to Follow-up|12|||
46846679|NCT00129272|83063382|FG001|Overall Study|Lost to Follow-up|11|||
46846680|NCT00129272|83063381|FG000|Overall Study|Withdrawal by Subject|5|||
46846681|NCT00129272|83063382|FG001|Overall Study|Withdrawal by Subject|11|||
46846682|NCT04899232|83063391|FG000|Screening Period|Physician Decision|1|||
46967918|NCT04681352|83210551|FG000|Overall Study|Withdrawal by Subject|22|||
46967919|NCT04471428|83210557|FG000|Overall Study|Withdrawal by Subject|29|||
46967920|NCT04471428|83210558|FG001|Overall Study|Withdrawal by Subject|1|||
46967921|NCT04471428|83210557|FG000|Overall Study|Physician Decision|0|||
46967922|NCT04471428|83210558|FG001|Overall Study|Physician Decision|1|||
46967923|NCT04471428|83210557|FG000|Overall Study|Reason Not Specified|0|||
46641438|NCT04403763|82829082|FG006|Stage 1|Early termination due to PK tube failure|0|||
46967924|NCT04471428|83210558|FG001|Overall Study|Reason Not Specified|2|||
46641439|NCT04403763|82829076|FG000|Stage 2A|Adverse Event|0|||
46641440|NCT04403763|82829077|FG001|Stage 2A|Adverse Event|0|||
46641441|NCT04403763|82829078|FG002|Stage 2A|Adverse Event|0|||
46641442|NCT04403763|82829079|FG003|Stage 2A|Adverse Event|0|||
46641443|NCT04403763|82829080|FG004|Stage 2A|Adverse Event|0|||
46641444|NCT04403763|82829081|FG005|Stage 2A|Adverse Event|0|||
46967925|NCT04471428|83210557|FG000|Overall Study|Death|106|||
46967926|NCT04471428|83210558|FG001|Overall Study|Death|114|||
46967927|NCT04471428|83210557|FG000|Overall Study|Ongoing in the study|45|||
46967928|NCT04471428|83210558|FG001|Overall Study|Ongoing in the study|68|||
46967929|NCT04339413|83210576|FG000|Overall Study|Reason Not Specified|2|||
46967930|NCT04339413|83210577|FG001|Overall Study|Reason Not Specified|7|||
46641445|NCT04403763|82829082|FG006|Stage 2A|Adverse Event|1|||
46641446|NCT04323436|82829107|FG000|Overall Study|Adverse Event|7|||
46641447|NCT04323436|82829108|FG001|Overall Study|Adverse Event|0|||
46775801|NCT00720434|82994285|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
46846683|NCT04899232|83063392|FG001|Screening Period|Physician Decision|0|||
46967931|NCT04339413|83210576|FG000|Overall Study|Study Terminated by Sponsor|30|||
46967932|NCT04339413|83210577|FG001|Overall Study|Study Terminated by Sponsor|33|||
46967933|NCT04339413|83210576|FG000|Overall Study|Progressive Disease|9|||
46967934|NCT04339413|83210577|FG001|Overall Study|Progressive Disease|6|||
46967935|NCT04339413|83210576|FG000|Overall Study|Withdrawal by Subject|9|||
46641448|NCT04323436|82829109|FG002|Overall Study|Adverse Event|0|||
46641449|NCT04323436|82829107|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
46641450|NCT04323436|82829108|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
46641451|NCT04323436|82829109|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
46641452|NCT04323436|82829107|FG000|Overall Study|Death|1|||
46641453|NCT04323436|82829108|FG001|Overall Study|Death|0|||
46641454|NCT04323436|82829109|FG002|Overall Study|Death|0|||
46775802|NCT00720434|82994286|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
46775803|NCT00720434|82994287|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
46775804|NCT00720434|82994288|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
46775805|NCT00720434|82994285|FG000|Open-Label Period (Week 5-72)|Other|4|||
46775806|NCT00720434|82994286|FG001|Open-Label Period (Week 5-72)|Other|3|||
46641455|NCT04323436|82829107|FG000|Overall Study|Physician Decision|2|||
46641456|NCT04323436|82829108|FG001|Overall Study|Physician Decision|0|||
46641457|NCT04323436|82829109|FG002|Overall Study|Physician Decision|0|||
46641458|NCT04323436|82829107|FG000|Overall Study|Progressive disease|10|||
46641459|NCT04323436|82829108|FG001|Overall Study|Progressive disease|0|||
46641460|NCT04323436|82829109|FG002|Overall Study|Progressive disease|0|||
46641461|NCT04323436|82829107|FG000|Overall Study|Subject decision|3|||
46641462|NCT04323436|82829108|FG001|Overall Study|Subject decision|0|||
46641463|NCT04323436|82829109|FG002|Overall Study|Subject decision|0|||
46641464|NCT04098068|82829130|FG000|Overall Study|Disease Progression|7|||
46641465|NCT04098068|82829130|FG000|Overall Study|Withdrawal by Subject|2|||
46641466|NCT04098068|82829130|FG000|Overall Study|New Cancer Diagnosis|1|||
46641467|NCT04084314|82829134|FG000|Overall Study|Subject/guardian decision|91|||
46641468|NCT04084314|82829134|FG000|Overall Study|Adverse Event|24|||
46641469|NCT04084314|82829134|FG000|Overall Study|Lost to Follow-up|19|||
46641470|NCT04084314|82829134|FG000|Overall Study|New therapy for study indication|9|||
46641471|NCT04084314|82829134|FG000|Overall Study|Pregnancy|9|||
46641472|NCT04084314|82829134|FG000|Overall Study|Withdrawal of informed consent|8|||
46641473|NCT04084314|82829134|FG000|Overall Study|Physician Decision|4|||
46641474|NCT04084314|82829134|FG000|Overall Study|Protocol Deviation|3|||
46641475|NCT04059484|82829140|FG000|Overall Study|Adverse Event|2|||
46641476|NCT04059484|82829141|FG001|Overall Study|Adverse Event|5|||
46641477|NCT04059484|82829140|FG000|Overall Study|Withdrawal by Subject|5|||
46641478|NCT04059484|82829141|FG001|Overall Study|Withdrawal by Subject|3|||
46641479|NCT04059484|82829140|FG000|Overall Study|Progressive disease|112|||
46641480|NCT04059484|82829141|FG001|Overall Study|Progressive disease|112|||
46641481|NCT04059484|82829140|FG000|Overall Study|Other|8|||
46641482|NCT04059484|82829141|FG001|Overall Study|Other|3|||
46641483|NCT04059484|82829140|FG000|Overall Study|Ongoing|20|||
46641484|NCT04059484|82829141|FG001|Overall Study|Ongoing|20|||
46641485|NCT03907969|82829161|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
46641486|NCT03907969|82829162|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
46641487|NCT03907969|82829163|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
46641488|NCT03907969|82829164|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
46641489|NCT03907969|82829165|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
46641490|NCT03907969|82829166|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
46641491|NCT03907969|82829167|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
46775807|NCT00720434|82994287|FG002|Open-Label Period (Week 5-72)|Other|3|||
46775808|NCT00720434|82994288|FG003|Open-Label Period (Week 5-72)|Other|2|||
46775809|NCT00776009|82994304|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
46775810|NCT00776009|82994305|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
46775811|NCT00776009|82994306|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
46775812|NCT00776009|82994307|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
46775813|NCT00776009|82994308|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
46775814|NCT00776009|82994309|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
46775815|NCT00776009|82994304|FG000|Period 1: First Intervention|Protocol Violation|0|||
46775816|NCT00776009|82994305|FG001|Period 1: First Intervention|Protocol Violation|1|||
46775817|NCT00776009|82994306|FG002|Period 1: First Intervention|Protocol Violation|0|||
46775818|NCT00776009|82994307|FG003|Period 1: First Intervention|Protocol Violation|0|||
46775819|NCT00776009|82994308|FG004|Period 1: First Intervention|Protocol Violation|1|||
46775820|NCT00776009|82994309|FG005|Period 1: First Intervention|Protocol Violation|0|||
46775821|NCT00776009|82994304|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
46775822|NCT00776009|82994305|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
46775823|NCT00776009|82994306|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
46775824|NCT00776009|82994307|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
46846684|NCT04899232|83063393|FG002|Screening Period|Physician Decision|0|||
46641492|NCT03907969|82829168|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
46641493|NCT03907969|82829169|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
46641494|NCT03907969|82829170|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
46641495|NCT03907969|82829171|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
46641496|NCT03907969|82829161|FG000|Monotherapy Part A|Progressive Disease|0|||
46641497|NCT03907969|82829162|FG001|Monotherapy Part A|Progressive Disease|1|||
46775825|NCT00776009|82994308|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
46775826|NCT00776009|82994309|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
46775827|NCT00776009|82994304|FG000|Period 2: Second Intervention|Protocol Violation|1|||
46775828|NCT00776009|82994305|FG001|Period 2: Second Intervention|Protocol Violation|0|||
46775829|NCT00776009|82994306|FG002|Period 2: Second Intervention|Protocol Violation|1|||
46775830|NCT00776009|82994307|FG003|Period 2: Second Intervention|Protocol Violation|0|||
46967936|NCT04339413|83210577|FG001|Overall Study|Withdrawal by Subject|10|||
46967937|NCT04339413|83210576|FG000|Overall Study|Physician Decision|3|||
46775831|NCT00776009|82994308|FG004|Period 2: Second Intervention|Protocol Violation|0|||
46775832|NCT00776009|82994309|FG005|Period 2: Second Intervention|Protocol Violation|0|||
46775833|NCT00776009|82994304|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
46775834|NCT00776009|82994305|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
46775835|NCT00776009|82994306|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
46775836|NCT00776009|82994307|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
46775837|NCT00776009|82994308|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
46775838|NCT00776009|82994309|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
46775839|NCT00694161|82994317|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
46775840|NCT00694161|82994317|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
46775841|NCT00694161|82994317|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
46775842|NCT00720356|82994321|FG000|Registration to Study|Determined to have methylated MGMT|67|||
46775843|NCT00720356|82994321|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
46775844|NCT00720356|82994321|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
46775845|NCT00720356|82994321|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
46775846|NCT00720356|82994321|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
46775847|NCT00720356|82994321|FG000|Follow up Until Death|Withdrawal by Subject|1|||
46846685|NCT04899232|83063391|FG000|Screening Period|Withdrawal by Subject|1|||
46846686|NCT04899232|83063392|FG001|Screening Period|Withdrawal by Subject|0|||
46846687|NCT04899232|83063393|FG002|Screening Period|Withdrawal by Subject|0|||
46846688|NCT04899232|83063391|FG000|Screening Period|Participant discharged before receiving intervention|3|||
46846689|NCT04899232|83063392|FG001|Screening Period|Participant discharged before receiving intervention|0|||
46846690|NCT04899232|83063393|FG002|Screening Period|Participant discharged before receiving intervention|0|||
46846691|NCT04559698|83063412|FG000|Overall Study|Lost to Follow-up|14|||
46846692|NCT04559698|83063413|FG001|Overall Study|Lost to Follow-up|15|||
46846693|NCT04559698|83063412|FG000|Overall Study|Withdrawal by Subject|0|||
46846694|NCT04559698|83063413|FG001|Overall Study|Withdrawal by Subject|1|||
46846695|NCT00133952|83063421|FG000|Overall Study|Adverse Event|1|||
46846696|NCT00133952|83063422|FG001|Overall Study|Adverse Event|2|||
46846697|NCT00133952|83063421|FG000|Overall Study|Death|3|||
46846698|NCT00133952|83063422|FG001|Overall Study|Death|2|||
46846699|NCT00133952|83063421|FG000|Overall Study|Lost to Follow-up|9|||
46846700|NCT00133952|83063422|FG001|Overall Study|Lost to Follow-up|14|||
46846701|NCT00133952|83063421|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
46846702|NCT00133952|83063422|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
46846703|NCT00133952|83063421|FG000|Overall Study|Protocol Violation|1|||
46846704|NCT00133952|83063422|FG001|Overall Study|Protocol Violation|1|||
46846705|NCT00133952|83063421|FG000|Overall Study|Withdrawal by Subject|20|||
46846706|NCT00133952|83063422|FG001|Overall Study|Withdrawal by Subject|4|||
46846707|NCT00133952|83063421|FG000|Overall Study|Physician Decision|4|||
46846708|NCT00133952|83063422|FG001|Overall Study|Physician Decision|3|||
46846709|NCT00133952|83063421|FG000|Overall Study|Sponsor Decision|0|||
46846710|NCT00133952|83063422|FG001|Overall Study|Sponsor Decision|1|||
46846711|NCT00118092|83063428|FG000|Overall Study|Withdrawal by Subject|1|||
46846712|NCT00118092|83063428|FG000|Overall Study|Protocol Violation|1|||
46846713|NCT04555096|83063435|FG000|Overall Study|Death|4|||
46846714|NCT04555096|83063436|FG001|Overall Study|Death|4|||
46846715|NCT04555096|83063435|FG000|Overall Study|Withdrawal by Subject|1|||
46846716|NCT04555096|83063436|FG001|Overall Study|Withdrawal by Subject|0|||
46846717|NCT04555096|83063435|FG000|Overall Study|Other|0|||
46846718|NCT04555096|83063436|FG001|Overall Study|Other|1|||
46846719|NCT00097500|83063444|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
46846720|NCT00097500|83063445|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
46846721|NCT00097500|83063444|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
46846722|NCT00097500|83063445|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
46846723|NCT00097500|83063444|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
46846724|NCT00097500|83063445|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
46967938|NCT04339413|83210577|FG001|Overall Study|Physician Decision|1|||
46775848|NCT00720356|82994321|FG000|Follow up Until Death|Alive at last data collection|4|||
46846725|NCT00097500|83063444|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
46846726|NCT00097500|83063445|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
46846727|NCT00097500|83063444|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
46846728|NCT00097500|83063445|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
46967939|NCT04339413|83210576|FG000|Overall Study|Death|2|||
46846729|NCT00097500|83063444|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
46846730|NCT00097500|83063445|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
46846731|NCT00097500|83063444|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
46846732|NCT00097500|83063445|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
46846733|NCT04551898|83063455|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
46846734|NCT04551898|83063456|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
46846735|NCT04551898|83063457|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
46846736|NCT04551898|83063458|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
46846737|NCT04551898|83063455|FG000|Overall Study|Withdrawal by Subject|5|||
46846738|NCT04551898|83063456|FG001|Overall Study|Withdrawal by Subject|1|||
46846739|NCT04551898|83063457|FG002|Overall Study|Withdrawal by Subject|2|||
46846740|NCT04551898|83063458|FG003|Overall Study|Withdrawal by Subject|2|||
46846741|NCT04551898|83063455|FG000|Overall Study|Lost to Follow-up|2|||
46846742|NCT04551898|83063456|FG001|Overall Study|Lost to Follow-up|1|||
46846743|NCT04551898|83063457|FG002|Overall Study|Lost to Follow-up|2|||
46846744|NCT04551898|83063458|FG003|Overall Study|Lost to Follow-up|2|||
46846745|NCT04551898|83063455|FG000|Overall Study|Death|1|||
46846746|NCT04551898|83063456|FG001|Overall Study|Death|0|||
46846747|NCT04551898|83063457|FG002|Overall Study|Death|0|||
46846748|NCT04551898|83063458|FG003|Overall Study|Death|0|||
46846749|NCT04551898|83063455|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
46846750|NCT04551898|83063456|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
47073148|NCT01673490|83361522|FG000|Overall Study|Adverse Event|3|||
47073149|NCT01673490|83361522|FG000|Overall Study|Withdrawal by Subject|3|||
47073150|NCT00215657|83361534|FG000|Overall Study|Adverse Event|5|||
47073151|NCT00215657|83361535|FG001|Overall Study|Adverse Event|1|||
47073152|NCT00215657|83361536|FG002|Overall Study|Adverse Event|3|||
47073153|NCT00215657|83361537|FG003|Overall Study|Adverse Event|0|||
47073154|NCT00215657|83361538|FG004|Overall Study|Adverse Event|3|||
47073155|NCT00215657|83361539|FG005|Overall Study|Adverse Event|1|||
46775849|NCT00720278|82994328|FG000|Overall Study|Adverse Event|5|||
46775850|NCT00720278|82994329|FG001|Overall Study|Adverse Event|3|||
46775851|NCT00720278|82994330|FG002|Overall Study|Adverse Event|4|||
46775852|NCT00720278|82994328|FG000|Overall Study|Withdrawal by Subject|0|||
46775853|NCT00720278|82994329|FG001|Overall Study|Withdrawal by Subject|1|||
46775854|NCT00720278|82994330|FG002|Overall Study|Withdrawal by Subject|0|||
46775855|NCT00720278|82994328|FG000|Overall Study|Lost to Follow-up|0|||
46775856|NCT00720278|82994329|FG001|Overall Study|Lost to Follow-up|0|||
46846751|NCT04551898|83063457|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
46846752|NCT04551898|83063458|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
46846753|NCT04849780|83063476|FG000|Period 1|Covid-19 Related|1|||
46846754|NCT04849780|83063477|FG001|Period 1|Covid-19 Related|0|||
46846755|NCT04849780|83063476|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
46846756|NCT04849780|83063477|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
46846757|NCT04849780|83063476|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
46846758|NCT04849780|83063477|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
46846759|NCT04823494|83063491|FG000|Overall Study|Programming software malfunction.|1|||
46846760|NCT04823494|83063492|FG001|Overall Study|Programming software malfunction.|0|||
46846761|NCT04823494|83063491|FG000|Overall Study|Withdrawal by Subject|1|||
46846762|NCT04823494|83063492|FG001|Overall Study|Withdrawal by Subject|0|||
46775857|NCT00720278|82994330|FG002|Overall Study|Lost to Follow-up|1|||
46775858|NCT00720278|82994328|FG000|Overall Study|Non-compliance|1|||
46775859|NCT00720278|82994329|FG001|Overall Study|Non-compliance|0|||
46775860|NCT00720278|82994330|FG002|Overall Study|Non-compliance|0|||
46775861|NCT00720278|82994328|FG000|Overall Study|eligibility criteria violation|1|||
46775862|NCT00720278|82994329|FG001|Overall Study|eligibility criteria violation|0|||
46775863|NCT00720278|82994330|FG002|Overall Study|eligibility criteria violation|1|||
46775864|NCT00720122|82994338|FG000|Overall Study|Lost to Follow-up|1|||
46846763|NCT04823494|83063491|FG000|Overall Study|Devices lost|0|||
46846764|NCT04823494|83063492|FG001|Overall Study|Devices lost|1|||
46846765|NCT04542694|83063502|FG000|Overall Study|The need for prohibited therapy|2|||
46846766|NCT04542694|83063503|FG001|Overall Study|The need for prohibited therapy|0|||
46846767|NCT04542694|83063502|FG000|Overall Study|Adverse Event|1|||
46775865|NCT00720122|82994338|FG000|Overall Study|Physician Decision|1|||
46775866|NCT00720122|82994338|FG000|Overall Study|Withdrawal by Subject|7|||
47073156|NCT00215657|83361540|FG006|Overall Study|Adverse Event|0|||
47073157|NCT00215657|83361541|FG007|Overall Study|Adverse Event|3|||
47073158|NCT00215657|83361534|FG000|Overall Study|Withdrawal by Subject|6|||
47073159|NCT00215657|83361535|FG001|Overall Study|Withdrawal by Subject|3|||
47073160|NCT00215657|83361536|FG002|Overall Study|Withdrawal by Subject|3|||
47073161|NCT00215657|83361537|FG003|Overall Study|Withdrawal by Subject|1|||
47073162|NCT00215657|83361538|FG004|Overall Study|Withdrawal by Subject|6|||
47073163|NCT00215657|83361539|FG005|Overall Study|Withdrawal by Subject|1|||
46775867|NCT00717860|82994344|FG000|Overall Study|Clinical adverse experience|5|||
46775868|NCT00717860|82994345|FG001|Overall Study|Clinical adverse experience|9|||
46775869|NCT00717860|82994344|FG000|Overall Study|Laboratory adverse experience|2|||
46775870|NCT00717860|82994345|FG001|Overall Study|Laboratory adverse experience|2|||
46775871|NCT00717860|82994344|FG000|Overall Study|Lack of Efficacy|7|||
46775872|NCT00717860|82994345|FG001|Overall Study|Lack of Efficacy|13|||
46775873|NCT00717860|82994344|FG000|Overall Study|Discontinued for other reason|6|||
46775874|NCT00717860|82994345|FG001|Overall Study|Discontinued for other reason|1|||
46775875|NCT00717860|82994344|FG000|Overall Study|Withdrew consent|7|||
46775876|NCT00717860|82994345|FG001|Overall Study|Withdrew consent|3|||
46775877|NCT00717314|82994353|FG000|Overall Study|Adverse Event|3|||
46846768|NCT04542694|83063503|FG001|Overall Study|Adverse Event|0|||
46775878|NCT00717314|82994354|FG001|Overall Study|Adverse Event|2|||
46775879|NCT00717314|82994353|FG000|Overall Study|Protocol Violation|1|||
46775880|NCT00717314|82994354|FG001|Overall Study|Protocol Violation|0|||
46775881|NCT00717314|82994353|FG000|Overall Study|Lost to Follow-up|1|||
46775882|NCT00717314|82994354|FG001|Overall Study|Lost to Follow-up|5|||
46775883|NCT00717314|82994353|FG000|Overall Study|Withdrawal by Subject|1|||
46775884|NCT00717314|82994354|FG001|Overall Study|Withdrawal by Subject|3|||
46775885|NCT00689793|82994362|FG000|Overall Study|Lost to Follow-up|4|||
46775886|NCT00689793|82994363|FG001|Overall Study|Lost to Follow-up|5|||
46775887|NCT00723944|82994373|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
46775888|NCT00723944|82994374|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
46775889|NCT00723944|82994373|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
46775890|NCT00723944|82994374|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
46775891|NCT00723944|82994373|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
46775892|NCT00723944|82994374|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
46775893|NCT00689481|82994382|FG000|Overall Study|Adverse Event|7|||
46775894|NCT00689481|82994383|FG001|Overall Study|Adverse Event|1|||
46775895|NCT00689481|82994382|FG000|Overall Study|Lost to Follow-up|4|||
46775896|NCT00689481|82994383|FG001|Overall Study|Lost to Follow-up|3|||
46775897|NCT00689481|82994382|FG000|Overall Study|Lack of Efficacy|4|||
46775898|NCT00689481|82994383|FG001|Overall Study|Lack of Efficacy|3|||
46775899|NCT00689481|82994382|FG000|Overall Study|Non-compliance with study treatment|1|||
46775900|NCT00689481|82994383|FG001|Overall Study|Non-compliance with study treatment|1|||
46846769|NCT04542694|83063502|FG000|Overall Study|Protocol Violation|1|||
46846770|NCT04542694|83063503|FG001|Overall Study|Protocol Violation|0|||
46846771|NCT00117312|83063513|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
46846772|NCT00117312|83063514|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
46846773|NCT00117312|83063515|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
46846774|NCT00117312|83063516|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
46846775|NCT00117312|83063513|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
46846776|NCT00117312|83063514|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
46846777|NCT00117312|83063515|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
46846778|NCT00117312|83063516|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
46846779|NCT00117312|83063513|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
46846780|NCT00117312|83063514|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
46846781|NCT00117312|83063515|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
46846782|NCT00117312|83063516|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
46846783|NCT00117312|83063513|FG000|Overall Study|Other|0|||
46846784|NCT00117312|83063514|FG001|Overall Study|Other|1|||
46846785|NCT00117312|83063515|FG002|Overall Study|Other|3|||
46846786|NCT00117312|83063516|FG003|Overall Study|Other|1|||
46846787|NCT00117312|83063513|FG000|Overall Study|Patient choice|0|||
46846788|NCT00117312|83063514|FG001|Overall Study|Patient choice|0|||
46846789|NCT00117312|83063515|FG002|Overall Study|Patient choice|2|||
46846790|NCT00117312|83063516|FG003|Overall Study|Patient choice|1|||
46846791|NCT00117312|83063513|FG000|Overall Study|Adverse Event|0|||
46846792|NCT00117312|83063514|FG001|Overall Study|Adverse Event|2|||
46846793|NCT00117312|83063515|FG002|Overall Study|Adverse Event|0|||
46967940|NCT04339413|83210577|FG001|Overall Study|Death|0|||
46775901|NCT00689481|82994382|FG000|Overall Study|Withdrawal by Subject|8|||
46846794|NCT00117312|83063516|FG003|Overall Study|Adverse Event|0|||
46967941|NCT04339413|83210576|FG000|Overall Study|Adverse Event|3|||
46775902|NCT00689481|82994383|FG001|Overall Study|Withdrawal by Subject|4|||
46775903|NCT00689481|82994382|FG000|Overall Study|Excluded medication started during study|0|||
46775904|NCT00689481|82994383|FG001|Overall Study|Excluded medication started during study|1|||
46846795|NCT00117312|83063513|FG000|Overall Study|Protocol Violation|0|||
46967942|NCT04339413|83210577|FG001|Overall Study|Adverse Event|0|||
46775905|NCT00689481|82994382|FG000|Overall Study|Subject early term, left on vacation|0|||
46775906|NCT00689481|82994383|FG001|Overall Study|Subject early term, left on vacation|1|||
46775907|NCT00688701|82994392|FG000|Overall Study|Adverse Event|1|||
46846796|NCT00117312|83063514|FG001|Overall Study|Protocol Violation|1|||
46846797|NCT00117312|83063515|FG002|Overall Study|Protocol Violation|3|||
46846798|NCT00117312|83063516|FG003|Overall Study|Protocol Violation|0|||
46846799|NCT00117312|83063513|FG000|Overall Study|PSA decrease <=50%|0|||
46846800|NCT00117312|83063514|FG001|Overall Study|PSA decrease <=50%|2|||
46641498|NCT03907969|82829163|FG002|Monotherapy Part A|Progressive Disease|0|||
46641499|NCT03907969|82829164|FG003|Monotherapy Part A|Progressive Disease|0|||
46641500|NCT03907969|82829165|FG004|Monotherapy Part A|Progressive Disease|0|||
46641501|NCT03907969|82829166|FG005|Monotherapy Part A|Progressive Disease|1|||
47073164|NCT00215657|83361540|FG006|Overall Study|Withdrawal by Subject|10|||
46775908|NCT00688701|82994393|FG001|Overall Study|Adverse Event|0|||
46641502|NCT03907969|82829167|FG006|Monotherapy Part A|Progressive Disease|2|||
46641503|NCT03907969|82829168|FG007|Monotherapy Part A|Progressive Disease|0|||
46641504|NCT03907969|82829169|FG008|Monotherapy Part A|Progressive Disease|0|||
46641505|NCT03907969|82829170|FG009|Monotherapy Part A|Progressive Disease|0|||
46641506|NCT03907969|82829171|FG010|Monotherapy Part A|Progressive Disease|0|||
46641507|NCT03907969|82829161|FG000|Monotherapy Part A|Death|0|||
46641508|NCT03907969|82829162|FG001|Monotherapy Part A|Death|0|||
46641509|NCT03907969|82829163|FG002|Monotherapy Part A|Death|1|||
46641510|NCT03907969|82829164|FG003|Monotherapy Part A|Death|1|||
46641511|NCT03907969|82829165|FG004|Monotherapy Part A|Death|0|||
46641512|NCT03907969|82829166|FG005|Monotherapy Part A|Death|1|||
46641513|NCT03907969|82829167|FG006|Monotherapy Part A|Death|0|||
46641514|NCT03907969|82829168|FG007|Monotherapy Part A|Death|0|||
46641515|NCT03907969|82829169|FG008|Monotherapy Part A|Death|0|||
46641516|NCT03907969|82829170|FG009|Monotherapy Part A|Death|0|||
46641517|NCT03907969|82829171|FG010|Monotherapy Part A|Death|0|||
46641518|NCT03907969|82829161|FG000|Combination Therapy Part A|Adverse Event|0|||
46641519|NCT03907969|82829162|FG001|Combination Therapy Part A|Adverse Event|0|||
46641520|NCT03907969|82829163|FG002|Combination Therapy Part A|Adverse Event|0|||
46641521|NCT03907969|82829164|FG003|Combination Therapy Part A|Adverse Event|0|||
46641522|NCT03907969|82829165|FG004|Combination Therapy Part A|Adverse Event|0|||
46641523|NCT03907969|82829166|FG005|Combination Therapy Part A|Adverse Event|0|||
46641524|NCT03907969|82829167|FG006|Combination Therapy Part A|Adverse Event|0|||
46641525|NCT03907969|82829168|FG007|Combination Therapy Part A|Adverse Event|0|||
46641526|NCT03907969|82829169|FG008|Combination Therapy Part A|Adverse Event|0|||
46641527|NCT03907969|82829170|FG009|Combination Therapy Part A|Adverse Event|1|||
46641528|NCT03907969|82829171|FG010|Combination Therapy Part A|Adverse Event|1|||
46641529|NCT03907969|82829161|FG000|Combination Therapy Part A|Progressive disease|0|||
46641530|NCT03907969|82829162|FG001|Combination Therapy Part A|Progressive disease|0|||
46641531|NCT03907969|82829163|FG002|Combination Therapy Part A|Progressive disease|0|||
46641532|NCT03907969|82829164|FG003|Combination Therapy Part A|Progressive disease|0|||
46641533|NCT03907969|82829165|FG004|Combination Therapy Part A|Progressive disease|0|||
46641534|NCT03907969|82829166|FG005|Combination Therapy Part A|Progressive disease|0|||
46641535|NCT03907969|82829167|FG006|Combination Therapy Part A|Progressive disease|0|||
46641536|NCT03907969|82829168|FG007|Combination Therapy Part A|Progressive disease|1|||
46641537|NCT03907969|82829169|FG008|Combination Therapy Part A|Progressive disease|0|||
46641538|NCT03907969|82829170|FG009|Combination Therapy Part A|Progressive disease|2|||
46775909|NCT00688701|82994394|FG002|Overall Study|Adverse Event|5|||
46775910|NCT00688701|82994395|FG003|Overall Study|Adverse Event|3|||
46775911|NCT00688701|82994392|FG000|Overall Study|Lack of Efficacy|0|||
46775912|NCT00688701|82994393|FG001|Overall Study|Lack of Efficacy|1|||
46775913|NCT00688701|82994394|FG002|Overall Study|Lack of Efficacy|0|||
46775914|NCT00688701|82994395|FG003|Overall Study|Lack of Efficacy|0|||
46775915|NCT00688701|82994392|FG000|Overall Study|Withdrawal by Subject|3|||
46846801|NCT00117312|83063515|FG002|Overall Study|PSA decrease <=50%|2|||
46846802|NCT00117312|83063516|FG003|Overall Study|PSA decrease <=50%|4|||
46641539|NCT03907969|82829171|FG010|Combination Therapy Part A|Progressive disease|3|||
46641540|NCT03907969|82829161|FG000|Combination Therapy Part A|Death|0|||
46641541|NCT03907969|82829162|FG001|Combination Therapy Part A|Death|0|||
46641542|NCT03907969|82829163|FG002|Combination Therapy Part A|Death|0|||
46641543|NCT03907969|82829164|FG003|Combination Therapy Part A|Death|0|||
46641544|NCT03907969|82829165|FG004|Combination Therapy Part A|Death|0|||
46641545|NCT03907969|82829166|FG005|Combination Therapy Part A|Death|0|||
46641546|NCT03907969|82829167|FG006|Combination Therapy Part A|Death|0|||
46641547|NCT03907969|82829168|FG007|Combination Therapy Part A|Death|0|||
46641548|NCT03907969|82829169|FG008|Combination Therapy Part A|Death|1|||
46641549|NCT03907969|82829170|FG009|Combination Therapy Part A|Death|0|||
46641550|NCT03907969|82829171|FG010|Combination Therapy Part A|Death|1|||
46641551|NCT03907969|82829161|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
46775916|NCT00688701|82994393|FG001|Overall Study|Withdrawal by Subject|3|||
46846803|NCT00117312|83063513|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
46641552|NCT03907969|82829162|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
46641553|NCT03907969|82829163|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
46641554|NCT03907969|82829164|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
46641555|NCT03907969|82829165|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
46641556|NCT03907969|82829166|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
46641557|NCT03907969|82829167|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
46641558|NCT03907969|82829168|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
46641559|NCT03907969|82829169|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
46775917|NCT00688701|82994394|FG002|Overall Study|Withdrawal by Subject|4|||
46775918|NCT00688701|82994395|FG003|Overall Study|Withdrawal by Subject|8|||
46775919|NCT00688701|82994392|FG000|Overall Study|Poor compliance to protocol|0|||
46775920|NCT00688701|82994393|FG001|Overall Study|Poor compliance to protocol|1|||
46775921|NCT00688701|82994394|FG002|Overall Study|Poor compliance to protocol|1|||
46775922|NCT00688701|82994395|FG003|Overall Study|Poor compliance to protocol|0|||
46775923|NCT00688623|82994415|FG000|Overall Study|Adverse Event|22|||
46775924|NCT00688623|82994415|FG000|Overall Study|abnormal lab value|1|||
46967943|NCT04327999|83210583|FG000|Overall Study|Protocol Violation|1|||
46967944|NCT04145037|83210593|FG000|Overall Study|Study terminated|2|||
46967945|NCT04145037|83210594|FG001|Overall Study|Study terminated|0|||
46641560|NCT03907969|82829170|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
46641561|NCT03907969|82829171|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
46641562|NCT03907969|82829161|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
46641563|NCT03907969|82829162|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
46641564|NCT03907969|82829163|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
46641565|NCT03907969|82829164|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
46641566|NCT03907969|82829165|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
46641567|NCT03907969|82829166|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
46641568|NCT03907969|82829167|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
46641569|NCT03907969|82829168|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
46775925|NCT00688623|82994415|FG000|Overall Study|Withdrawal by Subject|4|||
46775926|NCT00688623|82994415|FG000|Overall Study|Death|3|||
46775927|NCT00688623|82994415|FG000|Overall Study|disease progression|23|||
46775928|NCT00688623|82994415|FG000|Overall Study|Protocol Violation|2|||
46775929|NCT00717236|82994421|FG000|Double-Blind Period|Adverse Event|33|||
46775930|NCT00717236|82994422|FG001|Double-Blind Period|Adverse Event|6|||
46775931|NCT00717236|82994421|FG000|Double-Blind Period|Lack of Efficacy|6|||
46775932|NCT00717236|82994422|FG001|Double-Blind Period|Lack of Efficacy|6|||
46775933|NCT00717236|82994421|FG000|Double-Blind Period|Lost to Follow-up|3|||
46775934|NCT00717236|82994422|FG001|Double-Blind Period|Lost to Follow-up|5|||
46641570|NCT03907969|82829169|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
46641571|NCT03907969|82829170|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
46641572|NCT03907969|82829171|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
46641573|NCT03907969|82829161|FG000|Combination Therapy Part A|Physician Decision|0|||
46641574|NCT03907969|82829162|FG001|Combination Therapy Part A|Physician Decision|0|||
46641575|NCT03907969|82829163|FG002|Combination Therapy Part A|Physician Decision|0|||
46641576|NCT03907969|82829164|FG003|Combination Therapy Part A|Physician Decision|0|||
46641577|NCT03907969|82829165|FG004|Combination Therapy Part A|Physician Decision|0|||
46641578|NCT03907969|82829166|FG005|Combination Therapy Part A|Physician Decision|0|||
46641579|NCT03907969|82829167|FG006|Combination Therapy Part A|Physician Decision|0|||
46641580|NCT03907969|82829168|FG007|Combination Therapy Part A|Physician Decision|1|||
46641581|NCT03907969|82829169|FG008|Combination Therapy Part A|Physician Decision|0|||
46967946|NCT04145037|83210593|FG000|Overall Study|Withdrawal by Subject|1|||
46967947|NCT04145037|83210594|FG001|Overall Study|Withdrawal by Subject|0|||
46967948|NCT04145037|83210593|FG000|Overall Study|Lost to Follow-up|1|||
46967949|NCT04145037|83210594|FG001|Overall Study|Lost to Follow-up|0|||
46967950|NCT04097028|83210602|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
46641582|NCT03907969|82829170|FG009|Combination Therapy Part A|Physician Decision|0|||
46641583|NCT03907969|82829171|FG010|Combination Therapy Part A|Physician Decision|1|||
46967951|NCT04097028|83210602|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
46775935|NCT00717236|82994421|FG000|Double-Blind Period|Withdrawal by Subject|10|||
46775936|NCT00717236|82994422|FG001|Double-Blind Period|Withdrawal by Subject|2|||
46775937|NCT00717236|82994421|FG000|Double-Blind Period|Loss of efficacy|3|||
46967952|NCT04097028|83210602|FG000|Overall Study|Disease Progression prior to Surgery|2|||
46967953|NCT04097028|83210602|FG000|Overall Study|Adverse Event prior to Surgery|1|||
46967954|NCT03749330|83210621|FG000|Overall Study|Clinicians left work in the CICU|0|||
46967955|NCT03749330|83210622|FG001|Overall Study|Clinicians left work in the CICU|2|||
46967956|NCT03749330|83210623|FG002|Overall Study|Clinicians left work in the CICU|0|||
46641584|NCT03898180|82829204|FG000|Overall Study|Ongoing in Study|133|||
46641585|NCT03898180|82829205|FG001|Overall Study|Ongoing in Study|134|||
46775938|NCT00717236|82994422|FG001|Double-Blind Period|Loss of efficacy|0|||
46775939|NCT00717236|82994421|FG000|Double-Blind Period|Other: Death|1|||
46775940|NCT00717236|82994422|FG001|Double-Blind Period|Other: Death|0|||
46641586|NCT03898180|82829204|FG000|Overall Study|Withdrawal by Subject|3|||
46641587|NCT03898180|82829205|FG001|Overall Study|Withdrawal by Subject|2|||
46641588|NCT03898180|82829204|FG000|Overall Study|Death|109|||
46641589|NCT03898180|82829205|FG001|Overall Study|Death|106|||
46641590|NCT03684694|82829242|FG000|Phase 1|Withdrawal by Subject|1|||
46641591|NCT03684694|82829243|FG001|Phase 1|Withdrawal by Subject|0|||
46641592|NCT03684694|82829244|FG002|Phase 1|Withdrawal by Subject|0|||
46641593|NCT03684694|82829245|FG003|Phase 1|Withdrawal by Subject|0|||
46641594|NCT03684694|82829246|FG004|Phase 1|Withdrawal by Subject|0|||
46641595|NCT03684694|82829247|FG005|Phase 1|Withdrawal by Subject|0|||
46641596|NCT03684694|82829242|FG000|Phase 1|Investigator/Sponsor Decision|12|||
46641597|NCT03684694|82829243|FG001|Phase 1|Investigator/Sponsor Decision|2|||
46641598|NCT03684694|82829244|FG002|Phase 1|Investigator/Sponsor Decision|1|||
46641599|NCT03684694|82829245|FG003|Phase 1|Investigator/Sponsor Decision|0|||
46641600|NCT03684694|82829246|FG004|Phase 1|Investigator/Sponsor Decision|0|||
46641601|NCT03684694|82829247|FG005|Phase 1|Investigator/Sponsor Decision|0|||
46641602|NCT03684694|82829242|FG000|Phase 1|Death|24|||
46641603|NCT03684694|82829243|FG001|Phase 1|Death|0|||
46641604|NCT03684694|82829244|FG002|Phase 1|Death|3|||
46641605|NCT03684694|82829245|FG003|Phase 1|Death|0|||
46641606|NCT03684694|82829246|FG004|Phase 1|Death|0|||
46641607|NCT03684694|82829247|FG005|Phase 1|Death|0|||
46641608|NCT03684694|82829242|FG000|Phase 1|Lost to Follow-up|0|||
46641609|NCT03684694|82829243|FG001|Phase 1|Lost to Follow-up|0|||
46641610|NCT03684694|82829244|FG002|Phase 1|Lost to Follow-up|1|||
46641611|NCT03684694|82829245|FG003|Phase 1|Lost to Follow-up|0|||
46641612|NCT03684694|82829246|FG004|Phase 1|Lost to Follow-up|0|||
46641613|NCT03684694|82829247|FG005|Phase 1|Lost to Follow-up|0|||
46641614|NCT03684694|82829242|FG000|Phase 1|Miscellaneous|0|||
46641615|NCT03684694|82829243|FG001|Phase 1|Miscellaneous|1|||
46641616|NCT03684694|82829244|FG002|Phase 1|Miscellaneous|0|||
46641617|NCT03684694|82829245|FG003|Phase 1|Miscellaneous|0|||
46641618|NCT03684694|82829246|FG004|Phase 1|Miscellaneous|0|||
46641619|NCT03684694|82829247|FG005|Phase 1|Miscellaneous|0|||
46641620|NCT03684694|82829242|FG000|Phase 2|Withdrawal by Subject|0|||
46641621|NCT03684694|82829243|FG001|Phase 2|Withdrawal by Subject|0|||
46641622|NCT03684694|82829244|FG002|Phase 2|Withdrawal by Subject|0|||
46641623|NCT03684694|82829245|FG003|Phase 2|Withdrawal by Subject|0|||
46641624|NCT03684694|82829246|FG004|Phase 2|Withdrawal by Subject|0|||
46641625|NCT03684694|82829247|FG005|Phase 2|Withdrawal by Subject|1|||
46775941|NCT00717236|82994421|FG000|Double-Blind Period|Other: Pregnancy|1|||
46775942|NCT00717236|82994422|FG001|Double-Blind Period|Other: Pregnancy|0|||
46775943|NCT00717236|82994421|FG000|Double-Blind Period|Other: Protocol Violation|2|||
46775944|NCT00717236|82994422|FG001|Double-Blind Period|Other: Protocol Violation|0|||
46775945|NCT00717236|82994421|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
46775946|NCT00717236|82994422|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
46775947|NCT00717236|82994421|FG000|Double-Blind Period|Other: Site withdrew|2|||
46775948|NCT00717236|82994422|FG001|Double-Blind Period|Other: Site withdrew|0|||
46775949|NCT00717236|82994421|FG000|Double-Blind Period|Other: Screening failure|1|||
46775950|NCT00717236|82994422|FG001|Double-Blind Period|Other: Screening failure|0|||
46775951|NCT00717236|82994421|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
46775952|NCT00717236|82994422|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
46775953|NCT00717236|82994421|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
46775954|NCT00717236|82994422|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
46775955|NCT00717236|82994421|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
46775956|NCT00717236|82994422|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
46775957|NCT00717236|82994421|FG000|Double-Blind Period|Other: History of cancer|1|||
46775958|NCT00717236|82994422|FG001|Double-Blind Period|Other: History of cancer|0|||
46775959|NCT00717236|82994421|FG000|Double-Blind Period|Other: Sponsor request|1|||
46775960|NCT00717236|82994422|FG001|Double-Blind Period|Other: Sponsor request|0|||
46775961|NCT00717236|82994421|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
46775962|NCT00717236|82994422|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
46775963|NCT00717236|82994421|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
46775964|NCT00717236|82994422|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
46775965|NCT00717236|82994421|FG000|Double-Blind Period|Other: Subject moved|1|||
46846804|NCT00117312|83063514|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
46641626|NCT03684694|82829242|FG000|Phase 2|Investigator/Sponsor Decision|0|||
46641627|NCT03684694|82829243|FG001|Phase 2|Investigator/Sponsor Decision|0|||
46641628|NCT03684694|82829244|FG002|Phase 2|Investigator/Sponsor Decision|0|||
46641629|NCT03684694|82829245|FG003|Phase 2|Investigator/Sponsor Decision|17|||
46641630|NCT03684694|82829246|FG004|Phase 2|Investigator/Sponsor Decision|16|||
46641631|NCT03684694|82829247|FG005|Phase 2|Investigator/Sponsor Decision|6|||
46641632|NCT03684694|82829242|FG000|Phase 2|Death|0|||
46641633|NCT03684694|82829243|FG001|Phase 2|Death|0|||
46641634|NCT03684694|82829244|FG002|Phase 2|Death|0|||
46641635|NCT03684694|82829245|FG003|Phase 2|Death|28|||
46641636|NCT03684694|82829246|FG004|Phase 2|Death|14|||
46641637|NCT03684694|82829247|FG005|Phase 2|Death|3|||
46846805|NCT00117312|83063515|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
47073165|NCT00215657|83361541|FG007|Overall Study|Withdrawal by Subject|3|||
47073166|NCT00215657|83361534|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
47073167|NCT00215657|83361535|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
47073168|NCT00215657|83361536|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
47073169|NCT00215657|83361537|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
47073170|NCT00215657|83361538|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
47073171|NCT00215657|83361539|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
47073172|NCT00215657|83361540|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
47073173|NCT00215657|83361541|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
47073174|NCT00215657|83361534|FG000|Overall Study|Insufficient testosterone response|5|||
47073175|NCT00215657|83361535|FG001|Overall Study|Insufficient testosterone response|4|||
47073176|NCT00215657|83361536|FG002|Overall Study|Insufficient testosterone response|1|||
47073177|NCT00215657|83361537|FG003|Overall Study|Insufficient testosterone response|12|||
47073178|NCT00215657|83361538|FG004|Overall Study|Insufficient testosterone response|8|||
47073179|NCT00215657|83361539|FG005|Overall Study|Insufficient testosterone response|12|||
47073180|NCT00215657|83361540|FG006|Overall Study|Insufficient testosterone response|4|||
47073181|NCT00215657|83361541|FG007|Overall Study|Insufficient testosterone response|7|||
47073182|NCT00215657|83361534|FG000|Overall Study|Other|3|||
47073183|NCT00215657|83361535|FG001|Overall Study|Other|1|||
47073184|NCT00215657|83361536|FG002|Overall Study|Other|2|||
47073185|NCT00215657|83361537|FG003|Overall Study|Other|3|||
47073186|NCT00215657|83361538|FG004|Overall Study|Other|5|||
47073187|NCT00215657|83361539|FG005|Overall Study|Other|4|||
47073188|NCT00215657|83361540|FG006|Overall Study|Other|6|||
46775966|NCT00717236|82994422|FG001|Double-Blind Period|Other: Subject moved|1|||
46775967|NCT00717236|82994421|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
46775968|NCT00717236|82994422|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
46775969|NCT00717236|82994421|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
46775970|NCT00717236|82994422|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
46775971|NCT00717236|82994421|FG000|Double-Blind Period|Other: Transportation problems|0|||
46775972|NCT00717236|82994422|FG001|Double-Blind Period|Other: Transportation problems|1|||
46775973|NCT00717236|82994421|FG000|Double-Blind Period|Other: Investigator Decision|0|||
46775974|NCT00717236|82994422|FG001|Double-Blind Period|Other: Investigator Decision|1|||
46775975|NCT00717236|82994421|FG000|Open-Label Period|Adverse Event|29|||
46775976|NCT00717236|82994422|FG001|Open-Label Period|Adverse Event|4|||
46775977|NCT00717236|82994421|FG000|Open-Label Period|Lack of Efficacy|30|||
46775978|NCT00717236|82994422|FG001|Open-Label Period|Lack of Efficacy|8|||
46775979|NCT00717236|82994421|FG000|Open-Label Period|Lost to Follow-up|28|||
46775980|NCT00717236|82994422|FG001|Open-Label Period|Lost to Follow-up|4|||
46775981|NCT00717236|82994421|FG000|Open-Label Period|Withdrawal by Subject|20|||
46775982|NCT00717236|82994422|FG001|Open-Label Period|Withdrawal by Subject|2|||
46775983|NCT00717236|82994421|FG000|Open-Label Period|Loss of Efficacy|6|||
46775984|NCT00717236|82994422|FG001|Open-Label Period|Loss of Efficacy|1|||
46775985|NCT00717236|82994421|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
47073189|NCT00215657|83361541|FG007|Overall Study|Other|1|||
47073190|NCT00633061|83361561|FG000|Overall Study|Study closed|86|||
47073191|NCT00633061|83361562|FG001|Overall Study|Study closed|0|||
47073192|NCT00632827|83361570|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
47073193|NCT00632827|83361570|FG000|Overall Study|Death|2|||
46641638|NCT03684694|82829242|FG000|Phase 2|Lost to Follow-up|0|||
46641639|NCT03684694|82829243|FG001|Phase 2|Lost to Follow-up|0|||
46641640|NCT03684694|82829244|FG002|Phase 2|Lost to Follow-up|0|||
46641641|NCT03684694|82829245|FG003|Phase 2|Lost to Follow-up|1|||
46641642|NCT03684694|82829246|FG004|Phase 2|Lost to Follow-up|0|||
46641643|NCT03684694|82829247|FG005|Phase 2|Lost to Follow-up|0|||
46641644|NCT03684694|82829242|FG000|Phase 2|Miscellaneous|0|||
46641645|NCT03684694|82829243|FG001|Phase 2|Miscellaneous|0|||
46641646|NCT03684694|82829244|FG002|Phase 2|Miscellaneous|0|||
46641647|NCT03684694|82829245|FG003|Phase 2|Miscellaneous|3|||
46641648|NCT03684694|82829246|FG004|Phase 2|Miscellaneous|0|||
46641649|NCT03684694|82829247|FG005|Phase 2|Miscellaneous|0|||
46641650|NCT03345420|82829266|FG000|Overall Study|Withdrawal by Subject|1|||
46641651|NCT03283761|82829271|FG000|Study Treatment|Patient Non-Compliance|1|||
46641652|NCT03283761|82829271|FG000|Study Treatment|Alternative Cancer Therapy|7|||
46641653|NCT03283761|82829271|FG000|Study Treatment|Disease progression|21|||
46641654|NCT03283761|82829271|FG000|Study Treatment|Adverse Event|3|||
46641655|NCT03283761|82829271|FG000|Study Treatment|Withdrawal by Subject|4|||
46641656|NCT03283761|82829271|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
46641657|NCT03283761|82829271|FG000|Study Treatment|Symptomatic Deterioration|1|||
46641658|NCT03283761|82829271|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
46641659|NCT03283761|82829271|FG000|Follow up|Lost to Follow-up|1|||
46641660|NCT03283761|82829271|FG000|Follow up|Symptomatic Deterioration|1|||
46641661|NCT03283761|82829271|FG000|Follow up|Death|29|||
46641662|NCT03283761|82829271|FG000|Follow up|study terminated|4|||
46641663|NCT03283761|82829271|FG000|Follow up|Primary Investigator Withdrawal|1|||
46641664|NCT03283761|82829271|FG000|Follow up|Switched to alternative therapy|1|||
46641665|NCT03283761|82829271|FG000|Follow up|Subject is now in Hospice|1|||
46641666|NCT03258723|82829275|FG000|Overall Study|COVID Interruption of study|54|||
46641667|NCT03258723|82829275|FG000|Overall Study|Lost to Follow-up|8|||
46641668|NCT03230916|82829290|FG000|Overall Study|Withdrawal by Subject|0|||
46641669|NCT03230916|82829291|FG001|Overall Study|Withdrawal by Subject|0|||
46641670|NCT03230916|82829292|FG002|Overall Study|Withdrawal by Subject|0|||
46641671|NCT03230916|82829293|FG003|Overall Study|Withdrawal by Subject|0|||
46641672|NCT03230916|82829294|FG004|Overall Study|Withdrawal by Subject|0|||
46641673|NCT03230916|82829295|FG005|Overall Study|Withdrawal by Subject|1|||
46641674|NCT03230916|82829296|FG006|Overall Study|Withdrawal by Subject|0|||
46641675|NCT03230916|82829297|FG007|Overall Study|Withdrawal by Subject|0|||
46641676|NCT03230916|82829298|FG008|Overall Study|Withdrawal by Subject|0|||
46641677|NCT03230916|82829299|FG009|Overall Study|Withdrawal by Subject|0|||
46641678|NCT03230916|82829300|FG010|Overall Study|Withdrawal by Subject|0|||
46641679|NCT03068130|82829358|FG000|Overall Study|Adverse Event|19|||
46641680|NCT03068130|82829358|FG000|Overall Study|Death|14|||
46641681|NCT03068130|82829358|FG000|Overall Study|Lost to Follow-up|4|||
46641682|NCT03068130|82829358|FG000|Overall Study|Withdrawal by Subject|26|||
46641683|NCT03068130|82829358|FG000|Overall Study|Administrative Reasons|3|||
46641684|NCT03068130|82829358|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
46641685|NCT03068130|82829358|FG000|Overall Study|Study terminated by sponsor|194|||
46641686|NCT03015129|82829364|FG000|Overall Study|Death|2|||
46641687|NCT03015129|82829365|FG001|Overall Study|Death|2|||
46641688|NCT03015129|82829364|FG000|Overall Study|Lost to Follow-up|0|||
46641689|NCT03015129|82829365|FG001|Overall Study|Lost to Follow-up|1|||
46641690|NCT03015129|82829364|FG000|Overall Study|Progression of disease|38|||
46641691|NCT03015129|82829365|FG001|Overall Study|Progression of disease|33|||
46641692|NCT03015129|82829364|FG000|Overall Study|Adverse Event|0|||
46641693|NCT03015129|82829365|FG001|Overall Study|Adverse Event|4|||
46641694|NCT02859337|82829374|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
46641695|NCT02859337|82829375|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
46641696|NCT02859337|82829376|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
46641697|NCT02859337|82829374|FG000|Overall Study|Withdrawal by Subject|3|||
46641698|NCT02859337|82829375|FG001|Overall Study|Withdrawal by Subject|1|||
46641699|NCT02859337|82829376|FG002|Overall Study|Withdrawal by Subject|0|||
46641700|NCT02859337|82829374|FG000|Overall Study|Lost to Follow-up|1|||
46641701|NCT02859337|82829375|FG001|Overall Study|Lost to Follow-up|0|||
46641702|NCT02859337|82829376|FG002|Overall Study|Lost to Follow-up|0|||
46641703|NCT02657356|82829397|FG000|Overall Study|Death|1|||
46641704|NCT02657356|82829398|FG001|Overall Study|Death|0|||
46641705|NCT02657356|82829397|FG000|Overall Study|Withdrawal by Subject|5|||
46775986|NCT00717236|82994422|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
46775987|NCT00717236|82994421|FG000|Open-Label Period|Other: Lack of Compliance|1|||
46775988|NCT00717236|82994422|FG001|Open-Label Period|Other: Lack of Compliance|1|||
46775989|NCT00717236|82994421|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
46775990|NCT00717236|82994422|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
47073194|NCT00632827|83361570|FG000|Overall Study|Adverse Event|5|||
47073195|NCT00632827|83361570|FG000|Overall Study|Lost to Follow-up|1|||
46775991|NCT00717236|82994421|FG000|Open-Label Period|Other: Moved|1|||
46775992|NCT00717236|82994422|FG001|Open-Label Period|Other: Moved|0|||
47073196|NCT00214019|83361575|FG000|Overall Study|Lost to Follow-up|11|||
47073197|NCT00214019|83361575|FG000|Overall Study|Withdrawal by Subject|2|||
47073198|NCT00214019|83361575|FG000|Overall Study|Screen Failed prior to randomization|17|||
47073199|NCT00210119|83361582|FG000|Overall Study|Protocol Violation|1|||
47073200|NCT00210119|83361582|FG000|Overall Study|Withdrawal by Subject|1|||
47073201|NCT01044459|83361588|FG000|Overall Study|Withdrawal by Subject|21|||
47073202|NCT01044459|83361589|FG001|Overall Study|Withdrawal by Subject|28|||
47073203|NCT01044459|83361588|FG000|Overall Study|Terminated by Sponsor|22|||
47073204|NCT01044459|83361589|FG001|Overall Study|Terminated by Sponsor|21|||
47073205|NCT01044459|83361588|FG000|Overall Study|Adverse Event|22|||
47073206|NCT01044459|83361589|FG001|Overall Study|Adverse Event|20|||
47073207|NCT01044459|83361588|FG000|Overall Study|Lack of Efficacy|23|||
47073208|NCT01044459|83361589|FG001|Overall Study|Lack of Efficacy|12|||
47073209|NCT01044459|83361588|FG000|Overall Study|Protocol Violation|11|||
47073210|NCT01044459|83361589|FG001|Overall Study|Protocol Violation|16|||
47073211|NCT01044459|83361588|FG000|Overall Study|Other Reason|7|||
47073212|NCT01044459|83361589|FG001|Overall Study|Other Reason|14|||
47073213|NCT01044459|83361588|FG000|Overall Study|COPD exacerbation|9|||
47073214|NCT01044459|83361589|FG001|Overall Study|COPD exacerbation|8|||
47073215|NCT01044459|83361588|FG000|Overall Study|Lost to Follow-up|18|||
47073216|NCT01044459|83361589|FG001|Overall Study|Lost to Follow-up|12|||
47073217|NCT00980005|83361597|FG000|Overall Study|Withdrawal by Subject|6|||
47073218|NCT00980005|83361598|FG001|Overall Study|Withdrawal by Subject|17|||
47073219|NCT00980005|83361597|FG000|Overall Study|Lost to Follow-up|37|||
47073220|NCT00980005|83361598|FG001|Overall Study|Lost to Follow-up|43|||
47073221|NCT00980005|83361597|FG000|Overall Study|Other|4|||
47073222|NCT00980005|83361598|FG001|Overall Study|Other|3|||
47073223|NCT01044303|83361608|FG000|Overall Study|Lost to Follow-up|2|||
47073224|NCT00983437|83361615|FG000|Overall Study|Adverse Event|9|||
47073225|NCT00983437|83361615|FG000|Overall Study|Lack of Efficacy|1|||
47073226|NCT00983437|83361615|FG000|Overall Study|Withdrawal by Subject|8|||
47073227|NCT00983437|83361615|FG000|Overall Study|Noncompliance to Study Procedures|1|||
47073228|NCT00983437|83361615|FG000|Overall Study|Lost to Follow-up|2|||
47073229|NCT00983437|83361615|FG000|Overall Study|Other Reason|26|||
47073230|NCT01042977|83361621|FG000|Overall Study|Adverse Event|4|||
47073231|NCT01042977|83361622|FG001|Overall Study|Adverse Event|12|||
47073232|NCT01042977|83361621|FG000|Overall Study|Death|2|||
47073233|NCT01042977|83361622|FG001|Overall Study|Death|1|||
47073234|NCT01042977|83361621|FG000|Overall Study|Withdrawal by Subject|8|||
47073235|NCT01042977|83361622|FG001|Overall Study|Withdrawal by Subject|16|||
47073236|NCT01042977|83361621|FG000|Overall Study|Lost to Follow-up|0|||
47073237|NCT01042977|83361622|FG001|Overall Study|Lost to Follow-up|2|||
47073238|NCT01042977|83361621|FG000|Overall Study|Poor/non-compliance|3|||
47073239|NCT01042977|83361622|FG001|Overall Study|Poor/non-compliance|4|||
47073240|NCT01042977|83361621|FG000|Overall Study|Subject no longer meets study criteria|15|||
47073241|NCT01042977|83361622|FG001|Overall Study|Subject no longer meets study criteria|13|||
46775993|NCT00717236|82994421|FG000|Open-Label Period|Other: Investigator Decision|1|||
46775994|NCT00717236|82994422|FG001|Open-Label Period|Other: Investigator Decision|0|||
47073242|NCT01042977|83361621|FG000|Overall Study|Incorrect enrollment|6|||
47073243|NCT01042977|83361622|FG001|Overall Study|Incorrect enrollment|4|||
47073244|NCT01042977|83361621|FG000|Overall Study|Safety|0|||
47073245|NCT01042977|83361622|FG001|Overall Study|Safety|2|||
47073246|NCT01042977|83361621|FG000|Overall Study|Administrative reason by sponsor|0|||
47073247|NCT01042977|83361622|FG001|Overall Study|Administrative reason by sponsor|1|||
47073248|NCT01042977|83361621|FG000|Overall Study|Various|3|||
47073249|NCT01042977|83361622|FG001|Overall Study|Various|0|||
47073250|NCT01041573|83361632|FG000|Overall Study|Withdrawal by Subject|2|||
46775995|NCT00717236|82994421|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
46775996|NCT00717236|82994422|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
46775997|NCT00717236|82994421|FG000|Open-Label Period|Other: Sponsor Request|3|||
46775998|NCT00717236|82994422|FG001|Open-Label Period|Other: Sponsor Request|0|||
46775999|NCT00717236|82994421|FG000|Open-Label Period|Other: Cataract Surgery|1|||
46776000|NCT00717236|82994422|FG001|Open-Label Period|Other: Cataract Surgery|0|||
46776001|NCT00717236|82994421|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
46776002|NCT00717236|82994422|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
46776003|NCT00717236|82994421|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
46776004|NCT00717236|82994422|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
46776005|NCT00717236|82994421|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
46776006|NCT00717236|82994422|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
46776007|NCT00719810|82994433|FG000|Overall Study|Adverse Event|0|||
46776008|NCT00719810|82994434|FG001|Overall Study|Adverse Event|2|||
46776009|NCT00719810|82994435|FG002|Overall Study|Adverse Event|3|||
46776010|NCT00719810|82994433|FG000|Overall Study|Lost to Follow-up|2|||
46776011|NCT00719810|82994434|FG001|Overall Study|Lost to Follow-up|0|||
46776012|NCT00719810|82994435|FG002|Overall Study|Lost to Follow-up|3|||
46776013|NCT00719810|82994433|FG000|Overall Study|Physician Decision|0|||
46776014|NCT00719810|82994434|FG001|Overall Study|Physician Decision|1|||
46776015|NCT00719810|82994435|FG002|Overall Study|Physician Decision|0|||
46776016|NCT00719810|82994433|FG000|Overall Study|Withdrawal by Subject|1|||
46776017|NCT00719810|82994434|FG001|Overall Study|Withdrawal by Subject|1|||
46776018|NCT00719810|82994435|FG002|Overall Study|Withdrawal by Subject|2|||
46776019|NCT00719732|82994443|FG000|Overall Study|Lost to Follow-up|20|||
46776020|NCT00719732|82994443|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
46776021|NCT00719732|82994443|FG000|Overall Study|Illness not associated with device|1|||
46776022|NCT00723710|82994447|FG000|Overall Study|Disease progression|48|||
46776023|NCT00723710|82994447|FG000|Overall Study|Adverse Event|88|||
46776024|NCT00723710|82994447|FG000|Overall Study|Withdrawal by Subject|36|||
46776025|NCT00723710|82994447|FG000|Overall Study|Physician Decision|2|||
46776026|NCT00688545|82994453|FG000|Overall Study|Lost to Follow-up|1|||
46776027|NCT00688545|82994454|FG001|Overall Study|Lost to Follow-up|4|||
46776028|NCT00688545|82994453|FG000|Overall Study|Insurance/cost of drug|0|||
46641706|NCT02657356|82829398|FG001|Overall Study|Withdrawal by Subject|6|||
46641707|NCT02657356|82829397|FG000|Overall Study|Terminated by Sponsor|8|||
46641708|NCT02657356|82829398|FG001|Overall Study|Terminated by Sponsor|5|||
46641709|NCT02657356|82829397|FG000|Overall Study|Rolled over to EAP study|6|||
46641710|NCT02657356|82829398|FG001|Overall Study|Rolled over to EAP study|4|||
46641711|NCT02467270|82829407|FG000|Overall Study|Participants Never Treated|0|||
46641712|NCT02467270|82829408|FG001|Overall Study|Participants Never Treated|1|||
46641713|NCT02467270|82829409|FG002|Overall Study|Participants Never Treated|0|||
46641714|NCT02467270|82829407|FG000|Overall Study|Ongoing|50|||
46641715|NCT02467270|82829408|FG001|Overall Study|Ongoing|41|||
46641716|NCT02467270|82829409|FG002|Overall Study|Ongoing|43|||
46641717|NCT02467270|82829407|FG000|Overall Study|Adverse Event|16|||
46641718|NCT02467270|82829408|FG001|Overall Study|Adverse Event|15|||
46641719|NCT02467270|82829409|FG002|Overall Study|Adverse Event|14|||
46641720|NCT02467270|82829407|FG000|Overall Study|Progressive Disease|7|||
46641721|NCT02467270|82829408|FG001|Overall Study|Progressive Disease|7|||
46641722|NCT02467270|82829409|FG002|Overall Study|Progressive Disease|4|||
46641723|NCT02467270|82829407|FG000|Overall Study|Death|2|||
46641724|NCT02467270|82829408|FG001|Overall Study|Death|0|||
46641725|NCT02467270|82829409|FG002|Overall Study|Death|2|||
46641726|NCT02467270|82829407|FG000|Overall Study|Lack of Efficacy|12|||
46641727|NCT02467270|82829408|FG001|Overall Study|Lack of Efficacy|18|||
46641728|NCT02467270|82829409|FG002|Overall Study|Lack of Efficacy|23|||
46641729|NCT02467270|82829407|FG000|Overall Study|Non-compliance With Study Drug|0|||
46641730|NCT02467270|82829408|FG001|Overall Study|Non-compliance With Study Drug|2|||
46641731|NCT02467270|82829409|FG002|Overall Study|Non-compliance With Study Drug|1|||
46641732|NCT02467270|82829407|FG000|Overall Study|Lost to Follow-up|2|||
46641733|NCT02467270|82829408|FG001|Overall Study|Lost to Follow-up|1|||
46641734|NCT02467270|82829409|FG002|Overall Study|Lost to Follow-up|0|||
46641735|NCT02467270|82829407|FG000|Overall Study|Pregnancy|0|||
46641736|NCT02467270|82829408|FG001|Overall Study|Pregnancy|1|||
46641737|NCT02467270|82829409|FG002|Overall Study|Pregnancy|0|||
46641738|NCT02467270|82829407|FG000|Overall Study|Physician Decision|0|||
46641739|NCT02467270|82829408|FG001|Overall Study|Physician Decision|4|||
46641740|NCT02467270|82829409|FG002|Overall Study|Physician Decision|1|||
46641741|NCT02467270|82829407|FG000|Overall Study|Withdrawal by Subject|4|||
46641742|NCT02467270|82829408|FG001|Overall Study|Withdrawal by Subject|3|||
46641743|NCT02467270|82829409|FG002|Overall Study|Withdrawal by Subject|5|||
46641744|NCT02467270|82829407|FG000|Overall Study|Reason not Specified|1|||
46641745|NCT02467270|82829408|FG001|Overall Study|Reason not Specified|2|||
46641746|NCT02467270|82829409|FG002|Overall Study|Reason not Specified|1|||
46776029|NCT00688545|82994454|FG001|Overall Study|Insurance/cost of drug|1|||
46641747|NCT01981551|82829417|FG000|Overall Study|Refused further treatment|8|||
46776030|NCT00688545|82994453|FG000|Overall Study|Withdrawal by Subject|2|||
46776031|NCT00688545|82994454|FG001|Overall Study|Withdrawal by Subject|3|||
46776032|NCT00688545|82994453|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
46776033|NCT00688545|82994454|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
46776034|NCT00688467|82994464|FG000|Treatment Period 1|Adverse Event|2|||
46776035|NCT00688467|82994465|FG001|Treatment Period 1|Adverse Event|1|||
46776036|NCT00688467|82994464|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
46776037|NCT00688467|82994465|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
46776038|NCT00688467|82994464|FG000|Treatment Period 2|Protocol Violation|0|||
46776039|NCT00688467|82994465|FG001|Treatment Period 2|Protocol Violation|1|||
46776040|NCT00688467|82994464|FG000|Treatment Period 2|Adverse Event|0|||
46776041|NCT00688467|82994465|FG001|Treatment Period 2|Adverse Event|1|||
46776042|NCT00688155|82994475|FG000|Overall Study|Withdrawal by Subject|2|||
46776043|NCT00688155|82994476|FG001|Overall Study|Withdrawal by Subject|2|||
46776044|NCT00688155|82994477|FG002|Overall Study|Withdrawal by Subject|1|||
46776045|NCT00688155|82994478|FG003|Overall Study|Withdrawal by Subject|1|||
46641748|NCT01981551|82829417|FG000|Overall Study|Adverse Event|1|||
46641749|NCT01796197|82829421|FG000|Overall Study|Lost to Follow-up|1|||
46641750|NCT01796197|82829421|FG000|Overall Study|Lack of Efficacy|1|||
46641751|NCT01772472|82829427|FG000|Overall Study|Death|56|||
46641752|NCT01772472|82829428|FG001|Overall Study|Death|42|||
46641753|NCT01772472|82829427|FG000|Overall Study|Physician Decision|1|||
46641754|NCT01772472|82829428|FG001|Overall Study|Physician Decision|3|||
46641755|NCT01772472|82829427|FG000|Overall Study|Other|5|||
46641756|NCT01772472|82829428|FG001|Overall Study|Other|5|||
46641757|NCT01772472|82829427|FG000|Overall Study|Lost to Follow-up|12|||
46641758|NCT01772472|82829428|FG001|Overall Study|Lost to Follow-up|8|||
46641759|NCT01772472|82829427|FG000|Overall Study|Withdrawal by Subject|72|||
46641760|NCT01772472|82829428|FG001|Overall Study|Withdrawal by Subject|50|||
46641761|NCT01772472|82829427|FG000|Overall Study|Ongoing|597|||
46641762|NCT01772472|82829428|FG001|Overall Study|Ongoing|635|||
46641763|NCT01525082|82829434|FG000|Overall Study|Death|1|||
46641764|NCT00770809|82829444|FG000|Overall Study|Adverse Event|9|||
46641765|NCT00770809|82829445|FG001|Overall Study|Adverse Event|1|||
46776046|NCT00690573|82994488|FG000|Overall Study|Lack of Efficacy|8|||
46776047|NCT00690573|82994488|FG000|Overall Study|Withdrawal by Subject|1|||
46776048|NCT00719264|82994494|FG000|Overall Study|Adverse Event|41|||
46776049|NCT00719264|82994495|FG001|Overall Study|Adverse Event|49|||
46846806|NCT00117312|83063516|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
46776050|NCT00719264|82994494|FG000|Overall Study|Death|13|||
46776051|NCT00719264|82994495|FG001|Overall Study|Death|10|||
46641766|NCT00770809|82829446|FG002|Overall Study|Adverse Event|12|||
46641767|NCT00770809|82829444|FG000|Overall Study|Death|1|||
46641768|NCT00770809|82829445|FG001|Overall Study|Death|0|||
46776052|NCT00719264|82994494|FG000|Overall Study|Administrative Problems|6|||
46776053|NCT00719264|82994495|FG001|Overall Study|Administrative Problems|4|||
46641769|NCT00770809|82829446|FG002|Overall Study|Death|0|||
46641770|NCT00770809|82829444|FG000|Overall Study|Withdrawal by Subject|3|||
46641771|NCT00770809|82829445|FG001|Overall Study|Withdrawal by Subject|3|||
46776054|NCT00719264|82994494|FG000|Overall Study|Lost to Follow-up|1|||
46776055|NCT00719264|82994495|FG001|Overall Study|Lost to Follow-up|1|||
46776056|NCT00719264|82994494|FG000|Overall Study|Withdrawal by Subject|12|||
46776057|NCT00719264|82994495|FG001|Overall Study|Withdrawal by Subject|7|||
46776058|NCT00719264|82994494|FG000|Overall Study|Protocol Deviation|1|||
46776059|NCT00719264|82994495|FG001|Overall Study|Protocol Deviation|3|||
46776060|NCT00719264|82994494|FG000|Overall Study|New Cancer Therapy|4|||
46776061|NCT00719264|82994495|FG001|Overall Study|New Cancer Therapy|2|||
46776062|NCT00719264|82994494|FG000|Overall Study|Disease Progression|104|||
46776063|NCT00719264|82994495|FG001|Overall Study|Disease Progression|107|||
46776064|NCT00687609|82994501|FG000|Overall Study|Physician Decision|1|||
47073251|NCT01041573|83361633|FG001|Overall Study|Withdrawal by Subject|5|||
47073252|NCT01041573|83361634|FG002|Overall Study|Withdrawal by Subject|2|||
46776065|NCT00687609|82994501|FG000|Overall Study|Withdrawal by Subject|2|||
46776066|NCT00723554|82994505|FG000|Overall Study|Adverse Event|12|||
46776067|NCT00723554|82994505|FG000|Overall Study|Investigator's judgement|5|||
46776068|NCT00723554|82994505|FG000|Overall Study|Inhaled medication other than iloprost|4|||
46776069|NCT00723554|82994505|FG000|Overall Study|Withdrawal of consent|3|||
46776070|NCT00723554|82994505|FG000|Overall Study|Other|3|||
46776071|NCT00723554|82994505|FG000|Overall Study|Lost to Follow-up|1|||
46776072|NCT00723554|82994505|FG000|Overall Study|Non-compliance|1|||
46776073|NCT00687219|82994511|FG000|Overall Study|Adverse Event|8|||
46776074|NCT00687219|82994511|FG000|Overall Study|Discontinuance criteria met|7|||
46776075|NCT00687219|82994511|FG000|Overall Study|HCV-RNA positive conversion|34|||
46776076|NCT00687219|82994511|FG000|Overall Study|Withdrawal by Subject|1|||
46776077|NCT00687219|82994511|FG000|Overall Study|Lack of Efficacy|1|||
46776078|NCT00723398|82994520|FG000|Overall Study|Withdrawal by Subject|2|||
46776079|NCT00723398|82994521|FG001|Overall Study|Withdrawal by Subject|6|||
46776080|NCT00723398|82994522|FG002|Overall Study|Withdrawal by Subject|4|||
46776081|NCT00723398|82994523|FG003|Overall Study|Withdrawal by Subject|4|||
46776082|NCT00723398|82994524|FG004|Overall Study|Withdrawal by Subject|4|||
46776083|NCT00723398|82994520|FG000|Overall Study|Protocol Violation|2|||
46776084|NCT00723398|82994521|FG001|Overall Study|Protocol Violation|1|||
46776085|NCT00723398|82994522|FG002|Overall Study|Protocol Violation|5|||
46776086|NCT00723398|82994523|FG003|Overall Study|Protocol Violation|0|||
46776087|NCT00723398|82994524|FG004|Overall Study|Protocol Violation|0|||
46776088|NCT00723398|82994520|FG000|Overall Study|Physician Decision|2|||
46776089|NCT00723398|82994521|FG001|Overall Study|Physician Decision|2|||
46641772|NCT00770809|82829446|FG002|Overall Study|Withdrawal by Subject|7|||
46641773|NCT00770809|82829444|FG000|Overall Study|Progression|2|||
46641774|NCT00770809|82829445|FG001|Overall Study|Progression|2|||
46641775|NCT00770809|82829446|FG002|Overall Study|Progression|0|||
46641776|NCT00770809|82829444|FG000|Overall Study|Complicating illness|0|||
46967957|NCT03749330|83210624|FG003|Overall Study|Clinicians left work in the CICU|0|||
46967958|NCT03749330|83210625|FG004|Overall Study|Clinicians left work in the CICU|0|||
46641777|NCT00770809|82829445|FG001|Overall Study|Complicating illness|0|||
46641778|NCT00770809|82829446|FG002|Overall Study|Complicating illness|1|||
46641779|NCT00770809|82829444|FG000|Overall Study|Other Medical Reasons|2|||
46641780|NCT00770809|82829445|FG001|Overall Study|Other Medical Reasons|4|||
46641781|NCT00770809|82829446|FG002|Overall Study|Other Medical Reasons|3|||
46641782|NCT00104676|82829469|FG000|Overall Study|Death|3|||
46641783|NCT00104676|82829470|FG001|Overall Study|Death|2|||
46641784|NCT00104676|82829469|FG000|Overall Study|Withdrawal by Subject|0|||
46641785|NCT00104676|82829470|FG001|Overall Study|Withdrawal by Subject|2|||
46641786|NCT00104676|82829469|FG000|Overall Study|treatment interruption|4|||
46641787|NCT00104676|82829470|FG001|Overall Study|treatment interruption|10|||
46641788|NCT05131451|82831222|FG000|Overall Study|Protocol Violation|1|||
46641789|NCT05131451|82831223|FG001|Overall Study|Protocol Violation|0|||
46641790|NCT05108922|82831231|FG000|Overall Study|Adverse Event|0|||
46641791|NCT05108922|82831232|FG001|Overall Study|Adverse Event|1|||
46776090|NCT00723398|82994522|FG002|Overall Study|Physician Decision|5|||
46776091|NCT00723398|82994523|FG003|Overall Study|Physician Decision|0|||
46776092|NCT00723398|82994524|FG004|Overall Study|Physician Decision|1|||
46776093|NCT00723398|82994520|FG000|Overall Study|Adverse Event|0|||
46641792|NCT05108922|82831231|FG000|Overall Study|Physician Decision|1|||
46776094|NCT00723398|82994521|FG001|Overall Study|Adverse Event|5|||
46846807|NCT00117312|83063513|FG000|Overall Study|Hepatic abnormality|0|||
46846808|NCT00117312|83063514|FG001|Overall Study|Hepatic abnormality|1|||
46846809|NCT00117312|83063515|FG002|Overall Study|Hepatic abnormality|0|||
46641793|NCT05108922|82831232|FG001|Overall Study|Physician Decision|1|||
46641794|NCT05108922|82831231|FG000|Overall Study|Screen Failure|1|||
46776095|NCT00723398|82994522|FG002|Overall Study|Adverse Event|3|||
46776096|NCT00723398|82994523|FG003|Overall Study|Adverse Event|1|||
46776097|NCT00723398|82994524|FG004|Overall Study|Adverse Event|4|||
46776098|NCT00723398|82994520|FG000|Overall Study|Lost to Follow-up|0|||
46776099|NCT00723398|82994521|FG001|Overall Study|Lost to Follow-up|1|||
46776100|NCT00723398|82994522|FG002|Overall Study|Lost to Follow-up|0|||
46776101|NCT00723398|82994523|FG003|Overall Study|Lost to Follow-up|0|||
46776102|NCT00723398|82994524|FG004|Overall Study|Lost to Follow-up|0|||
46776103|NCT00716456|82994539|FG000|Overall Study|Adverse Event|0|||
46776104|NCT00716456|82994540|FG001|Overall Study|Adverse Event|2|||
46776105|NCT00716456|82994541|FG002|Overall Study|Adverse Event|0|||
46776106|NCT00684645|82994549|FG000|Overall Study|Death|2|||
46776107|NCT00684645|82994549|FG000|Overall Study|Progressive disease|67|||
46776108|NCT00684645|82994549|FG000|Overall Study|Adverse Event|27|||
46776109|NCT00684645|82994549|FG000|Overall Study|Lost to Follow-up|3|||
46967959|NCT03749330|83210626|FG005|Overall Study|Clinicians left work in the CICU|0|||
46967960|NCT03740737|83210648|FG000|Overall Study|Protocol deviation|13|||
47073253|NCT01041573|83361635|FG003|Overall Study|Withdrawal by Subject|0|||
46641795|NCT05108922|82831232|FG001|Overall Study|Screen Failure|1|||
46641796|NCT05108922|82831231|FG000|Overall Study|Withdrawal by Subject|7|||
46641797|NCT05108922|82831232|FG001|Overall Study|Withdrawal by Subject|4|||
46641798|NCT04874636|82831248|FG000|Overall Study|Adverse Event|17|||
46641799|NCT04874636|82831249|FG001|Overall Study|Adverse Event|7|||
46641800|NCT04874636|82831248|FG000|Overall Study|Lost to Follow-up|1|||
46641801|NCT04874636|82831249|FG001|Overall Study|Lost to Follow-up|0|||
46641802|NCT04874636|82831248|FG000|Overall Study|Non-Compliance with Study Drug|2|||
46641803|NCT04874636|82831249|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46641804|NCT04874636|82831248|FG000|Overall Study|Physician Decision|1|||
46641805|NCT04874636|82831249|FG001|Overall Study|Physician Decision|0|||
46641806|NCT04874636|82831248|FG000|Overall Study|Withdrawal by Subject|6|||
46641807|NCT04874636|82831249|FG001|Overall Study|Withdrawal by Subject|5|||
46641808|NCT04707157|82831265|FG000|Overall Study|Adverse Event|12|||
46641809|NCT04707157|82831266|FG001|Overall Study|Adverse Event|3|||
46641810|NCT04707157|82831265|FG000|Overall Study|Lost to Follow-up|2|||
46641811|NCT04707157|82831266|FG001|Overall Study|Lost to Follow-up|0|||
46641812|NCT04707157|82831265|FG000|Overall Study|Sponsor's decision|1|||
46641813|NCT04707157|82831266|FG001|Overall Study|Sponsor's decision|0|||
46641814|NCT04707157|82831265|FG000|Overall Study|Physician Decision|8|||
46641815|NCT04707157|82831266|FG001|Overall Study|Physician Decision|5|||
46641816|NCT04707157|82831265|FG000|Overall Study|Protocol Deviation|1|||
46641817|NCT04707157|82831266|FG001|Overall Study|Protocol Deviation|0|||
46641818|NCT04707157|82831265|FG000|Overall Study|Withdrawal by Subject|1|||
46641819|NCT04707157|82831266|FG001|Overall Study|Withdrawal by Subject|1|||
46641820|NCT04700449|82831275|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
46641821|NCT04700449|82831276|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
46641822|NCT04700449|82831277|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
46641823|NCT04700449|82831278|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
46776110|NCT00684645|82994549|FG000|Overall Study|Other|15|||
46776111|NCT00716144|82994557|FG000|Overall Study|Withdrawal by Subject|4|||
46776112|NCT00716144|82994558|FG001|Overall Study|Withdrawal by Subject|2|||
46776113|NCT00716144|82994559|FG002|Overall Study|Withdrawal by Subject|6|||
46776114|NCT00716144|82994560|FG003|Overall Study|Withdrawal by Subject|6|||
46967961|NCT03740737|83210649|FG001|Overall Study|Protocol deviation|0|||
47073254|NCT01041573|83361632|FG000|Overall Study|Death|1|||
47073255|NCT01041573|83361633|FG001|Overall Study|Death|0|||
47073256|NCT01041573|83361634|FG002|Overall Study|Death|0|||
47073257|NCT01041573|83361635|FG003|Overall Study|Death|0|||
47073258|NCT01041573|83361632|FG000|Overall Study|Lost to Follow-up|0|||
47073259|NCT01041573|83361633|FG001|Overall Study|Lost to Follow-up|1|||
47073260|NCT01041573|83361634|FG002|Overall Study|Lost to Follow-up|2|||
47073261|NCT01041573|83361635|FG003|Overall Study|Lost to Follow-up|1|||
47073262|NCT01041573|83361632|FG000|Overall Study|Adverse Event|0|||
47073263|NCT01041573|83361633|FG001|Overall Study|Adverse Event|2|||
47073264|NCT01041573|83361634|FG002|Overall Study|Adverse Event|0|||
47073265|NCT01041573|83361635|FG003|Overall Study|Adverse Event|0|||
47073266|NCT01041573|83361632|FG000|Overall Study|relocation|1|||
47073267|NCT01041573|83361633|FG001|Overall Study|relocation|4|||
47073268|NCT01041573|83361634|FG002|Overall Study|relocation|3|||
47073269|NCT01041573|83361635|FG003|Overall Study|relocation|1|||
46641824|NCT04700449|82831275|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
46641825|NCT04700449|82831276|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
46641826|NCT04700449|82831277|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
46641827|NCT04700449|82831278|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
46641828|NCT04700449|82831275|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
46641829|NCT04700449|82831276|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
46776115|NCT00716144|82994557|FG000|Overall Study|Lost to Follow-up|2|||
46776116|NCT00716144|82994558|FG001|Overall Study|Lost to Follow-up|2|||
46776117|NCT00716144|82994559|FG002|Overall Study|Lost to Follow-up|1|||
46776118|NCT00716144|82994560|FG003|Overall Study|Lost to Follow-up|2|||
47073270|NCT01041573|83361632|FG000|Overall Study|further blood extraction|0|||
47073271|NCT01041573|83361633|FG001|Overall Study|further blood extraction|1|||
47073272|NCT01041573|83361634|FG002|Overall Study|further blood extraction|0|||
47073273|NCT01041573|83361635|FG003|Overall Study|further blood extraction|0|||
46641830|NCT04700449|82831277|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
46641831|NCT04700449|82831278|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
46641832|NCT04700449|82831275|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
46641833|NCT04700449|82831276|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
46641834|NCT04700449|82831277|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
46641835|NCT04700449|82831278|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
46641836|NCT04700449|82831275|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
46641837|NCT04700449|82831276|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
46641838|NCT04700449|82831277|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
46641839|NCT04700449|82831278|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
46641840|NCT04700449|82831275|FG000|Stage 1: Double-Blind Period|Other|0|||
46641841|NCT04700449|82831276|FG001|Stage 1: Double-Blind Period|Other|0|||
46641842|NCT04700449|82831277|FG002|Stage 1: Double-Blind Period|Other|1|||
46641843|NCT04700449|82831278|FG003|Stage 1: Double-Blind Period|Other|0|||
46641844|NCT04700449|82831275|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
46641845|NCT04700449|82831276|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
46641846|NCT04700449|82831277|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
46641847|NCT04700449|82831278|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
46641848|NCT04700449|82831275|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
46641849|NCT04700449|82831276|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
46641850|NCT04700449|82831277|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
46641851|NCT04700449|82831278|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
46641852|NCT04700449|82831275|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
46641853|NCT04700449|82831276|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
46641854|NCT04700449|82831277|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
46641855|NCT04700449|82831278|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
46641856|NCT04700449|82831275|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
46641857|NCT04700449|82831276|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
46641858|NCT04700449|82831277|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
46641859|NCT04700449|82831278|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
46641860|NCT04700449|82831275|FG000|Stage 2 Sub-study 1|Other|1|||
46641861|NCT04700449|82831276|FG001|Stage 2 Sub-study 1|Other|2|||
46641862|NCT04700449|82831277|FG002|Stage 2 Sub-study 1|Other|0|||
46641863|NCT04700449|82831278|FG003|Stage 2 Sub-study 1|Other|0|||
46641864|NCT04700449|82831275|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
46641865|NCT04700449|82831276|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
46641866|NCT04700449|82831277|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
46641867|NCT04700449|82831278|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
46641868|NCT04700449|82831275|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
46641869|NCT04700449|82831276|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
46641870|NCT04700449|82831277|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
46641871|NCT04700449|82831278|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
46641872|NCT04700449|82831275|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
46641873|NCT04700449|82831276|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
46641874|NCT04700449|82831277|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
46641875|NCT04700449|82831278|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
46641876|NCT04700449|82831275|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
46641877|NCT04700449|82831276|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
46641878|NCT04700449|82831277|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
46641879|NCT04700449|82831278|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
46641880|NCT04700449|82831275|FG000|Stage 2 Sub-study 2|Other|0|||
46641881|NCT04700449|82831276|FG001|Stage 2 Sub-study 2|Other|0|||
46641882|NCT04700449|82831277|FG002|Stage 2 Sub-study 2|Other|0|||
46641883|NCT04700449|82831278|FG003|Stage 2 Sub-study 2|Other|5|||
46641884|NCT04667377|82831302|FG000|Dose Escalation Period|Other not specified below|3|||
46641885|NCT04667377|82831303|FG001|Dose Escalation Period|Other not specified below|3|||
46641886|NCT04667377|82831304|FG002|Dose Escalation Period|Other not specified below|2|||
46641887|NCT04667377|82831305|FG003|Dose Escalation Period|Other not specified below|1|||
46641888|NCT04667377|82831306|FG004|Dose Escalation Period|Other not specified below|3|||
46641889|NCT04667377|82831302|FG000|Dose Escalation Period|Protocol Violation|2|||
46641890|NCT04667377|82831303|FG001|Dose Escalation Period|Protocol Violation|2|||
46641891|NCT04667377|82831304|FG002|Dose Escalation Period|Protocol Violation|0|||
46641892|NCT04667377|82831305|FG003|Dose Escalation Period|Protocol Violation|2|||
46641893|NCT04667377|82831306|FG004|Dose Escalation Period|Protocol Violation|1|||
46641894|NCT04667377|82831302|FG000|Dose Escalation Period|Burden of study procedures|2|||
46641895|NCT04667377|82831303|FG001|Dose Escalation Period|Burden of study procedures|1|||
46641896|NCT04667377|82831304|FG002|Dose Escalation Period|Burden of study procedures|1|||
46641897|NCT04667377|82831305|FG003|Dose Escalation Period|Burden of study procedures|1|||
46641898|NCT04667377|82831306|FG004|Dose Escalation Period|Burden of study procedures|5|||
46846810|NCT00117312|83063516|FG003|Overall Study|Hepatic abnormality|1|||
46641899|NCT04667377|82831302|FG000|Dose Escalation Period|Change of residence|0|||
46641900|NCT04667377|82831303|FG001|Dose Escalation Period|Change of residence|0|||
46641901|NCT04667377|82831304|FG002|Dose Escalation Period|Change of residence|1|||
46846811|NCT00117312|83063513|FG000|Overall Study|Withdrawal by Subject|0|||
46846812|NCT00117312|83063514|FG001|Overall Study|Withdrawal by Subject|2|||
46641902|NCT04667377|82831305|FG003|Dose Escalation Period|Change of residence|0|||
46641903|NCT04667377|82831306|FG004|Dose Escalation Period|Change of residence|0|||
46641904|NCT04667377|82831302|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
46641905|NCT04667377|82831303|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
46641906|NCT04667377|82831304|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
46641907|NCT04667377|82831305|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
46641908|NCT04667377|82831306|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
46641909|NCT04667377|82831302|FG000|Dose Escalation Period|Adverse Event|9|||
46641910|NCT04667377|82831303|FG001|Dose Escalation Period|Adverse Event|10|||
46776119|NCT00716144|82994557|FG000|Overall Study|Adverse Event|0|||
46641911|NCT04667377|82831304|FG002|Dose Escalation Period|Adverse Event|12|||
46641912|NCT04667377|82831305|FG003|Dose Escalation Period|Adverse Event|17|||
46641913|NCT04667377|82831306|FG004|Dose Escalation Period|Adverse Event|3|||
46641914|NCT04667377|82831302|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
46641915|NCT04667377|82831303|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
46641916|NCT04667377|82831304|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
46641917|NCT04667377|82831305|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
46641918|NCT04667377|82831306|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
46641919|NCT04667377|82831302|FG000|Dose Escalation Period|Not treated|1|||
46776120|NCT00716144|82994558|FG001|Overall Study|Adverse Event|0|||
46776121|NCT00716144|82994559|FG002|Overall Study|Adverse Event|0|||
46776122|NCT00716144|82994560|FG003|Overall Study|Adverse Event|2|||
46776123|NCT00716144|82994557|FG000|Overall Study|Non-compliance|1|||
46776124|NCT00716144|82994558|FG001|Overall Study|Non-compliance|0|||
46846813|NCT00117312|83063515|FG002|Overall Study|Withdrawal by Subject|0|||
46846814|NCT00117312|83063516|FG003|Overall Study|Withdrawal by Subject|0|||
46846815|NCT00129116|83063531|FG000|Primary Phase|Lost to Follow-up|1|||
46846816|NCT00129116|83063532|FG001|Primary Phase|Lost to Follow-up|1|||
46846817|NCT00129116|83063533|FG002|Primary Phase|Lost to Follow-up|0|||
46846818|NCT00129116|83063534|FG003|Primary Phase|Lost to Follow-up|1|||
46846819|NCT00129116|83063535|FG004|Primary Phase|Lost to Follow-up|1|||
46846820|NCT00129116|83063531|FG000|Primary Phase|Protocol Violation|0|||
46846821|NCT00129116|83063532|FG001|Primary Phase|Protocol Violation|1|||
46846822|NCT00129116|83063533|FG002|Primary Phase|Protocol Violation|0|||
46846823|NCT00129116|83063534|FG003|Primary Phase|Protocol Violation|0|||
46846824|NCT00129116|83063535|FG004|Primary Phase|Protocol Violation|0|||
46846825|NCT00129116|83063531|FG000|Primary Phase|Adverse Event|1|||
46846826|NCT00129116|83063532|FG001|Primary Phase|Adverse Event|1|||
46846827|NCT00129116|83063533|FG002|Primary Phase|Adverse Event|0|||
46846828|NCT00129116|83063534|FG003|Primary Phase|Adverse Event|0|||
46776125|NCT00716144|82994559|FG002|Overall Study|Non-compliance|0|||
46776126|NCT00716144|82994560|FG003|Overall Study|Non-compliance|0|||
46776127|NCT00716144|82994557|FG000|Overall Study|Protocol Violation|2|||
46776128|NCT00716144|82994558|FG001|Overall Study|Protocol Violation|0|||
46641920|NCT04667377|82831303|FG001|Dose Escalation Period|Not treated|0|||
46776129|NCT00716144|82994559|FG002|Overall Study|Protocol Violation|1|||
46776130|NCT00716144|82994560|FG003|Overall Study|Protocol Violation|0|||
46776131|NCT00716144|82994557|FG000|Overall Study|Physician Decision|0|||
46846829|NCT00129116|83063535|FG004|Primary Phase|Adverse Event|0|||
46846830|NCT00129116|83063531|FG000|Primary Phase|Withdrawal by Subject|0|||
46846831|NCT00129116|83063532|FG001|Primary Phase|Withdrawal by Subject|1|||
46846832|NCT00129116|83063533|FG002|Primary Phase|Withdrawal by Subject|0|||
46776132|NCT00716144|82994558|FG001|Overall Study|Physician Decision|1|||
46776133|NCT00716144|82994559|FG002|Overall Study|Physician Decision|2|||
46846833|NCT00129116|83063534|FG003|Primary Phase|Withdrawal by Subject|0|||
46776134|NCT00716144|82994560|FG003|Overall Study|Physician Decision|2|||
46776135|NCT00716144|82994557|FG000|Overall Study|Intercurrent illness|0|||
46776136|NCT00716144|82994558|FG001|Overall Study|Intercurrent illness|0|||
46776137|NCT00716144|82994559|FG002|Overall Study|Intercurrent illness|1|||
46776138|NCT00716144|82994560|FG003|Overall Study|Intercurrent illness|0|||
46776139|NCT00716144|82994557|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
46776140|NCT00716144|82994558|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
46776141|NCT00716144|82994559|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
46776142|NCT00716144|82994560|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
46846834|NCT00129116|83063535|FG004|Primary Phase|Withdrawal by Subject|0|||
46846835|NCT00129116|83063531|FG000|Primary Phase|Other|0|||
46846836|NCT00129116|83063532|FG001|Primary Phase|Other|0|||
46846837|NCT00129116|83063533|FG002|Primary Phase|Other|1|||
46846838|NCT00129116|83063534|FG003|Primary Phase|Other|0|||
46846839|NCT00129116|83063535|FG004|Primary Phase|Other|0|||
46846840|NCT00129116|83063531|FG000|Booster Phase|Lost to Follow-up|2|||
46846841|NCT00129116|83063532|FG001|Booster Phase|Lost to Follow-up|0|||
46846842|NCT00129116|83063533|FG002|Booster Phase|Lost to Follow-up|0|||
46846843|NCT00129116|83063534|FG003|Booster Phase|Lost to Follow-up|0|||
46846844|NCT00129116|83063535|FG004|Booster Phase|Lost to Follow-up|1|||
46846845|NCT00117156|83063547|FG000|Overall Study|Adverse Event|9|||
46846846|NCT00117156|83063547|FG000|Overall Study|Physician Decision|1|||
46846847|NCT00117156|83063547|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
46846848|NCT00096954|83063553|FG000|Overall Study|Adverse Event|3|||
46846849|NCT00096954|83063554|FG001|Overall Study|Adverse Event|1|||
46846850|NCT00096954|83063553|FG000|Overall Study|Withdrawal by Subject|9|||
46846851|NCT00096954|83063554|FG001|Overall Study|Withdrawal by Subject|8|||
46846852|NCT00096954|83063553|FG000|Overall Study|Physician Decision|1|||
46846853|NCT00096954|83063554|FG001|Overall Study|Physician Decision|1|||
46846854|NCT00096954|83063553|FG000|Overall Study|Sponsors Decision|1|||
46846855|NCT00096954|83063554|FG001|Overall Study|Sponsors Decision|1|||
46846856|NCT00096954|83063553|FG000|Overall Study|Pregnancy|1|||
46846857|NCT00096954|83063554|FG001|Overall Study|Pregnancy|1|||
46846858|NCT00096954|83063553|FG000|Overall Study|Initiation of immunotherapy|1|||
46846859|NCT00096954|83063554|FG001|Overall Study|Initiation of immunotherapy|0|||
46846860|NCT00096954|83063553|FG000|Overall Study|Non-compliance|0|||
46846861|NCT00096954|83063554|FG001|Overall Study|Non-compliance|3|||
46846862|NCT00096954|83063553|FG000|Overall Study|Lost to Follow-up|8|||
46846863|NCT00096954|83063554|FG001|Overall Study|Lost to Follow-up|5|||
46846864|NCT00096486|83063564|FG000|Overall Study|Withdrawal by Subject|0|||
46846865|NCT00096486|83063565|FG001|Overall Study|Withdrawal by Subject|0|||
46846866|NCT00096486|83063566|FG002|Overall Study|Withdrawal by Subject|1|||
46846867|NCT00096486|83063567|FG003|Overall Study|Withdrawal by Subject|1|||
46846868|NCT00096486|83063564|FG000|Overall Study|Not Treated|0|||
46846869|NCT00096486|83063565|FG001|Overall Study|Not Treated|0|||
46846870|NCT00096486|83063566|FG002|Overall Study|Not Treated|1|||
46846871|NCT00096486|83063567|FG003|Overall Study|Not Treated|1|||
46846872|NCT00116844|83063579|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
47073274|NCT01041573|83361632|FG000|Overall Study|positive to anti-HCV|1|||
47073275|NCT01041573|83361633|FG001|Overall Study|positive to anti-HCV|0|||
47073276|NCT01041573|83361634|FG002|Overall Study|positive to anti-HCV|0|||
47073277|NCT01041573|83361635|FG003|Overall Study|positive to anti-HCV|0|||
47073278|NCT01041495|83361662|FG000|Overall Study|Withdrawal by Subject|2|||
47073279|NCT01041495|83361663|FG001|Overall Study|Withdrawal by Subject|5|||
47073280|NCT01041495|83361662|FG000|Overall Study|Adverse Event|2|||
47073281|NCT01041495|83361663|FG001|Overall Study|Adverse Event|1|||
47073282|NCT01041495|83361662|FG000|Overall Study|Lost to Follow-up|0|||
47073283|NCT01041495|83361663|FG001|Overall Study|Lost to Follow-up|1|||
47073284|NCT01041417|83361671|FG000|Overall Study|Adverse Event|5|||
47073285|NCT01041417|83361672|FG001|Overall Study|Adverse Event|2|||
46641921|NCT04667377|82831304|FG002|Dose Escalation Period|Not treated|0|||
46641922|NCT04667377|82831305|FG003|Dose Escalation Period|Not treated|0|||
46846873|NCT00116844|83063580|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
46776143|NCT00716144|82994557|FG000|Overall Study|Adverse event: left foot pain|0|||
46846874|NCT00116844|83063579|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
46846875|NCT00116844|83063580|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
46846876|NCT00116844|83063579|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
46846877|NCT00116844|83063580|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
46846878|NCT00116844|83063579|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
47073286|NCT01041417|83361671|FG000|Overall Study|Lost to Follow-up|1|||
47073287|NCT01041417|83361672|FG001|Overall Study|Lost to Follow-up|1|||
47073288|NCT01041417|83361671|FG000|Overall Study|Death|1|||
46967962|NCT03740737|83210648|FG000|Overall Study|Adverse Event|2|||
46967963|NCT03740737|83210649|FG001|Overall Study|Adverse Event|0|||
46967964|NCT03740737|83210648|FG000|Overall Study|Lost to Follow-up|1|||
46967965|NCT03740737|83210649|FG001|Overall Study|Lost to Follow-up|0|||
46967966|NCT03740737|83210648|FG000|Overall Study|Randomization failure|1|||
46967967|NCT03740737|83210649|FG001|Overall Study|Randomization failure|0|||
46967968|NCT03740737|83210648|FG000|Overall Study|Participant withdrew consent|1|||
46967969|NCT03740737|83210649|FG001|Overall Study|Participant withdrew consent|0|||
46967970|NCT03740737|83210648|FG000|Overall Study|Participant withdrew from trial|2|||
46967971|NCT03740737|83210649|FG001|Overall Study|Participant withdrew from trial|1|||
46967972|NCT03738618|83210658|FG000|Overall Study|Protocol deviation|23|||
46967973|NCT03738618|83210659|FG001|Overall Study|Protocol deviation|0|||
46967974|NCT03738618|83210658|FG000|Overall Study|Adverse Event|4|||
46967975|NCT03738618|83210659|FG001|Overall Study|Adverse Event|0|||
46967976|NCT03738618|83210658|FG000|Overall Study|Lost to Follow-up|2|||
46967977|NCT03738618|83210659|FG001|Overall Study|Lost to Follow-up|0|||
46967978|NCT03738618|83210658|FG000|Overall Study|Randomization failure|1|||
46967979|NCT03738618|83210659|FG001|Overall Study|Randomization failure|0|||
46967980|NCT03738618|83210658|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
46967981|NCT03738618|83210659|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
46967982|NCT03738618|83210658|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
46967983|NCT03738618|83210659|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
46967984|NCT03556891|83210667|FG000|Overall Study|Adverse Event|4|||
46967985|NCT03556891|83210667|FG000|Overall Study|MRI Need|3|||
46967986|NCT03556891|83210667|FG000|Overall Study|Device Failure|1|||
46967987|NCT03556891|83210667|FG000|Overall Study|Death|1|||
46967988|NCT03556891|83210667|FG000|Overall Study|Lost to Follow-up|1|||
46967989|NCT03556891|83210667|FG000|Overall Study|Missing at random|1|||
46967990|NCT03556891|83210667|FG000|Overall Study|Missing due to COVID|1|||
46967991|NCT03556891|83210667|FG000|Overall Study|Protocol Violation|1|||
46967992|NCT03484923|83210676|FG000|Overall Study|Adverse Event|3|||
46967993|NCT03484923|83210677|FG001|Overall Study|Adverse Event|3|||
46967994|NCT03484923|83210678|FG002|Overall Study|Adverse Event|5|||
46967995|NCT03484923|83210679|FG003|Overall Study|Adverse Event|11|||
46967996|NCT03484923|83210680|FG004|Overall Study|Adverse Event|1|||
46967997|NCT03484923|83210676|FG000|Overall Study|Death|2|||
46967998|NCT03484923|83210677|FG001|Overall Study|Death|2|||
46967999|NCT03484923|83210678|FG002|Overall Study|Death|3|||
46968000|NCT03484923|83210679|FG003|Overall Study|Death|0|||
46968001|NCT03484923|83210680|FG004|Overall Study|Death|1|||
46968002|NCT03484923|83210676|FG000|Overall Study|Physician Decision|6|||
46968003|NCT03484923|83210677|FG001|Overall Study|Physician Decision|7|||
46968004|NCT03484923|83210678|FG002|Overall Study|Physician Decision|6|||
46968005|NCT03484923|83210679|FG003|Overall Study|Physician Decision|3|||
46968006|NCT03484923|83210680|FG004|Overall Study|Physician Decision|2|||
47073289|NCT01041417|83361672|FG001|Overall Study|Death|0|||
47073290|NCT01040871|83361682|FG000|Overall Study|Adverse Event|6|||
47073291|NCT01040871|83361683|FG001|Overall Study|Adverse Event|2|||
47073292|NCT01040871|83361682|FG000|Overall Study|Withdrawal by Subject|2|||
47073293|NCT01040871|83361683|FG001|Overall Study|Withdrawal by Subject|0|||
47073294|NCT01040871|83361682|FG000|Overall Study|Death|1|||
47073295|NCT01040871|83361683|FG001|Overall Study|Death|3|||
47073296|NCT01040871|83361682|FG000|Overall Study|Lack of Efficacy|1|||
47073297|NCT01040871|83361683|FG001|Overall Study|Lack of Efficacy|1|||
47073298|NCT01040871|83361682|FG000|Overall Study|drug supply issue|1|||
46641923|NCT04667377|82831306|FG004|Dose Escalation Period|Not treated|0|||
46968007|NCT03484923|83210676|FG000|Overall Study|Progressive disease|33|||
46968008|NCT03484923|83210677|FG001|Overall Study|Progressive disease|28|||
46968009|NCT03484923|83210678|FG002|Overall Study|Progressive disease|26|||
46968010|NCT03484923|83210679|FG003|Overall Study|Progressive disease|30|||
46968011|NCT03484923|83210680|FG004|Overall Study|Progressive disease|16|||
46968012|NCT03484923|83210676|FG000|Overall Study|Subject Decision|1|||
46968013|NCT03484923|83210677|FG001|Overall Study|Subject Decision|3|||
46968014|NCT03484923|83210678|FG002|Overall Study|Subject Decision|3|||
46968015|NCT03484923|83210679|FG003|Overall Study|Subject Decision|0|||
46968016|NCT03484923|83210680|FG004|Overall Study|Subject Decision|1|||
46968017|NCT03146650|83210759|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
46968018|NCT03146650|83210759|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
46968019|NCT03146650|83210759|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
46968020|NCT03146650|83210759|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
46968021|NCT03146650|83210759|FG000|2 Year Follow-up|Death|11|||
46968022|NCT03146650|83210759|FG000|2 Year Follow-up|Still in follow-up|7|||
46968023|NCT03146650|83210759|FG000|2 Year Follow-up|Lost to Follow-up|1|||
46968024|NCT03091192|83210765|FG000|Overall Study|Study terminated by sponsor|21|||
47073299|NCT01040871|83361683|FG001|Overall Study|drug supply issue|0|||
47073300|NCT01040871|83361682|FG000|Overall Study|Randomized and Not Treated|2|||
47073301|NCT01040871|83361683|FG001|Overall Study|Randomized and Not Treated|1|||
47073302|NCT01040169|83361691|FG000|Overall Study|Lost to Follow-up|3|||
46968025|NCT03091192|83210766|FG001|Overall Study|Study terminated by sponsor|14|||
46968026|NCT03091192|83210765|FG000|Overall Study|Death|9|||
46968027|NCT03091192|83210766|FG001|Overall Study|Death|13|||
46968028|NCT03091192|83210765|FG000|Overall Study|Withdrawal by Subject|2|||
46968029|NCT03091192|83210766|FG001|Overall Study|Withdrawal by Subject|0|||
46968030|NCT03091192|83210765|FG000|Overall Study|Lost to Follow-up|1|||
46968031|NCT03091192|83210766|FG001|Overall Study|Lost to Follow-up|0|||
46968032|NCT02829723|83210802|FG000|Overall Study|Adverse Event|0|||
46968033|NCT02829723|83210803|FG001|Overall Study|Adverse Event|0|||
46968034|NCT02829723|83210804|FG002|Overall Study|Adverse Event|1|||
46968035|NCT02829723|83210805|FG003|Overall Study|Adverse Event|1|||
46968036|NCT02829723|83210806|FG004|Overall Study|Adverse Event|0|||
46968037|NCT02829723|83210807|FG005|Overall Study|Adverse Event|0|||
46968038|NCT02829723|83210808|FG006|Overall Study|Adverse Event|0|||
46968039|NCT02829723|83210809|FG007|Overall Study|Adverse Event|1|||
46968040|NCT02829723|83210810|FG008|Overall Study|Adverse Event|0|||
46968041|NCT02829723|83210811|FG009|Overall Study|Adverse Event|0|||
46968042|NCT02829723|83210812|FG010|Overall Study|Adverse Event|0|||
46968043|NCT02829723|83210813|FG011|Overall Study|Adverse Event|0|||
46968044|NCT02829723|83210814|FG012|Overall Study|Adverse Event|0|||
46968045|NCT02829723|83210815|FG013|Overall Study|Adverse Event|0|||
46968046|NCT02829723|83210816|FG014|Overall Study|Adverse Event|1|||
46968047|NCT02829723|83210817|FG015|Overall Study|Adverse Event|1|||
46968048|NCT02829723|83210818|FG016|Overall Study|Adverse Event|1|||
46968049|NCT02829723|83210819|FG017|Overall Study|Adverse Event|2|||
46968050|NCT02829723|83210820|FG018|Overall Study|Adverse Event|1|||
46968051|NCT02829723|83210821|FG019|Overall Study|Adverse Event|1|||
46968052|NCT02829723|83210822|FG020|Overall Study|Adverse Event|3|||
46968053|NCT02829723|83210823|FG021|Overall Study|Adverse Event|0|||
46968054|NCT02829723|83210824|FG022|Overall Study|Adverse Event|0|||
46968055|NCT02829723|83210825|FG023|Overall Study|Adverse Event|1|||
46968056|NCT02829723|83210826|FG024|Overall Study|Adverse Event|1|||
46968057|NCT02829723|83210827|FG025|Overall Study|Adverse Event|3|||
46968058|NCT02829723|83210828|FG026|Overall Study|Adverse Event|5|||
46968059|NCT02829723|83210802|FG000|Overall Study|Death|1|||
46968060|NCT02829723|83210803|FG001|Overall Study|Death|0|||
46968061|NCT02829723|83210804|FG002|Overall Study|Death|1|||
46968062|NCT02829723|83210805|FG003|Overall Study|Death|1|||
46968063|NCT02829723|83210806|FG004|Overall Study|Death|0|||
46968064|NCT02829723|83210807|FG005|Overall Study|Death|0|||
46968065|NCT02829723|83210808|FG006|Overall Study|Death|2|||
46968066|NCT02829723|83210809|FG007|Overall Study|Death|0|||
46968067|NCT02829723|83210810|FG008|Overall Study|Death|1|||
46968068|NCT02829723|83210811|FG009|Overall Study|Death|0|||
46968069|NCT02829723|83210812|FG010|Overall Study|Death|0|||
46968070|NCT02829723|83210813|FG011|Overall Study|Death|0|||
46968071|NCT02829723|83210814|FG012|Overall Study|Death|2|||
46968072|NCT02829723|83210815|FG013|Overall Study|Death|1|||
46968073|NCT02829723|83210816|FG014|Overall Study|Death|0|||
46776144|NCT00716144|82994558|FG001|Overall Study|Adverse event: left foot pain|1|||
46776145|NCT00716144|82994559|FG002|Overall Study|Adverse event: left foot pain|0|||
46776146|NCT00716144|82994560|FG003|Overall Study|Adverse event: left foot pain|0|||
46776147|NCT00716144|82994557|FG000|Overall Study|Clinical Depression|0|||
46968074|NCT02829723|83210817|FG015|Overall Study|Death|0|||
46776148|NCT00716144|82994558|FG001|Overall Study|Clinical Depression|1|||
46776149|NCT00716144|82994559|FG002|Overall Study|Clinical Depression|0|||
46776150|NCT00716144|82994560|FG003|Overall Study|Clinical Depression|0|||
46776151|NCT00576381|82994570|FG000|Overall Study|Reoperation|3|||
46776152|NCT00576381|82994570|FG000|Overall Study|Adverse Event|4|||
46776153|NCT00684567|82994574|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
46776154|NCT00684567|82994574|FG000|Monotherapy Period|Adverse Event|2|||
46776155|NCT00684567|82994574|FG000|Monotherapy Period|Death|1|||
47073303|NCT01040169|83361692|FG001|Overall Study|Lost to Follow-up|8|||
46776156|NCT00684567|82994574|FG000|Monotherapy Period|Progression of primary disease|11|||
46776157|NCT00684411|82994578|FG000|Overall Study|New Primary Cancer|1|||
46968075|NCT02829723|83210818|FG016|Overall Study|Death|0|||
46968076|NCT02829723|83210819|FG017|Overall Study|Death|0|||
46968077|NCT02829723|83210820|FG018|Overall Study|Death|0|||
46968078|NCT02829723|83210821|FG019|Overall Study|Death|0|||
46968079|NCT02829723|83210822|FG020|Overall Study|Death|0|||
46968080|NCT02829723|83210823|FG021|Overall Study|Death|2|||
46968081|NCT02829723|83210824|FG022|Overall Study|Death|0|||
46968082|NCT02829723|83210825|FG023|Overall Study|Death|0|||
46968083|NCT02829723|83210826|FG024|Overall Study|Death|0|||
46968084|NCT02829723|83210827|FG025|Overall Study|Death|1|||
46968085|NCT02829723|83210828|FG026|Overall Study|Death|2|||
47073304|NCT01673178|83361712|FG000|Overall Study|Lost to Follow-up|0|||
47073305|NCT01673178|83361713|FG001|Overall Study|Lost to Follow-up|1|||
46968086|NCT02829723|83210802|FG000|Overall Study|Physician Decision|0|||
46968087|NCT02829723|83210803|FG001|Overall Study|Physician Decision|0|||
46968088|NCT02829723|83210804|FG002|Overall Study|Physician Decision|0|||
46968089|NCT02829723|83210805|FG003|Overall Study|Physician Decision|0|||
47073306|NCT01673178|83361714|FG002|Overall Study|Lost to Follow-up|0|||
46968090|NCT02829723|83210806|FG004|Overall Study|Physician Decision|0|||
46968091|NCT02829723|83210807|FG005|Overall Study|Physician Decision|0|||
46968092|NCT02829723|83210808|FG006|Overall Study|Physician Decision|0|||
46968093|NCT02829723|83210809|FG007|Overall Study|Physician Decision|0|||
46968094|NCT02829723|83210810|FG008|Overall Study|Physician Decision|0|||
46846879|NCT00116844|83063580|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
46846880|NCT00116844|83063579|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
46846881|NCT00116844|83063580|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
46846882|NCT00116844|83063579|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
46846883|NCT00116844|83063580|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
46846884|NCT00116844|83063579|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
46846885|NCT00116844|83063580|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
46846886|NCT00116844|83063579|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
46846887|NCT00116844|83063580|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
46846888|NCT00116844|83063579|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
46846889|NCT00116844|83063580|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
46846890|NCT00128492|83063588|FG000|Overall Study|AE unrelated to study|2|||
46846891|NCT00128492|83063589|FG001|Overall Study|AE unrelated to study|9|||
46846892|NCT00128492|83063588|FG000|Overall Study|Study drug intolerance (AE)|2|||
46846893|NCT00128492|83063589|FG001|Overall Study|Study drug intolerance (AE)|8|||
46846894|NCT00128492|83063588|FG000|Overall Study|AE related to study|1|||
46846895|NCT00128492|83063589|FG001|Overall Study|AE related to study|4|||
46846896|NCT00128492|83063588|FG000|Overall Study|Death|1|||
46846897|NCT00128492|83063589|FG001|Overall Study|Death|0|||
46846898|NCT00128492|83063588|FG000|Overall Study|Lost to Follow-up|1|||
46846899|NCT00128492|83063589|FG001|Overall Study|Lost to Follow-up|5|||
46846900|NCT00128492|83063588|FG000|Overall Study|Noncompliance|0|||
46846901|NCT00128492|83063589|FG001|Overall Study|Noncompliance|5|||
46846902|NCT00128492|83063588|FG000|Overall Study|Personal or administrative|10|||
46846903|NCT00128492|83063589|FG001|Overall Study|Personal or administrative|22|||
46846904|NCT00128492|83063588|FG000|Overall Study|Withdrawal by Subject|3|||
46846905|NCT00128492|83063589|FG001|Overall Study|Withdrawal by Subject|5|||
46846906|NCT00128492|83063588|FG000|Overall Study|Pregnancy|0|||
46846907|NCT00128492|83063589|FG001|Overall Study|Pregnancy|1|||
46846908|NCT00132314|83063597|FG000|Overall Study|Lost to Follow-up|70|||
46846909|NCT00132314|83063598|FG001|Overall Study|Lost to Follow-up|62|||
46846910|NCT00132314|83063597|FG000|Overall Study|Lacked SSN|1|||
46846911|NCT00132314|83063598|FG001|Overall Study|Lacked SSN|3|||
46846912|NCT00132314|83063597|FG000|Overall Study|Refused intervention at baseline|2|||
46846913|NCT00132314|83063598|FG001|Overall Study|Refused intervention at baseline|7|||
46846914|NCT04539262|83063612|FG000|Overall Study|Adverse Event|0|||
46846915|NCT04539262|83063613|FG001|Overall Study|Adverse Event|0|||
46846916|NCT04539262|83063614|FG002|Overall Study|Adverse Event|1|||
46846917|NCT04539262|83063615|FG003|Overall Study|Adverse Event|0|||
46846918|NCT04539262|83063616|FG004|Overall Study|Adverse Event|0|||
46846919|NCT04539262|83063617|FG005|Overall Study|Adverse Event|0|||
46846920|NCT04539262|83063618|FG006|Overall Study|Adverse Event|0|||
46968095|NCT02829723|83210811|FG009|Overall Study|Physician Decision|1|||
46968096|NCT02829723|83210812|FG010|Overall Study|Physician Decision|1|||
46776158|NCT00684411|82994578|FG000|Overall Study|Disease Progression|10|||
46776159|NCT00684411|82994578|FG000|Overall Study|Adverse Event|1|||
46776160|NCT00686829|82994582|FG000|Overall Study|Adverse Event|5|||
46776161|NCT00686829|82994582|FG000|Overall Study|Lack of Efficacy|6|||
46776162|NCT00686829|82994582|FG000|Overall Study|Lost to Follow-up|4|||
46776163|NCT00686829|82994582|FG000|Overall Study|Withdrawal by Subject|14|||
46776164|NCT00686829|82994582|FG000|Overall Study|Protocol Violation|3|||
46776165|NCT00686829|82994582|FG000|Overall Study|Sponsor discontinued VCV|47|||
46776166|NCT00687297|82994588|FG000|Randomization|Withdrawal by Subject|2|||
46776167|NCT00687297|82994589|FG001|Randomization|Withdrawal by Subject|0|||
46776168|NCT00687297|82994588|FG000|Randomization|Withdrew before treatment, ineligible|1|||
46776169|NCT00687297|82994589|FG001|Randomization|Withdrew before treatment, ineligible|1|||
46776170|NCT00687297|82994588|FG000|Induction|Withdrawal by Subject|4|||
46776171|NCT00687297|82994589|FG001|Induction|Withdrawal by Subject|4|||
46776172|NCT00687297|82994588|FG000|Induction|Adverse Event|16|||
46776173|NCT00687297|82994589|FG001|Induction|Adverse Event|15|||
46776174|NCT00687297|82994588|FG000|Induction|Death|7|||
46846921|NCT04539262|83063619|FG007|Overall Study|Adverse Event|0|||
46846922|NCT04539262|83063612|FG000|Overall Study|Withdrew Consent|0|||
46846923|NCT04539262|83063613|FG001|Overall Study|Withdrew Consent|0|||
46846924|NCT04539262|83063614|FG002|Overall Study|Withdrew Consent|0|||
46846925|NCT04539262|83063615|FG003|Overall Study|Withdrew Consent|1|||
46846926|NCT04539262|83063616|FG004|Overall Study|Withdrew Consent|0|||
46968097|NCT02829723|83210813|FG011|Overall Study|Physician Decision|0|||
46968098|NCT02829723|83210814|FG012|Overall Study|Physician Decision|0|||
46776175|NCT00687297|82994589|FG001|Induction|Death|11|||
46776176|NCT00687297|82994588|FG000|Induction|Lack of Efficacy|17|||
46846927|NCT04539262|83063617|FG005|Overall Study|Withdrew Consent|0|||
46968099|NCT02829723|83210815|FG013|Overall Study|Physician Decision|1|||
46968100|NCT02829723|83210816|FG014|Overall Study|Physician Decision|0|||
46968101|NCT02829723|83210817|FG015|Overall Study|Physician Decision|0|||
46968102|NCT02829723|83210818|FG016|Overall Study|Physician Decision|2|||
46968103|NCT02829723|83210819|FG017|Overall Study|Physician Decision|0|||
46968104|NCT02829723|83210820|FG018|Overall Study|Physician Decision|0|||
46968105|NCT02829723|83210821|FG019|Overall Study|Physician Decision|0|||
46968106|NCT02829723|83210822|FG020|Overall Study|Physician Decision|0|||
46968107|NCT02829723|83210823|FG021|Overall Study|Physician Decision|0|||
46968108|NCT02829723|83210824|FG022|Overall Study|Physician Decision|1|||
46968109|NCT02829723|83210825|FG023|Overall Study|Physician Decision|1|||
46968110|NCT02829723|83210826|FG024|Overall Study|Physician Decision|1|||
46968111|NCT02829723|83210827|FG025|Overall Study|Physician Decision|1|||
46968112|NCT02829723|83210828|FG026|Overall Study|Physician Decision|3|||
46641924|NCT04667377|82831302|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
46641925|NCT04667377|82831303|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
46641926|NCT04667377|82831304|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
46641927|NCT04667377|82831305|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
46641928|NCT04667377|82831306|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
46641929|NCT04667377|82831302|FG000|Dose Escalation Period|Lost to Follow-up|0|||
46641930|NCT04667377|82831303|FG001|Dose Escalation Period|Lost to Follow-up|1|||
46641931|NCT04667377|82831304|FG002|Dose Escalation Period|Lost to Follow-up|0|||
46776177|NCT00687297|82994589|FG001|Induction|Lack of Efficacy|21|||
46776178|NCT00687297|82994588|FG000|Induction|Ineligible|0|||
46776179|NCT00687297|82994589|FG001|Induction|Ineligible|1|||
46776180|NCT00687297|82994588|FG000|Induction|Patient Noncompliance|1|||
46641932|NCT04667377|82831305|FG003|Dose Escalation Period|Lost to Follow-up|0|||
46641933|NCT04667377|82831306|FG004|Dose Escalation Period|Lost to Follow-up|0|||
46641934|NCT04667377|82831302|FG000|Maintenance Period|Perceived lack of efficacy|0|||
46641935|NCT04667377|82831303|FG001|Maintenance Period|Perceived lack of efficacy|2|||
46641936|NCT04667377|82831304|FG002|Maintenance Period|Perceived lack of efficacy|1|||
46641937|NCT04667377|82831305|FG003|Maintenance Period|Perceived lack of efficacy|0|||
46641938|NCT04667377|82831306|FG004|Maintenance Period|Perceived lack of efficacy|1|||
46641939|NCT04667377|82831302|FG000|Maintenance Period|Adverse Event|2|||
46641940|NCT04667377|82831303|FG001|Maintenance Period|Adverse Event|8|||
46641941|NCT04667377|82831304|FG002|Maintenance Period|Adverse Event|5|||
46641942|NCT04667377|82831305|FG003|Maintenance Period|Adverse Event|4|||
46641943|NCT04667377|82831306|FG004|Maintenance Period|Adverse Event|1|||
46641944|NCT04667377|82831302|FG000|Maintenance Period|Adverse event: COVID infection|0|||
46641945|NCT04667377|82831303|FG001|Maintenance Period|Adverse event: COVID infection|1|||
46641946|NCT04667377|82831304|FG002|Maintenance Period|Adverse event: COVID infection|0|||
46641947|NCT04667377|82831305|FG003|Maintenance Period|Adverse event: COVID infection|0|||
46641948|NCT04667377|82831306|FG004|Maintenance Period|Adverse event: COVID infection|0|||
46641949|NCT04667377|82831302|FG000|Maintenance Period|COVID-related|0|||
46641950|NCT04667377|82831303|FG001|Maintenance Period|COVID-related|0|||
46641951|NCT04667377|82831304|FG002|Maintenance Period|COVID-related|1|||
46641952|NCT04667377|82831305|FG003|Maintenance Period|COVID-related|1|||
46641953|NCT04667377|82831306|FG004|Maintenance Period|COVID-related|0|||
46641954|NCT04667377|82831302|FG000|Maintenance Period|Protocol Violation|1|||
46641955|NCT04667377|82831303|FG001|Maintenance Period|Protocol Violation|0|||
46641956|NCT04667377|82831304|FG002|Maintenance Period|Protocol Violation|0|||
46641957|NCT04667377|82831305|FG003|Maintenance Period|Protocol Violation|0|||
46641958|NCT04667377|82831306|FG004|Maintenance Period|Protocol Violation|1|||
46641959|NCT04667377|82831302|FG000|Maintenance Period|Burden of study procedures|1|||
46641960|NCT04667377|82831303|FG001|Maintenance Period|Burden of study procedures|2|||
46641961|NCT04667377|82831304|FG002|Maintenance Period|Burden of study procedures|0|||
46641962|NCT04667377|82831305|FG003|Maintenance Period|Burden of study procedures|1|||
46641963|NCT04667377|82831306|FG004|Maintenance Period|Burden of study procedures|0|||
46641964|NCT04667377|82831302|FG000|Maintenance Period|Change of residence|0|||
46641965|NCT04667377|82831303|FG001|Maintenance Period|Change of residence|1|||
46641966|NCT04667377|82831304|FG002|Maintenance Period|Change of residence|0|||
46641967|NCT04667377|82831305|FG003|Maintenance Period|Change of residence|0|||
46641968|NCT04667377|82831306|FG004|Maintenance Period|Change of residence|1|||
46641969|NCT04667377|82831302|FG000|Maintenance Period|Missing|1|||
46641970|NCT04667377|82831303|FG001|Maintenance Period|Missing|0|||
46641971|NCT04667377|82831304|FG002|Maintenance Period|Missing|0|||
46776181|NCT00687297|82994589|FG001|Induction|Patient Noncompliance|0|||
46776182|NCT00687297|82994588|FG000|Induction|Physician Decision|0|||
46776183|NCT00687297|82994589|FG001|Induction|Physician Decision|2|||
46776184|NCT00687297|82994588|FG000|Induction|Other|0|||
46776185|NCT00687297|82994589|FG001|Induction|Other|1|||
46968113|NCT02829723|83210802|FG000|Overall Study|Progressive disease|4|||
46968114|NCT02829723|83210803|FG001|Overall Study|Progressive disease|6|||
46641972|NCT04667377|82831305|FG003|Maintenance Period|Missing|0|||
46776186|NCT00684177|82994599|FG000|Overall Study|Adverse Event|4|||
46776187|NCT00684177|82994600|FG001|Overall Study|Adverse Event|3|||
46968115|NCT02829723|83210804|FG002|Overall Study|Progressive disease|3|||
46968116|NCT02829723|83210805|FG003|Overall Study|Progressive disease|3|||
46968117|NCT02829723|83210806|FG004|Overall Study|Progressive disease|3|||
46968118|NCT02829723|83210807|FG005|Overall Study|Progressive disease|5|||
46968119|NCT02829723|83210808|FG006|Overall Study|Progressive disease|4|||
46968120|NCT02829723|83210809|FG007|Overall Study|Progressive disease|6|||
46968121|NCT02829723|83210810|FG008|Overall Study|Progressive disease|8|||
46968122|NCT02829723|83210811|FG009|Overall Study|Progressive disease|4|||
46968123|NCT02829723|83210812|FG010|Overall Study|Progressive disease|9|||
46968124|NCT02829723|83210813|FG011|Overall Study|Progressive disease|0|||
46968125|NCT02829723|83210814|FG012|Overall Study|Progressive disease|3|||
46968126|NCT02829723|83210815|FG013|Overall Study|Progressive disease|4|||
46968127|NCT02829723|83210816|FG014|Overall Study|Progressive disease|2|||
46968128|NCT02829723|83210817|FG015|Overall Study|Progressive disease|4|||
46968129|NCT02829723|83210818|FG016|Overall Study|Progressive disease|5|||
46968130|NCT02829723|83210819|FG017|Overall Study|Progressive disease|3|||
46968131|NCT02829723|83210820|FG018|Overall Study|Progressive disease|4|||
46968132|NCT02829723|83210821|FG019|Overall Study|Progressive disease|4|||
46968133|NCT02829723|83210822|FG020|Overall Study|Progressive disease|7|||
46968134|NCT02829723|83210823|FG021|Overall Study|Progressive disease|6|||
46968135|NCT02829723|83210824|FG022|Overall Study|Progressive disease|3|||
46968136|NCT02829723|83210825|FG023|Overall Study|Progressive disease|3|||
46968137|NCT02829723|83210826|FG024|Overall Study|Progressive disease|3|||
46968138|NCT02829723|83210827|FG025|Overall Study|Progressive disease|16|||
46968139|NCT02829723|83210828|FG026|Overall Study|Progressive disease|10|||
46968140|NCT02829723|83210802|FG000|Overall Study|Subject/guardian decision|0|||
46968141|NCT02829723|83210803|FG001|Overall Study|Subject/guardian decision|1|||
46968142|NCT02829723|83210804|FG002|Overall Study|Subject/guardian decision|0|||
46968143|NCT02829723|83210805|FG003|Overall Study|Subject/guardian decision|1|||
46968144|NCT02829723|83210806|FG004|Overall Study|Subject/guardian decision|0|||
46968145|NCT02829723|83210807|FG005|Overall Study|Subject/guardian decision|0|||
46968146|NCT02829723|83210808|FG006|Overall Study|Subject/guardian decision|0|||
46968147|NCT02829723|83210809|FG007|Overall Study|Subject/guardian decision|1|||
46968148|NCT02829723|83210810|FG008|Overall Study|Subject/guardian decision|0|||
46968149|NCT02829723|83210811|FG009|Overall Study|Subject/guardian decision|0|||
46968150|NCT02829723|83210812|FG010|Overall Study|Subject/guardian decision|0|||
46968151|NCT02829723|83210813|FG011|Overall Study|Subject/guardian decision|0|||
46968152|NCT02829723|83210814|FG012|Overall Study|Subject/guardian decision|0|||
46968153|NCT02829723|83210815|FG013|Overall Study|Subject/guardian decision|0|||
46968154|NCT02829723|83210816|FG014|Overall Study|Subject/guardian decision|1|||
46968155|NCT02829723|83210817|FG015|Overall Study|Subject/guardian decision|0|||
46968156|NCT02829723|83210818|FG016|Overall Study|Subject/guardian decision|1|||
46968157|NCT02829723|83210819|FG017|Overall Study|Subject/guardian decision|0|||
46968158|NCT02829723|83210820|FG018|Overall Study|Subject/guardian decision|1|||
46968159|NCT02829723|83210821|FG019|Overall Study|Subject/guardian decision|0|||
46968160|NCT02829723|83210822|FG020|Overall Study|Subject/guardian decision|1|||
46968161|NCT02829723|83210823|FG021|Overall Study|Subject/guardian decision|0|||
46968162|NCT02829723|83210824|FG022|Overall Study|Subject/guardian decision|0|||
46641973|NCT04667377|82831306|FG004|Maintenance Period|Missing|0|||
46641974|NCT04667377|82831302|FG000|Maintenance Period|Other than listed above|2|||
46641975|NCT04667377|82831303|FG001|Maintenance Period|Other than listed above|0|||
46776188|NCT00684177|82994599|FG000|Overall Study|Lack of Efficacy|10|||
46776189|NCT00684177|82994600|FG001|Overall Study|Lack of Efficacy|15|||
46776190|NCT00684177|82994599|FG000|Overall Study|Protocol Violation|1|||
46776191|NCT00684177|82994600|FG001|Overall Study|Protocol Violation|0|||
46776192|NCT00684177|82994599|FG000|Overall Study|Lost to Follow-up|2|||
46776193|NCT00684177|82994600|FG001|Overall Study|Lost to Follow-up|1|||
46776194|NCT00684177|82994599|FG000|Overall Study|Physician Decision|2|||
46846928|NCT04539262|83063618|FG006|Overall Study|Withdrew Consent|0|||
46968163|NCT02829723|83210825|FG023|Overall Study|Subject/guardian decision|1|||
46968164|NCT02829723|83210826|FG024|Overall Study|Subject/guardian decision|0|||
46968165|NCT02829723|83210827|FG025|Overall Study|Subject/guardian decision|1|||
46968166|NCT02829723|83210828|FG026|Overall Study|Subject/guardian decision|1|||
46968167|NCT02829723|83210802|FG000|Overall Study|Study terminated by sponsor|0|||
46776195|NCT00684177|82994600|FG001|Overall Study|Physician Decision|0|||
46776196|NCT00684177|82994599|FG000|Overall Study|Withdrawal by Subject|1|||
46776197|NCT00684177|82994600|FG001|Overall Study|Withdrawal by Subject|2|||
46776198|NCT00684177|82994599|FG000|Overall Study|Other|1|||
46968168|NCT02829723|83210803|FG001|Overall Study|Study terminated by sponsor|0|||
46968169|NCT02829723|83210804|FG002|Overall Study|Study terminated by sponsor|0|||
46968170|NCT02829723|83210805|FG003|Overall Study|Study terminated by sponsor|0|||
46968171|NCT02829723|83210806|FG004|Overall Study|Study terminated by sponsor|0|||
46968172|NCT02829723|83210807|FG005|Overall Study|Study terminated by sponsor|0|||
46968173|NCT02829723|83210808|FG006|Overall Study|Study terminated by sponsor|0|||
46776199|NCT00684177|82994600|FG001|Overall Study|Other|2|||
46968174|NCT02829723|83210809|FG007|Overall Study|Study terminated by sponsor|0|||
46968175|NCT02829723|83210810|FG008|Overall Study|Study terminated by sponsor|0|||
46968176|NCT02829723|83210811|FG009|Overall Study|Study terminated by sponsor|0|||
46846929|NCT04539262|83063619|FG007|Overall Study|Withdrew Consent|0|||
46846930|NCT04539262|83063612|FG000|Overall Study|Randomized, Not treated|0|||
46846931|NCT04539262|83063613|FG001|Overall Study|Randomized, Not treated|1|||
46846932|NCT04539262|83063614|FG002|Overall Study|Randomized, Not treated|0|||
46846933|NCT04539262|83063615|FG003|Overall Study|Randomized, Not treated|0|||
46846934|NCT04539262|83063616|FG004|Overall Study|Randomized, Not treated|0|||
46968177|NCT02829723|83210812|FG010|Overall Study|Study terminated by sponsor|0|||
46968178|NCT02829723|83210813|FG011|Overall Study|Study terminated by sponsor|0|||
46968179|NCT02829723|83210814|FG012|Overall Study|Study terminated by sponsor|0|||
46641976|NCT04667377|82831304|FG002|Maintenance Period|Other than listed above|3|||
46641977|NCT04667377|82831305|FG003|Maintenance Period|Other than listed above|2|||
46641978|NCT04667377|82831306|FG004|Maintenance Period|Other than listed above|6|||
46641979|NCT04667377|82831302|FG000|Maintenance Period|Withdrawal by Subject|0|||
46641980|NCT04667377|82831303|FG001|Maintenance Period|Withdrawal by Subject|1|||
46641981|NCT04667377|82831304|FG002|Maintenance Period|Withdrawal by Subject|0|||
46641982|NCT04667377|82831305|FG003|Maintenance Period|Withdrawal by Subject|0|||
46641983|NCT04667377|82831306|FG004|Maintenance Period|Withdrawal by Subject|0|||
46641984|NCT04667377|82831302|FG000|Maintenance Period|Lost to Follow-up|1|||
46641985|NCT04667377|82831303|FG001|Maintenance Period|Lost to Follow-up|0|||
46641986|NCT04667377|82831304|FG002|Maintenance Period|Lost to Follow-up|1|||
46641987|NCT04667377|82831305|FG003|Maintenance Period|Lost to Follow-up|0|||
46641988|NCT04667377|82831306|FG004|Maintenance Period|Lost to Follow-up|1|||
46641989|NCT04537923|82831326|FG000|Overall Study|Adverse Event|2|||
46641990|NCT04537923|82831327|FG001|Overall Study|Adverse Event|1|||
46641991|NCT04537923|82831328|FG002|Overall Study|Adverse Event|2|||
46776200|NCT00684021|82994610|FG000|Overall Study|MRI Contraindicated|1|||
46776201|NCT00684021|82994611|FG001|Overall Study|MRI Contraindicated|1|||
46776202|NCT00684021|82994612|FG002|Overall Study|MRI Contraindicated|1|||
46776203|NCT00684021|82994613|FG003|Overall Study|MRI Contraindicated|0|||
46776204|NCT00684021|82994610|FG000|Overall Study|MRI not performed|0|||
46776205|NCT00684021|82994611|FG001|Overall Study|MRI not performed|1|||
46776206|NCT00684021|82994612|FG002|Overall Study|MRI not performed|1|||
46776207|NCT00684021|82994613|FG003|Overall Study|MRI not performed|2|||
46776208|NCT00684021|82994610|FG000|Overall Study|Death|1|||
46776209|NCT00684021|82994611|FG001|Overall Study|Death|0|||
46776210|NCT00684021|82994612|FG002|Overall Study|Death|0|||
46776211|NCT00684021|82994613|FG003|Overall Study|Death|0|||
46776212|NCT00576303|82994623|FG000|Dose Titration Period|Early withdrawal|17|||
46776213|NCT00576303|82994623|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
46776214|NCT00576303|82994623|FG000|Long Term Safety Period|Early withdrawal|16|||
46776215|NCT00686517|82994630|FG000|Treatment|Serious Adverse Event|1|||
46776216|NCT00686517|82994631|FG001|Treatment|Serious Adverse Event|2|||
46776217|NCT00686517|82994632|FG002|Treatment|Serious Adverse Event|1|||
46776218|NCT00686517|82994630|FG000|Treatment|Adverse Event|2|||
46776219|NCT00686517|82994631|FG001|Treatment|Adverse Event|0|||
46776220|NCT00686517|82994632|FG002|Treatment|Adverse Event|0|||
46776221|NCT00686517|82994630|FG000|Treatment|Poor Protocol Compliance|1|||
46776222|NCT00686517|82994631|FG001|Treatment|Poor Protocol Compliance|0|||
46776223|NCT00686517|82994632|FG002|Treatment|Poor Protocol Compliance|0|||
46776224|NCT00686517|82994630|FG000|Treatment|Protocol Violation|2|||
46776225|NCT00686517|82994631|FG001|Treatment|Protocol Violation|1|||
46776226|NCT00686517|82994632|FG002|Treatment|Protocol Violation|0|||
46776227|NCT00686205|82994642|FG000|Overall Study|Protocol Violation|127|||
46776228|NCT00686205|82994643|FG001|Overall Study|Protocol Violation|0|||
46776229|NCT00686205|82994642|FG000|Overall Study|Withdrawal by Subject|2|||
46776230|NCT00686205|82994643|FG001|Overall Study|Withdrawal by Subject|0|||
46776231|NCT00686205|82994642|FG000|Overall Study|Specimen handling procedure altered|5878|||
46776232|NCT00686205|82994643|FG001|Overall Study|Specimen handling procedure altered|0|||
46641992|NCT04537923|82831329|FG003|Overall Study|Adverse Event|4|||
46776233|NCT00686205|82994642|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
46776234|NCT00686205|82994643|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
46776235|NCT00571701|82994651|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
46776236|NCT00571701|82994652|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
46776237|NCT00571701|82994651|FG000|First Intervention 12 Months|Death|1|||
46776238|NCT00571701|82994652|FG001|First Intervention 12 Months|Death|0|||
46776239|NCT00571701|82994651|FG000|Second Intervention 12 Months|Adverse Event|0|||
46776240|NCT00571701|82994652|FG001|Second Intervention 12 Months|Adverse Event|1|||
46776241|NCT00571701|82994651|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
46776242|NCT00571701|82994652|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
46776243|NCT00686127|82994678|FG000|Overall Study|Withdrawal by Subject|14|||
46968180|NCT02829723|83210815|FG013|Overall Study|Study terminated by sponsor|0|||
46641993|NCT04537923|82831326|FG000|Overall Study|Death|3|||
46641994|NCT04537923|82831327|FG001|Overall Study|Death|3|||
46776244|NCT00686127|82994679|FG001|Overall Study|Withdrawal by Subject|6|||
46776245|NCT00718718|82994692|FG000|Prior to Week 12|Adverse Event|0|||
46776246|NCT00718718|82994693|FG001|Prior to Week 12|Adverse Event|0|||
46776247|NCT00718718|82994694|FG002|Prior to Week 12|Adverse Event|0|||
46968181|NCT02829723|83210816|FG014|Overall Study|Study terminated by sponsor|0|||
46968182|NCT02829723|83210817|FG015|Overall Study|Study terminated by sponsor|0|||
46968183|NCT02829723|83210818|FG016|Overall Study|Study terminated by sponsor|0|||
46968184|NCT02829723|83210819|FG017|Overall Study|Study terminated by sponsor|0|||
46968185|NCT02829723|83210820|FG018|Overall Study|Study terminated by sponsor|0|||
46968186|NCT02829723|83210821|FG019|Overall Study|Study terminated by sponsor|0|||
46968187|NCT02829723|83210822|FG020|Overall Study|Study terminated by sponsor|0|||
46968188|NCT02829723|83210823|FG021|Overall Study|Study terminated by sponsor|1|||
46968189|NCT02829723|83210824|FG022|Overall Study|Study terminated by sponsor|0|||
46968190|NCT02829723|83210825|FG023|Overall Study|Study terminated by sponsor|0|||
46641995|NCT04537923|82831328|FG002|Overall Study|Death|1|||
46776248|NCT00718718|82994695|FG003|Prior to Week 12|Adverse Event|0|||
46776249|NCT00718718|82994696|FG004|Prior to Week 12|Adverse Event|0|||
46776250|NCT00718718|82994697|FG005|Prior to Week 12|Adverse Event|0|||
46776251|NCT00718718|82994698|FG006|Prior to Week 12|Adverse Event|0|||
46776252|NCT00718718|82994699|FG007|Prior to Week 12|Adverse Event|1|||
46776253|NCT00718718|82994700|FG008|Prior to Week 12|Adverse Event|1|||
46776254|NCT00718718|82994701|FG009|Prior to Week 12|Adverse Event|0|||
46776255|NCT00718718|82994692|FG000|Prior to Week 12|Withdrawal by Subject|0|||
46776256|NCT00718718|82994693|FG001|Prior to Week 12|Withdrawal by Subject|0|||
46776257|NCT00718718|82994694|FG002|Prior to Week 12|Withdrawal by Subject|0|||
46776258|NCT00718718|82994695|FG003|Prior to Week 12|Withdrawal by Subject|0|||
46776259|NCT00718718|82994696|FG004|Prior to Week 12|Withdrawal by Subject|3|||
46776260|NCT00718718|82994697|FG005|Prior to Week 12|Withdrawal by Subject|0|||
46641996|NCT04537923|82831329|FG003|Overall Study|Death|11|||
46641997|NCT04537923|82831326|FG000|Overall Study|Lost to Follow-up|1|||
46641998|NCT04537923|82831327|FG001|Overall Study|Lost to Follow-up|2|||
46641999|NCT04537923|82831328|FG002|Overall Study|Lost to Follow-up|1|||
46642000|NCT04537923|82831329|FG003|Overall Study|Lost to Follow-up|6|||
46642001|NCT04537923|82831326|FG000|Overall Study|Physician Decision|1|||
46642002|NCT04537923|82831327|FG001|Overall Study|Physician Decision|0|||
46642003|NCT04537923|82831328|FG002|Overall Study|Physician Decision|2|||
46642004|NCT04537923|82831329|FG003|Overall Study|Physician Decision|5|||
46642005|NCT04537923|82831326|FG000|Overall Study|Pregnancy|1|||
46642006|NCT04537923|82831327|FG001|Overall Study|Pregnancy|0|||
46642007|NCT04537923|82831328|FG002|Overall Study|Pregnancy|0|||
46642008|NCT04537923|82831329|FG003|Overall Study|Pregnancy|0|||
46642009|NCT04537923|82831326|FG000|Overall Study|Withdrawal by Subject|4|||
46642010|NCT04537923|82831327|FG001|Overall Study|Withdrawal by Subject|4|||
46642011|NCT04537923|82831328|FG002|Overall Study|Withdrawal by Subject|4|||
46776261|NCT00718718|82994698|FG006|Prior to Week 12|Withdrawal by Subject|1|||
46776262|NCT00718718|82994699|FG007|Prior to Week 12|Withdrawal by Subject|1|||
46776263|NCT00718718|82994700|FG008|Prior to Week 12|Withdrawal by Subject|1|||
46776264|NCT00718718|82994701|FG009|Prior to Week 12|Withdrawal by Subject|0|||
46776265|NCT00718718|82994692|FG000|Prior to Week 12|Other|1|||
46776266|NCT00718718|82994693|FG001|Prior to Week 12|Other|0|||
46776267|NCT00718718|82994694|FG002|Prior to Week 12|Other|1|||
46776268|NCT00718718|82994695|FG003|Prior to Week 12|Other|0|||
46968191|NCT02829723|83210826|FG024|Overall Study|Study terminated by sponsor|0|||
46968192|NCT02829723|83210827|FG025|Overall Study|Study terminated by sponsor|0|||
46968193|NCT02829723|83210828|FG026|Overall Study|Study terminated by sponsor|0|||
46642012|NCT04537923|82831329|FG003|Overall Study|Withdrawal by Subject|58|||
46642013|NCT04537923|82831326|FG000|Overall Study|Missed study visits|2|||
46776269|NCT00718718|82994696|FG004|Prior to Week 12|Other|0|||
46776270|NCT00718718|82994697|FG005|Prior to Week 12|Other|0|||
46776271|NCT00718718|82994698|FG006|Prior to Week 12|Other|0|||
46642014|NCT04537923|82831327|FG001|Overall Study|Missed study visits|0|||
46642015|NCT04537923|82831328|FG002|Overall Study|Missed study visits|0|||
46642016|NCT04537923|82831329|FG003|Overall Study|Missed study visits|3|||
46642017|NCT04537923|82831326|FG000|Overall Study|Sponsor's decision|0|||
46642018|NCT04537923|82831327|FG001|Overall Study|Sponsor's decision|0|||
46776272|NCT00718718|82994699|FG007|Prior to Week 12|Other|0|||
46968194|NCT02815579|83210947|FG000|Overall Study|Non-payment of loan down-payment|16|||
46968195|NCT02815579|83210948|FG001|Overall Study|Non-payment of loan down-payment|0|||
46968196|NCT02815579|83210947|FG000|Overall Study|Withdrawal by Subject|7|||
46968197|NCT02815579|83210948|FG001|Overall Study|Withdrawal by Subject|1|||
46968198|NCT02815579|83210947|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
46968199|NCT02815579|83210948|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
46968200|NCT02815579|83210947|FG000|Overall Study|Lost to Follow-up|7|||
46968201|NCT02815579|83210948|FG001|Overall Study|Lost to Follow-up|4|||
46968202|NCT02815579|83210947|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
46968203|NCT02815579|83210948|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
46968204|NCT02815579|83210947|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
47073307|NCT01673178|83361715|FG003|Overall Study|Lost to Follow-up|0|||
47073308|NCT01673178|83361716|FG004|Overall Study|Lost to Follow-up|0|||
47073309|NCT01673178|83361712|FG000|Overall Study|Withdrawal by Subject|0|||
47073310|NCT01673178|83361713|FG001|Overall Study|Withdrawal by Subject|0|||
47073311|NCT01673178|83361714|FG002|Overall Study|Withdrawal by Subject|1|||
47073312|NCT01673178|83361715|FG003|Overall Study|Withdrawal by Subject|4|||
47073313|NCT01673178|83361716|FG004|Overall Study|Withdrawal by Subject|2|||
47073314|NCT01673178|83361712|FG000|Overall Study|Protocol Violation|1|||
46642019|NCT04537923|82831328|FG002|Overall Study|Sponsor's decision|1|||
46642020|NCT04537923|82831329|FG003|Overall Study|Sponsor's decision|1|||
46642021|NCT04537923|82831326|FG000|Overall Study|Safety reasons|1|||
46776273|NCT00718718|82994700|FG008|Prior to Week 12|Other|0|||
46776274|NCT00718718|82994701|FG009|Prior to Week 12|Other|0|||
46776275|NCT00718718|82994692|FG000|Week 12 to End of Study|Adverse Event|0|||
46776276|NCT00718718|82994693|FG001|Week 12 to End of Study|Adverse Event|0|||
46776277|NCT00718718|82994694|FG002|Week 12 to End of Study|Adverse Event|0|||
46776278|NCT00718718|82994695|FG003|Week 12 to End of Study|Adverse Event|0|||
46776279|NCT00718718|82994696|FG004|Week 12 to End of Study|Adverse Event|0|||
46776280|NCT00718718|82994697|FG005|Week 12 to End of Study|Adverse Event|0|||
46776281|NCT00718718|82994698|FG006|Week 12 to End of Study|Adverse Event|0|||
46776282|NCT00718718|82994699|FG007|Week 12 to End of Study|Adverse Event|1|||
46776283|NCT00718718|82994700|FG008|Week 12 to End of Study|Adverse Event|0|||
46776284|NCT00718718|82994701|FG009|Week 12 to End of Study|Adverse Event|0|||
46776285|NCT00718718|82994692|FG000|Week 12 to End of Study|Death|0|||
46776286|NCT00718718|82994693|FG001|Week 12 to End of Study|Death|0|||
46776287|NCT00718718|82994694|FG002|Week 12 to End of Study|Death|0|||
46776288|NCT00718718|82994695|FG003|Week 12 to End of Study|Death|0|||
46776289|NCT00718718|82994696|FG004|Week 12 to End of Study|Death|0|||
46776290|NCT00718718|82994697|FG005|Week 12 to End of Study|Death|1|||
46776291|NCT00718718|82994698|FG006|Week 12 to End of Study|Death|0|||
46776292|NCT00718718|82994699|FG007|Week 12 to End of Study|Death|0|||
46776293|NCT00718718|82994700|FG008|Week 12 to End of Study|Death|0|||
46776294|NCT00718718|82994701|FG009|Week 12 to End of Study|Death|0|||
46776295|NCT00718718|82994692|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
46776296|NCT00718718|82994693|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
46776297|NCT00718718|82994694|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
46776298|NCT00718718|82994695|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
46776299|NCT00718718|82994696|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
46776300|NCT00718718|82994697|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
46776301|NCT00718718|82994698|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
46642022|NCT04537923|82831327|FG001|Overall Study|Safety reasons|0|||
46642023|NCT04537923|82831328|FG002|Overall Study|Safety reasons|0|||
46776302|NCT00718718|82994699|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
46776303|NCT00718718|82994700|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
46776304|NCT00718718|82994701|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
46776305|NCT00718718|82994692|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
46776306|NCT00718718|82994693|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
46776307|NCT00718718|82994694|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
46776308|NCT00718718|82994695|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
46776309|NCT00718718|82994696|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
46776310|NCT00718718|82994697|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
46776311|NCT00718718|82994698|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
46776312|NCT00718718|82994699|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
47073315|NCT01673178|83361713|FG001|Overall Study|Protocol Violation|1|||
46776313|NCT00718718|82994700|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
46776314|NCT00718718|82994701|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
46776315|NCT00718718|82994692|FG000|Week 12 to End of Study|Other|0|||
47073316|NCT01673178|83361714|FG002|Overall Study|Protocol Violation|0|||
46642024|NCT04537923|82831329|FG003|Overall Study|Safety reasons|0|||
46642025|NCT04160468|82831352|FG000|Overall Study|Lost to Follow-up|19|||
46642026|NCT04160468|82831353|FG001|Overall Study|Lost to Follow-up|4|||
46642027|NCT04160468|82831352|FG000|Overall Study|Randomized but not dosed|6|||
46642028|NCT04160468|82831353|FG001|Overall Study|Randomized but not dosed|0|||
46642029|NCT04160468|82831352|FG000|Overall Study|Withdrawal by Subject|4|||
46642030|NCT04160468|82831353|FG001|Overall Study|Withdrawal by Subject|1|||
46642031|NCT04160468|82831352|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
46846935|NCT04539262|83063617|FG005|Overall Study|Randomized, Not treated|0|||
46846936|NCT04539262|83063618|FG006|Overall Study|Randomized, Not treated|1|||
46846937|NCT04539262|83063619|FG007|Overall Study|Randomized, Not treated|0|||
46846938|NCT03702010|83063642|FG000|Follow-up (30days)|Lack of Efficacy|2|||
46846939|NCT03702010|83063643|FG001|Follow-up (30days)|Lack of Efficacy|2|||
46846940|NCT04538170|83063657|FG000|Overall Study|Withdrawal by Subject|104|||
46846941|NCT04538170|83063658|FG001|Overall Study|Withdrawal by Subject|210|||
46846942|NCT04537234|83063670|FG000|Overall Study|Withdrawal by Subject|2|||
46846943|NCT04537234|83063671|FG001|Overall Study|Withdrawal by Subject|0|||
46846944|NCT04537078|83063679|FG000|Overall Study|Protocol Violation|3|||
46968205|NCT02815579|83210948|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
46642032|NCT04160468|82831353|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
46846945|NCT04537078|83063680|FG001|Overall Study|Protocol Violation|2|||
46846946|NCT04537078|83063679|FG000|Overall Study|Lost to Follow-up|1|||
46968206|NCT02815579|83210947|FG000|Overall Study|Death|5|||
46968207|NCT02815579|83210948|FG001|Overall Study|Death|4|||
46968208|NCT02815579|83210947|FG000|Overall Study|Imprisoned|0|||
46968209|NCT02815579|83210948|FG001|Overall Study|Imprisoned|2|||
46968210|NCT02815579|83210947|FG000|Overall Study|Did not meet enrollment criteria|0|||
46968211|NCT02815579|83210948|FG001|Overall Study|Did not meet enrollment criteria|1|||
46642033|NCT04160468|82831352|FG000|Overall Study|Participant incarcerated|1|||
46642034|NCT04160468|82831353|FG001|Overall Study|Participant incarcerated|0|||
46642035|NCT03761056|82831372|FG000|Overall Study|Still on Study|34|||
46642036|NCT03761056|82831372|FG000|Overall Study|Death|6|||
46642037|NCT03761056|82831372|FG000|Overall Study|Investigator Decision|1|||
46642038|NCT03761056|82831372|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
46642039|NCT03276572|82831394|FG000|Overall Study|In follow-up|0|||
46642040|NCT03276572|82831395|FG001|Overall Study|In follow-up|0|||
46642041|NCT03276572|82831396|FG002|Overall Study|In follow-up|0|||
46642042|NCT03276572|82831397|FG003|Overall Study|In follow-up|0|||
46642043|NCT03276572|82831398|FG004|Overall Study|In follow-up|0|||
46642044|NCT03276572|82831399|FG005|Overall Study|In follow-up|1|||
46642045|NCT03276572|82831400|FG006|Overall Study|In follow-up|1|||
46642046|NCT03276572|82831394|FG000|Overall Study|Lost to Follow-up|0|||
46642047|NCT03276572|82831395|FG001|Overall Study|Lost to Follow-up|0|||
46642048|NCT03276572|82831396|FG002|Overall Study|Lost to Follow-up|0|||
46642049|NCT03276572|82831397|FG003|Overall Study|Lost to Follow-up|0|||
46642050|NCT03276572|82831398|FG004|Overall Study|Lost to Follow-up|0|||
46642051|NCT03276572|82831399|FG005|Overall Study|Lost to Follow-up|0|||
46642052|NCT03276572|82831400|FG006|Overall Study|Lost to Follow-up|1|||
46642053|NCT02840877|82831426|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
46642054|NCT02840877|82831426|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
46642055|NCT02840877|82831426|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
46642056|NCT02840877|82831426|FG000|Baseline to 12 Weeks|Death|1|||
46642057|NCT02840877|82831426|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
46642058|NCT02840877|82831426|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
46642059|NCT02840877|82831426|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
46642060|NCT02840877|82831426|FG000|12 Weeks to 6 Months|Treatment failure|1|||
46642061|NCT02840877|82831426|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
46642062|NCT02840877|82831426|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
46642063|NCT02840877|82831426|FG000|12 Weeks to 6 Months|Death|1|||
46642064|NCT02840877|82831426|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
46642065|NCT02840877|82831426|FG000|6 Months to 18 Months|Treatment failure|7|||
46642066|NCT02840877|82831426|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
46642067|NCT02840877|82831426|FG000|6 Months to 18 Months|Moved/transferred out|6|||
46642068|NCT02840877|82831426|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
46642069|NCT02840877|82831426|FG000|6 Months to 18 Months|Death|4|||
46776316|NCT00718718|82994693|FG001|Week 12 to End of Study|Other|1|||
46776317|NCT00718718|82994694|FG002|Week 12 to End of Study|Other|0|||
46776318|NCT00718718|82994695|FG003|Week 12 to End of Study|Other|1|||
46776319|NCT00718718|82994696|FG004|Week 12 to End of Study|Other|0|||
46776320|NCT00718718|82994697|FG005|Week 12 to End of Study|Other|0|||
46776321|NCT00718718|82994698|FG006|Week 12 to End of Study|Other|1|||
46776322|NCT00718718|82994699|FG007|Week 12 to End of Study|Other|0|||
46776323|NCT00718718|82994700|FG008|Week 12 to End of Study|Other|0|||
46776324|NCT00718718|82994701|FG009|Week 12 to End of Study|Other|0|||
46776325|NCT00683787|82994730|FG000|Overall Study|Progression|3|||
46968212|NCT02722616|83210957|FG000|Overall Study|Sponsor closed study after one month|2|||
46968213|NCT02722616|83210958|FG001|Overall Study|Sponsor closed study after one month|0|||
46968214|NCT02722616|83210959|FG002|Overall Study|Sponsor closed study after one month|0|||
46968215|NCT02658487|83210967|FG000|Overall Study|Death|2|||
46968216|NCT02658487|83210967|FG000|Overall Study|Disease progression|10|||
46968217|NCT02658487|83210967|FG000|Overall Study|Alternative therapy|1|||
46968218|NCT02658487|83210967|FG000|Overall Study|Adverse Event|1|||
46968219|NCT02658487|83210967|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
46968220|NCT02658487|83210967|FG000|Overall Study|Refractory AML|1|||
46968221|NCT02553460|83210981|FG000|Overall Study|Death|3|||
46968222|NCT02553460|83210981|FG000|Overall Study|Withdrawal by Subject|1|||
46968223|NCT02553460|83210981|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
46968224|NCT02553460|83210981|FG000|Overall Study|Relapse or Transplant|14|||
46968225|NCT02553460|83210981|FG000|Overall Study|No response to treatment|2|||
46968226|NCT02553460|83210981|FG000|Overall Study|Still on therapy|7|||
46968227|NCT02553460|83210981|FG000|Overall Study|CAR T cells|1|||
46968228|NCT02453282|83210988|FG000|Overall Study|Death|275|||
46968229|NCT02453282|83210989|FG001|Overall Study|Death|277|||
46968230|NCT02453282|83210990|FG002|Overall Study|Death|296|||
46968231|NCT02453282|83210988|FG000|Overall Study|Lost to Follow-up|1|||
46968232|NCT02453282|83210989|FG001|Overall Study|Lost to Follow-up|0|||
46968233|NCT02453282|83210990|FG002|Overall Study|Lost to Follow-up|2|||
46968234|NCT02453282|83210988|FG000|Overall Study|Withdrawal by Subject|12|||
46968235|NCT02453282|83210989|FG001|Overall Study|Withdrawal by Subject|10|||
46968236|NCT02453282|83210990|FG002|Overall Study|Withdrawal by Subject|11|||
46968237|NCT02453282|83210988|FG000|Overall Study|Participants ongoing at data cut-off|85|||
46968238|NCT02453282|83210989|FG001|Overall Study|Participants ongoing at data cut-off|84|||
46968239|NCT02453282|83210990|FG002|Overall Study|Participants ongoing at data cut-off|62|||
46968240|NCT02453282|83210988|FG000|Overall Study|Other|1|||
46968241|NCT02453282|83210989|FG001|Overall Study|Other|1|||
46968242|NCT02453282|83210990|FG002|Overall Study|Other|1|||
46968243|NCT02296125|83211002|FG000|Overall Study|Withdrawal by Subject|18|||
46968244|NCT02296125|83211003|FG001|Overall Study|Withdrawal by Subject|8|||
46968245|NCT02296125|83211004|FG002|Overall Study|Withdrawal by Subject|6|||
46968246|NCT02296125|83211005|FG003|Overall Study|Withdrawal by Subject|2|||
46968247|NCT02296125|83211002|FG000|Overall Study|Adverse Event|41|||
46968248|NCT02296125|83211003|FG001|Overall Study|Adverse Event|52|||
46968249|NCT02296125|83211004|FG002|Overall Study|Adverse Event|9|||
46968250|NCT02296125|83211005|FG003|Overall Study|Adverse Event|4|||
46968251|NCT02296125|83211002|FG000|Overall Study|Severe non-compliance to protocol|0|||
46968252|NCT02296125|83211003|FG001|Overall Study|Severe non-compliance to protocol|1|||
46968253|NCT02296125|83211004|FG002|Overall Study|Severe non-compliance to protocol|0|||
46968254|NCT02296125|83211005|FG003|Overall Study|Severe non-compliance to protocol|0|||
46968255|NCT02296125|83211002|FG000|Overall Study|Condition under investigation worsened|153|||
46968256|NCT02296125|83211003|FG001|Overall Study|Condition under investigation worsened|199|||
46968257|NCT02296125|83211004|FG002|Overall Study|Condition under investigation worsened|39|||
46968258|NCT02296125|83211005|FG003|Overall Study|Condition under investigation worsened|56|||
46968259|NCT02296125|83211002|FG000|Overall Study|Any reason not specifically recorded|6|||
46968260|NCT02296125|83211003|FG001|Overall Study|Any reason not specifically recorded|4|||
46968261|NCT02296125|83211004|FG002|Overall Study|Any reason not specifically recorded|2|||
46968262|NCT02296125|83211005|FG003|Overall Study|Any reason not specifically recorded|0|||
46968263|NCT02286089|83211020|FG000|Overall Study|Ongoing in Study|1|||
46846947|NCT04537078|83063680|FG001|Overall Study|Lost to Follow-up|0|||
46846948|NCT04537078|83063679|FG000|Overall Study|Withdrawal by Subject|0|||
46846949|NCT04537078|83063680|FG001|Overall Study|Withdrawal by Subject|1|||
46846950|NCT04532164|83063693|FG000|Overall Study|Adverse Event|1|||
46846951|NCT04532164|83063693|FG000|Overall Study|Protocol Violation|5|||
46846952|NCT04532164|83063693|FG000|Overall Study|Lost to Follow-up|1|||
46846953|NCT04532164|83063693|FG000|Overall Study|Found to be Ineligible|3|||
46968264|NCT02286089|83211021|FG001|Overall Study|Ongoing in Study|1|||
46968265|NCT02286089|83211022|FG002|Overall Study|Ongoing in Study|4|||
46968266|NCT02286089|83211023|FG003|Overall Study|Ongoing in Study|10|||
46968267|NCT02286089|83211020|FG000|Overall Study|Withdrawal by Subject|0|||
46968268|NCT02286089|83211021|FG001|Overall Study|Withdrawal by Subject|0|||
46968269|NCT02286089|83211022|FG002|Overall Study|Withdrawal by Subject|2|||
46968270|NCT02286089|83211023|FG003|Overall Study|Withdrawal by Subject|2|||
46968271|NCT02087423|83211036|FG000|Overall Study|Withdrawal by Subject|20|||
46968272|NCT02087423|83211037|FG001|Overall Study|Withdrawal by Subject|20|||
46968273|NCT02087423|83211038|FG002|Overall Study|Withdrawal by Subject|3|||
46968274|NCT02087423|83211036|FG000|Overall Study|Death|68|||
46968275|NCT02087423|83211037|FG001|Overall Study|Death|207|||
46968276|NCT02087423|83211038|FG002|Overall Study|Death|40|||
46968277|NCT02087423|83211036|FG000|Overall Study|Lost to Follow-up|0|||
46968278|NCT02087423|83211037|FG001|Overall Study|Lost to Follow-up|2|||
46968279|NCT02087423|83211038|FG002|Overall Study|Lost to Follow-up|0|||
46968280|NCT02087423|83211036|FG000|Overall Study|Terminated from study at final DCO|23|||
46642070|NCT02840877|82831426|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
46846954|NCT04532164|83063693|FG000|Overall Study|Withdrawal by Subject|14|||
46846955|NCT00116688|83063700|FG000|Overall Study|Protocol deviation|1|||
46846956|NCT00116688|83063701|FG001|Overall Study|Protocol deviation|0|||
46846957|NCT00116688|83063700|FG000|Overall Study|Noncompliance|3|||
46846958|NCT00116688|83063701|FG001|Overall Study|Noncompliance|1|||
46846959|NCT00116688|83063700|FG000|Overall Study|Adverse Event|11|||
46846960|NCT00116688|83063701|FG001|Overall Study|Adverse Event|0|||
46846961|NCT00116688|83063700|FG000|Overall Study|Withdrawal by Subject|26|||
46846962|NCT00116688|83063701|FG001|Overall Study|Withdrawal by Subject|2|||
46846963|NCT00116688|83063700|FG000|Overall Study|Requirement for alternative therapy|11|||
46846964|NCT00116688|83063701|FG001|Overall Study|Requirement for alternative therapy|1|||
46846965|NCT00116688|83063700|FG000|Overall Study|Physician Decision|7|||
46846966|NCT00116688|83063701|FG001|Overall Study|Physician Decision|0|||
46846967|NCT00116688|83063700|FG000|Overall Study|Lost to Follow-up|3|||
46846968|NCT00116688|83063701|FG001|Overall Study|Lost to Follow-up|0|||
46846969|NCT00116688|83063700|FG000|Overall Study|Death|15|||
46846970|NCT00116688|83063701|FG001|Overall Study|Death|0|||
46846971|NCT00116688|83063700|FG000|Overall Study|Protocol-specified criteria|3|||
46846972|NCT00116688|83063701|FG001|Overall Study|Protocol-specified criteria|0|||
46846973|NCT00116688|83063700|FG000|Overall Study|Pregnancy|1|||
46846974|NCT00116688|83063701|FG001|Overall Study|Pregnancy|0|||
46846975|NCT00116688|83063700|FG000|Overall Study|Other|11|||
46846976|NCT00116688|83063701|FG001|Overall Study|Other|0|||
46776326|NCT00683787|82994731|FG001|Overall Study|Progression|3|||
46776327|NCT00683787|82994732|FG002|Overall Study|Progression|0|||
46776328|NCT00683787|82994730|FG000|Overall Study|Adverse Event|0|||
46776329|NCT00683787|82994731|FG001|Overall Study|Adverse Event|0|||
46776330|NCT00683787|82994732|FG002|Overall Study|Adverse Event|2|||
46776331|NCT00723008|82994742|FG000|Enrollment|Lost to Follow-up|1|||
46776332|NCT00723008|82994743|FG001|Enrollment|Lost to Follow-up|0|||
46776333|NCT00723008|82994742|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
46776334|NCT00723008|82994743|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
46776335|NCT00723008|82994742|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
46776336|NCT00723008|82994743|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
46776337|NCT00723008|82994742|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
46776338|NCT00723008|82994743|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
46776339|NCT00723008|82994742|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
46776340|NCT00723008|82994743|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
46776341|NCT00723008|82994742|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
46776342|NCT00723008|82994743|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
46776343|NCT00718640|82994757|FG000|Overall Study|Adverse Event|4|||
46776344|NCT00718640|82994757|FG000|Overall Study|Death|1|||
46776345|NCT00718640|82994757|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
46776346|NCT00715910|82994765|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
46776347|NCT00715910|82994766|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
46776348|NCT00715910|82994767|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
46776349|NCT00715910|82994768|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
46776350|NCT00715910|82994769|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
46776351|NCT00715910|82994770|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
46776352|NCT00715910|82994765|FG000|Booster and ESFU Phase|Other|0|||
46776353|NCT00715910|82994766|FG001|Booster and ESFU Phase|Other|0|||
46846977|NCT04531540|83063707|FG000|Overall Study|Adverse Event|1|||
46846978|NCT04531540|83063707|FG000|Overall Study|Protocol Violation|3|||
46846979|NCT04531540|83063707|FG000|Overall Study|Withdrawal by Subject|4|||
46846980|NCT04531540|83063707|FG000|Overall Study|Found to be Ineligible|1|||
46846981|NCT04799782|83063711|FG000|Washout|Physician Decision|2|||
46846982|NCT04799782|83063712|FG001|Washout|Physician Decision|0|||
46846983|NCT04799782|83063711|FG000|Washout|Withdrawal by Subject|0|||
46846984|NCT04799782|83063712|FG001|Washout|Withdrawal by Subject|2|||
46642071|NCT02840877|82831426|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
46642072|NCT02840877|82831426|FG000|6 Months to 18 Months|Still in study.|14|||
46642073|NCT02694185|82831432|FG000|Overall Study|Withdrawal by Subject|45|||
46846985|NCT04799782|83063711|FG000|Washout|Lost to Follow-up|0|||
46846986|NCT04799782|83063712|FG001|Washout|Lost to Follow-up|1|||
46846987|NCT03697252|83063720|FG000|Overall Study|Adverse Event|3|||
46846988|NCT03697252|83063721|FG001|Overall Study|Adverse Event|2|||
46642074|NCT02694185|82831433|FG001|Overall Study|Withdrawal by Subject|0|||
46776354|NCT00715910|82994767|FG002|Booster and ESFU Phase|Other|0|||
46846989|NCT03697252|83063720|FG000|Overall Study|Withdrawal by Subject|14|||
46846990|NCT03697252|83063721|FG001|Overall Study|Withdrawal by Subject|14|||
46846991|NCT03697252|83063720|FG000|Overall Study|Lost to Follow-up|0|||
46776355|NCT00715910|82994768|FG003|Booster and ESFU Phase|Other|5|||
46776356|NCT00715910|82994769|FG004|Booster and ESFU Phase|Other|1|||
46776357|NCT00715910|82994770|FG005|Booster and ESFU Phase|Other|0|||
46776358|NCT00715676|82994789|FG000|Overall Study|Adverse Event|3|||
46776359|NCT00715676|82994790|FG001|Overall Study|Adverse Event|5|||
46776360|NCT00715676|82994791|FG002|Overall Study|Adverse Event|21|||
46776361|NCT00715676|82994789|FG000|Overall Study|Withdrawal by Subject|1|||
46776362|NCT00715676|82994790|FG001|Overall Study|Withdrawal by Subject|3|||
46776363|NCT00715676|82994791|FG002|Overall Study|Withdrawal by Subject|8|||
46776364|NCT00715676|82994789|FG000|Overall Study|Lost to Follow-up|1|||
46776365|NCT00715676|82994790|FG001|Overall Study|Lost to Follow-up|2|||
46776366|NCT00715676|82994791|FG002|Overall Study|Lost to Follow-up|1|||
46846992|NCT03697252|83063721|FG001|Overall Study|Lost to Follow-up|1|||
46846993|NCT03697252|83063720|FG000|Overall Study|Physician Decision|1|||
46846994|NCT03697252|83063721|FG001|Overall Study|Physician Decision|1|||
46846995|NCT03697252|83063720|FG000|Overall Study|Other|0|||
46846996|NCT03697252|83063721|FG001|Overall Study|Other|1|||
46846997|NCT03701074|83063729|FG000|Overall Study|Physician Decision|1|||
46846998|NCT03701074|83063730|FG001|Overall Study|Physician Decision|0|||
46846999|NCT04728802|83063738|FG000|Overall Study|Withdrawal by Subject|4|||
46847000|NCT04728802|83063739|FG001|Overall Study|Withdrawal by Subject|20|||
46847001|NCT04728802|83063738|FG000|Overall Study|Physician Decision|7|||
46847002|NCT04728802|83063739|FG001|Overall Study|Physician Decision|7|||
46847003|NCT04728802|83063738|FG000|Overall Study|Protocol Violation|10|||
46847004|NCT04728802|83063739|FG001|Overall Study|Protocol Violation|4|||
46847005|NCT04728802|83063738|FG000|Overall Study|Transfer|1|||
46642075|NCT02684903|82831441|FG000|Overall Study|COVID-19 shutdown of lab|4|||
46642076|NCT02684903|82831442|FG001|Overall Study|COVID-19 shutdown of lab|6|||
46642077|NCT02684903|82831441|FG000|Overall Study|Lost to Follow-up|31|||
46642078|NCT02684903|82831442|FG001|Overall Study|Lost to Follow-up|41|||
46642079|NCT02621424|82831457|FG000|Overall Study|Withdrawal by Subject|1|||
46642080|NCT02621424|82831458|FG001|Overall Study|Withdrawal by Subject|2|||
46642081|NCT02616185|82831473|FG000|Overall Study|Death|0|||
46642082|NCT02616185|82831474|FG001|Overall Study|Death|0|||
46642083|NCT02616185|82831475|FG002|Overall Study|Death|0|||
46776367|NCT00715676|82994789|FG000|Overall Study|Terminated by Sponsor|1|||
46776368|NCT00715676|82994790|FG001|Overall Study|Terminated by Sponsor|0|||
46847006|NCT04728802|83063739|FG001|Overall Study|Transfer|0|||
46847007|NCT04728802|83063738|FG000|Overall Study|Death|4|||
46847008|NCT04728802|83063739|FG001|Overall Study|Death|5|||
46847009|NCT04728802|83063738|FG000|Overall Study|Other|3|||
46847010|NCT04728802|83063739|FG001|Overall Study|Other|0|||
46847011|NCT04715932|83063747|FG000|Overall Study|Lost to Follow-up|1|||
46847012|NCT04715932|83063748|FG001|Overall Study|Lost to Follow-up|0|||
46847013|NCT00130832|83063756|FG000|Overall Study|Adverse Event|1|||
46847014|NCT00130832|83063757|FG001|Overall Study|Adverse Event|1|||
46847015|NCT00130832|83063756|FG000|Overall Study|Lost to Follow-up|1|||
46847016|NCT00130832|83063757|FG001|Overall Study|Lost to Follow-up|2|||
46847017|NCT00130832|83063756|FG000|Overall Study|Protocol Violation|6|||
46968281|NCT02087423|83211037|FG001|Overall Study|Terminated from study at final DCO|36|||
46968282|NCT02087423|83211038|FG002|Overall Study|Terminated from study at final DCO|25|||
47073317|NCT01673178|83361715|FG003|Overall Study|Protocol Violation|1|||
46642084|NCT02616185|82831476|FG003|Overall Study|Death|1|||
46847018|NCT00130832|83063757|FG001|Overall Study|Protocol Violation|8|||
46642085|NCT02616185|82831477|FG004|Overall Study|Death|2|||
46642086|NCT02616185|82831478|FG005|Overall Study|Death|0|||
46642087|NCT02616185|82831479|FG006|Overall Study|Death|0|||
46642088|NCT02616185|82831480|FG007|Overall Study|Death|2|||
46847019|NCT00130832|83063756|FG000|Overall Study|Withdrawal by Subject|6|||
46847020|NCT00130832|83063757|FG001|Overall Study|Withdrawal by Subject|1|||
46847021|NCT00130832|83063756|FG000|Overall Study|Moved|2|||
46847022|NCT00130832|83063757|FG001|Overall Study|Moved|2|||
46847023|NCT00130832|83063756|FG000|Overall Study|Other|0|||
46847024|NCT00130832|83063757|FG001|Overall Study|Other|3|||
46847025|NCT00096018|83063765|FG000|Overall Study|Became Ineligible (not treated)|0|||
46847026|NCT00096018|83063766|FG001|Overall Study|Became Ineligible (not treated)|3|||
46847027|NCT00096018|83063765|FG000|Overall Study|Miscellaneous (not treated)|0|||
46847028|NCT00096018|83063766|FG001|Overall Study|Miscellaneous (not treated)|2|||
46847029|NCT00096018|83063765|FG000|Overall Study|Adverse Event|0|||
46847030|NCT00096018|83063766|FG001|Overall Study|Adverse Event|5|||
46847031|NCT00096018|83063765|FG000|Overall Study|Death|0|||
46847032|NCT00096018|83063766|FG001|Overall Study|Death|1|||
46847033|NCT00096018|83063765|FG000|Overall Study|Withdrawal by Subject|0|||
46847034|NCT00096018|83063766|FG001|Overall Study|Withdrawal by Subject|2|||
47073318|NCT01673178|83361716|FG004|Overall Study|Protocol Violation|0|||
47073319|NCT01673178|83361712|FG000|Overall Study|Adverse Event|1|||
46642089|NCT02616185|82831481|FG008|Overall Study|Death|1|||
46776369|NCT00715676|82994791|FG002|Overall Study|Terminated by Sponsor|0|||
46776370|NCT00715676|82994789|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
46847035|NCT00096018|83063765|FG000|Overall Study|Miscellaneous|2|||
46847036|NCT00096018|83063766|FG001|Overall Study|Miscellaneous|1|||
46847037|NCT04713748|83063772|FG000|Overall Study|Not enough kits allocated|35|||
46847038|NCT04702984|83063776|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
46847039|NCT04701658|83063782|FG000|Overall Study|Lost to Follow-up|6|||
46847040|NCT00128102|83063788|FG000|Overall Study|Site Discontinued|3|||
47073320|NCT01673178|83361713|FG001|Overall Study|Adverse Event|0|||
46968283|NCT01874353|83211050|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
46968284|NCT01874353|83211051|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
46968285|NCT01874353|83211052|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
46968286|NCT01874353|83211053|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
46968287|NCT01874353|83211050|FG000|Overall Study|Lost to Follow-up|2|||
46968288|NCT01874353|83211051|FG001|Overall Study|Lost to Follow-up|2|||
46968289|NCT01874353|83211052|FG002|Overall Study|Lost to Follow-up|2|||
47073321|NCT01673178|83361714|FG002|Overall Study|Adverse Event|0|||
47073322|NCT01673178|83361715|FG003|Overall Study|Adverse Event|2|||
47073323|NCT01673178|83361716|FG004|Overall Study|Adverse Event|0|||
47073324|NCT01673178|83361712|FG000|Overall Study|Other|1|||
46847041|NCT00128102|83063789|FG001|Overall Study|Site Discontinued|6|||
46847042|NCT00128102|83063788|FG000|Overall Study|Other|0|||
46847043|NCT00128102|83063789|FG001|Overall Study|Other|1|||
46847044|NCT00128102|83063788|FG000|Overall Study|Progressive Disease|255|||
46847045|NCT00128102|83063789|FG001|Overall Study|Progressive Disease|285|||
46847046|NCT00128102|83063788|FG000|Overall Study|Adverse Event|34|||
46847047|NCT00128102|83063789|FG001|Overall Study|Adverse Event|11|||
46847048|NCT00128102|83063788|FG000|Overall Study|Death|12|||
46847049|NCT00128102|83063789|FG001|Overall Study|Death|13|||
46847050|NCT00128102|83063788|FG000|Overall Study|Physician Decision|3|||
46847051|NCT00128102|83063789|FG001|Overall Study|Physician Decision|3|||
46847052|NCT00128102|83063788|FG000|Overall Study|Withdrawal by Subject|19|||
46847053|NCT00128102|83063789|FG001|Overall Study|Withdrawal by Subject|11|||
46847054|NCT00128102|83063788|FG000|Overall Study|Protocol Violation|2|||
46847055|NCT00128102|83063789|FG001|Overall Study|Protocol Violation|2|||
46847056|NCT04668274|83063795|FG000|Part 1 Study Period 1|Adverse Event|3|||
46847057|NCT04668274|83063796|FG001|Part 1 Study Period 1|Adverse Event|0|||
46847058|NCT04668274|83063797|FG002|Part 1 Study Period 1|Adverse Event|0|||
46847059|NCT04668274|83063798|FG003|Part 1 Study Period 1|Adverse Event|0|||
46847060|NCT04668274|83063795|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
46847061|NCT04668274|83063796|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
46847062|NCT04668274|83063797|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
46847063|NCT04668274|83063798|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
46847064|NCT04668274|83063795|FG000|Part 1 Study Period 2|Other|0|||
46847065|NCT04668274|83063796|FG001|Part 1 Study Period 2|Other|1|||
46847066|NCT04668274|83063797|FG002|Part 1 Study Period 2|Other|0|||
46847067|NCT04668274|83063798|FG003|Part 1 Study Period 2|Other|0|||
46847068|NCT04668274|83063795|FG000|Part 1 Study Period 3|Adverse Event|0|||
46847069|NCT04668274|83063796|FG001|Part 1 Study Period 3|Adverse Event|0|||
46847070|NCT04668274|83063797|FG002|Part 1 Study Period 3|Adverse Event|1|||
46847071|NCT04668274|83063798|FG003|Part 1 Study Period 3|Adverse Event|0|||
46847072|NCT04668274|83063795|FG000|Part 1 Study Period 3|Other|0|||
46847073|NCT04668274|83063796|FG001|Part 1 Study Period 3|Other|0|||
46847074|NCT04668274|83063797|FG002|Part 1 Study Period 3|Other|2|||
46847075|NCT04668274|83063798|FG003|Part 1 Study Period 3|Other|0|||
46847076|NCT04668274|83063795|FG000|Part 2 Study Period 4|Other|0|||
46847077|NCT04668274|83063796|FG001|Part 2 Study Period 4|Other|0|||
46847078|NCT04668274|83063797|FG002|Part 2 Study Period 4|Other|0|||
46847079|NCT04668274|83063798|FG003|Part 2 Study Period 4|Other|1|||
46847080|NCT04406194|83063813|FG000|Period 1|Withdrawal by Subject|0|||
46847081|NCT04406194|83063814|FG001|Period 1|Withdrawal by Subject|1|||
46847082|NCT03822884|83063829|FG000|Overall Study|Withdrawal by Subject|0|||
46847083|NCT03822884|83063830|FG001|Overall Study|Withdrawal by Subject|0|||
46847084|NCT03822884|83063831|FG002|Overall Study|Withdrawal by Subject|0|||
46847085|NCT03822884|83063832|FG003|Overall Study|Withdrawal by Subject|0|||
46847086|NCT03822884|83063833|FG004|Overall Study|Withdrawal by Subject|1|||
46847087|NCT03822884|83063834|FG005|Overall Study|Withdrawal by Subject|0|||
46847088|NCT03822416|83063844|FG000|Overall Study|Lost to Follow-up|1|||
46847089|NCT03822416|83063845|FG001|Overall Study|Lost to Follow-up|0|||
46847090|NCT03822416|83063844|FG000|Overall Study|Withdrawal by Subject|0|||
46847091|NCT03822416|83063845|FG001|Overall Study|Withdrawal by Subject|1|||
46847092|NCT04405570|83063855|FG000|Overall Study|Adverse Event|0|||
46847093|NCT04405570|83063856|FG001|Overall Study|Adverse Event|1|||
46847094|NCT04405570|83063857|FG002|Overall Study|Adverse Event|1|||
46847095|NCT04405570|83063858|FG003|Overall Study|Adverse Event|1|||
46847096|NCT04405570|83063855|FG000|Overall Study|Lost to Follow-up|0|||
46847097|NCT04405570|83063856|FG001|Overall Study|Lost to Follow-up|1|||
46847098|NCT04405570|83063857|FG002|Overall Study|Lost to Follow-up|0|||
46847099|NCT04405570|83063858|FG003|Overall Study|Lost to Follow-up|0|||
46847100|NCT04405570|83063855|FG000|Overall Study|Physician Decision|0|||
46847101|NCT04405570|83063856|FG001|Overall Study|Physician Decision|0|||
46847102|NCT04405570|83063857|FG002|Overall Study|Physician Decision|1|||
46847103|NCT04405570|83063858|FG003|Overall Study|Physician Decision|0|||
46847104|NCT04405570|83063855|FG000|Overall Study|Withdrawal by Subject|0|||
46847105|NCT04405570|83063856|FG001|Overall Study|Withdrawal by Subject|1|||
46847106|NCT04405570|83063857|FG002|Overall Study|Withdrawal by Subject|1|||
46642090|NCT02616185|82831473|FG000|Overall Study|Study terminated by sponsor|0|||
46968290|NCT01874353|83211053|FG003|Overall Study|Lost to Follow-up|0|||
46968291|NCT01874353|83211050|FG000|Overall Study|Death|110|||
46968292|NCT01874353|83211051|FG001|Overall Study|Death|60|||
46847107|NCT04405570|83063858|FG003|Overall Study|Withdrawal by Subject|0|||
46847108|NCT04405570|83063855|FG000|Overall Study|Randomized not dosed|0|||
46847109|NCT04405570|83063856|FG001|Overall Study|Randomized not dosed|2|||
46847110|NCT04405570|83063857|FG002|Overall Study|Randomized not dosed|0|||
46847111|NCT04405570|83063858|FG003|Overall Study|Randomized not dosed|0|||
46847112|NCT00127712|83063873|FG000|Overall Study|Adverse Event|3|||
46847113|NCT00127712|83063874|FG001|Overall Study|Adverse Event|0|||
46847114|NCT00127712|83063873|FG000|Overall Study|Lack of GI access to continue|2|||
46847115|NCT00127712|83063874|FG001|Overall Study|Lack of GI access to continue|0|||
46847116|NCT04404010|83063882|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
46847117|NCT04404010|83063883|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
46847118|NCT04401202|83063893|FG000|Overall Study|Lost to Follow-up|2|||
46847119|NCT04401202|83063894|FG001|Overall Study|Lost to Follow-up|2|||
46847120|NCT04401202|83063893|FG000|Overall Study|Adverse Event|0|||
46847121|NCT04401202|83063894|FG001|Overall Study|Adverse Event|1|||
46847122|NCT04401202|83063893|FG000|Overall Study|Hospitalized|4|||
46847123|NCT04401202|83063894|FG001|Overall Study|Hospitalized|1|||
46847124|NCT00096356|83063903|FG000|Overall Study|Adverse Event|11|||
46847125|NCT00096356|83063904|FG001|Overall Study|Adverse Event|9|||
46642091|NCT02616185|82831474|FG001|Overall Study|Study terminated by sponsor|0|||
46642092|NCT02616185|82831475|FG002|Overall Study|Study terminated by sponsor|1|||
46642093|NCT02616185|82831476|FG003|Overall Study|Study terminated by sponsor|0|||
46642094|NCT02616185|82831477|FG004|Overall Study|Study terminated by sponsor|0|||
46642095|NCT02616185|82831478|FG005|Overall Study|Study terminated by sponsor|0|||
46642096|NCT02616185|82831479|FG006|Overall Study|Study terminated by sponsor|5|||
46847126|NCT00096356|83063903|FG000|Overall Study|Physician Decision|5|||
46847127|NCT00096356|83063904|FG001|Overall Study|Physician Decision|3|||
46847128|NCT00096356|83063903|FG000|Overall Study|Withdrawal by Subject|17|||
46847129|NCT00096356|83063904|FG001|Overall Study|Withdrawal by Subject|23|||
46847130|NCT00096356|83063903|FG000|Overall Study|Lack of Efficacy|1|||
46847131|NCT00096356|83063904|FG001|Overall Study|Lack of Efficacy|0|||
46847132|NCT00096356|83063903|FG000|Overall Study|multiple reasons|10|||
46847133|NCT00096356|83063904|FG001|Overall Study|multiple reasons|18|||
46847134|NCT04358068|83063913|FG000|Overall Study|Did not initiate study treatment|2|||
46847135|NCT04358068|83063914|FG001|Overall Study|Did not initiate study treatment|2|||
46642097|NCT02616185|82831480|FG007|Overall Study|Study terminated by sponsor|2|||
46642098|NCT02616185|82831481|FG008|Overall Study|Study terminated by sponsor|0|||
46642099|NCT02616185|82831473|FG000|Overall Study|Participant refused further follow-up|1|||
46642100|NCT02616185|82831474|FG001|Overall Study|Participant refused further follow-up|1|||
46642101|NCT02616185|82831475|FG002|Overall Study|Participant refused further follow-up|2|||
46642102|NCT02616185|82831476|FG003|Overall Study|Participant refused further follow-up|3|||
46776371|NCT00715676|82994790|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
46776372|NCT00715676|82994791|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
46776373|NCT00715676|82994789|FG000|Overall Study|Use of Exclusionary Medication|0|||
46776374|NCT00715676|82994790|FG001|Overall Study|Use of Exclusionary Medication|0|||
46776375|NCT00715676|82994791|FG002|Overall Study|Use of Exclusionary Medication|1|||
46776376|NCT00715676|82994789|FG000|Overall Study|Elevated Blood Glucose|0|||
46776377|NCT00715676|82994790|FG001|Overall Study|Elevated Blood Glucose|1|||
46776378|NCT00715676|82994791|FG002|Overall Study|Elevated Blood Glucose|0|||
46776379|NCT00718328|82994801|FG000|Overall Study|Lost to Follow-up|1|||
46776380|NCT00718328|82994802|FG001|Overall Study|Lost to Follow-up|0|||
46776381|NCT00715520|82994811|FG000|Overall Study|Screen failure|8|||
46847136|NCT03694210|83063920|FG000|Overall Study|Death|1|||
46847137|NCT03694210|83063920|FG000|Overall Study|Screen Failure|7|||
46847138|NCT04339972|83063928|FG000|Overall Study|Scheduling Issues|3|||
46776382|NCT00715520|82994812|FG001|Overall Study|Screen failure|1|||
46776383|NCT00715520|82994813|FG002|Overall Study|Screen failure|1|||
46776384|NCT00715520|82994811|FG000|Overall Study|Withdrawal by Subject|2|||
46847139|NCT04339972|83063929|FG001|Overall Study|Scheduling Issues|3|||
46847140|NCT04339972|83063928|FG000|Overall Study|dropout|1|||
46847141|NCT04339972|83063929|FG001|Overall Study|dropout|1|||
46968293|NCT01874353|83211052|FG002|Overall Study|Death|13|||
46968294|NCT01874353|83211053|FG003|Overall Study|Death|7|||
46968295|NCT01874353|83211050|FG000|Overall Study|Withdrawal by Subject|13|||
46968296|NCT01874353|83211051|FG001|Overall Study|Withdrawal by Subject|11|||
46776385|NCT00715520|82994812|FG001|Overall Study|Withdrawal by Subject|0|||
46776386|NCT00715520|82994813|FG002|Overall Study|Withdrawal by Subject|1|||
46776387|NCT00790205|82994823|FG000|Overall Study|Lost to Follow-up|61|||
46776388|NCT00790205|82994824|FG001|Overall Study|Lost to Follow-up|71|||
46776389|NCT00790205|82994823|FG000|Overall Study|Withdrawal by Subject|299|||
46776390|NCT00790205|82994824|FG001|Overall Study|Withdrawal by Subject|363|||
46776391|NCT00715208|82994832|FG000|Overall Study|Withdrawal by Subject|1|||
46776392|NCT00715208|82994833|FG001|Overall Study|Withdrawal by Subject|1|||
46776393|NCT00715208|82994832|FG000|Overall Study|Adverse Event|0|||
46776394|NCT00715208|82994833|FG001|Overall Study|Adverse Event|6|||
46776395|NCT00715208|82994832|FG000|Overall Study|Lack of Efficacy|0|||
46776396|NCT00715208|82994833|FG001|Overall Study|Lack of Efficacy|2|||
46776397|NCT00587795|82994841|FG000|Overall Study|Withdrawal by Subject|1|||
46847142|NCT04339972|83063928|FG000|Overall Study|Technical issues|1|||
46847143|NCT04339972|83063929|FG001|Overall Study|Technical issues|0|||
46847144|NCT04339972|83063928|FG000|Overall Study|Claustraphobia|0|||
46847145|NCT04339972|83063929|FG001|Overall Study|Claustraphobia|1|||
46847146|NCT00096278|83063937|FG000|Overall Study|No follow-up data|15|||
46847147|NCT00096278|83063938|FG001|Overall Study|No follow-up data|18|||
46847148|NCT00096278|83063937|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
46847149|NCT00096278|83063938|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
46847150|NCT00095940|83063953|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
46776398|NCT00587795|82994842|FG001|Overall Study|Withdrawal by Subject|0|||
46776399|NCT00587639|82994848|FG000|Overall Study|Withdrawal by Subject|1|||
46776400|NCT00774995|82994856|FG000|Overall Study|Protocol Violation|0|||
46776401|NCT00774995|82994857|FG001|Overall Study|Protocol Violation|0|||
46776402|NCT00774995|82994858|FG002|Overall Study|Protocol Violation|1|||
46776403|NCT00774995|82994859|FG003|Overall Study|Protocol Violation|0|||
46847151|NCT00095940|83063954|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
46847152|NCT00095940|83063955|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
46847153|NCT00095940|83063956|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
46847154|NCT00095940|83063957|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
46847155|NCT00095940|83063958|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
46847156|NCT00095940|83063959|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
46847157|NCT00095940|83063960|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
46968297|NCT01874353|83211052|FG002|Overall Study|Withdrawal by Subject|0|||
46968298|NCT01874353|83211053|FG003|Overall Study|Withdrawal by Subject|0|||
46968299|NCT01802632|83211071|FG000|Overall Study|Death|28|||
46968300|NCT01802632|83211072|FG001|Overall Study|Death|1|||
46968301|NCT01802632|83211073|FG002|Overall Study|Death|38|||
46968302|NCT01802632|83211074|FG003|Overall Study|Death|0|||
46968303|NCT01802632|83211075|FG004|Overall Study|Death|2|||
46968304|NCT01802632|83211076|FG005|Overall Study|Death|0|||
46968305|NCT01802632|83211071|FG000|Overall Study|Withdrawal by Subject|4|||
46968306|NCT01802632|83211072|FG001|Overall Study|Withdrawal by Subject|2|||
46968307|NCT01802632|83211073|FG002|Overall Study|Withdrawal by Subject|7|||
46968308|NCT01802632|83211074|FG003|Overall Study|Withdrawal by Subject|3|||
46968309|NCT01802632|83211075|FG004|Overall Study|Withdrawal by Subject|0|||
46968310|NCT01802632|83211076|FG005|Overall Study|Withdrawal by Subject|1|||
46968311|NCT01802632|83211071|FG000|Overall Study|Objective Disease Progression|1|||
46968312|NCT01802632|83211072|FG001|Overall Study|Objective Disease Progression|12|||
46968313|NCT01802632|83211073|FG002|Overall Study|Objective Disease Progression|104|||
46968314|NCT01802632|83211074|FG003|Overall Study|Objective Disease Progression|6|||
46968315|NCT01802632|83211075|FG004|Overall Study|Objective Disease Progression|4|||
47073325|NCT01673178|83361713|FG001|Overall Study|Other|0|||
47073326|NCT01673178|83361714|FG002|Overall Study|Other|2|||
47073327|NCT01673178|83361715|FG003|Overall Study|Other|1|||
47073328|NCT01673178|83361716|FG004|Overall Study|Other|0|||
47073329|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
47073330|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
47073331|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
46968316|NCT01802632|83211076|FG005|Overall Study|Objective Disease Progression|4|||
46776404|NCT00713648|82994869|FG000|Overall Study|Adverse Event|1|||
46776405|NCT00713648|82994869|FG000|Overall Study|Unclassified|2|||
46776406|NCT00713648|82994869|FG000|Overall Study|According to Protocol|2|||
46776407|NCT00713648|82994869|FG000|Overall Study|Development of antibodies|3|||
46847158|NCT00095940|83063961|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
46968317|NCT01802632|83211071|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
46968318|NCT01802632|83211072|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
46968319|NCT01802632|83211073|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
46968320|NCT01802632|83211074|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
47073332|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
46968321|NCT01802632|83211075|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
46968322|NCT01802632|83211076|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
46968323|NCT01802632|83211071|FG000|Overall Study|Other (not specified)|0|||
46968324|NCT01802632|83211072|FG001|Overall Study|Other (not specified)|0|||
46968325|NCT01802632|83211073|FG002|Overall Study|Other (not specified)|7|||
46968326|NCT01802632|83211074|FG003|Overall Study|Other (not specified)|1|||
46968327|NCT01802632|83211075|FG004|Overall Study|Other (not specified)|0|||
46968328|NCT01802632|83211076|FG005|Overall Study|Other (not specified)|1|||
46968329|NCT01782131|83211090|FG000|Overall Study|Death|93|||
46968330|NCT01782131|83211091|FG001|Overall Study|Death|96|||
46968331|NCT01782131|83211090|FG000|Overall Study|Lost to Follow-up|1|||
46968332|NCT01782131|83211091|FG001|Overall Study|Lost to Follow-up|3|||
46968333|NCT01782131|83211090|FG000|Overall Study|Withdrawal by Subject|10|||
46968334|NCT01782131|83211091|FG001|Overall Study|Withdrawal by Subject|10|||
46968335|NCT01782131|83211090|FG000|Overall Study|Randomized but not treated|5|||
46968336|NCT01782131|83211091|FG001|Overall Study|Randomized but not treated|5|||
46968337|NCT01782131|83211090|FG000|Overall Study|Reason not provided|0|||
46968338|NCT01782131|83211091|FG001|Overall Study|Reason not provided|1|||
46968339|NCT01903733|83211110|FG000|Overall Study|Death|23|||
46968340|NCT01903733|83211111|FG001|Overall Study|Death|54|||
46968341|NCT01903733|83211112|FG002|Overall Study|Death|30|||
46968342|NCT01903733|83211113|FG003|Overall Study|Death|98|||
46968343|NCT01903733|83211110|FG000|Overall Study|Participant refused further follow-up|35|||
46968344|NCT01903733|83211111|FG001|Overall Study|Participant refused further follow-up|38|||
46968345|NCT01903733|83211112|FG002|Overall Study|Participant refused further follow-up|13|||
46968346|NCT01903733|83211113|FG003|Overall Study|Participant refused further follow-up|9|||
46968347|NCT01903733|83211110|FG000|Overall Study|Lost to Follow-up|18|||
46968348|NCT01903733|83211111|FG001|Overall Study|Lost to Follow-up|19|||
46968349|NCT01903733|83211112|FG002|Overall Study|Lost to Follow-up|6|||
47073333|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
47073334|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
47073335|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
46847159|NCT00095940|83063953|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
46847160|NCT00095940|83063954|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
46847161|NCT00095940|83063955|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
46847162|NCT00095940|83063956|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
46847163|NCT00095940|83063957|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
46847164|NCT00095940|83063958|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
46847165|NCT00095940|83063959|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
46847166|NCT00095940|83063960|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
46847167|NCT00095940|83063961|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
46847168|NCT00095940|83063953|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847169|NCT00095940|83063954|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847170|NCT00095940|83063955|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847171|NCT00095940|83063956|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847172|NCT00095940|83063957|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847173|NCT00095940|83063958|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847174|NCT00095940|83063959|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847175|NCT00095940|83063960|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
46847176|NCT00095940|83063961|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
46847177|NCT00114218|83063979|FG000|Overall Study|Wrong Cell Type|2|||
46847178|NCT00114218|83063979|FG000|Overall Study|Wrong Primary|1|||
46847179|NCT00114218|83063979|FG000|Overall Study|Never Treated|1|||
46968350|NCT01903733|83211113|FG003|Overall Study|Lost to Follow-up|9|||
46968351|NCT01903733|83211110|FG000|Overall Study|Other|10|||
46968352|NCT01903733|83211111|FG001|Overall Study|Other|15|||
46968353|NCT01903733|83211112|FG002|Overall Study|Other|12|||
47073336|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
47073337|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
47073338|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
47073339|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
46847180|NCT00095628|83063983|FG000|Overall Study|Disease progression prior to treatment|1|||
46847181|NCT04380142|83063989|FG000|LD/CD Stabilization Period|Adverse Event|3|||
46847182|NCT04380142|83063990|FG001|LD/CD Stabilization Period|Adverse Event|0|||
46847183|NCT04380142|83063991|FG002|LD/CD Stabilization Period|Adverse Event|0|||
46847184|NCT04380142|83063989|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
46968354|NCT01903733|83211113|FG003|Overall Study|Other|3|||
46968355|NCT01903733|83211110|FG000|Overall Study|Missing|2|||
46968356|NCT01903733|83211111|FG001|Overall Study|Missing|0|||
46968357|NCT01903733|83211112|FG002|Overall Study|Missing|0|||
46968358|NCT01903733|83211113|FG003|Overall Study|Missing|0|||
46968359|NCT01903733|83211110|FG000|Overall Study|Investigator request|18|||
47073340|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
46847185|NCT04380142|83063990|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
46847186|NCT04380142|83063991|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
46847187|NCT04380142|83063989|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
46847188|NCT04380142|83063990|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
46847189|NCT04380142|83063991|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
46847190|NCT04380142|83063989|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
46847191|NCT04380142|83063990|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
46847192|NCT04380142|83063991|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
46847193|NCT04380142|83063989|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
46847194|NCT04380142|83063990|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
46847195|NCT04380142|83063991|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
46847196|NCT04380142|83063989|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
46847197|NCT04380142|83063990|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
46847198|NCT04380142|83063991|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
46847199|NCT04380142|83063989|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46847200|NCT04380142|83063990|FG001|Double-Blind Treatment Period|Adverse Event|1|||
46847201|NCT04380142|83063991|FG002|Double-Blind Treatment Period|Adverse Event|14|||
46847202|NCT04380142|83063989|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
46847203|NCT04380142|83063990|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
46847204|NCT04380142|83063991|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
46847205|NCT04380142|83063989|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
46847206|NCT04380142|83063990|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
46847207|NCT04380142|83063991|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
46847208|NCT04380142|83063989|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
46847209|NCT04380142|83063990|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
46847210|NCT04380142|83063991|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
46847211|NCT04380142|83063989|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
46847212|NCT04380142|83063990|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
46847213|NCT04380142|83063991|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
46847214|NCT04380142|83063989|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
46847215|NCT04380142|83063990|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
46847216|NCT04380142|83063991|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
46847217|NCT04335136|83064001|FG000|Overall Study|Death|8|||
46847218|NCT04335136|83064002|FG001|Overall Study|Death|4|||
46847219|NCT04335136|83064001|FG000|Overall Study|Lost to Follow-up|2|||
46847220|NCT04335136|83064002|FG001|Overall Study|Lost to Follow-up|0|||
46847221|NCT04335136|83064001|FG000|Overall Study|Protocol Violation|1|||
46847222|NCT04335136|83064002|FG001|Overall Study|Protocol Violation|0|||
46847223|NCT04335136|83064001|FG000|Overall Study|Withdrawal by Subject|1|||
46847224|NCT04335136|83064002|FG001|Overall Study|Withdrawal by Subject|1|||
46847225|NCT04335136|83064001|FG000|Overall Study|Health-threatening condition|0|||
46847226|NCT04335136|83064002|FG001|Overall Study|Health-threatening condition|1|||
46847227|NCT04335136|83064001|FG000|Overall Study|Adverse Event|0|||
46847228|NCT04335136|83064002|FG001|Overall Study|Adverse Event|1|||
46847229|NCT04335136|83064001|FG000|Overall Study|Erroneously randomized|2|||
46847230|NCT04335136|83064002|FG001|Overall Study|Erroneously randomized|0|||
46847231|NCT04171414|83064008|FG000|Overall Study|Death|1|||
46847232|NCT04171414|83064008|FG000|Overall Study|Withdrawal by Subject|1|||
46847233|NCT04167670|83064015|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
46847234|NCT04167670|83064016|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
46847235|NCT04167670|83064017|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
46847236|NCT04167670|83064015|FG000|Overall Study|Significant protocol deviation|3|||
46847237|NCT04167670|83064016|FG001|Overall Study|Significant protocol deviation|1|||
46847238|NCT04167670|83064017|FG002|Overall Study|Significant protocol deviation|0|||
46847239|NCT04167670|83064015|FG000|Overall Study|Lost to Follow-up|0|||
46847240|NCT04167670|83064016|FG001|Overall Study|Lost to Follow-up|3|||
46847241|NCT04167670|83064017|FG002|Overall Study|Lost to Follow-up|3|||
46847242|NCT04167670|83064015|FG000|Overall Study|Voluntary Withdrawal|0|||
46847243|NCT04167670|83064016|FG001|Overall Study|Voluntary Withdrawal|1|||
46847244|NCT04167670|83064017|FG002|Overall Study|Voluntary Withdrawal|1|||
46847245|NCT04167670|83064015|FG000|Overall Study|Withdrawal of Consent|4|||
46968360|NCT01903733|83211111|FG001|Overall Study|Investigator request|0|||
46968361|NCT01903733|83211112|FG002|Overall Study|Investigator request|0|||
46968362|NCT01903733|83211113|FG003|Overall Study|Investigator request|0|||
46847246|NCT04167670|83064016|FG001|Overall Study|Withdrawal of Consent|1|||
46847247|NCT04167670|83064017|FG002|Overall Study|Withdrawal of Consent|3|||
46847248|NCT04167670|83064015|FG000|Overall Study|Miscellaneous|7|||
46847249|NCT04167670|83064016|FG001|Overall Study|Miscellaneous|5|||
46847250|NCT04167670|83064017|FG002|Overall Study|Miscellaneous|3|||
46847251|NCT00113516|83064025|FG000|Part 1|Adverse Event|6|||
46847252|NCT00113516|83064026|FG001|Part 1|Adverse Event|0|||
46968363|NCT01375205|83211135|FG000|Overall Study|Lost to Follow-up|15|||
46968364|NCT01375205|83211136|FG001|Overall Study|Lost to Follow-up|12|||
46968365|NCT01375205|83211135|FG000|Overall Study|Withdrawal by Subject|6|||
46968366|NCT01375205|83211136|FG001|Overall Study|Withdrawal by Subject|1|||
46968367|NCT00700271|83211144|FG000|Overall Study|Adverse Event|4|||
46968368|NCT00700271|83211145|FG001|Overall Study|Adverse Event|6|||
46968369|NCT00700271|83211144|FG000|Overall Study|Protocol Violation|1|||
46968370|NCT00700271|83211145|FG001|Overall Study|Protocol Violation|0|||
46968371|NCT00700271|83211144|FG000|Overall Study|Administrative Reasons|1|||
46968372|NCT00700271|83211145|FG001|Overall Study|Administrative Reasons|0|||
46968373|NCT00700271|83211144|FG000|Overall Study|Withdrawal by Subject|6|||
46968374|NCT00700271|83211145|FG001|Overall Study|Withdrawal by Subject|4|||
46968375|NCT00700271|83211144|FG000|Overall Study|Lost to Follow-up|2|||
46968376|NCT00700271|83211145|FG001|Overall Study|Lost to Follow-up|2|||
46968377|NCT01375049|83211151|FG000|Overall Study|Adverse Event|2|||
46968378|NCT01375049|83211151|FG000|Overall Study|Lost to Follow-up|1|||
46968379|NCT01375049|83211151|FG000|Overall Study|Withdrawal by Subject|2|||
46968380|NCT01375049|83211151|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
46968381|NCT01594749|83211161|FG000|Overall Study|Adverse Event|2|||
46847253|NCT00113516|83064025|FG000|Part 1|Death|3|||
46847254|NCT00113516|83064026|FG001|Part 1|Death|0|||
46847255|NCT00113516|83064025|FG000|Part 1|Other|3|||
46847256|NCT00113516|83064026|FG001|Part 1|Other|0|||
46847257|NCT00113516|83064025|FG000|Part 1|Withdrawal by Subject|2|||
46847258|NCT00113516|83064026|FG001|Part 1|Withdrawal by Subject|0|||
46847259|NCT00113516|83064025|FG000|Part 1|Lack of Efficacy|2|||
46847260|NCT00113516|83064026|FG001|Part 1|Lack of Efficacy|0|||
46847261|NCT00113516|83064025|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
46847262|NCT00113516|83064026|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
46847263|NCT00113516|83064025|FG000|Part 1|Laboratory Abnormality|1|||
46847264|NCT00113516|83064026|FG001|Part 1|Laboratory Abnormality|0|||
46847265|NCT00113516|83064025|FG000|Part 1|Ongoing|1|||
46847266|NCT00113516|83064026|FG001|Part 1|Ongoing|0|||
46847267|NCT00113516|83064025|FG000|Part 1|Missing|65|||
46847268|NCT00113516|83064026|FG001|Part 1|Missing|0|||
46847269|NCT00113516|83064025|FG000|Part 2|Adverse Event|0|||
46847270|NCT00113516|83064026|FG001|Part 2|Adverse Event|16|||
46847271|NCT00113516|83064025|FG000|Part 2|Death|0|||
46847272|NCT00113516|83064026|FG001|Part 2|Death|5|||
46847273|NCT00113516|83064025|FG000|Part 2|Lack of Efficacy|0|||
46847274|NCT00113516|83064026|FG001|Part 2|Lack of Efficacy|37|||
46847275|NCT00113516|83064025|FG000|Part 2|Withdrawal by Subject|0|||
46847276|NCT00113516|83064026|FG001|Part 2|Withdrawal by Subject|3|||
46847277|NCT00113516|83064025|FG000|Part 2|Other|0|||
46847278|NCT00113516|83064026|FG001|Part 2|Other|3|||
46847279|NCT00113516|83064025|FG000|Part 2|Laboratory Abnormality|0|||
46847280|NCT00113516|83064026|FG001|Part 2|Laboratory Abnormality|1|||
46847281|NCT00113516|83064025|FG000|Part 2|Ongoing|0|||
46847282|NCT00113516|83064026|FG001|Part 2|Ongoing|1|||
46847283|NCT04140292|83064047|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
46847284|NCT04140292|83064048|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
46847285|NCT04138810|83064057|FG000|Overall Study|Withdrawal by Subject|0|||
46847286|NCT04138810|83064058|FG001|Overall Study|Withdrawal by Subject|1|||
46847287|NCT04138810|83064057|FG000|Overall Study|Subject cancelled surgery|1|||
46847288|NCT04138810|83064058|FG001|Overall Study|Subject cancelled surgery|0|||
46847289|NCT00127166|83064066|FG000|Period I|Protocol Violation|0|||
46847290|NCT00127166|83064067|FG001|Period I|Protocol Violation|2|||
46847291|NCT00127166|83064066|FG000|Period I|Withdrawal by Subject|2|||
46847292|NCT00127166|83064067|FG001|Period I|Withdrawal by Subject|0|||
46847293|NCT00127166|83064066|FG000|Period I|Patient did not meet inclusion criteria|1|||
46847294|NCT00127166|83064067|FG001|Period I|Patient did not meet inclusion criteria|0|||
46968382|NCT01594749|83211162|FG001|Overall Study|Adverse Event|1|||
46847295|NCT00127166|83064066|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
46847296|NCT00127166|83064067|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
46968383|NCT01594749|83211161|FG000|Overall Study|Withdrawal by Subject|2|||
46968384|NCT01594749|83211162|FG001|Overall Study|Withdrawal by Subject|2|||
46968385|NCT01594749|83211161|FG000|Overall Study|Protocol Violation|2|||
46968386|NCT01594749|83211162|FG001|Overall Study|Protocol Violation|0|||
46847297|NCT00127166|83064066|FG000|Period II|Withdrawal by Subject|2|||
46847298|NCT00127166|83064067|FG001|Period II|Withdrawal by Subject|0|||
46847299|NCT00127166|83064066|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
46847300|NCT00127166|83064067|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
46847301|NCT00125138|83064077|FG000|Overall Study|Adverse Event|1|||
46968387|NCT01594749|83211161|FG000|Overall Study|Physician Decision|1|||
46847302|NCT00125138|83064078|FG001|Overall Study|Adverse Event|0|||
46847303|NCT00125138|83064079|FG002|Overall Study|Adverse Event|3|||
46847304|NCT00125138|83064080|FG003|Overall Study|Adverse Event|2|||
46847305|NCT00125138|83064077|FG000|Overall Study|Withdrawal by Subject|2|||
46968388|NCT01594749|83211162|FG001|Overall Study|Physician Decision|1|||
46847306|NCT00125138|83064078|FG001|Overall Study|Withdrawal by Subject|3|||
46847307|NCT00125138|83064079|FG002|Overall Study|Withdrawal by Subject|1|||
46847308|NCT00125138|83064080|FG003|Overall Study|Withdrawal by Subject|1|||
46847309|NCT00125138|83064077|FG000|Overall Study|Lack of Efficacy|0|||
46847310|NCT00125138|83064078|FG001|Overall Study|Lack of Efficacy|0|||
46847311|NCT00125138|83064079|FG002|Overall Study|Lack of Efficacy|0|||
46847312|NCT00125138|83064080|FG003|Overall Study|Lack of Efficacy|1|||
46847313|NCT00125138|83064077|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
46847314|NCT00125138|83064078|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
47073341|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
47073342|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
47073343|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
47073344|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
46776408|NCT00768053|82994873|FG000|Overall Study|Adverse Event|10|||
46776409|NCT00768053|82994873|FG000|Overall Study|Lost to Follow-up|1|||
46776410|NCT00683475|82994879|FG000|Overall Study|Withdrawal by Subject|1|||
46776411|NCT00683475|82994880|FG001|Overall Study|Withdrawal by Subject|0|||
46776412|NCT00683475|82994879|FG000|Overall Study|Never Treated: Adverse Event|2|||
46776413|NCT00683475|82994880|FG001|Overall Study|Never Treated: Adverse Event|3|||
46776414|NCT00683475|82994879|FG000|Overall Study|Never Treated: Progressive Disease|1|||
46776415|NCT00683475|82994880|FG001|Overall Study|Never Treated: Progressive Disease|0|||
46776416|NCT00685035|82994887|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
46776417|NCT00685035|82994888|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
46776418|NCT00773747|82994914|FG000|Overall Study|Lack of Efficacy|112|||
46776419|NCT00773747|82994915|FG001|Overall Study|Lack of Efficacy|144|||
46776420|NCT00773747|82994914|FG000|Overall Study|Physician Decision|26|||
46776421|NCT00773747|82994915|FG001|Overall Study|Physician Decision|18|||
46776422|NCT00773747|82994914|FG000|Overall Study|Lost to Follow-up|0|||
46776423|NCT00773747|82994915|FG001|Overall Study|Lost to Follow-up|1|||
46776424|NCT00773747|82994914|FG000|Overall Study|Protocol Violation|2|||
46776425|NCT00773747|82994915|FG001|Overall Study|Protocol Violation|2|||
46776426|NCT00773747|82994914|FG000|Overall Study|Withdrawal by Subject|89|||
46776427|NCT00773747|82994915|FG001|Overall Study|Withdrawal by Subject|61|||
46776428|NCT00773747|82994914|FG000|Overall Study|Adverse Event|61|||
46776429|NCT00773747|82994915|FG001|Overall Study|Adverse Event|62|||
46776430|NCT00773747|82994914|FG000|Overall Study|Death|5|||
46776431|NCT00773747|82994915|FG001|Overall Study|Death|8|||
46776432|NCT00773747|82994914|FG000|Overall Study|Not Treated|2|||
46776433|NCT00773747|82994915|FG001|Overall Study|Not Treated|0|||
46776434|NCT00784277|82994925|FG000|IR Treatment|Adverse Event|4|||
46776435|NCT00784277|82994926|FG001|IR Treatment|Adverse Event|8|||
46776436|NCT00784277|82994927|FG002|IR Treatment|Adverse Event|19|||
46776437|NCT00784277|82994928|FG003|IR Treatment|Adverse Event|35|||
46776438|NCT00784277|82994929|FG004|IR Treatment|Adverse Event|0|||
46776439|NCT00784277|82994930|FG005|IR Treatment|Adverse Event|0|||
46776440|NCT00784277|82994931|FG006|IR Treatment|Adverse Event|0|||
46847315|NCT00125138|83064079|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
46847316|NCT00125138|83064080|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
46847317|NCT04132336|83064097|FG000|Overall Study|Investigator Decision|0|||
46847318|NCT04132336|83064098|FG001|Overall Study|Investigator Decision|1|||
46847319|NCT04132336|83064099|FG002|Overall Study|Investigator Decision|0|||
46847320|NCT04132336|83064100|FG003|Overall Study|Investigator Decision|0|||
46847321|NCT04132336|83064101|FG004|Overall Study|Investigator Decision|0|||
46847322|NCT04132336|83064102|FG005|Overall Study|Investigator Decision|0|||
46847323|NCT04132336|83064103|FG006|Overall Study|Investigator Decision|0|||
46847324|NCT04131556|83064119|FG000|Overall Study|Adverse Event|1|||
46847325|NCT04131556|83064119|FG000|Overall Study|Withdrawal by Subject|1|||
46847326|NCT04295356|83064128|FG000|Overall Study|Physician Decision|1|||
46847327|NCT04295356|83064129|FG001|Overall Study|Physician Decision|0|||
46847328|NCT04295356|83064128|FG000|Overall Study|Lost to Follow-up|0|||
46847329|NCT04295356|83064129|FG001|Overall Study|Lost to Follow-up|3|||
46847330|NCT04295356|83064128|FG000|Overall Study|Protocol Violation|0|||
46847331|NCT04295356|83064129|FG001|Overall Study|Protocol Violation|1|||
46847332|NCT03691948|83064137|FG000|Overall Study|Lost to Follow-up|1|||
46776441|NCT00784277|82994925|FG000|IR Treatment|Lack of Efficacy|4|||
46776442|NCT00784277|82994926|FG001|IR Treatment|Lack of Efficacy|4|||
46776443|NCT00784277|82994927|FG002|IR Treatment|Lack of Efficacy|1|||
46776444|NCT00784277|82994928|FG003|IR Treatment|Lack of Efficacy|0|||
46776445|NCT00784277|82994929|FG004|IR Treatment|Lack of Efficacy|0|||
46776446|NCT00784277|82994930|FG005|IR Treatment|Lack of Efficacy|0|||
46776447|NCT00784277|82994931|FG006|IR Treatment|Lack of Efficacy|0|||
46776448|NCT00784277|82994925|FG000|IR Treatment|Lost to Follow-up|1|||
46847333|NCT03691948|83064138|FG001|Overall Study|Lost to Follow-up|3|||
46847334|NCT04126174|83064145|FG000|Overall Study|Lost to Follow-up|3|||
46847335|NCT04126174|83064146|FG001|Overall Study|Lost to Follow-up|3|||
46847336|NCT04124926|83064154|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
46847337|NCT04124926|83064155|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
46847338|NCT04124926|83064156|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
46847339|NCT04124926|83064157|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
46847340|NCT04124926|83064158|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
46847341|NCT04124926|83064154|FG000|Healing Phase|Protocol Violation|0|||
46847342|NCT04124926|83064155|FG001|Healing Phase|Protocol Violation|1|||
46847343|NCT04124926|83064156|FG002|Healing Phase|Protocol Violation|0|||
46847344|NCT04124926|83064157|FG003|Healing Phase|Protocol Violation|0|||
46847345|NCT04124926|83064158|FG004|Healing Phase|Protocol Violation|0|||
46847346|NCT04124926|83064154|FG000|Healing Phase|Lost to Follow-up|5|||
46847347|NCT04124926|83064155|FG001|Healing Phase|Lost to Follow-up|4|||
46968389|NCT01594749|83211161|FG000|Overall Study|Non-compliance with Protocol|0|||
46968390|NCT01594749|83211162|FG001|Overall Study|Non-compliance with Protocol|1|||
46847348|NCT04124926|83064156|FG002|Healing Phase|Lost to Follow-up|0|||
46847349|NCT04124926|83064157|FG003|Healing Phase|Lost to Follow-up|0|||
46847350|NCT04124926|83064158|FG004|Healing Phase|Lost to Follow-up|0|||
46847351|NCT04124926|83064154|FG000|Healing Phase|Voluntary Withdrawal|10|||
46847352|NCT04124926|83064155|FG001|Healing Phase|Voluntary Withdrawal|7|||
46847353|NCT04124926|83064156|FG002|Healing Phase|Voluntary Withdrawal|0|||
46847354|NCT04124926|83064157|FG003|Healing Phase|Voluntary Withdrawal|0|||
46847355|NCT04124926|83064158|FG004|Healing Phase|Voluntary Withdrawal|0|||
46847356|NCT04124926|83064154|FG000|Healing Phase|Withdrawal of Consent|5|||
46847357|NCT04124926|83064155|FG001|Healing Phase|Withdrawal of Consent|3|||
46847358|NCT04124926|83064156|FG002|Healing Phase|Withdrawal of Consent|0|||
46847359|NCT04124926|83064157|FG003|Healing Phase|Withdrawal of Consent|0|||
46847360|NCT04124926|83064158|FG004|Healing Phase|Withdrawal of Consent|0|||
46847361|NCT04124926|83064154|FG000|Healing Phase|Miscellaneous|8|||
46847362|NCT04124926|83064155|FG001|Healing Phase|Miscellaneous|7|||
46847363|NCT04124926|83064156|FG002|Healing Phase|Miscellaneous|0|||
46847364|NCT04124926|83064157|FG003|Healing Phase|Miscellaneous|0|||
46847365|NCT04124926|83064158|FG004|Healing Phase|Miscellaneous|0|||
46847366|NCT04124926|83064154|FG000|Healing Phase|Randomized but not Treated|0|||
46847367|NCT04124926|83064155|FG001|Healing Phase|Randomized but not Treated|3|||
46847368|NCT04124926|83064156|FG002|Healing Phase|Randomized but not Treated|0|||
46847369|NCT04124926|83064157|FG003|Healing Phase|Randomized but not Treated|0|||
46847370|NCT04124926|83064158|FG004|Healing Phase|Randomized but not Treated|0|||
46847371|NCT04124926|83064154|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
46847372|NCT04124926|83064155|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
46847373|NCT04124926|83064156|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
46847374|NCT04124926|83064157|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
46847375|NCT04124926|83064158|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
46847376|NCT04124926|83064154|FG000|Maintenance Phase|Protocol Violation|0|||
46847377|NCT04124926|83064155|FG001|Maintenance Phase|Protocol Violation|0|||
46847378|NCT04124926|83064156|FG002|Maintenance Phase|Protocol Violation|3|||
46847379|NCT04124926|83064157|FG003|Maintenance Phase|Protocol Violation|0|||
46847380|NCT04124926|83064158|FG004|Maintenance Phase|Protocol Violation|0|||
46847381|NCT04124926|83064154|FG000|Maintenance Phase|Lost to Follow-up|0|||
46847382|NCT04124926|83064155|FG001|Maintenance Phase|Lost to Follow-up|0|||
46968391|NCT01594749|83211161|FG000|Overall Study|Lost to Follow-up|1|||
46968392|NCT01594749|83211162|FG001|Overall Study|Lost to Follow-up|0|||
46968393|NCT01594749|83211161|FG000|Overall Study|Death|9|||
46968394|NCT01594749|83211162|FG001|Overall Study|Death|3|||
46968395|NCT01594749|83211161|FG000|Overall Study|Not Treated|4|||
46968396|NCT01594749|83211162|FG001|Overall Study|Not Treated|10|||
46968397|NCT01594749|83211161|FG000|Overall Study|Lost Source Documentation|1|||
46968398|NCT01594749|83211162|FG001|Overall Study|Lost Source Documentation|0|||
46968399|NCT02179918|83211173|FG000|Overall Study|Death|0|||
46776449|NCT00784277|82994926|FG001|IR Treatment|Lost to Follow-up|0|||
46776450|NCT00784277|82994927|FG002|IR Treatment|Lost to Follow-up|1|||
46776451|NCT00784277|82994928|FG003|IR Treatment|Lost to Follow-up|0|||
46776452|NCT00784277|82994929|FG004|IR Treatment|Lost to Follow-up|0|||
46776453|NCT00784277|82994930|FG005|IR Treatment|Lost to Follow-up|0|||
46776454|NCT00784277|82994931|FG006|IR Treatment|Lost to Follow-up|0|||
46776455|NCT00784277|82994925|FG000|IR Treatment|Withdrawal by Subject|5|||
46776456|NCT00784277|82994926|FG001|IR Treatment|Withdrawal by Subject|1|||
46776457|NCT00784277|82994927|FG002|IR Treatment|Withdrawal by Subject|4|||
46847383|NCT04124926|83064156|FG002|Maintenance Phase|Lost to Follow-up|7|||
46847384|NCT04124926|83064157|FG003|Maintenance Phase|Lost to Follow-up|8|||
46847385|NCT04124926|83064158|FG004|Maintenance Phase|Lost to Follow-up|9|||
46847386|NCT04124926|83064154|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
46847387|NCT04124926|83064155|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
46847388|NCT04124926|83064156|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
46847389|NCT04124926|83064157|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
46847390|NCT04124926|83064158|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
46847391|NCT04124926|83064154|FG000|Maintenance Phase|Pregnancy|0|||
46847392|NCT04124926|83064155|FG001|Maintenance Phase|Pregnancy|0|||
46968400|NCT02179918|83211174|FG001|Overall Study|Death|0|||
46968401|NCT02179918|83211175|FG002|Overall Study|Death|0|||
46968402|NCT02179918|83211176|FG003|Overall Study|Death|1|||
46968403|NCT02179918|83211177|FG004|Overall Study|Death|0|||
46968404|NCT02179918|83211173|FG000|Overall Study|Lost to Follow-up|0|||
46968405|NCT02179918|83211174|FG001|Overall Study|Lost to Follow-up|0|||
46968406|NCT02179918|83211175|FG002|Overall Study|Lost to Follow-up|1|||
46968407|NCT02179918|83211176|FG003|Overall Study|Lost to Follow-up|0|||
46968408|NCT02179918|83211177|FG004|Overall Study|Lost to Follow-up|0|||
46968409|NCT02179918|83211173|FG000|Overall Study|Progressive Disease|4|||
46968410|NCT02179918|83211174|FG001|Overall Study|Progressive Disease|1|||
46968411|NCT02179918|83211175|FG002|Overall Study|Progressive Disease|1|||
46968412|NCT02179918|83211176|FG003|Overall Study|Progressive Disease|2|||
46968413|NCT02179918|83211177|FG004|Overall Study|Progressive Disease|6|||
46968414|NCT02179918|83211173|FG000|Overall Study|Other|0|||
46968415|NCT02179918|83211174|FG001|Overall Study|Other|1|||
46968416|NCT02179918|83211175|FG002|Overall Study|Other|0|||
46968417|NCT02179918|83211176|FG003|Overall Study|Other|0|||
46968418|NCT02179918|83211177|FG004|Overall Study|Other|1|||
46968419|NCT02179918|83211173|FG000|Overall Study|Subject refused further follow-up|0|||
46968420|NCT02179918|83211174|FG001|Overall Study|Subject refused further follow-up|1|||
46968421|NCT02179918|83211175|FG002|Overall Study|Subject refused further follow-up|0|||
46968422|NCT02179918|83211176|FG003|Overall Study|Subject refused further follow-up|0|||
46968423|NCT02179918|83211177|FG004|Overall Study|Subject refused further follow-up|1|||
46968424|NCT02611479|83211190|FG000|Baseline Enrollment|Exited study|13|||
46968425|NCT02611479|83211190|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
46968426|NCT02611479|83211190|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
46968427|NCT02611479|83211190|FG000|Data Cleaning|No baseline function or pain metrics|2|||
46968428|NCT02153788|83211196|FG000|Overall Study|Physician Decision|2|||
46968429|NCT02153788|83211197|FG001|Overall Study|Physician Decision|1|||
46968430|NCT02153398|83211208|FG000|Overall Study|Withdrawal by Subject|1|||
46968431|NCT02153398|83211209|FG001|Overall Study|Withdrawal by Subject|0|||
46847393|NCT04124926|83064156|FG002|Maintenance Phase|Pregnancy|0|||
46847394|NCT04124926|83064157|FG003|Maintenance Phase|Pregnancy|1|||
46847395|NCT04124926|83064158|FG004|Maintenance Phase|Pregnancy|0|||
46847396|NCT04124926|83064154|FG000|Maintenance Phase|Lack of Efficacy|0|||
46847397|NCT04124926|83064155|FG001|Maintenance Phase|Lack of Efficacy|0|||
46847398|NCT04124926|83064156|FG002|Maintenance Phase|Lack of Efficacy|0|||
46847399|NCT04124926|83064157|FG003|Maintenance Phase|Lack of Efficacy|0|||
46847400|NCT04124926|83064158|FG004|Maintenance Phase|Lack of Efficacy|1|||
46847401|NCT04124926|83064154|FG000|Maintenance Phase|Withdrawal of Consent|0|||
46847402|NCT04124926|83064155|FG001|Maintenance Phase|Withdrawal of Consent|0|||
46847403|NCT04124926|83064156|FG002|Maintenance Phase|Withdrawal of Consent|5|||
46847404|NCT04124926|83064157|FG003|Maintenance Phase|Withdrawal of Consent|5|||
46847405|NCT04124926|83064158|FG004|Maintenance Phase|Withdrawal of Consent|5|||
46847406|NCT04124926|83064154|FG000|Maintenance Phase|Miscellaneous|0|||
46847407|NCT04124926|83064155|FG001|Maintenance Phase|Miscellaneous|0|||
46847408|NCT04124926|83064156|FG002|Maintenance Phase|Miscellaneous|1|||
46847409|NCT04124926|83064157|FG003|Maintenance Phase|Miscellaneous|2|||
46847410|NCT04124926|83064158|FG004|Maintenance Phase|Miscellaneous|4|||
46847411|NCT04124926|83064154|FG000|Maintenance Phase|Randomized but not Treated|0|||
46847412|NCT04124926|83064155|FG001|Maintenance Phase|Randomized but not Treated|0|||
46847413|NCT04124926|83064156|FG002|Maintenance Phase|Randomized but not Treated|2|||
46968432|NCT02153398|83211210|FG002|Overall Study|Withdrawal by Subject|0|||
46968433|NCT02153398|83211211|FG003|Overall Study|Withdrawal by Subject|0|||
46847414|NCT04124926|83064157|FG003|Maintenance Phase|Randomized but not Treated|2|||
46847415|NCT04124926|83064158|FG004|Maintenance Phase|Randomized but not Treated|0|||
46847416|NCT04274686|83064170|FG000|Overall Study|Physician Decision|1|||
46968434|NCT02153398|83211212|FG004|Overall Study|Withdrawal by Subject|0|||
46968435|NCT02153398|83211208|FG000|Overall Study|Adverse Event|0|||
46968436|NCT02153398|83211209|FG001|Overall Study|Adverse Event|0|||
46968437|NCT02153398|83211210|FG002|Overall Study|Adverse Event|1|||
46847417|NCT04274686|83064171|FG001|Overall Study|Physician Decision|0|||
46847418|NCT04113694|83064179|FG000|Overall Study|Adverse Event|2|||
46847419|NCT04113694|83064179|FG000|Overall Study|Lost to Follow-up|2|||
46847420|NCT04113694|83064179|FG000|Overall Study|Withdrawal by Subject|6|||
46847421|NCT04113694|83064179|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
46968438|NCT02153398|83211211|FG003|Overall Study|Adverse Event|1|||
46968439|NCT02153398|83211212|FG004|Overall Study|Adverse Event|0|||
46968440|NCT02118766|83211226|FG000|Overall Study|Adverse Event|7|||
46847422|NCT04105972|83064188|FG000|Overall Study|Adverse Event|2|||
46847423|NCT04105972|83064189|FG001|Overall Study|Adverse Event|1|||
46847424|NCT04102540|83064195|FG000|Overall Study|Withdrawn by PI|2|||
46847425|NCT04102540|83064195|FG000|Overall Study|Lost to Follow-up|6|||
46847426|NCT00124982|83064201|FG000|Short-term Period|Death|1|||
46847427|NCT00124982|83064202|FG001|Short-term Period|Death|1|||
46847428|NCT00124982|83064203|FG002|Short-term Period|Death|0|||
46847429|NCT00124982|83064201|FG000|Short-term Period|Adverse Event|17|||
46847430|NCT00124982|83064202|FG001|Short-term Period|Adverse Event|22|||
46847431|NCT00124982|83064203|FG002|Short-term Period|Adverse Event|0|||
46847432|NCT00124982|83064201|FG000|Short-term Period|Lack of Efficacy|32|||
46968441|NCT02118766|83211227|FG001|Overall Study|Adverse Event|2|||
46968442|NCT02118766|83211226|FG000|Overall Study|Withdrawal by Subject|3|||
46968443|NCT02118766|83211227|FG001|Overall Study|Withdrawal by Subject|6|||
46968444|NCT02118766|83211226|FG000|Overall Study|Lost to Follow-up|5|||
46968445|NCT02118766|83211227|FG001|Overall Study|Lost to Follow-up|4|||
46968446|NCT02118766|83211226|FG000|Overall Study|Withdrawal by parent/guardian|12|||
46968447|NCT02118766|83211227|FG001|Overall Study|Withdrawal by parent/guardian|18|||
46968448|NCT02118766|83211226|FG000|Overall Study|Other|3|||
46968449|NCT02118766|83211227|FG001|Overall Study|Other|1|||
46968450|NCT02614287|83211235|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
46968451|NCT02614287|83211236|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
46968452|NCT02614287|83211235|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
46968453|NCT02614287|83211236|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
46968454|NCT02614287|83211235|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
46968455|NCT02614287|83211236|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
46968456|NCT02614287|83211235|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
46968457|NCT02614287|83211236|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
46968458|NCT02614287|83211235|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
46968459|NCT02614287|83211236|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
46968460|NCT02614287|83211235|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
46968461|NCT02614287|83211236|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
46968462|NCT02614287|83211235|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
46968463|NCT02614287|83211236|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
46968464|NCT02614287|83211235|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
46968465|NCT02614287|83211236|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
46968466|NCT01374971|83211247|FG000|Overall Study|Withdrawal by Subject|1|||
46968467|NCT02178592|83211253|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
46968468|NCT02178592|83211254|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
46968469|NCT02178592|83211253|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
46968470|NCT02178592|83211254|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
46968471|NCT02178592|83211253|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
46968472|NCT02178592|83211254|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
46968473|NCT02178592|83211253|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
46968474|NCT02178592|83211254|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
46968475|NCT02178592|83211253|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
47073345|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
47073346|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
47073347|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
46847433|NCT00124982|83064202|FG001|Short-term Period|Lack of Efficacy|73|||
46847434|NCT00124982|83064203|FG002|Short-term Period|Lack of Efficacy|0|||
46847435|NCT00124982|83064201|FG000|Short-term Period|Lost to Follow-up|8|||
46847436|NCT00124982|83064202|FG001|Short-term Period|Lost to Follow-up|5|||
47073348|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
46776458|NCT00784277|82994928|FG003|IR Treatment|Withdrawal by Subject|6|||
46776459|NCT00784277|82994929|FG004|IR Treatment|Withdrawal by Subject|0|||
46776460|NCT00784277|82994930|FG005|IR Treatment|Withdrawal by Subject|0|||
46776461|NCT00784277|82994931|FG006|IR Treatment|Withdrawal by Subject|0|||
46776462|NCT00784277|82994925|FG000|IR Treatment|Resolution Of Pain|0|||
46776463|NCT00784277|82994926|FG001|IR Treatment|Resolution Of Pain|1|||
46776464|NCT00784277|82994927|FG002|IR Treatment|Resolution Of Pain|0|||
46776465|NCT00784277|82994928|FG003|IR Treatment|Resolution Of Pain|0|||
46776466|NCT00784277|82994929|FG004|IR Treatment|Resolution Of Pain|0|||
46847437|NCT00124982|83064203|FG002|Short-term Period|Lost to Follow-up|0|||
46847438|NCT00124982|83064201|FG000|Short-term Period|Withdrawal of Consent|7|||
46968476|NCT02178592|83211254|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
46968477|NCT02178592|83211253|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
46968478|NCT02178592|83211254|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
46968479|NCT02178592|83211253|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
46776467|NCT00784277|82994930|FG005|IR Treatment|Resolution Of Pain|0|||
46776468|NCT00784277|82994931|FG006|IR Treatment|Resolution Of Pain|0|||
46776469|NCT00784277|82994925|FG000|IR Treatment|Other|2|||
46847439|NCT00124982|83064202|FG001|Short-term Period|Withdrawal of Consent|9|||
46847440|NCT00124982|83064203|FG002|Short-term Period|Withdrawal of Consent|0|||
46847441|NCT00124982|83064201|FG000|Short-term Period|Poor/Non-compliance|3|||
46847442|NCT00124982|83064202|FG001|Short-term Period|Poor/Non-compliance|1|||
46847443|NCT00124982|83064203|FG002|Short-term Period|Poor/Non-compliance|0|||
46847444|NCT00124982|83064201|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
46847445|NCT00124982|83064202|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
46847446|NCT00124982|83064203|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
46847447|NCT00124982|83064201|FG000|Short-term Period|Participant Decision|1|||
46847448|NCT00124982|83064202|FG001|Short-term Period|Participant Decision|0|||
46847449|NCT00124982|83064203|FG002|Short-term Period|Participant Decision|0|||
46847450|NCT00124982|83064201|FG000|Short-term Period|Participant Chose Own Doctor|0|||
46847451|NCT00124982|83064202|FG001|Short-term Period|Participant Chose Own Doctor|1|||
46847452|NCT00124982|83064203|FG002|Short-term Period|Participant Chose Own Doctor|0|||
46847453|NCT00124982|83064201|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
46847454|NCT00124982|83064202|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
46847455|NCT00124982|83064203|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
46847456|NCT00124982|83064201|FG000|Short-term Period|Participant Had Lymphopenia|1|||
46847457|NCT00124982|83064202|FG001|Short-term Period|Participant Had Lymphopenia|0|||
46847458|NCT00124982|83064203|FG002|Short-term Period|Participant Had Lymphopenia|0|||
46847459|NCT00124982|83064201|FG000|Long-term Period|Death|0|||
46847460|NCT00124982|83064202|FG001|Long-term Period|Death|0|||
46847461|NCT00124982|83064203|FG002|Long-term Period|Death|1|||
46847462|NCT00124982|83064201|FG000|Long-term Period|Adverse Event|0|||
46847463|NCT00124982|83064202|FG001|Long-term Period|Adverse Event|0|||
46847464|NCT00124982|83064203|FG002|Long-term Period|Adverse Event|17|||
46847465|NCT00124982|83064201|FG000|Long-term Period|Lack of Efficacy|0|||
46847466|NCT00124982|83064202|FG001|Long-term Period|Lack of Efficacy|0|||
46847467|NCT00124982|83064203|FG002|Long-term Period|Lack of Efficacy|46|||
46847468|NCT00124982|83064201|FG000|Long-term Period|Lost to Follow-up|0|||
46847469|NCT00124982|83064202|FG001|Long-term Period|Lost to Follow-up|0|||
46847470|NCT00124982|83064203|FG002|Long-term Period|Lost to Follow-up|4|||
46847471|NCT00124982|83064201|FG000|Long-term Period|Withdrawal by Subject|0|||
46847472|NCT00124982|83064202|FG001|Long-term Period|Withdrawal by Subject|0|||
46847473|NCT00124982|83064203|FG002|Long-term Period|Withdrawal by Subject|16|||
46847474|NCT00124982|83064201|FG000|Long-term Period|Pregnancy|0|||
46847475|NCT00124982|83064202|FG001|Long-term Period|Pregnancy|0|||
46847476|NCT00124982|83064203|FG002|Long-term Period|Pregnancy|1|||
46847477|NCT00124982|83064201|FG000|Long-term Period|Poor/Non-compliance|0|||
46847478|NCT00124982|83064202|FG001|Long-term Period|Poor/Non-compliance|0|||
46847479|NCT00124982|83064203|FG002|Long-term Period|Poor/Non-compliance|2|||
46847480|NCT00124982|83064201|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
46847481|NCT00124982|83064202|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
46847482|NCT00124982|83064203|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
46847483|NCT00124982|83064201|FG000|Long-term Period|Neurologist Recommendation|0|||
46847484|NCT00124982|83064202|FG001|Long-term Period|Neurologist Recommendation|0|||
46847485|NCT00124982|83064203|FG002|Long-term Period|Neurologist Recommendation|1|||
46847486|NCT04263142|83064217|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
46847487|NCT04263142|83064218|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
46847488|NCT04263142|83064219|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
46847489|NCT04263142|83064220|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
46847490|NCT04263142|83064221|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
46847491|NCT04263142|83064217|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
46847492|NCT04263142|83064218|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
46847493|NCT04263142|83064219|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
46847494|NCT04263142|83064220|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
46847495|NCT04263142|83064221|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
46847496|NCT04095286|83064234|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847497|NCT04095286|83064235|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
46847498|NCT04095286|83064236|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847499|NCT04095286|83064237|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847500|NCT04095286|83064238|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847501|NCT04095286|83064239|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847502|NCT04095286|83064234|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
46847503|NCT04095286|83064235|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
46847504|NCT04095286|83064236|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
46847505|NCT04095286|83064237|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
46847506|NCT04095286|83064238|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
46847507|NCT04095286|83064239|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
46847508|NCT04095286|83064234|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
46847509|NCT04095286|83064235|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
46847510|NCT04095286|83064236|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
46968480|NCT02178592|83211254|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
46847511|NCT04095286|83064237|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
46847512|NCT04095286|83064238|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
46847513|NCT04095286|83064239|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
46847514|NCT04095286|83064234|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847515|NCT04095286|83064235|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847516|NCT04095286|83064236|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
46847517|NCT04095286|83064237|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847518|NCT04095286|83064238|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847519|NCT04095286|83064239|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
46847520|NCT04095286|83064234|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
46847521|NCT04095286|83064235|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
46847522|NCT04095286|83064236|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
46847523|NCT04095286|83064237|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
46847524|NCT04095286|83064238|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
46847525|NCT04095286|83064239|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
46968481|NCT02178592|83211253|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
46968482|NCT02178592|83211254|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
46968483|NCT02178592|83211253|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
46642103|NCT02616185|82831477|FG004|Overall Study|Participant refused further follow-up|4|||
46776470|NCT00784277|82994926|FG001|IR Treatment|Other|3|||
46776471|NCT00784277|82994927|FG002|IR Treatment|Other|3|||
46776472|NCT00784277|82994928|FG003|IR Treatment|Other|2|||
46776473|NCT00784277|82994929|FG004|IR Treatment|Other|0|||
46776474|NCT00784277|82994930|FG005|IR Treatment|Other|0|||
46776475|NCT00784277|82994931|FG006|IR Treatment|Other|0|||
46776476|NCT00784277|82994925|FG000|ER Treatment|Adverse Event|0|||
46776477|NCT00784277|82994926|FG001|ER Treatment|Adverse Event|0|||
46776478|NCT00784277|82994927|FG002|ER Treatment|Adverse Event|0|||
46776479|NCT00784277|82994928|FG003|ER Treatment|Adverse Event|0|||
46776480|NCT00784277|82994929|FG004|ER Treatment|Adverse Event|1|||
46776481|NCT00784277|82994930|FG005|ER Treatment|Adverse Event|7|||
46776482|NCT00784277|82994931|FG006|ER Treatment|Adverse Event|7|||
46776483|NCT00784277|82994925|FG000|ER Treatment|Lack of Efficacy|0|||
46776484|NCT00784277|82994926|FG001|ER Treatment|Lack of Efficacy|0|||
46776485|NCT00784277|82994927|FG002|ER Treatment|Lack of Efficacy|0|||
46776486|NCT00784277|82994928|FG003|ER Treatment|Lack of Efficacy|0|||
46776487|NCT00784277|82994929|FG004|ER Treatment|Lack of Efficacy|3|||
46776488|NCT00784277|82994930|FG005|ER Treatment|Lack of Efficacy|4|||
46776489|NCT00784277|82994931|FG006|ER Treatment|Lack of Efficacy|0|||
46776490|NCT00784277|82994925|FG000|ER Treatment|Lost to Follow-up|0|||
46776491|NCT00784277|82994926|FG001|ER Treatment|Lost to Follow-up|0|||
46776492|NCT00784277|82994927|FG002|ER Treatment|Lost to Follow-up|0|||
46776493|NCT00784277|82994928|FG003|ER Treatment|Lost to Follow-up|0|||
46776494|NCT00784277|82994929|FG004|ER Treatment|Lost to Follow-up|0|||
46776495|NCT00784277|82994930|FG005|ER Treatment|Lost to Follow-up|2|||
46776496|NCT00784277|82994931|FG006|ER Treatment|Lost to Follow-up|0|||
46776497|NCT00784277|82994925|FG000|ER Treatment|Withdrawal by Subject|0|||
46776498|NCT00784277|82994926|FG001|ER Treatment|Withdrawal by Subject|0|||
46776499|NCT00784277|82994927|FG002|ER Treatment|Withdrawal by Subject|0|||
46776500|NCT00784277|82994928|FG003|ER Treatment|Withdrawal by Subject|0|||
46776501|NCT00784277|82994929|FG004|ER Treatment|Withdrawal by Subject|2|||
46776502|NCT00784277|82994930|FG005|ER Treatment|Withdrawal by Subject|5|||
46776503|NCT00784277|82994931|FG006|ER Treatment|Withdrawal by Subject|3|||
46776504|NCT00784277|82994925|FG000|ER Treatment|Study Medication Non-Compliant|0|||
46776505|NCT00784277|82994926|FG001|ER Treatment|Study Medication Non-Compliant|0|||
46776506|NCT00784277|82994927|FG002|ER Treatment|Study Medication Non-Compliant|0|||
46776507|NCT00784277|82994928|FG003|ER Treatment|Study Medication Non-Compliant|0|||
46776508|NCT00784277|82994929|FG004|ER Treatment|Study Medication Non-Compliant|2|||
46776509|NCT00784277|82994930|FG005|ER Treatment|Study Medication Non-Compliant|3|||
46776510|NCT00784277|82994931|FG006|ER Treatment|Study Medication Non-Compliant|3|||
46968484|NCT02178592|83211254|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
46776511|NCT00784277|82994925|FG000|ER Treatment|Other|0|||
46776512|NCT00784277|82994926|FG001|ER Treatment|Other|0|||
46776513|NCT00784277|82994927|FG002|ER Treatment|Other|0|||
46776514|NCT00784277|82994928|FG003|ER Treatment|Other|0|||
46776515|NCT00784277|82994929|FG004|ER Treatment|Other|1|||
46776516|NCT00784277|82994930|FG005|ER Treatment|Other|3|||
46776517|NCT00784277|82994931|FG006|ER Treatment|Other|2|||
46776518|NCT00682929|82994947|FG000|Overall Study|Adverse Event|4|||
46776519|NCT00682929|82994948|FG001|Overall Study|Adverse Event|1|||
46776520|NCT00682929|82994949|FG002|Overall Study|Adverse Event|1|||
46776521|NCT00682929|82994947|FG000|Overall Study|Withdrawal by Subject|1|||
46776522|NCT00682929|82994948|FG001|Overall Study|Withdrawal by Subject|2|||
46776523|NCT00682929|82994949|FG002|Overall Study|Withdrawal by Subject|1|||
46776524|NCT00682929|82994947|FG000|Overall Study|dosing compliance < 80%|0|||
46847526|NCT04093414|83064249|FG000|3 Month Follow up|Physician Decision|0|||
46847527|NCT04093414|83064250|FG001|3 Month Follow up|Physician Decision|1|||
46847528|NCT04093414|83064249|FG000|6month Follow up|Physician Decision|1|||
46847529|NCT04093414|83064250|FG001|6month Follow up|Physician Decision|3|||
46847530|NCT04093258|83064256|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
46847531|NCT04093258|83064257|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
46847532|NCT04253236|83064265|FG000|Overall Study|Adverse Event|1|||
46847533|NCT04253236|83064266|FG001|Overall Study|Adverse Event|0|||
46847534|NCT04253236|83064265|FG000|Overall Study|Safety Concerns|1|||
46847535|NCT04253236|83064266|FG001|Overall Study|Safety Concerns|0|||
46847536|NCT04253236|83064265|FG000|Overall Study|Study Terminated by Sponsor|1|||
46847537|NCT04253236|83064266|FG001|Overall Study|Study Terminated by Sponsor|0|||
46847538|NCT04087720|83064272|FG000|Overall Study|Withdrawal by Subject|2|||
46847539|NCT04087720|83064272|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
46847540|NCT04086472|83064281|FG000|Overall Study|Lost to Follow-up|1|||
46847541|NCT04086472|83064282|FG001|Overall Study|Lost to Follow-up|0|||
46847542|NCT04086472|83064283|FG002|Overall Study|Lost to Follow-up|0|||
46847543|NCT04086472|83064284|FG003|Overall Study|Lost to Follow-up|0|||
46847544|NCT04086472|83064285|FG004|Overall Study|Lost to Follow-up|1|||
46847545|NCT04086472|83064281|FG000|Overall Study|Physician Decision|0|||
46847546|NCT04086472|83064282|FG001|Overall Study|Physician Decision|1|||
46847547|NCT04086472|83064283|FG002|Overall Study|Physician Decision|1|||
46847548|NCT04086472|83064284|FG003|Overall Study|Physician Decision|0|||
46847549|NCT04086472|83064285|FG004|Overall Study|Physician Decision|0|||
46847550|NCT04086472|83064281|FG000|Overall Study|Withdrawal by Subject|1|||
46847551|NCT04086472|83064282|FG001|Overall Study|Withdrawal by Subject|1|||
46847552|NCT04086472|83064283|FG002|Overall Study|Withdrawal by Subject|1|||
46847553|NCT04086472|83064284|FG003|Overall Study|Withdrawal by Subject|0|||
46847554|NCT04086472|83064285|FG004|Overall Study|Withdrawal by Subject|0|||
46847555|NCT04086472|83064281|FG000|Overall Study|Various reasons|2|||
46847556|NCT04086472|83064282|FG001|Overall Study|Various reasons|0|||
46847557|NCT04086472|83064283|FG002|Overall Study|Various reasons|0|||
46847558|NCT04086472|83064284|FG003|Overall Study|Various reasons|3|||
46847559|NCT04086472|83064285|FG004|Overall Study|Various reasons|1|||
46847560|NCT04249336|83064301|FG000|Overall Study|Lost to Follow-up|3|||
46847561|NCT04249336|83064302|FG001|Overall Study|Lost to Follow-up|3|||
46847562|NCT04249336|83064303|FG002|Overall Study|Lost to Follow-up|3|||
46847563|NCT04249336|83064304|FG003|Overall Study|Lost to Follow-up|3|||
46847564|NCT04245202|83064316|FG000|Overall Study|Lack of Efficacy|10|||
46968485|NCT02178592|83211253|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
46968486|NCT02178592|83211254|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
46968487|NCT02178592|83211253|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
46968488|NCT02178592|83211254|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
46642104|NCT02616185|82831478|FG005|Overall Study|Participant refused further follow-up|0|||
46642105|NCT02616185|82831479|FG006|Overall Study|Participant refused further follow-up|3|||
46642106|NCT02616185|82831480|FG007|Overall Study|Participant refused further follow-up|4|||
46642107|NCT02616185|82831481|FG008|Overall Study|Participant refused further follow-up|3|||
46776525|NCT00682929|82994948|FG001|Overall Study|dosing compliance < 80%|2|||
46847565|NCT04245202|83064317|FG001|Overall Study|Lack of Efficacy|1|||
46847566|NCT04079842|83064324|FG000|Overall Study|Request of subject|2|||
46776526|NCT00682929|82994949|FG002|Overall Study|dosing compliance < 80%|0|||
46776527|NCT00682929|82994947|FG000|Overall Study|lag in DEA renewal|1|||
46776528|NCT00682929|82994948|FG001|Overall Study|lag in DEA renewal|0|||
46776529|NCT00682929|82994949|FG002|Overall Study|lag in DEA renewal|0|||
46776530|NCT00680745|82994961|FG000|Overall Study|Withdrawal by Subject|8|||
46776531|NCT00680745|82994962|FG001|Overall Study|Withdrawal by Subject|3|||
46776532|NCT00680745|82994963|FG002|Overall Study|Withdrawal by Subject|2|||
46776533|NCT00680745|82994964|FG003|Overall Study|Withdrawal by Subject|8|||
46776534|NCT00680745|82994961|FG000|Overall Study|Lost to Follow-up|0|||
46776535|NCT00680745|82994962|FG001|Overall Study|Lost to Follow-up|1|||
46776536|NCT00680745|82994963|FG002|Overall Study|Lost to Follow-up|1|||
46776537|NCT00680745|82994964|FG003|Overall Study|Lost to Follow-up|0|||
46776538|NCT00680745|82994961|FG000|Overall Study|Death|1|||
46847567|NCT04079842|83064324|FG000|Overall Study|Unable to draw Arterial samples|1|||
46847568|NCT04078126|83064328|FG000|Washout|Study put on hold due to COVID-19|0|||
46847569|NCT04078126|83064329|FG001|Washout|Study put on hold due to COVID-19|2|||
46847570|NCT04078126|83064328|FG000|Period 2|Study put on hold due to COVID-19|1|||
46847571|NCT04078126|83064329|FG001|Period 2|Study put on hold due to COVID-19|1|||
46847572|NCT04073368|83064339|FG000|Overall Study|Adverse Event|2|||
46847573|NCT04073368|83064340|FG001|Overall Study|Adverse Event|0|||
46847574|NCT04073368|83064341|FG002|Overall Study|Adverse Event|1|||
46847575|NCT04073368|83064342|FG003|Overall Study|Adverse Event|1|||
46776539|NCT00680745|82994962|FG001|Overall Study|Death|0|||
46776540|NCT00680745|82994963|FG002|Overall Study|Death|1|||
46776541|NCT00680745|82994964|FG003|Overall Study|Death|0|||
46776542|NCT00680745|82994961|FG000|Overall Study|Adverse Event|5|||
46847576|NCT04073368|83064339|FG000|Overall Study|Withdrawal by Subject|2|||
46847577|NCT04073368|83064340|FG001|Overall Study|Withdrawal by Subject|2|||
46847578|NCT04073368|83064341|FG002|Overall Study|Withdrawal by Subject|1|||
46847579|NCT04073368|83064342|FG003|Overall Study|Withdrawal by Subject|1|||
46847580|NCT04073368|83064339|FG000|Overall Study|Lost to Follow-up|1|||
46847581|NCT04073368|83064340|FG001|Overall Study|Lost to Follow-up|1|||
46847582|NCT04073368|83064341|FG002|Overall Study|Lost to Follow-up|1|||
46847583|NCT04073368|83064342|FG003|Overall Study|Lost to Follow-up|0|||
46847584|NCT04073368|83064339|FG000|Overall Study|Protocol Violation|0|||
46847585|NCT04073368|83064340|FG001|Overall Study|Protocol Violation|1|||
46847586|NCT04073368|83064341|FG002|Overall Study|Protocol Violation|0|||
46847587|NCT04073368|83064342|FG003|Overall Study|Protocol Violation|0|||
46847588|NCT04073368|83064339|FG000|Overall Study|Subject noncompliance|7|||
46847589|NCT04073368|83064340|FG001|Overall Study|Subject noncompliance|4|||
46847590|NCT04073368|83064341|FG002|Overall Study|Subject noncompliance|0|||
46847591|NCT04073368|83064342|FG003|Overall Study|Subject noncompliance|0|||
46847592|NCT04380688|83064354|FG000|Overall Study|Death|2|||
46847593|NCT04380688|83064355|FG001|Overall Study|Death|2|||
46847594|NCT04380688|83064354|FG000|Overall Study|Lost to Follow-up|2|||
46847595|NCT04380688|83064355|FG001|Overall Study|Lost to Follow-up|4|||
46847596|NCT04380688|83064354|FG000|Overall Study|Withdrawal by Subject|3|||
46847597|NCT04380688|83064355|FG001|Overall Study|Withdrawal by Subject|3|||
46847598|NCT00124748|83064363|FG000|Overall Study|Adverse Event|8|||
46847599|NCT00124748|83064364|FG001|Overall Study|Adverse Event|39|||
46847600|NCT00124748|83064363|FG000|Overall Study|Abnormal laboratory Value|2|||
46847601|NCT00124748|83064364|FG001|Overall Study|Abnormal laboratory Value|2|||
46847602|NCT00124748|83064363|FG000|Overall Study|Abnormal Procedure|0|||
46847603|NCT00124748|83064364|FG001|Overall Study|Abnormal Procedure|1|||
46847604|NCT00124748|83064363|FG000|Overall Study|Lack of Efficacy|20|||
46847605|NCT00124748|83064364|FG001|Overall Study|Lack of Efficacy|41|||
46847606|NCT00124748|83064363|FG000|Overall Study|No longer requires study drug|1|||
46847607|NCT00124748|83064364|FG001|Overall Study|No longer requires study drug|1|||
46847608|NCT00124748|83064363|FG000|Overall Study|Protocol Violation|3|||
46847609|NCT00124748|83064364|FG001|Overall Study|Protocol Violation|1|||
46847610|NCT00124748|83064363|FG000|Overall Study|Withdrawal by Subject|5|||
46847611|NCT00124748|83064364|FG001|Overall Study|Withdrawal by Subject|15|||
46847612|NCT00124748|83064363|FG000|Overall Study|Lost to Follow-up|2|||
46847613|NCT00124748|83064364|FG001|Overall Study|Lost to Follow-up|7|||
46847614|NCT00124748|83064363|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
46847615|NCT00124748|83064364|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
46847616|NCT00124748|83064363|FG000|Overall Study|Death|1|||
46776543|NCT00680745|82994962|FG001|Overall Study|Adverse Event|3|||
46776544|NCT00680745|82994963|FG002|Overall Study|Adverse Event|3|||
46847617|NCT00124748|83064364|FG001|Overall Study|Death|3|||
46847618|NCT04070326|83064372|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
46847619|NCT04070326|83064373|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
46847620|NCT03689452|83064383|FG000|Overall Study|Lost to Follow-up|1|||
46776545|NCT00680745|82994964|FG003|Overall Study|Adverse Event|3|||
46776546|NCT00680745|82994961|FG000|Overall Study|Poor/Non-compliance|0|||
46776547|NCT00680745|82994962|FG001|Overall Study|Poor/Non-compliance|3|||
46776548|NCT00680745|82994963|FG002|Overall Study|Poor/Non-compliance|0|||
46776549|NCT00680745|82994964|FG003|Overall Study|Poor/Non-compliance|0|||
46776550|NCT00680745|82994961|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
46776551|NCT00680745|82994962|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
46847621|NCT03689452|83064384|FG001|Overall Study|Lost to Follow-up|1|||
46847622|NCT04067050|83064392|FG000|One Month|Lost to Follow-up|4|||
46847623|NCT04067050|83064393|FG001|One Month|Lost to Follow-up|0|||
46847624|NCT04067050|83064392|FG000|Two Month|Lost to Follow-up|1|||
46776552|NCT00680745|82994963|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
46776553|NCT00680745|82994964|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
46776554|NCT00680745|82994961|FG000|Overall Study|False Treatment|0|||
46776555|NCT00680745|82994962|FG001|Overall Study|False Treatment|1|||
46776556|NCT00680745|82994963|FG002|Overall Study|False Treatment|3|||
46847625|NCT04067050|83064393|FG001|Two Month|Lost to Follow-up|0|||
46847626|NCT04067050|83064392|FG000|Two Month|Adverse Event|1|||
46847627|NCT04067050|83064393|FG001|Two Month|Adverse Event|0|||
46847628|NCT04060654|83064399|FG000|Overall Study|Withdrawal by Subject|1|||
46776557|NCT00680745|82994964|FG003|Overall Study|False Treatment|0|||
46776558|NCT00680121|82994977|FG000|Overall Study|Lost to Follow-up|27|||
46847629|NCT04060654|83064399|FG000|Overall Study|Lost to Follow-up|5|||
46847630|NCT00096200|83064406|FG000|Overall Study|Adverse Event|0|||
46847631|NCT00096200|83064407|FG001|Overall Study|Adverse Event|4|||
46847632|NCT00096200|83064408|FG002|Overall Study|Adverse Event|0|||
46847633|NCT00096200|83064406|FG000|Overall Study|Withdrawal by Subject|1|||
46847634|NCT00096200|83064407|FG001|Overall Study|Withdrawal by Subject|2|||
46847635|NCT00096200|83064408|FG002|Overall Study|Withdrawal by Subject|0|||
46847636|NCT00096200|83064406|FG000|Overall Study|Ineligible pathology|0|||
46847637|NCT00096200|83064407|FG001|Overall Study|Ineligible pathology|1|||
46847638|NCT00096200|83064408|FG002|Overall Study|Ineligible pathology|0|||
46847639|NCT04059094|83064421|FG000|Overall Study|Adverse Event|0|||
46847640|NCT04059094|83064422|FG001|Overall Study|Adverse Event|0|||
46847641|NCT04059094|83064423|FG002|Overall Study|Adverse Event|0|||
46847642|NCT04059094|83064424|FG003|Overall Study|Adverse Event|0|||
46847643|NCT04059094|83064425|FG004|Overall Study|Adverse Event|1|||
46847644|NCT04059094|83064421|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
46847645|NCT04059094|83064422|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
46847646|NCT04059094|83064423|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
46847647|NCT04059094|83064424|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
46847648|NCT04059094|83064425|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
46847649|NCT00096044|83064441|FG000|Overall Study|Withdrawal by Subject|9|||
46847650|NCT00096044|83064441|FG000|Overall Study|Adverse Event|21|||
46847651|NCT00096044|83064441|FG000|Overall Study|Disease Progression|4|||
46847652|NCT03689374|83064447|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
46847653|NCT03689374|83064448|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
46847654|NCT03689374|83064449|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
46847655|NCT03689374|83064447|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
46847656|NCT03689374|83064448|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
46847657|NCT03689374|83064449|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
46776559|NCT00680121|82994978|FG001|Overall Study|Lost to Follow-up|23|||
46776560|NCT00767819|82994987|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
46776561|NCT00767819|82994988|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
46776562|NCT00767819|82994989|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
46776563|NCT00767819|82994987|FG000|Overall Study|Withdrawal by Subject|1|||
46776564|NCT00767819|82994988|FG001|Overall Study|Withdrawal by Subject|1|||
46776565|NCT00767819|82994989|FG002|Overall Study|Withdrawal by Subject|0|||
46776566|NCT00767819|82994987|FG000|Overall Study|Administrative problems|0|||
46847658|NCT03689374|83064447|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
46847659|NCT03689374|83064448|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
46968489|NCT02178592|83211253|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
46968490|NCT02178592|83211254|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
46968491|NCT02610777|83211265|FG000|Overall Study|Lost to Follow-up|1|||
46968492|NCT02610777|83211266|FG001|Overall Study|Lost to Follow-up|0|||
46968493|NCT02610777|83211265|FG000|Overall Study|Site Terminated by Sponsor|9|||
46968494|NCT02610777|83211266|FG001|Overall Study|Site Terminated by Sponsor|8|||
46968495|NCT02610777|83211265|FG000|Overall Study|Withdrawal by Subject|2|||
46968496|NCT02610777|83211266|FG001|Overall Study|Withdrawal by Subject|2|||
46968497|NCT02610777|83211265|FG000|Overall Study|Reason not Specified|0|||
46968498|NCT02610777|83211266|FG001|Overall Study|Reason not Specified|1|||
46968499|NCT02610777|83211265|FG000|Overall Study|Death|50|||
46968500|NCT02610777|83211266|FG001|Overall Study|Death|47|||
46968501|NCT01628692|83211280|FG000|Overall Study|Lack of Efficacy|4|||
46968502|NCT01628692|83211281|FG001|Overall Study|Lack of Efficacy|4|||
47073349|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
47073350|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
47073351|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
47073352|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
47073353|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
47073354|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
47073355|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
47073356|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
47073357|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
47073358|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
47073359|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
47073360|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
47073361|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
47073362|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
46968503|NCT01628692|83211282|FG002|Overall Study|Lack of Efficacy|5|||
47073363|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
47073364|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
46847660|NCT03689374|83064449|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
46847661|NCT03689374|83064447|FG000|Treatment Period (Week 0 to 52)|Death|0|||
46847662|NCT03689374|83064448|FG001|Treatment Period (Week 0 to 52)|Death|11|||
46847663|NCT03689374|83064449|FG002|Treatment Period (Week 0 to 52)|Death|1|||
46847664|NCT00123734|83064455|FG000|Overall Study|Death|3|||
46968504|NCT01628692|83211283|FG003|Overall Study|Lack of Efficacy|1|||
46968505|NCT01628692|83211284|FG004|Overall Study|Lack of Efficacy|4|||
46968506|NCT01628692|83211285|FG005|Overall Study|Lack of Efficacy|7|||
46847665|NCT00123734|83064455|FG000|Overall Study|Lost to Follow-up|3|||
46847666|NCT00123734|83064455|FG000|Overall Study|Dropout|1|||
46847667|NCT00123734|83064455|FG000|Overall Study|Withdrawal by Subject|1|||
46847668|NCT00112736|83064465|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
46847669|NCT00112736|83064466|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
46847670|NCT00123422|83064481|FG000|Overall Study|Physician Decision|2|||
46847671|NCT00123422|83064482|FG001|Overall Study|Physician Decision|2|||
46847672|NCT00123422|83064483|FG002|Overall Study|Physician Decision|6|||
46847673|NCT00123422|83064481|FG000|Overall Study|Withdrawal by Subject|1|||
46776567|NCT00767819|82994988|FG001|Overall Study|Administrative problems|1|||
46776568|NCT00767819|82994989|FG002|Overall Study|Administrative problems|0|||
46776569|NCT00767819|82994987|FG000|Overall Study|Death|2|||
46776570|NCT00767819|82994988|FG001|Overall Study|Death|3|||
46847674|NCT00123422|83064482|FG001|Overall Study|Withdrawal by Subject|2|||
46847675|NCT00123422|83064483|FG002|Overall Study|Withdrawal by Subject|2|||
46847676|NCT00123422|83064481|FG000|Overall Study|Lost to Follow-up|1|||
46847677|NCT00123422|83064482|FG001|Overall Study|Lost to Follow-up|2|||
46847678|NCT00123422|83064483|FG002|Overall Study|Lost to Follow-up|2|||
46847679|NCT04052620|83064493|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
46847680|NCT04052620|83064494|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
46847681|NCT04052620|83064493|FG000|Overall Study|Withdrawal by Subject|1|||
47073365|NCT03593213|83361745|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
47073366|NCT03593213|83361746|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
47073367|NCT03593213|83361747|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
46776571|NCT00767819|82994989|FG002|Overall Study|Death|0|||
46776572|NCT00767819|82994987|FG000|Overall Study|Adverse Event|2|||
46776573|NCT00767819|82994988|FG001|Overall Study|Adverse Event|0|||
46776574|NCT00767819|82994989|FG002|Overall Study|Adverse Event|0|||
46776575|NCT00767819|82994987|FG000|Overall Study|Abnormal lab values|1|||
46776576|NCT00767819|82994988|FG001|Overall Study|Abnormal lab values|0|||
46776577|NCT00767819|82994989|FG002|Overall Study|Abnormal lab values|0|||
46776578|NCT00767819|82994987|FG000|Overall Study|Lost to Follow-up|1|||
46776579|NCT00767819|82994988|FG001|Overall Study|Lost to Follow-up|0|||
46776580|NCT00767819|82994989|FG002|Overall Study|Lost to Follow-up|0|||
46776581|NCT00584870|82995000|FG000|Overall Study|Adverse Event|4|||
46776582|NCT00584870|82995001|FG001|Overall Study|Adverse Event|3|||
46776583|NCT00584870|82995002|FG002|Overall Study|Adverse Event|2|||
46776584|NCT00584870|82995000|FG000|Overall Study|Lost to Follow-up|4|||
46776585|NCT00584870|82995001|FG001|Overall Study|Lost to Follow-up|1|||
46776586|NCT00584870|82995002|FG002|Overall Study|Lost to Follow-up|1|||
46776587|NCT00584870|82995000|FG000|Overall Study|Lack of Efficacy|7|||
46776588|NCT00584870|82995001|FG001|Overall Study|Lack of Efficacy|14|||
46776589|NCT00584870|82995002|FG002|Overall Study|Lack of Efficacy|8|||
46776590|NCT00584870|82995000|FG000|Overall Study|Withdrawal by Subject|10|||
46776591|NCT00584870|82995001|FG001|Overall Study|Withdrawal by Subject|5|||
46776592|NCT00584870|82995002|FG002|Overall Study|Withdrawal by Subject|3|||
46776593|NCT00584870|82995000|FG000|Overall Study|Protocol Violation|1|||
46776594|NCT00584870|82995001|FG001|Overall Study|Protocol Violation|1|||
46776595|NCT00584870|82995002|FG002|Overall Study|Protocol Violation|2|||
46776596|NCT00584870|82995000|FG000|Overall Study|Did not met entrance criteria|1|||
46776597|NCT00584870|82995001|FG001|Overall Study|Did not met entrance criteria|0|||
46776598|NCT00584870|82995002|FG002|Overall Study|Did not met entrance criteria|0|||
46776599|NCT00584870|82995000|FG000|Overall Study|Other|2|||
46776600|NCT00584870|82995001|FG001|Overall Study|Other|0|||
46776601|NCT00584870|82995002|FG002|Overall Study|Other|0|||
46776602|NCT00584870|82995000|FG000|Overall Study|Randomized but not treated|0|||
46776603|NCT00584870|82995001|FG001|Overall Study|Randomized but not treated|1|||
46776604|NCT00584870|82995002|FG002|Overall Study|Randomized but not treated|2|||
46776605|NCT00679341|82995012|FG000|Overall Study|Disease progression|42|||
46776606|NCT00679341|82995013|FG001|Overall Study|Disease progression|36|||
46847682|NCT04052620|83064494|FG001|Overall Study|Withdrawal by Subject|0|||
46847683|NCT04052620|83064493|FG000|Overall Study|Lost to Follow-up|1|||
46847684|NCT04052620|83064494|FG001|Overall Study|Lost to Follow-up|1|||
46776607|NCT00679341|82995012|FG000|Overall Study|Adverse Event|5|||
46847685|NCT04052620|83064493|FG000|Overall Study|Adverse Event|1|||
46776608|NCT00679341|82995013|FG001|Overall Study|Adverse Event|6|||
46776609|NCT00679341|82995012|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
46776610|NCT00679341|82995013|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
46776611|NCT00679341|82995012|FG000|Overall Study|Death|1|||
46776612|NCT00679341|82995013|FG001|Overall Study|Death|1|||
46776613|NCT00679341|82995012|FG000|Overall Study|Other|1|||
46776614|NCT00679341|82995013|FG001|Overall Study|Other|0|||
46776615|NCT00679341|82995012|FG000|Overall Study|Physician Decision|1|||
46776616|NCT00679341|82995013|FG001|Overall Study|Physician Decision|0|||
46847686|NCT04052620|83064494|FG001|Overall Study|Adverse Event|0|||
46847687|NCT04052620|83064493|FG000|Overall Study|Subject did not meet study Criteria|0|||
46776617|NCT00679341|82995012|FG000|Overall Study|Not treated|0|||
46776618|NCT00679341|82995013|FG001|Overall Study|Not treated|2|||
46776619|NCT00679341|82995012|FG000|Overall Study|Physician/patient decision to withdraw|0|||
46776620|NCT00679341|82995013|FG001|Overall Study|Physician/patient decision to withdraw|6|||
46776621|NCT00679263|82995023|FG000|Visit 2/Dose 1|Adverse Event|1|||
46776622|NCT00679263|82995024|FG001|Visit 2/Dose 1|Adverse Event|0|||
46776623|NCT00679263|82995025|FG002|Visit 2/Dose 1|Adverse Event|0|||
46776624|NCT00679263|82995023|FG000|Visit 2/Dose 1|subject not compliance|1|||
46776625|NCT00679263|82995024|FG001|Visit 2/Dose 1|subject not compliance|1|||
46776626|NCT00679263|82995025|FG002|Visit 2/Dose 1|subject not compliance|0|||
46776627|NCT00680043|82995036|FG000|Overall Study|Withdrawal by Subject|1|||
46776628|NCT00680043|82995037|FG001|Overall Study|Withdrawal by Subject|0|||
46776629|NCT00680043|82995038|FG002|Overall Study|Withdrawal by Subject|0|||
46776630|NCT00680043|82995036|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
46776631|NCT00680043|82995037|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
46776632|NCT00680043|82995038|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
46776633|NCT00680043|82995036|FG000|Overall Study|Renal Transplant|1|||
46776634|NCT00680043|82995037|FG001|Overall Study|Renal Transplant|0|||
46776635|NCT00680043|82995038|FG002|Overall Study|Renal Transplant|4|||
46776636|NCT00682539|82995049|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
46776637|NCT00682539|82995050|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
46847688|NCT04052620|83064494|FG001|Overall Study|Subject did not meet study Criteria|1|||
46847689|NCT04052620|83064493|FG000|Overall Study|Screened failure, randomized by mistake|0|||
46847690|NCT04052620|83064494|FG001|Overall Study|Screened failure, randomized by mistake|1|||
46847691|NCT04052620|83064493|FG000|Overall Study|Personal reasons|2|||
46847692|NCT04052620|83064494|FG001|Overall Study|Personal reasons|4|||
46847693|NCT04052620|83064493|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
46847694|NCT04052620|83064494|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
46847695|NCT00112580|83064502|FG000|Overall Study|Adverse Event|1|||
46847696|NCT00112580|83064503|FG001|Overall Study|Adverse Event|2|||
46847697|NCT00112580|83064502|FG000|Overall Study|Disease progression|5|||
46847698|NCT00112580|83064503|FG001|Overall Study|Disease progression|16|||
46847699|NCT00112580|83064502|FG000|Overall Study|Participant withdrew consent|2|||
46847700|NCT00112580|83064503|FG001|Overall Study|Participant withdrew consent|1|||
46847701|NCT04238650|83064510|FG000|Overall Study|Withdrawal by Subject|0|||
46847702|NCT04238650|83064511|FG001|Overall Study|Withdrawal by Subject|1|||
46847703|NCT00095576|83064519|FG000|Overall Study|Adverse Event|5|||
46847704|NCT00095576|83064520|FG001|Overall Study|Adverse Event|3|||
46847705|NCT00095576|83064519|FG000|Overall Study|Lost to Follow-up|233|||
46847706|NCT00095576|83064520|FG001|Overall Study|Lost to Follow-up|229|||
46847707|NCT00095576|83064519|FG000|Overall Study|Protocol Violation|1|||
46847708|NCT00095576|83064520|FG001|Overall Study|Protocol Violation|0|||
46847709|NCT00095576|83064519|FG000|Overall Study|Withdrawal by Subject|34|||
46847710|NCT00095576|83064520|FG001|Overall Study|Withdrawal by Subject|47|||
46847711|NCT00095576|83064519|FG000|Overall Study|Option to switch to a rollover study|1097|||
46847712|NCT00095576|83064520|FG001|Overall Study|Option to switch to a rollover study|1099|||
46847713|NCT00095576|83064519|FG000|Overall Study|Site terminated|75|||
46847714|NCT00095576|83064520|FG001|Overall Study|Site terminated|67|||
46847715|NCT00095576|83064519|FG000|Overall Study|Subject moved|30|||
46847716|NCT00095576|83064520|FG001|Overall Study|Subject moved|36|||
46847717|NCT04049578|83064526|FG000|Overall Study|Physician Decision|1|||
46847718|NCT04044352|83064530|FG000|Overall Study|Lost to Follow-up|9|||
46847719|NCT04044352|83064530|FG000|Overall Study|Withdrawal by Subject|2|||
46847720|NCT04043962|83064535|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
46968507|NCT01628692|83211280|FG000|Overall Study|Adverse Event|2|||
46642108|NCT02616185|82831473|FG000|Overall Study|Not reported|0|||
46642109|NCT02616185|82831474|FG001|Overall Study|Not reported|0|||
46642110|NCT02616185|82831475|FG002|Overall Study|Not reported|0|||
46642111|NCT02616185|82831476|FG003|Overall Study|Not reported|1|||
46642112|NCT02616185|82831477|FG004|Overall Study|Not reported|3|||
46642113|NCT02616185|82831478|FG005|Overall Study|Not reported|1|||
46642114|NCT02616185|82831479|FG006|Overall Study|Not reported|0|||
46642115|NCT02616185|82831480|FG007|Overall Study|Not reported|5|||
46642116|NCT02616185|82831481|FG008|Overall Study|Not reported|2|||
46642117|NCT01967888|82831547|FG000|Overall Study|Lost to Follow-up|6|||
46776638|NCT00682539|82995051|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
46776639|NCT00682539|82995049|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
46776640|NCT00682539|82995050|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
46776641|NCT00682539|82995051|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
46776642|NCT00682461|82995061|FG000|Overall Study|Adverse Event|5|||
46847721|NCT04043962|83064535|FG000|Post-Treatment|Withdrawal by Subject|5|||
46847722|NCT04043962|83064535|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
46847723|NCT04043728|83064542|FG000|Overall Study|Lost to Follow-up|1|||
46776643|NCT00682461|82995062|FG001|Overall Study|Adverse Event|7|||
46776644|NCT00682461|82995061|FG000|Overall Study|Lost to Follow-up|8|||
46776645|NCT00682461|82995062|FG001|Overall Study|Lost to Follow-up|5|||
46776646|NCT00682461|82995061|FG000|Overall Study|Withdrawal by Subject|12|||
46776647|NCT00682461|82995062|FG001|Overall Study|Withdrawal by Subject|19|||
46776648|NCT00677235|82995071|FG000|Overall Study|Withdrawal by Subject|1|||
46776649|NCT00677235|82995072|FG001|Overall Study|Withdrawal by Subject|1|||
46776650|NCT00677235|82995071|FG000|Overall Study|Lost to Follow-up|2|||
46776651|NCT00677235|82995072|FG001|Overall Study|Lost to Follow-up|1|||
46847724|NCT04043728|83064543|FG001|Overall Study|Lost to Follow-up|2|||
46847725|NCT04043728|83064544|FG002|Overall Study|Lost to Follow-up|0|||
46847726|NCT04043416|83064554|FG000|Washout|Change in health condition|0|||
46847727|NCT04043416|83064555|FG001|Washout|Change in health condition|1|||
46847728|NCT00095498|83064567|FG000|Overall Study|Physician Decision|9|||
46847729|NCT00095498|83064568|FG001|Overall Study|Physician Decision|10|||
46847730|NCT00095498|83064569|FG002|Overall Study|Physician Decision|8|||
46847731|NCT00095498|83064567|FG000|Overall Study|Adverse Event|1|||
46847732|NCT00095498|83064568|FG001|Overall Study|Adverse Event|0|||
46847733|NCT00095498|83064569|FG002|Overall Study|Adverse Event|1|||
46847734|NCT00095498|83064567|FG000|Overall Study|Withdrawal by Subject|15|||
46847735|NCT00095498|83064568|FG001|Overall Study|Withdrawal by Subject|16|||
46847736|NCT00095498|83064569|FG002|Overall Study|Withdrawal by Subject|15|||
46847737|NCT00095498|83064567|FG000|Overall Study|Disease progression|0|||
46847738|NCT00095498|83064568|FG001|Overall Study|Disease progression|1|||
46776652|NCT00677235|82995071|FG000|Overall Study|Death|37|||
46776653|NCT00677235|82995072|FG001|Overall Study|Death|36|||
46776654|NCT00677235|82995071|FG000|Overall Study|Adverse Experience|1|||
46847739|NCT00095498|83064569|FG002|Overall Study|Disease progression|1|||
46847740|NCT00095498|83064567|FG000|Overall Study|Ineligibility determined|3|||
46847741|NCT00095498|83064568|FG001|Overall Study|Ineligibility determined|0|||
46847742|NCT00095498|83064569|FG002|Overall Study|Ineligibility determined|2|||
46776655|NCT00677235|82995072|FG001|Overall Study|Adverse Experience|0|||
46776656|NCT00676689|82995078|FG000|Overall Study|Screen Failure|2|||
46776657|NCT00676689|82995078|FG000|Overall Study|Death|2|||
46776658|NCT00676689|82995078|FG000|Overall Study|Lost to Follow-up|4|||
46776659|NCT00676689|82995078|FG000|Overall Study|Physician Decision|1|||
46776660|NCT00676689|82995078|FG000|Overall Study|Withdrawal by Subject|3|||
46776661|NCT00676689|82995078|FG000|Overall Study|Continuing FU|49|||
46776662|NCT00678795|82995084|FG000|Overall Study|Adverse Event|7|||
46776663|NCT00678795|82995085|FG001|Overall Study|Adverse Event|3|||
46776664|NCT00678795|82995084|FG000|Overall Study|Withdrawal by Subject|3|||
46776665|NCT00678795|82995085|FG001|Overall Study|Withdrawal by Subject|0|||
46776666|NCT00678795|82995084|FG000|Overall Study|Protocol Violation|0|||
46776667|NCT00678795|82995085|FG001|Overall Study|Protocol Violation|1|||
46776668|NCT00678795|82995084|FG000|Overall Study|Lost to Follow-up|0|||
46776669|NCT00678795|82995085|FG001|Overall Study|Lost to Follow-up|1|||
46776670|NCT00678795|82995084|FG000|Overall Study|Lack of Efficacy|1|||
46776671|NCT00678795|82995085|FG001|Overall Study|Lack of Efficacy|1|||
46776672|NCT00678639|82995093|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
46776673|NCT00678639|82995094|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
46847743|NCT00095498|83064567|FG000|Overall Study|Lost to Follow-up|1|||
46847744|NCT00095498|83064568|FG001|Overall Study|Lost to Follow-up|1|||
46847745|NCT00095498|83064569|FG002|Overall Study|Lost to Follow-up|2|||
46847746|NCT00095498|83064567|FG000|Overall Study|Noncompliance|1|||
46847747|NCT00095498|83064568|FG001|Overall Study|Noncompliance|0|||
46847748|NCT00095498|83064569|FG002|Overall Study|Noncompliance|1|||
46968508|NCT01628692|83211281|FG001|Overall Study|Adverse Event|0|||
46968509|NCT01628692|83211282|FG002|Overall Study|Adverse Event|2|||
46968510|NCT01628692|83211283|FG003|Overall Study|Adverse Event|0|||
46847749|NCT00095498|83064567|FG000|Overall Study|Other|6|||
46847750|NCT00095498|83064568|FG001|Overall Study|Other|7|||
46847751|NCT00095498|83064569|FG002|Overall Study|Other|6|||
46847752|NCT00095498|83064567|FG000|Overall Study|Protocol Violation|0|||
46847753|NCT00095498|83064568|FG001|Overall Study|Protocol Violation|0|||
46847754|NCT00095498|83064569|FG002|Overall Study|Protocol Violation|1|||
46847755|NCT00095498|83064567|FG000|Overall Study|Requirement for alternative therapy|1|||
46847756|NCT00095498|83064568|FG001|Overall Study|Requirement for alternative therapy|0|||
46847757|NCT00095498|83064569|FG002|Overall Study|Requirement for alternative therapy|2|||
46847758|NCT04237792|83064583|FG000|Treatment (Day 1)|Adverse Event|1|||
46847759|NCT04237792|83064584|FG001|Treatment (Day 1)|Adverse Event|0|||
46847760|NCT04237792|83064585|FG002|Treatment (Day 1)|Adverse Event|0|||
46847761|NCT04237792|83064586|FG003|Treatment (Day 1)|Adverse Event|0|||
46847762|NCT04237792|83064587|FG004|Treatment (Day 1)|Adverse Event|1|||
46847763|NCT04237792|83064588|FG005|Treatment (Day 1)|Adverse Event|1|||
46847764|NCT04237792|83064583|FG000|Treatment (Day 1)|Other|0|||
46847765|NCT04237792|83064584|FG001|Treatment (Day 1)|Other|0|||
46847766|NCT04237792|83064585|FG002|Treatment (Day 1)|Other|1|||
46847767|NCT04237792|83064586|FG003|Treatment (Day 1)|Other|0|||
46847768|NCT04237792|83064587|FG004|Treatment (Day 1)|Other|0|||
46847769|NCT04237792|83064588|FG005|Treatment (Day 1)|Other|1|||
46847770|NCT04237792|83064583|FG000|Treatment (Day 1)|Not treated|1|||
46847771|NCT04237792|83064584|FG001|Treatment (Day 1)|Not treated|1|||
46847772|NCT04237792|83064585|FG002|Treatment (Day 1)|Not treated|2|||
46847773|NCT04237792|83064586|FG003|Treatment (Day 1)|Not treated|1|||
46847774|NCT04237792|83064587|FG004|Treatment (Day 1)|Not treated|0|||
46847775|NCT04237792|83064588|FG005|Treatment (Day 1)|Not treated|1|||
46847776|NCT00122954|83064619|FG000|Overall Study|Withdrawal by Subject|2|||
46847777|NCT00122954|83064620|FG001|Overall Study|Withdrawal by Subject|2|||
46968511|NCT01628692|83211284|FG004|Overall Study|Adverse Event|0|||
46968512|NCT01628692|83211285|FG005|Overall Study|Adverse Event|0|||
46968513|NCT01628692|83211280|FG000|Overall Study|Withdrawal by Subject|0|||
46968514|NCT01628692|83211281|FG001|Overall Study|Withdrawal by Subject|1|||
46968515|NCT01628692|83211282|FG002|Overall Study|Withdrawal by Subject|1|||
46968516|NCT01628692|83211283|FG003|Overall Study|Withdrawal by Subject|0|||
46968517|NCT01628692|83211284|FG004|Overall Study|Withdrawal by Subject|0|||
46968518|NCT01628692|83211285|FG005|Overall Study|Withdrawal by Subject|0|||
46968519|NCT01628692|83211280|FG000|Overall Study|Death|0|||
46776674|NCT00678561|82995144|FG000|Overall Study|Adverse Event|0|||
46776675|NCT00678561|82995145|FG001|Overall Study|Adverse Event|1|||
46776676|NCT00678561|82995146|FG002|Overall Study|Adverse Event|1|||
46776677|NCT00678561|82995147|FG003|Overall Study|Adverse Event|0|||
46776678|NCT00678561|82995148|FG004|Overall Study|Adverse Event|1|||
46776679|NCT00678561|82995149|FG005|Overall Study|Adverse Event|0|||
46776680|NCT00678561|82995150|FG006|Overall Study|Adverse Event|0|||
46776681|NCT00678561|82995151|FG007|Overall Study|Adverse Event|0|||
46847778|NCT00122954|83064619|FG000|Overall Study|Protocol Violation|0|||
46847779|NCT00122954|83064620|FG001|Overall Study|Protocol Violation|1|||
46847780|NCT04491994|83064628|FG000|Overall Study|Withdrawal by Subject|10|||
46847781|NCT04491994|83064629|FG001|Overall Study|Withdrawal by Subject|5|||
46847782|NCT04491994|83064628|FG000|Overall Study|developed fever > 3 days|4|||
46847783|NCT04491994|83064629|FG001|Overall Study|developed fever > 3 days|1|||
47073368|NCT03593213|83361748|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
46776682|NCT00678561|82995144|FG000|Overall Study|Protocol Violation|0|||
46776683|NCT00678561|82995145|FG001|Overall Study|Protocol Violation|0|||
46776684|NCT00678561|82995146|FG002|Overall Study|Protocol Violation|0|||
46776685|NCT00678561|82995147|FG003|Overall Study|Protocol Violation|0|||
47073369|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
47073370|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
47073371|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
47073372|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
47073373|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
47073374|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
47073375|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
47073376|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
47073377|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
47073378|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
47073379|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
47073380|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
46776686|NCT00678561|82995148|FG004|Overall Study|Protocol Violation|1|||
46776687|NCT00678561|82995149|FG005|Overall Study|Protocol Violation|1|||
47073381|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
47073382|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
47073383|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
47073384|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
47073385|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
46776688|NCT00678561|82995150|FG006|Overall Study|Protocol Violation|0|||
46776689|NCT00678561|82995151|FG007|Overall Study|Protocol Violation|0|||
46776690|NCT00678561|82995144|FG000|Overall Study|Withdrawal by Subject|0|||
46776691|NCT00678561|82995145|FG001|Overall Study|Withdrawal by Subject|0|||
46776692|NCT00678561|82995146|FG002|Overall Study|Withdrawal by Subject|0|||
46776693|NCT00678561|82995147|FG003|Overall Study|Withdrawal by Subject|0|||
46776694|NCT00678561|82995148|FG004|Overall Study|Withdrawal by Subject|0|||
46776695|NCT00678561|82995149|FG005|Overall Study|Withdrawal by Subject|0|||
46776696|NCT00678561|82995150|FG006|Overall Study|Withdrawal by Subject|0|||
46776697|NCT00678561|82995151|FG007|Overall Study|Withdrawal by Subject|1|||
46776698|NCT00676143|82995178|FG000|Overall Study|Adverse Event|34|||
46776699|NCT00676143|82995179|FG001|Overall Study|Adverse Event|60|||
46776700|NCT00676143|82995178|FG000|Overall Study|Death|4|||
46776701|NCT00676143|82995179|FG001|Overall Study|Death|4|||
46776702|NCT00676143|82995178|FG000|Overall Study|Lack of Efficacy|0|||
46776703|NCT00676143|82995179|FG001|Overall Study|Lack of Efficacy|6|||
46968520|NCT01628692|83211281|FG001|Overall Study|Death|1|||
46776704|NCT00676143|82995178|FG000|Overall Study|Lost to Follow-up|0|||
46776705|NCT00676143|82995179|FG001|Overall Study|Lost to Follow-up|13|||
46776706|NCT00676143|82995178|FG000|Overall Study|Physician Decision|5|||
46776707|NCT00676143|82995179|FG001|Overall Study|Physician Decision|8|||
46776708|NCT00676143|82995178|FG000|Overall Study|Protocol Violation|4|||
46776709|NCT00676143|82995179|FG001|Overall Study|Protocol Violation|8|||
46776710|NCT00676143|82995178|FG000|Overall Study|Withdrawal by Subject|24|||
46776711|NCT00676143|82995179|FG001|Overall Study|Withdrawal by Subject|42|||
46968521|NCT01628692|83211282|FG002|Overall Study|Death|0|||
46776712|NCT00676143|82995178|FG000|Overall Study|Discontinuation of study by sponsor|65|||
46776713|NCT00676143|82995179|FG001|Overall Study|Discontinuation of study by sponsor|88|||
46776714|NCT00676143|82995178|FG000|Overall Study|Failed to return|2|||
46776715|NCT00676143|82995179|FG001|Overall Study|Failed to return|1|||
46776716|NCT00676143|82995178|FG000|Overall Study|Loss of caregiver|5|||
46776717|NCT00676143|82995179|FG001|Overall Study|Loss of caregiver|3|||
46776718|NCT00676143|82995178|FG000|Overall Study|Other|11|||
46776719|NCT00676143|82995179|FG001|Overall Study|Other|20|||
46776720|NCT00676143|82995178|FG000|Overall Study|Participant participation unknown|1|||
46776721|NCT00676143|82995179|FG001|Overall Study|Participant participation unknown|4|||
46776722|NCT00676143|82995178|FG000|Overall Study|Vasogenic edema recurrence|1|||
46776723|NCT00676143|82995179|FG001|Overall Study|Vasogenic edema recurrence|3|||
46776724|NCT00675597|82995204|FG000|Overall Study|Withdrawal by Subject|3|||
46776725|NCT00675441|82995212|FG000|Overall Study|Withdrawal by Subject|2|||
46776726|NCT00675441|82995212|FG000|Overall Study|Death|1|||
46776727|NCT00674973|82995227|FG000|Overall Study|Insufficient Therapeutic Response|77|||
46776728|NCT00674973|82995228|FG001|Overall Study|Insufficient Therapeutic Response|72|||
46776729|NCT00674973|82995227|FG000|Overall Study|Refused Treatment|1|||
46776730|NCT00674973|82995228|FG001|Overall Study|Refused Treatment|5|||
46776731|NCT00674973|82995227|FG000|Overall Study|Failure to Return|1|||
46776732|NCT00674973|82995228|FG001|Overall Study|Failure to Return|0|||
46776733|NCT00674973|82995227|FG000|Overall Study|Adverse Event|2|||
46776734|NCT00674973|82995228|FG001|Overall Study|Adverse Event|9|||
46847784|NCT04491994|83064628|FG000|Overall Study|Protocol Violation|11|||
46847785|NCT04491994|83064629|FG001|Overall Study|Protocol Violation|2|||
46847786|NCT04491994|83064628|FG000|Overall Study|Lost to Follow-up|4|||
46847787|NCT04491994|83064629|FG001|Overall Study|Lost to Follow-up|3|||
46847788|NCT04041700|83064635|FG000|Overall Study|Pregnancy|1|||
46847789|NCT04041700|83064635|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
46847790|NCT04227340|83064641|FG000|Overall Study|Withdrawal by Subject|3|||
46847791|NCT04033432|83064648|FG000|Overall Study|Progressive Disease|8|||
46847792|NCT04033432|83064648|FG000|Overall Study|Adverse Event|4|||
46847793|NCT04033432|83064648|FG000|Overall Study|Death|1|||
46847794|NCT04223830|83064653|FG000|Overall Study|Lost to Follow-up|9|||
46847795|NCT04223830|83064653|FG000|Overall Study|Adverse Event|1|||
46847796|NCT04032652|83064660|FG000|Overall Study|The study was terminated and the PI has|1|||
46847797|NCT04032652|83064661|FG001|Overall Study|The study was terminated and the PI has|1|||
46776735|NCT00674973|82995227|FG000|Overall Study|Death|19|||
46776736|NCT00674973|82995228|FG001|Overall Study|Death|15|||
46776737|NCT00674973|82995227|FG000|Overall Study|Protocol Violation|0|||
46776738|NCT00674973|82995228|FG001|Overall Study|Protocol Violation|1|||
46847798|NCT04031404|83064667|FG000|Baseline|Lost to Follow-up|0|||
46847799|NCT04031404|83064668|FG001|Baseline|Lost to Follow-up|1|||
46847800|NCT04031404|83064667|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
46847801|NCT04031404|83064668|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
46847802|NCT04031404|83064667|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
46776739|NCT00673179|82995236|FG000|Overall Study|Toxicity/Complications|3|||
46776740|NCT00673179|82995237|FG001|Overall Study|Toxicity/Complications|0|||
46776741|NCT00584012|82995243|FG000|Overall Study|Withdrawal by Subject|1|||
46776742|NCT00674817|82995247|FG000|Period 1|Withdrawal by Subject|2|||
46776743|NCT00674817|82995247|FG000|Period 1|Protocol Violation|1|||
46776744|NCT00674817|82995247|FG000|Period 3|Adverse Event|1|||
46776745|NCT00674817|82995247|FG000|Period 3|Protocol Violation|1|||
46776746|NCT00674817|82995247|FG000|Period 4|Adverse Event|1|||
46776747|NCT00672633|82995263|FG000|Overall Study|Withdrawal by Subject|0|||
46776748|NCT00672633|82995264|FG001|Overall Study|Withdrawal by Subject|1|||
46847803|NCT04031404|83064668|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
46847804|NCT04031404|83064667|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
46847805|NCT04031404|83064668|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
47073386|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
47073387|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
46776749|NCT00672555|82995270|FG000|Overall Study|Lost to Follow-up|4|||
46776750|NCT00672555|82995270|FG000|Overall Study|Did not want to answer questionnaire|2|||
46776751|NCT00672477|82995276|FG000|Overall Study|Adverse Event|10|||
46776752|NCT00672477|82995277|FG001|Overall Study|Adverse Event|7|||
46776753|NCT00672477|82995276|FG000|Overall Study|Death|7|||
46776754|NCT00672477|82995277|FG001|Overall Study|Death|11|||
46776755|NCT00672477|82995276|FG000|Overall Study|Physician Decision|2|||
46776756|NCT00672477|82995277|FG001|Overall Study|Physician Decision|0|||
46776757|NCT00672477|82995276|FG000|Overall Study|Protocol Violation|1|||
46776758|NCT00672477|82995277|FG001|Overall Study|Protocol Violation|1|||
46776759|NCT00672477|82995276|FG000|Overall Study|Withdrawal by Subject|5|||
46776760|NCT00672477|82995277|FG001|Overall Study|Withdrawal by Subject|3|||
46776761|NCT00672477|82995276|FG000|Overall Study|Lack of Efficacy|1|||
46847806|NCT04031404|83064667|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
46847807|NCT04031404|83064668|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
46847808|NCT04476784|83064684|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
46776762|NCT00672477|82995277|FG001|Overall Study|Lack of Efficacy|1|||
46776763|NCT00672477|82995276|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
46776764|NCT00672477|82995277|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
46847809|NCT04476784|83064685|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
46847810|NCT04026568|83064696|FG000|Overall Study|study terminated|0|||
46847811|NCT04026568|83064697|FG001|Overall Study|study terminated|1|||
46847812|NCT04025632|83064705|FG000|Overall Study|Adverse Event|1|||
46847813|NCT04025632|83064706|FG001|Overall Study|Adverse Event|1|||
46847814|NCT04025632|83064705|FG000|Overall Study|Withdrawal by Subject|1|||
46847815|NCT04025632|83064706|FG001|Overall Study|Withdrawal by Subject|1|||
46776765|NCT00674661|82995285|FG000|Overall Study|Other|5|||
46776766|NCT00674661|82995286|FG001|Overall Study|Other|7|||
46776767|NCT00674661|82995285|FG000|Overall Study|Lost to Follow-up|6|||
46776768|NCT00674661|82995286|FG001|Overall Study|Lost to Follow-up|3|||
46776769|NCT00674661|82995285|FG000|Overall Study|Withdrawal by Subject|0|||
46776770|NCT00674661|82995286|FG001|Overall Study|Withdrawal by Subject|5|||
46776771|NCT00671931|82995297|FG000|Overall Study|Physician Decision|1|||
46776772|NCT00671931|82995298|FG001|Overall Study|Physician Decision|0|||
46776773|NCT00671931|82995299|FG002|Overall Study|Physician Decision|0|||
46776774|NCT00671931|82995300|FG003|Overall Study|Physician Decision|2|||
46776775|NCT00671931|82995301|FG004|Overall Study|Physician Decision|1|||
46776776|NCT00673881|82995317|FG000|Overall Study|Withdrawal by Subject|1|||
46776777|NCT00671853|82995323|FG000|Overall Study|Lack of Efficacy|3|||
46776778|NCT00671853|82995324|FG001|Overall Study|Lack of Efficacy|7|||
46776779|NCT00671853|82995323|FG000|Overall Study|Adverse Event|7|||
46776780|NCT00671853|82995324|FG001|Overall Study|Adverse Event|1|||
46776781|NCT00671853|82995323|FG000|Overall Study|Withdrawal by Subject|1|||
46776782|NCT00671853|82995324|FG001|Overall Study|Withdrawal by Subject|5|||
46776783|NCT00671853|82995323|FG000|Overall Study|Lost to Follow-up|8|||
46776784|NCT00671853|82995324|FG001|Overall Study|Lost to Follow-up|8|||
46776785|NCT00671853|82995323|FG000|Overall Study|Physician Decision|0|||
46776786|NCT00671853|82995324|FG001|Overall Study|Physician Decision|2|||
46776787|NCT00671853|82995323|FG000|Overall Study|Non-adherence with study procedures|1|||
46776788|NCT00671853|82995324|FG001|Overall Study|Non-adherence with study procedures|4|||
46776789|NCT00570921|82995332|FG000|Overall Study|Protocol Violation|1|||
46776790|NCT00570921|82995332|FG000|Overall Study|Physician Decision|1|||
46776791|NCT00670449|82995340|FG000|Overall Study|Adverse Event|6|||
46776792|NCT00670449|82995341|FG001|Overall Study|Adverse Event|2|||
46776793|NCT00670449|82995342|FG002|Overall Study|Adverse Event|8|||
46776794|NCT00670449|82995343|FG003|Overall Study|Adverse Event|5|||
46776795|NCT00670449|82995340|FG000|Overall Study|Protocol Deviation|1|||
46776796|NCT00670449|82995341|FG001|Overall Study|Protocol Deviation|2|||
46776797|NCT00670449|82995342|FG002|Overall Study|Protocol Deviation|0|||
46776798|NCT00670449|82995343|FG003|Overall Study|Protocol Deviation|1|||
46776799|NCT00670449|82995340|FG000|Overall Study|Administrative Problems|0|||
46776800|NCT00670449|82995341|FG001|Overall Study|Administrative Problems|2|||
46776801|NCT00670449|82995342|FG002|Overall Study|Administrative Problems|0|||
46776802|NCT00670449|82995343|FG003|Overall Study|Administrative Problems|1|||
46776803|NCT00670449|82995340|FG000|Overall Study|Subject Withdrew Consent|0|||
46776804|NCT00670449|82995341|FG001|Overall Study|Subject Withdrew Consent|2|||
46776805|NCT00670449|82995342|FG002|Overall Study|Subject Withdrew Consent|0|||
46776806|NCT00670449|82995343|FG003|Overall Study|Subject Withdrew Consent|1|||
46776807|NCT00670449|82995340|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
46776808|NCT00670449|82995341|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46776809|NCT00670449|82995342|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
46776810|NCT00670449|82995343|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46776811|NCT00670449|82995340|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
46776812|NCT00670449|82995341|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
46847816|NCT04025632|83064705|FG000|Overall Study|Study Terminated by Sponsor|10|||
46776813|NCT00670449|82995342|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
46776814|NCT00670449|82995343|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
46776815|NCT00668733|82995354|FG000|Overall Study|Lost to Follow-up|2|||
46776816|NCT00668733|82995355|FG001|Overall Study|Lost to Follow-up|3|||
46776817|NCT00668733|82995354|FG000|Overall Study|Withdrawal by Subject|0|||
46776818|NCT00668733|82995355|FG001|Overall Study|Withdrawal by Subject|4|||
46776819|NCT00673257|82995361|FG000|Overall Study|Withdrawal by Subject|4|||
46776820|NCT00673257|82995361|FG000|Overall Study|Unable to obtain specimen|1|||
46776821|NCT00667875|82995368|FG000|Overall Study|Adverse Event|0|||
46776822|NCT00667875|82995369|FG001|Overall Study|Adverse Event|2|||
46776823|NCT00667875|82995370|FG002|Overall Study|Adverse Event|6|||
46776824|NCT00667875|82995368|FG000|Overall Study|Withdrawal by Subject|10|||
46776825|NCT00667875|82995369|FG001|Overall Study|Withdrawal by Subject|9|||
46776826|NCT00667875|82995370|FG002|Overall Study|Withdrawal by Subject|7|||
46776827|NCT03468998|82995390|FG000|Overall Study|Withdrawal by Subject|1|||
46776828|NCT03468998|82995391|FG001|Overall Study|Withdrawal by Subject|1|||
46776829|NCT03468998|82995392|FG002|Overall Study|Withdrawal by Subject|0|||
46776830|NCT03468998|82995393|FG003|Overall Study|Withdrawal by Subject|4|||
46776831|NCT03468998|82995394|FG004|Overall Study|Withdrawal by Subject|1|||
46776832|NCT03468998|82995395|FG005|Overall Study|Withdrawal by Subject|0|||
46776833|NCT00667251|82995409|FG000|Overall Study|Adverse Event|13|||
46776834|NCT00667251|82995410|FG001|Overall Study|Adverse Event|4|||
46776835|NCT00667251|82995409|FG000|Overall Study|Withdrawal by Subject|6|||
46776836|NCT00667251|82995410|FG001|Overall Study|Withdrawal by Subject|2|||
46776837|NCT00667251|82995409|FG000|Overall Study|Other/missing|46|||
46776838|NCT00667251|82995410|FG001|Overall Study|Other/missing|84|||
46776839|NCT00667251|82995409|FG000|Overall Study|Intercurrent Illness|4|||
46776840|NCT00667251|82995410|FG001|Overall Study|Intercurrent Illness|3|||
46776841|NCT00667251|82995409|FG000|Overall Study|Symptomatic progression|1|||
46776842|NCT00667251|82995410|FG001|Overall Study|Symptomatic progression|2|||
46776843|NCT00669903|82995428|FG000|Overall Study|Adverse Event|0|||
46776844|NCT00669903|82995429|FG001|Overall Study|Adverse Event|1|||
46776845|NCT00669903|82995430|FG002|Overall Study|Adverse Event|3|||
46776846|NCT00669903|82995431|FG003|Overall Study|Adverse Event|1|||
46776847|NCT00669903|82995428|FG000|Overall Study|Withdrawal by Subject|0|||
46776848|NCT00669903|82995429|FG001|Overall Study|Withdrawal by Subject|2|||
46776849|NCT00669903|82995430|FG002|Overall Study|Withdrawal by Subject|2|||
46776850|NCT00669903|82995431|FG003|Overall Study|Withdrawal by Subject|2|||
46776851|NCT00669903|82995428|FG000|Overall Study|Lost to Follow-up|1|||
46776852|NCT00669903|82995429|FG001|Overall Study|Lost to Follow-up|1|||
46776853|NCT00669903|82995430|FG002|Overall Study|Lost to Follow-up|0|||
46776854|NCT00669903|82995431|FG003|Overall Study|Lost to Follow-up|1|||
46776855|NCT00669903|82995428|FG000|Overall Study|Protocol Violation|0|||
46776856|NCT00669903|82995429|FG001|Overall Study|Protocol Violation|1|||
46776857|NCT00669903|82995430|FG002|Overall Study|Protocol Violation|0|||
46776858|NCT00669903|82995431|FG003|Overall Study|Protocol Violation|0|||
46776859|NCT03759392|82995443|FG000|Overall Study|Adverse Event|12|||
46776860|NCT03759392|82995444|FG001|Overall Study|Adverse Event|4|||
46776861|NCT03759392|82995443|FG000|Overall Study|Death|2|||
46776862|NCT03759392|82995444|FG001|Overall Study|Death|1|||
46776863|NCT03759392|82995443|FG000|Overall Study|Withdrawal by Subject|2|||
46776864|NCT03759392|82995444|FG001|Overall Study|Withdrawal by Subject|0|||
46776865|NCT03759392|82995443|FG000|Overall Study|Protocol Violation|2|||
46776866|NCT03759392|82995444|FG001|Overall Study|Protocol Violation|0|||
46776867|NCT03759392|82995443|FG000|Overall Study|Physician Decision|0|||
46847817|NCT04025632|83064706|FG001|Overall Study|Study Terminated by Sponsor|9|||
46968522|NCT01628692|83211283|FG003|Overall Study|Death|0|||
46968523|NCT01628692|83211284|FG004|Overall Study|Death|0|||
46776868|NCT03759392|82995444|FG001|Overall Study|Physician Decision|1|||
46776869|NCT03759392|82995443|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
46776870|NCT03759392|82995444|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
46776871|NCT03759392|82995443|FG000|Overall Study|No longer able to take medicines|1|||
46776872|NCT03759392|82995444|FG001|Overall Study|No longer able to take medicines|0|||
46776873|NCT03759392|82995443|FG000|Overall Study|Stopped taking study drug|1|||
46776874|NCT03759392|82995444|FG001|Overall Study|Stopped taking study drug|0|||
46776875|NCT00667719|82995450|FG000|Overall Study|Adverse Event|39|||
46776876|NCT00667719|82995450|FG000|Overall Study|Abnormal Test Procedure|1|||
46776877|NCT00667719|82995450|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
46776878|NCT00667719|82995450|FG000|Overall Study|Protocol Violation|3|||
46968524|NCT01628692|83211285|FG005|Overall Study|Death|0|||
46776879|NCT00667719|82995450|FG000|Overall Study|Withdrawal by Subject|17|||
46776880|NCT00667719|82995450|FG000|Overall Study|Lost to Follow-up|8|||
46776881|NCT00669669|82995459|FG000|Overall Study|To late to start treatment|1|||
46776882|NCT00467779|82995478|FG000|Stage 1|Adverse Event|1|||
46776883|NCT00467779|82995479|FG001|Stage 1|Adverse Event|0|||
46776884|NCT00467779|82995480|FG002|Stage 1|Adverse Event|0|||
46776885|NCT00467779|82995481|FG003|Stage 1|Adverse Event|0|||
46776886|NCT00467779|82995482|FG004|Stage 1|Adverse Event|0|||
46776887|NCT00467779|82995483|FG005|Stage 1|Adverse Event|1|||
46776888|NCT00467779|82995484|FG006|Stage 1|Adverse Event|2|||
46776889|NCT00467779|82995485|FG007|Stage 1|Adverse Event|1|||
46776890|NCT00467779|82995486|FG008|Stage 1|Adverse Event|0|||
46776891|NCT00467779|82995487|FG009|Stage 1|Adverse Event|0|||
46776892|NCT00467779|82995488|FG010|Stage 1|Adverse Event|0|||
46776893|NCT00467779|82995489|FG011|Stage 1|Adverse Event|0|||
46776894|NCT00467779|82995490|FG012|Stage 1|Adverse Event|0|||
46776895|NCT00467779|82995491|FG013|Stage 1|Adverse Event|0|||
46776896|NCT00467779|82995492|FG014|Stage 1|Adverse Event|0|||
46776897|NCT00467779|82995478|FG000|Stage 1|Disease Progression|2|||
46776898|NCT00467779|82995479|FG001|Stage 1|Disease Progression|2|||
46776899|NCT00467779|82995480|FG002|Stage 1|Disease Progression|2|||
46776900|NCT00467779|82995481|FG003|Stage 1|Disease Progression|3|||
46776901|NCT00467779|82995482|FG004|Stage 1|Disease Progression|2|||
46776902|NCT00467779|82995483|FG005|Stage 1|Disease Progression|2|||
46776903|NCT00467779|82995484|FG006|Stage 1|Disease Progression|4|||
46776904|NCT00467779|82995485|FG007|Stage 1|Disease Progression|5|||
46776905|NCT00467779|82995486|FG008|Stage 1|Disease Progression|0|||
46776906|NCT00467779|82995487|FG009|Stage 1|Disease Progression|0|||
46776907|NCT00467779|82995488|FG010|Stage 1|Disease Progression|0|||
46776908|NCT00467779|82995489|FG011|Stage 1|Disease Progression|0|||
46776909|NCT00467779|82995490|FG012|Stage 1|Disease Progression|0|||
46776910|NCT00467779|82995491|FG013|Stage 1|Disease Progression|0|||
46776911|NCT00467779|82995492|FG014|Stage 1|Disease Progression|0|||
46776912|NCT00467779|82995478|FG000|Stage 1|Unspecified Reason|1|||
46776913|NCT00467779|82995479|FG001|Stage 1|Unspecified Reason|0|||
46776914|NCT00467779|82995480|FG002|Stage 1|Unspecified Reason|1|||
46776915|NCT00467779|82995481|FG003|Stage 1|Unspecified Reason|0|||
46776916|NCT00467779|82995482|FG004|Stage 1|Unspecified Reason|1|||
46776917|NCT00467779|82995483|FG005|Stage 1|Unspecified Reason|2|||
46776918|NCT00467779|82995484|FG006|Stage 1|Unspecified Reason|0|||
46776919|NCT00467779|82995485|FG007|Stage 1|Unspecified Reason|0|||
46776920|NCT00467779|82995486|FG008|Stage 1|Unspecified Reason|0|||
46776921|NCT00467779|82995487|FG009|Stage 1|Unspecified Reason|0|||
46776922|NCT00467779|82995488|FG010|Stage 1|Unspecified Reason|0|||
46776923|NCT00467779|82995489|FG011|Stage 1|Unspecified Reason|0|||
46776924|NCT00467779|82995490|FG012|Stage 1|Unspecified Reason|0|||
46776925|NCT00467779|82995491|FG013|Stage 1|Unspecified Reason|0|||
46776926|NCT00467779|82995492|FG014|Stage 1|Unspecified Reason|0|||
46776927|NCT00467779|82995478|FG000|Stage 1|Physician Decision|0|||
46776928|NCT00467779|82995479|FG001|Stage 1|Physician Decision|1|||
46776929|NCT00467779|82995480|FG002|Stage 1|Physician Decision|0|||
46776930|NCT00467779|82995481|FG003|Stage 1|Physician Decision|0|||
46776931|NCT00467779|82995482|FG004|Stage 1|Physician Decision|0|||
46776932|NCT00467779|82995483|FG005|Stage 1|Physician Decision|0|||
46776933|NCT00467779|82995484|FG006|Stage 1|Physician Decision|0|||
46776934|NCT00467779|82995485|FG007|Stage 1|Physician Decision|0|||
46776935|NCT00467779|82995486|FG008|Stage 1|Physician Decision|0|||
46776936|NCT00467779|82995487|FG009|Stage 1|Physician Decision|0|||
46776937|NCT00467779|82995488|FG010|Stage 1|Physician Decision|0|||
46776938|NCT00467779|82995489|FG011|Stage 1|Physician Decision|0|||
46776939|NCT00467779|82995490|FG012|Stage 1|Physician Decision|0|||
46776940|NCT00467779|82995491|FG013|Stage 1|Physician Decision|0|||
46776941|NCT00467779|82995492|FG014|Stage 1|Physician Decision|0|||
46776942|NCT00467779|82995478|FG000|Stage 1|Withdrawal by Subject|0|||
46776943|NCT00467779|82995479|FG001|Stage 1|Withdrawal by Subject|0|||
46776944|NCT00467779|82995480|FG002|Stage 1|Withdrawal by Subject|0|||
46776945|NCT00467779|82995481|FG003|Stage 1|Withdrawal by Subject|0|||
46776946|NCT00467779|82995482|FG004|Stage 1|Withdrawal by Subject|0|||
46847818|NCT04025632|83064705|FG000|Overall Study|Physician Decision|3|||
46968525|NCT01628692|83211280|FG000|Overall Study|Poor compliance/noncompliance|1|||
46776947|NCT00467779|82995483|FG005|Stage 1|Withdrawal by Subject|0|||
46776948|NCT00467779|82995484|FG006|Stage 1|Withdrawal by Subject|1|||
46776949|NCT00467779|82995485|FG007|Stage 1|Withdrawal by Subject|1|||
46776950|NCT00467779|82995486|FG008|Stage 1|Withdrawal by Subject|0|||
46776951|NCT00467779|82995487|FG009|Stage 1|Withdrawal by Subject|0|||
46776952|NCT00467779|82995488|FG010|Stage 1|Withdrawal by Subject|0|||
46776953|NCT00467779|82995489|FG011|Stage 1|Withdrawal by Subject|0|||
46776954|NCT00467779|82995490|FG012|Stage 1|Withdrawal by Subject|0|||
46776955|NCT00467779|82995491|FG013|Stage 1|Withdrawal by Subject|0|||
46776956|NCT00467779|82995492|FG014|Stage 1|Withdrawal by Subject|0|||
46776957|NCT00467779|82995478|FG000|Stage 1A|Adverse Event|0|||
46776958|NCT00467779|82995479|FG001|Stage 1A|Adverse Event|0|||
46776959|NCT00467779|82995480|FG002|Stage 1A|Adverse Event|0|||
46776960|NCT00467779|82995481|FG003|Stage 1A|Adverse Event|0|||
46776961|NCT00467779|82995482|FG004|Stage 1A|Adverse Event|0|||
46776962|NCT00467779|82995483|FG005|Stage 1A|Adverse Event|0|||
46776963|NCT00467779|82995484|FG006|Stage 1A|Adverse Event|0|||
46776964|NCT00467779|82995485|FG007|Stage 1A|Adverse Event|0|||
46776965|NCT00467779|82995486|FG008|Stage 1A|Adverse Event|0|||
46776966|NCT00467779|82995487|FG009|Stage 1A|Adverse Event|0|||
46776967|NCT00467779|82995488|FG010|Stage 1A|Adverse Event|0|||
46776968|NCT00467779|82995489|FG011|Stage 1A|Adverse Event|0|||
46776969|NCT00467779|82995490|FG012|Stage 1A|Adverse Event|1|||
46776970|NCT00467779|82995491|FG013|Stage 1A|Adverse Event|0|||
46776971|NCT00467779|82995492|FG014|Stage 1A|Adverse Event|0|||
46776972|NCT00467779|82995478|FG000|Stage 1A|Death|0|||
46776973|NCT00467779|82995479|FG001|Stage 1A|Death|0|||
46776974|NCT00467779|82995480|FG002|Stage 1A|Death|0|||
46776975|NCT00467779|82995481|FG003|Stage 1A|Death|0|||
46776976|NCT00467779|82995482|FG004|Stage 1A|Death|0|||
46776977|NCT00467779|82995483|FG005|Stage 1A|Death|0|||
46776978|NCT00467779|82995484|FG006|Stage 1A|Death|0|||
46776979|NCT00467779|82995485|FG007|Stage 1A|Death|0|||
46776980|NCT00467779|82995486|FG008|Stage 1A|Death|0|||
46776981|NCT00467779|82995487|FG009|Stage 1A|Death|0|||
46776982|NCT00467779|82995488|FG010|Stage 1A|Death|0|||
46776983|NCT00467779|82995489|FG011|Stage 1A|Death|1|||
46776984|NCT00467779|82995490|FG012|Stage 1A|Death|1|||
46776985|NCT00467779|82995491|FG013|Stage 1A|Death|0|||
46776986|NCT00467779|82995492|FG014|Stage 1A|Death|0|||
46776987|NCT00467779|82995478|FG000|Stage 1A|Disease Progression|0|||
46776988|NCT00467779|82995479|FG001|Stage 1A|Disease Progression|0|||
46776989|NCT00467779|82995480|FG002|Stage 1A|Disease Progression|0|||
46776990|NCT00467779|82995481|FG003|Stage 1A|Disease Progression|0|||
46776991|NCT00467779|82995482|FG004|Stage 1A|Disease Progression|0|||
46776992|NCT00467779|82995483|FG005|Stage 1A|Disease Progression|0|||
46776993|NCT00467779|82995484|FG006|Stage 1A|Disease Progression|0|||
46776994|NCT00467779|82995485|FG007|Stage 1A|Disease Progression|0|||
46776995|NCT00467779|82995486|FG008|Stage 1A|Disease Progression|0|||
46642118|NCT01967888|82831548|FG001|Overall Study|Lost to Follow-up|4|||
46642119|NCT01967888|82831547|FG000|Overall Study|Withdrawal by Subject|1|||
46642120|NCT01967888|82831548|FG001|Overall Study|Withdrawal by Subject|1|||
46642121|NCT01967888|82831547|FG000|Overall Study|Did Not Have Transplant|1|||
46642122|NCT01967888|82831548|FG001|Overall Study|Did Not Have Transplant|0|||
46642123|NCT01967888|82831547|FG000|Overall Study|Research visit not done, data recorded|1|||
46642124|NCT01967888|82831548|FG001|Overall Study|Research visit not done, data recorded|0|||
46642125|NCT01967888|82831547|FG000|Overall Study|Subject excluded after randomization|1|||
46642126|NCT01967888|82831548|FG001|Overall Study|Subject excluded after randomization|0|||
46642127|NCT01967888|82831547|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
46642128|NCT01967888|82831548|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
46642129|NCT01967888|82831547|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
46776996|NCT00467779|82995487|FG009|Stage 1A|Disease Progression|2|||
46776997|NCT00467779|82995488|FG010|Stage 1A|Disease Progression|2|||
46776998|NCT00467779|82995489|FG011|Stage 1A|Disease Progression|5|||
46776999|NCT00467779|82995490|FG012|Stage 1A|Disease Progression|2|||
46777000|NCT00467779|82995491|FG013|Stage 1A|Disease Progression|0|||
46777001|NCT00467779|82995492|FG014|Stage 1A|Disease Progression|0|||
46777002|NCT00467779|82995478|FG000|Stage 1A|Physician Decision|0|||
46777003|NCT00467779|82995479|FG001|Stage 1A|Physician Decision|0|||
46777004|NCT00467779|82995480|FG002|Stage 1A|Physician Decision|0|||
46777005|NCT00467779|82995481|FG003|Stage 1A|Physician Decision|0|||
46777006|NCT00467779|82995482|FG004|Stage 1A|Physician Decision|0|||
46847819|NCT04025632|83064706|FG001|Overall Study|Physician Decision|1|||
46847820|NCT04024228|83064717|FG000|Overall Study|Adverse Event|1|||
46642130|NCT01967888|82831548|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
46642131|NCT00653068|82831571|FG000|Overall Study|Death|9|||
46777007|NCT00467779|82995483|FG005|Stage 1A|Physician Decision|0|||
46777008|NCT00467779|82995484|FG006|Stage 1A|Physician Decision|0|||
46777009|NCT00467779|82995485|FG007|Stage 1A|Physician Decision|0|||
46777010|NCT00467779|82995486|FG008|Stage 1A|Physician Decision|0|||
46777011|NCT00467779|82995487|FG009|Stage 1A|Physician Decision|1|||
46777012|NCT00467779|82995488|FG010|Stage 1A|Physician Decision|0|||
46777013|NCT00467779|82995489|FG011|Stage 1A|Physician Decision|0|||
46777014|NCT00467779|82995490|FG012|Stage 1A|Physician Decision|0|||
46777015|NCT00467779|82995491|FG013|Stage 1A|Physician Decision|0|||
46777016|NCT00467779|82995492|FG014|Stage 1A|Physician Decision|0|||
46777017|NCT00467779|82995478|FG000|Stage 1A|Withdrawal by Subject|0|||
46777018|NCT00467779|82995479|FG001|Stage 1A|Withdrawal by Subject|0|||
46777019|NCT00467779|82995480|FG002|Stage 1A|Withdrawal by Subject|0|||
46777020|NCT00467779|82995481|FG003|Stage 1A|Withdrawal by Subject|0|||
46777021|NCT00467779|82995482|FG004|Stage 1A|Withdrawal by Subject|0|||
46847821|NCT04024228|83064718|FG001|Overall Study|Adverse Event|0|||
46777022|NCT00467779|82995483|FG005|Stage 1A|Withdrawal by Subject|0|||
46777023|NCT00467779|82995484|FG006|Stage 1A|Withdrawal by Subject|0|||
46777024|NCT00467779|82995485|FG007|Stage 1A|Withdrawal by Subject|0|||
46777025|NCT00467779|82995486|FG008|Stage 1A|Withdrawal by Subject|0|||
46777026|NCT00467779|82995487|FG009|Stage 1A|Withdrawal by Subject|0|||
46777027|NCT00467779|82995488|FG010|Stage 1A|Withdrawal by Subject|1|||
46777028|NCT00467779|82995489|FG011|Stage 1A|Withdrawal by Subject|1|||
46777029|NCT00467779|82995490|FG012|Stage 1A|Withdrawal by Subject|1|||
46777030|NCT00467779|82995491|FG013|Stage 1A|Withdrawal by Subject|0|||
46777031|NCT00467779|82995492|FG014|Stage 1A|Withdrawal by Subject|0|||
46777032|NCT00467779|82995478|FG000|Stage 1A|Unspecified Reason|0|||
46777033|NCT00467779|82995479|FG001|Stage 1A|Unspecified Reason|0|||
47073388|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
47073389|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
47073390|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
47073391|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
47073392|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
47073393|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
47073394|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
47073395|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
47073396|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
47073397|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
46642132|NCT00653068|82831571|FG000|Overall Study|Lack of Efficacy|34|||
46642133|NCT00653068|82831571|FG000|Overall Study|Physician Decision|4|||
46777034|NCT00467779|82995480|FG002|Stage 1A|Unspecified Reason|0|||
46642134|NCT00653068|82831571|FG000|Overall Study|Withdrawal by Subject|1|||
46642135|NCT00653068|82831571|FG000|Overall Study|Ineligible|2|||
46642136|NCT00414648|82831580|FG000|Overall Study|Adverse Event|5|||
46642137|NCT00414648|82831581|FG001|Overall Study|Adverse Event|5|||
46642138|NCT00414648|82831580|FG000|Overall Study|Death|0|||
46642139|NCT00414648|82831581|FG001|Overall Study|Death|1|||
46642140|NCT00414648|82831580|FG000|Overall Study|Lack of Efficacy|0|||
46642141|NCT00414648|82831581|FG001|Overall Study|Lack of Efficacy|2|||
46777035|NCT00467779|82995481|FG003|Stage 1A|Unspecified Reason|0|||
46642142|NCT00414648|82831580|FG000|Overall Study|Withdrawal by Subject|0|||
46777036|NCT00467779|82995482|FG004|Stage 1A|Unspecified Reason|0|||
46777037|NCT00467779|82995483|FG005|Stage 1A|Unspecified Reason|0|||
46847822|NCT04024228|83064717|FG000|Overall Study|Protocol Deviation|0|||
46642143|NCT00414648|82831581|FG001|Overall Study|Withdrawal by Subject|1|||
46642144|NCT02538666|82832186|FG000|Pre-Treatment|Disease progression|1|||
46642145|NCT02538666|82832187|FG001|Pre-Treatment|Disease progression|0|||
46777038|NCT00467779|82995484|FG006|Stage 1A|Unspecified Reason|0|||
46777039|NCT00467779|82995485|FG007|Stage 1A|Unspecified Reason|0|||
46777040|NCT00467779|82995486|FG008|Stage 1A|Unspecified Reason|0|||
46777041|NCT00467779|82995487|FG009|Stage 1A|Unspecified Reason|0|||
46968526|NCT01628692|83211281|FG001|Overall Study|Poor compliance/noncompliance|0|||
46777042|NCT00467779|82995488|FG010|Stage 1A|Unspecified Reason|0|||
46777043|NCT00467779|82995489|FG011|Stage 1A|Unspecified Reason|1|||
46777044|NCT00467779|82995490|FG012|Stage 1A|Unspecified Reason|1|||
46777045|NCT00467779|82995491|FG013|Stage 1A|Unspecified Reason|0|||
46777046|NCT00467779|82995492|FG014|Stage 1A|Unspecified Reason|0|||
46777047|NCT00467779|82995478|FG000|Stage 2|Adverse Event|0|||
46777048|NCT00467779|82995479|FG001|Stage 2|Adverse Event|0|||
46777049|NCT00467779|82995480|FG002|Stage 2|Adverse Event|0|||
47073398|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
47073399|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
47073400|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
47073401|NCT03593213|83361745|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
47073402|NCT03593213|83361746|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
47073403|NCT03593213|83361747|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
47073404|NCT03593213|83361748|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
47073405|NCT00013611|83361792|FG000|Overall Study|Lost to Follow-up|91|||
47073406|NCT00013611|83361793|FG001|Overall Study|Lost to Follow-up|100|||
47073407|NCT00010257|83361801|FG000|Overall Study|Withdrawal by Subject|1|||
47073408|NCT00010257|83361802|FG001|Overall Study|Withdrawal by Subject|0|||
47073409|NCT00211757|83361840|FG000|Overall Study|Withdrawal by Subject|1|||
47073410|NCT00211757|83361841|FG001|Overall Study|Withdrawal by Subject|1|||
47073411|NCT00211757|83361840|FG000|Overall Study|Lack of Efficacy|0|||
47073412|NCT00211757|83361841|FG001|Overall Study|Lack of Efficacy|1|||
47073413|NCT02639052|83361858|FG000|Overall Study|Lost to Follow-up|1|||
47073414|NCT02635776|83361965|FG000|Overall Study|Physician Decision|1|||
47073415|NCT02635776|83361966|FG001|Overall Study|Physician Decision|0|||
47073416|NCT02635776|83361965|FG000|Overall Study|Adverse Event|51|||
47073417|NCT02635776|83361966|FG001|Overall Study|Adverse Event|3|||
47073418|NCT02635776|83361965|FG000|Overall Study|Withdrawal by Subject|41|||
47073419|NCT02635776|83361966|FG001|Overall Study|Withdrawal by Subject|7|||
47073420|NCT02635776|83361965|FG000|Overall Study|Lost to Follow-up|4|||
47073421|NCT02635776|83361966|FG001|Overall Study|Lost to Follow-up|0|||
47073422|NCT02635776|83361965|FG000|Overall Study|Other reasons|5|||
47073423|NCT02635776|83361966|FG001|Overall Study|Other reasons|1|||
47073424|NCT02704403|83361980|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
47073425|NCT02704403|83361981|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
47073426|NCT02704403|83361980|FG000|Overall Study|Administrative reasons by sponsor|1251|||
47073427|NCT02704403|83361981|FG001|Overall Study|Administrative reasons by sponsor|616|||
47073428|NCT02704403|83361980|FG000|Overall Study|Death|4|||
47073429|NCT02704403|83361981|FG001|Overall Study|Death|3|||
47073430|NCT02704403|83361980|FG000|Overall Study|Endpoint event|52|||
47073431|NCT02704403|83361981|FG001|Overall Study|Endpoint event|24|||
47073432|NCT02704403|83361980|FG000|Overall Study|Lost to Follow-up|22|||
47073433|NCT02704403|83361981|FG001|Overall Study|Lost to Follow-up|11|||
47073434|NCT02704403|83361980|FG000|Overall Study|Protocol Violation|15|||
47073435|NCT02704403|83361981|FG001|Overall Study|Protocol Violation|15|||
47073436|NCT02704403|83361980|FG000|Overall Study|Adverse Event|2|||
47073437|NCT02704403|83361981|FG001|Overall Study|Adverse Event|0|||
47073438|NCT02704403|83361980|FG000|Overall Study|Withdrawal by Subject|85|||
47073439|NCT02704403|83361981|FG001|Overall Study|Withdrawal by Subject|45|||
47073440|NCT02704403|83361980|FG000|Overall Study|Investigator decision|1|||
47073441|NCT02704403|83361981|FG001|Overall Study|Investigator decision|1|||
47073442|NCT02704403|83361980|FG000|Overall Study|Follow-up not possible|1|||
47073443|NCT02704403|83361981|FG001|Overall Study|Follow-up not possible|2|||
47073444|NCT02636868|83362016|FG000|Overall Study|Death|0|||
47073445|NCT02636868|83362017|FG001|Overall Study|Death|1|||
46847823|NCT04024228|83064718|FG001|Overall Study|Protocol Deviation|2|||
46968527|NCT01628692|83211282|FG002|Overall Study|Poor compliance/noncompliance|0|||
46968528|NCT01628692|83211283|FG003|Overall Study|Poor compliance/noncompliance|0|||
46968529|NCT01628692|83211284|FG004|Overall Study|Poor compliance/noncompliance|0|||
46968530|NCT01628692|83211285|FG005|Overall Study|Poor compliance/noncompliance|0|||
46968531|NCT01628692|83211280|FG000|Overall Study|Administrative reason by sponsor|0|||
46968532|NCT01628692|83211281|FG001|Overall Study|Administrative reason by sponsor|0|||
46968533|NCT01628692|83211282|FG002|Overall Study|Administrative reason by sponsor|0|||
47073446|NCT02636868|83362018|FG002|Overall Study|Death|2|||
47073447|NCT02635386|83362099|FG000|Overall Study|Pregnancy|2|||
47073448|NCT02635386|83362100|FG001|Overall Study|Pregnancy|0|||
47073449|NCT02635386|83362101|FG002|Overall Study|Pregnancy|0|||
46642146|NCT02538666|82832188|FG002|Pre-Treatment|Disease progression|0|||
47073450|NCT02635386|83362102|FG003|Overall Study|Pregnancy|0|||
47073451|NCT02635386|83362103|FG004|Overall Study|Pregnancy|2|||
46642147|NCT02538666|82832186|FG000|Pre-Treatment|no longer meets study criteria|1|||
46642148|NCT02538666|82832187|FG001|Pre-Treatment|no longer meets study criteria|0|||
46777050|NCT00467779|82995481|FG003|Stage 2|Adverse Event|0|||
46847824|NCT04024228|83064717|FG000|Overall Study|Withdrawal by Subject|3|||
46777051|NCT00467779|82995482|FG004|Stage 2|Adverse Event|0|||
46777052|NCT00467779|82995483|FG005|Stage 2|Adverse Event|0|||
46777053|NCT00467779|82995484|FG006|Stage 2|Adverse Event|0|||
46777054|NCT00467779|82995485|FG007|Stage 2|Adverse Event|0|||
46777055|NCT00467779|82995486|FG008|Stage 2|Adverse Event|1|||
46777056|NCT00467779|82995487|FG009|Stage 2|Adverse Event|0|||
46777057|NCT00467779|82995488|FG010|Stage 2|Adverse Event|0|||
46777058|NCT00467779|82995489|FG011|Stage 2|Adverse Event|0|||
46777059|NCT00467779|82995490|FG012|Stage 2|Adverse Event|0|||
46777060|NCT00467779|82995491|FG013|Stage 2|Adverse Event|0|||
46777061|NCT00467779|82995492|FG014|Stage 2|Adverse Event|0|||
46777062|NCT00467779|82995478|FG000|Stage 2|Death|0|||
46777063|NCT00467779|82995479|FG001|Stage 2|Death|0|||
46777064|NCT00467779|82995480|FG002|Stage 2|Death|0|||
46777065|NCT00467779|82995481|FG003|Stage 2|Death|0|||
46777066|NCT00467779|82995482|FG004|Stage 2|Death|0|||
46777067|NCT00467779|82995483|FG005|Stage 2|Death|0|||
46777068|NCT00467779|82995484|FG006|Stage 2|Death|0|||
46777069|NCT00467779|82995485|FG007|Stage 2|Death|0|||
46777070|NCT00467779|82995486|FG008|Stage 2|Death|1|||
46777071|NCT00467779|82995487|FG009|Stage 2|Death|0|||
46777072|NCT00467779|82995488|FG010|Stage 2|Death|0|||
46777073|NCT00467779|82995489|FG011|Stage 2|Death|0|||
46777074|NCT00467779|82995490|FG012|Stage 2|Death|0|||
46777075|NCT00467779|82995491|FG013|Stage 2|Death|0|||
46777076|NCT00467779|82995492|FG014|Stage 2|Death|0|||
46777077|NCT00467779|82995478|FG000|Stage 2|Disease Progression|0|||
46777078|NCT00467779|82995479|FG001|Stage 2|Disease Progression|0|||
46777079|NCT00467779|82995480|FG002|Stage 2|Disease Progression|0|||
46777080|NCT00467779|82995481|FG003|Stage 2|Disease Progression|0|||
46777081|NCT00467779|82995482|FG004|Stage 2|Disease Progression|0|||
46777082|NCT00467779|82995483|FG005|Stage 2|Disease Progression|0|||
46777083|NCT00467779|82995484|FG006|Stage 2|Disease Progression|0|||
46777084|NCT00467779|82995485|FG007|Stage 2|Disease Progression|0|||
46777085|NCT00467779|82995486|FG008|Stage 2|Disease Progression|16|||
46777086|NCT00467779|82995487|FG009|Stage 2|Disease Progression|0|||
46777087|NCT00467779|82995488|FG010|Stage 2|Disease Progression|0|||
46777088|NCT00467779|82995489|FG011|Stage 2|Disease Progression|0|||
46777089|NCT00467779|82995490|FG012|Stage 2|Disease Progression|0|||
46777090|NCT00467779|82995491|FG013|Stage 2|Disease Progression|0|||
46777091|NCT00467779|82995492|FG014|Stage 2|Disease Progression|0|||
46777092|NCT00467779|82995478|FG000|Stage 2|Unspecified Reason|0|||
46777093|NCT00467779|82995479|FG001|Stage 2|Unspecified Reason|0|||
46777094|NCT00467779|82995480|FG002|Stage 2|Unspecified Reason|0|||
46777095|NCT00467779|82995481|FG003|Stage 2|Unspecified Reason|0|||
46777096|NCT00467779|82995482|FG004|Stage 2|Unspecified Reason|0|||
46777097|NCT00467779|82995483|FG005|Stage 2|Unspecified Reason|0|||
46777098|NCT00467779|82995484|FG006|Stage 2|Unspecified Reason|0|||
46777099|NCT00467779|82995485|FG007|Stage 2|Unspecified Reason|0|||
46777100|NCT00467779|82995486|FG008|Stage 2|Unspecified Reason|3|||
46777101|NCT00467779|82995487|FG009|Stage 2|Unspecified Reason|0|||
46777102|NCT00467779|82995488|FG010|Stage 2|Unspecified Reason|0|||
46777103|NCT00467779|82995489|FG011|Stage 2|Unspecified Reason|0|||
46777104|NCT00467779|82995490|FG012|Stage 2|Unspecified Reason|0|||
46777105|NCT00467779|82995491|FG013|Stage 2|Unspecified Reason|0|||
46777106|NCT00467779|82995492|FG014|Stage 2|Unspecified Reason|0|||
46777107|NCT00467779|82995478|FG000|Stage 2A|Adverse Event|0|||
46777108|NCT00467779|82995479|FG001|Stage 2A|Adverse Event|0|||
46777109|NCT00467779|82995480|FG002|Stage 2A|Adverse Event|0|||
46777110|NCT00467779|82995481|FG003|Stage 2A|Adverse Event|0|||
46777111|NCT00467779|82995482|FG004|Stage 2A|Adverse Event|0|||
46777112|NCT00467779|82995483|FG005|Stage 2A|Adverse Event|0|||
46777113|NCT00467779|82995484|FG006|Stage 2A|Adverse Event|0|||
46777114|NCT00467779|82995485|FG007|Stage 2A|Adverse Event|0|||
46777115|NCT00467779|82995486|FG008|Stage 2A|Adverse Event|0|||
46777116|NCT00467779|82995487|FG009|Stage 2A|Adverse Event|0|||
46777117|NCT00467779|82995488|FG010|Stage 2A|Adverse Event|0|||
46777118|NCT00467779|82995489|FG011|Stage 2A|Adverse Event|0|||
46777119|NCT00467779|82995490|FG012|Stage 2A|Adverse Event|0|||
46777120|NCT00467779|82995491|FG013|Stage 2A|Adverse Event|2|||
46777121|NCT00467779|82995492|FG014|Stage 2A|Adverse Event|0|||
46847825|NCT04024228|83064718|FG001|Overall Study|Withdrawal by Subject|4|||
46847826|NCT04023994|83064732|FG000|Overall Study|Lost to Follow-up|0|||
46777122|NCT00467779|82995478|FG000|Stage 2A|Death|0|||
46777123|NCT00467779|82995479|FG001|Stage 2A|Death|0|||
46777124|NCT00467779|82995480|FG002|Stage 2A|Death|0|||
46777125|NCT00467779|82995481|FG003|Stage 2A|Death|0|||
46777126|NCT00467779|82995482|FG004|Stage 2A|Death|0|||
46777127|NCT00467779|82995483|FG005|Stage 2A|Death|0|||
46777128|NCT00467779|82995484|FG006|Stage 2A|Death|0|||
46777129|NCT00467779|82995485|FG007|Stage 2A|Death|0|||
46777130|NCT00467779|82995486|FG008|Stage 2A|Death|0|||
46777131|NCT00467779|82995487|FG009|Stage 2A|Death|0|||
46777132|NCT00467779|82995488|FG010|Stage 2A|Death|0|||
46777133|NCT00467779|82995489|FG011|Stage 2A|Death|0|||
46777134|NCT00467779|82995490|FG012|Stage 2A|Death|0|||
46777135|NCT00467779|82995491|FG013|Stage 2A|Death|1|||
46777136|NCT00467779|82995492|FG014|Stage 2A|Death|0|||
46847827|NCT04023994|83064733|FG001|Overall Study|Lost to Follow-up|1|||
46777137|NCT00467779|82995478|FG000|Stage 2A|Disease Progression|0|||
46777138|NCT00467779|82995479|FG001|Stage 2A|Disease Progression|0|||
46777139|NCT00467779|82995480|FG002|Stage 2A|Disease Progression|0|||
46777140|NCT00467779|82995481|FG003|Stage 2A|Disease Progression|0|||
46777141|NCT00467779|82995482|FG004|Stage 2A|Disease Progression|0|||
46777142|NCT00467779|82995483|FG005|Stage 2A|Disease Progression|0|||
46777143|NCT00467779|82995484|FG006|Stage 2A|Disease Progression|0|||
46777144|NCT00467779|82995485|FG007|Stage 2A|Disease Progression|0|||
46777145|NCT00467779|82995486|FG008|Stage 2A|Disease Progression|0|||
46777146|NCT00467779|82995487|FG009|Stage 2A|Disease Progression|0|||
46777147|NCT00467779|82995488|FG010|Stage 2A|Disease Progression|0|||
46777148|NCT00467779|82995489|FG011|Stage 2A|Disease Progression|0|||
46777149|NCT00467779|82995490|FG012|Stage 2A|Disease Progression|0|||
46777150|NCT00467779|82995491|FG013|Stage 2A|Disease Progression|10|||
46777151|NCT00467779|82995492|FG014|Stage 2A|Disease Progression|0|||
46777152|NCT00467779|82995478|FG000|Stage 2A|Unspecified Reason|0|||
46777153|NCT00467779|82995479|FG001|Stage 2A|Unspecified Reason|0|||
46777154|NCT00467779|82995480|FG002|Stage 2A|Unspecified Reason|0|||
46777155|NCT00467779|82995481|FG003|Stage 2A|Unspecified Reason|0|||
46777156|NCT00467779|82995482|FG004|Stage 2A|Unspecified Reason|0|||
46777157|NCT00467779|82995483|FG005|Stage 2A|Unspecified Reason|0|||
46777158|NCT00467779|82995484|FG006|Stage 2A|Unspecified Reason|0|||
46777159|NCT00467779|82995485|FG007|Stage 2A|Unspecified Reason|0|||
46777160|NCT00467779|82995486|FG008|Stage 2A|Unspecified Reason|0|||
46777161|NCT00467779|82995487|FG009|Stage 2A|Unspecified Reason|0|||
46777162|NCT00467779|82995488|FG010|Stage 2A|Unspecified Reason|0|||
46777163|NCT00467779|82995489|FG011|Stage 2A|Unspecified Reason|0|||
46777164|NCT00467779|82995490|FG012|Stage 2A|Unspecified Reason|0|||
46777165|NCT00467779|82995491|FG013|Stage 2A|Unspecified Reason|7|||
46777166|NCT00467779|82995492|FG014|Stage 2A|Unspecified Reason|0|||
46777167|NCT00467779|82995478|FG000|Stage 2A|Withdrawal by Subject|0|||
46777168|NCT00467779|82995479|FG001|Stage 2A|Withdrawal by Subject|0|||
46777169|NCT00467779|82995480|FG002|Stage 2A|Withdrawal by Subject|0|||
46777170|NCT00467779|82995481|FG003|Stage 2A|Withdrawal by Subject|0|||
46777171|NCT00467779|82995482|FG004|Stage 2A|Withdrawal by Subject|0|||
46777172|NCT00467779|82995483|FG005|Stage 2A|Withdrawal by Subject|0|||
46777173|NCT00467779|82995484|FG006|Stage 2A|Withdrawal by Subject|0|||
46777174|NCT00467779|82995485|FG007|Stage 2A|Withdrawal by Subject|0|||
46777175|NCT00467779|82995486|FG008|Stage 2A|Withdrawal by Subject|0|||
46777176|NCT00467779|82995487|FG009|Stage 2A|Withdrawal by Subject|0|||
46777177|NCT00467779|82995488|FG010|Stage 2A|Withdrawal by Subject|0|||
46847828|NCT04023994|83064734|FG002|Overall Study|Lost to Follow-up|2|||
46847829|NCT04023994|83064735|FG003|Overall Study|Lost to Follow-up|0|||
46847830|NCT04023994|83064736|FG004|Overall Study|Lost to Follow-up|0|||
46847831|NCT04023994|83064737|FG005|Overall Study|Lost to Follow-up|0|||
46847832|NCT04023994|83064732|FG000|Overall Study|Withdrawal by Subject|0|||
46847833|NCT04023994|83064733|FG001|Overall Study|Withdrawal by Subject|0|||
46847834|NCT04023994|83064734|FG002|Overall Study|Withdrawal by Subject|0|||
46847835|NCT04023994|83064735|FG003|Overall Study|Withdrawal by Subject|1|||
46847836|NCT04023994|83064736|FG004|Overall Study|Withdrawal by Subject|0|||
46847837|NCT04023994|83064737|FG005|Overall Study|Withdrawal by Subject|0|||
46847838|NCT04023682|83064756|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
46847839|NCT04018612|83064767|FG000|Overall Study|Withdrawal by Subject|1|||
46847840|NCT04018612|83064768|FG001|Overall Study|Withdrawal by Subject|0|||
46847841|NCT04018612|83064769|FG002|Overall Study|Withdrawal by Subject|1|||
46847842|NCT04209400|83064779|FG000|Overall Study|Withdrawal by Subject|0|||
46847843|NCT04209400|83064780|FG001|Overall Study|Withdrawal by Subject|1|||
46847844|NCT04207840|83064786|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
46847845|NCT04207840|83064787|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
46847846|NCT04207840|83064788|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
46777178|NCT00467779|82995489|FG011|Stage 2A|Withdrawal by Subject|0|||
46777179|NCT00467779|82995490|FG012|Stage 2A|Withdrawal by Subject|0|||
46847847|NCT04207840|83064786|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
46847848|NCT04207840|83064787|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
46777180|NCT00467779|82995491|FG013|Stage 2A|Withdrawal by Subject|1|||
46777181|NCT00467779|82995492|FG014|Stage 2A|Withdrawal by Subject|0|||
46777182|NCT00467779|82995478|FG000|Stage 3|Adverse Event|0|||
46777183|NCT00467779|82995479|FG001|Stage 3|Adverse Event|0|||
46777184|NCT00467779|82995480|FG002|Stage 3|Adverse Event|0|||
46777185|NCT00467779|82995481|FG003|Stage 3|Adverse Event|0|||
46777186|NCT00467779|82995482|FG004|Stage 3|Adverse Event|0|||
46777187|NCT00467779|82995483|FG005|Stage 3|Adverse Event|0|||
46777188|NCT00467779|82995484|FG006|Stage 3|Adverse Event|0|||
46777189|NCT00467779|82995485|FG007|Stage 3|Adverse Event|0|||
46847849|NCT04207840|83064788|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
46847850|NCT04006366|83064796|FG000|Overall Study|Withdrawal by Subject|1|||
46847851|NCT04191148|83064802|FG000|Overall Study|Withdrawal by Subject|1|||
46847852|NCT04191148|83064803|FG001|Overall Study|Withdrawal by Subject|0|||
46847853|NCT04191148|83064802|FG000|Overall Study|Adverse Event|1|||
46777190|NCT00467779|82995486|FG008|Stage 3|Adverse Event|0|||
46777191|NCT00467779|82995487|FG009|Stage 3|Adverse Event|0|||
46777192|NCT00467779|82995488|FG010|Stage 3|Adverse Event|0|||
46777193|NCT00467779|82995489|FG011|Stage 3|Adverse Event|0|||
46777194|NCT00467779|82995490|FG012|Stage 3|Adverse Event|0|||
46777195|NCT00467779|82995491|FG013|Stage 3|Adverse Event|0|||
46777196|NCT00467779|82995492|FG014|Stage 3|Adverse Event|2|||
46777197|NCT00467779|82995478|FG000|Stage 3|Death|0|||
46777198|NCT00467779|82995479|FG001|Stage 3|Death|0|||
46777199|NCT00467779|82995480|FG002|Stage 3|Death|0|||
46777200|NCT00467779|82995481|FG003|Stage 3|Death|0|||
46777201|NCT00467779|82995482|FG004|Stage 3|Death|0|||
46777202|NCT00467779|82995483|FG005|Stage 3|Death|0|||
46777203|NCT00467779|82995484|FG006|Stage 3|Death|0|||
47073452|NCT02635386|83362099|FG000|Overall Study|Withdrawal by Subject|1|||
47073453|NCT02635386|83362100|FG001|Overall Study|Withdrawal by Subject|1|||
47073454|NCT02635386|83362101|FG002|Overall Study|Withdrawal by Subject|0|||
47073455|NCT02635386|83362102|FG003|Overall Study|Withdrawal by Subject|1|||
47073456|NCT02635386|83362103|FG004|Overall Study|Withdrawal by Subject|0|||
47073457|NCT02635386|83362099|FG000|Overall Study|Physician Decision|0|||
47073458|NCT02635386|83362100|FG001|Overall Study|Physician Decision|1|||
47073459|NCT02635386|83362101|FG002|Overall Study|Physician Decision|0|||
47073460|NCT02635386|83362102|FG003|Overall Study|Physician Decision|0|||
47073461|NCT02635386|83362103|FG004|Overall Study|Physician Decision|0|||
47073462|NCT02635386|83362099|FG000|Overall Study|Moved Out of State|0|||
47073463|NCT02635386|83362100|FG001|Overall Study|Moved Out of State|1|||
47073464|NCT02635386|83362101|FG002|Overall Study|Moved Out of State|0|||
47073465|NCT02635386|83362102|FG003|Overall Study|Moved Out of State|0|||
47073466|NCT02635386|83362103|FG004|Overall Study|Moved Out of State|0|||
47073467|NCT02635386|83362099|FG000|Overall Study|Noncompliant|0|||
46642149|NCT02538666|82832188|FG002|Pre-Treatment|no longer meets study criteria|0|||
46642150|NCT02538666|82832186|FG000|Pre-Treatment|Withdrew Consent|0|||
46642151|NCT02538666|82832187|FG001|Pre-Treatment|Withdrew Consent|1|||
46642152|NCT02538666|82832188|FG002|Pre-Treatment|Withdrew Consent|1|||
46642153|NCT02538666|82832186|FG000|Treatment|Disease progression|270|||
46642154|NCT02538666|82832187|FG001|Treatment|Disease progression|227|||
46642155|NCT02538666|82832188|FG002|Treatment|Disease progression|165|||
46642156|NCT02538666|82832186|FG000|Treatment|Study drug toxicity|1|||
46642157|NCT02538666|82832187|FG001|Treatment|Study drug toxicity|29|||
46642158|NCT02538666|82832188|FG002|Treatment|Study drug toxicity|92|||
46642159|NCT02538666|82832186|FG000|Treatment|Death|0|||
46642160|NCT02538666|82832187|FG001|Treatment|Death|2|||
46642161|NCT02538666|82832188|FG002|Treatment|Death|3|||
46642162|NCT02538666|82832186|FG000|Treatment|Adverse event unrelated to study drug|8|||
46642163|NCT02538666|82832187|FG001|Treatment|Adverse event unrelated to study drug|10|||
46642164|NCT02538666|82832188|FG002|Treatment|Adverse event unrelated to study drug|15|||
46642165|NCT02538666|82832186|FG000|Treatment|Participant request to discontinue study treatment|3|||
46642166|NCT02538666|82832187|FG001|Treatment|Participant request to discontinue study treatment|6|||
46642167|NCT02538666|82832188|FG002|Treatment|Participant request to discontinue study treatment|11|||
46642168|NCT02538666|82832186|FG000|Treatment|Participant withdrew consent|2|||
46642169|NCT02538666|82832187|FG001|Treatment|Participant withdrew consent|5|||
46642170|NCT02538666|82832188|FG002|Treatment|Participant withdrew consent|3|||
46642171|NCT02538666|82832186|FG000|Treatment|Lost to Follow-up|0|||
46642172|NCT02538666|82832187|FG001|Treatment|Lost to Follow-up|1|||
46642173|NCT02538666|82832188|FG002|Treatment|Lost to Follow-up|1|||
46642174|NCT02538666|82832186|FG000|Treatment|Maximum clinical benefit|4|||
46642175|NCT02538666|82832187|FG001|Treatment|Maximum clinical benefit|3|||
46642176|NCT02538666|82832188|FG002|Treatment|Maximum clinical benefit|4|||
46642177|NCT02538666|82832186|FG000|Treatment|Poor/non-compliance|0|||
46642178|NCT02538666|82832187|FG001|Treatment|Poor/non-compliance|1|||
46642179|NCT02538666|82832188|FG002|Treatment|Poor/non-compliance|0|||
46642180|NCT02538666|82832186|FG000|Treatment|Participant no longer meets study criteria|0|||
46642181|NCT02538666|82832187|FG001|Treatment|Participant no longer meets study criteria|2|||
46642182|NCT02538666|82832188|FG002|Treatment|Participant no longer meets study criteria|0|||
46777204|NCT00467779|82995485|FG007|Stage 3|Death|0|||
46777205|NCT00467779|82995486|FG008|Stage 3|Death|0|||
46777206|NCT00467779|82995487|FG009|Stage 3|Death|0|||
47073468|NCT02635386|83362100|FG001|Overall Study|Noncompliant|2|||
47073469|NCT02635386|83362101|FG002|Overall Study|Noncompliant|1|||
46642183|NCT02538666|82832186|FG000|Treatment|Administrative reason by sponsor|0|||
46642184|NCT02538666|82832187|FG001|Treatment|Administrative reason by sponsor|0|||
46777207|NCT00467779|82995488|FG010|Stage 3|Death|0|||
46777208|NCT00467779|82995489|FG011|Stage 3|Death|0|||
46777209|NCT00467779|82995490|FG012|Stage 3|Death|0|||
47073470|NCT02635386|83362102|FG003|Overall Study|Noncompliant|1|||
46777210|NCT00467779|82995491|FG013|Stage 3|Death|0|||
46777211|NCT00467779|82995492|FG014|Stage 3|Death|1|||
46777212|NCT00467779|82995478|FG000|Stage 3|Disease Progression|0|||
46777213|NCT00467779|82995479|FG001|Stage 3|Disease Progression|0|||
46777214|NCT00467779|82995480|FG002|Stage 3|Disease Progression|0|||
46777215|NCT00467779|82995481|FG003|Stage 3|Disease Progression|0|||
46777216|NCT00467779|82995482|FG004|Stage 3|Disease Progression|0|||
46777217|NCT00467779|82995483|FG005|Stage 3|Disease Progression|0|||
46777218|NCT00467779|82995484|FG006|Stage 3|Disease Progression|0|||
46777219|NCT00467779|82995485|FG007|Stage 3|Disease Progression|0|||
46777220|NCT00467779|82995486|FG008|Stage 3|Disease Progression|0|||
46777221|NCT00467779|82995487|FG009|Stage 3|Disease Progression|0|||
46777222|NCT00467779|82995488|FG010|Stage 3|Disease Progression|0|||
46777223|NCT00467779|82995489|FG011|Stage 3|Disease Progression|0|||
46777224|NCT00467779|82995490|FG012|Stage 3|Disease Progression|0|||
46777225|NCT00467779|82995491|FG013|Stage 3|Disease Progression|0|||
46777226|NCT00467779|82995492|FG014|Stage 3|Disease Progression|9|||
46777227|NCT00467779|82995478|FG000|Stage 3|Unspecified Reason|0|||
46777228|NCT00467779|82995479|FG001|Stage 3|Unspecified Reason|0|||
46777229|NCT00467779|82995480|FG002|Stage 3|Unspecified Reason|0|||
46777230|NCT00467779|82995481|FG003|Stage 3|Unspecified Reason|0|||
46777231|NCT00467779|82995482|FG004|Stage 3|Unspecified Reason|0|||
46777232|NCT00467779|82995483|FG005|Stage 3|Unspecified Reason|0|||
46777233|NCT00467779|82995484|FG006|Stage 3|Unspecified Reason|0|||
46777234|NCT00467779|82995485|FG007|Stage 3|Unspecified Reason|0|||
46777235|NCT00467779|82995486|FG008|Stage 3|Unspecified Reason|0|||
46777236|NCT00467779|82995487|FG009|Stage 3|Unspecified Reason|0|||
46777237|NCT00467779|82995488|FG010|Stage 3|Unspecified Reason|0|||
46777238|NCT00467779|82995489|FG011|Stage 3|Unspecified Reason|0|||
46777239|NCT00467779|82995490|FG012|Stage 3|Unspecified Reason|0|||
46777240|NCT00467779|82995491|FG013|Stage 3|Unspecified Reason|0|||
46777241|NCT00467779|82995492|FG014|Stage 3|Unspecified Reason|5|||
46777242|NCT00570687|82995532|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777243|NCT00570687|82995533|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777244|NCT00570687|82995534|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777245|NCT00570687|82995535|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777246|NCT00570687|82995536|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
46777247|NCT00570687|82995537|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
46777248|NCT00570687|82995538|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
46777249|NCT00570687|82995539|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
46777250|NCT00570687|82995540|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
46777251|NCT00570687|82995541|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
46777252|NCT00570687|82995532|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777253|NCT00570687|82995533|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777254|NCT00570687|82995534|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777255|NCT00570687|82995535|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777256|NCT00570687|82995536|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777257|NCT00570687|82995537|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777258|NCT00570687|82995538|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777259|NCT00570687|82995539|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777260|NCT00570687|82995540|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
46777261|NCT00570687|82995541|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777262|NCT00570687|82995532|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777263|NCT00570687|82995533|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46847854|NCT04191148|83064803|FG001|Overall Study|Adverse Event|0|||
46847855|NCT04004260|83064813|FG000|Overall Study|Withdrawal by Subject|7|||
46847856|NCT04004260|83064814|FG001|Overall Study|Withdrawal by Subject|3|||
46968534|NCT01628692|83211283|FG003|Overall Study|Administrative reason by sponsor|0|||
46642185|NCT02538666|82832188|FG002|Treatment|Administrative reason by sponsor|1|||
46642186|NCT02538666|82832186|FG000|Treatment|Other reasons|8|||
46642187|NCT02538666|82832187|FG001|Treatment|Other reasons|15|||
46642188|NCT02538666|82832188|FG002|Treatment|Other reasons|5|||
46642189|NCT02538666|82832186|FG000|Treatment|Not reported|2|||
46642190|NCT02538666|82832187|FG001|Treatment|Not reported|2|||
46642191|NCT02538666|82832188|FG002|Treatment|Not reported|2|||
46642192|NCT02407236|82832242|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
46642193|NCT02407236|82832243|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
46642194|NCT02407236|82832244|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
46642195|NCT02407236|82832245|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
46642196|NCT02407236|82832246|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
46777264|NCT00570687|82995534|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777265|NCT00570687|82995535|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46642197|NCT02407236|82832247|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
46642198|NCT02407236|82832248|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
46777266|NCT00570687|82995536|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777267|NCT00570687|82995537|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46847857|NCT04004260|83064813|FG000|Overall Study|Lost to Follow-up|22|||
46777268|NCT00570687|82995538|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
46777269|NCT00570687|82995539|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777270|NCT00570687|82995540|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777271|NCT00570687|82995541|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
46777272|NCT03836677|82995555|FG000|Period 1|Adverse Event|0|||
46777273|NCT03836677|82995556|FG001|Period 1|Adverse Event|1|||
46777274|NCT03836677|82995555|FG000|Period 2|Severe non-compliance to protocol|1|||
46777275|NCT03836677|82995556|FG001|Period 2|Severe non-compliance to protocol|0|||
46777276|NCT00434161|82995587|FG000|Overall Study|Adverse Event|5|||
46847858|NCT04004260|83064814|FG001|Overall Study|Lost to Follow-up|12|||
46847859|NCT04004260|83064813|FG000|Overall Study|Did not engage in intervention|13|||
46847860|NCT04004260|83064814|FG001|Overall Study|Did not engage in intervention|17|||
46847861|NCT04470622|83064822|FG000|Overall Study|Withdrawal by Subject|0|||
46847862|NCT04470622|83064823|FG001|Overall Study|Withdrawal by Subject|1|||
46847863|NCT04470622|83064822|FG000|Overall Study|Screen Failure|0|||
46847864|NCT04470622|83064823|FG001|Overall Study|Screen Failure|1|||
46847865|NCT04470622|83064822|FG000|Overall Study|Death|0|||
46847866|NCT04470622|83064823|FG001|Overall Study|Death|1|||
46847867|NCT04465630|83064829|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
46847868|NCT04465630|83064829|FG000|Overall Study|Screen failure|8|||
46847869|NCT04465630|83064829|FG000|Overall Study|Baseline failure|16|||
46847870|NCT04182880|83064836|FG000|Overall Study|Pregnancy|1|||
46847871|NCT04182880|83064837|FG001|Overall Study|Pregnancy|0|||
46847872|NCT04465396|83064847|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
46847873|NCT04465396|83064848|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
46847874|NCT04465396|83064849|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
46847875|NCT04465396|83064850|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
46847876|NCT03999892|83064875|FG000|Overall Study|Lost to Follow-up|1|||
46847877|NCT03996694|83064879|FG000|First Washout (7 Days)|positive urine drug screen|0|||
46847878|NCT03996694|83064880|FG001|First Washout (7 Days)|positive urine drug screen|0|||
46847879|NCT03996694|83064881|FG002|First Washout (7 Days)|positive urine drug screen|1|||
46847880|NCT03996694|83064882|FG003|First Washout (7 Days)|positive urine drug screen|0|||
46847881|NCT03996694|83064883|FG004|First Washout (7 Days)|positive urine drug screen|0|||
46847882|NCT03996694|83064884|FG005|First Washout (7 Days)|positive urine drug screen|0|||
46847883|NCT03996694|83064879|FG000|First Washout (7 Days)|Adverse Event|0|||
46847884|NCT03996694|83064880|FG001|First Washout (7 Days)|Adverse Event|1|||
46847885|NCT03996694|83064881|FG002|First Washout (7 Days)|Adverse Event|0|||
46847886|NCT03996694|83064882|FG003|First Washout (7 Days)|Adverse Event|0|||
46847887|NCT03996694|83064883|FG004|First Washout (7 Days)|Adverse Event|0|||
46847888|NCT03996694|83064884|FG005|First Washout (7 Days)|Adverse Event|0|||
46847889|NCT03996694|83064879|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
46847890|NCT03996694|83064880|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
46847891|NCT03996694|83064881|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
46847892|NCT03996694|83064882|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
46847893|NCT03996694|83064883|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
46847894|NCT03996694|83064884|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
46847895|NCT03996694|83064879|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
46847896|NCT03996694|83064880|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
46847897|NCT03996694|83064881|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
46847898|NCT03996694|83064882|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
46847899|NCT03996694|83064883|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
46847900|NCT03996694|83064884|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
46847901|NCT04179838|83064900|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
46847902|NCT04179838|83064901|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
46847903|NCT04179838|83064900|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
46847904|NCT04179838|83064901|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
46847905|NCT03994120|83064909|FG000|Overall Study|Lost to Follow-up|3|||
46847906|NCT03994120|83064910|FG001|Overall Study|Lost to Follow-up|1|||
46847907|NCT04178590|83064916|FG000|Overall Study|Pregnancy|1|||
46847908|NCT04178590|83064916|FG000|Overall Study|Lost to Follow-up|1|||
46847909|NCT04175392|83064944|FG000|Overall Study|Withdrawal by Subject|3|||
46847910|NCT04175392|83064945|FG001|Overall Study|Withdrawal by Subject|2|||
46847911|NCT03986866|83064953|FG000|Overall Study|Withdrawal by Subject|0|||
46847912|NCT03986866|83064954|FG001|Overall Study|Withdrawal by Subject|3|||
46968535|NCT01628692|83211284|FG004|Overall Study|Administrative reason by sponsor|0|||
46968536|NCT01628692|83211285|FG005|Overall Study|Administrative reason by sponsor|1|||
46777277|NCT00434161|82995588|FG001|Overall Study|Adverse Event|1|||
46847913|NCT03986866|83064953|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
46847914|NCT03986866|83064954|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
46847915|NCT03980938|83064962|FG000|Treatment Period 1|Study Terminated|1|||
46847916|NCT03980938|83064963|FG001|Treatment Period 1|Study Terminated|1|||
46847917|NCT03980938|83064962|FG000|Treatment Period 2|Study Terminated|2|||
46847918|NCT03980938|83064963|FG001|Treatment Period 2|Study Terminated|2|||
46777278|NCT00434161|82995589|FG002|Overall Study|Adverse Event|4|||
46777279|NCT00434161|82995587|FG000|Overall Study|Lost to Follow-up|0|||
46777280|NCT00434161|82995588|FG001|Overall Study|Lost to Follow-up|1|||
46777281|NCT00434161|82995589|FG002|Overall Study|Lost to Follow-up|0|||
46777282|NCT00434161|82995587|FG000|Overall Study|Death|1|||
46777283|NCT00434161|82995588|FG001|Overall Study|Death|0|||
46777284|NCT00434161|82995589|FG002|Overall Study|Death|1|||
46777285|NCT00434161|82995587|FG000|Overall Study|Non-Compliance|1|||
46777286|NCT00434161|82995588|FG001|Overall Study|Non-Compliance|1|||
46777287|NCT00434161|82995589|FG002|Overall Study|Non-Compliance|0|||
46777288|NCT00434161|82995587|FG000|Overall Study|Withdrawal by Subject|2|||
46777289|NCT00434161|82995588|FG001|Overall Study|Withdrawal by Subject|0|||
46777290|NCT00434161|82995589|FG002|Overall Study|Withdrawal by Subject|3|||
46777291|NCT00434161|82995587|FG000|Overall Study|Logistical error study assessments|1|||
46777292|NCT00434161|82995588|FG001|Overall Study|Logistical error study assessments|0|||
46777293|NCT00434161|82995589|FG002|Overall Study|Logistical error study assessments|3|||
46777294|NCT00441103|82995606|FG000|Overall Study|Adverse Event|2|||
46777295|NCT00441103|82995607|FG001|Overall Study|Adverse Event|1|||
46777296|NCT00441103|82995606|FG000|Overall Study|Death|1|||
46777297|NCT00441103|82995607|FG001|Overall Study|Death|0|||
46777298|NCT00441103|82995606|FG000|Overall Study|Disease Progression|2|||
46777299|NCT00441103|82995607|FG001|Overall Study|Disease Progression|0|||
46777300|NCT00441103|82995606|FG000|Overall Study|Lost to Follow-up|1|||
46777301|NCT00441103|82995607|FG001|Overall Study|Lost to Follow-up|0|||
46847919|NCT03656692|83064969|FG000|Overall Study|Worsening of disease activity|2|||
46847920|NCT03656692|83064969|FG000|Overall Study|Physician Decision|1|||
46847921|NCT03682120|83064977|FG000|Overall Study|Lost to Follow-up|11|||
47073471|NCT02635386|83362103|FG004|Overall Study|Noncompliant|1|||
47073472|NCT02635386|83362099|FG000|Overall Study|side effects|0|||
47073473|NCT02635386|83362100|FG001|Overall Study|side effects|0|||
47073474|NCT02635386|83362101|FG002|Overall Study|side effects|1|||
47073475|NCT02635386|83362102|FG003|Overall Study|side effects|4|||
47073476|NCT02635386|83362103|FG004|Overall Study|side effects|6|||
47073477|NCT02635386|83362099|FG000|Overall Study|needed other major surgery|0|||
47073478|NCT02635386|83362100|FG001|Overall Study|needed other major surgery|1|||
47073479|NCT02635386|83362101|FG002|Overall Study|needed other major surgery|0|||
47073480|NCT02635386|83362102|FG003|Overall Study|needed other major surgery|0|||
47073481|NCT02635386|83362103|FG004|Overall Study|needed other major surgery|0|||
47073482|NCT02635386|83362099|FG000|Overall Study|Other medical problems not drug related|0|||
47073483|NCT02635386|83362100|FG001|Overall Study|Other medical problems not drug related|0|||
47073484|NCT02635386|83362101|FG002|Overall Study|Other medical problems not drug related|0|||
47073485|NCT02635386|83362102|FG003|Overall Study|Other medical problems not drug related|1|||
47073486|NCT02635386|83362103|FG004|Overall Study|Other medical problems not drug related|0|||
47073487|NCT02634606|83362201|FG000|Overall Study|unable to obtain the drug at start|13|||
47073488|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
47073489|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
47073490|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
47073491|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
47073492|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
47073493|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
47073494|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
47073495|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
47073496|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
47073497|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
46777302|NCT00441103|82995606|FG000|Overall Study|Protocol Violation|1|||
46777303|NCT00441103|82995607|FG001|Overall Study|Protocol Violation|0|||
46777304|NCT00441103|82995606|FG000|Overall Study|Participant unable to use Rebiject II|1|||
46777305|NCT00441103|82995607|FG001|Overall Study|Participant unable to use Rebiject II|0|||
46777306|NCT00441103|82995606|FG000|Overall Study|Participant refused MRI|1|||
46847922|NCT03682120|83064978|FG001|Overall Study|Lost to Follow-up|4|||
47073498|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
46777307|NCT00441103|82995607|FG001|Overall Study|Participant refused MRI|0|||
46777308|NCT00441103|82995606|FG000|Overall Study|Inclusion criteria absent|1|||
46777309|NCT00441103|82995607|FG001|Overall Study|Inclusion criteria absent|0|||
47073499|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
46777310|NCT00441103|82995606|FG000|Overall Study|Non-compliant|0|||
46777311|NCT00441103|82995607|FG001|Overall Study|Non-compliant|1|||
46847923|NCT03682120|83064979|FG002|Overall Study|Lost to Follow-up|5|||
46847924|NCT03682120|83064980|FG003|Overall Study|Lost to Follow-up|2|||
47073500|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
47073501|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
47073502|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
46777312|NCT00441103|82995606|FG000|Overall Study|Participant decided to withdraw|1|||
46777313|NCT00441103|82995607|FG001|Overall Study|Participant decided to withdraw|0|||
46777314|NCT00441103|82995606|FG000|Overall Study|Participant's reason|0|||
46777315|NCT00441103|82995607|FG001|Overall Study|Participant's reason|1|||
46777316|NCT00441103|82995606|FG000|Overall Study|Participant decided to stop|0|||
46777317|NCT00441103|82995607|FG001|Overall Study|Participant decided to stop|1|||
46777318|NCT00433771|82995614|FG000|Overall Study|screen fail|14|||
46777319|NCT00433771|82995614|FG000|Overall Study|Treated and later found to be ineligible|2|||
46777320|NCT00433771|82995614|FG000|Overall Study|Death|2|||
46777321|NCT00433771|82995614|FG000|Overall Study|Failure to deploy stent|1|||
46777322|NCT00433537|82995618|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
46777323|NCT00433537|82995619|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
46777324|NCT00433537|82995620|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
46777325|NCT00433537|82995618|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
46777326|NCT00433537|82995619|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
46777327|NCT00433537|82995620|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
46777328|NCT00433537|82995618|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
46777329|NCT00433537|82995619|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
46777330|NCT00433537|82995620|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
46777331|NCT00433537|82995618|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
46777332|NCT00433537|82995619|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
46777333|NCT00433537|82995620|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
46777334|NCT00433537|82995618|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
46777335|NCT00433537|82995619|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
46777336|NCT00433537|82995620|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
46777337|NCT00433537|82995618|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
46777338|NCT00433537|82995619|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
46777339|NCT00433537|82995620|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
46777340|NCT00433537|82995618|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
46777341|NCT00433537|82995619|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
46777342|NCT00433537|82995620|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
46777343|NCT00433537|82995618|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
46777344|NCT00433537|82995619|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
46777345|NCT00433537|82995620|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
46777346|NCT00433537|82995618|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
46777347|NCT00433537|82995619|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
46777348|NCT00433537|82995620|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
46777349|NCT00570765|82995630|FG000|DB Phase|Withdrawal by Subject|1|||
46777350|NCT00570765|82995631|FG001|DB Phase|Withdrawal by Subject|0|||
46777351|NCT00570765|82995632|FG002|DB Phase|Withdrawal by Subject|0|||
46777352|NCT00570765|82995633|FG003|DB Phase|Withdrawal by Subject|0|||
46777353|NCT00570765|82995630|FG000|DB Phase|Protocol Violation|0|||
46777354|NCT00570765|82995631|FG001|DB Phase|Protocol Violation|1|||
46777355|NCT00570765|82995632|FG002|DB Phase|Protocol Violation|0|||
46777356|NCT00570765|82995633|FG003|DB Phase|Protocol Violation|0|||
46777357|NCT00570765|82995630|FG000|DB Phase|Adverse Event|3|||
46777358|NCT00570765|82995631|FG001|DB Phase|Adverse Event|6|||
47073503|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
47073504|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
47073505|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
47073506|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
47073507|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
47073508|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
46642199|NCT02407236|82832249|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
46777359|NCT00570765|82995632|FG002|DB Phase|Adverse Event|0|||
46777360|NCT00570765|82995633|FG003|DB Phase|Adverse Event|0|||
46777361|NCT00570765|82995630|FG000|DB Phase|Did Not Receive Study Drug|0|||
47073509|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
47073510|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
46777362|NCT00570765|82995631|FG001|DB Phase|Did Not Receive Study Drug|0|||
46777363|NCT00570765|82995632|FG002|DB Phase|Did Not Receive Study Drug|1|||
46777364|NCT00570765|82995633|FG003|DB Phase|Did Not Receive Study Drug|0|||
46777365|NCT00570765|82995630|FG000|LTSE Phase|Withdrawal by Subject|0|||
46777366|NCT00570765|82995631|FG001|LTSE Phase|Withdrawal by Subject|0|||
46777367|NCT00570765|82995632|FG002|LTSE Phase|Withdrawal by Subject|0|||
46777368|NCT00570765|82995633|FG003|LTSE Phase|Withdrawal by Subject|1|||
46777369|NCT00570765|82995630|FG000|LTSE Phase|Adverse Event|0|||
46777370|NCT00570765|82995631|FG001|LTSE Phase|Adverse Event|0|||
46777371|NCT00570765|82995632|FG002|LTSE Phase|Adverse Event|0|||
46777372|NCT00570765|82995633|FG003|LTSE Phase|Adverse Event|7|||
46777373|NCT00570765|82995630|FG000|LTSE Phase|Physician Decision|0|||
46777374|NCT00570765|82995631|FG001|LTSE Phase|Physician Decision|0|||
46777375|NCT00570765|82995632|FG002|LTSE Phase|Physician Decision|0|||
46777376|NCT00570765|82995633|FG003|LTSE Phase|Physician Decision|4|||
46777377|NCT00667095|82995646|FG000|Overall Study|Withdrawal by Subject|0|||
46777378|NCT00667095|82995647|FG001|Overall Study|Withdrawal by Subject|1|||
46777379|NCT00433381|82995655|FG000|Overall Study|Ineligible / no protocol treatment|3|||
46777380|NCT00433381|82995656|FG001|Overall Study|Ineligible / no protocol treatment|3|||
46777381|NCT00667017|82995670|FG000|Overall Study|Withdrawal by Subject|1|||
46777382|NCT00666705|82995674|FG000|Overall Study|Withdrawal by Subject|1|||
46777383|NCT00433147|82995687|FG000|Overall Study|Adverse Event|0|||
46777384|NCT00433147|82995688|FG001|Overall Study|Adverse Event|1|||
46777385|NCT00433147|82995689|FG002|Overall Study|Adverse Event|0|||
46777386|NCT00433147|82995690|FG003|Overall Study|Adverse Event|0|||
46777387|NCT00666237|82995702|FG000|Overall Study|Death|5|||
46847925|NCT03682120|83064977|FG000|Overall Study|Physician Decision|1|||
46847926|NCT03682120|83064978|FG001|Overall Study|Physician Decision|0|||
46847927|NCT03682120|83064979|FG002|Overall Study|Physician Decision|0|||
46847928|NCT03682120|83064980|FG003|Overall Study|Physician Decision|0|||
46847929|NCT03682120|83064977|FG000|Overall Study|Withdrawal by Subject|1|||
46847930|NCT03682120|83064978|FG001|Overall Study|Withdrawal by Subject|2|||
46847931|NCT03682120|83064979|FG002|Overall Study|Withdrawal by Subject|3|||
46847932|NCT03682120|83064980|FG003|Overall Study|Withdrawal by Subject|0|||
46847933|NCT03682120|83064977|FG000|Overall Study|Death|0|||
46847934|NCT03682120|83064978|FG001|Overall Study|Death|1|||
46847935|NCT03682120|83064979|FG002|Overall Study|Death|0|||
46847936|NCT03682120|83064980|FG003|Overall Study|Death|0|||
46847937|NCT03682120|83064977|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
46847938|NCT03682120|83064978|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
46847939|NCT03682120|83064979|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
46847940|NCT03682120|83064980|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
46847941|NCT04428502|83064992|FG000|Overall Study|Did not meet entrance criteria|14|||
46847942|NCT04428424|83064997|FG000|Overall Study|Does not meet entrance criteria|132|||
46847943|NCT04428424|83064997|FG000|Overall Study|Lost to Follow-up|115|||
46847944|NCT03655756|83065001|FG000|Overall Study|Death|1|||
46847945|NCT00095238|83065007|FG000|Overall Study|Lack of Efficacy|9|||
46847946|NCT00095238|83065008|FG001|Overall Study|Lack of Efficacy|9|||
46847947|NCT00095238|83065007|FG000|Overall Study|Adverse Event|331|||
46847948|NCT00095238|83065008|FG001|Overall Study|Adverse Event|287|||
46847949|NCT00095238|83065007|FG000|Overall Study|Subject Withdrew Consent|208|||
47073511|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
47073512|NCT01672866|83362247|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
47073513|NCT01672866|83362248|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
47073514|NCT01672866|83362249|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
47073515|NCT01672866|83362247|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
47073516|NCT01672866|83362248|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
47073517|NCT01672866|83362249|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
46777388|NCT00666237|82995703|FG001|Overall Study|Death|5|||
46847950|NCT00095238|83065008|FG001|Overall Study|Subject Withdrew Consent|223|||
46777389|NCT00666237|82995702|FG000|Overall Study|Lost to Follow-up|29|||
46777390|NCT00666237|82995703|FG001|Overall Study|Lost to Follow-up|25|||
46777391|NCT00662025|82995709|FG000|Overall Study|Objective progression or relapse|51|||
46777392|NCT00662025|82995709|FG000|Overall Study|Adverse Event|7|||
46777393|NCT00662025|82995709|FG000|Overall Study|Withdrawal by Subject|1|||
46777394|NCT00662025|82995709|FG000|Overall Study|Results of other clinical study|2|||
46847951|NCT00095238|83065007|FG000|Overall Study|Death|154|||
46847952|NCT00095238|83065008|FG001|Overall Study|Death|170|||
46847953|NCT00095238|83065007|FG000|Overall Study|Lost to Follow-up|19|||
46847954|NCT00095238|83065008|FG001|Overall Study|Lost to Follow-up|24|||
46847955|NCT00095238|83065007|FG000|Overall Study|Noncompliance|44|||
46847956|NCT00095238|83065008|FG001|Overall Study|Noncompliance|45|||
46847957|NCT00095238|83065007|FG000|Overall Study|No longer met study criteria|4|||
46847958|NCT00095238|83065008|FG001|Overall Study|No longer met study criteria|5|||
46847959|NCT00095238|83065007|FG000|Overall Study|Study terminated by sponsor|0|||
46847960|NCT00095238|83065008|FG001|Overall Study|Study terminated by sponsor|1|||
46847961|NCT00095238|83065007|FG000|Overall Study|Missing|1|||
46847962|NCT00095238|83065008|FG001|Overall Study|Missing|0|||
46847963|NCT00095238|83065007|FG000|Overall Study|Other Reasons|87|||
46847964|NCT00095238|83065008|FG001|Overall Study|Other Reasons|88|||
46847965|NCT00082368|83065046|FG000|Overall Study|Not treated-pt had poor IV access|1|||
46847966|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
46847967|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
46847968|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
46847969|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
46847970|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
46847971|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
46847972|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
46847973|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
46847974|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
46847975|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
46847976|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
46847977|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
46847978|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
46847979|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
46847980|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
46847981|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
46847982|NCT00094770|83065052|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
46847983|NCT00094770|83065053|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
46847984|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
46847985|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
46847986|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
46847987|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
46847988|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
46847989|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
46847990|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
46968537|NCT01628692|83211280|FG000|Overall Study|Completed 12 Week only|0|||
46968538|NCT01628692|83211281|FG001|Overall Study|Completed 12 Week only|0|||
46968539|NCT01628692|83211282|FG002|Overall Study|Completed 12 Week only|0|||
46968540|NCT01628692|83211283|FG003|Overall Study|Completed 12 Week only|0|||
46968541|NCT01628692|83211284|FG004|Overall Study|Completed 12 Week only|0|||
46968542|NCT01628692|83211285|FG005|Overall Study|Completed 12 Week only|1|||
46968543|NCT02612727|83211304|FG000|Overall Study|Parent request|4|||
46968544|NCT02612727|83211305|FG001|Overall Study|Parent request|1|||
46968545|NCT02612727|83211304|FG000|Overall Study|Needed treatment incompatible with PT|1|||
46968546|NCT02612727|83211305|FG001|Overall Study|Needed treatment incompatible with PT|1|||
46968547|NCT02612727|83211304|FG000|Overall Study|Direct hyperbilirubinemia|0|||
46968548|NCT02612727|83211305|FG001|Overall Study|Direct hyperbilirubinemia|2|||
46847991|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
46847992|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
46847993|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
46847994|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
46847995|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
46847996|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
46847997|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
46847998|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
46968549|NCT01594827|83211313|FG000|Overall Study|Adverse Event|1|||
46968550|NCT01594827|83211314|FG001|Overall Study|Adverse Event|0|||
46968551|NCT01594827|83211313|FG000|Overall Study|Physician Decision|3|||
47073518|NCT01672866|83362247|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
47073519|NCT01672866|83362248|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
47073520|NCT01672866|83362249|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
47073521|NCT01672866|83362247|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
47073522|NCT01672866|83362248|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
47073523|NCT01672866|83362249|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
47073524|NCT01672866|83362247|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
47073525|NCT01672866|83362248|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
46847999|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
46848000|NCT00094770|83065052|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
46848001|NCT00094770|83065053|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
46848002|NCT00069576|83065061|FG000|Original Trial|Lost to Follow-up|25|||
46848003|NCT00069576|83065062|FG001|Original Trial|Lost to Follow-up|33|||
46848004|NCT00069576|83065061|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
46848005|NCT00069576|83065062|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
46848006|NCT00069264|83065068|FG000|Overall Study|Adverse Event|3|||
46968552|NCT01594827|83211314|FG001|Overall Study|Physician Decision|0|||
46968553|NCT02610231|83211322|FG000|Overall Study|Withdrawal by Subject|27|||
46968554|NCT02610231|83211322|FG000|Overall Study|Adverse Event|20|||
46968555|NCT02610231|83211322|FG000|Overall Study|Death|5|||
46968556|NCT02610231|83211322|FG000|Overall Study|Surgery|2|||
46968557|NCT02610231|83211322|FG000|Overall Study|Physician Decision|1|||
46968558|NCT02610231|83211322|FG000|Overall Study|Non Compliance|2|||
46848007|NCT00069264|83065068|FG000|Overall Study|Progressive Disease|23|||
46848008|NCT00069264|83065068|FG000|Overall Study|Withdrawal by Subject|3|||
46848009|NCT00069264|83065068|FG000|Overall Study|Discon Therapy|3|||
46848010|NCT00069108|83065074|FG000|Overall Study|Withdrawal by Subject|5|||
46848011|NCT00069108|83065075|FG001|Overall Study|Withdrawal by Subject|9|||
46848012|NCT00069108|83065074|FG000|Overall Study|Adverse Event|64|||
46968559|NCT02610231|83211322|FG000|Overall Study|Other|3|||
46968560|NCT02178358|83211332|FG000|Overall Study|Withdrawal by Subject|0|||
46848013|NCT00069108|83065075|FG001|Overall Study|Adverse Event|42|||
46848014|NCT00069108|83065074|FG000|Overall Study|Death|6|||
46848015|NCT00069108|83065075|FG001|Overall Study|Death|6|||
46848016|NCT00069108|83065074|FG000|Overall Study|Administration|15|||
46848017|NCT00069108|83065075|FG001|Overall Study|Administration|4|||
46848018|NCT00069108|83065074|FG000|Overall Study|Insufficient therapy|117|||
46848019|NCT00069108|83065075|FG001|Overall Study|Insufficient therapy|144|||
46848020|NCT00069108|83065074|FG000|Overall Study|Violation criteria|1|||
46968561|NCT02178358|83211333|FG001|Overall Study|Withdrawal by Subject|2|||
46968562|NCT02178358|83211334|FG002|Overall Study|Withdrawal by Subject|2|||
46968563|NCT02178358|83211332|FG000|Overall Study|Lost to Follow-up|1|||
46968564|NCT02178358|83211333|FG001|Overall Study|Lost to Follow-up|0|||
46968565|NCT02178358|83211334|FG002|Overall Study|Lost to Follow-up|0|||
46968566|NCT01598896|83211345|FG000|Overall Study|Withdrawal by Subject|0|||
46848021|NCT00069108|83065075|FG001|Overall Study|Violation criteria|4|||
46848022|NCT00069108|83065074|FG000|Overall Study|Refused treatment|5|||
46848023|NCT00069108|83065075|FG001|Overall Study|Refused treatment|10|||
46848024|NCT00094536|83065082|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
46848025|NCT00094536|83065082|FG000|Treatment and Follow-up|Adverse Event|4|||
46848026|NCT00094536|83065082|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
46848027|NCT00094536|83065082|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
46968567|NCT01598896|83211346|FG001|Overall Study|Withdrawal by Subject|1|||
46968568|NCT01598896|83211345|FG000|Overall Study|Lack of Efficacy|0|||
46968569|NCT01598896|83211346|FG001|Overall Study|Lack of Efficacy|1|||
46968570|NCT01598662|83211354|FG000|Overall Study|Lost to Follow-up|10|||
46968571|NCT01598662|83211355|FG001|Overall Study|Lost to Follow-up|17|||
46968572|NCT01598662|83211354|FG000|Overall Study|Physician Decision|1|||
46968573|NCT01598662|83211355|FG001|Overall Study|Physician Decision|2|||
46968574|NCT01598662|83211354|FG000|Overall Study|IUD expelled before month 6|0|||
46968575|NCT01598662|83211355|FG001|Overall Study|IUD expelled before month 6|2|||
46968576|NCT01629706|83211361|FG000|Phase 1 PureVision|Screen Failure|4|||
46968577|NCT01629706|83211361|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
46968578|NCT01629706|83211361|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
46968579|NCT01629706|83211361|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
46968580|NCT01629706|83211361|FG000|Phase 2 Habitual|Screen Failure|6|||
46968581|NCT01629706|83211361|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
46968582|NCT01629706|83211361|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
46968583|NCT01629706|83211361|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
46968584|NCT01629706|83211361|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
46968585|NCT02153086|83211369|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
46968586|NCT02153086|83211369|FG000|Overall Study|Other|2|||
46968587|NCT02117050|83211373|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
46968588|NCT02728895|83211380|FG000|Overall Study|Other|1|||
46968589|NCT02728895|83211381|FG001|Overall Study|Other|2|||
46968590|NCT02728895|83211380|FG000|Overall Study|Withdrawal by Subject|0|||
46968591|NCT02728895|83211381|FG001|Overall Study|Withdrawal by Subject|3|||
46968592|NCT02606877|83211389|FG000|Overall Study|Adverse Event|3|||
46968593|NCT02606877|83211390|FG001|Overall Study|Adverse Event|0|||
46968594|NCT02606877|83211389|FG000|Overall Study|Non-compliance with protocol|0|||
46968595|NCT02606877|83211390|FG001|Overall Study|Non-compliance with protocol|1|||
46848028|NCT00094536|83065082|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
46848029|NCT00094536|83065082|FG000|Treatment and Follow-up|Subject non-compliance|9|||
46968596|NCT02606877|83211389|FG000|Overall Study|Other than listed above|1|||
46968597|NCT02606877|83211390|FG001|Overall Study|Other than listed above|0|||
46848030|NCT00094536|83065082|FG000|Treatment and Follow-up|Unable to attend visits|1|||
46848031|NCT00405587|83065090|FG000|Overall Study|Death|0|||
46848032|NCT00405587|83065091|FG001|Overall Study|Death|0|||
46848033|NCT00405587|83065092|FG002|Overall Study|Death|0|||
46848034|NCT00405587|83065093|FG003|Overall Study|Death|1|||
46848035|NCT00405587|83065090|FG000|Overall Study|Disease Progression|22|||
46968598|NCT02606643|83211400|FG000|Overall Study|did not meet inclusion criteria|1|||
46968599|NCT02606643|83211401|FG001|Overall Study|did not meet inclusion criteria|3|||
46848036|NCT00405587|83065091|FG001|Overall Study|Disease Progression|23|||
46848037|NCT00405587|83065092|FG002|Overall Study|Disease Progression|21|||
46848038|NCT00405587|83065093|FG003|Overall Study|Disease Progression|17|||
46848039|NCT00405587|83065090|FG000|Overall Study|Physician Decision|3|||
46968600|NCT02609607|83211432|FG000|Overall Study|Lost to Follow-up|0|||
47073526|NCT01672866|83362249|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
46848040|NCT00405587|83065091|FG001|Overall Study|Physician Decision|2|||
46848041|NCT00405587|83065092|FG002|Overall Study|Physician Decision|0|||
46848042|NCT00405587|83065093|FG003|Overall Study|Physician Decision|0|||
46848043|NCT00405587|83065090|FG000|Overall Study|Adverse Event|1|||
46848044|NCT00405587|83065091|FG001|Overall Study|Adverse Event|0|||
46848045|NCT00405587|83065092|FG002|Overall Study|Adverse Event|0|||
46848046|NCT00405587|83065093|FG003|Overall Study|Adverse Event|0|||
46848047|NCT00405587|83065090|FG000|Overall Study|Lost to Follow-up|0|||
46848048|NCT00405587|83065091|FG001|Overall Study|Lost to Follow-up|1|||
46848049|NCT00405587|83065092|FG002|Overall Study|Lost to Follow-up|1|||
46848050|NCT00405587|83065093|FG003|Overall Study|Lost to Follow-up|0|||
46848051|NCT00405587|83065090|FG000|Overall Study|Radiation induced necrosis|0|||
46777395|NCT00662025|82995709|FG000|Overall Study|Target lesion cannot be evaluated|1|||
46777396|NCT00662025|82995709|FG000|Overall Study|Domestic circumstances|1|||
46777397|NCT00440947|82995713|FG000|36-Week Induction Phase|Adverse Event|16|||
46777398|NCT00440947|82995714|FG001|36-Week Induction Phase|Adverse Event|0|||
46777399|NCT00440947|82995715|FG002|36-Week Induction Phase|Adverse Event|0|||
46777400|NCT00440947|82995716|FG003|36-Week Induction Phase|Adverse Event|0|||
46848052|NCT00405587|83065091|FG001|Overall Study|Radiation induced necrosis|1|||
46848053|NCT00405587|83065092|FG002|Overall Study|Radiation induced necrosis|0|||
46848054|NCT00405587|83065093|FG003|Overall Study|Radiation induced necrosis|0|||
46848055|NCT00405587|83065090|FG000|Overall Study|Withdrawal by Subject|0|||
46848056|NCT00405587|83065091|FG001|Overall Study|Withdrawal by Subject|0|||
46848057|NCT00405587|83065092|FG002|Overall Study|Withdrawal by Subject|0|||
46848058|NCT00405587|83065093|FG003|Overall Study|Withdrawal by Subject|2|||
46848059|NCT00405587|83065090|FG000|Overall Study|Participant not dosed|0|||
46848060|NCT00405587|83065091|FG001|Overall Study|Participant not dosed|1|||
46848061|NCT00405587|83065092|FG002|Overall Study|Participant not dosed|0|||
46848062|NCT00405587|83065093|FG003|Overall Study|Participant not dosed|0|||
46848063|NCT00405275|83065131|FG000|Overall Study|Death|1|||
46848064|NCT00405275|83065132|FG001|Overall Study|Death|0|||
46848065|NCT00405275|83065131|FG000|Overall Study|Lost to Follow-up|5|||
46848066|NCT00405275|83065132|FG001|Overall Study|Lost to Follow-up|1|||
46848067|NCT00405275|83065131|FG000|Overall Study|Withdrawal by Subject|7|||
46848068|NCT00405275|83065132|FG001|Overall Study|Withdrawal by Subject|9|||
46848069|NCT00405275|83065131|FG000|Overall Study|Unwilling to continue|10|||
47073527|NCT04465877|83362475|FG000|Overall Study|Noncompliant with study requirements|0|||
47073528|NCT04465877|83362476|FG001|Overall Study|Noncompliant with study requirements|0|||
47073529|NCT04465877|83362477|FG002|Overall Study|Noncompliant with study requirements|1|||
46642200|NCT02407236|82832250|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
46642201|NCT02407236|82832251|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
46642202|NCT02407236|82832252|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
46642203|NCT02407236|82832253|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
46642204|NCT02407236|82832254|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
46777401|NCT00440947|82995717|FG004|36-Week Induction Phase|Adverse Event|0|||
46777402|NCT00440947|82995713|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
46777403|NCT00440947|82995714|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
46777404|NCT00440947|82995715|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
46777405|NCT00440947|82995716|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
46848070|NCT00405275|83065132|FG001|Overall Study|Unwilling to continue|9|||
46848071|NCT00404651|83065142|FG000|Overall Study|Serious Adverse Event|0|||
46848072|NCT00404651|83065143|FG001|Overall Study|Serious Adverse Event|0|||
46848073|NCT00404651|83065144|FG002|Overall Study|Serious Adverse Event|2|||
46848074|NCT00404651|83065145|FG003|Overall Study|Serious Adverse Event|0|||
46848075|NCT00404651|83065142|FG000|Overall Study|Protocol Violation|10|||
46968601|NCT02609607|83211433|FG001|Overall Study|Lost to Follow-up|1|||
46642205|NCT02407236|82832242|FG000|Induction Study (8 Weeks)|Death|0|||
46848076|NCT00404651|83065143|FG001|Overall Study|Protocol Violation|5|||
46848077|NCT00404651|83065144|FG002|Overall Study|Protocol Violation|14|||
46848078|NCT00404651|83065145|FG003|Overall Study|Protocol Violation|5|||
46848079|NCT00404651|83065142|FG000|Overall Study|Lost to Follow-up|15|||
46848080|NCT00404651|83065143|FG001|Overall Study|Lost to Follow-up|11|||
46848081|NCT00404651|83065144|FG002|Overall Study|Lost to Follow-up|13|||
46848082|NCT00404651|83065145|FG003|Overall Study|Lost to Follow-up|10|||
46848083|NCT00404651|83065142|FG000|Overall Study|Withdrawal by Subject|14|||
46848084|NCT00404651|83065143|FG001|Overall Study|Withdrawal by Subject|12|||
46848085|NCT00404651|83065144|FG002|Overall Study|Withdrawal by Subject|16|||
46968602|NCT02606253|83211442|FG000|Overall Study|Adverse Event|2|||
46848086|NCT00404651|83065145|FG003|Overall Study|Withdrawal by Subject|6|||
46848087|NCT00404495|83065157|FG000|Overall Study|Death|37|||
46848088|NCT00404495|83065158|FG001|Overall Study|Death|11|||
46848089|NCT00404495|83065157|FG000|Overall Study|Lost to Follow-up|5|||
46848090|NCT00404495|83065158|FG001|Overall Study|Lost to Follow-up|0|||
46848091|NCT00404495|83065157|FG000|Overall Study|Other|1|||
46848092|NCT00404495|83065158|FG001|Overall Study|Other|0|||
46848093|NCT00404495|83065157|FG000|Overall Study|Withdrawal by Subject|1|||
46848094|NCT00404495|83065158|FG001|Overall Study|Withdrawal by Subject|0|||
46848095|NCT00409409|83065166|FG000|Overall Study|Adverse Event|7|||
46848096|NCT00409409|83065167|FG001|Overall Study|Adverse Event|2|||
46848097|NCT00409409|83065166|FG000|Overall Study|Withdrawal by Subject|1|||
46848098|NCT00409409|83065167|FG001|Overall Study|Withdrawal by Subject|1|||
46848099|NCT00409409|83065166|FG000|Overall Study|Any other reason not above-mentioned|0|||
46848100|NCT00409409|83065167|FG001|Overall Study|Any other reason not above-mentioned|1|||
46848101|NCT00409331|83065173|FG000|Overall Study|Physician Decision|1|||
46848102|NCT00409175|83065179|FG000|Overall Study|Adverse Event|4|||
46848103|NCT00409175|83065180|FG001|Overall Study|Adverse Event|3|||
46848104|NCT00409175|83065179|FG000|Overall Study|Withdrawal by Subject|1|||
46848105|NCT00409175|83065180|FG001|Overall Study|Withdrawal by Subject|2|||
46848106|NCT00409175|83065179|FG000|Overall Study|Negative genotype|0|||
46848107|NCT00409175|83065180|FG001|Overall Study|Negative genotype|1|||
46848108|NCT00409175|83065179|FG000|Overall Study|Liver transplantation|13|||
46848109|NCT00409175|83065180|FG001|Overall Study|Liver transplantation|13|||
46848110|NCT00408629|83065188|FG000|Overall Study|Adverse Event|13|||
46848111|NCT00408629|83065189|FG001|Overall Study|Adverse Event|27|||
46848112|NCT00408629|83065188|FG000|Overall Study|Withdrawal by Subject|8|||
46848113|NCT00408629|83065189|FG001|Overall Study|Withdrawal by Subject|4|||
46848114|NCT00408629|83065188|FG000|Overall Study|Lost to Follow-up|1|||
46848115|NCT00408629|83065189|FG001|Overall Study|Lost to Follow-up|1|||
46848116|NCT00408629|83065188|FG000|Overall Study|Lack of Efficacy|63|||
46848117|NCT00408629|83065189|FG001|Overall Study|Lack of Efficacy|73|||
46848118|NCT00408629|83065188|FG000|Overall Study|Protocol Violation|1|||
46848119|NCT00408629|83065189|FG001|Overall Study|Protocol Violation|5|||
46848120|NCT00408629|83065188|FG000|Overall Study|Miscellaneous|11|||
46848121|NCT00408629|83065189|FG001|Overall Study|Miscellaneous|15|||
46848122|NCT00408317|83065196|FG000|First Intervention Period|Adverse Event|0|||
46848123|NCT00408317|83065197|FG001|First Intervention Period|Adverse Event|1|||
46848124|NCT00408317|83065196|FG000|Second Intervention Period|Adverse Event|2|||
46848125|NCT00408317|83065197|FG001|Second Intervention Period|Adverse Event|0|||
46848126|NCT00408317|83065196|FG000|Second Intervention Period|Protocol Violation|0|||
46848127|NCT00408317|83065197|FG001|Second Intervention Period|Protocol Violation|1|||
46848128|NCT00408317|83065196|FG000|Second Intervention Period|Withdrawal of consent|0|||
46848129|NCT00408317|83065197|FG001|Second Intervention Period|Withdrawal of consent|1|||
46848130|NCT00112502|83065211|FG000|Overall Study|Withdrawal by Subject|0|||
46848131|NCT00112502|83065212|FG001|Overall Study|Withdrawal by Subject|1|||
46968603|NCT02606253|83211443|FG001|Overall Study|Adverse Event|0|||
46968604|NCT02606253|83211444|FG002|Overall Study|Adverse Event|0|||
46968605|NCT02606253|83211442|FG000|Overall Study|Protocol Violation|2|||
47073530|NCT04465877|83362478|FG003|Overall Study|Noncompliant with study requirements|0|||
47073531|NCT04267133|83362535|FG000|Overall Study|Withdrawal by Subject|1|||
47073532|NCT04267133|83362535|FG000|Overall Study|Adverse Event|4|||
47073533|NCT02631876|83362666|FG000|Overall Study|Death|96|||
46777406|NCT00440947|82995717|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
46777407|NCT00440947|82995713|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
46777408|NCT00440947|82995714|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
46777409|NCT00440947|82995715|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
46777410|NCT00440947|82995716|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
46777411|NCT00440947|82995717|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
46777412|NCT00440947|82995713|FG000|36-Week Induction Phase|Non-compliance|10|||
46777413|NCT00440947|82995714|FG001|36-Week Induction Phase|Non-compliance|0|||
46777414|NCT00440947|82995715|FG002|36-Week Induction Phase|Non-compliance|0|||
46777415|NCT00440947|82995716|FG003|36-Week Induction Phase|Non-compliance|0|||
46777416|NCT00440947|82995717|FG004|36-Week Induction Phase|Non-compliance|0|||
46848132|NCT00112502|83065213|FG002|Overall Study|Withdrawal by Subject|1|||
46968606|NCT02606253|83211443|FG001|Overall Study|Protocol Violation|1|||
46777417|NCT00440947|82995713|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
46848133|NCT00112502|83065214|FG003|Overall Study|Withdrawal by Subject|4|||
46848134|NCT00112502|83065215|FG004|Overall Study|Withdrawal by Subject|2|||
46848135|NCT00112502|83065216|FG005|Overall Study|Withdrawal by Subject|5|||
46848136|NCT00112502|83065217|FG006|Overall Study|Withdrawal by Subject|3|||
46848137|NCT00112502|83065218|FG007|Overall Study|Withdrawal by Subject|7|||
46848138|NCT03822182|83065249|FG000|Overall Study|Protocol Violation|0|||
46848139|NCT03822182|83065250|FG001|Overall Study|Protocol Violation|1|||
46848140|NCT03822182|83065251|FG002|Overall Study|Protocol Violation|1|||
46968607|NCT02606253|83211444|FG002|Overall Study|Protocol Violation|0|||
46968608|NCT02606253|83211442|FG000|Overall Study|Physician Decision|1|||
46968609|NCT02606253|83211443|FG001|Overall Study|Physician Decision|1|||
46968610|NCT02606253|83211444|FG002|Overall Study|Physician Decision|0|||
46848141|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
46777418|NCT00440947|82995714|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
46777419|NCT00440947|82995715|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
46777420|NCT00440947|82995716|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
46777421|NCT00440947|82995717|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
46777422|NCT00440947|82995713|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
46777423|NCT00440947|82995714|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
46777424|NCT00440947|82995715|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
46968611|NCT02607735|83211454|FG000|Primary Study|Randomized but Never Treated|1|||
46777425|NCT00440947|82995716|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
46848142|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
46968612|NCT02607735|83211455|FG001|Primary Study|Randomized but Never Treated|0|||
46848143|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
46848144|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
46848145|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
46848146|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
46848147|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
46848148|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
46848149|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
46848150|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
46848151|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
46848152|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
46848153|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
46848154|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
46848155|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
46848156|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
46848157|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
46848158|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
46848159|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
46848160|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
46848161|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
46848162|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
46848163|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
46848164|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
46848165|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
46848166|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
46968613|NCT02607735|83211456|FG002|Primary Study|Randomized but Never Treated|0|||
46968614|NCT02607735|83211454|FG000|Primary Study|Lost to Follow-up|4|||
46968615|NCT02607735|83211455|FG001|Primary Study|Lost to Follow-up|0|||
46968616|NCT02607735|83211456|FG002|Primary Study|Lost to Follow-up|0|||
46968617|NCT02607735|83211454|FG000|Primary Study|Withdrew Consent|2|||
46968618|NCT02607735|83211455|FG001|Primary Study|Withdrew Consent|0|||
46968619|NCT02607735|83211456|FG002|Primary Study|Withdrew Consent|0|||
46968620|NCT02607735|83211454|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
46968621|NCT02607735|83211455|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
46968622|NCT02607735|83211456|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
46968623|NCT02607735|83211454|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
46968624|NCT02607735|83211455|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
46968625|NCT02607735|83211456|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
46968626|NCT04772313|83211464|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
46968627|NCT04772313|83211464|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
47073534|NCT02631876|83362667|FG001|Overall Study|Death|50|||
47073535|NCT02631876|83362666|FG000|Overall Study|Investigator's discretion|1|||
47073536|NCT02631876|83362667|FG001|Overall Study|Investigator's discretion|0|||
47073537|NCT02631876|83362666|FG000|Overall Study|Lost to Follow-up|2|||
47073538|NCT02631876|83362667|FG001|Overall Study|Lost to Follow-up|0|||
47073539|NCT02631876|83362666|FG000|Overall Study|Withdrawal by Subject|16|||
46968628|NCT01668537|83211471|FG000|Overall Study|Request to Discontinue Prematurely|1|||
46968629|NCT01668537|83211472|FG001|Overall Study|Request to Discontinue Prematurely|1|||
46968630|NCT01668537|83211471|FG000|Overall Study|Subject unwilling/unable to comply|5|||
46968631|NCT01668537|83211472|FG001|Overall Study|Subject unwilling/unable to comply|0|||
46968632|NCT01668537|83211471|FG000|Overall Study|Reason Precludes Participation|1|||
46968633|NCT01668537|83211472|FG001|Overall Study|Reason Precludes Participation|0|||
46968634|NCT01668537|83211471|FG000|Overall Study|Lost to Follow-up|13|||
46968635|NCT01668537|83211472|FG001|Overall Study|Lost to Follow-up|6|||
46968636|NCT01668537|83211471|FG000|Overall Study|Other|2|||
46968637|NCT01668537|83211472|FG001|Overall Study|Other|3|||
46968638|NCT01668147|83211478|FG000|Overall Study|Withdrawal by Subject|6|||
46968639|NCT02600559|83211495|FG000|Overall Study|Withdrawal by Subject|3|||
46968640|NCT02600559|83211495|FG000|Overall Study|Lost to Follow-up|20|||
47073540|NCT02631876|83362667|FG001|Overall Study|Withdrawal by Subject|9|||
47073541|NCT02631876|83362666|FG000|Overall Study|Other than specified|4|||
47073542|NCT02631876|83362667|FG001|Overall Study|Other than specified|4|||
47073543|NCT02633046|83362696|FG000|Overall Study|Adverse Event|8|||
47073544|NCT02633046|83362696|FG000|Overall Study|Physician Decision|7|||
46848167|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
46848168|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
46848169|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
46968641|NCT02601573|83211504|FG000|Overall Study|Lost to Follow-up|0|||
46968642|NCT02601573|83211505|FG001|Overall Study|Lost to Follow-up|3|||
46968643|NCT02601573|83211506|FG002|Overall Study|Lost to Follow-up|1|||
47073545|NCT02633046|83362696|FG000|Overall Study|Withdrawal by Subject|8|||
46968644|NCT02601573|83211507|FG003|Overall Study|Lost to Follow-up|0|||
46968645|NCT02601573|83211508|FG004|Overall Study|Lost to Follow-up|2|||
47073546|NCT02633046|83362696|FG000|Overall Study|Increased proteinuria|2|||
46848170|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
46848171|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
46848172|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
46848173|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
46848174|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
46848175|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
46848176|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
46848177|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
46848178|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
46848179|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
46848180|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
46848181|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
46848182|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
46848183|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
46848184|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
46848185|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
46848186|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
46848187|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
46848188|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
46848189|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
46848190|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
46848191|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
46848192|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
46848193|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
47073547|NCT02633046|83362696|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
47073548|NCT02633046|83362696|FG000|Overall Study|Mutual decision patient and physician|1|||
47073549|NCT01672788|83362755|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
46848194|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
46848195|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
46848196|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
46848197|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
46848198|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
46848199|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
46848200|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
46848201|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
46848202|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
46848203|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
46848204|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
46848205|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
46848206|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
46848207|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
46848208|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
46848209|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
46848210|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
46848211|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
46848212|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
46848213|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
46848214|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
46848215|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
46848216|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
46848217|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
46848218|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
46848219|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
46848220|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
46848221|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
46848222|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
46848223|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
46848224|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
47073550|NCT01672788|83362756|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
47073551|NCT01672788|83362757|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
47073552|NCT01672788|83362758|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
46848225|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
46848226|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
46848227|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
46848228|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
46848229|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
46848230|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
46848231|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
46848232|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
46848233|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
46848234|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
46848235|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
46848236|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
46848237|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
46848238|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
46848239|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
46848240|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
46848241|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
46848242|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
46848243|NCT00111800|83065266|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
46848244|NCT00111800|83065267|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
46848245|NCT00111800|83065268|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
46848246|NCT00111800|83065269|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
46848247|NCT00111800|83065270|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
46848248|NCT00111800|83065271|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
46848249|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
46848250|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
46848251|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
46848252|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
46848253|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
46848254|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
46848255|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
46848256|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
46848257|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
46848258|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
46848259|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
46848260|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
46848261|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
46848262|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
46848263|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
46848264|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
46848265|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
46848266|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
46848267|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
46848268|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
46848269|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
46848270|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
46848271|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
46848272|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
46848273|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
46848274|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
46848275|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
46848276|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
46848277|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
46848278|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
46848279|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
46968646|NCT02601573|83211504|FG000|Overall Study|Withdrawal by Subject|0|||
46968647|NCT02601573|83211505|FG001|Overall Study|Withdrawal by Subject|1|||
46968648|NCT02601573|83211506|FG002|Overall Study|Withdrawal by Subject|0|||
46968649|NCT02601573|83211507|FG003|Overall Study|Withdrawal by Subject|1|||
46968650|NCT02601573|83211508|FG004|Overall Study|Withdrawal by Subject|0|||
46968651|NCT02601027|83211522|FG000|Registration to Surgery|Withdrawal by Subject|20|||
47073553|NCT02632110|83362773|FG000|Overall Study|Withdrawal by Subject|1|||
47073554|NCT02632110|83362774|FG001|Overall Study|Withdrawal by Subject|1|||
46848280|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
46848281|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
46848282|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
46848283|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
46848284|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
46848285|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
46848286|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
46848287|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
46848288|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
46848289|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
46848290|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
46848291|NCT00111800|83065266|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
46848292|NCT00111800|83065267|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
46848293|NCT00111800|83065268|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
46848294|NCT00111800|83065269|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
46848295|NCT00111800|83065270|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
46848296|NCT00111800|83065271|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
46848297|NCT00094328|83065294|FG000|Overall Study|Lost to Follow-up|1|||
46848298|NCT00094172|83065300|FG000|Overall Study|Adverse Event|0|||
46848299|NCT00094172|83065301|FG001|Overall Study|Adverse Event|1|||
46968652|NCT02601027|83211523|FG001|Registration to Surgery|Withdrawal by Subject|10|||
46968653|NCT02600871|83211531|FG000|Overall Study|Lost to Follow-up|13|||
46968654|NCT02600871|83211532|FG001|Overall Study|Lost to Follow-up|10|||
46968655|NCT02598297|83211541|FG000|Overall Study|Study terminated by Sponsor|21|||
46968656|NCT02598297|83211542|FG001|Overall Study|Study terminated by Sponsor|23|||
46968657|NCT02598297|83211541|FG000|Overall Study|Adverse Event|1|||
46968658|NCT02598297|83211542|FG001|Overall Study|Adverse Event|1|||
46968659|NCT02598297|83211541|FG000|Overall Study|Physician Decision|1|||
46968660|NCT02598297|83211542|FG001|Overall Study|Physician Decision|0|||
46968661|NCT02598297|83211541|FG000|Overall Study|Subject/guardian decision|1|||
46968662|NCT02598297|83211542|FG001|Overall Study|Subject/guardian decision|0|||
46968663|NCT02598297|83211541|FG000|Overall Study|Followed for survival|1|||
46968664|NCT02598297|83211542|FG001|Overall Study|Followed for survival|0|||
46968665|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
46968666|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
46968667|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
46968668|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
46968669|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
46968670|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
46968671|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
46968672|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
46968673|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
46968674|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
46968675|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
46968676|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
46968677|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
46968678|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
46968679|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
46968680|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
46968681|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
46968682|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
46968683|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
46968684|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
46777426|NCT00440947|82995717|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
46777427|NCT00440947|82995713|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
46777428|NCT00440947|82995714|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
46777429|NCT00440947|82995715|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
46777430|NCT00440947|82995716|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
46777431|NCT00440947|82995717|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
46777432|NCT00440947|82995713|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
46777433|NCT00440947|82995714|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
46777434|NCT00440947|82995715|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
46777435|NCT00440947|82995716|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
46777436|NCT00440947|82995717|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
46777437|NCT00440947|82995713|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
46968685|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
46968686|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
46968687|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
46968688|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
46968689|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
46968690|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
46968691|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
46968692|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
46968693|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
46968694|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
46968695|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
46968696|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
46968697|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
46968698|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
46968699|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
46968700|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
46968701|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
46848300|NCT00094172|83065300|FG000|Overall Study|Lost to Follow-up|2|||
46848301|NCT00094172|83065301|FG001|Overall Study|Lost to Follow-up|0|||
46848302|NCT00094172|83065300|FG000|Overall Study|Protocol Violation|0|||
46848303|NCT00094172|83065301|FG001|Overall Study|Protocol Violation|1|||
46848304|NCT00094172|83065300|FG000|Overall Study|Withdrawal by Subject|10|||
46968702|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
46968703|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
46968704|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
46968705|NCT02596893|83211552|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
46968706|NCT02596893|83211553|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
46968707|NCT02596893|83211554|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
46968708|NCT02596893|83211555|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
46968709|NCT02592447|83211571|FG000|Overall Study|Lost to Follow-up|1|||
46968710|NCT02592447|83211572|FG001|Overall Study|Lost to Follow-up|0|||
46968711|NCT02592447|83211571|FG000|Overall Study|Ineligible after randomization|1|||
46968712|NCT02592447|83211572|FG001|Overall Study|Ineligible after randomization|0|||
46968713|NCT02592447|83211571|FG000|Overall Study|Withdrawal by Subject|0|||
46968714|NCT02592447|83211572|FG001|Overall Study|Withdrawal by Subject|1|||
46968715|NCT02595723|83211581|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
46968716|NCT02595723|83211582|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
46968717|NCT02595723|83211583|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
46968718|NCT02595723|83211581|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
46777438|NCT00440947|82995714|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
46777439|NCT00440947|82995715|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
46777440|NCT00440947|82995716|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
46777441|NCT00440947|82995717|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
46777442|NCT00440947|82995713|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
46777443|NCT00440947|82995714|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
46777444|NCT00440947|82995715|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
46777445|NCT00440947|82995716|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
46777446|NCT00440947|82995717|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
46777447|NCT00440947|82995713|FG000|36-Week Induction Phase|Incarceration|3|||
46777448|NCT00440947|82995714|FG001|36-Week Induction Phase|Incarceration|0|||
46777449|NCT00440947|82995715|FG002|36-Week Induction Phase|Incarceration|0|||
46777450|NCT00440947|82995716|FG003|36-Week Induction Phase|Incarceration|0|||
46777451|NCT00440947|82995717|FG004|36-Week Induction Phase|Incarceration|0|||
46777452|NCT00440947|82995713|FG000|36-Week Induction Phase|Pregnancy|1|||
46848305|NCT00094172|83065301|FG001|Overall Study|Withdrawal by Subject|5|||
46848306|NCT00094172|83065300|FG000|Overall Study|Primary endpoint met.|1|||
46848307|NCT00094172|83065301|FG001|Overall Study|Primary endpoint met.|0|||
46848308|NCT00094172|83065300|FG000|Overall Study|Started other MS therapy due to disease|1|||
46848309|NCT00094172|83065301|FG001|Overall Study|Started other MS therapy due to disease|0|||
46848310|NCT00094094|83065307|FG000|Overall Study|Death|2|||
46848311|NCT00094094|83065307|FG000|Overall Study|Lack of Efficacy|23|||
46848312|NCT00094094|83065307|FG000|Overall Study|Adverse Event|7|||
46848313|NCT00110396|83065311|FG000|Overall Study|Adverse Event|15|||
46848314|NCT00110396|83065311|FG000|Overall Study|Lost to Follow-up|1|||
46848315|NCT00110396|83065311|FG000|Overall Study|Administration of plasmapheresis|1|||
46968719|NCT02595723|83211582|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
46777453|NCT00440947|82995714|FG001|36-Week Induction Phase|Pregnancy|0|||
46848316|NCT00110396|83065311|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
46848317|NCT00110396|83065311|FG000|Overall Study|Lack of Efficacy|1|||
46848318|NCT00110396|83065311|FG000|Overall Study|Decided not to continue treatment|1|||
46848319|NCT00110396|83065311|FG000|Overall Study|Patient non-compliance|1|||
46848320|NCT00110396|83065311|FG000|Overall Study|Patient refused to continue|1|||
46848321|NCT00110396|83065311|FG000|Overall Study|Patient refused to participate|1|||
46848322|NCT00110396|83065311|FG000|Overall Study|Patient will|1|||
46848323|NCT00110396|83065311|FG000|Overall Study|Patient's decision|1|||
46848324|NCT00110396|83065311|FG000|Overall Study|Participation in MS vaccine study|1|||
46968720|NCT02595723|83211583|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
46968721|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
46968722|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
46968723|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
46968724|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
46848325|NCT00110396|83065311|FG000|Overall Study|Pregnancy|1|||
46848326|NCT00110396|83065311|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
46848327|NCT00110396|83065311|FG000|Overall Study|Protocol Violation|2|||
46848328|NCT00110396|83065311|FG000|Overall Study|Patient refused to come back|1|||
46848329|NCT00110396|83065311|FG000|Overall Study|The patient has refused|2|||
46848330|NCT00110396|83065311|FG000|Overall Study|The patient has refused to visit site|1|||
46848331|NCT00110396|83065311|FG000|Overall Study|Patient is to be administered copaxone|1|||
46848332|NCT03819218|83065315|FG000|Overall Study|Protocol Violation|1|||
46848333|NCT00407537|83065321|FG000|Overall Study|Death|5|||
46848334|NCT00407537|83065322|FG001|Overall Study|Death|2|||
46848335|NCT00407537|83065321|FG000|Overall Study|Adverse Event|36|||
46848336|NCT00407537|83065322|FG001|Overall Study|Adverse Event|0|||
46848337|NCT00407537|83065321|FG000|Overall Study|Lost to Follow-up|12|||
46848338|NCT00407537|83065322|FG001|Overall Study|Lost to Follow-up|19|||
46848339|NCT00407537|83065321|FG000|Overall Study|Other|6|||
46848340|NCT00407537|83065322|FG001|Overall Study|Other|7|||
46848341|NCT00407537|83065321|FG000|Overall Study|Withdrawal by Subject|34|||
46848342|NCT00407537|83065322|FG001|Overall Study|Withdrawal by Subject|16|||
46848343|NCT00094458|83065331|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
46848344|NCT00094458|83065332|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
46848345|NCT00094458|83065333|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
46968725|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
46968726|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
46968727|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
46968728|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
46968729|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
46968730|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
46968731|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
46642206|NCT02407236|82832243|FG001|Induction Study (8 Weeks)|Death|0|||
46642207|NCT02407236|82832244|FG002|Induction Study (8 Weeks)|Death|1|||
46642208|NCT02407236|82832245|FG003|Induction Study (8 Weeks)|Death|0|||
46642209|NCT02407236|82832246|FG004|Induction Study (8 Weeks)|Death|0|||
46848346|NCT00094458|83065334|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
46848347|NCT00094458|83065335|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
46848348|NCT00094458|83065336|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
47073555|NCT02632110|83362775|FG002|Overall Study|Withdrawal by Subject|0|||
47073556|NCT02632110|83362776|FG003|Overall Study|Withdrawal by Subject|0|||
47073557|NCT02632110|83362777|FG004|Overall Study|Withdrawal by Subject|1|||
47073558|NCT02632110|83362778|FG005|Overall Study|Withdrawal by Subject|1|||
47073559|NCT02632110|83362779|FG006|Overall Study|Withdrawal by Subject|3|||
47073560|NCT02632110|83362780|FG007|Overall Study|Withdrawal by Subject|3|||
47073561|NCT02632110|83362781|FG008|Overall Study|Withdrawal by Subject|1|||
47073562|NCT02632110|83362782|FG009|Overall Study|Withdrawal by Subject|1|||
47073563|NCT01672710|83363024|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
47073564|NCT01672710|83363025|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
47073565|NCT01672710|83363024|FG000|3 Month Follow up|Lost to Follow-up|2|||
47073566|NCT01672710|83363025|FG001|3 Month Follow up|Lost to Follow-up|3|||
46642210|NCT02407236|82832247|FG005|Induction Study (8 Weeks)|Death|0|||
46848349|NCT00094458|83065331|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
46968732|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
46968733|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
46968734|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
46968735|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
46968736|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
46968737|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
46968738|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
46968739|NCT01667679|83211593|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
46968740|NCT01667679|83211594|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
46968741|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
46968742|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
46968743|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
46968744|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
46968745|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
46968746|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
46968747|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
46968748|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
46968749|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
46968750|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
46968751|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
46968752|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
46968753|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
46968754|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
46968755|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
46968756|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
46968757|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
46968758|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
46968759|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
46968760|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
46968761|NCT01667679|83211593|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
46968762|NCT01667679|83211594|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
46968763|NCT02597049|83211605|FG000|Overall Study|Lost to Follow-up|0|||
46968764|NCT02597049|83211606|FG001|Overall Study|Lost to Follow-up|3|||
46968765|NCT02597049|83211607|FG002|Overall Study|Lost to Follow-up|2|||
46968766|NCT02597049|83211605|FG000|Overall Study|Withdrawal by Subject|2|||
46968767|NCT02597049|83211606|FG001|Overall Study|Withdrawal by Subject|2|||
46968768|NCT02597049|83211607|FG002|Overall Study|Withdrawal by Subject|1|||
46968769|NCT02597049|83211605|FG000|Overall Study|Adverse Event|2|||
46968770|NCT02597049|83211606|FG001|Overall Study|Adverse Event|0|||
46968771|NCT02597049|83211607|FG002|Overall Study|Adverse Event|0|||
46968772|NCT02597049|83211605|FG000|Overall Study|Death|2|||
46968773|NCT02597049|83211606|FG001|Overall Study|Death|0|||
46968774|NCT02597049|83211607|FG002|Overall Study|Death|0|||
46968775|NCT02597049|83211605|FG000|Overall Study|Noncompliant with Study Visits|1|||
46968776|NCT02597049|83211606|FG001|Overall Study|Noncompliant with Study Visits|0|||
46968777|NCT02597049|83211607|FG002|Overall Study|Noncompliant with Study Visits|0|||
46777454|NCT00440947|82995715|FG002|36-Week Induction Phase|Pregnancy|0|||
46777455|NCT00440947|82995716|FG003|36-Week Induction Phase|Pregnancy|0|||
46777456|NCT00440947|82995717|FG004|36-Week Induction Phase|Pregnancy|0|||
46777457|NCT00440947|82995713|FG000|48-Week Randomization Phase|Adverse Event|0|||
46777458|NCT00440947|82995714|FG001|48-Week Randomization Phase|Adverse Event|2|||
46777459|NCT00440947|82995715|FG002|48-Week Randomization Phase|Adverse Event|5|||
46777460|NCT00440947|82995716|FG003|48-Week Randomization Phase|Adverse Event|0|||
46777461|NCT00440947|82995717|FG004|48-Week Randomization Phase|Adverse Event|0|||
46968778|NCT02594163|83211617|FG000|Treatment Period|Progressive disease|2|||
46968779|NCT02594163|83211618|FG001|Treatment Period|Progressive disease|3|||
46968780|NCT02594163|83211617|FG000|Treatment Period|Adverse Event|1|||
46968781|NCT02594163|83211618|FG001|Treatment Period|Adverse Event|5|||
46968782|NCT02594163|83211617|FG000|Treatment Period|Physician Decision|1|||
46968783|NCT02594163|83211618|FG001|Treatment Period|Physician Decision|3|||
46968784|NCT02594163|83211617|FG000|Treatment Period|Study termination by sponsor|2|||
46968785|NCT02594163|83211618|FG001|Treatment Period|Study termination by sponsor|1|||
46968786|NCT02594163|83211617|FG000|Treatment Period|Other, Non-AE|1|||
46968787|NCT02594163|83211618|FG001|Treatment Period|Other, Non-AE|0|||
46777462|NCT00440947|82995713|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
46968788|NCT02594163|83211617|FG000|Follow-up Period|Withdrawal by Subject|0|||
46968789|NCT02594163|83211618|FG001|Follow-up Period|Withdrawal by Subject|1|||
46968790|NCT02594163|83211617|FG000|Follow-up Period|Study Termination by Sponsor|6|||
46968791|NCT02594163|83211618|FG001|Follow-up Period|Study Termination by Sponsor|4|||
46968792|NCT02594163|83211617|FG000|Follow-up Period|Lost to Follow-up|1|||
46968793|NCT02594163|83211618|FG001|Follow-up Period|Lost to Follow-up|0|||
46968794|NCT02594163|83211617|FG000|Follow-up Period|Death|2|||
46777463|NCT00440947|82995714|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
46968795|NCT02594163|83211618|FG001|Follow-up Period|Death|5|||
46968796|NCT02594163|83211617|FG000|Follow-up Period|Adverse Event|0|||
46968797|NCT02594163|83211618|FG001|Follow-up Period|Adverse Event|1|||
46968798|NCT02594163|83211617|FG000|Follow-up Period|Progressive Disease|2|||
46968799|NCT02594163|83211618|FG001|Follow-up Period|Progressive Disease|0|||
46968800|NCT02594163|83211617|FG000|Follow-up Period|Physician Decision|0|||
46848350|NCT00094458|83065332|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
46848351|NCT00094458|83065333|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
46848352|NCT00094458|83065334|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
46848353|NCT00094458|83065335|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
46848354|NCT00094458|83065336|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
46848355|NCT00094458|83065331|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
46848356|NCT00094458|83065332|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
46848357|NCT00094458|83065333|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
46848358|NCT00094458|83065334|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
46848359|NCT00094458|83065335|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
46848360|NCT00094458|83065336|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
46848361|NCT00094458|83065331|FG000|Main Study: Through Week 30|Adverse Event|38|||
46848362|NCT00094458|83065332|FG001|Main Study: Through Week 30|Adverse Event|20|||
46848363|NCT00094458|83065333|FG002|Main Study: Through Week 30|Adverse Event|28|||
46848364|NCT00094458|83065334|FG003|Main Study: Through Week 30|Adverse Event|0|||
46848365|NCT00094458|83065335|FG004|Main Study: Through Week 30|Adverse Event|0|||
46848366|NCT00094458|83065336|FG005|Main Study: Through Week 30|Adverse Event|0|||
46848367|NCT00094458|83065331|FG000|Main Study: Through Week 30|Death|1|||
46848368|NCT00094458|83065332|FG001|Main Study: Through Week 30|Death|0|||
46848369|NCT00094458|83065333|FG002|Main Study: Through Week 30|Death|0|||
46848370|NCT00094458|83065334|FG003|Main Study: Through Week 30|Death|0|||
46848371|NCT00094458|83065335|FG004|Main Study: Through Week 30|Death|0|||
46848372|NCT00094458|83065336|FG005|Main Study: Through Week 30|Death|0|||
46848373|NCT00094458|83065331|FG000|Main Study: Through Week 30|Other|19|||
46848374|NCT00094458|83065332|FG001|Main Study: Through Week 30|Other|16|||
46848375|NCT00094458|83065333|FG002|Main Study: Through Week 30|Other|9|||
46848376|NCT00094458|83065334|FG003|Main Study: Through Week 30|Other|0|||
46848377|NCT00094458|83065335|FG004|Main Study: Through Week 30|Other|0|||
46848378|NCT00094458|83065336|FG005|Main Study: Through Week 30|Other|0|||
46968801|NCT02594163|83211618|FG001|Follow-up Period|Physician Decision|1|||
46968802|NCT02712983|83211633|FG000|Treatment Phase|Adverse Event|3|||
46968803|NCT02712983|83211634|FG001|Treatment Phase|Adverse Event|1|||
46968804|NCT02712983|83211635|FG002|Treatment Phase|Adverse Event|1|||
46968805|NCT02712983|83211636|FG003|Treatment Phase|Adverse Event|4|||
46968806|NCT02712983|83211637|FG004|Treatment Phase|Adverse Event|3|||
46968807|NCT02712983|83211638|FG005|Treatment Phase|Adverse Event|0|||
46968808|NCT02712983|83211639|FG006|Treatment Phase|Adverse Event|6|||
46968809|NCT02712983|83211640|FG007|Treatment Phase|Adverse Event|6|||
46968810|NCT02712983|83211641|FG008|Treatment Phase|Adverse Event|1|||
46968811|NCT02712983|83211633|FG000|Treatment Phase|Protocol Deviation|0|||
46968812|NCT02712983|83211634|FG001|Treatment Phase|Protocol Deviation|0|||
47073567|NCT01672710|83363024|FG000|3 Month Follow up|follow up due after termination date|4|||
46968813|NCT02712983|83211635|FG002|Treatment Phase|Protocol Deviation|0|||
46968814|NCT02712983|83211636|FG003|Treatment Phase|Protocol Deviation|2|||
46968815|NCT02712983|83211637|FG004|Treatment Phase|Protocol Deviation|0|||
46968816|NCT02712983|83211638|FG005|Treatment Phase|Protocol Deviation|0|||
46968817|NCT02712983|83211639|FG006|Treatment Phase|Protocol Deviation|1|||
46968818|NCT02712983|83211640|FG007|Treatment Phase|Protocol Deviation|0|||
46968819|NCT02712983|83211641|FG008|Treatment Phase|Protocol Deviation|0|||
46968820|NCT02712983|83211633|FG000|Treatment Phase|Technical Problems|0|||
46968821|NCT02712983|83211634|FG001|Treatment Phase|Technical Problems|0|||
46968822|NCT02712983|83211635|FG002|Treatment Phase|Technical Problems|0|||
46968823|NCT02712983|83211636|FG003|Treatment Phase|Technical Problems|0|||
46968824|NCT02712983|83211637|FG004|Treatment Phase|Technical Problems|0|||
46968825|NCT02712983|83211638|FG005|Treatment Phase|Technical Problems|0|||
46968826|NCT02712983|83211639|FG006|Treatment Phase|Technical Problems|1|||
46968827|NCT02712983|83211640|FG007|Treatment Phase|Technical Problems|0|||
46968828|NCT02712983|83211641|FG008|Treatment Phase|Technical Problems|0|||
47073568|NCT01672710|83363025|FG001|3 Month Follow up|follow up due after termination date|1|||
46848379|NCT00094458|83065331|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
46968829|NCT02712983|83211633|FG000|Treatment Phase|Physician Decision|0|||
46968830|NCT02712983|83211634|FG001|Treatment Phase|Physician Decision|0|||
46968831|NCT02712983|83211635|FG002|Treatment Phase|Physician Decision|0|||
46968832|NCT02712983|83211636|FG003|Treatment Phase|Physician Decision|0|||
46968833|NCT02712983|83211637|FG004|Treatment Phase|Physician Decision|0|||
47073569|NCT02630472|83363060|FG000|Overall Study|Physician Decision|10|||
46848380|NCT00094458|83065332|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
46848381|NCT00094458|83065333|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
46848382|NCT00094458|83065334|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
46848383|NCT00094458|83065335|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
46848384|NCT00094458|83065336|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
46848385|NCT00094458|83065331|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
46848386|NCT00094458|83065332|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
46848387|NCT00094458|83065333|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
46968834|NCT02712983|83211638|FG005|Treatment Phase|Physician Decision|0|||
46968835|NCT02712983|83211639|FG006|Treatment Phase|Physician Decision|0|||
46968836|NCT02712983|83211640|FG007|Treatment Phase|Physician Decision|1|||
46968837|NCT02712983|83211641|FG008|Treatment Phase|Physician Decision|1|||
46968838|NCT02712983|83211633|FG000|Treatment Phase|Subject Decision|2|||
46968839|NCT02712983|83211634|FG001|Treatment Phase|Subject Decision|0|||
46968840|NCT02712983|83211635|FG002|Treatment Phase|Subject Decision|0|||
46968841|NCT02712983|83211636|FG003|Treatment Phase|Subject Decision|2|||
46968842|NCT02712983|83211637|FG004|Treatment Phase|Subject Decision|1|||
46968843|NCT02712983|83211638|FG005|Treatment Phase|Subject Decision|0|||
46968844|NCT02712983|83211639|FG006|Treatment Phase|Subject Decision|1|||
46968845|NCT02712983|83211640|FG007|Treatment Phase|Subject Decision|2|||
46968846|NCT02712983|83211641|FG008|Treatment Phase|Subject Decision|0|||
46968847|NCT02712983|83211633|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
46968848|NCT02712983|83211634|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
46968849|NCT02712983|83211635|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
46968850|NCT02712983|83211636|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
46968851|NCT02712983|83211637|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
46968852|NCT02712983|83211638|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
46968853|NCT02712983|83211639|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
46968854|NCT02712983|83211640|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
46968855|NCT02712983|83211641|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
46968856|NCT02712983|83211633|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968857|NCT02712983|83211634|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968858|NCT02712983|83211635|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968859|NCT02712983|83211636|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
46968860|NCT02712983|83211637|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968861|NCT02712983|83211638|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968862|NCT02712983|83211639|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968863|NCT02712983|83211640|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968864|NCT02712983|83211641|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
46968865|NCT02712983|83211633|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
46968866|NCT02712983|83211634|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
46968867|NCT02712983|83211635|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
46642211|NCT02407236|82832248|FG006|Induction Study (8 Weeks)|Death|0|||
46642212|NCT02407236|82832249|FG007|Induction Study (8 Weeks)|Death|0|||
46777464|NCT00440947|82995715|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
46968868|NCT02712983|83211636|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
47073570|NCT02630472|83363061|FG001|Overall Study|Physician Decision|0|||
47073571|NCT01670526|83363097|FG000|Overall Study|Withdrawal by Subject|3|||
47073572|NCT01670526|83363098|FG001|Overall Study|Withdrawal by Subject|1|||
47073573|NCT01670526|83363097|FG000|Overall Study|Lost to Follow-up|9|||
47073574|NCT01670526|83363098|FG001|Overall Study|Lost to Follow-up|5|||
47073575|NCT02630706|83363142|FG000|Overall Study|Adverse Event|2|||
47073576|NCT02630706|83363143|FG001|Overall Study|Adverse Event|1|||
47073577|NCT02630706|83363144|FG002|Overall Study|Adverse Event|1|||
47073578|NCT02630706|83363142|FG000|Overall Study|Lost to Follow-up|0|||
47073579|NCT02630706|83363143|FG001|Overall Study|Lost to Follow-up|1|||
47073580|NCT02630706|83363144|FG002|Overall Study|Lost to Follow-up|2|||
47073581|NCT02630706|83363142|FG000|Overall Study|Physician Decision|1|||
46642213|NCT02407236|82832250|FG008|Induction Study (8 Weeks)|Death|0|||
46777465|NCT00440947|82995716|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
46777466|NCT00440947|82995717|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
46777467|NCT00440947|82995713|FG000|48-Week Randomization Phase|Non-compliance|0|||
46777468|NCT00440947|82995714|FG001|48-Week Randomization Phase|Non-compliance|3|||
46777469|NCT00440947|82995715|FG002|48-Week Randomization Phase|Non-compliance|4|||
46777470|NCT00440947|82995716|FG003|48-Week Randomization Phase|Non-compliance|0|||
46777471|NCT00440947|82995717|FG004|48-Week Randomization Phase|Non-compliance|0|||
46777472|NCT00440947|82995713|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
46777473|NCT00440947|82995714|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
46777474|NCT00440947|82995715|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
46777475|NCT00440947|82995716|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
46968869|NCT02712983|83211637|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
47073582|NCT02630706|83363143|FG001|Overall Study|Physician Decision|1|||
47073583|NCT02630706|83363144|FG002|Overall Study|Physician Decision|0|||
47073584|NCT02630706|83363142|FG000|Overall Study|Pregnancy|0|||
46968870|NCT02712983|83211638|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
46968871|NCT02712983|83211639|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
46968872|NCT02712983|83211640|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
46968873|NCT02712983|83211641|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
46968874|NCT02596971|83211664|FG000|Overall Study|Death|5|||
46968875|NCT02596971|83211665|FG001|Overall Study|Death|1|||
47073585|NCT02630706|83363143|FG001|Overall Study|Pregnancy|1|||
47073586|NCT02630706|83363144|FG002|Overall Study|Pregnancy|0|||
47073587|NCT02630706|83363142|FG000|Overall Study|Withdrawal by Subject|4|||
47073588|NCT02630706|83363143|FG001|Overall Study|Withdrawal by Subject|5|||
47073589|NCT02630706|83363144|FG002|Overall Study|Withdrawal by Subject|7|||
47073590|NCT02089997|83363321|FG000|Overall Study|Case report forms uncollected|99|||
47073591|NCT02089997|83363321|FG000|Overall Study|Protocol Violation|147|||
47073592|NCT01363661|83363327|FG000|Overall Study|Adverse Event|9|||
47073593|NCT01363661|83363328|FG001|Overall Study|Adverse Event|2|||
47073594|NCT01363661|83363327|FG000|Overall Study|Withdrawal by Subject|1|||
46968876|NCT02596971|83211666|FG002|Overall Study|Death|5|||
46968877|NCT02596971|83211664|FG000|Overall Study|Withdrawal by Subject|5|||
46968878|NCT02596971|83211665|FG001|Overall Study|Withdrawal by Subject|1|||
46968879|NCT02596971|83211666|FG002|Overall Study|Withdrawal by Subject|4|||
46968880|NCT02593773|83211677|FG000|Overall Study|Voluntary Withdrawal|3|||
46968881|NCT02593773|83211677|FG000|Overall Study|Study Terminated by Sponsor|31|||
46968882|NCT02593773|83211677|FG000|Overall Study|Death|1|||
46968883|NCT02593539|83211681|FG000|Overall Study|Adverse Event|1|||
46968884|NCT00919763|83211690|FG000|Overall Study|Adverse Event|7|||
46968885|NCT00919763|83211691|FG001|Overall Study|Adverse Event|1|||
46968886|NCT00919763|83211690|FG000|Overall Study|Lost to Follow-up|1|||
46968887|NCT00919763|83211691|FG001|Overall Study|Lost to Follow-up|0|||
46968888|NCT00919763|83211690|FG000|Overall Study|Protocol Violation|1|||
46968889|NCT00919763|83211691|FG001|Overall Study|Protocol Violation|1|||
46968890|NCT00919763|83211690|FG000|Overall Study|Withdrawal by Subject|3|||
46968891|NCT00919763|83211691|FG001|Overall Study|Withdrawal by Subject|1|||
46968892|NCT00919763|83211690|FG000|Overall Study|Non-compliance|0|||
46968893|NCT00919763|83211691|FG001|Overall Study|Non-compliance|1|||
46968894|NCT02593305|83211709|FG000|Post 1|Comparison only group. No intervention.|0|||
46968895|NCT02593305|83211710|FG001|Post 1|Comparison only group. No intervention.|0|||
46968896|NCT02593305|83211711|FG002|Post 1|Comparison only group. No intervention.|10|||
46968897|NCT02593149|83211722|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
46968898|NCT02593149|83211723|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
46968899|NCT02593149|83211722|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
46968900|NCT02593149|83211723|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
46968901|NCT02177812|83211738|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
46968902|NCT02177812|83211739|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
46968903|NCT02177812|83211740|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
46968904|NCT02177812|83211741|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
46968905|NCT02177812|83211742|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
46968906|NCT02177812|83211743|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
46968907|NCT02177812|83211744|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
46968908|NCT02177812|83211745|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
46968909|NCT02177812|83211746|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
46968910|NCT02177812|83211738|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
46968911|NCT02177812|83211739|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
46968912|NCT02177812|83211740|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
46968913|NCT02177812|83211741|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
46968914|NCT02177812|83211742|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
46968915|NCT02177812|83211743|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
46968916|NCT02177812|83211744|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
47073595|NCT01363661|83363328|FG001|Overall Study|Withdrawal by Subject|1|||
46777476|NCT00440947|82995717|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
46777477|NCT00440947|82995713|FG000|48-Week Randomization Phase|Protocol Violation|0|||
46777478|NCT00440947|82995714|FG001|48-Week Randomization Phase|Protocol Violation|0|||
46777479|NCT00440947|82995715|FG002|48-Week Randomization Phase|Protocol Violation|1|||
46777480|NCT00440947|82995716|FG003|48-Week Randomization Phase|Protocol Violation|0|||
46777481|NCT00440947|82995717|FG004|48-Week Randomization Phase|Protocol Violation|0|||
46777482|NCT00440947|82995713|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
46777483|NCT00440947|82995714|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
46777484|NCT00440947|82995715|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
46777485|NCT00440947|82995716|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
47073596|NCT01363661|83363327|FG000|Overall Study|Protocol Violation|1|||
47073597|NCT01363661|83363328|FG001|Overall Study|Protocol Violation|0|||
46968917|NCT02177812|83211745|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
46968918|NCT02177812|83211746|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
46968919|NCT02177812|83211738|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
46968920|NCT02177812|83211739|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
46968921|NCT02177812|83211740|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
46968922|NCT02177812|83211741|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
46968923|NCT02177812|83211742|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
46968924|NCT02177812|83211743|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
46968925|NCT02177812|83211744|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
46968926|NCT02177812|83211745|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
46968927|NCT02177812|83211746|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
46968928|NCT01626352|83211790|FG000|Overall Study|Disease Progression|3|||
46968929|NCT01626352|83211790|FG000|Overall Study|Intercurrent Illness|2|||
46968930|NCT01626352|83211790|FG000|Overall Study|Death|2|||
46968931|NCT01626352|83211790|FG000|Overall Study|Withdrawal by Subject|1|||
46968932|NCT01626352|83211790|FG000|Overall Study|Non-Compliance|1|||
46968933|NCT01626352|83211790|FG000|Overall Study|Never Treated|1|||
46968934|NCT01626118|83211801|FG000|Overall Study|Lack of Efficacy|1|||
46968935|NCT01626118|83211802|FG001|Overall Study|Lack of Efficacy|0|||
46968936|NCT01626118|83211803|FG002|Overall Study|Lack of Efficacy|1|||
46968937|NCT01626118|83211804|FG003|Overall Study|Lack of Efficacy|3|||
46968938|NCT01626118|83211801|FG000|Overall Study|Lost to Follow-up|1|||
46968939|NCT01626118|83211802|FG001|Overall Study|Lost to Follow-up|0|||
46968940|NCT01626118|83211803|FG002|Overall Study|Lost to Follow-up|0|||
46968941|NCT01626118|83211804|FG003|Overall Study|Lost to Follow-up|0|||
46968942|NCT01626118|83211801|FG000|Overall Study|Adverse Event|0|||
46968943|NCT01626118|83211802|FG001|Overall Study|Adverse Event|1|||
46968944|NCT01626118|83211803|FG002|Overall Study|Adverse Event|1|||
46968945|NCT01626118|83211804|FG003|Overall Study|Adverse Event|0|||
46968946|NCT01626118|83211801|FG000|Overall Study|Investigator Decision|0|||
46968947|NCT01626118|83211802|FG001|Overall Study|Investigator Decision|1|||
46968948|NCT01626118|83211803|FG002|Overall Study|Investigator Decision|0|||
46968949|NCT01626118|83211804|FG003|Overall Study|Investigator Decision|0|||
46968950|NCT02152384|83211814|FG000|Period 1|Withdrawal by Subject|0|||
46968951|NCT02152384|83211815|FG001|Period 1|Withdrawal by Subject|1|||
46968952|NCT02152384|83211814|FG000|Period 1|Adverse Event|1|||
46968953|NCT02152384|83211815|FG001|Period 1|Adverse Event|1|||
46968954|NCT02177266|83211827|FG000|Overall Study|Adverse Event|0|||
46968955|NCT02177266|83211828|FG001|Overall Study|Adverse Event|1|||
46968956|NCT02177266|83211827|FG000|Overall Study|Withdrawal by Subject|1|||
46968957|NCT02177266|83211828|FG001|Overall Study|Withdrawal by Subject|0|||
46968958|NCT02177032|83211838|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
46968959|NCT02177032|83211839|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
46968960|NCT02177032|83211840|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
46968961|NCT02177032|83211841|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
46968962|NCT02177032|83211838|FG000|Overall Study|Lost to Follow-up|0|||
46968963|NCT02177032|83211839|FG001|Overall Study|Lost to Follow-up|2|||
46968964|NCT02177032|83211840|FG002|Overall Study|Lost to Follow-up|0|||
46968965|NCT02177032|83211841|FG003|Overall Study|Lost to Follow-up|0|||
46968966|NCT02177032|83211838|FG000|Overall Study|OTHER|2|||
46968967|NCT02177032|83211839|FG001|Overall Study|OTHER|0|||
46968968|NCT02177032|83211840|FG002|Overall Study|OTHER|1|||
46968969|NCT02177032|83211841|FG003|Overall Study|OTHER|0|||
46968970|NCT02177032|83211838|FG000|Overall Study|Withdrawal by Subject|1|||
46968971|NCT02177032|83211839|FG001|Overall Study|Withdrawal by Subject|0|||
46968972|NCT02177032|83211840|FG002|Overall Study|Withdrawal by Subject|1|||
46968973|NCT02177032|83211841|FG003|Overall Study|Withdrawal by Subject|0|||
47073598|NCT01363661|83363327|FG000|Overall Study|Lost to Follow-up|3|||
47073599|NCT01363661|83363328|FG001|Overall Study|Lost to Follow-up|1|||
47073600|NCT02628600|83363336|FG000|Overall Study|Death|2|||
47073601|NCT02628600|83363337|FG001|Overall Study|Death|1|||
47073602|NCT02628600|83363336|FG000|Overall Study|Adverse Event|3|||
47073603|NCT02628600|83363337|FG001|Overall Study|Adverse Event|20|||
47073604|NCT02628600|83363336|FG000|Overall Study|Protocol Violation|0|||
46968974|NCT02176642|83211864|FG000|Overall Study|Withdrawal by Subject|0|||
46968975|NCT02176642|83211865|FG001|Overall Study|Withdrawal by Subject|1|||
46968976|NCT02116660|83211873|FG000|Overall Study|Deteriorating renal function|0|||
46968977|NCT02116660|83211874|FG001|Overall Study|Deteriorating renal function|1|||
46777486|NCT00440947|82995717|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
46968978|NCT02116660|83211873|FG000|Overall Study|Adverse Event|1|||
46968979|NCT02116660|83211874|FG001|Overall Study|Adverse Event|1|||
46968980|NCT02116660|83211873|FG000|Overall Study|Withdrawal by Subject|0|||
46968981|NCT02116660|83211874|FG001|Overall Study|Withdrawal by Subject|2|||
46968982|NCT02116660|83211873|FG000|Overall Study|Organization reason|1|||
47073605|NCT02628600|83363337|FG001|Overall Study|Protocol Violation|1|||
46968983|NCT02116660|83211874|FG001|Overall Study|Organization reason|0|||
46968984|NCT02589405|83211882|FG000|Overall Study|Adverse Event|3|||
46968985|NCT02589405|83211882|FG000|Overall Study|Withdrawal by Subject|1|||
46968986|NCT02176018|83211888|FG000|Overall Study|Adverse Event|0|||
46968987|NCT02176018|83211889|FG001|Overall Study|Adverse Event|2|||
46968988|NCT02176018|83211888|FG000|Overall Study|Lost to Follow-up|3|||
46968989|NCT02176018|83211889|FG001|Overall Study|Lost to Follow-up|1|||
46968990|NCT02176018|83211888|FG000|Overall Study|Protocol Violation|1|||
46968991|NCT02176018|83211889|FG001|Overall Study|Protocol Violation|1|||
46968992|NCT02176018|83211888|FG000|Overall Study|Withdrawal by Subject|1|||
46968993|NCT02176018|83211889|FG001|Overall Study|Withdrawal by Subject|2|||
47073606|NCT02628600|83363336|FG000|Overall Study|Lack of Efficacy|2|||
47073607|NCT02628600|83363337|FG001|Overall Study|Lack of Efficacy|0|||
47073608|NCT02628600|83363336|FG000|Overall Study|Withdrawal by Subject|13|||
47073609|NCT02628600|83363337|FG001|Overall Study|Withdrawal by Subject|8|||
47073610|NCT02628600|83363336|FG000|Overall Study|Lost to Follow-up|1|||
47073611|NCT02628600|83363337|FG001|Overall Study|Lost to Follow-up|0|||
46968994|NCT02116582|83211895|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
47073612|NCT02628600|83363336|FG000|Overall Study|Physician Decision|2|||
47073613|NCT02628600|83363337|FG001|Overall Study|Physician Decision|2|||
47073614|NCT02628600|83363336|FG000|Overall Study|Other not specified|1|||
47073615|NCT02628600|83363337|FG001|Overall Study|Other not specified|0|||
46642214|NCT02407236|82832251|FG009|Induction Study (8 Weeks)|Death|0|||
46777487|NCT00440947|82995713|FG000|48-Week Randomization Phase|Pregnancy|0|||
46777488|NCT00440947|82995714|FG001|48-Week Randomization Phase|Pregnancy|0|||
46777489|NCT00440947|82995715|FG002|48-Week Randomization Phase|Pregnancy|1|||
46777490|NCT00440947|82995716|FG003|48-Week Randomization Phase|Pregnancy|0|||
46777491|NCT00440947|82995717|FG004|48-Week Randomization Phase|Pregnancy|0|||
46777492|NCT00440947|82995713|FG000|48-Week Randomization Phase|Incarceration|0|||
46777493|NCT00440947|82995714|FG001|48-Week Randomization Phase|Incarceration|3|||
46777494|NCT00440947|82995715|FG002|48-Week Randomization Phase|Incarceration|0|||
46777495|NCT00440947|82995716|FG003|48-Week Randomization Phase|Incarceration|0|||
46777496|NCT00440947|82995717|FG004|48-Week Randomization Phase|Incarceration|0|||
46777497|NCT00440947|82995713|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
46848388|NCT00094458|83065334|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
46848389|NCT00094458|83065335|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
46848390|NCT00094458|83065336|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
46848391|NCT00094458|83065331|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
46848392|NCT00094458|83065332|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
46848393|NCT00094458|83065333|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
46848394|NCT00094458|83065334|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
46848395|NCT00094458|83065335|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
46848396|NCT00094458|83065336|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
46848397|NCT00094458|83065331|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
46848398|NCT00094458|83065332|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
46848399|NCT00094458|83065333|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
46848400|NCT00094458|83065334|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
46848401|NCT00094458|83065335|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
46848402|NCT00094458|83065336|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
46848403|NCT00094458|83065331|FG000|OLE: Open-Label Extension|Adverse Event|0|||
46848404|NCT00094458|83065332|FG001|OLE: Open-Label Extension|Adverse Event|0|||
46848405|NCT00094458|83065333|FG002|OLE: Open-Label Extension|Adverse Event|0|||
46848406|NCT00094458|83065334|FG003|OLE: Open-Label Extension|Adverse Event|0|||
46848407|NCT00094458|83065335|FG004|OLE: Open-Label Extension|Adverse Event|3|||
46848408|NCT00094458|83065336|FG005|OLE: Open-Label Extension|Adverse Event|4|||
46848409|NCT00094458|83065331|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
46848410|NCT00094458|83065332|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
46848411|NCT00094458|83065333|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
46848412|NCT00094458|83065334|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
46848413|NCT00094458|83065335|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
46848414|NCT00094458|83065336|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
46848415|NCT00094458|83065331|FG000|OLE: Open-Label Extension|Patient decision|0|||
46848416|NCT00094458|83065332|FG001|OLE: Open-Label Extension|Patient decision|0|||
46848417|NCT00094458|83065333|FG002|OLE: Open-Label Extension|Patient decision|0|||
46848418|NCT00094458|83065334|FG003|OLE: Open-Label Extension|Patient decision|0|||
46848419|NCT00094458|83065335|FG004|OLE: Open-Label Extension|Patient decision|1|||
46848420|NCT00094458|83065336|FG005|OLE: Open-Label Extension|Patient decision|0|||
46848421|NCT00406367|83065352|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
46777498|NCT00440947|82995714|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
46777499|NCT00440947|82995715|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
46777500|NCT00440947|82995716|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
46777501|NCT00440947|82995717|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
46777502|NCT00440947|82995713|FG000|48-Week Randomization Phase|Physician Decision|0|||
46777503|NCT00440947|82995714|FG001|48-Week Randomization Phase|Physician Decision|2|||
46777504|NCT00440947|82995715|FG002|48-Week Randomization Phase|Physician Decision|0|||
46777505|NCT00440947|82995716|FG003|48-Week Randomization Phase|Physician Decision|0|||
46777506|NCT00440947|82995717|FG004|48-Week Randomization Phase|Physician Decision|0|||
46777507|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
46777508|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
46777509|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
46777510|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
46777511|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
46642215|NCT02407236|82832252|FG010|Induction Study (8 Weeks)|Death|0|||
46642216|NCT02407236|82832253|FG011|Induction Study (8 Weeks)|Death|0|||
46642217|NCT02407236|82832254|FG012|Induction Study (8 Weeks)|Death|0|||
46642218|NCT02407236|82832242|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
46642219|NCT02407236|82832243|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
46642220|NCT02407236|82832244|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
46642221|NCT02407236|82832245|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46642222|NCT02407236|82832246|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46777512|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
46777513|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
46777514|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
46777515|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
46777516|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
46777517|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
46848422|NCT00406367|83065353|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
46848423|NCT00406367|83065352|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
46848424|NCT00406367|83065353|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
46848425|NCT00406367|83065352|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
46848426|NCT00406367|83065353|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
46848427|NCT00406367|83065352|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
46848428|NCT00406367|83065353|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
46848429|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
46848430|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
46848431|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
46848432|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
46848433|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
46968995|NCT02116582|83211895|FG000|Overall Study|Adverse Event|22|||
46968996|NCT02116582|83211895|FG000|Overall Study|Death|9|||
46968997|NCT02116582|83211895|FG000|Overall Study|Progressive Disease|148|||
46968998|NCT02116582|83211895|FG000|Overall Study|Protocol Violation|3|||
46968999|NCT02116582|83211895|FG000|Overall Study|Withdrawal by Subject|8|||
46969000|NCT02116582|83211895|FG000|Overall Study|Other: Miscellaneous|11|||
46969001|NCT02116582|83211895|FG000|Overall Study|Lost to Follow-up|1|||
46969002|NCT02116582|83211895|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
46969003|NCT02589639|83211902|FG000|Overall Study|Lost to Follow-up|1|||
46969004|NCT02589639|83211903|FG001|Overall Study|Lost to Follow-up|0|||
46969005|NCT02589639|83211904|FG002|Overall Study|Lost to Follow-up|0|||
46969006|NCT02589639|83211902|FG000|Overall Study|Protocol Violation|1|||
46969007|NCT02589639|83211903|FG001|Overall Study|Protocol Violation|0|||
46969008|NCT02589639|83211904|FG002|Overall Study|Protocol Violation|0|||
46969009|NCT02589639|83211902|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
46969010|NCT02589639|83211903|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
46969011|NCT02589639|83211904|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
46969012|NCT02589639|83211902|FG000|Overall Study|Adverse Event|4|||
46642223|NCT02407236|82832247|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46848434|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
46848435|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
46848436|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
46848437|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
46848438|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
46969013|NCT02589639|83211903|FG001|Overall Study|Adverse Event|5|||
46969014|NCT02589639|83211904|FG002|Overall Study|Adverse Event|3|||
46969015|NCT02589639|83211902|FG000|Overall Study|Other reason than specified above|1|||
46969016|NCT02589639|83211903|FG001|Overall Study|Other reason than specified above|2|||
46642224|NCT02407236|82832248|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46642225|NCT02407236|82832249|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46969017|NCT02589639|83211904|FG002|Overall Study|Other reason than specified above|1|||
46969018|NCT02589639|83211902|FG000|Overall Study|Not Treated|0|||
46969019|NCT02589639|83211903|FG001|Overall Study|Not Treated|3|||
46969020|NCT02589639|83211904|FG002|Overall Study|Not Treated|0|||
46969021|NCT02151682|83211914|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
46969022|NCT02151682|83211915|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
46969023|NCT02151682|83211916|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
46969024|NCT02151682|83211917|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
46969025|NCT02151682|83211918|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
46969026|NCT02151682|83211919|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
46969027|NCT02151682|83211914|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
46969028|NCT02151682|83211915|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
46969029|NCT02151682|83211916|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
46969030|NCT02151682|83211917|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
46969031|NCT02151682|83211918|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
46969032|NCT02151682|83211919|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
46969033|NCT02151682|83211914|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
46969034|NCT02151682|83211915|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
46969035|NCT02151682|83211916|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
46969036|NCT02151682|83211917|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
46969037|NCT02151682|83211918|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
46969038|NCT02151682|83211919|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
46969039|NCT02151682|83211914|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
46969040|NCT02151682|83211915|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
46969041|NCT02151682|83211916|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
46969042|NCT02151682|83211917|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
46969043|NCT02151682|83211918|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
46969044|NCT02151682|83211919|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
46969045|NCT02151682|83211914|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
46969046|NCT02151682|83211915|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
46969047|NCT02151682|83211916|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
46969048|NCT02151682|83211917|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
46969049|NCT02151682|83211918|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
46969050|NCT02151682|83211919|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
46969051|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
46969052|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
46969053|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
46969054|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
46969055|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
46969056|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
46969057|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
46969058|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
46969059|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
46969060|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
46969061|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
46969062|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
46969063|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
46969064|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
46969065|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
46969066|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
46969067|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
46969068|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
46642226|NCT02407236|82832250|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46642227|NCT02407236|82832251|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46642228|NCT02407236|82832252|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46642229|NCT02407236|82832253|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46642230|NCT02407236|82832254|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
46642231|NCT02407236|82832242|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642232|NCT02407236|82832243|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642233|NCT02407236|82832244|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
46642234|NCT02407236|82832245|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46969069|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
46969070|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
46969071|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
46969072|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
46969073|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
46642235|NCT02407236|82832246|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46777518|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
46777519|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
46777520|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
46969074|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
46969075|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
46969076|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
46969077|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
46969078|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
46969079|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
46969080|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
46969081|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
46969082|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
46969083|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
46969084|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
46969085|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
46969086|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
46969087|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
46969088|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
46969089|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
46969090|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
46969091|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
46969092|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
46969093|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
47073616|NCT00591318|83363354|FG000|Overall Study|Lack of Efficacy|2|||
47073617|NCT00591318|83363355|FG001|Overall Study|Lack of Efficacy|0|||
47073618|NCT00591318|83363354|FG000|Overall Study|Adverse Event|2|||
47073619|NCT00591318|83363355|FG001|Overall Study|Adverse Event|0|||
47073620|NCT01360632|83363368|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
47073621|NCT01360632|83363369|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
47073622|NCT01360632|83363370|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
46777521|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
46777522|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
46777523|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
46777524|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
46969094|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
46969095|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
46969096|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
46969097|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
47073623|NCT01360632|83363371|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
47073624|NCT01360632|83363372|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
47073625|NCT01360632|83363368|FG000|Phase A (8 Weeks)|Adverse Event|60|||
47073626|NCT01360632|83363369|FG001|Phase A (8 Weeks)|Adverse Event|0|||
47073627|NCT01360632|83363370|FG002|Phase A (8 Weeks)|Adverse Event|0|||
47073628|NCT01360632|83363371|FG003|Phase A (8 Weeks)|Adverse Event|0|||
47073629|NCT01360632|83363372|FG004|Phase A (8 Weeks)|Adverse Event|0|||
47073630|NCT01360632|83363368|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
47073631|NCT01360632|83363369|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
47073632|NCT01360632|83363370|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
47073633|NCT01360632|83363371|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
47073634|NCT01360632|83363372|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
47073635|NCT01360632|83363368|FG000|Phase A (8 Weeks)|Physician Decision|10|||
46777525|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
46777526|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
46777527|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
46777528|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
46777529|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
46777530|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
47073636|NCT01360632|83363369|FG001|Phase A (8 Weeks)|Physician Decision|0|||
47073637|NCT01360632|83363370|FG002|Phase A (8 Weeks)|Physician Decision|0|||
47073638|NCT01360632|83363371|FG003|Phase A (8 Weeks)|Physician Decision|0|||
47073639|NCT01360632|83363372|FG004|Phase A (8 Weeks)|Physician Decision|0|||
47073640|NCT01360632|83363368|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
47073641|NCT01360632|83363369|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
47073642|NCT01360632|83363370|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
47073643|NCT01360632|83363371|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
47073644|NCT01360632|83363372|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
47073645|NCT01360632|83363368|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
47073646|NCT01360632|83363369|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
47073647|NCT01360632|83363370|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
47073648|NCT01360632|83363371|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
47073649|NCT01360632|83363372|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
46777531|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
46777532|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
46777533|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
46777534|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
46777535|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
46777536|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
46777537|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
47073650|NCT01360632|83363368|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
47073651|NCT01360632|83363369|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
47073652|NCT01360632|83363370|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
46777538|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
47073653|NCT01360632|83363371|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
47073654|NCT01360632|83363372|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
47073655|NCT01360632|83363368|FG000|Phase B (6 Weeks)|Adverse Event|0|||
47073656|NCT01360632|83363369|FG001|Phase B (6 Weeks)|Adverse Event|3|||
47073657|NCT01360632|83363370|FG002|Phase B (6 Weeks)|Adverse Event|9|||
47073658|NCT01360632|83363371|FG003|Phase B (6 Weeks)|Adverse Event|3|||
47073659|NCT01360632|83363372|FG004|Phase B (6 Weeks)|Adverse Event|0|||
47073660|NCT01360632|83363368|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
47073661|NCT01360632|83363369|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
47073662|NCT01360632|83363370|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
47073663|NCT01360632|83363371|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
46777539|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
46848439|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
46848440|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
46848441|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
46848442|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
46848443|NCT00406367|83065352|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
46848444|NCT00406367|83065353|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
46848445|NCT00394589|83065362|FG000|Overall Study|Adverse Event|2|||
47073664|NCT01360632|83363372|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
47073665|NCT01360632|83363368|FG000|Phase B (6 Weeks)|Physician Decision|0|||
47073666|NCT01360632|83363369|FG001|Phase B (6 Weeks)|Physician Decision|0|||
46848446|NCT00394589|83065363|FG001|Overall Study|Adverse Event|1|||
46848447|NCT00394589|83065364|FG002|Overall Study|Adverse Event|2|||
46777540|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
46848448|NCT00394589|83065362|FG000|Overall Study|Lack of Efficacy|2|||
47073667|NCT01360632|83363370|FG002|Phase B (6 Weeks)|Physician Decision|0|||
47073668|NCT01360632|83363371|FG003|Phase B (6 Weeks)|Physician Decision|1|||
47073669|NCT01360632|83363372|FG004|Phase B (6 Weeks)|Physician Decision|0|||
47073670|NCT01360632|83363368|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
46848449|NCT00394589|83065363|FG001|Overall Study|Lack of Efficacy|2|||
46848450|NCT00394589|83065364|FG002|Overall Study|Lack of Efficacy|3|||
47073671|NCT01360632|83363369|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
47073672|NCT01360632|83363370|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
47073673|NCT01360632|83363371|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
46848451|NCT00394589|83065362|FG000|Overall Study|Protocol Violation|4|||
46848452|NCT00394589|83065363|FG001|Overall Study|Protocol Violation|0|||
46848453|NCT00394589|83065364|FG002|Overall Study|Protocol Violation|2|||
46848454|NCT00068406|83065372|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
46848455|NCT00068406|83065372|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
46848456|NCT00403559|83065378|FG000|Overall Study|Adverse Event|0|||
46848457|NCT00403559|83065379|FG001|Overall Study|Adverse Event|1|||
46848458|NCT00403559|83065378|FG000|Overall Study|Lost to Follow-up|3|||
46848459|NCT00403559|83065379|FG001|Overall Study|Lost to Follow-up|3|||
46848460|NCT00403559|83065378|FG000|Overall Study|Withdrawal by Subject|1|||
46848461|NCT00403559|83065379|FG001|Overall Study|Withdrawal by Subject|0|||
46848462|NCT00403481|83065387|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
46848463|NCT00403481|83065387|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
46848464|NCT00403481|83065387|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
46848465|NCT00403481|83065387|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
46848466|NCT00403481|83065387|FG000|Olm 40 mg|Adverse Event|2|||
46848467|NCT00403481|83065387|FG000|Olm 40 mg|Protocol Violation|1|||
46848468|NCT00403481|83065387|FG000|Olm 40 mg|Withdrawal by Subject|1|||
46848469|NCT00403481|83065387|FG000|Olm 40 mg|Other|1|||
46848470|NCT00403481|83065387|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
46848471|NCT00403481|83065387|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
46848472|NCT00403481|83065387|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
46848473|NCT00403481|83065387|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
46848474|NCT00403481|83065387|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
46848475|NCT00403481|83065387|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
46848476|NCT00402779|83065396|FG000|Overall Study|Screen Failure|77|||
46848477|NCT00402779|83065397|FG001|Overall Study|Screen Failure|76|||
46848478|NCT00394433|83065403|FG000|Overall Study|Adverse Event|2|||
46848479|NCT00394433|83065403|FG000|Overall Study|Alternative Therapy|1|||
46848480|NCT00092534|83065409|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
46848481|NCT00092534|83065410|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
46848482|NCT00092534|83065411|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
46848483|NCT00092534|83065412|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
46848484|NCT00092534|83065413|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
46848485|NCT00092534|83065409|FG000|Base Study Vaccination Period|Adverse Event|3|||
46848486|NCT00092534|83065410|FG001|Base Study Vaccination Period|Adverse Event|1|||
46848487|NCT00092534|83065411|FG002|Base Study Vaccination Period|Adverse Event|0|||
46848488|NCT00092534|83065412|FG003|Base Study Vaccination Period|Adverse Event|0|||
46848489|NCT00092534|83065413|FG004|Base Study Vaccination Period|Adverse Event|0|||
46848490|NCT00092534|83065409|FG000|Base Study Vaccination Period|Death|5|||
46848491|NCT00092534|83065410|FG001|Base Study Vaccination Period|Death|4|||
46848492|NCT00092534|83065411|FG002|Base Study Vaccination Period|Death|0|||
46848493|NCT00092534|83065412|FG003|Base Study Vaccination Period|Death|0|||
46848494|NCT00092534|83065413|FG004|Base Study Vaccination Period|Death|0|||
46848495|NCT00092534|83065409|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
46848496|NCT00092534|83065410|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
46848497|NCT00092534|83065411|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
46848498|NCT00092534|83065412|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
46848499|NCT00092534|83065413|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
46848500|NCT00092534|83065409|FG000|Base Study Vaccination Period|Physician Decision|1|||
46848501|NCT00092534|83065410|FG001|Base Study Vaccination Period|Physician Decision|0|||
46848502|NCT00092534|83065411|FG002|Base Study Vaccination Period|Physician Decision|0|||
46848503|NCT00092534|83065412|FG003|Base Study Vaccination Period|Physician Decision|0|||
47073674|NCT01360632|83363372|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
47073675|NCT01360632|83363368|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
47073676|NCT01360632|83363369|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
47073677|NCT01360632|83363370|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
46777541|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
46777542|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
46777543|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
46777544|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
46777545|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
46777546|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
46777547|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
46777548|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
46777549|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
46848504|NCT00092534|83065413|FG004|Base Study Vaccination Period|Physician Decision|0|||
46848505|NCT00092534|83065409|FG000|Base Study Vaccination Period|Pregnancy|9|||
46848506|NCT00092534|83065410|FG001|Base Study Vaccination Period|Pregnancy|7|||
46848507|NCT00092534|83065411|FG002|Base Study Vaccination Period|Pregnancy|0|||
46848508|NCT00092534|83065412|FG003|Base Study Vaccination Period|Pregnancy|0|||
47073678|NCT01360632|83363371|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
46969098|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
46969099|NCT02151682|83211914|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
46969100|NCT02151682|83211915|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
46969101|NCT02151682|83211916|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
46969102|NCT02151682|83211917|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
46969103|NCT02151682|83211918|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
46969104|NCT02151682|83211919|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
46969105|NCT02151682|83211914|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
46969106|NCT02151682|83211915|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
46969107|NCT02151682|83211916|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
46969108|NCT02151682|83211917|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
46777550|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
46777551|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
46777552|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
46777553|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
46777554|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
46777555|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
46777556|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
46777557|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
46777558|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
46777559|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
46777560|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
46777561|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
46777562|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Other|0|||
46777563|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Other|0|||
46777564|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Other|0|||
46777565|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Other|1|||
46777566|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Other|0|||
46777567|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
46777568|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
46777569|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
46777570|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
46777571|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
46777572|NCT00440947|82995713|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
46777573|NCT00440947|82995714|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
46777574|NCT00440947|82995715|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
46777575|NCT00440947|82995716|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
46969109|NCT02151682|83211918|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
47073679|NCT01360632|83363372|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
47073680|NCT01360632|83363368|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
47073681|NCT01360632|83363369|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
47073682|NCT01360632|83363370|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
47073683|NCT01360632|83363371|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
47073684|NCT01360632|83363372|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
47073685|NCT01360632|83363368|FG000|Phase A+|Lost to Follow-up|0|||
47073686|NCT01360632|83363369|FG001|Phase A+|Lost to Follow-up|0|||
47073687|NCT01360632|83363370|FG002|Phase A+|Lost to Follow-up|0|||
47073688|NCT01360632|83363371|FG003|Phase A+|Lost to Follow-up|0|||
47073689|NCT01360632|83363372|FG004|Phase A+|Lost to Follow-up|2|||
47073690|NCT01360632|83363368|FG000|Phase A+|Adverse Event|0|||
47073691|NCT01360632|83363369|FG001|Phase A+|Adverse Event|0|||
47073692|NCT01360632|83363370|FG002|Phase A+|Adverse Event|0|||
47073693|NCT01360632|83363371|FG003|Phase A+|Adverse Event|0|||
47073694|NCT01360632|83363372|FG004|Phase A+|Adverse Event|2|||
47073695|NCT01360632|83363368|FG000|Phase A+|Met Withdrawal Criteria|0|||
47073696|NCT01360632|83363369|FG001|Phase A+|Met Withdrawal Criteria|0|||
47073697|NCT01360632|83363370|FG002|Phase A+|Met Withdrawal Criteria|0|||
47073698|NCT01360632|83363371|FG003|Phase A+|Met Withdrawal Criteria|0|||
47073699|NCT01360632|83363372|FG004|Phase A+|Met Withdrawal Criteria|7|||
47073700|NCT01360632|83363368|FG000|Phase A+|Physician Decision|0|||
46848509|NCT00092534|83065413|FG004|Base Study Vaccination Period|Pregnancy|0|||
46848510|NCT00092534|83065409|FG000|Base Study Vaccination Period|Protocol Violation|2|||
46848511|NCT00092534|83065410|FG001|Base Study Vaccination Period|Protocol Violation|1|||
46848512|NCT00092534|83065411|FG002|Base Study Vaccination Period|Protocol Violation|0|||
46848513|NCT00092534|83065412|FG003|Base Study Vaccination Period|Protocol Violation|0|||
46848514|NCT00092534|83065413|FG004|Base Study Vaccination Period|Protocol Violation|0|||
46848515|NCT00092534|83065409|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
46848516|NCT00092534|83065410|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
46848517|NCT00092534|83065411|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
46848518|NCT00092534|83065412|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
46848519|NCT00092534|83065413|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
46848520|NCT00092534|83065409|FG000|Base Study Vaccination Period|Moved|14|||
46848521|NCT00092534|83065410|FG001|Base Study Vaccination Period|Moved|12|||
46848522|NCT00092534|83065411|FG002|Base Study Vaccination Period|Moved|0|||
46848523|NCT00092534|83065412|FG003|Base Study Vaccination Period|Moved|0|||
46848524|NCT00092534|83065413|FG004|Base Study Vaccination Period|Moved|0|||
46848525|NCT00092534|83065409|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
46848526|NCT00092534|83065410|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
46848527|NCT00092534|83065411|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
46848528|NCT00092534|83065412|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
46848529|NCT00092534|83065413|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
46848530|NCT00092534|83065409|FG000|Base Study Vaccination Period|Travel|1|||
46848531|NCT00092534|83065410|FG001|Base Study Vaccination Period|Travel|0|||
46848532|NCT00092534|83065411|FG002|Base Study Vaccination Period|Travel|0|||
46848533|NCT00092534|83065412|FG003|Base Study Vaccination Period|Travel|0|||
46848534|NCT00092534|83065413|FG004|Base Study Vaccination Period|Travel|0|||
46848535|NCT00092534|83065409|FG000|Base Study Vaccination Period|Site Closed|0|||
46969110|NCT02151682|83211919|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
46969111|NCT02151682|83211914|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
47073701|NCT01360632|83363369|FG001|Phase A+|Physician Decision|0|||
46777576|NCT00440947|82995717|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
46777577|NCT00664521|82995740|FG000|Overall Study|Adverse Event|4|||
46777578|NCT00664521|82995741|FG001|Overall Study|Adverse Event|1|||
46777579|NCT00664521|82995740|FG000|Overall Study|Lost to Follow-up|1|||
46777580|NCT00664521|82995741|FG001|Overall Study|Lost to Follow-up|0|||
46777581|NCT00664521|82995740|FG000|Overall Study|Other|1|||
46777582|NCT00664521|82995741|FG001|Overall Study|Other|0|||
46777583|NCT00664209|82995747|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
46777584|NCT00664209|82995747|FG000|Study Treatment Period|Physician Decision|4|||
46848536|NCT00092534|83065410|FG001|Base Study Vaccination Period|Site Closed|1|||
46969112|NCT02151682|83211915|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
47073702|NCT01360632|83363370|FG002|Phase A+|Physician Decision|0|||
47073703|NCT01360632|83363371|FG003|Phase A+|Physician Decision|0|||
47073704|NCT01360632|83363372|FG004|Phase A+|Physician Decision|3|||
47073705|NCT01360632|83363368|FG000|Phase A+|Withdrawal by Subject|0|||
47073706|NCT01360632|83363369|FG001|Phase A+|Withdrawal by Subject|0|||
47073707|NCT01360632|83363370|FG002|Phase A+|Withdrawal by Subject|0|||
47073708|NCT01360632|83363371|FG003|Phase A+|Withdrawal by Subject|0|||
47073709|NCT01360632|83363372|FG004|Phase A+|Withdrawal by Subject|8|||
47073710|NCT01360632|83363368|FG000|Phase A+|Protocol Deviation|0|||
47073711|NCT01360632|83363369|FG001|Phase A+|Protocol Deviation|0|||
47073712|NCT01360632|83363370|FG002|Phase A+|Protocol Deviation|0|||
47073713|NCT01360632|83363371|FG003|Phase A+|Protocol Deviation|0|||
47073714|NCT01360632|83363372|FG004|Phase A+|Protocol Deviation|3|||
47073715|NCT04157400|83363418|FG000|Overall Study|Withdrawal by Subject|1|||
47073716|NCT04157400|83363418|FG000|Overall Study|Lost to Follow-up|3|||
47073717|NCT02626182|83363492|FG000|Overall Study|Adverse Event|2|||
47073718|NCT02626182|83363493|FG001|Overall Study|Adverse Event|0|||
47073719|NCT01669902|83363600|FG000|Overall Study|Adverse Event|11|||
47073720|NCT01669902|83363600|FG000|Overall Study|Lack of Efficacy|10|||
47073721|NCT01669902|83363600|FG000|Overall Study|Other|8|||
46777585|NCT00664209|82995747|FG000|Study Treatment Period|Withdrawal by Subject|2|||
46848537|NCT00092534|83065411|FG002|Base Study Vaccination Period|Site Closed|0|||
46848538|NCT00092534|83065412|FG003|Base Study Vaccination Period|Site Closed|0|||
46969113|NCT02151682|83211916|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
46969114|NCT02151682|83211917|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
47073722|NCT01670292|83363633|FG000|Overall Study|Lost to Follow-up|14|||
47073723|NCT01360554|83363870|FG000|Overall Study|Death|359|||
47073724|NCT01360554|83363871|FG001|Overall Study|Death|371|||
47073725|NCT01360554|83363870|FG000|Overall Study|Lost to Follow-up|4|||
47073726|NCT01360554|83363871|FG001|Overall Study|Lost to Follow-up|4|||
46777586|NCT00440557|82995755|FG000|Overall Study|Withdrawal by Subject|10|||
46777587|NCT00440557|82995756|FG001|Overall Study|Withdrawal by Subject|5|||
46848539|NCT00092534|83065413|FG004|Base Study Vaccination Period|Site Closed|0|||
46848540|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Adverse Event|2|||
46777588|NCT00440557|82995757|FG002|Overall Study|Withdrawal by Subject|11|||
46777589|NCT00440557|82995755|FG000|Overall Study|Lost to Follow-up|1|||
46777590|NCT00440557|82995756|FG001|Overall Study|Lost to Follow-up|2|||
46777591|NCT00440557|82995757|FG002|Overall Study|Lost to Follow-up|6|||
46777592|NCT00440557|82995755|FG000|Overall Study|Adverse Event|3|||
46777593|NCT00440557|82995756|FG001|Overall Study|Adverse Event|3|||
46777594|NCT00440557|82995757|FG002|Overall Study|Adverse Event|5|||
46777595|NCT00440557|82995755|FG000|Overall Study|Death|2|||
46777596|NCT00440557|82995756|FG001|Overall Study|Death|6|||
46777597|NCT00440557|82995757|FG002|Overall Study|Death|3|||
46848541|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Adverse Event|4|||
46848542|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Adverse Event|0|||
46848543|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Adverse Event|0|||
46848544|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Adverse Event|0|||
46848545|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Death|2|||
46848546|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Death|1|||
46777598|NCT00440557|82995755|FG000|Overall Study|Began Dialysis|4|||
46777599|NCT00440557|82995756|FG001|Overall Study|Began Dialysis|1|||
46848547|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Death|0|||
46848548|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Death|0|||
46848549|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Death|0|||
46848550|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
46848551|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
46848552|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
46848553|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
46848554|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
46848555|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Pregnancy|6|||
46848556|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Pregnancy|10|||
46848557|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Pregnancy|0|||
46848558|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Pregnancy|0|||
46848559|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Pregnancy|0|||
46848560|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
46848561|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
46848562|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
46848563|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
46848564|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
46848565|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
46848566|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
46848567|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
46848568|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
46848569|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
46848570|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Moved|62|||
46848571|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Moved|58|||
46848572|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Moved|0|||
46848573|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Moved|0|||
46848574|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Moved|0|||
46848575|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Travel|10|||
46848576|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Travel|7|||
46848577|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Travel|0|||
46848578|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Travel|0|||
46848579|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Travel|0|||
46848580|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Site Closed|0|||
46848581|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Site Closed|2|||
46848582|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Site Closed|0|||
46848583|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Site Closed|0|||
46848584|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Site Closed|0|||
46777600|NCT00440557|82995757|FG002|Overall Study|Began Dialysis|4|||
46777601|NCT00440557|82995755|FG000|Overall Study|Principal Investigator decision|0|||
46777602|NCT00440557|82995756|FG001|Overall Study|Principal Investigator decision|3|||
46777603|NCT00440557|82995757|FG002|Overall Study|Principal Investigator decision|1|||
46777604|NCT00440557|82995755|FG000|Overall Study|Patient moved|1|||
46848585|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
46848586|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
46848587|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
46848588|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
46848589|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
46848590|NCT00092534|83065409|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
46848591|NCT00092534|83065410|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
46777605|NCT00440557|82995756|FG001|Overall Study|Patient moved|2|||
46777606|NCT00440557|82995757|FG002|Overall Study|Patient moved|1|||
46848592|NCT00092534|83065411|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
46969115|NCT02151682|83211918|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
46969116|NCT02151682|83211919|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
46969117|NCT02151682|83211914|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
46969118|NCT02151682|83211915|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
46969119|NCT02151682|83211916|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
46969120|NCT02151682|83211917|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
46969121|NCT02151682|83211918|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
46969122|NCT02151682|83211919|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
46969123|NCT02151682|83211914|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
46969124|NCT02151682|83211915|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
46969125|NCT02151682|83211916|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
46969126|NCT02151682|83211917|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
46969127|NCT02151682|83211918|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
46969128|NCT02151682|83211919|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
46969129|NCT02174848|83211939|FG000|Overall Study|Adverse Event|2|||
46969130|NCT02174848|83211940|FG001|Overall Study|Adverse Event|1|||
46969131|NCT02174848|83211939|FG000|Overall Study|Withdrawal by Subject|3|||
46969132|NCT02174848|83211940|FG001|Overall Study|Withdrawal by Subject|3|||
46969133|NCT02174848|83211939|FG000|Overall Study|Lost to Follow-up|0|||
46969134|NCT02174848|83211940|FG001|Overall Study|Lost to Follow-up|1|||
46969135|NCT02174848|83211939|FG000|Overall Study|Worsening of disease|1|||
46969136|NCT02174848|83211940|FG001|Overall Study|Worsening of disease|1|||
46969137|NCT02174848|83211939|FG000|Overall Study|Unable to comply with study requirements|1|||
46969138|NCT02174848|83211940|FG001|Overall Study|Unable to comply with study requirements|0|||
46969139|NCT02151058|83211954|FG000|Overall Study|Withdrawal by Subject|1|||
46969140|NCT02151058|83211955|FG001|Overall Study|Withdrawal by Subject|1|||
46969141|NCT02151058|83211956|FG002|Overall Study|Withdrawal by Subject|3|||
46969142|NCT02151058|83211954|FG000|Overall Study|Lost to Follow-up|1|||
46969143|NCT02151058|83211955|FG001|Overall Study|Lost to Follow-up|0|||
46969144|NCT02151058|83211956|FG002|Overall Study|Lost to Follow-up|2|||
46969145|NCT02149810|83211966|FG000|Overall Study|Physician Decision|1|||
46969146|NCT02149810|83211967|FG001|Overall Study|Physician Decision|2|||
46969147|NCT02149810|83211966|FG000|Overall Study|Lost to Follow-up|2|||
46969148|NCT02149810|83211967|FG001|Overall Study|Lost to Follow-up|1|||
46969149|NCT02149810|83211966|FG000|Overall Study|Withdrawal by Subject|5|||
46969150|NCT02149810|83211967|FG001|Overall Study|Withdrawal by Subject|1|||
46969151|NCT02149420|83211976|FG000|Core Study|Administrative problems|0|||
46969152|NCT02149420|83211977|FG001|Core Study|Administrative problems|1|||
46969153|NCT02149420|83211978|FG002|Core Study|Administrative problems|2|||
46777607|NCT00440557|82995755|FG000|Overall Study|Principal Investigator's office closed|3|||
46777608|NCT00440557|82995756|FG001|Overall Study|Principal Investigator's office closed|6|||
46777609|NCT00440557|82995757|FG002|Overall Study|Principal Investigator's office closed|4|||
46777610|NCT00440557|82995755|FG000|Overall Study|Patient transferred to nursing home|0|||
46777611|NCT00440557|82995756|FG001|Overall Study|Patient transferred to nursing home|1|||
46777612|NCT00440557|82995757|FG002|Overall Study|Patient transferred to nursing home|0|||
46777613|NCT00440557|82995755|FG000|Overall Study|Patient had surgery|1|||
46777614|NCT00440557|82995756|FG001|Overall Study|Patient had surgery|0|||
46777615|NCT00440557|82995757|FG002|Overall Study|Patient had surgery|0|||
46777616|NCT00582608|82995817|FG000|Overall Study|Not Treated|7|||
46777617|NCT00582608|82995817|FG000|Overall Study|Patient Ineligible|1|||
46848593|NCT00092534|83065412|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
46848594|NCT00092534|83065413|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
46848595|NCT00092534|83065409|FG000|Base Study EXT|Lost to Follow-up|0|||
46848596|NCT00092534|83065410|FG001|Base Study EXT|Lost to Follow-up|0|||
46848597|NCT00092534|83065411|FG002|Base Study EXT|Lost to Follow-up|41|||
46848598|NCT00092534|83065412|FG003|Base Study EXT|Lost to Follow-up|0|||
46848599|NCT00092534|83065413|FG004|Base Study EXT|Lost to Follow-up|0|||
46969154|NCT02149420|83211976|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
46969155|NCT02149420|83211977|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
46969156|NCT02149420|83211978|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
46969157|NCT02149264|83211991|FG000|Overall Study|Withdrawal by Subject|9|||
46969158|NCT02149264|83211991|FG000|Overall Study|Adverse Event|7|||
46969159|NCT02149264|83211991|FG000|Overall Study|Physician Decision|3|||
46969160|NCT02149264|83211991|FG000|Overall Study|Protocol Violation|1|||
46969161|NCT02115256|83211997|FG000|Overall Study|Withdrawal by Subject|0|||
46848600|NCT00092534|83065409|FG000|Base Study EXT|Physician Decision|0|||
46777618|NCT00582608|82995817|FG000|Overall Study|Lack of accrual|4|||
46848601|NCT00092534|83065410|FG001|Base Study EXT|Physician Decision|0|||
46848602|NCT00092534|83065411|FG002|Base Study EXT|Physician Decision|1|||
46848603|NCT00092534|83065412|FG003|Base Study EXT|Physician Decision|0|||
46848604|NCT00092534|83065413|FG004|Base Study EXT|Physician Decision|0|||
46848605|NCT00092534|83065409|FG000|Base Study EXT|Pregnancy|0|||
46848606|NCT00092534|83065410|FG001|Base Study EXT|Pregnancy|0|||
46848607|NCT00092534|83065411|FG002|Base Study EXT|Pregnancy|12|||
46848608|NCT00092534|83065412|FG003|Base Study EXT|Pregnancy|0|||
46848609|NCT00092534|83065413|FG004|Base Study EXT|Pregnancy|0|||
46848610|NCT00092534|83065409|FG000|Base Study EXT|Withdrawal by Subject|0|||
46848611|NCT00092534|83065410|FG001|Base Study EXT|Withdrawal by Subject|0|||
46848612|NCT00092534|83065411|FG002|Base Study EXT|Withdrawal by Subject|18|||
46969162|NCT02115256|83211998|FG001|Overall Study|Withdrawal by Subject|1|||
46642236|NCT02407236|82832247|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642237|NCT02407236|82832248|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642238|NCT02407236|82832249|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642239|NCT02407236|82832250|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642240|NCT02407236|82832251|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642241|NCT02407236|82832252|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642242|NCT02407236|82832253|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642243|NCT02407236|82832254|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
46642244|NCT02407236|82832242|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
46642245|NCT02407236|82832243|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
46642246|NCT02407236|82832244|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
46642247|NCT02407236|82832245|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
46642248|NCT02407236|82832246|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
46642249|NCT02407236|82832247|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
46642250|NCT02407236|82832248|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
46642251|NCT02407236|82832249|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
46642252|NCT02407236|82832250|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
46642253|NCT02407236|82832251|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
46777619|NCT03014570|82995823|FG000|Overall Study|COVID-19 Restrictions|38|||
46777620|NCT03014570|82995824|FG001|Overall Study|COVID-19 Restrictions|24|||
46777621|NCT03014570|82995823|FG000|Overall Study|Death|70|||
46777622|NCT03014570|82995824|FG001|Overall Study|Death|79|||
46777623|NCT03014570|82995823|FG000|Overall Study|Transfer from facility|11|||
46777624|NCT03014570|82995824|FG001|Overall Study|Transfer from facility|14|||
46777625|NCT03014570|82995823|FG000|Overall Study|Hospitalized|5|||
46777626|NCT03014570|82995824|FG001|Overall Study|Hospitalized|3|||
46969163|NCT02173054|83212007|FG000|Overall Study|lack of compliance|1|||
46969164|NCT02173054|83212008|FG001|Overall Study|lack of compliance|0|||
46969165|NCT02173054|83212009|FG002|Overall Study|lack of compliance|0|||
46777627|NCT03014570|82995823|FG000|Overall Study|Transfer within facility|1|||
46777628|NCT03014570|82995824|FG001|Overall Study|Transfer within facility|0|||
46969166|NCT02173054|83212007|FG000|Overall Study|Withdrawal by Subject|0|||
46848613|NCT00092534|83065412|FG003|Base Study EXT|Withdrawal by Subject|0|||
47073727|NCT01360554|83363870|FG000|Overall Study|Withdrawal by Subject|23|||
47073728|NCT01360554|83363871|FG001|Overall Study|Withdrawal by Subject|24|||
47073729|NCT01360554|83363870|FG000|Overall Study|Study terminated by sponsor|49|||
47073730|NCT01360554|83363871|FG001|Overall Study|Study terminated by sponsor|37|||
47073731|NCT01360554|83363870|FG000|Overall Study|Other, not specified|1|||
47073732|NCT01360554|83363871|FG001|Overall Study|Other, not specified|0|||
47073733|NCT01360554|83363870|FG000|Overall Study|Randomized but not treated.|3|||
47073734|NCT01360554|83363871|FG001|Overall Study|Randomized but not treated.|3|||
47073735|NCT01360398|83363893|FG000|Overall Study|Withdrawal by Subject|14|||
47073736|NCT01360398|83363893|FG000|Overall Study|Other|7|||
47073737|NCT01360398|83363893|FG000|Overall Study|Migrated/moved from study area|1|||
47073738|NCT02626026|83363903|FG000|Overall Study|Randomized but Never Treated|0|||
47073739|NCT02626026|83363904|FG001|Overall Study|Randomized but Never Treated|0|||
47073740|NCT02626026|83363905|FG002|Overall Study|Randomized but Never Treated|0|||
47073741|NCT02626026|83363906|FG003|Overall Study|Randomized but Never Treated|0|||
47073742|NCT02626026|83363907|FG004|Overall Study|Randomized but Never Treated|1|||
47073743|NCT02626026|83363908|FG005|Overall Study|Randomized but Never Treated|0|||
47073744|NCT01765296|83364168|FG000|Overall Study|Protocol Violation|0|||
47073745|NCT01765296|83364169|FG001|Overall Study|Protocol Violation|5|||
47073746|NCT01765296|83364170|FG002|Overall Study|Protocol Violation|4|||
47073747|NCT01765296|83364168|FG000|Overall Study|Withdrawal by Subject|4|||
47073748|NCT01765296|83364169|FG001|Overall Study|Withdrawal by Subject|2|||
47073749|NCT01765296|83364170|FG002|Overall Study|Withdrawal by Subject|2|||
47073750|NCT01765296|83364168|FG000|Overall Study|Adverse Event|1|||
47073751|NCT01765296|83364169|FG001|Overall Study|Adverse Event|13|||
47073752|NCT01765296|83364170|FG002|Overall Study|Adverse Event|5|||
47073753|NCT01765296|83364168|FG000|Overall Study|Lack of Efficacy|0|||
47073754|NCT01765296|83364169|FG001|Overall Study|Lack of Efficacy|0|||
47073755|NCT01765296|83364170|FG002|Overall Study|Lack of Efficacy|2|||
47073756|NCT02089685|83364244|FG000|Overall Study|Adverse Event|1|||
47073757|NCT02089685|83364245|FG001|Overall Study|Adverse Event|0|||
47073758|NCT02089685|83364246|FG002|Overall Study|Adverse Event|0|||
47073759|NCT02089685|83364247|FG003|Overall Study|Adverse Event|0|||
47073760|NCT02089685|83364248|FG004|Overall Study|Adverse Event|1|||
47073761|NCT02089685|83364249|FG005|Overall Study|Adverse Event|0|||
47073762|NCT02089685|83364244|FG000|Overall Study|Clinical Progression|4|||
47073763|NCT02089685|83364245|FG001|Overall Study|Clinical Progression|0|||
47073764|NCT02089685|83364246|FG002|Overall Study|Clinical Progression|0|||
47073765|NCT02089685|83364247|FG003|Overall Study|Clinical Progression|5|||
47073766|NCT02089685|83364248|FG004|Overall Study|Clinical Progression|1|||
47073767|NCT02089685|83364249|FG005|Overall Study|Clinical Progression|2|||
47073768|NCT02089685|83364244|FG000|Overall Study|Excluded Medication|1|||
47073769|NCT02089685|83364245|FG001|Overall Study|Excluded Medication|0|||
47073770|NCT02089685|83364246|FG002|Overall Study|Excluded Medication|0|||
47073771|NCT02089685|83364247|FG003|Overall Study|Excluded Medication|11|||
47073772|NCT02089685|83364248|FG004|Overall Study|Excluded Medication|2|||
47073773|NCT02089685|83364249|FG005|Overall Study|Excluded Medication|1|||
46777629|NCT03014570|82995823|FG000|Overall Study|Site refusal|0|||
46777630|NCT03014570|82995824|FG001|Overall Study|Site refusal|11|||
46777631|NCT00427999|82995831|FG000|Overall Study|Adverse Event|6|||
46777632|NCT00427999|82995831|FG000|Overall Study|Abnormal laboratory values|1|||
47073774|NCT02089685|83364244|FG000|Overall Study|Progressive disease|13|||
47073775|NCT02089685|83364245|FG001|Overall Study|Progressive disease|10|||
47073776|NCT02089685|83364246|FG002|Overall Study|Progressive disease|3|||
47073777|NCT02089685|83364247|FG003|Overall Study|Progressive disease|51|||
47073778|NCT02089685|83364248|FG004|Overall Study|Progressive disease|17|||
47073779|NCT02089685|83364249|FG005|Overall Study|Progressive disease|12|||
47073780|NCT02089685|83364244|FG000|Overall Study|Follow up ended by sponsor|2|||
47073781|NCT02089685|83364245|FG001|Overall Study|Follow up ended by sponsor|2|||
47073782|NCT02089685|83364246|FG002|Overall Study|Follow up ended by sponsor|0|||
47073783|NCT02089685|83364247|FG003|Overall Study|Follow up ended by sponsor|70|||
47073784|NCT02089685|83364248|FG004|Overall Study|Follow up ended by sponsor|26|||
46848614|NCT00092534|83065413|FG004|Base Study EXT|Withdrawal by Subject|0|||
47073785|NCT02089685|83364249|FG005|Overall Study|Follow up ended by sponsor|26|||
47073786|NCT02089685|83364244|FG000|Overall Study|Withdrawal by Subject|0|||
47073787|NCT02089685|83364245|FG001|Overall Study|Withdrawal by Subject|2|||
47073788|NCT02089685|83364246|FG002|Overall Study|Withdrawal by Subject|0|||
47073789|NCT02089685|83364247|FG003|Overall Study|Withdrawal by Subject|8|||
47073790|NCT02089685|83364248|FG004|Overall Study|Withdrawal by Subject|1|||
47073791|NCT02089685|83364249|FG005|Overall Study|Withdrawal by Subject|1|||
46777633|NCT00427999|82995831|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
46777634|NCT00427999|82995831|FG000|Overall Study|Protocol Violation|2|||
46777635|NCT00427999|82995831|FG000|Overall Study|Withdrawal by Subject|9|||
46777636|NCT00427999|82995831|FG000|Overall Study|Death|1|||
46848615|NCT00092534|83065409|FG000|Base Study EXT|Participant moved|0|||
46848616|NCT00092534|83065410|FG001|Base Study EXT|Participant moved|0|||
46848617|NCT00092534|83065411|FG002|Base Study EXT|Participant moved|6|||
46848618|NCT00092534|83065412|FG003|Base Study EXT|Participant moved|0|||
46642254|NCT02407236|82832252|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
46642255|NCT02407236|82832253|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
46848619|NCT00092534|83065413|FG004|Base Study EXT|Participant moved|0|||
46848620|NCT00092534|83065409|FG000|Base Study EXT|Travel|0|||
46848621|NCT00092534|83065410|FG001|Base Study EXT|Travel|0|||
46848622|NCT00092534|83065411|FG002|Base Study EXT|Travel|2|||
46848623|NCT00092534|83065412|FG003|Base Study EXT|Travel|0|||
46848624|NCT00092534|83065413|FG004|Base Study EXT|Travel|0|||
46848625|NCT00092534|83065409|FG000|Base Study EXT|Site closed|0|||
46848626|NCT00092534|83065410|FG001|Base Study EXT|Site closed|0|||
46848627|NCT00092534|83065411|FG002|Base Study EXT|Site closed|21|||
46848628|NCT00092534|83065412|FG003|Base Study EXT|Site closed|0|||
47073792|NCT02089685|83364244|FG000|Overall Study|Status not recorded|1|||
47073793|NCT02089685|83364245|FG001|Overall Study|Status not recorded|0|||
47073794|NCT02089685|83364246|FG002|Overall Study|Status not recorded|0|||
47073795|NCT02089685|83364247|FG003|Overall Study|Status not recorded|0|||
46777637|NCT00661713|82995844|FG000|Overall Study|Death|1|||
46777638|NCT00661713|82995845|FG001|Overall Study|Death|0|||
46777639|NCT00661713|82995846|FG002|Overall Study|Death|0|||
46777640|NCT00661713|82995847|FG003|Overall Study|Death|0|||
46777641|NCT00661713|82995848|FG004|Overall Study|Death|1|||
46777642|NCT00661713|82995849|FG005|Overall Study|Death|0|||
46777643|NCT00661713|82995850|FG006|Overall Study|Death|0|||
46777644|NCT00661713|82995851|FG007|Overall Study|Death|0|||
46777645|NCT00661713|82995844|FG000|Overall Study|Unable to Classify|1|||
46777646|NCT00661713|82995845|FG001|Overall Study|Unable to Classify|0|||
46777647|NCT00661713|82995846|FG002|Overall Study|Unable to Classify|0|||
46777648|NCT00661713|82995847|FG003|Overall Study|Unable to Classify|0|||
46777649|NCT00661713|82995848|FG004|Overall Study|Unable to Classify|0|||
46777650|NCT00661713|82995849|FG005|Overall Study|Unable to Classify|0|||
46777651|NCT00661713|82995850|FG006|Overall Study|Unable to Classify|0|||
46777652|NCT00661713|82995851|FG007|Overall Study|Unable to Classify|0|||
46777653|NCT00661713|82995844|FG000|Overall Study|Protocol Violation|1|||
46777654|NCT00661713|82995845|FG001|Overall Study|Protocol Violation|6|||
46777655|NCT00661713|82995846|FG002|Overall Study|Protocol Violation|3|||
46777656|NCT00661713|82995847|FG003|Overall Study|Protocol Violation|3|||
46777657|NCT00661713|82995848|FG004|Overall Study|Protocol Violation|0|||
46777658|NCT00661713|82995849|FG005|Overall Study|Protocol Violation|2|||
46777659|NCT00661713|82995850|FG006|Overall Study|Protocol Violation|2|||
46777660|NCT00661713|82995851|FG007|Overall Study|Protocol Violation|1|||
46777661|NCT00661713|82995844|FG000|Overall Study|Withdrawal by Subject|11|||
46777662|NCT00661713|82995845|FG001|Overall Study|Withdrawal by Subject|25|||
46777663|NCT00661713|82995846|FG002|Overall Study|Withdrawal by Subject|12|||
46777664|NCT00661713|82995847|FG003|Overall Study|Withdrawal by Subject|21|||
46777665|NCT00661713|82995848|FG004|Overall Study|Withdrawal by Subject|12|||
46777666|NCT00661713|82995849|FG005|Overall Study|Withdrawal by Subject|26|||
46777667|NCT00661713|82995850|FG006|Overall Study|Withdrawal by Subject|45|||
46777668|NCT00661713|82995851|FG007|Overall Study|Withdrawal by Subject|9|||
46777669|NCT00661713|82995844|FG000|Overall Study|Lost to Follow-up|2|||
46777670|NCT00661713|82995845|FG001|Overall Study|Lost to Follow-up|7|||
46777671|NCT00661713|82995846|FG002|Overall Study|Lost to Follow-up|2|||
46777672|NCT00661713|82995847|FG003|Overall Study|Lost to Follow-up|2|||
46777673|NCT00661713|82995848|FG004|Overall Study|Lost to Follow-up|5|||
46777674|NCT00661713|82995849|FG005|Overall Study|Lost to Follow-up|7|||
46777675|NCT00661713|82995850|FG006|Overall Study|Lost to Follow-up|14|||
46777676|NCT00661713|82995851|FG007|Overall Study|Lost to Follow-up|1|||
47073796|NCT02089685|83364248|FG004|Overall Study|Status not recorded|1|||
47073797|NCT02089685|83364249|FG005|Overall Study|Status not recorded|0|||
47073798|NCT02089685|83364244|FG000|Overall Study|Death|0|||
47073799|NCT02089685|83364245|FG001|Overall Study|Death|0|||
47073800|NCT02089685|83364246|FG002|Overall Study|Death|0|||
47073801|NCT02089685|83364247|FG003|Overall Study|Death|7|||
47073802|NCT02089685|83364248|FG004|Overall Study|Death|2|||
47073803|NCT02089685|83364249|FG005|Overall Study|Death|5|||
47073804|NCT02089685|83364244|FG000|Overall Study|Lost to Follow-up|0|||
47073805|NCT02089685|83364245|FG001|Overall Study|Lost to Follow-up|0|||
47073806|NCT02089685|83364246|FG002|Overall Study|Lost to Follow-up|0|||
47073807|NCT02089685|83364247|FG003|Overall Study|Lost to Follow-up|1|||
47073808|NCT02089685|83364248|FG004|Overall Study|Lost to Follow-up|0|||
47073809|NCT02089685|83364249|FG005|Overall Study|Lost to Follow-up|0|||
47073810|NCT02089685|83364244|FG000|Overall Study|Physician Decision|0|||
47073811|NCT02089685|83364245|FG001|Overall Study|Physician Decision|0|||
46777677|NCT00661713|82995844|FG000|Overall Study|Administrative Reason|0|||
46777678|NCT00661713|82995845|FG001|Overall Study|Administrative Reason|1|||
46777679|NCT00661713|82995846|FG002|Overall Study|Administrative Reason|0|||
46777680|NCT00661713|82995847|FG003|Overall Study|Administrative Reason|2|||
46777681|NCT00661713|82995848|FG004|Overall Study|Administrative Reason|2|||
46777682|NCT00661713|82995849|FG005|Overall Study|Administrative Reason|2|||
47073812|NCT02089685|83364246|FG002|Overall Study|Physician Decision|0|||
46777683|NCT00661713|82995850|FG006|Overall Study|Administrative Reason|1|||
46777684|NCT00661713|82995851|FG007|Overall Study|Administrative Reason|0|||
46777685|NCT00661713|82995844|FG000|Overall Study|Adverse Event|0|||
46777686|NCT00661713|82995845|FG001|Overall Study|Adverse Event|0|||
46777687|NCT00661713|82995846|FG002|Overall Study|Adverse Event|0|||
46777688|NCT00661713|82995847|FG003|Overall Study|Adverse Event|0|||
46777689|NCT00661713|82995848|FG004|Overall Study|Adverse Event|0|||
46777690|NCT00661713|82995849|FG005|Overall Study|Adverse Event|0|||
46777691|NCT00661713|82995850|FG006|Overall Study|Adverse Event|1|||
46777692|NCT00661713|82995851|FG007|Overall Study|Adverse Event|0|||
47073813|NCT02089685|83364247|FG003|Overall Study|Physician Decision|0|||
47073814|NCT02089685|83364248|FG004|Overall Study|Physician Decision|0|||
47073815|NCT02089685|83364249|FG005|Overall Study|Physician Decision|4|||
47073816|NCT02089685|83364244|FG000|Overall Study|Screen failure|1|||
47073817|NCT02089685|83364245|FG001|Overall Study|Screen failure|0|||
47073818|NCT02089685|83364246|FG002|Overall Study|Screen failure|0|||
46777693|NCT00661713|82995844|FG000|Overall Study|Inappropriate Enrollment|0|||
46777694|NCT00661713|82995845|FG001|Overall Study|Inappropriate Enrollment|0|||
46777695|NCT00661713|82995846|FG002|Overall Study|Inappropriate Enrollment|0|||
46777696|NCT00661713|82995847|FG003|Overall Study|Inappropriate Enrollment|0|||
46777697|NCT00661713|82995848|FG004|Overall Study|Inappropriate Enrollment|0|||
46777698|NCT00661713|82995849|FG005|Overall Study|Inappropriate Enrollment|0|||
46777699|NCT00661713|82995850|FG006|Overall Study|Inappropriate Enrollment|1|||
46777700|NCT00661713|82995851|FG007|Overall Study|Inappropriate Enrollment|0|||
46777701|NCT03835975|82995876|FG000|Overall Study|Lost to Follow-up|1|||
46777702|NCT03835975|82995877|FG001|Overall Study|Lost to Follow-up|1|||
46777703|NCT03835975|82995878|FG002|Overall Study|Lost to Follow-up|0|||
46777704|NCT03835975|82995879|FG003|Overall Study|Lost to Follow-up|0|||
46777705|NCT03835975|82995880|FG004|Overall Study|Lost to Follow-up|0|||
46777706|NCT03835975|82995876|FG000|Overall Study|No longer met eligibility criteria|0|||
46777707|NCT03835975|82995877|FG001|Overall Study|No longer met eligibility criteria|1|||
46777708|NCT03835975|82995878|FG002|Overall Study|No longer met eligibility criteria|0|||
46777709|NCT03835975|82995879|FG003|Overall Study|No longer met eligibility criteria|0|||
46777710|NCT03835975|82995880|FG004|Overall Study|No longer met eligibility criteria|0|||
46777711|NCT03835975|82995876|FG000|Overall Study|Protocol Violation|1|||
46777712|NCT03835975|82995877|FG001|Overall Study|Protocol Violation|1|||
46777713|NCT03835975|82995878|FG002|Overall Study|Protocol Violation|2|||
46777714|NCT03835975|82995879|FG003|Overall Study|Protocol Violation|0|||
46777715|NCT03835975|82995880|FG004|Overall Study|Protocol Violation|0|||
46777716|NCT03835975|82995876|FG000|Overall Study|Withdrawal by Subject|1|||
46777717|NCT03835975|82995877|FG001|Overall Study|Withdrawal by Subject|0|||
46777718|NCT03835975|82995878|FG002|Overall Study|Withdrawal by Subject|1|||
46777719|NCT03835975|82995879|FG003|Overall Study|Withdrawal by Subject|1|||
46777720|NCT03835975|82995880|FG004|Overall Study|Withdrawal by Subject|0|||
46777721|NCT00427921|82995894|FG000|Overall Study|Adverse Event|26|||
46777722|NCT00427921|82995894|FG000|Overall Study|Withdrawal by Subject|4|||
46777723|NCT00427921|82995894|FG000|Overall Study|Lost to Follow-up|2|||
46848629|NCT00092534|83065413|FG004|Base Study EXT|Site closed|0|||
46848630|NCT00092534|83065409|FG000|Base Study EXT|Study ended|0|||
46848631|NCT00092534|83065410|FG001|Base Study EXT|Study ended|0|||
46848632|NCT00092534|83065411|FG002|Base Study EXT|Study ended|29|||
46848633|NCT00092534|83065412|FG003|Base Study EXT|Study ended|0|||
46848634|NCT00092534|83065413|FG004|Base Study EXT|Study ended|0|||
46848635|NCT00092534|83065409|FG000|Base Study EXT|Protocol Violation|0|||
46848636|NCT00092534|83065410|FG001|Base Study EXT|Protocol Violation|0|||
46848637|NCT00092534|83065411|FG002|Base Study EXT|Protocol Violation|15|||
46848638|NCT00092534|83065412|FG003|Base Study EXT|Protocol Violation|0|||
46848639|NCT00092534|83065413|FG004|Base Study EXT|Protocol Violation|0|||
46848640|NCT00092534|83065409|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
46848641|NCT00092534|83065410|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
46848642|NCT00092534|83065411|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
46848643|NCT00092534|83065412|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
46848644|NCT00092534|83065413|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
46848645|NCT00068250|83065426|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
46848646|NCT00068250|83065427|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
46848647|NCT00068250|83065428|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
46777724|NCT00427921|82995894|FG000|Overall Study|Other reason not specified|10|||
46777725|NCT00427921|82995894|FG000|Overall Study|Adverse Event + Hospitalization|1|||
46777726|NCT00427921|82995894|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
46777727|NCT00427921|82995894|FG000|Overall Study|Adverse Event + No Response|1|||
46777728|NCT00427921|82995894|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
46777729|NCT00427921|82995894|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
46777730|NCT00427921|82995894|FG000|Overall Study|Adverse Event + Lost Response|1|||
46777731|NCT00427921|82995894|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
46777732|NCT00427921|82995894|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
46777733|NCT00432991|82995900|FG000|Overall Study|Protocol Violation|7|||
46777734|NCT00432991|82995901|FG001|Overall Study|Protocol Violation|12|||
46777735|NCT00432835|82995909|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
46777736|NCT00432835|82995910|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
46777737|NCT00580970|82995918|FG000|Pre-treatment|Non-compliance|1|||
46777738|NCT00580970|82995918|FG000|Treatment (Lovastatin)|Non-compliance|6|||
46848648|NCT00068250|83065429|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
46848649|NCT00393887|83065439|FG000|Overall Study|Physician Decision|5|||
46777739|NCT00580970|82995918|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
46777740|NCT00580970|82995918|FG000|Treatment (Lovastatin)|Physician Decision|4|||
46777741|NCT00580970|82995918|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
46777742|NCT00580970|82995918|FG000|Treatment (Lovastatin)|Death|1|||
46777743|NCT00665925|82995926|FG000|Overall Study|Lack of Efficacy|10|||
46777744|NCT00665925|82995927|FG001|Overall Study|Lack of Efficacy|8|||
46848650|NCT00393887|83065440|FG001|Overall Study|Physician Decision|0|||
46848651|NCT00393887|83065439|FG000|Overall Study|Lost to Follow-up|11|||
46777745|NCT00665925|82995928|FG002|Overall Study|Lack of Efficacy|9|||
46777746|NCT00665925|82995929|FG003|Overall Study|Lack of Efficacy|8|||
46777747|NCT00665925|82995926|FG000|Overall Study|Lost to Follow-up|1|||
46777748|NCT00665925|82995927|FG001|Overall Study|Lost to Follow-up|2|||
46777749|NCT00665925|82995928|FG002|Overall Study|Lost to Follow-up|2|||
46777750|NCT00665925|82995929|FG003|Overall Study|Lost to Follow-up|2|||
46777751|NCT00665925|82995926|FG000|Overall Study|Withdrawal by Subject|2|||
46777752|NCT00665925|82995927|FG001|Overall Study|Withdrawal by Subject|2|||
46777753|NCT00665925|82995928|FG002|Overall Study|Withdrawal by Subject|3|||
46777754|NCT00665925|82995929|FG003|Overall Study|Withdrawal by Subject|2|||
46777755|NCT00665925|82995926|FG000|Overall Study|Physician Decision|0|||
46848652|NCT00393887|83065440|FG001|Overall Study|Lost to Follow-up|9|||
46848653|NCT00393029|83065448|FG000|Overall Study|Not treated|0|||
46848654|NCT00393029|83065449|FG001|Overall Study|Not treated|1|||
46848655|NCT00402233|83065460|FG000|Overall Study|Adverse Event|1|||
46848656|NCT00402233|83065461|FG001|Overall Study|Adverse Event|7|||
46848657|NCT00402233|83065462|FG002|Overall Study|Adverse Event|9|||
46848658|NCT00402233|83065463|FG003|Overall Study|Adverse Event|9|||
46848659|NCT00402233|83065460|FG000|Overall Study|Protocol Violation|0|||
46848660|NCT00402233|83065461|FG001|Overall Study|Protocol Violation|1|||
46848661|NCT00402233|83065462|FG002|Overall Study|Protocol Violation|0|||
46777756|NCT00665925|82995927|FG001|Overall Study|Physician Decision|0|||
46777757|NCT00665925|82995928|FG002|Overall Study|Physician Decision|1|||
46777758|NCT00665925|82995929|FG003|Overall Study|Physician Decision|2|||
46777759|NCT00665925|82995926|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
46777760|NCT00665925|82995927|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
46777761|NCT00665925|82995928|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
46777762|NCT00665925|82995929|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
46777763|NCT00665925|82995926|FG000|Overall Study|Adverse Event|1|||
46777764|NCT00665925|82995927|FG001|Overall Study|Adverse Event|5|||
46777765|NCT00665925|82995928|FG002|Overall Study|Adverse Event|10|||
46777766|NCT00665925|82995929|FG003|Overall Study|Adverse Event|5|||
46777767|NCT00665925|82995926|FG000|Overall Study|Enrolled by mistake|0|||
46777768|NCT00665925|82995927|FG001|Overall Study|Enrolled by mistake|0|||
46777769|NCT00665925|82995928|FG002|Overall Study|Enrolled by mistake|0|||
46777770|NCT00665925|82995929|FG003|Overall Study|Enrolled by mistake|1|||
46777771|NCT00665925|82995926|FG000|Overall Study|Due to exclusion criteria|1|||
46777772|NCT00665925|82995927|FG001|Overall Study|Due to exclusion criteria|0|||
46777773|NCT00665925|82995928|FG002|Overall Study|Due to exclusion criteria|0|||
46777774|NCT00665925|82995929|FG003|Overall Study|Due to exclusion criteria|0|||
46777775|NCT00426751|82995942|FG000|Overall Study|Adverse Event|8|||
46777776|NCT00426751|82995943|FG001|Overall Study|Adverse Event|1|||
46777777|NCT00426751|82995942|FG000|Overall Study|Lost to Follow-up|7|||
46777778|NCT00426751|82995943|FG001|Overall Study|Lost to Follow-up|6|||
46848662|NCT00402233|83065463|FG003|Overall Study|Protocol Violation|0|||
46848663|NCT00402233|83065460|FG000|Overall Study|Withdrawal by Subject|2|||
46848664|NCT00402233|83065461|FG001|Overall Study|Withdrawal by Subject|1|||
46848665|NCT00402233|83065462|FG002|Overall Study|Withdrawal by Subject|2|||
46848666|NCT00402233|83065463|FG003|Overall Study|Withdrawal by Subject|2|||
46848667|NCT00402233|83065460|FG000|Overall Study|Worsening of disease under study|2|||
46848668|NCT00402233|83065461|FG001|Overall Study|Worsening of disease under study|0|||
46848669|NCT00402233|83065462|FG002|Overall Study|Worsening of disease under study|0|||
46848670|NCT00402233|83065463|FG003|Overall Study|Worsening of disease under study|0|||
46848671|NCT00402233|83065460|FG000|Overall Study|Worsening of other pre-existing disease|0|||
46848672|NCT00402233|83065461|FG001|Overall Study|Worsening of other pre-existing disease|1|||
46848673|NCT00402233|83065462|FG002|Overall Study|Worsening of other pre-existing disease|0|||
46848674|NCT00402233|83065463|FG003|Overall Study|Worsening of other pre-existing disease|0|||
46848675|NCT00092456|83065477|FG000|Overall Study|Adverse Event|0|||
46848676|NCT00092456|83065478|FG001|Overall Study|Adverse Event|0|||
46848677|NCT00092456|83065479|FG002|Overall Study|Adverse Event|1|||
46848678|NCT00092456|83065480|FG003|Overall Study|Adverse Event|1|||
46777779|NCT00426751|82995942|FG000|Overall Study|Consent Withdrawn|0|||
46777780|NCT00426751|82995943|FG001|Overall Study|Consent Withdrawn|1|||
46777781|NCT00426751|82995942|FG000|Overall Study|Other Reasons|7|||
46777782|NCT00426751|82995943|FG001|Overall Study|Other Reasons|12|||
46848679|NCT00092456|83065477|FG000|Overall Study|Lost to Follow-up|2|||
46848680|NCT00092456|83065478|FG001|Overall Study|Lost to Follow-up|2|||
46848681|NCT00092456|83065479|FG002|Overall Study|Lost to Follow-up|1|||
46848682|NCT00092456|83065480|FG003|Overall Study|Lost to Follow-up|2|||
46848683|NCT00092456|83065477|FG000|Overall Study|Protocol Violation|5|||
46777783|NCT00440401|82995951|FG000|Overall Study|Adverse Event|2|||
46777784|NCT00440401|82995952|FG001|Overall Study|Adverse Event|1|||
46777785|NCT00440401|82995951|FG000|Overall Study|Other|2|||
46777786|NCT00440401|82995952|FG001|Overall Study|Other|5|||
46777787|NCT02598960|82995971|FG000|Treatment Period|Disease Progression|4|||
46848684|NCT00092456|83065478|FG001|Overall Study|Protocol Violation|7|||
46848685|NCT00092456|83065479|FG002|Overall Study|Protocol Violation|8|||
46848686|NCT00092456|83065480|FG003|Overall Study|Protocol Violation|6|||
46848687|NCT00092456|83065477|FG000|Overall Study|Withdrawal by Subject|13|||
46848688|NCT00092456|83065478|FG001|Overall Study|Withdrawal by Subject|5|||
46777788|NCT02598960|82995972|FG001|Treatment Period|Disease Progression|4|||
46777789|NCT02598960|82995973|FG002|Treatment Period|Disease Progression|4|||
46777790|NCT02598960|82995974|FG003|Treatment Period|Disease Progression|6|||
46777791|NCT02598960|82995975|FG004|Treatment Period|Disease Progression|8|||
46777792|NCT02598960|82995976|FG005|Treatment Period|Disease Progression|2|||
46777793|NCT02598960|82995977|FG006|Treatment Period|Disease Progression|2|||
46777794|NCT02598960|82995978|FG007|Treatment Period|Disease Progression|3|||
46777795|NCT02598960|82995979|FG008|Treatment Period|Disease Progression|7|||
46777796|NCT02598960|82995980|FG009|Treatment Period|Disease Progression|9|||
46777797|NCT02598960|82995981|FG010|Treatment Period|Disease Progression|7|||
46777798|NCT02598960|82995982|FG011|Treatment Period|Disease Progression|143|||
46777799|NCT02598960|82995983|FG012|Treatment Period|Disease Progression|23|||
46777800|NCT02598960|82995971|FG000|Treatment Period|Study drug toxicity|0|||
46777801|NCT02598960|82995972|FG001|Treatment Period|Study drug toxicity|0|||
46777802|NCT02598960|82995973|FG002|Treatment Period|Study drug toxicity|0|||
46777803|NCT02598960|82995974|FG003|Treatment Period|Study drug toxicity|0|||
46848689|NCT00092456|83065479|FG002|Overall Study|Withdrawal by Subject|16|||
46969167|NCT02173054|83212008|FG001|Overall Study|Withdrawal by Subject|0|||
46969168|NCT02173054|83212009|FG002|Overall Study|Withdrawal by Subject|1|||
46777804|NCT02598960|82995975|FG004|Treatment Period|Study drug toxicity|0|||
46777805|NCT02598960|82995976|FG005|Treatment Period|Study drug toxicity|0|||
46777806|NCT02598960|82995977|FG006|Treatment Period|Study drug toxicity|0|||
46777807|NCT02598960|82995978|FG007|Treatment Period|Study drug toxicity|0|||
46777808|NCT02598960|82995979|FG008|Treatment Period|Study drug toxicity|0|||
46777809|NCT02598960|82995980|FG009|Treatment Period|Study drug toxicity|1|||
46848690|NCT00092456|83065480|FG003|Overall Study|Withdrawal by Subject|6|||
46848691|NCT00092456|83065477|FG000|Overall Study|Moved|1|||
46848692|NCT00092456|83065478|FG001|Overall Study|Moved|1|||
46848693|NCT00092456|83065479|FG002|Overall Study|Moved|0|||
46848694|NCT00092456|83065480|FG003|Overall Study|Moved|1|||
46848695|NCT00092456|83065477|FG000|Overall Study|Other|4|||
46848696|NCT00092456|83065478|FG001|Overall Study|Other|2|||
46848697|NCT00092456|83065479|FG002|Overall Study|Other|3|||
46848698|NCT00092456|83065480|FG003|Overall Study|Other|0|||
46848699|NCT00067470|83065492|FG000|Overall Study|Withdrawal by Subject|0|||
46848700|NCT00067470|83065493|FG001|Overall Study|Withdrawal by Subject|1|||
46848701|NCT00401843|83065502|FG000|Overall Study|Achieved Complete Response|1|||
46848702|NCT00401843|83065503|FG001|Overall Study|Achieved Complete Response|5|||
46848703|NCT00401843|83065504|FG002|Overall Study|Achieved Complete Response|11|||
46848704|NCT00401843|83065502|FG000|Overall Study|Adverse Event|7|||
46848705|NCT00401843|83065503|FG001|Overall Study|Adverse Event|26|||
46848706|NCT00401843|83065504|FG002|Overall Study|Adverse Event|27|||
47073819|NCT02089685|83364247|FG003|Overall Study|Screen failure|0|||
47073820|NCT02089685|83364248|FG004|Overall Study|Screen failure|0|||
47073821|NCT02089685|83364249|FG005|Overall Study|Screen failure|0|||
47073822|NCT05282004|83364307|FG000|Overall Study|Adverse Event|2|||
47073823|NCT05004649|83364311|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
47073824|NCT05004649|83364311|FG000|Overall Study|Lost to Follow-up|1|||
47073825|NCT05004649|83364311|FG000|Overall Study|Withdrawal by Subject|2|||
47073826|NCT05004649|83364311|FG000|Overall Study|COVID-19|1|||
47073827|NCT04666298|83364321|FG000|Overall Study|Subject decision|1|||
47073828|NCT04666298|83364322|FG001|Overall Study|Subject decision|0|||
47073829|NCT04666298|83364323|FG002|Overall Study|Subject decision|0|||
47073830|NCT04666298|83364324|FG003|Overall Study|Subject decision|2|||
47073831|NCT04666298|83364321|FG000|Overall Study|Death|1|||
47073832|NCT04666298|83364322|FG001|Overall Study|Death|0|||
47073833|NCT04666298|83364323|FG002|Overall Study|Death|0|||
47073834|NCT04666298|83364324|FG003|Overall Study|Death|0|||
47073835|NCT04666298|83364321|FG000|Overall Study|Lost to Follow-up|0|||
47073836|NCT04666298|83364322|FG001|Overall Study|Lost to Follow-up|0|||
46777810|NCT02598960|82995981|FG010|Treatment Period|Study drug toxicity|0|||
46777811|NCT02598960|82995982|FG011|Treatment Period|Study drug toxicity|3|||
46777812|NCT02598960|82995983|FG012|Treatment Period|Study drug toxicity|0|||
46848707|NCT00401843|83065502|FG000|Overall Study|Death|0|||
46848708|NCT00401843|83065503|FG001|Overall Study|Death|8|||
46848709|NCT00401843|83065504|FG002|Overall Study|Death|10|||
46848710|NCT00401843|83065502|FG000|Overall Study|Disease progression|10|||
46848711|NCT00401843|83065503|FG001|Overall Study|Disease progression|60|||
47073837|NCT04666298|83364323|FG002|Overall Study|Lost to Follow-up|0|||
47073838|NCT04666298|83364324|FG003|Overall Study|Lost to Follow-up|1|||
47073839|NCT04666298|83364321|FG000|Overall Study|Physician Decision|0|||
47073840|NCT04666298|83364322|FG001|Overall Study|Physician Decision|0|||
47073841|NCT04666298|83364323|FG002|Overall Study|Physician Decision|0|||
47073842|NCT04666298|83364324|FG003|Overall Study|Physician Decision|1|||
46777813|NCT02598960|82995971|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
46777814|NCT02598960|82995972|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
46777815|NCT02598960|82995973|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
46777816|NCT02598960|82995974|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
46777817|NCT02598960|82995975|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
46777818|NCT02598960|82995976|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
46777819|NCT02598960|82995977|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
46777820|NCT02598960|82995978|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
46777821|NCT02598960|82995979|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
46777822|NCT02598960|82995980|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
46777823|NCT02598960|82995981|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
46777824|NCT02598960|82995982|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
46777825|NCT02598960|82995983|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
46777826|NCT02598960|82995971|FG000|Treatment Period|participant request to discontinue|0|||
46777827|NCT02598960|82995972|FG001|Treatment Period|participant request to discontinue|1|||
46777828|NCT02598960|82995973|FG002|Treatment Period|participant request to discontinue|0|||
46777829|NCT02598960|82995974|FG003|Treatment Period|participant request to discontinue|0|||
46777830|NCT02598960|82995975|FG004|Treatment Period|participant request to discontinue|1|||
46777831|NCT02598960|82995976|FG005|Treatment Period|participant request to discontinue|0|||
46777832|NCT02598960|82995977|FG006|Treatment Period|participant request to discontinue|0|||
46777833|NCT02598960|82995978|FG007|Treatment Period|participant request to discontinue|0|||
46777834|NCT02598960|82995979|FG008|Treatment Period|participant request to discontinue|0|||
46777835|NCT02598960|82995980|FG009|Treatment Period|participant request to discontinue|0|||
47073843|NCT04666298|83364321|FG000|Overall Study|Protocol deviation|0|||
46777836|NCT02598960|82995981|FG010|Treatment Period|participant request to discontinue|1|||
46777837|NCT02598960|82995982|FG011|Treatment Period|participant request to discontinue|4|||
46777838|NCT02598960|82995983|FG012|Treatment Period|participant request to discontinue|0|||
46777839|NCT02598960|82995971|FG000|Treatment Period|participant withdrew consent|0|||
46777840|NCT02598960|82995972|FG001|Treatment Period|participant withdrew consent|0|||
46777841|NCT02598960|82995973|FG002|Treatment Period|participant withdrew consent|0|||
46777842|NCT02598960|82995974|FG003|Treatment Period|participant withdrew consent|0|||
46777843|NCT02598960|82995975|FG004|Treatment Period|participant withdrew consent|0|||
46777844|NCT02598960|82995976|FG005|Treatment Period|participant withdrew consent|0|||
46777845|NCT02598960|82995977|FG006|Treatment Period|participant withdrew consent|0|||
46777846|NCT02598960|82995978|FG007|Treatment Period|participant withdrew consent|0|||
46777847|NCT02598960|82995979|FG008|Treatment Period|participant withdrew consent|0|||
46777848|NCT02598960|82995980|FG009|Treatment Period|participant withdrew consent|0|||
46777849|NCT02598960|82995981|FG010|Treatment Period|participant withdrew consent|0|||
46848712|NCT00401843|83065504|FG002|Overall Study|Disease progression|49|||
47073844|NCT04666298|83364322|FG001|Overall Study|Protocol deviation|0|||
47073845|NCT04666298|83364323|FG002|Overall Study|Protocol deviation|1|||
47073846|NCT04666298|83364324|FG003|Overall Study|Protocol deviation|0|||
47073847|NCT04188301|83364363|FG000|Month 3|Lost to Follow-up|0|||
47073848|NCT04188301|83364364|FG001|Month 3|Lost to Follow-up|0|||
47073849|NCT04188301|83364365|FG002|Month 3|Lost to Follow-up|1|||
46777850|NCT02598960|82995982|FG011|Treatment Period|participant withdrew consent|3|||
46777851|NCT02598960|82995983|FG012|Treatment Period|participant withdrew consent|0|||
46777852|NCT02598960|82995971|FG000|Treatment Period|No longer meets study criteria|0|||
46848713|NCT00401843|83065502|FG000|Overall Study|End of Study|1|||
46848714|NCT00401843|83065503|FG001|Overall Study|End of Study|1|||
46848715|NCT00401843|83065504|FG002|Overall Study|End of Study|2|||
46848716|NCT00401843|83065502|FG000|Overall Study|Lost to Follow-up|0|||
46848717|NCT00401843|83065503|FG001|Overall Study|Lost to Follow-up|0|||
46848718|NCT00401843|83065504|FG002|Overall Study|Lost to Follow-up|2|||
46848719|NCT00401843|83065502|FG000|Overall Study|Other Unspecified|0|||
46848720|NCT00401843|83065503|FG001|Overall Study|Other Unspecified|3|||
46848721|NCT00401843|83065504|FG002|Overall Study|Other Unspecified|5|||
46848722|NCT00401843|83065502|FG000|Overall Study|Physician Decision|0|||
47073850|NCT04188301|83364363|FG000|Month 12|Lost to Follow-up|0|||
46848723|NCT00401843|83065503|FG001|Overall Study|Physician Decision|16|||
46848724|NCT00401843|83065504|FG002|Overall Study|Physician Decision|10|||
46848725|NCT00401843|83065502|FG000|Overall Study|Protocol Violation|0|||
46848726|NCT00401843|83065503|FG001|Overall Study|Protocol Violation|0|||
46848727|NCT00401843|83065504|FG002|Overall Study|Protocol Violation|1|||
47073851|NCT04188301|83364364|FG001|Month 12|Lost to Follow-up|0|||
46777853|NCT02598960|82995972|FG001|Treatment Period|No longer meets study criteria|0|||
46777854|NCT02598960|82995973|FG002|Treatment Period|No longer meets study criteria|0|||
46777855|NCT02598960|82995974|FG003|Treatment Period|No longer meets study criteria|0|||
46777856|NCT02598960|82995975|FG004|Treatment Period|No longer meets study criteria|0|||
46777857|NCT02598960|82995976|FG005|Treatment Period|No longer meets study criteria|0|||
46777858|NCT02598960|82995977|FG006|Treatment Period|No longer meets study criteria|0|||
46777859|NCT02598960|82995978|FG007|Treatment Period|No longer meets study criteria|0|||
46777860|NCT02598960|82995979|FG008|Treatment Period|No longer meets study criteria|0|||
46777861|NCT02598960|82995980|FG009|Treatment Period|No longer meets study criteria|0|||
46777862|NCT02598960|82995981|FG010|Treatment Period|No longer meets study criteria|0|||
46777863|NCT02598960|82995982|FG011|Treatment Period|No longer meets study criteria|1|||
46777864|NCT02598960|82995983|FG012|Treatment Period|No longer meets study criteria|0|||
46777865|NCT02598960|82995971|FG000|Treatment Period|Other Reasons|0|||
46777866|NCT02598960|82995972|FG001|Treatment Period|Other Reasons|0|||
46777867|NCT02598960|82995973|FG002|Treatment Period|Other Reasons|0|||
46777868|NCT02598960|82995974|FG003|Treatment Period|Other Reasons|0|||
46777869|NCT02598960|82995975|FG004|Treatment Period|Other Reasons|0|||
46777870|NCT02598960|82995976|FG005|Treatment Period|Other Reasons|0|||
46777871|NCT02598960|82995977|FG006|Treatment Period|Other Reasons|0|||
46777872|NCT02598960|82995978|FG007|Treatment Period|Other Reasons|0|||
46848728|NCT00401843|83065502|FG000|Overall Study|Withdrawal by Subject|1|||
46848729|NCT00401843|83065503|FG001|Overall Study|Withdrawal by Subject|5|||
46848730|NCT00401843|83065504|FG002|Overall Study|Withdrawal by Subject|5|||
46848731|NCT00401843|83065502|FG000|Overall Study|Withdrawal of consent to study agent|1|||
46848732|NCT00401843|83065503|FG001|Overall Study|Withdrawal of consent to study agent|15|||
46848733|NCT00401843|83065504|FG002|Overall Study|Withdrawal of consent to study agent|17|||
46848734|NCT00401843|83065502|FG000|Overall Study|Randomized but not Treated|0|||
46848735|NCT00401843|83065503|FG001|Overall Study|Randomized but not Treated|2|||
46848736|NCT00401843|83065504|FG002|Overall Study|Randomized but not Treated|3|||
46848737|NCT00401843|83065502|FG000|Overall Study|Received incorrect treatment|0|||
46848738|NCT00401843|83065503|FG001|Overall Study|Received incorrect treatment|3|||
46848739|NCT00401843|83065504|FG002|Overall Study|Received incorrect treatment|0|||
46848740|NCT00401531|83065516|FG000|Overall Study|Adverse Event|2|||
46848741|NCT00401531|83065517|FG001|Overall Study|Adverse Event|0|||
46848742|NCT00401531|83065516|FG000|Overall Study|Protocol Violation|3|||
46848743|NCT00401531|83065517|FG001|Overall Study|Protocol Violation|7|||
46848744|NCT00401531|83065516|FG000|Overall Study|Lost to Follow-up|1|||
46848745|NCT00401531|83065517|FG001|Overall Study|Lost to Follow-up|1|||
46848746|NCT00401531|83065516|FG000|Overall Study|Withdrawal by Subject|3|||
46848747|NCT00401531|83065517|FG001|Overall Study|Withdrawal by Subject|2|||
46848748|NCT00401375|83065526|FG000|Overall Study|Protocol Violation|2|||
46848749|NCT00401375|83065527|FG001|Overall Study|Protocol Violation|2|||
46848750|NCT00401375|83065528|FG002|Overall Study|Protocol Violation|1|||
46848751|NCT00401375|83065526|FG000|Overall Study|Adverse Event|6|||
46848752|NCT00401375|83065527|FG001|Overall Study|Adverse Event|11|||
46848753|NCT00401375|83065528|FG002|Overall Study|Adverse Event|10|||
46848754|NCT00401375|83065526|FG000|Overall Study|Withdrawal by Subject|9|||
46848755|NCT00401375|83065527|FG001|Overall Study|Withdrawal by Subject|7|||
46848756|NCT00401375|83065528|FG002|Overall Study|Withdrawal by Subject|7|||
46848757|NCT00401375|83065526|FG000|Overall Study|Lost to Follow-up|0|||
46848758|NCT00401375|83065527|FG001|Overall Study|Lost to Follow-up|1|||
46848759|NCT00401375|83065528|FG002|Overall Study|Lost to Follow-up|1|||
46777873|NCT02598960|82995979|FG008|Treatment Period|Other Reasons|0|||
46848760|NCT00401375|83065526|FG000|Overall Study|Other than specified|2|||
46848761|NCT00401375|83065527|FG001|Overall Study|Other than specified|1|||
46969169|NCT02149108|83212054|FG000|Overall Study|Not treated|1|||
46969170|NCT02149108|83212055|FG001|Overall Study|Not treated|2|||
46777874|NCT02598960|82995980|FG009|Treatment Period|Other Reasons|0|||
46777875|NCT02598960|82995981|FG010|Treatment Period|Other Reasons|0|||
46777876|NCT02598960|82995982|FG011|Treatment Period|Other Reasons|0|||
46777877|NCT02598960|82995983|FG012|Treatment Period|Other Reasons|1|||
46848762|NCT00401375|83065528|FG002|Overall Study|Other than specified|3|||
46848763|NCT00401375|83065526|FG000|Overall Study|Randomized but not treated|3|||
46969171|NCT02149108|83212054|FG000|Overall Study|Progressive Disease (PD)|324|||
46848764|NCT00401375|83065527|FG001|Overall Study|Randomized but not treated|3|||
46848765|NCT00401375|83065528|FG002|Overall Study|Randomized but not treated|3|||
46848766|NCT00400985|83065536|FG000|Overall Study|Withdrawal by Subject|5|||
46848767|NCT00400985|83065536|FG000|Overall Study|system modification|8|||
46848768|NCT00400985|83065536|FG000|Overall Study|Death|30|||
46848769|NCT00400985|83065536|FG000|Overall Study|Lost to Follow-up|9|||
46848770|NCT00400517|83065540|FG000|Overall Study|Withdrawal by Subject|1|||
46848771|NCT00400517|83065540|FG000|Overall Study|Physician Decision|1|||
46848772|NCT00392171|83065544|FG000|Overall Study|Did not meet inclusion criteria|4|||
46848773|NCT00392171|83065544|FG000|Overall Study|Disease progression|101|||
46848774|NCT00391625|83065548|FG000|Month 14|Withdrawal by Subject|1|||
46848775|NCT00391625|83065548|FG000|Month 50|Physician Decision|1|||
47073852|NCT04188301|83364365|FG002|Month 12|Lost to Follow-up|2|||
46848776|NCT00091832|83065581|FG000|Overall Study|Physician Decision|1|||
46848777|NCT00091832|83065582|FG001|Overall Study|Physician Decision|0|||
46848778|NCT00091832|83065583|FG002|Overall Study|Physician Decision|0|||
46848779|NCT00091832|83065584|FG003|Overall Study|Physician Decision|0|||
46848780|NCT00091832|83065585|FG004|Overall Study|Physician Decision|0|||
46848781|NCT00091832|83065586|FG005|Overall Study|Physician Decision|0|||
46848782|NCT00091832|83065581|FG000|Overall Study|Adverse Event|0|||
46848783|NCT00091832|83065582|FG001|Overall Study|Adverse Event|0|||
46848784|NCT00091832|83065583|FG002|Overall Study|Adverse Event|0|||
46848785|NCT00091832|83065584|FG003|Overall Study|Adverse Event|1|||
46848786|NCT00091832|83065585|FG004|Overall Study|Adverse Event|3|||
46848787|NCT00091832|83065586|FG005|Overall Study|Adverse Event|0|||
46848788|NCT00091832|83065581|FG000|Overall Study|Withdrawal by Subject|4|||
46848789|NCT00091832|83065582|FG001|Overall Study|Withdrawal by Subject|5|||
46848790|NCT00091832|83065583|FG002|Overall Study|Withdrawal by Subject|0|||
46848791|NCT00091832|83065584|FG003|Overall Study|Withdrawal by Subject|1|||
46848792|NCT00091832|83065585|FG004|Overall Study|Withdrawal by Subject|3|||
46848793|NCT00091832|83065586|FG005|Overall Study|Withdrawal by Subject|1|||
46848794|NCT00091832|83065581|FG000|Overall Study|Death|6|||
46848795|NCT00091832|83065582|FG001|Overall Study|Death|4|||
46848796|NCT00091832|83065583|FG002|Overall Study|Death|5|||
46848797|NCT00091832|83065584|FG003|Overall Study|Death|8|||
46848798|NCT00091832|83065585|FG004|Overall Study|Death|5|||
46848799|NCT00091832|83065586|FG005|Overall Study|Death|6|||
46848800|NCT00091832|83065581|FG000|Overall Study|Disease Progression|2|||
46848801|NCT00091832|83065582|FG001|Overall Study|Disease Progression|0|||
46848802|NCT00091832|83065583|FG002|Overall Study|Disease Progression|0|||
46848803|NCT00091832|83065584|FG003|Overall Study|Disease Progression|1|||
46848804|NCT00091832|83065585|FG004|Overall Study|Disease Progression|1|||
46848805|NCT00091832|83065586|FG005|Overall Study|Disease Progression|2|||
46848806|NCT00091832|83065581|FG000|Overall Study|Ineligibility Determined|0|||
46848807|NCT00091832|83065582|FG001|Overall Study|Ineligibility Determined|0|||
46848808|NCT00091832|83065583|FG002|Overall Study|Ineligibility Determined|1|||
46848809|NCT00091832|83065584|FG003|Overall Study|Ineligibility Determined|0|||
46848810|NCT00091832|83065585|FG004|Overall Study|Ineligibility Determined|1|||
46848811|NCT00091832|83065586|FG005|Overall Study|Ineligibility Determined|0|||
46848812|NCT00091832|83065581|FG000|Overall Study|Lost to Follow-up|1|||
46848813|NCT00091832|83065582|FG001|Overall Study|Lost to Follow-up|0|||
46848814|NCT00091832|83065583|FG002|Overall Study|Lost to Follow-up|3|||
46848815|NCT00091832|83065584|FG003|Overall Study|Lost to Follow-up|3|||
46848816|NCT00091832|83065585|FG004|Overall Study|Lost to Follow-up|2|||
46848817|NCT00091832|83065586|FG005|Overall Study|Lost to Follow-up|1|||
46848818|NCT00091832|83065581|FG000|Overall Study|Noncompliance|0|||
46848819|NCT00091832|83065582|FG001|Overall Study|Noncompliance|1|||
46848820|NCT00091832|83065583|FG002|Overall Study|Noncompliance|0|||
46848821|NCT00091832|83065584|FG003|Overall Study|Noncompliance|0|||
46848822|NCT00091832|83065585|FG004|Overall Study|Noncompliance|0|||
46848823|NCT00091832|83065586|FG005|Overall Study|Noncompliance|0|||
46848824|NCT00091832|83065581|FG000|Overall Study|Other|0|||
46848825|NCT00091832|83065582|FG001|Overall Study|Other|1|||
46848826|NCT00091832|83065583|FG002|Overall Study|Other|2|||
46848827|NCT00091832|83065584|FG003|Overall Study|Other|0|||
46848828|NCT00091832|83065585|FG004|Overall Study|Other|0|||
46848829|NCT00091832|83065586|FG005|Overall Study|Other|0|||
46848830|NCT00091832|83065581|FG000|Overall Study|Protocol Violation|0|||
46848831|NCT00091832|83065582|FG001|Overall Study|Protocol Violation|0|||
46848832|NCT00091832|83065583|FG002|Overall Study|Protocol Violation|1|||
46969172|NCT02149108|83212055|FG001|Overall Study|Progressive Disease (PD)|318|||
46969173|NCT02149108|83212054|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
46969174|NCT02149108|83212055|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
46969175|NCT02149108|83212054|FG000|Overall Study|Other Adverse Event (AE)|8|||
46969176|NCT02149108|83212055|FG001|Overall Study|Other Adverse Event (AE)|18|||
46848833|NCT00091832|83065584|FG003|Overall Study|Protocol Violation|0|||
46848834|NCT00091832|83065585|FG004|Overall Study|Protocol Violation|0|||
46848835|NCT00091832|83065586|FG005|Overall Study|Protocol Violation|1|||
46969177|NCT02149108|83212054|FG000|Overall Study|Other not defined above|0|||
46969178|NCT02149108|83212055|FG001|Overall Study|Other not defined above|2|||
46848836|NCT00391391|83065604|FG000|Overall Study|Adverse Event|0|||
46848837|NCT00391391|83065605|FG001|Overall Study|Adverse Event|0|||
46848838|NCT00391391|83065606|FG002|Overall Study|Adverse Event|0|||
46848839|NCT00391391|83065607|FG003|Overall Study|Adverse Event|1|||
46848840|NCT00391391|83065604|FG000|Overall Study|Lost to Follow-up|1|||
46848841|NCT00391391|83065605|FG001|Overall Study|Lost to Follow-up|3|||
46848842|NCT00391391|83065606|FG002|Overall Study|Lost to Follow-up|7|||
46848843|NCT00391391|83065607|FG003|Overall Study|Lost to Follow-up|4|||
46848844|NCT00391391|83065604|FG000|Overall Study|Protocol Violation|2|||
46848845|NCT00391391|83065605|FG001|Overall Study|Protocol Violation|3|||
46848846|NCT00391391|83065606|FG002|Overall Study|Protocol Violation|6|||
46848847|NCT00391391|83065607|FG003|Overall Study|Protocol Violation|7|||
46848848|NCT00391391|83065604|FG000|Overall Study|Withdrawal by Subject|6|||
46848849|NCT00391391|83065605|FG001|Overall Study|Withdrawal by Subject|4|||
46848850|NCT00391391|83065606|FG002|Overall Study|Withdrawal by Subject|10|||
46848851|NCT00391391|83065607|FG003|Overall Study|Withdrawal by Subject|7|||
46848852|NCT00091442|83065619|FG000|Overall Study|Progressive Disease|220|||
46848853|NCT00091442|83065620|FG001|Overall Study|Progressive Disease|189|||
46848854|NCT00091442|83065619|FG000|Overall Study|Physician Decision|61|||
46848855|NCT00091442|83065620|FG001|Overall Study|Physician Decision|58|||
46848856|NCT00091442|83065619|FG000|Overall Study|Withdrawal by Subject|38|||
46848857|NCT00091442|83065620|FG001|Overall Study|Withdrawal by Subject|46|||
46848858|NCT00091442|83065619|FG000|Overall Study|Adverse Event|29|||
46848859|NCT00091442|83065620|FG001|Overall Study|Adverse Event|48|||
46848860|NCT00091442|83065619|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
46848861|NCT00091442|83065620|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
46848862|NCT00091442|83065619|FG000|Overall Study|Death|9|||
46848863|NCT00091442|83065620|FG001|Overall Study|Death|7|||
46848864|NCT00091442|83065619|FG000|Overall Study|Lost to Follow-up|1|||
46848865|NCT00091442|83065620|FG001|Overall Study|Lost to Follow-up|3|||
46848866|NCT00091442|83065619|FG000|Overall Study|Other|2|||
46848867|NCT00091442|83065620|FG001|Overall Study|Other|6|||
46848868|NCT00390689|83065629|FG000|Overall Study|Adverse Event|2|||
46848869|NCT00390689|83065630|FG001|Overall Study|Adverse Event|5|||
46848870|NCT00390689|83065631|FG002|Overall Study|Adverse Event|2|||
46848871|NCT00390689|83065629|FG000|Overall Study|Lack of Efficacy|0|||
46848872|NCT00390689|83065630|FG001|Overall Study|Lack of Efficacy|0|||
46848873|NCT00390689|83065631|FG002|Overall Study|Lack of Efficacy|1|||
46848874|NCT00390689|83065629|FG000|Overall Study|Protocol Violation|1|||
46848875|NCT00390689|83065630|FG001|Overall Study|Protocol Violation|0|||
46848876|NCT00390689|83065631|FG002|Overall Study|Protocol Violation|0|||
46848877|NCT00390689|83065629|FG000|Overall Study|Investigator's judgement|2|||
46848878|NCT00390689|83065630|FG001|Overall Study|Investigator's judgement|0|||
46777878|NCT02598960|82995971|FG000|Participants Entering Follow Up Period|Death|1|||
46777879|NCT02598960|82995972|FG001|Participants Entering Follow Up Period|Death|0|||
46777880|NCT02598960|82995973|FG002|Participants Entering Follow Up Period|Death|0|||
46777881|NCT02598960|82995974|FG003|Participants Entering Follow Up Period|Death|0|||
46777882|NCT02598960|82995975|FG004|Participants Entering Follow Up Period|Death|0|||
46777883|NCT02598960|82995976|FG005|Participants Entering Follow Up Period|Death|0|||
46777884|NCT02598960|82995977|FG006|Participants Entering Follow Up Period|Death|0|||
46777885|NCT02598960|82995978|FG007|Participants Entering Follow Up Period|Death|0|||
46777886|NCT02598960|82995979|FG008|Participants Entering Follow Up Period|Death|0|||
46777887|NCT02598960|82995980|FG009|Participants Entering Follow Up Period|Death|1|||
46777888|NCT02598960|82995981|FG010|Participants Entering Follow Up Period|Death|0|||
46848879|NCT00390689|83065631|FG002|Overall Study|Investigator's judgement|0|||
46848880|NCT00121238|83065648|FG000|Overall Study|disease progression before intervention|1|||
46848881|NCT00121238|83065648|FG000|Overall Study|Protocol Violation|2|||
46848882|NCT00390455|83065654|FG000|Overall Study|Adverse Event|17|||
46848883|NCT00390455|83065655|FG001|Overall Study|Adverse Event|3|||
46848884|NCT00390455|83065654|FG000|Overall Study|Withdrawal by Subject|8|||
46848885|NCT00390455|83065655|FG001|Overall Study|Withdrawal by Subject|8|||
46848886|NCT00390455|83065654|FG000|Overall Study|Alternate Treatment|0|||
46848887|NCT00390455|83065655|FG001|Overall Study|Alternate Treatment|1|||
46848888|NCT00390455|83065654|FG000|Overall Study|Other Medical Reasons|7|||
46848889|NCT00390455|83065655|FG001|Overall Study|Other Medical Reasons|11|||
46848890|NCT03812510|83065661|FG000|Overall Study|Lost to Follow-up|39|||
46848891|NCT03812510|83065661|FG000|Overall Study|Withdrawal by Subject|42|||
46848892|NCT03812510|83065661|FG000|Overall Study|Physician Decision|2|||
46848893|NCT03812510|83065661|FG000|Overall Study|Study Terminated by Sponsor|9|||
46848894|NCT03812510|83065661|FG000|Overall Study|Did Not Start Study Medication|55|||
46848895|NCT03812510|83065661|FG000|Overall Study|Adverse Event|5|||
46777889|NCT02598960|82995982|FG011|Participants Entering Follow Up Period|Death|11|||
46777890|NCT02598960|82995983|FG012|Participants Entering Follow Up Period|Death|2|||
46848896|NCT00390299|83065671|FG000|Overall Study|Cancellation|1|||
46848897|NCT00390299|83065672|FG001|Overall Study|Cancellation|0|||
46848898|NCT00390299|83065673|FG002|Overall Study|Cancellation|0|||
46848899|NCT00390299|83065674|FG003|Overall Study|Cancellation|0|||
46777891|NCT02598960|82995971|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777892|NCT02598960|82995972|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
46848900|NCT00390299|83065675|FG004|Overall Study|Cancellation|0|||
46848901|NCT00119678|83065691|FG000|Double-blind Treatment Period|Death|1|||
46848902|NCT00119678|83065692|FG001|Double-blind Treatment Period|Death|0|||
46848903|NCT00119678|83065691|FG000|Double-blind Treatment Period|Adverse Event|7|||
46848904|NCT00119678|83065692|FG001|Double-blind Treatment Period|Adverse Event|1|||
46848905|NCT00119678|83065691|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
46848906|NCT00119678|83065692|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
46848907|NCT00119678|83065691|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
46848908|NCT00119678|83065692|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
46848909|NCT00119678|83065691|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
46848910|NCT00119678|83065692|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
46848911|NCT00119678|83065691|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
46848912|NCT00119678|83065692|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
46848913|NCT00119678|83065691|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
46777893|NCT02598960|82995973|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
46848914|NCT00119678|83065692|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
46848915|NCT00119678|83065691|FG000|Double-blind Treatment Period|Pregnancy|0|||
46777894|NCT02598960|82995974|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777895|NCT02598960|82995975|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777896|NCT02598960|82995976|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777897|NCT02598960|82995977|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777898|NCT02598960|82995978|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777899|NCT02598960|82995979|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777900|NCT02598960|82995980|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777901|NCT02598960|82995981|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777902|NCT02598960|82995982|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
46777903|NCT02598960|82995983|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
46777904|NCT02598960|82995971|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
46777905|NCT02598960|82995972|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
46777906|NCT02598960|82995973|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
46777907|NCT02598960|82995974|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
46777908|NCT02598960|82995975|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
46777909|NCT02598960|82995976|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
46777910|NCT02598960|82995977|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
46777911|NCT02598960|82995978|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
46777912|NCT02598960|82995979|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
46777913|NCT02598960|82995980|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
46777914|NCT02598960|82995981|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
46777915|NCT02598960|82995982|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
46777916|NCT02598960|82995983|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
46777917|NCT02598960|82995971|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777918|NCT02598960|82995972|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777919|NCT02598960|82995973|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777920|NCT02598960|82995974|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777921|NCT02598960|82995975|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46848916|NCT00119678|83065692|FG001|Double-blind Treatment Period|Pregnancy|2|||
46848917|NCT00119678|83065691|FG000|Double-blind Treatment Period|Not treated|1|||
46848918|NCT00119678|83065692|FG001|Double-blind Treatment Period|Not treated|2|||
46848919|NCT00119678|83065691|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
46848920|NCT00119678|83065692|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
46848921|NCT00119678|83065691|FG000|Open-label Treatment Period|Death|1|||
46848922|NCT00119678|83065692|FG001|Open-label Treatment Period|Death|0|||
46848923|NCT00119678|83065691|FG000|Open-label Treatment Period|Adverse Event|3|||
46848924|NCT00119678|83065692|FG001|Open-label Treatment Period|Adverse Event|0|||
46848925|NCT00119678|83065691|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
46848926|NCT00119678|83065692|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
46848927|NCT00119678|83065691|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
46848928|NCT00119678|83065692|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
46848929|NCT00119678|83065691|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
46848930|NCT00119678|83065692|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
46848931|NCT00119678|83065691|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
46848932|NCT00119678|83065692|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
46848933|NCT00119678|83065691|FG000|Open-label Treatment Period|Pregnancy|1|||
46848934|NCT00119678|83065692|FG001|Open-label Treatment Period|Pregnancy|0|||
46848935|NCT00119678|83065691|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
46848936|NCT00119678|83065692|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
46848937|NCT00110084|83065700|FG000|Overall Study|Adverse Event|9|||
46848938|NCT00110084|83065700|FG000|Overall Study|Death|1|||
46848939|NCT00110084|83065700|FG000|Overall Study|Patient Refusal|10|||
46848940|NCT00110084|83065700|FG000|Overall Study|Alternate Therapy|5|||
46848941|NCT00110084|83065700|FG000|Overall Study|Intercurrent Illness|1|||
46848942|NCT00110084|83065700|FG000|Overall Study|Other|2|||
46848943|NCT00390221|83065707|FG000|Overall Study|Lost to Follow-up|0|||
46848944|NCT00390221|83065708|FG001|Overall Study|Lost to Follow-up|3|||
46848945|NCT00390221|83065709|FG002|Overall Study|Lost to Follow-up|0|||
46777922|NCT02598960|82995976|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777923|NCT02598960|82995977|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777924|NCT02598960|82995978|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777925|NCT02598960|82995979|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777926|NCT02598960|82995980|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777927|NCT02598960|82995981|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777928|NCT02598960|82995982|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
46777929|NCT02598960|82995983|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
46777930|NCT02598960|82995971|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
46777931|NCT02598960|82995972|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
46777932|NCT02598960|82995973|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
46848946|NCT00390221|83065707|FG000|Overall Study|Adverse Event|1|||
46848947|NCT00390221|83065708|FG001|Overall Study|Adverse Event|4|||
46848948|NCT00390221|83065709|FG002|Overall Study|Adverse Event|3|||
46848949|NCT00390221|83065707|FG000|Overall Study|Investigator Decision|0|||
46848950|NCT00390221|83065708|FG001|Overall Study|Investigator Decision|0|||
46848951|NCT00390221|83065709|FG002|Overall Study|Investigator Decision|1|||
46848952|NCT00390221|83065707|FG000|Overall Study|Withdrawal by Subject|13|||
46848953|NCT00390221|83065708|FG001|Overall Study|Withdrawal by Subject|9|||
46848954|NCT00390221|83065709|FG002|Overall Study|Withdrawal by Subject|7|||
46848955|NCT00390221|83065707|FG000|Overall Study|Subject Non-compliance|1|||
46848956|NCT00390221|83065708|FG001|Overall Study|Subject Non-compliance|0|||
46848957|NCT00390221|83065709|FG002|Overall Study|Subject Non-compliance|2|||
46848958|NCT00390221|83065707|FG000|Overall Study|Other|3|||
46848959|NCT00390221|83065708|FG001|Overall Study|Other|4|||
46848960|NCT00390221|83065709|FG002|Overall Study|Other|2|||
46848961|NCT00389831|83065720|FG000|Overall Study|Lack of Efficacy|0|||
46848962|NCT00389831|83065721|FG001|Overall Study|Lack of Efficacy|2|||
46848963|NCT00389831|83065720|FG000|Overall Study|Did not receive treatment.|0|||
46848964|NCT00389831|83065721|FG001|Overall Study|Did not receive treatment.|2|||
46848965|NCT00389831|83065720|FG000|Overall Study|Other reasons|0|||
46848966|NCT00389831|83065721|FG001|Overall Study|Other reasons|2|||
46848967|NCT00389831|83065720|FG000|Overall Study|Lost to Follow-up|0|||
46848968|NCT00389831|83065721|FG001|Overall Study|Lost to Follow-up|1|||
46848969|NCT00389597|83065743|FG000|Overall Study|Lost to Follow-up|8|||
46848970|NCT00389597|83065744|FG001|Overall Study|Lost to Follow-up|6|||
46848971|NCT00389597|83065745|FG002|Overall Study|Lost to Follow-up|4|||
46848972|NCT00389597|83065746|FG003|Overall Study|Lost to Follow-up|6|||
46848973|NCT00389519|83065760|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
46848974|NCT00389519|83065761|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
46848975|NCT00389519|83065762|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
46848976|NCT00389519|83065763|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
46848977|NCT00389519|83065760|FG000|Placebo Run-In|Withdrawal by Subject|19|||
46848978|NCT00389519|83065761|FG001|Placebo Run-In|Withdrawal by Subject|0|||
46848979|NCT00389519|83065762|FG002|Placebo Run-In|Withdrawal by Subject|0|||
46848980|NCT00389519|83065763|FG003|Placebo Run-In|Withdrawal by Subject|0|||
46848981|NCT00389519|83065760|FG000|Placebo Run-In|Reason not specified|40|||
46848982|NCT00389519|83065761|FG001|Placebo Run-In|Reason not specified|0|||
46848983|NCT00389519|83065762|FG002|Placebo Run-In|Reason not specified|0|||
46848984|NCT00389519|83065763|FG003|Placebo Run-In|Reason not specified|0|||
46848985|NCT00389519|83065760|FG000|Randomized|Did not receive study drug|2|||
46848986|NCT00389519|83065761|FG001|Randomized|Did not receive study drug|0|||
46848987|NCT00389519|83065762|FG002|Randomized|Did not receive study drug|0|||
46848988|NCT00389519|83065763|FG003|Randomized|Did not receive study drug|0|||
46848989|NCT00389519|83065760|FG000|Treated|Adverse Event|1|||
46848990|NCT00389519|83065761|FG001|Treated|Adverse Event|0|||
46848991|NCT00389519|83065762|FG002|Treated|Adverse Event|0|||
46848992|NCT00389519|83065763|FG003|Treated|Adverse Event|2|||
46848993|NCT00389519|83065760|FG000|Treated|Reason not specified|1|||
46848994|NCT00389519|83065761|FG001|Treated|Reason not specified|1|||
46969179|NCT02149108|83212054|FG000|Overall Study|Refusal to continue trial medication|15|||
46848995|NCT00389519|83065762|FG002|Treated|Reason not specified|0|||
46848996|NCT00389519|83065763|FG003|Treated|Reason not specified|2|||
46848997|NCT00389441|83065773|FG000|Overall Study|Adverse Event|7|||
46848998|NCT00389441|83065773|FG000|Overall Study|Death|4|||
46848999|NCT00389441|83065773|FG000|Overall Study|Lost to Follow-up|2|||
46849000|NCT00389441|83065773|FG000|Overall Study|Withdrawal by Subject|4|||
46849001|NCT00389441|83065773|FG000|Overall Study|Physician Decision|1|||
46849002|NCT00389441|83065773|FG000|Overall Study|Protocol Violation|1|||
46849003|NCT00389441|83065773|FG000|Overall Study|Global deterioration of health status|4|||
46849004|NCT00389441|83065773|FG000|Overall Study|Objective progression or relapse|26|||
46777933|NCT02598960|82995974|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
46777934|NCT02598960|82995975|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
46777935|NCT02598960|82995976|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
46777936|NCT02598960|82995977|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
46777937|NCT02598960|82995978|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
46777938|NCT02598960|82995979|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
46777939|NCT02598960|82995980|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
46969180|NCT02149108|83212055|FG001|Overall Study|Refusal to continue trial medication|11|||
46969181|NCT02149108|83212054|FG000|Overall Study|Lost to Follow-up|1|||
46969182|NCT02149108|83212055|FG001|Overall Study|Lost to Follow-up|0|||
46969183|NCT02148952|83212063|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
46969184|NCT02148952|83212064|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
46777940|NCT02598960|82995981|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
46777941|NCT02598960|82995982|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
46777942|NCT02598960|82995983|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
46777943|NCT00426361|82996014|FG000|Overall Study|Lost to Follow-up|3|||
46777944|NCT00426361|82996015|FG001|Overall Study|Lost to Follow-up|2|||
46777945|NCT00426361|82996016|FG002|Overall Study|Lost to Follow-up|5|||
46777946|NCT00426361|82996014|FG000|Overall Study|Withdrawal by Subject|1|||
46777947|NCT00426361|82996015|FG001|Overall Study|Withdrawal by Subject|3|||
46777948|NCT00426361|82996016|FG002|Overall Study|Withdrawal by Subject|0|||
46777949|NCT00665847|82996024|FG000|Overall Study|Adverse Event|8|||
46777950|NCT00665847|82996024|FG000|Overall Study|Withdrawal by Subject|2|||
46777951|NCT00665847|82996024|FG000|Overall Study|Subject non-compliant|8|||
46777952|NCT00665847|82996024|FG000|Overall Study|Subject reached a virologic endpoint|4|||
46777953|NCT00665847|82996024|FG000|Overall Study|Resistance to TMC125|1|||
46777954|NCT00665847|82996024|FG000|Overall Study|Subject ineligible to continue the trial|1|||
46777955|NCT00665847|82996024|FG000|Overall Study|Switch to Commercial Medication|1|||
46777956|NCT00426127|82996028|FG000|Overall Study|Adverse Event|1|||
46777957|NCT00426127|82996028|FG000|Overall Study|Removed due to disease progression|1|||
46777958|NCT00425503|82996032|FG000|Overall Study|Adverse Event|2|||
46777959|NCT00425503|82996032|FG000|Overall Study|Protocol Violation|1|||
46777960|NCT00425269|82996038|FG000|Overall Study|Pregnancy|5|||
46777961|NCT00425269|82996039|FG001|Overall Study|Pregnancy|7|||
46777962|NCT00425269|82996038|FG000|Overall Study|Lost to Follow-up|9|||
46777963|NCT00425269|82996039|FG001|Overall Study|Lost to Follow-up|9|||
46777964|NCT00425269|82996038|FG000|Overall Study|moved or medical reason|5|||
46777965|NCT00425269|82996039|FG001|Overall Study|moved or medical reason|4|||
46777966|NCT00430573|82996045|FG000|Overall Study|Withdrawal by Subject|5|||
46777967|NCT00430495|82996071|FG000|Overall Study|Adverse Event|2|||
46777968|NCT00430495|82996072|FG001|Overall Study|Adverse Event|3|||
46777969|NCT00430495|82996073|FG002|Overall Study|Adverse Event|2|||
46777970|NCT00430495|82996074|FG003|Overall Study|Adverse Event|0|||
46777971|NCT00430495|82996071|FG000|Overall Study|Death|0|||
46777972|NCT00430495|82996072|FG001|Overall Study|Death|0|||
46777973|NCT00430495|82996073|FG002|Overall Study|Death|1|||
46777974|NCT00430495|82996074|FG003|Overall Study|Death|0|||
46777975|NCT00430495|82996071|FG000|Overall Study|Lost to Follow-up|0|||
46777976|NCT00430495|82996072|FG001|Overall Study|Lost to Follow-up|1|||
46777977|NCT00430495|82996073|FG002|Overall Study|Lost to Follow-up|4|||
46777978|NCT00430495|82996074|FG003|Overall Study|Lost to Follow-up|0|||
46777979|NCT00430495|82996071|FG000|Overall Study|Protocol Violation|1|||
46777980|NCT00430495|82996072|FG001|Overall Study|Protocol Violation|0|||
46777981|NCT00430495|82996073|FG002|Overall Study|Protocol Violation|1|||
46777982|NCT00430495|82996074|FG003|Overall Study|Protocol Violation|0|||
46777983|NCT00430495|82996071|FG000|Overall Study|Disease Progression|1|||
46777984|NCT00430495|82996072|FG001|Overall Study|Disease Progression|1|||
46777985|NCT00430495|82996073|FG002|Overall Study|Disease Progression|0|||
46849005|NCT00389441|83065773|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
46969185|NCT02148952|83212063|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
46969186|NCT02148952|83212064|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
46969187|NCT02148952|83212063|FG000|Follow-Up|Lost to Follow-up|219|||
46777986|NCT00430495|82996074|FG003|Overall Study|Disease Progression|0|||
46777987|NCT00430495|82996071|FG000|Overall Study|Other|8|||
46777988|NCT00430495|82996072|FG001|Overall Study|Other|2|||
46777989|NCT00430495|82996073|FG002|Overall Study|Other|5|||
46777990|NCT00430495|82996074|FG003|Overall Study|Other|4|||
46777991|NCT00430495|82996071|FG000|Overall Study|Randomized but not Treated|2|||
46777992|NCT00430495|82996072|FG001|Overall Study|Randomized but not Treated|0|||
46777993|NCT00430495|82996073|FG002|Overall Study|Randomized but not Treated|0|||
46777994|NCT00430495|82996074|FG003|Overall Study|Randomized but not Treated|0|||
46777995|NCT00425113|82996086|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
46777996|NCT00425113|82996087|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
46777997|NCT00425113|82996086|FG000|Overall Study|diagnosis of abdominal TB|0|||
46777998|NCT00425113|82996087|FG001|Overall Study|diagnosis of abdominal TB|1|||
46849006|NCT00389441|83065773|FG000|Overall Study|Clinical progression|1|||
46849007|NCT00118898|83065781|FG000|Overall Study|Death|6|||
46642256|NCT02407236|82832254|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
46642257|NCT02407236|82832242|FG000|Induction Study (8 Weeks)|Other|2|||
46642258|NCT02407236|82832243|FG001|Induction Study (8 Weeks)|Other|1|||
46642259|NCT02407236|82832244|FG002|Induction Study (8 Weeks)|Other|5|||
46642260|NCT02407236|82832245|FG003|Induction Study (8 Weeks)|Other|0|||
46642261|NCT02407236|82832246|FG004|Induction Study (8 Weeks)|Other|0|||
46642262|NCT02407236|82832247|FG005|Induction Study (8 Weeks)|Other|0|||
46642263|NCT02407236|82832248|FG006|Induction Study (8 Weeks)|Other|0|||
46642264|NCT02407236|82832249|FG007|Induction Study (8 Weeks)|Other|0|||
46642265|NCT02407236|82832250|FG008|Induction Study (8 Weeks)|Other|0|||
46642266|NCT02407236|82832251|FG009|Induction Study (8 Weeks)|Other|0|||
46642267|NCT02407236|82832252|FG010|Induction Study (8 Weeks)|Other|0|||
46642268|NCT02407236|82832253|FG011|Induction Study (8 Weeks)|Other|0|||
46642269|NCT02407236|82832254|FG012|Induction Study (8 Weeks)|Other|0|||
46642270|NCT02407236|82832242|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642271|NCT02407236|82832243|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642272|NCT02407236|82832244|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642273|NCT02407236|82832245|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
46642274|NCT02407236|82832246|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
46642275|NCT02407236|82832247|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
46642276|NCT02407236|82832248|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
46642277|NCT02407236|82832249|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
46642278|NCT02407236|82832250|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642279|NCT02407236|82832251|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642280|NCT02407236|82832252|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642281|NCT02407236|82832253|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642282|NCT02407236|82832254|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
46642283|NCT02407236|82832242|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642284|NCT02407236|82832243|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642285|NCT02407236|82832244|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642286|NCT02407236|82832245|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
46642287|NCT02407236|82832246|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
46642288|NCT02407236|82832247|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
46642289|NCT02407236|82832248|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
46642290|NCT02407236|82832249|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
46642291|NCT02407236|82832250|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642292|NCT02407236|82832251|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642293|NCT02407236|82832252|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642294|NCT02407236|82832253|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642295|NCT02407236|82832254|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
46642296|NCT02407236|82832242|FG000|Maintenance Study (44 Weeks)|Other|0|||
46642297|NCT02407236|82832243|FG001|Maintenance Study (44 Weeks)|Other|0|||
46642298|NCT02407236|82832244|FG002|Maintenance Study (44 Weeks)|Other|0|||
46642299|NCT02407236|82832245|FG003|Maintenance Study (44 Weeks)|Other|5|||
46642300|NCT02407236|82832246|FG004|Maintenance Study (44 Weeks)|Other|7|||
46642301|NCT02407236|82832247|FG005|Maintenance Study (44 Weeks)|Other|8|||
46642302|NCT02407236|82832248|FG006|Maintenance Study (44 Weeks)|Other|4|||
46642303|NCT02407236|82832249|FG007|Maintenance Study (44 Weeks)|Other|6|||
46642304|NCT02407236|82832250|FG008|Maintenance Study (44 Weeks)|Other|0|||
46642305|NCT02407236|82832251|FG009|Maintenance Study (44 Weeks)|Other|0|||
46642306|NCT02407236|82832252|FG010|Maintenance Study (44 Weeks)|Other|0|||
46642307|NCT02407236|82832253|FG011|Maintenance Study (44 Weeks)|Other|0|||
46642308|NCT02407236|82832254|FG012|Maintenance Study (44 Weeks)|Other|0|||
46642309|NCT02407236|82832242|FG000|Maintenance Study (44 Weeks)|Death|0|||
46642310|NCT02407236|82832243|FG001|Maintenance Study (44 Weeks)|Death|0|||
46642311|NCT02407236|82832244|FG002|Maintenance Study (44 Weeks)|Death|0|||
46642312|NCT02407236|82832245|FG003|Maintenance Study (44 Weeks)|Death|0|||
46642313|NCT02407236|82832246|FG004|Maintenance Study (44 Weeks)|Death|0|||
46642314|NCT02407236|82832247|FG005|Maintenance Study (44 Weeks)|Death|0|||
46849008|NCT00118898|83065782|FG001|Overall Study|Death|11|||
46849009|NCT00118898|83065783|FG002|Overall Study|Death|6|||
46849010|NCT00118898|83065784|FG003|Overall Study|Death|8|||
46642315|NCT02407236|82832248|FG006|Maintenance Study (44 Weeks)|Death|0|||
46642316|NCT02407236|82832249|FG007|Maintenance Study (44 Weeks)|Death|1|||
46849011|NCT00118898|83065781|FG000|Overall Study|Lost to Follow-up|26|||
46849012|NCT00118898|83065782|FG001|Overall Study|Lost to Follow-up|34|||
46849013|NCT00118898|83065783|FG002|Overall Study|Lost to Follow-up|33|||
46849014|NCT00118898|83065784|FG003|Overall Study|Lost to Follow-up|33|||
46849015|NCT00118898|83065781|FG000|Overall Study|Withdrawal by Subject|10|||
46849016|NCT00118898|83065782|FG001|Overall Study|Withdrawal by Subject|5|||
46642317|NCT02407236|82832250|FG008|Maintenance Study (44 Weeks)|Death|0|||
46849017|NCT00118898|83065783|FG002|Overall Study|Withdrawal by Subject|8|||
46849018|NCT00118898|83065784|FG003|Overall Study|Withdrawal by Subject|8|||
46777999|NCT00425113|82996086|FG000|Overall Study|missing study drug more than 14 days|0|||
46778000|NCT00425113|82996087|FG001|Overall Study|missing study drug more than 14 days|1|||
46778001|NCT00425113|82996086|FG000|Overall Study|Withdrawal by Subject|1|||
46778002|NCT00425113|82996087|FG001|Overall Study|Withdrawal by Subject|0|||
46778003|NCT00440011|82996096|FG000|Overall Study|Adverse Event|2|||
46778004|NCT00440011|82996097|FG001|Overall Study|Adverse Event|0|||
46778005|NCT00440011|82996096|FG000|Overall Study|Lost to Follow-up|0|||
46778006|NCT00440011|82996097|FG001|Overall Study|Lost to Follow-up|2|||
46778007|NCT00440011|82996096|FG000|Overall Study|Protocol Violation|1|||
46778008|NCT00440011|82996097|FG001|Overall Study|Protocol Violation|1|||
46778009|NCT00440011|82996096|FG000|Overall Study|Withdrawal by Subject|1|||
46778010|NCT00440011|82996097|FG001|Overall Study|Withdrawal by Subject|0|||
46778011|NCT00663117|82996134|FG000|Overall Study|Lack of Efficacy|1|||
46778012|NCT00663117|82996135|FG001|Overall Study|Lack of Efficacy|0|||
46778013|NCT00570141|82996156|FG000|Overall Study|Adverse Event|1|||
46642318|NCT02407236|82832251|FG009|Maintenance Study (44 Weeks)|Death|0|||
46778014|NCT00570141|82996156|FG000|Overall Study|Missed visits|1|||
46778015|NCT00570141|82996156|FG000|Overall Study|Lost to Follow-up|1|||
46778016|NCT00579254|82996160|FG000|Overall Study|Lost to Follow-up|39|||
46642319|NCT02407236|82832252|FG010|Maintenance Study (44 Weeks)|Death|0|||
46778017|NCT00579254|82996160|FG000|Overall Study|Discontinued when study terminated|73|||
46778018|NCT00661089|82996166|FG000|Overall Study|1 subject withdrawal|0|||
46969188|NCT02148952|83212064|FG001|Follow-Up|Lost to Follow-up|231|||
46849019|NCT00118898|83065781|FG000|Overall Study|Site Closure|33|||
46849020|NCT00118898|83065782|FG001|Overall Study|Site Closure|31|||
46849021|NCT00118898|83065783|FG002|Overall Study|Site Closure|28|||
46849022|NCT00118898|83065784|FG003|Overall Study|Site Closure|37|||
46849023|NCT00118898|83065781|FG000|Overall Study|Severe debilitation|1|||
46849024|NCT00118898|83065782|FG001|Overall Study|Severe debilitation|4|||
46849025|NCT00118898|83065783|FG002|Overall Study|Severe debilitation|6|||
46849026|NCT00118898|83065784|FG003|Overall Study|Severe debilitation|4|||
46849027|NCT00118898|83065781|FG000|Overall Study|Not compliant with requirements|11|||
46849028|NCT00118898|83065782|FG001|Overall Study|Not compliant with requirements|13|||
46849029|NCT00118898|83065783|FG002|Overall Study|Not compliant with requirements|11|||
46849030|NCT00118898|83065784|FG003|Overall Study|Not compliant with requirements|11|||
46849031|NCT00118898|83065781|FG000|Overall Study|Not able to get to clinic|34|||
46849032|NCT00118898|83065782|FG001|Overall Study|Not able to get to clinic|43|||
46849033|NCT00118898|83065783|FG002|Overall Study|Not able to get to clinic|31|||
46849034|NCT00118898|83065784|FG003|Overall Study|Not able to get to clinic|40|||
46849035|NCT00118430|83065797|FG000|Overall Study|Withdrawal by Subject|6|||
46849036|NCT00118430|83065798|FG001|Overall Study|Withdrawal by Subject|2|||
47073853|NCT04188301|83364363|FG000|Month 12|Death|1|||
47073854|NCT04188301|83364364|FG001|Month 12|Death|1|||
47073855|NCT04188301|83364365|FG002|Month 12|Death|0|||
47073856|NCT04188301|83364363|FG000|Month 18|Lost to Follow-up|6|||
47073857|NCT04188301|83364364|FG001|Month 18|Lost to Follow-up|0|||
47073858|NCT04188301|83364365|FG002|Month 18|Lost to Follow-up|0|||
47073859|NCT04006925|83364375|FG000|Overall Study|Side effects|2|||
47073860|NCT04006925|83364376|FG001|Overall Study|Side effects|0|||
47073861|NCT03597061|83364388|FG000|Overall Study|Lost to Follow-up|1|||
47073862|NCT03597061|83364389|FG001|Overall Study|Lost to Follow-up|0|||
47073863|NCT03597061|83364388|FG000|Overall Study|Protocol Violation|0|||
47073864|NCT03597061|83364389|FG001|Overall Study|Protocol Violation|1|||
47073865|NCT03148795|83364417|FG000|Overall Study|Death|6|||
47073866|NCT03148795|83364417|FG000|Overall Study|Adverse Event|5|||
47073867|NCT03148795|83364417|FG000|Overall Study|Other|15|||
47073868|NCT03148795|83364417|FG000|Overall Study|No Longer Clinically Benefitting|2|||
47073869|NCT03148795|83364417|FG000|Overall Study|Global Deterioration Of Health Status|6|||
47073870|NCT03148795|83364417|FG000|Overall Study|Withdrawal by Subject|2|||
47073871|NCT03148795|83364417|FG000|Overall Study|Progressive Disease|62|||
47073872|NCT03148795|83364417|FG000|Overall Study|Ongoing|30|||
46778019|NCT00661089|82996167|FG001|Overall Study|1 subject withdrawal|1|||
47073873|NCT03146845|83364423|FG000|Overall Study|Reference ulcer healed|1|||
47073874|NCT03146845|83364424|FG001|Overall Study|Reference ulcer healed|0|||
46642320|NCT02407236|82832253|FG011|Maintenance Study (44 Weeks)|Death|0|||
46642321|NCT02407236|82832254|FG012|Maintenance Study (44 Weeks)|Death|0|||
46778020|NCT00661089|82996166|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
46778021|NCT00661089|82996167|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
46778022|NCT00582426|82996180|FG000|Overall Study|Lost to Follow-up|0|||
46778023|NCT00582426|82996181|FG001|Overall Study|Lost to Follow-up|2|||
46778024|NCT00582426|82996180|FG000|Overall Study|Adverse Event|4|||
46778025|NCT00582426|82996181|FG001|Overall Study|Adverse Event|2|||
46778026|NCT00582426|82996180|FG000|Overall Study|Protocol Violation|6|||
46642322|NCT02407236|82832242|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46642323|NCT02407236|82832243|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46778027|NCT00582426|82996181|FG001|Overall Study|Protocol Violation|2|||
46849037|NCT00118430|83065799|FG002|Overall Study|Withdrawal by Subject|0|||
46849038|NCT00118430|83065797|FG000|Overall Study|Lost to Follow-up|15|||
46849039|NCT00118430|83065798|FG001|Overall Study|Lost to Follow-up|22|||
46849040|NCT00118430|83065799|FG002|Overall Study|Lost to Follow-up|28|||
46849041|NCT00090584|83065808|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
46849042|NCT00090584|83065809|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
47073875|NCT03146845|83364423|FG000|Overall Study|Physician Decision|1|||
47073876|NCT03146845|83364424|FG001|Overall Study|Physician Decision|0|||
47073877|NCT03146845|83364423|FG000|Overall Study|Adverse Event|1|||
46778028|NCT00582426|82996180|FG000|Overall Study|Death|4|||
46778029|NCT00582426|82996181|FG001|Overall Study|Death|3|||
46778030|NCT00582426|82996180|FG000|Overall Study|Withdrawal by Subject|3|||
46778031|NCT00582426|82996181|FG001|Overall Study|Withdrawal by Subject|2|||
46778032|NCT00582426|82996180|FG000|Overall Study|Disease Progression|2|||
46778033|NCT00582426|82996181|FG001|Overall Study|Disease Progression|2|||
46778034|NCT00582426|82996180|FG000|Overall Study|Use of illicit drugs|1|||
46849043|NCT00090584|83065808|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
46849044|NCT00090584|83065809|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
47073878|NCT03146845|83364424|FG001|Overall Study|Adverse Event|0|||
47073879|NCT03146845|83364423|FG000|Overall Study|Withdrawal by Subject|2|||
46897011|NCT00706654|83122631|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
46897012|NCT00706654|83122632|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
46897013|NCT00706654|83122633|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
46897014|NCT00706654|83122634|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
46897015|NCT00706654|83122631|FG000|Oral Stabilization Phase|Withdrew consent|55|||
46897016|NCT00706654|83122632|FG001|Oral Stabilization Phase|Withdrew consent|0|||
46897017|NCT00706654|83122633|FG002|Oral Stabilization Phase|Withdrew consent|0|||
46897018|NCT00706654|83122634|FG003|Oral Stabilization Phase|Withdrew consent|0|||
46897019|NCT00706654|83122631|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
46897020|NCT00706654|83122632|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
46897021|NCT00706654|83122633|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
46897022|NCT00706654|83122634|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
46897023|NCT00706654|83122631|FG000|Oral Stabilization Phase|Adverse Event|21|||
46897024|NCT00706654|83122632|FG001|Oral Stabilization Phase|Adverse Event|0|||
46897025|NCT00706654|83122633|FG002|Oral Stabilization Phase|Adverse Event|0|||
46897026|NCT00706654|83122634|FG003|Oral Stabilization Phase|Adverse Event|0|||
46897027|NCT00706654|83122631|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
46897028|NCT00706654|83122632|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
46897029|NCT00706654|83122633|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
46897030|NCT00706654|83122634|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
46897031|NCT00706654|83122631|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
46897032|NCT00706654|83122632|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
46897033|NCT00706654|83122633|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
46897034|NCT00706654|83122634|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
46897035|NCT00706654|83122631|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
46897036|NCT00706654|83122632|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
46897037|NCT00706654|83122633|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
46897038|NCT00706654|83122634|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
46897039|NCT00706654|83122631|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
46897040|NCT00706654|83122632|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
46897041|NCT00706654|83122633|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
46897042|NCT00706654|83122634|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
46897043|NCT00706654|83122631|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
46897044|NCT00706654|83122632|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
46897045|NCT00706654|83122633|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
47073880|NCT03146845|83364424|FG001|Overall Study|Withdrawal by Subject|0|||
47073881|NCT03146845|83364423|FG000|Overall Study|Noncompliance|0|||
47073882|NCT03146845|83364424|FG001|Overall Study|Noncompliance|1|||
47073883|NCT03146845|83364423|FG000|Overall Study|Protocol Violation|0|||
47073884|NCT03146845|83364424|FG001|Overall Study|Protocol Violation|2|||
47073885|NCT03146845|83364423|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
47073886|NCT03146845|83364424|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
47073887|NCT02975700|83364430|FG000|Overall Study|Adverse Event|1|||
47073888|NCT02975700|83364430|FG000|Overall Study|Progressive disease|3|||
46778035|NCT00582426|82996181|FG001|Overall Study|Use of illicit drugs|0|||
46778036|NCT02387970|82996189|FG000|Overall Study|Did not complete 1-year follow up|1|||
46897046|NCT00706654|83122634|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
46897047|NCT00706654|83122631|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
46897048|NCT00706654|83122632|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
46897049|NCT00706654|83122633|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
46897050|NCT00706654|83122634|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
46897051|NCT00706654|83122631|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
46849045|NCT03670810|83065829|FG000|Main Study|Adverse Event|37|||
46849046|NCT03670810|83065830|FG001|Main Study|Adverse Event|38|||
46849047|NCT03670810|83065831|FG002|Main Study|Adverse Event|3|||
46969189|NCT02148952|83212063|FG000|Follow-Up|Withdrawal by Subject|46|||
46969190|NCT02148952|83212064|FG001|Follow-Up|Withdrawal by Subject|48|||
46969191|NCT02148718|83212078|FG000|Overall Study|Protocol Violation|26|||
46969192|NCT02148718|83212078|FG000|Overall Study|Discontinued Study Prematurely|5|||
46969193|NCT02148250|83212082|FG000|Screening|Withdrawal by Subject|5|||
46969194|NCT02148250|83212083|FG001|Screening|Withdrawal by Subject|0|||
46969195|NCT02147626|83212092|FG000|Overall Study|Lost to Follow-up|4|||
46969196|NCT02147626|83212093|FG001|Overall Study|Lost to Follow-up|4|||
46969197|NCT02147626|83212092|FG000|Overall Study|Pregnancy|1|||
46969198|NCT02147626|83212093|FG001|Overall Study|Pregnancy|2|||
46969199|NCT02147626|83212092|FG000|Overall Study|Withdrawal by Subject|0|||
46969200|NCT02147626|83212093|FG001|Overall Study|Withdrawal by Subject|1|||
46969201|NCT02172664|83212099|FG000|Overall Study|Lost to Follow-up|4|||
46969202|NCT02172664|83212100|FG001|Overall Study|Lost to Follow-up|4|||
46969203|NCT02172664|83212099|FG000|Overall Study|Death|1|||
46969204|NCT02172664|83212100|FG001|Overall Study|Death|1|||
46969205|NCT02172664|83212099|FG000|Overall Study|Moved out of area|1|||
46969206|NCT02172664|83212100|FG001|Overall Study|Moved out of area|1|||
46969207|NCT02172040|83212109|FG000|Overall Study|Adverse Event|0|||
46969208|NCT02172040|83212110|FG001|Overall Study|Adverse Event|2|||
46969209|NCT02172040|83212111|FG002|Overall Study|Adverse Event|0|||
46969210|NCT02172040|83212112|FG003|Overall Study|Adverse Event|0|||
46849048|NCT03670810|83065832|FG003|Main Study|Adverse Event|4|||
46849049|NCT03670810|83065833|FG004|Main Study|Adverse Event|4|||
46849050|NCT03670810|83065834|FG005|Main Study|Adverse Event|5|||
46849051|NCT03670810|83065835|FG006|Main Study|Adverse Event|0|||
46849052|NCT03670810|83065836|FG007|Main Study|Adverse Event|0|||
46849053|NCT03670810|83065837|FG008|Main Study|Adverse Event|0|||
46642324|NCT02407236|82832244|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46642325|NCT02407236|82832245|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46778037|NCT02387970|82996190|FG001|Overall Study|Did not complete 1-year follow up|2|||
46778038|NCT00580034|82996196|FG000|Overall Study|Toxicity|10|||
46778039|NCT00580034|82996197|FG001|Overall Study|Toxicity|0|||
46778040|NCT00773513|82996203|FG000|Overall Study|Renal Transplant|254|||
46778041|NCT00773513|82996204|FG001|Overall Study|Renal Transplant|263|||
46778042|NCT00773513|82996203|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
46778043|NCT00773513|82996204|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
46778044|NCT00773513|82996203|FG000|Overall Study|Withdrew Consent|68|||
46778045|NCT00773513|82996204|FG001|Overall Study|Withdrew Consent|69|||
46778046|NCT00773513|82996203|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
46778047|NCT00773513|82996204|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
46778048|NCT00773513|82996203|FG000|Overall Study|Failure to Return|22|||
46778049|NCT00773513|82996204|FG001|Overall Study|Failure to Return|8|||
46778050|NCT00773513|82996203|FG000|Overall Study|Insufficient Therapeutic Response|1|||
46778051|NCT00773513|82996204|FG001|Overall Study|Insufficient Therapeutic Response|18|||
46778052|NCT00773513|82996203|FG000|Overall Study|Reason Not Specified|159|||
46778053|NCT00773513|82996204|FG001|Overall Study|Reason Not Specified|126|||
46849054|NCT03670810|83065829|FG000|Main Study|Lack of Efficacy|8|||
46849055|NCT03670810|83065830|FG001|Main Study|Lack of Efficacy|9|||
46849056|NCT03670810|83065831|FG002|Main Study|Lack of Efficacy|3|||
46849057|NCT03670810|83065832|FG003|Main Study|Lack of Efficacy|4|||
46849058|NCT03670810|83065833|FG004|Main Study|Lack of Efficacy|0|||
46849059|NCT03670810|83065834|FG005|Main Study|Lack of Efficacy|0|||
46849060|NCT03670810|83065835|FG006|Main Study|Lack of Efficacy|0|||
46849061|NCT03670810|83065836|FG007|Main Study|Lack of Efficacy|0|||
46849062|NCT03670810|83065837|FG008|Main Study|Lack of Efficacy|0|||
46849063|NCT03670810|83065829|FG000|Main Study|Lost to Follow-up|9|||
46849064|NCT03670810|83065830|FG001|Main Study|Lost to Follow-up|7|||
46849065|NCT03670810|83065831|FG002|Main Study|Lost to Follow-up|4|||
46849066|NCT03670810|83065832|FG003|Main Study|Lost to Follow-up|6|||
46849067|NCT03670810|83065833|FG004|Main Study|Lost to Follow-up|1|||
46849068|NCT03670810|83065834|FG005|Main Study|Lost to Follow-up|0|||
46849069|NCT03670810|83065835|FG006|Main Study|Lost to Follow-up|0|||
46849070|NCT03670810|83065836|FG007|Main Study|Lost to Follow-up|0|||
46849071|NCT03670810|83065837|FG008|Main Study|Lost to Follow-up|0|||
46849072|NCT03670810|83065829|FG000|Main Study|Non-compliance with Study Drug|0|||
46849073|NCT03670810|83065830|FG001|Main Study|Non-compliance with Study Drug|2|||
46849074|NCT03670810|83065831|FG002|Main Study|Non-compliance with Study Drug|3|||
46849075|NCT03670810|83065832|FG003|Main Study|Non-compliance with Study Drug|0|||
46849076|NCT03670810|83065833|FG004|Main Study|Non-compliance with Study Drug|0|||
46849077|NCT03670810|83065834|FG005|Main Study|Non-compliance with Study Drug|0|||
46849078|NCT03670810|83065835|FG006|Main Study|Non-compliance with Study Drug|0|||
46849079|NCT03670810|83065836|FG007|Main Study|Non-compliance with Study Drug|1|||
46849080|NCT03670810|83065837|FG008|Main Study|Non-compliance with Study Drug|0|||
46849081|NCT03670810|83065829|FG000|Main Study|Physician Decision|3|||
46849082|NCT03670810|83065830|FG001|Main Study|Physician Decision|0|||
46849083|NCT03670810|83065831|FG002|Main Study|Physician Decision|1|||
46849084|NCT03670810|83065832|FG003|Main Study|Physician Decision|0|||
46849085|NCT03670810|83065833|FG004|Main Study|Physician Decision|0|||
46849086|NCT03670810|83065834|FG005|Main Study|Physician Decision|0|||
46849087|NCT03670810|83065835|FG006|Main Study|Physician Decision|1|||
46849088|NCT03670810|83065836|FG007|Main Study|Physician Decision|1|||
47073889|NCT02975700|83364430|FG000|Overall Study|Failed screening criteria|2|||
47073890|NCT02895360|83364440|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
47073891|NCT02895360|83364441|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
47073892|NCT02895360|83364442|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
47073893|NCT02895360|83364443|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
47073894|NCT02895360|83364444|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
47073895|NCT02895360|83364445|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
47073896|NCT02895360|83364440|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
47073897|NCT02895360|83364441|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
47073898|NCT02895360|83364442|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
47073899|NCT02895360|83364443|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
47073900|NCT02895360|83364444|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
47073901|NCT02895360|83364445|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
47073902|NCT02895360|83364440|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
46778054|NCT00773513|82996203|FG000|Overall Study|Death|531|||
46642326|NCT02407236|82832246|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46642327|NCT02407236|82832247|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46778055|NCT00773513|82996204|FG001|Overall Study|Death|545|||
46778056|NCT00767039|82996212|FG000|Overall Study|Death|5|||
46778057|NCT00767039|82996213|FG001|Overall Study|Death|2|||
46778058|NCT00662649|82996223|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
46778059|NCT00662649|82996224|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
46778060|NCT00662649|82996225|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
46778061|NCT00662649|82996226|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
46778062|NCT00662649|82996227|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
46778063|NCT00662649|82996223|FG000|Core Study (24 Months)|Adverse Event|22|||
46778064|NCT00662649|82996224|FG001|Core Study (24 Months)|Adverse Event|13|||
46778065|NCT00662649|82996225|FG002|Core Study (24 Months)|Adverse Event|18|||
46778066|NCT00662649|82996226|FG003|Core Study (24 Months)|Adverse Event|0|||
46778067|NCT00662649|82996227|FG004|Core Study (24 Months)|Adverse Event|0|||
46778068|NCT00662649|82996223|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
46778069|NCT00662649|82996224|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
46778070|NCT00662649|82996225|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
46778071|NCT00662649|82996226|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
46778072|NCT00662649|82996227|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
46778073|NCT00662649|82996223|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
46778074|NCT00662649|82996224|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
46849089|NCT03670810|83065837|FG008|Main Study|Physician Decision|0|||
46849090|NCT03670810|83065829|FG000|Main Study|Pregnancy|1|||
46849091|NCT03670810|83065830|FG001|Main Study|Pregnancy|2|||
46849092|NCT03670810|83065831|FG002|Main Study|Pregnancy|0|||
46849093|NCT03670810|83065832|FG003|Main Study|Pregnancy|0|||
46778075|NCT00662649|82996225|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
46778076|NCT00662649|82996226|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
46778077|NCT00662649|82996227|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
46778078|NCT00662649|82996223|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
46778079|NCT00662649|82996224|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
46778080|NCT00662649|82996225|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
46778081|NCT00662649|82996226|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
46778082|NCT00662649|82996227|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
46778083|NCT00662649|82996223|FG000|Core Study (24 Months)|Protocol Violation|5|||
46778084|NCT00662649|82996224|FG001|Core Study (24 Months)|Protocol Violation|5|||
46778085|NCT00662649|82996225|FG002|Core Study (24 Months)|Protocol Violation|4|||
46849094|NCT03670810|83065833|FG004|Main Study|Pregnancy|0|||
46849095|NCT03670810|83065834|FG005|Main Study|Pregnancy|0|||
46849096|NCT03670810|83065835|FG006|Main Study|Pregnancy|0|||
47073903|NCT02895360|83364441|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
47073904|NCT02895360|83364442|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
47073905|NCT02895360|83364443|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
47073906|NCT02895360|83364444|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
47073907|NCT02895360|83364445|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
47073908|NCT02895360|83364440|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
47073909|NCT02895360|83364441|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
46849097|NCT03670810|83065836|FG007|Main Study|Pregnancy|0|||
46849098|NCT03670810|83065837|FG008|Main Study|Pregnancy|0|||
46849099|NCT03670810|83065829|FG000|Main Study|Protocol Deviation|2|||
46849100|NCT03670810|83065830|FG001|Main Study|Protocol Deviation|12|||
46849101|NCT03670810|83065831|FG002|Main Study|Protocol Deviation|8|||
46849102|NCT03670810|83065832|FG003|Main Study|Protocol Deviation|4|||
46849103|NCT03670810|83065833|FG004|Main Study|Protocol Deviation|0|||
46849104|NCT03670810|83065834|FG005|Main Study|Protocol Deviation|0|||
46849105|NCT03670810|83065835|FG006|Main Study|Protocol Deviation|0|||
46849106|NCT03670810|83065836|FG007|Main Study|Protocol Deviation|0|||
46849107|NCT03670810|83065837|FG008|Main Study|Protocol Deviation|0|||
46849108|NCT03670810|83065829|FG000|Main Study|Withdrawal by Subject|21|||
46849109|NCT03670810|83065830|FG001|Main Study|Withdrawal by Subject|21|||
46849110|NCT03670810|83065831|FG002|Main Study|Withdrawal by Subject|8|||
46849111|NCT03670810|83065832|FG003|Main Study|Withdrawal by Subject|9|||
46969211|NCT02172040|83212109|FG000|Overall Study|Protocol Violation|0|||
47073910|NCT02895360|83364442|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
47073911|NCT02895360|83364443|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
47073912|NCT02895360|83364444|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
47073913|NCT02895360|83364445|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
47073914|NCT02895360|83364440|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
47073915|NCT02895360|83364441|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
47073916|NCT02895360|83364442|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
47073917|NCT02895360|83364443|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
46849112|NCT03670810|83065833|FG004|Main Study|Withdrawal by Subject|5|||
46849113|NCT03670810|83065834|FG005|Main Study|Withdrawal by Subject|2|||
46849114|NCT03670810|83065835|FG006|Main Study|Withdrawal by Subject|1|||
46849115|NCT03670810|83065836|FG007|Main Study|Withdrawal by Subject|1|||
46778086|NCT00662649|82996226|FG003|Core Study (24 Months)|Protocol Violation|0|||
46778087|NCT00662649|82996227|FG004|Core Study (24 Months)|Protocol Violation|0|||
46778088|NCT00662649|82996223|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
46778089|NCT00662649|82996224|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
46849116|NCT03670810|83065837|FG008|Main Study|Withdrawal by Subject|0|||
46849117|NCT03670810|83065829|FG000|Main Study|Participant did not want to take the three other treatments|1|||
46849118|NCT03670810|83065830|FG001|Main Study|Participant did not want to take the three other treatments|0|||
46849119|NCT03670810|83065831|FG002|Main Study|Participant did not want to take the three other treatments|0|||
46849120|NCT03670810|83065832|FG003|Main Study|Participant did not want to take the three other treatments|0|||
46849121|NCT03670810|83065833|FG004|Main Study|Participant did not want to take the three other treatments|0|||
46849122|NCT03670810|83065834|FG005|Main Study|Participant did not want to take the three other treatments|0|||
46849123|NCT03670810|83065835|FG006|Main Study|Participant did not want to take the three other treatments|0|||
46849124|NCT03670810|83065836|FG007|Main Study|Participant did not want to take the three other treatments|0|||
46849125|NCT03670810|83065837|FG008|Main Study|Participant did not want to take the three other treatments|0|||
46849126|NCT03670810|83065829|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46849127|NCT03670810|83065830|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
46969212|NCT02172040|83212110|FG001|Overall Study|Protocol Violation|1|||
46969213|NCT02172040|83212111|FG002|Overall Study|Protocol Violation|0|||
46969214|NCT02172040|83212112|FG003|Overall Study|Protocol Violation|0|||
46969215|NCT02172040|83212109|FG000|Overall Study|Withdrawal by Subject|0|||
46969216|NCT02172040|83212110|FG001|Overall Study|Withdrawal by Subject|0|||
46969217|NCT02172040|83212111|FG002|Overall Study|Withdrawal by Subject|1|||
46969218|NCT02172040|83212112|FG003|Overall Study|Withdrawal by Subject|0|||
46969219|NCT02172040|83212109|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
46969220|NCT02172040|83212110|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
46969221|NCT02172040|83212111|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
46969222|NCT02172040|83212112|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
46969223|NCT02172040|83212109|FG000|Overall Study|Family emergency abroad|0|||
46849128|NCT03670810|83065831|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46969224|NCT02172040|83212110|FG001|Overall Study|Family emergency abroad|0|||
46969225|NCT02172040|83212111|FG002|Overall Study|Family emergency abroad|0|||
46969226|NCT02172040|83212112|FG003|Overall Study|Family emergency abroad|1|||
46969227|NCT02112994|83212138|FG000|Overall Study|Progressive Disease|0|||
46969228|NCT02112994|83212139|FG001|Overall Study|Progressive Disease|0|||
46969229|NCT02112994|83212140|FG002|Overall Study|Progressive Disease|1|||
46969230|NCT02112994|83212138|FG000|Overall Study|Pregnancy|0|||
46969231|NCT02112994|83212139|FG001|Overall Study|Pregnancy|1|||
46969232|NCT02112994|83212140|FG002|Overall Study|Pregnancy|1|||
46969233|NCT02112994|83212138|FG000|Overall Study|Liver Transplant|0|||
46969234|NCT02112994|83212139|FG001|Overall Study|Liver Transplant|1|||
46969235|NCT02112994|83212140|FG002|Overall Study|Liver Transplant|0|||
46969236|NCT02112994|83212138|FG000|Overall Study|Withdrawal by Subject|0|||
46969237|NCT02112994|83212139|FG001|Overall Study|Withdrawal by Subject|0|||
46969238|NCT02112994|83212140|FG002|Overall Study|Withdrawal by Subject|1|||
46969239|NCT02147158|83212158|FG000|Treatment Course 1|Adverse Event|1|||
46969240|NCT02147158|83212159|FG001|Treatment Course 1|Adverse Event|4|||
46969241|NCT02147158|83212160|FG002|Treatment Course 1|Adverse Event|3|||
46969242|NCT02147158|83212161|FG003|Treatment Course 1|Adverse Event|4|||
46969243|NCT02147158|83212162|FG004|Treatment Course 1|Adverse Event|1|||
46969244|NCT02147158|83212163|FG005|Treatment Course 1|Adverse Event|2|||
46969245|NCT02147158|83212158|FG000|Treatment Course 1|Lost to Follow-up|2|||
46969246|NCT02147158|83212159|FG001|Treatment Course 1|Lost to Follow-up|4|||
46969247|NCT02147158|83212160|FG002|Treatment Course 1|Lost to Follow-up|3|||
46969248|NCT02147158|83212161|FG003|Treatment Course 1|Lost to Follow-up|3|||
46969249|NCT02147158|83212162|FG004|Treatment Course 1|Lost to Follow-up|2|||
46969250|NCT02147158|83212163|FG005|Treatment Course 1|Lost to Follow-up|4|||
46778090|NCT00662649|82996225|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
46778091|NCT00662649|82996226|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
46778092|NCT00662649|82996227|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
46778093|NCT00662649|82996223|FG000|Core Study (24 Months)|Death|1|||
46778094|NCT00662649|82996224|FG001|Core Study (24 Months)|Death|0|||
46778095|NCT00662649|82996225|FG002|Core Study (24 Months)|Death|2|||
46778096|NCT00662649|82996226|FG003|Core Study (24 Months)|Death|0|||
46778097|NCT00662649|82996227|FG004|Core Study (24 Months)|Death|0|||
46849129|NCT03670810|83065832|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46849130|NCT03670810|83065833|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46849131|NCT03670810|83065834|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46969251|NCT02147158|83212158|FG000|Treatment Course 1|Protocol Violation|0|||
46969252|NCT02147158|83212159|FG001|Treatment Course 1|Protocol Violation|0|||
46778098|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
47073918|NCT02895360|83364444|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
46969253|NCT02147158|83212160|FG002|Treatment Course 1|Protocol Violation|1|||
46969254|NCT02147158|83212161|FG003|Treatment Course 1|Protocol Violation|1|||
46969255|NCT02147158|83212162|FG004|Treatment Course 1|Protocol Violation|0|||
46969256|NCT02147158|83212163|FG005|Treatment Course 1|Protocol Violation|0|||
46969257|NCT02147158|83212158|FG000|Treatment Course 1|Withdrawal of Consent|1|||
46969258|NCT02147158|83212159|FG001|Treatment Course 1|Withdrawal of Consent|1|||
46969259|NCT02147158|83212160|FG002|Treatment Course 1|Withdrawal of Consent|1|||
46969260|NCT02147158|83212161|FG003|Treatment Course 1|Withdrawal of Consent|5|||
46969261|NCT02147158|83212162|FG004|Treatment Course 1|Withdrawal of Consent|3|||
46969262|NCT02147158|83212163|FG005|Treatment Course 1|Withdrawal of Consent|2|||
46969263|NCT02147158|83212158|FG000|Off-Treatment Interval 1|Adverse Event|1|||
46969264|NCT02147158|83212159|FG001|Off-Treatment Interval 1|Adverse Event|0|||
46969265|NCT02147158|83212160|FG002|Off-Treatment Interval 1|Adverse Event|0|||
47073919|NCT02895360|83364445|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
47073920|NCT02895360|83364440|FG000|Phase 2a|Adverse Event|0|||
47073921|NCT02895360|83364441|FG001|Phase 2a|Adverse Event|0|||
47073922|NCT02895360|83364442|FG002|Phase 2a|Adverse Event|0|||
46642328|NCT02407236|82832248|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46642329|NCT02407236|82832249|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
46849132|NCT03670810|83065835|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46849133|NCT03670810|83065836|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46849134|NCT03670810|83065837|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
46849135|NCT03670810|83065829|FG000|Main Study|Travel and Coronavirus issues|0|||
46849136|NCT03670810|83065830|FG001|Main Study|Travel and Coronavirus issues|0|||
46849137|NCT03670810|83065831|FG002|Main Study|Travel and Coronavirus issues|0|||
46849138|NCT03670810|83065832|FG003|Main Study|Travel and Coronavirus issues|1|||
46849139|NCT03670810|83065833|FG004|Main Study|Travel and Coronavirus issues|0|||
46849140|NCT03670810|83065834|FG005|Main Study|Travel and Coronavirus issues|0|||
46849141|NCT03670810|83065835|FG006|Main Study|Travel and Coronavirus issues|0|||
46849142|NCT03670810|83065836|FG007|Main Study|Travel and Coronavirus issues|0|||
46849143|NCT03670810|83065837|FG008|Main Study|Travel and Coronavirus issues|0|||
46849144|NCT03670810|83065829|FG000|Open Label Extension|Protocol Deviation|0|||
46849145|NCT03670810|83065830|FG001|Open Label Extension|Protocol Deviation|0|||
46849146|NCT03670810|83065831|FG002|Open Label Extension|Protocol Deviation|0|||
46849147|NCT03670810|83065832|FG003|Open Label Extension|Protocol Deviation|0|||
46849148|NCT03670810|83065833|FG004|Open Label Extension|Protocol Deviation|0|||
46849149|NCT03670810|83065834|FG005|Open Label Extension|Protocol Deviation|0|||
46849150|NCT03670810|83065835|FG006|Open Label Extension|Protocol Deviation|0|||
46849151|NCT03670810|83065836|FG007|Open Label Extension|Protocol Deviation|0|||
46849152|NCT03670810|83065837|FG008|Open Label Extension|Protocol Deviation|5|||
46849153|NCT03670810|83065829|FG000|Open Label Extension|Death|0|||
46849154|NCT03670810|83065830|FG001|Open Label Extension|Death|0|||
46849155|NCT03670810|83065831|FG002|Open Label Extension|Death|0|||
46849156|NCT03670810|83065832|FG003|Open Label Extension|Death|0|||
46849157|NCT03670810|83065833|FG004|Open Label Extension|Death|0|||
46849158|NCT03670810|83065834|FG005|Open Label Extension|Death|0|||
46849159|NCT03670810|83065835|FG006|Open Label Extension|Death|0|||
46969266|NCT02147158|83212161|FG003|Off-Treatment Interval 1|Adverse Event|1|||
47073923|NCT02895360|83364443|FG003|Phase 2a|Adverse Event|0|||
46642330|NCT02407236|82832250|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
46642331|NCT02407236|82832251|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
46642332|NCT02407236|82832252|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
46642333|NCT02407236|82832253|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
46642334|NCT02407236|82832254|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
46642335|NCT02407236|82832242|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642336|NCT02407236|82832243|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46778099|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
46778100|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
46778101|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
46778102|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
46778103|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
46778104|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
46778105|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
46778106|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
46778107|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
46849160|NCT03670810|83065836|FG007|Open Label Extension|Death|0|||
46849161|NCT03670810|83065837|FG008|Open Label Extension|Death|1|||
46849162|NCT03670810|83065829|FG000|Open Label Extension|COVID-19|0|||
47073924|NCT02895360|83364444|FG004|Phase 2a|Adverse Event|0|||
46849163|NCT03670810|83065830|FG001|Open Label Extension|COVID-19|0|||
46849164|NCT03670810|83065831|FG002|Open Label Extension|COVID-19|0|||
47073925|NCT02895360|83364445|FG005|Phase 2a|Adverse Event|1|||
46969267|NCT02147158|83212162|FG004|Off-Treatment Interval 1|Adverse Event|0|||
46969268|NCT02147158|83212163|FG005|Off-Treatment Interval 1|Adverse Event|0|||
46969269|NCT02147158|83212158|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
46969270|NCT02147158|83212159|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
46969271|NCT02147158|83212160|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
46969272|NCT02147158|83212161|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
46969273|NCT02147158|83212162|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
46969274|NCT02147158|83212163|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
46969275|NCT02147158|83212158|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
46969276|NCT02147158|83212159|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
46969277|NCT02147158|83212160|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
46969278|NCT02147158|83212161|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
46969279|NCT02147158|83212162|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
46969280|NCT02147158|83212163|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
46969281|NCT02147158|83212158|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
46969282|NCT02147158|83212159|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
46969283|NCT02147158|83212160|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
46969284|NCT02147158|83212161|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
46969285|NCT02147158|83212162|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
46969286|NCT02147158|83212163|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
46969287|NCT02147158|83212158|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
46969288|NCT02147158|83212159|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
46969289|NCT02147158|83212160|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
46969290|NCT02147158|83212161|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
46969291|NCT02147158|83212162|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
46969292|NCT02147158|83212163|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
46969293|NCT02147158|83212158|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
46969294|NCT02147158|83212159|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
46969295|NCT02147158|83212160|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
46969296|NCT02147158|83212161|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
46969297|NCT02147158|83212162|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
46969298|NCT02147158|83212163|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
46969299|NCT02147158|83212158|FG000|Treatment Course 2|Adverse Event|0|||
46969300|NCT02147158|83212159|FG001|Treatment Course 2|Adverse Event|4|||
46969301|NCT02147158|83212160|FG002|Treatment Course 2|Adverse Event|2|||
46969302|NCT02147158|83212161|FG003|Treatment Course 2|Adverse Event|1|||
46969303|NCT02147158|83212162|FG004|Treatment Course 2|Adverse Event|0|||
46969304|NCT02147158|83212163|FG005|Treatment Course 2|Adverse Event|1|||
46969305|NCT02147158|83212158|FG000|Treatment Course 2|Withdrawal of Consent|0|||
46969306|NCT02147158|83212159|FG001|Treatment Course 2|Withdrawal of Consent|1|||
46969307|NCT02147158|83212160|FG002|Treatment Course 2|Withdrawal of Consent|2|||
46969308|NCT02147158|83212161|FG003|Treatment Course 2|Withdrawal of Consent|3|||
46969309|NCT02147158|83212162|FG004|Treatment Course 2|Withdrawal of Consent|0|||
46969310|NCT02147158|83212163|FG005|Treatment Course 2|Withdrawal of Consent|0|||
46969311|NCT02147158|83212158|FG000|Treatment Course 2|Lost to Follow-up|1|||
46969312|NCT02147158|83212159|FG001|Treatment Course 2|Lost to Follow-up|0|||
46969313|NCT02147158|83212160|FG002|Treatment Course 2|Lost to Follow-up|1|||
46969314|NCT02147158|83212161|FG003|Treatment Course 2|Lost to Follow-up|1|||
46969315|NCT02147158|83212162|FG004|Treatment Course 2|Lost to Follow-up|0|||
46969316|NCT02147158|83212163|FG005|Treatment Course 2|Lost to Follow-up|1|||
46969317|NCT02147158|83212158|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
46969318|NCT02147158|83212159|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
46969319|NCT02147158|83212160|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
46969320|NCT02147158|83212161|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
47073926|NCT02895360|83364440|FG000|Phase 2a|Progressive disease|0|||
47073927|NCT02895360|83364441|FG001|Phase 2a|Progressive disease|0|||
46778108|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
46778109|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
46778110|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
46778111|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
46778112|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
46778113|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
46778114|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
46969321|NCT02147158|83212162|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
46969322|NCT02147158|83212163|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
46969323|NCT02147158|83212158|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
46969324|NCT02147158|83212159|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
46969325|NCT02147158|83212160|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
46969326|NCT02147158|83212161|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
46778115|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
46778116|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
47073928|NCT02895360|83364442|FG002|Phase 2a|Progressive disease|0|||
46849165|NCT03670810|83065832|FG003|Open Label Extension|COVID-19|0|||
46849166|NCT03670810|83065833|FG004|Open Label Extension|COVID-19|0|||
46849167|NCT03670810|83065834|FG005|Open Label Extension|COVID-19|0|||
46849168|NCT03670810|83065835|FG006|Open Label Extension|COVID-19|0|||
46849169|NCT03670810|83065836|FG007|Open Label Extension|COVID-19|0|||
46849170|NCT03670810|83065837|FG008|Open Label Extension|COVID-19|1|||
46849171|NCT03670810|83065829|FG000|Open Label Extension|Lack of Efficacy|0|||
46849172|NCT03670810|83065830|FG001|Open Label Extension|Lack of Efficacy|0|||
46849173|NCT03670810|83065831|FG002|Open Label Extension|Lack of Efficacy|0|||
46849174|NCT03670810|83065832|FG003|Open Label Extension|Lack of Efficacy|0|||
46849175|NCT03670810|83065833|FG004|Open Label Extension|Lack of Efficacy|0|||
46849176|NCT03670810|83065834|FG005|Open Label Extension|Lack of Efficacy|0|||
46849177|NCT03670810|83065835|FG006|Open Label Extension|Lack of Efficacy|0|||
46849178|NCT03670810|83065836|FG007|Open Label Extension|Lack of Efficacy|0|||
46849179|NCT03670810|83065837|FG008|Open Label Extension|Lack of Efficacy|39|||
46849180|NCT03670810|83065829|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
46849181|NCT03670810|83065830|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
46849182|NCT03670810|83065831|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
46849183|NCT03670810|83065832|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
46849184|NCT03670810|83065833|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
46849185|NCT03670810|83065834|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
46849186|NCT03670810|83065835|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
46849187|NCT03670810|83065836|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
46849188|NCT03670810|83065837|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
46849189|NCT03670810|83065829|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46849190|NCT03670810|83065830|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46849191|NCT03670810|83065831|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46849192|NCT03670810|83065832|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46849193|NCT03670810|83065833|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46849194|NCT03670810|83065834|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46849195|NCT03670810|83065835|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46849196|NCT03670810|83065836|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
46778117|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
46778118|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
46778119|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
46778120|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
46778121|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
46849197|NCT03670810|83065837|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
46849198|NCT03670810|83065829|FG000|Open Label Extension|Withdrawal by Subject|0|||
46849199|NCT03670810|83065830|FG001|Open Label Extension|Withdrawal by Subject|0|||
46849200|NCT03670810|83065831|FG002|Open Label Extension|Withdrawal by Subject|0|||
46849201|NCT03670810|83065832|FG003|Open Label Extension|Withdrawal by Subject|0|||
46849202|NCT03670810|83065833|FG004|Open Label Extension|Withdrawal by Subject|0|||
46849203|NCT03670810|83065834|FG005|Open Label Extension|Withdrawal by Subject|0|||
46778122|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
46778123|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
46778124|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
46778125|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
46778126|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
46778127|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
46778128|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
46778129|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
46778130|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
46778131|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
46778132|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
46778133|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
46778134|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
46778135|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
46778136|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
46778137|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
46778138|NCT00662649|82996223|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
46969327|NCT02147158|83212162|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
46969328|NCT02147158|83212163|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
46849204|NCT03670810|83065835|FG006|Open Label Extension|Withdrawal by Subject|0|||
46849205|NCT03670810|83065836|FG007|Open Label Extension|Withdrawal by Subject|0|||
46778139|NCT00662649|82996224|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
46778140|NCT00662649|82996225|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
46778141|NCT00662649|82996226|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
46778142|NCT00662649|82996227|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
46778143|NCT00766493|82996241|FG000|30 Days Post-Procedure|Discontinued|7|||
46778144|NCT00766493|82996241|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
46778145|NCT00766493|82996241|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
46778146|NCT00784043|82996247|FG000|Overall Study|Withdrawal by Subject|8|||
46778147|NCT00784043|82996248|FG001|Overall Study|Withdrawal by Subject|5|||
46849206|NCT03670810|83065837|FG008|Open Label Extension|Withdrawal by Subject|46|||
46849207|NCT03670810|83065829|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
46849208|NCT03670810|83065830|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
46849209|NCT03670810|83065831|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
47073929|NCT02895360|83364443|FG003|Phase 2a|Progressive disease|0|||
47073930|NCT02895360|83364444|FG004|Phase 2a|Progressive disease|11|||
47073931|NCT02895360|83364445|FG005|Phase 2a|Progressive disease|11|||
47073932|NCT02863809|83364479|FG000|Overall Study|Adverse Event|8|||
47073933|NCT02863809|83364480|FG001|Overall Study|Adverse Event|8|||
47073934|NCT02863809|83364479|FG000|Overall Study|Withdrawal by Subject|0|||
47073935|NCT02863809|83364480|FG001|Overall Study|Withdrawal by Subject|1|||
47073936|NCT02863809|83364479|FG000|Overall Study|Lost to Follow-up|1|||
47073937|NCT02863809|83364480|FG001|Overall Study|Lost to Follow-up|1|||
47073938|NCT02863809|83364479|FG000|Overall Study|Death|1|||
47073939|NCT02863809|83364480|FG001|Overall Study|Death|0|||
47073940|NCT02753530|83364504|FG000|Overall Study|Adverse Event|7|||
47073941|NCT02753530|83364505|FG001|Overall Study|Adverse Event|1|||
47073942|NCT02753530|83364504|FG000|Overall Study|Death|0|||
47073943|NCT02753530|83364505|FG001|Overall Study|Death|1|||
47073944|NCT02753530|83364504|FG000|Overall Study|Physician Decision|0|||
47073945|NCT02753530|83364505|FG001|Overall Study|Physician Decision|1|||
47073946|NCT02753530|83364504|FG000|Overall Study|Protocol Violation|1|||
47073947|NCT02753530|83364505|FG001|Overall Study|Protocol Violation|0|||
47073948|NCT02753530|83364504|FG000|Overall Study|Withdrawal by Subject|4|||
47073949|NCT02753530|83364505|FG001|Overall Study|Withdrawal by Subject|3|||
47073950|NCT02289079|83364517|FG000|Overall Study|Physician Decision|2|||
47073951|NCT02289079|83364518|FG001|Overall Study|Physician Decision|0|||
47073952|NCT02289079|83364517|FG000|Overall Study|Lost to Follow-up|0|||
47073953|NCT02289079|83364518|FG001|Overall Study|Lost to Follow-up|1|||
47073954|NCT00602667|83364585|FG000|Overall Study|Still on Therapy|0|||
47073955|NCT00602667|83364586|FG001|Overall Study|Still on Therapy|2|||
47073956|NCT00602667|83364587|FG002|Overall Study|Still on Therapy|2|||
47073957|NCT00602667|83364585|FG000|Overall Study|Death|0|||
47073958|NCT00602667|83364586|FG001|Overall Study|Death|1|||
47073959|NCT00602667|83364587|FG002|Overall Study|Death|1|||
47073960|NCT00602667|83364585|FG000|Overall Study|Family request|3|||
47073961|NCT00602667|83364586|FG001|Overall Study|Family request|25|||
47073962|NCT00602667|83364587|FG002|Overall Study|Family request|6|||
47073963|NCT00602667|83364585|FG000|Overall Study|Excessive toxicity|1|||
47073964|NCT00602667|83364586|FG001|Overall Study|Excessive toxicity|1|||
47073965|NCT00602667|83364587|FG002|Overall Study|Excessive toxicity|0|||
47073966|NCT00602667|83364585|FG000|Overall Study|Second malignancy|0|||
47073967|NCT00602667|83364586|FG001|Overall Study|Second malignancy|1|||
47073968|NCT00602667|83364587|FG002|Overall Study|Second malignancy|0|||
47073969|NCT00602667|83364585|FG000|Overall Study|Physician Decision|2|||
47073970|NCT00602667|83364586|FG001|Overall Study|Physician Decision|3|||
47073971|NCT00602667|83364587|FG002|Overall Study|Physician Decision|8|||
47073972|NCT00602667|83364585|FG000|Overall Study|Progressive disease|13|||
47073973|NCT00602667|83364586|FG001|Overall Study|Progressive disease|48|||
47073974|NCT00602667|83364587|FG002|Overall Study|Progressive disease|45|||
47073975|NCT00602667|83364585|FG000|Overall Study|Progressive disease prior to therapy|0|||
47073976|NCT00602667|83364586|FG001|Overall Study|Progressive disease prior to therapy|0|||
47073977|NCT00602667|83364587|FG002|Overall Study|Progressive disease prior to therapy|1|||
47073978|NCT02088905|83364626|FG000|Overall Study|Withdrawal by Subject|5|||
47073979|NCT02088905|83364627|FG001|Overall Study|Withdrawal by Subject|1|||
47073980|NCT02088047|83364635|FG000|Overall Study|Withdrawal by Subject|1|||
46849210|NCT03670810|83065832|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
47073981|NCT02088047|83364636|FG001|Overall Study|Withdrawal by Subject|0|||
47073982|NCT02086565|83364662|FG000|Overall Study|Lost to Follow-up|9|||
47073983|NCT02086565|83364663|FG001|Overall Study|Lost to Follow-up|7|||
47073984|NCT02086565|83364662|FG000|Overall Study|Withdrawal by Subject|2|||
47073985|NCT02086565|83364663|FG001|Overall Study|Withdrawal by Subject|1|||
47073986|NCT02086565|83364662|FG000|Overall Study|Death|3|||
47073987|NCT02086565|83364663|FG001|Overall Study|Death|2|||
47073988|NCT02086565|83364662|FG000|Overall Study|withdrawn by research team|2|||
46778148|NCT00784043|82996247|FG000|Overall Study|Protocol Terminated|23|||
46778149|NCT00784043|82996248|FG001|Overall Study|Protocol Terminated|1|||
46778150|NCT00773279|82996254|FG000|Period 1|Adverse Event|2|||
46778151|NCT00773279|82996255|FG001|Period 1|Adverse Event|1|||
46778152|NCT00773279|82996254|FG000|Period 1|Lack of Efficacy|0|||
46778153|NCT00773279|82996255|FG001|Period 1|Lack of Efficacy|2|||
46778154|NCT00773279|82996254|FG000|Period 1|Unclassified|5|||
46849211|NCT03670810|83065833|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
46849212|NCT03670810|83065834|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
46849213|NCT03670810|83065835|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
46849214|NCT03670810|83065836|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
46849215|NCT03670810|83065837|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
46849216|NCT03670810|83065829|FG000|Open Label Extension|Physician Decision|0|||
46849217|NCT03670810|83065830|FG001|Open Label Extension|Physician Decision|0|||
46849218|NCT03670810|83065831|FG002|Open Label Extension|Physician Decision|0|||
46849219|NCT03670810|83065832|FG003|Open Label Extension|Physician Decision|0|||
46849220|NCT03670810|83065833|FG004|Open Label Extension|Physician Decision|0|||
46849221|NCT03670810|83065834|FG005|Open Label Extension|Physician Decision|0|||
46849222|NCT03670810|83065835|FG006|Open Label Extension|Physician Decision|0|||
46849223|NCT03670810|83065836|FG007|Open Label Extension|Physician Decision|0|||
46849224|NCT03670810|83065837|FG008|Open Label Extension|Physician Decision|2|||
46849225|NCT03670810|83065829|FG000|Open Label Extension|Non-compliance with study drug|0|||
46849226|NCT03670810|83065830|FG001|Open Label Extension|Non-compliance with study drug|0|||
46849227|NCT03670810|83065831|FG002|Open Label Extension|Non-compliance with study drug|0|||
46849228|NCT03670810|83065832|FG003|Open Label Extension|Non-compliance with study drug|0|||
46849229|NCT03670810|83065833|FG004|Open Label Extension|Non-compliance with study drug|0|||
46849230|NCT03670810|83065834|FG005|Open Label Extension|Non-compliance with study drug|0|||
46849231|NCT03670810|83065835|FG006|Open Label Extension|Non-compliance with study drug|0|||
46849232|NCT03670810|83065836|FG007|Open Label Extension|Non-compliance with study drug|0|||
46849233|NCT03670810|83065837|FG008|Open Label Extension|Non-compliance with study drug|5|||
46849234|NCT03670810|83065829|FG000|Open Label Extension|Pregnancy|0|||
46969329|NCT02147158|83212158|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
46969330|NCT02147158|83212159|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
46969331|NCT02147158|83212160|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
46969332|NCT02147158|83212161|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
46969333|NCT02147158|83212162|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
46969334|NCT02147158|83212163|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
46969335|NCT02147158|83212158|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
46969336|NCT02147158|83212159|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
46969337|NCT02147158|83212160|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
46969338|NCT02147158|83212161|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
46969339|NCT02147158|83212162|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
46969340|NCT02147158|83212163|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
47073989|NCT02086565|83364663|FG001|Overall Study|withdrawn by research team|2|||
46778155|NCT00773279|82996255|FG001|Period 1|Unclassified|1|||
46778156|NCT00773279|82996254|FG000|Period 2|Adverse Event|0|||
46778157|NCT00773279|82996255|FG001|Period 2|Adverse Event|1|||
46778158|NCT00773279|82996254|FG000|Period 2|Lack of Efficacy|1|||
46778159|NCT00773279|82996255|FG001|Period 2|Lack of Efficacy|0|||
46778160|NCT00773279|82996254|FG000|Period 2|Protocol Violation|0|||
46778161|NCT00773279|82996255|FG001|Period 2|Protocol Violation|3|||
46778162|NCT00773279|82996254|FG000|Period 2|Unclassified|2|||
46778163|NCT00773279|82996255|FG001|Period 2|Unclassified|2|||
46778164|NCT00766415|82996264|FG000|Overall Study|Withdrawal by Subject|0|||
46778165|NCT00766415|82996265|FG001|Overall Study|Withdrawal by Subject|1|||
46778166|NCT00772967|82996271|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
46778167|NCT00772967|82996272|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
46778168|NCT00772967|82996273|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
46778169|NCT00772967|82996274|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
46849235|NCT03670810|83065830|FG001|Open Label Extension|Pregnancy|0|||
47073990|NCT02085941|83364671|FG000|Overall Study|Lack of Efficacy|1|||
47073991|NCT02085941|83364672|FG001|Overall Study|Lack of Efficacy|0|||
47073992|NCT02085941|83364671|FG000|Overall Study|Death|6|||
47073993|NCT02085941|83364672|FG001|Overall Study|Death|1|||
47073994|NCT02085941|83364671|FG000|Overall Study|Lost to Follow-up|1|||
47073995|NCT02085941|83364672|FG001|Overall Study|Lost to Follow-up|0|||
47073996|NCT02085941|83364671|FG000|Overall Study|Physician Decision|0|||
46778170|NCT00772967|82996275|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
46778171|NCT00772967|82996276|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
46778172|NCT00772967|82996271|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
46778173|NCT00772967|82996272|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
46778174|NCT00772967|82996273|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
46849236|NCT03670810|83065831|FG002|Open Label Extension|Pregnancy|0|||
46849237|NCT03670810|83065832|FG003|Open Label Extension|Pregnancy|0|||
46969341|NCT02147158|83212158|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
46969342|NCT02147158|83212159|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
46969343|NCT02147158|83212160|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
46778175|NCT00772967|82996274|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
46778176|NCT00772967|82996275|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
46778177|NCT00772967|82996276|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
46778178|NCT00772967|82996271|FG000|Crossover Treatment 3|Adverse Event|0|||
46778179|NCT00772967|82996272|FG001|Crossover Treatment 3|Adverse Event|0|||
46778180|NCT00772967|82996273|FG002|Crossover Treatment 3|Adverse Event|0|||
46778181|NCT00772967|82996274|FG003|Crossover Treatment 3|Adverse Event|0|||
46778182|NCT00772967|82996275|FG004|Crossover Treatment 3|Adverse Event|1|||
46778183|NCT00772967|82996276|FG005|Crossover Treatment 3|Adverse Event|0|||
46778184|NCT00662259|82996299|FG000|Overall Study|Adverse Event|2|||
46969344|NCT02147158|83212161|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
46969345|NCT02147158|83212162|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
46778185|NCT00662259|82996300|FG001|Overall Study|Adverse Event|0|||
46778186|NCT00660699|82996306|FG000|Overall Study|Withdrawal by Subject|2|||
47073997|NCT02085941|83364672|FG001|Overall Study|Physician Decision|2|||
47073998|NCT02085785|83364680|FG000|Overall Study|Withdrawal by Subject|2|||
46778187|NCT00582114|82996312|FG000|Overall Study|Death|4|||
46778188|NCT00582114|82996313|FG001|Overall Study|Death|4|||
46778189|NCT00582114|82996312|FG000|Overall Study|Kidney Transplant|3|||
46778190|NCT00582114|82996313|FG001|Overall Study|Kidney Transplant|1|||
46969346|NCT02147158|83212163|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
46969347|NCT02112448|83212182|FG000|Overall Study|lab values precluding use of ketorolac|2|||
46849238|NCT03670810|83065833|FG004|Open Label Extension|Pregnancy|0|||
46849239|NCT03670810|83065834|FG005|Open Label Extension|Pregnancy|0|||
46849240|NCT03670810|83065835|FG006|Open Label Extension|Pregnancy|0|||
46778191|NCT00582114|82996312|FG000|Overall Study|Lost to Follow-up|7|||
46778192|NCT00582114|82996313|FG001|Overall Study|Lost to Follow-up|6|||
46778193|NCT00582114|82996312|FG000|Overall Study|Withdrawal by Subject|8|||
46778194|NCT00582114|82996313|FG001|Overall Study|Withdrawal by Subject|16|||
46778195|NCT00582114|82996312|FG000|Overall Study|Adverse Event|1|||
46778196|NCT00582114|82996313|FG001|Overall Study|Adverse Event|1|||
46969348|NCT02112448|83212183|FG001|Overall Study|lab values precluding use of ketorolac|2|||
46969349|NCT02112448|83212182|FG000|Overall Study|Protocol Violation|1|||
46969350|NCT02112448|83212183|FG001|Overall Study|Protocol Violation|2|||
46969351|NCT02112448|83212182|FG000|Overall Study|Physician Decision|4|||
46969352|NCT02112448|83212183|FG001|Overall Study|Physician Decision|6|||
46969353|NCT02112448|83212182|FG000|Overall Study|required heparin so could not use ketoro|1|||
46969354|NCT02112448|83212183|FG001|Overall Study|required heparin so could not use ketoro|0|||
46969355|NCT02171260|83212195|FG000|Overall Study|Death|0|||
46969356|NCT02171260|83212196|FG001|Overall Study|Death|0|||
46969357|NCT02171260|83212197|FG002|Overall Study|Death|0|||
46969358|NCT02171260|83212198|FG003|Overall Study|Death|1|||
46969359|NCT02171260|83212195|FG000|Overall Study|Physician Decision|1|||
46969360|NCT02171260|83212196|FG001|Overall Study|Physician Decision|0|||
46969361|NCT02171260|83212197|FG002|Overall Study|Physician Decision|1|||
46969362|NCT02171260|83212198|FG003|Overall Study|Physician Decision|0|||
47073999|NCT02085785|83364681|FG001|Overall Study|Withdrawal by Subject|1|||
46778197|NCT00582114|82996312|FG000|Overall Study|Physician Decision|0|||
46778198|NCT00582114|82996313|FG001|Overall Study|Physician Decision|6|||
46778199|NCT00582114|82996312|FG000|Overall Study|Stopped by data safety monitoring board|19|||
46778200|NCT00582114|82996313|FG001|Overall Study|Stopped by data safety monitoring board|20|||
46778201|NCT00582036|82996321|FG000|Overall Study|Withdrawal by Subject|0|||
46849241|NCT03670810|83065836|FG007|Open Label Extension|Pregnancy|0|||
46849242|NCT03670810|83065837|FG008|Open Label Extension|Pregnancy|3|||
46969363|NCT02171260|83212195|FG000|Overall Study|Withdrawal by Subject|1|||
46969364|NCT02171260|83212196|FG001|Overall Study|Withdrawal by Subject|0|||
46969365|NCT02171260|83212197|FG002|Overall Study|Withdrawal by Subject|0|||
46969366|NCT02171260|83212198|FG003|Overall Study|Withdrawal by Subject|0|||
46969367|NCT02171260|83212195|FG000|Overall Study|Evidence of progressive disease|4|||
47074000|NCT02085785|83364680|FG000|Overall Study|Lost to Follow-up|0|||
46778202|NCT00582036|82996322|FG001|Overall Study|Withdrawal by Subject|1|||
46849243|NCT03670810|83065829|FG000|Open Label Extension|Adverse Event|0|||
46969368|NCT02171260|83212196|FG001|Overall Study|Evidence of progressive disease|6|||
46969369|NCT02171260|83212197|FG002|Overall Study|Evidence of progressive disease|4|||
46969370|NCT02171260|83212198|FG003|Overall Study|Evidence of progressive disease|4|||
46969371|NCT02110732|83212216|FG000|Overall Study|Physician Decision|5|||
46778203|NCT00581360|82996328|FG000|Overall Study|Withdrawal by Subject|1|||
46778204|NCT00660387|82996334|FG000|Overall Study|Adverse Event|1|||
46778205|NCT00660387|82996335|FG001|Overall Study|Adverse Event|2|||
46778206|NCT00660387|82996334|FG000|Overall Study|Lack of Efficacy|0|||
46778207|NCT00660387|82996335|FG001|Overall Study|Lack of Efficacy|1|||
46778208|NCT00660387|82996334|FG000|Overall Study|Protocol Violation|1|||
46849244|NCT03670810|83065830|FG001|Open Label Extension|Adverse Event|0|||
46849245|NCT03670810|83065831|FG002|Open Label Extension|Adverse Event|0|||
46849246|NCT03670810|83065832|FG003|Open Label Extension|Adverse Event|0|||
46849247|NCT03670810|83065833|FG004|Open Label Extension|Adverse Event|0|||
46849248|NCT03670810|83065834|FG005|Open Label Extension|Adverse Event|0|||
46849249|NCT03670810|83065835|FG006|Open Label Extension|Adverse Event|0|||
46849250|NCT03670810|83065836|FG007|Open Label Extension|Adverse Event|0|||
46849251|NCT03670810|83065837|FG008|Open Label Extension|Adverse Event|24|||
46849252|NCT03670810|83065829|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
46849253|NCT03670810|83065830|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
46849254|NCT03670810|83065831|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
46849255|NCT03670810|83065832|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
46849256|NCT03670810|83065833|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
46849257|NCT03670810|83065834|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
46849258|NCT03670810|83065835|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
46849259|NCT03670810|83065836|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
46849260|NCT03670810|83065837|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
46849261|NCT03670810|83065829|FG000|Open Label Extension|Lost to Follow-up|0|||
46849262|NCT03670810|83065830|FG001|Open Label Extension|Lost to Follow-up|0|||
46849263|NCT03670810|83065831|FG002|Open Label Extension|Lost to Follow-up|0|||
46849264|NCT03670810|83065832|FG003|Open Label Extension|Lost to Follow-up|0|||
46849265|NCT03670810|83065833|FG004|Open Label Extension|Lost to Follow-up|0|||
46849266|NCT03670810|83065834|FG005|Open Label Extension|Lost to Follow-up|0|||
46849267|NCT03670810|83065835|FG006|Open Label Extension|Lost to Follow-up|0|||
46849268|NCT03670810|83065836|FG007|Open Label Extension|Lost to Follow-up|0|||
46849269|NCT03670810|83065837|FG008|Open Label Extension|Lost to Follow-up|23|||
46849270|NCT00089648|83065851|FG000|Overall Study|Adverse Event|7|||
46849271|NCT00089648|83065851|FG000|Overall Study|Withdrawal by Subject|1|||
46849272|NCT00089648|83065851|FG000|Overall Study|Lack of Efficacy|33|||
46849273|NCT00118040|83065858|FG000|Overall Study|Adverse Event|0|||
46849274|NCT00118040|83065859|FG001|Overall Study|Adverse Event|1|||
46849275|NCT00118040|83065860|FG002|Overall Study|Adverse Event|0|||
46849276|NCT00118040|83065858|FG000|Overall Study|Withdrawal by Subject|0|||
46849277|NCT00118040|83065859|FG001|Overall Study|Withdrawal by Subject|0|||
46849278|NCT00118040|83065860|FG002|Overall Study|Withdrawal by Subject|2|||
46849279|NCT00118040|83065858|FG000|Overall Study|Medical Contraindication|0|||
46849280|NCT00118040|83065859|FG001|Overall Study|Medical Contraindication|0|||
46849281|NCT00118040|83065860|FG002|Overall Study|Medical Contraindication|1|||
46849282|NCT00118040|83065858|FG000|Overall Study|Non-Compliant Participant|1|||
46849283|NCT00118040|83065859|FG001|Overall Study|Non-Compliant Participant|1|||
46849284|NCT00118040|83065860|FG002|Overall Study|Non-Compliant Participant|2|||
46849285|NCT00118040|83065858|FG000|Overall Study|Other|0|||
46849286|NCT00118040|83065859|FG001|Overall Study|Other|0|||
46969372|NCT02110732|83212217|FG001|Overall Study|Physician Decision|2|||
46969373|NCT02110732|83212216|FG000|Overall Study|Lost to Follow-up|1|||
46969374|NCT02110732|83212217|FG001|Overall Study|Lost to Follow-up|1|||
46969375|NCT02109562|83212226|FG000|Overall Study|Insufficient clinical response|2|||
46778209|NCT00660387|82996335|FG001|Overall Study|Protocol Violation|0|||
46778210|NCT00582738|82996343|FG000|Overall Study|Administrative Problems|7|||
46778211|NCT00582738|82996344|FG001|Overall Study|Administrative Problems|8|||
46778212|NCT00582738|82996343|FG000|Overall Study|Adverse Event|0|||
46778213|NCT00582738|82996344|FG001|Overall Study|Adverse Event|5|||
46778214|NCT00582738|82996343|FG000|Overall Study|Graft Lost|0|||
46778215|NCT00582738|82996344|FG001|Overall Study|Graft Lost|1|||
46778216|NCT00582738|82996343|FG000|Overall Study|Other|1|||
46778217|NCT00582738|82996344|FG001|Overall Study|Other|0|||
46778218|NCT00582738|82996343|FG000|Overall Study|Protocol Violation|1|||
46778219|NCT00582738|82996344|FG001|Overall Study|Protocol Violation|1|||
46778220|NCT00582738|82996343|FG000|Overall Study|Withdrawal by Subject|0|||
46778221|NCT00582738|82996344|FG001|Overall Study|Withdrawal by Subject|3|||
46778222|NCT00772889|82996359|FG000|Overall Study|Adverse Event|7|||
46778223|NCT00772889|82996360|FG001|Overall Study|Adverse Event|4|||
46849287|NCT00118040|83065860|FG002|Overall Study|Other|1|||
46849288|NCT00389207|83065876|FG000|Overall Study|Adverse Event|26|||
46849289|NCT00389207|83065877|FG001|Overall Study|Adverse Event|32|||
46969376|NCT02109562|83212227|FG001|Overall Study|Insufficient clinical response|0|||
46969377|NCT02109562|83212228|FG002|Overall Study|Insufficient clinical response|4|||
46778224|NCT00772889|82996361|FG002|Overall Study|Adverse Event|0|||
46778225|NCT00772889|82996359|FG000|Overall Study|Withdrawal by Subject|9|||
46849290|NCT00389207|83065878|FG002|Overall Study|Adverse Event|10|||
46849291|NCT00389207|83065876|FG000|Overall Study|Protocol Violation|3|||
46849292|NCT00389207|83065877|FG001|Overall Study|Protocol Violation|1|||
46849293|NCT00389207|83065878|FG002|Overall Study|Protocol Violation|4|||
46849294|NCT00389207|83065876|FG000|Overall Study|Lost to Follow-up|12|||
46969378|NCT02109562|83212226|FG000|Overall Study|Adverse Event|0|||
46778226|NCT00772889|82996360|FG001|Overall Study|Withdrawal by Subject|8|||
46969379|NCT02109562|83212227|FG001|Overall Study|Adverse Event|2|||
46969380|NCT02109562|83212228|FG002|Overall Study|Adverse Event|3|||
46969381|NCT02109562|83212226|FG000|Overall Study|Lost to Follow-up|1|||
46969382|NCT02109562|83212227|FG001|Overall Study|Lost to Follow-up|0|||
46969383|NCT02109562|83212228|FG002|Overall Study|Lost to Follow-up|1|||
46969384|NCT02109562|83212226|FG000|Overall Study|Protocol Violation|0|||
46969385|NCT02109562|83212227|FG001|Overall Study|Protocol Violation|3|||
46969386|NCT02109562|83212228|FG002|Overall Study|Protocol Violation|1|||
46969387|NCT02109562|83212226|FG000|Overall Study|Withdrawal by Subject|20|||
46969388|NCT02109562|83212227|FG001|Overall Study|Withdrawal by Subject|25|||
46969389|NCT02109562|83212228|FG002|Overall Study|Withdrawal by Subject|21|||
46969390|NCT02109562|83212226|FG000|Overall Study|Physician Decision|3|||
46969391|NCT02109562|83212227|FG001|Overall Study|Physician Decision|4|||
46969392|NCT02109562|83212228|FG002|Overall Study|Physician Decision|5|||
46969393|NCT02109484|83212244|FG000|Overall Study|Lost to Follow-up|0|||
46969394|NCT02109484|83212245|FG001|Overall Study|Lost to Follow-up|0|||
46969395|NCT02109484|83212246|FG002|Overall Study|Lost to Follow-up|0|||
46969396|NCT02109484|83212247|FG003|Overall Study|Lost to Follow-up|1|||
46969397|NCT02109484|83212248|FG004|Overall Study|Lost to Follow-up|1|||
46969398|NCT02109484|83212249|FG005|Overall Study|Lost to Follow-up|0|||
46969399|NCT02109484|83212250|FG006|Overall Study|Lost to Follow-up|1|||
46969400|NCT02109484|83212251|FG007|Overall Study|Lost to Follow-up|0|||
46969401|NCT02109484|83212244|FG000|Overall Study|Withdrawal by Subject|0|||
46969402|NCT02109484|83212245|FG001|Overall Study|Withdrawal by Subject|0|||
46969403|NCT02109484|83212246|FG002|Overall Study|Withdrawal by Subject|0|||
46969404|NCT02109484|83212247|FG003|Overall Study|Withdrawal by Subject|0|||
46969405|NCT02109484|83212248|FG004|Overall Study|Withdrawal by Subject|1|||
46969406|NCT02109484|83212249|FG005|Overall Study|Withdrawal by Subject|1|||
46969407|NCT02109484|83212250|FG006|Overall Study|Withdrawal by Subject|1|||
47074001|NCT02085785|83364681|FG001|Overall Study|Lost to Follow-up|1|||
47074002|NCT02085161|83364709|FG000|Overall Study|Not Treated|1|||
47074003|NCT02085161|83364710|FG001|Overall Study|Not Treated|0|||
47074004|NCT02085161|83364711|FG002|Overall Study|Not Treated|0|||
47074005|NCT02085161|83364712|FG003|Overall Study|Not Treated|0|||
47074006|NCT02085161|83364709|FG000|Overall Study|Adverse Event|8|||
47074007|NCT02085161|83364710|FG001|Overall Study|Adverse Event|5|||
47074008|NCT02085161|83364711|FG002|Overall Study|Adverse Event|4|||
47074009|NCT02085161|83364712|FG003|Overall Study|Adverse Event|5|||
47074010|NCT02085161|83364709|FG000|Overall Study|Protocol Violation|0|||
47074011|NCT02085161|83364710|FG001|Overall Study|Protocol Violation|1|||
47074012|NCT02085161|83364711|FG002|Overall Study|Protocol Violation|0|||
47074013|NCT02085161|83364712|FG003|Overall Study|Protocol Violation|1|||
47074014|NCT02085161|83364709|FG000|Overall Study|Withdrawal by Subject|2|||
47074015|NCT02085161|83364710|FG001|Overall Study|Withdrawal by Subject|4|||
46849295|NCT00389207|83065877|FG001|Overall Study|Lost to Follow-up|9|||
46969408|NCT02109484|83212251|FG007|Overall Study|Withdrawal by Subject|0|||
46969409|NCT02109484|83212244|FG000|Overall Study|Physician Decision|0|||
46969410|NCT02109484|83212245|FG001|Overall Study|Physician Decision|0|||
46969411|NCT02109484|83212246|FG002|Overall Study|Physician Decision|0|||
46969412|NCT02109484|83212247|FG003|Overall Study|Physician Decision|0|||
46969413|NCT02109484|83212248|FG004|Overall Study|Physician Decision|2|||
47074016|NCT02085161|83364711|FG002|Overall Study|Withdrawal by Subject|0|||
47074017|NCT02085161|83364712|FG003|Overall Study|Withdrawal by Subject|3|||
47074018|NCT02085161|83364709|FG000|Overall Study|Other Reason|1|||
46969414|NCT02109484|83212249|FG005|Overall Study|Physician Decision|0|||
46969415|NCT02109484|83212250|FG006|Overall Study|Physician Decision|0|||
46969416|NCT02109484|83212251|FG007|Overall Study|Physician Decision|0|||
46969417|NCT02109484|83212244|FG000|Overall Study|Death|0|||
46969418|NCT02109484|83212245|FG001|Overall Study|Death|0|||
46969419|NCT02109484|83212246|FG002|Overall Study|Death|0|||
46969420|NCT02109484|83212247|FG003|Overall Study|Death|0|||
46969421|NCT02109484|83212248|FG004|Overall Study|Death|0|||
47074019|NCT02085161|83364710|FG001|Overall Study|Other Reason|0|||
46969422|NCT02109484|83212249|FG005|Overall Study|Death|0|||
47074020|NCT02085161|83364711|FG002|Overall Study|Other Reason|1|||
46969423|NCT02109484|83212250|FG006|Overall Study|Death|0|||
46969424|NCT02109484|83212251|FG007|Overall Study|Death|2|||
46969425|NCT02109484|83212244|FG000|Overall Study|Moved away from study area|0|||
46969426|NCT02109484|83212245|FG001|Overall Study|Moved away from study area|0|||
46969427|NCT02109484|83212246|FG002|Overall Study|Moved away from study area|0|||
46969428|NCT02109484|83212247|FG003|Overall Study|Moved away from study area|0|||
46969429|NCT02109484|83212248|FG004|Overall Study|Moved away from study area|0|||
46969430|NCT02109484|83212249|FG005|Overall Study|Moved away from study area|0|||
46969431|NCT02109484|83212250|FG006|Overall Study|Moved away from study area|1|||
46969432|NCT02109484|83212251|FG007|Overall Study|Moved away from study area|1|||
46969433|NCT02105974|83212288|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
46969434|NCT02105974|83212289|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
46969435|NCT02105974|83212290|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
46969436|NCT02105974|83212288|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
46969437|NCT02105974|83212289|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
46969438|NCT02105974|83212290|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
46969439|NCT02105974|83212288|FG000|2 Week Run-in Period|Adverse Event|6|||
46969440|NCT02105974|83212289|FG001|2 Week Run-in Period|Adverse Event|0|||
46969441|NCT02105974|83212290|FG002|2 Week Run-in Period|Adverse Event|0|||
46969442|NCT02105974|83212288|FG000|2 Week Run-in Period|Study closed/terminated|1|||
46969443|NCT02105974|83212289|FG001|2 Week Run-in Period|Study closed/terminated|0|||
46969444|NCT02105974|83212290|FG002|2 Week Run-in Period|Study closed/terminated|0|||
46969445|NCT02105974|83212288|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
46969446|NCT02105974|83212289|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
46969447|NCT02105974|83212290|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
46969448|NCT02105974|83212288|FG000|2 Week Run-in Period|Withdrew consent|23|||
46969449|NCT02105974|83212289|FG001|2 Week Run-in Period|Withdrew consent|0|||
46969450|NCT02105974|83212290|FG002|2 Week Run-in Period|Withdrew consent|0|||
46969451|NCT02105974|83212288|FG000|2 Week Run-in Period|Investigator discretion|8|||
46969452|NCT02105974|83212289|FG001|2 Week Run-in Period|Investigator discretion|0|||
46969453|NCT02105974|83212290|FG002|2 Week Run-in Period|Investigator discretion|0|||
46969454|NCT02105974|83212288|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
46969455|NCT02105974|83212289|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
46969456|NCT02105974|83212290|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
46969457|NCT02105974|83212288|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
46969458|NCT02105974|83212289|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
46969459|NCT02105974|83212290|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
46969460|NCT02105974|83212288|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
46969461|NCT02105974|83212289|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
46969462|NCT02105974|83212290|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
46969463|NCT02105974|83212288|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
46969464|NCT02105974|83212289|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
46849296|NCT00389207|83065878|FG002|Overall Study|Lost to Follow-up|7|||
46849297|NCT00389207|83065876|FG000|Overall Study|Withdrawal by Subject|5|||
46849298|NCT00389207|83065877|FG001|Overall Study|Withdrawal by Subject|7|||
46849299|NCT00389207|83065878|FG002|Overall Study|Withdrawal by Subject|11|||
46849300|NCT00389207|83065876|FG000|Overall Study|Other|17|||
46849301|NCT00389207|83065877|FG001|Overall Study|Other|23|||
46849302|NCT00389207|83065878|FG002|Overall Study|Other|9|||
46849303|NCT00388973|83065893|FG000|Overall Study|Adverse Event|16|||
46849304|NCT00388973|83065894|FG001|Overall Study|Adverse Event|6|||
46849305|NCT00388973|83065893|FG000|Overall Study|Lack of Efficacy|1|||
46849306|NCT00388973|83065894|FG001|Overall Study|Lack of Efficacy|12|||
46849307|NCT00388973|83065893|FG000|Overall Study|Protocol Violation|3|||
46849308|NCT00388973|83065894|FG001|Overall Study|Protocol Violation|0|||
46849309|NCT00388973|83065893|FG000|Overall Study|Withdrawal by Subject|14|||
46849310|NCT00388973|83065894|FG001|Overall Study|Withdrawal by Subject|17|||
46849311|NCT00388973|83065893|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
46969465|NCT02105974|83212290|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
46642337|NCT02407236|82832244|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642338|NCT02407236|82832245|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46969466|NCT02105974|83212288|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
46969467|NCT02105974|83212289|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
46969468|NCT02105974|83212290|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
46969469|NCT02105974|83212288|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
46849312|NCT00388973|83065894|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
46969470|NCT02105974|83212289|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
46849313|NCT00388973|83065893|FG000|Overall Study|Did not complete 61 days of treatment|5|||
46849314|NCT00388973|83065894|FG001|Overall Study|Did not complete 61 days of treatment|4|||
46849315|NCT00388973|83065893|FG000|Overall Study|Left region|0|||
46849316|NCT00388973|83065894|FG001|Overall Study|Left region|1|||
46849317|NCT00388973|83065893|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
46849318|NCT00388973|83065894|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
46849319|NCT00388583|83065902|FG000|Overall Study|Protocol Violation|1|||
46849320|NCT00388583|83065903|FG001|Overall Study|Protocol Violation|0|||
46849321|NCT00388583|83065902|FG000|Overall Study|Withdrawal by Subject|3|||
46849322|NCT00388583|83065903|FG001|Overall Study|Withdrawal by Subject|3|||
46849323|NCT00388583|83065902|FG000|Overall Study|Serious Adverse Event|2|||
46849324|NCT00388583|83065903|FG001|Overall Study|Serious Adverse Event|0|||
46849325|NCT00388583|83065902|FG000|Overall Study|Did not receive vaccine|0|||
46849326|NCT00388583|83065903|FG001|Overall Study|Did not receive vaccine|1|||
46849327|NCT00117572|83065911|FG000|Overall Study|Site withdrew before starting treatment|2|||
46849328|NCT00117572|83065912|FG001|Overall Study|Site withdrew before starting treatment|3|||
46849329|NCT00117572|83065911|FG000|Overall Study|Withdrawal by Subject|3|||
46849330|NCT00117572|83065912|FG001|Overall Study|Withdrawal by Subject|3|||
46849331|NCT00117572|83065911|FG000|Overall Study|Protocol Violation|1|||
46849332|NCT00117572|83065912|FG001|Overall Study|Protocol Violation|0|||
46849333|NCT00388505|83065920|FG000|Overall Study|Adverse Event or Death|43|||
46849334|NCT00388505|83065921|FG001|Overall Study|Adverse Event or Death|17|||
46849335|NCT00388505|83065920|FG000|Overall Study|Withdrawal by Subject|24|||
46849336|NCT00388505|83065921|FG001|Overall Study|Withdrawal by Subject|9|||
46778227|NCT00772889|82996361|FG002|Overall Study|Withdrawal by Subject|9|||
46778228|NCT00772889|82996359|FG000|Overall Study|Lost to Follow-up|6|||
46778229|NCT00772889|82996360|FG001|Overall Study|Lost to Follow-up|6|||
46778230|NCT00772889|82996361|FG002|Overall Study|Lost to Follow-up|7|||
46778231|NCT01247324|82996371|FG000|Overall Study|Death|6|||
46778232|NCT01247324|82996372|FG001|Overall Study|Death|10|||
46778233|NCT01247324|82996371|FG000|Overall Study|Physician Decision|2|||
46778234|NCT01247324|82996372|FG001|Overall Study|Physician Decision|3|||
46778235|NCT01247324|82996371|FG000|Overall Study|Non-compliance with study drug|3|||
46778236|NCT01247324|82996372|FG001|Overall Study|Non-compliance with study drug|0|||
46778237|NCT01247324|82996371|FG000|Overall Study|Lack of Efficacy|24|||
46778238|NCT01247324|82996372|FG001|Overall Study|Lack of Efficacy|14|||
46778239|NCT01247324|82996371|FG000|Overall Study|Non-compliance|3|||
46778240|NCT01247324|82996372|FG001|Overall Study|Non-compliance|2|||
46778241|NCT01247324|82996371|FG000|Overall Study|Pregnancy|5|||
46778242|NCT01247324|82996372|FG001|Overall Study|Pregnancy|10|||
46778243|NCT01247324|82996371|FG000|Overall Study|Protocol Violation|1|||
46778244|NCT01247324|82996372|FG001|Overall Study|Protocol Violation|1|||
46778245|NCT01247324|82996371|FG000|Overall Study|Reason not specified|42|||
46778246|NCT01247324|82996372|FG001|Overall Study|Reason not specified|32|||
46778247|NCT01247324|82996371|FG000|Overall Study|Consent withdrawn by participant|41|||
46778248|NCT01247324|82996372|FG001|Overall Study|Consent withdrawn by participant|56|||
46778249|NCT01247324|82996371|FG000|Overall Study|Adverse Event|49|||
46642339|NCT02407236|82832246|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642340|NCT02407236|82832247|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642341|NCT02407236|82832248|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642342|NCT02407236|82832249|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642343|NCT02407236|82832250|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642344|NCT02407236|82832251|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46778250|NCT01247324|82996372|FG001|Overall Study|Adverse Event|35|||
46778251|NCT01247324|82996371|FG000|Overall Study|Lost to Follow-up|3|||
46778252|NCT01247324|82996372|FG001|Overall Study|Lost to Follow-up|6|||
46778253|NCT01247324|82996371|FG000|Overall Study|Study Terminated by Sponsor|4|||
46778254|NCT01247324|82996372|FG001|Overall Study|Study Terminated by Sponsor|1|||
46778255|NCT01247324|82996371|FG000|Overall Study|Missing|2|||
46778256|NCT01247324|82996372|FG001|Overall Study|Missing|1|||
47074021|NCT02085161|83364712|FG003|Overall Study|Other Reason|1|||
47074022|NCT02082977|83365595|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
47074023|NCT02082977|83365596|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
46642345|NCT02407236|82832252|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
46778257|NCT00772577|82996387|FG000|Overall Study|Adverse Event|6|||
46849337|NCT00388505|83065920|FG000|Overall Study|Lost to Follow-up|5|||
46849338|NCT00388505|83065921|FG001|Overall Study|Lost to Follow-up|3|||
46778258|NCT00772577|82996388|FG001|Overall Study|Adverse Event|3|||
46778259|NCT00772577|82996387|FG000|Overall Study|Abnormal laboratory values|0|||
46778260|NCT00772577|82996388|FG001|Overall Study|Abnormal laboratory values|1|||
46778261|NCT00772577|82996387|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46778262|NCT00772577|82996388|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
46778263|NCT00772577|82996387|FG000|Overall Study|Patient withdrew consent|8|||
46849339|NCT00388505|83065920|FG000|Overall Study|Inappropriate Enrollment|0|||
46849340|NCT00388505|83065921|FG001|Overall Study|Inappropriate Enrollment|1|||
47074024|NCT02082977|83365597|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
47074025|NCT02082977|83365598|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
46778264|NCT00772577|82996388|FG001|Overall Study|Patient withdrew consent|5|||
46778265|NCT00772577|82996387|FG000|Overall Study|Lost to Follow-up|4|||
46778266|NCT00772577|82996388|FG001|Overall Study|Lost to Follow-up|3|||
46778267|NCT00772577|82996387|FG000|Overall Study|Administrative problems|2|||
46778268|NCT00772577|82996388|FG001|Overall Study|Administrative problems|1|||
46778269|NCT00772577|82996387|FG000|Overall Study|Protocol Deviation|3|||
46778270|NCT00772577|82996388|FG001|Overall Study|Protocol Deviation|2|||
46778271|NCT02345850|82996397|FG000|Overall Study|Not transplanted|10|||
46778272|NCT02345850|82996398|FG001|Overall Study|Not transplanted|5|||
46778273|NCT02345850|82996399|FG002|Overall Study|Not transplanted|4|||
46778274|NCT02345850|82996397|FG000|Overall Study|Lost to Follow-up|2|||
46778275|NCT02345850|82996398|FG001|Overall Study|Lost to Follow-up|3|||
46778276|NCT02345850|82996399|FG002|Overall Study|Lost to Follow-up|2|||
46778277|NCT02345850|82996397|FG000|Overall Study|Withdrawal by Subject|1|||
46778278|NCT02345850|82996398|FG001|Overall Study|Withdrawal by Subject|0|||
46778279|NCT02345850|82996399|FG002|Overall Study|Withdrawal by Subject|0|||
46778280|NCT00659607|82996407|FG000|Overall Study|No blood pressure recorded|147|||
46778281|NCT00659607|82996407|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
46778282|NCT00659607|82996407|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
46778283|NCT00659607|82996407|FG000|Overall Study|No recorded efficacy data|15|||
46778284|NCT00659607|82996407|FG000|Overall Study|Inconsistent BP measuring date|2|||
46778285|NCT02848092|82996415|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
46778286|NCT02848092|82996416|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
46778287|NCT02848092|82996415|FG000|1-month Post-training Follow-up|Adverse Event|2|||
46778288|NCT02848092|82996416|FG001|1-month Post-training Follow-up|Adverse Event|1|||
46778289|NCT02848092|82996415|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
46778290|NCT02848092|82996416|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
46778291|NCT02848092|82996415|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
46778292|NCT02848092|82996416|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
46778293|NCT02848092|82996415|FG000|1-month Post-training Follow-up|fatigue|0|||
46778294|NCT02848092|82996416|FG001|1-month Post-training Follow-up|fatigue|1|||
46778295|NCT02848092|82996415|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
46778296|NCT02848092|82996416|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
46778297|NCT02848092|82996415|FG000|6-month Post-training Follow-up|Adverse Event|1|||
46778298|NCT02848092|82996416|FG001|6-month Post-training Follow-up|Adverse Event|1|||
46849341|NCT00388505|83065920|FG000|Overall Study|Administrative Reason|1|||
46849342|NCT00388505|83065921|FG001|Overall Study|Administrative Reason|0|||
46849343|NCT00388505|83065920|FG000|Overall Study|Protocol Violation|6|||
46849344|NCT00388505|83065921|FG001|Overall Study|Protocol Violation|5|||
46849345|NCT00388505|83065920|FG000|Overall Study|Unable to classify|4|||
46849346|NCT00388505|83065921|FG001|Overall Study|Unable to classify|3|||
46849347|NCT00388349|83065927|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
46849348|NCT00388349|83065928|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
46849349|NCT00117338|83065938|FG000|Overall Study|Adverse Event|0|||
46849350|NCT00117338|83065939|FG001|Overall Study|Adverse Event|1|||
46849351|NCT00117338|83065938|FG000|Overall Study|Protocol Violation|3|||
46849352|NCT00117338|83065939|FG001|Overall Study|Protocol Violation|2|||
47074026|NCT02082977|83365599|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
47074027|NCT02082977|83365600|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
47074028|NCT02082977|83365601|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
47074029|NCT02082977|83365602|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
46849353|NCT00117338|83065938|FG000|Overall Study|Withdrawal by Subject|1|||
46849354|NCT00117338|83065939|FG001|Overall Study|Withdrawal by Subject|0|||
47074030|NCT02082977|83365603|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
47074031|NCT02082977|83365604|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
47074032|NCT02082977|83365595|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
46778299|NCT02848092|82996415|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
46778300|NCT02848092|82996416|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
46778301|NCT02848092|82996415|FG000|6-month Post-training Follow-up|frustrated with task|1|||
46778302|NCT02848092|82996416|FG001|6-month Post-training Follow-up|frustrated with task|0|||
46778303|NCT02848092|82996415|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
46849355|NCT00117338|83065938|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
46849356|NCT00117338|83065939|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
46849357|NCT00117338|83065938|FG000|Overall Study|Lack of Efficacy|0|||
46849358|NCT00117338|83065939|FG001|Overall Study|Lack of Efficacy|1|||
46849359|NCT00388037|83065945|FG000|Overall Study|Protocol Violation|1|||
46849360|NCT00387881|83065951|FG000|Overall Study|Lost to Follow-up|23|||
46849361|NCT00387881|83065952|FG001|Overall Study|Lost to Follow-up|23|||
46849362|NCT00387881|83065951|FG000|Overall Study|Protocol Violation|2|||
46849363|NCT00387881|83065952|FG001|Overall Study|Protocol Violation|12|||
46849364|NCT00387881|83065951|FG000|Overall Study|Withdrawal by Subject|15|||
46849365|NCT00387881|83065952|FG001|Overall Study|Withdrawal by Subject|18|||
46849366|NCT00387881|83065951|FG000|Overall Study|Sponsor terminated Study|0|||
46849367|NCT00387881|83065952|FG001|Overall Study|Sponsor terminated Study|1|||
46849368|NCT00387881|83065951|FG000|Overall Study|Not eligible|6|||
46849369|NCT00387881|83065952|FG001|Overall Study|Not eligible|7|||
46849370|NCT00387881|83065951|FG000|Overall Study|No opportunity to treat headache|32|||
46849371|NCT00387881|83065952|FG001|Overall Study|No opportunity to treat headache|34|||
46849372|NCT00387881|83065951|FG000|Overall Study|Not otherwise specified|11|||
46849373|NCT00387881|83065952|FG001|Overall Study|Not otherwise specified|7|||
46849374|NCT00084656|83065961|FG000|Overall Study|Other reasons|0|||
46849375|NCT00084656|83065962|FG001|Overall Study|Other reasons|12|||
46849376|NCT00084656|83065963|FG002|Overall Study|Other reasons|11|||
46849377|NCT00084656|83065961|FG000|Overall Study|Withdrawal by Subject|15|||
46849378|NCT00084656|83065962|FG001|Overall Study|Withdrawal by Subject|4|||
46849379|NCT00084656|83065963|FG002|Overall Study|Withdrawal by Subject|4|||
46849380|NCT00084656|83065961|FG000|Overall Study|Disease relapse|0|||
46849381|NCT00084656|83065962|FG001|Overall Study|Disease relapse|9|||
46849382|NCT00084656|83065963|FG002|Overall Study|Disease relapse|10|||
46849383|NCT00084656|83065961|FG000|Overall Study|Disease progression|9|||
46849384|NCT00084656|83065962|FG001|Overall Study|Disease progression|0|||
46849385|NCT00084656|83065963|FG002|Overall Study|Disease progression|0|||
46849386|NCT00084656|83065961|FG000|Overall Study|Lost to Follow-up|1|||
46849387|NCT00084656|83065962|FG001|Overall Study|Lost to Follow-up|0|||
46849388|NCT00084656|83065963|FG002|Overall Study|Lost to Follow-up|1|||
46849389|NCT00387725|83065977|FG000|Overall Study|Adverse Event|0|||
46849390|NCT00387725|83065978|FG001|Overall Study|Adverse Event|0|||
46849391|NCT00387725|83065979|FG002|Overall Study|Adverse Event|0|||
46849392|NCT00387725|83065980|FG003|Overall Study|Adverse Event|1|||
46849393|NCT00387725|83065977|FG000|Overall Study|Protocol Violation|0|||
46849394|NCT00387725|83065978|FG001|Overall Study|Protocol Violation|1|||
46849395|NCT00387725|83065979|FG002|Overall Study|Protocol Violation|0|||
46849396|NCT00387725|83065980|FG003|Overall Study|Protocol Violation|0|||
46849397|NCT00387725|83065977|FG000|Overall Study|Withdrawal by Subject|1|||
46849398|NCT00387725|83065978|FG001|Overall Study|Withdrawal by Subject|0|||
46849399|NCT00387725|83065979|FG002|Overall Study|Withdrawal by Subject|1|||
46849400|NCT00387725|83065980|FG003|Overall Study|Withdrawal by Subject|0|||
46849401|NCT00387725|83065977|FG000|Overall Study|Parent/legal guardian request|0|||
46849402|NCT00387725|83065978|FG001|Overall Study|Parent/legal guardian request|0|||
46849403|NCT00387725|83065979|FG002|Overall Study|Parent/legal guardian request|1|||
46849404|NCT00387725|83065980|FG003|Overall Study|Parent/legal guardian request|1|||
46849405|NCT00102596|83065990|FG000|Part A|Screen failures|6|||
46849406|NCT00102596|83065991|FG001|Part A|Screen failures|0|||
46849407|NCT00102596|83065990|FG000|Part A|Adverse Event|1|||
46849408|NCT00102596|83065991|FG001|Part A|Adverse Event|0|||
46849409|NCT00387647|83065998|FG000|Overall Study|Death|18|||
46969471|NCT02105974|83212290|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
46969472|NCT02105974|83212288|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
46969473|NCT02105974|83212289|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
46969474|NCT02105974|83212290|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
46969475|NCT02105662|83212296|FG000|Overall Study|Lost to Follow-up|5|||
46969476|NCT02105662|83212296|FG000|Overall Study|Withdrawal by Subject|1|||
46969477|NCT02143102|83212302|FG000|Overall Study|Lost to Follow-up|11|||
46969478|NCT02143102|83212303|FG001|Overall Study|Lost to Follow-up|0|||
46969479|NCT02143024|83212311|FG000|Overall Study|Lost to Follow-up|1|||
46969480|NCT02143024|83212312|FG001|Overall Study|Lost to Follow-up|1|||
46969481|NCT02143024|83212311|FG000|Overall Study|Withdrawal by Subject|1|||
46969482|NCT02143024|83212312|FG001|Overall Study|Withdrawal by Subject|0|||
46969483|NCT02142712|83212321|FG000|Overall Study|Lost to Follow-up|1|||
46969484|NCT02142712|83212322|FG001|Overall Study|Lost to Follow-up|1|||
46969485|NCT02142712|83212323|FG002|Overall Study|Lost to Follow-up|1|||
46969486|NCT02142712|83212324|FG003|Overall Study|Lost to Follow-up|0|||
47074033|NCT02082977|83365596|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
47074034|NCT02082977|83365597|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
46849410|NCT00386009|83066004|FG000|Overall Study|Adverse Event|0|||
46849411|NCT00386009|83066005|FG001|Overall Study|Adverse Event|2|||
47074035|NCT02082977|83365598|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
46849412|NCT00386009|83066004|FG000|Overall Study|Death|1|||
46969487|NCT02105272|83212335|FG000|Overall Study|Adverse Event|1|||
47074036|NCT02082977|83365599|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
47074037|NCT02082977|83365600|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
46969488|NCT02105272|83212336|FG001|Overall Study|Adverse Event|2|||
47074038|NCT02082977|83365601|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
47074039|NCT02082977|83365602|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
46969489|NCT02105272|83212335|FG000|Overall Study|Physician Decision|0|||
46849413|NCT00386009|83066005|FG001|Overall Study|Death|0|||
46849414|NCT00386009|83066004|FG000|Overall Study|Entry Criteria Not Met|0|||
46849415|NCT00386009|83066005|FG001|Overall Study|Entry Criteria Not Met|2|||
46849416|NCT00386009|83066004|FG000|Overall Study|Lost to Follow-up|1|||
46849417|NCT00386009|83066005|FG001|Overall Study|Lost to Follow-up|1|||
46849418|NCT00386009|83066004|FG000|Overall Study|Protocol Violation|1|||
46849419|NCT00386009|83066005|FG001|Overall Study|Protocol Violation|0|||
46849420|NCT00386009|83066004|FG000|Overall Study|Sponsor Decision|1|||
46969490|NCT02105272|83212336|FG001|Overall Study|Physician Decision|1|||
46969491|NCT02105272|83212335|FG000|Overall Study|Protocol Violation|2|||
46969492|NCT02105272|83212336|FG001|Overall Study|Protocol Violation|0|||
46969493|NCT02105272|83212335|FG000|Overall Study|Withdrawal by Subject|2|||
46849421|NCT00386009|83066005|FG001|Overall Study|Sponsor Decision|1|||
46849422|NCT00386009|83066004|FG000|Overall Study|Withdrawal by Subject|5|||
46849423|NCT00386009|83066005|FG001|Overall Study|Withdrawal by Subject|4|||
46849424|NCT00373685|83066013|FG000|Overall Study|Death|2|||
46849425|NCT00373685|83066014|FG001|Overall Study|Death|1|||
46849426|NCT00373685|83066013|FG000|Overall Study|Adverse Event|278|||
46849427|NCT00373685|83066014|FG001|Overall Study|Adverse Event|253|||
46849428|NCT00373685|83066013|FG000|Overall Study|Insufficient clinical response|169|||
46849429|NCT00373685|83066014|FG001|Overall Study|Insufficient clinical response|119|||
46849430|NCT00373685|83066013|FG000|Overall Study|Did not meet entrance criteria|167|||
46849431|NCT00373685|83066014|FG001|Overall Study|Did not meet entrance criteria|184|||
46849432|NCT00373685|83066013|FG000|Overall Study|Lost to follow up|83|||
46849433|NCT00373685|83066014|FG001|Overall Study|Lost to follow up|103|||
46849434|NCT00373685|83066013|FG000|Overall Study|No longer willing to participate|337|||
46849435|NCT00373685|83066014|FG001|Overall Study|No longer willing to participate|352|||
46849436|NCT00373685|83066013|FG000|Overall Study|Other|149|||
46849437|NCT00373685|83066014|FG001|Overall Study|Other|146|||
46849438|NCT00373685|83066013|FG000|Overall Study|Protocol Violation|191|||
46849439|NCT00373685|83066014|FG001|Overall Study|Protocol Violation|182|||
46849440|NCT00373685|83066013|FG000|Overall Study|Final Status Unknown|12|||
46849441|NCT00373685|83066014|FG001|Overall Study|Final Status Unknown|4|||
46849442|NCT00373685|83066013|FG000|Overall Study|Randomized, not treated|51|||
46849443|NCT00373685|83066014|FG001|Overall Study|Randomized, not treated|77|||
46849444|NCT00373529|83066020|FG000|Overall Study|Physician Decision|19|||
46849445|NCT00373529|83066020|FG000|Overall Study|Withdrawal by Subject|7|||
46849446|NCT00373529|83066020|FG000|Overall Study|Adverse Event|7|||
46849447|NCT00373529|83066020|FG000|Overall Study|Treatment failure|36|||
46849448|NCT00373529|83066020|FG000|Overall Study|Disease recurrence|10|||
46849449|NCT00373529|83066020|FG000|Overall Study|Death|16|||
46849450|NCT00373529|83066020|FG000|Overall Study|Need for treatment prohibited by study|1|||
46849451|NCT00373529|83066020|FG000|Overall Study|Other|8|||
46849452|NCT00373529|83066020|FG000|Overall Study|Failed independent confirmation of AML|3|||
46849453|NCT00373529|83066020|FG000|Overall Study|Consent violation|1|||
46849454|NCT00373295|83066024|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
46849455|NCT00373295|83066025|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
46849456|NCT00373295|83066026|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
46849457|NCT00373295|83066027|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
46849458|NCT00373295|83066028|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
46849459|NCT00373295|83066029|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
46849460|NCT00385541|83066039|FG000|Overall Study|severe pain, clinician requested unblind|0|||
46849461|NCT00385541|83066040|FG001|Overall Study|severe pain, clinician requested unblind|1|||
46849462|NCT00392015|83066052|FG000|Overall Study|Lost to Follow-up|2|||
46849463|NCT00392015|83066053|FG001|Overall Study|Lost to Follow-up|0|||
46849464|NCT00392015|83066054|FG002|Overall Study|Lost to Follow-up|2|||
46849465|NCT00392015|83066055|FG003|Overall Study|Lost to Follow-up|1|||
46849466|NCT00392015|83066056|FG004|Overall Study|Lost to Follow-up|1|||
46849467|NCT00392015|83066057|FG005|Overall Study|Lost to Follow-up|0|||
46849468|NCT00392015|83066052|FG000|Overall Study|Withdrawal by Subject|0|||
46849469|NCT00392015|83066053|FG001|Overall Study|Withdrawal by Subject|0|||
46969494|NCT02105272|83212336|FG001|Overall Study|Withdrawal by Subject|0|||
46969495|NCT02141854|83212347|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
46969496|NCT02141854|83212348|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46969497|NCT02141854|83212349|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46969498|NCT02141854|83212350|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46969499|NCT02141854|83212351|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
47074040|NCT02082977|83365603|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
47074041|NCT02082977|83365604|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
47074042|NCT02082977|83365595|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
47074043|NCT02082977|83365596|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
46849470|NCT00392015|83066054|FG002|Overall Study|Withdrawal by Subject|2|||
46849471|NCT00392015|83066055|FG003|Overall Study|Withdrawal by Subject|0|||
46849472|NCT00392015|83066056|FG004|Overall Study|Withdrawal by Subject|0|||
46849473|NCT00392015|83066057|FG005|Overall Study|Withdrawal by Subject|0|||
46849474|NCT00392015|83066052|FG000|Overall Study|Adverse Event|0|||
46849475|NCT00392015|83066053|FG001|Overall Study|Adverse Event|0|||
46849476|NCT00392015|83066054|FG002|Overall Study|Adverse Event|0|||
46849477|NCT00392015|83066055|FG003|Overall Study|Adverse Event|0|||
46849478|NCT00392015|83066056|FG004|Overall Study|Adverse Event|1|||
46849479|NCT00392015|83066057|FG005|Overall Study|Adverse Event|0|||
46849480|NCT00392015|83066052|FG000|Overall Study|Previous trial recipient|0|||
46849481|NCT00392015|83066053|FG001|Overall Study|Previous trial recipient|0|||
46849482|NCT00392015|83066054|FG002|Overall Study|Previous trial recipient|0|||
46849483|NCT00392015|83066055|FG003|Overall Study|Previous trial recipient|0|||
46849484|NCT00392015|83066056|FG004|Overall Study|Previous trial recipient|1|||
46849485|NCT00392015|83066057|FG005|Overall Study|Previous trial recipient|0|||
46849486|NCT00094302|83066078|FG000|Overall Study|Lost to Follow-up|43|||
46849487|NCT00094302|83066079|FG001|Overall Study|Lost to Follow-up|41|||
46849488|NCT00094302|83066078|FG000|Overall Study|Physician Decision|5|||
46849489|NCT00094302|83066079|FG001|Overall Study|Physician Decision|8|||
46849490|NCT00094302|83066078|FG000|Overall Study|Withdrawal by Subject|103|||
46849491|NCT00094302|83066079|FG001|Overall Study|Withdrawal by Subject|111|||
46849492|NCT00094302|83066078|FG000|Overall Study|Death|266|||
46849493|NCT00094302|83066079|FG001|Overall Study|Death|246|||
46849494|NCT00372905|83066085|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
46849495|NCT00372905|83066086|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
46849496|NCT00372905|83066087|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
46849497|NCT00372905|83066088|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
46849498|NCT00372905|83066085|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
46849499|NCT00372905|83066086|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
46849500|NCT00372905|83066087|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
46849501|NCT00372905|83066088|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
46849502|NCT00372905|83066085|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
46849503|NCT00372905|83066086|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
46849504|NCT00372905|83066087|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
46849505|NCT00372905|83066088|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
46849506|NCT00372905|83066085|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
46849507|NCT00372905|83066086|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
46849508|NCT00372905|83066087|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
46849509|NCT00372905|83066088|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
46849510|NCT00372905|83066085|FG000|Follow up Until Relapse or Progression|Study closed|0|||
46849511|NCT00372905|83066086|FG001|Follow up Until Relapse or Progression|Study closed|0|||
46849512|NCT00372905|83066087|FG002|Follow up Until Relapse or Progression|Study closed|0|||
46849513|NCT00372905|83066088|FG003|Follow up Until Relapse or Progression|Study closed|3|||
46849514|NCT00372905|83066085|FG000|Follow up Until Relapse or Progression|Other|0|||
46849515|NCT00372905|83066086|FG001|Follow up Until Relapse or Progression|Other|1|||
46849516|NCT00372905|83066087|FG002|Follow up Until Relapse or Progression|Other|0|||
46849517|NCT00372905|83066088|FG003|Follow up Until Relapse or Progression|Other|0|||
46849518|NCT00384839|83066098|FG000|Overall Study|Adverse Event|4|||
46849519|NCT00384839|83066098|FG000|Overall Study|Investigator Request|1|||
46849520|NCT00384839|83066098|FG000|Overall Study|Patient Request|1|||
46849521|NCT00384839|83066098|FG000|Overall Study|Ineligible|2|||
46849522|NCT00384293|83066104|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
46849523|NCT00384293|83066105|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
46849524|NCT00384293|83066106|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
46849525|NCT00384293|83066104|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
46849526|NCT00384293|83066105|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
46849527|NCT00384293|83066106|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
46849528|NCT00384293|83066104|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
46849529|NCT00384293|83066105|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
46849530|NCT00384293|83066106|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
46849531|NCT00384293|83066104|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
46849532|NCT00384293|83066105|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
46849533|NCT00384293|83066106|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
46849534|NCT00384293|83066104|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
46849535|NCT00384293|83066105|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
46849536|NCT00384293|83066106|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
46849537|NCT00384293|83066104|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
46849538|NCT00384293|83066105|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
46849539|NCT00384293|83066106|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
46849540|NCT00384293|83066104|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
46849541|NCT00384293|83066105|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
46849542|NCT00384293|83066106|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
46849543|NCT00384293|83066104|FG000|Post-randomization Period|Adverse Event|0|||
46849544|NCT00384293|83066105|FG001|Post-randomization Period|Adverse Event|23|||
46849545|NCT00384293|83066106|FG002|Post-randomization Period|Adverse Event|7|||
46849546|NCT00384293|83066104|FG000|Post-randomization Period|Lost to Follow-up|0|||
46849547|NCT00384293|83066105|FG001|Post-randomization Period|Lost to Follow-up|2|||
46849548|NCT00384293|83066106|FG002|Post-randomization Period|Lost to Follow-up|1|||
46849549|NCT00384293|83066104|FG000|Post-randomization Period|Protocol Violation|0|||
46849550|NCT00384293|83066105|FG001|Post-randomization Period|Protocol Violation|1|||
46849551|NCT00384293|83066106|FG002|Post-randomization Period|Protocol Violation|0|||
46849552|NCT00384293|83066104|FG000|Post-randomization Period|Withdrawal by Subject|0|||
46849553|NCT00384293|83066105|FG001|Post-randomization Period|Withdrawal by Subject|8|||
46849554|NCT00384293|83066106|FG002|Post-randomization Period|Withdrawal by Subject|6|||
46849555|NCT00384293|83066104|FG000|Post-randomization Period|Trial Termination|0|||
46849556|NCT00384293|83066105|FG001|Post-randomization Period|Trial Termination|180|||
46849557|NCT00384293|83066106|FG002|Post-randomization Period|Trial Termination|204|||
46849558|NCT00384293|83066104|FG000|Post-randomization Period|Patient Randomized in Error|0|||
46849559|NCT00384293|83066105|FG001|Post-randomization Period|Patient Randomized in Error|0|||
46849560|NCT00384293|83066106|FG002|Post-randomization Period|Patient Randomized in Error|1|||
46849561|NCT00067002|83066116|FG000|Overall Study|Early Death|1|||
46849562|NCT00067002|83066117|FG001|Overall Study|Early Death|2|||
46849563|NCT00067002|83066116|FG000|Overall Study|Delayed|1|||
46849564|NCT00067002|83066117|FG001|Overall Study|Delayed|1|||
46849565|NCT00067002|83066116|FG000|Overall Study|Graft Failure|5|||
46849566|NCT00067002|83066117|FG001|Overall Study|Graft Failure|6|||
46849567|NCT00091572|83066125|FG000|Overall Study|Lost to Follow-up|1|||
46849568|NCT00091572|83066126|FG001|Overall Study|Lost to Follow-up|1|||
46849569|NCT00091572|83066125|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
46849570|NCT00091572|83066126|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
46849571|NCT00091572|83066125|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
46849572|NCT00091572|83066126|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
46849573|NCT00091572|83066125|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
46849574|NCT00091572|83066126|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
46849575|NCT00091572|83066125|FG000|Overall Study|Other Reason|6|||
46849576|NCT00091572|83066126|FG001|Overall Study|Other Reason|13|||
46849577|NCT00091572|83066125|FG000|Overall Study|Ongoing (still on treatment)|8|||
46849578|NCT00091572|83066126|FG001|Overall Study|Ongoing (still on treatment)|12|||
46849579|NCT00091572|83066125|FG000|Overall Study|Major Protocol Violation|2|||
46849580|NCT00091572|83066126|FG001|Overall Study|Major Protocol Violation|0|||
46849581|NCT00091572|83066125|FG000|Overall Study|Toxicity (Related AE)|53|||
46849582|NCT00091572|83066126|FG001|Overall Study|Toxicity (Related AE)|9|||
46849583|NCT00084266|83066134|FG000|Overall Study|Death|42|||
46849584|NCT00084266|83066135|FG001|Overall Study|Death|39|||
46849585|NCT00084266|83066134|FG000|Overall Study|Adverse Event|8|||
46849586|NCT00084266|83066135|FG001|Overall Study|Adverse Event|5|||
46849587|NCT00084266|83066134|FG000|Overall Study|Lack of Efficacy|2|||
46849588|NCT00084266|83066135|FG001|Overall Study|Lack of Efficacy|4|||
46849589|NCT00084266|83066134|FG000|Overall Study|Lost to Follow-up|5|||
46849590|NCT00084266|83066135|FG001|Overall Study|Lost to Follow-up|3|||
46849591|NCT00084266|83066134|FG000|Overall Study|Participant not willing to participate|3|||
46849592|NCT00084266|83066135|FG001|Overall Study|Participant not willing to participate|8|||
46849593|NCT00084266|83066134|FG000|Overall Study|Other|360|||
46849594|NCT00084266|83066135|FG001|Overall Study|Other|344|||
46849595|NCT00084266|83066134|FG000|Overall Study|Randomized not treated|21|||
46849596|NCT00084266|83066135|FG001|Overall Study|Randomized not treated|20|||
46849597|NCT00091026|83066143|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
46849598|NCT00091026|83066144|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
46849599|NCT00091026|83066143|FG000|Overall Study|Patient withdrew and never received trea|0|||
46849600|NCT00091026|83066144|FG001|Overall Study|Patient withdrew and never received trea|2|||
46849601|NCT00091026|83066143|FG000|Overall Study|Unknown-never received treatment|0|||
46849602|NCT00091026|83066144|FG001|Overall Study|Unknown-never received treatment|1|||
46849603|NCT00116558|83066153|FG000|Overall Study|Death|11|||
46849604|NCT00116558|83066154|FG001|Overall Study|Death|5|||
46849605|NCT00116558|83066155|FG002|Overall Study|Death|3|||
46849606|NCT00116558|83066153|FG000|Overall Study|Withdrawal by Subject|17|||
46849607|NCT00116558|83066154|FG001|Overall Study|Withdrawal by Subject|3|||
46849608|NCT00116558|83066155|FG002|Overall Study|Withdrawal by Subject|12|||
46849609|NCT00116558|83066153|FG000|Overall Study|disease progression|3|||
46849610|NCT00116558|83066154|FG001|Overall Study|disease progression|7|||
46849611|NCT00116558|83066155|FG002|Overall Study|disease progression|18|||
46849612|NCT00116168|83066166|FG000|Overall Study|Lost to Follow-up|6|||
46849613|NCT00116168|83066167|FG001|Overall Study|Lost to Follow-up|5|||
46849614|NCT00116168|83066168|FG002|Overall Study|Lost to Follow-up|0|||
46849615|NCT00116168|83066169|FG003|Overall Study|Lost to Follow-up|0|||
46849616|NCT00115934|83066181|FG000|Overall Study|Lost to Follow-up|1|||
46849617|NCT00115934|83066182|FG001|Overall Study|Lost to Follow-up|0|||
46849618|NCT00115934|83066181|FG000|Overall Study|Did not receive intervention|3|||
46849619|NCT00115934|83066182|FG001|Overall Study|Did not receive intervention|2|||
46849620|NCT00115778|83066188|FG000|Overall Study|Withdrawal by Subject|0|||
46849621|NCT00115778|83066189|FG001|Overall Study|Withdrawal by Subject|1|||
46849622|NCT00100178|83066198|FG000|Overall Study|Lost to Follow-up|0|||
46849623|NCT00100178|83066199|FG001|Overall Study|Lost to Follow-up|6|||
46849624|NCT00100178|83066200|FG002|Overall Study|Lost to Follow-up|5|||
46849625|NCT00100178|83066198|FG000|Overall Study|Adverse Event|2|||
46849626|NCT00100178|83066199|FG001|Overall Study|Adverse Event|2|||
46849627|NCT00100178|83066200|FG002|Overall Study|Adverse Event|1|||
46849628|NCT00100178|83066198|FG000|Overall Study|Withdrawal by Subject|1|||
46849629|NCT00100178|83066199|FG001|Overall Study|Withdrawal by Subject|1|||
46849630|NCT00100178|83066200|FG002|Overall Study|Withdrawal by Subject|1|||
46849631|NCT00100178|83066198|FG000|Overall Study|Physician Decision|6|||
46849632|NCT00100178|83066199|FG001|Overall Study|Physician Decision|1|||
46849633|NCT00100178|83066200|FG002|Overall Study|Physician Decision|3|||
46849634|NCT00099632|83066214|FG000|Overall Study|Lost to Follow-up|1|||
46849635|NCT00099632|83066215|FG001|Overall Study|Lost to Follow-up|0|||
46849636|NCT00099632|83066216|FG002|Overall Study|Lost to Follow-up|3|||
46849637|NCT00099632|83066217|FG003|Overall Study|Lost to Follow-up|1|||
46849638|NCT00099632|83066218|FG004|Overall Study|Lost to Follow-up|1|||
46849639|NCT00099632|83066219|FG005|Overall Study|Lost to Follow-up|0|||
46849640|NCT00099632|83066214|FG000|Overall Study|Withdrawal by Subject|0|||
46849641|NCT00099632|83066215|FG001|Overall Study|Withdrawal by Subject|1|||
46969500|NCT02141854|83212352|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46969501|NCT02141854|83212347|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
46642346|NCT02407236|82832253|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46778304|NCT02848092|82996416|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
46778305|NCT02848092|82996415|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
46778306|NCT02848092|82996416|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
46969502|NCT02141854|83212348|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46969503|NCT02141854|83212349|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46969504|NCT02141854|83212350|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46969505|NCT02141854|83212351|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46969506|NCT02141854|83212352|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
47074044|NCT02082977|83365597|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
47074045|NCT02082977|83365598|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
47074046|NCT02082977|83365599|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
47074047|NCT02082977|83365600|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
47074048|NCT02082977|83365601|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
47074049|NCT02082977|83365602|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
47074050|NCT02082977|83365603|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
47074051|NCT02082977|83365604|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
46778307|NCT00660309|82996424|FG000|Overall Study|Adverse Event|2|||
46778308|NCT00660309|82996425|FG001|Overall Study|Adverse Event|0|||
46778309|NCT00660309|82996424|FG000|Overall Study|Withdrawal by Subject|0|||
46778310|NCT00660309|82996425|FG001|Overall Study|Withdrawal by Subject|3|||
46778311|NCT00581100|82996434|FG000|Overall Study|Death|1|||
46778312|NCT00581100|82996435|FG001|Overall Study|Death|0|||
46778313|NCT00581100|82996434|FG000|Overall Study|Adverse Event|2|||
46778314|NCT00581100|82996435|FG001|Overall Study|Adverse Event|1|||
46849642|NCT00099632|83066216|FG002|Overall Study|Withdrawal by Subject|0|||
46969507|NCT02141854|83212347|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
46969508|NCT02141854|83212348|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46969509|NCT02141854|83212349|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46969510|NCT02141854|83212350|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46969511|NCT02141854|83212351|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46969512|NCT02141854|83212352|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46969513|NCT02141854|83212347|FG000|Run-In Period (Pre-assignment)|Other|14|||
46969514|NCT02141854|83212348|FG001|Run-In Period (Pre-assignment)|Other|0|||
46969515|NCT02141854|83212349|FG002|Run-In Period (Pre-assignment)|Other|0|||
46969516|NCT02141854|83212350|FG003|Run-In Period (Pre-assignment)|Other|0|||
46969517|NCT02141854|83212351|FG004|Run-In Period (Pre-assignment)|Other|0|||
46969518|NCT02141854|83212352|FG005|Run-In Period (Pre-assignment)|Other|0|||
46969519|NCT02141854|83212347|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
46969520|NCT02141854|83212348|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
46969521|NCT02141854|83212349|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
46969522|NCT02141854|83212350|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
46969523|NCT02141854|83212351|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
46969524|NCT02141854|83212352|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
46969525|NCT02141854|83212347|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
46969526|NCT02141854|83212348|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46849643|NCT00099632|83066217|FG003|Overall Study|Withdrawal by Subject|0|||
46849644|NCT00099632|83066218|FG004|Overall Study|Withdrawal by Subject|0|||
46849645|NCT00099632|83066219|FG005|Overall Study|Withdrawal by Subject|1|||
47074052|NCT02082977|83365595|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
46849646|NCT00099632|83066214|FG000|Overall Study|Protocol Violation|0|||
46849647|NCT00099632|83066215|FG001|Overall Study|Protocol Violation|0|||
46849648|NCT00099632|83066216|FG002|Overall Study|Protocol Violation|0|||
46849649|NCT00099632|83066217|FG003|Overall Study|Protocol Violation|0|||
46849650|NCT00099632|83066218|FG004|Overall Study|Protocol Violation|0|||
46849651|NCT00099632|83066219|FG005|Overall Study|Protocol Violation|1|||
46849652|NCT00098774|83066233|FG000|Overall Study|Adverse Event|2|||
46849653|NCT00098774|83066233|FG000|Overall Study|Disease Progression|9|||
46849654|NCT00098774|83066233|FG000|Overall Study|Withdrawal by Subject|1|||
46849655|NCT00098774|83066233|FG000|Overall Study|Failed (to respond) during induction|4|||
46849656|NCT00098774|83066233|FG000|Overall Study|Physician Decision|2|||
46849657|NCT00384059|83066239|FG000|Infant Series|Not consented|2|||
46849658|NCT00384059|83066240|FG001|Infant Series|Not consented|6|||
46849659|NCT00384059|83066239|FG000|Infant Series|Withdrawal by Subject|2|||
46969527|NCT02141854|83212349|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46969528|NCT02141854|83212350|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46849660|NCT00384059|83066240|FG001|Infant Series|Withdrawal by Subject|2|||
46849661|NCT00384059|83066239|FG000|Infant Series|Adverse Event|1|||
46849662|NCT00384059|83066240|FG001|Infant Series|Adverse Event|2|||
46849663|NCT00384059|83066239|FG000|Infant Series|Protocol Violation|1|||
46849664|NCT00384059|83066240|FG001|Infant Series|Protocol Violation|2|||
46849665|NCT00384059|83066239|FG000|Infant Series|Lost to Follow-up|0|||
46849666|NCT00384059|83066240|FG001|Infant Series|Lost to Follow-up|1|||
46849667|NCT00384059|83066239|FG000|After Infant Series|Protocol Violation|2|||
46849668|NCT00384059|83066240|FG001|After Infant Series|Protocol Violation|3|||
46849669|NCT00384059|83066239|FG000|After Infant Series|Withdrawal by Subject|2|||
46849670|NCT00384059|83066240|FG001|After Infant Series|Withdrawal by Subject|2|||
46849671|NCT00384059|83066239|FG000|After Infant Series|Failed to Return|0|||
46849672|NCT00384059|83066240|FG001|After Infant Series|Failed to Return|2|||
46849673|NCT00384059|83066239|FG000|After Infant Series|Adverse Event|0|||
46849674|NCT00384059|83066240|FG001|After Infant Series|Adverse Event|1|||
46849675|NCT00384059|83066239|FG000|After Infant Series|Physician Decision|0|||
46849676|NCT00384059|83066240|FG001|After Infant Series|Physician Decision|1|||
46849677|NCT00384059|83066239|FG000|After Infant Series|Lost to Follow-up|0|||
46849678|NCT00384059|83066240|FG001|After Infant Series|Lost to Follow-up|1|||
46849679|NCT00384059|83066239|FG000|Toddler Dose|Lost to Follow-up|1|||
46849680|NCT00384059|83066240|FG001|Toddler Dose|Lost to Follow-up|1|||
46849681|NCT00384059|83066239|FG000|Toddler Dose|Failed to return|0|||
46849682|NCT00384059|83066240|FG001|Toddler Dose|Failed to return|1|||
46849683|NCT00383123|83066269|FG000|Overall Study|Adverse Event|1|||
46849684|NCT00383123|83066270|FG001|Overall Study|Adverse Event|0|||
46969529|NCT02141854|83212351|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46969530|NCT02141854|83212352|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46969531|NCT02141854|83212347|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
46969532|NCT02141854|83212348|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46969533|NCT02141854|83212349|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46969534|NCT02141854|83212350|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46969535|NCT02141854|83212351|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46969536|NCT02141854|83212352|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46969537|NCT02141854|83212347|FG000|Treatment Period|Protocol Violation|0|||
46778315|NCT00581100|82996434|FG000|Overall Study|Withdrawal by Subject|1|||
46778316|NCT00581100|82996435|FG001|Overall Study|Withdrawal by Subject|4|||
46778317|NCT00581100|82996434|FG000|Overall Study|Other|3|||
46778318|NCT00581100|82996435|FG001|Overall Study|Other|0|||
46778319|NCT00579098|82996443|FG000|Overall Study|Lost to Follow-up|2|||
46778320|NCT00579098|82996444|FG001|Overall Study|Lost to Follow-up|0|||
46778321|NCT00579098|82996443|FG000|Overall Study|Adverse Event|2|||
46778322|NCT00579098|82996444|FG001|Overall Study|Adverse Event|3|||
46778323|NCT00579098|82996443|FG000|Overall Study|Withdrawal by Subject|2|||
46778324|NCT00579098|82996444|FG001|Overall Study|Withdrawal by Subject|3|||
46778325|NCT00579098|82996443|FG000|Overall Study|AF returned after ablation|3|||
46778326|NCT00579098|82996444|FG001|Overall Study|AF returned after ablation|2|||
46778327|NCT00772109|82996454|FG000|Overall Study|Serious adverse event|1|||
46778328|NCT00772109|82996455|FG001|Overall Study|Serious adverse event|0|||
46778329|NCT00772109|82996456|FG002|Overall Study|Serious adverse event|1|||
46778330|NCT00772109|82996457|FG003|Overall Study|Serious adverse event|0|||
46778331|NCT00772109|82996454|FG000|Overall Study|Protocol Violation|5|||
46778332|NCT00772109|82996455|FG001|Overall Study|Protocol Violation|8|||
46778333|NCT00772109|82996456|FG002|Overall Study|Protocol Violation|7|||
46969538|NCT02141854|83212348|FG001|Treatment Period|Protocol Violation|1|||
46969539|NCT02141854|83212349|FG002|Treatment Period|Protocol Violation|0|||
46969540|NCT02141854|83212350|FG003|Treatment Period|Protocol Violation|2|||
46778334|NCT00772109|82996457|FG003|Overall Study|Protocol Violation|6|||
46778335|NCT00772109|82996454|FG000|Overall Study|Lost to Follow-up|7|||
46778336|NCT00772109|82996455|FG001|Overall Study|Lost to Follow-up|3|||
46849685|NCT00383123|83066269|FG000|Overall Study|Lost to Follow-up|68|||
46849686|NCT00383123|83066270|FG001|Overall Study|Lost to Follow-up|61|||
46849687|NCT00383123|83066269|FG000|Overall Study|Protocol Violation|5|||
46849688|NCT00383123|83066270|FG001|Overall Study|Protocol Violation|1|||
46849689|NCT00383123|83066269|FG000|Overall Study|Withdrawal by Subject|27|||
46849690|NCT00383123|83066270|FG001|Overall Study|Withdrawal by Subject|18|||
46849691|NCT00383123|83066269|FG000|Overall Study|Other reason|10|||
46849692|NCT00383123|83066270|FG001|Overall Study|Other reason|6|||
46849693|NCT00382967|83066278|FG000|Overall Study|Protocol Violation|1|||
46849694|NCT00382967|83066279|FG001|Overall Study|Protocol Violation|1|||
46849695|NCT00858364|83066287|FG000|Overall Study|Administrative Decision|3|||
46849696|NCT00858364|83066288|FG001|Overall Study|Administrative Decision|2|||
46849697|NCT00858364|83066287|FG000|Overall Study|Adverse Event|5|||
46849698|NCT00858364|83066288|FG001|Overall Study|Adverse Event|2|||
46849699|NCT00858364|83066287|FG000|Overall Study|Withdrawal by Subject|44|||
46849700|NCT00858364|83066288|FG001|Overall Study|Withdrawal by Subject|118|||
46849701|NCT00858364|83066287|FG000|Overall Study|Ineligibility Determined|1|||
46849702|NCT00858364|83066288|FG001|Overall Study|Ineligibility Determined|10|||
46849703|NCT00858364|83066287|FG000|Overall Study|Lost to Follow-up|24|||
46849704|NCT00858364|83066288|FG001|Overall Study|Lost to Follow-up|54|||
46849705|NCT00858364|83066287|FG000|Overall Study|Noncompliance|3|||
46849706|NCT00858364|83066288|FG001|Overall Study|Noncompliance|4|||
46849707|NCT00858364|83066287|FG000|Overall Study|Protocol Deviation|0|||
46849708|NCT00858364|83066288|FG001|Overall Study|Protocol Deviation|2|||
46849709|NCT00858364|83066287|FG000|Overall Study|Other|9|||
46849710|NCT00858364|83066288|FG001|Overall Study|Other|17|||
46849711|NCT00858364|83066287|FG000|Overall Study|Missing|1|||
46849712|NCT00858364|83066288|FG001|Overall Study|Missing|1|||
46849713|NCT00858364|83066287|FG000|Overall Study|Still on-study|114|||
46849714|NCT00858364|83066288|FG001|Overall Study|Still on-study|247|||
46849715|NCT00382733|83066294|FG000|Overall Study|Withdrawal by Subject|0|||
46849716|NCT00382733|83066295|FG001|Overall Study|Withdrawal by Subject|1|||
46849717|NCT00382733|83066296|FG002|Overall Study|Withdrawal by Subject|0|||
46849718|NCT00382733|83066297|FG003|Overall Study|Withdrawal by Subject|0|||
46849719|NCT00382733|83066298|FG004|Overall Study|Withdrawal by Subject|0|||
46849720|NCT03631732|83066313|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
46849721|NCT03631732|83066314|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
46849722|NCT03631732|83066313|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
46849723|NCT03631732|83066314|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
46849724|NCT03631732|83066313|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
46849725|NCT03631732|83066314|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
46849726|NCT03631732|83066313|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
46849727|NCT03631732|83066314|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
46849728|NCT03631732|83066313|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
46849729|NCT03631732|83066314|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
46849730|NCT03631732|83066313|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
46849731|NCT03631732|83066314|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
46849732|NCT03631732|83066313|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
46849733|NCT03631732|83066314|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
46849734|NCT03631732|83066313|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
46849735|NCT03631732|83066314|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
46849736|NCT03631732|83066313|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
46849737|NCT03631732|83066314|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
46849738|NCT03631732|83066313|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
46849739|NCT03631732|83066314|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
46778337|NCT00772109|82996456|FG002|Overall Study|Lost to Follow-up|5|||
46849740|NCT03630016|83066324|FG000|Overall Study|Poor Sensor Placement|1|||
46849741|NCT03628924|83066331|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
46849742|NCT03628924|83066332|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
46849743|NCT03628924|83066333|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
46849744|NCT03628924|83066334|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
46849745|NCT03628924|83066335|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
46849746|NCT03628924|83066336|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
46849747|NCT03628924|83066337|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
46849748|NCT03628924|83066331|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
47074053|NCT02082977|83365596|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
47074054|NCT02082977|83365597|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
46778338|NCT00772109|82996457|FG003|Overall Study|Lost to Follow-up|9|||
46778339|NCT00772109|82996454|FG000|Overall Study|Withdrawal by Subject|8|||
46778340|NCT00772109|82996455|FG001|Overall Study|Withdrawal by Subject|8|||
46778341|NCT00772109|82996456|FG002|Overall Study|Withdrawal by Subject|6|||
46778342|NCT00772109|82996457|FG003|Overall Study|Withdrawal by Subject|16|||
46778343|NCT00772031|82996469|FG000|Overall Study|Early termination of trial|12|||
46778344|NCT00772031|82996470|FG001|Overall Study|Early termination of trial|10|||
46778345|NCT00772031|82996469|FG000|Overall Study|Lost to Follow-up|20|||
46778346|NCT00772031|82996470|FG001|Overall Study|Lost to Follow-up|33|||
46849749|NCT03628924|83066332|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
46969541|NCT02141854|83212351|FG004|Treatment Period|Protocol Violation|2|||
46969542|NCT02141854|83212352|FG005|Treatment Period|Protocol Violation|1|||
46969543|NCT02141854|83212347|FG000|Treatment Period|Noncompliance|0|||
46969544|NCT02141854|83212348|FG001|Treatment Period|Noncompliance|0|||
46969545|NCT02141854|83212349|FG002|Treatment Period|Noncompliance|0|||
46969546|NCT02141854|83212350|FG003|Treatment Period|Noncompliance|1|||
46969547|NCT02141854|83212351|FG004|Treatment Period|Noncompliance|0|||
46969548|NCT02141854|83212352|FG005|Treatment Period|Noncompliance|0|||
46969549|NCT02141854|83212347|FG000|Treatment Period|Lack of Efficacy|0|||
46969550|NCT02141854|83212348|FG001|Treatment Period|Lack of Efficacy|0|||
46969551|NCT02141854|83212349|FG002|Treatment Period|Lack of Efficacy|0|||
46969552|NCT02141854|83212350|FG003|Treatment Period|Lack of Efficacy|1|||
46969553|NCT02141854|83212351|FG004|Treatment Period|Lack of Efficacy|1|||
47074055|NCT02082977|83365598|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
47074056|NCT02082977|83365599|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
47074057|NCT02082977|83365600|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
47074058|NCT02082977|83365601|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
47074059|NCT02082977|83365602|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
47074060|NCT02082977|83365603|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
47074061|NCT02082977|83365604|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
47074062|NCT02082977|83365595|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
47074063|NCT02082977|83365596|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
46642347|NCT02407236|82832254|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
46642348|NCT02407236|82832242|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46849750|NCT03628924|83066333|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
46849751|NCT03628924|83066334|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
46849752|NCT03628924|83066335|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
46849753|NCT03628924|83066336|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
46849754|NCT03628924|83066337|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
47074064|NCT02082977|83365597|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
46642349|NCT02407236|82832243|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46642350|NCT02407236|82832244|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46642351|NCT02407236|82832245|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46642352|NCT02407236|82832246|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46778347|NCT00580866|82996484|FG000|Overall Study|Lost to Follow-up|2|||
46778348|NCT00580866|82996485|FG001|Overall Study|Lost to Follow-up|2|||
46642353|NCT02407236|82832247|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46642354|NCT02407236|82832248|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46778349|NCT00771953|82996493|FG000|Overall Study|Adverse Event|5|||
46778350|NCT00771953|82996494|FG001|Overall Study|Adverse Event|3|||
46778351|NCT00771953|82996493|FG000|Overall Study|Death|2|||
46778352|NCT00771953|82996494|FG001|Overall Study|Death|2|||
46778353|NCT00771953|82996493|FG000|Overall Study|Progression before active Tx|1|||
46778354|NCT00771953|82996494|FG001|Overall Study|Progression before active Tx|2|||
46778355|NCT00771953|82996493|FG000|Overall Study|Sponsor decision|1|||
46778356|NCT00771953|82996494|FG001|Overall Study|Sponsor decision|0|||
46778357|NCT00771953|82996493|FG000|Overall Study|Other complicating disease|1|||
46778358|NCT00771953|82996494|FG001|Overall Study|Other complicating disease|0|||
46778359|NCT00771953|82996493|FG000|Overall Study|Withdrawal by Subject|0|||
46778360|NCT00771953|82996494|FG001|Overall Study|Withdrawal by Subject|3|||
46778361|NCT00621244|82996506|FG000|Overall Study|Withdrawal by Subject|7|||
46778362|NCT00621244|82996507|FG001|Overall Study|Withdrawal by Subject|3|||
46778363|NCT00621244|82996508|FG002|Overall Study|Withdrawal by Subject|3|||
46778364|NCT00621244|82996509|FG003|Overall Study|Withdrawal by Subject|3|||
46849755|NCT03628924|83066331|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
46849756|NCT03628924|83066332|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
46969554|NCT02141854|83212352|FG005|Treatment Period|Lack of Efficacy|7|||
46969555|NCT02141854|83212347|FG000|Treatment Period|Pregnancy|0|||
47074065|NCT02082977|83365598|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
47074066|NCT02082977|83365599|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
47074067|NCT02082977|83365600|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
47074068|NCT02082977|83365601|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
46642355|NCT02407236|82832249|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
46778365|NCT00621244|82996506|FG000|Overall Study|Disease progression|44|||
46778366|NCT00621244|82996507|FG001|Overall Study|Disease progression|20|||
47074069|NCT02082977|83365602|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
46969556|NCT02141854|83212348|FG001|Treatment Period|Pregnancy|1|||
47074070|NCT02082977|83365603|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
46778367|NCT00621244|82996508|FG002|Overall Study|Disease progression|20|||
46969557|NCT02141854|83212349|FG002|Treatment Period|Pregnancy|0|||
46969558|NCT02141854|83212350|FG003|Treatment Period|Pregnancy|0|||
46969559|NCT02141854|83212351|FG004|Treatment Period|Pregnancy|0|||
46969560|NCT02141854|83212352|FG005|Treatment Period|Pregnancy|0|||
46969561|NCT02141854|83212347|FG000|Treatment Period|Other|0|||
46969562|NCT02141854|83212348|FG001|Treatment Period|Other|1|||
46969563|NCT02141854|83212349|FG002|Treatment Period|Other|2|||
46969564|NCT02141854|83212350|FG003|Treatment Period|Other|0|||
46969565|NCT02141854|83212351|FG004|Treatment Period|Other|1|||
46969566|NCT02141854|83212352|FG005|Treatment Period|Other|2|||
46969567|NCT02141854|83212347|FG000|Treatment Period|Adverse Event|0|||
46969568|NCT02141854|83212348|FG001|Treatment Period|Adverse Event|2|||
46778368|NCT00621244|82996509|FG003|Overall Study|Disease progression|15|||
46849757|NCT03628924|83066333|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
46849758|NCT03628924|83066334|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
46849759|NCT03628924|83066335|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
46969569|NCT02141854|83212349|FG002|Treatment Period|Adverse Event|2|||
46969570|NCT02141854|83212350|FG003|Treatment Period|Adverse Event|0|||
46969571|NCT02141854|83212351|FG004|Treatment Period|Adverse Event|2|||
46969572|NCT02141854|83212352|FG005|Treatment Period|Adverse Event|2|||
46969573|NCT02141854|83212347|FG000|Treatment Period|Withdrawal by Subject|0|||
46969574|NCT02141854|83212348|FG001|Treatment Period|Withdrawal by Subject|2|||
46969575|NCT02141854|83212349|FG002|Treatment Period|Withdrawal by Subject|3|||
46969576|NCT02141854|83212350|FG003|Treatment Period|Withdrawal by Subject|3|||
46969577|NCT02141854|83212351|FG004|Treatment Period|Withdrawal by Subject|4|||
46969578|NCT02141854|83212352|FG005|Treatment Period|Withdrawal by Subject|7|||
46969579|NCT02141854|83212347|FG000|Treatment Period|Disease progression|0|||
46969580|NCT02141854|83212348|FG001|Treatment Period|Disease progression|2|||
46969581|NCT02141854|83212349|FG002|Treatment Period|Disease progression|1|||
46969582|NCT02141854|83212350|FG003|Treatment Period|Disease progression|3|||
46969583|NCT02141854|83212351|FG004|Treatment Period|Disease progression|0|||
46969584|NCT02141854|83212352|FG005|Treatment Period|Disease progression|18|||
46969585|NCT02141854|83212347|FG000|Treatment Period|Lost to Follow-up|0|||
46969586|NCT02141854|83212348|FG001|Treatment Period|Lost to Follow-up|1|||
46969587|NCT02141854|83212349|FG002|Treatment Period|Lost to Follow-up|1|||
46969588|NCT02141854|83212350|FG003|Treatment Period|Lost to Follow-up|1|||
46969589|NCT02141854|83212351|FG004|Treatment Period|Lost to Follow-up|0|||
46969590|NCT02141854|83212352|FG005|Treatment Period|Lost to Follow-up|1|||
46969591|NCT02587221|83212366|FG000|Overall Study|Adverse Event|3|||
46969592|NCT02587221|83212367|FG001|Overall Study|Adverse Event|3|||
46969593|NCT02587221|83212366|FG000|Overall Study|Death|33|||
46969594|NCT02587221|83212367|FG001|Overall Study|Death|34|||
46969595|NCT02587221|83212366|FG000|Overall Study|Withdrawal by Subject|66|||
46969596|NCT02587221|83212367|FG001|Overall Study|Withdrawal by Subject|61|||
46969597|NCT02587221|83212366|FG000|Overall Study|Lost to Follow-up|21|||
46969598|NCT02587221|83212367|FG001|Overall Study|Lost to Follow-up|19|||
46969599|NCT02587221|83212366|FG000|Overall Study|Protocol Violation|6|||
46778369|NCT00621244|82996506|FG000|Overall Study|Death|3|||
46778370|NCT00621244|82996507|FG001|Overall Study|Death|3|||
46778371|NCT00621244|82996508|FG002|Overall Study|Death|1|||
46778372|NCT00621244|82996509|FG003|Overall Study|Death|1|||
46778373|NCT00621244|82996506|FG000|Overall Study|Adverse Event|27|||
46778374|NCT00621244|82996507|FG001|Overall Study|Adverse Event|7|||
46778375|NCT00621244|82996508|FG002|Overall Study|Adverse Event|9|||
46778376|NCT00621244|82996509|FG003|Overall Study|Adverse Event|2|||
46778377|NCT00621244|82996506|FG000|Overall Study|Administrative problems|5|||
46778378|NCT00621244|82996507|FG001|Overall Study|Administrative problems|1|||
46778379|NCT00621244|82996508|FG002|Overall Study|Administrative problems|0|||
46778380|NCT00621244|82996509|FG003|Overall Study|Administrative problems|2|||
46778381|NCT00659529|82996583|FG000|Overall Study|Withdrawal by Subject|4|||
46969600|NCT02587221|83212367|FG001|Overall Study|Protocol Violation|5|||
46969601|NCT02587221|83212366|FG000|Overall Study|Other Reason or Unspecified|2|||
46969602|NCT02587221|83212367|FG001|Overall Study|Other Reason or Unspecified|1|||
46969603|NCT02141620|83212373|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
46969604|NCT02141620|83212374|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
46969605|NCT02106910|83212382|FG000|Overall Study|Lost to Follow-up|1|||
46969606|NCT02106910|83212383|FG001|Overall Study|Lost to Follow-up|1|||
46969607|NCT01664949|83212392|FG000|Overall Study|Adverse Event|11|||
46969608|NCT01664949|83212393|FG001|Overall Study|Adverse Event|12|||
46969609|NCT01664949|83212392|FG000|Overall Study|Lack of Efficacy|1|||
46969610|NCT01664949|83212393|FG001|Overall Study|Lack of Efficacy|1|||
46969611|NCT01664949|83212392|FG000|Overall Study|Lost to Follow-up|1|||
46969612|NCT01664949|83212393|FG001|Overall Study|Lost to Follow-up|2|||
46969613|NCT01664949|83212392|FG000|Overall Study|Personal Reasons|3|||
46969614|NCT01664949|83212393|FG001|Overall Study|Personal Reasons|4|||
46969615|NCT01664949|83212392|FG000|Overall Study|Protocol Violation|5|||
46969616|NCT01664949|83212393|FG001|Overall Study|Protocol Violation|5|||
46969617|NCT01664949|83212392|FG000|Overall Study|Other Miscellaneous Reasons|3|||
46969618|NCT01664949|83212393|FG001|Overall Study|Other Miscellaneous Reasons|1|||
46849760|NCT03628924|83066336|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
46849761|NCT03628924|83066337|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
46849762|NCT03628924|83066331|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46849763|NCT03628924|83066332|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
46849764|NCT03628924|83066333|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46849765|NCT03628924|83066334|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46849766|NCT03628924|83066335|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46849767|NCT03628924|83066336|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46849768|NCT03628924|83066337|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
46849769|NCT03628924|83066331|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
46849770|NCT03628924|83066332|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
46849771|NCT03628924|83066333|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
46849772|NCT03628924|83066334|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
46849773|NCT03628924|83066335|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
46969619|NCT02587143|83212401|FG000|Overall Study|Adverse Event|1|||
46969620|NCT02587143|83212402|FG001|Overall Study|Adverse Event|0|||
46969621|NCT02106832|83212412|FG000|Overall Study|Adverse Event|1|||
46969622|NCT02106832|83212413|FG001|Overall Study|Adverse Event|2|||
46969623|NCT02106832|83212414|FG002|Overall Study|Adverse Event|3|||
46969624|NCT02106832|83212415|FG003|Overall Study|Adverse Event|0|||
46969625|NCT02106832|83212412|FG000|Overall Study|Death|4|||
46969626|NCT02106832|83212413|FG001|Overall Study|Death|4|||
46969627|NCT02106832|83212414|FG002|Overall Study|Death|1|||
46969628|NCT02106832|83212415|FG003|Overall Study|Death|4|||
46969629|NCT02106832|83212412|FG000|Overall Study|Deterioration of general conditions|0|||
46969630|NCT02106832|83212413|FG001|Overall Study|Deterioration of general conditions|0|||
46969631|NCT02106832|83212414|FG002|Overall Study|Deterioration of general conditions|1|||
46969632|NCT02106832|83212415|FG003|Overall Study|Deterioration of general conditions|0|||
46969633|NCT02106832|83212412|FG000|Overall Study|Lost to Follow-up|0|||
46969634|NCT02106832|83212413|FG001|Overall Study|Lost to Follow-up|1|||
46969635|NCT02106832|83212414|FG002|Overall Study|Lost to Follow-up|1|||
46969636|NCT02106832|83212415|FG003|Overall Study|Lost to Follow-up|3|||
47074071|NCT02082977|83365604|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
46849774|NCT03628924|83066336|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
46849775|NCT03628924|83066337|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
46849776|NCT03628924|83066331|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
46849777|NCT03628924|83066332|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
46849778|NCT03628924|83066333|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
46849779|NCT03628924|83066334|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
46849780|NCT03628924|83066335|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
46849781|NCT03628924|83066336|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
46849782|NCT03628924|83066337|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
46849783|NCT03628924|83066331|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
46849784|NCT03628924|83066332|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
46849785|NCT03628924|83066333|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
46849786|NCT03628924|83066334|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
46849787|NCT03628924|83066335|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
46849788|NCT03628924|83066336|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
46849789|NCT03628924|83066337|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
46849790|NCT03628924|83066331|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
46849791|NCT03628924|83066332|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
46849792|NCT03628924|83066333|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
46849793|NCT03628924|83066334|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
46849794|NCT03628924|83066335|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
46849795|NCT03628924|83066336|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
47074072|NCT01624259|83365638|FG000|Overall Study|Adverse Event|18|||
46849796|NCT03628924|83066337|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
46849797|NCT03628924|83066331|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
46849798|NCT03628924|83066332|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
46969637|NCT02106832|83212412|FG000|Overall Study|Physician Decision|1|||
46969638|NCT02106832|83212413|FG001|Overall Study|Physician Decision|0|||
46969639|NCT02106832|83212414|FG002|Overall Study|Physician Decision|0|||
46969640|NCT02106832|83212415|FG003|Overall Study|Physician Decision|0|||
46969641|NCT02106832|83212412|FG000|Overall Study|Protocol Violation|0|||
46969642|NCT02106832|83212413|FG001|Overall Study|Protocol Violation|0|||
46969643|NCT02106832|83212414|FG002|Overall Study|Protocol Violation|0|||
46969644|NCT02106832|83212415|FG003|Overall Study|Protocol Violation|1|||
46969645|NCT02106832|83212412|FG000|Overall Study|Withdrawal by Subject|17|||
46969646|NCT02106832|83212413|FG001|Overall Study|Withdrawal by Subject|17|||
46969647|NCT02106832|83212414|FG002|Overall Study|Withdrawal by Subject|10|||
46969648|NCT02106832|83212415|FG003|Overall Study|Withdrawal by Subject|7|||
46849799|NCT03628924|83066333|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
46849800|NCT03628924|83066334|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
46849801|NCT03628924|83066335|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
46849802|NCT03628924|83066336|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
46849803|NCT03628924|83066337|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
46849804|NCT03628924|83066331|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
46849805|NCT03628924|83066332|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
46849806|NCT03628924|83066333|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
46849807|NCT03628924|83066334|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
46849808|NCT03628924|83066335|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
46849809|NCT03628924|83066336|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
46849810|NCT03628924|83066337|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
46849811|NCT03627832|83066351|FG000|Overall Study|Withdrawal by Subject|10|||
46849812|NCT03627832|83066352|FG001|Overall Study|Withdrawal by Subject|1|||
46849813|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
46849814|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
46849815|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
46969649|NCT02106832|83212412|FG000|Overall Study|Technical problems|0|||
46969650|NCT02106832|83212413|FG001|Overall Study|Technical problems|1|||
46969651|NCT02106832|83212414|FG002|Overall Study|Technical problems|0|||
46969652|NCT02106832|83212415|FG003|Overall Study|Technical problems|0|||
46642356|NCT02407236|82832250|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
46969653|NCT02106442|83212427|FG000|Overall Study|Case Report Forms Uncollected|7|||
46778382|NCT00659529|82996583|FG000|Overall Study|Protocol Violation|3|||
46778383|NCT00659529|82996583|FG000|Overall Study|Screen failure|9|||
46778384|NCT00578942|82996587|FG000|Overall Study|Lost to Follow-up|1|||
46778385|NCT00765245|82996593|FG000|Overall Study|disease progression|3|||
46778386|NCT00765245|82996594|FG001|Overall Study|disease progression|2|||
46778387|NCT00765245|82996593|FG000|Overall Study|Withdrawal by Subject|3|||
46778388|NCT00765245|82996594|FG001|Overall Study|Withdrawal by Subject|0|||
46778389|NCT00765245|82996593|FG000|Overall Study|Adverse Event|5|||
46778390|NCT00765245|82996594|FG001|Overall Study|Adverse Event|0|||
46778391|NCT00765245|82996593|FG000|Overall Study|Physician Decision|1|||
46778392|NCT00765245|82996594|FG001|Overall Study|Physician Decision|0|||
46778393|NCT00765245|82996593|FG000|Overall Study|Death|1|||
46969654|NCT02106442|83212427|FG000|Overall Study|Protocol Deviation|30|||
46969655|NCT02105116|83212431|FG000|Overall Study|not eligible for step 2 of trial|5|||
46969656|NCT02105116|83212431|FG000|Overall Study|Death|1|||
46778394|NCT00765245|82996594|FG001|Overall Study|Death|0|||
46969657|NCT02104804|83212437|FG000|Overall Study|Did not take study medication|0|||
46969658|NCT02104804|83212438|FG001|Overall Study|Did not take study medication|1|||
46969659|NCT02104804|83212437|FG000|Overall Study|Study specific discontinuation criteria|6|||
46969660|NCT02104804|83212438|FG001|Overall Study|Study specific discontinuation criteria|1|||
46969661|NCT02104804|83212437|FG000|Overall Study|Other listed|2|||
46969662|NCT02104804|83212438|FG001|Overall Study|Other listed|1|||
46969663|NCT02104804|83212437|FG000|Overall Study|Protocol Violation|0|||
46969664|NCT02104804|83212438|FG001|Overall Study|Protocol Violation|1|||
46969665|NCT02104804|83212437|FG000|Overall Study|Adverse Event|4|||
46969666|NCT02104804|83212438|FG001|Overall Study|Adverse Event|3|||
46969667|NCT02104804|83212437|FG000|Overall Study|Withdrawal by Subject|4|||
46642357|NCT02407236|82832251|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
46642358|NCT02407236|82832252|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
46642359|NCT02407236|82832253|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
46642360|NCT02407236|82832254|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
46642361|NCT02407236|82832242|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
46642362|NCT02407236|82832243|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
46778395|NCT00782795|82996602|FG000|Overall Study|Withdrawal by Subject|1|||
46778396|NCT00782795|82996603|FG001|Overall Study|Withdrawal by Subject|2|||
46969668|NCT02104804|83212438|FG001|Overall Study|Withdrawal by Subject|12|||
46642363|NCT02407236|82832244|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
46642364|NCT02407236|82832245|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
46778397|NCT00656799|82996609|FG000|Overall Study|Death|2|||
46778398|NCT00764699|82996613|FG000|Overall Study|PI left and study terminated|3|||
46778399|NCT00782717|82996619|FG000|Overall Study|Adverse Event|2|||
46778400|NCT00782717|82996620|FG001|Overall Study|Adverse Event|5|||
46778401|NCT00782717|82996619|FG000|Overall Study|Patient decision unrelated to AE|6|||
46778402|NCT00782717|82996620|FG001|Overall Study|Patient decision unrelated to AE|3|||
46969669|NCT02075008|83212444|FG000|Overall Study|Technical problems|1|||
46969670|NCT02075008|83212444|FG000|Overall Study|Pregnancy|1|||
46969671|NCT02075008|83212444|FG000|Overall Study|Physician Decision|1|||
46969672|NCT02075008|83212444|FG000|Overall Study|Lost to Follow-up|1|||
46969673|NCT02075008|83212444|FG000|Overall Study|Lack of Efficacy|1|||
46969674|NCT02075008|83212444|FG000|Overall Study|Death|1|||
46778403|NCT00782717|82996619|FG000|Overall Study|Noncompliance|2|||
46778404|NCT00782717|82996620|FG001|Overall Study|Noncompliance|1|||
46778405|NCT00782717|82996619|FG000|Overall Study|Treatment failure|3|||
46778406|NCT00782717|82996620|FG001|Overall Study|Treatment failure|14|||
46778407|NCT00782717|82996619|FG000|Overall Study|Enrollment close prior to surgery|1|||
46778408|NCT00782717|82996620|FG001|Overall Study|Enrollment close prior to surgery|0|||
46778409|NCT00782717|82996619|FG000|Overall Study|Did not meet entrance criteria|1|||
46778410|NCT00782717|82996620|FG001|Overall Study|Did not meet entrance criteria|3|||
46778411|NCT00782717|82996619|FG000|Overall Study|Exited in error|0|||
46778412|NCT00782717|82996620|FG001|Overall Study|Exited in error|2|||
46778413|NCT00656175|82996628|FG000|Overall Study|Adverse Event|1|||
46778414|NCT00656175|82996629|FG001|Overall Study|Adverse Event|0|||
46778415|NCT00656175|82996628|FG000|Overall Study|Transportation issues|0|||
46778416|NCT00656175|82996629|FG001|Overall Study|Transportation issues|1|||
46778417|NCT00620776|82996637|FG000|Overall Study|Did not receive treatment|3|||
46778418|NCT00620776|82996638|FG001|Overall Study|Did not receive treatment|5|||
46778419|NCT00620776|82996637|FG000|Overall Study|Adverse Event|2|||
46778420|NCT00620776|82996638|FG001|Overall Study|Adverse Event|3|||
46778421|NCT00620776|82996637|FG000|Overall Study|Lack of Efficacy|2|||
46778422|NCT00620776|82996638|FG001|Overall Study|Lack of Efficacy|1|||
46778423|NCT00620776|82996637|FG000|Overall Study|Lost to Follow-up|2|||
46778424|NCT00620776|82996638|FG001|Overall Study|Lost to Follow-up|5|||
46778425|NCT00620776|82996637|FG000|Overall Study|Withdrawal by Subject|3|||
46778426|NCT00620776|82996638|FG001|Overall Study|Withdrawal by Subject|2|||
46778427|NCT00656019|82996648|FG000|Overall Study|Not Eligible|10|||
46778428|NCT00656019|82996649|FG001|Overall Study|Not Eligible|0|||
46778429|NCT00656019|82996650|FG002|Overall Study|Not Eligible|0|||
46778430|NCT00656019|82996651|FG003|Overall Study|Not Eligible|0|||
46778431|NCT00656019|82996648|FG000|Overall Study|Withdrawal by Subject|2|||
46778432|NCT00656019|82996649|FG001|Overall Study|Withdrawal by Subject|0|||
46778433|NCT00656019|82996650|FG002|Overall Study|Withdrawal by Subject|0|||
46778434|NCT00656019|82996651|FG003|Overall Study|Withdrawal by Subject|0|||
46778435|NCT00656019|82996648|FG000|Overall Study|Lost to Follow-up|2|||
46778436|NCT00656019|82996649|FG001|Overall Study|Lost to Follow-up|1|||
46778437|NCT00656019|82996650|FG002|Overall Study|Lost to Follow-up|0|||
46778438|NCT00656019|82996651|FG003|Overall Study|Lost to Follow-up|0|||
46778439|NCT00782483|82996661|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
46778440|NCT00782171|82996667|FG000|Overall Study|Lost to Follow-up|2|||
46778441|NCT00782171|82996668|FG001|Overall Study|Lost to Follow-up|2|||
46778442|NCT00782171|82996667|FG000|Overall Study|Withdrawal by Subject|2|||
46778443|NCT00782171|82996668|FG001|Overall Study|Withdrawal by Subject|1|||
46778444|NCT00782171|82996667|FG000|Overall Study|complications|3|||
46778445|NCT00782171|82996668|FG001|Overall Study|complications|1|||
46778446|NCT00782171|82996667|FG000|Overall Study|others|7|||
46778447|NCT00782171|82996668|FG001|Overall Study|others|9|||
46778448|NCT00782171|82996667|FG000|Overall Study|not eligible|8|||
46849816|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
46849817|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
46849818|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849819|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849820|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849821|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849822|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849823|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849824|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849825|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849826|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849827|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
46969675|NCT02075008|83212444|FG000|Overall Study|Adverse Event|5|||
46969676|NCT02075008|83212444|FG000|Overall Study|Withdrawal by Subject|6|||
47074073|NCT01624259|83365639|FG001|Overall Study|Adverse Event|18|||
46969677|NCT02075008|83212444|FG000|Overall Study|Study terminated by Sponsor|159|||
46969678|NCT01666119|83212475|FG000|Overall Study|Adverse Event|6|||
46778449|NCT00782171|82996668|FG001|Overall Study|not eligible|6|||
46778450|NCT00764465|82996680|FG000|Overall Study|Adverse Event|2|||
46778451|NCT00764465|82996681|FG001|Overall Study|Adverse Event|0|||
46778452|NCT00764465|82996682|FG002|Overall Study|Adverse Event|0|||
46778453|NCT00764465|82996683|FG003|Overall Study|Adverse Event|1|||
46778454|NCT00764465|82996684|FG004|Overall Study|Adverse Event|1|||
46778455|NCT00764465|82996685|FG005|Overall Study|Adverse Event|1|||
46778456|NCT00764465|82996680|FG000|Overall Study|Withdrawal by Subject|0|||
46778457|NCT00764465|82996681|FG001|Overall Study|Withdrawal by Subject|1|||
46778458|NCT00764465|82996682|FG002|Overall Study|Withdrawal by Subject|1|||
46849828|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849829|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
46969679|NCT01666119|83212475|FG000|Overall Study|Withdrawal by Subject|16|||
46969680|NCT01666119|83212475|FG000|Overall Study|Lost to Follow-up|7|||
46778459|NCT00764465|82996683|FG003|Overall Study|Withdrawal by Subject|0|||
46778460|NCT00764465|82996684|FG004|Overall Study|Withdrawal by Subject|0|||
46778461|NCT00764465|82996685|FG005|Overall Study|Withdrawal by Subject|0|||
46778462|NCT00655863|82996705|FG000|Overall Study|Lost to Follow-up|0|||
46778463|NCT00655863|82996706|FG001|Overall Study|Lost to Follow-up|0|||
46778464|NCT00655863|82996707|FG002|Overall Study|Lost to Follow-up|1|||
46778465|NCT00781937|82996717|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
46778466|NCT00781937|82996718|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
46778467|NCT00781937|82996717|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
46778468|NCT00781937|82996718|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
46778469|NCT00781937|82996717|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
46778470|NCT00781937|82996718|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
46778471|NCT00781937|82996717|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
46778472|NCT00781937|82996718|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
46778473|NCT00781937|82996717|FG000|Main Trial Period Through Week 56|Unclassified|10|||
46778474|NCT00781937|82996718|FG001|Main Trial Period Through Week 56|Unclassified|15|||
46778475|NCT00781937|82996717|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
46778476|NCT00781937|82996718|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
46778477|NCT00781937|82996717|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
46778478|NCT00781937|82996718|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
46778479|NCT00659373|82996726|FG000|Overall Study|Withdrawal by Subject|3|||
46778480|NCT00659373|82996727|FG001|Overall Study|Withdrawal by Subject|5|||
46778481|NCT00659373|82996726|FG000|Overall Study|Assessment Missed|2|||
46778482|NCT00659373|82996727|FG001|Overall Study|Assessment Missed|2|||
46778483|NCT00439777|82996735|FG000|Treatment Period|Death|29|||
46778484|NCT00439777|82996736|FG001|Treatment Period|Death|21|||
46778485|NCT00439777|82996735|FG000|Treatment Period|Study terminated by sponsor|125|||
46778486|NCT00439777|82996736|FG001|Treatment Period|Study terminated by sponsor|132|||
46778487|NCT00439777|82996735|FG000|Treatment Period|Site closed by investigator|0|||
46778488|NCT00439777|82996736|FG001|Treatment Period|Site closed by investigator|1|||
46778489|NCT00439777|82996735|FG000|Treatment Period|Did not take study treatment|7|||
46778490|NCT00439777|82996736|FG001|Treatment Period|Did not take study treatment|8|||
46778491|NCT00439777|82996735|FG000|Treatment Period|Adverse Event|111|||
46778492|NCT00439777|82996736|FG001|Treatment Period|Adverse Event|92|||
46778493|NCT00439777|82996735|FG000|Treatment Period|Protocol Violation|23|||
46778494|NCT00439777|82996736|FG001|Treatment Period|Protocol Violation|30|||
46778495|NCT00439777|82996735|FG000|Treatment Period|Withdrawal by Subject|66|||
46778496|NCT00439777|82996736|FG001|Treatment Period|Withdrawal by Subject|118|||
46778497|NCT00439777|82996735|FG000|Treatment Period|Lack of Efficacy|1|||
46778498|NCT00439777|82996736|FG001|Treatment Period|Lack of Efficacy|4|||
46778499|NCT00439777|82996735|FG000|Treatment Period|Lost to Follow-up|8|||
46778500|NCT00439777|82996736|FG001|Treatment Period|Lost to Follow-up|10|||
46778501|NCT00439777|82996735|FG000|Treatment Period|Protocol driven decision point|1|||
46778502|NCT00439777|82996736|FG001|Treatment Period|Protocol driven decision point|3|||
46778503|NCT00439777|82996735|FG000|Treatment Period|Physician Decision|7|||
46778504|NCT00439777|82996736|FG001|Treatment Period|Physician Decision|18|||
46778505|NCT00439777|82996735|FG000|Treatment Period|Clinical endpoint reached|26|||
46778506|NCT00439777|82996736|FG001|Treatment Period|Clinical endpoint reached|13|||
46778507|NCT00439777|82996735|FG000|Treatment Period|Technical problems|3|||
46778508|NCT00439777|82996736|FG001|Treatment Period|Technical problems|1|||
46778509|NCT00439777|82996735|FG000|Treatment Period|Participant convenience|12|||
46778510|NCT00439777|82996736|FG001|Treatment Period|Participant convenience|8|||
46778511|NCT00439777|82996735|FG000|Observational Period|Protocol Violation|0|||
46778512|NCT00439777|82996736|FG001|Observational Period|Protocol Violation|2|||
46778513|NCT00439777|82996735|FG000|Observational Period|Withdrawal by Subject|9|||
46778514|NCT00439777|82996736|FG001|Observational Period|Withdrawal by Subject|5|||
46778515|NCT00439777|82996735|FG000|Observational Period|Lost to Follow-up|1|||
46778516|NCT00439777|82996736|FG001|Observational Period|Lost to Follow-up|11|||
46778517|NCT00439777|82996735|FG000|Observational Period|Death|27|||
46778518|NCT00439777|82996736|FG001|Observational Period|Death|20|||
46778519|NCT00439777|82996735|FG000|Observational Period|Study terminated by sponsor|3|||
46778520|NCT00439777|82996736|FG001|Observational Period|Study terminated by sponsor|1|||
46778521|NCT00439777|82996735|FG000|Observational Period|Protocol driven decision point|0|||
46778522|NCT00439777|82996736|FG001|Observational Period|Protocol driven decision point|1|||
46778523|NCT00439777|82996735|FG000|Observational Period|Lack of Efficacy|1|||
46778524|NCT00439777|82996736|FG001|Observational Period|Lack of Efficacy|0|||
47074074|NCT01624259|83365638|FG000|Overall Study|Protocol Violation|1|||
46778525|NCT00439777|82996735|FG000|Observational Period|Technical problems|0|||
46778526|NCT00439777|82996736|FG001|Observational Period|Technical problems|1|||
46778527|NCT00620854|82996748|FG000|Washout 1|Withdrawal by Subject|0|||
46778528|NCT00620854|82996749|FG001|Washout 1|Withdrawal by Subject|0|||
46778529|NCT00620854|82996750|FG002|Washout 1|Withdrawal by Subject|1|||
46778530|NCT00620854|82996751|FG003|Washout 1|Withdrawal by Subject|1|||
46778531|NCT00620854|82996752|FG004|Washout 1|Withdrawal by Subject|0|||
46778532|NCT00620854|82996753|FG005|Washout 1|Withdrawal by Subject|0|||
46778533|NCT00430027|82996764|FG000|Overall Study|Study terminated|8|||
46778534|NCT00429793|82996768|FG000|Overall Study|Improper pre-protocol treatment|3|||
46778535|NCT00429793|82996768|FG000|Overall Study|Required test not done|1|||
46778536|NCT00429793|82996768|FG000|Overall Study|Never treated|1|||
46778537|NCT00429793|82996768|FG000|Overall Study|Non-measurable|1|||
47074075|NCT01624259|83365639|FG001|Overall Study|Protocol Violation|2|||
47074076|NCT01624259|83365638|FG000|Overall Study|Withdrawal by Subject|5|||
47074077|NCT01624259|83365639|FG001|Overall Study|Withdrawal by Subject|7|||
47074078|NCT01624259|83365638|FG000|Overall Study|Physician Decision|1|||
47074079|NCT01624259|83365639|FG001|Overall Study|Physician Decision|1|||
47074080|NCT01624259|83365638|FG000|Overall Study|Lost to Follow-up|2|||
47074081|NCT01624259|83365639|FG001|Overall Study|Lost to Follow-up|3|||
47074082|NCT01624259|83365638|FG000|Overall Study|Abnormal laboratory measure|3|||
47074083|NCT01624259|83365639|FG001|Overall Study|Abnormal laboratory measure|0|||
46778538|NCT00424645|82996779|FG000|Overall Study|Death|1|||
46778539|NCT00424645|82996780|FG001|Overall Study|Death|0|||
46778540|NCT00763451|82996790|FG000|Overall Study|Adverse Event|4|||
46778541|NCT00763451|82996791|FG001|Overall Study|Adverse Event|6|||
46778542|NCT00763451|82996792|FG002|Overall Study|Adverse Event|19|||
46778543|NCT00763451|82996793|FG003|Overall Study|Adverse Event|14|||
46778544|NCT00763451|82996790|FG000|Overall Study|Lack of Efficacy|1|||
46778545|NCT00763451|82996791|FG001|Overall Study|Lack of Efficacy|4|||
46778546|NCT00763451|82996792|FG002|Overall Study|Lack of Efficacy|3|||
46778547|NCT00763451|82996793|FG003|Overall Study|Lack of Efficacy|2|||
46778548|NCT00763451|82996790|FG000|Overall Study|Withdrawal by Subject|1|||
46778549|NCT00763451|82996791|FG001|Overall Study|Withdrawal by Subject|6|||
46778550|NCT00763451|82996792|FG002|Overall Study|Withdrawal by Subject|9|||
46778551|NCT00763451|82996793|FG003|Overall Study|Withdrawal by Subject|7|||
46778552|NCT00763451|82996790|FG000|Overall Study|Protocol Violation|0|||
46778553|NCT00763451|82996791|FG001|Overall Study|Protocol Violation|0|||
46778554|NCT00763451|82996792|FG002|Overall Study|Protocol Violation|1|||
46778555|NCT00763451|82996793|FG003|Overall Study|Protocol Violation|0|||
46778556|NCT00763451|82996790|FG000|Overall Study|Poor Compliance to Protocol|1|||
46778557|NCT00763451|82996791|FG001|Overall Study|Poor Compliance to Protocol|1|||
46778558|NCT00763451|82996792|FG002|Overall Study|Poor Compliance to Protocol|2|||
46778559|NCT00763451|82996793|FG003|Overall Study|Poor Compliance to Protocol|2|||
46778560|NCT00763451|82996790|FG000|Overall Study|Familial and Personal Reasons|5|||
46778561|NCT00763451|82996791|FG001|Overall Study|Familial and Personal Reasons|3|||
46778562|NCT00763451|82996792|FG002|Overall Study|Familial and Personal Reasons|5|||
46778563|NCT00763451|82996793|FG003|Overall Study|Familial and Personal Reasons|4|||
46778564|NCT00763451|82996790|FG000|Overall Study|Randomized but not Treated|1|||
46778565|NCT00763451|82996791|FG001|Overall Study|Randomized but not Treated|1|||
46778566|NCT00763451|82996792|FG002|Overall Study|Randomized but not Treated|0|||
46778567|NCT00763451|82996793|FG003|Overall Study|Randomized but not Treated|0|||
46778568|NCT00763451|82996790|FG000|Overall Study|Study Site Reason|0|||
46778569|NCT00763451|82996791|FG001|Overall Study|Study Site Reason|1|||
46778570|NCT00763451|82996792|FG002|Overall Study|Study Site Reason|1|||
46778571|NCT00763451|82996793|FG003|Overall Study|Study Site Reason|1|||
46778572|NCT00762762|82996806|FG000|Overall Study|Did not return for appointments|6|||
46849830|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
46778573|NCT00762762|82996807|FG001|Overall Study|Did not return for appointments|8|||
46849831|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
47074084|NCT02081417|83365649|FG000|Overall Study|Lost to Follow-up|26|||
47074085|NCT02081417|83365650|FG001|Overall Study|Lost to Follow-up|23|||
46778574|NCT00424489|82996815|FG000|Overall Study|Death|3|||
46778575|NCT00578864|82996821|FG000|Overall Study|Death|1|||
46778576|NCT00578864|82996822|FG001|Overall Study|Death|0|||
46778577|NCT00770315|82996845|FG000|Overall Study|Adverse Event|11|||
46778578|NCT00770315|82996846|FG001|Overall Study|Adverse Event|17|||
46778579|NCT00770315|82996847|FG002|Overall Study|Adverse Event|16|||
46778580|NCT00770315|82996848|FG003|Overall Study|Adverse Event|6|||
46778581|NCT00770315|82996845|FG000|Overall Study|Lost to Follow-up|9|||
46778582|NCT00770315|82996846|FG001|Overall Study|Lost to Follow-up|5|||
46778583|NCT00770315|82996847|FG002|Overall Study|Lost to Follow-up|10|||
46778584|NCT00770315|82996848|FG003|Overall Study|Lost to Follow-up|3|||
46778585|NCT00770315|82996845|FG000|Overall Study|Withdrawal by Subject|13|||
46778586|NCT00770315|82996846|FG001|Overall Study|Withdrawal by Subject|17|||
46778587|NCT00770315|82996847|FG002|Overall Study|Withdrawal by Subject|24|||
46778588|NCT00770315|82996848|FG003|Overall Study|Withdrawal by Subject|20|||
46778589|NCT00770315|82996845|FG000|Overall Study|Noncompliance with Protocol|7|||
46778590|NCT00770315|82996846|FG001|Overall Study|Noncompliance with Protocol|4|||
46778591|NCT00770315|82996847|FG002|Overall Study|Noncompliance with Protocol|7|||
46778592|NCT00770315|82996848|FG003|Overall Study|Noncompliance with Protocol|9|||
46778593|NCT00587171|82996860|FG000|Overall Study|Lost to Follow-up|1|||
46778594|NCT00587171|82996861|FG001|Overall Study|Lost to Follow-up|1|||
46778595|NCT00763139|82996867|FG000|Overall Study|Adverse Event|4|||
46778596|NCT00763139|82996868|FG001|Overall Study|Adverse Event|2|||
46778597|NCT00763139|82996867|FG000|Overall Study|Withdrawal by Subject|0|||
46778598|NCT00763139|82996868|FG001|Overall Study|Withdrawal by Subject|1|||
46778599|NCT00763139|82996867|FG000|Overall Study|med change not allowed by protocol|1|||
46778600|NCT00763139|82996868|FG001|Overall Study|med change not allowed by protocol|0|||
46778601|NCT00781859|82996881|FG000|Overall Study|Adverse Event|2|||
46778602|NCT00781859|82996882|FG001|Overall Study|Adverse Event|2|||
46778603|NCT00781859|82996881|FG000|Overall Study|Withdrawal by Subject|8|||
46778604|NCT00781859|82996882|FG001|Overall Study|Withdrawal by Subject|4|||
46778605|NCT00781859|82996881|FG000|Overall Study|Lost to Follow-up|6|||
46778606|NCT00781859|82996882|FG001|Overall Study|Lost to Follow-up|3|||
46778607|NCT00781859|82996881|FG000|Overall Study|Death|3|||
46778608|NCT00781859|82996882|FG001|Overall Study|Death|0|||
46778609|NCT00580788|82996892|FG000|Overall Study|Adverse Event|0|||
46778610|NCT00580788|82996893|FG001|Overall Study|Adverse Event|0|||
46778611|NCT00580788|82996894|FG002|Overall Study|Adverse Event|0|||
46778612|NCT00580788|82996895|FG003|Overall Study|Adverse Event|1|||
46778613|NCT00417079|82996914|FG000|Overall Study|Disease progression|267|||
46778614|NCT00417079|82996915|FG001|Overall Study|Disease progression|180|||
46778615|NCT00417079|82996914|FG000|Overall Study|Adverse Event|32|||
46778616|NCT00417079|82996915|FG001|Overall Study|Adverse Event|67|||
46778617|NCT00417079|82996914|FG000|Overall Study|Non-compliance to protocol|0|||
46778618|NCT00417079|82996915|FG001|Overall Study|Non-compliance to protocol|1|||
46778619|NCT00417079|82996914|FG000|Overall Study|Lost to Follow-up|2|||
46778620|NCT00417079|82996915|FG001|Overall Study|Lost to Follow-up|0|||
46778621|NCT00417079|82996914|FG000|Overall Study|Withdrawal by Subject|17|||
46778622|NCT00417079|82996915|FG001|Overall Study|Withdrawal by Subject|8|||
46778623|NCT00417079|82996914|FG000|Overall Study|Not treated|6|||
46778624|NCT00417079|82996915|FG001|Overall Study|Not treated|7|||
46778625|NCT00417079|82996914|FG000|Overall Study|Screened failure|2|||
46778626|NCT00417079|82996915|FG001|Overall Study|Screened failure|1|||
46778627|NCT00417079|82996914|FG000|Overall Study|Investigator's decision|1|||
46778628|NCT00417079|82996915|FG001|Overall Study|Investigator's decision|4|||
46778629|NCT00417079|82996914|FG000|Overall Study|Non-confirmed Disease progression|1|||
46778630|NCT00417079|82996915|FG001|Overall Study|Non-confirmed Disease progression|1|||
46778631|NCT00417079|82996914|FG000|Overall Study|Clinical deterioration|1|||
46778632|NCT00417079|82996915|FG001|Overall Study|Clinical deterioration|0|||
46778633|NCT00417079|82996914|FG000|Overall Study|Screening error|2|||
46778634|NCT00417079|82996915|FG001|Overall Study|Screening error|1|||
46778635|NCT00417079|82996914|FG000|Overall Study|Withdrawal by subject's family|0|||
46778636|NCT00417079|82996915|FG001|Overall Study|Withdrawal by subject's family|1|||
46778637|NCT00417079|82996914|FG000|Overall Study|Patient unable to come to the clinic|0|||
46849832|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849833|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849834|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849835|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
46778638|NCT00417079|82996915|FG001|Overall Study|Patient unable to come to the clinic|1|||
46778639|NCT00417079|82996914|FG000|Overall Study|abnormal liver function tests|0|||
46778640|NCT00417079|82996915|FG001|Overall Study|abnormal liver function tests|1|||
46849836|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
46778641|NCT00429169|82996923|FG000|Overall Study|Lost to Follow-up|0|||
46778642|NCT00429169|82996924|FG001|Overall Study|Lost to Follow-up|1|||
46778643|NCT00429169|82996923|FG000|Overall Study|Ineligibility discovered after entry|2|||
46778644|NCT00429169|82996924|FG001|Overall Study|Ineligibility discovered after entry|1|||
46778645|NCT00416455|82996934|FG000|Overall Study|PET / CT not done|3|||
46778646|NCT00416455|82996935|FG001|Overall Study|PET / CT not done|5|||
46778647|NCT00416455|82996934|FG000|Overall Study|PET / CT poor quality|2|||
46778648|NCT00416455|82996935|FG001|Overall Study|PET / CT poor quality|1|||
46778649|NCT00416455|82996934|FG000|Overall Study|Inadequate pathology|11|||
46778650|NCT00416455|82996935|FG001|Overall Study|Inadequate pathology|2|||
47074086|NCT02081417|83365649|FG000|Overall Study|Moved Away|1|||
46778651|NCT00415909|82996952|FG000|Overall Study|Withdrawal by Subject|2|||
46778652|NCT00415909|82996952|FG000|Overall Study|Death|1|||
46778653|NCT00415597|82996956|FG000|Enrollment|Withdrawal by Subject|1|||
46778654|NCT00415597|82996956|FG000|Enrollment|Protocol Violation|1|||
46778655|NCT00415597|82996956|FG000|Treatment|Adverse Event|110|||
46778656|NCT00415597|82996956|FG000|Treatment|Lack of Efficacy|39|||
46778657|NCT00415597|82996956|FG000|Treatment|Protocol Violation|67|||
46778658|NCT00415597|82996956|FG000|Treatment|Physician Decision|3|||
46778659|NCT00415597|82996956|FG000|Treatment|Withdrawal by Subject|51|||
46778660|NCT00415597|82996956|FG000|Treatment|Lost to Follow-up|28|||
46778661|NCT00415597|82996956|FG000|Treatment|Drug Screen|2|||
46778662|NCT00415597|82996956|FG000|Treatment|Administrative|3|||
46778663|NCT00415597|82996956|FG000|Treatment|Sponsor Decision|1|||
46778664|NCT00415597|82996956|FG000|Treatment|Multiple Reasons|1|||
46778665|NCT00620542|82996962|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
46778666|NCT00620542|82996963|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
46778667|NCT00620542|82996964|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
46778668|NCT00620542|82996965|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
46778669|NCT00620542|82996962|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
46778670|NCT00620542|82996963|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
46778671|NCT00620542|82996964|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
46778672|NCT00620542|82996965|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
46778673|NCT00620542|82996962|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
46778674|NCT00620542|82996963|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
46778675|NCT00620542|82996964|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
46778676|NCT00620542|82996965|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
46778677|NCT00620542|82996962|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
46778678|NCT00620542|82996963|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
46778679|NCT00620542|82996964|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
46778680|NCT00620542|82996965|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
46778681|NCT00620542|82996962|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
46778682|NCT00620542|82996963|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
46778683|NCT00620542|82996964|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
46778684|NCT00620542|82996965|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
46778685|NCT00620542|82996962|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
46778686|NCT00620542|82996963|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
46778687|NCT00620542|82996964|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
46778688|NCT00620542|82996965|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
46778689|NCT00620542|82996962|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
46778690|NCT00620542|82996963|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
46778691|NCT00620542|82996964|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
46778692|NCT00620542|82996965|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
46778693|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
46778694|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
46778695|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
46778696|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
46778697|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
46778698|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
46778699|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
46778700|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
46778701|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
46778702|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
46778703|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
46778704|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
46849837|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849838|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
46849839|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849840|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
46778705|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
46778706|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
46778707|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
46778708|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
46778709|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
46778710|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
46849841|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46778711|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
46778712|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
46778713|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
46778714|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
46778715|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
46778716|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
46778717|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
46849842|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849843|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849844|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46778718|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
46778719|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
46778720|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
46778721|NCT00620542|82996962|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
46778722|NCT00620542|82996963|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
46778723|NCT00620542|82996964|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
46849845|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849846|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849847|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849848|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849849|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849850|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849851|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849852|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849853|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849854|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849855|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849856|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849857|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849858|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849859|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849860|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849861|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849862|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849863|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849864|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
46849865|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849866|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
46849867|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849868|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849869|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849870|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849871|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849872|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849873|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849874|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849875|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849876|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849877|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849878|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849879|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849880|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849881|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849882|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849883|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849884|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849885|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849886|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46969681|NCT01666119|83212475|FG000|Overall Study|non compliance with study medication, pa|18|||
47074087|NCT02081417|83365650|FG001|Overall Study|Moved Away|2|||
47074088|NCT02081417|83365649|FG000|Overall Study|Incarcerated|2|||
47074089|NCT02081417|83365650|FG001|Overall Study|Incarcerated|2|||
46778724|NCT00620542|82996965|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
46778725|NCT05096208|82996977|FG000|Overall Study|Lost to Follow-up|3|||
46778726|NCT05096208|82996978|FG001|Overall Study|Lost to Follow-up|5|||
46778727|NCT05096208|82996979|FG002|Overall Study|Lost to Follow-up|5|||
46778728|NCT05096208|82996980|FG003|Overall Study|Lost to Follow-up|2|||
46849887|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46969682|NCT01666119|83212475|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
46849888|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849889|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
47074090|NCT02081417|83365649|FG000|Overall Study|Death|4|||
47074091|NCT02081417|83365650|FG001|Overall Study|Death|3|||
47074092|NCT02081417|83365649|FG000|Overall Study|Withdrawal by Subject|4|||
46778729|NCT05096208|82996977|FG000|Overall Study|Withdrawal by Subject|0|||
46849890|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
46849891|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
46969683|NCT05128773|83212479|FG000|Overall Study|Sponsor decision to terminate study|3|||
46778730|NCT05096208|82996978|FG001|Overall Study|Withdrawal by Subject|1|||
46969684|NCT01665807|83212487|FG000|Overall Study|Withdrawal by Subject|2|||
47074093|NCT02081417|83365650|FG001|Overall Study|Withdrawal by Subject|0|||
46778731|NCT05096208|82996979|FG002|Overall Study|Withdrawal by Subject|2|||
46778732|NCT05096208|82996980|FG003|Overall Study|Withdrawal by Subject|3|||
46849892|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
47074094|NCT02081417|83365649|FG000|Overall Study|Admitted to Residential Treatment|2|||
47074095|NCT02081417|83365650|FG001|Overall Study|Admitted to Residential Treatment|0|||
46778733|NCT05096208|82996977|FG000|Overall Study|No longer met eligibility criteria|1|||
46778734|NCT05096208|82996978|FG001|Overall Study|No longer met eligibility criteria|0|||
46778735|NCT05096208|82996979|FG002|Overall Study|No longer met eligibility criteria|0|||
46778736|NCT05096208|82996980|FG003|Overall Study|No longer met eligibility criteria|0|||
46778737|NCT05096208|82996977|FG000|Overall Study|Other|0|||
46778738|NCT05096208|82996978|FG001|Overall Study|Other|0|||
46778739|NCT05096208|82996979|FG002|Overall Study|Other|1|||
46778740|NCT05096208|82996980|FG003|Overall Study|Other|0|||
46778741|NCT04555616|82996999|FG000|Overall Study|Death|1|||
46778742|NCT04555616|82997000|FG001|Overall Study|Death|0|||
46778743|NCT04555616|82997001|FG002|Overall Study|Death|1|||
46778744|NCT04555616|82996999|FG000|Overall Study|Withdrawal by Subject|2|||
46778745|NCT04555616|82997000|FG001|Overall Study|Withdrawal by Subject|1|||
46778746|NCT04555616|82997001|FG002|Overall Study|Withdrawal by Subject|0|||
46778747|NCT04177758|82997025|FG000|Overall Study|Lost to Follow-up|19|||
46778748|NCT04177758|82997026|FG001|Overall Study|Lost to Follow-up|11|||
46778749|NCT04003103|82997035|FG000|Overall Study|Death|1|||
46778750|NCT04003103|82997036|FG001|Overall Study|Death|0|||
46778751|NCT04003103|82997037|FG002|Overall Study|Death|0|||
46778752|NCT04003103|82997035|FG000|Overall Study|Lost to Follow-up|4|||
46778753|NCT04003103|82997036|FG001|Overall Study|Lost to Follow-up|3|||
46778754|NCT04003103|82997037|FG002|Overall Study|Lost to Follow-up|2|||
46778755|NCT04003103|82997035|FG000|Overall Study|Withdrawal by Subject|10|||
46778756|NCT04003103|82997036|FG001|Overall Study|Withdrawal by Subject|1|||
46778757|NCT04003103|82997037|FG002|Overall Study|Withdrawal by Subject|1|||
46778758|NCT04003103|82997035|FG000|Overall Study|Status not recorded|0|||
46778759|NCT04003103|82997036|FG001|Overall Study|Status not recorded|2|||
46778760|NCT04003103|82997037|FG002|Overall Study|Status not recorded|0|||
46778761|NCT03832322|82997087|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
46778762|NCT03832322|82997088|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
46778763|NCT03642990|82997104|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
46778764|NCT03642990|82997104|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
46778765|NCT03639311|82997110|FG000|Overall Study|Ongoing at the time of analysis|88|||
46778766|NCT03639311|82997111|FG001|Overall Study|Ongoing at the time of analysis|0|||
46778767|NCT03639311|82997110|FG000|Overall Study|Lost to Follow-up|1|||
46778768|NCT03639311|82997111|FG001|Overall Study|Lost to Follow-up|0|||
46778769|NCT03639311|82997110|FG000|Overall Study|Adverse Event|1|||
46778770|NCT03639311|82997111|FG001|Overall Study|Adverse Event|0|||
46778771|NCT03633825|82997122|FG000|Enrollment|Did not post on network|5066|||
46778772|NCT03633825|82997123|FG001|Enrollment|Did not post on network|5080|||
46778773|NCT03633825|82997122|FG000|Enrollment|Post not classified as crisis|13967|||
46778774|NCT03633825|82997123|FG001|Enrollment|Post not classified as crisis|13757|||
46778775|NCT03633825|82997122|FG000|Follow up|Lost to Follow-up|478|||
46778776|NCT03633825|82997123|FG001|Follow up|Lost to Follow-up|450|||
46778777|NCT05427539|82997129|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
46778778|NCT05427539|82997130|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
46778779|NCT05427539|82997129|FG000|Period 1|Withdrawal by Subject|1|||
46778780|NCT05427539|82997130|FG001|Period 1|Withdrawal by Subject|0|||
46849893|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
46849894|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
46849895|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
46849896|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
47074096|NCT02081417|83365649|FG000|Overall Study|Did not start treatment|17|||
46778781|NCT05144945|82997138|FG000|Overall Study|Withdrawal by Subject|1|||
46849897|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849898|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46778782|NCT05144945|82997139|FG001|Overall Study|Withdrawal by Subject|0|||
46778783|NCT03768336|82997183|FG000|Overall Study|Lost to Follow-up|3|||
46849899|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46969685|NCT01665807|83212488|FG001|Overall Study|Withdrawal by Subject|0|||
46969686|NCT01665807|83212489|FG002|Overall Study|Withdrawal by Subject|1|||
46778784|NCT03768336|82997184|FG001|Overall Study|Lost to Follow-up|2|||
46778785|NCT03768336|82997183|FG000|Overall Study|Became Ineligible|2|||
46778786|NCT03768336|82997184|FG001|Overall Study|Became Ineligible|0|||
46778787|NCT03768336|82997183|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
46778788|NCT03768336|82997184|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
46778789|NCT03768336|82997183|FG000|Overall Study|Missed final survey (post-treatment|0|||
46778790|NCT03768336|82997184|FG001|Overall Study|Missed final survey (post-treatment|1|||
46778791|NCT03742141|82997191|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
46778792|NCT02795104|82997198|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
46778793|NCT02795104|82997199|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
46778794|NCT02795104|82997200|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
46778795|NCT02795104|82997198|FG000|Overall Study|Withdrawal by Subject|0|||
46778796|NCT02795104|82997199|FG001|Overall Study|Withdrawal by Subject|2|||
46778797|NCT02795104|82997200|FG002|Overall Study|Withdrawal by Subject|0|||
46778798|NCT02795104|82997198|FG000|Overall Study|Lost to Follow-up|0|||
46778799|NCT02795104|82997199|FG001|Overall Study|Lost to Follow-up|0|||
46778800|NCT02795104|82997200|FG002|Overall Study|Lost to Follow-up|1|||
46778801|NCT02675244|82997213|FG000|Overall Study|Death|9|||
46778802|NCT02675244|82997214|FG001|Overall Study|Death|6|||
46778803|NCT02675244|82997213|FG000|Overall Study|Withdrawal by Subject|3|||
46778804|NCT02675244|82997214|FG001|Overall Study|Withdrawal by Subject|6|||
46778805|NCT02675244|82997213|FG000|Overall Study|Lost to Follow-up|1|||
46778806|NCT02675244|82997214|FG001|Overall Study|Lost to Follow-up|1|||
46778807|NCT02675244|82997213|FG000|Overall Study|Ongoing at 2 Years|190|||
46778808|NCT02675244|82997214|FG001|Overall Study|Ongoing at 2 Years|185|||
46778809|NCT01298323|82997284|FG000|Overall Study|Adverse Event|2|||
46778810|NCT01298323|82997285|FG001|Overall Study|Adverse Event|4|||
46849900|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849901|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849902|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849903|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46778811|NCT01298323|82997284|FG000|Overall Study|Death|11|||
46778812|NCT01298323|82997285|FG001|Overall Study|Death|16|||
46778813|NCT01298323|82997284|FG000|Overall Study|Lost to Follow-up|1|||
46778814|NCT01298323|82997285|FG001|Overall Study|Lost to Follow-up|0|||
46778815|NCT01298323|82997284|FG000|Overall Study|Withdrawal by Subject|6|||
46778816|NCT01298323|82997285|FG001|Overall Study|Withdrawal by Subject|3|||
46778817|NCT01298323|82997284|FG000|Overall Study|Protocol Violation|1|||
46778818|NCT01298323|82997285|FG001|Overall Study|Protocol Violation|0|||
46778819|NCT01298323|82997284|FG000|Overall Study|Other|10|||
46778820|NCT01298323|82997285|FG001|Overall Study|Other|9|||
46778821|NCT01298323|82997284|FG000|Overall Study|Ongoing|55|||
46778822|NCT01298323|82997285|FG001|Overall Study|Ongoing|55|||
46778823|NCT01298323|82997284|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46778824|NCT01298323|82997285|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
46778825|NCT01268579|82997291|FG000|Overall Study|Adverse Event|1|||
46778826|NCT01268579|82997291|FG000|Overall Study|Withdrawal by Subject|2|||
46778827|NCT01056523|82997295|FG000|Overall Study|Death|1|||
46778828|NCT01056523|82997296|FG001|Overall Study|Death|0|||
46778829|NCT01056523|82997297|FG002|Overall Study|Death|2|||
46778830|NCT01056523|82997298|FG003|Overall Study|Death|3|||
46778831|NCT01056523|82997299|FG004|Overall Study|Death|0|||
46778832|NCT01056523|82997300|FG005|Overall Study|Death|0|||
46778833|NCT01056523|82997301|FG006|Overall Study|Death|1|||
46778834|NCT00554788|82997322|FG000|Overall Study|Adverse Event|0|||
46778835|NCT00554788|82997323|FG001|Overall Study|Adverse Event|1|||
46849904|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849905|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46969687|NCT02584959|83212500|FG000|Period 1|Withdrawn from study|3|||
46969688|NCT02584959|83212501|FG001|Period 1|Withdrawn from study|4|||
46969689|NCT02584959|83212502|FG002|Period 1|Withdrawn from study|0|||
46969690|NCT02584959|83212500|FG000|Period 2|Withdrawn from study|6|||
46969691|NCT02584959|83212501|FG001|Period 2|Withdrawn from study|1|||
46849906|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849907|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849908|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849909|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849910|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46969692|NCT02584959|83212502|FG002|Period 2|Withdrawn from study|2|||
46969693|NCT02584257|83212519|FG000|Period 1|Withdrawal by Subject|0|||
47074097|NCT02081417|83365650|FG001|Overall Study|Did not start treatment|21|||
46969694|NCT02584257|83212520|FG001|Period 1|Withdrawal by Subject|0|||
47074098|NCT02081183|83365658|FG000|Overall Study|Lost to Follow-up|0|||
46778836|NCT00554788|82997324|FG002|Overall Study|Adverse Event|2|||
46778837|NCT00554788|82997322|FG000|Overall Study|Lost to Follow-up|4|||
46778838|NCT00554788|82997323|FG001|Overall Study|Lost to Follow-up|3|||
46778839|NCT00554788|82997324|FG002|Overall Study|Lost to Follow-up|3|||
46778840|NCT00554788|82997322|FG000|Overall Study|Physician Decision|1|||
46778841|NCT00554788|82997323|FG001|Overall Study|Physician Decision|1|||
46778842|NCT00554788|82997324|FG002|Overall Study|Physician Decision|3|||
46778843|NCT00554788|82997322|FG000|Overall Study|Withdrawal by Subject|0|||
46778844|NCT00554788|82997323|FG001|Overall Study|Withdrawal by Subject|0|||
46778845|NCT00554788|82997324|FG002|Overall Study|Withdrawal by Subject|1|||
46778846|NCT00554788|82997322|FG000|Overall Study|Refusal of further protocol therapy|0|||
46969695|NCT02584257|83212521|FG002|Period 1|Withdrawal by Subject|0|||
46778847|NCT00554788|82997323|FG001|Overall Study|Refusal of further protocol therapy|1|||
46642365|NCT02407236|82832246|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
46642366|NCT02407236|82832247|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
46642367|NCT02407236|82832248|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
46642368|NCT02407236|82832249|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
46642369|NCT02407236|82832250|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
46642370|NCT02407236|82832251|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
46642371|NCT02407236|82832252|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
46642372|NCT02407236|82832253|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
46642373|NCT02407236|82832254|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
46642374|NCT01893138|82832282|FG000|Double-Blind Period|Withdrawal by Subject|1|||
46642375|NCT01893138|82832283|FG001|Double-Blind Period|Withdrawal by Subject|1|||
46642376|NCT01893138|82832282|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
46642377|NCT01893138|82832283|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
46642378|NCT01893138|82832282|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
46642379|NCT01893138|82832283|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
46642380|NCT01893138|82832282|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
46642381|NCT01893138|82832283|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
46642382|NCT01893138|82832282|FG000|Open Label - Unblinded Period|Adverse Event|1|||
46642383|NCT01893138|82832283|FG001|Open Label - Unblinded Period|Adverse Event|0|||
46642384|NCT04309500|82832295|FG000|Overall Study|Lost to Follow-up|1|||
46642385|NCT04309500|82832296|FG001|Overall Study|Lost to Follow-up|0|||
46642386|NCT04309500|82832297|FG002|Overall Study|Lost to Follow-up|0|||
46642387|NCT04309500|82832298|FG003|Overall Study|Lost to Follow-up|0|||
46642388|NCT03671304|82833633|FG000|Overall Study|study terminated|7|||
46642389|NCT03447990|82833644|FG000|Overall Study|Withdrawal by Subject|0|||
46642390|NCT03447990|82833645|FG001|Overall Study|Withdrawal by Subject|0|||
46642391|NCT03447990|82833646|FG002|Overall Study|Withdrawal by Subject|0|||
46642392|NCT03447990|82833647|FG003|Overall Study|Withdrawal by Subject|0|||
46642393|NCT03447990|82833648|FG004|Overall Study|Withdrawal by Subject|0|||
46642394|NCT03447990|82833649|FG005|Overall Study|Withdrawal by Subject|0|||
46642395|NCT03447990|82833650|FG006|Overall Study|Withdrawal by Subject|1|||
46642396|NCT01376778|82833702|FG000|Overall Study|Lost to Follow-up|3|||
46642397|NCT01376778|82833703|FG001|Overall Study|Lost to Follow-up|2|||
46642398|NCT01074294|82833712|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
46642399|NCT01074294|82833713|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
46642400|NCT01074294|82833714|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
46642401|NCT01074294|82833715|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
46642402|NCT01074294|82833712|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
46642403|NCT01074294|82833713|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
46642404|NCT01074294|82833714|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
46642405|NCT01074294|82833715|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
46642406|NCT01074294|82833712|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
46642407|NCT01074294|82833713|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
46642408|NCT01074294|82833714|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
46642409|NCT01074294|82833715|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
46642410|NCT01074294|82833712|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
46642411|NCT01074294|82833713|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
46642412|NCT01074294|82833714|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
46642413|NCT01074294|82833715|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
46642414|NCT01074294|82833712|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
46642415|NCT01074294|82833713|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
46642416|NCT01074294|82833714|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
46642417|NCT01074294|82833715|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
46642418|NCT01074294|82833712|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
46642419|NCT01074294|82833713|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
46778848|NCT00554788|82997324|FG002|Overall Study|Refusal of further protocol therapy|1|||
46642420|NCT01074294|82833714|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
46642421|NCT01074294|82833715|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
46642422|NCT01074294|82833712|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
46642423|NCT01074294|82833713|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
46642424|NCT01074294|82833714|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
46642425|NCT01074294|82833715|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
46642426|NCT01074294|82833712|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
46642427|NCT01074294|82833713|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
46642428|NCT01074294|82833714|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
46642429|NCT01074294|82833715|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
46778849|NCT00554788|82997322|FG000|Overall Study|Progressive disease|0|||
46778850|NCT00554788|82997323|FG001|Overall Study|Progressive disease|0|||
46778851|NCT00554788|82997324|FG002|Overall Study|Progressive disease|3|||
46642430|NCT01074294|82833712|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
46642431|NCT01074294|82833713|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
46642432|NCT01074294|82833714|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
46642433|NCT01074294|82833715|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
46642434|NCT01074294|82833712|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
46642435|NCT01074294|82833713|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
46642436|NCT01074294|82833714|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
46642437|NCT01074294|82833715|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
46642438|NCT01074294|82833712|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
46642439|NCT01074294|82833713|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
46642440|NCT01074294|82833714|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
46642441|NCT01074294|82833715|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
46642442|NCT01074294|82833712|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
46642443|NCT01074294|82833713|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
46642444|NCT01074294|82833714|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
46642445|NCT01074294|82833715|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
46642446|NCT01074294|82833712|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
46642447|NCT01074294|82833713|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
46642448|NCT01074294|82833714|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
46642449|NCT01074294|82833715|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
46642450|NCT04753437|82834655|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
46642451|NCT04753437|82834656|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
46642452|NCT04753437|82834655|FG000|Overall Study|Liver Function Test Abnormalities|2|||
46642453|NCT04753437|82834656|FG001|Overall Study|Liver Function Test Abnormalities|4|||
46642454|NCT04605094|82834664|FG000|Overall Study|Adverse Event|2|||
46642455|NCT04605094|82834665|FG001|Overall Study|Adverse Event|2|||
46642456|NCT04605094|82834664|FG000|Overall Study|Lost to Follow-up|1|||
46642457|NCT04605094|82834665|FG001|Overall Study|Lost to Follow-up|4|||
46642458|NCT04605094|82834664|FG000|Overall Study|Physician Decision|2|||
46642459|NCT04605094|82834665|FG001|Overall Study|Physician Decision|2|||
46642460|NCT04605094|82834664|FG000|Overall Study|Study terminated by Sponsor|31|||
46642461|NCT04605094|82834665|FG001|Overall Study|Study terminated by Sponsor|33|||
46642462|NCT04605094|82834664|FG000|Overall Study|Withdrawal by Subject|22|||
46642463|NCT04605094|82834665|FG001|Overall Study|Withdrawal by Subject|19|||
46642464|NCT04605094|82834664|FG000|Overall Study|Other|1|||
46642465|NCT04605094|82834665|FG001|Overall Study|Other|1|||
46642466|NCT04526210|82834674|FG000|Overall Study|Sponsor decision|7|||
46642467|NCT04526210|82834675|FG001|Overall Study|Sponsor decision|5|||
46642468|NCT04526210|82834674|FG000|Overall Study|Withdrawal by Subject|3|||
46642469|NCT04526210|82834675|FG001|Overall Study|Withdrawal by Subject|2|||
46642470|NCT04149964|82834693|FG000|Overall Study|Lost to Follow-up|19|||
46642471|NCT04149964|82834694|FG001|Overall Study|Lost to Follow-up|18|||
46642472|NCT03842969|82834720|FG000|Overall Study|Participant declined follow-up visit|0|||
46642473|NCT03842969|82834721|FG001|Overall Study|Participant declined follow-up visit|1|||
46642474|NCT03842969|82834722|FG002|Overall Study|Participant declined follow-up visit|0|||
46642475|NCT03842969|82834720|FG000|Overall Study|Sponsor's decision|12|||
46642476|NCT03842969|82834721|FG001|Overall Study|Sponsor's decision|99|||
46642477|NCT03842969|82834722|FG002|Overall Study|Sponsor's decision|61|||
46778852|NCT00554788|82997322|FG000|Overall Study|Ineligible|2|||
46778853|NCT00554788|82997323|FG001|Overall Study|Ineligible|0|||
46778854|NCT00554788|82997324|FG002|Overall Study|Ineligible|1|||
46778855|NCT00410761|82997335|FG000|Overall Study|Adverse Event|29|||
46778856|NCT00410761|82997336|FG001|Overall Study|Adverse Event|3|||
46778857|NCT00410761|82997335|FG000|Overall Study|objective disease progression|71|||
46778858|NCT00410761|82997336|FG001|Overall Study|objective disease progression|55|||
46642478|NCT03842969|82834720|FG000|Overall Study|Pregnancy|0|||
46642479|NCT03842969|82834721|FG001|Overall Study|Pregnancy|0|||
46642480|NCT03842969|82834722|FG002|Overall Study|Pregnancy|1|||
46642481|NCT03842969|82834720|FG000|Overall Study|Death|1|||
46642482|NCT03842969|82834721|FG001|Overall Study|Death|0|||
46642483|NCT03842969|82834722|FG002|Overall Study|Death|1|||
46642484|NCT03842969|82834720|FG000|Overall Study|Withdrawal by Subject|3|||
46642485|NCT03842969|82834721|FG001|Overall Study|Withdrawal by Subject|30|||
46642486|NCT03842969|82834722|FG002|Overall Study|Withdrawal by Subject|18|||
46642487|NCT03842969|82834720|FG000|Overall Study|Protocol Violation|1|||
46778859|NCT00410761|82997335|FG000|Overall Study|Withdrawal by Subject|8|||
47074099|NCT02081183|83365659|FG001|Overall Study|Lost to Follow-up|1|||
47074100|NCT02081183|83365658|FG000|Overall Study|Protocol Violation|1|||
47074101|NCT02081183|83365659|FG001|Overall Study|Protocol Violation|0|||
47074102|NCT02081183|83365658|FG000|Overall Study|Other|3|||
47074103|NCT02081183|83365659|FG001|Overall Study|Other|3|||
47074104|NCT02080871|83365665|FG000|Overall Study|Death|1|||
46778860|NCT00410761|82997336|FG001|Overall Study|Withdrawal by Subject|4|||
46969696|NCT02584257|83212522|FG003|Period 1|Withdrawal by Subject|0|||
46969697|NCT02584257|83212523|FG004|Period 1|Withdrawal by Subject|0|||
46969698|NCT02584257|83212524|FG005|Period 1|Withdrawal by Subject|0|||
46969699|NCT02584257|83212525|FG006|Period 1|Withdrawal by Subject|1|||
46969700|NCT02584257|83212526|FG007|Period 1|Withdrawal by Subject|0|||
46969701|NCT02584257|83212527|FG008|Period 1|Withdrawal by Subject|0|||
47074105|NCT02080871|83365665|FG000|Overall Study|Lost to Follow-up|1|||
47074106|NCT02080481|83365671|FG000|Overall Study|Never received a block.|1|||
47074107|NCT02080481|83365672|FG001|Overall Study|Never received a block.|0|||
47074108|NCT02080403|83365680|FG000|Overall Study|Adverse Event|5|||
47074109|NCT02080403|83365681|FG001|Overall Study|Adverse Event|1|||
47074110|NCT02080403|83365680|FG000|Overall Study|Death|0|||
47074111|NCT02080403|83365681|FG001|Overall Study|Death|2|||
47074112|NCT02080403|83365680|FG000|Overall Study|Lost to Follow-up|2|||
46969702|NCT02584257|83212519|FG000|Period 2|Physician Decision|1|||
46969703|NCT02584257|83212520|FG001|Period 2|Physician Decision|0|||
47074113|NCT02080403|83365681|FG001|Overall Study|Lost to Follow-up|0|||
47074114|NCT02080403|83365680|FG000|Overall Study|Pregnancy|0|||
47074115|NCT02080403|83365681|FG001|Overall Study|Pregnancy|1|||
47074116|NCT02080403|83365680|FG000|Overall Study|Protocol Violation|3|||
46969704|NCT02584257|83212521|FG002|Period 2|Physician Decision|0|||
46969705|NCT02584257|83212522|FG003|Period 2|Physician Decision|0|||
46969706|NCT02584257|83212523|FG004|Period 2|Physician Decision|0|||
46969707|NCT02584257|83212524|FG005|Period 2|Physician Decision|0|||
46969708|NCT02584257|83212525|FG006|Period 2|Physician Decision|0|||
46642488|NCT03842969|82834721|FG001|Overall Study|Protocol Violation|1|||
46642489|NCT03842969|82834722|FG002|Overall Study|Protocol Violation|0|||
46642490|NCT03842969|82834720|FG000|Overall Study|Physician Decision|0|||
46642491|NCT03842969|82834721|FG001|Overall Study|Physician Decision|3|||
46642492|NCT03842969|82834722|FG002|Overall Study|Physician Decision|0|||
46642493|NCT03842969|82834720|FG000|Overall Study|Lost to Follow-up|0|||
46642494|NCT03842969|82834721|FG001|Overall Study|Lost to Follow-up|2|||
46642495|NCT03842969|82834722|FG002|Overall Study|Lost to Follow-up|0|||
46642496|NCT03842969|82834720|FG000|Overall Study|Adverse Event|0|||
46642497|NCT03842969|82834721|FG001|Overall Study|Adverse Event|2|||
46642498|NCT03842969|82834722|FG002|Overall Study|Adverse Event|0|||
46642499|NCT02587065|82834743|FG000|Overall Study|Adverse Event|14|||
46642500|NCT02587065|82834743|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
46642501|NCT02587065|82834743|FG000|Overall Study|Non-adherence to the Protocol|3|||
46642502|NCT02587065|82834743|FG000|Overall Study|Discontinuation of Study Medication|2|||
46642503|NCT02587065|82834743|FG000|Overall Study|Reason not Specified|3|||
46642504|NCT02544503|82834753|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
46642505|NCT02544503|82834754|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
46642506|NCT02544503|82834753|FG000|Overall Study|Lost to Follow-up|9|||
46642507|NCT02544503|82834754|FG001|Overall Study|Lost to Follow-up|0|||
46642508|NCT02544503|82834753|FG000|Overall Study|Withdrawal by Subject|1|||
46642509|NCT02544503|82834754|FG001|Overall Study|Withdrawal by Subject|0|||
46642510|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
46642511|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
46642512|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Adverse Event|57|||
46642513|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Adverse Event|49|||
46642514|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
46642515|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
46642516|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Site closure|3|||
46642517|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Site closure|2|||
46642518|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
46642519|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
46642520|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Physician Decision|48|||
46642521|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Physician Decision|38|||
46642522|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
46642523|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
46642524|NCT01705977|82834762|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
46642525|NCT01705977|82834763|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
46642526|NCT01705977|82834762|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
46642527|NCT01705977|82834763|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
46642528|NCT01705977|82834762|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
46642529|NCT01705977|82834763|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
46778861|NCT00410761|82997335|FG000|Overall Study|Other|12|||
47074117|NCT02080403|83365681|FG001|Overall Study|Protocol Violation|7|||
47074118|NCT02080403|83365680|FG000|Overall Study|Withdrawal by Subject|5|||
47074119|NCT02080403|83365681|FG001|Overall Study|Withdrawal by Subject|1|||
47074120|NCT02080091|83365687|FG000|Overall Study|Study Terminated|22|||
47074121|NCT02080091|83365687|FG000|Overall Study|Death|1|||
47074122|NCT02080091|83365687|FG000|Overall Study|Withdrawal by Subject|1|||
47074123|NCT02080091|83365687|FG000|Overall Study|Other|1|||
47074124|NCT02079077|83365693|FG000|Overall Study|Lost to Follow-up|5|||
47074125|NCT02079077|83365694|FG001|Overall Study|Lost to Follow-up|7|||
47074126|NCT02079077|83365693|FG000|Overall Study|Became STIs Positive|1|||
47074127|NCT02079077|83365694|FG001|Overall Study|Became STIs Positive|2|||
47074128|NCT02078219|83365722|FG000|Overall Study|Other|2|||
47074129|NCT02078219|83365723|FG001|Overall Study|Other|2|||
47074130|NCT02078219|83365724|FG002|Overall Study|Other|3|||
47074131|NCT02078219|83365725|FG003|Overall Study|Other|0|||
46642530|NCT01705977|82834762|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
46642531|NCT01705977|82834763|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
46642532|NCT01705977|82834762|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
46642533|NCT01705977|82834763|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
46778862|NCT00410761|82997336|FG001|Overall Study|Other|9|||
46778863|NCT00410761|82997335|FG000|Overall Study|Never received randomised treatment|0|||
46778864|NCT00410761|82997336|FG001|Overall Study|Never received randomised treatment|1|||
47074132|NCT02078219|83365726|FG004|Overall Study|Other|1|||
46778865|NCT00374595|82997342|FG000|Overall Study|Death|23|||
46642534|NCT01474889|82834772|FG000|Overall Study|Physician Decision|1|||
46642535|NCT01474889|82834773|FG001|Overall Study|Physician Decision|0|||
46642536|NCT01474889|82834774|FG002|Overall Study|Physician Decision|0|||
46642537|NCT01474889|82834772|FG000|Overall Study|Did not meet inclusion|1|||
46642538|NCT01474889|82834773|FG001|Overall Study|Did not meet inclusion|0|||
46642539|NCT01474889|82834774|FG002|Overall Study|Did not meet inclusion|0|||
46642540|NCT01474889|82834772|FG000|Overall Study|Withdrawal by Subject|0|||
46642541|NCT01474889|82834773|FG001|Overall Study|Withdrawal by Subject|1|||
46642542|NCT01474889|82834774|FG002|Overall Study|Withdrawal by Subject|0|||
46642543|NCT01231906|82834782|FG000|Overall Study|Lack of Efficacy|75|||
46642544|NCT01231906|82834783|FG001|Overall Study|Lack of Efficacy|68|||
46642545|NCT01231906|82834782|FG000|Overall Study|Lost to Follow-up|1|||
46642546|NCT01231906|82834783|FG001|Overall Study|Lost to Follow-up|0|||
46642547|NCT01231906|82834782|FG000|Overall Study|Physician Decision|34|||
46642548|NCT01231906|82834783|FG001|Overall Study|Physician Decision|24|||
46642549|NCT01231906|82834782|FG000|Overall Study|Withdrawal by Subject|0|||
46642550|NCT01231906|82834783|FG001|Overall Study|Withdrawal by Subject|4|||
46642551|NCT01231906|82834782|FG000|Overall Study|Ineligible|10|||
46642552|NCT01231906|82834783|FG001|Overall Study|Ineligible|3|||
46642553|NCT01231906|82834782|FG000|Overall Study|No treatment|1|||
46642554|NCT01231906|82834783|FG001|Overall Study|No treatment|2|||
46642555|NCT00724048|82834793|FG000|Overall Study|Adverse Event|1|||
46642556|NCT00724048|82834794|FG001|Overall Study|Adverse Event|1|||
46642557|NCT00724048|82834795|FG002|Overall Study|Adverse Event|1|||
46642558|NCT00724048|82834796|FG003|Overall Study|Adverse Event|0|||
46642559|NCT00724048|82834793|FG000|Overall Study|Lost to Follow-up|0|||
46642560|NCT00724048|82834794|FG001|Overall Study|Lost to Follow-up|1|||
46642561|NCT00724048|82834795|FG002|Overall Study|Lost to Follow-up|0|||
46642562|NCT00724048|82834796|FG003|Overall Study|Lost to Follow-up|0|||
46642563|NCT00724048|82834793|FG000|Overall Study|Withdrawal by Subject|1|||
46642564|NCT00724048|82834794|FG001|Overall Study|Withdrawal by Subject|2|||
46642565|NCT00724048|82834795|FG002|Overall Study|Withdrawal by Subject|1|||
46642566|NCT00724048|82834796|FG003|Overall Study|Withdrawal by Subject|2|||
46642567|NCT00724048|82834793|FG000|Overall Study|Investigator decision|0|||
46642568|NCT00724048|82834794|FG001|Overall Study|Investigator decision|0|||
46642569|NCT00724048|82834795|FG002|Overall Study|Investigator decision|1|||
46642570|NCT00724048|82834796|FG003|Overall Study|Investigator decision|0|||
46642571|NCT00724048|82834793|FG000|Overall Study|Did not tolerate study drug|0|||
46642572|NCT00724048|82834794|FG001|Overall Study|Did not tolerate study drug|0|||
46642573|NCT00724048|82834795|FG002|Overall Study|Did not tolerate study drug|0|||
46642574|NCT00724048|82834796|FG003|Overall Study|Did not tolerate study drug|1|||
46642575|NCT00724048|82834793|FG000|Overall Study|Other than specified|1|||
46642576|NCT00724048|82834794|FG001|Overall Study|Other than specified|1|||
46642577|NCT00724048|82834795|FG002|Overall Study|Other than specified|0|||
46642578|NCT00724048|82834796|FG003|Overall Study|Other than specified|0|||
46642579|NCT00160680|82834808|FG000|Overall Study|Adverse Event|0|||
46642580|NCT00160680|82834809|FG001|Overall Study|Adverse Event|1|||
46642581|NCT00160680|82834808|FG000|Overall Study|Lack of Efficacy|2|||
46642582|NCT00160680|82834809|FG001|Overall Study|Lack of Efficacy|1|||
46642583|NCT00160680|82834808|FG000|Overall Study|Lost to Follow-up|3|||
46642584|NCT00160680|82834809|FG001|Overall Study|Lost to Follow-up|2|||
46642585|NCT00160680|82834808|FG000|Overall Study|Withdrawal by Subject|4|||
46642586|NCT00160680|82834809|FG001|Overall Study|Withdrawal by Subject|9|||
46642587|NCT03671148|82835664|FG000|Overall Study|Adverse Event|3|||
46778866|NCT00374595|82997342|FG000|Overall Study|Withdrawal by Subject|39|||
46778867|NCT00374595|82997342|FG000|Overall Study|Lost to Follow-up|3|||
46778868|NCT00374595|82997342|FG000|Overall Study|too much time commitment|1|||
46778869|NCT00374595|82997342|FG000|Overall Study|transfer care to other clinical site|1|||
46642588|NCT03671148|82835665|FG001|Overall Study|Adverse Event|2|||
46642589|NCT03671148|82835664|FG000|Overall Study|Withdrawal by Subject|8|||
46642590|NCT03671148|82835665|FG001|Overall Study|Withdrawal by Subject|2|||
46642591|NCT03671148|82835664|FG000|Overall Study|Lost to Follow-up|1|||
46642592|NCT03671148|82835665|FG001|Overall Study|Lost to Follow-up|2|||
46849911|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46642593|NCT03671148|82835664|FG000|Overall Study|Lack of Efficacy|7|||
46642594|NCT03671148|82835665|FG001|Overall Study|Lack of Efficacy|2|||
46642595|NCT03671148|82835664|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
46642596|NCT03671148|82835665|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
46778870|NCT00374595|82997342|FG000|Overall Study|relocation|3|||
46642597|NCT03671148|82835664|FG000|Overall Study|Other|1|||
46642598|NCT03671148|82835665|FG001|Overall Study|Other|0|||
46778871|NCT03465540|82997352|FG000|Overall Study|Withdrawal by Subject|0|||
46778872|NCT03465540|82997353|FG001|Overall Study|Withdrawal by Subject|0|||
46969709|NCT02584257|83212526|FG007|Period 2|Physician Decision|0|||
46969710|NCT02584257|83212527|FG008|Period 2|Physician Decision|0|||
46969711|NCT02584257|83212519|FG000|Period 2|Adverse Event|0|||
46969712|NCT02584257|83212520|FG001|Period 2|Adverse Event|1|||
46969713|NCT02584257|83212521|FG002|Period 2|Adverse Event|0|||
46969714|NCT02584257|83212522|FG003|Period 2|Adverse Event|0|||
46969715|NCT02584257|83212523|FG004|Period 2|Adverse Event|0|||
46969716|NCT02584257|83212524|FG005|Period 2|Adverse Event|0|||
46969717|NCT02584257|83212525|FG006|Period 2|Adverse Event|0|||
46969718|NCT02584257|83212526|FG007|Period 2|Adverse Event|0|||
46969719|NCT02584257|83212527|FG008|Period 2|Adverse Event|0|||
46969720|NCT02583711|83212542|FG000|Overall Study|Withdrawal by Subject|0|||
46969721|NCT02583711|83212543|FG001|Overall Study|Withdrawal by Subject|10|||
46969722|NCT02583711|83212544|FG002|Overall Study|Withdrawal by Subject|0|||
46969723|NCT02583477|83212556|FG000|Overall Study|Adverse Event|0|||
46969724|NCT02583477|83212557|FG001|Overall Study|Adverse Event|2|||
46969725|NCT02583477|83212556|FG000|Overall Study|Death|1|||
46969726|NCT02583477|83212557|FG001|Overall Study|Death|16|||
46969727|NCT02583477|83212556|FG000|Overall Study|Study terminated|2|||
46969728|NCT02583477|83212557|FG001|Overall Study|Study terminated|2|||
46969729|NCT02583399|83212564|FG000|Overall Study|Able to be discharged|3|||
46969730|NCT02583399|83212564|FG000|Overall Study|Wanted to use a restricted medication|3|||
46969731|NCT02580591|83212572|FG000|Overall Study|Adverse Event|0|||
46969732|NCT02580591|83212573|FG001|Overall Study|Adverse Event|1|||
46969733|NCT02580591|83212574|FG002|Overall Study|Adverse Event|2|||
46778873|NCT03465540|82997354|FG002|Overall Study|Withdrawal by Subject|1|||
46778874|NCT03465540|82997355|FG003|Overall Study|Withdrawal by Subject|1|||
46778875|NCT03465540|82997356|FG004|Overall Study|Withdrawal by Subject|1|||
46778876|NCT03465540|82997357|FG005|Overall Study|Withdrawal by Subject|0|||
46849912|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46969734|NCT02580591|83212575|FG003|Overall Study|Adverse Event|5|||
46969735|NCT02580591|83212572|FG000|Overall Study|Protocol Violation|3|||
46969736|NCT02580591|83212573|FG001|Overall Study|Protocol Violation|2|||
46969737|NCT02580591|83212574|FG002|Overall Study|Protocol Violation|1|||
46969738|NCT02580591|83212575|FG003|Overall Study|Protocol Violation|1|||
46969739|NCT02580591|83212572|FG000|Overall Study|Lost to Follow-up|5|||
46969740|NCT02580591|83212573|FG001|Overall Study|Lost to Follow-up|3|||
46969741|NCT02580591|83212574|FG002|Overall Study|Lost to Follow-up|3|||
46969742|NCT02580591|83212575|FG003|Overall Study|Lost to Follow-up|1|||
47074133|NCT02078219|83365722|FG000|Overall Study|Withdrawal by Subject|0|||
47074134|NCT02078219|83365723|FG001|Overall Study|Withdrawal by Subject|1|||
47074135|NCT02078219|83365724|FG002|Overall Study|Withdrawal by Subject|0|||
47074136|NCT02078219|83365725|FG003|Overall Study|Withdrawal by Subject|1|||
47074137|NCT02078219|83365726|FG004|Overall Study|Withdrawal by Subject|1|||
47074138|NCT02078219|83365722|FG000|Overall Study|Protocol Violation|0|||
47074139|NCT02078219|83365723|FG001|Overall Study|Protocol Violation|0|||
47074140|NCT02078219|83365724|FG002|Overall Study|Protocol Violation|0|||
47074141|NCT02078219|83365725|FG003|Overall Study|Protocol Violation|1|||
47074142|NCT02078219|83365726|FG004|Overall Study|Protocol Violation|0|||
47074143|NCT02078219|83365722|FG000|Overall Study|Death|0|||
47074144|NCT02078219|83365723|FG001|Overall Study|Death|0|||
47074145|NCT02078219|83365724|FG002|Overall Study|Death|0|||
47074146|NCT02078219|83365725|FG003|Overall Study|Death|1|||
47074147|NCT02078219|83365726|FG004|Overall Study|Death|0|||
47074148|NCT02078219|83365722|FG000|Overall Study|Adverse Event|1|||
47074149|NCT02078219|83365723|FG001|Overall Study|Adverse Event|1|||
47074150|NCT02078219|83365724|FG002|Overall Study|Adverse Event|3|||
47074151|NCT02078219|83365725|FG003|Overall Study|Adverse Event|1|||
46642599|NCT03671148|82835664|FG000|Overall Study|Incomplete Randomization Visit|1|||
46642600|NCT03671148|82835665|FG001|Overall Study|Incomplete Randomization Visit|0|||
46778877|NCT03465540|82997352|FG000|Overall Study|Lost to Follow-up|0|||
46778878|NCT03465540|82997353|FG001|Overall Study|Lost to Follow-up|1|||
46969743|NCT02580591|83212572|FG000|Overall Study|Withdrawal by Subject|6|||
46969744|NCT02580591|83212573|FG001|Overall Study|Withdrawal by Subject|1|||
46969745|NCT02580591|83212574|FG002|Overall Study|Withdrawal by Subject|2|||
46969746|NCT02580591|83212575|FG003|Overall Study|Withdrawal by Subject|3|||
46969747|NCT02580591|83212572|FG000|Overall Study|Not treated|1|||
46969748|NCT02580591|83212573|FG001|Overall Study|Not treated|1|||
46969749|NCT02580591|83212574|FG002|Overall Study|Not treated|0|||
46969750|NCT02580591|83212575|FG003|Overall Study|Not treated|0|||
46969751|NCT02580591|83212572|FG000|Overall Study|Other than specified|3|||
46969752|NCT02580591|83212573|FG001|Overall Study|Other than specified|2|||
46969753|NCT02580591|83212574|FG002|Overall Study|Other than specified|5|||
46969754|NCT02580591|83212575|FG003|Overall Study|Other than specified|2|||
46969755|NCT02580357|83212588|FG000|Overall Study|Lost to Follow-up|2|||
47074152|NCT02078219|83365726|FG004|Overall Study|Adverse Event|0|||
46642601|NCT01430442|82835679|FG000|Overall Study|Subject Withdrew Consent|3|||
46642602|NCT01430442|82835680|FG001|Overall Study|Subject Withdrew Consent|0|||
46642603|NCT01430442|82835681|FG002|Overall Study|Subject Withdrew Consent|1|||
46642604|NCT01430442|82835682|FG003|Overall Study|Subject Withdrew Consent|0|||
46642605|NCT01430442|82835683|FG004|Overall Study|Subject Withdrew Consent|2|||
46642606|NCT01430442|82835684|FG005|Overall Study|Subject Withdrew Consent|1|||
46642607|NCT01430442|82835685|FG006|Overall Study|Subject Withdrew Consent|5|||
46642608|NCT01430442|82835686|FG007|Overall Study|Subject Withdrew Consent|2|||
46642609|NCT01430442|82835679|FG000|Overall Study|Lost to Follow-up|2|||
46642610|NCT01430442|82835680|FG001|Overall Study|Lost to Follow-up|0|||
46642611|NCT01430442|82835681|FG002|Overall Study|Lost to Follow-up|1|||
46642612|NCT01430442|82835682|FG003|Overall Study|Lost to Follow-up|2|||
46642613|NCT01430442|82835683|FG004|Overall Study|Lost to Follow-up|2|||
46642614|NCT01430442|82835684|FG005|Overall Study|Lost to Follow-up|1|||
46642615|NCT01430442|82835685|FG006|Overall Study|Lost to Follow-up|5|||
46642616|NCT01430442|82835686|FG007|Overall Study|Lost to Follow-up|1|||
46642617|NCT01430442|82835679|FG000|Overall Study|Pregnancy|1|||
46642618|NCT01430442|82835680|FG001|Overall Study|Pregnancy|0|||
46642619|NCT01430442|82835681|FG002|Overall Study|Pregnancy|0|||
46642620|NCT01430442|82835682|FG003|Overall Study|Pregnancy|0|||
46642621|NCT01430442|82835683|FG004|Overall Study|Pregnancy|0|||
46642622|NCT01430442|82835684|FG005|Overall Study|Pregnancy|1|||
46642623|NCT01430442|82835685|FG006|Overall Study|Pregnancy|0|||
46642624|NCT01430442|82835686|FG007|Overall Study|Pregnancy|0|||
46642625|NCT01430442|82835679|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
46642626|NCT01430442|82835680|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
46642627|NCT01430442|82835681|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
46642628|NCT01430442|82835682|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
46642629|NCT01430442|82835683|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
46642630|NCT01430442|82835684|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
46642631|NCT01430442|82835685|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
46642632|NCT01430442|82835686|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
46642633|NCT01420926|82835706|FG000|Overall Study|Adverse Event|6|||
46642634|NCT01420926|82835707|FG001|Overall Study|Adverse Event|4|||
46642635|NCT01420926|82835706|FG000|Overall Study|Death|18|||
46642636|NCT01420926|82835707|FG001|Overall Study|Death|17|||
46642637|NCT01420926|82835706|FG000|Overall Study|Withdrawal by Subject|11|||
46642638|NCT01420926|82835707|FG001|Overall Study|Withdrawal by Subject|17|||
46642639|NCT01420926|82835706|FG000|Overall Study|Non-protocol treatment|17|||
46642640|NCT01420926|82835707|FG001|Overall Study|Non-protocol treatment|20|||
46642641|NCT01420926|82835706|FG000|Overall Study|Physician Decision|8|||
46642642|NCT01420926|82835707|FG001|Overall Study|Physician Decision|5|||
46642643|NCT04303572|82836263|FG000|Overall Study|Study closed due to poor enrollment|1|||
46642644|NCT03551730|82836286|FG000|Overall Study|Adverse Event|1|||
46642645|NCT03551730|82836287|FG001|Overall Study|Adverse Event|0|||
46642646|NCT03551730|82836288|FG002|Overall Study|Adverse Event|0|||
46642647|NCT03551730|82836289|FG003|Overall Study|Adverse Event|0|||
46642648|NCT02534844|82836301|FG000|Part B|Withdrawal by Subject|0|||
46642649|NCT02534844|82836302|FG001|Part B|Withdrawal by Subject|0|||
46642650|NCT02534844|82836303|FG002|Part B|Withdrawal by Subject|0|||
46642651|NCT02534844|82836304|FG003|Part B|Withdrawal by Subject|0|||
46642652|NCT02534844|82836305|FG004|Part B|Withdrawal by Subject|2|||
46642653|NCT02534844|82836306|FG005|Part B|Withdrawal by Subject|1|||
46642654|NCT01818492|82836323|FG000|Overall Study|Adverse Event|2|||
46849913|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849914|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849915|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849916|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
46849917|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
46849918|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
46849919|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
46849920|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
46849921|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
46849922|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46642655|NCT01818492|82836323|FG000|Overall Study|Death|3|||
46642656|NCT01818492|82836323|FG000|Overall Study|Withdrawal by Subject|1|||
46642657|NCT01818492|82836323|FG000|Overall Study|Additional therapy when not allowed PP|4|||
46642658|NCT01239030|82836333|FG000|Double Blind|Adverse Event|0|||
46642659|NCT01239030|82836334|FG001|Double Blind|Adverse Event|1|||
46642660|NCT01239030|82836335|FG002|Double Blind|Adverse Event|0|||
46849923|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849924|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46642661|NCT01239030|82836336|FG003|Double Blind|Adverse Event|2|||
46642662|NCT01239030|82836337|FG004|Double Blind|Adverse Event|0|||
46642663|NCT01239030|82836333|FG000|Double Blind|Withdrawal by Subject|0|||
46642664|NCT01239030|82836334|FG001|Double Blind|Withdrawal by Subject|1|||
46642665|NCT01239030|82836335|FG002|Double Blind|Withdrawal by Subject|1|||
46642666|NCT01239030|82836336|FG003|Double Blind|Withdrawal by Subject|0|||
46642667|NCT01239030|82836337|FG004|Double Blind|Withdrawal by Subject|1|||
46642668|NCT01239030|82836333|FG000|Double Blind|Lost to Follow-up|1|||
46642669|NCT01239030|82836334|FG001|Double Blind|Lost to Follow-up|1|||
46642670|NCT01239030|82836335|FG002|Double Blind|Lost to Follow-up|0|||
46642671|NCT01239030|82836336|FG003|Double Blind|Lost to Follow-up|0|||
46642672|NCT01239030|82836337|FG004|Double Blind|Lost to Follow-up|0|||
46642673|NCT01239030|82836333|FG000|Double Blind|Physician Decision|0|||
46642674|NCT01239030|82836334|FG001|Double Blind|Physician Decision|1|||
46642675|NCT01239030|82836335|FG002|Double Blind|Physician Decision|0|||
46642676|NCT01239030|82836336|FG003|Double Blind|Physician Decision|0|||
46642677|NCT01239030|82836337|FG004|Double Blind|Physician Decision|0|||
46642678|NCT01239030|82836333|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
46969756|NCT02580357|83212589|FG001|Overall Study|Lost to Follow-up|0|||
46642679|NCT01239030|82836334|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
46642680|NCT01239030|82836335|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
46642681|NCT01239030|82836336|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
46778879|NCT03465540|82997354|FG002|Overall Study|Lost to Follow-up|0|||
46778880|NCT03465540|82997355|FG003|Overall Study|Lost to Follow-up|0|||
46778881|NCT03465540|82997356|FG004|Overall Study|Lost to Follow-up|1|||
46778882|NCT03465540|82997357|FG005|Overall Study|Lost to Follow-up|0|||
46778883|NCT03465540|82997352|FG000|Overall Study|Death|1|||
46969757|NCT02580357|83212590|FG002|Overall Study|Lost to Follow-up|0|||
46969758|NCT02580357|83212588|FG000|Overall Study|Protocol Violation|1|||
46969759|NCT02580357|83212589|FG001|Overall Study|Protocol Violation|0|||
46642682|NCT01239030|82836337|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
46642683|NCT01239030|82836333|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
46642684|NCT01239030|82836334|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
46642685|NCT01239030|82836335|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
46778884|NCT03465540|82997353|FG001|Overall Study|Death|1|||
46778885|NCT03465540|82997354|FG002|Overall Study|Death|0|||
46849925|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46969760|NCT02580357|83212590|FG002|Overall Study|Protocol Violation|0|||
46969761|NCT01664091|83212598|FG000|Overall Study|Death|1|||
46969762|NCT01664091|83212598|FG000|Overall Study|Disease Progression|2|||
46969763|NCT01664091|83212598|FG000|Overall Study|Lost to Follow-up|2|||
46969764|NCT01664091|83212598|FG000|Overall Study|Withdrawal by Subject|1|||
46969765|NCT02577315|83212605|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
46969766|NCT02577315|83212606|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
46849926|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849927|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849928|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
47074153|NCT02075255|83365741|FG000|Overall Study|Study specific withdrawal criteria|0|||
47074154|NCT02075255|83365742|FG001|Overall Study|Study specific withdrawal criteria|1|||
47074155|NCT02075255|83365743|FG002|Overall Study|Study specific withdrawal criteria|1|||
47074156|NCT02075255|83365741|FG000|Overall Study|Withdrawal by Subject|4|||
47074157|NCT02075255|83365742|FG001|Overall Study|Withdrawal by Subject|1|||
47074158|NCT02075255|83365743|FG002|Overall Study|Withdrawal by Subject|0|||
47074159|NCT02075255|83365741|FG000|Overall Study|Lost to Follow-up|0|||
46849929|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849930|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849931|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849932|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849933|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849934|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849935|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849936|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849937|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849938|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849939|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849940|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849941|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849942|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
46849943|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|moved|0|||
46849944|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|moved|1|||
46849945|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|moved|1|||
46849946|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|moved|0|||
46969767|NCT02711345|83212622|FG000|Overall Study|Adverse Event|0|||
46642686|NCT01239030|82836336|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
46969768|NCT02711345|83212623|FG001|Overall Study|Adverse Event|0|||
46778886|NCT03465540|82997355|FG003|Overall Study|Death|2|||
46778887|NCT03465540|82997356|FG004|Overall Study|Death|0|||
46778888|NCT03465540|82997357|FG005|Overall Study|Death|2|||
46642687|NCT01239030|82836337|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
46642688|NCT01239030|82836333|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
46642689|NCT01239030|82836334|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
46642690|NCT01239030|82836335|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
46642691|NCT01239030|82836336|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
46642692|NCT01239030|82836337|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
46642693|NCT01239030|82836333|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
46642694|NCT01239030|82836334|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
46642695|NCT01239030|82836335|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
46642696|NCT01239030|82836336|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
46642697|NCT01239030|82836337|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
46642698|NCT01086540|82836352|FG000|Overall Study|Death|3|||
46642699|NCT01086540|82836353|FG001|Overall Study|Death|1|||
46642700|NCT01086540|82836352|FG000|Overall Study|Physician Decision|2|||
46642701|NCT01086540|82836353|FG001|Overall Study|Physician Decision|1|||
46642702|NCT01086540|82836352|FG000|Overall Study|Addition of new therapy for PAH|1|||
46642703|NCT01086540|82836353|FG001|Overall Study|Addition of new therapy for PAH|0|||
46707426|NCT01196741|82922944|FG001|Overall Study|Dose limiting Adverse Event|1|||
46707427|NCT01196741|82922943|FG000|Overall Study|Withdrawal by Subject|3|||
46707428|NCT01196741|82922944|FG001|Overall Study|Withdrawal by Subject|0|||
46707429|NCT01196741|82922943|FG000|Overall Study|Other reason|3|||
46707430|NCT01196741|82922944|FG001|Overall Study|Other reason|3|||
46707431|NCT01196741|82922943|FG000|Overall Study|Other|3|||
46707432|NCT01196741|82922944|FG001|Overall Study|Other|2|||
46707433|NCT01196741|82922943|FG000|Overall Study|Protocol Violation|2|||
46707434|NCT01196741|82922944|FG001|Overall Study|Protocol Violation|1|||
46707435|NCT00983385|82922950|FG000|Observation Period|Not eligible to be dosed|20|||
46707436|NCT00983385|82922950|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
46707437|NCT00992511|82922973|FG000|Overall Study|Migrated/moved from study area|1|||
46707438|NCT00992511|82922974|FG001|Overall Study|Migrated/moved from study area|0|||
46707439|NCT00992511|82922975|FG002|Overall Study|Migrated/moved from study area|1|||
46707440|NCT00992511|82922976|FG003|Overall Study|Migrated/moved from study area|2|||
46707441|NCT00992511|82922973|FG000|Overall Study|Lost to Follow-up|1|||
46707442|NCT00992511|82922974|FG001|Overall Study|Lost to Follow-up|0|||
46707443|NCT00992511|82922975|FG002|Overall Study|Lost to Follow-up|0|||
46778889|NCT03465540|82997352|FG000|Overall Study|Protocol specified criteria|0|||
46778890|NCT03465540|82997353|FG001|Overall Study|Protocol specified criteria|2|||
46778891|NCT03465540|82997354|FG002|Overall Study|Protocol specified criteria|2|||
46778892|NCT03465540|82997355|FG003|Overall Study|Protocol specified criteria|0|||
46969769|NCT02711345|83212624|FG002|Overall Study|Adverse Event|0|||
46969770|NCT02711345|83212625|FG003|Overall Study|Adverse Event|1|||
46778893|NCT03465540|82997356|FG004|Overall Study|Protocol specified criteria|2|||
46778894|NCT03465540|82997357|FG005|Overall Study|Protocol specified criteria|0|||
46778895|NCT03055832|82997405|FG000|Week 2|Withdrawal by Subject|1|||
46778896|NCT03055832|82997406|FG001|Week 2|Withdrawal by Subject|0|||
46849947|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|moved|0|||
46969771|NCT02711345|83212626|FG004|Overall Study|Adverse Event|1|||
46969772|NCT02711345|83212627|FG005|Overall Study|Adverse Event|2|||
46969773|NCT02711345|83212628|FG006|Overall Study|Adverse Event|1|||
46969774|NCT02711345|83212629|FG007|Overall Study|Adverse Event|0|||
46969775|NCT02711345|83212630|FG008|Overall Study|Adverse Event|0|||
46969776|NCT02711345|83212631|FG009|Overall Study|Adverse Event|2|||
46969777|NCT02711345|83212622|FG000|Overall Study|Physician Decision|0|||
46969778|NCT02711345|83212623|FG001|Overall Study|Physician Decision|0|||
46969779|NCT02711345|83212624|FG002|Overall Study|Physician Decision|1|||
46849948|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|moved|0|||
46849949|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|moved|0|||
46849950|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|moved|0|||
46849951|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|moved|0|||
46969780|NCT02711345|83212625|FG003|Overall Study|Physician Decision|0|||
46969781|NCT02711345|83212626|FG004|Overall Study|Physician Decision|0|||
46969782|NCT02711345|83212627|FG005|Overall Study|Physician Decision|0|||
46778897|NCT02768870|82997447|FG000|Overall Study|Death|1|||
46778898|NCT02768870|82997447|FG000|Overall Study|Reoperation|6|||
46778899|NCT02768870|82997447|FG000|Overall Study|Lost to Follow-up|1|||
46778900|NCT02768870|82997447|FG000|Overall Study|Exit|4|||
46778901|NCT02750618|82997451|FG000|Overall Study|Withdrawal by Subject|1|||
46778902|NCT02537431|82997455|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
46849952|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|moved|0|||
46849953|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|moved|0|||
46849954|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|moved|0|||
46849955|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|moved|0|||
46849956|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|moved|0|||
46849957|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|moved|0|||
46849958|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|moved|0|||
46849959|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|moved|0|||
46849960|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|moved|0|||
46849961|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|moved|0|||
46849962|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|moved|0|||
46849963|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|moved|0|||
46849964|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|moved|0|||
46849965|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|moved|0|||
46849966|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|moved|0|||
46849967|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|moved|0|||
46849968|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|moved|0|||
46849969|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849970|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849971|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849972|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
46642704|NCT04567524|82839624|FG000|Overall Study|Adverse Event|1|||
46642705|NCT04567524|82839625|FG001|Overall Study|Adverse Event|1|||
46642706|NCT04567524|82839626|FG002|Overall Study|Adverse Event|0|||
46642707|NCT04567524|82839627|FG003|Overall Study|Adverse Event|0|||
46642708|NCT04567524|82839624|FG000|Overall Study|Withdrawal by Subject|2|||
46642709|NCT04567524|82839625|FG001|Overall Study|Withdrawal by Subject|0|||
46642710|NCT04567524|82839626|FG002|Overall Study|Withdrawal by Subject|0|||
46642711|NCT04567524|82839627|FG003|Overall Study|Withdrawal by Subject|1|||
46642712|NCT03370302|82839663|FG000|Dose Escalation Phase|Other|0|||
46642713|NCT03370302|82839664|FG001|Dose Escalation Phase|Other|1|||
46642714|NCT03370302|82839665|FG002|Dose Escalation Phase|Other|1|||
46778903|NCT02526160|82997461|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
46778904|NCT02526160|82997462|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
46778905|NCT02526160|82997461|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
46778906|NCT02526160|82997462|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
46778907|NCT02526160|82997461|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
46778908|NCT02526160|82997462|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
46778909|NCT02526160|82997461|FG000|Open-Label Treatment Extension Period I|Death|0|||
46778910|NCT02526160|82997462|FG001|Open-Label Treatment Extension Period I|Death|1|||
46778911|NCT02526160|82997461|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
46849973|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849974|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849975|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849976|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849977|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849978|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849979|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46642715|NCT03370302|82839666|FG003|Dose Escalation Phase|Other|0|||
46642716|NCT03370302|82839667|FG004|Dose Escalation Phase|Other|0|||
46642717|NCT03370302|82839668|FG005|Dose Escalation Phase|Other|0|||
46642718|NCT03370302|82839663|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
46642719|NCT03370302|82839664|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
46642720|NCT03370302|82839665|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
46642721|NCT03370302|82839666|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
46642722|NCT03370302|82839667|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
46642723|NCT03370302|82839668|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
46642724|NCT03370302|82839663|FG000|Dose Escalation Phase|Adverse Event|1|||
46642725|NCT03370302|82839664|FG001|Dose Escalation Phase|Adverse Event|0|||
46642726|NCT03370302|82839665|FG002|Dose Escalation Phase|Adverse Event|2|||
46642727|NCT03370302|82839666|FG003|Dose Escalation Phase|Adverse Event|0|||
46642728|NCT03370302|82839667|FG004|Dose Escalation Phase|Adverse Event|0|||
46642729|NCT03370302|82839668|FG005|Dose Escalation Phase|Adverse Event|0|||
46642730|NCT03370302|82839663|FG000|Dose Escalation Phase|Progressive Disease|2|||
46642731|NCT03370302|82839664|FG001|Dose Escalation Phase|Progressive Disease|4|||
46642732|NCT03370302|82839665|FG002|Dose Escalation Phase|Progressive Disease|2|||
46642733|NCT03370302|82839666|FG003|Dose Escalation Phase|Progressive Disease|0|||
46642734|NCT03370302|82839667|FG004|Dose Escalation Phase|Progressive Disease|3|||
46642735|NCT03370302|82839668|FG005|Dose Escalation Phase|Progressive Disease|1|||
46642736|NCT03370302|82839663|FG000|Dose Expansion Phase|Progressive Disease|0|||
46642737|NCT03370302|82839664|FG001|Dose Expansion Phase|Progressive Disease|0|||
46642738|NCT03370302|82839665|FG002|Dose Expansion Phase|Progressive Disease|0|||
46642739|NCT03370302|82839666|FG003|Dose Expansion Phase|Progressive Disease|6|||
46642740|NCT03370302|82839667|FG004|Dose Expansion Phase|Progressive Disease|0|||
46642741|NCT03370302|82839668|FG005|Dose Expansion Phase|Progressive Disease|0|||
46642742|NCT03327324|82839692|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642743|NCT03327324|82839693|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
46642744|NCT03327324|82839694|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642745|NCT03327324|82839695|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
46642746|NCT03327324|82839696|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642747|NCT03327324|82839697|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
46642748|NCT03327324|82839692|FG000|Baseline (Month 0-Month 3)|Refused|0|||
46642749|NCT03327324|82839693|FG001|Baseline (Month 0-Month 3)|Refused|0|||
46642750|NCT03327324|82839694|FG002|Baseline (Month 0-Month 3)|Refused|0|||
46642751|NCT03327324|82839695|FG003|Baseline (Month 0-Month 3)|Refused|0|||
46642752|NCT03327324|82839696|FG004|Baseline (Month 0-Month 3)|Refused|1|||
46642753|NCT03327324|82839697|FG005|Baseline (Month 0-Month 3)|Refused|0|||
46642754|NCT03327324|82839692|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
46642755|NCT03327324|82839693|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
46642756|NCT03327324|82839694|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
46642757|NCT03327324|82839695|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
46642758|NCT03327324|82839696|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
46642759|NCT03327324|82839697|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
46642760|NCT03327324|82839692|FG000|Baseline (Month 0-Month 3)|Death|0|||
46642761|NCT03327324|82839693|FG001|Baseline (Month 0-Month 3)|Death|0|||
46642762|NCT03327324|82839694|FG002|Baseline (Month 0-Month 3)|Death|0|||
46642763|NCT03327324|82839695|FG003|Baseline (Month 0-Month 3)|Death|0|||
46642764|NCT03327324|82839696|FG004|Baseline (Month 0-Month 3)|Death|1|||
46642765|NCT03327324|82839697|FG005|Baseline (Month 0-Month 3)|Death|0|||
46642766|NCT03327324|82839692|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642767|NCT03327324|82839693|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642768|NCT03327324|82839694|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642769|NCT03327324|82839695|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642770|NCT03327324|82839696|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642771|NCT03327324|82839697|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
46642772|NCT03327324|82839692|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642773|NCT03327324|82839693|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46778912|NCT02526160|82997462|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
46969783|NCT02711345|83212628|FG006|Overall Study|Physician Decision|0|||
46969784|NCT02711345|83212629|FG007|Overall Study|Physician Decision|0|||
46969785|NCT02711345|83212630|FG008|Overall Study|Physician Decision|1|||
46969786|NCT02711345|83212631|FG009|Overall Study|Physician Decision|0|||
46969787|NCT02711345|83212622|FG000|Overall Study|Progressive disease|1|||
46969788|NCT02711345|83212623|FG001|Overall Study|Progressive disease|3|||
46969789|NCT02711345|83212624|FG002|Overall Study|Progressive disease|5|||
46969790|NCT02711345|83212625|FG003|Overall Study|Progressive disease|3|||
46642774|NCT03327324|82839694|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
46642775|NCT03327324|82839695|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642776|NCT03327324|82839696|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642777|NCT03327324|82839697|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642778|NCT03327324|82839692|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
46642779|NCT03327324|82839693|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
46642780|NCT03327324|82839694|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
46642781|NCT03327324|82839695|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
46642782|NCT03327324|82839696|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
46642783|NCT03327324|82839697|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
46642784|NCT03327324|82839692|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
46642785|NCT03327324|82839693|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
46642786|NCT03327324|82839694|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
46642787|NCT03327324|82839695|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
46642788|NCT03327324|82839696|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
46642789|NCT03327324|82839697|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
46642790|NCT03327324|82839692|FG000|Intervention (Month 3-Month 6)|Death|1|||
46642791|NCT03327324|82839693|FG001|Intervention (Month 3-Month 6)|Death|0|||
46642792|NCT03327324|82839694|FG002|Intervention (Month 3-Month 6)|Death|1|||
46642793|NCT03327324|82839695|FG003|Intervention (Month 3-Month 6)|Death|1|||
46642794|NCT03327324|82839696|FG004|Intervention (Month 3-Month 6)|Death|1|||
46642795|NCT03327324|82839697|FG005|Intervention (Month 3-Month 6)|Death|0|||
46642796|NCT03327324|82839692|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642797|NCT03327324|82839693|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642798|NCT03327324|82839694|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642799|NCT03327324|82839695|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642800|NCT03327324|82839696|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642801|NCT03327324|82839697|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
46642802|NCT03327324|82839692|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
46642803|NCT03327324|82839693|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642804|NCT03327324|82839694|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642805|NCT03327324|82839695|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642806|NCT03327324|82839696|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642807|NCT03327324|82839697|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
46642808|NCT03327324|82839692|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
46642809|NCT03327324|82839693|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
46642810|NCT03327324|82839694|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
46642811|NCT03327324|82839695|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
46642812|NCT03327324|82839696|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
46642813|NCT03327324|82839697|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
46642814|NCT03327324|82839692|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
46642815|NCT03327324|82839693|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
46642816|NCT03327324|82839694|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
46642817|NCT03327324|82839695|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
46642818|NCT03327324|82839696|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
46642819|NCT03327324|82839697|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
46778913|NCT02526160|82997461|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
46778914|NCT02526160|82997462|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
46969791|NCT02711345|83212626|FG004|Overall Study|Progressive disease|7|||
46969792|NCT02711345|83212627|FG005|Overall Study|Progressive disease|2|||
46969793|NCT02711345|83212628|FG006|Overall Study|Progressive disease|8|||
46969794|NCT02711345|83212629|FG007|Overall Study|Progressive disease|4|||
46969795|NCT02711345|83212630|FG008|Overall Study|Progressive disease|5|||
46969796|NCT02711345|83212631|FG009|Overall Study|Progressive disease|6|||
46969797|NCT02711345|83212622|FG000|Overall Study|Subject/guardian decision|0|||
46969798|NCT02711345|83212623|FG001|Overall Study|Subject/guardian decision|0|||
46969799|NCT02711345|83212624|FG002|Overall Study|Subject/guardian decision|0|||
46849980|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849981|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849982|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849983|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849984|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849985|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849986|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849987|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849988|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849989|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849990|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849991|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849992|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849993|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849994|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
46849995|NCT00112437|83066363|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46849996|NCT00112437|83066364|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46849997|NCT00112437|83066365|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46849998|NCT00112437|83066366|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46849999|NCT00112437|83066367|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
46850000|NCT00112437|83066368|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850001|NCT00112437|83066369|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850002|NCT00112437|83066370|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46778915|NCT02526160|82997461|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
46778916|NCT02526160|82997462|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
46778917|NCT02526160|82997461|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
46778918|NCT02526160|82997462|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
46778919|NCT02157610|82997484|FG000|Overall Study|Death|4|||
46778920|NCT02157610|82997485|FG001|Overall Study|Death|4|||
46778921|NCT01511250|82997519|FG000|Overall Study|Withdrawal of Consent|1|||
46778922|NCT01511250|82997520|FG001|Overall Study|Withdrawal of Consent|0|||
46850003|NCT00112437|83066371|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850004|NCT00112437|83066372|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850005|NCT00112437|83066373|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850006|NCT00112437|83066374|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850007|NCT00112437|83066375|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850008|NCT00112437|83066376|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850009|NCT00112437|83066377|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850010|NCT00112437|83066378|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850011|NCT00112437|83066379|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850012|NCT00112437|83066380|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850013|NCT00112437|83066381|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850014|NCT00112437|83066382|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850015|NCT00112437|83066383|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850016|NCT00112437|83066384|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850017|NCT00112437|83066385|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850018|NCT00112437|83066386|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850019|NCT00112437|83066387|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850020|NCT00112437|83066388|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
46850021|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
46850022|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
46850023|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
46850024|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
46850025|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
46850026|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
46850027|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
46850028|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
46850029|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
46850030|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
46850031|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
46850032|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
46850033|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
46850034|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
47074160|NCT02075255|83365742|FG001|Overall Study|Lost to Follow-up|0|||
46642820|NCT03327324|82839692|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642821|NCT03327324|82839693|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642822|NCT03327324|82839694|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642823|NCT03327324|82839695|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
46642824|NCT03327324|82839696|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
46642825|NCT03327324|82839697|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
46642826|NCT03327324|82839692|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
46642827|NCT03327324|82839693|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
46850035|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
46850036|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
46850037|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
46850038|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
46850039|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
46850040|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
46850041|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
46850042|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
46850043|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
46850044|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
46850045|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
46850046|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
46850047|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850048|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850049|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850050|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850051|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850052|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
46850053|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
46850054|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850055|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850056|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
46850057|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46969800|NCT02711345|83212625|FG003|Overall Study|Subject/guardian decision|0|||
46969801|NCT02711345|83212626|FG004|Overall Study|Subject/guardian decision|0|||
46850058|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850059|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850060|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850061|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850062|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850063|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850064|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850065|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850066|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850067|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850068|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46642828|NCT03327324|82839694|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
46642829|NCT03327324|82839695|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
46642830|NCT03327324|82839696|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
46642831|NCT03327324|82839697|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
46642832|NCT03327324|82839692|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
46642833|NCT03327324|82839693|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
46642834|NCT03327324|82839694|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
46642835|NCT03327324|82839695|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
46642836|NCT03327324|82839696|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
46850069|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850070|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850071|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850072|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
46850073|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850074|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850075|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850076|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850077|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850078|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850079|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850080|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46969802|NCT02711345|83212627|FG005|Overall Study|Subject/guardian decision|2|||
46642837|NCT03327324|82839697|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
46642838|NCT03252522|82839703|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
46642839|NCT03252522|82839704|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
46642840|NCT03252522|82839705|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
46642841|NCT03252522|82839703|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
46642842|NCT03252522|82839704|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
46642843|NCT03252522|82839705|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
46642844|NCT03252522|82839703|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
46642845|NCT03252522|82839704|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
46642846|NCT03252522|82839705|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
46642847|NCT03252522|82839703|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
46642848|NCT03252522|82839704|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
46642849|NCT03252522|82839705|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
46642850|NCT03252522|82839703|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
46642851|NCT03252522|82839704|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
46642852|NCT03252522|82839705|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
46642853|NCT03252522|82839703|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
46642854|NCT03252522|82839704|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
46642855|NCT03252522|82839705|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
46642856|NCT03252522|82839703|FG000|Phase 2: Open Label|Adverse Event|0|||
46642857|NCT03252522|82839704|FG001|Phase 2: Open Label|Adverse Event|0|||
46642858|NCT03252522|82839705|FG002|Phase 2: Open Label|Adverse Event|2|||
46642859|NCT03252522|82839703|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
46642860|NCT03252522|82839704|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
46642861|NCT03252522|82839705|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
46642862|NCT02756364|82839720|FG000|Overall Study|Site Terminated by Sponsor|24|||
46642863|NCT02756364|82839721|FG001|Overall Study|Site Terminated by Sponsor|30|||
46642864|NCT02756364|82839722|FG002|Overall Study|Site Terminated by Sponsor|21|||
46642865|NCT02756364|82839720|FG000|Overall Study|Death|20|||
46642866|NCT02756364|82839721|FG001|Overall Study|Death|15|||
46642867|NCT02756364|82839722|FG002|Overall Study|Death|18|||
46642868|NCT02756364|82839720|FG000|Overall Study|Withdrawal by Patient|2|||
46642869|NCT02756364|82839721|FG001|Overall Study|Withdrawal by Patient|1|||
46642870|NCT02756364|82839722|FG002|Overall Study|Withdrawal by Patient|8|||
46642871|NCT02756364|82839720|FG000|Overall Study|Lost to Follow-up|0|||
46642872|NCT02756364|82839721|FG001|Overall Study|Lost to Follow-up|1|||
46642873|NCT02756364|82839722|FG002|Overall Study|Lost to Follow-up|1|||
46642874|NCT01906476|82839732|FG000|Overall Study|Lost to Follow-up|17|||
46642875|NCT01906476|82839733|FG001|Overall Study|Lost to Follow-up|16|||
46642876|NCT05343624|82839739|FG000|Overall Study|Chart review not completed|1|||
46642877|NCT04208412|82839772|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
46642878|NCT04208412|82839773|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
46969803|NCT02711345|83212628|FG006|Overall Study|Subject/guardian decision|3|||
46969804|NCT02711345|83212629|FG007|Overall Study|Subject/guardian decision|1|||
46969805|NCT02711345|83212630|FG008|Overall Study|Subject/guardian decision|0|||
46969806|NCT02711345|83212631|FG009|Overall Study|Subject/guardian decision|4|||
46969807|NCT02711345|83212622|FG000|Overall Study|Death|1|||
46969808|NCT02711345|83212623|FG001|Overall Study|Death|0|||
46969809|NCT02711345|83212624|FG002|Overall Study|Death|0|||
46969810|NCT02711345|83212625|FG003|Overall Study|Death|0|||
46969811|NCT02711345|83212626|FG004|Overall Study|Death|0|||
46969812|NCT02711345|83212627|FG005|Overall Study|Death|0|||
46969813|NCT02711345|83212628|FG006|Overall Study|Death|0|||
46969814|NCT02711345|83212629|FG007|Overall Study|Death|1|||
46969815|NCT02711345|83212630|FG008|Overall Study|Death|0|||
46969816|NCT02711345|83212631|FG009|Overall Study|Death|0|||
46969817|NCT02581995|83212668|FG000|Overall Study|Unspecified other|3|||
46969818|NCT02581995|83212668|FG000|Overall Study|Adverse Event|6|||
46642879|NCT04208412|82839772|FG000|Overall Study|Withdrawal by Subject|1|||
46969819|NCT02581995|83212668|FG000|Overall Study|Lost to Follow-up|5|||
46642880|NCT04208412|82839773|FG001|Overall Study|Withdrawal by Subject|0|||
46642881|NCT04208412|82839772|FG000|Overall Study|Lost to Follow-up|0|||
46642882|NCT04208412|82839773|FG001|Overall Study|Lost to Follow-up|1|||
46642883|NCT04095858|82839783|FG000|Overall Study|Death|1|||
46642884|NCT04095858|82839784|FG001|Overall Study|Death|0|||
46642885|NCT04095858|82839783|FG000|Overall Study|Study terminated by Sponsor|2|||
46642886|NCT04095858|82839784|FG001|Overall Study|Study terminated by Sponsor|4|||
46642887|NCT03937986|82839790|FG000|Overall Study|COVID-19 Pandemic|1|||
46969820|NCT02581995|83212668|FG000|Overall Study|Withdrawal by participant|12|||
46969821|NCT02581995|83212668|FG000|Overall Study|Physician Decision|1|||
46969822|NCT02581995|83212668|FG000|Overall Study|Death|4|||
46969823|NCT02577003|83212674|FG000|Overall Study|Adverse Event|2|||
46969824|NCT02577003|83212675|FG001|Overall Study|Adverse Event|4|||
47074161|NCT02075255|83365743|FG002|Overall Study|Lost to Follow-up|1|||
46778923|NCT01511250|82997521|FG002|Overall Study|Withdrawal of Consent|0|||
46778924|NCT01511250|82997522|FG003|Overall Study|Withdrawal of Consent|0|||
46778925|NCT01511250|82997523|FG004|Overall Study|Withdrawal of Consent|0|||
46778926|NCT01511250|82997524|FG005|Overall Study|Withdrawal of Consent|0|||
46778927|NCT01511250|82997525|FG006|Overall Study|Withdrawal of Consent|0|||
46778928|NCT01511250|82997526|FG007|Overall Study|Withdrawal of Consent|1|||
46778929|NCT01511250|82997527|FG008|Overall Study|Withdrawal of Consent|1|||
46778930|NCT01511250|82997528|FG009|Overall Study|Withdrawal of Consent|0|||
46778931|NCT01511250|82997519|FG000|Overall Study|Sponsor/Investigator Decision|1|||
46778932|NCT01511250|82997520|FG001|Overall Study|Sponsor/Investigator Decision|0|||
46969825|NCT02577003|83212674|FG000|Overall Study|Withdrawal by Subject|0|||
46642888|NCT03738150|82839805|FG000|Base Study|Withdrawal by Subject|1|||
46642889|NCT03738150|82839805|FG000|Extension Study|Withdrawal by Subject|1|||
46642890|NCT03567174|82839821|FG000|Overall Study|Death|24|||
46642891|NCT03567174|82839822|FG001|Overall Study|Death|31|||
46642892|NCT03567174|82839821|FG000|Overall Study|Lost to Follow-up|165|||
46642893|NCT03567174|82839822|FG001|Overall Study|Lost to Follow-up|174|||
46642894|NCT02545998|82839867|FG000|Overall Study|Lost to Follow-up|12|||
46642895|NCT02545998|82839868|FG001|Overall Study|Lost to Follow-up|3|||
46642896|NCT02545998|82839867|FG000|Overall Study|Withdrawal by Subject|3|||
46642897|NCT02545998|82839868|FG001|Overall Study|Withdrawal by Subject|2|||
46642898|NCT02257242|82839892|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
46642899|NCT02257242|82839893|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46642900|NCT02257242|82839894|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46642901|NCT02257242|82839895|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46642902|NCT02257242|82839896|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46642903|NCT02257242|82839897|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46642904|NCT02257242|82839898|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46642905|NCT02257242|82839899|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46778933|NCT01511250|82997521|FG002|Overall Study|Sponsor/Investigator Decision|0|||
46778934|NCT01511250|82997522|FG003|Overall Study|Sponsor/Investigator Decision|0|||
46778935|NCT01511250|82997523|FG004|Overall Study|Sponsor/Investigator Decision|0|||
46778936|NCT01511250|82997524|FG005|Overall Study|Sponsor/Investigator Decision|0|||
46778937|NCT01511250|82997525|FG006|Overall Study|Sponsor/Investigator Decision|0|||
46778938|NCT01511250|82997526|FG007|Overall Study|Sponsor/Investigator Decision|0|||
46778939|NCT01511250|82997527|FG008|Overall Study|Sponsor/Investigator Decision|0|||
46778940|NCT01511250|82997528|FG009|Overall Study|Sponsor/Investigator Decision|0|||
46778941|NCT01511250|82997519|FG000|Overall Study|Lost to Follow-up|7|||
46778942|NCT01511250|82997520|FG001|Overall Study|Lost to Follow-up|3|||
46778943|NCT01511250|82997521|FG002|Overall Study|Lost to Follow-up|3|||
46778944|NCT01511250|82997522|FG003|Overall Study|Lost to Follow-up|3|||
46778945|NCT01511250|82997523|FG004|Overall Study|Lost to Follow-up|0|||
46778946|NCT01511250|82997524|FG005|Overall Study|Lost to Follow-up|0|||
46778947|NCT01511250|82997525|FG006|Overall Study|Lost to Follow-up|2|||
46778948|NCT01511250|82997526|FG007|Overall Study|Lost to Follow-up|3|||
46778949|NCT01511250|82997527|FG008|Overall Study|Lost to Follow-up|13|||
46778950|NCT01511250|82997528|FG009|Overall Study|Lost to Follow-up|5|||
46778951|NCT01511250|82997519|FG000|Overall Study|Protocol Violation|0|||
46778952|NCT01511250|82997520|FG001|Overall Study|Protocol Violation|2|||
46850081|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
46850082|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850083|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850084|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850085|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850086|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850087|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850088|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850089|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850090|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46778953|NCT01511250|82997521|FG002|Overall Study|Protocol Violation|1|||
46778954|NCT01511250|82997522|FG003|Overall Study|Protocol Violation|0|||
46778955|NCT01511250|82997523|FG004|Overall Study|Protocol Violation|0|||
46850091|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850092|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46778956|NCT01511250|82997524|FG005|Overall Study|Protocol Violation|0|||
47074162|NCT02075255|83365741|FG000|Overall Study|Adverse Event|0|||
47074163|NCT02075255|83365742|FG001|Overall Study|Adverse Event|0|||
47074164|NCT02075255|83365743|FG002|Overall Study|Adverse Event|1|||
47074165|NCT02075255|83365741|FG000|Overall Study|Death|0|||
47074166|NCT02075255|83365742|FG001|Overall Study|Death|2|||
47074167|NCT02075255|83365743|FG002|Overall Study|Death|0|||
47074168|NCT02400671|83365914|FG000|Overall Study|Death|5|||
47074169|NCT02400671|83365915|FG001|Overall Study|Death|3|||
47074170|NCT02400671|83365916|FG002|Overall Study|Death|4|||
47074171|NCT02400671|83365914|FG000|Overall Study|Lost to Follow-up|20|||
47074172|NCT02400671|83365915|FG001|Overall Study|Lost to Follow-up|27|||
47074173|NCT02400671|83365916|FG002|Overall Study|Lost to Follow-up|24|||
46642906|NCT02257242|82839900|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
46642907|NCT01943916|82839930|FG000|Overall Study|Technically invalid images|10|||
46642908|NCT01943916|82839930|FG000|Overall Study|Enrollment Failure|23|||
46642909|NCT01943916|82839930|FG000|Overall Study|Pilot Phase exclusion|100|||
46642910|NCT01943916|82839930|FG000|Overall Study|Quality Assurance Reader Fail|130|||
46642911|NCT01943916|82839930|FG000|Overall Study|Technical Failure|39|||
46642912|NCT01943916|82839930|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
46642913|NCT01943916|82839930|FG000|Overall Study|No Truth Panel Review|38|||
46642914|NCT01943916|82839930|FG000|Overall Study|Protocol Deviation|1|||
46642915|NCT01564368|82839939|FG000|Overall Study|Ineligible|18|||
46642916|NCT01564368|82839939|FG000|Overall Study|Not Randomized in Parent study|116|||
46642917|NCT01564368|82839939|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
46642918|NCT01564368|82839939|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
46642919|NCT00281658|82839947|FG000|Randomized Phase|Adverse Event|0|||
46642920|NCT00281658|82839948|FG001|Randomized Phase|Adverse Event|2|||
46642921|NCT00281658|82839949|FG002|Randomized Phase|Adverse Event|0|||
46642922|NCT00281658|82839950|FG003|Randomized Phase|Adverse Event|0|||
46642923|NCT00281658|82839947|FG000|Randomized Phase|Lost to Follow-up|34|||
46642924|NCT00281658|82839948|FG001|Randomized Phase|Lost to Follow-up|27|||
46642925|NCT00281658|82839949|FG002|Randomized Phase|Lost to Follow-up|0|||
46642926|NCT00281658|82839950|FG003|Randomized Phase|Lost to Follow-up|0|||
46642927|NCT00281658|82839947|FG000|Randomized Phase|Withdrawal by Subject|8|||
46642928|NCT00281658|82839948|FG001|Randomized Phase|Withdrawal by Subject|7|||
46642929|NCT00281658|82839949|FG002|Randomized Phase|Withdrawal by Subject|0|||
46642930|NCT00281658|82839950|FG003|Randomized Phase|Withdrawal by Subject|0|||
46642931|NCT00281658|82839947|FG000|Randomized Phase|Study closed/terminated|1|||
46642932|NCT00281658|82839948|FG001|Randomized Phase|Study closed/terminated|1|||
46642933|NCT00281658|82839949|FG002|Randomized Phase|Study closed/terminated|0|||
46642934|NCT00281658|82839950|FG003|Randomized Phase|Study closed/terminated|0|||
46642935|NCT00281658|82839947|FG000|Randomized Phase|Disease progression|36|||
46642936|NCT00281658|82839948|FG001|Randomized Phase|Disease progression|27|||
46642937|NCT00281658|82839949|FG002|Randomized Phase|Disease progression|0|||
46642938|NCT00281658|82839950|FG003|Randomized Phase|Disease progression|0|||
46642939|NCT00281658|82839947|FG000|Randomized Phase|Physician Decision|1|||
46642940|NCT00281658|82839948|FG001|Randomized Phase|Physician Decision|1|||
46642941|NCT00281658|82839949|FG002|Randomized Phase|Physician Decision|0|||
46642942|NCT00281658|82839950|FG003|Randomized Phase|Physician Decision|0|||
46642943|NCT00281658|82839947|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
46642944|NCT00281658|82839948|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
46642945|NCT00281658|82839949|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
46642946|NCT00281658|82839950|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
46642947|NCT00281658|82839947|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
46642948|NCT00281658|82839948|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
46642949|NCT00281658|82839949|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
46642950|NCT00281658|82839950|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
46642951|NCT00281658|82839947|FG000|Randomized Phase|Treatment ongoing|1|||
46642952|NCT00281658|82839948|FG001|Randomized Phase|Treatment ongoing|0|||
46642953|NCT00281658|82839949|FG002|Randomized Phase|Treatment ongoing|0|||
46642954|NCT00281658|82839950|FG003|Randomized Phase|Treatment ongoing|0|||
46642955|NCT00281658|82839947|FG000|Open Label Phase|Adverse Event|0|||
46642956|NCT00281658|82839948|FG001|Open Label Phase|Adverse Event|0|||
46642957|NCT00281658|82839949|FG002|Open Label Phase|Adverse Event|1|||
46850093|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46642958|NCT00281658|82839950|FG003|Open Label Phase|Adverse Event|0|||
46642959|NCT00281658|82839947|FG000|Open Label Phase|Lost to Follow-up|0|||
46850094|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46642960|NCT00281658|82839948|FG001|Open Label Phase|Lost to Follow-up|0|||
46642961|NCT00281658|82839949|FG002|Open Label Phase|Lost to Follow-up|16|||
46642962|NCT00281658|82839950|FG003|Open Label Phase|Lost to Follow-up|2|||
46642963|NCT00281658|82839947|FG000|Open Label Phase|Withdrawal by Subject|0|||
46642964|NCT00281658|82839948|FG001|Open Label Phase|Withdrawal by Subject|0|||
46642965|NCT00281658|82839949|FG002|Open Label Phase|Withdrawal by Subject|3|||
46642966|NCT00281658|82839950|FG003|Open Label Phase|Withdrawal by Subject|2|||
46850095|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850096|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46642967|NCT00281658|82839947|FG000|Open Label Phase|Disease progression|0|||
46642968|NCT00281658|82839948|FG001|Open Label Phase|Disease progression|0|||
46642969|NCT00281658|82839949|FG002|Open Label Phase|Disease progression|18|||
46642970|NCT00281658|82839950|FG003|Open Label Phase|Disease progression|0|||
46642971|NCT00281658|82839947|FG000|Open Label Phase|Physician Decision|0|||
46642972|NCT00281658|82839948|FG001|Open Label Phase|Physician Decision|0|||
46642973|NCT00281658|82839949|FG002|Open Label Phase|Physician Decision|1|||
46642974|NCT00281658|82839950|FG003|Open Label Phase|Physician Decision|0|||
46642975|NCT00281658|82839947|FG000|Open Label Phase|Relocation of patient|0|||
46642976|NCT00281658|82839948|FG001|Open Label Phase|Relocation of patient|0|||
46642977|NCT00281658|82839949|FG002|Open Label Phase|Relocation of patient|1|||
46642978|NCT00281658|82839950|FG003|Open Label Phase|Relocation of patient|0|||
46642979|NCT00281658|82839947|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
46642980|NCT00281658|82839948|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
46642981|NCT00281658|82839949|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
46642982|NCT00281658|82839950|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
46642983|NCT02758626|82841319|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
46642984|NCT02758626|82841320|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
46642985|NCT02758626|82841319|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
46642986|NCT02758626|82841320|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
46642987|NCT02758626|82841319|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
46642988|NCT02758626|82841320|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
46642989|NCT02758626|82841319|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
46642990|NCT02758626|82841320|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
46642991|NCT02357784|82841326|FG000|Overall Study|Withdrawal by Subject|1|||
46642992|NCT01448616|82841333|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
46642993|NCT01448616|82841334|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
46642994|NCT01448616|82841335|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
46642995|NCT01448616|82841336|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
46642996|NCT01448616|82841333|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
46642997|NCT01448616|82841334|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
46642998|NCT01448616|82841335|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
46642999|NCT01448616|82841336|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
46643000|NCT01448616|82841333|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
46643001|NCT01448616|82841334|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
46643002|NCT01448616|82841335|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
46643003|NCT01448616|82841336|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
46643004|NCT01448616|82841333|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
46643005|NCT01448616|82841334|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
46643006|NCT01448616|82841335|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
46643007|NCT01448616|82841336|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
46643008|NCT01448616|82841333|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
46643009|NCT01448616|82841334|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
46643010|NCT01448616|82841335|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
46643011|NCT01448616|82841336|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
46643012|NCT00074412|82841373|FG000|Overall Study|Death|30|||
46643013|NCT00074412|82841374|FG001|Overall Study|Death|26|||
46643014|NCT00074412|82841373|FG000|Overall Study|Lost to Follow-up|52|||
46643015|NCT00074412|82841374|FG001|Overall Study|Lost to Follow-up|58|||
46643016|NCT04505592|82842380|FG000|Overall Study|Death|2|||
46643017|NCT04505592|82842381|FG001|Overall Study|Death|1|||
46643018|NCT04706793|82842666|FG000|Treatment|Disease worsening|10|||
46643019|NCT04706793|82842667|FG001|Treatment|Disease worsening|10|||
46850097|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850098|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
46850099|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850100|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850101|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850102|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
46643020|NCT04706793|82842666|FG000|Follow-up|Lack of Efficacy|1|||
46850103|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
46643021|NCT04706793|82842667|FG001|Follow-up|Lack of Efficacy|0|||
46643022|NCT04706793|82842666|FG000|Follow-up|Disease worsening|8|||
46643023|NCT04706793|82842667|FG001|Follow-up|Disease worsening|10|||
46643024|NCT04706793|82842666|FG000|Follow-up|Adverse Event|1|||
46643025|NCT04706793|82842667|FG001|Follow-up|Adverse Event|0|||
46643026|NCT04607148|82842677|FG000|Overall Study|Withdrawal by Subject|0|||
46643027|NCT04607148|82842678|FG001|Overall Study|Withdrawal by Subject|4|||
46643028|NCT04607148|82842679|FG002|Overall Study|Withdrawal by Subject|2|||
46643029|NCT04607148|82842680|FG003|Overall Study|Withdrawal by Subject|8|||
46643030|NCT04607148|82842677|FG000|Overall Study|Study Terminated by Sponsor|14|||
46643031|NCT04607148|82842678|FG001|Overall Study|Study Terminated by Sponsor|59|||
46643032|NCT04607148|82842679|FG002|Overall Study|Study Terminated by Sponsor|9|||
46643033|NCT04607148|82842680|FG003|Overall Study|Study Terminated by Sponsor|39|||
46643034|NCT04607148|82842677|FG000|Overall Study|Sponsor Decision|0|||
46643035|NCT04607148|82842678|FG001|Overall Study|Sponsor Decision|0|||
46643036|NCT04607148|82842679|FG002|Overall Study|Sponsor Decision|1|||
46643037|NCT04607148|82842680|FG003|Overall Study|Sponsor Decision|0|||
46643038|NCT04607148|82842677|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46643039|NCT04607148|82842678|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46643040|NCT04607148|82842679|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46643041|NCT04607148|82842680|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46643042|NCT04607148|82842677|FG000|Overall Study|Lost to Follow-up|0|||
46643043|NCT04607148|82842678|FG001|Overall Study|Lost to Follow-up|2|||
46643044|NCT04607148|82842679|FG002|Overall Study|Lost to Follow-up|0|||
46643045|NCT04607148|82842680|FG003|Overall Study|Lost to Follow-up|0|||
46643046|NCT04607148|82842677|FG000|Overall Study|Death|0|||
46643047|NCT04607148|82842678|FG001|Overall Study|Death|3|||
46643048|NCT04607148|82842679|FG002|Overall Study|Death|0|||
46643049|NCT04607148|82842680|FG003|Overall Study|Death|1|||
46643050|NCT04607148|82842677|FG000|Overall Study|Adverse Event|0|||
46643051|NCT04607148|82842678|FG001|Overall Study|Adverse Event|1|||
46643052|NCT04607148|82842679|FG002|Overall Study|Adverse Event|0|||
46643053|NCT04607148|82842680|FG003|Overall Study|Adverse Event|0|||
46643054|NCT04542057|82842692|FG000|Overall Study|Death|3|||
46643055|NCT04542057|82842693|FG001|Overall Study|Death|1|||
46643056|NCT04542057|82842692|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
46643057|NCT04542057|82842693|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
46643058|NCT04542057|82842692|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
46643059|NCT04542057|82842693|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
46643060|NCT04542057|82842692|FG000|Overall Study|Adverse Event|15|||
46643061|NCT04542057|82842693|FG001|Overall Study|Adverse Event|6|||
46643062|NCT04542057|82842692|FG000|Overall Study|COVID-19 adverse event|6|||
46643063|NCT04542057|82842693|FG001|Overall Study|COVID-19 adverse event|4|||
46643064|NCT04542057|82842692|FG000|Overall Study|Lack of Efficacy|2|||
46643065|NCT04542057|82842693|FG001|Overall Study|Lack of Efficacy|5|||
46643066|NCT04542057|82842692|FG000|Overall Study|Study terminated by sponsor|1|||
46643067|NCT04542057|82842693|FG001|Overall Study|Study terminated by sponsor|0|||
46643068|NCT04542057|82842692|FG000|Overall Study|Investigator discretion|2|||
46643069|NCT04542057|82842693|FG001|Overall Study|Investigator discretion|1|||
46643070|NCT04542057|82842692|FG000|Overall Study|Withdrawal by Subject|52|||
46643071|NCT04542057|82842693|FG001|Overall Study|Withdrawal by Subject|30|||
46778957|NCT01511250|82997525|FG006|Overall Study|Protocol Violation|0|||
46778958|NCT01511250|82997526|FG007|Overall Study|Protocol Violation|0|||
46778959|NCT01511250|82997527|FG008|Overall Study|Protocol Violation|0|||
46778960|NCT01511250|82997528|FG009|Overall Study|Protocol Violation|0|||
46778961|NCT01424566|82997550|FG000|Single-blind Treatment|Adverse Event|71|||
46778962|NCT01424566|82997551|FG001|Single-blind Treatment|Adverse Event|0|||
46643072|NCT04542057|82842692|FG000|Overall Study|Lost to Follow-up|8|||
46643073|NCT04542057|82842693|FG001|Overall Study|Lost to Follow-up|11|||
46643074|NCT04542057|82842692|FG000|Overall Study|Other|2|||
46643075|NCT04542057|82842693|FG001|Overall Study|Other|2|||
46643076|NCT04193527|82842707|FG000|Overall Study|Other|1|||
46643077|NCT04193527|82842708|FG001|Overall Study|Other|1|||
46643078|NCT04193527|82842709|FG002|Overall Study|Other|0|||
46643079|NCT03915470|82842722|FG000|Overall Study|Death|3|||
46643080|NCT03915470|82842723|FG001|Overall Study|Death|1|||
46778963|NCT01424566|82997552|FG002|Single-blind Treatment|Adverse Event|0|||
46778964|NCT01424566|82997550|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
46778965|NCT01424566|82997551|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
46778966|NCT01424566|82997552|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
46778967|NCT01424566|82997550|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
46778968|NCT01424566|82997551|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
46778969|NCT01424566|82997552|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
46778970|NCT01424566|82997550|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
46778971|NCT01424566|82997551|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
46778972|NCT01424566|82997552|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
46778973|NCT01424566|82997550|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
46643081|NCT03915470|82842722|FG000|Overall Study|Adverse Event|1|||
46643082|NCT03915470|82842723|FG001|Overall Study|Adverse Event|0|||
46643083|NCT03915470|82842722|FG000|Overall Study|Physician Decision|1|||
46643084|NCT03915470|82842723|FG001|Overall Study|Physician Decision|0|||
46643085|NCT03915470|82842722|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
46643086|NCT03915470|82842723|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
46643087|NCT03575468|82842731|FG000|Overall Study|Withdrawal by Subject|3|||
46643088|NCT03575468|82842732|FG001|Overall Study|Withdrawal by Subject|0|||
46643089|NCT03575468|82842731|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
46643090|NCT03575468|82842732|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
46643091|NCT03575468|82842731|FG000|Overall Study|Lost to Follow-up|13|||
46643092|NCT03575468|82842732|FG001|Overall Study|Lost to Follow-up|17|||
46643093|NCT03555981|82842740|FG000|Overall Study|Lost to Follow-up|0|||
46643094|NCT03555981|82842741|FG001|Overall Study|Lost to Follow-up|2|||
46643095|NCT03382834|82842749|FG000|Overall Study|Lost to Follow-up|1|||
46643096|NCT03382834|82842750|FG001|Overall Study|Lost to Follow-up|0|||
46643097|NCT03382834|82842749|FG000|Overall Study|Withdrawal by Subject|0|||
46850104|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850105|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850106|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850107|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
46850108|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850109|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850110|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850111|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850112|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850113|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850114|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
46643098|NCT03382834|82842750|FG001|Overall Study|Withdrawal by Subject|1|||
46643099|NCT03308942|82842761|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
46643100|NCT03308942|82842762|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
46643101|NCT03308942|82842763|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
46643102|NCT03308942|82842764|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
46643103|NCT03308942|82842765|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
46643104|NCT03308942|82842761|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
46643105|NCT03308942|82842762|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
46643106|NCT03308942|82842763|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
46643107|NCT03308942|82842764|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
46643108|NCT03308942|82842765|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
46643109|NCT03308942|82842761|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
46643110|NCT03308942|82842762|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
46643111|NCT03308942|82842763|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
46643112|NCT03308942|82842764|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
46643113|NCT03308942|82842765|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
46643114|NCT03308942|82842761|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
46643115|NCT03308942|82842762|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
46643116|NCT03308942|82842763|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
46778974|NCT01424566|82997551|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
46778975|NCT01424566|82997552|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
46778976|NCT01424566|82997550|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
46778977|NCT01424566|82997551|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
46778978|NCT01424566|82997552|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
46778979|NCT01424566|82997550|FG000|Double-blind Treatment|Adverse Event|0|||
46778980|NCT01424566|82997551|FG001|Double-blind Treatment|Adverse Event|21|||
46778981|NCT01424566|82997552|FG002|Double-blind Treatment|Adverse Event|13|||
46778982|NCT01424566|82997550|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
46778983|NCT01424566|82997551|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
46850115|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850116|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850117|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850118|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850119|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850120|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850121|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850122|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850123|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
46850124|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
46643117|NCT03308942|82842764|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
46643118|NCT03308942|82842765|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
46643119|NCT03308942|82842761|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
46643120|NCT03308942|82842762|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
46643121|NCT03308942|82842763|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
46643122|NCT03308942|82842764|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
46643123|NCT03308942|82842765|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
46643124|NCT03308942|82842761|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
46643125|NCT03308942|82842762|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
46643126|NCT03308942|82842763|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
46643127|NCT03308942|82842764|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
46643128|NCT03308942|82842765|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
46643129|NCT03308942|82842761|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
46643130|NCT03308942|82842762|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
46643131|NCT03308942|82842763|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
46643132|NCT03308942|82842764|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
46643133|NCT03308942|82842765|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
46643134|NCT03291431|82842780|FG000|Overall Study|Protocol Violation|2|||
46643135|NCT03291431|82842781|FG001|Overall Study|Protocol Violation|1|||
46643136|NCT03291431|82842780|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
46643137|NCT03291431|82842781|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
46643138|NCT03291431|82842780|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
46643139|NCT03291431|82842781|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
46643140|NCT03261401|82842800|FG000|Overall Study|Withdrawal by Subject|0|||
46643141|NCT03261401|82842801|FG001|Overall Study|Withdrawal by Subject|0|||
46643142|NCT03261401|82842802|FG002|Overall Study|Withdrawal by Subject|0|||
46643143|NCT03261401|82842803|FG003|Overall Study|Withdrawal by Subject|0|||
46643144|NCT03261401|82842804|FG004|Overall Study|Withdrawal by Subject|0|||
46643145|NCT03261401|82842805|FG005|Overall Study|Withdrawal by Subject|1|||
46643146|NCT03261401|82842806|FG006|Overall Study|Withdrawal by Subject|0|||
46643147|NCT03261401|82842807|FG007|Overall Study|Withdrawal by Subject|0|||
46643148|NCT03261401|82842808|FG008|Overall Study|Withdrawal by Subject|0|||
46643149|NCT03261401|82842809|FG009|Overall Study|Withdrawal by Subject|0|||
46643150|NCT03261401|82842810|FG010|Overall Study|Withdrawal by Subject|0|||
46643151|NCT03261401|82842811|FG011|Overall Study|Withdrawal by Subject|0|||
46643152|NCT03261401|82842812|FG012|Overall Study|Withdrawal by Subject|0|||
46643153|NCT03261401|82842800|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
46643154|NCT03261401|82842801|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
46643155|NCT03261401|82842802|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
46643156|NCT03261401|82842803|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
46643157|NCT03261401|82842804|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
46643158|NCT03261401|82842805|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
46643159|NCT03261401|82842806|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
46643160|NCT03261401|82842807|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
46643161|NCT03261401|82842808|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
46643162|NCT03261401|82842809|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
46643163|NCT03261401|82842810|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
46643164|NCT03261401|82842811|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
46643165|NCT03261401|82842812|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
46643166|NCT02998528|82842852|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
46643167|NCT02998528|82842853|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
46643168|NCT02998528|82842854|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
46643169|NCT02998528|82842852|FG000|Randomization Period|Participant withdrew consent|0|||
46643170|NCT02998528|82842853|FG001|Randomization Period|Participant withdrew consent|3|||
46643171|NCT02998528|82842854|FG002|Randomization Period|Participant withdrew consent|0|||
46643172|NCT02998528|82842852|FG000|Randomization Period|Participant no longer meets study criteria|1|||
46643173|NCT02998528|82842853|FG001|Randomization Period|Participant no longer meets study criteria|3|||
46643174|NCT02998528|82842854|FG002|Randomization Period|Participant no longer meets study criteria|2|||
46643175|NCT02998528|82842852|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
46643176|NCT02998528|82842853|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
46643177|NCT02998528|82842854|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
46850125|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850126|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850127|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850128|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46643178|NCT02998528|82842852|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
46643179|NCT02998528|82842853|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
46643180|NCT02998528|82842854|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
46643181|NCT02998528|82842852|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
46643182|NCT02998528|82842853|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
46643183|NCT02998528|82842854|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
46643184|NCT02998528|82842852|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
46643185|NCT02998528|82842853|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
46643186|NCT02998528|82842854|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
46643187|NCT02998528|82842852|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
46643188|NCT02998528|82842853|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
46643189|NCT02998528|82842854|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
46643190|NCT02998528|82842852|FG000|Neoadjuvant Treatment Period|Death|1|||
46643191|NCT02998528|82842853|FG001|Neoadjuvant Treatment Period|Death|0|||
46643192|NCT02998528|82842854|FG002|Neoadjuvant Treatment Period|Death|0|||
46643193|NCT02998528|82842852|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
46643194|NCT02998528|82842853|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
46643195|NCT02998528|82842854|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
46643196|NCT02998528|82842852|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
46643197|NCT02998528|82842853|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
46643198|NCT02998528|82842854|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
46643199|NCT02998528|82842852|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
46643200|NCT02998528|82842853|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
46643201|NCT02998528|82842854|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
46643202|NCT02998528|82842852|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
46643203|NCT02998528|82842853|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
46643204|NCT02998528|82842854|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
46643205|NCT02998528|82842852|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
46643206|NCT02998528|82842853|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
46643207|NCT02998528|82842854|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
46643208|NCT02998528|82842852|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
46643209|NCT02998528|82842853|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
46643210|NCT02998528|82842854|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
46643211|NCT02718911|82842875|FG000|Overall Study|Adverse Event|0|||
46643212|NCT02718911|82842876|FG001|Overall Study|Adverse Event|0|||
46643213|NCT02718911|82842877|FG002|Overall Study|Adverse Event|0|||
46643214|NCT02718911|82842878|FG003|Overall Study|Adverse Event|0|||
46643215|NCT02718911|82842879|FG004|Overall Study|Adverse Event|0|||
46643216|NCT02718911|82842880|FG005|Overall Study|Adverse Event|0|||
46643217|NCT02718911|82842881|FG006|Overall Study|Adverse Event|0|||
46643218|NCT02718911|82842882|FG007|Overall Study|Adverse Event|0|||
46643219|NCT02718911|82842883|FG008|Overall Study|Adverse Event|0|||
46643220|NCT02718911|82842884|FG009|Overall Study|Adverse Event|2|||
46643221|NCT02718911|82842875|FG000|Overall Study|Death|2|||
46643222|NCT02718911|82842876|FG001|Overall Study|Death|3|||
46643223|NCT02718911|82842877|FG002|Overall Study|Death|1|||
46643224|NCT02718911|82842878|FG003|Overall Study|Death|0|||
46643225|NCT02718911|82842879|FG004|Overall Study|Death|1|||
46643226|NCT02718911|82842880|FG005|Overall Study|Death|3|||
46643227|NCT02718911|82842881|FG006|Overall Study|Death|1|||
46643228|NCT02718911|82842882|FG007|Overall Study|Death|1|||
46643229|NCT02718911|82842883|FG008|Overall Study|Death|4|||
46643230|NCT02718911|82842884|FG009|Overall Study|Death|3|||
46643231|NCT02718911|82842875|FG000|Overall Study|Lost to Follow-up|0|||
46643232|NCT02718911|82842876|FG001|Overall Study|Lost to Follow-up|0|||
46643233|NCT02718911|82842877|FG002|Overall Study|Lost to Follow-up|0|||
46778984|NCT01424566|82997552|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
46778985|NCT01424566|82997550|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
46778986|NCT01424566|82997551|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
46778987|NCT01424566|82997552|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
46778988|NCT01424566|82997550|FG000|Double-blind Treatment|Lack of Efficacy|0|||
46778989|NCT01424566|82997551|FG001|Double-blind Treatment|Lack of Efficacy|1|||
46778990|NCT01424566|82997552|FG002|Double-blind Treatment|Lack of Efficacy|1|||
46969826|NCT02577003|83212675|FG001|Overall Study|Withdrawal by Subject|1|||
46643234|NCT02718911|82842878|FG003|Overall Study|Lost to Follow-up|0|||
46778991|NCT01361607|82997561|FG000|Overall Study|Adverse Event|38|||
46778992|NCT01361607|82997562|FG001|Overall Study|Adverse Event|29|||
46643235|NCT02718911|82842879|FG004|Overall Study|Lost to Follow-up|0|||
46778993|NCT01361607|82997561|FG000|Overall Study|Withdrawal by Subject|19|||
46969827|NCT02446899|83212683|FG000|Overall Study|Adverse Event|4|||
46969828|NCT02446899|83212684|FG001|Overall Study|Adverse Event|7|||
46969829|NCT02446899|83212683|FG000|Overall Study|Condition Under Investigation Worsened|1|||
46643236|NCT02718911|82842880|FG005|Overall Study|Lost to Follow-up|0|||
46643237|NCT02718911|82842881|FG006|Overall Study|Lost to Follow-up|0|||
46643238|NCT02718911|82842882|FG007|Overall Study|Lost to Follow-up|0|||
46643239|NCT02718911|82842883|FG008|Overall Study|Lost to Follow-up|1|||
46643240|NCT02718911|82842884|FG009|Overall Study|Lost to Follow-up|0|||
46643241|NCT02718911|82842875|FG000|Overall Study|Physician Decision|2|||
46643242|NCT02718911|82842876|FG001|Overall Study|Physician Decision|0|||
46643243|NCT02718911|82842877|FG002|Overall Study|Physician Decision|1|||
46643244|NCT02718911|82842878|FG003|Overall Study|Physician Decision|1|||
46643245|NCT02718911|82842879|FG004|Overall Study|Physician Decision|0|||
46643246|NCT02718911|82842880|FG005|Overall Study|Physician Decision|0|||
46643247|NCT02718911|82842881|FG006|Overall Study|Physician Decision|0|||
46643248|NCT02718911|82842882|FG007|Overall Study|Physician Decision|1|||
46643249|NCT02718911|82842883|FG008|Overall Study|Physician Decision|2|||
46643250|NCT02718911|82842884|FG009|Overall Study|Physician Decision|1|||
46643251|NCT02718911|82842875|FG000|Overall Study|Withdrawal by Subject|0|||
46643252|NCT02718911|82842876|FG001|Overall Study|Withdrawal by Subject|0|||
46643253|NCT02718911|82842877|FG002|Overall Study|Withdrawal by Subject|0|||
46643254|NCT02718911|82842878|FG003|Overall Study|Withdrawal by Subject|0|||
46643255|NCT02718911|82842879|FG004|Overall Study|Withdrawal by Subject|1|||
46643256|NCT02718911|82842880|FG005|Overall Study|Withdrawal by Subject|0|||
46643257|NCT02718911|82842881|FG006|Overall Study|Withdrawal by Subject|0|||
46643258|NCT02718911|82842882|FG007|Overall Study|Withdrawal by Subject|0|||
46643259|NCT02718911|82842883|FG008|Overall Study|Withdrawal by Subject|1|||
46643260|NCT02718911|82842884|FG009|Overall Study|Withdrawal by Subject|4|||
46643261|NCT02718911|82842875|FG000|Overall Study|Reason Not Collected|0|||
46643262|NCT02718911|82842876|FG001|Overall Study|Reason Not Collected|0|||
46643263|NCT02718911|82842877|FG002|Overall Study|Reason Not Collected|1|||
46643264|NCT02718911|82842878|FG003|Overall Study|Reason Not Collected|0|||
46643265|NCT02718911|82842879|FG004|Overall Study|Reason Not Collected|0|||
46643266|NCT02718911|82842880|FG005|Overall Study|Reason Not Collected|0|||
46643267|NCT02718911|82842881|FG006|Overall Study|Reason Not Collected|2|||
46643268|NCT02718911|82842882|FG007|Overall Study|Reason Not Collected|1|||
46643269|NCT02718911|82842883|FG008|Overall Study|Reason Not Collected|4|||
46643270|NCT02718911|82842884|FG009|Overall Study|Reason Not Collected|9|||
46643271|NCT02542267|82842908|FG000|Overall Study|Withdrawal by Subject|10|||
46643272|NCT02542267|82842908|FG000|Overall Study|Physician Decision|6|||
46643273|NCT02542267|82842908|FG000|Overall Study|Lost to Follow-up|4|||
46643274|NCT02542267|82842908|FG000|Overall Study|Death|13|||
46643275|NCT02542267|82842908|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
46850129|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850130|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
46850131|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
46850132|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
46850133|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
46850134|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
46850135|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850136|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850137|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46643276|NCT02542267|82842908|FG000|Overall Study|Other|9|||
46643277|NCT02017717|82842960|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643278|NCT02017717|82842961|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643279|NCT02017717|82842962|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643280|NCT02017717|82842963|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
46643281|NCT02017717|82842964|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643282|NCT02017717|82842965|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643283|NCT02017717|82842966|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643284|NCT02017717|82842967|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643285|NCT02017717|82842968|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
46643286|NCT02017717|82842960|FG000|Before Treatment Period|Participant request to stop therapy|0|||
46850138|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850139|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46643287|NCT02017717|82842961|FG001|Before Treatment Period|Participant request to stop therapy|0|||
46643288|NCT02017717|82842962|FG002|Before Treatment Period|Participant request to stop therapy|0|||
46643289|NCT02017717|82842963|FG003|Before Treatment Period|Participant request to stop therapy|0|||
46643290|NCT02017717|82842964|FG004|Before Treatment Period|Participant request to stop therapy|5|||
46643291|NCT02017717|82842965|FG005|Before Treatment Period|Participant request to stop therapy|0|||
46778994|NCT01361607|82997562|FG001|Overall Study|Withdrawal by Subject|8|||
46778995|NCT01361607|82997561|FG000|Overall Study|Withdrawal by Investigator|5|||
46778996|NCT01361607|82997562|FG001|Overall Study|Withdrawal by Investigator|3|||
46778997|NCT01361607|82997561|FG000|Overall Study|Lost to Follow-up|1|||
46778998|NCT01361607|82997562|FG001|Overall Study|Lost to Follow-up|0|||
46778999|NCT01361607|82997561|FG000|Overall Study|Met Withdrawal Criteria|1|||
46969830|NCT02446899|83212684|FG001|Overall Study|Condition Under Investigation Worsened|4|||
46969831|NCT02446899|83212683|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
46969832|NCT02446899|83212684|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
46969833|NCT02446899|83212683|FG000|Overall Study|Lack of Efficacy|2|||
46969834|NCT02446899|83212684|FG001|Overall Study|Lack of Efficacy|8|||
46969835|NCT02446899|83212683|FG000|Overall Study|Lost to Follow-up|1|||
46969836|NCT02446899|83212684|FG001|Overall Study|Lost to Follow-up|3|||
46969837|NCT02446899|83212683|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
46969838|NCT02446899|83212684|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
46969839|NCT02446899|83212683|FG000|Overall Study|Withdrawal by Subject|11|||
46969840|NCT02446899|83212684|FG001|Overall Study|Withdrawal by Subject|19|||
46969841|NCT02446899|83212683|FG000|Overall Study|Miscellaneous|5|||
46969842|NCT02446899|83212684|FG001|Overall Study|Miscellaneous|4|||
46969843|NCT02446899|83212683|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
46969844|NCT02446899|83212684|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
46969845|NCT02709785|83212693|FG000|Overall Study|Withdrawal by Subject|1|||
46969846|NCT02709785|83212694|FG001|Overall Study|Withdrawal by Subject|2|||
46969847|NCT02709785|83212695|FG002|Overall Study|Withdrawal by Subject|1|||
46969848|NCT02356887|83212703|FG000|Overall Study|poor compliance|2|||
46969849|NCT01604265|83212715|FG000|Overall Study|Adverse Event|1|||
46969850|NCT01604265|83212716|FG001|Overall Study|Adverse Event|0|||
46969851|NCT01604265|83212715|FG000|Overall Study|Withdrawal by Subject|1|||
46850140|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850141|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850142|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850143|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850144|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850145|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850146|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850147|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850148|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46850149|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46643292|NCT02017717|82842966|FG006|Before Treatment Period|Participant request to stop therapy|0|||
46779000|NCT01361607|82997562|FG001|Overall Study|Met Withdrawal Criteria|1|||
46779001|NCT01337089|82997569|FG000|Overall Study|Adverse Event|237|||
46779002|NCT01337089|82997569|FG000|Overall Study|Withdrawal by Subject|129|||
46779003|NCT01337089|82997569|FG000|Overall Study|Withdrawal by Investigator|33|||
46779004|NCT01337089|82997569|FG000|Overall Study|Met Withdrawal Criteria|3|||
46779005|NCT01337089|82997569|FG000|Overall Study|Lost to Follow-up|2|||
46779006|NCT00114530|82997583|FG000|Overall Study|Death|3|||
46779007|NCT00114530|82997584|FG001|Overall Study|Death|11|||
46779008|NCT00114530|82997583|FG000|Overall Study|Lost to Follow-up|1|||
46779009|NCT00114530|82997584|FG001|Overall Study|Lost to Follow-up|1|||
46850150|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
46969852|NCT01604265|83212716|FG001|Overall Study|Withdrawal by Subject|0|||
46969853|NCT01664247|83212724|FG000|Overall Study|Adverse Event|5|||
46969854|NCT01664247|83212725|FG001|Overall Study|Adverse Event|3|||
46969855|NCT01664247|83212724|FG000|Overall Study|Protocol Violation|3|||
46969856|NCT01664247|83212725|FG001|Overall Study|Protocol Violation|5|||
46969857|NCT01664247|83212724|FG000|Overall Study|Withdrawal Criteria|1|||
46969858|NCT01664247|83212725|FG001|Overall Study|Withdrawal Criteria|4|||
46969859|NCT01664247|83212724|FG000|Overall Study|Unclassified|5|||
46969860|NCT01664247|83212725|FG001|Overall Study|Unclassified|29|||
46969861|NCT03191903|83212749|FG000|Overall Study|Withdrawal by Subject|6|||
46969862|NCT03191903|83212750|FG001|Overall Study|Withdrawal by Subject|5|||
46643293|NCT02017717|82842967|FG007|Before Treatment Period|Participant request to stop therapy|0|||
46643294|NCT02017717|82842968|FG008|Before Treatment Period|Participant request to stop therapy|0|||
46643295|NCT02017717|82842960|FG000|Before Treatment Period|Participant withdrew consent|0|||
46643296|NCT02017717|82842961|FG001|Before Treatment Period|Participant withdrew consent|0|||
46643297|NCT02017717|82842962|FG002|Before Treatment Period|Participant withdrew consent|0|||
46643298|NCT02017717|82842963|FG003|Before Treatment Period|Participant withdrew consent|0|||
46643299|NCT02017717|82842964|FG004|Before Treatment Period|Participant withdrew consent|11|||
46643300|NCT02017717|82842965|FG005|Before Treatment Period|Participant withdrew consent|0|||
46643301|NCT02017717|82842966|FG006|Before Treatment Period|Participant withdrew consent|0|||
46643302|NCT02017717|82842967|FG007|Before Treatment Period|Participant withdrew consent|0|||
46643303|NCT02017717|82842968|FG008|Before Treatment Period|Participant withdrew consent|2|||
46643304|NCT02017717|82842960|FG000|Before Treatment Period|Lost to Follow-up|0|||
46643305|NCT02017717|82842961|FG001|Before Treatment Period|Lost to Follow-up|0|||
46643306|NCT02017717|82842962|FG002|Before Treatment Period|Lost to Follow-up|0|||
46643307|NCT02017717|82842963|FG003|Before Treatment Period|Lost to Follow-up|0|||
46643308|NCT02017717|82842964|FG004|Before Treatment Period|Lost to Follow-up|1|||
46643309|NCT02017717|82842965|FG005|Before Treatment Period|Lost to Follow-up|0|||
46643310|NCT02017717|82842966|FG006|Before Treatment Period|Lost to Follow-up|0|||
46643311|NCT02017717|82842967|FG007|Before Treatment Period|Lost to Follow-up|0|||
46643312|NCT02017717|82842968|FG008|Before Treatment Period|Lost to Follow-up|0|||
46643313|NCT02017717|82842960|FG000|Before Treatment Period|Participant no longer met criteria|0|||
46643314|NCT02017717|82842961|FG001|Before Treatment Period|Participant no longer met criteria|0|||
46643315|NCT02017717|82842962|FG002|Before Treatment Period|Participant no longer met criteria|0|||
46643316|NCT02017717|82842963|FG003|Before Treatment Period|Participant no longer met criteria|1|||
46643317|NCT02017717|82842964|FG004|Before Treatment Period|Participant no longer met criteria|2|||
46643318|NCT02017717|82842965|FG005|Before Treatment Period|Participant no longer met criteria|0|||
46643319|NCT02017717|82842966|FG006|Before Treatment Period|Participant no longer met criteria|0|||
46643320|NCT02017717|82842967|FG007|Before Treatment Period|Participant no longer met criteria|1|||
46643321|NCT02017717|82842968|FG008|Before Treatment Period|Participant no longer met criteria|0|||
46643322|NCT02017717|82842960|FG000|Before Treatment Period|other reason|0|||
46643323|NCT02017717|82842961|FG001|Before Treatment Period|other reason|0|||
46643324|NCT02017717|82842962|FG002|Before Treatment Period|other reason|0|||
46643325|NCT02017717|82842963|FG003|Before Treatment Period|other reason|0|||
46643326|NCT02017717|82842964|FG004|Before Treatment Period|other reason|1|||
46643327|NCT02017717|82842965|FG005|Before Treatment Period|other reason|0|||
46643328|NCT02017717|82842966|FG006|Before Treatment Period|other reason|0|||
46643329|NCT02017717|82842967|FG007|Before Treatment Period|other reason|0|||
46643330|NCT02017717|82842968|FG008|Before Treatment Period|other reason|0|||
46643331|NCT02017717|82842960|FG000|Treatment Period|Disease progression|7|||
46643332|NCT02017717|82842961|FG001|Treatment Period|Disease progression|9|||
46643333|NCT02017717|82842962|FG002|Treatment Period|Disease progression|12|||
46643334|NCT02017717|82842963|FG003|Treatment Period|Disease progression|165|||
46643335|NCT02017717|82842964|FG004|Treatment Period|Disease progression|134|||
46643336|NCT02017717|82842965|FG005|Treatment Period|Disease progression|20|||
46643337|NCT02017717|82842966|FG006|Treatment Period|Disease progression|26|||
46643338|NCT02017717|82842967|FG007|Treatment Period|Disease progression|17|||
46643339|NCT02017717|82842968|FG008|Treatment Period|Disease progression|22|||
46643340|NCT02017717|82842960|FG000|Treatment Period|Study drug toxicity|3|||
46643341|NCT02017717|82842961|FG001|Treatment Period|Study drug toxicity|0|||
46643342|NCT02017717|82842962|FG002|Treatment Period|Study drug toxicity|1|||
46643343|NCT02017717|82842963|FG003|Treatment Period|Study drug toxicity|7|||
46643344|NCT02017717|82842964|FG004|Treatment Period|Study drug toxicity|11|||
46643345|NCT02017717|82842965|FG005|Treatment Period|Study drug toxicity|4|||
46643346|NCT02017717|82842966|FG006|Treatment Period|Study drug toxicity|4|||
46643347|NCT02017717|82842967|FG007|Treatment Period|Study drug toxicity|5|||
46643348|NCT02017717|82842968|FG008|Treatment Period|Study drug toxicity|3|||
46643349|NCT02017717|82842960|FG000|Treatment Period|Death|0|||
46643350|NCT02017717|82842961|FG001|Treatment Period|Death|0|||
46643351|NCT02017717|82842962|FG002|Treatment Period|Death|1|||
46643352|NCT02017717|82842963|FG003|Treatment Period|Death|0|||
46643353|NCT02017717|82842964|FG004|Treatment Period|Death|0|||
46643354|NCT02017717|82842965|FG005|Treatment Period|Death|0|||
46643355|NCT02017717|82842966|FG006|Treatment Period|Death|0|||
46643356|NCT02017717|82842967|FG007|Treatment Period|Death|1|||
46779010|NCT00114530|82997583|FG000|Overall Study|Physician Decision|1|||
46643357|NCT02017717|82842968|FG008|Treatment Period|Death|0|||
46643358|NCT02017717|82842960|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
46779011|NCT00114530|82997584|FG001|Overall Study|Physician Decision|1|||
46779012|NCT00114530|82997583|FG000|Overall Study|Withdrawal by Subject|2|||
46779013|NCT00114530|82997584|FG001|Overall Study|Withdrawal by Subject|6|||
46779014|NCT00114530|82997583|FG000|Overall Study|Breast Cancer|1|||
46779015|NCT00114530|82997584|FG001|Overall Study|Breast Cancer|0|||
46779016|NCT00114530|82997583|FG000|Overall Study|Subject decision after endpoint failure|0|||
46969863|NCT03191903|83212751|FG002|Overall Study|Withdrawal by Subject|4|||
46969864|NCT03191903|83212749|FG000|Overall Study|Adverse Event|1|||
46707444|NCT00992511|82922976|FG003|Overall Study|Lost to Follow-up|2|||
46779017|NCT00114530|82997584|FG001|Overall Study|Subject decision after endpoint failure|1|||
46779018|NCT00114530|82997583|FG000|Overall Study|Ineligible|1|||
46779019|NCT00114530|82997584|FG001|Overall Study|Ineligible|0|||
46779020|NCT00618982|82997607|FG000|Overall Study|Adverse Event|23|||
46779021|NCT00618982|82997607|FG000|Overall Study|Withdrawal by Subject|1|||
46779022|NCT00618982|82997607|FG000|Overall Study|Protocol Violation|1|||
46779023|NCT00618982|82997607|FG000|Overall Study|ongoing, still treated with study med.|25|||
46779024|NCT00578786|82997617|FG000|Overall Study|Adverse Event|27|||
46779025|NCT00578786|82997618|FG001|Overall Study|Adverse Event|37|||
46779026|NCT00578786|82997619|FG002|Overall Study|Adverse Event|17|||
46969865|NCT03191903|83212750|FG001|Overall Study|Adverse Event|0|||
46643359|NCT02017717|82842961|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
46643360|NCT02017717|82842962|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
46643361|NCT02017717|82842963|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
46643362|NCT02017717|82842964|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
46643363|NCT02017717|82842965|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
46643364|NCT02017717|82842966|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
46643365|NCT02017717|82842967|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
46643366|NCT02017717|82842968|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
46643367|NCT02017717|82842960|FG000|Treatment Period|Participant request to stop therapy|0|||
46643368|NCT02017717|82842961|FG001|Treatment Period|Participant request to stop therapy|0|||
46643369|NCT02017717|82842962|FG002|Treatment Period|Participant request to stop therapy|3|||
46643370|NCT02017717|82842963|FG003|Treatment Period|Participant request to stop therapy|4|||
46643371|NCT02017717|82842964|FG004|Treatment Period|Participant request to stop therapy|7|||
46643372|NCT02017717|82842965|FG005|Treatment Period|Participant request to stop therapy|5|||
46643373|NCT02017717|82842966|FG006|Treatment Period|Participant request to stop therapy|0|||
46643374|NCT02017717|82842967|FG007|Treatment Period|Participant request to stop therapy|2|||
46643375|NCT02017717|82842968|FG008|Treatment Period|Participant request to stop therapy|1|||
46643376|NCT02017717|82842960|FG000|Treatment Period|Participant withdrew consent|0|||
46643377|NCT02017717|82842961|FG001|Treatment Period|Participant withdrew consent|0|||
46643378|NCT02017717|82842962|FG002|Treatment Period|Participant withdrew consent|1|||
46643379|NCT02017717|82842963|FG003|Treatment Period|Participant withdrew consent|1|||
46643380|NCT02017717|82842964|FG004|Treatment Period|Participant withdrew consent|4|||
46643381|NCT02017717|82842965|FG005|Treatment Period|Participant withdrew consent|0|||
46643382|NCT02017717|82842966|FG006|Treatment Period|Participant withdrew consent|0|||
46643383|NCT02017717|82842967|FG007|Treatment Period|Participant withdrew consent|2|||
46643384|NCT02017717|82842968|FG008|Treatment Period|Participant withdrew consent|0|||
46643385|NCT02017717|82842960|FG000|Treatment Period|Participant no longer met criteria|0|||
46643386|NCT02017717|82842961|FG001|Treatment Period|Participant no longer met criteria|0|||
46643387|NCT02017717|82842962|FG002|Treatment Period|Participant no longer met criteria|0|||
46643388|NCT02017717|82842963|FG003|Treatment Period|Participant no longer met criteria|0|||
46643389|NCT02017717|82842964|FG004|Treatment Period|Participant no longer met criteria|1|||
46643390|NCT02017717|82842965|FG005|Treatment Period|Participant no longer met criteria|0|||
46643391|NCT02017717|82842966|FG006|Treatment Period|Participant no longer met criteria|0|||
46643392|NCT02017717|82842967|FG007|Treatment Period|Participant no longer met criteria|0|||
46643393|NCT02017717|82842968|FG008|Treatment Period|Participant no longer met criteria|0|||
46643394|NCT02017717|82842960|FG000|Treatment Period|other reasons|0|||
46643395|NCT02017717|82842961|FG001|Treatment Period|other reasons|0|||
46643396|NCT02017717|82842962|FG002|Treatment Period|other reasons|0|||
46643397|NCT02017717|82842963|FG003|Treatment Period|other reasons|0|||
46643398|NCT02017717|82842964|FG004|Treatment Period|other reasons|1|||
46643399|NCT02017717|82842965|FG005|Treatment Period|other reasons|0|||
46643400|NCT02017717|82842966|FG006|Treatment Period|other reasons|0|||
46643401|NCT02017717|82842967|FG007|Treatment Period|other reasons|1|||
46643402|NCT02017717|82842968|FG008|Treatment Period|other reasons|1|||
46643403|NCT02017717|82842960|FG000|Treatment Period|Maximum clinical benefit|0|||
46643404|NCT02017717|82842961|FG001|Treatment Period|Maximum clinical benefit|0|||
46643405|NCT02017717|82842962|FG002|Treatment Period|Maximum clinical benefit|0|||
46643406|NCT02017717|82842963|FG003|Treatment Period|Maximum clinical benefit|0|||
46643407|NCT02017717|82842964|FG004|Treatment Period|Maximum clinical benefit|1|||
46643408|NCT02017717|82842965|FG005|Treatment Period|Maximum clinical benefit|0|||
46850151|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850152|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850153|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850154|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850155|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850156|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850157|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850158|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46643409|NCT02017717|82842966|FG006|Treatment Period|Maximum clinical benefit|0|||
46643410|NCT02017717|82842967|FG007|Treatment Period|Maximum clinical benefit|0|||
46850159|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850160|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
46969866|NCT03191903|83212751|FG002|Overall Study|Adverse Event|0|||
46643411|NCT02017717|82842968|FG008|Treatment Period|Maximum clinical benefit|0|||
46779027|NCT00578786|82997617|FG000|Overall Study|Lack of Efficacy|2|||
46779028|NCT00578786|82997618|FG001|Overall Study|Lack of Efficacy|5|||
46779029|NCT00578786|82997619|FG002|Overall Study|Lack of Efficacy|2|||
46779030|NCT00578786|82997617|FG000|Overall Study|Early Escape from Prior Study|2|||
46779031|NCT00578786|82997618|FG001|Overall Study|Early Escape from Prior Study|1|||
46779032|NCT00578786|82997619|FG002|Overall Study|Early Escape from Prior Study|2|||
46779033|NCT00578786|82997617|FG000|Overall Study|Withdrawal by Subject|7|||
46643412|NCT01539863|82842994|FG000|Overall Study|Lost to Follow-up|5|||
46643413|NCT01539863|82842995|FG001|Overall Study|Lost to Follow-up|4|||
46643414|NCT00942331|82843003|FG000|Overall Study|Did not start treatment|15|||
46643415|NCT00942331|82843004|FG001|Overall Study|Did not start treatment|22|||
46643416|NCT00827372|82843010|FG000|Overall Study|Adverse Event|5|||
46643417|NCT00827372|82843010|FG000|Overall Study|Lack of Efficacy|3|||
46643418|NCT00590902|82843019|FG000|Overall Study|Death|1|||
46643419|NCT00577122|82843025|FG000|Overall Study|Adverse Event|0|||
46643420|NCT00577122|82843026|FG001|Overall Study|Adverse Event|2|||
46643421|NCT00577122|82843025|FG000|Overall Study|Progression, relapse during active trt|6|||
46643422|NCT00577122|82843026|FG001|Overall Study|Progression, relapse during active trt|8|||
46643423|NCT00577122|82843025|FG000|Overall Study|Prog, refract disease during active trt|8|||
46643424|NCT00577122|82843026|FG001|Overall Study|Prog, refract disease during active trt|5|||
46643425|NCT00577122|82843025|FG000|Overall Study|Alternative Therapy|0|||
46643426|NCT00577122|82843026|FG001|Overall Study|Alternative Therapy|1|||
46643427|NCT00419770|82843035|FG000|Overall Study|Withdrawal by Subject|5|||
46643428|NCT00419770|82843036|FG001|Overall Study|Withdrawal by Subject|1|||
46643429|NCT00129701|82843042|FG000|Overall Study|Withdrawal by Subject|33|||
46643430|NCT04521114|82849022|FG000|Overall Study|Lost to Follow-up|1|||
46643431|NCT04521114|82849023|FG001|Overall Study|Lost to Follow-up|2|||
46643432|NCT04521114|82849024|FG002|Overall Study|Lost to Follow-up|0|||
46643433|NCT04521114|82849022|FG000|Overall Study|Withdrawal by Subject|1|||
46643434|NCT04521114|82849023|FG001|Overall Study|Withdrawal by Subject|2|||
46643435|NCT04521114|82849024|FG002|Overall Study|Withdrawal by Subject|2|||
46643436|NCT04521114|82849022|FG000|Overall Study|Adverse Event|1|||
46643437|NCT04521114|82849023|FG001|Overall Study|Adverse Event|0|||
46643438|NCT04521114|82849024|FG002|Overall Study|Adverse Event|0|||
46643439|NCT04521114|82849022|FG000|Overall Study|Sponsor Wish|1|||
46643440|NCT04521114|82849023|FG001|Overall Study|Sponsor Wish|0|||
46643441|NCT04521114|82849024|FG002|Overall Study|Sponsor Wish|0|||
46643442|NCT04521114|82849022|FG000|Overall Study|Withdrawal of Consent|2|||
46643443|NCT04521114|82849023|FG001|Overall Study|Withdrawal of Consent|2|||
46643444|NCT04521114|82849024|FG002|Overall Study|Withdrawal of Consent|0|||
46643445|NCT04360824|82849046|FG000|Overall Study|Withdrawal by Subject|2|||
46643446|NCT04360824|82849047|FG001|Overall Study|Withdrawal by Subject|1|||
46643447|NCT04360824|82849046|FG000|Overall Study|Did not receive assigned treatment|1|||
46643448|NCT04360824|82849047|FG001|Overall Study|Did not receive assigned treatment|3|||
46643449|NCT03711786|82849056|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
46643450|NCT03711786|82849057|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
46643451|NCT03711786|82849056|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
46643452|NCT03711786|82849057|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
46643453|NCT03711786|82849056|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
46643454|NCT03711786|82849057|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
46643455|NCT03711786|82849056|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
46643456|NCT03711786|82849057|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
46643457|NCT03711786|82849056|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
46643458|NCT03711786|82849057|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
46643459|NCT03711786|82849056|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
46643460|NCT03711786|82849057|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
46643461|NCT03691974|82849067|FG000|Overall Study|Physician Decision|1|||
46643462|NCT03691974|82849068|FG001|Overall Study|Physician Decision|0|||
46643463|NCT03691974|82849067|FG000|Overall Study|Adverse Event|1|||
46643464|NCT03691974|82849068|FG001|Overall Study|Adverse Event|0|||
46643465|NCT03691974|82849067|FG000|Overall Study|Withdrawal by Subject|11|||
46779034|NCT00578786|82997618|FG001|Overall Study|Withdrawal by Subject|8|||
46779035|NCT00578786|82997619|FG002|Overall Study|Withdrawal by Subject|5|||
46643466|NCT03691974|82849068|FG001|Overall Study|Withdrawal by Subject|9|||
46779036|NCT00578786|82997617|FG000|Overall Study|Protocol Violation|0|||
46779037|NCT00578786|82997618|FG001|Overall Study|Protocol Violation|3|||
46779038|NCT00578786|82997619|FG002|Overall Study|Protocol Violation|1|||
46779039|NCT00578786|82997617|FG000|Overall Study|Physician Decision|1|||
46643467|NCT03691974|82849067|FG000|Overall Study|Protocol Violation|1|||
46643468|NCT03691974|82849068|FG001|Overall Study|Protocol Violation|0|||
46643469|NCT03691974|82849067|FG000|Overall Study|Lost to Follow-up|8|||
46643470|NCT03691974|82849068|FG001|Overall Study|Lost to Follow-up|7|||
46643471|NCT02454972|82849095|FG000|Overall Study|Progressive disease|17|||
46779040|NCT00578786|82997618|FG001|Overall Study|Physician Decision|0|||
46779041|NCT00578786|82997619|FG002|Overall Study|Physician Decision|1|||
46643472|NCT02454972|82849096|FG001|Overall Study|Progressive disease|16|||
46643473|NCT02454972|82849097|FG002|Overall Study|Progressive disease|59|||
46643474|NCT02454972|82849098|FG003|Overall Study|Progressive disease|23|||
46643475|NCT02454972|82849099|FG004|Overall Study|Progressive disease|16|||
46643476|NCT02454972|82849100|FG005|Overall Study|Progressive disease|12|||
46643477|NCT02454972|82849101|FG006|Overall Study|Progressive disease|19|||
46643478|NCT02454972|82849102|FG007|Overall Study|Progressive disease|27|||
46643479|NCT02454972|82849103|FG008|Overall Study|Progressive disease|0|||
46643480|NCT02454972|82849095|FG000|Overall Study|Death|0|||
46643481|NCT02454972|82849096|FG001|Overall Study|Death|0|||
46643482|NCT02454972|82849097|FG002|Overall Study|Death|5|||
46643483|NCT02454972|82849098|FG003|Overall Study|Death|1|||
46643484|NCT02454972|82849099|FG004|Overall Study|Death|0|||
46643485|NCT02454972|82849100|FG005|Overall Study|Death|0|||
46643486|NCT02454972|82849101|FG006|Overall Study|Death|0|||
46643487|NCT02454972|82849102|FG007|Overall Study|Death|0|||
46643488|NCT02454972|82849103|FG008|Overall Study|Death|95|||
46643489|NCT02454972|82849095|FG000|Overall Study|Physician Decision|0|||
46643490|NCT02454972|82849096|FG001|Overall Study|Physician Decision|1|||
46643491|NCT02454972|82849097|FG002|Overall Study|Physician Decision|2|||
46643492|NCT02454972|82849098|FG003|Overall Study|Physician Decision|1|||
46643493|NCT02454972|82849099|FG004|Overall Study|Physician Decision|2|||
46643494|NCT02454972|82849100|FG005|Overall Study|Physician Decision|0|||
46643495|NCT02454972|82849101|FG006|Overall Study|Physician Decision|0|||
46643496|NCT02454972|82849102|FG007|Overall Study|Physician Decision|1|||
46643497|NCT02454972|82849103|FG008|Overall Study|Physician Decision|0|||
46643498|NCT02454972|82849095|FG000|Overall Study|Non treatment-related adverse event|2|||
46643499|NCT02454972|82849096|FG001|Overall Study|Non treatment-related adverse event|0|||
46643500|NCT02454972|82849097|FG002|Overall Study|Non treatment-related adverse event|1|||
46643501|NCT02454972|82849098|FG003|Overall Study|Non treatment-related adverse event|0|||
46643502|NCT02454972|82849099|FG004|Overall Study|Non treatment-related adverse event|0|||
46643503|NCT02454972|82849100|FG005|Overall Study|Non treatment-related adverse event|1|||
46643504|NCT02454972|82849101|FG006|Overall Study|Non treatment-related adverse event|0|||
46643505|NCT02454972|82849102|FG007|Overall Study|Non treatment-related adverse event|1|||
46643506|NCT02454972|82849103|FG008|Overall Study|Non treatment-related adverse event|0|||
46643507|NCT02454972|82849095|FG000|Overall Study|Treatment-related adverse events|0|||
46643508|NCT02454972|82849096|FG001|Overall Study|Treatment-related adverse events|1|||
46643509|NCT02454972|82849097|FG002|Overall Study|Treatment-related adverse events|1|||
46643510|NCT02454972|82849098|FG003|Overall Study|Treatment-related adverse events|0|||
46643511|NCT02454972|82849099|FG004|Overall Study|Treatment-related adverse events|2|||
46643512|NCT02454972|82849100|FG005|Overall Study|Treatment-related adverse events|0|||
46643513|NCT02454972|82849101|FG006|Overall Study|Treatment-related adverse events|0|||
46643514|NCT02454972|82849102|FG007|Overall Study|Treatment-related adverse events|2|||
46643515|NCT02454972|82849103|FG008|Overall Study|Treatment-related adverse events|0|||
46643516|NCT02454972|82849095|FG000|Overall Study|Patient moves to compassionate use|0|||
46643517|NCT02454972|82849096|FG001|Overall Study|Patient moves to compassionate use|0|||
46643518|NCT02454972|82849097|FG002|Overall Study|Patient moves to compassionate use|0|||
46643519|NCT02454972|82849098|FG003|Overall Study|Patient moves to compassionate use|0|||
46643520|NCT02454972|82849099|FG004|Overall Study|Patient moves to compassionate use|0|||
46643521|NCT02454972|82849100|FG005|Overall Study|Patient moves to compassionate use|0|||
46643522|NCT02454972|82849101|FG006|Overall Study|Patient moves to compassionate use|2|||
46643523|NCT02454972|82849102|FG007|Overall Study|Patient moves to compassionate use|0|||
46643524|NCT02454972|82849103|FG008|Overall Study|Patient moves to compassionate use|0|||
46643525|NCT02454972|82849095|FG000|Overall Study|Withdrawal by Subject|0|||
46643526|NCT02454972|82849096|FG001|Overall Study|Withdrawal by Subject|1|||
46643527|NCT02454972|82849097|FG002|Overall Study|Withdrawal by Subject|5|||
46643528|NCT02454972|82849098|FG003|Overall Study|Withdrawal by Subject|2|||
46643529|NCT02454972|82849099|FG004|Overall Study|Withdrawal by Subject|3|||
46779042|NCT00578786|82997617|FG000|Overall Study|Sponsor Decision|0|||
46643530|NCT02454972|82849100|FG005|Overall Study|Withdrawal by Subject|2|||
46643531|NCT02454972|82849101|FG006|Overall Study|Withdrawal by Subject|0|||
46779043|NCT00578786|82997618|FG001|Overall Study|Sponsor Decision|0|||
46643532|NCT02454972|82849102|FG007|Overall Study|Withdrawal by Subject|1|||
46643533|NCT02454972|82849103|FG008|Overall Study|Withdrawal by Subject|2|||
46643534|NCT02454972|82849095|FG000|Overall Study|Multiple delay/holds on treatment|0|||
46779044|NCT00578786|82997619|FG002|Overall Study|Sponsor Decision|1|||
46779045|NCT00578786|82997617|FG000|Overall Study|Lost to Follow-up|0|||
46643535|NCT02454972|82849096|FG001|Overall Study|Multiple delay/holds on treatment|0|||
46643536|NCT02454972|82849097|FG002|Overall Study|Multiple delay/holds on treatment|0|||
46779046|NCT00578786|82997618|FG001|Overall Study|Lost to Follow-up|4|||
46643537|NCT02454972|82849098|FG003|Overall Study|Multiple delay/holds on treatment|1|||
46643538|NCT02454972|82849099|FG004|Overall Study|Multiple delay/holds on treatment|0|||
46643539|NCT02454972|82849100|FG005|Overall Study|Multiple delay/holds on treatment|0|||
46643540|NCT02454972|82849101|FG006|Overall Study|Multiple delay/holds on treatment|0|||
46643541|NCT02454972|82849102|FG007|Overall Study|Multiple delay/holds on treatment|0|||
46643542|NCT02454972|82849103|FG008|Overall Study|Multiple delay/holds on treatment|0|||
46643543|NCT02454972|82849095|FG000|Overall Study|Never treated|0|||
46643544|NCT02454972|82849096|FG001|Overall Study|Never treated|0|||
46643545|NCT02454972|82849097|FG002|Overall Study|Never treated|3|||
46643546|NCT02454972|82849098|FG003|Overall Study|Never treated|1|||
46643547|NCT02454972|82849099|FG004|Overall Study|Never treated|1|||
46643548|NCT02454972|82849100|FG005|Overall Study|Never treated|0|||
46643549|NCT02454972|82849101|FG006|Overall Study|Never treated|0|||
46643550|NCT02454972|82849102|FG007|Overall Study|Never treated|0|||
46643551|NCT02454972|82849103|FG008|Overall Study|Never treated|5|||
46643552|NCT02454972|82849095|FG000|Overall Study|Lost to Follow-up|0|||
46643553|NCT02454972|82849096|FG001|Overall Study|Lost to Follow-up|0|||
46643554|NCT02454972|82849097|FG002|Overall Study|Lost to Follow-up|0|||
46643555|NCT02454972|82849098|FG003|Overall Study|Lost to Follow-up|0|||
46643556|NCT02454972|82849099|FG004|Overall Study|Lost to Follow-up|0|||
46643557|NCT02454972|82849100|FG005|Overall Study|Lost to Follow-up|0|||
46643558|NCT02454972|82849101|FG006|Overall Study|Lost to Follow-up|0|||
46643559|NCT02454972|82849102|FG007|Overall Study|Lost to Follow-up|0|||
46643560|NCT02454972|82849103|FG008|Overall Study|Lost to Follow-up|2|||
46643561|NCT02454972|82849095|FG000|Overall Study|Study termination|0|||
46643562|NCT02454972|82849096|FG001|Overall Study|Study termination|0|||
46643563|NCT02454972|82849097|FG002|Overall Study|Study termination|0|||
46643564|NCT02454972|82849098|FG003|Overall Study|Study termination|0|||
46643565|NCT02454972|82849099|FG004|Overall Study|Study termination|0|||
46643566|NCT02454972|82849100|FG005|Overall Study|Study termination|0|||
46643567|NCT02454972|82849101|FG006|Overall Study|Study termination|0|||
46643568|NCT02454972|82849102|FG007|Overall Study|Study termination|0|||
46643569|NCT02454972|82849103|FG008|Overall Study|Study termination|6|||
46643570|NCT00063882|82849121|FG000|Overall Study|Protocol Violation|3|||
46643571|NCT00063882|82849122|FG001|Overall Study|Protocol Violation|3|||
46779047|NCT00578786|82997619|FG002|Overall Study|Lost to Follow-up|0|||
46779048|NCT00578786|82997617|FG000|Overall Study|Pregnancy|0|||
46779049|NCT00578786|82997618|FG001|Overall Study|Pregnancy|1|||
46779050|NCT00578786|82997619|FG002|Overall Study|Pregnancy|0|||
46779051|NCT00578786|82997617|FG000|Overall Study|Not Otherwise Specified|0|||
46779052|NCT00578786|82997618|FG001|Overall Study|Not Otherwise Specified|4|||
46779053|NCT00578786|82997619|FG002|Overall Study|Not Otherwise Specified|1|||
46779054|NCT00578786|82997617|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
46779055|NCT00578786|82997618|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
46779056|NCT00578786|82997619|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
46779057|NCT00424255|82997639|FG000|Overall Study|Death|115|||
46779058|NCT00424255|82997640|FG001|Overall Study|Death|111|||
46779059|NCT00424255|82997639|FG000|Overall Study|Lost to Follow-up|26|||
46779060|NCT00424255|82997640|FG001|Overall Study|Lost to Follow-up|20|||
46779061|NCT00424255|82997639|FG000|Overall Study|Protocol Violation|0|||
46779062|NCT00424255|82997640|FG001|Overall Study|Protocol Violation|1|||
46643572|NCT00063882|82849121|FG000|Overall Study|Withdrawal by Subject|2|||
46643573|NCT00063882|82849122|FG001|Overall Study|Withdrawal by Subject|1|||
46643574|NCT01279044|82849131|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
46643575|NCT01279044|82849132|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
46643576|NCT01279044|82849133|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
46643577|NCT01279044|82849131|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
46643578|NCT01279044|82849132|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
46643579|NCT01279044|82849133|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
46643580|NCT01279044|82849131|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
46643581|NCT01279044|82849132|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
46643582|NCT01279044|82849133|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
46643583|NCT01278342|82849142|FG000|Overall Study|Physician Decision|0|||
46643584|NCT01278342|82849143|FG001|Overall Study|Physician Decision|1|||
46643585|NCT01278342|82849144|FG002|Overall Study|Physician Decision|0|||
46643586|NCT01278342|82849142|FG000|Overall Study|Lost to Follow-up|1|||
46643587|NCT01278342|82849143|FG001|Overall Study|Lost to Follow-up|0|||
46643588|NCT01278342|82849144|FG002|Overall Study|Lost to Follow-up|0|||
46643589|NCT01278342|82849142|FG000|Overall Study|Administrative problems|2|||
46643590|NCT01278342|82849143|FG001|Overall Study|Administrative problems|0|||
46643591|NCT01278342|82849144|FG002|Overall Study|Administrative problems|0|||
46643592|NCT01278342|82849142|FG000|Overall Study|Other|1|||
46643593|NCT01278342|82849143|FG001|Overall Study|Other|0|||
46643594|NCT01278342|82849144|FG002|Overall Study|Other|0|||
46643595|NCT01278030|82849154|FG000|Overall Study|Withdrawal by Subject|8|||
46643596|NCT01278030|82849155|FG001|Overall Study|Withdrawal by Subject|4|||
46643597|NCT01277718|82849161|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
46643598|NCT01277718|82849162|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
46643599|NCT01277718|82849161|FG000|Period 2 - Second Intervention|Physician Decision|0|||
46643600|NCT01277718|82849162|FG001|Period 2 - Second Intervention|Physician Decision|2|||
46643601|NCT01276236|82849170|FG000|Overall Study|Lack of Efficacy|2|||
46643602|NCT01276236|82849170|FG000|Overall Study|Withdrawal by Subject|4|||
46643603|NCT01275222|82849180|FG000|Phase l by Treatment|Adverse Event|1|||
46643604|NCT01275222|82849181|FG001|Phase l by Treatment|Adverse Event|4|||
46643605|NCT01275222|82849182|FG002|Phase l by Treatment|Adverse Event|2|||
46643606|NCT01275222|82849183|FG003|Phase l by Treatment|Adverse Event|3|||
46643607|NCT01275222|82849184|FG004|Phase l by Treatment|Adverse Event|0|||
46643608|NCT01275222|82849185|FG005|Phase l by Treatment|Adverse Event|0|||
46643609|NCT01275222|82849180|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
46643610|NCT01275222|82849181|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
46643611|NCT01275222|82849182|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
46643612|NCT01275222|82849183|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
46643613|NCT01275222|82849184|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
46643614|NCT01275222|82849185|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
46643615|NCT01275222|82849180|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
46643616|NCT01275222|82849181|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
46643617|NCT01275222|82849182|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
46643618|NCT01275222|82849183|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
46643619|NCT01275222|82849184|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
46643620|NCT01275222|82849185|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
46643621|NCT01275222|82849180|FG000|Phase l by Treatment|Disease progression|12|||
46643622|NCT01275222|82849181|FG001|Phase l by Treatment|Disease progression|8|||
46643623|NCT01275222|82849182|FG002|Phase l by Treatment|Disease progression|2|||
46643624|NCT01275222|82849183|FG003|Phase l by Treatment|Disease progression|5|||
46643625|NCT01275222|82849184|FG004|Phase l by Treatment|Disease progression|0|||
46643626|NCT01275222|82849185|FG005|Phase l by Treatment|Disease progression|0|||
46643627|NCT01275222|82849180|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
46643628|NCT01275222|82849181|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
46643629|NCT01275222|82849182|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
46643630|NCT01275222|82849183|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
46779063|NCT00424255|82997639|FG000|Overall Study|Withdrawal by Subject|34|||
46779064|NCT00424255|82997640|FG001|Overall Study|Withdrawal by Subject|38|||
46779065|NCT00424255|82997639|FG000|Overall Study|Physician Decision|3|||
46779066|NCT00424255|82997640|FG001|Overall Study|Physician Decision|7|||
46779067|NCT00424255|82997639|FG000|Overall Study|Cognitive Disturbance|1|||
46779068|NCT00424255|82997640|FG001|Overall Study|Cognitive Disturbance|0|||
46850161|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46643631|NCT01275222|82849184|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
46643632|NCT01275222|82849185|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
46643633|NCT01275222|82849180|FG000|Phase l by Treatment|Death|0|||
46643634|NCT01275222|82849181|FG001|Phase l by Treatment|Death|1|||
46643635|NCT01275222|82849182|FG002|Phase l by Treatment|Death|0|||
46643636|NCT01275222|82849183|FG003|Phase l by Treatment|Death|1|||
46779069|NCT00424255|82997639|FG000|Overall Study|Non-compliance by Participants|1|||
46643637|NCT01275222|82849184|FG004|Phase l by Treatment|Death|0|||
46643638|NCT01275222|82849185|FG005|Phase l by Treatment|Death|0|||
46643639|NCT01275222|82849180|FG000|Phase ll by Stratum|Adverse Event|0|||
46643640|NCT01275222|82849181|FG001|Phase ll by Stratum|Adverse Event|0|||
46643641|NCT01275222|82849182|FG002|Phase ll by Stratum|Adverse Event|0|||
46850162|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850163|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850164|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850165|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850166|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850167|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850168|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850169|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850170|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850171|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850172|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850173|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850174|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850175|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850176|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
46850177|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850178|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850179|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850180|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
47074174|NCT02400671|83365914|FG000|Overall Study|Withdrawal by Subject|2|||
46643642|NCT01275222|82849183|FG003|Phase ll by Stratum|Adverse Event|0|||
46643643|NCT01275222|82849184|FG004|Phase ll by Stratum|Adverse Event|2|||
46643644|NCT01275222|82849185|FG005|Phase ll by Stratum|Adverse Event|10|||
47074175|NCT02400671|83365915|FG001|Overall Study|Withdrawal by Subject|2|||
47074176|NCT02400671|83365916|FG002|Overall Study|Withdrawal by Subject|0|||
47074177|NCT00089999|83365926|FG000|Overall Study|Adverse Event|4|||
47074178|NCT00089999|83365927|FG001|Overall Study|Adverse Event|7|||
47074179|NCT00089999|83365926|FG000|Overall Study|Withdrawal by Subject|0|||
47074180|NCT00089999|83365927|FG001|Overall Study|Withdrawal by Subject|4|||
47074181|NCT00089999|83365926|FG000|Overall Study|Lost to Follow-up|2|||
47074182|NCT00089999|83365927|FG001|Overall Study|Lost to Follow-up|1|||
47074183|NCT00089999|83365926|FG000|Overall Study|Radiological Progression of Cancer|52|||
47074184|NCT00089999|83365927|FG001|Overall Study|Radiological Progression of Cancer|44|||
47074185|NCT00089999|83365926|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
47074186|NCT00089999|83365927|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
47074187|NCT00089999|83365926|FG000|Overall Study|Death|3|||
47074188|NCT00089999|83365927|FG001|Overall Study|Death|3|||
47074189|NCT00089999|83365926|FG000|Overall Study|Poor General Condition|1|||
47074190|NCT00089999|83365927|FG001|Overall Study|Poor General Condition|0|||
47074191|NCT00089999|83365926|FG000|Overall Study|Clinical Progression|1|||
47074192|NCT00089999|83365927|FG001|Overall Study|Clinical Progression|2|||
47074193|NCT00089999|83365926|FG000|Overall Study|Physician Decision|2|||
47074194|NCT00089999|83365927|FG001|Overall Study|Physician Decision|2|||
47074195|NCT00089999|83365926|FG000|Overall Study|Patient Underwent Surgery|2|||
47074196|NCT00089999|83365927|FG001|Overall Study|Patient Underwent Surgery|0|||
47074197|NCT00089999|83365926|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
47074198|NCT00089999|83365927|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
47074199|NCT00089843|83365938|FG000|Overall Study|Withdrawal by Subject|1|||
47074200|NCT00089843|83365939|FG001|Overall Study|Withdrawal by Subject|4|||
47074201|NCT00089843|83365940|FG002|Overall Study|Withdrawal by Subject|5|||
47074202|NCT00089843|83365941|FG003|Overall Study|Withdrawal by Subject|6|||
47074203|NCT00089843|83365938|FG000|Overall Study|Physician Decision|1|||
47074204|NCT00089843|83365939|FG001|Overall Study|Physician Decision|0|||
47074205|NCT00089843|83365940|FG002|Overall Study|Physician Decision|0|||
47074206|NCT00089843|83365941|FG003|Overall Study|Physician Decision|1|||
47074207|NCT00089297|83365951|FG000|Overall Study|Adverse Event|9|||
47074208|NCT00089297|83365951|FG000|Overall Study|Death|1|||
47074209|NCT00089297|83365951|FG000|Overall Study|Withdrawal by Subject|12|||
47074210|NCT00089297|83365951|FG000|Overall Study|Disease progression|2|||
47074211|NCT00089297|83365951|FG000|Overall Study|Ineligible|11|||
47074212|NCT00089297|83365951|FG000|Overall Study|Secondary malignancy|1|||
47074213|NCT00089297|83365951|FG000|Overall Study|IRB approval not ready|1|||
47074214|NCT00089297|83365951|FG000|Overall Study|Non-compliance|1|||
47074215|NCT00088907|83365993|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
47074216|NCT00088907|83365994|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
47074217|NCT00088907|83365993|FG000|Randomized Study (Step 1)|Adverse Event|14|||
47074218|NCT00088907|83365994|FG001|Randomized Study (Step 1)|Adverse Event|19|||
47074219|NCT00088907|83365993|FG000|Randomized Study (Step 1)|Death|11|||
46643645|NCT01275222|82849180|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
46643646|NCT01275222|82849181|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
46643647|NCT01275222|82849182|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
46643648|NCT01275222|82849183|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
46643649|NCT01275222|82849184|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
46643650|NCT01275222|82849185|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
46643651|NCT01275222|82849180|FG000|Phase ll by Stratum|Disease progression|0|||
46643652|NCT01275222|82849181|FG001|Phase ll by Stratum|Disease progression|0|||
46643653|NCT01275222|82849182|FG002|Phase ll by Stratum|Disease progression|0|||
46643654|NCT01275222|82849183|FG003|Phase ll by Stratum|Disease progression|0|||
46643655|NCT01275222|82849184|FG004|Phase ll by Stratum|Disease progression|23|||
46643656|NCT01275222|82849185|FG005|Phase ll by Stratum|Disease progression|31|||
46643657|NCT01275222|82849180|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
46643658|NCT01275222|82849181|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
46643659|NCT01275222|82849182|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
46643660|NCT01275222|82849183|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
46643661|NCT01275222|82849184|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
46643662|NCT01275222|82849185|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
46643663|NCT01275222|82849180|FG000|Phase ll by Stratum|Death|0|||
46643664|NCT01275222|82849181|FG001|Phase ll by Stratum|Death|0|||
46643665|NCT01275222|82849182|FG002|Phase ll by Stratum|Death|0|||
46643666|NCT01275222|82849183|FG003|Phase ll by Stratum|Death|0|||
46643667|NCT01275222|82849184|FG004|Phase ll by Stratum|Death|1|||
46643668|NCT01275222|82849185|FG005|Phase ll by Stratum|Death|1|||
46643669|NCT01275144|82849203|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
46643670|NCT01275144|82849204|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
46643671|NCT01275066|82849215|FG000|Overall Study|Withdrawal by Subject|0|||
46643672|NCT01275066|82849216|FG001|Overall Study|Withdrawal by Subject|0|||
46643673|NCT01275066|82849217|FG002|Overall Study|Withdrawal by Subject|1|||
46643674|NCT01275066|82849215|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
46643675|NCT01275066|82849216|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
46643676|NCT01275066|82849217|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
46643677|NCT01273038|82849227|FG000|Second Intervention (14 Days)|Adverse Event|0|||
46643678|NCT01273038|82849228|FG001|Second Intervention (14 Days)|Adverse Event|1|||
46643679|NCT01273038|82849227|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
46643680|NCT01273038|82849228|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
46643681|NCT01272180|82849238|FG000|Overall Study|Adverse Event|0|||
46643682|NCT01272180|82849239|FG001|Overall Study|Adverse Event|0|||
46643683|NCT01272180|82849240|FG002|Overall Study|Adverse Event|1|||
46643684|NCT01272180|82849241|FG003|Overall Study|Adverse Event|0|||
46643685|NCT01272180|82849238|FG000|Overall Study|Withdrawal by Subject|2|||
46643686|NCT01272180|82849239|FG001|Overall Study|Withdrawal by Subject|6|||
46643687|NCT01272180|82849240|FG002|Overall Study|Withdrawal by Subject|3|||
46643688|NCT01272180|82849241|FG003|Overall Study|Withdrawal by Subject|2|||
46643689|NCT01272180|82849238|FG000|Overall Study|Lost to Follow-up|15|||
46643690|NCT01272180|82849239|FG001|Overall Study|Lost to Follow-up|14|||
46969867|NCT02576145|83212766|FG000|Overall Study|Adverse Event|1|||
46643691|NCT01272180|82849240|FG002|Overall Study|Lost to Follow-up|8|||
46643692|NCT01272180|82849241|FG003|Overall Study|Lost to Follow-up|10|||
46643693|NCT01272180|82849238|FG000|Overall Study|Inappropriate enrollment|0|||
46643694|NCT01272180|82849239|FG001|Overall Study|Inappropriate enrollment|0|||
46643695|NCT01272180|82849240|FG002|Overall Study|Inappropriate enrollment|1|||
46643696|NCT01272180|82849241|FG003|Overall Study|Inappropriate enrollment|1|||
46643697|NCT01272180|82849238|FG000|Overall Study|Protocol Violation|0|||
46643698|NCT01272180|82849239|FG001|Overall Study|Protocol Violation|1|||
46643699|NCT01272180|82849240|FG002|Overall Study|Protocol Violation|0|||
46643700|NCT01272180|82849241|FG003|Overall Study|Protocol Violation|1|||
46643701|NCT01271712|82849257|FG000|Double Blind Treatment|Death|2|||
46643702|NCT01271712|82849258|FG001|Double Blind Treatment|Death|0|||
46643703|NCT01271712|82849257|FG000|Double Blind Treatment|Lack of Efficacy|1|||
46643704|NCT01271712|82849258|FG001|Double Blind Treatment|Lack of Efficacy|0|||
46643705|NCT01271712|82849257|FG000|Double Blind Treatment|Adverse Event|9|||
46643706|NCT01271712|82849258|FG001|Double Blind Treatment|Adverse Event|4|||
46643707|NCT01271712|82849257|FG000|Double Blind Treatment|Progressive disease|23|||
46643708|NCT01271712|82849258|FG001|Double Blind Treatment|Progressive disease|3|||
46643709|NCT01271712|82849257|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
46643710|NCT01271712|82849258|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
46643711|NCT01271712|82849257|FG000|Double Blind Treatment|Non compliance with study drug|2|||
46643712|NCT01271712|82849258|FG001|Double Blind Treatment|Non compliance with study drug|0|||
46643713|NCT01271712|82849257|FG000|Double Blind Treatment|receive no study drug|1|||
46643714|NCT01271712|82849258|FG001|Double Blind Treatment|receive no study drug|0|||
46643715|NCT01271712|82849257|FG000|Open Label Treatment|Death|6|||
46850181|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850182|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850183|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850184|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850185|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850186|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
46850187|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850188|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850189|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850190|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850191|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850192|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
46969868|NCT02576145|83212767|FG001|Overall Study|Adverse Event|0|||
46969869|NCT02576145|83212766|FG000|Overall Study|Withdrawal by Subject|1|||
46969870|NCT02576145|83212767|FG001|Overall Study|Withdrawal by Subject|0|||
46643716|NCT01271712|82849258|FG001|Open Label Treatment|Death|5|||
46969871|NCT02576145|83212766|FG000|Overall Study|Acute rejection|1|||
46969872|NCT02576145|83212767|FG001|Overall Study|Acute rejection|0|||
46969873|NCT02576145|83212766|FG000|Overall Study|Tetanus Titers Decreased|0|||
46969874|NCT02576145|83212767|FG001|Overall Study|Tetanus Titers Decreased|1|||
46969875|NCT02576067|83212812|FG000|Overall Study|Death|0|||
46969876|NCT02576067|83212813|FG001|Overall Study|Death|1|||
47074220|NCT00088907|83365994|FG001|Randomized Study (Step 1)|Death|12|||
47074221|NCT00088907|83365993|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
47074222|NCT00088907|83365994|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
47074223|NCT00088907|83365993|FG000|Randomized Study (Step 1)|complicating disease|3|||
47074224|NCT00088907|83365994|FG001|Randomized Study (Step 1)|complicating disease|1|||
47074225|NCT00088907|83365993|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
47074226|NCT00088907|83365994|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
47074227|NCT00088907|83365993|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
46643717|NCT01271712|82849257|FG000|Open Label Treatment|Withdrawal by Subject|6|||
46643718|NCT01271712|82849258|FG001|Open Label Treatment|Withdrawal by Subject|11|||
46643719|NCT01271712|82849257|FG000|Open Label Treatment|Physician Decision|2|||
46643720|NCT01271712|82849258|FG001|Open Label Treatment|Physician Decision|0|||
46779070|NCT00424255|82997640|FG001|Overall Study|Non-compliance by Participants|0|||
46643721|NCT01271712|82849257|FG000|Open Label Treatment|Adverse Event|14|||
46779071|NCT00424255|82997639|FG000|Overall Study|Fatigue|1|||
46779072|NCT00424255|82997640|FG001|Overall Study|Fatigue|0|||
46779073|NCT00424255|82997639|FG000|Overall Study|Disease Progression|0|||
46779074|NCT00424255|82997640|FG001|Overall Study|Disease Progression|2|||
46779075|NCT00424255|82997639|FG000|Overall Study|Sponsor Terminated Study|161|||
46779076|NCT00424255|82997640|FG001|Overall Study|Sponsor Terminated Study|167|||
46969877|NCT02576067|83212812|FG000|Overall Study|Lack of Efficacy|1|||
46969878|NCT02576067|83212813|FG001|Overall Study|Lack of Efficacy|0|||
46969879|NCT02576067|83212812|FG000|Overall Study|Lost to Follow-up|11|||
46969880|NCT02576067|83212813|FG001|Overall Study|Lost to Follow-up|0|||
46969881|NCT02576067|83212812|FG000|Overall Study|Withdrawal by Subject|11|||
46969882|NCT02576067|83212813|FG001|Overall Study|Withdrawal by Subject|2|||
46643722|NCT01271712|82849258|FG001|Open Label Treatment|Adverse Event|8|||
46643723|NCT01271712|82849257|FG000|Open Label Treatment|Progressive disease|59|||
46643724|NCT01271712|82849258|FG001|Open Label Treatment|Progressive disease|32|||
46779077|NCT00620074|82997646|FG000|Overall Study|Adverse Event|1|||
46779078|NCT00424177|82997650|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
46779079|NCT00424177|82997650|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
46969883|NCT02576067|83212812|FG000|Overall Study|study closure of main CIRT trial)|0|||
47074228|NCT00088907|83365994|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
46643725|NCT01271712|82849257|FG000|Open Label Treatment|transferred to rollover study|1|||
46643726|NCT01271712|82849258|FG001|Open Label Treatment|transferred to rollover study|0|||
46643727|NCT01271712|82849257|FG000|Open Label Treatment|Non-compliance with study drug|1|||
46643728|NCT01271712|82849258|FG001|Open Label Treatment|Non-compliance with study drug|0|||
46643729|NCT01271712|82849257|FG000|Open Label Treatment|Protocol Violation|0|||
46643730|NCT01271712|82849258|FG001|Open Label Treatment|Protocol Violation|1|||
46643731|NCT01271712|82849257|FG000|Open Label Treatment|Switching to other therapy|2|||
46643732|NCT01271712|82849258|FG001|Open Label Treatment|Switching to other therapy|1|||
46643733|NCT01271712|82849257|FG000|Safety Follow-up|Death|11|||
46643734|NCT01271712|82849258|FG001|Safety Follow-up|Death|7|||
46643735|NCT01271712|82849257|FG000|Safety Follow-up|Withdrawal by Subject|4|||
46643736|NCT01271712|82849258|FG001|Safety Follow-up|Withdrawal by Subject|2|||
46643737|NCT01271712|82849257|FG000|Safety Follow-up|Protocol Violation|1|||
46643738|NCT01271712|82849258|FG001|Safety Follow-up|Protocol Violation|1|||
46643739|NCT01271712|82849257|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
46643740|NCT01271712|82849258|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
46643741|NCT01271712|82849257|FG000|Safety Follow-up|No follow-up|1|||
46643742|NCT01271712|82849258|FG001|Safety Follow-up|No follow-up|1|||
46643743|NCT01271712|82849257|FG000|Safety Follow-up|Progressive disease|1|||
46643744|NCT01271712|82849258|FG001|Safety Follow-up|Progressive disease|0|||
46643745|NCT01271712|82849257|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
46643746|NCT01271712|82849258|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
46643747|NCT01271010|82849267|FG000|Overall Study|Reason not specified|11|||
46643748|NCT01271010|82849267|FG000|Overall Study|Start of new CLL therapy|1|||
46643749|NCT01271010|82849267|FG000|Overall Study|Protocol Violation|1|||
46643750|NCT01271010|82849267|FG000|Overall Study|Death|2|||
46643751|NCT01271010|82849267|FG000|Overall Study|Progression and relapse of disease|1|||
46643752|NCT01271010|82849267|FG000|Overall Study|Withdrawal by Subject|18|||
46643753|NCT01271010|82849267|FG000|Overall Study|Disease progression|27|||
46643754|NCT01270620|82849273|FG000|Overall Study|Withdrawal by Subject|1|||
46643755|NCT01270620|82849274|FG001|Overall Study|Withdrawal by Subject|3|||
46643756|NCT01270464|82849289|FG000|Overall Study|Protocol Violation|4|||
46643757|NCT01270464|82849290|FG001|Overall Study|Protocol Violation|3|||
46643758|NCT01270464|82849291|FG002|Overall Study|Protocol Violation|2|||
46643759|NCT01270464|82849289|FG000|Overall Study|Lack of Efficacy|2|||
46643760|NCT01270464|82849290|FG001|Overall Study|Lack of Efficacy|3|||
46643761|NCT01270464|82849291|FG002|Overall Study|Lack of Efficacy|1|||
46643762|NCT01270464|82849289|FG000|Overall Study|Adverse Event|9|||
46643763|NCT01270464|82849290|FG001|Overall Study|Adverse Event|1|||
46643764|NCT01270464|82849291|FG002|Overall Study|Adverse Event|7|||
46643765|NCT01270464|82849289|FG000|Overall Study|Withdrawal by Subject|2|||
46643766|NCT01270464|82849290|FG001|Overall Study|Withdrawal by Subject|1|||
46643767|NCT01270464|82849291|FG002|Overall Study|Withdrawal by Subject|4|||
46643768|NCT01270464|82849289|FG000|Overall Study|Lost to Follow-up|2|||
46643769|NCT01270464|82849290|FG001|Overall Study|Lost to Follow-up|3|||
46643770|NCT01270464|82849291|FG002|Overall Study|Lost to Follow-up|1|||
46643771|NCT01270464|82849289|FG000|Overall Study|Other|1|||
46643772|NCT01270464|82849290|FG001|Overall Study|Other|1|||
46643773|NCT01270464|82849291|FG002|Overall Study|Other|3|||
46850193|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850194|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850195|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
46779080|NCT00424177|82997650|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
46779081|NCT00424177|82997650|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
46779082|NCT00424177|82997650|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
46779083|NCT00424177|82997650|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
46779084|NCT00424177|82997650|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
46779085|NCT00424177|82997650|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
46779086|NCT00424177|82997650|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
46779087|NCT00424177|82997650|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
46850196|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
47074229|NCT00088907|83365993|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
47074230|NCT00088907|83365994|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
47074231|NCT00088907|83365993|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
47074232|NCT00088907|83365994|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
47074233|NCT00088907|83365993|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
47074234|NCT00088907|83365994|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
47074235|NCT00088907|83365993|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
47074236|NCT00088907|83365994|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
47074237|NCT00088829|83366001|FG000|Overall Study|PI left institution and study was close|22|||
47074238|NCT00088595|83366005|FG000|Overall Study|Adverse Event|11|||
47074239|NCT00088595|83366005|FG000|Overall Study|Withdrawal by Subject|8|||
47074240|NCT00088595|83366005|FG000|Overall Study|Ongoing (After Core)|7|||
47074241|NCT00088595|83366005|FG000|Overall Study|New Cancer Therapy|2|||
47074242|NCT00088205|83366019|FG000|Overall Study|Adverse Event|4|||
47074243|NCT00088205|83366019|FG000|Overall Study|Progressive Disease|51|||
47074244|NCT00088205|83366019|FG000|Overall Study|Physician Decision|1|||
47074245|NCT00088205|83366019|FG000|Overall Study|Death Due to Study Disease|4|||
47074246|NCT00085709|83366113|FG000|Overall Study|Adverse Event|8|||
47074247|NCT00085709|83366114|FG001|Overall Study|Adverse Event|0|||
47074248|NCT00085709|83366113|FG000|Overall Study|Death|8|||
47074249|NCT00085709|83366114|FG001|Overall Study|Death|2|||
47074250|NCT00085709|83366113|FG000|Overall Study|Refusal unrelated to adverse events|1|||
47074251|NCT00085709|83366114|FG001|Overall Study|Refusal unrelated to adverse events|2|||
47074252|NCT00085709|83366113|FG000|Overall Study|Progression|3|||
47074253|NCT00085709|83366114|FG001|Overall Study|Progression|4|||
47074254|NCT00085709|83366113|FG000|Overall Study|Not protocol specified|12|||
47074255|NCT00085709|83366114|FG001|Overall Study|Not protocol specified|22|||
47074256|NCT00085709|83366113|FG000|Overall Study|Not eligible|19|||
47074257|NCT00085709|83366114|FG001|Overall Study|Not eligible|19|||
47074258|NCT00085709|83366113|FG000|Overall Study|Withdrawal by Subject|2|||
47074259|NCT00085709|83366114|FG001|Overall Study|Withdrawal by Subject|1|||
47074260|NCT00085631|83366149|FG000|Overall Study|Missing Data|4|||
47074261|NCT00085631|83366150|FG001|Overall Study|Missing Data|11|||
47074262|NCT00085631|83366151|FG002|Overall Study|Missing Data|7|||
47074263|NCT00084929|83366167|FG000|Overall Study|ineligible - medical contraindication|1|||
47074264|NCT00084929|83366167|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
47074265|NCT00084929|83366167|FG000|Overall Study|Ineligible - Medical history|6|||
47074266|NCT00084929|83366167|FG000|Overall Study|Withdrawal by Subject|10|||
47074267|NCT00084929|83366167|FG000|Overall Study|Missing/incomplete CTC exam|9|||
46643774|NCT00249834|82849307|FG000|Overall Study|Ovarian stimulation failed|1|||
46643775|NCT00249834|82849308|FG001|Overall Study|Ovarian stimulation failed|0|||
46643776|NCT00249834|82849309|FG002|Overall Study|Ovarian stimulation failed|0|||
46643777|NCT00249834|82849310|FG003|Overall Study|Ovarian stimulation failed|0|||
46643778|NCT00249834|82849311|FG004|Overall Study|Ovarian stimulation failed|0|||
46643779|NCT00249834|82849312|FG005|Overall Study|Ovarian stimulation failed|0|||
46643780|NCT00249834|82849313|FG006|Overall Study|Ovarian stimulation failed|0|||
46643781|NCT00249834|82849314|FG007|Overall Study|Ovarian stimulation failed|0|||
46643782|NCT00249834|82849307|FG000|Overall Study|Failure of down-regulation|0|||
46643783|NCT00249834|82849308|FG001|Overall Study|Failure of down-regulation|0|||
46643784|NCT00249834|82849309|FG002|Overall Study|Failure of down-regulation|0|||
46643785|NCT00249834|82849310|FG003|Overall Study|Failure of down-regulation|0|||
46643786|NCT00249834|82849311|FG004|Overall Study|Failure of down-regulation|0|||
46643787|NCT00249834|82849312|FG005|Overall Study|Failure of down-regulation|0|||
46643788|NCT00249834|82849313|FG006|Overall Study|Failure of down-regulation|1|||
46643789|NCT00249834|82849314|FG007|Overall Study|Failure of down-regulation|0|||
46643790|NCT00249834|82849307|FG000|Overall Study|Protocol Violation|0|||
46643791|NCT00249834|82849308|FG001|Overall Study|Protocol Violation|19|||
46643792|NCT00249834|82849309|FG002|Overall Study|Protocol Violation|14|||
46643793|NCT00249834|82849310|FG003|Overall Study|Protocol Violation|8|||
46643794|NCT00249834|82849311|FG004|Overall Study|Protocol Violation|5|||
46643795|NCT00249834|82849312|FG005|Overall Study|Protocol Violation|2|||
46643796|NCT00249834|82849313|FG006|Overall Study|Protocol Violation|0|||
46643797|NCT00249834|82849314|FG007|Overall Study|Protocol Violation|0|||
46643798|NCT00249444|82849328|FG000|Overall Study|Lost to Follow-up|2|||
46643799|NCT00249444|82849329|FG001|Overall Study|Lost to Follow-up|2|||
46643800|NCT00249444|82849328|FG000|Overall Study|non-compliant|9|||
46643801|NCT00249444|82849329|FG001|Overall Study|non-compliant|11|||
46643802|NCT00249444|82849328|FG000|Overall Study|Adverse Event|1|||
46643803|NCT00249444|82849329|FG001|Overall Study|Adverse Event|1|||
46643804|NCT00249444|82849328|FG000|Overall Study|life event|0|||
46643805|NCT00249444|82849329|FG001|Overall Study|life event|1|||
46643806|NCT00249288|82849337|FG000|Overall Study|Lost to Follow-up|3|||
46643807|NCT00249288|82849338|FG001|Overall Study|Lost to Follow-up|3|||
46643808|NCT00249288|82849337|FG000|Overall Study|Withdrawal by Subject|2|||
46643809|NCT00249288|82849338|FG001|Overall Study|Withdrawal by Subject|2|||
46643810|NCT00247962|82849354|FG000|Overall Study|Adverse Event|15|||
46643811|NCT00247962|82849355|FG001|Overall Study|Adverse Event|12|||
47074268|NCT00084929|83366167|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
46643812|NCT00247962|82849354|FG000|Overall Study|Lost to Follow-up|3|||
46643813|NCT00247962|82849355|FG001|Overall Study|Lost to Follow-up|1|||
46643814|NCT00247962|82849354|FG000|Overall Study|Physician Decision|0|||
46643815|NCT00247962|82849355|FG001|Overall Study|Physician Decision|1|||
46779088|NCT00618826|82997662|FG000|Overall Study|Adverse Event|1|||
46779089|NCT00578448|82997667|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
46779090|NCT00578448|82997667|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
46779091|NCT00578448|82997667|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
46779092|NCT00578448|82997667|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
46779093|NCT00578318|82997675|FG000|Overall Study|Lost to Follow-up|2|||
46779094|NCT00578318|82997676|FG001|Overall Study|Lost to Follow-up|0|||
46850197|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850198|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850199|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850200|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850201|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
46850202|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
47074269|NCT00084617|83366225|FG000|Overall Study|Withdrawal by Subject|7|||
47074270|NCT00084617|83366225|FG000|Overall Study|Lack of Efficacy|1|||
47074271|NCT00084617|83366225|FG000|Overall Study|Protocol Violation|1|||
46643816|NCT00247962|82849354|FG000|Overall Study|Protocol Violation|1|||
46643817|NCT00247962|82849355|FG001|Overall Study|Protocol Violation|1|||
46779095|NCT00578318|82997675|FG000|Overall Study|Physician Decision|1|||
46779096|NCT00578318|82997676|FG001|Overall Study|Physician Decision|0|||
46779097|NCT00618748|82997685|FG000|Overall Study|Adverse Event|4|||
46779098|NCT00618748|82997686|FG001|Overall Study|Adverse Event|3|||
46779099|NCT00618748|82997687|FG002|Overall Study|Adverse Event|8|||
46850203|NCT00112437|83066363|FG000|Year 2 (12-Month Extension)|Moved|0|||
46850204|NCT00112437|83066364|FG001|Year 2 (12-Month Extension)|Moved|0|||
47074272|NCT00083915|83366319|FG000|Overall Study|Death|6|||
47074273|NCT00083915|83366320|FG001|Overall Study|Death|3|||
46643818|NCT00247962|82849354|FG000|Overall Study|Withdrawal by Subject|3|||
46643819|NCT00247962|82849355|FG001|Overall Study|Withdrawal by Subject|2|||
46643820|NCT00247962|82849354|FG000|Overall Study|Lack of Efficacy|4|||
46643821|NCT00247962|82849355|FG001|Overall Study|Lack of Efficacy|2|||
46643822|NCT00247416|82849363|FG000|Overall Study|3 patients were found to be ineligible|1|||
46643823|NCT00247416|82849364|FG001|Overall Study|3 patients were found to be ineligible|2|||
46779100|NCT00618748|82997685|FG000|Overall Study|Physician Decision|3|||
46969884|NCT02576067|83212813|FG001|Overall Study|study closure of main CIRT trial)|8|||
46969885|NCT02576067|83212812|FG000|Overall Study|not randomized, failed run-in|7|||
46969886|NCT02576067|83212813|FG001|Overall Study|not randomized, failed run-in|0|||
46969887|NCT02576067|83212812|FG000|Overall Study|screen failure/ re-enrolled|0|||
46969888|NCT02576067|83212813|FG001|Overall Study|screen failure/ re-enrolled|25|||
46969889|NCT02576067|83212812|FG000|Overall Study|Physician Decision|4|||
46969890|NCT02576067|83212813|FG001|Overall Study|Physician Decision|0|||
46969891|NCT02575911|83212819|FG000|Overall Study|Lost to Follow-up|1|||
46969892|NCT02575833|83212833|FG000|Overall Study|Withdrawal by Subject|0|||
46969893|NCT02575833|83212834|FG001|Overall Study|Withdrawal by Subject|1|||
46969894|NCT02575833|83212833|FG000|Overall Study|Lost to Follow-up|1|||
46969895|NCT02575833|83212834|FG001|Overall Study|Lost to Follow-up|0|||
46969896|NCT02709083|83212840|FG000|Overall Study|Original PI left institution|7|||
46969897|NCT02709005|83212846|FG000|Overall Study|Lost to Follow-up|1|||
46969898|NCT02709005|83212847|FG001|Overall Study|Lost to Follow-up|1|||
46969899|NCT02709005|83212846|FG000|Overall Study|Withdrawal by Subject|3|||
46969900|NCT02709005|83212847|FG001|Overall Study|Withdrawal by Subject|0|||
46850205|NCT00112437|83066365|FG002|Year 2 (12-Month Extension)|Moved|0|||
46850206|NCT00112437|83066366|FG003|Year 2 (12-Month Extension)|Moved|0|||
46969901|NCT02573883|83212855|FG000|Six Month Follow Up|Lost to Follow-up|1|||
46969902|NCT02573883|83212856|FG001|Six Month Follow Up|Lost to Follow-up|0|||
46969903|NCT02573883|83212857|FG002|Six Month Follow Up|Lost to Follow-up|0|||
47074274|NCT00083915|83366319|FG000|Overall Study|Physician Decision|11|||
47074275|NCT00083915|83366320|FG001|Overall Study|Physician Decision|6|||
47074276|NCT00083915|83366319|FG000|Overall Study|Withdrawal by Subject|8|||
46779101|NCT00618748|82997686|FG001|Overall Study|Physician Decision|1|||
46779102|NCT00618748|82997687|FG002|Overall Study|Physician Decision|1|||
46779103|NCT00618748|82997685|FG000|Overall Study|Withdrawal by Subject|4|||
46779104|NCT00618748|82997686|FG001|Overall Study|Withdrawal by Subject|1|||
46779105|NCT00618748|82997687|FG002|Overall Study|Withdrawal by Subject|5|||
46779106|NCT00658359|82997698|FG000|Overall Study|Death|3|||
46779107|NCT00658359|82997699|FG001|Overall Study|Death|1|||
46779108|NCT00658359|82997700|FG002|Overall Study|Death|2|||
46779109|NCT00658359|82997698|FG000|Overall Study|Adverse Event|13|||
46779110|NCT00658359|82997699|FG001|Overall Study|Adverse Event|6|||
46779111|NCT00658359|82997700|FG002|Overall Study|Adverse Event|9|||
46779112|NCT00658359|82997698|FG000|Overall Study|Protocol Violation|1|||
46779113|NCT00658359|82997699|FG001|Overall Study|Protocol Violation|0|||
46779114|NCT00658359|82997700|FG002|Overall Study|Protocol Violation|0|||
46779115|NCT00658359|82997698|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
46779116|NCT00658359|82997699|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
46779117|NCT00658359|82997700|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
46779118|NCT00658359|82997698|FG000|Overall Study|Withdrawal by Subject|7|||
46779119|NCT00658359|82997699|FG001|Overall Study|Withdrawal by Subject|4|||
46779120|NCT00658359|82997700|FG002|Overall Study|Withdrawal by Subject|2|||
46779121|NCT00658359|82997698|FG000|Overall Study|Lost to Follow-up|2|||
46779122|NCT00658359|82997699|FG001|Overall Study|Lost to Follow-up|2|||
46850207|NCT00112437|83066367|FG004|Year 2 (12-Month Extension)|Moved|0|||
46850208|NCT00112437|83066368|FG005|Year 2 (12-Month Extension)|Moved|0|||
46850209|NCT00112437|83066369|FG006|Year 2 (12-Month Extension)|Moved|0|||
46850210|NCT00112437|83066370|FG007|Year 2 (12-Month Extension)|Moved|0|||
46850211|NCT00112437|83066371|FG008|Year 2 (12-Month Extension)|Moved|0|||
46850212|NCT00112437|83066372|FG009|Year 2 (12-Month Extension)|Moved|1|||
46850213|NCT00112437|83066373|FG010|Year 2 (12-Month Extension)|Moved|0|||
46850214|NCT00112437|83066374|FG011|Year 2 (12-Month Extension)|Moved|0|||
46850215|NCT00112437|83066375|FG012|Year 2 (12-Month Extension)|Moved|0|||
46850216|NCT00112437|83066376|FG013|Year 2 (12-Month Extension)|Moved|0|||
46850217|NCT00112437|83066377|FG014|Year 2 (12-Month Extension)|Moved|0|||
46779123|NCT00658359|82997700|FG002|Overall Study|Lost to Follow-up|4|||
46779124|NCT00658359|82997698|FG000|Overall Study|Lack of Efficacy|0|||
46779125|NCT00658359|82997699|FG001|Overall Study|Lack of Efficacy|1|||
46779126|NCT00658359|82997700|FG002|Overall Study|Lack of Efficacy|0|||
46779127|NCT00619918|82997712|FG000|Overall Study|Withdrawal by Subject|4|||
46779128|NCT00619918|82997713|FG001|Overall Study|Withdrawal by Subject|3|||
46779129|NCT00619918|82997712|FG000|Overall Study|Physician Decision|8|||
46779130|NCT00619918|82997713|FG001|Overall Study|Physician Decision|8|||
46850218|NCT00112437|83066378|FG015|Year 2 (12-Month Extension)|Moved|0|||
46850219|NCT00112437|83066379|FG016|Year 2 (12-Month Extension)|Moved|0|||
46850220|NCT00112437|83066380|FG017|Year 2 (12-Month Extension)|Moved|0|||
46969904|NCT02573883|83212858|FG003|Six Month Follow Up|Lost to Follow-up|0|||
46969905|NCT02573883|83212855|FG000|One Year Follow Up|Lost to Follow-up|2|||
46969906|NCT02573883|83212856|FG001|One Year Follow Up|Lost to Follow-up|1|||
46969907|NCT02573883|83212857|FG002|One Year Follow Up|Lost to Follow-up|0|||
46969908|NCT02573883|83212858|FG003|One Year Follow Up|Lost to Follow-up|0|||
46969909|NCT02575365|83212873|FG000|Overall Study|Lost to Follow-up|4|||
46969910|NCT02707991|83212879|FG000|Overall Study|Protocol Violation|1|||
46969911|NCT02707991|83212880|FG001|Overall Study|Protocol Violation|0|||
46969912|NCT02707991|83212879|FG000|Overall Study|Became ineligible|0|||
46643824|NCT00246090|82849372|FG000|Overall Study|Adverse Event|25|||
46643825|NCT00246090|82849372|FG000|Overall Study|Withdrawal by Subject|7|||
46643826|NCT00246090|82849372|FG000|Overall Study|Progressive Disease|212|||
46643827|NCT00246090|82849372|FG000|Overall Study|Clinical Progression|30|||
46643828|NCT00246090|82849372|FG000|Overall Study|Physician Decision|11|||
46643829|NCT00246090|82849372|FG000|Overall Study|Not Otherwise Specified|10|||
46643830|NCT00246012|82849385|FG000|Overall Study|Adverse Event|0|||
46969913|NCT02707991|83212880|FG001|Overall Study|Became ineligible|1|||
46969914|NCT02707757|83212888|FG000|Overall Study|Protocol Violation|3|||
46969915|NCT02707757|83212889|FG001|Overall Study|Protocol Violation|2|||
46643831|NCT00246012|82849386|FG001|Overall Study|Adverse Event|0|||
46643832|NCT00246012|82849387|FG002|Overall Study|Adverse Event|0|||
46643833|NCT00246012|82849388|FG003|Overall Study|Adverse Event|0|||
46643834|NCT00246012|82849389|FG004|Overall Study|Adverse Event|0|||
46643835|NCT00246012|82849390|FG005|Overall Study|Adverse Event|1|||
46643836|NCT00246012|82849391|FG006|Overall Study|Adverse Event|0|||
46643837|NCT00246012|82849392|FG007|Overall Study|Adverse Event|0|||
46643838|NCT00246012|82849393|FG008|Overall Study|Adverse Event|2|||
46643839|NCT00246012|82849385|FG000|Overall Study|Withdrawal by Subject|0|||
46643840|NCT00246012|82849386|FG001|Overall Study|Withdrawal by Subject|0|||
46643841|NCT00246012|82849387|FG002|Overall Study|Withdrawal by Subject|0|||
46643842|NCT00246012|82849388|FG003|Overall Study|Withdrawal by Subject|0|||
46643843|NCT00246012|82849389|FG004|Overall Study|Withdrawal by Subject|0|||
46643844|NCT00246012|82849390|FG005|Overall Study|Withdrawal by Subject|1|||
46643845|NCT00246012|82849391|FG006|Overall Study|Withdrawal by Subject|0|||
46643846|NCT00246012|82849392|FG007|Overall Study|Withdrawal by Subject|0|||
46643847|NCT00246012|82849393|FG008|Overall Study|Withdrawal by Subject|0|||
46643848|NCT00246012|82849385|FG000|Overall Study|Disease progression|3|||
46643849|NCT00246012|82849386|FG001|Overall Study|Disease progression|1|||
46643850|NCT00246012|82849387|FG002|Overall Study|Disease progression|2|||
46643851|NCT00246012|82849388|FG003|Overall Study|Disease progression|3|||
46643852|NCT00246012|82849389|FG004|Overall Study|Disease progression|3|||
46643853|NCT00246012|82849390|FG005|Overall Study|Disease progression|25|||
46643854|NCT00246012|82849391|FG006|Overall Study|Disease progression|30|||
46643855|NCT00246012|82849392|FG007|Overall Study|Disease progression|27|||
46643856|NCT00246012|82849393|FG008|Overall Study|Disease progression|26|||
46643857|NCT00246012|82849385|FG000|Overall Study|Other|0|||
46643858|NCT00246012|82849386|FG001|Overall Study|Other|0|||
46643859|NCT00246012|82849387|FG002|Overall Study|Other|0|||
46969916|NCT02707757|83212888|FG000|Overall Study|Withdrawal by Subject|2|||
46969917|NCT02707757|83212889|FG001|Overall Study|Withdrawal by Subject|0|||
46969918|NCT02707757|83212888|FG000|Overall Study|Death|0|||
46969919|NCT02707757|83212889|FG001|Overall Study|Death|1|||
46969920|NCT02707757|83212888|FG000|Overall Study|Adverse Event|6|||
46969921|NCT02707757|83212889|FG001|Overall Study|Adverse Event|4|||
46969922|NCT02707757|83212888|FG000|Overall Study|Renal transplant/elective operation|1|||
46969923|NCT02707757|83212889|FG001|Overall Study|Renal transplant/elective operation|5|||
46643860|NCT00246012|82849388|FG003|Overall Study|Other|0|||
46850221|NCT00112437|83066381|FG018|Year 2 (12-Month Extension)|Moved|0|||
47074277|NCT00083915|83366320|FG001|Overall Study|Withdrawal by Subject|3|||
47074278|NCT00083915|83366319|FG000|Overall Study|disease progression|18|||
47074279|NCT00083915|83366320|FG001|Overall Study|disease progression|23|||
47074280|NCT00083915|83366319|FG000|Overall Study|Failure to collect|3|||
47074281|NCT00083915|83366320|FG001|Overall Study|Failure to collect|0|||
47074282|NCT00083915|83366319|FG000|Overall Study|No response|3|||
47074283|NCT00083915|83366320|FG001|Overall Study|No response|1|||
47074284|NCT00083915|83366319|FG000|Overall Study|Insurance issues|1|||
47074285|NCT00083915|83366320|FG001|Overall Study|Insurance issues|1|||
47074286|NCT04505722|83366816|FG000|Overall Study|Adverse Event|1|||
47074287|NCT04505722|83366817|FG001|Overall Study|Adverse Event|2|||
47074288|NCT04505722|83366816|FG000|Overall Study|Death|34|||
47074289|NCT04505722|83366817|FG001|Overall Study|Death|63|||
47074290|NCT04505722|83366816|FG000|Overall Study|Lost to Follow-up|271|||
47074291|NCT04505722|83366817|FG001|Overall Study|Lost to Follow-up|333|||
47074292|NCT04505722|83366816|FG000|Overall Study|Physician Decision|17|||
46643861|NCT00246012|82849389|FG004|Overall Study|Other|0|||
46643862|NCT00246012|82849390|FG005|Overall Study|Other|0|||
47074293|NCT04505722|83366817|FG001|Overall Study|Physician Decision|17|||
46643863|NCT00246012|82849391|FG006|Overall Study|Other|0|||
46643864|NCT00246012|82849392|FG007|Overall Study|Other|1|||
46643865|NCT00246012|82849393|FG008|Overall Study|Other|0|||
46643866|NCT00246012|82849385|FG000|Overall Study|Randomly assigned but not treated|0|||
46969924|NCT02572401|83212899|FG000|Overall Study|Lost to Follow-up|5|||
46969925|NCT02572401|83212900|FG001|Overall Study|Lost to Follow-up|8|||
46969926|NCT02572401|83212901|FG002|Overall Study|Lost to Follow-up|9|||
46969927|NCT02572401|83212902|FG003|Overall Study|Lost to Follow-up|9|||
46643867|NCT00246012|82849386|FG001|Overall Study|Randomly assigned but not treated|0|||
46643868|NCT00246012|82849387|FG002|Overall Study|Randomly assigned but not treated|0|||
46643869|NCT00246012|82849388|FG003|Overall Study|Randomly assigned but not treated|0|||
46643870|NCT00246012|82849389|FG004|Overall Study|Randomly assigned but not treated|0|||
46643871|NCT00246012|82849390|FG005|Overall Study|Randomly assigned but not treated|1|||
46643872|NCT00246012|82849391|FG006|Overall Study|Randomly assigned but not treated|1|||
46643873|NCT00246012|82849392|FG007|Overall Study|Randomly assigned but not treated|0|||
46643874|NCT00246012|82849393|FG008|Overall Study|Randomly assigned but not treated|0|||
46643875|NCT00245856|82849415|FG000|Period Two|Withdrawal by Subject|0|||
46643876|NCT00245856|82849416|FG001|Period Two|Withdrawal by Subject|1|||
46643877|NCT00245466|82849426|FG000|Overall Study|Adverse Event|2|||
46643878|NCT00245466|82849427|FG001|Overall Study|Adverse Event|8|||
46643879|NCT00245466|82849428|FG002|Overall Study|Adverse Event|4|||
46643880|NCT00245466|82849426|FG000|Overall Study|Low prostate specific antigen suppr|16|||
46643881|NCT00245466|82849427|FG001|Overall Study|Low prostate specific antigen suppr|14|||
46643882|NCT00245466|82849428|FG002|Overall Study|Low prostate specific antigen suppr|5|||
46643883|NCT00245466|82849426|FG000|Overall Study|Insufficient testosterone suppr|12|||
46643884|NCT00245466|82849427|FG001|Overall Study|Insufficient testosterone suppr|12|||
46643885|NCT00245466|82849428|FG002|Overall Study|Insufficient testosterone suppr|21|||
46643886|NCT00245466|82849426|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
46643887|NCT00245466|82849427|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
46643888|NCT00245466|82849428|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
46643889|NCT00245466|82849426|FG000|Overall Study|Withdrawal by Subject|2|||
46643890|NCT00245466|82849427|FG001|Overall Study|Withdrawal by Subject|2|||
46643891|NCT00245466|82849428|FG002|Overall Study|Withdrawal by Subject|1|||
46643892|NCT00245466|82849426|FG000|Overall Study|Lost to Follow-up|3|||
46643893|NCT00245466|82849427|FG001|Overall Study|Lost to Follow-up|0|||
46643894|NCT00245466|82849428|FG002|Overall Study|Lost to Follow-up|0|||
46643895|NCT00245466|82849426|FG000|Overall Study|Disease progression|0|||
46643896|NCT00245466|82849427|FG001|Overall Study|Disease progression|3|||
46643897|NCT00245466|82849428|FG002|Overall Study|Disease progression|1|||
46643898|NCT00245466|82849426|FG000|Overall Study|Protocol Violation|1|||
46643899|NCT00245466|82849427|FG001|Overall Study|Protocol Violation|2|||
46643900|NCT00245466|82849428|FG002|Overall Study|Protocol Violation|2|||
46643901|NCT00245466|82849426|FG000|Overall Study|Death|0|||
46643902|NCT00245466|82849427|FG001|Overall Study|Death|2|||
46643903|NCT00245466|82849428|FG002|Overall Study|Death|0|||
46643904|NCT00245466|82849426|FG000|Overall Study|Administrative reasons|0|||
46643905|NCT00245466|82849427|FG001|Overall Study|Administrative reasons|1|||
46643906|NCT00245466|82849428|FG002|Overall Study|Administrative reasons|0|||
46643907|NCT00244764|82849436|FG000|Overall Study|Adverse Event|37|||
46643908|NCT00244764|82849436|FG000|Overall Study|Lost to Follow-up|23|||
46643909|NCT00244764|82849436|FG000|Overall Study|Withdrawal by Subject|12|||
46643910|NCT00244764|82849436|FG000|Overall Study|Disease Progression|13|||
46643911|NCT00244764|82849436|FG000|Overall Study|Protocol Violation|2|||
46643912|NCT00244764|82849436|FG000|Overall Study|Death|1|||
46643913|NCT00244764|82849436|FG000|Overall Study|Off Study Medication for >21 Days|1|||
46643914|NCT00244764|82849436|FG000|Overall Study|Declining Performance Status|1|||
46643915|NCT00244764|82849436|FG000|Overall Study|Participant was Hospitalized until Death|1|||
46643916|NCT00244764|82849436|FG000|Overall Study|Primary Investigator Discretion|2|||
46643917|NCT00244764|82849436|FG000|Overall Study|Sponsor Terminated Study|2|||
46643918|NCT00244764|82849436|FG000|Overall Study|Developed Secondary Malignancy|1|||
46643919|NCT00244374|82849441|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
46643920|NCT00244374|82849442|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
46643921|NCT00244374|82849443|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
46779131|NCT00619918|82997712|FG000|Overall Study|Transfer to outside facility|3|||
46779132|NCT00619918|82997713|FG001|Overall Study|Transfer to outside facility|3|||
46969928|NCT02572401|83212899|FG000|Overall Study|Death|0|||
46969929|NCT02572401|83212900|FG001|Overall Study|Death|0|||
46969930|NCT02572401|83212901|FG002|Overall Study|Death|0|||
46969931|NCT02572401|83212902|FG003|Overall Study|Death|1|||
46643922|NCT00244374|82849444|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
46643923|NCT00244374|82849445|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
46643924|NCT00244374|82849441|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
46643925|NCT00244374|82849442|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
46643926|NCT00244374|82849443|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
46643927|NCT00244374|82849444|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
46707445|NCT00992511|82922973|FG000|Overall Study|Withdrawal by Subject|0|||
46707446|NCT00992511|82922974|FG001|Overall Study|Withdrawal by Subject|0|||
46707447|NCT00992511|82922975|FG002|Overall Study|Withdrawal by Subject|1|||
46707448|NCT00992511|82922976|FG003|Overall Study|Withdrawal by Subject|1|||
46707449|NCT01196429|82922988|FG000|Overall Study|Ineligible - inadequate pathology|1|||
46850222|NCT00112437|83066382|FG019|Year 2 (12-Month Extension)|Moved|0|||
46969932|NCT02431325|83212914|FG000|Overall Study|Adverse Event|3|||
46969933|NCT02431325|83212915|FG001|Overall Study|Adverse Event|0|||
46969934|NCT02431325|83212914|FG000|Overall Study|Lost to Follow-up|0|||
46969935|NCT02431325|83212915|FG001|Overall Study|Lost to Follow-up|1|||
46969936|NCT02431325|83212914|FG000|Overall Study|Withdrawal by Subject|1|||
46969937|NCT02431325|83212915|FG001|Overall Study|Withdrawal by Subject|2|||
46969938|NCT02431325|83212914|FG000|Overall Study|Declined to take study medication|1|||
46969939|NCT02431325|83212915|FG001|Overall Study|Declined to take study medication|0|||
46969940|NCT02431325|83212914|FG000|Overall Study|Withdrew before starting study medication|1|||
46969941|NCT02431325|83212915|FG001|Overall Study|Withdrew before starting study medication|0|||
46969942|NCT02431325|83212914|FG000|Overall Study|Placebo shortage|2|||
46643928|NCT00244374|82849445|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
46643929|NCT00244374|82849441|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
46643930|NCT00244374|82849442|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
46643931|NCT00244374|82849443|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
46643932|NCT00244374|82849444|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
46643933|NCT00244374|82849445|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
46643934|NCT00244374|82849441|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
46643935|NCT00244374|82849442|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
46643936|NCT00244374|82849443|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
46643937|NCT00244374|82849444|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
46643938|NCT00244374|82849445|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
46643939|NCT00244374|82849441|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
46779133|NCT00619918|82997712|FG000|Overall Study|Left before receiving first dose|5|||
46779134|NCT00619918|82997713|FG001|Overall Study|Left before receiving first dose|8|||
46779135|NCT01005914|82997719|FG000|Overall Study|Adverse Event|4|||
46779136|NCT01005914|82997719|FG000|Overall Study|Death|4|||
46969943|NCT02431325|83212915|FG001|Overall Study|Placebo shortage|0|||
46969944|NCT02103478|83212928|FG000|Overall Study|Adverse Event|0|||
46969945|NCT02103478|83212929|FG001|Overall Study|Adverse Event|0|||
47074294|NCT04505722|83366816|FG000|Overall Study|Protocol Violation|0|||
47074295|NCT04505722|83366817|FG001|Overall Study|Protocol Violation|1|||
47074296|NCT04505722|83366816|FG000|Overall Study|Withdrawal by Subject|376|||
47074297|NCT04505722|83366817|FG001|Overall Study|Withdrawal by Subject|714|||
47074298|NCT04505722|83366816|FG000|Overall Study|Other|61|||
47074299|NCT04505722|83366817|FG001|Overall Study|Other|98|||
47074300|NCT04505722|83366816|FG000|Overall Study|Still ongoing|21138|||
47074301|NCT04505722|83366817|FG001|Overall Study|Still ongoing|20662|||
47074302|NCT04505722|83366816|FG000|Overall Study|Randomized not vaccinated|276|||
47074303|NCT04505722|83366817|FG001|Overall Study|Randomized not vaccinated|260|||
47074304|NCT04463251|83366830|FG000|Overall Study|Death|1|||
47074305|NCT04463251|83366831|FG001|Overall Study|Death|0|||
47074306|NCT04463251|83366832|FG002|Overall Study|Death|1|||
47074307|NCT04463251|83366830|FG000|Overall Study|Adverse Event|0|||
47074308|NCT04463251|83366831|FG001|Overall Study|Adverse Event|1|||
47074309|NCT04463251|83366832|FG002|Overall Study|Adverse Event|0|||
46779137|NCT01005914|82997719|FG000|Overall Study|Lack of Efficacy|1|||
46779138|NCT01005914|82997719|FG000|Overall Study|Withdrawal by Subject|1|||
46779139|NCT00618514|82997730|FG000|Overall Study|Lost to Follow-up|11|||
46779140|NCT00618514|82997731|FG001|Overall Study|Lost to Follow-up|12|||
46779141|NCT00618514|82997732|FG002|Overall Study|Lost to Follow-up|4|||
46779142|NCT00655629|82997740|FG000|Overall Study|Adverse Event|4|||
46779143|NCT00655629|82997741|FG001|Overall Study|Adverse Event|1|||
46779144|NCT00655629|82997740|FG000|Overall Study|Lack of Efficacy|2|||
46779145|NCT00655629|82997741|FG001|Overall Study|Lack of Efficacy|12|||
46779146|NCT00655629|82997740|FG000|Overall Study|Lost to Follow-up|4|||
46779147|NCT00655629|82997741|FG001|Overall Study|Lost to Follow-up|3|||
46779148|NCT00655629|82997740|FG000|Overall Study|Protocol Violation|5|||
46969946|NCT02103478|83212930|FG002|Overall Study|Adverse Event|1|||
46969947|NCT02103478|83212931|FG003|Overall Study|Adverse Event|1|||
46969948|NCT02103478|83212932|FG004|Overall Study|Adverse Event|2|||
46969949|NCT02103478|83212933|FG005|Overall Study|Adverse Event|1|||
46969950|NCT02103478|83212934|FG006|Overall Study|Adverse Event|0|||
46969951|NCT02103478|83212935|FG007|Overall Study|Adverse Event|0|||
46969952|NCT02103478|83212936|FG008|Overall Study|Adverse Event|0|||
46643940|NCT00244374|82849442|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
46643941|NCT00244374|82849443|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
46643942|NCT00244374|82849444|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
46643943|NCT00244374|82849445|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
46643944|NCT00244374|82849441|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
46643945|NCT00244374|82849442|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
46643946|NCT00244374|82849443|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
46643947|NCT00244374|82849444|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
46643948|NCT00244374|82849445|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
46643949|NCT00244374|82849441|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
46643950|NCT00244374|82849442|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
46643951|NCT00244374|82849443|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
46643952|NCT00244374|82849444|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
46643953|NCT00244374|82849445|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
46643954|NCT00244374|82849441|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
46643955|NCT00244374|82849442|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
46643956|NCT00244374|82849443|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
46643957|NCT00244374|82849444|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
46643958|NCT00244374|82849445|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
46779149|NCT00655629|82997741|FG001|Overall Study|Protocol Violation|3|||
46779150|NCT00655629|82997740|FG000|Overall Study|consent withdrawn|6|||
46779151|NCT00655629|82997741|FG001|Overall Study|consent withdrawn|4|||
46969953|NCT02103478|83212928|FG000|Overall Study|Death|2|||
46969954|NCT02103478|83212929|FG001|Overall Study|Death|2|||
46969955|NCT02103478|83212930|FG002|Overall Study|Death|1|||
46969956|NCT02103478|83212931|FG003|Overall Study|Death|1|||
46969957|NCT02103478|83212932|FG004|Overall Study|Death|5|||
46969958|NCT02103478|83212933|FG005|Overall Study|Death|15|||
46969959|NCT02103478|83212934|FG006|Overall Study|Death|14|||
47074310|NCT04463251|83366830|FG000|Overall Study|Lost to Follow-up|0|||
47074311|NCT04463251|83366831|FG001|Overall Study|Lost to Follow-up|1|||
47074312|NCT04463251|83366832|FG002|Overall Study|Lost to Follow-up|0|||
47074313|NCT04463251|83366830|FG000|Overall Study|Withdrawal by Subject|0|||
47074314|NCT04463251|83366831|FG001|Overall Study|Withdrawal by Subject|2|||
47074315|NCT04463251|83366832|FG002|Overall Study|Withdrawal by Subject|2|||
47074316|NCT04254913|83366845|FG000|Overall Study|Adverse Event|1|||
47074317|NCT04160091|83366857|FG000|Overall Study|Terminated by Sponsor|7|||
47074318|NCT04160091|83366858|FG001|Overall Study|Terminated by Sponsor|3|||
47074319|NCT04160091|83366859|FG002|Overall Study|Terminated by Sponsor|5|||
47074320|NCT04160091|83366860|FG003|Overall Study|Terminated by Sponsor|2|||
47074321|NCT04160091|83366857|FG000|Overall Study|Noncompliance|0|||
47074322|NCT04160091|83366858|FG001|Overall Study|Noncompliance|0|||
47074323|NCT04160091|83366859|FG002|Overall Study|Noncompliance|0|||
47074324|NCT04160091|83366860|FG003|Overall Study|Noncompliance|1|||
47074325|NCT04160091|83366857|FG000|Overall Study|Withdrawal by Subject|0|||
47074326|NCT04160091|83366858|FG001|Overall Study|Withdrawal by Subject|0|||
46969960|NCT02103478|83212935|FG007|Overall Study|Death|10|||
46969961|NCT02103478|83212936|FG008|Overall Study|Death|11|||
47074327|NCT04160091|83366859|FG002|Overall Study|Withdrawal by Subject|0|||
47074328|NCT04160091|83366860|FG003|Overall Study|Withdrawal by Subject|1|||
46969962|NCT02103478|83212928|FG000|Overall Study|Progressive Disease|2|||
46969963|NCT02103478|83212929|FG001|Overall Study|Progressive Disease|1|||
46969964|NCT02103478|83212930|FG002|Overall Study|Progressive Disease|2|||
46969965|NCT02103478|83212931|FG003|Overall Study|Progressive Disease|0|||
46969966|NCT02103478|83212932|FG004|Overall Study|Progressive Disease|9|||
47074329|NCT04145895|83366872|FG000|Overall Study|Physician Decision|2|||
47074330|NCT04145895|83366873|FG001|Overall Study|Physician Decision|0|||
47074331|NCT04145895|83366872|FG000|Overall Study|Withdrawal by Subject|0|||
47074332|NCT04145895|83366873|FG001|Overall Study|Withdrawal by Subject|2|||
47074333|NCT04065074|83366900|FG000|Overall Study|Adverse Event|1|||
46969967|NCT02103478|83212933|FG005|Overall Study|Progressive Disease|1|||
47074334|NCT04065074|83366900|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
47074335|NCT03793010|83366906|FG000|Overall Study|Withdrawal by Subject|5|||
47074336|NCT03793010|83366907|FG001|Overall Study|Withdrawal by Subject|7|||
47074337|NCT03793010|83366906|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
47074338|NCT03793010|83366907|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
47074339|NCT03793010|83366906|FG000|Overall Study|Lost to Follow-up|1|||
47074340|NCT03793010|83366907|FG001|Overall Study|Lost to Follow-up|2|||
47074341|NCT03793010|83366906|FG000|Overall Study|Patient couldn't sit still for injection|1|||
47074342|NCT03793010|83366907|FG001|Overall Study|Patient couldn't sit still for injection|0|||
46643959|NCT00244374|82849441|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
46643960|NCT00244374|82849442|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
46643961|NCT00244374|82849443|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
46643962|NCT00244374|82849444|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
46643963|NCT00244374|82849445|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
46643964|NCT00242658|82849463|FG000|Overall Study|Lost to Follow-up|22|||
46643965|NCT00242658|82849464|FG001|Overall Study|Lost to Follow-up|19|||
46643966|NCT00242580|82849473|FG000|Overall Study|Adverse Event|3|||
46643967|NCT00242580|82849474|FG001|Overall Study|Adverse Event|0|||
46643968|NCT00242580|82849475|FG002|Overall Study|Adverse Event|2|||
46643969|NCT00242580|82849473|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
46643970|NCT00242580|82849474|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
46643971|NCT00242580|82849475|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
46643972|NCT00242580|82849473|FG000|Overall Study|Protocol Violation|0|||
46643973|NCT00242580|82849474|FG001|Overall Study|Protocol Violation|0|||
46643974|NCT00242580|82849475|FG002|Overall Study|Protocol Violation|1|||
46643975|NCT00242580|82849473|FG000|Overall Study|Subject withdrew consent|2|||
46643976|NCT00242580|82849474|FG001|Overall Study|Subject withdrew consent|2|||
46643977|NCT00242580|82849475|FG002|Overall Study|Subject withdrew consent|5|||
46643978|NCT00242580|82849473|FG000|Overall Study|Lost to Follow-up|0|||
46643979|NCT00242580|82849474|FG001|Overall Study|Lost to Follow-up|3|||
46643980|NCT00242580|82849475|FG002|Overall Study|Lost to Follow-up|0|||
46643981|NCT00242580|82849473|FG000|Overall Study|Death|1|||
46643982|NCT00242580|82849474|FG001|Overall Study|Death|2|||
46643983|NCT00242580|82849475|FG002|Overall Study|Death|1|||
46643984|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
46643985|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
46643986|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
46643987|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
46643988|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
46643989|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
46643990|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
46643991|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
46643992|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
46643993|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
46643994|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
46643995|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
46779152|NCT00578292|82997747|FG000|Overall Study|Death|1|||
46779153|NCT00578292|82997747|FG000|Overall Study|Graft failure|2|||
46779154|NCT00570063|82997753|FG000|Overall Study|Adverse Event|4|||
46779155|NCT00570063|82997754|FG001|Overall Study|Adverse Event|1|||
46779156|NCT00570063|82997753|FG000|Overall Study|Lack of Efficacy|0|||
46779157|NCT00570063|82997754|FG001|Overall Study|Lack of Efficacy|1|||
47074343|NCT03793010|83366906|FG000|Overall Study|Withdrew to pursue other treatment|1|||
47074344|NCT03793010|83366907|FG001|Overall Study|Withdrew to pursue other treatment|0|||
47074345|NCT03793010|83366906|FG000|Overall Study|Did not meet eligibility criteria|1|||
47074346|NCT03793010|83366907|FG001|Overall Study|Did not meet eligibility criteria|0|||
47074347|NCT03529942|83366956|FG000|Overall Study|Withdrawal by Subject|13|||
47074348|NCT03529942|83366956|FG000|Overall Study|Physician Decision|1|||
47074349|NCT03529942|83366956|FG000|Overall Study|Lost to Follow-up|7|||
47074350|NCT03529942|83366956|FG000|Overall Study|Needle inserted but no drug administered|1|||
47074351|NCT03529942|83366956|FG000|Overall Study|Personal reasons|1|||
47074352|NCT03382262|83366971|FG000|Overall Study|Physician Decision|0|||
47074353|NCT03382262|83366972|FG001|Overall Study|Physician Decision|0|||
47074354|NCT03382262|83366973|FG002|Overall Study|Physician Decision|1|||
46643996|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
46643997|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
46643998|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
46643999|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
46644000|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
46644001|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
46969968|NCT02103478|83212934|FG006|Overall Study|Progressive Disease|2|||
46969969|NCT02103478|83212935|FG007|Overall Study|Progressive Disease|0|||
46969970|NCT02103478|83212936|FG008|Overall Study|Progressive Disease|1|||
46644002|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
46644003|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
46644004|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
46969971|NCT02103478|83212928|FG000|Overall Study|Withdrawal by Subject|2|||
46969972|NCT02103478|83212929|FG001|Overall Study|Withdrawal by Subject|0|||
46969973|NCT02103478|83212930|FG002|Overall Study|Withdrawal by Subject|0|||
46969974|NCT02103478|83212931|FG003|Overall Study|Withdrawal by Subject|4|||
46644005|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
46644006|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
46644007|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
46644008|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
46644009|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
46644010|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
46644011|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
46644012|NCT00241644|82849487|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
46644013|NCT00241644|82849488|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
46644014|NCT00241644|82849489|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
46644015|NCT00241644|82849490|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
46644016|NCT00241644|82849487|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
46644017|NCT00241644|82849488|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
46644018|NCT00241644|82849489|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
46644019|NCT00241644|82849490|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
46644020|NCT00241644|82849487|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
46644021|NCT00241644|82849488|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
46644022|NCT00241644|82849489|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
46644023|NCT00241644|82849490|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
46644024|NCT00241644|82849487|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
46644025|NCT00241644|82849488|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
46644026|NCT00241644|82849489|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
46644027|NCT00241644|82849490|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
46644028|NCT00241644|82849487|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
46644029|NCT00241644|82849488|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
46644030|NCT00241644|82849489|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
46644031|NCT00241644|82849490|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
46644032|NCT00241644|82849487|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
46779158|NCT00570063|82997753|FG000|Overall Study|Withdrawal by Subject|4|||
46779159|NCT00570063|82997754|FG001|Overall Study|Withdrawal by Subject|3|||
46779160|NCT00570063|82997753|FG000|Overall Study|Sponsor's Decision|7|||
46779161|NCT00570063|82997754|FG001|Overall Study|Sponsor's Decision|3|||
46779162|NCT00577772|82997771|FG000|Overall Study|Lost to Follow-up|0|||
46779163|NCT00577772|82997772|FG001|Overall Study|Lost to Follow-up|1|||
46779164|NCT00578136|82997780|FG000|Overall Study|Not given intervention|1|||
46969975|NCT02103478|83212932|FG004|Overall Study|Withdrawal by Subject|0|||
46969976|NCT02103478|83212933|FG005|Overall Study|Withdrawal by Subject|0|||
46969977|NCT02103478|83212934|FG006|Overall Study|Withdrawal by Subject|1|||
46969978|NCT02103478|83212935|FG007|Overall Study|Withdrawal by Subject|1|||
46969979|NCT02103478|83212936|FG008|Overall Study|Withdrawal by Subject|0|||
46969980|NCT02103478|83212928|FG000|Overall Study|Lost to Follow-up|0|||
46969981|NCT02103478|83212929|FG001|Overall Study|Lost to Follow-up|0|||
46969982|NCT02103478|83212930|FG002|Overall Study|Lost to Follow-up|0|||
46969983|NCT02103478|83212931|FG003|Overall Study|Lost to Follow-up|0|||
46969984|NCT02103478|83212932|FG004|Overall Study|Lost to Follow-up|0|||
46969985|NCT02103478|83212933|FG005|Overall Study|Lost to Follow-up|0|||
46969986|NCT02103478|83212934|FG006|Overall Study|Lost to Follow-up|0|||
47074355|NCT03382262|83366974|FG003|Overall Study|Physician Decision|0|||
47074356|NCT03382262|83366971|FG000|Overall Study|Withdrawal by Subject|0|||
47074357|NCT03382262|83366972|FG001|Overall Study|Withdrawal by Subject|0|||
47074358|NCT03382262|83366973|FG002|Overall Study|Withdrawal by Subject|0|||
47074359|NCT03382262|83366974|FG003|Overall Study|Withdrawal by Subject|1|||
47074360|NCT03381274|83366989|FG000|Overall Study|Death|2|||
47074361|NCT03381274|83366990|FG001|Overall Study|Death|9|||
47074362|NCT03381274|83366991|FG002|Overall Study|Death|3|||
47074363|NCT03381274|83366992|FG003|Overall Study|Death|2|||
46644033|NCT00241644|82849488|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
46779165|NCT00578136|82997781|FG001|Overall Study|Not given intervention|1|||
46969987|NCT02103478|83212935|FG007|Overall Study|Lost to Follow-up|1|||
46969988|NCT02103478|83212936|FG008|Overall Study|Lost to Follow-up|0|||
46969989|NCT02103478|83212928|FG000|Overall Study|Other|1|||
47074364|NCT03381274|83366993|FG004|Overall Study|Death|3|||
47074365|NCT03381274|83366989|FG000|Overall Study|Lost to Follow-up|0|||
46779166|NCT00655551|82997790|FG000|All Periods Combined|Adverse Event|0|||
46779167|NCT00655551|82997791|FG001|All Periods Combined|Adverse Event|3|||
46779168|NCT00655551|82997792|FG002|All Periods Combined|Adverse Event|4|||
46779169|NCT00655551|82997790|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
46779170|NCT00655551|82997791|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
46779171|NCT00655551|82997792|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
46779172|NCT00655551|82997790|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
46779173|NCT00655551|82997791|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
46779174|NCT00655551|82997792|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
46779175|NCT00655551|82997790|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
46779176|NCT00655551|82997791|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
46850223|NCT00112437|83066383|FG020|Year 2 (12-Month Extension)|Moved|0|||
46850224|NCT00112437|83066384|FG021|Year 2 (12-Month Extension)|Moved|0|||
46850225|NCT00112437|83066385|FG022|Year 2 (12-Month Extension)|Moved|0|||
46850226|NCT00112437|83066386|FG023|Year 2 (12-Month Extension)|Moved|0|||
46850227|NCT00112437|83066387|FG024|Year 2 (12-Month Extension)|Moved|0|||
46779177|NCT00655551|82997792|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
46850228|NCT00112437|83066388|FG025|Year 2 (12-Month Extension)|Moved|0|||
46850229|NCT00112437|83066363|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
46850230|NCT00112437|83066364|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
46850231|NCT00112437|83066365|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
46850232|NCT00112437|83066366|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
46850233|NCT00112437|83066367|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
47074366|NCT03381274|83366990|FG001|Overall Study|Lost to Follow-up|0|||
47074367|NCT03381274|83366991|FG002|Overall Study|Lost to Follow-up|0|||
47074368|NCT03381274|83366992|FG003|Overall Study|Lost to Follow-up|1|||
47074369|NCT03381274|83366993|FG004|Overall Study|Lost to Follow-up|0|||
47074370|NCT03381274|83366989|FG000|Overall Study|Withdrawal by Subject|2|||
47074371|NCT03381274|83366990|FG001|Overall Study|Withdrawal by Subject|1|||
47074372|NCT03381274|83366991|FG002|Overall Study|Withdrawal by Subject|3|||
47074373|NCT03381274|83366992|FG003|Overall Study|Withdrawal by Subject|1|||
47074374|NCT03381274|83366993|FG004|Overall Study|Withdrawal by Subject|0|||
46850234|NCT00112437|83066368|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
46850235|NCT00112437|83066369|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
46850236|NCT00112437|83066370|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
46779178|NCT00312728|82997800|FG000|Overall Study|Progressive disease|53|||
46850237|NCT00112437|83066371|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
47074375|NCT03381274|83366989|FG000|Overall Study|Other|1|||
47074376|NCT03381274|83366990|FG001|Overall Study|Other|11|||
46644034|NCT00241644|82849489|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
46644035|NCT00241644|82849490|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
46644036|NCT03804684|82849511|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
46644037|NCT03804684|82849512|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
46644038|NCT04295772|82849527|FG000|Overall Study|Protocol Violation|1|||
46644039|NCT04295772|82849528|FG001|Overall Study|Protocol Violation|0|||
46644040|NCT04295772|82849527|FG000|Overall Study|Ongoing for safety monitoring|14|||
46644041|NCT04295772|82849528|FG001|Overall Study|Ongoing for safety monitoring|1|||
46644042|NCT04295772|82849527|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
46644043|NCT04295772|82849528|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
46644044|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #1|24|||
46644045|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #1|0|||
46644046|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
46644047|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
46644048|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
46644049|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644050|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
46644051|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
46644052|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
46779179|NCT00312728|82997800|FG000|Overall Study|Adverse Event|32|||
46779180|NCT00312728|82997800|FG000|Overall Study|Withdrawal by Subject|10|||
46779181|NCT00312728|82997800|FG000|Overall Study|Required non-protocol cancer treatment|2|||
46644053|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
46644054|NCT03888066|82849539|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
46644055|NCT03888066|82849540|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644056|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
46644057|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644058|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
46644059|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
46644060|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
46644061|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644062|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
46644063|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644064|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #2|5|||
46644065|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #2|0|||
46644066|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
46644067|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
46779182|NCT00312728|82997800|FG000|Overall Study|Protocol Violation|2|||
46779183|NCT00312728|82997800|FG000|Overall Study|Other|10|||
46779184|NCT00312728|82997800|FG000|Overall Study|Other|1|||
46779185|NCT00577824|82997807|FG000|Overall Study|Adverse Event|6|||
46779186|NCT00577824|82997808|FG001|Overall Study|Adverse Event|18|||
46779187|NCT00577824|82997809|FG002|Overall Study|Adverse Event|1|||
46850238|NCT00112437|83066372|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
46850239|NCT00112437|83066373|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
46850240|NCT00112437|83066374|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
46850241|NCT00112437|83066375|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
46850242|NCT00112437|83066376|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
46850243|NCT00112437|83066377|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
46969990|NCT02103478|83212929|FG001|Overall Study|Other|3|||
46644068|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
46644069|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
46644070|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
46644071|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
46644072|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #3|11|||
46644073|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #3|0|||
46644074|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
46644075|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
46644076|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
46644077|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
46644078|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
46644079|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644080|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #4|3|||
46644081|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #4|0|||
46644082|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
46644083|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
46644084|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
46644085|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
46644086|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
46644087|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
46644088|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
46644089|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
46644090|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
46644091|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644092|NCT03888066|82849539|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
46644093|NCT03888066|82849540|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
46644094|NCT03888066|82849539|FG000|Run-in Phase|AE (Adverse Event)|17|||
46644095|NCT03888066|82849540|FG001|Run-in Phase|AE (Adverse Event)|0|||
46644096|NCT03888066|82849539|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
46644097|NCT03888066|82849540|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
46644098|NCT03888066|82849539|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
46644099|NCT03888066|82849540|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644100|NCT03888066|82849539|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
46644101|NCT03888066|82849540|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644102|NCT03888066|82849539|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
46644103|NCT03888066|82849540|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
46644104|NCT03888066|82849539|FG000|Run-in Phase|Withdrawal by Subject|43|||
46644105|NCT03888066|82849540|FG001|Run-in Phase|Withdrawal by Subject|0|||
46644106|NCT03888066|82849539|FG000|Run-in Phase|AE; Physician Decision|1|||
46644107|NCT03888066|82849540|FG001|Run-in Phase|AE; Physician Decision|0|||
46644108|NCT03888066|82849539|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
46644109|NCT03888066|82849540|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
46644110|NCT03888066|82849539|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
46779188|NCT00577824|82997807|FG000|Overall Study|Patient decision|0|||
46779189|NCT00577824|82997808|FG001|Overall Study|Patient decision|1|||
46779190|NCT00577824|82997809|FG002|Overall Study|Patient decision|1|||
46644111|NCT03888066|82849540|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
46644112|NCT03888066|82849539|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
46779191|NCT00577824|82997807|FG000|Overall Study|Protocol Violation|1|||
46779192|NCT00577824|82997808|FG001|Overall Study|Protocol Violation|1|||
46779193|NCT00577824|82997809|FG002|Overall Study|Protocol Violation|0|||
46779194|NCT00617344|82997820|FG000|Overall Study|Serious adverse event|1|||
46779195|NCT00617344|82997821|FG001|Overall Study|Serious adverse event|0|||
47074377|NCT03381274|83366991|FG002|Overall Study|Other|0|||
47074378|NCT03381274|83366992|FG003|Overall Study|Other|2|||
47074379|NCT03381274|83366993|FG004|Overall Study|Other|2|||
47074380|NCT03365375|83367020|FG000|Overall Study|Withdrawal by Subject|0|||
47074381|NCT03365375|83367021|FG001|Overall Study|Withdrawal by Subject|1|||
47074382|NCT03365375|83367020|FG000|Overall Study|Lost to Follow-up|0|||
47074383|NCT03365375|83367021|FG001|Overall Study|Lost to Follow-up|4|||
47074384|NCT03282123|83367027|FG000|Overall Study|Withdrawal by Subject|5|||
47074385|NCT03046446|83367032|FG000|Overall Study|Lack of Efficacy|7|||
47074386|NCT03046446|83367032|FG000|Overall Study|Adverse Event|6|||
47074387|NCT03046446|83367032|FG000|Overall Study|Lost to Follow-up|3|||
47074388|NCT03046446|83367032|FG000|Overall Study|Withdrawal by Subject|14|||
47074389|NCT03046446|83367032|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
46644113|NCT03888066|82849540|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
46644114|NCT03888066|82849539|FG000|Run-in Phase|Death|1|||
46644115|NCT03888066|82849540|FG001|Run-in Phase|Death|0|||
46644116|NCT03888066|82849539|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
46644117|NCT03888066|82849540|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
46644118|NCT03888066|82849539|FG000|Run-in Phase|Physician Decision|1|||
46644119|NCT03888066|82849540|FG001|Run-in Phase|Physician Decision|0|||
46644120|NCT03888066|82849539|FG000|Run-in Phase|Protocol Violation|13|||
46644121|NCT03888066|82849540|FG001|Run-in Phase|Protocol Violation|0|||
46644122|NCT03888066|82849539|FG000|Run-in Phase|Sponsor Request|34|||
46644123|NCT03888066|82849540|FG001|Run-in Phase|Sponsor Request|0|||
46644124|NCT03888066|82849539|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
46644125|NCT03888066|82849540|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
46644126|NCT03888066|82849539|FG000|Run-in Phase|Withdrawal Of Consent|1|||
46644127|NCT03888066|82849540|FG001|Run-in Phase|Withdrawal Of Consent|0|||
46644128|NCT03888066|82849539|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
46644129|NCT03888066|82849540|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
46644130|NCT03888066|82849539|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
46644131|NCT03888066|82849540|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
46850244|NCT00112437|83066378|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
46850245|NCT00112437|83066379|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
46850246|NCT00112437|83066380|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
46969991|NCT02103478|83212930|FG002|Overall Study|Other|2|||
46969992|NCT02103478|83212931|FG003|Overall Study|Other|0|||
46969993|NCT02103478|83212932|FG004|Overall Study|Other|3|||
46969994|NCT02103478|83212933|FG005|Overall Study|Other|8|||
46969995|NCT02103478|83212934|FG006|Overall Study|Other|8|||
47074390|NCT03046446|83367032|FG000|Overall Study|Disease Progression (see caveats)|25|||
47074391|NCT03046446|83367032|FG000|Overall Study|Non OA related knee surgery|1|||
47074392|NCT02762370|83367061|FG000|Overall Study|Protocol Violation|1|||
47074393|NCT02762370|83367062|FG001|Overall Study|Protocol Violation|0|||
47074394|NCT02751580|83367070|FG000|Overall Study|Lost to Follow-up|4|||
47074395|NCT02751580|83367070|FG000|Overall Study|Death|2|||
47074396|NCT02717611|83367074|FG000|Overall Study|Death|13|||
47074397|NCT02717611|83367074|FG000|Overall Study|Withdrawal by Subject|6|||
47074398|NCT02717611|83367074|FG000|Overall Study|Active, not recruiting|40|||
47074399|NCT02717611|83367074|FG000|Overall Study|Complicating disease|1|||
47074400|NCT02513394|83367089|FG000|Overall Study|Withdrawal by Subject|11|||
47074401|NCT02513394|83367090|FG001|Overall Study|Withdrawal by Subject|23|||
47074402|NCT02513394|83367089|FG000|Overall Study|Ineligible|1|||
47074403|NCT02513394|83367090|FG001|Overall Study|Ineligible|0|||
47074404|NCT02284113|83367120|FG000|Overall Study|Adverse Event|1|||
47074405|NCT02284113|83367121|FG001|Overall Study|Adverse Event|0|||
47074406|NCT02284113|83367120|FG000|Overall Study|non-compliance|0|||
47074407|NCT02284113|83367121|FG001|Overall Study|non-compliance|1|||
47074408|NCT02284113|83367120|FG000|Overall Study|Withdrawal by Subject|0|||
47074409|NCT02284113|83367121|FG001|Overall Study|Withdrawal by Subject|1|||
47074410|NCT02284113|83367120|FG000|Overall Study|not provided|0|||
46644132|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
46644133|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
46644134|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
46644135|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
46779196|NCT00617344|82997822|FG002|Overall Study|Serious adverse event|0|||
46779197|NCT00617344|82997820|FG000|Overall Study|Other Adverse Event|1|||
46779198|NCT00617344|82997821|FG001|Overall Study|Other Adverse Event|1|||
46779199|NCT00617344|82997822|FG002|Overall Study|Other Adverse Event|0|||
46779200|NCT00617344|82997820|FG000|Overall Study|Protocol Violation|10|||
46779201|NCT00617344|82997821|FG001|Overall Study|Protocol Violation|8|||
46779202|NCT00617344|82997822|FG002|Overall Study|Protocol Violation|5|||
46779203|NCT00617344|82997820|FG000|Overall Study|Lost to Follow-up|5|||
46779204|NCT00617344|82997821|FG001|Overall Study|Lost to Follow-up|4|||
46779205|NCT00617344|82997822|FG002|Overall Study|Lost to Follow-up|1|||
46779206|NCT00617344|82997820|FG000|Overall Study|Withdrawal by Subject|8|||
46779207|NCT00617344|82997821|FG001|Overall Study|Withdrawal by Subject|9|||
46779208|NCT00617344|82997822|FG002|Overall Study|Withdrawal by Subject|2|||
46779209|NCT00654381|82997855|FG000|1st Stage|Adverse Event|3|||
46779210|NCT00654381|82997856|FG001|1st Stage|Adverse Event|3|||
46779211|NCT00654381|82997857|FG002|1st Stage|Adverse Event|3|||
46779212|NCT00654381|82997858|FG003|1st Stage|Adverse Event|3|||
46779213|NCT00654381|82997859|FG004|1st Stage|Adverse Event|2|||
46779214|NCT00654381|82997860|FG005|1st Stage|Adverse Event|1|||
46850247|NCT00112437|83066381|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
46850248|NCT00112437|83066382|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
47074411|NCT02284113|83367121|FG001|Overall Study|not provided|1|||
46644136|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
46644137|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
46779215|NCT00654381|82997855|FG000|1st Stage|Withdrawal by Subject|0|||
46969996|NCT02103478|83212935|FG007|Overall Study|Other|4|||
46644138|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
46644139|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
46644140|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
46644141|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
46644142|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
46644143|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
46644144|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
46644145|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
46644146|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
46644147|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
46644148|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
46644149|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
46644150|NCT03888066|82849539|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
46644151|NCT03888066|82849540|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
46644152|NCT01049334|82849549|FG000|Overall Study|Withdrawal by Subject|5|||
46644153|NCT01049334|82849550|FG001|Overall Study|Withdrawal by Subject|3|||
46644154|NCT01049334|82849549|FG000|Overall Study|Adverse Event|2|||
46644155|NCT01049334|82849550|FG001|Overall Study|Adverse Event|3|||
46644156|NCT01049334|82849549|FG000|Overall Study|Physician Decision|2|||
46779216|NCT00654381|82997856|FG001|1st Stage|Withdrawal by Subject|0|||
46779217|NCT00654381|82997857|FG002|1st Stage|Withdrawal by Subject|0|||
47074412|NCT02284113|83367120|FG000|Overall Study|surgery cancelled|2|||
47074413|NCT02284113|83367121|FG001|Overall Study|surgery cancelled|0|||
47074414|NCT02116972|83367130|FG000|Overall Study|Adverse Event|4|||
47074415|NCT02116972|83367131|FG001|Overall Study|Adverse Event|4|||
47074416|NCT02116972|83367132|FG002|Overall Study|Adverse Event|1|||
47074417|NCT02116972|83367130|FG000|Overall Study|Withdrawal by Subject|1|||
47074418|NCT02116972|83367131|FG001|Overall Study|Withdrawal by Subject|1|||
47074419|NCT02116972|83367132|FG002|Overall Study|Withdrawal by Subject|5|||
47074420|NCT02116972|83367130|FG000|Overall Study|Protocol Violation|1|||
47074421|NCT02116972|83367131|FG001|Overall Study|Protocol Violation|0|||
47074422|NCT02116972|83367132|FG002|Overall Study|Protocol Violation|1|||
47074423|NCT02116972|83367130|FG000|Overall Study|Lost to Follow-up|4|||
47074424|NCT02116972|83367131|FG001|Overall Study|Lost to Follow-up|3|||
47074425|NCT02116972|83367132|FG002|Overall Study|Lost to Follow-up|1|||
47074426|NCT02116972|83367130|FG000|Overall Study|Lack of Efficacy|6|||
47074427|NCT02116972|83367131|FG001|Overall Study|Lack of Efficacy|6|||
47074428|NCT02116972|83367132|FG002|Overall Study|Lack of Efficacy|5|||
47074429|NCT02116972|83367130|FG000|Overall Study|scheduling conflicts and relocation|3|||
47074430|NCT02116972|83367131|FG001|Overall Study|scheduling conflicts and relocation|3|||
47074431|NCT02116972|83367132|FG002|Overall Study|scheduling conflicts and relocation|6|||
47074432|NCT02008396|83367144|FG000|Overall Study|Protocol Violation|0|||
47074433|NCT02008396|83367145|FG001|Overall Study|Protocol Violation|1|||
47074434|NCT01904136|83367161|FG000|Overall Study|Physician Decision|0|||
47074435|NCT01904136|83367162|FG001|Overall Study|Physician Decision|0|||
47074436|NCT01904136|83367163|FG002|Overall Study|Physician Decision|0|||
47074437|NCT01904136|83367164|FG003|Overall Study|Physician Decision|0|||
47074438|NCT01904136|83367165|FG004|Overall Study|Physician Decision|0|||
47074439|NCT01904136|83367166|FG005|Overall Study|Physician Decision|1|||
47074440|NCT01904136|83367167|FG006|Overall Study|Physician Decision|0|||
47074441|NCT01904136|83367168|FG007|Overall Study|Physician Decision|0|||
47074442|NCT01904136|83367169|FG008|Overall Study|Physician Decision|0|||
47074443|NCT01828099|83367195|FG000|Overall Study|Adverse Event|15|||
47074444|NCT01828099|83367196|FG001|Overall Study|Adverse Event|18|||
47074445|NCT01828099|83367195|FG000|Overall Study|Death|9|||
47074446|NCT01828099|83367196|FG001|Overall Study|Death|11|||
47074447|NCT01828099|83367195|FG000|Overall Study|Lost to Follow-up|2|||
47074448|NCT01828099|83367196|FG001|Overall Study|Lost to Follow-up|0|||
47074449|NCT01828099|83367195|FG000|Overall Study|Non-compliance with study treatment|2|||
47074450|NCT01828099|83367196|FG001|Overall Study|Non-compliance with study treatment|0|||
47074451|NCT01828099|83367195|FG000|Overall Study|Physician Decision|7|||
46779218|NCT00654381|82997858|FG003|1st Stage|Withdrawal by Subject|1|||
46779219|NCT00654381|82997859|FG004|1st Stage|Withdrawal by Subject|0|||
46779220|NCT00654381|82997860|FG005|1st Stage|Withdrawal by Subject|1|||
47074452|NCT01828099|83367196|FG001|Overall Study|Physician Decision|11|||
47074453|NCT01828099|83367195|FG000|Overall Study|Progressive disease|51|||
47074454|NCT01828099|83367196|FG001|Overall Study|Progressive disease|94|||
47074455|NCT01828099|83367195|FG000|Overall Study|Protocol Violation|1|||
46779221|NCT00654381|82997855|FG000|1st Stage|Investigator's decision|0|||
46779222|NCT00654381|82997856|FG001|1st Stage|Investigator's decision|0|||
46779223|NCT00654381|82997857|FG002|1st Stage|Investigator's decision|0|||
46779224|NCT00654381|82997858|FG003|1st Stage|Investigator's decision|1|||
47074456|NCT01828099|83367196|FG001|Overall Study|Protocol Violation|0|||
47074457|NCT01828099|83367195|FG000|Overall Study|Subject/guardian decision|7|||
47074458|NCT01828099|83367196|FG001|Overall Study|Subject/guardian decision|23|||
47074459|NCT01793610|83367205|FG000|Overall Study|Withdrawal by Subject|1|||
46644157|NCT01049334|82849550|FG001|Overall Study|Physician Decision|0|||
46644158|NCT01049334|82849549|FG000|Overall Study|Protocol Violation|0|||
46644159|NCT01049334|82849550|FG001|Overall Study|Protocol Violation|1|||
46644160|NCT01048944|82849560|FG000|Overall Study|Protocol Violation|8|||
46644161|NCT01048944|82849561|FG001|Overall Study|Protocol Violation|10|||
46644162|NCT01048944|82849562|FG002|Overall Study|Protocol Violation|10|||
46644163|NCT01048944|82849563|FG003|Overall Study|Protocol Violation|2|||
46644164|NCT01048866|82849575|FG000|Overall Study|Adverse Event|1|||
46644165|NCT01048866|82849576|FG001|Overall Study|Adverse Event|0|||
46644166|NCT01048866|82849575|FG000|Overall Study|Protocol Violation|1|||
46644167|NCT01048866|82849576|FG001|Overall Study|Protocol Violation|0|||
46644168|NCT01048866|82849575|FG000|Overall Study|Physician Decision|1|||
46644169|NCT01048866|82849576|FG001|Overall Study|Physician Decision|0|||
46644170|NCT01048866|82849575|FG000|Overall Study|Withdrawal by Subject|0|||
46644171|NCT01048866|82849576|FG001|Overall Study|Withdrawal by Subject|2|||
46644172|NCT01048866|82849575|FG000|Overall Study|Lost to Follow-up|0|||
46644173|NCT01048866|82849576|FG001|Overall Study|Lost to Follow-up|2|||
46644174|NCT01048866|82849575|FG000|Overall Study|Other|1|||
46644175|NCT01048866|82849576|FG001|Overall Study|Other|1|||
46644176|NCT01048788|82849585|FG000|Overall Study|Adverse Event|5|||
46644177|NCT01048788|82849586|FG001|Overall Study|Adverse Event|1|||
46644178|NCT01048788|82849587|FG002|Overall Study|Adverse Event|1|||
46644179|NCT01048788|82849585|FG000|Overall Study|Lack of Efficacy|0|||
46644180|NCT01048788|82849586|FG001|Overall Study|Lack of Efficacy|0|||
46644181|NCT01048788|82849587|FG002|Overall Study|Lack of Efficacy|1|||
46644182|NCT01048788|82849585|FG000|Overall Study|Withdrawal by Subject|0|||
46644183|NCT01048788|82849586|FG001|Overall Study|Withdrawal by Subject|1|||
46644184|NCT01048788|82849587|FG002|Overall Study|Withdrawal by Subject|0|||
46644185|NCT01048242|82849597|FG000|Overall Study|See study flow chart|4|||
46644186|NCT01048242|82849598|FG001|Overall Study|See study flow chart|2|||
46644187|NCT01047306|82849606|FG000|Overall Study|Withdrawal by Subject|2|||
46644188|NCT01047306|82849607|FG001|Overall Study|Withdrawal by Subject|0|||
46644189|NCT01047306|82849606|FG000|Overall Study|Lost to Follow-up|1|||
46644190|NCT01047306|82849607|FG001|Overall Study|Lost to Follow-up|0|||
46644191|NCT01046682|82849617|FG000|Overall Study|Adverse Event|2|||
46644192|NCT01046682|82849618|FG001|Overall Study|Adverse Event|0|||
46644193|NCT01044732|82849626|FG000|Overall Study|Lost to Follow-up|2|||
46644194|NCT01044732|82849627|FG001|Overall Study|Lost to Follow-up|1|||
46644195|NCT01044732|82849626|FG000|Overall Study|Physician Decision|5|||
46644196|NCT01044732|82849627|FG001|Overall Study|Physician Decision|3|||
46644197|NCT01044732|82849626|FG000|Overall Study|Protocol Violation|11|||
46644198|NCT01044732|82849627|FG001|Overall Study|Protocol Violation|12|||
46644199|NCT01044732|82849626|FG000|Overall Study|Withdrawal by Subject|0|||
46644200|NCT01044732|82849627|FG001|Overall Study|Withdrawal by Subject|1|||
46644201|NCT01044732|82849626|FG000|Overall Study|Inadequate bowel preparation|11|||
46644202|NCT01044732|82849627|FG001|Overall Study|Inadequate bowel preparation|17|||
46644203|NCT01044732|82849626|FG000|Overall Study|Inability to reach cecum|5|||
46644204|NCT01044732|82849627|FG001|Overall Study|Inability to reach cecum|2|||
46644205|NCT01044732|82849626|FG000|Overall Study|Technical error or malfunction|15|||
46644206|NCT01044732|82849627|FG001|Overall Study|Technical error or malfunction|14|||
46644207|NCT01044498|82849637|FG000|Overall Study|Withdrew consent|1|||
46644208|NCT01044498|82849638|FG001|Overall Study|Withdrew consent|1|||
46644209|NCT01044498|82849637|FG000|Overall Study|Adverse Event|1|||
46644210|NCT01044498|82849638|FG001|Overall Study|Adverse Event|1|||
46644211|NCT01044498|82849637|FG000|Overall Study|Other|1|||
46644212|NCT01044498|82849638|FG001|Overall Study|Other|0|||
46644213|NCT01043874|82849644|FG000|Overall Study|Adverse Event|3|||
46644214|NCT01043874|82849644|FG000|Overall Study|Withdrawal by Subject|1|||
46644215|NCT01043874|82849644|FG000|Overall Study|Lack of Efficacy|1|||
46644216|NCT01043874|82849644|FG000|Overall Study|Administrative Problems|1|||
46850249|NCT00112437|83066383|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
46969997|NCT02103478|83212936|FG008|Overall Study|Other|2|||
46644217|NCT01042938|82849650|FG000|Overall Study|Withdrawal by Subject|1|||
46644218|NCT01042938|82849651|FG001|Overall Study|Withdrawal by Subject|1|||
46644219|NCT01042938|82849650|FG000|Overall Study|Protocol Violation|1|||
46644220|NCT01042938|82849651|FG001|Overall Study|Protocol Violation|1|||
46644221|NCT01042938|82849650|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
46644222|NCT01042938|82849651|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
46644223|NCT01042158|82849659|FG000|Overall Study|Physician Decision|1|||
46644224|NCT03408444|82849667|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
46644225|NCT03408444|82849668|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
46644226|NCT03408444|82849669|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
46644227|NCT03408444|82849670|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
46644228|NCT03408444|82849667|FG000|Overall Study|Lens Discomfort|0|||
46644229|NCT03408444|82849668|FG001|Overall Study|Lens Discomfort|1|||
46644230|NCT03408444|82849669|FG002|Overall Study|Lens Discomfort|0|||
46644231|NCT03408444|82849670|FG003|Overall Study|Lens Discomfort|0|||
46644232|NCT03408444|82849667|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
46644233|NCT03408444|82849668|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
46644234|NCT03408444|82849669|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
46644235|NCT03408444|82849670|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
46644236|NCT03408444|82849667|FG000|Overall Study|Withdrawal by Subject|0|||
46644237|NCT03408444|82849668|FG001|Overall Study|Withdrawal by Subject|2|||
46644238|NCT03408444|82849669|FG002|Overall Study|Withdrawal by Subject|3|||
46644239|NCT03408444|82849670|FG003|Overall Study|Withdrawal by Subject|0|||
46644240|NCT03408444|82849667|FG000|Overall Study|Lost to Follow-up|0|||
46644241|NCT03408444|82849668|FG001|Overall Study|Lost to Follow-up|0|||
46644242|NCT03408444|82849669|FG002|Overall Study|Lost to Follow-up|1|||
46644243|NCT03408444|82849670|FG003|Overall Study|Lost to Follow-up|0|||
46644244|NCT03408444|82849667|FG000|Overall Study|Adverse Event|0|||
46644245|NCT03408444|82849668|FG001|Overall Study|Adverse Event|0|||
46644246|NCT03408444|82849669|FG002|Overall Study|Adverse Event|0|||
46644247|NCT03408444|82849670|FG003|Overall Study|Adverse Event|1|||
46644248|NCT03408444|82849667|FG000|Overall Study|Lens Handling Difficulties|0|||
46644249|NCT03408444|82849668|FG001|Overall Study|Lens Handling Difficulties|0|||
46644250|NCT03408444|82849669|FG002|Overall Study|Lens Handling Difficulties|1|||
46644251|NCT03408444|82849670|FG003|Overall Study|Lens Handling Difficulties|0|||
46644252|NCT03408444|82849667|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
46644253|NCT03408444|82849668|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
46644254|NCT03408444|82849669|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
46644255|NCT03408444|82849670|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
47074460|NCT01793610|83367206|FG001|Overall Study|Withdrawal by Subject|0|||
47074461|NCT01793610|83367207|FG002|Overall Study|Withdrawal by Subject|1|||
46644256|NCT03400956|82849700|FG000|Treatment Period 1|Adverse Event|0|||
46644257|NCT03400956|82849701|FG001|Treatment Period 1|Adverse Event|1|||
46644258|NCT03400956|82849702|FG002|Treatment Period 1|Adverse Event|0|||
47074462|NCT01320085|83367259|FG000|Overall Study|Disease Progression|26|||
47074463|NCT01320085|83367260|FG001|Overall Study|Disease Progression|93|||
47074464|NCT01320085|83367261|FG002|Overall Study|Disease Progression|17|||
47074465|NCT01320085|83367259|FG000|Overall Study|Adverse Event|12|||
47074466|NCT01320085|83367260|FG001|Overall Study|Adverse Event|20|||
47074467|NCT01320085|83367261|FG002|Overall Study|Adverse Event|5|||
47074468|NCT01320085|83367259|FG000|Overall Study|Withdrawal by Subject|2|||
47074469|NCT01320085|83367260|FG001|Overall Study|Withdrawal by Subject|4|||
47074470|NCT01320085|83367261|FG002|Overall Study|Withdrawal by Subject|1|||
46644259|NCT03400956|82849700|FG000|Treatment Period 1|Lost to Follow-up|0|||
46644260|NCT03400956|82849701|FG001|Treatment Period 1|Lost to Follow-up|0|||
46644261|NCT03400956|82849702|FG002|Treatment Period 1|Lost to Follow-up|1|||
46644262|NCT03400956|82849700|FG000|Treatment Period 1|Protocol Violation|0|||
47074471|NCT01320085|83367259|FG000|Overall Study|Protocol Deviation|1|||
46644263|NCT03400956|82849701|FG001|Treatment Period 1|Protocol Violation|2|||
46644264|NCT03400956|82849702|FG002|Treatment Period 1|Protocol Violation|0|||
46644265|NCT03400956|82849700|FG000|Treatment Period 1|Study terminated by sponsor|3|||
46644266|NCT03400956|82849701|FG001|Treatment Period 1|Study terminated by sponsor|1|||
46644267|NCT03400956|82849702|FG002|Treatment Period 1|Study terminated by sponsor|1|||
46644268|NCT03400956|82849700|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46644269|NCT03400956|82849701|FG001|Treatment Period 1|Withdrawal by Subject|2|||
46644270|NCT03400956|82849702|FG002|Treatment Period 1|Withdrawal by Subject|4|||
46644271|NCT03400956|82849700|FG000|Treatment Period 1|Other|1|||
46644272|NCT03400956|82849701|FG001|Treatment Period 1|Other|2|||
46644273|NCT03400956|82849702|FG002|Treatment Period 1|Other|3|||
46644274|NCT03400956|82849700|FG000|Post-treatment Period 1|Adverse Event|0|||
46644275|NCT03400956|82849701|FG001|Post-treatment Period 1|Adverse Event|0|||
46644276|NCT03400956|82849702|FG002|Post-treatment Period 1|Adverse Event|1|||
46644277|NCT03400956|82849700|FG000|Post-treatment Period 1|Physician Decision|2|||
46644278|NCT03400956|82849701|FG001|Post-treatment Period 1|Physician Decision|3|||
46644279|NCT03400956|82849702|FG002|Post-treatment Period 1|Physician Decision|0|||
46644280|NCT03400956|82849700|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
46644281|NCT03400956|82849701|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
46644282|NCT03400956|82849702|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
46644283|NCT03400956|82849700|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
46644284|NCT03400956|82849701|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
46644285|NCT03400956|82849702|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
46644286|NCT03400956|82849700|FG000|Post-treatment Period 1|Other|4|||
46644287|NCT03400956|82849701|FG001|Post-treatment Period 1|Other|3|||
46644288|NCT03400956|82849702|FG002|Post-treatment Period 1|Other|4|||
46644289|NCT03400956|82849700|FG000|Treatment Period 2|Adverse Event|2|||
46644290|NCT03400956|82849701|FG001|Treatment Period 2|Adverse Event|1|||
46644291|NCT03400956|82849702|FG002|Treatment Period 2|Adverse Event|1|||
46644292|NCT03400956|82849700|FG000|Treatment Period 2|Lost to Follow-up|1|||
46779225|NCT00654381|82997859|FG004|1st Stage|Investigator's decision|0|||
46779226|NCT00654381|82997860|FG005|1st Stage|Investigator's decision|0|||
47074472|NCT01320085|83367260|FG001|Overall Study|Protocol Deviation|0|||
47074473|NCT01320085|83367261|FG002|Overall Study|Protocol Deviation|1|||
47074474|NCT01320085|83367259|FG000|Overall Study|Administrative problems|0|||
47074475|NCT01320085|83367260|FG001|Overall Study|Administrative problems|0|||
47074476|NCT01320085|83367261|FG002|Overall Study|Administrative problems|1|||
47074477|NCT01207492|83367282|FG000|Overall Study|Still on study|1|||
47074478|NCT01207492|83367282|FG000|Overall Study|Withdrawal by Subject|9|||
47074479|NCT01207492|83367282|FG000|Overall Study|Physician Decision|1|||
47074480|NCT01207492|83367282|FG000|Overall Study|Progressive disease|3|||
47074481|NCT01207492|83367282|FG000|Overall Study|Toxicity|1|||
46644293|NCT03400956|82849701|FG001|Treatment Period 2|Lost to Follow-up|1|||
46644294|NCT03400956|82849702|FG002|Treatment Period 2|Lost to Follow-up|0|||
46644295|NCT03400956|82849700|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46644296|NCT03400956|82849701|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46644297|NCT03400956|82849702|FG002|Treatment Period 2|Withdrawal by Subject|3|||
46644298|NCT03400956|82849700|FG000|Treatment Period 2|Other|1|||
46644299|NCT03400956|82849701|FG001|Treatment Period 2|Other|1|||
46644300|NCT03400956|82849702|FG002|Treatment Period 2|Other|0|||
46644301|NCT03400956|82849700|FG000|Follow-up Period|Withdrawal by Subject|0|||
46644302|NCT03400956|82849701|FG001|Follow-up Period|Withdrawal by Subject|0|||
46644303|NCT03400956|82849702|FG002|Follow-up Period|Withdrawal by Subject|1|||
46779227|NCT00654381|82997855|FG000|2nd Stage|Adverse Event|2|||
46779228|NCT00654381|82997856|FG001|2nd Stage|Adverse Event|0|||
46779229|NCT00654381|82997857|FG002|2nd Stage|Adverse Event|2|||
47074482|NCT01167140|83367286|FG000|Overall Study|Withdrawal by Subject|1|||
46644304|NCT03400956|82849700|FG000|Follow-up Period|Other|0|||
46644305|NCT03400956|82849701|FG001|Follow-up Period|Other|0|||
46644306|NCT03400956|82849702|FG002|Follow-up Period|Other|1|||
46644307|NCT00012012|82849715|FG000|Overall Study|Protocol Violation|1|||
46644308|NCT00012012|82849716|FG001|Overall Study|Protocol Violation|1|||
46644309|NCT00012012|82849715|FG000|Overall Study|Withdrawal by Subject|0|||
46644310|NCT00012012|82849716|FG001|Overall Study|Withdrawal by Subject|2|||
46644311|NCT00010374|82849722|FG000|Overall Study|False positive phrenic nerve test|1|||
46644312|NCT00559962|82849748|FG000|Overall Study|Adverse Event|1|||
46644313|NCT00559962|82849749|FG001|Overall Study|Adverse Event|7|||
46644314|NCT00559962|82849750|FG002|Overall Study|Adverse Event|8|||
46644315|NCT00559962|82849751|FG003|Overall Study|Adverse Event|5|||
46644316|NCT00559962|82849752|FG004|Overall Study|Adverse Event|11|||
46644317|NCT00559962|82849753|FG005|Overall Study|Adverse Event|4|||
46644318|NCT00559962|82849754|FG006|Overall Study|Adverse Event|4|||
46644319|NCT00559962|82849755|FG007|Overall Study|Adverse Event|2|||
46644320|NCT00559962|82849748|FG000|Overall Study|Lost to Follow-up|0|||
46644321|NCT00559962|82849749|FG001|Overall Study|Lost to Follow-up|1|||
46644322|NCT00559962|82849750|FG002|Overall Study|Lost to Follow-up|0|||
46644323|NCT00559962|82849751|FG003|Overall Study|Lost to Follow-up|0|||
46644324|NCT00559962|82849752|FG004|Overall Study|Lost to Follow-up|0|||
46644325|NCT00559962|82849753|FG005|Overall Study|Lost to Follow-up|0|||
46644326|NCT00559962|82849754|FG006|Overall Study|Lost to Follow-up|0|||
46644327|NCT00559962|82849755|FG007|Overall Study|Lost to Follow-up|0|||
46644328|NCT00559962|82849748|FG000|Overall Study|Withdrawal by Subject|1|||
46644329|NCT00559962|82849749|FG001|Overall Study|Withdrawal by Subject|1|||
46644330|NCT00559962|82849750|FG002|Overall Study|Withdrawal by Subject|2|||
46644331|NCT00559962|82849751|FG003|Overall Study|Withdrawal by Subject|0|||
46644332|NCT00559962|82849752|FG004|Overall Study|Withdrawal by Subject|3|||
46644333|NCT00559962|82849753|FG005|Overall Study|Withdrawal by Subject|1|||
46644334|NCT00559962|82849754|FG006|Overall Study|Withdrawal by Subject|0|||
46644335|NCT00559962|82849755|FG007|Overall Study|Withdrawal by Subject|2|||
46644336|NCT00559962|82849748|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
46644337|NCT00559962|82849749|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
46644338|NCT00559962|82849750|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
46644339|NCT00559962|82849751|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
46644340|NCT00559962|82849752|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
46644341|NCT00559962|82849753|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
46644342|NCT00559962|82849754|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
46644343|NCT00559962|82849755|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
46644344|NCT00559104|82849776|FG000|Overall Study|Lack of Efficacy|9|||
46644345|NCT00559104|82849777|FG001|Overall Study|Lack of Efficacy|0|||
46644346|NCT00558636|82849785|FG000|Treatment|Adverse Event|9|||
46644347|NCT00558636|82849786|FG001|Treatment|Adverse Event|2|||
46644348|NCT00558636|82849785|FG000|Treatment|Withdrawal by Subject|2|||
46644349|NCT00558636|82849786|FG001|Treatment|Withdrawal by Subject|0|||
46644350|NCT00558636|82849785|FG000|Treatment|Premature termination of the study|35|||
46644351|NCT00558636|82849786|FG001|Treatment|Premature termination of the study|37|||
46644352|NCT00558636|82849785|FG000|Treatment|Disease progression|1|||
46644353|NCT00558636|82849786|FG001|Treatment|Disease progression|5|||
46644354|NCT00558636|82849785|FG000|Follow-up|Premature termination of the study|12|||
46644355|NCT00558636|82849786|FG001|Follow-up|Premature termination of the study|7|||
46644356|NCT00558558|82849792|FG000|Overall Study|Unable to swallow|1|||
46644357|NCT00558558|82849792|FG000|Overall Study|Withdrawal by Subject|1|||
46644358|NCT00558558|82849792|FG000|Overall Study|Lack of Efficacy|4|||
46644359|NCT00557622|82849798|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
46644360|NCT00557622|82849799|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
46644361|NCT00557622|82849798|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
46644362|NCT00557622|82849799|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
46644363|NCT00557622|82849798|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
46644364|NCT00557622|82849799|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
47074483|NCT00402298|83367292|FG000|Overall Study|Withdrawal by Subject|1|||
46644365|NCT00557466|82849811|FG000|Overall Study|Adverse Event|3|||
46644366|NCT00557466|82849812|FG001|Overall Study|Adverse Event|1|||
46644367|NCT00557466|82849813|FG002|Overall Study|Adverse Event|4|||
46644368|NCT00557466|82849814|FG003|Overall Study|Adverse Event|1|||
46644369|NCT00557466|82849815|FG004|Overall Study|Adverse Event|2|||
46644370|NCT00557466|82849816|FG005|Overall Study|Adverse Event|4|||
46644371|NCT00557466|82849811|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46644372|NCT00557466|82849812|FG001|Overall Study|Abnormal laboratory value(s)|2|||
47074484|NCT00402298|83367293|FG001|Overall Study|Withdrawal by Subject|0|||
47074485|NCT04362761|83367468|FG000|Part A (48 Weeks)|Adverse Event|2|||
47074486|NCT04362761|83367468|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
46644373|NCT00557466|82849813|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46644374|NCT00557466|82849814|FG003|Overall Study|Abnormal laboratory value(s)|0|||
47074487|NCT04362761|83367468|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
46644375|NCT00557466|82849815|FG004|Overall Study|Abnormal laboratory value(s)|0|||
46644376|NCT00557466|82849816|FG005|Overall Study|Abnormal laboratory value(s)|0|||
46644377|NCT00557466|82849811|FG000|Overall Study|Protocol deviation|0|||
46644378|NCT00557466|82849812|FG001|Overall Study|Protocol deviation|1|||
46644379|NCT00557466|82849813|FG002|Overall Study|Protocol deviation|0|||
46644380|NCT00557466|82849814|FG003|Overall Study|Protocol deviation|2|||
46644381|NCT00557466|82849815|FG004|Overall Study|Protocol deviation|0|||
46644382|NCT00557466|82849816|FG005|Overall Study|Protocol deviation|0|||
46644383|NCT00557466|82849811|FG000|Overall Study|Subject withdrew consent|0|||
46644384|NCT00557466|82849812|FG001|Overall Study|Subject withdrew consent|0|||
46644385|NCT00557466|82849813|FG002|Overall Study|Subject withdrew consent|0|||
46644386|NCT00557466|82849814|FG003|Overall Study|Subject withdrew consent|0|||
46644387|NCT00557466|82849815|FG004|Overall Study|Subject withdrew consent|1|||
46644388|NCT00557466|82849816|FG005|Overall Study|Subject withdrew consent|2|||
46644389|NCT00557466|82849811|FG000|Overall Study|Administrative problems|0|||
46644390|NCT00557466|82849812|FG001|Overall Study|Administrative problems|1|||
46644391|NCT00557466|82849813|FG002|Overall Study|Administrative problems|1|||
46644392|NCT00557466|82849814|FG003|Overall Study|Administrative problems|0|||
46644393|NCT00557466|82849815|FG004|Overall Study|Administrative problems|0|||
46644394|NCT00557466|82849816|FG005|Overall Study|Administrative problems|0|||
46644395|NCT00557466|82849811|FG000|Overall Study|Abnormal test procedure results|0|||
46644396|NCT00557466|82849812|FG001|Overall Study|Abnormal test procedure results|0|||
46644397|NCT00557466|82849813|FG002|Overall Study|Abnormal test procedure results|1|||
46644398|NCT00557466|82849814|FG003|Overall Study|Abnormal test procedure results|0|||
46644399|NCT00557466|82849815|FG004|Overall Study|Abnormal test procedure results|0|||
46779230|NCT00654381|82997858|FG003|2nd Stage|Adverse Event|3|||
46779231|NCT00654381|82997859|FG004|2nd Stage|Adverse Event|7|||
46644400|NCT00557466|82849816|FG005|Overall Study|Abnormal test procedure results|0|||
46644401|NCT00557466|82849811|FG000|Overall Study|Lost to Follow-up|0|||
46779232|NCT00654381|82997860|FG005|2nd Stage|Adverse Event|2|||
46779233|NCT00654381|82997855|FG000|2nd Stage|Withdrawal by Subject|0|||
46779234|NCT00654381|82997856|FG001|2nd Stage|Withdrawal by Subject|0|||
46779235|NCT00654381|82997857|FG002|2nd Stage|Withdrawal by Subject|0|||
46779236|NCT00654381|82997858|FG003|2nd Stage|Withdrawal by Subject|0|||
46779237|NCT00654381|82997859|FG004|2nd Stage|Withdrawal by Subject|1|||
46779238|NCT00654381|82997860|FG005|2nd Stage|Withdrawal by Subject|1|||
46779239|NCT00654381|82997855|FG000|2nd Stage|Investigator's decision|0|||
46779240|NCT00654381|82997856|FG001|2nd Stage|Investigator's decision|0|||
46779241|NCT00654381|82997857|FG002|2nd Stage|Investigator's decision|1|||
46850250|NCT00112437|83066384|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
46850251|NCT00112437|83066385|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
46850252|NCT00112437|83066386|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
46850253|NCT00112437|83066387|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
46850254|NCT00112437|83066388|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
46850255|NCT00112437|83066363|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46969998|NCT02102464|83212968|FG000|Randomized Study|Withdrawal by Subject|0|||
46969999|NCT02102464|83212969|FG001|Randomized Study|Withdrawal by Subject|1|||
46779242|NCT00654381|82997858|FG003|2nd Stage|Investigator's decision|1|||
46850256|NCT00112437|83066364|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850257|NCT00112437|83066365|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46970000|NCT02102464|83212970|FG002|Randomized Study|Withdrawal by Subject|0|||
46644402|NCT00557466|82849812|FG001|Overall Study|Lost to Follow-up|0|||
46644403|NCT00557466|82849813|FG002|Overall Study|Lost to Follow-up|0|||
46644404|NCT00557466|82849814|FG003|Overall Study|Lost to Follow-up|1|||
46644405|NCT00557466|82849815|FG004|Overall Study|Lost to Follow-up|0|||
46644406|NCT00557466|82849816|FG005|Overall Study|Lost to Follow-up|0|||
46644407|NCT00557310|82849830|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
46644408|NCT00557310|82849830|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
46779243|NCT00654381|82997859|FG004|2nd Stage|Investigator's decision|0|||
46779244|NCT00654381|82997860|FG005|2nd Stage|Investigator's decision|0|||
46779245|NCT00654381|82997855|FG000|Extension Stage|Adverse Event|1|||
46779246|NCT00654381|82997856|FG001|Extension Stage|Adverse Event|2|||
46779247|NCT00654381|82997857|FG002|Extension Stage|Adverse Event|9|||
46779248|NCT00654381|82997858|FG003|Extension Stage|Adverse Event|7|||
46779249|NCT00654381|82997859|FG004|Extension Stage|Adverse Event|1|||
46779250|NCT00654381|82997860|FG005|Extension Stage|Adverse Event|1|||
46779251|NCT00654381|82997855|FG000|Extension Stage|Protocol Violation|0|||
46779252|NCT00654381|82997856|FG001|Extension Stage|Protocol Violation|0|||
46779253|NCT00654381|82997857|FG002|Extension Stage|Protocol Violation|0|||
46644409|NCT00557310|82849830|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
46644410|NCT00557310|82849830|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
46644411|NCT00557310|82849830|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
46644412|NCT00557310|82849830|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
46644413|NCT00555438|82849834|FG000|10 Days Post-operative|Death|4|||
46644414|NCT00555438|82849834|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
46644415|NCT00553644|82849838|FG000|Overall Study|Adverse Event|17|||
46644416|NCT00553644|82849838|FG000|Overall Study|Withdrawal by Subject|4|||
46644417|NCT00553644|82849838|FG000|Overall Study|Physician Decision|1|||
46644418|NCT00553644|82849838|FG000|Overall Study|Alternative therapy|6|||
46644419|NCT00553332|82849842|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
47074488|NCT04362761|83367468|FG000|Part A (48 Weeks)|Other|5|||
47074489|NCT04362761|83367468|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
47074490|NCT04362761|83367468|FG000|Part B (86 Weeks)|Other|4|||
47074491|NCT00632749|83367664|FG000|Overall Study|Progressive disease|3|||
47074492|NCT00632749|83367665|FG001|Overall Study|Progressive disease|2|||
47074493|NCT00632749|83367666|FG002|Overall Study|Progressive disease|2|||
47074494|NCT00632749|83367667|FG003|Overall Study|Progressive disease|2|||
46644420|NCT00552396|82849853|FG000|Overall Study|protocol withdrawal criteria|3|||
46644421|NCT00552396|82849854|FG001|Overall Study|protocol withdrawal criteria|3|||
46644422|NCT00552396|82849855|FG002|Overall Study|protocol withdrawal criteria|3|||
46644423|NCT00552396|82849856|FG003|Overall Study|protocol withdrawal criteria|6|||
46644424|NCT00552396|82849857|FG004|Overall Study|protocol withdrawal criteria|3|||
46644425|NCT00552396|82849858|FG005|Overall Study|protocol withdrawal criteria|3|||
46644426|NCT00552396|82849859|FG006|Overall Study|protocol withdrawal criteria|9|||
46644427|NCT00552240|82849895|FG000|Overall Study|Adverse Event|9|||
46644428|NCT00552240|82849896|FG001|Overall Study|Adverse Event|9|||
46644429|NCT00552240|82849895|FG000|Overall Study|Protocol Violation|1|||
46644430|NCT00552240|82849896|FG001|Overall Study|Protocol Violation|1|||
46644431|NCT00552240|82849895|FG000|Overall Study|Lost to Follow-up|5|||
46644432|NCT00552240|82849896|FG001|Overall Study|Lost to Follow-up|6|||
46644433|NCT00552240|82849895|FG000|Overall Study|Withdrawal by Subject|2|||
46850258|NCT00112437|83066366|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850259|NCT00112437|83066367|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850260|NCT00112437|83066368|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46970001|NCT02707601|83212981|FG000|Overall Study|Death|0|||
47074495|NCT00632749|83367668|FG004|Overall Study|Progressive disease|4|||
47074496|NCT00632749|83367669|FG005|Overall Study|Progressive disease|4|||
47074497|NCT00632749|83367670|FG006|Overall Study|Progressive disease|3|||
47074498|NCT00632749|83367671|FG007|Overall Study|Progressive disease|2|||
47074499|NCT00632749|83367672|FG008|Overall Study|Progressive disease|3|||
47074500|NCT00632749|83367673|FG009|Overall Study|Progressive disease|2|||
47074501|NCT00632749|83367674|FG010|Overall Study|Progressive disease|4|||
47074502|NCT00632749|83367675|FG011|Overall Study|Progressive disease|3|||
46644434|NCT00552240|82849896|FG001|Overall Study|Withdrawal by Subject|2|||
46644435|NCT00552240|82849895|FG000|Overall Study|Lack of Efficacy|6|||
46644436|NCT00552240|82849896|FG001|Overall Study|Lack of Efficacy|0|||
46779254|NCT00654381|82997858|FG003|Extension Stage|Protocol Violation|1|||
46779255|NCT00654381|82997859|FG004|Extension Stage|Protocol Violation|0|||
46779256|NCT00654381|82997860|FG005|Extension Stage|Protocol Violation|0|||
46779257|NCT00654381|82997855|FG000|Extension Stage|Lack of Efficacy|0|||
47074503|NCT00632749|83367676|FG012|Overall Study|Progressive disease|2|||
47074504|NCT00632749|83367677|FG013|Overall Study|Progressive disease|4|||
47074505|NCT00632749|83367664|FG000|Overall Study|Other Adverse event|1|||
47074506|NCT00632749|83367665|FG001|Overall Study|Other Adverse event|1|||
47074507|NCT00632749|83367666|FG002|Overall Study|Other Adverse event|1|||
46644437|NCT00552240|82849895|FG000|Overall Study|Other|1|||
46779258|NCT00654381|82997856|FG001|Extension Stage|Lack of Efficacy|0|||
46779259|NCT00654381|82997857|FG002|Extension Stage|Lack of Efficacy|1|||
46779260|NCT00654381|82997858|FG003|Extension Stage|Lack of Efficacy|0|||
46779261|NCT00654381|82997859|FG004|Extension Stage|Lack of Efficacy|0|||
46779262|NCT00654381|82997860|FG005|Extension Stage|Lack of Efficacy|0|||
46779263|NCT00654381|82997855|FG000|Extension Stage|Withdrawal by Subject|0|||
46779264|NCT00654381|82997856|FG001|Extension Stage|Withdrawal by Subject|0|||
46779265|NCT00654381|82997857|FG002|Extension Stage|Withdrawal by Subject|1|||
46779266|NCT00654381|82997858|FG003|Extension Stage|Withdrawal by Subject|1|||
46850261|NCT00112437|83066369|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850262|NCT00112437|83066370|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850263|NCT00112437|83066371|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850264|NCT00112437|83066372|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
47074508|NCT00632749|83367667|FG003|Overall Study|Other Adverse event|1|||
47074509|NCT00632749|83367668|FG004|Overall Study|Other Adverse event|2|||
47074510|NCT00632749|83367669|FG005|Overall Study|Other Adverse event|4|||
47074511|NCT00632749|83367670|FG006|Overall Study|Other Adverse event|1|||
47074512|NCT00632749|83367671|FG007|Overall Study|Other Adverse event|2|||
47074513|NCT00632749|83367672|FG008|Overall Study|Other Adverse event|2|||
47074514|NCT00632749|83367673|FG009|Overall Study|Other Adverse event|0|||
47074515|NCT00632749|83367674|FG010|Overall Study|Other Adverse event|1|||
47074516|NCT00632749|83367675|FG011|Overall Study|Other Adverse event|0|||
47074517|NCT00632749|83367676|FG012|Overall Study|Other Adverse event|1|||
47074518|NCT00632749|83367677|FG013|Overall Study|Other Adverse event|0|||
47074519|NCT00632749|83367664|FG000|Overall Study|Refuse to continue medication|0|||
47074520|NCT00632749|83367665|FG001|Overall Study|Refuse to continue medication|0|||
46644438|NCT00552240|82849896|FG001|Overall Study|Other|0|||
46644439|NCT00552084|82849904|FG000|Overall Study|Adverse Event|2|||
46644440|NCT00552084|82849905|FG001|Overall Study|Adverse Event|3|||
46644441|NCT00552084|82849904|FG000|Overall Study|Withdrawal by Subject|4|||
46644442|NCT00552084|82849905|FG001|Overall Study|Withdrawal by Subject|5|||
46644443|NCT00552084|82849904|FG000|Overall Study|Protocol Violation|1|||
46644444|NCT00552084|82849905|FG001|Overall Study|Protocol Violation|0|||
46644445|NCT00552084|82849904|FG000|Overall Study|change in anti-arrythmic drug|1|||
46644446|NCT00552084|82849905|FG001|Overall Study|change in anti-arrythmic drug|1|||
46644447|NCT00550836|82849913|FG000|Overall Study|Withdrawal by Subject|3|||
46644448|NCT00550836|82849914|FG001|Overall Study|Withdrawal by Subject|9|||
46644449|NCT00550680|82849920|FG000|Overall Study|Administrative Reasons|1|||
46644450|NCT00550680|82849920|FG000|Overall Study|Adverse Event|5|||
46644451|NCT00550680|82849920|FG000|Overall Study|Death|3|||
46644452|NCT00550680|82849920|FG000|Overall Study|Early Improvement|1|||
46644453|NCT00550680|82849920|FG000|Overall Study|Lost to Follow-up|3|||
46644454|NCT00550680|82849920|FG000|Overall Study|Lack of Efficacy|1|||
46644455|NCT00550680|82849920|FG000|Overall Study|Other|10|||
46644456|NCT00550680|82849920|FG000|Overall Study|Protocol Violation|7|||
46644457|NCT00550680|82849920|FG000|Overall Study|Refused Treatment|19|||
46644458|NCT00550680|82849920|FG000|Overall Study|Screen Failure|6|||
46644459|NCT00554190|82849924|FG000|Overall Study|Termination forms not completed|10|||
46644460|NCT00556374|82849930|FG000|Overall Study|Withdrawal by Subject|235|||
46644461|NCT00556374|82849931|FG001|Overall Study|Withdrawal by Subject|205|||
46644462|NCT00556374|82849930|FG000|Overall Study|Death|158|||
46644463|NCT00556374|82849931|FG001|Overall Study|Death|127|||
46644464|NCT00556374|82849930|FG000|Overall Study|Lost to Follow-up|24|||
46644465|NCT00556374|82849931|FG001|Overall Study|Lost to Follow-up|17|||
46644466|NCT00556374|82849930|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
46644467|NCT00556374|82849931|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
46644468|NCT04677959|82849962|FG000|Overall Study|Adverse Event|1|||
46779267|NCT00654381|82997859|FG004|Extension Stage|Withdrawal by Subject|1|||
46779268|NCT00654381|82997860|FG005|Extension Stage|Withdrawal by Subject|1|||
46779269|NCT00654381|82997855|FG000|Extension Stage|Closure of the trial site|0|||
46779270|NCT00654381|82997856|FG001|Extension Stage|Closure of the trial site|0|||
46779271|NCT00654381|82997857|FG002|Extension Stage|Closure of the trial site|0|||
46644469|NCT04677959|82849963|FG001|Overall Study|Adverse Event|9|||
46850265|NCT00112437|83066373|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850266|NCT00112437|83066374|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
46779272|NCT00654381|82997858|FG003|Extension Stage|Closure of the trial site|0|||
46779273|NCT00654381|82997859|FG004|Extension Stage|Closure of the trial site|1|||
46779274|NCT00654381|82997860|FG005|Extension Stage|Closure of the trial site|1|||
46779275|NCT00657267|82997890|FG000|Overall Study|Progressive disease|45|||
46779276|NCT00657267|82997890|FG000|Overall Study|Adverse Event|9|||
46779277|NCT00653991|82997898|FG000|3 Month Follow-up|Participant would not respond|150|||
46779278|NCT00653991|82997899|FG001|3 Month Follow-up|Participant would not respond|157|||
46779279|NCT00653991|82997898|FG000|6 Month Follow-up|Participant would not respond|133|||
46779280|NCT00653991|82997899|FG001|6 Month Follow-up|Participant would not respond|141|||
46779281|NCT00652899|82997907|FG000|Overall Study|Death|1|||
46779282|NCT00652899|82997907|FG000|Overall Study|Treating physician decision|1|||
46779283|NCT00617890|82997919|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
46779284|NCT00617890|82997920|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
46779285|NCT00617890|82997921|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
46779286|NCT00617890|82997922|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
46779287|NCT00617890|82997919|FG000|Overall Study|Lack of Efficacy|23|||
46779288|NCT00617890|82997920|FG001|Overall Study|Lack of Efficacy|26|||
46644470|NCT04677959|82849962|FG000|Overall Study|Withdrawal by Subject|2|||
46644471|NCT04677959|82849963|FG001|Overall Study|Withdrawal by Subject|15|||
46779289|NCT00617890|82997921|FG002|Overall Study|Lack of Efficacy|30|||
46779290|NCT00617890|82997922|FG003|Overall Study|Lack of Efficacy|97|||
46779291|NCT00617890|82997919|FG000|Overall Study|Lost to Follow-up|0|||
46779292|NCT00617890|82997920|FG001|Overall Study|Lost to Follow-up|0|||
46779293|NCT00617890|82997921|FG002|Overall Study|Lost to Follow-up|1|||
46779294|NCT00617890|82997922|FG003|Overall Study|Lost to Follow-up|2|||
46779295|NCT00617890|82997919|FG000|Overall Study|Withdrawal by Subject|4|||
46779296|NCT00617890|82997920|FG001|Overall Study|Withdrawal by Subject|1|||
46779297|NCT00617890|82997921|FG002|Overall Study|Withdrawal by Subject|0|||
46779298|NCT00617890|82997922|FG003|Overall Study|Withdrawal by Subject|2|||
46779299|NCT00617890|82997919|FG000|Overall Study|Protocol Violation|2|||
46779300|NCT00617890|82997920|FG001|Overall Study|Protocol Violation|1|||
46779301|NCT00617890|82997921|FG002|Overall Study|Protocol Violation|0|||
46779302|NCT00617890|82997922|FG003|Overall Study|Protocol Violation|0|||
46779303|NCT00617890|82997919|FG000|Overall Study|Adverse Event|1|||
46779304|NCT00617890|82997920|FG001|Overall Study|Adverse Event|0|||
46779305|NCT00617890|82997921|FG002|Overall Study|Adverse Event|3|||
46850267|NCT00112437|83066375|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850268|NCT00112437|83066376|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
46644472|NCT04677959|82849962|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46644473|NCT04677959|82849963|FG001|Overall Study|Withdrawal by parent/guardian|1|||
46644474|NCT04677959|82849962|FG000|Overall Study|Non-compliance with study drug|0|||
46644475|NCT04677959|82849963|FG001|Overall Study|Non-compliance with study drug|2|||
46644476|NCT04677959|82849962|FG000|Overall Study|Protocol deviation|0|||
46644477|NCT04677959|82849963|FG001|Overall Study|Protocol deviation|11|||
46644478|NCT04677959|82849962|FG000|Overall Study|Lost to Follow-up|9|||
47074521|NCT00632749|83367666|FG002|Overall Study|Refuse to continue medication|0|||
47074522|NCT00632749|83367667|FG003|Overall Study|Refuse to continue medication|1|||
47074523|NCT00632749|83367668|FG004|Overall Study|Refuse to continue medication|0|||
47074524|NCT00632749|83367669|FG005|Overall Study|Refuse to continue medication|0|||
47074525|NCT00632749|83367670|FG006|Overall Study|Refuse to continue medication|0|||
47074526|NCT00632749|83367671|FG007|Overall Study|Refuse to continue medication|0|||
47074527|NCT00632749|83367672|FG008|Overall Study|Refuse to continue medication|0|||
47074528|NCT00632749|83367673|FG009|Overall Study|Refuse to continue medication|1|||
47074529|NCT00632749|83367674|FG010|Overall Study|Refuse to continue medication|0|||
47074530|NCT00632749|83367675|FG011|Overall Study|Refuse to continue medication|0|||
47074531|NCT00632749|83367676|FG012|Overall Study|Refuse to continue medication|0|||
47074532|NCT00632749|83367677|FG013|Overall Study|Refuse to continue medication|0|||
47074533|NCT00632749|83367664|FG000|Overall Study|Reason other than those specified above|0|||
47074534|NCT00632749|83367665|FG001|Overall Study|Reason other than those specified above|2|||
46644479|NCT04677959|82849963|FG001|Overall Study|Lost to Follow-up|13|||
46644480|NCT04677959|82849962|FG000|Overall Study|Other than specified|0|||
46644481|NCT04677959|82849963|FG001|Overall Study|Other than specified|8|||
46779306|NCT00617890|82997922|FG003|Overall Study|Adverse Event|8|||
46779307|NCT00617890|82997919|FG000|Overall Study|Not treated|1|||
46779308|NCT00617890|82997920|FG001|Overall Study|Not treated|0|||
46850269|NCT00112437|83066377|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46779309|NCT00617890|82997921|FG002|Overall Study|Not treated|1|||
46779310|NCT00617890|82997922|FG003|Overall Study|Not treated|1|||
46779311|NCT00712166|82997937|FG000|Overall Study|Noncompliance|0|||
46779312|NCT00712166|82997938|FG001|Overall Study|Noncompliance|1|||
46779313|NCT00652743|82997949|FG000|Months 12-18|Lost to Follow-up|1|||
46850270|NCT00112437|83066378|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
46850271|NCT00112437|83066379|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46779314|NCT00652743|82997950|FG001|Months 12-18|Lost to Follow-up|2|||
46779315|NCT00652743|82997951|FG002|Months 12-18|Lost to Follow-up|7|||
46779316|NCT00652743|82997949|FG000|Months 24-30|Other|5|||
46779317|NCT00652743|82997950|FG001|Months 24-30|Other|1|||
46779318|NCT00652743|82997951|FG002|Months 24-30|Other|11|||
46779319|NCT00652743|82997949|FG000|Months 36-42|Serious Adverse Events|0|||
46779320|NCT00652743|82997950|FG001|Months 36-42|Serious Adverse Events|1|||
47074535|NCT00632749|83367666|FG002|Overall Study|Reason other than those specified above|0|||
47074536|NCT00632749|83367667|FG003|Overall Study|Reason other than those specified above|0|||
47074537|NCT00632749|83367668|FG004|Overall Study|Reason other than those specified above|1|||
47074538|NCT00632749|83367669|FG005|Overall Study|Reason other than those specified above|0|||
47074539|NCT00632749|83367670|FG006|Overall Study|Reason other than those specified above|1|||
47074540|NCT00632749|83367671|FG007|Overall Study|Reason other than those specified above|0|||
47074541|NCT00632749|83367672|FG008|Overall Study|Reason other than those specified above|0|||
47074542|NCT00632749|83367673|FG009|Overall Study|Reason other than those specified above|0|||
47074543|NCT00632749|83367674|FG010|Overall Study|Reason other than those specified above|2|||
47074544|NCT00632749|83367675|FG011|Overall Study|Reason other than those specified above|1|||
47074545|NCT00632749|83367676|FG012|Overall Study|Reason other than those specified above|0|||
47074546|NCT00632749|83367677|FG013|Overall Study|Reason other than those specified above|2|||
47074547|NCT00632359|83367738|FG000|Overall Study|Withdrawal by Subject|2|||
47074548|NCT00632203|83367745|FG000|Overall Study|Did not start study treatment|1|||
47074549|NCT00632203|83367746|FG001|Overall Study|Did not start study treatment|0|||
47074550|NCT03830333|83367767|FG000|Overall Study|Death|0|||
47074551|NCT03830333|83367768|FG001|Overall Study|Death|1|||
47074552|NCT03830333|83367767|FG000|Overall Study|Withdrawal by Subject|5|||
47074553|NCT03830333|83367768|FG001|Overall Study|Withdrawal by Subject|1|||
47074554|NCT03830333|83367767|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
47074555|NCT03830333|83367768|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
47074556|NCT00631969|83367854|FG000|Overall Study|Adverse Event|3|||
47074557|NCT00631969|83367855|FG001|Overall Study|Adverse Event|1|||
47074558|NCT00631969|83367854|FG000|Overall Study|Lack of Efficacy|2|||
47074559|NCT00631969|83367855|FG001|Overall Study|Lack of Efficacy|8|||
47074560|NCT00631969|83367854|FG000|Overall Study|Lost to Follow-up|2|||
47074561|NCT00631969|83367855|FG001|Overall Study|Lost to Follow-up|1|||
47074562|NCT00631969|83367854|FG000|Overall Study|Protocol Violation|1|||
47074563|NCT00631969|83367855|FG001|Overall Study|Protocol Violation|1|||
47074564|NCT00631969|83367854|FG000|Overall Study|Consent Withdrawn|5|||
47074565|NCT00631969|83367855|FG001|Overall Study|Consent Withdrawn|7|||
47074566|NCT00631969|83367854|FG000|Overall Study|Noncompliant With Study Medication|0|||
47074567|NCT00631969|83367855|FG001|Overall Study|Noncompliant With Study Medication|1|||
47074568|NCT00631969|83367854|FG000|Overall Study|No Drug Exposure|2|||
47074569|NCT00631969|83367855|FG001|Overall Study|No Drug Exposure|2|||
47074570|NCT00631657|83367891|FG000|6-Month Treatment Period|Adverse Event|47|||
47074571|NCT00631657|83367892|FG001|6-Month Treatment Period|Adverse Event|0|||
47074572|NCT00631657|83367893|FG002|6-Month Treatment Period|Adverse Event|7|||
47074573|NCT00631657|83367891|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
47074574|NCT00631657|83367892|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
47074575|NCT00631657|83367893|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
47074576|NCT00631657|83367891|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
47074577|NCT00631657|83367892|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
47074578|NCT00631657|83367893|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
47074579|NCT00631657|83367891|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
47074580|NCT00631657|83367892|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
47074581|NCT00631657|83367893|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
47074582|NCT00631657|83367891|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
47074583|NCT00631657|83367892|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
47074584|NCT00631657|83367893|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
47074585|NCT00631657|83367891|FG000|6-Month Treatment Period|Other|16|||
47074586|NCT00631657|83367892|FG001|6-Month Treatment Period|Other|0|||
47074587|NCT00631657|83367893|FG002|6-Month Treatment Period|Other|4|||
47074588|NCT00631657|83367891|FG000|6-Month Treatment Period|Not Treated|2|||
47074589|NCT00631657|83367892|FG001|6-Month Treatment Period|Not Treated|0|||
47074590|NCT00631657|83367893|FG002|6-Month Treatment Period|Not Treated|1|||
47074591|NCT00631657|83367891|FG000|7-Day Discontinuation Period|Not Treated|1|||
47074592|NCT00631657|83367892|FG001|7-Day Discontinuation Period|Not Treated|1|||
47074593|NCT00631657|83367893|FG002|7-Day Discontinuation Period|Not Treated|1|||
47074594|NCT00631657|83367891|FG000|7-Day Discontinuation Period|Other|1|||
47074595|NCT00631657|83367892|FG001|7-Day Discontinuation Period|Other|0|||
47074596|NCT00631657|83367893|FG002|7-Day Discontinuation Period|Other|0|||
46644482|NCT04330638|82849990|FG000|Overall Study|Adverse Event|9|||
46850272|NCT00112437|83066380|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
47074597|NCT00631189|83367931|FG000|Initial Phase|Protocol Violation|347|||
46779321|NCT00652743|82997951|FG002|Months 36-42|Serious Adverse Events|1|||
46644483|NCT04330638|82849991|FG001|Overall Study|Adverse Event|10|||
46644484|NCT04330638|82849992|FG002|Overall Study|Adverse Event|15|||
46644485|NCT04330638|82849993|FG003|Overall Study|Adverse Event|6|||
46644486|NCT04330638|82849994|FG004|Overall Study|Adverse Event|10|||
46644487|NCT04330638|82849995|FG005|Overall Study|Adverse Event|5|||
46644488|NCT04330638|82849990|FG000|Overall Study|Other|2|||
46644489|NCT04330638|82849991|FG001|Overall Study|Other|2|||
46644490|NCT04330638|82849992|FG002|Overall Study|Other|5|||
46970002|NCT02707601|83212982|FG001|Overall Study|Death|1|||
46970003|NCT02707601|83212981|FG000|Overall Study|Lack of Efficacy|0|||
46970004|NCT02707601|83212982|FG001|Overall Study|Lack of Efficacy|1|||
46970005|NCT02707601|83212981|FG000|Overall Study|Investigator's Discretion|1|||
46970006|NCT02707601|83212982|FG001|Overall Study|Investigator's Discretion|0|||
46644491|NCT04330638|82849993|FG003|Overall Study|Other|1|||
46644492|NCT04330638|82849994|FG004|Overall Study|Other|3|||
46644493|NCT04330638|82849995|FG005|Overall Study|Other|2|||
46644494|NCT04330638|82849990|FG000|Overall Study|Withdrawal by Subject|4|||
46644495|NCT04330638|82849991|FG001|Overall Study|Withdrawal by Subject|0|||
46644496|NCT04330638|82849992|FG002|Overall Study|Withdrawal by Subject|0|||
46644497|NCT04330638|82849993|FG003|Overall Study|Withdrawal by Subject|0|||
46644498|NCT04330638|82849994|FG004|Overall Study|Withdrawal by Subject|0|||
46644499|NCT04330638|82849995|FG005|Overall Study|Withdrawal by Subject|0|||
46644500|NCT04330638|82849990|FG000|Overall Study|Lost to Follow-up|3|||
46644501|NCT04330638|82849991|FG001|Overall Study|Lost to Follow-up|2|||
46644502|NCT04330638|82849992|FG002|Overall Study|Lost to Follow-up|3|||
46644503|NCT04330638|82849993|FG003|Overall Study|Lost to Follow-up|2|||
46644504|NCT04330638|82849994|FG004|Overall Study|Lost to Follow-up|3|||
46644505|NCT04330638|82849995|FG005|Overall Study|Lost to Follow-up|0|||
46644506|NCT04194541|82850016|FG000|Day 1 Through 13|Lost to Follow-up|3|||
46644507|NCT04194541|82850016|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
46779322|NCT00652743|82997949|FG000|Months 36-42|Withdrawal by Subject|1|||
46779323|NCT00652743|82997950|FG001|Months 36-42|Withdrawal by Subject|1|||
46779324|NCT00652743|82997951|FG002|Months 36-42|Withdrawal by Subject|0|||
46779325|NCT00652743|82997949|FG000|Months 36-42|Lost to Follow-up|0|||
46779326|NCT00652743|82997950|FG001|Months 36-42|Lost to Follow-up|1|||
46779327|NCT00652743|82997951|FG002|Months 36-42|Lost to Follow-up|0|||
46644508|NCT04194541|82850016|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
46779328|NCT00652743|82997949|FG000|Months 36-42|Migrated/moved from study area|1|||
46779329|NCT00652743|82997950|FG001|Months 36-42|Migrated/moved from study area|0|||
46779330|NCT00652743|82997951|FG002|Months 36-42|Migrated/moved from study area|0|||
46779331|NCT00652743|82997949|FG000|Months 36-42|Other|4|||
46779332|NCT00652743|82997950|FG001|Months 36-42|Other|2|||
46779333|NCT00652743|82997951|FG002|Months 36-42|Other|8|||
46779334|NCT00712010|82997962|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
46779335|NCT00653523|82997978|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
46779336|NCT00653523|82997978|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
46779337|NCT00653523|82997978|FG000|Overall Study|Adverse Event|7|||
46779338|NCT00653523|82997978|FG000|Overall Study|Withdrawal by Subject|6|||
46779339|NCT00653523|82997978|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
46644509|NCT04006392|82850034|FG000|Overall Study|Lost to Follow-up|0|||
46644510|NCT04006392|82850035|FG001|Overall Study|Lost to Follow-up|1|||
46644511|NCT03959423|82850043|FG000|Overall Study|Withdrawal by Subject|2|||
46644512|NCT03959423|82850044|FG001|Overall Study|Withdrawal by Subject|3|||
46644513|NCT03959423|82850043|FG000|Overall Study|Physician Decision|0|||
46644514|NCT03959423|82850044|FG001|Overall Study|Physician Decision|1|||
46644515|NCT03959423|82850043|FG000|Overall Study|Lost to Follow-up|1|||
46644516|NCT03959423|82850044|FG001|Overall Study|Lost to Follow-up|0|||
46644517|NCT03959423|82850043|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
46644518|NCT03959423|82850044|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46644519|NCT03786783|82850050|FG000|Overall Study|Death|1|||
46644520|NCT03786783|82850050|FG000|Overall Study|Physician Decision|6|||
46644521|NCT03786783|82850050|FG000|Overall Study|Withdrawal by Subject|2|||
46644522|NCT03786783|82850050|FG000|Overall Study|Disease Progression|7|||
46644523|NCT03786783|82850050|FG000|Overall Study|Patient/Parent Refusal|4|||
46644524|NCT03432494|82850064|FG000|Overall Study|Death|1|||
46644525|NCT03432494|82850064|FG000|Overall Study|Noncompliance|1|||
46644526|NCT03287830|82850070|FG000|Overall Study|Withdrawal by Subject|1|||
46644527|NCT03287830|82850071|FG001|Overall Study|Withdrawal by Subject|1|||
46644528|NCT03287830|82850070|FG000|Overall Study|not meeting inclusion criteria|5|||
46644529|NCT03287830|82850071|FG001|Overall Study|not meeting inclusion criteria|12|||
46644530|NCT03181633|82850081|FG000|Overall Study|Withdrawal by Subject|1|||
46644531|NCT03181633|82850081|FG000|Overall Study|Missing follow-up visit|1|||
46644532|NCT03122223|82850098|FG000|Overall Study|Withdrawal by Subject|2|||
46644533|NCT03122223|82850099|FG001|Overall Study|Withdrawal by Subject|2|||
46644534|NCT03122223|82850100|FG002|Overall Study|Withdrawal by Subject|1|||
46644535|NCT03122223|82850101|FG003|Overall Study|Withdrawal by Subject|0|||
46644536|NCT03122223|82850098|FG000|Overall Study|Lost to Follow-up|0|||
46644537|NCT03122223|82850099|FG001|Overall Study|Lost to Follow-up|2|||
46644538|NCT03122223|82850100|FG002|Overall Study|Lost to Follow-up|2|||
46644539|NCT03122223|82850101|FG003|Overall Study|Lost to Follow-up|0|||
46644540|NCT03122223|82850098|FG000|Overall Study|Participant unable to adhere|1|||
46644541|NCT03122223|82850099|FG001|Overall Study|Participant unable to adhere|1|||
46644542|NCT03122223|82850100|FG002|Overall Study|Participant unable to adhere|1|||
46644543|NCT03122223|82850101|FG003|Overall Study|Participant unable to adhere|0|||
46644544|NCT03077087|82850111|FG000|Overall Study|Physician Decision|2|||
46644545|NCT02853604|82850117|FG000|Overall Study|Withdrawal by Subject|12|||
46644546|NCT02853604|82850118|FG001|Overall Study|Withdrawal by Subject|35|||
46644547|NCT02853604|82850117|FG000|Overall Study|Lost to Follow-up|4|||
46644548|NCT02853604|82850118|FG001|Overall Study|Lost to Follow-up|8|||
46644549|NCT02853604|82850117|FG000|Overall Study|Death|1|||
46850273|NCT00112437|83066381|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
46644550|NCT02853604|82850118|FG001|Overall Study|Death|5|||
46644551|NCT02853604|82850117|FG000|Overall Study|Miscellaneous|11|||
46850274|NCT00112437|83066382|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850275|NCT00112437|83066383|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850276|NCT00112437|83066384|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850277|NCT00112437|83066385|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850278|NCT00112437|83066386|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46970007|NCT02707601|83212981|FG000|Overall Study|Withdrew Consent|0|||
46644552|NCT02853604|82850118|FG001|Overall Study|Miscellaneous|2|||
46644553|NCT02853604|82850117|FG000|Overall Study|Progressive Disease|0|||
46644554|NCT02853604|82850118|FG001|Overall Study|Progressive Disease|2|||
46644555|NCT02632552|82850144|FG000|Overall Study|Lost to Follow-up|14|||
46644556|NCT02632552|82850145|FG001|Overall Study|Lost to Follow-up|8|||
46644557|NCT02632552|82850144|FG000|Overall Study|Withdrawal by Subject|2|||
46644558|NCT02632552|82850145|FG001|Overall Study|Withdrawal by Subject|0|||
46644559|NCT02632552|82850144|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
46644560|NCT02632552|82850145|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
46644561|NCT01992653|82850178|FG000|Overall Study|Death|0|||
46644562|NCT01992653|82850179|FG001|Overall Study|Death|0|||
46644563|NCT01992653|82850180|FG002|Overall Study|Death|1|||
46644564|NCT01992653|82850181|FG003|Overall Study|Death|0|||
46644565|NCT01992653|82850182|FG004|Overall Study|Death|1|||
46644566|NCT01992653|82850183|FG005|Overall Study|Death|0|||
46644567|NCT01992653|82850184|FG006|Overall Study|Death|4|||
46644568|NCT01992653|82850185|FG007|Overall Study|Death|2|||
46644569|NCT01992653|82850178|FG000|Overall Study|Lost to Follow-up|0|||
46644570|NCT01992653|82850179|FG001|Overall Study|Lost to Follow-up|0|||
46644571|NCT01992653|82850180|FG002|Overall Study|Lost to Follow-up|0|||
46644572|NCT01992653|82850181|FG003|Overall Study|Lost to Follow-up|0|||
46644573|NCT01992653|82850182|FG004|Overall Study|Lost to Follow-up|0|||
46644574|NCT01992653|82850183|FG005|Overall Study|Lost to Follow-up|0|||
46644575|NCT01992653|82850184|FG006|Overall Study|Lost to Follow-up|0|||
46644576|NCT01992653|82850185|FG007|Overall Study|Lost to Follow-up|1|||
46644577|NCT01992653|82850178|FG000|Overall Study|Study Completed|0|||
46644578|NCT01992653|82850179|FG001|Overall Study|Study Completed|0|||
46644579|NCT01992653|82850180|FG002|Overall Study|Study Completed|0|||
46644580|NCT01992653|82850181|FG003|Overall Study|Study Completed|0|||
46644581|NCT01992653|82850182|FG004|Overall Study|Study Completed|0|||
46644582|NCT01992653|82850183|FG005|Overall Study|Study Completed|0|||
46644583|NCT01992653|82850184|FG006|Overall Study|Study Completed|0|||
46644584|NCT01992653|82850185|FG007|Overall Study|Study Completed|1|||
46644585|NCT01992653|82850178|FG000|Overall Study|Disease Progression|0|||
46644586|NCT01992653|82850179|FG001|Overall Study|Disease Progression|0|||
46644587|NCT01992653|82850180|FG002|Overall Study|Disease Progression|0|||
46644588|NCT01992653|82850181|FG003|Overall Study|Disease Progression|0|||
46644589|NCT01992653|82850182|FG004|Overall Study|Disease Progression|0|||
46644590|NCT01992653|82850183|FG005|Overall Study|Disease Progression|0|||
46644591|NCT01992653|82850184|FG006|Overall Study|Disease Progression|4|||
46644592|NCT01992653|82850185|FG007|Overall Study|Disease Progression|0|||
46644593|NCT01654276|82850220|FG000|Overall Study|Lack of Efficacy|1|||
46644594|NCT01654276|82850220|FG000|Overall Study|Lost to Follow-up|4|||
46644595|NCT01654276|82850220|FG000|Overall Study|Withdrawal by Subject|1|||
46644596|NCT01399658|82850224|FG000|Overall Study|Ineligible|1|||
46644597|NCT01399658|82850224|FG000|Overall Study|Machine Technical Issue|3|||
46644598|NCT01399658|82850224|FG000|Overall Study|Alternative therapy|1|||
46644599|NCT01399658|82850224|FG000|Overall Study|No reason given|1|||
46644600|NCT00590122|82850230|FG000|Overall Study|swallowed oral dissolving dose|1|||
46644601|NCT00590122|82850231|FG001|Overall Study|swallowed oral dissolving dose|0|||
46644602|NCT01386658|82850260|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
46644603|NCT01386658|82850261|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
46644604|NCT01386658|82850260|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
46779340|NCT00653523|82997978|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
46644605|NCT01386658|82850261|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
46644606|NCT01386684|82850271|FG000|Overall Study|Lost to Follow-up|51|||
46644607|NCT01386684|82850271|FG000|Overall Study|Other|51|||
46644608|NCT01386684|82850271|FG000|Overall Study|Death|47|||
46644609|NCT01386684|82850271|FG000|Overall Study|Withdrawal of Consent|44|||
46644610|NCT01386684|82850271|FG000|Overall Study|Alternative Therapy Required|37|||
46644611|NCT01386684|82850271|FG000|Overall Study|Disease Progression|28|||
46644612|NCT01386684|82850271|FG000|Overall Study|Adverse Event|20|||
46644613|NCT01386684|82850271|FG000|Overall Study|Noncompliance|8|||
46644614|NCT01386684|82850271|FG000|Overall Study|Protocol Violation|4|||
46644615|NCT01386684|82850271|FG000|Overall Study|Missing|3|||
46644616|NCT04980014|82850288|FG000|Overall Study|Participants who are Duplicated|1|||
46644617|NCT04980014|82850288|FG000|Overall Study|Follow-up Failure|13|||
46644618|NCT04980014|82850288|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
46644619|NCT04980014|82850288|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
46644620|NCT04980014|82850288|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
46644621|NCT05301322|82850311|FG000|Overall Study|Adverse Event|7|||
46644622|NCT05301322|82850312|FG001|Overall Study|Adverse Event|3|||
46644623|NCT05301322|82850311|FG000|Overall Study|Death|0|||
46644624|NCT05301322|82850312|FG001|Overall Study|Death|1|||
46644625|NCT05301322|82850311|FG000|Overall Study|Lost to Follow-up|2|||
46644626|NCT05301322|82850312|FG001|Overall Study|Lost to Follow-up|1|||
46779341|NCT02717442|82997984|FG000|Overall Study|Study Terminated by Sponsor|31|||
46779342|NCT02717442|82997985|FG001|Overall Study|Study Terminated by Sponsor|29|||
46779343|NCT02717442|82997984|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
46779344|NCT02717442|82997985|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
46779345|NCT02717442|82997984|FG000|Overall Study|Other - Not Specified|2|||
46779346|NCT02717442|82997985|FG001|Overall Study|Other - Not Specified|0|||
46779347|NCT05233085|82998010|FG000|Overall Study|Adverse Event|1|||
46779348|NCT05233085|82998011|FG001|Overall Study|Adverse Event|0|||
46779349|NCT05233085|82998012|FG002|Overall Study|Adverse Event|0|||
46779350|NCT05233085|82998013|FG003|Overall Study|Adverse Event|0|||
46779351|NCT04738734|82998031|FG000|Overall Study|Withdrawal by Subject|2|||
46779352|NCT04738734|82998032|FG001|Overall Study|Withdrawal by Subject|4|||
46779353|NCT04738734|82998031|FG000|Overall Study|Lost to Follow-up|5|||
46779354|NCT04738734|82998032|FG001|Overall Study|Lost to Follow-up|2|||
46779355|NCT04738734|82998031|FG000|Overall Study|Physician Decision|0|||
46779356|NCT04738734|82998032|FG001|Overall Study|Physician Decision|1|||
46779357|NCT04738734|82998031|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
46779358|NCT04738734|82998032|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
46779359|NCT04707196|82998040|FG000|Overall Study|Withdrawal by Subject|9|||
46779360|NCT04707196|82998041|FG001|Overall Study|Withdrawal by Subject|6|||
46779361|NCT04707196|82998040|FG000|Overall Study|Lost to Follow-up|1|||
46779362|NCT04707196|82998041|FG001|Overall Study|Lost to Follow-up|0|||
46779363|NCT04707196|82998040|FG000|Overall Study|Protocol Violation|4|||
46779364|NCT04707196|82998041|FG001|Overall Study|Protocol Violation|1|||
46779365|NCT04707196|82998040|FG000|Overall Study|Adverse Event|2|||
46779366|NCT04707196|82998041|FG001|Overall Study|Adverse Event|2|||
46779367|NCT04707196|82998040|FG000|Overall Study|Death|3|||
46779368|NCT04707196|82998041|FG001|Overall Study|Death|1|||
46779369|NCT04707196|82998040|FG000|Overall Study|Non-compliance with study drug|1|||
46779370|NCT04707196|82998041|FG001|Overall Study|Non-compliance with study drug|0|||
46779371|NCT04707196|82998040|FG000|Overall Study|Progressive disease|9|||
46779372|NCT04707196|82998041|FG001|Overall Study|Progressive disease|10|||
46779373|NCT04551963|82998068|FG000|Overall Study|Physician Decision|1|||
46779374|NCT04551963|82998069|FG001|Overall Study|Physician Decision|1|||
46779375|NCT04551963|82998068|FG000|Overall Study|Death|1|||
46779376|NCT04551963|82998069|FG001|Overall Study|Death|0|||
46779377|NCT04416555|82998079|FG000|Overall Study|Withdrawal by Subject|0|||
46779378|NCT04416555|82998080|FG001|Overall Study|Withdrawal by Subject|3|||
46850279|NCT00112437|83066387|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850280|NCT00112437|83066388|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
46850281|NCT00112437|83066363|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46644627|NCT05301322|82850311|FG000|Overall Study|Protocol Violation|3|||
46644628|NCT05301322|82850312|FG001|Overall Study|Protocol Violation|1|||
46644629|NCT05301322|82850311|FG000|Overall Study|Withdrawal by Subject|3|||
46644630|NCT05301322|82850312|FG001|Overall Study|Withdrawal by Subject|0|||
46644631|NCT05301322|82850311|FG000|Overall Study|Other|4|||
46779379|NCT04102007|82998086|FG000|Overall Study|Adverse Event|4|||
46779380|NCT04102007|82998086|FG000|Overall Study|Lost to Follow-up|3|||
46779381|NCT04102007|82998086|FG000|Overall Study|Withdrawal by Subject|12|||
46779382|NCT04102007|82998086|FG000|Overall Study|Eligibility Violation|5|||
46779383|NCT04102007|82998086|FG000|Overall Study|Lack of Efficacy|6|||
46779384|NCT04102007|82998086|FG000|Overall Study|Protocol Deviation|5|||
46850282|NCT00112437|83066364|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46970008|NCT02707601|83212982|FG001|Overall Study|Withdrew Consent|1|||
46779385|NCT04102007|82998086|FG000|Overall Study|Protocol Compliance|1|||
46779386|NCT04102007|82998086|FG000|Overall Study|Withdrew Treatment|2|||
46779387|NCT04102007|82998086|FG000|Overall Study|Pregnancy|1|||
46779388|NCT03898960|82998090|FG000|Overall Study|Death|10|||
46779389|NCT03734237|82998106|FG000|Overall Study|Lost to Follow-up|1|||
46779390|NCT03734237|82998107|FG001|Overall Study|Lost to Follow-up|3|||
46779391|NCT03734237|82998108|FG002|Overall Study|Lost to Follow-up|0|||
46779392|NCT03734237|82998106|FG000|Overall Study|Withdrawal by Subject|7|||
46970009|NCT02707601|83212981|FG000|Overall Study|Lost to Follow-up|1|||
46644632|NCT05301322|82850312|FG001|Overall Study|Other|0|||
46644633|NCT04956575|82850350|FG000|Overall Study|Death|1|||
46644634|NCT04956575|82850351|FG001|Overall Study|Death|0|||
46644635|NCT04956575|82850352|FG002|Overall Study|Death|0|||
46644636|NCT04956575|82850353|FG003|Overall Study|Death|0|||
46644637|NCT04956575|82850354|FG004|Overall Study|Death|0|||
46644638|NCT04956575|82850355|FG005|Overall Study|Death|0|||
46644639|NCT04956575|82850356|FG006|Overall Study|Death|0|||
46644640|NCT04956575|82850357|FG007|Overall Study|Death|1|||
46644641|NCT04956575|82850358|FG008|Overall Study|Death|0|||
46644642|NCT04956575|82850359|FG009|Overall Study|Death|1|||
46644643|NCT04956575|82850360|FG010|Overall Study|Death|0|||
46644644|NCT04956575|82850361|FG011|Overall Study|Death|0|||
46644645|NCT04956575|82850350|FG000|Overall Study|Lost to Follow-up|3|||
46644646|NCT04956575|82850351|FG001|Overall Study|Lost to Follow-up|4|||
46644647|NCT04956575|82850352|FG002|Overall Study|Lost to Follow-up|2|||
46644648|NCT04956575|82850353|FG003|Overall Study|Lost to Follow-up|3|||
46644649|NCT04956575|82850354|FG004|Overall Study|Lost to Follow-up|1|||
46644650|NCT04956575|82850355|FG005|Overall Study|Lost to Follow-up|10|||
46779393|NCT03734237|82998107|FG001|Overall Study|Withdrawal by Subject|9|||
46970010|NCT02707601|83212982|FG001|Overall Study|Lost to Follow-up|1|||
46970011|NCT02707601|83212981|FG000|Overall Study|Participants Randomized but Not Treated|2|||
46970012|NCT02707601|83212982|FG001|Overall Study|Participants Randomized but Not Treated|0|||
46970013|NCT02707055|83212994|FG000|Phase 1|Withdrawal by Subject|1|||
46970014|NCT02707055|83212995|FG001|Phase 1|Withdrawal by Subject|2|||
46970015|NCT02707055|83212994|FG000|Phase 1|Physician Decision|0|||
46970016|NCT02707055|83212995|FG001|Phase 1|Physician Decision|1|||
46970017|NCT02707055|83212994|FG000|Phase 2|Adverse Event|1|||
46970018|NCT02707055|83212995|FG001|Phase 2|Adverse Event|2|||
46970019|NCT02073682|83213003|FG000|Overall Study|Low Creatinine Clearance|1|||
46970020|NCT02073682|83213004|FG001|Overall Study|Low Creatinine Clearance|2|||
46970021|NCT02073682|83213003|FG000|Overall Study|Death|86|||
46970022|NCT02073682|83213004|FG001|Overall Study|Death|100|||
46970023|NCT02073682|83213003|FG000|Overall Study|Cancer Cured|10|||
46970024|NCT02073682|83213004|FG001|Overall Study|Cancer Cured|15|||
46970025|NCT02073682|83213003|FG000|Overall Study|ID: Patient Noncompliance|1|||
46970026|NCT02073682|83213004|FG001|Overall Study|ID: Patient Noncompliance|2|||
46970027|NCT02073682|83213003|FG000|Overall Study|ID: Palliative Treatment Only|10|||
47074598|NCT00631189|83367932|FG001|Initial Phase|Protocol Violation|0|||
47074599|NCT00631189|83367933|FG002|Initial Phase|Protocol Violation|0|||
47074600|NCT00631189|83367934|FG003|Initial Phase|Protocol Violation|0|||
47074601|NCT00631189|83367931|FG000|Initial Phase|Withdrawal by Subject|4|||
47074602|NCT00631189|83367932|FG001|Initial Phase|Withdrawal by Subject|0|||
47074603|NCT00631189|83367933|FG002|Initial Phase|Withdrawal by Subject|0|||
46644651|NCT04956575|82850356|FG006|Overall Study|Lost to Follow-up|11|||
46644652|NCT04956575|82850357|FG007|Overall Study|Lost to Follow-up|7|||
46970028|NCT02073682|83213004|FG001|Overall Study|ID: Palliative Treatment Only|7|||
46970029|NCT02073682|83213003|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
46970030|NCT02073682|83213004|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
47074604|NCT00631189|83367934|FG003|Initial Phase|Withdrawal by Subject|0|||
47074605|NCT00631189|83367931|FG000|Treatment Phase|Withdrawal by Subject|0|||
47074606|NCT00631189|83367932|FG001|Treatment Phase|Withdrawal by Subject|2|||
47074607|NCT00631189|83367933|FG002|Treatment Phase|Withdrawal by Subject|1|||
47074608|NCT00631189|83367934|FG003|Treatment Phase|Withdrawal by Subject|1|||
46644653|NCT04956575|82850358|FG008|Overall Study|Lost to Follow-up|4|||
46644654|NCT04956575|82850359|FG009|Overall Study|Lost to Follow-up|2|||
46644655|NCT04956575|82850360|FG010|Overall Study|Lost to Follow-up|3|||
46779394|NCT03734237|82998108|FG002|Overall Study|Withdrawal by Subject|10|||
46644656|NCT04956575|82850361|FG011|Overall Study|Lost to Follow-up|8|||
46644657|NCT04956575|82850350|FG000|Overall Study|Withdrawal by Subject|1|||
46779395|NCT03496623|82998168|FG000|Run-In Period (2 Weeks)|Death|1|||
47074609|NCT00631189|83367931|FG000|Treatment Phase|Protocol Violation|0|||
46779396|NCT03496623|82998169|FG001|Run-In Period (2 Weeks)|Death|0|||
46779397|NCT03496623|82998170|FG002|Run-In Period (2 Weeks)|Death|0|||
46779398|NCT03496623|82998171|FG003|Run-In Period (2 Weeks)|Death|0|||
46779399|NCT03496623|82998172|FG004|Run-In Period (2 Weeks)|Death|0|||
46779400|NCT03496623|82998168|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
46779401|NCT03496623|82998169|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
46779402|NCT03496623|82998170|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
46970031|NCT02073682|83213003|FG000|Overall Study|Platelet Count <50,000/mL|1|||
46644658|NCT04956575|82850351|FG001|Overall Study|Withdrawal by Subject|2|||
46644659|NCT04956575|82850352|FG002|Overall Study|Withdrawal by Subject|1|||
46644660|NCT04956575|82850353|FG003|Overall Study|Withdrawal by Subject|4|||
46644661|NCT04956575|82850354|FG004|Overall Study|Withdrawal by Subject|2|||
46644662|NCT04956575|82850355|FG005|Overall Study|Withdrawal by Subject|8|||
46644663|NCT04956575|82850356|FG006|Overall Study|Withdrawal by Subject|5|||
46644664|NCT04956575|82850357|FG007|Overall Study|Withdrawal by Subject|1|||
46644665|NCT04956575|82850358|FG008|Overall Study|Withdrawal by Subject|1|||
46644666|NCT04956575|82850359|FG009|Overall Study|Withdrawal by Subject|0|||
46644667|NCT04956575|82850360|FG010|Overall Study|Withdrawal by Subject|3|||
46644668|NCT04956575|82850361|FG011|Overall Study|Withdrawal by Subject|1|||
46644669|NCT04720105|82850412|FG000|Overall Study|Lack of Efficacy|1|||
46644670|NCT04720105|82850412|FG000|Overall Study|Lost to Follow-up|1|||
46644671|NCT04720105|82850412|FG000|Overall Study|Withdrawal by Subject|3|||
46644672|NCT04573309|82850422|FG000|Overall Study|Protocol Violation|1|||
46644673|NCT04573309|82850423|FG001|Overall Study|Protocol Violation|0|||
46644674|NCT04220866|82850440|FG000|Overall Study|Death|4|||
46644675|NCT04220866|82850441|FG001|Overall Study|Death|5|||
46644676|NCT04220866|82850440|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
46644677|NCT04220866|82850441|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
46644678|NCT04220866|82850440|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
46644679|NCT04220866|82850441|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
46644680|NCT04220866|82850440|FG000|Overall Study|Withdrawal by Subject|0|||
46644681|NCT04220866|82850441|FG001|Overall Study|Withdrawal by Subject|1|||
46779403|NCT03496623|82998171|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
46779404|NCT03496623|82998172|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
46779405|NCT03496623|82998168|FG000|Period 1 (12 Weeks)|Death|0|||
46779406|NCT03496623|82998169|FG001|Period 1 (12 Weeks)|Death|3|||
46779407|NCT03496623|82998170|FG002|Period 1 (12 Weeks)|Death|0|||
46779408|NCT03496623|82998171|FG003|Period 1 (12 Weeks)|Death|0|||
46779409|NCT03496623|82998172|FG004|Period 1 (12 Weeks)|Death|0|||
46779410|NCT03496623|82998168|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
46779411|NCT03496623|82998169|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
46779412|NCT03496623|82998170|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
46779413|NCT03496623|82998171|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
46970032|NCT02073682|83213004|FG001|Overall Study|Platelet Count <50,000/mL|2|||
46970033|NCT02073682|83213003|FG000|Overall Study|Surgery/Medical Procedure|3|||
46970034|NCT02073682|83213004|FG001|Overall Study|Surgery/Medical Procedure|1|||
46970035|NCT02073682|83213003|FG000|Overall Study|Withdrawal by Subject|6|||
46970036|NCT02073682|83213004|FG001|Overall Study|Withdrawal by Subject|8|||
46970037|NCT02073682|83213003|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
46970038|NCT02073682|83213004|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
46970039|NCT02073682|83213003|FG000|Overall Study|Cancer Progression|53|||
46970040|NCT02073682|83213004|FG001|Overall Study|Cancer Progression|33|||
46970041|NCT02073682|83213003|FG000|Overall Study|Protocol Violation|1|||
46970042|NCT02073682|83213004|FG001|Overall Study|Protocol Violation|0|||
46970043|NCT02073682|83213003|FG000|Overall Study|Adverse Event|79|||
46970044|NCT02073682|83213004|FG001|Overall Study|Adverse Event|62|||
46970045|NCT02073682|83213003|FG000|Overall Study|No reason provided|11|||
46970046|NCT02073682|83213004|FG001|Overall Study|No reason provided|9|||
46970047|NCT02073682|83213003|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
46970048|NCT02073682|83213004|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
46970049|NCT02073682|83213003|FG000|Overall Study|Lost to Follow-up|1|||
46970050|NCT02073682|83213004|FG001|Overall Study|Lost to Follow-up|1|||
46970051|NCT02073682|83213003|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
46850283|NCT00112437|83066365|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850284|NCT00112437|83066366|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850285|NCT00112437|83066367|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46970052|NCT02073682|83213004|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
46970053|NCT02072980|83213010|FG000|Period 2, Second Wear|Adverse Event|0|||
46850286|NCT00112437|83066368|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46970054|NCT02072980|83213011|FG001|Period 2, Second Wear|Adverse Event|1|||
46779414|NCT03496623|82998172|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
46779415|NCT03496623|82998168|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
46779416|NCT03496623|82998169|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
46779417|NCT03496623|82998170|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
46779418|NCT03496623|82998171|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
46779419|NCT03496623|82998172|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
46779420|NCT03496623|82998168|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
46779421|NCT03496623|82998169|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
46779422|NCT03496623|82998170|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
46779423|NCT03496623|82998171|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
46779424|NCT03496623|82998172|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
46779425|NCT03496623|82998168|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46779426|NCT03496623|82998169|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46779427|NCT03496623|82998170|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
46779428|NCT03496623|82998171|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46779429|NCT03496623|82998172|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46779430|NCT03496623|82998168|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
46779431|NCT03496623|82998169|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
46779432|NCT03496623|82998170|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
46779433|NCT03496623|82998171|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
46779434|NCT03496623|82998172|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
46779435|NCT03496623|82998168|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46779436|NCT03496623|82998169|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
46779437|NCT03496623|82998170|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46779438|NCT03496623|82998171|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46779439|NCT03496623|82998172|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46779440|NCT03224507|82998204|FG000|Overall Study|Death|3|||
46779441|NCT03224507|82998205|FG001|Overall Study|Death|0|||
46779442|NCT03224507|82998204|FG000|Overall Study|Lack of Efficacy|6|||
46779443|NCT03224507|82998205|FG001|Overall Study|Lack of Efficacy|0|||
46779444|NCT03224507|82998204|FG000|Overall Study|Withdrawal by Subject|6|||
46779445|NCT03224507|82998205|FG001|Overall Study|Withdrawal by Subject|0|||
46779446|NCT02646618|82998231|FG000|Overall Study|Lost to Follow-up|10|||
46779447|NCT02646618|82998232|FG001|Overall Study|Lost to Follow-up|14|||
46779448|NCT02285114|82998252|FG000|Overall Study|Investigator's Discretion|0|||
46779449|NCT02285114|82998253|FG001|Overall Study|Investigator's Discretion|2|||
46779450|NCT02285114|82998254|FG002|Overall Study|Investigator's Discretion|0|||
46779451|NCT02285114|82998252|FG000|Overall Study|Withdrew Consent|0|||
46779452|NCT02285114|82998253|FG001|Overall Study|Withdrew Consent|0|||
46779453|NCT02285114|82998254|FG002|Overall Study|Withdrew Consent|1|||
46779454|NCT02285114|82998252|FG000|Overall Study|Enrolled but not treated|1|||
46970055|NCT02706899|83213019|FG000|Overall Study|Withdrawal by Subject|1|||
46779455|NCT02285114|82998253|FG001|Overall Study|Enrolled but not treated|0|||
46779456|NCT02285114|82998254|FG002|Overall Study|Enrolled but not treated|0|||
46779457|NCT02285114|82998252|FG000|Overall Study|Still on study|21|||
46779458|NCT02285114|82998253|FG001|Overall Study|Still on study|5|||
46779459|NCT02285114|82998254|FG002|Overall Study|Still on study|2|||
46779460|NCT01952366|82998268|FG000|Overall Study|Death|22|||
46779461|NCT01952366|82998268|FG000|Overall Study|Withdrawal by Subject|9|||
46850287|NCT00112437|83066369|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46779462|NCT01626079|82998278|FG000|Overall Study|Death|167|||
46779463|NCT01626079|82998279|FG001|Overall Study|Death|192|||
46779464|NCT01626079|82998280|FG002|Overall Study|Death|39|||
46779465|NCT01626079|82998278|FG000|Overall Study|Withdrawal by Subject|23|||
46779466|NCT01626079|82998279|FG001|Overall Study|Withdrawal by Subject|37|||
46779467|NCT01626079|82998280|FG002|Overall Study|Withdrawal by Subject|5|||
46779468|NCT01626079|82998278|FG000|Overall Study|Lost to Follow-up|7|||
46779469|NCT01626079|82998279|FG001|Overall Study|Lost to Follow-up|4|||
46779470|NCT01626079|82998280|FG002|Overall Study|Lost to Follow-up|2|||
46970056|NCT02706899|83213020|FG001|Overall Study|Withdrawal by Subject|0|||
46779471|NCT01626079|82998278|FG000|Overall Study|Missed Visits|1|||
46779472|NCT01626079|82998279|FG001|Overall Study|Missed Visits|4|||
46779473|NCT01626079|82998280|FG002|Overall Study|Missed Visits|6|||
46970057|NCT02706899|83213019|FG000|Overall Study|Death|8|||
46850288|NCT00112437|83066370|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850289|NCT00112437|83066371|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850290|NCT00112437|83066372|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850291|NCT00112437|83066373|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850292|NCT00112437|83066374|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850293|NCT00112437|83066375|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850294|NCT00112437|83066376|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850295|NCT00112437|83066377|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850296|NCT00112437|83066378|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
46850297|NCT00112437|83066379|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850298|NCT00112437|83066380|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850299|NCT00112437|83066381|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850300|NCT00112437|83066382|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850301|NCT00112437|83066383|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850302|NCT00112437|83066384|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850303|NCT00112437|83066385|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850304|NCT00112437|83066386|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850305|NCT00112437|83066387|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850306|NCT00112437|83066388|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
46850307|NCT00112437|83066363|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
46779474|NCT01349959|82998291|FG000|Overall Study|Adverse Event|7|||
46779475|NCT01331681|82998298|FG000|Overall Study|Adverse Event|10|||
46779476|NCT01331681|82998299|FG001|Overall Study|Adverse Event|13|||
46779477|NCT01331681|82998300|FG002|Overall Study|Adverse Event|10|||
46779478|NCT01331681|82998298|FG000|Overall Study|Death|6|||
46779479|NCT01331681|82998299|FG001|Overall Study|Death|6|||
46779480|NCT01331681|82998300|FG002|Overall Study|Death|2|||
46779481|NCT01331681|82998298|FG000|Overall Study|Lack of Efficacy|0|||
46779482|NCT01331681|82998299|FG001|Overall Study|Lack of Efficacy|1|||
46779483|NCT01331681|82998300|FG002|Overall Study|Lack of Efficacy|0|||
46779484|NCT01331681|82998298|FG000|Overall Study|Withdrawal by Subject|12|||
46779485|NCT01331681|82998299|FG001|Overall Study|Withdrawal by Subject|8|||
46779486|NCT01331681|82998300|FG002|Overall Study|Withdrawal by Subject|15|||
46779487|NCT01331681|82998298|FG000|Overall Study|Protocol Violation|1|||
46779488|NCT01331681|82998299|FG001|Overall Study|Protocol Violation|1|||
46779489|NCT01331681|82998300|FG002|Overall Study|Protocol Violation|0|||
46779490|NCT01331681|82998298|FG000|Overall Study|Lost to Follow-up|2|||
46779491|NCT01331681|82998299|FG001|Overall Study|Lost to Follow-up|4|||
46779492|NCT01331681|82998300|FG002|Overall Study|Lost to Follow-up|1|||
46779493|NCT01331681|82998298|FG000|Overall Study|Physician Decision|2|||
46779494|NCT01331681|82998299|FG001|Overall Study|Physician Decision|0|||
46779495|NCT01331681|82998300|FG002|Overall Study|Physician Decision|4|||
46779496|NCT01331681|82998298|FG000|Overall Study|Therapeutic procedure required|1|||
46779497|NCT01331681|82998299|FG001|Overall Study|Therapeutic procedure required|0|||
46779498|NCT01331681|82998300|FG002|Overall Study|Therapeutic procedure required|0|||
46779499|NCT01331681|82998298|FG000|Overall Study|Sponsor decision|1|||
46779500|NCT01331681|82998299|FG001|Overall Study|Sponsor decision|1|||
46779501|NCT01331681|82998300|FG002|Overall Study|Sponsor decision|0|||
46779502|NCT01331681|82998298|FG000|Overall Study|Switching to other therapy|0|||
46779503|NCT01331681|82998299|FG001|Overall Study|Switching to other therapy|0|||
46779504|NCT01331681|82998300|FG002|Overall Study|Switching to other therapy|1|||
46850308|NCT00112437|83066364|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850309|NCT00112437|83066365|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850310|NCT00112437|83066366|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850311|NCT00112437|83066367|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
46779505|NCT01331681|82998298|FG000|Overall Study|Not Received Study Treatment|0|||
46779506|NCT01331681|82998299|FG001|Overall Study|Not Received Study Treatment|0|||
46779507|NCT01331681|82998300|FG002|Overall Study|Not Received Study Treatment|2|||
46779508|NCT01286272|82998310|FG000|Overall Study|Ineligible after beginning treatment|1|||
46779509|NCT01286272|82998311|FG001|Overall Study|Ineligible after beginning treatment|3|||
46779510|NCT01215136|82998319|FG000|Overall Study|Adverse Event|2|||
46779511|NCT01215136|82998320|FG001|Overall Study|Adverse Event|9|||
46779512|NCT01215136|82998319|FG000|Overall Study|Disease Progression|3|||
46779513|NCT01215136|82998320|FG001|Overall Study|Disease Progression|14|||
46779514|NCT01215136|82998319|FG000|Overall Study|Symptomatic Deterioration|1|||
46779515|NCT01215136|82998320|FG001|Overall Study|Symptomatic Deterioration|1|||
46779516|NCT01215136|82998319|FG000|Overall Study|Death|0|||
46779517|NCT01215136|82998320|FG001|Overall Study|Death|2|||
46970058|NCT02706899|83213020|FG001|Overall Study|Death|0|||
46779518|NCT01215136|82998319|FG000|Overall Study|Withdrawal by Subject|0|||
46779519|NCT01215136|82998320|FG001|Overall Study|Withdrawal by Subject|1|||
46779520|NCT00616018|82998351|FG000|Overall Study|Protocol Violation|3|||
46970059|NCT02706899|83213019|FG000|Overall Study|Study Termination by Sponsor|4|||
46850312|NCT00112437|83066368|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
46779521|NCT00424021|82998360|FG000|NCT00046319 Study Period|Adverse Event|1|||
46779522|NCT00424021|82998361|FG001|NCT00046319 Study Period|Adverse Event|0|||
46779523|NCT00424021|82998362|FG002|NCT00046319 Study Period|Adverse Event|1|||
46779524|NCT00424021|82998363|FG003|NCT00046319 Study Period|Adverse Event|1|||
46779525|NCT00424021|82998360|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
46779526|NCT00424021|82998361|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
46779527|NCT00424021|82998362|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
46779528|NCT00424021|82998363|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
46779529|NCT00424021|82998360|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
46779530|NCT00424021|82998361|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
46779531|NCT00424021|82998362|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
46779532|NCT00424021|82998363|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
46779533|NCT00424021|82998360|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
46779534|NCT00424021|82998361|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
46779535|NCT00424021|82998362|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
46779536|NCT00424021|82998363|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
46779537|NCT00424021|82998360|FG000|AMB-220-E Study Period|Adverse Event|1|||
46779538|NCT00424021|82998361|FG001|AMB-220-E Study Period|Adverse Event|1|||
46779539|NCT00424021|82998362|FG002|AMB-220-E Study Period|Adverse Event|3|||
46779540|NCT00424021|82998363|FG003|AMB-220-E Study Period|Adverse Event|7|||
46779541|NCT00424021|82998360|FG000|AMB-220-E Study Period|Death|0|||
46779542|NCT00424021|82998361|FG001|AMB-220-E Study Period|Death|0|||
46850313|NCT00112437|83066369|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850314|NCT00112437|83066370|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850315|NCT00112437|83066371|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
46779543|NCT00424021|82998362|FG002|AMB-220-E Study Period|Death|1|||
46779544|NCT00424021|82998363|FG003|AMB-220-E Study Period|Death|1|||
46779545|NCT00424021|82998360|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
46850316|NCT00112437|83066372|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850317|NCT00112437|83066373|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850318|NCT00112437|83066374|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850319|NCT00112437|83066375|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850320|NCT00112437|83066376|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850321|NCT00112437|83066377|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850322|NCT00112437|83066378|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
46850323|NCT00112437|83066379|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850324|NCT00112437|83066380|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850325|NCT00112437|83066381|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850326|NCT00112437|83066382|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850327|NCT00112437|83066383|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850328|NCT00112437|83066384|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850329|NCT00112437|83066385|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850330|NCT00112437|83066386|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850331|NCT00112437|83066387|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850332|NCT00112437|83066388|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
46850333|NCT00112437|83066363|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850334|NCT00112437|83066364|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850335|NCT00112437|83066365|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850336|NCT00112437|83066366|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850337|NCT00112437|83066367|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850338|NCT00112437|83066368|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850339|NCT00112437|83066369|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850340|NCT00112437|83066370|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850341|NCT00112437|83066371|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850342|NCT00112437|83066372|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850343|NCT00112437|83066373|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850344|NCT00112437|83066374|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
46850345|NCT00112437|83066375|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850346|NCT00112437|83066376|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850347|NCT00112437|83066377|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
46850348|NCT00112437|83066378|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850349|NCT00112437|83066379|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850350|NCT00112437|83066380|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850351|NCT00112437|83066381|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850352|NCT00112437|83066382|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850353|NCT00112437|83066383|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46779546|NCT00424021|82998361|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
46779547|NCT00424021|82998362|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
46779548|NCT00424021|82998363|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
46779549|NCT00424021|82998360|FG000|AMB-220-E Study Period|Physician Decision|0|||
46779550|NCT00424021|82998361|FG001|AMB-220-E Study Period|Physician Decision|0|||
46779551|NCT00424021|82998362|FG002|AMB-220-E Study Period|Physician Decision|0|||
46779552|NCT00424021|82998363|FG003|AMB-220-E Study Period|Physician Decision|1|||
46779553|NCT00617734|82998382|FG000|Overall Study|Withdrew Consent|2|||
46779554|NCT00617734|82998383|FG001|Overall Study|Withdrew Consent|0|||
46970060|NCT02706899|83213020|FG001|Overall Study|Study Termination by Sponsor|6|||
46850354|NCT00112437|83066384|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850355|NCT00112437|83066385|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850356|NCT00112437|83066386|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850357|NCT00112437|83066387|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850358|NCT00112437|83066388|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
46850359|NCT00112437|83066363|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850360|NCT00112437|83066364|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850361|NCT00112437|83066365|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850362|NCT00112437|83066366|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850363|NCT00112437|83066367|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850364|NCT00112437|83066368|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850365|NCT00112437|83066369|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850366|NCT00112437|83066370|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850367|NCT00112437|83066371|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850368|NCT00112437|83066372|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850369|NCT00112437|83066373|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
46850370|NCT00112437|83066374|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
46850371|NCT00112437|83066375|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850372|NCT00112437|83066376|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850373|NCT00112437|83066377|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850374|NCT00112437|83066378|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850375|NCT00112437|83066379|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850376|NCT00112437|83066380|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850377|NCT00112437|83066381|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46970061|NCT02072824|83213029|FG000|Overall Study|Insufficient clinical response|1|||
46970062|NCT02072824|83213030|FG001|Overall Study|Insufficient clinical response|0|||
46970063|NCT02072824|83213031|FG002|Overall Study|Insufficient clinical response|1|||
46970064|NCT02072824|83213029|FG000|Overall Study|No longer willing to participate|1|||
47074610|NCT00631189|83367932|FG001|Treatment Phase|Protocol Violation|1|||
46779555|NCT00617734|82998382|FG000|Overall Study|Adverse Event|4|||
46779556|NCT00617734|82998383|FG001|Overall Study|Adverse Event|1|||
46779557|NCT00617734|82998382|FG000|Overall Study|Protocol Violation|1|||
46779558|NCT00617734|82998383|FG001|Overall Study|Protocol Violation|0|||
46779559|NCT00617734|82998382|FG000|Overall Study|Found Ineligible After Randomization|1|||
46779560|NCT00617734|82998383|FG001|Overall Study|Found Ineligible After Randomization|4|||
46779561|NCT00617734|82998382|FG000|Overall Study|Lost to Follow-up|0|||
46779562|NCT00617734|82998383|FG001|Overall Study|Lost to Follow-up|1|||
46779563|NCT00577460|82998392|FG000|Overall Study|Adverse Event|11|||
46779564|NCT00577460|82998393|FG001|Overall Study|Adverse Event|7|||
46779565|NCT00577460|82998394|FG002|Overall Study|Adverse Event|14|||
46779566|NCT00577460|82998392|FG000|Overall Study|Protocol Violation|0|||
46779567|NCT00577460|82998393|FG001|Overall Study|Protocol Violation|1|||
46779568|NCT00577460|82998394|FG002|Overall Study|Protocol Violation|1|||
46779569|NCT00577460|82998392|FG000|Overall Study|Lost to Follow-up|0|||
46779570|NCT00577460|82998393|FG001|Overall Study|Lost to Follow-up|3|||
46779571|NCT00577460|82998394|FG002|Overall Study|Lost to Follow-up|4|||
46779572|NCT00577460|82998392|FG000|Overall Study|Withdrawal by Subject|5|||
47074611|NCT00631189|83367933|FG002|Treatment Phase|Protocol Violation|6|||
47074612|NCT00631189|83367934|FG003|Treatment Phase|Protocol Violation|2|||
47074613|NCT00631189|83367931|FG000|Treatment Phase|Adverse Event|0|||
46779573|NCT00577460|82998393|FG001|Overall Study|Withdrawal by Subject|5|||
46779574|NCT00577460|82998394|FG002|Overall Study|Withdrawal by Subject|6|||
46850378|NCT00112437|83066382|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
47074614|NCT00631189|83367932|FG001|Treatment Phase|Adverse Event|3|||
47074615|NCT00631189|83367933|FG002|Treatment Phase|Adverse Event|2|||
46779575|NCT00577460|82998392|FG000|Overall Study|Other|0|||
46779576|NCT00577460|82998393|FG001|Overall Study|Other|3|||
46779577|NCT00577460|82998394|FG002|Overall Study|Other|2|||
46779578|NCT00415519|82998411|FG000|Overall Study|Adverse Event|1|||
46779579|NCT00415519|82998412|FG001|Overall Study|Adverse Event|0|||
46779580|NCT00415519|82998411|FG000|Overall Study|Withdrawal by Subject|2|||
46779581|NCT00415519|82998412|FG001|Overall Study|Withdrawal by Subject|0|||
46779582|NCT00415519|82998411|FG000|Overall Study|Patient's convenience|1|||
46779583|NCT00415519|82998412|FG001|Overall Study|Patient's convenience|0|||
46779584|NCT00423943|82998420|FG000|Overall Study|Withdrawal by Subject|3|||
46850379|NCT00112437|83066383|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850380|NCT00112437|83066384|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850381|NCT00112437|83066385|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850382|NCT00112437|83066386|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850383|NCT00112437|83066387|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850384|NCT00112437|83066388|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
46850385|NCT00112437|83066363|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850386|NCT00112437|83066364|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850387|NCT00112437|83066365|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850388|NCT00112437|83066366|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850389|NCT00112437|83066367|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850390|NCT00112437|83066368|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850391|NCT00112437|83066369|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850392|NCT00112437|83066370|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850393|NCT00112437|83066371|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850394|NCT00112437|83066372|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850395|NCT00112437|83066373|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850396|NCT00112437|83066374|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850397|NCT00112437|83066375|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850398|NCT00112437|83066376|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850399|NCT00112437|83066377|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850400|NCT00112437|83066378|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46970065|NCT02072824|83213030|FG001|Overall Study|No longer willing to participate|0|||
46970066|NCT02072824|83213031|FG002|Overall Study|No longer willing to participate|1|||
46970067|NCT02072824|83213029|FG000|Overall Study|Medication error|0|||
46779585|NCT00423943|82998421|FG001|Overall Study|Withdrawal by Subject|1|||
46779586|NCT00428389|82998429|FG000|Core Phase|Adverse Event|6|||
46779587|NCT00428389|82998430|FG001|Core Phase|Adverse Event|4|||
46779588|NCT00428389|82998429|FG000|Core Phase|Lack of Efficacy|2|||
46779589|NCT00428389|82998430|FG001|Core Phase|Lack of Efficacy|0|||
46779590|NCT00428389|82998429|FG000|Core Phase|Abnormal test procedure result(s)|0|||
46779591|NCT00428389|82998430|FG001|Core Phase|Abnormal test procedure result(s)|1|||
46779592|NCT00428389|82998429|FG000|Core Phase|Withdrawal by Subject|3|||
46779593|NCT00428389|82998430|FG001|Core Phase|Withdrawal by Subject|4|||
46779594|NCT00428389|82998429|FG000|Core Phase|Protocol deviation|0|||
46779595|NCT00428389|82998430|FG001|Core Phase|Protocol deviation|2|||
46779596|NCT00428389|82998429|FG000|Extension Phase|Adverse Event|17|||
46779597|NCT00428389|82998430|FG001|Extension Phase|Adverse Event|11|||
46779598|NCT00428389|82998429|FG000|Extension Phase|Lack of Efficacy|4|||
46779599|NCT00428389|82998430|FG001|Extension Phase|Lack of Efficacy|3|||
46779600|NCT00428389|82998429|FG000|Extension Phase|Withdrawal by Subject|6|||
46779601|NCT00428389|82998430|FG001|Extension Phase|Withdrawal by Subject|6|||
46779602|NCT00428389|82998429|FG000|Extension Phase|Lost to Follow-up|0|||
46779603|NCT00428389|82998430|FG001|Extension Phase|Lost to Follow-up|3|||
46779604|NCT00428389|82998429|FG000|Extension Phase|Death|1|||
46779605|NCT00428389|82998430|FG001|Extension Phase|Death|0|||
46779606|NCT00428389|82998429|FG000|Extension Phase|Protocol Violation|3|||
46970068|NCT02072824|83213030|FG001|Overall Study|Medication error|1|||
46970069|NCT02072824|83213031|FG002|Overall Study|Medication error|0|||
47074616|NCT00631189|83367934|FG003|Treatment Phase|Adverse Event|4|||
46779607|NCT00428389|82998430|FG001|Extension Phase|Protocol Violation|2|||
46779608|NCT00428389|82998429|FG000|Extension Phase|Administrative problems|1|||
46779609|NCT00428389|82998430|FG001|Extension Phase|Administrative problems|1|||
46970070|NCT02072824|83213029|FG000|Overall Study|Adverse Event|0|||
47074617|NCT00631189|83367931|FG000|Treatment Phase|Lost to Follow-up|0|||
47074618|NCT00631189|83367932|FG001|Treatment Phase|Lost to Follow-up|1|||
47074619|NCT00631189|83367933|FG002|Treatment Phase|Lost to Follow-up|0|||
47074620|NCT00631189|83367934|FG003|Treatment Phase|Lost to Follow-up|0|||
47074621|NCT00631189|83367931|FG000|Treatment Phase|Pregnancy|0|||
47074622|NCT00631189|83367932|FG001|Treatment Phase|Pregnancy|0|||
47074623|NCT00631189|83367933|FG002|Treatment Phase|Pregnancy|1|||
47074624|NCT00631189|83367934|FG003|Treatment Phase|Pregnancy|0|||
47074625|NCT00631189|83367931|FG000|Treatment Phase|patient did not take pravastatin|0|||
47074626|NCT00631189|83367932|FG001|Treatment Phase|patient did not take pravastatin|0|||
46779610|NCT00616642|82998438|FG000|Overall Study|Withdrawal by Subject|0|||
46779611|NCT00616642|82998439|FG001|Overall Study|Withdrawal by Subject|1|||
46779612|NCT00406315|82998445|FG000|Overall Study|Death|1|||
46779613|NCT00406315|82998445|FG000|Overall Study|Adverse Event|39|||
46779614|NCT00406315|82998445|FG000|Overall Study|Laboratory Abnormality|4|||
46779615|NCT00406315|82998445|FG000|Overall Study|Lack of Efficacy|13|||
46779616|NCT00406315|82998445|FG000|Overall Study|Other|33|||
46779617|NCT00406315|82998445|FG000|Overall Study|Lost to Follow-up|21|||
46779618|NCT00406315|82998445|FG000|Overall Study|Withdrawal by Subject|30|||
46779619|NCT00711594|82998453|FG000|Overall Study|Progressive disease|2|||
46779620|NCT00711594|82998454|FG001|Overall Study|Progressive disease|2|||
46779621|NCT00711594|82998455|FG002|Overall Study|Progressive disease|6|||
46779622|NCT00711594|82998456|FG003|Overall Study|Progressive disease|44|||
46779623|NCT00711594|82998453|FG000|Overall Study|Other Adverse Event|1|||
46779624|NCT00711594|82998454|FG001|Overall Study|Other Adverse Event|0|||
46779625|NCT00711594|82998455|FG002|Overall Study|Other Adverse Event|0|||
46970071|NCT02072824|83213030|FG001|Overall Study|Adverse Event|0|||
46970072|NCT02072824|83213031|FG002|Overall Study|Adverse Event|1|||
46970073|NCT02072668|83213039|FG000|Second Intervention|Lost to Follow-up|1|||
46970074|NCT02072668|83213040|FG001|Second Intervention|Lost to Follow-up|0|||
46970075|NCT02140762|83213050|FG000|Overall Study|Adverse Event|1|||
46970076|NCT02140762|83213051|FG001|Overall Study|Adverse Event|1|||
46970077|NCT02140762|83213050|FG000|Overall Study|Lost to Follow-up|9|||
46970078|NCT02140762|83213051|FG001|Overall Study|Lost to Follow-up|5|||
46970079|NCT02140762|83213050|FG000|Overall Study|Protocol Violation|1|||
46970080|NCT02140762|83213051|FG001|Overall Study|Protocol Violation|1|||
46970081|NCT02140762|83213050|FG000|Overall Study|Withdrawal by Subject|6|||
46970082|NCT02140762|83213051|FG001|Overall Study|Withdrawal by Subject|4|||
46970083|NCT02140762|83213050|FG000|Overall Study|Other|0|||
46970084|NCT02140762|83213051|FG001|Overall Study|Other|1|||
46970085|NCT02101294|83213062|FG000|Overall Study|Withdrawal by Subject|5|||
46970086|NCT02101294|83213062|FG000|Overall Study|Lost to Follow-up|6|||
46970087|NCT01598506|83213069|FG000|Overall Study|Withdrawal by Subject|2|||
46970088|NCT02140060|83213080|FG000|Overall Study|Adverse Event|0|||
46970089|NCT02140060|83213081|FG001|Overall Study|Adverse Event|0|||
46970090|NCT02140060|83213082|FG002|Overall Study|Adverse Event|0|||
46970091|NCT02140060|83213083|FG003|Overall Study|Adverse Event|1|||
46970092|NCT02140060|83213084|FG004|Overall Study|Adverse Event|1|||
46970093|NCT02140060|83213085|FG005|Overall Study|Adverse Event|1|||
46970094|NCT02140060|83213080|FG000|Overall Study|Lack of Efficacy|0|||
46970095|NCT02140060|83213081|FG001|Overall Study|Lack of Efficacy|0|||
46970096|NCT02140060|83213082|FG002|Overall Study|Lack of Efficacy|0|||
46970097|NCT02140060|83213083|FG003|Overall Study|Lack of Efficacy|1|||
46970098|NCT02140060|83213084|FG004|Overall Study|Lack of Efficacy|0|||
46970099|NCT02140060|83213085|FG005|Overall Study|Lack of Efficacy|0|||
46970100|NCT02139982|83213110|FG000|Overall Study|Lack of Efficacy|0|||
46970101|NCT02139982|83213111|FG001|Overall Study|Lack of Efficacy|1|||
46970102|NCT02139982|83213112|FG002|Overall Study|Lack of Efficacy|0|||
46970103|NCT02139982|83213113|FG003|Overall Study|Lack of Efficacy|1|||
46970104|NCT02139982|83213114|FG004|Overall Study|Lack of Efficacy|0|||
46970105|NCT02139982|83213115|FG005|Overall Study|Lack of Efficacy|0|||
46970106|NCT02139982|83213116|FG006|Overall Study|Lack of Efficacy|0|||
46970107|NCT02139982|83213117|FG007|Overall Study|Lack of Efficacy|0|||
46970108|NCT02139982|83213118|FG008|Overall Study|Lack of Efficacy|0|||
46970109|NCT02139982|83213119|FG009|Overall Study|Lack of Efficacy|0|||
46970110|NCT02139826|83213141|FG000|Overall Study|Adverse Event|1|||
46970111|NCT02139592|83213151|FG000|Overall Study|Case Report Forms Uncollected|8|||
46970112|NCT02139280|83213157|FG000|Overall Study|No longer eligible|2|||
46970113|NCT02139280|83213158|FG001|Overall Study|No longer eligible|0|||
46970114|NCT02072434|83213166|FG000|Overall Study|Protocol Violation|10|||
46970115|NCT02072434|83213167|FG001|Overall Study|Protocol Violation|9|||
47074627|NCT00631189|83367933|FG002|Treatment Phase|patient did not take pravastatin|1|||
47074628|NCT00631189|83367934|FG003|Treatment Phase|patient did not take pravastatin|0|||
47074629|NCT00630877|83367947|FG000|Overall Study|Adverse Event|11|||
47074630|NCT00630877|83367948|FG001|Overall Study|Adverse Event|8|||
47074631|NCT00630877|83367949|FG002|Overall Study|Adverse Event|7|||
47074632|NCT00630877|83367947|FG000|Overall Study|Withdrawal by Subject|3|||
47074633|NCT00630877|83367948|FG001|Overall Study|Withdrawal by Subject|4|||
47074634|NCT00630877|83367949|FG002|Overall Study|Withdrawal by Subject|0|||
46970116|NCT02072434|83213166|FG000|Overall Study|Physician Decision|5|||
46970117|NCT02072434|83213167|FG001|Overall Study|Physician Decision|10|||
46970118|NCT02072434|83213166|FG000|Overall Study|Adverse event, serious fatal|1|||
46970119|NCT02072434|83213167|FG001|Overall Study|Adverse event, serious fatal|6|||
46970120|NCT02072434|83213166|FG000|Overall Study|Adverse Event|7|||
46970121|NCT02072434|83213167|FG001|Overall Study|Adverse Event|6|||
46970122|NCT02072434|83213166|FG000|Overall Study|Withdrawal by Subject|17|||
46970123|NCT02072434|83213167|FG001|Overall Study|Withdrawal by Subject|29|||
46970124|NCT02072434|83213166|FG000|Overall Study|Other|14|||
46970125|NCT02072434|83213167|FG001|Overall Study|Other|29|||
46779626|NCT00711594|82998456|FG003|Overall Study|Other Adverse Event|16|||
46779627|NCT00711594|82998453|FG000|Overall Study|Withdrawal by Subject|0|||
46779628|NCT00711594|82998454|FG001|Overall Study|Withdrawal by Subject|1|||
46779629|NCT00711594|82998455|FG002|Overall Study|Withdrawal by Subject|0|||
46779630|NCT00711594|82998456|FG003|Overall Study|Withdrawal by Subject|2|||
46779631|NCT00710762|82998470|FG000|Overall Study|Progressive disease|27|||
46779632|NCT00710762|82998471|FG001|Overall Study|Progressive disease|30|||
46779633|NCT00710762|82998470|FG000|Overall Study|Adverse Event other disease worsening|2|||
46779634|NCT00710762|82998471|FG001|Overall Study|Adverse Event other disease worsening|1|||
46779635|NCT00710762|82998470|FG000|Overall Study|Other Adverse Event|7|||
46779636|NCT00710762|82998471|FG001|Overall Study|Other Adverse Event|7|||
46779637|NCT00710762|82998470|FG000|Overall Study|Lost to Follow-up|1|||
46779638|NCT00710762|82998471|FG001|Overall Study|Lost to Follow-up|0|||
46779639|NCT00710762|82998470|FG000|Overall Study|Reason other than listed above|2|||
46779640|NCT00710762|82998471|FG001|Overall Study|Reason other than listed above|2|||
46850401|NCT00112437|83066379|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850402|NCT00112437|83066380|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850403|NCT00112437|83066381|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850404|NCT00112437|83066382|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850405|NCT00112437|83066383|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
46850406|NCT00112437|83066384|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
46850407|NCT00112437|83066385|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850408|NCT00112437|83066386|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850409|NCT00112437|83066387|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850410|NCT00112437|83066388|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
46850411|NCT00112437|83066363|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850412|NCT00112437|83066364|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850413|NCT00112437|83066365|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850414|NCT00112437|83066366|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850415|NCT00112437|83066367|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850416|NCT00112437|83066368|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850417|NCT00112437|83066369|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850418|NCT00112437|83066370|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850419|NCT00112437|83066371|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850420|NCT00112437|83066372|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850421|NCT00112437|83066373|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850422|NCT00112437|83066374|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850423|NCT00112437|83066375|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850424|NCT00112437|83066376|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850425|NCT00112437|83066377|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850426|NCT00112437|83066378|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850427|NCT00112437|83066379|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46644736|NCT03824938|82850492|FG000|Overall Study|Withdrawal by Subject|2|||
46644737|NCT03824938|82850493|FG001|Overall Study|Withdrawal by Subject|1|||
46644738|NCT03824938|82850494|FG002|Overall Study|Withdrawal by Subject|0|||
46644739|NCT03824938|82850495|FG003|Overall Study|Withdrawal by Subject|2|||
46644740|NCT03824938|82850496|FG004|Overall Study|Withdrawal by Subject|0|||
46644741|NCT03824938|82850497|FG005|Overall Study|Withdrawal by Subject|1|||
46644742|NCT03824938|82850492|FG000|Overall Study|Lost to Follow-up|0|||
46644743|NCT03824938|82850493|FG001|Overall Study|Lost to Follow-up|1|||
46644744|NCT03824938|82850494|FG002|Overall Study|Lost to Follow-up|0|||
46779641|NCT00573430|82998480|FG000|Overall Study|Incorrect enrollment of randomization|0|||
46779642|NCT00573430|82998481|FG001|Overall Study|Incorrect enrollment of randomization|4|||
46779643|NCT00573430|82998482|FG002|Overall Study|Incorrect enrollment of randomization|3|||
46779644|NCT00573430|82998480|FG000|Overall Study|Adverse Event|0|||
46779645|NCT00573430|82998481|FG001|Overall Study|Adverse Event|0|||
46779646|NCT00573430|82998482|FG002|Overall Study|Adverse Event|2|||
46779647|NCT00573430|82998480|FG000|Overall Study|Withdrawal by Subject|1|||
46779648|NCT00573430|82998481|FG001|Overall Study|Withdrawal by Subject|0|||
46779649|NCT00573430|82998482|FG002|Overall Study|Withdrawal by Subject|1|||
46779650|NCT00573430|82998480|FG000|Overall Study|Protocol Violation|0|||
46779651|NCT00573430|82998481|FG001|Overall Study|Protocol Violation|1|||
47074635|NCT00630877|83367947|FG000|Overall Study|Lost to Follow-up|2|||
47074636|NCT00630877|83367948|FG001|Overall Study|Lost to Follow-up|0|||
46644745|NCT03824938|82850495|FG003|Overall Study|Lost to Follow-up|0|||
46779652|NCT00573430|82998482|FG002|Overall Study|Protocol Violation|1|||
46779653|NCT00573430|82998480|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46779654|NCT00573430|82998481|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46779655|NCT00573430|82998482|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
46779656|NCT00711516|82998492|FG000|Overall Study|Adverse Event|1|||
46779657|NCT00711516|82998493|FG001|Overall Study|Adverse Event|1|||
46779658|NCT00711516|82998492|FG000|Overall Study|Withdrawal by Subject|0|||
46779659|NCT00711516|82998493|FG001|Overall Study|Withdrawal by Subject|1|||
46779660|NCT00711516|82998492|FG000|Overall Study|Protocol Violation|0|||
46779661|NCT00711516|82998493|FG001|Overall Study|Protocol Violation|1|||
46779662|NCT00615550|82998501|FG000|Overall Study|Lost to Follow-up|6|||
46779663|NCT00615550|82998502|FG001|Overall Study|Lost to Follow-up|1|||
46779664|NCT00577382|82998510|FG000|Overall Study|Adverse Event|0|||
46779665|NCT00577382|82998511|FG001|Overall Study|Adverse Event|6|||
46779666|NCT00577382|82998510|FG000|Overall Study|Withdrawal by Subject|0|||
46779667|NCT00577382|82998511|FG001|Overall Study|Withdrawal by Subject|1|||
46779668|NCT00577382|82998510|FG000|Overall Study|Progressive Disease|17|||
46779669|NCT00577382|82998511|FG001|Overall Study|Progressive Disease|19|||
46779670|NCT00577382|82998510|FG000|Overall Study|Intercurrent Illness|1|||
46779671|NCT00577382|82998511|FG001|Overall Study|Intercurrent Illness|2|||
46779672|NCT00577382|82998510|FG000|Overall Study|Death|1|||
46779673|NCT00577382|82998511|FG001|Overall Study|Death|1|||
46779674|NCT00577382|82998510|FG000|Overall Study|Lost to Follow-up|2|||
46779675|NCT00577382|82998511|FG001|Overall Study|Lost to Follow-up|2|||
46779676|NCT00614926|82998519|FG000|Overall Study|Burden of travel|1|||
46779677|NCT00614926|82998520|FG001|Overall Study|Burden of travel|0|||
46779678|NCT00614926|82998519|FG000|Overall Study|Adverse Event|3|||
46850428|NCT00112437|83066380|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850429|NCT00112437|83066381|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850430|NCT00112437|83066382|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850431|NCT00112437|83066383|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
46850432|NCT00112437|83066384|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850433|NCT00112437|83066385|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850434|NCT00112437|83066386|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850435|NCT00112437|83066387|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850436|NCT00112437|83066388|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
46850437|NCT00112437|83066363|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850438|NCT00112437|83066364|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850439|NCT00112437|83066365|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850440|NCT00112437|83066366|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850441|NCT00112437|83066367|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850442|NCT00112437|83066368|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850443|NCT00112437|83066369|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850444|NCT00112437|83066370|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850445|NCT00112437|83066371|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850446|NCT00112437|83066372|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850447|NCT00112437|83066373|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850448|NCT00112437|83066374|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850449|NCT00112437|83066375|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850450|NCT00112437|83066376|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850451|NCT00112437|83066377|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46779679|NCT00614926|82998520|FG001|Overall Study|Adverse Event|0|||
46779680|NCT00423319|82998528|FG000|Overall Study|Death|2|||
46850452|NCT00112437|83066378|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850453|NCT00112437|83066379|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850454|NCT00112437|83066380|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850455|NCT00112437|83066381|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850456|NCT00112437|83066382|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
47074637|NCT00630877|83367949|FG002|Overall Study|Lost to Follow-up|0|||
47074638|NCT00630877|83367947|FG000|Overall Study|Noncompliance|2|||
47074639|NCT00630877|83367948|FG001|Overall Study|Noncompliance|3|||
47074640|NCT00630877|83367949|FG002|Overall Study|Noncompliance|1|||
47074641|NCT00630877|83367947|FG000|Overall Study|Protocol violation|1|||
47074642|NCT00630877|83367948|FG001|Overall Study|Protocol violation|0|||
47074643|NCT00630877|83367949|FG002|Overall Study|Protocol violation|1|||
47074644|NCT00630877|83367947|FG000|Overall Study|Personal reasons|0|||
47074645|NCT00630877|83367948|FG001|Overall Study|Personal reasons|0|||
47074646|NCT00630877|83367949|FG002|Overall Study|Personal reasons|1|||
47074647|NCT02915783|83367961|FG000|Overall Study|Death|21|||
47074648|NCT02915783|83367961|FG000|Overall Study|Lost to Follow-up|1|||
47074649|NCT02915783|83367961|FG000|Overall Study|Withdrawal by Subject|2|||
46779681|NCT00423319|82998529|FG001|Overall Study|Death|0|||
46850457|NCT00112437|83066383|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
47074650|NCT00630331|83367976|FG000|Overall Study|Death|2|||
47074651|NCT00630331|83367977|FG001|Overall Study|Death|1|||
47074652|NCT00630331|83367978|FG002|Overall Study|Death|1|||
47074653|NCT00630331|83367976|FG000|Overall Study|Adverse Event|1|||
46644746|NCT03824938|82850496|FG004|Overall Study|Lost to Follow-up|1|||
46779682|NCT00423319|82998528|FG000|Overall Study|Adverse Event|93|||
46779683|NCT00423319|82998529|FG001|Overall Study|Adverse Event|112|||
46779684|NCT00423319|82998528|FG000|Overall Study|Withdrawal by Subject|86|||
46850458|NCT00112437|83066384|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
46850459|NCT00112437|83066385|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850460|NCT00112437|83066386|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850461|NCT00112437|83066387|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
46850462|NCT00112437|83066388|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
47074654|NCT00630331|83367977|FG001|Overall Study|Adverse Event|0|||
46779685|NCT00423319|82998529|FG001|Overall Study|Withdrawal by Subject|99|||
46779686|NCT00423319|82998528|FG000|Overall Study|Lost to Follow-up|4|||
46779687|NCT00423319|82998529|FG001|Overall Study|Lost to Follow-up|3|||
46779688|NCT00423319|82998528|FG000|Overall Study|Poor compliance or noncompliance|1|||
46779689|NCT00423319|82998529|FG001|Overall Study|Poor compliance or noncompliance|1|||
46779690|NCT00423319|82998528|FG000|Overall Study|No longer meets study criteria|15|||
46779691|NCT00423319|82998529|FG001|Overall Study|No longer meets study criteria|15|||
46779692|NCT00423319|82998528|FG000|Overall Study|Other|23|||
46779693|NCT00423319|82998529|FG001|Overall Study|Other|22|||
46779694|NCT00710684|82998539|FG000|Overall Study|Adverse Event|11|||
46779695|NCT00710684|82998540|FG001|Overall Study|Adverse Event|19|||
46779696|NCT00710684|82998541|FG002|Overall Study|Adverse Event|16|||
46850463|NCT00112437|83066363|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850464|NCT00112437|83066364|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850465|NCT00112437|83066365|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850466|NCT00112437|83066366|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850467|NCT00112437|83066367|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850468|NCT00112437|83066368|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
46970126|NCT02072434|83213166|FG000|Overall Study|Lost to Follow-up|0|||
47074655|NCT00630331|83367978|FG002|Overall Study|Adverse Event|0|||
46779697|NCT00710684|82998539|FG000|Overall Study|Lack of Efficacy|4|||
46779698|NCT00710684|82998540|FG001|Overall Study|Lack of Efficacy|3|||
46779699|NCT00710684|82998541|FG002|Overall Study|Lack of Efficacy|5|||
46779700|NCT00710684|82998539|FG000|Overall Study|Protocol Violation|5|||
46779701|NCT00710684|82998540|FG001|Overall Study|Protocol Violation|5|||
46779702|NCT00710684|82998541|FG002|Overall Study|Protocol Violation|5|||
46779703|NCT00710684|82998539|FG000|Overall Study|Lost to Follow-up|4|||
46779704|NCT00710684|82998540|FG001|Overall Study|Lost to Follow-up|6|||
46779705|NCT00710684|82998541|FG002|Overall Study|Lost to Follow-up|7|||
46779706|NCT00710684|82998539|FG000|Overall Study|Physician Decision|0|||
46779707|NCT00710684|82998540|FG001|Overall Study|Physician Decision|2|||
46779708|NCT00710684|82998541|FG002|Overall Study|Physician Decision|4|||
46779709|NCT00710684|82998539|FG000|Overall Study|Withdrawal by Subject|24|||
46779710|NCT00710684|82998540|FG001|Overall Study|Withdrawal by Subject|18|||
46779711|NCT00710684|82998541|FG002|Overall Study|Withdrawal by Subject|11|||
46779712|NCT00710684|82998539|FG000|Overall Study|Missing|1|||
46779713|NCT00710684|82998540|FG001|Overall Study|Missing|0|||
46779714|NCT00710684|82998541|FG002|Overall Study|Missing|0|||
46779715|NCT00710684|82998539|FG000|Overall Study|Did not continue after week 24|25|||
46779716|NCT00710684|82998540|FG001|Overall Study|Did not continue after week 24|21|||
46779717|NCT00710684|82998541|FG002|Overall Study|Did not continue after week 24|16|||
46779718|NCT00710606|82998557|FG000|Overall Study|Adverse Event|0|||
46779719|NCT00710606|82998558|FG001|Overall Study|Adverse Event|2|||
46779720|NCT00713544|82998572|FG000|Overall Study|Adverse Event|5|||
46850469|NCT00112437|83066369|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850470|NCT00112437|83066370|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850471|NCT00112437|83066371|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850472|NCT00112437|83066372|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
46970127|NCT02072434|83213167|FG001|Overall Study|Lost to Follow-up|1|||
47074656|NCT00630331|83367976|FG000|Overall Study|Withdrawal by Subject|12|||
47074657|NCT00630331|83367977|FG001|Overall Study|Withdrawal by Subject|7|||
47074658|NCT00630331|83367978|FG002|Overall Study|Withdrawal by Subject|5|||
47074659|NCT00630331|83367976|FG000|Overall Study|Lost to Follow-up|175|||
47074660|NCT00630331|83367977|FG001|Overall Study|Lost to Follow-up|143|||
47074661|NCT00630331|83367978|FG002|Overall Study|Lost to Follow-up|170|||
46779721|NCT00713544|82998573|FG001|Overall Study|Adverse Event|3|||
46779722|NCT00713544|82998574|FG002|Overall Study|Adverse Event|7|||
46779723|NCT00713544|82998575|FG003|Overall Study|Adverse Event|7|||
46970128|NCT02101060|83213175|FG000|Overall Study|Adverse Event|1|||
47074662|NCT00630331|83367976|FG000|Overall Study|Inappropriate enrollment|3|||
46779724|NCT00713544|82998576|FG004|Overall Study|Adverse Event|3|||
46779725|NCT00713544|82998577|FG005|Overall Study|Adverse Event|5|||
46970129|NCT02101060|83213176|FG001|Overall Study|Adverse Event|0|||
46970130|NCT02101060|83213175|FG000|Overall Study|Withdrawal by Subject|1|||
46970131|NCT02101060|83213176|FG001|Overall Study|Withdrawal by Subject|1|||
46644747|NCT03824938|82850497|FG005|Overall Study|Lost to Follow-up|0|||
46644748|NCT03636373|82850507|FG000|Overall Study|Study closure due to Covid-19|1|||
46644749|NCT03636373|82850508|FG001|Overall Study|Study closure due to Covid-19|0|||
46644750|NCT03004443|82850522|FG000|Overall Study|Pregnancy|0|||
46644751|NCT03004443|82850523|FG001|Overall Study|Pregnancy|1|||
46644752|NCT02277028|82850531|FG000|Overall Study|Lost to Follow-up|1|||
46644753|NCT02277028|82850532|FG001|Overall Study|Lost to Follow-up|0|||
46644754|NCT02277028|82850531|FG000|Overall Study|Withdrawal by Subject|0|||
46644755|NCT02277028|82850532|FG001|Overall Study|Withdrawal by Subject|1|||
46644756|NCT03735849|82850584|FG000|Overall Study|Lost to Follow-up|1|||
46644757|NCT03735849|82850585|FG001|Overall Study|Lost to Follow-up|0|||
46644758|NCT03735849|82850586|FG002|Overall Study|Lost to Follow-up|0|||
46644759|NCT03735849|82850584|FG000|Overall Study|Participant unable to adhere to visit|1|||
46644760|NCT03735849|82850585|FG001|Overall Study|Participant unable to adhere to visit|0|||
46644761|NCT03735849|82850586|FG002|Overall Study|Participant unable to adhere to visit|0|||
46644762|NCT03735849|82850584|FG000|Overall Study|Not Randomized|0|||
46644763|NCT03735849|82850585|FG001|Overall Study|Not Randomized|0|||
46644764|NCT03735849|82850586|FG002|Overall Study|Not Randomized|4|||
46644765|NCT03552393|82850593|FG000|Core Period|Kidney Transplant|1|||
46644766|NCT03552393|82850593|FG000|Core Period|Prohibited Medication|1|||
46644767|NCT03552393|82850593|FG000|Safety Extension Period|Kidney Transplant|4|||
46644768|NCT03333382|82850599|FG000|Overall Study|Lost to Follow-up|1|||
46644769|NCT03333382|82850600|FG001|Overall Study|Lost to Follow-up|0|||
46644770|NCT03107611|82850639|FG000|Overall Study|Adverse Event|1|||
46644771|NCT03107611|82850640|FG001|Overall Study|Adverse Event|0|||
46779726|NCT00713544|82998572|FG000|Overall Study|Withdrawal by Subject|2|||
46779727|NCT00713544|82998573|FG001|Overall Study|Withdrawal by Subject|0|||
47074663|NCT00630331|83367977|FG001|Overall Study|Inappropriate enrollment|6|||
47074664|NCT00630331|83367978|FG002|Overall Study|Inappropriate enrollment|3|||
47074665|NCT00630331|83367976|FG000|Overall Study|Unable to classify|9|||
47074666|NCT00630331|83367977|FG001|Overall Study|Unable to classify|4|||
47074667|NCT00630331|83367978|FG002|Overall Study|Unable to classify|3|||
47074668|NCT00630331|83367976|FG000|Overall Study|Protocol Violation|4|||
47074669|NCT00630331|83367977|FG001|Overall Study|Protocol Violation|5|||
47074670|NCT00630331|83367978|FG002|Overall Study|Protocol Violation|6|||
47074671|NCT00639509|83368057|FG000|Overall Study|Death|1|||
46644772|NCT03107611|82850641|FG002|Overall Study|Adverse Event|2|||
46779728|NCT00713544|82998574|FG002|Overall Study|Withdrawal by Subject|3|||
46644773|NCT03107611|82850639|FG000|Overall Study|Lost to Follow-up|3|||
46779729|NCT00713544|82998575|FG003|Overall Study|Withdrawal by Subject|2|||
46779730|NCT00713544|82998576|FG004|Overall Study|Withdrawal by Subject|3|||
46779731|NCT00713544|82998577|FG005|Overall Study|Withdrawal by Subject|1|||
46779732|NCT00713544|82998572|FG000|Overall Study|Protocol Violation|0|||
46850473|NCT00112437|83066373|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
46644774|NCT03107611|82850640|FG001|Overall Study|Lost to Follow-up|3|||
46644775|NCT03107611|82850641|FG002|Overall Study|Lost to Follow-up|3|||
46644776|NCT03107611|82850639|FG000|Overall Study|Protocol Violation|0|||
46779733|NCT00713544|82998573|FG001|Overall Study|Protocol Violation|0|||
46779734|NCT00713544|82998574|FG002|Overall Study|Protocol Violation|0|||
47074672|NCT00638963|83368063|FG000|Overall Study|Withdrawal by Subject|1|||
47074673|NCT00638963|83368064|FG001|Overall Study|Withdrawal by Subject|0|||
47074674|NCT00638183|83368070|FG000|Overall Study|Adverse Event|23|||
46779735|NCT00713544|82998575|FG003|Overall Study|Protocol Violation|0|||
46779736|NCT00713544|82998576|FG004|Overall Study|Protocol Violation|0|||
46779737|NCT00713544|82998577|FG005|Overall Study|Protocol Violation|1|||
46779738|NCT00713544|82998572|FG000|Overall Study|Physician Decision|0|||
46779739|NCT00713544|82998573|FG001|Overall Study|Physician Decision|0|||
46779740|NCT00713544|82998574|FG002|Overall Study|Physician Decision|0|||
46779741|NCT00713544|82998575|FG003|Overall Study|Physician Decision|0|||
46779742|NCT00713544|82998576|FG004|Overall Study|Physician Decision|0|||
46779743|NCT00713544|82998577|FG005|Overall Study|Physician Decision|2|||
46779744|NCT00713544|82998572|FG000|Overall Study|Lack of Efficacy|0|||
46779745|NCT00713544|82998573|FG001|Overall Study|Lack of Efficacy|1|||
46779746|NCT00713544|82998574|FG002|Overall Study|Lack of Efficacy|0|||
46779747|NCT00713544|82998575|FG003|Overall Study|Lack of Efficacy|1|||
46779748|NCT00713544|82998576|FG004|Overall Study|Lack of Efficacy|1|||
46779749|NCT00713544|82998577|FG005|Overall Study|Lack of Efficacy|0|||
46779750|NCT00713544|82998572|FG000|Overall Study|Lost to Follow-up|0|||
46779751|NCT00713544|82998573|FG001|Overall Study|Lost to Follow-up|0|||
46779752|NCT00713544|82998574|FG002|Overall Study|Lost to Follow-up|1|||
46779753|NCT00713544|82998575|FG003|Overall Study|Lost to Follow-up|0|||
46779754|NCT00713544|82998576|FG004|Overall Study|Lost to Follow-up|0|||
46779755|NCT00713544|82998577|FG005|Overall Study|Lost to Follow-up|0|||
46779756|NCT00713544|82998572|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
46779757|NCT00713544|82998573|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
46779758|NCT00713544|82998574|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
46779759|NCT00713544|82998575|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
46779760|NCT00713544|82998576|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
46779761|NCT00713544|82998577|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
46779762|NCT00713544|82998572|FG000|Overall Study|Incorrect enrollment|0|||
46779763|NCT00713544|82998573|FG001|Overall Study|Incorrect enrollment|1|||
46779764|NCT00713544|82998574|FG002|Overall Study|Incorrect enrollment|0|||
46779765|NCT00713544|82998575|FG003|Overall Study|Incorrect enrollment|0|||
46779766|NCT00713544|82998576|FG004|Overall Study|Incorrect enrollment|0|||
46779767|NCT00713544|82998577|FG005|Overall Study|Incorrect enrollment|0|||
46779768|NCT00713544|82998572|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
46779769|NCT00713544|82998573|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
46779770|NCT00713544|82998574|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
46779771|NCT00713544|82998575|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
46779772|NCT00713544|82998576|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
46779773|NCT00713544|82998577|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
46779774|NCT00415363|82998593|FG000|Overall Study|Withdrawal by Subject|4|||
46779775|NCT00415363|82998594|FG001|Overall Study|Withdrawal by Subject|4|||
46779776|NCT00415363|82998593|FG000|Overall Study|Adverse Event|4|||
46779777|NCT00415363|82998594|FG001|Overall Study|Adverse Event|4|||
46779778|NCT00415363|82998593|FG000|Overall Study|Lost to Follow-up|2|||
46779779|NCT00415363|82998594|FG001|Overall Study|Lost to Follow-up|1|||
46779780|NCT00415363|82998593|FG000|Overall Study|Physician Decision|3|||
46779781|NCT00415363|82998594|FG001|Overall Study|Physician Decision|1|||
46779782|NCT00415363|82998593|FG000|Overall Study|Death|16|||
46779783|NCT00415363|82998594|FG001|Overall Study|Death|12|||
46779784|NCT00415363|82998593|FG000|Overall Study|Progressive disease|26|||
46779785|NCT00415363|82998594|FG001|Overall Study|Progressive disease|32|||
46779786|NCT00415051|82998601|FG000|Overall Study|Protocol Violation|1|||
46779787|NCT00713258|82998607|FG000|Overall Study|Adverse Event|2|||
46779788|NCT00713258|82998608|FG001|Overall Study|Adverse Event|4|||
46779789|NCT00713258|82998607|FG000|Overall Study|Non-Compliance|2|||
46779790|NCT00713258|82998608|FG001|Overall Study|Non-Compliance|1|||
46644777|NCT03107611|82850640|FG001|Overall Study|Protocol Violation|0|||
46644778|NCT03107611|82850641|FG002|Overall Study|Protocol Violation|1|||
46644779|NCT03107611|82850639|FG000|Overall Study|Withdrawal by Subject|1|||
46644780|NCT03107611|82850640|FG001|Overall Study|Withdrawal by Subject|0|||
46644781|NCT03107611|82850641|FG002|Overall Study|Withdrawal by Subject|1|||
46644782|NCT03107611|82850639|FG000|Overall Study|Worsening signs/symptoms|2|||
46644783|NCT03107611|82850640|FG001|Overall Study|Worsening signs/symptoms|1|||
46644784|NCT03107611|82850641|FG002|Overall Study|Worsening signs/symptoms|2|||
46644785|NCT02720016|82850652|FG000|Overall Study|Separation of couple|6|||
46644786|NCT02720016|82850653|FG001|Overall Study|Separation of couple|8|||
46850474|NCT00112437|83066374|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850475|NCT00112437|83066375|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850476|NCT00112437|83066376|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850477|NCT00112437|83066377|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
46970132|NCT02101060|83213175|FG000|Overall Study|Lost to Follow-up|3|||
46970133|NCT02101060|83213176|FG001|Overall Study|Lost to Follow-up|3|||
46970134|NCT02139124|83213187|FG000|Overall Study|Adverse Event|2|||
46970135|NCT02139124|83213188|FG001|Overall Study|Adverse Event|0|||
46970136|NCT02139124|83213189|FG002|Overall Study|Adverse Event|1|||
47074675|NCT00638183|83368070|FG000|Overall Study|Lack of Efficacy|14|||
46644787|NCT02720016|82850654|FG002|Overall Study|Separation of couple|2|||
46644788|NCT02720016|82850652|FG000|Overall Study|Withdrawal by Subject|6|||
46644789|NCT02720016|82850653|FG001|Overall Study|Withdrawal by Subject|6|||
46644790|NCT02720016|82850654|FG002|Overall Study|Withdrawal by Subject|4|||
46644791|NCT02720016|82850652|FG000|Overall Study|Scheduling issues|2|||
46644792|NCT02720016|82850653|FG001|Overall Study|Scheduling issues|4|||
46644793|NCT02720016|82850654|FG002|Overall Study|Scheduling issues|7|||
46644794|NCT02720016|82850652|FG000|Overall Study|Childcare|2|||
46644795|NCT02720016|82850653|FG001|Overall Study|Childcare|0|||
46644796|NCT02720016|82850654|FG002|Overall Study|Childcare|2|||
46644797|NCT02720016|82850652|FG000|Overall Study|Withdrawal by PI|2|||
46644798|NCT02720016|82850653|FG001|Overall Study|Withdrawal by PI|2|||
46644799|NCT02720016|82850654|FG002|Overall Study|Withdrawal by PI|0|||
46644800|NCT02720016|82850652|FG000|Overall Study|Moved away|2|||
46644801|NCT02720016|82850653|FG001|Overall Study|Moved away|0|||
46644802|NCT02720016|82850654|FG002|Overall Study|Moved away|0|||
46644803|NCT02720016|82850652|FG000|Overall Study|Not Primary Health Concern|0|||
46644804|NCT02720016|82850653|FG001|Overall Study|Not Primary Health Concern|0|||
46644805|NCT02720016|82850654|FG002|Overall Study|Not Primary Health Concern|2|||
46644806|NCT02720016|82850652|FG000|Overall Study|Transportation issues|0|||
46644807|NCT02720016|82850653|FG001|Overall Study|Transportation issues|0|||
46644808|NCT02720016|82850654|FG002|Overall Study|Transportation issues|1|||
46644809|NCT02720016|82850652|FG000|Overall Study|Other|0|||
46644810|NCT02720016|82850653|FG001|Overall Study|Other|0|||
46644811|NCT02720016|82850654|FG002|Overall Study|Other|2|||
46644812|NCT02607956|82850665|FG000|Double-Blinded Phase|Withdrew Consent|17|||
46644813|NCT02607956|82850666|FG001|Double-Blinded Phase|Withdrew Consent|19|||
46644814|NCT02607956|82850667|FG002|Double-Blinded Phase|Withdrew Consent|0|||
46644815|NCT02607956|82850668|FG003|Double-Blinded Phase|Withdrew Consent|0|||
46644816|NCT02607956|82850665|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
46644817|NCT02607956|82850666|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
46644818|NCT02607956|82850667|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
46644819|NCT02607956|82850668|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
46644820|NCT02607956|82850665|FG000|Double-Blinded Phase|Randomized but never treated|7|||
46644821|NCT02607956|82850666|FG001|Double-Blinded Phase|Randomized but never treated|5|||
46644822|NCT02607956|82850667|FG002|Double-Blinded Phase|Randomized but never treated|0|||
46644823|NCT02607956|82850668|FG003|Double-Blinded Phase|Randomized but never treated|0|||
46644824|NCT02607956|82850665|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
46644825|NCT02607956|82850666|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
46644826|NCT02607956|82850667|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
46644827|NCT02607956|82850668|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
46644828|NCT02607956|82850665|FG000|Double-Blinded Phase|Death|4|||
46644829|NCT02607956|82850666|FG001|Double-Blinded Phase|Death|4|||
46644830|NCT02607956|82850667|FG002|Double-Blinded Phase|Death|0|||
46644831|NCT02607956|82850668|FG003|Double-Blinded Phase|Death|0|||
46644832|NCT02607956|82850665|FG000|Double-Blinded Phase|Adverse Event|4|||
46644833|NCT02607956|82850666|FG001|Double-Blinded Phase|Adverse Event|3|||
46644834|NCT02607956|82850667|FG002|Double-Blinded Phase|Adverse Event|0|||
46644835|NCT02607956|82850668|FG003|Double-Blinded Phase|Adverse Event|0|||
46644836|NCT02607956|82850665|FG000|Double-Blinded Phase|Protocol Violation|3|||
46970137|NCT02139124|83213190|FG003|Overall Study|Adverse Event|2|||
47074676|NCT00638183|83368070|FG000|Overall Study|Physician Decision|9|||
46644837|NCT02607956|82850666|FG001|Double-Blinded Phase|Protocol Violation|1|||
46644838|NCT02607956|82850667|FG002|Double-Blinded Phase|Protocol Violation|0|||
46644839|NCT02607956|82850668|FG003|Double-Blinded Phase|Protocol Violation|0|||
46644840|NCT02607956|82850665|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
46970138|NCT02139124|83213191|FG004|Overall Study|Adverse Event|5|||
47074677|NCT00638183|83368070|FG000|Overall Study|Lost to Follow-up|46|||
47074678|NCT00638183|83368070|FG000|Overall Study|Other reason not defined above|27|||
47074679|NCT00638027|83368076|FG000|Overall Study|Adverse Event|0|||
47074680|NCT00638027|83368077|FG001|Overall Study|Adverse Event|2|||
47074681|NCT00636155|83368083|FG000|Overall Study|Adverse Event|8|||
47074682|NCT00636155|83368083|FG000|Overall Study|Lack of Efficacy|1|||
47074683|NCT00636155|83368083|FG000|Overall Study|Withdrawal by Subject|3|||
47074684|NCT00636155|83368083|FG000|Overall Study|Stem cell transplant|1|||
47074685|NCT00636155|83368083|FG000|Overall Study|Physician Decision|5|||
47074686|NCT00634907|83368089|FG000|Overall Study|Withdrawal by Subject|3|||
46644841|NCT02607956|82850666|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
46644842|NCT02607956|82850667|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
46644843|NCT02607956|82850668|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
46644844|NCT02607956|82850665|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
46644845|NCT02607956|82850666|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
46644846|NCT02607956|82850667|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
46644847|NCT02607956|82850668|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
46644848|NCT02607956|82850665|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
46644849|NCT02607956|82850666|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
46644850|NCT02607956|82850667|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
46644851|NCT02607956|82850668|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
46644852|NCT02607956|82850665|FG000|Open-Label Extension Phase|Death|0|||
46644853|NCT02607956|82850666|FG001|Open-Label Extension Phase|Death|0|||
46644854|NCT02607956|82850667|FG002|Open-Label Extension Phase|Death|1|||
46644855|NCT02607956|82850668|FG003|Open-Label Extension Phase|Death|3|||
46644856|NCT02607956|82850665|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
46644857|NCT02607956|82850666|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
46644858|NCT02607956|82850667|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
46644859|NCT02607956|82850668|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
47074687|NCT00634907|83368090|FG001|Overall Study|Withdrawal by Subject|0|||
47074688|NCT00634907|83368089|FG000|Overall Study|Physician Decision|3|||
46779791|NCT00713258|82998607|FG000|Overall Study|Other|1|||
46970139|NCT02139124|83213187|FG000|Overall Study|Withdrawal by Subject|2|||
46970140|NCT02139124|83213188|FG001|Overall Study|Withdrawal by Subject|2|||
46644860|NCT02607956|82850665|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
46644861|NCT02607956|82850666|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
46644862|NCT02607956|82850667|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
46644863|NCT02607956|82850668|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
46644864|NCT02607956|82850665|FG000|Open-Label Extension Phase|Protocol Violation|0|||
46644865|NCT02607956|82850666|FG001|Open-Label Extension Phase|Protocol Violation|0|||
46644866|NCT02607956|82850667|FG002|Open-Label Extension Phase|Protocol Violation|0|||
46644867|NCT02607956|82850668|FG003|Open-Label Extension Phase|Protocol Violation|2|||
46644868|NCT02607956|82850665|FG000|Open-Label Extension Phase|Pregnancy|0|||
46644869|NCT02607956|82850666|FG001|Open-Label Extension Phase|Pregnancy|0|||
46644870|NCT02607956|82850667|FG002|Open-Label Extension Phase|Pregnancy|0|||
46644871|NCT02607956|82850668|FG003|Open-Label Extension Phase|Pregnancy|1|||
46644872|NCT02564523|82850698|FG000|Overall Study|Withdrawal by Subject|3|||
46644873|NCT02564523|82850699|FG001|Overall Study|Withdrawal by Subject|0|||
46644874|NCT02564523|82850700|FG002|Overall Study|Withdrawal by Subject|1|||
46644875|NCT02564523|82850701|FG003|Overall Study|Withdrawal by Subject|0|||
46644876|NCT02564523|82850702|FG004|Overall Study|Withdrawal by Subject|1|||
46644877|NCT02564523|82850703|FG005|Overall Study|Withdrawal by Subject|0|||
46644878|NCT02564523|82850704|FG006|Overall Study|Withdrawal by Subject|1|||
46644879|NCT02564523|82850705|FG007|Overall Study|Withdrawal by Subject|0|||
46644880|NCT02564523|82850706|FG008|Overall Study|Withdrawal by Subject|0|||
46644881|NCT02564523|82850707|FG009|Overall Study|Withdrawal by Subject|0|||
46644882|NCT02564523|82850708|FG010|Overall Study|Withdrawal by Subject|1|||
46644883|NCT02564523|82850709|FG011|Overall Study|Withdrawal by Subject|0|||
46644884|NCT02564523|82850710|FG012|Overall Study|Withdrawal by Subject|1|||
46779792|NCT00713258|82998608|FG001|Overall Study|Other|1|||
46850478|NCT00112437|83066378|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
46970141|NCT02139124|83213189|FG002|Overall Study|Withdrawal by Subject|2|||
46970142|NCT02139124|83213190|FG003|Overall Study|Withdrawal by Subject|2|||
46970143|NCT02139124|83213191|FG004|Overall Study|Withdrawal by Subject|3|||
46970144|NCT02139124|83213187|FG000|Overall Study|Protocol Violation|0|||
46970145|NCT02139124|83213188|FG001|Overall Study|Protocol Violation|0|||
46970146|NCT02139124|83213189|FG002|Overall Study|Protocol Violation|0|||
46970147|NCT02139124|83213190|FG003|Overall Study|Protocol Violation|1|||
46970148|NCT02139124|83213191|FG004|Overall Study|Protocol Violation|1|||
46970149|NCT02139124|83213187|FG000|Overall Study|non-compliant|1|||
46970150|NCT02139124|83213188|FG001|Overall Study|non-compliant|0|||
46970151|NCT02139124|83213189|FG002|Overall Study|non-compliant|0|||
46970152|NCT02139124|83213190|FG003|Overall Study|non-compliant|2|||
46970153|NCT02139124|83213191|FG004|Overall Study|non-compliant|0|||
46970154|NCT02139124|83213187|FG000|Overall Study|incarceration|0|||
46970155|NCT02139124|83213188|FG001|Overall Study|incarceration|0|||
46970156|NCT02139124|83213189|FG002|Overall Study|incarceration|1|||
46970157|NCT02139124|83213190|FG003|Overall Study|incarceration|0|||
46970158|NCT02139124|83213191|FG004|Overall Study|incarceration|0|||
46970159|NCT02139124|83213187|FG000|Overall Study|subject moved|1|||
46970160|NCT02139124|83213188|FG001|Overall Study|subject moved|0|||
46970161|NCT02139124|83213189|FG002|Overall Study|subject moved|0|||
46970162|NCT02139124|83213190|FG003|Overall Study|subject moved|0|||
46970163|NCT02139124|83213191|FG004|Overall Study|subject moved|0|||
46970164|NCT02139124|83213187|FG000|Overall Study|Lost to Follow-up|3|||
46970165|NCT02139124|83213188|FG001|Overall Study|Lost to Follow-up|2|||
46970166|NCT02139124|83213189|FG002|Overall Study|Lost to Follow-up|0|||
46970167|NCT02139124|83213190|FG003|Overall Study|Lost to Follow-up|5|||
46970168|NCT02139124|83213191|FG004|Overall Study|Lost to Follow-up|4|||
46970169|NCT02139046|83213208|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
46970170|NCT02139046|83213209|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
46970171|NCT02139046|83213210|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
46970172|NCT02139046|83213211|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
46970173|NCT02139046|83213212|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
46970174|NCT02139046|83213208|FG000|Overall Study|Major Protocol Deviation|9|||
46970175|NCT02139046|83213209|FG001|Overall Study|Major Protocol Deviation|10|||
46970176|NCT02139046|83213210|FG002|Overall Study|Major Protocol Deviation|16|||
46970177|NCT02139046|83213211|FG003|Overall Study|Major Protocol Deviation|12|||
46970178|NCT02139046|83213212|FG004|Overall Study|Major Protocol Deviation|6|||
46970179|NCT02139046|83213208|FG000|Overall Study|Lost to Follow-up|13|||
46970180|NCT02139046|83213209|FG001|Overall Study|Lost to Follow-up|16|||
46970181|NCT02139046|83213210|FG002|Overall Study|Lost to Follow-up|16|||
46970182|NCT02139046|83213211|FG003|Overall Study|Lost to Follow-up|18|||
46779793|NCT00710034|82998616|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
46644885|NCT02564523|82850711|FG013|Overall Study|Withdrawal by Subject|0|||
46644886|NCT02564523|82850712|FG014|Overall Study|Withdrawal by Subject|0|||
46644887|NCT02564523|82850713|FG015|Overall Study|Withdrawal by Subject|0|||
46644888|NCT02564523|82850714|FG016|Overall Study|Withdrawal by Subject|0|||
46644889|NCT02564523|82850715|FG017|Overall Study|Withdrawal by Subject|0|||
46644890|NCT02564523|82850698|FG000|Overall Study|Adverse Event|0|||
46644891|NCT02564523|82850699|FG001|Overall Study|Adverse Event|0|||
46644892|NCT02564523|82850700|FG002|Overall Study|Adverse Event|0|||
46644893|NCT02564523|82850701|FG003|Overall Study|Adverse Event|0|||
46644894|NCT02564523|82850702|FG004|Overall Study|Adverse Event|0|||
46644895|NCT02564523|82850703|FG005|Overall Study|Adverse Event|0|||
46644896|NCT02564523|82850704|FG006|Overall Study|Adverse Event|0|||
46644897|NCT02564523|82850705|FG007|Overall Study|Adverse Event|0|||
46644898|NCT02564523|82850706|FG008|Overall Study|Adverse Event|0|||
46644899|NCT02564523|82850707|FG009|Overall Study|Adverse Event|0|||
46644900|NCT02564523|82850708|FG010|Overall Study|Adverse Event|0|||
46644901|NCT02564523|82850709|FG011|Overall Study|Adverse Event|0|||
46644902|NCT02564523|82850710|FG012|Overall Study|Adverse Event|0|||
46644903|NCT02564523|82850711|FG013|Overall Study|Adverse Event|0|||
46644904|NCT02564523|82850712|FG014|Overall Study|Adverse Event|0|||
46644905|NCT02564523|82850713|FG015|Overall Study|Adverse Event|0|||
46644906|NCT02564523|82850714|FG016|Overall Study|Adverse Event|0|||
46644907|NCT02564523|82850715|FG017|Overall Study|Adverse Event|1|||
46644908|NCT02564523|82850698|FG000|Overall Study|Death|0|||
46644909|NCT02564523|82850699|FG001|Overall Study|Death|0|||
46644910|NCT02564523|82850700|FG002|Overall Study|Death|0|||
46644911|NCT02564523|82850701|FG003|Overall Study|Death|0|||
46644912|NCT02564523|82850702|FG004|Overall Study|Death|0|||
46644913|NCT02564523|82850703|FG005|Overall Study|Death|0|||
46644914|NCT02564523|82850704|FG006|Overall Study|Death|1|||
46644915|NCT02564523|82850705|FG007|Overall Study|Death|0|||
46644916|NCT02564523|82850706|FG008|Overall Study|Death|0|||
46644917|NCT02564523|82850707|FG009|Overall Study|Death|0|||
46644918|NCT02564523|82850708|FG010|Overall Study|Death|1|||
46644919|NCT02564523|82850709|FG011|Overall Study|Death|0|||
46644920|NCT02564523|82850710|FG012|Overall Study|Death|0|||
46644921|NCT02564523|82850711|FG013|Overall Study|Death|0|||
46644922|NCT02564523|82850712|FG014|Overall Study|Death|0|||
46644923|NCT02564523|82850713|FG015|Overall Study|Death|0|||
46644924|NCT02564523|82850714|FG016|Overall Study|Death|0|||
46644925|NCT02564523|82850715|FG017|Overall Study|Death|0|||
46644926|NCT02564523|82850698|FG000|Overall Study|Lost to Follow-up|2|||
46644927|NCT02564523|82850699|FG001|Overall Study|Lost to Follow-up|1|||
46644928|NCT02564523|82850700|FG002|Overall Study|Lost to Follow-up|4|||
46644929|NCT02564523|82850701|FG003|Overall Study|Lost to Follow-up|0|||
46644930|NCT02564523|82850702|FG004|Overall Study|Lost to Follow-up|1|||
46644931|NCT02564523|82850703|FG005|Overall Study|Lost to Follow-up|0|||
46644932|NCT02564523|82850704|FG006|Overall Study|Lost to Follow-up|1|||
46644933|NCT02564523|82850705|FG007|Overall Study|Lost to Follow-up|0|||
46644934|NCT02564523|82850706|FG008|Overall Study|Lost to Follow-up|0|||
46644935|NCT02564523|82850707|FG009|Overall Study|Lost to Follow-up|0|||
46644936|NCT02564523|82850708|FG010|Overall Study|Lost to Follow-up|0|||
46644937|NCT02564523|82850709|FG011|Overall Study|Lost to Follow-up|1|||
46779794|NCT00710034|82998617|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
46779795|NCT00710034|82998616|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
46644938|NCT02564523|82850710|FG012|Overall Study|Lost to Follow-up|1|||
46644939|NCT02564523|82850711|FG013|Overall Study|Lost to Follow-up|0|||
46644940|NCT02564523|82850712|FG014|Overall Study|Lost to Follow-up|0|||
46644941|NCT02564523|82850713|FG015|Overall Study|Lost to Follow-up|0|||
46644942|NCT02564523|82850714|FG016|Overall Study|Lost to Follow-up|0|||
46644943|NCT02564523|82850715|FG017|Overall Study|Lost to Follow-up|0|||
46644944|NCT02564523|82850698|FG000|Overall Study|Physician Decision|0|||
46644945|NCT02564523|82850699|FG001|Overall Study|Physician Decision|0|||
46644946|NCT02564523|82850700|FG002|Overall Study|Physician Decision|0|||
46779796|NCT00710034|82998617|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
47074689|NCT00634907|83368090|FG001|Overall Study|Physician Decision|9|||
46644947|NCT02564523|82850701|FG003|Overall Study|Physician Decision|0|||
46644948|NCT02564523|82850702|FG004|Overall Study|Physician Decision|1|||
46644949|NCT02564523|82850703|FG005|Overall Study|Physician Decision|0|||
46644950|NCT02564523|82850704|FG006|Overall Study|Physician Decision|0|||
46644951|NCT02564523|82850705|FG007|Overall Study|Physician Decision|0|||
46644952|NCT02564523|82850706|FG008|Overall Study|Physician Decision|0|||
46644953|NCT02564523|82850707|FG009|Overall Study|Physician Decision|0|||
46644954|NCT02564523|82850708|FG010|Overall Study|Physician Decision|1|||
46644955|NCT02564523|82850709|FG011|Overall Study|Physician Decision|0|||
46644956|NCT02564523|82850710|FG012|Overall Study|Physician Decision|0|||
46644957|NCT02564523|82850711|FG013|Overall Study|Physician Decision|0|||
46644958|NCT02564523|82850712|FG014|Overall Study|Physician Decision|0|||
46644959|NCT02564523|82850713|FG015|Overall Study|Physician Decision|0|||
46644960|NCT02564523|82850714|FG016|Overall Study|Physician Decision|0|||
46644961|NCT02564523|82850715|FG017|Overall Study|Physician Decision|0|||
46644962|NCT02564523|82850698|FG000|Overall Study|Protocol Violation|2|||
46644963|NCT02564523|82850699|FG001|Overall Study|Protocol Violation|2|||
46644964|NCT02564523|82850700|FG002|Overall Study|Protocol Violation|5|||
46644965|NCT02564523|82850701|FG003|Overall Study|Protocol Violation|0|||
46644966|NCT02564523|82850702|FG004|Overall Study|Protocol Violation|1|||
46644967|NCT02564523|82850703|FG005|Overall Study|Protocol Violation|0|||
46644968|NCT02564523|82850704|FG006|Overall Study|Protocol Violation|0|||
46644969|NCT02564523|82850705|FG007|Overall Study|Protocol Violation|0|||
47074690|NCT00634907|83368089|FG000|Overall Study|Withdrawal by Subject|11|||
47074691|NCT00634907|83368090|FG001|Overall Study|Withdrawal by Subject|8|||
47074692|NCT04740814|83368146|FG000|Overall Study|Adverse Event|3|||
47074693|NCT04740814|83368146|FG000|Overall Study|Protocol Violation|2|||
47074694|NCT04740814|83368146|FG000|Overall Study|Lost to Follow-up|2|||
47074695|NCT04740814|83368146|FG000|Overall Study|Withdrawal by Subject|3|||
47074696|NCT04461600|83368169|FG000|Overall Study|Death|6|||
47074697|NCT04461600|83368170|FG001|Overall Study|Death|5|||
47074698|NCT04461600|83368169|FG000|Overall Study|Withdrawal by Subject|0|||
47074699|NCT04461600|83368170|FG001|Overall Study|Withdrawal by Subject|1|||
47074700|NCT04282148|83368176|FG000|Overall Study|Death|1|||
47074701|NCT04282148|83368176|FG000|Overall Study|Withdrawal by Subject|1|||
47074702|NCT04282148|83368176|FG000|Overall Study|Physician Decision|1|||
47074703|NCT04209348|83368182|FG000|Overall Study|Lost to Follow-up|1|||
47074704|NCT04209348|83368183|FG001|Overall Study|Lost to Follow-up|0|||
47074705|NCT03839459|83368209|FG000|Overall Study|Withdrawal by Subject|2|||
47074706|NCT03839459|83368209|FG000|Overall Study|progression of disease|3|||
46779797|NCT00710034|82998616|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
46644970|NCT02564523|82850706|FG008|Overall Study|Protocol Violation|0|||
46644971|NCT02564523|82850707|FG009|Overall Study|Protocol Violation|0|||
46644972|NCT02564523|82850708|FG010|Overall Study|Protocol Violation|0|||
46644973|NCT02564523|82850709|FG011|Overall Study|Protocol Violation|0|||
46644974|NCT02564523|82850710|FG012|Overall Study|Protocol Violation|0|||
46644975|NCT02564523|82850711|FG013|Overall Study|Protocol Violation|0|||
46644976|NCT02564523|82850712|FG014|Overall Study|Protocol Violation|0|||
46644977|NCT02564523|82850713|FG015|Overall Study|Protocol Violation|0|||
46644978|NCT02564523|82850714|FG016|Overall Study|Protocol Violation|0|||
46779798|NCT00710034|82998617|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
46779799|NCT00710034|82998616|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
46779800|NCT00710034|82998617|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
46779801|NCT00710034|82998616|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
46779802|NCT00710034|82998617|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
46779803|NCT00710034|82998616|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
47074707|NCT03811834|83368213|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
47074708|NCT03251079|83368243|FG000|Overall Study|Withdrawal by Subject|1|||
47074709|NCT03250832|83368257|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
47074710|NCT03250832|83368258|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
47074711|NCT03250832|83368259|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
47074712|NCT03250832|83368260|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
47074713|NCT03250832|83368261|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
47074714|NCT03250832|83368262|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
46644979|NCT02564523|82850715|FG017|Overall Study|Protocol Violation|0|||
46644980|NCT02564523|82850698|FG000|Overall Study|Other|3|||
46644981|NCT02564523|82850699|FG001|Overall Study|Other|0|||
46644982|NCT02564523|82850700|FG002|Overall Study|Other|0|||
46644983|NCT02564523|82850701|FG003|Overall Study|Other|1|||
46644984|NCT02564523|82850702|FG004|Overall Study|Other|0|||
46779804|NCT00710034|82998617|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
46779805|NCT00710034|82998616|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
46779806|NCT00710034|82998617|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
46779807|NCT00710034|82998616|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
46779808|NCT00710034|82998617|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
46779809|NCT00710034|82998616|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
46779810|NCT00710034|82998617|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
46779811|NCT00710034|82998616|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
46779812|NCT00710034|82998617|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
46779813|NCT00710034|82998616|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
46779814|NCT00710034|82998617|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
46779815|NCT00414973|82998627|FG000|Overall Study|Withdrawal by Subject|14|||
46779816|NCT00414973|82998628|FG001|Overall Study|Withdrawal by Subject|4|||
46779817|NCT00414973|82998629|FG002|Overall Study|Withdrawal by Subject|1|||
46779818|NCT00414973|82998630|FG003|Overall Study|Withdrawal by Subject|0|||
46779819|NCT00414973|82998627|FG000|Overall Study|Adverse Event|10|||
47074715|NCT03250832|83368263|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
47074716|NCT03250832|83368264|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
47074717|NCT03250832|83368265|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
47074718|NCT03250832|83368266|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
47074719|NCT03250832|83368257|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
46644985|NCT02564523|82850703|FG005|Overall Study|Other|0|||
46644986|NCT02564523|82850704|FG006|Overall Study|Other|0|||
46644987|NCT02564523|82850705|FG007|Overall Study|Other|0|||
46644988|NCT02564523|82850706|FG008|Overall Study|Other|0|||
46644989|NCT02564523|82850707|FG009|Overall Study|Other|0|||
46644990|NCT02564523|82850708|FG010|Overall Study|Other|0|||
46644991|NCT02564523|82850709|FG011|Overall Study|Other|0|||
46644992|NCT02564523|82850710|FG012|Overall Study|Other|0|||
46644993|NCT02564523|82850711|FG013|Overall Study|Other|0|||
46644994|NCT02564523|82850712|FG014|Overall Study|Other|0|||
46644995|NCT02564523|82850713|FG015|Overall Study|Other|0|||
46644996|NCT02564523|82850714|FG016|Overall Study|Other|0|||
46644997|NCT02564523|82850715|FG017|Overall Study|Other|0|||
46644998|NCT01447628|82850822|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
46644999|NCT01447628|82850823|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
46645000|NCT01447628|82850824|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
46645001|NCT01447628|82850825|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
46645002|NCT00515853|82850847|FG000|Overall Study|Lost to Follow-up|9|||
46645003|NCT00515853|82850848|FG001|Overall Study|Lost to Follow-up|13|||
46645004|NCT00515853|82850847|FG000|Overall Study|Withdrawal by Subject|6|||
46645005|NCT00515853|82850848|FG001|Overall Study|Withdrawal by Subject|4|||
46645006|NCT00003458|82850854|FG000|Overall Study|Not evaluable|4|||
46645007|NCT05032872|82850861|FG000|Overall Study|Adverse Event|1|||
46645008|NCT05032872|82850862|FG001|Overall Study|Adverse Event|0|||
46645009|NCT05032872|82850861|FG000|Overall Study|Lost to Follow-up|2|||
46645010|NCT05032872|82850862|FG001|Overall Study|Lost to Follow-up|4|||
46645011|NCT05032872|82850861|FG000|Overall Study|Withdrawal by Subject|4|||
46645012|NCT05032872|82850862|FG001|Overall Study|Withdrawal by Subject|3|||
46645013|NCT04613739|82850888|FG000|Overall Study|Lost to Follow-up|6|||
46645014|NCT04613739|82850889|FG001|Overall Study|Lost to Follow-up|9|||
46645015|NCT04613739|82850888|FG000|Overall Study|potentially duplicative/fraudulent|1|||
46645016|NCT04613739|82850889|FG001|Overall Study|potentially duplicative/fraudulent|3|||
46645017|NCT04407806|82850916|FG000|Overall Study|Withdrawal by Subject|1|||
46645018|NCT04407806|82850917|FG001|Overall Study|Withdrawal by Subject|2|||
46645019|NCT04324021|82850926|FG000|Overall Study|Adverse Event|1|||
46645020|NCT04324021|82850927|FG001|Overall Study|Adverse Event|0|||
46645021|NCT04324021|82850928|FG002|Overall Study|Adverse Event|0|||
46645022|NCT04324021|82850926|FG000|Overall Study|Lack of Efficacy|0|||
46645023|NCT04324021|82850927|FG001|Overall Study|Lack of Efficacy|0|||
46645024|NCT04324021|82850928|FG002|Overall Study|Lack of Efficacy|1|||
46645025|NCT04324021|82850926|FG000|Overall Study|Death|1|||
46645026|NCT04324021|82850927|FG001|Overall Study|Death|1|||
46645027|NCT04324021|82850928|FG002|Overall Study|Death|0|||
46645028|NCT04209621|82850939|FG000|Overall Study|Death|1|||
46850479|NCT00112437|83066379|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850480|NCT00112437|83066380|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850481|NCT00112437|83066381|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
46645029|NCT04209621|82850939|FG000|Overall Study|Study Terminated Early|2|||
46645030|NCT04186663|82850944|FG000|Overall Study|Lost to Follow-up|1|||
46645031|NCT04186663|82850944|FG000|Overall Study|Unable to complete blood draw|3|||
46645032|NCT04158219|82850948|FG000|Overall Study|Lost to Follow-up|1|||
46645033|NCT03954743|82850981|FG000|Overall Study|Adverse Event|1|||
46645034|NCT03954743|82850982|FG001|Overall Study|Adverse Event|0|||
46645035|NCT03954743|82850981|FG000|Overall Study|Lost to Follow-up|6|||
46645036|NCT03954743|82850982|FG001|Overall Study|Lost to Follow-up|4|||
46645037|NCT03954743|82850981|FG000|Overall Study|Protocol Violation|1|||
46645038|NCT03954743|82850982|FG001|Overall Study|Protocol Violation|0|||
46645039|NCT03954743|82850981|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
46645040|NCT03954743|82850982|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
46645041|NCT03954743|82850981|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
46645042|NCT03954743|82850982|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46645043|NCT03880565|82850990|FG000|Overall Study|Withdrawal by Subject|1|||
46645044|NCT03880565|82850991|FG001|Overall Study|Withdrawal by Subject|0|||
46645045|NCT03782792|82850999|FG000|Overall Study|Patient left the country|0|||
47074720|NCT03250832|83368258|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
47074721|NCT03250832|83368259|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
47074722|NCT03250832|83368260|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
47074723|NCT03250832|83368261|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
47074724|NCT03250832|83368262|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
47074725|NCT03250832|83368263|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
47074726|NCT03250832|83368264|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
47074727|NCT03250832|83368265|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
47074728|NCT03250832|83368266|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
47074729|NCT03250832|83368257|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
47074730|NCT03250832|83368258|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
47074731|NCT03250832|83368259|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
46779820|NCT00414973|82998628|FG001|Overall Study|Adverse Event|0|||
46779821|NCT00414973|82998629|FG002|Overall Study|Adverse Event|1|||
46779822|NCT00414973|82998630|FG003|Overall Study|Adverse Event|0|||
46779823|NCT00414973|82998627|FG000|Overall Study|Protocol Violation|3|||
46645046|NCT03782792|82851000|FG001|Overall Study|Patient left the country|1|||
46645047|NCT03782792|82850999|FG000|Overall Study|Withdrawal by Subject|1|||
46779824|NCT00414973|82998628|FG001|Overall Study|Protocol Violation|4|||
46970183|NCT02139046|83213212|FG004|Overall Study|Lost to Follow-up|13|||
46645048|NCT03782792|82851000|FG001|Overall Study|Withdrawal by Subject|2|||
46779825|NCT00414973|82998629|FG002|Overall Study|Protocol Violation|0|||
46779826|NCT00414973|82998630|FG003|Overall Study|Protocol Violation|0|||
47074732|NCT03250832|83368260|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
46645049|NCT03733119|82851010|FG000|Overall Study|Physician Decision|2|||
46645050|NCT03733119|82851011|FG001|Overall Study|Physician Decision|1|||
46645051|NCT03733119|82851010|FG000|Overall Study|ineligible to treat per protocol|0|||
46645052|NCT03733119|82851011|FG001|Overall Study|ineligible to treat per protocol|1|||
46645053|NCT03661996|82851022|FG000|Overall Study|Adverse Event|0|||
46645054|NCT03661996|82851023|FG001|Overall Study|Adverse Event|0|||
46645055|NCT03661996|82851024|FG002|Overall Study|Adverse Event|1|||
46645056|NCT03661996|82851025|FG003|Overall Study|Adverse Event|1|||
46645057|NCT03661996|82851026|FG004|Overall Study|Adverse Event|0|||
46645058|NCT03661996|82851022|FG000|Overall Study|Lost to Follow-up|5|||
46645059|NCT03661996|82851023|FG001|Overall Study|Lost to Follow-up|1|||
46645060|NCT03661996|82851024|FG002|Overall Study|Lost to Follow-up|2|||
46645061|NCT03661996|82851025|FG003|Overall Study|Lost to Follow-up|2|||
46645062|NCT03661996|82851026|FG004|Overall Study|Lost to Follow-up|6|||
46645063|NCT03661996|82851022|FG000|Overall Study|Physician Decision|1|||
46645064|NCT03661996|82851023|FG001|Overall Study|Physician Decision|1|||
46645065|NCT03661996|82851024|FG002|Overall Study|Physician Decision|1|||
46645066|NCT03661996|82851025|FG003|Overall Study|Physician Decision|2|||
46645067|NCT03661996|82851026|FG004|Overall Study|Physician Decision|0|||
46645068|NCT03661996|82851022|FG000|Overall Study|Protocol Violation|0|||
46645069|NCT03661996|82851023|FG001|Overall Study|Protocol Violation|0|||
46645070|NCT03661996|82851024|FG002|Overall Study|Protocol Violation|0|||
46645071|NCT03661996|82851025|FG003|Overall Study|Protocol Violation|0|||
46645072|NCT03661996|82851026|FG004|Overall Study|Protocol Violation|1|||
46645073|NCT03661996|82851022|FG000|Overall Study|Withdrawal by Subject|3|||
46645074|NCT03661996|82851023|FG001|Overall Study|Withdrawal by Subject|5|||
46645075|NCT03661996|82851024|FG002|Overall Study|Withdrawal by Subject|1|||
46645076|NCT03661996|82851025|FG003|Overall Study|Withdrawal by Subject|7|||
46645077|NCT03661996|82851026|FG004|Overall Study|Withdrawal by Subject|7|||
46645078|NCT03661996|82851022|FG000|Overall Study|Sponsors Decision|2|||
46645079|NCT03661996|82851023|FG001|Overall Study|Sponsors Decision|0|||
46645080|NCT03661996|82851024|FG002|Overall Study|Sponsors Decision|0|||
46645081|NCT03661996|82851025|FG003|Overall Study|Sponsors Decision|0|||
46645082|NCT03661996|82851026|FG004|Overall Study|Sponsors Decision|0|||
46645083|NCT03661996|82851022|FG000|Overall Study|Other|1|||
46645084|NCT03661996|82851023|FG001|Overall Study|Other|1|||
46645085|NCT03661996|82851024|FG002|Overall Study|Other|1|||
46645086|NCT03661996|82851025|FG003|Overall Study|Other|1|||
46645087|NCT03661996|82851026|FG004|Overall Study|Other|0|||
46645088|NCT03633461|82851043|FG000|Overall Study|Lost to Follow-up|0|||
46645089|NCT03633461|82851044|FG001|Overall Study|Lost to Follow-up|1|||
46645090|NCT03499314|82851072|FG000|Overall Study|Time Commitment|1|||
46645091|NCT03499314|82851073|FG001|Overall Study|Time Commitment|2|||
46645092|NCT03499314|82851072|FG000|Overall Study|Medical issue unrelated to research study|1|||
46645093|NCT03499314|82851073|FG001|Overall Study|Medical issue unrelated to research study|1|||
46645094|NCT03369431|82851081|FG000|Overall Study|Lost to Follow-up|1|||
46645095|NCT03369431|82851082|FG001|Overall Study|Lost to Follow-up|3|||
46645096|NCT03369431|82851081|FG000|Overall Study|Withdrawal by Subject|2|||
46645097|NCT03369431|82851082|FG001|Overall Study|Withdrawal by Subject|3|||
46645098|NCT03369431|82851081|FG000|Overall Study|Protocol Violation|1|||
46645099|NCT03369431|82851082|FG001|Overall Study|Protocol Violation|1|||
46645100|NCT03336866|82851091|FG000|Overall Study|Lost to Follow-up|2|||
46970184|NCT02139046|83213208|FG000|Overall Study|Voluntary Withdrawal|20|||
47074733|NCT03250832|83368261|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
47074734|NCT03250832|83368262|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
47074735|NCT03250832|83368263|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
47074736|NCT03250832|83368264|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
46645101|NCT03336866|82851092|FG001|Overall Study|Lost to Follow-up|0|||
46645102|NCT03336866|82851093|FG002|Overall Study|Lost to Follow-up|3|||
46645103|NCT03336866|82851091|FG000|Overall Study|Withdrawal by Subject|1|||
46645104|NCT03336866|82851092|FG001|Overall Study|Withdrawal by Subject|1|||
46645105|NCT03336866|82851093|FG002|Overall Study|Withdrawal by Subject|0|||
46970185|NCT02139046|83213209|FG001|Overall Study|Voluntary Withdrawal|8|||
46970186|NCT02139046|83213210|FG002|Overall Study|Voluntary Withdrawal|10|||
46970187|NCT02139046|83213211|FG003|Overall Study|Voluntary Withdrawal|15|||
46970188|NCT02139046|83213212|FG004|Overall Study|Voluntary Withdrawal|16|||
46970189|NCT02139046|83213208|FG000|Overall Study|Lack of Efficacy|0|||
46970190|NCT02139046|83213209|FG001|Overall Study|Lack of Efficacy|1|||
46645106|NCT03336866|82851091|FG000|Overall Study|Noncompliance with clinic house rules|0|||
46645107|NCT03336866|82851092|FG001|Overall Study|Noncompliance with clinic house rules|0|||
46645108|NCT03336866|82851093|FG002|Overall Study|Noncompliance with clinic house rules|1|||
46645109|NCT03332173|82851106|FG000|Overall Study|Death|7|||
46645110|NCT03332173|82851106|FG000|Overall Study|Withdrawal by Subject|6|||
46970191|NCT02139046|83213210|FG002|Overall Study|Lack of Efficacy|2|||
46970192|NCT02139046|83213211|FG003|Overall Study|Lack of Efficacy|1|||
46645111|NCT03332173|82851106|FG000|Overall Study|Lost to Follow-up|2|||
46645112|NCT03332173|82851106|FG000|Overall Study|Transferred to long-term extension study|29|||
46645113|NCT03322293|82851113|FG000|Overall Study|Lost to Follow-up|0|||
46645114|NCT03322293|82851114|FG001|Overall Study|Lost to Follow-up|0|||
46645115|NCT03322293|82851115|FG002|Overall Study|Lost to Follow-up|1|||
46645116|NCT03254394|82851137|FG000|Overall Study|Withdrawal by Subject|0|||
46645117|NCT03254394|82851138|FG001|Overall Study|Withdrawal by Subject|2|||
46645118|NCT03253809|82851144|FG000|Overall Study|Unable to obtain study related data|14|||
46645119|NCT02998476|82851223|FG000|Overall Study|Lost to Follow-up|1|||
46645120|NCT02998476|82851224|FG001|Overall Study|Lost to Follow-up|0|||
46970193|NCT02139046|83213212|FG004|Overall Study|Lack of Efficacy|2|||
46970194|NCT02139046|83213208|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
46970195|NCT02139046|83213209|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
46970196|NCT02139046|83213210|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
46970197|NCT02139046|83213211|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
46970198|NCT02139046|83213212|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
46970199|NCT02139046|83213208|FG000|Overall Study|Other Miscellaneous Reasons|10|||
46970200|NCT02139046|83213209|FG001|Overall Study|Other Miscellaneous Reasons|9|||
46970201|NCT02139046|83213210|FG002|Overall Study|Other Miscellaneous Reasons|4|||
46970202|NCT02139046|83213211|FG003|Overall Study|Other Miscellaneous Reasons|9|||
46970203|NCT02139046|83213212|FG004|Overall Study|Other Miscellaneous Reasons|12|||
46970204|NCT02138890|83213226|FG000|Overall Study|Adverse Event|1|||
46970205|NCT02138890|83213227|FG001|Overall Study|Adverse Event|0|||
46970206|NCT02100670|83213238|FG000|Overall Study|Adverse Event|10|||
46970207|NCT02100670|83213239|FG001|Overall Study|Adverse Event|3|||
46970208|NCT02100670|83213240|FG002|Overall Study|Adverse Event|3|||
46970209|NCT02100670|83213241|FG003|Overall Study|Adverse Event|0|||
46645121|NCT02998476|82851223|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
46645122|NCT02998476|82851224|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
46645123|NCT02998476|82851223|FG000|Overall Study|Withdrawal by Subject|1|||
46645124|NCT02998476|82851224|FG001|Overall Study|Withdrawal by Subject|2|||
46645125|NCT02998476|82851223|FG000|Overall Study|Death|45|||
46645126|NCT02998476|82851224|FG001|Overall Study|Death|2|||
46645127|NCT02998476|82851223|FG000|Overall Study|Other|6|||
46645128|NCT02998476|82851224|FG001|Overall Study|Other|1|||
46645129|NCT02924064|82851242|FG000|Overall Study|Adverse Event|2|||
46645130|NCT02924064|82851243|FG001|Overall Study|Adverse Event|2|||
46645131|NCT02924064|82851242|FG000|Overall Study|Lost to Follow-up|0|||
46645132|NCT02924064|82851243|FG001|Overall Study|Lost to Follow-up|2|||
46645133|NCT02924064|82851242|FG000|Overall Study|Physician Decision|0|||
46645134|NCT02924064|82851243|FG001|Overall Study|Physician Decision|2|||
46645135|NCT02924064|82851242|FG000|Overall Study|Protocol Violation|1|||
46645136|NCT02924064|82851243|FG001|Overall Study|Protocol Violation|3|||
46645137|NCT02924064|82851242|FG000|Overall Study|Withdrawal by Subject|4|||
46645138|NCT02924064|82851243|FG001|Overall Study|Withdrawal by Subject|5|||
46645139|NCT02924064|82851242|FG000|Overall Study|Other|17|||
46645140|NCT02924064|82851243|FG001|Overall Study|Other|29|||
46645141|NCT02916706|82851251|FG000|Overall Study|Adverse Event|0|||
46645142|NCT02916706|82851252|FG001|Overall Study|Adverse Event|1|||
46645143|NCT02916706|82851251|FG000|Overall Study|Lost to Follow-up|0|||
46645144|NCT02916706|82851252|FG001|Overall Study|Lost to Follow-up|1|||
46645145|NCT02916706|82851251|FG000|Overall Study|Physician Decision|1|||
46645146|NCT02916706|82851252|FG001|Overall Study|Physician Decision|0|||
46645147|NCT02916706|82851251|FG000|Overall Study|Protocol Violation|3|||
46645148|NCT02916706|82851252|FG001|Overall Study|Protocol Violation|1|||
46645149|NCT02916706|82851251|FG000|Overall Study|Withdrawal by Subject|6|||
46779827|NCT00414973|82998627|FG000|Overall Study|Lost to Follow-up|0|||
46779828|NCT00414973|82998628|FG001|Overall Study|Lost to Follow-up|2|||
46779829|NCT00414973|82998629|FG002|Overall Study|Lost to Follow-up|0|||
46779830|NCT00414973|82998630|FG003|Overall Study|Lost to Follow-up|0|||
46779831|NCT00414973|82998627|FG000|Overall Study|Sponsor Decision|1|||
46779832|NCT00414973|82998628|FG001|Overall Study|Sponsor Decision|0|||
46970210|NCT02100670|83213238|FG000|Overall Study|Lost to Follow-up|1|||
46970211|NCT02100670|83213239|FG001|Overall Study|Lost to Follow-up|0|||
46970212|NCT02100670|83213240|FG002|Overall Study|Lost to Follow-up|0|||
47074737|NCT03250832|83368265|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
47074738|NCT03250832|83368266|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
46779833|NCT00414973|82998629|FG002|Overall Study|Sponsor Decision|0|||
46779834|NCT00414973|82998630|FG003|Overall Study|Sponsor Decision|0|||
46779835|NCT00414973|82998627|FG000|Overall Study|Death|0|||
46645150|NCT02916706|82851252|FG001|Overall Study|Withdrawal by Subject|9|||
46645151|NCT02916706|82851251|FG000|Overall Study|Other|5|||
46779836|NCT00414973|82998628|FG001|Overall Study|Death|0|||
46779837|NCT00414973|82998629|FG002|Overall Study|Death|1|||
46645152|NCT02916706|82851252|FG001|Overall Study|Other|19|||
46645153|NCT02889900|82851258|FG000|Overall Study|Adverse Event|11|||
46645154|NCT02889900|82851258|FG000|Overall Study|Condition under investigation worsened|32|||
46779838|NCT00414973|82998630|FG003|Overall Study|Death|0|||
46970213|NCT02100670|83213241|FG003|Overall Study|Lost to Follow-up|0|||
46970214|NCT02100670|83213238|FG000|Overall Study|Protocol Violation|0|||
46645155|NCT02889900|82851258|FG000|Overall Study|Other|5|||
46645156|NCT02889900|82851258|FG000|Overall Study|Withdrawal by Subject|7|||
46645157|NCT02889900|82851258|FG000|Overall Study|Not treated|2|||
46645158|NCT02866695|82851262|FG000|Overall Study|Adverse Event|1|||
46645159|NCT02866695|82851262|FG000|Overall Study|Lost to Follow-up|1|||
46645160|NCT02834793|82851268|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
46645161|NCT02834793|82851269|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
46645162|NCT02834793|82851270|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
46645163|NCT02834793|82851271|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
46645164|NCT02834793|82851268|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
46645165|NCT02834793|82851269|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
46970215|NCT02100670|83213239|FG001|Overall Study|Protocol Violation|1|||
46970216|NCT02100670|83213240|FG002|Overall Study|Protocol Violation|0|||
46645166|NCT02834793|82851270|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
46645167|NCT02834793|82851271|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
46645168|NCT02834793|82851268|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
46645169|NCT02834793|82851269|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
46645170|NCT02834793|82851270|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
46645171|NCT02834793|82851271|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
46645172|NCT02834793|82851268|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
46645173|NCT02834793|82851269|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
46645174|NCT02834793|82851270|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
46645175|NCT02834793|82851271|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
46645176|NCT02834793|82851268|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
46645177|NCT02834793|82851269|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
46850482|NCT00112437|83066382|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850483|NCT00112437|83066383|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850484|NCT00112437|83066384|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
46850485|NCT00112437|83066385|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850486|NCT00112437|83066386|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850487|NCT00112437|83066387|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850488|NCT00112437|83066388|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
46850489|NCT00112437|83066363|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850490|NCT00112437|83066364|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850491|NCT00112437|83066365|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850492|NCT00112437|83066366|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850493|NCT00112437|83066367|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850494|NCT00112437|83066368|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850495|NCT00112437|83066369|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850496|NCT00112437|83066370|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850497|NCT00112437|83066371|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46970217|NCT02100670|83213241|FG003|Overall Study|Protocol Violation|1|||
46970218|NCT02100670|83213238|FG000|Overall Study|Withdrawal of Consent|0|||
46970219|NCT02100670|83213239|FG001|Overall Study|Withdrawal of Consent|1|||
46970220|NCT02100670|83213240|FG002|Overall Study|Withdrawal of Consent|1|||
46970221|NCT02100670|83213241|FG003|Overall Study|Withdrawal of Consent|0|||
46970222|NCT02100670|83213238|FG000|Overall Study|No swelling no pain|1|||
46970223|NCT02100670|83213239|FG001|Overall Study|No swelling no pain|0|||
46970224|NCT02100670|83213240|FG002|Overall Study|No swelling no pain|0|||
46970225|NCT02100670|83213241|FG003|Overall Study|No swelling no pain|0|||
46970226|NCT02100670|83213238|FG000|Overall Study|Poor Efficacy|0|||
46970227|NCT02100670|83213239|FG001|Overall Study|Poor Efficacy|1|||
46970228|NCT02100670|83213240|FG002|Overall Study|Poor Efficacy|0|||
46970229|NCT02100670|83213241|FG003|Overall Study|Poor Efficacy|0|||
46645178|NCT02834793|82851270|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
46645179|NCT02834793|82851271|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
46645180|NCT02834793|82851268|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
46645181|NCT02834793|82851269|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
46645182|NCT02834793|82851270|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
46645183|NCT02834793|82851271|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
46645184|NCT02834793|82851268|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
46645185|NCT02834793|82851269|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
46645186|NCT02834793|82851270|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
46645187|NCT02834793|82851271|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
46645188|NCT02834793|82851268|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
46645189|NCT02834793|82851269|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
46645190|NCT02834793|82851270|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
46850498|NCT00112437|83066372|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46970230|NCT02100670|83213238|FG000|Overall Study|Physician Decision|0|||
46970231|NCT02100670|83213239|FG001|Overall Study|Physician Decision|1|||
46970232|NCT02100670|83213240|FG002|Overall Study|Physician Decision|0|||
46970233|NCT02100670|83213241|FG003|Overall Study|Physician Decision|0|||
46645191|NCT02834793|82851271|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
46645192|NCT02834793|82851268|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
46645193|NCT02834793|82851269|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
46645194|NCT02834793|82851270|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
46645195|NCT02834793|82851271|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
46645196|NCT02834793|82851268|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
46645197|NCT02834793|82851269|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
46645198|NCT02834793|82851270|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
46645199|NCT02834793|82851271|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
46645200|NCT02834793|82851268|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
46645201|NCT02834793|82851269|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
46645202|NCT02834793|82851270|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
46645203|NCT02834793|82851271|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
46645204|NCT02834793|82851268|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
46645205|NCT02834793|82851269|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
46645206|NCT02834793|82851270|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
46645207|NCT02834793|82851271|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
46645208|NCT02834793|82851268|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
46645209|NCT02834793|82851269|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
46645210|NCT02834793|82851270|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
46645211|NCT02834793|82851271|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
46645212|NCT02834793|82851268|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
46645213|NCT02834793|82851269|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
46645214|NCT02834793|82851270|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
46645215|NCT02834793|82851271|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
46645216|NCT02834793|82851268|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
46645217|NCT02834793|82851269|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
46645218|NCT02834793|82851270|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
46970234|NCT02100670|83213238|FG000|Overall Study|Withdrawal by Subject|1|||
47074739|NCT03250832|83368257|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074740|NCT03250832|83368258|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074741|NCT03250832|83368259|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074742|NCT03250832|83368260|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074743|NCT03250832|83368261|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074744|NCT03250832|83368262|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074745|NCT03250832|83368263|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074746|NCT03250832|83368264|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
47074747|NCT03250832|83368265|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
46645219|NCT02834793|82851271|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
46645220|NCT02810457|82851281|FG000|Overall Study|Randomised but no treatment received|2|||
46645221|NCT02810457|82851282|FG001|Overall Study|Randomised but no treatment received|1|||
46645222|NCT02810457|82851281|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
46645223|NCT02810457|82851282|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
46645224|NCT02810457|82851281|FG000|Overall Study|Adverse Event|37|||
46645225|NCT02810457|82851282|FG001|Overall Study|Adverse Event|43|||
46645226|NCT02810457|82851281|FG000|Overall Study|Patient decision|31|||
46645227|NCT02810457|82851282|FG001|Overall Study|Patient decision|35|||
46645228|NCT02810457|82851281|FG000|Overall Study|Patient lost to follow-up|2|||
46645229|NCT02810457|82851282|FG001|Overall Study|Patient lost to follow-up|2|||
46645230|NCT02810457|82851281|FG000|Overall Study|Death|39|||
46645231|NCT02810457|82851282|FG001|Overall Study|Death|28|||
46645232|NCT02810457|82851281|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
46645233|NCT02810457|82851282|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
46645234|NCT02810457|82851281|FG000|Overall Study|Clinical progression|15|||
46645235|NCT02810457|82851282|FG001|Overall Study|Clinical progression|16|||
46645236|NCT02810457|82851281|FG000|Overall Study|Investigator decision|3|||
46645237|NCT02810457|82851282|FG001|Overall Study|Investigator decision|2|||
46645238|NCT02810457|82851281|FG000|Overall Study|Patient ineligibility|3|||
46645239|NCT02810457|82851282|FG001|Overall Study|Patient ineligibility|0|||
46645240|NCT02810457|82851281|FG000|Overall Study|Miscalculated PD|1|||
46645241|NCT02810457|82851282|FG001|Overall Study|Miscalculated PD|0|||
46645242|NCT02810457|82851281|FG000|Overall Study|Physician Decision|0|||
46645243|NCT02810457|82851282|FG001|Overall Study|Physician Decision|1|||
46645244|NCT02745535|82851288|FG000|Overall Study|Death|1|||
46645245|NCT02745535|82851288|FG000|Overall Study|Adverse Event|3|||
46645246|NCT02745535|82851288|FG000|Overall Study|Lost to Follow-up|2|||
46645247|NCT02625090|82851322|FG000|Overall Study|Participant wants to be pregnant|2|||
46645248|NCT02625090|82851322|FG000|Overall Study|For the Promoter|1|||
46779839|NCT00423085|82998643|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
46779840|NCT00423085|82998644|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
46779841|NCT00423085|82998645|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
46779842|NCT00423085|82998646|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
47074748|NCT03250832|83368266|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
47074749|NCT03250832|83368257|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
47074750|NCT03250832|83368258|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
47074751|NCT03250832|83368259|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
47074752|NCT03250832|83368260|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
47074753|NCT03250832|83368261|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
47074754|NCT03250832|83368262|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
47074755|NCT03250832|83368263|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
46645249|NCT02625090|82851322|FG000|Overall Study|Sponsor's Decision|9|||
46645250|NCT02625090|82851322|FG000|Overall Study|Somnolence|1|||
47074756|NCT03250832|83368264|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
47074757|NCT03250832|83368265|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
46645251|NCT02625090|82851322|FG000|Overall Study|Study terminated by Sponsor|7|||
47074758|NCT03250832|83368266|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
47074759|NCT03250832|83368257|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074760|NCT03250832|83368258|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074761|NCT03250832|83368259|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074762|NCT03250832|83368260|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074763|NCT03250832|83368261|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074764|NCT03250832|83368262|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074765|NCT03250832|83368263|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074766|NCT03250832|83368264|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
46645252|NCT02625090|82851322|FG000|Overall Study|Negative Benefit/Risk|1|||
46645253|NCT02625090|82851322|FG000|Overall Study|Protocol Deviation|2|||
46645254|NCT02625090|82851322|FG000|Overall Study|Lack of Efficacy|16|||
46645255|NCT02625090|82851322|FG000|Overall Study|Adverse Event|3|||
46645256|NCT02539225|82851329|FG000|Part A|Adverse Event|13|||
46645257|NCT02539225|82851330|FG001|Part A|Adverse Event|4|||
46645258|NCT02539225|82851329|FG000|Part A|Withdrawal by Subject|2|||
46645259|NCT02539225|82851330|FG001|Part A|Withdrawal by Subject|4|||
46645260|NCT02539225|82851329|FG000|Part A|Physician Decision|4|||
46645261|NCT02539225|82851330|FG001|Part A|Physician Decision|7|||
46645262|NCT02539225|82851329|FG000|Part A|Did Not Receive study Drug|1|||
46850499|NCT00112437|83066373|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850500|NCT00112437|83066374|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850501|NCT00112437|83066375|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850502|NCT00112437|83066376|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850503|NCT00112437|83066377|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850504|NCT00112437|83066378|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
47074767|NCT03250832|83368265|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
46645263|NCT02539225|82851330|FG001|Part A|Did Not Receive study Drug|1|||
46645264|NCT02539225|82851329|FG000|Pre Treatment for Part B|Progressive disease|1|||
46645265|NCT02539225|82851330|FG001|Pre Treatment for Part B|Progressive disease|1|||
46645266|NCT02539225|82851329|FG000|Pre Treatment for Part B|Adverse Event|1|||
46645267|NCT02539225|82851330|FG001|Pre Treatment for Part B|Adverse Event|1|||
46645268|NCT02539225|82851329|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
46645269|NCT02539225|82851330|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
46645270|NCT02539225|82851329|FG000|Pre Treatment for Part B|Physician Decision|2|||
46645271|NCT02539225|82851330|FG001|Pre Treatment for Part B|Physician Decision|0|||
46645272|NCT02539225|82851329|FG000|Part B|Adverse Event|4|||
47074768|NCT03250832|83368266|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
47074769|NCT03250832|83368257|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
47074770|NCT03250832|83368258|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
47074771|NCT03250832|83368259|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
46645273|NCT02539225|82851330|FG001|Part B|Adverse Event|4|||
46645274|NCT02539225|82851329|FG000|Part B|Withdrawal by Subject|0|||
46645275|NCT02539225|82851330|FG001|Part B|Withdrawal by Subject|3|||
46645276|NCT02539225|82851329|FG000|Part B|Physician Decision|0|||
46645277|NCT02539225|82851330|FG001|Part B|Physician Decision|9|||
46645278|NCT02526017|82851350|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46645279|NCT02526017|82851351|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46645280|NCT02526017|82851352|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46645281|NCT02526017|82851353|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46645282|NCT02526017|82851354|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
46645283|NCT02526017|82851355|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46645284|NCT02526017|82851356|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46645285|NCT02526017|82851357|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46645286|NCT02526017|82851358|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
46779843|NCT00423085|82998643|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
46779844|NCT00423085|82998644|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
46779845|NCT00423085|82998645|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
46779846|NCT00423085|82998646|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
46779847|NCT00423085|82998643|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
46779848|NCT00423085|82998644|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
46779849|NCT00423085|82998645|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
46970235|NCT02100670|83213239|FG001|Overall Study|Withdrawal by Subject|0|||
46779850|NCT00423085|82998646|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
46779851|NCT00423085|82998643|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
46779852|NCT00423085|82998644|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
46970236|NCT02100670|83213240|FG002|Overall Study|Withdrawal by Subject|0|||
46970237|NCT02100670|83213241|FG003|Overall Study|Withdrawal by Subject|0|||
46970238|NCT02070484|83213260|FG000|Overall Study|Withdrawal by Subject|1|||
46970239|NCT02070484|83213261|FG001|Overall Study|Withdrawal by Subject|0|||
46645287|NCT02369653|82851427|FG000|Overall Study|Lost to Follow-up|0|||
46645288|NCT02369653|82851428|FG001|Overall Study|Lost to Follow-up|1|||
46645289|NCT02369653|82851427|FG000|Overall Study|Administrative reason by sponsor|0|||
46645290|NCT02369653|82851428|FG001|Overall Study|Administrative reason by sponsor|1|||
46645291|NCT02369653|82851427|FG000|Overall Study|Death|1|||
46645292|NCT02369653|82851428|FG001|Overall Study|Death|2|||
46645293|NCT02369653|82851427|FG000|Overall Study|Participant withdrew consent|13|||
46645294|NCT02369653|82851428|FG001|Overall Study|Participant withdrew consent|3|||
46645295|NCT02284568|82851441|FG000|Overall Study|Adverse Event|2|||
46645296|NCT02284568|82851442|FG001|Overall Study|Adverse Event|9|||
46645297|NCT02284568|82851443|FG002|Overall Study|Adverse Event|4|||
46645298|NCT02284568|82851441|FG000|Overall Study|Withdrawal by Subject|22|||
46645299|NCT02284568|82851442|FG001|Overall Study|Withdrawal by Subject|21|||
46645300|NCT02284568|82851443|FG002|Overall Study|Withdrawal by Subject|1|||
46645301|NCT02284568|82851441|FG000|Overall Study|Noncompliance with study drug admin|1|||
46645302|NCT02284568|82851442|FG001|Overall Study|Noncompliance with study drug admin|2|||
46645303|NCT02284568|82851443|FG002|Overall Study|Noncompliance with study drug admin|0|||
46645304|NCT02284568|82851441|FG000|Overall Study|Noncompliance|1|||
46645305|NCT02284568|82851442|FG001|Overall Study|Noncompliance|0|||
46645306|NCT02284568|82851443|FG002|Overall Study|Noncompliance|0|||
46645307|NCT02284568|82851441|FG000|Overall Study|Protocol Violation|0|||
46645308|NCT02284568|82851442|FG001|Overall Study|Protocol Violation|1|||
46645309|NCT02284568|82851443|FG002|Overall Study|Protocol Violation|0|||
46645310|NCT02284568|82851441|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
46645311|NCT02284568|82851442|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
46645312|NCT02284568|82851443|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
46645313|NCT02284568|82851441|FG000|Overall Study|Lost to Follow-up|0|||
46645314|NCT02284568|82851442|FG001|Overall Study|Lost to Follow-up|3|||
46645315|NCT02284568|82851443|FG002|Overall Study|Lost to Follow-up|0|||
46645316|NCT02284568|82851441|FG000|Overall Study|Lack of Efficacy|4|||
46645317|NCT02284568|82851442|FG001|Overall Study|Lack of Efficacy|7|||
46645318|NCT02284568|82851443|FG002|Overall Study|Lack of Efficacy|0|||
46645319|NCT02284568|82851441|FG000|Overall Study|Other|1|||
46645320|NCT02284568|82851442|FG001|Overall Study|Other|2|||
46645321|NCT02284568|82851443|FG002|Overall Study|Other|0|||
46645322|NCT02284568|82851441|FG000|Overall Study|Withdrew before taking study drug|0|||
46645323|NCT02284568|82851442|FG001|Overall Study|Withdrew before taking study drug|1|||
46645324|NCT02284568|82851443|FG002|Overall Study|Withdrew before taking study drug|0|||
46645325|NCT02195986|82851458|FG000|Overall Study|Adverse Event|3|||
46645326|NCT02195986|82851459|FG001|Overall Study|Adverse Event|0|||
46645327|NCT02195986|82851460|FG002|Overall Study|Adverse Event|0|||
46645328|NCT02195986|82851458|FG000|Overall Study|Withdrawal by Subject|0|||
46645329|NCT02195986|82851459|FG001|Overall Study|Withdrawal by Subject|3|||
46645330|NCT02195986|82851460|FG002|Overall Study|Withdrawal by Subject|0|||
46645331|NCT02195986|82851458|FG000|Overall Study|Family Emergency|0|||
46645332|NCT02195986|82851459|FG001|Overall Study|Family Emergency|0|||
46645333|NCT02195986|82851460|FG002|Overall Study|Family Emergency|1|||
46645334|NCT02195986|82851458|FG000|Overall Study|Protocol Violation|0|||
46645335|NCT02195986|82851459|FG001|Overall Study|Protocol Violation|1|||
46645336|NCT02195986|82851460|FG002|Overall Study|Protocol Violation|1|||
46645337|NCT02195986|82851458|FG000|Overall Study|Non-compliance|0|||
46645338|NCT02195986|82851459|FG001|Overall Study|Non-compliance|1|||
46645339|NCT02195986|82851460|FG002|Overall Study|Non-compliance|0|||
46645340|NCT01982630|82851476|FG000|Overall Study|Adverse Event|2|||
46645341|NCT01982630|82851477|FG001|Overall Study|Adverse Event|0|||
46970240|NCT02100514|83213269|FG000|Treatment Period|Adverse Event|0|||
47074772|NCT03250832|83368260|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
47074773|NCT03250832|83368261|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
47074774|NCT03250832|83368262|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
47074775|NCT03250832|83368263|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
47074776|NCT03250832|83368264|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
47074777|NCT03250832|83368265|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
46645342|NCT01982630|82851478|FG002|Overall Study|Adverse Event|1|||
46645343|NCT01982630|82851479|FG003|Overall Study|Adverse Event|0|||
46645344|NCT01982630|82851480|FG004|Overall Study|Adverse Event|1|||
46645345|NCT01982630|82851481|FG005|Overall Study|Adverse Event|2|||
46645346|NCT01982630|82851482|FG006|Overall Study|Adverse Event|1|||
46645347|NCT01982630|82851483|FG007|Overall Study|Adverse Event|0|||
46970241|NCT02100514|83213270|FG001|Treatment Period|Adverse Event|5|||
46645348|NCT01982630|82851476|FG000|Overall Study|Physician Decision|1|||
46645349|NCT01982630|82851477|FG001|Overall Study|Physician Decision|0|||
46645350|NCT01982630|82851478|FG002|Overall Study|Physician Decision|2|||
46779853|NCT00423085|82998645|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
46645351|NCT01982630|82851479|FG003|Overall Study|Physician Decision|1|||
46645352|NCT01982630|82851480|FG004|Overall Study|Physician Decision|2|||
46970242|NCT02100514|83213271|FG002|Treatment Period|Adverse Event|0|||
46645353|NCT01982630|82851481|FG005|Overall Study|Physician Decision|0|||
46645354|NCT01982630|82851482|FG006|Overall Study|Physician Decision|0|||
46645355|NCT01982630|82851483|FG007|Overall Study|Physician Decision|0|||
46645356|NCT01982630|82851476|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
46645357|NCT01982630|82851477|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
46645358|NCT01982630|82851478|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
46645359|NCT01982630|82851479|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
46645360|NCT01982630|82851480|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
46645361|NCT01982630|82851481|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
46645362|NCT01982630|82851482|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
46645363|NCT01982630|82851483|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
46645364|NCT01982630|82851476|FG000|Overall Study|Withdrawal by Subject|0|||
46645365|NCT01982630|82851477|FG001|Overall Study|Withdrawal by Subject|0|||
46645366|NCT01982630|82851478|FG002|Overall Study|Withdrawal by Subject|0|||
46645367|NCT01982630|82851479|FG003|Overall Study|Withdrawal by Subject|0|||
46645368|NCT01982630|82851480|FG004|Overall Study|Withdrawal by Subject|0|||
46645369|NCT01982630|82851481|FG005|Overall Study|Withdrawal by Subject|1|||
46645370|NCT01982630|82851482|FG006|Overall Study|Withdrawal by Subject|0|||
46645371|NCT01982630|82851483|FG007|Overall Study|Withdrawal by Subject|0|||
46645372|NCT01729754|82851549|FG000|Part 1|Adverse Event|2|||
46645373|NCT01729754|82851550|FG001|Part 1|Adverse Event|0|||
46645374|NCT01729754|82851551|FG002|Part 1|Adverse Event|0|||
46645375|NCT01729754|82851552|FG003|Part 1|Adverse Event|1|||
46645376|NCT01729754|82851553|FG004|Part 1|Adverse Event|0|||
46645377|NCT01729754|82851554|FG005|Part 1|Adverse Event|0|||
46645378|NCT01729754|82851555|FG006|Part 1|Adverse Event|2|||
46645379|NCT01729754|82851556|FG007|Part 1|Adverse Event|0|||
46645380|NCT01729754|82851557|FG008|Part 1|Adverse Event|0|||
46645381|NCT01729754|82851558|FG009|Part 1|Adverse Event|5|||
46645382|NCT01729754|82851549|FG000|Part 1|Lack of Efficacy|1|||
46645383|NCT01729754|82851550|FG001|Part 1|Lack of Efficacy|0|||
46645384|NCT01729754|82851551|FG002|Part 1|Lack of Efficacy|0|||
46645385|NCT01729754|82851552|FG003|Part 1|Lack of Efficacy|0|||
46645386|NCT01729754|82851553|FG004|Part 1|Lack of Efficacy|0|||
46645387|NCT01729754|82851554|FG005|Part 1|Lack of Efficacy|0|||
46645388|NCT01729754|82851555|FG006|Part 1|Lack of Efficacy|2|||
46645389|NCT01729754|82851556|FG007|Part 1|Lack of Efficacy|0|||
46645390|NCT01729754|82851557|FG008|Part 1|Lack of Efficacy|0|||
46645391|NCT01729754|82851558|FG009|Part 1|Lack of Efficacy|0|||
46645392|NCT01729754|82851549|FG000|Part 1|Lost to Follow-up|1|||
46645393|NCT01729754|82851550|FG001|Part 1|Lost to Follow-up|0|||
46645394|NCT01729754|82851551|FG002|Part 1|Lost to Follow-up|0|||
46645395|NCT01729754|82851552|FG003|Part 1|Lost to Follow-up|2|||
46645396|NCT01729754|82851553|FG004|Part 1|Lost to Follow-up|0|||
46645397|NCT01729754|82851554|FG005|Part 1|Lost to Follow-up|0|||
46645398|NCT01729754|82851555|FG006|Part 1|Lost to Follow-up|3|||
46645399|NCT01729754|82851556|FG007|Part 1|Lost to Follow-up|0|||
46645400|NCT01729754|82851557|FG008|Part 1|Lost to Follow-up|0|||
46645401|NCT01729754|82851558|FG009|Part 1|Lost to Follow-up|3|||
46645402|NCT01729754|82851549|FG000|Part 1|Non-compliance with Study Drug|1|||
46645403|NCT01729754|82851550|FG001|Part 1|Non-compliance with Study Drug|0|||
46645404|NCT01729754|82851551|FG002|Part 1|Non-compliance with Study Drug|0|||
46645405|NCT01729754|82851552|FG003|Part 1|Non-compliance with Study Drug|0|||
46645406|NCT01729754|82851553|FG004|Part 1|Non-compliance with Study Drug|0|||
46645407|NCT01729754|82851554|FG005|Part 1|Non-compliance with Study Drug|0|||
46645408|NCT01729754|82851555|FG006|Part 1|Non-compliance with Study Drug|0|||
46779854|NCT00423085|82998646|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
46779855|NCT00423085|82998643|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
46779856|NCT00423085|82998644|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
47074778|NCT03250832|83368266|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
46645409|NCT01729754|82851556|FG007|Part 1|Non-compliance with Study Drug|0|||
46645410|NCT01729754|82851557|FG008|Part 1|Non-compliance with Study Drug|0|||
46645411|NCT01729754|82851558|FG009|Part 1|Non-compliance with Study Drug|0|||
46779857|NCT00423085|82998645|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
47074779|NCT03250832|83368257|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
46645412|NCT01729754|82851549|FG000|Part 1|Physician Decision|0|||
46645413|NCT01729754|82851550|FG001|Part 1|Physician Decision|0|||
46645414|NCT01729754|82851551|FG002|Part 1|Physician Decision|0|||
46645415|NCT01729754|82851552|FG003|Part 1|Physician Decision|0|||
46645416|NCT01729754|82851553|FG004|Part 1|Physician Decision|0|||
46645417|NCT01729754|82851554|FG005|Part 1|Physician Decision|0|||
46645418|NCT01729754|82851555|FG006|Part 1|Physician Decision|0|||
46645419|NCT01729754|82851556|FG007|Part 1|Physician Decision|0|||
47074780|NCT03250832|83368258|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
47074781|NCT03250832|83368259|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
47074782|NCT03250832|83368260|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
47074783|NCT03250832|83368261|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
46645420|NCT01729754|82851557|FG008|Part 1|Physician Decision|0|||
46645421|NCT01729754|82851558|FG009|Part 1|Physician Decision|4|||
46645422|NCT01729754|82851549|FG000|Part 1|Pregnancy|0|||
46645423|NCT01729754|82851550|FG001|Part 1|Pregnancy|0|||
46645424|NCT01729754|82851551|FG002|Part 1|Pregnancy|0|||
46645425|NCT01729754|82851552|FG003|Part 1|Pregnancy|1|||
46645426|NCT01729754|82851553|FG004|Part 1|Pregnancy|0|||
46645427|NCT01729754|82851554|FG005|Part 1|Pregnancy|0|||
46645428|NCT01729754|82851555|FG006|Part 1|Pregnancy|0|||
46645429|NCT01729754|82851556|FG007|Part 1|Pregnancy|0|||
46645430|NCT01729754|82851557|FG008|Part 1|Pregnancy|0|||
46645431|NCT01729754|82851558|FG009|Part 1|Pregnancy|1|||
46645432|NCT01729754|82851549|FG000|Part 1|Progressive Disease|0|||
46645433|NCT01729754|82851550|FG001|Part 1|Progressive Disease|0|||
46645434|NCT01729754|82851551|FG002|Part 1|Progressive Disease|0|||
46645435|NCT01729754|82851552|FG003|Part 1|Progressive Disease|0|||
46645436|NCT01729754|82851553|FG004|Part 1|Progressive Disease|0|||
46645437|NCT01729754|82851554|FG005|Part 1|Progressive Disease|0|||
46645438|NCT01729754|82851555|FG006|Part 1|Progressive Disease|0|||
46645439|NCT01729754|82851556|FG007|Part 1|Progressive Disease|0|||
46645440|NCT01729754|82851557|FG008|Part 1|Progressive Disease|0|||
46645441|NCT01729754|82851558|FG009|Part 1|Progressive Disease|1|||
46645442|NCT01729754|82851549|FG000|Part 1|Protocol Violation|2|||
46645443|NCT01729754|82851550|FG001|Part 1|Protocol Violation|0|||
46645444|NCT01729754|82851551|FG002|Part 1|Protocol Violation|0|||
46645445|NCT01729754|82851552|FG003|Part 1|Protocol Violation|1|||
46645446|NCT01729754|82851553|FG004|Part 1|Protocol Violation|0|||
46645447|NCT01729754|82851554|FG005|Part 1|Protocol Violation|0|||
46645448|NCT01729754|82851555|FG006|Part 1|Protocol Violation|1|||
46645449|NCT01729754|82851556|FG007|Part 1|Protocol Violation|0|||
46645450|NCT01729754|82851557|FG008|Part 1|Protocol Violation|0|||
46645451|NCT01729754|82851558|FG009|Part 1|Protocol Violation|0|||
46645452|NCT01729754|82851549|FG000|Part 1|Withdrawal by Subject|5|||
46645453|NCT01729754|82851550|FG001|Part 1|Withdrawal by Subject|0|||
46645454|NCT01729754|82851551|FG002|Part 1|Withdrawal by Subject|0|||
46645455|NCT01729754|82851552|FG003|Part 1|Withdrawal by Subject|7|||
46645456|NCT01729754|82851553|FG004|Part 1|Withdrawal by Subject|0|||
46645457|NCT01729754|82851554|FG005|Part 1|Withdrawal by Subject|0|||
46645458|NCT01729754|82851555|FG006|Part 1|Withdrawal by Subject|5|||
46645459|NCT01729754|82851556|FG007|Part 1|Withdrawal by Subject|0|||
46645460|NCT01729754|82851557|FG008|Part 1|Withdrawal by Subject|0|||
46645461|NCT01729754|82851558|FG009|Part 1|Withdrawal by Subject|6|||
46645462|NCT01729754|82851549|FG000|Part 1|Other Protocol Specified Criteria|2|||
46645463|NCT01729754|82851550|FG001|Part 1|Other Protocol Specified Criteria|0|||
46645464|NCT01729754|82851551|FG002|Part 1|Other Protocol Specified Criteria|0|||
46645465|NCT01729754|82851552|FG003|Part 1|Other Protocol Specified Criteria|0|||
46645466|NCT01729754|82851553|FG004|Part 1|Other Protocol Specified Criteria|0|||
46645467|NCT01729754|82851554|FG005|Part 1|Other Protocol Specified Criteria|0|||
46645468|NCT01729754|82851555|FG006|Part 1|Other Protocol Specified Criteria|1|||
46645469|NCT01729754|82851556|FG007|Part 1|Other Protocol Specified Criteria|0|||
46645470|NCT01729754|82851557|FG008|Part 1|Other Protocol Specified Criteria|0|||
46645471|NCT01729754|82851558|FG009|Part 1|Other Protocol Specified Criteria|4|||
46645472|NCT01729754|82851549|FG000|Part 2|Adverse Event|2|||
46645473|NCT01729754|82851550|FG001|Part 2|Adverse Event|0|||
46645474|NCT01729754|82851551|FG002|Part 2|Adverse Event|0|||
46645475|NCT01729754|82851552|FG003|Part 2|Adverse Event|0|||
46645476|NCT01729754|82851553|FG004|Part 2|Adverse Event|0|||
46645477|NCT01729754|82851554|FG005|Part 2|Adverse Event|0|||
46645478|NCT01729754|82851555|FG006|Part 2|Adverse Event|0|||
47074784|NCT03250832|83368262|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
47074785|NCT03250832|83368263|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
47074786|NCT03250832|83368264|FG007|Part 2A (Up to Approximately 30 Months)|Other|2|||
47074787|NCT03250832|83368265|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
47074788|NCT03250832|83368266|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
47074789|NCT03250832|83368257|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
46645479|NCT01729754|82851556|FG007|Part 2|Adverse Event|0|||
46645480|NCT01729754|82851557|FG008|Part 2|Adverse Event|1|||
46645481|NCT01729754|82851558|FG009|Part 2|Adverse Event|2|||
46645482|NCT01729754|82851549|FG000|Part 2|Lack of Efficacy|0|||
46645483|NCT01729754|82851550|FG001|Part 2|Lack of Efficacy|0|||
46645484|NCT01729754|82851551|FG002|Part 2|Lack of Efficacy|0|||
46850505|NCT00112437|83066379|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46970243|NCT02100514|83213272|FG003|Treatment Period|Adverse Event|0|||
46645485|NCT01729754|82851552|FG003|Part 2|Lack of Efficacy|0|||
47074790|NCT03250832|83368258|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
46645486|NCT01729754|82851553|FG004|Part 2|Lack of Efficacy|0|||
46645487|NCT01729754|82851554|FG005|Part 2|Lack of Efficacy|0|||
46645488|NCT01729754|82851555|FG006|Part 2|Lack of Efficacy|0|||
46645489|NCT01729754|82851556|FG007|Part 2|Lack of Efficacy|0|||
46645490|NCT01729754|82851557|FG008|Part 2|Lack of Efficacy|2|||
46645491|NCT01729754|82851558|FG009|Part 2|Lack of Efficacy|2|||
46645492|NCT01729754|82851549|FG000|Part 2|Lost to Follow-up|0|||
46645493|NCT01729754|82851550|FG001|Part 2|Lost to Follow-up|0|||
46645494|NCT01729754|82851551|FG002|Part 2|Lost to Follow-up|0|||
46645495|NCT01729754|82851552|FG003|Part 2|Lost to Follow-up|2|||
46645496|NCT01729754|82851553|FG004|Part 2|Lost to Follow-up|0|||
46645497|NCT01729754|82851554|FG005|Part 2|Lost to Follow-up|0|||
46645498|NCT01729754|82851555|FG006|Part 2|Lost to Follow-up|0|||
46645499|NCT01729754|82851556|FG007|Part 2|Lost to Follow-up|1|||
46645500|NCT01729754|82851557|FG008|Part 2|Lost to Follow-up|0|||
46645501|NCT01729754|82851558|FG009|Part 2|Lost to Follow-up|2|||
46645502|NCT01729754|82851549|FG000|Part 2|Non-Compliance with Study Drug|0|||
46645503|NCT01729754|82851550|FG001|Part 2|Non-Compliance with Study Drug|0|||
46645504|NCT01729754|82851551|FG002|Part 2|Non-Compliance with Study Drug|0|||
46645505|NCT01729754|82851552|FG003|Part 2|Non-Compliance with Study Drug|0|||
46645506|NCT01729754|82851553|FG004|Part 2|Non-Compliance with Study Drug|0|||
46645507|NCT01729754|82851554|FG005|Part 2|Non-Compliance with Study Drug|0|||
46645508|NCT01729754|82851555|FG006|Part 2|Non-Compliance with Study Drug|0|||
46645509|NCT01729754|82851556|FG007|Part 2|Non-Compliance with Study Drug|0|||
46645510|NCT01729754|82851557|FG008|Part 2|Non-Compliance with Study Drug|0|||
46645511|NCT01729754|82851558|FG009|Part 2|Non-Compliance with Study Drug|1|||
46645512|NCT01729754|82851549|FG000|Part 2|Pregnancy|0|||
46645513|NCT01729754|82851550|FG001|Part 2|Pregnancy|0|||
46645514|NCT01729754|82851551|FG002|Part 2|Pregnancy|0|||
46645515|NCT01729754|82851552|FG003|Part 2|Pregnancy|1|||
46645516|NCT01729754|82851553|FG004|Part 2|Pregnancy|0|||
46645517|NCT01729754|82851554|FG005|Part 2|Pregnancy|0|||
46645518|NCT01729754|82851555|FG006|Part 2|Pregnancy|0|||
46645519|NCT01729754|82851556|FG007|Part 2|Pregnancy|0|||
46645520|NCT01729754|82851557|FG008|Part 2|Pregnancy|0|||
46645521|NCT01729754|82851558|FG009|Part 2|Pregnancy|1|||
46645522|NCT01729754|82851549|FG000|Part 2|Withdrawal by Subject|3|||
46645523|NCT01729754|82851550|FG001|Part 2|Withdrawal by Subject|0|||
46645524|NCT01729754|82851551|FG002|Part 2|Withdrawal by Subject|0|||
46645525|NCT01729754|82851552|FG003|Part 2|Withdrawal by Subject|2|||
46645526|NCT01729754|82851553|FG004|Part 2|Withdrawal by Subject|0|||
46645527|NCT01729754|82851554|FG005|Part 2|Withdrawal by Subject|0|||
46645528|NCT01729754|82851555|FG006|Part 2|Withdrawal by Subject|0|||
46645529|NCT01729754|82851556|FG007|Part 2|Withdrawal by Subject|1|||
46645530|NCT01729754|82851557|FG008|Part 2|Withdrawal by Subject|1|||
46645531|NCT01729754|82851558|FG009|Part 2|Withdrawal by Subject|4|||
46645532|NCT01729754|82851549|FG000|Part 2|Other Protocol Specified Criteria|1|||
46645533|NCT01729754|82851550|FG001|Part 2|Other Protocol Specified Criteria|0|||
46645534|NCT01729754|82851551|FG002|Part 2|Other Protocol Specified Criteria|0|||
46645535|NCT01729754|82851552|FG003|Part 2|Other Protocol Specified Criteria|0|||
46645536|NCT01729754|82851553|FG004|Part 2|Other Protocol Specified Criteria|0|||
46645537|NCT01729754|82851554|FG005|Part 2|Other Protocol Specified Criteria|0|||
46645538|NCT01729754|82851555|FG006|Part 2|Other Protocol Specified Criteria|0|||
46645539|NCT01729754|82851556|FG007|Part 2|Other Protocol Specified Criteria|1|||
46645540|NCT01729754|82851557|FG008|Part 2|Other Protocol Specified Criteria|0|||
46645541|NCT01729754|82851558|FG009|Part 2|Other Protocol Specified Criteria|0|||
46645542|NCT01729754|82851549|FG000|Part 3|Adverse Event|0|||
46645543|NCT01729754|82851550|FG001|Part 3|Adverse Event|0|||
46645544|NCT01729754|82851551|FG002|Part 3|Adverse Event|1|||
46645545|NCT01729754|82851552|FG003|Part 3|Adverse Event|0|||
46645546|NCT01729754|82851553|FG004|Part 3|Adverse Event|0|||
46645547|NCT01729754|82851554|FG005|Part 3|Adverse Event|5|||
46645548|NCT01729754|82851555|FG006|Part 3|Adverse Event|0|||
46645549|NCT01729754|82851556|FG007|Part 3|Adverse Event|0|||
46970244|NCT02100514|83213273|FG004|Treatment Period|Adverse Event|0|||
46970245|NCT02100514|83213269|FG000|Treatment Period|Death|2|||
46645550|NCT01729754|82851557|FG008|Part 3|Adverse Event|0|||
46645551|NCT01729754|82851558|FG009|Part 3|Adverse Event|3|||
46645552|NCT01729754|82851549|FG000|Part 3|Death|0|||
46645553|NCT01729754|82851550|FG001|Part 3|Death|0|||
46645554|NCT01729754|82851551|FG002|Part 3|Death|0|||
46645555|NCT01729754|82851552|FG003|Part 3|Death|0|||
46645556|NCT01729754|82851553|FG004|Part 3|Death|0|||
46645557|NCT01729754|82851554|FG005|Part 3|Death|2|||
46645558|NCT01729754|82851555|FG006|Part 3|Death|0|||
46645559|NCT01729754|82851556|FG007|Part 3|Death|0|||
46645560|NCT01729754|82851557|FG008|Part 3|Death|0|||
46645561|NCT01729754|82851558|FG009|Part 3|Death|0|||
46645562|NCT01729754|82851549|FG000|Part 3|Lack of Efficacy|0|||
46645563|NCT01729754|82851550|FG001|Part 3|Lack of Efficacy|0|||
46645564|NCT01729754|82851551|FG002|Part 3|Lack of Efficacy|0|||
46645565|NCT01729754|82851552|FG003|Part 3|Lack of Efficacy|0|||
46645566|NCT01729754|82851553|FG004|Part 3|Lack of Efficacy|2|||
46645567|NCT01729754|82851554|FG005|Part 3|Lack of Efficacy|0|||
46645568|NCT01729754|82851555|FG006|Part 3|Lack of Efficacy|0|||
46645569|NCT01729754|82851556|FG007|Part 3|Lack of Efficacy|0|||
46645570|NCT01729754|82851557|FG008|Part 3|Lack of Efficacy|0|||
46645571|NCT01729754|82851558|FG009|Part 3|Lack of Efficacy|4|||
46645572|NCT01729754|82851549|FG000|Part 3|Lost to Follow-up|0|||
46645573|NCT01729754|82851550|FG001|Part 3|Lost to Follow-up|1|||
46645574|NCT01729754|82851551|FG002|Part 3|Lost to Follow-up|2|||
46645575|NCT01729754|82851552|FG003|Part 3|Lost to Follow-up|0|||
46645576|NCT01729754|82851553|FG004|Part 3|Lost to Follow-up|0|||
46645577|NCT01729754|82851554|FG005|Part 3|Lost to Follow-up|3|||
46645578|NCT01729754|82851555|FG006|Part 3|Lost to Follow-up|0|||
46645579|NCT01729754|82851556|FG007|Part 3|Lost to Follow-up|0|||
46645580|NCT01729754|82851557|FG008|Part 3|Lost to Follow-up|1|||
46645581|NCT01729754|82851558|FG009|Part 3|Lost to Follow-up|0|||
46645582|NCT01729754|82851549|FG000|Part 3|Physician Decision|0|||
46645583|NCT01729754|82851550|FG001|Part 3|Physician Decision|0|||
46645584|NCT01729754|82851551|FG002|Part 3|Physician Decision|1|||
46645585|NCT01729754|82851552|FG003|Part 3|Physician Decision|0|||
46645586|NCT01729754|82851553|FG004|Part 3|Physician Decision|0|||
46645587|NCT01729754|82851554|FG005|Part 3|Physician Decision|0|||
46645588|NCT01729754|82851555|FG006|Part 3|Physician Decision|0|||
46645589|NCT01729754|82851556|FG007|Part 3|Physician Decision|0|||
46645590|NCT01729754|82851557|FG008|Part 3|Physician Decision|0|||
46645591|NCT01729754|82851558|FG009|Part 3|Physician Decision|0|||
46645592|NCT01729754|82851549|FG000|Part 3|Withdrawal by Subject|0|||
46645593|NCT01729754|82851550|FG001|Part 3|Withdrawal by Subject|4|||
46645594|NCT01729754|82851551|FG002|Part 3|Withdrawal by Subject|1|||
46645595|NCT01729754|82851552|FG003|Part 3|Withdrawal by Subject|0|||
46645596|NCT01729754|82851553|FG004|Part 3|Withdrawal by Subject|2|||
46645597|NCT01729754|82851554|FG005|Part 3|Withdrawal by Subject|1|||
46645598|NCT01729754|82851555|FG006|Part 3|Withdrawal by Subject|0|||
46645599|NCT01729754|82851556|FG007|Part 3|Withdrawal by Subject|2|||
46645600|NCT01729754|82851557|FG008|Part 3|Withdrawal by Subject|0|||
46645601|NCT01729754|82851558|FG009|Part 3|Withdrawal by Subject|0|||
46645602|NCT01729754|82851549|FG000|Part 3|Other Protocol Specified Criteria|0|||
46645603|NCT01729754|82851550|FG001|Part 3|Other Protocol Specified Criteria|0|||
46645604|NCT01729754|82851551|FG002|Part 3|Other Protocol Specified Criteria|0|||
46645605|NCT01729754|82851552|FG003|Part 3|Other Protocol Specified Criteria|0|||
46645606|NCT01729754|82851553|FG004|Part 3|Other Protocol Specified Criteria|0|||
46850506|NCT00112437|83066380|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850507|NCT00112437|83066381|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46645607|NCT01729754|82851554|FG005|Part 3|Other Protocol Specified Criteria|2|||
46645608|NCT01729754|82851555|FG006|Part 3|Other Protocol Specified Criteria|0|||
46645609|NCT01729754|82851556|FG007|Part 3|Other Protocol Specified Criteria|1|||
46645610|NCT01729754|82851557|FG008|Part 3|Other Protocol Specified Criteria|0|||
46645611|NCT01729754|82851558|FG009|Part 3|Other Protocol Specified Criteria|0|||
46645612|NCT01515306|82851603|FG000|Overall Study|Adverse Event|3|||
46645613|NCT01515306|82851604|FG001|Overall Study|Adverse Event|2|||
46645614|NCT01515306|82851603|FG000|Overall Study|Progressive Disease|19|||
46645615|NCT01515306|82851604|FG001|Overall Study|Progressive Disease|9|||
46645616|NCT01515306|82851603|FG000|Overall Study|Withdrawal by Subject|1|||
46645617|NCT01515306|82851604|FG001|Overall Study|Withdrawal by Subject|2|||
46645618|NCT01515306|82851603|FG000|Overall Study|Physician Decision|1|||
46645619|NCT01515306|82851604|FG001|Overall Study|Physician Decision|1|||
46645620|NCT01423851|82851625|FG000|Whole Study|Disease progression|2|||
46645621|NCT01423851|82851626|FG001|Whole Study|Disease progression|1|||
46645622|NCT01423851|82851627|FG002|Whole Study|Disease progression|1|||
46645623|NCT01423851|82851628|FG003|Whole Study|Disease progression|4|||
46645624|NCT01423851|82851629|FG004|Whole Study|Disease progression|1|||
46645625|NCT01423851|82851630|FG005|Whole Study|Disease progression|3|||
46779858|NCT00423085|82998646|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
46779859|NCT00423085|82998643|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
46779860|NCT00423085|82998644|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
46779861|NCT00423085|82998645|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
46645626|NCT01423851|82851631|FG006|Whole Study|Disease progression|1|||
46645627|NCT01423851|82851632|FG007|Whole Study|Disease progression|4|||
46779862|NCT00423085|82998646|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
46779863|NCT00423085|82998643|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
46970246|NCT02100514|83213270|FG001|Treatment Period|Death|2|||
46645628|NCT01423851|82851633|FG008|Whole Study|Disease progression|0|||
46645629|NCT01423851|82851634|FG009|Whole Study|Disease progression|2|||
46645630|NCT01423851|82851635|FG010|Whole Study|Disease progression|10|||
46645631|NCT01423851|82851625|FG000|Whole Study|Physician Decision|0|||
46645632|NCT01423851|82851626|FG001|Whole Study|Physician Decision|1|||
46645633|NCT01423851|82851627|FG002|Whole Study|Physician Decision|2|||
46645634|NCT01423851|82851628|FG003|Whole Study|Physician Decision|0|||
46645635|NCT01423851|82851629|FG004|Whole Study|Physician Decision|2|||
46645636|NCT01423851|82851630|FG005|Whole Study|Physician Decision|0|||
46645637|NCT01423851|82851631|FG006|Whole Study|Physician Decision|2|||
46645638|NCT01423851|82851632|FG007|Whole Study|Physician Decision|1|||
46645639|NCT01423851|82851633|FG008|Whole Study|Physician Decision|3|||
46645640|NCT01423851|82851634|FG009|Whole Study|Physician Decision|4|||
46645641|NCT01423851|82851635|FG010|Whole Study|Physician Decision|12|||
46645642|NCT01423851|82851625|FG000|Whole Study|Withdrawal by Subject|1|||
46645643|NCT01423851|82851626|FG001|Whole Study|Withdrawal by Subject|1|||
46645644|NCT01423851|82851627|FG002|Whole Study|Withdrawal by Subject|0|||
46645645|NCT01423851|82851628|FG003|Whole Study|Withdrawal by Subject|0|||
46645646|NCT01423851|82851629|FG004|Whole Study|Withdrawal by Subject|0|||
46645647|NCT01423851|82851630|FG005|Whole Study|Withdrawal by Subject|0|||
46645648|NCT01423851|82851631|FG006|Whole Study|Withdrawal by Subject|0|||
46645649|NCT01423851|82851632|FG007|Whole Study|Withdrawal by Subject|0|||
46645650|NCT01423851|82851633|FG008|Whole Study|Withdrawal by Subject|2|||
46645651|NCT01423851|82851634|FG009|Whole Study|Withdrawal by Subject|0|||
46645652|NCT01423851|82851635|FG010|Whole Study|Withdrawal by Subject|4|||
46645653|NCT01423851|82851625|FG000|Whole Study|Adverse Event|0|||
46645654|NCT01423851|82851626|FG001|Whole Study|Adverse Event|0|||
46645655|NCT01423851|82851627|FG002|Whole Study|Adverse Event|0|||
46645656|NCT01423851|82851628|FG003|Whole Study|Adverse Event|2|||
46645657|NCT01423851|82851629|FG004|Whole Study|Adverse Event|0|||
46645658|NCT01423851|82851630|FG005|Whole Study|Adverse Event|0|||
46645659|NCT01423851|82851631|FG006|Whole Study|Adverse Event|0|||
46645660|NCT01423851|82851632|FG007|Whole Study|Adverse Event|3|||
46645661|NCT01423851|82851633|FG008|Whole Study|Adverse Event|3|||
46645662|NCT01423851|82851634|FG009|Whole Study|Adverse Event|2|||
46850508|NCT00112437|83066382|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46645663|NCT01423851|82851635|FG010|Whole Study|Adverse Event|3|||
46645664|NCT01334606|82851677|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
46645665|NCT01317875|82851693|FG000|Overall Study|Other|0|||
46645666|NCT01317875|82851694|FG001|Overall Study|Other|0|||
46645667|NCT01317875|82851695|FG002|Overall Study|Other|1|||
46645668|NCT01317875|82851696|FG003|Overall Study|Other|0|||
46645669|NCT01317875|82851697|FG004|Overall Study|Other|0|||
46645670|NCT01317875|82851698|FG005|Overall Study|Other|0|||
46645671|NCT01317875|82851699|FG006|Overall Study|Other|0|||
46645672|NCT01317875|82851700|FG007|Overall Study|Other|0|||
46645673|NCT01317875|82851701|FG008|Overall Study|Other|0|||
46645674|NCT01317875|82851702|FG009|Overall Study|Other|0|||
46645675|NCT01317875|82851693|FG000|Overall Study|Noncompliance with study drug|0|||
46645676|NCT01317875|82851694|FG001|Overall Study|Noncompliance with study drug|0|||
46645677|NCT01317875|82851695|FG002|Overall Study|Noncompliance with study drug|1|||
46645678|NCT01317875|82851696|FG003|Overall Study|Noncompliance with study drug|0|||
46645679|NCT01317875|82851697|FG004|Overall Study|Noncompliance with study drug|0|||
46645680|NCT01317875|82851698|FG005|Overall Study|Noncompliance with study drug|0|||
46645681|NCT01317875|82851699|FG006|Overall Study|Noncompliance with study drug|0|||
46645682|NCT01317875|82851700|FG007|Overall Study|Noncompliance with study drug|0|||
46645683|NCT01317875|82851701|FG008|Overall Study|Noncompliance with study drug|0|||
46645684|NCT01317875|82851702|FG009|Overall Study|Noncompliance with study drug|0|||
46645685|NCT01317875|82851693|FG000|Overall Study|Progressive Disease|1|||
46645686|NCT01317875|82851694|FG001|Overall Study|Progressive Disease|0|||
46645687|NCT01317875|82851695|FG002|Overall Study|Progressive Disease|2|||
46645688|NCT01317875|82851696|FG003|Overall Study|Progressive Disease|0|||
46645689|NCT01317875|82851697|FG004|Overall Study|Progressive Disease|1|||
46645690|NCT01317875|82851698|FG005|Overall Study|Progressive Disease|0|||
46645691|NCT01317875|82851699|FG006|Overall Study|Progressive Disease|0|||
46645692|NCT01317875|82851700|FG007|Overall Study|Progressive Disease|1|||
46645693|NCT01317875|82851701|FG008|Overall Study|Progressive Disease|0|||
46645694|NCT01317875|82851702|FG009|Overall Study|Progressive Disease|0|||
46645695|NCT01317875|82851693|FG000|Overall Study|Withdrawal by Subject|0|||
46645696|NCT01317875|82851694|FG001|Overall Study|Withdrawal by Subject|0|||
46645697|NCT01317875|82851695|FG002|Overall Study|Withdrawal by Subject|0|||
46645698|NCT01317875|82851696|FG003|Overall Study|Withdrawal by Subject|0|||
46645699|NCT01317875|82851697|FG004|Overall Study|Withdrawal by Subject|1|||
46970247|NCT02100514|83213271|FG002|Treatment Period|Death|0|||
46970248|NCT02100514|83213272|FG003|Treatment Period|Death|0|||
46970249|NCT02100514|83213273|FG004|Treatment Period|Death|0|||
46970250|NCT02100514|83213269|FG000|Treatment Period|Lost to Follow-up|5|||
47074791|NCT03250832|83368259|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
47074792|NCT03250832|83368260|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
47074793|NCT03250832|83368261|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
47074794|NCT03250832|83368262|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
47074795|NCT03250832|83368263|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
47074796|NCT03250832|83368264|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
47074797|NCT03250832|83368265|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
47074798|NCT03250832|83368266|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
47074799|NCT03250832|83368257|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
47074800|NCT03250832|83368258|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
47074801|NCT03250832|83368259|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
47074802|NCT03250832|83368260|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
46645700|NCT01317875|82851698|FG005|Overall Study|Withdrawal by Subject|0|||
46645701|NCT01317875|82851699|FG006|Overall Study|Withdrawal by Subject|0|||
46645702|NCT01317875|82851700|FG007|Overall Study|Withdrawal by Subject|3|||
46645703|NCT01317875|82851701|FG008|Overall Study|Withdrawal by Subject|0|||
46645704|NCT01317875|82851702|FG009|Overall Study|Withdrawal by Subject|0|||
46645705|NCT01317875|82851693|FG000|Overall Study|Physician Decision|0|||
46970251|NCT02100514|83213270|FG001|Treatment Period|Lost to Follow-up|17|||
46970252|NCT02100514|83213271|FG002|Treatment Period|Lost to Follow-up|0|||
46970253|NCT02100514|83213272|FG003|Treatment Period|Lost to Follow-up|0|||
46970254|NCT02100514|83213273|FG004|Treatment Period|Lost to Follow-up|0|||
46970255|NCT02100514|83213269|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
46970256|NCT02100514|83213270|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
46970257|NCT02100514|83213271|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
46645706|NCT01317875|82851694|FG001|Overall Study|Physician Decision|1|||
46645707|NCT01317875|82851695|FG002|Overall Study|Physician Decision|1|||
46645708|NCT01317875|82851696|FG003|Overall Study|Physician Decision|0|||
46645709|NCT01317875|82851697|FG004|Overall Study|Physician Decision|2|||
46645710|NCT01317875|82851698|FG005|Overall Study|Physician Decision|0|||
46645711|NCT01317875|82851699|FG006|Overall Study|Physician Decision|0|||
46645712|NCT01317875|82851700|FG007|Overall Study|Physician Decision|2|||
46645713|NCT01317875|82851701|FG008|Overall Study|Physician Decision|0|||
46645714|NCT01317875|82851702|FG009|Overall Study|Physician Decision|0|||
46645715|NCT01317875|82851693|FG000|Overall Study|Death|0|||
46645716|NCT01317875|82851694|FG001|Overall Study|Death|0|||
46645717|NCT01317875|82851695|FG002|Overall Study|Death|2|||
46645718|NCT01317875|82851696|FG003|Overall Study|Death|1|||
46645719|NCT01317875|82851697|FG004|Overall Study|Death|0|||
46645720|NCT01317875|82851698|FG005|Overall Study|Death|1|||
46645721|NCT01317875|82851699|FG006|Overall Study|Death|0|||
46645722|NCT01317875|82851700|FG007|Overall Study|Death|4|||
46645723|NCT01317875|82851701|FG008|Overall Study|Death|0|||
46645724|NCT01317875|82851702|FG009|Overall Study|Death|0|||
46645725|NCT01317875|82851693|FG000|Overall Study|Adverse Event|2|||
46645726|NCT01317875|82851694|FG001|Overall Study|Adverse Event|1|||
46645727|NCT01317875|82851695|FG002|Overall Study|Adverse Event|2|||
46645728|NCT01317875|82851696|FG003|Overall Study|Adverse Event|1|||
46645729|NCT01317875|82851697|FG004|Overall Study|Adverse Event|5|||
46645730|NCT01317875|82851698|FG005|Overall Study|Adverse Event|1|||
46645731|NCT01317875|82851699|FG006|Overall Study|Adverse Event|2|||
46645732|NCT01317875|82851700|FG007|Overall Study|Adverse Event|5|||
46645733|NCT01317875|82851701|FG008|Overall Study|Adverse Event|0|||
46645734|NCT01317875|82851702|FG009|Overall Study|Adverse Event|0|||
46645735|NCT00500071|82851778|FG000|Screening and Washout Phase|Protocol Violation|1|||
46645736|NCT00500071|82851778|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
46645737|NCT00500071|82851778|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
46645738|NCT00500071|82851778|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
46645739|NCT00500071|82851778|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
46645740|NCT00500071|82851778|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
46645741|NCT00500071|82851778|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
46645742|NCT00447122|82851786|FG000|Overall Study|worsening medical condition -came off|0|||
46645743|NCT00447122|82851787|FG001|Overall Study|worsening medical condition -came off|1|||
46645744|NCT00447122|82851788|FG002|Overall Study|worsening medical condition -came off|0|||
46645745|NCT00447122|82851789|FG003|Overall Study|worsening medical condition -came off|0|||
46645746|NCT00382252|82851799|FG000|Overall Study|Death|4|||
46645747|NCT00382252|82851799|FG000|Overall Study|Protocol Violation|8|||
46645748|NCT00382252|82851799|FG000|Overall Study|Not treated by RFA|1|||
46645749|NCT00290251|82851806|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
46645750|NCT00290251|82851807|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
46645751|NCT00290251|82851808|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
46645752|NCT00290251|82851809|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
46645753|NCT00290251|82851810|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
46645754|NCT00290251|82851811|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
46645755|NCT00290251|82851806|FG000|Treatment 1 (Months 2-4)|headache|0|||
46645756|NCT00290251|82851807|FG001|Treatment 1 (Months 2-4)|headache|0|||
46645757|NCT00290251|82851808|FG002|Treatment 1 (Months 2-4)|headache|0|||
46645758|NCT00290251|82851809|FG003|Treatment 1 (Months 2-4)|headache|0|||
46645759|NCT00290251|82851810|FG004|Treatment 1 (Months 2-4)|headache|1|||
46645760|NCT00290251|82851811|FG005|Treatment 1 (Months 2-4)|headache|0|||
46779864|NCT00423085|82998644|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
46779865|NCT00423085|82998645|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
46645761|NCT00290251|82851806|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
46645762|NCT00290251|82851807|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
46645763|NCT00290251|82851808|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
46645764|NCT00290251|82851809|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
46779866|NCT00423085|82998646|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
46779867|NCT00423085|82998643|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
46645765|NCT00290251|82851810|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
46645766|NCT00290251|82851811|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
46645767|NCT01403948|82851847|FG000|Overall Study|Progressive disease|0|||
46645768|NCT01403948|82851848|FG001|Overall Study|Progressive disease|2|||
46779868|NCT00423085|82998644|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
46779869|NCT00423085|82998645|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
46645769|NCT01403948|82851849|FG002|Overall Study|Progressive disease|2|||
46645770|NCT01403948|82851850|FG003|Overall Study|Progressive disease|4|||
46645771|NCT01403948|82851851|FG004|Overall Study|Progressive disease|2|||
46645772|NCT01403948|82851852|FG005|Overall Study|Progressive disease|6|||
46645773|NCT01403948|82851853|FG006|Overall Study|Progressive disease|2|||
46645774|NCT01403948|82851854|FG007|Overall Study|Progressive disease|4|||
46645775|NCT01403948|82851855|FG008|Overall Study|Progressive disease|5|||
46645776|NCT01403948|82851856|FG009|Overall Study|Progressive disease|5|||
46645777|NCT01403948|82851847|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
46645778|NCT01403948|82851848|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
46645779|NCT01403948|82851849|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
46645780|NCT01403948|82851850|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
46645781|NCT01403948|82851851|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
46645782|NCT01403948|82851852|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
46645783|NCT01403948|82851853|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
46645784|NCT01403948|82851854|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
46645785|NCT01403948|82851855|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
46645786|NCT01403948|82851856|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
46645787|NCT01403948|82851847|FG000|Overall Study|Lost to Follow-up|0|||
46645788|NCT01403948|82851848|FG001|Overall Study|Lost to Follow-up|0|||
46645789|NCT01403948|82851849|FG002|Overall Study|Lost to Follow-up|0|||
46645790|NCT01403948|82851850|FG003|Overall Study|Lost to Follow-up|0|||
46645791|NCT01403948|82851851|FG004|Overall Study|Lost to Follow-up|0|||
46645792|NCT01403948|82851852|FG005|Overall Study|Lost to Follow-up|0|||
46645793|NCT01403948|82851853|FG006|Overall Study|Lost to Follow-up|0|||
46645794|NCT01403948|82851854|FG007|Overall Study|Lost to Follow-up|0|||
46645795|NCT01403948|82851855|FG008|Overall Study|Lost to Follow-up|0|||
46645796|NCT01403948|82851856|FG009|Overall Study|Lost to Follow-up|1|||
46645797|NCT01403948|82851847|FG000|Overall Study|Refused cont. medication|0|||
46645798|NCT01403948|82851848|FG001|Overall Study|Refused cont. medication|0|||
46645799|NCT01403948|82851849|FG002|Overall Study|Refused cont. medication|0|||
46645800|NCT01403948|82851850|FG003|Overall Study|Refused cont. medication|0|||
46645801|NCT01403948|82851851|FG004|Overall Study|Refused cont. medication|1|||
46645802|NCT01403948|82851852|FG005|Overall Study|Refused cont. medication|0|||
46645803|NCT01403948|82851853|FG006|Overall Study|Refused cont. medication|0|||
46645804|NCT01403948|82851854|FG007|Overall Study|Refused cont. medication|0|||
46645805|NCT01403948|82851855|FG008|Overall Study|Refused cont. medication|0|||
46645806|NCT01403948|82851856|FG009|Overall Study|Refused cont. medication|1|||
46645807|NCT01403948|82851847|FG000|Overall Study|other than above|1|||
46645808|NCT01403948|82851848|FG001|Overall Study|other than above|2|||
46645809|NCT01403948|82851849|FG002|Overall Study|other than above|1|||
46645810|NCT01403948|82851850|FG003|Overall Study|other than above|0|||
46645811|NCT01403948|82851851|FG004|Overall Study|other than above|1|||
46645812|NCT01403948|82851852|FG005|Overall Study|other than above|1|||
46645813|NCT01403948|82851853|FG006|Overall Study|other than above|2|||
46645814|NCT01403948|82851854|FG007|Overall Study|other than above|0|||
46645815|NCT01403948|82851855|FG008|Overall Study|other than above|0|||
46645816|NCT01403948|82851856|FG009|Overall Study|other than above|0|||
46645817|NCT01404312|82851884|FG000|Overall Study|Death|21|||
46645818|NCT01404312|82851885|FG001|Overall Study|Death|27|||
46645819|NCT01404312|82851884|FG000|Overall Study|Withdrawal by Subject|15|||
46645820|NCT01404312|82851885|FG001|Overall Study|Withdrawal by Subject|18|||
46645821|NCT01404312|82851884|FG000|Overall Study|Participant Unable to get to clinic|93|||
46970258|NCT02100514|83213272|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
46645822|NCT01404312|82851885|FG001|Overall Study|Participant Unable to get to clinic|103|||
46970259|NCT02100514|83213273|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
46645823|NCT01404312|82851884|FG000|Overall Study|Lost to Follow-up|115|||
46645824|NCT01404312|82851885|FG001|Overall Study|Lost to Follow-up|111|||
46645825|NCT01404312|82851884|FG000|Overall Study|Site closed|22|||
46645826|NCT01404312|82851885|FG001|Overall Study|Site closed|21|||
46645827|NCT01404312|82851884|FG000|Overall Study|Participant not willing to adhere to req|31|||
46645828|NCT01404312|82851885|FG001|Overall Study|Participant not willing to adhere to req|29|||
46645829|NCT01404312|82851884|FG000|Overall Study|Severe debilitation, unable to continue|1|||
46645830|NCT01404312|82851885|FG001|Overall Study|Severe debilitation, unable to continue|2|||
46645831|NCT01414608|82851894|FG000|Overall Study|Ineligible|5|||
46645832|NCT01414608|82851895|FG001|Overall Study|Ineligible|2|||
46645833|NCT01420861|82851905|FG000|Overall Study|Adverse Event|2|||
46779870|NCT00423085|82998646|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
46779871|NCT00423085|82998643|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
46779872|NCT00423085|82998644|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
46779873|NCT00423085|82998645|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
46779874|NCT00423085|82998646|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
46779875|NCT00423085|82998643|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
46779876|NCT00423085|82998644|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
46779877|NCT00423085|82998645|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
46779878|NCT00423085|82998646|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
46779879|NCT00423085|82998643|FG000|52-Week Open-Label Extension Phase|Death|0|||
46970260|NCT02100514|83213269|FG000|Treatment Period|Protocol Violation|1|||
46779880|NCT00423085|82998644|FG001|52-Week Open-Label Extension Phase|Death|0|||
46779881|NCT00423085|82998645|FG002|52-Week Open-Label Extension Phase|Death|0|||
46779882|NCT00423085|82998646|FG003|52-Week Open-Label Extension Phase|Death|2|||
46779883|NCT00414661|82998660|FG000|Overall Study|Death|2|||
46970261|NCT02100514|83213270|FG001|Treatment Period|Protocol Violation|1|||
46779884|NCT00414661|82998661|FG001|Overall Study|Death|5|||
46779885|NCT00414661|82998662|FG002|Overall Study|Death|0|||
46779886|NCT00414661|82998663|FG003|Overall Study|Death|0|||
46970262|NCT02100514|83213271|FG002|Treatment Period|Protocol Violation|0|||
46645834|NCT01420861|82851905|FG000|Overall Study|Study terminated by Sponsor|7|||
46645835|NCT01420861|82851905|FG000|Overall Study|Screen failure|7|||
46779887|NCT00414661|82998660|FG000|Overall Study|Lost to Follow-up|1|||
46645836|NCT01420861|82851905|FG000|Overall Study|Randomized not Treated|2|||
46645837|NCT01425008|82851928|FG000|Dose Escalation Phase|Progressive Disease|2|||
46645838|NCT01425008|82851929|FG001|Dose Escalation Phase|Progressive Disease|3|||
46645839|NCT01425008|82851930|FG002|Dose Escalation Phase|Progressive Disease|2|||
46645840|NCT01425008|82851931|FG003|Dose Escalation Phase|Progressive Disease|3|||
46645841|NCT01425008|82851932|FG004|Dose Escalation Phase|Progressive Disease|5|||
46645842|NCT01425008|82851933|FG005|Dose Escalation Phase|Progressive Disease|4|||
46645843|NCT01425008|82851934|FG006|Dose Escalation Phase|Progressive Disease|0|||
46645844|NCT01425008|82851935|FG007|Dose Escalation Phase|Progressive Disease|2|||
46645845|NCT01425008|82851936|FG008|Dose Escalation Phase|Progressive Disease|6|||
46645846|NCT01425008|82851937|FG009|Dose Escalation Phase|Progressive Disease|2|||
46645847|NCT01425008|82851938|FG010|Dose Escalation Phase|Progressive Disease|0|||
46645848|NCT01425008|82851939|FG011|Dose Escalation Phase|Progressive Disease|0|||
46645849|NCT01425008|82851940|FG012|Dose Escalation Phase|Progressive Disease|0|||
46645850|NCT01425008|82851941|FG013|Dose Escalation Phase|Progressive Disease|0|||
46645851|NCT01425008|82851942|FG014|Dose Escalation Phase|Progressive Disease|0|||
46645852|NCT01425008|82851943|FG015|Dose Escalation Phase|Progressive Disease|0|||
46645853|NCT01425008|82851944|FG016|Dose Escalation Phase|Progressive Disease|0|||
46645854|NCT01425008|82851945|FG017|Dose Escalation Phase|Progressive Disease|0|||
46645855|NCT01425008|82851946|FG018|Dose Escalation Phase|Progressive Disease|0|||
46645856|NCT01425008|82851928|FG000|Dose Escalation Phase|Adverse Event|2|||
46645857|NCT01425008|82851929|FG001|Dose Escalation Phase|Adverse Event|0|||
46645858|NCT01425008|82851930|FG002|Dose Escalation Phase|Adverse Event|0|||
46645859|NCT01425008|82851931|FG003|Dose Escalation Phase|Adverse Event|0|||
46645860|NCT01425008|82851932|FG004|Dose Escalation Phase|Adverse Event|0|||
46645861|NCT01425008|82851933|FG005|Dose Escalation Phase|Adverse Event|2|||
46645862|NCT01425008|82851934|FG006|Dose Escalation Phase|Adverse Event|0|||
46645863|NCT01425008|82851935|FG007|Dose Escalation Phase|Adverse Event|0|||
46645864|NCT01425008|82851936|FG008|Dose Escalation Phase|Adverse Event|2|||
46645865|NCT01425008|82851937|FG009|Dose Escalation Phase|Adverse Event|0|||
46645866|NCT01425008|82851938|FG010|Dose Escalation Phase|Adverse Event|0|||
46645867|NCT01425008|82851939|FG011|Dose Escalation Phase|Adverse Event|0|||
46645868|NCT01425008|82851940|FG012|Dose Escalation Phase|Adverse Event|0|||
47074803|NCT03250832|83368261|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
47074804|NCT03250832|83368262|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
47074805|NCT03250832|83368263|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
47074806|NCT03250832|83368264|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
47074807|NCT03250832|83368265|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
47074808|NCT03250832|83368266|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
47074809|NCT03250832|83368257|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074810|NCT03250832|83368258|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074811|NCT03250832|83368259|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074812|NCT03250832|83368260|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074813|NCT03250832|83368261|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074814|NCT03250832|83368262|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074815|NCT03250832|83368263|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074816|NCT03250832|83368264|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
47074817|NCT03250832|83368265|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
47074818|NCT03250832|83368266|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
47074819|NCT03250832|83368257|FG000|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074820|NCT03250832|83368258|FG001|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074821|NCT03250832|83368259|FG002|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074822|NCT03250832|83368260|FG003|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074823|NCT03250832|83368261|FG004|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074824|NCT03250832|83368262|FG005|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074825|NCT03250832|83368263|FG006|Part 2B (Up to Approximately 29 Months)|Other|0|||
46645869|NCT01425008|82851941|FG013|Dose Escalation Phase|Adverse Event|0|||
46645870|NCT01425008|82851942|FG014|Dose Escalation Phase|Adverse Event|0|||
46645871|NCT01425008|82851943|FG015|Dose Escalation Phase|Adverse Event|0|||
46645872|NCT01425008|82851944|FG016|Dose Escalation Phase|Adverse Event|0|||
46645873|NCT01425008|82851945|FG017|Dose Escalation Phase|Adverse Event|0|||
46645874|NCT01425008|82851946|FG018|Dose Escalation Phase|Adverse Event|0|||
46645875|NCT01425008|82851928|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645876|NCT01425008|82851929|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645877|NCT01425008|82851930|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645878|NCT01425008|82851931|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645879|NCT01425008|82851932|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
46645880|NCT01425008|82851933|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645881|NCT01425008|82851934|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
46645882|NCT01425008|82851935|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
46645883|NCT01425008|82851936|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
46645884|NCT01425008|82851937|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645885|NCT01425008|82851938|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645886|NCT01425008|82851939|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645887|NCT01425008|82851940|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645888|NCT01425008|82851941|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645889|NCT01425008|82851942|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645890|NCT01425008|82851943|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645891|NCT01425008|82851944|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645892|NCT01425008|82851945|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645893|NCT01425008|82851946|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46645894|NCT01425008|82851928|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
46645895|NCT01425008|82851929|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
46645896|NCT01425008|82851930|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
46645897|NCT01425008|82851931|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
46645898|NCT01425008|82851932|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
46645899|NCT01425008|82851933|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
46645900|NCT01425008|82851934|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
46645901|NCT01425008|82851935|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
46645902|NCT01425008|82851936|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
46645903|NCT01425008|82851937|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
46645904|NCT01425008|82851938|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
46645905|NCT01425008|82851939|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
46645906|NCT01425008|82851940|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
46645907|NCT01425008|82851941|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
46645908|NCT01425008|82851942|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
46645909|NCT01425008|82851943|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
46645910|NCT01425008|82851944|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
46645911|NCT01425008|82851945|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
46645912|NCT01425008|82851946|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
46645913|NCT01425008|82851928|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645914|NCT01425008|82851929|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645915|NCT01425008|82851930|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
46645916|NCT01425008|82851931|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645917|NCT01425008|82851932|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645918|NCT01425008|82851933|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645919|NCT01425008|82851934|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645920|NCT01425008|82851935|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645921|NCT01425008|82851936|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
46645922|NCT01425008|82851937|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
46779888|NCT00414661|82998661|FG001|Overall Study|Lost to Follow-up|4|||
46779889|NCT00414661|82998662|FG002|Overall Study|Lost to Follow-up|0|||
46779890|NCT00414661|82998663|FG003|Overall Study|Lost to Follow-up|1|||
46779891|NCT00414661|82998660|FG000|Overall Study|Withdrawal by Subject|5|||
46779892|NCT00414661|82998661|FG001|Overall Study|Withdrawal by Subject|2|||
46779893|NCT00414661|82998662|FG002|Overall Study|Withdrawal by Subject|2|||
47074826|NCT03250832|83368264|FG007|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074827|NCT03250832|83368265|FG008|Part 2B (Up to Approximately 29 Months)|Other|0|||
47074828|NCT03250832|83368266|FG009|Part 2B (Up to Approximately 29 Months)|Other|1|||
47074829|NCT03174275|83368295|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
47074830|NCT03174275|83368295|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
47074831|NCT03174275|83368295|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
47074832|NCT03174275|83368295|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
47074833|NCT03174275|83368295|FG000|Adjuvant Chemotherapy|Progression|1|||
47074834|NCT03174275|83368295|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
47074835|NCT03174275|83368295|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
46645923|NCT01425008|82851938|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645924|NCT01425008|82851939|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645925|NCT01425008|82851940|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645926|NCT01425008|82851941|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645927|NCT01425008|82851942|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645928|NCT01425008|82851943|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645929|NCT01425008|82851944|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645930|NCT01425008|82851945|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645931|NCT01425008|82851946|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
46645932|NCT01425008|82851928|FG000|Dose Escalation Phase|Other|0|||
46645933|NCT01425008|82851929|FG001|Dose Escalation Phase|Other|0|||
46645934|NCT01425008|82851930|FG002|Dose Escalation Phase|Other|0|||
46645935|NCT01425008|82851931|FG003|Dose Escalation Phase|Other|0|||
46645936|NCT01425008|82851932|FG004|Dose Escalation Phase|Other|0|||
46645937|NCT01425008|82851933|FG005|Dose Escalation Phase|Other|0|||
46645938|NCT01425008|82851934|FG006|Dose Escalation Phase|Other|0|||
46645939|NCT01425008|82851935|FG007|Dose Escalation Phase|Other|0|||
46645940|NCT01425008|82851936|FG008|Dose Escalation Phase|Other|1|||
46645941|NCT01425008|82851937|FG009|Dose Escalation Phase|Other|0|||
46645942|NCT01425008|82851938|FG010|Dose Escalation Phase|Other|0|||
46645943|NCT01425008|82851939|FG011|Dose Escalation Phase|Other|0|||
46645944|NCT01425008|82851940|FG012|Dose Escalation Phase|Other|0|||
46645945|NCT01425008|82851941|FG013|Dose Escalation Phase|Other|0|||
46645946|NCT01425008|82851942|FG014|Dose Escalation Phase|Other|0|||
46645947|NCT01425008|82851943|FG015|Dose Escalation Phase|Other|0|||
46645948|NCT01425008|82851944|FG016|Dose Escalation Phase|Other|0|||
46645949|NCT01425008|82851945|FG017|Dose Escalation Phase|Other|0|||
46645950|NCT01425008|82851946|FG018|Dose Escalation Phase|Other|0|||
46645951|NCT01425008|82851928|FG000|Dose Expansion Phase|Progressive Disease|0|||
46645952|NCT01425008|82851929|FG001|Dose Expansion Phase|Progressive Disease|0|||
46645953|NCT01425008|82851930|FG002|Dose Expansion Phase|Progressive Disease|0|||
46645954|NCT01425008|82851931|FG003|Dose Expansion Phase|Progressive Disease|0|||
46645955|NCT01425008|82851932|FG004|Dose Expansion Phase|Progressive Disease|0|||
46645956|NCT01425008|82851933|FG005|Dose Expansion Phase|Progressive Disease|0|||
46645957|NCT01425008|82851934|FG006|Dose Expansion Phase|Progressive Disease|0|||
46645958|NCT01425008|82851935|FG007|Dose Expansion Phase|Progressive Disease|0|||
46645959|NCT01425008|82851936|FG008|Dose Expansion Phase|Progressive Disease|0|||
46645960|NCT01425008|82851937|FG009|Dose Expansion Phase|Progressive Disease|0|||
46645961|NCT01425008|82851938|FG010|Dose Expansion Phase|Progressive Disease|10|||
46645962|NCT01425008|82851939|FG011|Dose Expansion Phase|Progressive Disease|4|||
46645963|NCT01425008|82851940|FG012|Dose Expansion Phase|Progressive Disease|12|||
46645964|NCT01425008|82851941|FG013|Dose Expansion Phase|Progressive Disease|1|||
46645965|NCT01425008|82851942|FG014|Dose Expansion Phase|Progressive Disease|5|||
46645966|NCT01425008|82851943|FG015|Dose Expansion Phase|Progressive Disease|8|||
46645967|NCT01425008|82851944|FG016|Dose Expansion Phase|Progressive Disease|9|||
46645968|NCT01425008|82851945|FG017|Dose Expansion Phase|Progressive Disease|2|||
46645969|NCT01425008|82851946|FG018|Dose Expansion Phase|Progressive Disease|10|||
46645970|NCT01425008|82851928|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
46645971|NCT01425008|82851929|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
46645972|NCT01425008|82851930|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
46645973|NCT01425008|82851931|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
46645974|NCT01425008|82851932|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
46645975|NCT01425008|82851933|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
46645976|NCT01425008|82851934|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
46645977|NCT01425008|82851935|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
46645978|NCT01425008|82851936|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
46645979|NCT01425008|82851937|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
46645980|NCT01425008|82851938|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
46645981|NCT01425008|82851939|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
46645982|NCT01425008|82851940|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
46645983|NCT01425008|82851941|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
46645984|NCT01425008|82851942|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
46645985|NCT01425008|82851943|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
46645986|NCT01425008|82851944|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
46645987|NCT01425008|82851945|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
46645988|NCT01425008|82851946|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
46645989|NCT01425008|82851928|FG000|Dose Expansion Phase|Other|0|||
46645990|NCT01425008|82851929|FG001|Dose Expansion Phase|Other|0|||
46645991|NCT01425008|82851930|FG002|Dose Expansion Phase|Other|0|||
46645992|NCT01425008|82851931|FG003|Dose Expansion Phase|Other|0|||
46645993|NCT01425008|82851932|FG004|Dose Expansion Phase|Other|0|||
46645994|NCT01425008|82851933|FG005|Dose Expansion Phase|Other|0|||
46645995|NCT01425008|82851934|FG006|Dose Expansion Phase|Other|0|||
46645996|NCT01425008|82851935|FG007|Dose Expansion Phase|Other|0|||
46645997|NCT01425008|82851936|FG008|Dose Expansion Phase|Other|0|||
46645998|NCT01425008|82851937|FG009|Dose Expansion Phase|Other|0|||
46645999|NCT01425008|82851938|FG010|Dose Expansion Phase|Other|0|||
46646000|NCT01425008|82851939|FG011|Dose Expansion Phase|Other|0|||
46646001|NCT01425008|82851940|FG012|Dose Expansion Phase|Other|1|||
46646002|NCT01425008|82851941|FG013|Dose Expansion Phase|Other|0|||
46646003|NCT01425008|82851942|FG014|Dose Expansion Phase|Other|0|||
46646004|NCT01425008|82851943|FG015|Dose Expansion Phase|Other|0|||
46646005|NCT01425008|82851944|FG016|Dose Expansion Phase|Other|2|||
46646006|NCT01425008|82851945|FG017|Dose Expansion Phase|Other|0|||
46646007|NCT01425008|82851946|FG018|Dose Expansion Phase|Other|4|||
46646008|NCT01425008|82851928|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646009|NCT01425008|82851929|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646010|NCT01425008|82851930|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646011|NCT01425008|82851931|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646012|NCT01425008|82851932|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646013|NCT01425008|82851933|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646014|NCT01425008|82851934|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646015|NCT01425008|82851935|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646016|NCT01425008|82851936|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646017|NCT01425008|82851937|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646018|NCT01425008|82851938|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
46646019|NCT01425008|82851939|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
46646020|NCT01425008|82851940|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646021|NCT01425008|82851941|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646022|NCT01425008|82851942|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646023|NCT01425008|82851943|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
46646024|NCT01425008|82851944|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
46646025|NCT01425008|82851945|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
46646026|NCT01425008|82851946|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
46646027|NCT01425008|82851928|FG000|Dose Expansion Phase|Adverse Event|0|||
46646028|NCT01425008|82851929|FG001|Dose Expansion Phase|Adverse Event|0|||
46646029|NCT01425008|82851930|FG002|Dose Expansion Phase|Adverse Event|0|||
46646030|NCT01425008|82851931|FG003|Dose Expansion Phase|Adverse Event|0|||
46646031|NCT01425008|82851932|FG004|Dose Expansion Phase|Adverse Event|0|||
46646032|NCT01425008|82851933|FG005|Dose Expansion Phase|Adverse Event|0|||
46646033|NCT01425008|82851934|FG006|Dose Expansion Phase|Adverse Event|0|||
46646034|NCT01425008|82851935|FG007|Dose Expansion Phase|Adverse Event|0|||
46646035|NCT01425008|82851936|FG008|Dose Expansion Phase|Adverse Event|0|||
46646036|NCT01425008|82851937|FG009|Dose Expansion Phase|Adverse Event|0|||
46646037|NCT01425008|82851938|FG010|Dose Expansion Phase|Adverse Event|2|||
46646038|NCT01425008|82851939|FG011|Dose Expansion Phase|Adverse Event|3|||
46646039|NCT01425008|82851940|FG012|Dose Expansion Phase|Adverse Event|3|||
46646040|NCT01425008|82851941|FG013|Dose Expansion Phase|Adverse Event|0|||
46646041|NCT01425008|82851942|FG014|Dose Expansion Phase|Adverse Event|1|||
46646042|NCT01425008|82851943|FG015|Dose Expansion Phase|Adverse Event|1|||
46646043|NCT01425008|82851944|FG016|Dose Expansion Phase|Adverse Event|5|||
46646044|NCT01425008|82851945|FG017|Dose Expansion Phase|Adverse Event|0|||
46646045|NCT01425008|82851946|FG018|Dose Expansion Phase|Adverse Event|3|||
46646046|NCT01425008|82851928|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
46646047|NCT01425008|82851929|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
46646048|NCT01425008|82851930|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
46646049|NCT01425008|82851931|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
46646050|NCT01425008|82851932|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
46646051|NCT01425008|82851933|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
47074836|NCT03174275|83368295|FG000|Adjuvant Durvalumab|Progression|1|||
46646052|NCT01425008|82851934|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
46646053|NCT01425008|82851935|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
46646054|NCT01425008|82851936|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
46646055|NCT01425008|82851937|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
46646056|NCT01425008|82851938|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
46646057|NCT01425008|82851939|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
46646058|NCT01425008|82851940|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
46646059|NCT01425008|82851941|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
46646060|NCT01425008|82851942|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
46646061|NCT01425008|82851943|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
46646062|NCT01425008|82851944|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
46646063|NCT01425008|82851945|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
46646064|NCT01425008|82851946|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
46646065|NCT01425008|82851928|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646066|NCT01425008|82851929|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646067|NCT01425008|82851930|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646068|NCT01425008|82851931|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646069|NCT01425008|82851932|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646070|NCT01425008|82851933|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646071|NCT01425008|82851934|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646072|NCT01425008|82851935|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646073|NCT01425008|82851936|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646074|NCT01425008|82851937|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646075|NCT01425008|82851938|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646076|NCT01425008|82851939|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646077|NCT01425008|82851940|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646078|NCT01425008|82851941|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646079|NCT01425008|82851942|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646080|NCT01425008|82851943|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646081|NCT01425008|82851944|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646082|NCT01425008|82851945|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46646083|NCT01425008|82851946|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
46646084|NCT04072146|82852001|FG000|Overall Study|Adverse Event|0|||
46646085|NCT04072146|82852002|FG001|Overall Study|Adverse Event|1|||
46646086|NCT03861481|82852016|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
46646087|NCT03861481|82852017|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
46646088|NCT03861481|82852016|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
46646089|NCT03861481|82852017|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
46646090|NCT03861481|82852016|FG000|Overall Study|Relapse|1|||
46646091|NCT03861481|82852017|FG001|Overall Study|Relapse|0|||
46646092|NCT03861481|82852016|FG000|Overall Study|Withdrawal by Subject|0|||
46646093|NCT03861481|82852017|FG001|Overall Study|Withdrawal by Subject|1|||
46646094|NCT03861481|82852016|FG000|Overall Study|Lack of Efficacy|4|||
46646095|NCT03861481|82852017|FG001|Overall Study|Lack of Efficacy|5|||
46646096|NCT03648476|82852029|FG000|Overall Study|Withdrawal by Subject|2|||
46646097|NCT03648476|82852030|FG001|Overall Study|Withdrawal by Subject|1|||
46646098|NCT04545060|82852052|FG000|Overall Study|Adverse Event|0|||
46646099|NCT04545060|82852053|FG001|Overall Study|Adverse Event|1|||
46646100|NCT04545060|82852052|FG000|Overall Study|Death|0|||
46646101|NCT04545060|82852053|FG001|Overall Study|Death|5|||
46646102|NCT04545060|82852052|FG000|Overall Study|Lost to Follow-up|10|||
46646103|NCT04545060|82852053|FG001|Overall Study|Lost to Follow-up|13|||
46646104|NCT04545060|82852052|FG000|Overall Study|Physician Decision|3|||
46646105|NCT04545060|82852053|FG001|Overall Study|Physician Decision|0|||
46646106|NCT04545060|82852052|FG000|Overall Study|Withdrawal by Subject|17|||
46646107|NCT04545060|82852053|FG001|Overall Study|Withdrawal by Subject|22|||
46646108|NCT03533660|82852130|FG000|Overall Study|Withdrawal by Subject|2|||
46646109|NCT03533660|82852131|FG001|Overall Study|Withdrawal by Subject|2|||
46646110|NCT03533660|82852130|FG000|Overall Study|Death|2|||
46646111|NCT03533660|82852131|FG001|Overall Study|Death|4|||
46646112|NCT03533660|82852130|FG000|Overall Study|Adverse Event|0|||
46646113|NCT03533660|82852131|FG001|Overall Study|Adverse Event|2|||
46646114|NCT03416127|82852145|FG000|Overall Study|Withdrawal by Subject|0|||
46646115|NCT03416127|82852146|FG001|Overall Study|Withdrawal by Subject|1|||
46646116|NCT03416127|82852147|FG002|Overall Study|Withdrawal by Subject|1|||
46646117|NCT02986334|82852181|FG000|Overall Study|Withdrawal by Subject|0|||
46646118|NCT02986334|82852182|FG001|Overall Study|Withdrawal by Subject|1|||
46646119|NCT02986334|82852183|FG002|Overall Study|Withdrawal by Subject|2|||
46646120|NCT02986334|82852181|FG000|Overall Study|Lost to Follow-up|1|||
46646121|NCT02986334|82852182|FG001|Overall Study|Lost to Follow-up|2|||
47074837|NCT03174275|83368295|FG000|Adjuvant Durvalumab|Adverse Event|3|||
47074838|NCT03174275|83368295|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
47074839|NCT03174275|83368295|FG000|Adjuvant Radiotherapy|Progression|1|||
47074840|NCT03174275|83368295|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
47074841|NCT02817464|83368301|FG000|Overall Study|Lost to Follow-up|1|||
47074842|NCT02817464|83368302|FG001|Overall Study|Lost to Follow-up|0|||
47074843|NCT02817464|83368301|FG000|Overall Study|Discontinued early due to personal decision|1|||
47074844|NCT02817464|83368302|FG001|Overall Study|Discontinued early due to personal decision|1|||
46779894|NCT00414661|82998663|FG003|Overall Study|Withdrawal by Subject|2|||
47074845|NCT02752165|83368310|FG000|Overall Study|Withdrawal by Subject|6|||
46646122|NCT02986334|82852183|FG002|Overall Study|Lost to Follow-up|1|||
46646123|NCT02986334|82852181|FG000|Overall Study|Adverse Event|0|||
46646124|NCT02986334|82852182|FG001|Overall Study|Adverse Event|2|||
46646125|NCT02986334|82852183|FG002|Overall Study|Adverse Event|1|||
46646126|NCT02986334|82852181|FG000|Overall Study|non compliance in phone ratings|2|||
46646127|NCT02986334|82852182|FG001|Overall Study|non compliance in phone ratings|1|||
46779895|NCT00414661|82998660|FG000|Overall Study|Other|6|||
46646128|NCT02986334|82852183|FG002|Overall Study|non compliance in phone ratings|2|||
46646129|NCT02986334|82852181|FG000|Overall Study|undisclosed comorbidities|0|||
46646130|NCT02986334|82852182|FG001|Overall Study|undisclosed comorbidities|1|||
46646131|NCT02986334|82852183|FG002|Overall Study|undisclosed comorbidities|1|||
46646132|NCT02210221|82852205|FG000|Overall Study|Lack of Efficacy|7|||
46646133|NCT02210221|82852205|FG000|Overall Study|Withdrawal by Subject|43|||
46646134|NCT02124902|82852218|FG000|Overall Study|Adverse Event|7|||
46646135|NCT02124902|82852219|FG001|Overall Study|Adverse Event|2|||
46646136|NCT02124902|82852218|FG000|Overall Study|Went to alternative treatment|4|||
46646137|NCT02124902|82852219|FG001|Overall Study|Went to alternative treatment|0|||
46646138|NCT02124902|82852218|FG000|Overall Study|Withdrawal by Subject|2|||
46646139|NCT02124902|82852219|FG001|Overall Study|Withdrawal by Subject|1|||
46646140|NCT02124902|82852218|FG000|Overall Study|Physician Decision|2|||
46646141|NCT02124902|82852219|FG001|Overall Study|Physician Decision|0|||
46646142|NCT02124902|82852218|FG000|Overall Study|Not eligible|1|||
46646143|NCT02124902|82852219|FG001|Overall Study|Not eligible|0|||
46646144|NCT02124902|82852218|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
46646145|NCT02124902|82852219|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
46646146|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
46646147|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
46646148|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
46646149|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
46646150|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
46646151|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
46646152|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
46646153|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
46646154|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
46646155|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
46646156|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
46646157|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
46646158|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
46646159|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
46646160|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
46646161|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
46646162|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
46646163|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
46646164|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
46646165|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
46646166|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Death|0|||
46646167|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Death|1|||
46646168|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Death|0|||
46646169|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Death|0|||
46646170|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
46646171|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
46646172|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
46646173|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
46646174|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
46646175|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
46646176|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
46646177|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
46646178|NCT01940341|82852227|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
46646179|NCT01940341|82852228|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
46646180|NCT01940341|82852229|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
46646181|NCT01940341|82852230|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
46646182|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
46646183|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
46646184|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
46646185|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
46646186|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
46779896|NCT00414661|82998661|FG001|Overall Study|Other|3|||
46779897|NCT00414661|82998662|FG002|Overall Study|Other|0|||
46779898|NCT00414661|82998663|FG003|Overall Study|Other|0|||
46779899|NCT00405067|82998676|FG000|Overall Study|Adverse Event|4|||
46779900|NCT00405067|82998677|FG001|Overall Study|Adverse Event|9|||
46779901|NCT00405067|82998678|FG002|Overall Study|Adverse Event|4|||
46646187|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
46646188|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
46646189|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
46779902|NCT00405067|82998676|FG000|Overall Study|Lost to Follow-up|0|||
46779903|NCT00405067|82998677|FG001|Overall Study|Lost to Follow-up|0|||
46646190|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
46646191|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
46646192|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
46646193|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
46646194|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
46646195|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
46646196|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
46646197|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
46646198|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
46646199|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
46646200|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
46646201|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
46646202|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
46646203|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
46646204|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
46646205|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
46646206|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
46646207|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
46646208|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
46646209|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
46646210|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
46646211|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
46646212|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
46646213|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
46646214|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
46646215|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
46646216|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
46646217|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
46646218|NCT01940341|82852227|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
46646219|NCT01940341|82852228|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
46646220|NCT01940341|82852229|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
46646221|NCT01940341|82852230|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
46646222|NCT01877837|82852238|FG000|Overall Study|Lost to Follow-up|1|||
46646223|NCT01877837|82852238|FG000|Overall Study|Ineligible|4|||
46646224|NCT01624142|82852244|FG000|Overall Study|Withdrawal by Subject|14|||
46646225|NCT01624142|82852245|FG001|Overall Study|Withdrawal by Subject|4|||
46646226|NCT01624142|82852244|FG000|Overall Study|Death|3|||
46646227|NCT01624142|82852245|FG001|Overall Study|Death|6|||
46646228|NCT01624142|82852244|FG000|Overall Study|Study Closure|12|||
46646229|NCT01624142|82852245|FG001|Overall Study|Study Closure|6|||
46646230|NCT01624142|82852244|FG000|Overall Study|Lost to Follow-up|2|||
46646231|NCT01624142|82852245|FG001|Overall Study|Lost to Follow-up|0|||
46646232|NCT01624142|82852244|FG000|Overall Study|Other|1|||
46646233|NCT01624142|82852245|FG001|Overall Study|Other|0|||
46646234|NCT01535807|82852254|FG000|Overall Study|Withdrawal by Subject|1|||
46646235|NCT01535807|82852255|FG001|Overall Study|Withdrawal by Subject|1|||
46646236|NCT01535807|82852254|FG000|Overall Study|Data collection error|1|||
46646237|NCT01535807|82852255|FG001|Overall Study|Data collection error|1|||
46646238|NCT01375764|82852267|FG000|Overall Study|Lost to Follow-up|0|||
46646239|NCT01375764|82852268|FG001|Overall Study|Lost to Follow-up|1|||
46646240|NCT01375764|82852269|FG002|Overall Study|Lost to Follow-up|0|||
46646241|NCT01375764|82852270|FG003|Overall Study|Lost to Follow-up|0|||
46646242|NCT01375764|82852271|FG004|Overall Study|Lost to Follow-up|0|||
46646243|NCT01375764|82852267|FG000|Overall Study|Withdrawal by Subject|2|||
46646244|NCT01375764|82852268|FG001|Overall Study|Withdrawal by Subject|0|||
46646245|NCT01375764|82852269|FG002|Overall Study|Withdrawal by Subject|0|||
46646246|NCT01375764|82852270|FG003|Overall Study|Withdrawal by Subject|0|||
46779904|NCT00405067|82998678|FG002|Overall Study|Lost to Follow-up|1|||
46646247|NCT01375764|82852271|FG004|Overall Study|Withdrawal by Subject|1|||
46779905|NCT00708708|82998686|FG000|Overall Study|Another therapy instead of Enbrel|141|||
46779906|NCT00708708|82998686|FG000|Overall Study|Lost to Follow-up|52|||
46779907|NCT00708708|82998686|FG000|Overall Study|Withdrawal by Subject|51|||
46779908|NCT00708708|82998686|FG000|Overall Study|Intolerance|42|||
46779909|NCT00708708|82998686|FG000|Overall Study|Another therapy along with Enbrel|15|||
46779910|NCT00708708|82998686|FG000|Overall Study|Other unspecified|11|||
46646248|NCT01375764|82852267|FG000|Overall Study|Other|0|||
46646249|NCT01375764|82852268|FG001|Overall Study|Other|0|||
46779911|NCT00708708|82998686|FG000|Overall Study|Good effectiveness|9|||
47074846|NCT02752165|83368311|FG001|Overall Study|Withdrawal by Subject|6|||
46646250|NCT01375764|82852269|FG002|Overall Study|Other|0|||
46646251|NCT01375764|82852270|FG003|Overall Study|Other|1|||
46646252|NCT01375764|82852271|FG004|Overall Study|Other|0|||
46646253|NCT00722046|82852290|FG000|Overall Study|Adverse Event|0|||
46646254|NCT00722046|82852291|FG001|Overall Study|Adverse Event|1|||
46646255|NCT00722046|82852292|FG002|Overall Study|Adverse Event|2|||
46646256|NCT00722046|82852293|FG003|Overall Study|Adverse Event|1|||
46646257|NCT00722046|82852294|FG004|Overall Study|Adverse Event|2|||
46646258|NCT00722046|82852295|FG005|Overall Study|Adverse Event|1|||
46646259|NCT00722046|82852296|FG006|Overall Study|Adverse Event|0|||
46646260|NCT00722046|82852290|FG000|Overall Study|Death|0|||
46646261|NCT00722046|82852291|FG001|Overall Study|Death|1|||
46646262|NCT00722046|82852292|FG002|Overall Study|Death|0|||
46646263|NCT00722046|82852293|FG003|Overall Study|Death|0|||
46646264|NCT00722046|82852294|FG004|Overall Study|Death|0|||
46646265|NCT00722046|82852295|FG005|Overall Study|Death|0|||
46646266|NCT00722046|82852296|FG006|Overall Study|Death|2|||
46646267|NCT00722046|82852290|FG000|Overall Study|Protocol Violation|1|||
46646268|NCT00722046|82852291|FG001|Overall Study|Protocol Violation|0|||
46646269|NCT00722046|82852292|FG002|Overall Study|Protocol Violation|0|||
46646270|NCT00722046|82852293|FG003|Overall Study|Protocol Violation|0|||
46646271|NCT00722046|82852294|FG004|Overall Study|Protocol Violation|0|||
46646272|NCT00722046|82852295|FG005|Overall Study|Protocol Violation|1|||
46646273|NCT00722046|82852296|FG006|Overall Study|Protocol Violation|0|||
46646274|NCT00722046|82852290|FG000|Overall Study|Withdrawal by Subject|3|||
46646275|NCT00722046|82852291|FG001|Overall Study|Withdrawal by Subject|3|||
46646276|NCT00722046|82852292|FG002|Overall Study|Withdrawal by Subject|4|||
46646277|NCT00722046|82852293|FG003|Overall Study|Withdrawal by Subject|4|||
46646278|NCT00722046|82852294|FG004|Overall Study|Withdrawal by Subject|4|||
46646279|NCT00722046|82852295|FG005|Overall Study|Withdrawal by Subject|7|||
46646280|NCT00722046|82852296|FG006|Overall Study|Withdrawal by Subject|3|||
46646281|NCT00722046|82852290|FG000|Overall Study|Randomized, but not treated|1|||
46646282|NCT00722046|82852291|FG001|Overall Study|Randomized, but not treated|1|||
46646283|NCT00722046|82852292|FG002|Overall Study|Randomized, but not treated|0|||
46646284|NCT00722046|82852293|FG003|Overall Study|Randomized, but not treated|2|||
46646285|NCT00722046|82852294|FG004|Overall Study|Randomized, but not treated|0|||
46646286|NCT00722046|82852295|FG005|Overall Study|Randomized, but not treated|0|||
46646287|NCT00722046|82852296|FG006|Overall Study|Randomized, but not treated|0|||
46646288|NCT00722046|82852290|FG000|Overall Study|Other|0|||
46646289|NCT00722046|82852291|FG001|Overall Study|Other|0|||
46646290|NCT00722046|82852292|FG002|Overall Study|Other|1|||
46646291|NCT00722046|82852293|FG003|Overall Study|Other|1|||
46646292|NCT00722046|82852294|FG004|Overall Study|Other|3|||
46646293|NCT00722046|82852295|FG005|Overall Study|Other|2|||
46646294|NCT00722046|82852296|FG006|Overall Study|Other|1|||
46646295|NCT00614523|82852316|FG000|Overall Study|Adverse Event|4|||
46646296|NCT00614523|82852317|FG001|Overall Study|Adverse Event|20|||
46646297|NCT00614523|82852316|FG000|Overall Study|Death|5|||
46646298|NCT00614523|82852317|FG001|Overall Study|Death|8|||
46646299|NCT00614523|82852316|FG000|Overall Study|Lack of Efficacy|9|||
46646300|NCT00614523|82852317|FG001|Overall Study|Lack of Efficacy|11|||
46646301|NCT00614523|82852316|FG000|Overall Study|Lost to Follow-up|0|||
46646302|NCT00614523|82852317|FG001|Overall Study|Lost to Follow-up|1|||
46646303|NCT00614523|82852316|FG000|Overall Study|Protocol Violation|3|||
46646304|NCT00614523|82852317|FG001|Overall Study|Protocol Violation|2|||
46646305|NCT00614523|82852316|FG000|Overall Study|Withdrawal by Subject|12|||
46646306|NCT00614523|82852317|FG001|Overall Study|Withdrawal by Subject|22|||
46646307|NCT00614523|82852316|FG000|Overall Study|Other|6|||
46646308|NCT00614523|82852317|FG001|Overall Study|Other|11|||
46779912|NCT00708708|82998686|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
46779913|NCT00708708|82998686|FG000|Overall Study|Administrative reasons|7|||
46779914|NCT00708708|82998686|FG000|Overall Study|Lack of effectiveness|4|||
46779915|NCT00708708|82998686|FG000|Overall Study|Lack of compliance|3|||
46779916|NCT00708708|82998686|FG000|Overall Study|Pregnancy|3|||
46779917|NCT00708708|82998686|FG000|Overall Study|Adverse Event|3|||
46779918|NCT00708708|82998686|FG000|Overall Study|Missing values|392|||
46779919|NCT00404755|82998693|FG000|Phase I (Bupropion)|Adverse Event|3|||
46779920|NCT00404755|82998693|FG000|Phase I (Bupropion)|Other|1|||
46646309|NCT00614523|82852316|FG000|Overall Study|Ineligibility Determined|1|||
46646310|NCT00614523|82852317|FG001|Overall Study|Ineligibility Determined|2|||
46646311|NCT00614523|82852316|FG000|Overall Study|Disease Progression|0|||
46646312|NCT00614523|82852317|FG001|Overall Study|Disease Progression|8|||
46779921|NCT00404755|82998693|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
46779922|NCT00614614|82998703|FG000|Primary Vaccination Phase|Adverse Event|6|||
46646313|NCT00614523|82852316|FG000|Overall Study|Administrative Decision|23|||
46646314|NCT00614523|82852317|FG001|Overall Study|Administrative Decision|46|||
46646315|NCT00523341|82852325|FG000|Overall Study|Withdrawal by Subject|399|||
46646316|NCT00523341|82852326|FG001|Overall Study|Withdrawal by Subject|427|||
46646317|NCT00523341|82852325|FG000|Overall Study|Other|181|||
46646318|NCT00523341|82852326|FG001|Overall Study|Other|198|||
46646319|NCT00523341|82852325|FG000|Overall Study|Adverse Event|122|||
46779923|NCT00614614|82998704|FG001|Primary Vaccination Phase|Adverse Event|0|||
47074847|NCT02752165|83368310|FG000|Overall Study|Protocol Violation|6|||
47074848|NCT02752165|83368311|FG001|Overall Study|Protocol Violation|5|||
47074849|NCT02752165|83368310|FG000|Overall Study|Lost to Follow-up|33|||
47074850|NCT02752165|83368311|FG001|Overall Study|Lost to Follow-up|38|||
47074851|NCT02358031|83368320|FG000|Overall Study|Death|226|||
46779924|NCT00614614|82998705|FG002|Primary Vaccination Phase|Adverse Event|0|||
46779925|NCT00614614|82998706|FG003|Primary Vaccination Phase|Adverse Event|0|||
46779926|NCT00614614|82998707|FG004|Primary Vaccination Phase|Adverse Event|0|||
47074852|NCT02358031|83368321|FG001|Overall Study|Death|204|||
47074853|NCT02358031|83368322|FG002|Overall Study|Death|249|||
47074854|NCT02358031|83368320|FG000|Overall Study|Lost to Follow-up|0|||
47074855|NCT02358031|83368321|FG001|Overall Study|Lost to Follow-up|1|||
47074856|NCT02358031|83368322|FG002|Overall Study|Lost to Follow-up|1|||
47074857|NCT02358031|83368320|FG000|Overall Study|Withdrawal by Subject|14|||
47074858|NCT02358031|83368321|FG001|Overall Study|Withdrawal by Subject|12|||
47074859|NCT02358031|83368322|FG002|Overall Study|Withdrawal by Subject|17|||
47074860|NCT02358031|83368320|FG000|Overall Study|Ongoing in Study|61|||
47074861|NCT02358031|83368321|FG001|Overall Study|Ongoing in Study|64|||
47074862|NCT02358031|83368322|FG002|Overall Study|Ongoing in Study|33|||
47074863|NCT02037919|83368332|FG000|Overall Study|Lost to Follow-up|30|||
47074864|NCT02037919|83368333|FG001|Overall Study|Lost to Follow-up|45|||
46779927|NCT00614614|82998703|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
46779928|NCT00614614|82998704|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
46779929|NCT00614614|82998705|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
46779930|NCT00614614|82998706|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
46779931|NCT00614614|82998707|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
46779932|NCT00614614|82998703|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
46779933|NCT00614614|82998704|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
46779934|NCT00614614|82998705|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
46779935|NCT00614614|82998706|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
46779936|NCT00614614|82998707|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
46779937|NCT00614614|82998703|FG000|Primary Vaccination Phase|Protocol Violation|9|||
46779938|NCT00614614|82998704|FG001|Primary Vaccination Phase|Protocol Violation|3|||
46779939|NCT00614614|82998705|FG002|Primary Vaccination Phase|Protocol Violation|0|||
47074865|NCT01949662|83368341|FG000|Overall Study|Death|9|||
47074866|NCT01949662|83368342|FG001|Overall Study|Death|7|||
47074867|NCT01949662|83368341|FG000|Overall Study|Discharged before an agitation event|8|||
47074868|NCT01949662|83368342|FG001|Overall Study|Discharged before an agitation event|3|||
47074869|NCT01949662|83368341|FG000|Overall Study|Dropped out|1|||
46646320|NCT00523341|82852326|FG001|Overall Study|Adverse Event|155|||
46646321|NCT00523341|82852325|FG000|Overall Study|Death|101|||
46646322|NCT00523341|82852326|FG001|Overall Study|Death|110|||
46646323|NCT00523341|82852325|FG000|Overall Study|Lost to Follow-up|73|||
46646324|NCT00523341|82852326|FG001|Overall Study|Lost to Follow-up|61|||
46646325|NCT00523341|82852325|FG000|Overall Study|Non-compliance|20|||
46646326|NCT00523341|82852326|FG001|Overall Study|Non-compliance|13|||
46646327|NCT00523341|82852325|FG000|Overall Study|Physician Decision|14|||
46646328|NCT00523341|82852326|FG001|Overall Study|Physician Decision|13|||
46646329|NCT00523341|82852325|FG000|Overall Study|Requirement for Alternative Therapy|4|||
46646330|NCT00523341|82852326|FG001|Overall Study|Requirement for Alternative Therapy|14|||
46646331|NCT00523341|82852325|FG000|Overall Study|Protocol Deviation|6|||
46646332|NCT00523341|82852326|FG001|Overall Study|Protocol Deviation|5|||
46646333|NCT00523341|82852325|FG000|Overall Study|Ineligibility Determined|3|||
46646334|NCT00523341|82852326|FG001|Overall Study|Ineligibility Determined|4|||
46646335|NCT00523341|82852325|FG000|Overall Study|Disease Progression|1|||
46646336|NCT00523341|82852326|FG001|Overall Study|Disease Progression|0|||
46646337|NCT00364013|82852334|FG000|Overall Study|Ineligibility determined|4|||
46646338|NCT00364013|82852335|FG001|Overall Study|Ineligibility determined|2|||
46646339|NCT00364013|82852334|FG000|Overall Study|Adverse Event|4|||
46646340|NCT00364013|82852335|FG001|Overall Study|Adverse Event|3|||
46646341|NCT00364013|82852334|FG000|Overall Study|Withdrawal by Subject|13|||
46646342|NCT00364013|82852335|FG001|Overall Study|Withdrawal by Subject|18|||
46646343|NCT00364013|82852334|FG000|Overall Study|Physician Decision|3|||
46646344|NCT00364013|82852335|FG001|Overall Study|Physician Decision|3|||
46646345|NCT00364013|82852334|FG000|Overall Study|Lost to Follow-up|10|||
46646346|NCT00364013|82852335|FG001|Overall Study|Lost to Follow-up|3|||
46646347|NCT00364013|82852334|FG000|Overall Study|Protocol-specified criteria|6|||
46646348|NCT00364013|82852335|FG001|Overall Study|Protocol-specified criteria|6|||
46646349|NCT00364013|82852334|FG000|Overall Study|Other|41|||
46646350|NCT00364013|82852335|FG001|Overall Study|Other|47|||
46646351|NCT00364013|82852334|FG000|Overall Study|Ongoing|20|||
46646352|NCT00364013|82852335|FG001|Overall Study|Ongoing|13|||
46646353|NCT00345839|82852347|FG000|Overall Study|Withdrawal by Subject|91|||
46646354|NCT00345839|82852348|FG001|Overall Study|Withdrawal by Subject|98|||
46646355|NCT00345839|82852347|FG000|Overall Study|Lost to Follow-up|58|||
46646356|NCT00345839|82852348|FG001|Overall Study|Lost to Follow-up|61|||
46646357|NCT00330759|82852356|FG000|Overall Study|Death|316|||
46646358|NCT00330759|82852357|FG001|Overall Study|Death|310|||
46646359|NCT00330759|82852356|FG000|Overall Study|Disease progression|104|||
46646360|NCT00330759|82852357|FG001|Overall Study|Disease progression|126|||
46646361|NCT00330759|82852356|FG000|Overall Study|Withdrawal by Subject|143|||
46646362|NCT00330759|82852357|FG001|Overall Study|Withdrawal by Subject|124|||
46646363|NCT00330759|82852356|FG000|Overall Study|Adverse Event|48|||
46646364|NCT00330759|82852357|FG001|Overall Study|Adverse Event|36|||
46646365|NCT00330759|82852356|FG000|Overall Study|Participant request|31|||
46646366|NCT00330759|82852357|FG001|Overall Study|Participant request|22|||
46646367|NCT00330759|82852356|FG000|Overall Study|Lost to Follow-up|16|||
46646368|NCT00330759|82852357|FG001|Overall Study|Lost to Follow-up|22|||
46646369|NCT00330759|82852356|FG000|Overall Study|Noncompliance|15|||
46646370|NCT00330759|82852357|FG001|Overall Study|Noncompliance|17|||
46646371|NCT00330759|82852356|FG000|Overall Study|Physician Decision|1|||
46646372|NCT00330759|82852357|FG001|Overall Study|Physician Decision|2|||
46646373|NCT00330759|82852356|FG000|Overall Study|Protocol deviation|0|||
46646374|NCT00330759|82852357|FG001|Overall Study|Protocol deviation|2|||
46646375|NCT00330759|82852356|FG000|Overall Study|Ineligibility determined|2|||
46646376|NCT00330759|82852357|FG001|Overall Study|Ineligibility determined|1|||
46646377|NCT00330759|82852356|FG000|Overall Study|Other|36|||
46646378|NCT00330759|82852357|FG001|Overall Study|Other|44|||
46646379|NCT00113763|82852365|FG000|Overall Study|Adverse Event|5|||
46646380|NCT00113763|82852366|FG001|Overall Study|Adverse Event|2|||
46646381|NCT00113763|82852365|FG000|Overall Study|Disease Progression|28|||
46646382|NCT00113763|82852366|FG001|Overall Study|Disease Progression|14|||
46646383|NCT00113763|82852365|FG000|Overall Study|Lost to Follow-up|10|||
46646384|NCT00113763|82852366|FG001|Overall Study|Lost to Follow-up|0|||
46646385|NCT00113763|82852365|FG000|Overall Study|Withdrawal by Subject|1|||
46779940|NCT00614614|82998706|FG003|Primary Vaccination Phase|Protocol Violation|0|||
46646386|NCT00113763|82852366|FG001|Overall Study|Withdrawal by Subject|4|||
46646387|NCT00113763|82852365|FG000|Overall Study|Other|27|||
46646388|NCT00113763|82852366|FG001|Overall Study|Other|6|||
46646389|NCT00113763|82852365|FG000|Overall Study|Non-compliance|1|||
46646390|NCT00113763|82852366|FG001|Overall Study|Non-compliance|0|||
46646391|NCT00113763|82852365|FG000|Overall Study|Ongoing|1|||
46646392|NCT00113763|82852366|FG001|Overall Study|Ongoing|0|||
46646393|NCT05166902|82852380|FG000|First Intervention|Lost to Follow-up|0|||
46646394|NCT05166902|82852381|FG001|First Intervention|Lost to Follow-up|1|||
46646395|NCT05142566|82852387|FG000|Overall Study|Protocol Violation|1|||
46646396|NCT05083949|82852393|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
46646397|NCT05083949|82852394|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
46646398|NCT05083949|82852393|FG000|Period 1|Adverse Event|1|||
46646399|NCT05083949|82852394|FG001|Period 1|Adverse Event|1|||
46646400|NCT05083949|82852393|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
46646401|NCT05083949|82852394|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
46646402|NCT05083949|82852393|FG000|Period 2|Adverse Event|0|||
46646403|NCT05083949|82852394|FG001|Period 2|Adverse Event|2|||
46646404|NCT04982575|82852406|FG000|Overall Study|Withdrawal by Subject|2|||
46646405|NCT04982575|82852407|FG001|Overall Study|Withdrawal by Subject|0|||
46646406|NCT04982575|82852408|FG002|Overall Study|Withdrawal by Subject|2|||
46646407|NCT05286658|82852418|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
46646408|NCT05286658|82852418|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
46646409|NCT05069415|82852424|FG000|Overall Study|Withdrawal by Subject|2|||
46646410|NCT05069415|82852425|FG001|Overall Study|Withdrawal by Subject|0|||
46646411|NCT05069415|82852424|FG000|Overall Study|Adverse Event|2|||
46646412|NCT05069415|82852425|FG001|Overall Study|Adverse Event|0|||
46646413|NCT04759131|82852441|FG000|Overall Study|Investigator's discretion|1|||
46646414|NCT04759131|82852442|FG001|Overall Study|Investigator's discretion|0|||
46779941|NCT00614614|82998707|FG004|Primary Vaccination Phase|Protocol Violation|0|||
46646415|NCT04759131|82852441|FG000|Overall Study|Subject withdrawal|1|||
46646416|NCT04759131|82852442|FG001|Overall Study|Subject withdrawal|0|||
46646417|NCT04737031|82852455|FG000|Overall Study|Patients who did not have a treatment visit|0|||
46646418|NCT04737031|82852456|FG001|Overall Study|Patients who did not have a treatment visit|31|||
46646419|NCT04737031|82852457|FG002|Overall Study|Patients who did not have a treatment visit|93|||
46646420|NCT04737031|82852458|FG003|Overall Study|Patients who did not have a treatment visit|227|||
46646421|NCT04701333|82852470|FG000|Overall Study|Lost to Follow-up|3|||
46646422|NCT04701333|82852471|FG001|Overall Study|Lost to Follow-up|7|||
46646423|NCT04701333|82852470|FG000|Overall Study|Withdrawal by Subject|0|||
46646424|NCT04701333|82852471|FG001|Overall Study|Withdrawal by Subject|1|||
46646425|NCT04493242|82852489|FG000|Overall Study|Death|10|||
46646426|NCT04493242|82852490|FG001|Overall Study|Death|14|||
46646427|NCT04493242|82852491|FG002|Overall Study|Death|16|||
46646428|NCT04493242|82852489|FG000|Overall Study|Lost to Follow-up|1|||
46646429|NCT04493242|82852490|FG001|Overall Study|Lost to Follow-up|1|||
46646430|NCT04493242|82852491|FG002|Overall Study|Lost to Follow-up|0|||
46646431|NCT04493242|82852489|FG000|Overall Study|Withdrawal by Subject|1|||
46646432|NCT04493242|82852490|FG001|Overall Study|Withdrawal by Subject|0|||
46646433|NCT04493242|82852491|FG002|Overall Study|Withdrawal by Subject|0|||
46646434|NCT04493242|82852489|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
46646435|NCT04493242|82852490|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
46646436|NCT04493242|82852491|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
46646437|NCT04493242|82852489|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
46646438|NCT04493242|82852490|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
46646439|NCT04493242|82852491|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
46646440|NCT04476277|82852503|FG000|Overall Study|Withdrawal by Subject|0|||
46646441|NCT04476277|82852504|FG001|Overall Study|Withdrawal by Subject|0|||
46646442|NCT04476277|82852505|FG002|Overall Study|Withdrawal by Subject|1|||
46779942|NCT00614614|82998703|FG000|Primary Vaccination Phase|Other|4|||
46779943|NCT00614614|82998704|FG001|Primary Vaccination Phase|Other|0|||
46779944|NCT00614614|82998705|FG002|Primary Vaccination Phase|Other|0|||
46779945|NCT00614614|82998706|FG003|Primary Vaccination Phase|Other|0|||
46779946|NCT00614614|82998707|FG004|Primary Vaccination Phase|Other|0|||
46779947|NCT00614614|82998703|FG000|Booster Vaccination Phase|Adverse Event|0|||
46779948|NCT00614614|82998704|FG001|Booster Vaccination Phase|Adverse Event|0|||
46779949|NCT00614614|82998705|FG002|Booster Vaccination Phase|Adverse Event|1|||
46779950|NCT00614614|82998706|FG003|Booster Vaccination Phase|Adverse Event|1|||
46779951|NCT00614614|82998707|FG004|Booster Vaccination Phase|Adverse Event|0|||
46779952|NCT00614614|82998703|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
46779953|NCT00614614|82998704|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
46779954|NCT00614614|82998705|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
46779955|NCT00614614|82998706|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
46779956|NCT00614614|82998707|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
46779957|NCT00614614|82998703|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
46779958|NCT00614614|82998704|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
46779959|NCT00614614|82998705|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
46779960|NCT00614614|82998706|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
46779961|NCT00614614|82998707|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
47074870|NCT01949662|83368342|FG001|Overall Study|Dropped out|3|||
46646443|NCT04476277|82852506|FG003|Overall Study|Withdrawal by Subject|0|||
46646444|NCT04439357|82852516|FG000|Overall Study|Disease Progression|4|||
46646445|NCT04337931|82852523|FG000|Overall Study|Death|4|||
46646446|NCT04337931|82852524|FG001|Overall Study|Death|1|||
46646447|NCT04337931|82852525|FG002|Overall Study|Death|7|||
46646448|NCT04337931|82852523|FG000|Overall Study|Withdrawal by Subject|0|||
46646449|NCT04337931|82852524|FG001|Overall Study|Withdrawal by Subject|1|||
46646450|NCT04337931|82852525|FG002|Overall Study|Withdrawal by Subject|0|||
46646451|NCT04337931|82852523|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
46646452|NCT04337931|82852524|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
46646453|NCT04337931|82852525|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
46646454|NCT04337931|82852523|FG000|Overall Study|Study terminated by sponsor|3|||
46646455|NCT04337931|82852524|FG001|Overall Study|Study terminated by sponsor|6|||
46646456|NCT04337931|82852525|FG002|Overall Study|Study terminated by sponsor|2|||
46646457|NCT04337931|82852523|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
46646458|NCT04337931|82852524|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
46646459|NCT04337931|82852525|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
46646460|NCT04337931|82852523|FG000|Overall Study|Colorectal cancer treatment|1|||
46646461|NCT04337931|82852524|FG001|Overall Study|Colorectal cancer treatment|0|||
46646462|NCT04337931|82852525|FG002|Overall Study|Colorectal cancer treatment|0|||
46646463|NCT04337931|82852523|FG000|Overall Study|Participant decision|0|||
46646464|NCT04337931|82852524|FG001|Overall Study|Participant decision|1|||
46646465|NCT04337931|82852525|FG002|Overall Study|Participant decision|0|||
46646466|NCT04143217|82852534|FG000|Overall Study|Withdrawal by Subject|42|||
46646467|NCT04143217|82852534|FG000|Overall Study|Adverse Event|29|||
46646468|NCT04143217|82852534|FG000|Overall Study|Lost to Follow-up|29|||
46646469|NCT04143217|82852534|FG000|Overall Study|Lack of Efficacy|15|||
46646470|NCT04143217|82852534|FG000|Overall Study|Physician Decision|1|||
46646471|NCT04143217|82852534|FG000|Overall Study|Non-Compliance With Study Drug|6|||
46646472|NCT04143217|82852534|FG000|Overall Study|Other, Multiple Categories|11|||
46646473|NCT03845075|82852559|FG000|Part 1 - DB|Withdrawal by Subject|1|||
46646474|NCT03845075|82852560|FG001|Part 1 - DB|Withdrawal by Subject|1|||
46646475|NCT03845075|82852561|FG002|Part 1 - DB|Withdrawal by Subject|0|||
46646476|NCT03845075|82852562|FG003|Part 1 - DB|Withdrawal by Subject|0|||
46646477|NCT03845075|82852559|FG000|Part 1 - DB|Adverse Event|0|||
46646478|NCT03845075|82852560|FG001|Part 1 - DB|Adverse Event|1|||
46646479|NCT03845075|82852561|FG002|Part 1 - DB|Adverse Event|0|||
46779962|NCT00614614|82998703|FG000|Booster Vaccination Phase|Protocol Violation|0|||
46779963|NCT00614614|82998704|FG001|Booster Vaccination Phase|Protocol Violation|0|||
46779964|NCT00614614|82998705|FG002|Booster Vaccination Phase|Protocol Violation|2|||
46779965|NCT00614614|82998706|FG003|Booster Vaccination Phase|Protocol Violation|3|||
46779966|NCT00614614|82998707|FG004|Booster Vaccination Phase|Protocol Violation|0|||
46779967|NCT00614614|82998703|FG000|Booster Vaccination Phase|Other|0|||
46779968|NCT00614614|82998704|FG001|Booster Vaccination Phase|Other|1|||
46779969|NCT00614614|82998705|FG002|Booster Vaccination Phase|Other|3|||
46779970|NCT00614614|82998706|FG003|Booster Vaccination Phase|Other|2|||
46779971|NCT00614614|82998707|FG004|Booster Vaccination Phase|Other|1|||
46779972|NCT00713310|82998724|FG000|Overall Study|Adverse Event|5|||
46779973|NCT00713310|82998725|FG001|Overall Study|Adverse Event|2|||
46779974|NCT00713310|82998724|FG000|Overall Study|Lack of Efficacy|0|||
46779975|NCT00713310|82998725|FG001|Overall Study|Lack of Efficacy|2|||
46646480|NCT03845075|82852562|FG003|Part 1 - DB|Adverse Event|0|||
46646481|NCT03845075|82852559|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
46779976|NCT00713310|82998724|FG000|Overall Study|Withdrawal by Subject|0|||
46779977|NCT00713310|82998725|FG001|Overall Study|Withdrawal by Subject|2|||
46779978|NCT00422461|82998735|FG000|Overall Study|Adverse Event|1|||
46779979|NCT00422461|82998736|FG001|Overall Study|Adverse Event|2|||
46779980|NCT00422461|82998737|FG002|Overall Study|Adverse Event|1|||
46779981|NCT00422461|82998738|FG003|Overall Study|Adverse Event|1|||
46779982|NCT00422461|82998735|FG000|Overall Study|Other|0|||
46779983|NCT00422461|82998736|FG001|Overall Study|Other|0|||
46779984|NCT00422461|82998737|FG002|Overall Study|Other|0|||
46779985|NCT00422461|82998738|FG003|Overall Study|Other|2|||
46779986|NCT00422461|82998735|FG000|Overall Study|Participants no longer willing to participate in study|1|||
46779987|NCT00422461|82998736|FG001|Overall Study|Participants no longer willing to participate in study|0|||
46779988|NCT00422461|82998737|FG002|Overall Study|Participants no longer willing to participate in study|0|||
46779989|NCT00422461|82998738|FG003|Overall Study|Participants no longer willing to participate in study|0|||
46779990|NCT00422461|82998735|FG000|Overall Study|Randomized but not treated|1|||
46779991|NCT00422461|82998736|FG001|Overall Study|Randomized but not treated|1|||
46779992|NCT00422461|82998737|FG002|Overall Study|Randomized but not treated|0|||
46779993|NCT00422461|82998738|FG003|Overall Study|Randomized but not treated|0|||
47074871|NCT01949662|83368341|FG000|Overall Study|Ineligible|0|||
47074872|NCT01949662|83368342|FG001|Overall Study|Ineligible|1|||
47074873|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
46779994|NCT00712920|82998751|FG000|Overall Study|Adverse Event|3|||
46779995|NCT00712920|82998752|FG001|Overall Study|Adverse Event|4|||
46779996|NCT00712920|82998753|FG002|Overall Study|Adverse Event|7|||
46646482|NCT03845075|82852560|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
46779997|NCT00712920|82998751|FG000|Overall Study|Withdrawal by Subject|4|||
46779998|NCT00712920|82998752|FG001|Overall Study|Withdrawal by Subject|2|||
46779999|NCT00712920|82998753|FG002|Overall Study|Withdrawal by Subject|1|||
46780000|NCT00712920|82998751|FG000|Overall Study|Lost to Follow-up|1|||
47074874|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074875|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074876|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
47074877|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
47074878|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074879|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074880|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074881|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074882|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
47074883|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074884|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
47074885|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
47074886|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
47074887|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
47074888|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
47074889|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
46646483|NCT03845075|82852561|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
46646484|NCT03845075|82852562|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
46646485|NCT03662659|82852574|FG000|Pre-treatment|Participant no longer met study criteria|1|||
46646486|NCT03662659|82852575|FG001|Pre-treatment|Participant no longer met study criteria|1|||
46646487|NCT03662659|82852574|FG000|Pre-treatment|Other reasons|1|||
46646488|NCT03662659|82852575|FG001|Pre-treatment|Other reasons|0|||
46646489|NCT03662659|82852574|FG000|Treatment|Completed Treatment|0|||
46646490|NCT03662659|82852575|FG001|Treatment|Completed Treatment|3|||
46646491|NCT03662659|82852574|FG000|Treatment|Disease Progression|69|||
46646492|NCT03662659|82852575|FG001|Treatment|Disease Progression|78|||
46646493|NCT03662659|82852574|FG000|Treatment|Study Drug Toxicity|18|||
46646494|NCT03662659|82852575|FG001|Treatment|Study Drug Toxicity|8|||
46646495|NCT03662659|82852574|FG000|Treatment|Death|12|||
46646496|NCT03662659|82852575|FG001|Treatment|Death|7|||
46646497|NCT03662659|82852574|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
46646498|NCT03662659|82852575|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
46646499|NCT03662659|82852574|FG000|Treatment|Withdrawal by Subject|1|||
46646500|NCT03662659|82852575|FG001|Treatment|Withdrawal by Subject|1|||
46646501|NCT03662659|82852574|FG000|Treatment|Poor/Non-compliance|1|||
46646502|NCT03662659|82852575|FG001|Treatment|Poor/Non-compliance|0|||
46646503|NCT03662659|82852574|FG000|Treatment|Participant no longer meets study criteria|1|||
46646504|NCT03662659|82852575|FG001|Treatment|Participant no longer meets study criteria|0|||
46646505|NCT03662659|82852574|FG000|Treatment|Other reasons|6|||
46646506|NCT03662659|82852575|FG001|Treatment|Other reasons|5|||
46646507|NCT03542682|82852596|FG000|Overall Study|COVID-19 Protocol|0|||
46646508|NCT03542682|82852597|FG001|Overall Study|COVID-19 Protocol|1|||
46646509|NCT03480386|82852607|FG000|Overall Study|Did not complete measures at 3-months|17|||
46646510|NCT03480386|82852608|FG001|Overall Study|Did not complete measures at 3-months|14|||
46646511|NCT03480386|82852607|FG000|Overall Study|No baseline measures|11|||
46780001|NCT00712920|82998752|FG001|Overall Study|Lost to Follow-up|4|||
46780002|NCT00712920|82998753|FG002|Overall Study|Lost to Follow-up|0|||
46780003|NCT00712920|82998751|FG000|Overall Study|Lack of Efficacy|1|||
46780004|NCT00712920|82998752|FG001|Overall Study|Lack of Efficacy|0|||
46780005|NCT00712920|82998753|FG002|Overall Study|Lack of Efficacy|1|||
46780006|NCT00712920|82998751|FG000|Overall Study|Other|5|||
46780007|NCT00712920|82998752|FG001|Overall Study|Other|7|||
46780008|NCT00712920|82998753|FG002|Overall Study|Other|3|||
46780009|NCT00712920|82998751|FG000|Overall Study|Non-compliance|3|||
46780010|NCT00712920|82998752|FG001|Overall Study|Non-compliance|0|||
46780011|NCT00712920|82998753|FG002|Overall Study|Non-compliance|0|||
46780012|NCT00612586|82998772|FG000|Overall Study|Adverse Event|6|||
47074890|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
47074891|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
46646512|NCT03480386|82852608|FG001|Overall Study|No baseline measures|14|||
46646513|NCT03480386|82852607|FG000|Overall Study|Death|0|||
46646514|NCT03480386|82852608|FG001|Overall Study|Death|5|||
46646515|NCT03480386|82852607|FG000|Overall Study|Withdrawal by Subject|12|||
46646516|NCT03480386|82852608|FG001|Overall Study|Withdrawal by Subject|8|||
46780013|NCT00612586|82998773|FG001|Overall Study|Adverse Event|2|||
46646517|NCT03480386|82852607|FG000|Overall Study|Lost to Follow-up|2|||
46646518|NCT03480386|82852608|FG001|Overall Study|Lost to Follow-up|1|||
46780014|NCT00612586|82998772|FG000|Overall Study|Death|1|||
46780015|NCT00612586|82998773|FG001|Overall Study|Death|0|||
46780016|NCT00612586|82998772|FG000|Overall Study|Entry Criteria Not Met|0|||
46780017|NCT00612586|82998773|FG001|Overall Study|Entry Criteria Not Met|2|||
46780018|NCT00612586|82998772|FG000|Overall Study|Withdrawal by Subject|7|||
46646519|NCT03480386|82852607|FG000|Overall Study|Complicating disease|0|||
46970263|NCT02100514|83213272|FG003|Treatment Period|Protocol Violation|0|||
46970264|NCT02100514|83213273|FG004|Treatment Period|Protocol Violation|0|||
46970265|NCT02100514|83213269|FG000|Treatment Period|Withdrawal by Subject|12|||
46970266|NCT02100514|83213270|FG001|Treatment Period|Withdrawal by Subject|37|||
46970267|NCT02100514|83213271|FG002|Treatment Period|Withdrawal by Subject|0|||
46970268|NCT02100514|83213272|FG003|Treatment Period|Withdrawal by Subject|0|||
46970269|NCT02100514|83213273|FG004|Treatment Period|Withdrawal by Subject|0|||
46970270|NCT02100514|83213269|FG000|Treatment Period|Other|9|||
46970271|NCT02100514|83213270|FG001|Treatment Period|Other|11|||
46970272|NCT02100514|83213271|FG002|Treatment Period|Other|0|||
46970273|NCT02100514|83213272|FG003|Treatment Period|Other|0|||
46970274|NCT02100514|83213273|FG004|Treatment Period|Other|0|||
46970275|NCT02100514|83213269|FG000|Extension Period|Withdrew consent|0|||
46970276|NCT02100514|83213270|FG001|Extension Period|Withdrew consent|0|||
46970277|NCT02100514|83213271|FG002|Extension Period|Withdrew consent|2|||
46970278|NCT02100514|83213272|FG003|Extension Period|Withdrew consent|0|||
46970279|NCT02100514|83213273|FG004|Extension Period|Withdrew consent|0|||
46970280|NCT02069392|83213289|FG000|Overall Study|Withdrawal by Subject|4|||
46970281|NCT02069392|83213290|FG001|Overall Study|Withdrawal by Subject|2|||
46970282|NCT02047318|83213298|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
46970283|NCT02047318|83213298|FG000|Core Study Period|Adverse Event|1|||
46970284|NCT02047318|83213298|FG000|Core Study Period|Withdrawal by caregiver|3|||
46970285|NCT02047318|83213298|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
46970286|NCT02100124|83213316|FG000|Overall Study|Lost to Follow-up|5|||
46970287|NCT02100124|83213317|FG001|Overall Study|Lost to Follow-up|11|||
46970288|NCT02100124|83213318|FG002|Overall Study|Lost to Follow-up|3|||
46970289|NCT02100124|83213316|FG000|Overall Study|Withdrawal by Subject|1|||
46970290|NCT02100124|83213317|FG001|Overall Study|Withdrawal by Subject|0|||
46970291|NCT02100124|83213318|FG002|Overall Study|Withdrawal by Subject|0|||
46970292|NCT02068768|83213326|FG000|Overall Study|Lost to Follow-up|5|||
46970293|NCT02068768|83213326|FG000|Overall Study|Early Termination by Sponsor|2|||
46970294|NCT02046616|83213330|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
46970295|NCT02046616|83213330|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
46970296|NCT02046616|83213330|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
46970297|NCT02046616|83213330|FG000|24-Week Treatment Period|Physician Decision|3|||
46970298|NCT02046616|83213330|FG000|24-Week Treatment Period|Other|1|||
46970299|NCT02046616|83213330|FG000|8-Week FU Period|Lost to Follow-up|1|||
46970300|NCT02099344|83213336|FG000|Overall Study|Physician Decision|1|||
46970301|NCT02099344|83213337|FG001|Overall Study|Physician Decision|0|||
46970302|NCT02068222|83213345|FG000|Overall Study|Lost to Follow-up|1|||
46970303|NCT02099110|83213354|FG000|Overall Study|Protocol Violation|2|||
46970304|NCT02099110|83213355|FG001|Overall Study|Protocol Violation|1|||
46970305|NCT02099110|83213356|FG002|Overall Study|Protocol Violation|0|||
46970306|NCT02099110|83213357|FG003|Overall Study|Protocol Violation|3|||
46970307|NCT02099110|83213358|FG004|Overall Study|Protocol Violation|1|||
46970308|NCT02099110|83213354|FG000|Overall Study|Participant moved|1|||
46970309|NCT02099110|83213355|FG001|Overall Study|Participant moved|1|||
46970310|NCT02099110|83213356|FG002|Overall Study|Participant moved|1|||
46970311|NCT02099110|83213357|FG003|Overall Study|Participant moved|0|||
46646520|NCT03480386|82852608|FG001|Overall Study|Complicating disease|1|||
46970312|NCT02099110|83213358|FG004|Overall Study|Participant moved|2|||
46970313|NCT02099110|83213354|FG000|Overall Study|Withdrawal by Subject|7|||
46970314|NCT02099110|83213355|FG001|Overall Study|Withdrawal by Subject|11|||
46970315|NCT02099110|83213356|FG002|Overall Study|Withdrawal by Subject|13|||
46970316|NCT02099110|83213357|FG003|Overall Study|Withdrawal by Subject|9|||
46970317|NCT02099110|83213358|FG004|Overall Study|Withdrawal by Subject|13|||
46970318|NCT02099110|83213354|FG000|Overall Study|Adverse Event|3|||
46970319|NCT02099110|83213355|FG001|Overall Study|Adverse Event|5|||
46970320|NCT02099110|83213356|FG002|Overall Study|Adverse Event|2|||
46970321|NCT02099110|83213357|FG003|Overall Study|Adverse Event|3|||
46970322|NCT02099110|83213358|FG004|Overall Study|Adverse Event|2|||
46970323|NCT02099110|83213354|FG000|Overall Study|Lost to Follow-up|6|||
46970324|NCT02099110|83213355|FG001|Overall Study|Lost to Follow-up|12|||
46646521|NCT03480386|82852607|FG000|Overall Study|Disease progression|3|||
46970325|NCT02099110|83213356|FG002|Overall Study|Lost to Follow-up|11|||
46970326|NCT02099110|83213357|FG003|Overall Study|Lost to Follow-up|5|||
46970327|NCT02099110|83213358|FG004|Overall Study|Lost to Follow-up|6|||
46970328|NCT02099110|83213354|FG000|Overall Study|Death|0|||
46970329|NCT02099110|83213355|FG001|Overall Study|Death|1|||
46970330|NCT02099110|83213356|FG002|Overall Study|Death|0|||
46970331|NCT02099110|83213357|FG003|Overall Study|Death|0|||
46970332|NCT02099110|83213358|FG004|Overall Study|Death|0|||
46970333|NCT02099110|83213354|FG000|Overall Study|Screen failure|0|||
46970334|NCT02099110|83213355|FG001|Overall Study|Screen failure|0|||
46970335|NCT02099110|83213356|FG002|Overall Study|Screen failure|0|||
46970336|NCT02099110|83213357|FG003|Overall Study|Screen failure|0|||
46970337|NCT02099110|83213358|FG004|Overall Study|Screen failure|1|||
46646522|NCT03480386|82852608|FG001|Overall Study|Disease progression|0|||
46646523|NCT03480386|82852607|FG000|Overall Study|Became ineligible|0|||
46646524|NCT03480386|82852608|FG001|Overall Study|Became ineligible|2|||
46646525|NCT03476343|82852614|FG000|Overall Study|Clinical exam moved to another scanner|7|||
46646526|NCT03476343|82852614|FG000|Overall Study|Clinical order cancelled|4|||
46646527|NCT03476343|82852614|FG000|Overall Study|Neonate did not settle down for the scan|1|||
46646528|NCT03412591|82852620|FG000|Overall Study|Withdrawal by Subject|1|||
46646529|NCT03412591|82852621|FG001|Overall Study|Withdrawal by Subject|8|||
46646530|NCT03412591|82852620|FG000|Overall Study|Adverse Event|0|||
46646531|NCT03412591|82852621|FG001|Overall Study|Adverse Event|1|||
46646532|NCT03389477|82852629|FG000|Step 1|Withdrawal by Subject|1|||
46646533|NCT03389477|82852630|FG001|Step 1|Withdrawal by Subject|0|||
46646534|NCT03389477|82852629|FG000|Step 2|Withdrawal by Subject|1|||
46646535|NCT03389477|82852630|FG001|Step 2|Withdrawal by Subject|2|||
46646536|NCT03389477|82852629|FG000|Step 2|Disease progression|1|||
46646537|NCT03389477|82852630|FG001|Step 2|Disease progression|0|||
46646538|NCT03389477|82852629|FG000|Step 2|Death|0|||
46646539|NCT03389477|82852630|FG001|Step 2|Death|1|||
46646540|NCT03389477|82852629|FG000|Step 2|Poor performance status and nutrition|0|||
46646541|NCT03389477|82852630|FG001|Step 2|Poor performance status and nutrition|1|||
46646542|NCT03389477|82852629|FG000|Step 3|Withdrawal after 3 cycles|0|||
46646543|NCT03389477|82852630|FG001|Step 3|Withdrawal after 3 cycles|1|||
46646544|NCT03389477|82852629|FG000|Step 3|Still receiving active treatment|4|||
46646545|NCT03389477|82852630|FG001|Step 3|Still receiving active treatment|0|||
46646546|NCT03389477|82852629|FG000|Step 3|Progressive disease after 2 cycles|1|||
46646547|NCT03389477|82852630|FG001|Step 3|Progressive disease after 2 cycles|0|||
46646548|NCT03289039|82852640|FG000|Overall Study|Withdrawal by Subject|0|||
46646549|NCT03289039|82852641|FG001|Overall Study|Withdrawal by Subject|1|||
46646550|NCT03289039|82852640|FG000|Overall Study|Became ineligible prior to treatment start|0|||
46646551|NCT03289039|82852641|FG001|Overall Study|Became ineligible prior to treatment start|1|||
46646552|NCT03289039|82852640|FG000|Overall Study|progressed before treatment start|1|||
46646553|NCT03289039|82852641|FG001|Overall Study|progressed before treatment start|0|||
46646554|NCT03275402|82852647|FG000|Overall Study|Death|17|||
46646555|NCT03275402|82852647|FG000|Overall Study|Study terminated by sponsor|21|||
46646556|NCT03275402|82852647|FG000|Overall Study|Withdrawal by Subject|1|||
46646557|NCT02864953|82852676|FG000|Overall Study|Adverse Event|22|||
46646558|NCT02864953|82852677|FG001|Overall Study|Adverse Event|19|||
46646559|NCT02864953|82852676|FG000|Overall Study|Withdrawal by Subject|1|||
46646560|NCT02864953|82852677|FG001|Overall Study|Withdrawal by Subject|0|||
46646561|NCT02864953|82852676|FG000|Overall Study|Physician Decision|4|||
46646562|NCT02864953|82852677|FG001|Overall Study|Physician Decision|2|||
46646563|NCT02864953|82852676|FG000|Overall Study|Death|3|||
46646564|NCT02864953|82852677|FG001|Overall Study|Death|13|||
46646565|NCT02864953|82852676|FG000|Overall Study|Reason not specified|14|||
46646566|NCT02864953|82852677|FG001|Overall Study|Reason not specified|12|||
46646567|NCT02864953|82852676|FG000|Overall Study|Withdrew Prior to Dosing|9|||
46646568|NCT02864953|82852677|FG001|Overall Study|Withdrew Prior to Dosing|8|||
46646569|NCT02829918|82852683|FG000|Overall Study|Death|2|||
46646570|NCT02829918|82852683|FG000|Overall Study|Withdrawal by Subject|4|||
46646571|NCT02829918|82852683|FG000|Overall Study|Adverse Event|1|||
46646572|NCT02829918|82852683|FG000|Overall Study|Progression|1|||
46646573|NCT02512965|82852715|FG000|Overall Study|Withdrawal by Subject|0|||
46646574|NCT02512965|82852716|FG001|Overall Study|Withdrawal by Subject|4|||
46646575|NCT02456857|82852731|FG000|Overall Study|Disease Progression|4|||
46646576|NCT02435849|82852737|FG000|Overall Study|Death|23|||
46646577|NCT02435849|82852738|FG001|Overall Study|Death|0|||
46646578|NCT02435849|82852737|FG000|Overall Study|Lack of Efficacy|10|||
46646579|NCT02435849|82852738|FG001|Overall Study|Lack of Efficacy|0|||
47074892|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
47074893|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
47074894|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
47074895|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
47074896|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
46646580|NCT02435849|82852737|FG000|Overall Study|New therapy for study indication|8|||
46646581|NCT02435849|82852738|FG001|Overall Study|New therapy for study indication|0|||
46646582|NCT02435849|82852737|FG000|Overall Study|Subject/guardian decision|5|||
46646583|NCT02435849|82852738|FG001|Overall Study|Subject/guardian decision|1|||
47074897|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
46646584|NCT02435849|82852737|FG000|Overall Study|Lost to Follow-up|1|||
46646585|NCT02435849|82852738|FG001|Overall Study|Lost to Follow-up|0|||
46780019|NCT00612586|82998773|FG001|Overall Study|Withdrawal by Subject|9|||
46646586|NCT02435849|82852737|FG000|Overall Study|Physician Decision|1|||
46646587|NCT02435849|82852738|FG001|Overall Study|Physician Decision|0|||
46646588|NCT02197234|82852744|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
46646589|NCT02197234|82852744|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
46780020|NCT00612586|82998772|FG000|Overall Study|Physician Decision|1|||
46646590|NCT02197234|82852744|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
46646591|NCT02197234|82852744|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
46646592|NCT02197234|82852744|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
46646593|NCT02197234|82852744|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
46646594|NCT02197234|82852744|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
46646595|NCT02152631|82852753|FG000|Overall Study|Adverse Event|32|||
46646596|NCT02152631|82852754|FG001|Overall Study|Adverse Event|4|||
46646597|NCT02152631|82852753|FG000|Overall Study|Withdrawal by Subject|13|||
46646598|NCT02152631|82852754|FG001|Overall Study|Withdrawal by Subject|16|||
46646599|NCT02152631|82852753|FG000|Overall Study|Noncompliance with study drug|1|||
46646600|NCT02152631|82852754|FG001|Overall Study|Noncompliance with study drug|0|||
46646601|NCT02152631|82852753|FG000|Overall Study|Physician Decision|1|||
46646602|NCT02152631|82852754|FG001|Overall Study|Physician Decision|2|||
46646603|NCT02152631|82852753|FG000|Overall Study|Lost to Follow-up|0|||
46646604|NCT02152631|82852754|FG001|Overall Study|Lost to Follow-up|1|||
46646605|NCT02152631|82852753|FG000|Overall Study|On Treatment|19|||
46646606|NCT02152631|82852754|FG001|Overall Study|On Treatment|3|||
46646607|NCT02075840|82852762|FG000|Overall Study|Withdrawal by Subject|13|||
46646608|NCT02075840|82852763|FG001|Overall Study|Withdrawal by Subject|22|||
46646609|NCT02075840|82852762|FG000|Overall Study|Reason not specified|1|||
46646610|NCT02075840|82852763|FG001|Overall Study|Reason not specified|0|||
46646611|NCT02075840|82852762|FG000|Overall Study|Adverse Event|0|||
46646612|NCT02075840|82852763|FG001|Overall Study|Adverse Event|2|||
46646613|NCT02075840|82852762|FG000|Overall Study|Death|35|||
46646614|NCT02075840|82852763|FG001|Overall Study|Death|40|||
46646615|NCT02075840|82852762|FG000|Overall Study|Lost to Follow-up|3|||
46646616|NCT02075840|82852763|FG001|Overall Study|Lost to Follow-up|2|||
46646617|NCT02075840|82852762|FG000|Overall Study|Physician Decision|1|||
46646618|NCT02075840|82852763|FG001|Overall Study|Physician Decision|3|||
46646619|NCT02075840|82852762|FG000|Overall Study|Ongoing at CCOD|99|||
46646620|NCT02075840|82852763|FG001|Overall Study|Ongoing at CCOD|82|||
46646621|NCT02048813|82852771|FG000|Overall Study|Still on treatment|279|||
46646622|NCT02048813|82852772|FG001|Overall Study|Still on treatment|0|||
46646623|NCT02048813|82852771|FG000|Overall Study|Adverse Event|40|||
46646624|NCT02048813|82852772|FG001|Overall Study|Adverse Event|38|||
46780021|NCT00612586|82998773|FG001|Overall Study|Physician Decision|2|||
46780022|NCT00612586|82998772|FG000|Overall Study|Sponsor Decision|1|||
47074898|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
47074899|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
47074900|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
47074901|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
47074902|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
47074903|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
47074904|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
47074905|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
47074906|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
47074907|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
47074908|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
47074909|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
47074910|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
47074911|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
47074912|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
47074913|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
47074914|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
47074915|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
47074916|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
46646625|NCT02048813|82852771|FG000|Overall Study|Disease progression|13|||
46646626|NCT02048813|82852772|FG001|Overall Study|Disease progression|3|||
46646627|NCT02048813|82852771|FG000|Overall Study|Withdrawal by Subject|7|||
46646628|NCT02048813|82852772|FG001|Overall Study|Withdrawal by Subject|8|||
46646629|NCT02048813|82852771|FG000|Overall Study|Death|2|||
46780023|NCT00612586|82998773|FG001|Overall Study|Sponsor Decision|1|||
46780024|NCT00612586|82998772|FG000|Overall Study|Progressive Disease|26|||
46646630|NCT02048813|82852772|FG001|Overall Study|Death|1|||
46646631|NCT02048813|82852771|FG000|Overall Study|Complication|2|||
46646632|NCT02048813|82852772|FG001|Overall Study|Complication|2|||
46646633|NCT02048813|82852771|FG000|Overall Study|Non-protocol therapy|0|||
46646634|NCT02048813|82852772|FG001|Overall Study|Non-protocol therapy|1|||
46646635|NCT02048813|82852771|FG000|Overall Study|Second primary cancer|2|||
46646636|NCT02048813|82852772|FG001|Overall Study|Second primary cancer|0|||
46646637|NCT02048813|82852771|FG000|Overall Study|Insurance|2|||
46646638|NCT02048813|82852772|FG001|Overall Study|Insurance|0|||
46646639|NCT02048813|82852771|FG000|Overall Study|Wound infection/healing|2|||
46646640|NCT02048813|82852772|FG001|Overall Study|Wound infection/healing|0|||
46646641|NCT02048813|82852771|FG000|Overall Study|Missed appointment|3|||
46646642|NCT02048813|82852772|FG001|Overall Study|Missed appointment|0|||
46646643|NCT02048813|82852771|FG000|Overall Study|Never started treatment|2|||
46646644|NCT02048813|82852772|FG001|Overall Study|Never started treatment|17|||
46646645|NCT05776901|82852813|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
46646646|NCT05344560|82852817|FG000|Period 1|Subject out of visit window|1|||
46646647|NCT05344560|82852818|FG001|Period 1|Subject out of visit window|1|||
46646648|NCT05344560|82852817|FG000|Period 2|Covid-19 Related|1|||
46646649|NCT05344560|82852818|FG001|Period 2|Covid-19 Related|0|||
46646650|NCT05344560|82852817|FG000|Period 2|Adverse Event|1|||
46646651|NCT05344560|82852818|FG001|Period 2|Adverse Event|0|||
46646652|NCT05344560|82852817|FG000|Period 2|Subject out of visit window|1|||
46646653|NCT05344560|82852818|FG001|Period 2|Subject out of visit window|1|||
46646654|NCT05344560|82852817|FG000|Period 3|Subject out of visit window|1|||
46646655|NCT05344560|82852818|FG001|Period 3|Subject out of visit window|0|||
46646656|NCT05024058|82852838|FG000|Treatment|Study terminated by sponsor|5|||
46646657|NCT05024058|82852839|FG001|Treatment|Study terminated by sponsor|6|||
46646658|NCT05024058|82852840|FG002|Treatment|Study terminated by sponsor|4|||
46646659|NCT05024058|82852841|FG003|Treatment|Study terminated by sponsor|2|||
46646660|NCT05024058|82852842|FG004|Treatment|Study terminated by sponsor|3|||
46646661|NCT05024058|82852843|FG005|Treatment|Study terminated by sponsor|3|||
46646662|NCT05024058|82852844|FG006|Treatment|Study terminated by sponsor|1|||
46646663|NCT05024058|82852845|FG007|Treatment|Study terminated by sponsor|3|||
46646664|NCT05024058|82852846|FG008|Treatment|Study terminated by sponsor|6|||
46646665|NCT05024058|82852847|FG009|Treatment|Study terminated by sponsor|6|||
46646666|NCT05024058|82852838|FG000|Follow-up|Withdrawal by Subject|1|||
46646667|NCT05024058|82852839|FG001|Follow-up|Withdrawal by Subject|0|||
46646668|NCT05024058|82852840|FG002|Follow-up|Withdrawal by Subject|1|||
46646669|NCT05024058|82852841|FG003|Follow-up|Withdrawal by Subject|0|||
46646670|NCT05024058|82852842|FG004|Follow-up|Withdrawal by Subject|0|||
46646671|NCT05024058|82852843|FG005|Follow-up|Withdrawal by Subject|0|||
46646672|NCT05024058|82852844|FG006|Follow-up|Withdrawal by Subject|0|||
46646673|NCT05024058|82852845|FG007|Follow-up|Withdrawal by Subject|1|||
46646674|NCT05024058|82852846|FG008|Follow-up|Withdrawal by Subject|0|||
46646675|NCT05024058|82852847|FG009|Follow-up|Withdrawal by Subject|1|||
46646676|NCT05013008|82852870|FG000|Overall Study|Exclusion from mBFAS|5|||
46646677|NCT05013008|82852871|FG001|Overall Study|Exclusion from mBFAS|25|||
46646678|NCT04826900|82852879|FG000|Overall Study|Family factor|1|||
46646679|NCT04826900|82852880|FG001|Overall Study|Family factor|1|||
46646680|NCT04721158|82852886|FG000|Overall Study|Lost to Follow-up|4|||
46646681|NCT04721158|82852886|FG000|Overall Study|Device did not connect|1|||
46646682|NCT04263766|82852893|FG000|Overall Study|Withdrawal by Subject|6|||
46646683|NCT04263766|82852894|FG001|Overall Study|Withdrawal by Subject|4|||
46646684|NCT04263766|82852893|FG000|Overall Study|Lack of Efficacy|1|||
46646685|NCT04263766|82852894|FG001|Overall Study|Lack of Efficacy|3|||
46646686|NCT04203199|82852916|FG000|First Intervention Period|Lost to Follow-up|0|||
46646687|NCT04203199|82852917|FG001|First Intervention Period|Lost to Follow-up|1|||
46646688|NCT04203199|82852916|FG000|Second Intervention Period|Medication change|1|||
46646689|NCT04203199|82852917|FG001|Second Intervention Period|Medication change|0|||
46646690|NCT04191733|82852925|FG000|Overall Study|Withdrawn due to study closure|13|||
46646691|NCT04191733|82852926|FG001|Overall Study|Withdrawn due to study closure|14|||
46646692|NCT04191733|82852925|FG000|Overall Study|Withdrawal by Subject|2|||
46646693|NCT04191733|82852926|FG001|Overall Study|Withdrawal by Subject|4|||
46646694|NCT04191733|82852925|FG000|Overall Study|Physician Decision|1|||
46646695|NCT04191733|82852926|FG001|Overall Study|Physician Decision|1|||
46646696|NCT04191733|82852925|FG000|Overall Study|Lost to Follow-up|5|||
46646697|NCT04191733|82852926|FG001|Overall Study|Lost to Follow-up|6|||
46646698|NCT04191733|82852925|FG000|Overall Study|Death|0|||
46646699|NCT04191733|82852926|FG001|Overall Study|Death|1|||
46646700|NCT04049097|82852932|FG000|Overall Study|Adverse Event|18|||
46646701|NCT04049097|82852932|FG000|Overall Study|Death|2|||
46646702|NCT04049097|82852932|FG000|Overall Study|Lost to Follow-up|1|||
46646703|NCT04049097|82852932|FG000|Overall Study|Physician Decision|2|||
46646704|NCT04049097|82852932|FG000|Overall Study|Withdrawal by Subject|9|||
46646705|NCT04049097|82852932|FG000|Overall Study|Protocol Violation|2|||
46646706|NCT04049097|82852932|FG000|Overall Study|Other|1|||
46646707|NCT04049097|82852932|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
46646708|NCT04002310|82852941|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
46646709|NCT04002310|82852942|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
46646710|NCT04002310|82852943|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
46646711|NCT04002310|82852944|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
46646712|NCT04002310|82852945|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
46646713|NCT03887650|82852968|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
46646714|NCT03887650|82852969|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
46646715|NCT03887650|82852968|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
46646716|NCT03887650|82852969|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
46646717|NCT03887650|82852968|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
46646718|NCT03887650|82852969|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
46646719|NCT03345342|82853007|FG000|Open-Label Phase|Adverse Event|30|||
46646720|NCT03345342|82853008|FG001|Open-Label Phase|Adverse Event|0|||
46646721|NCT03345342|82853009|FG002|Open-Label Phase|Adverse Event|0|||
46646722|NCT03345342|82853010|FG003|Open-Label Phase|Adverse Event|0|||
46646723|NCT03345342|82853011|FG004|Open-Label Phase|Adverse Event|0|||
46646724|NCT03345342|82853007|FG000|Open-Label Phase|Death|1|||
46646725|NCT03345342|82853008|FG001|Open-Label Phase|Death|0|||
46646726|NCT03345342|82853009|FG002|Open-Label Phase|Death|0|||
46646727|NCT03345342|82853010|FG003|Open-Label Phase|Death|0|||
46646728|NCT03345342|82853011|FG004|Open-Label Phase|Death|0|||
46646729|NCT03345342|82853007|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
46646730|NCT03345342|82853008|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
46646731|NCT03345342|82853009|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
46646732|NCT03345342|82853010|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
46646733|NCT03345342|82853011|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
46646734|NCT03345342|82853007|FG000|Open-Label Phase|Lack of Efficacy|6|||
46646735|NCT03345342|82853008|FG001|Open-Label Phase|Lack of Efficacy|0|||
46646736|NCT03345342|82853009|FG002|Open-Label Phase|Lack of Efficacy|0|||
46646737|NCT03345342|82853010|FG003|Open-Label Phase|Lack of Efficacy|0|||
46646738|NCT03345342|82853011|FG004|Open-Label Phase|Lack of Efficacy|0|||
46646739|NCT03345342|82853007|FG000|Open-Label Phase|Lost to Follow-up|9|||
46646740|NCT03345342|82853008|FG001|Open-Label Phase|Lost to Follow-up|0|||
46646741|NCT03345342|82853009|FG002|Open-Label Phase|Lost to Follow-up|0|||
46646742|NCT03345342|82853010|FG003|Open-Label Phase|Lost to Follow-up|0|||
46646743|NCT03345342|82853011|FG004|Open-Label Phase|Lost to Follow-up|0|||
46646744|NCT03345342|82853007|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
46646745|NCT03345342|82853008|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
46646746|NCT03345342|82853009|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
46646747|NCT03345342|82853010|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
46646748|NCT03345342|82853011|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
46646749|NCT03345342|82853007|FG000|Open-Label Phase|Physician Decision|4|||
46646750|NCT03345342|82853008|FG001|Open-Label Phase|Physician Decision|0|||
46646751|NCT03345342|82853009|FG002|Open-Label Phase|Physician Decision|0|||
46646752|NCT03345342|82853010|FG003|Open-Label Phase|Physician Decision|0|||
46646753|NCT03345342|82853011|FG004|Open-Label Phase|Physician Decision|0|||
46646754|NCT03345342|82853007|FG000|Open-Label Phase|Protocol Violation|8|||
46646755|NCT03345342|82853008|FG001|Open-Label Phase|Protocol Violation|0|||
46646756|NCT03345342|82853009|FG002|Open-Label Phase|Protocol Violation|0|||
46646757|NCT03345342|82853010|FG003|Open-Label Phase|Protocol Violation|0|||
46646758|NCT03345342|82853011|FG004|Open-Label Phase|Protocol Violation|0|||
46646759|NCT03345342|82853007|FG000|Open-Label Phase|Withdrawal by Subject|57|||
46646760|NCT03345342|82853008|FG001|Open-Label Phase|Withdrawal by Subject|0|||
47074917|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
47074918|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
47074919|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
47074920|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
47074921|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
47074922|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
47074923|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
47074924|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
47074925|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
47074926|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
47074927|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
47074928|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
46646761|NCT03345342|82853009|FG002|Open-Label Phase|Withdrawal by Subject|0|||
46646762|NCT03345342|82853010|FG003|Open-Label Phase|Withdrawal by Subject|0|||
47074929|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
46646763|NCT03345342|82853011|FG004|Open-Label Phase|Withdrawal by Subject|0|||
46646764|NCT03345342|82853007|FG000|Open-Label Phase|Other|15|||
46646765|NCT03345342|82853008|FG001|Open-Label Phase|Other|0|||
46646766|NCT03345342|82853009|FG002|Open-Label Phase|Other|0|||
46646767|NCT03345342|82853010|FG003|Open-Label Phase|Other|0|||
46646768|NCT03345342|82853011|FG004|Open-Label Phase|Other|0|||
46646769|NCT03345342|82853007|FG000|Double-Blind Phase|Adverse Event|0|||
46646770|NCT03345342|82853008|FG001|Double-Blind Phase|Adverse Event|1|||
46646771|NCT03345342|82853009|FG002|Double-Blind Phase|Adverse Event|6|||
46646772|NCT03345342|82853010|FG003|Double-Blind Phase|Adverse Event|0|||
46646773|NCT03345342|82853011|FG004|Double-Blind Phase|Adverse Event|0|||
46646774|NCT03345342|82853007|FG000|Double-Blind Phase|Death|0|||
46646775|NCT03345342|82853008|FG001|Double-Blind Phase|Death|2|||
46646776|NCT03345342|82853009|FG002|Double-Blind Phase|Death|1|||
46646777|NCT03345342|82853010|FG003|Double-Blind Phase|Death|0|||
46646778|NCT03345342|82853011|FG004|Double-Blind Phase|Death|0|||
46646779|NCT03345342|82853007|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
46646780|NCT03345342|82853008|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
46646781|NCT03345342|82853009|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
46646782|NCT03345342|82853010|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
46646783|NCT03345342|82853011|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
46646784|NCT03345342|82853007|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46646785|NCT03345342|82853008|FG001|Double-Blind Phase|Lost to Follow-up|1|||
46646786|NCT03345342|82853009|FG002|Double-Blind Phase|Lost to Follow-up|7|||
46646787|NCT03345342|82853010|FG003|Double-Blind Phase|Lost to Follow-up|0|||
46646788|NCT03345342|82853011|FG004|Double-Blind Phase|Lost to Follow-up|0|||
46646789|NCT03345342|82853007|FG000|Double-Blind Phase|Physician Decision|0|||
46646790|NCT03345342|82853008|FG001|Double-Blind Phase|Physician Decision|1|||
46646791|NCT03345342|82853009|FG002|Double-Blind Phase|Physician Decision|4|||
46646792|NCT03345342|82853010|FG003|Double-Blind Phase|Physician Decision|0|||
46646793|NCT03345342|82853011|FG004|Double-Blind Phase|Physician Decision|0|||
46646794|NCT03345342|82853007|FG000|Double-Blind Phase|Protocol Violation|0|||
46646795|NCT03345342|82853008|FG001|Double-Blind Phase|Protocol Violation|0|||
46646796|NCT03345342|82853009|FG002|Double-Blind Phase|Protocol Violation|1|||
46646797|NCT03345342|82853010|FG003|Double-Blind Phase|Protocol Violation|0|||
46646798|NCT03345342|82853011|FG004|Double-Blind Phase|Protocol Violation|0|||
46646799|NCT03345342|82853007|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
46646800|NCT03345342|82853008|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
46646801|NCT03345342|82853009|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
46646802|NCT03345342|82853010|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
46646803|NCT03345342|82853011|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
46646804|NCT03345342|82853007|FG000|Double-Blind Phase|Other|0|||
46780025|NCT00612586|82998773|FG001|Overall Study|Progressive Disease|24|||
46780026|NCT00612586|82998772|FG000|Overall Study|Randomized and Not Treated|1|||
46780027|NCT00612586|82998773|FG001|Overall Study|Randomized and Not Treated|1|||
47074930|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074931|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074932|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074933|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
46646805|NCT03345342|82853008|FG001|Double-Blind Phase|Other|1|||
46646806|NCT03345342|82853009|FG002|Double-Blind Phase|Other|3|||
46646807|NCT03345342|82853010|FG003|Double-Blind Phase|Other|0|||
46646808|NCT03345342|82853011|FG004|Double-Blind Phase|Other|0|||
46646809|NCT03345342|82853007|FG000|Follow-Up Phase|Adverse Event|0|||
46646810|NCT03345342|82853008|FG001|Follow-Up Phase|Adverse Event|0|||
46646811|NCT03345342|82853009|FG002|Follow-Up Phase|Adverse Event|0|||
46646812|NCT03345342|82853010|FG003|Follow-Up Phase|Adverse Event|0|||
46646813|NCT03345342|82853011|FG004|Follow-Up Phase|Adverse Event|4|||
46646814|NCT03345342|82853007|FG000|Follow-Up Phase|Lost to Follow-up|0|||
46646815|NCT03345342|82853008|FG001|Follow-Up Phase|Lost to Follow-up|0|||
46646816|NCT03345342|82853009|FG002|Follow-Up Phase|Lost to Follow-up|0|||
46646817|NCT03345342|82853010|FG003|Follow-Up Phase|Lost to Follow-up|0|||
46646818|NCT03345342|82853011|FG004|Follow-Up Phase|Lost to Follow-up|6|||
46646819|NCT03345342|82853007|FG000|Follow-Up Phase|Physician Decision|0|||
46646820|NCT03345342|82853008|FG001|Follow-Up Phase|Physician Decision|0|||
46646821|NCT03345342|82853009|FG002|Follow-Up Phase|Physician Decision|0|||
46646822|NCT03345342|82853010|FG003|Follow-Up Phase|Physician Decision|0|||
46646823|NCT03345342|82853011|FG004|Follow-Up Phase|Physician Decision|5|||
46646824|NCT03345342|82853007|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
46646825|NCT03345342|82853008|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
46646826|NCT03345342|82853009|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
46646827|NCT03345342|82853010|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
46646828|NCT03345342|82853011|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
46646829|NCT03345342|82853007|FG000|Follow-Up Phase|Other|0|||
46780028|NCT00614380|82998784|FG000|Overall Study|Adverse Event|14|||
46646830|NCT03345342|82853008|FG001|Follow-Up Phase|Other|0|||
46646831|NCT03345342|82853009|FG002|Follow-Up Phase|Other|0|||
46646832|NCT03345342|82853010|FG003|Follow-Up Phase|Other|3|||
46646833|NCT03345342|82853011|FG004|Follow-Up Phase|Other|1|||
46780029|NCT00614380|82998785|FG001|Overall Study|Adverse Event|4|||
46780030|NCT00614380|82998786|FG002|Overall Study|Adverse Event|0|||
46646834|NCT03192176|82853035|FG000|Overall Study|Adverse Event|1|||
46646835|NCT03192176|82853036|FG001|Overall Study|Adverse Event|0|||
46646836|NCT03192176|82853037|FG002|Overall Study|Adverse Event|4|||
46646837|NCT03192176|82853038|FG003|Overall Study|Adverse Event|5|||
46646838|NCT03192176|82853039|FG004|Overall Study|Adverse Event|3|||
46646839|NCT03192176|82853040|FG005|Overall Study|Adverse Event|2|||
46646840|NCT03192176|82853041|FG006|Overall Study|Adverse Event|3|||
46646841|NCT03192176|82853042|FG007|Overall Study|Adverse Event|3|||
46646842|NCT03192176|82853035|FG000|Overall Study|Lost to Follow-up|0|||
46646843|NCT03192176|82853036|FG001|Overall Study|Lost to Follow-up|0|||
46646844|NCT03192176|82853037|FG002|Overall Study|Lost to Follow-up|1|||
46646845|NCT03192176|82853038|FG003|Overall Study|Lost to Follow-up|2|||
46646846|NCT03192176|82853039|FG004|Overall Study|Lost to Follow-up|3|||
46646847|NCT03192176|82853040|FG005|Overall Study|Lost to Follow-up|1|||
46646848|NCT03192176|82853041|FG006|Overall Study|Lost to Follow-up|1|||
46646849|NCT03192176|82853042|FG007|Overall Study|Lost to Follow-up|1|||
46646850|NCT03192176|82853035|FG000|Overall Study|Physician Decision|1|||
46646851|NCT03192176|82853036|FG001|Overall Study|Physician Decision|0|||
46646852|NCT03192176|82853037|FG002|Overall Study|Physician Decision|0|||
46646853|NCT03192176|82853038|FG003|Overall Study|Physician Decision|0|||
46646854|NCT03192176|82853039|FG004|Overall Study|Physician Decision|0|||
46646855|NCT03192176|82853040|FG005|Overall Study|Physician Decision|2|||
46646856|NCT03192176|82853041|FG006|Overall Study|Physician Decision|1|||
46646857|NCT03192176|82853042|FG007|Overall Study|Physician Decision|0|||
46646858|NCT03192176|82853035|FG000|Overall Study|Protocol Deviation|1|||
46646859|NCT03192176|82853036|FG001|Overall Study|Protocol Deviation|1|||
46646860|NCT03192176|82853037|FG002|Overall Study|Protocol Deviation|0|||
46646861|NCT03192176|82853038|FG003|Overall Study|Protocol Deviation|0|||
46646862|NCT03192176|82853039|FG004|Overall Study|Protocol Deviation|2|||
46646863|NCT03192176|82853040|FG005|Overall Study|Protocol Deviation|0|||
46646864|NCT03192176|82853041|FG006|Overall Study|Protocol Deviation|0|||
46646865|NCT03192176|82853042|FG007|Overall Study|Protocol Deviation|0|||
46646866|NCT03192176|82853035|FG000|Overall Study|Withdrawal by Subject|3|||
46646867|NCT03192176|82853036|FG001|Overall Study|Withdrawal by Subject|4|||
46646868|NCT03192176|82853037|FG002|Overall Study|Withdrawal by Subject|0|||
46646869|NCT03192176|82853038|FG003|Overall Study|Withdrawal by Subject|4|||
46646870|NCT03192176|82853039|FG004|Overall Study|Withdrawal by Subject|3|||
46646871|NCT03192176|82853040|FG005|Overall Study|Withdrawal by Subject|4|||
46646872|NCT03192176|82853041|FG006|Overall Study|Withdrawal by Subject|4|||
46646873|NCT03192176|82853042|FG007|Overall Study|Withdrawal by Subject|2|||
46646874|NCT03192176|82853035|FG000|Overall Study|Miscellaneous|1|||
46646875|NCT03192176|82853036|FG001|Overall Study|Miscellaneous|0|||
46646876|NCT03192176|82853037|FG002|Overall Study|Miscellaneous|1|||
46646877|NCT03192176|82853038|FG003|Overall Study|Miscellaneous|1|||
46646878|NCT03192176|82853039|FG004|Overall Study|Miscellaneous|1|||
46646879|NCT03192176|82853040|FG005|Overall Study|Miscellaneous|2|||
46646880|NCT03192176|82853041|FG006|Overall Study|Miscellaneous|0|||
46646881|NCT03192176|82853042|FG007|Overall Study|Miscellaneous|1|||
46646882|NCT02531594|82853071|FG000|Overall Study|Withdrawal by Subject|7|||
46646883|NCT02531594|82853072|FG001|Overall Study|Withdrawal by Subject|8|||
46646884|NCT02365467|82853087|FG000|Overall Study|Death|3|||
46646885|NCT01256593|82853100|FG000|Overall Study|Protocol Violation|26|||
46646886|NCT01256593|82853100|FG000|Overall Study|No Drug Administration Information|2|||
46646887|NCT01256593|82853100|FG000|Overall Study|No Visit After Treatment|186|||
46646888|NCT00562640|82853118|FG000|Overall Study|Death|0|||
46780031|NCT00614380|82998787|FG003|Overall Study|Adverse Event|0|||
47074934|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074935|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074936|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074937|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074938|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074939|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074940|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
47074941|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074942|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074943|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
46780032|NCT00614380|82998784|FG000|Overall Study|Lost to Follow-up|6|||
46646889|NCT00562640|82853119|FG001|Overall Study|Death|1|||
46646890|NCT00562640|82853120|FG002|Overall Study|Death|1|||
46646891|NCT00562640|82853121|FG003|Overall Study|Death|0|||
46646892|NCT04554394|82853146|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
46646893|NCT04554394|82853147|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
46646894|NCT04554394|82853146|FG000|Overall Study|Withdrawal by Subject|2|||
46646895|NCT04554394|82853147|FG001|Overall Study|Withdrawal by Subject|2|||
46646896|NCT04554394|82853146|FG000|Overall Study|Lost to Follow-up|2|||
46646897|NCT04554394|82853147|FG001|Overall Study|Lost to Follow-up|2|||
46646898|NCT04554394|82853146|FG000|Overall Study|Physician Decision|1|||
46646899|NCT04554394|82853147|FG001|Overall Study|Physician Decision|1|||
46646900|NCT04518410|82853177|FG000|Overall Study|Lost to Follow-up|1|||
46646901|NCT04518410|82853178|FG001|Overall Study|Lost to Follow-up|1|||
46646902|NCT04518410|82853179|FG002|Overall Study|Lost to Follow-up|8|||
46646903|NCT04518410|82853180|FG003|Overall Study|Lost to Follow-up|5|||
46646904|NCT04518410|82853181|FG004|Overall Study|Lost to Follow-up|92|||
46646905|NCT04518410|82853182|FG005|Overall Study|Lost to Follow-up|27|||
46646906|NCT04518410|82853183|FG006|Overall Study|Lost to Follow-up|26|||
46646907|NCT04518410|82853184|FG007|Overall Study|Lost to Follow-up|3|||
46646908|NCT04518410|82853185|FG008|Overall Study|Lost to Follow-up|2|||
46646909|NCT04518410|82853186|FG009|Overall Study|Lost to Follow-up|15|||
46646910|NCT04518410|82853187|FG010|Overall Study|Lost to Follow-up|9|||
46646911|NCT04518410|82853188|FG011|Overall Study|Lost to Follow-up|13|||
46646912|NCT04518410|82853189|FG012|Overall Study|Lost to Follow-up|9|||
46646913|NCT04518410|82853190|FG013|Overall Study|Lost to Follow-up|14|||
46646914|NCT04518410|82853191|FG014|Overall Study|Lost to Follow-up|8|||
46646915|NCT04518410|82853192|FG015|Overall Study|Lost to Follow-up|10|||
46646916|NCT04518410|82853193|FG016|Overall Study|Lost to Follow-up|6|||
46646917|NCT04518410|82853194|FG017|Overall Study|Lost to Follow-up|8|||
46646918|NCT04518410|82853195|FG018|Overall Study|Lost to Follow-up|20|||
46646919|NCT04518410|82853196|FG019|Overall Study|Lost to Follow-up|6|||
46646920|NCT04518410|82853197|FG020|Overall Study|Lost to Follow-up|4|||
46646921|NCT04518410|82853198|FG021|Overall Study|Lost to Follow-up|22|||
46646922|NCT04518410|82853199|FG022|Overall Study|Lost to Follow-up|1|||
46646923|NCT04518410|82853200|FG023|Overall Study|Lost to Follow-up|7|||
46646924|NCT04518410|82853201|FG024|Overall Study|Lost to Follow-up|6|||
46646925|NCT04518410|82853177|FG000|Overall Study|Withdrawal by Subject|1|||
46646926|NCT04518410|82853178|FG001|Overall Study|Withdrawal by Subject|2|||
46646927|NCT04518410|82853179|FG002|Overall Study|Withdrawal by Subject|2|||
46646928|NCT04518410|82853180|FG003|Overall Study|Withdrawal by Subject|3|||
46646929|NCT04518410|82853181|FG004|Overall Study|Withdrawal by Subject|20|||
46646930|NCT04518410|82853182|FG005|Overall Study|Withdrawal by Subject|21|||
46646931|NCT04518410|82853183|FG006|Overall Study|Withdrawal by Subject|27|||
46646932|NCT04518410|82853184|FG007|Overall Study|Withdrawal by Subject|6|||
46646933|NCT04518410|82853185|FG008|Overall Study|Withdrawal by Subject|2|||
46646934|NCT04518410|82853186|FG009|Overall Study|Withdrawal by Subject|12|||
46646935|NCT04518410|82853187|FG010|Overall Study|Withdrawal by Subject|6|||
46646936|NCT04518410|82853188|FG011|Overall Study|Withdrawal by Subject|7|||
46646937|NCT04518410|82853189|FG012|Overall Study|Withdrawal by Subject|2|||
46646938|NCT04518410|82853190|FG013|Overall Study|Withdrawal by Subject|13|||
46646939|NCT04518410|82853191|FG014|Overall Study|Withdrawal by Subject|4|||
46646940|NCT04518410|82853192|FG015|Overall Study|Withdrawal by Subject|9|||
46646941|NCT04518410|82853193|FG016|Overall Study|Withdrawal by Subject|0|||
46646942|NCT04518410|82853194|FG017|Overall Study|Withdrawal by Subject|14|||
46646943|NCT04518410|82853195|FG018|Overall Study|Withdrawal by Subject|13|||
46646944|NCT04518410|82853196|FG019|Overall Study|Withdrawal by Subject|9|||
46646945|NCT04518410|82853197|FG020|Overall Study|Withdrawal by Subject|13|||
46646946|NCT04518410|82853198|FG021|Overall Study|Withdrawal by Subject|3|||
46646947|NCT04518410|82853199|FG022|Overall Study|Withdrawal by Subject|2|||
46646948|NCT04518410|82853200|FG023|Overall Study|Withdrawal by Subject|9|||
46646949|NCT04518410|82853201|FG024|Overall Study|Withdrawal by Subject|8|||
46646950|NCT04518410|82853177|FG000|Overall Study|Other|1|||
46850509|NCT00112437|83066383|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
46850510|NCT00112437|83066384|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
46646951|NCT04518410|82853178|FG001|Overall Study|Other|0|||
46646952|NCT04518410|82853179|FG002|Overall Study|Other|0|||
46646953|NCT04518410|82853180|FG003|Overall Study|Other|1|||
46646954|NCT04518410|82853181|FG004|Overall Study|Other|6|||
46646955|NCT04518410|82853182|FG005|Overall Study|Other|6|||
46646956|NCT04518410|82853183|FG006|Overall Study|Other|5|||
46646957|NCT04518410|82853184|FG007|Overall Study|Other|2|||
46646958|NCT04518410|82853185|FG008|Overall Study|Other|0|||
46646959|NCT04518410|82853186|FG009|Overall Study|Other|1|||
46646960|NCT04518410|82853187|FG010|Overall Study|Other|0|||
46646961|NCT04518410|82853188|FG011|Overall Study|Other|2|||
46646962|NCT04518410|82853189|FG012|Overall Study|Other|0|||
46646963|NCT04518410|82853190|FG013|Overall Study|Other|0|||
46646964|NCT04518410|82853191|FG014|Overall Study|Other|0|||
46646965|NCT04518410|82853192|FG015|Overall Study|Other|3|||
46646966|NCT04518410|82853193|FG016|Overall Study|Other|1|||
46646967|NCT04518410|82853194|FG017|Overall Study|Other|1|||
46646968|NCT04518410|82853195|FG018|Overall Study|Other|1|||
46646969|NCT04518410|82853196|FG019|Overall Study|Other|0|||
46646970|NCT04518410|82853197|FG020|Overall Study|Other|0|||
46646971|NCT04518410|82853198|FG021|Overall Study|Other|0|||
46646972|NCT04518410|82853199|FG022|Overall Study|Other|1|||
46646973|NCT04518410|82853200|FG023|Overall Study|Other|2|||
46646974|NCT04518410|82853201|FG024|Overall Study|Other|2|||
46646975|NCT04518410|82853177|FG000|Overall Study|Protocol Violation|0|||
46850511|NCT00112437|83066385|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
47074944|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074945|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074946|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074947|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074948|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
47074949|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
47074950|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
47074951|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
47074952|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
47074953|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
47074954|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
47074955|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
47074956|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
47074957|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
47074958|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
47074959|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
47074960|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
47074961|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
47074962|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
47074963|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
47074964|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
47074965|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
47074966|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
47074967|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
47074968|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074969|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074970|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074971|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074972|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
47074973|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074974|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
46646976|NCT04518410|82853178|FG001|Overall Study|Protocol Violation|0|||
46646977|NCT04518410|82853179|FG002|Overall Study|Protocol Violation|0|||
46646978|NCT04518410|82853180|FG003|Overall Study|Protocol Violation|2|||
47074975|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074976|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074977|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
46646979|NCT04518410|82853181|FG004|Overall Study|Protocol Violation|17|||
46646980|NCT04518410|82853182|FG005|Overall Study|Protocol Violation|1|||
46646981|NCT04518410|82853183|FG006|Overall Study|Protocol Violation|2|||
46646982|NCT04518410|82853184|FG007|Overall Study|Protocol Violation|1|||
46646983|NCT04518410|82853185|FG008|Overall Study|Protocol Violation|0|||
46646984|NCT04518410|82853186|FG009|Overall Study|Protocol Violation|0|||
46646985|NCT04518410|82853187|FG010|Overall Study|Protocol Violation|0|||
46646986|NCT04518410|82853188|FG011|Overall Study|Protocol Violation|0|||
46646987|NCT04518410|82853189|FG012|Overall Study|Protocol Violation|0|||
46646988|NCT04518410|82853190|FG013|Overall Study|Protocol Violation|0|||
46646989|NCT04518410|82853191|FG014|Overall Study|Protocol Violation|0|||
46646990|NCT04518410|82853192|FG015|Overall Study|Protocol Violation|0|||
46646991|NCT04518410|82853193|FG016|Overall Study|Protocol Violation|1|||
46646992|NCT04518410|82853194|FG017|Overall Study|Protocol Violation|1|||
46646993|NCT04518410|82853195|FG018|Overall Study|Protocol Violation|0|||
46646994|NCT04518410|82853196|FG019|Overall Study|Protocol Violation|0|||
46646995|NCT04518410|82853197|FG020|Overall Study|Protocol Violation|1|||
46646996|NCT04518410|82853198|FG021|Overall Study|Protocol Violation|2|||
46646997|NCT04518410|82853199|FG022|Overall Study|Protocol Violation|0|||
46646998|NCT04518410|82853200|FG023|Overall Study|Protocol Violation|3|||
46646999|NCT04518410|82853201|FG024|Overall Study|Protocol Violation|0|||
46647000|NCT04518410|82853177|FG000|Overall Study|Death|0|||
46647001|NCT04518410|82853178|FG001|Overall Study|Death|0|||
46647002|NCT04518410|82853179|FG002|Overall Study|Death|0|||
46647003|NCT04518410|82853180|FG003|Overall Study|Death|0|||
46647004|NCT04518410|82853181|FG004|Overall Study|Death|12|||
46647005|NCT04518410|82853182|FG005|Overall Study|Death|2|||
46647006|NCT04518410|82853183|FG006|Overall Study|Death|11|||
46647007|NCT04518410|82853184|FG007|Overall Study|Death|0|||
46647008|NCT04518410|82853185|FG008|Overall Study|Death|1|||
46647009|NCT04518410|82853186|FG009|Overall Study|Death|0|||
46647010|NCT04518410|82853187|FG010|Overall Study|Death|0|||
46647011|NCT04518410|82853188|FG011|Overall Study|Death|0|||
46647012|NCT04518410|82853189|FG012|Overall Study|Death|0|||
46647013|NCT04518410|82853190|FG013|Overall Study|Death|1|||
46647014|NCT04518410|82853191|FG014|Overall Study|Death|1|||
46647015|NCT04518410|82853192|FG015|Overall Study|Death|0|||
46647016|NCT04518410|82853193|FG016|Overall Study|Death|0|||
46647017|NCT04518410|82853194|FG017|Overall Study|Death|1|||
46647018|NCT04518410|82853195|FG018|Overall Study|Death|3|||
46647019|NCT04518410|82853196|FG019|Overall Study|Death|4|||
46647020|NCT04518410|82853197|FG020|Overall Study|Death|1|||
46647021|NCT04518410|82853198|FG021|Overall Study|Death|0|||
46647022|NCT04518410|82853199|FG022|Overall Study|Death|0|||
46647023|NCT04518410|82853200|FG023|Overall Study|Death|0|||
46647024|NCT04518410|82853201|FG024|Overall Study|Death|0|||
46647025|NCT04518410|82853177|FG000|Overall Study|Requirement to start alternative therapy|0|||
46647026|NCT04518410|82853178|FG001|Overall Study|Requirement to start alternative therapy|0|||
46647027|NCT04518410|82853179|FG002|Overall Study|Requirement to start alternative therapy|1|||
46647028|NCT04518410|82853180|FG003|Overall Study|Requirement to start alternative therapy|0|||
46647029|NCT04518410|82853181|FG004|Overall Study|Requirement to start alternative therapy|0|||
46647030|NCT04518410|82853182|FG005|Overall Study|Requirement to start alternative therapy|0|||
46647031|NCT04518410|82853183|FG006|Overall Study|Requirement to start alternative therapy|0|||
46647032|NCT04518410|82853184|FG007|Overall Study|Requirement to start alternative therapy|0|||
46647033|NCT04518410|82853185|FG008|Overall Study|Requirement to start alternative therapy|0|||
46647034|NCT04518410|82853186|FG009|Overall Study|Requirement to start alternative therapy|0|||
46647035|NCT04518410|82853187|FG010|Overall Study|Requirement to start alternative therapy|0|||
46647036|NCT04518410|82853188|FG011|Overall Study|Requirement to start alternative therapy|0|||
46647037|NCT04518410|82853189|FG012|Overall Study|Requirement to start alternative therapy|0|||
46647038|NCT04518410|82853190|FG013|Overall Study|Requirement to start alternative therapy|0|||
46647039|NCT04518410|82853191|FG014|Overall Study|Requirement to start alternative therapy|0|||
46647040|NCT04518410|82853192|FG015|Overall Study|Requirement to start alternative therapy|0|||
46647041|NCT04518410|82853193|FG016|Overall Study|Requirement to start alternative therapy|0|||
46647042|NCT04518410|82853194|FG017|Overall Study|Requirement to start alternative therapy|0|||
46647043|NCT04518410|82853195|FG018|Overall Study|Requirement to start alternative therapy|0|||
46647044|NCT04518410|82853196|FG019|Overall Study|Requirement to start alternative therapy|0|||
46647045|NCT04518410|82853197|FG020|Overall Study|Requirement to start alternative therapy|0|||
46647046|NCT04518410|82853198|FG021|Overall Study|Requirement to start alternative therapy|0|||
46647047|NCT04518410|82853199|FG022|Overall Study|Requirement to start alternative therapy|1|||
46647048|NCT04518410|82853200|FG023|Overall Study|Requirement to start alternative therapy|0|||
46647049|NCT04518410|82853201|FG024|Overall Study|Requirement to start alternative therapy|0|||
46647050|NCT04518410|82853177|FG000|Overall Study|Ongoing in study|0|||
46647051|NCT04518410|82853178|FG001|Overall Study|Ongoing in study|0|||
46647052|NCT04518410|82853179|FG002|Overall Study|Ongoing in study|0|||
46647053|NCT04518410|82853180|FG003|Overall Study|Ongoing in study|0|||
46647054|NCT04518410|82853181|FG004|Overall Study|Ongoing in study|0|||
46647055|NCT04518410|82853182|FG005|Overall Study|Ongoing in study|0|||
46647056|NCT04518410|82853183|FG006|Overall Study|Ongoing in study|0|||
46647057|NCT04518410|82853184|FG007|Overall Study|Ongoing in study|0|||
46647058|NCT04518410|82853185|FG008|Overall Study|Ongoing in study|0|||
46647059|NCT04518410|82853186|FG009|Overall Study|Ongoing in study|0|||
46647060|NCT04518410|82853187|FG010|Overall Study|Ongoing in study|0|||
46647061|NCT04518410|82853188|FG011|Overall Study|Ongoing in study|0|||
46647062|NCT04518410|82853189|FG012|Overall Study|Ongoing in study|0|||
46647063|NCT04518410|82853190|FG013|Overall Study|Ongoing in study|0|||
46647064|NCT04518410|82853191|FG014|Overall Study|Ongoing in study|0|||
46647065|NCT04518410|82853192|FG015|Overall Study|Ongoing in study|0|||
46647066|NCT04518410|82853193|FG016|Overall Study|Ongoing in study|0|||
46647067|NCT04518410|82853194|FG017|Overall Study|Ongoing in study|193|||
46647068|NCT04518410|82853195|FG018|Overall Study|Ongoing in study|173|||
46647069|NCT04518410|82853196|FG019|Overall Study|Ongoing in study|50|||
46647070|NCT04518410|82853197|FG020|Overall Study|Ongoing in study|65|||
46647071|NCT04518410|82853198|FG021|Overall Study|Ongoing in study|0|||
46647072|NCT04518410|82853199|FG022|Overall Study|Ongoing in study|0|||
46647073|NCT04518410|82853200|FG023|Overall Study|Ongoing in study|0|||
46647074|NCT04518410|82853201|FG024|Overall Study|Ongoing in study|0|||
46647075|NCT04518410|82853177|FG000|Overall Study|Randomized but not treated|0|||
46647076|NCT04518410|82853178|FG001|Overall Study|Randomized but not treated|0|||
46647077|NCT04518410|82853179|FG002|Overall Study|Randomized but not treated|0|||
46647078|NCT04518410|82853180|FG003|Overall Study|Randomized but not treated|2|||
46647079|NCT04518410|82853181|FG004|Overall Study|Randomized but not treated|6|||
46647080|NCT04518410|82853182|FG005|Overall Study|Randomized but not treated|6|||
46647081|NCT04518410|82853183|FG006|Overall Study|Randomized but not treated|3|||
46647082|NCT04518410|82853184|FG007|Overall Study|Randomized but not treated|3|||
46647083|NCT04518410|82853185|FG008|Overall Study|Randomized but not treated|0|||
46647084|NCT04518410|82853186|FG009|Overall Study|Randomized but not treated|4|||
46647085|NCT04518410|82853187|FG010|Overall Study|Randomized but not treated|0|||
46647086|NCT04518410|82853188|FG011|Overall Study|Randomized but not treated|0|||
46647087|NCT04518410|82853189|FG012|Overall Study|Randomized but not treated|1|||
46647088|NCT04518410|82853190|FG013|Overall Study|Randomized but not treated|4|||
46647089|NCT04518410|82853191|FG014|Overall Study|Randomized but not treated|3|||
46647090|NCT04518410|82853192|FG015|Overall Study|Randomized but not treated|3|||
46647091|NCT04518410|82853193|FG016|Overall Study|Randomized but not treated|4|||
46647092|NCT04518410|82853194|FG017|Overall Study|Randomized but not treated|6|||
46647093|NCT04518410|82853195|FG018|Overall Study|Randomized but not treated|4|||
46647094|NCT04518410|82853196|FG019|Overall Study|Randomized but not treated|0|||
46647095|NCT04518410|82853197|FG020|Overall Study|Randomized but not treated|0|||
46647096|NCT04518410|82853198|FG021|Overall Study|Randomized but not treated|5|||
46647097|NCT04518410|82853199|FG022|Overall Study|Randomized but not treated|0|||
46647098|NCT04518410|82853200|FG023|Overall Study|Randomized but not treated|3|||
46647099|NCT04518410|82853201|FG024|Overall Study|Randomized but not treated|1|||
46647100|NCT04518410|82853177|FG000|Overall Study|Screen Fail but Randomized|0|||
46647101|NCT04518410|82853178|FG001|Overall Study|Screen Fail but Randomized|0|||
46647102|NCT04518410|82853179|FG002|Overall Study|Screen Fail but Randomized|0|||
46647103|NCT04518410|82853180|FG003|Overall Study|Screen Fail but Randomized|0|||
46647104|NCT04518410|82853181|FG004|Overall Study|Screen Fail but Randomized|2|||
46647105|NCT04518410|82853182|FG005|Overall Study|Screen Fail but Randomized|0|||
46647106|NCT04518410|82853183|FG006|Overall Study|Screen Fail but Randomized|0|||
46647107|NCT04518410|82853184|FG007|Overall Study|Screen Fail but Randomized|0|||
46647108|NCT04518410|82853185|FG008|Overall Study|Screen Fail but Randomized|0|||
46647109|NCT04518410|82853186|FG009|Overall Study|Screen Fail but Randomized|0|||
46647110|NCT04518410|82853187|FG010|Overall Study|Screen Fail but Randomized|0|||
46647111|NCT04518410|82853188|FG011|Overall Study|Screen Fail but Randomized|0|||
46647112|NCT04518410|82853189|FG012|Overall Study|Screen Fail but Randomized|0|||
46647113|NCT04518410|82853190|FG013|Overall Study|Screen Fail but Randomized|0|||
46647114|NCT04518410|82853191|FG014|Overall Study|Screen Fail but Randomized|0|||
46647115|NCT04518410|82853192|FG015|Overall Study|Screen Fail but Randomized|0|||
46647116|NCT04518410|82853193|FG016|Overall Study|Screen Fail but Randomized|0|||
46647117|NCT04518410|82853194|FG017|Overall Study|Screen Fail but Randomized|0|||
46647118|NCT04518410|82853195|FG018|Overall Study|Screen Fail but Randomized|0|||
46647119|NCT04518410|82853196|FG019|Overall Study|Screen Fail but Randomized|0|||
46647120|NCT04518410|82853197|FG020|Overall Study|Screen Fail but Randomized|0|||
46647121|NCT04518410|82853198|FG021|Overall Study|Screen Fail but Randomized|0|||
46647122|NCT04518410|82853199|FG022|Overall Study|Screen Fail but Randomized|0|||
46647123|NCT04518410|82853200|FG023|Overall Study|Screen Fail but Randomized|0|||
47074978|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
46647124|NCT04518410|82853201|FG024|Overall Study|Screen Fail but Randomized|0|||
46647125|NCT04518410|82853177|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647126|NCT04518410|82853178|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647127|NCT04518410|82853179|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647128|NCT04518410|82853180|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647129|NCT04518410|82853181|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
46647130|NCT04518410|82853182|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
46647131|NCT04518410|82853183|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|9|||
46647132|NCT04518410|82853184|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647133|NCT04518410|82853185|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
46647134|NCT04518410|82853186|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647135|NCT04518410|82853187|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647136|NCT04518410|82853188|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647137|NCT04518410|82853189|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647138|NCT04518410|82853190|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647139|NCT04518410|82853191|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647140|NCT04518410|82853192|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647141|NCT04518410|82853193|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647142|NCT04518410|82853194|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647143|NCT04518410|82853195|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647144|NCT04518410|82853196|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647145|NCT04518410|82853197|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647146|NCT04518410|82853198|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647147|NCT04518410|82853199|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
46647148|NCT04518410|82853200|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
46647149|NCT04518410|82853201|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
46647150|NCT04518410|82853177|FG000|Overall Study|Dual Enrolled Subject|0|||
46780033|NCT00614380|82998785|FG001|Overall Study|Lost to Follow-up|1|||
46647151|NCT04518410|82853178|FG001|Overall Study|Dual Enrolled Subject|0|||
46647152|NCT04518410|82853179|FG002|Overall Study|Dual Enrolled Subject|0|||
46647153|NCT04518410|82853180|FG003|Overall Study|Dual Enrolled Subject|0|||
46647154|NCT04518410|82853181|FG004|Overall Study|Dual Enrolled Subject|0|||
46647155|NCT04518410|82853182|FG005|Overall Study|Dual Enrolled Subject|0|||
46647156|NCT04518410|82853183|FG006|Overall Study|Dual Enrolled Subject|0|||
46647157|NCT04518410|82853184|FG007|Overall Study|Dual Enrolled Subject|0|||
46647158|NCT04518410|82853185|FG008|Overall Study|Dual Enrolled Subject|0|||
46647159|NCT04518410|82853186|FG009|Overall Study|Dual Enrolled Subject|0|||
46647160|NCT04518410|82853187|FG010|Overall Study|Dual Enrolled Subject|0|||
46647161|NCT04518410|82853188|FG011|Overall Study|Dual Enrolled Subject|0|||
46647162|NCT04518410|82853189|FG012|Overall Study|Dual Enrolled Subject|0|||
46647163|NCT04518410|82853190|FG013|Overall Study|Dual Enrolled Subject|0|||
46647164|NCT04518410|82853191|FG014|Overall Study|Dual Enrolled Subject|0|||
46647165|NCT04518410|82853192|FG015|Overall Study|Dual Enrolled Subject|0|||
46647166|NCT04518410|82853193|FG016|Overall Study|Dual Enrolled Subject|0|||
46647167|NCT04518410|82853194|FG017|Overall Study|Dual Enrolled Subject|1|||
46647168|NCT04518410|82853195|FG018|Overall Study|Dual Enrolled Subject|0|||
46647169|NCT04518410|82853196|FG019|Overall Study|Dual Enrolled Subject|0|||
46647170|NCT04518410|82853197|FG020|Overall Study|Dual Enrolled Subject|0|||
46647171|NCT04518410|82853198|FG021|Overall Study|Dual Enrolled Subject|0|||
46647172|NCT04518410|82853199|FG022|Overall Study|Dual Enrolled Subject|0|||
46647173|NCT04518410|82853200|FG023|Overall Study|Dual Enrolled Subject|0|||
46647174|NCT04518410|82853201|FG024|Overall Study|Dual Enrolled Subject|0|||
46647175|NCT04517864|82853261|FG000|Placebo-Controlled Phase|Adverse Event|1|||
46647176|NCT04517864|82853262|FG001|Placebo-Controlled Phase|Adverse Event|0|||
46647177|NCT04517864|82853261|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
46647178|NCT04517864|82853262|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
46647179|NCT04517864|82853261|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
46647180|NCT04517864|82853262|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
46647181|NCT04517864|82853261|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
46647182|NCT04517864|82853262|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
46647183|NCT04517864|82853261|FG000|Active Therapy Extension Phase|Adverse Event|1|||
46647184|NCT04517864|82853262|FG001|Active Therapy Extension Phase|Adverse Event|0|||
46647185|NCT04507204|82853283|FG000|Overall Study|Adverse Event|8|||
46647186|NCT04507204|82853284|FG001|Overall Study|Adverse Event|13|||
46647187|NCT04507204|82853283|FG000|Overall Study|Death|0|||
46647188|NCT04507204|82853284|FG001|Overall Study|Death|1|||
46647189|NCT04507204|82853283|FG000|Overall Study|Lost to Follow-up|15|||
46647190|NCT04507204|82853284|FG001|Overall Study|Lost to Follow-up|14|||
46647191|NCT04507204|82853283|FG000|Overall Study|Poor Compliance with Protocol|2|||
46647192|NCT04507204|82853284|FG001|Overall Study|Poor Compliance with Protocol|4|||
46647193|NCT04507204|82853283|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
46647194|NCT04507204|82853284|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
46647195|NCT04507204|82853283|FG000|Overall Study|Withdrawal of Patient Consent|21|||
46647196|NCT04507204|82853284|FG001|Overall Study|Withdrawal of Patient Consent|13|||
46647197|NCT04135937|82853308|FG000|Overall Study|Lost to Follow-up|2|||
46647198|NCT04135937|82853308|FG000|Overall Study|Withdrawal by Subject|1|||
47074979|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074980|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074981|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074982|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074983|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
46647199|NCT04060147|82853312|FG000|Overall Study|Withdrew consent|1|||
46647200|NCT04019041|82853346|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
46647201|NCT04019041|82853347|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
46647202|NCT04019041|82853348|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
46647203|NCT04019041|82853349|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
46647204|NCT04019041|82853350|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
47074984|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074985|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074986|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
47074987|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
47074988|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
46647205|NCT04019041|82853351|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
46647206|NCT04019041|82853346|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
46647207|NCT04019041|82853347|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
46647208|NCT04019041|82853348|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
46647209|NCT04019041|82853349|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
46647210|NCT04019041|82853350|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
46647211|NCT04019041|82853351|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
46647212|NCT04019041|82853346|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
46647213|NCT04019041|82853347|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
46647214|NCT04019041|82853348|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
46647215|NCT04019041|82853349|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
46647216|NCT04019041|82853350|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
46647217|NCT04019041|82853351|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
46647218|NCT04019041|82853346|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
46647219|NCT04019041|82853347|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
46647220|NCT04019041|82853348|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
46647221|NCT04019041|82853349|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
46647222|NCT04019041|82853350|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
46647223|NCT04019041|82853351|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
46647224|NCT04019041|82853346|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
46647225|NCT04019041|82853347|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
46647226|NCT04019041|82853348|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
46647227|NCT04019041|82853349|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
46647228|NCT04019041|82853350|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
46647229|NCT04019041|82853351|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
46647230|NCT04019041|82853346|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
46647231|NCT04019041|82853347|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
46647232|NCT04019041|82853348|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
46647233|NCT04019041|82853349|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
46647234|NCT04019041|82853350|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
46647235|NCT04019041|82853351|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
46647236|NCT04019041|82853346|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
46647237|NCT04019041|82853347|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
46647238|NCT04019041|82853348|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
46647239|NCT04019041|82853349|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
46647240|NCT04019041|82853350|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
46647241|NCT04019041|82853351|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
46647242|NCT04019041|82853346|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
46647243|NCT04019041|82853347|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
46647244|NCT04019041|82853348|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
46647245|NCT04019041|82853349|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
46647246|NCT04019041|82853350|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
46647247|NCT04019041|82853351|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
46647248|NCT04019041|82853346|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
46647249|NCT04019041|82853347|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
46647250|NCT04019041|82853348|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
46647251|NCT04019041|82853349|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
46647252|NCT04019041|82853350|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
46647253|NCT04019041|82853351|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
46647254|NCT03919448|82853380|FG000|Overall Study|Withdrawal by Subject|1|||
46647255|NCT03919448|82853381|FG001|Overall Study|Withdrawal by Subject|0|||
46647256|NCT03919448|82853382|FG002|Overall Study|Withdrawal by Subject|0|||
46647257|NCT03795922|82853409|FG000|Overall Study|Adverse Event|2|||
46647258|NCT03795922|82853410|FG001|Overall Study|Adverse Event|1|||
46647259|NCT03795922|82853409|FG000|Overall Study|Withdrawal by Subject|5|||
46647260|NCT03795922|82853410|FG001|Overall Study|Withdrawal by Subject|13|||
46647261|NCT03795922|82853409|FG000|Overall Study|Lost to Follow-up|2|||
46647262|NCT03795922|82853410|FG001|Overall Study|Lost to Follow-up|3|||
46647263|NCT03795922|82853409|FG000|Overall Study|Pregnancy|0|||
46647264|NCT03795922|82853410|FG001|Overall Study|Pregnancy|1|||
47074989|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
47074990|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
47074991|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
47074992|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
47074993|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
47074994|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
46647265|NCT03795922|82853409|FG000|Overall Study|Physician Decision|1|||
46647266|NCT03795922|82853410|FG001|Overall Study|Physician Decision|2|||
46647267|NCT03795922|82853409|FG000|Overall Study|Protocol Violation|0|||
46647268|NCT03795922|82853410|FG001|Overall Study|Protocol Violation|1|||
46647269|NCT03795922|82853409|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
46647270|NCT03795922|82853410|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
46647271|NCT03794089|82853420|FG000|Overall Study|Lost to Follow-up|4|||
46647272|NCT03794089|82853421|FG001|Overall Study|Lost to Follow-up|1|||
46647273|NCT03794089|82853420|FG000|Overall Study|Withdrawal by Subject|2|||
46647274|NCT03794089|82853421|FG001|Overall Study|Withdrawal by Subject|0|||
46647275|NCT03769025|82853429|FG000|Overall Study|Withdrawal by Subject|1|||
46647276|NCT03769025|82853430|FG001|Overall Study|Withdrawal by Subject|1|||
46647277|NCT03769025|82853429|FG000|Overall Study|Lost to Follow-up|4|||
46647278|NCT03769025|82853430|FG001|Overall Study|Lost to Follow-up|3|||
46647279|NCT03762473|82853438|FG000|Overall Study|Death|1|||
46647280|NCT03762473|82853439|FG001|Overall Study|Death|0|||
46647281|NCT03745989|82853448|FG000|Overall Study|Death|3|||
46647282|NCT03745989|82853449|FG001|Overall Study|Death|7|||
46647283|NCT03745989|82853450|FG002|Overall Study|Death|4|||
46647284|NCT03745989|82853448|FG000|Overall Study|Lost to Follow-up|0|||
46647285|NCT03745989|82853449|FG001|Overall Study|Lost to Follow-up|2|||
46647286|NCT03745989|82853450|FG002|Overall Study|Lost to Follow-up|0|||
46647287|NCT03745989|82853448|FG000|Overall Study|Sponsor Decision|0|||
46647288|NCT03745989|82853449|FG001|Overall Study|Sponsor Decision|2|||
46647289|NCT03745989|82853450|FG002|Overall Study|Sponsor Decision|8|||
46647290|NCT03745989|82853448|FG000|Overall Study|Withdrawal by Subject|0|||
46647291|NCT03745989|82853449|FG001|Overall Study|Withdrawal by Subject|1|||
46647292|NCT03745989|82853450|FG002|Overall Study|Withdrawal by Subject|3|||
46647293|NCT03646656|82853480|FG000|Overall Study|Lost to Follow-up|1|||
46647294|NCT03646656|82853481|FG001|Overall Study|Lost to Follow-up|0|||
46647295|NCT03646656|82853480|FG000|Overall Study|Withdrawal by Subject|2|||
46647296|NCT03646656|82853481|FG001|Overall Study|Withdrawal by Subject|0|||
46647297|NCT03555435|82853494|FG000|Overall Study|Lost to Follow-up|17|||
46647298|NCT03555435|82853495|FG001|Overall Study|Lost to Follow-up|19|||
46647299|NCT03555435|82853496|FG002|Overall Study|Lost to Follow-up|8|||
46647300|NCT03521115|82853506|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
46647301|NCT03521115|82853507|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
46647302|NCT03521115|82853506|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
46647303|NCT03521115|82853507|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
46647304|NCT03520413|82853521|FG000|Overall Study|Lost to Follow-up|1|||
46647305|NCT03520413|82853522|FG001|Overall Study|Lost to Follow-up|1|||
46647306|NCT03520413|82853521|FG000|Overall Study|Withdrawal by Subject|1|||
46647307|NCT03520413|82853522|FG001|Overall Study|Withdrawal by Subject|2|||
46647308|NCT03520413|82853521|FG000|Overall Study|Death|0|||
46647309|NCT03520413|82853522|FG001|Overall Study|Death|1|||
46647310|NCT03520413|82853521|FG000|Overall Study|Physician Decision|3|||
46647311|NCT03520413|82853522|FG001|Overall Study|Physician Decision|3|||
46647312|NCT03520413|82853521|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
46647313|NCT03520413|82853522|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
46647314|NCT03419897|82853529|FG000|Overall Study|Death|180|||
46647315|NCT03419897|82853529|FG000|Overall Study|Lost to Follow-up|1|||
46647316|NCT03419897|82853529|FG000|Overall Study|Withdrawal by Subject|6|||
46647317|NCT03419897|82853529|FG000|Overall Study|Sponsor Decision|61|||
46647318|NCT03419897|82853529|FG000|Overall Study|Physician Decision|1|||
46647319|NCT03418129|82853536|FG000|Overall Study|Lost to Follow-up|11|||
46647320|NCT03418129|82853537|FG001|Overall Study|Lost to Follow-up|20|||
46647321|NCT03418129|82853538|FG002|Overall Study|Lost to Follow-up|15|||
46647322|NCT03418129|82853536|FG000|Overall Study|Withdrawal by Subject|3|||
46647323|NCT03418129|82853537|FG001|Overall Study|Withdrawal by Subject|6|||
46780034|NCT00614380|82998786|FG002|Overall Study|Lost to Follow-up|0|||
47074995|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
47074996|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
47074997|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
46647324|NCT03418129|82853538|FG002|Overall Study|Withdrawal by Subject|4|||
46647325|NCT03344796|82853556|FG000|Overall Study|Lost to Follow-up|0|||
46647326|NCT03344796|82853557|FG001|Overall Study|Lost to Follow-up|0|||
46647327|NCT03344796|82853558|FG002|Overall Study|Lost to Follow-up|0|||
46647328|NCT03344796|82853559|FG003|Overall Study|Lost to Follow-up|0|||
46647329|NCT03344796|82853560|FG004|Overall Study|Lost to Follow-up|0|||
46647330|NCT03344796|82853561|FG005|Overall Study|Lost to Follow-up|2|||
46647331|NCT03335488|82853584|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
46780035|NCT00614380|82998787|FG003|Overall Study|Lost to Follow-up|0|||
46780036|NCT00614380|82998784|FG000|Overall Study|Non compliant with the protocol|12|||
46780037|NCT00614380|82998785|FG001|Overall Study|Non compliant with the protocol|2|||
46647332|NCT03335488|82853585|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
46647333|NCT03335488|82853584|FG000|Safety Extension Period|Adverse Event|1|||
46780038|NCT00614380|82998786|FG002|Overall Study|Non compliant with the protocol|1|||
46647334|NCT03335488|82853585|FG001|Safety Extension Period|Adverse Event|0|||
46647335|NCT03335488|82853584|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
46647336|NCT03335488|82853585|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
46647337|NCT03261700|82853604|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
46647338|NCT03261700|82853605|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
46647339|NCT03238417|82853616|FG000|Overall|non-response|955|||
46647340|NCT03238417|82853617|FG001|Overall|non-response|1920|||
46850512|NCT00112437|83066386|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
47074998|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
47074999|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
47075000|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
47075001|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
47075002|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
47075003|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
47075004|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
47075005|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
46647341|NCT03238417|82853616|FG000|Overall|partial completion|48|||
46647342|NCT03238417|82853617|FG001|Overall|partial completion|68|||
46647343|NCT03238417|82853616|FG000|Baseline|Partial completion|17|||
46647344|NCT03238417|82853617|FG001|Baseline|Partial completion|48|||
46647345|NCT03238417|82853616|FG000|Baseline|non-response|372|||
46647346|NCT03238417|82853617|FG001|Baseline|non-response|669|||
46647347|NCT03238417|82853616|FG000|12-month|non-response|296|||
46647348|NCT03238417|82853617|FG001|12-month|non-response|669|||
46647349|NCT03238417|82853616|FG000|12-month|partial completion|23|||
46647350|NCT03238417|82853617|FG001|12-month|partial completion|37|||
46647351|NCT03238417|82853616|FG000|24-month|non-response|287|||
46647352|NCT03238417|82853617|FG001|24-month|non-response|594|||
46647353|NCT03238417|82853616|FG000|24-month|partial completion|8|||
46647354|NCT03238417|82853617|FG001|24-month|partial completion|31|||
46647355|NCT03215277|82853625|FG000|Overall Study|Adverse Event|2|||
46647356|NCT03215277|82853626|FG001|Overall Study|Adverse Event|3|||
46647357|NCT03215277|82853625|FG000|Overall Study|Death|1|||
46647358|NCT03215277|82853626|FG001|Overall Study|Death|0|||
46647359|NCT03215277|82853625|FG000|Overall Study|Lost to Follow-up|0|||
46647360|NCT03215277|82853626|FG001|Overall Study|Lost to Follow-up|1|||
46647361|NCT03215277|82853625|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
46647362|NCT03215277|82853626|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
46647363|NCT03185013|82853636|FG000|Overall Study|Withdrawal by Subject|5|||
46647364|NCT03185013|82853637|FG001|Overall Study|Withdrawal by Subject|3|||
46647365|NCT03185013|82853636|FG000|Overall Study|Adverse Event|1|||
46647366|NCT03185013|82853637|FG001|Overall Study|Adverse Event|0|||
46647367|NCT03185013|82853636|FG000|Overall Study|Progressive Disease|1|||
46647368|NCT03185013|82853637|FG001|Overall Study|Progressive Disease|0|||
46647369|NCT03185013|82853636|FG000|Overall Study|Lost to Follow-up|8|||
46647370|NCT03185013|82853637|FG001|Overall Study|Lost to Follow-up|2|||
46647371|NCT03185013|82853636|FG000|Overall Study|Physician Decision|1|||
46647372|NCT03185013|82853637|FG001|Overall Study|Physician Decision|0|||
46647373|NCT03185013|82853636|FG000|Overall Study|Protocol Deviation|2|||
46647374|NCT03185013|82853637|FG001|Overall Study|Protocol Deviation|0|||
46647375|NCT03185013|82853636|FG000|Overall Study|Reason not Specified|3|||
46647376|NCT03185013|82853637|FG001|Overall Study|Reason not Specified|2|||
46647377|NCT03185013|82853636|FG000|Overall Study|Death|1|||
46647378|NCT03185013|82853637|FG001|Overall Study|Death|0|||
46647379|NCT03182907|82853645|FG000|Overall Study|Death|3|||
46647380|NCT03182907|82853646|FG001|Overall Study|Death|0|||
46647381|NCT03182907|82853645|FG000|Overall Study|Protocol Violation|4|||
46647382|NCT03182907|82853646|FG001|Overall Study|Protocol Violation|0|||
46647383|NCT03182907|82853645|FG000|Overall Study|Lost to Follow-up|1|||
46647384|NCT03182907|82853646|FG001|Overall Study|Lost to Follow-up|0|||
46647385|NCT03182907|82853645|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46647386|NCT03182907|82853646|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
46647387|NCT03036813|82853658|FG000|Overall Study|Adverse Event|6|||
46647388|NCT03036813|82853659|FG001|Overall Study|Adverse Event|11|||
46647389|NCT03036813|82853660|FG002|Overall Study|Adverse Event|6|||
46647390|NCT03036813|82853658|FG000|Overall Study|Withdrawal by Subject|12|||
46647391|NCT03036813|82853659|FG001|Overall Study|Withdrawal by Subject|6|||
46647392|NCT03036813|82853660|FG002|Overall Study|Withdrawal by Subject|10|||
46647393|NCT03036813|82853658|FG000|Overall Study|Lost to Follow-up|1|||
46850513|NCT00112437|83066387|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46850514|NCT00112437|83066388|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
46647394|NCT03036813|82853659|FG001|Overall Study|Lost to Follow-up|1|||
46647395|NCT03036813|82853660|FG002|Overall Study|Lost to Follow-up|0|||
46647396|NCT03036813|82853658|FG000|Overall Study|Physician Decision|2|||
46850515|NCT00112437|83066363|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850516|NCT00112437|83066364|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46647397|NCT03036813|82853659|FG001|Overall Study|Physician Decision|1|||
46647398|NCT03036813|82853660|FG002|Overall Study|Physician Decision|1|||
46647399|NCT03036813|82853658|FG000|Overall Study|Non-Compliance|1|||
46647400|NCT03036813|82853659|FG001|Overall Study|Non-Compliance|5|||
46647401|NCT03036813|82853660|FG002|Overall Study|Non-Compliance|3|||
46647402|NCT03036813|82853658|FG000|Overall Study|Pregnancy|0|||
46647403|NCT03036813|82853659|FG001|Overall Study|Pregnancy|0|||
46647404|NCT03036813|82853660|FG002|Overall Study|Pregnancy|1|||
46647405|NCT03036813|82853658|FG000|Overall Study|Other|0|||
46647406|NCT03036813|82853659|FG001|Overall Study|Other|3|||
46647407|NCT03036813|82853660|FG002|Overall Study|Other|5|||
46647408|NCT03007953|82853673|FG000|Overall Study|Withdrawal by Subject|5|||
46647409|NCT03007953|82853674|FG001|Overall Study|Withdrawal by Subject|2|||
46647410|NCT03007953|82853673|FG000|Overall Study|Death|5|||
46647411|NCT03007953|82853674|FG001|Overall Study|Death|7|||
46647412|NCT03007953|82853673|FG000|Overall Study|Lost to Follow-up|3|||
46647413|NCT03007953|82853674|FG001|Overall Study|Lost to Follow-up|2|||
46647414|NCT03007953|82853673|FG000|Overall Study|Enrolled in Hospice|3|||
46647415|NCT03007953|82853674|FG001|Overall Study|Enrolled in Hospice|2|||
46647416|NCT02919618|82853689|FG000|Overall Study|Death|1|||
46647417|NCT02911701|82853706|FG000|Overall Study|Withdrawal by Subject|2|||
46647418|NCT02911701|82853707|FG001|Overall Study|Withdrawal by Subject|4|||
46647419|NCT02911701|82853706|FG000|Overall Study|Adverse Event|1|||
46647420|NCT02911701|82853707|FG001|Overall Study|Adverse Event|0|||
46647421|NCT02896257|82853717|FG000|Providers|Without eligible patients|21|||
46647422|NCT02896257|82853718|FG001|Providers|Without eligible patients|28|||
46647423|NCT02896257|82853717|FG000|Patients|PFT entry criteria not met|43|||
46647424|NCT02896257|82853718|FG001|Patients|PFT entry criteria not met|50|||
46647425|NCT02896257|82853717|FG000|Patients|No capacity to review|8|||
46647426|NCT02896257|82853718|FG001|Patients|No capacity to review|11|||
46647427|NCT02896257|82853717|FG000|Patients|Appointment rescheduled/cancelled|5|||
46647428|NCT02896257|82853718|FG001|Patients|Appointment rescheduled/cancelled|7|||
46647429|NCT02896257|82853717|FG000|Patients|PCP not assigned a clinic|4|||
46647430|NCT02896257|82853718|FG001|Patients|PCP not assigned a clinic|0|||
46647431|NCT02896257|82853717|FG000|Patients|No history of COPD|0|||
46647432|NCT02896257|82853718|FG001|Patients|No history of COPD|1|||
46647433|NCT02896257|82853717|FG000|Patients|Deceased between review and index date|0|||
46647434|NCT02896257|82853718|FG001|Patients|Deceased between review and index date|1|||
46647435|NCT02896257|82853717|FG000|Patients|No ICS Rx upon review|1|||
46647436|NCT02896257|82853718|FG001|Patients|No ICS Rx upon review|1|||
46647437|NCT02896257|82853717|FG000|Patients|Protocol Violation|2|||
46647438|NCT02896257|82853718|FG001|Patients|Protocol Violation|1|||
46647439|NCT02896257|82853717|FG000|Patients|Hospice care|0|||
46647440|NCT02896257|82853718|FG001|Patients|Hospice care|1|||
46647441|NCT02874742|82853728|FG000|Overall Study|Death|0|||
46647442|NCT02874742|82853729|FG001|Overall Study|Death|1|||
46647443|NCT02874742|82853730|FG002|Overall Study|Death|0|||
46647444|NCT02874742|82853728|FG000|Overall Study|Lost to Follow-up|5|||
46647445|NCT02874742|82853729|FG001|Overall Study|Lost to Follow-up|4|||
46647446|NCT02874742|82853730|FG002|Overall Study|Lost to Follow-up|1|||
46780039|NCT00614380|82998787|FG003|Overall Study|Non compliant with the protocol|2|||
46780040|NCT00614380|82998784|FG000|Overall Study|Consent withdrawn|3|||
46780041|NCT00614380|82998785|FG001|Overall Study|Consent withdrawn|1|||
46780042|NCT00614380|82998786|FG002|Overall Study|Consent withdrawn|0|||
46780043|NCT00614380|82998787|FG003|Overall Study|Consent withdrawn|0|||
46780044|NCT00612508|82998804|FG000|Overall Study|Withdrawal by Subject|3|||
46780045|NCT00612508|82998805|FG001|Overall Study|Withdrawal by Subject|4|||
46780046|NCT00613834|82998815|FG000|Overall Study|Withdrawal by Subject|0|||
46780047|NCT00613834|82998816|FG001|Overall Study|Withdrawal by Subject|3|||
47075006|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
46780048|NCT00613366|82998830|FG000|Overall Study|Withdrawal by Subject|3|||
46780049|NCT00613366|82998831|FG001|Overall Study|Withdrawal by Subject|2|||
46780050|NCT00612352|82998839|FG000|Overall Study|Adverse Event|1|||
47075007|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
47075008|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
47075009|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
47075010|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
46647447|NCT02874742|82853728|FG000|Overall Study|Withdrawal by Subject|17|||
46647448|NCT02874742|82853729|FG001|Overall Study|Withdrawal by Subject|8|||
46647449|NCT02874742|82853730|FG002|Overall Study|Withdrawal by Subject|0|||
46647450|NCT02874742|82853728|FG000|Overall Study|Other|4|||
46647451|NCT02874742|82853729|FG001|Overall Study|Other|1|||
46647452|NCT02874742|82853730|FG002|Overall Study|Other|0|||
46647453|NCT02874742|82853728|FG000|Overall Study|Progressive Disease|1|||
46647454|NCT02874742|82853729|FG001|Overall Study|Progressive Disease|0|||
46647455|NCT02874742|82853730|FG002|Overall Study|Progressive Disease|0|||
46647456|NCT02874742|82853728|FG000|Overall Study|Screen Failure|0|||
46647457|NCT02874742|82853729|FG001|Overall Study|Screen Failure|2|||
46647458|NCT02874742|82853730|FG002|Overall Study|Screen Failure|0|||
46647459|NCT02749292|82853740|FG000|Overall Study|Physician Decision|1|||
46780051|NCT00612352|82998840|FG001|Overall Study|Adverse Event|0|||
46780052|NCT00612352|82998839|FG000|Overall Study|Withdrawal by Subject|3|||
46780053|NCT00612352|82998840|FG001|Overall Study|Withdrawal by Subject|5|||
46647460|NCT02749292|82853741|FG001|Overall Study|Physician Decision|0|||
46850517|NCT00112437|83066365|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850518|NCT00112437|83066366|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850519|NCT00112437|83066367|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850520|NCT00112437|83066368|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850521|NCT00112437|83066369|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850522|NCT00112437|83066370|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850523|NCT00112437|83066371|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850524|NCT00112437|83066372|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850525|NCT00112437|83066373|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850526|NCT00112437|83066374|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46970338|NCT02099110|83213354|FG000|Overall Study|Non-compliance with study drug|2|||
46970339|NCT02099110|83213355|FG001|Overall Study|Non-compliance with study drug|0|||
46970340|NCT02099110|83213356|FG002|Overall Study|Non-compliance with study drug|0|||
46970341|NCT02099110|83213357|FG003|Overall Study|Non-compliance with study drug|0|||
46970342|NCT02099110|83213358|FG004|Overall Study|Non-compliance with study drug|1|||
46970343|NCT02099110|83213354|FG000|Overall Study|Physician Decision|3|||
46970344|NCT02099110|83213355|FG001|Overall Study|Physician Decision|0|||
46970345|NCT02099110|83213356|FG002|Overall Study|Physician Decision|1|||
46970346|NCT02099110|83213357|FG003|Overall Study|Physician Decision|2|||
46970347|NCT02099110|83213358|FG004|Overall Study|Physician Decision|1|||
46970348|NCT02098876|83213372|FG000|Overall Study|Withdrawal by Subject|5|||
46970349|NCT02098876|83213373|FG001|Overall Study|Withdrawal by Subject|5|||
46970350|NCT01624090|83213383|FG000|Overall Study|DLT, taken off therapy|0|||
46970351|NCT01624090|83213384|FG001|Overall Study|DLT, taken off therapy|1|||
46970352|NCT01624090|83213385|FG002|Overall Study|DLT, taken off therapy|0|||
46970353|NCT01624090|83213386|FG003|Overall Study|DLT, taken off therapy|0|||
46970354|NCT01624090|83213383|FG000|Overall Study|Withdrew prior to treatment|0|||
46970355|NCT01624090|83213384|FG001|Overall Study|Withdrew prior to treatment|1|||
46970356|NCT01624090|83213385|FG002|Overall Study|Withdrew prior to treatment|0|||
46970357|NCT01624090|83213386|FG003|Overall Study|Withdrew prior to treatment|0|||
46970358|NCT01624090|83213383|FG000|Overall Study|Died on study|0|||
46970359|NCT01624090|83213384|FG001|Overall Study|Died on study|0|||
46970360|NCT01624090|83213385|FG002|Overall Study|Died on study|2|||
46970361|NCT01624090|83213386|FG003|Overall Study|Died on study|0|||
46970362|NCT01624090|83213383|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
46970363|NCT01624090|83213384|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
46970364|NCT01624090|83213385|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
46970365|NCT01624090|83213386|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
46970366|NCT01624090|83213383|FG000|Overall Study|Dose escalated|0|||
46970367|NCT01624090|83213384|FG001|Overall Study|Dose escalated|0|||
46970368|NCT01624090|83213385|FG002|Overall Study|Dose escalated|3|||
46970369|NCT01624090|83213386|FG003|Overall Study|Dose escalated|0|||
46970370|NCT02571777|83213401|FG000|Overall Study|Subject/guardian decision|34|||
46970371|NCT02571777|83213402|FG001|Overall Study|Subject/guardian decision|26|||
46970372|NCT02571777|83213403|FG002|Overall Study|Subject/guardian decision|26|||
46970373|NCT02571777|83213404|FG003|Overall Study|Subject/guardian decision|25|||
46970374|NCT02571777|83213405|FG004|Overall Study|Subject/guardian decision|27|||
46970375|NCT02571777|83213401|FG000|Overall Study|Protocol Deviation|2|||
46970376|NCT02571777|83213402|FG001|Overall Study|Protocol Deviation|3|||
46970377|NCT02571777|83213403|FG002|Overall Study|Protocol Deviation|4|||
46970378|NCT02571777|83213404|FG003|Overall Study|Protocol Deviation|8|||
46970379|NCT02571777|83213405|FG004|Overall Study|Protocol Deviation|4|||
46970380|NCT02571777|83213401|FG000|Overall Study|Death|1|||
46970381|NCT02571777|83213402|FG001|Overall Study|Death|1|||
46970382|NCT02571777|83213403|FG002|Overall Study|Death|4|||
46970383|NCT02571777|83213404|FG003|Overall Study|Death|0|||
46970384|NCT02571777|83213405|FG004|Overall Study|Death|0|||
46970385|NCT02571777|83213401|FG000|Overall Study|Lost to Follow-up|1|||
46970386|NCT02571777|83213402|FG001|Overall Study|Lost to Follow-up|1|||
46970387|NCT02571777|83213403|FG002|Overall Study|Lost to Follow-up|2|||
46970388|NCT02571777|83213404|FG003|Overall Study|Lost to Follow-up|0|||
46970389|NCT02571777|83213405|FG004|Overall Study|Lost to Follow-up|1|||
46850527|NCT00112437|83066375|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
47075011|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
46850528|NCT00112437|83066376|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850529|NCT00112437|83066377|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850530|NCT00112437|83066378|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850531|NCT00112437|83066379|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850532|NCT00112437|83066380|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850533|NCT00112437|83066381|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46970390|NCT02571777|83213401|FG000|Overall Study|Physician Decision|1|||
46970391|NCT02571777|83213402|FG001|Overall Study|Physician Decision|7|||
46970392|NCT02571777|83213403|FG002|Overall Study|Physician Decision|5|||
46970393|NCT02571777|83213404|FG003|Overall Study|Physician Decision|2|||
46970394|NCT02571777|83213405|FG004|Overall Study|Physician Decision|4|||
46970395|NCT02571777|83213401|FG000|Overall Study|Pregnancy|0|||
46647461|NCT02749292|82853740|FG000|Overall Study|Withdrawal by Subject|5|||
46647462|NCT02749292|82853741|FG001|Overall Study|Withdrawal by Subject|7|||
46647463|NCT02749292|82853740|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
46647464|NCT02749292|82853741|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
46647465|NCT02749292|82853740|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
46647466|NCT02749292|82853741|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
46647467|NCT02749292|82853740|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
46647468|NCT02749292|82853741|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
46647469|NCT02749292|82853740|FG000|Overall Study|Adverse Event|4|||
46647470|NCT02749292|82853741|FG001|Overall Study|Adverse Event|1|||
46647471|NCT02749292|82853740|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
46647472|NCT02749292|82853741|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
46647473|NCT02749292|82853740|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
46647474|NCT02749292|82853741|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
46647475|NCT02749292|82853740|FG000|Overall Study|Requiring glucocorticoids|0|||
46647476|NCT02749292|82853741|FG001|Overall Study|Requiring glucocorticoids|3|||
46647477|NCT02749292|82853740|FG000|Overall Study|Cancer|1|||
46647478|NCT02749292|82853741|FG001|Overall Study|Cancer|0|||
46647479|NCT02689076|82853760|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
46647480|NCT02689076|82853761|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
46647481|NCT02689076|82853762|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
46647482|NCT02689076|82853760|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
46647483|NCT02689076|82853761|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
46647484|NCT02689076|82853762|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
46647485|NCT02689076|82853760|FG000|Overall Study|Did not have an HIE match|2|||
46647486|NCT02689076|82853761|FG001|Overall Study|Did not have an HIE match|0|||
46647487|NCT02689076|82853762|FG002|Overall Study|Did not have an HIE match|0|||
46647488|NCT02689076|82853760|FG000|Overall Study|Death during non-VA encounter|2|||
46647489|NCT02689076|82853761|FG001|Overall Study|Death during non-VA encounter|5|||
46647490|NCT02689076|82853762|FG002|Overall Study|Death during non-VA encounter|0|||
46647491|NCT02689076|82853760|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
46647492|NCT02689076|82853761|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
46647493|NCT02689076|82853762|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
46647494|NCT02689076|82853760|FG000|Overall Study|Participant no longer active in VA system|1|||
46647495|NCT02689076|82853761|FG001|Overall Study|Participant no longer active in VA system|0|||
46780054|NCT00612352|82998839|FG000|Overall Study|moved out of state|1|||
46780055|NCT00612352|82998840|FG001|Overall Study|moved out of state|0|||
46780056|NCT00612352|82998839|FG000|Overall Study|didn't return calls/show up on test date|4|||
46780057|NCT00612352|82998840|FG001|Overall Study|didn't return calls/show up on test date|1|||
46780058|NCT00704730|82998848|FG000|Overall Study|Adverse Event|35|||
46780059|NCT00704730|82998849|FG001|Overall Study|Adverse Event|9|||
46780060|NCT00704730|82998848|FG000|Overall Study|Death|11|||
46780061|NCT00704730|82998849|FG001|Overall Study|Death|5|||
46780062|NCT00704730|82998848|FG000|Overall Study|Physician Decision|2|||
46780063|NCT00704730|82998849|FG001|Overall Study|Physician Decision|0|||
46780064|NCT00704730|82998848|FG000|Overall Study|Did not receive drug|5|||
46780065|NCT00704730|82998849|FG001|Overall Study|Did not receive drug|2|||
46780066|NCT00704730|82998848|FG000|Overall Study|Disease progression per PI|58|||
46780067|NCT00704730|82998849|FG001|Overall Study|Disease progression per PI|67|||
46780068|NCT00704730|82998848|FG000|Overall Study|data unavailable|1|||
46780069|NCT00704730|82998849|FG001|Overall Study|data unavailable|0|||
46780070|NCT00704730|82998848|FG000|Overall Study|Withdrawal by Subject|9|||
46780071|NCT00704730|82998849|FG001|Overall Study|Withdrawal by Subject|13|||
46780072|NCT00651261|82998858|FG000|Overall Study|Adverse Event|32|||
46780073|NCT00651261|82998859|FG001|Overall Study|Adverse Event|22|||
46780074|NCT00651261|82998858|FG000|Overall Study|Death|18|||
46780075|NCT00651261|82998859|FG001|Overall Study|Death|18|||
46780076|NCT00651261|82998858|FG000|Overall Study|Withdrawal by Subject|22|||
46780077|NCT00651261|82998859|FG001|Overall Study|Withdrawal by Subject|40|||
46780078|NCT00651261|82998858|FG000|Overall Study|Induction failure|24|||
46780079|NCT00651261|82998859|FG001|Overall Study|Induction failure|35|||
46780080|NCT00651261|82998858|FG000|Overall Study|Disease progression|58|||
46780081|NCT00651261|82998859|FG001|Overall Study|Disease progression|58|||
46780082|NCT00651261|82998858|FG000|Overall Study|Alternative therapy|109|||
46780083|NCT00651261|82998859|FG001|Overall Study|Alternative therapy|107|||
46780084|NCT00651261|82998858|FG000|Overall Study|Other disease or participant decisions|23|||
46850534|NCT00112437|83066382|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46970396|NCT02571777|83213402|FG001|Overall Study|Pregnancy|0|||
46780085|NCT00651261|82998859|FG001|Overall Study|Other disease or participant decisions|23|||
46780086|NCT00651261|82998858|FG000|Overall Study|Never treated|5|||
46647496|NCT02689076|82853762|FG002|Overall Study|Participant no longer active in VA system|0|||
46647497|NCT02689076|82853760|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
46647498|NCT02689076|82853761|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
46647499|NCT02689076|82853762|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
46647500|NCT02576990|82853772|FG000|Overall Study|Death|29|||
46647501|NCT02576990|82853773|FG001|Overall Study|Death|18|||
46647502|NCT02576990|82853772|FG000|Overall Study|Physician Decision|1|||
46647503|NCT02576990|82853773|FG001|Overall Study|Physician Decision|0|||
46647504|NCT02576990|82853772|FG000|Overall Study|Screen failure|2|||
46647505|NCT02576990|82853773|FG001|Overall Study|Screen failure|0|||
46647506|NCT02576990|82853772|FG000|Overall Study|Sponsor's decision|24|||
46647507|NCT02576990|82853773|FG001|Overall Study|Sponsor's decision|4|||
46647508|NCT02576990|82853772|FG000|Overall Study|Withdrawal by Subject|0|||
46647509|NCT02576990|82853773|FG001|Overall Study|Withdrawal by Subject|2|||
46647510|NCT02550561|82853779|FG000|Overall Study|Lost to Follow-up|5|||
46647511|NCT02550561|82853779|FG000|Overall Study|Withdrawal by Subject|1|||
46647512|NCT02524171|82853789|FG000|6-month Follow-up|Lost to Follow-up|53|||
46647513|NCT02524171|82853790|FG001|6-month Follow-up|Lost to Follow-up|45|||
46647514|NCT02524171|82853789|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
46647515|NCT02524171|82853790|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
46647516|NCT02511106|82853798|FG000|Overall Study|Lost to Follow-up|1|||
46647517|NCT02511106|82853799|FG001|Overall Study|Lost to Follow-up|2|||
46647518|NCT02511106|82853798|FG000|Overall Study|Withdrawal by Subject|19|||
46647519|NCT02511106|82853799|FG001|Overall Study|Withdrawal by Subject|14|||
46647520|NCT02511106|82853798|FG000|Overall Study|Ongoing study at data cut-off|309|||
46647521|NCT02511106|82853799|FG001|Overall Study|Ongoing study at data cut-off|307|||
46647522|NCT02511106|82853798|FG000|Overall Study|Without specified reason|1|||
46647523|NCT02511106|82853799|FG001|Overall Study|Without specified reason|0|||
46647524|NCT02511106|82853798|FG000|Overall Study|Missing|1|||
46647525|NCT02511106|82853799|FG001|Overall Study|Missing|0|||
46647526|NCT02500589|82853809|FG000|Overall Study|Withdrawal by Subject|11|||
46647527|NCT02500589|82853810|FG001|Overall Study|Withdrawal by Subject|14|||
46647528|NCT02500589|82853809|FG000|Overall Study|Lost to Follow-up|10|||
46647529|NCT02500589|82853810|FG001|Overall Study|Lost to Follow-up|12|||
46647530|NCT02500589|82853809|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
46647531|NCT02500589|82853810|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
46647532|NCT02500589|82853809|FG000|Overall Study|Death|7|||
46647533|NCT02500589|82853810|FG001|Overall Study|Death|5|||
46647534|NCT02481830|82853822|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
46647535|NCT02481830|82853823|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
46647536|NCT02481830|82853822|FG000|Pre-treatment|Withdrawal by Subject|0|||
46647537|NCT02481830|82853823|FG001|Pre-treatment|Withdrawal by Subject|10|||
47075012|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
47075013|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
47075014|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
47075015|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
47075016|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
47075017|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
47075018|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
47075019|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
47075020|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
47075021|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
47075022|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
47075023|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
47075024|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
47075025|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075026|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075027|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075028|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075029|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075030|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
46647538|NCT02481830|82853822|FG000|Pre-treatment|Disease Progression|1|||
46647539|NCT02481830|82853823|FG001|Pre-treatment|Disease Progression|1|||
46647540|NCT02481830|82853822|FG000|Pre-treatment|Other reasons|0|||
46647541|NCT02481830|82853823|FG001|Pre-treatment|Other reasons|1|||
46647542|NCT02481830|82853822|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
46647543|NCT02481830|82853823|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
46647544|NCT02481830|82853822|FG000|Treatment|Disease Progression|233|||
46647545|NCT02481830|82853823|FG001|Treatment|Disease Progression|171|||
46647546|NCT02481830|82853822|FG000|Treatment|Study drug toxicity|18|||
46647547|NCT02481830|82853823|FG001|Treatment|Study drug toxicity|38|||
46647548|NCT02481830|82853822|FG000|Treatment|Death|1|||
46647549|NCT02481830|82853823|FG001|Treatment|Death|1|||
46647550|NCT02481830|82853822|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
46647551|NCT02481830|82853823|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
46647552|NCT02481830|82853822|FG000|Treatment|Participants request to discontinue Study treatment|6|||
46647553|NCT02481830|82853823|FG001|Treatment|Participants request to discontinue Study treatment|34|||
46647554|NCT02481830|82853822|FG000|Treatment|Withdrawal by Subject|2|||
46647555|NCT02481830|82853823|FG001|Treatment|Withdrawal by Subject|3|||
46647556|NCT02481830|82853822|FG000|Treatment|Lost to Follow-up|1|||
46647557|NCT02481830|82853823|FG001|Treatment|Lost to Follow-up|0|||
46647558|NCT02481830|82853822|FG000|Treatment|Maximum Clinical Benefit|0|||
46647559|NCT02481830|82853823|FG001|Treatment|Maximum Clinical Benefit|5|||
46647560|NCT02481830|82853822|FG000|Treatment|Administrative reason by sponsor|1|||
46647561|NCT02481830|82853823|FG001|Treatment|Administrative reason by sponsor|1|||
46647562|NCT02481830|82853822|FG000|Treatment|Other reasons|6|||
46647563|NCT02481830|82853823|FG001|Treatment|Other reasons|1|||
46647564|NCT02477111|82853829|FG000|Overall Study|Death|5|||
46647565|NCT02477111|82853829|FG000|Overall Study|Withdrawal by Subject|2|||
46647566|NCT02477111|82853829|FG000|Overall Study|missed visit|4|||
46647567|NCT02425943|82853837|FG000|Overall Study|Adverse Event|3|||
46647568|NCT02425943|82853838|FG001|Overall Study|Adverse Event|1|||
46647569|NCT02425943|82853837|FG000|Overall Study|Lost to Follow-up|59|||
46647570|NCT02425943|82853838|FG001|Overall Study|Lost to Follow-up|37|||
46647571|NCT02425943|82853837|FG000|Overall Study|Protocol Violation|4|||
46647572|NCT02425943|82853838|FG001|Overall Study|Protocol Violation|1|||
46647573|NCT02425943|82853837|FG000|Overall Study|Withdrawal by Subject|64|||
46647574|NCT02425943|82853838|FG001|Overall Study|Withdrawal by Subject|31|||
46647575|NCT02425943|82853837|FG000|Overall Study|Other|6|||
46647576|NCT02425943|82853838|FG001|Overall Study|Other|0|||
46647577|NCT02383173|82853848|FG000|Overall Study|Palliative Care Team withdrew|0|||
46647578|NCT02383173|82853849|FG001|Overall Study|Palliative Care Team withdrew|2|||
46647579|NCT02380690|82853857|FG000|Overall Study|Lost to Follow-up|14|||
46647580|NCT02380690|82853858|FG001|Overall Study|Lost to Follow-up|4|||
46647581|NCT02380690|82853857|FG000|Overall Study|Withdrawal by Subject|20|||
46647582|NCT02380690|82853858|FG001|Overall Study|Withdrawal by Subject|8|||
46780087|NCT00651261|82998859|FG001|Overall Study|Never treated|3|||
46780088|NCT00651183|82998867|FG000|Overall Study|Lack of Efficacy|1|||
46850535|NCT00112437|83066383|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850536|NCT00112437|83066384|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850537|NCT00112437|83066385|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
46850538|NCT00112437|83066386|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
46850539|NCT00112437|83066387|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
46850540|NCT00112437|83066388|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
46850541|NCT00112437|83066363|FG000|Years 6-10 (60-Month Extension)|Death|0|||
46850542|NCT00112437|83066364|FG001|Years 6-10 (60-Month Extension)|Death|0|||
46850543|NCT00112437|83066365|FG002|Years 6-10 (60-Month Extension)|Death|0|||
46850544|NCT00112437|83066366|FG003|Years 6-10 (60-Month Extension)|Death|0|||
46850545|NCT00112437|83066367|FG004|Years 6-10 (60-Month Extension)|Death|0|||
46850546|NCT00112437|83066368|FG005|Years 6-10 (60-Month Extension)|Death|0|||
46780089|NCT00651183|82998868|FG001|Overall Study|Lack of Efficacy|0|||
46780090|NCT00651183|82998867|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
46850547|NCT00112437|83066369|FG006|Years 6-10 (60-Month Extension)|Death|0|||
46850548|NCT00112437|83066370|FG007|Years 6-10 (60-Month Extension)|Death|0|||
47075031|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
46780091|NCT00651183|82998868|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
46780092|NCT00651183|82998867|FG000|Overall Study|Tolerability insufficient|5|||
46780093|NCT00651183|82998868|FG001|Overall Study|Tolerability insufficient|2|||
46780094|NCT00651183|82998867|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
46780095|NCT00651183|82998868|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
46850549|NCT00112437|83066371|FG008|Years 6-10 (60-Month Extension)|Death|0|||
46780096|NCT00651183|82998867|FG000|Overall Study|Withdrawal by Subject|6|||
46850550|NCT00112437|83066372|FG009|Years 6-10 (60-Month Extension)|Death|0|||
46850551|NCT00112437|83066373|FG010|Years 6-10 (60-Month Extension)|Death|0|||
46780097|NCT00651183|82998868|FG001|Overall Study|Withdrawal by Subject|3|||
46850552|NCT00112437|83066374|FG011|Years 6-10 (60-Month Extension)|Death|0|||
46647583|NCT02311673|82853900|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
46647584|NCT02311673|82853901|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
46647585|NCT02311673|82853902|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
46647586|NCT02311673|82853903|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
46647587|NCT02233738|82853937|FG000|Overall Study|Lost to Follow-up|5|||
46850553|NCT00112437|83066375|FG012|Years 6-10 (60-Month Extension)|Death|0|||
46850554|NCT00112437|83066376|FG013|Years 6-10 (60-Month Extension)|Death|0|||
46850555|NCT00112437|83066377|FG014|Years 6-10 (60-Month Extension)|Death|0|||
46850556|NCT00112437|83066378|FG015|Years 6-10 (60-Month Extension)|Death|0|||
46850557|NCT00112437|83066379|FG016|Years 6-10 (60-Month Extension)|Death|0|||
46850558|NCT00112437|83066380|FG017|Years 6-10 (60-Month Extension)|Death|0|||
46850559|NCT00112437|83066381|FG018|Years 6-10 (60-Month Extension)|Death|0|||
46850560|NCT00112437|83066382|FG019|Years 6-10 (60-Month Extension)|Death|0|||
46850561|NCT00112437|83066383|FG020|Years 6-10 (60-Month Extension)|Death|0|||
46850562|NCT00112437|83066384|FG021|Years 6-10 (60-Month Extension)|Death|0|||
46850563|NCT00112437|83066385|FG022|Years 6-10 (60-Month Extension)|Death|0|||
46850564|NCT00112437|83066386|FG023|Years 6-10 (60-Month Extension)|Death|2|||
46850565|NCT00112437|83066387|FG024|Years 6-10 (60-Month Extension)|Death|0|||
46850566|NCT00112437|83066388|FG025|Years 6-10 (60-Month Extension)|Death|0|||
46850567|NCT00112437|83066363|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850568|NCT00112437|83066364|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850569|NCT00112437|83066365|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850570|NCT00112437|83066366|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850571|NCT00112437|83066367|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850572|NCT00112437|83066368|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850573|NCT00112437|83066369|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850574|NCT00112437|83066370|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850575|NCT00112437|83066371|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850576|NCT00112437|83066372|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850577|NCT00112437|83066373|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850578|NCT00112437|83066374|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850579|NCT00112437|83066375|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850580|NCT00112437|83066376|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850581|NCT00112437|83066377|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850582|NCT00112437|83066378|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850583|NCT00112437|83066379|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850584|NCT00112437|83066380|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850585|NCT00112437|83066381|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850586|NCT00112437|83066382|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850587|NCT00112437|83066383|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850588|NCT00112437|83066384|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850589|NCT00112437|83066385|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850590|NCT00112437|83066386|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850591|NCT00112437|83066387|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
46850592|NCT00112437|83066388|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
46850593|NCT00112437|83066363|FG000|Years 6-10 (60-Month Extension)|Other|0|||
46850594|NCT00112437|83066364|FG001|Years 6-10 (60-Month Extension)|Other|0|||
46850595|NCT00112437|83066365|FG002|Years 6-10 (60-Month Extension)|Other|0|||
46850596|NCT00112437|83066366|FG003|Years 6-10 (60-Month Extension)|Other|0|||
46850597|NCT00112437|83066367|FG004|Years 6-10 (60-Month Extension)|Other|0|||
46850598|NCT00112437|83066368|FG005|Years 6-10 (60-Month Extension)|Other|0|||
46850599|NCT00112437|83066369|FG006|Years 6-10 (60-Month Extension)|Other|0|||
46850600|NCT00112437|83066370|FG007|Years 6-10 (60-Month Extension)|Other|0|||
46850601|NCT00112437|83066371|FG008|Years 6-10 (60-Month Extension)|Other|0|||
46970397|NCT02571777|83213403|FG002|Overall Study|Pregnancy|0|||
46970398|NCT02571777|83213404|FG003|Overall Study|Pregnancy|2|||
46970399|NCT02571777|83213405|FG004|Overall Study|Pregnancy|0|||
46780098|NCT00651183|82998867|FG000|Overall Study|Lost to Follow-up|3|||
46780099|NCT00651183|82998868|FG001|Overall Study|Lost to Follow-up|1|||
46780100|NCT00651183|82998867|FG000|Overall Study|Other reasons|4|||
46780101|NCT00651183|82998868|FG001|Overall Study|Other reasons|2|||
46780102|NCT00651183|82998867|FG000|Overall Study|missing|1|||
46780103|NCT00651183|82998868|FG001|Overall Study|missing|0|||
46780104|NCT00699972|82998877|FG000|Overall Study|Adverse Event|7|||
46780105|NCT00699972|82998878|FG001|Overall Study|Adverse Event|9|||
46780106|NCT00699972|82998879|FG002|Overall Study|Adverse Event|24|||
46780107|NCT00699972|82998877|FG000|Overall Study|Lost to Follow-up|0|||
46850602|NCT00112437|83066372|FG009|Years 6-10 (60-Month Extension)|Other|0|||
46850603|NCT00112437|83066373|FG010|Years 6-10 (60-Month Extension)|Other|0|||
47075032|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
46850604|NCT00112437|83066374|FG011|Years 6-10 (60-Month Extension)|Other|0|||
46780108|NCT00699972|82998878|FG001|Overall Study|Lost to Follow-up|2|||
46780109|NCT00699972|82998879|FG002|Overall Study|Lost to Follow-up|0|||
46780110|NCT00699972|82998877|FG000|Overall Study|Withdrawal by Subject|3|||
46850605|NCT00112437|83066375|FG012|Years 6-10 (60-Month Extension)|Other|0|||
46850606|NCT00112437|83066376|FG013|Years 6-10 (60-Month Extension)|Other|0|||
46970400|NCT02571075|83213419|FG000|Overall Study|Lost to Follow-up|20|||
47075033|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
46780111|NCT00699972|82998878|FG001|Overall Study|Withdrawal by Subject|7|||
46647588|NCT02233738|82853938|FG001|Overall Study|Lost to Follow-up|12|||
46647589|NCT02233738|82853937|FG000|Overall Study|Death|0|||
46647590|NCT02233738|82853938|FG001|Overall Study|Death|1|||
46647591|NCT02233738|82853937|FG000|Overall Study|Withdrawal by Subject|0|||
46647592|NCT02233738|82853938|FG001|Overall Study|Withdrawal by Subject|1|||
46647593|NCT02233738|82853937|FG000|Overall Study|Did not return after Baseline|3|||
46647594|NCT02233738|82853938|FG001|Overall Study|Did not return after Baseline|2|||
46647595|NCT01959698|82854126|FG000|Overall Study|Adverse Event|0|||
46647596|NCT01959698|82854127|FG001|Overall Study|Adverse Event|0|||
46647597|NCT01959698|82854128|FG002|Overall Study|Adverse Event|0|||
46647598|NCT01959698|82854129|FG003|Overall Study|Adverse Event|0|||
46647599|NCT01959698|82854130|FG004|Overall Study|Adverse Event|0|||
46647600|NCT01959698|82854131|FG005|Overall Study|Adverse Event|0|||
46647601|NCT01959698|82854132|FG006|Overall Study|Adverse Event|1|||
46647602|NCT01959698|82854126|FG000|Overall Study|Physician Decision|1|||
46647603|NCT01959698|82854127|FG001|Overall Study|Physician Decision|0|||
46647604|NCT01959698|82854128|FG002|Overall Study|Physician Decision|1|||
46647605|NCT01959698|82854129|FG003|Overall Study|Physician Decision|2|||
46647606|NCT01959698|82854130|FG004|Overall Study|Physician Decision|0|||
46647607|NCT01959698|82854131|FG005|Overall Study|Physician Decision|3|||
46647608|NCT01959698|82854132|FG006|Overall Study|Physician Decision|3|||
46647609|NCT01614197|82854167|FG000|Overall Study|Withdrawal by Subject|0|||
46647610|NCT01614197|82854168|FG001|Overall Study|Withdrawal by Subject|1|||
46647611|NCT01614197|82854169|FG002|Overall Study|Withdrawal by Subject|0|||
46647612|NCT01614197|82854170|FG003|Overall Study|Withdrawal by Subject|0|||
46647613|NCT01236521|82854204|FG000|Overall Study|Withdrawal by Subject|12|||
46647614|NCT01236521|82854205|FG001|Overall Study|Withdrawal by Subject|17|||
46647615|NCT01236521|82854204|FG000|Overall Study|Death|2|||
46647616|NCT01236521|82854205|FG001|Overall Study|Death|1|||
46647617|NCT01236521|82854204|FG000|Overall Study|Lost to Follow-up|9|||
46647618|NCT01236521|82854205|FG001|Overall Study|Lost to Follow-up|7|||
46647619|NCT01226797|82854213|FG000|Overall Study|Adverse Event|1|||
46647620|NCT01226797|82854214|FG001|Overall Study|Adverse Event|0|||
46647621|NCT01226797|82854213|FG000|Overall Study|No longer willing to participate|1|||
46647622|NCT01226797|82854214|FG001|Overall Study|No longer willing to participate|0|||
46647623|NCT01226797|82854213|FG000|Overall Study|Protocol Violation|0|||
46647624|NCT01226797|82854214|FG001|Overall Study|Protocol Violation|1|||
46647625|NCT01142908|82854222|FG000|Overall Study|Lost to Follow-up|19|||
46647626|NCT01142908|82854223|FG001|Overall Study|Lost to Follow-up|13|||
46647627|NCT01142908|82854222|FG000|Overall Study|Death|1|||
46647628|NCT01142908|82854223|FG001|Overall Study|Death|4|||
46647629|NCT01142908|82854222|FG000|Overall Study|Excluded - did not meet criteria|9|||
46647630|NCT01142908|82854223|FG001|Overall Study|Excluded - did not meet criteria|5|||
46647631|NCT01142908|82854222|FG000|Overall Study|Withdrawal by Subject|3|||
46647632|NCT01142908|82854223|FG001|Overall Study|Withdrawal by Subject|0|||
46647633|NCT04962230|82854272|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
46647634|NCT04962230|82854272|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
46647635|NCT04919317|82854353|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
46647636|NCT04919317|82854354|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
46647637|NCT04919317|82854353|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
46647638|NCT04919317|82854354|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
46647639|NCT04789577|82854424|FG000|Overall Study|Withdrawal by Subject|1|||
46647640|NCT04789577|82854425|FG001|Overall Study|Withdrawal by Subject|1|||
46647641|NCT04789577|82854426|FG002|Overall Study|Withdrawal by Subject|1|||
46647642|NCT04789577|82854427|FG003|Overall Study|Withdrawal by Subject|3|||
46647643|NCT04789577|82854428|FG004|Overall Study|Withdrawal by Subject|1|||
46647644|NCT04789577|82854429|FG005|Overall Study|Withdrawal by Subject|7|||
46647645|NCT04789577|82854430|FG006|Overall Study|Withdrawal by Subject|1|||
46647646|NCT04789577|82854424|FG000|Overall Study|Lost to Follow-up|7|||
46647647|NCT04789577|82854425|FG001|Overall Study|Lost to Follow-up|12|||
46647648|NCT04789577|82854426|FG002|Overall Study|Lost to Follow-up|7|||
46647649|NCT04789577|82854427|FG003|Overall Study|Lost to Follow-up|10|||
46647650|NCT04789577|82854428|FG004|Overall Study|Lost to Follow-up|8|||
46647651|NCT04789577|82854429|FG005|Overall Study|Lost to Follow-up|6|||
46647652|NCT04789577|82854430|FG006|Overall Study|Lost to Follow-up|10|||
46647653|NCT04789577|82854424|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
46647654|NCT04789577|82854425|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
46647655|NCT04789577|82854426|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
46647656|NCT04789577|82854427|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
46647657|NCT04789577|82854428|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
46647658|NCT04789577|82854429|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
46647659|NCT04789577|82854430|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
46647660|NCT04789577|82854424|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
46647661|NCT04789577|82854425|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
46647662|NCT04789577|82854426|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
46647663|NCT04789577|82854427|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
46647664|NCT04789577|82854428|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
46647665|NCT04789577|82854429|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
46647666|NCT04789577|82854430|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
46647667|NCT04480463|82854491|FG000|Overall Study|Death|0|||
46647668|NCT04480463|82854492|FG001|Overall Study|Death|1|||
46647669|NCT04480463|82854491|FG000|Overall Study|Adverse Event|6|||
46647670|NCT04480463|82854492|FG001|Overall Study|Adverse Event|8|||
46647671|NCT04480463|82854491|FG000|Overall Study|Lost to Follow-up|3|||
46647672|NCT04480463|82854492|FG001|Overall Study|Lost to Follow-up|2|||
46647673|NCT04480463|82854491|FG000|Overall Study|Physician Decision|2|||
46647674|NCT04480463|82854492|FG001|Overall Study|Physician Decision|5|||
46647675|NCT04480463|82854491|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
46647676|NCT04480463|82854492|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
46647677|NCT04480463|82854491|FG000|Overall Study|Protocol Violation|2|||
46647678|NCT04480463|82854492|FG001|Overall Study|Protocol Violation|1|||
46647679|NCT04480463|82854491|FG000|Overall Study|Withdrawal by Subject|6|||
46647680|NCT04480463|82854492|FG001|Overall Study|Withdrawal by Subject|7|||
46647681|NCT04480463|82854491|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
46647682|NCT04480463|82854492|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
46647683|NCT04480463|82854491|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
46647684|NCT04480463|82854492|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
46647685|NCT04480463|82854491|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
46780112|NCT00699972|82998879|FG002|Overall Study|Withdrawal by Subject|4|||
46780113|NCT00699972|82998877|FG000|Overall Study|Lack of Efficacy|2|||
46647686|NCT04480463|82854492|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
46647687|NCT04480463|82854491|FG000|Overall Study|Other|6|||
46647688|NCT04480463|82854492|FG001|Overall Study|Other|4|||
46780114|NCT00699972|82998878|FG001|Overall Study|Lack of Efficacy|0|||
46780115|NCT00699972|82998879|FG002|Overall Study|Lack of Efficacy|2|||
46780116|NCT00699972|82998877|FG000|Overall Study|Administrative/Other|3|||
46780117|NCT00699972|82998878|FG001|Overall Study|Administrative/Other|1|||
46850607|NCT00112437|83066377|FG014|Years 6-10 (60-Month Extension)|Other|0|||
46647689|NCT04285853|82854500|FG000|Overall Study|Withdrawal by Subject|1|||
46647690|NCT04285853|82854501|FG001|Overall Study|Withdrawal by Subject|0|||
46647691|NCT04285853|82854500|FG000|Overall Study|Lost to Follow-up|9|||
46647692|NCT04285853|82854501|FG001|Overall Study|Lost to Follow-up|5|||
46647693|NCT04102579|82854509|FG000|Overall Study|Withdrawal by Subject|3|||
46647694|NCT04102579|82854510|FG001|Overall Study|Withdrawal by Subject|4|||
46647695|NCT04102579|82854509|FG000|Overall Study|Lost to Follow-up|0|||
46647696|NCT04102579|82854510|FG001|Overall Study|Lost to Follow-up|1|||
46647697|NCT04102579|82854509|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
46647698|NCT04102579|82854510|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
46647699|NCT04102579|82854509|FG000|Overall Study|Other than Specified|1|||
46647700|NCT04102579|82854510|FG001|Overall Study|Other than Specified|0|||
46647701|NCT04102579|82854509|FG000|Overall Study|Not Dosed with Study Drug|0|||
46647702|NCT04102579|82854510|FG001|Overall Study|Not Dosed with Study Drug|1|||
46647703|NCT04034004|82854620|FG000|Overall Study|Withdrawal by Subject|1|||
46647704|NCT04034004|82854621|FG001|Overall Study|Withdrawal by Subject|2|||
46647705|NCT04034004|82854622|FG002|Overall Study|Withdrawal by Subject|2|||
46647706|NCT04034004|82854623|FG003|Overall Study|Withdrawal by Subject|3|||
46647707|NCT04034004|82854620|FG000|Overall Study|could not find vein to administer IV|2|||
46647708|NCT04034004|82854621|FG001|Overall Study|could not find vein to administer IV|1|||
46647709|NCT04034004|82854622|FG002|Overall Study|could not find vein to administer IV|0|||
46647710|NCT04034004|82854623|FG003|Overall Study|could not find vein to administer IV|0|||
46647711|NCT04034004|82854620|FG000|Overall Study|nurse accidentally unblinded subject|0|||
46647712|NCT04034004|82854621|FG001|Overall Study|nurse accidentally unblinded subject|0|||
46647713|NCT04034004|82854622|FG002|Overall Study|nurse accidentally unblinded subject|0|||
46647714|NCT04034004|82854623|FG003|Overall Study|nurse accidentally unblinded subject|1|||
46647715|NCT03629223|82854638|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
46647716|NCT03629223|82854639|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
46647717|NCT03629223|82854640|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
46647718|NCT03629223|82854641|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
46647719|NCT03629223|82854642|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
46647720|NCT03629223|82854643|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
46647721|NCT03629223|82854638|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
46647722|NCT03629223|82854639|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
46647723|NCT03629223|82854640|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
46647724|NCT03629223|82854641|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
46647725|NCT03629223|82854642|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
46647726|NCT03629223|82854643|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
46647727|NCT03629223|82854638|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
46647728|NCT03629223|82854639|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
46647729|NCT03629223|82854640|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
46647730|NCT03629223|82854641|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
46647731|NCT03629223|82854642|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
46647732|NCT03629223|82854643|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
46647733|NCT03629223|82854638|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
46647734|NCT03629223|82854639|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
46647735|NCT03629223|82854640|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
46647736|NCT03629223|82854641|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
46647737|NCT03629223|82854642|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
46647738|NCT03629223|82854643|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
46647739|NCT03629223|82854638|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
46647740|NCT03629223|82854639|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
46647741|NCT03629223|82854640|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
46647742|NCT03629223|82854641|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
46647743|NCT03629223|82854642|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
46647744|NCT03629223|82854643|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
46647745|NCT03395405|82854659|FG000|Overall Study|Death|0|||
46647746|NCT03395405|82854660|FG001|Overall Study|Death|2|||
46647747|NCT03395405|82854659|FG000|Overall Study|Lost to Follow-up|0|||
46647748|NCT03395405|82854660|FG001|Overall Study|Lost to Follow-up|1|||
46647749|NCT03395405|82854659|FG000|Overall Study|Protocol Violation|0|||
46647750|NCT03395405|82854660|FG001|Overall Study|Protocol Violation|1|||
46970401|NCT02571075|83213420|FG001|Overall Study|Lost to Follow-up|24|||
46647751|NCT03395405|82854659|FG000|Overall Study|Withdrawal by Subject|3|||
46647752|NCT03395405|82854660|FG001|Overall Study|Withdrawal by Subject|1|||
46970402|NCT02705105|83213434|FG000|Treatment|Objective Disease Progression|1|||
46970403|NCT02705105|83213435|FG001|Treatment|Objective Disease Progression|50|||
47075034|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
46647753|NCT03395405|82854659|FG000|Overall Study|COVID-19 Pandemic|1|||
46647754|NCT03395405|82854660|FG001|Overall Study|COVID-19 Pandemic|0|||
46647755|NCT03381248|82854668|FG000|0-6 Months|Withdrawal by Subject|4|||
46647756|NCT03381248|82854669|FG001|0-6 Months|Withdrawal by Subject|1|||
46647757|NCT03381248|82854668|FG000|0-6 Months|Lost to Follow-up|3|||
46647758|NCT03381248|82854669|FG001|0-6 Months|Lost to Follow-up|2|||
46647759|NCT03381248|82854668|FG000|0-6 Months|Lack of Efficacy|1|||
46647760|NCT03381248|82854669|FG001|0-6 Months|Lack of Efficacy|0|||
46780118|NCT00699972|82998879|FG002|Overall Study|Administrative/Other|4|||
46780119|NCT00699972|82998877|FG000|Overall Study|Randomized, Not Treated|1|||
46780120|NCT00699972|82998878|FG001|Overall Study|Randomized, Not Treated|0|||
46780121|NCT00699972|82998879|FG002|Overall Study|Randomized, Not Treated|1|||
46780122|NCT00642759|82998887|FG000|Overall Study|Protocol Violation|1|||
46780123|NCT00611026|82998895|FG000|Randomized to Double-blind Treatment|Not treated|2|||
46780124|NCT00611026|82998896|FG001|Randomized to Double-blind Treatment|Not treated|1|||
46780125|NCT00611026|82998897|FG002|Randomized to Double-blind Treatment|Not treated|3|||
46780126|NCT00611026|82998895|FG000|Double-blind Treatment Period|Death|1|||
46780127|NCT00611026|82998896|FG001|Double-blind Treatment Period|Death|0|||
46780128|NCT00611026|82998897|FG002|Double-blind Treatment Period|Death|0|||
46780129|NCT00611026|82998895|FG000|Double-blind Treatment Period|Adverse Event|9|||
46780130|NCT00611026|82998896|FG001|Double-blind Treatment Period|Adverse Event|28|||
46780131|NCT00611026|82998897|FG002|Double-blind Treatment Period|Adverse Event|46|||
46780132|NCT00611026|82998895|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
46780133|NCT00611026|82998896|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
46780134|NCT00611026|82998897|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
46780135|NCT00611026|82998895|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
46780136|NCT00611026|82998896|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
46780137|NCT00611026|82998897|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
46780138|NCT00611026|82998895|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
46780139|NCT00611026|82998896|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
46780140|NCT00611026|82998897|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
46780141|NCT00611026|82998895|FG000|Double-blind Treatment Period|Other|13|||
46780142|NCT00611026|82998896|FG001|Double-blind Treatment Period|Other|20|||
46780143|NCT00611026|82998897|FG002|Double-blind Treatment Period|Other|18|||
46780144|NCT00646113|82998907|FG000|Overall Study|Lost to Follow-up|5|||
46780145|NCT00646113|82998907|FG000|Overall Study|Adverse Event|3|||
46780146|NCT00422383|82998916|FG000|Overall Study|Adverse Event|5|||
46780147|NCT00422383|82998917|FG001|Overall Study|Adverse Event|3|||
46780148|NCT00422383|82998918|FG002|Overall Study|Adverse Event|1|||
46780149|NCT00422383|82998919|FG003|Overall Study|Adverse Event|1|||
46780150|NCT00422383|82998920|FG004|Overall Study|Adverse Event|0|||
46780151|NCT00422383|82998916|FG000|Overall Study|Lack of Efficacy|4|||
46780152|NCT00422383|82998917|FG001|Overall Study|Lack of Efficacy|4|||
46780153|NCT00422383|82998918|FG002|Overall Study|Lack of Efficacy|2|||
46780154|NCT00422383|82998919|FG003|Overall Study|Lack of Efficacy|1|||
46780155|NCT00422383|82998920|FG004|Overall Study|Lack of Efficacy|1|||
46780156|NCT00422383|82998916|FG000|Overall Study|Lost to Follow-up|0|||
46780157|NCT00422383|82998917|FG001|Overall Study|Lost to Follow-up|1|||
46780158|NCT00422383|82998918|FG002|Overall Study|Lost to Follow-up|0|||
46780159|NCT00422383|82998919|FG003|Overall Study|Lost to Follow-up|0|||
46780160|NCT00422383|82998920|FG004|Overall Study|Lost to Follow-up|1|||
46780161|NCT00422383|82998916|FG000|Overall Study|Protocol Violation|1|||
46780162|NCT00422383|82998917|FG001|Overall Study|Protocol Violation|1|||
46780163|NCT00422383|82998918|FG002|Overall Study|Protocol Violation|1|||
46780164|NCT00422383|82998919|FG003|Overall Study|Protocol Violation|0|||
46780165|NCT00422383|82998920|FG004|Overall Study|Protocol Violation|0|||
46780166|NCT00422383|82998916|FG000|Overall Study|Withdrawal by Subject|5|||
46780167|NCT00422383|82998917|FG001|Overall Study|Withdrawal by Subject|5|||
46780168|NCT00422383|82998918|FG002|Overall Study|Withdrawal by Subject|0|||
46780169|NCT00422383|82998919|FG003|Overall Study|Withdrawal by Subject|0|||
46780170|NCT00422383|82998920|FG004|Overall Study|Withdrawal by Subject|1|||
46780171|NCT00612040|82998941|FG000|Overall Study|Adverse Event|0|||
46780172|NCT00612040|82998942|FG001|Overall Study|Adverse Event|2|||
46780173|NCT00612040|82998943|FG002|Overall Study|Adverse Event|1|||
47075035|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
46647761|NCT03381248|82854668|FG000|0-6 Months|Adverse Event|1|||
46780174|NCT00612040|82998941|FG000|Overall Study|Protocol Violation|1|||
46647762|NCT03381248|82854669|FG001|0-6 Months|Adverse Event|0|||
46780175|NCT00612040|82998942|FG001|Overall Study|Protocol Violation|2|||
46780176|NCT00612040|82998943|FG002|Overall Study|Protocol Violation|1|||
46780177|NCT00612040|82998941|FG000|Overall Study|Lack of Efficacy|2|||
46780178|NCT00612040|82998942|FG001|Overall Study|Lack of Efficacy|1|||
46780179|NCT00612040|82998943|FG002|Overall Study|Lack of Efficacy|0|||
46780180|NCT00612040|82998941|FG000|Overall Study|Unclassified|2|||
46780181|NCT00612040|82998942|FG001|Overall Study|Unclassified|2|||
46647763|NCT03381248|82854668|FG000|0-6 Months|Protocol Violation|2|||
46647764|NCT03381248|82854669|FG001|0-6 Months|Protocol Violation|1|||
46647765|NCT03381248|82854668|FG000|0-6 Months|Physician Decision|1|||
46780182|NCT00612040|82998943|FG002|Overall Study|Unclassified|5|||
46647766|NCT03381248|82854669|FG001|0-6 Months|Physician Decision|0|||
46647767|NCT03381248|82854668|FG000|0-6 Months|Planning another procedure|1|||
46647768|NCT03381248|82854669|FG001|0-6 Months|Planning another procedure|2|||
46647769|NCT03381248|82854668|FG000|6-12 Months|Withdrawal by Subject|1|||
46647770|NCT03381248|82854669|FG001|6-12 Months|Withdrawal by Subject|3|||
46647771|NCT03381248|82854668|FG000|6-12 Months|Lost to Follow-up|0|||
46647772|NCT03381248|82854669|FG001|6-12 Months|Lost to Follow-up|2|||
46647773|NCT03381248|82854668|FG000|6-12 Months|Protocol Violation|3|||
46647774|NCT03381248|82854669|FG001|6-12 Months|Protocol Violation|2|||
46647775|NCT03381248|82854668|FG000|6-12 Months|Planning another procedure|6|||
46647776|NCT03381248|82854669|FG001|6-12 Months|Planning another procedure|2|||
46647777|NCT03381248|82854668|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
46647778|NCT03381248|82854669|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
46647779|NCT03381248|82854668|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
46647780|NCT03381248|82854669|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
46647781|NCT03381248|82854668|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
46647782|NCT03381248|82854669|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
46647783|NCT03354663|82854680|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
46647784|NCT03354663|82854680|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
46647785|NCT03354663|82854680|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
46647786|NCT03354663|82854680|FG000|Completed 30-day Visit|Missed Visit|1|||
46647787|NCT03305419|82854696|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
46647788|NCT03305419|82854697|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
46647789|NCT03305419|82854698|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
46647790|NCT03305419|82854699|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
46647791|NCT03305419|82854700|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
46647792|NCT03305419|82854701|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
46647793|NCT03305419|82854702|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
46647794|NCT03305419|82854703|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
46647795|NCT03305419|82854696|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
46647796|NCT03305419|82854697|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
46647797|NCT03305419|82854698|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
46647798|NCT03305419|82854699|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
46647799|NCT03305419|82854700|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
46647800|NCT03305419|82854701|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
46647801|NCT03305419|82854702|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
46647802|NCT03305419|82854703|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
46647803|NCT03305419|82854696|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
46647804|NCT03305419|82854697|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
46647805|NCT03305419|82854698|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
46647806|NCT03305419|82854699|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
46647807|NCT03305419|82854700|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
46647808|NCT03305419|82854701|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
46647809|NCT03305419|82854702|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
46647810|NCT03305419|82854703|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
46647811|NCT03305419|82854696|FG000|Part B (14 Days)|Adverse Event|0|||
46647812|NCT03305419|82854697|FG001|Part B (14 Days)|Adverse Event|0|||
46647813|NCT03305419|82854698|FG002|Part B (14 Days)|Adverse Event|0|||
46647814|NCT03305419|82854699|FG003|Part B (14 Days)|Adverse Event|0|||
46647815|NCT03305419|82854700|FG004|Part B (14 Days)|Adverse Event|1|||
46647816|NCT03305419|82854701|FG005|Part B (14 Days)|Adverse Event|2|||
46647817|NCT03305419|82854702|FG006|Part B (14 Days)|Adverse Event|4|||
46647818|NCT03305419|82854703|FG007|Part B (14 Days)|Adverse Event|0|||
46647819|NCT03305419|82854696|FG000|Part B (14 Days)|Physician Decision|0|||
46647820|NCT03305419|82854697|FG001|Part B (14 Days)|Physician Decision|0|||
46647821|NCT03305419|82854698|FG002|Part B (14 Days)|Physician Decision|0|||
46647822|NCT03305419|82854699|FG003|Part B (14 Days)|Physician Decision|0|||
46647823|NCT03305419|82854700|FG004|Part B (14 Days)|Physician Decision|2|||
46647824|NCT03305419|82854701|FG005|Part B (14 Days)|Physician Decision|8|||
46647825|NCT03305419|82854702|FG006|Part B (14 Days)|Physician Decision|1|||
46647826|NCT03305419|82854703|FG007|Part B (14 Days)|Physician Decision|0|||
46647827|NCT03096782|82854746|FG000|Overall Study|Death|1|||
46647828|NCT03096782|82854746|FG000|Overall Study|Participant Relapsed|1|||
46647829|NCT03052049|82854750|FG000|Overall Study|Withdrawal by Subject|2|||
46647830|NCT03019536|82854770|FG000|Overall Study|Withdrawal by Subject|1|||
46647831|NCT03019536|82854771|FG001|Overall Study|Withdrawal by Subject|1|||
46647832|NCT03019536|82854772|FG002|Overall Study|Withdrawal by Subject|0|||
46647833|NCT03019536|82854770|FG000|Overall Study|Adverse Event|0|||
46647834|NCT03019536|82854771|FG001|Overall Study|Adverse Event|0|||
46647835|NCT03019536|82854772|FG002|Overall Study|Adverse Event|2|||
46647836|NCT02673775|82854782|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
46647837|NCT02673775|82854783|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
46647838|NCT02673775|82854782|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
46647839|NCT02673775|82854783|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
46647840|NCT02673775|82854782|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
46647841|NCT02673775|82854783|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
46647842|NCT02673775|82854782|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
46647843|NCT02673775|82854783|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
46647844|NCT02666768|82854789|FG000|Overall Study|Withdrawal by Subject|4|||
46647845|NCT02471144|82854797|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
46647846|NCT02471144|82854798|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
46647847|NCT02471144|82854799|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
46647848|NCT02471144|82854800|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
46647849|NCT02471144|82854801|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
46647850|NCT02471144|82854802|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
46647851|NCT02471144|82854803|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
46647852|NCT02471144|82854804|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
46647853|NCT02471144|82854805|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
46647854|NCT02471144|82854806|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
46647855|NCT02471144|82854807|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
46647856|NCT02471144|82854797|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647857|NCT02471144|82854798|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647858|NCT02471144|82854799|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647859|NCT02471144|82854800|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
46647860|NCT02471144|82854801|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647861|NCT02471144|82854802|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647862|NCT02471144|82854803|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647863|NCT02471144|82854804|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647864|NCT02471144|82854805|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647865|NCT02471144|82854806|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647866|NCT02471144|82854807|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
46647867|NCT02471144|82854797|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647868|NCT02471144|82854798|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647869|NCT02471144|82854799|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
46647870|NCT02471144|82854800|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46780183|NCT00422227|82998953|FG000|Overall Study|Adverse Event|3|||
46780184|NCT00422227|82998954|FG001|Overall Study|Adverse Event|8|||
46780185|NCT00422227|82998953|FG000|Overall Study|Lost to Follow-up|1|||
47075036|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075037|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075038|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
47075039|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075040|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075041|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
47075042|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
46647871|NCT02471144|82854801|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647872|NCT02471144|82854802|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647873|NCT02471144|82854803|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647874|NCT02471144|82854804|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647875|NCT02471144|82854805|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647876|NCT02471144|82854806|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647877|NCT02471144|82854807|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
46647878|NCT02471144|82854797|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
46647879|NCT02471144|82854798|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
46780186|NCT00422227|82998954|FG001|Overall Study|Lost to Follow-up|3|||
46647880|NCT02471144|82854799|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647881|NCT02471144|82854800|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647882|NCT02471144|82854801|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647883|NCT02471144|82854802|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647884|NCT02471144|82854803|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647885|NCT02471144|82854804|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647886|NCT02471144|82854805|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647887|NCT02471144|82854806|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647888|NCT02471144|82854807|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
46647889|NCT02471144|82854797|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647890|NCT02471144|82854798|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647891|NCT02471144|82854799|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647892|NCT02471144|82854800|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647893|NCT02471144|82854801|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
46647894|NCT02471144|82854802|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647895|NCT02471144|82854803|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
46647896|NCT02471144|82854804|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647897|NCT02471144|82854805|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
46647898|NCT02471144|82854806|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647899|NCT02471144|82854807|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
46647900|NCT02471144|82854797|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647901|NCT02471144|82854798|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647902|NCT02471144|82854799|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647903|NCT02471144|82854800|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647904|NCT02471144|82854801|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647905|NCT02471144|82854802|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
46647906|NCT02471144|82854803|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647907|NCT02471144|82854804|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647908|NCT02471144|82854805|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
46647909|NCT02471144|82854806|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647910|NCT02471144|82854807|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
46647911|NCT02471144|82854797|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647912|NCT02471144|82854798|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647913|NCT02471144|82854799|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647914|NCT02471144|82854800|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647915|NCT02471144|82854801|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647916|NCT02471144|82854802|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647917|NCT02471144|82854803|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647918|NCT02471144|82854804|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647919|NCT02471144|82854805|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
46647920|NCT02471144|82854806|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647921|NCT02471144|82854807|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
46647922|NCT02471144|82854797|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647923|NCT02471144|82854798|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647924|NCT02471144|82854799|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647925|NCT02471144|82854800|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647926|NCT02471144|82854801|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647927|NCT02471144|82854802|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647928|NCT02471144|82854803|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647929|NCT02471144|82854804|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
46647930|NCT02471144|82854805|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
46647931|NCT02471144|82854806|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647932|NCT02471144|82854807|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
46647933|NCT02471144|82854797|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46780187|NCT00422227|82998953|FG000|Overall Study|Withdrawal by Subject|0|||
46780188|NCT00422227|82998954|FG001|Overall Study|Withdrawal by Subject|4|||
46780189|NCT00421993|82998964|FG000|Overall Study|Withdrawal by Subject|22|||
46647934|NCT02471144|82854798|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46647935|NCT02471144|82854799|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46647936|NCT02471144|82854800|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46647937|NCT02471144|82854801|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46647938|NCT02471144|82854802|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46647939|NCT02471144|82854803|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46647940|NCT02471144|82854804|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46780190|NCT00421993|82998965|FG001|Overall Study|Withdrawal by Subject|23|||
46970404|NCT02705105|83213434|FG000|Treatment|Withdrawal by Subject|3|||
46647941|NCT02471144|82854805|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
46647942|NCT02471144|82854806|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
46647943|NCT02471144|82854807|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
46647944|NCT02471144|82854797|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647945|NCT02471144|82854798|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647946|NCT02471144|82854799|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647947|NCT02471144|82854800|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647948|NCT02471144|82854801|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647949|NCT02471144|82854802|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647950|NCT02471144|82854803|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647951|NCT02471144|82854804|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647952|NCT02471144|82854805|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647953|NCT02471144|82854806|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
46647954|NCT02471144|82854807|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
46647955|NCT02471144|82854797|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647956|NCT02471144|82854798|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647957|NCT02471144|82854799|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647958|NCT02471144|82854800|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647959|NCT02471144|82854801|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647960|NCT02471144|82854802|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647961|NCT02471144|82854803|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647962|NCT02471144|82854804|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647963|NCT02471144|82854805|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647964|NCT02471144|82854806|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
46647965|NCT02471144|82854807|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
46647966|NCT02471144|82854797|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647967|NCT02471144|82854798|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647968|NCT02471144|82854799|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647969|NCT02471144|82854800|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647970|NCT02471144|82854801|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647971|NCT02471144|82854802|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647972|NCT02471144|82854803|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647973|NCT02471144|82854804|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647974|NCT02471144|82854805|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
46647975|NCT02471144|82854806|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
46647976|NCT02471144|82854807|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
46647977|NCT02471144|82854797|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647978|NCT02471144|82854798|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647979|NCT02471144|82854799|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647980|NCT02471144|82854800|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647981|NCT02471144|82854801|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647982|NCT02471144|82854802|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647983|NCT02471144|82854803|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647984|NCT02471144|82854804|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647985|NCT02471144|82854805|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647986|NCT02471144|82854806|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
46647987|NCT02471144|82854807|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
46647988|NCT02471144|82854797|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647989|NCT02471144|82854798|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647990|NCT02471144|82854799|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647991|NCT02471144|82854800|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647992|NCT02471144|82854801|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647993|NCT02471144|82854802|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647994|NCT02471144|82854803|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647995|NCT02471144|82854804|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647996|NCT02471144|82854805|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
46647997|NCT02471144|82854806|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
46647998|NCT02471144|82854807|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
46647999|NCT02403674|82854829|FG000|Overall Study|Adverse Event|10|||
46648000|NCT02403674|82854830|FG001|Overall Study|Adverse Event|23|||
46648001|NCT02403674|82854829|FG000|Overall Study|Death|1|||
46648002|NCT02403674|82854830|FG001|Overall Study|Death|3|||
46648003|NCT02403674|82854829|FG000|Overall Study|Lack of Efficacy|18|||
46648004|NCT02403674|82854830|FG001|Overall Study|Lack of Efficacy|10|||
46648005|NCT02403674|82854829|FG000|Overall Study|Lost to Follow-up|6|||
46648006|NCT02403674|82854830|FG001|Overall Study|Lost to Follow-up|7|||
46648007|NCT02403674|82854829|FG000|Overall Study|Noncompliance with study drug|1|||
46648008|NCT02403674|82854830|FG001|Overall Study|Noncompliance with study drug|2|||
46648009|NCT02403674|82854829|FG000|Overall Study|Withdrawal by Subject|8|||
46648010|NCT02403674|82854830|FG001|Overall Study|Withdrawal by Subject|11|||
46648011|NCT02403674|82854829|FG000|Overall Study|Physician Decision|2|||
46648012|NCT02403674|82854830|FG001|Overall Study|Physician Decision|2|||
46648013|NCT02403674|82854829|FG000|Overall Study|Not treated with study drug|4|||
46648014|NCT02403674|82854830|FG001|Overall Study|Not treated with study drug|2|||
46648015|NCT02403674|82854829|FG000|Overall Study|Pregnancy|1|||
46648016|NCT02403674|82854830|FG001|Overall Study|Pregnancy|1|||
46648017|NCT02403674|82854829|FG000|Overall Study|Protocol Violation|4|||
46648018|NCT02403674|82854830|FG001|Overall Study|Protocol Violation|2|||
46648019|NCT02352948|82854847|FG000|Overall Study|Death|47|||
46648020|NCT02352948|82854848|FG001|Overall Study|Death|48|||
46648021|NCT02352948|82854849|FG002|Overall Study|Death|114|||
46648022|NCT02352948|82854850|FG003|Overall Study|Death|74|||
46648023|NCT02352948|82854851|FG004|Overall Study|Death|77|||
46648024|NCT02352948|82854852|FG005|Overall Study|Death|44|||
46648025|NCT02352948|82854847|FG000|Overall Study|Lost to Follow-up|1|||
46648026|NCT02352948|82854848|FG001|Overall Study|Lost to Follow-up|0|||
46648027|NCT02352948|82854849|FG002|Overall Study|Lost to Follow-up|2|||
46648028|NCT02352948|82854850|FG003|Overall Study|Lost to Follow-up|1|||
46648029|NCT02352948|82854851|FG004|Overall Study|Lost to Follow-up|2|||
46648030|NCT02352948|82854852|FG005|Overall Study|Lost to Follow-up|1|||
46648031|NCT02352948|82854847|FG000|Overall Study|Withdrawal by Subject|1|||
46648032|NCT02352948|82854848|FG001|Overall Study|Withdrawal by Subject|10|||
46648033|NCT02352948|82854849|FG002|Overall Study|Withdrawal by Subject|11|||
46648034|NCT02352948|82854850|FG003|Overall Study|Withdrawal by Subject|23|||
46648035|NCT02352948|82854851|FG004|Overall Study|Withdrawal by Subject|9|||
46648036|NCT02352948|82854852|FG005|Overall Study|Withdrawal by Subject|4|||
46648037|NCT02352948|82854847|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46648038|NCT02352948|82854848|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
46648039|NCT02352948|82854849|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
46648040|NCT02352948|82854850|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
46648041|NCT02352948|82854851|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
46648042|NCT02352948|82854852|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
46648043|NCT02352948|82854847|FG000|Overall Study|Other|0|||
46648044|NCT02352948|82854848|FG001|Overall Study|Other|0|||
46648045|NCT02352948|82854849|FG002|Overall Study|Other|2|||
46648046|NCT02352948|82854850|FG003|Overall Study|Other|0|||
46648047|NCT02352948|82854851|FG004|Overall Study|Other|0|||
46648048|NCT02352948|82854852|FG005|Overall Study|Other|0|||
46648049|NCT02125461|82854928|FG000|Overall Study|Withdrawal by Subject|30|||
46648050|NCT02125461|82854929|FG001|Overall Study|Withdrawal by Subject|16|||
46648051|NCT02125461|82854928|FG000|Overall Study|Lost to Follow-up|8|||
46648052|NCT02125461|82854929|FG001|Overall Study|Lost to Follow-up|3|||
46648053|NCT02125461|82854928|FG000|Overall Study|Death|260|||
46648054|NCT02125461|82854929|FG001|Overall Study|Death|149|||
46648055|NCT02125461|82854928|FG000|Overall Study|Missing Termination Reason|0|||
46648056|NCT02125461|82854929|FG001|Overall Study|Missing Termination Reason|1|||
46648057|NCT02096042|82854935|FG000|Overall Study|Disease Progression|1|||
46648058|NCT02096042|82854936|FG001|Overall Study|Disease Progression|0|||
46648059|NCT02096042|82854937|FG002|Overall Study|Disease Progression|0|||
46648060|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
46648061|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
46648062|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
46648063|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
46648064|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
46648065|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
46648066|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
46648067|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
46648068|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
46648069|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
46780191|NCT00421993|82998966|FG002|Overall Study|Withdrawal by Subject|23|||
46780192|NCT00421993|82998967|FG003|Overall Study|Withdrawal by Subject|24|||
46648070|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
46648071|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
46648072|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
46648073|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
46648074|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
46648075|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
46648076|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
46648077|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
46648078|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
46648079|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
46648080|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
46648081|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
46648082|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
46648083|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
46648084|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Death|2|||
46648085|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Death|1|||
46648086|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Death|0|||
46648087|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Death|0|||
46648088|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
46648089|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
46648090|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
46648091|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
46648092|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
46648093|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
46648094|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
46648095|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
46648096|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
46648097|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
46648098|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
46648099|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
46648100|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
46648101|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
46648102|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
46648103|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
46648104|NCT01940471|82854946|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
46648105|NCT01940471|82854947|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
46648106|NCT01940471|82854948|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
46648107|NCT01940471|82854949|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
46648108|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
46648109|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
46648110|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
46648111|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
46780193|NCT00421993|82998964|FG000|Overall Study|Lost to Follow-up|18|||
46780194|NCT00421993|82998965|FG001|Overall Study|Lost to Follow-up|19|||
46780195|NCT00421993|82998966|FG002|Overall Study|Lost to Follow-up|22|||
46780196|NCT00421993|82998967|FG003|Overall Study|Lost to Follow-up|20|||
46780197|NCT00421993|82998964|FG000|Overall Study|Adverse Event|11|||
47075043|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
47075044|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
47075045|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075046|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075047|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075048|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075049|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
47075050|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075051|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075052|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075053|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075054|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075055|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075056|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075057|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075058|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
47075059|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075060|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075061|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
47075062|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
47075063|NCT01915498|83368366|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075064|NCT01915498|83368367|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075065|NCT01915498|83368368|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075066|NCT01915498|83368369|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075067|NCT01915498|83368370|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075068|NCT01915498|83368371|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
46648112|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
46648113|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
46780198|NCT00421993|82998965|FG001|Overall Study|Adverse Event|1|||
46648114|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
46648115|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
46648116|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
46648117|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
46648118|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
46648119|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
46648120|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
46648121|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
46648122|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
46648123|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
46648124|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
46648125|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
46648126|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
46648127|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
46648128|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
46648129|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
46648130|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
46648131|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
46648132|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
46648133|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
46648134|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
46648135|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
46648136|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
46648137|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
46648138|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
46648139|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
46648140|NCT01940471|82854946|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
46648141|NCT01940471|82854947|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
46648142|NCT01940471|82854948|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
46648143|NCT01940471|82854949|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
46648144|NCT01751906|82854969|FG000|Overall Study|Lost to Follow-up|151|||
46648145|NCT01751906|82854970|FG001|Overall Study|Lost to Follow-up|68|||
46648146|NCT01751906|82854969|FG000|Overall Study|Withdrawal by Subject|22|||
46648147|NCT01751906|82854970|FG001|Overall Study|Withdrawal by Subject|18|||
46648148|NCT01751906|82854969|FG000|Overall Study|Physician Decision|5|||
46648149|NCT01751906|82854970|FG001|Overall Study|Physician Decision|2|||
46648150|NCT01751906|82854969|FG000|Overall Study|Death|84|||
46648151|NCT01751906|82854970|FG001|Overall Study|Death|43|||
46648152|NCT01751906|82854969|FG000|Overall Study|Denied on premises for follow-up by law|1|||
46648153|NCT01751906|82854970|FG001|Overall Study|Denied on premises for follow-up by law|0|||
46648154|NCT01730937|82854978|FG000|Overall Study|Protocol Violation|5|||
46648155|NCT01730937|82854979|FG001|Overall Study|Protocol Violation|11|||
46648156|NCT01560416|82854987|FG000|Randomized Phase|Crossover Participants|7|||
46648157|NCT01560416|82854988|FG001|Randomized Phase|Crossover Participants|0|||
46648158|NCT01279850|82855000|FG000|Overall Study|Protocol Violation|50|||
46648159|NCT01279850|82855000|FG000|Overall Study|No Drug Administration Information|7|||
46648160|NCT01279850|82855000|FG000|Overall Study|No Visit After Treatment|34|||
46648161|NCT01035463|82855006|FG000|Overall Study|Adverse Event|0|||
46648162|NCT01035463|82855007|FG001|Overall Study|Adverse Event|0|||
46648163|NCT01035463|82855008|FG002|Overall Study|Adverse Event|4|||
46648164|NCT01035463|82855009|FG003|Overall Study|Adverse Event|1|||
46648165|NCT01035463|82855010|FG004|Overall Study|Adverse Event|5|||
46648166|NCT01035463|82855011|FG005|Overall Study|Adverse Event|7|||
46648167|NCT01035463|82855006|FG000|Overall Study|Withdrawal by Subject|0|||
46648168|NCT01035463|82855007|FG001|Overall Study|Withdrawal by Subject|2|||
46648169|NCT01035463|82855008|FG002|Overall Study|Withdrawal by Subject|1|||
46648170|NCT01035463|82855009|FG003|Overall Study|Withdrawal by Subject|0|||
46648171|NCT01035463|82855010|FG004|Overall Study|Withdrawal by Subject|1|||
46648172|NCT01035463|82855011|FG005|Overall Study|Withdrawal by Subject|4|||
46648173|NCT01035463|82855006|FG000|Overall Study|Disease progression|0|||
47075069|NCT01915498|83368372|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075070|NCT01915498|83368373|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075071|NCT01915498|83368374|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
46648174|NCT01035463|82855007|FG001|Overall Study|Disease progression|0|||
46648175|NCT01035463|82855008|FG002|Overall Study|Disease progression|0|||
46648176|NCT01035463|82855009|FG003|Overall Study|Disease progression|0|||
46648177|NCT01035463|82855010|FG004|Overall Study|Disease progression|0|||
47075072|NCT01915498|83368375|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
46648178|NCT01035463|82855011|FG005|Overall Study|Disease progression|3|||
46648179|NCT01035463|82855006|FG000|Overall Study|Other Malignancy|0|||
46648180|NCT01035463|82855007|FG001|Overall Study|Other Malignancy|0|||
46648181|NCT01035463|82855008|FG002|Overall Study|Other Malignancy|0|||
46648182|NCT01035463|82855009|FG003|Overall Study|Other Malignancy|0|||
46648183|NCT01035463|82855010|FG004|Overall Study|Other Malignancy|0|||
46648184|NCT01035463|82855011|FG005|Overall Study|Other Malignancy|2|||
46648185|NCT01035463|82855006|FG000|Overall Study|Other|0|||
46648186|NCT01035463|82855007|FG001|Overall Study|Other|0|||
46648187|NCT01035463|82855008|FG002|Overall Study|Other|0|||
46648188|NCT01035463|82855009|FG003|Overall Study|Other|1|||
46648189|NCT01035463|82855010|FG004|Overall Study|Other|0|||
46648190|NCT01035463|82855011|FG005|Overall Study|Other|2|||
46648191|NCT00936390|82855020|FG000|Overall Study|Protocol Violation|21|||
46648192|NCT00936390|82855021|FG001|Overall Study|Protocol Violation|25|||
46648193|NCT01470326|82855038|FG000|Overall Study|Protocol Violation|32|||
46648194|NCT01470326|82855038|FG000|Overall Study|No Drug Administration Information|2|||
46648195|NCT01470326|82855038|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
46648196|NCT01480180|82855053|FG000|Main Phase|Withdrawal criteria|12|||
46648197|NCT01480180|82855054|FG001|Main Phase|Withdrawal criteria|1|||
46648198|NCT01480180|82855055|FG002|Main Phase|Withdrawal criteria|0|||
46648199|NCT01480180|82855056|FG003|Main Phase|Withdrawal criteria|0|||
46648200|NCT01480180|82855057|FG004|Main Phase|Withdrawal criteria|0|||
46648201|NCT01480180|82855058|FG005|Main Phase|Withdrawal criteria|0|||
46648202|NCT01480180|82855053|FG000|Main Phase|Lack of Efficacy|1|||
46648203|NCT01480180|82855054|FG001|Main Phase|Lack of Efficacy|0|||
46648204|NCT01480180|82855055|FG002|Main Phase|Lack of Efficacy|0|||
46648205|NCT01480180|82855056|FG003|Main Phase|Lack of Efficacy|0|||
46648206|NCT01480180|82855057|FG004|Main Phase|Lack of Efficacy|0|||
46648207|NCT01480180|82855058|FG005|Main Phase|Lack of Efficacy|0|||
46648208|NCT01480180|82855053|FG000|Main Phase|Non-compliance|3|||
46648209|NCT01480180|82855054|FG001|Main Phase|Non-compliance|0|||
46648210|NCT01480180|82855055|FG002|Main Phase|Non-compliance|0|||
46648211|NCT01480180|82855056|FG003|Main Phase|Non-compliance|0|||
46648212|NCT01480180|82855057|FG004|Main Phase|Non-compliance|0|||
46648213|NCT01480180|82855058|FG005|Main Phase|Non-compliance|0|||
46648214|NCT01480180|82855053|FG000|Main Phase|Unclassified|3|||
46648215|NCT01480180|82855054|FG001|Main Phase|Unclassified|0|||
46648216|NCT01480180|82855055|FG002|Main Phase|Unclassified|0|||
46648217|NCT01480180|82855056|FG003|Main Phase|Unclassified|0|||
46648218|NCT01480180|82855057|FG004|Main Phase|Unclassified|0|||
47075073|NCT01915498|83368376|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075074|NCT01915498|83368377|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075075|NCT01915498|83368378|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
47075076|NCT01915498|83368379|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
47075077|NCT01915498|83368380|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
46648219|NCT01480180|82855058|FG005|Main Phase|Unclassified|0|||
47075078|NCT01915498|83368381|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
47075079|NCT01915498|83368382|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
47075080|NCT01915498|83368383|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
47075081|NCT01915498|83368384|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
46648220|NCT01480180|82855053|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
46648221|NCT01480180|82855054|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
46648222|NCT01480180|82855055|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
46648223|NCT01480180|82855056|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
46648224|NCT01480180|82855057|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
46648225|NCT01480180|82855058|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
46648226|NCT01480180|82855053|FG000|Extension Phase, Part 1|Unclassified|0|||
46648227|NCT01480180|82855054|FG001|Extension Phase, Part 1|Unclassified|0|||
46648228|NCT01480180|82855055|FG002|Extension Phase, Part 1|Unclassified|1|||
46648229|NCT01480180|82855056|FG003|Extension Phase, Part 1|Unclassified|0|||
46648230|NCT01480180|82855057|FG004|Extension Phase, Part 1|Unclassified|0|||
46648231|NCT01480180|82855058|FG005|Extension Phase, Part 1|Unclassified|0|||
46648232|NCT01480180|82855053|FG000|Extension Phase, Part 1|Adverse Event|0|||
46780199|NCT00421993|82998966|FG002|Overall Study|Adverse Event|6|||
46780200|NCT00421993|82998967|FG003|Overall Study|Adverse Event|4|||
46780201|NCT00421993|82998964|FG000|Overall Study|Protocol Violation|2|||
46780202|NCT00421993|82998965|FG001|Overall Study|Protocol Violation|2|||
46780203|NCT00421993|82998966|FG002|Overall Study|Protocol Violation|0|||
46780204|NCT00421993|82998967|FG003|Overall Study|Protocol Violation|1|||
46780205|NCT00421993|82998964|FG000|Overall Study|Lack of Efficacy|0|||
46780206|NCT00421993|82998965|FG001|Overall Study|Lack of Efficacy|3|||
46780207|NCT00421993|82998966|FG002|Overall Study|Lack of Efficacy|0|||
46780208|NCT00421993|82998967|FG003|Overall Study|Lack of Efficacy|5|||
46780209|NCT00421993|82998964|FG000|Overall Study|Pregnancy|0|||
46780210|NCT00421993|82998965|FG001|Overall Study|Pregnancy|1|||
46780211|NCT00421993|82998966|FG002|Overall Study|Pregnancy|1|||
46780212|NCT00421993|82998967|FG003|Overall Study|Pregnancy|2|||
46780213|NCT00421993|82998964|FG000|Overall Study|Subject transportation issues|0|||
46780214|NCT00421993|82998965|FG001|Overall Study|Subject transportation issues|0|||
46780215|NCT00421993|82998966|FG002|Overall Study|Subject transportation issues|0|||
46780216|NCT00421993|82998967|FG003|Overall Study|Subject transportation issues|1|||
46780217|NCT00413959|82998977|FG000|Overall Study|Pt had only one cycle.|1|||
46780218|NCT00645567|82998981|FG000|Overall Study|Adverse Event|1|||
46780219|NCT00611884|82998993|FG000|Overall Study|Adverse Event|1|||
46780220|NCT00611884|82998994|FG001|Overall Study|Adverse Event|0|||
46780221|NCT00611884|82998995|FG002|Overall Study|Adverse Event|0|||
46780222|NCT00611884|82998996|FG003|Overall Study|Adverse Event|1|||
46780223|NCT00611884|82998993|FG000|Overall Study|Non-Compliance|1|||
46780224|NCT00611884|82998994|FG001|Overall Study|Non-Compliance|4|||
46780225|NCT00611884|82998995|FG002|Overall Study|Non-Compliance|2|||
46780226|NCT00611884|82998996|FG003|Overall Study|Non-Compliance|2|||
46780227|NCT00611884|82998993|FG000|Overall Study|Lack of Efficacy|0|||
46780228|NCT00611884|82998994|FG001|Overall Study|Lack of Efficacy|1|||
46780229|NCT00611884|82998995|FG002|Overall Study|Lack of Efficacy|0|||
46780230|NCT00611884|82998996|FG003|Overall Study|Lack of Efficacy|0|||
46780231|NCT00611884|82998993|FG000|Overall Study|Unclassified|7|||
46780232|NCT00611884|82998994|FG001|Overall Study|Unclassified|4|||
46780233|NCT00611884|82998995|FG002|Overall Study|Unclassified|2|||
46780234|NCT00611884|82998996|FG003|Overall Study|Unclassified|3|||
46780235|NCT00420745|82999008|FG000|Overall Study|Adverse Event|2|||
46780236|NCT00420745|82999009|FG001|Overall Study|Adverse Event|2|||
46780237|NCT00420745|82999008|FG000|Overall Study|Lost to Follow-up|10|||
46780238|NCT00420745|82999009|FG001|Overall Study|Lost to Follow-up|2|||
46780239|NCT00420745|82999008|FG000|Overall Study|Protocol Violation|1|||
46780240|NCT00420745|82999009|FG001|Overall Study|Protocol Violation|0|||
46780241|NCT00420745|82999008|FG000|Overall Study|Physician Decision|1|||
46780242|NCT00420745|82999009|FG001|Overall Study|Physician Decision|1|||
46780243|NCT00420745|82999008|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
46780244|NCT00420745|82999009|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
46780245|NCT00420745|82999008|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
46780246|NCT00420745|82999009|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
46780247|NCT00611806|82999017|FG000|Overall Study|Withdrawal by Subject|8|||
46780248|NCT00611806|82999018|FG001|Overall Study|Withdrawal by Subject|2|||
46780249|NCT00611806|82999017|FG000|Overall Study|Adverse Event|2|||
47075082|NCT01915498|83368366|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075083|NCT01915498|83368367|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075084|NCT01915498|83368368|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075085|NCT01915498|83368369|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075086|NCT01915498|83368370|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075087|NCT01915498|83368371|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075088|NCT01915498|83368372|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075089|NCT01915498|83368373|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075090|NCT01915498|83368374|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
46648233|NCT01480180|82855054|FG001|Extension Phase, Part 1|Adverse Event|0|||
46648234|NCT01480180|82855055|FG002|Extension Phase, Part 1|Adverse Event|4|||
46648235|NCT01480180|82855056|FG003|Extension Phase, Part 1|Adverse Event|1|||
46648236|NCT01480180|82855057|FG004|Extension Phase, Part 1|Adverse Event|0|||
46780250|NCT00611806|82999018|FG001|Overall Study|Adverse Event|1|||
46780251|NCT00611806|82999017|FG000|Overall Study|Lost to Follow-up|6|||
46780252|NCT00611806|82999018|FG001|Overall Study|Lost to Follow-up|0|||
46780253|NCT00413413|82999027|FG000|Single-Blind|Adverse Event|0|||
46780254|NCT00413413|82999028|FG001|Single-Blind|Adverse Event|9|||
46780255|NCT00413413|82999029|FG002|Single-Blind|Adverse Event|0|||
46780256|NCT00413413|82999027|FG000|Single-Blind|Lack of Efficacy|0|||
46780257|NCT00413413|82999028|FG001|Single-Blind|Lack of Efficacy|5|||
46780258|NCT00413413|82999029|FG002|Single-Blind|Lack of Efficacy|0|||
46780259|NCT00413413|82999027|FG000|Single-Blind|Subject no longer requires study drug|0|||
46648237|NCT01480180|82855058|FG005|Extension Phase, Part 1|Adverse Event|0|||
46648238|NCT01480180|82855053|FG000|Extension Phase, Part 1|Change of treatment|0|||
46648239|NCT01480180|82855054|FG001|Extension Phase, Part 1|Change of treatment|0|||
46648240|NCT01480180|82855055|FG002|Extension Phase, Part 1|Change of treatment|0|||
46648241|NCT01480180|82855056|FG003|Extension Phase, Part 1|Change of treatment|9|||
46648242|NCT01480180|82855057|FG004|Extension Phase, Part 1|Change of treatment|0|||
46648243|NCT01480180|82855058|FG005|Extension Phase, Part 1|Change of treatment|0|||
47075091|NCT01915498|83368375|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075092|NCT01915498|83368376|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075093|NCT01915498|83368377|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075094|NCT01915498|83368378|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075095|NCT01915498|83368379|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
46648244|NCT01480180|82855053|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
46648245|NCT01480180|82855054|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
46648246|NCT01480180|82855055|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
46648247|NCT01480180|82855056|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
46648248|NCT01480180|82855057|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
46648249|NCT01480180|82855058|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
46648250|NCT01480180|82855053|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
46648251|NCT01480180|82855054|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
46648252|NCT01480180|82855055|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
46648253|NCT01480180|82855056|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
46648254|NCT01480180|82855057|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
46648255|NCT01480180|82855058|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
46648256|NCT01480180|82855053|FG000|Extension Phase, Part 2|Unclassified|0|||
46648257|NCT01480180|82855054|FG001|Extension Phase, Part 2|Unclassified|0|||
46648258|NCT01480180|82855055|FG002|Extension Phase, Part 2|Unclassified|3|||
46648259|NCT01480180|82855056|FG003|Extension Phase, Part 2|Unclassified|1|||
46648260|NCT01480180|82855057|FG004|Extension Phase, Part 2|Unclassified|1|||
46648261|NCT01480180|82855058|FG005|Extension Phase, Part 2|Unclassified|0|||
46648262|NCT04112173|82855126|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
46648263|NCT03872453|82855134|FG000|Overall Study|Adverse Event|1|||
46648264|NCT03872453|82855135|FG001|Overall Study|Adverse Event|1|||
46970405|NCT02705105|83213435|FG001|Treatment|Withdrawal by Subject|5|||
47075096|NCT01915498|83368380|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075097|NCT01915498|83368381|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075098|NCT01915498|83368382|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075099|NCT01915498|83368383|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
47075100|NCT01915498|83368384|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
47075101|NCT01889238|83368472|FG000|Overall Study|Treatment ongoing|9|||
47075102|NCT01302769|83368478|FG000|Overall Study|Lost to Follow-up|1|||
47075103|NCT01302769|83368479|FG001|Overall Study|Lost to Follow-up|1|||
47075104|NCT00099437|83368496|FG000|Overall Study|Lost to Follow-up|30|||
47075105|NCT00099437|83368497|FG001|Overall Study|Lost to Follow-up|33|||
47075106|NCT00099437|83368496|FG000|Overall Study|Death|293|||
47075107|NCT00099437|83368497|FG001|Overall Study|Death|261|||
47075108|NCT00099437|83368496|FG000|Overall Study|Withdrawal by Subject|6|||
47075109|NCT00099437|83368497|FG001|Overall Study|Withdrawal by Subject|10|||
47075110|NCT00099437|83368496|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
47075111|NCT00099437|83368497|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
47075112|NCT00634751|83368511|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
47075113|NCT00634751|83368512|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
47075114|NCT00634751|83368513|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
47075115|NCT00634751|83368514|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
47075116|NCT00634751|83368511|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
47075117|NCT00634751|83368512|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
47075118|NCT00634751|83368513|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
47075119|NCT00634751|83368514|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
47075120|NCT00634751|83368511|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
47075121|NCT00634751|83368512|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
46648265|NCT03872453|82855136|FG002|Overall Study|Adverse Event|0|||
46648266|NCT03872453|82855137|FG003|Overall Study|Adverse Event|0|||
46850608|NCT00112437|83066378|FG015|Years 6-10 (60-Month Extension)|Other|0|||
47075122|NCT00634751|83368513|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
47075123|NCT00634751|83368514|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
47075124|NCT05604781|83368541|FG000|Overall Study|Lost to Follow-up|3|||
47075125|NCT05604781|83368541|FG000|Overall Study|Adverse Event|1|||
47075126|NCT00634049|83368553|FG000|Overall Study|Never received study drug|1|||
46648267|NCT03872453|82855134|FG000|Overall Study|Lost to Follow-up|8|||
46648268|NCT03872453|82855135|FG001|Overall Study|Lost to Follow-up|7|||
46648269|NCT03872453|82855136|FG002|Overall Study|Lost to Follow-up|4|||
46648270|NCT03872453|82855137|FG003|Overall Study|Lost to Follow-up|4|||
46648271|NCT03872453|82855134|FG000|Overall Study|Never Treated Migraine|19|||
46648272|NCT03872453|82855135|FG001|Overall Study|Never Treated Migraine|17|||
46648273|NCT03872453|82855136|FG002|Overall Study|Never Treated Migraine|13|||
46648274|NCT03872453|82855137|FG003|Overall Study|Never Treated Migraine|12|||
46648275|NCT03872453|82855134|FG000|Overall Study|Pregnancy|1|||
46648276|NCT03872453|82855135|FG001|Overall Study|Pregnancy|0|||
46648277|NCT03872453|82855136|FG002|Overall Study|Pregnancy|0|||
46648278|NCT03872453|82855137|FG003|Overall Study|Pregnancy|0|||
46648279|NCT03872453|82855134|FG000|Overall Study|Protocol Deviation|2|||
46648280|NCT03872453|82855135|FG001|Overall Study|Protocol Deviation|0|||
46780260|NCT00413413|82999028|FG001|Single-Blind|Subject no longer requires study drug|151|||
46780261|NCT00413413|82999029|FG002|Single-Blind|Subject no longer requires study drug|0|||
46780262|NCT00413413|82999027|FG000|Single-Blind|Protocol Violation|0|||
46780263|NCT00413413|82999028|FG001|Single-Blind|Protocol Violation|16|||
46780264|NCT00413413|82999029|FG002|Single-Blind|Protocol Violation|0|||
46780265|NCT00413413|82999027|FG000|Single-Blind|Withdrawal by Subject|0|||
46780266|NCT00413413|82999028|FG001|Single-Blind|Withdrawal by Subject|27|||
46780267|NCT00413413|82999029|FG002|Single-Blind|Withdrawal by Subject|0|||
46780268|NCT00413413|82999027|FG000|Single-Blind|Lost to Follow-up|0|||
46780269|NCT00413413|82999028|FG001|Single-Blind|Lost to Follow-up|8|||
46780270|NCT00413413|82999029|FG002|Single-Blind|Lost to Follow-up|0|||
46780271|NCT00413413|82999027|FG000|Double-Blind|Adverse Event|6|||
46780272|NCT00413413|82999028|FG001|Double-Blind|Adverse Event|0|||
46780273|NCT00413413|82999029|FG002|Double-Blind|Adverse Event|5|||
46780274|NCT00413413|82999027|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
46780275|NCT00413413|82999028|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
46780276|NCT00413413|82999029|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
46780277|NCT00413413|82999027|FG000|Double-Blind|Protocol deviation|1|||
46780278|NCT00413413|82999028|FG001|Double-Blind|Protocol deviation|2|||
46780279|NCT00413413|82999029|FG002|Double-Blind|Protocol deviation|1|||
46780280|NCT00413413|82999027|FG000|Double-Blind|Subject withdrew consent|4|||
46780281|NCT00413413|82999028|FG001|Double-Blind|Subject withdrew consent|6|||
46780282|NCT00413413|82999029|FG002|Double-Blind|Subject withdrew consent|9|||
46780283|NCT00413413|82999027|FG000|Double-Blind|Lost to Follow-up|3|||
46780284|NCT00413413|82999028|FG001|Double-Blind|Lost to Follow-up|4|||
46780285|NCT00413413|82999029|FG002|Double-Blind|Lost to Follow-up|2|||
46780286|NCT00610714|82999039|FG000|Overall Study|Adverse Event|3|||
46780287|NCT00610714|82999040|FG001|Overall Study|Adverse Event|1|||
46780288|NCT00610714|82999039|FG000|Overall Study|Death|12|||
46780289|NCT00610714|82999040|FG001|Overall Study|Death|18|||
46780290|NCT00610714|82999039|FG000|Overall Study|Withdrawal by Subject|9|||
46780291|NCT00610714|82999040|FG001|Overall Study|Withdrawal by Subject|3|||
46780292|NCT00610714|82999039|FG000|Overall Study|Study completion at 120 PFS events|2|||
46780293|NCT00610714|82999040|FG001|Overall Study|Study completion at 120 PFS events|2|||
46780294|NCT00403585|82999046|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
46780295|NCT00403585|82999046|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
46780296|NCT00403585|82999046|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
46780297|NCT00645411|82999054|FG000|Overall Study|Adverse Event|0|||
46780298|NCT00645411|82999055|FG001|Overall Study|Adverse Event|0|||
46780299|NCT00645411|82999056|FG002|Overall Study|Adverse Event|0|||
46780300|NCT00645411|82999057|FG003|Overall Study|Adverse Event|2|||
46970406|NCT02705105|83213434|FG000|Treatment|Adverse Event|0|||
46648281|NCT03872453|82855136|FG002|Overall Study|Protocol Deviation|0|||
46780301|NCT00645411|82999054|FG000|Overall Study|Withdrawal by Subject|2|||
46780302|NCT00645411|82999055|FG001|Overall Study|Withdrawal by Subject|1|||
46780303|NCT00645411|82999056|FG002|Overall Study|Withdrawal by Subject|19|||
46780304|NCT00645411|82999057|FG003|Overall Study|Withdrawal by Subject|21|||
46780305|NCT00645411|82999054|FG000|Overall Study|Lost to Follow-up|10|||
46780306|NCT00645411|82999055|FG001|Overall Study|Lost to Follow-up|5|||
46780307|NCT00645411|82999056|FG002|Overall Study|Lost to Follow-up|124|||
46780308|NCT00645411|82999057|FG003|Overall Study|Lost to Follow-up|75|||
46780309|NCT00645411|82999054|FG000|Overall Study|Protocol Violation|1|||
46780310|NCT00645411|82999055|FG001|Overall Study|Protocol Violation|0|||
46780311|NCT00645411|82999056|FG002|Overall Study|Protocol Violation|1|||
46780312|NCT00645411|82999057|FG003|Overall Study|Protocol Violation|0|||
46780313|NCT00645411|82999054|FG000|Overall Study|Inappropriate enrollment|0|||
46648282|NCT03872453|82855137|FG003|Overall Study|Protocol Deviation|2|||
46648283|NCT03872453|82855134|FG000|Overall Study|Withdrawal by Subject|0|||
46648284|NCT03872453|82855135|FG001|Overall Study|Withdrawal by Subject|1|||
46780314|NCT00645411|82999055|FG001|Overall Study|Inappropriate enrollment|0|||
46780315|NCT00645411|82999056|FG002|Overall Study|Inappropriate enrollment|4|||
46780316|NCT00645411|82999057|FG003|Overall Study|Inappropriate enrollment|1|||
46780317|NCT00645411|82999054|FG000|Overall Study|Unable to classify|0|||
46780318|NCT00645411|82999055|FG001|Overall Study|Unable to classify|0|||
46780319|NCT00645411|82999056|FG002|Overall Study|Unable to classify|3|||
46780320|NCT00645411|82999057|FG003|Overall Study|Unable to classify|4|||
46780321|NCT00403273|82999076|FG000|Overall Study|Lost to Follow-up|3|||
46780322|NCT00403273|82999077|FG001|Overall Study|Lost to Follow-up|2|||
46780323|NCT00403273|82999076|FG000|Overall Study|Physician Decision|0|||
46850609|NCT00112437|83066379|FG016|Years 6-10 (60-Month Extension)|Other|0|||
46850610|NCT00112437|83066380|FG017|Years 6-10 (60-Month Extension)|Other|0|||
46850611|NCT00112437|83066381|FG018|Years 6-10 (60-Month Extension)|Other|0|||
46850612|NCT00112437|83066382|FG019|Years 6-10 (60-Month Extension)|Other|0|||
46850613|NCT00112437|83066383|FG020|Years 6-10 (60-Month Extension)|Other|0|||
46850614|NCT00112437|83066384|FG021|Years 6-10 (60-Month Extension)|Other|0|||
46850615|NCT00112437|83066385|FG022|Years 6-10 (60-Month Extension)|Other|0|||
46850616|NCT00112437|83066386|FG023|Years 6-10 (60-Month Extension)|Other|0|||
46850617|NCT00112437|83066387|FG024|Years 6-10 (60-Month Extension)|Other|1|||
46850618|NCT00112437|83066388|FG025|Years 6-10 (60-Month Extension)|Other|0|||
46850619|NCT00112437|83066363|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850620|NCT00112437|83066364|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850621|NCT00112437|83066365|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850622|NCT00112437|83066366|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850623|NCT00112437|83066367|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850624|NCT00112437|83066368|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850625|NCT00112437|83066369|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850626|NCT00112437|83066370|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850627|NCT00112437|83066371|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850628|NCT00112437|83066372|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850629|NCT00112437|83066373|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850630|NCT00112437|83066374|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850631|NCT00112437|83066375|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850632|NCT00112437|83066376|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850633|NCT00112437|83066377|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850634|NCT00112437|83066378|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850635|NCT00112437|83066379|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850636|NCT00112437|83066380|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850637|NCT00112437|83066381|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850638|NCT00112437|83066382|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46648285|NCT03872453|82855136|FG002|Overall Study|Withdrawal by Subject|2|||
46648286|NCT03872453|82855137|FG003|Overall Study|Withdrawal by Subject|0|||
46648287|NCT03872453|82855134|FG000|Overall Study|Other Than Specified|1|||
46648288|NCT03872453|82855135|FG001|Overall Study|Other Than Specified|0|||
46648289|NCT03872453|82855136|FG002|Overall Study|Other Than Specified|0|||
46648290|NCT03872453|82855137|FG003|Overall Study|Other Than Specified|0|||
46648291|NCT03726879|82855149|FG000|Overall Study|Death|6|||
46648292|NCT03726879|82855150|FG001|Overall Study|Death|4|||
46648293|NCT03726879|82855149|FG000|Overall Study|Physician Decision|0|||
46648294|NCT03726879|82855150|FG001|Overall Study|Physician Decision|2|||
46648295|NCT03726879|82855149|FG000|Overall Study|Protocol Violation|0|||
46648296|NCT03726879|82855150|FG001|Overall Study|Protocol Violation|1|||
46780324|NCT00403273|82999077|FG001|Overall Study|Physician Decision|1|||
46850639|NCT00112437|83066383|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850640|NCT00112437|83066384|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850641|NCT00112437|83066385|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46850642|NCT00112437|83066386|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
46850643|NCT00112437|83066387|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46648297|NCT03726879|82855149|FG000|Overall Study|Withdrawal by Subject|5|||
46648298|NCT03726879|82855150|FG001|Overall Study|Withdrawal by Subject|5|||
46780325|NCT00403273|82999076|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
46970407|NCT02705105|83213435|FG001|Treatment|Adverse Event|17|||
46970408|NCT02705105|83213434|FG000|Treatment|Clinical Disease Progression|0|||
46970409|NCT02705105|83213435|FG001|Treatment|Clinical Disease Progression|32|||
46970410|NCT02705105|83213434|FG000|Treatment|Physician Decision|0|||
46970411|NCT02705105|83213435|FG001|Treatment|Physician Decision|3|||
46970412|NCT02705105|83213434|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
46970413|NCT02705105|83213435|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
46970414|NCT02705105|83213434|FG000|Follow-Up|Death|3|||
46970415|NCT02705105|83213435|FG001|Follow-Up|Death|68|||
46970416|NCT02705105|83213434|FG000|Follow-Up|Withdrawal by Subject|1|||
46970417|NCT02705105|83213435|FG001|Follow-Up|Withdrawal by Subject|14|||
46970418|NCT02705105|83213434|FG000|Follow-Up|Study Terminated|0|||
46970419|NCT02705105|83213435|FG001|Follow-Up|Study Terminated|26|||
46970420|NCT02705105|83213434|FG000|Follow-Up|Discontinued per Amendment 3|0|||
46970421|NCT02705105|83213435|FG001|Follow-Up|Discontinued per Amendment 3|2|||
46970422|NCT02097472|83213461|FG000|Received Vaccination 2|Adverse Event|0|||
46970423|NCT02097472|83213462|FG001|Received Vaccination 2|Adverse Event|0|||
46970424|NCT02097472|83213463|FG002|Received Vaccination 2|Adverse Event|0|||
46970425|NCT02097472|83213464|FG003|Received Vaccination 2|Adverse Event|0|||
46970426|NCT02097472|83213465|FG004|Received Vaccination 2|Adverse Event|0|||
46970427|NCT02097472|83213466|FG005|Received Vaccination 2|Adverse Event|0|||
46970428|NCT02097472|83213467|FG006|Received Vaccination 2|Adverse Event|1|||
46970429|NCT02097472|83213468|FG007|Received Vaccination 2|Adverse Event|0|||
46970430|NCT01623310|83213552|FG000|Overall Study|Adverse Event|21|||
46970431|NCT01623310|83213552|FG000|Overall Study|Lost to Follow-up|18|||
46970432|NCT01623310|83213552|FG000|Overall Study|Lack of Efficacy|6|||
46970433|NCT01623310|83213552|FG000|Overall Study|Protocol Violation|6|||
46970434|NCT01623310|83213552|FG000|Overall Study|Withdrawal by Subject|25|||
46970435|NCT01623310|83213552|FG000|Overall Study|Became potentially child-bearing|1|||
46970436|NCT01623310|83213552|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
46970437|NCT01623310|83213552|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
46970438|NCT02046226|83213556|FG000|Overall Study|Lost to Follow-up|7|||
46970439|NCT02046148|83213563|FG000|Overall Study|Lost to Follow-up|1|||
46970440|NCT02046148|83213564|FG001|Overall Study|Lost to Follow-up|1|||
46970441|NCT02046148|83213563|FG000|Overall Study|Withdrawal by Subject|0|||
46970442|NCT02046148|83213564|FG001|Overall Study|Withdrawal by Subject|2|||
46970443|NCT02097238|83213570|FG000|Overall Study|Death|1|||
46970444|NCT02097238|83213570|FG000|Overall Study|Physician Decision|1|||
46970445|NCT02097238|83213570|FG000|Overall Study|Progressive Disease|17|||
46970446|NCT02704091|83213577|FG000|Overall Study|Adverse Event|4|||
46970447|NCT02704091|83213578|FG001|Overall Study|Adverse Event|3|||
46970448|NCT02704091|83213577|FG000|Overall Study|Protocol Violation|5|||
46970449|NCT02704091|83213578|FG001|Overall Study|Protocol Violation|3|||
46970450|NCT02704091|83213577|FG000|Overall Study|Consent withdrawn|4|||
46970451|NCT02704091|83213578|FG001|Overall Study|Consent withdrawn|4|||
46970452|NCT02704091|83213577|FG000|Overall Study|Lost to Follow-up|13|||
46970453|NCT02704091|83213578|FG001|Overall Study|Lost to Follow-up|5|||
46970454|NCT02704091|83213577|FG000|Overall Study|Other|2|||
46970455|NCT02704091|83213578|FG001|Overall Study|Other|8|||
46970456|NCT02702609|83213586|FG000|Overall Study|Lost to Follow-up|8|||
46970457|NCT02702609|83213587|FG001|Overall Study|Lost to Follow-up|4|||
46970458|NCT02702609|83213586|FG000|Overall Study|Physician Decision|1|||
46970459|NCT02702609|83213587|FG001|Overall Study|Physician Decision|0|||
46970460|NCT02046070|83213596|FG000|Overall Study|Progressive Disease|18|||
46970461|NCT02046070|83213597|FG001|Overall Study|Progressive Disease|11|||
46970462|NCT02046070|83213598|FG002|Overall Study|Progressive Disease|40|||
46970463|NCT02046070|83213596|FG000|Overall Study|Adverse Event|8|||
46970464|NCT02046070|83213597|FG001|Overall Study|Adverse Event|10|||
46970465|NCT02046070|83213598|FG002|Overall Study|Adverse Event|17|||
46970466|NCT02046070|83213596|FG000|Overall Study|Withdrawal by Subject|1|||
46648299|NCT03726879|82855149|FG000|Overall Study|TSH result is unstable|0|||
46648300|NCT03726879|82855150|FG001|Overall Study|TSH result is unstable|1|||
46970467|NCT02046070|83213597|FG001|Overall Study|Withdrawal by Subject|2|||
46970468|NCT02046070|83213598|FG002|Overall Study|Withdrawal by Subject|6|||
46970469|NCT02046070|83213596|FG000|Overall Study|Study Terminated by Sponsor|1|||
46970470|NCT02046070|83213597|FG001|Overall Study|Study Terminated by Sponsor|1|||
46970471|NCT02046070|83213598|FG002|Overall Study|Study Terminated by Sponsor|1|||
46970472|NCT02046070|83213596|FG000|Overall Study|Reason not Specified|4|||
46970473|NCT02046070|83213597|FG001|Overall Study|Reason not Specified|4|||
46970474|NCT02046070|83213598|FG002|Overall Study|Reason not Specified|6|||
46970475|NCT01663857|83213610|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
46970476|NCT01663857|83213611|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
46970477|NCT01663857|83213612|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
46970478|NCT01663857|83213613|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
46970479|NCT01663857|83213610|FG000|Overall Study|Lost to Follow-up|0|||
46970480|NCT01663857|83213611|FG001|Overall Study|Lost to Follow-up|0|||
46970481|NCT01663857|83213612|FG002|Overall Study|Lost to Follow-up|3|||
46970482|NCT01663857|83213613|FG003|Overall Study|Lost to Follow-up|1|||
46648301|NCT03726879|82855149|FG000|Overall Study|Continuing on Study|215|||
46648302|NCT03726879|82855150|FG001|Overall Study|Continuing on Study|215|||
46648303|NCT03721835|82855156|FG000|Overall Study|Participant not able to return|1|||
46648304|NCT03721835|82855156|FG000|Overall Study|Lost to Follow-up|1|||
46648305|NCT03721835|82855156|FG000|Overall Study|Revision of the components of the study device|2|||
46648306|NCT03721835|82855156|FG000|Overall Study|Sponsor terminated study|6|||
46648307|NCT03721835|82855156|FG000|Overall Study|Death|1|||
46648308|NCT03721835|82855156|FG000|Overall Study|Sponsor decision|1|||
46648309|NCT03565991|82855162|FG000|Overall Study|Other|11|||
46648310|NCT03565991|82855163|FG001|Overall Study|Other|0|||
46648311|NCT03565991|82855162|FG000|Overall Study|Global deterioration of health status|14|||
46648312|NCT03565991|82855163|FG001|Overall Study|Global deterioration of health status|4|||
46648313|NCT03565991|82855162|FG000|Overall Study|Withdrawal by Subject|2|||
46648314|NCT03565991|82855163|FG001|Overall Study|Withdrawal by Subject|6|||
46648315|NCT03565991|82855162|FG000|Overall Study|Progressive disease|121|||
46648316|NCT03565991|82855163|FG001|Overall Study|Progressive disease|29|||
46648317|NCT03565991|82855162|FG000|Overall Study|Death|3|||
46648318|NCT03565991|82855163|FG001|Overall Study|Death|0|||
46648319|NCT03565991|82855162|FG000|Overall Study|Adverse Event|7|||
46648320|NCT03565991|82855163|FG001|Overall Study|Adverse Event|2|||
46648321|NCT03186638|82855173|FG000|Overall Study|Withdrawal by Subject|4|||
46648322|NCT03186638|82855174|FG001|Overall Study|Withdrawal by Subject|4|||
46648323|NCT03186638|82855173|FG000|Overall Study|Withdrawn due to medical problem|3|||
46648324|NCT03186638|82855174|FG001|Overall Study|Withdrawn due to medical problem|2|||
46648325|NCT03186638|82855173|FG000|Overall Study|Lost to Follow-up|1|||
46648326|NCT03186638|82855174|FG001|Overall Study|Lost to Follow-up|0|||
46648327|NCT02691663|82855191|FG000|Overall Study|Screen failure after baseline|2|||
46648328|NCT02691663|82855192|FG001|Overall Study|Screen failure after baseline|2|||
46648329|NCT02691663|82855191|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
46648330|NCT02691663|82855192|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
46648331|NCT02691663|82855191|FG000|Overall Study|Withdrawn after Follow up 2|1|||
46648332|NCT02691663|82855192|FG001|Overall Study|Withdrawn after Follow up 2|1|||
46648333|NCT02691663|82855191|FG000|Overall Study|Lost to Follow-up|3|||
46648334|NCT02691663|82855192|FG001|Overall Study|Lost to Follow-up|2|||
46648335|NCT02639065|82855199|FG000|Study Treatment|Disease Progression|13|||
46648336|NCT02639065|82855199|FG000|Study Treatment|Adverse Event|9|||
46648337|NCT02639065|82855199|FG000|Study Treatment|Withdrawal by Subject|1|||
46648338|NCT02639065|82855199|FG000|Follow up|Subject refused to follow up|1|||
46648339|NCT02639065|82855199|FG000|Follow up|Symptomatic Deterioration|2|||
46648340|NCT02639065|82855199|FG000|Follow up|Death|2|||
46648341|NCT02639065|82855199|FG000|Follow up|Study Terminated|1|||
46648342|NCT02639065|82855199|FG000|Follow up|Disease Progression|3|||
46648343|NCT02566785|82855205|FG000|Overall Study|Lost to Follow-up|0|||
46648344|NCT02566785|82855206|FG001|Overall Study|Lost to Follow-up|2|||
46648345|NCT02566785|82855205|FG000|Overall Study|Worsening condition|1|||
46648346|NCT02566785|82855206|FG001|Overall Study|Worsening condition|1|||
46648347|NCT02344537|82855214|FG000|Overall Study|Protocol Violation|1|||
46648348|NCT02344537|82855215|FG001|Overall Study|Protocol Violation|1|||
46648349|NCT02344537|82855214|FG000|Overall Study|Subject started another treatment after wk 6|1|||
46648350|NCT02344537|82855215|FG001|Overall Study|Subject started another treatment after wk 6|0|||
46648351|NCT02344537|82855214|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
46648352|NCT02344537|82855215|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
46648353|NCT01092702|82855232|FG000|Overall Study|Withdrawal by Subject|7|||
46648354|NCT01092702|82855232|FG000|Overall Study|Lost to Follow-up|2|||
46648355|NCT00658879|82855261|FG000|Overall Study|Protocol Violation|1|||
46648356|NCT00591851|82855265|FG000|Overall Study|Withdrawal by Subject|3|||
46648357|NCT00591851|82855265|FG000|Overall Study|Adverse Event|2|||
46648358|NCT00591851|82855265|FG000|Overall Study|Progressive Disease|1|||
46648359|NCT00336024|82855271|FG000|Overall Study|Death|2|||
46648360|NCT00336024|82855272|FG001|Overall Study|Death|1|||
46648361|NCT00336024|82855271|FG000|Overall Study|Physician Decision|4|||
46648362|NCT00336024|82855272|FG001|Overall Study|Physician Decision|1|||
46648363|NCT00336024|82855271|FG000|Overall Study|Protocol Violation|1|||
46648364|NCT00336024|82855272|FG001|Overall Study|Protocol Violation|0|||
46780326|NCT00403273|82999077|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
46780327|NCT00402727|82999100|FG000|Overall Study|Adverse Event|10|||
46970483|NCT02094898|83213629|FG000|Overall Study|Clinical Worsening|2|||
46648365|NCT00336024|82855271|FG000|Overall Study|Withdrawal by Subject|1|||
46648366|NCT00336024|82855272|FG001|Overall Study|Withdrawal by Subject|2|||
46648367|NCT00336024|82855271|FG000|Overall Study|Failure to fulfill consolidation|1|||
46648368|NCT00336024|82855272|FG001|Overall Study|Failure to fulfill consolidation|1|||
46648369|NCT00336024|82855271|FG000|Overall Study|Progressive Disease|4|||
46648370|NCT00336024|82855272|FG001|Overall Study|Progressive Disease|7|||
46648371|NCT00336024|82855271|FG000|Overall Study|Ineligible|7|||
46648372|NCT00336024|82855272|FG001|Overall Study|Ineligible|7|||
46648373|NCT00133705|82855280|FG000|Overall Study|Withdrawal by Subject|2|||
46648374|NCT00133705|82855281|FG001|Overall Study|Withdrawal by Subject|3|||
46648375|NCT01545050|82855292|FG000|Overall Study|Lack of Efficacy|0|||
46648376|NCT01545050|82855293|FG001|Overall Study|Lack of Efficacy|0|||
46648377|NCT01545050|82855294|FG002|Overall Study|Lack of Efficacy|0|||
46648378|NCT01545050|82855295|FG003|Overall Study|Lack of Efficacy|3|||
46648379|NCT01545050|82855296|FG004|Overall Study|Lack of Efficacy|2|||
46648380|NCT01545050|82855292|FG000|Overall Study|Adverse Event|1|||
46648381|NCT01545050|82855293|FG001|Overall Study|Adverse Event|1|||
46648382|NCT01545050|82855294|FG002|Overall Study|Adverse Event|2|||
46648383|NCT01545050|82855295|FG003|Overall Study|Adverse Event|2|||
46648384|NCT01545050|82855296|FG004|Overall Study|Adverse Event|0|||
46648385|NCT01545050|82855292|FG000|Overall Study|Discontinued study treatment|1|||
46648386|NCT01545050|82855293|FG001|Overall Study|Discontinued study treatment|0|||
46648387|NCT01545050|82855294|FG002|Overall Study|Discontinued study treatment|0|||
46648388|NCT01545050|82855295|FG003|Overall Study|Discontinued study treatment|0|||
46648389|NCT01545050|82855296|FG004|Overall Study|Discontinued study treatment|0|||
46648390|NCT01545050|82855292|FG000|Overall Study|Withdrawal by Subject|1|||
46648391|NCT01545050|82855293|FG001|Overall Study|Withdrawal by Subject|0|||
46648392|NCT01545050|82855294|FG002|Overall Study|Withdrawal by Subject|0|||
46648393|NCT01545050|82855295|FG003|Overall Study|Withdrawal by Subject|2|||
46648394|NCT01545050|82855296|FG004|Overall Study|Withdrawal by Subject|1|||
46648395|NCT01545050|82855292|FG000|Overall Study|Participant no longer meets study criteria|0|||
46648396|NCT01545050|82855293|FG001|Overall Study|Participant no longer meets study criteria|2|||
46648397|NCT01545050|82855294|FG002|Overall Study|Participant no longer meets study criteria|0|||
46648398|NCT01545050|82855295|FG003|Overall Study|Participant no longer meets study criteria|0|||
46648399|NCT01545050|82855296|FG004|Overall Study|Participant no longer meets study criteria|1|||
46648400|NCT01545050|82855292|FG000|Overall Study|Administrative reason by sponsor|4|||
46648401|NCT01545050|82855293|FG001|Overall Study|Administrative reason by sponsor|2|||
46648402|NCT01545050|82855294|FG002|Overall Study|Administrative reason by sponsor|3|||
46648403|NCT01545050|82855295|FG003|Overall Study|Administrative reason by sponsor|5|||
46648404|NCT01545050|82855296|FG004|Overall Study|Administrative reason by sponsor|5|||
46648405|NCT01555021|82855323|FG000|Overall Study|Lost to Follow-up|1|||
46648406|NCT01555021|82855324|FG001|Overall Study|Lost to Follow-up|2|||
46648407|NCT04721925|82855338|FG000|2-Month Assessment|Lost to Follow-up|5|||
46648408|NCT04721925|82855339|FG001|2-Month Assessment|Lost to Follow-up|3|||
46648409|NCT04721925|82855338|FG000|4-Month Assessment|Lost to Follow-up|3|||
46648410|NCT04721925|82855339|FG001|4-Month Assessment|Lost to Follow-up|6|||
46648411|NCT04677660|82855346|FG000|Overall Study|Lost to Follow-up|0|||
46648412|NCT04677660|82855347|FG001|Overall Study|Lost to Follow-up|2|||
46648413|NCT04677660|82855346|FG000|Overall Study|Withdrawal by Subject|0|||
46648414|NCT04677660|82855347|FG001|Overall Study|Withdrawal by Subject|1|||
46648415|NCT04677660|82855346|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
46648416|NCT04677660|82855347|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
46648417|NCT04518995|82855356|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
46648418|NCT04518995|82855357|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
46648419|NCT04518995|82855358|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
46648420|NCT04518995|82855356|FG000|Overall Study|Lack of Efficacy|2|||
46648421|NCT04518995|82855357|FG001|Overall Study|Lack of Efficacy|1|||
46648422|NCT04518995|82855358|FG002|Overall Study|Lack of Efficacy|0|||
46648423|NCT04518995|82855356|FG000|Overall Study|Non-compliance With Study Drug|0|||
46648424|NCT04518995|82855357|FG001|Overall Study|Non-compliance With Study Drug|3|||
46648425|NCT04518995|82855358|FG002|Overall Study|Non-compliance With Study Drug|2|||
46648426|NCT04518995|82855356|FG000|Overall Study|Pregnancy|0|||
46648427|NCT04518995|82855357|FG001|Overall Study|Pregnancy|0|||
46648428|NCT04518995|82855358|FG002|Overall Study|Pregnancy|1|||
46648429|NCT04518995|82855356|FG000|Overall Study|Protocol Violation|2|||
46648430|NCT04518995|82855357|FG001|Overall Study|Protocol Violation|0|||
46648431|NCT04518995|82855358|FG002|Overall Study|Protocol Violation|1|||
46648432|NCT04518995|82855356|FG000|Overall Study|Reason not Specified|4|||
46648433|NCT04518995|82855357|FG001|Overall Study|Reason not Specified|11|||
46648434|NCT04518995|82855358|FG002|Overall Study|Reason not Specified|2|||
46648435|NCT04518995|82855356|FG000|Overall Study|Lost to Follow-up|1|||
46648436|NCT04518995|82855357|FG001|Overall Study|Lost to Follow-up|10|||
46648437|NCT04518995|82855358|FG002|Overall Study|Lost to Follow-up|6|||
46648438|NCT04474691|82855366|FG000|Overall Study|Withdrawal by Subject|9|||
46648439|NCT04014075|82855398|FG000|Overall Study|Progressive Disease|48|||
46648440|NCT04014075|82855398|FG000|Overall Study|Adverse Event|11|||
46648441|NCT04014075|82855398|FG000|Overall Study|Clinical Progression|4|||
46648442|NCT04014075|82855398|FG000|Overall Study|Death|2|||
46648443|NCT04014075|82855398|FG000|Overall Study|Withdrawal by Subject|2|||
46648444|NCT04014075|82855398|FG000|Overall Study|Miscellaneous|1|||
46648445|NCT04014075|82855398|FG000|Overall Study|Physician Decision|1|||
46648446|NCT03840174|82855406|FG000|Overall Study|Withdrawal by Subject|1|||
46648447|NCT03840174|82855407|FG001|Overall Study|Withdrawal by Subject|0|||
46648448|NCT03840174|82855408|FG002|Overall Study|Withdrawal by Subject|0|||
46648449|NCT03840174|82855409|FG003|Overall Study|Withdrawal by Subject|0|||
46648450|NCT03786718|82855420|FG000|Overall Study|Lost to Follow-up|3|||
46648451|NCT03786718|82855420|FG000|Overall Study|Withdrawal by Subject|1|||
46648452|NCT03786718|82855420|FG000|Overall Study|Did not use the intervention|2|||
46648453|NCT03786718|82855420|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
46648454|NCT03400943|82855453|FG000|Treatment Period 1|Adverse Event|0|||
46648455|NCT03400943|82855454|FG001|Treatment Period 1|Adverse Event|0|||
46648456|NCT03400943|82855455|FG002|Treatment Period 1|Adverse Event|0|||
46648457|NCT03400943|82855456|FG003|Treatment Period 1|Adverse Event|1|||
46648458|NCT03400943|82855453|FG000|Treatment Period 1|Lost to Follow-up|1|||
46648459|NCT03400943|82855454|FG001|Treatment Period 1|Lost to Follow-up|0|||
46648460|NCT03400943|82855455|FG002|Treatment Period 1|Lost to Follow-up|0|||
46648461|NCT03400943|82855456|FG003|Treatment Period 1|Lost to Follow-up|0|||
46648462|NCT03400943|82855453|FG000|Treatment Period 1|Protocol Violation|0|||
46648463|NCT03400943|82855454|FG001|Treatment Period 1|Protocol Violation|1|||
46648464|NCT03400943|82855455|FG002|Treatment Period 1|Protocol Violation|1|||
46648465|NCT03400943|82855456|FG003|Treatment Period 1|Protocol Violation|0|||
46648466|NCT03400943|82855453|FG000|Treatment Period 1|Study terminated by sponsor|2|||
46648467|NCT03400943|82855454|FG001|Treatment Period 1|Study terminated by sponsor|0|||
46648468|NCT03400943|82855455|FG002|Treatment Period 1|Study terminated by sponsor|0|||
46648469|NCT03400943|82855456|FG003|Treatment Period 1|Study terminated by sponsor|1|||
46648470|NCT03400943|82855453|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46648471|NCT03400943|82855454|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46648472|NCT03400943|82855455|FG002|Treatment Period 1|Withdrawal by Subject|3|||
46648473|NCT03400943|82855456|FG003|Treatment Period 1|Withdrawal by Subject|1|||
46648474|NCT03400943|82855453|FG000|Treatment Period 1|Other|2|||
46648475|NCT03400943|82855454|FG001|Treatment Period 1|Other|1|||
46648476|NCT03400943|82855455|FG002|Treatment Period 1|Other|2|||
46648477|NCT03400943|82855456|FG003|Treatment Period 1|Other|2|||
46648478|NCT03400943|82855453|FG000|Post-treatment Period 1|Adverse Event|2|||
46648479|NCT03400943|82855454|FG001|Post-treatment Period 1|Adverse Event|0|||
46648480|NCT03400943|82855455|FG002|Post-treatment Period 1|Adverse Event|0|||
46648481|NCT03400943|82855456|FG003|Post-treatment Period 1|Adverse Event|0|||
46648482|NCT03400943|82855453|FG000|Post-treatment Period 1|Protocol Violation|1|||
46648483|NCT03400943|82855454|FG001|Post-treatment Period 1|Protocol Violation|0|||
46648484|NCT03400943|82855455|FG002|Post-treatment Period 1|Protocol Violation|0|||
46648485|NCT03400943|82855456|FG003|Post-treatment Period 1|Protocol Violation|0|||
46648486|NCT03400943|82855453|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
46648487|NCT03400943|82855454|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
46648488|NCT03400943|82855455|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
46648489|NCT03400943|82855456|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
46648490|NCT03400943|82855453|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
46648491|NCT03400943|82855454|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
46648492|NCT03400943|82855455|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
46648493|NCT03400943|82855456|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
46648494|NCT03400943|82855453|FG000|Post-treatment Period 1|Other|2|||
46648495|NCT03400943|82855454|FG001|Post-treatment Period 1|Other|0|||
46648496|NCT03400943|82855455|FG002|Post-treatment Period 1|Other|4|||
46648497|NCT03400943|82855456|FG003|Post-treatment Period 1|Other|5|||
46648498|NCT03400943|82855453|FG000|Treatment Period 2|Study terminated by sponsor|0|||
46648499|NCT03400943|82855454|FG001|Treatment Period 2|Study terminated by sponsor|1|||
46648500|NCT03400943|82855455|FG002|Treatment Period 2|Study terminated by sponsor|0|||
46648501|NCT03400943|82855456|FG003|Treatment Period 2|Study terminated by sponsor|0|||
46648502|NCT03400943|82855453|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46648503|NCT03400943|82855454|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46648504|NCT03400943|82855455|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46648505|NCT03400943|82855456|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46648506|NCT03400943|82855453|FG000|Treatment Period 2|Other|1|||
46648507|NCT03400943|82855454|FG001|Treatment Period 2|Other|6|||
46648508|NCT03400943|82855455|FG002|Treatment Period 2|Other|0|||
46850644|NCT00112437|83066388|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
46648509|NCT03400943|82855456|FG003|Treatment Period 2|Other|0|||
46648510|NCT03400943|82855453|FG000|Follow-up Period|Withdrawal by Subject|1|||
46648511|NCT03400943|82855454|FG001|Follow-up Period|Withdrawal by Subject|0|||
46648512|NCT03400943|82855455|FG002|Follow-up Period|Withdrawal by Subject|0|||
46648513|NCT03400943|82855456|FG003|Follow-up Period|Withdrawal by Subject|0|||
46648514|NCT03321526|82855470|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
46648515|NCT03321526|82855471|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
46648516|NCT03321526|82855470|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
46648517|NCT03321526|82855471|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
46648518|NCT03321526|82855470|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
46648519|NCT03321526|82855471|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
46648520|NCT03321526|82855470|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
46648521|NCT03321526|82855471|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
46648522|NCT03321526|82855470|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
46648523|NCT03321526|82855471|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
46648524|NCT03321526|82855470|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
46648525|NCT03321526|82855471|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
46970484|NCT02094898|83213629|FG000|Overall Study|Adverse Event|2|||
46970485|NCT02094898|83213629|FG000|Overall Study|Lack of Efficacy|1|||
46970486|NCT02045836|83213637|FG000|Overall Study|Adverse Event|4|||
46970487|NCT02045836|83213638|FG001|Overall Study|Adverse Event|4|||
46970488|NCT02045836|83213637|FG000|Overall Study|Withdrawal by Subject|1|||
46970489|NCT02045836|83213638|FG001|Overall Study|Withdrawal by Subject|1|||
46970490|NCT02045836|83213637|FG000|Overall Study|Lost to Follow-up|4|||
46970491|NCT02045836|83213638|FG001|Overall Study|Lost to Follow-up|7|||
46970492|NCT02045836|83213637|FG000|Overall Study|Migrated from study area|0|||
46970493|NCT02045836|83213638|FG001|Overall Study|Migrated from study area|2|||
46970494|NCT02569437|83213647|FG000|Overall Study|Lost to Follow-up|12|||
46970495|NCT02569437|83213648|FG001|Overall Study|Lost to Follow-up|14|||
46970496|NCT02045212|83213656|FG000|Overall Study|Adverse Event|0|||
46970497|NCT02045212|83213657|FG001|Overall Study|Adverse Event|1|||
46970498|NCT02045212|83213656|FG000|Overall Study|Withdrawal by Subject|1|||
46970499|NCT02045212|83213657|FG001|Overall Study|Withdrawal by Subject|0|||
46970500|NCT02045212|83213656|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
46970501|NCT02045212|83213657|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
46648526|NCT03321526|82855470|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
46648527|NCT03321526|82855471|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
46648528|NCT03321526|82855470|FG000|Follow-up Phase (2 Weeks)|Other|24|||
46970502|NCT02044822|83213667|FG000|Overall Study|Study Terminated by Sponsor|77|||
46970503|NCT02044822|83213667|FG000|Overall Study|Investigator's Discretion|10|||
46970504|NCT02044822|83213667|FG000|Overall Study|Withdrew Consent|3|||
46970505|NCT02044822|83213667|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
46970506|NCT02044822|83213667|FG000|Overall Study|Lost to Follow-up|1|||
46970507|NCT02044510|83213673|FG000|Overall Study|Adverse Event|1|||
46970508|NCT02044510|83213674|FG001|Overall Study|Adverse Event|2|||
46648529|NCT03321526|82855471|FG001|Follow-up Phase (2 Weeks)|Other|24|||
46648530|NCT03153111|82855485|FG000|Overall Study|Death|2|||
46648531|NCT03153111|82855486|FG001|Overall Study|Death|5|||
46648532|NCT03153111|82855485|FG000|Overall Study|Lost to Follow-up|1|||
46648533|NCT03153111|82855486|FG001|Overall Study|Lost to Follow-up|0|||
46648534|NCT03153111|82855485|FG000|Overall Study|Physician Decision|5|||
46648535|NCT03153111|82855486|FG001|Overall Study|Physician Decision|1|||
46648536|NCT03153111|82855485|FG000|Overall Study|Withdrawal by Subject|3|||
46648537|NCT03153111|82855486|FG001|Overall Study|Withdrawal by Subject|3|||
46648538|NCT03126435|82855494|FG000|Overall Study|Death|90|||
46648539|NCT03126435|82855495|FG001|Overall Study|Death|84|||
46648540|NCT03126435|82855494|FG000|Overall Study|Lost to Follow-up|4|||
46648541|NCT03126435|82855495|FG001|Overall Study|Lost to Follow-up|3|||
46648542|NCT03126435|82855494|FG000|Overall Study|Physician Decision|0|||
46648543|NCT03126435|82855495|FG001|Overall Study|Physician Decision|1|||
46648544|NCT03126435|82855494|FG000|Overall Study|Withdrawal by Subject|6|||
46648545|NCT03126435|82855495|FG001|Overall Study|Withdrawal by Subject|12|||
46648546|NCT03126435|82855494|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
46648547|NCT03126435|82855495|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
46648548|NCT02823574|82855507|FG000|Randomization|Disease Progression|0|||
46648549|NCT02823574|82855508|FG001|Randomization|Disease Progression|0|||
46648550|NCT02823574|82855509|FG002|Randomization|Disease Progression|1|||
46648551|NCT02823574|82855510|FG003|Randomization|Disease Progression|0|||
46648552|NCT02823574|82855507|FG000|Randomization|AE unrelated to Study Drug|1|||
46648553|NCT02823574|82855508|FG001|Randomization|AE unrelated to Study Drug|0|||
46648554|NCT02823574|82855509|FG002|Randomization|AE unrelated to Study Drug|0|||
46648555|NCT02823574|82855510|FG003|Randomization|AE unrelated to Study Drug|0|||
46648556|NCT02823574|82855507|FG000|Treatment Period|Poor/Non Compliance|1|||
46648557|NCT02823574|82855508|FG001|Treatment Period|Poor/Non Compliance|0|||
46648558|NCT02823574|82855509|FG002|Treatment Period|Poor/Non Compliance|0|||
46648559|NCT02823574|82855510|FG003|Treatment Period|Poor/Non Compliance|1|||
46648560|NCT02823574|82855507|FG000|Treatment Period|Maximum Clinical Benefit|8|||
46648561|NCT02823574|82855508|FG001|Treatment Period|Maximum Clinical Benefit|4|||
46648562|NCT02823574|82855509|FG002|Treatment Period|Maximum Clinical Benefit|7|||
46648563|NCT02823574|82855510|FG003|Treatment Period|Maximum Clinical Benefit|1|||
46648564|NCT02823574|82855507|FG000|Treatment Period|Lost to Follow-up|1|||
46648565|NCT02823574|82855508|FG001|Treatment Period|Lost to Follow-up|1|||
46648566|NCT02823574|82855509|FG002|Treatment Period|Lost to Follow-up|0|||
46648567|NCT02823574|82855510|FG003|Treatment Period|Lost to Follow-up|0|||
46648568|NCT02823574|82855507|FG000|Treatment Period|Participant withdrew consent|4|||
46648569|NCT02823574|82855508|FG001|Treatment Period|Participant withdrew consent|0|||
46648570|NCT02823574|82855509|FG002|Treatment Period|Participant withdrew consent|0|||
46648571|NCT02823574|82855510|FG003|Treatment Period|Participant withdrew consent|1|||
46648572|NCT02823574|82855507|FG000|Treatment Period|Participant request to discontinue|5|||
46648573|NCT02823574|82855508|FG001|Treatment Period|Participant request to discontinue|0|||
46648574|NCT02823574|82855509|FG002|Treatment Period|Participant request to discontinue|3|||
46648575|NCT02823574|82855510|FG003|Treatment Period|Participant request to discontinue|2|||
46648576|NCT02823574|82855507|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
46648577|NCT02823574|82855508|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
46648578|NCT02823574|82855509|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
46648579|NCT02823574|82855510|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
46648580|NCT02823574|82855507|FG000|Treatment Period|Study Drug Toxicity|11|||
46648581|NCT02823574|82855508|FG001|Treatment Period|Study Drug Toxicity|2|||
46970509|NCT02067676|83213686|FG000|Overall Study|Withdrawal by Subject|1|||
46970510|NCT02067676|83213687|FG001|Overall Study|Withdrawal by Subject|0|||
46970511|NCT02067676|83213688|FG002|Overall Study|Withdrawal by Subject|0|||
46648582|NCT02823574|82855509|FG002|Treatment Period|Study Drug Toxicity|14|||
46648583|NCT02823574|82855510|FG003|Treatment Period|Study Drug Toxicity|4|||
46648584|NCT02823574|82855507|FG000|Treatment Period|Disease Progression|113|||
46648585|NCT02823574|82855508|FG001|Treatment Period|Disease Progression|64|||
46648586|NCT02823574|82855509|FG002|Treatment Period|Disease Progression|82|||
46648587|NCT02823574|82855510|FG003|Treatment Period|Disease Progression|43|||
46648588|NCT02823574|82855507|FG000|Treatment Period|Other reasons|5|||
46648589|NCT02823574|82855508|FG001|Treatment Period|Other reasons|9|||
46648590|NCT02823574|82855509|FG002|Treatment Period|Other reasons|3|||
46648591|NCT02823574|82855510|FG003|Treatment Period|Other reasons|6|||
46648592|NCT02823574|82855507|FG000|Treatment Period|Participant no longer meets study criteria|0|||
46648593|NCT02823574|82855508|FG001|Treatment Period|Participant no longer meets study criteria|0|||
46648594|NCT02823574|82855509|FG002|Treatment Period|Participant no longer meets study criteria|1|||
46648595|NCT02823574|82855510|FG003|Treatment Period|Participant no longer meets study criteria|0|||
46648596|NCT02823574|82855507|FG000|Treatment Period|Death|0|||
46648597|NCT02823574|82855508|FG001|Treatment Period|Death|0|||
46648598|NCT02823574|82855509|FG002|Treatment Period|Death|3|||
46648599|NCT02823574|82855510|FG003|Treatment Period|Death|1|||
46648600|NCT02746809|82855523|FG000|Enrollment|Inclusion Exclusion not met|9|||
46648601|NCT02746809|82855523|FG000|Enrollment|Withdrawal by Subject|1|||
46648602|NCT02746809|82855523|FG000|Enrollment|Expected Enrollment Met|2|||
46648603|NCT02746809|82855523|FG000|Procedure|Death|1|||
46648604|NCT02746809|82855523|FG000|1-Month|Death|5|||
46648605|NCT02746809|82855523|FG000|6-Month|Death|2|||
46648606|NCT02746809|82855523|FG000|6-Month|Withdrawal by Subject|1|||
46648607|NCT02746809|82855523|FG000|12-Month|Death|3|||
46648608|NCT02746809|82855523|FG000|12-Month|Withdrawal by Subject|2|||
46648609|NCT02746809|82855523|FG000|24-Month|Death|1|||
46648610|NCT02746809|82855523|FG000|24-Month|Withdrawal by Subject|1|||
46648611|NCT02746809|82855523|FG000|36-Month|Death|8|||
46648612|NCT02746809|82855523|FG000|36-Month|Withdrawal by Subject|1|||
46648613|NCT02746809|82855523|FG000|48-Month|Death|7|||
46648614|NCT02746809|82855523|FG000|48-Month|Withdrawal by Subject|1|||
46648615|NCT02746809|82855523|FG000|60-Month|Death|1|||
46648616|NCT02746809|82855523|FG000|60-Month|Lost to Follow-up|2|||
46648617|NCT02525796|82855532|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
46648618|NCT02525796|82855533|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
46648619|NCT02525796|82855534|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
46648620|NCT02525796|82855532|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
46648621|NCT02525796|82855533|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
46648622|NCT02525796|82855534|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
46648623|NCT02525796|82855532|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
46648624|NCT02525796|82855533|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
46648625|NCT02525796|82855534|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
46648626|NCT02525796|82855532|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
46648627|NCT02525796|82855533|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
46648628|NCT02525796|82855534|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
46648629|NCT02525796|82855532|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
46648630|NCT02525796|82855533|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
46648631|NCT02525796|82855534|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
46648632|NCT02360280|82855550|FG000|Overall Study|Withdrawal by Subject|2|||
46648633|NCT02360280|82855551|FG001|Overall Study|Withdrawal by Subject|0|||
46648634|NCT02360280|82855550|FG000|Overall Study|Adverse Event|0|||
46648635|NCT02360280|82855551|FG001|Overall Study|Adverse Event|1|||
46648636|NCT02360280|82855550|FG000|Overall Study|Lost to Follow-up|1|||
46648637|NCT02360280|82855551|FG001|Overall Study|Lost to Follow-up|0|||
46648638|NCT02201251|82855559|FG000|Overall Study|Adverse Event|1|||
46850645|NCT00112437|83066363|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46648639|NCT02201251|82855560|FG001|Overall Study|Adverse Event|1|||
46648640|NCT02201251|82855559|FG000|Overall Study|Protocol Violation|1|||
46648641|NCT02201251|82855560|FG001|Overall Study|Protocol Violation|0|||
46648642|NCT02201251|82855559|FG000|Overall Study|Noncompliance with Study Drug|0|||
46648643|NCT02201251|82855560|FG001|Overall Study|Noncompliance with Study Drug|1|||
46648644|NCT02201251|82855559|FG000|Overall Study|Withdrawal by Subject|2|||
46648645|NCT02201251|82855560|FG001|Overall Study|Withdrawal by Subject|1|||
46648646|NCT02027545|82855568|FG000|Overall Study|Failed to sign HIPAA|0|||
46648647|NCT02027545|82855569|FG001|Overall Study|Failed to sign HIPAA|2|||
46648648|NCT02027545|82855568|FG000|Overall Study|Failed to attend study visit|2|||
46648649|NCT02027545|82855569|FG001|Overall Study|Failed to attend study visit|0|||
46648650|NCT02027545|82855568|FG000|Overall Study|Protocol Violation|1|||
46648651|NCT02027545|82855569|FG001|Overall Study|Protocol Violation|0|||
46648652|NCT01867242|82855587|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
46648653|NCT01867242|82855588|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
46648654|NCT01867242|82855589|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
46648655|NCT01858688|82855597|FG000|Overall Study|Withdrawal by Subject|8|||
46648656|NCT01858688|82855597|FG000|Overall Study|Participant began another therapy|3|||
46648657|NCT01858688|82855597|FG000|Overall Study|Physician Decision|2|||
46648658|NCT01858688|82855597|FG000|Overall Study|Progressive Disease|2|||
46648659|NCT01858688|82855597|FG000|Overall Study|Reason not reproted|5|||
46648660|NCT01599234|82855616|FG000|Overall Study|Adverse Event|9|||
46648661|NCT01599234|82855617|FG001|Overall Study|Adverse Event|5|||
46648662|NCT01599234|82855616|FG000|Overall Study|Withdrawal by Subject|2|||
46648663|NCT01599234|82855617|FG001|Overall Study|Withdrawal by Subject|1|||
46648664|NCT01599234|82855616|FG000|Overall Study|Lost to Follow-up|1|||
46648665|NCT01599234|82855617|FG001|Overall Study|Lost to Follow-up|2|||
46648666|NCT01599234|82855616|FG000|Overall Study|Lack of Efficacy|2|||
46648667|NCT01599234|82855617|FG001|Overall Study|Lack of Efficacy|4|||
46648668|NCT01599234|82855616|FG000|Overall Study|Unable to operate spray|1|||
46648669|NCT01599234|82855617|FG001|Overall Study|Unable to operate spray|0|||
46648670|NCT01599234|82855616|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
46648671|NCT01599234|82855617|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
47075127|NCT00634049|83368553|FG000|Overall Study|Died prior to receiving study drug|1|||
47075128|NCT00634049|83368553|FG000|Overall Study|Screening failure|1|||
47075129|NCT00632099|83368592|FG000|Overall Study|Lost to Follow-up|3|||
47075130|NCT00632099|83368593|FG001|Overall Study|Lost to Follow-up|3|||
47075131|NCT00632021|83368601|FG000|Overall Study|Withdrawal/death|4|||
47075132|NCT00632021|83368602|FG001|Overall Study|Withdrawal/death|7|||
47075133|NCT00631475|83368609|FG000|Overall Study|Death|18|||
47075134|NCT00631475|83368609|FG000|Overall Study|Adverse Event|14|||
47075135|NCT00631475|83368609|FG000|Overall Study|Withdrew consent|5|||
47075136|NCT00631475|83368609|FG000|Overall Study|Preparation for lung transplant|8|||
46648672|NCT01599234|82855616|FG000|Overall Study|Death|1|||
46648673|NCT01599234|82855617|FG001|Overall Study|Death|0|||
46648674|NCT01599234|82855616|FG000|Overall Study|Patient would not stop driving|1|||
46648675|NCT01599234|82855617|FG001|Overall Study|Patient would not stop driving|0|||
46648676|NCT01599234|82855616|FG000|Overall Study|Contra-indication discovered|0|||
46648677|NCT01599234|82855617|FG001|Overall Study|Contra-indication discovered|1|||
46648678|NCT01599234|82855616|FG000|Overall Study|Pregnancy|0|||
46648679|NCT01599234|82855617|FG001|Overall Study|Pregnancy|1|||
46648680|NCT01393301|82855625|FG000|Overall Study|Lost to Follow-up|5|||
46648681|NCT01393301|82855626|FG001|Overall Study|Lost to Follow-up|3|||
46648682|NCT01393301|82855625|FG000|Overall Study|Withdrawal by Subject|2|||
46648683|NCT01393301|82855626|FG001|Overall Study|Withdrawal by Subject|0|||
46648684|NCT01393301|82855625|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
46648685|NCT01393301|82855626|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
46648686|NCT00716625|82855632|FG000|Overall Study|Safety was not Assessable|1|||
46648687|NCT00713323|82855659|FG000|Overall Study|Adverse Event|75|||
46648688|NCT00713323|82855659|FG000|Overall Study|Withdrawal by Subject|15|||
46648689|NCT00713323|82855659|FG000|Overall Study|Lost to Follow-up|11|||
46648690|NCT00713323|82855659|FG000|Overall Study|Lack of Efficacy|36|||
46648691|NCT00713323|82855659|FG000|Overall Study|Low creatine clearance at screening|1|||
46648692|NCT00713323|82855659|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
46648693|NCT00713323|82855659|FG000|Overall Study|Surgery cured allodynic pain|1|||
46648694|NCT00713323|82855659|FG000|Overall Study|Pain free|1|||
46780328|NCT00402727|82999101|FG001|Overall Study|Adverse Event|6|||
46780329|NCT00402727|82999100|FG000|Overall Study|Death|1|||
46780330|NCT00402727|82999101|FG001|Overall Study|Death|0|||
47075137|NCT00631163|83368630|FG000|Number of Participants in Year 1|Adverse Event|12|||
47075138|NCT00631163|83368630|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
46648695|NCT00713323|82855659|FG000|Overall Study|Non-compliance|1|||
46648696|NCT00713323|82855659|FG000|Overall Study|Pain resolved|1|||
46648697|NCT00713323|82855659|FG000|Overall Study|Subject travelling to USA|1|||
46648698|NCT00713323|82855659|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
47075139|NCT00631163|83368630|FG000|Number of Participants in Year 1|Death|6|||
46648699|NCT00713323|82855659|FG000|Overall Study|Treatment that may interact with Sativex|1|||
46648700|NCT00710554|82855676|FG000|Overall Study|Adverse Event|24|||
46648701|NCT00710554|82855677|FG001|Overall Study|Adverse Event|7|||
46648702|NCT00710554|82855676|FG000|Overall Study|Withdrawal by Subject|7|||
46648703|NCT00710554|82855677|FG001|Overall Study|Withdrawal by Subject|3|||
46648704|NCT00710554|82855676|FG000|Overall Study|Lost to Follow-up|7|||
46648705|NCT00710554|82855677|FG001|Overall Study|Lost to Follow-up|1|||
46648706|NCT00710554|82855676|FG000|Overall Study|Lack of Efficacy|11|||
46648707|NCT00710554|82855677|FG001|Overall Study|Lack of Efficacy|12|||
46648708|NCT00710554|82855676|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
46648709|NCT00710554|82855677|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
46648710|NCT00710424|82855685|FG000|Overall Study|Adverse Event|30|||
46648711|NCT00710424|82855686|FG001|Overall Study|Adverse Event|12|||
46648712|NCT00710424|82855685|FG000|Overall Study|Lack of Efficacy|4|||
46648713|NCT00710424|82855686|FG001|Overall Study|Lack of Efficacy|5|||
46648714|NCT00710424|82855685|FG000|Overall Study|Withdrawal by Subject|5|||
46648715|NCT00710424|82855686|FG001|Overall Study|Withdrawal by Subject|3|||
46648716|NCT00710424|82855685|FG000|Overall Study|Lost to Follow-up|0|||
46648717|NCT00710424|82855686|FG001|Overall Study|Lost to Follow-up|1|||
46648718|NCT00710424|82855685|FG000|Overall Study|Refused medication, no side effects|1|||
46648719|NCT00710424|82855686|FG001|Overall Study|Refused medication, no side effects|0|||
46648720|NCT00710424|82855685|FG000|Overall Study|Non-compliance with stable analgesia|1|||
46648721|NCT00710424|82855686|FG001|Overall Study|Non-compliance with stable analgesia|0|||
46648722|NCT00710424|82855685|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
46648723|NCT00710424|82855686|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
46648724|NCT00710424|82855685|FG000|Overall Study|Subject thought medication changed|1|||
46648725|NCT00710424|82855686|FG001|Overall Study|Subject thought medication changed|0|||
46648726|NCT00710424|82855685|FG000|Overall Study|Ceased treatment due to travel|1|||
46648727|NCT00710424|82855686|FG001|Overall Study|Ceased treatment due to travel|0|||
46648728|NCT00710424|82855685|FG000|Overall Study|Subject preferred paracetamol|0|||
46648729|NCT00710424|82855686|FG001|Overall Study|Subject preferred paracetamol|1|||
46648730|NCT00710424|82855685|FG000|Overall Study|Felt good so stopped treatment|0|||
46648731|NCT00710424|82855686|FG001|Overall Study|Felt good so stopped treatment|1|||
46648732|NCT00118846|82855716|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
46648733|NCT00118846|82855717|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
46648734|NCT00118846|82855716|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
46648735|NCT00118846|82855717|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
46648736|NCT00118846|82855716|FG000|Overall Study|Physician Decision|1|||
46780331|NCT00402727|82999100|FG000|Overall Study|Lack of Efficacy|1|||
46780332|NCT00402727|82999101|FG001|Overall Study|Lack of Efficacy|3|||
46780333|NCT00402727|82999100|FG000|Overall Study|Lost to Follow-up|24|||
46780334|NCT00402727|82999101|FG001|Overall Study|Lost to Follow-up|11|||
46780335|NCT00402727|82999100|FG000|Overall Study|Physician Decision|1|||
46780336|NCT00402727|82999101|FG001|Overall Study|Physician Decision|1|||
46780337|NCT00402727|82999100|FG000|Overall Study|Protocol Violation|0|||
46780338|NCT00402727|82999101|FG001|Overall Study|Protocol Violation|4|||
46780339|NCT00402727|82999100|FG000|Overall Study|Withdrawal by Subject|3|||
46780340|NCT00402727|82999101|FG001|Overall Study|Withdrawal by Subject|7|||
46780341|NCT00402727|82999100|FG000|Overall Study|supply problems|2|||
46780342|NCT00402727|82999101|FG001|Overall Study|supply problems|1|||
46780343|NCT00402727|82999100|FG000|Overall Study|non-compliance|0|||
46780344|NCT00402727|82999101|FG001|Overall Study|non-compliance|1|||
46780345|NCT00402649|82999107|FG000|Overall Study|Lost to Follow-up|1|||
46780346|NCT00402649|82999107|FG000|Overall Study|Withdrawal by Subject|1|||
46780347|NCT00402337|82999116|FG000|Overall Study|Adverse Event|0|||
46780348|NCT00402337|82999117|FG001|Overall Study|Adverse Event|2|||
46780349|NCT00402337|82999118|FG002|Overall Study|Adverse Event|2|||
46780350|NCT00402337|82999119|FG003|Overall Study|Adverse Event|3|||
46780351|NCT00402337|82999120|FG004|Overall Study|Adverse Event|2|||
46780352|NCT00402337|82999116|FG000|Overall Study|Noncompliance|0|||
46780353|NCT00402337|82999117|FG001|Overall Study|Noncompliance|0|||
46780354|NCT00402337|82999118|FG002|Overall Study|Noncompliance|0|||
46970512|NCT02067676|83213689|FG003|Overall Study|Withdrawal by Subject|0|||
46970513|NCT02067676|83213690|FG004|Overall Study|Withdrawal by Subject|0|||
46648737|NCT00118846|82855717|FG001|Overall Study|Physician Decision|0|||
46648738|NCT00118846|82855716|FG000|Overall Study|Medical condition|2|||
46648739|NCT00118846|82855717|FG001|Overall Study|Medical condition|2|||
46648740|NCT00118846|82855716|FG000|Overall Study|Lost to Follow-up|0|||
46648741|NCT00118846|82855717|FG001|Overall Study|Lost to Follow-up|2|||
46648742|NCT00118846|82855716|FG000|Overall Study|Personal reason|4|||
46648743|NCT00118846|82855717|FG001|Overall Study|Personal reason|5|||
46780355|NCT00402337|82999119|FG003|Overall Study|Noncompliance|0|||
46780356|NCT00402337|82999120|FG004|Overall Study|Noncompliance|2|||
46970514|NCT02067676|83213691|FG005|Overall Study|Withdrawal by Subject|0|||
46648744|NCT04705051|82855723|FG000|Overall Study|Enrolled but not treated|1|||
46648745|NCT04705051|82855723|FG000|Overall Study|Study terminated by sponsor|23|||
46780357|NCT00402337|82999116|FG000|Overall Study|Withdrawal by Subject|5|||
46780358|NCT00402337|82999117|FG001|Overall Study|Withdrawal by Subject|3|||
46780359|NCT00402337|82999118|FG002|Overall Study|Withdrawal by Subject|1|||
46780360|NCT00402337|82999119|FG003|Overall Study|Withdrawal by Subject|6|||
46780361|NCT00402337|82999120|FG004|Overall Study|Withdrawal by Subject|4|||
46780362|NCT00402337|82999116|FG000|Overall Study|Lost to Follow-up|0|||
46970515|NCT01623154|83213710|FG000|Overall Study|Did not drink Pranactin Citric|4|||
46970516|NCT03174431|83213718|FG000|Overall Study|Withdrawal by Subject|14|||
46970517|NCT03174431|83213719|FG001|Overall Study|Withdrawal by Subject|11|||
46970518|NCT03174431|83213718|FG000|Overall Study|alternative treatment|2|||
46970519|NCT03174431|83213719|FG001|Overall Study|alternative treatment|0|||
46970520|NCT03174431|83213718|FG000|Overall Study|Lost to Follow-up|1|||
46970521|NCT03174431|83213719|FG001|Overall Study|Lost to Follow-up|5|||
46970522|NCT00702689|83213725|FG000|Overall Study|Withdrawal by Subject|4|||
46970523|NCT00702689|83213725|FG000|Overall Study|Recurrent malignancy|1|||
46970524|NCT00702689|83213725|FG000|Overall Study|Adverse Event|1|||
46970525|NCT02065570|83213731|FG000|Induction Study|Adverse Event|5|||
46970526|NCT02065570|83213732|FG001|Induction Study|Adverse Event|12|||
46970527|NCT02065570|83213733|FG002|Induction Study|Adverse Event|0|||
46648746|NCT04464421|82855730|FG000|Overall Study|Lost to Follow-up|2|||
46648747|NCT04464421|82855731|FG001|Overall Study|Lost to Follow-up|2|||
46648748|NCT04112784|82855749|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
46780363|NCT00402337|82999117|FG001|Overall Study|Lost to Follow-up|0|||
46780364|NCT00402337|82999118|FG002|Overall Study|Lost to Follow-up|1|||
46780365|NCT00402337|82999119|FG003|Overall Study|Lost to Follow-up|2|||
46780366|NCT00402337|82999120|FG004|Overall Study|Lost to Follow-up|0|||
46780367|NCT00402337|82999116|FG000|Overall Study|Physician Decision|0|||
46780368|NCT00402337|82999117|FG001|Overall Study|Physician Decision|0|||
46780369|NCT00402337|82999118|FG002|Overall Study|Physician Decision|0|||
46780370|NCT00402337|82999119|FG003|Overall Study|Physician Decision|1|||
46780371|NCT00402337|82999120|FG004|Overall Study|Physician Decision|0|||
46780372|NCT00402337|82999116|FG000|Overall Study|Other Reason|0|||
46780373|NCT00402337|82999117|FG001|Overall Study|Other Reason|1|||
46780374|NCT00402337|82999118|FG002|Overall Study|Other Reason|0|||
46780375|NCT00402337|82999119|FG003|Overall Study|Other Reason|0|||
46780376|NCT00402337|82999120|FG004|Overall Study|Other Reason|0|||
46780377|NCT00650091|82999134|FG000|Amended Study Design|Withdrawal by Subject|12|||
46780378|NCT00650091|82999135|FG001|Amended Study Design|Withdrawal by Subject|11|||
46780379|NCT00650091|82999136|FG002|Amended Study Design|Withdrawal by Subject|0|||
46780380|NCT00650091|82999134|FG000|Amended Study Design|Physician Decision|5|||
46780381|NCT00650091|82999135|FG001|Amended Study Design|Physician Decision|0|||
46780382|NCT00650091|82999136|FG002|Amended Study Design|Physician Decision|0|||
46780383|NCT00650091|82999134|FG000|Amended Study Design|Adverse Event|1|||
46780384|NCT00650091|82999135|FG001|Amended Study Design|Adverse Event|4|||
46780385|NCT00650091|82999136|FG002|Amended Study Design|Adverse Event|0|||
46780386|NCT00650091|82999134|FG000|Amended Study Design|Lung transplantation|4|||
46780387|NCT00650091|82999135|FG001|Amended Study Design|Lung transplantation|2|||
46780388|NCT00650091|82999136|FG002|Amended Study Design|Lung transplantation|0|||
46780389|NCT00650091|82999134|FG000|Amended Study Design|Other|1|||
46780390|NCT00650091|82999135|FG001|Amended Study Design|Other|3|||
46780391|NCT00650091|82999136|FG002|Amended Study Design|Other|0|||
46780392|NCT00642369|82999146|FG000|Overall Study|Adverse Event|2|||
46780393|NCT00642369|82999147|FG001|Overall Study|Adverse Event|3|||
46780394|NCT00642369|82999146|FG000|Overall Study|Withdrawal by Subject|1|||
46780395|NCT00642369|82999147|FG001|Overall Study|Withdrawal by Subject|0|||
46780396|NCT00642369|82999146|FG000|Overall Study|misdiagnosis|0|||
46780397|NCT00642369|82999147|FG001|Overall Study|misdiagnosis|1|||
46780398|NCT00642369|82999146|FG000|Overall Study|Lack of Efficacy|2|||
46780399|NCT00642369|82999147|FG001|Overall Study|Lack of Efficacy|2|||
46780400|NCT00645099|82999172|FG000|Overall Study|Lack of Efficacy|15|||
46780401|NCT00645099|82999173|FG001|Overall Study|Lack of Efficacy|6|||
46780402|NCT00645099|82999172|FG000|Overall Study|Withdrawal by Subject|30|||
46780403|NCT00645099|82999173|FG001|Overall Study|Withdrawal by Subject|22|||
46780404|NCT00645099|82999172|FG000|Overall Study|Lost to Follow-up|6|||
46780405|NCT00645099|82999173|FG001|Overall Study|Lost to Follow-up|4|||
46780406|NCT00645099|82999172|FG000|Overall Study|Adverse Event|11|||
46780407|NCT00645099|82999173|FG001|Overall Study|Adverse Event|5|||
46780408|NCT00645099|82999172|FG000|Overall Study|Other|9|||
46780409|NCT00645099|82999173|FG001|Overall Study|Other|5|||
46780410|NCT00420511|82999181|FG000|Overall Study|Adverse Event|1|||
46970528|NCT02065570|83213734|FG003|Induction Study|Adverse Event|0|||
46970529|NCT02065570|83213731|FG000|Induction Study|Withdrawal by Subject|2|||
46970530|NCT02065570|83213732|FG001|Induction Study|Withdrawal by Subject|3|||
46780411|NCT00420511|82999182|FG001|Overall Study|Adverse Event|1|||
46780412|NCT00420511|82999181|FG000|Overall Study|Lost to Follow-up|1|||
46780413|NCT00420511|82999182|FG001|Overall Study|Lost to Follow-up|0|||
46780414|NCT00420199|82999192|FG000|Overall Study|Participant no longer met study criteria|1|||
46780415|NCT00420199|82999193|FG001|Overall Study|Participant no longer met study criteria|0|||
46780416|NCT00649389|82999208|FG000|Overall Study|Adverse Event|22|||
46780417|NCT00649389|82999209|FG001|Overall Study|Adverse Event|46|||
46780418|NCT00649389|82999210|FG002|Overall Study|Adverse Event|38|||
46780419|NCT00649389|82999211|FG003|Overall Study|Adverse Event|48|||
46780420|NCT00649389|82999208|FG000|Overall Study|Lost to Follow-up|15|||
46970531|NCT02065570|83213733|FG002|Induction Study|Withdrawal by Subject|0|||
46648749|NCT04112784|82855749|FG000|Overall Study|Screen Failures|4|||
46648750|NCT04049617|82855759|FG000|Overall Study|Adverse Event|0|||
46648751|NCT04049617|82855760|FG001|Overall Study|Adverse Event|0|||
46648752|NCT04049617|82855761|FG002|Overall Study|Adverse Event|0|||
46648753|NCT04049617|82855762|FG003|Overall Study|Adverse Event|1|||
46648754|NCT04049617|82855763|FG004|Overall Study|Adverse Event|0|||
46648755|NCT04049617|82855764|FG005|Overall Study|Adverse Event|0|||
46648756|NCT04049617|82855759|FG000|Overall Study|Death|0|||
46648757|NCT04049617|82855760|FG001|Overall Study|Death|0|||
46648758|NCT04049617|82855761|FG002|Overall Study|Death|0|||
46648759|NCT04049617|82855762|FG003|Overall Study|Death|0|||
46648760|NCT04049617|82855763|FG004|Overall Study|Death|0|||
46648761|NCT04049617|82855764|FG005|Overall Study|Death|1|||
46648762|NCT04049617|82855759|FG000|Overall Study|Lost to Follow-up|0|||
46648763|NCT04049617|82855760|FG001|Overall Study|Lost to Follow-up|0|||
46648764|NCT04049617|82855761|FG002|Overall Study|Lost to Follow-up|0|||
46648765|NCT04049617|82855762|FG003|Overall Study|Lost to Follow-up|1|||
46648766|NCT04049617|82855763|FG004|Overall Study|Lost to Follow-up|0|||
46648767|NCT04049617|82855764|FG005|Overall Study|Lost to Follow-up|0|||
46648768|NCT04049617|82855759|FG000|Overall Study|Withdrew consent|0|||
46648769|NCT04049617|82855760|FG001|Overall Study|Withdrew consent|0|||
46648770|NCT04049617|82855761|FG002|Overall Study|Withdrew consent|1|||
46648771|NCT04049617|82855762|FG003|Overall Study|Withdrew consent|0|||
46648772|NCT04049617|82855763|FG004|Overall Study|Withdrew consent|0|||
46648773|NCT04049617|82855764|FG005|Overall Study|Withdrew consent|0|||
46648774|NCT03911154|82855780|FG000|Overall Study|Withdrawal by Subject|1|||
46648775|NCT03781778|82855798|FG000|Overall Study|Withdrawal by Subject|2|||
46648776|NCT03781778|82855799|FG001|Overall Study|Withdrawal by Subject|2|||
46648777|NCT03710590|82855807|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
46648778|NCT03710590|82855808|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
46648779|NCT03465722|82855860|FG000|Overall Study|Withdrawal by Subject|21|||
46648780|NCT03465722|82855861|FG001|Overall Study|Withdrawal by Subject|14|||
46648781|NCT03465722|82855860|FG000|Overall Study|Death|89|||
46648782|NCT03465722|82855861|FG001|Overall Study|Death|87|||
46648783|NCT03465722|82855860|FG000|Overall Study|Lost to Follow-up|5|||
46648784|NCT03465722|82855861|FG001|Overall Study|Lost to Follow-up|3|||
46648785|NCT03465722|82855860|FG000|Overall Study|Administrative/Other|33|||
46648786|NCT03465722|82855861|FG001|Overall Study|Administrative/Other|32|||
46648787|NCT03465722|82855860|FG000|Overall Study|Not treated|1|||
46648788|NCT03465722|82855861|FG001|Overall Study|Not treated|2|||
46648789|NCT03465722|82855860|FG000|Overall Study|Sponsor decision|91|||
46648790|NCT03465722|82855861|FG001|Overall Study|Sponsor decision|98|||
46648791|NCT03205423|82855867|FG000|Overall Study|Personal|1|||
46648792|NCT03205423|82855868|FG001|Overall Study|Personal|1|||
46648793|NCT03205423|82855867|FG000|Overall Study|Physician Decision|0|||
46648794|NCT03205423|82855868|FG001|Overall Study|Physician Decision|2|||
46648795|NCT03073603|82855877|FG000|Overall Study|Noncompliance|3|||
46648796|NCT03073603|82855878|FG001|Overall Study|Noncompliance|1|||
46648797|NCT03073603|82855877|FG000|Overall Study|Adverse Event|5|||
46648798|NCT03073603|82855878|FG001|Overall Study|Adverse Event|3|||
46648799|NCT03073603|82855877|FG000|Overall Study|Physician Decision|1|||
46648800|NCT03073603|82855878|FG001|Overall Study|Physician Decision|2|||
46648801|NCT03073603|82855877|FG000|Overall Study|Required treatment not allowed by protocol|1|||
46648802|NCT03073603|82855878|FG001|Overall Study|Required treatment not allowed by protocol|0|||
46648803|NCT03073603|82855877|FG000|Overall Study|Financial or insurance-related|8|||
46648804|NCT03073603|82855878|FG001|Overall Study|Financial or insurance-related|0|||
46648805|NCT03073603|82855877|FG000|Overall Study|Withdrawal by Subject|0|||
46648806|NCT03073603|82855878|FG001|Overall Study|Withdrawal by Subject|1|||
46970532|NCT02065570|83213734|FG003|Induction Study|Withdrawal by Subject|0|||
46970533|NCT02065570|83213731|FG000|Induction Study|Lost to Follow-up|1|||
46970534|NCT02065570|83213732|FG001|Induction Study|Lost to Follow-up|1|||
46970535|NCT02065570|83213733|FG002|Induction Study|Lost to Follow-up|0|||
46970536|NCT02065570|83213734|FG003|Induction Study|Lost to Follow-up|0|||
46648807|NCT03073603|82855877|FG000|Overall Study|Discontinued DMT|4|||
46648808|NCT03073603|82855878|FG001|Overall Study|Discontinued DMT|0|||
46648809|NCT03073603|82855877|FG000|Overall Study|Restarted DMT|0|||
46648810|NCT03073603|82855878|FG001|Overall Study|Restarted DMT|1|||
46648811|NCT03002155|82855886|FG000|Overall Study|Lost to Follow-up|1|||
46648812|NCT03002155|82855887|FG001|Overall Study|Lost to Follow-up|2|||
46648813|NCT03002155|82855886|FG000|Overall Study|Withdrawal by Subject|1|||
46648814|NCT03002155|82855887|FG001|Overall Study|Withdrawal by Subject|0|||
46648815|NCT03002155|82855886|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
46648816|NCT03002155|82855887|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
46648817|NCT02918006|82855897|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
46648818|NCT02918006|82855898|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
46648819|NCT02918006|82855899|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
46648820|NCT02918006|82855897|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
46648821|NCT02918006|82855898|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
46648822|NCT02918006|82855899|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
46648823|NCT02918006|82855897|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
46648824|NCT02918006|82855898|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
46648825|NCT02918006|82855899|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
46648826|NCT02918006|82855897|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
46648827|NCT02918006|82855898|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
46648828|NCT02918006|82855899|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
46648829|NCT02918006|82855897|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
46648830|NCT02918006|82855898|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
46648831|NCT02918006|82855899|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
46648832|NCT02918006|82855897|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
46648833|NCT02918006|82855898|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
46648834|NCT02918006|82855899|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
46648835|NCT02918006|82855897|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
46648836|NCT02918006|82855898|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
46648837|NCT02918006|82855899|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
46648838|NCT02918006|82855897|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
46648839|NCT02918006|82855898|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
46648840|NCT02918006|82855899|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
46648841|NCT02918006|82855897|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
46648842|NCT02918006|82855898|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
46648843|NCT02918006|82855899|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
46648844|NCT02179749|82855944|FG000|Overall Study|Adverse Event|0|||
46648845|NCT02179749|82855945|FG001|Overall Study|Adverse Event|0|||
46648846|NCT02179749|82855946|FG002|Overall Study|Adverse Event|1|||
46648847|NCT02179749|82855944|FG000|Overall Study|Withdrawal by Subject|0|||
46648848|NCT02179749|82855945|FG001|Overall Study|Withdrawal by Subject|0|||
46648849|NCT02179749|82855946|FG002|Overall Study|Withdrawal by Subject|1|||
46648850|NCT02075593|82855957|FG000|Overall Study|Withdrawal by Subject|1|||
46648851|NCT00641186|82855990|FG000|Overall Study|Adverse Event|3|||
46648852|NCT05487456|82856020|FG000|Overall Study|Withdrawal by Subject|0|||
46648853|NCT05487456|82856021|FG001|Overall Study|Withdrawal by Subject|0|||
46648854|NCT05487456|82856022|FG002|Overall Study|Withdrawal by Subject|1|||
46648855|NCT05487456|82856023|FG003|Overall Study|Withdrawal by Subject|0|||
46648856|NCT05427916|82856036|FG000|Overall Study|Adverse Event|3|||
46648857|NCT05427916|82856037|FG001|Overall Study|Adverse Event|0|||
46648858|NCT05427916|82856036|FG000|Overall Study|Lack of Efficacy|6|||
46648859|NCT05427916|82856037|FG001|Overall Study|Lack of Efficacy|0|||
46648860|NCT05427916|82856036|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
46648861|NCT05427916|82856037|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
46648862|NCT05346640|82856047|FG000|Overall Study|Lack of Efficacy|2|||
46648863|NCT05346640|82856047|FG000|Overall Study|Lost to Follow-up|14|||
46648864|NCT05346640|82856047|FG000|Overall Study|Protocol Violation|4|||
46648865|NCT05346640|82856047|FG000|Overall Study|Withdrawal by Subject|2|||
46648866|NCT05346640|82856047|FG000|Overall Study|Physiological Complications|3|||
46648867|NCT05346640|82856047|FG000|Overall Study|Other Reason|3|||
46648868|NCT05255068|82856051|FG000|Overall Study|Lost to Follow-up|0|||
46648869|NCT05255068|82856052|FG001|Overall Study|Lost to Follow-up|1|||
46648870|NCT05133323|82856081|FG000|Overall Study|Lack of Efficacy|0|||
46648871|NCT05133323|82856082|FG001|Overall Study|Lack of Efficacy|0|||
46648872|NCT05133323|82856083|FG002|Overall Study|Lack of Efficacy|1|||
46648873|NCT05133323|82856081|FG000|Overall Study|Withdrawal by Subject|2|||
46648874|NCT05133323|82856082|FG001|Overall Study|Withdrawal by Subject|1|||
46648875|NCT05133323|82856083|FG002|Overall Study|Withdrawal by Subject|0|||
46648876|NCT05035550|82856093|FG000|Overall Study|Withdrawal by Subject|3|||
46648877|NCT05035550|82856094|FG001|Overall Study|Withdrawal by Subject|0|||
46648878|NCT04927312|82856100|FG000|Overall Study|Adverse Event|1|||
46648879|NCT04927312|82856100|FG000|Overall Study|Death|1|||
46648880|NCT04927312|82856100|FG000|Overall Study|Withdrawal by Subject|1|||
46648881|NCT04927312|82856100|FG000|Overall Study|Other|1|||
46648882|NCT04857892|82856118|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
46648883|NCT04857892|82856119|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
47075140|NCT00631163|83368630|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
47075141|NCT00631163|83368630|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
46648884|NCT04857892|82856120|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
46648885|NCT04857892|82856121|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
46648886|NCT04857892|82856122|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
46648887|NCT04857892|82856118|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
46648888|NCT04857892|82856119|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
47075142|NCT00631163|83368630|FG000|Number of Participants in Year 1|Administrative problems|6|||
46648889|NCT04857892|82856120|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
46648890|NCT04857892|82856121|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
46648891|NCT04857892|82856122|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
46648892|NCT04857892|82856118|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
46648893|NCT04857892|82856119|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
46648894|NCT04857892|82856120|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
46648895|NCT04857892|82856121|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
46648896|NCT04857892|82856122|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
46648897|NCT04744831|82856143|FG000|Overall Study|Progressive Disease|31|||
46648898|NCT04744831|82856144|FG001|Overall Study|Progressive Disease|27|||
46648899|NCT04744831|82856145|FG002|Overall Study|Progressive Disease|25|||
47075143|NCT00631163|83368630|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
47075144|NCT00631163|83368630|FG000|Number of Participants in Year 2|Adverse Event|1|||
47075145|NCT00631163|83368630|FG000|Number of Participants in Year 2|Protocol Violation|1|||
47075146|NCT00631163|83368630|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
47075147|NCT00631007|83368647|FG000|Overall Study|Adverse Event|0|||
46648900|NCT04744831|82856143|FG000|Overall Study|Adverse Event|3|||
46648901|NCT04744831|82856144|FG001|Overall Study|Adverse Event|3|||
46648902|NCT04744831|82856145|FG002|Overall Study|Adverse Event|3|||
46648903|NCT04744831|82856143|FG000|Overall Study|Clinical Progression|3|||
46648904|NCT04744831|82856144|FG001|Overall Study|Clinical Progression|2|||
46648905|NCT04744831|82856145|FG002|Overall Study|Clinical Progression|5|||
46648906|NCT04744831|82856143|FG000|Overall Study|Other|0|||
46648907|NCT04744831|82856144|FG001|Overall Study|Other|2|||
46648908|NCT04744831|82856145|FG002|Overall Study|Other|1|||
46648909|NCT04744831|82856143|FG000|Overall Study|Death|0|||
46648910|NCT04744831|82856144|FG001|Overall Study|Death|2|||
46648911|NCT04744831|82856145|FG002|Overall Study|Death|1|||
46648912|NCT04669691|82856158|FG000|Overall Study|Death|0|||
46648913|NCT04669691|82856159|FG001|Overall Study|Death|1|||
46648914|NCT04669691|82856160|FG002|Overall Study|Death|0|||
46648915|NCT04669691|82856161|FG003|Overall Study|Death|0|||
46648916|NCT04669691|82856162|FG004|Overall Study|Death|0|||
46648917|NCT04669691|82856163|FG005|Overall Study|Death|0|||
46648918|NCT04646213|82856177|FG000|Overall Study|Physician Decision|3|||
46648919|NCT04646213|82856177|FG000|Overall Study|Withdrawal by Subject|2|||
46648920|NCT04612725|82856184|FG000|Overall Study|Adverse Event|1|||
46648921|NCT04612725|82856185|FG001|Overall Study|Adverse Event|3|||
46648922|NCT04612725|82856186|FG002|Overall Study|Adverse Event|1|||
46648923|NCT04612725|82856187|FG003|Overall Study|Adverse Event|0|||
46648924|NCT04612725|82856188|FG004|Overall Study|Adverse Event|1|||
46648925|NCT04612725|82856184|FG000|Overall Study|Lost to Follow-up|0|||
46648926|NCT04612725|82856185|FG001|Overall Study|Lost to Follow-up|1|||
46648927|NCT04612725|82856186|FG002|Overall Study|Lost to Follow-up|0|||
46648928|NCT04612725|82856187|FG003|Overall Study|Lost to Follow-up|0|||
46648929|NCT04612725|82856188|FG004|Overall Study|Lost to Follow-up|0|||
46648930|NCT04612725|82856184|FG000|Overall Study|Physician Decision|2|||
46648931|NCT04612725|82856185|FG001|Overall Study|Physician Decision|0|||
46648932|NCT04612725|82856186|FG002|Overall Study|Physician Decision|0|||
46648933|NCT04612725|82856187|FG003|Overall Study|Physician Decision|0|||
46648934|NCT04612725|82856188|FG004|Overall Study|Physician Decision|0|||
46648935|NCT04612725|82856184|FG000|Overall Study|Study terminated by sponsor|3|||
46648936|NCT04612725|82856185|FG001|Overall Study|Study terminated by sponsor|1|||
46648937|NCT04612725|82856186|FG002|Overall Study|Study terminated by sponsor|2|||
46648938|NCT04612725|82856187|FG003|Overall Study|Study terminated by sponsor|4|||
46648939|NCT04612725|82856188|FG004|Overall Study|Study terminated by sponsor|5|||
46648940|NCT04612725|82856184|FG000|Overall Study|Withdrawal by Subject|8|||
46648941|NCT04612725|82856185|FG001|Overall Study|Withdrawal by Subject|3|||
46648942|NCT04612725|82856186|FG002|Overall Study|Withdrawal by Subject|5|||
46648943|NCT04612725|82856187|FG003|Overall Study|Withdrawal by Subject|1|||
47075148|NCT00631007|83368648|FG001|Overall Study|Adverse Event|2|||
46648944|NCT04612725|82856188|FG004|Overall Study|Withdrawal by Subject|9|||
46648945|NCT04612725|82856184|FG000|Overall Study|Other|0|||
46648946|NCT04612725|82856185|FG001|Overall Study|Other|0|||
46648947|NCT04612725|82856186|FG002|Overall Study|Other|0|||
46648948|NCT04612725|82856187|FG003|Overall Study|Other|0|||
46648949|NCT04612725|82856188|FG004|Overall Study|Other|1|||
46648950|NCT04610684|82856199|FG000|Study Treatment|Withdrawal by Subject|1|||
46648951|NCT04610684|82856199|FG000|Study Treatment|Disease Progression|2|||
46648952|NCT04610684|82856199|FG000|Follow up|Death|2|||
46648953|NCT04610684|82856199|FG000|Follow up|Withdrawal by Subject|1|||
46648954|NCT04602221|82856212|FG000|Overall Study|Discontinuation of trial treatment|0|||
46648955|NCT04602221|82856213|FG001|Overall Study|Discontinuation of trial treatment|0|||
46648956|NCT04602221|82856214|FG002|Overall Study|Discontinuation of trial treatment|1|||
46648957|NCT04602221|82856215|FG003|Overall Study|Discontinuation of trial treatment|0|||
47075149|NCT00631007|83368649|FG002|Overall Study|Adverse Event|0|||
46648958|NCT04602221|82856216|FG004|Overall Study|Discontinuation of trial treatment|0|||
46648959|NCT04602221|82856217|FG005|Overall Study|Discontinuation of trial treatment|0|||
46648960|NCT04602221|82856218|FG006|Overall Study|Discontinuation of trial treatment|0|||
46648961|NCT04602221|82856219|FG007|Overall Study|Discontinuation of trial treatment|0|||
46648962|NCT04602221|82856220|FG008|Overall Study|Discontinuation of trial treatment|0|||
46648963|NCT04602221|82856221|FG009|Overall Study|Discontinuation of trial treatment|0|||
46648964|NCT04602221|82856222|FG010|Overall Study|Discontinuation of trial treatment|0|||
46648965|NCT04602221|82856223|FG011|Overall Study|Discontinuation of trial treatment|0|||
46648966|NCT04602221|82856224|FG012|Overall Study|Discontinuation of trial treatment|0|||
46648967|NCT04602221|82856225|FG013|Overall Study|Discontinuation of trial treatment|0|||
46648968|NCT04602221|82856226|FG014|Overall Study|Discontinuation of trial treatment|0|||
46648969|NCT04602221|82856227|FG015|Overall Study|Discontinuation of trial treatment|0|||
46648970|NCT04602221|82856228|FG016|Overall Study|Discontinuation of trial treatment|0|||
46648971|NCT04602221|82856229|FG017|Overall Study|Discontinuation of trial treatment|0|||
46648972|NCT04602221|82856212|FG000|Overall Study|Other than listed|0|||
46648973|NCT04602221|82856213|FG001|Overall Study|Other than listed|0|||
46648974|NCT04602221|82856214|FG002|Overall Study|Other than listed|0|||
46648975|NCT04602221|82856215|FG003|Overall Study|Other than listed|0|||
46648976|NCT04602221|82856216|FG004|Overall Study|Other than listed|0|||
46648977|NCT04602221|82856217|FG005|Overall Study|Other than listed|0|||
46648978|NCT04602221|82856218|FG006|Overall Study|Other than listed|0|||
46648979|NCT04602221|82856219|FG007|Overall Study|Other than listed|0|||
46648980|NCT04602221|82856220|FG008|Overall Study|Other than listed|0|||
46648981|NCT04602221|82856221|FG009|Overall Study|Other than listed|0|||
46648982|NCT04602221|82856222|FG010|Overall Study|Other than listed|0|||
46648983|NCT04602221|82856223|FG011|Overall Study|Other than listed|0|||
46648984|NCT04602221|82856224|FG012|Overall Study|Other than listed|0|||
46648985|NCT04602221|82856225|FG013|Overall Study|Other than listed|0|||
46648986|NCT04602221|82856226|FG014|Overall Study|Other than listed|0|||
46648987|NCT04602221|82856227|FG015|Overall Study|Other than listed|1|||
46648988|NCT04602221|82856228|FG016|Overall Study|Other than listed|0|||
46648989|NCT04602221|82856229|FG017|Overall Study|Other than listed|1|||
46648990|NCT04602221|82856212|FG000|Overall Study|Withdrawal by Subject|0|||
46648991|NCT04602221|82856213|FG001|Overall Study|Withdrawal by Subject|0|||
46648992|NCT04602221|82856214|FG002|Overall Study|Withdrawal by Subject|0|||
46648993|NCT04602221|82856215|FG003|Overall Study|Withdrawal by Subject|0|||
46648994|NCT04602221|82856216|FG004|Overall Study|Withdrawal by Subject|0|||
46648995|NCT04602221|82856217|FG005|Overall Study|Withdrawal by Subject|0|||
46648996|NCT04602221|82856218|FG006|Overall Study|Withdrawal by Subject|0|||
46648997|NCT04602221|82856219|FG007|Overall Study|Withdrawal by Subject|0|||
46648998|NCT04602221|82856220|FG008|Overall Study|Withdrawal by Subject|0|||
46648999|NCT04602221|82856221|FG009|Overall Study|Withdrawal by Subject|0|||
46649000|NCT04602221|82856222|FG010|Overall Study|Withdrawal by Subject|0|||
46649001|NCT04602221|82856223|FG011|Overall Study|Withdrawal by Subject|0|||
46649002|NCT04602221|82856224|FG012|Overall Study|Withdrawal by Subject|1|||
46649003|NCT04602221|82856225|FG013|Overall Study|Withdrawal by Subject|0|||
46649004|NCT04602221|82856226|FG014|Overall Study|Withdrawal by Subject|0|||
46649005|NCT04602221|82856227|FG015|Overall Study|Withdrawal by Subject|0|||
46649006|NCT04602221|82856228|FG016|Overall Study|Withdrawal by Subject|0|||
46649007|NCT04602221|82856229|FG017|Overall Study|Withdrawal by Subject|0|||
46649008|NCT04602221|82856212|FG000|Overall Study|Lost to Follow-up|0|||
46649009|NCT04602221|82856213|FG001|Overall Study|Lost to Follow-up|0|||
46649010|NCT04602221|82856214|FG002|Overall Study|Lost to Follow-up|0|||
46649011|NCT04602221|82856215|FG003|Overall Study|Lost to Follow-up|0|||
46649012|NCT04602221|82856216|FG004|Overall Study|Lost to Follow-up|0|||
46649013|NCT04602221|82856217|FG005|Overall Study|Lost to Follow-up|1|||
46649014|NCT04602221|82856218|FG006|Overall Study|Lost to Follow-up|0|||
46649015|NCT04602221|82856219|FG007|Overall Study|Lost to Follow-up|0|||
46649016|NCT04602221|82856220|FG008|Overall Study|Lost to Follow-up|0|||
46649017|NCT04602221|82856221|FG009|Overall Study|Lost to Follow-up|0|||
46649018|NCT04602221|82856222|FG010|Overall Study|Lost to Follow-up|0|||
46649019|NCT04602221|82856223|FG011|Overall Study|Lost to Follow-up|0|||
46649020|NCT04602221|82856224|FG012|Overall Study|Lost to Follow-up|0|||
46649021|NCT04602221|82856225|FG013|Overall Study|Lost to Follow-up|0|||
46649022|NCT04602221|82856226|FG014|Overall Study|Lost to Follow-up|0|||
46649023|NCT04602221|82856227|FG015|Overall Study|Lost to Follow-up|0|||
46649024|NCT04602221|82856228|FG016|Overall Study|Lost to Follow-up|0|||
46649025|NCT04602221|82856229|FG017|Overall Study|Lost to Follow-up|0|||
46649026|NCT04556136|82856246|FG000|Overall Study|Lost to Follow-up|6|||
46649027|NCT04556136|82856247|FG001|Overall Study|Lost to Follow-up|6|||
46780421|NCT00649389|82999209|FG001|Overall Study|Lost to Follow-up|17|||
46780422|NCT00649389|82999210|FG002|Overall Study|Lost to Follow-up|21|||
47075150|NCT00631007|83368650|FG003|Overall Study|Adverse Event|2|||
47075151|NCT00631007|83368651|FG004|Overall Study|Adverse Event|3|||
47075152|NCT00631007|83368652|FG005|Overall Study|Adverse Event|2|||
46649028|NCT04556136|82856246|FG000|Overall Study|Physician Decision|2|||
46649029|NCT04556136|82856247|FG001|Overall Study|Physician Decision|1|||
46649030|NCT04556136|82856246|FG000|Overall Study|Withdrawal by Subject|2|||
46649031|NCT04556136|82856247|FG001|Overall Study|Withdrawal by Subject|1|||
46780423|NCT00649389|82999211|FG003|Overall Study|Lost to Follow-up|26|||
46649032|NCT04531462|82856255|FG000|Overall Study|Withdrawal by Subject|3|||
46649033|NCT04531462|82856256|FG001|Overall Study|Withdrawal by Subject|1|||
46649034|NCT04531462|82856255|FG000|Overall Study|Adverse Event|3|||
46649035|NCT04531462|82856256|FG001|Overall Study|Adverse Event|3|||
46649036|NCT04525547|82856262|FG000|Overall Study|Not treated with Ofev|2|||
46649037|NCT04525547|82856262|FG000|Overall Study|Off-label use|2|||
46649038|NCT04525547|82856262|FG000|Overall Study|Lost to Follow-up|1|||
46649039|NCT04511819|82856268|FG000|Overall Study|Non-compliance with study drug|5|||
46649040|NCT04511819|82856269|FG001|Overall Study|Non-compliance with study drug|1|||
46649041|NCT04511819|82856268|FG000|Overall Study|Withdrawal by Subject|0|||
46649042|NCT04511819|82856269|FG001|Overall Study|Withdrawal by Subject|3|||
46649043|NCT04511819|82856268|FG000|Overall Study|Adverse Event|0|||
46649044|NCT04511819|82856269|FG001|Overall Study|Adverse Event|1|||
46649045|NCT04511819|82856268|FG000|Overall Study|Protocol deviation|1|||
46649046|NCT04511819|82856269|FG001|Overall Study|Protocol deviation|0|||
46649047|NCT04430348|82856281|FG000|Overall Study|Death|3|||
46649048|NCT04430348|82856282|FG001|Overall Study|Death|2|||
46649049|NCT04430348|82856283|FG002|Overall Study|Death|2|||
46649050|NCT04430348|82856284|FG003|Overall Study|Death|2|||
46649051|NCT04430348|82856285|FG004|Overall Study|Death|2|||
46649052|NCT04430348|82856286|FG005|Overall Study|Death|3|||
46649053|NCT04430348|82856281|FG000|Overall Study|Lost to Follow-up|0|||
46649054|NCT04430348|82856282|FG001|Overall Study|Lost to Follow-up|0|||
46649055|NCT04430348|82856283|FG002|Overall Study|Lost to Follow-up|0|||
46649056|NCT04430348|82856284|FG003|Overall Study|Lost to Follow-up|1|||
46649057|NCT04430348|82856285|FG004|Overall Study|Lost to Follow-up|0|||
46649058|NCT04430348|82856286|FG005|Overall Study|Lost to Follow-up|0|||
46649059|NCT04430348|82856281|FG000|Overall Study|Adverse Event|0|||
46649060|NCT04430348|82856282|FG001|Overall Study|Adverse Event|0|||
46649061|NCT04430348|82856283|FG002|Overall Study|Adverse Event|0|||
46649062|NCT04430348|82856284|FG003|Overall Study|Adverse Event|0|||
46649063|NCT04430348|82856285|FG004|Overall Study|Adverse Event|0|||
46649064|NCT04430348|82856286|FG005|Overall Study|Adverse Event|1|||
46649065|NCT04430348|82856281|FG000|Overall Study|Withdrawal by Subject|0|||
46649066|NCT04430348|82856282|FG001|Overall Study|Withdrawal by Subject|1|||
46649067|NCT04430348|82856283|FG002|Overall Study|Withdrawal by Subject|0|||
46649068|NCT04430348|82856284|FG003|Overall Study|Withdrawal by Subject|0|||
46649069|NCT04430348|82856285|FG004|Overall Study|Withdrawal by Subject|0|||
46649070|NCT04430348|82856286|FG005|Overall Study|Withdrawal by Subject|1|||
46649071|NCT04430348|82856281|FG000|Overall Study|Study Terminated by Sponsor|0|||
46649072|NCT04430348|82856282|FG001|Overall Study|Study Terminated by Sponsor|0|||
46649073|NCT04430348|82856283|FG002|Overall Study|Study Terminated by Sponsor|2|||
46649074|NCT04430348|82856284|FG003|Overall Study|Study Terminated by Sponsor|0|||
46649075|NCT04430348|82856285|FG004|Overall Study|Study Terminated by Sponsor|1|||
46649076|NCT04430348|82856286|FG005|Overall Study|Study Terminated by Sponsor|1|||
46850646|NCT00112437|83066364|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850647|NCT00112437|83066365|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850648|NCT00112437|83066366|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850649|NCT00112437|83066367|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46970537|NCT02065570|83213731|FG000|Induction Study|Other, Not Specified|6|||
46649077|NCT04390841|82856300|FG000|Overall Study|Withdrawal by Subject|2|||
46649078|NCT04250714|82856322|FG000|Overall Study|Treatment - withdrawal by subject|14|||
46649079|NCT04250714|82856322|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
46649080|NCT04250714|82856322|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
46649081|NCT04250714|82856322|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
46649082|NCT04250714|82856322|FG000|Overall Study|Treatment - Death|1|||
46649083|NCT04250714|82856322|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
46649084|NCT04250714|82856322|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
46780424|NCT00649389|82999208|FG000|Overall Study|Protocol Violation|11|||
46850650|NCT00112437|83066368|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46649085|NCT04250714|82856322|FG000|Overall Study|Attempt|2|||
46649086|NCT04250714|82856322|FG000|Overall Study|Intent|7|||
46649087|NCT04172597|82856333|FG000|Overall Study|Disease Progression|0|||
46649088|NCT04172597|82856334|FG001|Overall Study|Disease Progression|0|||
46649089|NCT04172597|82856335|FG002|Overall Study|Disease Progression|0|||
46649090|NCT04172597|82856336|FG003|Overall Study|Disease Progression|0|||
46649091|NCT04172597|82856337|FG004|Overall Study|Disease Progression|1|||
47075153|NCT00631007|83368647|FG000|Overall Study|Lost to Follow-up|2|||
47075154|NCT00631007|83368648|FG001|Overall Study|Lost to Follow-up|1|||
47075155|NCT00631007|83368649|FG002|Overall Study|Lost to Follow-up|2|||
47075156|NCT00631007|83368650|FG003|Overall Study|Lost to Follow-up|4|||
47075157|NCT00631007|83368651|FG004|Overall Study|Lost to Follow-up|5|||
47075158|NCT00631007|83368652|FG005|Overall Study|Lost to Follow-up|3|||
47075159|NCT00631007|83368647|FG000|Overall Study|Physician Decision|1|||
47075160|NCT00631007|83368648|FG001|Overall Study|Physician Decision|0|||
47075161|NCT00631007|83368649|FG002|Overall Study|Physician Decision|1|||
47075162|NCT00631007|83368650|FG003|Overall Study|Physician Decision|0|||
47075163|NCT00631007|83368651|FG004|Overall Study|Physician Decision|0|||
47075164|NCT00631007|83368652|FG005|Overall Study|Physician Decision|2|||
46649104|NCT04014361|82856370|FG000|Period 2|Physician Decision|0|||
46649105|NCT04014361|82856371|FG001|Period 2|Physician Decision|0|||
46649106|NCT04014361|82856372|FG002|Period 2|Physician Decision|0|||
46649107|NCT04014361|82856373|FG003|Period 2|Physician Decision|1|||
46649108|NCT04014361|82856374|FG004|Period 2|Physician Decision|0|||
46649109|NCT04014361|82856375|FG005|Period 2|Physician Decision|0|||
46649110|NCT04014361|82856376|FG006|Period 2|Physician Decision|0|||
46649111|NCT04014361|82856377|FG007|Period 2|Physician Decision|0|||
46649112|NCT03981419|82856412|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
46649113|NCT03981419|82856413|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
46649114|NCT03952559|82856424|FG000|Double Blind Treatment Period|Adverse Event|0|||
46649115|NCT03952559|82856425|FG001|Double Blind Treatment Period|Adverse Event|2|||
46649116|NCT03952559|82856426|FG002|Double Blind Treatment Period|Adverse Event|1|||
46649117|NCT03952559|82856427|FG003|Double Blind Treatment Period|Adverse Event|0|||
46649118|NCT03952559|82856428|FG004|Double Blind Treatment Period|Adverse Event|1|||
46649119|NCT03952559|82856424|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
46649120|NCT03952559|82856425|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
46649121|NCT03952559|82856426|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
46649122|NCT03952559|82856427|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
46649123|NCT03952559|82856428|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
46649124|NCT03952559|82856424|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
46649125|NCT03952559|82856425|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
46649126|NCT03952559|82856426|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
46649127|NCT03952559|82856427|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
46649128|NCT03952559|82856428|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
46649129|NCT03952559|82856424|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
46649130|NCT03952559|82856425|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
46850651|NCT00112437|83066369|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46970538|NCT02065570|83213732|FG001|Induction Study|Other, Not Specified|5|||
46970539|NCT02065570|83213733|FG002|Induction Study|Other, Not Specified|0|||
46970540|NCT02065570|83213734|FG003|Induction Study|Other, Not Specified|0|||
46970541|NCT02065570|83213731|FG000|Maintenance Study|Adverse Event|0|||
46970542|NCT02065570|83213732|FG001|Maintenance Study|Adverse Event|0|||
46970543|NCT02065570|83213733|FG002|Maintenance Study|Adverse Event|8|||
46649131|NCT03952559|82856426|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
46649132|NCT03952559|82856427|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
46649133|NCT03952559|82856428|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
46649134|NCT03946670|82856466|FG000|Overall Study|Progressive Disease|26|||
46780425|NCT00649389|82999209|FG001|Overall Study|Protocol Violation|13|||
46850652|NCT00112437|83066370|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850653|NCT00112437|83066371|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850654|NCT00112437|83066372|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850655|NCT00112437|83066373|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850656|NCT00112437|83066374|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46970544|NCT02065570|83213734|FG003|Maintenance Study|Adverse Event|8|||
46970545|NCT02065570|83213731|FG000|Maintenance Study|Withdrawal by Subject|0|||
46970546|NCT02065570|83213732|FG001|Maintenance Study|Withdrawal by Subject|0|||
46970547|NCT02065570|83213733|FG002|Maintenance Study|Withdrawal by Subject|1|||
46649135|NCT03946670|82856467|FG001|Overall Study|Progressive Disease|23|||
46780426|NCT00649389|82999210|FG002|Overall Study|Protocol Violation|9|||
46780427|NCT00649389|82999211|FG003|Overall Study|Protocol Violation|8|||
46780428|NCT00649389|82999208|FG000|Overall Study|Withdrawal by Subject|20|||
46780429|NCT00649389|82999209|FG001|Overall Study|Withdrawal by Subject|21|||
46780430|NCT00649389|82999210|FG002|Overall Study|Withdrawal by Subject|19|||
46780431|NCT00649389|82999211|FG003|Overall Study|Withdrawal by Subject|23|||
46780432|NCT00649389|82999208|FG000|Overall Study|Other|3|||
46780433|NCT00649389|82999209|FG001|Overall Study|Other|9|||
46780434|NCT00649389|82999210|FG002|Overall Study|Other|1|||
46780435|NCT00649389|82999211|FG003|Overall Study|Other|6|||
46780436|NCT00402103|82999223|FG000|Overall Study|Adverse Event|60|||
46780437|NCT00402103|82999224|FG001|Overall Study|Adverse Event|7|||
46780438|NCT00402103|82999223|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
47075165|NCT00631007|83368647|FG000|Overall Study|Persistent Hyperglycemia|2|||
46649136|NCT03946670|82856466|FG000|Overall Study|Adverse Event|7|||
46649137|NCT03946670|82856467|FG001|Overall Study|Adverse Event|9|||
46649138|NCT03946670|82856466|FG000|Overall Study|Death|5|||
46649139|NCT03946670|82856467|FG001|Overall Study|Death|6|||
46649140|NCT03946670|82856466|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
46649141|NCT03946670|82856467|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
46649142|NCT03946670|82856466|FG000|Overall Study|Subject Decision|4|||
46649143|NCT03946670|82856467|FG001|Overall Study|Subject Decision|4|||
46649144|NCT03946670|82856466|FG000|Overall Study|Physician Decision|3|||
46649145|NCT03946670|82856467|FG001|Overall Study|Physician Decision|3|||
46970548|NCT02065570|83213734|FG003|Maintenance Study|Withdrawal by Subject|4|||
46970549|NCT02065570|83213731|FG000|Maintenance Study|Lost to Follow-up|0|||
46970550|NCT02065570|83213732|FG001|Maintenance Study|Lost to Follow-up|0|||
46970551|NCT02065570|83213733|FG002|Maintenance Study|Lost to Follow-up|2|||
46970552|NCT02065570|83213734|FG003|Maintenance Study|Lost to Follow-up|2|||
46970553|NCT02065570|83213731|FG000|Maintenance Study|Other, Not Specified|0|||
46970554|NCT02065570|83213732|FG001|Maintenance Study|Other, Not Specified|0|||
46970555|NCT02065570|83213733|FG002|Maintenance Study|Other, Not Specified|11|||
46970556|NCT02065570|83213734|FG003|Maintenance Study|Other, Not Specified|5|||
46970557|NCT02566005|83213747|FG000|Overall Study|vaginal bleeding|0|||
46970558|NCT02566005|83213748|FG001|Overall Study|vaginal bleeding|1|||
46970559|NCT02566005|83213747|FG000|Overall Study|received foley|8|||
46970560|NCT02566005|83213748|FG001|Overall Study|received foley|0|||
46649146|NCT03946670|82856466|FG000|Overall Study|New Therapy for Study Indication|1|||
46970561|NCT02566005|83213747|FG000|Overall Study|did not receive foley|0|||
46970562|NCT02566005|83213748|FG001|Overall Study|did not receive foley|1|||
46970563|NCT02566005|83213747|FG000|Overall Study|labor after randomization|0|||
46970564|NCT02566005|83213748|FG001|Overall Study|labor after randomization|4|||
46970565|NCT02065336|83213766|FG000|Extension Phase|Study Terminated by Sponsor|0|||
46970566|NCT02065336|83213767|FG001|Extension Phase|Study Terminated by Sponsor|0|||
46970567|NCT02065336|83213768|FG002|Extension Phase|Study Terminated by Sponsor|0|||
46970568|NCT02065336|83213769|FG003|Extension Phase|Study Terminated by Sponsor|0|||
46970569|NCT02065336|83213770|FG004|Extension Phase|Study Terminated by Sponsor|0|||
46970570|NCT02065336|83213771|FG005|Extension Phase|Study Terminated by Sponsor|0|||
46970571|NCT02065336|83213772|FG006|Extension Phase|Study Terminated by Sponsor|0|||
46970572|NCT02065336|83213773|FG007|Extension Phase|Study Terminated by Sponsor|0|||
46970573|NCT02065336|83213774|FG008|Extension Phase|Study Terminated by Sponsor|2|||
46970574|NCT02065336|83213775|FG009|Extension Phase|Study Terminated by Sponsor|8|||
46970575|NCT02701985|83213808|FG000|Overall Study|Withdrawal by Subject|1|||
46970576|NCT02701985|83213809|FG001|Overall Study|Withdrawal by Subject|1|||
46970577|NCT02701985|83213808|FG000|Overall Study|Lost to Follow-up|1|||
46970578|NCT02701985|83213809|FG001|Overall Study|Lost to Follow-up|0|||
46970579|NCT02701985|83213808|FG000|Overall Study|Death|1|||
46970580|NCT02701985|83213809|FG001|Overall Study|Death|0|||
46970581|NCT02701985|83213808|FG000|Overall Study|Adverse Event|0|||
46970582|NCT02701985|83213809|FG001|Overall Study|Adverse Event|5|||
46970583|NCT02064868|83213818|FG000|Overall Study|Lost to Follow-up|14|||
46970584|NCT02064868|83213819|FG001|Overall Study|Lost to Follow-up|8|||
46970585|NCT02064868|83213818|FG000|Overall Study|Physician Decision|1|||
46970586|NCT02064868|83213819|FG001|Overall Study|Physician Decision|0|||
46970587|NCT02064868|83213818|FG000|Overall Study|Withdrawal by Subject|14|||
46970588|NCT02064868|83213819|FG001|Overall Study|Withdrawal by Subject|3|||
46970589|NCT02064868|83213818|FG000|Overall Study|Technical Problems or Missing|5|||
46970590|NCT02064868|83213819|FG001|Overall Study|Technical Problems or Missing|2|||
46970591|NCT02064166|83213827|FG000|Overall Study|Adverse Event|1|||
46970592|NCT02064166|83213828|FG001|Overall Study|Adverse Event|0|||
46970593|NCT02565615|83213861|FG000|Overall Study|Death|0|||
46970594|NCT02565615|83213862|FG001|Overall Study|Death|1|||
46649147|NCT03946670|82856467|FG001|Overall Study|New Therapy for Study Indication|0|||
46649148|NCT03946670|82856466|FG000|Overall Study|Not treated|1|||
46649149|NCT03946670|82856467|FG001|Overall Study|Not treated|1|||
46970595|NCT02565615|83213863|FG002|Overall Study|Death|0|||
46970596|NCT02565615|83213864|FG003|Overall Study|Death|0|||
46970597|NCT02565615|83213865|FG004|Overall Study|Death|4|||
46970598|NCT02565615|83213861|FG000|Overall Study|Not willing to participate in study|2|||
46970599|NCT02565615|83213862|FG001|Overall Study|Not willing to participate in study|21|||
46970600|NCT02565615|83213863|FG002|Overall Study|Not willing to participate in study|0|||
46970601|NCT02565615|83213864|FG003|Overall Study|Not willing to participate in study|1|||
46649150|NCT03934203|82856473|FG000|Overall Study|Adverse Event|0|||
46649151|NCT03934203|82856474|FG001|Overall Study|Adverse Event|0|||
46780439|NCT00402103|82999224|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46780440|NCT00402103|82999223|FG000|Overall Study|Condition no longer requires study drug|2|||
46780441|NCT00402103|82999224|FG001|Overall Study|Condition no longer requires study drug|0|||
46780442|NCT00402103|82999223|FG000|Overall Study|Protocol Deviation|8|||
46780443|NCT00402103|82999224|FG001|Overall Study|Protocol Deviation|0|||
46780444|NCT00402103|82999223|FG000|Overall Study|Patient withdrew consent|12|||
46780445|NCT00402103|82999224|FG001|Overall Study|Patient withdrew consent|1|||
46780446|NCT00402103|82999223|FG000|Overall Study|Lost to Follow-up|6|||
46780447|NCT00402103|82999224|FG001|Overall Study|Lost to Follow-up|3|||
46780448|NCT00402103|82999223|FG000|Overall Study|Administrative problems|2|||
46780449|NCT00402103|82999224|FG001|Overall Study|Administrative problems|0|||
46780450|NCT00641667|82999234|FG000|Overall Study|Withdrawal by Subject|1|||
46780451|NCT00641667|82999234|FG000|Overall Study|Adverse Event|1|||
46780452|NCT00641667|82999234|FG000|Overall Study|Physician Decision|1|||
46780453|NCT00641667|82999234|FG000|Overall Study|Worsening of underlying disease|3|||
46780454|NCT00704184|82999243|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
46780455|NCT00704184|82999244|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
46780456|NCT00704184|82999245|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
46850657|NCT00112437|83066375|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850658|NCT00112437|83066376|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850659|NCT00112437|83066377|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850660|NCT00112437|83066378|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850661|NCT00112437|83066379|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850662|NCT00112437|83066380|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850663|NCT00112437|83066381|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850664|NCT00112437|83066382|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850665|NCT00112437|83066383|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850666|NCT00112437|83066384|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46780457|NCT00704184|82999246|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
46780458|NCT00704184|82999247|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
46780459|NCT00704184|82999243|FG000|Open-Label Treatment|Adverse Event|0|||
46850667|NCT00112437|83066385|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
46970602|NCT02565615|83213865|FG004|Overall Study|Not willing to participate in study|169|||
46850668|NCT00112437|83066386|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
46850669|NCT00112437|83066387|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
46850670|NCT00112437|83066388|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
46850671|NCT03653416|83066444|FG000|Overall Study|Protocol Violation|6|||
46970603|NCT02565615|83213861|FG000|Overall Study|Lost to Follow-up|0|||
46970604|NCT02565615|83213862|FG001|Overall Study|Lost to Follow-up|4|||
46780460|NCT00704184|82999244|FG001|Open-Label Treatment|Adverse Event|0|||
46780461|NCT00704184|82999245|FG002|Open-Label Treatment|Adverse Event|2|||
46970605|NCT02565615|83213863|FG002|Overall Study|Lost to Follow-up|0|||
46780462|NCT00704184|82999246|FG003|Open-Label Treatment|Adverse Event|0|||
46780463|NCT00704184|82999247|FG004|Open-Label Treatment|Adverse Event|1|||
46850672|NCT03653416|83066445|FG001|Overall Study|Protocol Violation|1|||
46970606|NCT02565615|83213864|FG003|Overall Study|Lost to Follow-up|1|||
46649152|NCT03934203|82856475|FG002|Overall Study|Adverse Event|1|||
46780464|NCT00704184|82999243|FG000|Open-Label Treatment|Lack of Efficacy|0|||
46780465|NCT00704184|82999244|FG001|Open-Label Treatment|Lack of Efficacy|2|||
46780466|NCT00704184|82999245|FG002|Open-Label Treatment|Lack of Efficacy|2|||
46780467|NCT00704184|82999246|FG003|Open-Label Treatment|Lack of Efficacy|2|||
46780468|NCT00704184|82999247|FG004|Open-Label Treatment|Lack of Efficacy|1|||
46780469|NCT00704184|82999243|FG000|Open-Label Treatment|Physician Decision|0|||
46780470|NCT00704184|82999244|FG001|Open-Label Treatment|Physician Decision|0|||
46780471|NCT00704184|82999245|FG002|Open-Label Treatment|Physician Decision|0|||
46780472|NCT00704184|82999246|FG003|Open-Label Treatment|Physician Decision|0|||
46780473|NCT00704184|82999247|FG004|Open-Label Treatment|Physician Decision|1|||
46780474|NCT00704184|82999243|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
46780475|NCT00704184|82999244|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
46780476|NCT00704184|82999245|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
46780477|NCT00704184|82999246|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
46780478|NCT00704184|82999247|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
46780479|NCT00641043|82999261|FG000|Overall Study|Adverse Event|6|||
46780480|NCT00641043|82999262|FG001|Overall Study|Adverse Event|4|||
46780481|NCT00641043|82999261|FG000|Overall Study|Protocol Violation|2|||
46780482|NCT00641043|82999262|FG001|Overall Study|Protocol Violation|3|||
46780483|NCT00641043|82999261|FG000|Overall Study|Lost to Follow-up|3|||
46780484|NCT00641043|82999262|FG001|Overall Study|Lost to Follow-up|2|||
46780485|NCT00641043|82999261|FG000|Overall Study|Withdrawal by Subject|4|||
46780486|NCT00641043|82999262|FG001|Overall Study|Withdrawal by Subject|4|||
46780487|NCT00641043|82999261|FG000|Overall Study|Other incl. lack of efficacy|4|||
46780488|NCT00641043|82999262|FG001|Overall Study|Other incl. lack of efficacy|2|||
46780489|NCT00402025|82999271|FG000|Overall Study|Adverse Event|0|||
46780490|NCT00402025|82999272|FG001|Overall Study|Adverse Event|0|||
46780491|NCT00402025|82999273|FG002|Overall Study|Adverse Event|2|||
46780492|NCT00402025|82999271|FG000|Overall Study|Death|0|||
46780493|NCT00402025|82999272|FG001|Overall Study|Death|1|||
46780494|NCT00402025|82999273|FG002|Overall Study|Death|5|||
46780495|NCT00402025|82999271|FG000|Overall Study|Disease Progression|1|||
46780496|NCT00402025|82999272|FG001|Overall Study|Disease Progression|1|||
46649153|NCT03934203|82856476|FG003|Overall Study|Adverse Event|0|||
46649154|NCT03934203|82856477|FG004|Overall Study|Adverse Event|1|||
46649155|NCT03934203|82856478|FG005|Overall Study|Adverse Event|0|||
46649156|NCT03934203|82856479|FG006|Overall Study|Adverse Event|2|||
46780497|NCT00402025|82999273|FG002|Overall Study|Disease Progression|2|||
46780498|NCT00402025|82999271|FG000|Overall Study|Physician Decision|1|||
46780499|NCT00402025|82999272|FG001|Overall Study|Physician Decision|1|||
46780500|NCT00402025|82999273|FG002|Overall Study|Physician Decision|0|||
46780501|NCT00402025|82999271|FG000|Overall Study|Participant Decision|0|||
46780502|NCT00402025|82999272|FG001|Overall Study|Participant Decision|0|||
46780503|NCT00402025|82999273|FG002|Overall Study|Participant Decision|1|||
46780504|NCT00609622|82999283|FG000|Overall Study|Adverse Event|14|||
46780505|NCT00609622|82999284|FG001|Overall Study|Adverse Event|10|||
46780506|NCT00609622|82999283|FG000|Overall Study|Withdrawal by Subject|4|||
46780507|NCT00609622|82999284|FG001|Overall Study|Withdrawal by Subject|20|||
46780508|NCT00609622|82999283|FG000|Overall Study|Death|1|||
46780509|NCT00609622|82999284|FG001|Overall Study|Death|4|||
46780510|NCT00609622|82999283|FG000|Overall Study|Protocol Violation|1|||
46780511|NCT00609622|82999284|FG001|Overall Study|Protocol Violation|1|||
46780512|NCT00609622|82999283|FG000|Overall Study|Objective progression or relapse|47|||
46780513|NCT00609622|82999284|FG001|Overall Study|Objective progression or relapse|41|||
46780514|NCT00609622|82999283|FG000|Overall Study|Study terminated by sponsor|16|||
46780515|NCT00609622|82999284|FG001|Overall Study|Study terminated by sponsor|3|||
46780516|NCT00609622|82999283|FG000|Overall Study|Other|7|||
46780517|NCT00609622|82999284|FG001|Overall Study|Other|14|||
46780518|NCT00609622|82999283|FG000|Overall Study|Global deterioration of health status|6|||
46780519|NCT00609622|82999284|FG001|Overall Study|Global deterioration of health status|2|||
46649157|NCT03934203|82856480|FG007|Overall Study|Adverse Event|0|||
46649158|NCT03934203|82856481|FG008|Overall Study|Adverse Event|0|||
46649159|NCT03934203|82856482|FG009|Overall Study|Adverse Event|0|||
46649160|NCT03934203|82856483|FG010|Overall Study|Adverse Event|0|||
46649161|NCT03934203|82856484|FG011|Overall Study|Adverse Event|0|||
46649162|NCT03934203|82856485|FG012|Overall Study|Adverse Event|0|||
46780520|NCT00699660|82999292|FG000|Overall Study|Lost to Follow-up|4|||
46780521|NCT00699660|82999293|FG001|Overall Study|Lost to Follow-up|2|||
46780522|NCT00699660|82999292|FG000|Overall Study|missing reports and recording failures|10|||
46780523|NCT00699660|82999293|FG001|Overall Study|missing reports and recording failures|6|||
46649163|NCT03934203|82856486|FG013|Overall Study|Adverse Event|1|||
46780524|NCT00627705|82999301|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
46780525|NCT00627705|82999302|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
46780526|NCT00627705|82999301|FG000|Overall Study|Adverse Event|1|||
46780527|NCT00627705|82999302|FG001|Overall Study|Adverse Event|0|||
46649164|NCT03934203|82856487|FG014|Overall Study|Adverse Event|0|||
46780528|NCT00627705|82999301|FG000|Overall Study|Withdrawal by Subject|0|||
46780529|NCT00627705|82999302|FG001|Overall Study|Withdrawal by Subject|2|||
46649165|NCT03887052|82856507|FG000|Overall Study|Adverse Event|2|||
46649166|NCT03887052|82856507|FG000|Overall Study|Physician Decision|2|||
46649167|NCT03887052|82856507|FG000|Overall Study|Withdrawal by Subject|3|||
46649168|NCT03887052|82856507|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
46649169|NCT03887052|82856507|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
46649170|NCT03858049|82856513|FG000|Overall Study|Adverse Event|16|||
46649171|NCT03858049|82856514|FG001|Overall Study|Adverse Event|9|||
46649172|NCT03858049|82856513|FG000|Overall Study|Other|1|||
46649173|NCT03858049|82856514|FG001|Overall Study|Other|1|||
46649174|NCT03664765|82856531|FG000|Overall Study|Withdrawal by Subject|4|||
46649175|NCT03664765|82856532|FG001|Overall Study|Withdrawal by Subject|1|||
46649176|NCT03664765|82856531|FG000|Overall Study|Lost to Follow-up|0|||
46649177|NCT03664765|82856532|FG001|Overall Study|Lost to Follow-up|1|||
46649178|NCT03660930|82856547|FG000|Overall Study|Adverse Event|0|||
46649179|NCT03660930|82856548|FG001|Overall Study|Adverse Event|0|||
46649180|NCT03660930|82856549|FG002|Overall Study|Adverse Event|0|||
46649181|NCT03660930|82856550|FG003|Overall Study|Adverse Event|2|||
46649182|NCT03660930|82856551|FG004|Overall Study|Adverse Event|0|||
46649183|NCT03660930|82856552|FG005|Overall Study|Adverse Event|1|||
46649184|NCT03660930|82856553|FG006|Overall Study|Adverse Event|0|||
46649185|NCT03660930|82856554|FG007|Overall Study|Adverse Event|0|||
46649186|NCT03660930|82856547|FG000|Overall Study|Withdrawal by Subject|0|||
46649187|NCT03660930|82856548|FG001|Overall Study|Withdrawal by Subject|0|||
46649188|NCT03660930|82856549|FG002|Overall Study|Withdrawal by Subject|0|||
46649189|NCT03660930|82856550|FG003|Overall Study|Withdrawal by Subject|0|||
46649190|NCT03660930|82856551|FG004|Overall Study|Withdrawal by Subject|0|||
46649191|NCT03660930|82856552|FG005|Overall Study|Withdrawal by Subject|1|||
46649192|NCT03660930|82856553|FG006|Overall Study|Withdrawal by Subject|0|||
46649193|NCT03660930|82856554|FG007|Overall Study|Withdrawal by Subject|0|||
46649194|NCT03660930|82856547|FG000|Overall Study|On Treatment|0|||
46649195|NCT03660930|82856548|FG001|Overall Study|On Treatment|0|||
46649196|NCT03660930|82856549|FG002|Overall Study|On Treatment|0|||
46649197|NCT03660930|82856550|FG003|Overall Study|On Treatment|0|||
46649198|NCT03660930|82856551|FG004|Overall Study|On Treatment|0|||
46649199|NCT03660930|82856552|FG005|Overall Study|On Treatment|0|||
46649200|NCT03660930|82856553|FG006|Overall Study|On Treatment|0|||
46649201|NCT03660930|82856554|FG007|Overall Study|On Treatment|1|||
46649202|NCT03660930|82856547|FG000|Overall Study|In Follow-up|0|||
46649203|NCT03660930|82856548|FG001|Overall Study|In Follow-up|0|||
46649204|NCT03660930|82856549|FG002|Overall Study|In Follow-up|0|||
46649205|NCT03660930|82856550|FG003|Overall Study|In Follow-up|0|||
46649206|NCT03660930|82856551|FG004|Overall Study|In Follow-up|0|||
46649207|NCT03660930|82856552|FG005|Overall Study|In Follow-up|0|||
46649208|NCT03660930|82856553|FG006|Overall Study|In Follow-up|1|||
46649209|NCT03660930|82856554|FG007|Overall Study|In Follow-up|2|||
46649210|NCT03528369|82856582|FG000|Overall Study|Withdrawal by Subject|2|||
46649211|NCT03528369|82856583|FG001|Overall Study|Withdrawal by Subject|0|||
46649212|NCT03528369|82856584|FG002|Overall Study|Withdrawal by Subject|0|||
46649213|NCT03528369|82856582|FG000|Overall Study|Lost to Follow-up|1|||
46649214|NCT03528369|82856583|FG001|Overall Study|Lost to Follow-up|0|||
46649215|NCT03528369|82856584|FG002|Overall Study|Lost to Follow-up|0|||
46649216|NCT03528369|82856582|FG000|Overall Study|Adverse Event|0|||
46649217|NCT03528369|82856583|FG001|Overall Study|Adverse Event|1|||
46649218|NCT03528369|82856584|FG002|Overall Study|Adverse Event|0|||
46649219|NCT03428152|82856594|FG000|Overall Study|Physician Decision|4|||
46649220|NCT03428152|82856595|FG001|Overall Study|Physician Decision|2|||
46649221|NCT03428152|82856594|FG000|Overall Study|Protocol Violation|3|||
46649222|NCT03428152|82856595|FG001|Overall Study|Protocol Violation|5|||
46649223|NCT03428152|82856594|FG000|Overall Study|Lack of Efficacy|0|||
46649224|NCT03428152|82856595|FG001|Overall Study|Lack of Efficacy|4|||
46780530|NCT00627705|82999301|FG000|Overall Study|Lost to Follow-up|0|||
46649225|NCT03312751|82856603|FG000|Overall Study|Death|7|||
46649226|NCT03312751|82856604|FG001|Overall Study|Death|9|||
46649227|NCT03312751|82856603|FG000|Overall Study|Study discontinuation due to other reason|0|||
46649228|NCT03312751|82856604|FG001|Overall Study|Study discontinuation due to other reason|1|||
46649229|NCT03124407|82856657|FG000|Overall Study|Lost to Follow-up|1|||
46649230|NCT03124407|82856658|FG001|Overall Study|Lost to Follow-up|0|||
46649231|NCT03124407|82856659|FG002|Overall Study|Lost to Follow-up|0|||
46649232|NCT03124407|82856660|FG003|Overall Study|Lost to Follow-up|0|||
46649233|NCT03124407|82856657|FG000|Overall Study|Adverse Event|0|||
46649234|NCT03124407|82856658|FG001|Overall Study|Adverse Event|0|||
46649235|NCT03124407|82856659|FG002|Overall Study|Adverse Event|1|||
46780531|NCT00627705|82999302|FG001|Overall Study|Lost to Follow-up|1|||
46649236|NCT03124407|82856660|FG003|Overall Study|Adverse Event|0|||
46649237|NCT03064490|82856674|FG000|Overall Study|Physician Decision|5|||
46649238|NCT02923739|82856687|FG000|Overall Study|Withdrawal by Subject|2|||
46649239|NCT02923739|82856688|FG001|Overall Study|Withdrawal by Subject|0|||
46649240|NCT02923739|82856689|FG002|Overall Study|Withdrawal by Subject|0|||
46649241|NCT02923739|82856690|FG003|Overall Study|Withdrawal by Subject|0|||
46649242|NCT02923739|82856687|FG000|Overall Study|Failed Screening|3|||
46649243|NCT02923739|82856688|FG001|Overall Study|Failed Screening|0|||
46649244|NCT02923739|82856689|FG002|Overall Study|Failed Screening|0|||
46649245|NCT02923739|82856690|FG003|Overall Study|Failed Screening|0|||
46649246|NCT02747004|82856721|FG000|Overall Study|Withdrawal by Subject|8|||
46970607|NCT02565615|83213865|FG004|Overall Study|Lost to Follow-up|765|||
46970608|NCT02565615|83213861|FG000|Overall Study|Not meeting eligibility criteria|0|||
46649247|NCT02747004|82856722|FG001|Overall Study|Withdrawal by Subject|5|||
46649248|NCT02747004|82856723|FG002|Overall Study|Withdrawal by Subject|4|||
46649249|NCT02747004|82856721|FG000|Overall Study|Lost to Follow-up|1|||
46649250|NCT02747004|82856722|FG001|Overall Study|Lost to Follow-up|2|||
46649251|NCT02747004|82856723|FG002|Overall Study|Lost to Follow-up|2|||
46649252|NCT02747004|82856721|FG000|Overall Study|on study treatment/follow-up|48|||
46649253|NCT02747004|82856722|FG001|Overall Study|on study treatment/follow-up|42|||
46649254|NCT02747004|82856723|FG002|Overall Study|on study treatment/follow-up|41|||
46649255|NCT02720094|82856733|FG000|Overall Study|Scheduled exit visit/end of study|2|||
46649256|NCT02720094|82856734|FG001|Overall Study|Scheduled exit visit/end of study|1|||
46649257|NCT02720094|82856733|FG000|Overall Study|Death|4|||
46649258|NCT02720094|82856734|FG001|Overall Study|Death|7|||
46649259|NCT02720094|82856733|FG000|Overall Study|Withdrawal by Subject|55|||
46649260|NCT02720094|82856734|FG001|Overall Study|Withdrawal by Subject|56|||
46970609|NCT02565615|83213862|FG001|Overall Study|Not meeting eligibility criteria|7|||
46649261|NCT02720094|82856733|FG000|Overall Study|Lost to Follow-up|2|||
46649262|NCT02720094|82856734|FG001|Overall Study|Lost to Follow-up|7|||
46649263|NCT02720094|82856733|FG000|Overall Study|Physician Decision|1|||
46649264|NCT02720094|82856734|FG001|Overall Study|Physician Decision|3|||
46649265|NCT02720094|82856733|FG000|Overall Study|Inappropriate enrollment|1|||
46649266|NCT02720094|82856734|FG001|Overall Study|Inappropriate enrollment|3|||
46649267|NCT02720094|82856733|FG000|Overall Study|Ongoing|2210|||
46649268|NCT02720094|82856734|FG001|Overall Study|Ongoing|2203|||
46649269|NCT02720094|82856733|FG000|Overall Study|Relocation|1|||
46649270|NCT02720094|82856734|FG001|Overall Study|Relocation|1|||
46649271|NCT02670837|82856744|FG000|Overall Study|Death|2|||
46649272|NCT02670837|82856745|FG001|Overall Study|Death|0|||
46649273|NCT02670837|82856746|FG002|Overall Study|Death|0|||
46649274|NCT02653300|82856752|FG000|Overall Study|Withdrawal by Subject|2|||
46649275|NCT02499328|82856780|FG000|Overall Study|Withdrawal by Subject|1|||
46649276|NCT02499328|82856781|FG001|Overall Study|Withdrawal by Subject|1|||
46649277|NCT02499328|82856782|FG002|Overall Study|Withdrawal by Subject|5|||
46649278|NCT02499328|82856783|FG003|Overall Study|Withdrawal by Subject|3|||
46649279|NCT02499328|82856784|FG004|Overall Study|Withdrawal by Subject|5|||
46649280|NCT02499328|82856785|FG005|Overall Study|Withdrawal by Subject|0|||
46649281|NCT02499328|82856786|FG006|Overall Study|Withdrawal by Subject|0|||
46649282|NCT02499328|82856787|FG007|Overall Study|Withdrawal by Subject|0|||
46649283|NCT02499328|82856788|FG008|Overall Study|Withdrawal by Subject|2|||
46649284|NCT02499328|82856789|FG009|Overall Study|Withdrawal by Subject|2|||
46649285|NCT02499328|82856790|FG010|Overall Study|Withdrawal by Subject|0|||
46649286|NCT02499328|82856791|FG011|Overall Study|Withdrawal by Subject|3|||
46649287|NCT02499328|82856792|FG012|Overall Study|Withdrawal by Subject|7|||
46649288|NCT02499328|82856793|FG013|Overall Study|Withdrawal by Subject|3|||
46649289|NCT02499328|82856794|FG014|Overall Study|Withdrawal by Subject|1|||
46649290|NCT02499328|82856795|FG015|Overall Study|Withdrawal by Subject|0|||
46649291|NCT02499328|82856796|FG016|Overall Study|Withdrawal by Subject|0|||
46649292|NCT02499328|82856797|FG017|Overall Study|Withdrawal by Subject|3|||
46649293|NCT02499328|82856798|FG018|Overall Study|Withdrawal by Subject|0|||
46649294|NCT02499328|82856780|FG000|Overall Study|Lost to Follow-up|0|||
46649295|NCT02499328|82856781|FG001|Overall Study|Lost to Follow-up|1|||
46649296|NCT02499328|82856782|FG002|Overall Study|Lost to Follow-up|1|||
46649297|NCT02499328|82856783|FG003|Overall Study|Lost to Follow-up|2|||
46649298|NCT02499328|82856784|FG004|Overall Study|Lost to Follow-up|0|||
46649299|NCT02499328|82856785|FG005|Overall Study|Lost to Follow-up|0|||
46649300|NCT02499328|82856786|FG006|Overall Study|Lost to Follow-up|0|||
46649301|NCT02499328|82856787|FG007|Overall Study|Lost to Follow-up|2|||
46649302|NCT02499328|82856788|FG008|Overall Study|Lost to Follow-up|3|||
46649303|NCT02499328|82856789|FG009|Overall Study|Lost to Follow-up|0|||
46649304|NCT02499328|82856790|FG010|Overall Study|Lost to Follow-up|0|||
46649305|NCT02499328|82856791|FG011|Overall Study|Lost to Follow-up|0|||
46649306|NCT02499328|82856792|FG012|Overall Study|Lost to Follow-up|0|||
46649307|NCT02499328|82856793|FG013|Overall Study|Lost to Follow-up|0|||
46649308|NCT02499328|82856794|FG014|Overall Study|Lost to Follow-up|0|||
46649309|NCT02499328|82856795|FG015|Overall Study|Lost to Follow-up|0|||
46649310|NCT02499328|82856796|FG016|Overall Study|Lost to Follow-up|0|||
46649311|NCT02499328|82856797|FG017|Overall Study|Lost to Follow-up|0|||
46649312|NCT02499328|82856798|FG018|Overall Study|Lost to Follow-up|1|||
46649313|NCT02499328|82856780|FG000|Overall Study|Death|0|||
46649314|NCT02499328|82856781|FG001|Overall Study|Death|3|||
46649315|NCT02499328|82856782|FG002|Overall Study|Death|3|||
46649316|NCT02499328|82856783|FG003|Overall Study|Death|2|||
46649317|NCT02499328|82856784|FG004|Overall Study|Death|4|||
46649318|NCT02499328|82856785|FG005|Overall Study|Death|7|||
46649319|NCT02499328|82856786|FG006|Overall Study|Death|3|||
46649320|NCT02499328|82856787|FG007|Overall Study|Death|0|||
46649321|NCT02499328|82856788|FG008|Overall Study|Death|2|||
46649322|NCT02499328|82856789|FG009|Overall Study|Death|6|||
46649323|NCT02499328|82856790|FG010|Overall Study|Death|6|||
46649324|NCT02499328|82856791|FG011|Overall Study|Death|20|||
46649325|NCT02499328|82856792|FG012|Overall Study|Death|9|||
46649326|NCT02499328|82856793|FG013|Overall Study|Death|7|||
46649327|NCT02499328|82856794|FG014|Overall Study|Death|3|||
46649328|NCT02499328|82856795|FG015|Overall Study|Death|1|||
46649329|NCT02499328|82856796|FG016|Overall Study|Death|1|||
46649330|NCT02499328|82856797|FG017|Overall Study|Death|16|||
46649331|NCT02499328|82856798|FG018|Overall Study|Death|5|||
46649332|NCT02499328|82856780|FG000|Overall Study|"Other"|2|||
46649333|NCT02499328|82856781|FG001|Overall Study|"Other"|2|||
46649334|NCT02499328|82856782|FG002|Overall Study|"Other"|1|||
46649335|NCT02499328|82856783|FG003|Overall Study|"Other"|3|||
46649336|NCT02499328|82856784|FG004|Overall Study|"Other"|6|||
46649337|NCT02499328|82856785|FG005|Overall Study|"Other"|2|||
46649338|NCT02499328|82856786|FG006|Overall Study|"Other"|3|||
46649339|NCT02499328|82856787|FG007|Overall Study|"Other"|4|||
46649340|NCT02499328|82856788|FG008|Overall Study|"Other"|6|||
46649341|NCT02499328|82856789|FG009|Overall Study|"Other"|16|||
46649342|NCT02499328|82856790|FG010|Overall Study|"Other"|13|||
46649343|NCT02499328|82856791|FG011|Overall Study|"Other"|31|||
46649344|NCT02499328|82856792|FG012|Overall Study|"Other"|8|||
46649345|NCT02499328|82856793|FG013|Overall Study|"Other"|7|||
46649346|NCT02499328|82856794|FG014|Overall Study|"Other"|6|||
46649347|NCT02499328|82856795|FG015|Overall Study|"Other"|0|||
46649348|NCT02499328|82856796|FG016|Overall Study|"Other"|0|||
46649349|NCT02499328|82856797|FG017|Overall Study|"Other"|34|||
46649350|NCT02499328|82856798|FG018|Overall Study|"Other"|43|||
46649351|NCT02499328|82856780|FG000|Overall Study|Disease Progression|0|||
46649352|NCT02499328|82856781|FG001|Overall Study|Disease Progression|0|||
46649353|NCT02499328|82856782|FG002|Overall Study|Disease Progression|0|||
46649354|NCT02499328|82856783|FG003|Overall Study|Disease Progression|0|||
46649355|NCT02499328|82856784|FG004|Overall Study|Disease Progression|0|||
46649356|NCT02499328|82856785|FG005|Overall Study|Disease Progression|0|||
46649357|NCT02499328|82856786|FG006|Overall Study|Disease Progression|1|||
46649358|NCT02499328|82856787|FG007|Overall Study|Disease Progression|0|||
46649359|NCT02499328|82856788|FG008|Overall Study|Disease Progression|1|||
46649360|NCT02499328|82856789|FG009|Overall Study|Disease Progression|0|||
46649361|NCT02499328|82856790|FG010|Overall Study|Disease Progression|1|||
46649362|NCT02499328|82856791|FG011|Overall Study|Disease Progression|0|||
46649363|NCT02499328|82856792|FG012|Overall Study|Disease Progression|0|||
46649364|NCT02499328|82856793|FG013|Overall Study|Disease Progression|0|||
46649365|NCT02499328|82856794|FG014|Overall Study|Disease Progression|0|||
46649366|NCT02499328|82856795|FG015|Overall Study|Disease Progression|0|||
46649367|NCT02499328|82856796|FG016|Overall Study|Disease Progression|0|||
46649368|NCT02499328|82856797|FG017|Overall Study|Disease Progression|2|||
46649369|NCT02499328|82856798|FG018|Overall Study|Disease Progression|0|||
46649370|NCT02499328|82856780|FG000|Overall Study|Adverse Event|1|||
46649371|NCT02499328|82856781|FG001|Overall Study|Adverse Event|0|||
46649372|NCT02499328|82856782|FG002|Overall Study|Adverse Event|0|||
46649373|NCT02499328|82856783|FG003|Overall Study|Adverse Event|1|||
46649374|NCT02499328|82856784|FG004|Overall Study|Adverse Event|0|||
46649375|NCT02499328|82856785|FG005|Overall Study|Adverse Event|0|||
46649376|NCT02499328|82856786|FG006|Overall Study|Adverse Event|0|||
46649377|NCT02499328|82856787|FG007|Overall Study|Adverse Event|0|||
46649378|NCT02499328|82856788|FG008|Overall Study|Adverse Event|0|||
46649379|NCT02499328|82856789|FG009|Overall Study|Adverse Event|0|||
46649380|NCT02499328|82856790|FG010|Overall Study|Adverse Event|0|||
46649381|NCT02499328|82856791|FG011|Overall Study|Adverse Event|0|||
46649382|NCT02499328|82856792|FG012|Overall Study|Adverse Event|1|||
46649383|NCT02499328|82856793|FG013|Overall Study|Adverse Event|0|||
46649384|NCT02499328|82856794|FG014|Overall Study|Adverse Event|0|||
46649385|NCT02499328|82856795|FG015|Overall Study|Adverse Event|0|||
46649386|NCT02499328|82856796|FG016|Overall Study|Adverse Event|0|||
46649387|NCT02499328|82856797|FG017|Overall Study|Adverse Event|0|||
46649388|NCT02499328|82856798|FG018|Overall Study|Adverse Event|0|||
46649389|NCT02451943|82856883|FG000|Overall Study|On Treatment|4|||
46649390|NCT02451943|82856884|FG001|Overall Study|On Treatment|4|||
46649391|NCT02451943|82856883|FG000|Overall Study|Withdrawal by Subject|13|||
46649392|NCT02451943|82856884|FG001|Overall Study|Withdrawal by Subject|16|||
46649393|NCT02451943|82856883|FG000|Overall Study|Lost to Follow-up|3|||
46649394|NCT02451943|82856884|FG001|Overall Study|Lost to Follow-up|4|||
46649395|NCT02155699|82856928|FG000|Overall Study|Withdrawal by Subject|0|||
46649396|NCT02155699|82856929|FG001|Overall Study|Withdrawal by Subject|3|||
46649397|NCT02155699|82856930|FG002|Overall Study|Withdrawal by Subject|6|||
46649398|NCT02155699|82856931|FG003|Overall Study|Withdrawal by Subject|1|||
46649399|NCT02155699|82856928|FG000|Overall Study|Lost to Follow-up|0|||
46649400|NCT02155699|82856929|FG001|Overall Study|Lost to Follow-up|0|||
46649401|NCT02155699|82856930|FG002|Overall Study|Lost to Follow-up|0|||
46649402|NCT02155699|82856931|FG003|Overall Study|Lost to Follow-up|3|||
46649403|NCT02155699|82856928|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
46649404|NCT02155699|82856929|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
46649405|NCT02155699|82856930|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
46649406|NCT02155699|82856931|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
46649407|NCT02136134|82856976|FG000|Overall Study|Death|170|||
46649408|NCT02136134|82856977|FG001|Overall Study|Death|148|||
46649409|NCT02136134|82856976|FG000|Overall Study|Withdrawal by Subject|19|||
46649410|NCT02136134|82856977|FG001|Overall Study|Withdrawal by Subject|10|||
46649411|NCT02136134|82856976|FG000|Overall Study|Lost to Follow-up|3|||
46649412|NCT02136134|82856977|FG001|Overall Study|Lost to Follow-up|3|||
46649413|NCT02136134|82856976|FG000|Overall Study|Uspecified|55|||
46649414|NCT02136134|82856977|FG001|Overall Study|Uspecified|90|||
46649415|NCT02107703|82856986|FG000|Overall Study|Withdrawal by Subject|46|||
46649416|NCT02107703|82856987|FG001|Overall Study|Withdrawal by Subject|21|||
46649417|NCT02107703|82856986|FG000|Overall Study|Lost to Follow-up|20|||
46649418|NCT02107703|82856987|FG001|Overall Study|Lost to Follow-up|9|||
46649419|NCT02107703|82856986|FG000|Overall Study|On study treatment/follow up|48|||
46649420|NCT02107703|82856987|FG001|Overall Study|On study treatment/follow up|5|||
46649421|NCT02096588|82856995|FG000|Overall Study|Lack of Efficacy|2|||
46649422|NCT02096588|82856996|FG001|Overall Study|Lack of Efficacy|0|||
46649423|NCT02096588|82856995|FG000|Overall Study|Withdrawal by Subject|0|||
46649424|NCT02096588|82856996|FG001|Overall Study|Withdrawal by Subject|1|||
46649425|NCT02044458|82857004|FG000|Overall Study|Protocol Violation|3|||
46649426|NCT02044458|82857005|FG001|Overall Study|Protocol Violation|8|||
46649427|NCT02008721|82857013|FG000|Overall Study|Withdrawal by Subject|5|||
46649428|NCT02008721|82857014|FG001|Overall Study|Withdrawal by Subject|1|||
46649429|NCT02008721|82857013|FG000|Overall Study|Death|4|||
46649430|NCT02008721|82857014|FG001|Overall Study|Death|2|||
46649431|NCT02008721|82857013|FG000|Overall Study|Adverse Event|3|||
46649432|NCT02008721|82857014|FG001|Overall Study|Adverse Event|5|||
46780532|NCT00610168|82999310|FG000|Overall Study|Withdrawal by Subject|2|||
46780533|NCT00610168|82999311|FG001|Overall Study|Withdrawal by Subject|0|||
46780534|NCT00644787|82999317|FG000|Period 1: Titration Phase|Adverse Event|11|||
46780535|NCT00644787|82999318|FG001|Period 1: Titration Phase|Adverse Event|0|||
46780536|NCT00644787|82999319|FG002|Period 1: Titration Phase|Adverse Event|0|||
46780537|NCT00644787|82999317|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
46649433|NCT02008721|82857013|FG000|Overall Study|Protocol Violation|3|||
46649434|NCT02008721|82857014|FG001|Overall Study|Protocol Violation|2|||
46649435|NCT01892722|82857024|FG000|Overall Study|Protocol deviation|0|||
46649436|NCT01892722|82857025|FG001|Overall Study|Protocol deviation|1|||
46649437|NCT01892722|82857024|FG000|Overall Study|Administrative problems|0|||
46649438|NCT01892722|82857025|FG001|Overall Study|Administrative problems|1|||
46649439|NCT01892722|82857024|FG000|Overall Study|Patient/guardian decision|0|||
46649440|NCT01892722|82857025|FG001|Overall Study|Patient/guardian decision|2|||
46649441|NCT01892722|82857024|FG000|Overall Study|Physician Decision|1|||
46649442|NCT01892722|82857025|FG001|Overall Study|Physician Decision|2|||
46649443|NCT01892722|82857024|FG000|Overall Study|Adverse Event|3|||
46649444|NCT01892722|82857025|FG001|Overall Study|Adverse Event|2|||
46649445|NCT01892722|82857024|FG000|Overall Study|Lack of Efficacy|0|||
46649446|NCT01892722|82857025|FG001|Overall Study|Lack of Efficacy|7|||
46970610|NCT02565615|83213863|FG002|Overall Study|Not meeting eligibility criteria|0|||
46970611|NCT02565615|83213864|FG003|Overall Study|Not meeting eligibility criteria|0|||
46970612|NCT02565615|83213865|FG004|Overall Study|Not meeting eligibility criteria|25|||
46970613|NCT02565615|83213861|FG000|Overall Study|Reason not defined|0|||
46970614|NCT02565615|83213862|FG001|Overall Study|Reason not defined|2|||
46970615|NCT02565615|83213863|FG002|Overall Study|Reason not defined|0|||
46970616|NCT02565615|83213864|FG003|Overall Study|Reason not defined|1|||
46970617|NCT02565615|83213865|FG004|Overall Study|Reason not defined|62|||
46970618|NCT02565615|83213861|FG000|Overall Study|Adverse Event|1|||
46970619|NCT02565615|83213862|FG001|Overall Study|Adverse Event|1|||
46970620|NCT02565615|83213863|FG002|Overall Study|Adverse Event|0|||
46649447|NCT01892722|82857024|FG000|Overall Study|Withdrawal by Subject|3|||
46649448|NCT01892722|82857025|FG001|Overall Study|Withdrawal by Subject|5|||
46649449|NCT01827904|82857033|FG000|Main Study|Withdrawal by Subject|1|||
46649450|NCT01827904|82857034|FG001|Main Study|Withdrawal by Subject|0|||
46649451|NCT01827904|82857035|FG002|Main Study|Withdrawal by Subject|0|||
46649452|NCT01827904|82857033|FG000|Main Study|Adverse Event|1|||
46649453|NCT01827904|82857034|FG001|Main Study|Adverse Event|0|||
46649454|NCT01827904|82857035|FG002|Main Study|Adverse Event|0|||
46649455|NCT01827904|82857033|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
46649456|NCT01827904|82857034|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
46649457|NCT01827904|82857035|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
46649458|NCT01827904|82857033|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
46649459|NCT01827904|82857034|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
46649460|NCT01827904|82857035|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
46649461|NCT01827904|82857033|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
46649462|NCT01827904|82857034|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
46649463|NCT01827904|82857035|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
46649464|NCT01827904|82857033|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
46649465|NCT01827904|82857034|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
46649466|NCT01827904|82857035|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
46649467|NCT01827904|82857033|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
46780538|NCT00644787|82999318|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
46780539|NCT00644787|82999319|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
46780540|NCT00644787|82999317|FG000|Period 1: Titration Phase|Physician Decision|1|||
46649468|NCT01827904|82857034|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
46780541|NCT00644787|82999318|FG001|Period 1: Titration Phase|Physician Decision|0|||
46780542|NCT00644787|82999319|FG002|Period 1: Titration Phase|Physician Decision|0|||
46970621|NCT02565615|83213864|FG003|Overall Study|Adverse Event|0|||
46970622|NCT02565615|83213865|FG004|Overall Study|Adverse Event|9|||
46970623|NCT02565615|83213861|FG000|Overall Study|Untreated|0|||
46649469|NCT01827904|82857035|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
46649470|NCT01827904|82857033|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
46649471|NCT01827904|82857034|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
46970624|NCT02565615|83213862|FG001|Overall Study|Untreated|0|||
46970625|NCT02565615|83213863|FG002|Overall Study|Untreated|0|||
46649472|NCT01827904|82857035|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
46649473|NCT01827904|82857033|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
46649474|NCT01827904|82857034|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
46649475|NCT01827904|82857035|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
46649476|NCT01827904|82857033|FG000|Long-term Annual Follow-up|Physician Decision|1|||
46649477|NCT01827904|82857034|FG001|Long-term Annual Follow-up|Physician Decision|0|||
46649478|NCT01827904|82857035|FG002|Long-term Annual Follow-up|Physician Decision|0|||
46649479|NCT01827904|82857033|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
46649480|NCT01827904|82857034|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
46649481|NCT01827904|82857035|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
46649482|NCT01827904|82857033|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
46649483|NCT01827904|82857034|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
46649484|NCT01827904|82857035|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
46649485|NCT01798004|82857047|FG000|Overall Study|Death|2|||
46649486|NCT01798004|82857047|FG000|Overall Study|Lack of Efficacy|8|||
46649487|NCT01798004|82857047|FG000|Overall Study|Physician Decision|25|||
46649488|NCT01798004|82857047|FG000|Overall Study|Withdrawal by Subject|4|||
46649489|NCT01798004|82857047|FG000|Overall Study|Ineligible|4|||
46649490|NCT01798004|82857047|FG000|Overall Study|Patient/parent refusal|7|||
46649491|NCT01798004|82857047|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
46649492|NCT01798004|82857047|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
46649493|NCT01562782|82857064|FG000|Overall Study|Withdrawal by Subject|3|||
46649494|NCT01562782|82857065|FG001|Overall Study|Withdrawal by Subject|3|||
46649495|NCT01562782|82857064|FG000|Overall Study|screen failure|1|||
46649496|NCT01562782|82857065|FG001|Overall Study|screen failure|2|||
46649497|NCT01543698|82857086|FG000|Phase 1b|Disease progression|2|||
46649498|NCT01543698|82857087|FG001|Phase 1b|Disease progression|4|||
46649499|NCT01543698|82857088|FG002|Phase 1b|Disease progression|3|||
46649500|NCT01543698|82857089|FG003|Phase 1b|Disease progression|2|||
46649501|NCT01543698|82857090|FG004|Phase 1b|Disease progression|10|||
46649502|NCT01543698|82857091|FG005|Phase 1b|Disease progression|6|||
46649503|NCT01543698|82857092|FG006|Phase 1b|Disease progression|5|||
46649504|NCT01543698|82857093|FG007|Phase 1b|Disease progression|3|||
46649505|NCT01543698|82857094|FG008|Phase 1b|Disease progression|4|||
46649506|NCT01543698|82857095|FG009|Phase 1b|Disease progression|5|||
46649507|NCT01543698|82857096|FG010|Phase 1b|Disease progression|1|||
46649508|NCT01543698|82857097|FG011|Phase 1b|Disease progression|0|||
46649509|NCT01543698|82857098|FG012|Phase 1b|Disease progression|0|||
46649510|NCT01543698|82857099|FG013|Phase 1b|Disease progression|0|||
46649511|NCT01543698|82857100|FG014|Phase 1b|Disease progression|0|||
46649512|NCT01543698|82857086|FG000|Phase 1b|Death|0|||
46649513|NCT01543698|82857087|FG001|Phase 1b|Death|0|||
46649514|NCT01543698|82857088|FG002|Phase 1b|Death|1|||
46780543|NCT00644787|82999317|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
46780544|NCT00644787|82999318|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
46780545|NCT00644787|82999319|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
46780546|NCT00644787|82999317|FG000|Period 1: Titration Phase|Worsening of complications|1|||
46780547|NCT00644787|82999318|FG001|Period 1: Titration Phase|Worsening of complications|0|||
46780548|NCT00644787|82999319|FG002|Period 1: Titration Phase|Worsening of complications|0|||
46780549|NCT00644787|82999317|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
46780550|NCT00644787|82999318|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
46780551|NCT00644787|82999319|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
46780552|NCT00644787|82999317|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
46780553|NCT00644787|82999318|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
46780554|NCT00644787|82999319|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
46780555|NCT00644787|82999317|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
46780556|NCT00644787|82999318|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
46780557|NCT00644787|82999319|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
46780558|NCT00644787|82999317|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
46780559|NCT00644787|82999318|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
46780560|NCT00644787|82999319|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
46780561|NCT00644787|82999317|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
46780562|NCT00644787|82999318|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
46780563|NCT00644787|82999319|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
46970626|NCT02565615|83213864|FG003|Overall Study|Untreated|0|||
46970627|NCT02565615|83213865|FG004|Overall Study|Untreated|567|||
46970628|NCT02701361|83213880|FG000|Overall Study|Lost to Follow-up|5|||
46970629|NCT02701361|83213881|FG001|Overall Study|Lost to Follow-up|2|||
46970630|NCT02701361|83213882|FG002|Overall Study|Lost to Follow-up|1|||
46649515|NCT01543698|82857089|FG003|Phase 1b|Death|1|||
46649516|NCT01543698|82857090|FG004|Phase 1b|Death|0|||
46649517|NCT01543698|82857091|FG005|Phase 1b|Death|0|||
46649518|NCT01543698|82857092|FG006|Phase 1b|Death|0|||
46649519|NCT01543698|82857093|FG007|Phase 1b|Death|0|||
46649520|NCT01543698|82857094|FG008|Phase 1b|Death|0|||
46649521|NCT01543698|82857095|FG009|Phase 1b|Death|0|||
46649522|NCT01543698|82857096|FG010|Phase 1b|Death|1|||
46649523|NCT01543698|82857097|FG011|Phase 1b|Death|0|||
46649524|NCT01543698|82857098|FG012|Phase 1b|Death|0|||
46649525|NCT01543698|82857099|FG013|Phase 1b|Death|0|||
46649526|NCT01543698|82857100|FG014|Phase 1b|Death|0|||
46649527|NCT01543698|82857086|FG000|Phase 1b|Withdrawal by Subject|0|||
46649528|NCT01543698|82857087|FG001|Phase 1b|Withdrawal by Subject|1|||
46649529|NCT01543698|82857088|FG002|Phase 1b|Withdrawal by Subject|0|||
46649530|NCT01543698|82857089|FG003|Phase 1b|Withdrawal by Subject|1|||
46649531|NCT01543698|82857090|FG004|Phase 1b|Withdrawal by Subject|0|||
46649532|NCT01543698|82857091|FG005|Phase 1b|Withdrawal by Subject|0|||
46649533|NCT01543698|82857092|FG006|Phase 1b|Withdrawal by Subject|1|||
46649534|NCT01543698|82857093|FG007|Phase 1b|Withdrawal by Subject|0|||
46649535|NCT01543698|82857094|FG008|Phase 1b|Withdrawal by Subject|0|||
46649536|NCT01543698|82857095|FG009|Phase 1b|Withdrawal by Subject|0|||
46649537|NCT01543698|82857096|FG010|Phase 1b|Withdrawal by Subject|0|||
46649538|NCT01543698|82857097|FG011|Phase 1b|Withdrawal by Subject|0|||
46649539|NCT01543698|82857098|FG012|Phase 1b|Withdrawal by Subject|0|||
46649540|NCT01543698|82857099|FG013|Phase 1b|Withdrawal by Subject|0|||
46649541|NCT01543698|82857100|FG014|Phase 1b|Withdrawal by Subject|0|||
46649542|NCT01543698|82857086|FG000|Phase 1b|Adverse Event|1|||
46649543|NCT01543698|82857087|FG001|Phase 1b|Adverse Event|0|||
46649544|NCT01543698|82857088|FG002|Phase 1b|Adverse Event|0|||
46649545|NCT01543698|82857089|FG003|Phase 1b|Adverse Event|1|||
46649546|NCT01543698|82857090|FG004|Phase 1b|Adverse Event|2|||
46649547|NCT01543698|82857091|FG005|Phase 1b|Adverse Event|2|||
46649548|NCT01543698|82857092|FG006|Phase 1b|Adverse Event|0|||
46649549|NCT01543698|82857093|FG007|Phase 1b|Adverse Event|0|||
46649550|NCT01543698|82857094|FG008|Phase 1b|Adverse Event|1|||
46649551|NCT01543698|82857095|FG009|Phase 1b|Adverse Event|1|||
46649552|NCT01543698|82857096|FG010|Phase 1b|Adverse Event|2|||
46649553|NCT01543698|82857097|FG011|Phase 1b|Adverse Event|0|||
46649554|NCT01543698|82857098|FG012|Phase 1b|Adverse Event|0|||
46649555|NCT01543698|82857099|FG013|Phase 1b|Adverse Event|0|||
46649556|NCT01543698|82857100|FG014|Phase 1b|Adverse Event|0|||
46649557|NCT01543698|82857086|FG000|Phase 1b|Administrative problems|1|||
46649558|NCT01543698|82857087|FG001|Phase 1b|Administrative problems|0|||
46649559|NCT01543698|82857088|FG002|Phase 1b|Administrative problems|0|||
46649560|NCT01543698|82857089|FG003|Phase 1b|Administrative problems|0|||
46649561|NCT01543698|82857090|FG004|Phase 1b|Administrative problems|1|||
46649562|NCT01543698|82857091|FG005|Phase 1b|Administrative problems|0|||
46649563|NCT01543698|82857092|FG006|Phase 1b|Administrative problems|0|||
46649564|NCT01543698|82857093|FG007|Phase 1b|Administrative problems|1|||
46649565|NCT01543698|82857094|FG008|Phase 1b|Administrative problems|0|||
46649566|NCT01543698|82857095|FG009|Phase 1b|Administrative problems|0|||
46649567|NCT01543698|82857096|FG010|Phase 1b|Administrative problems|2|||
46649568|NCT01543698|82857097|FG011|Phase 1b|Administrative problems|0|||
46649569|NCT01543698|82857098|FG012|Phase 1b|Administrative problems|0|||
46649570|NCT01543698|82857099|FG013|Phase 1b|Administrative problems|0|||
46649571|NCT01543698|82857100|FG014|Phase 1b|Administrative problems|0|||
46649572|NCT01543698|82857086|FG000|Phase 1b|Protocol Violation|2|||
46649573|NCT01543698|82857087|FG001|Phase 1b|Protocol Violation|0|||
46649574|NCT01543698|82857088|FG002|Phase 1b|Protocol Violation|0|||
46780564|NCT00644787|82999317|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
46780565|NCT00644787|82999318|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
46780566|NCT00644787|82999319|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
46780567|NCT00644787|82999317|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
46780568|NCT00644787|82999318|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
46780569|NCT00644787|82999319|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
46780570|NCT00699582|82999330|FG000|Overall Study|Adverse Event|4|||
46780571|NCT00699582|82999331|FG001|Overall Study|Adverse Event|11|||
46780572|NCT00699582|82999332|FG002|Overall Study|Adverse Event|23|||
46780573|NCT00699582|82999330|FG000|Overall Study|Withdrawal by Subject|6|||
46780574|NCT00699582|82999331|FG001|Overall Study|Withdrawal by Subject|7|||
46780575|NCT00699582|82999332|FG002|Overall Study|Withdrawal by Subject|4|||
47075166|NCT00631007|83368648|FG001|Overall Study|Persistent Hyperglycemia|2|||
46780576|NCT00699582|82999330|FG000|Overall Study|Lack of Efficacy|1|||
46780577|NCT00699582|82999331|FG001|Overall Study|Lack of Efficacy|0|||
47075167|NCT00631007|83368649|FG002|Overall Study|Persistent Hyperglycemia|5|||
46780578|NCT00699582|82999332|FG002|Overall Study|Lack of Efficacy|1|||
46649575|NCT01543698|82857089|FG003|Phase 1b|Protocol Violation|0|||
46649576|NCT01543698|82857090|FG004|Phase 1b|Protocol Violation|0|||
46649577|NCT01543698|82857091|FG005|Phase 1b|Protocol Violation|0|||
46649578|NCT01543698|82857092|FG006|Phase 1b|Protocol Violation|0|||
46649579|NCT01543698|82857093|FG007|Phase 1b|Protocol Violation|0|||
46649580|NCT01543698|82857094|FG008|Phase 1b|Protocol Violation|0|||
46649581|NCT01543698|82857095|FG009|Phase 1b|Protocol Violation|0|||
46649582|NCT01543698|82857096|FG010|Phase 1b|Protocol Violation|0|||
46649583|NCT01543698|82857097|FG011|Phase 1b|Protocol Violation|0|||
46649584|NCT01543698|82857098|FG012|Phase 1b|Protocol Violation|0|||
46649585|NCT01543698|82857099|FG013|Phase 1b|Protocol Violation|0|||
46649586|NCT01543698|82857100|FG014|Phase 1b|Protocol Violation|0|||
46649587|NCT01543698|82857086|FG000|Phase 2|Protocol Violation|0|||
46780579|NCT00699582|82999330|FG000|Overall Study|Progressive Disease|1|||
46780580|NCT00699582|82999331|FG001|Overall Study|Progressive Disease|0|||
46780581|NCT00699582|82999332|FG002|Overall Study|Progressive Disease|0|||
46780582|NCT00699582|82999330|FG000|Overall Study|Administrative/Other|4|||
46780583|NCT00699582|82999331|FG001|Overall Study|Administrative/Other|3|||
46780584|NCT00699582|82999332|FG002|Overall Study|Administrative/Other|0|||
46780585|NCT00699582|82999330|FG000|Overall Study|Randomized, Not Treated|2|||
46780586|NCT00699582|82999331|FG001|Overall Study|Randomized, Not Treated|1|||
46780587|NCT00699582|82999332|FG002|Overall Study|Randomized, Not Treated|0|||
46780588|NCT00640341|82999343|FG000|Overall Study|Adverse Event|0|||
46780589|NCT00640341|82999344|FG001|Overall Study|Adverse Event|0|||
46780590|NCT00640341|82999345|FG002|Overall Study|Adverse Event|1|||
46780591|NCT00640341|82999343|FG000|Overall Study|Positive Slit Lamp Findings|0|||
46780592|NCT00640341|82999344|FG001|Overall Study|Positive Slit Lamp Findings|0|||
46780593|NCT00640341|82999345|FG002|Overall Study|Positive Slit Lamp Findings|1|||
46780594|NCT00640341|82999343|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
46780595|NCT00640341|82999344|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
46780596|NCT00640341|82999345|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
46780597|NCT00640341|82999343|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
46780598|NCT00640341|82999344|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
46780599|NCT00640341|82999345|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
46780600|NCT00640341|82999343|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
46780601|NCT00640341|82999344|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
46780602|NCT00640341|82999345|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
46780603|NCT00640341|82999343|FG000|Overall Study|Lost to Follow-up|2|||
46780604|NCT00640341|82999344|FG001|Overall Study|Lost to Follow-up|0|||
46780605|NCT00640341|82999345|FG002|Overall Study|Lost to Follow-up|0|||
46780606|NCT00640341|82999343|FG000|Overall Study|Withdrawal by Subject|4|||
46780607|NCT00640341|82999344|FG001|Overall Study|Withdrawal by Subject|0|||
46780608|NCT00640341|82999345|FG002|Overall Study|Withdrawal by Subject|1|||
46780609|NCT00640341|82999343|FG000|Overall Study|Unacceptable Lens Movement|1|||
46780610|NCT00640341|82999344|FG001|Overall Study|Unacceptable Lens Movement|0|||
46780611|NCT00640341|82999345|FG002|Overall Study|Unacceptable Lens Movement|0|||
46780612|NCT00640341|82999343|FG000|Overall Study|Poor fit/Uncomfortable|4|||
46780613|NCT00640341|82999344|FG001|Overall Study|Poor fit/Uncomfortable|0|||
46780614|NCT00640341|82999345|FG002|Overall Study|Poor fit/Uncomfortable|0|||
46780615|NCT00640341|82999343|FG000|Overall Study|Ineligable at Baseline|5|||
46780616|NCT00640341|82999344|FG001|Overall Study|Ineligable at Baseline|3|||
46780617|NCT00640341|82999345|FG002|Overall Study|Ineligable at Baseline|2|||
46780618|NCT00640341|82999343|FG000|Overall Study|Adverse event and positive slit lamp|1|||
46780619|NCT00640341|82999344|FG001|Overall Study|Adverse event and positive slit lamp|0|||
46780620|NCT00640341|82999345|FG002|Overall Study|Adverse event and positive slit lamp|0|||
46780621|NCT00699348|82999353|FG000|Overall Study|Death|6|||
46780622|NCT00699348|82999353|FG000|Overall Study|Adverse Event|15|||
46780623|NCT00699348|82999353|FG000|Overall Study|Withdrawal by Subject|11|||
46780624|NCT00699348|82999353|FG000|Overall Study|Protocol Violation|10|||
46780625|NCT00699348|82999353|FG000|Overall Study|Lack of Efficacy|8|||
46780626|NCT00699348|82999353|FG000|Overall Study|Failure to return|1|||
47075168|NCT00631007|83368650|FG003|Overall Study|Persistent Hyperglycemia|1|||
46780627|NCT00699348|82999353|FG000|Overall Study|Blood transfusion|24|||
46780628|NCT00699348|82999353|FG000|Overall Study|Renal transplantation|10|||
46780629|NCT00699348|82999353|FG000|Overall Study|Other|5|||
46780630|NCT00643851|82999360|FG000|Overall Study|Death|0|||
46780631|NCT00643851|82999361|FG001|Overall Study|Death|1|||
47075169|NCT00631007|83368651|FG004|Overall Study|Persistent Hyperglycemia|2|||
47075170|NCT00631007|83368652|FG005|Overall Study|Persistent Hyperglycemia|5|||
47075171|NCT00631007|83368647|FG000|Overall Study|Withdrawal by Subject|4|||
47075172|NCT00631007|83368648|FG001|Overall Study|Withdrawal by Subject|5|||
46649588|NCT01543698|82857087|FG001|Phase 2|Protocol Violation|0|||
46649589|NCT01543698|82857088|FG002|Phase 2|Protocol Violation|0|||
46780632|NCT00643851|82999362|FG002|Overall Study|Death|0|||
46850673|NCT00112359|83066453|FG000|Overall Study|Unrelated adverse event|16|||
46649590|NCT01543698|82857089|FG003|Phase 2|Protocol Violation|0|||
46780633|NCT00643851|82999360|FG000|Overall Study|Lack of Efficacy|0|||
46780634|NCT00643851|82999361|FG001|Overall Study|Lack of Efficacy|1|||
46780635|NCT00643851|82999362|FG002|Overall Study|Lack of Efficacy|0|||
46780636|NCT00643851|82999360|FG000|Overall Study|Adverse Event|2|||
46850674|NCT00112359|83066454|FG001|Overall Study|Unrelated adverse event|8|||
46780637|NCT00643851|82999361|FG001|Overall Study|Adverse Event|6|||
46780638|NCT00643851|82999362|FG002|Overall Study|Adverse Event|6|||
46780639|NCT00643851|82999360|FG000|Overall Study|Lost to Follow-up|4|||
46780640|NCT00643851|82999361|FG001|Overall Study|Lost to Follow-up|6|||
46780641|NCT00643851|82999362|FG002|Overall Study|Lost to Follow-up|9|||
46649591|NCT01543698|82857090|FG004|Phase 2|Protocol Violation|0|||
46649592|NCT01543698|82857091|FG005|Phase 2|Protocol Violation|0|||
46649593|NCT01543698|82857092|FG006|Phase 2|Protocol Violation|0|||
46649594|NCT01543698|82857093|FG007|Phase 2|Protocol Violation|0|||
46649595|NCT01543698|82857094|FG008|Phase 2|Protocol Violation|0|||
46649596|NCT01543698|82857095|FG009|Phase 2|Protocol Violation|0|||
46649597|NCT01543698|82857096|FG010|Phase 2|Protocol Violation|0|||
46649598|NCT01543698|82857097|FG011|Phase 2|Protocol Violation|0|||
46649599|NCT01543698|82857098|FG012|Phase 2|Protocol Violation|1|||
46649600|NCT01543698|82857099|FG013|Phase 2|Protocol Violation|0|||
46649601|NCT01543698|82857100|FG014|Phase 2|Protocol Violation|0|||
46649602|NCT01543698|82857086|FG000|Phase 2|Disease progression|0|||
46649603|NCT01543698|82857087|FG001|Phase 2|Disease progression|0|||
46649604|NCT01543698|82857088|FG002|Phase 2|Disease progression|0|||
46649605|NCT01543698|82857089|FG003|Phase 2|Disease progression|0|||
46649606|NCT01543698|82857090|FG004|Phase 2|Disease progression|0|||
46649607|NCT01543698|82857091|FG005|Phase 2|Disease progression|0|||
46649608|NCT01543698|82857092|FG006|Phase 2|Disease progression|0|||
46649609|NCT01543698|82857093|FG007|Phase 2|Disease progression|0|||
46649610|NCT01543698|82857094|FG008|Phase 2|Disease progression|0|||
46780642|NCT00643851|82999360|FG000|Overall Study|Withdrawal by Subject|8|||
46649611|NCT01543698|82857095|FG009|Phase 2|Disease progression|0|||
46780643|NCT00643851|82999361|FG001|Overall Study|Withdrawal by Subject|15|||
46780644|NCT00643851|82999362|FG002|Overall Study|Withdrawal by Subject|9|||
46649612|NCT01543698|82857096|FG010|Phase 2|Disease progression|0|||
46649613|NCT01543698|82857097|FG011|Phase 2|Disease progression|10|||
46649614|NCT01543698|82857098|FG012|Phase 2|Disease progression|21|||
46649615|NCT01543698|82857099|FG013|Phase 2|Disease progression|30|||
46649616|NCT01543698|82857100|FG014|Phase 2|Disease progression|25|||
46649617|NCT01543698|82857086|FG000|Phase 2|Death|0|||
46649618|NCT01543698|82857087|FG001|Phase 2|Death|0|||
46649619|NCT01543698|82857088|FG002|Phase 2|Death|0|||
46649620|NCT01543698|82857089|FG003|Phase 2|Death|0|||
46649621|NCT01543698|82857090|FG004|Phase 2|Death|0|||
46649622|NCT01543698|82857091|FG005|Phase 2|Death|0|||
46780645|NCT00643851|82999360|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
46780646|NCT00643851|82999361|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
46780647|NCT00643851|82999362|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
46780648|NCT03667690|82999372|FG000|Overall Study|Adverse Event|0|||
46780649|NCT03667690|82999373|FG001|Overall Study|Adverse Event|3|||
46780650|NCT03667690|82999372|FG000|Overall Study|Death|22|||
46780651|NCT03667690|82999373|FG001|Overall Study|Death|21|||
46780652|NCT03667690|82999372|FG000|Overall Study|Lost to Follow-up|4|||
46780653|NCT03667690|82999373|FG001|Overall Study|Lost to Follow-up|5|||
46780654|NCT03667690|82999372|FG000|Overall Study|Withdrawal by Subject|7|||
46780655|NCT03667690|82999373|FG001|Overall Study|Withdrawal by Subject|8|||
46780656|NCT03667690|82999372|FG000|Overall Study|Subject could not return for additional investigational product|1|||
46780657|NCT03667690|82999373|FG001|Overall Study|Subject could not return for additional investigational product|0|||
46780658|NCT03667690|82999372|FG000|Overall Study|Subject discharged to hospice care|2|||
46780659|NCT03667690|82999373|FG001|Overall Study|Subject discharged to hospice care|0|||
46780660|NCT03667690|82999372|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
46780661|NCT03667690|82999373|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
46780662|NCT03667690|82999372|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
46780663|NCT03667690|82999373|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
46780664|NCT03667690|82999372|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
46780665|NCT03667690|82999373|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
46780666|NCT03667690|82999372|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
46780667|NCT03667690|82999373|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
46780668|NCT03667690|82999372|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
46780669|NCT03667690|82999373|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
46780670|NCT00627393|82999381|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
46780671|NCT00627393|82999382|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
46780672|NCT00627393|82999381|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
46780673|NCT00627393|82999382|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
46780674|NCT00627393|82999381|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
46780675|NCT00627393|82999382|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
46780676|NCT00627393|82999381|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
46780677|NCT00627393|82999382|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
46780678|NCT00696774|82999393|FG000|Period II|Adverse Event|0|||
46780679|NCT00696774|82999394|FG001|Period II|Adverse Event|0|||
46780680|NCT00696774|82999395|FG002|Period II|Adverse Event|15|||
46780681|NCT00696774|82999393|FG000|Period II|Lost to Follow-up|0|||
46780682|NCT00696774|82999394|FG001|Period II|Lost to Follow-up|0|||
46780683|NCT00696774|82999395|FG002|Period II|Lost to Follow-up|4|||
46780684|NCT00696774|82999393|FG000|Period II|Protocol Violation|0|||
46780685|NCT00696774|82999394|FG001|Period II|Protocol Violation|0|||
46780686|NCT00696774|82999395|FG002|Period II|Protocol Violation|11|||
46780687|NCT00696774|82999393|FG000|Period II|Withdrawal by Subject|0|||
46780688|NCT00696774|82999394|FG001|Period II|Withdrawal by Subject|0|||
46780689|NCT00696774|82999395|FG002|Period II|Withdrawal by Subject|4|||
46780690|NCT00696774|82999393|FG000|Period II|Sponsor Decision|0|||
46780691|NCT00696774|82999394|FG001|Period II|Sponsor Decision|0|||
46780692|NCT00696774|82999395|FG002|Period II|Sponsor Decision|0|||
46780693|NCT00696774|82999393|FG000|Period II|Lack of Efficacy|0|||
46780694|NCT00696774|82999394|FG001|Period II|Lack of Efficacy|0|||
46850675|NCT00112359|83066453|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
46850676|NCT00112359|83066454|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
46780695|NCT00696774|82999395|FG002|Period II|Lack of Efficacy|2|||
46780696|NCT00696774|82999393|FG000|Period III|Adverse Event|1|||
46780697|NCT00696774|82999394|FG001|Period III|Adverse Event|1|||
46780698|NCT00696774|82999395|FG002|Period III|Adverse Event|0|||
46649623|NCT01543698|82857092|FG006|Phase 2|Death|0|||
46780699|NCT00696774|82999393|FG000|Period III|Lost to Follow-up|2|||
46780700|NCT00696774|82999394|FG001|Period III|Lost to Follow-up|1|||
46850677|NCT00112359|83066453|FG000|Overall Study|Related adverse event|5|||
46780701|NCT00696774|82999395|FG002|Period III|Lost to Follow-up|0|||
46780702|NCT00696774|82999393|FG000|Period III|Protocol Violation|1|||
46780703|NCT00696774|82999394|FG001|Period III|Protocol Violation|1|||
46850678|NCT00112359|83066454|FG001|Overall Study|Related adverse event|3|||
46649624|NCT01543698|82857093|FG007|Phase 2|Death|0|||
46649625|NCT01543698|82857094|FG008|Phase 2|Death|0|||
46649626|NCT01543698|82857095|FG009|Phase 2|Death|0|||
46649627|NCT01543698|82857096|FG010|Phase 2|Death|0|||
46649628|NCT01543698|82857097|FG011|Phase 2|Death|0|||
46649629|NCT01543698|82857098|FG012|Phase 2|Death|1|||
46649630|NCT01543698|82857099|FG013|Phase 2|Death|1|||
46649631|NCT01543698|82857100|FG014|Phase 2|Death|1|||
46649632|NCT01543698|82857086|FG000|Phase 2|Administrative problems|0|||
46649633|NCT01543698|82857087|FG001|Phase 2|Administrative problems|0|||
46649634|NCT01543698|82857088|FG002|Phase 2|Administrative problems|0|||
46649635|NCT01543698|82857089|FG003|Phase 2|Administrative problems|0|||
46649636|NCT01543698|82857090|FG004|Phase 2|Administrative problems|0|||
46649637|NCT01543698|82857091|FG005|Phase 2|Administrative problems|0|||
46649638|NCT01543698|82857092|FG006|Phase 2|Administrative problems|0|||
46649639|NCT01543698|82857093|FG007|Phase 2|Administrative problems|0|||
46649640|NCT01543698|82857094|FG008|Phase 2|Administrative problems|0|||
46649641|NCT01543698|82857095|FG009|Phase 2|Administrative problems|0|||
46649642|NCT01543698|82857096|FG010|Phase 2|Administrative problems|0|||
46649643|NCT01543698|82857097|FG011|Phase 2|Administrative problems|0|||
46649644|NCT01543698|82857098|FG012|Phase 2|Administrative problems|0|||
46649645|NCT01543698|82857099|FG013|Phase 2|Administrative problems|3|||
46649646|NCT01543698|82857100|FG014|Phase 2|Administrative problems|1|||
46649647|NCT01543698|82857086|FG000|Phase 2|Withdrawal by Subject|0|||
46649648|NCT01543698|82857087|FG001|Phase 2|Withdrawal by Subject|0|||
46649649|NCT01543698|82857088|FG002|Phase 2|Withdrawal by Subject|0|||
46649650|NCT01543698|82857089|FG003|Phase 2|Withdrawal by Subject|0|||
46649651|NCT01543698|82857090|FG004|Phase 2|Withdrawal by Subject|0|||
46649652|NCT01543698|82857091|FG005|Phase 2|Withdrawal by Subject|0|||
46649653|NCT01543698|82857092|FG006|Phase 2|Withdrawal by Subject|0|||
46649654|NCT01543698|82857093|FG007|Phase 2|Withdrawal by Subject|0|||
46649655|NCT01543698|82857094|FG008|Phase 2|Withdrawal by Subject|0|||
46649656|NCT01543698|82857095|FG009|Phase 2|Withdrawal by Subject|0|||
46649657|NCT01543698|82857096|FG010|Phase 2|Withdrawal by Subject|0|||
46649658|NCT01543698|82857097|FG011|Phase 2|Withdrawal by Subject|0|||
46649659|NCT01543698|82857098|FG012|Phase 2|Withdrawal by Subject|0|||
46649660|NCT01543698|82857099|FG013|Phase 2|Withdrawal by Subject|3|||
46649661|NCT01543698|82857100|FG014|Phase 2|Withdrawal by Subject|1|||
46649662|NCT01543698|82857086|FG000|Phase 2|Adverse Event|0|||
46649663|NCT01543698|82857087|FG001|Phase 2|Adverse Event|0|||
46649664|NCT01543698|82857088|FG002|Phase 2|Adverse Event|0|||
46649665|NCT01543698|82857089|FG003|Phase 2|Adverse Event|0|||
46649666|NCT01543698|82857090|FG004|Phase 2|Adverse Event|0|||
46649667|NCT01543698|82857091|FG005|Phase 2|Adverse Event|0|||
46649668|NCT01543698|82857092|FG006|Phase 2|Adverse Event|0|||
46649669|NCT01543698|82857093|FG007|Phase 2|Adverse Event|0|||
46649670|NCT01543698|82857094|FG008|Phase 2|Adverse Event|0|||
46649671|NCT01543698|82857095|FG009|Phase 2|Adverse Event|0|||
46649672|NCT01543698|82857096|FG010|Phase 2|Adverse Event|0|||
46649673|NCT01543698|82857097|FG011|Phase 2|Adverse Event|1|||
46649674|NCT01543698|82857098|FG012|Phase 2|Adverse Event|3|||
46649675|NCT01543698|82857099|FG013|Phase 2|Adverse Event|5|||
46649676|NCT01543698|82857100|FG014|Phase 2|Adverse Event|14|||
46649677|NCT00537914|82857234|FG000|Overall Study|Death|1|||
46649678|NCT00537914|82857234|FG000|Overall Study|Adverse Event|7|||
46649679|NCT00537914|82857234|FG000|Overall Study|Treatment failure|10|||
46649680|NCT00537914|82857234|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
46649681|NCT00537914|82857234|FG000|Overall Study|Lost to Follow-up|19|||
46649682|NCT00537914|82857234|FG000|Overall Study|Withdrawal of informed consent|59|||
46649683|NCT01595009|82857240|FG000|Core|Patients completed per protocol|85|||
46649684|NCT01595009|82857241|FG001|Core|Patients completed per protocol|44|||
46649685|NCT01595009|82857242|FG002|Core|Patients completed per protocol|0|||
46649686|NCT01595009|82857243|FG003|Core|Patients completed per protocol|0|||
46649687|NCT01595009|82857240|FG000|Core|Adverse Event|19|||
46970631|NCT02701361|83213880|FG000|Overall Study|Withdrawal by Subject|4|||
46649688|NCT01595009|82857241|FG001|Core|Adverse Event|23|||
46649689|NCT01595009|82857242|FG002|Core|Adverse Event|0|||
46649690|NCT01595009|82857243|FG003|Core|Adverse Event|0|||
46649691|NCT01595009|82857240|FG000|Core|Disease progression|14|||
46649692|NCT01595009|82857241|FG001|Core|Disease progression|26|||
46649693|NCT01595009|82857242|FG002|Core|Disease progression|0|||
46649694|NCT01595009|82857243|FG003|Core|Disease progression|0|||
46970632|NCT02701361|83213881|FG001|Overall Study|Withdrawal by Subject|0|||
46970633|NCT02701361|83213882|FG002|Overall Study|Withdrawal by Subject|0|||
46649695|NCT01595009|82857240|FG000|Core|Withdrawal by Subject|4|||
46649696|NCT01595009|82857241|FG001|Core|Withdrawal by Subject|17|||
46649697|NCT01595009|82857242|FG002|Core|Withdrawal by Subject|0|||
46649698|NCT01595009|82857243|FG003|Core|Withdrawal by Subject|0|||
46649699|NCT01595009|82857240|FG000|Core|Death|3|||
46649700|NCT01595009|82857241|FG001|Core|Death|6|||
46649701|NCT01595009|82857242|FG002|Core|Death|0|||
46649702|NCT01595009|82857243|FG003|Core|Death|0|||
46649703|NCT01595009|82857240|FG000|Core|Lost to Follow-up|1|||
46649704|NCT01595009|82857241|FG001|Core|Lost to Follow-up|2|||
46649705|NCT01595009|82857242|FG002|Core|Lost to Follow-up|0|||
46649706|NCT01595009|82857243|FG003|Core|Lost to Follow-up|0|||
46649707|NCT01595009|82857240|FG000|Core|Protocol deviation|0|||
46649708|NCT01595009|82857241|FG001|Core|Protocol deviation|1|||
46649709|NCT01595009|82857242|FG002|Core|Protocol deviation|0|||
46649710|NCT01595009|82857243|FG003|Core|Protocol deviation|0|||
46649711|NCT01595009|82857240|FG000|Core|Administrative problems|0|||
46649712|NCT01595009|82857241|FG001|Core|Administrative problems|1|||
46649713|NCT01595009|82857242|FG002|Core|Administrative problems|0|||
46649714|NCT01595009|82857243|FG003|Core|Administrative problems|0|||
46649715|NCT01595009|82857240|FG000|Extension|Administrative problems|0|||
46649716|NCT01595009|82857241|FG001|Extension|Administrative problems|0|||
46649717|NCT01595009|82857242|FG002|Extension|Administrative problems|0|||
46649718|NCT01595009|82857243|FG003|Extension|Administrative problems|1|||
46649719|NCT01595009|82857240|FG000|Extension|Patients completed per protocol|0|||
46649720|NCT01595009|82857241|FG001|Extension|Patients completed per protocol|0|||
46649721|NCT01595009|82857242|FG002|Extension|Patients completed per protocol|0|||
46649722|NCT01595009|82857243|FG003|Extension|Patients completed per protocol|2|||
46649723|NCT01595009|82857240|FG000|Extension|Disease progression|0|||
46649724|NCT01595009|82857241|FG001|Extension|Disease progression|0|||
46649725|NCT01595009|82857242|FG002|Extension|Disease progression|4|||
46649726|NCT01595009|82857243|FG003|Extension|Disease progression|7|||
46649727|NCT01595009|82857240|FG000|Extension|Adverse Event|0|||
46649728|NCT01595009|82857241|FG001|Extension|Adverse Event|0|||
46649729|NCT01595009|82857242|FG002|Extension|Adverse Event|0|||
46649730|NCT01595009|82857243|FG003|Extension|Adverse Event|1|||
46649731|NCT05553808|82857260|FG000|Overall Study|Death|25|||
46649732|NCT05553808|82857261|FG001|Overall Study|Death|62|||
46649733|NCT05553808|82857260|FG000|Overall Study|Site Closed|6|||
46649734|NCT05553808|82857261|FG001|Overall Study|Site Closed|6|||
46649735|NCT05553808|82857260|FG000|Overall Study|Lost to Follow-up|1|||
46649736|NCT05553808|82857261|FG001|Overall Study|Lost to Follow-up|0|||
46649737|NCT05553808|82857260|FG000|Overall Study|Withdrawal by Subject|3|||
46649738|NCT05553808|82857261|FG001|Overall Study|Withdrawal by Subject|2|||
46649739|NCT04997161|82857277|FG000|Overall Study|Study terminated by sponsor|3|||
46649740|NCT04753216|82857281|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
46649741|NCT04753216|82857281|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
46649742|NCT04753216|82857281|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
46649743|NCT04530747|82857314|FG000|Overall Study|Withdrawal by Subject|1|||
46649744|NCT04530747|82857315|FG001|Overall Study|Withdrawal by Subject|0|||
46649745|NCT04040751|82857336|FG000|Overall Study|Withdrawal by Subject|2|||
46649746|NCT04040751|82857337|FG001|Overall Study|Withdrawal by Subject|0|||
46649747|NCT04040751|82857338|FG002|Overall Study|Withdrawal by Subject|2|||
46780704|NCT00696774|82999395|FG002|Period III|Protocol Violation|0|||
46780705|NCT00696774|82999393|FG000|Period III|Withdrawal by Subject|1|||
46780706|NCT00696774|82999394|FG001|Period III|Withdrawal by Subject|2|||
46780707|NCT00696774|82999395|FG002|Period III|Withdrawal by Subject|0|||
46780708|NCT00696774|82999393|FG000|Period III|Sponsor Decision|2|||
46780709|NCT00696774|82999394|FG001|Period III|Sponsor Decision|0|||
46780710|NCT00696774|82999395|FG002|Period III|Sponsor Decision|0|||
46780711|NCT00696774|82999393|FG000|Period III|Lack of Efficacy|0|||
46780712|NCT00696774|82999394|FG001|Period III|Lack of Efficacy|2|||
46780713|NCT00696774|82999395|FG002|Period III|Lack of Efficacy|0|||
46780714|NCT00608842|82999407|FG000|Overall Study|Participant's Request|0|||
46780715|NCT00608842|82999408|FG001|Overall Study|Participant's Request|1|||
46780716|NCT00608842|82999409|FG002|Overall Study|Participant's Request|2|||
46780717|NCT00608842|82999410|FG003|Overall Study|Participant's Request|1|||
46850679|NCT00112359|83066453|FG000|Overall Study|Lost to Follow-up|0|||
47075173|NCT00631007|83368649|FG002|Overall Study|Withdrawal by Subject|2|||
47075174|NCT00631007|83368650|FG003|Overall Study|Withdrawal by Subject|2|||
47075175|NCT00631007|83368651|FG004|Overall Study|Withdrawal by Subject|1|||
47075176|NCT00631007|83368652|FG005|Overall Study|Withdrawal by Subject|3|||
47075177|NCT00631007|83368647|FG000|Overall Study|Other|2|||
47075178|NCT00631007|83368648|FG001|Overall Study|Other|1|||
47075179|NCT00631007|83368649|FG002|Overall Study|Other|0|||
46649748|NCT04040751|82857339|FG003|Overall Study|Withdrawal by Subject|0|||
46649749|NCT03997916|82857349|FG000|Overall Study|Protocol Violation|35|||
46649750|NCT03596177|82857368|FG000|Single Blind Period|Withdrawal by Subject|1|||
46649751|NCT03596177|82857369|FG001|Single Blind Period|Withdrawal by Subject|1|||
46649752|NCT03596177|82857368|FG000|Single Blind Period|Other|1|||
46649753|NCT03596177|82857369|FG001|Single Blind Period|Other|0|||
46649754|NCT03596177|82857368|FG000|Double Blind Period|Withdrawal by Subject|0|||
46649755|NCT03596177|82857369|FG001|Double Blind Period|Withdrawal by Subject|1|||
46649756|NCT03596177|82857368|FG000|Double Blind Period|Other|0|||
46649757|NCT03596177|82857369|FG001|Double Blind Period|Other|4|||
46649758|NCT03596177|82857368|FG000|Double Blind Period|Death during safety follow-up|0|||
46649759|NCT03596177|82857369|FG001|Double Blind Period|Death during safety follow-up|1|||
46649760|NCT03579459|82857379|FG000|Overall Study|Adverse Event|7|||
46649761|NCT03579459|82857380|FG001|Overall Study|Adverse Event|6|||
46649762|NCT03579459|82857381|FG002|Overall Study|Adverse Event|2|||
46780718|NCT00608842|82999407|FG000|Overall Study|Lost to Follow-up|1|||
46780719|NCT00608842|82999408|FG001|Overall Study|Lost to Follow-up|0|||
46780720|NCT00608842|82999409|FG002|Overall Study|Lost to Follow-up|0|||
46780721|NCT00608842|82999410|FG003|Overall Study|Lost to Follow-up|0|||
46780722|NCT00626925|82999422|FG000|Overall Study|Lost to Follow-up|1|||
46780723|NCT00626925|82999423|FG001|Overall Study|Lost to Follow-up|2|||
46780724|NCT00626925|82999422|FG000|Overall Study|relapse|1|||
46780725|NCT00626925|82999423|FG001|Overall Study|relapse|0|||
46780726|NCT00626925|82999422|FG000|Overall Study|Adverse effect|6|||
46780727|NCT00626925|82999423|FG001|Overall Study|Adverse effect|2|||
46780728|NCT00626925|82999422|FG000|Overall Study|Lack of Efficacy|1|||
46780729|NCT00626925|82999423|FG001|Overall Study|Lack of Efficacy|4|||
46780730|NCT00626925|82999422|FG000|Overall Study|Time constraints|3|||
46780731|NCT00626925|82999423|FG001|Overall Study|Time constraints|1|||
46780732|NCT00698646|82999446|FG000|Overall Study|Adverse Event|8|||
46780733|NCT00698646|82999447|FG001|Overall Study|Adverse Event|7|||
46780734|NCT00698646|82999448|FG002|Overall Study|Adverse Event|8|||
46780735|NCT00698646|82999446|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
46780736|NCT00698646|82999447|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
46780737|NCT00698646|82999448|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
46780738|NCT00698646|82999446|FG000|Overall Study|Protocol Deviation|6|||
46780739|NCT00698646|82999447|FG001|Overall Study|Protocol Deviation|2|||
46780740|NCT00698646|82999448|FG002|Overall Study|Protocol Deviation|3|||
46780741|NCT00698646|82999446|FG000|Overall Study|Withdrawal by Subject|10|||
46780742|NCT00698646|82999447|FG001|Overall Study|Withdrawal by Subject|11|||
46780743|NCT00698646|82999448|FG002|Overall Study|Withdrawal by Subject|8|||
46780744|NCT00698646|82999446|FG000|Overall Study|Lost to Follow-up|0|||
46780745|NCT00698646|82999447|FG001|Overall Study|Lost to Follow-up|0|||
46780746|NCT00698646|82999448|FG002|Overall Study|Lost to Follow-up|2|||
46780747|NCT00698646|82999446|FG000|Overall Study|Administrative problems|1|||
46780748|NCT00698646|82999447|FG001|Overall Study|Administrative problems|0|||
46780749|NCT00698646|82999448|FG002|Overall Study|Administrative problems|1|||
46780750|NCT00609466|82999459|FG000|Overall Study|Withdrawal by Subject|0|||
46780751|NCT00609466|82999460|FG001|Overall Study|Withdrawal by Subject|1|||
46780752|NCT00609466|82999461|FG002|Overall Study|Withdrawal by Subject|1|||
46780753|NCT00609466|82999459|FG000|Overall Study|Adverse Event|2|||
46780754|NCT00609466|82999460|FG001|Overall Study|Adverse Event|3|||
46780755|NCT00609466|82999461|FG002|Overall Study|Adverse Event|1|||
46850680|NCT00112359|83066454|FG001|Overall Study|Lost to Follow-up|1|||
46780756|NCT00609466|82999459|FG000|Overall Study|Lack of Efficacy|0|||
46780757|NCT00609466|82999460|FG001|Overall Study|Lack of Efficacy|2|||
46780758|NCT00609466|82999461|FG002|Overall Study|Lack of Efficacy|2|||
46850681|NCT00112359|83066453|FG000|Overall Study|Personal/administrative|1|||
46850682|NCT00112359|83066454|FG001|Overall Study|Personal/administrative|1|||
46850683|NCT00112359|83066453|FG000|Overall Study|Other|3|||
46850684|NCT00112359|83066454|FG001|Overall Study|Other|0|||
46850685|NCT00119379|83066462|FG000|Overall Study|Adverse Event|4|||
46850686|NCT00119379|83066463|FG001|Overall Study|Adverse Event|1|||
46850687|NCT00118911|83066471|FG000|Overall Study|Withdrawal by Subject|2|||
46850688|NCT00118911|83066472|FG001|Overall Study|Withdrawal by Subject|5|||
46850689|NCT00131937|83066478|FG000|Overall Study|Adverse Event|3|||
46850690|NCT00131937|83066478|FG000|Overall Study|Withdrawal by Subject|2|||
46850691|NCT00131937|83066478|FG000|Overall Study|Physician Decision|1|||
46850692|NCT00131937|83066478|FG000|Overall Study|Disease Progression|7|||
46850693|NCT00131937|83066478|FG000|Overall Study|Alternative therapy|1|||
46850694|NCT00131469|83066484|FG000|Overall Study|Withdrawal by Subject|3|||
46850695|NCT00131469|83066485|FG001|Overall Study|Withdrawal by Subject|4|||
46850696|NCT00131469|83066484|FG000|Overall Study|Protocol Violation|3|||
46850697|NCT00131469|83066485|FG001|Overall Study|Protocol Violation|1|||
46850698|NCT00131469|83066484|FG000|Overall Study|Death|0|||
46850699|NCT00131469|83066485|FG001|Overall Study|Death|1|||
46850700|NCT00131469|83066484|FG000|Overall Study|Lost to Follow-up|0|||
46850701|NCT00131469|83066485|FG001|Overall Study|Lost to Follow-up|1|||
46850702|NCT00131469|83066484|FG000|Overall Study|scan not analyzable|3|||
46780759|NCT00608530|82999473|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
46780760|NCT00608530|82999474|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
46780761|NCT00608530|82999475|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
46780762|NCT00608530|82999476|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
46780763|NCT00608530|82999473|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
46850703|NCT00131469|83066485|FG001|Overall Study|scan not analyzable|6|||
46850704|NCT00372593|83066494|FG000|Overall Study|Adverse Event|43|||
46850705|NCT00372593|83066495|FG001|Overall Study|Adverse Event|45|||
46850706|NCT00372593|83066496|FG002|Overall Study|Adverse Event|0|||
46850707|NCT00372593|83066494|FG000|Overall Study|Death|16|||
46850708|NCT00372593|83066495|FG001|Overall Study|Death|20|||
46780764|NCT00608530|82999474|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
46850709|NCT00372593|83066496|FG002|Overall Study|Death|1|||
46850710|NCT00372593|83066494|FG000|Overall Study|Lack of Efficacy|82|||
46850711|NCT00372593|83066495|FG001|Overall Study|Lack of Efficacy|71|||
46850712|NCT00372593|83066496|FG002|Overall Study|Lack of Efficacy|2|||
46780765|NCT00608530|82999475|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
46780766|NCT00608530|82999476|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
46780767|NCT00608530|82999473|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
46780768|NCT00608530|82999474|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
46780769|NCT00608530|82999475|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
46780770|NCT00608530|82999476|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
46780771|NCT00608530|82999473|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
46780772|NCT00608530|82999474|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
46780773|NCT00608530|82999475|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
46780774|NCT00608530|82999476|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
46780775|NCT00608530|82999473|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
46780776|NCT00608530|82999474|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
46780777|NCT00608530|82999475|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
46780778|NCT00608530|82999476|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
46780779|NCT00608530|82999473|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
46780780|NCT00608530|82999474|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
46780781|NCT00608530|82999475|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
46780782|NCT00608530|82999476|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
46780783|NCT00642993|82999493|FG000|Overall Study|Adverse Event|85|||
46780784|NCT00642993|82999494|FG001|Overall Study|Adverse Event|4|||
46780785|NCT00642993|82999493|FG000|Overall Study|Lost to Follow-up|8|||
46780786|NCT00642993|82999494|FG001|Overall Study|Lost to Follow-up|4|||
46780787|NCT00642993|82999493|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
46780788|NCT00642993|82999494|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
46780789|NCT00642993|82999493|FG000|Overall Study|Protocol Violation|1|||
46780790|NCT00642993|82999494|FG001|Overall Study|Protocol Violation|4|||
46780791|NCT00642993|82999493|FG000|Overall Study|Did not meet protocol eligibility|0|||
46780792|NCT00642993|82999494|FG001|Overall Study|Did not meet protocol eligibility|1|||
46780793|NCT00642993|82999493|FG000|Overall Study|Administrative|1|||
46780794|NCT00642993|82999494|FG001|Overall Study|Administrative|0|||
46780795|NCT00696696|82999500|FG000|Overall Study|Adverse Event|5|||
46780796|NCT00696696|82999500|FG000|Overall Study|Withdrawal by Subject|8|||
46780797|NCT00696696|82999500|FG000|Overall Study|Physician Decision|2|||
46780798|NCT00696696|82999500|FG000|Overall Study|Death|3|||
46780799|NCT00699192|82999507|FG000|Overall Study|Missing|1|||
46780800|NCT00699192|82999508|FG001|Overall Study|Missing|1|||
46780801|NCT00699192|82999509|FG002|Overall Study|Missing|1|||
46780802|NCT00699192|82999507|FG000|Overall Study|Adverse Event|9|||
46780803|NCT00699192|82999508|FG001|Overall Study|Adverse Event|4|||
46780804|NCT00699192|82999509|FG002|Overall Study|Adverse Event|3|||
46780805|NCT00699192|82999507|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46780806|NCT00699192|82999508|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46780807|NCT00699192|82999509|FG002|Overall Study|Abnormal test procedure result(s)|1|||
46780808|NCT00699192|82999507|FG000|Overall Study|Lack of Efficacy|0|||
47075180|NCT00631007|83368650|FG003|Overall Study|Other|0|||
47075181|NCT00631007|83368651|FG004|Overall Study|Other|1|||
47075182|NCT00631007|83368652|FG005|Overall Study|Other|0|||
47075183|NCT00630539|83368670|FG000|Overall Study|Adverse Event|1|||
46780809|NCT00699192|82999508|FG001|Overall Study|Lack of Efficacy|0|||
46780810|NCT00699192|82999509|FG002|Overall Study|Lack of Efficacy|1|||
46780811|NCT00699192|82999507|FG000|Overall Study|Withdrawal by Subject|3|||
46780812|NCT00699192|82999508|FG001|Overall Study|Withdrawal by Subject|2|||
46780813|NCT00699192|82999509|FG002|Overall Study|Withdrawal by Subject|4|||
46780814|NCT00699192|82999507|FG000|Overall Study|Administrative problems|1|||
46780815|NCT00699192|82999508|FG001|Overall Study|Administrative problems|3|||
46780816|NCT00699192|82999509|FG002|Overall Study|Administrative problems|1|||
46780817|NCT00699192|82999507|FG000|Overall Study|Protocol Violation|2|||
46780818|NCT00699192|82999508|FG001|Overall Study|Protocol Violation|2|||
46780819|NCT00699192|82999509|FG002|Overall Study|Protocol Violation|0|||
46780820|NCT00401245|82999521|FG000|Double Blind Titration Phase|Adverse Event|3|||
46780821|NCT00401245|82999522|FG001|Double Blind Titration Phase|Adverse Event|2|||
46780822|NCT00401245|82999523|FG002|Double Blind Titration Phase|Adverse Event|5|||
46780823|NCT00401245|82999524|FG003|Double Blind Titration Phase|Adverse Event|12|||
47075184|NCT00630539|83368671|FG001|Overall Study|Adverse Event|3|||
47075185|NCT00630539|83368672|FG002|Overall Study|Adverse Event|1|||
47075186|NCT00630539|83368673|FG003|Overall Study|Adverse Event|2|||
47075187|NCT00630539|83368670|FG000|Overall Study|Withdrawal by Subject|0|||
47075188|NCT00630539|83368671|FG001|Overall Study|Withdrawal by Subject|1|||
46780824|NCT00401245|82999525|FG004|Double Blind Titration Phase|Adverse Event|0|||
46780825|NCT00401245|82999526|FG005|Double Blind Titration Phase|Adverse Event|0|||
46780826|NCT00401245|82999527|FG006|Double Blind Titration Phase|Adverse Event|0|||
47075189|NCT00630539|83368672|FG002|Overall Study|Withdrawal by Subject|0|||
47075190|NCT00630539|83368673|FG003|Overall Study|Withdrawal by Subject|1|||
46850713|NCT00372593|83066494|FG000|Overall Study|Lost to Follow-up|1|||
47075191|NCT00630305|83368751|FG000|Overall Study|Withdrawal by Subject|1|||
47075192|NCT00630305|83368751|FG000|Overall Study|Inability to insert contact lens|1|||
47075193|NCT01926197|83368977|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
46649763|NCT03579459|82857382|FG003|Overall Study|Adverse Event|6|||
46649764|NCT03579459|82857379|FG000|Overall Study|Death|1|||
46649765|NCT03579459|82857380|FG001|Overall Study|Death|0|||
46649766|NCT03579459|82857381|FG002|Overall Study|Death|1|||
46649767|NCT03579459|82857382|FG003|Overall Study|Death|2|||
46649768|NCT03579459|82857379|FG000|Overall Study|Lost to Follow-up|6|||
46649769|NCT03579459|82857380|FG001|Overall Study|Lost to Follow-up|2|||
46649770|NCT03579459|82857381|FG002|Overall Study|Lost to Follow-up|4|||
46649771|NCT03579459|82857382|FG003|Overall Study|Lost to Follow-up|1|||
46649772|NCT03579459|82857379|FG000|Overall Study|Physician Decision|0|||
46649773|NCT03579459|82857380|FG001|Overall Study|Physician Decision|1|||
46649774|NCT03579459|82857381|FG002|Overall Study|Physician Decision|0|||
46649775|NCT03579459|82857382|FG003|Overall Study|Physician Decision|1|||
46649776|NCT03579459|82857379|FG000|Overall Study|Protocol Violation|1|||
46649777|NCT03579459|82857380|FG001|Overall Study|Protocol Violation|2|||
46649778|NCT03579459|82857381|FG002|Overall Study|Protocol Violation|3|||
46649779|NCT03579459|82857382|FG003|Overall Study|Protocol Violation|5|||
46649780|NCT03579459|82857379|FG000|Overall Study|Withdrawal by Subject|12|||
46649781|NCT03579459|82857380|FG001|Overall Study|Withdrawal by Subject|8|||
46649782|NCT03579459|82857381|FG002|Overall Study|Withdrawal by Subject|11|||
46649783|NCT03579459|82857382|FG003|Overall Study|Withdrawal by Subject|8|||
46649784|NCT03579459|82857379|FG000|Overall Study|Medication error without associated adverse event|2|||
46649785|NCT03579459|82857380|FG001|Overall Study|Medication error without associated adverse event|1|||
46649786|NCT03579459|82857381|FG002|Overall Study|Medication error without associated adverse event|1|||
46649787|NCT03579459|82857382|FG003|Overall Study|Medication error without associated adverse event|0|||
46780827|NCT00401245|82999528|FG007|Double Blind Titration Phase|Adverse Event|0|||
46780828|NCT00401245|82999521|FG000|Double Blind Titration Phase|Other|0|||
46780829|NCT00401245|82999522|FG001|Double Blind Titration Phase|Other|0|||
46780830|NCT00401245|82999523|FG002|Double Blind Titration Phase|Other|1|||
46780831|NCT00401245|82999524|FG003|Double Blind Titration Phase|Other|0|||
46780832|NCT00401245|82999525|FG004|Double Blind Titration Phase|Other|0|||
46780833|NCT00401245|82999526|FG005|Double Blind Titration Phase|Other|0|||
46780834|NCT00401245|82999527|FG006|Double Blind Titration Phase|Other|0|||
46780835|NCT00401245|82999528|FG007|Double Blind Titration Phase|Other|0|||
46780836|NCT00401245|82999521|FG000|Double Blind Titration Phase|Protocol Violation|0|||
46780837|NCT00401245|82999522|FG001|Double Blind Titration Phase|Protocol Violation|0|||
46780838|NCT00401245|82999523|FG002|Double Blind Titration Phase|Protocol Violation|0|||
46780839|NCT00401245|82999524|FG003|Double Blind Titration Phase|Protocol Violation|1|||
46780840|NCT00401245|82999525|FG004|Double Blind Titration Phase|Protocol Violation|0|||
46780841|NCT00401245|82999526|FG005|Double Blind Titration Phase|Protocol Violation|0|||
46780842|NCT00401245|82999527|FG006|Double Blind Titration Phase|Protocol Violation|0|||
46780843|NCT00401245|82999528|FG007|Double Blind Titration Phase|Protocol Violation|0|||
46780844|NCT00401245|82999521|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
46780845|NCT00401245|82999522|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
46780846|NCT00401245|82999523|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
46780847|NCT00401245|82999524|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
46780848|NCT00401245|82999525|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
46780849|NCT00401245|82999526|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
46780850|NCT00401245|82999527|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
46780851|NCT00401245|82999528|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
46780852|NCT00401245|82999521|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
46780853|NCT00401245|82999522|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
46780854|NCT00401245|82999523|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
46780855|NCT00401245|82999524|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
46780856|NCT00401245|82999525|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
46850714|NCT00372593|83066495|FG001|Overall Study|Lost to Follow-up|0|||
46649788|NCT03579459|82857379|FG000|Overall Study|Other|0|||
46649789|NCT03579459|82857380|FG001|Overall Study|Other|1|||
46649790|NCT03579459|82857381|FG002|Overall Study|Other|1|||
46649791|NCT03579459|82857382|FG003|Overall Study|Other|0|||
46649792|NCT03579459|82857379|FG000|Overall Study|Randomized not vaccinated|0|||
46780857|NCT00401245|82999526|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
46780858|NCT00401245|82999527|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
46850715|NCT00372593|83066496|FG002|Overall Study|Lost to Follow-up|0|||
46649793|NCT03579459|82857380|FG001|Overall Study|Randomized not vaccinated|2|||
46649794|NCT03579459|82857381|FG002|Overall Study|Randomized not vaccinated|0|||
46649795|NCT03579459|82857382|FG003|Overall Study|Randomized not vaccinated|1|||
46649796|NCT04449276|82857409|FG000|Overall Study|Adverse Event|1|||
46649797|NCT04449276|82857410|FG001|Overall Study|Adverse Event|2|||
46649798|NCT04449276|82857411|FG002|Overall Study|Adverse Event|0|||
46649799|NCT04449276|82857412|FG003|Overall Study|Adverse Event|0|||
46649800|NCT04449276|82857413|FG004|Overall Study|Adverse Event|2|||
46649801|NCT04449276|82857414|FG005|Overall Study|Adverse Event|0|||
46649802|NCT04449276|82857415|FG006|Overall Study|Adverse Event|0|||
46649803|NCT04449276|82857416|FG007|Overall Study|Adverse Event|1|||
46649804|NCT04449276|82857409|FG000|Overall Study|Withdrawal by Subject|2|||
46649805|NCT04449276|82857410|FG001|Overall Study|Withdrawal by Subject|0|||
46649806|NCT04449276|82857411|FG002|Overall Study|Withdrawal by Subject|0|||
46649807|NCT04449276|82857412|FG003|Overall Study|Withdrawal by Subject|1|||
46649808|NCT04449276|82857413|FG004|Overall Study|Withdrawal by Subject|0|||
46649809|NCT04449276|82857414|FG005|Overall Study|Withdrawal by Subject|0|||
46649810|NCT04449276|82857415|FG006|Overall Study|Withdrawal by Subject|0|||
46649811|NCT04449276|82857416|FG007|Overall Study|Withdrawal by Subject|0|||
46649812|NCT04449276|82857409|FG000|Overall Study|Other|0|||
46649813|NCT04449276|82857410|FG001|Overall Study|Other|2|||
46649814|NCT04449276|82857411|FG002|Overall Study|Other|3|||
46649815|NCT04449276|82857412|FG003|Overall Study|Other|2|||
46649816|NCT04449276|82857413|FG004|Overall Study|Other|0|||
46649817|NCT04449276|82857414|FG005|Overall Study|Other|0|||
46649818|NCT04449276|82857415|FG006|Overall Study|Other|0|||
46649819|NCT04449276|82857416|FG007|Overall Study|Other|1|||
46649820|NCT04391894|82857456|FG000|Overall Study|Adverse Event|1|||
46649821|NCT04391894|82857457|FG001|Overall Study|Adverse Event|1|||
46649822|NCT04391894|82857458|FG002|Overall Study|Adverse Event|1|||
46649823|NCT04391894|82857459|FG003|Overall Study|Adverse Event|1|||
46649824|NCT04391894|82857460|FG004|Overall Study|Adverse Event|1|||
46649825|NCT04391894|82857456|FG000|Overall Study|Lost to Follow-up|1|||
46649826|NCT04391894|82857457|FG001|Overall Study|Lost to Follow-up|0|||
46649827|NCT04391894|82857458|FG002|Overall Study|Lost to Follow-up|0|||
46649828|NCT04391894|82857459|FG003|Overall Study|Lost to Follow-up|0|||
46649829|NCT04391894|82857460|FG004|Overall Study|Lost to Follow-up|0|||
46649830|NCT04391894|82857456|FG000|Overall Study|Protocol Violation|0|||
46649831|NCT04391894|82857457|FG001|Overall Study|Protocol Violation|0|||
46649832|NCT04391894|82857458|FG002|Overall Study|Protocol Violation|0|||
46649833|NCT04391894|82857459|FG003|Overall Study|Protocol Violation|1|||
46649834|NCT04391894|82857460|FG004|Overall Study|Protocol Violation|0|||
46649835|NCT04391894|82857456|FG000|Overall Study|Withdrawal by Subject|2|||
46649836|NCT04391894|82857457|FG001|Overall Study|Withdrawal by Subject|0|||
46649837|NCT04391894|82857458|FG002|Overall Study|Withdrawal by Subject|3|||
46649838|NCT04391894|82857459|FG003|Overall Study|Withdrawal by Subject|0|||
46649839|NCT04391894|82857460|FG004|Overall Study|Withdrawal by Subject|1|||
46649840|NCT04391894|82857456|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
46649841|NCT04391894|82857457|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
46649842|NCT04391894|82857458|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
46649843|NCT04391894|82857459|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
46649844|NCT04391894|82857460|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
46649845|NCT03851705|82857478|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
46649846|NCT03851705|82857479|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
46649847|NCT03851705|82857480|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
46649848|NCT03851705|82857481|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
46649849|NCT03851705|82857478|FG000|Part 1: Double-Blind Period|Other reason|1|||
46649850|NCT03851705|82857479|FG001|Part 1: Double-Blind Period|Other reason|0|||
46649851|NCT03851705|82857480|FG002|Part 1: Double-Blind Period|Other reason|0|||
46649852|NCT03851705|82857481|FG003|Part 1: Double-Blind Period|Other reason|0|||
46649853|NCT03851705|82857478|FG000|Part 2: Open-Label Period|Other reason|0|||
46649854|NCT03851705|82857479|FG001|Part 2: Open-Label Period|Other reason|0|||
47075194|NCT01926197|83368978|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
46850716|NCT00372593|83066494|FG000|Overall Study|Physician Decision|42|||
47075195|NCT01926197|83368977|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
47075196|NCT01926197|83368978|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
47075197|NCT00989963|83369003|FG000|Overall Study|Adverse Event|1|||
46649855|NCT03851705|82857480|FG002|Part 2: Open-Label Period|Other reason|0|||
46649856|NCT03851705|82857481|FG003|Part 2: Open-Label Period|Other reason|1|||
46649857|NCT03851705|82857478|FG000|Part 2: Open-Label Period|Death|0|||
46649858|NCT03851705|82857479|FG001|Part 2: Open-Label Period|Death|0|||
46649859|NCT03851705|82857480|FG002|Part 2: Open-Label Period|Death|3|||
46649860|NCT03851705|82857481|FG003|Part 2: Open-Label Period|Death|0|||
46649861|NCT03851705|82857478|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
46649862|NCT03851705|82857479|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
46649863|NCT03851705|82857480|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
46649864|NCT03851705|82857481|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
46649865|NCT03824366|82857494|FG000|Overall Study|Death|1|||
46649866|NCT03824366|82857494|FG000|Overall Study|Previously unidentified metal artifact|1|||
46649867|NCT03824366|82857494|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
46649868|NCT03824366|82857494|FG000|Overall Study|Withdrawal by Subject|1|||
47075198|NCT00989963|83369004|FG001|Overall Study|Adverse Event|1|||
46649869|NCT03810313|82857500|FG000|Overall Study|Study terminated by sponsor|164|||
46649870|NCT03810313|82857501|FG001|Overall Study|Study terminated by sponsor|159|||
46649871|NCT03810313|82857500|FG000|Overall Study|Subject decision|10|||
46649872|NCT03810313|82857501|FG001|Overall Study|Subject decision|11|||
46649873|NCT03810313|82857500|FG000|Overall Study|Lost to Follow-up|3|||
46649874|NCT03810313|82857501|FG001|Overall Study|Lost to Follow-up|3|||
46649875|NCT03810313|82857500|FG000|Overall Study|Adverse Event|2|||
46649876|NCT03810313|82857501|FG001|Overall Study|Adverse Event|1|||
46649877|NCT03810313|82857500|FG000|Overall Study|Death|2|||
46649878|NCT03810313|82857501|FG001|Overall Study|Death|1|||
46649879|NCT03810313|82857500|FG000|Overall Study|Physician Decision|0|||
46649880|NCT03810313|82857501|FG001|Overall Study|Physician Decision|1|||
46649881|NCT03802630|82857510|FG000|Overall Study|Study terminated by sponsor|130|||
46649882|NCT03802630|82857511|FG001|Overall Study|Study terminated by sponsor|134|||
46649883|NCT03802630|82857510|FG000|Overall Study|Subject decision|16|||
46649884|NCT03802630|82857511|FG001|Overall Study|Subject decision|9|||
46649885|NCT03802630|82857510|FG000|Overall Study|Adverse Event|3|||
46649886|NCT03802630|82857511|FG001|Overall Study|Adverse Event|1|||
46649887|NCT03802630|82857510|FG000|Overall Study|Lost to Follow-up|2|||
46649888|NCT03802630|82857511|FG001|Overall Study|Lost to Follow-up|2|||
46649889|NCT03802630|82857510|FG000|Overall Study|Physician Decision|2|||
46649890|NCT03802630|82857511|FG001|Overall Study|Physician Decision|0|||
46649891|NCT03802630|82857510|FG000|Overall Study|Death|0|||
46649892|NCT03802630|82857511|FG001|Overall Study|Death|2|||
46649893|NCT03775213|82857520|FG000|Overall Study|Withdrawal by Subject|51|||
46649894|NCT03775213|82857521|FG001|Overall Study|Withdrawal by Subject|53|||
46649895|NCT03775213|82857520|FG000|Overall Study|Incomplete Survey|7|||
46649896|NCT03775213|82857521|FG001|Overall Study|Incomplete Survey|7|||
46649897|NCT03710564|82857529|FG000|Overall Study|Study Terminated by Sponsor|104|||
46649898|NCT03710564|82857530|FG001|Overall Study|Study Terminated by Sponsor|55|||
46649899|NCT03710564|82857529|FG000|Overall Study|Withdrawal by Subject|57|||
46649900|NCT03710564|82857530|FG001|Overall Study|Withdrawal by Subject|25|||
46649901|NCT03710564|82857529|FG000|Overall Study|Death|10|||
46649902|NCT03710564|82857530|FG001|Overall Study|Death|4|||
46649903|NCT03710564|82857529|FG000|Overall Study|Lost to Follow-up|5|||
46649904|NCT03710564|82857530|FG001|Overall Study|Lost to Follow-up|4|||
46649905|NCT03710564|82857529|FG000|Overall Study|Protocol Violation|3|||
46649906|NCT03710564|82857530|FG001|Overall Study|Protocol Violation|2|||
46649907|NCT03710564|82857529|FG000|Overall Study|Adverse Event|3|||
46649908|NCT03710564|82857530|FG001|Overall Study|Adverse Event|0|||
46649909|NCT03710564|82857529|FG000|Overall Study|Physician Decision|2|||
46649910|NCT03710564|82857530|FG001|Overall Study|Physician Decision|3|||
46649911|NCT03624127|82857540|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
46649912|NCT03624127|82857541|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
46649913|NCT03624127|82857542|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
46649914|NCT03624127|82857540|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
46649915|NCT03624127|82857541|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
46649916|NCT03624127|82857542|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
46649917|NCT03624127|82857540|FG000|Treatment Week 0 - Week 16|Death|0|||
46649918|NCT03624127|82857541|FG001|Treatment Week 0 - Week 16|Death|1|||
46649919|NCT03624127|82857542|FG002|Treatment Week 0 - Week 16|Death|0|||
46649920|NCT03624127|82857540|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
46649921|NCT03624127|82857541|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
46649922|NCT03624127|82857542|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
46649923|NCT03624127|82857540|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
46649924|NCT03624127|82857541|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
46780859|NCT00401245|82999528|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
46780860|NCT00401245|82999521|FG000|Open Label Phase|Adverse Event|5|||
46780861|NCT00401245|82999522|FG001|Open Label Phase|Adverse Event|14|||
46780862|NCT00401245|82999523|FG002|Open Label Phase|Adverse Event|6|||
46780863|NCT00401245|82999524|FG003|Open Label Phase|Adverse Event|7|||
46780864|NCT00401245|82999525|FG004|Open Label Phase|Adverse Event|0|||
46780865|NCT00401245|82999526|FG005|Open Label Phase|Adverse Event|0|||
46780866|NCT00401245|82999527|FG006|Open Label Phase|Adverse Event|0|||
46649925|NCT03624127|82857542|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
46649926|NCT03624127|82857540|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
46649927|NCT03624127|82857541|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
46649928|NCT03624127|82857542|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
46649929|NCT03624127|82857540|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
46649930|NCT03624127|82857541|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
46780867|NCT00401245|82999528|FG007|Open Label Phase|Adverse Event|0|||
46649931|NCT03624127|82857542|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
46649932|NCT03624127|82857540|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
46649933|NCT03624127|82857541|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
46780868|NCT00401245|82999521|FG000|Open Label Phase|Lost to Follow-up|5|||
46780869|NCT00401245|82999522|FG001|Open Label Phase|Lost to Follow-up|7|||
46649934|NCT03624127|82857542|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
46649935|NCT03624127|82857540|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
46649936|NCT03624127|82857541|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
46649937|NCT03624127|82857542|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
46649938|NCT03624127|82857540|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
46649939|NCT03624127|82857541|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
46649940|NCT03624127|82857542|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
46649941|NCT03624127|82857540|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
46649942|NCT03624127|82857541|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
46649943|NCT03624127|82857542|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
46649944|NCT03624127|82857540|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
46649945|NCT03624127|82857541|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
46649946|NCT03624127|82857542|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
46649947|NCT03624127|82857540|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
46649948|NCT03624127|82857541|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
46649949|NCT03624127|82857542|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
46649950|NCT03624127|82857540|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
46649951|NCT03624127|82857541|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
46649952|NCT03624127|82857542|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
46649953|NCT03624127|82857540|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
46649954|NCT03624127|82857541|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
46649955|NCT03624127|82857542|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
46649956|NCT03624127|82857540|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
46649957|NCT03624127|82857541|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
46649958|NCT03624127|82857542|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
46649959|NCT03624127|82857540|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
46649960|NCT03624127|82857541|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
46649961|NCT03624127|82857542|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
46649962|NCT03624127|82857540|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
46649963|NCT03624127|82857541|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
46649964|NCT03624127|82857542|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
46649965|NCT03624127|82857540|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
46649966|NCT03624127|82857541|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
46649967|NCT03624127|82857542|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
46649968|NCT03624127|82857540|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
46649969|NCT03624127|82857541|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
46649970|NCT03624127|82857542|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
46649971|NCT03624127|82857540|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
46649972|NCT03624127|82857541|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
46649973|NCT03624127|82857542|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
46649974|NCT03616912|82857560|FG000|Overall Study|Adverse Event|17|||
46649975|NCT03616912|82857561|FG001|Overall Study|Adverse Event|21|||
46649976|NCT03616912|82857562|FG002|Overall Study|Adverse Event|9|||
46649977|NCT03616912|82857563|FG003|Overall Study|Adverse Event|0|||
46649978|NCT03616912|82857564|FG004|Overall Study|Adverse Event|0|||
46649979|NCT03616912|82857565|FG005|Overall Study|Adverse Event|0|||
46780870|NCT00401245|82999523|FG002|Open Label Phase|Lost to Follow-up|5|||
46780871|NCT00401245|82999524|FG003|Open Label Phase|Lost to Follow-up|4|||
46780872|NCT00401245|82999525|FG004|Open Label Phase|Lost to Follow-up|0|||
46649980|NCT03616912|82857560|FG000|Overall Study|Death|1|||
46649981|NCT03616912|82857561|FG001|Overall Study|Death|1|||
46649982|NCT03616912|82857562|FG002|Overall Study|Death|0|||
46649983|NCT03616912|82857563|FG003|Overall Study|Death|0|||
46780873|NCT00401245|82999526|FG005|Open Label Phase|Lost to Follow-up|0|||
46850717|NCT00372593|83066495|FG001|Overall Study|Physician Decision|41|||
47075199|NCT00989963|83369005|FG002|Overall Study|Adverse Event|1|||
47075200|NCT00989573|83369043|FG000|Overall Study|Adverse Event|8|||
47075201|NCT00989573|83369044|FG001|Overall Study|Adverse Event|12|||
47075202|NCT00989573|83369045|FG002|Overall Study|Adverse Event|4|||
47075203|NCT00989573|83369043|FG000|Overall Study|Physician Decision|0|||
47075204|NCT00989573|83369044|FG001|Overall Study|Physician Decision|2|||
47075205|NCT00989573|83369045|FG002|Overall Study|Physician Decision|0|||
47075206|NCT00989573|83369043|FG000|Overall Study|Protocol Violation|1|||
47075207|NCT00989573|83369044|FG001|Overall Study|Protocol Violation|1|||
47075208|NCT00989573|83369045|FG002|Overall Study|Protocol Violation|1|||
47075209|NCT00989573|83369043|FG000|Overall Study|Withdrawal by Subject|4|||
47075210|NCT00989573|83369044|FG001|Overall Study|Withdrawal by Subject|7|||
47075211|NCT00989573|83369045|FG002|Overall Study|Withdrawal by Subject|3|||
47075212|NCT04126213|83369119|FG000|Overall Study|Lost to Follow-up|9|||
47075213|NCT04126213|83369120|FG001|Overall Study|Lost to Follow-up|1|||
47075214|NCT04126213|83369121|FG002|Overall Study|Lost to Follow-up|5|||
47075215|NCT04126213|83369122|FG003|Overall Study|Lost to Follow-up|10|||
47075216|NCT04126213|83369123|FG004|Overall Study|Lost to Follow-up|4|||
47075217|NCT04126213|83369124|FG005|Overall Study|Lost to Follow-up|7|||
47075218|NCT04126213|83369119|FG000|Overall Study|Withdrawal by Subject|3|||
46649984|NCT03616912|82857564|FG004|Overall Study|Death|0|||
46649985|NCT03616912|82857565|FG005|Overall Study|Death|0|||
46649986|NCT03616912|82857560|FG000|Overall Study|Lack of Efficacy|13|||
46649987|NCT03616912|82857561|FG001|Overall Study|Lack of Efficacy|6|||
46649988|NCT03616912|82857562|FG002|Overall Study|Lack of Efficacy|8|||
46649989|NCT03616912|82857563|FG003|Overall Study|Lack of Efficacy|4|||
46649990|NCT03616912|82857564|FG004|Overall Study|Lack of Efficacy|5|||
46649991|NCT03616912|82857565|FG005|Overall Study|Lack of Efficacy|1|||
46649992|NCT03616912|82857560|FG000|Overall Study|Lost to Follow-up|1|||
46649993|NCT03616912|82857561|FG001|Overall Study|Lost to Follow-up|2|||
46649994|NCT03616912|82857562|FG002|Overall Study|Lost to Follow-up|3|||
46649995|NCT03616912|82857563|FG003|Overall Study|Lost to Follow-up|0|||
46649996|NCT03616912|82857564|FG004|Overall Study|Lost to Follow-up|0|||
46649997|NCT03616912|82857565|FG005|Overall Study|Lost to Follow-up|0|||
46649998|NCT03616912|82857560|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
46649999|NCT03616912|82857561|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
46650000|NCT03616912|82857562|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
46650001|NCT03616912|82857563|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
46650002|NCT03616912|82857564|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
46650003|NCT03616912|82857565|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
46650004|NCT03616912|82857560|FG000|Overall Study|Withdrawal by Subject|12|||
46650005|NCT03616912|82857561|FG001|Overall Study|Withdrawal by Subject|12|||
46650006|NCT03616912|82857562|FG002|Overall Study|Withdrawal by Subject|15|||
46650007|NCT03616912|82857563|FG003|Overall Study|Withdrawal by Subject|2|||
46650008|NCT03616912|82857564|FG004|Overall Study|Withdrawal by Subject|0|||
46650009|NCT03616912|82857565|FG005|Overall Study|Withdrawal by Subject|2|||
46650010|NCT03616912|82857560|FG000|Overall Study|Study Terminated by Sponsor|0|||
46650011|NCT03616912|82857561|FG001|Overall Study|Study Terminated by Sponsor|0|||
46650012|NCT03616912|82857562|FG002|Overall Study|Study Terminated by Sponsor|0|||
46650013|NCT03616912|82857563|FG003|Overall Study|Study Terminated by Sponsor|10|||
46650014|NCT03616912|82857564|FG004|Overall Study|Study Terminated by Sponsor|9|||
46650015|NCT03616912|82857565|FG005|Overall Study|Study Terminated by Sponsor|11|||
46650016|NCT03616912|82857560|FG000|Overall Study|Protocol Deviation|1|||
46650017|NCT03616912|82857561|FG001|Overall Study|Protocol Deviation|1|||
46650018|NCT03616912|82857562|FG002|Overall Study|Protocol Deviation|0|||
46650019|NCT03616912|82857563|FG003|Overall Study|Protocol Deviation|0|||
46650020|NCT03616912|82857564|FG004|Overall Study|Protocol Deviation|0|||
46650021|NCT03616912|82857565|FG005|Overall Study|Protocol Deviation|0|||
46650022|NCT03616912|82857560|FG000|Overall Study|Pregnancy|1|||
46650023|NCT03616912|82857561|FG001|Overall Study|Pregnancy|0|||
46650024|NCT03616912|82857562|FG002|Overall Study|Pregnancy|4|||
46650025|NCT03616912|82857563|FG003|Overall Study|Pregnancy|0|||
46650026|NCT03616912|82857564|FG004|Overall Study|Pregnancy|0|||
46650027|NCT03616912|82857565|FG005|Overall Study|Pregnancy|0|||
46650028|NCT03616912|82857560|FG000|Overall Study|Protocol Violation|1|||
46650029|NCT03616912|82857561|FG001|Overall Study|Protocol Violation|0|||
46780874|NCT00401245|82999527|FG006|Open Label Phase|Lost to Follow-up|0|||
46780875|NCT00401245|82999528|FG007|Open Label Phase|Lost to Follow-up|0|||
46780876|NCT00401245|82999521|FG000|Open Label Phase|Other|4|||
46780877|NCT00401245|82999522|FG001|Open Label Phase|Other|8|||
46780878|NCT00401245|82999523|FG002|Open Label Phase|Other|7|||
46780879|NCT00401245|82999524|FG003|Open Label Phase|Other|8|||
46780880|NCT00401245|82999525|FG004|Open Label Phase|Other|0|||
46780881|NCT00401245|82999526|FG005|Open Label Phase|Other|0|||
46970634|NCT02701361|83213880|FG000|Overall Study|timed out in rehab center|0|||
46970635|NCT02701361|83213881|FG001|Overall Study|timed out in rehab center|1|||
46970636|NCT02701361|83213882|FG002|Overall Study|timed out in rehab center|0|||
46970637|NCT02701361|83213880|FG000|Overall Study|incarceration|0|||
46970638|NCT02701361|83213881|FG001|Overall Study|incarceration|0|||
46970639|NCT02701361|83213882|FG002|Overall Study|incarceration|1|||
46970640|NCT01662999|83213907|FG000|Period 3|Withdrawal by Subject|0|||
46970641|NCT01662999|83213908|FG001|Period 3|Withdrawal by Subject|1|||
46970642|NCT01662999|83213909|FG002|Period 3|Withdrawal by Subject|0|||
47075219|NCT04126213|83369120|FG001|Overall Study|Withdrawal by Subject|2|||
47075220|NCT04126213|83369121|FG002|Overall Study|Withdrawal by Subject|1|||
46650030|NCT03616912|82857562|FG002|Overall Study|Protocol Violation|2|||
46650031|NCT03616912|82857563|FG003|Overall Study|Protocol Violation|0|||
46650032|NCT03616912|82857564|FG004|Overall Study|Protocol Violation|0|||
46650033|NCT03616912|82857565|FG005|Overall Study|Protocol Violation|0|||
46650034|NCT03616912|82857560|FG000|Overall Study|Physician Decision|2|||
46650035|NCT03616912|82857561|FG001|Overall Study|Physician Decision|0|||
46970643|NCT01662999|83213910|FG003|Period 3|Withdrawal by Subject|0|||
46650036|NCT03616912|82857562|FG002|Overall Study|Physician Decision|0|||
46650037|NCT03616912|82857563|FG003|Overall Study|Physician Decision|0|||
46650038|NCT03616912|82857564|FG004|Overall Study|Physician Decision|1|||
47075221|NCT04126213|83369122|FG003|Overall Study|Withdrawal by Subject|1|||
46650039|NCT03616912|82857565|FG005|Overall Study|Physician Decision|0|||
46650040|NCT03616912|82857560|FG000|Overall Study|Randomized But Never Treated|0|||
46780882|NCT00401245|82999527|FG006|Open Label Phase|Other|0|||
46780883|NCT00401245|82999528|FG007|Open Label Phase|Other|0|||
46650041|NCT03616912|82857561|FG001|Overall Study|Randomized But Never Treated|2|||
46650042|NCT03616912|82857562|FG002|Overall Study|Randomized But Never Treated|0|||
46650043|NCT03616912|82857563|FG003|Overall Study|Randomized But Never Treated|0|||
46650044|NCT03616912|82857564|FG004|Overall Study|Randomized But Never Treated|0|||
46650045|NCT03616912|82857565|FG005|Overall Study|Randomized But Never Treated|0|||
46650046|NCT03499899|82857582|FG000|Overall Study|Adverse Event|2|||
46650047|NCT03499899|82857583|FG001|Overall Study|Adverse Event|3|||
46650048|NCT03499899|82857584|FG002|Overall Study|Adverse Event|3|||
46650049|NCT03499899|82857582|FG000|Overall Study|Death|0|||
46650050|NCT03499899|82857583|FG001|Overall Study|Death|0|||
46650051|NCT03499899|82857584|FG002|Overall Study|Death|1|||
46650052|NCT03499899|82857582|FG000|Overall Study|Physician Decision|3|||
46650053|NCT03499899|82857583|FG001|Overall Study|Physician Decision|6|||
46650054|NCT03499899|82857584|FG002|Overall Study|Physician Decision|6|||
46650055|NCT03499899|82857582|FG000|Overall Study|Progressive disease|15|||
46650056|NCT03499899|82857583|FG001|Overall Study|Progressive disease|23|||
46650057|NCT03499899|82857584|FG002|Overall Study|Progressive disease|23|||
46650058|NCT03499899|82857582|FG000|Overall Study|Patient decision|0|||
46650059|NCT03499899|82857583|FG001|Overall Study|Patient decision|1|||
46650060|NCT03499899|82857584|FG002|Overall Study|Patient decision|1|||
46650061|NCT03499899|82857582|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
46650062|NCT03499899|82857583|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
46650063|NCT03499899|82857584|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
46650064|NCT03481634|82857600|FG000|Overall Study|Withdrawal by Subject|16|||
46650065|NCT03481634|82857601|FG001|Overall Study|Withdrawal by Subject|19|||
46650066|NCT03481634|82857602|FG002|Overall Study|Withdrawal by Subject|14|||
46650067|NCT03481634|82857600|FG000|Overall Study|Protocol Violation|1|||
46650068|NCT03481634|82857601|FG001|Overall Study|Protocol Violation|0|||
46650069|NCT03481634|82857602|FG002|Overall Study|Protocol Violation|1|||
46650070|NCT03481634|82857600|FG000|Overall Study|Progressive disease|0|||
46650071|NCT03481634|82857601|FG001|Overall Study|Progressive disease|1|||
46650072|NCT03481634|82857602|FG002|Overall Study|Progressive disease|0|||
46650073|NCT03481634|82857600|FG000|Overall Study|Physician Decision|3|||
46650074|NCT03481634|82857601|FG001|Overall Study|Physician Decision|0|||
46650075|NCT03481634|82857602|FG002|Overall Study|Physician Decision|1|||
46650076|NCT03481634|82857600|FG000|Overall Study|Lost to Follow-up|3|||
46650077|NCT03481634|82857601|FG001|Overall Study|Lost to Follow-up|4|||
46650078|NCT03481634|82857602|FG002|Overall Study|Lost to Follow-up|4|||
46650079|NCT03481634|82857600|FG000|Overall Study|Death|4|||
46650080|NCT03481634|82857601|FG001|Overall Study|Death|8|||
46650081|NCT03481634|82857602|FG002|Overall Study|Death|7|||
46650082|NCT03481634|82857600|FG000|Overall Study|Adverse Event|6|||
46650083|NCT03481634|82857601|FG001|Overall Study|Adverse Event|3|||
46650084|NCT03481634|82857602|FG002|Overall Study|Adverse Event|7|||
46650085|NCT03373461|82857616|FG000|Part 2|Adverse Event|0|||
46650086|NCT03373461|82857617|FG001|Part 2|Adverse Event|1|||
46650087|NCT03373461|82857618|FG002|Part 2|Adverse Event|0|||
46650088|NCT03373461|82857619|FG003|Part 2|Adverse Event|0|||
46650089|NCT03373461|82857620|FG004|Part 2|Adverse Event|1|||
46650090|NCT03364751|82857671|FG000|Overall Study|Withdrawal by Subject|1|||
46650091|NCT03364751|82857672|FG001|Overall Study|Withdrawal by Subject|0|||
46650092|NCT03364751|82857673|FG002|Overall Study|Withdrawal by Subject|0|||
46650093|NCT03364751|82857674|FG003|Overall Study|Withdrawal by Subject|0|||
46650094|NCT03364751|82857671|FG000|Overall Study|Lost to Follow-up|0|||
46650095|NCT03364751|82857672|FG001|Overall Study|Lost to Follow-up|1|||
46650096|NCT03364751|82857673|FG002|Overall Study|Lost to Follow-up|0|||
46650097|NCT03364751|82857674|FG003|Overall Study|Lost to Follow-up|0|||
46650098|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
46650099|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
46650100|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
46650101|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
46970644|NCT01662999|83213911|FG004|Period 3|Withdrawal by Subject|0|||
46970645|NCT01662999|83213912|FG005|Period 3|Withdrawal by Subject|0|||
46970646|NCT02565381|83213945|FG000|Overall Study|Lost to Follow-up|1|||
46970647|NCT02565381|83213946|FG001|Overall Study|Lost to Follow-up|0|||
46970648|NCT02565381|83213947|FG002|Overall Study|Lost to Follow-up|1|||
46650102|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
46650103|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
46650104|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
46650105|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
46650106|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
46650107|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
46650108|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
46650109|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
46650110|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
46850718|NCT00372593|83066496|FG002|Overall Study|Physician Decision|0|||
46650111|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
46650112|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
46650113|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
46650114|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
46650115|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
46650116|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
46650117|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
46650118|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
46650119|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
46650120|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
46650121|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
46650122|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
46650123|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
46650124|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
46650125|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
46650126|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Death|0|||
46650127|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Death|1|||
46650128|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Death|0|||
46650129|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Death|0|||
46650130|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
46650131|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
46650132|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
46650133|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
46650134|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
46650135|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
46650136|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
46650137|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
46650138|NCT02990806|82857694|FG000|Stage 1 (22 Weeks)|Other|1|||
46650139|NCT02990806|82857695|FG001|Stage 1 (22 Weeks)|Other|3|||
46650140|NCT02990806|82857696|FG002|Stage 1 (22 Weeks)|Other|0|||
46650141|NCT02990806|82857697|FG003|Stage 1 (22 Weeks)|Other|0|||
46650142|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
46650143|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
46650144|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
46650145|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
46650146|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Death|1|||
46650147|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Death|0|||
46650148|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Death|0|||
46650149|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Death|0|||
46780884|NCT00401245|82999521|FG000|Open Label Phase|Protocol Violation|0|||
46780885|NCT00401245|82999522|FG001|Open Label Phase|Protocol Violation|1|||
46780886|NCT00401245|82999523|FG002|Open Label Phase|Protocol Violation|0|||
46780887|NCT00401245|82999524|FG003|Open Label Phase|Protocol Violation|1|||
46780888|NCT00401245|82999525|FG004|Open Label Phase|Protocol Violation|0|||
46780889|NCT00401245|82999526|FG005|Open Label Phase|Protocol Violation|0|||
46780890|NCT00401245|82999527|FG006|Open Label Phase|Protocol Violation|0|||
46780891|NCT00401245|82999528|FG007|Open Label Phase|Protocol Violation|0|||
46780892|NCT00401245|82999521|FG000|Open Label Phase|Withdrawal by Subject|3|||
46780893|NCT00401245|82999522|FG001|Open Label Phase|Withdrawal by Subject|3|||
46780894|NCT00401245|82999523|FG002|Open Label Phase|Withdrawal by Subject|2|||
46780895|NCT00401245|82999524|FG003|Open Label Phase|Withdrawal by Subject|1|||
46780896|NCT00401245|82999525|FG004|Open Label Phase|Withdrawal by Subject|0|||
46780897|NCT00401245|82999526|FG005|Open Label Phase|Withdrawal by Subject|0|||
46780898|NCT00401245|82999527|FG006|Open Label Phase|Withdrawal by Subject|0|||
46850719|NCT00372593|83066494|FG000|Overall Study|Ineligible|20|||
46850720|NCT00372593|83066495|FG001|Overall Study|Ineligible|21|||
46850721|NCT00372593|83066496|FG002|Overall Study|Ineligible|1|||
46650150|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
46650151|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
46650152|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
46650153|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
46650154|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
46650155|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
46780899|NCT00401245|82999528|FG007|Open Label Phase|Withdrawal by Subject|0|||
46780900|NCT00401245|82999521|FG000|Open Label Phase|Lack of Efficacy|4|||
46780901|NCT00401245|82999522|FG001|Open Label Phase|Lack of Efficacy|2|||
46780902|NCT00401245|82999523|FG002|Open Label Phase|Lack of Efficacy|3|||
46650156|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
46650157|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
46650158|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
46650159|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
46650160|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
46780903|NCT00401245|82999524|FG003|Open Label Phase|Lack of Efficacy|0|||
46970649|NCT02063854|83213962|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
46650161|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
46650162|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
46650163|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
46650164|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
46650165|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
46650166|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
46650167|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
46650168|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
46650169|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
46650170|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
46650171|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
46650172|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
46650173|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
46650174|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
46650175|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
46650176|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
46650177|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
46650178|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
46650179|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
46650180|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
46650181|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
46650182|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
46650183|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
46650184|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
46650185|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
46650186|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Other|3|||
46650187|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Other|0|||
46650188|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Other|4|||
46650189|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Other|1|||
46650190|NCT02990806|82857694|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
46650191|NCT02990806|82857695|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
46650192|NCT02990806|82857696|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
46650193|NCT02990806|82857697|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
46650194|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
46650195|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
46650196|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
46650197|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
46650198|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
46650199|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
46650200|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
46650201|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
46650202|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
46650203|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
46650204|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
46650205|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
46650206|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
46650207|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
46650208|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
46650209|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
46650210|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
46650211|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
46650212|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
46650213|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
46650214|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
46650215|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
46650216|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
46650217|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
46650218|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
46650219|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
46650220|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
46650221|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
46650222|NCT02990806|82857694|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
46650223|NCT02990806|82857695|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
46650224|NCT02990806|82857696|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
46650225|NCT02990806|82857697|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
46650226|NCT02420821|82857760|FG000|Overall Study|Lost to Follow-up|6|||
46650227|NCT02420821|82857761|FG001|Overall Study|Lost to Follow-up|6|||
46650228|NCT02420821|82857760|FG000|Overall Study|Non-compliance|0|||
46650229|NCT02420821|82857761|FG001|Overall Study|Non-compliance|2|||
46650230|NCT02420821|82857760|FG000|Overall Study|Physician Decision|6|||
46650231|NCT02420821|82857761|FG001|Overall Study|Physician Decision|2|||
46650232|NCT02420821|82857760|FG000|Overall Study|Withdrawal by Subject|32|||
46650233|NCT02420821|82857761|FG001|Overall Study|Withdrawal by Subject|25|||
46650234|NCT02420821|82857760|FG000|Overall Study|Death|270|||
46650235|NCT02420821|82857761|FG001|Overall Study|Death|263|||
46650236|NCT02420821|82857760|FG000|Overall Study|Study Terminated By Sponsor|145|||
46650237|NCT02420821|82857761|FG001|Overall Study|Study Terminated By Sponsor|149|||
46650238|NCT02420821|82857760|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
46650239|NCT02420821|82857761|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
46650240|NCT02420821|82857760|FG000|Overall Study|Adverse Event|0|||
46650241|NCT02420821|82857761|FG001|Overall Study|Adverse Event|1|||
46650242|NCT02420821|82857760|FG000|Overall Study|Protinuria|0|||
46650243|NCT02420821|82857761|FG001|Overall Study|Protinuria|1|||
46650244|NCT02420821|82857760|FG000|Overall Study|Progressive Disease|1|||
46650245|NCT02420821|82857761|FG001|Overall Study|Progressive Disease|1|||
46650246|NCT02420821|82857760|FG000|Overall Study|Disease Progression|0|||
46650247|NCT02420821|82857761|FG001|Overall Study|Disease Progression|1|||
46650248|NCT02420821|82857760|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
46650249|NCT02420821|82857761|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
46650250|NCT02039063|82857792|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
46650251|NCT02039063|82857793|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
46650252|NCT02039063|82857794|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
46650253|NCT02039063|82857795|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
46650254|NCT02039063|82857792|FG000|Treatment Phase|Progression of disease|0|||
46650255|NCT02039063|82857793|FG001|Treatment Phase|Progression of disease|0|||
46650256|NCT02039063|82857794|FG002|Treatment Phase|Progression of disease|1|||
46650257|NCT02039063|82857795|FG003|Treatment Phase|Progression of disease|1|||
46650258|NCT02039063|82857792|FG000|Extension Phase|Inadequate therapeutic effect|0|||
46970650|NCT02063854|83213963|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
46970651|NCT02063854|83213964|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
46970652|NCT02063854|83213965|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
47075222|NCT04126213|83369123|FG004|Overall Study|Withdrawal by Subject|1|||
47075223|NCT04126213|83369124|FG005|Overall Study|Withdrawal by Subject|1|||
46650259|NCT02039063|82857793|FG001|Extension Phase|Inadequate therapeutic effect|1|||
46650260|NCT02039063|82857794|FG002|Extension Phase|Inadequate therapeutic effect|2|||
46650261|NCT02039063|82857795|FG003|Extension Phase|Inadequate therapeutic effect|0|||
46650262|NCT02039063|82857792|FG000|Extension Phase|Progression of disease|0|||
46650263|NCT02039063|82857793|FG001|Extension Phase|Progression of disease|0|||
46650264|NCT02039063|82857794|FG002|Extension Phase|Progression of disease|0|||
46650265|NCT02039063|82857795|FG003|Extension Phase|Progression of disease|1|||
46650266|NCT02039063|82857792|FG000|Extension Phase|Adverse Event|0|||
46650267|NCT02039063|82857793|FG001|Extension Phase|Adverse Event|0|||
46650268|NCT02039063|82857794|FG002|Extension Phase|Adverse Event|1|||
46650269|NCT02039063|82857795|FG003|Extension Phase|Adverse Event|0|||
46650270|NCT01746173|82857812|FG000|Overall Study|Disease Progression|2|||
46650271|NCT02995733|82857852|FG000|Overall Study|Study site closed|9|||
46650272|NCT02995733|82857853|FG001|Overall Study|Study site closed|10|||
46650273|NCT02995733|82857852|FG000|Overall Study|Death|3|||
46650274|NCT02995733|82857853|FG001|Overall Study|Death|4|||
46650275|NCT02995733|82857852|FG000|Overall Study|Withdrawal by Subject|6|||
46650276|NCT02995733|82857853|FG001|Overall Study|Withdrawal by Subject|2|||
46650277|NCT02995733|82857852|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
46650278|NCT02995733|82857853|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
46650279|NCT02995733|82857852|FG000|Overall Study|Lost to Follow-up|48|||
46650280|NCT02995733|82857853|FG001|Overall Study|Lost to Follow-up|37|||
46650281|NCT02995733|82857852|FG000|Overall Study|Other|0|||
46650282|NCT02995733|82857853|FG001|Overall Study|Other|1|||
46650283|NCT02815566|82857870|FG000|Overall Study|Adverse Event|1|||
46650284|NCT02815566|82857871|FG001|Overall Study|Adverse Event|1|||
46650285|NCT02815566|82857870|FG000|Overall Study|Withdrawal by Subject|1|||
46650286|NCT02815566|82857871|FG001|Overall Study|Withdrawal by Subject|0|||
46970653|NCT02063854|83213966|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
46650287|NCT02815566|82857870|FG000|Overall Study|Lost to Follow-up|0|||
46650288|NCT02815566|82857871|FG001|Overall Study|Lost to Follow-up|1|||
46650289|NCT02525783|82857878|FG000|Overall Study|Lost to Follow-up|10|||
46650290|NCT02466243|82857894|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
46650291|NCT02466243|82857895|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
46970654|NCT02063854|83213967|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
46650292|NCT02466243|82857894|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
46970655|NCT02063854|83213968|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
46650293|NCT02466243|82857895|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
46650294|NCT02466243|82857894|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
46650295|NCT02466243|82857895|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
46650296|NCT02466243|82857894|FG000|Part B Open-label Treatment Period|Missing|2|||
46650297|NCT02466243|82857895|FG001|Part B Open-label Treatment Period|Missing|2|||
46650298|NCT02321098|82857908|FG000|12 Weeks Treament|Lost to Follow-up|1|||
46650299|NCT02321098|82857909|FG001|12 Weeks Treament|Lost to Follow-up|1|||
46650300|NCT02321098|82857910|FG002|12 Weeks Treament|Lost to Follow-up|0|||
46650301|NCT02321098|82857908|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
46650302|NCT02321098|82857909|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
46650303|NCT02321098|82857910|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
46650304|NCT02321098|82857908|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
46650305|NCT02321098|82857909|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
46650306|NCT02321098|82857910|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
46650307|NCT02321098|82857908|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
46650308|NCT02321098|82857909|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
46650309|NCT02321098|82857910|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
46650310|NCT01627561|82857932|FG000|Overall Study|Lost to Follow-up|1|||
46650311|NCT01627561|82857933|FG001|Overall Study|Lost to Follow-up|0|||
46650312|NCT01627561|82857932|FG000|Overall Study|Withdrawal by Subject|0|||
46650313|NCT01627561|82857933|FG001|Overall Study|Withdrawal by Subject|1|||
46650314|NCT01627561|82857932|FG000|Overall Study|Migrated/moved from study area|0|||
46650315|NCT01627561|82857933|FG001|Overall Study|Migrated/moved from study area|2|||
46650316|NCT01652534|82857967|FG000|Overall Study|Lack of Efficacy|1|||
46650317|NCT01652534|82857968|FG001|Overall Study|Lack of Efficacy|0|||
46650318|NCT04709575|82857976|FG000|Overall Study|Withdrawal by Subject|6|||
46650319|NCT04709575|82857977|FG001|Overall Study|Withdrawal by Subject|2|||
46650320|NCT04709575|82857976|FG000|Overall Study|Lost to Follow-up|2|||
46650321|NCT04709575|82857977|FG001|Overall Study|Lost to Follow-up|2|||
46650322|NCT04709575|82857976|FG000|Overall Study|Adverse Event|1|||
46650323|NCT04709575|82857977|FG001|Overall Study|Adverse Event|0|||
46650324|NCT04709575|82857976|FG000|Overall Study|Protocol Violation|1|||
46650325|NCT04709575|82857977|FG001|Overall Study|Protocol Violation|1|||
46780904|NCT00401245|82999525|FG004|Open Label Phase|Lack of Efficacy|0|||
46780905|NCT00401245|82999526|FG005|Open Label Phase|Lack of Efficacy|0|||
46780906|NCT00401245|82999527|FG006|Open Label Phase|Lack of Efficacy|0|||
46780907|NCT00401245|82999528|FG007|Open Label Phase|Lack of Efficacy|0|||
46780908|NCT00401245|82999521|FG000|Double Blind Tapering Phase|Adverse Event|0|||
46780909|NCT00401245|82999522|FG001|Double Blind Tapering Phase|Adverse Event|0|||
46780910|NCT00401245|82999523|FG002|Double Blind Tapering Phase|Adverse Event|0|||
46780911|NCT00401245|82999524|FG003|Double Blind Tapering Phase|Adverse Event|0|||
46780912|NCT00401245|82999525|FG004|Double Blind Tapering Phase|Adverse Event|1|||
46780913|NCT00401245|82999526|FG005|Double Blind Tapering Phase|Adverse Event|1|||
46780914|NCT00401245|82999527|FG006|Double Blind Tapering Phase|Adverse Event|2|||
46780915|NCT00401245|82999528|FG007|Double Blind Tapering Phase|Adverse Event|4|||
46780916|NCT00401245|82999521|FG000|Double Blind Tapering Phase|Investigator request|0|||
46780917|NCT00401245|82999522|FG001|Double Blind Tapering Phase|Investigator request|0|||
46780918|NCT00401245|82999523|FG002|Double Blind Tapering Phase|Investigator request|0|||
46850722|NCT03666988|83066511|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
46850723|NCT03666988|83066512|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
46850724|NCT03666988|83066513|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
46850725|NCT03666988|83066514|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
46850726|NCT03666988|83066515|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
46850727|NCT03666988|83066516|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
46850728|NCT03666988|83066511|FG000|Part 1 (Up to 28 Months)|Other|0|||
46850729|NCT03666988|83066512|FG001|Part 1 (Up to 28 Months)|Other|1|||
46850730|NCT03666988|83066513|FG002|Part 1 (Up to 28 Months)|Other|1|||
46850731|NCT03666988|83066514|FG003|Part 1 (Up to 28 Months)|Other|0|||
46850732|NCT03666988|83066515|FG004|Part 1 (Up to 28 Months)|Other|0|||
46850733|NCT03666988|83066516|FG005|Part 1 (Up to 28 Months)|Other|0|||
46850734|NCT03666988|83066511|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
46850735|NCT03666988|83066512|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
46850736|NCT03666988|83066513|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
46850737|NCT03666988|83066514|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
46850738|NCT03666988|83066515|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
46650326|NCT04450407|82857986|FG000|Overall Study|Withdrawal by Subject|10|||
46650327|NCT04450407|82857987|FG001|Overall Study|Withdrawal by Subject|1|||
46650328|NCT04450407|82857988|FG002|Overall Study|Withdrawal by Subject|4|||
46650329|NCT04450407|82857986|FG000|Overall Study|Adverse Event|0|||
46650330|NCT04450407|82857987|FG001|Overall Study|Adverse Event|0|||
46850739|NCT03666988|83066516|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
46650331|NCT04450407|82857988|FG002|Overall Study|Adverse Event|1|||
46780919|NCT00401245|82999524|FG003|Double Blind Tapering Phase|Investigator request|0|||
46780920|NCT00401245|82999525|FG004|Double Blind Tapering Phase|Investigator request|0|||
46780921|NCT00401245|82999526|FG005|Double Blind Tapering Phase|Investigator request|0|||
46780922|NCT00401245|82999527|FG006|Double Blind Tapering Phase|Investigator request|0|||
46780923|NCT00401245|82999528|FG007|Double Blind Tapering Phase|Investigator request|1|||
46780924|NCT00401245|82999521|FG000|Double Blind Tapering Phase|Other|0|||
46780925|NCT00401245|82999522|FG001|Double Blind Tapering Phase|Other|0|||
46780926|NCT00401245|82999523|FG002|Double Blind Tapering Phase|Other|0|||
46780927|NCT00401245|82999524|FG003|Double Blind Tapering Phase|Other|0|||
46780928|NCT00401245|82999525|FG004|Double Blind Tapering Phase|Other|1|||
46780929|NCT00401245|82999526|FG005|Double Blind Tapering Phase|Other|0|||
46780930|NCT00401245|82999527|FG006|Double Blind Tapering Phase|Other|2|||
46780931|NCT00401245|82999528|FG007|Double Blind Tapering Phase|Other|2|||
46780932|NCT00401245|82999521|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
46780933|NCT00401245|82999522|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
46780934|NCT00401245|82999523|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
46780935|NCT00401245|82999524|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
46780936|NCT00401245|82999525|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
46780937|NCT00401245|82999526|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
46780938|NCT00401245|82999527|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
46780939|NCT00401245|82999528|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
46780940|NCT00401245|82999521|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
46780941|NCT00401245|82999522|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
46780942|NCT00401245|82999523|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
46780943|NCT00401245|82999524|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
46780944|NCT00401245|82999525|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
46780945|NCT00401245|82999526|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
46780946|NCT00401245|82999527|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
46780947|NCT00401245|82999528|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
46780948|NCT00696384|82999548|FG000|Open Label Phase|Adverse Event|27|||
46780949|NCT00696384|82999549|FG001|Open Label Phase|Adverse Event|0|||
46780950|NCT00696384|82999550|FG002|Open Label Phase|Adverse Event|0|||
46780951|NCT00696384|82999548|FG000|Open Label Phase|Protocol Violation|18|||
46780952|NCT00696384|82999549|FG001|Open Label Phase|Protocol Violation|0|||
46780953|NCT00696384|82999550|FG002|Open Label Phase|Protocol Violation|0|||
46780954|NCT00696384|82999548|FG000|Open Label Phase|Lost to Follow-up|24|||
46780955|NCT00696384|82999549|FG001|Open Label Phase|Lost to Follow-up|0|||
46780956|NCT00696384|82999550|FG002|Open Label Phase|Lost to Follow-up|0|||
46780957|NCT00696384|82999548|FG000|Open Label Phase|Withdrawal by Subject|37|||
46780958|NCT00696384|82999549|FG001|Open Label Phase|Withdrawal by Subject|0|||
46780959|NCT00696384|82999550|FG002|Open Label Phase|Withdrawal by Subject|0|||
46780960|NCT00696384|82999548|FG000|Open Label Phase|Other|6|||
46780961|NCT00696384|82999549|FG001|Open Label Phase|Other|0|||
46780962|NCT00696384|82999550|FG002|Open Label Phase|Other|0|||
46780963|NCT00696384|82999548|FG000|Open Label Phase|Lack of Efficacy|3|||
46780964|NCT00696384|82999549|FG001|Open Label Phase|Lack of Efficacy|0|||
46780965|NCT00696384|82999550|FG002|Open Label Phase|Lack of Efficacy|0|||
46780966|NCT00696384|82999548|FG000|Open Label Phase|Physician Decision|4|||
46780967|NCT00696384|82999549|FG001|Open Label Phase|Physician Decision|0|||
46780968|NCT00696384|82999550|FG002|Open Label Phase|Physician Decision|0|||
46780969|NCT00696384|82999548|FG000|Double Blind Phase|Adverse Event|0|||
46780970|NCT00696384|82999549|FG001|Double Blind Phase|Adverse Event|2|||
46780971|NCT00696384|82999550|FG002|Double Blind Phase|Adverse Event|2|||
46650332|NCT04450407|82857986|FG000|Overall Study|Lost to Follow-up|1|||
46650333|NCT04450407|82857987|FG001|Overall Study|Lost to Follow-up|0|||
46650334|NCT04450407|82857988|FG002|Overall Study|Lost to Follow-up|0|||
46650335|NCT04450407|82857986|FG000|Overall Study|Physician Decision|0|||
46650336|NCT04450407|82857987|FG001|Overall Study|Physician Decision|0|||
46650337|NCT04450407|82857988|FG002|Overall Study|Physician Decision|1|||
46650338|NCT04450407|82857986|FG000|Overall Study|Pregnancy|1|||
46780972|NCT00696384|82999548|FG000|Double Blind Phase|Lost to Follow-up|0|||
46780973|NCT00696384|82999549|FG001|Double Blind Phase|Lost to Follow-up|2|||
46780974|NCT00696384|82999550|FG002|Double Blind Phase|Lost to Follow-up|1|||
46780975|NCT00696384|82999548|FG000|Double Blind Phase|Withdrawal by Subject|0|||
46780976|NCT00696384|82999549|FG001|Double Blind Phase|Withdrawal by Subject|4|||
46970656|NCT02063854|83213962|FG000|Overall Study|Major Protocol Deviation|0|||
46780977|NCT00696384|82999550|FG002|Double Blind Phase|Withdrawal by Subject|3|||
46780978|NCT00696384|82999548|FG000|Double Blind Phase|Lack of Efficacy|0|||
46780979|NCT00696384|82999549|FG001|Double Blind Phase|Lack of Efficacy|1|||
46780980|NCT00696384|82999550|FG002|Double Blind Phase|Lack of Efficacy|0|||
46780981|NCT00696384|82999548|FG000|Double Blind Phase|Physician Decision|0|||
46780982|NCT00696384|82999549|FG001|Double Blind Phase|Physician Decision|2|||
46780983|NCT00696384|82999550|FG002|Double Blind Phase|Physician Decision|0|||
46780984|NCT00636675|82999561|FG000|Overall Study|Lost to Follow-up|121|||
46780985|NCT00636675|82999562|FG001|Overall Study|Lost to Follow-up|31|||
46780986|NCT00636675|82999561|FG000|Overall Study|Withdrawal by Subject|19|||
46780987|NCT00636675|82999562|FG001|Overall Study|Withdrawal by Subject|10|||
46780988|NCT00699998|82999572|FG000|Overall Study|Withdrawal by Subject|194|||
46650339|NCT04450407|82857987|FG001|Overall Study|Pregnancy|0|||
46650340|NCT04450407|82857988|FG002|Overall Study|Pregnancy|0|||
46650341|NCT04450407|82857986|FG000|Overall Study|Protocol Violation|2|||
46650342|NCT04450407|82857987|FG001|Overall Study|Protocol Violation|0|||
46650343|NCT04450407|82857988|FG002|Overall Study|Protocol Violation|0|||
46650344|NCT04450407|82857986|FG000|Overall Study|Investigational site terminated by sponsor|3|||
46650345|NCT04450407|82857987|FG001|Overall Study|Investigational site terminated by sponsor|0|||
46650346|NCT04450407|82857988|FG002|Overall Study|Investigational site terminated by sponsor|2|||
46650347|NCT04388826|82857997|FG000|Overall Study|Lost to Follow-up|3|||
46650348|NCT04388826|82857998|FG001|Overall Study|Lost to Follow-up|2|||
46650349|NCT04388826|82857997|FG000|Overall Study|Adverse Event|1|||
46650350|NCT04388826|82857998|FG001|Overall Study|Adverse Event|0|||
46650351|NCT04218266|82858020|FG000|Overall Study|Death|1|||
46650352|NCT04218266|82858021|FG001|Overall Study|Death|2|||
46650353|NCT04218266|82858022|FG002|Overall Study|Death|3|||
46650354|NCT04218266|82858020|FG000|Overall Study|Adverse Event|13|||
46650355|NCT04218266|82858021|FG001|Overall Study|Adverse Event|14|||
46650356|NCT04218266|82858022|FG002|Overall Study|Adverse Event|11|||
46650357|NCT04218266|82858020|FG000|Overall Study|Other|7|||
46650358|NCT04218266|82858021|FG001|Overall Study|Other|5|||
46650359|NCT04218266|82858022|FG002|Overall Study|Other|14|||
46650360|NCT04218266|82858020|FG000|Overall Study|Physician Decision|1|||
46650361|NCT04218266|82858021|FG001|Overall Study|Physician Decision|3|||
46650362|NCT04218266|82858022|FG002|Overall Study|Physician Decision|2|||
46650363|NCT04218266|82858020|FG000|Overall Study|Non-compliance with study drug|0|||
46650364|NCT04218266|82858021|FG001|Overall Study|Non-compliance with study drug|0|||
46650365|NCT04218266|82858022|FG002|Overall Study|Non-compliance with study drug|1|||
46650366|NCT04218266|82858020|FG000|Overall Study|Withdrawal by Subject|1|||
46650367|NCT04218266|82858021|FG001|Overall Study|Withdrawal by Subject|3|||
46650368|NCT04218266|82858022|FG002|Overall Study|Withdrawal by Subject|1|||
46650369|NCT04218266|82858020|FG000|Overall Study|Study drug never administered|2|||
46650370|NCT04218266|82858021|FG001|Overall Study|Study drug never administered|0|||
46650371|NCT04218266|82858022|FG002|Overall Study|Study drug never administered|0|||
46650372|NCT03894904|82858044|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
46650373|NCT03894904|82858045|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
46650374|NCT03894904|82858044|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
46650375|NCT03894904|82858045|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
46650376|NCT03099265|82858065|FG000|Overall Study|Adverse Event|1|||
46650377|NCT02658656|82858083|FG000|Screening|Failed eligibility criteria|0|||
46650378|NCT02658656|82858084|FG001|Screening|Failed eligibility criteria|0|||
46650379|NCT02658656|82858085|FG002|Screening|Failed eligibility criteria|263|||
46650380|NCT02658656|82858083|FG000|Randomization|Withdrawal by Subject|8|||
46650381|NCT02658656|82858084|FG001|Randomization|Withdrawal by Subject|7|||
46650382|NCT02658656|82858085|FG002|Randomization|Withdrawal by Subject|0|||
46650383|NCT02658656|82858083|FG000|Randomization|Lost to Follow-up|1|||
46650384|NCT02658656|82858084|FG001|Randomization|Lost to Follow-up|3|||
46650385|NCT02658656|82858085|FG002|Randomization|Lost to Follow-up|0|||
46650386|NCT02658656|82858083|FG000|Randomization|Adverse Event|4|||
46650387|NCT02658656|82858084|FG001|Randomization|Adverse Event|0|||
46650388|NCT02658656|82858085|FG002|Randomization|Adverse Event|0|||
46650389|NCT02658656|82858083|FG000|Randomization|Administrative Termination|3|||
46650390|NCT02658656|82858084|FG001|Randomization|Administrative Termination|1|||
46650391|NCT02658656|82858085|FG002|Randomization|Administrative Termination|0|||
46650392|NCT02658656|82858083|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
46650393|NCT02658656|82858084|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
46650394|NCT02658656|82858085|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
46650395|NCT02658656|82858083|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
46650396|NCT02658656|82858084|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
46650397|NCT02658656|82858085|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
46650398|NCT02658656|82858083|FG000|Randomization|Not eligible for Randomization|1|||
46650399|NCT02658656|82858084|FG001|Randomization|Not eligible for Randomization|0|||
46650400|NCT02658656|82858085|FG002|Randomization|Not eligible for Randomization|0|||
46650401|NCT02658656|82858083|FG000|Randomization|Protocol Violation|1|||
46650402|NCT02658656|82858084|FG001|Randomization|Protocol Violation|0|||
46650403|NCT02658656|82858085|FG002|Randomization|Protocol Violation|0|||
46650404|NCT05141175|82858143|FG000|Overall Study|Withdrawal by Subject|1|||
46650405|NCT04869345|82858149|FG000|Overall Study|Lost to Follow-up|8|||
46650406|NCT04869345|82858150|FG001|Overall Study|Lost to Follow-up|3|||
46650407|NCT03321929|82858220|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
46650408|NCT03250624|82858227|FG000|Overall Study|Lack of Efficacy|1|||
46650409|NCT03250624|82858228|FG001|Overall Study|Lack of Efficacy|4|||
46650410|NCT03250624|82858227|FG000|Overall Study|Adverse Event|0|||
46970657|NCT02063854|83213963|FG001|Overall Study|Major Protocol Deviation|0|||
46650411|NCT03250624|82858228|FG001|Overall Study|Adverse Event|1|||
46650412|NCT03250624|82858227|FG000|Overall Study|Other|1|||
46650413|NCT03250624|82858228|FG001|Overall Study|Other|2|||
46650414|NCT02507297|82858236|FG000|Overall Study|Withdrawal by Subject|1|||
46650415|NCT02507297|82858237|FG001|Overall Study|Withdrawal by Subject|0|||
46650416|NCT02507297|82858236|FG000|Overall Study|Lost to Follow-up|0|||
46650417|NCT02507297|82858237|FG001|Overall Study|Lost to Follow-up|1|||
46650418|NCT01333514|82858245|FG000|Overall Study|Withdrawal by Subject|1|||
46650419|NCT01333514|82858246|FG001|Overall Study|Withdrawal by Subject|0|||
46650420|NCT02066636|82858255|FG000|Overall Study|Disease progression|51|||
46650421|NCT02066636|82858256|FG001|Overall Study|Disease progression|60|||
46650422|NCT02066636|82858257|FG002|Overall Study|Disease progression|700|||
46650423|NCT02066636|82858255|FG000|Overall Study|Study drug toxicity|13|||
46650424|NCT02066636|82858256|FG001|Overall Study|Study drug toxicity|2|||
46650425|NCT02066636|82858257|FG002|Overall Study|Study drug toxicity|58|||
46650426|NCT02066636|82858255|FG000|Overall Study|Death|4|||
46650427|NCT02066636|82858256|FG001|Overall Study|Death|2|||
46650428|NCT02066636|82858257|FG002|Overall Study|Death|158|||
46650429|NCT02066636|82858255|FG000|Overall Study|Adverse event unrelated to study drug|6|||
46650430|NCT02066636|82858256|FG001|Overall Study|Adverse event unrelated to study drug|4|||
46650431|NCT02066636|82858257|FG002|Overall Study|Adverse event unrelated to study drug|45|||
46650432|NCT02066636|82858255|FG000|Overall Study|Participant request to discontinue treatment|12|||
46650433|NCT02066636|82858256|FG001|Overall Study|Participant request to discontinue treatment|12|||
46650434|NCT02066636|82858257|FG002|Overall Study|Participant request to discontinue treatment|70|||
46650435|NCT02066636|82858255|FG000|Overall Study|Participant withdrew consent|10|||
46650436|NCT02066636|82858256|FG001|Overall Study|Participant withdrew consent|18|||
46650437|NCT02066636|82858257|FG002|Overall Study|Participant withdrew consent|61|||
46650438|NCT02066636|82858255|FG000|Overall Study|Lost to Follow-up|0|||
46650439|NCT02066636|82858256|FG001|Overall Study|Lost to Follow-up|2|||
46650440|NCT02066636|82858257|FG002|Overall Study|Lost to Follow-up|2|||
46650441|NCT02066636|82858255|FG000|Overall Study|Maximum clinical benefit|2|||
46650442|NCT02066636|82858256|FG001|Overall Study|Maximum clinical benefit|2|||
46650443|NCT02066636|82858257|FG002|Overall Study|Maximum clinical benefit|3|||
46650444|NCT02066636|82858255|FG000|Overall Study|Poor/non-compliance|2|||
46650445|NCT02066636|82858256|FG001|Overall Study|Poor/non-compliance|1|||
46650446|NCT02066636|82858257|FG002|Overall Study|Poor/non-compliance|1|||
46650447|NCT02066636|82858255|FG000|Overall Study|Participant no loner meets study criteria|3|||
46650448|NCT02066636|82858256|FG001|Overall Study|Participant no loner meets study criteria|2|||
46650449|NCT02066636|82858257|FG002|Overall Study|Participant no loner meets study criteria|28|||
46650450|NCT02066636|82858255|FG000|Overall Study|Administrative reasons by sponsor|8|||
46650451|NCT02066636|82858256|FG001|Overall Study|Administrative reasons by sponsor|5|||
46650452|NCT02066636|82858257|FG002|Overall Study|Administrative reasons by sponsor|0|||
46650453|NCT02066636|82858255|FG000|Overall Study|Other reasons|16|||
46650454|NCT02066636|82858256|FG001|Overall Study|Other reasons|15|||
46650455|NCT02066636|82858257|FG002|Overall Study|Other reasons|50|||
46650456|NCT01486264|82858269|FG000|Overall Study|Death|1|||
46650457|NCT01486264|82858270|FG001|Overall Study|Death|1|||
46650458|NCT01486264|82858269|FG000|Overall Study|Adverse Event|3|||
46650459|NCT01486264|82858270|FG001|Overall Study|Adverse Event|3|||
46650460|NCT01486264|82858269|FG000|Overall Study|Lack of Efficacy|6|||
46650461|NCT01486264|82858270|FG001|Overall Study|Lack of Efficacy|10|||
46650462|NCT01486264|82858269|FG000|Overall Study|Withdrawal by Subject|7|||
46650463|NCT01486264|82858270|FG001|Overall Study|Withdrawal by Subject|18|||
46650464|NCT01486264|82858269|FG000|Overall Study|Physician Decision|1|||
46650465|NCT01486264|82858270|FG001|Overall Study|Physician Decision|1|||
46780989|NCT00699998|82999573|FG001|Overall Study|Withdrawal by Subject|83|||
46780990|NCT00699998|82999574|FG002|Overall Study|Withdrawal by Subject|202|||
46780991|NCT00699998|82999575|FG003|Overall Study|Withdrawal by Subject|80|||
46780992|NCT00699998|82999572|FG000|Overall Study|Physician Decision|3|||
46650466|NCT01486264|82858269|FG000|Overall Study|Protocol Violation|3|||
46650467|NCT01486264|82858270|FG001|Overall Study|Protocol Violation|0|||
46650468|NCT01486264|82858269|FG000|Overall Study|Lost to Follow-up|3|||
46650469|NCT01486264|82858270|FG001|Overall Study|Lost to Follow-up|2|||
46650470|NCT01486264|82858269|FG000|Overall Study|Other|5|||
46650471|NCT01486264|82858270|FG001|Overall Study|Other|11|||
46650472|NCT01486264|82858269|FG000|Overall Study|Not treated|0|||
46650473|NCT01486264|82858270|FG001|Overall Study|Not treated|1|||
46650474|NCT01323270|82858278|FG000|Overall Study|Withdrawal by Subject|19|||
46650475|NCT01323270|82858279|FG001|Overall Study|Withdrawal by Subject|10|||
46650476|NCT01323270|82858278|FG000|Overall Study|Protocol Violation|9|||
46650477|NCT01323270|82858279|FG001|Overall Study|Protocol Violation|7|||
46650478|NCT01323270|82858278|FG000|Overall Study|Lost to Follow-up|4|||
46650479|NCT01323270|82858279|FG001|Overall Study|Lost to Follow-up|6|||
46650480|NCT01323270|82858278|FG000|Overall Study|Adverse Event|8|||
46650481|NCT01323270|82858279|FG001|Overall Study|Adverse Event|0|||
46650482|NCT01323270|82858278|FG000|Overall Study|Other|0|||
46650483|NCT01323270|82858279|FG001|Overall Study|Other|3|||
46780993|NCT00699998|82999573|FG001|Overall Study|Physician Decision|2|||
46650484|NCT01323270|82858278|FG000|Overall Study|Physician Decision|0|||
46650485|NCT01323270|82858279|FG001|Overall Study|Physician Decision|2|||
46650486|NCT01323270|82858278|FG000|Overall Study|Not eligible|1|||
46650487|NCT01323270|82858279|FG001|Overall Study|Not eligible|1|||
46650488|NCT01323270|82858278|FG000|Overall Study|Death|1|||
46650489|NCT01323270|82858279|FG001|Overall Study|Death|0|||
46650490|NCT01323270|82858278|FG000|Overall Study|Randomized, but not vaccinated|1|||
46650491|NCT01323270|82858279|FG001|Overall Study|Randomized, but not vaccinated|0|||
46650492|NCT01300728|82858288|FG000|Overall Study|Withdrawal by Subject|1|||
46650493|NCT01300728|82858289|FG001|Overall Study|Withdrawal by Subject|1|||
46650494|NCT01300728|82858288|FG000|Overall Study|Physician Decision|1|||
46650495|NCT01300728|82858289|FG001|Overall Study|Physician Decision|0|||
46650496|NCT01299480|82858300|FG000|Overall Study|No longer willing to participate|19|||
46650497|NCT01299480|82858301|FG001|Overall Study|No longer willing to participate|17|||
46650498|NCT01299480|82858302|FG002|Overall Study|No longer willing to participate|14|||
46650499|NCT01299480|82858303|FG003|Overall Study|No longer willing to participate|13|||
46650500|NCT01299480|82858304|FG004|Overall Study|No longer willing to participate|10|||
46650501|NCT01299480|82858300|FG000|Overall Study|Protocol Violation|7|||
46650502|NCT01299480|82858301|FG001|Overall Study|Protocol Violation|5|||
46650503|NCT01299480|82858302|FG002|Overall Study|Protocol Violation|8|||
46650504|NCT01299480|82858303|FG003|Overall Study|Protocol Violation|1|||
46650505|NCT01299480|82858304|FG004|Overall Study|Protocol Violation|1|||
46650506|NCT01299480|82858300|FG000|Overall Study|Withdrawal by Subject|3|||
46650507|NCT01299480|82858301|FG001|Overall Study|Withdrawal by Subject|4|||
46650508|NCT01299480|82858302|FG002|Overall Study|Withdrawal by Subject|7|||
46650509|NCT01299480|82858303|FG003|Overall Study|Withdrawal by Subject|3|||
46650510|NCT01299480|82858304|FG004|Overall Study|Withdrawal by Subject|4|||
46650511|NCT01299480|82858300|FG000|Overall Study|Adverse Event|6|||
46650512|NCT01299480|82858301|FG001|Overall Study|Adverse Event|4|||
46650513|NCT01299480|82858302|FG002|Overall Study|Adverse Event|5|||
46650514|NCT01299480|82858303|FG003|Overall Study|Adverse Event|4|||
46650515|NCT01299480|82858304|FG004|Overall Study|Adverse Event|0|||
46650516|NCT01299480|82858300|FG000|Overall Study|Withdrawal due to pregnancy|0|||
46650517|NCT01299480|82858301|FG001|Overall Study|Withdrawal due to pregnancy|1|||
46650518|NCT01299480|82858302|FG002|Overall Study|Withdrawal due to pregnancy|1|||
46650519|NCT01299480|82858303|FG003|Overall Study|Withdrawal due to pregnancy|0|||
46650520|NCT01299480|82858304|FG004|Overall Study|Withdrawal due to pregnancy|0|||
46650521|NCT01299480|82858300|FG000|Overall Study|Physician Decision|1|||
46650522|NCT01299480|82858301|FG001|Overall Study|Physician Decision|1|||
46650523|NCT01299480|82858302|FG002|Overall Study|Physician Decision|0|||
46650524|NCT01299480|82858303|FG003|Overall Study|Physician Decision|2|||
46650525|NCT01299480|82858304|FG004|Overall Study|Physician Decision|0|||
46650526|NCT01299480|82858300|FG000|Overall Study|Lost to Follow-up|3|||
46650527|NCT01299480|82858301|FG001|Overall Study|Lost to Follow-up|1|||
46650528|NCT01299480|82858302|FG002|Overall Study|Lost to Follow-up|2|||
46650529|NCT01299480|82858303|FG003|Overall Study|Lost to Follow-up|1|||
46650530|NCT01299480|82858304|FG004|Overall Study|Lost to Follow-up|2|||
46650531|NCT01299480|82858300|FG000|Overall Study|Other|3|||
46650532|NCT01299480|82858301|FG001|Overall Study|Other|2|||
46650533|NCT01299480|82858302|FG002|Overall Study|Other|3|||
46650534|NCT01299480|82858303|FG003|Overall Study|Other|0|||
46650535|NCT01299480|82858304|FG004|Overall Study|Other|3|||
46650536|NCT01299480|82858300|FG000|Overall Study|Started, but not vaccinated|0|||
46650537|NCT01299480|82858301|FG001|Overall Study|Started, but not vaccinated|0|||
46650538|NCT01299480|82858302|FG002|Overall Study|Started, but not vaccinated|1|||
47075224|NCT04126213|83369119|FG000|Overall Study|Other|0|||
47075225|NCT04126213|83369120|FG001|Overall Study|Other|0|||
46650539|NCT01299480|82858303|FG003|Overall Study|Started, but not vaccinated|1|||
46650540|NCT01299480|82858304|FG004|Overall Study|Started, but not vaccinated|0|||
46650541|NCT05631548|82858319|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
46650542|NCT05631548|82858320|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
46650543|NCT05278858|82858350|FG000|Overall Study|Withdrawal by Subject|1|||
46650544|NCT05239221|82858370|FG000|Overall Study|Adverse Event|0|||
46650545|NCT05239221|82858371|FG001|Overall Study|Adverse Event|0|||
46650546|NCT05239221|82858372|FG002|Overall Study|Adverse Event|0|||
46650547|NCT05239221|82858373|FG003|Overall Study|Adverse Event|0|||
46650548|NCT05239221|82858374|FG004|Overall Study|Adverse Event|0|||
46650549|NCT05239221|82858375|FG005|Overall Study|Adverse Event|0|||
46650550|NCT05239221|82858376|FG006|Overall Study|Adverse Event|1|||
46650551|NCT05239221|82858377|FG007|Overall Study|Adverse Event|0|||
46650552|NCT05239221|82858378|FG008|Overall Study|Adverse Event|0|||
46850740|NCT03666988|83066511|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
46850741|NCT03666988|83066512|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
47075226|NCT04126213|83369121|FG002|Overall Study|Other|2|||
46650553|NCT05239221|82858379|FG009|Overall Study|Adverse Event|0|||
46650554|NCT05239221|82858380|FG010|Overall Study|Adverse Event|1|||
46650555|NCT05239221|82858381|FG011|Overall Study|Adverse Event|1|||
46650556|NCT05239221|82858382|FG012|Overall Study|Adverse Event|0|||
46650557|NCT05239221|82858383|FG013|Overall Study|Adverse Event|0|||
46650558|NCT05239221|82858384|FG014|Overall Study|Adverse Event|0|||
46650559|NCT05239221|82858385|FG015|Overall Study|Adverse Event|0|||
46650560|NCT05239221|82858370|FG000|Overall Study|Withdrawal by Subject|0|||
46650561|NCT05239221|82858371|FG001|Overall Study|Withdrawal by Subject|0|||
46650562|NCT05239221|82858372|FG002|Overall Study|Withdrawal by Subject|0|||
46650563|NCT05239221|82858373|FG003|Overall Study|Withdrawal by Subject|0|||
46650564|NCT05239221|82858374|FG004|Overall Study|Withdrawal by Subject|0|||
46650565|NCT05239221|82858375|FG005|Overall Study|Withdrawal by Subject|0|||
46650566|NCT05239221|82858376|FG006|Overall Study|Withdrawal by Subject|0|||
46650567|NCT05239221|82858377|FG007|Overall Study|Withdrawal by Subject|0|||
46780994|NCT00699998|82999574|FG002|Overall Study|Physician Decision|1|||
46780995|NCT00699998|82999575|FG003|Overall Study|Physician Decision|1|||
46780996|NCT00699998|82999572|FG000|Overall Study|Lost to Follow-up|2|||
46780997|NCT00699998|82999573|FG001|Overall Study|Lost to Follow-up|1|||
46780998|NCT00699998|82999574|FG002|Overall Study|Lost to Follow-up|3|||
46780999|NCT00699998|82999575|FG003|Overall Study|Lost to Follow-up|1|||
46781000|NCT00696072|82999592|FG000|Overall Study|continuing active treatment|10|||
46850742|NCT03666988|83066513|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
46650568|NCT05239221|82858378|FG008|Overall Study|Withdrawal by Subject|0|||
46650569|NCT05239221|82858379|FG009|Overall Study|Withdrawal by Subject|0|||
46650570|NCT05239221|82858380|FG010|Overall Study|Withdrawal by Subject|1|||
46650571|NCT05239221|82858381|FG011|Overall Study|Withdrawal by Subject|0|||
46650572|NCT05239221|82858382|FG012|Overall Study|Withdrawal by Subject|0|||
46650573|NCT05239221|82858383|FG013|Overall Study|Withdrawal by Subject|0|||
46650574|NCT05239221|82858384|FG014|Overall Study|Withdrawal by Subject|0|||
46650575|NCT05239221|82858385|FG015|Overall Study|Withdrawal by Subject|1|||
46650576|NCT04751656|82858455|FG000|Overall Study|Lost to Follow-up|1|||
46650577|NCT04682366|82858471|FG000|Overall Study|Lost to Follow-up|1|||
46650578|NCT04682366|82858472|FG001|Overall Study|Lost to Follow-up|1|||
46650579|NCT04390243|82858507|FG000|Overall Study|Death|1|||
46650580|NCT04390243|82858507|FG000|Overall Study|Disease Progression|4|||
46650581|NCT04390243|82858507|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
46650582|NCT04378270|82858511|FG000|Overall Study|Lack of Efficacy|1|||
46650583|NCT04378270|82858511|FG000|Overall Study|Withdrawal by Subject|1|||
46650584|NCT04378270|82858511|FG000|Overall Study|Screen Failure|1|||
46650585|NCT04378270|82858511|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
46650586|NCT04200651|82858517|FG000|Overall Study|Moved to another country during follow-up|2|||
46650587|NCT04200651|82858518|FG001|Overall Study|Moved to another country during follow-up|2|||
46650588|NCT04200651|82858517|FG000|Overall Study|Lost to Follow-up|1|||
46650589|NCT04200651|82858518|FG001|Overall Study|Lost to Follow-up|3|||
46650590|NCT03813147|82858545|FG000|Overall Study|Lack of Efficacy|4|||
46650591|NCT03813147|82858546|FG001|Overall Study|Lack of Efficacy|4|||
46650592|NCT03813147|82858545|FG000|Overall Study|Physician Decision|2|||
46650593|NCT03813147|82858546|FG001|Overall Study|Physician Decision|1|||
46650594|NCT03691207|82858554|FG000|Overall Study|Death|41|||
46650595|NCT03691207|82858555|FG001|Overall Study|Death|26|||
46650596|NCT03691207|82858554|FG000|Overall Study|Lost to Follow-up|1|||
46650597|NCT03691207|82858555|FG001|Overall Study|Lost to Follow-up|1|||
46650598|NCT03691207|82858554|FG000|Overall Study|Withdrawal by Subject|2|||
46650599|NCT03691207|82858555|FG001|Overall Study|Withdrawal by Subject|8|||
46650600|NCT03691207|82858554|FG000|Overall Study|Sponsor decision|1|||
46650601|NCT03691207|82858555|FG001|Overall Study|Sponsor decision|7|||
46650602|NCT03511664|82858572|FG000|Overall Study|Treatment ongoing|49|||
46650603|NCT03511664|82858573|FG001|Overall Study|Treatment ongoing|5|||
46650604|NCT03511664|82858572|FG000|Overall Study|Entered long-term follow-up|140|||
46650605|NCT03511664|82858573|FG001|Overall Study|Entered long-term follow-up|50|||
46650606|NCT03511664|82858572|FG000|Overall Study|Withdrawal by Subject|29|||
46650607|NCT03511664|82858573|FG001|Overall Study|Withdrawal by Subject|53|||
46650608|NCT03511664|82858572|FG000|Overall Study|Lost to Follow-up|4|||
46650609|NCT03511664|82858573|FG001|Overall Study|Lost to Follow-up|4|||
46650610|NCT03511664|82858572|FG000|Overall Study|Physician Decision|0|||
46781001|NCT00696072|82999593|FG001|Overall Study|continuing active treatment|13|||
46850743|NCT03666988|83066514|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
46850744|NCT03666988|83066515|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
46781002|NCT00696072|82999592|FG000|Overall Study|Adverse Event|10|||
46781003|NCT00696072|82999593|FG001|Overall Study|Adverse Event|6|||
46781004|NCT00696072|82999592|FG000|Overall Study|Patient Request|3|||
46781005|NCT00696072|82999593|FG001|Overall Study|Patient Request|7|||
46781006|NCT00696072|82999592|FG000|Overall Study|Investigator Request|1|||
46781007|NCT00696072|82999593|FG001|Overall Study|Investigator Request|4|||
46781008|NCT00696072|82999592|FG000|Overall Study|Sponsor Request|0|||
46850745|NCT03666988|83066516|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
46850746|NCT03666988|83066511|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
46850747|NCT03666988|83066512|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
46850748|NCT03666988|83066513|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
46781009|NCT00696072|82999593|FG001|Overall Study|Sponsor Request|1|||
46781010|NCT00696072|82999592|FG000|Overall Study|Disease Progression|32|||
46781011|NCT00696072|82999593|FG001|Overall Study|Disease Progression|30|||
46781012|NCT00696072|82999592|FG000|Overall Study|Non-specified|1|||
46781013|NCT00696072|82999593|FG001|Overall Study|Non-specified|2|||
46781014|NCT00634647|82999600|FG000|Overall Study|death on study|3|||
46781015|NCT00634647|82999600|FG000|Overall Study|refused further treatment|3|||
46781016|NCT00634647|82999600|FG000|Overall Study|declined to participate before treatment|1|||
46781017|NCT00576732|82999607|FG000|DOUBLE BLIND|Adverse Event|0|||
46970658|NCT02063854|83213964|FG002|Overall Study|Major Protocol Deviation|3|||
46970659|NCT02063854|83213965|FG003|Overall Study|Major Protocol Deviation|0|||
46650611|NCT03511664|82858573|FG001|Overall Study|Physician Decision|1|||
46650612|NCT03110770|82858610|FG000|Overall Study|Death|1|||
46781018|NCT00576732|82999608|FG001|DOUBLE BLIND|Adverse Event|0|||
46781019|NCT00576732|82999609|FG002|DOUBLE BLIND|Adverse Event|1|||
46781020|NCT00576732|82999610|FG003|DOUBLE BLIND|Adverse Event|0|||
46781021|NCT00576732|82999611|FG004|DOUBLE BLIND|Adverse Event|0|||
46781022|NCT00576732|82999612|FG005|DOUBLE BLIND|Adverse Event|0|||
46781023|NCT00576732|82999607|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
46781024|NCT00576732|82999608|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
46781025|NCT00576732|82999609|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
46781026|NCT00576732|82999610|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
46850749|NCT03666988|83066514|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
46970660|NCT02063854|83213966|FG004|Overall Study|Major Protocol Deviation|0|||
46970661|NCT02063854|83213967|FG005|Overall Study|Major Protocol Deviation|0|||
46970662|NCT02063854|83213968|FG006|Overall Study|Major Protocol Deviation|0|||
46650613|NCT03110770|82858611|FG001|Overall Study|Death|0|||
46650614|NCT03110770|82858612|FG002|Overall Study|Death|0|||
46650615|NCT03110770|82858613|FG003|Overall Study|Death|1|||
46650616|NCT03110770|82858614|FG004|Overall Study|Death|0|||
46650617|NCT03110770|82858610|FG000|Overall Study|Enrolled but did not receive product|0|||
46650618|NCT03110770|82858611|FG001|Overall Study|Enrolled but did not receive product|0|||
46650619|NCT03110770|82858612|FG002|Overall Study|Enrolled but did not receive product|0|||
46650620|NCT03110770|82858613|FG003|Overall Study|Enrolled but did not receive product|8|||
46650621|NCT03110770|82858614|FG004|Overall Study|Enrolled but did not receive product|7|||
46650622|NCT03110770|82858610|FG000|Overall Study|Lost to Follow-up|0|||
46650623|NCT03110770|82858611|FG001|Overall Study|Lost to Follow-up|0|||
46650624|NCT03110770|82858612|FG002|Overall Study|Lost to Follow-up|0|||
46650625|NCT03110770|82858613|FG003|Overall Study|Lost to Follow-up|53|||
46650626|NCT03110770|82858614|FG004|Overall Study|Lost to Follow-up|45|||
46650627|NCT03110770|82858610|FG000|Overall Study|Investigator Decision|0|||
46650628|NCT03110770|82858611|FG001|Overall Study|Investigator Decision|0|||
46650629|NCT03110770|82858612|FG002|Overall Study|Investigator Decision|0|||
46650630|NCT03110770|82858613|FG003|Overall Study|Investigator Decision|5|||
46650631|NCT03110770|82858614|FG004|Overall Study|Investigator Decision|3|||
46650632|NCT03110770|82858610|FG000|Overall Study|Withdrawal by Subject|0|||
46650633|NCT03110770|82858611|FG001|Overall Study|Withdrawal by Subject|0|||
46650634|NCT03110770|82858612|FG002|Overall Study|Withdrawal by Subject|0|||
46650635|NCT03110770|82858613|FG003|Overall Study|Withdrawal by Subject|24|||
46650636|NCT03110770|82858614|FG004|Overall Study|Withdrawal by Subject|24|||
46650637|NCT03110770|82858610|FG000|Overall Study|Moved from area|5|||
46650638|NCT03110770|82858611|FG001|Overall Study|Moved from area|0|||
46650639|NCT03110770|82858612|FG002|Overall Study|Moved from area|2|||
46650640|NCT03110770|82858613|FG003|Overall Study|Moved from area|42|||
46650641|NCT03110770|82858614|FG004|Overall Study|Moved from area|43|||
46650642|NCT03110770|82858610|FG000|Overall Study|Illness/Injury unrelated to product|0|||
46650643|NCT03110770|82858611|FG001|Overall Study|Illness/Injury unrelated to product|0|||
46650644|NCT03110770|82858612|FG002|Overall Study|Illness/Injury unrelated to product|0|||
46650645|NCT03110770|82858613|FG003|Overall Study|Illness/Injury unrelated to product|0|||
46650646|NCT03110770|82858614|FG004|Overall Study|Illness/Injury unrelated to product|1|||
46650647|NCT03110354|82858633|FG000|Overall Study|Death|1|||
46650648|NCT03110354|82858634|FG001|Overall Study|Death|0|||
46650649|NCT03110354|82858635|FG002|Overall Study|Death|0|||
46650650|NCT03110354|82858636|FG003|Overall Study|Death|1|||
46650651|NCT03110354|82858637|FG004|Overall Study|Death|0|||
46650652|NCT03110354|82858633|FG000|Overall Study|Start of new therapy|0|||
46650653|NCT03110354|82858634|FG001|Overall Study|Start of new therapy|0|||
46650654|NCT03110354|82858635|FG002|Overall Study|Start of new therapy|0|||
46650655|NCT03110354|82858636|FG003|Overall Study|Start of new therapy|0|||
46650656|NCT03110354|82858637|FG004|Overall Study|Start of new therapy|1|||
46650657|NCT03110354|82858633|FG000|Overall Study|Failure to achieve response|2|||
46650658|NCT03110354|82858634|FG001|Overall Study|Failure to achieve response|3|||
46650659|NCT03110354|82858635|FG002|Overall Study|Failure to achieve response|0|||
46650660|NCT03110354|82858636|FG003|Overall Study|Failure to achieve response|2|||
46650661|NCT03110354|82858637|FG004|Overall Study|Failure to achieve response|1|||
46650662|NCT03110354|82858633|FG000|Overall Study|Progressive disease|1|||
46650663|NCT03110354|82858634|FG001|Overall Study|Progressive disease|1|||
46650664|NCT03110354|82858635|FG002|Overall Study|Progressive disease|3|||
46650665|NCT03110354|82858636|FG003|Overall Study|Progressive disease|4|||
46650666|NCT03110354|82858637|FG004|Overall Study|Progressive disease|2|||
46650667|NCT03110354|82858633|FG000|Overall Study|Adverse Event|0|||
46650668|NCT03110354|82858634|FG001|Overall Study|Adverse Event|0|||
46650669|NCT03110354|82858635|FG002|Overall Study|Adverse Event|0|||
46650670|NCT03110354|82858636|FG003|Overall Study|Adverse Event|2|||
46650671|NCT03110354|82858637|FG004|Overall Study|Adverse Event|2|||
46650672|NCT03110354|82858633|FG000|Overall Study|Other|0|||
46650673|NCT03110354|82858634|FG001|Overall Study|Other|0|||
46650674|NCT03110354|82858635|FG002|Overall Study|Other|0|||
46650675|NCT03110354|82858636|FG003|Overall Study|Other|1|||
46781027|NCT00576732|82999611|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
46781028|NCT00576732|82999612|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
46781029|NCT00576732|82999607|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
46781030|NCT00576732|82999608|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
46970663|NCT02063854|83213962|FG000|Overall Study|Voluntary Withdrawal|2|||
46970664|NCT02063854|83213963|FG001|Overall Study|Voluntary Withdrawal|0|||
46650676|NCT03110354|82858637|FG004|Overall Study|Other|1|||
46650677|NCT02948400|82858680|FG000|Overall Study|Withdrawal by Subject|17|||
46650678|NCT02948400|82858681|FG001|Overall Study|Withdrawal by Subject|10|||
46650679|NCT02948400|82858680|FG000|Overall Study|failed to attend appointments|47|||
46650680|NCT02948400|82858681|FG001|Overall Study|failed to attend appointments|34|||
46650681|NCT02948400|82858680|FG000|Overall Study|COVID-related closure|6|||
46650682|NCT02948400|82858681|FG001|Overall Study|COVID-related closure|2|||
46650683|NCT02948400|82858680|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
46650684|NCT02948400|82858681|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
46650685|NCT02948400|82858680|FG000|Overall Study|motion sickness in virtual reality|2|||
46650686|NCT02948400|82858681|FG001|Overall Study|motion sickness in virtual reality|0|||
46650687|NCT02695628|82858687|FG000|Overall Study|Withdrawal by Subject|1|||
46650688|NCT02671435|82858706|FG000|Overall Study|Death|1|||
46650689|NCT02671435|82858707|FG001|Overall Study|Death|3|||
46650690|NCT02671435|82858708|FG002|Overall Study|Death|0|||
46650691|NCT02671435|82858709|FG003|Overall Study|Death|16|||
46650692|NCT02671435|82858710|FG004|Overall Study|Death|14|||
46650693|NCT02671435|82858711|FG005|Overall Study|Death|29|||
46650694|NCT02671435|82858712|FG006|Overall Study|Death|34|||
46650695|NCT02671435|82858713|FG007|Overall Study|Death|28|||
46650696|NCT02671435|82858714|FG008|Overall Study|Death|19|||
46650697|NCT02671435|82858715|FG009|Overall Study|Death|10|||
46650698|NCT02671435|82858716|FG010|Overall Study|Death|8|||
46650699|NCT02671435|82858717|FG011|Overall Study|Death|29|||
46650700|NCT02671435|82858718|FG012|Overall Study|Death|29|||
46650701|NCT02671435|82858719|FG013|Overall Study|Death|29|||
46650702|NCT02671435|82858720|FG014|Overall Study|Death|27|||
46650703|NCT02671435|82858706|FG000|Overall Study|Lost to Follow-up|0|||
46650704|NCT02671435|82858707|FG001|Overall Study|Lost to Follow-up|0|||
46650705|NCT02671435|82858708|FG002|Overall Study|Lost to Follow-up|1|||
46650706|NCT02671435|82858709|FG003|Overall Study|Lost to Follow-up|0|||
46650707|NCT02671435|82858710|FG004|Overall Study|Lost to Follow-up|1|||
46650708|NCT02671435|82858711|FG005|Overall Study|Lost to Follow-up|1|||
46650709|NCT02671435|82858712|FG006|Overall Study|Lost to Follow-up|2|||
46650710|NCT02671435|82858713|FG007|Overall Study|Lost to Follow-up|2|||
46650711|NCT02671435|82858714|FG008|Overall Study|Lost to Follow-up|0|||
46650712|NCT02671435|82858715|FG009|Overall Study|Lost to Follow-up|2|||
46650713|NCT02671435|82858716|FG010|Overall Study|Lost to Follow-up|0|||
46650714|NCT02671435|82858717|FG011|Overall Study|Lost to Follow-up|3|||
46650715|NCT02671435|82858718|FG012|Overall Study|Lost to Follow-up|3|||
46650716|NCT02671435|82858719|FG013|Overall Study|Lost to Follow-up|2|||
46650717|NCT02671435|82858720|FG014|Overall Study|Lost to Follow-up|0|||
46650718|NCT02671435|82858706|FG000|Overall Study|Withdrawal by Subject|2|||
46650719|NCT02671435|82858707|FG001|Overall Study|Withdrawal by Subject|0|||
46650720|NCT02671435|82858708|FG002|Overall Study|Withdrawal by Subject|2|||
46650721|NCT02671435|82858709|FG003|Overall Study|Withdrawal by Subject|2|||
46650722|NCT02671435|82858710|FG004|Overall Study|Withdrawal by Subject|2|||
46650723|NCT02671435|82858711|FG005|Overall Study|Withdrawal by Subject|7|||
46650724|NCT02671435|82858712|FG006|Overall Study|Withdrawal by Subject|2|||
46650725|NCT02671435|82858713|FG007|Overall Study|Withdrawal by Subject|7|||
46650726|NCT02671435|82858714|FG008|Overall Study|Withdrawal by Subject|1|||
46650727|NCT02671435|82858715|FG009|Overall Study|Withdrawal by Subject|1|||
46650728|NCT02671435|82858716|FG010|Overall Study|Withdrawal by Subject|2|||
46650729|NCT02671435|82858717|FG011|Overall Study|Withdrawal by Subject|4|||
46650730|NCT02671435|82858718|FG012|Overall Study|Withdrawal by Subject|4|||
46650731|NCT02671435|82858719|FG013|Overall Study|Withdrawal by Subject|4|||
46650732|NCT02671435|82858720|FG014|Overall Study|Withdrawal by Subject|2|||
46650733|NCT02671435|82858706|FG000|Overall Study|Un-specified|0|||
46650734|NCT02671435|82858707|FG001|Overall Study|Un-specified|0|||
46650735|NCT02671435|82858708|FG002|Overall Study|Un-specified|0|||
46650736|NCT02671435|82858709|FG003|Overall Study|Un-specified|0|||
46650737|NCT02671435|82858710|FG004|Overall Study|Un-specified|1|||
46650738|NCT02671435|82858711|FG005|Overall Study|Un-specified|3|||
46650739|NCT02671435|82858712|FG006|Overall Study|Un-specified|2|||
46650740|NCT02671435|82858713|FG007|Overall Study|Un-specified|3|||
46650741|NCT02671435|82858714|FG008|Overall Study|Un-specified|0|||
46781031|NCT00576732|82999609|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
46781032|NCT00576732|82999610|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
46781033|NCT00576732|82999611|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
46781034|NCT00576732|82999612|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
46781035|NCT00576732|82999607|FG000|DOUBLE BLIND|OTHER|0|||
46970665|NCT02063854|83213964|FG002|Overall Study|Voluntary Withdrawal|8|||
46970666|NCT02063854|83213965|FG003|Overall Study|Voluntary Withdrawal|1|||
46970667|NCT02063854|83213966|FG004|Overall Study|Voluntary Withdrawal|3|||
46650742|NCT02671435|82858715|FG009|Overall Study|Un-specified|5|||
46650743|NCT02671435|82858716|FG010|Overall Study|Un-specified|8|||
46650744|NCT02671435|82858717|FG011|Overall Study|Un-specified|4|||
46650745|NCT02671435|82858718|FG012|Overall Study|Un-specified|5|||
46650746|NCT02671435|82858719|FG013|Overall Study|Un-specified|9|||
46650747|NCT02671435|82858720|FG014|Overall Study|Un-specified|8|||
46650748|NCT01922076|82858784|FG000|Overall Study|Adverse Event|0|||
46650749|NCT01922076|82858785|FG001|Overall Study|Adverse Event|0|||
46650750|NCT01922076|82858786|FG002|Overall Study|Adverse Event|0|||
46650751|NCT01922076|82858787|FG003|Overall Study|Adverse Event|0|||
46650752|NCT01922076|82858788|FG004|Overall Study|Adverse Event|1|||
46650753|NCT01922076|82858789|FG005|Overall Study|Adverse Event|0|||
46781036|NCT00576732|82999608|FG001|DOUBLE BLIND|OTHER|2|||
46650754|NCT01922076|82858790|FG006|Overall Study|Adverse Event|0|||
46650755|NCT01922076|82858784|FG000|Overall Study|Physician Decision|0|||
46650756|NCT01922076|82858785|FG001|Overall Study|Physician Decision|0|||
46650757|NCT01922076|82858786|FG002|Overall Study|Physician Decision|1|||
46650758|NCT01922076|82858787|FG003|Overall Study|Physician Decision|0|||
46650759|NCT01922076|82858788|FG004|Overall Study|Physician Decision|0|||
46650760|NCT01922076|82858789|FG005|Overall Study|Physician Decision|0|||
46650761|NCT01922076|82858790|FG006|Overall Study|Physician Decision|0|||
46650762|NCT01922076|82858784|FG000|Overall Study|Withdrawal by Subject|0|||
46650763|NCT01922076|82858785|FG001|Overall Study|Withdrawal by Subject|0|||
46650764|NCT01922076|82858786|FG002|Overall Study|Withdrawal by Subject|0|||
46650765|NCT01922076|82858787|FG003|Overall Study|Withdrawal by Subject|1|||
46650766|NCT01922076|82858788|FG004|Overall Study|Withdrawal by Subject|0|||
46650767|NCT01922076|82858789|FG005|Overall Study|Withdrawal by Subject|1|||
46650768|NCT01922076|82858790|FG006|Overall Study|Withdrawal by Subject|1|||
46650769|NCT01366092|82858822|FG000|Overall Study|Progressive cGVHD|2|||
46650770|NCT01366092|82858822|FG000|Overall Study|Physician Decision|1|||
46650771|NCT01366092|82858822|FG000|Overall Study|Withdrawal by Subject|1|||
46650772|NCT04700137|82858880|FG000|Overall Study|Lost to Follow-up|1|||
46650773|NCT04700137|82858881|FG001|Overall Study|Lost to Follow-up|6|||
46650774|NCT04700137|82858882|FG002|Overall Study|Lost to Follow-up|1|||
46650775|NCT04700137|82858883|FG003|Overall Study|Lost to Follow-up|1|||
46650776|NCT04700137|82858880|FG000|Overall Study|Withdrawal by Subject|0|||
46650777|NCT04700137|82858881|FG001|Overall Study|Withdrawal by Subject|0|||
46650778|NCT04700137|82858882|FG002|Overall Study|Withdrawal by Subject|1|||
46650779|NCT04700137|82858883|FG003|Overall Study|Withdrawal by Subject|0|||
46650780|NCT04700137|82858880|FG000|Overall Study|Death|0|||
46650781|NCT04700137|82858881|FG001|Overall Study|Death|0|||
46650782|NCT04700137|82858882|FG002|Overall Study|Death|1|||
46650783|NCT04700137|82858883|FG003|Overall Study|Death|0|||
46650784|NCT04260191|82858913|FG000|Overall Study|Decision by Sponsor|0|||
46650785|NCT04260191|82858914|FG001|Overall Study|Decision by Sponsor|1|||
46650786|NCT04260191|82858915|FG002|Overall Study|Decision by Sponsor|0|||
46650787|NCT04260191|82858913|FG000|Overall Study|Withdrawal by Subject|1|||
46650788|NCT04260191|82858914|FG001|Overall Study|Withdrawal by Subject|0|||
46650789|NCT04260191|82858915|FG002|Overall Study|Withdrawal by Subject|3|||
46650790|NCT04260191|82858913|FG000|Overall Study|Death|4|||
46650791|NCT04260191|82858914|FG001|Overall Study|Death|3|||
46650792|NCT04260191|82858915|FG002|Overall Study|Death|2|||
46650793|NCT03188510|82858976|FG000|Overall Study|Inappropriate behavior with site staff|0|||
46650794|NCT03188510|82858977|FG001|Overall Study|Inappropriate behavior with site staff|1|||
46650795|NCT03188510|82858978|FG002|Overall Study|Inappropriate behavior with site staff|0|||
46650796|NCT03100149|82858989|FG000|Overall Study|Adverse Event|0|||
46650797|NCT03100149|82858990|FG001|Overall Study|Adverse Event|1|||
46650798|NCT03100149|82858991|FG002|Overall Study|Adverse Event|0|||
46650799|NCT03100149|82858989|FG000|Overall Study|Participant Moved out of Country|0|||
46650800|NCT03100149|82858990|FG001|Overall Study|Participant Moved out of Country|0|||
46650801|NCT03100149|82858991|FG002|Overall Study|Participant Moved out of Country|1|||
46650802|NCT03100149|82858989|FG000|Overall Study|Withdrawal by Subject|0|||
46650803|NCT03100149|82858990|FG001|Overall Study|Withdrawal by Subject|3|||
46650804|NCT03100149|82858991|FG002|Overall Study|Withdrawal by Subject|1|||
46650805|NCT03075527|82858999|FG000|Overall Study|Ongoing treatment|2|||
46650806|NCT02734004|82859019|FG000|Overall Study|Death|36|||
46650807|NCT02734004|82859020|FG001|Overall Study|Death|24|||
46650808|NCT02734004|82859021|FG002|Overall Study|Death|26|||
46650809|NCT02734004|82859022|FG003|Overall Study|Death|35|||
46650810|NCT02734004|82859023|FG004|Overall Study|Death|13|||
46650811|NCT02734004|82859024|FG005|Overall Study|Death|17|||
46650812|NCT02734004|82859025|FG006|Overall Study|Death|20|||
46650813|NCT02734004|82859019|FG000|Overall Study|Lost to Follow-up|1|||
46650814|NCT02734004|82859020|FG001|Overall Study|Lost to Follow-up|1|||
46650815|NCT02734004|82859021|FG002|Overall Study|Lost to Follow-up|0|||
46650816|NCT02734004|82859022|FG003|Overall Study|Lost to Follow-up|0|||
46650817|NCT02734004|82859023|FG004|Overall Study|Lost to Follow-up|1|||
46650818|NCT02734004|82859024|FG005|Overall Study|Lost to Follow-up|0|||
46650819|NCT02734004|82859025|FG006|Overall Study|Lost to Follow-up|0|||
46650820|NCT02734004|82859019|FG000|Overall Study|Withdrawal by Subject|3|||
46650821|NCT02734004|82859020|FG001|Overall Study|Withdrawal by Subject|1|||
46650822|NCT02734004|82859021|FG002|Overall Study|Withdrawal by Subject|1|||
46970668|NCT02063854|83213967|FG005|Overall Study|Voluntary Withdrawal|6|||
46650823|NCT02734004|82859022|FG003|Overall Study|Withdrawal by Subject|1|||
46650824|NCT02734004|82859023|FG004|Overall Study|Withdrawal by Subject|3|||
46970669|NCT02063854|83213968|FG006|Overall Study|Voluntary Withdrawal|1|||
46970670|NCT02063854|83213962|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
46650825|NCT02734004|82859024|FG005|Overall Study|Withdrawal by Subject|0|||
46650826|NCT02734004|82859025|FG006|Overall Study|Withdrawal by Subject|2|||
46850750|NCT03666988|83066515|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
46650827|NCT02734004|82859019|FG000|Overall Study|Other|0|||
46650828|NCT02734004|82859020|FG001|Overall Study|Other|8|||
46650829|NCT02734004|82859021|FG002|Overall Study|Other|7|||
46650830|NCT02734004|82859022|FG003|Overall Study|Other|4|||
46650831|NCT02734004|82859023|FG004|Overall Study|Other|34|||
46650832|NCT02734004|82859024|FG005|Overall Study|Other|14|||
46650833|NCT02734004|82859025|FG006|Overall Study|Other|10|||
46650834|NCT02677922|82859054|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
46650835|NCT02677922|82859055|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
46650836|NCT02677922|82859056|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
46650837|NCT02677922|82859057|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
46650838|NCT02677922|82859058|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
46650839|NCT02677922|82859059|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
46650840|NCT02677922|82859054|FG000|Treatment Period|Adverse Event|0|||
46650841|NCT02677922|82859055|FG001|Treatment Period|Adverse Event|0|||
46650842|NCT02677922|82859056|FG002|Treatment Period|Adverse Event|1|||
46650843|NCT02677922|82859057|FG003|Treatment Period|Adverse Event|3|||
46650844|NCT02677922|82859058|FG004|Treatment Period|Adverse Event|5|||
46650845|NCT02677922|82859059|FG005|Treatment Period|Adverse Event|2|||
46650846|NCT02677922|82859054|FG000|Treatment Period|Progressive Disease|1|||
46650847|NCT02677922|82859055|FG001|Treatment Period|Progressive Disease|1|||
46650848|NCT02677922|82859056|FG002|Treatment Period|Progressive Disease|0|||
46650849|NCT02677922|82859057|FG003|Treatment Period|Progressive Disease|0|||
46650850|NCT02677922|82859058|FG004|Treatment Period|Progressive Disease|8|||
46650851|NCT02677922|82859059|FG005|Treatment Period|Progressive Disease|7|||
46650852|NCT02677922|82859054|FG000|Treatment Period|Lack of Efficacy|0|||
46650853|NCT02677922|82859055|FG001|Treatment Period|Lack of Efficacy|0|||
46650854|NCT02677922|82859056|FG002|Treatment Period|Lack of Efficacy|0|||
46650855|NCT02677922|82859057|FG003|Treatment Period|Lack of Efficacy|1|||
46650856|NCT02677922|82859058|FG004|Treatment Period|Lack of Efficacy|1|||
46650857|NCT02677922|82859059|FG005|Treatment Period|Lack of Efficacy|6|||
46650858|NCT02677922|82859054|FG000|Treatment Period|Withdrawal by Subject|0|||
46650859|NCT02677922|82859055|FG001|Treatment Period|Withdrawal by Subject|0|||
46650860|NCT02677922|82859056|FG002|Treatment Period|Withdrawal by Subject|1|||
46650861|NCT02677922|82859057|FG003|Treatment Period|Withdrawal by Subject|3|||
46650862|NCT02677922|82859058|FG004|Treatment Period|Withdrawal by Subject|5|||
46650863|NCT02677922|82859059|FG005|Treatment Period|Withdrawal by Subject|5|||
46650864|NCT02677922|82859054|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
46650865|NCT02677922|82859055|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
46650866|NCT02677922|82859056|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
46650867|NCT02677922|82859057|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
46650868|NCT02677922|82859058|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
46650869|NCT02677922|82859059|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
46650870|NCT02677922|82859054|FG000|Treatment Period|Disease Relapse|0|||
46650871|NCT02677922|82859055|FG001|Treatment Period|Disease Relapse|0|||
46650872|NCT02677922|82859056|FG002|Treatment Period|Disease Relapse|0|||
46650873|NCT02677922|82859057|FG003|Treatment Period|Disease Relapse|3|||
46650874|NCT02677922|82859058|FG004|Treatment Period|Disease Relapse|6|||
46650875|NCT02677922|82859059|FG005|Treatment Period|Disease Relapse|1|||
46650876|NCT02677922|82859054|FG000|Treatment Period|Allogeneic HSCT|1|||
46650877|NCT02677922|82859055|FG001|Treatment Period|Allogeneic HSCT|0|||
46650878|NCT02677922|82859056|FG002|Treatment Period|Allogeneic HSCT|0|||
46650879|NCT02677922|82859057|FG003|Treatment Period|Allogeneic HSCT|1|||
46650880|NCT02677922|82859058|FG004|Treatment Period|Allogeneic HSCT|4|||
46650881|NCT02677922|82859059|FG005|Treatment Period|Allogeneic HSCT|1|||
46650882|NCT02677922|82859054|FG000|Treatment Period|Other Reasons|0|||
46650883|NCT02677922|82859055|FG001|Treatment Period|Other Reasons|0|||
46650884|NCT02677922|82859056|FG002|Treatment Period|Other Reasons|0|||
46650885|NCT02677922|82859057|FG003|Treatment Period|Other Reasons|1|||
46650886|NCT02677922|82859058|FG004|Treatment Period|Other Reasons|3|||
46650887|NCT02677922|82859059|FG005|Treatment Period|Other Reasons|5|||
46650888|NCT02677922|82859054|FG000|Treatment Period|Death|0|||
46650889|NCT02677922|82859055|FG001|Treatment Period|Death|0|||
46650890|NCT02677922|82859056|FG002|Treatment Period|Death|0|||
46650891|NCT02677922|82859057|FG003|Treatment Period|Death|0|||
46650892|NCT02677922|82859058|FG004|Treatment Period|Death|12|||
46650893|NCT02677922|82859059|FG005|Treatment Period|Death|1|||
46650894|NCT02677922|82859054|FG000|Treatment Period|Non-compliance with Study Drug|0|||
46650895|NCT02677922|82859055|FG001|Treatment Period|Non-compliance with Study Drug|0|||
46650896|NCT02677922|82859056|FG002|Treatment Period|Non-compliance with Study Drug|0|||
46650897|NCT02677922|82859057|FG003|Treatment Period|Non-compliance with Study Drug|0|||
46650898|NCT02677922|82859058|FG004|Treatment Period|Non-compliance with Study Drug|1|||
46650899|NCT02677922|82859059|FG005|Treatment Period|Non-compliance with Study Drug|0|||
46650900|NCT02677922|82859054|FG000|Treatment Period|Physician Decision|0|||
46650901|NCT02677922|82859055|FG001|Treatment Period|Physician Decision|0|||
46781037|NCT00576732|82999609|FG002|DOUBLE BLIND|OTHER|1|||
46850751|NCT03666988|83066516|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
46650902|NCT02677922|82859056|FG002|Treatment Period|Physician Decision|0|||
46650903|NCT02677922|82859057|FG003|Treatment Period|Physician Decision|0|||
46650904|NCT02677922|82859058|FG004|Treatment Period|Physician Decision|0|||
46650905|NCT02677922|82859059|FG005|Treatment Period|Physician Decision|1|||
46650906|NCT02677922|82859054|FG000|Treatment Period|Symptomatic Deterioration|0|||
46650907|NCT02677922|82859055|FG001|Treatment Period|Symptomatic Deterioration|0|||
46650908|NCT02677922|82859056|FG002|Treatment Period|Symptomatic Deterioration|0|||
46650909|NCT02677922|82859057|FG003|Treatment Period|Symptomatic Deterioration|0|||
46650910|NCT02677922|82859058|FG004|Treatment Period|Symptomatic Deterioration|1|||
46650911|NCT02677922|82859059|FG005|Treatment Period|Symptomatic Deterioration|0|||
46650912|NCT02567799|82859077|FG000|Concurrent Chemoradiotherapy|Death|1|||
46650913|NCT02567799|82859078|FG001|Concurrent Chemoradiotherapy|Death|0|||
46650914|NCT02567799|82859079|FG002|Concurrent Chemoradiotherapy|Death|0|||
46650915|NCT02567799|82859077|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
46650916|NCT02567799|82859078|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
46650917|NCT02567799|82859079|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
46650918|NCT02567799|82859077|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
46650919|NCT02567799|82859078|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
46650920|NCT02567799|82859079|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
46650921|NCT02567799|82859077|FG000|Follow-up|Death|1|||
46650922|NCT02567799|82859078|FG001|Follow-up|Death|0|||
46650923|NCT02567799|82859079|FG002|Follow-up|Death|1|||
46650924|NCT02567799|82859077|FG000|Follow-up|Progressive Disease|1|||
46650925|NCT02567799|82859078|FG001|Follow-up|Progressive Disease|1|||
46650926|NCT02567799|82859079|FG002|Follow-up|Progressive Disease|3|||
46650927|NCT01696994|82859097|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
46650928|NCT01696994|82859098|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
46650929|NCT01696994|82859097|FG000|Overall Study|Died Before Randomization|1|||
46650930|NCT01696994|82859098|FG001|Overall Study|Died Before Randomization|2|||
46650931|NCT01696994|82859097|FG000|Overall Study|Died Before ASU (Control)|73|||
46650932|NCT01696994|82859098|FG001|Overall Study|Died Before ASU (Control)|0|||
46650933|NCT01696994|82859097|FG000|Overall Study|No Ovaries at Baseline|4807|||
46650934|NCT01696994|82859098|FG001|Overall Study|No Ovaries at Baseline|4851|||
46650935|NCT01696994|82859097|FG000|Overall Study|Refused ASU (Control)|311|||
46650936|NCT01696994|82859098|FG001|Overall Study|Refused ASU (Control)|0|||
46650937|NCT01696994|82859097|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
46650938|NCT01696994|82859098|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
46650939|NCT01696981|82859108|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
46650940|NCT01696981|82859109|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
46650941|NCT01696981|82859108|FG000|Overall Study|Died Before Randomization|3|||
46650942|NCT01696981|82859109|FG001|Overall Study|Died Before Randomization|8|||
46650943|NCT01696981|82859108|FG000|Overall Study|Died Before ASU (Control)|278|||
46650944|NCT01696981|82859109|FG001|Overall Study|Died Before ASU (Control)|0|||
46650945|NCT01696981|82859108|FG000|Overall Study|Refused ASU (Control)|920|||
46650946|NCT01696981|82859109|FG001|Overall Study|Refused ASU (Control)|0|||
46650947|NCT01696981|82859108|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
46650948|NCT01696981|82859109|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
46650949|NCT01696968|82859117|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
46650950|NCT01696968|82859118|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
46650951|NCT01696968|82859117|FG000|Overall Study|Died Before Randomization|3|||
46650952|NCT01696968|82859118|FG001|Overall Study|Died Before Randomization|8|||
46650953|NCT01696968|82859117|FG000|Overall Study|Died Before ASU (Control)|278|||
46650954|NCT01696968|82859118|FG001|Overall Study|Died Before ASU (Control)|0|||
46650955|NCT01696968|82859117|FG000|Overall Study|Refused ASU (Control)|920|||
46781038|NCT00576732|82999610|FG003|DOUBLE BLIND|OTHER|0|||
46781039|NCT00576732|82999611|FG004|DOUBLE BLIND|OTHER|0|||
46650956|NCT01696968|82859118|FG001|Overall Study|Refused ASU (Control)|0|||
46650957|NCT01696968|82859117|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
46650958|NCT01696968|82859118|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
46650959|NCT01155050|82859129|FG000|Overall Study|Lost to Follow-up|15|||
46650960|NCT01155050|82859130|FG001|Overall Study|Lost to Follow-up|20|||
46781040|NCT00576732|82999612|FG005|DOUBLE BLIND|OTHER|0|||
46781041|NCT00576732|82999607|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
46781042|NCT00576732|82999608|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
46781043|NCT00576732|82999609|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
46650961|NCT01155050|82859131|FG002|Overall Study|Lost to Follow-up|19|||
46650962|NCT01155050|82859132|FG003|Overall Study|Lost to Follow-up|22|||
46650963|NCT00002540|82859154|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
46650964|NCT00002540|82859155|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
46650965|NCT00002540|82859154|FG000|Overall Study|Died Before Randomization|2|||
46650966|NCT00002540|82859155|FG001|Overall Study|Died Before Randomization|6|||
46781044|NCT00576732|82999610|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
46650967|NCT00002540|82859154|FG000|Overall Study|Died Before ASU (Control)|202|||
46650968|NCT00002540|82859155|FG001|Overall Study|Died Before ASU (Control)|0|||
46650969|NCT00002540|82859154|FG000|Overall Study|Refused ASU (Control)|597|||
46781045|NCT00576732|82999611|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
46781046|NCT00576732|82999612|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
46781047|NCT00576732|82999607|FG000|DOUBLE BLIND|Protocol Violation|1|||
46650970|NCT00002540|82859155|FG001|Overall Study|Refused ASU (Control)|0|||
46650971|NCT00002540|82859154|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
46650972|NCT00002540|82859155|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
46650973|NCT04799405|82859170|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
46650974|NCT04529499|82859180|FG000|Overall Study|Withdrawal by Subject|9|||
46650975|NCT04529499|82859181|FG001|Overall Study|Withdrawal by Subject|11|||
46650976|NCT04529499|82859180|FG000|Overall Study|Physician Decision|1|||
46650977|NCT04529499|82859181|FG001|Overall Study|Physician Decision|2|||
46650978|NCT04529499|82859180|FG000|Overall Study|Adverse Event|4|||
46650979|NCT04529499|82859181|FG001|Overall Study|Adverse Event|4|||
46650980|NCT04529499|82859180|FG000|Overall Study|Death|14|||
46650981|NCT04529499|82859181|FG001|Overall Study|Death|11|||
46650982|NCT04529499|82859180|FG000|Overall Study|Lost to Follow-up|1|||
46650983|NCT04529499|82859181|FG001|Overall Study|Lost to Follow-up|1|||
46650984|NCT04529499|82859180|FG000|Overall Study|Others|7|||
46650985|NCT04529499|82859181|FG001|Overall Study|Others|11|||
46970671|NCT02063854|83213963|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
46970672|NCT02063854|83213964|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
46970673|NCT02063854|83213965|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
46970674|NCT02063854|83213966|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
46970675|NCT02063854|83213967|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
46970676|NCT02063854|83213968|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
46970677|NCT02063854|83213962|FG000|Overall Study|Reason Not Specified|1|||
46970678|NCT02063854|83213963|FG001|Overall Study|Reason Not Specified|0|||
46970679|NCT02063854|83213964|FG002|Overall Study|Reason Not Specified|0|||
46970680|NCT02063854|83213965|FG003|Overall Study|Reason Not Specified|0|||
46970681|NCT02063854|83213966|FG004|Overall Study|Reason Not Specified|0|||
46970682|NCT02063854|83213967|FG005|Overall Study|Reason Not Specified|0|||
46970683|NCT02063854|83213968|FG006|Overall Study|Reason Not Specified|0|||
46970684|NCT02063854|83213962|FG000|Overall Study|Did Not Receive Study Drug|0|||
46970685|NCT02063854|83213963|FG001|Overall Study|Did Not Receive Study Drug|0|||
46970686|NCT02063854|83213964|FG002|Overall Study|Did Not Receive Study Drug|0|||
46970687|NCT02063854|83213965|FG003|Overall Study|Did Not Receive Study Drug|0|||
46970688|NCT02063854|83213966|FG004|Overall Study|Did Not Receive Study Drug|0|||
46970689|NCT02063854|83213967|FG005|Overall Study|Did Not Receive Study Drug|1|||
46970690|NCT02063854|83213968|FG006|Overall Study|Did Not Receive Study Drug|0|||
46970691|NCT02063698|83213988|FG000|Overall Study|did not complete booklet for days 2-8|1|||
46970692|NCT02063698|83213989|FG001|Overall Study|did not complete booklet for days 2-8|2|||
46970693|NCT02062450|83213997|FG000|Overall Study|No follow-up visit|124|||
46970694|NCT02561247|83214005|FG000|Overall Study|Protocol Violation|1|||
46970695|NCT02561247|83214005|FG000|Overall Study|Withdrawal by Subject|1|||
46970696|NCT02561247|83214005|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
46970697|NCT02061592|83214011|FG000|Period 1|Withdrawal by Subject|1|||
46970698|NCT02061592|83214012|FG001|Period 1|Withdrawal by Subject|0|||
46970699|NCT02061592|83214011|FG000|Period 1|Protocol Violation|1|||
46970700|NCT02061592|83214012|FG001|Period 1|Protocol Violation|0|||
46970701|NCT02061592|83214011|FG000|Period 2|Lost to Follow-up|0|||
46970702|NCT02061592|83214012|FG001|Period 2|Lost to Follow-up|1|||
46970703|NCT01663623|83214022|FG000|Overall Study|Adverse Event|3|||
46970704|NCT01663623|83214023|FG001|Overall Study|Adverse Event|7|||
46970705|NCT01663623|83214022|FG000|Overall Study|Lack of Efficacy|5|||
46970706|NCT01663623|83214023|FG001|Overall Study|Lack of Efficacy|6|||
46970707|NCT01663623|83214022|FG000|Overall Study|Protocol Violation|0|||
46970708|NCT01663623|83214023|FG001|Overall Study|Protocol Violation|1|||
46970709|NCT01663623|83214022|FG000|Overall Study|Other-Study closed/terminated|1|||
46970710|NCT01663623|83214023|FG001|Overall Study|Other-Study closed/terminated|1|||
46970711|NCT01663623|83214022|FG000|Overall Study|Physician Decision|1|||
46970712|NCT01663623|83214023|FG001|Overall Study|Physician Decision|4|||
46970713|NCT01663623|83214022|FG000|Overall Study|Withdrawal by Subject|2|||
46970714|NCT01663623|83214023|FG001|Overall Study|Withdrawal by Subject|1|||
46970715|NCT02042950|83214029|FG000|Overall Study|Progressive Disease|4|||
46970716|NCT02042404|83214033|FG000|Overall Study|Death|1|||
46970717|NCT02042404|83214034|FG001|Overall Study|Death|0|||
46650986|NCT04501094|82859189|FG000|Overall Study|Death (unrelated to research)|1|||
46650987|NCT04501094|82859190|FG001|Overall Study|Death (unrelated to research)|0|||
46650988|NCT04414618|82859198|FG000|Overall Study|Death|3|||
46650989|NCT04414618|82859199|FG001|Overall Study|Death|3|||
46650990|NCT04414618|82859198|FG000|Overall Study|Withdrawal by Subject|2|||
46650991|NCT04414618|82859199|FG001|Overall Study|Withdrawal by Subject|1|||
46650992|NCT04414618|82859198|FG000|Overall Study|Lost to Follow-up|2|||
46970718|NCT02042404|83214033|FG000|Overall Study|Unrelated Adverse Event|3|||
46970719|NCT02042404|83214034|FG001|Overall Study|Unrelated Adverse Event|0|||
46970720|NCT02042404|83214033|FG000|Overall Study|Inability to meet time requirements|1|||
46970721|NCT02042404|83214034|FG001|Overall Study|Inability to meet time requirements|0|||
46970722|NCT02042014|83214041|FG000|Overall Study|Adverse Event|1|||
46970723|NCT02042014|83214041|FG000|Overall Study|Physician Decision|7|||
46650993|NCT04414618|82859199|FG001|Overall Study|Lost to Follow-up|3|||
46650994|NCT04414618|82859198|FG000|Overall Study|Physician Decision|1|||
46650995|NCT04414618|82859199|FG001|Overall Study|Physician Decision|0|||
46650996|NCT04412057|82859208|FG000|Overall Study|Death|3|||
46650997|NCT04412057|82859209|FG001|Overall Study|Death|7|||
46650998|NCT04412057|82859208|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
46650999|NCT04412057|82859209|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
46651000|NCT04402060|82859218|FG000|Overall Study|Death|1|||
46651001|NCT04402060|82859219|FG001|Overall Study|Death|12|||
46651002|NCT04402060|82859220|FG002|Overall Study|Death|7|||
46651003|NCT04402060|82859218|FG000|Overall Study|Adverse Event|0|||
46651004|NCT04402060|82859219|FG001|Overall Study|Adverse Event|0|||
46651005|NCT04402060|82859220|FG002|Overall Study|Adverse Event|1|||
46651006|NCT04402060|82859218|FG000|Overall Study|Withdrawal by Subject|0|||
46651007|NCT04402060|82859219|FG001|Overall Study|Withdrawal by Subject|1|||
46651008|NCT04402060|82859220|FG002|Overall Study|Withdrawal by Subject|2|||
46651009|NCT04402060|82859218|FG000|Overall Study|Sponsor Request|0|||
46651010|NCT04402060|82859219|FG001|Overall Study|Sponsor Request|2|||
46651011|NCT04402060|82859220|FG002|Overall Study|Sponsor Request|0|||
46651012|NCT04402060|82859218|FG000|Overall Study|Physician Decision|0|||
46651013|NCT04402060|82859219|FG001|Overall Study|Physician Decision|0|||
46651014|NCT04402060|82859220|FG002|Overall Study|Physician Decision|1|||
46651015|NCT04402060|82859218|FG000|Overall Study|Other|0|||
46651016|NCT04402060|82859219|FG001|Overall Study|Other|1|||
46651017|NCT04402060|82859220|FG002|Overall Study|Other|0|||
46651018|NCT04376684|82859255|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
46651019|NCT04376684|82859256|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
46651020|NCT04376684|82859257|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
46651021|NCT04376684|82859258|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
46651022|NCT04376684|82859255|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
46651023|NCT04376684|82859256|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
46651024|NCT04376684|82859257|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
46651025|NCT04376684|82859258|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
46651026|NCT04376684|82859255|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
46651027|NCT04376684|82859256|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
46651028|NCT04376684|82859257|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
46651029|NCT04376684|82859258|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
46651030|NCT04376684|82859255|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
46651031|NCT04376684|82859256|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
46651032|NCT04376684|82859257|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
46651033|NCT04376684|82859258|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
46651034|NCT04376684|82859255|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
46651035|NCT04376684|82859256|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
46651036|NCT04376684|82859257|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
46651037|NCT04376684|82859258|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
46651038|NCT04376684|82859255|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
46651039|NCT04376684|82859256|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
46651040|NCT04376684|82859257|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
46651041|NCT04376684|82859258|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
46651042|NCT04376684|82859255|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
46651043|NCT04376684|82859256|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
46651044|NCT04376684|82859257|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
46651045|NCT04376684|82859258|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
47075227|NCT04126213|83369122|FG003|Overall Study|Other|2|||
47075228|NCT04126213|83369123|FG004|Overall Study|Other|0|||
47075229|NCT04126213|83369124|FG005|Overall Study|Other|1|||
47075230|NCT04126213|83369119|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
47075231|NCT04126213|83369120|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
47075232|NCT04126213|83369121|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
47075233|NCT04126213|83369122|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
47075234|NCT04126213|83369123|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
47075235|NCT04126213|83369124|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
46651046|NCT04353284|82859270|FG000|Overall Study|Adverse Event|1|||
46651047|NCT04353284|82859271|FG001|Overall Study|Adverse Event|1|||
46651048|NCT04353284|82859270|FG000|Overall Study|Lost to Follow-up|1|||
46651049|NCT04353284|82859271|FG001|Overall Study|Lost to Follow-up|0|||
46651050|NCT04294147|82859279|FG000|Overall Study|Protocol Violation|2|||
46651051|NCT04294147|82859280|FG001|Overall Study|Protocol Violation|0|||
46651052|NCT04231825|82859292|FG000|Overall Study|Protocol Violation|3|||
46781048|NCT00576732|82999608|FG001|DOUBLE BLIND|Protocol Violation|0|||
47075236|NCT04128319|83369141|FG000|Overall Study|Death|3|||
46651053|NCT04231825|82859293|FG001|Overall Study|Protocol Violation|3|||
46651054|NCT04231825|82859292|FG000|Overall Study|Lost to Follow-up|0|||
46651055|NCT04231825|82859293|FG001|Overall Study|Lost to Follow-up|1|||
46651056|NCT04178772|82859299|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
46651057|NCT04178772|82859299|FG000|Overall Study|study terminated early due to COVID-19|7|||
46781049|NCT00576732|82999609|FG002|DOUBLE BLIND|Protocol Violation|0|||
46651058|NCT04148651|82859303|FG000|Overall Study|Lost to Follow-up|2|||
46651059|NCT03924427|82859316|FG000|Overall Study|Adverse Event|4|||
46651060|NCT03924427|82859316|FG000|Overall Study|Lack of Efficacy|1|||
46651061|NCT03924427|82859316|FG000|Overall Study|Withdrawal by Subject|1|||
46651062|NCT03642132|82859360|FG000|Chemotherapy Period|Adverse Event|1|||
46651063|NCT03642132|82859361|FG001|Chemotherapy Period|Adverse Event|1|||
46651064|NCT03642132|82859362|FG002|Chemotherapy Period|Adverse Event|0|||
46651065|NCT03642132|82859360|FG000|Chemotherapy Period|Physician's decision|4|||
46651066|NCT03642132|82859361|FG001|Chemotherapy Period|Physician's decision|1|||
46651067|NCT03642132|82859362|FG002|Chemotherapy Period|Physician's decision|0|||
46651068|NCT03642132|82859360|FG000|Chemotherapy Period|Progressive disease|0|||
46651069|NCT03642132|82859361|FG001|Chemotherapy Period|Progressive disease|0|||
46651070|NCT03642132|82859362|FG002|Chemotherapy Period|Progressive disease|1|||
46651071|NCT03642132|82859360|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
46651072|NCT03642132|82859361|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
46651073|NCT03642132|82859362|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
46651074|NCT03642132|82859360|FG000|Chemotherapy Period|Other|1|||
46651075|NCT03642132|82859361|FG001|Chemotherapy Period|Other|0|||
46651076|NCT03642132|82859362|FG002|Chemotherapy Period|Other|2|||
46651077|NCT03642132|82859360|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
46651078|NCT03642132|82859361|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
46651079|NCT03642132|82859362|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
46651080|NCT03642132|82859360|FG000|Maintenance Period|Adverse Event|1|||
46651081|NCT03642132|82859361|FG001|Maintenance Period|Adverse Event|2|||
46651082|NCT03642132|82859362|FG002|Maintenance Period|Adverse Event|0|||
46651083|NCT03642132|82859360|FG000|Maintenance Period|Non-compliance with study drug|0|||
46651084|NCT03642132|82859361|FG001|Maintenance Period|Non-compliance with study drug|0|||
46651085|NCT03642132|82859362|FG002|Maintenance Period|Non-compliance with study drug|1|||
46651086|NCT03642132|82859360|FG000|Maintenance Period|Physician's decision|2|||
46651087|NCT03642132|82859361|FG001|Maintenance Period|Physician's decision|2|||
46651088|NCT03642132|82859362|FG002|Maintenance Period|Physician's decision|2|||
46651089|NCT03642132|82859360|FG000|Maintenance Period|Progressive disease|9|||
46651090|NCT03642132|82859361|FG001|Maintenance Period|Progressive disease|3|||
46651091|NCT03642132|82859362|FG002|Maintenance Period|Progressive disease|6|||
46651092|NCT03642132|82859360|FG000|Maintenance Period|Other|0|||
46651093|NCT03642132|82859361|FG001|Maintenance Period|Other|0|||
46651094|NCT03642132|82859362|FG002|Maintenance Period|Other|3|||
46651095|NCT03642132|82859360|FG000|Maintenance Period|Withdrawal by Subject|1|||
46651096|NCT03642132|82859361|FG001|Maintenance Period|Withdrawal by Subject|1|||
46651097|NCT03642132|82859362|FG002|Maintenance Period|Withdrawal by Subject|2|||
46651098|NCT03642132|82859360|FG000|Follow-up Period|Other|0|||
46651099|NCT03642132|82859361|FG001|Follow-up Period|Other|0|||
46651100|NCT03642132|82859362|FG002|Follow-up Period|Other|1|||
46651101|NCT03642132|82859360|FG000|Follow-up Period|Withdrawal by Subject|1|||
46651102|NCT03642132|82859361|FG001|Follow-up Period|Withdrawal by Subject|2|||
46651103|NCT03642132|82859362|FG002|Follow-up Period|Withdrawal by Subject|0|||
46651104|NCT03642132|82859360|FG000|Follow-up Period|Study terminated by sponsor|1|||
46651105|NCT03642132|82859361|FG001|Follow-up Period|Study terminated by sponsor|0|||
46651106|NCT03642132|82859362|FG002|Follow-up Period|Study terminated by sponsor|1|||
46651107|NCT03642132|82859360|FG000|Follow-up Period|Lack of Efficacy|1|||
46651108|NCT03642132|82859361|FG001|Follow-up Period|Lack of Efficacy|0|||
46651109|NCT03642132|82859362|FG002|Follow-up Period|Lack of Efficacy|0|||
46651110|NCT03642132|82859360|FG000|Follow-up Period|Death|1|||
46651111|NCT03642132|82859361|FG001|Follow-up Period|Death|0|||
46651112|NCT03642132|82859362|FG002|Follow-up Period|Death|2|||
46651113|NCT03642132|82859360|FG000|Follow-up Period|Adverse Event|1|||
46651114|NCT03642132|82859361|FG001|Follow-up Period|Adverse Event|0|||
46651115|NCT03642132|82859362|FG002|Follow-up Period|Adverse Event|0|||
47075237|NCT05038293|83369187|FG000|Overall Study|device was not operating properly for one subject.|1|||
47075238|NCT05038293|83369188|FG001|Overall Study|device was not operating properly for one subject.|0|||
47075239|NCT05038293|83369187|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
47075240|NCT05038293|83369188|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
46651116|NCT03056339|82859374|FG000|Overall Study|Failed Requirements|0|||
46651117|NCT03056339|82859375|FG001|Overall Study|Failed Requirements|2|||
46651118|NCT03056339|82859376|FG002|Overall Study|Failed Requirements|7|||
46651119|NCT03056339|82859377|FG003|Overall Study|Failed Requirements|1|||
46651120|NCT03008122|82859390|FG000|Overall Study|Physician Decision|3|||
46651121|NCT03008122|82859391|FG001|Overall Study|Physician Decision|2|||
46651122|NCT03008122|82859392|FG002|Overall Study|Physician Decision|0|||
46651123|NCT03008122|82859390|FG000|Overall Study|Withdrawal by Subject|1|||
46651124|NCT03008122|82859391|FG001|Overall Study|Withdrawal by Subject|3|||
46651125|NCT03008122|82859392|FG002|Overall Study|Withdrawal by Subject|0|||
46651126|NCT03008122|82859390|FG000|Overall Study|Lost to Follow-up|4|||
46651127|NCT03008122|82859391|FG001|Overall Study|Lost to Follow-up|8|||
46651128|NCT03008122|82859392|FG002|Overall Study|Lost to Follow-up|3|||
46651129|NCT03008122|82859390|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
46651130|NCT03008122|82859391|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
46651131|NCT03008122|82859392|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
46651132|NCT03008122|82859390|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
46651133|NCT03008122|82859391|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
46651134|NCT03008122|82859392|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
46651135|NCT03008122|82859390|FG000|Overall Study|Death|0|||
46651136|NCT03008122|82859391|FG001|Overall Study|Death|0|||
46651137|NCT03008122|82859392|FG002|Overall Study|Death|1|||
46651138|NCT01817751|82859434|FG000|Overall Study|Physician Decision|1|||
46651139|NCT01349322|82859450|FG000|Overall Study|Protocol Violation|45|||
46651140|NCT01349322|82859451|FG001|Overall Study|Protocol Violation|47|||
46651141|NCT01182415|82859463|FG000|Overall Study|Lost to Follow-up|1|||
46651142|NCT01030523|82859469|FG000|Initial Study (5 Years)|Death|1|||
46651143|NCT01030523|82859470|FG001|Initial Study (5 Years)|Death|0|||
46651144|NCT01030523|82859469|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
46651145|NCT01030523|82859470|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
46651146|NCT01030523|82859469|FG000|Initial Study (5 Years)|Implant failure|1|||
46651147|NCT01030523|82859470|FG001|Initial Study (5 Years)|Implant failure|0|||
46651148|NCT01030523|82859469|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
46651149|NCT01030523|82859470|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
46651150|NCT01030523|82859469|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
46651151|NCT01030523|82859470|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
46651152|NCT01030523|82859469|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
46651153|NCT01030523|82859470|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
46651154|NCT03811574|82859509|FG000|Overall Study|Withdrawal by Subject|2|||
46651155|NCT03811574|82859510|FG001|Overall Study|Withdrawal by Subject|4|||
46651156|NCT03811574|82859511|FG002|Overall Study|Withdrawal by Subject|0|||
46651157|NCT03727750|82859534|FG000|Overall Study|Death|45|||
46651158|NCT03727750|82859534|FG000|Overall Study|Withdrawal by Subject|2|||
46651159|NCT03727750|82859534|FG000|Overall Study|Lost to Follow-up|1|||
46651160|NCT03727750|82859534|FG000|Overall Study|Other|1|||
46651161|NCT03715829|82859544|FG000|Dose Ranging Period|Adverse Event|2|||
46651162|NCT03715829|82859545|FG001|Dose Ranging Period|Adverse Event|4|||
46651163|NCT03715829|82859546|FG002|Dose Ranging Period|Adverse Event|5|||
46651164|NCT03715829|82859547|FG003|Dose Ranging Period|Adverse Event|2|||
46651165|NCT03715829|82859548|FG004|Dose Ranging Period|Adverse Event|3|||
46651166|NCT03715829|82859549|FG005|Dose Ranging Period|Adverse Event|3|||
46781050|NCT00576732|82999610|FG003|DOUBLE BLIND|Protocol Violation|0|||
46781051|NCT00576732|82999611|FG004|DOUBLE BLIND|Protocol Violation|0|||
46781052|NCT00576732|82999612|FG005|DOUBLE BLIND|Protocol Violation|0|||
46781053|NCT00576732|82999607|FG000|OPEN LABEL|Adverse Event|0|||
46781054|NCT00576732|82999608|FG001|OPEN LABEL|Adverse Event|0|||
46781055|NCT00576732|82999609|FG002|OPEN LABEL|Adverse Event|0|||
46781056|NCT00576732|82999610|FG003|OPEN LABEL|Adverse Event|4|||
46781057|NCT00576732|82999611|FG004|OPEN LABEL|Adverse Event|0|||
46781058|NCT00576732|82999612|FG005|OPEN LABEL|Adverse Event|1|||
46781059|NCT00576732|82999607|FG000|OPEN LABEL|Lost to Follow-up|0|||
46781060|NCT00576732|82999608|FG001|OPEN LABEL|Lost to Follow-up|0|||
46781061|NCT00576732|82999609|FG002|OPEN LABEL|Lost to Follow-up|0|||
46781062|NCT00576732|82999610|FG003|OPEN LABEL|Lost to Follow-up|2|||
46781063|NCT00576732|82999611|FG004|OPEN LABEL|Lost to Follow-up|1|||
46781064|NCT00576732|82999612|FG005|OPEN LABEL|Lost to Follow-up|1|||
46781065|NCT00576732|82999607|FG000|OPEN LABEL|Withdrawal by Subject|0|||
46781066|NCT00576732|82999608|FG001|OPEN LABEL|Withdrawal by Subject|0|||
46781067|NCT00576732|82999609|FG002|OPEN LABEL|Withdrawal by Subject|0|||
46781068|NCT00576732|82999610|FG003|OPEN LABEL|Withdrawal by Subject|1|||
46781069|NCT00576732|82999611|FG004|OPEN LABEL|Withdrawal by Subject|0|||
47075241|NCT04753164|83369205|FG000|Overall Study|Adverse Event|0|||
47075242|NCT04753164|83369206|FG001|Overall Study|Adverse Event|2|||
47075243|NCT04753164|83369205|FG000|Overall Study|Withdrawal by Subject|9|||
47075244|NCT04753164|83369206|FG001|Overall Study|Withdrawal by Subject|7|||
47075245|NCT04753164|83369205|FG000|Overall Study|Lost to Follow-up|6|||
47075246|NCT04753164|83369206|FG001|Overall Study|Lost to Follow-up|6|||
47075247|NCT04753164|83369205|FG000|Overall Study|Other|12|||
47075248|NCT04753164|83369206|FG001|Overall Study|Other|5|||
46651167|NCT03715829|82859550|FG006|Dose Ranging Period|Adverse Event|0|||
46651168|NCT03715829|82859551|FG007|Dose Ranging Period|Adverse Event|0|||
46651169|NCT03715829|82859552|FG008|Dose Ranging Period|Adverse Event|0|||
46651170|NCT03715829|82859553|FG009|Dose Ranging Period|Adverse Event|0|||
46781070|NCT00576732|82999612|FG005|OPEN LABEL|Withdrawal by Subject|1|||
47075249|NCT04729101|83369214|FG000|Overall Study|Adverse Event|1|||
47075250|NCT04729101|83369215|FG001|Overall Study|Adverse Event|0|||
46651171|NCT03715829|82859554|FG010|Dose Ranging Period|Adverse Event|0|||
46651172|NCT03715829|82859544|FG000|Dose Ranging Period|Lack of Efficacy|0|||
46651173|NCT03715829|82859545|FG001|Dose Ranging Period|Lack of Efficacy|1|||
46651174|NCT03715829|82859546|FG002|Dose Ranging Period|Lack of Efficacy|0|||
46781071|NCT00576732|82999607|FG000|OPEN LABEL|OTHER|0|||
46781072|NCT00576732|82999608|FG001|OPEN LABEL|OTHER|0|||
46781073|NCT00576732|82999609|FG002|OPEN LABEL|OTHER|0|||
46781074|NCT00576732|82999610|FG003|OPEN LABEL|OTHER|0|||
46781075|NCT00576732|82999611|FG004|OPEN LABEL|OTHER|0|||
46781076|NCT00576732|82999612|FG005|OPEN LABEL|OTHER|2|||
46781077|NCT00576732|82999607|FG000|OPEN LABEL|Lack of Efficacy|0|||
46781078|NCT00576732|82999608|FG001|OPEN LABEL|Lack of Efficacy|0|||
46781079|NCT00576732|82999609|FG002|OPEN LABEL|Lack of Efficacy|0|||
46651175|NCT03715829|82859547|FG003|Dose Ranging Period|Lack of Efficacy|1|||
46651176|NCT03715829|82859548|FG004|Dose Ranging Period|Lack of Efficacy|0|||
46781080|NCT00576732|82999610|FG003|OPEN LABEL|Lack of Efficacy|2|||
46781081|NCT00576732|82999611|FG004|OPEN LABEL|Lack of Efficacy|2|||
46781082|NCT00576732|82999612|FG005|OPEN LABEL|Lack of Efficacy|3|||
46781083|NCT00576732|82999607|FG000|OPEN LABEL|Protocol Violation|0|||
46781084|NCT00576732|82999608|FG001|OPEN LABEL|Protocol Violation|0|||
46781085|NCT00576732|82999609|FG002|OPEN LABEL|Protocol Violation|0|||
46781086|NCT00576732|82999610|FG003|OPEN LABEL|Protocol Violation|2|||
46781087|NCT00576732|82999611|FG004|OPEN LABEL|Protocol Violation|1|||
46781088|NCT00576732|82999612|FG005|OPEN LABEL|Protocol Violation|0|||
46781089|NCT00697788|82999624|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
46781090|NCT00697788|82999625|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
46781091|NCT00697788|82999626|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
46781092|NCT00697788|82999627|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
46781093|NCT00697788|82999628|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
46781094|NCT00697788|82999629|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
46781095|NCT00697788|82999630|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
46781096|NCT00697788|82999631|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
46781097|NCT00697788|82999624|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
46781098|NCT00697788|82999625|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
46781099|NCT00697788|82999626|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
46781100|NCT00697788|82999627|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
46781101|NCT00697788|82999628|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
46781102|NCT00697788|82999629|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
46781103|NCT00697788|82999630|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
46781104|NCT00697788|82999631|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
46781105|NCT00400153|82999661|FG000|Overall Study|AE due to study disease worsening|14|||
46781106|NCT00400153|82999662|FG001|Overall Study|AE due to study disease worsening|19|||
46850752|NCT00382109|83066536|FG000|Overall Study|Adverse Event|3|||
46970724|NCT02041702|83214047|FG000|Overall Study|Lost to Follow-up|1|||
46970725|NCT02041702|83214048|FG001|Overall Study|Lost to Follow-up|6|||
46651177|NCT03715829|82859549|FG005|Dose Ranging Period|Lack of Efficacy|0|||
46970726|NCT02041702|83214047|FG000|Overall Study|Death|4|||
46970727|NCT02041702|83214048|FG001|Overall Study|Death|0|||
46781107|NCT00400153|82999663|FG002|Overall Study|AE due to study disease worsening|20|||
46781108|NCT00400153|82999661|FG000|Overall Study|AE due to other disease worsening|2|||
46781109|NCT00400153|82999662|FG001|Overall Study|AE due to other disease worsening|1|||
46970728|NCT02041702|83214047|FG000|Overall Study|Withdrawal by Subject|4|||
46781110|NCT00400153|82999663|FG002|Overall Study|AE due to other disease worsening|0|||
46781111|NCT00400153|82999661|FG000|Overall Study|AE due to other condition|3|||
46781112|NCT00400153|82999662|FG001|Overall Study|AE due to other condition|14|||
46781113|NCT00400153|82999663|FG002|Overall Study|AE due to other condition|15|||
46970729|NCT02041702|83214048|FG001|Overall Study|Withdrawal by Subject|3|||
46651178|NCT03715829|82859550|FG006|Dose Ranging Period|Lack of Efficacy|0|||
46651179|NCT03715829|82859551|FG007|Dose Ranging Period|Lack of Efficacy|0|||
46651180|NCT03715829|82859552|FG008|Dose Ranging Period|Lack of Efficacy|0|||
46651181|NCT03715829|82859553|FG009|Dose Ranging Period|Lack of Efficacy|0|||
46651182|NCT03715829|82859554|FG010|Dose Ranging Period|Lack of Efficacy|0|||
46651183|NCT03715829|82859544|FG000|Dose Ranging Period|Lost to Follow-up|2|||
46651184|NCT03715829|82859545|FG001|Dose Ranging Period|Lost to Follow-up|0|||
46651185|NCT03715829|82859546|FG002|Dose Ranging Period|Lost to Follow-up|1|||
46651186|NCT03715829|82859547|FG003|Dose Ranging Period|Lost to Follow-up|1|||
46651187|NCT03715829|82859548|FG004|Dose Ranging Period|Lost to Follow-up|1|||
46651188|NCT03715829|82859549|FG005|Dose Ranging Period|Lost to Follow-up|2|||
46651189|NCT03715829|82859550|FG006|Dose Ranging Period|Lost to Follow-up|0|||
46651190|NCT03715829|82859551|FG007|Dose Ranging Period|Lost to Follow-up|0|||
46651191|NCT03715829|82859552|FG008|Dose Ranging Period|Lost to Follow-up|0|||
46651192|NCT03715829|82859553|FG009|Dose Ranging Period|Lost to Follow-up|0|||
46651193|NCT03715829|82859554|FG010|Dose Ranging Period|Lost to Follow-up|0|||
46651194|NCT03715829|82859544|FG000|Dose Ranging Period|Protocol Violation|0|||
46651195|NCT03715829|82859545|FG001|Dose Ranging Period|Protocol Violation|0|||
46651196|NCT03715829|82859546|FG002|Dose Ranging Period|Protocol Violation|0|||
46651197|NCT03715829|82859547|FG003|Dose Ranging Period|Protocol Violation|1|||
46651198|NCT03715829|82859548|FG004|Dose Ranging Period|Protocol Violation|0|||
46651199|NCT03715829|82859549|FG005|Dose Ranging Period|Protocol Violation|0|||
46651200|NCT03715829|82859550|FG006|Dose Ranging Period|Protocol Violation|0|||
46651201|NCT03715829|82859551|FG007|Dose Ranging Period|Protocol Violation|0|||
46651202|NCT03715829|82859552|FG008|Dose Ranging Period|Protocol Violation|0|||
46651203|NCT03715829|82859553|FG009|Dose Ranging Period|Protocol Violation|0|||
46651204|NCT03715829|82859554|FG010|Dose Ranging Period|Protocol Violation|0|||
46651205|NCT03715829|82859544|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
46651206|NCT03715829|82859545|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
46651207|NCT03715829|82859546|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
46651208|NCT03715829|82859547|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
46651209|NCT03715829|82859548|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
46651210|NCT03715829|82859549|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
46651211|NCT03715829|82859550|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
46651212|NCT03715829|82859551|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
46651213|NCT03715829|82859552|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
46651214|NCT03715829|82859553|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
46651215|NCT03715829|82859554|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
46651216|NCT03715829|82859544|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651217|NCT03715829|82859545|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651218|NCT03715829|82859546|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
46651219|NCT03715829|82859547|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651220|NCT03715829|82859548|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651221|NCT03715829|82859549|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651222|NCT03715829|82859550|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651223|NCT03715829|82859551|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651224|NCT03715829|82859552|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651225|NCT03715829|82859553|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651226|NCT03715829|82859554|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
46651227|NCT03715829|82859544|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651228|NCT03715829|82859545|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651229|NCT03715829|82859546|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
46651230|NCT03715829|82859547|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651231|NCT03715829|82859548|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
46651232|NCT03715829|82859549|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651233|NCT03715829|82859550|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651234|NCT03715829|82859551|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651235|NCT03715829|82859552|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651236|NCT03715829|82859553|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651237|NCT03715829|82859554|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
46651238|NCT03715829|82859544|FG000|Dose Ranging Period|Other|0|||
46651239|NCT03715829|82859545|FG001|Dose Ranging Period|Other|0|||
46781114|NCT00400153|82999661|FG000|Overall Study|Protocol Violation|7|||
46970730|NCT02041702|83214047|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
46651240|NCT03715829|82859546|FG002|Dose Ranging Period|Other|2|||
47075251|NCT04729101|83369214|FG000|Overall Study|Physician Decision|1|||
46651241|NCT03715829|82859547|FG003|Dose Ranging Period|Other|0|||
46781115|NCT00400153|82999662|FG001|Overall Study|Protocol Violation|4|||
46651242|NCT03715829|82859548|FG004|Dose Ranging Period|Other|0|||
46781116|NCT00400153|82999663|FG002|Overall Study|Protocol Violation|9|||
46781117|NCT00400153|82999661|FG000|Overall Study|Lost to Follow-up|2|||
46781118|NCT00400153|82999662|FG001|Overall Study|Lost to Follow-up|1|||
46781119|NCT00400153|82999663|FG002|Overall Study|Lost to Follow-up|4|||
46781120|NCT00400153|82999661|FG000|Overall Study|Withdrawal by Subject|12|||
46781121|NCT00400153|82999662|FG001|Overall Study|Withdrawal by Subject|11|||
46781122|NCT00400153|82999663|FG002|Overall Study|Withdrawal by Subject|10|||
46781123|NCT00400153|82999661|FG000|Overall Study|Other reasons - not mentioned above|8|||
46781124|NCT00400153|82999662|FG001|Overall Study|Other reasons - not mentioned above|5|||
46781125|NCT00400153|82999663|FG002|Overall Study|Other reasons - not mentioned above|3|||
46781126|NCT00631917|82999678|FG000|Overall Study|Adverse Event|34|||
46781127|NCT00631917|82999679|FG001|Overall Study|Adverse Event|45|||
47075252|NCT04729101|83369215|FG001|Overall Study|Physician Decision|0|||
47075253|NCT04729101|83369214|FG000|Overall Study|Withdrawal by Subject|1|||
47075254|NCT04729101|83369215|FG001|Overall Study|Withdrawal by Subject|0|||
47075255|NCT04569968|83369241|FG000|Overall Study|Lost to Follow-up|2|||
47075256|NCT04569968|83369242|FG001|Overall Study|Lost to Follow-up|5|||
47075257|NCT04569968|83369241|FG000|Overall Study|Story of head and/or neck surgery|2|||
47075258|NCT04569968|83369242|FG001|Overall Study|Story of head and/or neck surgery|2|||
47075259|NCT04569968|83369241|FG000|Overall Study|Time of stroke onset|8|||
47075260|NCT04569968|83369242|FG001|Overall Study|Time of stroke onset|7|||
47075261|NCT04569968|83369241|FG000|Overall Study|Type of strokr|12|||
47075262|NCT04569968|83369242|FG001|Overall Study|Type of strokr|8|||
47075263|NCT04569968|83369241|FG000|Overall Study|Cooperation|8|||
47075264|NCT04569968|83369242|FG001|Overall Study|Cooperation|8|||
47075265|NCT04569968|83369241|FG000|Overall Study|Age interval|17|||
47075266|NCT04569968|83369242|FG001|Overall Study|Age interval|6|||
47075267|NCT04569968|83369241|FG000|Overall Study|Denial of participation to the study|0|||
47075268|NCT04569968|83369242|FG001|Overall Study|Denial of participation to the study|3|||
47075269|NCT04569968|83369241|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
47075270|NCT04569968|83369242|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
47075271|NCT04569968|83369241|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
47075272|NCT04569968|83369242|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
47075273|NCT04569968|83369241|FG000|Overall Study|Quarantine|1|||
47075274|NCT04569968|83369242|FG001|Overall Study|Quarantine|0|||
47075275|NCT04569968|83369241|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
47075276|NCT04569968|83369242|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
47075277|NCT04569968|83369241|FG000|Overall Study|Repetitive stroke|8|||
47075278|NCT04569968|83369242|FG001|Overall Study|Repetitive stroke|0|||
47075279|NCT04569968|83369241|FG000|Overall Study|Insufficient mastication|1|||
47075280|NCT04569968|83369242|FG001|Overall Study|Insufficient mastication|0|||
47075281|NCT04569968|83369241|FG000|Overall Study|Infection|1|||
47075282|NCT04569968|83369242|FG001|Overall Study|Infection|0|||
47075283|NCT03385304|83369250|FG000|Overall Study|Death|19|||
47075284|NCT03385304|83369251|FG001|Overall Study|Death|7|||
47075285|NCT03385304|83369250|FG000|Overall Study|Lost to Follow-up|17|||
47075286|NCT03385304|83369251|FG001|Overall Study|Lost to Follow-up|14|||
47075287|NCT03385304|83369250|FG000|Overall Study|Withdrawal by Subject|3|||
47075288|NCT03385304|83369251|FG001|Overall Study|Withdrawal by Subject|2|||
47075289|NCT03385304|83369250|FG000|Overall Study|Incarceration|2|||
47075290|NCT03385304|83369251|FG001|Overall Study|Incarceration|3|||
47075291|NCT03325608|83369261|FG000|Overall Study|Lost to Follow-up|47|||
47075292|NCT03325608|83369262|FG001|Overall Study|Lost to Follow-up|47|||
47075293|NCT03325608|83369263|FG002|Overall Study|Lost to Follow-up|41|||
47075294|NCT03325608|83369264|FG003|Overall Study|Lost to Follow-up|41|||
46781128|NCT00631917|82999678|FG000|Overall Study|Abnormal laboratory value(s)|2|||
47075295|NCT03325608|83369261|FG000|Overall Study|Death|44|||
47075296|NCT03325608|83369262|FG001|Overall Study|Death|0|||
47075297|NCT03325608|83369263|FG002|Overall Study|Death|41|||
47075298|NCT03325608|83369264|FG003|Overall Study|Death|0|||
47075299|NCT03325608|83369261|FG000|Overall Study|Death of Care Recipient|0|||
47075300|NCT03325608|83369262|FG001|Overall Study|Death of Care Recipient|44|||
47075301|NCT03325608|83369263|FG002|Overall Study|Death of Care Recipient|0|||
46781129|NCT00631917|82999679|FG001|Overall Study|Abnormal laboratory value(s)|1|||
47075302|NCT03325608|83369264|FG003|Overall Study|Death of Care Recipient|41|||
47075303|NCT03325608|83369261|FG000|Overall Study|Withdrawal by Subject|44|||
46781130|NCT00631917|82999678|FG000|Overall Study|Abnormal test procedure result(s)|3|||
46781131|NCT00631917|82999679|FG001|Overall Study|Abnormal test procedure result(s)|2|||
46781132|NCT00631917|82999678|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
46781133|NCT00631917|82999679|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
46781134|NCT00631917|82999678|FG000|Overall Study|No longer required study drug|0|||
46781135|NCT00631917|82999679|FG001|Overall Study|No longer required study drug|1|||
46781136|NCT00631917|82999678|FG000|Overall Study|Protocol deviation|6|||
46781137|NCT00631917|82999679|FG001|Overall Study|Protocol deviation|5|||
46781138|NCT00631917|82999678|FG000|Overall Study|Subject withdrew consent|25|||
46781139|NCT00631917|82999679|FG001|Overall Study|Subject withdrew consent|33|||
46781140|NCT00631917|82999678|FG000|Overall Study|Lost to Follow-up|7|||
46781141|NCT00631917|82999679|FG001|Overall Study|Lost to Follow-up|7|||
46651243|NCT03715829|82859549|FG005|Dose Ranging Period|Other|3|||
46651244|NCT03715829|82859550|FG006|Dose Ranging Period|Other|0|||
46651245|NCT03715829|82859551|FG007|Dose Ranging Period|Other|0|||
46651246|NCT03715829|82859552|FG008|Dose Ranging Period|Other|0|||
46651247|NCT03715829|82859553|FG009|Dose Ranging Period|Other|0|||
46651248|NCT03715829|82859554|FG010|Dose Ranging Period|Other|0|||
46651249|NCT03715829|82859544|FG000|Extension Period|Adverse Event|0|||
46651250|NCT03715829|82859545|FG001|Extension Period|Adverse Event|0|||
46651251|NCT03715829|82859546|FG002|Extension Period|Adverse Event|0|||
46651252|NCT03715829|82859547|FG003|Extension Period|Adverse Event|0|||
46651253|NCT03715829|82859548|FG004|Extension Period|Adverse Event|0|||
46651254|NCT03715829|82859549|FG005|Extension Period|Adverse Event|0|||
46651255|NCT03715829|82859550|FG006|Extension Period|Adverse Event|3|||
46651256|NCT03715829|82859551|FG007|Extension Period|Adverse Event|1|||
46651257|NCT03715829|82859552|FG008|Extension Period|Adverse Event|6|||
46651258|NCT03715829|82859553|FG009|Extension Period|Adverse Event|0|||
46651259|NCT03715829|82859554|FG010|Extension Period|Adverse Event|0|||
46651260|NCT03715829|82859544|FG000|Extension Period|Lack of Efficacy|0|||
46651261|NCT03715829|82859545|FG001|Extension Period|Lack of Efficacy|0|||
46651262|NCT03715829|82859546|FG002|Extension Period|Lack of Efficacy|0|||
46651263|NCT03715829|82859547|FG003|Extension Period|Lack of Efficacy|0|||
46651264|NCT03715829|82859548|FG004|Extension Period|Lack of Efficacy|0|||
46651265|NCT03715829|82859549|FG005|Extension Period|Lack of Efficacy|0|||
46651266|NCT03715829|82859550|FG006|Extension Period|Lack of Efficacy|1|||
46651267|NCT03715829|82859551|FG007|Extension Period|Lack of Efficacy|9|||
46651268|NCT03715829|82859552|FG008|Extension Period|Lack of Efficacy|2|||
46651269|NCT03715829|82859553|FG009|Extension Period|Lack of Efficacy|0|||
46651270|NCT03715829|82859554|FG010|Extension Period|Lack of Efficacy|0|||
46651271|NCT03715829|82859544|FG000|Extension Period|Lost to Follow-up|0|||
46651272|NCT03715829|82859545|FG001|Extension Period|Lost to Follow-up|0|||
46651273|NCT03715829|82859546|FG002|Extension Period|Lost to Follow-up|0|||
46651274|NCT03715829|82859547|FG003|Extension Period|Lost to Follow-up|0|||
46651275|NCT03715829|82859548|FG004|Extension Period|Lost to Follow-up|0|||
46651276|NCT03715829|82859549|FG005|Extension Period|Lost to Follow-up|0|||
46651277|NCT03715829|82859550|FG006|Extension Period|Lost to Follow-up|0|||
46651278|NCT03715829|82859551|FG007|Extension Period|Lost to Follow-up|0|||
46651279|NCT03715829|82859552|FG008|Extension Period|Lost to Follow-up|2|||
46651280|NCT03715829|82859553|FG009|Extension Period|Lost to Follow-up|0|||
46651281|NCT03715829|82859554|FG010|Extension Period|Lost to Follow-up|0|||
46651282|NCT03715829|82859544|FG000|Extension Period|Protocol Violation|0|||
46651283|NCT03715829|82859545|FG001|Extension Period|Protocol Violation|0|||
46651284|NCT03715829|82859546|FG002|Extension Period|Protocol Violation|0|||
46781142|NCT00631917|82999678|FG000|Overall Study|Administrative problems|2|||
46781143|NCT00631917|82999679|FG001|Overall Study|Administrative problems|0|||
46781144|NCT00631917|82999678|FG000|Overall Study|Death|1|||
46781145|NCT00631917|82999679|FG001|Overall Study|Death|0|||
46651285|NCT03715829|82859547|FG003|Extension Period|Protocol Violation|0|||
46651286|NCT03715829|82859548|FG004|Extension Period|Protocol Violation|0|||
46651287|NCT03715829|82859549|FG005|Extension Period|Protocol Violation|0|||
46651288|NCT03715829|82859550|FG006|Extension Period|Protocol Violation|0|||
46651289|NCT03715829|82859551|FG007|Extension Period|Protocol Violation|0|||
46651290|NCT03715829|82859552|FG008|Extension Period|Protocol Violation|1|||
46781146|NCT00419341|82999696|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
46781147|NCT00419341|82999696|FG000|Wash in/Wash Out Period|Adverse Event|2|||
46781148|NCT00419341|82999696|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
46651291|NCT03715829|82859553|FG009|Extension Period|Protocol Violation|0|||
46651292|NCT03715829|82859554|FG010|Extension Period|Protocol Violation|0|||
46651293|NCT03715829|82859544|FG000|Extension Period|Withdrawal by Subject|0|||
46850753|NCT00382109|83066537|FG001|Overall Study|Adverse Event|0|||
46850754|NCT00382109|83066536|FG000|Overall Study|Physician Decision|6|||
46850755|NCT00382109|83066537|FG001|Overall Study|Physician Decision|1|||
46781149|NCT00419341|82999696|FG000|Efficacy Period|Withdrawal by Subject|6|||
46781150|NCT00419341|82999696|FG000|Efficacy Period|Protocol Violation|1|||
46781151|NCT00419341|82999696|FG000|Efficacy Period|Lost to Follow-up|1|||
46781152|NCT00419341|82999696|FG000|Efficacy Period|Non-compliance|1|||
46781153|NCT00419341|82999696|FG000|Efficacy Period|Termination of study site|1|||
46781154|NCT00694122|82999702|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
46781155|NCT00694122|82999703|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
46781156|NCT00694122|82999702|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
46781157|NCT00694122|82999703|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
46781158|NCT00694122|82999702|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
46781159|NCT00694122|82999703|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
46781160|NCT03922620|82999716|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
46781161|NCT03922620|82999717|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
46781162|NCT00419263|82999726|FG000|Overall Study|Lost to Follow-up|2|||
46850756|NCT00382109|83066536|FG000|Overall Study|Withdrawal by Subject|1|||
46850757|NCT00382109|83066537|FG001|Overall Study|Withdrawal by Subject|0|||
46850758|NCT00382109|83066536|FG000|Overall Study|ineligible|2|||
46850759|NCT00382109|83066537|FG001|Overall Study|ineligible|0|||
46850760|NCT00382109|83066536|FG000|Overall Study|Other|0|||
46850761|NCT00382109|83066537|FG001|Overall Study|Other|2|||
46850762|NCT00382109|83066536|FG000|Overall Study|consent withdrawal|0|||
46970731|NCT02041702|83214048|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
46850763|NCT00382109|83066537|FG001|Overall Study|consent withdrawal|1|||
46850764|NCT03651622|83066549|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
46850765|NCT03651622|83066550|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
46850766|NCT03651622|83066551|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
46850767|NCT03651622|83066549|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
46850768|NCT03651622|83066550|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
46850769|NCT03651622|83066551|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
46850770|NCT03651622|83066549|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
46850771|NCT03651622|83066550|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
47075304|NCT03325608|83369262|FG001|Overall Study|Withdrawal by Subject|44|||
47075305|NCT03325608|83369263|FG002|Overall Study|Withdrawal by Subject|30|||
47075306|NCT03325608|83369264|FG003|Overall Study|Withdrawal by Subject|30|||
47075307|NCT03183141|83369274|FG000|Overall Study|Withdrawal by Subject|2|||
47075308|NCT03183141|83369275|FG001|Overall Study|Withdrawal by Subject|4|||
47075309|NCT03183141|83369274|FG000|Overall Study|Death|0|||
47075310|NCT03183141|83369275|FG001|Overall Study|Death|8|||
47075311|NCT02957539|83369284|FG000|Baseline to Week 16|Lost to Follow-up|8|||
47075312|NCT02957539|83369285|FG001|Baseline to Week 16|Lost to Follow-up|10|||
47075313|NCT02957539|83369286|FG002|Baseline to Week 16|Lost to Follow-up|16|||
46651294|NCT03715829|82859545|FG001|Extension Period|Withdrawal by Subject|0|||
46651295|NCT03715829|82859546|FG002|Extension Period|Withdrawal by Subject|0|||
46651296|NCT03715829|82859547|FG003|Extension Period|Withdrawal by Subject|0|||
46651297|NCT03715829|82859548|FG004|Extension Period|Withdrawal by Subject|0|||
46651298|NCT03715829|82859549|FG005|Extension Period|Withdrawal by Subject|0|||
46651299|NCT03715829|82859550|FG006|Extension Period|Withdrawal by Subject|3|||
46651300|NCT03715829|82859551|FG007|Extension Period|Withdrawal by Subject|3|||
46651301|NCT03715829|82859552|FG008|Extension Period|Withdrawal by Subject|12|||
46651302|NCT03715829|82859553|FG009|Extension Period|Withdrawal by Subject|3|||
46651303|NCT03715829|82859554|FG010|Extension Period|Withdrawal by Subject|0|||
46651304|NCT03715829|82859544|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651305|NCT03715829|82859545|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651306|NCT03715829|82859546|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651307|NCT03715829|82859547|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651308|NCT03715829|82859548|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
46781163|NCT00419263|82999727|FG001|Overall Study|Lost to Follow-up|1|||
46781164|NCT00419263|82999728|FG002|Overall Study|Lost to Follow-up|1|||
46781165|NCT00419263|82999726|FG000|Overall Study|Randomized in Error, Not Treated|1|||
46850772|NCT03651622|83066551|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
46850773|NCT03651622|83066549|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
47075314|NCT02957539|83369284|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
46651309|NCT03715829|82859549|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651310|NCT03715829|82859550|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651311|NCT03715829|82859551|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
46651312|NCT03715829|82859552|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
46651313|NCT03715829|82859553|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651314|NCT03715829|82859554|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
46651315|NCT03715829|82859544|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651316|NCT03715829|82859545|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651317|NCT03715829|82859546|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651318|NCT03715829|82859547|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651319|NCT03715829|82859548|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651320|NCT03715829|82859549|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651321|NCT03715829|82859550|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651322|NCT03715829|82859551|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651323|NCT03715829|82859552|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
46651324|NCT03715829|82859553|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651325|NCT03715829|82859554|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
46651326|NCT03715829|82859544|FG000|Extension Period|Other|0|||
46651327|NCT03715829|82859545|FG001|Extension Period|Other|0|||
46651328|NCT03715829|82859546|FG002|Extension Period|Other|0|||
46651329|NCT03715829|82859547|FG003|Extension Period|Other|0|||
46651330|NCT03715829|82859548|FG004|Extension Period|Other|0|||
46651331|NCT03715829|82859549|FG005|Extension Period|Other|0|||
46651332|NCT03715829|82859550|FG006|Extension Period|Other|1|||
46651333|NCT03715829|82859551|FG007|Extension Period|Other|2|||
46651334|NCT03715829|82859552|FG008|Extension Period|Other|4|||
46651335|NCT03715829|82859553|FG009|Extension Period|Other|0|||
46651336|NCT03715829|82859554|FG010|Extension Period|Other|0|||
46651337|NCT03575104|82859616|FG000|Overall Study|Adverse Event|4|||
46651338|NCT03575104|82859617|FG001|Overall Study|Adverse Event|3|||
46651339|NCT03575104|82859618|FG002|Overall Study|Adverse Event|4|||
46651340|NCT03575104|82859616|FG000|Overall Study|Withdrawal by Subject|13|||
46651341|NCT03575104|82859617|FG001|Overall Study|Withdrawal by Subject|16|||
46651342|NCT03575104|82859618|FG002|Overall Study|Withdrawal by Subject|11|||
46651343|NCT03575104|82859616|FG000|Overall Study|Other reasons|6|||
46651344|NCT03575104|82859617|FG001|Overall Study|Other reasons|8|||
46651345|NCT03575104|82859618|FG002|Overall Study|Other reasons|6|||
46651346|NCT03575104|82859616|FG000|Overall Study|Lost to Follow-up|1|||
46651347|NCT03575104|82859617|FG001|Overall Study|Lost to Follow-up|2|||
46651348|NCT03575104|82859618|FG002|Overall Study|Lost to Follow-up|1|||
46651349|NCT03569475|82859629|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
46651350|NCT03569475|82859630|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
46651351|NCT03569475|82859631|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
46651352|NCT03569475|82859629|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
46651353|NCT03569475|82859630|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
46651354|NCT03569475|82859631|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
46651355|NCT03569475|82859629|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
46970732|NCT02041702|83214047|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
46970733|NCT02041702|83214048|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
46970734|NCT02565147|83214056|FG000|Overall Study|Withdrawal by Subject|5|||
46970735|NCT02565147|83214057|FG001|Overall Study|Withdrawal by Subject|1|||
46970736|NCT02565147|83214056|FG000|Overall Study|Lost to Follow-up|0|||
46970737|NCT02565147|83214057|FG001|Overall Study|Lost to Follow-up|1|||
46970738|NCT02565147|83214056|FG000|Overall Study|Death|1|||
46970739|NCT02565147|83214057|FG001|Overall Study|Death|1|||
46970740|NCT02061280|83214065|FG000|Overall Study|Protocol Violation|12|||
46970741|NCT02061280|83214066|FG001|Overall Study|Protocol Violation|8|||
46970742|NCT02061280|83214065|FG000|Overall Study|moved out of state|0|||
46970743|NCT02061280|83214066|FG001|Overall Study|moved out of state|1|||
46970744|NCT02061280|83214065|FG000|Overall Study|Withdrawal by Subject|1|||
46651356|NCT03569475|82859630|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
46651357|NCT03569475|82859631|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
46651358|NCT03569475|82859629|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
46651359|NCT03569475|82859630|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
46651360|NCT03569475|82859631|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
46651361|NCT03569475|82859629|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
46651362|NCT03569475|82859630|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
46970745|NCT02061280|83214066|FG001|Overall Study|Withdrawal by Subject|2|||
46970746|NCT02061280|83214065|FG000|Overall Study|Lost to Follow-up|5|||
46970747|NCT02061280|83214066|FG001|Overall Study|Lost to Follow-up|1|||
46970748|NCT02061202|83214077|FG000|Overall Study|Lost to Follow-up|1|||
46970749|NCT02061202|83214078|FG001|Overall Study|Lost to Follow-up|1|||
46970750|NCT02059408|83214087|FG000|Overall Study|Did not get tested|0|||
46970751|NCT02059408|83214088|FG001|Overall Study|Did not get tested|330|||
46970752|NCT02059408|83214089|FG002|Overall Study|Did not get tested|358|||
46651363|NCT03569475|82859631|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
46651364|NCT03569475|82859629|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
46651365|NCT03569475|82859630|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
46651366|NCT03569475|82859631|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
46651367|NCT03569475|82859629|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
46651368|NCT03569475|82859630|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
46970753|NCT01625338|83214102|FG000|Overall Study|Enrolled but not Treated|0|||
46970754|NCT01625338|83214103|FG001|Overall Study|Enrolled but not Treated|0|||
46970755|NCT01625338|83214104|FG002|Overall Study|Enrolled but not Treated|1|||
46970756|NCT01625338|83214102|FG000|Overall Study|Efficacy Failure|27|||
46970757|NCT01625338|83214103|FG001|Overall Study|Efficacy Failure|39|||
46970758|NCT01625338|83214104|FG002|Overall Study|Efficacy Failure|31|||
46970759|NCT01625338|83214102|FG000|Overall Study|Lost to Follow-up|3|||
46651369|NCT03569475|82859631|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
46651370|NCT03569475|82859629|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
46651371|NCT03569475|82859630|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
46651372|NCT03569475|82859631|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
46651373|NCT03569475|82859629|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
46651374|NCT03569475|82859630|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
46651375|NCT03569475|82859631|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
46651376|NCT03545191|82859645|FG000|Overall Study|Death|1|||
46651377|NCT03545191|82859646|FG001|Overall Study|Death|0|||
46651378|NCT03545191|82859647|FG002|Overall Study|Death|0|||
46781166|NCT00419263|82999727|FG001|Overall Study|Randomized in Error, Not Treated|1|||
46781167|NCT00419263|82999728|FG002|Overall Study|Randomized in Error, Not Treated|0|||
46970760|NCT01625338|83214103|FG001|Overall Study|Lost to Follow-up|3|||
46651379|NCT03545191|82859645|FG000|Overall Study|Adverse Event|4|||
46651380|NCT03545191|82859646|FG001|Overall Study|Adverse Event|2|||
46651381|NCT03545191|82859647|FG002|Overall Study|Adverse Event|7|||
46651382|NCT03545191|82859645|FG000|Overall Study|Other reasons|3|||
46651383|NCT03545191|82859646|FG001|Overall Study|Other reasons|11|||
46651384|NCT03545191|82859647|FG002|Overall Study|Other reasons|8|||
46651385|NCT03545191|82859645|FG000|Overall Study|Withdrawal by Subject|13|||
46651386|NCT03545191|82859646|FG001|Overall Study|Withdrawal by Subject|10|||
46651387|NCT03545191|82859647|FG002|Overall Study|Withdrawal by Subject|12|||
46651388|NCT03545191|82859645|FG000|Overall Study|Lost to Follow-up|1|||
46651389|NCT03545191|82859646|FG001|Overall Study|Lost to Follow-up|2|||
46651390|NCT03545191|82859647|FG002|Overall Study|Lost to Follow-up|3|||
46651391|NCT03500549|82859657|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
46651392|NCT03500549|82859658|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
46651393|NCT03500549|82859657|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
46651394|NCT03500549|82859658|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
46651395|NCT03366792|82859678|FG000|Overall Study|Withdrawal by Subject|7|||
46651396|NCT03366792|82859678|FG000|Overall Study|Lost to Follow-up|2|||
46651397|NCT03366792|82859678|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
46651398|NCT03366792|82859678|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
46651399|NCT03342053|82859684|FG000|Overall Study|Adverse Event|2|||
46651400|NCT03342053|82859685|FG001|Overall Study|Adverse Event|0|||
46651401|NCT03342053|82859684|FG000|Overall Study|Withdrawal by Subject|0|||
46651402|NCT03342053|82859685|FG001|Overall Study|Withdrawal by Subject|1|||
46651403|NCT03325777|82859693|FG000|Overall Study|Lost to Follow-up|9|||
46651404|NCT03325777|82859694|FG001|Overall Study|Lost to Follow-up|12|||
46651405|NCT03283241|82859702|FG000|Overall Study|Adverse Event|4|||
46651406|NCT03283241|82859703|FG001|Overall Study|Adverse Event|1|||
46651407|NCT03283241|82859702|FG000|Overall Study|Withdrawal by Subject|0|||
46651408|NCT03283241|82859703|FG001|Overall Study|Withdrawal by Subject|1|||
46651409|NCT03283241|82859702|FG000|Overall Study|Subject relocated to Finland|0|||
46651410|NCT03283241|82859703|FG001|Overall Study|Subject relocated to Finland|1|||
46781168|NCT00419263|82999726|FG000|Overall Study|Adverse Event|0|||
46781169|NCT00419263|82999727|FG001|Overall Study|Adverse Event|0|||
46651411|NCT03242772|82859711|FG000|Overall Study|Lost to Follow-up|2|||
46651412|NCT03242772|82859712|FG001|Overall Study|Lost to Follow-up|0|||
46651413|NCT03242772|82859711|FG000|Overall Study|Physician Decision|0|||
46781170|NCT00419263|82999728|FG002|Overall Study|Adverse Event|1|||
46970761|NCT01625338|83214104|FG002|Overall Study|Lost to Follow-up|2|||
46970762|NCT01625338|83214102|FG000|Overall Study|Investigator Decision|0|||
46970763|NCT01625338|83214103|FG001|Overall Study|Investigator Decision|2|||
46651414|NCT03242772|82859712|FG001|Overall Study|Physician Decision|1|||
46651415|NCT03242772|82859711|FG000|Overall Study|Withdrawal by Subject|1|||
46651416|NCT03242772|82859712|FG001|Overall Study|Withdrawal by Subject|0|||
46970764|NCT01625338|83214104|FG002|Overall Study|Investigator Decision|1|||
46651417|NCT03236311|82859720|FG000|Overall Study|Study terminated by sponsor|0|||
46651418|NCT03236311|82859721|FG001|Overall Study|Study terminated by sponsor|2|||
46651419|NCT03236311|82859720|FG000|Overall Study|Adverse Event|0|||
46651420|NCT03236311|82859721|FG001|Overall Study|Adverse Event|1|||
46651421|NCT03192046|82859729|FG000|Overall Study|Withdrawal by Subject|1|||
46651422|NCT03192046|82859730|FG001|Overall Study|Withdrawal by Subject|1|||
46651423|NCT03190369|82859738|FG000|Overall Study|Poor compliance to protocol|0|||
46651424|NCT03190369|82859739|FG001|Overall Study|Poor compliance to protocol|1|||
46651425|NCT03190369|82859738|FG000|Overall Study|Withdraw before treatment|1|||
46651426|NCT03190369|82859739|FG001|Overall Study|Withdraw before treatment|5|||
46651427|NCT03190369|82859738|FG000|Overall Study|Randomized but not treated|0|||
46651428|NCT03190369|82859739|FG001|Overall Study|Randomized but not treated|2|||
46651429|NCT04657198|82859748|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
46651430|NCT04657198|82859749|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
46651431|NCT04657198|82859750|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
46651432|NCT04590586|82859764|FG000|Overall Study|Death|7|||
46651433|NCT04590586|82859765|FG001|Overall Study|Death|1|||
46651434|NCT04590586|82859766|FG002|Overall Study|Death|37|||
46651435|NCT04590586|82859767|FG003|Overall Study|Death|34|||
46651436|NCT04590586|82859768|FG004|Overall Study|Death|19|||
46651437|NCT04590586|82859769|FG005|Overall Study|Death|3|||
46651438|NCT04590586|82859764|FG000|Overall Study|Lost to Follow-up|3|||
46651439|NCT04590586|82859765|FG001|Overall Study|Lost to Follow-up|0|||
46651440|NCT04590586|82859766|FG002|Overall Study|Lost to Follow-up|11|||
46781171|NCT00419263|82999726|FG000|Overall Study|Withdrawal by Subject|0|||
46781172|NCT00419263|82999727|FG001|Overall Study|Withdrawal by Subject|0|||
46781173|NCT00419263|82999728|FG002|Overall Study|Withdrawal by Subject|1|||
46781174|NCT00399763|82999739|FG000|Overall Study|Lost to Follow-up|2|||
46781175|NCT00399763|82999740|FG001|Overall Study|Lost to Follow-up|3|||
46781176|NCT00699842|82999749|FG000|Overall Study|Death|0|||
46781177|NCT00699842|82999750|FG001|Overall Study|Death|1|||
46781178|NCT00699842|82999751|FG002|Overall Study|Death|0|||
46781179|NCT00399529|82999759|FG000|Overall Study|Off Study Prior to Treatment|2|||
46781180|NCT00712712|82999764|FG000|Overall Study|Protocol Violation|11|||
46781181|NCT00712712|82999764|FG000|Overall Study|Radiofrequency not done|3|||
46781182|NCT00712712|82999764|FG000|Overall Study|Death|8|||
46781183|NCT00712712|82999764|FG000|Overall Study|Withdrawal by Subject|1|||
46781184|NCT00411151|82999768|FG000|Overall Study|Death|38|||
46781185|NCT00411151|82999768|FG000|Overall Study|Withdrawal by Subject|2|||
46781186|NCT00411151|82999768|FG000|Overall Study|Lost to Follow-up|2|||
46781187|NCT00411151|82999768|FG000|Overall Study|Protocol Violation|1|||
46781188|NCT00411151|82999768|FG000|Overall Study|Trial prematurely closed|4|||
46781189|NCT00607048|82999774|FG000|Overall Study|Adverse Event|0|||
46781190|NCT00607048|82999775|FG001|Overall Study|Adverse Event|1|||
46781191|NCT00607048|82999776|FG002|Overall Study|Adverse Event|0|||
46781192|NCT00607048|82999777|FG003|Overall Study|Adverse Event|0|||
46781193|NCT00607048|82999778|FG004|Overall Study|Adverse Event|4|||
46781194|NCT00607048|82999779|FG005|Overall Study|Adverse Event|0|||
46781195|NCT00607048|82999774|FG000|Overall Study|Global deterioration of health|1|||
46781196|NCT00607048|82999775|FG001|Overall Study|Global deterioration of health|0|||
46781197|NCT00607048|82999776|FG002|Overall Study|Global deterioration of health|0|||
46781198|NCT00607048|82999777|FG003|Overall Study|Global deterioration of health|0|||
46781199|NCT00607048|82999778|FG004|Overall Study|Global deterioration of health|0|||
46781200|NCT00607048|82999779|FG005|Overall Study|Global deterioration of health|0|||
46781201|NCT00607048|82999774|FG000|Overall Study|Objective disease progression - relapse|1|||
46781202|NCT00607048|82999775|FG001|Overall Study|Objective disease progression - relapse|2|||
46781203|NCT00607048|82999776|FG002|Overall Study|Objective disease progression - relapse|4|||
46781204|NCT00607048|82999777|FG003|Overall Study|Objective disease progression - relapse|2|||
46781205|NCT00607048|82999778|FG004|Overall Study|Objective disease progression - relapse|2|||
46781206|NCT00607048|82999779|FG005|Overall Study|Objective disease progression - relapse|2|||
46781207|NCT00607048|82999774|FG000|Overall Study|Withdrawal by Subject|0|||
46781208|NCT00607048|82999775|FG001|Overall Study|Withdrawal by Subject|0|||
46781209|NCT00607048|82999776|FG002|Overall Study|Withdrawal by Subject|0|||
46781210|NCT00607048|82999777|FG003|Overall Study|Withdrawal by Subject|1|||
46781211|NCT00607048|82999778|FG004|Overall Study|Withdrawal by Subject|0|||
46781212|NCT00607048|82999779|FG005|Overall Study|Withdrawal by Subject|2|||
46781213|NCT00607048|82999774|FG000|Overall Study|Other|1|||
46781214|NCT00607048|82999775|FG001|Overall Study|Other|1|||
46781215|NCT00607048|82999776|FG002|Overall Study|Other|0|||
46781216|NCT00607048|82999777|FG003|Overall Study|Other|0|||
46651441|NCT04590586|82859767|FG003|Overall Study|Lost to Follow-up|11|||
46651442|NCT04590586|82859768|FG004|Overall Study|Lost to Follow-up|6|||
46781217|NCT00607048|82999778|FG004|Overall Study|Other|0|||
46850774|NCT03651622|83066550|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
46781218|NCT00607048|82999779|FG005|Overall Study|Other|1|||
46781219|NCT00699608|82999795|FG000|First Intervention|Withdrawal by Subject|0|||
46781220|NCT00699608|82999796|FG001|First Intervention|Withdrawal by Subject|0|||
46651443|NCT04590586|82859769|FG005|Overall Study|Lost to Follow-up|0|||
46651444|NCT04590586|82859764|FG000|Overall Study|Withdrawal by Subject|0|||
46651445|NCT04590586|82859765|FG001|Overall Study|Withdrawal by Subject|0|||
46651446|NCT04590586|82859766|FG002|Overall Study|Withdrawal by Subject|6|||
46651447|NCT04590586|82859767|FG003|Overall Study|Withdrawal by Subject|0|||
46651448|NCT04590586|82859768|FG004|Overall Study|Withdrawal by Subject|3|||
46651449|NCT04590586|82859769|FG005|Overall Study|Withdrawal by Subject|0|||
46651450|NCT04590586|82859764|FG000|Overall Study|Other|3|||
46651451|NCT04590586|82859765|FG001|Overall Study|Other|0|||
46651452|NCT04590586|82859766|FG002|Overall Study|Other|1|||
46651453|NCT04590586|82859767|FG003|Overall Study|Other|1|||
46651454|NCT04590586|82859768|FG004|Overall Study|Other|2|||
46651455|NCT04590586|82859769|FG005|Overall Study|Other|1|||
46651456|NCT04312009|82859795|FG000|Overall Study|Withdrawal by Subject|2|||
46651457|NCT04312009|82859796|FG001|Overall Study|Withdrawal by Subject|1|||
46651458|NCT03937466|82859811|FG000|Overall Study|not eligbile after the 2-week diary|9|||
46651459|NCT03937466|82859811|FG000|Overall Study|never returned their diary|6|||
46651460|NCT03937466|82859811|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
46651461|NCT03937466|82859811|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
46651462|NCT03850483|82859824|FG000|Treatment for Stage 1|Adverse Event|1|||
46651463|NCT03850483|82859825|FG001|Treatment for Stage 1|Adverse Event|1|||
46651464|NCT03850483|82859826|FG002|Treatment for Stage 1|Adverse Event|3|||
46651465|NCT03850483|82859827|FG003|Treatment for Stage 1|Adverse Event|0|||
46651466|NCT03850483|82859828|FG004|Treatment for Stage 1|Adverse Event|2|||
46651467|NCT03850483|82859829|FG005|Treatment for Stage 1|Adverse Event|0|||
46651468|NCT03850483|82859830|FG006|Treatment for Stage 1|Adverse Event|2|||
46651469|NCT03850483|82859831|FG007|Treatment for Stage 1|Adverse Event|2|||
46651470|NCT03850483|82859832|FG008|Treatment for Stage 1|Adverse Event|0|||
46651471|NCT03850483|82859833|FG009|Treatment for Stage 1|Adverse Event|0|||
46651472|NCT03850483|82859824|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
46651473|NCT03850483|82859825|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
46651474|NCT03850483|82859826|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
46651475|NCT03850483|82859827|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
46651476|NCT03850483|82859828|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
46651477|NCT03850483|82859829|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
46651478|NCT03850483|82859830|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
46651479|NCT03850483|82859831|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
46651480|NCT03850483|82859832|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
46651481|NCT03850483|82859833|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
46651482|NCT03850483|82859824|FG000|Treatment for Stage 1|Protocol Violation|1|||
46850775|NCT03651622|83066551|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
46651483|NCT03850483|82859825|FG001|Treatment for Stage 1|Protocol Violation|0|||
46651484|NCT03850483|82859826|FG002|Treatment for Stage 1|Protocol Violation|0|||
46651485|NCT03850483|82859827|FG003|Treatment for Stage 1|Protocol Violation|0|||
46651486|NCT03850483|82859828|FG004|Treatment for Stage 1|Protocol Violation|0|||
46651487|NCT03850483|82859829|FG005|Treatment for Stage 1|Protocol Violation|0|||
46850776|NCT03651622|83066549|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
46651488|NCT03850483|82859830|FG006|Treatment for Stage 1|Protocol Violation|1|||
46651489|NCT03850483|82859831|FG007|Treatment for Stage 1|Protocol Violation|0|||
46651490|NCT03850483|82859832|FG008|Treatment for Stage 1|Protocol Violation|0|||
46651491|NCT03850483|82859833|FG009|Treatment for Stage 1|Protocol Violation|0|||
46850777|NCT03651622|83066550|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
46970765|NCT01625338|83214102|FG000|Overall Study|Subject Withdrew Consent|1|||
47075315|NCT02957539|83369285|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
47075316|NCT02957539|83369286|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
47075317|NCT02957539|83369284|FG000|Week 16 to 32|Withdrawal by Subject|3|||
47075318|NCT02957539|83369285|FG001|Week 16 to 32|Withdrawal by Subject|3|||
47075319|NCT02957539|83369286|FG002|Week 16 to 32|Withdrawal by Subject|1|||
47075320|NCT02957539|83369284|FG000|Week 16 to 32|Lost to Follow-up|8|||
47075321|NCT02957539|83369285|FG001|Week 16 to 32|Lost to Follow-up|7|||
47075322|NCT02957539|83369286|FG002|Week 16 to 32|Lost to Follow-up|5|||
47075323|NCT02957539|83369284|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
47075324|NCT02957539|83369285|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
47075325|NCT02957539|83369286|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
47075326|NCT02957539|83369284|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
47075327|NCT02957539|83369285|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
47075328|NCT02957539|83369286|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
47075329|NCT02690077|83369299|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
47075330|NCT02690077|83369300|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
47075331|NCT02690077|83369299|FG000|Overall Study|Withdrawal by Subject|0|||
47075332|NCT02690077|83369300|FG001|Overall Study|Withdrawal by Subject|5|||
46651492|NCT03850483|82859824|FG000|Treatment for Stage 1|Physician Decision|0|||
46651493|NCT03850483|82859825|FG001|Treatment for Stage 1|Physician Decision|0|||
46651494|NCT03850483|82859826|FG002|Treatment for Stage 1|Physician Decision|0|||
46651495|NCT03850483|82859827|FG003|Treatment for Stage 1|Physician Decision|0|||
46651496|NCT03850483|82859828|FG004|Treatment for Stage 1|Physician Decision|0|||
46651497|NCT03850483|82859829|FG005|Treatment for Stage 1|Physician Decision|1|||
46651498|NCT03850483|82859830|FG006|Treatment for Stage 1|Physician Decision|0|||
46651499|NCT03850483|82859831|FG007|Treatment for Stage 1|Physician Decision|0|||
46651500|NCT03850483|82859832|FG008|Treatment for Stage 1|Physician Decision|0|||
46651501|NCT03850483|82859833|FG009|Treatment for Stage 1|Physician Decision|0|||
46651502|NCT03850483|82859824|FG000|Treatment for Stage 1|Other|0|||
46651503|NCT03850483|82859825|FG001|Treatment for Stage 1|Other|0|||
46651504|NCT03850483|82859826|FG002|Treatment for Stage 1|Other|0|||
46651505|NCT03850483|82859827|FG003|Treatment for Stage 1|Other|0|||
46651506|NCT03850483|82859828|FG004|Treatment for Stage 1|Other|2|||
46651507|NCT03850483|82859829|FG005|Treatment for Stage 1|Other|1|||
46651508|NCT03850483|82859830|FG006|Treatment for Stage 1|Other|0|||
46651509|NCT03850483|82859831|FG007|Treatment for Stage 1|Other|0|||
46651510|NCT03850483|82859832|FG008|Treatment for Stage 1|Other|0|||
46651511|NCT03850483|82859833|FG009|Treatment for Stage 1|Other|0|||
46651512|NCT03850483|82859824|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651513|NCT03850483|82859825|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651514|NCT03850483|82859826|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
46651515|NCT03850483|82859827|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651516|NCT03850483|82859828|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651517|NCT03850483|82859829|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651518|NCT03850483|82859830|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651519|NCT03850483|82859831|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651520|NCT03850483|82859832|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651521|NCT03850483|82859833|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
46651522|NCT03850483|82859824|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651523|NCT03850483|82859825|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651524|NCT03850483|82859826|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651525|NCT03850483|82859827|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651526|NCT03850483|82859828|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651527|NCT03850483|82859829|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
46651528|NCT03850483|82859830|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651529|NCT03850483|82859831|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651530|NCT03850483|82859832|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651531|NCT03850483|82859833|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
46651532|NCT03850483|82859824|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
46651533|NCT03850483|82859825|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
46651534|NCT03850483|82859826|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
46651535|NCT03850483|82859827|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
46651536|NCT03850483|82859828|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
46651537|NCT03850483|82859829|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
46651538|NCT03850483|82859830|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
46651539|NCT03850483|82859831|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
46850778|NCT03651622|83066551|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
46850779|NCT00381797|83066564|FG000|Overall Study|Withdrawal by Subject|1|||
47075333|NCT02690077|83369299|FG000|Overall Study|Excluded by IRB|0|||
47075334|NCT02690077|83369300|FG001|Overall Study|Excluded by IRB|2|||
47075335|NCT00545077|83369308|FG000|Overall Study|Treatment not received|5|||
47075336|NCT00545077|83369309|FG001|Overall Study|Treatment not received|1|||
47075337|NCT00545077|83369308|FG000|Overall Study|Disease Progression|131|||
47075338|NCT00545077|83369309|FG001|Overall Study|Disease Progression|98|||
47075339|NCT00545077|83369308|FG000|Overall Study|Withdrawal by Subject|3|||
47075340|NCT00545077|83369309|FG001|Overall Study|Withdrawal by Subject|14|||
47075341|NCT00545077|83369308|FG000|Overall Study|Physician Decision|6|||
47075342|NCT00545077|83369309|FG001|Overall Study|Physician Decision|3|||
47075343|NCT00545077|83369308|FG000|Overall Study|Lost to Follow-up|2|||
47075344|NCT00545077|83369309|FG001|Overall Study|Lost to Follow-up|0|||
47075345|NCT00545077|83369308|FG000|Overall Study|Protocol Violation|1|||
47075346|NCT00545077|83369309|FG001|Overall Study|Protocol Violation|0|||
47075347|NCT00545077|83369308|FG000|Overall Study|Adverse Event|0|||
47075348|NCT00545077|83369309|FG001|Overall Study|Adverse Event|31|||
47075349|NCT00545077|83369308|FG000|Overall Study|Death|0|||
47075350|NCT00545077|83369309|FG001|Overall Study|Death|8|||
47075351|NCT00130533|83369317|FG000|Overall Study|Withdrawal by Subject|33|||
47075352|NCT00130533|83369318|FG001|Overall Study|Withdrawal by Subject|6|||
47075353|NCT00130533|83369317|FG000|Overall Study|Adverse Event|34|||
47075354|NCT00130533|83369318|FG001|Overall Study|Adverse Event|1|||
47075355|NCT00130533|83369317|FG000|Overall Study|Disease relapse|9|||
47075356|NCT00130533|83369318|FG001|Overall Study|Disease relapse|13|||
47075357|NCT00130533|83369317|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
47075358|NCT00130533|83369318|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
47075359|NCT00130533|83369317|FG000|Overall Study|Death|4|||
47075360|NCT00130533|83369318|FG001|Overall Study|Death|2|||
47075361|NCT00130533|83369317|FG000|Overall Study|Protocol Violation|5|||
47075362|NCT00130533|83369318|FG001|Overall Study|Protocol Violation|1|||
47075363|NCT00130533|83369317|FG000|Overall Study|Lost to Follow-up|1|||
46651540|NCT03850483|82859832|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
46651541|NCT03850483|82859833|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
46651542|NCT03850483|82859824|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
46651543|NCT03850483|82859825|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
46651544|NCT03850483|82859826|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
46651545|NCT03850483|82859827|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
46651546|NCT03850483|82859828|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
46651547|NCT03850483|82859829|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
46651548|NCT03850483|82859830|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
46651549|NCT03850483|82859831|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
46651550|NCT03850483|82859832|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
46651551|NCT03850483|82859833|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
46651552|NCT03850483|82859824|FG000|Treatment for Stage 1|Death|0|||
46651553|NCT03850483|82859825|FG001|Treatment for Stage 1|Death|0|||
46651554|NCT03850483|82859826|FG002|Treatment for Stage 1|Death|0|||
46651555|NCT03850483|82859827|FG003|Treatment for Stage 1|Death|0|||
46651556|NCT03850483|82859828|FG004|Treatment for Stage 1|Death|0|||
46651557|NCT03850483|82859829|FG005|Treatment for Stage 1|Death|1|||
46651558|NCT03850483|82859830|FG006|Treatment for Stage 1|Death|0|||
46651559|NCT03850483|82859831|FG007|Treatment for Stage 1|Death|0|||
46651560|NCT03850483|82859832|FG008|Treatment for Stage 1|Death|0|||
46651561|NCT03850483|82859833|FG009|Treatment for Stage 1|Death|0|||
46651562|NCT03850483|82859824|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
46651563|NCT03850483|82859825|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
46651564|NCT03850483|82859826|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
46651565|NCT03850483|82859827|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
46651566|NCT03850483|82859828|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
46651567|NCT03850483|82859829|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
46651568|NCT03850483|82859830|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
46651569|NCT03850483|82859831|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
46651570|NCT03850483|82859832|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
46651571|NCT03850483|82859833|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
46651572|NCT03850483|82859824|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
46651573|NCT03850483|82859825|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
46651574|NCT03850483|82859826|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
46651575|NCT03850483|82859827|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
46651576|NCT03850483|82859828|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
46651577|NCT03850483|82859829|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
46651578|NCT03850483|82859830|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
46651579|NCT03850483|82859831|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
46651580|NCT03850483|82859832|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
46651581|NCT03850483|82859833|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
46651582|NCT03850483|82859824|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651583|NCT03850483|82859825|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651584|NCT03850483|82859826|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651585|NCT03850483|82859827|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651586|NCT03850483|82859828|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651587|NCT03850483|82859829|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651588|NCT03850483|82859830|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
46651589|NCT03850483|82859831|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
46651590|NCT03850483|82859832|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651591|NCT03850483|82859833|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
46651592|NCT03850483|82859824|FG000|Follow-up for Stage 1|Physician Decision|0|||
46651593|NCT03850483|82859825|FG001|Follow-up for Stage 1|Physician Decision|0|||
46781221|NCT00699608|82999797|FG002|First Intervention|Withdrawal by Subject|1|||
46781222|NCT00699608|82999798|FG003|First Intervention|Withdrawal by Subject|0|||
46781223|NCT00699608|82999799|FG004|First Intervention|Withdrawal by Subject|0|||
46781224|NCT00699608|82999800|FG005|First Intervention|Withdrawal by Subject|0|||
46781225|NCT00699608|82999795|FG000|First Intervention|Protocol Violation|0|||
46651594|NCT03850483|82859826|FG002|Follow-up for Stage 1|Physician Decision|0|||
46651595|NCT03850483|82859827|FG003|Follow-up for Stage 1|Physician Decision|0|||
46651596|NCT03850483|82859828|FG004|Follow-up for Stage 1|Physician Decision|1|||
46651597|NCT03850483|82859829|FG005|Follow-up for Stage 1|Physician Decision|0|||
46651598|NCT03850483|82859830|FG006|Follow-up for Stage 1|Physician Decision|1|||
46651599|NCT03850483|82859831|FG007|Follow-up for Stage 1|Physician Decision|0|||
46651600|NCT03850483|82859832|FG008|Follow-up for Stage 1|Physician Decision|0|||
46781226|NCT00699608|82999796|FG001|First Intervention|Protocol Violation|0|||
46781227|NCT00699608|82999797|FG002|First Intervention|Protocol Violation|0|||
47075364|NCT00130533|83369318|FG001|Overall Study|Lost to Follow-up|1|||
47075365|NCT00130533|83369317|FG000|Overall Study|Sponsor´s decision|2|||
46651601|NCT03850483|82859833|FG009|Follow-up for Stage 1|Physician Decision|0|||
46651602|NCT03850483|82859824|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
46651603|NCT03850483|82859825|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
46651604|NCT03850483|82859826|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
46651605|NCT03850483|82859827|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
46651606|NCT03850483|82859828|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
46651607|NCT03850483|82859829|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
46651608|NCT03850483|82859830|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
46651609|NCT03850483|82859831|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
46651610|NCT03850483|82859832|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
46651611|NCT03850483|82859833|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
46651612|NCT03850483|82859824|FG000|Follow-up for Stage 1|Adverse Event|0|||
46651613|NCT03850483|82859825|FG001|Follow-up for Stage 1|Adverse Event|0|||
46651614|NCT03850483|82859826|FG002|Follow-up for Stage 1|Adverse Event|1|||
46651615|NCT03850483|82859827|FG003|Follow-up for Stage 1|Adverse Event|0|||
46651616|NCT03850483|82859828|FG004|Follow-up for Stage 1|Adverse Event|0|||
46651617|NCT03850483|82859829|FG005|Follow-up for Stage 1|Adverse Event|1|||
46651618|NCT03850483|82859830|FG006|Follow-up for Stage 1|Adverse Event|0|||
46651619|NCT03850483|82859831|FG007|Follow-up for Stage 1|Adverse Event|0|||
46651620|NCT03850483|82859832|FG008|Follow-up for Stage 1|Adverse Event|0|||
46651621|NCT03850483|82859833|FG009|Follow-up for Stage 1|Adverse Event|0|||
46651622|NCT03850483|82859824|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
46651623|NCT03850483|82859825|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
46651624|NCT03850483|82859826|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
46651625|NCT03850483|82859827|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
46651626|NCT03850483|82859828|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
46651627|NCT03850483|82859829|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
46651628|NCT03850483|82859830|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
46651629|NCT03850483|82859831|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
46651630|NCT03850483|82859832|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
46651631|NCT03850483|82859833|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
46651632|NCT03850483|82859824|FG000|Follow-up for Stage 1|Other|0|||
46651633|NCT03850483|82859825|FG001|Follow-up for Stage 1|Other|2|||
46651634|NCT03850483|82859826|FG002|Follow-up for Stage 1|Other|0|||
46651635|NCT03850483|82859827|FG003|Follow-up for Stage 1|Other|2|||
46651636|NCT03850483|82859828|FG004|Follow-up for Stage 1|Other|0|||
46781228|NCT00699608|82999798|FG003|First Intervention|Protocol Violation|0|||
46781229|NCT00699608|82999799|FG004|First Intervention|Protocol Violation|1|||
46781230|NCT00699608|82999800|FG005|First Intervention|Protocol Violation|0|||
46781231|NCT00699608|82999795|FG000|Second Intervention|Adverse Event|0|||
46781232|NCT00699608|82999796|FG001|Second Intervention|Adverse Event|0|||
46781233|NCT00699608|82999797|FG002|Second Intervention|Adverse Event|1|||
46781234|NCT00699608|82999798|FG003|Second Intervention|Adverse Event|0|||
46781235|NCT00699608|82999799|FG004|Second Intervention|Adverse Event|0|||
46781236|NCT00699608|82999800|FG005|Second Intervention|Adverse Event|0|||
46781237|NCT00699608|82999795|FG000|Second Intervention|Withdrawal by Subject|0|||
46781238|NCT00699608|82999796|FG001|Second Intervention|Withdrawal by Subject|0|||
46781239|NCT00699608|82999797|FG002|Second Intervention|Withdrawal by Subject|0|||
46781240|NCT00699608|82999798|FG003|Second Intervention|Withdrawal by Subject|1|||
46781241|NCT00699608|82999799|FG004|Second Intervention|Withdrawal by Subject|0|||
46781242|NCT00699608|82999800|FG005|Second Intervention|Withdrawal by Subject|0|||
46781243|NCT03823404|82999811|FG000|Overall Study|Lost to Follow-up|1|||
46781244|NCT03823404|82999812|FG001|Overall Study|Lost to Follow-up|2|||
46781245|NCT03823404|82999813|FG002|Overall Study|Lost to Follow-up|3|||
46970766|NCT01625338|83214103|FG001|Overall Study|Subject Withdrew Consent|0|||
46970767|NCT01625338|83214104|FG002|Overall Study|Subject Withdrew Consent|2|||
46970768|NCT01625338|83214102|FG000|Overall Study|Adverse Event|1|||
46970769|NCT01625338|83214103|FG001|Overall Study|Adverse Event|0|||
46970770|NCT01625338|83214104|FG002|Overall Study|Adverse Event|1|||
46970771|NCT01625338|83214102|FG000|Overall Study|Study Discontinued by Sponsor|0|||
46970772|NCT01625338|83214103|FG001|Overall Study|Study Discontinued by Sponsor|0|||
46970773|NCT01625338|83214104|FG002|Overall Study|Study Discontinued by Sponsor|1|||
46970774|NCT02560623|83214116|FG000|Overall Study|Unable to swallow sponge|0|||
46651637|NCT03850483|82859829|FG005|Follow-up for Stage 1|Other|1|||
46651638|NCT03850483|82859830|FG006|Follow-up for Stage 1|Other|0|||
46651639|NCT03850483|82859831|FG007|Follow-up for Stage 1|Other|0|||
46651640|NCT03850483|82859832|FG008|Follow-up for Stage 1|Other|0|||
46651641|NCT03850483|82859833|FG009|Follow-up for Stage 1|Other|0|||
46781246|NCT03823404|82999811|FG000|Overall Study|Protocol Violation|2|||
46781247|NCT03823404|82999812|FG001|Overall Study|Protocol Violation|0|||
46781248|NCT03823404|82999813|FG002|Overall Study|Protocol Violation|2|||
47075366|NCT00130533|83369318|FG001|Overall Study|Sponsor´s decision|0|||
46781249|NCT03823404|82999811|FG000|Overall Study|Adverse Event|35|||
46781250|NCT03823404|82999812|FG001|Overall Study|Adverse Event|38|||
46651642|NCT03850483|82859824|FG000|Treatment for Stage 2|Adverse Event|0|||
46651643|NCT03850483|82859825|FG001|Treatment for Stage 2|Adverse Event|0|||
46651644|NCT03850483|82859826|FG002|Treatment for Stage 2|Adverse Event|0|||
46651645|NCT03850483|82859827|FG003|Treatment for Stage 2|Adverse Event|0|||
46651646|NCT03850483|82859828|FG004|Treatment for Stage 2|Adverse Event|0|||
46651647|NCT03850483|82859829|FG005|Treatment for Stage 2|Adverse Event|0|||
46651648|NCT03850483|82859830|FG006|Treatment for Stage 2|Adverse Event|0|||
46651649|NCT03850483|82859831|FG007|Treatment for Stage 2|Adverse Event|0|||
46651650|NCT03850483|82859832|FG008|Treatment for Stage 2|Adverse Event|0|||
46651651|NCT03850483|82859833|FG009|Treatment for Stage 2|Adverse Event|1|||
46651652|NCT03850483|82859824|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
46651653|NCT03850483|82859825|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
46651654|NCT03850483|82859826|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
46651655|NCT03850483|82859827|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
46651656|NCT03850483|82859828|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
46651657|NCT03850483|82859829|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
46651658|NCT03850483|82859830|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
46651659|NCT03850483|82859831|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
46651660|NCT03850483|82859832|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
46651661|NCT03850483|82859833|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
46651662|NCT03850483|82859824|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
46651663|NCT03850483|82859825|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
46651664|NCT03850483|82859826|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
46651665|NCT03850483|82859827|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
46651666|NCT03850483|82859828|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
46651667|NCT03850483|82859829|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
46651668|NCT03850483|82859830|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
46651669|NCT03850483|82859831|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
46651670|NCT03850483|82859832|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
46651671|NCT03850483|82859833|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
46651672|NCT03850483|82859824|FG000|Treatment for Stage 2|Physician Decision|0|||
46651673|NCT03850483|82859825|FG001|Treatment for Stage 2|Physician Decision|0|||
46651674|NCT03850483|82859826|FG002|Treatment for Stage 2|Physician Decision|0|||
46651675|NCT03850483|82859827|FG003|Treatment for Stage 2|Physician Decision|0|||
46651676|NCT03850483|82859828|FG004|Treatment for Stage 2|Physician Decision|0|||
46651677|NCT03850483|82859829|FG005|Treatment for Stage 2|Physician Decision|0|||
46651678|NCT03850483|82859830|FG006|Treatment for Stage 2|Physician Decision|0|||
46651679|NCT03850483|82859831|FG007|Treatment for Stage 2|Physician Decision|0|||
46651680|NCT03850483|82859832|FG008|Treatment for Stage 2|Physician Decision|0|||
46651681|NCT03850483|82859833|FG009|Treatment for Stage 2|Physician Decision|1|||
46651682|NCT03850483|82859824|FG000|Treatment for Stage 2|Protocol Violation|0|||
46651683|NCT03850483|82859825|FG001|Treatment for Stage 2|Protocol Violation|0|||
46651684|NCT03850483|82859826|FG002|Treatment for Stage 2|Protocol Violation|0|||
46651685|NCT03850483|82859827|FG003|Treatment for Stage 2|Protocol Violation|0|||
46651686|NCT03850483|82859828|FG004|Treatment for Stage 2|Protocol Violation|0|||
46651687|NCT03850483|82859829|FG005|Treatment for Stage 2|Protocol Violation|0|||
46651688|NCT03850483|82859830|FG006|Treatment for Stage 2|Protocol Violation|0|||
46651689|NCT03850483|82859831|FG007|Treatment for Stage 2|Protocol Violation|0|||
46651690|NCT03850483|82859832|FG008|Treatment for Stage 2|Protocol Violation|1|||
46651691|NCT03850483|82859833|FG009|Treatment for Stage 2|Protocol Violation|0|||
46651692|NCT03850483|82859824|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
46651693|NCT03850483|82859825|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
46651694|NCT03850483|82859826|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
46651695|NCT03850483|82859827|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
46651696|NCT03850483|82859828|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
46651697|NCT03850483|82859829|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
47075367|NCT00130533|83369317|FG000|Overall Study|Second Primary Malignancy|0|||
47075368|NCT00130533|83369318|FG001|Overall Study|Second Primary Malignancy|1|||
47075369|NCT00130533|83369317|FG000|Overall Study|Other|12|||
47075370|NCT00130533|83369318|FG001|Overall Study|Other|5|||
46651698|NCT03850483|82859830|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
46651699|NCT03850483|82859831|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
46651700|NCT03850483|82859832|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
46651701|NCT03850483|82859833|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
46651702|NCT03850483|82859824|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651703|NCT03850483|82859825|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651704|NCT03850483|82859826|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651705|NCT03850483|82859827|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651706|NCT03850483|82859828|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651707|NCT03850483|82859829|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651708|NCT03850483|82859830|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46781251|NCT03823404|82999813|FG002|Overall Study|Adverse Event|8|||
47075371|NCT00129935|83369326|FG000|Overall Study|Adverse Event|18|||
46651709|NCT03850483|82859831|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651710|NCT03850483|82859832|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
46651711|NCT03850483|82859833|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
46651712|NCT03850483|82859824|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
46651713|NCT03850483|82859825|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
46651714|NCT03850483|82859826|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
46651715|NCT03850483|82859827|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
46651716|NCT03850483|82859828|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
46651717|NCT03850483|82859829|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
46651718|NCT03850483|82859830|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
46651719|NCT03850483|82859831|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
46651720|NCT03850483|82859832|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
46651721|NCT03850483|82859833|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
46651722|NCT03850483|82859824|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
46651723|NCT03850483|82859825|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
46651724|NCT03850483|82859826|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
46651725|NCT03850483|82859827|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
46651726|NCT03850483|82859828|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
46651727|NCT03850483|82859829|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
46651728|NCT03850483|82859830|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
46651729|NCT03850483|82859831|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
46651730|NCT03850483|82859832|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
46651731|NCT03850483|82859833|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
46651732|NCT03850483|82859824|FG000|Follow-up For Stage 2|Other|0|||
46651733|NCT03850483|82859825|FG001|Follow-up For Stage 2|Other|0|||
46651734|NCT03850483|82859826|FG002|Follow-up For Stage 2|Other|0|||
46651735|NCT03850483|82859827|FG003|Follow-up For Stage 2|Other|0|||
46651736|NCT03850483|82859828|FG004|Follow-up For Stage 2|Other|0|||
46651737|NCT03850483|82859829|FG005|Follow-up For Stage 2|Other|0|||
46651738|NCT03850483|82859830|FG006|Follow-up For Stage 2|Other|0|||
46781252|NCT03823404|82999811|FG000|Overall Study|Withdrawal by Subject|38|||
46781253|NCT03823404|82999812|FG001|Overall Study|Withdrawal by Subject|40|||
46781254|NCT03823404|82999813|FG002|Overall Study|Withdrawal by Subject|35|||
46781255|NCT03823404|82999811|FG000|Overall Study|Death|4|||
46781256|NCT03823404|82999812|FG001|Overall Study|Death|0|||
46781257|NCT03823404|82999813|FG002|Overall Study|Death|0|||
46781258|NCT03823404|82999811|FG000|Overall Study|Other: Various reasons provided|5|||
46781259|NCT03823404|82999812|FG001|Overall Study|Other: Various reasons provided|5|||
46781260|NCT03823404|82999813|FG002|Overall Study|Other: Various reasons provided|6|||
46781261|NCT00706706|82999821|FG000|Overall Study|Death|53|||
46781262|NCT00706706|82999821|FG000|Overall Study|Lost to Follow-up|7|||
46781263|NCT00706706|82999821|FG000|Overall Study|Study endpoint had reached|45|||
46781264|NCT00410605|82999825|FG000|Overall Study|Adverse Event|12|||
46781265|NCT00410605|82999825|FG000|Overall Study|Physician Decision|3|||
46781266|NCT00410605|82999825|FG000|Overall Study|Withdrawal by Subject|5|||
46781267|NCT00410605|82999825|FG000|Overall Study|Started Non-Protocol Therapy|3|||
46781268|NCT00410605|82999825|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
46781269|NCT00410605|82999825|FG000|Overall Study|Transferred to another Institution|1|||
46781270|NCT00418717|82999829|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
46781271|NCT00418717|82999829|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
46781272|NCT00572572|82999835|FG000|Overall Study|Withdrawal by Subject|3|||
46781273|NCT00572572|82999836|FG001|Overall Study|Withdrawal by Subject|6|||
46781274|NCT00418561|82999845|FG000|Overall Study|Participant's (guardian's) decision|0|||
46781275|NCT00418561|82999846|FG001|Overall Study|Participant's (guardian's) decision|1|||
46781276|NCT00418561|82999847|FG002|Overall Study|Participant's (guardian's) decision|0|||
46781277|NCT00398047|82999855|FG000|Overall Study|all patient progressed before completion|3|||
46781278|NCT00631371|82999862|FG000|Overall Study|Lost to Follow-up|24|||
46781279|NCT00631371|82999863|FG001|Overall Study|Lost to Follow-up|19|||
46781280|NCT00631371|82999862|FG000|Overall Study|Other reason|5|||
46781281|NCT00631371|82999863|FG001|Overall Study|Other reason|12|||
46781282|NCT00631371|82999862|FG000|Overall Study|subject request|38|||
46781283|NCT00631371|82999863|FG001|Overall Study|subject request|45|||
46970775|NCT02560623|83214117|FG001|Overall Study|Unable to swallow sponge|1|||
46651739|NCT03850483|82859831|FG007|Follow-up For Stage 2|Other|0|||
46651740|NCT03850483|82859832|FG008|Follow-up For Stage 2|Other|0|||
46651741|NCT03850483|82859833|FG009|Follow-up For Stage 2|Other|1|||
46651742|NCT03473925|82859864|FG000|Overall Study|Death|48|||
46651743|NCT03473925|82859865|FG001|Overall Study|Death|44|||
46781284|NCT00631371|82999862|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
46781285|NCT00631371|82999863|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
46781286|NCT00631371|82999862|FG000|Overall Study|Death|263|||
46781287|NCT00631371|82999863|FG001|Overall Study|Death|239|||
46781288|NCT00409747|82999869|FG000|Overall Study|Withdrawal by Subject|1|||
46651744|NCT03473925|82859864|FG000|Overall Study|Sponsor Decision|2|||
46970776|NCT02560623|83214118|FG002|Overall Study|Unable to swallow sponge|0|||
46651745|NCT03473925|82859865|FG001|Overall Study|Sponsor Decision|7|||
46651746|NCT03473925|82859864|FG000|Overall Study|Withdrawal by Subject|1|||
46651747|NCT03473925|82859865|FG001|Overall Study|Withdrawal by Subject|3|||
46651748|NCT03473925|82859864|FG000|Overall Study|Not Treated|1|||
46651749|NCT03473925|82859865|FG001|Overall Study|Not Treated|1|||
46651750|NCT03230097|82859873|FG000|Overall Study|Adverse Event|2|||
46651751|NCT03230097|82859874|FG001|Overall Study|Adverse Event|1|||
46651752|NCT03230097|82859873|FG000|Overall Study|non-compliance|0|||
46651753|NCT03230097|82859874|FG001|Overall Study|non-compliance|1|||
46651754|NCT03230097|82859873|FG000|Overall Study|Lost to Follow-up|2|||
46651755|NCT03230097|82859874|FG001|Overall Study|Lost to Follow-up|4|||
46651756|NCT03230097|82859873|FG000|Overall Study|Withdrawal by Subject|7|||
46651757|NCT03230097|82859874|FG001|Overall Study|Withdrawal by Subject|3|||
46651758|NCT03230097|82859873|FG000|Overall Study|Trial termination|4|||
46970777|NCT02560623|83214119|FG003|Overall Study|Unable to swallow sponge|0|||
46970778|NCT02560623|83214116|FG000|Overall Study|Intervention prior to sponge administration|0|||
46970779|NCT02560623|83214117|FG001|Overall Study|Intervention prior to sponge administration|1|||
46970780|NCT02560623|83214118|FG002|Overall Study|Intervention prior to sponge administration|0|||
46970781|NCT02560623|83214119|FG003|Overall Study|Intervention prior to sponge administration|0|||
46970782|NCT02560389|83214132|FG000|Overall Study|Lost to Follow-up|1|||
46970783|NCT02560389|83214133|FG001|Overall Study|Lost to Follow-up|2|||
46970784|NCT02560389|83214134|FG002|Overall Study|Lost to Follow-up|2|||
46970785|NCT02560389|83214132|FG000|Overall Study|Tested positive for illicit substance|0|||
46970786|NCT02560389|83214133|FG001|Overall Study|Tested positive for illicit substance|1|||
46970787|NCT02560389|83214134|FG002|Overall Study|Tested positive for illicit substance|0|||
46970788|NCT02564211|83214142|FG000|Overall Study|Adverse Event|4|||
46970789|NCT02093026|83214146|FG000|Overall Study|Adverse Event|26|||
46970790|NCT02093026|83214146|FG000|Overall Study|Death|10|||
46970791|NCT02093026|83214146|FG000|Overall Study|Other|157|||
46970792|NCT02040844|83214154|FG000|Overall Study|Adverse Event|0|||
46970793|NCT02040844|83214155|FG001|Overall Study|Adverse Event|0|||
46970794|NCT02040844|83214156|FG002|Overall Study|Adverse Event|1|||
46970795|NCT02040844|83214154|FG000|Overall Study|Withdrawal by Subject|16|||
46970796|NCT02040844|83214155|FG001|Overall Study|Withdrawal by Subject|22|||
46970797|NCT02040844|83214156|FG002|Overall Study|Withdrawal by Subject|25|||
46970798|NCT02040844|83214154|FG000|Overall Study|Lost to Follow-up|12|||
46970799|NCT02040844|83214155|FG001|Overall Study|Lost to Follow-up|9|||
46970800|NCT02040844|83214156|FG002|Overall Study|Lost to Follow-up|13|||
46970801|NCT02040844|83214154|FG000|Overall Study|Missing|13|||
46970802|NCT02040844|83214155|FG001|Overall Study|Missing|3|||
46970803|NCT02040844|83214156|FG002|Overall Study|Missing|2|||
46970804|NCT02040844|83214154|FG000|Overall Study|Non-specified|8|||
46651759|NCT03230097|82859874|FG001|Overall Study|Trial termination|5|||
46651760|NCT03230097|82859873|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
46651761|NCT03230097|82859874|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
47075372|NCT00129935|83369327|FG001|Overall Study|Adverse Event|56|||
47075373|NCT00129935|83369326|FG000|Overall Study|Death|1|||
46651762|NCT03230097|82859873|FG000|Overall Study|outcome event|0|||
46651763|NCT03230097|82859874|FG001|Overall Study|outcome event|1|||
46651764|NCT02803593|82859899|FG000|Overall Study|Lost to Follow-up|17|||
46651765|NCT02803593|82859900|FG001|Overall Study|Lost to Follow-up|35|||
46651766|NCT02663908|82859908|FG000|Overall Study|Withdrawal by Subject|8|||
46651767|NCT02663908|82859909|FG001|Overall Study|Withdrawal by Subject|5|||
46651768|NCT02663908|82859908|FG000|Overall Study|Lost to Follow-up|1|||
46651769|NCT02663908|82859909|FG001|Overall Study|Lost to Follow-up|5|||
46651770|NCT02663908|82859908|FG000|Overall Study|Adverse Event|13|||
46651771|NCT02663908|82859909|FG001|Overall Study|Adverse Event|11|||
46651772|NCT02663908|82859908|FG000|Overall Study|Protocol Violation|1|||
46651773|NCT02663908|82859909|FG001|Overall Study|Protocol Violation|2|||
46651774|NCT02663908|82859908|FG000|Overall Study|Lack of therapeutic response|2|||
46651775|NCT02663908|82859909|FG001|Overall Study|Lack of therapeutic response|0|||
46651776|NCT02663908|82859908|FG000|Overall Study|COVID-19|1|||
46781289|NCT00630747|82999873|FG000|Overall Study|Death|1|||
46970805|NCT02040844|83214155|FG001|Overall Study|Non-specified|2|||
46651777|NCT02663908|82859909|FG001|Overall Study|COVID-19|0|||
46850780|NCT00381797|83066565|FG001|Overall Study|Withdrawal by Subject|1|||
46970806|NCT02040844|83214156|FG002|Overall Study|Non-specified|5|||
46970807|NCT02040844|83214154|FG000|Overall Study|Concomitant medication|1|||
46970808|NCT02040844|83214155|FG001|Overall Study|Concomitant medication|3|||
46970809|NCT02040844|83214156|FG002|Overall Study|Concomitant medication|1|||
46970810|NCT02059174|83214164|FG000|Period 1|Withdrawal by Subject|0|||
46970811|NCT02059174|83214165|FG001|Period 1|Withdrawal by Subject|2|||
46970812|NCT02059174|83214164|FG000|Period 2|Withdrawal by Subject|0|||
46970813|NCT02059174|83214165|FG001|Period 2|Withdrawal by Subject|2|||
46651778|NCT02663908|82859908|FG000|Overall Study|Site closed|1|||
46651779|NCT02663908|82859909|FG001|Overall Study|Site closed|0|||
46651780|NCT02663908|82859908|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
46707450|NCT01196429|82922989|FG001|Overall Study|Ineligible - inadequate pathology|0|||
46651781|NCT02663908|82859909|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
46651782|NCT02663908|82859908|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
46651783|NCT02663908|82859909|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
46651784|NCT02663908|82859908|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
46651785|NCT02663908|82859909|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
46651786|NCT02663908|82859908|FG000|Overall Study|Death|1|||
46651787|NCT02663908|82859909|FG001|Overall Study|Death|0|||
46651788|NCT02663908|82859908|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
46651789|NCT02663908|82859909|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
46651790|NCT02663908|82859908|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
46651791|NCT02663908|82859909|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
46651792|NCT02650284|82859917|FG000|Overall Study|Lost to Follow-up|3|||
46651793|NCT02650284|82859918|FG001|Overall Study|Lost to Follow-up|3|||
46651794|NCT02650284|82859917|FG000|Overall Study|Consent incorrectly taken|0|||
46651795|NCT02650284|82859918|FG001|Overall Study|Consent incorrectly taken|1|||
46651796|NCT02175030|82859926|FG000|Overall Study|Failed screen after consent|7|||
46651797|NCT02175030|82859927|FG001|Overall Study|Failed screen after consent|6|||
46651798|NCT02175030|82859926|FG000|Overall Study|Failed IUD Insertion|20|||
46651799|NCT02175030|82859927|FG001|Overall Study|Failed IUD Insertion|21|||
46651800|NCT02175030|82859926|FG000|Overall Study|Physician Decision|1|||
46651801|NCT02175030|82859927|FG001|Overall Study|Physician Decision|1|||
46651802|NCT02175030|82859926|FG000|Overall Study|Lost to Follow-up|6|||
46651803|NCT02175030|82859927|FG001|Overall Study|Lost to Follow-up|6|||
46651804|NCT02175030|82859926|FG000|Overall Study|Withdrawal by Subject|1|||
46651805|NCT02175030|82859927|FG001|Overall Study|Withdrawal by Subject|4|||
46651806|NCT03096834|82859952|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
46651807|NCT03096834|82859953|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
46651808|NCT03096834|82859954|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
46651809|NCT03096834|82859955|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
46651810|NCT03096834|82859952|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
46651811|NCT03096834|82859953|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
46651812|NCT03096834|82859954|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
46651813|NCT03096834|82859955|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
46651814|NCT03096834|82859952|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
46651815|NCT03096834|82859953|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
46651816|NCT03096834|82859954|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
46651817|NCT03096834|82859955|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
46651818|NCT03096834|82859952|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
46651819|NCT03096834|82859953|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
46651820|NCT03096834|82859954|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
46651821|NCT03096834|82859955|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
46651822|NCT03096834|82859952|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
46651823|NCT03096834|82859953|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
46651824|NCT03096834|82859954|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
46651825|NCT03096834|82859955|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
46651826|NCT03096834|82859952|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
46651827|NCT03096834|82859953|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
46651828|NCT03096834|82859954|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
46651829|NCT03096834|82859955|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
46651830|NCT03096834|82859952|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
46651831|NCT03096834|82859953|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
46651832|NCT03096834|82859954|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
46651833|NCT03096834|82859955|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
46651834|NCT03096834|82859952|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
46651835|NCT03096834|82859953|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
46651836|NCT03096834|82859954|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
46651837|NCT03096834|82859955|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
47075374|NCT00129935|83369327|FG001|Overall Study|Death|1|||
47075375|NCT00129935|83369326|FG000|Overall Study|Withdrawal by Subject|7|||
47075376|NCT00129935|83369327|FG001|Overall Study|Withdrawal by Subject|20|||
47075377|NCT00129935|83369326|FG000|Overall Study|Protocol Violation|0|||
47075378|NCT00129935|83369327|FG001|Overall Study|Protocol Violation|4|||
47075379|NCT00129935|83369326|FG000|Overall Study|Physician Decision|3|||
46651838|NCT03096834|82859952|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
46651839|NCT03096834|82859953|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
46651840|NCT03096834|82859954|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
46651841|NCT03096834|82859955|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
46651842|NCT03096834|82859952|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
46651843|NCT03096834|82859953|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
47075380|NCT00129935|83369327|FG001|Overall Study|Physician Decision|4|||
46651844|NCT03096834|82859954|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
46651845|NCT03096834|82859955|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
46651846|NCT03096834|82859952|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
46651847|NCT03096834|82859953|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
46651848|NCT03096834|82859954|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
46651849|NCT03096834|82859955|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
46651850|NCT03096834|82859952|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
46651851|NCT03096834|82859953|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
46651852|NCT03096834|82859954|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
46651853|NCT03096834|82859955|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
46651854|NCT03012815|82859966|FG000|Overall Study|Lost to Follow-up|1|||
46651855|NCT03012815|82859967|FG001|Overall Study|Lost to Follow-up|0|||
46651856|NCT03012815|82859966|FG000|Overall Study|Physician Decision|3|||
46651857|NCT03012815|82859967|FG001|Overall Study|Physician Decision|2|||
46651858|NCT03012815|82859966|FG000|Overall Study|Adverse Event|1|||
46651859|NCT03012815|82859967|FG001|Overall Study|Adverse Event|0|||
46651860|NCT03001011|82859976|FG000|Overall Study|Adverse Event|9|||
46651861|NCT03001011|82859977|FG001|Overall Study|Adverse Event|3|||
46970814|NCT02059174|83214164|FG000|Period 2|Protocol Violation|1|||
46970815|NCT02059174|83214165|FG001|Period 2|Protocol Violation|0|||
46970816|NCT02059174|83214164|FG000|Period 3|Physician Decision|1|||
46970817|NCT02059174|83214165|FG001|Period 3|Physician Decision|0|||
46970818|NCT02092324|83214173|FG000|Overall Study|Adverse Event|1|||
46651862|NCT03001011|82859976|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
46651863|NCT03001011|82859977|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
46651864|NCT03001011|82859976|FG000|Overall Study|Other than specified above|3|||
46651865|NCT03001011|82859977|FG001|Overall Study|Other than specified above|8|||
46651866|NCT02993757|82859986|FG000|Overall Study|Non compliance with the protocol|155|||
46651867|NCT02993757|82859987|FG001|Overall Study|Non compliance with the protocol|170|||
46651868|NCT02993757|82859986|FG000|Overall Study|Lost to Follow-up|1|||
46651869|NCT02993757|82859987|FG001|Overall Study|Lost to Follow-up|0|||
46781290|NCT00630747|82999873|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
46651870|NCT02993757|82859986|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
46781291|NCT00630747|82999873|FG000|Overall Study|Returned to country of origin|1|||
46781292|NCT00397891|82999882|FG000|Overall Study|Withdrawal by Subject|1|||
46651871|NCT02993757|82859987|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
46651872|NCT02979535|82859995|FG000|Overall Study|Non compliance with the protocol|78|||
46651873|NCT02979535|82859996|FG001|Overall Study|Non compliance with the protocol|82|||
46651874|NCT02979535|82859995|FG000|Overall Study|Consent withdrawn by participant|11|||
46651875|NCT02979535|82859996|FG001|Overall Study|Consent withdrawn by participant|18|||
46651876|NCT02979535|82859995|FG000|Overall Study|Lost to Follow-up|6|||
46651877|NCT02979535|82859996|FG001|Overall Study|Lost to Follow-up|1|||
46651878|NCT02978716|82860005|FG000|Overall Study|Death|25|||
46651879|NCT02978716|82860006|FG001|Overall Study|Death|13|||
46651880|NCT02978716|82860007|FG002|Overall Study|Death|20|||
46651881|NCT02978716|82860005|FG000|Overall Study|Lost to Follow-up|0|||
46651882|NCT02978716|82860006|FG001|Overall Study|Lost to Follow-up|0|||
46651883|NCT02978716|82860007|FG002|Overall Study|Lost to Follow-up|1|||
46651884|NCT02978716|82860005|FG000|Overall Study|Withdrawal by Subject|6|||
46651885|NCT02978716|82860006|FG001|Overall Study|Withdrawal by Subject|4|||
46651886|NCT02978716|82860007|FG002|Overall Study|Withdrawal by Subject|5|||
46651887|NCT02978716|82860005|FG000|Overall Study|Sponsor terminated|2|||
46651888|NCT02978716|82860006|FG001|Overall Study|Sponsor terminated|13|||
46651889|NCT02978716|82860007|FG002|Overall Study|Sponsor terminated|9|||
46651890|NCT02978716|82860005|FG000|Overall Study|Other|1|||
46651891|NCT02978716|82860006|FG001|Overall Study|Other|3|||
46651892|NCT02978716|82860007|FG002|Overall Study|Other|0|||
46651893|NCT02973321|82860022|FG000|Overall Study|Other than specified|0|||
46651894|NCT02973321|82860023|FG001|Overall Study|Other than specified|5|||
46651895|NCT02973321|82860024|FG002|Overall Study|Other than specified|3|||
46651896|NCT02973321|82860025|FG003|Overall Study|Other than specified|3|||
46651897|NCT02973321|82860026|FG004|Overall Study|Other than specified|1|||
46651898|NCT02973321|82860022|FG000|Overall Study|Lack of Efficacy|0|||
46651899|NCT02973321|82860023|FG001|Overall Study|Lack of Efficacy|0|||
46651900|NCT02973321|82860024|FG002|Overall Study|Lack of Efficacy|0|||
46651901|NCT02973321|82860025|FG003|Overall Study|Lack of Efficacy|0|||
46781293|NCT00397891|82999883|FG001|Overall Study|Withdrawal by Subject|0|||
46781294|NCT00397891|82999884|FG002|Overall Study|Withdrawal by Subject|0|||
46781295|NCT00397891|82999885|FG003|Overall Study|Withdrawal by Subject|0|||
46781296|NCT00397891|82999886|FG004|Overall Study|Withdrawal by Subject|1|||
46781297|NCT00397189|82999900|FG000|3 Weeks Period|Lost to Follow-up|5|||
46781298|NCT00397189|82999901|FG001|3 Weeks Period|Lost to Follow-up|4|||
46781299|NCT00397189|82999900|FG000|3 Weeks Period|Adverse Event|3|||
46781300|NCT00397189|82999901|FG001|3 Weeks Period|Adverse Event|2|||
46781301|NCT00397189|82999900|FG000|3 Weeks Period|Withdrawal by Subject|13|||
46970819|NCT02092324|83214173|FG000|Overall Study|Lack of Efficacy|6|||
46781302|NCT00397189|82999901|FG001|3 Weeks Period|Withdrawal by Subject|9|||
46651902|NCT02973321|82860026|FG004|Overall Study|Lack of Efficacy|1|||
46651903|NCT02973321|82860022|FG000|Overall Study|Adverse Event|1|||
46651904|NCT02973321|82860023|FG001|Overall Study|Adverse Event|10|||
46651905|NCT02973321|82860024|FG002|Overall Study|Adverse Event|11|||
46651906|NCT02973321|82860025|FG003|Overall Study|Adverse Event|13|||
46651907|NCT02973321|82860026|FG004|Overall Study|Adverse Event|3|||
46651908|NCT02943785|82860041|FG000|Overall Study|Adverse Event|112|||
46651909|NCT02943785|82860042|FG001|Overall Study|Adverse Event|97|||
46651910|NCT02943785|82860041|FG000|Overall Study|Withdrawal by Subject|63|||
46651911|NCT02943785|82860042|FG001|Overall Study|Withdrawal by Subject|126|||
46651912|NCT02943785|82860041|FG000|Overall Study|Physician Decision|23|||
46651913|NCT02943785|82860042|FG001|Overall Study|Physician Decision|47|||
46651914|NCT02943785|82860041|FG000|Overall Study|Death|46|||
46651915|NCT02943785|82860042|FG001|Overall Study|Death|46|||
46651916|NCT02943785|82860041|FG000|Overall Study|Lost to Follow-up|1|||
46651917|NCT02943785|82860042|FG001|Overall Study|Lost to Follow-up|0|||
46651918|NCT02943785|82860041|FG000|Overall Study|Other|16|||
46651919|NCT02943785|82860042|FG001|Overall Study|Other|19|||
46651920|NCT02943785|82860041|FG000|Overall Study|Did not receive any study medication|21|||
46651921|NCT02943785|82860042|FG001|Overall Study|Did not receive any study medication|28|||
46651922|NCT02923674|82860051|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
46651923|NCT02923674|82860052|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
46651924|NCT02923674|82860053|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
46651925|NCT02923674|82860051|FG000|Overall Study|Lost to Follow-up|7|||
46651926|NCT02923674|82860052|FG001|Overall Study|Lost to Follow-up|12|||
46651927|NCT02923674|82860053|FG002|Overall Study|Lost to Follow-up|7|||
46651928|NCT02923674|82860051|FG000|Overall Study|Problem with intervention|2|||
46651929|NCT02923674|82860052|FG001|Overall Study|Problem with intervention|2|||
46651930|NCT02923674|82860053|FG002|Overall Study|Problem with intervention|1|||
46651931|NCT02923674|82860051|FG000|Overall Study|Adverse Event|3|||
46651932|NCT02923674|82860052|FG001|Overall Study|Adverse Event|1|||
46651933|NCT02923674|82860053|FG002|Overall Study|Adverse Event|1|||
46651934|NCT02923674|82860051|FG000|Overall Study|Withdrawal by Subject|2|||
46651935|NCT02923674|82860052|FG001|Overall Study|Withdrawal by Subject|2|||
46651936|NCT02923674|82860053|FG002|Overall Study|Withdrawal by Subject|2|||
46651937|NCT02921971|82860063|FG000|Overall Study|Adverse Event|1|||
46651938|NCT02921971|82860064|FG001|Overall Study|Adverse Event|2|||
46651939|NCT02921971|82860063|FG000|Overall Study|Lack of Efficacy|3|||
46651940|NCT02921971|82860064|FG001|Overall Study|Lack of Efficacy|1|||
46651941|NCT02921971|82860063|FG000|Overall Study|Other than specified above|2|||
46651942|NCT02921971|82860064|FG001|Overall Study|Other than specified above|1|||
46651943|NCT02886286|82860072|FG000|Overall Study|pump motor stall|0|||
46651944|NCT02886286|82860073|FG001|Overall Study|pump motor stall|1|||
46651945|NCT02865187|82860081|FG000|Overall Study|Lost to Follow-up|12|||
46651946|NCT02865187|82860082|FG001|Overall Study|Lost to Follow-up|7|||
46651947|NCT02865187|82860081|FG000|Overall Study|Adverse Event|1|||
46651948|NCT02865187|82860082|FG001|Overall Study|Adverse Event|0|||
46651949|NCT02824198|82860090|FG000|Overall Study|Non-compliance with the protocol|5|||
46651950|NCT02824198|82860091|FG001|Overall Study|Non-compliance with the protocol|1|||
46651951|NCT02824198|82860090|FG000|Overall Study|Lost to Follow-up|5|||
46651952|NCT02824198|82860091|FG001|Overall Study|Lost to Follow-up|2|||
46651953|NCT02824198|82860090|FG000|Overall Study|Withdrawal by Subject|5|||
46651954|NCT02824198|82860091|FG001|Overall Study|Withdrawal by Subject|0|||
46651955|NCT02787551|82860101|FG000|Core Period: 26 Weeks|Adverse Event|10|||
46651956|NCT02787551|82860102|FG001|Core Period: 26 Weeks|Adverse Event|0|||
46651957|NCT02787551|82860101|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
46651958|NCT02787551|82860102|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
46651959|NCT02787551|82860101|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
46651960|NCT02787551|82860102|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
46651961|NCT02787551|82860101|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
46651962|NCT02787551|82860102|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
46651963|NCT02787551|82860101|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
46651964|NCT02787551|82860102|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
46651965|NCT02787551|82860101|FG000|Core Period: 26 Weeks|Other than specified|3|||
46651966|NCT02787551|82860102|FG001|Core Period: 26 Weeks|Other than specified|1|||
46651967|NCT02787551|82860101|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
46651968|NCT02787551|82860102|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
46651969|NCT02787551|82860101|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
46651970|NCT02787551|82860102|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
46651971|NCT02787551|82860101|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
46651972|NCT02787551|82860102|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
46651973|NCT02735044|82860122|FG000|Overall Study|Adverse Event|3|||
46651974|NCT02735044|82860123|FG001|Overall Study|Adverse Event|3|||
46651975|NCT02735044|82860122|FG000|Overall Study|Lack of Efficacy|1|||
46651976|NCT02735044|82860123|FG001|Overall Study|Lack of Efficacy|0|||
46651977|NCT02735044|82860122|FG000|Overall Study|Poor compliance to protocol|7|||
46651978|NCT02735044|82860123|FG001|Overall Study|Poor compliance to protocol|7|||
46651979|NCT02735044|82860122|FG000|Overall Study|Randomized and not treated|0|||
46651980|NCT02735044|82860123|FG001|Overall Study|Randomized and not treated|2|||
46651981|NCT02735044|82860122|FG000|Overall Study|Other, not specified above|5|||
46651982|NCT02735044|82860123|FG001|Overall Study|Other, not specified above|11|||
46651983|NCT02720744|82860131|FG000|Overall Study|Protocol Violation|0|||
46651984|NCT02720744|82860132|FG001|Overall Study|Protocol Violation|2|||
46651985|NCT02720744|82860131|FG000|Overall Study|Pregnancy|2|||
46651986|NCT02720744|82860132|FG001|Overall Study|Pregnancy|0|||
46651987|NCT02720744|82860131|FG000|Overall Study|Lack of Efficacy|2|||
46651988|NCT02720744|82860132|FG001|Overall Study|Lack of Efficacy|8|||
46651989|NCT02720744|82860131|FG000|Overall Study|Adverse Event|21|||
46651990|NCT02720744|82860132|FG001|Overall Study|Adverse Event|3|||
46651991|NCT02720744|82860131|FG000|Overall Study|Withdrawal by Subject|11|||
46651992|NCT02720744|82860132|FG001|Overall Study|Withdrawal by Subject|11|||
46651993|NCT02720744|82860131|FG000|Overall Study|Lost to follow up|2|||
46651994|NCT02720744|82860132|FG001|Overall Study|Lost to follow up|0|||
46651995|NCT02720744|82860131|FG000|Overall Study|Non Compliance with Investigational Product|0|||
46651996|NCT02720744|82860132|FG001|Overall Study|Non Compliance with Investigational Product|1|||
46651997|NCT02720744|82860131|FG000|Overall Study|Excluded Concomitant Medication|0|||
46651998|NCT02720744|82860132|FG001|Overall Study|Excluded Concomitant Medication|1|||
46651999|NCT02692651|82860140|FG000|Study Treatment|Death|7|||
46652000|NCT02692651|82860141|FG001|Study Treatment|Death|3|||
46652001|NCT02692651|82860140|FG000|Study Treatment|comfort care|1|||
46652002|NCT02692651|82860141|FG001|Study Treatment|comfort care|1|||
46652003|NCT02692651|82860140|FG000|Study Treatment|Protocol violation per treating team preference|8|||
46652004|NCT02692651|82860141|FG001|Study Treatment|Protocol violation per treating team preference|6|||
46652005|NCT02692651|82860140|FG000|Post Study Treatment Follow-up|Death|4|||
46652006|NCT02692651|82860141|FG001|Post Study Treatment Follow-up|Death|4|||
46652007|NCT02674061|82860149|FG000|Overall Study|Death|229|||
46652008|NCT02674061|82860150|FG001|Overall Study|Death|77|||
46652009|NCT02674061|82860149|FG000|Overall Study|Lost to Follow-up|3|||
46652010|NCT02674061|82860150|FG001|Overall Study|Lost to Follow-up|3|||
46652011|NCT02674061|82860149|FG000|Overall Study|Withdrawal by Subject|9|||
46652012|NCT02674061|82860150|FG001|Overall Study|Withdrawal by Subject|1|||
46652013|NCT02674061|82860149|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
46652014|NCT02674061|82860150|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
46652015|NCT02628444|82860170|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
46652016|NCT02628444|82860171|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46652017|NCT02628444|82860172|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46652018|NCT02628444|82860173|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46652019|NCT02628444|82860174|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46652020|NCT02628444|82860175|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46781303|NCT00397189|82999900|FG000|3 Weeks Period|Physician Decision|0|||
46970820|NCT02092324|83214173|FG000|Overall Study|Proceed to Transplant|3|||
46970821|NCT02092324|83214173|FG000|Overall Study|Physician Decision|7|||
46970822|NCT02092324|83214173|FG000|Overall Study|Misdiagnosis|2|||
46970823|NCT02040766|83214185|FG000|Overall Study|Adverse Event|1|||
46970824|NCT02040766|83214186|FG001|Overall Study|Adverse Event|1|||
46970825|NCT02040766|83214187|FG002|Overall Study|Adverse Event|1|||
46970826|NCT02040766|83214188|FG003|Overall Study|Adverse Event|0|||
46970827|NCT02040766|83214189|FG004|Overall Study|Adverse Event|2|||
46970828|NCT02040766|83214185|FG000|Overall Study|Withdrawal by Subject|4|||
46970829|NCT02040766|83214186|FG001|Overall Study|Withdrawal by Subject|3|||
46970830|NCT02040766|83214187|FG002|Overall Study|Withdrawal by Subject|2|||
46970831|NCT02040766|83214188|FG003|Overall Study|Withdrawal by Subject|3|||
46970832|NCT02040766|83214189|FG004|Overall Study|Withdrawal by Subject|2|||
46970833|NCT02040766|83214185|FG000|Overall Study|Non-compliance|0|||
47075381|NCT00129935|83369326|FG000|Overall Study|Recurrence|1|||
47075382|NCT00129935|83369327|FG001|Overall Study|Recurrence|3|||
47075383|NCT00129935|83369326|FG000|Overall Study|Second primary|0|||
47075384|NCT00129935|83369327|FG001|Overall Study|Second primary|1|||
47075385|NCT00129935|83369326|FG000|Overall Study|Other|3|||
46781304|NCT00397189|82999901|FG001|3 Weeks Period|Physician Decision|2|||
46970834|NCT02040766|83214186|FG001|Overall Study|Non-compliance|1|||
46970835|NCT02040766|83214187|FG002|Overall Study|Non-compliance|0|||
46970836|NCT02040766|83214188|FG003|Overall Study|Non-compliance|0|||
46970837|NCT02040766|83214189|FG004|Overall Study|Non-compliance|0|||
46970838|NCT02040766|83214185|FG000|Overall Study|Protocol Violation|2|||
46652021|NCT02628444|82860176|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46781305|NCT00397189|82999900|FG000|3 Weeks Period|Protocol Violation|0|||
47075386|NCT00129935|83369327|FG001|Overall Study|Other|2|||
47075387|NCT00129935|83369326|FG000|Overall Study|Crossed to the other arm|2|||
46652022|NCT02628444|82860177|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46652023|NCT02628444|82860178|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
46652024|NCT02628444|82860170|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
46652025|NCT02628444|82860171|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
46652026|NCT02628444|82860172|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
46652027|NCT02628444|82860173|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
46652028|NCT02628444|82860174|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
46652029|NCT02628444|82860175|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
46652030|NCT02628444|82860176|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
46652031|NCT02628444|82860177|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
46652032|NCT02628444|82860178|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
46652033|NCT02628444|82860170|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
46652034|NCT02628444|82860171|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
46652035|NCT02628444|82860172|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
46652036|NCT02628444|82860173|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652037|NCT02628444|82860174|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652038|NCT02628444|82860175|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652039|NCT02628444|82860176|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652040|NCT02628444|82860177|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652041|NCT02628444|82860178|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652042|NCT02628444|82860170|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
46652043|NCT02628444|82860171|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
46652044|NCT02628444|82860172|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
46652045|NCT02628444|82860173|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
46652046|NCT02628444|82860174|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
46652047|NCT02628444|82860175|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
46652048|NCT02628444|82860176|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
46652049|NCT02628444|82860177|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
46652050|NCT02628444|82860178|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
46652051|NCT02628444|82860170|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
46652052|NCT02628444|82860171|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
46652053|NCT02628444|82860172|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
46652054|NCT02628444|82860173|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
46652055|NCT02628444|82860174|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
46652056|NCT02628444|82860175|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
46652057|NCT02628444|82860176|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
46652058|NCT02628444|82860177|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
46652059|NCT02628444|82860178|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
46652060|NCT02628444|82860170|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652061|NCT02628444|82860171|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652062|NCT02628444|82860172|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652063|NCT02628444|82860173|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
46652064|NCT02628444|82860174|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652065|NCT02628444|82860175|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652066|NCT02628444|82860176|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652067|NCT02628444|82860177|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652068|NCT02628444|82860178|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
46652069|NCT02628444|82860170|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
46652070|NCT02628444|82860171|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
46652071|NCT02628444|82860172|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
46652072|NCT02628444|82860173|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
46652073|NCT02628444|82860174|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
46652074|NCT02628444|82860175|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
46652075|NCT02628444|82860176|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
46652076|NCT02628444|82860177|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
46652077|NCT02628444|82860178|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
46652078|NCT02628444|82860170|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652079|NCT02628444|82860171|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652080|NCT02628444|82860172|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
46652081|NCT02628444|82860173|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
46652082|NCT02628444|82860174|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
46652083|NCT02628444|82860175|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
46652084|NCT02628444|82860176|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
46652085|NCT02628444|82860177|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
46652086|NCT02628444|82860178|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
46652087|NCT02628444|82860170|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
46652088|NCT02628444|82860171|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
46652089|NCT02628444|82860172|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
46652090|NCT02628444|82860173|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
46652091|NCT02628444|82860174|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
46652092|NCT02628444|82860175|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
46652093|NCT02628444|82860176|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
46652094|NCT02628444|82860177|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
46652095|NCT02628444|82860178|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
46652096|NCT02628444|82860170|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
46652097|NCT02628444|82860171|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
46652098|NCT02628444|82860172|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
46652099|NCT02628444|82860173|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
46652100|NCT02628444|82860174|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
46652101|NCT02628444|82860175|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
46652102|NCT02628444|82860176|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
46652103|NCT02628444|82860177|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
46652104|NCT02628444|82860178|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
46652105|NCT02623725|82860214|FG000|Overall Study|Non compliance with protocol|9|||
46652106|NCT02623725|82860215|FG001|Overall Study|Non compliance with protocol|3|||
46652107|NCT02623725|82860214|FG000|Overall Study|Serious adverse event|0|||
46652108|NCT02623725|82860215|FG001|Overall Study|Serious adverse event|2|||
46652109|NCT02623725|82860214|FG000|Overall Study|Withdrawal by Subject|7|||
46652110|NCT02623725|82860215|FG001|Overall Study|Withdrawal by Subject|1|||
46652111|NCT02608684|82860223|FG000|Overall Study|Physician Decision|2|||
46652112|NCT02608684|82860223|FG000|Overall Study|Withdrawal by Subject|1|||
46652113|NCT02587520|82860245|FG000|Overall Study|Protocol Violation|2|||
46652114|NCT02587520|82860246|FG001|Overall Study|Protocol Violation|0|||
46652115|NCT02587520|82860247|FG002|Overall Study|Protocol Violation|0|||
46652116|NCT02587520|82860248|FG003|Overall Study|Protocol Violation|2|||
46652117|NCT02587520|82860249|FG004|Overall Study|Protocol Violation|0|||
46652118|NCT02587520|82860250|FG005|Overall Study|Protocol Violation|1|||
46652119|NCT02587520|82860251|FG006|Overall Study|Protocol Violation|1|||
46652120|NCT02587520|82860252|FG007|Overall Study|Protocol Violation|1|||
46652121|NCT02587520|82860253|FG008|Overall Study|Protocol Violation|3|||
46652122|NCT02587520|82860254|FG009|Overall Study|Protocol Violation|3|||
46652123|NCT02587520|82860255|FG010|Overall Study|Protocol Violation|1|||
46652124|NCT02587520|82860256|FG011|Overall Study|Protocol Violation|2|||
46652125|NCT02587520|82860257|FG012|Overall Study|Protocol Violation|0|||
46652126|NCT02587520|82860258|FG013|Overall Study|Protocol Violation|0|||
46652127|NCT02587520|82860259|FG014|Overall Study|Protocol Violation|0|||
46652128|NCT02587520|82860260|FG015|Overall Study|Protocol Violation|0|||
46652129|NCT02587520|82860261|FG016|Overall Study|Protocol Violation|0|||
46652130|NCT02587520|82860262|FG017|Overall Study|Protocol Violation|0|||
47075388|NCT00129935|83369327|FG001|Overall Study|Crossed to the other arm|1|||
46652131|NCT02587520|82860245|FG000|Overall Study|Adverse Event|0|||
46652132|NCT02587520|82860246|FG001|Overall Study|Adverse Event|0|||
46652133|NCT02587520|82860247|FG002|Overall Study|Adverse Event|0|||
46652134|NCT02587520|82860248|FG003|Overall Study|Adverse Event|0|||
46652135|NCT02587520|82860249|FG004|Overall Study|Adverse Event|0|||
46652136|NCT02587520|82860250|FG005|Overall Study|Adverse Event|0|||
46850781|NCT00381797|83066566|FG002|Overall Study|Withdrawal by Subject|0|||
47075389|NCT00129935|83369326|FG000|Overall Study|Incorrect study treatment|1|||
47075390|NCT00129935|83369327|FG001|Overall Study|Incorrect study treatment|0|||
47075391|NCT01647828|83369342|FG000|Overall Study|Death|3|||
47075392|NCT01647828|83369343|FG001|Overall Study|Death|4|||
46652137|NCT02587520|82860251|FG006|Overall Study|Adverse Event|0|||
47075393|NCT01647828|83369344|FG002|Overall Study|Death|4|||
47075394|NCT01647828|83369345|FG003|Overall Study|Death|5|||
47075395|NCT01647828|83369346|FG004|Overall Study|Death|6|||
46850782|NCT00381797|83066567|FG003|Overall Study|Withdrawal by Subject|0|||
46850783|NCT00381797|83066568|FG004|Overall Study|Withdrawal by Subject|2|||
47075396|NCT01647828|83369347|FG005|Overall Study|Death|3|||
46652138|NCT02587520|82860252|FG007|Overall Study|Adverse Event|0|||
46652139|NCT02587520|82860253|FG008|Overall Study|Adverse Event|0|||
46652140|NCT02587520|82860254|FG009|Overall Study|Adverse Event|0|||
46652141|NCT02587520|82860255|FG010|Overall Study|Adverse Event|0|||
46652142|NCT02587520|82860256|FG011|Overall Study|Adverse Event|1|||
46652143|NCT02587520|82860257|FG012|Overall Study|Adverse Event|0|||
46652144|NCT02587520|82860258|FG013|Overall Study|Adverse Event|0|||
46652145|NCT02587520|82860259|FG014|Overall Study|Adverse Event|0|||
46652146|NCT02587520|82860260|FG015|Overall Study|Adverse Event|0|||
46652147|NCT02587520|82860261|FG016|Overall Study|Adverse Event|0|||
46652148|NCT02587520|82860262|FG017|Overall Study|Adverse Event|0|||
46652149|NCT02587520|82860245|FG000|Overall Study|Withdrawal by Subject|0|||
46652150|NCT02587520|82860246|FG001|Overall Study|Withdrawal by Subject|0|||
46652151|NCT02587520|82860247|FG002|Overall Study|Withdrawal by Subject|1|||
46652152|NCT02587520|82860248|FG003|Overall Study|Withdrawal by Subject|1|||
46652153|NCT02587520|82860249|FG004|Overall Study|Withdrawal by Subject|0|||
46652154|NCT02587520|82860250|FG005|Overall Study|Withdrawal by Subject|1|||
46652155|NCT02587520|82860251|FG006|Overall Study|Withdrawal by Subject|1|||
46652156|NCT02587520|82860252|FG007|Overall Study|Withdrawal by Subject|0|||
46652157|NCT02587520|82860253|FG008|Overall Study|Withdrawal by Subject|0|||
46652158|NCT02587520|82860254|FG009|Overall Study|Withdrawal by Subject|0|||
46652159|NCT02587520|82860255|FG010|Overall Study|Withdrawal by Subject|0|||
46652160|NCT02587520|82860256|FG011|Overall Study|Withdrawal by Subject|0|||
46652161|NCT02587520|82860257|FG012|Overall Study|Withdrawal by Subject|0|||
46652162|NCT02587520|82860258|FG013|Overall Study|Withdrawal by Subject|1|||
46652163|NCT02587520|82860259|FG014|Overall Study|Withdrawal by Subject|0|||
46652164|NCT02587520|82860260|FG015|Overall Study|Withdrawal by Subject|0|||
46652165|NCT02587520|82860261|FG016|Overall Study|Withdrawal by Subject|0|||
46652166|NCT02587520|82860262|FG017|Overall Study|Withdrawal by Subject|0|||
46652167|NCT02587520|82860245|FG000|Overall Study|Lost to Follow-up|0|||
46652168|NCT02587520|82860246|FG001|Overall Study|Lost to Follow-up|2|||
46652169|NCT02587520|82860247|FG002|Overall Study|Lost to Follow-up|0|||
46652170|NCT02587520|82860248|FG003|Overall Study|Lost to Follow-up|2|||
46652171|NCT02587520|82860249|FG004|Overall Study|Lost to Follow-up|0|||
46652172|NCT02587520|82860250|FG005|Overall Study|Lost to Follow-up|1|||
46652173|NCT02587520|82860251|FG006|Overall Study|Lost to Follow-up|1|||
46652174|NCT02587520|82860252|FG007|Overall Study|Lost to Follow-up|1|||
46652175|NCT02587520|82860253|FG008|Overall Study|Lost to Follow-up|0|||
46652176|NCT02587520|82860254|FG009|Overall Study|Lost to Follow-up|2|||
46652177|NCT02587520|82860255|FG010|Overall Study|Lost to Follow-up|2|||
46652178|NCT02587520|82860256|FG011|Overall Study|Lost to Follow-up|1|||
46652179|NCT02587520|82860257|FG012|Overall Study|Lost to Follow-up|0|||
46652180|NCT02587520|82860258|FG013|Overall Study|Lost to Follow-up|0|||
46652181|NCT02587520|82860259|FG014|Overall Study|Lost to Follow-up|0|||
46652182|NCT02587520|82860260|FG015|Overall Study|Lost to Follow-up|0|||
46652183|NCT02587520|82860261|FG016|Overall Study|Lost to Follow-up|0|||
46652184|NCT02587520|82860262|FG017|Overall Study|Lost to Follow-up|0|||
46652185|NCT02584829|82860302|FG000|Overall Study|Physician Decision|1|||
46652186|NCT02584829|82860303|FG001|Overall Study|Physician Decision|0|||
46652187|NCT02584829|82860302|FG000|Overall Study|Withdrawal by Subject|0|||
46652188|NCT02584829|82860303|FG001|Overall Study|Withdrawal by Subject|1|||
46652189|NCT02584829|82860302|FG000|Overall Study|Progressive Disease|0|||
46652190|NCT02584829|82860303|FG001|Overall Study|Progressive Disease|3|||
46652191|NCT02570308|82860316|FG000|Overall Study|Death|1|||
46652192|NCT02570308|82860317|FG001|Overall Study|Death|5|||
46652193|NCT02570308|82860318|FG002|Overall Study|Death|4|||
46652194|NCT02570308|82860319|FG003|Overall Study|Death|4|||
46850784|NCT00381797|83066564|FG000|Overall Study|Ineligible|0|||
46850785|NCT00381797|83066565|FG001|Overall Study|Ineligible|0|||
47075397|NCT01647828|83369348|FG006|Overall Study|Death|10|||
47075398|NCT01647828|83369349|FG007|Overall Study|Death|60|||
47075399|NCT01647828|83369350|FG008|Overall Study|Death|71|||
46652195|NCT02570308|82860320|FG004|Overall Study|Death|69|||
46652196|NCT02570308|82860316|FG000|Overall Study|Lost to Follow-up|0|||
46652197|NCT02570308|82860317|FG001|Overall Study|Lost to Follow-up|0|||
46652198|NCT02570308|82860318|FG002|Overall Study|Lost to Follow-up|0|||
46652199|NCT02570308|82860319|FG003|Overall Study|Lost to Follow-up|0|||
46652200|NCT02570308|82860320|FG004|Overall Study|Lost to Follow-up|2|||
46652201|NCT02570308|82860316|FG000|Overall Study|Withdrawal by Subject|0|||
46652202|NCT02570308|82860317|FG001|Overall Study|Withdrawal by Subject|0|||
46652203|NCT02570308|82860318|FG002|Overall Study|Withdrawal by Subject|0|||
47075400|NCT01647828|83369342|FG000|Overall Study|Withdrawal by Subject|2|||
46652204|NCT02570308|82860319|FG003|Overall Study|Withdrawal by Subject|0|||
46652205|NCT02570308|82860320|FG004|Overall Study|Withdrawal by Subject|1|||
46652206|NCT02570308|82860316|FG000|Overall Study|Other|0|||
46652207|NCT02570308|82860317|FG001|Overall Study|Other|0|||
46652208|NCT02570308|82860318|FG002|Overall Study|Other|0|||
46652209|NCT02570308|82860319|FG003|Overall Study|Other|0|||
46652210|NCT02570308|82860320|FG004|Overall Study|Other|2|||
46652211|NCT02497612|82860342|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
46652212|NCT02497612|82860343|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
46652213|NCT02497612|82860344|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
46652214|NCT02497612|82860345|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
46652215|NCT02497612|82860342|FG000|Overall Study|Participant's request|2|||
46652216|NCT02497612|82860343|FG001|Overall Study|Participant's request|3|||
46652217|NCT02497612|82860344|FG002|Overall Study|Participant's request|4|||
46652218|NCT02497612|82860345|FG003|Overall Study|Participant's request|1|||
46652219|NCT02497612|82860342|FG000|Overall Study|Investigator's judgement|1|||
46652220|NCT02497612|82860343|FG001|Overall Study|Investigator's judgement|0|||
46652221|NCT02497612|82860344|FG002|Overall Study|Investigator's judgement|0|||
46652222|NCT02497612|82860345|FG003|Overall Study|Investigator's judgement|2|||
46652223|NCT02497612|82860342|FG000|Overall Study|Adverse Event|3|||
46652224|NCT02497612|82860343|FG001|Overall Study|Adverse Event|1|||
46652225|NCT02497612|82860344|FG002|Overall Study|Adverse Event|4|||
46652226|NCT02497612|82860345|FG003|Overall Study|Adverse Event|1|||
46652227|NCT02497612|82860342|FG000|Overall Study|Lost to Follow-up|1|||
46652228|NCT02497612|82860343|FG001|Overall Study|Lost to Follow-up|1|||
46652229|NCT02497612|82860344|FG002|Overall Study|Lost to Follow-up|0|||
46652230|NCT02497612|82860345|FG003|Overall Study|Lost to Follow-up|1|||
46652231|NCT02497612|82860342|FG000|Overall Study|Other unspecified|1|||
46652232|NCT02497612|82860343|FG001|Overall Study|Other unspecified|1|||
46652233|NCT02497612|82860344|FG002|Overall Study|Other unspecified|2|||
46652234|NCT02497612|82860345|FG003|Overall Study|Other unspecified|0|||
46652235|NCT02497612|82860342|FG000|Overall Study|Not eligible|1|||
46652236|NCT02497612|82860343|FG001|Overall Study|Not eligible|0|||
46652237|NCT02497612|82860344|FG002|Overall Study|Not eligible|0|||
46652238|NCT02497612|82860345|FG003|Overall Study|Not eligible|1|||
46781306|NCT00397189|82999901|FG001|3 Weeks Period|Protocol Violation|3|||
46781307|NCT00397189|82999900|FG000|3 Weeks Period|Other|0|||
46781308|NCT00397189|82999901|FG001|3 Weeks Period|Other|2|||
46781309|NCT00606034|82999909|FG000|Overall Study|incarceration|1|||
46781310|NCT00397033|82999918|FG000|Overall Study|Adverse Event|7|||
46970839|NCT02040766|83214186|FG001|Overall Study|Protocol Violation|1|||
46970840|NCT02040766|83214187|FG002|Overall Study|Protocol Violation|2|||
46781311|NCT00397033|82999919|FG001|Overall Study|Adverse Event|10|||
46652239|NCT02460458|82860355|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
46652240|NCT02460458|82860355|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
46652241|NCT02460458|82860355|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
46652242|NCT02460458|82860355|FG000|First Prospective Phase|Lost to Follow-up|16|||
46652243|NCT02460458|82860355|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
46652244|NCT02457559|82860370|FG000|Overall Study|Progressive Disease|1|||
46652245|NCT02457559|82860371|FG001|Overall Study|Progressive Disease|2|||
46781312|NCT00397033|82999920|FG002|Overall Study|Adverse Event|4|||
46781313|NCT00397033|82999918|FG000|Overall Study|Lack of Efficacy|22|||
46781314|NCT00397033|82999919|FG001|Overall Study|Lack of Efficacy|12|||
46781315|NCT00397033|82999920|FG002|Overall Study|Lack of Efficacy|9|||
46652246|NCT02457559|82860372|FG002|Overall Study|Progressive Disease|3|||
46652247|NCT02457559|82860373|FG003|Overall Study|Progressive Disease|0|||
46652248|NCT02457559|82860374|FG004|Overall Study|Progressive Disease|0|||
46652249|NCT02457559|82860375|FG005|Overall Study|Progressive Disease|2|||
46652250|NCT02457559|82860376|FG006|Overall Study|Progressive Disease|1|||
46652251|NCT02457559|82860377|FG007|Overall Study|Progressive Disease|0|||
46652252|NCT02457559|82860378|FG008|Overall Study|Progressive Disease|1|||
46652253|NCT02457559|82860379|FG009|Overall Study|Progressive Disease|1|||
46652254|NCT02457559|82860380|FG010|Overall Study|Progressive Disease|1|||
46652255|NCT02457559|82860370|FG000|Overall Study|Investigator's Discretion|0|||
46652256|NCT02457559|82860371|FG001|Overall Study|Investigator's Discretion|0|||
46652257|NCT02457559|82860372|FG002|Overall Study|Investigator's Discretion|2|||
46652258|NCT02457559|82860373|FG003|Overall Study|Investigator's Discretion|0|||
46652259|NCT02457559|82860374|FG004|Overall Study|Investigator's Discretion|1|||
46652260|NCT02457559|82860375|FG005|Overall Study|Investigator's Discretion|0|||
46652261|NCT02457559|82860376|FG006|Overall Study|Investigator's Discretion|1|||
46652262|NCT02457559|82860377|FG007|Overall Study|Investigator's Discretion|0|||
46652263|NCT02457559|82860378|FG008|Overall Study|Investigator's Discretion|1|||
46652264|NCT02457559|82860379|FG009|Overall Study|Investigator's Discretion|0|||
46652265|NCT02457559|82860380|FG010|Overall Study|Investigator's Discretion|1|||
46652266|NCT02457559|82860370|FG000|Overall Study|Adverse Event|0|||
46652267|NCT02457559|82860371|FG001|Overall Study|Adverse Event|1|||
46652268|NCT02457559|82860372|FG002|Overall Study|Adverse Event|2|||
46652269|NCT02457559|82860373|FG003|Overall Study|Adverse Event|0|||
46652270|NCT02457559|82860374|FG004|Overall Study|Adverse Event|0|||
46652271|NCT02457559|82860375|FG005|Overall Study|Adverse Event|0|||
46652272|NCT02457559|82860376|FG006|Overall Study|Adverse Event|0|||
46652273|NCT02457559|82860377|FG007|Overall Study|Adverse Event|0|||
46652274|NCT02457559|82860378|FG008|Overall Study|Adverse Event|0|||
46652275|NCT02457559|82860379|FG009|Overall Study|Adverse Event|0|||
46652276|NCT02457559|82860380|FG010|Overall Study|Adverse Event|0|||
46652277|NCT02457559|82860370|FG000|Overall Study|Reason not Specified|1|||
46652278|NCT02457559|82860371|FG001|Overall Study|Reason not Specified|0|||
46652279|NCT02457559|82860372|FG002|Overall Study|Reason not Specified|0|||
46652280|NCT02457559|82860373|FG003|Overall Study|Reason not Specified|0|||
46652281|NCT02457559|82860374|FG004|Overall Study|Reason not Specified|0|||
46652282|NCT02457559|82860375|FG005|Overall Study|Reason not Specified|0|||
46652283|NCT02457559|82860376|FG006|Overall Study|Reason not Specified|0|||
46652284|NCT02457559|82860377|FG007|Overall Study|Reason not Specified|0|||
46652285|NCT02457559|82860378|FG008|Overall Study|Reason not Specified|0|||
46652286|NCT02457559|82860379|FG009|Overall Study|Reason not Specified|2|||
46652287|NCT02457559|82860380|FG010|Overall Study|Reason not Specified|0|||
46652288|NCT02457559|82860370|FG000|Overall Study|Death|0|||
46652289|NCT02457559|82860371|FG001|Overall Study|Death|0|||
46652290|NCT02457559|82860372|FG002|Overall Study|Death|0|||
46652291|NCT02457559|82860373|FG003|Overall Study|Death|0|||
46652292|NCT02457559|82860374|FG004|Overall Study|Death|0|||
46652293|NCT02457559|82860375|FG005|Overall Study|Death|0|||
46652294|NCT02457559|82860376|FG006|Overall Study|Death|0|||
46652295|NCT02457559|82860377|FG007|Overall Study|Death|0|||
46652296|NCT02457559|82860378|FG008|Overall Study|Death|1|||
46652297|NCT02457559|82860379|FG009|Overall Study|Death|1|||
46652298|NCT02457559|82860380|FG010|Overall Study|Death|0|||
46652299|NCT02381652|82860430|FG000|Overall Study|Withdrawal by Subject|0|||
46652300|NCT02381652|82860431|FG001|Overall Study|Withdrawal by Subject|0|||
46652301|NCT02381652|82860432|FG002|Overall Study|Withdrawal by Subject|1|||
46652302|NCT02367794|82860441|FG000|Overall Study|Death|252|||
46652303|NCT02367794|82860442|FG001|Overall Study|Death|245|||
46652304|NCT02367794|82860443|FG002|Overall Study|Death|243|||
46781316|NCT00397033|82999918|FG000|Overall Study|Lost to Follow-up|3|||
47075401|NCT01647828|83369343|FG001|Overall Study|Withdrawal by Subject|0|||
46652305|NCT02367794|82860441|FG000|Overall Study|Lost to Follow-up|1|||
46781317|NCT00397033|82999919|FG001|Overall Study|Lost to Follow-up|3|||
46652306|NCT02367794|82860442|FG001|Overall Study|Lost to Follow-up|2|||
46652307|NCT02367794|82860443|FG002|Overall Study|Lost to Follow-up|2|||
46652308|NCT02367794|82860441|FG000|Overall Study|Physician Decision|0|||
46652309|NCT02367794|82860442|FG001|Overall Study|Physician Decision|5|||
46652310|NCT02367794|82860443|FG002|Overall Study|Physician Decision|3|||
46652311|NCT02367794|82860441|FG000|Overall Study|Protocol Violation|1|||
46652312|NCT02367794|82860442|FG001|Overall Study|Protocol Violation|0|||
46652313|NCT02367794|82860443|FG002|Overall Study|Protocol Violation|1|||
46652314|NCT02367794|82860441|FG000|Overall Study|Withdrawal by Subject|25|||
46652315|NCT02367794|82860442|FG001|Overall Study|Withdrawal by Subject|12|||
46652316|NCT02367794|82860443|FG002|Overall Study|Withdrawal by Subject|20|||
46970841|NCT02040766|83214188|FG003|Overall Study|Protocol Violation|3|||
47075402|NCT01647828|83369344|FG002|Overall Study|Withdrawal by Subject|0|||
46652317|NCT02367794|82860441|FG000|Overall Study|Brain metastasis|1|||
46652318|NCT02367794|82860442|FG001|Overall Study|Brain metastasis|0|||
46652319|NCT02367794|82860443|FG002|Overall Study|Brain metastasis|0|||
46652320|NCT02367794|82860441|FG000|Overall Study|Randomized in error|0|||
46652321|NCT02367794|82860442|FG001|Overall Study|Randomized in error|0|||
46652322|NCT02367794|82860443|FG002|Overall Study|Randomized in error|1|||
46652323|NCT02367794|82860441|FG000|Overall Study|Patient unable to receive carboplatin|0|||
46652324|NCT02367794|82860442|FG001|Overall Study|Patient unable to receive carboplatin|0|||
46652325|NCT02367794|82860443|FG002|Overall Study|Patient unable to receive carboplatin|1|||
46652326|NCT02367794|82860441|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
46652327|NCT02367794|82860442|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
46652328|NCT02367794|82860443|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
46652329|NCT02367794|82860441|FG000|Overall Study|Adverse Event|0|||
46652330|NCT02367794|82860442|FG001|Overall Study|Adverse Event|0|||
46652331|NCT02367794|82860443|FG002|Overall Study|Adverse Event|2|||
46652332|NCT02367794|82860441|FG000|Overall Study|Study Terminated By Sponsor|0|||
46652333|NCT02367794|82860442|FG001|Overall Study|Study Terminated By Sponsor|1|||
46652334|NCT02367794|82860443|FG002|Overall Study|Study Terminated By Sponsor|1|||
46652335|NCT02367794|82860441|FG000|Overall Study|Moved to Roll-Over Study|0|||
46652336|NCT02367794|82860442|FG001|Overall Study|Moved to Roll-Over Study|15|||
46652337|NCT02367794|82860443|FG002|Overall Study|Moved to Roll-Over Study|13|||
46652338|NCT02367794|82860441|FG000|Overall Study|Sponsor Request|60|||
46652339|NCT02367794|82860442|FG001|Overall Study|Sponsor Request|57|||
46652340|NCT02367794|82860443|FG002|Overall Study|Sponsor Request|45|||
46652341|NCT02367794|82860441|FG000|Overall Study|Moved into PTAP Study|0|||
46652342|NCT02367794|82860442|FG001|Overall Study|Moved into PTAP Study|2|||
46652343|NCT02367794|82860443|FG002|Overall Study|Moved into PTAP Study|3|||
46652344|NCT02367794|82860441|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
46652345|NCT02367794|82860442|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
46652346|NCT02367794|82860443|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
46652347|NCT02367794|82860441|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
46652348|NCT02367794|82860442|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
46652349|NCT02367794|82860443|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
46652350|NCT02367794|82860441|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
46652351|NCT02367794|82860442|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
46652352|NCT02367794|82860443|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
46652353|NCT02367794|82860441|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
46652354|NCT02367794|82860442|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
46652355|NCT02367794|82860443|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
46652356|NCT02353832|82860476|FG000|Overall Study|Ineligible after enrollment|1|||
46652357|NCT02353832|82860476|FG000|Overall Study|Lost to Follow-up|1|||
46652358|NCT02353728|82860480|FG000|Overall Study|Subject non-compliance|1|||
46652359|NCT02345070|82860487|FG000|Overall Study|Adverse Event|12|||
46652360|NCT02345070|82860488|FG001|Overall Study|Adverse Event|8|||
46652361|NCT02345070|82860489|FG002|Overall Study|Adverse Event|16|||
46652362|NCT02345070|82860487|FG000|Overall Study|Poor compliance to protocol|2|||
46652363|NCT02345070|82860488|FG001|Overall Study|Poor compliance to protocol|0|||
46652364|NCT02345070|82860489|FG002|Overall Study|Poor compliance to protocol|0|||
46652365|NCT02345070|82860487|FG000|Overall Study|Other than specified above|6|||
46652366|NCT02345070|82860488|FG001|Overall Study|Other than specified above|3|||
46652367|NCT02345070|82860489|FG002|Overall Study|Other than specified above|7|||
46652368|NCT02325466|82860497|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
46652369|NCT02325466|82860498|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
46652370|NCT02325466|82860499|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
46652371|NCT02325466|82860497|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
46652372|NCT02325466|82860498|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
46652373|NCT02325466|82860499|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
46652374|NCT02325466|82860497|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
46652375|NCT02325466|82860498|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
46652376|NCT02325466|82860499|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
46781318|NCT00397033|82999920|FG002|Overall Study|Lost to Follow-up|3|||
46781319|NCT00397033|82999918|FG000|Overall Study|Withdrawal by Subject|12|||
46652377|NCT02325466|82860497|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
46652378|NCT02325466|82860498|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
46652379|NCT02325466|82860499|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
46652380|NCT02325466|82860497|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
46652381|NCT02325466|82860498|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
46652382|NCT02325466|82860499|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
46652383|NCT02325466|82860497|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
46652384|NCT02325466|82860498|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
46652385|NCT02325466|82860499|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
46652386|NCT02325466|82860497|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
46652387|NCT02325466|82860498|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
46781320|NCT00397033|82999919|FG001|Overall Study|Withdrawal by Subject|7|||
46652388|NCT02325466|82860499|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
46652389|NCT02325466|82860497|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
46652390|NCT02325466|82860498|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
46652391|NCT02325466|82860499|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
46652392|NCT02325466|82860497|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
46652393|NCT02325466|82860498|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
46652394|NCT02325466|82860499|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
46652395|NCT02322710|82860510|FG000|Overall Study|No efficacy assessment post-baseline|0|||
46652396|NCT02322710|82860511|FG001|Overall Study|No efficacy assessment post-baseline|1|||
46652397|NCT02322710|82860510|FG000|Overall Study|Protocol Violation|20|||
46652398|NCT02322710|82860511|FG001|Overall Study|Protocol Violation|25|||
46652399|NCT02234310|82860554|FG000|Overall Study|Physician Decision|1|||
46652400|NCT02234310|82860554|FG000|Overall Study|Adverse Event|1|||
47075403|NCT01647828|83369345|FG003|Overall Study|Withdrawal by Subject|1|||
47075404|NCT01647828|83369346|FG004|Overall Study|Withdrawal by Subject|0|||
47075405|NCT01647828|83369347|FG005|Overall Study|Withdrawal by Subject|0|||
47075406|NCT01647828|83369348|FG006|Overall Study|Withdrawal by Subject|1|||
47075407|NCT01647828|83369349|FG007|Overall Study|Withdrawal by Subject|0|||
47075408|NCT01647828|83369350|FG008|Overall Study|Withdrawal by Subject|2|||
47075409|NCT01647828|83369342|FG000|Overall Study|Study terminated by Sponsor|0|||
47075410|NCT01647828|83369343|FG001|Overall Study|Study terminated by Sponsor|0|||
46652401|NCT02234310|82860554|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
46652402|NCT02234310|82860554|FG000|Overall Study|Withdrawal by Subject|2|||
46652403|NCT02106195|82860587|FG000|Overall Study|Adverse Event|2|||
46652404|NCT02106195|82860587|FG000|Overall Study|Protocol Violation|1|||
46652405|NCT02104180|82860599|FG000|Overall Study|Protocol Violation|1|||
46652406|NCT02104180|82860600|FG001|Overall Study|Protocol Violation|0|||
46652407|NCT01943825|82860623|FG000|Overall Study|Lost to Follow-up|9|||
46652408|NCT01943825|82860624|FG001|Overall Study|Lost to Follow-up|3|||
46652409|NCT01943825|82860625|FG002|Overall Study|Lost to Follow-up|12|||
46652410|NCT01943825|82860626|FG003|Overall Study|Lost to Follow-up|8|||
46652411|NCT01943825|82860623|FG000|Overall Study|Withdrawal by Subject|1|||
46652412|NCT01943825|82860624|FG001|Overall Study|Withdrawal by Subject|0|||
46652413|NCT01943825|82860625|FG002|Overall Study|Withdrawal by Subject|3|||
46652414|NCT01943825|82860626|FG003|Overall Study|Withdrawal by Subject|2|||
46652415|NCT01943825|82860623|FG000|Overall Study|Other than specified above|0|||
46652416|NCT01943825|82860624|FG001|Overall Study|Other than specified above|1|||
46652417|NCT01943825|82860625|FG002|Overall Study|Other than specified above|0|||
46652418|NCT01943825|82860626|FG003|Overall Study|Other than specified above|1|||
46652419|NCT01722331|82860658|FG000|Part 1|Adverse Event|5|||
46652420|NCT01722331|82860659|FG001|Part 1|Adverse Event|0|||
46652421|NCT01722331|82860660|FG002|Part 1|Adverse Event|0|||
46652422|NCT01722331|82860661|FG003|Part 1|Adverse Event|0|||
46652423|NCT01722331|82860662|FG004|Part 1|Adverse Event|0|||
46652424|NCT01722331|82860663|FG005|Part 1|Adverse Event|0|||
46652425|NCT01722331|82860664|FG006|Part 1|Adverse Event|0|||
46652426|NCT01722331|82860658|FG000|Part 1|Lack of Efficacy|0|||
46652427|NCT01722331|82860659|FG001|Part 1|Lack of Efficacy|0|||
46652428|NCT01722331|82860660|FG002|Part 1|Lack of Efficacy|1|||
46652429|NCT01722331|82860661|FG003|Part 1|Lack of Efficacy|0|||
46652430|NCT01722331|82860662|FG004|Part 1|Lack of Efficacy|2|||
46652431|NCT01722331|82860663|FG005|Part 1|Lack of Efficacy|0|||
46652432|NCT01722331|82860664|FG006|Part 1|Lack of Efficacy|0|||
46652433|NCT01722331|82860658|FG000|Part 1|Lost to Follow-up|1|||
46652434|NCT01722331|82860659|FG001|Part 1|Lost to Follow-up|0|||
46652435|NCT01722331|82860660|FG002|Part 1|Lost to Follow-up|2|||
46652436|NCT01722331|82860661|FG003|Part 1|Lost to Follow-up|0|||
46652437|NCT01722331|82860662|FG004|Part 1|Lost to Follow-up|1|||
46652438|NCT01722331|82860663|FG005|Part 1|Lost to Follow-up|0|||
46652439|NCT01722331|82860664|FG006|Part 1|Lost to Follow-up|0|||
46652440|NCT01722331|82860658|FG000|Part 1|Physician Decision|0|||
46652441|NCT01722331|82860659|FG001|Part 1|Physician Decision|0|||
46652442|NCT01722331|82860660|FG002|Part 1|Physician Decision|3|||
46652443|NCT01722331|82860661|FG003|Part 1|Physician Decision|0|||
46652444|NCT01722331|82860662|FG004|Part 1|Physician Decision|1|||
46652445|NCT01722331|82860663|FG005|Part 1|Physician Decision|0|||
46652446|NCT01722331|82860664|FG006|Part 1|Physician Decision|0|||
46652447|NCT01722331|82860658|FG000|Part 1|Pregnancy|1|||
46652448|NCT01722331|82860659|FG001|Part 1|Pregnancy|0|||
46652449|NCT01722331|82860660|FG002|Part 1|Pregnancy|0|||
46652450|NCT01722331|82860661|FG003|Part 1|Pregnancy|0|||
46652451|NCT01722331|82860662|FG004|Part 1|Pregnancy|0|||
46652452|NCT01722331|82860663|FG005|Part 1|Pregnancy|0|||
46652453|NCT01722331|82860664|FG006|Part 1|Pregnancy|0|||
46652454|NCT01722331|82860658|FG000|Part 1|Progressive Disease|0|||
46652455|NCT01722331|82860659|FG001|Part 1|Progressive Disease|0|||
46652456|NCT01722331|82860660|FG002|Part 1|Progressive Disease|0|||
46652457|NCT01722331|82860661|FG003|Part 1|Progressive Disease|0|||
46652458|NCT01722331|82860662|FG004|Part 1|Progressive Disease|1|||
46652459|NCT01722331|82860663|FG005|Part 1|Progressive Disease|0|||
46652460|NCT01722331|82860664|FG006|Part 1|Progressive Disease|0|||
46781321|NCT00397033|82999920|FG002|Overall Study|Withdrawal by Subject|5|||
46781322|NCT00397033|82999918|FG000|Overall Study|Other|0|||
46781323|NCT00397033|82999919|FG001|Overall Study|Other|5|||
46781324|NCT00397033|82999920|FG002|Overall Study|Other|2|||
46781325|NCT00572728|82999928|FG000|Overall Study|Withdrawal by Subject|10|||
47075411|NCT01647828|83369344|FG002|Overall Study|Study terminated by Sponsor|0|||
47075412|NCT01647828|83369345|FG003|Overall Study|Study terminated by Sponsor|0|||
47075413|NCT01647828|83369346|FG004|Overall Study|Study terminated by Sponsor|0|||
47075414|NCT01647828|83369347|FG005|Overall Study|Study terminated by Sponsor|0|||
46970842|NCT02040766|83214189|FG004|Overall Study|Protocol Violation|0|||
46970843|NCT02040766|83214185|FG000|Overall Study|Lost to Follow-up|4|||
46652461|NCT01722331|82860658|FG000|Part 1|Protocol Violation|1|||
46652462|NCT01722331|82860659|FG001|Part 1|Protocol Violation|0|||
46652463|NCT01722331|82860660|FG002|Part 1|Protocol Violation|0|||
46652464|NCT01722331|82860661|FG003|Part 1|Protocol Violation|0|||
46652465|NCT01722331|82860662|FG004|Part 1|Protocol Violation|1|||
46652466|NCT01722331|82860663|FG005|Part 1|Protocol Violation|0|||
46652467|NCT01722331|82860664|FG006|Part 1|Protocol Violation|0|||
46652468|NCT01722331|82860658|FG000|Part 1|Withdrawal by Subject|2|||
46781326|NCT00572728|82999928|FG000|Overall Study|Ineligible|3|||
47075415|NCT01647828|83369348|FG006|Overall Study|Study terminated by Sponsor|1|||
46652469|NCT01722331|82860659|FG001|Part 1|Withdrawal by Subject|0|||
46652470|NCT01722331|82860660|FG002|Part 1|Withdrawal by Subject|3|||
46652471|NCT01722331|82860661|FG003|Part 1|Withdrawal by Subject|0|||
46652472|NCT01722331|82860662|FG004|Part 1|Withdrawal by Subject|3|||
46652473|NCT01722331|82860663|FG005|Part 1|Withdrawal by Subject|0|||
46652474|NCT01722331|82860664|FG006|Part 1|Withdrawal by Subject|0|||
46652475|NCT01722331|82860658|FG000|Part 2|Adverse Event|3|||
46781327|NCT00572728|82999928|FG000|Overall Study|Enrolled under Amendment 4|5|||
46652476|NCT01722331|82860659|FG001|Part 2|Adverse Event|0|||
46652477|NCT01722331|82860660|FG002|Part 2|Adverse Event|0|||
46652478|NCT01722331|82860661|FG003|Part 2|Adverse Event|0|||
46652479|NCT01722331|82860662|FG004|Part 2|Adverse Event|0|||
46652480|NCT01722331|82860663|FG005|Part 2|Adverse Event|1|||
46652481|NCT01722331|82860664|FG006|Part 2|Adverse Event|0|||
46652482|NCT01722331|82860658|FG000|Part 2|Lack of Efficacy|3|||
46652483|NCT01722331|82860659|FG001|Part 2|Lack of Efficacy|0|||
46652484|NCT01722331|82860660|FG002|Part 2|Lack of Efficacy|11|||
46652485|NCT01722331|82860661|FG003|Part 2|Lack of Efficacy|0|||
46652486|NCT01722331|82860662|FG004|Part 2|Lack of Efficacy|0|||
46652487|NCT01722331|82860663|FG005|Part 2|Lack of Efficacy|3|||
46652488|NCT01722331|82860664|FG006|Part 2|Lack of Efficacy|3|||
46652489|NCT01722331|82860658|FG000|Part 2|Lost to Follow-up|0|||
46652490|NCT01722331|82860659|FG001|Part 2|Lost to Follow-up|0|||
46652491|NCT01722331|82860660|FG002|Part 2|Lost to Follow-up|3|||
46652492|NCT01722331|82860661|FG003|Part 2|Lost to Follow-up|0|||
46652493|NCT01722331|82860662|FG004|Part 2|Lost to Follow-up|0|||
46652494|NCT01722331|82860663|FG005|Part 2|Lost to Follow-up|1|||
46652495|NCT01722331|82860664|FG006|Part 2|Lost to Follow-up|1|||
46652496|NCT01722331|82860658|FG000|Part 2|Non-Compliance with Study Drug|1|||
46652497|NCT01722331|82860659|FG001|Part 2|Non-Compliance with Study Drug|0|||
46652498|NCT01722331|82860660|FG002|Part 2|Non-Compliance with Study Drug|1|||
46652499|NCT01722331|82860661|FG003|Part 2|Non-Compliance with Study Drug|0|||
46652500|NCT01722331|82860662|FG004|Part 2|Non-Compliance with Study Drug|0|||
46652501|NCT01722331|82860663|FG005|Part 2|Non-Compliance with Study Drug|0|||
46652502|NCT01722331|82860664|FG006|Part 2|Non-Compliance with Study Drug|0|||
46652503|NCT01722331|82860658|FG000|Part 2|Physician Decision|0|||
46652504|NCT01722331|82860659|FG001|Part 2|Physician Decision|0|||
46652505|NCT01722331|82860660|FG002|Part 2|Physician Decision|2|||
46652506|NCT01722331|82860661|FG003|Part 2|Physician Decision|0|||
46652507|NCT01722331|82860662|FG004|Part 2|Physician Decision|0|||
46652508|NCT01722331|82860663|FG005|Part 2|Physician Decision|0|||
46652509|NCT01722331|82860664|FG006|Part 2|Physician Decision|0|||
46652510|NCT01722331|82860658|FG000|Part 2|Pregnancy|0|||
46652511|NCT01722331|82860659|FG001|Part 2|Pregnancy|0|||
46652512|NCT01722331|82860660|FG002|Part 2|Pregnancy|0|||
46652513|NCT01722331|82860661|FG003|Part 2|Pregnancy|0|||
46652514|NCT01722331|82860662|FG004|Part 2|Pregnancy|0|||
46652515|NCT01722331|82860663|FG005|Part 2|Pregnancy|1|||
46652516|NCT01722331|82860664|FG006|Part 2|Pregnancy|0|||
46652517|NCT01722331|82860658|FG000|Part 2|Progressive Disease|0|||
46652518|NCT01722331|82860659|FG001|Part 2|Progressive Disease|0|||
46652519|NCT01722331|82860660|FG002|Part 2|Progressive Disease|1|||
46652520|NCT01722331|82860661|FG003|Part 2|Progressive Disease|0|||
46652521|NCT01722331|82860662|FG004|Part 2|Progressive Disease|0|||
46652522|NCT01722331|82860663|FG005|Part 2|Progressive Disease|0|||
46652523|NCT01722331|82860664|FG006|Part 2|Progressive Disease|0|||
46652524|NCT01722331|82860658|FG000|Part 2|Protocol Violation|1|||
46652525|NCT01722331|82860659|FG001|Part 2|Protocol Violation|0|||
46652526|NCT01722331|82860660|FG002|Part 2|Protocol Violation|0|||
46652527|NCT01722331|82860661|FG003|Part 2|Protocol Violation|0|||
46652528|NCT01722331|82860662|FG004|Part 2|Protocol Violation|0|||
46652529|NCT01722331|82860663|FG005|Part 2|Protocol Violation|0|||
46652530|NCT01722331|82860664|FG006|Part 2|Protocol Violation|0|||
46652531|NCT01722331|82860658|FG000|Part 2|Withdrawal by Subject|5|||
46652532|NCT01722331|82860659|FG001|Part 2|Withdrawal by Subject|0|||
46652533|NCT01722331|82860660|FG002|Part 2|Withdrawal by Subject|3|||
46652534|NCT01722331|82860661|FG003|Part 2|Withdrawal by Subject|0|||
46652535|NCT01722331|82860662|FG004|Part 2|Withdrawal by Subject|0|||
46781328|NCT00572728|82999928|FG000|Overall Study|Offstudy due to complicating disease|1|||
47075416|NCT01647828|83369349|FG007|Overall Study|Study terminated by Sponsor|26|||
47075417|NCT01647828|83369350|FG008|Overall Study|Study terminated by Sponsor|16|||
46652536|NCT01722331|82860663|FG005|Part 2|Withdrawal by Subject|2|||
46652537|NCT01722331|82860664|FG006|Part 2|Withdrawal by Subject|2|||
46652538|NCT01722331|82860658|FG000|Part 2|Other Protocol Specified Criteria|6|||
47075418|NCT01647828|83369342|FG000|Overall Study|Lost to Follow-up|0|||
46652539|NCT01722331|82860659|FG001|Part 2|Other Protocol Specified Criteria|0|||
47075419|NCT01647828|83369343|FG001|Overall Study|Lost to Follow-up|0|||
46652540|NCT01722331|82860660|FG002|Part 2|Other Protocol Specified Criteria|10|||
46652541|NCT01722331|82860661|FG003|Part 2|Other Protocol Specified Criteria|0|||
46652542|NCT01722331|82860662|FG004|Part 2|Other Protocol Specified Criteria|0|||
46652543|NCT01722331|82860663|FG005|Part 2|Other Protocol Specified Criteria|2|||
46652544|NCT01722331|82860664|FG006|Part 2|Other Protocol Specified Criteria|1|||
46652545|NCT01722331|82860658|FG000|Part 3|Adverse Event|2|||
46652546|NCT01722331|82860659|FG001|Part 3|Adverse Event|2|||
46652547|NCT01722331|82860660|FG002|Part 3|Adverse Event|0|||
46652548|NCT01722331|82860661|FG003|Part 3|Adverse Event|1|||
46652549|NCT01722331|82860662|FG004|Part 3|Adverse Event|0|||
46652550|NCT01722331|82860663|FG005|Part 3|Adverse Event|0|||
46652551|NCT01722331|82860664|FG006|Part 3|Adverse Event|0|||
46652552|NCT01722331|82860658|FG000|Part 3|Death|1|||
46652553|NCT01722331|82860659|FG001|Part 3|Death|0|||
46652554|NCT01722331|82860660|FG002|Part 3|Death|0|||
46652555|NCT01722331|82860661|FG003|Part 3|Death|0|||
46652556|NCT01722331|82860662|FG004|Part 3|Death|0|||
46652557|NCT01722331|82860663|FG005|Part 3|Death|0|||
46652558|NCT01722331|82860664|FG006|Part 3|Death|0|||
46652559|NCT01722331|82860658|FG000|Part 3|Lack of Efficacy|1|||
46652560|NCT01722331|82860659|FG001|Part 3|Lack of Efficacy|0|||
46652561|NCT01722331|82860660|FG002|Part 3|Lack of Efficacy|0|||
46652562|NCT01722331|82860661|FG003|Part 3|Lack of Efficacy|0|||
46652563|NCT01722331|82860662|FG004|Part 3|Lack of Efficacy|0|||
46652564|NCT01722331|82860663|FG005|Part 3|Lack of Efficacy|0|||
46652565|NCT01722331|82860664|FG006|Part 3|Lack of Efficacy|0|||
46652566|NCT01722331|82860658|FG000|Part 3|Lost to Follow-up|3|||
46652567|NCT01722331|82860659|FG001|Part 3|Lost to Follow-up|4|||
46652568|NCT01722331|82860660|FG002|Part 3|Lost to Follow-up|0|||
46652569|NCT01722331|82860661|FG003|Part 3|Lost to Follow-up|0|||
46652570|NCT01722331|82860662|FG004|Part 3|Lost to Follow-up|0|||
46652571|NCT01722331|82860663|FG005|Part 3|Lost to Follow-up|1|||
46652572|NCT01722331|82860664|FG006|Part 3|Lost to Follow-up|0|||
46652573|NCT01722331|82860658|FG000|Part 3|Non-Compliance with Study Drug|0|||
46652574|NCT01722331|82860659|FG001|Part 3|Non-Compliance with Study Drug|1|||
46652575|NCT01722331|82860660|FG002|Part 3|Non-Compliance with Study Drug|0|||
46652576|NCT01722331|82860661|FG003|Part 3|Non-Compliance with Study Drug|0|||
46652577|NCT01722331|82860662|FG004|Part 3|Non-Compliance with Study Drug|0|||
46652578|NCT01722331|82860663|FG005|Part 3|Non-Compliance with Study Drug|0|||
46652579|NCT01722331|82860664|FG006|Part 3|Non-Compliance with Study Drug|0|||
46652580|NCT01722331|82860658|FG000|Part 3|Physician Decision|1|||
46652581|NCT01722331|82860659|FG001|Part 3|Physician Decision|1|||
46652582|NCT01722331|82860660|FG002|Part 3|Physician Decision|0|||
46652583|NCT01722331|82860661|FG003|Part 3|Physician Decision|0|||
46652584|NCT01722331|82860662|FG004|Part 3|Physician Decision|0|||
46652585|NCT01722331|82860663|FG005|Part 3|Physician Decision|0|||
46652586|NCT01722331|82860664|FG006|Part 3|Physician Decision|1|||
46652587|NCT01722331|82860658|FG000|Part 3|Protocol Violation|2|||
46652588|NCT01722331|82860659|FG001|Part 3|Protocol Violation|1|||
46652589|NCT01722331|82860660|FG002|Part 3|Protocol Violation|0|||
46652590|NCT01722331|82860661|FG003|Part 3|Protocol Violation|0|||
46652591|NCT01722331|82860662|FG004|Part 3|Protocol Violation|0|||
46652592|NCT01722331|82860663|FG005|Part 3|Protocol Violation|0|||
46652593|NCT01722331|82860664|FG006|Part 3|Protocol Violation|0|||
46652594|NCT01722331|82860658|FG000|Part 3|Withdrawal by Subject|4|||
46652595|NCT01722331|82860659|FG001|Part 3|Withdrawal by Subject|7|||
46652596|NCT01722331|82860660|FG002|Part 3|Withdrawal by Subject|0|||
46652597|NCT01722331|82860661|FG003|Part 3|Withdrawal by Subject|0|||
46652598|NCT01722331|82860662|FG004|Part 3|Withdrawal by Subject|0|||
46652599|NCT01722331|82860663|FG005|Part 3|Withdrawal by Subject|2|||
46652600|NCT01722331|82860664|FG006|Part 3|Withdrawal by Subject|1|||
46652601|NCT01722331|82860658|FG000|Part 3|Other Protocol Specified Criteria|1|||
46652602|NCT01722331|82860659|FG001|Part 3|Other Protocol Specified Criteria|1|||
46652603|NCT01722331|82860660|FG002|Part 3|Other Protocol Specified Criteria|0|||
46652604|NCT01722331|82860661|FG003|Part 3|Other Protocol Specified Criteria|0|||
46652605|NCT01722331|82860662|FG004|Part 3|Other Protocol Specified Criteria|0|||
46652606|NCT01722331|82860663|FG005|Part 3|Other Protocol Specified Criteria|0|||
46652607|NCT01722331|82860664|FG006|Part 3|Other Protocol Specified Criteria|0|||
46652608|NCT01630590|82860676|FG000|Overall Study|Adverse Event|9|||
46652609|NCT01630590|82860676|FG000|Overall Study|Lack of Efficacy|37|||
46781329|NCT00572728|82999928|FG000|Overall Study|FLT1 not completed|4|||
46781330|NCT00572728|82999928|FG000|Overall Study|First Chemotherapy not initiated|2|||
46781331|NCT00572728|82999928|FG000|Overall Study|FLT2 not completed|5|||
46781332|NCT00572728|82999928|FG000|Overall Study|Second chemotherapy not initiated|1|||
47075420|NCT01647828|83369344|FG002|Overall Study|Lost to Follow-up|0|||
47075421|NCT01647828|83369345|FG003|Overall Study|Lost to Follow-up|0|||
47075422|NCT01647828|83369346|FG004|Overall Study|Lost to Follow-up|0|||
47075423|NCT01647828|83369347|FG005|Overall Study|Lost to Follow-up|0|||
46652610|NCT01630590|82860676|FG000|Overall Study|Withdrawal by Subject|4|||
46652611|NCT01630590|82860676|FG000|Overall Study|2nd primary tumor|2|||
46652612|NCT01630590|82860676|FG000|Overall Study|Automobile accident|1|||
46652613|NCT01630590|82860676|FG000|Overall Study|Maximum benefit|4|||
46652614|NCT01619085|82860680|FG000|Overall Study|Adverse Event|231|||
46652615|NCT01619085|82860680|FG000|Overall Study|Protocol Violation|4|||
46652616|NCT01619085|82860680|FG000|Overall Study|Lost to Follow-up|3|||
46652617|NCT01619085|82860680|FG000|Overall Study|Withdrawal by Subject|45|||
46652618|NCT01619085|82860680|FG000|Overall Study|Other than specified|96|||
46652619|NCT01619085|82860680|FG000|Overall Study|Not treated|1|||
46652620|NCT01619085|82860680|FG000|Overall Study|Death|145|||
46652621|NCT01499095|82860693|FG000|Overall Study|Randomized But Not Treated|1|||
46652622|NCT01499095|82860694|FG001|Overall Study|Randomized But Not Treated|1|||
46970844|NCT02040766|83214186|FG001|Overall Study|Lost to Follow-up|1|||
47075424|NCT01647828|83369348|FG006|Overall Study|Lost to Follow-up|0|||
46652623|NCT01499095|82860693|FG000|Overall Study|Adverse Event|12|||
46652624|NCT01499095|82860694|FG001|Overall Study|Adverse Event|7|||
46652625|NCT01499095|82860693|FG000|Overall Study|Lack of Efficacy|2|||
46652626|NCT01499095|82860694|FG001|Overall Study|Lack of Efficacy|1|||
46652627|NCT01499095|82860693|FG000|Overall Study|Protocol Violation|6|||
46652628|NCT01499095|82860694|FG001|Overall Study|Protocol Violation|7|||
46652629|NCT01499095|82860693|FG000|Overall Study|Received Rescue Therapy|32|||
46652630|NCT01499095|82860694|FG001|Overall Study|Received Rescue Therapy|40|||
46652631|NCT01499095|82860693|FG000|Overall Study|Diverse Reasons|22|||
46652632|NCT01499095|82860694|FG001|Overall Study|Diverse Reasons|25|||
46652633|NCT01499095|82860693|FG000|Overall Study|Lost to Follow-up|6|||
46652634|NCT01499095|82860694|FG001|Overall Study|Lost to Follow-up|4|||
46652635|NCT01499095|82860693|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
46652636|NCT01499095|82860694|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
46652637|NCT01499095|82860693|FG000|Overall Study|Hypoglycemia|3|||
46652638|NCT01499095|82860694|FG001|Overall Study|Hypoglycemia|1|||
46652639|NCT01499095|82860693|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
46652640|NCT01499095|82860694|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
46652641|NCT01499095|82860693|FG000|Overall Study|Change in Injection Schedule|2|||
46652642|NCT01499095|82860694|FG001|Overall Study|Change in Injection Schedule|0|||
46652643|NCT01499095|82860693|FG000|Overall Study|Perceived Lack of Efficacy|1|||
46652644|NCT01499095|82860694|FG001|Overall Study|Perceived Lack of Efficacy|1|||
46652645|NCT01499082|82860705|FG000|Overall Study|Randomized but not Treated|0|||
46652646|NCT01499082|82860706|FG001|Overall Study|Randomized but not Treated|1|||
46652647|NCT01499082|82860705|FG000|Overall Study|Adverse Event|12|||
46652648|NCT01499082|82860706|FG001|Overall Study|Adverse Event|16|||
46652649|NCT01499082|82860705|FG000|Overall Study|Lack of Efficacy|1|||
46652650|NCT01499082|82860706|FG001|Overall Study|Lack of Efficacy|1|||
46652651|NCT01499082|82860705|FG000|Overall Study|Protocol Violation|6|||
46652652|NCT01499082|82860706|FG001|Overall Study|Protocol Violation|8|||
46652653|NCT01499082|82860705|FG000|Overall Study|Diverse Reasons|18|||
46652654|NCT01499082|82860706|FG001|Overall Study|Diverse Reasons|14|||
46652655|NCT01499082|82860705|FG000|Overall Study|Site Closure for Noncompliance|5|||
46652656|NCT01499082|82860706|FG001|Overall Study|Site Closure for Noncompliance|2|||
46652657|NCT01499082|82860705|FG000|Overall Study|Hypoglycemia|2|||
46652658|NCT01499082|82860706|FG001|Overall Study|Hypoglycemia|3|||
46652659|NCT01499082|82860705|FG000|Overall Study|Lost to Follow-up|1|||
46652660|NCT01499082|82860706|FG001|Overall Study|Lost to Follow-up|3|||
46652661|NCT01488890|82860718|FG000|Overall Study|Serious adverse event|2|||
46652662|NCT01488890|82860719|FG001|Overall Study|Serious adverse event|0|||
46652663|NCT01488890|82860720|FG002|Overall Study|Serious adverse event|0|||
46652664|NCT01488890|82860721|FG003|Overall Study|Serious adverse event|0|||
46652665|NCT01488890|82860718|FG000|Overall Study|Protocol Violation|3|||
46652666|NCT01488890|82860719|FG001|Overall Study|Protocol Violation|0|||
46652667|NCT01488890|82860720|FG002|Overall Study|Protocol Violation|4|||
46652668|NCT01488890|82860721|FG003|Overall Study|Protocol Violation|0|||
46652669|NCT01488890|82860718|FG000|Overall Study|Lost to Follow-up|13|||
46652670|NCT01488890|82860719|FG001|Overall Study|Lost to Follow-up|10|||
46652671|NCT01488890|82860720|FG002|Overall Study|Lost to Follow-up|20|||
46652672|NCT01488890|82860721|FG003|Overall Study|Lost to Follow-up|3|||
46652673|NCT01488890|82860718|FG000|Overall Study|Withdrawal by Subject|14|||
46652674|NCT01488890|82860719|FG001|Overall Study|Withdrawal by Subject|10|||
46652675|NCT01488890|82860720|FG002|Overall Study|Withdrawal by Subject|11|||
46652676|NCT01488890|82860721|FG003|Overall Study|Withdrawal by Subject|2|||
46652677|NCT01436396|82860737|FG000|Overall Study|Protocol Violation|7|||
46652678|NCT01436396|82860738|FG001|Overall Study|Protocol Violation|5|||
46652679|NCT01436396|82860737|FG000|Overall Study|Adverse Event|1|||
46652680|NCT01436396|82860738|FG001|Overall Study|Adverse Event|2|||
46652681|NCT01436396|82860737|FG000|Overall Study|Withdrawal by Subject|19|||
46652682|NCT01436396|82860738|FG001|Overall Study|Withdrawal by Subject|29|||
46652683|NCT01436396|82860737|FG000|Overall Study|Serious adverse event|2|||
46652684|NCT01436396|82860738|FG001|Overall Study|Serious adverse event|3|||
46652685|NCT01436396|82860737|FG000|Overall Study|Lost to Follow-up|3|||
46850786|NCT00381797|83066566|FG002|Overall Study|Ineligible|0|||
46850787|NCT00381797|83066567|FG003|Overall Study|Ineligible|1|||
46652686|NCT01436396|82860738|FG001|Overall Study|Lost to Follow-up|3|||
46652687|NCT01411241|82860746|FG000|Overall Study|Protocol Violation|0|||
46652688|NCT01411241|82860747|FG001|Overall Study|Protocol Violation|5|||
46652689|NCT01411241|82860746|FG000|Overall Study|Withdrawal by Subject|9|||
46652690|NCT01411241|82860747|FG001|Overall Study|Withdrawal by Subject|10|||
46652691|NCT01411241|82860746|FG000|Overall Study|Serious Adverse Event|0|||
46652692|NCT01411241|82860747|FG001|Overall Study|Serious Adverse Event|3|||
46652693|NCT01411241|82860746|FG000|Overall Study|Lost to Follow-up|2|||
46850788|NCT00381797|83066568|FG004|Overall Study|Ineligible|0|||
46652694|NCT01411241|82860747|FG001|Overall Study|Lost to Follow-up|4|||
46652695|NCT01374516|82860755|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
46850789|NCT03665038|83066604|FG000|Overall Study|Lost to Follow-up|0|||
46850790|NCT03665038|83066605|FG001|Overall Study|Lost to Follow-up|0|||
46652696|NCT01374516|82860756|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
46652697|NCT01374516|82860755|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
46652698|NCT01374516|82860756|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
46652699|NCT01374516|82860755|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
46652700|NCT01374516|82860756|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
46652701|NCT01374516|82860755|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
46652702|NCT01374516|82860756|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
46652703|NCT01374516|82860755|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
46652704|NCT01374516|82860756|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
46652705|NCT01374516|82860755|FG000|Surveillance Expansion Period|Protocol Violation|386|||
46652706|NCT01374516|82860756|FG001|Surveillance Expansion Period|Protocol Violation|217|||
46652707|NCT01374516|82860755|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
46652708|NCT01374516|82860756|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
46652709|NCT01374516|82860755|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
46652710|NCT01374516|82860756|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
46652711|NCT01374516|82860755|FG000|Surveillance Expansion Period|Serious adverse event|20|||
46652712|NCT01374516|82860756|FG001|Surveillance Expansion Period|Serious adverse event|5|||
46652713|NCT01373281|82860771|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
46652714|NCT01373281|82860772|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
46652715|NCT01373281|82860771|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
46652716|NCT01373281|82860772|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
46652717|NCT01373281|82860771|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
46652718|NCT01373281|82860772|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
46652719|NCT01373281|82860771|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
46652720|NCT01373281|82860772|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
46652721|NCT01373281|82860771|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
46652722|NCT01373281|82860772|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
46652723|NCT01373281|82860771|FG000|Surveillance Expansion Period|Protocol Violation|9|||
46652724|NCT01373281|82860772|FG001|Surveillance Expansion Period|Protocol Violation|1|||
46652725|NCT01373281|82860771|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
46652726|NCT01373281|82860772|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
46652727|NCT01373281|82860771|FG000|Surveillance Expansion Period|Serious adverse event|3|||
46652728|NCT01373281|82860772|FG001|Surveillance Expansion Period|Serious adverse event|4|||
46652729|NCT01254422|82860787|FG000|Overall Study|Protocol Violation|1|||
46652730|NCT01254422|82860788|FG001|Overall Study|Protocol Violation|0|||
46652731|NCT01254422|82860787|FG000|Overall Study|Adverse Event|1|||
46652732|NCT01254422|82860788|FG001|Overall Study|Adverse Event|0|||
46652733|NCT01254422|82860787|FG000|Overall Study|Serious adverse event|0|||
46652734|NCT01254422|82860788|FG001|Overall Study|Serious adverse event|1|||
46652735|NCT01254422|82860787|FG000|Overall Study|Lost to Follow-up|1|||
46652736|NCT01254422|82860788|FG001|Overall Study|Lost to Follow-up|0|||
46652737|NCT01187433|82860796|FG000|Overall Study|Protocol Violation|6|||
46652738|NCT01187433|82860797|FG001|Overall Study|Protocol Violation|2|||
46652739|NCT01187433|82860796|FG000|Overall Study|Withdrawal by Subject|5|||
46652740|NCT01187433|82860797|FG001|Overall Study|Withdrawal by Subject|2|||
46652741|NCT01150045|82860807|FG000|Overall Study|Protocol Violation|0|||
46652742|NCT01150045|82860808|FG001|Overall Study|Protocol Violation|1|||
46652743|NCT01150045|82860809|FG002|Overall Study|Protocol Violation|0|||
46652744|NCT01150045|82860810|FG003|Overall Study|Protocol Violation|1|||
46652745|NCT01098032|82860820|FG000|Overall Study|Withdrawal by Subject|1|||
46652746|NCT01098032|82860821|FG001|Overall Study|Withdrawal by Subject|1|||
46652747|NCT01034306|82860829|FG000|Overall Study|Adverse Event|1|||
46652748|NCT01034306|82860830|FG001|Overall Study|Adverse Event|0|||
46652749|NCT01034306|82860829|FG000|Overall Study|Lost to Follow-up|0|||
46652750|NCT01034306|82860830|FG001|Overall Study|Lost to Follow-up|1|||
46652751|NCT01034306|82860829|FG000|Overall Study|Withdrawal by Subject|2|||
46652752|NCT01034306|82860830|FG001|Overall Study|Withdrawal by Subject|2|||
46652753|NCT01034306|82860829|FG000|Overall Study|hospitalized and decided to stop|1|||
46652754|NCT01034306|82860830|FG001|Overall Study|hospitalized and decided to stop|0|||
46652755|NCT01034306|82860829|FG000|Overall Study|Noncomplience|1|||
46652756|NCT01034306|82860830|FG001|Overall Study|Noncomplience|0|||
46652757|NCT00993447|82860838|FG000|Overall Study|Withdrawal by Subject|23|||
46652758|NCT00993447|82860839|FG001|Overall Study|Withdrawal by Subject|8|||
46652759|NCT00993447|82860838|FG000|Overall Study|Protocol Violation|12|||
46652760|NCT00993447|82860839|FG001|Overall Study|Protocol Violation|8|||
46652761|NCT00993447|82860838|FG000|Overall Study|Lost to Follow-up|1|||
46652762|NCT00993447|82860839|FG001|Overall Study|Lost to Follow-up|3|||
46652763|NCT00993447|82860838|FG000|Overall Study|Adverse Event|1|||
46652764|NCT00993447|82860839|FG001|Overall Study|Adverse Event|0|||
46652765|NCT00945009|82860848|FG000|Overall Study|Lack of Efficacy|10|||
46652766|NCT00945009|82860849|FG001|Overall Study|Lack of Efficacy|0|||
46652767|NCT00945009|82860850|FG002|Overall Study|Lack of Efficacy|0|||
46652768|NCT00945009|82860848|FG000|Overall Study|Physician Decision|21|||
46652769|NCT00945009|82860849|FG001|Overall Study|Physician Decision|4|||
46652770|NCT00945009|82860850|FG002|Overall Study|Physician Decision|3|||
46652771|NCT00945009|82860848|FG000|Overall Study|Protocol Violation|6|||
46652772|NCT00945009|82860849|FG001|Overall Study|Protocol Violation|1|||
46652773|NCT00945009|82860850|FG002|Overall Study|Protocol Violation|0|||
46652774|NCT00945009|82860848|FG000|Overall Study|Withdrawal by Subject|1|||
46652775|NCT00945009|82860849|FG001|Overall Study|Withdrawal by Subject|0|||
46652776|NCT00945009|82860850|FG002|Overall Study|Withdrawal by Subject|0|||
46652777|NCT00945009|82860848|FG000|Overall Study|Ineligible|6|||
46652778|NCT00945009|82860849|FG001|Overall Study|Ineligible|1|||
46652779|NCT00945009|82860850|FG002|Overall Study|Ineligible|0|||
46652780|NCT00945009|82860848|FG000|Overall Study|Inevaluable|0|||
46652781|NCT00945009|82860849|FG001|Overall Study|Inevaluable|1|||
46652782|NCT00945009|82860850|FG002|Overall Study|Inevaluable|0|||
46652783|NCT00945009|82860848|FG000|Overall Study|Refusal of further protocol|1|||
46652784|NCT00945009|82860849|FG001|Overall Study|Refusal of further protocol|0|||
46652785|NCT00945009|82860850|FG002|Overall Study|Refusal of further protocol|0|||
46652786|NCT00880893|82860866|FG000|Overall Study|Protocol Violation|13|||
46652787|NCT00880893|82860867|FG001|Overall Study|Protocol Violation|1|||
46652788|NCT00880893|82860866|FG000|Overall Study|Withdrawal by Subject|15|||
46652789|NCT00880893|82860867|FG001|Overall Study|Withdrawal by Subject|11|||
46652790|NCT00880893|82860866|FG000|Overall Study|Lost to Follow-up|76|||
46652791|NCT00880893|82860867|FG001|Overall Study|Lost to Follow-up|33|||
46652792|NCT00880893|82860866|FG000|Overall Study|Serious adverse event|3|||
46652793|NCT00880893|82860867|FG001|Overall Study|Serious adverse event|0|||
46652794|NCT00587301|82860873|FG000|Overall Study|Screen Failure|9|||
46652795|NCT00587301|82860873|FG000|Overall Study|Lost to Follow-up|22|||
46652796|NCT00587301|82860873|FG000|Overall Study|Withdrawal by Subject|7|||
46652797|NCT00587301|82860873|FG000|Overall Study|Protocol Violation|7|||
46652798|NCT00579527|82860877|FG000|Overall Study|Death|4|||
46652799|NCT00576836|82860882|FG000|Overall Study|Death|0|||
46652800|NCT00576836|82860883|FG001|Overall Study|Death|1|||
46652801|NCT00576836|82860882|FG000|Overall Study|Physician Decision|0|||
46652802|NCT00576836|82860883|FG001|Overall Study|Physician Decision|1|||
46652803|NCT00576407|82860887|FG000|Overall Study|Death|7|||
46652804|NCT00576407|82860887|FG000|Overall Study|Physician Decision|1|||
46652805|NCT00531232|82860895|FG000|Overall Study|Investigator decision|0|||
46652806|NCT00531232|82860896|FG001|Overall Study|Investigator decision|0|||
46652807|NCT00531232|82860897|FG002|Overall Study|Investigator decision|4|||
46652808|NCT00531232|82860895|FG000|Overall Study|Participants refused further treatment|0|||
46652809|NCT00531232|82860896|FG001|Overall Study|Participants refused further treatment|1|||
46652810|NCT00531232|82860897|FG002|Overall Study|Participants refused further treatment|2|||
46652811|NCT00531232|82860895|FG000|Overall Study|Adverse events (AEs)|1|||
46652812|NCT00531232|82860896|FG001|Overall Study|Adverse events (AEs)|2|||
46652813|NCT00531232|82860897|FG002|Overall Study|Adverse events (AEs)|2|||
46652814|NCT00531232|82860895|FG000|Overall Study|Treatment failure|1|||
46652815|NCT00531232|82860896|FG001|Overall Study|Treatment failure|3|||
46652816|NCT00531232|82860897|FG002|Overall Study|Treatment failure|7|||
46652817|NCT00531232|82860895|FG000|Overall Study|Disease recurrence|0|||
46652818|NCT00531232|82860896|FG001|Overall Study|Disease recurrence|0|||
46652819|NCT00531232|82860897|FG002|Overall Study|Disease recurrence|1|||
46652820|NCT00531232|82860895|FG000|Overall Study|Deceased|2|||
46652821|NCT00531232|82860896|FG001|Overall Study|Deceased|2|||
46652822|NCT00531232|82860897|FG002|Overall Study|Deceased|2|||
46652823|NCT00531232|82860895|FG000|Overall Study|Withdrawal by Subject|0|||
46652824|NCT00531232|82860896|FG001|Overall Study|Withdrawal by Subject|1|||
46652825|NCT00531232|82860897|FG002|Overall Study|Withdrawal by Subject|2|||
46652826|NCT00531232|82860895|FG000|Overall Study|Other|0|||
46652827|NCT00531232|82860896|FG001|Overall Study|Other|0|||
46652828|NCT00531232|82860897|FG002|Overall Study|Other|5|||
46652829|NCT01701583|82860910|FG000|Overall Study|Withdrawal by Subject|2|||
46652830|NCT01701583|82860911|FG001|Overall Study|Withdrawal by Subject|0|||
46652831|NCT01714817|82860920|FG000|Year 1 Period|Lack of Efficacy|11|||
46652832|NCT01714817|82860921|FG001|Year 1 Period|Lack of Efficacy|9|||
46652833|NCT01714817|82860920|FG000|Year 1 Period|Adverse Event|20|||
46850791|NCT03665038|83066606|FG002|Overall Study|Lost to Follow-up|1|||
46652834|NCT01714817|82860921|FG001|Year 1 Period|Adverse Event|17|||
46652835|NCT01714817|82860920|FG000|Year 1 Period|Withdrawal by Subject|6|||
46652836|NCT01714817|82860921|FG001|Year 1 Period|Withdrawal by Subject|7|||
46652837|NCT01714817|82860920|FG000|Year 1 Period|Death|1|||
46652838|NCT01714817|82860921|FG001|Year 1 Period|Death|1|||
46652839|NCT01714817|82860920|FG000|Year 1 Period|Lost to Follow-up|0|||
46652840|NCT01714817|82860921|FG001|Year 1 Period|Lost to Follow-up|2|||
46652841|NCT01714817|82860920|FG000|Year 1 Period|Poor / non-compliance|0|||
46652842|NCT01714817|82860921|FG001|Year 1 Period|Poor / non-compliance|1|||
46652843|NCT01714817|82860920|FG000|Year 1 Period|Pregnancy|2|||
46652844|NCT01714817|82860921|FG001|Year 1 Period|Pregnancy|0|||
46652845|NCT01714817|82860920|FG000|Year 1 Period|Participant no longer meets criteria|6|||
46652846|NCT01714817|82860921|FG001|Year 1 Period|Participant no longer meets criteria|2|||
46652847|NCT01714817|82860920|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
46652848|NCT01714817|82860921|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
46652849|NCT01714817|82860920|FG000|Year 1 Period|Change in Concomitant Medication|0|||
46652850|NCT01714817|82860921|FG001|Year 1 Period|Change in Concomitant Medication|1|||
46652851|NCT01714817|82860920|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
46652852|NCT01714817|82860921|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
46781333|NCT00572728|82999928|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
46781334|NCT00572728|82999928|FG000|Overall Study|Pathology missing|1|||
46781335|NCT00699374|82999936|FG000|Overall Study|Death|93|||
46781336|NCT00699374|82999937|FG001|Overall Study|Death|83|||
46781337|NCT00699374|82999936|FG000|Overall Study|Adverse Event|70|||
46781338|NCT00699374|82999937|FG001|Overall Study|Adverse Event|67|||
46781339|NCT00699374|82999936|FG000|Overall Study|Global deterioration of health status|7|||
46850792|NCT03664024|83066616|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
46850793|NCT03664024|83066616|FG000|Overall Study|Lost to Follow-up|2|||
46850794|NCT03664024|83066616|FG000|Overall Study|Withdrawal by Subject|2|||
46850795|NCT03664024|83066616|FG000|Overall Study|Death|80|||
46781340|NCT00699374|82999937|FG001|Overall Study|Global deterioration of health status|8|||
46781341|NCT00699374|82999936|FG000|Overall Study|Lost to Follow-up|3|||
46781342|NCT00699374|82999937|FG001|Overall Study|Lost to Follow-up|5|||
46781343|NCT00699374|82999936|FG000|Overall Study|Withdrawal by Subject|34|||
46781344|NCT00699374|82999937|FG001|Overall Study|Withdrawal by Subject|44|||
46781345|NCT00699374|82999936|FG000|Overall Study|Objective progression or relapse|281|||
46781346|NCT00699374|82999937|FG001|Overall Study|Objective progression or relapse|277|||
46781347|NCT00699374|82999936|FG000|Overall Study|Other|18|||
46781348|NCT00699374|82999937|FG001|Overall Study|Other|15|||
46781349|NCT00699374|82999936|FG000|Overall Study|Protocol Violation|2|||
46781350|NCT00699374|82999937|FG001|Overall Study|Protocol Violation|6|||
46781351|NCT00699374|82999936|FG000|Overall Study|Study terminated by sponsor|13|||
46781352|NCT00699374|82999937|FG001|Overall Study|Study terminated by sponsor|28|||
46781353|NCT00699374|82999936|FG000|Overall Study|Randomized but not treated|4|||
46781354|NCT00699374|82999937|FG001|Overall Study|Randomized but not treated|2|||
46781355|NCT00699374|82999936|FG000|Overall Study|Died 28 days after last dose|5|||
46781356|NCT00699374|82999937|FG001|Overall Study|Died 28 days after last dose|9|||
46781357|NCT00606892|82999943|FG000|First Intervention|Protocol Violation|1|||
46781358|NCT00606892|82999944|FG001|First Intervention|Protocol Violation|4|||
46781359|NCT00625443|82999979|FG000|Overall Study|Adverse Event|1|||
46781360|NCT00625443|82999980|FG001|Overall Study|Adverse Event|4|||
46781361|NCT00625443|82999981|FG002|Overall Study|Adverse Event|0|||
46781362|NCT00625443|82999979|FG000|Overall Study|Non-compliance with protocol|0|||
46781363|NCT00625443|82999980|FG001|Overall Study|Non-compliance with protocol|1|||
46781364|NCT00625443|82999981|FG002|Overall Study|Non-compliance with protocol|0|||
46781365|NCT00625443|82999979|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
46781366|NCT00625443|82999980|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
46781367|NCT00625443|82999981|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
46781368|NCT00625443|82999979|FG000|Overall Study|Withdrawal by Subject|0|||
46781369|NCT00625443|82999980|FG001|Overall Study|Withdrawal by Subject|1|||
46781370|NCT00625443|82999981|FG002|Overall Study|Withdrawal by Subject|2|||
46781371|NCT00625443|82999979|FG000|Overall Study|Physician Decision|0|||
46781372|NCT00625443|82999980|FG001|Overall Study|Physician Decision|4|||
46781373|NCT00625443|82999981|FG002|Overall Study|Physician Decision|2|||
46781374|NCT00625443|82999979|FG000|Overall Study|Other|0|||
46781375|NCT00625443|82999980|FG001|Overall Study|Other|1|||
46850796|NCT00381563|83066625|FG000|Overall Study|Withdrawal by Subject|5|||
46850797|NCT00381563|83066626|FG001|Overall Study|Withdrawal by Subject|5|||
46850798|NCT00381563|83066625|FG000|Overall Study|Lost to Follow-up|2|||
46781376|NCT00625443|82999981|FG002|Overall Study|Other|1|||
46781377|NCT00625365|82999992|FG000|Overall Study|Withdrawal by Subject|1|||
46781378|NCT00625365|82999992|FG000|Overall Study|No IV access|5|||
46781379|NCT00625365|82999992|FG000|Overall Study|VSD|1|||
46781380|NCT00606580|82999999|FG000|Overall Study|Lost to Follow-up|1|||
46850799|NCT00381563|83066626|FG001|Overall Study|Lost to Follow-up|0|||
46850800|NCT00381563|83066625|FG000|Overall Study|Protocol Violation|0|||
46850801|NCT00381563|83066626|FG001|Overall Study|Protocol Violation|1|||
46781381|NCT00606580|83000000|FG001|Overall Study|Lost to Follow-up|1|||
46781382|NCT00606580|83000001|FG002|Overall Study|Lost to Follow-up|4|||
46781383|NCT00606580|82999999|FG000|Overall Study|Clinical failures|1|||
46781384|NCT00606580|83000000|FG001|Overall Study|Clinical failures|0|||
46781385|NCT00606580|83000001|FG002|Overall Study|Clinical failures|12|||
46781386|NCT00606580|82999999|FG000|Overall Study|Withdrawal by investigator|0|||
46781387|NCT00606580|83000000|FG001|Overall Study|Withdrawal by investigator|1|||
46781388|NCT00606580|83000001|FG002|Overall Study|Withdrawal by investigator|6|||
46781389|NCT00606580|82999999|FG000|Overall Study|Withdrawal by Subject|0|||
46781390|NCT00606580|83000000|FG001|Overall Study|Withdrawal by Subject|1|||
46781391|NCT00606580|83000001|FG002|Overall Study|Withdrawal by Subject|0|||
46781392|NCT00629265|83000011|FG000|Overall Study|Lost to Follow-up|4|||
46781393|NCT00629265|83000012|FG001|Overall Study|Lost to Follow-up|5|||
46781394|NCT00629265|83000011|FG000|Overall Study|Withdrawal by Subject|11|||
46781395|NCT00629265|83000012|FG001|Overall Study|Withdrawal by Subject|8|||
46781396|NCT00629265|83000011|FG000|Overall Study|Death|1|||
46781397|NCT00629265|83000012|FG001|Overall Study|Death|0|||
46781398|NCT00629265|83000011|FG000|Overall Study|Adverse Event|2|||
46781399|NCT00629265|83000012|FG001|Overall Study|Adverse Event|0|||
46781400|NCT00629265|83000011|FG000|Overall Study|HNC Recurrence|4|||
46781401|NCT00629265|83000012|FG001|Overall Study|HNC Recurrence|0|||
46781402|NCT00629265|83000011|FG000|Overall Study|Other CA Requiring Treatment|1|||
46781403|NCT00629265|83000012|FG001|Overall Study|Other CA Requiring Treatment|3|||
46781404|NCT00629265|83000011|FG000|Overall Study|Needed Esophageal Dilation|4|||
46781405|NCT00629265|83000012|FG001|Overall Study|Needed Esophageal Dilation|1|||
46781406|NCT00629265|83000011|FG000|Overall Study|Unrelated Medical Complications|3|||
46781407|NCT00629265|83000012|FG001|Overall Study|Unrelated Medical Complications|1|||
46781408|NCT00629265|83000011|FG000|Overall Study|Unknown Reason|2|||
46781409|NCT00629265|83000012|FG001|Overall Study|Unknown Reason|2|||
46781410|NCT00606502|83000020|FG000|Randomization|Randomized but not treated|3|||
46781411|NCT00606502|83000021|FG001|Randomization|Randomized but not treated|0|||
46781412|NCT00606502|83000020|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
46781413|NCT00606502|83000021|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
46652853|NCT01714817|82860920|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
46652854|NCT01714817|82860921|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
46652855|NCT01714817|82860920|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
46652856|NCT01714817|82860921|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
46652857|NCT01714817|82860920|FG000|Year 2 Period|Lack of Efficacy|4|||
46652858|NCT01714817|82860921|FG001|Year 2 Period|Lack of Efficacy|12|||
46652859|NCT01714817|82860920|FG000|Year 2 Period|Adverse Event|7|||
46652860|NCT01714817|82860921|FG001|Year 2 Period|Adverse Event|6|||
46652861|NCT01714817|82860920|FG000|Year 2 Period|Participant request to stop treatment|4|||
46652862|NCT01714817|82860921|FG001|Year 2 Period|Participant request to stop treatment|4|||
46652863|NCT01714817|82860920|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
46652864|NCT01714817|82860921|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
46652865|NCT01714817|82860920|FG000|Year 2 Period|Participant withdrew consent|1|||
46652866|NCT01714817|82860921|FG001|Year 2 Period|Participant withdrew consent|5|||
46652867|NCT01714817|82860920|FG000|Year 2 Period|Participant no longer meets criteria|1|||
46652868|NCT01714817|82860921|FG001|Year 2 Period|Participant no longer meets criteria|4|||
46652869|NCT01714817|82860920|FG000|Year 2 Period|Lost to Follow-up|2|||
46652870|NCT01714817|82860921|FG001|Year 2 Period|Lost to Follow-up|0|||
46652871|NCT01714817|82860920|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
46652872|NCT01714817|82860921|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
46652873|NCT01714817|82860920|FG000|Year 2 Period|Pregnancy|1|||
46652874|NCT01714817|82860921|FG001|Year 2 Period|Pregnancy|1|||
46652875|NCT01714817|82860920|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
46652876|NCT01714817|82860921|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
46781414|NCT00605722|83000027|FG000|Overall Study|Adverse Event|6|||
46850802|NCT00381095|83066633|FG000|Overall Study|Death|3|||
47075425|NCT01647828|83369349|FG007|Overall Study|Lost to Follow-up|2|||
47075426|NCT01647828|83369350|FG008|Overall Study|Lost to Follow-up|0|||
47075427|NCT00989261|83369372|FG000|Overall Study|Still in follow up|12|||
46781415|NCT00605722|83000027|FG000|Overall Study|Insufficient therapeutic response|44|||
46781416|NCT00605722|83000027|FG000|Overall Study|Failure to return|1|||
46781417|NCT00605566|83000031|FG000|Overall Study|Adverse Event|1|||
46850803|NCT00381095|83066634|FG001|Overall Study|Death|4|||
46850804|NCT00381095|83066633|FG000|Overall Study|Lack of Efficacy|2|||
47075428|NCT00989261|83369373|FG001|Overall Study|Still in follow up|21|||
47075429|NCT00989261|83369372|FG000|Overall Study|Withdrawal by Subject|0|||
47075430|NCT00989261|83369373|FG001|Overall Study|Withdrawal by Subject|1|||
46652877|NCT01714817|82860920|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
46781418|NCT00605566|83000031|FG000|Overall Study|Clinical deterioration|1|||
46781419|NCT00605566|83000031|FG000|Overall Study|Poor compliance in run-in period|1|||
46652878|NCT01714817|82860921|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
46652879|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
46652880|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
46652881|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
46652882|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
46652883|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
46652884|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
46652885|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
46652886|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
46652887|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
46652888|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
46652889|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
46652890|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
46652891|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
46652892|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
46652893|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
46652894|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
46652895|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
46652896|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
46652897|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
46652898|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
46652899|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
46652900|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
46652901|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
46652902|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
46652903|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
46652904|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
46652905|NCT01714817|82860920|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
46652906|NCT01714817|82860921|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
46652907|NCT04477187|82860958|FG000|Overall Study|Lost to Follow-up|2|||
46652908|NCT04142242|82860978|FG000|Stage I|Non-compliance with the protocol|1|||
46652909|NCT04142242|82860979|FG001|Stage I|Non-compliance with the protocol|0|||
46652910|NCT04142242|82860980|FG002|Stage I|Non-compliance with the protocol|0|||
46652911|NCT04142242|82860981|FG003|Stage I|Non-compliance with the protocol|0|||
46652912|NCT04142242|82860982|FG004|Stage I|Non-compliance with the protocol|0|||
46652913|NCT04142242|82860983|FG005|Stage I|Non-compliance with the protocol|1|||
46652914|NCT04142242|82860978|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
46652915|NCT04142242|82860979|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
46652916|NCT04142242|82860980|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
46652917|NCT04142242|82860981|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
46652918|NCT04142242|82860982|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
46652919|NCT04142242|82860983|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
46652920|NCT04142242|82860978|FG000|Stage II|Non-compliance with the protocol|0|||
46652921|NCT04142242|82860979|FG001|Stage II|Non-compliance with the protocol|0|||
46652922|NCT04142242|82860980|FG002|Stage II|Non-compliance with the protocol|0|||
46652923|NCT04142242|82860981|FG003|Stage II|Non-compliance with the protocol|2|||
46652924|NCT04142242|82860982|FG004|Stage II|Non-compliance with the protocol|0|||
46652925|NCT04142242|82860983|FG005|Stage II|Non-compliance with the protocol|0|||
46652926|NCT04142242|82860978|FG000|Stage II|Lost to Follow-up|0|||
46652927|NCT04142242|82860979|FG001|Stage II|Lost to Follow-up|0|||
46652928|NCT04142242|82860980|FG002|Stage II|Lost to Follow-up|1|||
46652929|NCT04142242|82860981|FG003|Stage II|Lost to Follow-up|2|||
46652930|NCT04142242|82860982|FG004|Stage II|Lost to Follow-up|0|||
46652931|NCT04142242|82860983|FG005|Stage II|Lost to Follow-up|0|||
46652932|NCT04142242|82860978|FG000|Stage II|Withdrawal by Subject|0|||
46652933|NCT04142242|82860979|FG001|Stage II|Withdrawal by Subject|0|||
46652934|NCT04142242|82860980|FG002|Stage II|Withdrawal by Subject|5|||
46652935|NCT04142242|82860981|FG003|Stage II|Withdrawal by Subject|9|||
46652936|NCT04142242|82860982|FG004|Stage II|Withdrawal by Subject|0|||
47075431|NCT00989261|83369372|FG000|Overall Study|Lost to Follow-up|3|||
47075432|NCT00989261|83369373|FG001|Overall Study|Lost to Follow-up|0|||
47075433|NCT00988559|83369392|FG000|Overall Study|Withdrawal by Subject|1|||
46652937|NCT04142242|82860983|FG005|Stage II|Withdrawal by Subject|0|||
46652938|NCT03912259|82861002|FG000|Overall Study|Adverse Event (AE)|2|||
46652939|NCT03912259|82861003|FG001|Overall Study|Adverse Event (AE)|4|||
46652940|NCT03912259|82861002|FG000|Overall Study|Lack of Efficacy|4|||
46652941|NCT03912259|82861003|FG001|Overall Study|Lack of Efficacy|1|||
46652942|NCT03912259|82861002|FG000|Overall Study|Withdrawal by Subject|11|||
46970845|NCT02040766|83214187|FG002|Overall Study|Lost to Follow-up|3|||
46652943|NCT03912259|82861003|FG001|Overall Study|Withdrawal by Subject|1|||
46652944|NCT03871829|82861012|FG000|Overall Study|Lost to Follow-up|0|||
46652945|NCT03871829|82861013|FG001|Overall Study|Lost to Follow-up|1|||
46652946|NCT03871829|82861012|FG000|Overall Study|Withdrawal by Subject|1|||
46652947|NCT03871829|82861013|FG001|Overall Study|Withdrawal by Subject|1|||
46652948|NCT03871829|82861012|FG000|Overall Study|Death|12|||
46652949|NCT03871829|82861013|FG001|Overall Study|Death|8|||
46652950|NCT03871829|82861012|FG000|Overall Study|Study terminated by sponsor|31|||
46652951|NCT03871829|82861013|FG001|Overall Study|Study terminated by sponsor|34|||
46652952|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
46652953|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
46652954|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
46652955|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
46652956|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
46652957|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
46652958|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
46652959|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
46652960|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
46652961|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
46652962|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
46652963|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
46652964|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
46652965|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
46652966|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
46652967|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
46652968|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
46652969|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
46652970|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
46652971|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
46652972|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
46652973|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
46652974|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
46652975|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
46652976|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
46652977|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
46652978|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
46652979|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
46652980|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
46652981|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
46652982|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
46652983|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
46652984|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
46652985|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
46652986|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
46652987|NCT03373383|82861060|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
46652988|NCT03373383|82861061|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
46652989|NCT03373383|82861062|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
46652990|NCT03373383|82861063|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
46652991|NCT03373383|82861064|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
46652992|NCT03373383|82861060|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
46652993|NCT03373383|82861061|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
46652994|NCT03373383|82861062|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
46652995|NCT03373383|82861063|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
46652996|NCT03373383|82861064|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
46652997|NCT03320018|82861093|FG000|Treatment Period|Withdrawal by Subject|1|||
46652998|NCT03320018|82861094|FG001|Treatment Period|Withdrawal by Subject|0|||
46652999|NCT03320018|82861093|FG000|Day 90 Follow up|Death|0|||
46653000|NCT03320018|82861094|FG001|Day 90 Follow up|Death|1|||
46653001|NCT03230318|82861102|FG000|Overall Study|Radiographic disease progression|72|||
46850805|NCT00381095|83066634|FG001|Overall Study|Lack of Efficacy|4|||
46850806|NCT00381095|83066633|FG000|Overall Study|Other|2|||
46653002|NCT03230318|82861103|FG001|Overall Study|Radiographic disease progression|19|||
46653003|NCT03230318|82861102|FG000|Overall Study|Clinical progression|17|||
46653004|NCT03230318|82861103|FG001|Overall Study|Clinical progression|7|||
46653005|NCT03230318|82861102|FG000|Overall Study|Adverse Event|5|||
46653006|NCT03230318|82861103|FG001|Overall Study|Adverse Event|3|||
46653007|NCT03230318|82861102|FG000|Overall Study|Physician Decision|2|||
46653008|NCT03230318|82861103|FG001|Overall Study|Physician Decision|3|||
46653009|NCT03230318|82861102|FG000|Overall Study|Death|3|||
46850807|NCT00381095|83066634|FG001|Overall Study|Other|2|||
46653010|NCT03230318|82861103|FG001|Overall Study|Death|2|||
46653011|NCT03230318|82861102|FG000|Overall Study|Lost to Follow-up|1|||
46850808|NCT00381095|83066633|FG000|Overall Study|Protocol Violation|1|||
46653012|NCT03230318|82861103|FG001|Overall Study|Lost to Follow-up|0|||
46653013|NCT03230318|82861102|FG000|Overall Study|Withdrawal by Subject|1|||
46653014|NCT03230318|82861103|FG001|Overall Study|Withdrawal by Subject|3|||
46653015|NCT03230318|82861102|FG000|Overall Study|Other|3|||
46653016|NCT03230318|82861103|FG001|Overall Study|Other|7|||
46653017|NCT03080883|82861114|FG000|Overall Study|Withdrawal by Subject|11|||
46653018|NCT03080883|82861115|FG001|Overall Study|Withdrawal by Subject|15|||
46653019|NCT03080883|82861114|FG000|Overall Study|Adverse Event|22|||
46653020|NCT03080883|82861115|FG001|Overall Study|Adverse Event|22|||
46653021|NCT03080883|82861114|FG000|Overall Study|Alternative Therapy|0|||
46653022|NCT03080883|82861115|FG001|Overall Study|Alternative Therapy|3|||
46653023|NCT03080883|82861114|FG000|Overall Study|Other Complicating Disease|9|||
46653024|NCT03080883|82861115|FG001|Overall Study|Other Complicating Disease|5|||
46653025|NCT03080883|82861114|FG000|Overall Study|Death|21|||
46653026|NCT03080883|82861115|FG001|Overall Study|Death|16|||
46653027|NCT03080883|82861114|FG000|Overall Study|Physician Decision|2|||
46653028|NCT03080883|82861115|FG001|Overall Study|Physician Decision|2|||
46653029|NCT03080883|82861114|FG000|Overall Study|Disease Progression|2|||
46653030|NCT03080883|82861115|FG001|Overall Study|Disease Progression|8|||
46653031|NCT03080883|82861114|FG000|Overall Study|Lost to Follow-up|1|||
46653032|NCT03080883|82861115|FG001|Overall Study|Lost to Follow-up|1|||
46653033|NCT03060291|82861124|FG000|3-month Follow-up|Declined to respond|8|||
46653034|NCT03060291|82861125|FG001|3-month Follow-up|Declined to respond|10|||
46653035|NCT03060291|82861126|FG002|3-month Follow-up|Declined to respond|2|||
46653036|NCT03060291|82861124|FG000|6-month Follow-up|Declined to respond|7|||
46653037|NCT03060291|82861125|FG001|6-month Follow-up|Declined to respond|13|||
46653038|NCT03060291|82861126|FG002|6-month Follow-up|Declined to respond|4|||
46653039|NCT03060291|82861124|FG000|12-month Follow-up|Declined to respond|7|||
46653040|NCT03060291|82861125|FG001|12-month Follow-up|Declined to respond|16|||
46653041|NCT03060291|82861126|FG002|12-month Follow-up|Declined to respond|6|||
46653042|NCT01514864|82861172|FG000|Overall Study|Disease progression|7|||
46653043|NCT01514864|82861173|FG001|Overall Study|Disease progression|5|||
46653044|NCT01514864|82861172|FG000|Overall Study|Study drug toxicity|2|||
46653045|NCT01514864|82861173|FG001|Overall Study|Study drug toxicity|0|||
46653046|NCT01458366|82861185|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
46653047|NCT01458366|82861186|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
46653048|NCT01458366|82861187|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
46653049|NCT01458366|82861188|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
46653050|NCT01458366|82861189|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
46653051|NCT01458366|82861185|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
46653052|NCT01458366|82861186|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
46653053|NCT01458366|82861187|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
46653054|NCT01458366|82861188|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
46653055|NCT01458366|82861189|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
46653056|NCT00364286|82861206|FG000|Overall Study|Withdrawal by Subject|1|||
46653057|NCT00364286|82861206|FG000|Overall Study|Adverse Event|2|||
46653058|NCT01755689|82861235|FG000|Overall Study|Withdrawal by Subject|1|||
46653059|NCT01755689|82861236|FG001|Overall Study|Withdrawal by Subject|3|||
46653060|NCT01755689|82861237|FG002|Overall Study|Withdrawal by Subject|2|||
46653061|NCT01755689|82861238|FG003|Overall Study|Withdrawal by Subject|1|||
46653062|NCT01755689|82861239|FG004|Overall Study|Withdrawal by Subject|1|||
46653063|NCT01755689|82861235|FG000|Overall Study|Migrated/moved from study area|0|||
46653064|NCT01755689|82861236|FG001|Overall Study|Migrated/moved from study area|1|||
46653065|NCT01755689|82861237|FG002|Overall Study|Migrated/moved from study area|1|||
46653066|NCT01755689|82861238|FG003|Overall Study|Migrated/moved from study area|1|||
46653067|NCT01755689|82861239|FG004|Overall Study|Migrated/moved from study area|1|||
46653068|NCT01755689|82861235|FG000|Overall Study|Lost to Follow-up|1|||
46653069|NCT01755689|82861236|FG001|Overall Study|Lost to Follow-up|0|||
46653070|NCT01755689|82861237|FG002|Overall Study|Lost to Follow-up|1|||
46850809|NCT00381095|83066634|FG001|Overall Study|Protocol Violation|1|||
46850810|NCT00381095|83066633|FG000|Overall Study|Withdrawal by Subject|3|||
46653071|NCT01755689|82861238|FG003|Overall Study|Lost to Follow-up|0|||
46653072|NCT01755689|82861239|FG004|Overall Study|Lost to Follow-up|2|||
46653073|NCT01755689|82861235|FG000|Overall Study|Pregnancy|1|||
46653074|NCT01755689|82861236|FG001|Overall Study|Pregnancy|1|||
46653075|NCT01755689|82861237|FG002|Overall Study|Pregnancy|2|||
46850811|NCT00381095|83066634|FG001|Overall Study|Withdrawal by Subject|3|||
46850812|NCT00381095|83066633|FG000|Overall Study|Adverse Event|2|||
46970846|NCT02040766|83214188|FG003|Overall Study|Lost to Follow-up|1|||
46653076|NCT01755689|82861238|FG003|Overall Study|Pregnancy|4|||
46653077|NCT01755689|82861239|FG004|Overall Study|Pregnancy|2|||
46653078|NCT01762761|82861261|FG000|Overall Study|Adverse Event|15|||
46653079|NCT01762761|82861262|FG001|Overall Study|Adverse Event|17|||
46653080|NCT01762761|82861261|FG000|Overall Study|Lack of Efficacy|9|||
46653081|NCT01762761|82861262|FG001|Overall Study|Lack of Efficacy|25|||
46653082|NCT01762761|82861261|FG000|Overall Study|Protocol Violation|1|||
46850813|NCT00381095|83066634|FG001|Overall Study|Adverse Event|7|||
46653083|NCT01762761|82861262|FG001|Overall Study|Protocol Violation|1|||
46653084|NCT01762761|82861261|FG000|Overall Study|Study closed/terminated|0|||
46653085|NCT01762761|82861262|FG001|Overall Study|Study closed/terminated|2|||
46653086|NCT01762761|82861261|FG000|Overall Study|Lost to Follow-up|3|||
46653087|NCT01762761|82861262|FG001|Overall Study|Lost to Follow-up|6|||
46653088|NCT01762761|82861261|FG000|Overall Study|Physician Decision|4|||
46653089|NCT01762761|82861262|FG001|Overall Study|Physician Decision|6|||
46653090|NCT01762761|82861261|FG000|Overall Study|Withdrawal by Subject|7|||
46653091|NCT01762761|82861262|FG001|Overall Study|Withdrawal by Subject|8|||
46653092|NCT01763788|82861273|FG000|Overall Study|Lost to Follow-up|0|||
46653093|NCT01763788|82861274|FG001|Overall Study|Lost to Follow-up|0|||
46653094|NCT01763788|82861275|FG002|Overall Study|Lost to Follow-up|1|||
46970847|NCT02040766|83214189|FG004|Overall Study|Lost to Follow-up|4|||
46970848|NCT02040766|83214185|FG000|Overall Study|Not reported|1|||
46970849|NCT02040766|83214186|FG001|Overall Study|Not reported|0|||
46970850|NCT02040766|83214187|FG002|Overall Study|Not reported|0|||
46970851|NCT02040766|83214188|FG003|Overall Study|Not reported|0|||
46970852|NCT02040766|83214189|FG004|Overall Study|Not reported|0|||
46970853|NCT02040766|83214185|FG000|Overall Study|Lack of Efficacy|6|||
46970854|NCT02040766|83214186|FG001|Overall Study|Lack of Efficacy|3|||
46970855|NCT02040766|83214187|FG002|Overall Study|Lack of Efficacy|4|||
46970856|NCT02040766|83214188|FG003|Overall Study|Lack of Efficacy|6|||
46970857|NCT02040766|83214189|FG004|Overall Study|Lack of Efficacy|5|||
46970858|NCT02040532|83214202|FG000|Overall Study|Lost to Follow-up|1|||
46970859|NCT02040532|83214202|FG000|Overall Study|Physician Decision|4|||
46970860|NCT02040532|83214202|FG000|Overall Study|Adverse Event|4|||
46970861|NCT02040532|83214202|FG000|Overall Study|Withdrawal by Subject|3|||
46970862|NCT02039908|83214206|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
46970863|NCT02039908|83214207|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
46970864|NCT02039908|83214208|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
46970865|NCT02039908|83214209|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
46970866|NCT02039908|83214206|FG000|Phase 1-Summer|Protocol Violation|6|||
46970867|NCT02039908|83214207|FG001|Phase 1-Summer|Protocol Violation|0|||
46970868|NCT02039908|83214208|FG002|Phase 1-Summer|Protocol Violation|0|||
46970869|NCT02039908|83214209|FG003|Phase 1-Summer|Protocol Violation|0|||
46970870|NCT02039908|83214206|FG000|Phase 2-School Year|Lost to Follow-up|0|||
46970871|NCT02039908|83214207|FG001|Phase 2-School Year|Lost to Follow-up|0|||
46970872|NCT02039908|83214208|FG002|Phase 2-School Year|Lost to Follow-up|1|||
46970873|NCT02039908|83214209|FG003|Phase 2-School Year|Lost to Follow-up|3|||
46970874|NCT02039908|83214206|FG000|Phase 2-School Year|Protocol Violation|0|||
46970875|NCT02039908|83214207|FG001|Phase 2-School Year|Protocol Violation|0|||
46970876|NCT02039908|83214208|FG002|Phase 2-School Year|Protocol Violation|3|||
46970877|NCT02039908|83214209|FG003|Phase 2-School Year|Protocol Violation|0|||
46970878|NCT02039908|83214206|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
46970879|NCT02039908|83214207|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
46970880|NCT02039908|83214208|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
46970881|NCT02039908|83214209|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
46970882|NCT02058940|83214217|FG000|Overall Study|Discharged from Critical Care Unit|1|||
46970883|NCT02058628|83214223|FG000|Overall Study|Adverse Event|1|||
46970884|NCT02058628|83214224|FG001|Overall Study|Adverse Event|0|||
46970885|NCT02058628|83214223|FG000|Overall Study|Withdrawal by Subject|2|||
46970886|NCT02058628|83214224|FG001|Overall Study|Withdrawal by Subject|2|||
46970887|NCT02058628|83214223|FG000|Overall Study|Lost to Follow-up|2|||
46970888|NCT02058628|83214224|FG001|Overall Study|Lost to Follow-up|4|||
46970889|NCT02058628|83214223|FG000|Overall Study|Not in time schedule|0|||
46970890|NCT02058628|83214224|FG001|Overall Study|Not in time schedule|1|||
46970891|NCT02058628|83214223|FG000|Overall Study|The visit date was not in timeline|0|||
46970892|NCT02058628|83214224|FG001|Overall Study|The visit date was not in timeline|1|||
46653095|NCT01763788|82861276|FG003|Overall Study|Lost to Follow-up|0|||
46653096|NCT01774370|82861286|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
46653097|NCT01774370|82861286|FG000|Overall Study|Administered prior to the contract date|4|||
46970893|NCT02058628|83214223|FG000|Overall Study|A lot of time for study for participant|1|||
46970894|NCT02058628|83214224|FG001|Overall Study|A lot of time for study for participant|0|||
46970895|NCT02058628|83214223|FG000|Overall Study|Non compliance|1|||
46970896|NCT02058628|83214224|FG001|Overall Study|Non compliance|0|||
46970897|NCT02058160|83214235|FG000|Overall Study|Randomized but not treated|2|||
46970898|NCT02058160|83214236|FG001|Overall Study|Randomized but not treated|4|||
46970899|NCT02058160|83214235|FG000|Overall Study|Poor compliance to protocol|4|||
46970900|NCT02058160|83214236|FG001|Overall Study|Poor compliance to protocol|1|||
46970901|NCT02058160|83214235|FG000|Overall Study|Adverse Event|12|||
46970902|NCT02058160|83214236|FG001|Overall Study|Adverse Event|3|||
46970903|NCT02058160|83214235|FG000|Overall Study|Lost to Follow-up|1|||
46653098|NCT01774370|82861286|FG000|Overall Study|Subjects of contraindications|34|||
46653099|NCT01774370|82861286|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
46970904|NCT02058160|83214236|FG001|Overall Study|Lost to Follow-up|0|||
46970905|NCT02058160|83214235|FG000|Overall Study|Other than specified above|12|||
46970906|NCT02058160|83214236|FG001|Overall Study|Other than specified above|6|||
46653100|NCT01774370|82861286|FG000|Overall Study|Follow-up failure|34|||
46653101|NCT01777295|82861292|FG000|Overall Study|Withdrawal by Subject|2|||
46653102|NCT01777295|82861293|FG001|Overall Study|Withdrawal by Subject|2|||
46653103|NCT01777295|82861292|FG000|Overall Study|Pregnancy|0|||
46653104|NCT01777295|82861293|FG001|Overall Study|Pregnancy|1|||
46653105|NCT01777295|82861292|FG000|Overall Study|Personal problem|1|||
46653106|NCT01777295|82861293|FG001|Overall Study|Personal problem|0|||
46653107|NCT01777295|82861292|FG000|Overall Study|Investigator call for AEs check|1|||
46653108|NCT01777295|82861293|FG001|Overall Study|Investigator call for AEs check|0|||
46653109|NCT01787552|82861330|FG000|Overall Study|Withdrawal by Subject|2|||
46653110|NCT01787552|82861331|FG001|Overall Study|Withdrawal by Subject|0|||
46653111|NCT01787552|82861332|FG002|Overall Study|Withdrawal by Subject|0|||
46653112|NCT01787552|82861333|FG003|Overall Study|Withdrawal by Subject|4|||
46970907|NCT02090764|83214244|FG000|Overall Study|Adverse Event|1|||
46970908|NCT02090764|83214245|FG001|Overall Study|Adverse Event|3|||
46970909|NCT02090764|83214244|FG000|Overall Study|Lack of Efficacy|0|||
46970910|NCT02090764|83214245|FG001|Overall Study|Lack of Efficacy|13|||
46970911|NCT02090764|83214244|FG000|Overall Study|Withdrawal by Subject|2|||
46970912|NCT02090764|83214245|FG001|Overall Study|Withdrawal by Subject|1|||
46970913|NCT02090764|83214244|FG000|Overall Study|Intercurrent illness and other|1|||
46970914|NCT02090764|83214245|FG001|Overall Study|Intercurrent illness and other|1|||
46970915|NCT02090764|83214244|FG000|Overall Study|Lost to Follow-up|2|||
46970916|NCT02090764|83214245|FG001|Overall Study|Lost to Follow-up|2|||
46653113|NCT01787552|82861330|FG000|Overall Study|Physician Decision|2|||
46653114|NCT01787552|82861331|FG001|Overall Study|Physician Decision|2|||
46653115|NCT01787552|82861332|FG002|Overall Study|Physician Decision|1|||
46653116|NCT01787552|82861333|FG003|Overall Study|Physician Decision|2|||
46653117|NCT01787552|82861330|FG000|Overall Study|Death|0|||
46653118|NCT01787552|82861331|FG001|Overall Study|Death|0|||
46653119|NCT01787552|82861332|FG002|Overall Study|Death|0|||
46653120|NCT01787552|82861333|FG003|Overall Study|Death|1|||
46653121|NCT01787552|82861330|FG000|Overall Study|Adverse Event|2|||
46653122|NCT01787552|82861331|FG001|Overall Study|Adverse Event|5|||
46653123|NCT01787552|82861332|FG002|Overall Study|Adverse Event|2|||
46653124|NCT01787552|82861333|FG003|Overall Study|Adverse Event|16|||
46653125|NCT01787552|82861330|FG000|Overall Study|Study terminated by Sponsor|0|||
46653126|NCT01787552|82861331|FG001|Overall Study|Study terminated by Sponsor|0|||
46653127|NCT01787552|82861332|FG002|Overall Study|Study terminated by Sponsor|1|||
46653128|NCT01787552|82861333|FG003|Overall Study|Study terminated by Sponsor|3|||
46653129|NCT01787552|82861330|FG000|Overall Study|Progressive Disease|2|||
46653130|NCT01787552|82861331|FG001|Overall Study|Progressive Disease|2|||
46653131|NCT01787552|82861332|FG002|Overall Study|Progressive Disease|1|||
46653132|NCT01787552|82861333|FG003|Overall Study|Progressive Disease|1|||
46653133|NCT01808261|82861350|FG000|Overall Study|Physician Decision|0|||
46653134|NCT01808261|82861351|FG001|Overall Study|Physician Decision|2|||
46653135|NCT01808261|82861350|FG000|Overall Study|Study Closed/Terminated|25|||
46653136|NCT01808261|82861351|FG001|Overall Study|Study Closed/Terminated|23|||
46653137|NCT01808261|82861350|FG000|Overall Study|Adverse event, non-fatal|2|||
46653138|NCT01808261|82861351|FG001|Overall Study|Adverse event, non-fatal|0|||
46653139|NCT01808261|82861350|FG000|Overall Study|Consent withdrawn by subject|6|||
46653140|NCT01808261|82861351|FG001|Overall Study|Consent withdrawn by subject|7|||
46653141|NCT01808261|82861350|FG000|Overall Study|Lost to Follow-up|3|||
46653142|NCT01808261|82861351|FG001|Overall Study|Lost to Follow-up|1|||
46653143|NCT01814826|82861370|FG000|Overall Study|Other|3|||
46653144|NCT01814826|82861371|FG001|Overall Study|Other|5|||
46653145|NCT01814826|82861372|FG002|Overall Study|Other|0|||
46653146|NCT01814826|82861370|FG000|Overall Study|Death|29|||
46653147|NCT01814826|82861371|FG001|Overall Study|Death|24|||
46653148|NCT01814826|82861372|FG002|Overall Study|Death|3|||
46653149|NCT01819467|82861383|FG000|Overall Study|Physician Decision|20|||
46653150|NCT01819467|82861384|FG001|Overall Study|Physician Decision|9|||
46653151|NCT01829711|82861390|FG000|Overall Study|Lost to Follow-up|2|||
46653152|NCT01829711|82861390|FG000|Overall Study|Withdrawal by Subject|3|||
46653153|NCT01829711|82861390|FG000|Overall Study|Death|4|||
46653154|NCT01829711|82861390|FG000|Overall Study|Started new therapies|17|||
46653155|NCT01829711|82861390|FG000|Overall Study|Adverse Event|3|||
46653156|NCT01829711|82861390|FG000|Overall Study|Due to progression of disease|13|||
46653157|NCT01829711|82861390|FG000|Overall Study|Due to lack of response|1|||
46653158|NCT01846273|82861397|FG000|Overall Study|Adverse Event|9|||
46653159|NCT01846273|82861398|FG001|Overall Study|Adverse Event|7|||
46653160|NCT01846273|82861399|FG002|Overall Study|Adverse Event|0|||
46653161|NCT01846273|82861397|FG000|Overall Study|Subject withdrew consent|5|||
46653162|NCT01846273|82861398|FG001|Overall Study|Subject withdrew consent|8|||
46653163|NCT01846273|82861399|FG002|Overall Study|Subject withdrew consent|0|||
46653164|NCT01846273|82861397|FG000|Overall Study|Lost to Follow-up|2|||
46653165|NCT01846273|82861398|FG001|Overall Study|Lost to Follow-up|1|||
46653166|NCT01846273|82861399|FG002|Overall Study|Lost to Follow-up|0|||
46970917|NCT02057692|83214255|FG000|Overall Study|Adverse Event|1|||
46970918|NCT02057692|83214256|FG001|Overall Study|Adverse Event|0|||
46653167|NCT01846273|82861397|FG000|Overall Study|Administrative problems|1|||
46653168|NCT01846273|82861398|FG001|Overall Study|Administrative problems|0|||
46653169|NCT01846273|82861399|FG002|Overall Study|Administrative problems|0|||
46653170|NCT01846273|82861397|FG000|Overall Study|Death|2|||
46653171|NCT01846273|82861398|FG001|Overall Study|Death|1|||
46653172|NCT01846273|82861399|FG002|Overall Study|Death|0|||
46653173|NCT01846273|82861397|FG000|Overall Study|Disease Progression|0|||
46653174|NCT01846273|82861398|FG001|Overall Study|Disease Progression|4|||
46653175|NCT01846273|82861399|FG002|Overall Study|Disease Progression|0|||
46653176|NCT01846273|82861397|FG000|Overall Study|Protocol Deviation|2|||
46653177|NCT01846273|82861398|FG001|Overall Study|Protocol Deviation|3|||
46653178|NCT01846273|82861399|FG002|Overall Study|Protocol Deviation|0|||
46653179|NCT01846273|82861397|FG000|Overall Study|Physician Decision|1|||
46653180|NCT01846273|82861398|FG001|Overall Study|Physician Decision|2|||
46653181|NCT01846273|82861399|FG002|Overall Study|Physician Decision|0|||
46653182|NCT01871896|82861407|FG000|Overall Study|Lost to Follow-up|1|||
46653183|NCT05855616|82861414|FG000|Overall Study|Lost to Follow-up|1|||
46653184|NCT05855616|82861415|FG001|Overall Study|Lost to Follow-up|2|||
46653185|NCT04752475|82861425|FG000|Overall Study|Withdrawal by Subject|1|||
46653186|NCT04752475|82861426|FG001|Overall Study|Withdrawal by Subject|1|||
46653187|NCT03846947|82861472|FG000|Overall Study|technical issues with imaging sequence|2|||
46653188|NCT03675308|82861485|FG000|Overall Study|Adverse Event|3|||
46653189|NCT03675308|82861486|FG001|Overall Study|Adverse Event|2|||
46653190|NCT03675308|82861485|FG000|Overall Study|Withdrawal by Subject|6|||
46653191|NCT03675308|82861486|FG001|Overall Study|Withdrawal by Subject|4|||
46653192|NCT03675308|82861485|FG000|Overall Study|Lost to Follow-up|3|||
46653193|NCT03675308|82861486|FG001|Overall Study|Lost to Follow-up|0|||
46970919|NCT02057692|83214257|FG002|Overall Study|Adverse Event|0|||
46970920|NCT02057692|83214258|FG003|Overall Study|Adverse Event|0|||
47075434|NCT00988559|83369393|FG001|Overall Study|Withdrawal by Subject|1|||
47075435|NCT00988559|83369394|FG002|Overall Study|Withdrawal by Subject|0|||
47075436|NCT00988559|83369395|FG003|Overall Study|Withdrawal by Subject|1|||
47075437|NCT00988559|83369392|FG000|Overall Study|Pregnancy|0|||
47075438|NCT00988559|83369393|FG001|Overall Study|Pregnancy|1|||
47075439|NCT00988559|83369394|FG002|Overall Study|Pregnancy|1|||
47075440|NCT00988559|83369395|FG003|Overall Study|Pregnancy|0|||
47075441|NCT00988559|83369392|FG000|Overall Study|Lost to Follow-up|0|||
47075442|NCT00988559|83369393|FG001|Overall Study|Lost to Follow-up|0|||
47075443|NCT00988559|83369394|FG002|Overall Study|Lost to Follow-up|1|||
47075444|NCT00988559|83369395|FG003|Overall Study|Lost to Follow-up|0|||
47075445|NCT00988169|83369405|FG000|Overall Study|Withdrawal by Subject|1|||
47075446|NCT00988091|83369432|FG000|Double-blind Period|Withdrawal by Subject|15|||
47075447|NCT00988091|83369433|FG001|Double-blind Period|Withdrawal by Subject|13|||
47075448|NCT00988091|83369432|FG000|Double-blind Period|Lost to Follow-up|12|||
47075449|NCT00988091|83369433|FG001|Double-blind Period|Lost to Follow-up|14|||
47075450|NCT00988091|83369432|FG000|Double-blind Period|Other|8|||
47075451|NCT00988091|83369433|FG001|Double-blind Period|Other|8|||
47075452|NCT00988091|83369432|FG000|Double-blind Period|Adverse Event|6|||
47075453|NCT00988091|83369433|FG001|Double-blind Period|Adverse Event|9|||
47075454|NCT00988091|83369432|FG000|Double-blind Period|Use of exclusionary medication|2|||
47075455|NCT00988091|83369433|FG001|Double-blind Period|Use of exclusionary medication|3|||
47075456|NCT00988091|83369432|FG000|Open-label Period|Adverse Event|4|||
47075457|NCT00988091|83369433|FG001|Open-label Period|Adverse Event|7|||
47075458|NCT00988091|83369432|FG000|Open-label Period|Use of exclusionary medication|1|||
47075459|NCT00988091|83369433|FG001|Open-label Period|Use of exclusionary medication|1|||
47075460|NCT00988091|83369432|FG000|Open-label Period|Protocol Violation|1|||
46653194|NCT03675308|82861485|FG000|Overall Study|Lack of Efficacy|1|||
46653195|NCT03675308|82861486|FG001|Overall Study|Lack of Efficacy|1|||
46653196|NCT03675308|82861485|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
46653197|NCT03675308|82861486|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
46653198|NCT03675308|82861485|FG000|Overall Study|Other|0|||
46970921|NCT02057692|83214255|FG000|Overall Study|Lost to Follow-up|0|||
46653199|NCT03675308|82861486|FG001|Overall Study|Other|1|||
46653200|NCT02914613|82861494|FG000|Overall Study|Withdrawal by Subject|1|||
46653201|NCT02914613|82861495|FG001|Overall Study|Withdrawal by Subject|2|||
46653202|NCT02914613|82861494|FG000|Overall Study|Adverse Event|1|||
46653203|NCT02914613|82861495|FG001|Overall Study|Adverse Event|0|||
46653204|NCT02586207|82861505|FG000|Overall Study|Physician Decision|1|||
46653205|NCT02586207|82861505|FG000|Overall Study|Withdrawal by Subject|1|||
46653206|NCT02573324|82861512|FG000|Overall Study|Withdrawal by Subject|26|||
46653207|NCT02573324|82861513|FG001|Overall Study|Withdrawal by Subject|23|||
46653208|NCT02573324|82861514|FG002|Overall Study|Withdrawal by Subject|3|||
46653209|NCT02573324|82861512|FG000|Overall Study|Lost to Follow-up|4|||
46653210|NCT02573324|82861513|FG001|Overall Study|Lost to Follow-up|5|||
46653211|NCT02573324|82861514|FG002|Overall Study|Lost to Follow-up|0|||
46653212|NCT02573324|82861512|FG000|Overall Study|Study Terminated by Sponsor|107|||
46653213|NCT02573324|82861513|FG001|Overall Study|Study Terminated by Sponsor|89|||
46653214|NCT02573324|82861514|FG002|Overall Study|Study Terminated by Sponsor|2|||
46653215|NCT02573324|82861512|FG000|Overall Study|Death|182|||
46653216|NCT02573324|82861513|FG001|Overall Study|Death|200|||
46653217|NCT02573324|82861514|FG002|Overall Study|Death|1|||
46653218|NCT02573324|82861512|FG000|Overall Study|Other, Not Specified|20|||
46653219|NCT02573324|82861513|FG001|Overall Study|Other, Not Specified|27|||
46653220|NCT02573324|82861514|FG002|Overall Study|Other, Not Specified|0|||
46653221|NCT02573324|82861512|FG000|Overall Study|Unknown Reason|2|||
46653222|NCT02573324|82861513|FG001|Overall Study|Unknown Reason|0|||
46653223|NCT02573324|82861514|FG002|Overall Study|Unknown Reason|0|||
46653224|NCT02296684|82861530|FG000|Overall Study|Withdrawal by Subject|0|||
46653225|NCT02296684|82861531|FG001|Overall Study|Withdrawal by Subject|1|||
46653226|NCT02296684|82861532|FG002|Overall Study|Withdrawal by Subject|1|||
46653227|NCT02296684|82861530|FG000|Overall Study|Death|2|||
46653228|NCT02296684|82861531|FG001|Overall Study|Death|0|||
46653229|NCT02296684|82861532|FG002|Overall Study|Death|0|||
46653230|NCT02107261|82861541|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
46653231|NCT02107261|82861542|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
46653232|NCT02107261|82861541|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
46653233|NCT02107261|82861542|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
46653234|NCT02014597|82861552|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
46653235|NCT02014597|82861553|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
46653236|NCT01342367|82861561|FG000|Overall Study|Death|1|||
46653237|NCT01342367|82861562|FG001|Overall Study|Death|0|||
46653238|NCT01342367|82861561|FG000|Overall Study|Withdrawal by Subject|1|||
46653239|NCT01342367|82861562|FG001|Overall Study|Withdrawal by Subject|2|||
46653240|NCT01185171|82861568|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
46653241|NCT01185171|82861568|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
46653242|NCT01185171|82861568|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
46653243|NCT01185171|82861568|FG000|Maintenance|Elevated liver transaminases|3|||
46653244|NCT01185171|82861568|FG000|Maintenance|Rush|2|||
46653245|NCT01185171|82861568|FG000|Maintenance|Diarrhea|1|||
46653246|NCT01185171|82861568|FG000|Maintenance|Xerostomia|1|||
46653247|NCT01185171|82861568|FG000|Maintenance|Nausea|1|||
46653248|NCT01185171|82861568|FG000|Maintenance|Comorbid Illness|2|||
46653249|NCT01185171|82861568|FG000|Maintenance|Withdrawal by Subject|1|||
46653250|NCT01185171|82861568|FG000|Maintenance|Disease Recurrence|1|||
46653251|NCT00896493|82861572|FG000|Overall Study|Early disease relapse|3|||
46653252|NCT01875185|82861587|FG000|Overall Study|study was terminated|52|||
46653253|NCT01875185|82861588|FG001|Overall Study|study was terminated|48|||
46653254|NCT01901432|82861617|FG000|Overall Study|Adverse Event|0|||
46653255|NCT01901432|82861618|FG001|Overall Study|Adverse Event|1|||
46653256|NCT01901432|82861619|FG002|Overall Study|Adverse Event|1|||
46653257|NCT01901432|82861620|FG003|Overall Study|Adverse Event|0|||
46653258|NCT01901432|82861621|FG004|Overall Study|Adverse Event|1|||
46653259|NCT01901432|82861617|FG000|Overall Study|Withdrawal by Subject|0|||
46970922|NCT02057692|83214256|FG001|Overall Study|Lost to Follow-up|0|||
47075461|NCT00988091|83369433|FG001|Open-label Period|Protocol Violation|1|||
46653260|NCT01901432|82861618|FG001|Overall Study|Withdrawal by Subject|0|||
46653261|NCT01901432|82861619|FG002|Overall Study|Withdrawal by Subject|1|||
46653262|NCT01901432|82861620|FG003|Overall Study|Withdrawal by Subject|0|||
46653263|NCT01901432|82861621|FG004|Overall Study|Withdrawal by Subject|5|||
46653264|NCT01901432|82861617|FG000|Overall Study|Physician Decision|0|||
46653265|NCT01901432|82861618|FG001|Overall Study|Physician Decision|0|||
46653266|NCT01901432|82861619|FG002|Overall Study|Physician Decision|0|||
46653267|NCT01901432|82861620|FG003|Overall Study|Physician Decision|0|||
46653268|NCT01901432|82861621|FG004|Overall Study|Physician Decision|2|||
46653269|NCT01901432|82861617|FG000|Overall Study|Patient decision to stop study drug|0|||
46653270|NCT01901432|82861618|FG001|Overall Study|Patient decision to stop study drug|0|||
46653271|NCT01901432|82861619|FG002|Overall Study|Patient decision to stop study drug|0|||
46653272|NCT01901432|82861620|FG003|Overall Study|Patient decision to stop study drug|0|||
46653273|NCT01901432|82861621|FG004|Overall Study|Patient decision to stop study drug|1|||
46653274|NCT01904279|82861642|FG000|Overall Study|Lack of Efficacy|2|||
46653275|NCT01904279|82861643|FG001|Overall Study|Lack of Efficacy|3|||
46653276|NCT01904279|82861642|FG000|Overall Study|Withdrawal by Subject|1|||
46653277|NCT01904279|82861643|FG001|Overall Study|Withdrawal by Subject|0|||
46653278|NCT01917318|82861652|FG000|First Treatment|Withdrawal by Subject|0|||
46653279|NCT01917318|82861653|FG001|First Treatment|Withdrawal by Subject|1|||
46653280|NCT01923168|82861662|FG000|Overall Study|Protocol Violation|1|||
46653281|NCT01923168|82861663|FG001|Overall Study|Protocol Violation|1|||
46653282|NCT01923168|82861664|FG002|Overall Study|Protocol Violation|0|||
46653283|NCT01923168|82861662|FG000|Overall Study|Subject/guardian decision|14|||
46653284|NCT01923168|82861663|FG001|Overall Study|Subject/guardian decision|14|||
46653285|NCT01923168|82861664|FG002|Overall Study|Subject/guardian decision|4|||
46653286|NCT01923168|82861662|FG000|Overall Study|Adverse Event|12|||
46653287|NCT01923168|82861663|FG001|Overall Study|Adverse Event|12|||
46653288|NCT01923168|82861664|FG002|Overall Study|Adverse Event|0|||
46653289|NCT01923168|82861662|FG000|Overall Study|Physician Decision|6|||
46653290|NCT01923168|82861663|FG001|Overall Study|Physician Decision|9|||
46653291|NCT01923168|82861664|FG002|Overall Study|Physician Decision|5|||
46653292|NCT01923168|82861662|FG000|Overall Study|Progressive disease|4|||
46653293|NCT01923168|82861663|FG001|Overall Study|Progressive disease|3|||
46653294|NCT01923168|82861664|FG002|Overall Study|Progressive disease|7|||
46653295|NCT01923168|82861662|FG000|Overall Study|Death|0|||
46653296|NCT01923168|82861663|FG001|Overall Study|Death|0|||
46653297|NCT01923168|82861664|FG002|Overall Study|Death|1|||
46653298|NCT01931098|82861674|FG000|Overall Study|Withdrawal by Subject|0|||
46653299|NCT01931098|82861675|FG001|Overall Study|Withdrawal by Subject|1|||
46653300|NCT01931098|82861674|FG000|Overall Study|Enrolled in different protocol|0|||
46653301|NCT01931098|82861675|FG001|Overall Study|Enrolled in different protocol|1|||
46653302|NCT01931098|82861674|FG000|Overall Study|Unable to begin trmt:active infection|0|||
46653303|NCT01931098|82861675|FG001|Overall Study|Unable to begin trmt:active infection|1|||
46653304|NCT01931098|82861674|FG000|Overall Study|Refused further treatment|0|||
46653305|NCT01931098|82861675|FG001|Overall Study|Refused further treatment|1|||
46653306|NCT05097716|82861685|FG000|Period 1|Adverse Event|1|||
46653307|NCT05097716|82861685|FG000|Period 1|Close contact with highly-transmissible infection|1|||
46653308|NCT04781647|82861706|FG000|Overall Study|Study terminated by Sponsor|11|||
46653309|NCT04781647|82861707|FG001|Overall Study|Study terminated by Sponsor|9|||
46653310|NCT04781647|82861708|FG002|Overall Study|Study terminated by Sponsor|9|||
46653311|NCT04781647|82861706|FG000|Overall Study|Withdrawal by Subject|1|||
46653312|NCT04781647|82861707|FG001|Overall Study|Withdrawal by Subject|2|||
47075462|NCT00988091|83369432|FG000|Open-label Period|Withdrawal by Subject|10|||
47075463|NCT00988091|83369433|FG001|Open-label Period|Withdrawal by Subject|16|||
47075464|NCT00988091|83369432|FG000|Open-label Period|Lost to Follow-up|3|||
47075465|NCT00988091|83369433|FG001|Open-label Period|Lost to Follow-up|5|||
47075466|NCT00988091|83369432|FG000|Open-label Period|Other|2|||
47075467|NCT00988091|83369433|FG001|Open-label Period|Other|3|||
47075468|NCT02623218|83369723|FG000|Overall Study|Lost to Follow-up|0|||
47075469|NCT02623218|83369724|FG001|Overall Study|Lost to Follow-up|1|||
47075470|NCT02623218|83369725|FG002|Overall Study|Lost to Follow-up|0|||
47075471|NCT02623218|83369726|FG003|Overall Study|Lost to Follow-up|0|||
47075472|NCT02623218|83369727|FG004|Overall Study|Lost to Follow-up|0|||
47075473|NCT02622828|83369752|FG000|Overall Study|participant withdrew|3|||
47075474|NCT02621034|83369888|FG000|Overall Study|Lost to Follow-up|3|||
47075475|NCT02621034|83369889|FG001|Overall Study|Lost to Follow-up|2|||
47075476|NCT02621034|83369890|FG002|Overall Study|Lost to Follow-up|5|||
47075477|NCT02620020|83369952|FG000|Overall Study|Adverse Event|8|||
47075478|NCT02620020|83369953|FG001|Overall Study|Adverse Event|4|||
47075479|NCT02620020|83369954|FG002|Overall Study|Adverse Event|3|||
47075480|NCT02620020|83369955|FG003|Overall Study|Adverse Event|5|||
47075481|NCT02620020|83369952|FG000|Overall Study|Lost to Follow-up|4|||
47075482|NCT02620020|83369953|FG001|Overall Study|Lost to Follow-up|8|||
47075483|NCT02620020|83369954|FG002|Overall Study|Lost to Follow-up|1|||
46653313|NCT04781647|82861708|FG002|Overall Study|Withdrawal by Subject|0|||
46653314|NCT04781647|82861706|FG000|Overall Study|Adverse Event|0|||
46653315|NCT04781647|82861707|FG001|Overall Study|Adverse Event|1|||
46653316|NCT04781647|82861708|FG002|Overall Study|Adverse Event|1|||
46653317|NCT04781647|82861706|FG000|Overall Study|Protocol Violation|1|||
46653318|NCT04781647|82861707|FG001|Overall Study|Protocol Violation|0|||
46653319|NCT04781647|82861708|FG002|Overall Study|Protocol Violation|0|||
47075484|NCT02620020|83369955|FG003|Overall Study|Lost to Follow-up|4|||
47075485|NCT02620020|83369952|FG000|Overall Study|Physician Decision|7|||
47075486|NCT02620020|83369953|FG001|Overall Study|Physician Decision|4|||
46653320|NCT04781647|82861706|FG000|Overall Study|Pregnancy|0|||
47075487|NCT02620020|83369954|FG002|Overall Study|Physician Decision|3|||
47075488|NCT02620020|83369955|FG003|Overall Study|Physician Decision|4|||
47075489|NCT02620020|83369952|FG000|Overall Study|Protocol Violation|5|||
47075490|NCT02620020|83369953|FG001|Overall Study|Protocol Violation|2|||
46653321|NCT04781647|82861707|FG001|Overall Study|Pregnancy|0|||
46653322|NCT04781647|82861708|FG002|Overall Study|Pregnancy|1|||
47075491|NCT02620020|83369954|FG002|Overall Study|Protocol Violation|1|||
46653323|NCT04781647|82861706|FG000|Overall Study|Virology rebounded|1|||
46653324|NCT04781647|82861707|FG001|Overall Study|Virology rebounded|0|||
46653325|NCT04781647|82861708|FG002|Overall Study|Virology rebounded|0|||
46653326|NCT04727528|82861720|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
46653327|NCT04727528|82861721|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
46653328|NCT04727528|82861720|FG000|Open-label Period|Randomized who did not receive treatment|1|||
46653329|NCT04727528|82861721|FG001|Open-label Period|Randomized who did not receive treatment|0|||
46653330|NCT04727528|82861720|FG000|Double-blind Treatment Phase|Adverse Event|0|||
46653331|NCT04727528|82861721|FG001|Double-blind Treatment Phase|Adverse Event|1|||
46653332|NCT04727528|82861720|FG000|Double-blind Treatment Phase|Death|0|||
46653333|NCT04727528|82861721|FG001|Double-blind Treatment Phase|Death|1|||
46653334|NCT04727528|82861720|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
46653335|NCT04727528|82861721|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
46653336|NCT04727528|82861720|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
46653337|NCT04727528|82861721|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
46653338|NCT04727528|82861720|FG000|Double-blind Treatment Phase|Physician Decision|0|||
46653339|NCT04727528|82861721|FG001|Double-blind Treatment Phase|Physician Decision|1|||
46653340|NCT04727528|82861720|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
46653341|NCT04727528|82861721|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
46970923|NCT02057692|83214257|FG002|Overall Study|Lost to Follow-up|0|||
46970924|NCT02057692|83214258|FG003|Overall Study|Lost to Follow-up|1|||
46970925|NCT02038036|83214276|FG000|Core Study|Adverse Event|7|||
46970926|NCT02038036|83214277|FG001|Core Study|Adverse Event|7|||
46970927|NCT02038036|83214276|FG000|Core Study|Death|1|||
46970928|NCT02038036|83214277|FG001|Core Study|Death|1|||
46970929|NCT02038036|83214276|FG000|Core Study|Disease progression|2|||
46970930|NCT02038036|83214277|FG001|Core Study|Disease progression|2|||
46970931|NCT02038036|83214276|FG000|Core Study|Lost to Follow-up|0|||
46970932|NCT02038036|83214277|FG001|Core Study|Lost to Follow-up|1|||
46970933|NCT02038036|83214276|FG000|Core Study|Physician Decision|2|||
46970934|NCT02038036|83214277|FG001|Core Study|Physician Decision|1|||
46970935|NCT02038036|83214276|FG000|Core Study|Subject/guardian decision|0|||
46970936|NCT02038036|83214277|FG001|Core Study|Subject/guardian decision|1|||
46970937|NCT02038036|83214276|FG000|Core Study|Withdrawal by Subject|3|||
46970938|NCT02038036|83214277|FG001|Core Study|Withdrawal by Subject|1|||
46970939|NCT02038036|83214276|FG000|Crossover Period|Withdrawal by Subject|0|||
46970940|NCT02038036|83214277|FG001|Crossover Period|Withdrawal by Subject|3|||
46970941|NCT02038036|83214276|FG000|Crossover Period|Adverse Event|0|||
46970942|NCT02038036|83214277|FG001|Crossover Period|Adverse Event|9|||
46970943|NCT02038036|83214276|FG000|Crossover Period|Death|0|||
46970944|NCT02038036|83214277|FG001|Crossover Period|Death|2|||
46970945|NCT02038036|83214276|FG000|Crossover Period|Disease progression|0|||
46970946|NCT02038036|83214277|FG001|Crossover Period|Disease progression|3|||
46970947|NCT02038036|83214276|FG000|Crossover Period|Lost to Follow-up|0|||
46970948|NCT02038036|83214277|FG001|Crossover Period|Lost to Follow-up|1|||
46970949|NCT02038036|83214276|FG000|Crossover Period|Physician Decision|0|||
46970950|NCT02038036|83214277|FG001|Crossover Period|Physician Decision|2|||
47075492|NCT02620020|83369955|FG003|Overall Study|Protocol Violation|1|||
47075493|NCT02620020|83369952|FG000|Overall Study|Withdrawal by Subject|20|||
46653342|NCT04674189|82861749|FG000|Overall Study|Adverse Event|0|||
46653343|NCT04674189|82861750|FG001|Overall Study|Adverse Event|0|||
46970951|NCT02037568|83214288|FG000|Overall Study|Withdrawal by Subject|17|||
46970952|NCT02037568|83214289|FG001|Overall Study|Withdrawal by Subject|24|||
47075494|NCT02620020|83369953|FG001|Overall Study|Withdrawal by Subject|16|||
47075495|NCT02620020|83369954|FG002|Overall Study|Withdrawal by Subject|17|||
47075496|NCT02620020|83369955|FG003|Overall Study|Withdrawal by Subject|12|||
47075497|NCT02620020|83369952|FG000|Overall Study|Death|0|||
47075498|NCT02620020|83369953|FG001|Overall Study|Death|1|||
47075499|NCT02620020|83369954|FG002|Overall Study|Death|0|||
47075500|NCT02620020|83369955|FG003|Overall Study|Death|0|||
46970953|NCT02037568|83214288|FG000|Overall Study|Lost to Follow-up|16|||
46970954|NCT02037568|83214289|FG001|Overall Study|Lost to Follow-up|13|||
47075501|NCT02549989|83369965|FG000|Overall Study|Adverse Event|4|||
47075502|NCT02549989|83369965|FG000|Overall Study|Death|1|||
46970955|NCT02037568|83214288|FG000|Overall Study|Screen Failure|3|||
46970956|NCT02037568|83214289|FG001|Overall Study|Screen Failure|1|||
46970957|NCT02037568|83214288|FG000|Overall Study|Patient did not receive transplant|0|||
46970958|NCT02037568|83214289|FG001|Overall Study|Patient did not receive transplant|1|||
46970959|NCT02088034|83214298|FG000|Overall Study|Lost to Follow-up|1|||
46970960|NCT02088034|83214299|FG001|Overall Study|Lost to Follow-up|1|||
47075503|NCT02549989|83369965|FG000|Overall Study|Lack of Efficacy|19|||
46970961|NCT02088034|83214300|FG002|Overall Study|Lost to Follow-up|0|||
46970962|NCT02088034|83214298|FG000|Overall Study|Pregnancy|2|||
46970963|NCT02088034|83214299|FG001|Overall Study|Pregnancy|1|||
46970964|NCT02088034|83214300|FG002|Overall Study|Pregnancy|2|||
46970965|NCT02037256|83214310|FG000|Overall Study|Protocol Violation|0|||
46970966|NCT02037256|83214311|FG001|Overall Study|Protocol Violation|1|||
46970967|NCT02037256|83214310|FG000|Overall Study|Withdrawn prior to Velcade|0|||
46970968|NCT02037256|83214311|FG001|Overall Study|Withdrawn prior to Velcade|2|||
46970969|NCT02035696|83214323|FG000|Overall Study|Lost to Follow-up|0|||
46970970|NCT02035696|83214324|FG001|Overall Study|Lost to Follow-up|3|||
46970971|NCT02035696|83214325|FG002|Overall Study|Lost to Follow-up|1|||
46970972|NCT02035696|83214326|FG003|Overall Study|Lost to Follow-up|2|||
46970973|NCT02035696|83214323|FG000|Overall Study|Withdrawal by Subject|3|||
46970974|NCT02035696|83214324|FG001|Overall Study|Withdrawal by Subject|0|||
46970975|NCT02035696|83214325|FG002|Overall Study|Withdrawal by Subject|2|||
46970976|NCT02035696|83214326|FG003|Overall Study|Withdrawal by Subject|1|||
46970977|NCT02057458|83214340|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
46970978|NCT02057458|83214341|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
46970979|NCT02057458|83214342|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
46970980|NCT02057458|83214340|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
46970981|NCT02057458|83214341|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
46970982|NCT02057458|83214342|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
46970983|NCT02057458|83214340|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
46781420|NCT00396877|83000037|FG000|Overall Study|Lost to Follow-up|2|||
46781421|NCT00396877|83000038|FG001|Overall Study|Lost to Follow-up|1|||
46781422|NCT00396877|83000037|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
46781423|NCT00396877|83000038|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
46781424|NCT00628251|83000047|FG000|Randomised Part|Withdrawal by Subject|0|||
46781425|NCT00628251|83000048|FG001|Randomised Part|Withdrawal by Subject|0|||
46781426|NCT00628251|83000049|FG002|Randomised Part|Withdrawal by Subject|1|||
46781427|NCT00628251|83000047|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
46781428|NCT00628251|83000048|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
46781429|NCT00628251|83000049|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
46781430|NCT00628251|83000047|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
46781431|NCT00628251|83000048|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
46781432|NCT00628251|83000049|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
46781433|NCT00628251|83000047|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
46781434|NCT00628251|83000048|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
46781435|NCT00628251|83000049|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
46781436|NCT00628251|83000047|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
46781437|NCT00628251|83000048|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
46781438|NCT00628251|83000049|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
46781439|NCT00628251|83000047|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
46781440|NCT00628251|83000048|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
46781441|NCT00628251|83000049|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
46781442|NCT00625131|83000061|FG000|Overall Study|Lost to Follow-up|3|||
46781443|NCT00625131|83000062|FG001|Overall Study|Lost to Follow-up|2|||
46781444|NCT00625131|83000063|FG002|Overall Study|Lost to Follow-up|0|||
46781445|NCT00625131|83000061|FG000|Overall Study|Withdrawal by Subject|1|||
46781446|NCT00625131|83000062|FG001|Overall Study|Withdrawal by Subject|0|||
46781447|NCT00625131|83000063|FG002|Overall Study|Withdrawal by Subject|5|||
46781448|NCT00408499|83000069|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
46781449|NCT00408499|83000070|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
46781450|NCT00408499|83000071|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
46781451|NCT00408499|83000072|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
46781452|NCT00408499|83000073|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
46781453|NCT00408499|83000069|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
46781454|NCT00408499|83000070|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
46781455|NCT00408499|83000071|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
46781456|NCT00408499|83000072|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
46970984|NCT02057458|83214341|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
47075504|NCT02549989|83369965|FG000|Overall Study|Withdrawal by Subject|3|||
46781457|NCT00408499|83000073|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
46970985|NCT02057458|83214342|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
46970986|NCT02057068|83214374|FG000|Overall Study|Withdrawal by Subject|2|||
47075505|NCT00987935|83370124|FG000|Overall Study|Progressive disease|3|||
46781458|NCT00408499|83000069|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
46781459|NCT00408499|83000070|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
46781460|NCT00408499|83000071|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
46781461|NCT00408499|83000072|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
46850814|NCT03619174|83066642|FG000|Overall Study|Lost to Follow-up|3|||
46781462|NCT00408499|83000073|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
46781463|NCT00408499|83000069|FG000|Phase II- MTD Expansion|Adverse Event|0|||
46781464|NCT00408499|83000070|FG001|Phase II- MTD Expansion|Adverse Event|0|||
46781465|NCT00408499|83000071|FG002|Phase II- MTD Expansion|Adverse Event|0|||
46781466|NCT00408499|83000072|FG003|Phase II- MTD Expansion|Adverse Event|0|||
46781467|NCT00408499|83000073|FG004|Phase II- MTD Expansion|Adverse Event|9|||
46781468|NCT00408499|83000069|FG000|Phase II- MTD Expansion|Death|0|||
46781469|NCT00408499|83000070|FG001|Phase II- MTD Expansion|Death|0|||
46781470|NCT00408499|83000071|FG002|Phase II- MTD Expansion|Death|0|||
46781471|NCT00408499|83000072|FG003|Phase II- MTD Expansion|Death|0|||
46781472|NCT00408499|83000073|FG004|Phase II- MTD Expansion|Death|2|||
46781473|NCT00408499|83000069|FG000|Phase II- MTD Expansion|Physician Decision|0|||
46781474|NCT00408499|83000070|FG001|Phase II- MTD Expansion|Physician Decision|0|||
46781475|NCT00408499|83000071|FG002|Phase II- MTD Expansion|Physician Decision|0|||
46781476|NCT00408499|83000072|FG003|Phase II- MTD Expansion|Physician Decision|0|||
46781477|NCT00408499|83000073|FG004|Phase II- MTD Expansion|Physician Decision|1|||
46781478|NCT00408499|83000069|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
46781479|NCT00408499|83000070|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
46781480|NCT00408499|83000071|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
46781481|NCT00408499|83000072|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
46781482|NCT00408499|83000073|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
47075506|NCT00987935|83370125|FG001|Overall Study|Progressive disease|2|||
47075507|NCT00987935|83370126|FG002|Overall Study|Progressive disease|3|||
47075508|NCT00987935|83370127|FG003|Overall Study|Progressive disease|2|||
47075509|NCT00987935|83370128|FG004|Overall Study|Progressive disease|5|||
47075510|NCT00987935|83370129|FG005|Overall Study|Progressive disease|3|||
47075511|NCT00987935|83370130|FG006|Overall Study|Progressive disease|9|||
47075512|NCT00987935|83370131|FG007|Overall Study|Progressive disease|48|||
47075513|NCT00987935|83370132|FG008|Overall Study|Progressive disease|23|||
47075514|NCT00987935|83370124|FG000|Overall Study|Adverse Event|0|||
47075515|NCT00987935|83370125|FG001|Overall Study|Adverse Event|1|||
47075516|NCT00987935|83370126|FG002|Overall Study|Adverse Event|0|||
47075517|NCT00987935|83370127|FG003|Overall Study|Adverse Event|1|||
47075518|NCT00987935|83370128|FG004|Overall Study|Adverse Event|1|||
47075519|NCT00987935|83370129|FG005|Overall Study|Adverse Event|0|||
47075520|NCT00987935|83370130|FG006|Overall Study|Adverse Event|2|||
47075521|NCT00987935|83370131|FG007|Overall Study|Adverse Event|10|||
47075522|NCT00987935|83370132|FG008|Overall Study|Adverse Event|6|||
47075523|NCT00987935|83370124|FG000|Overall Study|Refused to continue taking trial med.|1|||
47075524|NCT00987935|83370125|FG001|Overall Study|Refused to continue taking trial med.|0|||
47075525|NCT00987935|83370126|FG002|Overall Study|Refused to continue taking trial med.|0|||
47075526|NCT00987935|83370127|FG003|Overall Study|Refused to continue taking trial med.|0|||
47075527|NCT00987935|83370128|FG004|Overall Study|Refused to continue taking trial med.|1|||
47075528|NCT00987935|83370129|FG005|Overall Study|Refused to continue taking trial med.|0|||
47075529|NCT00987935|83370130|FG006|Overall Study|Refused to continue taking trial med.|4|||
47075530|NCT00987935|83370131|FG007|Overall Study|Refused to continue taking trial med.|4|||
47075531|NCT00987935|83370132|FG008|Overall Study|Refused to continue taking trial med.|2|||
47075532|NCT00987935|83370124|FG000|Overall Study|Reason other than those specified above|0|||
47075533|NCT00987935|83370125|FG001|Overall Study|Reason other than those specified above|0|||
47075534|NCT00987935|83370126|FG002|Overall Study|Reason other than those specified above|0|||
47075535|NCT00987935|83370127|FG003|Overall Study|Reason other than those specified above|0|||
47075536|NCT00987935|83370128|FG004|Overall Study|Reason other than those specified above|0|||
47075537|NCT00987935|83370129|FG005|Overall Study|Reason other than those specified above|0|||
47075538|NCT00987935|83370130|FG006|Overall Study|Reason other than those specified above|0|||
47075539|NCT00987935|83370131|FG007|Overall Study|Reason other than those specified above|0|||
47075540|NCT00987935|83370132|FG008|Overall Study|Reason other than those specified above|1|||
46781483|NCT00408499|83000069|FG000|Phase II- MTD Expansion|treatment delay|0|||
46781484|NCT00408499|83000070|FG001|Phase II- MTD Expansion|treatment delay|0|||
47075541|NCT01597050|83370160|FG000|Overall Study|Withdrawal by Subject|1|||
47075542|NCT01597050|83370161|FG001|Overall Study|Withdrawal by Subject|0|||
47075543|NCT00987623|83370178|FG000|Overall Study|Lost to Follow-up|2|||
47075544|NCT00987623|83370179|FG001|Overall Study|Lost to Follow-up|1|||
47075545|NCT00987623|83370178|FG000|Overall Study|Time/job conflict|2|||
47075546|NCT00987623|83370179|FG001|Overall Study|Time/job conflict|0|||
47075547|NCT00987623|83370178|FG000|Overall Study|Discomfort|1|||
47075548|NCT00987623|83370179|FG001|Overall Study|Discomfort|0|||
46653344|NCT04674189|82861751|FG002|Overall Study|Adverse Event|1|||
46781485|NCT00408499|83000071|FG002|Phase II- MTD Expansion|treatment delay|0|||
46781486|NCT00408499|83000072|FG003|Phase II- MTD Expansion|treatment delay|0|||
46850815|NCT03619174|83066643|FG001|Overall Study|Lost to Follow-up|0|||
46850816|NCT03619174|83066642|FG000|Overall Study|Withdrawal by Subject|4|||
47075549|NCT00987623|83370178|FG000|Overall Study|Biomicroscopy|0|||
47075550|NCT00987623|83370179|FG001|Overall Study|Biomicroscopy|1|||
46653345|NCT04674189|82861749|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
46653346|NCT04674189|82861750|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
46653347|NCT04674189|82861751|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
46653348|NCT04674189|82861749|FG000|Overall Study|Physician Decision|1|||
46653349|NCT04674189|82861750|FG001|Overall Study|Physician Decision|0|||
46653350|NCT04674189|82861751|FG002|Overall Study|Physician Decision|0|||
46653351|NCT04674189|82861749|FG000|Overall Study|Withdrawal by Participant|83|||
46653352|NCT04674189|82861750|FG001|Overall Study|Withdrawal by Participant|71|||
46653353|NCT04674189|82861751|FG002|Overall Study|Withdrawal by Participant|142|||
46653354|NCT04674189|82861749|FG000|Overall Study|Lost to Follow-up|55|||
46653355|NCT04674189|82861750|FG001|Overall Study|Lost to Follow-up|53|||
46653356|NCT04674189|82861751|FG002|Overall Study|Lost to Follow-up|44|||
46653357|NCT04674189|82861749|FG000|Overall Study|Miscellaneous|27|||
46653358|NCT04674189|82861750|FG001|Overall Study|Miscellaneous|23|||
46653359|NCT04674189|82861751|FG002|Overall Study|Miscellaneous|207|||
46653360|NCT04674189|82861749|FG000|Overall Study|Did Not Receive Treatment|3|||
46653361|NCT04674189|82861750|FG001|Overall Study|Did Not Receive Treatment|1|||
46653362|NCT04674189|82861751|FG002|Overall Study|Did Not Receive Treatment|2|||
46653363|NCT04380857|82861783|FG000|Overall Study|Lost to Follow-up|3|||
46653364|NCT04380857|82861784|FG001|Overall Study|Lost to Follow-up|3|||
46653365|NCT04189588|82861793|FG000|Overall Study|Death|0|||
46653366|NCT04189588|82861794|FG001|Overall Study|Death|1|||
46653367|NCT04189588|82861793|FG000|Overall Study|Lost to Follow-up|0|||
46653368|NCT04189588|82861794|FG001|Overall Study|Lost to Follow-up|1|||
46653369|NCT04162210|82861802|FG000|Overall Study|Lost to Follow-up|4|||
46653370|NCT04162210|82861803|FG001|Overall Study|Lost to Follow-up|1|||
46653371|NCT04162210|82861802|FG000|Overall Study|Withdrawal by Subject|17|||
46653372|NCT04162210|82861803|FG001|Overall Study|Withdrawal by Subject|9|||
46653373|NCT04162210|82861802|FG000|Overall Study|Ongoing|113|||
46653374|NCT04162210|82861803|FG001|Overall Study|Ongoing|59|||
46653375|NCT04010461|82861809|FG000|Overall Study|COVID based withdrawal|5|||
46653376|NCT04010461|82861809|FG000|Overall Study|Withdrawal by Subject|5|||
46653377|NCT04010461|82861809|FG000|Overall Study|Adverse Event|1|||
46653378|NCT04010461|82861809|FG000|Overall Study|No Motor Threshold obtainable|1|||
46653379|NCT04010461|82861809|FG000|Overall Study|Physician Decision|1|||
46653380|NCT03985423|82861818|FG000|Overall Study|Adverse Event|1|||
46653381|NCT03985423|82861818|FG000|Overall Study|Death|2|||
46653382|NCT03985423|82861818|FG000|Overall Study|Physician Decision|1|||
46653383|NCT03985423|82861818|FG000|Overall Study|Withdrawal by Subject|2|||
46653384|NCT03985423|82861818|FG000|Overall Study|Lack of insurance and citizenship|1|||
46653385|NCT03875092|82861824|FG000|Overall Study|Adverse Event|2|||
46653386|NCT03875092|82861825|FG001|Overall Study|Adverse Event|5|||
46653387|NCT03875092|82861824|FG000|Overall Study|Death|28|||
46653388|NCT03875092|82861825|FG001|Overall Study|Death|41|||
46653389|NCT03875092|82861824|FG000|Overall Study|Ongoing in Study|35|||
46653390|NCT03875092|82861825|FG001|Overall Study|Ongoing in Study|14|||
46653391|NCT03634072|82861833|FG000|Overall Study|Early termination of overall study|1|||
46653392|NCT03634072|82861834|FG001|Overall Study|Early termination of overall study|0|||
46653393|NCT02975882|82861874|FG000|Overall Study|Adverse Event|1|||
46653394|NCT02975882|82861875|FG001|Overall Study|Adverse Event|2|||
46653395|NCT02975882|82861876|FG002|Overall Study|Adverse Event|1|||
46653396|NCT02975882|82861877|FG003|Overall Study|Adverse Event|1|||
46653397|NCT02975882|82861874|FG000|Overall Study|Death|0|||
46781487|NCT00408499|83000073|FG004|Phase II- MTD Expansion|treatment delay|3|||
46781488|NCT00621777|83000093|FG000|Open Phase|Adverse Event|20|||
46970987|NCT02057068|83214375|FG001|Overall Study|Withdrawal by Subject|2|||
46970988|NCT02057068|83214374|FG000|Overall Study|Caregiver (CG) Health|0|||
46970989|NCT02057068|83214375|FG001|Overall Study|Caregiver (CG) Health|2|||
46970990|NCT02057068|83214374|FG000|Overall Study|Carepartner (CP) Health|4|||
46970991|NCT02057068|83214375|FG001|Overall Study|Carepartner (CP) Health|2|||
46970992|NCT02057068|83214374|FG000|Overall Study|Lost to Follow-up|2|||
46970993|NCT02057068|83214375|FG001|Overall Study|Lost to Follow-up|2|||
46970994|NCT02056834|83214383|FG000|Overall Study|Lost to Follow-up|7|||
46970995|NCT02087176|83214388|FG000|Overall Study|Withdrawal by Subject|1|||
46970996|NCT02087176|83214388|FG000|Overall Study|Death|10|||
46653398|NCT02975882|82861875|FG001|Overall Study|Death|1|||
46653399|NCT02975882|82861876|FG002|Overall Study|Death|0|||
46653400|NCT02975882|82861877|FG003|Overall Study|Death|0|||
46653401|NCT02975882|82861874|FG000|Overall Study|Lack of Efficacy|3|||
46653402|NCT02975882|82861875|FG001|Overall Study|Lack of Efficacy|7|||
46653403|NCT02975882|82861876|FG002|Overall Study|Lack of Efficacy|4|||
46653404|NCT02975882|82861877|FG003|Overall Study|Lack of Efficacy|3|||
46653405|NCT02975882|82861874|FG000|Overall Study|Physician Decision|0|||
46653406|NCT02975882|82861875|FG001|Overall Study|Physician Decision|2|||
46970997|NCT02087176|83214388|FG000|Overall Study|Censored|19|||
46653407|NCT02975882|82861876|FG002|Overall Study|Physician Decision|4|||
46653408|NCT02975882|82861877|FG003|Overall Study|Physician Decision|2|||
46653409|NCT02975882|82861874|FG000|Overall Study|Ineligible|0|||
46653410|NCT02975882|82861875|FG001|Overall Study|Ineligible|1|||
46970998|NCT02087176|83214388|FG000|Overall Study|Study Terminated by Sponsor|2|||
46653411|NCT02975882|82861876|FG002|Overall Study|Ineligible|0|||
46653412|NCT02975882|82861877|FG003|Overall Study|Ineligible|0|||
46653413|NCT02775435|82861889|FG000|Overall Study|Adverse Event|48|||
46653414|NCT02775435|82861890|FG001|Overall Study|Adverse Event|25|||
46653415|NCT02775435|82861889|FG000|Overall Study|Lost to Follow-up|0|||
46653416|NCT02775435|82861890|FG001|Overall Study|Lost to Follow-up|2|||
46653417|NCT02775435|82861889|FG000|Overall Study|Physician Decision|5|||
46653418|NCT02775435|82861890|FG001|Overall Study|Physician Decision|6|||
46653419|NCT02775435|82861889|FG000|Overall Study|Withdrawal by Subject|5|||
46653420|NCT02775435|82861890|FG001|Overall Study|Withdrawal by Subject|9|||
46653421|NCT02775435|82861889|FG000|Overall Study|Progressive Disease|86|||
46653422|NCT02775435|82861890|FG001|Overall Study|Progressive Disease|140|||
46653423|NCT02775435|82861889|FG000|Overall Study|Clinical Progression|13|||
46653424|NCT02775435|82861890|FG001|Overall Study|Clinical Progression|26|||
46653425|NCT02775435|82861889|FG000|Overall Study|Ongoing in Study|121|||
46653426|NCT02775435|82861890|FG001|Overall Study|Ongoing in Study|72|||
46653427|NCT02775435|82861889|FG000|Overall Study|Not Treated|0|||
46653428|NCT02775435|82861890|FG001|Overall Study|Not Treated|1|||
46653429|NCT02685826|82861899|FG000|Overall Study|Adverse Event|2|||
46653430|NCT02685826|82861900|FG001|Overall Study|Adverse Event|0|||
46653431|NCT02685826|82861901|FG002|Overall Study|Adverse Event|1|||
46653432|NCT02685826|82861899|FG000|Overall Study|Progressive Disease|2|||
46653433|NCT02685826|82861900|FG001|Overall Study|Progressive Disease|1|||
46653434|NCT02685826|82861901|FG002|Overall Study|Progressive Disease|0|||
46653435|NCT02685826|82861899|FG000|Overall Study|Withdrawal by Subject|2|||
46653436|NCT02685826|82861900|FG001|Overall Study|Withdrawal by Subject|0|||
46653437|NCT02685826|82861901|FG002|Overall Study|Withdrawal by Subject|0|||
46653438|NCT02685826|82861899|FG000|Overall Study|Full Clinical Hold by FDA|19|||
46653439|NCT02685826|82861900|FG001|Overall Study|Full Clinical Hold by FDA|9|||
46653440|NCT02685826|82861901|FG002|Overall Study|Full Clinical Hold by FDA|20|||
46653441|NCT01177683|82861912|FG000|Study Treatment|Disease Progressions during treatment|2|||
46653442|NCT01177683|82861913|FG001|Study Treatment|Disease Progressions during treatment|0|||
46653443|NCT01177683|82861914|FG002|Study Treatment|Disease Progressions during treatment|3|||
46653444|NCT01177683|82861912|FG000|Study Treatment|Adverse Event|0|||
46653445|NCT01177683|82861913|FG001|Study Treatment|Adverse Event|1|||
46653446|NCT01177683|82861914|FG002|Study Treatment|Adverse Event|12|||
46653447|NCT01177683|82861912|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
46653448|NCT01177683|82861913|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
46653449|NCT01177683|82861914|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
46653450|NCT01177683|82861912|FG000|Study Treatment|Alternative therapy|0|||
46653451|NCT01177683|82861913|FG001|Study Treatment|Alternative therapy|0|||
46653452|NCT01177683|82861914|FG002|Study Treatment|Alternative therapy|4|||
46653453|NCT01177683|82861912|FG000|Study Treatment|Physician Decision|1|||
46653454|NCT01177683|82861913|FG001|Study Treatment|Physician Decision|0|||
46653455|NCT01177683|82861914|FG002|Study Treatment|Physician Decision|1|||
46653456|NCT01177683|82861912|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
46653457|NCT01177683|82861913|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
46653458|NCT01177683|82861914|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
46653459|NCT01177683|82861912|FG000|Study Treatment|Symptomatic Deterioration|0|||
46653460|NCT01177683|82861913|FG001|Study Treatment|Symptomatic Deterioration|0|||
46653461|NCT01177683|82861914|FG002|Study Treatment|Symptomatic Deterioration|1|||
46653462|NCT01177683|82861912|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
46653463|NCT01177683|82861913|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
46653464|NCT01177683|82861914|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
46653465|NCT01177683|82861912|FG000|Follow up|Patient lost to follow up|0|||
46653466|NCT01177683|82861913|FG001|Follow up|Patient lost to follow up|0|||
46653467|NCT01177683|82861914|FG002|Follow up|Patient lost to follow up|2|||
46653468|NCT01177683|82861912|FG000|Follow up|Death|2|||
46653469|NCT01177683|82861913|FG001|Follow up|Death|1|||
46653470|NCT01177683|82861914|FG002|Follow up|Death|7|||
46653471|NCT01177683|82861912|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
46653472|NCT01177683|82861913|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
46653473|NCT01177683|82861914|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
46653474|NCT01084252|82861939|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
46653475|NCT01084252|82861940|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
46653476|NCT01084252|82861941|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
46653477|NCT01084252|82861942|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
46653478|NCT01084252|82861943|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
46653479|NCT01084252|82861944|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
46653480|NCT01084252|82861945|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
46653481|NCT01084252|82861946|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
46653482|NCT01084252|82861947|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
46653483|NCT01084252|82861948|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
46653484|NCT01084252|82861949|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
46653485|NCT01084252|82861950|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
46653486|NCT01084252|82861951|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
46653487|NCT01084252|82861952|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
46653488|NCT01084252|82861939|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
46653489|NCT01084252|82861940|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
46653490|NCT01084252|82861941|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
46653491|NCT01084252|82861942|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
46653492|NCT01084252|82861943|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
46653493|NCT01084252|82861944|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
46653494|NCT01084252|82861945|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
46653495|NCT01084252|82861946|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
46653496|NCT01084252|82861947|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
46653497|NCT01084252|82861948|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
46653498|NCT01084252|82861949|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
46653499|NCT01084252|82861950|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
46653500|NCT01084252|82861951|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
46653501|NCT01084252|82861952|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
46653502|NCT01084252|82861939|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
46653503|NCT01084252|82861940|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
46653504|NCT01084252|82861941|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
46653505|NCT01084252|82861942|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
46653506|NCT01084252|82861943|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
46653507|NCT01084252|82861944|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
46653508|NCT01084252|82861945|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
46653509|NCT01084252|82861946|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
46653510|NCT01084252|82861947|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
46653511|NCT01084252|82861948|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
46653512|NCT01084252|82861949|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
46653513|NCT01084252|82861950|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
46653514|NCT01084252|82861951|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
46653515|NCT01084252|82861952|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
46653516|NCT01084252|82861939|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653517|NCT01084252|82861940|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653518|NCT01084252|82861941|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653519|NCT01084252|82861942|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653520|NCT01084252|82861943|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653521|NCT01084252|82861944|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653522|NCT01084252|82861945|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653523|NCT01084252|82861946|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653524|NCT01084252|82861947|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653525|NCT01084252|82861948|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
46653526|NCT01084252|82861949|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
46653527|NCT01084252|82861950|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
46653528|NCT01084252|82861951|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653529|NCT01084252|82861952|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
46653530|NCT01084252|82861939|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653531|NCT01084252|82861940|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653532|NCT01084252|82861941|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653533|NCT01084252|82861942|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653534|NCT01084252|82861943|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653535|NCT01084252|82861944|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653536|NCT01084252|82861945|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653537|NCT01084252|82861946|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653538|NCT01084252|82861947|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
46653539|NCT01084252|82861948|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
46653540|NCT01084252|82861949|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
46653541|NCT01084252|82861950|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
46653542|NCT01084252|82861951|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46653543|NCT01084252|82861952|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
46970999|NCT02056288|83214394|FG000|In-Hospital Data|Surgery cancelled|1|||
46971000|NCT02056288|83214395|FG001|In-Hospital Data|Surgery cancelled|0|||
46971001|NCT02056288|83214394|FG000|In-Hospital Data|Protocol Violation|3|||
47075551|NCT00987623|83370178|FG000|Overall Study|Influenza|0|||
47075552|NCT00987623|83370179|FG001|Overall Study|Influenza|1|||
47075553|NCT00987467|83370185|FG000|Overall Study|Lost to Follow-up|2|||
47075554|NCT04990440|83370193|FG000|Overall Study|Sponsor's Decision|0|||
46653544|NCT01084252|82861939|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653545|NCT01084252|82861940|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46971002|NCT02056288|83214395|FG001|In-Hospital Data|Protocol Violation|0|||
47075555|NCT04990440|83370194|FG001|Overall Study|Sponsor's Decision|0|||
47075556|NCT04990440|83370195|FG002|Overall Study|Sponsor's Decision|1|||
46653546|NCT01084252|82861941|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653547|NCT01084252|82861942|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653548|NCT01084252|82861943|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653549|NCT01084252|82861944|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653550|NCT01084252|82861945|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653551|NCT01084252|82861946|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653552|NCT01084252|82861947|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
46653553|NCT01084252|82861948|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653554|NCT01084252|82861949|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
46653555|NCT01084252|82861950|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
46653556|NCT01084252|82861951|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653557|NCT01084252|82861952|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
46653558|NCT01084252|82861939|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653559|NCT01084252|82861940|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653560|NCT01084252|82861941|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653561|NCT01084252|82861942|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653562|NCT01084252|82861943|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653563|NCT01084252|82861944|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653564|NCT01084252|82861945|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653565|NCT01084252|82861946|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
47075557|NCT04829747|83370203|FG000|Overall Study|Protocol Violation|1|||
47075558|NCT04258423|83370241|FG000|Overall Study|Study Closure|2|||
47075559|NCT04258423|83370242|FG001|Overall Study|Study Closure|2|||
47075560|NCT04178967|83370250|FG000|Induction Period|Adverse Event|4|||
47075561|NCT04178967|83370251|FG001|Induction Period|Adverse Event|6|||
47075562|NCT04178967|83370252|FG002|Induction Period|Adverse Event|0|||
47075563|NCT04178967|83370253|FG003|Induction Period|Adverse Event|0|||
47075564|NCT04178967|83370254|FG004|Induction Period|Adverse Event|0|||
47075565|NCT04178967|83370255|FG005|Induction Period|Adverse Event|0|||
47075566|NCT04178967|83370256|FG006|Induction Period|Adverse Event|0|||
46653566|NCT01084252|82861947|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
46653567|NCT01084252|82861948|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
46653568|NCT01084252|82861949|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
46653569|NCT01084252|82861950|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
46653570|NCT01084252|82861951|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653571|NCT01084252|82861952|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
46653572|NCT01084252|82861939|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653573|NCT01084252|82861940|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
47075567|NCT04178967|83370257|FG007|Induction Period|Adverse Event|0|||
47075568|NCT04178967|83370258|FG008|Induction Period|Adverse Event|0|||
47075569|NCT04178967|83370259|FG009|Induction Period|Adverse Event|0|||
47075570|NCT04178967|83370260|FG010|Induction Period|Adverse Event|0|||
46653574|NCT01084252|82861941|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653575|NCT01084252|82861942|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653576|NCT01084252|82861943|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653577|NCT01084252|82861944|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653578|NCT01084252|82861945|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46781489|NCT00621777|83000094|FG001|Open Phase|Adverse Event|0|||
46781490|NCT00621777|83000093|FG000|Open Phase|Did not abstain during open phase|56|||
46781491|NCT00621777|83000094|FG001|Open Phase|Did not abstain during open phase|0|||
46781492|NCT00621777|83000093|FG000|Open Phase|Withdrawal by Subject|17|||
46781493|NCT00621777|83000094|FG001|Open Phase|Withdrawal by Subject|0|||
46781494|NCT00621777|83000093|FG000|Open Phase|administrative|13|||
46781495|NCT00621777|83000094|FG001|Open Phase|administrative|0|||
46781496|NCT00621777|83000093|FG000|Open Phase|Lost to Follow-up|10|||
46781497|NCT00621777|83000094|FG001|Open Phase|Lost to Follow-up|0|||
46781498|NCT00621777|83000093|FG000|Randomized Phase|Adverse Event|3|||
46781499|NCT00621777|83000094|FG001|Randomized Phase|Adverse Event|3|||
46781500|NCT00621777|83000093|FG000|Randomized Phase|Lost to Follow-up|3|||
46781501|NCT00621777|83000094|FG001|Randomized Phase|Lost to Follow-up|3|||
46781502|NCT00621777|83000093|FG000|Randomized Phase|Withdrawal by Subject|1|||
46781503|NCT00621777|83000094|FG001|Randomized Phase|Withdrawal by Subject|9|||
46781504|NCT00621777|83000093|FG000|Randomized Phase|administrative|0|||
46781505|NCT00621777|83000094|FG001|Randomized Phase|administrative|3|||
46781506|NCT00621777|83000093|FG000|Randomized Phase|Death|0|||
46781507|NCT00621777|83000094|FG001|Randomized Phase|Death|1|||
46781508|NCT00408421|83000104|FG000|Treatment Initial Randomization|Adverse Event|5|||
46781509|NCT00408421|83000105|FG001|Treatment Initial Randomization|Adverse Event|9|||
46781510|NCT00408421|83000106|FG002|Treatment Initial Randomization|Adverse Event|0|||
46781511|NCT00408421|83000104|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
46781512|NCT00408421|83000105|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
46781513|NCT00408421|83000106|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
46781514|NCT00408421|83000104|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
46781515|NCT00408421|83000105|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
46781516|NCT00408421|83000106|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
46781517|NCT00408421|83000104|FG000|Treatment Initial Randomization|Physician Decision|1|||
46781518|NCT00408421|83000105|FG001|Treatment Initial Randomization|Physician Decision|0|||
46781519|NCT00408421|83000106|FG002|Treatment Initial Randomization|Physician Decision|0|||
46781520|NCT00408421|83000104|FG000|Treatment Initial Randomization|Protocol Violation|0|||
46781521|NCT00408421|83000105|FG001|Treatment Initial Randomization|Protocol Violation|1|||
46781522|NCT00408421|83000106|FG002|Treatment Initial Randomization|Protocol Violation|0|||
46781523|NCT00408421|83000104|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
46781524|NCT00408421|83000105|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
46781525|NCT00408421|83000106|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
46781526|NCT00408421|83000104|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
46781527|NCT00408421|83000105|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
46781528|NCT00408421|83000106|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
46781529|NCT00408421|83000104|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
46781530|NCT00408421|83000105|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
46781531|NCT00408421|83000106|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
46781532|NCT00408421|83000104|FG000|Treatment Re-Randomization|Adverse Event|2|||
46781533|NCT00408421|83000105|FG001|Treatment Re-Randomization|Adverse Event|2|||
46781534|NCT00408421|83000106|FG002|Treatment Re-Randomization|Adverse Event|4|||
46781535|NCT00408421|83000104|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
46781536|NCT00408421|83000105|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
46781537|NCT00408421|83000106|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
46781538|NCT00408421|83000104|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
46781539|NCT00408421|83000105|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
46781540|NCT00408421|83000106|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
46781541|NCT00408421|83000104|FG000|Treatment Re-Randomization|Physician Decision|1|||
46781542|NCT00408421|83000105|FG001|Treatment Re-Randomization|Physician Decision|3|||
46781543|NCT00408421|83000106|FG002|Treatment Re-Randomization|Physician Decision|0|||
46781544|NCT00408421|83000104|FG000|Treatment Re-Randomization|Protocol Violation|1|||
46653579|NCT01084252|82861946|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653580|NCT01084252|82861947|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653581|NCT01084252|82861948|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653582|NCT01084252|82861949|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653583|NCT01084252|82861950|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
46653584|NCT01084252|82861951|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
46653585|NCT01084252|82861952|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
46653586|NCT01084252|82861939|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653587|NCT01084252|82861940|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653588|NCT01084252|82861941|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653589|NCT01084252|82861942|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653590|NCT01084252|82861943|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653591|NCT01084252|82861944|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653592|NCT01084252|82861945|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653593|NCT01084252|82861946|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653594|NCT01084252|82861947|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653595|NCT01084252|82861948|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653596|NCT01084252|82861949|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653597|NCT01084252|82861950|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
46653598|NCT01084252|82861951|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
46653599|NCT01084252|82861952|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
46653600|NCT01084252|82861939|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653601|NCT01084252|82861940|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653602|NCT01084252|82861941|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653603|NCT01084252|82861942|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653604|NCT01084252|82861943|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653605|NCT01084252|82861944|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653606|NCT01084252|82861945|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653607|NCT01084252|82861946|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653608|NCT01084252|82861947|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653609|NCT01084252|82861948|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653610|NCT01084252|82861949|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653611|NCT01084252|82861950|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653612|NCT01084252|82861951|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
46653613|NCT01084252|82861952|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
46653614|NCT01084252|82861939|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653615|NCT01084252|82861940|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653616|NCT01084252|82861941|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653617|NCT01084252|82861942|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653618|NCT01084252|82861943|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653619|NCT01084252|82861944|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653620|NCT01084252|82861945|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653621|NCT01084252|82861946|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46850817|NCT03619174|83066643|FG001|Overall Study|Withdrawal by Subject|3|||
46850818|NCT03619174|83066642|FG000|Overall Study|Pregnancy|1|||
46850819|NCT03619174|83066643|FG001|Overall Study|Pregnancy|1|||
46850820|NCT03619174|83066642|FG000|Overall Study|Discomfort during treatment|1|||
46850821|NCT03619174|83066643|FG001|Overall Study|Discomfort during treatment|0|||
46653622|NCT01084252|82861947|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653623|NCT01084252|82861948|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653624|NCT01084252|82861949|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653625|NCT01084252|82861950|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
46653626|NCT01084252|82861951|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
46653627|NCT01084252|82861952|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
46653628|NCT01084252|82861939|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653629|NCT01084252|82861940|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653630|NCT01084252|82861941|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653631|NCT01084252|82861942|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653632|NCT01084252|82861943|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653633|NCT01084252|82861944|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653634|NCT01084252|82861945|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653635|NCT01084252|82861946|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653636|NCT01084252|82861947|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653637|NCT01084252|82861948|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653638|NCT01084252|82861949|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653639|NCT01084252|82861950|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
46653640|NCT01084252|82861951|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
46850822|NCT00112047|83066651|FG000|Randomized Phase|Lost to Follow-up|26|||
46971003|NCT02056288|83214394|FG000|In-Hospital Data|Physician Decision|1|||
46653641|NCT01084252|82861952|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
46653642|NCT01084252|82861939|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653643|NCT01084252|82861940|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653644|NCT01084252|82861941|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653645|NCT01084252|82861942|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653646|NCT01084252|82861943|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653647|NCT01084252|82861944|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653648|NCT01084252|82861945|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653649|NCT01084252|82861946|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653650|NCT01084252|82861947|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653651|NCT01084252|82861948|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653652|NCT01084252|82861949|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653653|NCT01084252|82861950|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653654|NCT01084252|82861951|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
46653655|NCT01084252|82861952|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
46653656|NCT00993044|82862016|FG000|Irinotecan 50 mg|Physician Decision|1|||
46653657|NCT00116272|82862023|FG000|Overall Study|Lost to Follow-up|11|||
46653658|NCT00116272|82862024|FG001|Overall Study|Lost to Follow-up|6|||
46653659|NCT01945021|82862032|FG000|Overall Study|Adverse Event|1|||
46653660|NCT01945021|82862032|FG000|Overall Study|Withdrawal of consent|12|||
46653661|NCT01945021|82862032|FG000|Overall Study|Lost to Follow-up|5|||
46653662|NCT01945021|82862032|FG000|Overall Study|Death|65|||
46653663|NCT01945060|82862038|FG000|Overall Study|Lost to follow up|1|||
46653664|NCT01945060|82862039|FG001|Overall Study|Lost to follow up|0|||
46653665|NCT01945060|82862038|FG000|Overall Study|Distress related to IV access|0|||
46653666|NCT01945060|82862039|FG001|Overall Study|Distress related to IV access|1|||
46653667|NCT03951077|82862082|FG000|Overall Study|Adverse Event|1|||
46653668|NCT03951077|82862083|FG001|Overall Study|Adverse Event|0|||
46653669|NCT03951077|82862084|FG002|Overall Study|Adverse Event|0|||
46653670|NCT03951077|82862085|FG003|Overall Study|Adverse Event|0|||
46653671|NCT03951077|82862086|FG004|Overall Study|Adverse Event|0|||
46653672|NCT03951077|82862087|FG005|Overall Study|Adverse Event|0|||
46653673|NCT03951077|82862082|FG000|Overall Study|Withdrawal by Subject|3|||
46653674|NCT03951077|82862083|FG001|Overall Study|Withdrawal by Subject|3|||
46653675|NCT03951077|82862084|FG002|Overall Study|Withdrawal by Subject|0|||
46653676|NCT03951077|82862085|FG003|Overall Study|Withdrawal by Subject|3|||
46653677|NCT03951077|82862086|FG004|Overall Study|Withdrawal by Subject|3|||
46653678|NCT03951077|82862087|FG005|Overall Study|Withdrawal by Subject|2|||
46653679|NCT03951077|82862082|FG000|Overall Study|Lost to Follow-up|1|||
46653680|NCT03951077|82862083|FG001|Overall Study|Lost to Follow-up|1|||
46653681|NCT03951077|82862084|FG002|Overall Study|Lost to Follow-up|2|||
46653682|NCT03951077|82862085|FG003|Overall Study|Lost to Follow-up|3|||
46653683|NCT03951077|82862086|FG004|Overall Study|Lost to Follow-up|2|||
46653684|NCT03951077|82862087|FG005|Overall Study|Lost to Follow-up|3|||
46653685|NCT03951077|82862082|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
46653686|NCT03951077|82862083|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
46653687|NCT03951077|82862084|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
46653688|NCT03951077|82862085|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
46653689|NCT03951077|82862086|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
46653690|NCT03951077|82862087|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
46653691|NCT03951077|82862082|FG000|Overall Study|Other, Not Specified|12|||
46653692|NCT03951077|82862083|FG001|Overall Study|Other, Not Specified|10|||
46653693|NCT03951077|82862084|FG002|Overall Study|Other, Not Specified|10|||
46653694|NCT03951077|82862085|FG003|Overall Study|Other, Not Specified|5|||
46653695|NCT03951077|82862086|FG004|Overall Study|Other, Not Specified|9|||
46653696|NCT03951077|82862087|FG005|Overall Study|Other, Not Specified|6|||
46653697|NCT03951077|82862082|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
46653698|NCT03951077|82862083|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
46653699|NCT03951077|82862084|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
46653700|NCT03951077|82862085|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
46653701|NCT03951077|82862086|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
46653702|NCT03951077|82862087|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
46653703|NCT03873246|82862104|FG000|Overall Study|Adverse Event|1|||
46653704|NCT03873246|82862105|FG001|Overall Study|Adverse Event|3|||
46653705|NCT03873246|82862106|FG002|Overall Study|Adverse Event|3|||
46653706|NCT03873246|82862104|FG000|Overall Study|Lost to Follow-up|4|||
46653707|NCT03873246|82862105|FG001|Overall Study|Lost to Follow-up|4|||
46653708|NCT03873246|82862106|FG002|Overall Study|Lost to Follow-up|5|||
46653709|NCT03873246|82862104|FG000|Overall Study|Protocol Violation|0|||
46653710|NCT03873246|82862105|FG001|Overall Study|Protocol Violation|1|||
46653711|NCT03873246|82862106|FG002|Overall Study|Protocol Violation|0|||
46653712|NCT03873246|82862104|FG000|Overall Study|Withdrawal by Subject|0|||
46653713|NCT03873246|82862105|FG001|Overall Study|Withdrawal by Subject|4|||
46653714|NCT03873246|82862106|FG002|Overall Study|Withdrawal by Subject|1|||
46653715|NCT03769649|82862115|FG000|Overall Study|Lost to Follow-up|4|||
46653716|NCT02862548|82862141|FG000|Randomized Phase (Up to Week 48)|Death|0|||
46653717|NCT02862548|82862142|FG001|Randomized Phase (Up to Week 48)|Death|1|||
46653718|NCT02862548|82862141|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
46653719|NCT02862548|82862142|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
46653720|NCT02862548|82862141|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
46653721|NCT02862548|82862142|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
46653722|NCT02862548|82862141|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
46653723|NCT02862548|82862142|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
46653724|NCT02335099|82862161|FG000|Treatment|Withdrawal by Subject|1|||
46653725|NCT02335099|82862162|FG001|Treatment|Withdrawal by Subject|3|||
46653726|NCT02335099|82862161|FG000|Treatment|Lost to Follow-up|2|||
46653727|NCT02335099|82862162|FG001|Treatment|Lost to Follow-up|0|||
46653728|NCT02335099|82862161|FG000|Treatment|Death|1|||
46653729|NCT02335099|82862162|FG001|Treatment|Death|0|||
46653730|NCT02335099|82862161|FG000|Treatment|Adverse Event|1|||
46653731|NCT02335099|82862162|FG001|Treatment|Adverse Event|2|||
46653732|NCT02335099|82862161|FG000|Follow-up|Death|0|||
46653733|NCT02335099|82862162|FG001|Follow-up|Death|1|||
46653734|NCT02330562|82862179|FG000|Overall Study|Adverse Event|0|||
46653735|NCT02330562|82862180|FG001|Overall Study|Adverse Event|0|||
46653736|NCT02330562|82862181|FG002|Overall Study|Adverse Event|3|||
46653737|NCT02330562|82862182|FG003|Overall Study|Adverse Event|0|||
46653738|NCT02330562|82862183|FG004|Overall Study|Adverse Event|3|||
46653739|NCT02330562|82862184|FG005|Overall Study|Adverse Event|1|||
46653740|NCT02330562|82862185|FG006|Overall Study|Adverse Event|0|||
46653741|NCT02330562|82862186|FG007|Overall Study|Adverse Event|0|||
46653742|NCT02330562|82862187|FG008|Overall Study|Adverse Event|0|||
46653743|NCT02330562|82862188|FG009|Overall Study|Adverse Event|1|||
46653744|NCT02330562|82862189|FG010|Overall Study|Adverse Event|1|||
46653745|NCT02330562|82862179|FG000|Overall Study|Participant decision|1|||
46653746|NCT02330562|82862180|FG001|Overall Study|Participant decision|0|||
46653747|NCT02330562|82862181|FG002|Overall Study|Participant decision|4|||
46653748|NCT02330562|82862182|FG003|Overall Study|Participant decision|1|||
46653749|NCT02330562|82862183|FG004|Overall Study|Participant decision|5|||
46653750|NCT02330562|82862184|FG005|Overall Study|Participant decision|2|||
46653751|NCT02330562|82862185|FG006|Overall Study|Participant decision|0|||
46653752|NCT02330562|82862186|FG007|Overall Study|Participant decision|0|||
46653753|NCT02330562|82862187|FG008|Overall Study|Participant decision|0|||
46653754|NCT02330562|82862188|FG009|Overall Study|Participant decision|3|||
46653755|NCT02330562|82862189|FG010|Overall Study|Participant decision|0|||
46653756|NCT02330562|82862179|FG000|Overall Study|Disease progression|5|||
46653757|NCT02330562|82862180|FG001|Overall Study|Disease progression|3|||
46653758|NCT02330562|82862181|FG002|Overall Study|Disease progression|20|||
46653759|NCT02330562|82862182|FG003|Overall Study|Disease progression|28|||
46653760|NCT02330562|82862183|FG004|Overall Study|Disease progression|23|||
46653761|NCT02330562|82862184|FG005|Overall Study|Disease progression|7|||
46653762|NCT02330562|82862185|FG006|Overall Study|Disease progression|1|||
46653763|NCT02330562|82862186|FG007|Overall Study|Disease progression|1|||
46653764|NCT02330562|82862187|FG008|Overall Study|Disease progression|1|||
46653765|NCT02330562|82862188|FG009|Overall Study|Disease progression|0|||
46653766|NCT02330562|82862189|FG010|Overall Study|Disease progression|5|||
46653767|NCT02330562|82862179|FG000|Overall Study|Other reasons|0|||
46653768|NCT02330562|82862180|FG001|Overall Study|Other reasons|0|||
46653769|NCT02330562|82862181|FG002|Overall Study|Other reasons|0|||
46653770|NCT02330562|82862182|FG003|Overall Study|Other reasons|1|||
46653771|NCT02330562|82862183|FG004|Overall Study|Other reasons|0|||
46653772|NCT02330562|82862184|FG005|Overall Study|Other reasons|0|||
46653773|NCT02330562|82862185|FG006|Overall Study|Other reasons|0|||
46653774|NCT02330562|82862186|FG007|Overall Study|Other reasons|0|||
46653775|NCT02330562|82862187|FG008|Overall Study|Other reasons|0|||
46653776|NCT02330562|82862188|FG009|Overall Study|Other reasons|0|||
46781545|NCT00408421|83000105|FG001|Treatment Re-Randomization|Protocol Violation|1|||
46781546|NCT00408421|83000106|FG002|Treatment Re-Randomization|Protocol Violation|0|||
46653777|NCT02330562|82862189|FG010|Overall Study|Other reasons|0|||
46653778|NCT02330562|82862179|FG000|Overall Study|Withdrawal by Subject|0|||
46653779|NCT02330562|82862180|FG001|Overall Study|Withdrawal by Subject|0|||
46653780|NCT02330562|82862181|FG002|Overall Study|Withdrawal by Subject|0|||
46653781|NCT02330562|82862182|FG003|Overall Study|Withdrawal by Subject|0|||
46653782|NCT02330562|82862183|FG004|Overall Study|Withdrawal by Subject|0|||
46653783|NCT02330562|82862184|FG005|Overall Study|Withdrawal by Subject|0|||
46653784|NCT02330562|82862185|FG006|Overall Study|Withdrawal by Subject|0|||
46653785|NCT02330562|82862186|FG007|Overall Study|Withdrawal by Subject|0|||
46653786|NCT02330562|82862187|FG008|Overall Study|Withdrawal by Subject|0|||
46653787|NCT02330562|82862188|FG009|Overall Study|Withdrawal by Subject|1|||
46653788|NCT02330562|82862189|FG010|Overall Study|Withdrawal by Subject|0|||
46653789|NCT03703102|82862303|FG000|Overall Study|Adverse Event|4|||
46653790|NCT03703102|82862304|FG001|Overall Study|Adverse Event|3|||
46653791|NCT03703102|82862305|FG002|Overall Study|Adverse Event|7|||
46653792|NCT03703102|82862306|FG003|Overall Study|Adverse Event|3|||
46653793|NCT03703102|82862307|FG004|Overall Study|Adverse Event|13|||
46653794|NCT03703102|82862303|FG000|Overall Study|Lack of Efficacy|4|||
46653795|NCT03703102|82862304|FG001|Overall Study|Lack of Efficacy|0|||
46653796|NCT03703102|82862305|FG002|Overall Study|Lack of Efficacy|1|||
46653797|NCT03703102|82862306|FG003|Overall Study|Lack of Efficacy|4|||
46653798|NCT03703102|82862307|FG004|Overall Study|Lack of Efficacy|1|||
46653799|NCT03703102|82862303|FG000|Overall Study|Lost to Follow-up|0|||
46653800|NCT03703102|82862304|FG001|Overall Study|Lost to Follow-up|0|||
46653801|NCT03703102|82862305|FG002|Overall Study|Lost to Follow-up|1|||
46653802|NCT03703102|82862306|FG003|Overall Study|Lost to Follow-up|2|||
46653803|NCT03703102|82862307|FG004|Overall Study|Lost to Follow-up|2|||
46653804|NCT03703102|82862303|FG000|Overall Study|Physician Decision|2|||
46653805|NCT03703102|82862304|FG001|Overall Study|Physician Decision|2|||
46653806|NCT03703102|82862305|FG002|Overall Study|Physician Decision|2|||
46653807|NCT03703102|82862306|FG003|Overall Study|Physician Decision|2|||
46653808|NCT03703102|82862307|FG004|Overall Study|Physician Decision|4|||
46653809|NCT03703102|82862303|FG000|Overall Study|Withdrawal by Subject|7|||
46653810|NCT03703102|82862304|FG001|Overall Study|Withdrawal by Subject|5|||
46653811|NCT03703102|82862305|FG002|Overall Study|Withdrawal by Subject|5|||
46653812|NCT03703102|82862306|FG003|Overall Study|Withdrawal by Subject|5|||
46653813|NCT03703102|82862307|FG004|Overall Study|Withdrawal by Subject|9|||
46653814|NCT03703102|82862303|FG000|Overall Study|Ineligibility|0|||
46653815|NCT03703102|82862304|FG001|Overall Study|Ineligibility|0|||
46653816|NCT03703102|82862305|FG002|Overall Study|Ineligibility|1|||
46653817|NCT03703102|82862306|FG003|Overall Study|Ineligibility|0|||
46653818|NCT03703102|82862307|FG004|Overall Study|Ineligibility|0|||
46653819|NCT03703102|82862303|FG000|Overall Study|Protocol Deviation|4|||
46653820|NCT03703102|82862304|FG001|Overall Study|Protocol Deviation|4|||
46653821|NCT03703102|82862305|FG002|Overall Study|Protocol Deviation|3|||
46653822|NCT03703102|82862306|FG003|Overall Study|Protocol Deviation|0|||
46653823|NCT03703102|82862307|FG004|Overall Study|Protocol Deviation|0|||
46653824|NCT03703102|82862303|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46653825|NCT03703102|82862304|FG001|Overall Study|Non-Compliance with Study Drug|1|||
46653826|NCT03703102|82862305|FG002|Overall Study|Non-Compliance with Study Drug|2|||
46653827|NCT03703102|82862306|FG003|Overall Study|Non-Compliance with Study Drug|1|||
46653828|NCT03703102|82862307|FG004|Overall Study|Non-Compliance with Study Drug|4|||
46653829|NCT03395704|82862326|FG000|Overall Study|Adverse Event|2|||
46653830|NCT03395704|82862327|FG001|Overall Study|Adverse Event|1|||
46653831|NCT03395704|82862326|FG000|Overall Study|Withdrawal by Subject|2|||
46653832|NCT03395704|82862327|FG001|Overall Study|Withdrawal by Subject|1|||
46653833|NCT03395704|82862326|FG000|Overall Study|Physician Decision|0|||
46653834|NCT03395704|82862327|FG001|Overall Study|Physician Decision|1|||
46653835|NCT03335813|82862333|FG000|Overall Study|Withdrawal by Subject|1|||
46653836|NCT03246503|82862337|FG000|Overall Study|Lost to Follow-up|23|||
46653837|NCT03246503|82862337|FG000|Overall Study|Withdrawal by Subject|20|||
46653838|NCT03246503|82862337|FG000|Overall Study|Physician Decision|5|||
46653839|NCT03246503|82862337|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
46781547|NCT00408421|83000104|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
46781548|NCT00408421|83000105|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
46781549|NCT00408421|83000106|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
46781550|NCT00604786|83000116|FG000|Overall Study|Lost to Follow-up|2|||
46781551|NCT00604786|83000117|FG001|Overall Study|Lost to Follow-up|0|||
46781552|NCT00407797|83000123|FG000|Overall Study|Lost to Follow-up|2|||
46781553|NCT00407797|83000123|FG000|Overall Study|Adverse Event|6|||
46781554|NCT00407797|83000123|FG000|Overall Study|Other|7|||
46781555|NCT00407797|83000123|FG000|Overall Study|Withdrawal by Subject|3|||
46781556|NCT00568126|83000129|FG000|Overall Study|Adverse Event|3|||
46781557|NCT00568126|83000130|FG001|Overall Study|Adverse Event|0|||
46781558|NCT00568126|83000129|FG000|Overall Study|Withdrawal by Subject|2|||
46781559|NCT00568126|83000130|FG001|Overall Study|Withdrawal by Subject|3|||
46653840|NCT02514447|82862398|FG000|Overall Study|Withdrawal by Subject|3|||
46653841|NCT02514447|82862399|FG001|Overall Study|Withdrawal by Subject|1|||
46653842|NCT02514447|82862400|FG002|Overall Study|Withdrawal by Subject|1|||
46653843|NCT02514447|82862401|FG003|Overall Study|Withdrawal by Subject|0|||
46653844|NCT02514447|82862402|FG004|Overall Study|Withdrawal by Subject|0|||
46653845|NCT02514447|82862403|FG005|Overall Study|Withdrawal by Subject|0|||
46653846|NCT02514447|82862404|FG006|Overall Study|Withdrawal by Subject|0|||
46653847|NCT02514447|82862405|FG007|Overall Study|Withdrawal by Subject|1|||
46653848|NCT02514447|82862406|FG008|Overall Study|Withdrawal by Subject|1|||
46653849|NCT02514447|82862398|FG000|Overall Study|Death|24|||
46653850|NCT02514447|82862399|FG001|Overall Study|Death|28|||
46653851|NCT02514447|82862400|FG002|Overall Study|Death|29|||
46781560|NCT00568126|83000129|FG000|Overall Study|Lost to Follow-up|4|||
46781561|NCT00568126|83000130|FG001|Overall Study|Lost to Follow-up|3|||
46781562|NCT00568126|83000129|FG000|Overall Study|Lack of Efficacy|0|||
46781563|NCT00568126|83000130|FG001|Overall Study|Lack of Efficacy|1|||
46653852|NCT02514447|82862401|FG003|Overall Study|Death|0|||
46653853|NCT02514447|82862402|FG004|Overall Study|Death|3|||
46653854|NCT02514447|82862403|FG005|Overall Study|Death|4|||
46653855|NCT02514447|82862404|FG006|Overall Study|Death|8|||
46653856|NCT02514447|82862405|FG007|Overall Study|Death|6|||
46653857|NCT02514447|82862406|FG008|Overall Study|Death|5|||
46653858|NCT02514447|82862398|FG000|Overall Study|Lost to Follow-up|1|||
46653859|NCT02514447|82862399|FG001|Overall Study|Lost to Follow-up|0|||
47075571|NCT04178967|83370250|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
47075572|NCT04178967|83370251|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
47075573|NCT04178967|83370252|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
47075574|NCT04178967|83370253|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
47075575|NCT04178967|83370254|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
46653860|NCT02514447|82862400|FG002|Overall Study|Lost to Follow-up|0|||
46653861|NCT02514447|82862401|FG003|Overall Study|Lost to Follow-up|0|||
46653862|NCT02514447|82862402|FG004|Overall Study|Lost to Follow-up|0|||
46653863|NCT02514447|82862403|FG005|Overall Study|Lost to Follow-up|0|||
46653864|NCT02514447|82862404|FG006|Overall Study|Lost to Follow-up|0|||
46653865|NCT02514447|82862405|FG007|Overall Study|Lost to Follow-up|0|||
46653866|NCT02514447|82862406|FG008|Overall Study|Lost to Follow-up|1|||
46653867|NCT02514447|82862398|FG000|Overall Study|Sponsor Termination of Study|0|||
46653868|NCT02514447|82862399|FG001|Overall Study|Sponsor Termination of Study|1|||
46653869|NCT02514447|82862400|FG002|Overall Study|Sponsor Termination of Study|1|||
46653870|NCT02514447|82862401|FG003|Overall Study|Sponsor Termination of Study|0|||
46653871|NCT02514447|82862402|FG004|Overall Study|Sponsor Termination of Study|0|||
46653872|NCT02514447|82862403|FG005|Overall Study|Sponsor Termination of Study|0|||
46653873|NCT02514447|82862404|FG006|Overall Study|Sponsor Termination of Study|0|||
46653874|NCT02514447|82862405|FG007|Overall Study|Sponsor Termination of Study|0|||
46653875|NCT02514447|82862406|FG008|Overall Study|Sponsor Termination of Study|0|||
46653876|NCT02514447|82862398|FG000|Overall Study|Study completion per Investigator|1|||
46653877|NCT02514447|82862399|FG001|Overall Study|Study completion per Investigator|0|||
46653878|NCT02514447|82862400|FG002|Overall Study|Study completion per Investigator|1|||
46653879|NCT02514447|82862401|FG003|Overall Study|Study completion per Investigator|2|||
46653880|NCT02514447|82862402|FG004|Overall Study|Study completion per Investigator|0|||
46653881|NCT02514447|82862403|FG005|Overall Study|Study completion per Investigator|0|||
46653882|NCT02514447|82862404|FG006|Overall Study|Study completion per Investigator|0|||
46653883|NCT02514447|82862405|FG007|Overall Study|Study completion per Investigator|0|||
46653884|NCT02514447|82862406|FG008|Overall Study|Study completion per Investigator|1|||
46653885|NCT01785563|82862450|FG000|Overall Study|Physician Decision|10|||
46653886|NCT01785563|82862450|FG000|Overall Study|Withdrawal by Subject|1|||
46653887|NCT01785563|82862450|FG000|Overall Study|Protocol Violation|2|||
46653888|NCT01434290|82862456|FG000|Overall Study|Protocol Violation|6|||
46653889|NCT01434290|82862457|FG001|Overall Study|Protocol Violation|3|||
46653890|NCT01434290|82862456|FG000|Overall Study|No protocol treatment|2|||
46653891|NCT01434290|82862457|FG001|Overall Study|No protocol treatment|4|||
46653892|NCT00750269|82862469|FG000|Overall Study|Protocol Violation|0|||
46653893|NCT00750269|82862470|FG001|Overall Study|Protocol Violation|1|||
46653894|NCT00750269|82862471|FG002|Overall Study|Protocol Violation|1|||
46653895|NCT00750269|82862472|FG003|Overall Study|Protocol Violation|2|||
46653896|NCT00750269|82862473|FG004|Overall Study|Protocol Violation|4|||
46653897|NCT00750269|82862469|FG000|Overall Study|Withdrawal by Subject|0|||
46653898|NCT00750269|82862470|FG001|Overall Study|Withdrawal by Subject|0|||
46653899|NCT00750269|82862471|FG002|Overall Study|Withdrawal by Subject|2|||
46653900|NCT00750269|82862472|FG003|Overall Study|Withdrawal by Subject|2|||
46653901|NCT00750269|82862473|FG004|Overall Study|Withdrawal by Subject|2|||
46653902|NCT00750269|82862469|FG000|Overall Study|Physician Decision|0|||
46653903|NCT00750269|82862470|FG001|Overall Study|Physician Decision|0|||
46653904|NCT00750269|82862471|FG002|Overall Study|Physician Decision|0|||
46653905|NCT00750269|82862472|FG003|Overall Study|Physician Decision|0|||
46781564|NCT00568126|83000129|FG000|Overall Study|Physician Decision|2|||
47075576|NCT04178967|83370255|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
47075577|NCT04178967|83370256|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
47075578|NCT04178967|83370257|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
46653906|NCT00750269|82862473|FG004|Overall Study|Physician Decision|2|||
46653907|NCT00750269|82862469|FG000|Overall Study|Patient too large for positioning|0|||
47075579|NCT04178967|83370258|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
47075580|NCT04178967|83370259|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
47075581|NCT04178967|83370260|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
46653908|NCT00750269|82862470|FG001|Overall Study|Patient too large for positioning|0|||
46653909|NCT00750269|82862471|FG002|Overall Study|Patient too large for positioning|1|||
46653910|NCT00750269|82862472|FG003|Overall Study|Patient too large for positioning|0|||
46653911|NCT00750269|82862473|FG004|Overall Study|Patient too large for positioning|0|||
46653912|NCT00750269|82862469|FG000|Overall Study|Site error|0|||
46653913|NCT00750269|82862470|FG001|Overall Study|Site error|0|||
46653914|NCT00750269|82862471|FG002|Overall Study|Site error|0|||
46653915|NCT00750269|82862472|FG003|Overall Study|Site error|1|||
46653916|NCT00750269|82862473|FG004|Overall Study|Site error|0|||
46653917|NCT00750269|82862469|FG000|Overall Study|SBRT plan could not be drawn|0|||
46653918|NCT00750269|82862470|FG001|Overall Study|SBRT plan could not be drawn|0|||
46653919|NCT00750269|82862471|FG002|Overall Study|SBRT plan could not be drawn|0|||
46653920|NCT00750269|82862472|FG003|Overall Study|SBRT plan could not be drawn|0|||
46653921|NCT00750269|82862473|FG004|Overall Study|SBRT plan could not be drawn|1|||
46653922|NCT00750269|82862469|FG000|Overall Study|Fiducials could not be placed|0|||
46653923|NCT00750269|82862470|FG001|Overall Study|Fiducials could not be placed|0|||
46653924|NCT00750269|82862471|FG002|Overall Study|Fiducials could not be placed|0|||
46653925|NCT00750269|82862472|FG003|Overall Study|Fiducials could not be placed|0|||
46653926|NCT00750269|82862473|FG004|Overall Study|Fiducials could not be placed|1|||
46653927|NCT00712322|82862495|FG000|Overall Study|Protocol deviation|0|||
46653928|NCT00712322|82862496|FG001|Overall Study|Protocol deviation|1|||
46653929|NCT00712322|82862497|FG002|Overall Study|Protocol deviation|0|||
46653930|NCT00323856|82862505|FG000|Overall Study|Withdrawal by Subject|1|||
46653931|NCT00323856|82862505|FG000|Overall Study|Was uncooperative and noncompliant|1|||
46653932|NCT00323856|82862505|FG000|Overall Study|Reason not specified|1|||
46653933|NCT00323856|82862505|FG000|Overall Study|Missing|2|||
46653934|NCT04594941|82862520|FG000|Overall Study|Other|0|||
46653935|NCT04594941|82862521|FG001|Overall Study|Other|3|||
46653936|NCT04594941|82862522|FG002|Overall Study|Other|1|||
46653937|NCT04594941|82862523|FG003|Overall Study|Other|0|||
46653938|NCT04524663|82862541|FG000|Overall Study|Withdrawal by Subject|0|||
46653939|NCT04524663|82862542|FG001|Overall Study|Withdrawal by Subject|2|||
46653940|NCT03738423|82862571|FG000|Overall Study|Withdrawal by Subject|9|||
46653941|NCT03738423|82862572|FG001|Overall Study|Withdrawal by Subject|12|||
46653942|NCT03738423|82862573|FG002|Overall Study|Withdrawal by Subject|9|||
46653943|NCT03738423|82862574|FG003|Overall Study|Withdrawal by Subject|12|||
46653944|NCT03738423|82862575|FG004|Overall Study|Withdrawal by Subject|10|||
46653945|NCT03738423|82862571|FG000|Overall Study|Lack of Efficacy|3|||
46653946|NCT03738423|82862572|FG001|Overall Study|Lack of Efficacy|1|||
46653947|NCT03738423|82862573|FG002|Overall Study|Lack of Efficacy|1|||
46653948|NCT03738423|82862574|FG003|Overall Study|Lack of Efficacy|1|||
46653949|NCT03738423|82862575|FG004|Overall Study|Lack of Efficacy|2|||
46653950|NCT03738423|82862571|FG000|Overall Study|Lost to Follow-up|1|||
46653951|NCT03738423|82862572|FG001|Overall Study|Lost to Follow-up|0|||
46653952|NCT03738423|82862573|FG002|Overall Study|Lost to Follow-up|1|||
46653953|NCT03738423|82862574|FG003|Overall Study|Lost to Follow-up|1|||
46653954|NCT03738423|82862575|FG004|Overall Study|Lost to Follow-up|0|||
46653955|NCT03738423|82862571|FG000|Overall Study|Protocol Violation|1|||
46653956|NCT03738423|82862572|FG001|Overall Study|Protocol Violation|0|||
46653957|NCT03738423|82862573|FG002|Overall Study|Protocol Violation|0|||
46653958|NCT03738423|82862574|FG003|Overall Study|Protocol Violation|0|||
46653959|NCT03738423|82862575|FG004|Overall Study|Protocol Violation|1|||
46653960|NCT03738423|82862571|FG000|Overall Study|Physician Decision|0|||
46653961|NCT03738423|82862572|FG001|Overall Study|Physician Decision|0|||
46653962|NCT03738423|82862573|FG002|Overall Study|Physician Decision|1|||
46653963|NCT03738423|82862574|FG003|Overall Study|Physician Decision|0|||
46653964|NCT03738423|82862575|FG004|Overall Study|Physician Decision|1|||
46653965|NCT03738423|82862571|FG000|Overall Study|Death|0|||
46653966|NCT03738423|82862572|FG001|Overall Study|Death|0|||
46653967|NCT03738423|82862573|FG002|Overall Study|Death|0|||
46653968|NCT03738423|82862574|FG003|Overall Study|Death|0|||
46653969|NCT03738423|82862575|FG004|Overall Study|Death|1|||
46653970|NCT03738423|82862571|FG000|Overall Study|Randomized but never treated|0|||
46653971|NCT03738423|82862572|FG001|Overall Study|Randomized but never treated|0|||
46653972|NCT03738423|82862573|FG002|Overall Study|Randomized but never treated|1|||
46653973|NCT03738423|82862574|FG003|Overall Study|Randomized but never treated|1|||
46653974|NCT03738423|82862575|FG004|Overall Study|Randomized but never treated|0|||
46653975|NCT03712228|82862593|FG000|Treatment Period 1|Lack of Efficacy|0|||
46850823|NCT00112047|83066652|FG001|Randomized Phase|Lost to Follow-up|33|||
46653976|NCT03712228|82862594|FG001|Treatment Period 1|Lack of Efficacy|0|||
46653977|NCT03712228|82862595|FG002|Treatment Period 1|Lack of Efficacy|0|||
46850824|NCT00112047|83066651|FG000|Randomized Phase|Adverse Event|10|||
46653978|NCT03712228|82862596|FG003|Treatment Period 1|Lack of Efficacy|0|||
46653979|NCT03712228|82862597|FG004|Treatment Period 1|Lack of Efficacy|0|||
46653980|NCT03712228|82862598|FG005|Treatment Period 1|Lack of Efficacy|1|||
46653981|NCT03712228|82862593|FG000|Treatment Period 2|Pregnancy|0|||
46653982|NCT03712228|82862594|FG001|Treatment Period 2|Pregnancy|0|||
46850825|NCT00112047|83066652|FG001|Randomized Phase|Adverse Event|10|||
46653983|NCT03712228|82862595|FG002|Treatment Period 2|Pregnancy|0|||
46653984|NCT03712228|82862596|FG003|Treatment Period 2|Pregnancy|1|||
46653985|NCT03712228|82862597|FG004|Treatment Period 2|Pregnancy|0|||
46653986|NCT03712228|82862598|FG005|Treatment Period 2|Pregnancy|0|||
46653987|NCT03712228|82862593|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46653988|NCT03712228|82862594|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46781565|NCT00568126|83000130|FG001|Overall Study|Physician Decision|2|||
46971004|NCT02056288|83214395|FG001|In-Hospital Data|Physician Decision|0|||
46971005|NCT02056288|83214394|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
46971006|NCT02056288|83214395|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
46971007|NCT02086162|83214403|FG000|Overall Study|Withdrawal by Subject|4|||
46971008|NCT02086162|83214404|FG001|Overall Study|Withdrawal by Subject|4|||
46971009|NCT02086162|83214403|FG000|Overall Study|moved|1|||
46971010|NCT02086162|83214404|FG001|Overall Study|moved|1|||
46971011|NCT02086162|83214403|FG000|Overall Study|Lost to Follow-up|4|||
46971012|NCT02086162|83214404|FG001|Overall Study|Lost to Follow-up|2|||
46971013|NCT02086162|83214403|FG000|Overall Study|Death|1|||
46971014|NCT02086162|83214404|FG001|Overall Study|Death|0|||
46971015|NCT02700815|83214418|FG000|Overall Study|Adverse Event|0|||
46971016|NCT02700815|83214419|FG001|Overall Study|Adverse Event|6|||
46971017|NCT02700815|83214420|FG002|Overall Study|Adverse Event|2|||
46971018|NCT02700815|83214421|FG003|Overall Study|Adverse Event|3|||
46971019|NCT02700815|83214418|FG000|Overall Study|Lack of Efficacy|0|||
46971020|NCT02700815|83214419|FG001|Overall Study|Lack of Efficacy|0|||
46971021|NCT02700815|83214420|FG002|Overall Study|Lack of Efficacy|1|||
46971022|NCT02700815|83214421|FG003|Overall Study|Lack of Efficacy|2|||
46971023|NCT02700815|83214418|FG000|Overall Study|Lost to Follow-up|1|||
46971024|NCT02700815|83214419|FG001|Overall Study|Lost to Follow-up|0|||
46971025|NCT02700815|83214420|FG002|Overall Study|Lost to Follow-up|0|||
46971026|NCT02700815|83214421|FG003|Overall Study|Lost to Follow-up|1|||
46971027|NCT02700815|83214418|FG000|Overall Study|Refusal to continue medication|0|||
46971028|NCT02700815|83214419|FG001|Overall Study|Refusal to continue medication|1|||
46971029|NCT02700815|83214420|FG002|Overall Study|Refusal to continue medication|0|||
46971030|NCT02700815|83214421|FG003|Overall Study|Refusal to continue medication|1|||
46971031|NCT02700815|83214418|FG000|Overall Study|Withdrawal by Subject|0|||
46971032|NCT02700815|83214419|FG001|Overall Study|Withdrawal by Subject|0|||
46971033|NCT02700815|83214420|FG002|Overall Study|Withdrawal by Subject|1|||
46971034|NCT02700815|83214421|FG003|Overall Study|Withdrawal by Subject|0|||
46971035|NCT00708305|83214431|FG000|Period 1|Protocol Violation|1|||
46971036|NCT00708305|83214432|FG001|Period 1|Protocol Violation|0|||
46971037|NCT00708305|83214433|FG002|Period 1|Protocol Violation|1|||
46971038|NCT00708305|83214434|FG003|Period 1|Protocol Violation|0|||
46971039|NCT00708305|83214431|FG000|Period 1|Other Reason|0|||
46971040|NCT00708305|83214432|FG001|Period 1|Other Reason|0|||
46971041|NCT00708305|83214433|FG002|Period 1|Other Reason|0|||
46971042|NCT00708305|83214434|FG003|Period 1|Other Reason|2|||
46971043|NCT00708305|83214431|FG000|Period 2|Lost to Follow-up|0|||
46971044|NCT00708305|83214432|FG001|Period 2|Lost to Follow-up|1|||
46971045|NCT00708305|83214433|FG002|Period 2|Lost to Follow-up|0|||
46971046|NCT00708305|83214434|FG003|Period 2|Lost to Follow-up|0|||
46971047|NCT00708305|83214431|FG000|Period 2|Protocol Violation|0|||
46971048|NCT00708305|83214432|FG001|Period 2|Protocol Violation|1|||
46971049|NCT00708305|83214433|FG002|Period 2|Protocol Violation|0|||
46971050|NCT00708305|83214434|FG003|Period 2|Protocol Violation|0|||
46971051|NCT00708305|83214431|FG000|Period 2|Other Reason|1|||
46971052|NCT00708305|83214432|FG001|Period 2|Other Reason|0|||
46971053|NCT00708305|83214433|FG002|Period 2|Other Reason|0|||
46971054|NCT00708305|83214434|FG003|Period 2|Other Reason|1|||
46971055|NCT00708305|83214431|FG000|Period 3|Protocol Violation|0|||
46971056|NCT00708305|83214432|FG001|Period 3|Protocol Violation|2|||
46971057|NCT00708305|83214433|FG002|Period 3|Protocol Violation|0|||
46971058|NCT00708305|83214434|FG003|Period 3|Protocol Violation|0|||
46971059|NCT00708305|83214431|FG000|Period 3|Other Reason|1|||
46971060|NCT00708305|83214432|FG001|Period 3|Other Reason|0|||
46971061|NCT00708305|83214433|FG002|Period 3|Other Reason|0|||
46971062|NCT00708305|83214434|FG003|Period 3|Other Reason|0|||
46971063|NCT02055976|83214456|FG000|Overall Study|Other|0|||
46971064|NCT02055976|83214457|FG001|Overall Study|Other|0|||
46971065|NCT02055976|83214458|FG002|Overall Study|Other|1|||
46971066|NCT02055976|83214459|FG003|Overall Study|Other|0|||
46971067|NCT02055976|83214460|FG004|Overall Study|Other|0|||
46971068|NCT02055976|83214461|FG005|Overall Study|Other|0|||
46971069|NCT02055976|83214462|FG006|Overall Study|Other|0|||
46971070|NCT02055976|83214463|FG007|Overall Study|Other|0|||
46971071|NCT02055976|83214464|FG008|Overall Study|Other|0|||
46971072|NCT02055976|83214456|FG000|Overall Study|Adverse Event|0|||
46971073|NCT02055976|83214457|FG001|Overall Study|Adverse Event|0|||
46971074|NCT02055976|83214458|FG002|Overall Study|Adverse Event|0|||
46971075|NCT02055976|83214459|FG003|Overall Study|Adverse Event|0|||
46971076|NCT02055976|83214460|FG004|Overall Study|Adverse Event|0|||
46971077|NCT02055976|83214461|FG005|Overall Study|Adverse Event|1|||
46971078|NCT02055976|83214462|FG006|Overall Study|Adverse Event|1|||
47075582|NCT04178967|83370250|FG000|Induction Period|Lack of Efficacy|4|||
46971079|NCT02055976|83214463|FG007|Overall Study|Adverse Event|0|||
46971080|NCT02055976|83214464|FG008|Overall Study|Adverse Event|0|||
46971081|NCT02055976|83214456|FG000|Overall Study|Does not meet entrance criteria|0|||
46971082|NCT02055976|83214457|FG001|Overall Study|Does not meet entrance criteria|0|||
46971083|NCT02055976|83214458|FG002|Overall Study|Does not meet entrance criteria|0|||
46653989|NCT03712228|82862595|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46653990|NCT03712228|82862596|FG003|Treatment Period 2|Withdrawal by Subject|1|||
46653991|NCT03712228|82862597|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46653992|NCT03712228|82862598|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46653993|NCT03600818|82862617|FG000|Overall Study|Adverse Event|4|||
46653994|NCT03600818|82862618|FG001|Overall Study|Adverse Event|7|||
46653995|NCT03600818|82862617|FG000|Overall Study|Lack of Efficacy|9|||
46653996|NCT03600818|82862618|FG001|Overall Study|Lack of Efficacy|4|||
46653997|NCT03600818|82862617|FG000|Overall Study|Withdrawal by Subject|4|||
46653998|NCT03600818|82862618|FG001|Overall Study|Withdrawal by Subject|3|||
46653999|NCT03600818|82862617|FG000|Overall Study|Other-unspecified|5|||
46654000|NCT03600818|82862618|FG001|Overall Study|Other-unspecified|3|||
46654001|NCT03600818|82862617|FG000|Overall Study|Randomized and not treated|0|||
46654002|NCT03600818|82862618|FG001|Overall Study|Randomized and not treated|1|||
46654003|NCT03578276|82862627|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
46654004|NCT03578276|82862628|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
46654005|NCT02034110|82862693|FG000|Overall Study|Physician Decision|0|||
46654006|NCT02034110|82862694|FG001|Overall Study|Physician Decision|0|||
46654007|NCT02034110|82862695|FG002|Overall Study|Physician Decision|0|||
46654008|NCT02034110|82862696|FG003|Overall Study|Physician Decision|0|||
46654009|NCT02034110|82862697|FG004|Overall Study|Physician Decision|2|||
46654010|NCT02034110|82862698|FG005|Overall Study|Physician Decision|0|||
46654011|NCT02034110|82862699|FG006|Overall Study|Physician Decision|1|||
46654012|NCT02034110|82862700|FG007|Overall Study|Physician Decision|0|||
46654013|NCT02034110|82862693|FG000|Overall Study|Lost to Follow-up|1|||
46654014|NCT02034110|82862694|FG001|Overall Study|Lost to Follow-up|0|||
46654015|NCT02034110|82862695|FG002|Overall Study|Lost to Follow-up|0|||
46654016|NCT02034110|82862696|FG003|Overall Study|Lost to Follow-up|0|||
46654017|NCT02034110|82862697|FG004|Overall Study|Lost to Follow-up|1|||
46654018|NCT02034110|82862698|FG005|Overall Study|Lost to Follow-up|0|||
46654019|NCT02034110|82862699|FG006|Overall Study|Lost to Follow-up|1|||
46654020|NCT02034110|82862700|FG007|Overall Study|Lost to Follow-up|0|||
46654021|NCT02034110|82862693|FG000|Overall Study|Withdrawal by Subject|5|||
46654022|NCT02034110|82862694|FG001|Overall Study|Withdrawal by Subject|7|||
46654023|NCT02034110|82862695|FG002|Overall Study|Withdrawal by Subject|0|||
46654024|NCT02034110|82862696|FG003|Overall Study|Withdrawal by Subject|3|||
46654025|NCT02034110|82862697|FG004|Overall Study|Withdrawal by Subject|7|||
46654026|NCT02034110|82862698|FG005|Overall Study|Withdrawal by Subject|0|||
46654027|NCT02034110|82862699|FG006|Overall Study|Withdrawal by Subject|3|||
46654028|NCT02034110|82862700|FG007|Overall Study|Withdrawal by Subject|1|||
46654029|NCT02034110|82862693|FG000|Overall Study|Study closed by sponsor|6|||
46654030|NCT02034110|82862694|FG001|Overall Study|Study closed by sponsor|2|||
46654031|NCT02034110|82862695|FG002|Overall Study|Study closed by sponsor|0|||
46654032|NCT02034110|82862696|FG003|Overall Study|Study closed by sponsor|6|||
46654033|NCT02034110|82862697|FG004|Overall Study|Study closed by sponsor|7|||
46654034|NCT02034110|82862698|FG005|Overall Study|Study closed by sponsor|0|||
46654035|NCT02034110|82862699|FG006|Overall Study|Study closed by sponsor|42|||
46654036|NCT02034110|82862700|FG007|Overall Study|Study closed by sponsor|0|||
46654037|NCT01498458|82862746|FG000|Overall Study|Adverse Event|4|||
46654038|NCT01498458|82862746|FG000|Overall Study|Physician Decision|3|||
46654039|NCT01427712|82862755|FG000|Overall Study|Transfer to a different hospital|2|||
46654040|NCT01427712|82862755|FG000|Overall Study|Lost to Follow-up|1|||
46654041|NCT01427712|82862755|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
46654042|NCT01427712|82862755|FG000|Overall Study|Failure to visit|1|||
46654043|NCT01369147|82862762|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
46654044|NCT01369147|82862763|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
46654045|NCT01369147|82862764|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
46654046|NCT04846231|82862780|FG000|Overall Study|Lost to Follow-up|1|||
46654047|NCT04846231|82862781|FG001|Overall Study|Lost to Follow-up|0|||
46654048|NCT04846231|82862782|FG002|Overall Study|Lost to Follow-up|0|||
46654049|NCT04846231|82862783|FG003|Overall Study|Lost to Follow-up|0|||
46654050|NCT04846231|82862784|FG004|Overall Study|Lost to Follow-up|0|||
46654051|NCT04846231|82862785|FG005|Overall Study|Lost to Follow-up|0|||
46654052|NCT04846231|82862786|FG006|Overall Study|Lost to Follow-up|0|||
46654053|NCT04846231|82862787|FG007|Overall Study|Lost to Follow-up|1|||
46654054|NCT04846231|82862780|FG000|Overall Study|Withdrawal by Subject|0|||
46654055|NCT04846231|82862781|FG001|Overall Study|Withdrawal by Subject|1|||
46654056|NCT04846231|82862782|FG002|Overall Study|Withdrawal by Subject|2|||
46654057|NCT04846231|82862783|FG003|Overall Study|Withdrawal by Subject|1|||
46654058|NCT04846231|82862784|FG004|Overall Study|Withdrawal by Subject|0|||
46654059|NCT04846231|82862785|FG005|Overall Study|Withdrawal by Subject|0|||
46654060|NCT04846231|82862786|FG006|Overall Study|Withdrawal by Subject|0|||
46654061|NCT04846231|82862787|FG007|Overall Study|Withdrawal by Subject|0|||
46654062|NCT04846231|82862780|FG000|Overall Study|Protocol Violation|0|||
46654063|NCT04846231|82862781|FG001|Overall Study|Protocol Violation|1|||
46654064|NCT04846231|82862782|FG002|Overall Study|Protocol Violation|0|||
46654065|NCT04846231|82862783|FG003|Overall Study|Protocol Violation|0|||
46654066|NCT04846231|82862784|FG004|Overall Study|Protocol Violation|0|||
46654067|NCT04846231|82862785|FG005|Overall Study|Protocol Violation|0|||
46654068|NCT04846231|82862786|FG006|Overall Study|Protocol Violation|0|||
46654069|NCT04846231|82862787|FG007|Overall Study|Protocol Violation|0|||
46654070|NCT04846231|82862780|FG000|Overall Study|Adverse Event|0|||
46654071|NCT04846231|82862781|FG001|Overall Study|Adverse Event|0|||
46781566|NCT00407563|83000136|FG000|Overall Study|Patient continues on treatment|1|||
46781567|NCT00567892|83000142|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
46781568|NCT00567892|83000143|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
46781569|NCT00567892|83000144|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
46781570|NCT00567892|83000145|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
46781571|NCT00567892|83000142|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
46781572|NCT00567892|83000143|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
46781573|NCT00567892|83000144|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
46781574|NCT00567892|83000145|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
46781575|NCT00623103|83000159|FG000|Overall Study|Adverse Event|70|||
46781576|NCT00623103|83000160|FG001|Overall Study|Adverse Event|60|||
46781577|NCT00623103|83000159|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
46781578|NCT00623103|83000160|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
46781579|NCT00623103|83000159|FG000|Overall Study|Withdrawal by Subject|18|||
46781580|NCT00623103|83000160|FG001|Overall Study|Withdrawal by Subject|24|||
46781581|NCT00623103|83000159|FG000|Overall Study|Lost to Follow-up|4|||
46781582|NCT00623103|83000160|FG001|Overall Study|Lost to Follow-up|1|||
46781583|NCT00623103|83000159|FG000|Overall Study|Administrative problems|2|||
46781584|NCT00623103|83000160|FG001|Overall Study|Administrative problems|4|||
46781585|NCT00623103|83000159|FG000|Overall Study|Death|11|||
46781586|NCT00623103|83000160|FG001|Overall Study|Death|11|||
46781587|NCT00623103|83000159|FG000|Overall Study|Protocol deviation|2|||
46781588|NCT00623103|83000160|FG001|Overall Study|Protocol deviation|1|||
46781589|NCT00396565|83000169|FG000|Overall Study|Physician Decision|3|||
46781590|NCT00396565|83000170|FG001|Overall Study|Physician Decision|1|||
46781591|NCT00396565|83000171|FG002|Overall Study|Physician Decision|2|||
46781592|NCT00396565|83000169|FG000|Overall Study|Adverse Event|5|||
46781593|NCT00396565|83000170|FG001|Overall Study|Adverse Event|13|||
46781594|NCT00396565|83000171|FG002|Overall Study|Adverse Event|3|||
46781595|NCT00396565|83000169|FG000|Overall Study|Withdrawal by Subject|8|||
46781596|NCT00396565|83000170|FG001|Overall Study|Withdrawal by Subject|13|||
46781597|NCT00396565|83000171|FG002|Overall Study|Withdrawal by Subject|1|||
46781598|NCT00396565|83000169|FG000|Overall Study|Lack of Efficacy|32|||
46781599|NCT00396565|83000170|FG001|Overall Study|Lack of Efficacy|64|||
46781600|NCT00396565|83000171|FG002|Overall Study|Lack of Efficacy|11|||
46781601|NCT00394771|83000183|FG000|Overall Study|Did not meet protocol requirements|1|||
46781602|NCT00394771|83000184|FG001|Overall Study|Did not meet protocol requirements|0|||
46781603|NCT00394771|83000185|FG002|Overall Study|Did not meet protocol requirements|2|||
46781604|NCT00394771|83000186|FG003|Overall Study|Did not meet protocol requirements|0|||
46781605|NCT00394771|83000183|FG000|Overall Study|Protocol Violation|2|||
46781606|NCT00394771|83000184|FG001|Overall Study|Protocol Violation|4|||
46781607|NCT00394771|83000185|FG002|Overall Study|Protocol Violation|9|||
46781608|NCT00394771|83000186|FG003|Overall Study|Protocol Violation|7|||
46781609|NCT00394771|83000183|FG000|Overall Study|Withdrawal by Subject|10|||
46781610|NCT00394771|83000184|FG001|Overall Study|Withdrawal by Subject|6|||
46781611|NCT00394771|83000185|FG002|Overall Study|Withdrawal by Subject|8|||
46781612|NCT00394771|83000186|FG003|Overall Study|Withdrawal by Subject|12|||
46781613|NCT00394771|83000183|FG000|Overall Study|Adverse Event|10|||
46781614|NCT00394771|83000184|FG001|Overall Study|Adverse Event|5|||
46781615|NCT00394771|83000185|FG002|Overall Study|Adverse Event|12|||
46781616|NCT00394771|83000186|FG003|Overall Study|Adverse Event|8|||
46781617|NCT00394771|83000183|FG000|Overall Study|Participant pregnant|0|||
46781618|NCT00394771|83000184|FG001|Overall Study|Participant pregnant|1|||
46781619|NCT00394771|83000185|FG002|Overall Study|Participant pregnant|2|||
46781620|NCT00394771|83000186|FG003|Overall Study|Participant pregnant|2|||
46781621|NCT00394771|83000183|FG000|Overall Study|Lost to Follow-up|15|||
46781622|NCT00394771|83000184|FG001|Overall Study|Lost to Follow-up|15|||
46850826|NCT00112047|83066651|FG000|Randomized Phase|Withrawal of consent|10|||
46850827|NCT00112047|83066652|FG001|Randomized Phase|Withrawal of consent|18|||
46654072|NCT04846231|82862782|FG002|Overall Study|Adverse Event|0|||
46781623|NCT00394771|83000185|FG002|Overall Study|Lost to Follow-up|13|||
46781624|NCT00394771|83000186|FG003|Overall Study|Lost to Follow-up|10|||
46781625|NCT00394771|83000183|FG000|Overall Study|Other|3|||
46781626|NCT00394771|83000184|FG001|Overall Study|Other|3|||
46850828|NCT00112047|83066651|FG000|Randomized Phase|Sub-optimal virological response|3|||
46781627|NCT00394771|83000185|FG002|Overall Study|Other|1|||
46781628|NCT00394771|83000186|FG003|Overall Study|Other|0|||
46781629|NCT00396409|83000198|FG000|Period 1 - 2007|Adverse Event|0|||
46781630|NCT00396409|83000199|FG001|Period 1 - 2007|Adverse Event|1|||
46781631|NCT00396409|83000198|FG000|Period 1 - 2007|Lack of Efficacy|0|||
46781632|NCT00396409|83000199|FG001|Period 1 - 2007|Lack of Efficacy|1|||
46654073|NCT04846231|82862783|FG003|Overall Study|Adverse Event|0|||
46654074|NCT04846231|82862784|FG004|Overall Study|Adverse Event|0|||
46654075|NCT04846231|82862785|FG005|Overall Study|Adverse Event|0|||
46654076|NCT04846231|82862786|FG006|Overall Study|Adverse Event|1|||
46654077|NCT04846231|82862787|FG007|Overall Study|Adverse Event|1|||
46654078|NCT04533594|82862813|FG000|Overall Study|Death|26|||
46654079|NCT04447846|82862817|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
46654080|NCT04405245|82862824|FG000|Overall Study|Adverse Event|0|||
46654081|NCT04405245|82862825|FG001|Overall Study|Adverse Event|1|||
46654082|NCT04405245|82862826|FG002|Overall Study|Adverse Event|0|||
46654083|NCT04198805|82862838|FG000|Overall Study|Death|0|||
46654084|NCT04198805|82862839|FG001|Overall Study|Death|0|||
46654085|NCT04198805|82862840|FG002|Overall Study|Death|0|||
46654086|NCT04198805|82862841|FG003|Overall Study|Death|1|||
46654087|NCT04198805|82862838|FG000|Overall Study|Early Termination|8|||
46654088|NCT04198805|82862839|FG001|Overall Study|Early Termination|4|||
46654089|NCT04198805|82862840|FG002|Overall Study|Early Termination|6|||
46654090|NCT04198805|82862841|FG003|Overall Study|Early Termination|9|||
46654091|NCT04179890|82862857|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
46654092|NCT04179890|82862858|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
46654093|NCT04179890|82862857|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
46654094|NCT04179890|82862858|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
46654095|NCT04179890|82862857|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
46654096|NCT04179890|82862858|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
46654097|NCT04179890|82862857|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
46654098|NCT04179890|82862858|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
46654099|NCT04179890|82862857|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
46654100|NCT04179890|82862858|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
46654101|NCT04179890|82862857|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
46654102|NCT04179890|82862858|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
46654103|NCT04179890|82862857|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
46654104|NCT04179890|82862858|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
46654105|NCT04179890|82862857|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
46654106|NCT04179890|82862858|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
46654107|NCT04179890|82862857|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
46654108|NCT04179890|82862858|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
46654109|NCT03721016|82862899|FG000|Overall Study|Adverse Event|0|||
46654110|NCT03721016|82862900|FG001|Overall Study|Adverse Event|1|||
46654111|NCT03721016|82862901|FG002|Overall Study|Adverse Event|1|||
46654112|NCT03721016|82862899|FG000|Overall Study|Withdrawal by Subject|8|||
46654113|NCT03721016|82862900|FG001|Overall Study|Withdrawal by Subject|16|||
46654114|NCT03721016|82862901|FG002|Overall Study|Withdrawal by Subject|13|||
46654115|NCT03721016|82862899|FG000|Overall Study|Lost to Follow-up|4|||
46654116|NCT03721016|82862900|FG001|Overall Study|Lost to Follow-up|6|||
46654117|NCT03721016|82862901|FG002|Overall Study|Lost to Follow-up|5|||
46654118|NCT03721016|82862899|FG000|Overall Study|Physician Decision|0|||
46654119|NCT03721016|82862900|FG001|Overall Study|Physician Decision|1|||
46654120|NCT03721016|82862901|FG002|Overall Study|Physician Decision|2|||
46654121|NCT03721016|82862899|FG000|Overall Study|Protocol Violation|0|||
46654122|NCT03721016|82862900|FG001|Overall Study|Protocol Violation|1|||
46654123|NCT03721016|82862901|FG002|Overall Study|Protocol Violation|0|||
46654124|NCT03721016|82862899|FG000|Overall Study|Site terminated by sponsor|3|||
46654125|NCT03721016|82862900|FG001|Overall Study|Site terminated by sponsor|7|||
46654126|NCT03721016|82862901|FG002|Overall Study|Site terminated by sponsor|6|||
46654127|NCT03721016|82862899|FG000|Overall Study|Subject exited early due to COVID-19|1|||
46654128|NCT03721016|82862900|FG001|Overall Study|Subject exited early due to COVID-19|0|||
46654129|NCT03721016|82862901|FG002|Overall Study|Subject exited early due to COVID-19|0|||
46654130|NCT03117998|82862937|FG000|Overall Study|Adverse Event|1|||
46654131|NCT03117998|82862938|FG001|Overall Study|Adverse Event|0|||
46654132|NCT03117998|82862939|FG002|Overall Study|Adverse Event|0|||
46654133|NCT03117998|82862940|FG003|Overall Study|Adverse Event|0|||
46654134|NCT03117998|82862941|FG004|Overall Study|Adverse Event|0|||
47075583|NCT04178967|83370251|FG001|Induction Period|Lack of Efficacy|1|||
47075584|NCT04178967|83370252|FG002|Induction Period|Lack of Efficacy|0|||
47075585|NCT04178967|83370253|FG003|Induction Period|Lack of Efficacy|0|||
47075586|NCT04178967|83370254|FG004|Induction Period|Lack of Efficacy|0|||
46654135|NCT03117998|82862942|FG005|Overall Study|Adverse Event|0|||
46654136|NCT03117998|82862937|FG000|Overall Study|Withdrawal by Subject|0|||
47075587|NCT04178967|83370255|FG005|Induction Period|Lack of Efficacy|0|||
46654137|NCT03117998|82862938|FG001|Overall Study|Withdrawal by Subject|0|||
46654138|NCT03117998|82862939|FG002|Overall Study|Withdrawal by Subject|2|||
46654139|NCT03117998|82862940|FG003|Overall Study|Withdrawal by Subject|3|||
46654140|NCT03117998|82862941|FG004|Overall Study|Withdrawal by Subject|3|||
46654141|NCT03117998|82862942|FG005|Overall Study|Withdrawal by Subject|0|||
46654142|NCT03117998|82862937|FG000|Overall Study|Physician Decision|0|||
46654143|NCT03117998|82862938|FG001|Overall Study|Physician Decision|1|||
46654144|NCT03117998|82862939|FG002|Overall Study|Physician Decision|1|||
46654145|NCT03117998|82862940|FG003|Overall Study|Physician Decision|0|||
46654146|NCT03117998|82862941|FG004|Overall Study|Physician Decision|0|||
46654147|NCT03117998|82862942|FG005|Overall Study|Physician Decision|0|||
46654148|NCT03117998|82862937|FG000|Overall Study|Lost to Follow-up|0|||
46654149|NCT03117998|82862938|FG001|Overall Study|Lost to Follow-up|0|||
46654150|NCT03117998|82862939|FG002|Overall Study|Lost to Follow-up|0|||
46654151|NCT03117998|82862940|FG003|Overall Study|Lost to Follow-up|1|||
46654152|NCT03117998|82862941|FG004|Overall Study|Lost to Follow-up|4|||
46654153|NCT03117998|82862942|FG005|Overall Study|Lost to Follow-up|0|||
46654154|NCT03117998|82862937|FG000|Overall Study|Subject noncompliance|0|||
46654155|NCT03117998|82862938|FG001|Overall Study|Subject noncompliance|0|||
46654156|NCT03117998|82862939|FG002|Overall Study|Subject noncompliance|1|||
46654157|NCT03117998|82862940|FG003|Overall Study|Subject noncompliance|0|||
46654158|NCT03117998|82862941|FG004|Overall Study|Subject noncompliance|0|||
46654159|NCT03117998|82862942|FG005|Overall Study|Subject noncompliance|2|||
46654160|NCT03117998|82862937|FG000|Overall Study|Protocol Violation|0|||
46654161|NCT03117998|82862938|FG001|Overall Study|Protocol Violation|0|||
46654162|NCT03117998|82862939|FG002|Overall Study|Protocol Violation|0|||
46654163|NCT03117998|82862940|FG003|Overall Study|Protocol Violation|0|||
46654164|NCT03117998|82862941|FG004|Overall Study|Protocol Violation|0|||
46654165|NCT03117998|82862942|FG005|Overall Study|Protocol Violation|1|||
46654166|NCT03100370|82862967|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46654167|NCT03100370|82862968|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46654168|NCT03100370|82862969|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46654169|NCT03100370|82862970|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
46654170|NCT03100370|82862971|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46654171|NCT03100370|82862972|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
46654172|NCT02920008|82862982|FG000|Overall Study|Death|117|||
46654173|NCT02920008|82862983|FG001|Overall Study|Death|127|||
46654174|NCT02920008|82862982|FG000|Overall Study|Withdrawal by Subject|3|||
46654175|NCT02920008|82862983|FG001|Overall Study|Withdrawal by Subject|6|||
46654176|NCT02920008|82862982|FG000|Overall Study|Lost to Follow-up|0|||
46654177|NCT02920008|82862983|FG001|Overall Study|Lost to Follow-up|1|||
46654178|NCT02766335|82862991|FG000|Initial Registration|Adverse Event|6|||
46654179|NCT02766335|82862992|FG001|Initial Registration|Adverse Event|3|||
46654180|NCT02766335|82862993|FG002|Initial Registration|Adverse Event|0|||
46654181|NCT02766335|82862991|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
46654182|NCT02766335|82862992|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
46654183|NCT02766335|82862993|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
46654184|NCT02766335|82862991|FG000|Initial Registration|Progression/relapse|49|||
46654185|NCT02766335|82862992|FG001|Initial Registration|Progression/relapse|15|||
46654186|NCT02766335|82862993|FG002|Initial Registration|Progression/relapse|0|||
46781633|NCT00396409|83000198|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
47075588|NCT04178967|83370256|FG006|Induction Period|Lack of Efficacy|0|||
47075589|NCT04178967|83370257|FG007|Induction Period|Lack of Efficacy|0|||
47075590|NCT04178967|83370258|FG008|Induction Period|Lack of Efficacy|0|||
47075591|NCT04178967|83370259|FG009|Induction Period|Lack of Efficacy|0|||
47075592|NCT04178967|83370260|FG010|Induction Period|Lack of Efficacy|0|||
47075593|NCT04178967|83370250|FG000|Induction Period|Protocol Violation|0|||
46654187|NCT02766335|82862991|FG000|Initial Registration|Death|1|||
47075594|NCT04178967|83370251|FG001|Induction Period|Protocol Violation|6|||
47075595|NCT04178967|83370252|FG002|Induction Period|Protocol Violation|0|||
47075596|NCT04178967|83370253|FG003|Induction Period|Protocol Violation|0|||
47075597|NCT04178967|83370254|FG004|Induction Period|Protocol Violation|0|||
47075598|NCT04178967|83370255|FG005|Induction Period|Protocol Violation|0|||
46654188|NCT02766335|82862992|FG001|Initial Registration|Death|3|||
46654189|NCT02766335|82862993|FG002|Initial Registration|Death|0|||
46654190|NCT02766335|82862991|FG000|Initial Registration|not protocol specified|1|||
46654191|NCT02766335|82862992|FG001|Initial Registration|not protocol specified|9|||
46654192|NCT02766335|82862993|FG002|Initial Registration|not protocol specified|0|||
46654193|NCT02766335|82862991|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
46654194|NCT02766335|82862992|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
46654195|NCT02766335|82862993|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
47075599|NCT04178967|83370256|FG006|Induction Period|Protocol Violation|0|||
46654196|NCT02766335|82862991|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
46654197|NCT02766335|82862992|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
46654198|NCT02766335|82862993|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
46654199|NCT02577523|82863001|FG000|Overall Study|Adverse Event|1|||
46654200|NCT02577523|82863002|FG001|Overall Study|Adverse Event|1|||
46654201|NCT02577523|82863001|FG000|Overall Study|Lack of Efficacy|1|||
46654202|NCT02577523|82863002|FG001|Overall Study|Lack of Efficacy|1|||
46654203|NCT02577523|82863001|FG000|Overall Study|Withdrawal by Subject|1|||
46654204|NCT02577523|82863002|FG001|Overall Study|Withdrawal by Subject|0|||
46654205|NCT02177695|82863021|FG000|ITT Analysis|Ineligible|5|||
46654206|NCT02177695|82863022|FG001|ITT Analysis|Ineligible|5|||
46654207|NCT02177695|82863021|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
46654208|NCT02177695|82863022|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
46654209|NCT02177695|82863021|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
46654210|NCT02177695|82863022|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
46654211|NCT02177695|82863021|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
46654212|NCT02177695|82863022|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
46654213|NCT01719237|82863037|FG000|Overall Study|Physician Decision|0|||
46654214|NCT01719237|82863038|FG001|Overall Study|Physician Decision|1|||
46654215|NCT01956669|82863061|FG000|Overall Study|Disease Progression|12|||
46654216|NCT01956669|82863062|FG001|Overall Study|Disease Progression|7|||
46654217|NCT01956669|82863063|FG002|Overall Study|Disease Progression|7|||
46654218|NCT01956669|82863064|FG003|Overall Study|Disease Progression|8|||
46654219|NCT01956669|82863065|FG004|Overall Study|Disease Progression|4|||
46654220|NCT01956669|82863066|FG005|Overall Study|Disease Progression|3|||
46654221|NCT01956669|82863067|FG006|Overall Study|Disease Progression|5|||
46654222|NCT01956669|82863061|FG000|Overall Study|Adverse Event|0|||
46654223|NCT01956669|82863062|FG001|Overall Study|Adverse Event|2|||
46654224|NCT01956669|82863063|FG002|Overall Study|Adverse Event|2|||
46654225|NCT01956669|82863064|FG003|Overall Study|Adverse Event|1|||
46654226|NCT01956669|82863065|FG004|Overall Study|Adverse Event|0|||
46654227|NCT01956669|82863066|FG005|Overall Study|Adverse Event|0|||
46654228|NCT01956669|82863067|FG006|Overall Study|Adverse Event|0|||
46654229|NCT01956669|82863061|FG000|Overall Study|Physician Decision|0|||
46654230|NCT01956669|82863062|FG001|Overall Study|Physician Decision|2|||
46654231|NCT01956669|82863063|FG002|Overall Study|Physician Decision|0|||
46654232|NCT01956669|82863064|FG003|Overall Study|Physician Decision|0|||
46654233|NCT01956669|82863065|FG004|Overall Study|Physician Decision|0|||
46654234|NCT01956669|82863066|FG005|Overall Study|Physician Decision|1|||
46654235|NCT01956669|82863067|FG006|Overall Study|Physician Decision|0|||
46654236|NCT01956669|82863061|FG000|Overall Study|Withdrawal by Subject|0|||
46654237|NCT01956669|82863062|FG001|Overall Study|Withdrawal by Subject|0|||
46654238|NCT01956669|82863063|FG002|Overall Study|Withdrawal by Subject|1|||
46654239|NCT01956669|82863064|FG003|Overall Study|Withdrawal by Subject|1|||
46654240|NCT01956669|82863065|FG004|Overall Study|Withdrawal by Subject|0|||
46654241|NCT01956669|82863066|FG005|Overall Study|Withdrawal by Subject|0|||
46654242|NCT01956669|82863067|FG006|Overall Study|Withdrawal by Subject|1|||
46654243|NCT01967823|82863096|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
46654244|NCT04807400|82863154|FG000|Overall Study|Adverse Event|2|||
46654245|NCT04807400|82863155|FG001|Overall Study|Adverse Event|3|||
46654246|NCT04807400|82863156|FG002|Overall Study|Adverse Event|3|||
46654247|NCT04807400|82863154|FG000|Overall Study|Death|2|||
46654248|NCT04807400|82863155|FG001|Overall Study|Death|0|||
46654249|NCT04807400|82863156|FG002|Overall Study|Death|0|||
46654250|NCT04807400|82863154|FG000|Overall Study|Lost to Follow-up|8|||
46654251|NCT04807400|82863155|FG001|Overall Study|Lost to Follow-up|6|||
46654252|NCT04807400|82863156|FG002|Overall Study|Lost to Follow-up|6|||
46654253|NCT04807400|82863154|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46654254|NCT04807400|82863155|FG001|Overall Study|Non-Compliance With Study Drug|4|||
46654255|NCT04807400|82863156|FG002|Overall Study|Non-Compliance With Study Drug|1|||
46654256|NCT04807400|82863154|FG000|Overall Study|Participant Decision|20|||
46654257|NCT04807400|82863155|FG001|Overall Study|Participant Decision|19|||
46654258|NCT04807400|82863156|FG002|Overall Study|Participant Decision|26|||
46654259|NCT04807400|82863154|FG000|Overall Study|Physician Decision|0|||
46654260|NCT04807400|82863155|FG001|Overall Study|Physician Decision|1|||
46781634|NCT00396409|83000199|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
46781635|NCT00396409|83000198|FG000|Period 1 - 2007|Lost to Follow-up|2|||
46781636|NCT00396409|83000199|FG001|Period 1 - 2007|Lost to Follow-up|3|||
46781637|NCT00396409|83000198|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
46781638|NCT00396409|83000199|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
46781639|NCT00396409|83000198|FG000|Period 2 - 2008|Protocol Violation|1|||
46781640|NCT00396409|83000199|FG001|Period 2 - 2008|Protocol Violation|0|||
46654261|NCT04807400|82863156|FG002|Overall Study|Physician Decision|0|||
46654262|NCT04807400|82863154|FG000|Overall Study|Protocol Violation|4|||
46654263|NCT04807400|82863155|FG001|Overall Study|Protocol Violation|3|||
46654264|NCT04807400|82863156|FG002|Overall Study|Protocol Violation|7|||
46654265|NCT04807400|82863154|FG000|Overall Study|Withdrawal by Subject|13|||
46654266|NCT04807400|82863155|FG001|Overall Study|Withdrawal by Subject|9|||
46654267|NCT04807400|82863156|FG002|Overall Study|Withdrawal by Subject|20|||
46654268|NCT04807400|82863154|FG000|Overall Study|Mis-randomized|1|||
46654269|NCT04807400|82863155|FG001|Overall Study|Mis-randomized|0|||
46654270|NCT04807400|82863156|FG002|Overall Study|Mis-randomized|0|||
46654271|NCT04762160|82863167|FG000|Overall Study|Study terminated early due to business reasons|5|||
46654272|NCT04645966|82863180|FG000|Vaccination Phase|Adverse Event|1|||
46654273|NCT04645966|82863181|FG001|Vaccination Phase|Adverse Event|0|||
46654274|NCT04645966|82863182|FG002|Vaccination Phase|Adverse Event|0|||
46654275|NCT04645966|82863183|FG003|Vaccination Phase|Adverse Event|0|||
46654276|NCT04645966|82863184|FG004|Vaccination Phase|Adverse Event|0|||
46654277|NCT04645966|82863185|FG005|Vaccination Phase|Adverse Event|0|||
46654278|NCT04645966|82863186|FG006|Vaccination Phase|Adverse Event|1|||
46654279|NCT04645966|82863187|FG007|Vaccination Phase|Adverse Event|0|||
46654280|NCT04645966|82863188|FG008|Vaccination Phase|Adverse Event|0|||
46654281|NCT04645966|82863180|FG000|Vaccination Phase|Death|0|||
46654282|NCT04645966|82863181|FG001|Vaccination Phase|Death|0|||
46654283|NCT04645966|82863182|FG002|Vaccination Phase|Death|0|||
46654284|NCT04645966|82863183|FG003|Vaccination Phase|Death|0|||
46654285|NCT04645966|82863184|FG004|Vaccination Phase|Death|0|||
46654286|NCT04645966|82863185|FG005|Vaccination Phase|Death|1|||
46654287|NCT04645966|82863186|FG006|Vaccination Phase|Death|0|||
46654288|NCT04645966|82863187|FG007|Vaccination Phase|Death|0|||
46654289|NCT04645966|82863188|FG008|Vaccination Phase|Death|0|||
46654290|NCT04645966|82863180|FG000|Vaccination Phase|Protocol Violation|0|||
46654291|NCT04645966|82863181|FG001|Vaccination Phase|Protocol Violation|0|||
46654292|NCT04645966|82863182|FG002|Vaccination Phase|Protocol Violation|0|||
46654293|NCT04645966|82863183|FG003|Vaccination Phase|Protocol Violation|0|||
46654294|NCT04645966|82863184|FG004|Vaccination Phase|Protocol Violation|1|||
46654295|NCT04645966|82863185|FG005|Vaccination Phase|Protocol Violation|0|||
46654296|NCT04645966|82863186|FG006|Vaccination Phase|Protocol Violation|0|||
46654297|NCT04645966|82863187|FG007|Vaccination Phase|Protocol Violation|0|||
46654298|NCT04645966|82863188|FG008|Vaccination Phase|Protocol Violation|0|||
46654299|NCT04645966|82863180|FG000|Vaccination Phase|Study terminated by sponsor|0|||
46654300|NCT04645966|82863181|FG001|Vaccination Phase|Study terminated by sponsor|0|||
46654301|NCT04645966|82863182|FG002|Vaccination Phase|Study terminated by sponsor|14|||
46654302|NCT04645966|82863183|FG003|Vaccination Phase|Study terminated by sponsor|15|||
46654303|NCT04645966|82863184|FG004|Vaccination Phase|Study terminated by sponsor|47|||
46654304|NCT04645966|82863185|FG005|Vaccination Phase|Study terminated by sponsor|43|||
46654305|NCT04645966|82863186|FG006|Vaccination Phase|Study terminated by sponsor|29|||
46654306|NCT04645966|82863187|FG007|Vaccination Phase|Study terminated by sponsor|29|||
46654307|NCT04645966|82863188|FG008|Vaccination Phase|Study terminated by sponsor|12|||
46654308|NCT04645966|82863180|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
46654309|NCT04645966|82863181|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
46654310|NCT04645966|82863182|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
46654311|NCT04645966|82863183|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
46654312|NCT04645966|82863184|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
46654313|NCT04645966|82863185|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
46654314|NCT04645966|82863186|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
46654315|NCT04645966|82863187|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
46654316|NCT04645966|82863188|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
46654317|NCT04645966|82863180|FG000|Vaccination Phase|Other|0|||
46654318|NCT04645966|82863181|FG001|Vaccination Phase|Other|0|||
46654319|NCT04645966|82863182|FG002|Vaccination Phase|Other|0|||
46654320|NCT04645966|82863183|FG003|Vaccination Phase|Other|0|||
46654321|NCT04645966|82863184|FG004|Vaccination Phase|Other|0|||
46654322|NCT04645966|82863185|FG005|Vaccination Phase|Other|2|||
46654323|NCT04645966|82863186|FG006|Vaccination Phase|Other|0|||
46654324|NCT04645966|82863187|FG007|Vaccination Phase|Other|0|||
46654325|NCT04645966|82863188|FG008|Vaccination Phase|Other|0|||
46654326|NCT04645966|82863180|FG000|Vaccination Phase|Lost to Follow-up|0|||
46781641|NCT00396409|83000198|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
46781642|NCT00396409|83000199|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
46781643|NCT00396409|83000198|FG000|Period 2 - 2008|Lost to Follow-up|3|||
46850829|NCT00112047|83066652|FG001|Randomized Phase|Sub-optimal virological response|13|||
46654327|NCT04645966|82863181|FG001|Vaccination Phase|Lost to Follow-up|0|||
46654328|NCT04645966|82863182|FG002|Vaccination Phase|Lost to Follow-up|0|||
46654329|NCT04645966|82863183|FG003|Vaccination Phase|Lost to Follow-up|0|||
46654330|NCT04645966|82863184|FG004|Vaccination Phase|Lost to Follow-up|0|||
46654331|NCT04645966|82863185|FG005|Vaccination Phase|Lost to Follow-up|0|||
46654332|NCT04645966|82863186|FG006|Vaccination Phase|Lost to Follow-up|0|||
46654333|NCT04645966|82863187|FG007|Vaccination Phase|Lost to Follow-up|1|||
46654334|NCT04645966|82863188|FG008|Vaccination Phase|Lost to Follow-up|0|||
46654335|NCT04645966|82863180|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
46654336|NCT04645966|82863181|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
46654337|NCT04645966|82863182|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
46654338|NCT04645966|82863183|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
46654339|NCT04645966|82863184|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
46654340|NCT04645966|82863185|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
46654341|NCT04645966|82863186|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
46654342|NCT04645966|82863187|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
46654343|NCT04645966|82863188|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
46654344|NCT04645966|82863180|FG000|Follow-up Phase|Lost to Follow-up|0|||
46654345|NCT04645966|82863181|FG001|Follow-up Phase|Lost to Follow-up|0|||
46654346|NCT04645966|82863182|FG002|Follow-up Phase|Lost to Follow-up|0|||
46654347|NCT04645966|82863183|FG003|Follow-up Phase|Lost to Follow-up|0|||
46654348|NCT04645966|82863184|FG004|Follow-up Phase|Lost to Follow-up|0|||
46654349|NCT04645966|82863185|FG005|Follow-up Phase|Lost to Follow-up|0|||
46654350|NCT04645966|82863186|FG006|Follow-up Phase|Lost to Follow-up|0|||
46654351|NCT04645966|82863187|FG007|Follow-up Phase|Lost to Follow-up|1|||
46654352|NCT04645966|82863188|FG008|Follow-up Phase|Lost to Follow-up|0|||
46654353|NCT04313608|82863242|FG000|Overall Study|Death|12|||
46654354|NCT04313608|82863243|FG001|Overall Study|Death|3|||
46654355|NCT03885908|82863252|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
46654356|NCT03885908|82863253|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
46654357|NCT03885908|82863252|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
46654358|NCT03885908|82863253|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
46654359|NCT03885908|82863252|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
46654360|NCT03885908|82863253|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
46654361|NCT03885908|82863252|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
46654362|NCT03885908|82863253|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
46654363|NCT03816332|82863259|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
46654364|NCT03816332|82863259|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
46654365|NCT03735121|82863279|FG000|Overall Study|Death|3|||
46654366|NCT03735121|82863280|FG001|Overall Study|Death|6|||
46654367|NCT03735121|82863281|FG002|Overall Study|Death|8|||
46654368|NCT03735121|82863282|FG003|Overall Study|Death|37|||
46654369|NCT03735121|82863283|FG004|Overall Study|Death|86|||
46654370|NCT03735121|82863279|FG000|Overall Study|Withdrawal by Subject|1|||
46654371|NCT03735121|82863280|FG001|Overall Study|Withdrawal by Subject|1|||
46654372|NCT03735121|82863281|FG002|Overall Study|Withdrawal by Subject|3|||
46654373|NCT03735121|82863282|FG003|Overall Study|Withdrawal by Subject|4|||
46654374|NCT03735121|82863283|FG004|Overall Study|Withdrawal by Subject|2|||
46654375|NCT03735121|82863279|FG000|Overall Study|Progressive Disease|0|||
46654376|NCT03735121|82863280|FG001|Overall Study|Progressive Disease|0|||
46654377|NCT03735121|82863281|FG002|Overall Study|Progressive Disease|1|||
46654378|NCT03735121|82863282|FG003|Overall Study|Progressive Disease|0|||
46654379|NCT03735121|82863283|FG004|Overall Study|Progressive Disease|0|||
46654380|NCT03735121|82863279|FG000|Overall Study|Lost to Follow-up|0|||
46654381|NCT03735121|82863280|FG001|Overall Study|Lost to Follow-up|0|||
46654382|NCT03735121|82863281|FG002|Overall Study|Lost to Follow-up|0|||
46654383|NCT03735121|82863282|FG003|Overall Study|Lost to Follow-up|0|||
46654384|NCT03735121|82863283|FG004|Overall Study|Lost to Follow-up|1|||
46654385|NCT03735121|82863279|FG000|Overall Study|Ongoing|3|||
46654386|NCT03735121|82863280|FG001|Overall Study|Ongoing|3|||
46654387|NCT03735121|82863281|FG002|Overall Study|Ongoing|26|||
46654388|NCT03735121|82863282|FG003|Overall Study|Ongoing|83|||
46654389|NCT03735121|82863283|FG004|Overall Study|Ongoing|158|||
46654390|NCT03698994|82863307|FG000|Overall Study|Adverse Event|2|||
46654391|NCT03698994|82863307|FG000|Overall Study|Death|1|||
46654392|NCT03698994|82863307|FG000|Overall Study|Physician Decision|1|||
46654393|NCT03698994|82863307|FG000|Overall Study|Withdrawal by Subject|3|||
46654394|NCT03698994|82863307|FG000|Overall Study|Progressive Disease|12|||
46654395|NCT03602586|82863311|FG000|Overall Study|Withdrawal by Subject|3|||
46654396|NCT03583606|82863318|FG000|Overall Study|Lost to Follow-up|0|||
46654397|NCT03583606|82863319|FG001|Overall Study|Lost to Follow-up|1|||
46654398|NCT03583606|82863320|FG002|Overall Study|Lost to Follow-up|0|||
46654399|NCT03583606|82863318|FG000|Overall Study|Ineligible at baseline|1|||
46654400|NCT03583606|82863319|FG001|Overall Study|Ineligible at baseline|0|||
46654401|NCT03583606|82863320|FG002|Overall Study|Ineligible at baseline|0|||
46654402|NCT03580356|82863333|FG000|Treatment Period|Withdrawal by Subject|13|||
46654403|NCT03580356|82863334|FG001|Treatment Period|Withdrawal by Subject|0|||
46654404|NCT03580356|82863335|FG002|Treatment Period|Withdrawal by Subject|13|||
46654405|NCT03580356|82863336|FG003|Treatment Period|Withdrawal by Subject|1|||
46654406|NCT03580356|82863337|FG004|Treatment Period|Withdrawal by Subject|17|||
46654407|NCT03580356|82863338|FG005|Treatment Period|Withdrawal by Subject|0|||
46654408|NCT03580356|82863339|FG006|Treatment Period|Withdrawal by Subject|5|||
46781644|NCT00396409|83000199|FG001|Period 2 - 2008|Lost to Follow-up|1|||
46654409|NCT03580356|82863340|FG007|Treatment Period|Withdrawal by Subject|0|||
46654410|NCT03580356|82863333|FG000|Treatment Period|Adverse Event|10|||
46654411|NCT03580356|82863334|FG001|Treatment Period|Adverse Event|0|||
46654412|NCT03580356|82863335|FG002|Treatment Period|Adverse Event|13|||
46654413|NCT03580356|82863336|FG003|Treatment Period|Adverse Event|0|||
46654414|NCT03580356|82863337|FG004|Treatment Period|Adverse Event|5|||
46654415|NCT03580356|82863338|FG005|Treatment Period|Adverse Event|0|||
46654416|NCT03580356|82863339|FG006|Treatment Period|Adverse Event|8|||
46654417|NCT03580356|82863340|FG007|Treatment Period|Adverse Event|0|||
46654418|NCT03580356|82863333|FG000|Treatment Period|Protocol Violation|5|||
46654419|NCT03580356|82863334|FG001|Treatment Period|Protocol Violation|0|||
46654420|NCT03580356|82863335|FG002|Treatment Period|Protocol Violation|6|||
46654421|NCT03580356|82863336|FG003|Treatment Period|Protocol Violation|1|||
46654422|NCT03580356|82863337|FG004|Treatment Period|Protocol Violation|9|||
46654423|NCT03580356|82863338|FG005|Treatment Period|Protocol Violation|1|||
46654424|NCT03580356|82863339|FG006|Treatment Period|Protocol Violation|1|||
46654425|NCT03580356|82863340|FG007|Treatment Period|Protocol Violation|0|||
46654426|NCT03580356|82863333|FG000|Treatment Period|Lack of Efficacy|6|||
46654427|NCT03580356|82863334|FG001|Treatment Period|Lack of Efficacy|0|||
46654428|NCT03580356|82863335|FG002|Treatment Period|Lack of Efficacy|2|||
46654429|NCT03580356|82863336|FG003|Treatment Period|Lack of Efficacy|0|||
46654430|NCT03580356|82863337|FG004|Treatment Period|Lack of Efficacy|3|||
46654431|NCT03580356|82863338|FG005|Treatment Period|Lack of Efficacy|0|||
46654432|NCT03580356|82863339|FG006|Treatment Period|Lack of Efficacy|3|||
46654433|NCT03580356|82863340|FG007|Treatment Period|Lack of Efficacy|0|||
46654434|NCT03580356|82863333|FG000|Treatment Period|Pregnancy|1|||
46654435|NCT03580356|82863334|FG001|Treatment Period|Pregnancy|0|||
46654436|NCT03580356|82863335|FG002|Treatment Period|Pregnancy|7|||
46654437|NCT03580356|82863336|FG003|Treatment Period|Pregnancy|0|||
46654438|NCT03580356|82863337|FG004|Treatment Period|Pregnancy|2|||
46654439|NCT03580356|82863338|FG005|Treatment Period|Pregnancy|0|||
46654440|NCT03580356|82863339|FG006|Treatment Period|Pregnancy|1|||
46654441|NCT03580356|82863340|FG007|Treatment Period|Pregnancy|0|||
46654442|NCT03580356|82863333|FG000|Treatment Period|Physician Decision|2|||
46654443|NCT03580356|82863334|FG001|Treatment Period|Physician Decision|0|||
46654444|NCT03580356|82863335|FG002|Treatment Period|Physician Decision|1|||
46654445|NCT03580356|82863336|FG003|Treatment Period|Physician Decision|0|||
46654446|NCT03580356|82863337|FG004|Treatment Period|Physician Decision|4|||
46654447|NCT03580356|82863338|FG005|Treatment Period|Physician Decision|0|||
46654448|NCT03580356|82863339|FG006|Treatment Period|Physician Decision|2|||
46654449|NCT03580356|82863340|FG007|Treatment Period|Physician Decision|0|||
46654450|NCT03580356|82863333|FG000|Treatment Period|Lost to Follow-up|1|||
46654451|NCT03580356|82863334|FG001|Treatment Period|Lost to Follow-up|1|||
46654452|NCT03580356|82863335|FG002|Treatment Period|Lost to Follow-up|1|||
46654453|NCT03580356|82863336|FG003|Treatment Period|Lost to Follow-up|0|||
46654454|NCT03580356|82863337|FG004|Treatment Period|Lost to Follow-up|3|||
46654455|NCT03580356|82863338|FG005|Treatment Period|Lost to Follow-up|0|||
46654456|NCT03580356|82863339|FG006|Treatment Period|Lost to Follow-up|1|||
46654457|NCT03580356|82863340|FG007|Treatment Period|Lost to Follow-up|0|||
46654458|NCT03580356|82863333|FG000|Treatment Period|Death|0|||
46654459|NCT03580356|82863334|FG001|Treatment Period|Death|0|||
46654460|NCT03580356|82863335|FG002|Treatment Period|Death|1|||
46654461|NCT03580356|82863336|FG003|Treatment Period|Death|0|||
46654462|NCT03580356|82863337|FG004|Treatment Period|Death|0|||
46654463|NCT03580356|82863338|FG005|Treatment Period|Death|0|||
46654464|NCT03580356|82863339|FG006|Treatment Period|Death|0|||
46654465|NCT03580356|82863340|FG007|Treatment Period|Death|0|||
46654466|NCT03580356|82863333|FG000|Treatment Period|Technical problems|0|||
46654467|NCT03580356|82863334|FG001|Treatment Period|Technical problems|0|||
46654468|NCT03580356|82863335|FG002|Treatment Period|Technical problems|0|||
46654469|NCT03580356|82863336|FG003|Treatment Period|Technical problems|0|||
46654470|NCT03580356|82863337|FG004|Treatment Period|Technical problems|1|||
46654471|NCT03580356|82863338|FG005|Treatment Period|Technical problems|0|||
46654472|NCT03580356|82863339|FG006|Treatment Period|Technical problems|0|||
46654473|NCT03580356|82863340|FG007|Treatment Period|Technical problems|0|||
46654474|NCT03580356|82863333|FG000|Treatment Period|Misrandomized, no treatment|0|||
46654475|NCT03580356|82863334|FG001|Treatment Period|Misrandomized, no treatment|0|||
46971084|NCT02055976|83214459|FG003|Overall Study|Does not meet entrance criteria|0|||
46654476|NCT03580356|82863335|FG002|Treatment Period|Misrandomized, no treatment|1|||
46654477|NCT03580356|82863336|FG003|Treatment Period|Misrandomized, no treatment|0|||
46654478|NCT03580356|82863337|FG004|Treatment Period|Misrandomized, no treatment|2|||
46654479|NCT03580356|82863338|FG005|Treatment Period|Misrandomized, no treatment|0|||
46654480|NCT03580356|82863339|FG006|Treatment Period|Misrandomized, no treatment|0|||
46654481|NCT03580356|82863340|FG007|Treatment Period|Misrandomized, no treatment|0|||
46654482|NCT03580356|82863333|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
46654483|NCT03580356|82863334|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
46654484|NCT03580356|82863335|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
46654485|NCT03580356|82863336|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
46654486|NCT03580356|82863337|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
46654487|NCT03580356|82863338|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
46654488|NCT03580356|82863339|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
46654489|NCT03580356|82863340|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
46654490|NCT03580356|82863333|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
46654491|NCT03580356|82863334|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
46654492|NCT03580356|82863335|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
46654493|NCT03580356|82863336|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
46654494|NCT03580356|82863337|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
46654495|NCT03580356|82863338|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
46654496|NCT03580356|82863339|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
46654497|NCT03580356|82863340|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
46654498|NCT03580356|82863333|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
46654499|NCT03580356|82863334|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
46654500|NCT03580356|82863335|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
46654501|NCT03580356|82863336|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
46654502|NCT03580356|82863337|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
46654503|NCT03580356|82863338|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
46654504|NCT03580356|82863339|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
46654505|NCT03580356|82863340|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
46654506|NCT03580356|82863333|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
46654507|NCT03580356|82863334|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
46654508|NCT03580356|82863335|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
46654509|NCT03580356|82863336|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
46781645|NCT02924376|83000211|FG000|Overall Study|Progressive Disease|4|||
46781646|NCT02924376|83000212|FG001|Overall Study|Progressive Disease|0|||
46781647|NCT02924376|83000213|FG002|Overall Study|Progressive Disease|1|||
46781648|NCT02924376|83000214|FG003|Overall Study|Progressive Disease|0|||
46781649|NCT02924376|83000211|FG000|Overall Study|Death|73|||
46781650|NCT02924376|83000212|FG001|Overall Study|Death|18|||
46781651|NCT02924376|83000213|FG002|Overall Study|Death|15|||
46781652|NCT02924376|83000214|FG003|Overall Study|Death|2|||
46781653|NCT02924376|83000211|FG000|Overall Study|Lost to Follow-up|3|||
46781654|NCT02924376|83000212|FG001|Overall Study|Lost to Follow-up|0|||
46781655|NCT02924376|83000213|FG002|Overall Study|Lost to Follow-up|0|||
46781656|NCT02924376|83000214|FG003|Overall Study|Lost to Follow-up|0|||
46781657|NCT02924376|83000211|FG000|Overall Study|Study Terminated by Sponsor|19|||
46781658|NCT02924376|83000212|FG001|Overall Study|Study Terminated by Sponsor|0|||
46781659|NCT02924376|83000213|FG002|Overall Study|Study Terminated by Sponsor|0|||
46781660|NCT02924376|83000214|FG003|Overall Study|Study Terminated by Sponsor|0|||
46781661|NCT02924376|83000211|FG000|Overall Study|Physician Decision|1|||
46781662|NCT02924376|83000212|FG001|Overall Study|Physician Decision|0|||
46781663|NCT02924376|83000213|FG002|Overall Study|Physician Decision|0|||
46781664|NCT02924376|83000214|FG003|Overall Study|Physician Decision|0|||
46781665|NCT02924376|83000211|FG000|Overall Study|Withdrawal by Subject|7|||
46781666|NCT02924376|83000212|FG001|Overall Study|Withdrawal by Subject|2|||
46781667|NCT02924376|83000213|FG002|Overall Study|Withdrawal by Subject|1|||
46781668|NCT02924376|83000214|FG003|Overall Study|Withdrawal by Subject|0|||
46781669|NCT02924376|83000211|FG000|Overall Study|Rolled Over to Another Study|1|||
46781670|NCT02924376|83000212|FG001|Overall Study|Rolled Over to Another Study|0|||
46781671|NCT02924376|83000213|FG002|Overall Study|Rolled Over to Another Study|0|||
46781672|NCT02924376|83000214|FG003|Overall Study|Rolled Over to Another Study|0|||
46781673|NCT00693420|83000229|FG000|Overall Study|Adverse Event|4|||
46781674|NCT00693420|83000230|FG001|Overall Study|Adverse Event|4|||
46781675|NCT00693420|83000229|FG000|Overall Study|Lost to Follow-up|0|||
46781676|NCT00693420|83000230|FG001|Overall Study|Lost to Follow-up|3|||
46781677|NCT00693420|83000229|FG000|Overall Study|Withdrawal by Subject|1|||
46781678|NCT00693420|83000230|FG001|Overall Study|Withdrawal by Subject|0|||
46781679|NCT00693420|83000229|FG000|Overall Study|Protocol Violation|0|||
46781680|NCT00693420|83000230|FG001|Overall Study|Protocol Violation|2|||
46781681|NCT00693420|83000229|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
46781682|NCT00693420|83000230|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
46654510|NCT03580356|82863337|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
46654511|NCT03580356|82863338|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
46654512|NCT03580356|82863339|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
46781683|NCT00693420|83000229|FG000|Overall Study|Personal Reasons|1|||
46781684|NCT00693420|83000230|FG001|Overall Study|Personal Reasons|4|||
46781685|NCT00695136|83000236|FG000|Overall Study|Withdrawal by Subject|1|||
46781686|NCT00695136|83000236|FG000|Overall Study|unrelated adverse event|1|||
46781687|NCT00605176|83000252|FG000|Overall Study|Adverse Event|2|||
46781688|NCT00605176|83000253|FG001|Overall Study|Adverse Event|1|||
46781689|NCT00605176|83000254|FG002|Overall Study|Adverse Event|3|||
46781690|NCT00605176|83000252|FG000|Overall Study|Withdrawal by Subject|4|||
46781691|NCT00605176|83000253|FG001|Overall Study|Withdrawal by Subject|2|||
46781692|NCT00605176|83000254|FG002|Overall Study|Withdrawal by Subject|4|||
46654513|NCT03580356|82863340|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
46654514|NCT03580356|82863333|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
46654515|NCT03580356|82863334|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
46654516|NCT03580356|82863335|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
46654517|NCT03580356|82863336|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
46654518|NCT03580356|82863337|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
46654519|NCT03580356|82863338|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
46654520|NCT03580356|82863339|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
46654521|NCT03580356|82863340|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
46654522|NCT03580356|82863333|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
46654523|NCT03580356|82863334|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
46654524|NCT03580356|82863335|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
46654525|NCT03580356|82863336|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
46654526|NCT03580356|82863337|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
46654527|NCT03580356|82863338|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
46654528|NCT03580356|82863339|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
46654529|NCT03580356|82863340|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
46654530|NCT03580356|82863333|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
46654531|NCT03580356|82863334|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
46654532|NCT03580356|82863335|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
46654533|NCT03580356|82863336|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
46654534|NCT03580356|82863337|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
46654535|NCT03580356|82863338|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
46654536|NCT03580356|82863339|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
46654537|NCT03580356|82863340|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
46654538|NCT03220035|82863381|FG000|Overall Study|Adverse Event|1|||
46654539|NCT03220035|82863381|FG000|Overall Study|Protocol Violation|1|||
46654540|NCT03220035|82863381|FG000|Overall Study|Progressive Disease|2|||
46654541|NCT03213691|82863385|FG000|Overall Study|Adverse Event|2|||
46654542|NCT03213691|82863385|FG000|Overall Study|Death|3|||
46654543|NCT03213691|82863385|FG000|Overall Study|Physician Decision|1|||
46654544|NCT03213691|82863385|FG000|Overall Study|Progressive Disease|14|||
46654545|NCT03213691|82863385|FG000|Overall Study|Ineligible|1|||
46654546|NCT03213665|82863389|FG000|Overall Study|Adverse Event|1|||
46654547|NCT03213665|82863389|FG000|Overall Study|Physician Decision|2|||
46654548|NCT03213665|82863389|FG000|Overall Study|Withdrawal by Subject|3|||
46654549|NCT03213665|82863389|FG000|Overall Study|Progressive Disease|13|||
46654550|NCT03017885|82863416|FG000|Overall Study|Adverse Event|2|||
46654551|NCT03017885|82863417|FG001|Overall Study|Adverse Event|0|||
46654552|NCT03017885|82863418|FG002|Overall Study|Adverse Event|0|||
46654553|NCT03017885|82863419|FG003|Overall Study|Adverse Event|0|||
46654554|NCT03017885|82863420|FG004|Overall Study|Adverse Event|0|||
46654555|NCT03017885|82863421|FG005|Overall Study|Adverse Event|0|||
46654556|NCT03017885|82863416|FG000|Overall Study|Progression of disease|4|||
46654557|NCT03017885|82863417|FG001|Overall Study|Progression of disease|3|||
46654558|NCT03017885|82863418|FG002|Overall Study|Progression of disease|4|||
46654559|NCT03017885|82863419|FG003|Overall Study|Progression of disease|0|||
46654560|NCT03017885|82863420|FG004|Overall Study|Progression of disease|0|||
46654561|NCT03017885|82863421|FG005|Overall Study|Progression of disease|0|||
46654562|NCT03017885|82863416|FG000|Overall Study|Other than listed|1|||
46654563|NCT03017885|82863417|FG001|Overall Study|Other than listed|2|||
46654564|NCT03017885|82863418|FG002|Overall Study|Other than listed|1|||
46654565|NCT03017885|82863419|FG003|Overall Study|Other than listed|0|||
46654566|NCT03017885|82863420|FG004|Overall Study|Other than listed|0|||
46654567|NCT03017885|82863421|FG005|Overall Study|Other than listed|0|||
46654568|NCT03017885|82863416|FG000|Overall Study|Lost to Follow-up|2|||
46654569|NCT03017885|82863417|FG001|Overall Study|Lost to Follow-up|0|||
46654570|NCT03017885|82863418|FG002|Overall Study|Lost to Follow-up|3|||
46654571|NCT03017885|82863419|FG003|Overall Study|Lost to Follow-up|0|||
46654572|NCT03017885|82863420|FG004|Overall Study|Lost to Follow-up|0|||
46654573|NCT03017885|82863421|FG005|Overall Study|Lost to Follow-up|0|||
46654574|NCT03017885|82863416|FG000|Overall Study|Change to other anti-cancer therapy|0|||
46654575|NCT03017885|82863417|FG001|Overall Study|Change to other anti-cancer therapy|0|||
46654576|NCT03017885|82863418|FG002|Overall Study|Change to other anti-cancer therapy|1|||
46654577|NCT03017885|82863419|FG003|Overall Study|Change to other anti-cancer therapy|0|||
46971085|NCT02055976|83214460|FG004|Overall Study|Does not meet entrance criteria|0|||
46654578|NCT03017885|82863420|FG004|Overall Study|Change to other anti-cancer therapy|0|||
46654579|NCT03017885|82863421|FG005|Overall Study|Change to other anti-cancer therapy|0|||
46654580|NCT02828358|82863458|FG000|Overall Study|Physician Decision|7|||
46781693|NCT00605176|83000252|FG000|Overall Study|Lost to Follow-up|2|||
46781694|NCT00605176|83000253|FG001|Overall Study|Lost to Follow-up|2|||
46654581|NCT02828358|82863459|FG001|Overall Study|Physician Decision|1|||
46654582|NCT02828358|82863458|FG000|Overall Study|Treatment Failure|6|||
46654583|NCT02828358|82863459|FG001|Overall Study|Treatment Failure|0|||
46654584|NCT02828358|82863458|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
46654585|NCT02828358|82863459|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
46654586|NCT02828358|82863458|FG000|Overall Study|Refusal of further protocol therapy|2|||
46654587|NCT02828358|82863459|FG001|Overall Study|Refusal of further protocol therapy|0|||
46654588|NCT02828358|82863458|FG000|Overall Study|Relapse|25|||
46654589|NCT02828358|82863459|FG001|Overall Study|Relapse|0|||
46654590|NCT02828358|82863458|FG000|Overall Study|Still on therapy|5|||
46654591|NCT02828358|82863459|FG001|Overall Study|Still on therapy|0|||
46654592|NCT02589522|82863467|FG000|Overall Study|Physician Decision|1|||
46654593|NCT02589522|82863468|FG001|Overall Study|Physician Decision|2|||
46654594|NCT02589522|82863469|FG002|Overall Study|Physician Decision|0|||
46654595|NCT02589522|82863467|FG000|Overall Study|Did not start treatment|1|||
46654596|NCT02589522|82863468|FG001|Overall Study|Did not start treatment|0|||
46654597|NCT02589522|82863469|FG002|Overall Study|Did not start treatment|0|||
46654598|NCT02319837|82863480|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
46654599|NCT02319837|82863481|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
46654600|NCT02319837|82863482|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
46654601|NCT02319837|82863480|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
46654602|NCT02319837|82863481|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
46654603|NCT02319837|82863482|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
46654604|NCT02319837|82863480|FG000|Study Treatment Phase|Adverse Event|73|||
46654605|NCT02319837|82863481|FG001|Study Treatment Phase|Adverse Event|36|||
46654606|NCT02319837|82863482|FG002|Study Treatment Phase|Adverse Event|63|||
46654607|NCT02319837|82863480|FG000|Study Treatment Phase|Development of castration resistance|0|||
46654608|NCT02319837|82863481|FG001|Study Treatment Phase|Development of castration resistance|2|||
46654609|NCT02319837|82863482|FG002|Study Treatment Phase|Development of castration resistance|0|||
46654610|NCT02319837|82863480|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
46654611|NCT02319837|82863481|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
46654612|NCT02319837|82863482|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
46654613|NCT02319837|82863480|FG000|Study Treatment Phase|Protocol Violation|2|||
46654614|NCT02319837|82863481|FG001|Study Treatment Phase|Protocol Violation|2|||
46654615|NCT02319837|82863482|FG002|Study Treatment Phase|Protocol Violation|1|||
46654616|NCT02319837|82863480|FG000|Study Treatment Phase|Lost to Follow-up|0|||
46654617|NCT02319837|82863481|FG001|Study Treatment Phase|Lost to Follow-up|1|||
46654618|NCT02319837|82863482|FG002|Study Treatment Phase|Lost to Follow-up|0|||
46654619|NCT02319837|82863480|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
46654620|NCT02319837|82863481|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
46654621|NCT02319837|82863482|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
46654622|NCT02319837|82863480|FG000|Study Treatment Phase|Other|0|||
46654623|NCT02319837|82863481|FG001|Study Treatment Phase|Other|1|||
46654624|NCT02319837|82863482|FG002|Study Treatment Phase|Other|0|||
46654625|NCT02319837|82863480|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
46654626|NCT02319837|82863481|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
46654627|NCT02319837|82863482|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
46654628|NCT02319837|82863480|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
46654629|NCT02319837|82863481|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
46654630|NCT02319837|82863482|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
46654631|NCT02319837|82863480|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
46654632|NCT02319837|82863481|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
46654633|NCT02319837|82863482|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
46654634|NCT02319837|82863480|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
46654635|NCT02319837|82863481|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
46654636|NCT02319837|82863482|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
46654637|NCT02319837|82863480|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
46654638|NCT02319837|82863481|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
46654639|NCT02319837|82863482|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
46654640|NCT02319837|82863480|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
46654641|NCT02319837|82863481|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
46654642|NCT02319837|82863482|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
46654643|NCT02319837|82863480|FG000|Long-Term Follow-Up Phase|Death|33|||
46654644|NCT02319837|82863481|FG001|Long-Term Follow-Up Phase|Death|54|||
46654645|NCT02319837|82863482|FG002|Long-Term Follow-Up Phase|Death|42|||
46654646|NCT02231710|82863491|FG000|Overall Study|Physician Decision|1|||
46971086|NCT02055976|83214461|FG005|Overall Study|Does not meet entrance criteria|0|||
46971087|NCT02055976|83214462|FG006|Overall Study|Does not meet entrance criteria|1|||
46654647|NCT01572480|82863504|FG000|Participants Enrolled|Withdrawal by Subject|1|||
46654648|NCT01572480|82863504|FG000|Drug Administration|Discontinued drug/Off Study|1|||
46654649|NCT01572480|82863504|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
46654650|NCT01572480|82863504|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
46707451|NCT01196429|82922988|FG000|Overall Study|Ineligible - wrong cell type|1|||
46707452|NCT01196429|82922989|FG001|Overall Study|Ineligible - wrong cell type|0|||
46707453|NCT01196429|82922988|FG000|Overall Study|Refused - Never Treated|1|||
46707454|NCT01196429|82922989|FG001|Overall Study|Refused - Never Treated|0|||
46707455|NCT01157364|82923003|FG000|Overall Study|Other Reasons|1|||
46707456|NCT01157364|82923004|FG001|Overall Study|Other Reasons|1|||
46707457|NCT01157364|82923005|FG002|Overall Study|Other Reasons|2|||
46707458|NCT01157364|82923006|FG003|Overall Study|Other Reasons|1|||
46707459|NCT01157364|82923007|FG004|Overall Study|Other Reasons|0|||
46707460|NCT01157364|82923008|FG005|Overall Study|Other Reasons|0|||
46707461|NCT01157364|82923003|FG000|Overall Study|Personal Reasons|0|||
46707462|NCT01157364|82923004|FG001|Overall Study|Personal Reasons|2|||
46707463|NCT01157364|82923005|FG002|Overall Study|Personal Reasons|0|||
46707464|NCT01157364|82923006|FG003|Overall Study|Personal Reasons|0|||
46707465|NCT01157364|82923007|FG004|Overall Study|Personal Reasons|1|||
46707466|NCT01157364|82923008|FG005|Overall Study|Personal Reasons|1|||
46707467|NCT01157364|82923003|FG000|Overall Study|Lost to Follow-up|1|||
46707468|NCT01157364|82923004|FG001|Overall Study|Lost to Follow-up|0|||
46707469|NCT01157364|82923005|FG002|Overall Study|Lost to Follow-up|1|||
46707470|NCT01157364|82923006|FG003|Overall Study|Lost to Follow-up|0|||
46707471|NCT01157364|82923007|FG004|Overall Study|Lost to Follow-up|0|||
46707472|NCT01157364|82923008|FG005|Overall Study|Lost to Follow-up|0|||
46707473|NCT01157364|82923003|FG000|Overall Study|Lack of Efficacy|0|||
46707474|NCT01157364|82923004|FG001|Overall Study|Lack of Efficacy|0|||
46707475|NCT01157364|82923005|FG002|Overall Study|Lack of Efficacy|0|||
46707476|NCT01157364|82923006|FG003|Overall Study|Lack of Efficacy|1|||
46707477|NCT01157364|82923007|FG004|Overall Study|Lack of Efficacy|0|||
46707478|NCT01157364|82923008|FG005|Overall Study|Lack of Efficacy|0|||
46707479|NCT01157364|82923003|FG000|Overall Study|Adverse Event|0|||
46707480|NCT01157364|82923004|FG001|Overall Study|Adverse Event|1|||
46707481|NCT01157364|82923005|FG002|Overall Study|Adverse Event|1|||
46707482|NCT01157364|82923006|FG003|Overall Study|Adverse Event|0|||
46707483|NCT01157364|82923007|FG004|Overall Study|Adverse Event|1|||
46707484|NCT01157364|82923008|FG005|Overall Study|Adverse Event|0|||
46707485|NCT01195415|82923022|FG000|Overall Study|No repeat biopsy due to progression|2|||
46707486|NCT01195103|82923029|FG000|Overall Study|Withdrawal by Subject|1|||
46707487|NCT01195103|82923030|FG001|Overall Study|Withdrawal by Subject|0|||
46707488|NCT01195103|82923031|FG002|Overall Study|Withdrawal by Subject|0|||
46707489|NCT01194869|82923039|FG000|Overall Study|Disease Progression|2|||
46707490|NCT01194869|82923039|FG000|Overall Study|Toxicity|2|||
46707491|NCT01177800|82923045|FG000|Overall Study|Adverse Event|9|||
46707492|NCT01177800|82923046|FG001|Overall Study|Adverse Event|3|||
46707493|NCT01177800|82923045|FG000|Overall Study|Protocol Violation|0|||
46707494|NCT01177800|82923046|FG001|Overall Study|Protocol Violation|1|||
46707495|NCT01177800|82923045|FG000|Overall Study|Physician Decision|1|||
46707496|NCT01177800|82923046|FG001|Overall Study|Physician Decision|0|||
46707497|NCT01177800|82923045|FG000|Overall Study|Withdrawal of informed consent|0|||
46707498|NCT01177800|82923046|FG001|Overall Study|Withdrawal of informed consent|1|||
46707499|NCT01177722|82923056|FG000|Overall Study|Serious Adverse Event|0|||
46707500|NCT01177722|82923057|FG001|Overall Study|Serious Adverse Event|0|||
46707501|NCT01177722|82923058|FG002|Overall Study|Serious Adverse Event|1|||
46707502|NCT01177722|82923059|FG003|Overall Study|Serious Adverse Event|0|||
46707503|NCT01177722|82923056|FG000|Overall Study|Protocol Violation|0|||
46707504|NCT01177722|82923057|FG001|Overall Study|Protocol Violation|0|||
46707505|NCT01177722|82923058|FG002|Overall Study|Protocol Violation|1|||
46707506|NCT01177722|82923059|FG003|Overall Study|Protocol Violation|0|||
46707507|NCT01177722|82923056|FG000|Overall Study|Lost to Follow-up|3|||
46707508|NCT01177722|82923057|FG001|Overall Study|Lost to Follow-up|4|||
46707509|NCT01177722|82923058|FG002|Overall Study|Lost to Follow-up|3|||
46707510|NCT01177722|82923059|FG003|Overall Study|Lost to Follow-up|1|||
46707511|NCT01177722|82923056|FG000|Overall Study|Withdrawal by Subject|10|||
46707512|NCT01177722|82923057|FG001|Overall Study|Withdrawal by Subject|6|||
46707513|NCT01177722|82923058|FG002|Overall Study|Withdrawal by Subject|4|||
46707514|NCT01177722|82923059|FG003|Overall Study|Withdrawal by Subject|6|||
46707515|NCT01177410|82923073|FG000|Overall Study|Adverse Event|0|||
46707516|NCT01177410|82923074|FG001|Overall Study|Adverse Event|2|||
46707517|NCT01177410|82923075|FG002|Overall Study|Adverse Event|2|||
46707518|NCT01177410|82923073|FG000|Overall Study|Withdrawal by Subject|1|||
46707519|NCT01177410|82923074|FG001|Overall Study|Withdrawal by Subject|4|||
46707520|NCT01177410|82923075|FG002|Overall Study|Withdrawal by Subject|3|||
46707521|NCT01177410|82923073|FG000|Overall Study|Lost to Follow-up|0|||
46707522|NCT01177410|82923074|FG001|Overall Study|Lost to Follow-up|1|||
46707523|NCT01177410|82923075|FG002|Overall Study|Lost to Follow-up|0|||
46781695|NCT00605176|83000254|FG002|Overall Study|Lost to Follow-up|1|||
46654651|NCT01982760|82863510|FG000|Overall Study|Physician Decision|1|||
46654652|NCT01982760|82863511|FG001|Overall Study|Physician Decision|0|||
46654653|NCT01985022|82863519|FG000|Overall Study|Lost to Follow-up|0|||
46654654|NCT01985022|82863520|FG001|Overall Study|Lost to Follow-up|1|||
46654655|NCT01985022|82863519|FG000|Overall Study|Protocol Violation|0|||
46654656|NCT01985022|82863520|FG001|Overall Study|Protocol Violation|1|||
46654657|NCT01985022|82863519|FG000|Overall Study|Withdrawal by Subject|4|||
46654658|NCT01985022|82863520|FG001|Overall Study|Withdrawal by Subject|1|||
46654659|NCT01989676|82863528|FG000|Overall Study|Death|52|||
46654660|NCT01989676|82863529|FG001|Overall Study|Death|60|||
46654661|NCT01989676|82863528|FG000|Overall Study|Protocol Violation|2|||
46654662|NCT01989676|82863529|FG001|Overall Study|Protocol Violation|1|||
46654663|NCT01989676|82863528|FG000|Overall Study|Lost to Follow-up|8|||
46654664|NCT01989676|82863529|FG001|Overall Study|Lost to Follow-up|18|||
46654665|NCT01989676|82863528|FG000|Overall Study|No longer willing to participate in study|26|||
46654666|NCT01989676|82863529|FG001|Overall Study|No longer willing to participate in study|26|||
46654667|NCT01989676|82863528|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
46654668|NCT01989676|82863529|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
46654669|NCT01989676|82863528|FG000|Overall Study|Other|4|||
46654670|NCT01989676|82863529|FG001|Overall Study|Other|3|||
46654671|NCT02001974|82863539|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
46654672|NCT02001974|82863540|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
46654673|NCT02001974|82863541|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
46654674|NCT02001974|82863539|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
46654675|NCT02001974|82863540|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
46654676|NCT02001974|82863541|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
46654677|NCT02001974|82863539|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
46654678|NCT02001974|82863540|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
46654679|NCT02001974|82863541|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
46654680|NCT02001974|82863539|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
46654681|NCT02001974|82863540|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
46654682|NCT02001974|82863541|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
46654683|NCT05229406|82863579|FG000|Overall Study|Withdrawal by Subject|1|||
46654684|NCT05229406|82863580|FG001|Overall Study|Withdrawal by Subject|2|||
46654685|NCT04971187|82863595|FG000|Overall Study|Screen failures|2|||
46654686|NCT04756154|82863620|FG000|Overall Study|Did not meet treatment day baseline|30|||
46654687|NCT04756154|82863621|FG001|Overall Study|Did not meet treatment day baseline|28|||
46654688|NCT04756154|82863622|FG002|Overall Study|Did not meet treatment day baseline|7|||
46654689|NCT04756154|82863620|FG000|Overall Study|Did not return for final sample collection|1|||
46654690|NCT04756154|82863621|FG001|Overall Study|Did not return for final sample collection|1|||
46654691|NCT04756154|82863622|FG002|Overall Study|Did not return for final sample collection|0|||
46654692|NCT04614246|82863640|FG000|Overall Study|Adverse Event|0|||
46654693|NCT04614246|82863641|FG001|Overall Study|Adverse Event|1|||
46654694|NCT04614246|82863642|FG002|Overall Study|Adverse Event|1|||
46971088|NCT02055976|83214463|FG007|Overall Study|Does not meet entrance criteria|0|||
46971089|NCT02055976|83214464|FG008|Overall Study|Does not meet entrance criteria|0|||
46971090|NCT02055976|83214456|FG000|Overall Study|Lost to Follow-up|0|||
46971091|NCT02055976|83214457|FG001|Overall Study|Lost to Follow-up|0|||
46971092|NCT02055976|83214458|FG002|Overall Study|Lost to Follow-up|0|||
46971093|NCT02055976|83214459|FG003|Overall Study|Lost to Follow-up|1|||
46971094|NCT02055976|83214460|FG004|Overall Study|Lost to Follow-up|0|||
46971095|NCT02055976|83214461|FG005|Overall Study|Lost to Follow-up|0|||
46971096|NCT02055976|83214462|FG006|Overall Study|Lost to Follow-up|0|||
46971097|NCT02055976|83214463|FG007|Overall Study|Lost to Follow-up|0|||
46971098|NCT02055976|83214464|FG008|Overall Study|Lost to Follow-up|0|||
46971099|NCT02055898|83214493|FG000|First Intervention (5 Days)|Physician Decision|2|||
46971100|NCT02055898|83214494|FG001|First Intervention (5 Days)|Physician Decision|0|||
46654695|NCT04614246|82863643|FG003|Overall Study|Adverse Event|2|||
46654696|NCT04614246|82863644|FG004|Overall Study|Adverse Event|1|||
46654697|NCT04614246|82863640|FG000|Overall Study|Lost to Follow-up|0|||
46654698|NCT04614246|82863641|FG001|Overall Study|Lost to Follow-up|1|||
46654699|NCT04614246|82863642|FG002|Overall Study|Lost to Follow-up|0|||
46654700|NCT04614246|82863643|FG003|Overall Study|Lost to Follow-up|1|||
46971101|NCT02055898|83214493|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
46971102|NCT02055898|83214494|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
46971103|NCT02564055|83214506|FG000|Overall Study|Adverse Event|1|||
46971104|NCT02564055|83214507|FG001|Overall Study|Adverse Event|0|||
46971105|NCT02564055|83214508|FG002|Overall Study|Adverse Event|4|||
46654701|NCT04614246|82863644|FG004|Overall Study|Lost to Follow-up|3|||
46654702|NCT04614246|82863640|FG000|Overall Study|Other reason|0|||
46654703|NCT04614246|82863641|FG001|Overall Study|Other reason|1|||
46971106|NCT02564055|83214509|FG003|Overall Study|Adverse Event|1|||
46971107|NCT02564055|83214510|FG004|Overall Study|Adverse Event|4|||
46971108|NCT02564055|83214511|FG005|Overall Study|Adverse Event|1|||
46971109|NCT02564055|83214506|FG000|Overall Study|Protocol Violation|1|||
46971110|NCT02564055|83214507|FG001|Overall Study|Protocol Violation|0|||
46971111|NCT02564055|83214508|FG002|Overall Study|Protocol Violation|0|||
46971112|NCT02564055|83214509|FG003|Overall Study|Protocol Violation|0|||
46971113|NCT02564055|83214510|FG004|Overall Study|Protocol Violation|0|||
46971114|NCT02564055|83214511|FG005|Overall Study|Protocol Violation|0|||
46971115|NCT02564055|83214506|FG000|Overall Study|Reached stopping criteria|0|||
46971116|NCT02564055|83214507|FG001|Overall Study|Reached stopping criteria|0|||
46971117|NCT02564055|83214508|FG002|Overall Study|Reached stopping criteria|0|||
46971118|NCT02564055|83214509|FG003|Overall Study|Reached stopping criteria|0|||
46654704|NCT04614246|82863642|FG002|Overall Study|Other reason|2|||
46654705|NCT04614246|82863643|FG003|Overall Study|Other reason|0|||
46654706|NCT04614246|82863644|FG004|Overall Study|Other reason|0|||
46654707|NCT04614246|82863640|FG000|Overall Study|Withdrawal by Subject|4|||
46654708|NCT04614246|82863641|FG001|Overall Study|Withdrawal by Subject|2|||
46654709|NCT04614246|82863642|FG002|Overall Study|Withdrawal by Subject|4|||
46654710|NCT04614246|82863643|FG003|Overall Study|Withdrawal by Subject|3|||
46654711|NCT04614246|82863644|FG004|Overall Study|Withdrawal by Subject|4|||
46654712|NCT04614246|82863640|FG000|Overall Study|Physician Decision|0|||
46654713|NCT04614246|82863641|FG001|Overall Study|Physician Decision|2|||
46654714|NCT04614246|82863642|FG002|Overall Study|Physician Decision|1|||
46654715|NCT04614246|82863643|FG003|Overall Study|Physician Decision|0|||
46654716|NCT04614246|82863644|FG004|Overall Study|Physician Decision|0|||
46654717|NCT04614246|82863640|FG000|Overall Study|Study terminated by sponsor|10|||
46654718|NCT04614246|82863641|FG001|Overall Study|Study terminated by sponsor|15|||
46654719|NCT04614246|82863642|FG002|Overall Study|Study terminated by sponsor|12|||
46654720|NCT04614246|82863643|FG003|Overall Study|Study terminated by sponsor|13|||
46654721|NCT04614246|82863644|FG004|Overall Study|Study terminated by sponsor|9|||
46654722|NCT04614246|82863640|FG000|Overall Study|Pregnancy|2|||
46654723|NCT04614246|82863641|FG001|Overall Study|Pregnancy|0|||
46654724|NCT04614246|82863642|FG002|Overall Study|Pregnancy|1|||
46654725|NCT04614246|82863643|FG003|Overall Study|Pregnancy|0|||
46654726|NCT04614246|82863644|FG004|Overall Study|Pregnancy|0|||
46654727|NCT04593823|82863662|FG000|Overall Study|Withdrawal by Subject|1|||
46654728|NCT04593823|82863663|FG001|Overall Study|Withdrawal by Subject|1|||
46654729|NCT04593823|82863662|FG000|Overall Study|Lost to Follow-up|0|||
46654730|NCT04593823|82863663|FG001|Overall Study|Lost to Follow-up|1|||
46654731|NCT04556383|82863683|FG000|PCP|Lack of Efficacy|28|||
46654732|NCT04556383|82863684|FG001|PCP|Lack of Efficacy|23|||
46654733|NCT04556383|82863685|FG002|PCP|Lack of Efficacy|23|||
46654734|NCT04556383|82863686|FG003|PCP|Lack of Efficacy|0|||
46654735|NCT04556383|82863683|FG000|PCP|Study terminated by sponsor|15|||
46654736|NCT04556383|82863684|FG001|PCP|Study terminated by sponsor|13|||
46654737|NCT04556383|82863685|FG002|PCP|Study terminated by sponsor|16|||
46654738|NCT04556383|82863686|FG003|PCP|Study terminated by sponsor|0|||
46654739|NCT04556383|82863683|FG000|PCP|Withdrawal by Subject|8|||
46654740|NCT04556383|82863684|FG001|PCP|Withdrawal by Subject|6|||
46654741|NCT04556383|82863685|FG002|PCP|Withdrawal by Subject|6|||
46654742|NCT04556383|82863686|FG003|PCP|Withdrawal by Subject|0|||
46654743|NCT04556383|82863683|FG000|PCP|Adverse Event|1|||
46654744|NCT04556383|82863684|FG001|PCP|Adverse Event|7|||
46654745|NCT04556383|82863685|FG002|PCP|Adverse Event|7|||
46654746|NCT04556383|82863686|FG003|PCP|Adverse Event|0|||
46654747|NCT04556383|82863683|FG000|PCP|Other, Not Specified|1|||
46654748|NCT04556383|82863684|FG001|PCP|Other, Not Specified|2|||
46654749|NCT04556383|82863685|FG002|PCP|Other, Not Specified|1|||
46654750|NCT04556383|82863686|FG003|PCP|Other, Not Specified|0|||
46654751|NCT04556383|82863683|FG000|PCP|Protocol Violation|1|||
46654752|NCT04556383|82863684|FG001|PCP|Protocol Violation|0|||
46654753|NCT04556383|82863685|FG002|PCP|Protocol Violation|1|||
46654754|NCT04556383|82863686|FG003|PCP|Protocol Violation|0|||
46654755|NCT04556383|82863683|FG000|PCP|Lost to Follow-up|1|||
46654756|NCT04556383|82863684|FG001|PCP|Lost to Follow-up|0|||
46654757|NCT04556383|82863685|FG002|PCP|Lost to Follow-up|0|||
46654758|NCT04556383|82863686|FG003|PCP|Lost to Follow-up|0|||
46654759|NCT04556383|82863683|FG000|PCP|Physician Decision|0|||
46654760|NCT04556383|82863684|FG001|PCP|Physician Decision|1|||
46654761|NCT04556383|82863685|FG002|PCP|Physician Decision|0|||
46654762|NCT04556383|82863686|FG003|PCP|Physician Decision|0|||
46654763|NCT04556383|82863683|FG000|PCP|Site terminated by sponsor|0|||
46781696|NCT00605176|83000252|FG000|Overall Study|Non-complicance with study procedures|1|||
46654764|NCT04556383|82863684|FG001|PCP|Site terminated by sponsor|1|||
46971119|NCT02564055|83214510|FG004|Overall Study|Reached stopping criteria|0|||
46654765|NCT04556383|82863685|FG002|PCP|Site terminated by sponsor|0|||
46971120|NCT02564055|83214511|FG005|Overall Study|Reached stopping criteria|1|||
46971121|NCT02564055|83214506|FG000|Overall Study|Lost to Follow-up|0|||
46654766|NCT04556383|82863686|FG003|PCP|Site terminated by sponsor|0|||
46654767|NCT04556383|82863683|FG000|OLE|Study terminated by sponsor|0|||
46654768|NCT04556383|82863684|FG001|OLE|Study terminated by sponsor|0|||
46654769|NCT04556383|82863685|FG002|OLE|Study terminated by sponsor|0|||
46654770|NCT04556383|82863686|FG003|OLE|Study terminated by sponsor|68|||
46654771|NCT04556383|82863683|FG000|OLE|Withdrawal by Subject|0|||
46654772|NCT04556383|82863684|FG001|OLE|Withdrawal by Subject|0|||
46971122|NCT02564055|83214507|FG001|Overall Study|Lost to Follow-up|1|||
46654773|NCT04556383|82863685|FG002|OLE|Withdrawal by Subject|0|||
46654774|NCT04556383|82863686|FG003|OLE|Withdrawal by Subject|10|||
46654775|NCT04556383|82863683|FG000|OLE|Lack of Efficacy|0|||
46654776|NCT04556383|82863684|FG001|OLE|Lack of Efficacy|0|||
46654777|NCT04556383|82863685|FG002|OLE|Lack of Efficacy|0|||
46654778|NCT04556383|82863686|FG003|OLE|Lack of Efficacy|7|||
46654779|NCT04556383|82863683|FG000|OLE|Adverse Event|0|||
46654780|NCT04556383|82863684|FG001|OLE|Adverse Event|0|||
46654781|NCT04556383|82863685|FG002|OLE|Adverse Event|0|||
46654782|NCT04556383|82863686|FG003|OLE|Adverse Event|2|||
46654783|NCT04556383|82863683|FG000|OLE|Other, Not Specified|0|||
46654784|NCT04556383|82863684|FG001|OLE|Other, Not Specified|0|||
46850830|NCT00112047|83066651|FG000|Randomized Phase|Noncompliance|8|||
46850831|NCT00112047|83066652|FG001|Randomized Phase|Noncompliance|4|||
46850832|NCT00112047|83066651|FG000|Randomized Phase|Protocol Violation|2|||
46850833|NCT00112047|83066652|FG001|Randomized Phase|Protocol Violation|0|||
46850834|NCT00112047|83066651|FG000|Randomized Phase|Pregnancy|3|||
46971123|NCT02564055|83214508|FG002|Overall Study|Lost to Follow-up|4|||
46654785|NCT04556383|82863685|FG002|OLE|Other, Not Specified|0|||
46654786|NCT04556383|82863686|FG003|OLE|Other, Not Specified|2|||
46654787|NCT04556383|82863683|FG000|OLE|Death|0|||
46654788|NCT04556383|82863684|FG001|OLE|Death|0|||
46654789|NCT04556383|82863685|FG002|OLE|Death|0|||
46654790|NCT04556383|82863686|FG003|OLE|Death|1|||
46654791|NCT04556383|82863683|FG000|OLE|Lost to Follow-up|0|||
46654792|NCT04556383|82863684|FG001|OLE|Lost to Follow-up|0|||
46654793|NCT04556383|82863685|FG002|OLE|Lost to Follow-up|0|||
46654794|NCT04556383|82863686|FG003|OLE|Lost to Follow-up|1|||
46654795|NCT04444752|82863720|FG000|Overall Study|Adverse Event|1|||
46654796|NCT04444752|82863721|FG001|Overall Study|Adverse Event|0|||
46654797|NCT04444752|82863722|FG002|Overall Study|Adverse Event|0|||
46654798|NCT04444752|82863723|FG003|Overall Study|Adverse Event|2|||
46654799|NCT04444752|82863720|FG000|Overall Study|Lost to Follow-up|2|||
46654800|NCT04444752|82863721|FG001|Overall Study|Lost to Follow-up|6|||
46654801|NCT04444752|82863722|FG002|Overall Study|Lost to Follow-up|2|||
46654802|NCT04444752|82863723|FG003|Overall Study|Lost to Follow-up|5|||
46654803|NCT04444752|82863720|FG000|Overall Study|Physician Decision|0|||
46654804|NCT04444752|82863721|FG001|Overall Study|Physician Decision|0|||
46654805|NCT04444752|82863722|FG002|Overall Study|Physician Decision|0|||
46654806|NCT04444752|82863723|FG003|Overall Study|Physician Decision|2|||
46654807|NCT04444752|82863720|FG000|Overall Study|Pregnancy|0|||
46654808|NCT04444752|82863721|FG001|Overall Study|Pregnancy|0|||
46654809|NCT04444752|82863722|FG002|Overall Study|Pregnancy|0|||
46654810|NCT04444752|82863723|FG003|Overall Study|Pregnancy|1|||
46654811|NCT04444752|82863720|FG000|Overall Study|Withdrawal by Subject|6|||
46654812|NCT04444752|82863721|FG001|Overall Study|Withdrawal by Subject|5|||
46781697|NCT00605176|83000253|FG001|Overall Study|Non-complicance with study procedures|0|||
46781698|NCT00605176|83000254|FG002|Overall Study|Non-complicance with study procedures|0|||
46781699|NCT00605176|83000252|FG000|Overall Study|Use of concomitant therapy|1|||
46781700|NCT00605176|83000253|FG001|Overall Study|Use of concomitant therapy|0|||
46781701|NCT00605176|83000254|FG002|Overall Study|Use of concomitant therapy|1|||
46781702|NCT00605176|83000252|FG000|Overall Study|Other (not due to AE)|1|||
46781703|NCT00605176|83000253|FG001|Overall Study|Other (not due to AE)|1|||
46781704|NCT00605176|83000254|FG002|Overall Study|Other (not due to AE)|0|||
46781705|NCT00694356|83000265|FG000|Overall Study|Adverse Event|1|||
46781706|NCT00694356|83000266|FG001|Overall Study|Adverse Event|0|||
46971124|NCT02564055|83214509|FG003|Overall Study|Lost to Follow-up|2|||
46654813|NCT04444752|82863722|FG002|Overall Study|Withdrawal by Subject|3|||
46654814|NCT04444752|82863723|FG003|Overall Study|Withdrawal by Subject|4|||
46654815|NCT04444752|82863720|FG000|Overall Study|Protocol Violation|1|||
46654816|NCT04444752|82863721|FG001|Overall Study|Protocol Violation|1|||
46654817|NCT04444752|82863722|FG002|Overall Study|Protocol Violation|0|||
46654818|NCT04444752|82863723|FG003|Overall Study|Protocol Violation|0|||
46654819|NCT04444752|82863720|FG000|Overall Study|Patient moving out of town|1|||
46654820|NCT04444752|82863721|FG001|Overall Study|Patient moving out of town|0|||
46654821|NCT04444752|82863722|FG002|Overall Study|Patient moving out of town|0|||
46654822|NCT04444752|82863723|FG003|Overall Study|Patient moving out of town|1|||
46654823|NCT04444752|82863720|FG000|Overall Study|Lack of Efficacy|0|||
46654824|NCT04444752|82863721|FG001|Overall Study|Lack of Efficacy|0|||
46654825|NCT04444752|82863722|FG002|Overall Study|Lack of Efficacy|0|||
46781707|NCT00694356|83000267|FG002|Overall Study|Adverse Event|0|||
46971125|NCT02564055|83214510|FG004|Overall Study|Lost to Follow-up|1|||
46971126|NCT02564055|83214511|FG005|Overall Study|Lost to Follow-up|0|||
46781708|NCT00694356|83000265|FG000|Overall Study|Progressive Disease|2|||
46654826|NCT04444752|82863723|FG003|Overall Study|Lack of Efficacy|1|||
46654827|NCT04444752|82863720|FG000|Overall Study|Death|0|||
46654828|NCT04444752|82863721|FG001|Overall Study|Death|0|||
46654829|NCT04444752|82863722|FG002|Overall Study|Death|1|||
46654830|NCT04444752|82863723|FG003|Overall Study|Death|0|||
46654831|NCT04429022|82863735|FG000|Overall Study|Protocol Violation|18|||
46654832|NCT04429022|82863736|FG001|Overall Study|Protocol Violation|1|||
46654833|NCT04351373|82863766|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
46654834|NCT04239924|82863779|FG000|Overall Study|Lost to Follow-up|2|||
46654835|NCT04154904|82863791|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
46654836|NCT04154904|82863792|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
46654837|NCT04154904|82863793|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
46654838|NCT04034238|82863815|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
46654839|NCT04034238|82863816|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
46654840|NCT04034238|82863817|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
46654841|NCT04034238|82863818|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
46654842|NCT04034238|82863815|FG000|Dose Escalation Phase|Screen failures|0|||
46654843|NCT04034238|82863816|FG001|Dose Escalation Phase|Screen failures|0|||
46654844|NCT04034238|82863817|FG002|Dose Escalation Phase|Screen failures|0|||
46654845|NCT04034238|82863818|FG003|Dose Escalation Phase|Screen failures|2|||
46654846|NCT04034238|82863815|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
46654847|NCT04034238|82863816|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
46654848|NCT04034238|82863817|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
46654849|NCT04034238|82863818|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
46654850|NCT04034238|82863815|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
46654851|NCT04034238|82863816|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
46654852|NCT04034238|82863817|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
46654853|NCT04034238|82863818|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
46654854|NCT03956056|82863829|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
46654855|NCT03956056|82863829|FG000|Overall Study|Lack of Efficacy|1|||
46654856|NCT03954041|82863836|FG000|Overall Study|Lost to Follow-up|3|||
46654857|NCT03954041|82863837|FG001|Overall Study|Lost to Follow-up|3|||
46654858|NCT03954041|82863838|FG002|Overall Study|Lost to Follow-up|6|||
46654859|NCT03954041|82863836|FG000|Overall Study|Death|4|||
46654860|NCT03954041|82863837|FG001|Overall Study|Death|0|||
46654861|NCT03954041|82863838|FG002|Overall Study|Death|1|||
46654862|NCT03954041|82863836|FG000|Overall Study|Death by neurologic criteria|0|||
46654863|NCT03954041|82863837|FG001|Overall Study|Death by neurologic criteria|0|||
46654864|NCT03954041|82863838|FG002|Overall Study|Death by neurologic criteria|1|||
46654865|NCT03954041|82863836|FG000|Overall Study|Reason not specified|7|||
46654866|NCT03954041|82863837|FG001|Overall Study|Reason not specified|4|||
46654867|NCT03954041|82863838|FG002|Overall Study|Reason not specified|2|||
46654868|NCT03954041|82863836|FG000|Overall Study|Withdrew prior to dosing|4|||
46654869|NCT03954041|82863837|FG001|Overall Study|Withdrew prior to dosing|2|||
46654870|NCT03954041|82863838|FG002|Overall Study|Withdrew prior to dosing|0|||
46654871|NCT03926195|82863848|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
46654872|NCT03926195|82863849|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
46654873|NCT03926195|82863848|FG000|EXT Phase (Through Week 26)|Ongoing in the study|29|||
46654874|NCT03926195|82863849|FG001|EXT Phase (Through Week 26)|Ongoing in the study|36|||
46654875|NCT03926195|82863848|FG000|EXT Phase (Through Week 26)|Adverse Event|5|||
46654876|NCT03926195|82863849|FG001|EXT Phase (Through Week 26)|Adverse Event|0|||
46781709|NCT00694356|83000266|FG001|Overall Study|Progressive Disease|6|||
46781710|NCT00694356|83000267|FG002|Overall Study|Progressive Disease|6|||
46781711|NCT00692406|83000275|FG000|Overall Study|PI dropped, bad data|57|||
46781712|NCT00567502|83000292|FG000|Overall Study|Lost to Follow-up|91|||
46781713|NCT00567502|83000293|FG001|Overall Study|Lost to Follow-up|14|||
46781714|NCT00567502|83000294|FG002|Overall Study|Lost to Follow-up|351|||
46781715|NCT00567502|83000295|FG003|Overall Study|Lost to Follow-up|2|||
46781716|NCT00567502|83000292|FG000|Overall Study|Death|65|||
46781717|NCT00567502|83000293|FG001|Overall Study|Death|16|||
46781718|NCT00567502|83000294|FG002|Overall Study|Death|360|||
46781719|NCT00567502|83000295|FG003|Overall Study|Death|5|||
46781720|NCT00567502|83000292|FG000|Overall Study|Other|64|||
46781721|NCT00567502|83000293|FG001|Overall Study|Other|2|||
46781722|NCT00567502|83000294|FG002|Overall Study|Other|134|||
46781723|NCT00567502|83000295|FG003|Overall Study|Other|6|||
46781724|NCT00567502|83000292|FG000|Overall Study|Participant request|12|||
46781725|NCT00567502|83000293|FG001|Overall Study|Participant request|1|||
46654877|NCT03926195|82863848|FG000|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|12|||
46654878|NCT03926195|82863849|FG001|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|11|||
46781726|NCT00567502|83000294|FG002|Overall Study|Participant request|33|||
46781727|NCT00567502|83000295|FG003|Overall Study|Participant request|1|||
46781728|NCT00567502|83000292|FG000|Overall Study|Sponsor request|9|||
46781729|NCT00567502|83000293|FG001|Overall Study|Sponsor request|0|||
46781730|NCT00567502|83000294|FG002|Overall Study|Sponsor request|30|||
46781731|NCT00567502|83000295|FG003|Overall Study|Sponsor request|1|||
46781732|NCT00567502|83000292|FG000|Overall Study|Never Initiated Treatment|0|||
46781733|NCT00567502|83000293|FG001|Overall Study|Never Initiated Treatment|0|||
46781734|NCT00567502|83000294|FG002|Overall Study|Never Initiated Treatment|0|||
46654879|NCT03926195|82863848|FG000|EXT Phase (Through Week 26)|Withdrawal by Subject|0|||
46654880|NCT03926195|82863849|FG001|EXT Phase (Through Week 26)|Withdrawal by Subject|2|||
46781735|NCT00567502|83000295|FG003|Overall Study|Never Initiated Treatment|72|||
46654881|NCT03908476|82863864|FG000|Overall Study|Death|3|||
46654882|NCT03908476|82863865|FG001|Overall Study|Death|0|||
46654883|NCT03908476|82863864|FG000|Overall Study|Lost to Follow-up|3|||
46654884|NCT03908476|82863865|FG001|Overall Study|Lost to Follow-up|1|||
46654885|NCT03908476|82863864|FG000|Overall Study|Withdrawal by Subject|7|||
46654886|NCT03908476|82863865|FG001|Overall Study|Withdrawal by Subject|1|||
46654887|NCT03908476|82863864|FG000|Overall Study|Physician Decision|2|||
46654888|NCT03908476|82863865|FG001|Overall Study|Physician Decision|0|||
46654889|NCT03908476|82863864|FG000|Overall Study|System Explanted and not Replaced|4|||
46654890|NCT03908476|82863865|FG001|Overall Study|System Explanted and not Replaced|0|||
46654891|NCT03908476|82863864|FG000|Overall Study|Intrathecal Pump|1|||
46654892|NCT03908476|82863865|FG001|Overall Study|Intrathecal Pump|0|||
46654893|NCT03908476|82863864|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
46654894|NCT03908476|82863865|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
46654895|NCT03830866|82863873|FG000|Overall Study|Ongoing study at DCO|312|||
46654896|NCT03830866|82863874|FG001|Overall Study|Ongoing study at DCO|295|||
46654897|NCT03830866|82863873|FG000|Overall Study|Death|58|||
46654898|NCT03830866|82863874|FG001|Overall Study|Death|74|||
46654899|NCT03830866|82863873|FG000|Overall Study|Lost to Follow-up|0|||
46654900|NCT03830866|82863874|FG001|Overall Study|Lost to Follow-up|1|||
46654901|NCT03830866|82863873|FG000|Overall Study|Withdrawal by Subject|15|||
46654902|NCT03830866|82863874|FG001|Overall Study|Withdrawal by Subject|13|||
46654903|NCT03830866|82863873|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
46654904|NCT03830866|82863874|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
46654905|NCT03830866|82863873|FG000|Overall Study|Other|0|||
46654906|NCT03830866|82863874|FG001|Overall Study|Other|1|||
46654907|NCT03699007|82863891|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
46654908|NCT03699007|82863892|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
46654909|NCT03699007|82863891|FG000|6-month Follow Up|Lost to Follow-up|2|||
46654910|NCT03699007|82863892|FG001|6-month Follow Up|Lost to Follow-up|3|||
46654911|NCT03581188|82863902|FG000|Overall Study|Inclusion criteria not met|3|||
46654912|NCT03581188|82863903|FG001|Overall Study|Inclusion criteria not met|2|||
46654913|NCT03581188|82863902|FG000|Overall Study|Lost to Follow-up|5|||
46654914|NCT03581188|82863903|FG001|Overall Study|Lost to Follow-up|5|||
46654915|NCT03581188|82863902|FG000|Overall Study|Discontinued intervention|11|||
46654916|NCT03581188|82863903|FG001|Overall Study|Discontinued intervention|8|||
46654917|NCT03576131|82863920|FG000|Overall Study|Investigator decision|0|||
46654918|NCT03576131|82863921|FG001|Overall Study|Investigator decision|0|||
46654919|NCT03576131|82863922|FG002|Overall Study|Investigator decision|0|||
46654920|NCT03576131|82863923|FG003|Overall Study|Investigator decision|1|||
46654921|NCT03576131|82863924|FG004|Overall Study|Investigator decision|0|||
46654922|NCT03576131|82863925|FG005|Overall Study|Investigator decision|1|||
46850835|NCT00112047|83066652|FG001|Randomized Phase|Pregnancy|1|||
46654923|NCT03576131|82863926|FG006|Overall Study|Investigator decision|0|||
46654924|NCT03576131|82863927|FG007|Overall Study|Investigator decision|0|||
46654925|NCT03576131|82863920|FG000|Overall Study|Withdrawal by Subject|1|||
46654926|NCT03576131|82863921|FG001|Overall Study|Withdrawal by Subject|1|||
46654927|NCT03576131|82863922|FG002|Overall Study|Withdrawal by Subject|0|||
46654928|NCT03576131|82863923|FG003|Overall Study|Withdrawal by Subject|1|||
46654929|NCT03576131|82863924|FG004|Overall Study|Withdrawal by Subject|2|||
46654930|NCT03576131|82863925|FG005|Overall Study|Withdrawal by Subject|3|||
46654931|NCT03576131|82863926|FG006|Overall Study|Withdrawal by Subject|1|||
46654932|NCT03576131|82863927|FG007|Overall Study|Withdrawal by Subject|0|||
46654933|NCT03576131|82863920|FG000|Overall Study|Death|3|||
46654934|NCT03576131|82863921|FG001|Overall Study|Death|3|||
46654935|NCT03576131|82863922|FG002|Overall Study|Death|1|||
46654936|NCT03576131|82863923|FG003|Overall Study|Death|5|||
46654937|NCT03576131|82863924|FG004|Overall Study|Death|4|||
46654938|NCT03576131|82863925|FG005|Overall Study|Death|1|||
46654939|NCT03576131|82863926|FG006|Overall Study|Death|0|||
46654940|NCT03576131|82863927|FG007|Overall Study|Death|1|||
46654941|NCT03576131|82863920|FG000|Overall Study|New anti-cancer treatment|5|||
46654942|NCT03576131|82863921|FG001|Overall Study|New anti-cancer treatment|1|||
46654943|NCT03576131|82863922|FG002|Overall Study|New anti-cancer treatment|2|||
46654944|NCT03576131|82863923|FG003|Overall Study|New anti-cancer treatment|3|||
46654945|NCT03576131|82863924|FG004|Overall Study|New anti-cancer treatment|0|||
46654946|NCT03576131|82863925|FG005|Overall Study|New anti-cancer treatment|0|||
46654947|NCT03576131|82863926|FG006|Overall Study|New anti-cancer treatment|0|||
46654948|NCT03576131|82863927|FG007|Overall Study|New anti-cancer treatment|0|||
46654949|NCT03576131|82863920|FG000|Overall Study|Unspecified reason|0|||
46654950|NCT03576131|82863921|FG001|Overall Study|Unspecified reason|0|||
46654951|NCT03576131|82863922|FG002|Overall Study|Unspecified reason|1|||
46654952|NCT03576131|82863923|FG003|Overall Study|Unspecified reason|1|||
46654953|NCT03576131|82863924|FG004|Overall Study|Unspecified reason|1|||
46654954|NCT03576131|82863925|FG005|Overall Study|Unspecified reason|1|||
46654955|NCT03576131|82863926|FG006|Overall Study|Unspecified reason|0|||
46654956|NCT03576131|82863927|FG007|Overall Study|Unspecified reason|0|||
46654957|NCT03576131|82863920|FG000|Overall Study|Subject non-compliance|0|||
46654958|NCT03576131|82863921|FG001|Overall Study|Subject non-compliance|0|||
46654959|NCT03576131|82863922|FG002|Overall Study|Subject non-compliance|0|||
46654960|NCT03576131|82863923|FG003|Overall Study|Subject non-compliance|0|||
46654961|NCT03576131|82863924|FG004|Overall Study|Subject non-compliance|0|||
46654962|NCT03576131|82863925|FG005|Overall Study|Subject non-compliance|1|||
46654963|NCT03576131|82863926|FG006|Overall Study|Subject non-compliance|0|||
46654964|NCT03576131|82863927|FG007|Overall Study|Subject non-compliance|0|||
46654965|NCT03454529|82863964|FG000|Overall Study|Did not receive treatment|6|||
46654966|NCT03454529|82863964|FG000|Overall Study|Received < 80% doses|1|||
46654967|NCT03409731|82863968|FG000|Overall Study|Withdrawal by Subject|1|||
46654968|NCT03409731|82863968|FG000|Overall Study|Death|4|||
46654969|NCT02988817|82864010|FG000|Overall Study|Withdrawal by Subject|1|||
46654970|NCT02988817|82864011|FG001|Overall Study|Withdrawal by Subject|0|||
46654971|NCT02988817|82864012|FG002|Overall Study|Withdrawal by Subject|0|||
46654972|NCT02988817|82864013|FG003|Overall Study|Withdrawal by Subject|1|||
46654973|NCT02988817|82864014|FG004|Overall Study|Withdrawal by Subject|3|||
46654974|NCT02988817|82864015|FG005|Overall Study|Withdrawal by Subject|1|||
46654975|NCT02988817|82864016|FG006|Overall Study|Withdrawal by Subject|2|||
46654976|NCT02988817|82864017|FG007|Overall Study|Withdrawal by Subject|1|||
46654977|NCT02988817|82864018|FG008|Overall Study|Withdrawal by Subject|1|||
46654978|NCT02988817|82864019|FG009|Overall Study|Withdrawal by Subject|1|||
46654979|NCT02988817|82864020|FG010|Overall Study|Withdrawal by Subject|1|||
46654980|NCT02988817|82864021|FG011|Overall Study|Withdrawal by Subject|12|||
46654981|NCT02988817|82864022|FG012|Overall Study|Withdrawal by Subject|6|||
46654982|NCT02988817|82864023|FG013|Overall Study|Withdrawal by Subject|6|||
46781736|NCT00396331|83000320|FG000|Overall Study|Failed to mobilize - no transplant|8|||
46781737|NCT00396331|83000320|FG000|Overall Study|Did not go on to transplant|5|||
46781738|NCT00396331|83000320|FG000|Overall Study|Lost to Follow-up|3|||
46781739|NCT00396331|83000320|FG000|Overall Study|Death|16|||
47075600|NCT04178967|83370257|FG007|Induction Period|Protocol Violation|0|||
47075601|NCT04178967|83370258|FG008|Induction Period|Protocol Violation|0|||
47075602|NCT04178967|83370259|FG009|Induction Period|Protocol Violation|0|||
47075603|NCT04178967|83370260|FG010|Induction Period|Protocol Violation|0|||
46781740|NCT00396253|83000332|FG000|Overall Study|Protocol Violation|1|||
46781741|NCT00396253|83000332|FG000|Overall Study|Withdrawal by Subject|7|||
46781742|NCT00396253|83000332|FG000|Overall Study|Death|3|||
46781743|NCT00396253|83000332|FG000|Overall Study|Physician Decision|1|||
46781744|NCT00396253|83000332|FG000|Overall Study|Change in eligibility status|1|||
46781745|NCT00604162|83000336|FG000|Overall Study|Physician Decision|3|||
46781746|NCT00604162|83000336|FG000|Overall Study|Withdrawal by Subject|1|||
46781747|NCT00396097|83000345|FG000|Overall Study|Withdrawal by Subject|17|||
46781748|NCT00396097|83000346|FG001|Overall Study|Withdrawal by Subject|17|||
46781749|NCT00396097|83000345|FG000|Overall Study|Lost to Follow-up|4|||
46781750|NCT00396097|83000346|FG001|Overall Study|Lost to Follow-up|9|||
46654983|NCT02988817|82864024|FG014|Overall Study|Withdrawal by Subject|4|||
46654984|NCT02988817|82864025|FG015|Overall Study|Withdrawal by Subject|5|||
46654985|NCT02988817|82864026|FG016|Overall Study|Withdrawal by Subject|4|||
46654986|NCT02988817|82864027|FG017|Overall Study|Withdrawal by Subject|11|||
46654987|NCT02988817|82864028|FG018|Overall Study|Withdrawal by Subject|4|||
46781751|NCT00396097|83000345|FG000|Overall Study|Other|3|||
46781752|NCT00396097|83000346|FG001|Overall Study|Other|5|||
46781753|NCT00396097|83000345|FG000|Overall Study|Protocol Violation|0|||
46654988|NCT02988817|82864029|FG019|Overall Study|Withdrawal by Subject|2|||
46654989|NCT02988817|82864010|FG000|Overall Study|Death|0|||
46654990|NCT02988817|82864011|FG001|Overall Study|Death|1|||
46654991|NCT02988817|82864012|FG002|Overall Study|Death|3|||
46654992|NCT02988817|82864013|FG003|Overall Study|Death|1|||
46654993|NCT02988817|82864014|FG004|Overall Study|Death|6|||
46654994|NCT02988817|82864015|FG005|Overall Study|Death|10|||
46654995|NCT02988817|82864016|FG006|Overall Study|Death|1|||
46654996|NCT02988817|82864017|FG007|Overall Study|Death|2|||
46654997|NCT02988817|82864018|FG008|Overall Study|Death|1|||
46654998|NCT02988817|82864019|FG009|Overall Study|Death|5|||
46654999|NCT02988817|82864020|FG010|Overall Study|Death|1|||
46655000|NCT02988817|82864021|FG011|Overall Study|Death|8|||
46655001|NCT02988817|82864022|FG012|Overall Study|Death|9|||
46655002|NCT02988817|82864023|FG013|Overall Study|Death|17|||
46655003|NCT02988817|82864024|FG014|Overall Study|Death|18|||
46655004|NCT02988817|82864025|FG015|Overall Study|Death|30|||
46781754|NCT00396097|83000346|FG001|Overall Study|Protocol Violation|6|||
46781755|NCT00396097|83000345|FG000|Overall Study|Adverse Event|1|||
46781756|NCT00396097|83000346|FG001|Overall Study|Adverse Event|5|||
46971127|NCT02564055|83214506|FG000|Overall Study|Physician Decision|0|||
46971128|NCT02564055|83214507|FG001|Overall Study|Physician Decision|0|||
46971129|NCT02564055|83214508|FG002|Overall Study|Physician Decision|1|||
46971130|NCT02564055|83214509|FG003|Overall Study|Physician Decision|0|||
46971131|NCT02564055|83214510|FG004|Overall Study|Physician Decision|0|||
46971132|NCT02564055|83214511|FG005|Overall Study|Physician Decision|0|||
46971133|NCT02564055|83214506|FG000|Overall Study|Withdrawal by Subject|4|||
46971134|NCT02564055|83214507|FG001|Overall Study|Withdrawal by Subject|4|||
46971135|NCT02564055|83214508|FG002|Overall Study|Withdrawal by Subject|3|||
46971136|NCT02564055|83214509|FG003|Overall Study|Withdrawal by Subject|3|||
46971137|NCT02564055|83214510|FG004|Overall Study|Withdrawal by Subject|10|||
46971138|NCT02564055|83214511|FG005|Overall Study|Withdrawal by Subject|10|||
46971139|NCT02563899|83214529|FG000|Overall Study|Protocol Violation|1|||
46971140|NCT02563899|83214530|FG001|Overall Study|Protocol Violation|0|||
46971141|NCT02563899|83214531|FG002|Overall Study|Protocol Violation|0|||
46971142|NCT02563899|83214532|FG003|Overall Study|Protocol Violation|0|||
46971143|NCT02563899|83214529|FG000|Overall Study|Withdrawal by Subject|0|||
46971144|NCT02563899|83214530|FG001|Overall Study|Withdrawal by Subject|0|||
46971145|NCT02563899|83214531|FG002|Overall Study|Withdrawal by Subject|1|||
46971146|NCT02563899|83214532|FG003|Overall Study|Withdrawal by Subject|0|||
46971147|NCT02699099|83214546|FG000|Overall Study|Adverse Event|1|||
46971148|NCT02699099|83214547|FG001|Overall Study|Adverse Event|0|||
46971149|NCT02699099|83214548|FG002|Overall Study|Adverse Event|2|||
46971150|NCT02699099|83214546|FG000|Overall Study|Lost to Follow-up|0|||
46971151|NCT02699099|83214547|FG001|Overall Study|Lost to Follow-up|1|||
46971152|NCT02699099|83214548|FG002|Overall Study|Lost to Follow-up|0|||
46971153|NCT02699099|83214546|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
46971154|NCT02699099|83214547|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
46971155|NCT02699099|83214548|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
46971156|NCT02698865|83214560|FG000|Overall Study|Other|11|||
46971157|NCT02698865|83214561|FG001|Overall Study|Other|11|||
46971158|NCT02698865|83214560|FG000|Overall Study|Withdrawal by Subject|20|||
46971159|NCT02698865|83214561|FG001|Overall Study|Withdrawal by Subject|16|||
46971160|NCT02698865|83214560|FG000|Overall Study|Physician Decision|0|||
46971161|NCT02698865|83214561|FG001|Overall Study|Physician Decision|4|||
46971162|NCT02698865|83214560|FG000|Overall Study|Lost to Follow-up|4|||
46971163|NCT02698865|83214561|FG001|Overall Study|Lost to Follow-up|2|||
46971164|NCT02698787|83214569|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
46971165|NCT02698787|83214570|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
46781757|NCT00396097|83000345|FG000|Overall Study|Insufficient Clinical Response|1|||
46781758|NCT00396097|83000346|FG001|Overall Study|Insufficient Clinical Response|4|||
46781759|NCT00375505|83000358|FG000|Overall Study|Adverse Event|1|||
46781760|NCT00375505|83000359|FG001|Overall Study|Adverse Event|2|||
46781761|NCT00375427|83000367|FG000|Overall Study|Adverse Event|21|||
46655005|NCT02988817|82864026|FG016|Overall Study|Death|17|||
46655006|NCT02988817|82864027|FG017|Overall Study|Death|38|||
46655007|NCT02988817|82864028|FG018|Overall Study|Death|14|||
46781762|NCT00375427|83000368|FG001|Overall Study|Adverse Event|27|||
46655008|NCT02988817|82864029|FG019|Overall Study|Death|16|||
46655009|NCT02988817|82864010|FG000|Overall Study|Other|0|||
46971166|NCT02698475|83214577|FG000|Main Study Period|Lack of Efficacy|1|||
46655010|NCT02988817|82864011|FG001|Overall Study|Other|0|||
46655011|NCT02988817|82864012|FG002|Overall Study|Other|0|||
46971167|NCT02698475|83214577|FG000|Main Study Period|Protocol Violation|2|||
46971168|NCT02698475|83214577|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
46971169|NCT02698475|83214577|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
46655012|NCT02988817|82864013|FG003|Overall Study|Other|1|||
46655013|NCT02988817|82864014|FG004|Overall Study|Other|1|||
46655014|NCT02988817|82864015|FG005|Overall Study|Other|0|||
46655015|NCT02988817|82864016|FG006|Overall Study|Other|0|||
46655016|NCT02988817|82864017|FG007|Overall Study|Other|0|||
46971170|NCT02698475|83214577|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
46655017|NCT02988817|82864018|FG008|Overall Study|Other|0|||
46655018|NCT02988817|82864019|FG009|Overall Study|Other|0|||
46655019|NCT02988817|82864020|FG010|Overall Study|Other|0|||
46781763|NCT00375427|83000367|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46781764|NCT00375427|83000368|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46781765|NCT00375427|83000367|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46781766|NCT00375427|83000368|FG001|Overall Study|Abnormal laboratory value(s)|2|||
46781767|NCT00375427|83000367|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
46971171|NCT02698475|83214577|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
46971172|NCT02698475|83214577|FG000|Long-Term Extension Period|Other|1|||
46971173|NCT02559687|83214584|FG000|Overall Study|Death|112|||
46971174|NCT02559687|83214584|FG000|Overall Study|Sponsor Decision|5|||
46971175|NCT02559687|83214584|FG000|Overall Study|Withdrawal by Subject|4|||
46971176|NCT04294719|83214598|FG000|Overall Study|Withdrawal by Subject|1|||
46781768|NCT00375427|83000368|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
46781769|NCT00375427|83000367|FG000|Overall Study|Patient no longer requires study drug|3|||
46781770|NCT00375427|83000368|FG001|Overall Study|Patient no longer requires study drug|7|||
46781771|NCT00375427|83000367|FG000|Overall Study|Protocol Violation|10|||
46781772|NCT00375427|83000368|FG001|Overall Study|Protocol Violation|8|||
46971177|NCT02703311|83214606|FG000|Overall Study|Death|5|||
46971178|NCT02703311|83214606|FG000|Overall Study|Withdrawal by Subject|3|||
46971179|NCT02697617|83214610|FG000|Overall Study|Withdrawal by Subject|0|||
46971180|NCT02697617|83214611|FG001|Overall Study|Withdrawal by Subject|2|||
46971181|NCT02697617|83214610|FG000|Overall Study|Pregnancy|1|||
46971182|NCT02697617|83214611|FG001|Overall Study|Pregnancy|0|||
46971183|NCT02698241|83214621|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
46971184|NCT02698241|83214621|FG000|Overall Study|Screening not met|7|||
46971185|NCT02698241|83214621|FG000|Overall Study|Withdrawal by Subject|7|||
46971186|NCT02698241|83214621|FG000|Overall Study|Physician Decision|2|||
46971187|NCT02698241|83214621|FG000|Overall Study|Subject underwent system modification|2|||
46971188|NCT02698241|83214621|FG000|Overall Study|Lost to Follow-up|3|||
46971189|NCT02698241|83214621|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
46971190|NCT02698241|83214621|FG000|Overall Study|geographic and licensing issue|1|||
46971191|NCT02698241|83214621|FG000|Overall Study|Death|2|||
46971192|NCT01663233|83214627|FG000|Overall Study|Withdrawal by Subject|3|||
46971193|NCT01663233|83214628|FG001|Overall Study|Withdrawal by Subject|2|||
46971194|NCT01663233|83214627|FG000|Overall Study|Protocol Deviation|1|||
46971195|NCT01663233|83214628|FG001|Overall Study|Protocol Deviation|4|||
46971196|NCT01663233|83214627|FG000|Overall Study|Lost to Follow-up|0|||
46971197|NCT01663233|83214628|FG001|Overall Study|Lost to Follow-up|1|||
46971198|NCT02556255|83214647|FG000|Overall Study|Lost to Follow-up|4|||
46971199|NCT02556801|83214655|FG000|Overall Study|Lost to Follow-up|1|||
46971200|NCT02556801|83214656|FG001|Overall Study|Lost to Follow-up|0|||
46971201|NCT02556801|83214657|FG002|Overall Study|Lost to Follow-up|2|||
46971202|NCT02556801|83214658|FG003|Overall Study|Lost to Follow-up|0|||
46971203|NCT02556801|83214655|FG000|Overall Study|Withdrawal by Subject|1|||
46971204|NCT02556801|83214656|FG001|Overall Study|Withdrawal by Subject|1|||
46971205|NCT02556801|83214657|FG002|Overall Study|Withdrawal by Subject|1|||
46971206|NCT02556801|83214658|FG003|Overall Study|Withdrawal by Subject|0|||
46971207|NCT02556801|83214655|FG000|Overall Study|Protocol Violation|0|||
46971208|NCT02556801|83214656|FG001|Overall Study|Protocol Violation|3|||
46971209|NCT02556801|83214657|FG002|Overall Study|Protocol Violation|1|||
46971210|NCT02556801|83214658|FG003|Overall Study|Protocol Violation|1|||
46971211|NCT02556801|83214655|FG000|Overall Study|Adverse Event|0|||
46971212|NCT02556801|83214656|FG001|Overall Study|Adverse Event|2|||
46971213|NCT02556801|83214657|FG002|Overall Study|Adverse Event|0|||
46971214|NCT02556801|83214658|FG003|Overall Study|Adverse Event|3|||
46971215|NCT02556801|83214655|FG000|Overall Study|Pregnancy|0|||
46971216|NCT02556801|83214656|FG001|Overall Study|Pregnancy|1|||
46971217|NCT02556801|83214657|FG002|Overall Study|Pregnancy|0|||
46971218|NCT02556801|83214658|FG003|Overall Study|Pregnancy|0|||
46971219|NCT02556801|83214655|FG000|Overall Study|Personal reasons patient|0|||
46655020|NCT02988817|82864021|FG011|Overall Study|Other|0|||
46781773|NCT00375427|83000367|FG000|Overall Study|Withdrawal by Subject|9|||
46655021|NCT02988817|82864022|FG012|Overall Study|Other|0|||
46971220|NCT02556801|83214656|FG001|Overall Study|Personal reasons patient|0|||
46655022|NCT02988817|82864023|FG013|Overall Study|Other|0|||
46971221|NCT02556801|83214657|FG002|Overall Study|Personal reasons patient|0|||
46971222|NCT02556801|83214658|FG003|Overall Study|Personal reasons patient|1|||
46971223|NCT02556177|83214670|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
46971224|NCT02556177|83214671|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
46971225|NCT02554929|83214679|FG000|Overall Study|Lost to Follow-up|4|||
46971226|NCT02554929|83214680|FG001|Overall Study|Lost to Follow-up|4|||
46971227|NCT02554929|83214679|FG000|Overall Study|Withdrawal by Subject|2|||
46971228|NCT02554929|83214680|FG001|Overall Study|Withdrawal by Subject|8|||
46971229|NCT02697773|83214698|FG000|Overall Study|Adverse Event|2|||
46971230|NCT02697773|83214699|FG001|Overall Study|Adverse Event|1|||
46971231|NCT02697773|83214700|FG002|Overall Study|Adverse Event|2|||
46971232|NCT02697773|83214698|FG000|Overall Study|Death|0|||
46971233|NCT02697773|83214699|FG001|Overall Study|Death|0|||
46971234|NCT02697773|83214700|FG002|Overall Study|Death|2|||
46971235|NCT02697773|83214698|FG000|Overall Study|Lack of Efficacy|4|||
46971236|NCT02697773|83214699|FG001|Overall Study|Lack of Efficacy|6|||
46971237|NCT02697773|83214700|FG002|Overall Study|Lack of Efficacy|6|||
46971238|NCT02697773|83214698|FG000|Overall Study|Lost to Follow-up|5|||
46971239|NCT02697773|83214699|FG001|Overall Study|Lost to Follow-up|5|||
46971240|NCT02697773|83214700|FG002|Overall Study|Lost to Follow-up|7|||
46971241|NCT02697773|83214698|FG000|Overall Study|Other|15|||
46971242|NCT02697773|83214699|FG001|Overall Study|Other|11|||
46971243|NCT02697773|83214700|FG002|Overall Study|Other|10|||
46971244|NCT02697773|83214698|FG000|Overall Study|Protocol Violation|1|||
46971245|NCT02697773|83214699|FG001|Overall Study|Protocol Violation|1|||
46971246|NCT02697773|83214700|FG002|Overall Study|Protocol Violation|0|||
46971247|NCT02697773|83214698|FG000|Overall Study|Withdrawal by Subject|10|||
46971248|NCT02697773|83214699|FG001|Overall Study|Withdrawal by Subject|13|||
46971249|NCT02697773|83214700|FG002|Overall Study|Withdrawal by Subject|13|||
46971250|NCT02697773|83214698|FG000|Overall Study|Randomized but not treated|1|||
46971251|NCT02697773|83214699|FG001|Overall Study|Randomized but not treated|1|||
46971252|NCT02697773|83214700|FG002|Overall Study|Randomized but not treated|0|||
46971253|NCT02693171|83214708|FG000|Overall Study|Adverse Event|1|||
47075604|NCT04178967|83370250|FG000|Induction Period|Withdrawal by Subject|6|||
47075605|NCT04178967|83370251|FG001|Induction Period|Withdrawal by Subject|4|||
47075606|NCT04178967|83370252|FG002|Induction Period|Withdrawal by Subject|0|||
47075607|NCT04178967|83370253|FG003|Induction Period|Withdrawal by Subject|0|||
46655023|NCT02988817|82864024|FG014|Overall Study|Other|0|||
46655024|NCT02988817|82864025|FG015|Overall Study|Other|1|||
46655025|NCT02988817|82864026|FG016|Overall Study|Other|0|||
47075608|NCT04178967|83370254|FG004|Induction Period|Withdrawal by Subject|0|||
46655026|NCT02988817|82864027|FG017|Overall Study|Other|0|||
46655027|NCT02988817|82864028|FG018|Overall Study|Other|0|||
46655028|NCT02988817|82864029|FG019|Overall Study|Other|0|||
46655029|NCT02988817|82864010|FG000|Overall Study|Lost to Follow-up|0|||
46655030|NCT02988817|82864011|FG001|Overall Study|Lost to Follow-up|0|||
46655031|NCT02988817|82864012|FG002|Overall Study|Lost to Follow-up|0|||
46655032|NCT02988817|82864013|FG003|Overall Study|Lost to Follow-up|0|||
46655033|NCT02988817|82864014|FG004|Overall Study|Lost to Follow-up|0|||
46655034|NCT02988817|82864015|FG005|Overall Study|Lost to Follow-up|0|||
46655035|NCT02988817|82864016|FG006|Overall Study|Lost to Follow-up|0|||
46655036|NCT02988817|82864017|FG007|Overall Study|Lost to Follow-up|0|||
46655037|NCT02988817|82864018|FG008|Overall Study|Lost to Follow-up|1|||
46655038|NCT02988817|82864019|FG009|Overall Study|Lost to Follow-up|0|||
46655039|NCT02988817|82864020|FG010|Overall Study|Lost to Follow-up|1|||
46655040|NCT02988817|82864021|FG011|Overall Study|Lost to Follow-up|1|||
46655041|NCT02988817|82864022|FG012|Overall Study|Lost to Follow-up|0|||
46655042|NCT02988817|82864023|FG013|Overall Study|Lost to Follow-up|0|||
46655043|NCT02988817|82864024|FG014|Overall Study|Lost to Follow-up|1|||
46655044|NCT02988817|82864025|FG015|Overall Study|Lost to Follow-up|1|||
46655045|NCT02988817|82864026|FG016|Overall Study|Lost to Follow-up|2|||
46655046|NCT02988817|82864027|FG017|Overall Study|Lost to Follow-up|3|||
46655047|NCT02988817|82864028|FG018|Overall Study|Lost to Follow-up|0|||
46655048|NCT02988817|82864029|FG019|Overall Study|Lost to Follow-up|0|||
46655049|NCT02988817|82864010|FG000|Overall Study|Sponsor decision|0|||
46971254|NCT02693171|83214708|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
46971255|NCT02692703|83214712|FG000|Overall Study|Lost to Follow-up|1|||
47075609|NCT04178967|83370255|FG005|Induction Period|Withdrawal by Subject|0|||
47075610|NCT04178967|83370256|FG006|Induction Period|Withdrawal by Subject|0|||
46655050|NCT02988817|82864011|FG001|Overall Study|Sponsor decision|0|||
46655051|NCT02988817|82864012|FG002|Overall Study|Sponsor decision|0|||
46655052|NCT02988817|82864013|FG003|Overall Study|Sponsor decision|0|||
46655053|NCT02988817|82864014|FG004|Overall Study|Sponsor decision|0|||
46655054|NCT02988817|82864015|FG005|Overall Study|Sponsor decision|0|||
46655055|NCT02988817|82864016|FG006|Overall Study|Sponsor decision|0|||
46655056|NCT02988817|82864017|FG007|Overall Study|Sponsor decision|0|||
46655057|NCT02988817|82864018|FG008|Overall Study|Sponsor decision|0|||
46971256|NCT02692703|83214712|FG000|Overall Study|Other|1|||
46971257|NCT02692235|83214718|FG000|Overall Study|Withdrawal by Subject|2|||
46971258|NCT02692235|83214719|FG001|Overall Study|Withdrawal by Subject|1|||
46655058|NCT02988817|82864019|FG009|Overall Study|Sponsor decision|0|||
46655059|NCT02988817|82864020|FG010|Overall Study|Sponsor decision|0|||
46655060|NCT02988817|82864021|FG011|Overall Study|Sponsor decision|1|||
46655061|NCT02988817|82864022|FG012|Overall Study|Sponsor decision|1|||
46655062|NCT02988817|82864023|FG013|Overall Study|Sponsor decision|2|||
46655063|NCT02988817|82864024|FG014|Overall Study|Sponsor decision|2|||
46655064|NCT02988817|82864025|FG015|Overall Study|Sponsor decision|6|||
46655065|NCT02988817|82864026|FG016|Overall Study|Sponsor decision|2|||
46655066|NCT02988817|82864027|FG017|Overall Study|Sponsor decision|3|||
46655067|NCT02988817|82864028|FG018|Overall Study|Sponsor decision|2|||
46655068|NCT02988817|82864029|FG019|Overall Study|Sponsor decision|7|||
46655069|NCT02988817|82864010|FG000|Overall Study|Physician Decision|0|||
46655070|NCT02988817|82864011|FG001|Overall Study|Physician Decision|0|||
46655071|NCT02988817|82864012|FG002|Overall Study|Physician Decision|0|||
46655072|NCT02988817|82864013|FG003|Overall Study|Physician Decision|0|||
46655073|NCT02988817|82864014|FG004|Overall Study|Physician Decision|0|||
46655074|NCT02988817|82864015|FG005|Overall Study|Physician Decision|0|||
46655075|NCT02988817|82864016|FG006|Overall Study|Physician Decision|0|||
46655076|NCT02988817|82864017|FG007|Overall Study|Physician Decision|0|||
46655077|NCT02988817|82864018|FG008|Overall Study|Physician Decision|0|||
46655078|NCT02988817|82864019|FG009|Overall Study|Physician Decision|0|||
46655079|NCT02988817|82864020|FG010|Overall Study|Physician Decision|0|||
46655080|NCT02988817|82864021|FG011|Overall Study|Physician Decision|0|||
46655081|NCT02988817|82864022|FG012|Overall Study|Physician Decision|0|||
46655082|NCT02988817|82864023|FG013|Overall Study|Physician Decision|0|||
46655083|NCT02988817|82864024|FG014|Overall Study|Physician Decision|0|||
46655084|NCT02988817|82864025|FG015|Overall Study|Physician Decision|1|||
46655085|NCT02988817|82864026|FG016|Overall Study|Physician Decision|0|||
46655086|NCT02988817|82864027|FG017|Overall Study|Physician Decision|0|||
46655087|NCT02988817|82864028|FG018|Overall Study|Physician Decision|1|||
46655088|NCT02988817|82864029|FG019|Overall Study|Physician Decision|1|||
46655089|NCT02960659|82864084|FG000|Overall Study|Withdrawal by Subject|1|||
46655090|NCT02960659|82864085|FG001|Overall Study|Withdrawal by Subject|0|||
46655091|NCT02960659|82864084|FG000|Overall Study|Poor compliance|0|||
46655092|NCT02960659|82864085|FG001|Overall Study|Poor compliance|1|||
46655093|NCT02844933|82864093|FG000|Overall Study|Discontinued due to premature termination of study|3|||
46655094|NCT02844933|82864094|FG001|Overall Study|Discontinued due to premature termination of study|2|||
46655095|NCT02499835|82864123|FG000|Overall Study|Withdrawal by Subject|1|||
46655096|NCT02499835|82864124|FG001|Overall Study|Withdrawal by Subject|0|||
46655097|NCT02499835|82864125|FG002|Overall Study|Withdrawal by Subject|0|||
46655098|NCT02499835|82864126|FG003|Overall Study|Withdrawal by Subject|1|||
46655099|NCT02499835|82864123|FG000|Overall Study|Physician Decision|0|||
46655100|NCT02499835|82864124|FG001|Overall Study|Physician Decision|3|||
46655101|NCT02499835|82864125|FG002|Overall Study|Physician Decision|18|||
46655102|NCT02499835|82864126|FG003|Overall Study|Physician Decision|7|||
46655103|NCT02499835|82864123|FG000|Overall Study|Adverse Event|0|||
46655104|NCT02499835|82864124|FG001|Overall Study|Adverse Event|0|||
46655105|NCT02499835|82864125|FG002|Overall Study|Adverse Event|0|||
46655106|NCT02499835|82864126|FG003|Overall Study|Adverse Event|1|||
46655107|NCT02499835|82864123|FG000|Overall Study|Disease progression|2|||
46655108|NCT02499835|82864124|FG001|Overall Study|Disease progression|1|||
46655109|NCT02499835|82864125|FG002|Overall Study|Disease progression|0|||
46655110|NCT02499835|82864126|FG003|Overall Study|Disease progression|7|||
46655111|NCT02460497|82864138|FG000|Overall Study|Participant Requested Withdrawal|4|||
46655112|NCT02460497|82864138|FG000|Overall Study|Non-Compliance|1|||
46655113|NCT02460497|82864138|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
46655114|NCT02460497|82864138|FG000|Overall Study|Lost to Follow-up|2|||
46655115|NCT02460497|82864138|FG000|Overall Study|Investigator Decision|1|||
46655116|NCT02460289|82864142|FG000|Overall Study|Adverse Event|1|||
46655117|NCT02460289|82864142|FG000|Overall Study|Withdrawal by Subject|8|||
46655118|NCT02460289|82864142|FG000|Overall Study|Lost to Follow-up|1|||
46655119|NCT02354651|82864153|FG000|Overall Study|Withdrawal by Subject|2|||
46971259|NCT02692235|83214718|FG000|Overall Study|Adverse Event|1|||
46971260|NCT02692235|83214719|FG001|Overall Study|Adverse Event|2|||
46655120|NCT02354651|82864153|FG000|Overall Study|Physician Decision|1|||
46655121|NCT02253316|82864160|FG000|Consolidation|Progression|4|||
46655122|NCT02253316|82864161|FG001|Consolidation|Progression|0|||
46655123|NCT02253316|82864162|FG002|Consolidation|Progression|0|||
46781774|NCT00375427|83000368|FG001|Overall Study|Withdrawal by Subject|13|||
46781775|NCT00375427|83000367|FG000|Overall Study|Lost to Follow-up|1|||
46781776|NCT00375427|83000368|FG001|Overall Study|Lost to Follow-up|1|||
46781777|NCT00375427|83000367|FG000|Overall Study|Administrative reasons|0|||
46781778|NCT00375427|83000368|FG001|Overall Study|Administrative reasons|1|||
46781779|NCT00375427|83000367|FG000|Overall Study|Death|11|||
46781780|NCT00375427|83000368|FG001|Overall Study|Death|10|||
46781781|NCT00393913|83000374|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
46781782|NCT00393913|83000374|FG000|Initial Assessment|Withdrawal by Subject|16|||
46781783|NCT00393913|83000374|FG000|CPAP|Withdrawal by Subject|3|||
46781784|NCT00393913|83000374|FG000|CPAP|Physician Decision|1|||
46781785|NCT00393913|83000374|FG000|CPAP|TEchnical problem with CPAP|3|||
46781786|NCT00567268|83000379|FG000|Overall Study|Protocol Violation|7|||
46781787|NCT00567268|83000379|FG000|Overall Study|Lost to Follow-up|36|||
46655124|NCT02253316|82864160|FG000|Consolidation|Non-Compliance|1|||
46655125|NCT02253316|82864161|FG001|Consolidation|Non-Compliance|0|||
46655126|NCT02253316|82864162|FG002|Consolidation|Non-Compliance|0|||
46655127|NCT02253316|82864160|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
46655128|NCT02253316|82864161|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
46655129|NCT02253316|82864162|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
46655130|NCT02253316|82864160|FG000|Consolidation|Secondary Malignancy|2|||
46971261|NCT02552121|83214733|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
46971262|NCT02552121|83214734|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
46971263|NCT02552121|83214735|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
46971264|NCT02552121|83214736|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
46971265|NCT02552121|83214737|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
46655131|NCT02253316|82864161|FG001|Consolidation|Secondary Malignancy|0|||
46655132|NCT02253316|82864162|FG002|Consolidation|Secondary Malignancy|0|||
46781788|NCT00567268|83000379|FG000|Overall Study|No Visit After First Day of Treatment|2|||
46781789|NCT00567268|83000379|FG000|Overall Study|No Drug Administration|4|||
46655133|NCT02253316|82864160|FG000|Consolidation|Adverse Event|7|||
46655134|NCT02253316|82864161|FG001|Consolidation|Adverse Event|0|||
46655135|NCT02253316|82864162|FG002|Consolidation|Adverse Event|0|||
46655136|NCT02253316|82864160|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
46655137|NCT02253316|82864161|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
46655138|NCT02253316|82864162|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
46655139|NCT02253316|82864160|FG000|Maintenance|Physician Decision|0|||
46655140|NCT02253316|82864161|FG001|Maintenance|Physician Decision|5|||
46655141|NCT02253316|82864162|FG002|Maintenance|Physician Decision|16|||
46655142|NCT02253316|82864160|FG000|Maintenance|Non-Compliance|0|||
46655143|NCT02253316|82864161|FG001|Maintenance|Non-Compliance|1|||
46655144|NCT02253316|82864162|FG002|Maintenance|Non-Compliance|1|||
46655145|NCT02253316|82864160|FG000|Maintenance|Secondary Malignancy|0|||
46655146|NCT02253316|82864161|FG001|Maintenance|Secondary Malignancy|2|||
46655147|NCT02253316|82864162|FG002|Maintenance|Secondary Malignancy|5|||
46655148|NCT02253316|82864160|FG000|Maintenance|Adverse Event|0|||
46655149|NCT02253316|82864161|FG001|Maintenance|Adverse Event|8|||
46655150|NCT02253316|82864162|FG002|Maintenance|Adverse Event|12|||
46655151|NCT02253316|82864160|FG000|Maintenance|Still receiving active treatment|0|||
46655152|NCT02253316|82864161|FG001|Maintenance|Still receiving active treatment|8|||
46655153|NCT02253316|82864162|FG002|Maintenance|Still receiving active treatment|1|||
46655154|NCT02214160|82864173|FG000|Overall Study|Withdrawal by Subject|1|||
46655155|NCT02214160|82864174|FG001|Overall Study|Withdrawal by Subject|0|||
46655156|NCT02214160|82864175|FG002|Overall Study|Withdrawal by Subject|6|||
46655157|NCT02214160|82864173|FG000|Overall Study|Death|2|||
46655158|NCT02214160|82864174|FG001|Overall Study|Death|2|||
46655159|NCT02214160|82864175|FG002|Overall Study|Death|1|||
46655160|NCT02214160|82864173|FG000|Overall Study|Subject Non-Compliance|0|||
46655161|NCT02214160|82864174|FG001|Overall Study|Subject Non-Compliance|3|||
46655162|NCT02214160|82864175|FG002|Overall Study|Subject Non-Compliance|1|||
46655163|NCT02214160|82864173|FG000|Overall Study|Adverse Event|0|||
46655164|NCT02214160|82864174|FG001|Overall Study|Adverse Event|1|||
46655165|NCT02214160|82864175|FG002|Overall Study|Adverse Event|1|||
46655166|NCT02214160|82864173|FG000|Overall Study|Sponsor Decision|0|||
46655167|NCT02214160|82864174|FG001|Overall Study|Sponsor Decision|2|||
46655168|NCT02214160|82864175|FG002|Overall Study|Sponsor Decision|0|||
46655169|NCT02214160|82864173|FG000|Overall Study|Protocol Violation|1|||
46655170|NCT02214160|82864174|FG001|Overall Study|Protocol Violation|0|||
46655171|NCT02214160|82864175|FG002|Overall Study|Protocol Violation|0|||
46655172|NCT02214160|82864173|FG000|Overall Study|Physician Decision|0|||
46655173|NCT02214160|82864174|FG001|Overall Study|Physician Decision|0|||
46655174|NCT02214160|82864175|FG002|Overall Study|Physician Decision|1|||
46655175|NCT02059265|82864196|FG000|Overall Study|Ineligible|4|||
46655176|NCT04983589|82864210|FG000|Overall Study|Withdrawal by Subject|0|||
46655177|NCT04983589|82864211|FG001|Overall Study|Withdrawal by Subject|3|||
46655178|NCT04983589|82864210|FG000|Overall Study|COVID-19 Infection|1|||
46655179|NCT04983589|82864211|FG001|Overall Study|COVID-19 Infection|0|||
46655180|NCT04983589|82864210|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
46655181|NCT04983589|82864211|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
46655182|NCT04783389|82864232|FG000|Overall Study|Withdrawal by Subject|2|||
46655183|NCT04783389|82864233|FG001|Overall Study|Withdrawal by Subject|0|||
46655184|NCT04783389|82864234|FG002|Overall Study|Withdrawal by Subject|0|||
46655185|NCT04783389|82864232|FG000|Overall Study|Termination of Study by Sponsor|10|||
46655186|NCT04783389|82864233|FG001|Overall Study|Termination of Study by Sponsor|12|||
46655187|NCT04783389|82864234|FG002|Overall Study|Termination of Study by Sponsor|14|||
46655188|NCT04556591|82864255|FG000|Overall Study|Lost to Follow-up|1|||
46655189|NCT04556591|82864256|FG001|Overall Study|Lost to Follow-up|0|||
46655190|NCT04556591|82864255|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
46655191|NCT04556591|82864256|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
46655192|NCT04428034|82864265|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
46655193|NCT04364984|82864276|FG000|Overall Study|Death|2|||
46655194|NCT04364984|82864277|FG001|Overall Study|Death|2|||
46655195|NCT04364984|82864278|FG002|Overall Study|Death|0|||
46655196|NCT04294095|82864288|FG000|Overall Study|Adverse Event|1|||
46655197|NCT04294095|82864289|FG001|Overall Study|Adverse Event|0|||
46655198|NCT04266028|82864305|FG000|Overall Study|Adverse Event|0|||
46781790|NCT00567268|83000379|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
46781791|NCT03976648|83000420|FG000|Overall Study|Adverse Event|0|||
46781792|NCT03976648|83000421|FG001|Overall Study|Adverse Event|2|||
46655199|NCT04266028|82864306|FG001|Overall Study|Adverse Event|0|||
46655200|NCT04266028|82864307|FG002|Overall Study|Adverse Event|1|||
46655201|NCT04266028|82864308|FG003|Overall Study|Adverse Event|0|||
46655202|NCT04266028|82864309|FG004|Overall Study|Adverse Event|1|||
46655203|NCT04266028|82864310|FG005|Overall Study|Adverse Event|0|||
46655204|NCT04266028|82864311|FG006|Overall Study|Adverse Event|2|||
46655205|NCT04266028|82864312|FG007|Overall Study|Adverse Event|0|||
46655206|NCT04266028|82864305|FG000|Overall Study|temporary halt of the study|0|||
46655207|NCT04266028|82864306|FG001|Overall Study|temporary halt of the study|0|||
46655208|NCT04266028|82864307|FG002|Overall Study|temporary halt of the study|0|||
46655209|NCT04266028|82864308|FG003|Overall Study|temporary halt of the study|0|||
46850836|NCT00112047|83066651|FG000|Randomized Phase|Death|1|||
46655210|NCT04266028|82864309|FG004|Overall Study|temporary halt of the study|0|||
46655211|NCT04266028|82864310|FG005|Overall Study|temporary halt of the study|0|||
46655212|NCT04266028|82864311|FG006|Overall Study|temporary halt of the study|2|||
46655213|NCT04266028|82864312|FG007|Overall Study|temporary halt of the study|1|||
46655214|NCT04266028|82864305|FG000|Overall Study|Onset of birch pollen season|0|||
46655215|NCT04266028|82864306|FG001|Overall Study|Onset of birch pollen season|0|||
46655216|NCT04266028|82864307|FG002|Overall Study|Onset of birch pollen season|0|||
46655217|NCT04266028|82864308|FG003|Overall Study|Onset of birch pollen season|0|||
46655218|NCT04266028|82864309|FG004|Overall Study|Onset of birch pollen season|1|||
46655219|NCT04266028|82864310|FG005|Overall Study|Onset of birch pollen season|0|||
46655220|NCT04266028|82864311|FG006|Overall Study|Onset of birch pollen season|0|||
46655221|NCT04266028|82864312|FG007|Overall Study|Onset of birch pollen season|0|||
46655222|NCT03994731|82864354|FG000|Pegloticase + IMM Period|Death|2|||
46655223|NCT03994731|82864355|FG001|Pegloticase + IMM Period|Death|0|||
46655224|NCT03994731|82864354|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
46655225|NCT03994731|82864355|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
46655226|NCT03994731|82864354|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
46655227|NCT03994731|82864355|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
46655228|NCT03801915|82864367|FG000|Overall Study|Screen failure|0|||
46655229|NCT03801915|82864368|FG001|Overall Study|Screen failure|0|||
46655230|NCT03801915|82864369|FG002|Overall Study|Screen failure|1|||
46655231|NCT03801915|82864367|FG000|Overall Study|Ineligible|1|||
46655232|NCT03801915|82864368|FG001|Overall Study|Ineligible|0|||
46655233|NCT03801915|82864369|FG002|Overall Study|Ineligible|0|||
46655234|NCT03801915|82864367|FG000|Overall Study|Physician Decision|2|||
46655235|NCT03801915|82864368|FG001|Overall Study|Physician Decision|1|||
46655236|NCT03801915|82864369|FG002|Overall Study|Physician Decision|0|||
46655237|NCT03581305|82864383|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
46655238|NCT03581305|82864384|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
46655239|NCT03581305|82864383|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
46655240|NCT03581305|82864384|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
46655241|NCT03581305|82864383|FG000|Serotonergic Study|Withdrawal by Subject|5|||
46655242|NCT03581305|82864384|FG001|Serotonergic Study|Withdrawal by Subject|1|||
46655243|NCT03556202|82864395|FG000|Extension Treatment Period|Adverse Event|18|||
46655244|NCT03556202|82864396|FG001|Extension Treatment Period|Adverse Event|14|||
46655245|NCT03556202|82864397|FG002|Extension Treatment Period|Adverse Event|9|||
46655246|NCT03556202|82864395|FG000|Extension Treatment Period|Death|2|||
46655247|NCT03556202|82864396|FG001|Extension Treatment Period|Death|6|||
46655248|NCT03556202|82864397|FG002|Extension Treatment Period|Death|0|||
46655249|NCT03556202|82864395|FG000|Extension Treatment Period|Lack of Efficacy|5|||
46655250|NCT03556202|82864396|FG001|Extension Treatment Period|Lack of Efficacy|12|||
46655251|NCT03556202|82864397|FG002|Extension Treatment Period|Lack of Efficacy|18|||
46655252|NCT03556202|82864395|FG000|Extension Treatment Period|Lost to Follow-up|9|||
46655253|NCT03556202|82864396|FG001|Extension Treatment Period|Lost to Follow-up|20|||
46655254|NCT03556202|82864397|FG002|Extension Treatment Period|Lost to Follow-up|2|||
46655255|NCT03556202|82864395|FG000|Extension Treatment Period|Pregnancy|2|||
46655256|NCT03556202|82864396|FG001|Extension Treatment Period|Pregnancy|4|||
46971266|NCT02552121|83214738|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
46655257|NCT03556202|82864397|FG002|Extension Treatment Period|Pregnancy|3|||
46655258|NCT03556202|82864395|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
46850837|NCT00112047|83066652|FG001|Randomized Phase|Death|3|||
46655259|NCT03556202|82864396|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
46655260|NCT03556202|82864397|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
46655261|NCT03556202|82864395|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
46655262|NCT03556202|82864396|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
46655263|NCT03556202|82864397|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
46655264|NCT03556202|82864395|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
46655265|NCT03556202|82864396|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
46655266|NCT03556202|82864397|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
46655267|NCT03556202|82864395|FG000|Extension Treatment Period|Physician Decision|0|||
46655268|NCT03556202|82864396|FG001|Extension Treatment Period|Physician Decision|8|||
46655269|NCT03556202|82864397|FG002|Extension Treatment Period|Physician Decision|2|||
46655270|NCT03556202|82864395|FG000|Extension Treatment Period|Protocol Violation|0|||
46655271|NCT03556202|82864396|FG001|Extension Treatment Period|Protocol Violation|1|||
46655272|NCT03556202|82864397|FG002|Extension Treatment Period|Protocol Violation|1|||
46655273|NCT03556202|82864395|FG000|Extension Treatment Period|Sponsor Decision|0|||
46655274|NCT03556202|82864396|FG001|Extension Treatment Period|Sponsor Decision|1|||
46655275|NCT03556202|82864397|FG002|Extension Treatment Period|Sponsor Decision|0|||
46655276|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
46655277|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
46655278|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
46655279|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Death|1|||
46655280|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Death|0|||
46655281|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Death|0|||
46655282|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
46655283|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
46655284|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
46655285|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
46655286|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
46655287|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
46655288|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
46655289|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
46655290|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
46655291|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
46655292|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
46655293|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
46655294|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
46655295|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
46655296|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
46655297|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
46655298|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
46655299|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
46655300|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
46655301|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
46655302|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
46655303|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
46655304|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
46655305|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
46655306|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
46655307|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
46655308|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
46655309|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
46655310|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
46655311|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
46781793|NCT03976648|83000420|FG000|Overall Study|Study terminated by sponsor|21|||
46781794|NCT03976648|83000421|FG001|Overall Study|Study terminated by sponsor|8|||
46781795|NCT00566254|83000429|FG000|Overall Study|Adverse Event|3|||
46781796|NCT00566254|83000430|FG001|Overall Study|Adverse Event|1|||
46781797|NCT00566254|83000429|FG000|Overall Study|Protocol Violation|1|||
46971267|NCT02552121|83214739|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
46655312|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
46655313|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
46655314|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
46655315|NCT03556202|82864395|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
46655316|NCT03556202|82864396|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
46655317|NCT03556202|82864397|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
46655318|NCT03541174|82864411|FG000|Part 1 Double-Blind|Adverse Event|6|||
46655319|NCT03541174|82864412|FG001|Part 1 Double-Blind|Adverse Event|5|||
46655320|NCT03541174|82864413|FG002|Part 1 Double-Blind|Adverse Event|2|||
46655321|NCT03541174|82864414|FG003|Part 1 Double-Blind|Adverse Event|0|||
46655322|NCT03541174|82864415|FG004|Part 1 Double-Blind|Adverse Event|0|||
46655323|NCT03541174|82864416|FG005|Part 1 Double-Blind|Adverse Event|0|||
46655324|NCT03541174|82864411|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
46655325|NCT03541174|82864412|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
46655326|NCT03541174|82864413|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
46655327|NCT03541174|82864414|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
46655328|NCT03541174|82864415|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
46655329|NCT03541174|82864416|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
46655330|NCT03541174|82864411|FG000|Part 1 Double-Blind|Other reasons|3|||
46655331|NCT03541174|82864412|FG001|Part 1 Double-Blind|Other reasons|2|||
46655332|NCT03541174|82864413|FG002|Part 1 Double-Blind|Other reasons|3|||
46655333|NCT03541174|82864414|FG003|Part 1 Double-Blind|Other reasons|0|||
46655334|NCT03541174|82864415|FG004|Part 1 Double-Blind|Other reasons|0|||
46655335|NCT03541174|82864416|FG005|Part 1 Double-Blind|Other reasons|0|||
46655336|NCT03541174|82864411|FG000|Part 2 Single-Blind|Adverse Event|0|||
46655337|NCT03541174|82864412|FG001|Part 2 Single-Blind|Adverse Event|0|||
46655338|NCT03541174|82864413|FG002|Part 2 Single-Blind|Adverse Event|0|||
46655339|NCT03541174|82864414|FG003|Part 2 Single-Blind|Adverse Event|25|||
46655340|NCT03541174|82864415|FG004|Part 2 Single-Blind|Adverse Event|0|||
46655341|NCT03541174|82864416|FG005|Part 2 Single-Blind|Adverse Event|0|||
46655342|NCT03541174|82864411|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
46655343|NCT03541174|82864412|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
46655344|NCT03541174|82864413|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
46655345|NCT03541174|82864414|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
46655346|NCT03541174|82864415|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
46655347|NCT03541174|82864416|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
46655348|NCT03541174|82864411|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
46655349|NCT03541174|82864412|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
46655350|NCT03541174|82864413|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
46655351|NCT03541174|82864414|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
46655352|NCT03541174|82864415|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
46655353|NCT03541174|82864416|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
46655354|NCT03541174|82864411|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
46655355|NCT03541174|82864412|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
46655356|NCT03541174|82864413|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
46655357|NCT03541174|82864414|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
46655358|NCT03541174|82864415|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
46655359|NCT03541174|82864416|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
46655360|NCT03541174|82864411|FG000|Part 2 Single-Blind|Death|0|||
46655361|NCT03541174|82864412|FG001|Part 2 Single-Blind|Death|0|||
46655362|NCT03541174|82864413|FG002|Part 2 Single-Blind|Death|0|||
46655363|NCT03541174|82864414|FG003|Part 2 Single-Blind|Death|5|||
46655364|NCT03541174|82864415|FG004|Part 2 Single-Blind|Death|0|||
46655365|NCT03541174|82864416|FG005|Part 2 Single-Blind|Death|0|||
46655366|NCT03541174|82864411|FG000|Part 2 Single-Blind|Pregnancy|0|||
46655367|NCT03541174|82864412|FG001|Part 2 Single-Blind|Pregnancy|0|||
46655368|NCT03541174|82864413|FG002|Part 2 Single-Blind|Pregnancy|0|||
46655369|NCT03541174|82864414|FG003|Part 2 Single-Blind|Pregnancy|1|||
46655370|NCT03541174|82864415|FG004|Part 2 Single-Blind|Pregnancy|0|||
46655371|NCT03541174|82864416|FG005|Part 2 Single-Blind|Pregnancy|0|||
46655372|NCT03541174|82864411|FG000|Part 2 Single-Blind|Other reasons|0|||
46655373|NCT03541174|82864412|FG001|Part 2 Single-Blind|Other reasons|0|||
46655374|NCT03541174|82864413|FG002|Part 2 Single-Blind|Other reasons|0|||
46655375|NCT03541174|82864414|FG003|Part 2 Single-Blind|Other reasons|32|||
46655376|NCT03541174|82864415|FG004|Part 2 Single-Blind|Other reasons|0|||
46655377|NCT03541174|82864416|FG005|Part 2 Single-Blind|Other reasons|0|||
46655378|NCT03541174|82864411|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
46655379|NCT03541174|82864412|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
46655380|NCT03541174|82864413|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
46655381|NCT03541174|82864414|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
46655382|NCT03541174|82864415|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
46655383|NCT03541174|82864416|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
46655384|NCT03541174|82864411|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
46655385|NCT03541174|82864412|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
46781798|NCT00566254|83000430|FG001|Overall Study|Protocol Violation|3|||
46781799|NCT00566254|83000429|FG000|Overall Study|Withdrawal by Subject|1|||
46655386|NCT03541174|82864413|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
46655387|NCT03541174|82864414|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
46781800|NCT00566254|83000430|FG001|Overall Study|Withdrawal by Subject|2|||
46781801|NCT00566254|83000429|FG000|Overall Study|Lack of Efficacy|5|||
46781802|NCT00566254|83000430|FG001|Overall Study|Lack of Efficacy|6|||
46781803|NCT00566254|83000429|FG000|Overall Study|Other|0|||
46971268|NCT02552121|83214740|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
46971269|NCT02552121|83214733|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
46971270|NCT02552121|83214734|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
46971271|NCT02552121|83214735|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
46655388|NCT03541174|82864415|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
46655389|NCT03541174|82864416|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
46655390|NCT03541174|82864411|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
46655391|NCT03541174|82864412|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
46655392|NCT03541174|82864413|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
46655393|NCT03541174|82864414|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
46655394|NCT03541174|82864415|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
46655395|NCT03541174|82864416|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
46655396|NCT03541174|82864411|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
46655397|NCT03541174|82864412|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
46655398|NCT03541174|82864413|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
46655399|NCT03541174|82864414|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
46655400|NCT03541174|82864415|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
46655401|NCT03541174|82864416|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
46655402|NCT03541174|82864411|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
46655403|NCT03541174|82864412|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
46655404|NCT03541174|82864413|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
46655405|NCT03541174|82864414|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
46655406|NCT03541174|82864415|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
46781804|NCT00566254|83000430|FG001|Overall Study|Other|2|||
46971272|NCT02552121|83214736|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
46971273|NCT02552121|83214737|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
46781805|NCT00393523|83000441|FG000|Overall Study|Lost to Follow-up|0|||
46655407|NCT03541174|82864416|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
46655408|NCT03281304|82864448|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
46971274|NCT02552121|83214738|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
46971275|NCT02552121|83214739|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
46971276|NCT02552121|83214740|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
46971277|NCT02552121|83214733|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
46971278|NCT02552121|83214734|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
46781806|NCT00393523|83000442|FG001|Overall Study|Lost to Follow-up|0|||
46781807|NCT00393523|83000443|FG002|Overall Study|Lost to Follow-up|0|||
46781808|NCT00393523|83000444|FG003|Overall Study|Lost to Follow-up|2|||
46781809|NCT00393523|83000445|FG004|Overall Study|Lost to Follow-up|1|||
46781810|NCT00393523|83000441|FG000|Overall Study|Protocol Violation|6|||
46781811|NCT00393523|83000442|FG001|Overall Study|Protocol Violation|2|||
46781812|NCT00393523|83000443|FG002|Overall Study|Protocol Violation|0|||
46781813|NCT00393523|83000444|FG003|Overall Study|Protocol Violation|1|||
46781814|NCT00393523|83000445|FG004|Overall Study|Protocol Violation|0|||
46781815|NCT00393523|83000441|FG000|Overall Study|Withdrawal by Subject|6|||
46781816|NCT00393523|83000442|FG001|Overall Study|Withdrawal by Subject|7|||
46781817|NCT00393523|83000443|FG002|Overall Study|Withdrawal by Subject|2|||
46781818|NCT00393523|83000444|FG003|Overall Study|Withdrawal by Subject|3|||
46781819|NCT00393523|83000445|FG004|Overall Study|Withdrawal by Subject|0|||
46781820|NCT00393523|83000441|FG000|Overall Study|Difficulties in specimen collection|0|||
46781821|NCT00393523|83000442|FG001|Overall Study|Difficulties in specimen collection|0|||
46781822|NCT00393523|83000443|FG002|Overall Study|Difficulties in specimen collection|1|||
46781823|NCT00393523|83000444|FG003|Overall Study|Difficulties in specimen collection|0|||
46850838|NCT00112047|83066651|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
46850839|NCT00112047|83066652|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
46655409|NCT03281304|82864449|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
46850840|NCT00112047|83066651|FG000|Randomized Phase|Inability to swallow pills|0|||
46850841|NCT00112047|83066652|FG001|Randomized Phase|Inability to swallow pills|1|||
46850842|NCT00112047|83066651|FG000|Randomized Phase|Incarceration|3|||
46850843|NCT00112047|83066652|FG001|Randomized Phase|Incarceration|2|||
46850844|NCT00112047|83066651|FG000|Randomized Phase|Moved out of State|0|||
46850845|NCT00112047|83066652|FG001|Randomized Phase|Moved out of State|1|||
46850846|NCT00112047|83066651|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
46850847|NCT00112047|83066652|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
46850848|NCT00112047|83066651|FG000|Randomized Phase|High Hepatitis B DNA|0|||
46850849|NCT00112047|83066652|FG001|Randomized Phase|High Hepatitis B DNA|1|||
46850850|NCT00112047|83066651|FG000|Atripla Phase|Adverse Event|2|||
46850851|NCT00112047|83066652|FG001|Atripla Phase|Adverse Event|1|||
46850852|NCT00112047|83066651|FG000|Atripla Phase|Lost to Follow-up|5|||
46850853|NCT00112047|83066652|FG001|Atripla Phase|Lost to Follow-up|7|||
46850854|NCT00112047|83066651|FG000|Atripla Phase|Pregnancy|0|||
46850855|NCT00112047|83066652|FG001|Atripla Phase|Pregnancy|1|||
46971279|NCT02552121|83214735|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
46971280|NCT02552121|83214736|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
46971281|NCT02552121|83214737|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
46971282|NCT02552121|83214738|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
46971283|NCT02552121|83214739|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
46971284|NCT02552121|83214740|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
46971285|NCT02552121|83214733|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
46971286|NCT02552121|83214734|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
46971287|NCT02552121|83214735|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
46971288|NCT02552121|83214736|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
46971289|NCT02552121|83214737|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
46971290|NCT02552121|83214738|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
46655410|NCT03281304|82864448|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
46655411|NCT03281304|82864449|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
46655412|NCT03281304|82864448|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
46655413|NCT03281304|82864449|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
46655414|NCT03281304|82864448|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
46655415|NCT03281304|82864449|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
46655416|NCT03281304|82864448|FG000|Treatment Phase (up to 42 Months)|Death|0|||
46655417|NCT03281304|82864449|FG001|Treatment Phase (up to 42 Months)|Death|1|||
46655418|NCT03281304|82864448|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
46655419|NCT03281304|82864449|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
46655420|NCT03281304|82864448|FG000|Treatment Phase (up to 42 Months)|Other|0|||
46971291|NCT02552121|83214739|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
46971292|NCT02552121|83214740|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
46971293|NCT02552121|83214733|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
46971294|NCT02552121|83214734|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
46971295|NCT02552121|83214735|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
46971296|NCT02552121|83214736|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
46971297|NCT02552121|83214737|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
46971298|NCT02552121|83214738|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
46971299|NCT02552121|83214739|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
46655421|NCT03281304|82864449|FG001|Treatment Phase (up to 42 Months)|Other|2|||
46655422|NCT03281304|82864448|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
46655423|NCT03281304|82864449|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
46655424|NCT03204305|82864458|FG000|Overall Study|Lost to Follow-up|6|||
46655425|NCT03204305|82864459|FG001|Overall Study|Lost to Follow-up|4|||
46655426|NCT03204305|82864460|FG002|Overall Study|Lost to Follow-up|0|||
46655427|NCT03204305|82864461|FG003|Overall Study|Lost to Follow-up|0|||
46655428|NCT03204305|82864458|FG000|Overall Study|Physician Decision|1|||
46655429|NCT03204305|82864459|FG001|Overall Study|Physician Decision|0|||
46655430|NCT03204305|82864460|FG002|Overall Study|Physician Decision|0|||
46655431|NCT03204305|82864461|FG003|Overall Study|Physician Decision|0|||
46655432|NCT03204305|82864458|FG000|Overall Study|failure to place arterial line|2|||
46971300|NCT02552121|83214740|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
46971301|NCT02552121|83214733|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
46971302|NCT02552121|83214734|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
46971303|NCT02552121|83214735|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
46971304|NCT02552121|83214736|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
46971305|NCT02552121|83214737|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
46971306|NCT02552121|83214738|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
46971307|NCT02552121|83214739|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
46971308|NCT02552121|83214740|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
46971309|NCT02552121|83214733|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
46971310|NCT02552121|83214734|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
46971311|NCT02552121|83214735|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
47075611|NCT04178967|83370257|FG007|Induction Period|Withdrawal by Subject|0|||
47075612|NCT04178967|83370258|FG008|Induction Period|Withdrawal by Subject|0|||
47075613|NCT04178967|83370259|FG009|Induction Period|Withdrawal by Subject|0|||
47075614|NCT04178967|83370260|FG010|Induction Period|Withdrawal by Subject|0|||
47075615|NCT04178967|83370250|FG000|Induction Period|Lost to Follow-up|2|||
47075616|NCT04178967|83370251|FG001|Induction Period|Lost to Follow-up|0|||
47075617|NCT04178967|83370252|FG002|Induction Period|Lost to Follow-up|0|||
47075618|NCT04178967|83370253|FG003|Induction Period|Lost to Follow-up|0|||
47075619|NCT04178967|83370254|FG004|Induction Period|Lost to Follow-up|0|||
47075620|NCT04178967|83370255|FG005|Induction Period|Lost to Follow-up|0|||
47075621|NCT04178967|83370256|FG006|Induction Period|Lost to Follow-up|0|||
46655433|NCT03204305|82864459|FG001|Overall Study|failure to place arterial line|1|||
46655434|NCT03204305|82864460|FG002|Overall Study|failure to place arterial line|0|||
46655435|NCT03204305|82864461|FG003|Overall Study|failure to place arterial line|0|||
46655436|NCT03204305|82864458|FG000|Overall Study|Withdrawal by Subject|2|||
46655437|NCT03204305|82864459|FG001|Overall Study|Withdrawal by Subject|0|||
46655438|NCT03204305|82864460|FG002|Overall Study|Withdrawal by Subject|0|||
46655439|NCT03204305|82864461|FG003|Overall Study|Withdrawal by Subject|0|||
46655440|NCT03200717|82864473|FG000|Overall Study|Progressive disease|24|||
46655441|NCT03200717|82864474|FG001|Overall Study|Progressive disease|5|||
46655442|NCT03200717|82864473|FG000|Overall Study|Adverse Event|11|||
46655443|NCT03200717|82864474|FG001|Overall Study|Adverse Event|8|||
46655444|NCT03200717|82864473|FG000|Overall Study|Physician Decision|3|||
46655445|NCT03200717|82864474|FG001|Overall Study|Physician Decision|2|||
46655446|NCT03200717|82864473|FG000|Overall Study|Death|2|||
46655447|NCT03200717|82864474|FG001|Overall Study|Death|0|||
46655448|NCT03200717|82864473|FG000|Overall Study|Subject/Guardian Decision|1|||
46655449|NCT03200717|82864474|FG001|Overall Study|Subject/Guardian Decision|0|||
46655450|NCT03105700|82864483|FG000|Overall Study|screen fail|3|||
46655451|NCT03105700|82864483|FG000|Overall Study|Lost to Follow-up|4|||
46655452|NCT02738853|82864506|FG000|Enrollment|Inclusion/Exclusion not met|21|||
46655453|NCT02738853|82864506|FG000|Enrollment|Withdrawal by Subject|3|||
46655454|NCT02738853|82864506|FG000|Enrollment|Subject treated with commercially available device|6|||
46655455|NCT02738853|82864506|FG000|Enrollment|Study Enrollment Closed|3|||
46655456|NCT02738853|82864506|FG000|Procedure|Death|1|||
46655457|NCT02738853|82864506|FG000|1 Month|Death|2|||
46655458|NCT02738853|82864506|FG000|6 Month|Death|4|||
46655459|NCT02738853|82864506|FG000|6 Month|Withdrawal by Subject|2|||
46655460|NCT02738853|82864506|FG000|1 Year|Death|6|||
46655461|NCT02738853|82864506|FG000|1 Year|Withdrawal by Subject|1|||
46655462|NCT02738853|82864506|FG000|2 Year|Death|2|||
46655463|NCT02738853|82864506|FG000|2 Year|Lost to Follow-up|1|||
46655464|NCT02738853|82864506|FG000|3 Year|Death|2|||
46655465|NCT02738853|82864506|FG000|3 Year|Withdrawal by Subject|1|||
46655466|NCT02738853|82864506|FG000|4 Year|Death|9|||
46655467|NCT02738853|82864506|FG000|5 Year|Lost to Follow-up|4|||
46655468|NCT02358538|82864514|FG000|Through Week 26|Adverse Event|0|||
46655469|NCT02358538|82864515|FG001|Through Week 26|Adverse Event|1|||
46655470|NCT02358538|82864516|FG002|Through Week 26|Adverse Event|1|||
46655471|NCT02358538|82864517|FG003|Through Week 26|Adverse Event|2|||
46655472|NCT02358538|82864514|FG000|Through Week 26|Lack of Efficacy|1|||
46655473|NCT02358538|82864515|FG001|Through Week 26|Lack of Efficacy|1|||
46655474|NCT02358538|82864516|FG002|Through Week 26|Lack of Efficacy|3|||
46655475|NCT02358538|82864517|FG003|Through Week 26|Lack of Efficacy|3|||
46655476|NCT02358538|82864514|FG000|Through Week 26|Withdrawal by Subject|1|||
46655477|NCT02358538|82864515|FG001|Through Week 26|Withdrawal by Subject|0|||
46655478|NCT02358538|82864516|FG002|Through Week 26|Withdrawal by Subject|0|||
46655479|NCT02358538|82864517|FG003|Through Week 26|Withdrawal by Subject|0|||
46655480|NCT02358538|82864514|FG000|Through Week 26|Non-Compliance|0|||
46655481|NCT02358538|82864515|FG001|Through Week 26|Non-Compliance|0|||
46655482|NCT02358538|82864516|FG002|Through Week 26|Non-Compliance|1|||
46655483|NCT02358538|82864517|FG003|Through Week 26|Non-Compliance|0|||
46655484|NCT02358538|82864514|FG000|Through Week 26|Family did not see benefit from IP|1|||
46655485|NCT02358538|82864515|FG001|Through Week 26|Family did not see benefit from IP|0|||
46655486|NCT02358538|82864516|FG002|Through Week 26|Family did not see benefit from IP|0|||
46655487|NCT02358538|82864517|FG003|Through Week 26|Family did not see benefit from IP|0|||
46655488|NCT02358538|82864514|FG000|52 Week Extension Period|Lack of Efficacy|0|||
46655489|NCT02358538|82864515|FG001|52 Week Extension Period|Lack of Efficacy|0|||
46655490|NCT02358538|82864516|FG002|52 Week Extension Period|Lack of Efficacy|2|||
46655491|NCT02358538|82864517|FG003|52 Week Extension Period|Lack of Efficacy|4|||
46655492|NCT02056119|82864552|FG000|Overall Study|Death|1|||
46655493|NCT02056119|82864553|FG001|Overall Study|Death|2|||
46655494|NCT02056119|82864552|FG000|Overall Study|Intubated for less than 24 hrs|2|||
46655495|NCT02056119|82864553|FG001|Overall Study|Intubated for less than 24 hrs|7|||
46655496|NCT02056119|82864552|FG000|Overall Study|No aerosol treatments were given.|3|||
46655497|NCT02056119|82864553|FG001|Overall Study|No aerosol treatments were given.|2|||
46655498|NCT02056119|82864552|FG000|Overall Study|Received Metaneb treatment|0|||
46971312|NCT02552121|83214736|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
46971313|NCT02552121|83214737|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
46655499|NCT02056119|82864553|FG001|Overall Study|Received Metaneb treatment|2|||
46971314|NCT02552121|83214738|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
46655500|NCT02056119|82864552|FG000|Overall Study|Protocol Violation|4|||
46655501|NCT02056119|82864553|FG001|Overall Study|Protocol Violation|7|||
46655502|NCT02038452|82864561|FG000|Overall Study|Withdrawal by Subject|7|||
46971315|NCT02552121|83214739|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
46655503|NCT02038452|82864562|FG001|Overall Study|Withdrawal by Subject|9|||
46655504|NCT02038452|82864561|FG000|Overall Study|Lost to Follow-up|31|||
46655505|NCT02038452|82864562|FG001|Overall Study|Lost to Follow-up|28|||
46655506|NCT01238172|82864601|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
46655507|NCT01238172|82864602|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
46655508|NCT01238172|82864601|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
46655509|NCT01238172|82864602|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
46655510|NCT00967005|82864610|FG000|Overall Study|Lost to Follow-up|7|||
46655511|NCT00967005|82864611|FG001|Overall Study|Lost to Follow-up|10|||
46655512|NCT00203996|82864643|FG000|Overall Study|Lost to Follow-up|0|||
46655513|NCT00203996|82864644|FG001|Overall Study|Lost to Follow-up|0|||
46971316|NCT02552121|83214740|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
47075622|NCT04178967|83370257|FG007|Induction Period|Lost to Follow-up|0|||
47075623|NCT04178967|83370258|FG008|Induction Period|Lost to Follow-up|0|||
47075624|NCT04178967|83370259|FG009|Induction Period|Lost to Follow-up|0|||
47075625|NCT04178967|83370260|FG010|Induction Period|Lost to Follow-up|0|||
47075626|NCT04178967|83370250|FG000|Induction Period|Participant Missed Study Visits|0|||
47075627|NCT04178967|83370251|FG001|Induction Period|Participant Missed Study Visits|1|||
47075628|NCT04178967|83370252|FG002|Induction Period|Participant Missed Study Visits|0|||
47075629|NCT04178967|83370253|FG003|Induction Period|Participant Missed Study Visits|0|||
47075630|NCT04178967|83370254|FG004|Induction Period|Participant Missed Study Visits|0|||
47075631|NCT04178967|83370255|FG005|Induction Period|Participant Missed Study Visits|0|||
47075632|NCT04178967|83370256|FG006|Induction Period|Participant Missed Study Visits|0|||
47075633|NCT04178967|83370257|FG007|Induction Period|Participant Missed Study Visits|0|||
47075634|NCT04178967|83370258|FG008|Induction Period|Participant Missed Study Visits|0|||
46781824|NCT00393523|83000445|FG004|Overall Study|Difficulties in specimen collection|0|||
46781825|NCT00393523|83000441|FG000|Overall Study|Vaccine supply issue|0|||
46781826|NCT00393523|83000442|FG001|Overall Study|Vaccine supply issue|0|||
46781827|NCT00393523|83000443|FG002|Overall Study|Vaccine supply issue|1|||
46781828|NCT00393523|83000444|FG003|Overall Study|Vaccine supply issue|0|||
46781829|NCT00393523|83000445|FG004|Overall Study|Vaccine supply issue|0|||
46781830|NCT00393367|83000458|FG000|Overall Study|Protocol Violation|2|||
46781831|NCT00393367|83000459|FG001|Overall Study|Protocol Violation|5|||
46781832|NCT00393367|83000458|FG000|Overall Study|Withdrawal by Subject|0|||
46781833|NCT00393367|83000459|FG001|Overall Study|Withdrawal by Subject|2|||
46781834|NCT00395863|83000469|FG000|Overall Study|Patients did not complete both exams|2|||
46781835|NCT00395863|83000470|FG001|Overall Study|Patients did not complete both exams|3|||
46781836|NCT00395629|83000482|FG000|Core Study|Adverse Event|0|||
46781837|NCT00395629|83000483|FG001|Core Study|Adverse Event|3|||
46781838|NCT00395629|83000484|FG002|Core Study|Adverse Event|4|||
46781839|NCT00395629|83000482|FG000|Core Study|Abnormal laboratory value(s)|0|||
46781840|NCT00395629|83000483|FG001|Core Study|Abnormal laboratory value(s)|0|||
46781841|NCT00395629|83000484|FG002|Core Study|Abnormal laboratory value(s)|1|||
46781842|NCT00395629|83000482|FG000|Core Study|Protocol Violation|1|||
46781843|NCT00395629|83000483|FG001|Core Study|Protocol Violation|0|||
46781844|NCT00395629|83000484|FG002|Core Study|Protocol Violation|0|||
46781845|NCT00395629|83000482|FG000|Core Study|Withdrawal by Subject|0|||
46781846|NCT00395629|83000483|FG001|Core Study|Withdrawal by Subject|1|||
46781847|NCT00395629|83000484|FG002|Core Study|Withdrawal by Subject|1|||
46781848|NCT00395629|83000482|FG000|Core Study|Lost to Follow-up|0|||
46781849|NCT00395629|83000483|FG001|Core Study|Lost to Follow-up|0|||
46781850|NCT00395629|83000484|FG002|Core Study|Lost to Follow-up|1|||
46781851|NCT00395629|83000482|FG000|Extension Study|Adverse Event|0|||
46781852|NCT00395629|83000483|FG001|Extension Study|Adverse Event|0|||
46850856|NCT00112047|83066651|FG000|Atripla Phase|Death|0|||
46850857|NCT00112047|83066652|FG001|Atripla Phase|Death|2|||
46850858|NCT00112047|83066651|FG000|Atripla Phase|Withdrew consent|7|||
46850859|NCT00112047|83066652|FG001|Atripla Phase|Withdrew consent|7|||
46850860|NCT00112047|83066651|FG000|Atripla Phase|Sub-optimal virological response|0|||
46850861|NCT00112047|83066652|FG001|Atripla Phase|Sub-optimal virological response|1|||
46850862|NCT00112047|83066651|FG000|Atripla Phase|Non-compliance|1|||
47075635|NCT04178967|83370259|FG009|Induction Period|Participant Missed Study Visits|0|||
47075636|NCT04178967|83370260|FG010|Induction Period|Participant Missed Study Visits|0|||
47075637|NCT04178967|83370250|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
47075638|NCT04178967|83370251|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
47075639|NCT04178967|83370252|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
47075640|NCT04178967|83370253|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
46781853|NCT00395629|83000484|FG002|Extension Study|Adverse Event|2|||
46781854|NCT00395629|83000482|FG000|Extension Study|Administrative problems|0|||
46850863|NCT00112047|83066652|FG001|Atripla Phase|Non-compliance|0|||
46850864|NCT00112047|83066651|FG000|Atripla Phase|Other|3|||
46850865|NCT00112047|83066652|FG001|Atripla Phase|Other|1|||
46850866|NCT03658876|83066665|FG000|Overall Study|Protocol Violation|3|||
46850867|NCT03658876|83066666|FG001|Overall Study|Protocol Violation|2|||
46850868|NCT03658876|83066665|FG000|Overall Study|Withdrawal by Subject|2|||
46850869|NCT03658876|83066666|FG001|Overall Study|Withdrawal by Subject|0|||
46850870|NCT03658876|83066665|FG000|Overall Study|Death|0|||
46850871|NCT03658876|83066666|FG001|Overall Study|Death|1|||
46850872|NCT03658876|83066665|FG000|Overall Study|Intercurrent illness|6|||
46850873|NCT03658876|83066666|FG001|Overall Study|Intercurrent illness|4|||
46655514|NCT00203996|82864645|FG002|Overall Study|Lost to Follow-up|0|||
46655515|NCT00203996|82864646|FG003|Overall Study|Lost to Follow-up|1|||
46655516|NCT00203996|82864647|FG004|Overall Study|Lost to Follow-up|0|||
46655517|NCT00203996|82864648|FG005|Overall Study|Lost to Follow-up|0|||
46655518|NCT00203996|82864649|FG006|Overall Study|Lost to Follow-up|0|||
46655519|NCT00203996|82864650|FG007|Overall Study|Lost to Follow-up|0|||
46655520|NCT00203996|82864651|FG008|Overall Study|Lost to Follow-up|0|||
46655521|NCT00203996|82864652|FG009|Overall Study|Lost to Follow-up|0|||
46655522|NCT00203996|82864643|FG000|Overall Study|Protocol Violation|0|||
46655523|NCT00203996|82864644|FG001|Overall Study|Protocol Violation|0|||
46655524|NCT00203996|82864645|FG002|Overall Study|Protocol Violation|0|||
46655525|NCT00203996|82864646|FG003|Overall Study|Protocol Violation|6|||
46655526|NCT00203996|82864647|FG004|Overall Study|Protocol Violation|1|||
46655527|NCT00203996|82864648|FG005|Overall Study|Protocol Violation|0|||
46655528|NCT00203996|82864649|FG006|Overall Study|Protocol Violation|0|||
46655529|NCT00203996|82864650|FG007|Overall Study|Protocol Violation|0|||
46655530|NCT00203996|82864651|FG008|Overall Study|Protocol Violation|0|||
46655531|NCT00203996|82864652|FG009|Overall Study|Protocol Violation|0|||
46655532|NCT00203996|82864643|FG000|Overall Study|Physician Decision|0|||
46655533|NCT00203996|82864644|FG001|Overall Study|Physician Decision|0|||
46655534|NCT00203996|82864645|FG002|Overall Study|Physician Decision|0|||
46850874|NCT03658876|83066665|FG000|Overall Study|Transplantation/other operation|1|||
46850875|NCT03658876|83066666|FG001|Overall Study|Transplantation/other operation|5|||
46850876|NCT03618628|83066672|FG000|Overall Study|Death|1|||
46655535|NCT00203996|82864646|FG003|Overall Study|Physician Decision|2|||
46655536|NCT00203996|82864647|FG004|Overall Study|Physician Decision|0|||
46655537|NCT00203996|82864648|FG005|Overall Study|Physician Decision|0|||
46850877|NCT03618628|83066672|FG000|Overall Study|Lost to Follow-up|1|||
46850878|NCT03616600|83066678|FG000|Overall Study|Withdrawal by Subject|1|||
46850879|NCT03616600|83066679|FG001|Overall Study|Withdrawal by Subject|0|||
46850880|NCT00380393|83066688|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
46850881|NCT00380393|83066689|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
46850882|NCT00380393|83066688|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
46850883|NCT00380393|83066689|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
46850884|NCT00380393|83066688|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
47075641|NCT04178967|83370254|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
47075642|NCT04178967|83370255|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
47075643|NCT04178967|83370256|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
47075644|NCT04178967|83370257|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
47075645|NCT04178967|83370258|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
47075646|NCT04178967|83370259|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
47075647|NCT04178967|83370260|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
47075648|NCT04178967|83370250|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075649|NCT04178967|83370251|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075650|NCT04178967|83370252|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075651|NCT04178967|83370253|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075652|NCT04178967|83370254|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075653|NCT04178967|83370255|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
47075654|NCT04178967|83370256|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075655|NCT04178967|83370257|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075656|NCT04178967|83370258|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075657|NCT04178967|83370259|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075658|NCT04178967|83370260|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
47075659|NCT04178967|83370250|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
46655538|NCT00203996|82864649|FG006|Overall Study|Physician Decision|0|||
46655539|NCT00203996|82864650|FG007|Overall Study|Physician Decision|0|||
46850885|NCT00380393|83066689|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
46655540|NCT00203996|82864651|FG008|Overall Study|Physician Decision|0|||
46655541|NCT00203996|82864652|FG009|Overall Study|Physician Decision|1|||
46655542|NCT00203996|82864643|FG000|Overall Study|CPAP machine malfunction|0|||
46655543|NCT00203996|82864644|FG001|Overall Study|CPAP machine malfunction|0|||
46655544|NCT00203996|82864645|FG002|Overall Study|CPAP machine malfunction|0|||
46655545|NCT00203996|82864646|FG003|Overall Study|CPAP machine malfunction|1|||
46655546|NCT00203996|82864647|FG004|Overall Study|CPAP machine malfunction|0|||
46655547|NCT00203996|82864648|FG005|Overall Study|CPAP machine malfunction|0|||
46655548|NCT00203996|82864649|FG006|Overall Study|CPAP machine malfunction|0|||
46655549|NCT00203996|82864650|FG007|Overall Study|CPAP machine malfunction|0|||
46655550|NCT00203996|82864651|FG008|Overall Study|CPAP machine malfunction|0|||
46655551|NCT00203996|82864652|FG009|Overall Study|CPAP machine malfunction|0|||
46655552|NCT00203996|82864643|FG000|Overall Study|Scheduling issue|0|||
46655553|NCT00203996|82864644|FG001|Overall Study|Scheduling issue|0|||
46655554|NCT00203996|82864645|FG002|Overall Study|Scheduling issue|0|||
46655555|NCT00203996|82864646|FG003|Overall Study|Scheduling issue|0|||
46655556|NCT00203996|82864647|FG004|Overall Study|Scheduling issue|0|||
46655557|NCT00203996|82864648|FG005|Overall Study|Scheduling issue|0|||
46655558|NCT00203996|82864649|FG006|Overall Study|Scheduling issue|0|||
46655559|NCT00203996|82864650|FG007|Overall Study|Scheduling issue|2|||
46655560|NCT00203996|82864651|FG008|Overall Study|Scheduling issue|0|||
46655561|NCT00203996|82864652|FG009|Overall Study|Scheduling issue|0|||
46655562|NCT02014558|82864681|FG000|Overall Study|Never Received Study Drug|0|||
46655563|NCT02014558|82864682|FG001|Overall Study|Never Received Study Drug|0|||
46655564|NCT02014558|82864683|FG002|Overall Study|Never Received Study Drug|0|||
46655565|NCT02014558|82864684|FG003|Overall Study|Never Received Study Drug|0|||
46655566|NCT02014558|82864685|FG004|Overall Study|Never Received Study Drug|1|||
46655567|NCT02014558|82864686|FG005|Overall Study|Never Received Study Drug|0|||
46655568|NCT02014558|82864687|FG006|Overall Study|Never Received Study Drug|1|||
46655569|NCT02014558|82864688|FG007|Overall Study|Never Received Study Drug|0|||
46655570|NCT02014558|82864689|FG008|Overall Study|Never Received Study Drug|2|||
46655571|NCT02014558|82864690|FG009|Overall Study|Never Received Study Drug|0|||
46655572|NCT02014558|82864691|FG010|Overall Study|Never Received Study Drug|2|||
46655573|NCT02014558|82864692|FG011|Overall Study|Never Received Study Drug|2|||
46655574|NCT02014558|82864693|FG012|Overall Study|Never Received Study Drug|0|||
46655575|NCT02014558|82864681|FG000|Overall Study|Adverse Event|0|||
46655576|NCT02014558|82864682|FG001|Overall Study|Adverse Event|0|||
46655577|NCT02014558|82864683|FG002|Overall Study|Adverse Event|0|||
46655578|NCT02014558|82864684|FG003|Overall Study|Adverse Event|0|||
46655579|NCT02014558|82864685|FG004|Overall Study|Adverse Event|1|||
46655580|NCT02014558|82864686|FG005|Overall Study|Adverse Event|0|||
46655581|NCT02014558|82864687|FG006|Overall Study|Adverse Event|0|||
46971317|NCT02552121|83214733|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
46971318|NCT02552121|83214734|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
46971319|NCT02552121|83214735|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
46971320|NCT02552121|83214736|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
46971321|NCT02552121|83214737|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
46971322|NCT02552121|83214738|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
46971323|NCT02552121|83214739|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
46971324|NCT02552121|83214740|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
46971325|NCT02552121|83214733|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
46971326|NCT02552121|83214734|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
46971327|NCT02552121|83214735|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
46971328|NCT02552121|83214736|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
46971329|NCT02552121|83214737|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
46971330|NCT02552121|83214738|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
46971331|NCT02552121|83214739|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
46971332|NCT02552121|83214740|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
46971333|NCT02552121|83214733|FG000|Part 2: Cohort Expansion|Death|0|||
46655582|NCT02014558|82864688|FG007|Overall Study|Adverse Event|0|||
46655583|NCT02014558|82864689|FG008|Overall Study|Adverse Event|2|||
46655584|NCT02014558|82864690|FG009|Overall Study|Adverse Event|2|||
46655585|NCT02014558|82864691|FG010|Overall Study|Adverse Event|5|||
46655586|NCT02014558|82864692|FG011|Overall Study|Adverse Event|21|||
46655587|NCT02014558|82864693|FG012|Overall Study|Adverse Event|3|||
46655588|NCT02014558|82864681|FG000|Overall Study|Death|1|||
46655589|NCT02014558|82864682|FG001|Overall Study|Death|0|||
46655590|NCT02014558|82864683|FG002|Overall Study|Death|0|||
46655591|NCT02014558|82864684|FG003|Overall Study|Death|0|||
46655592|NCT02014558|82864685|FG004|Overall Study|Death|0|||
46655593|NCT02014558|82864686|FG005|Overall Study|Death|0|||
46655594|NCT02014558|82864687|FG006|Overall Study|Death|1|||
46655595|NCT02014558|82864688|FG007|Overall Study|Death|1|||
46971334|NCT02552121|83214734|FG001|Part 2: Cohort Expansion|Death|0|||
46971335|NCT02552121|83214735|FG002|Part 2: Cohort Expansion|Death|1|||
46655596|NCT02014558|82864689|FG008|Overall Study|Death|2|||
46655597|NCT02014558|82864690|FG009|Overall Study|Death|5|||
46655598|NCT02014558|82864691|FG010|Overall Study|Death|5|||
46655599|NCT02014558|82864692|FG011|Overall Study|Death|19|||
46655600|NCT02014558|82864693|FG012|Overall Study|Death|2|||
46655601|NCT02014558|82864681|FG000|Overall Study|Lack of Efficacy|1|||
46655602|NCT02014558|82864682|FG001|Overall Study|Lack of Efficacy|2|||
46655603|NCT02014558|82864683|FG002|Overall Study|Lack of Efficacy|1|||
46655604|NCT02014558|82864684|FG003|Overall Study|Lack of Efficacy|1|||
46655605|NCT02014558|82864685|FG004|Overall Study|Lack of Efficacy|0|||
46655606|NCT02014558|82864686|FG005|Overall Study|Lack of Efficacy|0|||
46655607|NCT02014558|82864687|FG006|Overall Study|Lack of Efficacy|1|||
46655608|NCT02014558|82864688|FG007|Overall Study|Lack of Efficacy|3|||
46655609|NCT02014558|82864689|FG008|Overall Study|Lack of Efficacy|3|||
46655610|NCT02014558|82864690|FG009|Overall Study|Lack of Efficacy|3|||
46655611|NCT02014558|82864691|FG010|Overall Study|Lack of Efficacy|16|||
46655612|NCT02014558|82864692|FG011|Overall Study|Lack of Efficacy|8|||
46655613|NCT02014558|82864693|FG012|Overall Study|Lack of Efficacy|5|||
46655614|NCT02014558|82864681|FG000|Overall Study|Lost to Follow-up|0|||
46655615|NCT02014558|82864682|FG001|Overall Study|Lost to Follow-up|0|||
46655616|NCT02014558|82864683|FG002|Overall Study|Lost to Follow-up|0|||
46655617|NCT02014558|82864684|FG003|Overall Study|Lost to Follow-up|0|||
46655618|NCT02014558|82864685|FG004|Overall Study|Lost to Follow-up|0|||
46655619|NCT02014558|82864686|FG005|Overall Study|Lost to Follow-up|0|||
46655620|NCT02014558|82864687|FG006|Overall Study|Lost to Follow-up|0|||
46655621|NCT02014558|82864688|FG007|Overall Study|Lost to Follow-up|0|||
46655622|NCT02014558|82864689|FG008|Overall Study|Lost to Follow-up|0|||
46655623|NCT02014558|82864690|FG009|Overall Study|Lost to Follow-up|0|||
46655624|NCT02014558|82864691|FG010|Overall Study|Lost to Follow-up|1|||
46655625|NCT02014558|82864692|FG011|Overall Study|Lost to Follow-up|0|||
46655626|NCT02014558|82864693|FG012|Overall Study|Lost to Follow-up|0|||
46655627|NCT02014558|82864681|FG000|Overall Study|Progressive Disease|1|||
46655628|NCT02014558|82864682|FG001|Overall Study|Progressive Disease|0|||
46655629|NCT02014558|82864683|FG002|Overall Study|Progressive Disease|1|||
46655630|NCT02014558|82864684|FG003|Overall Study|Progressive Disease|1|||
46655631|NCT02014558|82864685|FG004|Overall Study|Progressive Disease|1|||
46655632|NCT02014558|82864686|FG005|Overall Study|Progressive Disease|2|||
46655633|NCT02014558|82864687|FG006|Overall Study|Progressive Disease|1|||
46655634|NCT02014558|82864688|FG007|Overall Study|Progressive Disease|6|||
46655635|NCT02014558|82864689|FG008|Overall Study|Progressive Disease|5|||
46655636|NCT02014558|82864690|FG009|Overall Study|Progressive Disease|6|||
46655637|NCT02014558|82864691|FG010|Overall Study|Progressive Disease|22|||
46655638|NCT02014558|82864692|FG011|Overall Study|Progressive Disease|31|||
46655639|NCT02014558|82864693|FG012|Overall Study|Progressive Disease|6|||
46655640|NCT02014558|82864681|FG000|Overall Study|Withdrawal by Subject|0|||
46655641|NCT02014558|82864682|FG001|Overall Study|Withdrawal by Subject|0|||
46655642|NCT02014558|82864683|FG002|Overall Study|Withdrawal by Subject|0|||
46655643|NCT02014558|82864684|FG003|Overall Study|Withdrawal by Subject|0|||
46655644|NCT02014558|82864685|FG004|Overall Study|Withdrawal by Subject|1|||
46655645|NCT02014558|82864686|FG005|Overall Study|Withdrawal by Subject|0|||
46655646|NCT02014558|82864687|FG006|Overall Study|Withdrawal by Subject|0|||
46655647|NCT02014558|82864688|FG007|Overall Study|Withdrawal by Subject|0|||
46655648|NCT02014558|82864689|FG008|Overall Study|Withdrawal by Subject|0|||
46655649|NCT02014558|82864690|FG009|Overall Study|Withdrawal by Subject|2|||
46655650|NCT02014558|82864691|FG010|Overall Study|Withdrawal by Subject|6|||
46655651|NCT02014558|82864692|FG011|Overall Study|Withdrawal by Subject|10|||
46655652|NCT02014558|82864693|FG012|Overall Study|Withdrawal by Subject|0|||
46655653|NCT02014558|82864681|FG000|Overall Study|Miscellaneous|2|||
46655654|NCT02014558|82864682|FG001|Overall Study|Miscellaneous|1|||
46655655|NCT02014558|82864683|FG002|Overall Study|Miscellaneous|1|||
46655656|NCT02014558|82864684|FG003|Overall Study|Miscellaneous|1|||
46655657|NCT02014558|82864685|FG004|Overall Study|Miscellaneous|0|||
46655658|NCT02014558|82864686|FG005|Overall Study|Miscellaneous|1|||
46655659|NCT02014558|82864687|FG006|Overall Study|Miscellaneous|0|||
46655660|NCT02014558|82864688|FG007|Overall Study|Miscellaneous|1|||
46655661|NCT02014558|82864689|FG008|Overall Study|Miscellaneous|1|||
46655662|NCT02014558|82864690|FG009|Overall Study|Miscellaneous|3|||
46655663|NCT02014558|82864691|FG010|Overall Study|Miscellaneous|12|||
46655664|NCT02014558|82864692|FG011|Overall Study|Miscellaneous|11|||
46655665|NCT02014558|82864693|FG012|Overall Study|Miscellaneous|1|||
46655666|NCT02024555|82864748|FG000|Overall Study|Lost to Follow-up|1|||
46781855|NCT00395629|83000483|FG001|Extension Study|Administrative problems|0|||
46781856|NCT00395629|83000484|FG002|Extension Study|Administrative problems|1|||
46781857|NCT00392665|83000497|FG000|Overall Study|Death|16|||
46781858|NCT00392665|83000498|FG001|Overall Study|Death|14|||
46655667|NCT02024555|82864749|FG001|Overall Study|Lost to Follow-up|1|||
46655668|NCT02024555|82864748|FG000|Overall Study|Withdrawal by Subject|5|||
46655669|NCT02024555|82864749|FG001|Overall Study|Withdrawal by Subject|1|||
46655670|NCT02040584|82864757|FG000|Overall Study|Adverse Event|13|||
46655671|NCT02040584|82864758|FG001|Overall Study|Adverse Event|6|||
46781859|NCT00392665|83000497|FG000|Overall Study|Lost to Follow-up|1|||
46655672|NCT02040584|82864757|FG000|Overall Study|Protocol Violation|9|||
46655673|NCT02040584|82864758|FG001|Overall Study|Protocol Violation|11|||
46655674|NCT02040584|82864757|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46655675|NCT02040584|82864758|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46655676|NCT02040584|82864757|FG000|Overall Study|Death|6|||
46655677|NCT02040584|82864758|FG001|Overall Study|Death|3|||
46655678|NCT02040584|82864757|FG000|Overall Study|Transplant rejection/retransplant|0|||
46655679|NCT02040584|82864758|FG001|Overall Study|Transplant rejection/retransplant|1|||
46655680|NCT02040584|82864757|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
46655681|NCT02040584|82864758|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
46655682|NCT02045797|82864777|FG000|Overall Study|Adverse Event|3|||
46655683|NCT02045797|82864778|FG001|Overall Study|Adverse Event|1|||
46655684|NCT02045797|82864779|FG002|Overall Study|Adverse Event|0|||
46655685|NCT02045797|82864777|FG000|Overall Study|Lack of Efficacy|1|||
46655686|NCT02045797|82864778|FG001|Overall Study|Lack of Efficacy|0|||
46655687|NCT02045797|82864779|FG002|Overall Study|Lack of Efficacy|0|||
46655688|NCT02045797|82864777|FG000|Overall Study|Lost to Follow-up|2|||
46655689|NCT02045797|82864778|FG001|Overall Study|Lost to Follow-up|3|||
46971336|NCT02552121|83214736|FG003|Part 2: Cohort Expansion|Death|0|||
46971337|NCT02552121|83214737|FG004|Part 2: Cohort Expansion|Death|0|||
46971338|NCT02552121|83214738|FG005|Part 2: Cohort Expansion|Death|0|||
46655690|NCT02045797|82864779|FG002|Overall Study|Lost to Follow-up|1|||
46655691|NCT02045797|82864777|FG000|Overall Study|Physician Decision|0|||
46655692|NCT02045797|82864778|FG001|Overall Study|Physician Decision|1|||
46781860|NCT00392665|83000498|FG001|Overall Study|Lost to Follow-up|1|||
46781861|NCT00622869|83000507|FG000|Overall Study|Subject Withdrew Consent|13|||
46781862|NCT00622869|83000508|FG001|Overall Study|Subject Withdrew Consent|17|||
46781863|NCT00622869|83000509|FG002|Overall Study|Subject Withdrew Consent|11|||
46655693|NCT02045797|82864779|FG002|Overall Study|Physician Decision|0|||
46655694|NCT02045797|82864777|FG000|Overall Study|Withdrawal by Subject|1|||
46655695|NCT02045797|82864778|FG001|Overall Study|Withdrawal by Subject|2|||
46655696|NCT02045797|82864779|FG002|Overall Study|Withdrawal by Subject|0|||
46655697|NCT03385239|82864809|FG000|Overall Study|Voluntary Withdrawal|2|||
46655698|NCT03385239|82864810|FG001|Overall Study|Voluntary Withdrawal|3|||
46655699|NCT03385239|82864811|FG002|Overall Study|Voluntary Withdrawal|2|||
46655700|NCT03385239|82864812|FG003|Overall Study|Voluntary Withdrawal|3|||
46655701|NCT03385239|82864813|FG004|Overall Study|Voluntary Withdrawal|0|||
46655702|NCT03385239|82864809|FG000|Overall Study|Adverse Event|0|||
46655703|NCT03385239|82864810|FG001|Overall Study|Adverse Event|0|||
46655704|NCT03385239|82864811|FG002|Overall Study|Adverse Event|1|||
46655705|NCT03385239|82864812|FG003|Overall Study|Adverse Event|0|||
46655706|NCT03385239|82864813|FG004|Overall Study|Adverse Event|0|||
46655707|NCT03385239|82864809|FG000|Overall Study|Other|0|||
46655708|NCT03385239|82864810|FG001|Overall Study|Other|0|||
46655709|NCT03385239|82864811|FG002|Overall Study|Other|0|||
46655710|NCT03385239|82864812|FG003|Overall Study|Other|1|||
46655711|NCT03385239|82864813|FG004|Overall Study|Other|0|||
46655712|NCT03020160|82864831|FG000|Overall Study|Withdrawal by Subject|1|||
46655713|NCT03020160|82864832|FG001|Overall Study|Withdrawal by Subject|0|||
46655714|NCT02593110|82864843|FG000|Overall Study|Withdrawal by Subject|0|||
46655715|NCT02593110|82864844|FG001|Overall Study|Withdrawal by Subject|3|||
46655716|NCT02593110|82864845|FG002|Overall Study|Withdrawal by Subject|3|||
46655717|NCT02593110|82864846|FG003|Overall Study|Withdrawal by Subject|2|||
46655718|NCT02593110|82864843|FG000|Overall Study|Death|0|||
46655719|NCT02593110|82864844|FG001|Overall Study|Death|0|||
46655720|NCT02593110|82864845|FG002|Overall Study|Death|1|||
46655721|NCT02593110|82864846|FG003|Overall Study|Death|0|||
46655722|NCT02373813|82864859|FG000|Run-In Period|Other, Not Specified|5|||
46655723|NCT02373813|82864860|FG001|Run-In Period|Other, Not Specified|0|||
46655724|NCT02373813|82864861|FG002|Run-In Period|Other, Not Specified|0|||
46781864|NCT00622869|83000507|FG000|Overall Study|Administrative Problems|11|||
46781865|NCT00622869|83000508|FG001|Overall Study|Administrative Problems|17|||
46971339|NCT02552121|83214739|FG006|Part 2: Cohort Expansion|Death|0|||
46971340|NCT02552121|83214740|FG007|Part 2: Cohort Expansion|Death|0|||
46655725|NCT02373813|82864862|FG003|Run-In Period|Other, Not Specified|0|||
46655726|NCT02373813|82864859|FG000|Run-In Period|Withdrawal by Subject|16|||
46655727|NCT02373813|82864860|FG001|Run-In Period|Withdrawal by Subject|0|||
46781866|NCT00622869|83000509|FG002|Overall Study|Administrative Problems|13|||
46781867|NCT00622869|83000507|FG000|Overall Study|Death|12|||
46850886|NCT00380393|83066688|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
46850887|NCT00380393|83066689|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
46850888|NCT00380393|83066688|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
46850889|NCT00380393|83066689|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
46850890|NCT00380393|83066688|FG000|Month 14|Withdrawal by Subject|9|||
46850891|NCT00380393|83066689|FG001|Month 14|Withdrawal by Subject|7|||
46850892|NCT00380393|83066688|FG000|Month 14|Death|1|||
46850893|NCT00380393|83066689|FG001|Month 14|Death|0|||
46850894|NCT00380393|83066688|FG000|Month 14|Lost to Follow-up|0|||
46655728|NCT02373813|82864861|FG002|Run-In Period|Withdrawal by Subject|0|||
46655729|NCT02373813|82864862|FG003|Run-In Period|Withdrawal by Subject|0|||
46655730|NCT02373813|82864859|FG000|Run-In Period|Decision by Sponsor|11|||
46655731|NCT02373813|82864860|FG001|Run-In Period|Decision by Sponsor|0|||
46655732|NCT02373813|82864861|FG002|Run-In Period|Decision by Sponsor|0|||
46655733|NCT02373813|82864862|FG003|Run-In Period|Decision by Sponsor|0|||
46655734|NCT02373813|82864859|FG000|Run-In Period|Protocol Violation|75|||
46655735|NCT02373813|82864860|FG001|Run-In Period|Protocol Violation|0|||
46655736|NCT02373813|82864861|FG002|Run-In Period|Protocol Violation|0|||
46655737|NCT02373813|82864862|FG003|Run-In Period|Protocol Violation|0|||
46655738|NCT02373813|82864859|FG000|Run-In Period|Lost to Follow-up|2|||
46655739|NCT02373813|82864860|FG001|Run-In Period|Lost to Follow-up|0|||
46655740|NCT02373813|82864861|FG002|Run-In Period|Lost to Follow-up|0|||
46655741|NCT02373813|82864862|FG003|Run-In Period|Lost to Follow-up|0|||
46655742|NCT02373813|82864859|FG000|Run-In Period|Adverse Event|3|||
46655743|NCT02373813|82864860|FG001|Run-In Period|Adverse Event|0|||
46655744|NCT02373813|82864861|FG002|Run-In Period|Adverse Event|0|||
46655745|NCT02373813|82864862|FG003|Run-In Period|Adverse Event|0|||
46655746|NCT02373813|82864859|FG000|Run-In Period|Noncompliance|1|||
46655747|NCT02373813|82864860|FG001|Run-In Period|Noncompliance|0|||
46655748|NCT02373813|82864861|FG002|Run-In Period|Noncompliance|0|||
46655749|NCT02373813|82864862|FG003|Run-In Period|Noncompliance|0|||
46655750|NCT02373813|82864859|FG000|Run-In Period|Ineligibility Determined|3|||
46655751|NCT02373813|82864860|FG001|Run-In Period|Ineligibility Determined|0|||
46655752|NCT02373813|82864861|FG002|Run-In Period|Ineligibility Determined|0|||
46655753|NCT02373813|82864862|FG003|Run-In Period|Ineligibility Determined|0|||
46655754|NCT02373813|82864859|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
46655755|NCT02373813|82864860|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
46655756|NCT02373813|82864861|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
46655757|NCT02373813|82864862|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
46655758|NCT02373813|82864859|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
46655759|NCT02373813|82864860|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
46655760|NCT02373813|82864861|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
46655761|NCT02373813|82864862|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
46655762|NCT02373813|82864859|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46655763|NCT02373813|82864860|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
46655764|NCT02373813|82864861|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
46655765|NCT02373813|82864862|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
46655766|NCT02373813|82864859|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46655767|NCT02373813|82864860|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
46655768|NCT02373813|82864861|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
46655769|NCT02373813|82864862|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
46655770|NCT03863509|82864897|FG000|Overall Study|COVID-19 shutdown period|0|||
46655771|NCT03863509|82864898|FG001|Overall Study|COVID-19 shutdown period|4|||
46655772|NCT03863509|82864899|FG002|Overall Study|COVID-19 shutdown period|0|||
46655773|NCT03863509|82864897|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
46655774|NCT03863509|82864898|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
46655775|NCT03863509|82864899|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
46655776|NCT03863509|82864897|FG000|Overall Study|Lost to Follow-up|8|||
46655777|NCT03863509|82864898|FG001|Overall Study|Lost to Follow-up|0|||
46655778|NCT03863509|82864899|FG002|Overall Study|Lost to Follow-up|2|||
46655779|NCT03863509|82864897|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
46655780|NCT03863509|82864898|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
46655781|NCT03863509|82864899|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
46655782|NCT03863509|82864897|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
46655783|NCT03863509|82864898|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
46781868|NCT00622869|83000508|FG001|Overall Study|Death|15|||
46781869|NCT00622869|83000509|FG002|Overall Study|Death|10|||
46781870|NCT00622869|83000507|FG000|Overall Study|Lost to Follow-up|2|||
46781871|NCT00622869|83000508|FG001|Overall Study|Lost to Follow-up|4|||
46781872|NCT00622869|83000509|FG002|Overall Study|Lost to Follow-up|2|||
46781873|NCT00622869|83000507|FG000|Overall Study|Graft Loss|5|||
46781874|NCT00622869|83000508|FG001|Overall Study|Graft Loss|3|||
46781875|NCT00622869|83000509|FG002|Overall Study|Graft Loss|2|||
46781876|NCT00622869|83000507|FG000|Overall Study|Missing|0|||
46655784|NCT03863509|82864899|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
46655785|NCT03116347|82864928|FG000|Overall Study|Withdrawal by Subject|1|||
46655786|NCT03116347|82864929|FG001|Overall Study|Withdrawal by Subject|2|||
46655787|NCT00001213|82864975|FG000|Overall Study|Death|18|||
46781877|NCT00622869|83000508|FG001|Overall Study|Missing|1|||
46781878|NCT00622869|83000509|FG002|Overall Study|Missing|1|||
46781879|NCT00395083|83000519|FG000|Overall Study|Withdrawal by Subject|6|||
46655788|NCT00000135|82864981|FG000|Overall Study|Death|27|||
46655789|NCT00000135|82864982|FG001|Overall Study|Death|14|||
46781880|NCT00395083|83000520|FG001|Overall Study|Withdrawal by Subject|5|||
46850895|NCT00380393|83066689|FG001|Month 14|Lost to Follow-up|1|||
46781881|NCT00395083|83000519|FG000|Overall Study|Developed another disease|4|||
46781882|NCT00395083|83000520|FG001|Overall Study|Developed another disease|3|||
46781883|NCT00366457|83000526|FG000|Overall Study|never began study therapy|2|||
46781884|NCT00624819|83000534|FG000|Follow-up Period: Year 4|Parents decision|0|||
46781885|NCT00624819|83000535|FG001|Follow-up Period: Year 4|Parents decision|0|||
46655790|NCT00001723|82864990|FG000|Overall Study|Lack of Efficacy|6|||
46655791|NCT00001723|82864991|FG001|Overall Study|Lack of Efficacy|7|||
46655792|NCT00001723|82864990|FG000|Overall Study|Lack of family interest|4|||
46655793|NCT00001723|82864991|FG001|Overall Study|Lack of family interest|5|||
46655794|NCT00001723|82864990|FG000|Overall Study|Lost to Follow-up|2|||
46655795|NCT00001723|82864991|FG001|Overall Study|Lost to Follow-up|2|||
46655796|NCT00001723|82864990|FG000|Overall Study|medication intolerance|1|||
46655797|NCT00001723|82864991|FG001|Overall Study|medication intolerance|2|||
46655798|NCT00000378|82865003|FG000|Overall Study|Lack of Efficacy|16|||
46655799|NCT00000378|82865004|FG001|Overall Study|Lack of Efficacy|14|||
46655800|NCT01350115|82865012|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
46655801|NCT01350115|82865013|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
46655802|NCT01350115|82865012|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
46655803|NCT01350115|82865013|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
46655804|NCT01350115|82865012|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
46655805|NCT01350115|82865013|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
46655806|NCT04142983|82865021|FG000|Overall Study|Lost to Follow-up|73|||
46655807|NCT04142983|82865021|FG000|Overall Study|Withdrawal by Subject|10|||
46655808|NCT04142983|82865021|FG000|Overall Study|Physician Decision|1|||
46655809|NCT04142983|82865021|FG000|Overall Study|Adverse Event|1|||
46655810|NCT04142983|82865021|FG000|Overall Study|No longer eligible|4|||
46655811|NCT04142983|82865021|FG000|Overall Study|Screen Failure|10|||
46655812|NCT03801031|82865037|FG000|Overall Study|Lost to Follow-up|1|||
46655813|NCT03801031|82865038|FG001|Overall Study|Lost to Follow-up|0|||
46655814|NCT03801031|82865037|FG000|Overall Study|Unable to comply|1|||
46655815|NCT03801031|82865038|FG001|Overall Study|Unable to comply|0|||
46655816|NCT03801031|82865037|FG000|Overall Study|Withdrawal by Subject|0|||
46655817|NCT03801031|82865038|FG001|Overall Study|Withdrawal by Subject|1|||
46655818|NCT03357952|82865046|FG000|Overall Study|Withdrawal by Subject|0|||
46655819|NCT03357952|82865047|FG001|Overall Study|Withdrawal by Subject|1|||
46655820|NCT03357952|82865046|FG000|Overall Study|Sponsor Decision|9|||
46655821|NCT03357952|82865047|FG001|Overall Study|Sponsor Decision|0|||
46655822|NCT03055858|82865053|FG000|Overall Study|Death|9|||
46655823|NCT03055858|82865053|FG000|Overall Study|Withdrawal by Subject|11|||
46655824|NCT03055858|82865053|FG000|Overall Study|Lost to Follow-up|6|||
46655825|NCT03055858|82865053|FG000|Overall Study|Missed Follow-Up Visits|18|||
46655826|NCT02393716|82865078|FG000|Overall Study|Death|29|||
46655827|NCT02393716|82865078|FG000|Overall Study|Withdrawal by Subject|8|||
46655828|NCT02393716|82865078|FG000|Overall Study|Device Explanted|8|||
46655829|NCT02393716|82865078|FG000|Overall Study|Missed visit|16|||
46655830|NCT00584233|82865083|FG000|Overall Study|Withdrawal by Subject|5|||
46655831|NCT00584233|82865083|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
46655832|NCT00001566|82865095|FG000|Overall Study|patients' choice to discontinue protocol|3|||
46655833|NCT00001566|82865095|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
46655834|NCT00001566|82865095|FG000|Overall Study|Death|13|||
46655835|NCT00001566|82865095|FG000|Overall Study|Lost to Follow-up|1|||
46655836|NCT00001566|82865095|FG000|Overall Study|unable to complete initial apheresis|1|||
46655837|NCT00001575|82865099|FG000|Overall Study|Screening failures-Ph I portion|22|||
46781886|NCT00624819|83000536|FG002|Follow-up Period: Year 4|Parents decision|1|||
46781887|NCT00624819|83000537|FG003|Follow-up Period: Year 4|Parents decision|0|||
46971341|NCT02552355|83214785|FG000|Overall Study|Adverse Event|0|||
46971342|NCT02552355|83214786|FG001|Overall Study|Adverse Event|2|||
46655838|NCT00001575|82865099|FG000|Overall Study|Withdrawn/deaths|23|||
46655839|NCT00001596|82865105|FG000|Overall Study|Death|1|||
46655840|NCT00001596|82865106|FG001|Overall Study|Death|0|||
46655841|NCT00001596|82865105|FG000|Overall Study|Withdrawal by Subject|3|||
46655842|NCT00001596|82865106|FG001|Overall Study|Withdrawal by Subject|1|||
46655843|NCT00001596|82865105|FG000|Overall Study|Study Termination|12|||
46655844|NCT00001596|82865106|FG001|Overall Study|Study Termination|9|||
46655845|NCT00001596|82865105|FG000|Overall Study|Adverse Event|1|||
46655846|NCT00001596|82865106|FG001|Overall Study|Adverse Event|0|||
46655847|NCT01349803|82865143|FG000|Overall Study|Adverse Event|0|||
46781888|NCT00624819|83000534|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
46971343|NCT02552355|83214787|FG002|Overall Study|Adverse Event|2|||
46655848|NCT01349803|82865144|FG001|Overall Study|Adverse Event|0|||
46655849|NCT01349803|82865145|FG002|Overall Study|Adverse Event|0|||
46655850|NCT01349803|82865146|FG003|Overall Study|Adverse Event|2|||
46655851|NCT01349803|82865143|FG000|Overall Study|Withdrawal by Subject|1|||
46655852|NCT01349803|82865144|FG001|Overall Study|Withdrawal by Subject|0|||
46655853|NCT01349803|82865145|FG002|Overall Study|Withdrawal by Subject|0|||
46655854|NCT01349803|82865146|FG003|Overall Study|Withdrawal by Subject|0|||
46655855|NCT01349803|82865143|FG000|Overall Study|Protocol-specified criteria|0|||
46655856|NCT01349803|82865144|FG001|Overall Study|Protocol-specified criteria|1|||
46655857|NCT01349803|82865145|FG002|Overall Study|Protocol-specified criteria|3|||
46655858|NCT01349803|82865146|FG003|Overall Study|Protocol-specified criteria|0|||
46655859|NCT03969641|82865272|FG000|Overall Study|Lost to Follow-up|5|||
46655860|NCT03969641|82865273|FG001|Overall Study|Lost to Follow-up|3|||
46655861|NCT03969641|82865272|FG000|Overall Study|Withdrawal by Subject|1|||
46655862|NCT03969641|82865273|FG001|Overall Study|Withdrawal by Subject|2|||
46655863|NCT03969641|82865272|FG000|Overall Study|Found to be ineligible|1|||
46655864|NCT03969641|82865273|FG001|Overall Study|Found to be ineligible|1|||
46655865|NCT03969641|82865272|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
46655866|NCT03969641|82865273|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
46655867|NCT03969641|82865272|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
46655868|NCT03969641|82865273|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
46655869|NCT03969641|82865272|FG000|Overall Study|Elective termination|0|||
46655870|NCT03969641|82865273|FG001|Overall Study|Elective termination|1|||
46655871|NCT04540887|82865405|FG000|Overall Study|Withdrawal by Subject|2|||
46655872|NCT04294680|82865416|FG000|Overall Study|Withdrawal by Subject|2|||
46655873|NCT04294680|82865417|FG001|Overall Study|Withdrawal by Subject|1|||
46655874|NCT04294680|82865416|FG000|Overall Study|Follow-up visits completed outside of window|1|||
46655875|NCT04294680|82865417|FG001|Overall Study|Follow-up visits completed outside of window|0|||
46655876|NCT01350102|82865427|FG000|Overall Study|Adverse Event|0|||
46655877|NCT01350102|82865428|FG001|Overall Study|Adverse Event|0|||
46655878|NCT01350102|82865429|FG002|Overall Study|Adverse Event|1|||
46655879|NCT01350102|82865430|FG003|Overall Study|Adverse Event|0|||
46655880|NCT04059549|82865444|FG000|Overall Study|Withdrawal by Subject|2|||
46655881|NCT04059549|82865445|FG001|Overall Study|Withdrawal by Subject|0|||
46655882|NCT04041570|82865457|FG000|Overall Study|Moved from Area|0|||
46655883|NCT04041570|82865458|FG001|Overall Study|Moved from Area|2|||
46655884|NCT03879408|82865470|FG000|Overall Study|Lost to Follow-up|0|||
46655885|NCT03879408|82865471|FG001|Overall Study|Lost to Follow-up|3|||
46655886|NCT03879408|82865472|FG002|Overall Study|Lost to Follow-up|2|||
46655887|NCT03879408|82865473|FG003|Overall Study|Lost to Follow-up|1|||
46655888|NCT03879408|82865474|FG004|Overall Study|Lost to Follow-up|0|||
46655889|NCT03879408|82865470|FG000|Overall Study|Withdrawal by Subject|2|||
46655890|NCT03879408|82865471|FG001|Overall Study|Withdrawal by Subject|1|||
46655891|NCT03879408|82865472|FG002|Overall Study|Withdrawal by Subject|1|||
46655892|NCT03879408|82865473|FG003|Overall Study|Withdrawal by Subject|0|||
46655893|NCT03879408|82865474|FG004|Overall Study|Withdrawal by Subject|1|||
46655894|NCT02993406|82865492|FG000|Overall Study|Withdrawal by Subject|170|||
46655895|NCT02993406|82865493|FG001|Overall Study|Withdrawal by Subject|196|||
46655896|NCT02993406|82865492|FG000|Overall Study|Physician Decision|3|||
46655897|NCT02993406|82865493|FG001|Overall Study|Physician Decision|5|||
46655898|NCT02993406|82865492|FG000|Overall Study|Lost to Follow-up|12|||
46655899|NCT02993406|82865493|FG001|Overall Study|Lost to Follow-up|13|||
46655900|NCT02993406|82865492|FG000|Overall Study|Unclassifiable Response|105|||
46655901|NCT02993406|82865493|FG001|Overall Study|Unclassifiable Response|139|||
46655902|NCT02993406|82865492|FG000|Overall Study|Administrative decision|1|||
46655903|NCT02993406|82865493|FG001|Overall Study|Administrative decision|0|||
46655904|NCT02993406|82865492|FG000|Overall Study|Sponsor decision|4|||
46655905|NCT02993406|82865493|FG001|Overall Study|Sponsor decision|5|||
46655906|NCT00819780|82865501|FG000|Overall Study|Did not receive study drug|3|||
46655907|NCT00819780|82865502|FG001|Overall Study|Did not receive study drug|4|||
46655908|NCT00819780|82865501|FG000|Overall Study|Still in treatment|25|||
46655909|NCT00819780|82865502|FG001|Overall Study|Still in treatment|17|||
46655910|NCT00000620|82865594|FG000|Overall Study|Death|86|||
46655911|NCT00000620|82865595|FG001|Overall Study|Death|67|||
46655912|NCT00000620|82865596|FG002|Overall Study|Death|112|||
46655913|NCT00000620|82865597|FG003|Overall Study|Death|126|||
46655914|NCT00000620|82865598|FG004|Overall Study|Death|64|||
46655915|NCT00000620|82865599|FG005|Overall Study|Death|77|||
46655916|NCT00000620|82865600|FG006|Overall Study|Death|91|||
46655917|NCT00000620|82865601|FG007|Overall Study|Death|95|||
46655918|NCT00000620|82865594|FG000|Overall Study|Lost to Follow-up|14|||
46655919|NCT00000620|82865595|FG001|Overall Study|Lost to Follow-up|14|||
46655920|NCT00000620|82865596|FG002|Overall Study|Lost to Follow-up|14|||
46655921|NCT00000620|82865597|FG003|Overall Study|Lost to Follow-up|14|||
46655922|NCT00000620|82865598|FG004|Overall Study|Lost to Follow-up|15|||
46655923|NCT00000620|82865599|FG005|Overall Study|Lost to Follow-up|15|||
46655924|NCT00000620|82865600|FG006|Overall Study|Lost to Follow-up|13|||
46850896|NCT00380393|83066688|FG000|Month 14|Migrated/moved from study area|39|||
46655925|NCT00000620|82865601|FG007|Overall Study|Lost to Follow-up|14|||
46655926|NCT00000620|82865594|FG000|Overall Study|Withdrawal by Subject|40|||
46655927|NCT00000620|82865595|FG001|Overall Study|Withdrawal by Subject|27|||
46655928|NCT00000620|82865596|FG002|Overall Study|Withdrawal by Subject|28|||
46655929|NCT00000620|82865597|FG003|Overall Study|Withdrawal by Subject|27|||
46655930|NCT00000620|82865598|FG004|Overall Study|Withdrawal by Subject|30|||
46655931|NCT00000620|82865599|FG005|Overall Study|Withdrawal by Subject|32|||
46655932|NCT00000620|82865600|FG006|Overall Study|Withdrawal by Subject|32|||
46655933|NCT00000620|82865601|FG007|Overall Study|Withdrawal by Subject|21|||
46655934|NCT00000620|82865594|FG000|Overall Study|missed closeout visit|22|||
46655935|NCT00000620|82865595|FG001|Overall Study|missed closeout visit|28|||
46655936|NCT00000620|82865596|FG002|Overall Study|missed closeout visit|16|||
46655937|NCT00000620|82865597|FG003|Overall Study|missed closeout visit|11|||
46655938|NCT00000620|82865598|FG004|Overall Study|missed closeout visit|26|||
46655939|NCT00000620|82865599|FG005|Overall Study|missed closeout visit|28|||
46655940|NCT00000620|82865600|FG006|Overall Study|missed closeout visit|13|||
46655941|NCT00000620|82865601|FG007|Overall Study|missed closeout visit|16|||
46655942|NCT00001262|82865664|FG000|Overall Study|Death|10|||
46655943|NCT00001262|82865665|FG001|Overall Study|Death|11|||
46655944|NCT00001262|82865666|FG002|Overall Study|Death|0|||
46655945|NCT00001262|82865664|FG000|Overall Study|Withdrawal by Subject|0|||
46655946|NCT00001262|82865665|FG001|Overall Study|Withdrawal by Subject|3|||
46655947|NCT00001262|82865666|FG002|Overall Study|Withdrawal by Subject|0|||
46971344|NCT02552355|83214788|FG003|Overall Study|Adverse Event|0|||
46971345|NCT02552355|83214785|FG000|Overall Study|Withdrawal by Subject|0|||
46655948|NCT00001277|82865683|FG000|Overall Study|Adverse Event|0|||
46655949|NCT00001277|82865684|FG001|Overall Study|Adverse Event|0|||
46655950|NCT00001277|82865685|FG002|Overall Study|Adverse Event|1|||
46655951|NCT00001277|82865683|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
46655952|NCT00001277|82865684|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
46971346|NCT02552355|83214786|FG001|Overall Study|Withdrawal by Subject|0|||
46971347|NCT02552355|83214787|FG002|Overall Study|Withdrawal by Subject|0|||
46971348|NCT02552355|83214788|FG003|Overall Study|Withdrawal by Subject|1|||
46971349|NCT02551731|83214798|FG000|Overall Study|Withdrawal by Subject|2|||
46971350|NCT02542605|83214802|FG000|Part B: Challenge Phase|Sponsor decision|1|||
46971351|NCT02542605|83214803|FG001|Part B: Challenge Phase|Sponsor decision|0|||
46971352|NCT02542605|83214804|FG002|Part B: Challenge Phase|Sponsor decision|0|||
46971353|NCT02542605|83214802|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
46971354|NCT02542605|83214803|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
46971355|NCT02542605|83214804|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
46971356|NCT02550873|83214815|FG000|Randomized Double Blind|Adverse Event|3|||
46971357|NCT02550873|83214816|FG001|Randomized Double Blind|Adverse Event|1|||
46971358|NCT02550873|83214817|FG002|Randomized Double Blind|Adverse Event|0|||
46971359|NCT02550873|83214815|FG000|Randomized Double Blind|Disease progression|1|||
46971360|NCT02550873|83214816|FG001|Randomized Double Blind|Disease progression|1|||
46971361|NCT02550873|83214817|FG002|Randomized Double Blind|Disease progression|0|||
46971362|NCT02550873|83214815|FG000|Open Label Extension|Study ongoing|0|||
46971363|NCT02550873|83214816|FG001|Open Label Extension|Study ongoing|0|||
46971364|NCT02550873|83214817|FG002|Open Label Extension|Study ongoing|111|||
46971365|NCT02550795|83214855|FG000|Overall Study|Physician Decision|0|||
46971366|NCT02550795|83214856|FG001|Overall Study|Physician Decision|1|||
46971367|NCT02550795|83214857|FG002|Overall Study|Physician Decision|0|||
46971368|NCT02541903|83214865|FG000|Overall Study|Death|1|||
46971369|NCT02541669|83214874|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
46971370|NCT02541669|83214875|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
46971371|NCT02541669|83214876|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
46971372|NCT02541669|83214877|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
46971373|NCT02541669|83214878|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
46971374|NCT02549859|83214889|FG000|Long-term 60 Hz DBS|Study Closed|1|||
47075660|NCT04178967|83370251|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075661|NCT04178967|83370252|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075662|NCT04178967|83370253|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
47075663|NCT04178967|83370254|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075664|NCT04178967|83370255|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075665|NCT04178967|83370256|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075666|NCT04178967|83370257|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075667|NCT04178967|83370258|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075668|NCT04178967|83370259|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
47075669|NCT04178967|83370260|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
46655953|NCT00001277|82865685|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
46655954|NCT00001703|82865727|FG000|Overall Study|progressed disease|2|||
46655955|NCT00001703|82865727|FG000|Overall Study|No evidence of disease|1|||
46655956|NCT00001703|82865727|FG000|Overall Study|recurrent disease|2|||
46655957|NCT01349907|82865751|FG000|Overall Study|Adverse Event|37|||
46655958|NCT01349907|82865752|FG001|Overall Study|Adverse Event|11|||
46655959|NCT01349907|82865751|FG000|Overall Study|Treatment failure|13|||
46655960|NCT01349907|82865752|FG001|Overall Study|Treatment failure|4|||
46655961|NCT01349907|82865751|FG000|Overall Study|Lost to Follow-up|25|||
46655962|NCT01349907|82865752|FG001|Overall Study|Lost to Follow-up|6|||
46655963|NCT01349907|82865751|FG000|Overall Study|Withdrawal by Subject|30|||
46971375|NCT02688647|83214899|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
46655964|NCT01349907|82865752|FG001|Overall Study|Withdrawal by Subject|8|||
46655965|NCT01349907|82865751|FG000|Overall Study|Protocol Violation|33|||
46655966|NCT01349907|82865752|FG001|Overall Study|Protocol Violation|13|||
46655967|NCT01349907|82865751|FG000|Overall Study|Administrative|1|||
46655968|NCT01349907|82865752|FG001|Overall Study|Administrative|1|||
46655969|NCT05512949|82865761|FG000|Overall Study|Lost to Follow-up|4|||
46655970|NCT05512949|82865762|FG001|Overall Study|Lost to Follow-up|6|||
46655971|NCT05512949|82865763|FG002|Overall Study|Lost to Follow-up|2|||
46655972|NCT05512949|82865761|FG000|Overall Study|Protocol Violation|0|||
46655973|NCT05512949|82865762|FG001|Overall Study|Protocol Violation|0|||
46655974|NCT05512949|82865763|FG002|Overall Study|Protocol Violation|1|||
46655975|NCT05512949|82865761|FG000|Overall Study|Withdrawal by Subject|1|||
46655976|NCT05512949|82865762|FG001|Overall Study|Withdrawal by Subject|1|||
46655977|NCT05512949|82865763|FG002|Overall Study|Withdrawal by Subject|2|||
46655978|NCT05512949|82865761|FG000|Overall Study|Completion status unknown|1|||
46655979|NCT05512949|82865762|FG001|Overall Study|Completion status unknown|3|||
46655980|NCT05512949|82865763|FG002|Overall Study|Completion status unknown|0|||
46655981|NCT04794491|82865790|FG000|Overall Study|Adverse Event|1|||
46655982|NCT04794491|82865790|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
46655983|NCT04794491|82865790|FG000|Overall Study|Noncompliance With Study Intervention|1|||
46655984|NCT04794491|82865790|FG000|Overall Study|Withdrawal by Subject|2|||
46655985|NCT04436289|82865798|FG000|Overall Study|Death prior to hospital discharge|8|||
46655986|NCT04436289|82865799|FG001|Overall Study|Death prior to hospital discharge|5|||
46655987|NCT04436289|82865800|FG002|Overall Study|Death prior to hospital discharge|0|||
46655988|NCT04436289|82865801|FG003|Overall Study|Death prior to hospital discharge|1|||
46655989|NCT04436289|82865798|FG000|Overall Study|Withdrawal by Subject|0|||
46971376|NCT02688647|83214900|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
46971377|NCT02688647|83214899|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
46971378|NCT02688647|83214900|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
46971379|NCT02688647|83214899|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
46971380|NCT02688647|83214900|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
46971381|NCT02688647|83214899|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
46971382|NCT02688647|83214900|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
46971383|NCT02688647|83214899|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
46971384|NCT02688647|83214900|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
46971385|NCT02688647|83214899|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
46655990|NCT04436289|82865799|FG001|Overall Study|Withdrawal by Subject|1|||
46655991|NCT04436289|82865800|FG002|Overall Study|Withdrawal by Subject|4|||
46971386|NCT02688647|83214900|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
46971387|NCT02688647|83214899|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
46971388|NCT02688647|83214900|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
46971389|NCT02687711|83214918|FG000|Overall Study|Adverse Event|89|||
46971390|NCT02687711|83214918|FG000|Overall Study|Lack of Efficacy|70|||
46971391|NCT02687711|83214918|FG000|Overall Study|Lost to Follow-up|20|||
46971392|NCT02687711|83214918|FG000|Overall Study|Consent withdrawn|15|||
46971393|NCT02687711|83214918|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
46971394|NCT02687711|83214918|FG000|Overall Study|Too expensive|4|||
46971395|NCT02687711|83214918|FG000|Overall Study|Participant moved abroad|1|||
46971396|NCT02687711|83214918|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
46971397|NCT02687711|83214918|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
46971398|NCT02687711|83214918|FG000|Overall Study|Disliked taste|1|||
46971399|NCT02687711|83214918|FG000|Overall Study|Low mood|1|||
46971400|NCT02687711|83214918|FG000|Overall Study|Side effects|1|||
46655992|NCT04436289|82865801|FG003|Overall Study|Withdrawal by Subject|0|||
46655993|NCT04436289|82865798|FG000|Overall Study|Extended hospital stay|0|||
46971401|NCT02687711|83214918|FG000|Overall Study|Change of Hospital|1|||
46971402|NCT02687711|83214918|FG000|Overall Study|Liver Encephalopathy|1|||
46971403|NCT02687711|83214918|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
46971404|NCT02687711|83214918|FG000|Overall Study|Withdrawn due to intake interruption|1|||
46971405|NCT02687711|83214918|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
46971406|NCT02687711|83214918|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
46971407|NCT02687711|83214918|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
46971408|NCT01662063|83214924|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
46655994|NCT04436289|82865799|FG001|Overall Study|Extended hospital stay|1|||
46655995|NCT04436289|82865800|FG002|Overall Study|Extended hospital stay|0|||
46655996|NCT04436289|82865801|FG003|Overall Study|Extended hospital stay|0|||
46655997|NCT04436289|82865798|FG000|Overall Study|Lost to Follow-up|0|||
46655998|NCT04436289|82865799|FG001|Overall Study|Lost to Follow-up|4|||
46655999|NCT04436289|82865800|FG002|Overall Study|Lost to Follow-up|1|||
46850897|NCT00380393|83066689|FG001|Month 14|Migrated/moved from study area|42|||
46971409|NCT01662063|83214925|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
46971410|NCT01662063|83214926|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
46971411|NCT01662063|83214924|FG000|Overall Study|Lack of Efficacy|1|||
46971412|NCT01662063|83214925|FG001|Overall Study|Lack of Efficacy|6|||
47075670|NCT04178967|83370250|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
47075671|NCT04178967|83370251|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
46850898|NCT00380393|83066688|FG000|Month 14|Protocol Violation|2|||
46850899|NCT00380393|83066689|FG001|Month 14|Protocol Violation|0|||
46850900|NCT00380393|83066688|FG000|Month 14|Others|6|||
46850901|NCT00380393|83066689|FG001|Month 14|Others|6|||
46850902|NCT00380081|83066701|FG000|Overall Study|Withdrawal by Subject|0|||
46850903|NCT00380081|83066702|FG001|Overall Study|Withdrawal by Subject|0|||
46850904|NCT00380081|83066703|FG002|Overall Study|Withdrawal by Subject|0|||
46850905|NCT00380081|83066704|FG003|Overall Study|Withdrawal by Subject|0|||
47075672|NCT04178967|83370252|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
46656000|NCT04436289|82865801|FG003|Overall Study|Lost to Follow-up|3|||
46656001|NCT04396795|82865816|FG000|Month 1|Lost to Follow-up|2|||
46656002|NCT04396795|82865817|FG001|Month 1|Lost to Follow-up|3|||
46656003|NCT04396795|82865816|FG000|Month 3|Lost to Follow-up|1|||
46656004|NCT04396795|82865817|FG001|Month 3|Lost to Follow-up|3|||
46656005|NCT04396795|82865816|FG000|Month 6|Lost to Follow-up|3|||
46656006|NCT04396795|82865817|FG001|Month 6|Lost to Follow-up|3|||
46656007|NCT04211766|82865825|FG000|Overall Study|Withdrawal by Subject|5|||
46656008|NCT04211766|82865826|FG001|Overall Study|Withdrawal by Subject|1|||
46656009|NCT03773562|82865874|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
46656010|NCT03773562|82865874|FG000|Overall Study|Lost to Follow-up|10|||
46656011|NCT03773562|82865874|FG000|Overall Study|Withdrawal by Subject|1|||
46656012|NCT03706456|82865887|FG000|Overall Study|Lack of Efficacy|1|||
46656013|NCT03706456|82865887|FG000|Overall Study|Ongoing|21|||
46656014|NCT03599141|82865901|FG000|Overall Study|Lost to Follow-up|3|||
46656015|NCT03599141|82865902|FG001|Overall Study|Lost to Follow-up|1|||
46656016|NCT03525678|82865911|FG000|Overall Study|Withdrawal by Subject|8|||
46656017|NCT03525678|82865912|FG001|Overall Study|Withdrawal by Subject|2|||
46656018|NCT03525678|82865913|FG002|Overall Study|Withdrawal by Subject|2|||
46656019|NCT03525678|82865911|FG000|Overall Study|Physician Decision|2|||
46656020|NCT03525678|82865912|FG001|Overall Study|Physician Decision|4|||
46656021|NCT03525678|82865913|FG002|Overall Study|Physician Decision|0|||
46656022|NCT03525678|82865911|FG000|Overall Study|Lost to Follow-up|2|||
46656023|NCT03525678|82865912|FG001|Overall Study|Lost to Follow-up|1|||
46656024|NCT03525678|82865913|FG002|Overall Study|Lost to Follow-up|2|||
46656025|NCT03525678|82865911|FG000|Overall Study|Death|70|||
46656026|NCT03525678|82865912|FG001|Overall Study|Death|80|||
46656027|NCT03525678|82865913|FG002|Overall Study|Death|16|||
46656028|NCT03525678|82865911|FG000|Overall Study|other reasons|14|||
46656029|NCT03525678|82865912|FG001|Overall Study|other reasons|10|||
46656030|NCT03525678|82865913|FG002|Overall Study|other reasons|5|||
46656031|NCT03525678|82865911|FG000|Overall Study|ongoing at the time of analysis|1|||
46656032|NCT03525678|82865912|FG001|Overall Study|ongoing at the time of analysis|2|||
46656033|NCT03525678|82865913|FG002|Overall Study|ongoing at the time of analysis|0|||
46656034|NCT03439514|82865936|FG000|Double-Blind Treatment Period|Other|4|||
46656035|NCT03439514|82865937|FG001|Double-Blind Treatment Period|Other|1|||
46656036|NCT03439514|82865936|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
46656037|NCT03439514|82865937|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
46656038|NCT03439514|82865936|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
46656039|NCT03439514|82865937|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
46850906|NCT00380081|83066705|FG004|Overall Study|Withdrawal by Subject|1|||
46850907|NCT00380081|83066706|FG005|Overall Study|Withdrawal by Subject|0|||
46850908|NCT00380081|83066701|FG000|Overall Study|Family Emergency|0|||
46850909|NCT00380081|83066702|FG001|Overall Study|Family Emergency|0|||
46850910|NCT00380081|83066703|FG002|Overall Study|Family Emergency|0|||
46850911|NCT00380081|83066704|FG003|Overall Study|Family Emergency|0|||
46850912|NCT00380081|83066705|FG004|Overall Study|Family Emergency|0|||
46656040|NCT03439514|82865936|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
46656041|NCT03439514|82865937|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
46656042|NCT03439514|82865936|FG000|Double-Blind Treatment Period|Death|1|||
46656043|NCT03439514|82865937|FG001|Double-Blind Treatment Period|Death|2|||
46656044|NCT03272828|82865949|FG000|Overall Study|Lost to Follow-up|7|||
46656045|NCT03272828|82865950|FG001|Overall Study|Lost to Follow-up|7|||
46656046|NCT03272828|82865949|FG000|Overall Study|Withdrawal by Subject|2|||
46656047|NCT03272828|82865950|FG001|Overall Study|Withdrawal by Subject|0|||
46656048|NCT03272828|82865949|FG000|Overall Study|Deceased|1|||
46656049|NCT03272828|82865950|FG001|Overall Study|Deceased|1|||
46656050|NCT03272828|82865949|FG000|Overall Study|Failed implant|1|||
46850913|NCT00380081|83066706|FG005|Overall Study|Family Emergency|1|||
46850914|NCT03579940|83066725|FG000|Period 2|Withdrawal by Subject|0|||
46971413|NCT01662063|83214926|FG002|Overall Study|Lack of Efficacy|0|||
46656051|NCT03272828|82865950|FG001|Overall Study|Failed implant|2|||
46656052|NCT03250273|82865962|FG000|Overall Study|Disease Progression|2|||
46656053|NCT03250273|82865963|FG001|Overall Study|Disease Progression|11|||
46656054|NCT03250273|82865962|FG000|Overall Study|Death|0|||
46656055|NCT03250273|82865963|FG001|Overall Study|Death|1|||
46656056|NCT03122886|82865982|FG000|Overall Study|Withdrawal by Subject|1|||
46656057|NCT03122886|82865983|FG001|Overall Study|Withdrawal by Subject|2|||
46656058|NCT02910401|82865997|FG000|Overall Study|Study closure Study closure|0|||
46656059|NCT02910401|82865998|FG001|Overall Study|Study closure Study closure|0|||
46656060|NCT02910401|82865999|FG002|Overall Study|Study closure Study closure|2|||
46656061|NCT02910401|82865997|FG000|Overall Study|Physician Decision|1|||
46656062|NCT02910401|82865998|FG001|Overall Study|Physician Decision|0|||
46656063|NCT02910401|82865999|FG002|Overall Study|Physician Decision|0|||
46656064|NCT02609503|82866029|FG000|Overall Study|Adverse Event|1|||
46656065|NCT02609503|82866029|FG000|Overall Study|Death|1|||
46656066|NCT02609503|82866029|FG000|Overall Study|Withdrawal by Subject|1|||
46656067|NCT02609503|82866029|FG000|Overall Study|Disease progression|1|||
46656068|NCT02437110|82866061|FG000|Screening|Lost to Follow-up|3|||
46656069|NCT02437110|82866061|FG000|Screening|Physician Decision|1|||
46656070|NCT02437110|82866061|FG000|ART|Adverse Event|3|||
46656071|NCT02437110|82866061|FG000|ART|Protocol Violation|3|||
46656072|NCT02437110|82866061|FG000|ART|Withdrawal by Subject|4|||
46656073|NCT02437110|82866061|FG000|ART|Lost to follow-up prior to start of intervention|1|||
46656074|NCT02437110|82866061|FG000|ART|Physician decision prior to start of intervention|2|||
46656075|NCT02437110|82866061|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
46656076|NCT02437110|82866061|FG000|Post-ART|Lost to Follow-up|3|||
46656077|NCT02437110|82866061|FG000|Post-ART|Protocol Violation|4|||
46656078|NCT02437110|82866061|FG000|Post-ART|Withdrawal by Subject|3|||
46656079|NCT02268851|82866073|FG000|Overall Study|Death|0|||
46656080|NCT02268851|82866074|FG001|Overall Study|Death|0|||
46656081|NCT02268851|82866075|FG002|Overall Study|Death|0|||
46656082|NCT02268851|82866076|FG003|Overall Study|Death|1|||
46656083|NCT02268851|82866077|FG004|Overall Study|Death|2|||
46656084|NCT02268851|82866078|FG005|Overall Study|Death|1|||
46656085|NCT02268851|82866073|FG000|Overall Study|Adverse Event|0|||
46656086|NCT02268851|82866074|FG001|Overall Study|Adverse Event|0|||
46656087|NCT02268851|82866075|FG002|Overall Study|Adverse Event|0|||
46656088|NCT02268851|82866076|FG003|Overall Study|Adverse Event|0|||
46656089|NCT02268851|82866077|FG004|Overall Study|Adverse Event|2|||
46656090|NCT02268851|82866078|FG005|Overall Study|Adverse Event|2|||
46656091|NCT02268851|82866073|FG000|Overall Study|Withdrawal by Subject|0|||
46656092|NCT02268851|82866074|FG001|Overall Study|Withdrawal by Subject|0|||
46656093|NCT02268851|82866075|FG002|Overall Study|Withdrawal by Subject|0|||
46656094|NCT02268851|82866076|FG003|Overall Study|Withdrawal by Subject|2|||
46656095|NCT02268851|82866077|FG004|Overall Study|Withdrawal by Subject|0|||
46656096|NCT02268851|82866078|FG005|Overall Study|Withdrawal by Subject|1|||
46656097|NCT02268851|82866073|FG000|Overall Study|Progressive Disease|1|||
46656098|NCT02268851|82866074|FG001|Overall Study|Progressive Disease|3|||
46656099|NCT02268851|82866075|FG002|Overall Study|Progressive Disease|0|||
46656100|NCT02268851|82866076|FG003|Overall Study|Progressive Disease|0|||
46656101|NCT02268851|82866077|FG004|Overall Study|Progressive Disease|1|||
46656102|NCT02268851|82866078|FG005|Overall Study|Progressive Disease|4|||
46656103|NCT02268851|82866073|FG000|Overall Study|Physician Decision|0|||
46656104|NCT02268851|82866074|FG001|Overall Study|Physician Decision|0|||
46656105|NCT02268851|82866075|FG002|Overall Study|Physician Decision|1|||
46656106|NCT02268851|82866076|FG003|Overall Study|Physician Decision|0|||
46656107|NCT02268851|82866077|FG004|Overall Study|Physician Decision|0|||
46656108|NCT02268851|82866078|FG005|Overall Study|Physician Decision|1|||
46656109|NCT02268851|82866073|FG000|Overall Study|Patient Compliance|0|||
46656110|NCT02268851|82866074|FG001|Overall Study|Patient Compliance|0|||
46656111|NCT02268851|82866075|FG002|Overall Study|Patient Compliance|0|||
46656112|NCT02268851|82866076|FG003|Overall Study|Patient Compliance|0|||
46656113|NCT02268851|82866077|FG004|Overall Study|Patient Compliance|1|||
46656114|NCT02268851|82866078|FG005|Overall Study|Patient Compliance|1|||
46656115|NCT02268851|82866073|FG000|Overall Study|Co-Morbid Condition|0|||
46656116|NCT02268851|82866074|FG001|Overall Study|Co-Morbid Condition|0|||
46656117|NCT02268851|82866075|FG002|Overall Study|Co-Morbid Condition|0|||
46656118|NCT02268851|82866076|FG003|Overall Study|Co-Morbid Condition|0|||
46656119|NCT02268851|82866077|FG004|Overall Study|Co-Morbid Condition|1|||
46656120|NCT02268851|82866078|FG005|Overall Study|Co-Morbid Condition|1|||
46656121|NCT01846663|82866094|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
46656122|NCT01846663|82866095|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
46656123|NCT01846663|82866094|FG000|Overall Study|Withdrawal by Subject|1|||
46656124|NCT01846663|82866095|FG001|Overall Study|Withdrawal by Subject|0|||
46656125|NCT01846663|82866094|FG000|Overall Study|Adverse Event|1|||
46656126|NCT01846663|82866095|FG001|Overall Study|Adverse Event|2|||
46656127|NCT01659151|82866101|FG000|Overall Study|Inadequate TIL growth|1|||
46656128|NCT04847141|82866222|FG000|Overall Study|Adverse Event|1|||
46656129|NCT04847141|82866223|FG001|Overall Study|Adverse Event|0|||
46656130|NCT04847141|82866224|FG002|Overall Study|Adverse Event|1|||
46656131|NCT04847141|82866222|FG000|Overall Study|Withdrawal by Subject|2|||
46656132|NCT04847141|82866223|FG001|Overall Study|Withdrawal by Subject|4|||
46656133|NCT04847141|82866224|FG002|Overall Study|Withdrawal by Subject|3|||
46656134|NCT04847141|82866222|FG000|Overall Study|Lost to Follow-up|7|||
46656135|NCT04847141|82866223|FG001|Overall Study|Lost to Follow-up|5|||
46656136|NCT04847141|82866224|FG002|Overall Study|Lost to Follow-up|7|||
46656137|NCT04847141|82866222|FG000|Overall Study|Reason not Specified|0|||
46656138|NCT04847141|82866223|FG001|Overall Study|Reason not Specified|1|||
46656139|NCT04847141|82866224|FG002|Overall Study|Reason not Specified|0|||
46656140|NCT01349829|82866234|FG000|Overall Study|Lost to Follow-up|4|||
46656141|NCT01349829|82866235|FG001|Overall Study|Lost to Follow-up|8|||
46656142|NCT01349829|82866234|FG000|Overall Study|Consent withdrawal|3|||
46656143|NCT01349829|82866235|FG001|Overall Study|Consent withdrawal|8|||
46656144|NCT01349829|82866234|FG000|Overall Study|Migrated/moved|2|||
46656145|NCT01349829|82866235|FG001|Overall Study|Migrated/moved|7|||
46656146|NCT01350128|82866243|FG000|Overall Study|Withdrawal by Subject|3|||
46656147|NCT01350128|82866243|FG000|Overall Study|Protocol discontinuation criteria|8|||
46656148|NCT01350128|82866243|FG000|Overall Study|Physician Decision|1|||
46656149|NCT01350128|82866243|FG000|Overall Study|Lost to Follow-up|2|||
46656150|NCT03893825|82866302|FG000|Overall Study|Death|2|||
46656151|NCT03893825|82866303|FG001|Overall Study|Death|1|||
46656152|NCT03893825|82866302|FG000|Overall Study|Adverse Event|0|||
46656153|NCT03893825|82866303|FG001|Overall Study|Adverse Event|2|||
46656154|NCT03893825|82866302|FG000|Overall Study|Withdrawal by Subject|19|||
46656155|NCT03893825|82866303|FG001|Overall Study|Withdrawal by Subject|21|||
46656156|NCT03893825|82866302|FG000|Overall Study|Protocol deviation|1|||
46656157|NCT03893825|82866303|FG001|Overall Study|Protocol deviation|0|||
46656158|NCT03893825|82866302|FG000|Overall Study|Lost to Follow-up|10|||
46656159|NCT03893825|82866303|FG001|Overall Study|Lost to Follow-up|10|||
46656160|NCT03893825|82866302|FG000|Overall Study|Other than specified|7|||
46656161|NCT03893825|82866303|FG001|Overall Study|Other than specified|6|||
46656162|NCT03890666|82866311|FG000|Overall Study|Withdrawal by Subject|0|||
46656163|NCT03890666|82866312|FG001|Overall Study|Withdrawal by Subject|1|||
46656164|NCT03890666|82866311|FG000|Overall Study|Protocol deviation|1|||
46656165|NCT03890666|82866312|FG001|Overall Study|Protocol deviation|4|||
46656166|NCT03890666|82866311|FG000|Overall Study|Lost to Follow-up|2|||
46656167|NCT03890666|82866312|FG001|Overall Study|Lost to Follow-up|5|||
46656168|NCT03890666|82866311|FG000|Overall Study|Other than specified|1|||
46656169|NCT03890666|82866312|FG001|Overall Study|Other than specified|8|||
46656170|NCT03090737|82866350|FG000|Overall Study|Other reasons|1|||
46656171|NCT03090737|82866350|FG000|Overall Study|Completed treatment as per protocol|17|||
46656172|NCT03090737|82866350|FG000|Overall Study|Maximum clinical benefit|2|||
46656173|NCT03090737|82866350|FG000|Overall Study|Adverse event unrelated to study drug|7|||
46656174|NCT03090737|82866350|FG000|Overall Study|Study drug toxicity|4|||
46656175|NCT03090737|82866350|FG000|Overall Study|Disease progression|98|||
46656176|NCT03004976|82866395|FG000|Overall Study|Lost to Follow-up|7|||
46656177|NCT03004976|82866396|FG001|Overall Study|Lost to Follow-up|5|||
46656178|NCT03004976|82866395|FG000|Overall Study|Physician Decision|1|||
46656179|NCT03004976|82866396|FG001|Overall Study|Physician Decision|0|||
46656180|NCT03004976|82866395|FG000|Overall Study|Withdrawal by Subject|1|||
46656181|NCT03004976|82866396|FG001|Overall Study|Withdrawal by Subject|0|||
46656182|NCT03004976|82866395|FG000|Overall Study|Death|4|||
46656183|NCT03004976|82866396|FG001|Overall Study|Death|1|||
46656184|NCT02985866|82866404|FG000|Overall Study|Poor CGM data|1|||
46656185|NCT02985866|82866405|FG001|Overall Study|Poor CGM data|1|||
46656186|NCT02762981|82866430|FG000|Overall Study|Adverse Event|2|||
46656187|NCT02762981|82866431|FG001|Overall Study|Adverse Event|3|||
46656188|NCT02762981|82866432|FG002|Overall Study|Adverse Event|1|||
46656189|NCT02762981|82866433|FG003|Overall Study|Adverse Event|1|||
46656190|NCT02762981|82866434|FG004|Overall Study|Adverse Event|3|||
46656191|NCT02762981|82866430|FG000|Overall Study|Physician Decision|0|||
47075673|NCT04178967|83370253|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
46656192|NCT02762981|82866431|FG001|Overall Study|Physician Decision|1|||
46656193|NCT02762981|82866432|FG002|Overall Study|Physician Decision|0|||
46656194|NCT02762981|82866433|FG003|Overall Study|Physician Decision|0|||
46656195|NCT02762981|82866434|FG004|Overall Study|Physician Decision|1|||
46656196|NCT02762981|82866430|FG000|Overall Study|Disease progression|11|||
46656197|NCT02762981|82866431|FG001|Overall Study|Disease progression|23|||
46656198|NCT02762981|82866432|FG002|Overall Study|Disease progression|4|||
46656199|NCT02762981|82866433|FG003|Overall Study|Disease progression|10|||
46656200|NCT02762981|82866434|FG004|Overall Study|Disease progression|1|||
46656201|NCT02762981|82866430|FG000|Overall Study|Enrolled not treated|1|||
46656202|NCT02762981|82866431|FG001|Overall Study|Enrolled not treated|5|||
46656203|NCT02762981|82866432|FG002|Overall Study|Enrolled not treated|0|||
46656204|NCT02762981|82866433|FG003|Overall Study|Enrolled not treated|2|||
46656205|NCT02762981|82866434|FG004|Overall Study|Enrolled not treated|0|||
46656206|NCT02762981|82866430|FG000|Overall Study|Other|2|||
46656207|NCT02762981|82866431|FG001|Overall Study|Other|3|||
46656208|NCT02762981|82866432|FG002|Overall Study|Other|1|||
46656209|NCT02762981|82866433|FG003|Overall Study|Other|0|||
46656210|NCT02762981|82866434|FG004|Overall Study|Other|0|||
46656211|NCT02762981|82866430|FG000|Overall Study|Missing|1|||
46656212|NCT02762981|82866431|FG001|Overall Study|Missing|0|||
46656213|NCT02762981|82866432|FG002|Overall Study|Missing|0|||
46656214|NCT02762981|82866433|FG003|Overall Study|Missing|0|||
46656215|NCT02762981|82866434|FG004|Overall Study|Missing|0|||
46656216|NCT02762981|82866430|FG000|Overall Study|Withdrawal by Subject|0|||
46656217|NCT02762981|82866431|FG001|Overall Study|Withdrawal by Subject|5|||
46656218|NCT02762981|82866432|FG002|Overall Study|Withdrawal by Subject|1|||
46656219|NCT02762981|82866433|FG003|Overall Study|Withdrawal by Subject|3|||
46656220|NCT02762981|82866434|FG004|Overall Study|Withdrawal by Subject|0|||
46656221|NCT00001832|82866510|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
46656222|NCT00001832|82866511|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
46656223|NCT00001832|82866512|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
46656224|NCT00001832|82866513|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
46656225|NCT00001832|82866514|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
46656226|NCT00001832|82866515|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
46656227|NCT00001832|82866516|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
46656228|NCT00001832|82866517|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
46656229|NCT00001832|82866518|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
46656230|NCT00001832|82866519|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
46656231|NCT00001832|82866520|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
46656232|NCT00001832|82866521|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
46656233|NCT00001832|82866522|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
46656234|NCT00001832|82866523|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
46656235|NCT00001832|82866524|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
46656236|NCT00001832|82866510|FG000|Treatment Period|Death during treatment|0|||
46656237|NCT00001832|82866511|FG001|Treatment Period|Death during treatment|0|||
46656238|NCT00001832|82866512|FG002|Treatment Period|Death during treatment|0|||
46656239|NCT00001832|82866513|FG003|Treatment Period|Death during treatment|0|||
46656240|NCT00001832|82866514|FG004|Treatment Period|Death during treatment|0|||
46656241|NCT00001832|82866515|FG005|Treatment Period|Death during treatment|1|||
46656242|NCT00001832|82866516|FG006|Treatment Period|Death during treatment|0|||
46656243|NCT00001832|82866517|FG007|Treatment Period|Death during treatment|0|||
46656244|NCT00001832|82866518|FG008|Treatment Period|Death during treatment|0|||
46656245|NCT00001832|82866519|FG009|Treatment Period|Death during treatment|0|||
46656246|NCT00001832|82866520|FG010|Treatment Period|Death during treatment|0|||
46850915|NCT03579940|83066726|FG001|Period 2|Withdrawal by Subject|0|||
46850916|NCT03579940|83066727|FG002|Period 2|Withdrawal by Subject|1|||
46971414|NCT01662063|83214924|FG000|Overall Study|Lost to Follow-up|0|||
46971415|NCT01662063|83214925|FG001|Overall Study|Lost to Follow-up|4|||
47075674|NCT04178967|83370254|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
47075675|NCT04178967|83370255|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
47075676|NCT04178967|83370256|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
47075677|NCT04178967|83370257|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
47075678|NCT04178967|83370258|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
47075679|NCT04178967|83370259|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
47075680|NCT04178967|83370260|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
47075681|NCT04178967|83370250|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47075682|NCT04178967|83370251|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47075683|NCT04178967|83370252|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47075684|NCT04178967|83370253|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47075685|NCT04178967|83370254|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
47075686|NCT04178967|83370255|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
47075687|NCT04178967|83370256|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47075688|NCT04178967|83370257|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
47075689|NCT04178967|83370258|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
46656247|NCT00001832|82866521|FG011|Treatment Period|Death during treatment|0|||
46656248|NCT00001832|82866522|FG012|Treatment Period|Death during treatment|0|||
46656249|NCT00001832|82866523|FG013|Treatment Period|Death during treatment|0|||
46656250|NCT00001832|82866524|FG014|Treatment Period|Death during treatment|0|||
46656251|NCT00001832|82866510|FG000|Treatment Period|Not treated|0|||
46971416|NCT01662063|83214926|FG002|Overall Study|Lost to Follow-up|0|||
46656252|NCT00001832|82866511|FG001|Treatment Period|Not treated|0|||
47075690|NCT04178967|83370259|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47075691|NCT04178967|83370260|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
47075692|NCT04178967|83370250|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
47075693|NCT04178967|83370251|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
47075694|NCT04178967|83370252|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
47075695|NCT04178967|83370253|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
47075696|NCT04178967|83370254|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
47075697|NCT04178967|83370255|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
46971417|NCT01662063|83214924|FG000|Overall Study|Protocol Violation|1|||
46971418|NCT01662063|83214925|FG001|Overall Study|Protocol Violation|0|||
46971419|NCT01662063|83214926|FG002|Overall Study|Protocol Violation|0|||
46971420|NCT01662063|83214924|FG000|Overall Study|Withdrawal by Subject|2|||
46971421|NCT01662063|83214925|FG001|Overall Study|Withdrawal by Subject|4|||
46971422|NCT01662063|83214926|FG002|Overall Study|Withdrawal by Subject|1|||
46781889|NCT00624819|83000535|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
46971423|NCT01662063|83214924|FG000|Overall Study|Physician Decision|0|||
46971424|NCT01662063|83214925|FG001|Overall Study|Physician Decision|2|||
46971425|NCT01662063|83214926|FG002|Overall Study|Physician Decision|0|||
46971426|NCT01662063|83214924|FG000|Overall Study|Other|0|||
46971427|NCT01662063|83214925|FG001|Overall Study|Other|1|||
46971428|NCT01662063|83214926|FG002|Overall Study|Other|0|||
46971429|NCT02548455|83214934|FG000|Overall Study|Withdrawal by Subject|27|||
46971430|NCT02548455|83214934|FG000|Overall Study|Death|26|||
46971431|NCT02548455|83214934|FG000|Overall Study|Lost to Follow-up|14|||
46971432|NCT02548455|83214934|FG000|Overall Study|Visit not completed|173|||
46971433|NCT02691455|83214940|FG000|Overall Study|Withdrawal by Subject|1|||
46656253|NCT00001832|82866512|FG002|Treatment Period|Not treated|0|||
46656254|NCT00001832|82866513|FG003|Treatment Period|Not treated|0|||
46781890|NCT00624819|83000536|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
46656255|NCT00001832|82866514|FG004|Treatment Period|Not treated|0|||
46656256|NCT00001832|82866515|FG005|Treatment Period|Not treated|0|||
46656257|NCT00001832|82866516|FG006|Treatment Period|Not treated|0|||
46656258|NCT00001832|82866517|FG007|Treatment Period|Not treated|1|||
46656259|NCT00001832|82866518|FG008|Treatment Period|Not treated|0|||
46656260|NCT00001832|82866519|FG009|Treatment Period|Not treated|0|||
46656261|NCT00001832|82866520|FG010|Treatment Period|Not treated|0|||
46656262|NCT00001832|82866521|FG011|Treatment Period|Not treated|0|||
46656263|NCT00001832|82866522|FG012|Treatment Period|Not treated|0|||
46656264|NCT00001832|82866523|FG013|Treatment Period|Not treated|0|||
46656265|NCT00001832|82866524|FG014|Treatment Period|Not treated|0|||
46656266|NCT01349816|82866749|FG000|Overall Study|Withdrawal by Subject|4|||
46656267|NCT01349816|82866749|FG000|Overall Study|Physician Decision|1|||
46656268|NCT01349816|82866749|FG000|Overall Study|Adverse Event|14|||
46656269|NCT01349816|82866749|FG000|Overall Study|Lost to Follow-up|2|||
46656270|NCT01349816|82866749|FG000|Overall Study|Protocol Violation|1|||
46656271|NCT01349816|82866749|FG000|Overall Study|Protocol-specified criteria|8|||
46656272|NCT05201807|82866928|FG000|Overall Study|Adverse Event|1|||
46656273|NCT05201807|82866928|FG000|Overall Study|COVID-19 Related|1|||
46656274|NCT04978337|82866934|FG000|Overall Study|Withdrawal by Subject|0|||
46656275|NCT04978337|82866935|FG001|Overall Study|Withdrawal by Subject|1|||
46656276|NCT04828707|82866944|FG000|Overall Study|Lost to Follow-up|3|||
46656277|NCT04828707|82866945|FG001|Overall Study|Lost to Follow-up|2|||
46656278|NCT04828707|82866944|FG000|Overall Study|Withdrawal by Subject|2|||
46656279|NCT04828707|82866945|FG001|Overall Study|Withdrawal by Subject|1|||
46656280|NCT04629534|82866953|FG000|Overall Study|Physician Decision|1|||
46656281|NCT04629534|82866954|FG001|Overall Study|Physician Decision|0|||
46656282|NCT04629534|82866953|FG000|Overall Study|Protocol Violation|0|||
46656283|NCT04629534|82866954|FG001|Overall Study|Protocol Violation|2|||
46656284|NCT04481191|82866966|FG000|Overall Study|Withdrawn by parent/guardian|15|||
46656285|NCT04481191|82866967|FG001|Overall Study|Withdrawn by parent/guardian|10|||
46656286|NCT03695185|82866990|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
46656287|NCT03695185|82866990|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
46656288|NCT03695185|82866990|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
46656289|NCT03695185|82866990|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
46656290|NCT03695185|82866990|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
46656291|NCT03695185|82866990|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
46656292|NCT03596164|82866997|FG000|Overall Study|Adverse Event|0|||
46656293|NCT03596164|82866998|FG001|Overall Study|Adverse Event|1|||
46656294|NCT03596164|82866997|FG000|Overall Study|Death|1|||
46656295|NCT03596164|82866998|FG001|Overall Study|Death|0|||
46656296|NCT02990468|82867009|FG000|Phase 2: MTD|Change in treatment|0|||
46656297|NCT02990468|82867010|FG001|Phase 2: MTD|Change in treatment|0|||
46656298|NCT02990468|82867011|FG002|Phase 2: MTD|Change in treatment|1|||
46656299|NCT02855944|82867021|FG000|Period 1: Treatment|Ongoing|14|||
46656300|NCT02855944|82867022|FG001|Period 1: Treatment|Ongoing|0|||
46656301|NCT02855944|82867021|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
46781891|NCT00624819|83000537|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
46781892|NCT03832387|83000549|FG000|Overall Study|Protocol Violation|2|||
46781893|NCT03832387|83000550|FG001|Overall Study|Protocol Violation|6|||
46781894|NCT03832387|83000549|FG000|Overall Study|EXCLUSION CRITERIA|3|||
46656302|NCT02855944|82867022|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
46656303|NCT02855944|82867021|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
46971434|NCT02691455|83214941|FG001|Overall Study|Withdrawal by Subject|2|||
46971435|NCT02691455|83214940|FG000|Overall Study|Lost to Follow-up|15|||
46971436|NCT02691455|83214941|FG001|Overall Study|Lost to Follow-up|15|||
46971437|NCT02534883|83214949|FG000|Overall Study|Early Termination|8|||
46656304|NCT02855944|82867022|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
46656305|NCT02681055|82867029|FG000|Weeks 5-12|Adverse Event|1|||
46656306|NCT02409342|82867036|FG000|Overall Study|Death|211|||
46656307|NCT02409342|82867037|FG001|Overall Study|Death|201|||
46656308|NCT02409342|82867036|FG000|Overall Study|Withdrawal by Subject|24|||
46656309|NCT02409342|82867037|FG001|Overall Study|Withdrawal by Subject|17|||
46656310|NCT02409342|82867036|FG000|Overall Study|Study Terminated By Sponsor|48|||
46656311|NCT02409342|82867037|FG001|Overall Study|Study Terminated By Sponsor|59|||
46656312|NCT02409342|82867036|FG000|Overall Study|Lost to Follow-up|3|||
46656313|NCT02409342|82867037|FG001|Overall Study|Lost to Follow-up|5|||
46656314|NCT02409342|82867036|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
46656315|NCT02409342|82867037|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
46656316|NCT02409342|82867036|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
46656317|NCT02409342|82867037|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
46656318|NCT02409342|82867036|FG000|Overall Study|Sponsor Decision|1|||
46656319|NCT02409342|82867037|FG001|Overall Study|Sponsor Decision|0|||
46656320|NCT02336503|82867049|FG000|Overall Study|Lost to Follow-up|0|||
46656321|NCT02336503|82867050|FG001|Overall Study|Lost to Follow-up|3|||
46656322|NCT02336503|82867051|FG002|Overall Study|Lost to Follow-up|0|||
46656323|NCT02336503|82867052|FG003|Overall Study|Lost to Follow-up|2|||
46656324|NCT02336503|82867049|FG000|Overall Study|Withdrawal by Subject|2|||
46656325|NCT02336503|82867050|FG001|Overall Study|Withdrawal by Subject|0|||
46656326|NCT02336503|82867051|FG002|Overall Study|Withdrawal by Subject|0|||
46656327|NCT02336503|82867052|FG003|Overall Study|Withdrawal by Subject|4|||
46656328|NCT02336503|82867049|FG000|Overall Study|Adverse Event|0|||
46656329|NCT02336503|82867050|FG001|Overall Study|Adverse Event|0|||
46656330|NCT02336503|82867051|FG002|Overall Study|Adverse Event|1|||
46656331|NCT02336503|82867052|FG003|Overall Study|Adverse Event|0|||
46656332|NCT02255409|82867068|FG000|Overall Study|Administrative Reason|3|||
46656333|NCT02255409|82867069|FG001|Overall Study|Administrative Reason|7|||
46656334|NCT02255409|82867068|FG000|Overall Study|Withdrawal by Subject|1|||
46656335|NCT02255409|82867069|FG001|Overall Study|Withdrawal by Subject|5|||
46656336|NCT02255409|82867068|FG000|Overall Study|Lost to Follow-up|10|||
46656337|NCT02255409|82867069|FG001|Overall Study|Lost to Follow-up|19|||
46656338|NCT00465517|82867100|FG000|Overall Study|Adverse Event|7|||
46656339|NCT00465517|82867101|FG001|Overall Study|Adverse Event|3|||
46656340|NCT00465517|82867100|FG000|Overall Study|Lost to Follow-up|1|||
46656341|NCT00465517|82867101|FG001|Overall Study|Lost to Follow-up|0|||
46656342|NCT00465517|82867100|FG000|Overall Study|Withdrawal by Subject|4|||
46656343|NCT00465517|82867101|FG001|Overall Study|Withdrawal by Subject|1|||
46656344|NCT05050578|82867109|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
46656345|NCT05050578|82867110|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
46656346|NCT05050578|82867109|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
46656347|NCT05050578|82867110|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
46656348|NCT05050578|82867109|FG000|Period 2, 30 Days|Protocol Violation|0|||
46656349|NCT05050578|82867110|FG001|Period 2, 30 Days|Protocol Violation|1|||
46656350|NCT05028361|82867121|FG000|Overall Study|Withdrawal by Subject|1|||
46656351|NCT05028361|82867122|FG001|Overall Study|Withdrawal by Subject|0|||
46656352|NCT04490278|82867128|FG000|Overall Study|Lost to Follow-up|6|||
46656353|NCT04004221|82867132|FG000|Overall Study|Death|89|||
46656354|NCT04004221|82867132|FG000|Overall Study|Withdrawal by Subject|5|||
46781895|NCT03832387|83000550|FG001|Overall Study|EXCLUSION CRITERIA|1|||
46781896|NCT00366301|83000560|FG000|Overall Study|Lost to Follow-up|4|||
46781897|NCT00366301|83000561|FG001|Overall Study|Lost to Follow-up|4|||
46781898|NCT00366301|83000562|FG002|Overall Study|Lost to Follow-up|3|||
46781899|NCT00366301|83000563|FG003|Overall Study|Lost to Follow-up|7|||
46656355|NCT04004221|82867132|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
46656356|NCT04004221|82867132|FG000|Overall Study|Sponsor Decision|9|||
46656357|NCT04004221|82867132|FG000|Overall Study|Participant refused to enter LTE|1|||
46656358|NCT03775512|82867138|FG000|Overall Study|Death|1|||
46656359|NCT03775512|82867139|FG001|Overall Study|Death|1|||
46656360|NCT03775512|82867138|FG000|Overall Study|Withdrawal by Subject|7|||
46656361|NCT03775512|82867139|FG001|Overall Study|Withdrawal by Subject|4|||
46656362|NCT03775512|82867138|FG000|Overall Study|Lost to Follow-up|5|||
46656363|NCT03775512|82867139|FG001|Overall Study|Lost to Follow-up|5|||
46971438|NCT02534883|83214950|FG001|Overall Study|Early Termination|3|||
46781900|NCT00366301|83000560|FG000|Overall Study|Withdrawal by Subject|4|||
46656364|NCT03775512|82867138|FG000|Overall Study|Excluded before Catheter insertion|14|||
46656365|NCT03775512|82867139|FG001|Overall Study|Excluded before Catheter insertion|5|||
46656366|NCT03775512|82867138|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
46656367|NCT03775512|82867139|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
46656368|NCT03775512|82867138|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
46656369|NCT03775512|82867139|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
46656370|NCT03620747|82867145|FG000|Overall Study|Participant decision|7|||
46656371|NCT03620747|82867145|FG000|Overall Study|Adverse Event|6|||
46656372|NCT03620747|82867145|FG000|Overall Study|Lack of Efficacy|1|||
46656373|NCT03620747|82867145|FG000|Overall Study|Poor compliance to protocol|2|||
46656374|NCT03620747|82867145|FG000|Overall Study|Other-unspecified|3|||
46656375|NCT02954536|82867183|FG000|Overall Study|Adverse Event|2|||
46656376|NCT02954536|82867183|FG000|Overall Study|Death|12|||
46656377|NCT02919670|82867189|FG000|Overall Study|Only 17 participants met compliance|43|||
46656378|NCT02919670|82867190|FG001|Overall Study|Only 17 participants met compliance|39|||
46656379|NCT02250326|82867289|FG000|Treatment Period|Death|1|||
46656380|NCT02250326|82867290|FG001|Treatment Period|Death|12|||
46656381|NCT02250326|82867291|FG002|Treatment Period|Death|2|||
46656382|NCT02250326|82867289|FG000|Treatment Period|Adverse Event|8|||
46656383|NCT02250326|82867290|FG001|Treatment Period|Adverse Event|4|||
46656384|NCT02250326|82867291|FG002|Treatment Period|Adverse Event|8|||
46656385|NCT02250326|82867289|FG000|Treatment Period|Progressive Disease|42|||
46656386|NCT02250326|82867290|FG001|Treatment Period|Progressive Disease|36|||
46656387|NCT02250326|82867291|FG002|Treatment Period|Progressive Disease|45|||
46656388|NCT02250326|82867289|FG000|Treatment Period|Symptomatic Deterioration|9|||
46656389|NCT02250326|82867290|FG001|Treatment Period|Symptomatic Deterioration|4|||
46656390|NCT02250326|82867291|FG002|Treatment Period|Symptomatic Deterioration|10|||
46656391|NCT02250326|82867289|FG000|Treatment Period|Withdrawal by Subject|11|||
46656392|NCT02250326|82867290|FG001|Treatment Period|Withdrawal by Subject|5|||
46656393|NCT02250326|82867291|FG002|Treatment Period|Withdrawal by Subject|4|||
46656394|NCT02250326|82867289|FG000|Treatment Period|Miscellaneous|8|||
46656395|NCT02250326|82867290|FG001|Treatment Period|Miscellaneous|2|||
46656396|NCT02250326|82867291|FG002|Treatment Period|Miscellaneous|7|||
46656397|NCT02250326|82867289|FG000|Treatment Period|Randomized or assigned; not treated|2|||
46656398|NCT02250326|82867290|FG001|Treatment Period|Randomized or assigned; not treated|1|||
46656399|NCT02250326|82867291|FG002|Treatment Period|Randomized or assigned; not treated|1|||
46656400|NCT02250326|82867289|FG000|Follow-Up Period|Death|46|||
46656401|NCT02250326|82867290|FG001|Follow-Up Period|Death|26|||
46656402|NCT02250326|82867291|FG002|Follow-Up Period|Death|32|||
46656403|NCT02250326|82867289|FG000|Follow-Up Period|Unknown or Missing|2|||
46781901|NCT00366301|83000561|FG001|Overall Study|Withdrawal by Subject|2|||
46781902|NCT00366301|83000562|FG002|Overall Study|Withdrawal by Subject|1|||
46781903|NCT00366301|83000563|FG003|Overall Study|Withdrawal by Subject|1|||
46781904|NCT00365989|83000573|FG000|Overall Study|Withdrawal by Subject|1|||
46781905|NCT00365989|83000573|FG000|Overall Study|Non-compliance|1|||
46781906|NCT00622713|83000578|FG000|Overall Study|Adverse Event|35|||
46971439|NCT02685995|83214958|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
46971440|NCT02685995|83214959|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
46971441|NCT02548143|83214967|FG000|Overall Study|Adverse Event|1|||
46971442|NCT02548143|83214968|FG001|Overall Study|Adverse Event|0|||
46971443|NCT02548143|83214967|FG000|Overall Study|Withdrawal by Subject|0|||
46971444|NCT02548143|83214968|FG001|Overall Study|Withdrawal by Subject|1|||
46971445|NCT02547441|83214976|FG000|Double-Blind Study Period|Adverse Event|4|||
46971446|NCT02547441|83214977|FG001|Double-Blind Study Period|Adverse Event|9|||
47075698|NCT04178967|83370256|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
47075699|NCT04178967|83370257|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
47075700|NCT04178967|83370258|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
47075701|NCT04178967|83370259|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
47075702|NCT04178967|83370260|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
47075703|NCT04178967|83370250|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47075704|NCT04178967|83370251|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47075705|NCT04178967|83370252|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
46656404|NCT02250326|82867290|FG001|Follow-Up Period|Unknown or Missing|3|||
46781907|NCT00622713|83000578|FG000|Overall Study|Administrative problems|4|||
46971447|NCT02547441|83214976|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
46971448|NCT02547441|83214977|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
46971449|NCT02547441|83214976|FG000|Double-Blind Study Period|Physician Decision|1|||
47075706|NCT04178967|83370253|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
46656405|NCT02250326|82867291|FG002|Follow-Up Period|Unknown or Missing|3|||
46656406|NCT02250326|82867289|FG000|Follow-Up Period|Lost to Follow-up|1|||
46656407|NCT02250326|82867290|FG001|Follow-Up Period|Lost to Follow-up|1|||
46656408|NCT02250326|82867291|FG002|Follow-Up Period|Lost to Follow-up|3|||
46656409|NCT01567722|82867303|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
46971450|NCT02547441|83214977|FG001|Double-Blind Study Period|Physician Decision|0|||
46656410|NCT01567722|82867304|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
46656411|NCT01567722|82867305|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
46656412|NCT01567722|82867303|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
46656413|NCT01567722|82867304|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
46656414|NCT01567722|82867305|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
46656415|NCT01567722|82867303|FG000|Overall Study|Protocol closure by the OCG|2|||
46656416|NCT01567722|82867304|FG001|Overall Study|Protocol closure by the OCG|0|||
46656417|NCT01567722|82867305|FG002|Overall Study|Protocol closure by the OCG|0|||
46656418|NCT01567722|82867303|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
46656419|NCT01567722|82867304|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
46656420|NCT01567722|82867305|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
46656421|NCT01349790|82867330|FG000|Overall Study|Investigator Judgement|3|||
46656422|NCT01349790|82867330|FG000|Overall Study|Death|2|||
46656423|NCT01349790|82867330|FG000|Overall Study|Withdrawal by Patient|2|||
46656424|NCT01349790|82867330|FG000|Overall Study|Adverse Event|1|||
46656425|NCT01349790|82867330|FG000|Overall Study|Lost to Follow-up|1|||
46656426|NCT01349595|82867336|FG000|Overall Study|Lack of funding|2|||
46656427|NCT01349595|82867337|FG001|Overall Study|Lack of funding|2|||
46656428|NCT01349673|82867347|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
46656429|NCT01349673|82867347|FG000|Overall Study|No Longer Qualified For Study|1|||
46656430|NCT01349673|82867347|FG000|Overall Study|Site Closure|10|||
46656431|NCT01349673|82867347|FG000|Overall Study|Withdrawal by Subject|21|||
46656432|NCT01349673|82867347|FG000|Overall Study|Lost to Follow-up|6|||
46656433|NCT01349673|82867347|FG000|Overall Study|Adverse Event|17|||
46656434|NCT01349673|82867347|FG000|Overall Study|Study Terminated By Sponsor|50|||
46656435|NCT01349673|82867347|FG000|Overall Study|Lack of Efficacy|8|||
46656436|NCT04725682|82867377|FG000|Overall Study|Withdrawal by Subject|7|||
46656437|NCT04725682|82867378|FG001|Overall Study|Withdrawal by Subject|5|||
46656438|NCT04725682|82867377|FG000|Overall Study|Failed to comply with the requirements|2|||
46656439|NCT04725682|82867378|FG001|Overall Study|Failed to comply with the requirements|1|||
46656440|NCT04725682|82867377|FG000|Overall Study|Adverse Event|1|||
46656441|NCT04725682|82867378|FG001|Overall Study|Adverse Event|1|||
46656442|NCT04725682|82867377|FG000|Overall Study|Death|0|||
46656443|NCT04725682|82867378|FG001|Overall Study|Death|1|||
46656444|NCT01349660|82867410|FG000|Overall Study|Still Receiving Study Treatment|0|||
46656445|NCT01349660|82867411|FG001|Overall Study|Still Receiving Study Treatment|0|||
46656446|NCT01349660|82867412|FG002|Overall Study|Still Receiving Study Treatment|1|||
46656447|NCT01349660|82867410|FG000|Overall Study|Disease Progression|2|||
46656448|NCT01349660|82867411|FG001|Overall Study|Disease Progression|4|||
46656449|NCT01349660|82867412|FG002|Overall Study|Disease Progression|50|||
46656450|NCT01349660|82867410|FG000|Overall Study|Adverse Event|1|||
46656451|NCT01349660|82867411|FG001|Overall Study|Adverse Event|1|||
46656452|NCT01349660|82867412|FG002|Overall Study|Adverse Event|12|||
46656453|NCT01349660|82867410|FG000|Overall Study|Withdrawal by Subject|2|||
46656454|NCT01349660|82867411|FG001|Overall Study|Withdrawal by Subject|0|||
46656455|NCT01349660|82867412|FG002|Overall Study|Withdrawal by Subject|9|||
46656456|NCT01349660|82867410|FG000|Overall Study|Death|1|||
46656457|NCT01349660|82867411|FG001|Overall Study|Death|1|||
46656458|NCT01349660|82867412|FG002|Overall Study|Death|0|||
46656459|NCT01349660|82867410|FG000|Overall Study|Non-Permitted Interventions|0|||
46656460|NCT01349660|82867411|FG001|Overall Study|Non-Permitted Interventions|0|||
46656461|NCT01349660|82867412|FG002|Overall Study|Non-Permitted Interventions|2|||
46656462|NCT01349660|82867410|FG000|Overall Study|Study Compliance|0|||
46656463|NCT01349660|82867411|FG001|Overall Study|Study Compliance|0|||
46656464|NCT01349660|82867412|FG002|Overall Study|Study Compliance|1|||
46656465|NCT01349660|82867410|FG000|Overall Study|Declining Performance Status|0|||
46656466|NCT01349660|82867411|FG001|Overall Study|Declining Performance Status|0|||
46656467|NCT01349660|82867412|FG002|Overall Study|Declining Performance Status|1|||
46656468|NCT01349569|82867431|FG000|Overall Study|Lack of Efficacy|4|||
46656469|NCT05221749|82867482|FG000|Overall Study|Lost to Follow-up|2|||
46656470|NCT05221749|82867483|FG001|Overall Study|Lost to Follow-up|3|||
46656471|NCT04965389|82867537|FG000|Overall Study|Other reasons|1|||
46656472|NCT04965389|82867538|FG001|Overall Study|Other reasons|0|||
46656473|NCT04965389|82867539|FG002|Overall Study|Other reasons|0|||
46656474|NCT04965389|82867540|FG003|Overall Study|Other reasons|0|||
47075707|NCT04178967|83370254|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47075708|NCT04178967|83370255|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
47075709|NCT04178967|83370256|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
47075710|NCT04178967|83370257|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
47075711|NCT04178967|83370258|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47075712|NCT04178967|83370259|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
47075713|NCT04178967|83370260|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
46656475|NCT04965389|82867537|FG000|Overall Study|Participant withdrew consent|0|||
47075714|NCT04178967|83370250|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075715|NCT04178967|83370251|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075716|NCT04178967|83370252|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075717|NCT04178967|83370253|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075718|NCT04178967|83370254|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075719|NCT04178967|83370255|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
46971451|NCT02547441|83214976|FG000|Double-Blind Study Period|Protocol Violation|1|||
46971452|NCT02547441|83214977|FG001|Double-Blind Study Period|Protocol Violation|2|||
46781908|NCT00622713|83000578|FG000|Overall Study|Withdrawal by Subject|11|||
46781909|NCT00622713|83000578|FG000|Overall Study|Lost to Follow-up|5|||
46781910|NCT00622713|83000578|FG000|Overall Study|Death|2|||
46781911|NCT00622713|83000578|FG000|Overall Study|Subject no longer required study drug|1|||
46781912|NCT00622713|83000578|FG000|Overall Study|Did not meet eligibility criteria|1|||
46781913|NCT00392197|83000584|FG000|Overall Study|Adverse Event|4|||
46781914|NCT00392197|83000585|FG001|Overall Study|Adverse Event|12|||
46781915|NCT00392197|83000584|FG000|Overall Study|Lack of Efficacy|3|||
46781916|NCT00392197|83000585|FG001|Overall Study|Lack of Efficacy|4|||
46781917|NCT00392197|83000584|FG000|Overall Study|Lost to Follow-up|0|||
46781918|NCT00392197|83000585|FG001|Overall Study|Lost to Follow-up|1|||
46781919|NCT00392197|83000584|FG000|Overall Study|Physician Decision|3|||
46781920|NCT00392197|83000585|FG001|Overall Study|Physician Decision|2|||
46781921|NCT00392197|83000584|FG000|Overall Study|Protocol Violation|7|||
47075720|NCT04178967|83370256|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075721|NCT04178967|83370257|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075722|NCT04178967|83370258|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
47075723|NCT04178967|83370259|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
47075724|NCT04178967|83370260|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
47075725|NCT04178967|83370250|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075726|NCT04178967|83370251|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075727|NCT04178967|83370252|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075728|NCT04178967|83370253|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075729|NCT04178967|83370254|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075730|NCT04178967|83370255|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075731|NCT04178967|83370256|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075732|NCT04178967|83370257|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
47075733|NCT04178967|83370258|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
46781922|NCT00392197|83000585|FG001|Overall Study|Protocol Violation|5|||
46781923|NCT00392197|83000584|FG000|Overall Study|Withdrawal by Subject|4|||
46971453|NCT02547441|83214976|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
46971454|NCT02547441|83214977|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
47075734|NCT04178967|83370259|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
47075735|NCT04178967|83370260|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
47075736|NCT04178967|83370250|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075737|NCT04178967|83370251|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075738|NCT04178967|83370252|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075739|NCT04178967|83370253|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075740|NCT04178967|83370254|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075741|NCT04178967|83370255|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075742|NCT04178967|83370256|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075743|NCT04178967|83370257|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075744|NCT04178967|83370258|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075745|NCT04178967|83370259|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
47075746|NCT04178967|83370260|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
47075747|NCT04178967|83370250|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47075748|NCT04178967|83370251|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47075749|NCT04178967|83370252|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47075750|NCT04178967|83370253|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47075751|NCT04178967|83370254|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46971455|NCT02547441|83214976|FG000|Double-Blind Study Period|Sponsor Decision|1|||
46971456|NCT02547441|83214977|FG001|Double-Blind Study Period|Sponsor Decision|0|||
46971457|NCT02547441|83214976|FG000|Open-Label Study Period|Adverse Event|10|||
46656476|NCT04965389|82867538|FG001|Overall Study|Participant withdrew consent|1|||
46656477|NCT04965389|82867539|FG002|Overall Study|Participant withdrew consent|0|||
46781924|NCT00392197|83000585|FG001|Overall Study|Withdrawal by Subject|6|||
46781925|NCT00391807|83000591|FG000|Overall Study|Did not receive study medication|23|||
46781926|NCT00391807|83000591|FG000|Overall Study|Adverse Event|177|||
46781927|NCT00391807|83000591|FG000|Overall Study|Pregnancy|25|||
46781928|NCT00391807|83000591|FG000|Overall Study|Lost to Follow-up|227|||
46781929|NCT00391807|83000591|FG000|Overall Study|Withdrawal by Subject|147|||
46971458|NCT02547441|83214977|FG001|Open-Label Study Period|Adverse Event|11|||
46656478|NCT04965389|82867540|FG003|Overall Study|Participant withdrew consent|0|||
46656479|NCT04965389|82867537|FG000|Overall Study|Poor/Non-compliance|0|||
46656480|NCT04965389|82867538|FG001|Overall Study|Poor/Non-compliance|1|||
46656481|NCT04965389|82867539|FG002|Overall Study|Poor/Non-compliance|0|||
46656482|NCT04965389|82867540|FG003|Overall Study|Poor/Non-compliance|0|||
46656483|NCT04935931|82867557|FG000|Overall Study|Withdrawal by Subject|1|||
46656484|NCT04839393|82867569|FG000|Overall Study|Adverse Event|0|||
46656485|NCT04839393|82867570|FG001|Overall Study|Adverse Event|0|||
46656486|NCT04839393|82867571|FG002|Overall Study|Adverse Event|2|||
46656487|NCT04839393|82867569|FG000|Overall Study|Withdrawal by participant|0|||
46656488|NCT04839393|82867570|FG001|Overall Study|Withdrawal by participant|0|||
46656489|NCT04839393|82867571|FG002|Overall Study|Withdrawal by participant|1|||
46656490|NCT04677712|82867634|FG000|Overall Study|Lost to Follow-up|0|||
46656491|NCT04677712|82867635|FG001|Overall Study|Lost to Follow-up|1|||
46656492|NCT04677712|82867636|FG002|Overall Study|Lost to Follow-up|0|||
46656493|NCT04677712|82867637|FG003|Overall Study|Lost to Follow-up|0|||
46656494|NCT04677712|82867638|FG004|Overall Study|Lost to Follow-up|0|||
46656495|NCT04677712|82867639|FG005|Overall Study|Lost to Follow-up|0|||
46656496|NCT04630002|82867662|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
46656497|NCT04630002|82867663|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
46656498|NCT04630002|82867664|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
46656499|NCT04630002|82867662|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
46656500|NCT04630002|82867663|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
46656501|NCT04630002|82867664|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
46656502|NCT04630002|82867662|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
46656503|NCT04630002|82867663|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
46656504|NCT04630002|82867664|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
46656505|NCT04630002|82867662|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
46656506|NCT04630002|82867663|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
46656507|NCT04630002|82867664|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
46656508|NCT04630002|82867662|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
46656509|NCT04630002|82867663|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
46656510|NCT04630002|82867664|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
46656511|NCT04630002|82867662|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
46656512|NCT04630002|82867663|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
46656513|NCT04630002|82867664|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
46656514|NCT04630002|82867662|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
46656515|NCT04630002|82867663|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
46656516|NCT04630002|82867664|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
46656517|NCT04630002|82867662|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
46656518|NCT04630002|82867663|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
46656519|NCT04630002|82867664|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
46656520|NCT04576923|82867697|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
46656521|NCT04526197|82867711|FG000|Period 1|Adverse Event|0|||
46656522|NCT04526197|82867712|FG001|Period 1|Adverse Event|1|||
46656523|NCT04526197|82867711|FG000|Period 1|Withdrawal by Subject|1|||
46656524|NCT04526197|82867712|FG001|Period 1|Withdrawal by Subject|0|||
46656525|NCT04526197|82867711|FG000|Period 2|Adverse Event|0|||
46656526|NCT04526197|82867712|FG001|Period 2|Adverse Event|1|||
46656527|NCT04526197|82867711|FG000|Period 2|Withdrawal by Subject|0|||
46656528|NCT04526197|82867712|FG001|Period 2|Withdrawal by Subject|1|||
46656529|NCT04412668|82867722|FG000|Overall Study|Death - multiple comorbidities|2|||
46656530|NCT04412668|82867723|FG001|Overall Study|Death - multiple comorbidities|0|||
46656531|NCT04412668|82867724|FG002|Overall Study|Death - multiple comorbidities|0|||
46656532|NCT04412668|82867722|FG000|Overall Study|Withdrawal by Subject|3|||
46656533|NCT04412668|82867723|FG001|Overall Study|Withdrawal by Subject|0|||
46656534|NCT04412668|82867724|FG002|Overall Study|Withdrawal by Subject|0|||
46656535|NCT04412668|82867722|FG000|Overall Study|Other than Specified|2|||
46656536|NCT04412668|82867723|FG001|Overall Study|Other than Specified|0|||
46656537|NCT04412668|82867724|FG002|Overall Study|Other than Specified|0|||
46656538|NCT04360551|82867734|FG000|Overall Study|Withdrawal by Subject|1|||
46656539|NCT04360551|82867735|FG001|Overall Study|Withdrawal by Subject|0|||
46656540|NCT04299087|82867743|FG000|Overall Study|Lost to Follow-up|2|||
46656541|NCT04299087|82867744|FG001|Overall Study|Lost to Follow-up|1|||
46656542|NCT04288778|82867750|FG000|Overall Study|Withdrawal by Subject|2|||
46656543|NCT04288778|82867750|FG000|Overall Study|Adverse Event|5|||
46656544|NCT04288778|82867750|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46656545|NCT04288778|82867750|FG000|Overall Study|Other|1|||
46656546|NCT04288778|82867750|FG000|Overall Study|Started but not treated|2|||
46656547|NCT04233164|82867769|FG000|Overall Study|Unable to obtain specimen|0|||
46656548|NCT04233164|82867770|FG001|Overall Study|Unable to obtain specimen|1|||
46656549|NCT04147195|82867786|FG000|Overall Study|Adverse Event|0|||
46656550|NCT04147195|82867787|FG001|Overall Study|Adverse Event|3|||
46656551|NCT04147195|82867786|FG000|Overall Study|Study Terminated by Sponsor|4|||
46656552|NCT04147195|82867787|FG001|Overall Study|Study Terminated by Sponsor|2|||
46656553|NCT04147195|82867786|FG000|Overall Study|Withdrawal by Subject|0|||
46656554|NCT04147195|82867787|FG001|Overall Study|Withdrawal by Subject|1|||
46656555|NCT04092816|82867800|FG000|Overall Study|Lost to Follow-up|1|||
46656556|NCT04092816|82867801|FG001|Overall Study|Lost to Follow-up|2|||
46656557|NCT03985878|82867818|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
46850917|NCT03579940|83066728|FG003|Period 2|Withdrawal by Subject|0|||
47075752|NCT04178967|83370255|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47075753|NCT04178967|83370256|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47075754|NCT04178967|83370257|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
47075755|NCT04178967|83370258|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
47075756|NCT04178967|83370259|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
47075757|NCT04178967|83370260|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
47075758|NCT04178967|83370250|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075759|NCT04178967|83370251|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075760|NCT04178967|83370252|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075761|NCT04178967|83370253|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075762|NCT04178967|83370254|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075763|NCT04178967|83370255|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075764|NCT04178967|83370256|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075765|NCT04178967|83370257|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075766|NCT04178967|83370258|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075767|NCT04178967|83370259|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
47075768|NCT04178967|83370260|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
47075769|NCT04178967|83370250|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075770|NCT04178967|83370251|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075771|NCT04178967|83370252|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075772|NCT04178967|83370253|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075773|NCT04178967|83370254|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075774|NCT04178967|83370255|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075775|NCT04178967|83370256|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075776|NCT04178967|83370257|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075777|NCT04178967|83370258|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075778|NCT04178967|83370259|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
47075779|NCT04178967|83370260|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
47075780|NCT04163900|83370282|FG000|Overall Study|Radiological disease progression|112|||
47075781|NCT04163900|83370283|FG001|Overall Study|Radiological disease progression|127|||
47075782|NCT04163900|83370282|FG000|Overall Study|Study closure|98|||
47075783|NCT04163900|83370283|FG001|Overall Study|Study closure|133|||
47075784|NCT04163900|83370282|FG000|Overall Study|Adverse Event|78|||
47075785|NCT04163900|83370283|FG001|Overall Study|Adverse Event|32|||
47075786|NCT04163900|83370282|FG000|Overall Study|Withdrawal by Subject|37|||
47075787|NCT04163900|83370283|FG001|Overall Study|Withdrawal by Subject|34|||
47075788|NCT04163900|83370282|FG000|Overall Study|Death|29|||
47075789|NCT04163900|83370283|FG001|Overall Study|Death|16|||
47075790|NCT04163900|83370282|FG000|Overall Study|Physician Decision|17|||
47075791|NCT04163900|83370283|FG001|Overall Study|Physician Decision|25|||
47075792|NCT04163900|83370282|FG000|Overall Study|Clinical disease progression|14|||
47075793|NCT04163900|83370283|FG001|Overall Study|Clinical disease progression|13|||
47075794|NCT04163900|83370282|FG000|Overall Study|Protocol Violation|3|||
47075795|NCT04163900|83370283|FG001|Overall Study|Protocol Violation|4|||
47075796|NCT04163900|83370282|FG000|Overall Study|Lost to Follow-up|0|||
47075797|NCT04163900|83370283|FG001|Overall Study|Lost to Follow-up|1|||
47075798|NCT04161495|83370291|FG000|Overall Study|Withdrawal by Subject|3|||
47075799|NCT04161495|83370292|FG001|Overall Study|Withdrawal by Subject|0|||
47075800|NCT04161495|83370291|FG000|Overall Study|Protocol Violation|1|||
47075801|NCT04161495|83370292|FG001|Overall Study|Protocol Violation|0|||
47075802|NCT04161495|83370291|FG000|Overall Study|Prohibited concomitant medication|3|||
47075803|NCT04161495|83370292|FG001|Overall Study|Prohibited concomitant medication|0|||
47075804|NCT04161495|83370291|FG000|Overall Study|Adverse Event|1|||
47075805|NCT04161495|83370292|FG001|Overall Study|Adverse Event|0|||
46656558|NCT03985878|82867818|FG000|Overall Study|Study Terminated by Sponsor|12|||
47075806|NCT04161495|83370291|FG000|Overall Study|Other - Unspecified|1|||
47075807|NCT04161495|83370292|FG001|Overall Study|Other - Unspecified|0|||
47075808|NCT04161495|83370291|FG000|Overall Study|Death|0|||
47075809|NCT04161495|83370292|FG001|Overall Study|Death|1|||
47075810|NCT04108000|83370321|FG000|Overall Study|Death of patient|1|||
47075811|NCT04108000|83370322|FG001|Overall Study|Death of patient|0|||
47075812|NCT04108000|83370323|FG002|Overall Study|Death of patient|1|||
47075813|NCT04108000|83370324|FG003|Overall Study|Death of patient|0|||
46656559|NCT03985878|82867818|FG000|Overall Study|Withdrawal by Subject|1|||
46656560|NCT03774394|82867900|FG000|Overall Study|Withdrawal by Subject|2|||
46656561|NCT03774394|82867901|FG001|Overall Study|Withdrawal by Subject|0|||
46656562|NCT03765788|82867909|FG000|Overall Study|Subject decision|2|||
46656563|NCT03765788|82867910|FG001|Overall Study|Subject decision|3|||
46656564|NCT03765788|82867909|FG000|Overall Study|Physician Decision|2|||
46656565|NCT03765788|82867910|FG001|Overall Study|Physician Decision|4|||
46656566|NCT03765788|82867909|FG000|Overall Study|Death|0|||
46656567|NCT03765788|82867910|FG001|Overall Study|Death|1|||
46656568|NCT03765788|82867909|FG000|Overall Study|Lost to Follow-up|1|||
46656569|NCT03765788|82867910|FG001|Overall Study|Lost to Follow-up|0|||
46656570|NCT03692403|82867921|FG000|Overall Study|Withdrawal by Subject|1|||
46656571|NCT03692403|82867922|FG001|Overall Study|Withdrawal by Subject|0|||
46656572|NCT03692403|82867923|FG002|Overall Study|Withdrawal by Subject|1|||
46656573|NCT03692403|82867924|FG003|Overall Study|Withdrawal by Subject|0|||
46656574|NCT03692403|82867921|FG000|Overall Study|Adverse Event|0|||
47075814|NCT04108000|83370321|FG000|Overall Study|Withdrawal by Subject|2|||
47075815|NCT04108000|83370322|FG001|Overall Study|Withdrawal by Subject|2|||
47075816|NCT04108000|83370323|FG002|Overall Study|Withdrawal by Subject|0|||
47075817|NCT04108000|83370324|FG003|Overall Study|Withdrawal by Subject|0|||
47075818|NCT04108000|83370321|FG000|Overall Study|Death of surrogate partner|0|||
47075819|NCT04108000|83370322|FG001|Overall Study|Death of surrogate partner|1|||
47075820|NCT04108000|83370323|FG002|Overall Study|Death of surrogate partner|0|||
47075821|NCT04108000|83370324|FG003|Overall Study|Death of surrogate partner|1|||
47075822|NCT03945266|83370340|FG000|Overall Study|Withdrawal by Subject|1|||
47075823|NCT03945266|83370341|FG001|Overall Study|Withdrawal by Subject|0|||
47075824|NCT03945266|83370340|FG000|Overall Study|Miscarriage|0|||
47075825|NCT03945266|83370341|FG001|Overall Study|Miscarriage|2|||
47075826|NCT03945266|83370340|FG000|Overall Study|Lost to Follow-up|1|||
47075827|NCT03945266|83370341|FG001|Overall Study|Lost to Follow-up|0|||
47075828|NCT03916484|83370355|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
47075829|NCT03916484|83370356|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
47075830|NCT03916484|83370357|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
47075831|NCT03916484|83370358|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
47075832|NCT03916484|83370355|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
46656575|NCT03692403|82867922|FG001|Overall Study|Adverse Event|0|||
46656576|NCT03692403|82867923|FG002|Overall Study|Adverse Event|0|||
46656577|NCT03692403|82867924|FG003|Overall Study|Adverse Event|1|||
46656578|NCT03692403|82867921|FG000|Overall Study|Pregnancy|0|||
46656579|NCT03692403|82867922|FG001|Overall Study|Pregnancy|1|||
46656580|NCT03692403|82867923|FG002|Overall Study|Pregnancy|0|||
46656581|NCT03692403|82867924|FG003|Overall Study|Pregnancy|0|||
46656582|NCT03692403|82867921|FG000|Overall Study|Other|0|||
46656583|NCT03692403|82867922|FG001|Overall Study|Other|0|||
46656584|NCT03692403|82867923|FG002|Overall Study|Other|1|||
46656585|NCT03692403|82867924|FG003|Overall Study|Other|0|||
46656586|NCT03654651|82867939|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
46656587|NCT03654651|82867940|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
46656588|NCT03649230|82867947|FG000|Overall Study|Adverse Event|12|||
46656589|NCT03649230|82867947|FG000|Overall Study|Death|8|||
46656590|NCT03649230|82867947|FG000|Overall Study|Withdrawal by Subject|6|||
46656591|NCT03649230|82867947|FG000|Overall Study|Physician Decision|5|||
46656592|NCT03649230|82867947|FG000|Overall Study|Disease progression|5|||
46656593|NCT03649230|82867947|FG000|Overall Study|Switched to non-HEC|5|||
46656594|NCT03649230|82867947|FG000|Overall Study|Chemotherapy discontinued|4|||
46781930|NCT00391807|83000591|FG000|Overall Study|Protocol Violation|20|||
46781931|NCT00391807|83000591|FG000|Overall Study|Various|96|||
47075833|NCT03916484|83370356|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
47075834|NCT03916484|83370357|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
47075835|NCT03916484|83370358|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
47075836|NCT03769311|83370373|FG000|Overall Study|Withdrawal by Subject|1|||
47075837|NCT03738566|83370381|FG000|Initial Study Phase|Withdrawal by Subject|1|||
47075838|NCT03738566|83370382|FG001|Initial Study Phase|Withdrawal by Subject|1|||
46656595|NCT03649230|82867947|FG000|Overall Study|Received only 3 HEC cycles|4|||
46656596|NCT03649230|82867947|FG000|Overall Study|Screen Failure|3|||
46656597|NCT03649230|82867947|FG000|Overall Study|Patient stopped treatment|2|||
46656598|NCT03649230|82867947|FG000|Overall Study|Protocol Violation|1|||
46656599|NCT03649230|82867947|FG000|Overall Study|Non-compliance|1|||
46656600|NCT03649230|82867947|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
46656601|NCT03626545|82867958|FG000|Overall Study|Progressive disease|3|||
46781932|NCT00624585|83000595|FG000|Overall Study|Death|3|||
47075839|NCT03738566|83370383|FG002|Initial Study Phase|Withdrawal by Subject|2|||
47075840|NCT03738566|83370384|FG003|Initial Study Phase|Withdrawal by Subject|0|||
47075841|NCT03738566|83370381|FG000|Initial Study Phase|Death|0|||
47075842|NCT03738566|83370382|FG001|Initial Study Phase|Death|1|||
46656602|NCT03626545|82867959|FG001|Overall Study|Progressive disease|82|||
46656603|NCT03626545|82867960|FG002|Overall Study|Progressive disease|85|||
46781933|NCT00624585|83000595|FG000|Overall Study|Disease Progression|6|||
46656604|NCT03626545|82867958|FG000|Overall Study|Adverse Event|3|||
46656605|NCT03626545|82867959|FG001|Overall Study|Adverse Event|13|||
46656606|NCT03626545|82867960|FG002|Overall Study|Adverse Event|10|||
46656607|NCT03626545|82867958|FG000|Overall Study|Physician Decision|1|||
46656608|NCT03626545|82867959|FG001|Overall Study|Physician Decision|18|||
46656609|NCT03626545|82867960|FG002|Overall Study|Physician Decision|14|||
46656610|NCT03626545|82867958|FG000|Overall Study|Subject Decision|0|||
46656611|NCT03626545|82867959|FG001|Overall Study|Subject Decision|5|||
46656612|NCT03626545|82867960|FG002|Overall Study|Subject Decision|5|||
46656613|NCT03626545|82867958|FG000|Overall Study|Death|1|||
46656614|NCT03626545|82867959|FG001|Overall Study|Death|1|||
46656615|NCT03626545|82867960|FG002|Overall Study|Death|1|||
46656616|NCT03626545|82867958|FG000|Overall Study|Protocol Deviation|0|||
46656617|NCT03626545|82867959|FG001|Overall Study|Protocol Deviation|1|||
46656618|NCT03626545|82867960|FG002|Overall Study|Protocol Deviation|1|||
46656619|NCT03626545|82867958|FG000|Overall Study|Guardian Decision|0|||
46656620|NCT03626545|82867959|FG001|Overall Study|Guardian Decision|0|||
46656621|NCT03626545|82867960|FG002|Overall Study|Guardian Decision|1|||
46656622|NCT03575143|82867977|FG000|Overall Study|Lost to Follow-up|0|||
46656623|NCT03575143|82867978|FG001|Overall Study|Lost to Follow-up|0|||
46656624|NCT03575143|82867979|FG002|Overall Study|Lost to Follow-up|4|||
46656625|NCT03575143|82867977|FG000|Overall Study|Withdrawal by Subject|0|||
46656626|NCT03575143|82867978|FG001|Overall Study|Withdrawal by Subject|0|||
46656627|NCT03575143|82867979|FG002|Overall Study|Withdrawal by Subject|5|||
46656628|NCT03575143|82867977|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
46656629|NCT03575143|82867978|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
46656630|NCT03575143|82867979|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
46656631|NCT03548064|82867997|FG000|Overall Study|Withdrawal by Subject|0|||
46656632|NCT03548064|82867998|FG001|Overall Study|Withdrawal by Subject|0|||
46656633|NCT03548064|82867999|FG002|Overall Study|Withdrawal by Subject|0|||
46656634|NCT03548064|82868000|FG003|Overall Study|Withdrawal by Subject|1|||
46656635|NCT03548064|82868001|FG004|Overall Study|Withdrawal by Subject|0|||
46656636|NCT03548064|82868002|FG005|Overall Study|Withdrawal by Subject|0|||
46656637|NCT03548064|82868003|FG006|Overall Study|Withdrawal by Subject|0|||
46781934|NCT00624585|83000595|FG000|Overall Study|Adverse Event|3|||
46781935|NCT00622635|83000599|FG000|Treatment Period 1|Adverse Event|0|||
46781936|NCT00622635|83000600|FG001|Treatment Period 1|Adverse Event|0|||
46781937|NCT00622635|83000601|FG002|Treatment Period 1|Adverse Event|1|||
46781938|NCT00622635|83000602|FG003|Treatment Period 1|Adverse Event|0|||
46781939|NCT00622635|83000603|FG004|Treatment Period 1|Adverse Event|0|||
46781940|NCT00622635|83000604|FG005|Treatment Period 1|Adverse Event|0|||
46781941|NCT00622635|83000599|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46781942|NCT00622635|83000600|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46781943|NCT00622635|83000601|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46781944|NCT00622635|83000602|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46781945|NCT00622635|83000603|FG004|Treatment Period 1|Withdrawal by Subject|0|||
47075843|NCT03738566|83370383|FG002|Initial Study Phase|Death|0|||
47075844|NCT03738566|83370384|FG003|Initial Study Phase|Death|0|||
46656638|NCT03548064|82868004|FG007|Overall Study|Withdrawal by Subject|0|||
46656639|NCT03548064|82867997|FG000|Overall Study|Lost to Follow-up|0|||
46656640|NCT03548064|82867998|FG001|Overall Study|Lost to Follow-up|0|||
46656641|NCT03548064|82867999|FG002|Overall Study|Lost to Follow-up|0|||
46656642|NCT03548064|82868000|FG003|Overall Study|Lost to Follow-up|0|||
46656643|NCT03548064|82868001|FG004|Overall Study|Lost to Follow-up|2|||
46656644|NCT03548064|82868002|FG005|Overall Study|Lost to Follow-up|0|||
46656645|NCT03548064|82868003|FG006|Overall Study|Lost to Follow-up|0|||
46781946|NCT00622635|83000604|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46781947|NCT00622635|83000599|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
46781948|NCT00622635|83000600|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
46781949|NCT00622635|83000601|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
46850918|NCT03579940|83066729|FG004|Period 2|Withdrawal by Subject|0|||
46850919|NCT03579940|83066730|FG005|Period 2|Withdrawal by Subject|0|||
46850920|NCT03579940|83066731|FG006|Period 2|Withdrawal by Subject|0|||
46850921|NCT03579940|83066732|FG007|Period 2|Withdrawal by Subject|0|||
47075845|NCT03738566|83370381|FG000|Initial Study Phase|Treatment failure|5|||
47075846|NCT03738566|83370382|FG001|Initial Study Phase|Treatment failure|0|||
47075847|NCT03738566|83370383|FG002|Initial Study Phase|Treatment failure|0|||
46656646|NCT03548064|82868004|FG007|Overall Study|Lost to Follow-up|0|||
46850922|NCT03579940|83066733|FG008|Period 2|Withdrawal by Subject|0|||
46656647|NCT03548064|82867997|FG000|Overall Study|Covid-19 Pandemic|0|||
46656648|NCT03548064|82867998|FG001|Overall Study|Covid-19 Pandemic|0|||
46656649|NCT03548064|82867999|FG002|Overall Study|Covid-19 Pandemic|0|||
46656650|NCT03548064|82868000|FG003|Overall Study|Covid-19 Pandemic|0|||
46656651|NCT03548064|82868001|FG004|Overall Study|Covid-19 Pandemic|10|||
46656652|NCT03548064|82868002|FG005|Overall Study|Covid-19 Pandemic|3|||
46656653|NCT03548064|82868003|FG006|Overall Study|Covid-19 Pandemic|0|||
46850923|NCT03579940|83066734|FG009|Period 2|Withdrawal by Subject|0|||
46656654|NCT03548064|82868004|FG007|Overall Study|Covid-19 Pandemic|0|||
46656655|NCT03512197|82868030|FG000|Overall Study|Guardian decision|1|||
46656656|NCT03512197|82868031|FG001|Overall Study|Guardian decision|1|||
46656657|NCT03512197|82868030|FG000|Overall Study|Lack of Efficacy|19|||
46656658|NCT03512197|82868031|FG001|Overall Study|Lack of Efficacy|11|||
46656659|NCT03512197|82868030|FG000|Overall Study|New Therapy for Study Indication|16|||
46656660|NCT03512197|82868031|FG001|Overall Study|New Therapy for Study Indication|16|||
46656661|NCT03512197|82868030|FG000|Overall Study|Physician Decision|60|||
46656662|NCT03512197|82868031|FG001|Overall Study|Physician Decision|60|||
46656663|NCT03512197|82868030|FG000|Overall Study|Protocol Violation|0|||
46656664|NCT03512197|82868031|FG001|Overall Study|Protocol Violation|2|||
46656665|NCT03512197|82868030|FG000|Overall Study|Terminated by Sponsored|46|||
46656666|NCT03512197|82868031|FG001|Overall Study|Terminated by Sponsored|50|||
46656667|NCT03512197|82868030|FG000|Overall Study|Subject Decision|15|||
46656668|NCT03512197|82868031|FG001|Overall Study|Subject Decision|12|||
46656669|NCT03512197|82868030|FG000|Overall Study|Withdrawal of informed consent|20|||
46656670|NCT03512197|82868031|FG001|Overall Study|Withdrawal of informed consent|14|||
46656671|NCT03512197|82868030|FG000|Overall Study|Adverse Event|30|||
46656672|NCT03512197|82868031|FG001|Overall Study|Adverse Event|34|||
46656673|NCT03512197|82868030|FG000|Overall Study|Death|14|||
46656674|NCT03512197|82868031|FG001|Overall Study|Death|9|||
46656675|NCT03512197|82868030|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
46656676|NCT03512197|82868031|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
46656677|NCT03512197|82868030|FG000|Overall Study|Missing|3|||
46656678|NCT03512197|82868031|FG001|Overall Study|Missing|13|||
46656679|NCT03502330|82868051|FG000|Overall Study|Adverse Event|2|||
46656680|NCT03502330|82868052|FG001|Overall Study|Adverse Event|1|||
46656681|NCT03502330|82868053|FG002|Overall Study|Adverse Event|0|||
46656682|NCT03502330|82868054|FG003|Overall Study|Adverse Event|0|||
46781950|NCT00622635|83000602|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
46781951|NCT00622635|83000603|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
46656683|NCT03502330|82868055|FG004|Overall Study|Adverse Event|1|||
46656684|NCT03502330|82868056|FG005|Overall Study|Adverse Event|0|||
46656685|NCT03502330|82868057|FG006|Overall Study|Adverse Event|1|||
46656686|NCT03502330|82868058|FG007|Overall Study|Adverse Event|1|||
46656687|NCT03502330|82868059|FG008|Overall Study|Adverse Event|0|||
46656688|NCT03502330|82868051|FG000|Overall Study|Lack of Efficacy|1|||
46656689|NCT03502330|82868052|FG001|Overall Study|Lack of Efficacy|5|||
46656690|NCT03502330|82868053|FG002|Overall Study|Lack of Efficacy|3|||
46656691|NCT03502330|82868054|FG003|Overall Study|Lack of Efficacy|5|||
46656692|NCT03502330|82868055|FG004|Overall Study|Lack of Efficacy|1|||
46656693|NCT03502330|82868056|FG005|Overall Study|Lack of Efficacy|5|||
46656694|NCT03502330|82868057|FG006|Overall Study|Lack of Efficacy|5|||
46656695|NCT03502330|82868058|FG007|Overall Study|Lack of Efficacy|6|||
46656696|NCT03502330|82868059|FG008|Overall Study|Lack of Efficacy|0|||
46656697|NCT03502330|82868051|FG000|Overall Study|Physician Decision|0|||
46656698|NCT03502330|82868052|FG001|Overall Study|Physician Decision|0|||
46656699|NCT03502330|82868053|FG002|Overall Study|Physician Decision|0|||
46656700|NCT03502330|82868054|FG003|Overall Study|Physician Decision|0|||
46656701|NCT03502330|82868055|FG004|Overall Study|Physician Decision|1|||
46656702|NCT03502330|82868056|FG005|Overall Study|Physician Decision|0|||
46656703|NCT03502330|82868057|FG006|Overall Study|Physician Decision|0|||
46656704|NCT03502330|82868058|FG007|Overall Study|Physician Decision|0|||
46656705|NCT03502330|82868059|FG008|Overall Study|Physician Decision|0|||
46656706|NCT03502330|82868051|FG000|Overall Study|Withdrawal by Subject|0|||
46656707|NCT03502330|82868052|FG001|Overall Study|Withdrawal by Subject|0|||
46656708|NCT03502330|82868053|FG002|Overall Study|Withdrawal by Subject|0|||
46656709|NCT03502330|82868054|FG003|Overall Study|Withdrawal by Subject|0|||
46656710|NCT03502330|82868055|FG004|Overall Study|Withdrawal by Subject|0|||
46656711|NCT03502330|82868056|FG005|Overall Study|Withdrawal by Subject|1|||
46656712|NCT03502330|82868057|FG006|Overall Study|Withdrawal by Subject|0|||
46656713|NCT03502330|82868058|FG007|Overall Study|Withdrawal by Subject|1|||
46656714|NCT03502330|82868059|FG008|Overall Study|Withdrawal by Subject|0|||
46971459|NCT02547441|83214976|FG000|Open-Label Study Period|Lack of Efficacy|3|||
46971460|NCT02547441|83214977|FG001|Open-Label Study Period|Lack of Efficacy|2|||
46971461|NCT02547441|83214976|FG000|Open-Label Study Period|Lost to Follow-up|7|||
46656715|NCT03502330|82868051|FG000|Overall Study|Death|0|||
46656716|NCT03502330|82868052|FG001|Overall Study|Death|0|||
46656717|NCT03502330|82868053|FG002|Overall Study|Death|0|||
46656718|NCT03502330|82868054|FG003|Overall Study|Death|0|||
46656719|NCT03502330|82868055|FG004|Overall Study|Death|0|||
46656720|NCT03502330|82868056|FG005|Overall Study|Death|0|||
46656721|NCT03502330|82868057|FG006|Overall Study|Death|2|||
46656722|NCT03502330|82868058|FG007|Overall Study|Death|0|||
46656723|NCT03502330|82868059|FG008|Overall Study|Death|0|||
46656724|NCT03460756|82868081|FG000|Overall Study|Adverse Event|0|||
46656725|NCT03460756|82868082|FG001|Overall Study|Adverse Event|0|||
46656726|NCT03460756|82868083|FG002|Overall Study|Adverse Event|0|||
46656727|NCT03460756|82868084|FG003|Overall Study|Adverse Event|1|||
46656728|NCT03460756|82868081|FG000|Overall Study|Lack of Efficacy|0|||
46656729|NCT03460756|82868082|FG001|Overall Study|Lack of Efficacy|0|||
46656730|NCT03460756|82868083|FG002|Overall Study|Lack of Efficacy|0|||
46656731|NCT03460756|82868084|FG003|Overall Study|Lack of Efficacy|2|||
46656732|NCT03460756|82868081|FG000|Overall Study|Lost to Follow-up|0|||
46656733|NCT03460756|82868082|FG001|Overall Study|Lost to Follow-up|1|||
46656734|NCT03460756|82868083|FG002|Overall Study|Lost to Follow-up|2|||
46656735|NCT03460756|82868084|FG003|Overall Study|Lost to Follow-up|1|||
46656736|NCT03460756|82868081|FG000|Overall Study|Pregnancy|0|||
46656737|NCT03460756|82868082|FG001|Overall Study|Pregnancy|0|||
46656738|NCT03460756|82868083|FG002|Overall Study|Pregnancy|0|||
46656739|NCT03460756|82868084|FG003|Overall Study|Pregnancy|1|||
46656740|NCT03460756|82868081|FG000|Overall Study|Protocol Violation|0|||
46656741|NCT03460756|82868082|FG001|Overall Study|Protocol Violation|0|||
46656742|NCT03460756|82868083|FG002|Overall Study|Protocol Violation|0|||
46656743|NCT03460756|82868084|FG003|Overall Study|Protocol Violation|1|||
46656744|NCT03460756|82868081|FG000|Overall Study|Withdrawal by Subject|0|||
46656745|NCT03460756|82868082|FG001|Overall Study|Withdrawal by Subject|4|||
46656746|NCT03460756|82868083|FG002|Overall Study|Withdrawal by Subject|7|||
46656747|NCT03460756|82868084|FG003|Overall Study|Withdrawal by Subject|3|||
46656748|NCT03459443|82868096|FG000|Overall Study|Lack of Efficacy|3|||
46656749|NCT03459443|82868096|FG000|Overall Study|Adverse Event|1|||
46656750|NCT03459443|82868096|FG000|Overall Study|Sponsor's decision to close the study|18|||
46656751|NCT03316885|82868109|FG000|Overall Study|Adverse Event|1|||
46656752|NCT03316885|82868109|FG000|Overall Study|Death|10|||
46656753|NCT03316885|82868109|FG000|Overall Study|Lost to Follow-up|4|||
46656754|NCT03316885|82868109|FG000|Overall Study|Withdrawal by Subject|9|||
46656755|NCT03316885|82868109|FG000|Overall Study|COVID related|8|||
46656756|NCT03259074|82868141|FG000|Overall Study|Adverse Event|9|||
46656757|NCT03259074|82868142|FG001|Overall Study|Adverse Event|12|||
46656758|NCT03259074|82868143|FG002|Overall Study|Adverse Event|8|||
46656759|NCT03259074|82868141|FG000|Overall Study|Death|1|||
46656760|NCT03259074|82868142|FG001|Overall Study|Death|1|||
46656761|NCT03259074|82868143|FG002|Overall Study|Death|3|||
46656762|NCT03259074|82868141|FG000|Overall Study|Lost to Follow-up|2|||
46656763|NCT03259074|82868142|FG001|Overall Study|Lost to Follow-up|4|||
46656764|NCT03259074|82868143|FG002|Overall Study|Lost to Follow-up|3|||
46656765|NCT03259074|82868141|FG000|Overall Study|New Therapy For Study Indication|1|||
46656766|NCT03259074|82868142|FG001|Overall Study|New Therapy For Study Indication|2|||
46656767|NCT03259074|82868143|FG002|Overall Study|New Therapy For Study Indication|2|||
46656768|NCT03259074|82868141|FG000|Overall Study|Physician Decision|4|||
46656769|NCT03259074|82868142|FG001|Overall Study|Physician Decision|12|||
46656770|NCT03259074|82868143|FG002|Overall Study|Physician Decision|10|||
46656771|NCT03259074|82868141|FG000|Overall Study|Pregnancy|1|||
46656772|NCT03259074|82868142|FG001|Overall Study|Pregnancy|1|||
46656773|NCT03259074|82868143|FG002|Overall Study|Pregnancy|0|||
46656774|NCT03259074|82868141|FG000|Overall Study|Progressive Disease|1|||
46656775|NCT03259074|82868142|FG001|Overall Study|Progressive Disease|0|||
46656776|NCT03259074|82868143|FG002|Overall Study|Progressive Disease|0|||
46971462|NCT02547441|83214977|FG001|Open-Label Study Period|Lost to Follow-up|8|||
46781952|NCT00622635|83000604|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
46971463|NCT02547441|83214976|FG000|Open-Label Study Period|Physician Decision|1|||
46971464|NCT02547441|83214977|FG001|Open-Label Study Period|Physician Decision|0|||
46971465|NCT02547441|83214976|FG000|Open-Label Study Period|Protocol Violation|2|||
46971466|NCT02547441|83214977|FG001|Open-Label Study Period|Protocol Violation|0|||
46971467|NCT02547441|83214976|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
46971468|NCT02547441|83214977|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
46971469|NCT02547441|83214976|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
46971470|NCT02547441|83214977|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
46971471|NCT02540265|83214987|FG000|Overall Study|Lost to Follow-up|0|||
46971472|NCT02540265|83214988|FG001|Overall Study|Lost to Follow-up|0|||
46971473|NCT02540265|83214989|FG002|Overall Study|Lost to Follow-up|1|||
46971474|NCT02547363|83214999|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
46971475|NCT02547363|83215000|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
46971476|NCT02547363|83214999|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
46971477|NCT02547363|83215000|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
46971478|NCT02547363|83214999|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
46656777|NCT03259074|82868141|FG000|Overall Study|Protocol Deviation|1|||
46656778|NCT03259074|82868142|FG001|Overall Study|Protocol Deviation|1|||
46656779|NCT03259074|82868143|FG002|Overall Study|Protocol Deviation|3|||
46971479|NCT02547363|83215000|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
46971480|NCT02547363|83214999|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
46656780|NCT03259074|82868141|FG000|Overall Study|Subject/Guardian Decision|13|||
46656781|NCT03259074|82868142|FG001|Overall Study|Subject/Guardian Decision|16|||
46656782|NCT03259074|82868143|FG002|Overall Study|Subject/Guardian Decision|14|||
46656783|NCT03159104|82868153|FG000|Overall Study|Violation of inclusion criteria|1|||
46656784|NCT03159104|82868154|FG001|Overall Study|Violation of inclusion criteria|2|||
46656785|NCT03149237|82868162|FG000|Overall Study|Withdrawal by Subject|4|||
46656786|NCT03149237|82868163|FG001|Overall Study|Withdrawal by Subject|5|||
46656787|NCT03132467|82868169|FG000|Overall Study|Adverse Event|2|||
46656788|NCT03132467|82868169|FG000|Overall Study|Withdrawal by Subject|2|||
46656789|NCT03127852|82868176|FG000|Overall Study|Withdrawal by Subject|4|||
46656790|NCT03127852|82868177|FG001|Overall Study|Withdrawal by Subject|1|||
46656791|NCT03127852|82868176|FG000|Overall Study|Death|1|||
46656792|NCT03127852|82868177|FG001|Overall Study|Death|1|||
47075848|NCT03738566|83370384|FG003|Initial Study Phase|Treatment failure|0|||
47075849|NCT03738566|83370381|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
47075850|NCT03738566|83370382|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
47075851|NCT03738566|83370383|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
47075852|NCT03738566|83370384|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
47075853|NCT03533751|83370419|FG000|Overall Study|Withdrawal by Subject|12|||
47075854|NCT03533751|83370420|FG001|Overall Study|Withdrawal by Subject|6|||
47075855|NCT03533751|83370421|FG002|Overall Study|Withdrawal by Subject|11|||
47075856|NCT03533751|83370422|FG003|Overall Study|Withdrawal by Subject|9|||
47075857|NCT03533751|83370423|FG004|Overall Study|Withdrawal by Subject|10|||
47075858|NCT03533751|83370419|FG000|Overall Study|Adverse Event|4|||
47075859|NCT03533751|83370420|FG001|Overall Study|Adverse Event|7|||
47075860|NCT03533751|83370421|FG002|Overall Study|Adverse Event|2|||
47075861|NCT03533751|83370422|FG003|Overall Study|Adverse Event|4|||
47075862|NCT03533751|83370423|FG004|Overall Study|Adverse Event|5|||
47075863|NCT03533751|83370419|FG000|Overall Study|Physician Decision|0|||
47075864|NCT03533751|83370420|FG001|Overall Study|Physician Decision|2|||
47075865|NCT03533751|83370421|FG002|Overall Study|Physician Decision|1|||
47075866|NCT03533751|83370422|FG003|Overall Study|Physician Decision|2|||
47075867|NCT03533751|83370423|FG004|Overall Study|Physician Decision|1|||
47075868|NCT03533751|83370419|FG000|Overall Study|Sponsor Decision|0|||
47075869|NCT03533751|83370420|FG001|Overall Study|Sponsor Decision|0|||
47075870|NCT03533751|83370421|FG002|Overall Study|Sponsor Decision|1|||
47075871|NCT03533751|83370422|FG003|Overall Study|Sponsor Decision|1|||
47075872|NCT03533751|83370423|FG004|Overall Study|Sponsor Decision|0|||
47075873|NCT03533751|83370419|FG000|Overall Study|Lost to Follow-up|3|||
47075874|NCT03533751|83370420|FG001|Overall Study|Lost to Follow-up|7|||
47075875|NCT03533751|83370421|FG002|Overall Study|Lost to Follow-up|6|||
47075876|NCT03533751|83370422|FG003|Overall Study|Lost to Follow-up|4|||
47075877|NCT03533751|83370423|FG004|Overall Study|Lost to Follow-up|3|||
47075878|NCT03533751|83370419|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
47075879|NCT03533751|83370420|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
46656793|NCT03107793|82868183|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
46656794|NCT03107793|82868184|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
46656795|NCT03107793|82868185|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
46781953|NCT00622635|83000599|FG000|Treatment Period 2|Adverse Event|1|||
46781954|NCT00622635|83000600|FG001|Treatment Period 2|Adverse Event|0|||
46781955|NCT00622635|83000601|FG002|Treatment Period 2|Adverse Event|0|||
46781956|NCT00622635|83000602|FG003|Treatment Period 2|Adverse Event|0|||
46781957|NCT00622635|83000603|FG004|Treatment Period 2|Adverse Event|0|||
46781958|NCT00622635|83000604|FG005|Treatment Period 2|Adverse Event|0|||
46781959|NCT00622635|83000599|FG000|Treatment Period 3|Adverse Event|0|||
46850924|NCT03579940|83066735|FG010|Period 2|Withdrawal by Subject|0|||
46850925|NCT00098306|83066770|FG000|Double Blind|Randomized, not treated|9|||
46656796|NCT03107793|82868186|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
46656797|NCT03107793|82868187|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
46656798|NCT03107793|82868183|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
46656799|NCT03107793|82868184|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
46656800|NCT03107793|82868185|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
46656801|NCT03107793|82868186|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
46656802|NCT03107793|82868187|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
46656803|NCT03107793|82868183|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
46656804|NCT03107793|82868184|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
46656805|NCT03107793|82868185|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
46656806|NCT03107793|82868186|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
46656807|NCT03107793|82868187|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
46781960|NCT00622635|83000600|FG001|Treatment Period 3|Adverse Event|0|||
46781961|NCT00622635|83000601|FG002|Treatment Period 3|Adverse Event|0|||
47075880|NCT03533751|83370421|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
47075881|NCT03533751|83370422|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
47075882|NCT03533751|83370423|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
46656808|NCT03107793|82868183|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
46656809|NCT03107793|82868184|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46656810|NCT03107793|82868185|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46656811|NCT03107793|82868186|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46656812|NCT03107793|82868187|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46656813|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
46656814|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
46656815|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
46656816|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
46656817|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
46656818|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
46656819|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
46656820|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
46656821|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
46656822|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
46656823|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
46656824|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
46656825|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
46656826|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
46656827|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
46656828|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
46656829|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
46656830|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
46656831|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
46656832|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
46656833|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
46656834|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
46656835|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
46656836|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
46656837|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
46656838|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
46656839|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
46656840|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
46656841|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
46656842|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
46656843|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
46656844|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
46656845|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
46656846|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
46656847|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
46656848|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
46656849|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
46656850|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
46656851|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
46656852|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
46656853|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
46656854|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
46656855|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
46656856|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
46656857|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
46656858|NCT03107793|82868183|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
46656859|NCT03107793|82868184|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
46656860|NCT03107793|82868185|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
46781962|NCT00622635|83000602|FG003|Treatment Period 3|Adverse Event|2|||
46850926|NCT00098306|83066771|FG001|Double Blind|Randomized, not treated|5|||
46656861|NCT03107793|82868186|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
46656862|NCT03107793|82868187|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
46656863|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
46656864|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
46656865|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
46656866|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
46656867|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
46656868|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
46656869|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
46656870|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
46656871|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
46656872|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
46656873|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
46656874|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
46656875|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
46656876|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
46781963|NCT00622635|83000603|FG004|Treatment Period 3|Adverse Event|0|||
46781964|NCT00622635|83000604|FG005|Treatment Period 3|Adverse Event|0|||
46781965|NCT00622635|83000599|FG000|Treatment Period 3|Withdrawal by Subject|0|||
46781966|NCT00622635|83000600|FG001|Treatment Period 3|Withdrawal by Subject|0|||
46781967|NCT00622635|83000601|FG002|Treatment Period 3|Withdrawal by Subject|0|||
46781968|NCT00622635|83000602|FG003|Treatment Period 3|Withdrawal by Subject|1|||
46781969|NCT00622635|83000603|FG004|Treatment Period 3|Withdrawal by Subject|0|||
46781970|NCT00622635|83000604|FG005|Treatment Period 3|Withdrawal by Subject|0|||
46781971|NCT00391027|83000614|FG000|Overall Study|Adverse Event|8|||
46781972|NCT00391027|83000615|FG001|Overall Study|Adverse Event|8|||
46781973|NCT00391027|83000614|FG000|Overall Study|Lack of Efficacy|3|||
46781974|NCT00391027|83000615|FG001|Overall Study|Lack of Efficacy|0|||
46781975|NCT00391027|83000614|FG000|Overall Study|Withdrawal by Subject|10|||
46781976|NCT00391027|83000615|FG001|Overall Study|Withdrawal by Subject|1|||
46781977|NCT00391027|83000614|FG000|Overall Study|Other|4|||
46781978|NCT00391027|83000615|FG001|Overall Study|Other|3|||
46781979|NCT00622401|83000624|FG000|Overall Study|Disease progression prior to treatment|3|||
46781980|NCT00622401|83000625|FG001|Overall Study|Disease progression prior to treatment|2|||
46781981|NCT00622401|83000626|FG002|Overall Study|Disease progression prior to treatment|0|||
46781982|NCT00621621|83000636|FG000|Overall Study|Subjects were exited at EP study|30|||
46781983|NCT00621621|83000637|FG001|Overall Study|Subjects were exited at EP study|0|||
46781984|NCT00621543|83000645|FG000|Overall Study|Lost to Follow-up|23|||
46781985|NCT00623805|83000651|FG000|Overall Study|Adverse Event|9|||
46781986|NCT00623805|83000652|FG001|Overall Study|Adverse Event|6|||
46781987|NCT00623805|83000651|FG000|Overall Study|Death|2|||
46781988|NCT00623805|83000652|FG001|Overall Study|Death|0|||
46850927|NCT00098306|83066772|FG002|Double Blind|Randomized, not treated|2|||
46850928|NCT00098306|83066773|FG003|Double Blind|Randomized, not treated|0|||
46850929|NCT00098306|83066774|FG004|Double Blind|Randomized, not treated|0|||
46781989|NCT00623805|83000651|FG000|Overall Study|Lack of Efficacy|3|||
46781990|NCT00623805|83000652|FG001|Overall Study|Lack of Efficacy|7|||
46850930|NCT00098306|83066775|FG005|Double Blind|Randomized, not treated|0|||
46850931|NCT00098306|83066776|FG006|Double Blind|Randomized, not treated|0|||
46850932|NCT00098306|83066770|FG000|Double Blind|Ongoing at cut-off date|151|||
46850933|NCT00098306|83066771|FG001|Double Blind|Ongoing at cut-off date|166|||
46850934|NCT00098306|83066772|FG002|Double Blind|Ongoing at cut-off date|72|||
46850935|NCT00098306|83066773|FG003|Double Blind|Ongoing at cut-off date|0|||
46850936|NCT00098306|83066774|FG004|Double Blind|Ongoing at cut-off date|0|||
46850937|NCT00098306|83066775|FG005|Double Blind|Ongoing at cut-off date|0|||
46656877|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
46656878|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Death|0|||
46656879|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Death|0|||
46656880|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Death|0|||
46656881|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Death|0|||
46656882|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Death|1|||
46656883|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
46656884|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
46656885|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
46656886|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
46656887|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
46656888|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
46656889|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
46656890|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
46656891|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
46656892|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
46656893|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
46656894|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
46656895|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
46656896|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
46656897|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
46656898|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
46656899|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
46656900|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
46656901|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
46656902|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
46656903|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
46656904|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
46656905|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
46656906|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
46656907|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
46656908|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Other|0|||
46656909|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Other|0|||
46656910|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Other|0|||
46656911|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Other|1|||
46656912|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Other|3|||
46656913|NCT03107793|82868183|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
46656914|NCT03107793|82868184|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
46656915|NCT03107793|82868185|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
46656916|NCT03107793|82868186|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
46656917|NCT03107793|82868187|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
46656918|NCT03013543|82868206|FG000|Overall Study|Withdrawal by Subject|0|||
46656919|NCT03013543|82868207|FG001|Overall Study|Withdrawal by Subject|2|||
46656920|NCT03013543|82868208|FG002|Overall Study|Withdrawal by Subject|0|||
46656921|NCT03013543|82868209|FG003|Overall Study|Withdrawal by Subject|5|||
46656922|NCT03013543|82868210|FG004|Overall Study|Withdrawal by Subject|6|||
46656923|NCT03013543|82868211|FG005|Overall Study|Withdrawal by Subject|2|||
46656924|NCT03013543|82868212|FG006|Overall Study|Withdrawal by Subject|3|||
46656925|NCT03013543|82868213|FG007|Overall Study|Withdrawal by Subject|1|||
46656926|NCT03013543|82868214|FG008|Overall Study|Withdrawal by Subject|0|||
46656927|NCT03013543|82868215|FG009|Overall Study|Withdrawal by Subject|4|||
46656928|NCT03013543|82868206|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
46656929|NCT03013543|82868207|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
46656930|NCT03013543|82868208|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
46656931|NCT03013543|82868209|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
46656932|NCT03013543|82868210|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
46656933|NCT03013543|82868211|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
46656934|NCT03013543|82868212|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
46656935|NCT03013543|82868213|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
46656936|NCT03013543|82868214|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
46656937|NCT03013543|82868215|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
46656938|NCT03013543|82868206|FG000|Overall Study|Other|0|||
46656939|NCT03013543|82868207|FG001|Overall Study|Other|0|||
46971481|NCT02547363|83215000|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
46971482|NCT02547363|83214999|FG000|12-month Follow-up|Withdrawal by Subject|4|||
46971483|NCT02547363|83215000|FG001|12-month Follow-up|Withdrawal by Subject|3|||
46971484|NCT02547363|83214999|FG000|12-month Follow-up|Lost to Follow-up|4|||
46971485|NCT02547363|83215000|FG001|12-month Follow-up|Lost to Follow-up|1|||
46971486|NCT02547363|83214999|FG000|12-month Follow-up|Lack of Efficacy|1|||
46971487|NCT02547363|83215000|FG001|12-month Follow-up|Lack of Efficacy|1|||
46971488|NCT02547363|83214999|FG000|12-month Follow-up|Other|1|||
46971489|NCT02547363|83215000|FG001|12-month Follow-up|Other|0|||
46971490|NCT02539797|83215008|FG000|Overall Study|Lost to Follow-up|0|||
46971491|NCT02539797|83215009|FG001|Overall Study|Lost to Follow-up|1|||
46971492|NCT02539797|83215010|FG002|Overall Study|Lost to Follow-up|0|||
46971493|NCT02684357|83215021|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
46971494|NCT02684357|83215022|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
46971495|NCT02684357|83215023|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
46971496|NCT02684357|83215024|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
46971497|NCT02684357|83215025|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
47075883|NCT03533751|83370419|FG000|Overall Study|Other|0|||
47075884|NCT03533751|83370420|FG001|Overall Study|Other|2|||
47075885|NCT03533751|83370421|FG002|Overall Study|Other|1|||
47075886|NCT03533751|83370422|FG003|Overall Study|Other|0|||
47075887|NCT03533751|83370423|FG004|Overall Study|Other|3|||
47075888|NCT04856917|83370442|FG000|Overall Study|Withdrawal by Subject|4|||
47075889|NCT04856917|83370443|FG001|Overall Study|Withdrawal by Subject|3|||
47075890|NCT04856917|83370444|FG002|Overall Study|Withdrawal by Subject|1|||
47075891|NCT04856917|83370442|FG000|Overall Study|Lost to Follow-up|3|||
47075892|NCT04856917|83370443|FG001|Overall Study|Lost to Follow-up|1|||
47075893|NCT04856917|83370444|FG002|Overall Study|Lost to Follow-up|1|||
47075894|NCT04856917|83370442|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
47075895|NCT04856917|83370443|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
47075896|NCT04856917|83370444|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
47075897|NCT04856917|83370442|FG000|Overall Study|Other|1|||
47075898|NCT04856917|83370443|FG001|Overall Study|Other|1|||
47075899|NCT04856917|83370444|FG002|Overall Study|Other|0|||
47075900|NCT04615247|83370482|FG000|Overall Study|Adverse Event|0|||
47075901|NCT04615247|83370483|FG001|Overall Study|Adverse Event|2|||
47075902|NCT04615247|83370482|FG000|Overall Study|Withdrawal by Subject|1|||
47075903|NCT04615247|83370483|FG001|Overall Study|Withdrawal by Subject|1|||
47075904|NCT04552132|83370504|FG000|Overall Study|Lost to Follow-up|4|||
47075905|NCT04552132|83370505|FG001|Overall Study|Lost to Follow-up|3|||
47075906|NCT04552132|83370504|FG000|Overall Study|Protocol Violation|1|||
47075907|NCT04552132|83370505|FG001|Overall Study|Protocol Violation|0|||
47075908|NCT04421456|83370514|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
47075909|NCT04421456|83370515|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
47075910|NCT04421456|83370516|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
47075911|NCT04421456|83370514|FG000|Randomized Treatment Period|Adverse Event|0|||
47075912|NCT04421456|83370515|FG001|Randomized Treatment Period|Adverse Event|1|||
47075913|NCT04421456|83370516|FG002|Randomized Treatment Period|Adverse Event|0|||
47075914|NCT04421456|83370514|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
47075915|NCT04421456|83370515|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
47075916|NCT04421456|83370516|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
47075917|NCT04421456|83370514|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
47075918|NCT04421456|83370515|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
47075919|NCT04421456|83370516|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
46971498|NCT02684357|83215026|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
46971499|NCT02684357|83215021|FG000|Part A|Lost to Follow-up|0|||
46971500|NCT02684357|83215022|FG001|Part A|Lost to Follow-up|2|||
46971501|NCT02684357|83215023|FG002|Part A|Lost to Follow-up|2|||
46971502|NCT02684357|83215024|FG003|Part A|Lost to Follow-up|0|||
46971503|NCT02684357|83215025|FG004|Part A|Lost to Follow-up|0|||
46971504|NCT02684357|83215026|FG005|Part A|Lost to Follow-up|0|||
46971505|NCT02684357|83215021|FG000|Part A|Withdrawal by Subject|3|||
46971506|NCT02684357|83215022|FG001|Part A|Withdrawal by Subject|0|||
46971507|NCT02684357|83215023|FG002|Part A|Withdrawal by Subject|0|||
46971508|NCT02684357|83215024|FG003|Part A|Withdrawal by Subject|0|||
46971509|NCT02684357|83215025|FG004|Part A|Withdrawal by Subject|0|||
46971510|NCT02684357|83215026|FG005|Part A|Withdrawal by Subject|0|||
46971511|NCT02684357|83215021|FG000|Part A|Other|0|||
46971512|NCT02684357|83215022|FG001|Part A|Other|1|||
46971513|NCT02684357|83215023|FG002|Part A|Other|0|||
47075920|NCT04421456|83370514|FG000|Randomized Treatment Period|Participant non-compliance|1|||
47075921|NCT04421456|83370515|FG001|Randomized Treatment Period|Participant non-compliance|1|||
47075922|NCT04421456|83370516|FG002|Randomized Treatment Period|Participant non-compliance|2|||
46971514|NCT02684357|83215024|FG003|Part A|Other|0|||
46971515|NCT02684357|83215025|FG004|Part A|Other|0|||
46971516|NCT02684357|83215026|FG005|Part A|Other|0|||
46971517|NCT02684357|83215021|FG000|Part B|Adverse Event (Other)|0|||
47075923|NCT04421456|83370514|FG000|Randomized Treatment Period|Other|0|||
46971518|NCT02684357|83215022|FG001|Part B|Adverse Event (Other)|0|||
46971519|NCT02684357|83215023|FG002|Part B|Adverse Event (Other)|0|||
46971520|NCT02684357|83215024|FG003|Part B|Adverse Event (Other)|1|||
47075924|NCT04421456|83370515|FG001|Randomized Treatment Period|Other|1|||
47075925|NCT04421456|83370516|FG002|Randomized Treatment Period|Other|3|||
47075926|NCT04341363|83370525|FG000|Overall Study|Adverse Event|1|||
47075927|NCT04341363|83370525|FG000|Overall Study|Withdrawal by Subject|1|||
47075928|NCT04268303|83370536|FG000|Overall Study|Lost to Follow-up|1|||
47075929|NCT04268303|83370537|FG001|Overall Study|Lost to Follow-up|1|||
47075930|NCT04268303|83370538|FG002|Overall Study|Lost to Follow-up|2|||
47075931|NCT04268303|83370536|FG000|Overall Study|Withdrawal by Subject|0|||
47075932|NCT04268303|83370537|FG001|Overall Study|Withdrawal by Subject|1|||
47075933|NCT04268303|83370538|FG002|Overall Study|Withdrawal by Subject|1|||
47075934|NCT04268303|83370536|FG000|Overall Study|Adverse Event|2|||
47075935|NCT04268303|83370537|FG001|Overall Study|Adverse Event|0|||
47075936|NCT04268303|83370538|FG002|Overall Study|Adverse Event|0|||
47075937|NCT04092452|83370582|FG000|Overall Study|Adverse Event|1|||
47075938|NCT04092452|83370583|FG001|Overall Study|Adverse Event|3|||
47075939|NCT04092452|83370584|FG002|Overall Study|Adverse Event|3|||
47075940|NCT04092452|83370585|FG003|Overall Study|Adverse Event|7|||
47075941|NCT04092452|83370582|FG000|Overall Study|Lack of Efficacy|1|||
47075942|NCT04092452|83370583|FG001|Overall Study|Lack of Efficacy|1|||
47075943|NCT04092452|83370584|FG002|Overall Study|Lack of Efficacy|1|||
47075944|NCT04092452|83370585|FG003|Overall Study|Lack of Efficacy|0|||
47075945|NCT04092452|83370582|FG000|Overall Study|Lost to Follow-up|4|||
47075946|NCT04092452|83370583|FG001|Overall Study|Lost to Follow-up|3|||
47075947|NCT04092452|83370584|FG002|Overall Study|Lost to Follow-up|5|||
46656940|NCT03013543|82868208|FG002|Overall Study|Other|2|||
46656941|NCT03013543|82868209|FG003|Overall Study|Other|0|||
46656942|NCT03013543|82868210|FG004|Overall Study|Other|2|||
46656943|NCT03013543|82868211|FG005|Overall Study|Other|0|||
46781991|NCT00623805|83000651|FG000|Overall Study|Lost to Follow-up|2|||
46971521|NCT02684357|83215025|FG004|Part B|Adverse Event (Other)|1|||
46971522|NCT02684357|83215026|FG005|Part B|Adverse Event (Other)|1|||
46971523|NCT02684357|83215021|FG000|Part B|Lost to Follow-up|0|||
46971524|NCT02684357|83215022|FG001|Part B|Lost to Follow-up|0|||
47075948|NCT04092452|83370585|FG003|Overall Study|Lost to Follow-up|1|||
47075949|NCT04092452|83370582|FG000|Overall Study|Non-Compliance With Study Drug|0|||
47075950|NCT04092452|83370583|FG001|Overall Study|Non-Compliance With Study Drug|0|||
47075951|NCT04092452|83370584|FG002|Overall Study|Non-Compliance With Study Drug|1|||
47075952|NCT04092452|83370585|FG003|Overall Study|Non-Compliance With Study Drug|1|||
47075953|NCT04092452|83370582|FG000|Overall Study|Physician Decision|1|||
47075954|NCT04092452|83370583|FG001|Overall Study|Physician Decision|0|||
47075955|NCT04092452|83370584|FG002|Overall Study|Physician Decision|1|||
46656944|NCT03013543|82868212|FG006|Overall Study|Other|0|||
46656945|NCT03013543|82868213|FG007|Overall Study|Other|0|||
46971525|NCT02684357|83215023|FG002|Part B|Lost to Follow-up|0|||
46656946|NCT03013543|82868214|FG008|Overall Study|Other|1|||
46656947|NCT03013543|82868215|FG009|Overall Study|Other|0|||
46656948|NCT03013543|82868206|FG000|Overall Study|Adverse Event|0|||
46656949|NCT03013543|82868207|FG001|Overall Study|Adverse Event|0|||
46656950|NCT03013543|82868208|FG002|Overall Study|Adverse Event|0|||
46656951|NCT03013543|82868209|FG003|Overall Study|Adverse Event|3|||
46656952|NCT03013543|82868210|FG004|Overall Study|Adverse Event|2|||
46656953|NCT03013543|82868211|FG005|Overall Study|Adverse Event|1|||
46656954|NCT03013543|82868212|FG006|Overall Study|Adverse Event|3|||
46656955|NCT03013543|82868213|FG007|Overall Study|Adverse Event|8|||
46656956|NCT03013543|82868214|FG008|Overall Study|Adverse Event|0|||
46656957|NCT03013543|82868215|FG009|Overall Study|Adverse Event|2|||
46656958|NCT03013543|82868206|FG000|Overall Study|Death|0|||
46656959|NCT03013543|82868207|FG001|Overall Study|Death|0|||
46656960|NCT03013543|82868208|FG002|Overall Study|Death|0|||
46656961|NCT03013543|82868209|FG003|Overall Study|Death|1|||
46656962|NCT03013543|82868210|FG004|Overall Study|Death|0|||
46850938|NCT00098306|83066776|FG006|Double Blind|Ongoing at cut-off date|0|||
46850939|NCT00098306|83066770|FG000|Double Blind|Adverse Event|11|||
46850940|NCT00098306|83066771|FG001|Double Blind|Adverse Event|10|||
46850941|NCT00098306|83066772|FG002|Double Blind|Adverse Event|6|||
46656963|NCT03013543|82868211|FG005|Overall Study|Death|0|||
46656964|NCT03013543|82868212|FG006|Overall Study|Death|0|||
46656965|NCT03013543|82868213|FG007|Overall Study|Death|0|||
46656966|NCT03013543|82868214|FG008|Overall Study|Death|0|||
46656967|NCT03013543|82868215|FG009|Overall Study|Death|0|||
46656968|NCT03013543|82868206|FG000|Overall Study|Lack of Efficacy|0|||
46656969|NCT03013543|82868207|FG001|Overall Study|Lack of Efficacy|0|||
46656970|NCT03013543|82868208|FG002|Overall Study|Lack of Efficacy|0|||
46656971|NCT03013543|82868209|FG003|Overall Study|Lack of Efficacy|1|||
46656972|NCT03013543|82868210|FG004|Overall Study|Lack of Efficacy|0|||
46656973|NCT03013543|82868211|FG005|Overall Study|Lack of Efficacy|0|||
46656974|NCT03013543|82868212|FG006|Overall Study|Lack of Efficacy|0|||
46656975|NCT03013543|82868213|FG007|Overall Study|Lack of Efficacy|0|||
46656976|NCT03013543|82868214|FG008|Overall Study|Lack of Efficacy|0|||
46656977|NCT03013543|82868215|FG009|Overall Study|Lack of Efficacy|0|||
46656978|NCT03013543|82868206|FG000|Overall Study|Lost to Follow-up|0|||
46656979|NCT03013543|82868207|FG001|Overall Study|Lost to Follow-up|0|||
46656980|NCT03013543|82868208|FG002|Overall Study|Lost to Follow-up|0|||
46656981|NCT03013543|82868209|FG003|Overall Study|Lost to Follow-up|1|||
46656982|NCT03013543|82868210|FG004|Overall Study|Lost to Follow-up|0|||
46656983|NCT03013543|82868211|FG005|Overall Study|Lost to Follow-up|0|||
46656984|NCT03013543|82868212|FG006|Overall Study|Lost to Follow-up|1|||
46656985|NCT03013543|82868213|FG007|Overall Study|Lost to Follow-up|0|||
46850942|NCT00098306|83066773|FG003|Double Blind|Adverse Event|0|||
46850943|NCT00098306|83066774|FG004|Double Blind|Adverse Event|0|||
46850944|NCT00098306|83066775|FG005|Double Blind|Adverse Event|0|||
46656986|NCT03013543|82868214|FG008|Overall Study|Lost to Follow-up|0|||
46656987|NCT03013543|82868215|FG009|Overall Study|Lost to Follow-up|2|||
46656988|NCT03013543|82868206|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46656989|NCT03013543|82868207|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46656990|NCT03013543|82868208|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46656991|NCT03013543|82868209|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46656992|NCT03013543|82868210|FG004|Overall Study|Non-Compliance With Study Drug|0|||
46656993|NCT03013543|82868211|FG005|Overall Study|Non-Compliance With Study Drug|0|||
46656994|NCT03013543|82868212|FG006|Overall Study|Non-Compliance With Study Drug|0|||
46656995|NCT03013543|82868213|FG007|Overall Study|Non-Compliance With Study Drug|0|||
46656996|NCT03013543|82868214|FG008|Overall Study|Non-Compliance With Study Drug|1|||
46656997|NCT03013543|82868215|FG009|Overall Study|Non-Compliance With Study Drug|0|||
46656998|NCT03013543|82868206|FG000|Overall Study|Physician Decision|0|||
46656999|NCT03013543|82868207|FG001|Overall Study|Physician Decision|0|||
46657000|NCT03013543|82868208|FG002|Overall Study|Physician Decision|0|||
46657001|NCT03013543|82868209|FG003|Overall Study|Physician Decision|0|||
46657002|NCT03013543|82868210|FG004|Overall Study|Physician Decision|1|||
46657003|NCT03013543|82868211|FG005|Overall Study|Physician Decision|0|||
46657004|NCT03013543|82868212|FG006|Overall Study|Physician Decision|0|||
46971526|NCT02684357|83215024|FG003|Part B|Lost to Follow-up|1|||
46657005|NCT03013543|82868213|FG007|Overall Study|Physician Decision|0|||
46657006|NCT03013543|82868214|FG008|Overall Study|Physician Decision|0|||
46657007|NCT03013543|82868215|FG009|Overall Study|Physician Decision|0|||
46657008|NCT03013543|82868206|FG000|Overall Study|Protocol Violation|0|||
46971527|NCT02684357|83215025|FG004|Part B|Lost to Follow-up|1|||
46657009|NCT03013543|82868207|FG001|Overall Study|Protocol Violation|0|||
46657010|NCT03013543|82868208|FG002|Overall Study|Protocol Violation|0|||
46657011|NCT03013543|82868209|FG003|Overall Study|Protocol Violation|0|||
46657012|NCT03013543|82868210|FG004|Overall Study|Protocol Violation|0|||
46850945|NCT00098306|83066776|FG006|Double Blind|Adverse Event|0|||
46657013|NCT03013543|82868211|FG005|Overall Study|Protocol Violation|0|||
46850946|NCT00098306|83066770|FG000|Double Blind|Lack of Efficacy|43|||
46850947|NCT00098306|83066771|FG001|Double Blind|Lack of Efficacy|34|||
46971528|NCT02684357|83215026|FG005|Part B|Lost to Follow-up|7|||
46781992|NCT00623805|83000652|FG001|Overall Study|Lost to Follow-up|2|||
46971529|NCT02684357|83215021|FG000|Part B|Withdrawal by Subject|0|||
46971530|NCT02684357|83215022|FG001|Part B|Withdrawal by Subject|0|||
46971531|NCT02684357|83215023|FG002|Part B|Withdrawal by Subject|0|||
46971532|NCT02684357|83215024|FG003|Part B|Withdrawal by Subject|0|||
46971533|NCT02684357|83215025|FG004|Part B|Withdrawal by Subject|2|||
46781993|NCT00623805|83000651|FG000|Overall Study|Protocol Violation|1|||
46781994|NCT00623805|83000652|FG001|Overall Study|Protocol Violation|1|||
46781995|NCT00623805|83000651|FG000|Overall Study|Reason not Specified|3|||
46781996|NCT00623805|83000652|FG001|Overall Study|Reason not Specified|6|||
46781997|NCT00621309|83000658|FG000|Overall Study|Withdrawal by Subject|2|||
46781998|NCT00621309|83000659|FG001|Overall Study|Withdrawal by Subject|0|||
46781999|NCT00621309|83000660|FG002|Overall Study|Withdrawal by Subject|1|||
46782000|NCT00621309|83000661|FG003|Overall Study|Withdrawal by Subject|1|||
46782001|NCT00621309|83000662|FG004|Overall Study|Withdrawal by Subject|1|||
46971534|NCT02684357|83215026|FG005|Part B|Withdrawal by Subject|4|||
47075956|NCT04092452|83370585|FG003|Overall Study|Physician Decision|0|||
47075957|NCT04092452|83370582|FG000|Overall Study|Pregnancy|2|||
47075958|NCT04092452|83370583|FG001|Overall Study|Pregnancy|0|||
47075959|NCT04092452|83370584|FG002|Overall Study|Pregnancy|0|||
47075960|NCT04092452|83370585|FG003|Overall Study|Pregnancy|0|||
47075961|NCT04092452|83370582|FG000|Overall Study|Protocol Deviation|1|||
47075962|NCT04092452|83370583|FG001|Overall Study|Protocol Deviation|0|||
47075963|NCT04092452|83370584|FG002|Overall Study|Protocol Deviation|0|||
47075964|NCT04092452|83370585|FG003|Overall Study|Protocol Deviation|0|||
47075965|NCT04092452|83370582|FG000|Overall Study|Withdrawal by Subject|3|||
47075966|NCT04092452|83370583|FG001|Overall Study|Withdrawal by Subject|10|||
47075967|NCT04092452|83370584|FG002|Overall Study|Withdrawal by Subject|3|||
47075968|NCT04092452|83370585|FG003|Overall Study|Withdrawal by Subject|5|||
47075969|NCT04092452|83370582|FG000|Overall Study|Other|0|||
47075970|NCT04092452|83370583|FG001|Overall Study|Other|0|||
47075971|NCT04092452|83370584|FG002|Overall Study|Other|1|||
47075972|NCT04092452|83370585|FG003|Overall Study|Other|2|||
47075973|NCT04029116|83370600|FG000|Overall Study|Adverse Event|0|||
47075974|NCT04029116|83370601|FG001|Overall Study|Adverse Event|2|||
47075975|NCT04029116|83370600|FG000|Overall Study|Lost to Follow-up|3|||
47075976|NCT04029116|83370601|FG001|Overall Study|Lost to Follow-up|5|||
47075977|NCT04029116|83370600|FG000|Overall Study|Physician Decision|2|||
47075978|NCT04029116|83370601|FG001|Overall Study|Physician Decision|0|||
47075979|NCT04029116|83370600|FG000|Overall Study|Pregnancy|1|||
47075980|NCT04029116|83370601|FG001|Overall Study|Pregnancy|2|||
47075981|NCT04029116|83370600|FG000|Overall Study|Withdrawal by Subject|4|||
47075982|NCT04029116|83370601|FG001|Overall Study|Withdrawal by Subject|6|||
47075983|NCT04029116|83370600|FG000|Overall Study|Other|2|||
47075984|NCT04029116|83370601|FG001|Overall Study|Other|1|||
47075985|NCT03734029|83370632|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
46971535|NCT02684357|83215021|FG000|Part B|Other|0|||
47075986|NCT03734029|83370633|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
47075987|NCT03734029|83370632|FG000|Overall Study|Adverse Event|60|||
47075988|NCT03734029|83370633|FG001|Overall Study|Adverse Event|14|||
47075989|NCT03734029|83370632|FG000|Overall Study|Withdrawal by Subject|12|||
46657014|NCT03013543|82868212|FG006|Overall Study|Protocol Violation|0|||
46657015|NCT03013543|82868213|FG007|Overall Study|Protocol Violation|0|||
46657016|NCT03013543|82868214|FG008|Overall Study|Protocol Violation|0|||
46657017|NCT03013543|82868215|FG009|Overall Study|Protocol Violation|1|||
46657018|NCT02811549|82868241|FG000|Overall Study|Lost to Follow-up|1|||
46657019|NCT02811549|82868241|FG000|Overall Study|Withdrawal by Subject|3|||
46971536|NCT02684357|83215022|FG001|Part B|Other|0|||
46971537|NCT02684357|83215023|FG002|Part B|Other|0|||
46657020|NCT02811549|82868241|FG000|Overall Study|Subject screen failed|4|||
46657021|NCT02811549|82868241|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
46657022|NCT02426125|82868269|FG000|Overall Study|Lost to Follow-up|14|||
46657023|NCT02426125|82868270|FG001|Overall Study|Lost to Follow-up|12|||
46657024|NCT02426125|82868269|FG000|Overall Study|Withdrawal by Subject|13|||
46657025|NCT02426125|82868270|FG001|Overall Study|Withdrawal by Subject|14|||
46657026|NCT02426125|82868269|FG000|Overall Study|Death|185|||
46657027|NCT02426125|82868270|FG001|Overall Study|Death|200|||
46657028|NCT02426125|82868269|FG000|Overall Study|Randomized, But Never Treated|5|||
46657029|NCT02426125|82868270|FG001|Overall Study|Randomized, But Never Treated|2|||
46657030|NCT02331277|82868289|FG000|Overall Study|Withdrawal by Subject|1|||
46657031|NCT02331277|82868290|FG001|Overall Study|Withdrawal by Subject|0|||
46657032|NCT02120365|82868308|FG000|Overall Study|Withdrawal by Subject|0|||
46657033|NCT02120365|82868309|FG001|Overall Study|Withdrawal by Subject|0|||
46657034|NCT02120365|82868310|FG002|Overall Study|Withdrawal by Subject|2|||
46657035|NCT02120365|82868311|FG003|Overall Study|Withdrawal by Subject|4|||
46657036|NCT02120365|82868312|FG004|Overall Study|Withdrawal by Subject|0|||
46657037|NCT02120365|82868313|FG005|Overall Study|Withdrawal by Subject|2|||
46657038|NCT00938340|82868385|FG000|Overall Study|Withdrawal by Subject|3|||
46971538|NCT02684357|83215024|FG003|Part B|Other|1|||
46971539|NCT02684357|83215025|FG004|Part B|Other|0|||
46971540|NCT02684357|83215026|FG005|Part B|Other|1|||
46971541|NCT02684279|83215039|FG000|Overall Study|Adverse Event|87|||
46971542|NCT02684279|83215039|FG000|Overall Study|Lack of Efficacy|4|||
46971543|NCT02684279|83215039|FG000|Overall Study|Lost to Follow-up|61|||
46971544|NCT02684279|83215039|FG000|Overall Study|Protocol Violation|6|||
46971545|NCT02684279|83215039|FG000|Overall Study|Pregnancy|8|||
46971546|NCT02684279|83215039|FG000|Overall Study|Withdrawal by Subject|92|||
46971547|NCT02684279|83215039|FG000|Overall Study|non-compliance with study drug|9|||
46971548|NCT02684279|83215039|FG000|Overall Study|non compliance with study visits|2|||
46971549|NCT02684279|83215039|FG000|Overall Study|subject to have surgery|1|||
46971550|NCT02684279|83215039|FG000|Overall Study|family emergency|1|||
46971551|NCT02684279|83215039|FG000|Overall Study|Site closures|7|||
46971552|NCT02684279|83215039|FG000|Overall Study|Physician Decision|1|||
46971553|NCT02534493|83215043|FG000|Overall Study|Lost to Follow-up|1|||
46971554|NCT02534493|83215043|FG000|Overall Study|Withdrawal by Subject|1|||
46971555|NCT02547129|83215051|FG000|Overall Study|Difficulty with ongoing infection|1|||
46971556|NCT02547129|83215052|FG001|Overall Study|Difficulty with ongoing infection|0|||
46971557|NCT02546193|83215060|FG000|Overall Study|Withdrawal by Subject|2|||
46971558|NCT02546193|83215061|FG001|Overall Study|Withdrawal by Subject|0|||
46971559|NCT02546193|83215062|FG002|Overall Study|Withdrawal by Subject|1|||
46971560|NCT02546193|83215063|FG003|Overall Study|Withdrawal by Subject|0|||
46971561|NCT02546193|83215060|FG000|Overall Study|Not eligible at time of induction|4|||
46971562|NCT02546193|83215061|FG001|Overall Study|Not eligible at time of induction|6|||
46971563|NCT02546193|83215062|FG002|Overall Study|Not eligible at time of induction|1|||
46971564|NCT02546193|83215063|FG003|Overall Study|Not eligible at time of induction|0|||
46971565|NCT02538471|83215069|FG000|Overall Study|Progression of disease|2|||
46971566|NCT01661595|83215077|FG000|Phase 1: Week 0-4|Adverse Event|1|||
46971567|NCT01661595|83215078|FG001|Phase 1: Week 0-4|Adverse Event|0|||
47075990|NCT03734029|83370633|FG001|Overall Study|Withdrawal by Subject|11|||
47075991|NCT03734029|83370632|FG000|Overall Study|Clinical progression by investigator|10|||
46657039|NCT00938340|82868385|FG000|Overall Study|Protocol Violation|1|||
46657040|NCT00938340|82868385|FG000|Overall Study|Adverse Event|1|||
46657041|NCT00539643|82868442|FG000|Overall Study|Adverse Event|1|||
46657042|NCT00539643|82868443|FG001|Overall Study|Adverse Event|0|||
46657043|NCT00539643|82868442|FG000|Overall Study|Death|2|||
46657044|NCT00539643|82868443|FG001|Overall Study|Death|1|||
46657045|NCT00539643|82868442|FG000|Overall Study|Physician Decision|3|||
46657046|NCT00539643|82868443|FG001|Overall Study|Physician Decision|1|||
46657047|NCT00539643|82868442|FG000|Overall Study|Withdrawal by Subject|0|||
46971568|NCT01661595|83215079|FG002|Phase 1: Week 0-4|Adverse Event|0|||
46971569|NCT01661595|83215080|FG003|Phase 1: Week 0-4|Adverse Event|0|||
46971570|NCT01661595|83215077|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
46971571|NCT01661595|83215078|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
46971572|NCT01661595|83215079|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
46657048|NCT00539643|82868443|FG001|Overall Study|Withdrawal by Subject|1|||
46657049|NCT00039130|82868458|FG000|Overall Study|Adverse Event|11|||
46971573|NCT01661595|83215080|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
46971574|NCT02213133|83215100|FG000|Overall Study|Participant discontinued study therapy|2|||
47075992|NCT03734029|83370633|FG001|Overall Study|Clinical progression by investigator|8|||
46657050|NCT00039130|82868458|FG000|Overall Study|Death|9|||
46657051|NCT00039130|82868458|FG000|Overall Study|Withdrawal by Subject|3|||
46657052|NCT00039130|82868458|FG000|Overall Study|Progression|2|||
46657053|NCT00039130|82868458|FG000|Overall Study|Subsequent treatment|2|||
46657054|NCT00039130|82868458|FG000|Overall Study|Physician Decision|3|||
46657055|NCT00005957|82868464|FG000|Overall Study|No treated|3|||
46657056|NCT00005957|82868465|FG001|Overall Study|No treated|9|||
46657057|NCT00005957|82868464|FG000|Overall Study|Crossover to the other arm|5|||
46657058|NCT00005957|82868465|FG001|Overall Study|Crossover to the other arm|19|||
46657059|NCT04920916|82868545|FG000|Phase IIa 60 Day Study|Death|2|||
46657060|NCT04920916|82868546|FG001|Phase IIa 60 Day Study|Death|5|||
46657061|NCT04920916|82868545|FG000|1 Year Follow up (Phone Call)|Death|1|||
46657062|NCT04920916|82868546|FG001|1 Year Follow up (Phone Call)|Death|3|||
46657063|NCT04920916|82868545|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
46782002|NCT00621309|83000663|FG005|Overall Study|Withdrawal by Subject|1|||
46782003|NCT00567190|83000671|FG000|Overall Study|Death|235|||
46782004|NCT00567190|83000672|FG001|Overall Study|Death|280|||
46782005|NCT00567190|83000671|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
46782006|NCT00567190|83000672|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
46782007|NCT00691938|83000690|FG000|Overall Study|QTc prolongation|1|||
47075993|NCT03734029|83370632|FG000|Overall Study|Death|5|||
47075994|NCT03734029|83370633|FG001|Overall Study|Death|2|||
47075995|NCT03734029|83370632|FG000|Overall Study|Physician Decision|4|||
47075996|NCT03734029|83370633|FG001|Overall Study|Physician Decision|3|||
47075997|NCT03734029|83370632|FG000|Overall Study|Other|2|||
47075998|NCT03734029|83370633|FG001|Overall Study|Other|0|||
47075999|NCT03734029|83370632|FG000|Overall Study|Lost to Follow-up|0|||
47076000|NCT03734029|83370633|FG001|Overall Study|Lost to Follow-up|1|||
46657064|NCT04920916|82868546|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
46657065|NCT04419493|82868559|FG000|Wash-out After Period 1|Adverse Event|1|||
46657066|NCT04419493|82868560|FG001|Wash-out After Period 1|Adverse Event|2|||
46657067|NCT04419493|82868561|FG002|Wash-out After Period 1|Adverse Event|1|||
46657068|NCT04419493|82868562|FG003|Wash-out After Period 1|Adverse Event|0|||
46657069|NCT04147611|82868590|FG000|Overall Study|Physician Decision|0|||
46657070|NCT04147611|82868591|FG001|Overall Study|Physician Decision|1|||
46657071|NCT03603964|82868622|FG000|Overall Study|Death|9|||
46657072|NCT03603964|82868622|FG000|Overall Study|Withdrawal by participant|7|||
46657073|NCT03603964|82868622|FG000|Overall Study|Study terminated by Sponsor|19|||
46657074|NCT03363919|82868639|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
46657075|NCT03363919|82868640|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
46657076|NCT03363919|82868639|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
46657077|NCT03363919|82868640|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
46657078|NCT03191864|82868651|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
46657079|NCT03191864|82868652|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
46657080|NCT03191864|82868653|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
46782008|NCT00691938|83000691|FG001|Overall Study|QTc prolongation|0|||
46782009|NCT00691938|83000692|FG002|Overall Study|QTc prolongation|0|||
46782010|NCT00691938|83000693|FG003|Overall Study|QTc prolongation|0|||
46782011|NCT00691938|83000694|FG004|Overall Study|QTc prolongation|0|||
46657081|NCT03191864|82868654|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
46657082|NCT03191864|82868655|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
46657083|NCT03191864|82868656|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
46657084|NCT03191864|82868651|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
46657085|NCT03191864|82868652|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
46782012|NCT00691938|83000695|FG005|Overall Study|QTc prolongation|0|||
46782013|NCT00691938|83000696|FG006|Overall Study|QTc prolongation|0|||
46850948|NCT00098306|83066772|FG002|Double Blind|Lack of Efficacy|17|||
46850949|NCT00098306|83066773|FG003|Double Blind|Lack of Efficacy|0|||
46850950|NCT00098306|83066774|FG004|Double Blind|Lack of Efficacy|0|||
46850951|NCT00098306|83066775|FG005|Double Blind|Lack of Efficacy|0|||
46850952|NCT00098306|83066776|FG006|Double Blind|Lack of Efficacy|0|||
46850953|NCT00098306|83066770|FG000|Double Blind|Death|1|||
46850954|NCT00098306|83066771|FG001|Double Blind|Death|4|||
46850955|NCT00098306|83066772|FG002|Double Blind|Death|1|||
46850956|NCT00098306|83066773|FG003|Double Blind|Death|0|||
46850957|NCT00098306|83066774|FG004|Double Blind|Death|0|||
46850958|NCT00098306|83066775|FG005|Double Blind|Death|0|||
46850959|NCT00098306|83066776|FG006|Double Blind|Death|0|||
47076001|NCT03734029|83370632|FG000|Overall Study|Randomized, but not treated|2|||
47076002|NCT03734029|83370633|FG001|Overall Study|Randomized, but not treated|12|||
46657086|NCT03191864|82868653|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
46657087|NCT03191864|82868654|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
46657088|NCT03191864|82868655|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
46657089|NCT03191864|82868656|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
46657090|NCT03191864|82868651|FG000|Baseline Symptom Assessment|Adverse Event|0|||
46657091|NCT03191864|82868652|FG001|Baseline Symptom Assessment|Adverse Event|0|||
46657092|NCT03191864|82868653|FG002|Baseline Symptom Assessment|Adverse Event|0|||
46657093|NCT03191864|82868654|FG003|Baseline Symptom Assessment|Adverse Event|0|||
46657094|NCT03191864|82868655|FG004|Baseline Symptom Assessment|Adverse Event|0|||
46657095|NCT03191864|82868656|FG005|Baseline Symptom Assessment|Adverse Event|2|||
46657096|NCT03191864|82868651|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
46657097|NCT03191864|82868652|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
46657098|NCT03191864|82868653|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
46657099|NCT03191864|82868654|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
46657100|NCT03191864|82868655|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
46657101|NCT03191864|82868656|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
46657102|NCT03191864|82868651|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
46657103|NCT03191864|82868652|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
46657104|NCT03191864|82868653|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
47076003|NCT03724032|83370642|FG000|Overall Study|Physician Decision|1|||
47076004|NCT03724032|83370643|FG001|Overall Study|Physician Decision|0|||
47076005|NCT03724032|83370644|FG002|Overall Study|Physician Decision|0|||
47076006|NCT03724032|83370642|FG000|Overall Study|Protocol Violation|2|||
47076007|NCT03724032|83370643|FG001|Overall Study|Protocol Violation|2|||
47076008|NCT03724032|83370644|FG002|Overall Study|Protocol Violation|1|||
47076009|NCT03657797|83370665|FG000|Overall Study|Lost to Follow-up|0|||
47076010|NCT03657797|83370666|FG001|Overall Study|Lost to Follow-up|1|||
47076011|NCT03657797|83370667|FG002|Overall Study|Lost to Follow-up|1|||
47076012|NCT03657797|83370668|FG003|Overall Study|Lost to Follow-up|0|||
47076013|NCT03657797|83370665|FG000|Overall Study|Physician Decision|0|||
47076014|NCT03657797|83370666|FG001|Overall Study|Physician Decision|1|||
47076015|NCT03657797|83370667|FG002|Overall Study|Physician Decision|0|||
47076016|NCT03657797|83370668|FG003|Overall Study|Physician Decision|0|||
47076017|NCT03657797|83370665|FG000|Overall Study|Withdrawal by Subject|0|||
47076018|NCT03657797|83370666|FG001|Overall Study|Withdrawal by Subject|1|||
47076019|NCT03657797|83370667|FG002|Overall Study|Withdrawal by Subject|2|||
46657105|NCT03191864|82868654|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
46657106|NCT03191864|82868655|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
46657107|NCT03191864|82868656|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
46657108|NCT03191864|82868651|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
46657109|NCT03191864|82868652|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
46657110|NCT03191864|82868653|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
46657111|NCT03191864|82868654|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
46657112|NCT03191864|82868655|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
46657113|NCT03191864|82868656|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
46657114|NCT03191864|82868651|FG000|Part 1 - Induction|Adverse Event|0|||
46657115|NCT03191864|82868652|FG001|Part 1 - Induction|Adverse Event|2|||
46657116|NCT03191864|82868653|FG002|Part 1 - Induction|Adverse Event|0|||
46657117|NCT03191864|82868654|FG003|Part 1 - Induction|Adverse Event|1|||
46782014|NCT00365365|83000710|FG000|Overall Study|Randomized but not treated|0|||
46782015|NCT00365365|83000711|FG001|Overall Study|Randomized but not treated|2|||
46782016|NCT00365365|83000712|FG002|Overall Study|Randomized but not treated|0|||
46782017|NCT00365365|83000710|FG000|Overall Study|Poor compliance to protocol|0|||
46657118|NCT03191864|82868655|FG004|Part 1 - Induction|Adverse Event|0|||
46657119|NCT03191864|82868656|FG005|Part 1 - Induction|Adverse Event|2|||
46657120|NCT03191864|82868651|FG000|Part 1 - Induction|Randomized but never dosed|0|||
46782018|NCT00365365|83000711|FG001|Overall Study|Poor compliance to protocol|1|||
46782019|NCT00365365|83000712|FG002|Overall Study|Poor compliance to protocol|0|||
47076020|NCT03657797|83370668|FG003|Overall Study|Withdrawal by Subject|0|||
47076021|NCT03657797|83370665|FG000|Overall Study|Adverse Event|0|||
47076022|NCT03657797|83370666|FG001|Overall Study|Adverse Event|0|||
47076023|NCT03657797|83370667|FG002|Overall Study|Adverse Event|2|||
47076024|NCT03657797|83370668|FG003|Overall Study|Adverse Event|0|||
46850960|NCT00098306|83066770|FG000|Double Blind|Participant defaulted|19|||
47076025|NCT03551938|83370684|FG000|3-Month Follow Up|Lost to Follow-up|39|||
47076026|NCT03551938|83370685|FG001|3-Month Follow Up|Lost to Follow-up|38|||
47076027|NCT03551938|83370684|FG000|6-Month Follow Up|Lost to Follow-up|46|||
47076028|NCT03551938|83370685|FG001|6-Month Follow Up|Lost to Follow-up|42|||
47076029|NCT03551938|83370684|FG000|9-Month Follow Up|Lost to Follow-up|44|||
47076030|NCT03551938|83370685|FG001|9-Month Follow Up|Lost to Follow-up|43|||
46782020|NCT00365365|83000710|FG000|Overall Study|Lost to Follow-up|3|||
46782021|NCT00365365|83000711|FG001|Overall Study|Lost to Follow-up|3|||
46782022|NCT00365365|83000712|FG002|Overall Study|Lost to Follow-up|3|||
46782023|NCT00365365|83000710|FG000|Overall Study|Death|1|||
46782024|NCT00365365|83000711|FG001|Overall Study|Death|3|||
46782025|NCT00365365|83000712|FG002|Overall Study|Death|0|||
46782026|NCT00365365|83000710|FG000|Overall Study|Subject's request|11|||
46782027|NCT00365365|83000711|FG001|Overall Study|Subject's request|13|||
46782028|NCT00365365|83000712|FG002|Overall Study|Subject's request|1|||
46971575|NCT02213133|83215101|FG001|Overall Study|Participant discontinued study therapy|0|||
46971576|NCT02213133|83215102|FG002|Overall Study|Participant discontinued study therapy|0|||
46657121|NCT03191864|82868652|FG001|Part 1 - Induction|Randomized but never dosed|0|||
46657122|NCT03191864|82868653|FG002|Part 1 - Induction|Randomized but never dosed|1|||
46657123|NCT03191864|82868654|FG003|Part 1 - Induction|Randomized but never dosed|0|||
46657124|NCT03191864|82868655|FG004|Part 1 - Induction|Randomized but never dosed|0|||
46657125|NCT03191864|82868656|FG005|Part 1 - Induction|Randomized but never dosed|0|||
46657126|NCT03191864|82868651|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
46657127|NCT03191864|82868652|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
46657128|NCT03191864|82868653|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
46657129|NCT03191864|82868654|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
46657130|NCT03191864|82868655|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
46657131|NCT03191864|82868656|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
46657132|NCT03191864|82868651|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
46657133|NCT03191864|82868652|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
46657134|NCT03191864|82868653|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
46657135|NCT03191864|82868654|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
46657136|NCT03191864|82868655|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
46657137|NCT03191864|82868656|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
46657138|NCT03191864|82868651|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
46657139|NCT03191864|82868652|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
46657140|NCT03191864|82868653|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
46657141|NCT03191864|82868654|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
46657142|NCT03191864|82868655|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
46657143|NCT03191864|82868656|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
46657144|NCT03191864|82868651|FG000|Part 2 - Maintenance|Physician Decision|1|||
46657145|NCT03191864|82868652|FG001|Part 2 - Maintenance|Physician Decision|0|||
46657146|NCT03191864|82868653|FG002|Part 2 - Maintenance|Physician Decision|0|||
46657147|NCT03191864|82868654|FG003|Part 2 - Maintenance|Physician Decision|0|||
46657148|NCT03191864|82868655|FG004|Part 2 - Maintenance|Physician Decision|0|||
46657149|NCT03191864|82868656|FG005|Part 2 - Maintenance|Physician Decision|0|||
46657150|NCT03191864|82868651|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
46657151|NCT03191864|82868652|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
46657152|NCT03191864|82868653|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
46657153|NCT03191864|82868654|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
46657154|NCT03191864|82868655|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
46657155|NCT03191864|82868656|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
46657156|NCT03191864|82868651|FG000|Part 2 - Maintenance|Adverse Event|0|||
46657157|NCT03191864|82868652|FG001|Part 2 - Maintenance|Adverse Event|0|||
46657158|NCT03191864|82868653|FG002|Part 2 - Maintenance|Adverse Event|0|||
46971577|NCT02213133|83215100|FG000|Overall Study|Participant withdrew informed consent|2|||
46971578|NCT02213133|83215101|FG001|Overall Study|Participant withdrew informed consent|1|||
46657159|NCT03191864|82868654|FG003|Part 2 - Maintenance|Adverse Event|0|||
46657160|NCT03191864|82868655|FG004|Part 2 - Maintenance|Adverse Event|1|||
46657161|NCT03191864|82868656|FG005|Part 2 - Maintenance|Adverse Event|0|||
46657162|NCT03191864|82868651|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
46657163|NCT03191864|82868652|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
46657164|NCT03191864|82868653|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
46971579|NCT02213133|83215102|FG002|Overall Study|Participant withdrew informed consent|2|||
46971580|NCT02213133|83215100|FG000|Overall Study|Disease progression|11|||
46782029|NCT00365365|83000710|FG000|Overall Study|Disease progression/relapse|9|||
46971581|NCT02213133|83215101|FG001|Overall Study|Disease progression|2|||
46657165|NCT03191864|82868654|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
46657166|NCT03191864|82868655|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
46657167|NCT03191864|82868656|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
46657168|NCT03191864|82868651|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
46657169|NCT03191864|82868652|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
46657170|NCT03191864|82868653|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
46657171|NCT03191864|82868654|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
46657172|NCT03191864|82868655|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
46657173|NCT03191864|82868656|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
46657174|NCT02636725|82868720|FG000|Baseline|Adverse Event|1|||
46657175|NCT02636725|82868720|FG000|Baseline|Lack of Efficacy|2|||
46657176|NCT02573493|82868728|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
46657177|NCT02573493|82868729|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
46657178|NCT02573493|82868730|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
46657179|NCT02573493|82868731|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
46657180|NCT02327078|82868764|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
46657181|NCT02327078|82868765|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
46657182|NCT02327078|82868766|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
46657183|NCT02327078|82868767|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
46657184|NCT02327078|82868768|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
46657185|NCT02327078|82868769|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
46657186|NCT02327078|82868770|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
46657187|NCT02327078|82868771|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
46657188|NCT02327078|82868772|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
46657189|NCT02327078|82868764|FG000|Overall Study|Death|2|||
46657190|NCT02327078|82868765|FG001|Overall Study|Death|4|||
46657191|NCT02327078|82868766|FG002|Overall Study|Death|10|||
46657192|NCT02327078|82868767|FG003|Overall Study|Death|6|||
46657193|NCT02327078|82868768|FG004|Overall Study|Death|4|||
46657194|NCT02327078|82868769|FG005|Overall Study|Death|3|||
46657195|NCT02327078|82868770|FG006|Overall Study|Death|2|||
46657196|NCT02327078|82868771|FG007|Overall Study|Death|51|||
46657197|NCT02327078|82868772|FG008|Overall Study|Death|97|||
46657198|NCT02327078|82868764|FG000|Overall Study|Lost to Follow-up|0|||
46657199|NCT02327078|82868765|FG001|Overall Study|Lost to Follow-up|1|||
46657200|NCT02327078|82868766|FG002|Overall Study|Lost to Follow-up|1|||
46657201|NCT02327078|82868767|FG003|Overall Study|Lost to Follow-up|0|||
46657202|NCT02327078|82868768|FG004|Overall Study|Lost to Follow-up|0|||
46657203|NCT02327078|82868769|FG005|Overall Study|Lost to Follow-up|0|||
46657204|NCT02327078|82868770|FG006|Overall Study|Lost to Follow-up|0|||
46657205|NCT02327078|82868771|FG007|Overall Study|Lost to Follow-up|2|||
46657206|NCT02327078|82868772|FG008|Overall Study|Lost to Follow-up|5|||
46657207|NCT02327078|82868764|FG000|Overall Study|Site Terminated by Sponsor|1|||
46657208|NCT02327078|82868765|FG001|Overall Study|Site Terminated by Sponsor|0|||
46657209|NCT02327078|82868766|FG002|Overall Study|Site Terminated by Sponsor|1|||
46657210|NCT02327078|82868767|FG003|Overall Study|Site Terminated by Sponsor|4|||
46657211|NCT02327078|82868768|FG004|Overall Study|Site Terminated by Sponsor|0|||
46657212|NCT02327078|82868769|FG005|Overall Study|Site Terminated by Sponsor|0|||
46657213|NCT02327078|82868770|FG006|Overall Study|Site Terminated by Sponsor|0|||
46657214|NCT02327078|82868771|FG007|Overall Study|Site Terminated by Sponsor|11|||
46657215|NCT02327078|82868772|FG008|Overall Study|Site Terminated by Sponsor|25|||
46657216|NCT02327078|82868764|FG000|Overall Study|Physician Decision|0|||
46657217|NCT02327078|82868765|FG001|Overall Study|Physician Decision|0|||
46657218|NCT02327078|82868766|FG002|Overall Study|Physician Decision|0|||
46657219|NCT02327078|82868767|FG003|Overall Study|Physician Decision|1|||
46657220|NCT02327078|82868768|FG004|Overall Study|Physician Decision|0|||
46657221|NCT02327078|82868769|FG005|Overall Study|Physician Decision|0|||
46657222|NCT02327078|82868770|FG006|Overall Study|Physician Decision|0|||
46657223|NCT02327078|82868771|FG007|Overall Study|Physician Decision|0|||
46657224|NCT02327078|82868772|FG008|Overall Study|Physician Decision|1|||
46657225|NCT02327078|82868764|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
46657226|NCT02327078|82868765|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
46657227|NCT02327078|82868766|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
46657228|NCT02327078|82868767|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
46657229|NCT02327078|82868768|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
46657230|NCT02327078|82868769|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
46657231|NCT02327078|82868770|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
46657232|NCT02327078|82868771|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
46657233|NCT02327078|82868772|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
46657234|NCT02327078|82868764|FG000|Overall Study|Reason not Specified|0|||
46657235|NCT02327078|82868765|FG001|Overall Study|Reason not Specified|0|||
46657236|NCT02327078|82868766|FG002|Overall Study|Reason not Specified|0|||
46657237|NCT02327078|82868767|FG003|Overall Study|Reason not Specified|0|||
46657238|NCT02327078|82868768|FG004|Overall Study|Reason not Specified|0|||
46657239|NCT02327078|82868769|FG005|Overall Study|Reason not Specified|0|||
46657240|NCT02327078|82868770|FG006|Overall Study|Reason not Specified|0|||
46657241|NCT02327078|82868771|FG007|Overall Study|Reason not Specified|5|||
46657242|NCT02327078|82868772|FG008|Overall Study|Reason not Specified|12|||
46657243|NCT02304458|82868815|FG000|Overall Study|Adverse Event|0|||
46657244|NCT02304458|82868816|FG001|Overall Study|Adverse Event|0|||
46657245|NCT02304458|82868817|FG002|Overall Study|Adverse Event|7|||
46657246|NCT02304458|82868818|FG003|Overall Study|Adverse Event|0|||
46657247|NCT02304458|82868819|FG004|Overall Study|Adverse Event|0|||
46657248|NCT02304458|82868820|FG005|Overall Study|Adverse Event|0|||
46657249|NCT02304458|82868821|FG006|Overall Study|Adverse Event|3|||
46657250|NCT02304458|82868822|FG007|Overall Study|Adverse Event|4|||
46657251|NCT02304458|82868815|FG000|Overall Study|Death|0|||
46657252|NCT02304458|82868816|FG001|Overall Study|Death|0|||
46657253|NCT02304458|82868817|FG002|Overall Study|Death|2|||
46657254|NCT02304458|82868818|FG003|Overall Study|Death|0|||
46657255|NCT02304458|82868819|FG004|Overall Study|Death|0|||
46657256|NCT02304458|82868820|FG005|Overall Study|Death|0|||
46657257|NCT02304458|82868821|FG006|Overall Study|Death|1|||
46657258|NCT02304458|82868822|FG007|Overall Study|Death|0|||
46657259|NCT02304458|82868815|FG000|Overall Study|Lack of Efficacy|4|||
46657260|NCT02304458|82868816|FG001|Overall Study|Lack of Efficacy|6|||
46657261|NCT02304458|82868817|FG002|Overall Study|Lack of Efficacy|38|||
46657262|NCT02304458|82868818|FG003|Overall Study|Lack of Efficacy|5|||
46657263|NCT02304458|82868819|FG004|Overall Study|Lack of Efficacy|6|||
46657264|NCT02304458|82868820|FG005|Overall Study|Lack of Efficacy|6|||
46657265|NCT02304458|82868821|FG006|Overall Study|Lack of Efficacy|21|||
46657266|NCT02304458|82868822|FG007|Overall Study|Lack of Efficacy|4|||
46657267|NCT02304458|82868815|FG000|Overall Study|Physician Decision|2|||
46657268|NCT02304458|82868816|FG001|Overall Study|Physician Decision|0|||
46657269|NCT02304458|82868817|FG002|Overall Study|Physician Decision|16|||
46657270|NCT02304458|82868818|FG003|Overall Study|Physician Decision|1|||
46657271|NCT02304458|82868819|FG004|Overall Study|Physician Decision|0|||
46657272|NCT02304458|82868820|FG005|Overall Study|Physician Decision|0|||
46657273|NCT02304458|82868821|FG006|Overall Study|Physician Decision|3|||
46657274|NCT02304458|82868822|FG007|Overall Study|Physician Decision|0|||
46657275|NCT02304458|82868815|FG000|Overall Study|Protocol Violation|0|||
46657276|NCT02304458|82868816|FG001|Overall Study|Protocol Violation|0|||
46657277|NCT02304458|82868817|FG002|Overall Study|Protocol Violation|1|||
46657278|NCT02304458|82868818|FG003|Overall Study|Protocol Violation|0|||
46657279|NCT02304458|82868819|FG004|Overall Study|Protocol Violation|0|||
46657280|NCT02304458|82868820|FG005|Overall Study|Protocol Violation|0|||
46657281|NCT02304458|82868821|FG006|Overall Study|Protocol Violation|0|||
46657282|NCT02304458|82868822|FG007|Overall Study|Protocol Violation|0|||
46657283|NCT02304458|82868815|FG000|Overall Study|Withdrawal by Subject|1|||
46657284|NCT02304458|82868816|FG001|Overall Study|Withdrawal by Subject|0|||
46657285|NCT02304458|82868817|FG002|Overall Study|Withdrawal by Subject|7|||
46657286|NCT02304458|82868818|FG003|Overall Study|Withdrawal by Subject|0|||
46657287|NCT02304458|82868819|FG004|Overall Study|Withdrawal by Subject|0|||
46657288|NCT02304458|82868820|FG005|Overall Study|Withdrawal by Subject|0|||
46657289|NCT02304458|82868821|FG006|Overall Study|Withdrawal by Subject|1|||
46657290|NCT02304458|82868822|FG007|Overall Study|Withdrawal by Subject|0|||
46657291|NCT02187224|82868858|FG000|Overall Study|Did not show up for test day|1|||
46657292|NCT02187224|82868859|FG001|Overall Study|Did not show up for test day|0|||
46657293|NCT02176226|82868869|FG000|Overall Study|Lost to Follow-up|3|||
46657294|NCT02176226|82868869|FG000|Overall Study|Withdrew prior to treatment|6|||
46657295|NCT01958021|82868875|FG000|Overall Study|Progressive disease|87|||
46657296|NCT01958021|82868876|FG001|Overall Study|Progressive disease|146|||
46657297|NCT01958021|82868875|FG000|Overall Study|Adverse Event|25|||
46657298|NCT01958021|82868876|FG001|Overall Study|Adverse Event|7|||
46971582|NCT02213133|83215102|FG002|Overall Study|Disease progression|0|||
46971583|NCT02213133|83215100|FG000|Overall Study|Adverse Event (AE)|1|||
46971584|NCT02213133|83215101|FG001|Overall Study|Adverse Event (AE)|0|||
46657299|NCT01958021|82868875|FG000|Overall Study|Subject/guardian decision|12|||
46657300|NCT01958021|82868876|FG001|Overall Study|Subject/guardian decision|13|||
46657301|NCT01958021|82868875|FG000|Overall Study|Physician Decision|10|||
46657302|NCT01958021|82868876|FG001|Overall Study|Physician Decision|13|||
46971585|NCT02213133|83215102|FG002|Overall Study|Adverse Event (AE)|0|||
46971586|NCT02213133|83215100|FG000|Overall Study|Death|16|||
46657303|NCT01958021|82868875|FG000|Overall Study|Protocol Violation|3|||
46657304|NCT01958021|82868876|FG001|Overall Study|Protocol Violation|1|||
46657305|NCT01958021|82868875|FG000|Overall Study|Death|2|||
46657306|NCT01958021|82868876|FG001|Overall Study|Death|0|||
46657307|NCT05059600|82868882|FG000|Overall Study|Enrolled but not Treated|10|||
46657308|NCT04608448|82868895|FG000|Overall Study|Withdrawal by Subject|1|||
46657309|NCT04608448|82868895|FG000|Overall Study|Adverse Event|1|||
46971587|NCT02213133|83215101|FG001|Overall Study|Death|2|||
46657310|NCT04530344|82868905|FG000|Overall Study|Lost to Follow-up|3|||
46657311|NCT04530344|82868906|FG001|Overall Study|Lost to Follow-up|3|||
46657312|NCT04530344|82868907|FG002|Overall Study|Lost to Follow-up|3|||
46657313|NCT04530344|82868908|FG003|Overall Study|Lost to Follow-up|10|||
46657314|NCT04530344|82868905|FG000|Overall Study|Withdrawal by Subject|14|||
46657315|NCT04530344|82868906|FG001|Overall Study|Withdrawal by Subject|5|||
46657316|NCT04530344|82868907|FG002|Overall Study|Withdrawal by Subject|18|||
46657317|NCT04530344|82868908|FG003|Overall Study|Withdrawal by Subject|33|||
46657318|NCT04530344|82868905|FG000|Overall Study|Adverse Event|0|||
46657319|NCT04530344|82868906|FG001|Overall Study|Adverse Event|0|||
46657320|NCT04530344|82868907|FG002|Overall Study|Adverse Event|0|||
46657321|NCT04530344|82868908|FG003|Overall Study|Adverse Event|1|||
46657322|NCT04530344|82868905|FG000|Overall Study|Lack of Efficacy|0|||
46657323|NCT04530344|82868906|FG001|Overall Study|Lack of Efficacy|0|||
46657324|NCT04530344|82868907|FG002|Overall Study|Lack of Efficacy|0|||
46657325|NCT04530344|82868908|FG003|Overall Study|Lack of Efficacy|1|||
46657326|NCT04530344|82868905|FG000|Overall Study|Physician Decision|0|||
46657327|NCT04530344|82868906|FG001|Overall Study|Physician Decision|0|||
46657328|NCT04530344|82868907|FG002|Overall Study|Physician Decision|1|||
46657329|NCT04530344|82868908|FG003|Overall Study|Physician Decision|1|||
46657330|NCT04530344|82868905|FG000|Overall Study|Pregnancy|0|||
46657331|NCT04530344|82868906|FG001|Overall Study|Pregnancy|0|||
46657332|NCT04530344|82868907|FG002|Overall Study|Pregnancy|2|||
46657333|NCT04530344|82868908|FG003|Overall Study|Pregnancy|1|||
46657334|NCT04530344|82868905|FG000|Overall Study|Protocol Violation|0|||
46657335|NCT04530344|82868906|FG001|Overall Study|Protocol Violation|0|||
46657336|NCT04530344|82868907|FG002|Overall Study|Protocol Violation|0|||
46657337|NCT04530344|82868908|FG003|Overall Study|Protocol Violation|1|||
46657338|NCT04530344|82868905|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
46657339|NCT04530344|82868906|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
46657340|NCT04530344|82868907|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
46657341|NCT04530344|82868908|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
46657342|NCT04530344|82868905|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
46657343|NCT04530344|82868906|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
46657344|NCT04530344|82868907|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
46657345|NCT04530344|82868908|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
46657346|NCT04530344|82868905|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
46657347|NCT04530344|82868906|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
46657348|NCT04530344|82868907|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
46657349|NCT04530344|82868908|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
46657350|NCT04530344|82868905|FG000|Overall Study|Personal Reasons|0|||
46657351|NCT04530344|82868906|FG001|Overall Study|Personal Reasons|0|||
46657352|NCT04530344|82868907|FG002|Overall Study|Personal Reasons|0|||
46657353|NCT04530344|82868908|FG003|Overall Study|Personal Reasons|1|||
46657354|NCT04530344|82868905|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
46657355|NCT04530344|82868906|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
46657356|NCT04530344|82868907|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
46657357|NCT04530344|82868908|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
46657358|NCT04058886|82868933|FG000|Overall Study|Withdrawal by Subject|4|||
46657359|NCT04058886|82868933|FG000|Overall Study|Inadequate deafness interpreter service|1|||
46657360|NCT03704194|82868956|FG000|Overall Study|Withdrawal by Subject|0|||
46657361|NCT03704194|82868957|FG001|Overall Study|Withdrawal by Subject|1|||
46657362|NCT03451422|82868971|FG000|Overall Study|Lost to Follow-up|0|||
46657363|NCT03451422|82868972|FG001|Overall Study|Lost to Follow-up|0|||
46657364|NCT03451422|82868973|FG002|Overall Study|Lost to Follow-up|0|||
46657365|NCT03451422|82868974|FG003|Overall Study|Lost to Follow-up|0|||
46657366|NCT03451422|82868975|FG004|Overall Study|Lost to Follow-up|0|||
46657367|NCT03451422|82868976|FG005|Overall Study|Lost to Follow-up|1|||
46657368|NCT03451422|82868971|FG000|Overall Study|Decision by sponsor|1|||
46657369|NCT03451422|82868972|FG001|Overall Study|Decision by sponsor|0|||
46657370|NCT03451422|82868973|FG002|Overall Study|Decision by sponsor|1|||
46657371|NCT03451422|82868974|FG003|Overall Study|Decision by sponsor|0|||
46657372|NCT03451422|82868975|FG004|Overall Study|Decision by sponsor|0|||
46971588|NCT02213133|83215102|FG002|Overall Study|Death|1|||
46657373|NCT03451422|82868976|FG005|Overall Study|Decision by sponsor|0|||
46850961|NCT00098306|83066771|FG001|Double Blind|Participant defaulted|18|||
46971589|NCT02213133|83215100|FG000|Overall Study|Other|5|||
46657374|NCT03451422|82868971|FG000|Overall Study|Withdrawal by Subject|0|||
46657375|NCT03451422|82868972|FG001|Overall Study|Withdrawal by Subject|0|||
46657376|NCT03451422|82868973|FG002|Overall Study|Withdrawal by Subject|2|||
46657377|NCT03451422|82868974|FG003|Overall Study|Withdrawal by Subject|3|||
46657378|NCT03451422|82868975|FG004|Overall Study|Withdrawal by Subject|2|||
46657379|NCT03451422|82868976|FG005|Overall Study|Withdrawal by Subject|1|||
46657380|NCT03446573|82868997|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
46657381|NCT03446573|82868998|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
46850962|NCT00098306|83066772|FG002|Double Blind|Participant defaulted|11|||
46657382|NCT03446573|82868997|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
46657383|NCT03446573|82868998|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
46657384|NCT03446573|82868997|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
46657385|NCT03446573|82868998|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
46657386|NCT03446573|82868997|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
46657387|NCT03446573|82868998|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
46657388|NCT03446573|82868997|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
46657389|NCT03446573|82868998|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
46657390|NCT03446573|82868997|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
46657391|NCT03446573|82868998|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
46657392|NCT03446573|82868997|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
46657393|NCT03446573|82868998|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
46657394|NCT03446573|82868997|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
46657395|NCT03446573|82868998|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
46657396|NCT03446573|82868997|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
46657397|NCT03446573|82868998|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
46657398|NCT03446573|82868997|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
46657399|NCT03446573|82868998|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
46657400|NCT03446573|82868997|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
46657401|NCT03446573|82868998|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
46657402|NCT03446573|82868997|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
46657403|NCT03446573|82868998|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
46657404|NCT03446573|82868997|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
46657405|NCT03446573|82868998|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
46657406|NCT03422536|82869016|FG000|Randomized|Physician Decision|1|||
46657407|NCT03422536|82869017|FG001|Randomized|Physician Decision|1|||
46657408|NCT03422536|82869016|FG000|Allocation - Received Intervention|Disease progression|19|||
46657409|NCT03422536|82869017|FG001|Allocation - Received Intervention|Disease progression|25|||
46657410|NCT03422536|82869016|FG000|Allocation - Received Intervention|Death|1|||
46657411|NCT03422536|82869017|FG001|Allocation - Received Intervention|Death|3|||
46657412|NCT03422536|82869016|FG000|Allocation - Received Intervention|Adverse Event|1|||
46657413|NCT03422536|82869017|FG001|Allocation - Received Intervention|Adverse Event|0|||
46657414|NCT03422536|82869016|FG000|Allocation - Received Intervention|Physician Decision|1|||
46657415|NCT03422536|82869017|FG001|Allocation - Received Intervention|Physician Decision|1|||
46657416|NCT03422536|82869016|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
46657417|NCT03422536|82869017|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
46657418|NCT03422536|82869016|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
46657419|NCT03422536|82869017|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
46657420|NCT03228394|82869031|FG000|Overall Study|Lost to Follow-up|0|||
46657421|NCT03228394|82869032|FG001|Overall Study|Lost to Follow-up|0|||
46657422|NCT03228394|82869033|FG002|Overall Study|Lost to Follow-up|1|||
46657423|NCT03228394|82869034|FG003|Overall Study|Lost to Follow-up|1|||
46657424|NCT03228394|82869035|FG004|Overall Study|Lost to Follow-up|0|||
46657425|NCT03228394|82869036|FG005|Overall Study|Lost to Follow-up|0|||
46657426|NCT03228394|82869037|FG006|Overall Study|Lost to Follow-up|2|||
46657427|NCT03228394|82869038|FG007|Overall Study|Lost to Follow-up|0|||
46657428|NCT03228394|82869031|FG000|Overall Study|Withdrawal by Subject|0|||
46657429|NCT03228394|82869032|FG001|Overall Study|Withdrawal by Subject|0|||
46657430|NCT03228394|82869033|FG002|Overall Study|Withdrawal by Subject|1|||
46657431|NCT03228394|82869034|FG003|Overall Study|Withdrawal by Subject|0|||
46657432|NCT03228394|82869035|FG004|Overall Study|Withdrawal by Subject|0|||
46657433|NCT03228394|82869036|FG005|Overall Study|Withdrawal by Subject|0|||
46657434|NCT03228394|82869037|FG006|Overall Study|Withdrawal by Subject|1|||
46657435|NCT03228394|82869038|FG007|Overall Study|Withdrawal by Subject|3|||
46657436|NCT03228394|82869031|FG000|Overall Study|Protocol Violation|0|||
46657437|NCT03228394|82869032|FG001|Overall Study|Protocol Violation|0|||
46657438|NCT03228394|82869033|FG002|Overall Study|Protocol Violation|0|||
46657439|NCT03228394|82869034|FG003|Overall Study|Protocol Violation|1|||
46657440|NCT03228394|82869035|FG004|Overall Study|Protocol Violation|0|||
46657441|NCT03228394|82869036|FG005|Overall Study|Protocol Violation|0|||
46657442|NCT03228394|82869037|FG006|Overall Study|Protocol Violation|0|||
46657443|NCT03228394|82869038|FG007|Overall Study|Protocol Violation|0|||
46657444|NCT03228394|82869031|FG000|Overall Study|Physician Decision|0|||
46657445|NCT03228394|82869032|FG001|Overall Study|Physician Decision|0|||
46657446|NCT03228394|82869033|FG002|Overall Study|Physician Decision|0|||
46657447|NCT03228394|82869034|FG003|Overall Study|Physician Decision|0|||
46657448|NCT03228394|82869035|FG004|Overall Study|Physician Decision|0|||
46850963|NCT00098306|83066773|FG003|Double Blind|Participant defaulted|0|||
46657449|NCT03228394|82869036|FG005|Overall Study|Physician Decision|0|||
46657450|NCT03228394|82869037|FG006|Overall Study|Physician Decision|1|||
46657451|NCT03228394|82869038|FG007|Overall Study|Physician Decision|0|||
46657452|NCT03228394|82869031|FG000|Overall Study|Noncompliance|0|||
46657453|NCT03228394|82869032|FG001|Overall Study|Noncompliance|0|||
46657454|NCT03228394|82869033|FG002|Overall Study|Noncompliance|0|||
46657455|NCT03228394|82869034|FG003|Overall Study|Noncompliance|0|||
46657456|NCT03228394|82869035|FG004|Overall Study|Noncompliance|0|||
46657457|NCT03228394|82869036|FG005|Overall Study|Noncompliance|0|||
46657458|NCT03228394|82869037|FG006|Overall Study|Noncompliance|1|||
46657459|NCT03228394|82869038|FG007|Overall Study|Noncompliance|0|||
46657460|NCT03008070|82869060|FG000|Overall Study|Adverse Event|3|||
46971590|NCT02213133|83215101|FG001|Overall Study|Other|0|||
46657461|NCT03008070|82869061|FG001|Overall Study|Adverse Event|3|||
46657462|NCT03008070|82869062|FG002|Overall Study|Adverse Event|3|||
46657463|NCT03008070|82869060|FG000|Overall Study|Lost to Follow-up|1|||
46657464|NCT03008070|82869061|FG001|Overall Study|Lost to Follow-up|1|||
46657465|NCT03008070|82869062|FG002|Overall Study|Lost to Follow-up|0|||
46657466|NCT03008070|82869060|FG000|Overall Study|Non compliance|0|||
46657467|NCT03008070|82869061|FG001|Overall Study|Non compliance|1|||
46657468|NCT03008070|82869062|FG002|Overall Study|Non compliance|1|||
46657469|NCT03008070|82869060|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
46657470|NCT03008070|82869061|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
46657471|NCT03008070|82869062|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
46657472|NCT03008070|82869060|FG000|Overall Study|Withdrawal by Subject|2|||
46657473|NCT03008070|82869061|FG001|Overall Study|Withdrawal by Subject|0|||
46657474|NCT03008070|82869062|FG002|Overall Study|Withdrawal by Subject|1|||
46657475|NCT03008070|82869060|FG000|Overall Study|Use of prohibited drug|0|||
46657476|NCT03008070|82869061|FG001|Overall Study|Use of prohibited drug|0|||
46657477|NCT03008070|82869062|FG002|Overall Study|Use of prohibited drug|2|||
46657478|NCT02979353|82869074|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
46657479|NCT02979353|82869075|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
46657480|NCT02979353|82869074|FG000|Overall Study|Withdrawal by Subject|16|||
46657481|NCT02979353|82869075|FG001|Overall Study|Withdrawal by Subject|12|||
46657482|NCT02979353|82869074|FG000|Overall Study|Death|10|||
46657483|NCT02979353|82869075|FG001|Overall Study|Death|11|||
46657484|NCT02979353|82869074|FG000|Overall Study|Transfer to Hospice Care|19|||
46657485|NCT02979353|82869075|FG001|Overall Study|Transfer to Hospice Care|14|||
46657486|NCT02979353|82869074|FG000|Overall Study|Lost to Follow-up|1|||
46657487|NCT02979353|82869075|FG001|Overall Study|Lost to Follow-up|5|||
46657488|NCT02633397|82869094|FG000|Overall Study|Adverse Event|8|||
46657489|NCT02633397|82869095|FG001|Overall Study|Adverse Event|8|||
46657490|NCT02633397|82869094|FG000|Overall Study|Study Burden|4|||
46657491|NCT02633397|82869095|FG001|Overall Study|Study Burden|1|||
46657492|NCT02633397|82869094|FG000|Overall Study|Treatment interruption|2|||
46657493|NCT02633397|82869095|FG001|Overall Study|Treatment interruption|5|||
46657494|NCT02633397|82869094|FG000|Overall Study|Death|2|||
46657495|NCT02633397|82869095|FG001|Overall Study|Death|2|||
46657496|NCT02633397|82869094|FG000|Overall Study|Physician Decision|0|||
46657497|NCT02633397|82869095|FG001|Overall Study|Physician Decision|1|||
46657498|NCT02592707|82869105|FG000|Overall Study|Consent Withdrawn|0|||
46971591|NCT02213133|83215102|FG002|Overall Study|Other|0|||
46971592|NCT02684981|83215114|FG000|Overall Study|Permanently discontinued the treatment|157|||
46971593|NCT02684981|83215115|FG001|Overall Study|Permanently discontinued the treatment|161|||
46971594|NCT02684981|83215116|FG002|Overall Study|Permanently discontinued the treatment|110|||
46971595|NCT02684981|83215114|FG000|Overall Study|Other|83|||
46971596|NCT02684981|83215115|FG001|Overall Study|Other|49|||
47076031|NCT03525600|83370694|FG000|Overall Study|Adverse Event|9|||
47076032|NCT03525600|83370695|FG001|Overall Study|Adverse Event|6|||
47076033|NCT03525600|83370696|FG002|Overall Study|Adverse Event|5|||
47076034|NCT03525600|83370697|FG003|Overall Study|Adverse Event|3|||
47076035|NCT03525600|83370694|FG000|Overall Study|Lost to Follow-up|2|||
47076036|NCT03525600|83370695|FG001|Overall Study|Lost to Follow-up|4|||
46657499|NCT02592707|82869106|FG001|Overall Study|Consent Withdrawn|1|||
46657500|NCT02592707|82869107|FG002|Overall Study|Consent Withdrawn|2|||
46657501|NCT02592707|82869108|FG003|Overall Study|Consent Withdrawn|0|||
46657502|NCT02592707|82869105|FG000|Overall Study|Death|1|||
46657503|NCT02592707|82869106|FG001|Overall Study|Death|0|||
46657504|NCT02592707|82869107|FG002|Overall Study|Death|0|||
46657505|NCT02592707|82869108|FG003|Overall Study|Death|0|||
46657506|NCT02592707|82869105|FG000|Overall Study|Progressive Disease|4|||
46657507|NCT02592707|82869106|FG001|Overall Study|Progressive Disease|4|||
46657508|NCT02592707|82869107|FG002|Overall Study|Progressive Disease|3|||
46657509|NCT02592707|82869108|FG003|Overall Study|Progressive Disease|3|||
46971597|NCT02684981|83215116|FG002|Overall Study|Other|17|||
46971598|NCT02146833|83215130|FG000|Overall Study|Death|10|||
47076037|NCT03525600|83370696|FG002|Overall Study|Lost to Follow-up|4|||
46971599|NCT02146833|83215130|FG000|Overall Study|No longer consented to study treatment|1|||
47076038|NCT03525600|83370697|FG003|Overall Study|Lost to Follow-up|0|||
46657510|NCT02592707|82869105|FG000|Overall Study|Other|0|||
46971600|NCT02690207|83215134|FG000|Overall Study|Lost to Follow-up|48|||
47076039|NCT03525600|83370694|FG000|Overall Study|Physician Decision|1|||
46657511|NCT02592707|82869106|FG001|Overall Study|Other|0|||
46657512|NCT02592707|82869107|FG002|Overall Study|Other|1|||
46657513|NCT02592707|82869108|FG003|Overall Study|Other|2|||
46657514|NCT02592707|82869105|FG000|Overall Study|Never entered LTFU period|1|||
46657515|NCT02592707|82869106|FG001|Overall Study|Never entered LTFU period|0|||
46657516|NCT02592707|82869107|FG002|Overall Study|Never entered LTFU period|0|||
46657517|NCT02592707|82869108|FG003|Overall Study|Never entered LTFU period|2|||
46657518|NCT01423812|82869136|FG000|Overall Study|Lost to Follow-up|2|||
46657519|NCT01423812|82869137|FG001|Overall Study|Lost to Follow-up|2|||
46657520|NCT01423812|82869136|FG000|Overall Study|Withdrawal by Subject|1|||
46657521|NCT01423812|82869137|FG001|Overall Study|Withdrawal by Subject|2|||
46657522|NCT00965718|82869145|FG000|Overall Study|Withdrawal by Subject|4|||
46657523|NCT00792740|82869160|FG000|Overall Study|Disease Worsening|3|||
46657524|NCT00792740|82869161|FG001|Overall Study|Disease Worsening|2|||
46657525|NCT00792740|82869160|FG000|Overall Study|Personal Reason|1|||
46657526|NCT00792740|82869161|FG001|Overall Study|Personal Reason|0|||
46657527|NCT00792740|82869160|FG000|Overall Study|Adverse Event|1|||
46657528|NCT00792740|82869161|FG001|Overall Study|Adverse Event|3|||
46657529|NCT00792740|82869160|FG000|Overall Study|Patient's withdrawal of consent|0|||
46657530|NCT00792740|82869161|FG001|Overall Study|Patient's withdrawal of consent|1|||
46657531|NCT00792740|82869160|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
46657532|NCT00792740|82869161|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
46657533|NCT00792740|82869160|FG000|Overall Study|Other reasons|0|||
47076040|NCT03525600|83370695|FG001|Overall Study|Physician Decision|0|||
47076041|NCT03525600|83370696|FG002|Overall Study|Physician Decision|2|||
47076042|NCT03525600|83370697|FG003|Overall Study|Physician Decision|0|||
47076043|NCT03525600|83370694|FG000|Overall Study|Consent withdrawal|36|||
47076044|NCT03525600|83370695|FG001|Overall Study|Consent withdrawal|20|||
47076045|NCT03525600|83370696|FG002|Overall Study|Consent withdrawal|6|||
47076046|NCT03525600|83370697|FG003|Overall Study|Consent withdrawal|13|||
47076047|NCT03525600|83370694|FG000|Overall Study|Death|7|||
46971601|NCT02690207|83215134|FG000|Overall Study|Withdrawal by Subject|46|||
46971602|NCT02690207|83215134|FG000|Overall Study|Protocol Violation|2|||
46971603|NCT02690207|83215134|FG000|Overall Study|Serious adverse event|110|||
46971604|NCT02690207|83215134|FG000|Overall Study|Non-serious Adverse Event|18|||
46971605|NCT02690207|83215134|FG000|Overall Study|Migrated/moved from study area|5|||
46971606|NCT02690207|83215134|FG000|Overall Study|Suspected HZ Episode|1|||
46971607|NCT02690207|83215134|FG000|Overall Study|Other reasons for withdrawal|23|||
46971608|NCT02689349|83215140|FG000|Overall Study|Not implanted|4|||
46971609|NCT02689349|83215141|FG001|Overall Study|Not implanted|0|||
46971610|NCT02689349|83215140|FG000|Overall Study|Withdrawal by Subject|9|||
46971611|NCT02689349|83215141|FG001|Overall Study|Withdrawal by Subject|0|||
46971612|NCT02679287|83215152|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
46971613|NCT02679287|83215153|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
46971614|NCT02679287|83215152|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
46971615|NCT02679287|83215153|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
46971616|NCT02679287|83215152|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
46971617|NCT02679287|83215153|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
46971618|NCT02679287|83215152|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
46971619|NCT02679287|83215153|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
46971620|NCT02679287|83215152|FG000|Period 2|Work/Scheduling Conflict|1|||
46971621|NCT02679287|83215153|FG001|Period 2|Work/Scheduling Conflict|0|||
46971622|NCT02679287|83215152|FG000|Period 2|Disliked Mobile System|2|||
46971623|NCT02679287|83215153|FG001|Period 2|Disliked Mobile System|0|||
46971624|NCT02679287|83215152|FG000|Period 3|Work/Scheduling Conflict|0|||
46971625|NCT02679287|83215153|FG001|Period 3|Work/Scheduling Conflict|1|||
46971626|NCT02544633|83215169|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
46971627|NCT02544633|83215170|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
46971628|NCT02544633|83215171|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
46971629|NCT02544633|83215172|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
46971630|NCT02544633|83215169|FG000|Treatment Period|Adverse Event|7|||
47076048|NCT03525600|83370695|FG001|Overall Study|Death|6|||
46657534|NCT00792740|82869161|FG001|Overall Study|Other reasons|1|||
46657535|NCT01058863|82869177|FG000|Overall Study|Lost to Follow-up|1|||
46657536|NCT01058863|82869177|FG000|Overall Study|Withdrawal by Subject|1|||
46657537|NCT01058863|82869177|FG000|Overall Study|Sponsor requested withdrawal|1|||
46971631|NCT02544633|83215170|FG001|Treatment Period|Adverse Event|4|||
46971632|NCT02544633|83215171|FG002|Treatment Period|Adverse Event|0|||
46971633|NCT02544633|83215172|FG003|Treatment Period|Adverse Event|5|||
47076049|NCT03525600|83370696|FG002|Overall Study|Death|4|||
47076050|NCT03525600|83370697|FG003|Overall Study|Death|3|||
46657538|NCT01058863|82869177|FG000|Overall Study|Randomized in error|1|||
46971634|NCT02544633|83215169|FG000|Treatment Period|Lack of Efficacy|17|||
46971635|NCT02544633|83215170|FG001|Treatment Period|Lack of Efficacy|11|||
46971636|NCT02544633|83215171|FG002|Treatment Period|Lack of Efficacy|5|||
46657539|NCT01058395|82869192|FG000|Overall Study|Death|2|||
46657540|NCT01058395|82869193|FG001|Overall Study|Death|1|||
46657541|NCT01058395|82869192|FG000|Overall Study|Lost to Follow-up|1|||
46657542|NCT01058395|82869193|FG001|Overall Study|Lost to Follow-up|0|||
46657543|NCT01058356|82869199|FG000|Overall Study|Adverse Event|5|||
46657544|NCT01058356|82869199|FG000|Overall Study|Administration of contraindicated drugs|12|||
46657545|NCT01058356|82869199|FG000|Overall Study|Withdrawal by Subject|21|||
46657546|NCT01058356|82869199|FG000|Overall Study|Lost to Follow-up|4|||
46657547|NCT01058005|82869206|FG000|Overall Study|Adverse Event|0|||
46657548|NCT01058005|82869207|FG001|Overall Study|Adverse Event|2|||
46657549|NCT01058005|82869208|FG002|Overall Study|Adverse Event|1|||
46657550|NCT01058005|82869206|FG000|Overall Study|Physician Decision|2|||
46657551|NCT01058005|82869207|FG001|Overall Study|Physician Decision|2|||
46657552|NCT01058005|82869208|FG002|Overall Study|Physician Decision|0|||
46657553|NCT01058005|82869206|FG000|Overall Study|Withdrawal by Subject|4|||
46657554|NCT01058005|82869207|FG001|Overall Study|Withdrawal by Subject|5|||
46657555|NCT01058005|82869208|FG002|Overall Study|Withdrawal by Subject|11|||
46657556|NCT01058005|82869206|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
46657557|NCT01058005|82869207|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
46657558|NCT01058005|82869208|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
46657559|NCT01058005|82869206|FG000|Overall Study|Reason Missing|5|||
46657560|NCT01058005|82869207|FG001|Overall Study|Reason Missing|3|||
46657561|NCT01058005|82869208|FG002|Overall Study|Reason Missing|1|||
46657562|NCT01056640|82869218|FG000|Overall Study|Withdrawal by Subject|11|||
46657563|NCT01056640|82869219|FG001|Overall Study|Withdrawal by Subject|8|||
46657564|NCT01056640|82869218|FG000|Overall Study|Death|15|||
46657565|NCT01056640|82869219|FG001|Overall Study|Death|4|||
46657566|NCT01056484|82869227|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
46657567|NCT01056484|82869228|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
46657568|NCT01056484|82869227|FG000|Randomized Controlled Trial|Physician Decision|1|||
46657569|NCT01056484|82869228|FG001|Randomized Controlled Trial|Physician Decision|0|||
46657570|NCT01056484|82869227|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
46657571|NCT01056484|82869228|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
46657572|NCT01055314|82869237|FG000|Overall Study|Adverse Event|7|||
46657573|NCT01055314|82869238|FG001|Overall Study|Adverse Event|4|||
46657574|NCT01055314|82869237|FG000|Overall Study|Death|2|||
46657575|NCT01055314|82869238|FG001|Overall Study|Death|1|||
46657576|NCT01055314|82869237|FG000|Overall Study|Lack of Efficacy|11|||
46657577|NCT01055314|82869238|FG001|Overall Study|Lack of Efficacy|19|||
46657578|NCT01055314|82869237|FG000|Overall Study|Physician Decision|10|||
46657579|NCT01055314|82869238|FG001|Overall Study|Physician Decision|5|||
46657580|NCT01055314|82869237|FG000|Overall Study|Withdrawal by Subject|1|||
46657581|NCT01055314|82869238|FG001|Overall Study|Withdrawal by Subject|0|||
46657582|NCT01055314|82869237|FG000|Overall Study|Ineligible|3|||
46657583|NCT01055314|82869238|FG001|Overall Study|Ineligible|5|||
46657584|NCT01055314|82869237|FG000|Overall Study|Refusal of further protocol therapy|10|||
46657585|NCT01055314|82869238|FG001|Overall Study|Refusal of further protocol therapy|4|||
46657586|NCT01055314|82869237|FG000|Overall Study|No treatment|1|||
46657587|NCT01055314|82869238|FG001|Overall Study|No treatment|0|||
46657588|NCT01055197|82869247|FG000|Overall Study|Protocol Violation|7|||
46657589|NCT01055197|82869248|FG001|Overall Study|Protocol Violation|2|||
47076051|NCT03525600|83370694|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
47076052|NCT03525600|83370695|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
47076053|NCT03525600|83370696|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
47076054|NCT03525600|83370697|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
47076055|NCT03525600|83370694|FG000|Overall Study|Other|0|||
46657590|NCT01055197|82869247|FG000|Overall Study|Withdrawal by Subject|2|||
46657591|NCT01055197|82869248|FG001|Overall Study|Withdrawal by Subject|0|||
46657592|NCT01054885|82869260|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
46657593|NCT01054885|82869261|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657594|NCT01054885|82869262|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657595|NCT01054885|82869263|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657596|NCT01054885|82869264|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657597|NCT01054885|82869265|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657598|NCT01054885|82869266|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657599|NCT01054885|82869260|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
46657600|NCT01054885|82869261|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657601|NCT01054885|82869262|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657602|NCT01054885|82869263|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657603|NCT01054885|82869264|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657604|NCT01054885|82869265|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657605|NCT01054885|82869266|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
47076056|NCT03525600|83370695|FG001|Overall Study|Other|1|||
47076057|NCT03525600|83370696|FG002|Overall Study|Other|0|||
46657606|NCT01054885|82869260|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
46657607|NCT01054885|82869261|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657608|NCT01054885|82869262|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657609|NCT01054885|82869263|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46971637|NCT02544633|83215172|FG003|Treatment Period|Lack of Efficacy|5|||
46971638|NCT02544633|83215169|FG000|Treatment Period|Global Deterioration of Health|3|||
46971639|NCT02544633|83215170|FG001|Treatment Period|Global Deterioration of Health|3|||
46971640|NCT02544633|83215171|FG002|Treatment Period|Global Deterioration of Health|0|||
46971641|NCT02544633|83215172|FG003|Treatment Period|Global Deterioration of Health|1|||
46971642|NCT02544633|83215169|FG000|Treatment Period|Withdrawal by Subject|1|||
46971643|NCT02544633|83215170|FG001|Treatment Period|Withdrawal by Subject|0|||
46971644|NCT02544633|83215171|FG002|Treatment Period|Withdrawal by Subject|0|||
46971645|NCT02544633|83215172|FG003|Treatment Period|Withdrawal by Subject|0|||
46657610|NCT01054885|82869264|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657611|NCT01054885|82869265|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657612|NCT01054885|82869266|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657613|NCT01054885|82869260|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
46657614|NCT01054885|82869261|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657615|NCT01054885|82869262|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657616|NCT01054885|82869263|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657617|NCT01054885|82869264|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657618|NCT01054885|82869265|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657619|NCT01054885|82869266|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657620|NCT01054885|82869260|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
46657621|NCT01054885|82869261|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657622|NCT01054885|82869262|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657623|NCT01054885|82869263|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657624|NCT01054885|82869264|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657625|NCT01054885|82869265|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657626|NCT01054885|82869266|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657627|NCT01054885|82869260|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
46971646|NCT02544633|83215169|FG000|Treatment Period|Lost to Follow-up|0|||
46971647|NCT02544633|83215170|FG001|Treatment Period|Lost to Follow-up|1|||
46657628|NCT01054885|82869261|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657629|NCT01054885|82869262|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657630|NCT01054885|82869263|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657631|NCT01054885|82869264|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657632|NCT01054885|82869265|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657633|NCT01054885|82869266|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657634|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
46657635|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
46657636|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
46657637|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
46657638|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
46657639|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
46657640|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
46657641|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46657642|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46657643|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
46657644|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
46657645|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46657646|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
46657647|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46657648|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
46657649|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
46657650|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
46971648|NCT02544633|83215171|FG002|Treatment Period|Lost to Follow-up|0|||
46971649|NCT02544633|83215172|FG003|Treatment Period|Lost to Follow-up|0|||
46971650|NCT02544633|83215169|FG000|Treatment Period|Death|0|||
46971651|NCT02544633|83215170|FG001|Treatment Period|Death|0|||
46971652|NCT02544633|83215171|FG002|Treatment Period|Death|1|||
46971653|NCT02544633|83215172|FG003|Treatment Period|Death|0|||
46971654|NCT02544633|83215169|FG000|Treatment Period|Non-compliance|0|||
46971655|NCT02544633|83215170|FG001|Treatment Period|Non-compliance|0|||
46971656|NCT02544633|83215171|FG002|Treatment Period|Non-compliance|1|||
46971657|NCT02544633|83215172|FG003|Treatment Period|Non-compliance|0|||
46971658|NCT02544633|83215169|FG000|Treatment Period|Clinical Disease Progression|0|||
46657651|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
46657652|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
46657653|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
46657654|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
46657655|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
46657656|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
46657657|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
46657658|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
46657659|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
46657660|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
46657661|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
46657662|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
46657663|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
46657664|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
46657665|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
46657666|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
46657667|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
46657668|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
46657669|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
46657670|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
46657671|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
46657672|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
46657673|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
46657674|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
46657675|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
46657676|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46657677|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
46657678|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
46657679|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46657680|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46657681|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
46657682|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
46657683|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
46657684|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
46657685|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
46657686|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
46657687|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
46657688|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
46657689|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
46657690|NCT01054885|82869260|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
46657691|NCT01054885|82869261|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
46657692|NCT01054885|82869262|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
46657693|NCT01054885|82869263|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
46657694|NCT01054885|82869264|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
46657695|NCT01054885|82869265|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
46657696|NCT01054885|82869266|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
46657697|NCT01054846|82869283|FG000|Overall Study|Lost to Follow-up|76|||
46657698|NCT01054846|82869284|FG001|Overall Study|Lost to Follow-up|17|||
46657699|NCT01054729|82869293|FG000|Overall Study|Randomized but Not Treated|0|||
46657700|NCT01054729|82869294|FG001|Overall Study|Randomized but Not Treated|1|||
46971659|NCT02544633|83215170|FG001|Treatment Period|Clinical Disease Progression|0|||
47076058|NCT03525600|83370697|FG003|Overall Study|Other|0|||
47076059|NCT03472040|83370714|FG000|Overall Study|Physician Decision|0|||
47076060|NCT03472040|83370715|FG001|Overall Study|Physician Decision|3|||
47076061|NCT03472040|83370714|FG000|Overall Study|Withdrawal by Subject|10|||
47076062|NCT03472040|83370715|FG001|Overall Study|Withdrawal by Subject|23|||
47076063|NCT03472040|83370714|FG000|Overall Study|Perceived Lack of Efficacy|29|||
47076064|NCT03472040|83370715|FG001|Overall Study|Perceived Lack of Efficacy|30|||
47076065|NCT03472040|83370714|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
47076066|NCT03472040|83370715|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
47076067|NCT03472040|83370714|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
47076068|NCT03472040|83370715|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
46657701|NCT01054729|82869295|FG002|Overall Study|Randomized but Not Treated|0|||
46657702|NCT01054729|82869296|FG003|Overall Study|Randomized but Not Treated|0|||
46657703|NCT01054729|82869293|FG000|Overall Study|Adverse Event|1|||
46657704|NCT01054729|82869294|FG001|Overall Study|Adverse Event|1|||
46657705|NCT01054729|82869295|FG002|Overall Study|Adverse Event|2|||
46657706|NCT01054729|82869296|FG003|Overall Study|Adverse Event|1|||
46657707|NCT01054729|82869293|FG000|Overall Study|Withdrawal by Subject|1|||
46657708|NCT01054729|82869294|FG001|Overall Study|Withdrawal by Subject|0|||
46657709|NCT01054729|82869295|FG002|Overall Study|Withdrawal by Subject|1|||
46657710|NCT01054729|82869296|FG003|Overall Study|Withdrawal by Subject|0|||
46657711|NCT01054729|82869293|FG000|Overall Study|Lost to Follow-up|0|||
46657712|NCT01054729|82869294|FG001|Overall Study|Lost to Follow-up|1|||
46657713|NCT01054729|82869295|FG002|Overall Study|Lost to Follow-up|0|||
46657714|NCT01054729|82869296|FG003|Overall Study|Lost to Follow-up|0|||
46657715|NCT01054729|82869293|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
46657716|NCT01054729|82869294|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
46657717|NCT01054729|82869295|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
46657718|NCT01054729|82869296|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
46657719|NCT01054729|82869293|FG000|Overall Study|Non-responder|1|||
46657720|NCT01054729|82869294|FG001|Overall Study|Non-responder|0|||
46657721|NCT01054729|82869295|FG002|Overall Study|Non-responder|1|||
46657722|NCT01054729|82869296|FG003|Overall Study|Non-responder|1|||
46657723|NCT01054729|82869293|FG000|Overall Study|PEG/RBV Non-responder|1|||
46657724|NCT01054729|82869294|FG001|Overall Study|PEG/RBV Non-responder|0|||
46657725|NCT01054729|82869295|FG002|Overall Study|PEG/RBV Non-responder|1|||
46657726|NCT01054729|82869296|FG003|Overall Study|PEG/RBV Non-responder|0|||
46657727|NCT01054729|82869293|FG000|Overall Study|Personal/Obligations|0|||
46657728|NCT01054729|82869294|FG001|Overall Study|Personal/Obligations|1|||
46782030|NCT00365365|83000711|FG001|Overall Study|Disease progression/relapse|6|||
46782031|NCT00365365|83000712|FG002|Overall Study|Disease progression/relapse|7|||
46782032|NCT00365365|83000710|FG000|Overall Study|Adverse Event|6|||
46782033|NCT00365365|83000711|FG001|Overall Study|Adverse Event|6|||
46782034|NCT00365365|83000712|FG002|Overall Study|Adverse Event|3|||
46782035|NCT00365365|83000710|FG000|Overall Study|Moved|2|||
46782036|NCT00365365|83000711|FG001|Overall Study|Moved|0|||
46782037|NCT00365365|83000712|FG002|Overall Study|Moved|0|||
46782038|NCT00365365|83000710|FG000|Overall Study|New cancer|1|||
46782039|NCT00365365|83000711|FG001|Overall Study|New cancer|0|||
46782040|NCT00365365|83000712|FG002|Overall Study|New cancer|0|||
46782041|NCT00365365|83000710|FG000|Overall Study|Withdrew consent|1|||
46782042|NCT00365365|83000711|FG001|Overall Study|Withdrew consent|1|||
46782043|NCT00365365|83000712|FG002|Overall Study|Withdrew consent|0|||
46782044|NCT00365365|83000710|FG000|Overall Study|Second malignancy|0|||
46782045|NCT00365365|83000711|FG001|Overall Study|Second malignancy|1|||
46782046|NCT00365365|83000712|FG002|Overall Study|Second malignancy|0|||
46782047|NCT00365365|83000710|FG000|Overall Study|Patient/physician decision|0|||
46782048|NCT00365365|83000711|FG001|Overall Study|Patient/physician decision|0|||
46782049|NCT00365365|83000712|FG002|Overall Study|Patient/physician decision|1|||
46782050|NCT00623727|83000722|FG000|Double Blind (DB)|Adverse Event|1|||
46782051|NCT00623727|83000723|FG001|Double Blind (DB)|Adverse Event|3|||
46782052|NCT00623727|83000722|FG000|Double Blind (DB)|Physician Decision|0|||
46782053|NCT00623727|83000723|FG001|Double Blind (DB)|Physician Decision|1|||
46782054|NCT00623727|83000722|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
46782055|NCT00623727|83000723|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
46782056|NCT00623727|83000722|FG000|Double Blind (DB)|Lack of Efficacy|2|||
46782057|NCT00623727|83000723|FG001|Double Blind (DB)|Lack of Efficacy|2|||
46971660|NCT02544633|83215171|FG002|Treatment Period|Clinical Disease Progression|0|||
46971661|NCT02544633|83215172|FG003|Treatment Period|Clinical Disease Progression|1|||
46782058|NCT00623727|83000722|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
46971662|NCT02544633|83215169|FG000|Survival Follow-up Period|Death|12|||
46971663|NCT02544633|83215170|FG001|Survival Follow-up Period|Death|14|||
46971664|NCT02544633|83215171|FG002|Survival Follow-up Period|Death|3|||
46782059|NCT00623727|83000723|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
46782060|NCT00623727|83000722|FG000|Double Blind (DB)|Lost to Follow-up|1|||
46782061|NCT00623727|83000723|FG001|Double Blind (DB)|Lost to Follow-up|1|||
46782062|NCT00623727|83000722|FG000|Double Blind (DB)|Protocol Violation|2|||
46782063|NCT00623727|83000723|FG001|Double Blind (DB)|Protocol Violation|2|||
46782064|NCT00623727|83000722|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
46782065|NCT00623727|83000723|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
46782066|NCT00623727|83000722|FG000|Open Label Follow-up|Study termination|0|||
46782067|NCT00623727|83000723|FG001|Open Label Follow-up|Study termination|6|||
46782068|NCT00623727|83000722|FG000|Open Label Follow-up|Participant convenience|0|||
46782069|NCT00623727|83000723|FG001|Open Label Follow-up|Participant convenience|1|||
46782070|NCT00372775|83000731|FG000|Overall Study|Adverse Event|8|||
46782071|NCT00372775|83000731|FG000|Overall Study|Death|15|||
46782072|NCT00372775|83000731|FG000|Overall Study|Objective progression or relapse|30|||
46971665|NCT02544633|83215172|FG003|Survival Follow-up Period|Death|9|||
46657729|NCT01054729|82869295|FG002|Overall Study|Personal/Obligations|0|||
46657730|NCT01054729|82869296|FG003|Overall Study|Personal/Obligations|0|||
46657731|NCT01054729|82869293|FG000|Overall Study|Subject moved|0|||
46657732|NCT01054729|82869294|FG001|Overall Study|Subject moved|0|||
46657733|NCT01054729|82869295|FG002|Overall Study|Subject moved|1|||
46657734|NCT01054729|82869296|FG003|Overall Study|Subject moved|0|||
46657735|NCT01054729|82869293|FG000|Overall Study|Lack of Efficacy|0|||
46657736|NCT01054729|82869294|FG001|Overall Study|Lack of Efficacy|0|||
46657737|NCT01054729|82869295|FG002|Overall Study|Lack of Efficacy|0|||
46657738|NCT01054729|82869296|FG003|Overall Study|Lack of Efficacy|1|||
46657739|NCT01054573|82869310|FG000|Overall Study|Adverse Event|1|||
46657740|NCT01054573|82869311|FG001|Overall Study|Adverse Event|0|||
46657741|NCT01054573|82869312|FG002|Overall Study|Adverse Event|1|||
46657742|NCT01054573|82869313|FG003|Overall Study|Adverse Event|1|||
46657743|NCT01054573|82869310|FG000|Overall Study|Lost to Follow-up|0|||
46657744|NCT01054573|82869311|FG001|Overall Study|Lost to Follow-up|2|||
46657745|NCT01054573|82869312|FG002|Overall Study|Lost to Follow-up|0|||
46657746|NCT01054573|82869313|FG003|Overall Study|Lost to Follow-up|0|||
46657747|NCT01054573|82869310|FG000|Overall Study|Withdrawal by Subject|0|||
46657748|NCT01054573|82869311|FG001|Overall Study|Withdrawal by Subject|2|||
46657749|NCT01054573|82869312|FG002|Overall Study|Withdrawal by Subject|2|||
46657750|NCT01054573|82869313|FG003|Overall Study|Withdrawal by Subject|1|||
46657751|NCT01054456|82869332|FG000|Overall Study|Other|1|||
46657752|NCT01054300|82869338|FG000|Period 1|Adverse Event|1|||
46657753|NCT01054300|82869339|FG001|Period 1|Adverse Event|0|||
46657754|NCT01054300|82869340|FG002|Period 1|Adverse Event|0|||
46657755|NCT01054300|82869341|FG003|Period 1|Adverse Event|0|||
46657756|NCT01054300|82869338|FG000|Period 2|Withdrawal by Subject|0|||
46657757|NCT01054300|82869339|FG001|Period 2|Withdrawal by Subject|0|||
46657758|NCT01054300|82869340|FG002|Period 2|Withdrawal by Subject|1|||
46657759|NCT01054300|82869341|FG003|Period 2|Withdrawal by Subject|0|||
46657760|NCT01053988|82869356|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
46657761|NCT01053988|82869357|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657762|NCT01053988|82869358|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657763|NCT01053988|82869359|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657764|NCT01053988|82869360|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657765|NCT01053988|82869361|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
46657766|NCT01053988|82869356|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
46657767|NCT01053988|82869357|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657768|NCT01053988|82869358|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657769|NCT01053988|82869359|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657770|NCT01053988|82869360|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657771|NCT01053988|82869361|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
46657772|NCT01053988|82869356|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
46657773|NCT01053988|82869357|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657774|NCT01053988|82869358|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657775|NCT01053988|82869359|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657776|NCT01053988|82869360|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657777|NCT01053988|82869361|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
46657778|NCT01053988|82869356|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
46657779|NCT01053988|82869357|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657780|NCT01053988|82869358|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657781|NCT01053988|82869359|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657782|NCT01053988|82869360|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657783|NCT01053988|82869361|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
46657784|NCT01053988|82869356|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
46657785|NCT01053988|82869357|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657786|NCT01053988|82869358|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657787|NCT01053988|82869359|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657788|NCT01053988|82869360|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657789|NCT01053988|82869361|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
46657790|NCT01053988|82869356|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
46657791|NCT01053988|82869357|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657792|NCT01053988|82869358|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657793|NCT01053988|82869359|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657794|NCT01053988|82869360|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657795|NCT01053988|82869361|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
46657796|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
46657797|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
46657798|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
46657799|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
46657800|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
46657801|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
46657802|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46657803|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
46657804|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
46657805|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
46657806|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
46657807|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
46657808|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
46657809|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
46657810|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
46657811|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
46657812|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
46657813|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
46657814|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
46657815|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
46971666|NCT02544633|83215169|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
46971667|NCT02544633|83215170|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
46971668|NCT02544633|83215171|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
46971669|NCT02544633|83215172|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
46971670|NCT02544633|83215169|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
46971671|NCT02544633|83215170|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
46971672|NCT02544633|83215171|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
46971673|NCT02544633|83215172|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
46971674|NCT02544633|83215169|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
46971675|NCT02544633|83215170|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
46971676|NCT02544633|83215171|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
46971677|NCT02544633|83215172|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
46971678|NCT02678351|83215194|FG000|Overall Study|Withdrawal by Subject|1|||
46971679|NCT02683187|83215198|FG000|Overall Study|Failed IV access|3|||
46971680|NCT02683187|83215198|FG000|Overall Study|Withdrawal by Subject|5|||
46971681|NCT02683109|83215208|FG000|Overall Study|Adverse Event|1|||
46971682|NCT02683109|83215209|FG001|Overall Study|Adverse Event|0|||
46971683|NCT02544321|83215218|FG000|Overall Study|Withdrawal by Subject|1|||
46971684|NCT02544321|83215219|FG001|Overall Study|Withdrawal by Subject|2|||
46971685|NCT02544321|83215218|FG000|Overall Study|Adverse Event|1|||
46971686|NCT02544321|83215219|FG001|Overall Study|Adverse Event|1|||
46971687|NCT02544321|83215218|FG000|Overall Study|Protocol Violation|0|||
46971688|NCT02544321|83215219|FG001|Overall Study|Protocol Violation|1|||
46971689|NCT02533401|83215234|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
46971690|NCT02533401|83215234|FG000|Overall Study|Death|5|||
46971691|NCT02533401|83215234|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
46971692|NCT02533401|83215234|FG000|Overall Study|Lost to Follow-up|1|||
46971693|NCT02533401|83215234|FG000|Overall Study|Violation of Selection Criteria|1|||
46971694|NCT02536833|83215242|FG000|Overall Study|Discontinued Before Treatment|0|||
46971695|NCT02536833|83215243|FG001|Overall Study|Discontinued Before Treatment|0|||
46971696|NCT02536833|83215244|FG002|Overall Study|Discontinued Before Treatment|1|||
46971697|NCT02536833|83215245|FG003|Overall Study|Discontinued Before Treatment|2|||
46971698|NCT02536833|83215242|FG000|Overall Study|Adverse Event|1|||
46971699|NCT02536833|83215243|FG001|Overall Study|Adverse Event|3|||
46657816|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
46657817|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
46657818|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
46657819|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
46657820|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
46657821|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
46657822|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
46657823|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
46657824|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
46971700|NCT02536833|83215244|FG002|Overall Study|Adverse Event|4|||
46971701|NCT02536833|83215245|FG003|Overall Study|Adverse Event|1|||
46971702|NCT02536833|83215242|FG000|Overall Study|Lost to Follow-up|2|||
46971703|NCT02536833|83215243|FG001|Overall Study|Lost to Follow-up|1|||
46971704|NCT02536833|83215244|FG002|Overall Study|Lost to Follow-up|2|||
46971705|NCT02536833|83215245|FG003|Overall Study|Lost to Follow-up|2|||
46971706|NCT02536833|83215242|FG000|Overall Study|Physician Decision|0|||
46971707|NCT02536833|83215243|FG001|Overall Study|Physician Decision|0|||
46657825|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
46657826|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46657827|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
46657828|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46657829|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
46657830|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
46657831|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
46657832|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
46657833|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
46657834|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
46657835|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
46657836|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
46657837|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
46657838|NCT01053988|82869356|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
46657839|NCT01053988|82869357|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
46657840|NCT01053988|82869358|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
46657841|NCT01053988|82869359|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
46657842|NCT01053988|82869360|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
46657843|NCT01053988|82869361|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
46657844|NCT01053247|82869376|FG000|Overall Study|Withdrawal by Subject|9|||
46657845|NCT01053247|82869377|FG001|Overall Study|Withdrawal by Subject|4|||
46657846|NCT01053247|82869378|FG002|Overall Study|Withdrawal by Subject|15|||
46657847|NCT01053247|82869376|FG000|Overall Study|Lack of Efficacy|1|||
46657848|NCT01053247|82869377|FG001|Overall Study|Lack of Efficacy|0|||
46657849|NCT01053247|82869378|FG002|Overall Study|Lack of Efficacy|1|||
46657850|NCT01053247|82869376|FG000|Overall Study|Protocol Violation|2|||
46657851|NCT01053247|82869377|FG001|Overall Study|Protocol Violation|1|||
46657852|NCT01053247|82869378|FG002|Overall Study|Protocol Violation|2|||
46782073|NCT00372775|83000731|FG000|Overall Study|Global deterioration of health status|6|||
46782074|NCT00372775|83000731|FG000|Overall Study|Withdrawal by Subject|1|||
46850964|NCT00098306|83066774|FG004|Double Blind|Participant defaulted|0|||
46657853|NCT01053247|82869376|FG000|Overall Study|Lost to Follow-up|8|||
46657854|NCT01053247|82869377|FG001|Overall Study|Lost to Follow-up|5|||
46657855|NCT01053247|82869378|FG002|Overall Study|Lost to Follow-up|7|||
46657856|NCT01053247|82869376|FG000|Overall Study|Adverse Event|0|||
46657857|NCT01053247|82869377|FG001|Overall Study|Adverse Event|9|||
46657858|NCT01053247|82869378|FG002|Overall Study|Adverse Event|3|||
46657859|NCT01052662|82869389|FG000|Overall Study|Lost to Follow-up|15|||
46657860|NCT01052662|82869390|FG001|Overall Study|Lost to Follow-up|13|||
46657861|NCT01052662|82869391|FG002|Overall Study|Lost to Follow-up|18|||
46657862|NCT01052662|82869389|FG000|Overall Study|Withdrawal by Subject|3|||
46657863|NCT01052662|82869390|FG001|Overall Study|Withdrawal by Subject|2|||
46657864|NCT01052662|82869391|FG002|Overall Study|Withdrawal by Subject|1|||
46657865|NCT01052662|82869389|FG000|Overall Study|Pharmacy issue|1|||
46657866|NCT01052662|82869390|FG001|Overall Study|Pharmacy issue|3|||
46657867|NCT01052662|82869391|FG002|Overall Study|Pharmacy issue|3|||
46657868|NCT01052662|82869389|FG000|Overall Study|Adverse Event|1|||
46657869|NCT01052662|82869390|FG001|Overall Study|Adverse Event|1|||
46657870|NCT01052662|82869391|FG002|Overall Study|Adverse Event|0|||
46657871|NCT01052662|82869389|FG000|Overall Study|Legal Problem|2|||
46657872|NCT01052662|82869390|FG001|Overall Study|Legal Problem|0|||
46657873|NCT01052662|82869391|FG002|Overall Study|Legal Problem|0|||
46657874|NCT01052662|82869389|FG000|Overall Study|Administrative|0|||
46782075|NCT00372775|83000731|FG000|Overall Study|Other|1|||
46782076|NCT00372775|83000731|FG000|Overall Study|Not Treated|2|||
46782077|NCT00372697|83000737|FG000|Overall Study|Protocol Violation|1|||
46782078|NCT00372697|83000738|FG001|Overall Study|Protocol Violation|1|||
46782079|NCT00690378|83000746|FG000|Overall Study|Adverse Event|1|||
46850965|NCT00098306|83066775|FG005|Double Blind|Participant defaulted|0|||
46850966|NCT00098306|83066776|FG006|Double Blind|Participant defaulted|0|||
46850967|NCT00098306|83066770|FG000|Double Blind|Un-specified|7|||
46850968|NCT00098306|83066771|FG001|Double Blind|Un-specified|3|||
46850969|NCT00098306|83066772|FG002|Double Blind|Un-specified|11|||
46850970|NCT00098306|83066773|FG003|Double Blind|Un-specified|0|||
46850971|NCT00098306|83066774|FG004|Double Blind|Un-specified|0|||
46850972|NCT00098306|83066775|FG005|Double Blind|Un-specified|0|||
46850973|NCT00098306|83066776|FG006|Double Blind|Un-specified|0|||
46850974|NCT00098306|83066770|FG000|Open Label|Lack of Efficacy|0|||
46850975|NCT00098306|83066771|FG001|Open Label|Lack of Efficacy|0|||
46850976|NCT00098306|83066772|FG002|Open Label|Lack of Efficacy|0|||
46850977|NCT00098306|83066773|FG003|Open Label|Lack of Efficacy|13|||
46850978|NCT00098306|83066774|FG004|Open Label|Lack of Efficacy|0|||
46850979|NCT00098306|83066775|FG005|Open Label|Lack of Efficacy|0|||
46850980|NCT00098306|83066776|FG006|Open Label|Lack of Efficacy|0|||
46850981|NCT00098306|83066770|FG000|Open Label|Adverse Event|0|||
46850982|NCT00098306|83066771|FG001|Open Label|Adverse Event|0|||
46657875|NCT01052662|82869390|FG001|Overall Study|Administrative|3|||
46657876|NCT01052662|82869391|FG002|Overall Study|Administrative|0|||
46657877|NCT01052116|82869401|FG000|Overall Study|Lost to Follow-up|11|||
46657878|NCT01052116|82869402|FG001|Overall Study|Lost to Follow-up|17|||
46657879|NCT01052116|82869401|FG000|Overall Study|Withdrawal by Subject|3|||
46657880|NCT01052116|82869402|FG001|Overall Study|Withdrawal by Subject|6|||
46657881|NCT01052116|82869401|FG000|Overall Study|Spirometry not performed|0|||
46657882|NCT01052116|82869402|FG001|Overall Study|Spirometry not performed|4|||
46657883|NCT01052077|82869410|FG000|Phase A|Lost to Follow-up|22|||
46657884|NCT01052077|82869411|FG001|Phase A|Lost to Follow-up|0|||
46657885|NCT01052077|82869412|FG002|Phase A|Lost to Follow-up|0|||
46657886|NCT01052077|82869413|FG003|Phase A|Lost to Follow-up|0|||
46657887|NCT01052077|82869410|FG000|Phase A|Adverse Event|32|||
46657888|NCT01052077|82869411|FG001|Phase A|Adverse Event|0|||
46657889|NCT01052077|82869412|FG002|Phase A|Adverse Event|0|||
46657890|NCT01052077|82869413|FG003|Phase A|Adverse Event|0|||
46657891|NCT01052077|82869410|FG000|Phase A|Met Withdrawal Criteria|26|||
46657892|NCT01052077|82869411|FG001|Phase A|Met Withdrawal Criteria|0|||
46657893|NCT01052077|82869412|FG002|Phase A|Met Withdrawal Criteria|0|||
46657894|NCT01052077|82869413|FG003|Phase A|Met Withdrawal Criteria|0|||
46657895|NCT01052077|82869410|FG000|Phase A|Physician Decision|10|||
46657896|NCT01052077|82869411|FG001|Phase A|Physician Decision|0|||
46657897|NCT01052077|82869412|FG002|Phase A|Physician Decision|0|||
46657898|NCT01052077|82869413|FG003|Phase A|Physician Decision|0|||
46657899|NCT01052077|82869410|FG000|Phase A|Withdrawal by Subject|29|||
46657900|NCT01052077|82869411|FG001|Phase A|Withdrawal by Subject|0|||
46782080|NCT00690378|83000747|FG001|Overall Study|Adverse Event|0|||
46782081|NCT00690378|83000746|FG000|Overall Study|Withdrawal by Subject|2|||
46657901|NCT01052077|82869412|FG002|Phase A|Withdrawal by Subject|0|||
46657902|NCT01052077|82869413|FG003|Phase A|Withdrawal by Subject|0|||
46657903|NCT01052077|82869410|FG000|Phase A|Protocol Deviation|27|||
46657904|NCT01052077|82869411|FG001|Phase A|Protocol Deviation|0|||
46657905|NCT01052077|82869412|FG002|Phase A|Protocol Deviation|0|||
46657906|NCT01052077|82869413|FG003|Phase A|Protocol Deviation|0|||
46657907|NCT01052077|82869410|FG000|Phase B|Lost to Follow-up|0|||
46657908|NCT01052077|82869411|FG001|Phase B|Lost to Follow-up|2|||
46657909|NCT01052077|82869412|FG002|Phase B|Lost to Follow-up|3|||
46657910|NCT01052077|82869413|FG003|Phase B|Lost to Follow-up|0|||
46657911|NCT01052077|82869410|FG000|Phase B|Adverse Event|0|||
46657912|NCT01052077|82869411|FG001|Phase B|Adverse Event|9|||
46657913|NCT01052077|82869412|FG002|Phase B|Adverse Event|2|||
46657914|NCT01052077|82869413|FG003|Phase B|Adverse Event|0|||
46657915|NCT01052077|82869410|FG000|Phase B|Met Withdrawal Criteria|0|||
46657916|NCT01052077|82869411|FG001|Phase B|Met Withdrawal Criteria|2|||
46657917|NCT01052077|82869412|FG002|Phase B|Met Withdrawal Criteria|1|||
46657918|NCT01052077|82869413|FG003|Phase B|Met Withdrawal Criteria|0|||
46657919|NCT01052077|82869410|FG000|Phase B|Physician Decision|0|||
46657920|NCT01052077|82869411|FG001|Phase B|Physician Decision|1|||
46657921|NCT01052077|82869412|FG002|Phase B|Physician Decision|1|||
46657922|NCT01052077|82869413|FG003|Phase B|Physician Decision|0|||
46657923|NCT01052077|82869410|FG000|Phase B|Withdrawal by Subject|0|||
46657924|NCT01052077|82869411|FG001|Phase B|Withdrawal by Subject|0|||
46657925|NCT01052077|82869412|FG002|Phase B|Withdrawal by Subject|5|||
46657926|NCT01052077|82869413|FG003|Phase B|Withdrawal by Subject|0|||
46657927|NCT01052077|82869410|FG000|Phase B|Protocol Deviation|0|||
46657928|NCT01052077|82869411|FG001|Phase B|Protocol Deviation|3|||
46657929|NCT01052077|82869412|FG002|Phase B|Protocol Deviation|4|||
46657930|NCT01052077|82869413|FG003|Phase B|Protocol Deviation|0|||
46657931|NCT01052077|82869410|FG000|Phase B|Lack of Efficacy|0|||
46657932|NCT01052077|82869411|FG001|Phase B|Lack of Efficacy|1|||
46657933|NCT01052077|82869412|FG002|Phase B|Lack of Efficacy|0|||
46657934|NCT01052077|82869413|FG003|Phase B|Lack of Efficacy|0|||
46657935|NCT01052077|82869410|FG000|Phase A+|Lost to Follow-up|0|||
46657936|NCT01052077|82869411|FG001|Phase A+|Lost to Follow-up|0|||
46657937|NCT01052077|82869412|FG002|Phase A+|Lost to Follow-up|0|||
46782082|NCT00690378|83000747|FG001|Overall Study|Withdrawal by Subject|0|||
46657938|NCT01052077|82869413|FG003|Phase A+|Lost to Follow-up|8|||
46657939|NCT01052077|82869410|FG000|Phase A+|Adverse Event|0|||
46657940|NCT01052077|82869411|FG001|Phase A+|Adverse Event|0|||
46782083|NCT00690378|83000746|FG000|Overall Study|Protocol Violation|1|||
46782084|NCT00690378|83000747|FG001|Overall Study|Protocol Violation|0|||
46782085|NCT00690378|83000746|FG000|Overall Study|Lost to Follow-up|2|||
46657941|NCT01052077|82869412|FG002|Phase A+|Adverse Event|0|||
46657942|NCT01052077|82869413|FG003|Phase A+|Adverse Event|4|||
46657943|NCT01052077|82869410|FG000|Phase A+|Met Withdrawal Criteria|0|||
46657944|NCT01052077|82869411|FG001|Phase A+|Met Withdrawal Criteria|0|||
46657945|NCT01052077|82869412|FG002|Phase A+|Met Withdrawal Criteria|0|||
46657946|NCT01052077|82869413|FG003|Phase A+|Met Withdrawal Criteria|2|||
46657947|NCT01052077|82869410|FG000|Phase A+|Withdrawal by Subject|0|||
46657948|NCT01052077|82869411|FG001|Phase A+|Withdrawal by Subject|0|||
46657949|NCT01052077|82869412|FG002|Phase A+|Withdrawal by Subject|0|||
46657950|NCT01052077|82869413|FG003|Phase A+|Withdrawal by Subject|7|||
46657951|NCT01052038|82869422|FG000|Overall Study|Lost to Follow-up|2|||
46657952|NCT01052038|82869423|FG001|Overall Study|Lost to Follow-up|3|||
46657953|NCT01052038|82869424|FG002|Overall Study|Lost to Follow-up|1|||
46657954|NCT01052038|82869422|FG000|Overall Study|Protocol Violation|2|||
46657955|NCT01052038|82869423|FG001|Overall Study|Protocol Violation|3|||
46657956|NCT01052038|82869424|FG002|Overall Study|Protocol Violation|3|||
46657957|NCT01051960|82869432|FG000|Overall Study|Adverse Event|1|||
46657958|NCT01051921|82869436|FG000|Overall Study|Physician Decision|9|||
46657959|NCT01051921|82869436|FG000|Overall Study|Adverse Event|8|||
46657960|NCT01051921|82869436|FG000|Overall Study|Withdrawal by Subject|7|||
46657961|NCT01051921|82869436|FG000|Overall Study|Lost to Follow-up|4|||
46657962|NCT01051921|82869436|FG000|Overall Study|virological failure|1|||
46657963|NCT01051921|82869436|FG000|Overall Study|patient moved|1|||
46657964|NCT01051063|82869442|FG000|Overall Study|Death|2|||
46657965|NCT01051063|82869443|FG001|Overall Study|Death|2|||
46657966|NCT01051063|82869442|FG000|Overall Study|Withdrawal by Subject|1|||
46657967|NCT01051063|82869443|FG001|Overall Study|Withdrawal by Subject|1|||
46657968|NCT01051063|82869442|FG000|Overall Study|Termination of the study|5|||
46657969|NCT01051063|82869443|FG001|Overall Study|Termination of the study|0|||
46657970|NCT01051063|82869442|FG000|Overall Study|Moved from the study site area|1|||
46657971|NCT01051063|82869443|FG001|Overall Study|Moved from the study site area|0|||
46657972|NCT01051063|82869442|FG000|Overall Study|Other|1|||
46657973|NCT01051063|82869443|FG001|Overall Study|Other|0|||
46657974|NCT01051063|82869442|FG000|Overall Study|Lost to Follow-up|0|||
46657975|NCT01051063|82869443|FG001|Overall Study|Lost to Follow-up|1|||
46657976|NCT01050790|82869450|FG000|Overall Study|Adverse Event|1|||
46657977|NCT01050673|82869457|FG000|Overall Study|Physician Decision|4|||
46657978|NCT01050673|82869458|FG001|Overall Study|Physician Decision|5|||
46657979|NCT01050205|82869466|FG000|Overall Study|Lost to Follow-up|7|||
46657980|NCT01050205|82869467|FG001|Overall Study|Lost to Follow-up|1|||
46657981|NCT01050205|82869466|FG000|Overall Study|Withdrawal by Subject|1|||
46657982|NCT01050205|82869467|FG001|Overall Study|Withdrawal by Subject|1|||
46657983|NCT01050205|82869466|FG000|Overall Study|Relocated from area|1|||
46657984|NCT01050205|82869467|FG001|Overall Study|Relocated from area|2|||
46657985|NCT01050205|82869466|FG000|Overall Study|Discontinued Intervention|2|||
46657986|NCT01050205|82869467|FG001|Overall Study|Discontinued Intervention|0|||
46657987|NCT01059448|82869477|FG000|Overall Study|Adverse Event|1|||
46657988|NCT01059448|82869478|FG001|Overall Study|Adverse Event|3|||
46657989|NCT01059448|82869479|FG002|Overall Study|Adverse Event|0|||
46657990|NCT01059448|82869480|FG003|Overall Study|Adverse Event|1|||
46657991|NCT01059448|82869477|FG000|Overall Study|Withdrawal by Subject|2|||
46657992|NCT01059448|82869478|FG001|Overall Study|Withdrawal by Subject|0|||
46657993|NCT01059448|82869479|FG002|Overall Study|Withdrawal by Subject|2|||
46657994|NCT01059448|82869480|FG003|Overall Study|Withdrawal by Subject|4|||
46657995|NCT01059448|82869477|FG000|Overall Study|Disease Progression|2|||
46657996|NCT01059448|82869478|FG001|Overall Study|Disease Progression|1|||
46657997|NCT01059448|82869479|FG002|Overall Study|Disease Progression|4|||
46657998|NCT01059448|82869480|FG003|Overall Study|Disease Progression|2|||
46657999|NCT01059448|82869477|FG000|Overall Study|Administrative Decision|43|||
46658000|NCT01059448|82869478|FG001|Overall Study|Administrative Decision|49|||
46658001|NCT01059448|82869479|FG002|Overall Study|Administrative Decision|45|||
46658002|NCT01059448|82869480|FG003|Overall Study|Administrative Decision|46|||
46658003|NCT01059448|82869477|FG000|Overall Study|Lost to Follow-up|0|||
46658004|NCT01059448|82869478|FG001|Overall Study|Lost to Follow-up|0|||
46658005|NCT01059448|82869479|FG002|Overall Study|Lost to Follow-up|2|||
46658006|NCT01059448|82869480|FG003|Overall Study|Lost to Follow-up|0|||
46658007|NCT01059448|82869477|FG000|Overall Study|Death|0|||
46658008|NCT01059448|82869478|FG001|Overall Study|Death|1|||
46658009|NCT01059448|82869479|FG002|Overall Study|Death|0|||
46658010|NCT01059448|82869480|FG003|Overall Study|Death|0|||
46658011|NCT01059448|82869477|FG000|Overall Study|Other|1|||
46658012|NCT01059448|82869478|FG001|Overall Study|Other|1|||
46658013|NCT01059448|82869479|FG002|Overall Study|Other|0|||
46658014|NCT01059448|82869480|FG003|Overall Study|Other|1|||
46658015|NCT01058707|82869501|FG000|Overall Study|Disease Progression|15|||
46658016|NCT01058707|82869502|FG001|Overall Study|Disease Progression|20|||
46658017|NCT01058707|82869503|FG002|Overall Study|Disease Progression|20|||
46658018|NCT01058707|82869504|FG003|Overall Study|Disease Progression|15|||
46658019|NCT01058707|82869505|FG004|Overall Study|Disease Progression|23|||
46658020|NCT01058707|82869506|FG005|Overall Study|Disease Progression|10|||
46658021|NCT01058707|82869507|FG006|Overall Study|Disease Progression|12|||
46658022|NCT01058707|82869501|FG000|Overall Study|Adverse Event|11|||
46658023|NCT01058707|82869502|FG001|Overall Study|Adverse Event|4|||
46658024|NCT01058707|82869503|FG002|Overall Study|Adverse Event|7|||
46658025|NCT01058707|82869504|FG003|Overall Study|Adverse Event|6|||
46658026|NCT01058707|82869505|FG004|Overall Study|Adverse Event|7|||
46658027|NCT01058707|82869506|FG005|Overall Study|Adverse Event|3|||
46658028|NCT01058707|82869507|FG006|Overall Study|Adverse Event|1|||
46658029|NCT01058707|82869501|FG000|Overall Study|Subject Decision|5|||
46658030|NCT01058707|82869502|FG001|Overall Study|Subject Decision|3|||
46658031|NCT01058707|82869503|FG002|Overall Study|Subject Decision|3|||
46658032|NCT01058707|82869504|FG003|Overall Study|Subject Decision|1|||
46658033|NCT01058707|82869505|FG004|Overall Study|Subject Decision|2|||
46658034|NCT01058707|82869506|FG005|Overall Study|Subject Decision|3|||
46658035|NCT01058707|82869507|FG006|Overall Study|Subject Decision|6|||
46658036|NCT01058707|82869501|FG000|Overall Study|Lost to Follow-up|0|||
46658037|NCT01058707|82869502|FG001|Overall Study|Lost to Follow-up|0|||
46658038|NCT01058707|82869503|FG002|Overall Study|Lost to Follow-up|1|||
46658039|NCT01058707|82869504|FG003|Overall Study|Lost to Follow-up|0|||
46658040|NCT01058707|82869505|FG004|Overall Study|Lost to Follow-up|0|||
46658041|NCT01058707|82869506|FG005|Overall Study|Lost to Follow-up|0|||
46658042|NCT01058707|82869507|FG006|Overall Study|Lost to Follow-up|0|||
46658043|NCT01058707|82869501|FG000|Overall Study|Reason Not Specified|0|||
46658044|NCT01058707|82869502|FG001|Overall Study|Reason Not Specified|3|||
46658045|NCT01058707|82869503|FG002|Overall Study|Reason Not Specified|2|||
46658046|NCT01058707|82869504|FG003|Overall Study|Reason Not Specified|0|||
46658047|NCT01058707|82869505|FG004|Overall Study|Reason Not Specified|7|||
46658048|NCT01058707|82869506|FG005|Overall Study|Reason Not Specified|1|||
46658049|NCT01058707|82869507|FG006|Overall Study|Reason Not Specified|7|||
46658050|NCT01054144|82869545|FG000|Overall Study|Death|2|||
46658051|NCT03276052|82869552|FG000|Overall Study|Withdrawal by Subject|5|||
46658052|NCT03276052|82869552|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
46658053|NCT00105586|82869562|FG000|Overall Study|Adverse Event|4|||
46658054|NCT00105586|82869563|FG001|Overall Study|Adverse Event|3|||
46658055|NCT00105586|82869562|FG000|Overall Study|Physician Decision|13|||
46658056|NCT00105586|82869563|FG001|Overall Study|Physician Decision|13|||
46658057|NCT01059643|82869571|FG000|Overall Study|Adverse Event|3|||
46658058|NCT01059643|82869571|FG000|Overall Study|Withdrawal by Subject|2|||
46658059|NCT01059643|82869571|FG000|Overall Study|Physician Decision|1|||
46658060|NCT01059565|82869580|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
46658061|NCT01059565|82869581|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
46658062|NCT01059565|82869580|FG000|24-Week Randomized Phase|Adverse Event|5|||
46658063|NCT01059565|82869581|FG001|24-Week Randomized Phase|Adverse Event|0|||
46658064|NCT01059565|82869580|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
46658065|NCT01059565|82869581|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
46658066|NCT01059565|82869580|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
46658067|NCT01059565|82869581|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
46658068|NCT01059565|82869580|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
46658069|NCT01059565|82869581|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
46658070|NCT01059565|82869580|FG000|24-Week Open-Label Phase|Adverse Event|2|||
46658071|NCT01059565|82869581|FG001|24-Week Open-Label Phase|Adverse Event|0|||
46658072|NCT01059565|82869580|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
46658073|NCT01059565|82869581|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
46658074|NCT01059565|82869580|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
46658075|NCT01059565|82869581|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
46658076|NCT01059565|82869580|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
46658077|NCT01059565|82869581|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
46658078|NCT01059565|82869580|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
46658079|NCT01059565|82869581|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
46658080|NCT01059565|82869580|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
46658081|NCT01059565|82869581|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
46658082|NCT01059526|82869591|FG000|Overall Study|Patient enrolled but not treated|20|||
46658083|NCT01059526|82869592|FG001|Overall Study|Patient enrolled but not treated|17|||
46658084|NCT01059526|82869591|FG000|Overall Study|Adverse Event|2|||
46658085|NCT01059526|82869592|FG001|Overall Study|Adverse Event|2|||
46658086|NCT01059526|82869591|FG000|Overall Study|Protocol Violation|0|||
46658087|NCT01059526|82869592|FG001|Overall Study|Protocol Violation|1|||
46658088|NCT01059526|82869591|FG000|Overall Study|Withdrawal by Subject|3|||
46658089|NCT01059526|82869592|FG001|Overall Study|Withdrawal by Subject|1|||
46658090|NCT01059526|82869591|FG000|Overall Study|Lost to Follow-up|4|||
46658091|NCT01059526|82869592|FG001|Overall Study|Lost to Follow-up|1|||
46658092|NCT01059526|82869591|FG000|Overall Study|Patient found to be dermatographic|1|||
46658093|NCT01059526|82869592|FG001|Overall Study|Patient found to be dermatographic|0|||
46658094|NCT03277261|82869600|FG000|Overall Study|Adverse Event|17|||
46658095|NCT03277261|82869601|FG001|Overall Study|Adverse Event|1|||
46658096|NCT03277261|82869600|FG000|Overall Study|Participant Withdrawal of Consent|6|||
46658097|NCT03277261|82869601|FG001|Overall Study|Participant Withdrawal of Consent|15|||
46658098|NCT03277261|82869600|FG000|Overall Study|Investigator / Sponsor Decision|4|||
46658099|NCT03277261|82869601|FG001|Overall Study|Investigator / Sponsor Decision|2|||
46658100|NCT03277261|82869600|FG000|Overall Study|Pregnancy|2|||
46658101|NCT03277261|82869601|FG001|Overall Study|Pregnancy|0|||
46658102|NCT03277261|82869600|FG000|Overall Study|Lost to Follow-up|2|||
46658103|NCT03277261|82869601|FG001|Overall Study|Lost to Follow-up|2|||
46658104|NCT03277261|82869600|FG000|Overall Study|Lack of Efficacy|2|||
46658105|NCT03277261|82869601|FG001|Overall Study|Lack of Efficacy|2|||
46782086|NCT00690378|83000747|FG001|Overall Study|Lost to Follow-up|3|||
46782087|NCT00690378|83000746|FG000|Overall Study|Did not meet inc/exc criteria|13|||
46782088|NCT00690378|83000747|FG001|Overall Study|Did not meet inc/exc criteria|11|||
46782089|NCT00690378|83000746|FG000|Overall Study|Social problem|1|||
46782090|NCT00690378|83000747|FG001|Overall Study|Social problem|0|||
46782091|NCT00574275|83000755|FG000|Overall Study|Randomized but not treated|2|||
46782092|NCT00574275|83000756|FG001|Overall Study|Randomized but not treated|3|||
46782093|NCT00574275|83000755|FG000|Overall Study|Adverse Event|32|||
46782094|NCT00574275|83000756|FG001|Overall Study|Adverse Event|76|||
46782095|NCT00574275|83000755|FG000|Overall Study|Disease progression|160|||
46782096|NCT00574275|83000756|FG001|Overall Study|Disease progression|146|||
46782097|NCT00574275|83000755|FG000|Overall Study|Lost to Follow-up|2|||
46658106|NCT03277261|82869600|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
46658107|NCT03277261|82869601|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
46658108|NCT03277690|82869623|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
46658109|NCT03277690|82869624|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
46658110|NCT03277690|82869623|FG000|Dose Titration and Maintenance|Physician Decision|1|||
46658111|NCT03277690|82869624|FG001|Dose Titration and Maintenance|Physician Decision|0|||
46658112|NCT03277690|82869623|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
46658113|NCT03277690|82869624|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
46658114|NCT03277690|82869623|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
46658115|NCT03277690|82869624|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
46782098|NCT00574275|83000756|FG001|Overall Study|Lost to Follow-up|1|||
46782099|NCT00574275|83000755|FG000|Overall Study|Study stopped based on DMC decision|62|||
46782100|NCT00574275|83000756|FG001|Overall Study|Study stopped based on DMC decision|23|||
46782101|NCT00574275|83000755|FG000|Overall Study|Withdrawal by Subject|15|||
46782102|NCT00574275|83000756|FG001|Overall Study|Withdrawal by Subject|17|||
46782103|NCT00574275|83000755|FG000|Overall Study|Error calculating tumor measurement|1|||
46782104|NCT00574275|83000756|FG001|Overall Study|Error calculating tumor measurement|0|||
46782105|NCT00574275|83000755|FG000|Overall Study|Physician Decision|1|||
46658116|NCT03277690|82869623|FG000|Dose Titration and Maintenance|Adverse Event|15|||
46658117|NCT03277690|82869624|FG001|Dose Titration and Maintenance|Adverse Event|0|||
46782106|NCT00574275|83000756|FG001|Overall Study|Physician Decision|1|||
46782107|NCT00574275|83000755|FG000|Overall Study|Protocol Violation|0|||
46782108|NCT00574275|83000756|FG001|Overall Study|Protocol Violation|1|||
46782109|NCT00574275|83000755|FG000|Overall Study|Patient and Investigator decision|0|||
46782110|NCT00574275|83000756|FG001|Overall Study|Patient and Investigator decision|1|||
46782111|NCT00574275|83000755|FG000|Overall Study|Insurance change|0|||
46782112|NCT00574275|83000756|FG001|Overall Study|Insurance change|1|||
46782113|NCT00574275|83000755|FG000|Overall Study|Operation for curative intent|0|||
46782114|NCT00574275|83000756|FG001|Overall Study|Operation for curative intent|1|||
46782115|NCT00567112|83000762|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
46782116|NCT00567112|83000763|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
46782117|NCT00567112|83000764|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
46658118|NCT03277690|82869623|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
46658119|NCT03277690|82869624|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
46658120|NCT03277690|82869623|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
46658121|NCT03277690|82869624|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
46658122|NCT03271021|82869633|FG000|Overall Study|Adverse Event|3|||
46658123|NCT03271021|82869634|FG001|Overall Study|Adverse Event|2|||
46658124|NCT03271021|82869633|FG000|Overall Study|Withdrawal by Subject|36|||
46658125|NCT03271021|82869634|FG001|Overall Study|Withdrawal by Subject|53|||
46658126|NCT03271021|82869633|FG000|Overall Study|Lost to Follow-up|34|||
46658127|NCT03271021|82869634|FG001|Overall Study|Lost to Follow-up|39|||
46658128|NCT03271021|82869633|FG000|Overall Study|Protocol Violation|6|||
46658129|NCT03271021|82869634|FG001|Overall Study|Protocol Violation|4|||
46658130|NCT03271021|82869633|FG000|Overall Study|Abnormal Lab Results|1|||
46658131|NCT03271021|82869634|FG001|Overall Study|Abnormal Lab Results|0|||
46658132|NCT03271021|82869633|FG000|Overall Study|Miscellaneous|9|||
46658133|NCT03271021|82869634|FG001|Overall Study|Miscellaneous|8|||
46658134|NCT01249651|82869655|FG000|Overall Study|Withdrawal by Subject|4|||
46658135|NCT01249651|82869655|FG000|Overall Study|Adverse Event|1|||
46658136|NCT01249651|82869655|FG000|Overall Study|Protocol Violation|1|||
46782118|NCT00567112|83000762|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
46782119|NCT00567112|83000763|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
46782120|NCT00567112|83000764|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
46782121|NCT00567112|83000762|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
46782122|NCT00567112|83000763|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
46782123|NCT00567112|83000764|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
46658137|NCT01249651|82869655|FG000|Overall Study|Sponsor Decision|1|||
46658138|NCT01249417|82869662|FG000|Randomised Population|Study treatment not received|0|||
46658139|NCT01249417|82869663|FG001|Randomised Population|Study treatment not received|0|||
46658140|NCT01249417|82869664|FG002|Randomised Population|Study treatment not received|2|||
46782124|NCT01618656|83000784|FG000|Overall Study|Withdrawal by Subject|7|||
46782125|NCT01618656|83000785|FG001|Overall Study|Withdrawal by Subject|3|||
46782126|NCT01618656|83000784|FG000|Overall Study|Physician Decision|1|||
46782127|NCT01618656|83000785|FG001|Overall Study|Physician Decision|1|||
46782128|NCT03978832|83000791|FG000|Overall Study|Adverse Event|1|||
46782129|NCT03978832|83000791|FG000|Overall Study|Lost to Follow-up|1|||
46782130|NCT03978832|83000791|FG000|Overall Study|Withdrawal by Subject|6|||
46782131|NCT03978832|83000791|FG000|Overall Study|Physician Decision|2|||
46782132|NCT03978832|83000791|FG000|Overall Study|did not pass screening criteria|44|||
46782133|NCT00566722|83000798|FG000|Overall Study|Adverse Event|0|||
46782134|NCT00566722|83000799|FG001|Overall Study|Adverse Event|1|||
46782135|NCT00566722|83000800|FG002|Overall Study|Adverse Event|0|||
46782136|NCT00566722|83000798|FG000|Overall Study|Withdrawal by Subject|0|||
46782137|NCT00566722|83000799|FG001|Overall Study|Withdrawal by Subject|0|||
46782138|NCT00566722|83000800|FG002|Overall Study|Withdrawal by Subject|1|||
46782139|NCT00566722|83000798|FG000|Overall Study|Lost to Follow-up|1|||
46782140|NCT00566722|83000799|FG001|Overall Study|Lost to Follow-up|1|||
46782141|NCT00566722|83000800|FG002|Overall Study|Lost to Follow-up|1|||
46782142|NCT00566722|83000798|FG000|Overall Study|Lack of Efficacy|1|||
46782143|NCT00566722|83000799|FG001|Overall Study|Lack of Efficacy|2|||
46782144|NCT00566722|83000800|FG002|Overall Study|Lack of Efficacy|4|||
46782145|NCT00566722|83000798|FG000|Overall Study|Did not meet exclusion criteria|0|||
46782146|NCT00566722|83000799|FG001|Overall Study|Did not meet exclusion criteria|0|||
46782147|NCT00566722|83000800|FG002|Overall Study|Did not meet exclusion criteria|2|||
46782148|NCT00566722|83000798|FG000|Overall Study|Serious adverse event|0|||
46782149|NCT00566722|83000799|FG001|Overall Study|Serious adverse event|1|||
46782150|NCT00566722|83000800|FG002|Overall Study|Serious adverse event|0|||
46782151|NCT00566722|83000798|FG000|Overall Study|Noncompliant with drug administration|0|||
46782152|NCT00566722|83000799|FG001|Overall Study|Noncompliant with drug administration|0|||
46782153|NCT00566722|83000800|FG002|Overall Study|Noncompliant with drug administration|1|||
46782154|NCT00691704|83000811|FG000|Induction Therapy|Disease Progression|1|||
46782155|NCT00691704|83000811|FG000|Induction Therapy|Active Hepatitis|1|||
46782156|NCT00691704|83000811|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
46658141|NCT01249417|82869662|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
46658142|NCT01249417|82869663|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
46658143|NCT01249417|82869664|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
46658144|NCT01249417|82869662|FG000|Treatment Phase - ITT Population|Other|0|||
46658145|NCT01249417|82869663|FG001|Treatment Phase - ITT Population|Other|0|||
46658146|NCT01249417|82869664|FG002|Treatment Phase - ITT Population|Other|1|||
46658147|NCT01249417|82869662|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
46782157|NCT00691704|83000811|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
46782158|NCT00691704|83000811|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
46971708|NCT02536833|83215244|FG002|Overall Study|Physician Decision|0|||
46971709|NCT02536833|83215245|FG003|Overall Study|Physician Decision|1|||
46971710|NCT02536833|83215242|FG000|Overall Study|Site Terminated by Sponsor|2|||
46971711|NCT02536833|83215243|FG001|Overall Study|Site Terminated by Sponsor|2|||
46658148|NCT01249417|82869663|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
46658149|NCT01249417|82869664|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
46658150|NCT01249417|82869662|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
46658151|NCT01249417|82869663|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
46658152|NCT01249417|82869664|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
46658153|NCT01249417|82869662|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
46658154|NCT01249417|82869663|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
46782159|NCT00566020|83000815|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
46782160|NCT00566020|83000816|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
46782161|NCT00566020|83000815|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
46782162|NCT00566020|83000816|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
46971712|NCT02536833|83215244|FG002|Overall Study|Site Terminated by Sponsor|2|||
46971713|NCT02536833|83215245|FG003|Overall Study|Site Terminated by Sponsor|2|||
46971714|NCT02536833|83215242|FG000|Overall Study|Subject Non-Compliance|0|||
46971715|NCT02536833|83215243|FG001|Overall Study|Subject Non-Compliance|1|||
46971716|NCT02536833|83215244|FG002|Overall Study|Subject Non-Compliance|1|||
46971717|NCT02536833|83215245|FG003|Overall Study|Subject Non-Compliance|0|||
46971718|NCT02536833|83215242|FG000|Overall Study|Withdrawal by Subject|4|||
46971719|NCT02536833|83215243|FG001|Overall Study|Withdrawal by Subject|3|||
46971720|NCT02536833|83215244|FG002|Overall Study|Withdrawal by Subject|5|||
46782163|NCT00566020|83000815|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
46782164|NCT00566020|83000816|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
46782165|NCT00566020|83000815|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
46782166|NCT00566020|83000816|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
46850983|NCT00098306|83066772|FG002|Open Label|Adverse Event|0|||
46971721|NCT02536833|83215245|FG003|Overall Study|Withdrawal by Subject|11|||
46971722|NCT02680847|83215259|FG000|Overall Study|Other|2|||
46782167|NCT00566020|83000815|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
46782168|NCT00566020|83000816|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
46782169|NCT00566020|83000815|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
46658155|NCT01249417|82869664|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
46658156|NCT01249261|82869674|FG000|Overall Study|Withdrawal by Subject|1|||
46658157|NCT01249261|82869675|FG001|Overall Study|Withdrawal by Subject|0|||
46658158|NCT01248949|82869691|FG000|Overall Study|Lost to Follow-up|2|||
46658159|NCT01248949|82869692|FG001|Overall Study|Lost to Follow-up|2|||
46658160|NCT01248949|82869693|FG002|Overall Study|Lost to Follow-up|2|||
46658161|NCT01248949|82869694|FG003|Overall Study|Lost to Follow-up|1|||
46658162|NCT01248949|82869695|FG004|Overall Study|Lost to Follow-up|0|||
46658163|NCT01248949|82869691|FG000|Overall Study|Withdrawal by Subject|5|||
46658164|NCT01248949|82869692|FG001|Overall Study|Withdrawal by Subject|3|||
46658165|NCT01248949|82869693|FG002|Overall Study|Withdrawal by Subject|11|||
46658166|NCT01248949|82869694|FG003|Overall Study|Withdrawal by Subject|3|||
46658167|NCT01248949|82869695|FG004|Overall Study|Withdrawal by Subject|1|||
46658168|NCT01248949|82869691|FG000|Overall Study|Death|22|||
46658169|NCT01248949|82869692|FG001|Overall Study|Death|7|||
46658170|NCT01248949|82869693|FG002|Overall Study|Death|21|||
46658171|NCT01248949|82869694|FG003|Overall Study|Death|6|||
46658172|NCT01248949|82869695|FG004|Overall Study|Death|2|||
46658173|NCT01248949|82869691|FG000|Overall Study|Alternative Therapy|1|||
46658174|NCT01248949|82869692|FG001|Overall Study|Alternative Therapy|0|||
46658175|NCT01248949|82869693|FG002|Overall Study|Alternative Therapy|0|||
46658176|NCT01248949|82869694|FG003|Overall Study|Alternative Therapy|0|||
46658177|NCT01248949|82869695|FG004|Overall Study|Alternative Therapy|0|||
46658178|NCT01248949|82869691|FG000|Overall Study|Alternative Therapy.|1|||
46658179|NCT01248949|82869692|FG001|Overall Study|Alternative Therapy.|0|||
46658180|NCT01248949|82869693|FG002|Overall Study|Alternative Therapy.|0|||
46658181|NCT01248949|82869694|FG003|Overall Study|Alternative Therapy.|0|||
46658182|NCT01248949|82869695|FG004|Overall Study|Alternative Therapy.|0|||
46658183|NCT01248949|82869691|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
46658184|NCT01248949|82869692|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
46658185|NCT01248949|82869693|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
46658186|NCT01248949|82869694|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
46658187|NCT01248949|82869695|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
46658188|NCT01248949|82869691|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
46658189|NCT01248949|82869692|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
46658190|NCT01248949|82869693|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
46658191|NCT01248949|82869694|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
46658192|NCT01248949|82869695|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
46658193|NCT01248949|82869691|FG000|Overall Study|Participant Went To Hospice|0|||
46658194|NCT01248949|82869692|FG001|Overall Study|Participant Went To Hospice|0|||
46658195|NCT01248949|82869693|FG002|Overall Study|Participant Went To Hospice|1|||
46658196|NCT01248949|82869694|FG003|Overall Study|Participant Went To Hospice|0|||
46658197|NCT01248949|82869695|FG004|Overall Study|Participant Went To Hospice|0|||
46658198|NCT01248949|82869691|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
46658199|NCT01248949|82869692|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
46658200|NCT01248949|82869693|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
46658201|NCT01248949|82869694|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
46658202|NCT01248949|82869695|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
46658203|NCT01248949|82869691|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
46658204|NCT01248949|82869692|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
46658205|NCT01248949|82869693|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
46658206|NCT01248949|82869694|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
46658207|NCT01248949|82869695|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
46658208|NCT01248949|82869691|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
46658209|NCT01248949|82869692|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
46658210|NCT01248949|82869693|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
46658211|NCT01248949|82869694|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
46658212|NCT01248949|82869695|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
46658213|NCT01248949|82869691|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
46658214|NCT01248949|82869692|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
46782170|NCT00566020|83000816|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
46658215|NCT01248949|82869693|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
46658216|NCT01248949|82869694|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
46782171|NCT00564070|83000823|FG000|Overall Study|Lost to Follow-up|9|||
46658217|NCT01248949|82869695|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
46658218|NCT01248793|82869709|FG000|Overall Study|Lost to Follow-up|0|||
46658219|NCT01248793|82869710|FG001|Overall Study|Lost to Follow-up|1|||
46658220|NCT01248793|82869709|FG000|Overall Study|Adverse Event|1|||
46658221|NCT01248793|82869710|FG001|Overall Study|Adverse Event|1|||
46782172|NCT00564070|83000824|FG001|Overall Study|Lost to Follow-up|7|||
46782173|NCT00564070|83000823|FG000|Overall Study|Worsening depression, referred to care|3|||
46782174|NCT00564070|83000824|FG001|Overall Study|Worsening depression, referred to care|0|||
46782175|NCT00690612|83000830|FG000|Overall Study|Adverse Event|1|||
46782176|NCT00690612|83000830|FG000|Overall Study|Withdrawal by Subject|2|||
46782177|NCT00621153|83000836|FG000|Overall Study|Safety Reason|8|||
46782178|NCT00621153|83000837|FG001|Overall Study|Safety Reason|7|||
46782179|NCT00621153|83000836|FG000|Overall Study|Adverse Event|3|||
46782180|NCT00621153|83000837|FG001|Overall Study|Adverse Event|2|||
46782181|NCT00621153|83000836|FG000|Overall Study|Lost to Follow-up|5|||
46782182|NCT00621153|83000837|FG001|Overall Study|Lost to Follow-up|1|||
46782183|NCT00621153|83000836|FG000|Overall Study|Withdrawal by Subject|4|||
46782184|NCT00621153|83000837|FG001|Overall Study|Withdrawal by Subject|5|||
46782185|NCT00574119|83000843|FG000|Overall Study|Adverse Event|1|||
46782186|NCT00574119|83000843|FG000|Overall Study|Protocol Violation|1|||
46782187|NCT00574119|83000843|FG000|Overall Study|Withdrawal by Subject|1|||
46782188|NCT00574119|83000843|FG000|Overall Study|Physician Decision|1|||
46782189|NCT00705614|83000849|FG000|Initial Intervention|Adverse Event|40|||
46782190|NCT00705614|83000850|FG001|Initial Intervention|Adverse Event|21|||
46782191|NCT00705614|83000849|FG000|Initial Intervention|Lost to Follow-up|310|||
46782192|NCT00705614|83000850|FG001|Initial Intervention|Lost to Follow-up|191|||
46658222|NCT01248793|82869709|FG000|Overall Study|Protocol Violation|0|||
46658223|NCT01248793|82869710|FG001|Overall Study|Protocol Violation|1|||
46658224|NCT01248793|82869709|FG000|Overall Study|Withdrawal by Subject|3|||
46658225|NCT01248793|82869710|FG001|Overall Study|Withdrawal by Subject|3|||
46658226|NCT01248364|82869720|FG000|Overall Study|Adverse Event|0|||
46658227|NCT01248364|82869721|FG001|Overall Study|Adverse Event|1|||
46782193|NCT00705614|83000849|FG000|Initial Intervention|Withdrawal by Subject|114|||
46782194|NCT00705614|83000850|FG001|Initial Intervention|Withdrawal by Subject|71|||
46658228|NCT01248364|82869722|FG002|Overall Study|Adverse Event|0|||
46658229|NCT01248364|82869723|FG003|Overall Study|Adverse Event|0|||
46658230|NCT01248130|82869735|FG000|Overall Study|Protocol Violation|1|||
46658231|NCT01248130|82869736|FG001|Overall Study|Protocol Violation|0|||
46658232|NCT01248130|82869735|FG000|Overall Study|Ineligible|1|||
46782195|NCT00705614|83000849|FG000|Initial Intervention|Administrative Reason|51|||
46658233|NCT01248130|82869736|FG001|Overall Study|Ineligible|0|||
46782196|NCT00705614|83000850|FG001|Initial Intervention|Administrative Reason|38|||
46782197|NCT00705614|83000849|FG000|Initial Intervention|Status completion unknown|3|||
46782198|NCT00705614|83000850|FG001|Initial Intervention|Status completion unknown|0|||
46782199|NCT00705614|83000849|FG000|Switch to Remicade|Adverse Event|0|||
46782200|NCT00705614|83000850|FG001|Switch to Remicade|Adverse Event|5|||
46782201|NCT00705614|83000849|FG000|Switch to Remicade|Lost to Follow-up|0|||
46782202|NCT00705614|83000850|FG001|Switch to Remicade|Lost to Follow-up|23|||
46782203|NCT00705614|83000849|FG000|Switch to Remicade|Withdrawal by Subject|0|||
46782204|NCT00705614|83000850|FG001|Switch to Remicade|Withdrawal by Subject|12|||
46658234|NCT01248013|82869742|FG000|Overall Study|Withdrawal by Subject|14|||
46658235|NCT01247350|82869751|FG000|Overall Study|Adverse Event|0|||
46658236|NCT01247350|82869752|FG001|Overall Study|Adverse Event|0|||
46658237|NCT01247350|82869753|FG002|Overall Study|Adverse Event|1|||
46658238|NCT01247350|82869754|FG003|Overall Study|Adverse Event|0|||
46658239|NCT01247350|82869755|FG004|Overall Study|Adverse Event|0|||
46658240|NCT01247350|82869751|FG000|Overall Study|Withdrawal by Subject|0|||
46658241|NCT01247350|82869752|FG001|Overall Study|Withdrawal by Subject|0|||
46658242|NCT01247350|82869753|FG002|Overall Study|Withdrawal by Subject|0|||
46658243|NCT01247350|82869754|FG003|Overall Study|Withdrawal by Subject|1|||
46658244|NCT01247350|82869755|FG004|Overall Study|Withdrawal by Subject|0|||
46658245|NCT01247350|82869751|FG000|Overall Study|Entry criteria not met|0|||
46658246|NCT01247350|82869752|FG001|Overall Study|Entry criteria not met|0|||
46658247|NCT01247350|82869753|FG002|Overall Study|Entry criteria not met|0|||
46658248|NCT01247350|82869754|FG003|Overall Study|Entry criteria not met|0|||
46658249|NCT01247350|82869755|FG004|Overall Study|Entry criteria not met|1|||
46658250|NCT01246999|82869785|FG000|Overall Study|Lost to Follow-up|0|||
46782205|NCT00705614|83000849|FG000|Switch to Remicade|Administrative Reason|0|||
46782206|NCT00705614|83000850|FG001|Switch to Remicade|Administrative Reason|9|||
46782207|NCT00620763|83000858|FG000|Period: First Intervention|Withdrawal by Subject|0|||
46782208|NCT00620763|83000859|FG001|Period: First Intervention|Withdrawal by Subject|2|||
46658251|NCT01246999|82869786|FG001|Overall Study|Lost to Follow-up|1|||
46658252|NCT01246999|82869787|FG002|Overall Study|Lost to Follow-up|0|||
46782209|NCT00620763|83000858|FG000|Period: First Intervention|Protocol Violation|0|||
46782210|NCT00620763|83000859|FG001|Period: First Intervention|Protocol Violation|3|||
46782211|NCT00620763|83000858|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
46850984|NCT00098306|83066773|FG003|Open Label|Adverse Event|2|||
46658253|NCT01246999|82869788|FG003|Overall Study|Lost to Follow-up|0|||
46658254|NCT01246999|82869785|FG000|Overall Study|Withdrawal by Subject|0|||
46658255|NCT01246999|82869786|FG001|Overall Study|Withdrawal by Subject|0|||
46658256|NCT01246999|82869787|FG002|Overall Study|Withdrawal by Subject|0|||
46658257|NCT01246999|82869788|FG003|Overall Study|Withdrawal by Subject|2|||
46658258|NCT01245751|82869805|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
46658259|NCT01245751|82869806|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
46658260|NCT01245751|82869807|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
46658261|NCT01245751|82869808|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
46658262|NCT01245751|82869805|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
46658263|NCT01245751|82869806|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
46658264|NCT01245751|82869807|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
46658265|NCT01245751|82869808|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
46658266|NCT01245751|82869805|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
46658267|NCT01245751|82869806|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
46658268|NCT01245751|82869807|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
46658269|NCT01245751|82869808|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
46658270|NCT01245673|82869819|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
46658271|NCT01245283|82869826|FG000|Overall Study|Lost to Follow-up|14|||
46658272|NCT01245283|82869827|FG001|Overall Study|Lost to Follow-up|11|||
46658273|NCT01245283|82869828|FG002|Overall Study|Lost to Follow-up|11|||
46658274|NCT01245049|82869841|FG000|Overall Study|Migrated/moved from study area|0|||
46658275|NCT01245049|82869842|FG001|Overall Study|Migrated/moved from study area|1|||
46658276|NCT01245049|82869841|FG000|Overall Study|Withdrawal by Subject|0|||
46658277|NCT01245049|82869842|FG001|Overall Study|Withdrawal by Subject|1|||
46658278|NCT01245049|82869841|FG000|Overall Study|Lost to Follow-up|1|||
46658279|NCT01245049|82869842|FG001|Overall Study|Lost to Follow-up|2|||
46658280|NCT01244893|82869848|FG000|Baseline|Protocol Violation|0|||
46971723|NCT02680847|83215260|FG001|Overall Study|Other|0|||
46971724|NCT02680847|83215261|FG002|Overall Study|Other|0|||
46658281|NCT01244893|82869849|FG001|Baseline|Protocol Violation|1|||
46658282|NCT01244893|82869848|FG000|1-Week Follow Up|Lost to Follow-up|1|||
46658283|NCT01244893|82869849|FG001|1-Week Follow Up|Lost to Follow-up|0|||
46658284|NCT01244815|82869864|FG000|Overall Study|Not Treated|0|||
46658285|NCT01244815|82869865|FG001|Overall Study|Not Treated|1|||
46658286|NCT01244815|82869866|FG002|Overall Study|Not Treated|0|||
46658287|NCT01244815|82869867|FG003|Overall Study|Not Treated|0|||
46658288|NCT01244815|82869864|FG000|Overall Study|Adverse Event|4|||
46658289|NCT01244815|82869865|FG001|Overall Study|Adverse Event|7|||
46658290|NCT01244815|82869866|FG002|Overall Study|Adverse Event|5|||
46658291|NCT01244815|82869867|FG003|Overall Study|Adverse Event|5|||
46658292|NCT01244815|82869864|FG000|Overall Study|Treatment Failure|0|||
46658293|NCT01244815|82869865|FG001|Overall Study|Treatment Failure|0|||
46658294|NCT01244815|82869866|FG002|Overall Study|Treatment Failure|0|||
46658295|NCT01244815|82869867|FG003|Overall Study|Treatment Failure|1|||
46658296|NCT01244815|82869864|FG000|Overall Study|Lost to Follow-up|3|||
46658297|NCT01244815|82869865|FG001|Overall Study|Lost to Follow-up|2|||
46658298|NCT01244815|82869866|FG002|Overall Study|Lost to Follow-up|3|||
46658299|NCT01244815|82869867|FG003|Overall Study|Lost to Follow-up|2|||
46658300|NCT01244815|82869864|FG000|Overall Study|Withdrawal by Subject|0|||
46658301|NCT01244815|82869865|FG001|Overall Study|Withdrawal by Subject|2|||
46658302|NCT01244815|82869866|FG002|Overall Study|Withdrawal by Subject|0|||
46658303|NCT01244815|82869867|FG003|Overall Study|Withdrawal by Subject|3|||
46658304|NCT01244815|82869864|FG000|Overall Study|Protocol Violation|7|||
46782212|NCT00620763|83000859|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
46782213|NCT00562978|83000867|FG000|Overall Study|Patient had imaging dose only|1|||
46782214|NCT00562978|83000868|FG001|Overall Study|Patient had imaging dose only|11|||
46782215|NCT00620373|83000874|FG000|Overall Study|Unverified cancer status|33|||
46658305|NCT01244815|82869865|FG001|Overall Study|Protocol Violation|4|||
46658306|NCT01244815|82869866|FG002|Overall Study|Protocol Violation|3|||
46658307|NCT01244815|82869867|FG003|Overall Study|Protocol Violation|1|||
46658308|NCT01244815|82869864|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
46658309|NCT01244815|82869865|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
46658310|NCT01244815|82869866|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
46658311|NCT01244815|82869867|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
46658312|NCT01244425|82869879|FG000|Overall Study|Withdrawal by Subject|2|||
46658313|NCT01244425|82869880|FG001|Overall Study|Withdrawal by Subject|2|||
46658314|NCT01244425|82869879|FG000|Overall Study|Adverse Event|1|||
46658315|NCT01244425|82869880|FG001|Overall Study|Adverse Event|1|||
46658316|NCT01244191|82869896|FG000|Overall Study|Progressive disease|295|||
46658317|NCT01244191|82869897|FG001|Overall Study|Progressive disease|350|||
46658318|NCT01244191|82869896|FG000|Overall Study|Clinical disease progression|54|||
46658319|NCT01244191|82869897|FG001|Overall Study|Clinical disease progression|36|||
46658320|NCT01244191|82869896|FG000|Overall Study|Adverse Event|65|||
46658321|NCT01244191|82869897|FG001|Overall Study|Adverse Event|48|||
46658322|NCT01244191|82869896|FG000|Overall Study|Death|22|||
46658323|NCT01244191|82869897|FG001|Overall Study|Death|29|||
46658324|NCT01244191|82869896|FG000|Overall Study|Lost to Follow-up|0|||
46658325|NCT01244191|82869897|FG001|Overall Study|Lost to Follow-up|2|||
46658326|NCT01244191|82869896|FG000|Overall Study|Protocol Violation|1|||
46658327|NCT01244191|82869897|FG001|Overall Study|Protocol Violation|2|||
46658328|NCT01244191|82869896|FG000|Overall Study|Withdrawal by Subject|31|||
46658329|NCT01244191|82869897|FG001|Overall Study|Withdrawal by Subject|23|||
46658330|NCT01244191|82869896|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
46658331|NCT01244191|82869897|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
46658332|NCT01244035|82869903|FG000|Part 1: Period 1|Adverse Event|0|||
46658333|NCT01244035|82869904|FG001|Part 1: Period 1|Adverse Event|0|||
46658334|NCT01244035|82869905|FG002|Part 1: Period 1|Adverse Event|0|||
46658335|NCT01244035|82869906|FG003|Part 1: Period 1|Adverse Event|0|||
46658336|NCT01244035|82869907|FG004|Part 1: Period 1|Adverse Event|0|||
46658337|NCT01244035|82869908|FG005|Part 1: Period 1|Adverse Event|1|||
46658338|NCT01244035|82869903|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
46658339|NCT01244035|82869904|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
46658340|NCT01244035|82869905|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
46658341|NCT01244035|82869906|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
46658342|NCT01244035|82869907|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
46658343|NCT01244035|82869908|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
46658344|NCT01244035|82869903|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
46658345|NCT01244035|82869904|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
46658346|NCT01244035|82869905|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
46658347|NCT01244035|82869906|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
46658348|NCT01244035|82869907|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
46658349|NCT01244035|82869908|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
46658350|NCT01244035|82869903|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
46658351|NCT01244035|82869904|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
46658352|NCT01244035|82869905|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
46658353|NCT01244035|82869906|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
46658354|NCT01244035|82869907|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
46658355|NCT01244035|82869908|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
46658356|NCT01244035|82869903|FG000|Part 1: Period 3|Adverse Event|0|||
46658357|NCT01244035|82869904|FG001|Part 1: Period 3|Adverse Event|0|||
46658358|NCT01244035|82869905|FG002|Part 1: Period 3|Adverse Event|0|||
46658359|NCT01244035|82869906|FG003|Part 1: Period 3|Adverse Event|0|||
46658360|NCT01244035|82869907|FG004|Part 1: Period 3|Adverse Event|0|||
46658361|NCT01244035|82869908|FG005|Part 1: Period 3|Adverse Event|1|||
46658362|NCT01244035|82869903|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
46658363|NCT01244035|82869904|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
46658364|NCT01244035|82869905|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
46658365|NCT01244035|82869906|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
46658366|NCT01244035|82869907|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
46658367|NCT01244035|82869908|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
46658368|NCT01244035|82869903|FG000|Part 1: Period 3|Protocol Deviation|0|||
46658369|NCT01244035|82869904|FG001|Part 1: Period 3|Protocol Deviation|1|||
46658370|NCT01244035|82869905|FG002|Part 1: Period 3|Protocol Deviation|0|||
46658371|NCT01244035|82869906|FG003|Part 1: Period 3|Protocol Deviation|0|||
46658372|NCT01244035|82869907|FG004|Part 1: Period 3|Protocol Deviation|0|||
46658373|NCT01244035|82869908|FG005|Part 1: Period 3|Protocol Deviation|0|||
46658374|NCT01243762|82869944|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
46658375|NCT01243762|82869945|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
46658376|NCT01243762|82869946|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
46658377|NCT01243762|82869947|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
46658378|NCT01243762|82869948|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
46658379|NCT01243762|82869949|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
46658380|NCT01243762|82869950|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
46658381|NCT01243762|82869944|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
46658382|NCT01243762|82869945|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
46658383|NCT01243762|82869946|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
46658384|NCT01243762|82869947|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
46658385|NCT01243762|82869948|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
46658386|NCT01243762|82869949|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
46658387|NCT01243762|82869950|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
46658388|NCT01243762|82869944|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
46658389|NCT01243762|82869945|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
46658390|NCT01243762|82869946|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
46658391|NCT01243762|82869947|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
46658392|NCT01243762|82869948|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
46658393|NCT01243762|82869949|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
46658394|NCT01243762|82869950|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
46658395|NCT01243762|82869944|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
46658396|NCT01243762|82869945|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
46658397|NCT01243762|82869946|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
46658398|NCT01243762|82869947|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
46658399|NCT01243762|82869948|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
46658400|NCT01243762|82869949|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
46658401|NCT01243762|82869950|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
46658402|NCT01243762|82869944|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
46658403|NCT01243762|82869945|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
46658404|NCT01243762|82869946|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
46658405|NCT01243762|82869947|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
46658406|NCT01243762|82869948|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
46658407|NCT01243762|82869949|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
46658408|NCT01243762|82869950|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
46658409|NCT01243762|82869944|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
46658410|NCT01243762|82869945|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
46658411|NCT01243762|82869946|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
46658412|NCT01243762|82869947|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
46658413|NCT01243762|82869948|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
46658414|NCT01243762|82869949|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
46658415|NCT01243762|82869950|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
46658416|NCT01243762|82869944|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
46658417|NCT01243762|82869945|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
46658418|NCT01243762|82869946|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
46658419|NCT01243762|82869947|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
46658420|NCT01243762|82869948|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
46658421|NCT01243762|82869949|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
46658422|NCT01243762|82869950|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
46658423|NCT01243762|82869944|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
46658424|NCT01243762|82869945|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
46658425|NCT01243762|82869946|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
46658426|NCT01243762|82869947|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
46658427|NCT01243762|82869948|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
46658428|NCT01243762|82869949|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
46658429|NCT01243762|82869950|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
46658430|NCT01243411|82869969|FG000|Overall Study|Withdrawal by Subject|18|||
46658431|NCT01243411|82869969|FG000|Overall Study|Lost to Follow-up|10|||
46658432|NCT01243411|82869969|FG000|Overall Study|Adverse Event|5|||
46658433|NCT01243411|82869969|FG000|Overall Study|Other|8|||
46658434|NCT01243177|82869975|FG000|Overall Study|Lack of Efficacy|47|||
46658435|NCT01243177|82869976|FG001|Overall Study|Lack of Efficacy|31|||
46658436|NCT01243177|82869975|FG000|Overall Study|Protocol Violation|11|||
46658437|NCT01243177|82869976|FG001|Overall Study|Protocol Violation|10|||
46658438|NCT01243177|82869975|FG000|Overall Study|Lost to Follow-up|15|||
46658439|NCT01243177|82869976|FG001|Overall Study|Lost to Follow-up|18|||
46658440|NCT01243177|82869975|FG000|Overall Study|Withdrawal by Subject|46|||
46658441|NCT01243177|82869976|FG001|Overall Study|Withdrawal by Subject|38|||
46658442|NCT01243177|82869975|FG000|Overall Study|AE, serious fatal|0|||
46658443|NCT01243177|82869976|FG001|Overall Study|AE, serious fatal|1|||
46658444|NCT01243177|82869975|FG000|Overall Study|SAE, non-fatal|7|||
46658445|NCT01243177|82869976|FG001|Overall Study|SAE, non-fatal|9|||
46658446|NCT01243177|82869975|FG000|Overall Study|AE, non-serious non-fatal|40|||
46658447|NCT01243177|82869976|FG001|Overall Study|AE, non-serious non-fatal|58|||
46658448|NCT01243177|82869975|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
46658449|NCT01243177|82869976|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
46782216|NCT00372619|83000888|FG000|Overall Study|Ineligible|0|||
46782217|NCT00372619|83000889|FG001|Overall Study|Ineligible|0|||
46782218|NCT00372619|83000890|FG002|Overall Study|Ineligible|0|||
46782219|NCT00372619|83000891|FG003|Overall Study|Ineligible|0|||
46971725|NCT02680847|83215259|FG000|Overall Study|No longer met eligibility criteria|2|||
46658450|NCT01243177|82869975|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
46658451|NCT01243177|82869976|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
46658452|NCT01243177|82869975|FG000|Overall Study|Other Reason|11|||
46658453|NCT01243177|82869976|FG001|Overall Study|Other Reason|12|||
46658454|NCT01242748|82869984|FG000|Overall Study|Adverse Event|10|||
46658455|NCT01242748|82869985|FG001|Overall Study|Adverse Event|5|||
46658456|NCT01242748|82869984|FG000|Overall Study|Lost to Follow-up|6|||
46658457|NCT01242748|82869985|FG001|Overall Study|Lost to Follow-up|2|||
46658458|NCT01242748|82869984|FG000|Overall Study|Physician Decision|3|||
46658459|NCT01242748|82869985|FG001|Overall Study|Physician Decision|2|||
46658460|NCT01242748|82869984|FG000|Overall Study|Protocol Violation|1|||
46658461|NCT01242748|82869985|FG001|Overall Study|Protocol Violation|0|||
46658462|NCT01242748|82869984|FG000|Overall Study|Withdrawal by Subject|10|||
46658463|NCT01242748|82869985|FG001|Overall Study|Withdrawal by Subject|2|||
46658464|NCT01242748|82869984|FG000|Overall Study|Miscellaneous reasons|8|||
46658465|NCT01242748|82869985|FG001|Overall Study|Miscellaneous reasons|3|||
46658466|NCT01242514|82869994|FG000|Overall Study|e.g., project closure|1042|||
46658467|NCT01242514|82869995|FG001|Overall Study|e.g., project closure|305|||
46658468|NCT01242514|82869996|FG002|Overall Study|e.g., project closure|171|||
46658469|NCT01242514|82869994|FG000|Overall Study|Subject decision|33|||
46658470|NCT01242514|82869995|FG001|Overall Study|Subject decision|8|||
46658471|NCT01242514|82869996|FG002|Overall Study|Subject decision|2|||
46658472|NCT01242514|82869994|FG000|Overall Study|Severe non-compliance to protocol|5|||
46658473|NCT01242514|82869995|FG001|Overall Study|Severe non-compliance to protocol|2|||
46658474|NCT01242514|82869996|FG002|Overall Study|Severe non-compliance to protocol|1|||
46658475|NCT01242514|82869994|FG000|Overall Study|Lack of therapeutic response|99|||
46658476|NCT01242514|82869995|FG001|Overall Study|Lack of therapeutic response|16|||
46658477|NCT01242514|82869996|FG002|Overall Study|Lack of therapeutic response|10|||
46658478|NCT01242514|82869994|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
46658479|NCT01242514|82869995|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
46658480|NCT01242514|82869996|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
46658481|NCT01242514|82869994|FG000|Overall Study|Lost to Follow-up|14|||
46658482|NCT01242514|82869995|FG001|Overall Study|Lost to Follow-up|5|||
46658483|NCT01242514|82869996|FG002|Overall Study|Lost to Follow-up|4|||
46658484|NCT01242514|82869994|FG000|Overall Study|Adverse Event|129|||
46658485|NCT01242514|82869995|FG001|Overall Study|Adverse Event|18|||
46658486|NCT01242514|82869996|FG002|Overall Study|Adverse Event|19|||
46658487|NCT01242085|82870007|FG000|Overall Study|Withdrawal by Subject|4|||
46658488|NCT01242085|82870008|FG001|Overall Study|Withdrawal by Subject|2|||
46658489|NCT01242085|82870009|FG002|Overall Study|Withdrawal by Subject|0|||
46658490|NCT01242085|82870007|FG000|Overall Study|medically unable to have surgery|4|||
46658491|NCT01242085|82870008|FG001|Overall Study|medically unable to have surgery|5|||
46658492|NCT01242085|82870009|FG002|Overall Study|medically unable to have surgery|0|||
46658493|NCT01241461|82870017|FG000|Overall Study|Progressive Disease|3|||
46658494|NCT01241461|82870018|FG001|Overall Study|Progressive Disease|6|||
46658495|NCT01240135|82870030|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
46658496|NCT01240135|82870031|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
46658497|NCT01240135|82870030|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
46658498|NCT01240135|82870031|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
46658499|NCT01247701|82870037|FG000|Overall Study|Death|2|||
46658500|NCT01247701|82870037|FG000|Overall Study|Relapsed|8|||
46658501|NCT01248247|82870045|FG000|Overall Study|Adverse Event|2|||
46658502|NCT01248247|82870046|FG001|Overall Study|Adverse Event|4|||
46658503|NCT01248247|82870047|FG002|Overall Study|Adverse Event|4|||
46658504|NCT01248247|82870048|FG003|Overall Study|Adverse Event|2|||
46658505|NCT01248247|82870045|FG000|Overall Study|Death|0|||
46971726|NCT02680847|83215260|FG001|Overall Study|No longer met eligibility criteria|2|||
46658506|NCT01248247|82870046|FG001|Overall Study|Death|1|||
46782220|NCT00372619|83000892|FG004|Overall Study|Ineligible|0|||
46850985|NCT00098306|83066774|FG004|Open Label|Adverse Event|0|||
46850986|NCT00098306|83066775|FG005|Open Label|Adverse Event|0|||
46850987|NCT00098306|83066776|FG006|Open Label|Adverse Event|0|||
46850988|NCT00098306|83066770|FG000|Open Label|Death|0|||
46850989|NCT00098306|83066771|FG001|Open Label|Death|0|||
46850990|NCT00098306|83066772|FG002|Open Label|Death|0|||
46850991|NCT00098306|83066773|FG003|Open Label|Death|4|||
46850992|NCT00098306|83066774|FG004|Open Label|Death|0|||
46850993|NCT00098306|83066775|FG005|Open Label|Death|0|||
46850994|NCT00098306|83066776|FG006|Open Label|Death|0|||
46850995|NCT00098306|83066770|FG000|Open Label|Participant defaulted|0|||
46658507|NCT01248247|82870047|FG002|Overall Study|Death|4|||
46658508|NCT01248247|82870048|FG003|Overall Study|Death|7|||
46658509|NCT01248247|82870045|FG000|Overall Study|Lost to Follow-up|0|||
46658510|NCT01248247|82870046|FG001|Overall Study|Lost to Follow-up|1|||
46658511|NCT01248247|82870047|FG002|Overall Study|Lost to Follow-up|1|||
46658512|NCT01248247|82870048|FG003|Overall Study|Lost to Follow-up|0|||
46658513|NCT01248247|82870045|FG000|Overall Study|Alternative treatment|0|||
46658514|NCT01248247|82870046|FG001|Overall Study|Alternative treatment|1|||
46658515|NCT01248247|82870047|FG002|Overall Study|Alternative treatment|0|||
46658516|NCT01248247|82870048|FG003|Overall Study|Alternative treatment|0|||
46658517|NCT01248247|82870045|FG000|Overall Study|Other|2|||
46658518|NCT01248247|82870046|FG001|Overall Study|Other|8|||
46658519|NCT01248247|82870047|FG002|Overall Study|Other|8|||
46658520|NCT01248247|82870048|FG003|Overall Study|Other|5|||
46658521|NCT01248247|82870045|FG000|Overall Study|Progression|18|||
46658522|NCT01248247|82870046|FG001|Overall Study|Progression|27|||
46658523|NCT01248247|82870047|FG002|Overall Study|Progression|56|||
46658524|NCT01248247|82870048|FG003|Overall Study|Progression|44|||
46658525|NCT01248247|82870045|FG000|Overall Study|Refuse further treatment|0|||
46658526|NCT01248247|82870046|FG001|Overall Study|Refuse further treatment|0|||
46658527|NCT01248247|82870047|FG002|Overall Study|Refuse further treatment|1|||
46658528|NCT01248247|82870048|FG003|Overall Study|Refuse further treatment|2|||
46658529|NCT01248247|82870045|FG000|Overall Study|Complicating disease|0|||
46658530|NCT01248247|82870046|FG001|Overall Study|Complicating disease|0|||
46658531|NCT01248247|82870047|FG002|Overall Study|Complicating disease|1|||
46658532|NCT01248247|82870048|FG003|Overall Study|Complicating disease|1|||
46658533|NCT02598583|82870060|FG000|Extension Period|Withdrawal by Subject|1|||
46658534|NCT02598583|82870061|FG001|Extension Period|Withdrawal by Subject|0|||
46658535|NCT04940130|82870083|FG000|Overall Study|Travel|1|||
46658536|NCT04940130|82870084|FG001|Overall Study|Travel|0|||
46658537|NCT04940130|82870085|FG002|Overall Study|Travel|2|||
46658538|NCT04940130|82870083|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
46658539|NCT04940130|82870084|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
46658540|NCT04940130|82870085|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
46658541|NCT04940130|82870083|FG000|Overall Study|Adverse Event|0|||
46658542|NCT04940130|82870084|FG001|Overall Study|Adverse Event|0|||
46658543|NCT04940130|82870085|FG002|Overall Study|Adverse Event|2|||
46658544|NCT04940130|82870083|FG000|Overall Study|Disease progression/treatment failure|0|||
46658545|NCT04940130|82870084|FG001|Overall Study|Disease progression/treatment failure|0|||
46658546|NCT04940130|82870085|FG002|Overall Study|Disease progression/treatment failure|1|||
46658547|NCT04940130|82870083|FG000|Overall Study|Participant refusal|0|||
46658548|NCT04940130|82870084|FG001|Overall Study|Participant refusal|0|||
46658549|NCT04940130|82870085|FG002|Overall Study|Participant refusal|1|||
46658550|NCT04581824|82870099|FG000|Overall Study|Ongoing|75|||
46658551|NCT04581824|82870100|FG001|Overall Study|Ongoing|69|||
46658552|NCT04581824|82870099|FG000|Overall Study|Withdrawal by Subject|3|||
46658553|NCT04581824|82870100|FG001|Overall Study|Withdrawal by Subject|5|||
46658554|NCT04581824|82870099|FG000|Overall Study|Lost to Follow-up|1|||
46658555|NCT04581824|82870100|FG001|Overall Study|Lost to Follow-up|0|||
46658556|NCT04458922|82870118|FG000|Overall Study|Withdrawal by Subject|1|||
46658557|NCT04458922|82870119|FG001|Overall Study|Withdrawal by Subject|0|||
46658558|NCT04458922|82870120|FG002|Overall Study|Withdrawal by Subject|2|||
46658559|NCT04458922|82870118|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
46658560|NCT04458922|82870119|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
46658561|NCT04458922|82870120|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
46658562|NCT04458922|82870118|FG000|Overall Study|Adverse Event|1|||
46658563|NCT04458922|82870119|FG001|Overall Study|Adverse Event|0|||
46658564|NCT04458922|82870120|FG002|Overall Study|Adverse Event|0|||
46658565|NCT04458922|82870118|FG000|Overall Study|Started new study|0|||
46658566|NCT04458922|82870119|FG001|Overall Study|Started new study|0|||
46658567|NCT04458922|82870120|FG002|Overall Study|Started new study|1|||
46658568|NCT04458922|82870118|FG000|Overall Study|Progressive disease|6|||
46658569|NCT04458922|82870119|FG001|Overall Study|Progressive disease|8|||
46658570|NCT04458922|82870120|FG002|Overall Study|Progressive disease|2|||
46971727|NCT02680847|83215261|FG002|Overall Study|No longer met eligibility criteria|0|||
47076069|NCT03472040|83370714|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
46971728|NCT02680847|83215259|FG000|Overall Study|Unwilling to participate in study|1|||
46658571|NCT04458922|82870118|FG000|Overall Study|Death|1|||
46658572|NCT04458922|82870119|FG001|Overall Study|Death|0|||
46658573|NCT04458922|82870120|FG002|Overall Study|Death|2|||
46658574|NCT04458922|82870118|FG000|Overall Study|Participant started chemotherapy|0|||
46658575|NCT04458922|82870119|FG001|Overall Study|Participant started chemotherapy|1|||
46658576|NCT04458922|82870120|FG002|Overall Study|Participant started chemotherapy|0|||
46658577|NCT04333147|82870130|FG000|Overall Study|Adverse Event|43|||
47076070|NCT03472040|83370715|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
46658578|NCT04333147|82870131|FG001|Overall Study|Adverse Event|40|||
46658579|NCT04333147|82870130|FG000|Overall Study|Lack of Efficacy|49|||
46658580|NCT04333147|82870131|FG001|Overall Study|Lack of Efficacy|48|||
46658581|NCT04333147|82870130|FG000|Overall Study|Lost to Follow-up|19|||
46658582|NCT04333147|82870131|FG001|Overall Study|Lost to Follow-up|16|||
46658583|NCT04333147|82870130|FG000|Overall Study|Physician Decision|17|||
46658584|NCT04333147|82870131|FG001|Overall Study|Physician Decision|20|||
46658585|NCT04333147|82870130|FG000|Overall Study|Withdrawal by Subject|65|||
46658586|NCT04333147|82870131|FG001|Overall Study|Withdrawal by Subject|68|||
46658587|NCT04333147|82870130|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
46658588|NCT04333147|82870131|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
46658589|NCT04333147|82870130|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
46658590|NCT04333147|82870131|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
46658591|NCT04333147|82870130|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
46658592|NCT04333147|82870131|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
46658593|NCT04313244|82870139|FG000|Overall Study|Withdrawal of Consent|3|||
46658594|NCT04313244|82870140|FG001|Overall Study|Withdrawal of Consent|3|||
46658595|NCT04313244|82870139|FG000|Overall Study|Met Exclusion Criteria|1|||
46658596|NCT04313244|82870140|FG001|Overall Study|Met Exclusion Criteria|0|||
46658597|NCT04313244|82870139|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
46658598|NCT04313244|82870140|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
46658599|NCT04128696|82870190|FG000|Overall Study|Lost to Follow-up|0|||
46658600|NCT04128696|82870191|FG001|Overall Study|Lost to Follow-up|1|||
46658601|NCT04128696|82870190|FG000|Overall Study|Withdrawal by Subject|8|||
46658602|NCT04128696|82870191|FG001|Overall Study|Withdrawal by Subject|5|||
46658603|NCT04128696|82870190|FG000|Overall Study|In Follow-up|47|||
46658604|NCT04128696|82870191|FG001|Overall Study|In Follow-up|51|||
46658605|NCT04128696|82870190|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
46658606|NCT04128696|82870191|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
46971729|NCT02680847|83215260|FG001|Overall Study|Unwilling to participate in study|1|||
46782221|NCT00372619|83000893|FG005|Overall Study|Ineligible|2|||
46658607|NCT03848065|82870254|FG000|Overall Study|Death|0|||
46658608|NCT03848065|82870255|FG001|Overall Study|Death|1|||
46658609|NCT03848065|82870256|FG002|Overall Study|Death|0|||
46658610|NCT03848065|82870254|FG000|Overall Study|Lost to Follow-up|0|||
46658611|NCT03848065|82870255|FG001|Overall Study|Lost to Follow-up|0|||
46658612|NCT03848065|82870256|FG002|Overall Study|Lost to Follow-up|1|||
46658613|NCT03848065|82870254|FG000|Overall Study|Physician Decision|0|||
46658614|NCT03848065|82870255|FG001|Overall Study|Physician Decision|0|||
46658615|NCT03848065|82870256|FG002|Overall Study|Physician Decision|1|||
46658616|NCT03834220|82870267|FG000|Overall Study|Adverse Event|1|||
46658617|NCT03834220|82870268|FG001|Overall Study|Adverse Event|0|||
46658618|NCT03834220|82870269|FG002|Overall Study|Adverse Event|0|||
46658619|NCT03834220|82870267|FG000|Overall Study|Death|8|||
46658620|NCT03834220|82870268|FG001|Overall Study|Death|1|||
46658621|NCT03834220|82870269|FG002|Overall Study|Death|17|||
46658622|NCT03834220|82870267|FG000|Overall Study|Reason not Specified|9|||
46658623|NCT03834220|82870268|FG001|Overall Study|Reason not Specified|0|||
46658624|NCT03834220|82870269|FG002|Overall Study|Reason not Specified|6|||
46658625|NCT03834220|82870267|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
46658626|NCT03834220|82870268|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
46658627|NCT03834220|82870269|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
46658628|NCT03834220|82870267|FG000|Overall Study|Withdrawal of Consent|2|||
46658629|NCT03834220|82870268|FG001|Overall Study|Withdrawal of Consent|2|||
46658630|NCT03834220|82870269|FG002|Overall Study|Withdrawal of Consent|2|||
46658631|NCT03682770|82870281|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
46658632|NCT03682770|82870282|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
46782222|NCT00372619|83000894|FG006|Overall Study|Ineligible|0|||
46782223|NCT00372619|83000888|FG000|Overall Study|Inevaluable|0|||
46782224|NCT00372619|83000889|FG001|Overall Study|Inevaluable|0|||
46782225|NCT00372619|83000890|FG002|Overall Study|Inevaluable|0|||
46782226|NCT00372619|83000891|FG003|Overall Study|Inevaluable|0|||
47076071|NCT03472040|83370714|FG000|Overall Study|Subject Non-compliance|2|||
47076072|NCT03472040|83370715|FG001|Overall Study|Subject Non-compliance|5|||
47076073|NCT03472040|83370714|FG000|Overall Study|Discontinuation due to Rash|0|||
46658633|NCT03682770|82870283|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
46658634|NCT03682770|82870284|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
46658635|NCT03682770|82870285|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
46782227|NCT00372619|83000892|FG004|Overall Study|Inevaluable|0|||
46658636|NCT03682770|82870286|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
47076074|NCT03472040|83370715|FG001|Overall Study|Discontinuation due to Rash|1|||
46658637|NCT03682770|82870287|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
46658638|NCT03682770|82870281|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
46658639|NCT03682770|82870282|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
46658640|NCT03682770|82870283|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
46658641|NCT03682770|82870284|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
46782228|NCT00372619|83000893|FG005|Overall Study|Inevaluable|1|||
46658642|NCT03682770|82870285|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
46658643|NCT03682770|82870286|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
46658644|NCT03682770|82870287|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
46658645|NCT03682770|82870281|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
46658646|NCT03682770|82870282|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
46658647|NCT03682770|82870283|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
46658648|NCT03682770|82870284|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
46658649|NCT03682770|82870285|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
46658650|NCT03682770|82870286|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
46658651|NCT03682770|82870287|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
46658652|NCT03682770|82870281|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
46658653|NCT03682770|82870282|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
46658654|NCT03682770|82870283|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
46658655|NCT03682770|82870284|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
46782229|NCT00372619|83000894|FG006|Overall Study|Inevaluable|0|||
46782230|NCT00562588|83000912|FG000|Overall Study|Adverse Event|40|||
46782231|NCT00562588|83000913|FG001|Overall Study|Adverse Event|58|||
46782232|NCT00562588|83000912|FG000|Overall Study|Protocol Violation|30|||
46658656|NCT03682770|82870285|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
46658657|NCT03682770|82870286|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
46658658|NCT03682770|82870287|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
46658659|NCT03682770|82870281|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
46658660|NCT03682770|82870282|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
46658661|NCT03682770|82870283|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
46658662|NCT03682770|82870284|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
46658663|NCT03682770|82870285|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
46782233|NCT00562588|83000913|FG001|Overall Study|Protocol Violation|26|||
46782234|NCT00562588|83000912|FG000|Overall Study|Lost to Follow-up|12|||
46782235|NCT00562588|83000913|FG001|Overall Study|Lost to Follow-up|4|||
46782236|NCT00562588|83000912|FG000|Overall Study|Withdrawal by Subject|10|||
46782237|NCT00562588|83000913|FG001|Overall Study|Withdrawal by Subject|9|||
46782238|NCT00562588|83000912|FG000|Overall Study|Other|0|||
46782239|NCT00562588|83000913|FG001|Overall Study|Other|2|||
46782240|NCT00622167|83000919|FG000|Overall Study|Did not meet angiographic criteria|20|||
46782241|NCT00562354|83000925|FG000|Overall Study|Physician Decision|0|||
46782242|NCT00562354|83000926|FG001|Overall Study|Physician Decision|1|||
46782243|NCT00562354|83000925|FG000|Overall Study|Lost to Follow-up|0|||
46782244|NCT00562354|83000926|FG001|Overall Study|Lost to Follow-up|1|||
46782245|NCT00372385|83000938|FG000|Overall Study|Adverse Event|6|||
46782246|NCT00372385|83000939|FG001|Overall Study|Adverse Event|11|||
46782247|NCT00372385|83000940|FG002|Overall Study|Adverse Event|9|||
46782248|NCT00372385|83000941|FG003|Overall Study|Adverse Event|7|||
46782249|NCT00372385|83000938|FG000|Overall Study|Noncompliance|0|||
46782250|NCT00372385|83000939|FG001|Overall Study|Noncompliance|1|||
46782251|NCT00372385|83000940|FG002|Overall Study|Noncompliance|1|||
46782252|NCT00372385|83000941|FG003|Overall Study|Noncompliance|1|||
46782253|NCT00372385|83000938|FG000|Overall Study|Physician Decision|1|||
46782254|NCT00372385|83000939|FG001|Overall Study|Physician Decision|0|||
46782255|NCT00372385|83000940|FG002|Overall Study|Physician Decision|0|||
46782256|NCT00372385|83000941|FG003|Overall Study|Physician Decision|0|||
46782257|NCT00372385|83000938|FG000|Overall Study|Lost to Follow-up|2|||
46782258|NCT00372385|83000939|FG001|Overall Study|Lost to Follow-up|0|||
46782259|NCT00372385|83000940|FG002|Overall Study|Lost to Follow-up|0|||
46782260|NCT00372385|83000941|FG003|Overall Study|Lost to Follow-up|0|||
46782261|NCT00372385|83000938|FG000|Overall Study|Withdrawal by Subject|2|||
46782262|NCT00372385|83000939|FG001|Overall Study|Withdrawal by Subject|1|||
46782263|NCT00372385|83000940|FG002|Overall Study|Withdrawal by Subject|0|||
46782264|NCT00372385|83000941|FG003|Overall Study|Withdrawal by Subject|0|||
46782265|NCT00372385|83000938|FG000|Overall Study|Refusal of Treatment|3|||
46782266|NCT00372385|83000939|FG001|Overall Study|Refusal of Treatment|6|||
46658664|NCT03682770|82870286|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
46782267|NCT00372385|83000940|FG002|Overall Study|Refusal of Treatment|0|||
46782268|NCT00372385|83000941|FG003|Overall Study|Refusal of Treatment|0|||
46782269|NCT00372385|83000938|FG000|Overall Study|No Response|1|||
46782270|NCT00372385|83000939|FG001|Overall Study|No Response|1|||
46782271|NCT00372385|83000940|FG002|Overall Study|No Response|0|||
46782272|NCT00372385|83000941|FG003|Overall Study|No Response|0|||
46782273|NCT00372385|83000938|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
46782274|NCT00372385|83000939|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
46782275|NCT00372385|83000940|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
46782276|NCT00372385|83000941|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
46782277|NCT00372385|83000938|FG000|Overall Study|Virologic Stopping Rule|17|||
46782278|NCT00372385|83000939|FG001|Overall Study|Virologic Stopping Rule|0|||
46782279|NCT00372385|83000940|FG002|Overall Study|Virologic Stopping Rule|0|||
46782280|NCT00372385|83000941|FG003|Overall Study|Virologic Stopping Rule|0|||
46658665|NCT03682770|82870287|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
46658666|NCT03682770|82870281|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
46658667|NCT03682770|82870282|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
46658668|NCT03682770|82870283|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
46658669|NCT03682770|82870284|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
46658670|NCT03682770|82870285|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
46658671|NCT03682770|82870286|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
46658672|NCT03682770|82870287|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
46658673|NCT03682770|82870281|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
46658674|NCT03682770|82870282|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
46658675|NCT03682770|82870283|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
46658676|NCT03682770|82870284|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
46658677|NCT03682770|82870285|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
46658678|NCT03682770|82870286|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
46658679|NCT03682770|82870287|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
46658680|NCT03682770|82870281|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
46658681|NCT03682770|82870282|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
46658682|NCT03682770|82870283|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
46658683|NCT03682770|82870284|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
46658684|NCT03682770|82870285|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
46658685|NCT03682770|82870286|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
46658686|NCT03682770|82870287|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
46658687|NCT03682770|82870281|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
46658688|NCT03682770|82870282|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
46658689|NCT03682770|82870283|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
46658690|NCT03682770|82870284|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
46658691|NCT03682770|82870285|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
46658692|NCT03682770|82870286|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
46658693|NCT03682770|82870287|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
46658694|NCT03682770|82870281|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
46658695|NCT03682770|82870282|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
46658696|NCT03682770|82870283|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
46658697|NCT03682770|82870284|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
46658698|NCT03682770|82870285|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
46658699|NCT03682770|82870286|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
46658700|NCT03682770|82870287|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
46658701|NCT03682770|82870281|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
46658702|NCT03682770|82870282|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
46658703|NCT03682770|82870283|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
46658704|NCT03682770|82870284|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
46658705|NCT03682770|82870285|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
46658706|NCT03682770|82870286|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
46658707|NCT03682770|82870287|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
46658708|NCT03682770|82870281|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
46658709|NCT03682770|82870282|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
46782281|NCT03830281|83000954|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
46782282|NCT03830281|83000955|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
46782283|NCT03830281|83000954|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
46782284|NCT03830281|83000955|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
46971730|NCT02680847|83215261|FG002|Overall Study|Unwilling to participate in study|0|||
47076075|NCT03472040|83370714|FG000|Overall Study|Subsequent Ineligibility|0|||
47076076|NCT03472040|83370715|FG001|Overall Study|Subsequent Ineligibility|2|||
47076077|NCT03472040|83370714|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
47076078|NCT03472040|83370715|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
47076079|NCT03323385|83370733|FG000|Overall Study|Withdrawal by Subject|1|||
47076080|NCT03323385|83370734|FG001|Overall Study|Withdrawal by Subject|2|||
47076081|NCT03323385|83370733|FG000|Overall Study|Noncompliance|0|||
47076082|NCT03323385|83370734|FG001|Overall Study|Noncompliance|1|||
47076083|NCT03161483|83370744|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
47076084|NCT03161483|83370745|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
47076085|NCT03161483|83370746|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
46658710|NCT03682770|82870283|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
46782285|NCT03830281|83000954|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
46782286|NCT03830281|83000955|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
46782287|NCT03830281|83000954|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
46782288|NCT03830281|83000955|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
46782289|NCT03830281|83000954|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
46782290|NCT03830281|83000955|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
46658711|NCT03682770|82870284|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
46658712|NCT03682770|82870285|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
46782291|NCT03830281|83000954|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
46971731|NCT02680847|83215259|FG000|Overall Study|Lack of Efficacy|0|||
46971732|NCT02680847|83215260|FG001|Overall Study|Lack of Efficacy|0|||
46971733|NCT02680847|83215261|FG002|Overall Study|Lack of Efficacy|2|||
46971734|NCT02680847|83215259|FG000|Overall Study|Adverse Event|0|||
46971735|NCT02680847|83215260|FG001|Overall Study|Adverse Event|0|||
46971736|NCT02680847|83215261|FG002|Overall Study|Adverse Event|1|||
46971737|NCT02532855|83215271|FG000|Overall Study|Lost to Follow-up|4|||
46971738|NCT02532855|83215272|FG001|Overall Study|Lost to Follow-up|3|||
46971739|NCT02532855|83215271|FG000|Overall Study|Withdrawal by Subject|4|||
46971740|NCT02532855|83215272|FG001|Overall Study|Withdrawal by Subject|8|||
46971741|NCT02530125|83215278|FG000|Completed Treatment|Early termination of study|1|||
46971742|NCT02530125|83215278|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
46971743|NCT01661205|83215282|FG000|Overall Study|Physician Decision|2|||
46658713|NCT03682770|82870286|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
46658714|NCT03682770|82870287|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
46658715|NCT03651271|82870306|FG000|Overall Study|Death|4|||
46658716|NCT03651271|82870307|FG001|Overall Study|Death|37|||
46658717|NCT03651271|82870308|FG002|Overall Study|Death|0|||
46658718|NCT03651271|82870309|FG003|Overall Study|Death|2|||
46658719|NCT03651271|82870310|FG004|Overall Study|Death|6|||
46658720|NCT03651271|82870306|FG000|Overall Study|Lost to Follow-up|1|||
46658721|NCT03651271|82870307|FG001|Overall Study|Lost to Follow-up|5|||
46658722|NCT03651271|82870308|FG002|Overall Study|Lost to Follow-up|0|||
46658723|NCT03651271|82870309|FG003|Overall Study|Lost to Follow-up|1|||
46658724|NCT03651271|82870310|FG004|Overall Study|Lost to Follow-up|0|||
46658725|NCT03651271|82870306|FG000|Overall Study|Physician Decision|0|||
46658726|NCT03651271|82870307|FG001|Overall Study|Physician Decision|2|||
46658727|NCT03651271|82870308|FG002|Overall Study|Physician Decision|0|||
46658728|NCT03651271|82870309|FG003|Overall Study|Physician Decision|0|||
46658729|NCT03651271|82870310|FG004|Overall Study|Physician Decision|0|||
46658730|NCT03651271|82870306|FG000|Overall Study|Withdrawal by Subject|1|||
46658731|NCT03651271|82870307|FG001|Overall Study|Withdrawal by Subject|15|||
46658732|NCT03651271|82870308|FG002|Overall Study|Withdrawal by Subject|0|||
46658733|NCT03651271|82870309|FG003|Overall Study|Withdrawal by Subject|0|||
46658734|NCT03651271|82870310|FG004|Overall Study|Withdrawal by Subject|1|||
46658735|NCT03651271|82870306|FG000|Overall Study|Patient medically unable to continue|0|||
46658736|NCT03651271|82870307|FG001|Overall Study|Patient medically unable to continue|0|||
46658737|NCT03651271|82870308|FG002|Overall Study|Patient medically unable to continue|0|||
46658738|NCT03651271|82870309|FG003|Overall Study|Patient medically unable to continue|1|||
46658739|NCT03651271|82870310|FG004|Overall Study|Patient medically unable to continue|0|||
46971744|NCT02055820|83215296|FG000|Phase I: Dose-Finding|Death|1|||
47076086|NCT03161483|83370747|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
47076087|NCT03161483|83370744|FG000|Treatment Period|Death|1|||
46658740|NCT03569891|82870325|FG000|Lead-in|Ineligible during lead-in|8|||
46658741|NCT03569891|82870325|FG000|Lead-in|Withdrawal by Subject|3|||
46658742|NCT03569891|82870325|FG000|Lead-in|Risks related to COVID-19|2|||
46658743|NCT03569891|82870325|FG000|AMT-061|Adverse Event|1|||
46658744|NCT03473548|82870334|FG000|Overall Study|Did not attempt HST testing|3|||
46658745|NCT03473548|82870335|FG001|Overall Study|Did not attempt HST testing|0|||
46658746|NCT03375203|82870344|FG000|Overall Study|Protocol Violation|0|||
46658747|NCT03375203|82870345|FG001|Overall Study|Protocol Violation|0|||
46658748|NCT03375203|82870346|FG002|Overall Study|Protocol Violation|1|||
46658749|NCT03375203|82870347|FG003|Overall Study|Protocol Violation|0|||
46782292|NCT03830281|83000955|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
46782293|NCT03830281|83000954|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
46658750|NCT03375203|82870348|FG004|Overall Study|Protocol Violation|0|||
46658751|NCT03375203|82870344|FG000|Overall Study|Adverse Event|2|||
46658752|NCT03375203|82870345|FG001|Overall Study|Adverse Event|3|||
46658753|NCT03375203|82870346|FG002|Overall Study|Adverse Event|0|||
46782294|NCT03830281|83000955|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
46658754|NCT03375203|82870347|FG003|Overall Study|Adverse Event|2|||
46658755|NCT03375203|82870348|FG004|Overall Study|Adverse Event|2|||
46658756|NCT03375203|82870344|FG000|Overall Study|Withdrawal by Subject|3|||
46971745|NCT02055820|83215297|FG001|Phase I: Dose-Finding|Death|0|||
46971746|NCT02055820|83215298|FG002|Phase I: Dose-Finding|Death|1|||
46971747|NCT02055820|83215299|FG003|Phase I: Dose-Finding|Death|2|||
46971748|NCT02055820|83215300|FG004|Phase I: Dose-Finding|Death|0|||
46658757|NCT03375203|82870345|FG001|Overall Study|Withdrawal by Subject|0|||
46658758|NCT03375203|82870346|FG002|Overall Study|Withdrawal by Subject|1|||
46658759|NCT03375203|82870347|FG003|Overall Study|Withdrawal by Subject|0|||
46658760|NCT03375203|82870348|FG004|Overall Study|Withdrawal by Subject|2|||
46658761|NCT03375203|82870344|FG000|Overall Study|Non-compliance with study drug|1|||
46658762|NCT03375203|82870345|FG001|Overall Study|Non-compliance with study drug|0|||
46658763|NCT03375203|82870346|FG002|Overall Study|Non-compliance with study drug|0|||
46658764|NCT03375203|82870347|FG003|Overall Study|Non-compliance with study drug|0|||
46658765|NCT03375203|82870348|FG004|Overall Study|Non-compliance with study drug|0|||
46658766|NCT03375203|82870344|FG000|Overall Study|Randomized, not treated.|0|||
46658767|NCT03375203|82870345|FG001|Overall Study|Randomized, not treated.|1|||
46658768|NCT03375203|82870346|FG002|Overall Study|Randomized, not treated.|0|||
46658769|NCT03375203|82870347|FG003|Overall Study|Randomized, not treated.|0|||
46658770|NCT03375203|82870348|FG004|Overall Study|Randomized, not treated.|0|||
46658771|NCT03365882|82870363|FG000|Randomization|Still Receiving Protocol Treatment|2|||
46658772|NCT03365882|82870364|FG001|Randomization|Still Receiving Protocol Treatment|0|||
46658773|NCT03365882|82870363|FG000|Randomization|Adverse Event|1|||
46658774|NCT03365882|82870364|FG001|Randomization|Adverse Event|2|||
46658775|NCT03365882|82870363|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
46658776|NCT03365882|82870364|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
46658777|NCT03365882|82870363|FG000|Randomization|Progression/Relapse|21|||
46658778|NCT03365882|82870364|FG001|Randomization|Progression/Relapse|3|||
46658779|NCT03365882|82870363|FG000|Randomization|Death|1|||
46658780|NCT03365882|82870364|FG001|Randomization|Death|0|||
46658781|NCT03365882|82870363|FG000|Randomization|Other - Not Protocol Specified|1|||
46658782|NCT03365882|82870364|FG001|Randomization|Other - Not Protocol Specified|1|||
46658783|NCT03365882|82870363|FG000|Randomization|Major Protocol Deviation|0|||
46658784|NCT03365882|82870364|FG001|Randomization|Major Protocol Deviation|1|||
46658785|NCT03365882|82870363|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
46658786|NCT03365882|82870364|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
46658787|NCT03365882|82870363|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
46658788|NCT03365882|82870364|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
46658789|NCT03365882|82870363|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
46658790|NCT03365882|82870364|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
46658791|NCT03365882|82870363|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
46658792|NCT03365882|82870364|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
46658793|NCT03181789|82870375|FG000|Overall Study|Withdrawal by Subject|0|||
46658794|NCT03181789|82870376|FG001|Overall Study|Withdrawal by Subject|1|||
46658795|NCT03181789|82870377|FG002|Overall Study|Withdrawal by Subject|1|||
46658796|NCT03181789|82870378|FG003|Overall Study|Withdrawal by Subject|0|||
46658797|NCT03181789|82870375|FG000|Overall Study|Lost to Follow-up|7|||
46658798|NCT03181789|82870376|FG001|Overall Study|Lost to Follow-up|1|||
46658799|NCT03181789|82870377|FG002|Overall Study|Lost to Follow-up|0|||
46658800|NCT03181789|82870378|FG003|Overall Study|Lost to Follow-up|0|||
46658801|NCT03181789|82870375|FG000|Overall Study|Participant unable to adhere to visit|0|||
46658802|NCT03181789|82870376|FG001|Overall Study|Participant unable to adhere to visit|1|||
46658803|NCT03181789|82870377|FG002|Overall Study|Participant unable to adhere to visit|0|||
46658804|NCT03181789|82870378|FG003|Overall Study|Participant unable to adhere to visit|0|||
46658805|NCT03106779|82870400|FG000|Overall Study|Lack of Efficacy|33|||
46658806|NCT03106779|82870401|FG001|Overall Study|Lack of Efficacy|24|||
46658807|NCT03106779|82870400|FG000|Overall Study|Adverse Event|8|||
46658808|NCT03106779|82870401|FG001|Overall Study|Adverse Event|16|||
46658809|NCT03106779|82870400|FG000|Overall Study|Physician Decision|10|||
46658810|NCT03106779|82870401|FG001|Overall Study|Physician Decision|6|||
46658811|NCT03106779|82870400|FG000|Overall Study|Patient/guardian decision|4|||
46658812|NCT03106779|82870401|FG001|Overall Study|Patient/guardian decision|3|||
46658813|NCT03106779|82870400|FG000|Overall Study|Progressive disease|1|||
46658814|NCT03106779|82870401|FG001|Overall Study|Progressive disease|3|||
46658815|NCT03106779|82870400|FG000|Overall Study|Lost to Follow-up|1|||
46658816|NCT03106779|82870401|FG001|Overall Study|Lost to Follow-up|2|||
46658817|NCT03106779|82870400|FG000|Overall Study|Death|1|||
46658818|NCT03106779|82870401|FG001|Overall Study|Death|0|||
47076088|NCT03161483|83370745|FG001|Treatment Period|Death|0|||
46658819|NCT03106779|82870400|FG000|Overall Study|Protocol Violation|1|||
46658820|NCT03106779|82870401|FG001|Overall Study|Protocol Violation|0|||
46658821|NCT03106779|82870400|FG000|Overall Study|Not treated|1|||
46658822|NCT03106779|82870401|FG001|Overall Study|Not treated|0|||
46658823|NCT02903160|82870416|FG000|Overall Study|Adverse Event|2|||
46658824|NCT02903160|82870416|FG000|Overall Study|Death|1|||
46658825|NCT02903160|82870416|FG000|Overall Study|Lost to Follow-up|2|||
46658826|NCT02903160|82870416|FG000|Overall Study|Withdrawal by Subject|1|||
46658827|NCT02903160|82870416|FG000|Overall Study|Medical Insurance Barriers|1|||
46658828|NCT02768792|82870420|FG000|Overall Study|Adverse Event|1|||
46658829|NCT02545127|82870430|FG000|Overall Study|Lost to Follow-up|1|||
46658830|NCT02545127|82870431|FG001|Overall Study|Lost to Follow-up|0|||
46658831|NCT01824875|82870439|FG000|Overall Study|Disease progression|22|||
46658832|NCT01824875|82870440|FG001|Overall Study|Disease progression|15|||
46658833|NCT01824875|82870439|FG000|Overall Study|Withdrawal by Subject|5|||
46658834|NCT01824875|82870440|FG001|Overall Study|Withdrawal by Subject|4|||
46658835|NCT01824875|82870439|FG000|Overall Study|Adverse Event|4|||
46658836|NCT01824875|82870440|FG001|Overall Study|Adverse Event|10|||
46658837|NCT01824875|82870439|FG000|Overall Study|Alternative therapy|3|||
46658838|NCT01824875|82870440|FG001|Overall Study|Alternative therapy|0|||
46658839|NCT01824875|82870439|FG000|Overall Study|Complicating disease|1|||
46658840|NCT01824875|82870440|FG001|Overall Study|Complicating disease|0|||
46658841|NCT01824875|82870439|FG000|Overall Study|Physician Decision|0|||
46658842|NCT01824875|82870440|FG001|Overall Study|Physician Decision|1|||
46658843|NCT01824875|82870439|FG000|Overall Study|Non-compliance|1|||
46658844|NCT01824875|82870440|FG001|Overall Study|Non-compliance|1|||
46658845|NCT01824875|82870439|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
46658846|NCT01824875|82870440|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
46658847|NCT01824875|82870439|FG000|Overall Study|Administrative issues|0|||
46658848|NCT01824875|82870440|FG001|Overall Study|Administrative issues|2|||
46658849|NCT01824875|82870439|FG000|Overall Study|Ineligible or never started treatment|9|||
46658850|NCT01824875|82870440|FG001|Overall Study|Ineligible or never started treatment|5|||
46658851|NCT01824875|82870439|FG000|Overall Study|Other|0|||
46658852|NCT01824875|82870440|FG001|Overall Study|Other|2|||
46658853|NCT01814397|82870450|FG000|Overall Study|Adverse Event|7|||
46658854|NCT01814397|82870450|FG000|Overall Study|Withdrawal by Subject|7|||
46658855|NCT01665144|82870456|FG000|Overall Study|New therapy for study indication|2|||
46658856|NCT01665144|82870457|FG001|Overall Study|New therapy for study indication|1|||
46658857|NCT01665144|82870456|FG000|Overall Study|Technical problems|2|||
46658858|NCT01665144|82870457|FG001|Overall Study|Technical problems|0|||
47076089|NCT03161483|83370746|FG002|Treatment Period|Death|0|||
47076090|NCT03161483|83370747|FG003|Treatment Period|Death|0|||
47076091|NCT03161483|83370744|FG000|Treatment Period|Adverse Event|5|||
47076092|NCT03161483|83370745|FG001|Treatment Period|Adverse Event|2|||
47076093|NCT03161483|83370746|FG002|Treatment Period|Adverse Event|1|||
47076094|NCT03161483|83370747|FG003|Treatment Period|Adverse Event|11|||
47076095|NCT03161483|83370744|FG000|Treatment Period|Pregnancy|1|||
46658859|NCT01665144|82870456|FG000|Overall Study|Death|3|||
46658860|NCT01665144|82870457|FG001|Overall Study|Death|1|||
46658861|NCT01665144|82870456|FG000|Overall Study|Protocol deviation|3|||
46658862|NCT01665144|82870457|FG001|Overall Study|Protocol deviation|1|||
46658863|NCT01665144|82870456|FG000|Overall Study|Non-compliance w/study treatment|5|||
46658864|NCT01665144|82870457|FG001|Overall Study|Non-compliance w/study treatment|0|||
46658865|NCT01665144|82870456|FG000|Overall Study|Progressive disease|8|||
46658866|NCT01665144|82870457|FG001|Overall Study|Progressive disease|4|||
46658867|NCT01665144|82870456|FG000|Overall Study|Lost to Follow-up|9|||
46658868|NCT01665144|82870457|FG001|Overall Study|Lost to Follow-up|8|||
46658869|NCT01665144|82870456|FG000|Overall Study|Physician Decision|13|||
46658870|NCT01665144|82870457|FG001|Overall Study|Physician Decision|1|||
46658871|NCT01665144|82870456|FG000|Overall Study|Lack of Efficacy|16|||
46782295|NCT03830281|83000954|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
46782296|NCT03830281|83000955|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
46782297|NCT03830281|83000954|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
46782298|NCT03830281|83000955|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
47076096|NCT03161483|83370745|FG001|Treatment Period|Pregnancy|0|||
47076097|NCT03161483|83370746|FG002|Treatment Period|Pregnancy|0|||
47076098|NCT03161483|83370747|FG003|Treatment Period|Pregnancy|0|||
47076099|NCT03161483|83370744|FG000|Treatment Period|Lack of Efficacy|0|||
47076100|NCT03161483|83370745|FG001|Treatment Period|Lack of Efficacy|0|||
47076101|NCT03161483|83370746|FG002|Treatment Period|Lack of Efficacy|0|||
47076102|NCT03161483|83370747|FG003|Treatment Period|Lack of Efficacy|1|||
47076103|NCT03161483|83370744|FG000|Treatment Period|Withdrawal by Subject|2|||
47076104|NCT03161483|83370745|FG001|Treatment Period|Withdrawal by Subject|5|||
47076105|NCT03161483|83370746|FG002|Treatment Period|Withdrawal by Subject|2|||
46658872|NCT01665144|82870457|FG001|Overall Study|Lack of Efficacy|11|||
46658873|NCT01665144|82870456|FG000|Overall Study|Adverse Event|45|||
46782299|NCT00563368|83000969|FG000|Overall Study|Lost to Follow-up|14|||
46782300|NCT00563368|83000970|FG001|Overall Study|Lost to Follow-up|14|||
46658874|NCT01665144|82870457|FG001|Overall Study|Adverse Event|18|||
46658875|NCT01665144|82870456|FG000|Overall Study|Withdrawal by Subject|96|||
46658876|NCT01665144|82870457|FG001|Overall Study|Withdrawal by Subject|77|||
46658877|NCT01602666|82870465|FG000|Induction Chemotherapy|Death|2|||
46658878|NCT01602666|82870466|FG001|Induction Chemotherapy|Death|1|||
46782301|NCT00563368|83000971|FG002|Overall Study|Lost to Follow-up|12|||
47076106|NCT03161483|83370747|FG003|Treatment Period|Withdrawal by Subject|6|||
47076107|NCT03161483|83370744|FG000|Treatment Period|Lost to Follow-up|0|||
47076108|NCT03161483|83370745|FG001|Treatment Period|Lost to Follow-up|0|||
47076109|NCT03161483|83370746|FG002|Treatment Period|Lost to Follow-up|0|||
47076110|NCT03161483|83370747|FG003|Treatment Period|Lost to Follow-up|1|||
47076111|NCT03161483|83370744|FG000|Treatment Period|Protocol Violation|0|||
46850996|NCT00098306|83066771|FG001|Open Label|Participant defaulted|0|||
46850997|NCT00098306|83066772|FG002|Open Label|Participant defaulted|0|||
46850998|NCT00098306|83066773|FG003|Open Label|Participant defaulted|24|||
46850999|NCT00098306|83066774|FG004|Open Label|Participant defaulted|0|||
46851000|NCT00098306|83066775|FG005|Open Label|Participant defaulted|0|||
47076112|NCT03161483|83370745|FG001|Treatment Period|Protocol Violation|0|||
47076113|NCT03161483|83370746|FG002|Treatment Period|Protocol Violation|0|||
46782302|NCT00563368|83000972|FG003|Overall Study|Lost to Follow-up|6|||
46782303|NCT00563368|83000973|FG004|Overall Study|Lost to Follow-up|9|||
46782304|NCT00563368|83000974|FG005|Overall Study|Lost to Follow-up|8|||
46782305|NCT00563368|83000975|FG006|Overall Study|Lost to Follow-up|9|||
46782306|NCT00563368|83000969|FG000|Overall Study|Adverse Event|3|||
46782307|NCT00563368|83000970|FG001|Overall Study|Adverse Event|4|||
46782308|NCT00563368|83000971|FG002|Overall Study|Adverse Event|5|||
46782309|NCT00563368|83000972|FG003|Overall Study|Adverse Event|9|||
46782310|NCT00563368|83000973|FG004|Overall Study|Adverse Event|6|||
46782311|NCT00563368|83000974|FG005|Overall Study|Adverse Event|10|||
47076114|NCT03161483|83370747|FG003|Treatment Period|Protocol Violation|1|||
47076115|NCT03161483|83370744|FG000|Treatment Period|Other reasons|1|||
47076116|NCT03161483|83370745|FG001|Treatment Period|Other reasons|1|||
47076117|NCT03161483|83370746|FG002|Treatment Period|Other reasons|0|||
47076118|NCT03161483|83370747|FG003|Treatment Period|Other reasons|0|||
47076119|NCT03132636|83370761|FG000|Overall Study|Adverse Event|1|||
47076120|NCT03132636|83370762|FG001|Overall Study|Adverse Event|2|||
46658879|NCT01602666|82870465|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
46658880|NCT01602666|82870466|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
46658881|NCT01602666|82870465|FG000|Induction Chemotherapy|Physician Decision|12|||
46658882|NCT01602666|82870466|FG001|Induction Chemotherapy|Physician Decision|5|||
46658883|NCT01602666|82870465|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
46658884|NCT01602666|82870466|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
46658885|NCT01602666|82870465|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
46658886|NCT01602666|82870466|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
46658887|NCT01602666|82870465|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
46658888|NCT01602666|82870466|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
46658889|NCT01602666|82870465|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
46658890|NCT01602666|82870466|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
46658891|NCT01602666|82870465|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
46658892|NCT01602666|82870466|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
46658893|NCT01602666|82870465|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
46658894|NCT01602666|82870466|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
46658895|NCT01602666|82870465|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
46658896|NCT01602666|82870466|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
46658897|NCT01602666|82870465|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
46658898|NCT01602666|82870466|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
46658899|NCT01527149|82870474|FG000|Overall Study|Death|2|||
46658900|NCT00946881|82870496|FG000|First Treatment|Withdrawal by Subject|1|||
46658901|NCT00946881|82870496|FG000|First Treatment|Patient relocated to another state|1|||
46658902|NCT00946881|82870496|FG000|Retreatment|Withdrawal by Subject|1|||
46658903|NCT00616967|82870523|FG000|Overall Study|Withdrawal by Subject|0|||
46658904|NCT00616967|82870524|FG001|Overall Study|Withdrawal by Subject|0|||
46658905|NCT00616967|82870525|FG002|Overall Study|Withdrawal by Subject|1|||
46707524|NCT01156116|82923085|FG000|Overall Study|Withdrawal by Subject|3|||
46707525|NCT01156116|82923086|FG001|Overall Study|Withdrawal by Subject|1|||
46707526|NCT01156116|82923085|FG000|Overall Study|CPAP intolerance|2|||
46707527|NCT01156116|82923086|FG001|Overall Study|CPAP intolerance|0|||
46707528|NCT01155726|82923092|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
46707529|NCT01155726|82923093|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
46707530|NCT01155726|82923094|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
46707531|NCT01155726|82923095|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
46707532|NCT01155570|82923117|FG000|Overall Study|Adverse Event|39|||
46707533|NCT01155570|82923117|FG000|Overall Study|Lack of Efficacy|46|||
46707534|NCT01155570|82923117|FG000|Overall Study|Participant's Economic Reasons|17|||
46707535|NCT01155570|82923117|FG000|Overall Study|No Hospital Visits|7|||
46782312|NCT00563368|83000975|FG006|Overall Study|Adverse Event|17|||
46782313|NCT00563368|83000969|FG000|Overall Study|Withdrawal by Subject|11|||
46782314|NCT00563368|83000970|FG001|Overall Study|Withdrawal by Subject|6|||
46782315|NCT00563368|83000971|FG002|Overall Study|Withdrawal by Subject|5|||
46782316|NCT00563368|83000972|FG003|Overall Study|Withdrawal by Subject|7|||
46782317|NCT00563368|83000973|FG004|Overall Study|Withdrawal by Subject|8|||
46782318|NCT00563368|83000974|FG005|Overall Study|Withdrawal by Subject|5|||
46782319|NCT00563368|83000975|FG006|Overall Study|Withdrawal by Subject|4|||
46782320|NCT00563368|83000969|FG000|Overall Study|protocol non-compliance|1|||
46782321|NCT00563368|83000970|FG001|Overall Study|protocol non-compliance|1|||
46782322|NCT00563368|83000971|FG002|Overall Study|protocol non-compliance|2|||
46782323|NCT00563368|83000972|FG003|Overall Study|protocol non-compliance|1|||
46782324|NCT00563368|83000973|FG004|Overall Study|protocol non-compliance|0|||
46782325|NCT00563368|83000974|FG005|Overall Study|protocol non-compliance|1|||
46782326|NCT00563368|83000975|FG006|Overall Study|protocol non-compliance|3|||
46782327|NCT00563368|83000969|FG000|Overall Study|Pregnancy|1|||
46782328|NCT00563368|83000970|FG001|Overall Study|Pregnancy|0|||
46782329|NCT00563368|83000971|FG002|Overall Study|Pregnancy|1|||
46782330|NCT00563368|83000972|FG003|Overall Study|Pregnancy|2|||
46782331|NCT00563368|83000973|FG004|Overall Study|Pregnancy|1|||
46782332|NCT00563368|83000974|FG005|Overall Study|Pregnancy|2|||
46782333|NCT00563368|83000975|FG006|Overall Study|Pregnancy|0|||
46782334|NCT00563368|83000969|FG000|Overall Study|requirement for restricted medication|0|||
46782335|NCT00563368|83000970|FG001|Overall Study|requirement for restricted medication|0|||
46782336|NCT00563368|83000971|FG002|Overall Study|requirement for restricted medication|2|||
46782337|NCT00563368|83000972|FG003|Overall Study|requirement for restricted medication|0|||
46782338|NCT00563368|83000973|FG004|Overall Study|requirement for restricted medication|0|||
46782339|NCT00563368|83000974|FG005|Overall Study|requirement for restricted medication|0|||
46782340|NCT00563368|83000975|FG006|Overall Study|requirement for restricted medication|0|||
46782341|NCT00563368|83000969|FG000|Overall Study|Other|5|||
46782342|NCT00563368|83000970|FG001|Overall Study|Other|5|||
46782343|NCT00563368|83000971|FG002|Overall Study|Other|3|||
46782344|NCT00563368|83000972|FG003|Overall Study|Other|4|||
46782345|NCT00563368|83000973|FG004|Overall Study|Other|4|||
46782346|NCT00563368|83000974|FG005|Overall Study|Other|4|||
46782347|NCT00563368|83000975|FG006|Overall Study|Other|0|||
46782348|NCT00390013|83000994|FG000|Phase 1|tired|0|||
46782349|NCT00390013|83000995|FG001|Phase 1|tired|0|||
46782350|NCT00390013|83000996|FG002|Phase 1|tired|0|||
46782351|NCT00390013|83000997|FG003|Phase 1|tired|1|||
46782352|NCT00390013|83000994|FG000|Phase 2 First Treatment|tired|1|||
46782353|NCT00390013|83000995|FG001|Phase 2 First Treatment|tired|0|||
46782354|NCT00390013|83000996|FG002|Phase 2 First Treatment|tired|0|||
46782355|NCT00390013|83000997|FG003|Phase 2 First Treatment|tired|0|||
46782356|NCT00390013|83000994|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
46782357|NCT00390013|83000995|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
46782358|NCT00390013|83000996|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
46782359|NCT00390013|83000997|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
46782360|NCT00561652|83001005|FG000|Overall Study|Withdrawal by Subject|0|||
46782361|NCT00561652|83001006|FG001|Overall Study|Withdrawal by Subject|1|||
46782362|NCT00697346|83001015|FG000|Overall Study|Adverse Event|4|||
46782363|NCT00697346|83001016|FG001|Overall Study|Adverse Event|5|||
46782364|NCT00697346|83001017|FG002|Overall Study|Adverse Event|0|||
46782365|NCT00697346|83001015|FG000|Overall Study|Progressive Disease|19|||
46782366|NCT00697346|83001016|FG001|Overall Study|Progressive Disease|18|||
46782367|NCT00697346|83001017|FG002|Overall Study|Progressive Disease|0|||
46782368|NCT00697346|83001015|FG000|Overall Study|Symptomatic Deterioration|0|||
46782369|NCT00697346|83001016|FG001|Overall Study|Symptomatic Deterioration|1|||
46782370|NCT00697346|83001017|FG002|Overall Study|Symptomatic Deterioration|0|||
46782371|NCT00697346|83001015|FG000|Overall Study|Withdrawal by Subject|2|||
46782372|NCT00697346|83001016|FG001|Overall Study|Withdrawal by Subject|2|||
46782373|NCT00697346|83001017|FG002|Overall Study|Withdrawal by Subject|0|||
46782374|NCT00697346|83001015|FG000|Overall Study|Reason not Specified|3|||
46782375|NCT00697346|83001016|FG001|Overall Study|Reason not Specified|0|||
46782376|NCT00697346|83001017|FG002|Overall Study|Reason not Specified|1|||
46782377|NCT00562120|83001044|FG000|First Intervention Period|Adverse Event|1|||
46782378|NCT00562120|83001045|FG001|First Intervention Period|Adverse Event|0|||
46782379|NCT00562120|83001046|FG002|First Intervention Period|Adverse Event|0|||
46782380|NCT00562120|83001047|FG003|First Intervention Period|Adverse Event|0|||
46782381|NCT00562120|83001044|FG000|First Intervention Period|Randomized but not Treated|1|||
46782382|NCT00562120|83001045|FG001|First Intervention Period|Randomized but not Treated|0|||
46782383|NCT00562120|83001046|FG002|First Intervention Period|Randomized but not Treated|0|||
46782384|NCT00562120|83001047|FG003|First Intervention Period|Randomized but not Treated|0|||
46782385|NCT00561730|83001057|FG000|Overall Study|Adverse Event|2|||
46782386|NCT00561730|83001057|FG000|Overall Study|Handling of the drug|1|||
46782387|NCT00561730|83001057|FG000|Overall Study|Lost to Follow-up|5|||
47076121|NCT03132636|83370761|FG000|Overall Study|Death|4|||
47076122|NCT03132636|83370762|FG001|Overall Study|Death|7|||
47076123|NCT03132636|83370761|FG000|Overall Study|Lost to Follow-up|2|||
46782388|NCT00561730|83001057|FG000|Overall Study|Not specified reasons|1|||
46782389|NCT00697112|83001063|FG000|Overall Study|Adverse Event|8|||
46782390|NCT00697112|83001063|FG000|Overall Study|Lost to Follow-up|1|||
46782391|NCT00697112|83001063|FG000|Overall Study|Did not meet inclusion criteria|1|||
46782392|NCT00621855|83001072|FG000|Overall Study|Adverse Event|32|||
46782393|NCT00621855|83001073|FG001|Overall Study|Adverse Event|31|||
46782394|NCT00621855|83001074|FG002|Overall Study|Adverse Event|48|||
46782395|NCT00621855|83001075|FG003|Overall Study|Adverse Event|34|||
46782396|NCT00621855|83001076|FG004|Overall Study|Adverse Event|31|||
46782397|NCT00621855|83001072|FG000|Overall Study|Lost to Follow-up|0|||
46782398|NCT00621855|83001073|FG001|Overall Study|Lost to Follow-up|1|||
46782399|NCT00621855|83001074|FG002|Overall Study|Lost to Follow-up|3|||
46782400|NCT00621855|83001075|FG003|Overall Study|Lost to Follow-up|4|||
46658906|NCT05172050|82870600|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
46658907|NCT05172050|82870601|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
46658908|NCT05172050|82870602|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
46658909|NCT05172050|82870600|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
46658910|NCT05172050|82870601|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
46658911|NCT05172050|82870602|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
46658912|NCT05172050|82870600|FG000|Overall Study|Other|2|||
46658913|NCT05172050|82870601|FG001|Overall Study|Other|2|||
46658914|NCT05172050|82870602|FG002|Overall Study|Other|1|||
46658915|NCT04924062|82870615|FG000|Overall Study|Death|49|||
46658916|NCT04924062|82870616|FG001|Overall Study|Death|63|||
46658917|NCT04924062|82870615|FG000|Overall Study|Participant On-going|26|||
46658918|NCT04924062|82870616|FG001|Overall Study|Participant On-going|20|||
46658919|NCT04826484|82870624|FG000|Overall Study|Lost to Follow-up|2|||
46658920|NCT04826484|82870625|FG001|Overall Study|Lost to Follow-up|0|||
46658921|NCT04820842|82870634|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
46658922|NCT04820842|82870635|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
46658923|NCT04820842|82870636|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
46658924|NCT04820842|82870637|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
46658925|NCT04820842|82870638|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
46658926|NCT04820842|82870639|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
46658927|NCT04820842|82870640|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
46658928|NCT04820842|82870634|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
46658929|NCT04820842|82870635|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
46658930|NCT04820842|82870636|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
46658931|NCT04820842|82870637|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658932|NCT04820842|82870638|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658933|NCT04820842|82870639|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658934|NCT04820842|82870640|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658935|NCT04820842|82870634|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46658936|NCT04820842|82870635|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
46658937|NCT04820842|82870636|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46658938|NCT04820842|82870637|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46658939|NCT04820842|82870638|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46658940|NCT04820842|82870639|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46658941|NCT04820842|82870640|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
46658942|NCT04820842|82870634|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658943|NCT04820842|82870635|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658944|NCT04820842|82870636|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658945|NCT04820842|82870637|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
46658946|NCT04820842|82870638|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658947|NCT04820842|82870639|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
46658948|NCT04820842|82870640|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
46658949|NCT04744285|82870670|FG000|Overall Study|Withdrawal by Subject|1|||
46658950|NCT04744285|82870671|FG001|Overall Study|Withdrawal by Subject|1|||
46658951|NCT04744285|82870672|FG002|Overall Study|Withdrawal by Subject|2|||
46658952|NCT04744285|82870673|FG003|Overall Study|Withdrawal by Subject|1|||
46782401|NCT00621855|83001076|FG004|Overall Study|Lost to Follow-up|1|||
46782402|NCT00621855|83001072|FG000|Overall Study|Protocol Violation|16|||
46851001|NCT00098306|83066776|FG006|Open Label|Participant defaulted|0|||
46782403|NCT00621855|83001073|FG001|Overall Study|Protocol Violation|8|||
46782404|NCT00621855|83001074|FG002|Overall Study|Protocol Violation|6|||
46782405|NCT00621855|83001075|FG003|Overall Study|Protocol Violation|7|||
46851002|NCT00098306|83066770|FG000|Open Label|Un-specified|0|||
46851003|NCT00098306|83066771|FG001|Open Label|Un-specified|0|||
46851004|NCT00098306|83066772|FG002|Open Label|Un-specified|0|||
46658953|NCT04737187|82870685|FG000|Overall Study|Continuing the study on treatment|32|||
46658954|NCT04737187|82870686|FG001|Overall Study|Continuing the study on treatment|4|||
46658955|NCT04737187|82870685|FG000|Overall Study|Radiological Progressive Disease|145|||
46782406|NCT00621855|83001076|FG004|Overall Study|Protocol Violation|8|||
46782407|NCT00621855|83001072|FG000|Overall Study|Withdrawal by Subject|16|||
46658956|NCT04737187|82870686|FG001|Overall Study|Radiological Progressive Disease|146|||
46658957|NCT04737187|82870685|FG000|Overall Study|Clinical Progressive Disease|20|||
46658958|NCT04737187|82870686|FG001|Overall Study|Clinical Progressive Disease|20|||
46658959|NCT04737187|82870685|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
46658960|NCT04737187|82870686|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
46658961|NCT04737187|82870685|FG000|Overall Study|Adverse Event|16|||
46658962|NCT04737187|82870686|FG001|Overall Study|Adverse Event|16|||
46658963|NCT04737187|82870685|FG000|Overall Study|Physician Decision|2|||
46658964|NCT04737187|82870686|FG001|Overall Study|Physician Decision|0|||
46658965|NCT04737187|82870685|FG000|Overall Study|Withdrawal by Subject|5|||
46658966|NCT04737187|82870686|FG001|Overall Study|Withdrawal by Subject|8|||
46658967|NCT04555044|82870694|FG000|Overall Study|Adverse Event|0|||
46782408|NCT00621855|83001073|FG001|Overall Study|Withdrawal by Subject|11|||
46782409|NCT00621855|83001074|FG002|Overall Study|Withdrawal by Subject|13|||
46782410|NCT00621855|83001075|FG003|Overall Study|Withdrawal by Subject|13|||
46782411|NCT00621855|83001076|FG004|Overall Study|Withdrawal by Subject|9|||
46782412|NCT00621855|83001072|FG000|Overall Study|Other|9|||
46782413|NCT00621855|83001073|FG001|Overall Study|Other|7|||
46658968|NCT04555044|82870695|FG001|Overall Study|Adverse Event|1|||
46658969|NCT04492722|82870715|FG000|Overall Study|Adverse Event|7|||
46658970|NCT04492722|82870716|FG001|Overall Study|Adverse Event|2|||
46658971|NCT04492722|82870717|FG002|Overall Study|Adverse Event|3|||
46658972|NCT04492722|82870718|FG003|Overall Study|Adverse Event|0|||
46658973|NCT04492722|82870715|FG000|Overall Study|Death|0|||
46658974|NCT04492722|82870716|FG001|Overall Study|Death|0|||
46658975|NCT04492722|82870717|FG002|Overall Study|Death|0|||
46658976|NCT04492722|82870718|FG003|Overall Study|Death|1|||
46658977|NCT04492722|82870715|FG000|Overall Study|Lost to Follow-up|0|||
46658978|NCT04492722|82870716|FG001|Overall Study|Lost to Follow-up|1|||
46658979|NCT04492722|82870717|FG002|Overall Study|Lost to Follow-up|0|||
46658980|NCT04492722|82870718|FG003|Overall Study|Lost to Follow-up|1|||
46658981|NCT04492722|82870715|FG000|Overall Study|Physician Decision|0|||
46658982|NCT04492722|82870716|FG001|Overall Study|Physician Decision|3|||
46658983|NCT04492722|82870717|FG002|Overall Study|Physician Decision|1|||
46658984|NCT04492722|82870718|FG003|Overall Study|Physician Decision|1|||
46658985|NCT04492722|82870715|FG000|Overall Study|Withdrawal by Subject|6|||
46658986|NCT04492722|82870716|FG001|Overall Study|Withdrawal by Subject|6|||
46658987|NCT04492722|82870717|FG002|Overall Study|Withdrawal by Subject|0|||
46658988|NCT04492722|82870718|FG003|Overall Study|Withdrawal by Subject|3|||
46658989|NCT04492722|82870715|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
46658990|NCT04492722|82870716|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
46658991|NCT04492722|82870717|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
46658992|NCT04492722|82870718|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
46658993|NCT04492722|82870715|FG000|Overall Study|Due to Covid-19 pandemic|7|||
46658994|NCT04492722|82870716|FG001|Overall Study|Due to Covid-19 pandemic|3|||
46658995|NCT04492722|82870717|FG002|Overall Study|Due to Covid-19 pandemic|7|||
46782414|NCT00621855|83001074|FG002|Overall Study|Other|6|||
46782415|NCT00621855|83001075|FG003|Overall Study|Other|5|||
46782416|NCT00621855|83001076|FG004|Overall Study|Other|4|||
46782417|NCT00621855|83001072|FG000|Overall Study|Patients did not receive study drug|3|||
46782418|NCT00621855|83001073|FG001|Overall Study|Patients did not receive study drug|3|||
46782419|NCT00621855|83001074|FG002|Overall Study|Patients did not receive study drug|5|||
46851005|NCT00098306|83066773|FG003|Open Label|Un-specified|15|||
47076124|NCT03132636|83370762|FG001|Overall Study|Lost to Follow-up|2|||
46851006|NCT00098306|83066774|FG004|Open Label|Un-specified|0|||
46851007|NCT00098306|83066775|FG005|Open Label|Un-specified|0|||
46851008|NCT00098306|83066776|FG006|Open Label|Un-specified|0|||
46658996|NCT04492722|82870718|FG003|Overall Study|Due to Covid-19 pandemic|6|||
46658997|NCT04492722|82870715|FG000|Overall Study|Failure to meet randomisation criteria|2|||
46782420|NCT00621855|83001075|FG003|Overall Study|Patients did not receive study drug|4|||
46782421|NCT00621855|83001076|FG004|Overall Study|Patients did not receive study drug|2|||
46658998|NCT04492722|82870716|FG001|Overall Study|Failure to meet randomisation criteria|3|||
46658999|NCT04492722|82870717|FG002|Overall Study|Failure to meet randomisation criteria|4|||
46851009|NCT00098306|83066770|FG000|Open Label|Ongoing at cut-off date|0|||
46851010|NCT00098306|83066771|FG001|Open Label|Ongoing at cut-off date|0|||
46851011|NCT00098306|83066772|FG002|Open Label|Ongoing at cut-off date|0|||
46659000|NCT04492722|82870718|FG003|Overall Study|Failure to meet randomisation criteria|2|||
46659001|NCT04492722|82870715|FG000|Overall Study|Early termination from the study|54|||
46659002|NCT04492722|82870716|FG001|Overall Study|Early termination from the study|51|||
46659003|NCT04492722|82870717|FG002|Overall Study|Early termination from the study|50|||
46659004|NCT04492722|82870718|FG003|Overall Study|Early termination from the study|50|||
46659005|NCT04492722|82870715|FG000|Overall Study|Missing|3|||
46659006|NCT04492722|82870716|FG001|Overall Study|Missing|0|||
46659007|NCT04492722|82870717|FG002|Overall Study|Missing|0|||
46659008|NCT04492722|82870718|FG003|Overall Study|Missing|5|||
46659009|NCT04492722|82870715|FG000|Overall Study|Participants who did not receive treatment|0|||
46659010|NCT04492722|82870716|FG001|Overall Study|Participants who did not receive treatment|1|||
46659011|NCT04492722|82870717|FG002|Overall Study|Participants who did not receive treatment|4|||
46659012|NCT04492722|82870718|FG003|Overall Study|Participants who did not receive treatment|0|||
46659013|NCT04466618|82870730|FG000|Overall Study|Withdrawal by Subject|0|||
46659014|NCT04466618|82870731|FG001|Overall Study|Withdrawal by Subject|1|||
46659015|NCT04460326|82870743|FG000|Completed at Least 4 Meals|Early discharge|5|||
46659016|NCT04460326|82870744|FG001|Completed at Least 4 Meals|Early discharge|5|||
46659017|NCT04460326|82870743|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
46659018|NCT04460326|82870744|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
46659019|NCT04460326|82870743|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
46659020|NCT04460326|82870744|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
46659021|NCT04460326|82870743|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
46659022|NCT04460326|82870744|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
46659023|NCT04460326|82870743|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
46659024|NCT04460326|82870744|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
46659025|NCT04460326|82870743|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
46659026|NCT04460326|82870744|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
46659027|NCT04271735|82870752|FG000|Overall Study|Physician Decision|2|||
46659028|NCT04271735|82870753|FG001|Overall Study|Physician Decision|0|||
46659029|NCT04221373|82870761|FG000|Overall Study|Physician Decision|4|||
46659030|NCT04221373|82870762|FG001|Overall Study|Physician Decision|0|||
46659031|NCT04206605|82870770|FG000|Overall Study|Adverse Event|0|||
46659032|NCT04206605|82870771|FG001|Overall Study|Adverse Event|1|||
46659033|NCT04206605|82870770|FG000|Overall Study|Withdrawal by Subject|1|||
46659034|NCT04206605|82870771|FG001|Overall Study|Withdrawal by Subject|0|||
46659035|NCT04177212|82870781|FG000|Overall Study|Withdrawal by Subject|9|||
46659036|NCT04177212|82870782|FG001|Overall Study|Withdrawal by Subject|7|||
46659037|NCT04177212|82870781|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
46659038|NCT04177212|82870782|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
46659039|NCT04177212|82870781|FG000|Overall Study|Physician Decision|1|||
46659040|NCT04177212|82870782|FG001|Overall Study|Physician Decision|0|||
46659041|NCT04177212|82870781|FG000|Overall Study|Lost to Follow-up|0|||
46659042|NCT04177212|82870782|FG001|Overall Study|Lost to Follow-up|3|||
46659043|NCT04177212|82870781|FG000|Overall Study|Adverse Event|0|||
46659044|NCT04177212|82870782|FG001|Overall Study|Adverse Event|1|||
46659045|NCT04177212|82870781|FG000|Overall Study|Other|1|||
46659046|NCT04177212|82870782|FG001|Overall Study|Other|2|||
46659047|NCT04065841|82870798|FG000|Overall Study|Adverse Event|4|||
46659048|NCT04065841|82870799|FG001|Overall Study|Adverse Event|2|||
46659049|NCT04065841|82870800|FG002|Overall Study|Adverse Event|10|||
46659050|NCT04065841|82870801|FG003|Overall Study|Adverse Event|1|||
46659051|NCT04065841|82870798|FG000|Overall Study|Lost to Follow-up|1|||
46659052|NCT04065841|82870799|FG001|Overall Study|Lost to Follow-up|2|||
46659053|NCT04065841|82870800|FG002|Overall Study|Lost to Follow-up|2|||
46659054|NCT04065841|82870801|FG003|Overall Study|Lost to Follow-up|2|||
46659055|NCT04065841|82870798|FG000|Overall Study|Physician Decision|1|||
46659056|NCT04065841|82870799|FG001|Overall Study|Physician Decision|0|||
46782422|NCT00561574|83001090|FG000|Overall Study|Adverse Event|21|||
46782423|NCT00561574|83001091|FG001|Overall Study|Adverse Event|24|||
46971749|NCT02055820|83215301|FG005|Phase I: Dose-Finding|Death|1|||
46971750|NCT02055820|83215302|FG006|Phase I: Dose-Finding|Death|1|||
47076125|NCT03132636|83370761|FG000|Overall Study|Protocol Violation|1|||
46659057|NCT04065841|82870800|FG002|Overall Study|Physician Decision|0|||
46659058|NCT04065841|82870801|FG003|Overall Study|Physician Decision|0|||
46659059|NCT04065841|82870798|FG000|Overall Study|Protocol Violation|0|||
46659060|NCT04065841|82870799|FG001|Overall Study|Protocol Violation|1|||
46659061|NCT04065841|82870800|FG002|Overall Study|Protocol Violation|0|||
46659062|NCT04065841|82870801|FG003|Overall Study|Protocol Violation|0|||
46659063|NCT04065841|82870798|FG000|Overall Study|Study terminated by Sponsor|22|||
46659064|NCT04065841|82870799|FG001|Overall Study|Study terminated by Sponsor|16|||
46659065|NCT04065841|82870800|FG002|Overall Study|Study terminated by Sponsor|28|||
46659066|NCT04065841|82870801|FG003|Overall Study|Study terminated by Sponsor|17|||
46659067|NCT04065841|82870798|FG000|Overall Study|Withdrawal by Subject|1|||
46659068|NCT04065841|82870799|FG001|Overall Study|Withdrawal by Subject|1|||
46782424|NCT00561574|83001090|FG000|Overall Study|Lack of Efficacy|11|||
47076126|NCT03132636|83370762|FG001|Overall Study|Protocol Violation|1|||
46659069|NCT04065841|82870800|FG002|Overall Study|Withdrawal by Subject|2|||
46659070|NCT04065841|82870801|FG003|Overall Study|Withdrawal by Subject|0|||
46659071|NCT04045132|82870814|FG000|Overall Study|Lost to Follow-up|3|||
46782425|NCT00561574|83001091|FG001|Overall Study|Lack of Efficacy|21|||
46782426|NCT00561574|83001090|FG000|Overall Study|Withdrawal by Subject|4|||
46782427|NCT00561574|83001091|FG001|Overall Study|Withdrawal by Subject|4|||
46782428|NCT00561574|83001090|FG000|Overall Study|Reason Unrelated to Trial|6|||
46782429|NCT00561574|83001091|FG001|Overall Study|Reason Unrelated to Trial|2|||
46782430|NCT00561574|83001090|FG000|Overall Study|Lost to Follow-up|1|||
46782431|NCT00561574|83001091|FG001|Overall Study|Lost to Follow-up|0|||
46782432|NCT00561574|83001090|FG000|Overall Study|Other|5|||
46782433|NCT00561574|83001091|FG001|Overall Study|Other|7|||
46782434|NCT00619827|83001099|FG000|Overall Study|Adverse Event|1|||
46782435|NCT00619827|83001100|FG001|Overall Study|Adverse Event|2|||
46782436|NCT00619827|83001099|FG000|Overall Study|Withdrawal by Subject|2|||
46782437|NCT00619827|83001100|FG001|Overall Study|Withdrawal by Subject|2|||
46782438|NCT00687804|83001109|FG000|Core Study|Adverse Event|5|||
46851012|NCT00098306|83066773|FG003|Open Label|Ongoing at cut-off date|269|||
47076127|NCT03132636|83370761|FG000|Overall Study|Participant Decision|1|||
47076128|NCT03132636|83370762|FG001|Overall Study|Participant Decision|9|||
47076129|NCT03132636|83370761|FG000|Overall Study|Sponsor Decision|0|||
46659072|NCT04045132|82870815|FG001|Overall Study|Lost to Follow-up|6|||
46659073|NCT03912831|82870838|FG000|Overall Study|Death|1|||
46659074|NCT03912831|82870839|FG001|Overall Study|Death|1|||
46659075|NCT03912831|82870840|FG002|Overall Study|Death|1|||
46659076|NCT03912831|82870841|FG003|Overall Study|Death|1|||
46659077|NCT03912831|82870842|FG004|Overall Study|Death|1|||
46659078|NCT03912831|82870843|FG005|Overall Study|Death|1|||
46659079|NCT03912831|82870838|FG000|Overall Study|Reason not Specified|0|||
46659080|NCT03912831|82870839|FG001|Overall Study|Reason not Specified|0|||
46659081|NCT03912831|82870840|FG002|Overall Study|Reason not Specified|0|||
47076130|NCT03132636|83370762|FG001|Overall Study|Sponsor Decision|1|||
47076131|NCT03132636|83370761|FG000|Overall Study|Progressive disease|32|||
46659082|NCT03912831|82870841|FG003|Overall Study|Reason not Specified|0|||
46659083|NCT03912831|82870842|FG004|Overall Study|Reason not Specified|1|||
47076132|NCT03132636|83370762|FG001|Overall Study|Progressive disease|36|||
47076133|NCT03132636|83370761|FG000|Overall Study|Withdrawal of consent|2|||
46659084|NCT03912831|82870843|FG005|Overall Study|Reason not Specified|0|||
46659085|NCT03912831|82870838|FG000|Overall Study|Withdrawal by Participant|0|||
46659086|NCT03912831|82870839|FG001|Overall Study|Withdrawal by Participant|0|||
46659087|NCT03912831|82870840|FG002|Overall Study|Withdrawal by Participant|0|||
46659088|NCT03912831|82870841|FG003|Overall Study|Withdrawal by Participant|0|||
46659089|NCT03912831|82870842|FG004|Overall Study|Withdrawal by Participant|1|||
46659090|NCT03912831|82870843|FG005|Overall Study|Withdrawal by Participant|0|||
46659091|NCT03665285|82870880|FG000|Overall Study|Started New Anticancer Treatment|1|||
46659092|NCT03665285|82870881|FG001|Overall Study|Started New Anticancer Treatment|1|||
46659093|NCT03665285|82870882|FG002|Overall Study|Started New Anticancer Treatment|2|||
46659094|NCT03665285|82870883|FG003|Overall Study|Started New Anticancer Treatment|4|||
46659095|NCT03665285|82870884|FG004|Overall Study|Started New Anticancer Treatment|1|||
46659096|NCT03665285|82870885|FG005|Overall Study|Started New Anticancer Treatment|1|||
46659097|NCT03665285|82870886|FG006|Overall Study|Started New Anticancer Treatment|2|||
46659098|NCT03665285|82870887|FG007|Overall Study|Started New Anticancer Treatment|15|||
46659099|NCT03665285|82870888|FG008|Overall Study|Started New Anticancer Treatment|1|||
46659100|NCT03665285|82870880|FG000|Overall Study|Disease Progression|0|||
46659101|NCT03665285|82870881|FG001|Overall Study|Disease Progression|0|||
46659102|NCT03665285|82870882|FG002|Overall Study|Disease Progression|3|||
46659103|NCT03665285|82870883|FG003|Overall Study|Disease Progression|1|||
46659104|NCT03665285|82870884|FG004|Overall Study|Disease Progression|0|||
46659105|NCT03665285|82870885|FG005|Overall Study|Disease Progression|0|||
46659106|NCT03665285|82870886|FG006|Overall Study|Disease Progression|0|||
46851013|NCT00098306|83066774|FG004|Open Label|Ongoing at cut-off date|62|||
47076134|NCT03132636|83370762|FG001|Overall Study|Withdrawal of consent|5|||
47076135|NCT03132636|83370761|FG000|Overall Study|Study ongoing|9|||
46659107|NCT03665285|82870887|FG007|Overall Study|Disease Progression|7|||
46659108|NCT03665285|82870888|FG008|Overall Study|Disease Progression|1|||
46659109|NCT03665285|82870880|FG000|Overall Study|Hospice|0|||
46659110|NCT03665285|82870881|FG001|Overall Study|Hospice|0|||
46659111|NCT03665285|82870882|FG002|Overall Study|Hospice|0|||
46659112|NCT03665285|82870883|FG003|Overall Study|Hospice|0|||
46659113|NCT03665285|82870884|FG004|Overall Study|Hospice|0|||
46782439|NCT00687804|83001110|FG001|Core Study|Adverse Event|3|||
46782440|NCT00687804|83001111|FG002|Core Study|Adverse Event|3|||
46851014|NCT00098306|83066775|FG005|Open Label|Ongoing at cut-off date|0|||
47076136|NCT03132636|83370762|FG001|Overall Study|Study ongoing|10|||
46659114|NCT03665285|82870885|FG005|Overall Study|Hospice|0|||
46659115|NCT03665285|82870886|FG006|Overall Study|Hospice|0|||
46659116|NCT03665285|82870887|FG007|Overall Study|Hospice|2|||
46659117|NCT03665285|82870888|FG008|Overall Study|Hospice|0|||
46659118|NCT03665285|82870880|FG000|Overall Study|Withdrawal by Subject|0|||
46659119|NCT03665285|82870881|FG001|Overall Study|Withdrawal by Subject|0|||
46659120|NCT03665285|82870882|FG002|Overall Study|Withdrawal by Subject|0|||
46659121|NCT03665285|82870883|FG003|Overall Study|Withdrawal by Subject|0|||
46782441|NCT00687804|83001109|FG000|Core Study|Abnormal laboratory value(s)|1|||
46659122|NCT03665285|82870884|FG004|Overall Study|Withdrawal by Subject|1|||
46659123|NCT03665285|82870885|FG005|Overall Study|Withdrawal by Subject|0|||
46659124|NCT03665285|82870886|FG006|Overall Study|Withdrawal by Subject|0|||
46659125|NCT03665285|82870887|FG007|Overall Study|Withdrawal by Subject|2|||
46659126|NCT03665285|82870888|FG008|Overall Study|Withdrawal by Subject|0|||
46659127|NCT03665285|82870880|FG000|Overall Study|Physician Decision|0|||
46659128|NCT03665285|82870881|FG001|Overall Study|Physician Decision|0|||
46659129|NCT03665285|82870882|FG002|Overall Study|Physician Decision|0|||
46659130|NCT03665285|82870883|FG003|Overall Study|Physician Decision|0|||
46659131|NCT03665285|82870884|FG004|Overall Study|Physician Decision|0|||
46659132|NCT03665285|82870885|FG005|Overall Study|Physician Decision|0|||
46659133|NCT03665285|82870886|FG006|Overall Study|Physician Decision|0|||
46659134|NCT03665285|82870887|FG007|Overall Study|Physician Decision|2|||
46659135|NCT03665285|82870888|FG008|Overall Study|Physician Decision|0|||
46659136|NCT03524612|82870917|FG000|Overall Study|Lack of Efficacy|10|||
46659137|NCT03524612|82870917|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
46659138|NCT03524612|82870917|FG000|Overall Study|Adverse Event|10|||
46659139|NCT03524612|82870917|FG000|Overall Study|Withdrawal by Subject|7|||
46659140|NCT03524612|82870917|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
46659141|NCT03524612|82870917|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
46659142|NCT03524612|82870917|FG000|Overall Study|New therapy for study indication|6|||
46659143|NCT03524612|82870917|FG000|Overall Study|Death|3|||
46659144|NCT03524612|82870917|FG000|Overall Study|Lost to Follow-up|2|||
46659145|NCT03524612|82870917|FG000|Overall Study|Protocol Violation|1|||
46659146|NCT03495453|82870924|FG000|Overall Study|Withdrawal by Subject|0|||
46659147|NCT03495453|82870925|FG001|Overall Study|Withdrawal by Subject|1|||
46659148|NCT03212794|82870933|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
46659149|NCT03212794|82870934|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
46659150|NCT03212794|82870933|FG000|Overall Study|Lost to Follow-up|5|||
46659151|NCT03212794|82870934|FG001|Overall Study|Lost to Follow-up|6|||
46659152|NCT03212794|82870933|FG000|Overall Study|Incarcerated; unable to participate|2|||
46659153|NCT03212794|82870934|FG001|Overall Study|Incarcerated; unable to participate|0|||
46659154|NCT03212794|82870933|FG000|Overall Study|Withdrawal by Subject|1|||
46659155|NCT03212794|82870934|FG001|Overall Study|Withdrawal by Subject|0|||
46659156|NCT03212794|82870933|FG000|Overall Study|Death|0|||
46659157|NCT03212794|82870934|FG001|Overall Study|Death|1|||
46782442|NCT00687804|83001110|FG001|Core Study|Abnormal laboratory value(s)|0|||
46782443|NCT00687804|83001111|FG002|Core Study|Abnormal laboratory value(s)|0|||
46782444|NCT00687804|83001109|FG000|Core Study|Lack of Efficacy|1|||
46782445|NCT00687804|83001110|FG001|Core Study|Lack of Efficacy|1|||
46782446|NCT00687804|83001111|FG002|Core Study|Lack of Efficacy|1|||
46782447|NCT00687804|83001109|FG000|Core Study|Withdrawal by Subject|4|||
46782448|NCT00687804|83001110|FG001|Core Study|Withdrawal by Subject|7|||
46782449|NCT00687804|83001111|FG002|Core Study|Withdrawal by Subject|7|||
46782450|NCT00687804|83001109|FG000|Core Study|Lost to Follow-up|0|||
46782451|NCT00687804|83001110|FG001|Core Study|Lost to Follow-up|1|||
46782452|NCT00687804|83001111|FG002|Core Study|Lost to Follow-up|0|||
46782453|NCT00687804|83001109|FG000|Core Study|Death|2|||
46782454|NCT00687804|83001110|FG001|Core Study|Death|2|||
46782455|NCT00687804|83001111|FG002|Core Study|Death|2|||
46782456|NCT00687804|83001109|FG000|Core Study|Protocol Violation|1|||
46782457|NCT00687804|83001110|FG001|Core Study|Protocol Violation|1|||
46782458|NCT00687804|83001111|FG002|Core Study|Protocol Violation|0|||
46782459|NCT00687804|83001109|FG000|Open-Label Extension Study|Adverse Event|2|||
46782460|NCT00687804|83001110|FG001|Open-Label Extension Study|Adverse Event|2|||
46782461|NCT00687804|83001111|FG002|Open-Label Extension Study|Adverse Event|2|||
46782462|NCT00687804|83001109|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
46782463|NCT00687804|83001110|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
46782464|NCT00687804|83001111|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
46782465|NCT00687804|83001109|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
46659158|NCT03212794|82870933|FG000|Overall Study|Found to be ineligible after allocation|0|||
46659159|NCT03212794|82870934|FG001|Overall Study|Found to be ineligible after allocation|1|||
46659160|NCT03212794|82870933|FG000|Overall Study|Relocated out of area|2|||
46659161|NCT03212794|82870934|FG001|Overall Study|Relocated out of area|0|||
46782466|NCT00687804|83001110|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
46782467|NCT00687804|83001111|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
46782468|NCT00687804|83001109|FG000|Open-Label Extension Study|Administrative problems|1|||
46782469|NCT00687804|83001110|FG001|Open-Label Extension Study|Administrative problems|1|||
46659162|NCT03194958|82870944|FG000|Overall Study|Death|0|||
46659163|NCT03194958|82870945|FG001|Overall Study|Death|1|||
46659164|NCT03194958|82870946|FG002|Overall Study|Death|1|||
46659165|NCT03194958|82870947|FG003|Overall Study|Death|1|||
46659166|NCT03194958|82870944|FG000|Overall Study|Withdrawal by Subject|24|||
46659167|NCT03194958|82870945|FG001|Overall Study|Withdrawal by Subject|27|||
46782470|NCT00687804|83001111|FG002|Open-Label Extension Study|Administrative problems|0|||
46782471|NCT00687804|83001109|FG000|Open-Label Extension Study|Death|2|||
46782472|NCT00687804|83001110|FG001|Open-Label Extension Study|Death|3|||
46782473|NCT00687804|83001111|FG002|Open-Label Extension Study|Death|3|||
46782474|NCT00689052|83001138|FG000|Overall Study|Adverse Event|4|||
46782475|NCT00689052|83001139|FG001|Overall Study|Adverse Event|6|||
46782476|NCT00689052|83001138|FG000|Overall Study|Protocol Violation|1|||
46782477|NCT00689052|83001139|FG001|Overall Study|Protocol Violation|0|||
46782478|NCT00689052|83001138|FG000|Overall Study|Lost to Follow-up|2|||
46782479|NCT00689052|83001139|FG001|Overall Study|Lost to Follow-up|0|||
46782480|NCT00689052|83001138|FG000|Overall Study|Withdrawal by Subject|2|||
46782481|NCT00689052|83001139|FG001|Overall Study|Withdrawal by Subject|0|||
46782482|NCT00689052|83001138|FG000|Overall Study|Early termination of the trial|22|||
46782483|NCT00689052|83001139|FG001|Overall Study|Early termination of the trial|24|||
46782484|NCT00560950|83001149|FG000|Overall Study|Lost to Follow-up|1|||
46782485|NCT00560950|83001150|FG001|Overall Study|Lost to Follow-up|0|||
46782486|NCT00576758|83001160|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
46782487|NCT00576758|83001161|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
46782488|NCT00576758|83001160|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
46782489|NCT00576758|83001161|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
46782490|NCT00576758|83001160|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
46782491|NCT00576758|83001161|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
46782492|NCT00576758|83001160|FG000|Induction Treatment Period|Death|1|||
46782493|NCT00576758|83001161|FG001|Induction Treatment Period|Death|0|||
46782494|NCT00576758|83001160|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
46782495|NCT00576758|83001161|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
46782496|NCT00576758|83001160|FG000|Induction Treatment Period|Withdrew consent|1|||
46782497|NCT00576758|83001161|FG001|Induction Treatment Period|Withdrew consent|0|||
46782498|NCT00576758|83001160|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
46782499|NCT00576758|83001161|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
46782500|NCT00576758|83001160|FG000|Extension Treatment Period|Death|1|||
46782501|NCT00576758|83001161|FG001|Extension Treatment Period|Death|1|||
46782502|NCT00576758|83001160|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
46782503|NCT00576758|83001161|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
46782504|NCT00576758|83001160|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
46782505|NCT00576758|83001161|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
46782506|NCT00576758|83001160|FG000|Extension Treatment Period|Administrative/Other|3|||
46782507|NCT00576758|83001161|FG001|Extension Treatment Period|Administrative/Other|1|||
46782508|NCT00576758|83001160|FG000|Follow-up Period|Administrative/Other|6|||
46782509|NCT00576758|83001161|FG001|Follow-up Period|Administrative/Other|8|||
46782510|NCT00576758|83001160|FG000|Follow-up Period|Death|3|||
46782511|NCT00576758|83001161|FG001|Follow-up Period|Death|3|||
46782512|NCT00576758|83001160|FG000|Follow-up Period|Insufficient therapeutic response|16|||
46782513|NCT00576758|83001161|FG001|Follow-up Period|Insufficient therapeutic response|5|||
46782514|NCT00576758|83001160|FG000|Follow-up Period|Withdrew consent|2|||
46782515|NCT00576758|83001161|FG001|Follow-up Period|Withdrew consent|1|||
46782516|NCT00560794|83001168|FG000|Overall Study|Adverse Event|2|||
46782517|NCT00560794|83001168|FG000|Overall Study|Patient was not Compliant|1|||
46782518|NCT00560794|83001168|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
46782519|NCT00560794|83001168|FG000|Overall Study|Hematological Relapse|1|||
46782520|NCT00560794|83001168|FG000|Overall Study|Received Bone Marrow Transplant|6|||
46782521|NCT00619359|83001176|FG000|Overall Study|Adverse Event|32|||
46782522|NCT00619359|83001177|FG001|Overall Study|Adverse Event|36|||
46782523|NCT00619359|83001176|FG000|Overall Study|Lost to Follow-up|12|||
46782524|NCT00619359|83001177|FG001|Overall Study|Lost to Follow-up|16|||
46782525|NCT00619359|83001176|FG000|Overall Study|Physician Decision|0|||
46782526|NCT00619359|83001177|FG001|Overall Study|Physician Decision|7|||
46782527|NCT00619359|83001176|FG000|Overall Study|Protocol Violation|1|||
46782528|NCT00619359|83001177|FG001|Overall Study|Protocol Violation|1|||
46782529|NCT00619359|83001176|FG000|Overall Study|Withdrawal by Subject|19|||
46782530|NCT00619359|83001177|FG001|Overall Study|Withdrawal by Subject|20|||
46782531|NCT00619359|83001176|FG000|Overall Study|Progressive Disease|3|||
46782532|NCT00619359|83001177|FG001|Overall Study|Progressive Disease|1|||
46971751|NCT02055820|83215303|FG007|Phase I: Dose-Finding|Death|0|||
46782533|NCT00372229|83001185|FG000|Study Phase|Graft loss|0|||
46782534|NCT00372229|83001186|FG001|Study Phase|Graft loss|3|||
46782535|NCT00372229|83001185|FG000|Study Phase|Protocol Violation|3|||
46782536|NCT00372229|83001186|FG001|Study Phase|Protocol Violation|4|||
46782537|NCT00372229|83001185|FG000|Study Phase|Consent withdrawn|16|||
46782538|NCT00372229|83001186|FG001|Study Phase|Consent withdrawn|14|||
46782539|NCT00372229|83001185|FG000|Study Phase|Refused treatment/did not cooperate|3|||
46782540|NCT00372229|83001186|FG001|Study Phase|Refused treatment/did not cooperate|1|||
46782541|NCT00372229|83001185|FG000|Study Phase|Death|3|||
46782542|NCT00372229|83001186|FG001|Study Phase|Death|2|||
46782543|NCT00372229|83001185|FG000|Study Phase|Reason not specified|3|||
46782544|NCT00372229|83001186|FG001|Study Phase|Reason not specified|2|||
46782545|NCT00372229|83001185|FG000|Study Phase|Lost to Follow-up|3|||
46782546|NCT00372229|83001186|FG001|Study Phase|Lost to Follow-up|3|||
46782547|NCT00372229|83001185|FG000|Follow-Up Phase|Graft loss|8|||
46782548|NCT00372229|83001186|FG001|Follow-Up Phase|Graft loss|7|||
46782549|NCT00372229|83001185|FG000|Follow-Up Phase|Consent withdrawn|13|||
46782550|NCT00372229|83001186|FG001|Follow-Up Phase|Consent withdrawn|19|||
46782551|NCT00372229|83001185|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
46782552|NCT00372229|83001186|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
46782553|NCT00372229|83001185|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
46782554|NCT00372229|83001186|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
46782555|NCT00372229|83001185|FG000|Follow-Up Phase|Death|9|||
46782556|NCT00372229|83001186|FG001|Follow-Up Phase|Death|12|||
46782557|NCT00372229|83001185|FG000|Follow-Up Phase|Administrative|1|||
46782558|NCT00372229|83001186|FG001|Follow-Up Phase|Administrative|0|||
46782559|NCT00372229|83001185|FG000|Follow-Up Phase|Reason not specified|2|||
46782560|NCT00372229|83001186|FG001|Follow-Up Phase|Reason not specified|3|||
46782561|NCT00372229|83001185|FG000|Follow-Up Phase|Lost to Follow-up|12|||
46782562|NCT00372229|83001186|FG001|Follow-Up Phase|Lost to Follow-up|10|||
46782563|NCT00698828|83001199|FG000|Overall Study|Adverse Event|3|||
46782564|NCT00698828|83001200|FG001|Overall Study|Adverse Event|4|||
46782565|NCT00698828|83001201|FG002|Overall Study|Adverse Event|4|||
46782566|NCT00698828|83001199|FG000|Overall Study|Death|0|||
46782567|NCT00698828|83001200|FG001|Overall Study|Death|0|||
46782568|NCT00698828|83001201|FG002|Overall Study|Death|1|||
46971752|NCT02055820|83215304|FG008|Phase I: Dose-Finding|Death|0|||
47076137|NCT03132636|83370761|FG000|Overall Study|Other|1|||
47076138|NCT03132636|83370762|FG001|Overall Study|Other|2|||
47076139|NCT02906202|83370768|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
47076140|NCT02869789|83370776|FG000|Overall Study|Disease progression|184|||
47076141|NCT02869789|83370777|FG001|Overall Study|Disease progression|109|||
47076142|NCT02869789|83370778|FG002|Overall Study|Disease progression|260|||
47076143|NCT02869789|83370779|FG003|Overall Study|Disease progression|19|||
47076144|NCT02869789|83370776|FG000|Overall Study|Study drug toxicity|90|||
47076145|NCT02869789|83370777|FG001|Overall Study|Study drug toxicity|32|||
47076146|NCT02869789|83370778|FG002|Overall Study|Study drug toxicity|55|||
47076147|NCT02869789|83370779|FG003|Overall Study|Study drug toxicity|14|||
47076148|NCT02869789|83370776|FG000|Overall Study|Death|7|||
47076149|NCT02869789|83370777|FG001|Overall Study|Death|3|||
47076150|NCT02869789|83370778|FG002|Overall Study|Death|5|||
47076151|NCT02869789|83370779|FG003|Overall Study|Death|1|||
47076152|NCT02869789|83370776|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
47076153|NCT02869789|83370777|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
47076154|NCT02869789|83370778|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
47076155|NCT02869789|83370779|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
46659168|NCT03194958|82870946|FG002|Overall Study|Withdrawal by Subject|7|||
46659169|NCT03194958|82870947|FG003|Overall Study|Withdrawal by Subject|22|||
46659170|NCT03194958|82870944|FG000|Overall Study|Lost to Follow-up|168|||
46659171|NCT03194958|82870945|FG001|Overall Study|Lost to Follow-up|196|||
46659172|NCT03194958|82870946|FG002|Overall Study|Lost to Follow-up|174|||
46659173|NCT03194958|82870947|FG003|Overall Study|Lost to Follow-up|186|||
46659174|NCT03123783|82870964|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
46659175|NCT03123783|82870965|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
46782569|NCT00698828|83001199|FG000|Overall Study|Exacerbation of COPD|1|||
46971753|NCT02055820|83215305|FG009|Phase I: Dose-Finding|Death|0|||
46971754|NCT02055820|83215296|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46971755|NCT02055820|83215297|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46971756|NCT02055820|83215298|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46971757|NCT02055820|83215299|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46971758|NCT02055820|83215300|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46971759|NCT02055820|83215301|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
46971760|NCT02055820|83215302|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46782570|NCT00698828|83001200|FG001|Overall Study|Exacerbation of COPD|3|||
46782571|NCT00698828|83001201|FG002|Overall Study|Exacerbation of COPD|0|||
47076156|NCT02869789|83370776|FG000|Overall Study|Participant request to discontinue study treatment|10|||
46782572|NCT00698828|83001199|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
46782573|NCT00698828|83001200|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
46782574|NCT00698828|83001201|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
46782575|NCT00698828|83001199|FG000|Overall Study|Investigator/Sponsor decision|1|||
47076157|NCT02869789|83370777|FG001|Overall Study|Participant request to discontinue study treatment|5|||
47076158|NCT02869789|83370778|FG002|Overall Study|Participant request to discontinue study treatment|5|||
47076159|NCT02869789|83370779|FG003|Overall Study|Participant request to discontinue study treatment|3|||
46659176|NCT03123783|82870966|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
46971761|NCT02055820|83215303|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46971762|NCT02055820|83215304|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46659177|NCT03123783|82870967|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
46659178|NCT03123783|82870968|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
46659179|NCT03123783|82870969|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
46659180|NCT03123783|82870970|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
46659181|NCT03123783|82870964|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
46659182|NCT03123783|82870965|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
46659183|NCT03123783|82870966|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
46659184|NCT03123783|82870967|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
46659185|NCT03123783|82870968|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
46659186|NCT03123783|82870969|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
46659187|NCT03123783|82870970|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
46659188|NCT03123783|82870964|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
46659189|NCT03123783|82870965|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
46659190|NCT03123783|82870966|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
46659191|NCT03123783|82870967|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
46659192|NCT03123783|82870968|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
46659193|NCT03123783|82870969|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
46659194|NCT03123783|82870970|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
46659195|NCT03123783|82870964|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
46659196|NCT03123783|82870965|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
46659197|NCT03123783|82870966|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
46659198|NCT03123783|82870967|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
46659199|NCT03123783|82870968|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
46659200|NCT03123783|82870969|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
46659201|NCT03123783|82870970|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
46659202|NCT03003962|82871011|FG000|Overall Study|Withdrawal by Subject|5|||
46659203|NCT03003962|82871012|FG001|Overall Study|Withdrawal by Subject|17|||
46659204|NCT03003962|82871011|FG000|Overall Study|Death|274|||
46659205|NCT03003962|82871012|FG001|Overall Study|Death|277|||
46659206|NCT03003962|82871011|FG000|Overall Study|Participants ongoing at DCO|55|||
46659207|NCT03003962|82871012|FG001|Overall Study|Participants ongoing at DCO|40|||
46659208|NCT02943408|82871022|FG000|Overall Study|Lost to Follow-up|7|||
46659209|NCT02943408|82871023|FG001|Overall Study|Lost to Follow-up|1|||
46659210|NCT02943408|82871022|FG000|Overall Study|Withdrawal by Subject|0|||
46659211|NCT02943408|82871023|FG001|Overall Study|Withdrawal by Subject|1|||
46659212|NCT02728102|82871032|FG000|Overall Study|Death|3|||
46659213|NCT02728102|82871033|FG001|Overall Study|Death|0|||
46659214|NCT02728102|82871034|FG002|Overall Study|Death|1|||
46659215|NCT02728102|82871032|FG000|Overall Study|Withdrawal by Subject|0|||
46659216|NCT02728102|82871033|FG001|Overall Study|Withdrawal by Subject|2|||
46659217|NCT02728102|82871034|FG002|Overall Study|Withdrawal by Subject|3|||
46659218|NCT02728102|82871032|FG000|Overall Study|Physician Decision|1|||
46659219|NCT02728102|82871033|FG001|Overall Study|Physician Decision|1|||
46659220|NCT02728102|82871034|FG002|Overall Study|Physician Decision|0|||
46659221|NCT02728102|82871032|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
46659222|NCT02728102|82871033|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
46659223|NCT02728102|82871034|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
46659224|NCT02728102|82871032|FG000|Overall Study|Covid|0|||
46659225|NCT02728102|82871033|FG001|Overall Study|Covid|0|||
46659226|NCT02728102|82871034|FG002|Overall Study|Covid|1|||
46659227|NCT02660580|82871045|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
46659228|NCT02660580|82871046|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
46659229|NCT02660580|82871047|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
46659230|NCT02660580|82871048|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
46971763|NCT02055820|83215305|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
46971764|NCT02055820|83215296|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971765|NCT02055820|83215297|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971766|NCT02055820|83215298|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971767|NCT02055820|83215299|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
46971768|NCT02055820|83215300|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971769|NCT02055820|83215301|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971770|NCT02055820|83215302|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
46659231|NCT02660580|82871049|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
46659232|NCT02660580|82871045|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
46659233|NCT02660580|82871046|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
46659234|NCT02660580|82871047|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
46971771|NCT02055820|83215303|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971772|NCT02055820|83215304|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971773|NCT02055820|83215305|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
46971774|NCT02055820|83215296|FG000|Phase II: Expansion|Death|0|||
46971775|NCT02055820|83215297|FG001|Phase II: Expansion|Death|0|||
46971776|NCT02055820|83215298|FG002|Phase II: Expansion|Death|0|||
46971777|NCT02055820|83215299|FG003|Phase II: Expansion|Death|0|||
46971778|NCT02055820|83215300|FG004|Phase II: Expansion|Death|33|||
46971779|NCT02055820|83215301|FG005|Phase II: Expansion|Death|0|||
46971780|NCT02055820|83215302|FG006|Phase II: Expansion|Death|0|||
46659235|NCT02660580|82871048|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
46659236|NCT02660580|82871049|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
46659237|NCT02660580|82871045|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
46659238|NCT02660580|82871046|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
46659239|NCT02660580|82871047|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
46659240|NCT02660580|82871048|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
46659241|NCT02660580|82871049|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
46659242|NCT02660580|82871045|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
46659243|NCT02660580|82871046|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
46659244|NCT02660580|82871047|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
46659245|NCT02660580|82871048|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
46659246|NCT02660580|82871049|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
46659247|NCT02660580|82871045|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
46659248|NCT02660580|82871046|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
46659249|NCT02660580|82871047|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
46659250|NCT02660580|82871048|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
46659251|NCT02660580|82871049|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
46659252|NCT02660580|82871045|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
46659253|NCT02660580|82871046|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
46659254|NCT02660580|82871047|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
46659255|NCT02660580|82871048|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
46659256|NCT02660580|82871049|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
46659257|NCT02660580|82871045|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
46659258|NCT02660580|82871046|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
46659259|NCT02660580|82871047|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
46659260|NCT02660580|82871048|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
46659261|NCT02660580|82871049|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
46659262|NCT02660580|82871045|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
46659263|NCT02660580|82871046|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
46659264|NCT02660580|82871047|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
46659265|NCT02660580|82871048|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
46659266|NCT02660580|82871049|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
46659267|NCT02660580|82871045|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
46659268|NCT02660580|82871046|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
46659269|NCT02660580|82871047|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
46659270|NCT02660580|82871048|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
46659271|NCT02660580|82871049|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
46782576|NCT00698828|83001200|FG001|Overall Study|Investigator/Sponsor decision|0|||
46782577|NCT00698828|83001201|FG002|Overall Study|Investigator/Sponsor decision|2|||
46782578|NCT00698828|83001199|FG000|Overall Study|Lost to Follow-up|1|||
46782579|NCT00698828|83001200|FG001|Overall Study|Lost to Follow-up|1|||
46782580|NCT00698828|83001201|FG002|Overall Study|Lost to Follow-up|0|||
46782581|NCT00698828|83001199|FG000|Overall Study|Withdrew consent|0|||
46782582|NCT00698828|83001200|FG001|Overall Study|Withdrew consent|7|||
46782583|NCT00698828|83001201|FG002|Overall Study|Withdrew consent|4|||
46782584|NCT00698828|83001199|FG000|Overall Study|Withdrew consent (not treated)|2|||
46782585|NCT00698828|83001200|FG001|Overall Study|Withdrew consent (not treated)|0|||
46782586|NCT00698828|83001201|FG002|Overall Study|Withdrew consent (not treated)|0|||
46782587|NCT00619515|83001209|FG000|Overall Study|Study Termination by IRB|73|||
46782588|NCT03167606|83001215|FG000|Overall Study|Lost to Follow-up|73|||
46782589|NCT03167606|83001216|FG001|Overall Study|Lost to Follow-up|64|||
46782590|NCT03167606|83001215|FG000|Overall Study|Withdrawal by Subject|6|||
46782591|NCT03167606|83001216|FG001|Overall Study|Withdrawal by Subject|5|||
46782592|NCT03167606|83001215|FG000|Overall Study|Withdrawal by Investigator|0|||
46782593|NCT03167606|83001216|FG001|Overall Study|Withdrawal by Investigator|2|||
46971781|NCT02055820|83215303|FG007|Phase II: Expansion|Death|0|||
46971782|NCT02055820|83215304|FG008|Phase II: Expansion|Death|0|||
46971783|NCT02055820|83215305|FG009|Phase II: Expansion|Death|0|||
46971784|NCT02055820|83215296|FG000|Phase II: Expansion|Lost to Follow-up|0|||
46971785|NCT02055820|83215297|FG001|Phase II: Expansion|Lost to Follow-up|0|||
47076160|NCT02869789|83370776|FG000|Overall Study|Withdrawal by Subject|5|||
46659272|NCT02660580|82871045|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
46659273|NCT02660580|82871046|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
46659274|NCT02660580|82871047|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
46659275|NCT02660580|82871048|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
46659276|NCT02660580|82871049|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
46659277|NCT02660580|82871045|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
46659278|NCT02660580|82871046|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
46659279|NCT02660580|82871047|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
46659280|NCT02660580|82871048|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
46659281|NCT02660580|82871049|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
46659282|NCT02660580|82871045|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
46659283|NCT02660580|82871046|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
46782594|NCT00688740|83001224|FG000|Overall Study|Adverse Event|45|||
46782595|NCT00688740|83001225|FG001|Overall Study|Adverse Event|8|||
46659284|NCT02660580|82871047|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
46659285|NCT02660580|82871048|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
46659286|NCT02660580|82871049|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
46659287|NCT02660580|82871045|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
46659288|NCT02660580|82871046|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
46659289|NCT02660580|82871047|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
46659290|NCT02660580|82871048|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
46659291|NCT02660580|82871049|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
46659292|NCT02600897|82871077|FG000|Overall Study|Death|1|||
46659293|NCT02600897|82871078|FG001|Overall Study|Death|2|||
46659294|NCT02600897|82871079|FG002|Overall Study|Death|1|||
46659295|NCT02600897|82871080|FG003|Overall Study|Death|2|||
46659296|NCT02600897|82871081|FG004|Overall Study|Death|3|||
46659297|NCT02600897|82871082|FG005|Overall Study|Death|2|||
46659298|NCT02600897|82871083|FG006|Overall Study|Death|10|||
46659299|NCT02600897|82871084|FG007|Overall Study|Death|7|||
46659300|NCT02600897|82871085|FG008|Overall Study|Death|20|||
46659301|NCT02600897|82871077|FG000|Overall Study|Lost to Follow-up|1|||
46659302|NCT02600897|82871078|FG001|Overall Study|Lost to Follow-up|0|||
46659303|NCT02600897|82871079|FG002|Overall Study|Lost to Follow-up|0|||
46659304|NCT02600897|82871080|FG003|Overall Study|Lost to Follow-up|0|||
46659305|NCT02600897|82871081|FG004|Overall Study|Lost to Follow-up|0|||
46659306|NCT02600897|82871082|FG005|Overall Study|Lost to Follow-up|0|||
46659307|NCT02600897|82871083|FG006|Overall Study|Lost to Follow-up|0|||
46659308|NCT02600897|82871084|FG007|Overall Study|Lost to Follow-up|1|||
46659309|NCT02600897|82871085|FG008|Overall Study|Lost to Follow-up|0|||
46659310|NCT02600897|82871077|FG000|Overall Study|Withdrawal by Subject|0|||
46659311|NCT02600897|82871078|FG001|Overall Study|Withdrawal by Subject|0|||
46659312|NCT02600897|82871079|FG002|Overall Study|Withdrawal by Subject|0|||
46659313|NCT02600897|82871080|FG003|Overall Study|Withdrawal by Subject|0|||
46659314|NCT02600897|82871081|FG004|Overall Study|Withdrawal by Subject|0|||
46659315|NCT02600897|82871082|FG005|Overall Study|Withdrawal by Subject|0|||
46659316|NCT02600897|82871083|FG006|Overall Study|Withdrawal by Subject|0|||
46659317|NCT02600897|82871084|FG007|Overall Study|Withdrawal by Subject|4|||
46659318|NCT02600897|82871085|FG008|Overall Study|Withdrawal by Subject|2|||
46659319|NCT02600897|82871077|FG000|Overall Study|Reason Not Specified|0|||
46659320|NCT02600897|82871078|FG001|Overall Study|Reason Not Specified|0|||
46659321|NCT02600897|82871079|FG002|Overall Study|Reason Not Specified|0|||
46659322|NCT02600897|82871080|FG003|Overall Study|Reason Not Specified|0|||
46659323|NCT02600897|82871081|FG004|Overall Study|Reason Not Specified|0|||
46659324|NCT02600897|82871082|FG005|Overall Study|Reason Not Specified|0|||
46659325|NCT02600897|82871083|FG006|Overall Study|Reason Not Specified|0|||
46659326|NCT02600897|82871084|FG007|Overall Study|Reason Not Specified|0|||
46659327|NCT02600897|82871085|FG008|Overall Study|Reason Not Specified|1|||
46659328|NCT02399215|82871114|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
46659329|NCT02399215|82871114|FG000|Overall Study|Withdrawal by Subject|1|||
46659330|NCT02365649|82871124|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46782596|NCT00688740|83001224|FG000|Overall Study|Death|2|||
46782597|NCT00688740|83001225|FG001|Overall Study|Death|2|||
46782598|NCT00688740|83001224|FG000|Overall Study|Lost to Follow-up|0|||
46659331|NCT02365649|82871125|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46782599|NCT00688740|83001225|FG001|Overall Study|Lost to Follow-up|1|||
46782600|NCT00688740|83001224|FG000|Overall Study|Consent Withdrawn|17|||
46782601|NCT00688740|83001225|FG001|Overall Study|Consent Withdrawn|17|||
46659332|NCT02365649|82871126|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46659333|NCT02365649|82871127|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
46782602|NCT00688740|83001224|FG000|Overall Study|Breast Cancer Relapse|1|||
46782603|NCT00688740|83001225|FG001|Overall Study|Breast Cancer Relapse|4|||
47076161|NCT02869789|83370777|FG001|Overall Study|Withdrawal by Subject|2|||
46659334|NCT02365649|82871128|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46659335|NCT02365649|82871129|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46659336|NCT02365649|82871130|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46659337|NCT02365649|82871131|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46659338|NCT02365649|82871132|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46659339|NCT02365649|82871133|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
46659340|NCT02365649|82871124|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
46659341|NCT02365649|82871125|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
46659342|NCT02365649|82871126|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
46659343|NCT02365649|82871127|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
46659344|NCT02365649|82871128|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
46659345|NCT02365649|82871129|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
46659346|NCT02365649|82871130|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
46659347|NCT02365649|82871131|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
46659348|NCT02365649|82871132|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
46659349|NCT02365649|82871133|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
46659350|NCT02365649|82871124|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
46659351|NCT02365649|82871125|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
46659352|NCT02365649|82871126|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
46659353|NCT02365649|82871127|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
46659354|NCT02365649|82871128|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
46659355|NCT02365649|82871129|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
46659356|NCT02365649|82871130|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
46659357|NCT02365649|82871131|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
46659358|NCT02365649|82871132|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
46659359|NCT02365649|82871133|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
46659360|NCT02365649|82871124|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
46782604|NCT00688740|83001224|FG000|Overall Study|Violation of Inclusion Criteria|1|||
46782605|NCT00688740|83001225|FG001|Overall Study|Violation of Inclusion Criteria|3|||
46782606|NCT00552760|83001233|FG000|Overall Study|Adverse Event|3|||
46782607|NCT00552760|83001234|FG001|Overall Study|Adverse Event|5|||
46782608|NCT00552760|83001233|FG000|Overall Study|Relapsed- Depressed Event|10|||
46782609|NCT00552760|83001234|FG001|Overall Study|Relapsed- Depressed Event|16|||
46659361|NCT02365649|82871125|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
46659362|NCT02365649|82871126|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
46659363|NCT02365649|82871127|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
46659364|NCT02365649|82871128|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
46659365|NCT02365649|82871129|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
46659366|NCT02365649|82871130|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
46659367|NCT02365649|82871131|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
46659368|NCT02365649|82871132|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
46659369|NCT02365649|82871133|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
46659370|NCT02365649|82871124|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
46659371|NCT02365649|82871125|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
46659372|NCT02365649|82871126|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
46659373|NCT02365649|82871127|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
46659374|NCT02365649|82871128|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
46659375|NCT02365649|82871129|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
46659376|NCT02365649|82871130|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
46659377|NCT02365649|82871131|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
46659378|NCT02365649|82871132|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
46659379|NCT02365649|82871133|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
46659380|NCT02365649|82871124|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
46659381|NCT02365649|82871125|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
46659382|NCT02365649|82871126|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
46659383|NCT02365649|82871127|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
46659384|NCT02365649|82871128|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
46659385|NCT02365649|82871129|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
46659386|NCT02365649|82871130|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
46659387|NCT02365649|82871131|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
46782610|NCT00552760|83001233|FG000|Overall Study|Relapse- Manic Event|3|||
46782611|NCT00552760|83001234|FG001|Overall Study|Relapse- Manic Event|3|||
46782612|NCT00552760|83001233|FG000|Overall Study|Relapsed- Mixed Event|3|||
46782613|NCT00552760|83001234|FG001|Overall Study|Relapsed- Mixed Event|5|||
46782614|NCT00552760|83001233|FG000|Overall Study|Protocol Violation|0|||
46782615|NCT00552760|83001234|FG001|Overall Study|Protocol Violation|1|||
46782616|NCT00552760|83001233|FG000|Overall Study|Lost to Follow-up|1|||
46782617|NCT00552760|83001234|FG001|Overall Study|Lost to Follow-up|1|||
46782618|NCT00552760|83001233|FG000|Overall Study|Non-compliance|1|||
46659388|NCT02365649|82871132|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
46659389|NCT02365649|82871133|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
46659390|NCT02365649|82871124|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659391|NCT02365649|82871125|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659392|NCT02365649|82871126|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
46659393|NCT02365649|82871127|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659394|NCT02365649|82871128|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659395|NCT02365649|82871129|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659396|NCT02365649|82871130|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659397|NCT02365649|82871131|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659398|NCT02365649|82871132|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659399|NCT02365649|82871133|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
46659400|NCT02365649|82871124|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659401|NCT02365649|82871125|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659402|NCT02365649|82871126|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659403|NCT02365649|82871127|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659404|NCT02365649|82871128|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659405|NCT02365649|82871129|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659406|NCT02365649|82871130|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
46659407|NCT02365649|82871131|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659408|NCT02365649|82871132|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659409|NCT02365649|82871133|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
46659410|NCT02365649|82871124|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
46659411|NCT02365649|82871125|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
46659412|NCT02365649|82871126|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
46659413|NCT02365649|82871127|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
46659414|NCT02365649|82871128|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
46659415|NCT02365649|82871129|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
46659416|NCT02365649|82871130|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
46659417|NCT02365649|82871131|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
46659418|NCT02365649|82871132|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
46659419|NCT02365649|82871133|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
46659420|NCT02365649|82871124|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
46659421|NCT02365649|82871125|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
46659422|NCT02365649|82871126|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
46659423|NCT02365649|82871127|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
46659424|NCT02365649|82871128|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
46659425|NCT02365649|82871129|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
46659426|NCT02365649|82871130|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
46659427|NCT02365649|82871131|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
46659428|NCT02365649|82871132|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
46659429|NCT02365649|82871133|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
46659430|NCT02365649|82871124|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
46659431|NCT02365649|82871125|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
46659432|NCT02365649|82871126|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
46659433|NCT02365649|82871127|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
46659434|NCT02365649|82871128|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
46659435|NCT02365649|82871129|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
46659436|NCT02365649|82871130|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
46659437|NCT02365649|82871131|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
46659438|NCT02365649|82871132|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
46659439|NCT02365649|82871133|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
46659440|NCT02365649|82871124|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46659441|NCT02365649|82871125|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46659442|NCT02365649|82871126|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46659443|NCT02365649|82871127|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46659444|NCT02365649|82871128|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46659445|NCT02365649|82871129|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46659446|NCT02365649|82871130|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
46659447|NCT02365649|82871131|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46659448|NCT02365649|82871132|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
46659449|NCT02365649|82871133|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
46782619|NCT00552760|83001234|FG001|Overall Study|Non-compliance|1|||
46782620|NCT00552760|83001233|FG000|Overall Study|Medical Condition|1|||
46659450|NCT02110225|82871175|FG000|Overall Study|Lost to Follow-up|0|||
46659451|NCT02110225|82871176|FG001|Overall Study|Lost to Follow-up|1|||
46659452|NCT02110225|82871177|FG002|Overall Study|Lost to Follow-up|0|||
46659453|NCT02016820|82871188|FG000|Overall Study|Lost to Follow-up|2|||
46659454|NCT02016820|82871189|FG001|Overall Study|Lost to Follow-up|4|||
46659455|NCT01902173|82871201|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
46659456|NCT01902173|82871202|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
46659457|NCT01902173|82871203|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
46659458|NCT01902173|82871204|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
46659459|NCT01902173|82871205|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
46659460|NCT01902173|82871206|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
46659461|NCT01902173|82871201|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
46659462|NCT01902173|82871202|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
46659463|NCT01902173|82871203|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
46659464|NCT01902173|82871204|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
46659465|NCT01902173|82871205|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
46659466|NCT01902173|82871206|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
46659467|NCT01902173|82871201|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
46659468|NCT01902173|82871202|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
46659469|NCT01902173|82871203|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
46659470|NCT01902173|82871204|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
46659471|NCT01902173|82871205|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
46659472|NCT01902173|82871206|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
46659473|NCT01902173|82871201|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
46659474|NCT01902173|82871202|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
46659475|NCT01902173|82871203|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
46782621|NCT00552760|83001234|FG001|Overall Study|Medical Condition|1|||
46782622|NCT00552760|83001233|FG000|Overall Study|Withdrawal by Subject|3|||
46782623|NCT00552760|83001234|FG001|Overall Study|Withdrawal by Subject|0|||
46782624|NCT00552760|83001233|FG000|Overall Study|Medication Change|1|||
46782625|NCT00552760|83001234|FG001|Overall Study|Medication Change|0|||
46782626|NCT00686790|83001240|FG000|Overall Study|Adverse Event|2|||
46782627|NCT00686790|83001240|FG000|Overall Study|Withdrawal by Subject|1|||
46782628|NCT00686790|83001240|FG000|Overall Study|Death|1|||
46782629|NCT00686790|83001240|FG000|Overall Study|Lost to Follow-up|12|||
46851015|NCT00098306|83066776|FG006|Open Label|Ongoing at cut-off date|0|||
46851016|NCT00098306|83066770|FG000|Observational Phase|Death|0|||
46851017|NCT00098306|83066771|FG001|Observational Phase|Death|0|||
46659476|NCT01902173|82871204|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
46659477|NCT01902173|82871205|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
46659478|NCT01902173|82871206|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
46659479|NCT01902173|82871201|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
46659480|NCT01902173|82871202|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
46659481|NCT01902173|82871203|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
46659482|NCT01902173|82871204|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
46659483|NCT01902173|82871205|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
46659484|NCT01902173|82871206|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
46659485|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
46659486|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
46659487|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
46659488|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
46659489|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
46659490|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
46659491|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
46659492|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
46659493|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
46659494|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
46659495|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
46659496|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
46659497|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
46659498|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
46851018|NCT00098306|83066772|FG002|Observational Phase|Death|0|||
46659499|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
46659500|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
46659501|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
46659502|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
46782630|NCT00686712|83001247|FG000|Overall Study|Protocol Violation|8|||
46782631|NCT00686712|83001248|FG001|Overall Study|Protocol Violation|8|||
46851019|NCT00098306|83066773|FG003|Observational Phase|Death|0|||
46782632|NCT00686712|83001249|FG002|Overall Study|Protocol Violation|10|||
46851020|NCT00098306|83066774|FG004|Observational Phase|Death|0|||
46851021|NCT00098306|83066775|FG005|Observational Phase|Death|5|||
46659503|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
46659504|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
46659505|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
46659506|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
46659507|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
46659508|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
46659509|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
46659510|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
46659511|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
46659512|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
46659513|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
46659514|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
46659515|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
46659516|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
46659517|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
46659518|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
46659519|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
46659520|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
46659521|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
46659522|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
46659523|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
46659524|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
46659525|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
46659526|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
46659527|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
46659528|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
46659529|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
46659530|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
46659531|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
46659532|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
46659533|NCT01902173|82871201|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
46659534|NCT01902173|82871202|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
46659535|NCT01902173|82871203|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
46659536|NCT01902173|82871204|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
46659537|NCT01902173|82871205|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
46659538|NCT01902173|82871206|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
46659539|NCT01756456|82871244|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
46659540|NCT01756456|82871245|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
46659541|NCT01756456|82871246|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
46659542|NCT01756456|82871247|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
46659543|NCT01756456|82871248|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
46659544|NCT01756456|82871249|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
46659545|NCT01756456|82871244|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
46659546|NCT01756456|82871245|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
46659547|NCT01756456|82871246|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
46659548|NCT01756456|82871247|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
46659549|NCT01756456|82871248|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
46659550|NCT01756456|82871249|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
46659551|NCT01756456|82871244|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
46659552|NCT01756456|82871245|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
46659553|NCT01756456|82871246|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
46659554|NCT01756456|82871247|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
46659555|NCT01756456|82871248|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
46659556|NCT01756456|82871249|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
46659557|NCT01756456|82871244|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
46659558|NCT01756456|82871245|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
46659559|NCT01756456|82871246|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
46659560|NCT01756456|82871247|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
46659561|NCT01756456|82871248|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
46659562|NCT01756456|82871249|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
46659563|NCT01756456|82871244|FG000|Treatment Period: Phase I/II|Other causes|0|||
46659564|NCT01756456|82871245|FG001|Treatment Period: Phase I/II|Other causes|0|||
46659565|NCT01756456|82871246|FG002|Treatment Period: Phase I/II|Other causes|0|||
46659566|NCT01756456|82871247|FG003|Treatment Period: Phase I/II|Other causes|1|||
46659567|NCT01756456|82871248|FG004|Treatment Period: Phase I/II|Other causes|2|||
46659568|NCT01756456|82871249|FG005|Treatment Period: Phase I/II|Other causes|2|||
46659569|NCT01756456|82871244|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
46659570|NCT01756456|82871245|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
46782633|NCT00686712|83001247|FG000|Overall Study|Lost to Follow-up|1|||
46659571|NCT01756456|82871246|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
46659572|NCT01756456|82871247|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
46659573|NCT01756456|82871248|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
46659574|NCT01756456|82871249|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
46659575|NCT01756456|82871244|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
46659576|NCT01756456|82871245|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
46782634|NCT00686712|83001248|FG001|Overall Study|Lost to Follow-up|2|||
46971786|NCT02055820|83215298|FG002|Phase II: Expansion|Lost to Follow-up|0|||
46971787|NCT02055820|83215299|FG003|Phase II: Expansion|Lost to Follow-up|0|||
46971788|NCT02055820|83215300|FG004|Phase II: Expansion|Lost to Follow-up|4|||
46971789|NCT02055820|83215301|FG005|Phase II: Expansion|Lost to Follow-up|0|||
46971790|NCT02055820|83215302|FG006|Phase II: Expansion|Lost to Follow-up|0|||
46971791|NCT02055820|83215303|FG007|Phase II: Expansion|Lost to Follow-up|0|||
46971792|NCT02055820|83215304|FG008|Phase II: Expansion|Lost to Follow-up|0|||
46971793|NCT02055820|83215305|FG009|Phase II: Expansion|Lost to Follow-up|0|||
46971794|NCT02055820|83215296|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
46971795|NCT02055820|83215297|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
46971796|NCT02055820|83215298|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
46971797|NCT02055820|83215299|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
46971798|NCT02055820|83215300|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
46971799|NCT02055820|83215301|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
46971800|NCT02055820|83215302|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
46971801|NCT02055820|83215303|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
46971802|NCT02055820|83215304|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
46971803|NCT02055820|83215305|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
46971804|NCT02055352|83215349|FG000|Overall Study|Adverse Event|0|||
46971805|NCT02055352|83215350|FG001|Overall Study|Adverse Event|1|||
46971806|NCT02055352|83215349|FG000|Overall Study|Non-eligible|0|||
46971807|NCT02055352|83215350|FG001|Overall Study|Non-eligible|1|||
46971808|NCT02055352|83215349|FG000|Overall Study|Poor compliance|1|||
46971809|NCT02055352|83215350|FG001|Overall Study|Poor compliance|1|||
46971810|NCT02055352|83215349|FG000|Overall Study|Death|1|||
46971811|NCT02055352|83215350|FG001|Overall Study|Death|2|||
46971812|NCT02055352|83215349|FG000|Overall Study|Patient decision|1|||
46971813|NCT02055352|83215350|FG001|Overall Study|Patient decision|1|||
46971814|NCT02055352|83215349|FG000|Overall Study|Use of prohibited treatment|0|||
46971815|NCT02055352|83215350|FG001|Overall Study|Use of prohibited treatment|3|||
46971816|NCT02055352|83215349|FG000|Overall Study|AE, study drug would be detrimental|1|||
46971817|NCT02055352|83215350|FG001|Overall Study|AE, study drug would be detrimental|3|||
46971818|NCT02055352|83215349|FG000|Overall Study|Withdrawal of informed consent|1|||
46971819|NCT02055352|83215350|FG001|Overall Study|Withdrawal of informed consent|0|||
46971820|NCT02055352|83215349|FG000|Overall Study|Reason unknown|1|||
46971821|NCT02055352|83215350|FG001|Overall Study|Reason unknown|5|||
46971822|NCT02034916|83215358|FG000|Overall Study|Death|39|||
46971823|NCT02034916|83215359|FG001|Overall Study|Death|28|||
46971824|NCT02034916|83215358|FG000|Overall Study|Withdrawal by Subject|2|||
46971825|NCT02034916|83215359|FG001|Overall Study|Withdrawal by Subject|1|||
46971826|NCT02034916|83215358|FG000|Overall Study|Lost to Follow-up|4|||
46971827|NCT02034916|83215359|FG001|Overall Study|Lost to Follow-up|1|||
46659577|NCT01756456|82871246|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
46971828|NCT02034916|83215358|FG000|Overall Study|Study terminated by sponsor|4|||
46971829|NCT02034916|83215359|FG001|Overall Study|Study terminated by sponsor|5|||
46971830|NCT01374425|83215368|FG000|Overall Study|Radiographic Disease Progression|86|||
46971831|NCT01374425|83215369|FG001|Overall Study|Radiographic Disease Progression|81|||
46971832|NCT01374425|83215368|FG000|Overall Study|Clinical Disease Progression|9|||
46971833|NCT01374425|83215369|FG001|Overall Study|Clinical Disease Progression|6|||
46971834|NCT01374425|83215368|FG000|Overall Study|Adverse Event|29|||
46971835|NCT01374425|83215369|FG001|Overall Study|Adverse Event|18|||
46971836|NCT01374425|83215368|FG000|Overall Study|Death (Progression of Disease)|1|||
46971837|NCT01374425|83215369|FG001|Overall Study|Death (Progression of Disease)|0|||
46659578|NCT01756456|82871247|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
46659579|NCT01756456|82871248|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
46782635|NCT00686712|83001249|FG002|Overall Study|Lost to Follow-up|3|||
46971838|NCT01374425|83215368|FG000|Overall Study|Death (Adverse Event)|2|||
46971839|NCT01374425|83215369|FG001|Overall Study|Death (Adverse Event)|4|||
46971840|NCT01374425|83215368|FG000|Overall Study|Withdrawal by Subject|6|||
46971841|NCT01374425|83215369|FG001|Overall Study|Withdrawal by Subject|7|||
46971842|NCT01374425|83215368|FG000|Overall Study|Refused Treatment|10|||
46971843|NCT01374425|83215369|FG001|Overall Study|Refused Treatment|24|||
46971844|NCT01374425|83215368|FG000|Overall Study|Protocol Violation|2|||
46971845|NCT01374425|83215369|FG001|Overall Study|Protocol Violation|3|||
46971846|NCT01374425|83215368|FG000|Overall Study|Sponsor Decision|0|||
46971847|NCT01374425|83215369|FG001|Overall Study|Sponsor Decision|1|||
46971848|NCT01374425|83215368|FG000|Overall Study|Lost to Follow-up|2|||
46971849|NCT01374425|83215369|FG001|Overall Study|Lost to Follow-up|1|||
46659580|NCT01756456|82871249|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
46782636|NCT00686712|83001247|FG000|Overall Study|Adverse Event|1|||
46782637|NCT00686712|83001248|FG001|Overall Study|Adverse Event|1|||
46782638|NCT00686712|83001249|FG002|Overall Study|Adverse Event|0|||
46782639|NCT00686634|83001260|FG000|Overall Study|Protocol Violation|6|||
46782640|NCT00560404|83001267|FG000|Overall Study|Adverse Event|2|||
46782641|NCT00560404|83001268|FG001|Overall Study|Adverse Event|3|||
46782642|NCT00560404|83001267|FG000|Overall Study|Death|3|||
46782643|NCT00560404|83001268|FG001|Overall Study|Death|3|||
46782644|NCT00560404|83001267|FG000|Overall Study|Protocol Violation|12|||
46782645|NCT00560404|83001268|FG001|Overall Study|Protocol Violation|7|||
46782646|NCT00560404|83001267|FG000|Overall Study|Administrative Reasons|1|||
46782647|NCT00560404|83001268|FG001|Overall Study|Administrative Reasons|1|||
46971850|NCT01374425|83215368|FG000|Overall Study|Other|41|||
46971851|NCT01374425|83215369|FG001|Overall Study|Other|43|||
46659581|NCT01756456|82871244|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
46659582|NCT01756456|82871245|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
46659583|NCT01756456|82871246|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
46659584|NCT01756456|82871247|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
46659585|NCT01756456|82871248|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
46659586|NCT01756456|82871249|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
46659587|NCT01756456|82871244|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
46659588|NCT01756456|82871245|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
46659589|NCT01756456|82871246|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
46659590|NCT01756456|82871247|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
46659591|NCT01756456|82871248|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
46659592|NCT01756456|82871249|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
46659593|NCT01756456|82871244|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
46659594|NCT01756456|82871245|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
46659595|NCT01756456|82871246|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
46659596|NCT01756456|82871247|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
46659597|NCT01756456|82871248|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
46659598|NCT01756456|82871249|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
46659599|NCT01756456|82871244|FG000|Follow Up Period Phase I/II|Other causes|0|||
46659600|NCT01756456|82871245|FG001|Follow Up Period Phase I/II|Other causes|0|||
46659601|NCT01756456|82871246|FG002|Follow Up Period Phase I/II|Other causes|0|||
46659602|NCT01756456|82871247|FG003|Follow Up Period Phase I/II|Other causes|1|||
46659603|NCT01756456|82871248|FG004|Follow Up Period Phase I/II|Other causes|3|||
46659604|NCT01756456|82871249|FG005|Follow Up Period Phase I/II|Other causes|5|||
46659605|NCT01477333|82871325|FG000|Overall Study|Adverse Event|1|||
46659606|NCT01477333|82871325|FG000|Overall Study|Withdrawal by Subject|1|||
46659607|NCT01477333|82871325|FG000|Overall Study|Clinical Deterioration|1|||
46659608|NCT01262625|82871347|FG000|Overall Study|Administrative Error|1|||
46659609|NCT01262625|82871348|FG001|Overall Study|Administrative Error|1|||
46659610|NCT01262625|82871347|FG000|Overall Study|Site Closed|1|||
46659611|NCT01262625|82871348|FG001|Overall Study|Site Closed|0|||
46659612|NCT04831736|82871398|FG000|Overall Study|Withdrawal by Subject|0|||
46659613|NCT04831736|82871399|FG001|Overall Study|Withdrawal by Subject|1|||
46659614|NCT04583956|82871414|FG000|Overall Study|Death|9|||
46659615|NCT04583956|82871415|FG001|Overall Study|Death|11|||
46659616|NCT04583956|82871414|FG000|Overall Study|Lost to Follow-up|7|||
46659617|NCT04583956|82871415|FG001|Overall Study|Lost to Follow-up|9|||
46659618|NCT04583956|82871414|FG000|Overall Study|Protocol Violation|2|||
46659619|NCT04583956|82871415|FG001|Overall Study|Protocol Violation|0|||
46659620|NCT04583956|82871414|FG000|Overall Study|Withdrawal by Subject|0|||
46659621|NCT04583956|82871415|FG001|Overall Study|Withdrawal by Subject|2|||
46659622|NCT04583956|82871414|FG000|Overall Study|Randomized but not dosed|2|||
46659623|NCT04583956|82871415|FG001|Overall Study|Randomized but not dosed|3|||
46659624|NCT04583956|82871414|FG000|Overall Study|Withdrawal of consent before product administration|1|||
46659625|NCT04583956|82871415|FG001|Overall Study|Withdrawal of consent before product administration|0|||
47076162|NCT02869789|83370778|FG002|Overall Study|Withdrawal by Subject|7|||
46659626|NCT04463680|82871431|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
46659627|NCT04463680|82871431|FG000|Overall Study|Not eligible due to implant duration of use|1|||
46659628|NCT04463680|82871431|FG000|Overall Study|Withdrawal by Subject|3|||
46659629|NCT04449029|82871443|FG000|Overall Study|Adverse Event|0|||
46659630|NCT04449029|82871444|FG001|Overall Study|Adverse Event|1|||
46659631|NCT04449029|82871445|FG002|Overall Study|Adverse Event|1|||
46659632|NCT04449029|82871446|FG003|Overall Study|Adverse Event|0|||
46659633|NCT04449029|82871447|FG004|Overall Study|Adverse Event|1|||
46659634|NCT04449029|82871448|FG005|Overall Study|Adverse Event|0|||
46659635|NCT04449029|82871449|FG006|Overall Study|Adverse Event|1|||
46782648|NCT00560404|83001267|FG000|Overall Study|Withdrew Consent|4|||
46782649|NCT00560404|83001268|FG001|Overall Study|Withdrew Consent|0|||
46782650|NCT00560404|83001267|FG000|Overall Study|Failure to return|1|||
46782651|NCT00560404|83001268|FG001|Overall Study|Failure to return|2|||
46971852|NCT02085460|83215399|FG000|Overall Study|Adverse Event|2|||
46659636|NCT04449029|82871450|FG007|Overall Study|Adverse Event|0|||
46659637|NCT04449029|82871443|FG000|Overall Study|Lost to Follow-up|0|||
46659638|NCT04449029|82871444|FG001|Overall Study|Lost to Follow-up|1|||
46659639|NCT04449029|82871445|FG002|Overall Study|Lost to Follow-up|0|||
46659640|NCT04449029|82871446|FG003|Overall Study|Lost to Follow-up|0|||
46659641|NCT04449029|82871447|FG004|Overall Study|Lost to Follow-up|0|||
46659642|NCT04449029|82871448|FG005|Overall Study|Lost to Follow-up|0|||
46659643|NCT04449029|82871449|FG006|Overall Study|Lost to Follow-up|0|||
46659644|NCT04449029|82871450|FG007|Overall Study|Lost to Follow-up|0|||
46659645|NCT04449029|82871443|FG000|Overall Study|Protocol Violation|0|||
46659646|NCT04449029|82871444|FG001|Overall Study|Protocol Violation|1|||
46659647|NCT04449029|82871445|FG002|Overall Study|Protocol Violation|0|||
46659648|NCT04449029|82871446|FG003|Overall Study|Protocol Violation|0|||
46659649|NCT04449029|82871447|FG004|Overall Study|Protocol Violation|0|||
46659650|NCT04449029|82871448|FG005|Overall Study|Protocol Violation|0|||
46659651|NCT04449029|82871449|FG006|Overall Study|Protocol Violation|0|||
46659652|NCT04449029|82871450|FG007|Overall Study|Protocol Violation|0|||
46659653|NCT04449029|82871443|FG000|Overall Study|Physician Decision|0|||
46659654|NCT04449029|82871444|FG001|Overall Study|Physician Decision|0|||
46659655|NCT04449029|82871445|FG002|Overall Study|Physician Decision|0|||
46659656|NCT04449029|82871446|FG003|Overall Study|Physician Decision|0|||
46659657|NCT04449029|82871447|FG004|Overall Study|Physician Decision|0|||
46659658|NCT04449029|82871448|FG005|Overall Study|Physician Decision|1|||
46659659|NCT04449029|82871449|FG006|Overall Study|Physician Decision|0|||
46659660|NCT04449029|82871450|FG007|Overall Study|Physician Decision|0|||
46659661|NCT04449029|82871443|FG000|Overall Study|Withdrawal by Subject|3|||
46659662|NCT04449029|82871444|FG001|Overall Study|Withdrawal by Subject|0|||
46659663|NCT04449029|82871445|FG002|Overall Study|Withdrawal by Subject|1|||
46659664|NCT04449029|82871446|FG003|Overall Study|Withdrawal by Subject|1|||
46659665|NCT04449029|82871447|FG004|Overall Study|Withdrawal by Subject|5|||
46659666|NCT04449029|82871448|FG005|Overall Study|Withdrawal by Subject|1|||
46659667|NCT04449029|82871449|FG006|Overall Study|Withdrawal by Subject|4|||
46659668|NCT04449029|82871450|FG007|Overall Study|Withdrawal by Subject|0|||
46659669|NCT04193202|82871480|FG000|Overall Study|Adverse Event|2|||
46659670|NCT04193202|82871481|FG001|Overall Study|Adverse Event|1|||
46659671|NCT04193202|82871480|FG000|Overall Study|Death|0|||
46659672|NCT04193202|82871481|FG001|Overall Study|Death|1|||
46659673|NCT04193202|82871480|FG000|Overall Study|Physician Decision|1|||
46659674|NCT04193202|82871481|FG001|Overall Study|Physician Decision|1|||
46659675|NCT04193202|82871480|FG000|Overall Study|Protocol Violation|2|||
46659676|NCT04193202|82871481|FG001|Overall Study|Protocol Violation|2|||
46659677|NCT04193202|82871480|FG000|Overall Study|Withdrawal by Subject|11|||
46659678|NCT04193202|82871481|FG001|Overall Study|Withdrawal by Subject|5|||
46659679|NCT04159935|82871489|FG000|Overall Study|Study terminated due to COVID-19|1|||
46659680|NCT04159935|82871490|FG001|Overall Study|Study terminated due to COVID-19|3|||
46659681|NCT03871543|82871514|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
46659682|NCT03871543|82871514|FG000|Period 1|Investigator Error|1|||
46659683|NCT03871543|82871514|FG000|Period 1|Protocol Violation|2|||
46659684|NCT03871543|82871514|FG000|Period 1|COVID-19 Related|1|||
46659685|NCT03871543|82871514|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
46659686|NCT03871543|82871514|FG000|Period 1|Withdrawal by Subject|10|||
46659687|NCT03871543|82871514|FG000|Period 2|Adverse Event|1|||
46659688|NCT03871543|82871514|FG000|Period 2|Withdrawal by Subject|1|||
46659689|NCT03843125|82871526|FG000|Overall Study|Adverse Event|17|||
46659690|NCT03843125|82871527|FG001|Overall Study|Adverse Event|13|||
46659691|NCT03843125|82871528|FG002|Overall Study|Adverse Event|5|||
46659692|NCT03843125|82871529|FG003|Overall Study|Adverse Event|9|||
46659693|NCT03843125|82871526|FG000|Overall Study|Death|0|||
46659694|NCT03843125|82871527|FG001|Overall Study|Death|6|||
46659695|NCT03843125|82871528|FG002|Overall Study|Death|2|||
46659696|NCT03843125|82871529|FG003|Overall Study|Death|0|||
46659697|NCT03843125|82871526|FG000|Overall Study|Lack of Efficacy|14|||
46659698|NCT03843125|82871527|FG001|Overall Study|Lack of Efficacy|11|||
46659699|NCT03843125|82871528|FG002|Overall Study|Lack of Efficacy|9|||
46659700|NCT03843125|82871529|FG003|Overall Study|Lack of Efficacy|4|||
46659701|NCT03843125|82871526|FG000|Overall Study|Lost to Follow-up|3|||
46659702|NCT03843125|82871527|FG001|Overall Study|Lost to Follow-up|4|||
46659703|NCT03843125|82871528|FG002|Overall Study|Lost to Follow-up|0|||
46659704|NCT03843125|82871529|FG003|Overall Study|Lost to Follow-up|2|||
46659705|NCT03843125|82871526|FG000|Overall Study|Other|12|||
46659706|NCT03843125|82871527|FG001|Overall Study|Other|14|||
46659707|NCT03843125|82871528|FG002|Overall Study|Other|3|||
46659708|NCT03843125|82871529|FG003|Overall Study|Other|4|||
46659709|NCT03843125|82871526|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
46659710|NCT03843125|82871527|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
46659711|NCT03843125|82871528|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
46659712|NCT03843125|82871529|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
46659713|NCT03843125|82871526|FG000|Overall Study|Study Terminated by Sponsor|318|||
46659714|NCT03843125|82871527|FG001|Overall Study|Study Terminated by Sponsor|318|||
46659715|NCT03843125|82871528|FG002|Overall Study|Study Terminated by Sponsor|163|||
46659716|NCT03843125|82871529|FG003|Overall Study|Study Terminated by Sponsor|163|||
46659717|NCT03843125|82871526|FG000|Overall Study|Withdrawal by Subject|23|||
46659718|NCT03843125|82871527|FG001|Overall Study|Withdrawal by Subject|12|||
46659719|NCT03843125|82871528|FG002|Overall Study|Withdrawal by Subject|6|||
46659720|NCT03843125|82871529|FG003|Overall Study|Withdrawal by Subject|9|||
46659721|NCT03843125|82871526|FG000|Overall Study|Missing data|0|||
46659722|NCT03843125|82871527|FG001|Overall Study|Missing data|1|||
46659723|NCT03843125|82871528|FG002|Overall Study|Missing data|1|||
46659724|NCT03843125|82871529|FG003|Overall Study|Missing data|0|||
46659725|NCT03603509|82871542|FG000|Overall Study|Lost to Follow-up|3|||
46659726|NCT03603509|82871543|FG001|Overall Study|Lost to Follow-up|4|||
46659727|NCT03567993|82871551|FG000|Overall Study|Lost to Follow-up|4|||
46659728|NCT03567993|82871552|FG001|Overall Study|Lost to Follow-up|2|||
46659729|NCT03567993|82871551|FG000|Overall Study|Death|1|||
46659730|NCT03567993|82871552|FG001|Overall Study|Death|1|||
46659731|NCT03567993|82871551|FG000|Overall Study|Withdrawal by Subject|1|||
46659732|NCT03567993|82871552|FG001|Overall Study|Withdrawal by Subject|0|||
46659733|NCT03386487|82871569|FG000|Overall Study|Lost to Follow-up|5|||
46659734|NCT03386487|82871570|FG001|Overall Study|Lost to Follow-up|6|||
46659735|NCT03386487|82871569|FG000|Overall Study|Withdrawal by Subject|11|||
46659736|NCT03386487|82871570|FG001|Overall Study|Withdrawal by Subject|7|||
46782652|NCT00560404|83001267|FG000|Overall Study|Other withdrawal reason|13|||
46782653|NCT00560404|83001268|FG001|Overall Study|Other withdrawal reason|5|||
46782654|NCT03967444|83001276|FG000|Overall Study|Lost to Follow-up|1|||
46971853|NCT02085460|83215400|FG001|Overall Study|Adverse Event|2|||
46971854|NCT02085460|83215401|FG002|Overall Study|Adverse Event|1|||
46971855|NCT02085460|83215399|FG000|Overall Study|Physician Decision|1|||
46971856|NCT02085460|83215400|FG001|Overall Study|Physician Decision|1|||
46971857|NCT02085460|83215401|FG002|Overall Study|Physician Decision|2|||
46971858|NCT02085460|83215399|FG000|Overall Study|Withdrawal by Subject|11|||
46971859|NCT02085460|83215400|FG001|Overall Study|Withdrawal by Subject|5|||
46971860|NCT02085460|83215401|FG002|Overall Study|Withdrawal by Subject|7|||
46971861|NCT02084134|83215411|FG000|Overall Study|Protocol Violation|4|||
46971862|NCT02084134|83215412|FG001|Overall Study|Protocol Violation|2|||
46782655|NCT03967444|83001277|FG001|Overall Study|Lost to Follow-up|2|||
46782656|NCT00619983|83001287|FG000|Test Drug Alone|Withdrawal by Subject|1|||
46782657|NCT00619983|83001288|FG001|Test Drug Alone|Withdrawal by Subject|0|||
46782658|NCT00619983|83001289|FG002|Test Drug Alone|Withdrawal by Subject|0|||
46782659|NCT00619983|83001290|FG003|Test Drug Alone|Withdrawal by Subject|1|||
46782660|NCT00619983|83001287|FG000|Test Drug Alone|Failure of daily diary device|1|||
46782661|NCT00619983|83001288|FG001|Test Drug Alone|Failure of daily diary device|1|||
46782662|NCT00619983|83001289|FG002|Test Drug Alone|Failure of daily diary device|2|||
46782663|NCT00619983|83001290|FG003|Test Drug Alone|Failure of daily diary device|2|||
46782664|NCT00576420|83001303|FG000|Overall Study|Death|0|||
46782665|NCT00576420|83001304|FG001|Overall Study|Death|0|||
46782666|NCT00576420|83001305|FG002|Overall Study|Death|1|||
46782667|NCT00364351|83001356|FG000|Overall Study|Adverse Event|90|||
46782668|NCT00364351|83001357|FG001|Overall Study|Adverse Event|44|||
46782669|NCT00364351|83001356|FG000|Overall Study|Condition under investigation worsened|469|||
46782670|NCT00364351|83001357|FG001|Overall Study|Condition under investigation worsened|497|||
46782671|NCT00364351|83001356|FG000|Overall Study|Prohibited concomitant medication|0|||
46782672|NCT00364351|83001357|FG001|Overall Study|Prohibited concomitant medication|2|||
46782673|NCT00364351|83001356|FG000|Overall Study|Lost to Follow-up|1|||
46782674|NCT00364351|83001357|FG001|Overall Study|Lost to Follow-up|1|||
46782675|NCT00364351|83001356|FG000|Overall Study|Withdrawal by Subject|30|||
46971863|NCT02084134|83215411|FG000|Overall Study|Death|0|||
46971864|NCT02084134|83215412|FG001|Overall Study|Death|1|||
46971865|NCT02034058|83215418|FG000|Overall Study|Death|3|||
46971866|NCT01374269|83215424|FG000|Overall Study|Withdrawal by Subject|4|||
46971867|NCT01374269|83215425|FG001|Overall Study|Withdrawal by Subject|0|||
46971868|NCT01374269|83215424|FG000|Overall Study|Lost to Follow-up|1|||
47076163|NCT02869789|83370779|FG003|Overall Study|Withdrawal by Subject|2|||
46971869|NCT01374269|83215425|FG001|Overall Study|Lost to Follow-up|3|||
46971870|NCT01374269|83215424|FG000|Overall Study|closed research|1|||
46971871|NCT01374269|83215425|FG001|Overall Study|closed research|2|||
46782676|NCT00364351|83001357|FG001|Overall Study|Withdrawal by Subject|29|||
46782677|NCT00364351|83001356|FG000|Overall Study|Incorrect enrollment|1|||
46782678|NCT00364351|83001357|FG001|Overall Study|Incorrect enrollment|1|||
46971872|NCT02679755|83215433|FG000|Overall Study|Death|0|||
46971873|NCT02679755|83215434|FG001|Overall Study|Death|3|||
47076164|NCT02869789|83370776|FG000|Overall Study|Lost to Follow-up|0|||
46659737|NCT03386487|82871569|FG000|Overall Study|Physician Decision|11|||
46659738|NCT03386487|82871570|FG001|Overall Study|Physician Decision|8|||
46659739|NCT03066258|82871585|FG000|Overall Study|Death|1|||
46782679|NCT00364351|83001356|FG000|Overall Study|Sponsor decision|1|||
46971874|NCT02679755|83215433|FG000|Overall Study|Global deterioration of health status|1|||
46971875|NCT02679755|83215434|FG001|Overall Study|Global deterioration of health status|8|||
46971876|NCT02679755|83215433|FG000|Overall Study|Lost to Follow-up|1|||
47076165|NCT02869789|83370777|FG001|Overall Study|Lost to Follow-up|0|||
47076166|NCT02869789|83370778|FG002|Overall Study|Lost to Follow-up|2|||
46659740|NCT03066258|82871586|FG001|Overall Study|Death|0|||
46659741|NCT03066258|82871587|FG002|Overall Study|Death|0|||
46659742|NCT03066258|82871588|FG003|Overall Study|Death|0|||
46659743|NCT03066258|82871589|FG004|Overall Study|Death|1|||
46659744|NCT03024255|82871605|FG000|Overall Study|Adverse Event|1|||
46659745|NCT03024255|82871606|FG001|Overall Study|Adverse Event|4|||
46659746|NCT03024255|82871607|FG002|Overall Study|Adverse Event|8|||
46659747|NCT03024255|82871608|FG003|Overall Study|Adverse Event|0|||
46659748|NCT03024255|82871605|FG000|Overall Study|Withdrawal by Subject|3|||
46659749|NCT03024255|82871606|FG001|Overall Study|Withdrawal by Subject|1|||
46659750|NCT03024255|82871607|FG002|Overall Study|Withdrawal by Subject|0|||
46659751|NCT03024255|82871608|FG003|Overall Study|Withdrawal by Subject|3|||
47076167|NCT02869789|83370779|FG003|Overall Study|Lost to Follow-up|0|||
47076168|NCT02869789|83370776|FG000|Overall Study|Maximum clinical benefit|5|||
47076169|NCT02869789|83370777|FG001|Overall Study|Maximum clinical benefit|2|||
47076170|NCT02869789|83370778|FG002|Overall Study|Maximum clinical benefit|1|||
47076171|NCT02869789|83370779|FG003|Overall Study|Maximum clinical benefit|0|||
47076172|NCT02869789|83370776|FG000|Overall Study|Poor/Non-compliance|0|||
47076173|NCT02869789|83370777|FG001|Overall Study|Poor/Non-compliance|2|||
47076174|NCT02869789|83370778|FG002|Overall Study|Poor/Non-compliance|1|||
47076175|NCT02869789|83370779|FG003|Overall Study|Poor/Non-compliance|0|||
47076176|NCT02869789|83370776|FG000|Overall Study|Participant no longer meets study criteria|0|||
47076177|NCT02869789|83370777|FG001|Overall Study|Participant no longer meets study criteria|1|||
47076178|NCT02869789|83370778|FG002|Overall Study|Participant no longer meets study criteria|1|||
47076179|NCT02869789|83370779|FG003|Overall Study|Participant no longer meets study criteria|0|||
47076180|NCT02869789|83370776|FG000|Overall Study|Administrative reason by sponsor|0|||
47076181|NCT02869789|83370777|FG001|Overall Study|Administrative reason by sponsor|0|||
46782680|NCT00364351|83001357|FG001|Overall Study|Sponsor decision|0|||
46782681|NCT00364351|83001356|FG000|Overall Study|Poor treatment compliance|0|||
46782682|NCT00364351|83001357|FG001|Overall Study|Poor treatment compliance|3|||
46782683|NCT00364351|83001356|FG000|Overall Study|Investigator error|0|||
46782684|NCT00364351|83001357|FG001|Overall Study|Investigator error|2|||
47076182|NCT02869789|83370778|FG002|Overall Study|Administrative reason by sponsor|1|||
47076183|NCT02869789|83370779|FG003|Overall Study|Administrative reason by sponsor|0|||
47076184|NCT02869789|83370776|FG000|Overall Study|Other reasons|4|||
47076185|NCT02869789|83370777|FG001|Overall Study|Other reasons|8|||
47076186|NCT02869789|83370778|FG002|Overall Study|Other reasons|6|||
47076187|NCT02869789|83370779|FG003|Overall Study|Other reasons|0|||
47076188|NCT02760485|83370800|FG000|Phase 1|Death|3|||
47076189|NCT02760485|83370801|FG001|Phase 1|Death|6|||
47076190|NCT02760485|83370802|FG002|Phase 1|Death|0|||
47076191|NCT02760485|83370800|FG000|Phase 1|Withdrawal by Subject|2|||
47076192|NCT02760485|83370801|FG001|Phase 1|Withdrawal by Subject|0|||
47076193|NCT02760485|83370802|FG002|Phase 1|Withdrawal by Subject|0|||
47076194|NCT02760485|83370800|FG000|Phase 1|Progressive Disease|1|||
46659752|NCT03024255|82871605|FG000|Overall Study|Protocol Violation|0|||
46659753|NCT03024255|82871606|FG001|Overall Study|Protocol Violation|0|||
46659754|NCT03024255|82871607|FG002|Overall Study|Protocol Violation|2|||
46659755|NCT03024255|82871608|FG003|Overall Study|Protocol Violation|0|||
46659756|NCT03024255|82871605|FG000|Overall Study|Lost to Follow-up|1|||
46659757|NCT03024255|82871606|FG001|Overall Study|Lost to Follow-up|2|||
46659758|NCT03024255|82871607|FG002|Overall Study|Lost to Follow-up|1|||
46659759|NCT03024255|82871608|FG003|Overall Study|Lost to Follow-up|1|||
46659760|NCT03024255|82871605|FG000|Overall Study|Lack of Efficacy|1|||
46659761|NCT03024255|82871606|FG001|Overall Study|Lack of Efficacy|0|||
46659762|NCT03024255|82871607|FG002|Overall Study|Lack of Efficacy|0|||
46659763|NCT03024255|82871608|FG003|Overall Study|Lack of Efficacy|0|||
46782685|NCT00364351|83001356|FG000|Overall Study|Patient could not travel to site|0|||
46782686|NCT00364351|83001357|FG001|Overall Study|Patient could not travel to site|1|||
46782687|NCT00364351|83001356|FG000|Overall Study|Randomised treatment not started|0|||
46782688|NCT00364351|83001357|FG001|Overall Study|Randomised treatment not started|3|||
46782689|NCT00388297|83001367|FG000|Overall Study|Lost to Follow-up|16|||
46782690|NCT00388297|83001368|FG001|Overall Study|Lost to Follow-up|12|||
46782691|NCT00388297|83001369|FG002|Overall Study|Lost to Follow-up|11|||
46851022|NCT00098306|83066776|FG006|Observational Phase|Death|4|||
47076195|NCT02760485|83370801|FG001|Phase 1|Progressive Disease|0|||
47076196|NCT02760485|83370802|FG002|Phase 1|Progressive Disease|0|||
47076197|NCT02760485|83370800|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
47076198|NCT02760485|83370801|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
47076199|NCT02760485|83370802|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
47076200|NCT02760485|83370800|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
46659764|NCT03024255|82871605|FG000|Overall Study|Protocol Noncompliance|1|||
46659765|NCT03024255|82871606|FG001|Overall Study|Protocol Noncompliance|1|||
46659766|NCT03024255|82871607|FG002|Overall Study|Protocol Noncompliance|0|||
46659767|NCT03024255|82871608|FG003|Overall Study|Protocol Noncompliance|1|||
46659768|NCT01252953|82871631|FG000|Overall Study|Withdrawal by Subject|16|||
46659769|NCT01252953|82871632|FG001|Overall Study|Withdrawal by Subject|17|||
46659770|NCT01252953|82871631|FG000|Overall Study|Lost to Follow-up|22|||
46659771|NCT01252953|82871632|FG001|Overall Study|Lost to Follow-up|21|||
46659772|NCT01234480|82871639|FG000|Overall Study|Pregnancy|88|||
46659773|NCT01234480|82871639|FG000|Overall Study|>36/Normal History|50|||
46659774|NCT01234480|82871639|FG000|Overall Study|Age|3|||
46659775|NCT01234480|82871639|FG000|Overall Study|HPV Vaccine History|28|||
46659776|NCT01234480|82871639|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
46659777|NCT01234480|82871639|FG000|Overall Study|Hysterectomy|2|||
46659778|NCT01234480|82871639|FG000|Overall Study|Hysterectomy post enrollment|1|||
46659779|NCT01234480|82871639|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
46782692|NCT00388297|83001370|FG003|Overall Study|Lost to Follow-up|8|||
46782693|NCT00686166|83001380|FG000|Overall Study|Adverse Event|7|||
46782694|NCT00686166|83001380|FG000|Overall Study|Withdrawal by Subject|1|||
46782695|NCT00686166|83001380|FG000|Overall Study|Progression/Relapse|1|||
46782696|NCT00686166|83001380|FG000|Overall Study|Death|1|||
46782697|NCT00686166|83001380|FG000|Overall Study|Not Protocol Specified|1|||
46782698|NCT00686166|83001380|FG000|Overall Study|Ineligible|5|||
46782699|NCT00686166|83001380|FG000|Overall Study|Did not begin protocol therapy|4|||
46971877|NCT02679755|83215434|FG001|Overall Study|Lost to Follow-up|0|||
46971878|NCT02679755|83215433|FG000|Overall Study|Objective progression or relapse|24|||
46659780|NCT01234480|82871639|FG000|Overall Study|Informed Consent Form Violation|30|||
46659781|NCT01234480|82871639|FG000|Overall Study|Incorrect Visit|3|||
46659782|NCT01234480|82871639|FG000|Overall Study|No Florida Lab License|20|||
46659783|NCT01234480|82871639|FG000|Overall Study|Out of Window|42|||
46659784|NCT01234480|82871639|FG000|Overall Study|Sample Processing/Storage|92|||
46659785|NCT01234480|82871639|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
46659786|NCT01234480|82871639|FG000|Overall Study|Site/Subject non-compliance|44|||
46659787|NCT01234480|82871639|FG000|Overall Study|Missing Sample|9|||
46659788|NCT00877851|82871648|FG000|Overall Study|Lost to Follow-up|5|||
46659789|NCT00877851|82871649|FG001|Overall Study|Lost to Follow-up|5|||
46659790|NCT00877851|82871648|FG000|Overall Study|computer problem|3|||
46659791|NCT00877851|82871649|FG001|Overall Study|computer problem|0|||
46659792|NCT00877851|82871648|FG000|Overall Study|no longer interested in participating|1|||
46659793|NCT00877851|82871649|FG001|Overall Study|no longer interested in participating|0|||
46659794|NCT00837616|82871657|FG000|Overall Study|Withdrawal by Subject|0|||
46659795|NCT00837616|82871658|FG001|Overall Study|Withdrawal by Subject|1|||
46659796|NCT00176254|82871664|FG000|Overall Study|Lost to Follow-up|1|||
46659797|NCT03083873|82871677|FG000|Overall Study|Death|6|||
46659798|NCT03083873|82871678|FG001|Overall Study|Death|15|||
46659799|NCT03083873|82871679|FG002|Overall Study|Death|13|||
46659800|NCT03083873|82871680|FG003|Overall Study|Death|9|||
46659801|NCT03083873|82871681|FG004|Overall Study|Death|0|||
46659802|NCT03083873|82871677|FG000|Overall Study|Sponsor Terminated Study|0|||
46659803|NCT03083873|82871678|FG001|Overall Study|Sponsor Terminated Study|1|||
46659804|NCT03083873|82871679|FG002|Overall Study|Sponsor Terminated Study|2|||
46659805|NCT03083873|82871680|FG003|Overall Study|Sponsor Terminated Study|3|||
46659806|NCT03083873|82871681|FG004|Overall Study|Sponsor Terminated Study|0|||
46659807|NCT03083873|82871677|FG000|Overall Study|Lost to Follow-up|0|||
46659808|NCT03083873|82871678|FG001|Overall Study|Lost to Follow-up|1|||
46659809|NCT03083873|82871679|FG002|Overall Study|Lost to Follow-up|1|||
46659810|NCT03083873|82871680|FG003|Overall Study|Lost to Follow-up|0|||
46659811|NCT03083873|82871681|FG004|Overall Study|Lost to Follow-up|0|||
46659812|NCT03083873|82871677|FG000|Overall Study|Withdrawal by Subject|2|||
46659813|NCT03083873|82871678|FG001|Overall Study|Withdrawal by Subject|0|||
46659814|NCT03083873|82871679|FG002|Overall Study|Withdrawal by Subject|0|||
46659815|NCT03083873|82871680|FG003|Overall Study|Withdrawal by Subject|0|||
46659816|NCT03083873|82871681|FG004|Overall Study|Withdrawal by Subject|0|||
46659817|NCT03083873|82871677|FG000|Overall Study|Did Not Receive TIL|2|||
46659818|NCT03083873|82871678|FG001|Overall Study|Did Not Receive TIL|5|||
46782700|NCT00363649|83001391|FG000|Overall Study|Withdrawal by Subject|1|||
46659819|NCT03083873|82871679|FG002|Overall Study|Did Not Receive TIL|3|||
46782701|NCT00363649|83001392|FG001|Overall Study|Withdrawal by Subject|1|||
46782702|NCT00363649|83001391|FG000|Overall Study|Adverse Event|6|||
46782703|NCT00363649|83001392|FG001|Overall Study|Adverse Event|0|||
46782704|NCT00684060|83001400|FG000|Overall Study|Lost to Follow-up|1|||
46782705|NCT00684060|83001401|FG001|Overall Study|Lost to Follow-up|0|||
46782706|NCT00684060|83001400|FG000|Overall Study|New stenosis identified|1|||
46782707|NCT00684060|83001401|FG001|Overall Study|New stenosis identified|0|||
46659820|NCT03083873|82871680|FG003|Overall Study|Did Not Receive TIL|1|||
46659821|NCT03083873|82871681|FG004|Overall Study|Did Not Receive TIL|0|||
46659822|NCT04834726|82871715|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
46659823|NCT04834726|82871716|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
46659824|NCT04834726|82871717|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
46659825|NCT04834726|82871718|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
46659826|NCT04834726|82871719|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
46659827|NCT04834726|82871720|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
46659828|NCT04834726|82871721|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
46659829|NCT04834726|82871722|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
46659830|NCT04834726|82871723|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
46659831|NCT04732949|82871739|FG000|Overall Study|Withdrawal by Subject|23|||
46659832|NCT04732949|82871740|FG001|Overall Study|Withdrawal by Subject|27|||
46659833|NCT04732949|82871739|FG000|Overall Study|Protocol Violation|0|||
46659834|NCT04732949|82871740|FG001|Overall Study|Protocol Violation|1|||
46659835|NCT04732949|82871739|FG000|Overall Study|Non-compliance|0|||
46659836|NCT04732949|82871740|FG001|Overall Study|Non-compliance|2|||
46659837|NCT04732949|82871739|FG000|Overall Study|Physician Decision|2|||
46659838|NCT04732949|82871740|FG001|Overall Study|Physician Decision|1|||
46659839|NCT04732949|82871739|FG000|Overall Study|Serious adverse event (Fatal)|16|||
46659840|NCT04732949|82871740|FG001|Overall Study|Serious adverse event (Fatal)|18|||
46659841|NCT04732949|82871739|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
46659842|NCT04732949|82871740|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
46659843|NCT04732949|82871739|FG000|Overall Study|Non-serious adverse event|1|||
46659844|NCT04732949|82871740|FG001|Overall Study|Non-serious adverse event|3|||
46659845|NCT04732949|82871739|FG000|Overall Study|Lost to Follow-up|26|||
46659846|NCT04732949|82871740|FG001|Overall Study|Lost to Follow-up|27|||
46659847|NCT04732949|82871739|FG000|Overall Study|Other|6|||
46659848|NCT04732949|82871740|FG001|Overall Study|Other|3|||
46659849|NCT04235504|82871795|FG000|Study Phase|Withdrawal by Subject|5|||
46659850|NCT04235504|82871796|FG001|Study Phase|Withdrawal by Subject|2|||
46659851|NCT04235504|82871797|FG002|Study Phase|Withdrawal by Subject|0|||
46659852|NCT04235504|82871798|FG003|Study Phase|Withdrawal by Subject|0|||
46659853|NCT04235504|82871795|FG000|Continuation Phase|Withdrawal by Subject|0|||
46659854|NCT04235504|82871796|FG001|Continuation Phase|Withdrawal by Subject|4|||
46659855|NCT04235504|82871797|FG002|Continuation Phase|Withdrawal by Subject|0|||
46782708|NCT00684060|83001400|FG000|Overall Study|Unable to collect MRI|1|||
46782709|NCT00684060|83001401|FG001|Overall Study|Unable to collect MRI|2|||
46782710|NCT00684060|83001400|FG000|Overall Study|Death|0|||
46782711|NCT00684060|83001401|FG001|Overall Study|Death|1|||
46782712|NCT03131648|83001409|FG000|Initial Treatment Period|Not dosed|2|||
46782713|NCT03131648|83001410|FG001|Initial Treatment Period|Not dosed|2|||
46782714|NCT03131648|83001411|FG002|Initial Treatment Period|Not dosed|0|||
46782715|NCT03131648|83001412|FG003|Initial Treatment Period|Not dosed|0|||
46782716|NCT03131648|83001413|FG004|Initial Treatment Period|Not dosed|0|||
46782717|NCT03131648|83001414|FG005|Initial Treatment Period|Not dosed|0|||
46782718|NCT03131648|83001415|FG006|Initial Treatment Period|Not dosed|0|||
46782719|NCT03131648|83001416|FG007|Initial Treatment Period|Not dosed|0|||
46971879|NCT02679755|83215434|FG001|Overall Study|Objective progression or relapse|83|||
46971880|NCT02679755|83215433|FG000|Overall Study|Not defined|0|||
46659856|NCT04235504|82871798|FG003|Continuation Phase|Withdrawal by Subject|0|||
46659857|NCT04235504|82871795|FG000|Continuation Phase|Adverse Event|0|||
46659858|NCT04235504|82871796|FG001|Continuation Phase|Adverse Event|1|||
46659859|NCT04235504|82871797|FG002|Continuation Phase|Adverse Event|0|||
46659860|NCT04235504|82871798|FG003|Continuation Phase|Adverse Event|0|||
46659861|NCT04235504|82871795|FG000|Continuation Phase|Physician Decision|1|||
46659862|NCT04235504|82871796|FG001|Continuation Phase|Physician Decision|2|||
46659863|NCT04235504|82871797|FG002|Continuation Phase|Physician Decision|1|||
46782720|NCT03131648|83001409|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
46782721|NCT03131648|83001410|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
46782722|NCT03131648|83001411|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46782723|NCT03131648|83001412|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46659864|NCT04235504|82871798|FG003|Continuation Phase|Physician Decision|0|||
46782724|NCT03131648|83001413|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46782725|NCT03131648|83001414|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46659865|NCT04172987|82871813|FG000|Lead In Period|Adverse Event|1|||
46659866|NCT04172987|82871813|FG000|Lead In Period|Protocol Violation|1|||
46659867|NCT04172987|82871813|FG000|Period 1|Physician Decision|1|||
46659868|NCT04172987|82871813|FG000|Period 2|Adverse Event|5|||
46659869|NCT04172987|82871813|FG000|Period 2|Dosing Termination by Sponsor|4|||
46659870|NCT03705832|82871822|FG000|Overall Study|Physician Decision|0|||
46659871|NCT03705832|82871823|FG001|Overall Study|Physician Decision|1|||
46659872|NCT03705832|82871822|FG000|Overall Study|Withdrawal by Subject|1|||
46659873|NCT03705832|82871823|FG001|Overall Study|Withdrawal by Subject|0|||
46659874|NCT03447743|82871829|FG000|Overall Study|Withdrawal by Subject|2|||
46659875|NCT03447743|82871829|FG000|Overall Study|Lost to Follow-up|3|||
46659876|NCT03447743|82871829|FG000|Overall Study|Adverse Event|1|||
46659877|NCT03447743|82871829|FG000|Overall Study|Did not meet criteria to continue|1|||
46659878|NCT03433755|82871837|FG000|Overall Study|Lost to Follow-up|1|||
46659879|NCT03433755|82871838|FG001|Overall Study|Lost to Follow-up|0|||
46659880|NCT03433755|82871839|FG002|Overall Study|Lost to Follow-up|0|||
46659881|NCT03433755|82871840|FG003|Overall Study|Lost to Follow-up|0|||
46659882|NCT03433755|82871837|FG000|Overall Study|Decision by Sponsor|1|||
46659883|NCT03433755|82871838|FG001|Overall Study|Decision by Sponsor|0|||
46659884|NCT03433755|82871839|FG002|Overall Study|Decision by Sponsor|0|||
46659885|NCT03433755|82871840|FG003|Overall Study|Decision by Sponsor|0|||
46659886|NCT03406507|82871863|FG000|Extension Period|Lack of Efficacy|0|||
46659887|NCT03406507|82871864|FG001|Extension Period|Lack of Efficacy|1|||
46659888|NCT03283150|82871873|FG000|Overall Study|Withdrawal by Subject|6|||
46659889|NCT03283150|82871874|FG001|Overall Study|Withdrawal by Subject|0|||
46659890|NCT03283150|82871875|FG002|Overall Study|Withdrawal by Subject|0|||
46659891|NCT03218917|82871886|FG000|Overall Study|Adverse Event|3|||
46659892|NCT03218917|82871887|FG001|Overall Study|Adverse Event|3|||
46659893|NCT03218917|82871888|FG002|Overall Study|Adverse Event|2|||
46659894|NCT03218917|82871886|FG000|Overall Study|Subject withdrew consent|2|||
46659895|NCT03218917|82871887|FG001|Overall Study|Subject withdrew consent|4|||
46659896|NCT03218917|82871888|FG002|Overall Study|Subject withdrew consent|10|||
46659897|NCT03218917|82871886|FG000|Overall Study|Physician Decision|0|||
46659898|NCT03218917|82871887|FG001|Overall Study|Physician Decision|1|||
46659899|NCT03218917|82871888|FG002|Overall Study|Physician Decision|1|||
46659900|NCT03218917|82871886|FG000|Overall Study|Lost to Follow-up|1|||
46659901|NCT03218917|82871887|FG001|Overall Study|Lost to Follow-up|0|||
46659902|NCT03218917|82871888|FG002|Overall Study|Lost to Follow-up|0|||
46659903|NCT03218917|82871886|FG000|Overall Study|Reason Missing|0|||
46659904|NCT03218917|82871887|FG001|Overall Study|Reason Missing|2|||
46659905|NCT03218917|82871888|FG002|Overall Study|Reason Missing|0|||
46659906|NCT03218917|82871886|FG000|Overall Study|Death|0|||
46659907|NCT03218917|82871887|FG001|Overall Study|Death|1|||
46659908|NCT03218917|82871888|FG002|Overall Study|Death|0|||
46659909|NCT03218917|82871886|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46659910|NCT03218917|82871887|FG001|Overall Study|Non-Compliance with Study Drug|1|||
46659911|NCT03218917|82871888|FG002|Overall Study|Non-Compliance with Study Drug|0|||
46659912|NCT03056040|82871899|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
46659913|NCT03056040|82871900|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
46659914|NCT03056040|82871899|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
46659915|NCT03056040|82871900|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
46659916|NCT03056040|82871899|FG000|Primary Evaluation Period|Pregnancy|0|||
46659917|NCT03056040|82871900|FG001|Primary Evaluation Period|Pregnancy|1|||
46659918|NCT03056040|82871899|FG000|Extension Period|Physician Decision|3|||
46659919|NCT03056040|82871900|FG001|Extension Period|Physician Decision|3|||
46659920|NCT03056040|82871899|FG000|Extension Period|Lost to Follow-up|0|||
46659921|NCT03056040|82871900|FG001|Extension Period|Lost to Follow-up|1|||
46659922|NCT03056040|82871899|FG000|Extension Period|Death|0|||
46659923|NCT03056040|82871900|FG001|Extension Period|Death|3|||
46659924|NCT03056040|82871899|FG000|Extension Period|Withdrawal by Subject|1|||
46659925|NCT03056040|82871900|FG001|Extension Period|Withdrawal by Subject|0|||
46659926|NCT03021499|82871911|FG000|Overall Study|Adverse Event|1|||
46971881|NCT02679755|83215434|FG001|Overall Study|Not defined|2|||
46971882|NCT02679755|83215433|FG000|Overall Study|Withdrawal by participant|6|||
46971883|NCT02679755|83215434|FG001|Overall Study|Withdrawal by participant|3|||
46971884|NCT02679755|83215433|FG000|Overall Study|Adverse Event|1|||
46971885|NCT02679755|83215434|FG001|Overall Study|Adverse Event|4|||
46971886|NCT02679755|83215433|FG000|Overall Study|Adverse events not related to study drug|1|||
46659927|NCT03021499|82871912|FG001|Overall Study|Adverse Event|0|||
46659928|NCT03021499|82871911|FG000|Overall Study|Death|1|||
46659929|NCT03021499|82871912|FG001|Overall Study|Death|5|||
46659930|NCT03021499|82871911|FG000|Overall Study|Lack of Efficacy|0|||
46659931|NCT03021499|82871912|FG001|Overall Study|Lack of Efficacy|1|||
46659932|NCT03021499|82871911|FG000|Overall Study|Lost to Follow-up|1|||
46659933|NCT03021499|82871912|FG001|Overall Study|Lost to Follow-up|3|||
46659934|NCT03021499|82871911|FG000|Overall Study|Physician Decision|2|||
46659935|NCT03021499|82871912|FG001|Overall Study|Physician Decision|3|||
46659936|NCT03021499|82871911|FG000|Overall Study|Pregnancy|1|||
46971887|NCT02679755|83215434|FG001|Overall Study|Adverse events not related to study drug|2|||
46659937|NCT03021499|82871912|FG001|Overall Study|Pregnancy|0|||
46659938|NCT03021499|82871911|FG000|Overall Study|Withdrawal by Subject|7|||
46659939|NCT03021499|82871912|FG001|Overall Study|Withdrawal by Subject|14|||
46659940|NCT03021499|82871911|FG000|Overall Study|Prohibited medication required|1|||
46659941|NCT03021499|82871912|FG001|Overall Study|Prohibited medication required|0|||
46659942|NCT03021499|82871911|FG000|Overall Study|Protocol non-compliance|1|||
46659943|NCT03021499|82871912|FG001|Overall Study|Protocol non-compliance|1|||
46659944|NCT03021499|82871911|FG000|Overall Study|None of the above|0|||
46659945|NCT03021499|82871912|FG001|Overall Study|None of the above|4|||
46659946|NCT03021499|82871911|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
46659947|NCT03021499|82871912|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
46659948|NCT02726581|82871941|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
46659949|NCT02726581|82871942|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
46659950|NCT02726581|82871943|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
46659951|NCT02726581|82871941|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
46659952|NCT02726581|82871942|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
46659953|NCT02726581|82871943|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
46659954|NCT02726581|82871941|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
46659955|NCT02726581|82871942|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46659956|NCT02726581|82871943|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46659957|NCT02726581|82871941|FG000|Treatment Period|Disease progression|47|||
46659958|NCT02726581|82871942|FG001|Treatment Period|Disease progression|50|||
46659959|NCT02726581|82871943|FG002|Treatment Period|Disease progression|16|||
46659960|NCT02726581|82871941|FG000|Treatment Period|Other reasons|9|||
46659961|NCT02726581|82871942|FG001|Treatment Period|Other reasons|8|||
46659962|NCT02726581|82871943|FG002|Treatment Period|Other reasons|2|||
46659963|NCT02726581|82871941|FG000|Treatment Period|Study drug toxicity|6|||
46659964|NCT02726581|82871942|FG001|Treatment Period|Study drug toxicity|3|||
46659965|NCT02726581|82871943|FG002|Treatment Period|Study drug toxicity|2|||
46659966|NCT02726581|82871941|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
46659967|NCT02726581|82871942|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
46659968|NCT02726581|82871943|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
46659969|NCT02726581|82871941|FG000|Treatment Period|Participant withdrew consent|3|||
46659970|NCT02726581|82871942|FG001|Treatment Period|Participant withdrew consent|1|||
46659971|NCT02726581|82871943|FG002|Treatment Period|Participant withdrew consent|1|||
46659972|NCT02726581|82871941|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
46659973|NCT02726581|82871942|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
46659974|NCT02726581|82871943|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
46659975|NCT02726581|82871941|FG000|Treatment Period|Maximum clinical benefit|0|||
46659976|NCT02726581|82871942|FG001|Treatment Period|Maximum clinical benefit|2|||
46659977|NCT02726581|82871943|FG002|Treatment Period|Maximum clinical benefit|0|||
46659978|NCT02726581|82871941|FG000|Treatment Period|Death|1|||
46659979|NCT02726581|82871942|FG001|Treatment Period|Death|0|||
46659980|NCT02726581|82871943|FG002|Treatment Period|Death|0|||
46659981|NCT02726581|82871941|FG000|Treatment Period|Poor/non-compliance|1|||
46659982|NCT02726581|82871942|FG001|Treatment Period|Poor/non-compliance|0|||
46659983|NCT02726581|82871943|FG002|Treatment Period|Poor/non-compliance|0|||
46659984|NCT02726581|82871941|FG000|Treatment Period|Participant no longer meets study criteria|0|||
46659985|NCT02726581|82871942|FG001|Treatment Period|Participant no longer meets study criteria|1|||
46659986|NCT02726581|82871943|FG002|Treatment Period|Participant no longer meets study criteria|0|||
46659987|NCT02700048|82871953|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
46659988|NCT02700048|82871954|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
46659989|NCT02425904|82871971|FG000|Overall Study|Lost to Follow-up|1|||
46659990|NCT02425904|82871972|FG001|Overall Study|Lost to Follow-up|0|||
46659991|NCT02425904|82871971|FG000|Overall Study|Withdrawal by Subject|2|||
46659992|NCT02425904|82871972|FG001|Overall Study|Withdrawal by Subject|0|||
46659993|NCT02425904|82871971|FG000|Overall Study|Death|0|||
46659994|NCT02425904|82871972|FG001|Overall Study|Death|3|||
46659995|NCT01964989|82871994|FG000|Overall Study|Protocol Violation|3|||
46851023|NCT00098306|83066770|FG000|Observational Phase|Participant defaulted|0|||
46851024|NCT00098306|83066771|FG001|Observational Phase|Participant defaulted|0|||
46851025|NCT00098306|83066772|FG002|Observational Phase|Participant defaulted|0|||
46851026|NCT00098306|83066773|FG003|Observational Phase|Participant defaulted|0|||
46851027|NCT00098306|83066774|FG004|Observational Phase|Participant defaulted|0|||
46659996|NCT01964989|82871995|FG001|Overall Study|Protocol Violation|4|||
46659997|NCT01964989|82871994|FG000|Overall Study|Administrative Reason|103|||
46659998|NCT01964989|82871995|FG001|Overall Study|Administrative Reason|95|||
46659999|NCT01964989|82871994|FG000|Overall Study|Adverse Event|0|||
46660000|NCT01964989|82871995|FG001|Overall Study|Adverse Event|1|||
46660001|NCT01964989|82871994|FG000|Overall Study|Death|1|||
46660002|NCT01964989|82871995|FG001|Overall Study|Death|3|||
46660003|NCT01964989|82871994|FG000|Overall Study|Withdrawal by Subject|156|||
46660004|NCT01964989|82871995|FG001|Overall Study|Withdrawal by Subject|160|||
46660005|NCT01964989|82871994|FG000|Overall Study|Lost to Follow-up|254|||
46660006|NCT01964989|82871995|FG001|Overall Study|Lost to Follow-up|232|||
46660007|NCT01964989|82871994|FG000|Overall Study|Other|267|||
46660008|NCT01964989|82871995|FG001|Overall Study|Other|252|||
46660009|NCT01575860|82872023|FG000|Overall Study|Withdrawal by Subject|1|||
46660010|NCT01575860|82872023|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
46660011|NCT01416831|82872030|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
46660012|NCT01416831|82872031|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
46660013|NCT02921269|82872075|FG000|Overall Study|Did not complete DLT period|1|||
46660014|NCT04303559|82872114|FG000|Overall Study|Study closed due to poor enrollment.|1|||
46660015|NCT03784820|82872120|FG000|Overall Study|Lost to Follow-up|5|||
46660016|NCT03784820|82872121|FG001|Overall Study|Lost to Follow-up|5|||
46660017|NCT03784820|82872122|FG002|Overall Study|Lost to Follow-up|3|||
46660018|NCT03784820|82872123|FG003|Overall Study|Lost to Follow-up|3|||
46660019|NCT03769675|82872131|FG000|Overall Study|Lost to Follow-up|1|||
46660020|NCT03729245|82872137|FG000|Overall Study|Lost to Follow-up|5|||
46660021|NCT03729245|82872138|FG001|Overall Study|Lost to Follow-up|6|||
46660022|NCT03729245|82872137|FG000|Overall Study|Withdrawal by Subject|16|||
46660023|NCT03729245|82872138|FG001|Overall Study|Withdrawal by Subject|19|||
46660024|NCT03729245|82872137|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
46660025|NCT03729245|82872138|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
46660026|NCT03311711|82872158|FG000|Overall Study|Death|1|||
46660027|NCT03311711|82872159|FG001|Overall Study|Death|0|||
46660028|NCT03311711|82872160|FG002|Overall Study|Death|0|||
46660029|NCT03311711|82872161|FG003|Overall Study|Death|0|||
46660030|NCT03311711|82872162|FG004|Overall Study|Death|0|||
46660031|NCT03311711|82872163|FG005|Overall Study|Death|0|||
46660032|NCT03311711|82872164|FG006|Overall Study|Death|1|||
46660033|NCT03311711|82872165|FG007|Overall Study|Death|0|||
46660034|NCT03311711|82872166|FG008|Overall Study|Death|1|||
46660035|NCT03311711|82872167|FG009|Overall Study|Death|0|||
46660036|NCT03311711|82872158|FG000|Overall Study|Death of dyad partner|0|||
46660037|NCT03311711|82872159|FG001|Overall Study|Death of dyad partner|1|||
46660038|NCT03311711|82872160|FG002|Overall Study|Death of dyad partner|0|||
46660039|NCT03311711|82872161|FG003|Overall Study|Death of dyad partner|0|||
46660040|NCT03311711|82872162|FG004|Overall Study|Death of dyad partner|0|||
46660041|NCT03311711|82872163|FG005|Overall Study|Death of dyad partner|0|||
46660042|NCT03311711|82872164|FG006|Overall Study|Death of dyad partner|0|||
46660043|NCT03311711|82872165|FG007|Overall Study|Death of dyad partner|1|||
46660044|NCT03311711|82872166|FG008|Overall Study|Death of dyad partner|0|||
46660045|NCT03311711|82872167|FG009|Overall Study|Death of dyad partner|1|||
46660046|NCT03311711|82872158|FG000|Overall Study|Lost to Follow-up|2|||
46660047|NCT03311711|82872159|FG001|Overall Study|Lost to Follow-up|2|||
46660048|NCT03311711|82872160|FG002|Overall Study|Lost to Follow-up|0|||
46660049|NCT03311711|82872161|FG003|Overall Study|Lost to Follow-up|0|||
46660050|NCT03311711|82872162|FG004|Overall Study|Lost to Follow-up|0|||
46660051|NCT03311711|82872163|FG005|Overall Study|Lost to Follow-up|0|||
46660052|NCT03311711|82872164|FG006|Overall Study|Lost to Follow-up|1|||
46660053|NCT03311711|82872165|FG007|Overall Study|Lost to Follow-up|1|||
46660054|NCT03311711|82872166|FG008|Overall Study|Lost to Follow-up|0|||
46660055|NCT03311711|82872167|FG009|Overall Study|Lost to Follow-up|0|||
46660056|NCT03311711|82872158|FG000|Overall Study|Withdrawal by Subject|1|||
46660057|NCT03311711|82872159|FG001|Overall Study|Withdrawal by Subject|1|||
46660058|NCT03311711|82872160|FG002|Overall Study|Withdrawal by Subject|0|||
46660059|NCT03311711|82872161|FG003|Overall Study|Withdrawal by Subject|0|||
46782726|NCT03131648|83001415|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46782727|NCT03131648|83001416|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
46782728|NCT03131648|83001409|FG000|Open-label Treatment|Discontinued IMP|0|||
46782729|NCT03131648|83001410|FG001|Open-label Treatment|Discontinued IMP|0|||
46971888|NCT02675075|83215445|FG000|Overall Study|Lost to Follow-up|3|||
46660060|NCT03311711|82872162|FG004|Overall Study|Withdrawal by Subject|0|||
46660061|NCT03311711|82872163|FG005|Overall Study|Withdrawal by Subject|0|||
46971889|NCT02675075|83215446|FG001|Overall Study|Lost to Follow-up|0|||
46660062|NCT03311711|82872164|FG006|Overall Study|Withdrawal by Subject|3|||
46660063|NCT03311711|82872165|FG007|Overall Study|Withdrawal by Subject|3|||
46660064|NCT03311711|82872166|FG008|Overall Study|Withdrawal by Subject|0|||
46660065|NCT03311711|82872167|FG009|Overall Study|Withdrawal by Subject|0|||
46660066|NCT03311555|82872194|FG000|Overall Study|Adverse Event|1|||
46660067|NCT03270891|82872201|FG000|Overall Study|Lost to Follow-up|3|||
46782730|NCT03131648|83001411|FG002|Open-label Treatment|Discontinued IMP|0|||
46660068|NCT03270891|82872202|FG001|Overall Study|Lost to Follow-up|6|||
46660069|NCT03270891|82872203|FG002|Overall Study|Lost to Follow-up|0|||
46660070|NCT03270891|82872201|FG000|Overall Study|Withdrawal by Subject|1|||
46782731|NCT03131648|83001412|FG003|Open-label Treatment|Discontinued IMP|0|||
46782732|NCT03131648|83001413|FG004|Open-label Treatment|Discontinued IMP|0|||
46782733|NCT03131648|83001414|FG005|Open-label Treatment|Discontinued IMP|0|||
46660071|NCT03270891|82872202|FG001|Overall Study|Withdrawal by Subject|0|||
46660072|NCT03270891|82872203|FG002|Overall Study|Withdrawal by Subject|0|||
46660073|NCT03270891|82872201|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
46660074|NCT03270891|82872202|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
46660075|NCT03270891|82872203|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
46660076|NCT02992743|82872211|FG000|Overall Study|Withdrawal by Subject|1|||
46660077|NCT02992743|82872212|FG001|Overall Study|Withdrawal by Subject|1|||
46660078|NCT02992743|82872211|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
46660079|NCT02992743|82872212|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
46660080|NCT02992743|82872211|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
46660081|NCT02992743|82872212|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
46660082|NCT02992743|82872211|FG000|Overall Study|No measurable disease|1|||
46660083|NCT02992743|82872212|FG001|Overall Study|No measurable disease|0|||
46660084|NCT02992743|82872211|FG000|Overall Study|Lost to Follow-up|0|||
46660085|NCT02992743|82872212|FG001|Overall Study|Lost to Follow-up|1|||
46660086|NCT02853344|82872220|FG000|Overall Study|Lost to Follow-up|1|||
46660087|NCT02853344|82872221|FG001|Overall Study|Lost to Follow-up|1|||
46660088|NCT02853344|82872220|FG000|Overall Study|Withdrawal by Subject|2|||
46660089|NCT02853344|82872221|FG001|Overall Study|Withdrawal by Subject|4|||
46660090|NCT02853344|82872220|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
46660091|NCT02853344|82872221|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
46660092|NCT02853344|82872220|FG000|Overall Study|Death|70|||
46660093|NCT02853344|82872221|FG001|Overall Study|Death|112|||
46660094|NCT02739620|82872232|FG000|Overall Study|Lost to Follow-up|3|||
46660095|NCT02739620|82872233|FG001|Overall Study|Lost to Follow-up|1|||
46660096|NCT02739620|82872232|FG000|Overall Study|Adverse Event|0|||
46660097|NCT02739620|82872233|FG001|Overall Study|Adverse Event|1|||
46660098|NCT02675426|82872242|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
46660099|NCT02675426|82872243|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
46660100|NCT02675426|82872244|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
46660101|NCT02675426|82872245|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
46660102|NCT02675426|82872242|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
46660103|NCT02675426|82872243|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
46660104|NCT02675426|82872244|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
46660105|NCT02675426|82872245|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
46660106|NCT02675426|82872242|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
46660107|NCT02675426|82872243|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
46660108|NCT02675426|82872244|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
46660109|NCT02675426|82872245|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
46660110|NCT02675426|82872242|FG000|Period 1: Week 1 to Week 12|Other|2|||
46660111|NCT02675426|82872243|FG001|Period 1: Week 1 to Week 12|Other|1|||
46660112|NCT02675426|82872244|FG002|Period 1: Week 1 to Week 12|Other|0|||
46660113|NCT02675426|82872245|FG003|Period 1: Week 1 to Week 12|Other|2|||
46660114|NCT02675426|82872242|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
46660115|NCT02675426|82872243|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
46660116|NCT02675426|82872244|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
46660117|NCT02675426|82872245|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
46660118|NCT02675426|82872242|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
46660119|NCT02675426|82872243|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
46660120|NCT02675426|82872244|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
46660121|NCT02675426|82872245|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
46660122|NCT02675426|82872242|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
46660123|NCT02675426|82872243|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
46660124|NCT02675426|82872244|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
46660125|NCT02675426|82872245|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
46660126|NCT02675426|82872242|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
46660127|NCT02675426|82872243|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
46782734|NCT03131648|83001415|FG006|Open-label Treatment|Discontinued IMP|112|||
46782735|NCT03131648|83001416|FG007|Open-label Treatment|Discontinued IMP|0|||
46971890|NCT02673515|83215456|FG000|Overall Study|Lack of motivation|2|||
46660128|NCT02675426|82872244|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
46660129|NCT02675426|82872245|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
46660130|NCT02675426|82872242|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
46660131|NCT02675426|82872243|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
46782736|NCT03131648|83001409|FG000|Open-label Treatment|Completed Week 50|0|||
46782737|NCT03131648|83001410|FG001|Open-label Treatment|Completed Week 50|0|||
46660132|NCT02675426|82872244|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
46782738|NCT03131648|83001411|FG002|Open-label Treatment|Completed Week 50|0|||
46660133|NCT02675426|82872245|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
46660134|NCT02675426|82872242|FG000|Period 2: Week 12 to Week 260|Other|8|||
46660135|NCT02675426|82872243|FG001|Period 2: Week 12 to Week 260|Other|12|||
46660136|NCT02675426|82872244|FG002|Period 2: Week 12 to Week 260|Other|23|||
46660137|NCT02675426|82872245|FG003|Period 2: Week 12 to Week 260|Other|15|||
46660138|NCT02060721|82872286|FG000|Overall Study|Lost to Follow-up|1|||
46660139|NCT02060721|82872286|FG000|Overall Study|Physician Decision|2|||
46660140|NCT02060721|82872286|FG000|Overall Study|Death|14|||
46660141|NCT02060721|82872286|FG000|Overall Study|Withdrawal by Subject|2|||
46782739|NCT03131648|83001412|FG003|Open-label Treatment|Completed Week 50|0|||
46782740|NCT03131648|83001413|FG004|Open-label Treatment|Completed Week 50|0|||
46782741|NCT03131648|83001414|FG005|Open-label Treatment|Completed Week 50|0|||
46782742|NCT03131648|83001415|FG006|Open-label Treatment|Completed Week 50|6|||
46782743|NCT03131648|83001416|FG007|Open-label Treatment|Completed Week 50|0|||
46782744|NCT03131648|83001409|FG000|Maintenance Treatment Period|Not dosed|0|||
46782745|NCT03131648|83001410|FG001|Maintenance Treatment Period|Not dosed|0|||
46782746|NCT03131648|83001411|FG002|Maintenance Treatment Period|Not dosed|3|||
46782747|NCT03131648|83001412|FG003|Maintenance Treatment Period|Not dosed|2|||
46782748|NCT03131648|83001413|FG004|Maintenance Treatment Period|Not dosed|1|||
46782749|NCT03131648|83001414|FG005|Maintenance Treatment Period|Not dosed|0|||
46782750|NCT03131648|83001415|FG006|Maintenance Treatment Period|Not dosed|0|||
46660142|NCT02060721|82872286|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
46660143|NCT01359956|82872294|FG000|Overall Study|Death|58|||
46660144|NCT01359956|82872295|FG001|Overall Study|Death|60|||
46660145|NCT01359956|82872296|FG002|Overall Study|Death|66|||
46660146|NCT01359956|82872297|FG003|Overall Study|Death|57|||
46851028|NCT00098306|83066775|FG005|Observational Phase|Participant defaulted|34|||
46851029|NCT00098306|83066776|FG006|Observational Phase|Participant defaulted|18|||
46851030|NCT00098306|83066770|FG000|Observational Phase|Un-specified|0|||
46971891|NCT02673515|83215457|FG001|Overall Study|Lack of motivation|1|||
46660147|NCT01359956|82872294|FG000|Overall Study|Lost to Follow-up|3|||
46660148|NCT01359956|82872295|FG001|Overall Study|Lost to Follow-up|4|||
46660149|NCT01359956|82872296|FG002|Overall Study|Lost to Follow-up|1|||
46660150|NCT01359956|82872297|FG003|Overall Study|Lost to Follow-up|1|||
46660151|NCT01306045|82872310|FG000|Met General Eligibility Criteria|Screen failures|193|||
46660152|NCT01306045|82872311|FG001|Met General Eligibility Criteria|Screen failures|11|||
46660153|NCT01306045|82872312|FG002|Met General Eligibility Criteria|Screen failures|8|||
46660154|NCT05121480|82872361|FG000|Overall Study|Lack of Efficacy|2|||
46660155|NCT05121480|82872362|FG001|Overall Study|Lack of Efficacy|2|||
46660156|NCT05121480|82872363|FG002|Overall Study|Lack of Efficacy|1|||
46660157|NCT05121480|82872364|FG003|Overall Study|Lack of Efficacy|4|||
46660158|NCT05121480|82872365|FG004|Overall Study|Lack of Efficacy|0|||
46660159|NCT05121480|82872366|FG005|Overall Study|Lack of Efficacy|1|||
46660160|NCT05121480|82872367|FG006|Overall Study|Lack of Efficacy|0|||
46782751|NCT03131648|83001416|FG007|Maintenance Treatment Period|Not dosed|0|||
46782752|NCT03131648|83001409|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
46782753|NCT03131648|83001410|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
46782754|NCT03131648|83001411|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
46782755|NCT03131648|83001412|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
46782756|NCT03131648|83001413|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
46782757|NCT03131648|83001414|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
46782758|NCT03131648|83001415|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
46782759|NCT03131648|83001416|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
46851031|NCT00098306|83066771|FG001|Observational Phase|Un-specified|0|||
46971892|NCT02667275|83215465|FG000|Overall Study|Protocol Violation|11|||
47076201|NCT02760485|83370801|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
46660161|NCT05121480|82872368|FG007|Overall Study|Lack of Efficacy|2|||
46660162|NCT05121480|82872361|FG000|Overall Study|Treatment Failure|0|||
46660163|NCT05121480|82872362|FG001|Overall Study|Treatment Failure|2|||
46660164|NCT05121480|82872363|FG002|Overall Study|Treatment Failure|0|||
46660165|NCT05121480|82872364|FG003|Overall Study|Treatment Failure|1|||
46660166|NCT05121480|82872365|FG004|Overall Study|Treatment Failure|0|||
46782760|NCT03131648|83001409|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
46782761|NCT03131648|83001410|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
46782762|NCT03131648|83001411|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
46782763|NCT03131648|83001412|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
46782764|NCT03131648|83001413|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
46782765|NCT03131648|83001414|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
46782766|NCT03131648|83001415|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
46782767|NCT03131648|83001416|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
46851032|NCT00098306|83066772|FG002|Observational Phase|Un-specified|0|||
46782768|NCT03131648|83001409|FG000|Maintenance Treatment Period|Completed Week 50|0|||
46782769|NCT03131648|83001410|FG001|Maintenance Treatment Period|Completed Week 50|0|||
46971893|NCT02667275|83215466|FG001|Overall Study|Protocol Violation|7|||
46660167|NCT05121480|82872366|FG005|Overall Study|Treatment Failure|0|||
46660168|NCT05121480|82872367|FG006|Overall Study|Treatment Failure|0|||
46660169|NCT05121480|82872368|FG007|Overall Study|Treatment Failure|0|||
46660170|NCT05121480|82872361|FG000|Overall Study|Adverse Event|0|||
46660171|NCT05121480|82872362|FG001|Overall Study|Adverse Event|1|||
46660172|NCT05121480|82872363|FG002|Overall Study|Adverse Event|0|||
46660173|NCT05121480|82872364|FG003|Overall Study|Adverse Event|5|||
46660174|NCT05121480|82872365|FG004|Overall Study|Adverse Event|3|||
46660175|NCT05121480|82872366|FG005|Overall Study|Adverse Event|2|||
46660176|NCT05121480|82872367|FG006|Overall Study|Adverse Event|0|||
46660177|NCT05121480|82872368|FG007|Overall Study|Adverse Event|4|||
46660178|NCT05121480|82872361|FG000|Overall Study|Withdrawal by Subject|4|||
46660179|NCT05121480|82872362|FG001|Overall Study|Withdrawal by Subject|9|||
46660180|NCT05121480|82872363|FG002|Overall Study|Withdrawal by Subject|1|||
46660181|NCT05121480|82872364|FG003|Overall Study|Withdrawal by Subject|8|||
46660182|NCT05121480|82872365|FG004|Overall Study|Withdrawal by Subject|0|||
46660183|NCT05121480|82872366|FG005|Overall Study|Withdrawal by Subject|9|||
46660184|NCT05121480|82872367|FG006|Overall Study|Withdrawal by Subject|0|||
46660185|NCT05121480|82872368|FG007|Overall Study|Withdrawal by Subject|4|||
46660186|NCT05121480|82872361|FG000|Overall Study|Non-compliance with the protocol|0|||
46660187|NCT05121480|82872362|FG001|Overall Study|Non-compliance with the protocol|0|||
46660188|NCT05121480|82872363|FG002|Overall Study|Non-compliance with the protocol|0|||
46660189|NCT05121480|82872364|FG003|Overall Study|Non-compliance with the protocol|0|||
46660190|NCT05121480|82872365|FG004|Overall Study|Non-compliance with the protocol|1|||
46660191|NCT05121480|82872366|FG005|Overall Study|Non-compliance with the protocol|6|||
46660192|NCT05121480|82872367|FG006|Overall Study|Non-compliance with the protocol|0|||
46660193|NCT05121480|82872368|FG007|Overall Study|Non-compliance with the protocol|1|||
46660194|NCT05121480|82872361|FG000|Overall Study|Lost to Follow-up|0|||
46660195|NCT05121480|82872362|FG001|Overall Study|Lost to Follow-up|4|||
46782770|NCT03131648|83001411|FG002|Maintenance Treatment Period|Completed Week 50|0|||
46782771|NCT03131648|83001412|FG003|Maintenance Treatment Period|Completed Week 50|0|||
46782772|NCT03131648|83001413|FG004|Maintenance Treatment Period|Completed Week 50|1|||
46782773|NCT03131648|83001414|FG005|Maintenance Treatment Period|Completed Week 50|0|||
46782774|NCT03131648|83001415|FG006|Maintenance Treatment Period|Completed Week 50|0|||
46782775|NCT03131648|83001416|FG007|Maintenance Treatment Period|Completed Week 50|0|||
46782776|NCT03131648|83001409|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
46782777|NCT03131648|83001410|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
46782778|NCT03131648|83001411|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
46782779|NCT03131648|83001412|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
46782780|NCT03131648|83001413|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
46782781|NCT03131648|83001414|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
46782782|NCT03131648|83001415|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
46782783|NCT03131648|83001416|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
46782784|NCT00618813|83001433|FG000|Overall Study|Lack of Efficacy|1|||
46782785|NCT00618813|83001433|FG000|Overall Study|Physician Decision|2|||
46782786|NCT00618813|83001433|FG000|Overall Study|Withdrawal by Subject|1|||
46782787|NCT00685698|83001437|FG000|Overall Study|Withdrawal by Subject|1|||
46782788|NCT00685698|83001437|FG000|Overall Study|Protocol Violation|6|||
46782789|NCT00685698|83001437|FG000|Overall Study|Adverse Event|3|||
46782790|NCT00685698|83001437|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
46782791|NCT00685698|83001437|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
46782792|NCT00685698|83001437|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
46782793|NCT00549328|83001453|FG000|Overall Study|Adverse Event|2|||
46782794|NCT00549328|83001453|FG000|Overall Study|Disease Progression|10|||
46782795|NCT00549328|83001453|FG000|Overall Study|Death|1|||
46782796|NCT00549328|83001453|FG000|Overall Study|Use of Prohibited Medication|1|||
46782797|NCT00696410|83001459|FG000|Overall Study|Lost to Follow-up|2|||
46782798|NCT00696410|83001460|FG001|Overall Study|Lost to Follow-up|0|||
46782799|NCT00696410|83001459|FG000|Overall Study|Withdrawal by Subject|8|||
46782800|NCT00696410|83001460|FG001|Overall Study|Withdrawal by Subject|0|||
47076202|NCT02760485|83370802|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
47076203|NCT02760485|83370800|FG000|Phase 2|Death|0|||
47076204|NCT02760485|83370801|FG001|Phase 2|Death|0|||
46782801|NCT00696410|83001459|FG000|Overall Study|Physician Decision|3|||
46782802|NCT00696410|83001460|FG001|Overall Study|Physician Decision|0|||
46782803|NCT00683904|83001473|FG000|Dose Level 1|Disease progression|2|||
46782804|NCT00683904|83001474|FG001|Dose Level 1|Disease progression|0|||
46782805|NCT00683904|83001473|FG000|Dose Level 1|Adverse Event|1|||
46782806|NCT00683904|83001474|FG001|Dose Level 1|Adverse Event|0|||
46782807|NCT00683904|83001473|FG000|Dose Level 2|Adverse Event|0|||
46660196|NCT05121480|82872363|FG002|Overall Study|Lost to Follow-up|1|||
46660197|NCT05121480|82872364|FG003|Overall Study|Lost to Follow-up|3|||
46660198|NCT05121480|82872365|FG004|Overall Study|Lost to Follow-up|1|||
46660199|NCT05121480|82872366|FG005|Overall Study|Lost to Follow-up|1|||
46782808|NCT00683904|83001474|FG001|Dose Level 2|Adverse Event|2|||
47076205|NCT02760485|83370802|FG002|Phase 2|Death|12|||
46782809|NCT00363415|83001488|FG000|Overall Study|Progressive Disease|196|||
46782810|NCT00363415|83001489|FG001|Overall Study|Progressive Disease|107|||
46782811|NCT00363415|83001488|FG000|Overall Study|Sponsor Decision|67|||
46782812|NCT00363415|83001489|FG001|Overall Study|Sponsor Decision|31|||
46782813|NCT00363415|83001488|FG000|Overall Study|Death|32|||
46782814|NCT00363415|83001489|FG001|Overall Study|Death|29|||
46782815|NCT00363415|83001488|FG000|Overall Study|Adverse Event|24|||
46782816|NCT00363415|83001489|FG001|Overall Study|Adverse Event|15|||
46782817|NCT00363415|83001488|FG000|Overall Study|Physician Decision|18|||
46782818|NCT00363415|83001489|FG001|Overall Study|Physician Decision|35|||
46782819|NCT00363415|83001488|FG000|Overall Study|Entry Criteria Not Met|11|||
46782820|NCT00363415|83001489|FG001|Overall Study|Entry Criteria Not Met|10|||
46782821|NCT00363415|83001488|FG000|Overall Study|Withdrawal by Subject|9|||
46782822|NCT00363415|83001489|FG001|Overall Study|Withdrawal by Subject|15|||
46851033|NCT00098306|83066773|FG003|Observational Phase|Un-specified|0|||
46851034|NCT00098306|83066774|FG004|Observational Phase|Un-specified|0|||
46851035|NCT00098306|83066775|FG005|Observational Phase|Un-specified|7|||
46851036|NCT00098306|83066776|FG006|Observational Phase|Un-specified|4|||
46660200|NCT05121480|82872367|FG006|Overall Study|Lost to Follow-up|1|||
46660201|NCT05121480|82872368|FG007|Overall Study|Lost to Follow-up|4|||
46660202|NCT05121480|82872361|FG000|Overall Study|Physician Decision|0|||
46660203|NCT05121480|82872362|FG001|Overall Study|Physician Decision|0|||
46660204|NCT05121480|82872363|FG002|Overall Study|Physician Decision|0|||
46660205|NCT05121480|82872364|FG003|Overall Study|Physician Decision|0|||
46660206|NCT05121480|82872365|FG004|Overall Study|Physician Decision|0|||
46660207|NCT05121480|82872366|FG005|Overall Study|Physician Decision|1|||
46660208|NCT05121480|82872367|FG006|Overall Study|Physician Decision|0|||
46660209|NCT05121480|82872368|FG007|Overall Study|Physician Decision|1|||
46660210|NCT05121480|82872361|FG000|Overall Study|Other Reason|0|||
46660211|NCT05121480|82872362|FG001|Overall Study|Other Reason|0|||
46660212|NCT05121480|82872363|FG002|Overall Study|Other Reason|0|||
46660213|NCT05121480|82872364|FG003|Overall Study|Other Reason|0|||
46660214|NCT05121480|82872365|FG004|Overall Study|Other Reason|0|||
46660215|NCT05121480|82872366|FG005|Overall Study|Other Reason|1|||
46660216|NCT05121480|82872367|FG006|Overall Study|Other Reason|1|||
46660217|NCT05121480|82872368|FG007|Overall Study|Other Reason|1|||
46660218|NCT04772755|82872394|FG000|Overall Study|Withdrawal by Subject|1|||
46660219|NCT04772755|82872395|FG001|Overall Study|Withdrawal by Subject|0|||
46660220|NCT04772755|82872394|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
46660221|NCT04772755|82872395|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
46660222|NCT04590040|82872405|FG000|Treatment Period|Lost to Follow-up|2|||
46660223|NCT04590040|82872406|FG001|Treatment Period|Lost to Follow-up|5|||
46660224|NCT04590040|82872407|FG002|Treatment Period|Lost to Follow-up|0|||
46660225|NCT04590040|82872405|FG000|Treatment Period|Physician Decision|0|||
46660226|NCT04590040|82872406|FG001|Treatment Period|Physician Decision|0|||
46660227|NCT04590040|82872407|FG002|Treatment Period|Physician Decision|2|||
46660228|NCT04430335|82872425|FG000|Overall Study|Withdrawal by Subject|1|||
46660229|NCT03690427|82872438|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
46660230|NCT03690427|82872439|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
46660231|NCT03658668|82872448|FG000|Overall Study|Time Commitment|1|||
46660232|NCT03658668|82872449|FG001|Overall Study|Time Commitment|1|||
46660233|NCT03469934|82872457|FG000|Overall Study|Withdrawal by Subject|0|||
46660234|NCT03469934|82872458|FG001|Overall Study|Withdrawal by Subject|1|||
46660235|NCT03004404|82872475|FG000|Period 2|Adverse Event|0|||
46660236|NCT03004404|82872476|FG001|Period 2|Adverse Event|0|||
46660237|NCT03004404|82872477|FG002|Period 2|Adverse Event|0|||
46660238|NCT03004404|82872478|FG003|Period 2|Adverse Event|0|||
46660239|NCT03004404|82872479|FG004|Period 2|Adverse Event|0|||
46851037|NCT03615040|83066791|FG000|Overall Study|Withdrawal by Subject|2|||
46660240|NCT03004404|82872480|FG005|Period 2|Adverse Event|0|||
46660241|NCT03004404|82872481|FG006|Period 2|Adverse Event|0|||
46660242|NCT03004404|82872482|FG007|Period 2|Adverse Event|0|||
46660243|NCT03004404|82872483|FG008|Period 2|Adverse Event|1|||
46660244|NCT03004404|82872484|FG009|Period 2|Adverse Event|0|||
46660245|NCT03004404|82872485|FG010|Period 2|Adverse Event|0|||
46660246|NCT03004404|82872486|FG011|Period 2|Adverse Event|0|||
46660247|NCT03004404|82872487|FG012|Period 2|Adverse Event|0|||
46782823|NCT00363415|83001488|FG000|Overall Study|Lost to Follow-up|3|||
46782824|NCT00363415|83001489|FG001|Overall Study|Lost to Follow-up|3|||
46782825|NCT00363415|83001488|FG000|Overall Study|Protocol Violation|1|||
46782826|NCT00363415|83001489|FG001|Overall Study|Protocol Violation|4|||
46782827|NCT00696020|83001499|FG000|Overall Study|Adverse Event|3|||
47076206|NCT02760485|83370800|FG000|Phase 2|Withdrawal by Subject|0|||
46660248|NCT03004404|82872488|FG013|Period 2|Adverse Event|0|||
46660249|NCT03004404|82872489|FG014|Period 2|Adverse Event|0|||
46660250|NCT03004404|82872490|FG015|Period 2|Adverse Event|1|||
46660251|NCT02335268|82872557|FG000|Overall Study|Physician Decision|5|||
46782828|NCT00696020|83001500|FG001|Overall Study|Adverse Event|1|||
46782829|NCT00696020|83001501|FG002|Overall Study|Adverse Event|2|||
46782830|NCT00696020|83001502|FG003|Overall Study|Adverse Event|1|||
46660252|NCT02335268|82872558|FG001|Overall Study|Physician Decision|1|||
46660253|NCT02335268|82872557|FG000|Overall Study|Lack of Efficacy|2|||
46660254|NCT02335268|82872558|FG001|Overall Study|Lack of Efficacy|1|||
46660255|NCT02335268|82872557|FG000|Overall Study|Adverse Event|5|||
46660256|NCT02335268|82872558|FG001|Overall Study|Adverse Event|2|||
46660257|NCT02335268|82872557|FG000|Overall Study|increase blasts|2|||
46660258|NCT02335268|82872558|FG001|Overall Study|increase blasts|0|||
46660259|NCT02335268|82872557|FG000|Overall Study|Withdrawal by Subject|3|||
46660260|NCT02335268|82872558|FG001|Overall Study|Withdrawal by Subject|2|||
46660261|NCT01029002|82872580|FG000|Overall Study|Lost to Follow-up|2|||
46660262|NCT01029002|82872581|FG001|Overall Study|Lost to Follow-up|4|||
46660263|NCT01011478|82872589|FG000|Overall Study|No follow up data|12|||
46660264|NCT01011478|82872590|FG001|Overall Study|No follow up data|7|||
46660265|NCT00546260|82872598|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
46660266|NCT00546260|82872599|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
46660267|NCT02896192|82872622|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
46660268|NCT02896192|82872622|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
46660269|NCT02896192|82872622|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
46660270|NCT01356940|82872638|FG000|First Intervention (28 Days)|Adverse Event|1|||
46660271|NCT01356940|82872639|FG001|First Intervention (28 Days)|Adverse Event|0|||
46660272|NCT01356940|82872638|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
46660273|NCT01356940|82872639|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
46660274|NCT01330030|82872658|FG000|Overall Study|Lost to Follow-up|16|||
46660275|NCT01330030|82872659|FG001|Overall Study|Lost to Follow-up|17|||
46660276|NCT00477295|82872774|FG000|Overall Study|Adverse Event|31|||
46660277|NCT00477295|82872775|FG001|Overall Study|Adverse Event|35|||
46660278|NCT00477295|82872774|FG000|Overall Study|Withdrawal by Subject|35|||
46660279|NCT00477295|82872775|FG001|Overall Study|Withdrawal by Subject|24|||
46660280|NCT00477295|82872774|FG000|Overall Study|Lack of Efficacy|23|||
46660281|NCT00477295|82872775|FG001|Overall Study|Lack of Efficacy|23|||
46660282|NCT00477295|82872774|FG000|Overall Study|Protocol Violation|3|||
46660283|NCT00477295|82872775|FG001|Overall Study|Protocol Violation|8|||
46660284|NCT00477295|82872774|FG000|Overall Study|Physician Decision|4|||
46660285|NCT00477295|82872775|FG001|Overall Study|Physician Decision|5|||
46782831|NCT00696020|83001499|FG000|Overall Study|Lack of Efficacy|1|||
46782832|NCT00696020|83001500|FG001|Overall Study|Lack of Efficacy|0|||
46782833|NCT00696020|83001501|FG002|Overall Study|Lack of Efficacy|0|||
46782834|NCT00696020|83001502|FG003|Overall Study|Lack of Efficacy|0|||
46782835|NCT00696020|83001499|FG000|Overall Study|Protocol Violation|0|||
46782836|NCT00696020|83001500|FG001|Overall Study|Protocol Violation|0|||
46782837|NCT00696020|83001501|FG002|Overall Study|Protocol Violation|0|||
46782838|NCT00696020|83001502|FG003|Overall Study|Protocol Violation|1|||
46782839|NCT00696020|83001499|FG000|Overall Study|Withdrawal by Subject|0|||
46782840|NCT00696020|83001500|FG001|Overall Study|Withdrawal by Subject|1|||
46782841|NCT00696020|83001501|FG002|Overall Study|Withdrawal by Subject|0|||
46660286|NCT00477295|82872774|FG000|Overall Study|Lost to Follow-up|21|||
46660287|NCT00477295|82872775|FG001|Overall Study|Lost to Follow-up|11|||
46660288|NCT00477295|82872774|FG000|Overall Study|Other|4|||
46660289|NCT00477295|82872775|FG001|Overall Study|Other|3|||
46660290|NCT00476593|82872787|FG000|Overall Study|Lost to Follow-up|10|||
46660291|NCT00476593|82872788|FG001|Overall Study|Lost to Follow-up|2|||
46660292|NCT00476593|82872789|FG002|Overall Study|Lost to Follow-up|8|||
46660293|NCT00476593|82872790|FG003|Overall Study|Lost to Follow-up|22|||
46660294|NCT00476476|82872802|FG000|Overall Study|Adverse Event|2|||
46660295|NCT00476476|82872803|FG001|Overall Study|Adverse Event|7|||
46851038|NCT03615040|83066792|FG001|Overall Study|Withdrawal by Subject|1|||
47076207|NCT02760485|83370801|FG001|Phase 2|Withdrawal by Subject|0|||
47076208|NCT02760485|83370802|FG002|Phase 2|Withdrawal by Subject|3|||
46660296|NCT00476476|82872802|FG000|Overall Study|Progressive Disease|0|||
46660297|NCT00476476|82872803|FG001|Overall Study|Progressive Disease|17|||
46660298|NCT00476086|82872808|FG000|Overall Study|Alternative therapy|1|||
46660299|NCT00476086|82872808|FG000|Overall Study|Progressive Disease|4|||
46660300|NCT00476047|82872814|FG000|Overall Study|Lost to Follow-up|1|||
46660301|NCT00476008|82872822|FG000|Overall Study|Adverse Event|4|||
46660302|NCT00476008|82872823|FG001|Overall Study|Adverse Event|4|||
46660303|NCT00476008|82872822|FG000|Overall Study|Placebo concerns|2|||
46660304|NCT00476008|82872823|FG001|Overall Study|Placebo concerns|2|||
46660305|NCT00476008|82872822|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
46660306|NCT00476008|82872823|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
46660307|NCT00476008|82872822|FG000|Overall Study|Withdrawal by Subject|0|||
46782842|NCT00696020|83001502|FG003|Overall Study|Withdrawal by Subject|1|||
46782843|NCT00696020|83001499|FG000|Overall Study|Other not stated above|0|||
46782844|NCT00696020|83001500|FG001|Overall Study|Other not stated above|0|||
46782845|NCT00696020|83001501|FG002|Overall Study|Other not stated above|1|||
46782846|NCT00696020|83001502|FG003|Overall Study|Other not stated above|1|||
46660308|NCT00476008|82872823|FG001|Overall Study|Withdrawal by Subject|1|||
46660309|NCT00476008|82872822|FG000|Overall Study|Death|1|||
46660310|NCT00476008|82872823|FG001|Overall Study|Death|0|||
46660311|NCT00475735|82872839|FG000|Treatment Period 1|Adverse Event|2|||
46660312|NCT00475735|82872840|FG001|Treatment Period 1|Adverse Event|0|||
46660313|NCT00475735|82872841|FG002|Treatment Period 1|Adverse Event|0|||
46660314|NCT00475735|82872842|FG003|Treatment Period 1|Adverse Event|0|||
46660315|NCT00475735|82872843|FG004|Treatment Period 1|Adverse Event|0|||
46660316|NCT00475735|82872844|FG005|Treatment Period 1|Adverse Event|0|||
46660317|NCT00475735|82872839|FG000|Treatment Period 1|Lack of Efficacy|1|||
46660318|NCT00475735|82872840|FG001|Treatment Period 1|Lack of Efficacy|0|||
46660319|NCT00475735|82872841|FG002|Treatment Period 1|Lack of Efficacy|0|||
46660320|NCT00475735|82872842|FG003|Treatment Period 1|Lack of Efficacy|0|||
46660321|NCT00475735|82872843|FG004|Treatment Period 1|Lack of Efficacy|0|||
46660322|NCT00475735|82872844|FG005|Treatment Period 1|Lack of Efficacy|0|||
46660323|NCT00475735|82872839|FG000|Treatment Period 1|Lost to Follow-up|0|||
46660324|NCT00475735|82872840|FG001|Treatment Period 1|Lost to Follow-up|0|||
46660325|NCT00475735|82872841|FG002|Treatment Period 1|Lost to Follow-up|0|||
46660326|NCT00475735|82872842|FG003|Treatment Period 1|Lost to Follow-up|0|||
46660327|NCT00475735|82872843|FG004|Treatment Period 1|Lost to Follow-up|0|||
46660328|NCT00475735|82872844|FG005|Treatment Period 1|Lost to Follow-up|1|||
46660329|NCT00475735|82872839|FG000|Treatment Period 1|Protocol Violation|0|||
46660330|NCT00475735|82872840|FG001|Treatment Period 1|Protocol Violation|0|||
46782847|NCT00576576|83001514|FG000|Overall Study|Lost to Follow-up|6|||
46782848|NCT00576576|83001514|FG000|Overall Study|Protocol Violation|1|||
46782849|NCT00695864|83001533|FG000|Placebo|Withdrawal by Subject|1|||
46782850|NCT00695864|83001533|FG000|Placebo|Physician Decision|4|||
46782851|NCT00684996|83001539|FG000|Overall Study|Adverse Event|1|||
46782852|NCT00684996|83001539|FG000|Overall Study|Refusal unrelated to adverse event|1|||
46782853|NCT00684996|83001539|FG000|Overall Study|Progression/relapse|2|||
46782854|NCT00684996|83001539|FG000|Overall Study|Other reasons not protocol specified|1|||
46660331|NCT00475735|82872841|FG002|Treatment Period 1|Protocol Violation|0|||
46660332|NCT00475735|82872842|FG003|Treatment Period 1|Protocol Violation|1|||
46660333|NCT00475735|82872843|FG004|Treatment Period 1|Protocol Violation|0|||
46660334|NCT00475735|82872844|FG005|Treatment Period 1|Protocol Violation|0|||
46660335|NCT00475735|82872839|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46660336|NCT00475735|82872840|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46660337|NCT00475735|82872841|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46660338|NCT00475735|82872842|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46660339|NCT00475735|82872843|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46660340|NCT00475735|82872844|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46782855|NCT00684762|83001546|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
46782856|NCT00684762|83001547|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
46782857|NCT00695786|83001557|FG000|Overall Study|Adverse Event|0|||
46782858|NCT00695786|83001558|FG001|Overall Study|Adverse Event|3|||
46660341|NCT00475735|82872839|FG000|Treatment Period 1|DC due to AE but continuing|0|||
46660342|NCT00475735|82872840|FG001|Treatment Period 1|DC due to AE but continuing|0|||
46660343|NCT00475735|82872841|FG002|Treatment Period 1|DC due to AE but continuing|0|||
46660344|NCT00475735|82872842|FG003|Treatment Period 1|DC due to AE but continuing|1|||
46660345|NCT00475735|82872843|FG004|Treatment Period 1|DC due to AE but continuing|2|||
46660346|NCT00475735|82872844|FG005|Treatment Period 1|DC due to AE but continuing|2|||
46660347|NCT00475735|82872839|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
46660348|NCT00475735|82872840|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
46660349|NCT00475735|82872841|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
46660350|NCT00475735|82872842|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
46660351|NCT00475735|82872843|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
46660352|NCT00475735|82872844|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
46660353|NCT00475735|82872839|FG000|Treatment Washout|Lost to Follow-up|0|||
46660354|NCT00475735|82872840|FG001|Treatment Washout|Lost to Follow-up|1|||
46660355|NCT00475735|82872841|FG002|Treatment Washout|Lost to Follow-up|0|||
46782859|NCT00695786|83001559|FG002|Overall Study|Adverse Event|4|||
46782860|NCT00695786|83001560|FG003|Overall Study|Adverse Event|2|||
47076209|NCT02760485|83370800|FG000|Phase 2|Progressive Disease|0|||
47076210|NCT02760485|83370801|FG001|Phase 2|Progressive Disease|0|||
47076211|NCT02760485|83370802|FG002|Phase 2|Progressive Disease|1|||
46782861|NCT00695786|83001557|FG000|Overall Study|Lost to Follow-up|0|||
46660356|NCT00475735|82872842|FG003|Treatment Washout|Lost to Follow-up|0|||
46660357|NCT00475735|82872843|FG004|Treatment Washout|Lost to Follow-up|0|||
46660358|NCT00475735|82872844|FG005|Treatment Washout|Lost to Follow-up|0|||
46660359|NCT00475735|82872839|FG000|Treatment Washout|Protocol Violation|0|||
46660360|NCT00475735|82872840|FG001|Treatment Washout|Protocol Violation|1|||
46660361|NCT00475735|82872841|FG002|Treatment Washout|Protocol Violation|0|||
46660362|NCT00475735|82872842|FG003|Treatment Washout|Protocol Violation|0|||
46660363|NCT00475735|82872843|FG004|Treatment Washout|Protocol Violation|0|||
46782862|NCT00695786|83001558|FG001|Overall Study|Lost to Follow-up|5|||
46782863|NCT00695786|83001559|FG002|Overall Study|Lost to Follow-up|1|||
46782864|NCT00695786|83001560|FG003|Overall Study|Lost to Follow-up|1|||
46782865|NCT00695786|83001557|FG000|Overall Study|Withdrawal by Subject|0|||
46782866|NCT00695786|83001558|FG001|Overall Study|Withdrawal by Subject|4|||
46782867|NCT00695786|83001559|FG002|Overall Study|Withdrawal by Subject|3|||
46782868|NCT00695786|83001560|FG003|Overall Study|Withdrawal by Subject|1|||
46782869|NCT00695786|83001557|FG000|Overall Study|Deemed Ineligible|1|||
46782870|NCT00695786|83001558|FG001|Overall Study|Deemed Ineligible|0|||
46782871|NCT00695786|83001559|FG002|Overall Study|Deemed Ineligible|0|||
46782872|NCT00695786|83001560|FG003|Overall Study|Deemed Ineligible|0|||
46660364|NCT00475735|82872844|FG005|Treatment Washout|Protocol Violation|0|||
46660365|NCT00475735|82872839|FG000|Treatment Period 2|Adverse Event|0|||
46660366|NCT00475735|82872840|FG001|Treatment Period 2|Adverse Event|1|||
46660367|NCT00475735|82872841|FG002|Treatment Period 2|Adverse Event|0|||
46660368|NCT00475735|82872842|FG003|Treatment Period 2|Adverse Event|2|||
46660369|NCT00475735|82872843|FG004|Treatment Period 2|Adverse Event|0|||
46660370|NCT00475735|82872844|FG005|Treatment Period 2|Adverse Event|0|||
46660371|NCT00475735|82872839|FG000|Treatment Period 2|Lack of Efficacy|0|||
46660372|NCT00475735|82872840|FG001|Treatment Period 2|Lack of Efficacy|0|||
46660373|NCT00475735|82872841|FG002|Treatment Period 2|Lack of Efficacy|0|||
46660374|NCT00475735|82872842|FG003|Treatment Period 2|Lack of Efficacy|0|||
46660375|NCT00475735|82872843|FG004|Treatment Period 2|Lack of Efficacy|0|||
46660376|NCT00475735|82872844|FG005|Treatment Period 2|Lack of Efficacy|1|||
46660377|NCT00475735|82872839|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46660378|NCT00475735|82872840|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46660379|NCT00475735|82872841|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46660380|NCT00475735|82872842|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46660381|NCT00475735|82872843|FG004|Treatment Period 2|Withdrawal by Subject|1|||
46660382|NCT00475735|82872844|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46660383|NCT00475657|82872852|FG000|Overall Study|Death|1|||
46660384|NCT00475657|82872852|FG000|Overall Study|Sponsor's Decision|3|||
46660385|NCT00475423|82872856|FG000|Overall Study|Protocol Violation|5|||
46660386|NCT00475423|82872856|FG000|Overall Study|Adverse Event|4|||
46660387|NCT00475423|82872856|FG000|Overall Study|Withdrawal by Subject|6|||
46660388|NCT00475423|82872856|FG000|Overall Study|Lack of Efficacy|8|||
46660389|NCT00475423|82872856|FG000|Overall Study|Death|1|||
46660390|NCT00475423|82872856|FG000|Overall Study|Reason not specified|1|||
46660391|NCT00475423|82872856|FG000|Overall Study|Lost to Follow-up|7|||
46660392|NCT00475306|82872864|FG000|Overall Study|Protocol Violation|1|||
46660393|NCT00475306|82872865|FG001|Overall Study|Protocol Violation|1|||
46660394|NCT00475306|82872866|FG002|Overall Study|Protocol Violation|0|||
46660395|NCT00475306|82872867|FG003|Overall Study|Protocol Violation|1|||
46660396|NCT00475228|82872879|FG000|Overall Study|Lost to Follow-up|17|||
46660397|NCT00475228|82872880|FG001|Overall Study|Lost to Follow-up|17|||
46660398|NCT05179421|82872949|FG000|First Infusion Day|Adverse Event|1|||
46660399|NCT05179421|82872950|FG001|First Infusion Day|Adverse Event|0|||
46660400|NCT05087966|82872960|FG000|Overall Study|Lost to Follow-up|1|||
46660401|NCT05087966|82872960|FG000|Overall Study|Withdrawal by Subject|5|||
46782873|NCT00695786|83001557|FG000|Overall Study|Lack of Efficacy|0|||
46782874|NCT00695786|83001558|FG001|Overall Study|Lack of Efficacy|0|||
46782875|NCT00695786|83001559|FG002|Overall Study|Lack of Efficacy|0|||
46782876|NCT00695786|83001560|FG003|Overall Study|Lack of Efficacy|4|||
46782877|NCT00387127|83001572|FG000|Overall Study|Lost to Follow-up|0|||
46782878|NCT00387127|83001573|FG001|Overall Study|Lost to Follow-up|4|||
46782879|NCT00387127|83001572|FG000|Overall Study|Death|16|||
46782880|NCT00387127|83001573|FG001|Overall Study|Death|16|||
46782881|NCT00387127|83001572|FG000|Overall Study|Physician Decision|0|||
46782882|NCT00387127|83001573|FG001|Overall Study|Physician Decision|1|||
46782883|NCT00387127|83001572|FG000|Overall Study|Withdrawal by Subject|3|||
46971894|NCT02667275|83215465|FG000|Overall Study|Lost to Follow-up|0|||
46971895|NCT02667275|83215466|FG001|Overall Study|Lost to Follow-up|2|||
46971896|NCT02667275|83215465|FG000|Overall Study|Withdrawal by Subject|0|||
46971897|NCT02667275|83215466|FG001|Overall Study|Withdrawal by Subject|5|||
46971898|NCT02667275|83215465|FG000|Overall Study|Discontinued early without completing|0|||
46660402|NCT04696055|82872966|FG000|Overall Study|Adverse Event|10|||
46660403|NCT04696055|82872967|FG001|Overall Study|Adverse Event|0|||
46660404|NCT04696055|82872966|FG000|Overall Study|Death|2|||
46660405|NCT04696055|82872967|FG001|Overall Study|Death|1|||
46660406|NCT04696055|82872966|FG000|Overall Study|Other|4|||
46660407|NCT04696055|82872967|FG001|Overall Study|Other|0|||
46660408|NCT04696055|82872966|FG000|Overall Study|Physician Decision|1|||
46660409|NCT04696055|82872967|FG001|Overall Study|Physician Decision|0|||
46660410|NCT04696055|82872966|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
46660411|NCT04696055|82872967|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
46660412|NCT04696055|82872966|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
46660413|NCT04696055|82872967|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
46782884|NCT00387127|83001573|FG001|Overall Study|Withdrawal by Subject|2|||
46782885|NCT00387127|83001572|FG000|Overall Study|Required by Protocol Amendment #4|12|||
46782886|NCT00387127|83001573|FG001|Overall Study|Required by Protocol Amendment #4|10|||
46782887|NCT00387127|83001572|FG000|Overall Study|Serious Adverse Event|1|||
46971899|NCT02667275|83215466|FG001|Overall Study|Discontinued early without completing|1|||
46782888|NCT00387127|83001573|FG001|Overall Study|Serious Adverse Event|1|||
46782889|NCT00387127|83001572|FG000|Overall Study|Sponsor Unblinded|1|||
46782890|NCT00387127|83001573|FG001|Overall Study|Sponsor Unblinded|0|||
46782891|NCT00683592|83001583|FG000|Overall Study|Adverse Event|12|||
46782892|NCT00683592|83001584|FG001|Overall Study|Adverse Event|4|||
46782893|NCT00683592|83001583|FG000|Overall Study|Withdrawal by Subject|11|||
46782894|NCT00683592|83001584|FG001|Overall Study|Withdrawal by Subject|11|||
46782895|NCT00683592|83001583|FG000|Overall Study|Lost to Follow-up|17|||
46782896|NCT00683592|83001584|FG001|Overall Study|Lost to Follow-up|17|||
46782897|NCT00683592|83001583|FG000|Overall Study|Lack of Efficacy|3|||
46782898|NCT00683592|83001584|FG001|Overall Study|Lack of Efficacy|7|||
46782899|NCT00683592|83001583|FG000|Overall Study|Physician Decision|0|||
46782900|NCT00683592|83001584|FG001|Overall Study|Physician Decision|1|||
46782901|NCT00683592|83001583|FG000|Overall Study|Non-compliance|3|||
46971900|NCT02672423|83215475|FG000|Period 1|Adverse Event|0|||
46971901|NCT02672423|83215476|FG001|Period 1|Adverse Event|0|||
46971902|NCT02672423|83215477|FG002|Period 1|Adverse Event|0|||
46971903|NCT02672423|83215478|FG003|Period 1|Adverse Event|0|||
46971904|NCT02672423|83215479|FG004|Period 1|Adverse Event|1|||
46971905|NCT02672423|83215480|FG005|Period 1|Adverse Event|0|||
46660414|NCT04696055|82872966|FG000|Overall Study|Subject Decision|1|||
46660415|NCT04696055|82872967|FG001|Overall Study|Subject Decision|2|||
46660416|NCT04696055|82872966|FG000|Overall Study|Ongoing with study treatment|13|||
46660417|NCT04696055|82872967|FG001|Overall Study|Ongoing with study treatment|10|||
46660418|NCT04639713|82872973|FG000|Overall Study|Protocol Noncompliance|2|||
46660419|NCT04639713|82872973|FG000|Overall Study|Withdrawal by Subject|1|||
46660420|NCT04505293|82872996|FG000|Overall Study|Lost to Follow-up|2|||
46660421|NCT04505293|82872996|FG000|Overall Study|Withdrawal by Subject|6|||
46660422|NCT04505293|82872996|FG000|Overall Study|CT scan unreadable|277|||
46660423|NCT03989102|82873029|FG000|Year 1|Withdrawal by Subject|6|||
46660424|NCT03989102|82873030|FG001|Year 1|Withdrawal by Subject|2|||
46660425|NCT03989102|82873031|FG002|Year 1|Withdrawal by Subject|7|||
46660426|NCT03989102|82873029|FG000|Year 1|Lost to Follow-up|5|||
46660427|NCT03989102|82873030|FG001|Year 1|Lost to Follow-up|2|||
46660428|NCT03989102|82873031|FG002|Year 1|Lost to Follow-up|5|||
46660429|NCT03989102|82873029|FG000|Year 1|Subject met withdrawal criteria|1|||
46660430|NCT03989102|82873030|FG001|Year 1|Subject met withdrawal criteria|0|||
46660431|NCT03989102|82873031|FG002|Year 1|Subject met withdrawal criteria|1|||
46660432|NCT03989102|82873029|FG000|Year 2|Lost to Follow-up|7|||
46971906|NCT02672423|83215481|FG006|Period 1|Adverse Event|0|||
46971907|NCT02672423|83215482|FG007|Period 1|Adverse Event|0|||
46971908|NCT02672423|83215483|FG008|Period 1|Adverse Event|0|||
46971909|NCT02672423|83215484|FG009|Period 1|Adverse Event|0|||
46971910|NCT02672423|83215475|FG000|Period 2|Withdrawal by Subject|0|||
46971911|NCT02672423|83215476|FG001|Period 2|Withdrawal by Subject|0|||
46971912|NCT02672423|83215477|FG002|Period 2|Withdrawal by Subject|1|||
46971913|NCT02672423|83215478|FG003|Period 2|Withdrawal by Subject|0|||
46971914|NCT02672423|83215479|FG004|Period 2|Withdrawal by Subject|0|||
46971915|NCT02672423|83215480|FG005|Period 2|Withdrawal by Subject|0|||
46971916|NCT02672423|83215481|FG006|Period 2|Withdrawal by Subject|0|||
46971917|NCT02672423|83215482|FG007|Period 2|Withdrawal by Subject|0|||
46971918|NCT02672423|83215483|FG008|Period 2|Withdrawal by Subject|0|||
46971919|NCT02672423|83215484|FG009|Period 2|Withdrawal by Subject|0|||
46971920|NCT02672423|83215475|FG000|Period 3|Withdrawal by Subject|0|||
46971921|NCT02672423|83215476|FG001|Period 3|Withdrawal by Subject|0|||
46971922|NCT02672423|83215477|FG002|Period 3|Withdrawal by Subject|0|||
46971923|NCT02672423|83215478|FG003|Period 3|Withdrawal by Subject|0|||
46660433|NCT03989102|82873030|FG001|Year 2|Lost to Follow-up|3|||
46660434|NCT03989102|82873031|FG002|Year 2|Lost to Follow-up|4|||
46660435|NCT03989102|82873029|FG000|Year 2|Withdrawal by Subject|3|||
46782902|NCT00683592|83001584|FG001|Overall Study|Non-compliance|5|||
46782903|NCT00683592|83001583|FG000|Overall Study|Other|1|||
46782904|NCT00683592|83001584|FG001|Overall Study|Other|1|||
47076212|NCT02760485|83370800|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
46660436|NCT03989102|82873030|FG001|Year 2|Withdrawal by Subject|1|||
46660437|NCT03989102|82873031|FG002|Year 2|Withdrawal by Subject|2|||
46660438|NCT03989102|82873029|FG000|Year 2|Subject non-compliant|3|||
46660439|NCT03989102|82873030|FG001|Year 2|Subject non-compliant|2|||
46660440|NCT03989102|82873031|FG002|Year 2|Subject non-compliant|0|||
46660441|NCT03989102|82873029|FG000|Year 2|Travel|1|||
46782905|NCT00695396|83001593|FG000|Overall Study|Study Closed Prematurely|5|||
46782906|NCT00695396|83001594|FG001|Overall Study|Study Closed Prematurely|6|||
46660442|NCT03989102|82873030|FG001|Year 2|Travel|0|||
46660443|NCT03989102|82873031|FG002|Year 2|Travel|1|||
46782907|NCT00695396|83001595|FG002|Overall Study|Study Closed Prematurely|8|||
46971924|NCT02672423|83215479|FG004|Period 3|Withdrawal by Subject|0|||
46971925|NCT02672423|83215480|FG005|Period 3|Withdrawal by Subject|0|||
46971926|NCT02672423|83215481|FG006|Period 3|Withdrawal by Subject|0|||
46971927|NCT02672423|83215482|FG007|Period 3|Withdrawal by Subject|1|||
46971928|NCT02672423|83215483|FG008|Period 3|Withdrawal by Subject|0|||
46971929|NCT02672423|83215484|FG009|Period 3|Withdrawal by Subject|0|||
46660444|NCT03989102|82873029|FG000|Year 2|P16 missing|4|||
46660445|NCT03989102|82873030|FG001|Year 2|P16 missing|2|||
46660446|NCT03989102|82873031|FG002|Year 2|P16 missing|1|||
46660447|NCT03989102|82873029|FG000|Year 2|P11 missing|1|||
46660448|NCT03989102|82873030|FG001|Year 2|P11 missing|3|||
46660449|NCT03989102|82873031|FG002|Year 2|P11 missing|7|||
46660450|NCT03989102|82873029|FG000|Year 2|Definitive displacement outside the study site|0|||
46660451|NCT03989102|82873030|FG001|Year 2|Definitive displacement outside the study site|1|||
46660452|NCT03989102|82873031|FG002|Year 2|Definitive displacement outside the study site|0|||
46660453|NCT03989102|82873029|FG000|Year 2|Subject missed last study visit|0|||
46660454|NCT03989102|82873030|FG001|Year 2|Subject missed last study visit|1|||
46660455|NCT03989102|82873031|FG002|Year 2|Subject missed last study visit|0|||
46660456|NCT03989102|82873029|FG000|Year 2|Death|0|||
46660457|NCT03989102|82873030|FG001|Year 2|Death|1|||
46660458|NCT03989102|82873031|FG002|Year 2|Death|0|||
46660459|NCT03989102|82873029|FG000|Year 2|Subject not reachable|0|||
46660460|NCT03989102|82873030|FG001|Year 2|Subject not reachable|0|||
46660461|NCT03989102|82873031|FG002|Year 2|Subject not reachable|1|||
46660462|NCT03989102|82873029|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
46660463|NCT03989102|82873030|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
46660464|NCT03989102|82873031|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
46660465|NCT03989102|82873029|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
46660466|NCT03989102|82873030|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
46660467|NCT03989102|82873031|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
46660468|NCT03989102|82873029|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
46660469|NCT03989102|82873030|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
46660470|NCT03989102|82873031|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
46782908|NCT00695396|83001593|FG000|Overall Study|Withdrawal by Subject|2|||
46660471|NCT03989102|82873029|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
46660472|NCT03989102|82873030|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
46660473|NCT03989102|82873031|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
46660474|NCT03989102|82873029|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
46660475|NCT03989102|82873030|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
46660476|NCT03989102|82873031|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
46660477|NCT03989102|82873029|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
46660478|NCT03989102|82873030|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
46660479|NCT03989102|82873031|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
46660480|NCT03921528|82873053|FG000|Overall Study|Withdrawal by Subject|0|||
46660481|NCT03921528|82873054|FG001|Overall Study|Withdrawal by Subject|1|||
46660482|NCT03921528|82873055|FG002|Overall Study|Withdrawal by Subject|0|||
46660483|NCT03921528|82873056|FG003|Overall Study|Withdrawal by Subject|0|||
46660484|NCT03921528|82873057|FG004|Overall Study|Withdrawal by Subject|0|||
46660485|NCT03837899|82873082|FG000|Overall Study|Death|6|||
46660486|NCT03837899|82873083|FG001|Overall Study|Death|8|||
46660487|NCT03837899|82873084|FG002|Overall Study|Death|3|||
46660488|NCT03837899|82873085|FG003|Overall Study|Death|7|||
46660489|NCT03837899|82873086|FG004|Overall Study|Death|8|||
46660490|NCT03837899|82873087|FG005|Overall Study|Death|7|||
46660491|NCT03837899|82873082|FG000|Overall Study|Moved to post-trial access program|0|||
46660492|NCT03837899|82873083|FG001|Overall Study|Moved to post-trial access program|1|||
46660493|NCT03837899|82873084|FG002|Overall Study|Moved to post-trial access program|0|||
46971930|NCT02672423|83215475|FG000|Period 3|Physician Decision|0|||
46971931|NCT02672423|83215476|FG001|Period 3|Physician Decision|0|||
46971932|NCT02672423|83215477|FG002|Period 3|Physician Decision|0|||
46971933|NCT02672423|83215478|FG003|Period 3|Physician Decision|0|||
46971934|NCT02672423|83215479|FG004|Period 3|Physician Decision|0|||
46971935|NCT02672423|83215480|FG005|Period 3|Physician Decision|1|||
46971936|NCT02672423|83215481|FG006|Period 3|Physician Decision|0|||
46971937|NCT02672423|83215482|FG007|Period 3|Physician Decision|0|||
46971938|NCT02672423|83215483|FG008|Period 3|Physician Decision|0|||
46971939|NCT02672423|83215484|FG009|Period 3|Physician Decision|0|||
46971940|NCT02670551|83215508|FG000|Overall Study|Adverse Event|4|||
46971941|NCT02670551|83215509|FG001|Overall Study|Adverse Event|7|||
46660494|NCT03837899|82873085|FG003|Overall Study|Moved to post-trial access program|0|||
46660495|NCT03837899|82873086|FG004|Overall Study|Moved to post-trial access program|0|||
46660496|NCT03837899|82873087|FG005|Overall Study|Moved to post-trial access program|0|||
46660497|NCT03837899|82873082|FG000|Overall Study|Other|0|||
46660498|NCT03837899|82873083|FG001|Overall Study|Other|0|||
46660499|NCT03837899|82873084|FG002|Overall Study|Other|0|||
46660500|NCT03837899|82873085|FG003|Overall Study|Other|0|||
46660501|NCT03837899|82873086|FG004|Overall Study|Other|0|||
46660502|NCT03837899|82873087|FG005|Overall Study|Other|2|||
46660503|NCT03837899|82873082|FG000|Overall Study|Lost to Follow-up|0|||
46971942|NCT02670551|83215510|FG002|Overall Study|Adverse Event|9|||
46971943|NCT02670551|83215508|FG000|Overall Study|Lack of Efficacy|2|||
46971944|NCT02670551|83215509|FG001|Overall Study|Lack of Efficacy|0|||
46971945|NCT02670551|83215510|FG002|Overall Study|Lack of Efficacy|3|||
46660504|NCT03837899|82873083|FG001|Overall Study|Lost to Follow-up|1|||
46660505|NCT03837899|82873084|FG002|Overall Study|Lost to Follow-up|0|||
46660506|NCT03837899|82873085|FG003|Overall Study|Lost to Follow-up|0|||
46660507|NCT03837899|82873086|FG004|Overall Study|Lost to Follow-up|0|||
46660508|NCT03837899|82873087|FG005|Overall Study|Lost to Follow-up|0|||
46660509|NCT03837899|82873082|FG000|Overall Study|Withdrawal by Subject|0|||
46660510|NCT03837899|82873083|FG001|Overall Study|Withdrawal by Subject|0|||
46660511|NCT03837899|82873084|FG002|Overall Study|Withdrawal by Subject|0|||
46660512|NCT03837899|82873085|FG003|Overall Study|Withdrawal by Subject|1|||
46660513|NCT03837899|82873086|FG004|Overall Study|Withdrawal by Subject|0|||
46660514|NCT03837899|82873087|FG005|Overall Study|Withdrawal by Subject|0|||
46660515|NCT03837899|82873082|FG000|Overall Study|Study specific discontinuation criteria|0|||
46660516|NCT03837899|82873083|FG001|Overall Study|Study specific discontinuation criteria|1|||
46660517|NCT03837899|82873084|FG002|Overall Study|Study specific discontinuation criteria|0|||
46660518|NCT03837899|82873085|FG003|Overall Study|Study specific discontinuation criteria|0|||
46660519|NCT03837899|82873086|FG004|Overall Study|Study specific discontinuation criteria|3|||
46660520|NCT03837899|82873087|FG005|Overall Study|Study specific discontinuation criteria|1|||
46660521|NCT03789318|82873111|FG000|Overall Study|Adverse Event|0|||
46660522|NCT03789318|82873112|FG001|Overall Study|Adverse Event|0|||
46660523|NCT03789318|82873113|FG002|Overall Study|Adverse Event|1|||
46660524|NCT03789318|82873114|FG003|Overall Study|Adverse Event|1|||
46660525|NCT03789318|82873115|FG004|Overall Study|Adverse Event|0|||
46660526|NCT03789318|82873111|FG000|Overall Study|Lost to Follow-up|0|||
46660527|NCT03789318|82873112|FG001|Overall Study|Lost to Follow-up|0|||
46660528|NCT03789318|82873113|FG002|Overall Study|Lost to Follow-up|1|||
46660529|NCT03789318|82873114|FG003|Overall Study|Lost to Follow-up|0|||
46660530|NCT03789318|82873115|FG004|Overall Study|Lost to Follow-up|0|||
46660531|NCT03789318|82873111|FG000|Overall Study|Withdrawal by Subject|0|||
46660532|NCT03789318|82873112|FG001|Overall Study|Withdrawal by Subject|0|||
46660533|NCT03789318|82873113|FG002|Overall Study|Withdrawal by Subject|1|||
46660534|NCT03789318|82873114|FG003|Overall Study|Withdrawal by Subject|0|||
46660535|NCT03789318|82873115|FG004|Overall Study|Withdrawal by Subject|0|||
46660536|NCT03749447|82873129|FG000|Overall Study|Adverse Event|11|||
46660537|NCT03749447|82873130|FG001|Overall Study|Adverse Event|3|||
46660538|NCT03749447|82873129|FG000|Overall Study|Death|1|||
46660539|NCT03749447|82873130|FG001|Overall Study|Death|1|||
46660540|NCT03749447|82873129|FG000|Overall Study|Lost to Follow-up|2|||
46660541|NCT03749447|82873130|FG001|Overall Study|Lost to Follow-up|2|||
46660542|NCT03749447|82873129|FG000|Overall Study|Reason Not Specified|0|||
46660543|NCT03749447|82873130|FG001|Overall Study|Reason Not Specified|3|||
46660544|NCT03749447|82873129|FG000|Overall Study|Physician Decision|4|||
46660545|NCT03749447|82873130|FG001|Overall Study|Physician Decision|3|||
46660546|NCT03749447|82873129|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
46660547|NCT03749447|82873130|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
46660548|NCT03749447|82873129|FG000|Overall Study|Study Terminated By Sponsor|112|||
46660549|NCT03749447|82873130|FG001|Overall Study|Study Terminated By Sponsor|105|||
46660550|NCT03749447|82873129|FG000|Overall Study|Withdrawal by Subject|12|||
46660551|NCT03749447|82873130|FG001|Overall Study|Withdrawal by Subject|6|||
46660552|NCT03749447|82873129|FG000|Overall Study|Non-compliance With Study Drug|0|||
46660553|NCT03749447|82873130|FG001|Overall Study|Non-compliance With Study Drug|1|||
46660554|NCT03688100|82873159|FG000|Overall Study|Lost to Follow-up|21|||
46660555|NCT03688100|82873160|FG001|Overall Study|Lost to Follow-up|15|||
46660556|NCT03688100|82873161|FG002|Overall Study|Lost to Follow-up|15|||
46660557|NCT03688100|82873162|FG003|Overall Study|Lost to Follow-up|18|||
46660558|NCT03688100|82873159|FG000|Overall Study|Withdrawal by Subject|19|||
46660559|NCT03688100|82873160|FG001|Overall Study|Withdrawal by Subject|16|||
46660560|NCT03688100|82873161|FG002|Overall Study|Withdrawal by Subject|0|||
46660561|NCT03688100|82873162|FG003|Overall Study|Withdrawal by Subject|0|||
46660562|NCT03688100|82873159|FG000|Overall Study|Death|36|||
46660563|NCT03688100|82873160|FG001|Overall Study|Death|27|||
46660564|NCT03688100|82873161|FG002|Overall Study|Death|0|||
46660565|NCT03688100|82873162|FG003|Overall Study|Death|0|||
46660566|NCT03646513|82873172|FG000|Overall Study|Premature study termination|4|||
46660567|NCT03547908|82873178|FG000|Overall Study|Still On Study|115|||
46660568|NCT03547908|82873179|FG001|Overall Study|Still On Study|118|||
46660569|NCT03547908|82873178|FG000|Overall Study|Lost to Follow-up|2|||
46660570|NCT03547908|82873179|FG001|Overall Study|Lost to Follow-up|2|||
46660571|NCT03547908|82873178|FG000|Overall Study|Withdrew Consent|2|||
46660572|NCT03547908|82873179|FG001|Overall Study|Withdrew Consent|1|||
46660573|NCT03547908|82873178|FG000|Overall Study|Adverse Event|1|||
46660574|NCT03547908|82873179|FG001|Overall Study|Adverse Event|0|||
46660575|NCT03547908|82873178|FG000|Overall Study|Death|1|||
46660576|NCT03547908|82873179|FG001|Overall Study|Death|0|||
46660577|NCT03547908|82873178|FG000|Overall Study|Investigator's Discretion|0|||
46660578|NCT03547908|82873179|FG001|Overall Study|Investigator's Discretion|1|||
46660579|NCT03547908|82873178|FG000|Overall Study|Randomized But Never Treated|1|||
46660580|NCT03547908|82873179|FG001|Overall Study|Randomized But Never Treated|0|||
46660581|NCT03518086|82873187|FG000|Overall Study|Adverse Event|23|||
46660582|NCT03518086|82873188|FG001|Overall Study|Adverse Event|15|||
46660583|NCT03518086|82873189|FG002|Overall Study|Adverse Event|0|||
46660584|NCT03518086|82873190|FG003|Overall Study|Adverse Event|0|||
46660585|NCT03518086|82873187|FG000|Overall Study|Withdrawal by Subject|8|||
46660586|NCT03518086|82873188|FG001|Overall Study|Withdrawal by Subject|5|||
46660587|NCT03518086|82873189|FG002|Overall Study|Withdrawal by Subject|0|||
46660588|NCT03518086|82873190|FG003|Overall Study|Withdrawal by Subject|0|||
46660589|NCT03518086|82873187|FG000|Overall Study|Lack of Efficacy|5|||
46660590|NCT03518086|82873188|FG001|Overall Study|Lack of Efficacy|5|||
46660591|NCT03518086|82873189|FG002|Overall Study|Lack of Efficacy|0|||
46660592|NCT03518086|82873190|FG003|Overall Study|Lack of Efficacy|0|||
46660593|NCT03518086|82873187|FG000|Overall Study|Protocol Violation|1|||
46660594|NCT03518086|82873188|FG001|Overall Study|Protocol Violation|5|||
46660595|NCT03518086|82873189|FG002|Overall Study|Protocol Violation|0|||
46660596|NCT03518086|82873190|FG003|Overall Study|Protocol Violation|0|||
46660597|NCT03518086|82873187|FG000|Overall Study|Lost to Follow-up|0|||
46660598|NCT03518086|82873188|FG001|Overall Study|Lost to Follow-up|3|||
46660599|NCT03518086|82873189|FG002|Overall Study|Lost to Follow-up|0|||
46660600|NCT03518086|82873190|FG003|Overall Study|Lost to Follow-up|0|||
46660601|NCT03518086|82873187|FG000|Overall Study|Insufficient Diary Data|0|||
46660602|NCT03518086|82873188|FG001|Overall Study|Insufficient Diary Data|2|||
46660603|NCT03518086|82873189|FG002|Overall Study|Insufficient Diary Data|0|||
46660604|NCT03518086|82873190|FG003|Overall Study|Insufficient Diary Data|0|||
46660605|NCT03518086|82873187|FG000|Overall Study|Non- compliance to Protocol|0|||
46660606|NCT03518086|82873188|FG001|Overall Study|Non- compliance to Protocol|1|||
46660607|NCT03518086|82873189|FG002|Overall Study|Non- compliance to Protocol|0|||
46660608|NCT03518086|82873190|FG003|Overall Study|Non- compliance to Protocol|0|||
46660609|NCT03518086|82873187|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
46660610|NCT03518086|82873188|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
46660611|NCT03518086|82873189|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
46660612|NCT03518086|82873190|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
46660613|NCT03518086|82873187|FG000|Overall Study|Site Terminated by Sponsor|0|||
46660614|NCT03518086|82873188|FG001|Overall Study|Site Terminated by Sponsor|1|||
46660615|NCT03518086|82873189|FG002|Overall Study|Site Terminated by Sponsor|0|||
46660616|NCT03518086|82873190|FG003|Overall Study|Site Terminated by Sponsor|0|||
46660617|NCT03472924|82873199|FG000|Overall Study|Adverse Event|1|||
46660618|NCT03472924|82873200|FG001|Overall Study|Adverse Event|0|||
46660619|NCT03284710|82873210|FG000|Overall Study|Withdrawal by Subject|1|||
46660620|NCT03284710|82873211|FG001|Overall Study|Withdrawal by Subject|0|||
46660621|NCT03284710|82873212|FG002|Overall Study|Withdrawal by Subject|1|||
46660622|NCT03284710|82873213|FG003|Overall Study|Withdrawal by Subject|6|||
46660623|NCT03284710|82873210|FG000|Overall Study|Lost to Follow-up|3|||
46660624|NCT03284710|82873211|FG001|Overall Study|Lost to Follow-up|3|||
46660625|NCT03284710|82873212|FG002|Overall Study|Lost to Follow-up|1|||
46660626|NCT03284710|82873213|FG003|Overall Study|Lost to Follow-up|0|||
46660627|NCT03284710|82873210|FG000|Overall Study|Physician Decision|1|||
46660628|NCT03284710|82873211|FG001|Overall Study|Physician Decision|0|||
46660629|NCT03284710|82873212|FG002|Overall Study|Physician Decision|0|||
46660630|NCT03284710|82873213|FG003|Overall Study|Physician Decision|0|||
46660631|NCT03284710|82873210|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
46660632|NCT03284710|82873211|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
46660633|NCT03284710|82873212|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
46660634|NCT03284710|82873213|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
46660635|NCT03284710|82873210|FG000|Overall Study|HIV Infection|0|||
46660636|NCT03284710|82873211|FG001|Overall Study|HIV Infection|2|||
46660637|NCT03284710|82873212|FG002|Overall Study|HIV Infection|2|||
46660638|NCT03284710|82873213|FG003|Overall Study|HIV Infection|1|||
46660639|NCT03237286|82873233|FG000|Overall Study|Withdrawal by Subject|1|||
46660640|NCT03237286|82873234|FG001|Overall Study|Withdrawal by Subject|0|||
46660641|NCT03237286|82873235|FG002|Overall Study|Withdrawal by Subject|2|||
46660642|NCT03237286|82873233|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
46660643|NCT03237286|82873234|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
46660644|NCT03237286|82873235|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
46660645|NCT03232931|82873244|FG000|Overall Study|Physician Decision|1|||
46660646|NCT03232931|82873245|FG001|Overall Study|Physician Decision|1|||
46660647|NCT03232931|82873244|FG000|Overall Study|Withdrawal by Subject|6|||
46660648|NCT03232931|82873245|FG001|Overall Study|Withdrawal by Subject|0|||
46660649|NCT03232931|82873244|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
46660650|NCT03232931|82873245|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
46660651|NCT03232931|82873244|FG000|Overall Study|Parent did not record voice|1|||
46660652|NCT03232931|82873245|FG001|Overall Study|Parent did not record voice|2|||
46660653|NCT03232931|82873244|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
46851039|NCT03615040|83066791|FG000|Overall Study|Physician Decision|2|||
46660654|NCT03232931|82873245|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
46660655|NCT03155997|82873253|FG000|Overall Study|Withdrawal by Subject|119|||
46660656|NCT03155997|82873254|FG001|Overall Study|Withdrawal by Subject|134|||
46660657|NCT03155997|82873253|FG000|Overall Study|Lost to Follow-up|12|||
46660658|NCT03155997|82873254|FG001|Overall Study|Lost to Follow-up|13|||
46660659|NCT03155997|82873253|FG000|Overall Study|Missing disposition data|0|||
46660660|NCT03155997|82873254|FG001|Overall Study|Missing disposition data|1|||
46660661|NCT03155997|82873253|FG000|Overall Study|On study treatment|2027|||
46660662|NCT03155997|82873254|FG001|Overall Study|On study treatment|2074|||
46660663|NCT03103750|82873260|FG000|Overall Study|Adverse Event|1|||
46660664|NCT03103750|82873261|FG001|Overall Study|Adverse Event|0|||
46660665|NCT03103750|82873260|FG000|Overall Study|Lost to Follow-up|1|||
46660666|NCT03103750|82873261|FG001|Overall Study|Lost to Follow-up|0|||
46660667|NCT03103750|82873260|FG000|Overall Study|PET Equipment Related|2|||
46660668|NCT03103750|82873261|FG001|Overall Study|PET Equipment Related|2|||
46660669|NCT02974088|82873269|FG000|Overall Study|Lost to Follow-up|0|||
46660670|NCT02974088|82873270|FG001|Overall Study|Lost to Follow-up|2|||
46660671|NCT02974088|82873269|FG000|Overall Study|Adverse Event|0|||
46660672|NCT02974088|82873270|FG001|Overall Study|Adverse Event|1|||
46660673|NCT02677896|82873295|FG000|Double Blind Period (up to 35 Months)|Death|113|||
46660674|NCT02677896|82873296|FG001|Double Blind Period (up to 35 Months)|Death|189|||
46660675|NCT02677896|82873295|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
46660676|NCT02677896|82873296|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
46660677|NCT02677896|82873295|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
46660678|NCT02677896|82873296|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
46660679|NCT02677896|82873295|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
46660680|NCT02677896|82873296|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
46660681|NCT02677896|82873295|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
46660682|NCT02677896|82873296|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
46660683|NCT02677896|82873295|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
46660684|NCT02677896|82873296|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
46660685|NCT02677896|82873295|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
46660686|NCT02677896|82873296|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
46660687|NCT02677896|82873295|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
46660688|NCT02677896|82873296|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
46660689|NCT02677896|82873295|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
46660690|NCT02677896|82873296|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
46660691|NCT02677896|82873295|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
46660692|NCT02677896|82873296|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
46660693|NCT02677896|82873295|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
46660694|NCT02677896|82873296|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
46660695|NCT02677896|82873295|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
46660696|NCT02677896|82873296|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
46660697|NCT02677896|82873295|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
46660698|NCT02677896|82873296|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
46660699|NCT02677896|82873295|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
46660700|NCT02677896|82873296|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
46660701|NCT02675231|82873306|FG000|Overall Study|Withdrawal by Subject|1|||
46660702|NCT02675231|82873307|FG001|Overall Study|Withdrawal by Subject|3|||
46660703|NCT02675231|82873308|FG002|Overall Study|Withdrawal by Subject|1|||
46660704|NCT02675231|82873306|FG000|Overall Study|Lost to Follow-up|2|||
46660705|NCT02675231|82873307|FG001|Overall Study|Lost to Follow-up|2|||
46660706|NCT02675231|82873308|FG002|Overall Study|Lost to Follow-up|2|||
46660707|NCT02675231|82873306|FG000|Overall Study|On study treatment/follow up|23|||
46660708|NCT02675231|82873307|FG001|Overall Study|On study treatment/follow up|31|||
46660709|NCT02675231|82873308|FG002|Overall Study|On study treatment/follow up|23|||
46660710|NCT02632721|82873331|FG000|Overall Study|Adverse Event|0|||
46660711|NCT02632721|82873332|FG001|Overall Study|Adverse Event|0|||
46660712|NCT02632721|82873333|FG002|Overall Study|Adverse Event|2|||
46660713|NCT02632721|82873334|FG003|Overall Study|Adverse Event|5|||
46660714|NCT02632721|82873335|FG004|Overall Study|Adverse Event|3|||
46660715|NCT02632721|82873331|FG000|Overall Study|Dose limiting toxicity|0|||
46660716|NCT02632721|82873332|FG001|Overall Study|Dose limiting toxicity|0|||
46660717|NCT02632721|82873333|FG002|Overall Study|Dose limiting toxicity|0|||
46660718|NCT02632721|82873334|FG003|Overall Study|Dose limiting toxicity|1|||
46660719|NCT02632721|82873335|FG004|Overall Study|Dose limiting toxicity|0|||
46660720|NCT02632721|82873331|FG000|Overall Study|Progressive disease|3|||
46660721|NCT02632721|82873332|FG001|Overall Study|Progressive disease|0|||
46660722|NCT02632721|82873333|FG002|Overall Study|Progressive disease|4|||
46660723|NCT02632721|82873334|FG003|Overall Study|Progressive disease|6|||
46660724|NCT02632721|82873335|FG004|Overall Study|Progressive disease|5|||
46660725|NCT02632721|82873331|FG000|Overall Study|Refused to continue taking trial medication|0|||
46660726|NCT02632721|82873332|FG001|Overall Study|Refused to continue taking trial medication|1|||
46660727|NCT02632721|82873333|FG002|Overall Study|Refused to continue taking trial medication|1|||
46660728|NCT02632721|82873334|FG003|Overall Study|Refused to continue taking trial medication|1|||
46660729|NCT02632721|82873335|FG004|Overall Study|Refused to continue taking trial medication|2|||
46660730|NCT02632721|82873331|FG000|Overall Study|Inadequate clinical condition|0|||
46660731|NCT02632721|82873332|FG001|Overall Study|Inadequate clinical condition|0|||
46660732|NCT02632721|82873333|FG002|Overall Study|Inadequate clinical condition|0|||
46660733|NCT02632721|82873334|FG003|Overall Study|Inadequate clinical condition|0|||
46660734|NCT02632721|82873335|FG004|Overall Study|Inadequate clinical condition|1|||
46660735|NCT02632721|82873331|FG000|Overall Study|No meet eligibility|0|||
46660736|NCT02632721|82873332|FG001|Overall Study|No meet eligibility|0|||
46660737|NCT02632721|82873333|FG002|Overall Study|No meet eligibility|0|||
46660738|NCT02632721|82873334|FG003|Overall Study|No meet eligibility|0|||
46660739|NCT02632721|82873335|FG004|Overall Study|No meet eligibility|1|||
46660740|NCT02632721|82873331|FG000|Overall Study|Allergic reaction|0|||
46660741|NCT02632721|82873332|FG001|Overall Study|Allergic reaction|0|||
46660742|NCT02632721|82873333|FG002|Overall Study|Allergic reaction|0|||
46660743|NCT02632721|82873334|FG003|Overall Study|Allergic reaction|1|||
46660744|NCT02632721|82873335|FG004|Overall Study|Allergic reaction|0|||
46660745|NCT02632721|82873331|FG000|Overall Study|Receiving Decitabine locally|0|||
46660746|NCT02632721|82873332|FG001|Overall Study|Receiving Decitabine locally|0|||
46660747|NCT02632721|82873333|FG002|Overall Study|Receiving Decitabine locally|1|||
46660748|NCT02632721|82873334|FG003|Overall Study|Receiving Decitabine locally|0|||
46660749|NCT02632721|82873335|FG004|Overall Study|Receiving Decitabine locally|0|||
46660750|NCT02632721|82873331|FG000|Overall Study|No benefit from study treatment|1|||
46660751|NCT02632721|82873332|FG001|Overall Study|No benefit from study treatment|1|||
46660752|NCT02632721|82873333|FG002|Overall Study|No benefit from study treatment|0|||
46660753|NCT02632721|82873334|FG003|Overall Study|No benefit from study treatment|0|||
46660754|NCT02632721|82873335|FG004|Overall Study|No benefit from study treatment|1|||
46660755|NCT02632721|82873331|FG000|Overall Study|Patient wish for other treatment|0|||
46660756|NCT02632721|82873332|FG001|Overall Study|Patient wish for other treatment|1|||
46660757|NCT02632721|82873333|FG002|Overall Study|Patient wish for other treatment|0|||
46660758|NCT02632721|82873334|FG003|Overall Study|Patient wish for other treatment|0|||
46660759|NCT02632721|82873335|FG004|Overall Study|Patient wish for other treatment|0|||
46660760|NCT02632721|82873331|FG000|Overall Study|Relapsed Pneumonia|0|||
46660761|NCT02632721|82873332|FG001|Overall Study|Relapsed Pneumonia|0|||
46660762|NCT02632721|82873333|FG002|Overall Study|Relapsed Pneumonia|0|||
46660763|NCT02632721|82873334|FG003|Overall Study|Relapsed Pneumonia|0|||
46660764|NCT02632721|82873335|FG004|Overall Study|Relapsed Pneumonia|1|||
46660765|NCT02632721|82873331|FG000|Overall Study|Therapy refractory AML|0|||
46660766|NCT02632721|82873332|FG001|Overall Study|Therapy refractory AML|0|||
46660767|NCT02632721|82873333|FG002|Overall Study|Therapy refractory AML|0|||
46660768|NCT02632721|82873334|FG003|Overall Study|Therapy refractory AML|0|||
46660769|NCT02632721|82873335|FG004|Overall Study|Therapy refractory AML|1|||
46660770|NCT02632721|82873331|FG000|Overall Study|Increase of white blood cell count|0|||
46660771|NCT02632721|82873332|FG001|Overall Study|Increase of white blood cell count|0|||
46660772|NCT02632721|82873333|FG002|Overall Study|Increase of white blood cell count|0|||
46660773|NCT02632721|82873334|FG003|Overall Study|Increase of white blood cell count|0|||
46660774|NCT02632721|82873335|FG004|Overall Study|Increase of white blood cell count|1|||
46660775|NCT02632721|82873331|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
46660776|NCT02632721|82873332|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
46660777|NCT02632721|82873333|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
46660778|NCT02632721|82873334|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
46660779|NCT02632721|82873335|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
46660780|NCT02576509|82873350|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
46660781|NCT02576509|82873351|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
46660782|NCT02576509|82873350|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
46660783|NCT02576509|82873351|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
46660784|NCT02576509|82873350|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
46660785|NCT02576509|82873351|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
46660786|NCT02576509|82873350|FG000|Treatment Period|Disease progression|245|||
46660787|NCT02576509|82873351|FG001|Treatment Period|Disease progression|240|||
46660788|NCT02576509|82873350|FG000|Treatment Period|Study drug toxicity|32|||
46660789|NCT02576509|82873351|FG001|Treatment Period|Study drug toxicity|41|||
46660790|NCT02576509|82873350|FG000|Treatment Period|Death|1|||
46660791|NCT02576509|82873351|FG001|Treatment Period|Death|1|||
46660792|NCT02576509|82873350|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
46660793|NCT02576509|82873351|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
46660794|NCT02576509|82873350|FG000|Treatment Period|Participant request to stop treatment|8|||
46660795|NCT02576509|82873351|FG001|Treatment Period|Participant request to stop treatment|17|||
46660796|NCT02576509|82873350|FG000|Treatment Period|Participant withdrew consent|2|||
46660797|NCT02576509|82873351|FG001|Treatment Period|Participant withdrew consent|7|||
46660798|NCT02576509|82873350|FG000|Treatment Period|Lost to Follow-up|0|||
46660799|NCT02576509|82873351|FG001|Treatment Period|Lost to Follow-up|1|||
46660800|NCT02576509|82873350|FG000|Treatment Period|Maximum clinical benefit|1|||
46660801|NCT02576509|82873351|FG001|Treatment Period|Maximum clinical benefit|0|||
46660802|NCT02576509|82873350|FG000|Treatment Period|Poor/non-compliance|0|||
46660803|NCT02576509|82873351|FG001|Treatment Period|Poor/non-compliance|1|||
46660804|NCT02576509|82873350|FG000|Treatment Period|Participant no longer meets criteria|1|||
46660805|NCT02576509|82873351|FG001|Treatment Period|Participant no longer meets criteria|0|||
46660806|NCT02576509|82873350|FG000|Treatment Period|Other reason|2|||
46660807|NCT02576509|82873351|FG001|Treatment Period|Other reason|7|||
46660808|NCT02576509|82873350|FG000|Follow-up Period|Death|41|||
46660809|NCT02576509|82873351|FG001|Follow-up Period|Death|35|||
46660810|NCT02576509|82873350|FG000|Follow-up Period|Participant withdrew consent|7|||
46660811|NCT02576509|82873351|FG001|Follow-up Period|Participant withdrew consent|14|||
46660812|NCT02576509|82873350|FG000|Follow-up Period|Lost to Follow-up|0|||
46660813|NCT02576509|82873351|FG001|Follow-up Period|Lost to Follow-up|1|||
46660814|NCT02576509|82873350|FG000|Follow-up Period|Other reason|1|||
46660815|NCT02576509|82873351|FG001|Follow-up Period|Other reason|2|||
46660816|NCT02157883|82873357|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
46660817|NCT02157883|82873357|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
46660818|NCT02157883|82873357|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
46660819|NCT02157883|82873357|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
46660820|NCT02157883|82873357|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
46660821|NCT02148003|82873366|FG000|Overall Study|Failed inclusion criteria|1|||
46660822|NCT02148003|82873367|FG001|Overall Study|Failed inclusion criteria|0|||
46660823|NCT02148003|82873366|FG000|Overall Study|Met exclusion criteria|0|||
46660824|NCT02148003|82873367|FG001|Overall Study|Met exclusion criteria|1|||
46660825|NCT02148003|82873366|FG000|Overall Study|Withdrawal by Subject|0|||
46660826|NCT02148003|82873367|FG001|Overall Study|Withdrawal by Subject|1|||
46660827|NCT02080520|82873375|FG000|Overall Study|Self-reported symptoms|5|||
46660828|NCT02080520|82873376|FG001|Overall Study|Self-reported symptoms|6|||
46660829|NCT02080520|82873375|FG000|Overall Study|Unable to contact|2|||
46660830|NCT02080520|82873376|FG001|Overall Study|Unable to contact|1|||
46660831|NCT02080520|82873375|FG000|Overall Study|Initiated aspirin|2|||
46660832|NCT02080520|82873376|FG001|Overall Study|Initiated aspirin|0|||
46660833|NCT02080520|82873375|FG000|Overall Study|Atrial fibrillation|1|||
46660834|NCT02080520|82873376|FG001|Overall Study|Atrial fibrillation|1|||
46660835|NCT02080520|82873375|FG000|Overall Study|Cancer|1|||
46660836|NCT02080520|82873376|FG001|Overall Study|Cancer|2|||
46660837|NCT02080520|82873375|FG000|Overall Study|Not interested in study|1|||
46660838|NCT02080520|82873376|FG001|Overall Study|Not interested in study|3|||
46660839|NCT02080520|82873375|FG000|Overall Study|Too busy|1|||
46660840|NCT02080520|82873376|FG001|Overall Study|Too busy|1|||
46660841|NCT02080520|82873375|FG000|Overall Study|Work-related injury|1|||
46660842|NCT02080520|82873376|FG001|Overall Study|Work-related injury|0|||
46660843|NCT02080520|82873375|FG000|Overall Study|Personal reasons|0|||
46660844|NCT02080520|82873376|FG001|Overall Study|Personal reasons|3|||
46660845|NCT00667563|82873397|FG000|Overall Study|Protocol Violation|24|||
46660846|NCT05186311|82873410|FG000|Part A: Serum|Withdrawal by Subject|1|||
46660847|NCT04854434|82873418|FG000|Overall Study|Death|1|||
46660848|NCT04854434|82873419|FG001|Overall Study|Death|3|||
46660849|NCT04854434|82873420|FG002|Overall Study|Death|4|||
46660850|NCT04854434|82873418|FG000|Overall Study|Study Terminated by Sponsor|2|||
46660851|NCT04854434|82873419|FG001|Overall Study|Study Terminated by Sponsor|0|||
46660852|NCT04854434|82873420|FG002|Overall Study|Study Terminated by Sponsor|0|||
46660853|NCT04854434|82873418|FG000|Overall Study|Other|1|||
46660854|NCT04854434|82873419|FG001|Overall Study|Other|1|||
46660855|NCT04854434|82873420|FG002|Overall Study|Other|0|||
46660856|NCT03797014|82873455|FG000|Overall Study|Withdrawal by Subject|1|||
46660857|NCT03797014|82873455|FG000|Overall Study|Lost to Follow-up|1|||
46660858|NCT03797014|82873455|FG000|Overall Study|Protocol Violation|1|||
46660859|NCT03596450|82873461|FG000|Overall Study|Death|4|||
46660860|NCT03596450|82873462|FG001|Overall Study|Death|4|||
46660861|NCT03596450|82873461|FG000|Overall Study|Protocol Violation|7|||
46660862|NCT03596450|82873462|FG001|Overall Study|Protocol Violation|12|||
46660863|NCT03596450|82873461|FG000|Overall Study|Lost to Follow-up|7|||
46660864|NCT03596450|82873462|FG001|Overall Study|Lost to Follow-up|6|||
46660865|NCT03596450|82873461|FG000|Overall Study|Adverse Event|9|||
46660866|NCT03596450|82873462|FG001|Overall Study|Adverse Event|6|||
46660867|NCT03596450|82873461|FG000|Overall Study|Withdrawal by Subject|16|||
46660868|NCT03596450|82873462|FG001|Overall Study|Withdrawal by Subject|9|||
46660869|NCT03596450|82873461|FG000|Overall Study|Accidentally Randomized|2|||
46660870|NCT03596450|82873462|FG001|Overall Study|Accidentally Randomized|0|||
46660871|NCT03596450|82873461|FG000|Overall Study|Other reasons|21|||
46660872|NCT03596450|82873462|FG001|Overall Study|Other reasons|22|||
46660873|NCT03596450|82873461|FG000|Overall Study|Missed the Year 1 study visit|56|||
46660874|NCT03596450|82873462|FG001|Overall Study|Missed the Year 1 study visit|50|||
46660875|NCT03300817|82873477|FG000|Overall Study|Withdrawal by Subject|1|||
46660876|NCT03300817|82873477|FG000|Overall Study|Adverse Event|1|||
46660877|NCT03300817|82873477|FG000|Overall Study|Subject Found to be Ineligible|2|||
46660878|NCT02948842|82873507|FG000|Overall Study|Withdrawal by Subject|4|||
46660879|NCT02782468|82873515|FG000|Overall Study|Progressive Disease|2|||
46660880|NCT02782468|82873516|FG001|Overall Study|Progressive Disease|5|||
46660881|NCT02782468|82873517|FG002|Overall Study|Progressive Disease|0|||
46971946|NCT02670551|83215508|FG000|Overall Study|Withdrawal of Consent|6|||
46971947|NCT02670551|83215509|FG001|Overall Study|Withdrawal of Consent|3|||
46971948|NCT02670551|83215510|FG002|Overall Study|Withdrawal of Consent|8|||
46971949|NCT02670551|83215508|FG000|Overall Study|Lost to Follow-up|5|||
46971950|NCT02670551|83215509|FG001|Overall Study|Lost to Follow-up|7|||
46971951|NCT02670551|83215510|FG002|Overall Study|Lost to Follow-up|6|||
46971952|NCT02670551|83215508|FG000|Overall Study|Protocol Violation|1|||
46971953|NCT02670551|83215509|FG001|Overall Study|Protocol Violation|0|||
46971954|NCT02670551|83215510|FG002|Overall Study|Protocol Violation|0|||
46971955|NCT02670551|83215508|FG000|Overall Study|Noncompliance with study drug|3|||
46971956|NCT02670551|83215509|FG001|Overall Study|Noncompliance with study drug|3|||
46971957|NCT02670551|83215510|FG002|Overall Study|Noncompliance with study drug|2|||
46971958|NCT02670551|83215508|FG000|Overall Study|Other Miscellaneous Reasons|2|||
46971959|NCT02670551|83215509|FG001|Overall Study|Other Miscellaneous Reasons|3|||
46660882|NCT02782468|82873518|FG003|Overall Study|Progressive Disease|4|||
46660883|NCT02782468|82873515|FG000|Overall Study|Adverse Event|0|||
46660884|NCT02782468|82873516|FG001|Overall Study|Adverse Event|2|||
46660885|NCT02782468|82873517|FG002|Overall Study|Adverse Event|2|||
46660886|NCT02782468|82873518|FG003|Overall Study|Adverse Event|3|||
46660887|NCT02782468|82873515|FG000|Overall Study|Other|0|||
46660888|NCT02782468|82873516|FG001|Overall Study|Other|0|||
46660889|NCT02782468|82873517|FG002|Overall Study|Other|1|||
46660890|NCT02782468|82873518|FG003|Overall Study|Other|1|||
46660891|NCT02782468|82873515|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
46660892|NCT02782468|82873516|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
46660893|NCT02782468|82873517|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
46660894|NCT02782468|82873518|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
46660895|NCT02782468|82873515|FG000|Overall Study|Symptomatic Deterioration|0|||
46660896|NCT02782468|82873516|FG001|Overall Study|Symptomatic Deterioration|0|||
46660897|NCT02782468|82873517|FG002|Overall Study|Symptomatic Deterioration|0|||
46660898|NCT02782468|82873518|FG003|Overall Study|Symptomatic Deterioration|1|||
46660899|NCT02782468|82873515|FG000|Overall Study|Withdrawal by Subject|1|||
46660900|NCT02782468|82873516|FG001|Overall Study|Withdrawal by Subject|0|||
46660901|NCT02782468|82873517|FG002|Overall Study|Withdrawal by Subject|0|||
46660902|NCT02782468|82873518|FG003|Overall Study|Withdrawal by Subject|0|||
46660903|NCT02563769|82873540|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
46660904|NCT02563769|82873541|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
46660905|NCT02563769|82873542|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
46660906|NCT02420717|82873578|FG000|Overall Study|Did not receive all study medication|2|||
46971960|NCT02670551|83215510|FG002|Overall Study|Other Miscellaneous Reasons|3|||
46971961|NCT02670551|83215508|FG000|Overall Study|Did Not Receive Treatment|5|||
46971962|NCT02670551|83215509|FG001|Overall Study|Did Not Receive Treatment|3|||
46971963|NCT02670551|83215510|FG002|Overall Study|Did Not Receive Treatment|0|||
46971964|NCT02670473|83215518|FG000|Overall Study|Withdrawal by Subject|1|||
46971965|NCT02667119|83215533|FG000|Overall Study|Lost to Follow-up|3|||
46660907|NCT02420717|82873579|FG001|Overall Study|Did not receive all study medication|0|||
46660908|NCT02420717|82873580|FG002|Overall Study|Did not receive all study medication|0|||
46660909|NCT01970306|82873606|FG000|Overall Study|Not eligible|3|||
46660910|NCT01970306|82873606|FG000|Overall Study|Not able to be treated|9|||
46660911|NCT01574274|82873612|FG000|Overall Study|Ineligible|0|||
46660912|NCT01574274|82873613|FG001|Overall Study|Ineligible|1|||
46660913|NCT01574274|82873612|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
46660914|NCT01574274|82873613|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
46660915|NCT01574274|82873612|FG000|Overall Study|Ph+ B-ALL|3|||
46660916|NCT01574274|82873613|FG001|Overall Study|Ph+ B-ALL|4|||
46660917|NCT01574274|82873612|FG000|Overall Study|Induction Death|2|||
46660918|NCT01574274|82873613|FG001|Overall Study|Induction Death|0|||
46660919|NCT01574274|82873612|FG000|Overall Study|Induction Failure|4|||
46660920|NCT01574274|82873613|FG001|Overall Study|Induction Failure|1|||
46660921|NCT01574274|82873612|FG000|Overall Study|Adverse Event|16|||
46660922|NCT01574274|82873613|FG001|Overall Study|Adverse Event|13|||
46660923|NCT01574274|82873612|FG000|Overall Study|Remission Death|1|||
46660924|NCT01574274|82873613|FG001|Overall Study|Remission Death|0|||
46971966|NCT02667119|83215534|FG001|Overall Study|Lost to Follow-up|0|||
46971967|NCT02670083|83215542|FG000|Overall Study|Adverse Event|16|||
46971968|NCT02670083|83215543|FG001|Overall Study|Adverse Event|13|||
46660925|NCT01574274|82873612|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
46660926|NCT01574274|82873613|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
46660927|NCT01574274|82873612|FG000|Overall Study|Other, unknown|3|||
46660928|NCT01574274|82873613|FG001|Overall Study|Other, unknown|2|||
46660929|NCT01268514|82873623|FG000|Overall Study|Adverse Event|20|||
46660930|NCT01268514|82873623|FG000|Overall Study|Death|8|||
46660931|NCT01268514|82873623|FG000|Overall Study|Lost to Follow-up|5|||
46660932|NCT01268514|82873623|FG000|Overall Study|Withdrawal by Subject|3|||
46660933|NCT01268514|82873623|FG000|Overall Study|Withdrawal by Surgeon|5|||
46660934|NCT00625586|82873629|FG000|Overall Study|Adverse Event|1|||
46660935|NCT00625586|82873629|FG000|Overall Study|Progressive disease|1|||
46660936|NCT00400946|82873638|FG000|Overall Study|Ineligible|0|||
46660937|NCT00400946|82873639|FG001|Overall Study|Ineligible|0|||
46660938|NCT00400946|82873640|FG002|Overall Study|Ineligible|0|||
46660939|NCT00400946|82873641|FG003|Overall Study|Ineligible|5|||
46660940|NCT00400946|82873642|FG004|Overall Study|Ineligible|1|||
46660941|NCT00400946|82873638|FG000|Overall Study|Induction Failure|0|||
46660942|NCT00400946|82873639|FG001|Overall Study|Induction Failure|0|||
46660943|NCT00400946|82873640|FG002|Overall Study|Induction Failure|0|||
46660944|NCT00400946|82873641|FG003|Overall Study|Induction Failure|11|||
46660945|NCT00400946|82873642|FG004|Overall Study|Induction Failure|8|||
46660946|NCT00400946|82873638|FG000|Overall Study|Induction Death|0|||
46660947|NCT00400946|82873639|FG001|Overall Study|Induction Death|0|||
46660948|NCT00400946|82873640|FG002|Overall Study|Induction Death|0|||
46971969|NCT02670083|83215542|FG000|Overall Study|Death|4|||
46971970|NCT02670083|83215543|FG001|Overall Study|Death|6|||
46660949|NCT00400946|82873641|FG003|Overall Study|Induction Death|13|||
46660950|NCT00400946|82873642|FG004|Overall Study|Induction Death|3|||
46660951|NCT00400946|82873638|FG000|Overall Study|Lost to Follow-up|1|||
46660952|NCT00400946|82873639|FG001|Overall Study|Lost to Follow-up|1|||
46660953|NCT00400946|82873640|FG002|Overall Study|Lost to Follow-up|0|||
46660954|NCT00400946|82873641|FG003|Overall Study|Lost to Follow-up|0|||
46660955|NCT00400946|82873642|FG004|Overall Study|Lost to Follow-up|1|||
46660956|NCT00400946|82873638|FG000|Overall Study|Remission Death|1|||
46660957|NCT00400946|82873639|FG001|Overall Study|Remission Death|1|||
46660958|NCT00400946|82873640|FG002|Overall Study|Remission Death|0|||
46660959|NCT00400946|82873641|FG003|Overall Study|Remission Death|0|||
46660960|NCT00400946|82873642|FG004|Overall Study|Remission Death|1|||
46660961|NCT00400946|82873638|FG000|Overall Study|Relapse|9|||
46660962|NCT00400946|82873639|FG001|Overall Study|Relapse|2|||
46660963|NCT00400946|82873640|FG002|Overall Study|Relapse|1|||
46660964|NCT00400946|82873641|FG003|Overall Study|Relapse|1|||
46660965|NCT00400946|82873642|FG004|Overall Study|Relapse|5|||
46660966|NCT00400946|82873638|FG000|Overall Study|Transplant in CR1|0|||
46660967|NCT00400946|82873639|FG001|Overall Study|Transplant in CR1|0|||
46782909|NCT00695396|83001594|FG001|Overall Study|Withdrawal by Subject|2|||
46782910|NCT00695396|83001595|FG002|Overall Study|Withdrawal by Subject|0|||
46782911|NCT02656706|83001603|FG000|Overall Study|Insurance Denial|1|||
46782912|NCT00575328|83001609|FG000|Overall Study|Adverse Event|1|||
46782913|NCT00575328|83001610|FG001|Overall Study|Adverse Event|1|||
46782914|NCT00575328|83001609|FG000|Overall Study|Lost to Follow-up|2|||
46782915|NCT00575328|83001610|FG001|Overall Study|Lost to Follow-up|1|||
46782916|NCT00575094|83001616|FG000|Overall Study|Adverse Event|2|||
46782917|NCT00575094|83001616|FG000|Overall Study|Withdrawal by Subject|1|||
46782918|NCT00553696|83001624|FG000|Overall Study|Adverse Event|2|||
46782919|NCT00553696|83001625|FG001|Overall Study|Adverse Event|4|||
46782920|NCT00553696|83001626|FG002|Overall Study|Adverse Event|0|||
46782921|NCT00553696|83001627|FG003|Overall Study|Adverse Event|1|||
46782922|NCT00553696|83001624|FG000|Overall Study|Global deterioration of health status|0|||
46782923|NCT00553696|83001625|FG001|Overall Study|Global deterioration of health status|2|||
46782924|NCT00553696|83001626|FG002|Overall Study|Global deterioration of health status|0|||
46782925|NCT00553696|83001627|FG003|Overall Study|Global deterioration of health status|0|||
46782926|NCT00553696|83001624|FG000|Overall Study|Objective progression or relapse|2|||
46660968|NCT00400946|82873640|FG002|Overall Study|Transplant in CR1|0|||
46660969|NCT00400946|82873641|FG003|Overall Study|Transplant in CR1|10|||
46660970|NCT00400946|82873642|FG004|Overall Study|Transplant in CR1|1|||
46660971|NCT00400946|82873638|FG000|Overall Study|Withdrawal by Subject|2|||
46851040|NCT03615040|83066792|FG001|Overall Study|Physician Decision|2|||
46971971|NCT02670083|83215542|FG000|Overall Study|Lost to Follow-up|2|||
46660972|NCT00400946|82873639|FG001|Overall Study|Withdrawal by Subject|5|||
46660973|NCT00400946|82873640|FG002|Overall Study|Withdrawal by Subject|1|||
46660974|NCT00400946|82873641|FG003|Overall Study|Withdrawal by Subject|5|||
46660975|NCT00400946|82873642|FG004|Overall Study|Withdrawal by Subject|8|||
46660976|NCT00400946|82873638|FG000|Overall Study|Clinical|1|||
46660977|NCT00400946|82873639|FG001|Overall Study|Clinical|2|||
46660978|NCT00400946|82873640|FG002|Overall Study|Clinical|0|||
46660979|NCT00400946|82873641|FG003|Overall Study|Clinical|2|||
46660980|NCT00400946|82873642|FG004|Overall Study|Clinical|9|||
46782927|NCT00553696|83001625|FG001|Overall Study|Objective progression or relapse|9|||
46782928|NCT00553696|83001626|FG002|Overall Study|Objective progression or relapse|6|||
46782929|NCT00553696|83001627|FG003|Overall Study|Objective progression or relapse|0|||
46782930|NCT00553696|83001624|FG000|Overall Study|Withdrawal by Subject|0|||
46782931|NCT00553696|83001625|FG001|Overall Study|Withdrawal by Subject|1|||
46782932|NCT00553696|83001626|FG002|Overall Study|Withdrawal by Subject|0|||
46782933|NCT00553696|83001627|FG003|Overall Study|Withdrawal by Subject|0|||
46660981|NCT00400946|82873638|FG000|Overall Study|Other|0|||
46660982|NCT00400946|82873639|FG001|Overall Study|Other|0|||
46660983|NCT00400946|82873640|FG002|Overall Study|Other|0|||
46660984|NCT00400946|82873641|FG003|Overall Study|Other|0|||
46660985|NCT00400946|82873642|FG004|Overall Study|Other|1|||
46660986|NCT00475033|82873662|FG000|Infant Series|Failed to return|3|||
46660987|NCT00475033|82873663|FG001|Infant Series|Failed to return|4|||
46660988|NCT00475033|82873662|FG000|Infant Series|Parent or legal guardian request|1|||
46660989|NCT00475033|82873663|FG001|Infant Series|Parent or legal guardian request|5|||
46660990|NCT00475033|82873662|FG000|Infant Series|Protocol Violation|1|||
46660991|NCT00475033|82873663|FG001|Infant Series|Protocol Violation|2|||
46660992|NCT00475033|82873662|FG000|Infant Series|Lost to Follow-up|2|||
46660993|NCT00475033|82873663|FG001|Infant Series|Lost to Follow-up|0|||
46660994|NCT00475033|82873662|FG000|Infant Series|Adverse Event|0|||
46660995|NCT00475033|82873663|FG001|Infant Series|Adverse Event|2|||
46660996|NCT00475033|82873662|FG000|After the Infant Series|Adverse Event|0|||
46660997|NCT00475033|82873663|FG001|After the Infant Series|Adverse Event|4|||
46660998|NCT00475033|82873662|FG000|After the Infant Series|Parent or legal guardian request|2|||
46660999|NCT00475033|82873663|FG001|After the Infant Series|Parent or legal guardian request|2|||
46661000|NCT00475033|82873662|FG000|After the Infant Series|Failed to return|2|||
46661001|NCT00475033|82873663|FG001|After the Infant Series|Failed to return|1|||
46661002|NCT00475033|82873662|FG000|After the Infant Series|Protocol Violation|1|||
46661003|NCT00475033|82873663|FG001|After the Infant Series|Protocol Violation|0|||
46661004|NCT00475033|82873662|FG000|After the Infant Series|Lost to Follow-up|1|||
46661005|NCT00475033|82873663|FG001|After the Infant Series|Lost to Follow-up|0|||
46661006|NCT00475033|82873662|FG000|After the Infant Series|Other|0|||
46661007|NCT00475033|82873663|FG001|After the Infant Series|Other|1|||
46661008|NCT00475033|82873662|FG000|Toddler Dose|Parent or legal guardian request|2|||
46661009|NCT00475033|82873663|FG001|Toddler Dose|Parent or legal guardian request|0|||
46661010|NCT00475033|82873662|FG000|Toddler Dose|Failed to return|1|||
46661011|NCT00475033|82873663|FG001|Toddler Dose|Failed to return|0|||
46661012|NCT00475033|82873662|FG000|Toddler Dose|Lost to Follow-up|1|||
46661013|NCT00475033|82873663|FG001|Toddler Dose|Lost to Follow-up|0|||
46661014|NCT00474994|82873676|FG000|Overall Study|Patient Not treated|1|||
46661015|NCT00474994|82873676|FG000|Overall Study|Patient evaluable for toxicity only|3|||
46661016|NCT00474994|82873676|FG000|Overall Study|Patient found to be ineligible|1|||
46661017|NCT00474955|82873680|FG000|Overall Study|Adverse Event|2|||
46661018|NCT00474955|82873680|FG000|Overall Study|Drug unavailability|1|||
46661019|NCT00474955|82873680|FG000|Overall Study|Personal reasons|5|||
46661020|NCT00474487|82873688|FG000|Overall Study|Withdrawal by Subject|6|||
46661021|NCT00474487|82873689|FG001|Overall Study|Withdrawal by Subject|0|||
46661022|NCT00474487|82873690|FG002|Overall Study|Withdrawal by Subject|0|||
46661023|NCT00474487|82873691|FG003|Overall Study|Withdrawal by Subject|0|||
46661024|NCT00474487|82873688|FG000|Overall Study|Lost to Follow-up|20|||
46661025|NCT00474487|82873689|FG001|Overall Study|Lost to Follow-up|1|||
46661026|NCT00474487|82873690|FG002|Overall Study|Lost to Follow-up|7|||
46661027|NCT00474487|82873691|FG003|Overall Study|Lost to Follow-up|0|||
46661028|NCT00474487|82873688|FG000|Overall Study|Inappropriate enrollment|4|||
46661029|NCT00474487|82873689|FG001|Overall Study|Inappropriate enrollment|0|||
46661030|NCT00474487|82873690|FG002|Overall Study|Inappropriate enrollment|7|||
46661031|NCT00474487|82873691|FG003|Overall Study|Inappropriate enrollment|0|||
46661032|NCT00474487|82873688|FG000|Overall Study|Death|0|||
46661033|NCT00474487|82873689|FG001|Overall Study|Death|1|||
46661034|NCT00474487|82873690|FG002|Overall Study|Death|0|||
46782934|NCT00553540|83001642|FG000|Overall Study|discharged after first visit|2|||
46782935|NCT00553540|83001643|FG001|Overall Study|discharged after first visit|5|||
46782936|NCT00617409|83001652|FG000|Overall Study|Withdrawal by Subject|4|||
46782937|NCT00617409|83001653|FG001|Overall Study|Withdrawal by Subject|1|||
46782938|NCT00617409|83001654|FG002|Overall Study|Withdrawal by Subject|2|||
46782939|NCT00617409|83001652|FG000|Overall Study|Adverse Event|0|||
46661035|NCT00474487|82873691|FG003|Overall Study|Death|0|||
46661036|NCT00474253|82873703|FG000|Overall Study|Withdrew consent|2|||
46661037|NCT00474253|82873704|FG001|Overall Study|Withdrew consent|0|||
46661038|NCT00474253|82873703|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
46661039|NCT00474253|82873704|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
46661040|NCT00474253|82873703|FG000|Overall Study|Lost to Follow-up|1|||
46661041|NCT00474253|82873704|FG001|Overall Study|Lost to Follow-up|0|||
46661042|NCT00474253|82873703|FG000|Overall Study|Discharged prior to study completion|0|||
46661043|NCT00474253|82873704|FG001|Overall Study|Discharged prior to study completion|1|||
46661044|NCT00474058|82873712|FG000|Overall Study|Adverse Event|11|||
46661045|NCT00474058|82873713|FG001|Overall Study|Adverse Event|6|||
46661046|NCT00474058|82873712|FG000|Overall Study|Lack of Efficacy|0|||
46661047|NCT00474058|82873713|FG001|Overall Study|Lack of Efficacy|4|||
46661048|NCT00474058|82873712|FG000|Overall Study|Withdrawal by Subject|11|||
46661049|NCT00474058|82873713|FG001|Overall Study|Withdrawal by Subject|7|||
46661050|NCT00474058|82873712|FG000|Overall Study|Other|2|||
46661051|NCT00474058|82873713|FG001|Overall Study|Other|0|||
46661052|NCT00473824|82873721|FG000|Overall Study|Virologic Breakthrough|1|||
46661053|NCT00473824|82873722|FG001|Overall Study|Virologic Breakthrough|0|||
46661054|NCT00473824|82873721|FG000|Overall Study|Adverse Event|1|||
46661055|NCT00473824|82873722|FG001|Overall Study|Adverse Event|0|||
46661056|NCT00473824|82873721|FG000|Overall Study|Death|1|||
46661057|NCT00473824|82873722|FG001|Overall Study|Death|0|||
46661058|NCT00473824|82873721|FG000|Overall Study|Lost to Follow-up|1|||
46661059|NCT00473824|82873722|FG001|Overall Study|Lost to Follow-up|0|||
46661060|NCT00473824|82873721|FG000|Overall Study|Withdrawal by physician|1|||
46661061|NCT00473824|82873722|FG001|Overall Study|Withdrawal by physician|0|||
46661062|NCT00473746|82873733|FG000|Period 1 (Phase 1)|Adverse Event|1|||
46661063|NCT00473746|82873734|FG001|Period 1 (Phase 1)|Adverse Event|0|||
46661064|NCT00473746|82873735|FG002|Period 1 (Phase 1)|Adverse Event|0|||
46661065|NCT00473746|82873736|FG003|Period 1 (Phase 1)|Adverse Event|0|||
46661066|NCT00473746|82873737|FG004|Period 1 (Phase 1)|Adverse Event|0|||
46661067|NCT00473746|82873733|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
46661068|NCT00473746|82873734|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
46661069|NCT00473746|82873735|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
46661070|NCT00473746|82873736|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
46661071|NCT00473746|82873737|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
46661072|NCT00473746|82873733|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
46661073|NCT00473746|82873734|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
46661074|NCT00473746|82873735|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
46661075|NCT00473746|82873736|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
46661076|NCT00473746|82873737|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
46661077|NCT00473746|82873733|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
46661078|NCT00473746|82873734|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
46661079|NCT00473746|82873735|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
46661080|NCT00473746|82873736|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
46661081|NCT00473746|82873737|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
46661082|NCT00473746|82873733|FG000|Period 1 (Phase 1)|Reason not specified|0|||
46661083|NCT00473746|82873734|FG001|Period 1 (Phase 1)|Reason not specified|1|||
46661084|NCT00473746|82873735|FG002|Period 1 (Phase 1)|Reason not specified|0|||
46661085|NCT00473746|82873736|FG003|Period 1 (Phase 1)|Reason not specified|0|||
46661086|NCT00473746|82873737|FG004|Period 1 (Phase 1)|Reason not specified|0|||
46661087|NCT00473746|82873733|FG000|Period 2 (Phase 2)|Adverse Event|0|||
46661088|NCT00473746|82873734|FG001|Period 2 (Phase 2)|Adverse Event|0|||
46661089|NCT00473746|82873735|FG002|Period 2 (Phase 2)|Adverse Event|0|||
46661090|NCT00473746|82873736|FG003|Period 2 (Phase 2)|Adverse Event|0|||
46661091|NCT00473746|82873737|FG004|Period 2 (Phase 2)|Adverse Event|3|||
46661092|NCT00473746|82873733|FG000|Period 2 (Phase 2)|Death|0|||
46661093|NCT00473746|82873734|FG001|Period 2 (Phase 2)|Death|0|||
46661094|NCT00473746|82873735|FG002|Period 2 (Phase 2)|Death|0|||
46661095|NCT00473746|82873736|FG003|Period 2 (Phase 2)|Death|0|||
46661096|NCT00473746|82873737|FG004|Period 2 (Phase 2)|Death|1|||
46661097|NCT00473746|82873733|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
46661098|NCT00473746|82873734|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
46661099|NCT00473746|82873735|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
46782940|NCT00617409|83001653|FG001|Overall Study|Adverse Event|2|||
46782941|NCT00617409|83001654|FG002|Overall Study|Adverse Event|3|||
46782942|NCT00617409|83001652|FG000|Overall Study|Disease Progression|8|||
46782943|NCT00617409|83001653|FG001|Overall Study|Disease Progression|8|||
46782944|NCT00617409|83001654|FG002|Overall Study|Disease Progression|18|||
46782945|NCT00617409|83001652|FG000|Overall Study|Death|3|||
46661100|NCT00473746|82873736|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
46661101|NCT00473746|82873737|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
46661102|NCT00473746|82873733|FG000|Period 2 (Phase 2)|Reason not specified|0|||
46661103|NCT00473746|82873734|FG001|Period 2 (Phase 2)|Reason not specified|0|||
46661104|NCT00473746|82873735|FG002|Period 2 (Phase 2)|Reason not specified|0|||
46782946|NCT00617409|83001653|FG001|Overall Study|Death|5|||
46782947|NCT00617409|83001654|FG002|Overall Study|Death|4|||
46661105|NCT00473746|82873736|FG003|Period 2 (Phase 2)|Reason not specified|0|||
46661106|NCT00473746|82873737|FG004|Period 2 (Phase 2)|Reason not specified|3|||
46661107|NCT00473668|82873754|FG000|Overall Study|Withdrawal by Subject|0|||
46661108|NCT00473668|82873755|FG001|Overall Study|Withdrawal by Subject|2|||
46661109|NCT00473668|82873756|FG002|Overall Study|Withdrawal by Subject|0|||
46661110|NCT00473668|82873754|FG000|Overall Study|Migrated/moved from study area|3|||
46661111|NCT00473668|82873755|FG001|Overall Study|Migrated/moved from study area|2|||
46661112|NCT00473668|82873756|FG002|Overall Study|Migrated/moved from study area|0|||
46661113|NCT00473668|82873754|FG000|Overall Study|Lost to Follow-up|0|||
46661114|NCT00473668|82873755|FG001|Overall Study|Lost to Follow-up|4|||
46782948|NCT00617409|83001652|FG000|Overall Study|Alternative Therapy|1|||
46782949|NCT00617409|83001653|FG001|Overall Study|Alternative Therapy|2|||
46782950|NCT00617409|83001654|FG002|Overall Study|Alternative Therapy|0|||
46782951|NCT00695318|83001665|FG000|Overall Study|Lost to Follow-up|1|||
46782952|NCT00695318|83001666|FG001|Overall Study|Lost to Follow-up|0|||
46782953|NCT00695318|83001665|FG000|Overall Study|Withdrawal by Subject|2|||
46782954|NCT00695318|83001666|FG001|Overall Study|Withdrawal by Subject|0|||
46782955|NCT00695318|83001665|FG000|Overall Study|Death|1|||
46782956|NCT00695318|83001666|FG001|Overall Study|Death|1|||
46661115|NCT00473668|82873756|FG002|Overall Study|Lost to Follow-up|6|||
46661116|NCT00473668|82873754|FG000|Overall Study|Other|2|||
46661117|NCT00473668|82873755|FG001|Overall Study|Other|3|||
46661118|NCT00473668|82873756|FG002|Overall Study|Other|4|||
46661119|NCT00473590|82873766|FG000|Overall Study|Adverse Event|3|||
46661120|NCT00473590|82873767|FG001|Overall Study|Adverse Event|3|||
46782957|NCT00695318|83001665|FG000|Overall Study|Study Terminated|1|||
46661121|NCT00473590|82873766|FG000|Overall Study|Death|4|||
46661122|NCT00473590|82873767|FG001|Overall Study|Death|2|||
46661123|NCT00473590|82873766|FG000|Overall Study|Progression not resulting in death|24|||
46661124|NCT00473590|82873767|FG001|Overall Study|Progression not resulting in death|20|||
46661125|NCT00473590|82873766|FG000|Overall Study|Non-protocol-specified therapy|7|||
46661126|NCT00473590|82873767|FG001|Overall Study|Non-protocol-specified therapy|5|||
46661127|NCT00473590|82873766|FG000|Overall Study|Physician Decision|2|||
46661128|NCT00473590|82873767|FG001|Overall Study|Physician Decision|4|||
46661129|NCT00473590|82873766|FG000|Overall Study|Withdrawal by Subject|5|||
46661130|NCT00473590|82873767|FG001|Overall Study|Withdrawal by Subject|3|||
46661131|NCT00473590|82873766|FG000|Overall Study|Other|0|||
46661132|NCT00473590|82873767|FG001|Overall Study|Other|1|||
46661133|NCT00473512|82873778|FG000|Period 1 (Phase 1)|Adverse Event|0|||
46661134|NCT00473512|82873779|FG001|Period 1 (Phase 1)|Adverse Event|0|||
46661135|NCT00473512|82873780|FG002|Period 1 (Phase 1)|Adverse Event|0|||
46661136|NCT00473512|82873781|FG003|Period 1 (Phase 1)|Adverse Event|5|||
46661137|NCT00473512|82873782|FG004|Period 1 (Phase 1)|Adverse Event|0|||
46782958|NCT00695318|83001666|FG001|Overall Study|Study Terminated|0|||
46782959|NCT00386425|83001680|FG000|Overall Study|Physician Decision|3|||
46782960|NCT00386425|83001681|FG001|Overall Study|Physician Decision|0|||
46782961|NCT00386425|83001682|FG002|Overall Study|Physician Decision|0|||
46782962|NCT00386425|83001680|FG000|Overall Study|Withdrawal by Subject|0|||
46782963|NCT00386425|83001681|FG001|Overall Study|Withdrawal by Subject|1|||
46782964|NCT00386425|83001682|FG002|Overall Study|Withdrawal by Subject|0|||
46782965|NCT00694304|83001694|FG000|Overall Study|Adverse Event|42|||
46782966|NCT00694304|83001694|FG000|Overall Study|Lack of Efficacy|35|||
46782967|NCT00694304|83001694|FG000|Overall Study|Non-compliance With Study Product|16|||
46782968|NCT00694304|83001694|FG000|Overall Study|Protocol Violation|6|||
46782969|NCT00694304|83001694|FG000|Overall Study|Withdrawal of Consent|61|||
46782970|NCT00694304|83001694|FG000|Overall Study|Lost to Follow-up|15|||
46782971|NCT00694304|83001694|FG000|Overall Study|Administrative or Other Reasons|32|||
46782972|NCT00371839|83001701|FG000|Overall Study|Death|4|||
46782973|NCT00371839|83001702|FG001|Overall Study|Death|0|||
46782974|NCT00371839|83001703|FG002|Overall Study|Death|0|||
46782975|NCT00371839|83001701|FG000|Overall Study|Withdrawal by Subject|7|||
46782976|NCT00371839|83001702|FG001|Overall Study|Withdrawal by Subject|4|||
46971972|NCT02670083|83215543|FG001|Overall Study|Lost to Follow-up|2|||
46971973|NCT02670083|83215542|FG000|Overall Study|Multiple Reasons|9|||
46971974|NCT02670083|83215543|FG001|Overall Study|Multiple Reasons|9|||
46661138|NCT00473512|82873778|FG000|Period 1 (Phase 1)|Death|0|||
46661139|NCT00473512|82873779|FG001|Period 1 (Phase 1)|Death|0|||
46661140|NCT00473512|82873780|FG002|Period 1 (Phase 1)|Death|0|||
46661141|NCT00473512|82873781|FG003|Period 1 (Phase 1)|Death|1|||
46782977|NCT00371839|83001703|FG002|Overall Study|Withdrawal by Subject|0|||
46782978|NCT00371839|83001701|FG000|Overall Study|Lost to Follow-up|6|||
46782979|NCT00371839|83001702|FG001|Overall Study|Lost to Follow-up|3|||
46782980|NCT00371839|83001703|FG002|Overall Study|Lost to Follow-up|2|||
46782981|NCT00682890|83001711|FG000|Overall Study|Lost to Follow-up|1|||
46782982|NCT00682890|83001712|FG001|Overall Study|Lost to Follow-up|1|||
46782983|NCT00682890|83001711|FG000|Overall Study|subject moved away|0|||
46782984|NCT00682890|83001712|FG001|Overall Study|subject moved away|1|||
46782985|NCT00682890|83001711|FG000|Overall Study|heavy menstrual bleeding|1|||
46782986|NCT00682890|83001712|FG001|Overall Study|heavy menstrual bleeding|0|||
46782987|NCT00385723|83001721|FG000|Overall Study|Lost to Follow-up|1|||
46782988|NCT00385723|83001722|FG001|Overall Study|Lost to Follow-up|1|||
46782989|NCT00385723|83001723|FG002|Overall Study|Lost to Follow-up|0|||
46782990|NCT00385723|83001721|FG000|Overall Study|Withdrawal by Subject|1|||
46782991|NCT00385723|83001722|FG001|Overall Study|Withdrawal by Subject|0|||
46661142|NCT00473512|82873782|FG004|Period 1 (Phase 1)|Death|0|||
46661143|NCT00473512|82873778|FG000|Period 1 (Phase 1)|Disease Progression|1|||
46661144|NCT00473512|82873779|FG001|Period 1 (Phase 1)|Disease Progression|1|||
46782992|NCT00385723|83001723|FG002|Overall Study|Withdrawal by Subject|2|||
46661145|NCT00473512|82873780|FG002|Period 1 (Phase 1)|Disease Progression|0|||
46661146|NCT00473512|82873781|FG003|Period 1 (Phase 1)|Disease Progression|10|||
46661147|NCT00473512|82873782|FG004|Period 1 (Phase 1)|Disease Progression|1|||
46661148|NCT00473512|82873778|FG000|Period 1 (Phase 1)|Other|0|||
46661149|NCT00473512|82873779|FG001|Period 1 (Phase 1)|Other|0|||
46661150|NCT00473512|82873780|FG002|Period 1 (Phase 1)|Other|0|||
46661151|NCT00473512|82873781|FG003|Period 1 (Phase 1)|Other|1|||
46661152|NCT00473512|82873782|FG004|Period 1 (Phase 1)|Other|0|||
46661153|NCT00473512|82873778|FG000|Period 2 (Phase 2)|Adverse Event|0|||
46661154|NCT00473512|82873779|FG001|Period 2 (Phase 2)|Adverse Event|0|||
46661155|NCT00473512|82873780|FG002|Period 2 (Phase 2)|Adverse Event|0|||
46661156|NCT00473512|82873781|FG003|Period 2 (Phase 2)|Adverse Event|1|||
46661157|NCT00473512|82873782|FG004|Period 2 (Phase 2)|Adverse Event|0|||
46661158|NCT00473512|82873778|FG000|Period 2 (Phase 2)|Death|0|||
46661159|NCT00473512|82873779|FG001|Period 2 (Phase 2)|Death|0|||
46661160|NCT00473512|82873780|FG002|Period 2 (Phase 2)|Death|0|||
46661161|NCT00473512|82873781|FG003|Period 2 (Phase 2)|Death|1|||
46661162|NCT00473512|82873782|FG004|Period 2 (Phase 2)|Death|1|||
46661163|NCT00473512|82873778|FG000|Period 2 (Phase 2)|Disease Progression|0|||
46661164|NCT00473512|82873779|FG001|Period 2 (Phase 2)|Disease Progression|2|||
46661165|NCT00473512|82873780|FG002|Period 2 (Phase 2)|Disease Progression|2|||
46661166|NCT00473512|82873781|FG003|Period 2 (Phase 2)|Disease Progression|17|||
46661167|NCT00473512|82873782|FG004|Period 2 (Phase 2)|Disease Progression|1|||
46661168|NCT00473512|82873778|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
46661169|NCT00473512|82873779|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
46661170|NCT00473512|82873780|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
46661171|NCT00473512|82873781|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
46661172|NCT00473512|82873782|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
46661173|NCT00473512|82873778|FG000|Period 2 (Phase 2)|Other|1|||
46661174|NCT00473512|82873779|FG001|Period 2 (Phase 2)|Other|0|||
46661175|NCT00473512|82873780|FG002|Period 2 (Phase 2)|Other|0|||
46661176|NCT00473512|82873781|FG003|Period 2 (Phase 2)|Other|3|||
46661177|NCT00473512|82873782|FG004|Period 2 (Phase 2)|Other|0|||
46661178|NCT00473434|82873802|FG000|Overall Study|Physician Decision|3|||
46661179|NCT00473434|82873802|FG000|Overall Study|Withdrawal by Subject|9|||
46661180|NCT00473434|82873802|FG000|Overall Study|Compliance|3|||
46661181|NCT00473434|82873802|FG000|Overall Study|Lack of Efficacy|3|||
46661182|NCT00473434|82873802|FG000|Overall Study|Adverse Event|3|||
46661183|NCT00473434|82873802|FG000|Overall Study|Patient was selling medication to others|1|||
46661184|NCT00473434|82873802|FG000|Overall Study|Safety evaluation|1|||
46661185|NCT00473434|82873802|FG000|Overall Study|Reason not specified|6|||
46661186|NCT00473434|82873802|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
46661187|NCT00473434|82873802|FG000|Overall Study|Switching to trial medication|1|||
46661188|NCT00473434|82873802|FG000|Overall Study|No longer required|1|||
46661189|NCT00473083|82873822|FG000|Overall Study|Adverse Event|1|||
46661190|NCT00473083|82873823|FG001|Overall Study|Adverse Event|0|||
46661191|NCT00473083|82873824|FG002|Overall Study|Adverse Event|0|||
46661192|NCT00472420|82873835|FG000|Induction Treatment Period|Physician Decision|9|||
46661193|NCT00472420|82873835|FG000|Induction Treatment Period|Adverse Event|3|||
46661194|NCT00472420|82873835|FG000|Induction Treatment Period|Non-compliance|1|||
46661195|NCT00472420|82873835|FG000|Induction Treatment Period|Death|3|||
46661196|NCT00472420|82873835|FG000|Follow-up Period|Death|5|||
46661197|NCT00472420|82873835|FG000|Follow-up Period|Physician Decision|9|||
46782993|NCT00698516|83001731|FG000|Overall Study|Study Termination|2|||
46782994|NCT00698516|83001731|FG000|Overall Study|Withdrawal by Subject|3|||
46782995|NCT00679302|83001741|FG000|Overall Study|Lost to Follow-up|8|||
46782996|NCT00679302|83001742|FG001|Overall Study|Lost to Follow-up|4|||
47076213|NCT02760485|83370801|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
47076214|NCT02760485|83370802|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
47076215|NCT02634333|83370837|FG000|Overall Study|Completed out of Window|3|||
47076216|NCT02634333|83370838|FG001|Overall Study|Completed out of Window|2|||
47076217|NCT02634333|83370837|FG000|Overall Study|Missed Visit|5|||
47076218|NCT02634333|83370838|FG001|Overall Study|Missed Visit|2|||
46661198|NCT00472420|82873835|FG000|Follow-up Period|Lost to Follow-up|2|||
46661199|NCT00472420|82873835|FG000|Follow-up Period|Protocol Violation|1|||
46661200|NCT00472303|82873841|FG000|Titration Phase|Adverse Event|22|||
46661201|NCT00472303|82873842|FG001|Titration Phase|Adverse Event|12|||
46661202|NCT00472303|82873843|FG002|Titration Phase|Adverse Event|0|||
46661203|NCT00472303|82873841|FG000|Titration Phase|Death|4|||
46782997|NCT00690482|83001771|FG000|Overall Study|Adverse Event|2|||
46851041|NCT03615040|83066791|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
46661204|NCT00472303|82873842|FG001|Titration Phase|Death|2|||
46661205|NCT00472303|82873843|FG002|Titration Phase|Death|0|||
46661206|NCT00472303|82873841|FG000|Titration Phase|Lack of Efficacy|10|||
46661207|NCT00472303|82873842|FG001|Titration Phase|Lack of Efficacy|0|||
46661208|NCT00472303|82873843|FG002|Titration Phase|Lack of Efficacy|0|||
46661209|NCT00472303|82873841|FG000|Titration Phase|Withdrawal by Subject|16|||
46661210|NCT00472303|82873842|FG001|Titration Phase|Withdrawal by Subject|13|||
46661211|NCT00472303|82873843|FG002|Titration Phase|Withdrawal by Subject|0|||
46782998|NCT00690482|83001772|FG001|Overall Study|Adverse Event|1|||
46661212|NCT00472303|82873841|FG000|Titration Phase|Trial Medication non-compliant|4|||
47076219|NCT02634333|83370837|FG000|Overall Study|Lost to Follow-up|12|||
47076220|NCT02634333|83370838|FG001|Overall Study|Lost to Follow-up|7|||
47076221|NCT02634333|83370837|FG000|Overall Study|Withdrawal by Subject|9|||
47076222|NCT02634333|83370838|FG001|Overall Study|Withdrawal by Subject|13|||
46661213|NCT00472303|82873842|FG001|Titration Phase|Trial Medication non-compliant|1|||
46661214|NCT00472303|82873843|FG002|Titration Phase|Trial Medication non-compliant|0|||
46661215|NCT00472303|82873841|FG000|Titration Phase|Other|3|||
46661216|NCT00472303|82873842|FG001|Titration Phase|Other|1|||
46661217|NCT00472303|82873843|FG002|Titration Phase|Other|0|||
46661218|NCT00472303|82873841|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
46661219|NCT00472303|82873842|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
46661220|NCT00472303|82873843|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
46661221|NCT00472303|82873841|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
46661222|NCT00472303|82873842|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
46661223|NCT00472303|82873843|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
46661224|NCT00472303|82873841|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
46661225|NCT00472303|82873842|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
46661226|NCT00472303|82873843|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
46661227|NCT00472303|82873841|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
46661228|NCT00472303|82873842|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
46661229|NCT00472303|82873843|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
46661230|NCT00472303|82873841|FG000|Discontinuations After Titration Phase|Other|5|||
46661231|NCT00472303|82873842|FG001|Discontinuations After Titration Phase|Other|0|||
46661232|NCT00472303|82873843|FG002|Discontinuations After Titration Phase|Other|0|||
46661233|NCT00472303|82873841|FG000|Maintenance Phase|Adverse Event|5|||
46661234|NCT00472303|82873842|FG001|Maintenance Phase|Adverse Event|6|||
46661235|NCT00472303|82873843|FG002|Maintenance Phase|Adverse Event|6|||
46661236|NCT00472303|82873841|FG000|Maintenance Phase|Death|3|||
46661237|NCT00472303|82873842|FG001|Maintenance Phase|Death|0|||
46661238|NCT00472303|82873843|FG002|Maintenance Phase|Death|2|||
46661239|NCT00472303|82873841|FG000|Maintenance Phase|Lack of Efficacy|2|||
46661240|NCT00472303|82873842|FG001|Maintenance Phase|Lack of Efficacy|2|||
46661241|NCT00472303|82873843|FG002|Maintenance Phase|Lack of Efficacy|4|||
46661242|NCT00472303|82873841|FG000|Maintenance Phase|Withdrawal by Subject|6|||
46661243|NCT00472303|82873842|FG001|Maintenance Phase|Withdrawal by Subject|7|||
46661244|NCT00472303|82873843|FG002|Maintenance Phase|Withdrawal by Subject|3|||
46661245|NCT00472303|82873841|FG000|Maintenance Phase|Trial medication non-compliant|0|||
46661246|NCT00472303|82873842|FG001|Maintenance Phase|Trial medication non-compliant|0|||
46661247|NCT00472303|82873843|FG002|Maintenance Phase|Trial medication non-compliant|1|||
46661248|NCT00472303|82873841|FG000|Maintenance Phase|Resolution of pain|0|||
46661249|NCT00472303|82873842|FG001|Maintenance Phase|Resolution of pain|0|||
46661250|NCT00472303|82873843|FG002|Maintenance Phase|Resolution of pain|1|||
46661251|NCT00472303|82873841|FG000|Maintenance Phase|Other|1|||
46661252|NCT00472303|82873842|FG001|Maintenance Phase|Other|1|||
46661253|NCT00472303|82873843|FG002|Maintenance Phase|Other|0|||
46661254|NCT00471718|82873871|FG000|Overall Study|Adverse Event|3|||
46661255|NCT00471718|82873871|FG000|Overall Study|other complicating disease|1|||
46661256|NCT00471718|82873871|FG000|Overall Study|disease progression|22|||
46661257|NCT00471718|82873871|FG000|Overall Study|Withdrawal by Subject|1|||
46661258|NCT00471445|82873881|FG000|Overall Study|Withdrawal by Subject|1|||
46661259|NCT00471445|82873882|FG001|Overall Study|Withdrawal by Subject|1|||
46661260|NCT00471445|82873881|FG000|Overall Study|Ineligible|1|||
46661261|NCT00471445|82873882|FG001|Overall Study|Ineligible|0|||
46661262|NCT00471445|82873881|FG000|Overall Study|Protocol Violation|0|||
46661263|NCT00471445|82873882|FG001|Overall Study|Protocol Violation|1|||
46661264|NCT00471328|82873890|FG000|Core Phase|Adverse Event|18|||
46661265|NCT00471328|82873891|FG001|Core Phase|Adverse Event|6|||
46661266|NCT00471328|82873890|FG000|Core Phase|Death|8|||
46661267|NCT00471328|82873891|FG001|Core Phase|Death|4|||
46661268|NCT00471328|82873890|FG000|Core Phase|Withdrawal by Subject|2|||
46661269|NCT00471328|82873891|FG001|Core Phase|Withdrawal by Subject|2|||
46661270|NCT00471328|82873890|FG000|Core Phase|Abnormal laboratory value|1|||
47076223|NCT02634333|83370837|FG000|Overall Study|Death|11|||
47076224|NCT02634333|83370838|FG001|Overall Study|Death|8|||
46661271|NCT00471328|82873891|FG001|Core Phase|Abnormal laboratory value|0|||
46661272|NCT00471328|82873890|FG000|Core Phase|Disease Progression|78|||
47076225|NCT02515630|83370847|FG000|Overall Study|Withdrawal by Subject|5|||
46661273|NCT00471328|82873891|FG001|Core Phase|Disease Progression|53|||
46661274|NCT00471328|82873890|FG000|Core Phase|Administrative Problem|0|||
46661275|NCT00471328|82873891|FG001|Core Phase|Administrative Problem|1|||
46661276|NCT00471328|82873890|FG000|Core Phase|Protocol Deviation|0|||
47076226|NCT02515630|83370847|FG000|Overall Study|Adverse Event|4|||
46661277|NCT00471328|82873891|FG001|Core Phase|Protocol Deviation|1|||
46661278|NCT00471328|82873890|FG000|Extension Phase|Adverse Event|3|||
46661279|NCT00471328|82873891|FG001|Extension Phase|Adverse Event|12|||
47076227|NCT02515630|83370847|FG000|Overall Study|Physician Decision|4|||
46661280|NCT00471328|82873890|FG000|Extension Phase|Withdrawal by Subject|0|||
46661281|NCT00471328|82873891|FG001|Extension Phase|Withdrawal by Subject|2|||
46661282|NCT00471328|82873890|FG000|Extension Phase|Death|1|||
46661283|NCT00471328|82873891|FG001|Extension Phase|Death|7|||
46661284|NCT00471328|82873890|FG000|Extension Phase|Protocol Deviation|3|||
46661285|NCT00471328|82873891|FG001|Extension Phase|Protocol Deviation|1|||
46971975|NCT02670083|83215542|FG000|Overall Study|Physician Decision|0|||
46971976|NCT02670083|83215543|FG001|Overall Study|Physician Decision|2|||
46971977|NCT02670083|83215542|FG000|Overall Study|Study Terminated By Sponsor|257|||
46661286|NCT00471328|82873890|FG000|Extension Phase|Treatment duration as per protocol|0|||
46661287|NCT00471328|82873891|FG001|Extension Phase|Treatment duration as per protocol|1|||
46661288|NCT00471328|82873890|FG000|Extension Phase|Disease Progression|32|||
46661289|NCT00471328|82873891|FG001|Extension Phase|Disease Progression|44|||
46661290|NCT00471328|82873890|FG000|Extension Phase|New cancer Therapy|1|||
46661291|NCT00471328|82873891|FG001|Extension Phase|New cancer Therapy|0|||
46661292|NCT00471328|82873890|FG000|Extension Phase|Administrative Problem|1|||
46661293|NCT00471328|82873891|FG001|Extension Phase|Administrative Problem|0|||
46661294|NCT00470470|82873899|FG000|Overall Study|Adverse Event|2|||
46661295|NCT00470470|82873899|FG000|Overall Study|Death|2|||
46661296|NCT00470470|82873899|FG000|Overall Study|Not treated|1|||
46661297|NCT00470275|82873903|FG000|Overall Study|Death|1|||
46661298|NCT00470275|82873903|FG000|Overall Study|Lack of Efficacy|7|||
46661299|NCT00470275|82873903|FG000|Overall Study|Withdrawal by Subject|2|||
46661300|NCT00470158|82873912|FG000|Overall Study|Death|0|||
46661301|NCT00470158|82873913|FG001|Overall Study|Death|0|||
46661302|NCT00470158|82873914|FG002|Overall Study|Death|0|||
46661303|NCT00470158|82873915|FG003|Overall Study|Death|0|||
46661304|NCT00470158|82873916|FG004|Overall Study|Death|2|||
46661305|NCT00470158|82873912|FG000|Overall Study|Lost to Follow-up|7|||
46661306|NCT00470158|82873913|FG001|Overall Study|Lost to Follow-up|8|||
46661307|NCT00470158|82873914|FG002|Overall Study|Lost to Follow-up|8|||
46661308|NCT00470158|82873915|FG003|Overall Study|Lost to Follow-up|5|||
46661309|NCT00470158|82873916|FG004|Overall Study|Lost to Follow-up|4|||
46661310|NCT00470158|82873912|FG000|Overall Study|Protocol Violation|1|||
46661311|NCT00470158|82873913|FG001|Overall Study|Protocol Violation|0|||
46661312|NCT00470158|82873914|FG002|Overall Study|Protocol Violation|0|||
46661313|NCT00470158|82873915|FG003|Overall Study|Protocol Violation|0|||
46661314|NCT00470158|82873916|FG004|Overall Study|Protocol Violation|0|||
46661315|NCT00475540|82873930|FG000|36 Months|Lost to Follow-up|4|||
46661316|NCT00475540|82873931|FG001|36 Months|Lost to Follow-up|4|||
46661317|NCT00475540|82873930|FG000|36 Months|Death|1|||
46661318|NCT00475540|82873931|FG001|36 Months|Death|2|||
46661319|NCT00475540|82873930|FG000|36 Months|Censored due to reoperation|3|||
46661320|NCT00475540|82873931|FG001|36 Months|Censored due to reoperation|0|||
46661321|NCT00472186|82873939|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
46661322|NCT00472186|82873940|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
46661323|NCT00479713|82873950|FG000|Overall Study|Adverse Event|8|||
46661324|NCT00479713|82873951|FG001|Overall Study|Adverse Event|6|||
46661325|NCT00479713|82873950|FG000|Overall Study|Death|1|||
46661326|NCT00479713|82873951|FG001|Overall Study|Death|0|||
46661327|NCT00479713|82873950|FG000|Overall Study|Lost to Follow-up|0|||
46661328|NCT00479713|82873951|FG001|Overall Study|Lost to Follow-up|1|||
46661329|NCT00479713|82873950|FG000|Overall Study|Protocol Violation|0|||
46661330|NCT00479713|82873951|FG001|Overall Study|Protocol Violation|1|||
46661331|NCT00479713|82873950|FG000|Overall Study|Withdrawal by Subject|4|||
46661332|NCT00479713|82873951|FG001|Overall Study|Withdrawal by Subject|1|||
46661333|NCT00474526|82873983|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
46661334|NCT00474526|82873984|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
46661335|NCT00474526|82873985|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
46661336|NCT00474526|82873986|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
46661337|NCT00474526|82873987|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
46661338|NCT00474526|82873988|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
46661339|NCT00474526|82873989|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
46661340|NCT00474526|82873990|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
46661341|NCT00474526|82873991|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
46661342|NCT00474526|82873992|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
46782999|NCT00690482|83001771|FG000|Overall Study|Incorrect enrolment|0|||
46661343|NCT00474526|82873993|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
46661344|NCT00474526|82873994|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
46661345|NCT00474526|82873995|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
46661346|NCT00474526|82873996|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
46661347|NCT00474526|82873997|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
46661348|NCT00474526|82873998|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
46783000|NCT00690482|83001772|FG001|Overall Study|Incorrect enrolment|1|||
46783001|NCT00690482|83001771|FG000|Overall Study|Study-specific discontinuation criteria|1|||
46783002|NCT00690482|83001772|FG001|Overall Study|Study-specific discontinuation criteria|0|||
46783003|NCT00690482|83001771|FG000|Overall Study|Intake of prohibited medicine|1|||
46661349|NCT00474526|82873999|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
46661350|NCT00474526|82873983|FG000|Overall Study|Adverse Event|2|||
46661351|NCT00474526|82873984|FG001|Overall Study|Adverse Event|0|||
46661352|NCT00474526|82873985|FG002|Overall Study|Adverse Event|2|||
46661353|NCT00474526|82873986|FG003|Overall Study|Adverse Event|4|||
46661354|NCT00474526|82873987|FG004|Overall Study|Adverse Event|2|||
46661355|NCT00474526|82873988|FG005|Overall Study|Adverse Event|1|||
46661356|NCT00474526|82873989|FG006|Overall Study|Adverse Event|1|||
46661357|NCT00474526|82873990|FG007|Overall Study|Adverse Event|0|||
46661358|NCT00474526|82873991|FG008|Overall Study|Adverse Event|0|||
46661359|NCT00474526|82873992|FG009|Overall Study|Adverse Event|0|||
46661360|NCT00474526|82873993|FG010|Overall Study|Adverse Event|0|||
46661361|NCT00474526|82873994|FG011|Overall Study|Adverse Event|0|||
46661362|NCT00474526|82873995|FG012|Overall Study|Adverse Event|0|||
46661363|NCT00474526|82873996|FG013|Overall Study|Adverse Event|0|||
46661364|NCT00474526|82873997|FG014|Overall Study|Adverse Event|1|||
46661365|NCT00474526|82873998|FG015|Overall Study|Adverse Event|1|||
46661366|NCT00474526|82873999|FG016|Overall Study|Adverse Event|0|||
46661367|NCT00474526|82873983|FG000|Overall Study|Death|0|||
46661368|NCT00474526|82873984|FG001|Overall Study|Death|0|||
46661369|NCT00474526|82873985|FG002|Overall Study|Death|0|||
46661370|NCT00474526|82873986|FG003|Overall Study|Death|0|||
46661371|NCT00474526|82873987|FG004|Overall Study|Death|0|||
46661372|NCT00474526|82873988|FG005|Overall Study|Death|0|||
46661373|NCT00474526|82873989|FG006|Overall Study|Death|0|||
46661374|NCT00474526|82873990|FG007|Overall Study|Death|0|||
46661375|NCT00474526|82873991|FG008|Overall Study|Death|0|||
46661376|NCT00474526|82873992|FG009|Overall Study|Death|0|||
46661377|NCT00474526|82873993|FG010|Overall Study|Death|0|||
46661378|NCT00474526|82873994|FG011|Overall Study|Death|0|||
46661379|NCT00474526|82873995|FG012|Overall Study|Death|0|||
46661380|NCT00474526|82873996|FG013|Overall Study|Death|3|||
46661381|NCT00474526|82873997|FG014|Overall Study|Death|0|||
46661382|NCT00474526|82873998|FG015|Overall Study|Death|0|||
46661383|NCT00474526|82873999|FG016|Overall Study|Death|0|||
46661384|NCT00474526|82873983|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661385|NCT00474526|82873984|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
46661386|NCT00474526|82873985|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661387|NCT00474526|82873986|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
46661388|NCT00474526|82873987|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
46661389|NCT00474526|82873988|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661390|NCT00474526|82873989|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661391|NCT00474526|82873990|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661392|NCT00474526|82873991|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661393|NCT00474526|82873992|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661394|NCT00474526|82873993|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661395|NCT00474526|82873994|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661396|NCT00474526|82873995|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661397|NCT00474526|82873996|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
46661398|NCT00474526|82873997|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
46661399|NCT00474526|82873998|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661400|NCT00474526|82873999|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
46661401|NCT00474526|82873983|FG000|Overall Study|Lost to Follow-up|8|||
46661402|NCT00474526|82873984|FG001|Overall Study|Lost to Follow-up|6|||
46661403|NCT00474526|82873985|FG002|Overall Study|Lost to Follow-up|13|||
46661404|NCT00474526|82873986|FG003|Overall Study|Lost to Follow-up|29|||
46661405|NCT00474526|82873987|FG004|Overall Study|Lost to Follow-up|11|||
46661406|NCT00474526|82873988|FG005|Overall Study|Lost to Follow-up|5|||
46971978|NCT02670083|83215543|FG001|Overall Study|Study Terminated By Sponsor|254|||
47076228|NCT02515630|83370847|FG000|Overall Study|Death|2|||
47076229|NCT02515630|83370847|FG000|Overall Study|Disease Progression|1|||
47076230|NCT02450331|83370856|FG000|Overall Study|Death|162|||
46661407|NCT00474526|82873989|FG006|Overall Study|Lost to Follow-up|8|||
46661408|NCT00474526|82873990|FG007|Overall Study|Lost to Follow-up|1|||
46661409|NCT00474526|82873991|FG008|Overall Study|Lost to Follow-up|0|||
46661410|NCT00474526|82873992|FG009|Overall Study|Lost to Follow-up|6|||
46661411|NCT00474526|82873993|FG010|Overall Study|Lost to Follow-up|2|||
46971979|NCT02670083|83215542|FG000|Overall Study|Symptomatic Deterioration|0|||
46971980|NCT02670083|83215543|FG001|Overall Study|Symptomatic Deterioration|2|||
46661412|NCT00474526|82873994|FG011|Overall Study|Lost to Follow-up|4|||
46661413|NCT00474526|82873995|FG012|Overall Study|Lost to Follow-up|6|||
46661414|NCT00474526|82873996|FG013|Overall Study|Lost to Follow-up|74|||
46661415|NCT00474526|82873997|FG014|Overall Study|Lost to Follow-up|29|||
46661416|NCT00474526|82873998|FG015|Overall Study|Lost to Follow-up|4|||
46661417|NCT00474526|82873999|FG016|Overall Study|Lost to Follow-up|5|||
46783004|NCT00690482|83001772|FG001|Overall Study|Intake of prohibited medicine|0|||
46661418|NCT00474526|82873983|FG000|Overall Study|Protocol Violation|2|||
46661419|NCT00474526|82873984|FG001|Overall Study|Protocol Violation|6|||
46661420|NCT00474526|82873985|FG002|Overall Study|Protocol Violation|4|||
46661421|NCT00474526|82873986|FG003|Overall Study|Protocol Violation|12|||
46661422|NCT00474526|82873987|FG004|Overall Study|Protocol Violation|3|||
46661423|NCT00474526|82873988|FG005|Overall Study|Protocol Violation|1|||
46661424|NCT00474526|82873989|FG006|Overall Study|Protocol Violation|3|||
46661425|NCT00474526|82873990|FG007|Overall Study|Protocol Violation|0|||
46661426|NCT00474526|82873991|FG008|Overall Study|Protocol Violation|0|||
46661427|NCT00474526|82873992|FG009|Overall Study|Protocol Violation|4|||
46661428|NCT00474526|82873993|FG010|Overall Study|Protocol Violation|2|||
46661429|NCT00474526|82873994|FG011|Overall Study|Protocol Violation|2|||
46661430|NCT00474526|82873995|FG012|Overall Study|Protocol Violation|4|||
46661431|NCT00474526|82873996|FG013|Overall Study|Protocol Violation|19|||
46661432|NCT00474526|82873997|FG014|Overall Study|Protocol Violation|9|||
46661433|NCT00474526|82873998|FG015|Overall Study|Protocol Violation|6|||
46661434|NCT00474526|82873999|FG016|Overall Study|Protocol Violation|2|||
46661435|NCT00474526|82873983|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
46661436|NCT00474526|82873984|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
46661437|NCT00474526|82873985|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
46661438|NCT00474526|82873986|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
46661439|NCT00474526|82873987|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
46661440|NCT00474526|82873988|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
46661441|NCT00474526|82873989|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
46661442|NCT00474526|82873990|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
46661443|NCT00474526|82873991|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
46661444|NCT00474526|82873992|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
46661445|NCT00474526|82873993|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
46661446|NCT00474526|82873994|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
46661447|NCT00474526|82873995|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
46661448|NCT00474526|82873996|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
46661449|NCT00474526|82873997|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
46661450|NCT00474526|82873998|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
46661451|NCT00474526|82873999|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
46661452|NCT00474526|82873983|FG000|Overall Study|Withdrawal by Subject|9|||
46661453|NCT00474526|82873984|FG001|Overall Study|Withdrawal by Subject|24|||
46661454|NCT00474526|82873985|FG002|Overall Study|Withdrawal by Subject|21|||
46661455|NCT00474526|82873986|FG003|Overall Study|Withdrawal by Subject|52|||
46661456|NCT00474526|82873987|FG004|Overall Study|Withdrawal by Subject|38|||
46661457|NCT00474526|82873988|FG005|Overall Study|Withdrawal by Subject|6|||
46661458|NCT00474526|82873989|FG006|Overall Study|Withdrawal by Subject|12|||
46661459|NCT00474526|82873990|FG007|Overall Study|Withdrawal by Subject|4|||
46661460|NCT00474526|82873991|FG008|Overall Study|Withdrawal by Subject|4|||
46661461|NCT00474526|82873992|FG009|Overall Study|Withdrawal by Subject|13|||
46661462|NCT00474526|82873993|FG010|Overall Study|Withdrawal by Subject|5|||
46661463|NCT00474526|82873994|FG011|Overall Study|Withdrawal by Subject|4|||
46661464|NCT00474526|82873995|FG012|Overall Study|Withdrawal by Subject|4|||
46661465|NCT00474526|82873996|FG013|Overall Study|Withdrawal by Subject|37|||
46661466|NCT00474526|82873997|FG014|Overall Study|Withdrawal by Subject|22|||
46661467|NCT00474526|82873998|FG015|Overall Study|Withdrawal by Subject|1|||
46661468|NCT00474526|82873999|FG016|Overall Study|Withdrawal by Subject|1|||
46661469|NCT00478426|82874085|FG000|Overall Study|Withdrawal by Subject|1|||
46661470|NCT00477412|82874093|FG000|Overall Study|Death|0|||
46661471|NCT00477412|82874094|FG001|Overall Study|Death|0|||
46661472|NCT00477412|82874095|FG002|Overall Study|Death|0|||
46661473|NCT00477412|82874096|FG003|Overall Study|Death|4|||
46661474|NCT00477412|82874093|FG000|Overall Study|Lost to Follow-up|0|||
46783005|NCT00690482|83001771|FG000|Overall Study|withdrew consent at rand.day|0|||
46783006|NCT00690482|83001772|FG001|Overall Study|withdrew consent at rand.day|1|||
46783007|NCT00385255|83001780|FG000|Overall Study|Serious Adverse Event|1|||
46783008|NCT00385255|83001781|FG001|Overall Study|Serious Adverse Event|2|||
46783009|NCT00385255|83001780|FG000|Overall Study|Protocol Violation|0|||
46971981|NCT02670083|83215542|FG000|Overall Study|Withdrawal by Subject|32|||
46661475|NCT00477412|82874094|FG001|Overall Study|Lost to Follow-up|0|||
46661476|NCT00477412|82874095|FG002|Overall Study|Lost to Follow-up|0|||
46661477|NCT00477412|82874096|FG003|Overall Study|Lost to Follow-up|1|||
46661478|NCT00477412|82874093|FG000|Overall Study|Withdrawal by Subject|0|||
46661479|NCT00477412|82874094|FG001|Overall Study|Withdrawal by Subject|0|||
46661480|NCT00477412|82874095|FG002|Overall Study|Withdrawal by Subject|0|||
46661481|NCT00477412|82874096|FG003|Overall Study|Withdrawal by Subject|2|||
46661482|NCT00477412|82874093|FG000|Overall Study|Second Malignancy|0|||
46661483|NCT00477412|82874094|FG001|Overall Study|Second Malignancy|0|||
46661484|NCT00477412|82874095|FG002|Overall Study|Second Malignancy|0|||
46661485|NCT00477412|82874096|FG003|Overall Study|Second Malignancy|1|||
46783010|NCT00385255|83001781|FG001|Overall Study|Protocol Violation|4|||
46783011|NCT00385255|83001780|FG000|Overall Study|Withdrawal by Subject|0|||
46661486|NCT00477412|82874093|FG000|Overall Study|Adverse Event|1|||
46661487|NCT00477412|82874094|FG001|Overall Study|Adverse Event|0|||
46661488|NCT00477412|82874095|FG002|Overall Study|Adverse Event|1|||
46661489|NCT00477412|82874096|FG003|Overall Study|Adverse Event|0|||
46661490|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
46661491|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
46661492|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
46661493|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
46661494|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
46661495|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
46661496|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
46661497|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
46661498|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
46661499|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
46661500|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
46661501|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
46661502|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
46661503|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
46661504|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
46661505|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
46661506|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
46661507|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
46661508|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
46661509|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
46661510|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
46661511|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
46661512|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
46661513|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
46661514|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
46661515|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
46661516|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
46661517|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
46661518|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
46661519|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
46661520|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
46661521|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
46661522|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
46661523|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
46661524|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
46661525|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
46661526|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
46661527|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
46661528|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
46661529|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
46661530|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
46661531|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
46661532|NCT01089556|82874106|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
46661533|NCT01089556|82874107|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
46661534|NCT01089556|82874108|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
46661535|NCT01089556|82874109|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
46661536|NCT01089556|82874110|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
46661537|NCT01089556|82874111|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
46661538|NCT01089556|82874106|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
46661539|NCT01089556|82874107|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
46661540|NCT01089556|82874108|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
46661541|NCT01089556|82874109|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
46661542|NCT01089556|82874110|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
46661543|NCT01089556|82874111|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
46661544|NCT01089556|82874106|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
46661545|NCT01089556|82874107|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
46783012|NCT00385255|83001781|FG001|Overall Study|Withdrawal by Subject|8|||
46783013|NCT00385255|83001780|FG000|Overall Study|Migrated/moved from study area|0|||
46783014|NCT00385255|83001781|FG001|Overall Study|Migrated/moved from study area|1|||
46783015|NCT00385255|83001780|FG000|Overall Study|Lost to Follow-up|20|||
46783016|NCT00385255|83001781|FG001|Overall Study|Lost to Follow-up|58|||
46783017|NCT00698204|83001793|FG000|Overall Study|Withdrawal by Subject|1|||
46783018|NCT00698204|83001794|FG001|Overall Study|Withdrawal by Subject|0|||
46661546|NCT01089556|82874108|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
46783019|NCT00549718|83001806|FG000|Overall Study|Insufficient clinical response|20|||
46783020|NCT00549718|83001807|FG001|Overall Study|Insufficient clinical response|7|||
46661547|NCT01089556|82874109|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
46661548|NCT01089556|82874110|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
46783021|NCT00549718|83001808|FG002|Overall Study|Insufficient clinical response|18|||
46783022|NCT00549718|83001809|FG003|Overall Study|Insufficient clinical response|32|||
46783023|NCT00549718|83001806|FG000|Overall Study|Adverse Event|6|||
46783024|NCT00549718|83001807|FG001|Overall Study|Adverse Event|8|||
46783025|NCT00549718|83001808|FG002|Overall Study|Adverse Event|7|||
46783026|NCT00549718|83001809|FG003|Overall Study|Adverse Event|3|||
46783027|NCT00549718|83001806|FG000|Overall Study|Lost to Follow-up|4|||
46783028|NCT00549718|83001807|FG001|Overall Study|Lost to Follow-up|2|||
46661549|NCT01089556|82874111|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
46661550|NCT01089556|82874106|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
46661551|NCT01089556|82874107|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
46661552|NCT01089556|82874108|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
46661553|NCT01089556|82874109|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
46661554|NCT01089556|82874110|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
46661555|NCT01089556|82874111|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
46661556|NCT01089556|82874106|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
46661557|NCT01089556|82874107|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
46661558|NCT01089556|82874108|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
46661559|NCT01089556|82874109|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
46661560|NCT01089556|82874110|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
46661561|NCT01089556|82874111|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
46661562|NCT01089556|82874106|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
46661563|NCT01089556|82874107|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
46661564|NCT01089556|82874108|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
46661565|NCT01089556|82874109|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
46661566|NCT01089556|82874110|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
46661567|NCT01089556|82874111|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
46661568|NCT01089556|82874106|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
46661569|NCT01089556|82874107|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
46661570|NCT01089556|82874108|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
46661571|NCT01089556|82874109|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
46661572|NCT01089556|82874110|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
46661573|NCT01089556|82874111|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
46661574|NCT01089556|82874106|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
46661575|NCT01089556|82874107|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
46661576|NCT01089556|82874108|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
46661577|NCT01089556|82874109|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
46661578|NCT01089556|82874110|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
46661579|NCT01089556|82874111|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
46661580|NCT01089127|82874129|FG000|Overall Study|Adverse Event|5|||
46661581|NCT01089127|82874130|FG001|Overall Study|Adverse Event|1|||
46661582|NCT01089127|82874131|FG002|Overall Study|Adverse Event|1|||
46661583|NCT01089127|82874132|FG003|Overall Study|Adverse Event|0|||
46783029|NCT00549718|83001808|FG002|Overall Study|Lost to Follow-up|0|||
46783030|NCT00549718|83001809|FG003|Overall Study|Lost to Follow-up|6|||
46783031|NCT00549718|83001806|FG000|Overall Study|Withdrawal by Subject|9|||
46783032|NCT00549718|83001807|FG001|Overall Study|Withdrawal by Subject|18|||
46783033|NCT00549718|83001808|FG002|Overall Study|Withdrawal by Subject|12|||
46661584|NCT01089127|82874133|FG004|Overall Study|Adverse Event|0|||
46661585|NCT01089127|82874134|FG005|Overall Study|Adverse Event|1|||
46661586|NCT01089127|82874129|FG000|Overall Study|Subject withdrew consent|0|||
46661587|NCT01089127|82874130|FG001|Overall Study|Subject withdrew consent|1|||
46661588|NCT01089127|82874131|FG002|Overall Study|Subject withdrew consent|1|||
46661589|NCT01089127|82874132|FG003|Overall Study|Subject withdrew consent|1|||
46661590|NCT01089127|82874133|FG004|Overall Study|Subject withdrew consent|0|||
46661591|NCT01089127|82874134|FG005|Overall Study|Subject withdrew consent|2|||
46661592|NCT01089127|82874129|FG000|Overall Study|Abnormal test procedure result(s)|2|||
46783034|NCT00549718|83001809|FG003|Overall Study|Withdrawal by Subject|13|||
46851042|NCT03615040|83066792|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
46851043|NCT03615040|83066791|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
46661593|NCT01089127|82874130|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46661594|NCT01089127|82874131|FG002|Overall Study|Abnormal test procedure result(s)|0|||
46661595|NCT01089127|82874132|FG003|Overall Study|Abnormal test procedure result(s)|0|||
46661596|NCT01089127|82874133|FG004|Overall Study|Abnormal test procedure result(s)|0|||
46783035|NCT00549718|83001806|FG000|Overall Study|Administrative|2|||
46783036|NCT00549718|83001807|FG001|Overall Study|Administrative|2|||
46783037|NCT00549718|83001808|FG002|Overall Study|Administrative|2|||
46783038|NCT00549718|83001809|FG003|Overall Study|Administrative|1|||
46783039|NCT00371761|83001821|FG000|Overall Study|Adverse Event|1|||
46783040|NCT00371761|83001822|FG001|Overall Study|Adverse Event|1|||
46661597|NCT01089127|82874134|FG005|Overall Study|Abnormal test procedure result(s)|0|||
46661598|NCT01089127|82874129|FG000|Overall Study|Lost to Follow-up|1|||
46661599|NCT01089127|82874130|FG001|Overall Study|Lost to Follow-up|1|||
46661600|NCT01089127|82874131|FG002|Overall Study|Lost to Follow-up|0|||
46661601|NCT01089127|82874132|FG003|Overall Study|Lost to Follow-up|0|||
46661602|NCT01089127|82874133|FG004|Overall Study|Lost to Follow-up|1|||
46661603|NCT01089127|82874134|FG005|Overall Study|Lost to Follow-up|0|||
46661604|NCT01089127|82874129|FG000|Overall Study|Protocol deviation|0|||
46661605|NCT01089127|82874130|FG001|Overall Study|Protocol deviation|1|||
46661606|NCT01089127|82874131|FG002|Overall Study|Protocol deviation|0|||
46661607|NCT01089127|82874132|FG003|Overall Study|Protocol deviation|0|||
46661608|NCT01089127|82874133|FG004|Overall Study|Protocol deviation|1|||
46661609|NCT01089127|82874134|FG005|Overall Study|Protocol deviation|0|||
46661610|NCT01087957|82874150|FG000|Overall Study|Death|2|||
46661611|NCT01087957|82874151|FG001|Overall Study|Death|2|||
46661612|NCT01087957|82874150|FG000|Overall Study|Lost to Follow-up|3|||
46661613|NCT01087957|82874151|FG001|Overall Study|Lost to Follow-up|4|||
46661614|NCT01087957|82874150|FG000|Overall Study|Protocol Violation|13|||
46661615|NCT01087957|82874151|FG001|Overall Study|Protocol Violation|25|||
46661616|NCT01087957|82874150|FG000|Overall Study|Withdrawal by Subject|18|||
46661617|NCT01087957|82874151|FG001|Overall Study|Withdrawal by Subject|15|||
46661618|NCT01087957|82874150|FG000|Overall Study|Physician Decision|5|||
46661619|NCT01087957|82874151|FG001|Overall Study|Physician Decision|9|||
46661620|NCT01087723|82874159|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
46661621|NCT01087723|82874160|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
46661622|NCT01087723|82874159|FG000|Overall Study|Withdrawal by Subject|10|||
46661623|NCT01087723|82874160|FG001|Overall Study|Withdrawal by Subject|13|||
46661624|NCT01087723|82874159|FG000|Overall Study|Physician Decision|2|||
46661625|NCT01087723|82874160|FG001|Overall Study|Physician Decision|0|||
46661626|NCT01087723|82874159|FG000|Overall Study|Lost to Follow-up|1|||
46661627|NCT01087723|82874160|FG001|Overall Study|Lost to Follow-up|4|||
46661628|NCT01087723|82874159|FG000|Overall Study|Reason Not Specified|1|||
46661629|NCT01087723|82874160|FG001|Overall Study|Reason Not Specified|2|||
46661630|NCT01087528|82874166|FG000|Overall Study|Withdrawal by Subject|1|||
46661631|NCT01087528|82874166|FG000|Overall Study|Incomplete CE procedure|6|||
46661632|NCT01085812|82874172|FG000|Open-Label Period|Adverse Event|0|||
46661633|NCT01085812|82874173|FG001|Open-Label Period|Adverse Event|80|||
46661634|NCT01085812|82874172|FG000|Open-Label Period|Lack of Efficacy|0|||
46661635|NCT01085812|82874173|FG001|Open-Label Period|Lack of Efficacy|26|||
46661636|NCT01085812|82874172|FG000|Open-Label Period|Protocol Violation|0|||
46661637|NCT01085812|82874173|FG001|Open-Label Period|Protocol Violation|39|||
46661638|NCT01085812|82874172|FG000|Open-Label Period|Withdrawal by Subject|0|||
46661639|NCT01085812|82874173|FG001|Open-Label Period|Withdrawal by Subject|53|||
46661640|NCT01085812|82874172|FG000|Open-Label Period|Lost to Follow-up|0|||
46661641|NCT01085812|82874173|FG001|Open-Label Period|Lost to Follow-up|42|||
46661642|NCT01085812|82874172|FG000|Double-Blind Period|Adverse Event|3|||
46661643|NCT01085812|82874173|FG001|Double-Blind Period|Adverse Event|8|||
46661644|NCT01085812|82874172|FG000|Double-Blind Period|Protocol Violation|2|||
46661645|NCT01085812|82874173|FG001|Double-Blind Period|Protocol Violation|7|||
46661646|NCT01085812|82874172|FG000|Double-Blind Period|Withdrawal by Subject|11|||
46661647|NCT01085812|82874173|FG001|Double-Blind Period|Withdrawal by Subject|24|||
46661648|NCT01085812|82874172|FG000|Double-Blind Period|Lost to Follow-up|5|||
46661649|NCT01085812|82874173|FG001|Double-Blind Period|Lost to Follow-up|17|||
46661650|NCT01085812|82874172|FG000|Double-Blind Period|Other Reasons|0|||
46661651|NCT01085812|82874173|FG001|Double-Blind Period|Other Reasons|2|||
46661652|NCT01085812|82874172|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
46661653|NCT01085812|82874173|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
46661654|NCT01085812|82874172|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
46661655|NCT01085812|82874173|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
46661656|NCT01085812|82874172|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
46661657|NCT01085812|82874173|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
46661658|NCT01085812|82874172|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
46661659|NCT01085812|82874173|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
46661660|NCT01085812|82874172|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
46661661|NCT01085812|82874173|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
46661662|NCT01085734|82874182|FG000|Overall Study|Adverse Event|0|||
46661663|NCT01085734|82874183|FG001|Overall Study|Adverse Event|2|||
46851044|NCT03615040|83066792|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
46661664|NCT01085734|82874182|FG000|Overall Study|Death|1|||
46661665|NCT01085734|82874183|FG001|Overall Study|Death|0|||
46661666|NCT01085734|82874182|FG000|Overall Study|Lost to Follow-up|0|||
46661667|NCT01085734|82874183|FG001|Overall Study|Lost to Follow-up|1|||
46661668|NCT01085734|82874182|FG000|Overall Study|Withdrawal by Subject|0|||
46661669|NCT01085734|82874183|FG001|Overall Study|Withdrawal by Subject|1|||
46661670|NCT01084603|82874190|FG000|Baseline|Withdrawal by Subject|2|||
46851045|NCT03615040|83066791|FG000|Overall Study|Death|0|||
46661671|NCT01084603|82874190|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
46661672|NCT01084603|82874190|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
46661673|NCT01084603|82874190|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
46661674|NCT01084603|82874190|FG000|Washout Period 4|Adverse Event|1|||
46661675|NCT01084174|82874205|FG000|Overall Study|gastrointestinal symptoms|1|||
46661676|NCT01084174|82874206|FG001|Overall Study|gastrointestinal symptoms|1|||
46661677|NCT01084174|82874205|FG000|Overall Study|Eosinophilic esophagitis|0|||
46661678|NCT01084174|82874206|FG001|Overall Study|Eosinophilic esophagitis|1|||
46661679|NCT01084174|82874205|FG000|Overall Study|Anaphylaxis|0|||
46661680|NCT01084174|82874206|FG001|Overall Study|Anaphylaxis|1|||
46661681|NCT01084174|82874205|FG000|Overall Study|Participant noncompliance|0|||
46661682|NCT01084174|82874206|FG001|Overall Study|Participant noncompliance|1|||
46661683|NCT01084135|82874216|FG000|20 Week|Physician Decision|0|||
46661684|NCT01084135|82874217|FG001|20 Week|Physician Decision|1|||
46661685|NCT01083316|82874225|FG000|Overall Study|Adverse Event|2|||
46661686|NCT01083316|82874225|FG000|Overall Study|Withdrawal by Subject|1|||
46661687|NCT01083160|82874230|FG000|Overall Study|Adverse Event|1|||
46661688|NCT01083121|82874234|FG000|Overall Study|Use of Humira outside the approved label|81|||
46661689|NCT01082614|82874244|FG000|Overall Study|Adverse Event|1|||
46661690|NCT01082614|82874245|FG001|Overall Study|Adverse Event|4|||
46661691|NCT01082614|82874244|FG000|Overall Study|Equipment Malfunction|0|||
46661692|NCT01082614|82874245|FG001|Overall Study|Equipment Malfunction|1|||
46661693|NCT01082614|82874244|FG000|Overall Study|Physician Decision|2|||
46661694|NCT01082614|82874245|FG001|Overall Study|Physician Decision|0|||
46661695|NCT01081873|82874251|FG000|Overall Study|Death|86|||
46661696|NCT01081873|82874251|FG000|Overall Study|Withdrawal by Subject|10|||
46661697|NCT01081873|82874251|FG000|Overall Study|Lost to Follow-up|142|||
46661698|NCT01081873|82874251|FG000|Overall Study|Progression of prostate cancer|13|||
46661699|NCT01081873|82874251|FG000|Overall Study|Other|47|||
46661700|NCT01081795|82874283|FG000|Overall Study|Adverse Event|18|||
46661701|NCT01081795|82874284|FG001|Overall Study|Adverse Event|23|||
46661702|NCT01081795|82874285|FG002|Overall Study|Adverse Event|6|||
46661703|NCT01081795|82874283|FG000|Overall Study|Lack of Efficacy|7|||
46661704|NCT01081795|82874284|FG001|Overall Study|Lack of Efficacy|5|||
46661705|NCT01081795|82874285|FG002|Overall Study|Lack of Efficacy|19|||
46661706|NCT01081795|82874283|FG000|Overall Study|Subject's schedule|1|||
46661707|NCT01081795|82874284|FG001|Overall Study|Subject's schedule|1|||
46661708|NCT01081795|82874285|FG002|Overall Study|Subject's schedule|2|||
46661709|NCT01081795|82874283|FG000|Overall Study|Revocation of informed consent|2|||
46661710|NCT01081795|82874284|FG001|Overall Study|Revocation of informed consent|0|||
46661711|NCT01081795|82874285|FG002|Overall Study|Revocation of informed consent|0|||
46661712|NCT01081795|82874283|FG000|Overall Study|Ineligible for participation|1|||
46661713|NCT01081795|82874284|FG001|Overall Study|Ineligible for participation|0|||
46661714|NCT01081795|82874285|FG002|Overall Study|Ineligible for participation|0|||
46783041|NCT00371761|83001821|FG000|Overall Study|Withdrawal by Subject|1|||
46783042|NCT00371761|83001822|FG001|Overall Study|Withdrawal by Subject|3|||
46783043|NCT00371761|83001821|FG000|Overall Study|Investigator Judgment|2|||
46783044|NCT00371761|83001822|FG001|Overall Study|Investigator Judgment|3|||
46971982|NCT02670083|83215543|FG001|Overall Study|Withdrawal by Subject|31|||
46971983|NCT02670083|83215542|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46971984|NCT02670083|83215543|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46971985|NCT02669849|83215553|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
46971986|NCT02669849|83215554|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
46971987|NCT02669849|83215555|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
46971988|NCT02669849|83215553|FG000|Overall Study|Lost to Follow-up|1|||
46971989|NCT02669849|83215554|FG001|Overall Study|Lost to Follow-up|0|||
46971990|NCT02669849|83215555|FG002|Overall Study|Lost to Follow-up|3|||
46661715|NCT01081795|82874283|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
46661716|NCT01081795|82874284|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
46661717|NCT01081795|82874285|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
46661718|NCT01081795|82874283|FG000|Overall Study|Using drug with restricted days of use|2|||
46783045|NCT00371761|83001821|FG000|Overall Study|Study termination|4|||
46783046|NCT00371761|83001822|FG001|Overall Study|Study termination|3|||
46783047|NCT00549640|83001830|FG000|Overall Study|Withdrawal by Subject|6|||
46971991|NCT02669849|83215553|FG000|Overall Study|Death|1|||
46971992|NCT02669849|83215554|FG001|Overall Study|Death|1|||
46971993|NCT02669849|83215555|FG002|Overall Study|Death|2|||
46971994|NCT02669849|83215553|FG000|Overall Study|Study terminated by sponsor|16|||
46971995|NCT02669849|83215554|FG001|Overall Study|Study terminated by sponsor|1|||
46971996|NCT02669849|83215555|FG002|Overall Study|Study terminated by sponsor|14|||
46971997|NCT02669849|83215553|FG000|Overall Study|Other|0|||
46971998|NCT02669849|83215554|FG001|Overall Study|Other|0|||
46971999|NCT02669849|83215555|FG002|Overall Study|Other|2|||
46972000|NCT03625895|83215563|FG000|Overall Study|Protocol Violation|585|||
46972001|NCT02663687|83215572|FG000|Overall Study|Adverse Event|1|||
46972002|NCT02663687|83215573|FG001|Overall Study|Adverse Event|0|||
46972003|NCT02663687|83215574|FG002|Overall Study|Adverse Event|0|||
46972004|NCT02663687|83215575|FG003|Overall Study|Adverse Event|0|||
46972005|NCT02663687|83215576|FG004|Overall Study|Adverse Event|0|||
46972006|NCT02663687|83215572|FG000|Overall Study|Other|1|||
46972007|NCT02663687|83215573|FG001|Overall Study|Other|0|||
46972008|NCT02663687|83215574|FG002|Overall Study|Other|1|||
46972009|NCT02663687|83215575|FG003|Overall Study|Other|0|||
46972010|NCT02663687|83215576|FG004|Overall Study|Other|0|||
46972011|NCT02663453|83215607|FG000|Overall Study|Death|4|||
46972012|NCT02663453|83215608|FG001|Overall Study|Death|4|||
46972013|NCT02663453|83215607|FG000|Overall Study|Withdrawal by Subject|1|||
46972014|NCT02663453|83215608|FG001|Overall Study|Withdrawal by Subject|0|||
46972015|NCT02055118|83215617|FG000|Overall Study|Withdrawal by Subject|0|||
46972016|NCT02055118|83215618|FG001|Overall Study|Withdrawal by Subject|2|||
46972017|NCT02055118|83215619|FG002|Overall Study|Withdrawal by Subject|0|||
46972018|NCT02084056|83215630|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
46661719|NCT01081795|82874284|FG001|Overall Study|Using drug with restricted days of use|3|||
46661720|NCT01081795|82874285|FG002|Overall Study|Using drug with restricted days of use|2|||
46661721|NCT01081795|82874283|FG000|Overall Study|Other|1|||
46661722|NCT01081795|82874284|FG001|Overall Study|Other|2|||
46661723|NCT01081795|82874285|FG002|Overall Study|Other|0|||
46661724|NCT01081678|82874297|FG000|Overall Study|Ineligibility Determined|0|||
46661725|NCT01081678|82874298|FG001|Overall Study|Ineligibility Determined|0|||
46661726|NCT01081678|82874299|FG002|Overall Study|Ineligibility Determined|1|||
46661727|NCT01081678|82874300|FG003|Overall Study|Ineligibility Determined|1|||
46661728|NCT01081678|82874297|FG000|Overall Study|Noncompliance|3|||
46661729|NCT01081678|82874298|FG001|Overall Study|Noncompliance|4|||
46661730|NCT01081678|82874299|FG002|Overall Study|Noncompliance|5|||
46661731|NCT01081678|82874300|FG003|Overall Study|Noncompliance|2|||
46661732|NCT01081678|82874297|FG000|Overall Study|Adverse Event|2|||
46661733|NCT01081678|82874298|FG001|Overall Study|Adverse Event|1|||
46661734|NCT01081678|82874299|FG002|Overall Study|Adverse Event|2|||
46661735|NCT01081678|82874300|FG003|Overall Study|Adverse Event|2|||
46661736|NCT01081678|82874297|FG000|Overall Study|Withdrawal by Subject|15|||
46661737|NCT01081678|82874298|FG001|Overall Study|Withdrawal by Subject|7|||
46661738|NCT01081678|82874299|FG002|Overall Study|Withdrawal by Subject|17|||
46661739|NCT01081678|82874300|FG003|Overall Study|Withdrawal by Subject|14|||
46661740|NCT01081678|82874297|FG000|Overall Study|Administrative Decision|1|||
46661741|NCT01081678|82874298|FG001|Overall Study|Administrative Decision|0|||
46661742|NCT01081678|82874299|FG002|Overall Study|Administrative Decision|0|||
46661743|NCT01081678|82874300|FG003|Overall Study|Administrative Decision|1|||
46661744|NCT01081678|82874297|FG000|Overall Study|Lost to Follow-up|4|||
46661745|NCT01081678|82874298|FG001|Overall Study|Lost to Follow-up|1|||
46661746|NCT01081678|82874299|FG002|Overall Study|Lost to Follow-up|4|||
46661747|NCT01081678|82874300|FG003|Overall Study|Lost to Follow-up|3|||
46661748|NCT01081678|82874297|FG000|Overall Study|Death|2|||
46661749|NCT01081678|82874298|FG001|Overall Study|Death|2|||
46661750|NCT01081678|82874299|FG002|Overall Study|Death|2|||
46661751|NCT01081678|82874300|FG003|Overall Study|Death|6|||
46661752|NCT01081678|82874297|FG000|Overall Study|Other|0|||
46972019|NCT02084056|83215631|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
46661753|NCT01081678|82874298|FG001|Overall Study|Other|1|||
46661754|NCT01081678|82874299|FG002|Overall Study|Other|0|||
46661755|NCT01081678|82874300|FG003|Overall Study|Other|0|||
46661756|NCT01081249|82874310|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
46661757|NCT01081249|82874311|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
46661758|NCT01081132|82874319|FG000|Overall Study|Lack of Efficacy|25|||
46661759|NCT01081132|82874320|FG001|Overall Study|Lack of Efficacy|9|||
46661760|NCT01081132|82874319|FG000|Overall Study|Withdrawal by Subject|13|||
46661761|NCT01081132|82874320|FG001|Overall Study|Withdrawal by Subject|16|||
46661762|NCT01081132|82874319|FG000|Overall Study|Lost to Follow-up|4|||
46661763|NCT01081132|82874320|FG001|Overall Study|Lost to Follow-up|11|||
46661764|NCT01081132|82874319|FG000|Overall Study|Adverse Event|3|||
46661765|NCT01081132|82874320|FG001|Overall Study|Adverse Event|9|||
46661766|NCT01081132|82874319|FG000|Overall Study|Non Compliance|4|||
46661767|NCT01081132|82874320|FG001|Overall Study|Non Compliance|2|||
46972020|NCT02084056|83215632|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
46972021|NCT02084056|83215633|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
46972022|NCT02084056|83215630|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
46661768|NCT01081132|82874319|FG000|Overall Study|Lack Of Compliance|0|||
46661769|NCT01081132|82874320|FG001|Overall Study|Lack Of Compliance|1|||
46661770|NCT01081132|82874319|FG000|Overall Study|Missed Visits|1|||
46661771|NCT01081132|82874320|FG001|Overall Study|Missed Visits|1|||
46661772|NCT01081132|82874319|FG000|Overall Study|Stopped Taking Meds|2|||
46661773|NCT01081132|82874320|FG001|Overall Study|Stopped Taking Meds|0|||
46661774|NCT01081132|82874319|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
46661775|NCT01081132|82874320|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
46661776|NCT01081132|82874319|FG000|Overall Study|Declined Taper Phase|0|||
46661777|NCT01081132|82874320|FG001|Overall Study|Declined Taper Phase|1|||
46661778|NCT01081132|82874319|FG000|Overall Study|Protocol Violation|3|||
46661779|NCT01081132|82874320|FG001|Overall Study|Protocol Violation|1|||
46661780|NCT01080625|82874329|FG000|Overall Study|Physician Decision|0|||
46661781|NCT01080625|82874330|FG001|Overall Study|Physician Decision|2|||
46661782|NCT01080625|82874331|FG002|Overall Study|Physician Decision|1|||
46661783|NCT01059903|82874341|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
46661784|NCT01059903|82874342|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
46661785|NCT05562011|82874377|FG000|Overall Study|Withdrawal by Subject|3|||
46661786|NCT05562011|82874377|FG000|Overall Study|Lost to Follow-up|1|||
46661787|NCT05562011|82874377|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
46661788|NCT05562011|82874377|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
46661789|NCT05562011|82874377|FG000|Overall Study|Device malfunction|13|||
46661790|NCT05089708|82874436|FG000|Overall Study|Lost to Follow-up|9|||
46661791|NCT05089708|82874437|FG001|Overall Study|Lost to Follow-up|7|||
46661792|NCT05089708|82874436|FG000|Overall Study|Withdrawal by Subject|3|||
46661793|NCT05089708|82874437|FG001|Overall Study|Withdrawal by Subject|1|||
46783048|NCT00549640|83001831|FG001|Overall Study|Withdrawal by Subject|12|||
46783049|NCT00549640|83001830|FG000|Overall Study|Adverse Event|5|||
46972023|NCT02084056|83215631|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
46972024|NCT02084056|83215632|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
46972025|NCT02084056|83215633|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
46972026|NCT01625182|83215645|FG000|Overall Study|Administrative problems|1|||
46972027|NCT01625182|83215646|FG001|Overall Study|Administrative problems|0|||
46972028|NCT01625182|83215645|FG000|Overall Study|Protocol deviation|0|||
46972029|NCT01625182|83215646|FG001|Overall Study|Protocol deviation|2|||
46972030|NCT01625182|83215645|FG000|Overall Study|Adverse Event|2|||
46972031|NCT01625182|83215646|FG001|Overall Study|Adverse Event|0|||
46972032|NCT01625182|83215645|FG000|Overall Study|Withdrawal by Subject|5|||
46972033|NCT01625182|83215646|FG001|Overall Study|Withdrawal by Subject|1|||
46972034|NCT01625182|83215645|FG000|Overall Study|Lack of Efficacy|12|||
46972035|NCT01625182|83215646|FG001|Overall Study|Lack of Efficacy|8|||
46972036|NCT02661815|83215657|FG000|Overall Study|Withdrawal by Subject|1|||
46972037|NCT02661815|83215658|FG001|Overall Study|Withdrawal by Subject|0|||
46972038|NCT02661815|83215659|FG002|Overall Study|Withdrawal by Subject|0|||
46972039|NCT02661815|83215660|FG003|Overall Study|Withdrawal by Subject|0|||
46972040|NCT02053792|83215676|FG000|Overall Study|Physician Decision|0|||
46972041|NCT02053792|83215677|FG001|Overall Study|Physician Decision|1|||
46972042|NCT02053792|83215676|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
46972043|NCT02053792|83215677|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
46972044|NCT02053792|83215676|FG000|Overall Study|Lack of Efficacy|1|||
46972045|NCT02053792|83215677|FG001|Overall Study|Lack of Efficacy|0|||
46972046|NCT02053792|83215676|FG000|Overall Study|Adverse Event|1|||
46972047|NCT02053792|83215677|FG001|Overall Study|Adverse Event|0|||
46972048|NCT02053792|83215676|FG000|Overall Study|Withdrawal by Subject|2|||
46972049|NCT02053792|83215677|FG001|Overall Study|Withdrawal by Subject|2|||
46972050|NCT02053792|83215676|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
46972051|NCT02053792|83215677|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
46661794|NCT05089708|82874436|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
46661795|NCT05089708|82874437|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
46661796|NCT05089708|82874436|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
46972052|NCT02053792|83215676|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
46972053|NCT02053792|83215677|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
46972054|NCT02082340|83215685|FG000|Overall Study|Lost to Follow-up|1|||
46972055|NCT02082340|83215686|FG001|Overall Study|Lost to Follow-up|1|||
46972056|NCT02053246|83215692|FG000|Overall Study|Withdrawal by Subject|3|||
46661797|NCT05089708|82874437|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
46661798|NCT04642638|82874489|FG000|Overall Study|Withdrawal by Subject|23|||
46783050|NCT00549640|83001831|FG001|Overall Study|Adverse Event|0|||
46783051|NCT00549640|83001830|FG000|Overall Study|Lost to Follow-up|7|||
46783052|NCT00549640|83001831|FG001|Overall Study|Lost to Follow-up|4|||
46972057|NCT02053246|83215692|FG000|Overall Study|Physician Decision|1|||
46972058|NCT02053168|83215696|FG000|Overall Study|Withdrawal by Subject|1|||
46661799|NCT04642638|82874490|FG001|Overall Study|Withdrawal by Subject|29|||
46661800|NCT04642638|82874491|FG002|Overall Study|Withdrawal by Subject|9|||
46661801|NCT04642638|82874492|FG003|Overall Study|Withdrawal by Subject|7|||
46661802|NCT04642638|82874493|FG004|Overall Study|Withdrawal by Subject|61|||
46661803|NCT04642638|82874494|FG005|Overall Study|Withdrawal by Subject|27|||
46661804|NCT04642638|82874489|FG000|Overall Study|Lost to Follow-up|17|||
46661805|NCT04642638|82874490|FG001|Overall Study|Lost to Follow-up|18|||
46661806|NCT04642638|82874491|FG002|Overall Study|Lost to Follow-up|5|||
46661807|NCT04642638|82874492|FG003|Overall Study|Lost to Follow-up|5|||
46661808|NCT04642638|82874493|FG004|Overall Study|Lost to Follow-up|6|||
46661809|NCT04642638|82874494|FG005|Overall Study|Lost to Follow-up|3|||
46661810|NCT04642638|82874489|FG000|Overall Study|Adverse Event|0|||
46661811|NCT04642638|82874490|FG001|Overall Study|Adverse Event|0|||
46661812|NCT04642638|82874491|FG002|Overall Study|Adverse Event|1|||
46661813|NCT04642638|82874492|FG003|Overall Study|Adverse Event|0|||
46661814|NCT04642638|82874493|FG004|Overall Study|Adverse Event|10|||
46661815|NCT04642638|82874494|FG005|Overall Study|Adverse Event|3|||
46661816|NCT04642638|82874489|FG000|Overall Study|Reason Not Specified|1|||
46661817|NCT04642638|82874490|FG001|Overall Study|Reason Not Specified|4|||
46661818|NCT04642638|82874491|FG002|Overall Study|Reason Not Specified|0|||
46661819|NCT04642638|82874492|FG003|Overall Study|Reason Not Specified|0|||
46661820|NCT04642638|82874493|FG004|Overall Study|Reason Not Specified|38|||
46661821|NCT04642638|82874494|FG005|Overall Study|Reason Not Specified|16|||
46661822|NCT04642638|82874489|FG000|Overall Study|Physician Decision|0|||
46661823|NCT04642638|82874490|FG001|Overall Study|Physician Decision|0|||
46661824|NCT04642638|82874491|FG002|Overall Study|Physician Decision|0|||
46661825|NCT04642638|82874492|FG003|Overall Study|Physician Decision|0|||
46661826|NCT04642638|82874493|FG004|Overall Study|Physician Decision|2|||
46661827|NCT04642638|82874494|FG005|Overall Study|Physician Decision|1|||
46661828|NCT04642638|82874489|FG000|Overall Study|Protocol Deviation|0|||
46661829|NCT04642638|82874490|FG001|Overall Study|Protocol Deviation|0|||
46661830|NCT04642638|82874491|FG002|Overall Study|Protocol Deviation|0|||
46661831|NCT04642638|82874492|FG003|Overall Study|Protocol Deviation|0|||
46661832|NCT04642638|82874493|FG004|Overall Study|Protocol Deviation|1|||
46661833|NCT04642638|82874494|FG005|Overall Study|Protocol Deviation|3|||
46661834|NCT04642638|82874489|FG000|Overall Study|Study Terminated|0|||
46661835|NCT04642638|82874490|FG001|Overall Study|Study Terminated|0|||
46661836|NCT04642638|82874491|FG002|Overall Study|Study Terminated|0|||
46661837|NCT04642638|82874492|FG003|Overall Study|Study Terminated|0|||
46661838|NCT04642638|82874493|FG004|Overall Study|Study Terminated|484|||
46661839|NCT04642638|82874494|FG005|Overall Study|Study Terminated|250|||
46661840|NCT04642638|82874489|FG000|Overall Study|Pregnancy|0|||
46661841|NCT04642638|82874490|FG001|Overall Study|Pregnancy|0|||
46661842|NCT04642638|82874491|FG002|Overall Study|Pregnancy|0|||
46661843|NCT04642638|82874492|FG003|Overall Study|Pregnancy|0|||
46661844|NCT04642638|82874493|FG004|Overall Study|Pregnancy|1|||
46661845|NCT04642638|82874494|FG005|Overall Study|Pregnancy|0|||
46661846|NCT04634825|82874512|FG000|Overall Study|Death|10|||
46661847|NCT04634825|82874513|FG001|Overall Study|Death|3|||
46661848|NCT04634825|82874512|FG000|Overall Study|Lost to Follow-up|1|||
46661849|NCT04634825|82874513|FG001|Overall Study|Lost to Follow-up|0|||
46661850|NCT04634825|82874512|FG000|Overall Study|Study terminated by sponsor|35|||
46661851|NCT04634825|82874513|FG001|Overall Study|Study terminated by sponsor|11|||
46661852|NCT04634825|82874512|FG000|Overall Study|Withdrawal by Subject|2|||
46661853|NCT04634825|82874513|FG001|Overall Study|Withdrawal by Subject|0|||
46661854|NCT04398537|82874527|FG000|Overall Study|Physician Decision|10|||
46661855|NCT04398537|82874528|FG001|Overall Study|Physician Decision|15|||
46661856|NCT04176939|82874548|FG000|Overall Study|Adverse Event|7|||
46661857|NCT04176939|82874548|FG000|Overall Study|Unspecified reason|2|||
46661858|NCT04176939|82874548|FG000|Overall Study|Migrated/Moved from the study area|1|||
46661859|NCT04176939|82874548|FG000|Overall Study|Withdrawal by Subject|4|||
46783053|NCT00549562|83001853|FG000|Overall Study|Adverse Event|1|||
46783054|NCT00549562|83001853|FG000|Overall Study|Lack of Efficacy|1|||
47076231|NCT02450331|83370857|FG001|Overall Study|Death|171|||
47076232|NCT02450331|83370856|FG000|Overall Study|Lost to Follow-up|14|||
46661860|NCT04176939|82874548|FG000|Overall Study|In follow-up|54|||
46661861|NCT03894891|82874568|FG000|Overall Study|Withdrawal by Subject|1|||
46661862|NCT03894891|82874568|FG000|Overall Study|Completed protocol treatment per protocol|5|||
46783055|NCT00681564|83001859|FG000|Overall Study|Lost to Follow-up|6|||
46783056|NCT00681564|83001860|FG001|Overall Study|Lost to Follow-up|6|||
46661863|NCT03863080|82874575|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
46661864|NCT03863080|82874576|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
46661865|NCT03863080|82874577|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
46661866|NCT03863080|82874578|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
46661867|NCT03863080|82874575|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
46661868|NCT03863080|82874576|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
46661869|NCT03863080|82874577|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
46783057|NCT00681564|83001859|FG000|Overall Study|Withdrawal by Subject|0|||
46661870|NCT03863080|82874578|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
46661871|NCT03863080|82874575|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
46661872|NCT03863080|82874576|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
46661873|NCT03863080|82874577|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
46661874|NCT03863080|82874578|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
46661875|NCT03834493|82874593|FG000|Overall Study|Participants Ongoing|311|||
46661876|NCT03834493|82874594|FG001|Overall Study|Participants Ongoing|324|||
46661877|NCT03834493|82874593|FG000|Overall Study|Withdrawal by Subject|20|||
46661878|NCT03834493|82874594|FG001|Overall Study|Withdrawal by Subject|17|||
46661879|NCT03834493|82874593|FG000|Overall Study|Physician Decision|1|||
46661880|NCT03834493|82874594|FG001|Overall Study|Physician Decision|0|||
46661881|NCT03834493|82874593|FG000|Overall Study|Death|289|||
46661882|NCT03834493|82874594|FG001|Overall Study|Death|282|||
46661883|NCT03483103|82874601|FG000|Pre-Treatment Phase|Other reasons|1|||
46661884|NCT03483103|82874601|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
46661885|NCT03483103|82874601|FG000|Pre-Treatment Phase|Disease-related complications|1|||
46661886|NCT03483103|82874601|FG000|Pre-Treatment Phase|Death|5|||
46661887|NCT03483103|82874601|FG000|Treatment Phase|Withdrawal by Subject|7|||
46661888|NCT03483103|82874601|FG000|Treatment Phase|Other reasons|1|||
46661889|NCT03483103|82874601|FG000|Treatment Phase|Death|23|||
46661890|NCT03483103|82874601|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
46661891|NCT03483103|82874601|FG000|Treatment Phase|Received nonconforming product|1|||
46661892|NCT03412747|82874617|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
46661893|NCT03412747|82874618|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
46661894|NCT03412747|82874619|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
46661895|NCT03412747|82874617|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
46661896|NCT03412747|82874618|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
46661897|NCT03412747|82874619|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
46661898|NCT03412747|82874617|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
46661899|NCT03412747|82874618|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
46661900|NCT03412747|82874619|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
46661901|NCT03412747|82874617|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
46661902|NCT03412747|82874618|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
46661903|NCT03412747|82874619|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
46661904|NCT03412747|82874617|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
46783058|NCT00681564|83001860|FG001|Overall Study|Withdrawal by Subject|1|||
46783059|NCT00681564|83001859|FG000|Overall Study|Death|0|||
46783060|NCT00681564|83001860|FG001|Overall Study|Death|1|||
46783061|NCT00677352|83001868|FG000|Treatment Phase|Adverse Event|14|||
46783062|NCT00677352|83001869|FG001|Treatment Phase|Adverse Event|22|||
46783063|NCT00677352|83001868|FG000|Treatment Phase|Lack of Efficacy|2|||
46783064|NCT00677352|83001869|FG001|Treatment Phase|Lack of Efficacy|3|||
46783065|NCT00677352|83001868|FG000|Treatment Phase|Lost to Follow-up|0|||
46783066|NCT00677352|83001869|FG001|Treatment Phase|Lost to Follow-up|1|||
46783067|NCT00677352|83001868|FG000|Treatment Phase|Withdrawal by Subject|7|||
46783068|NCT00677352|83001869|FG001|Treatment Phase|Withdrawal by Subject|7|||
46783069|NCT00677352|83001868|FG000|Treatment Phase|Physician Decision|1|||
46783070|NCT00677352|83001869|FG001|Treatment Phase|Physician Decision|0|||
46783071|NCT00677352|83001868|FG000|Treatment Phase|Pregnancy|0|||
46783072|NCT00677352|83001869|FG001|Treatment Phase|Pregnancy|1|||
46783073|NCT00677352|83001868|FG000|Treatment Phase|Protocol Violation|1|||
46783074|NCT00677352|83001869|FG001|Treatment Phase|Protocol Violation|1|||
46783075|NCT00677352|83001868|FG000|Treatment Phase|Transference or work related matter|0|||
46783076|NCT00677352|83001869|FG001|Treatment Phase|Transference or work related matter|5|||
46783077|NCT00677352|83001868|FG000|Treatment Phase|Not treated|0|||
46783078|NCT00677352|83001869|FG001|Treatment Phase|Not treated|2|||
46783079|NCT00677352|83001868|FG000|Tapering Phase|Adverse Event|1|||
46783080|NCT00677352|83001869|FG001|Tapering Phase|Adverse Event|5|||
46783081|NCT00677352|83001868|FG000|Tapering Phase|Withdrawal by Subject|5|||
46783082|NCT00677352|83001869|FG001|Tapering Phase|Withdrawal by Subject|3|||
46972059|NCT02053168|83215696|FG000|Overall Study|Physician Decision|1|||
46661905|NCT03412747|82874618|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
46661906|NCT03412747|82874619|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
46661907|NCT03412747|82874617|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
46661908|NCT03412747|82874618|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
46661909|NCT03412747|82874619|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
46661910|NCT03412747|82874617|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
46661911|NCT03412747|82874618|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
46783083|NCT00677352|83001868|FG000|Tapering Phase|Pregnancy|0|||
46783084|NCT00677352|83001869|FG001|Tapering Phase|Pregnancy|1|||
46783085|NCT00677352|83001868|FG000|Tapering Phase|Job transfer|0|||
46783086|NCT00677352|83001869|FG001|Tapering Phase|Job transfer|1|||
46783087|NCT00371683|83001882|FG000|DB Treatment Period-Randomized Patients|Death|1|||
46783088|NCT00371683|83001883|FG001|DB Treatment Period-Randomized Patients|Death|1|||
46661912|NCT03412747|82874619|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
46661913|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
46661914|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
46661915|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
46661916|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
46661917|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
46661918|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
46661919|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
46783089|NCT00371683|83001882|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
46783090|NCT00371683|83001883|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
46783091|NCT00371683|83001882|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
46783092|NCT00371683|83001883|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
46783093|NCT00371683|83001882|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
46783094|NCT00371683|83001883|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
46783095|NCT00371683|83001882|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
46783096|NCT00371683|83001883|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
46783097|NCT00371683|83001882|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
46783098|NCT00371683|83001883|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
46783099|NCT00371683|83001882|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
46783100|NCT00371683|83001883|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
46783101|NCT00371683|83001882|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
46783102|NCT00371683|83001883|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
46783103|NCT00371683|83001882|FG000|Follow-Up Period - Randomized Patients|Death|0|||
46783104|NCT00371683|83001883|FG001|Follow-Up Period - Randomized Patients|Death|2|||
46783105|NCT00371683|83001882|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
46783106|NCT00371683|83001883|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
46783107|NCT00371683|83001882|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
46783108|NCT00371683|83001883|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
46783109|NCT03951766|83001899|FG000|Treatment Phase|Lost to Follow-up|1|||
46783110|NCT03951766|83001899|FG000|Follow-up Phase|Lost to Follow-up|10|||
46783111|NCT00371137|83001908|FG000|Overall Study|Adverse Event|20|||
46783112|NCT00371137|83001909|FG001|Overall Study|Adverse Event|35|||
46783113|NCT00371137|83001910|FG002|Overall Study|Adverse Event|42|||
46783114|NCT00371137|83001908|FG000|Overall Study|Withdrawal by Subject|11|||
46783115|NCT00371137|83001909|FG001|Overall Study|Withdrawal by Subject|10|||
46783116|NCT00371137|83001910|FG002|Overall Study|Withdrawal by Subject|15|||
46783117|NCT00371137|83001908|FG000|Overall Study|Lost to Follow-up|6|||
46783118|NCT00371137|83001909|FG001|Overall Study|Lost to Follow-up|3|||
46783119|NCT00371137|83001910|FG002|Overall Study|Lost to Follow-up|5|||
46783120|NCT00371137|83001908|FG000|Overall Study|Lack of Efficacy|30|||
46783121|NCT00371137|83001909|FG001|Overall Study|Lack of Efficacy|12|||
46783122|NCT00371137|83001910|FG002|Overall Study|Lack of Efficacy|13|||
46783123|NCT00371137|83001908|FG000|Overall Study|Sponsor Decision|2|||
46783124|NCT00371137|83001909|FG001|Overall Study|Sponsor Decision|1|||
46783125|NCT00371137|83001910|FG002|Overall Study|Sponsor Decision|2|||
46783126|NCT00371137|83001908|FG000|Overall Study|Physician Decision|1|||
46783127|NCT00371137|83001909|FG001|Overall Study|Physician Decision|1|||
46783128|NCT00371137|83001910|FG002|Overall Study|Physician Decision|1|||
46851046|NCT03615040|83066792|FG001|Overall Study|Death|2|||
46851047|NCT00068822|83066800|FG000|First Randomized Intervention|Lost to Follow-up|1|||
46851048|NCT00068822|83066801|FG001|First Randomized Intervention|Lost to Follow-up|2|||
46851049|NCT00068588|83066810|FG000|Overall Study|Adverse Event|0|||
46851050|NCT00068588|83066811|FG001|Overall Study|Adverse Event|0|||
46851051|NCT00068588|83066812|FG002|Overall Study|Adverse Event|2|||
46972060|NCT02053168|83215696|FG000|Overall Study|Lost to Follow-up|1|||
46972061|NCT02052466|83215700|FG000|Overall Study|Withdrawal by Subject|1|||
46972062|NCT02052466|83215700|FG000|Overall Study|Acromial fracture|1|||
46972063|NCT02032888|83215707|FG000|Treatment Period|Poor compliance/noncompliance|1|||
46972064|NCT02032888|83215708|FG001|Treatment Period|Poor compliance/noncompliance|1|||
46972065|NCT02032888|83215709|FG002|Treatment Period|Poor compliance/noncompliance|0|||
46972066|NCT02032888|83215707|FG000|Treatment Period|Other|1|||
46972067|NCT02032888|83215708|FG001|Treatment Period|Other|1|||
46972068|NCT02032888|83215709|FG002|Treatment Period|Other|0|||
46783129|NCT00371137|83001908|FG000|Overall Study|Protocol Violation|2|||
46783130|NCT00371137|83001909|FG001|Overall Study|Protocol Violation|1|||
46783131|NCT00371137|83001910|FG002|Overall Study|Protocol Violation|1|||
46783132|NCT03753789|83001918|FG000|Overall Study|Withdrawal by Subject|2|||
46783133|NCT00616239|83001922|FG000|Overall Study|Withdrawal by Subject|2|||
46783134|NCT00547534|83001926|FG000|Overall Study|Adverse Event|7|||
46851052|NCT00068588|83066810|FG000|Overall Study|Withdrawal by Subject|0|||
46851053|NCT00068588|83066811|FG001|Overall Study|Withdrawal by Subject|0|||
46783135|NCT00547534|83001926|FG000|Overall Study|Disease Progression|4|||
46783136|NCT00384397|83001934|FG000|Overall Study|Adverse Event|0|||
46783137|NCT00384397|83001935|FG001|Overall Study|Adverse Event|1|||
46783138|NCT00384397|83001936|FG002|Overall Study|Adverse Event|2|||
46661920|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
46661921|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
46661922|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
46661923|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
46661924|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
46661925|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
46661926|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
46661927|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
46661928|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
46661929|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
46661930|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
46661931|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
46661932|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
46661933|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
46661934|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
46661935|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
46661936|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
46783139|NCT00384397|83001934|FG000|Overall Study|Protocol Violation|7|||
46783140|NCT00384397|83001935|FG001|Overall Study|Protocol Violation|15|||
46661937|NCT03412747|82874617|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
46661938|NCT03412747|82874618|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
46661939|NCT03412747|82874619|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
46661940|NCT03410992|82874639|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661941|NCT03410992|82874640|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
46661942|NCT03410992|82874641|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661943|NCT03410992|82874642|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661944|NCT03410992|82874643|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661945|NCT03410992|82874644|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661946|NCT03410992|82874645|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661947|NCT03410992|82874646|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661948|NCT03410992|82874647|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46783141|NCT00384397|83001936|FG002|Overall Study|Protocol Violation|13|||
46783142|NCT00384397|83001934|FG000|Overall Study|Lost to Follow-up|11|||
46783143|NCT00384397|83001935|FG001|Overall Study|Lost to Follow-up|13|||
46783144|NCT00384397|83001936|FG002|Overall Study|Lost to Follow-up|3|||
46783145|NCT00384397|83001934|FG000|Overall Study|Withdrawal by Subject|14|||
46783146|NCT00384397|83001935|FG001|Overall Study|Withdrawal by Subject|17|||
46783147|NCT00384397|83001936|FG002|Overall Study|Withdrawal by Subject|15|||
46783148|NCT00384085|83001947|FG000|Overall Study|Adverse Event|5|||
46783149|NCT00384085|83001948|FG001|Overall Study|Adverse Event|5|||
46783150|NCT00384085|83001949|FG002|Overall Study|Adverse Event|4|||
46783151|NCT00384085|83001947|FG000|Overall Study|Lack of Efficacy|0|||
46661949|NCT03410992|82874648|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46661950|NCT03410992|82874649|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
46783152|NCT00384085|83001948|FG001|Overall Study|Lack of Efficacy|3|||
46783153|NCT00384085|83001949|FG002|Overall Study|Lack of Efficacy|2|||
46783154|NCT00384085|83001947|FG000|Overall Study|No longer Requires Study Treatment|1|||
46783155|NCT00384085|83001948|FG001|Overall Study|No longer Requires Study Treatment|0|||
46783156|NCT00384085|83001949|FG002|Overall Study|No longer Requires Study Treatment|1|||
46783157|NCT00384085|83001947|FG000|Overall Study|Protocol Violation|2|||
46783158|NCT00384085|83001948|FG001|Overall Study|Protocol Violation|2|||
46783159|NCT00384085|83001949|FG002|Overall Study|Protocol Violation|2|||
46783160|NCT00384085|83001947|FG000|Overall Study|Lost to Follow-up|9|||
46783161|NCT00384085|83001948|FG001|Overall Study|Lost to Follow-up|9|||
46783162|NCT00384085|83001949|FG002|Overall Study|Lost to Follow-up|10|||
46783163|NCT00384085|83001947|FG000|Overall Study|Progressive Disease|0|||
46783164|NCT00384085|83001948|FG001|Overall Study|Progressive Disease|1|||
46783165|NCT00384085|83001949|FG002|Overall Study|Progressive Disease|0|||
46783166|NCT00384085|83001947|FG000|Overall Study|Withdrawal by Subject|14|||
46783167|NCT00384085|83001948|FG001|Overall Study|Withdrawal by Subject|19|||
46783168|NCT00384085|83001949|FG002|Overall Study|Withdrawal by Subject|29|||
46783169|NCT00384085|83001947|FG000|Overall Study|Patient non-compliant|4|||
46783170|NCT00384085|83001948|FG001|Overall Study|Patient non-compliant|4|||
46661951|NCT03410992|82874639|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
46783171|NCT00384085|83001949|FG002|Overall Study|Patient non-compliant|5|||
46783172|NCT00384085|83001947|FG000|Overall Study|Physician Decision|1|||
46783173|NCT00384085|83001948|FG001|Overall Study|Physician Decision|0|||
46783174|NCT00384085|83001949|FG002|Overall Study|Physician Decision|0|||
46783175|NCT00384085|83001947|FG000|Overall Study|Loss of site personnel|1|||
46783176|NCT00384085|83001948|FG001|Overall Study|Loss of site personnel|0|||
46783177|NCT00384085|83001949|FG002|Overall Study|Loss of site personnel|1|||
46783178|NCT00384085|83001947|FG000|Overall Study|Sponsor decision|1|||
46783179|NCT00384085|83001948|FG001|Overall Study|Sponsor decision|2|||
46783180|NCT00384085|83001949|FG002|Overall Study|Sponsor decision|1|||
46783181|NCT00384085|83001947|FG000|Overall Study|Patient moved|1|||
46783182|NCT00384085|83001948|FG001|Overall Study|Patient moved|0|||
46783183|NCT00384085|83001949|FG002|Overall Study|Patient moved|1|||
46783184|NCT00384085|83001947|FG000|Overall Study|Patient required surgery|0|||
46783185|NCT00384085|83001948|FG001|Overall Study|Patient required surgery|1|||
46783186|NCT00384085|83001949|FG002|Overall Study|Patient required surgery|0|||
46783187|NCT00361231|83001959|FG000|Overall Study|Physician Decision|3|||
46783188|NCT00361231|83001959|FG000|Overall Study|Symptomatic deterioration|5|||
46783189|NCT00361231|83001959|FG000|Overall Study|Radiographic disease progression|16|||
46783190|NCT00361231|83001959|FG000|Overall Study|Withdrawal by Subject|4|||
46783191|NCT00361231|83001959|FG000|Overall Study|Adverse Event|6|||
46783192|NCT00676650|83001965|FG000|Overall Study|Death|45|||
46783193|NCT00676650|83001966|FG001|Overall Study|Death|14|||
46783194|NCT00676650|83001965|FG000|Overall Study|Adverse Event|159|||
46783195|NCT00676650|83001966|FG001|Overall Study|Adverse Event|21|||
46783196|NCT00676650|83001965|FG000|Overall Study|Global deterioration of health status|66|||
46783197|NCT00676650|83001966|FG001|Overall Study|Global deterioration of health status|31|||
46783198|NCT00676650|83001965|FG000|Overall Study|Lost to Follow-up|0|||
46783199|NCT00676650|83001966|FG001|Overall Study|Lost to Follow-up|1|||
46783200|NCT00676650|83001965|FG000|Overall Study|Objective progression or relapse|189|||
46661952|NCT03410992|82874640|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
46661953|NCT03410992|82874641|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661954|NCT03410992|82874642|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661955|NCT03410992|82874643|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661956|NCT03410992|82874644|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661957|NCT03410992|82874645|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661958|NCT03410992|82874646|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661959|NCT03410992|82874647|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661960|NCT03410992|82874648|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661961|NCT03410992|82874649|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
46661962|NCT03410992|82874639|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
46661963|NCT03410992|82874640|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
46661964|NCT03410992|82874641|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661965|NCT03410992|82874642|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661966|NCT03410992|82874643|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661967|NCT03410992|82874644|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661968|NCT03410992|82874645|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661969|NCT03410992|82874646|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661970|NCT03410992|82874647|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661971|NCT03410992|82874648|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661972|NCT03410992|82874649|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
46661973|NCT03410992|82874639|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
46661974|NCT03410992|82874640|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661975|NCT03410992|82874641|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661976|NCT03410992|82874642|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661977|NCT03410992|82874643|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661978|NCT03410992|82874644|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661979|NCT03410992|82874645|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661980|NCT03410992|82874646|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661981|NCT03410992|82874647|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661982|NCT03410992|82874648|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661983|NCT03410992|82874649|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
46661984|NCT03410992|82874639|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
46661985|NCT03410992|82874640|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
46661986|NCT03410992|82874641|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46783201|NCT00676650|83001966|FG001|Overall Study|Objective progression or relapse|140|||
46783202|NCT00676650|83001965|FG000|Overall Study|Other|14|||
46783203|NCT00676650|83001966|FG001|Overall Study|Other|10|||
46972069|NCT02032888|83215707|FG000|Follow-up Period|Lost to Follow-up|1|||
46972070|NCT02032888|83215708|FG001|Follow-up Period|Lost to Follow-up|1|||
46783204|NCT00676650|83001965|FG000|Overall Study|Protocol Violation|3|||
46783205|NCT00676650|83001966|FG001|Overall Study|Protocol Violation|1|||
46783206|NCT00676650|83001965|FG000|Overall Study|Study terminated by sponsor|57|||
46783207|NCT00676650|83001966|FG001|Overall Study|Study terminated by sponsor|43|||
47076233|NCT02450331|83370857|FG001|Overall Study|Lost to Follow-up|12|||
46661987|NCT03410992|82874642|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661988|NCT03410992|82874643|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661989|NCT03410992|82874644|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661990|NCT03410992|82874645|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661991|NCT03410992|82874646|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661992|NCT03410992|82874647|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661993|NCT03410992|82874648|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661994|NCT03410992|82874649|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
46661995|NCT03410992|82874639|FG000|Week 16 Assessment|Incorrect escapers|0|||
46661996|NCT03410992|82874640|FG001|Week 16 Assessment|Incorrect escapers|6|||
46661997|NCT03410992|82874641|FG002|Week 16 Assessment|Incorrect escapers|0|||
46661998|NCT03410992|82874642|FG003|Week 16 Assessment|Incorrect escapers|0|||
46661999|NCT03410992|82874643|FG004|Week 16 Assessment|Incorrect escapers|0|||
46662000|NCT03410992|82874644|FG005|Week 16 Assessment|Incorrect escapers|0|||
46662001|NCT03410992|82874645|FG006|Week 16 Assessment|Incorrect escapers|0|||
46662002|NCT03410992|82874646|FG007|Week 16 Assessment|Incorrect escapers|0|||
46662003|NCT03410992|82874647|FG008|Week 16 Assessment|Incorrect escapers|0|||
46662004|NCT03410992|82874648|FG009|Week 16 Assessment|Incorrect escapers|0|||
46662005|NCT03410992|82874649|FG010|Week 16 Assessment|Incorrect escapers|0|||
46662006|NCT03410992|82874639|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662007|NCT03410992|82874640|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662008|NCT03410992|82874641|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662009|NCT03410992|82874642|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
46662010|NCT03410992|82874643|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
46972071|NCT02032888|83215709|FG002|Follow-up Period|Lost to Follow-up|0|||
46972072|NCT02032888|83215707|FG000|Follow-up Period|Death|1|||
46662011|NCT03410992|82874644|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662012|NCT03410992|82874645|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662013|NCT03410992|82874646|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662014|NCT03410992|82874647|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662015|NCT03410992|82874648|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662016|NCT03410992|82874649|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
46662017|NCT03410992|82874639|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662018|NCT03410992|82874640|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662019|NCT03410992|82874641|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662020|NCT03410992|82874642|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
46662021|NCT03410992|82874643|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
46662022|NCT03410992|82874644|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
46662023|NCT03410992|82874645|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662024|NCT03410992|82874646|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662025|NCT03410992|82874647|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662026|NCT03410992|82874648|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662027|NCT03410992|82874649|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
46662028|NCT03410992|82874639|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662029|NCT03410992|82874640|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662030|NCT03410992|82874641|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662031|NCT03410992|82874642|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662032|NCT03410992|82874643|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662033|NCT03410992|82874644|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
46662034|NCT03410992|82874645|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662035|NCT03410992|82874646|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662036|NCT03410992|82874647|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662037|NCT03410992|82874648|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662038|NCT03410992|82874649|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
46662039|NCT03410992|82874639|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46662040|NCT03410992|82874640|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46662041|NCT03410992|82874641|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46783208|NCT00676650|83001965|FG000|Overall Study|Withdrawal by Subject|48|||
46783209|NCT00676650|83001966|FG001|Overall Study|Withdrawal by Subject|24|||
46783210|NCT00676650|83001965|FG000|Overall Study|Randomized but not treated|3|||
46783211|NCT00676650|83001966|FG001|Overall Study|Randomized but not treated|4|||
46662042|NCT03410992|82874642|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
46783212|NCT00573183|83001974|FG000|Overall Study|Lost to Follow-up|52|||
46783213|NCT00573183|83001975|FG001|Overall Study|Lost to Follow-up|50|||
47076234|NCT02450331|83370856|FG000|Overall Study|Withdrawal by Subject|55|||
46662043|NCT03410992|82874643|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
46783214|NCT00573183|83001974|FG000|Overall Study|Withdrawal by Subject|8|||
46783215|NCT00573183|83001975|FG001|Overall Study|Withdrawal by Subject|2|||
46783216|NCT00573183|83001974|FG000|Overall Study|Death|0|||
46783217|NCT00573183|83001975|FG001|Overall Study|Death|1|||
46783218|NCT00573183|83001974|FG000|Overall Study|Adverse Event|2|||
46783219|NCT00573183|83001975|FG001|Overall Study|Adverse Event|0|||
46783220|NCT00573183|83001974|FG000|Overall Study|Incarceration|5|||
46783221|NCT00573183|83001975|FG001|Overall Study|Incarceration|8|||
46783222|NCT00573183|83001974|FG000|Overall Study|Other|5|||
46783223|NCT00573183|83001975|FG001|Overall Study|Other|2|||
46783224|NCT00615459|83001983|FG000|Period I|Adverse Event|2|||
46783225|NCT00615459|83001984|FG001|Period I|Adverse Event|0|||
46783226|NCT00615459|83001985|FG002|Period I|Adverse Event|1|||
46662044|NCT03410992|82874644|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
46662045|NCT03410992|82874645|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46662046|NCT03410992|82874646|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46662047|NCT03410992|82874647|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46662048|NCT03410992|82874648|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46783227|NCT00615459|83001986|FG003|Period I|Adverse Event|0|||
46783228|NCT00615459|83001983|FG000|Period I|Subject withdrew consent|1|||
46783229|NCT00615459|83001984|FG001|Period I|Subject withdrew consent|0|||
46783230|NCT00615459|83001985|FG002|Period I|Subject withdrew consent|0|||
46783231|NCT00615459|83001986|FG003|Period I|Subject withdrew consent|1|||
46783232|NCT00615459|83001983|FG000|Period I|Abnormal test procedure results|1|||
46783233|NCT00615459|83001984|FG001|Period I|Abnormal test procedure results|1|||
46783234|NCT00615459|83001985|FG002|Period I|Abnormal test procedure results|1|||
46662049|NCT03410992|82874649|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
46662050|NCT03410992|82874639|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662051|NCT03410992|82874640|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662052|NCT03410992|82874641|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662053|NCT03410992|82874642|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662054|NCT03410992|82874643|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662055|NCT03410992|82874644|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662056|NCT03410992|82874645|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662057|NCT03410992|82874646|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
46662058|NCT03410992|82874647|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662059|NCT03410992|82874648|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662060|NCT03410992|82874649|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
46662061|NCT03410992|82874639|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662062|NCT03410992|82874640|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662063|NCT03410992|82874641|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662064|NCT03410992|82874642|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662065|NCT03410992|82874643|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662066|NCT03410992|82874644|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662067|NCT03410992|82874645|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662068|NCT03410992|82874646|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662069|NCT03410992|82874647|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
46662070|NCT03410992|82874648|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662071|NCT03410992|82874649|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
46662072|NCT03370913|82874679|FG000|Overall Study|Death|1|||
46662073|NCT03370913|82874679|FG000|Overall Study|Lost to Follow-up|1|||
46662074|NCT03342404|82874685|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
46662075|NCT03342404|82874686|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
46662076|NCT03342404|82874685|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
46662077|NCT03342404|82874686|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
46662078|NCT03342404|82874685|FG000|Blinded Treatment Phase|Adverse Event|5|||
46662079|NCT03342404|82874686|FG001|Blinded Treatment Phase|Adverse Event|4|||
46662080|NCT03342404|82874685|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
46662081|NCT03342404|82874686|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
46662082|NCT03342404|82874685|FG000|Blinded Treatment Phase|Other reasons|1|||
46662083|NCT03342404|82874686|FG001|Blinded Treatment Phase|Other reasons|0|||
46662084|NCT03342404|82874685|FG000|Blinded Treatment Phase|Physician Decision|1|||
46662085|NCT03342404|82874686|FG001|Blinded Treatment Phase|Physician Decision|0|||
46662086|NCT03342404|82874685|FG000|Blinded Treatment Phase|Death|1|||
46662087|NCT03342404|82874686|FG001|Blinded Treatment Phase|Death|0|||
46662088|NCT03342404|82874685|FG000|Open-Label Phase|Lost to Follow-up|0|||
46662089|NCT03342404|82874686|FG001|Open-Label Phase|Lost to Follow-up|1|||
46662090|NCT03342404|82874685|FG000|Open-Label Phase|Other reasons|0|||
46662091|NCT03342404|82874686|FG001|Open-Label Phase|Other reasons|1|||
46662092|NCT03342404|82874685|FG000|Open-Label Phase|Adverse Event|0|||
46662093|NCT03342404|82874686|FG001|Open-Label Phase|Adverse Event|3|||
46662094|NCT03342404|82874685|FG000|Open-Label Phase|Withdrawal by Subject|0|||
46662095|NCT03342404|82874686|FG001|Open-Label Phase|Withdrawal by Subject|6|||
46662096|NCT03213457|82874705|FG000|Overall Study|Not Treated|1|||
46662097|NCT03213457|82874706|FG001|Overall Study|Not Treated|1|||
46662098|NCT03213457|82874707|FG002|Overall Study|Not Treated|0|||
46662099|NCT03213457|82874705|FG000|Overall Study|Adverse Event|16|||
46662100|NCT03213457|82874706|FG001|Overall Study|Adverse Event|9|||
46662101|NCT03213457|82874707|FG002|Overall Study|Adverse Event|41|||
46662102|NCT03213457|82874705|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46662103|NCT03213457|82874706|FG001|Overall Study|Non-Compliance With Study Drug|2|||
46662104|NCT03213457|82874707|FG002|Overall Study|Non-Compliance With Study Drug|7|||
46662105|NCT03213457|82874705|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
46662106|NCT03213457|82874706|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
46662107|NCT03213457|82874707|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
46662108|NCT03213457|82874705|FG000|Overall Study|Withdrawal by Subject|18|||
46662109|NCT03213457|82874706|FG001|Overall Study|Withdrawal by Subject|7|||
46662110|NCT03213457|82874707|FG002|Overall Study|Withdrawal by Subject|35|||
46662111|NCT03213457|82874705|FG000|Overall Study|Lost to Follow-up|12|||
46662112|NCT03213457|82874706|FG001|Overall Study|Lost to Follow-up|12|||
46783235|NCT00615459|83001986|FG003|Period I|Abnormal test procedure results|0|||
46783236|NCT00615459|83001983|FG000|Period II|Adverse Event|1|||
46851054|NCT00068588|83066812|FG002|Overall Study|Withdrawal by Subject|1|||
46662113|NCT03213457|82874707|FG002|Overall Study|Lost to Follow-up|33|||
46662114|NCT03213457|82874705|FG000|Overall Study|Pregnancy|11|||
46662115|NCT03213457|82874706|FG001|Overall Study|Pregnancy|0|||
46662116|NCT03213457|82874707|FG002|Overall Study|Pregnancy|7|||
46662117|NCT03213457|82874705|FG000|Overall Study|Protocol Violation|1|||
46662118|NCT03213457|82874706|FG001|Overall Study|Protocol Violation|1|||
46662119|NCT03213457|82874707|FG002|Overall Study|Protocol Violation|6|||
46662120|NCT03213457|82874705|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
46662121|NCT03213457|82874706|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
46662122|NCT03213457|82874707|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
46662123|NCT03213457|82874705|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
46662124|NCT03213457|82874706|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
46662125|NCT03213457|82874707|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
46662126|NCT03213457|82874705|FG000|Overall Study|Lack of Efficacy|12|||
46662127|NCT03213457|82874706|FG001|Overall Study|Lack of Efficacy|2|||
46783237|NCT00615459|83001984|FG001|Period II|Adverse Event|0|||
46783238|NCT00615459|83001985|FG002|Period II|Adverse Event|0|||
46783239|NCT00615459|83001986|FG003|Period II|Adverse Event|0|||
46783240|NCT00615459|83001983|FG000|Period II|Lost to Follow-up|0|||
46783241|NCT00615459|83001984|FG001|Period II|Lost to Follow-up|0|||
46783242|NCT00615459|83001985|FG002|Period II|Lost to Follow-up|0|||
46783243|NCT00615459|83001986|FG003|Period II|Lost to Follow-up|1|||
46783244|NCT00615459|83001983|FG000|Period III|Adverse Event|0|||
46783245|NCT00615459|83001984|FG001|Period III|Adverse Event|1|||
46783246|NCT00615459|83001985|FG002|Period III|Adverse Event|0|||
46662128|NCT03213457|82874707|FG002|Overall Study|Lack of Efficacy|9|||
46662129|NCT03213457|82874705|FG000|Overall Study|Other, Not Specified|11|||
46662130|NCT03213457|82874706|FG001|Overall Study|Other, Not Specified|3|||
46662131|NCT03213457|82874707|FG002|Overall Study|Other, Not Specified|26|||
46662132|NCT03198078|82874718|FG000|Overall Study|Adverse Event|0|||
46662133|NCT03198078|82874719|FG001|Overall Study|Adverse Event|1|||
46662134|NCT03198078|82874720|FG002|Overall Study|Adverse Event|2|||
46662135|NCT03198078|82874718|FG000|Overall Study|Lack of Efficacy|0|||
46662136|NCT03198078|82874719|FG001|Overall Study|Lack of Efficacy|0|||
46662137|NCT03198078|82874720|FG002|Overall Study|Lack of Efficacy|3|||
46662138|NCT03198078|82874718|FG000|Overall Study|Lost to Follow-up|1|||
46662139|NCT03198078|82874719|FG001|Overall Study|Lost to Follow-up|0|||
46662140|NCT03198078|82874720|FG002|Overall Study|Lost to Follow-up|0|||
46662141|NCT03198078|82874718|FG000|Overall Study|Pregnancy|0|||
46662142|NCT03198078|82874719|FG001|Overall Study|Pregnancy|1|||
46662143|NCT03198078|82874720|FG002|Overall Study|Pregnancy|0|||
46662144|NCT03198078|82874718|FG000|Overall Study|Withdrawal by Subject|1|||
46662145|NCT03198078|82874719|FG001|Overall Study|Withdrawal by Subject|0|||
46662146|NCT03198078|82874720|FG002|Overall Study|Withdrawal by Subject|2|||
46783247|NCT00615459|83001986|FG003|Period III|Adverse Event|0|||
46783248|NCT00615459|83001983|FG000|Period III|Administrative problems|0|||
46851055|NCT00068588|83066810|FG000|Overall Study|Poor KPS|0|||
46851056|NCT00068588|83066811|FG001|Overall Study|Poor KPS|0|||
46851057|NCT00068588|83066812|FG002|Overall Study|Poor KPS|1|||
46851058|NCT03650452|83066821|FG000|Overall Study|Physician Decision|1|||
46851059|NCT03650452|83066822|FG001|Overall Study|Physician Decision|0|||
46662147|NCT03198078|82874718|FG000|Overall Study|Withdrawal by Caregiver|1|||
46662148|NCT03198078|82874719|FG001|Overall Study|Withdrawal by Caregiver|3|||
46662149|NCT03198078|82874720|FG002|Overall Study|Withdrawal by Caregiver|5|||
46662150|NCT02808650|82874744|FG000|Overall Study|Death|0|||
46662151|NCT02808650|82874745|FG001|Overall Study|Death|0|||
46662152|NCT02808650|82874746|FG002|Overall Study|Death|0|||
46662153|NCT02808650|82874747|FG003|Overall Study|Death|0|||
46662154|NCT02808650|82874748|FG004|Overall Study|Death|1|||
46662155|NCT02808650|82874744|FG000|Overall Study|Lack of Efficacy|5|||
46662156|NCT02808650|82874745|FG001|Overall Study|Lack of Efficacy|5|||
46662157|NCT02808650|82874746|FG002|Overall Study|Lack of Efficacy|6|||
46662158|NCT02808650|82874747|FG003|Overall Study|Lack of Efficacy|5|||
46662159|NCT02808650|82874748|FG004|Overall Study|Lack of Efficacy|4|||
46662160|NCT02808650|82874744|FG000|Overall Study|Physician Decision|1|||
46662161|NCT02808650|82874745|FG001|Overall Study|Physician Decision|1|||
46662162|NCT02808650|82874746|FG002|Overall Study|Physician Decision|0|||
46851060|NCT03650452|83066821|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
46851061|NCT03650452|83066822|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
46851062|NCT03650452|83066821|FG000|Overall Study|Adverse Event|3|||
46851063|NCT03650452|83066822|FG001|Overall Study|Adverse Event|4|||
46662163|NCT02808650|82874747|FG003|Overall Study|Physician Decision|0|||
46662164|NCT02808650|82874748|FG004|Overall Study|Physician Decision|0|||
46662165|NCT02808650|82874744|FG000|Overall Study|Withdrawal by Subject|0|||
46851064|NCT03650452|83066821|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
46783249|NCT00615459|83001984|FG001|Period III|Administrative problems|1|||
46851065|NCT03650452|83066822|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
46851066|NCT03575806|83066830|FG000|Overall Study|Withdrawal by Subject|0|||
46851067|NCT03575806|83066831|FG001|Overall Study|Withdrawal by Subject|2|||
46662166|NCT02808650|82874745|FG001|Overall Study|Withdrawal by Subject|0|||
46662167|NCT02808650|82874746|FG002|Overall Study|Withdrawal by Subject|0|||
46662168|NCT02808650|82874747|FG003|Overall Study|Withdrawal by Subject|1|||
46662169|NCT02808650|82874748|FG004|Overall Study|Withdrawal by Subject|1|||
46662170|NCT02630693|82874763|FG000|Overall Study|No receive treatment|0|||
46783250|NCT00615459|83001985|FG002|Period III|Administrative problems|1|||
46662171|NCT02630693|82874764|FG001|Overall Study|No receive treatment|1|||
46662172|NCT02626338|82874773|FG000|Overall Study|Lack of Efficacy|3|||
46662173|NCT02626338|82874774|FG001|Overall Study|Lack of Efficacy|2|||
46662174|NCT02626338|82874775|FG002|Overall Study|Lack of Efficacy|0|||
46662175|NCT02603146|82874787|FG000|Overall Study|Lost to Follow-up|5|||
46662176|NCT02603146|82874788|FG001|Overall Study|Lost to Follow-up|6|||
46662177|NCT02603146|82874787|FG000|Overall Study|Withdrawal by Subject|8|||
46662178|NCT02603146|82874788|FG001|Overall Study|Withdrawal by Subject|10|||
46662179|NCT02603146|82874787|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
46662180|NCT02603146|82874788|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
46662181|NCT02603146|82874787|FG000|Overall Study|Participant moved|2|||
46662182|NCT02603146|82874788|FG001|Overall Study|Participant moved|0|||
46662183|NCT02603146|82874787|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
46662184|NCT02603146|82874788|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
46662185|NCT01723774|82874858|FG000|Neoadjuvant|Ki67 > 10%|4|||
46662186|NCT01723774|82874859|FG001|Neoadjuvant|Ki67 > 10%|0|||
46662187|NCT01723774|82874860|FG002|Neoadjuvant|Ki67 > 10%|10|||
46662188|NCT01723774|82874861|FG003|Neoadjuvant|Ki67 > 10%|0|||
46662189|NCT01723774|82874858|FG000|Neoadjuvant|Withdrawal by Subject|3|||
46662190|NCT01723774|82874859|FG001|Neoadjuvant|Withdrawal by Subject|1|||
46662191|NCT01723774|82874860|FG002|Neoadjuvant|Withdrawal by Subject|0|||
46662192|NCT01723774|82874861|FG003|Neoadjuvant|Withdrawal by Subject|0|||
46662193|NCT01723774|82874858|FG000|Neoadjuvant|Disease progression|0|||
46662194|NCT01723774|82874859|FG001|Neoadjuvant|Disease progression|1|||
46662195|NCT01723774|82874860|FG002|Neoadjuvant|Disease progression|1|||
46662196|NCT01723774|82874861|FG003|Neoadjuvant|Disease progression|0|||
46662197|NCT01723774|82874858|FG000|Neoadjuvant|Adverse Event|0|||
46662198|NCT01723774|82874859|FG001|Neoadjuvant|Adverse Event|1|||
46662199|NCT01723774|82874860|FG002|Neoadjuvant|Adverse Event|2|||
46662200|NCT01723774|82874861|FG003|Neoadjuvant|Adverse Event|0|||
46662201|NCT01723774|82874858|FG000|Neoadjuvant|High estradiol|0|||
46662202|NCT01723774|82874859|FG001|Neoadjuvant|High estradiol|1|||
46662203|NCT01723774|82874860|FG002|Neoadjuvant|High estradiol|0|||
46662204|NCT01723774|82874861|FG003|Neoadjuvant|High estradiol|0|||
46662205|NCT00920582|82874888|FG000|Overall Study|Lost to Follow-up|5|||
46662206|NCT00920582|82874889|FG001|Overall Study|Lost to Follow-up|1|||
46662207|NCT00920582|82874890|FG002|Overall Study|Lost to Follow-up|2|||
46662208|NCT00920582|82874891|FG003|Overall Study|Lost to Follow-up|0|||
46662209|NCT00920582|82874888|FG000|Overall Study|Withdrawal by Subject|5|||
46662210|NCT00920582|82874889|FG001|Overall Study|Withdrawal by Subject|4|||
46662211|NCT00920582|82874890|FG002|Overall Study|Withdrawal by Subject|6|||
46662212|NCT00920582|82874891|FG003|Overall Study|Withdrawal by Subject|3|||
46662213|NCT00920582|82874888|FG000|Overall Study|Protocol Violation|1|||
46662214|NCT00920582|82874889|FG001|Overall Study|Protocol Violation|0|||
46662215|NCT00920582|82874890|FG002|Overall Study|Protocol Violation|0|||
46662216|NCT00920582|82874891|FG003|Overall Study|Protocol Violation|0|||
46662217|NCT00920582|82874888|FG000|Overall Study|Other|2|||
46662218|NCT00920582|82874889|FG001|Overall Study|Other|1|||
46662219|NCT00920582|82874890|FG002|Overall Study|Other|3|||
46662220|NCT00920582|82874891|FG003|Overall Study|Other|2|||
46662221|NCT00199888|82874929|FG000|Overall Study|Lost to Follow-up|1|||
46662222|NCT00199849|82874936|FG000|Overall Study|Unrelated illness or complication|0|||
46662223|NCT00199849|82874937|FG001|Overall Study|Unrelated illness or complication|1|||
46662224|NCT00199849|82874938|FG002|Overall Study|Unrelated illness or complication|0|||
46662225|NCT00199849|82874936|FG000|Overall Study|Progressive disease requiring intervention|0|||
46662226|NCT00199849|82874937|FG001|Overall Study|Progressive disease requiring intervention|0|||
46662227|NCT00199849|82874938|FG002|Overall Study|Progressive disease requiring intervention|1|||
46662228|NCT00199849|82874936|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
46662229|NCT00199849|82874937|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
46662230|NCT00199849|82874938|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
46662231|NCT00199381|82874946|FG000|Overall Study|Withdrawal by Subject|38|||
46662232|NCT00199381|82874946|FG000|Overall Study|Adverse Event|73|||
46662233|NCT00199381|82874946|FG000|Overall Study|Protocol Violation|6|||
46783251|NCT00615459|83001986|FG003|Period III|Administrative problems|0|||
46783252|NCT00615459|83001983|FG000|Period III|Unsatisfactory therapeutic effect|0|||
46783253|NCT00615459|83001984|FG001|Period III|Unsatisfactory therapeutic effect|1|||
46783254|NCT00615459|83001985|FG002|Period III|Unsatisfactory therapeutic effect|0|||
46783255|NCT00615459|83001986|FG003|Period III|Unsatisfactory therapeutic effect|0|||
46783256|NCT00383149|83002000|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
46972073|NCT02032888|83215708|FG001|Follow-up Period|Death|1|||
46972074|NCT02032888|83215709|FG002|Follow-up Period|Death|0|||
46662234|NCT00199381|82874946|FG000|Overall Study|Lack of Efficacy|27|||
46662235|NCT00199381|82874946|FG000|Overall Study|Not including due to early termination|37|||
46662236|NCT00199381|82874946|FG000|Overall Study|Study termination by Sponsor|323|||
46662237|NCT00198133|82874952|FG000|Overall Study|Disease progression|2|||
46662238|NCT00198133|82874953|FG001|Overall Study|Disease progression|5|||
46662239|NCT00198133|82874952|FG000|Overall Study|Adverse Event|1|||
46662240|NCT00198133|82874953|FG001|Overall Study|Adverse Event|3|||
46662241|NCT00198133|82874952|FG000|Overall Study|Withdrawal by Subject|1|||
46662242|NCT00198133|82874953|FG001|Overall Study|Withdrawal by Subject|0|||
46662243|NCT00198133|82874952|FG000|Overall Study|Physician Decision|1|||
46662244|NCT00198133|82874953|FG001|Overall Study|Physician Decision|0|||
46662245|NCT00197236|82874962|FG000|Overall Study|Adverse Event|1|||
46662246|NCT00197236|82874963|FG001|Overall Study|Adverse Event|0|||
46662247|NCT00197236|82874964|FG002|Overall Study|Adverse Event|1|||
46662248|NCT00197236|82874962|FG000|Overall Study|Lost to Follow-up|5|||
46662249|NCT00197236|82874963|FG001|Overall Study|Lost to Follow-up|14|||
46662250|NCT00197236|82874964|FG002|Overall Study|Lost to Follow-up|6|||
46662251|NCT00197236|82874962|FG000|Overall Study|Protocol Violation|0|||
46662252|NCT00197236|82874963|FG001|Overall Study|Protocol Violation|0|||
46662253|NCT00197236|82874964|FG002|Overall Study|Protocol Violation|1|||
46662254|NCT00197236|82874962|FG000|Overall Study|Withdrawal by Subject|7|||
46662255|NCT00197236|82874963|FG001|Overall Study|Withdrawal by Subject|3|||
46972075|NCT02032888|83215707|FG000|Follow-up Period|Other|1|||
46972076|NCT02032888|83215708|FG001|Follow-up Period|Other|0|||
47076235|NCT02450331|83370857|FG001|Overall Study|Withdrawal by Subject|44|||
46662256|NCT00197236|82874964|FG002|Overall Study|Withdrawal by Subject|11|||
46662257|NCT00197236|82874962|FG000|Overall Study|Study drug/medication expiration|1|||
46662258|NCT00197236|82874963|FG001|Overall Study|Study drug/medication expiration|0|||
46662259|NCT00197236|82874964|FG002|Overall Study|Study drug/medication expiration|3|||
46662260|NCT00197236|82874962|FG000|Overall Study|Returned out of specified time window|0|||
46662261|NCT00197236|82874963|FG001|Overall Study|Returned out of specified time window|0|||
46662262|NCT00197236|82874964|FG002|Overall Study|Returned out of specified time window|1|||
46662263|NCT00197002|82874978|FG000|Overall Study|Adverse Event|0|||
46662264|NCT00197002|82874979|FG001|Overall Study|Adverse Event|1|||
46662265|NCT00197002|82874980|FG002|Overall Study|Adverse Event|0|||
46662266|NCT00197002|82874978|FG000|Overall Study|Protocol Violation|1|||
46662267|NCT00197002|82874979|FG001|Overall Study|Protocol Violation|0|||
46662268|NCT00197002|82874980|FG002|Overall Study|Protocol Violation|2|||
46662269|NCT00197002|82874978|FG000|Overall Study|Withdrawal by Subject|9|||
46662270|NCT00197002|82874979|FG001|Overall Study|Withdrawal by Subject|5|||
46662271|NCT00197002|82874980|FG002|Overall Study|Withdrawal by Subject|7|||
46662272|NCT00197002|82874978|FG000|Overall Study|Migrated/moved from study area|3|||
46662273|NCT00197002|82874979|FG001|Overall Study|Migrated/moved from study area|5|||
46662274|NCT00197002|82874980|FG002|Overall Study|Migrated/moved from study area|1|||
46662275|NCT00197002|82874978|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
46662276|NCT00197002|82874979|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
46662277|NCT00197002|82874980|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
46662278|NCT00197002|82874978|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
46662279|NCT00197002|82874979|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
46662280|NCT00197002|82874980|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
46662281|NCT00197002|82874978|FG000|Overall Study|Others|3|||
46662282|NCT00197002|82874979|FG001|Overall Study|Others|1|||
46662283|NCT00197002|82874980|FG002|Overall Study|Others|1|||
46662284|NCT00196105|82874994|FG000|Overall Study|Lost to Follow-up|4|||
46662285|NCT00196105|82874995|FG001|Overall Study|Lost to Follow-up|5|||
46662286|NCT00196105|82874996|FG002|Overall Study|Lost to Follow-up|7|||
46662287|NCT00195715|82875004|FG000|Overall Study|Adverse Event|122|||
46662288|NCT00195715|82875004|FG000|Overall Study|Withdrawal by Subject|58|||
46662289|NCT00195715|82875004|FG000|Overall Study|Lost to Follow-up|27|||
46662290|NCT00195715|82875004|FG000|Overall Study|Protocol Violation|13|||
46662291|NCT00195715|82875004|FG000|Overall Study|Lack of Efficacy|93|||
46662292|NCT00195715|82875004|FG000|Overall Study|Pregnancy|14|||
46662293|NCT00195715|82875004|FG000|Overall Study|Investigative site closure|8|||
46662294|NCT00195715|82875004|FG000|Overall Study|Subject moved/relocated|7|||
46662295|NCT00195715|82875004|FG000|Overall Study|Subject non-compliance|6|||
46662296|NCT00195715|82875004|FG000|Overall Study|Subject started commercial Humira|5|||
46662297|NCT00195715|82875004|FG000|Overall Study|Subject choice|3|||
46662298|NCT00195715|82875004|FG000|Overall Study|Loss of response/no improvement|3|||
46662299|NCT00195715|82875004|FG000|Overall Study|Sponsor stopped study|1|||
46662300|NCT00195715|82875004|FG000|Overall Study|Administrative reasons|2|||
46662301|NCT00195715|82875004|FG000|Overall Study|Investigator's decision|2|||
46662302|NCT00195715|82875004|FG000|Overall Study|Subject wants to get pregnant|4|||
47076236|NCT02450331|83370856|FG000|Overall Study|Non-specified other|1|||
46662303|NCT00195715|82875004|FG000|Overall Study|Use of prohibited medication|2|||
46662304|NCT00195715|82875004|FG000|Overall Study|Planned surgery|2|||
46662305|NCT00195715|82875004|FG000|Overall Study|Increased infection rate|1|||
46662306|NCT00195715|82875004|FG000|Overall Study|Ineligible|1|||
46662307|NCT00195715|82875004|FG000|Overall Study|Colonic stricture|1|||
46662308|NCT00195715|82875004|FG000|Overall Study|Sponsor discontinued trial|1|||
46662309|NCT00195715|82875004|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
46662310|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Adverse Event|82|||
46662311|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Death|6|||
46662312|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
46662313|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
46662314|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
46662315|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
46662316|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
46662317|NCT00195676|82875008|FG000|Period O - Open-label Treatment|Other reasons|68|||
46662318|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
46662319|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
46662320|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
46662321|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
46662322|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
46662323|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
46662324|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
46662325|NCT00195676|82875008|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
46662326|NCT00195676|82875008|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
46662327|NCT00195676|82875008|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
46662328|NCT00195676|82875008|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
46662329|NCT00195676|82875008|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
46662330|NCT00195676|82875008|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
46662331|NCT00194077|82875018|FG000|Overall Study|Lack of Efficacy|22|||
46662332|NCT00194077|82875019|FG001|Overall Study|Lack of Efficacy|29|||
46662333|NCT00194077|82875018|FG000|Overall Study|Study nonadherence|1|||
46662334|NCT00194077|82875019|FG001|Overall Study|Study nonadherence|0|||
46662335|NCT00194077|82875018|FG000|Overall Study|Withdrawal by Subject|1|||
46662336|NCT00194077|82875019|FG001|Overall Study|Withdrawal by Subject|1|||
46662337|NCT00193609|82875025|FG000|Overall Study|Lack of Efficacy|2|||
46662338|NCT00193609|82875025|FG000|Overall Study|Adverse Event|2|||
46662339|NCT00193180|82875029|FG000|Overall Study|Lack of Efficacy|1|||
46662340|NCT00193180|82875029|FG000|Overall Study|Adverse Event|8|||
46662341|NCT00193180|82875029|FG000|Overall Study|Protocol Violation|1|||
46662342|NCT00193063|82875034|FG000|Overall Study|Lack of Efficacy|3|||
46662343|NCT00193063|82875034|FG000|Overall Study|Adverse Event|1|||
46662344|NCT00191854|82875041|FG000|Overall Study|Death|26|||
46662345|NCT00191854|82875042|FG001|Overall Study|Death|23|||
46662346|NCT00191854|82875043|FG002|Overall Study|Death|29|||
46662347|NCT00191854|82875041|FG000|Overall Study|Lost to Follow-up|7|||
46662348|NCT00191854|82875042|FG001|Overall Study|Lost to Follow-up|5|||
46662349|NCT00191854|82875043|FG002|Overall Study|Lost to Follow-up|5|||
46662350|NCT00191854|82875041|FG000|Overall Study|Withdrawal by Subject|4|||
46662351|NCT00191854|82875042|FG001|Overall Study|Withdrawal by Subject|2|||
46662352|NCT00191854|82875043|FG002|Overall Study|Withdrawal by Subject|3|||
46662353|NCT00191854|82875041|FG000|Overall Study|Sponsor Decision|0|||
46662354|NCT00191854|82875042|FG001|Overall Study|Sponsor Decision|0|||
46662355|NCT00191854|82875043|FG002|Overall Study|Sponsor Decision|1|||
46662356|NCT00191854|82875041|FG000|Overall Study|Screen Failure|0|||
46662357|NCT00191854|82875042|FG001|Overall Study|Screen Failure|0|||
46662358|NCT00191854|82875043|FG002|Overall Study|Screen Failure|1|||
46662359|NCT00191815|82875051|FG000|Overall Study|Adverse Event|2|||
46662360|NCT00191815|82875051|FG000|Overall Study|Disease progression or relapse|24|||
46662361|NCT00191815|82875051|FG000|Overall Study|Death|2|||
46662362|NCT00191815|82875051|FG000|Overall Study|Protocol Violation|3|||
46662363|NCT00191815|82875051|FG000|Overall Study|Physician Decision|2|||
46662364|NCT00191815|82875051|FG000|Overall Study|Withdrawal by Subject|7|||
46783257|NCT00383149|83002000|FG000|Overall Study|Death|2|||
46783258|NCT00383149|83002000|FG000|Overall Study|Disease Progression|38|||
46783259|NCT00383149|83002000|FG000|Overall Study|Lost to Follow-up|1|||
46662365|NCT00191386|82875055|FG000|Overall Study|Adverse Event|16|||
46662366|NCT00191386|82875055|FG000|Overall Study|Lost to Follow-up|1|||
46662367|NCT00191386|82875055|FG000|Overall Study|Entry Criteria Exclusion|3|||
46662368|NCT00191386|82875055|FG000|Overall Study|Protocol Violation|18|||
46662369|NCT00191386|82875055|FG000|Overall Study|Withdrawal by Subject|96|||
46662370|NCT00191386|82875055|FG000|Overall Study|Physician Decision|11|||
46783260|NCT00383149|83002000|FG000|Overall Study|Other|1|||
46783261|NCT00383149|83002000|FG000|Overall Study|Study Drug Toxicity|4|||
46662371|NCT00191386|82875055|FG000|Overall Study|Lack of Efficacy|15|||
46662372|NCT00191308|82875059|FG000|Overall Study|Adverse Event|1|||
46662373|NCT00191269|82875065|FG000|Overall Study|Protocol Violation|0|||
46662374|NCT00191269|82875066|FG001|Overall Study|Protocol Violation|2|||
46662375|NCT00191269|82875065|FG000|Overall Study|Adverse Event|1|||
46662376|NCT00191269|82875066|FG001|Overall Study|Adverse Event|4|||
46662377|NCT00191269|82875065|FG000|Overall Study|Progression of Disease|4|||
46662378|NCT00191269|82875066|FG001|Overall Study|Progression of Disease|42|||
46783262|NCT00383149|83002000|FG000|Overall Study|Request to Discontinue Treatment|4|||
46662379|NCT00191269|82875065|FG000|Overall Study|Lack of Efficacy|1|||
46662380|NCT00191269|82875066|FG001|Overall Study|Lack of Efficacy|5|||
46783263|NCT00383149|83002000|FG000|Overall Study|Participant Withdrew Consent|1|||
46662381|NCT00191269|82875065|FG000|Overall Study|Withdrawal by Subject|0|||
46662382|NCT00191269|82875066|FG001|Overall Study|Withdrawal by Subject|1|||
46662383|NCT00191269|82875065|FG000|Overall Study|Pathologic Aggrevation|0|||
46662384|NCT00191269|82875066|FG001|Overall Study|Pathologic Aggrevation|1|||
46662385|NCT00191269|82875065|FG000|Overall Study|Physician Decision|0|||
46662386|NCT00191269|82875066|FG001|Overall Study|Physician Decision|3|||
46662387|NCT00191191|82875075|FG000|Overall Study|Entry Criteria Exclusion|2|||
46662388|NCT00191191|82875076|FG001|Overall Study|Entry Criteria Exclusion|0|||
46783264|NCT00382993|83002006|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
46783265|NCT00382993|83002007|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
46783266|NCT00382993|83002006|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
46783267|NCT00382993|83002007|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
46783268|NCT00382993|83002006|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
46783269|NCT00382993|83002007|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
46783270|NCT00382993|83002006|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
46783271|NCT00382993|83002007|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
46783272|NCT00382993|83002006|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
46783273|NCT00382993|83002007|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
46783274|NCT00382993|83002006|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
46783275|NCT00382993|83002007|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
46662389|NCT00191191|82875075|FG000|Overall Study|Treated with Another Systemic Agent|1|||
46662390|NCT00191191|82875076|FG001|Overall Study|Treated with Another Systemic Agent|1|||
46783276|NCT00382993|83002006|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
46783277|NCT00382993|83002007|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
46783278|NCT00382993|83002006|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
46783279|NCT00382993|83002007|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
46783280|NCT00382993|83002006|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
46783281|NCT00382993|83002007|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
46783282|NCT00382993|83002006|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
46783283|NCT00382993|83002007|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
46783284|NCT00369967|83002015|FG000|Overall Study|Lost to Follow-up|23|||
46783285|NCT00369967|83002016|FG001|Overall Study|Lost to Follow-up|12|||
46783286|NCT00616629|83002031|FG000|Overall Study|Protocol Violation|1|||
46783287|NCT00616629|83002032|FG001|Overall Study|Protocol Violation|2|||
46662391|NCT00191191|82875075|FG000|Overall Study|Adverse Event|11|||
46662392|NCT00191191|82875076|FG001|Overall Study|Adverse Event|21|||
46662393|NCT00191191|82875075|FG000|Overall Study|Progressive Disease|84|||
46662394|NCT00191191|82875076|FG001|Overall Study|Progressive Disease|72|||
46662395|NCT00191191|82875075|FG000|Overall Study|Toxicity After Dose Reduction|7|||
46662396|NCT00191191|82875076|FG001|Overall Study|Toxicity After Dose Reduction|8|||
46662397|NCT00191191|82875075|FG000|Overall Study|Family/Caregiver Decision|5|||
46662398|NCT00191191|82875076|FG001|Overall Study|Family/Caregiver Decision|7|||
46662399|NCT00191191|82875075|FG000|Overall Study|Lost to Follow-up|1|||
46662400|NCT00191191|82875076|FG001|Overall Study|Lost to Follow-up|0|||
46662401|NCT00191191|82875075|FG000|Overall Study|Physician Decision|3|||
46662402|NCT00191191|82875076|FG001|Overall Study|Physician Decision|2|||
46662403|NCT00191191|82875075|FG000|Overall Study|Good Clinical Practice Violation|0|||
46662404|NCT00191191|82875076|FG001|Overall Study|Good Clinical Practice Violation|1|||
46662405|NCT00191152|82875084|FG000|Initial Treatment|Adverse Event|43|||
46662406|NCT00191152|82875085|FG001|Initial Treatment|Adverse Event|67|||
46662407|NCT00191152|82875084|FG000|Initial Treatment|Physician Decision|40|||
46662408|NCT00191152|82875085|FG001|Initial Treatment|Physician Decision|31|||
46662409|NCT00191152|82875084|FG000|Initial Treatment|Withdrawal by Subject|40|||
46662410|NCT00191152|82875085|FG001|Initial Treatment|Withdrawal by Subject|28|||
46662411|NCT00191152|82875084|FG000|Initial Treatment|Lost to Follow-up|0|||
46662412|NCT00191152|82875085|FG001|Initial Treatment|Lost to Follow-up|6|||
46662413|NCT00191152|82875084|FG000|Initial Treatment|Other|18|||
46662414|NCT00191152|82875085|FG001|Initial Treatment|Other|21|||
46662415|NCT00191152|82875084|FG000|Crossover Treatment|Adverse Event|8|||
46662416|NCT00191152|82875085|FG001|Crossover Treatment|Adverse Event|8|||
46662417|NCT00191152|82875084|FG000|Crossover Treatment|Physician Decision|7|||
46662418|NCT00191152|82875085|FG001|Crossover Treatment|Physician Decision|7|||
46662419|NCT00191152|82875084|FG000|Crossover Treatment|Withdrawal by Subject|6|||
46783288|NCT00616629|83002033|FG002|Overall Study|Protocol Violation|1|||
46783289|NCT00616629|83002034|FG003|Overall Study|Protocol Violation|0|||
46783290|NCT00616629|83002035|FG004|Overall Study|Protocol Violation|0|||
46783291|NCT00616629|83002031|FG000|Overall Study|AV-block|1|||
46783292|NCT00616629|83002032|FG001|Overall Study|AV-block|0|||
46783293|NCT00616629|83002033|FG002|Overall Study|AV-block|0|||
46783294|NCT00616629|83002034|FG003|Overall Study|AV-block|0|||
46783295|NCT00616629|83002035|FG004|Overall Study|AV-block|0|||
46783296|NCT00369655|83002047|FG000|Overall Study|Refusal of further treatment|2|||
46783297|NCT00615069|83002051|FG000|Overall Study|Death|10|||
46783298|NCT00615069|83002051|FG000|Overall Study|Physician Decision|2|||
46783299|NCT00615069|83002051|FG000|Overall Study|Withdrawal by Subject|4|||
46783300|NCT00676338|83002059|FG000|Overall Study|Adverse Event|6|||
46783301|NCT00676338|83002060|FG001|Overall Study|Adverse Event|6|||
46783302|NCT00676338|83002061|FG002|Overall Study|Adverse Event|5|||
46783303|NCT00676338|83002062|FG003|Overall Study|Adverse Event|1|||
46783304|NCT00676338|83002059|FG000|Overall Study|Lost to Follow-up|4|||
47076237|NCT02450331|83370857|FG001|Overall Study|Non-specified other|1|||
47076238|NCT02335944|83370874|FG000|Treatment Phase|Progressive Disease|2|||
47076239|NCT02335944|83370875|FG001|Treatment Phase|Progressive Disease|5|||
47076240|NCT02335944|83370876|FG002|Treatment Phase|Progressive Disease|2|||
47076241|NCT02335944|83370877|FG003|Treatment Phase|Progressive Disease|11|||
47076242|NCT02335944|83370878|FG004|Treatment Phase|Progressive Disease|4|||
47076243|NCT02335944|83370879|FG005|Treatment Phase|Progressive Disease|25|||
47076244|NCT02335944|83370880|FG006|Treatment Phase|Progressive Disease|2|||
46783305|NCT00676338|83002060|FG001|Overall Study|Lost to Follow-up|1|||
46783306|NCT00676338|83002061|FG002|Overall Study|Lost to Follow-up|3|||
46783307|NCT00676338|83002062|FG003|Overall Study|Lost to Follow-up|4|||
46783308|NCT00676338|83002059|FG000|Overall Study|Physician Decision|3|||
46783309|NCT00676338|83002060|FG001|Overall Study|Physician Decision|3|||
47076245|NCT02335944|83370881|FG007|Treatment Phase|Progressive Disease|30|||
47076246|NCT02335944|83370882|FG008|Treatment Phase|Progressive Disease|27|||
46662420|NCT00191152|82875085|FG001|Crossover Treatment|Withdrawal by Subject|9|||
46662421|NCT00191152|82875084|FG000|Crossover Treatment|Lost to Follow-up|2|||
46662422|NCT00191152|82875085|FG001|Crossover Treatment|Lost to Follow-up|1|||
46662423|NCT00191152|82875084|FG000|Crossover Treatment|Other|4|||
46783310|NCT00676338|83002061|FG002|Overall Study|Physician Decision|2|||
46783311|NCT00676338|83002062|FG003|Overall Study|Physician Decision|3|||
46783312|NCT00676338|83002059|FG000|Overall Study|Protocol Violation|5|||
46783313|NCT00676338|83002060|FG001|Overall Study|Protocol Violation|9|||
46783314|NCT00676338|83002061|FG002|Overall Study|Protocol Violation|2|||
46662424|NCT00191152|82875085|FG001|Crossover Treatment|Other|3|||
46662425|NCT00190684|82875103|FG000|Overall Study|Adverse Event|86|||
46662426|NCT00190684|82875103|FG000|Overall Study|Satisfactory response|80|||
46662427|NCT00190684|82875103|FG000|Overall Study|Lack of efficacy|204|||
46783315|NCT00676338|83002062|FG003|Overall Study|Protocol Violation|5|||
46783316|NCT00676338|83002059|FG000|Overall Study|Withdrawal by Subject|17|||
46783317|NCT00676338|83002060|FG001|Overall Study|Withdrawal by Subject|9|||
46783318|NCT00676338|83002061|FG002|Overall Study|Withdrawal by Subject|12|||
46783319|NCT00676338|83002062|FG003|Overall Study|Withdrawal by Subject|6|||
46972077|NCT02032888|83215709|FG002|Follow-up Period|Other|0|||
46972078|NCT02082262|83215726|FG000|Overall Study|Withdrawal by Subject|3|||
46972079|NCT02082262|83215726|FG000|Overall Study|Adverse Event|48|||
46662428|NCT00190684|82875103|FG000|Overall Study|Lost to Follow-up|232|||
46662429|NCT00190684|82875103|FG000|Overall Study|Patient moved|60|||
46662430|NCT00190684|82875103|FG000|Overall Study|Patient Decision|432|||
46662431|NCT00190684|82875103|FG000|Overall Study|Clinical relapse|67|||
46662432|NCT00190684|82875103|FG000|Overall Study|Sponsor's decision|17|||
46662433|NCT00190684|82875103|FG000|Overall Study|Physician Decision|84|||
46662434|NCT00190684|82875103|FG000|Overall Study|Protocol Violation|123|||
46662435|NCT00190684|82875103|FG000|Overall Study|Study Period III Completed|103|||
46662436|NCT00190684|82875103|FG000|Overall Study|Study Period V Completed|1|||
46662437|NCT00179959|82875114|FG000|Overall Study|Lost to Follow-up|3|||
46662438|NCT00179959|82875115|FG001|Overall Study|Lost to Follow-up|1|||
46662439|NCT00179959|82875114|FG000|Overall Study|Withdrawal by Subject|3|||
46662440|NCT00179959|82875115|FG001|Overall Study|Withdrawal by Subject|2|||
46662441|NCT00179647|82875121|FG000|Overall Study|Adverse Event|294|||
46662442|NCT00179647|82875121|FG000|Overall Study|Lack of Efficacy|478|||
46662443|NCT00179647|82875121|FG000|Overall Study|Withdrawal by Subject|83|||
46783320|NCT00676338|83002059|FG000|Overall Study|Entry Criteria Not Met|0|||
46972080|NCT04697069|83215732|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
46972081|NCT04697069|83215733|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
46972082|NCT04697069|83215732|FG000|Overall Study|Study termination|2|||
46972083|NCT04697069|83215733|FG001|Overall Study|Study termination|1|||
46972084|NCT02082184|83215741|FG000|Overall Study|Adverse Event|1|||
46972085|NCT02082184|83215742|FG001|Overall Study|Adverse Event|0|||
46972086|NCT02082184|83215741|FG000|Overall Study|Medical diagnosis|1|||
46972087|NCT02082184|83215742|FG001|Overall Study|Medical diagnosis|2|||
46972088|NCT02082184|83215741|FG000|Overall Study|Device associated symptoms|5|||
46972089|NCT02082184|83215742|FG001|Overall Study|Device associated symptoms|0|||
46972090|NCT02082184|83215741|FG000|Overall Study|Withdrawal by Subject|3|||
46972091|NCT02082184|83215742|FG001|Overall Study|Withdrawal by Subject|2|||
46972092|NCT02082184|83215741|FG000|Overall Study|Protocol Violation|0|||
46972093|NCT02082184|83215742|FG001|Overall Study|Protocol Violation|6|||
46972094|NCT02082184|83215741|FG000|Overall Study|Lost to Follow-up|0|||
46972095|NCT02082184|83215742|FG001|Overall Study|Lost to Follow-up|2|||
46972096|NCT02082184|83215741|FG000|Overall Study|Subject non-compliance|0|||
46972097|NCT02082184|83215742|FG001|Overall Study|Subject non-compliance|1|||
46972098|NCT01624870|83215748|FG000|Overall Study|Death|19|||
46972099|NCT01624870|83215748|FG000|Overall Study|Withdrawal by Subject|1|||
46972100|NCT01624870|83215748|FG000|Overall Study|CoreValve not implanted|6|||
46972101|NCT01624870|83215748|FG000|Overall Study|Lost to follow up|1|||
46972102|NCT02031640|83215759|FG000|Screening Period|Adverse Event|1|||
46972103|NCT02031640|83215760|FG001|Screening Period|Adverse Event|0|||
46972104|NCT02031640|83215761|FG002|Screening Period|Adverse Event|0|||
46783321|NCT00676338|83002060|FG001|Overall Study|Entry Criteria Not Met|2|||
46783322|NCT00676338|83002061|FG002|Overall Study|Entry Criteria Not Met|1|||
46972105|NCT02031640|83215762|FG003|Screening Period|Adverse Event|0|||
46972106|NCT02031640|83215763|FG004|Screening Period|Adverse Event|0|||
46972107|NCT02031640|83215764|FG005|Screening Period|Adverse Event|0|||
46972108|NCT02031640|83215759|FG000|Screening Period|Withdrawal by Subject|29|||
46972109|NCT02031640|83215760|FG001|Screening Period|Withdrawal by Subject|0|||
46972110|NCT02031640|83215761|FG002|Screening Period|Withdrawal by Subject|0|||
46972111|NCT02031640|83215762|FG003|Screening Period|Withdrawal by Subject|0|||
46972112|NCT02031640|83215763|FG004|Screening Period|Withdrawal by Subject|0|||
46662444|NCT00179647|82875121|FG000|Overall Study|Lost to Follow-up|4|||
46662445|NCT00179647|82875121|FG000|Overall Study|Death|94|||
46783323|NCT00676338|83002062|FG003|Overall Study|Entry Criteria Not Met|1|||
46783324|NCT00676338|83002059|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
46783325|NCT00676338|83002060|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
46972113|NCT02031640|83215764|FG005|Screening Period|Withdrawal by Subject|0|||
46972114|NCT02031640|83215759|FG000|Screening Period|Inclusion criteria not met|312|||
46972115|NCT02031640|83215760|FG001|Screening Period|Inclusion criteria not met|0|||
46662446|NCT00179647|82875121|FG000|Overall Study|Other|960|||
46662447|NCT00179413|82875127|FG000|Overall Study|Adverse Event|38|||
46662448|NCT00179413|82875128|FG001|Overall Study|Adverse Event|20|||
46662449|NCT00179413|82875127|FG000|Overall Study|Withdrawal by Subject|87|||
46662450|NCT00179413|82875128|FG001|Overall Study|Withdrawal by Subject|95|||
46662451|NCT00178633|82875134|FG000|Overall Study|Lost to Follow-up|6|||
46662452|NCT00178399|82875139|FG000|Overall Study|Physician Decision|4|||
46662453|NCT00178399|82875139|FG000|Overall Study|Withdrawal by Subject|8|||
46662454|NCT00178399|82875139|FG000|Overall Study|Lost to Follow-up|1|||
46662455|NCT00178126|82875146|FG000|Overall Study|Lost to Follow-up|21|||
46662456|NCT00178126|82875147|FG001|Overall Study|Lost to Follow-up|21|||
46662457|NCT00178126|82875146|FG000|Overall Study|did not receive intervention|4|||
46662458|NCT00178126|82875147|FG001|Overall Study|did not receive intervention|6|||
46662459|NCT00177307|82875153|FG000|Overall Study|Withdrawal by Subject|1|||
46662460|NCT00176605|82875161|FG000|Overall Study|Withdrawal by Subject|2|||
46662461|NCT00176488|82875165|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
46662462|NCT00175825|82875173|FG000|Overall Study|Adverse Event|3|||
46662463|NCT00175825|82875174|FG001|Overall Study|Adverse Event|2|||
46662464|NCT00175825|82875175|FG002|Overall Study|Adverse Event|1|||
46662465|NCT00175825|82875176|FG003|Overall Study|Adverse Event|1|||
46662466|NCT00175825|82875173|FG000|Overall Study|Lost to Follow-up|1|||
46662467|NCT00175825|82875174|FG001|Overall Study|Lost to Follow-up|2|||
46662468|NCT00175825|82875175|FG002|Overall Study|Lost to Follow-up|0|||
46662469|NCT00175825|82875176|FG003|Overall Study|Lost to Follow-up|0|||
46662470|NCT00175825|82875173|FG000|Overall Study|Withdrawal by Subject|1|||
46662471|NCT00175825|82875174|FG001|Overall Study|Withdrawal by Subject|0|||
46662472|NCT00175825|82875175|FG002|Overall Study|Withdrawal by Subject|0|||
46662473|NCT00175825|82875176|FG003|Overall Study|Withdrawal by Subject|0|||
46662474|NCT00174967|82875190|FG000|Overall Study|Adverse Event|1|||
46662475|NCT00174967|82875191|FG001|Overall Study|Adverse Event|2|||
46662476|NCT00174967|82875192|FG002|Overall Study|Adverse Event|2|||
46662477|NCT00174967|82875193|FG003|Overall Study|Adverse Event|1|||
46662478|NCT00174967|82875190|FG000|Overall Study|Gout Flare|0|||
46662479|NCT00174967|82875191|FG001|Overall Study|Gout Flare|0|||
46662480|NCT00174967|82875192|FG002|Overall Study|Gout Flare|0|||
46662481|NCT00174967|82875193|FG003|Overall Study|Gout Flare|1|||
46662482|NCT00174967|82875190|FG000|Overall Study|Other|0|||
46662483|NCT00174967|82875191|FG001|Overall Study|Other|1|||
46662484|NCT00174967|82875192|FG002|Overall Study|Other|0|||
46662485|NCT00174967|82875193|FG003|Overall Study|Other|0|||
46662486|NCT00174265|82875205|FG000|Overall Study|Adverse Event|7|||
46662487|NCT00174265|82875206|FG001|Overall Study|Adverse Event|4|||
46662488|NCT00174265|82875205|FG000|Overall Study|Lack of Efficacy|2|||
46662489|NCT00174265|82875206|FG001|Overall Study|Lack of Efficacy|2|||
46662490|NCT00174265|82875205|FG000|Overall Study|Withdrawal by Subject|3|||
46662491|NCT00174265|82875206|FG001|Overall Study|Withdrawal by Subject|5|||
46662492|NCT00174265|82875205|FG000|Overall Study|Lost to Follow-up|1|||
46662493|NCT00174265|82875206|FG001|Overall Study|Lost to Follow-up|0|||
46662494|NCT00174265|82875205|FG000|Overall Study|Other (Not specified)|16|||
46662495|NCT00174265|82875206|FG001|Overall Study|Other (Not specified)|10|||
46662496|NCT00172042|82875214|FG000|Overall Study|Adverse Event|27|||
46662497|NCT00172042|82875215|FG001|Overall Study|Adverse Event|13|||
46662498|NCT00172042|82875214|FG000|Overall Study|Abnormal laboratory value(s)|5|||
46662499|NCT00172042|82875215|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46662500|NCT00172042|82875214|FG000|Overall Study|Abnormal test procedure(s)|0|||
46662501|NCT00172042|82875215|FG001|Overall Study|Abnormal test procedure(s)|3|||
46662502|NCT00172042|82875214|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
46662503|NCT00172042|82875215|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
46662504|NCT00172042|82875214|FG000|Overall Study|Patient no longer requires study drug|10|||
46662505|NCT00172042|82875215|FG001|Overall Study|Patient no longer requires study drug|8|||
46662506|NCT00172042|82875214|FG000|Overall Study|Protocol Violation|8|||
46662507|NCT00172042|82875215|FG001|Overall Study|Protocol Violation|7|||
46972116|NCT02031640|83215761|FG002|Screening Period|Inclusion criteria not met|0|||
46662508|NCT00172042|82875214|FG000|Overall Study|Withdrawal by Subject|37|||
46662509|NCT00172042|82875215|FG001|Overall Study|Withdrawal by Subject|25|||
46662510|NCT00172042|82875214|FG000|Overall Study|Lost to Follow-up|3|||
46662511|NCT00172042|82875215|FG001|Overall Study|Lost to Follow-up|5|||
46662512|NCT00172042|82875214|FG000|Overall Study|Administrative problems|13|||
46662513|NCT00172042|82875215|FG001|Overall Study|Administrative problems|10|||
46662514|NCT00172042|82875214|FG000|Overall Study|Death|42|||
46662515|NCT00172042|82875215|FG001|Overall Study|Death|42|||
46662516|NCT00171925|82875223|FG000|Overall Study|Adverse Event|10|||
46662517|NCT00171925|82875224|FG001|Overall Study|Adverse Event|6|||
46662518|NCT00171925|82875223|FG000|Overall Study|Protocol Violation|1|||
46662519|NCT00171925|82875224|FG001|Overall Study|Protocol Violation|1|||
46662520|NCT00171925|82875223|FG000|Overall Study|Withdrawal by Subject|6|||
46662521|NCT00171925|82875224|FG001|Overall Study|Withdrawal by Subject|9|||
46662522|NCT00171925|82875223|FG000|Overall Study|Lost to Follow-up|2|||
46662523|NCT00171925|82875224|FG001|Overall Study|Lost to Follow-up|2|||
46662524|NCT00171925|82875223|FG000|Overall Study|Administrative problems|10|||
46662525|NCT00171925|82875224|FG001|Overall Study|Administrative problems|11|||
46662526|NCT00171925|82875223|FG000|Overall Study|Death|1|||
46662527|NCT00171925|82875224|FG001|Overall Study|Death|2|||
46662528|NCT00171340|82875232|FG000|Overall Study|Adverse Event|46|||
46662529|NCT00171340|82875233|FG001|Overall Study|Adverse Event|42|||
46662530|NCT00171340|82875232|FG000|Overall Study|Lack of Efficacy|29|||
46662531|NCT00171340|82875233|FG001|Overall Study|Lack of Efficacy|41|||
46662532|NCT00171340|82875232|FG000|Overall Study|Protocol Violation|7|||
46662533|NCT00171340|82875233|FG001|Overall Study|Protocol Violation|8|||
46662534|NCT00171340|82875232|FG000|Overall Study|Withdrawal by Subject|22|||
46662535|NCT00171340|82875233|FG001|Overall Study|Withdrawal by Subject|19|||
46662536|NCT00171340|82875232|FG000|Overall Study|Lost to Follow-up|0|||
46662537|NCT00171340|82875233|FG001|Overall Study|Lost to Follow-up|5|||
46662538|NCT00171340|82875232|FG000|Overall Study|Abnormal Laboratory Results|2|||
46662539|NCT00171340|82875233|FG001|Overall Study|Abnormal Laboratory Results|0|||
46662540|NCT00171340|82875232|FG000|Overall Study|Abnormal Test Procedure Results|6|||
46662541|NCT00171340|82875233|FG001|Overall Study|Abnormal Test Procedure Results|11|||
46662542|NCT00171340|82875232|FG000|Overall Study|No Longer Required Study Drug|1|||
46662543|NCT00171340|82875233|FG001|Overall Study|No Longer Required Study Drug|1|||
46662544|NCT00171340|82875232|FG000|Overall Study|Administrative Problems|5|||
46662545|NCT00171340|82875233|FG001|Overall Study|Administrative Problems|2|||
46662546|NCT00171340|82875232|FG000|Overall Study|Death|6|||
46662547|NCT00171340|82875233|FG001|Overall Study|Death|6|||
46662548|NCT00171301|82875243|FG000|Overall Study|Death|1|||
46662549|NCT00171301|82875244|FG001|Overall Study|Death|2|||
46662550|NCT00171301|82875243|FG000|Overall Study|Adverse Event|1|||
46662551|NCT00171301|82875244|FG001|Overall Study|Adverse Event|2|||
46662552|NCT00171301|82875243|FG000|Overall Study|Lost to Follow-up|6|||
46662553|NCT00171301|82875244|FG001|Overall Study|Lost to Follow-up|2|||
46662554|NCT00171301|82875243|FG000|Overall Study|Protocol Violation|0|||
46662555|NCT00171301|82875244|FG001|Overall Study|Protocol Violation|2|||
46662556|NCT00171301|82875243|FG000|Overall Study|Withdrawal by Subject|0|||
46662557|NCT00171301|82875244|FG001|Overall Study|Withdrawal by Subject|1|||
46662558|NCT00171223|82875254|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
46662559|NCT00171223|82875255|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
46662560|NCT00171223|82875256|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
46662561|NCT00171223|82875254|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
46662562|NCT00171223|82875255|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
46662563|NCT00171223|82875256|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
46662564|NCT00171223|82875254|FG000|Overall Study|Abnormal Procedure|1|||
46662565|NCT00171223|82875255|FG001|Overall Study|Abnormal Procedure|0|||
46662566|NCT00171223|82875256|FG002|Overall Study|Abnormal Procedure|0|||
46662567|NCT00171223|82875254|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
47076247|NCT02335944|83370883|FG009|Treatment Phase|Progressive Disease|0|||
46662568|NCT00171223|82875255|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
46662569|NCT00171223|82875256|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
46662570|NCT00171223|82875254|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
46662571|NCT00171223|82875255|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
46662572|NCT00171223|82875256|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
46662573|NCT00171223|82875254|FG000|Overall Study|Protocol Violation|2|||
46662574|NCT00171223|82875255|FG001|Overall Study|Protocol Violation|2|||
46662575|NCT00171223|82875256|FG002|Overall Study|Protocol Violation|3|||
46662576|NCT00171223|82875254|FG000|Overall Study|Participant Withdrew Consent|12|||
46662577|NCT00171223|82875255|FG001|Overall Study|Participant Withdrew Consent|21|||
47076248|NCT02335944|83370874|FG000|Treatment Phase|Adverse Event|2|||
47076249|NCT02335944|83370875|FG001|Treatment Phase|Adverse Event|0|||
47076250|NCT02335944|83370876|FG002|Treatment Phase|Adverse Event|0|||
47076251|NCT02335944|83370877|FG003|Treatment Phase|Adverse Event|2|||
47076252|NCT02335944|83370878|FG004|Treatment Phase|Adverse Event|1|||
46662578|NCT00171223|82875256|FG002|Overall Study|Participant Withdrew Consent|15|||
47076253|NCT02335944|83370879|FG005|Treatment Phase|Adverse Event|15|||
47076254|NCT02335944|83370880|FG006|Treatment Phase|Adverse Event|0|||
46662579|NCT00171223|82875254|FG000|Overall Study|Lost to Follow-up|5|||
46662580|NCT00171223|82875255|FG001|Overall Study|Lost to Follow-up|2|||
46662581|NCT00171223|82875256|FG002|Overall Study|Lost to Follow-up|3|||
46662582|NCT00171223|82875254|FG000|Overall Study|Administrative Problems|4|||
46662583|NCT00171223|82875255|FG001|Overall Study|Administrative Problems|7|||
46662584|NCT00171223|82875256|FG002|Overall Study|Administrative Problems|6|||
46662585|NCT00171223|82875254|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
46662586|NCT00171223|82875255|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
46662587|NCT00171223|82875256|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
46662588|NCT00171223|82875254|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
46662589|NCT00171223|82875255|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
46662590|NCT00171223|82875256|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
46662591|NCT00479674|82875262|FG000|Overall Study|Adverse Event|18|||
46662592|NCT00479674|82875262|FG000|Overall Study|Withdrawal by Subject|6|||
46662593|NCT00479674|82875262|FG000|Overall Study|Physician Decision|14|||
46662594|NCT00479674|82875262|FG000|Overall Study|none provided|3|||
46662595|NCT00479401|82875269|FG000|Overall Study|Adverse Event|24|||
46662596|NCT00479401|82875270|FG001|Overall Study|Adverse Event|20|||
46662597|NCT00479401|82875271|FG002|Overall Study|Adverse Event|4|||
46662598|NCT00479401|82875269|FG000|Overall Study|Lack of Efficacy|2|||
46662599|NCT00479401|82875270|FG001|Overall Study|Lack of Efficacy|2|||
46662600|NCT00479401|82875271|FG002|Overall Study|Lack of Efficacy|4|||
46662601|NCT00479401|82875269|FG000|Overall Study|Protocol Violation|2|||
46662602|NCT00479401|82875270|FG001|Overall Study|Protocol Violation|1|||
46662603|NCT00479401|82875271|FG002|Overall Study|Protocol Violation|1|||
46662604|NCT00479401|82875269|FG000|Overall Study|Lost to Follow-up|1|||
46662605|NCT00479401|82875270|FG001|Overall Study|Lost to Follow-up|1|||
46662606|NCT00479401|82875271|FG002|Overall Study|Lost to Follow-up|1|||
46662607|NCT00479401|82875269|FG000|Overall Study|Withdrawal by Subject|16|||
46662608|NCT00479401|82875270|FG001|Overall Study|Withdrawal by Subject|10|||
46662609|NCT00479401|82875271|FG002|Overall Study|Withdrawal by Subject|2|||
46662610|NCT00479401|82875269|FG000|Overall Study|Exclusion criteria, relocation|4|||
46662611|NCT00479401|82875270|FG001|Overall Study|Exclusion criteria, relocation|3|||
46662612|NCT00479401|82875271|FG002|Overall Study|Exclusion criteria, relocation|0|||
46662613|NCT00478777|82875279|FG000|Overall Study|Adverse Event|29|||
46662614|NCT00478777|82875279|FG000|Overall Study|Lack of Efficacy|23|||
46662615|NCT00478777|82875279|FG000|Overall Study|Withdrawal by Subject|4|||
46662616|NCT00478777|82875279|FG000|Overall Study|Death|3|||
46662617|NCT00478777|82875279|FG000|Overall Study|Protocol Violation|3|||
46662618|NCT00478777|82875279|FG000|Overall Study|Lost to Follow-up|3|||
46662619|NCT00478777|82875279|FG000|Overall Study|Physician Decision|1|||
46662620|NCT00478777|82875279|FG000|Overall Study|Intolerance of therapy|1|||
46662621|NCT00478777|82875279|FG000|Overall Study|Lack of compliance|1|||
46662622|NCT00478777|82875279|FG000|Overall Study|Lymphocytes infusion|1|||
46662623|NCT00478777|82875279|FG000|Overall Study|End of therapy|2|||
46662624|NCT00478777|82875279|FG000|Overall Study|Not treated with lenalidomide|6|||
46662625|NCT00477607|82875285|FG000|Overall Study|Lost to Follow-up|7|||
46662626|NCT00477607|82875286|FG001|Overall Study|Lost to Follow-up|7|||
46662627|NCT00477490|82875297|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
46662628|NCT00477490|82875298|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
46662629|NCT00477490|82875299|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
46662630|NCT00477490|82875300|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
46662631|NCT00477490|82875301|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
46662632|NCT00477490|82875302|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
46662633|NCT00477490|82875303|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
46662634|NCT00477490|82875304|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
46662635|NCT00477490|82875305|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
46662636|NCT00477490|82875297|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
46662637|NCT00477490|82875298|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
46662638|NCT00477490|82875299|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
46662639|NCT00477490|82875300|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
46662640|NCT00477490|82875301|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
46662641|NCT00477490|82875302|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
46662642|NCT00477490|82875303|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
46662643|NCT00477490|82875304|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
46662644|NCT00477490|82875305|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
46662645|NCT00477490|82875297|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
46662646|NCT00477490|82875298|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
46662647|NCT00477490|82875299|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
46662648|NCT00477490|82875300|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
46662649|NCT00477490|82875301|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
46972117|NCT02031640|83215762|FG003|Screening Period|Inclusion criteria not met|0|||
46972118|NCT02031640|83215763|FG004|Screening Period|Inclusion criteria not met|0|||
46972119|NCT02031640|83215764|FG005|Screening Period|Inclusion criteria not met|0|||
46662650|NCT00477490|82875302|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
46662651|NCT00477490|82875303|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
46972120|NCT02031640|83215759|FG000|Screening Period|Exclusion criteria met|30|||
46662652|NCT00477490|82875304|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
46662653|NCT00477490|82875305|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
46662654|NCT00477490|82875297|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
46662655|NCT00477490|82875298|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
46662656|NCT00477490|82875299|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
46662657|NCT00477490|82875300|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
46662658|NCT00477490|82875301|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
46662659|NCT00477490|82875302|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
46972121|NCT02031640|83215760|FG001|Screening Period|Exclusion criteria met|0|||
46662660|NCT00477490|82875303|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
46662661|NCT00477490|82875304|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
46662662|NCT00477490|82875305|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
46662663|NCT00477490|82875297|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
46662664|NCT00477490|82875298|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
46662665|NCT00477490|82875299|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
46662666|NCT00477490|82875300|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
46662667|NCT00477490|82875301|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
46662668|NCT00477490|82875302|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
46662669|NCT00477490|82875303|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
46662670|NCT00477490|82875304|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
46662671|NCT00477490|82875305|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
46662672|NCT00477490|82875297|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
46662673|NCT00477490|82875298|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
46662674|NCT00477490|82875299|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
46662675|NCT00477490|82875300|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
46662676|NCT00477490|82875301|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
46662677|NCT00477490|82875302|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
46662678|NCT00477490|82875303|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
46662679|NCT00477490|82875304|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
46662680|NCT00477490|82875305|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
46662681|NCT00477490|82875297|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
46662682|NCT00477490|82875298|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
46662683|NCT00477490|82875299|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
46662684|NCT00477490|82875300|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
46662685|NCT00477490|82875301|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
46662686|NCT00477490|82875302|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
46662687|NCT00477490|82875303|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
46662688|NCT00477490|82875304|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
46662689|NCT00477490|82875305|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
46662690|NCT00477490|82875297|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
46662691|NCT00477490|82875298|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
46662692|NCT00477490|82875299|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
46662693|NCT00477490|82875300|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
46662694|NCT00477490|82875301|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
46662695|NCT00477490|82875302|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
46662696|NCT00477490|82875303|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
46662697|NCT00477490|82875304|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
46662698|NCT00477490|82875305|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
46662699|NCT00477490|82875297|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
46662700|NCT00477490|82875298|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
46662701|NCT00477490|82875299|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
46662702|NCT00477490|82875300|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
46662703|NCT00477490|82875301|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
46662704|NCT00477490|82875302|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
46662705|NCT00477490|82875303|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
46662706|NCT00477490|82875304|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
46662707|NCT00477490|82875305|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
46662708|NCT00477490|82875297|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
46662709|NCT00477490|82875298|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
46662710|NCT00477490|82875299|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
46662711|NCT00477490|82875300|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
46783326|NCT00676338|83002061|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
46783327|NCT00676338|83002062|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
46783328|NCT00382291|83002075|FG000|Overall Study|Adverse Event|1|||
46783329|NCT00382291|83002076|FG001|Overall Study|Adverse Event|2|||
46783330|NCT00382291|83002077|FG002|Overall Study|Adverse Event|2|||
46783331|NCT00382291|83002075|FG000|Overall Study|Protocol Violation|1|||
46783332|NCT00382291|83002076|FG001|Overall Study|Protocol Violation|0|||
46783333|NCT00382291|83002077|FG002|Overall Study|Protocol Violation|0|||
46783334|NCT00382291|83002075|FG000|Overall Study|Temporary study suspension|2|||
46783335|NCT00382291|83002076|FG001|Overall Study|Temporary study suspension|2|||
46783336|NCT00382291|83002077|FG002|Overall Study|Temporary study suspension|5|||
46783337|NCT00382291|83002075|FG000|Overall Study|Withdrawal by Subject|0|||
46783338|NCT00382291|83002076|FG001|Overall Study|Withdrawal by Subject|2|||
46783339|NCT00382291|83002077|FG002|Overall Study|Withdrawal by Subject|0|||
46783340|NCT00382291|83002075|FG000|Overall Study|Physician Decision|0|||
46662712|NCT00477490|82875301|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
46662713|NCT00477490|82875302|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
46662714|NCT00477490|82875303|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
46662715|NCT00477490|82875304|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
46662716|NCT00477490|82875305|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
46662717|NCT00477490|82875297|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
46662718|NCT00477490|82875298|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
46662719|NCT00477490|82875299|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
46662720|NCT00477490|82875300|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
46662721|NCT00477490|82875301|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
46662722|NCT00477490|82875302|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
46662723|NCT00477490|82875303|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
46662724|NCT00477490|82875304|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
46662725|NCT00477490|82875305|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
46662726|NCT00477490|82875297|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662727|NCT00477490|82875298|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
46662728|NCT00477490|82875299|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662729|NCT00477490|82875300|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662730|NCT00477490|82875301|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662731|NCT00477490|82875302|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662732|NCT00477490|82875303|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662733|NCT00477490|82875304|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662734|NCT00477490|82875305|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
46662735|NCT00477490|82875297|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
46662736|NCT00477490|82875298|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
46662737|NCT00477490|82875299|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
46662738|NCT00477490|82875300|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
46662739|NCT00477490|82875301|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
46662740|NCT00477490|82875302|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
46662741|NCT00477490|82875303|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
46662742|NCT00477490|82875304|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
46662743|NCT00477490|82875305|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
46662744|NCT00477490|82875297|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
46662745|NCT00477490|82875298|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
46662746|NCT00477490|82875299|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
46783341|NCT00382291|83002076|FG001|Overall Study|Physician Decision|1|||
46783342|NCT00382291|83002077|FG002|Overall Study|Physician Decision|0|||
46783343|NCT00382291|83002075|FG000|Overall Study|Lack of Efficacy|0|||
46783344|NCT00382291|83002076|FG001|Overall Study|Lack of Efficacy|0|||
46783345|NCT00382291|83002077|FG002|Overall Study|Lack of Efficacy|1|||
46783346|NCT00547378|83002099|FG000|Randomized Cohort|Withdrawal by Subject|7|||
46783347|NCT00547378|83002100|FG001|Randomized Cohort|Withdrawal by Subject|5|||
46783348|NCT00547378|83002101|FG002|Randomized Cohort|Withdrawal by Subject|0|||
46783349|NCT00547378|83002099|FG000|Randomized Cohort|Death|0|||
46783350|NCT00547378|83002100|FG001|Randomized Cohort|Death|1|||
46783351|NCT00547378|83002101|FG002|Randomized Cohort|Death|0|||
46783352|NCT00547378|83002099|FG000|Randomized Cohort|Lost to Follow-up|1|||
46783353|NCT00547378|83002100|FG001|Randomized Cohort|Lost to Follow-up|0|||
47076255|NCT02335944|83370881|FG007|Treatment Phase|Adverse Event|5|||
47076256|NCT02335944|83370882|FG008|Treatment Phase|Adverse Event|7|||
47076257|NCT02335944|83370883|FG009|Treatment Phase|Adverse Event|0|||
47076258|NCT02335944|83370874|FG000|Treatment Phase|Physician Decision|0|||
47076259|NCT02335944|83370875|FG001|Treatment Phase|Physician Decision|0|||
47076260|NCT02335944|83370876|FG002|Treatment Phase|Physician Decision|0|||
46783354|NCT00547378|83002101|FG002|Randomized Cohort|Lost to Follow-up|0|||
46783355|NCT00547378|83002099|FG000|Randomized Cohort|Adverse Event|1|||
46783356|NCT00547378|83002100|FG001|Randomized Cohort|Adverse Event|0|||
46783357|NCT00547378|83002101|FG002|Randomized Cohort|Adverse Event|0|||
46783358|NCT00547378|83002099|FG000|Randomized Cohort|Other reasons|2|||
46783359|NCT00547378|83002100|FG001|Randomized Cohort|Other reasons|0|||
46783360|NCT00547378|83002101|FG002|Randomized Cohort|Other reasons|0|||
46783361|NCT00547378|83002099|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
46783362|NCT00547378|83002100|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
46783363|NCT00547378|83002101|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
46783364|NCT00547378|83002099|FG000|All Implanted Cohort|Adverse Event|4|||
46783365|NCT00547378|83002100|FG001|All Implanted Cohort|Adverse Event|10|||
47076261|NCT02335944|83370877|FG003|Treatment Phase|Physician Decision|1|||
46662747|NCT00477490|82875300|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
46662748|NCT00477490|82875301|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
46783366|NCT00547378|83002101|FG002|All Implanted Cohort|Adverse Event|17|||
46783367|NCT00547378|83002099|FG000|All Implanted Cohort|Lost to Follow-up|0|||
46783368|NCT00547378|83002100|FG001|All Implanted Cohort|Lost to Follow-up|1|||
46783369|NCT00547378|83002101|FG002|All Implanted Cohort|Lost to Follow-up|14|||
46662749|NCT00477490|82875302|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
46662750|NCT00477490|82875303|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
46662751|NCT00477490|82875304|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
46662752|NCT00477490|82875305|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
46662753|NCT00477334|82875335|FG000|Overall Study|Discontinued prior to taking study drug|106|||
46662754|NCT00477334|82875336|FG001|Overall Study|Discontinued prior to taking study drug|53|||
46662755|NCT00477334|82875335|FG000|Overall Study|Adverse Event|1|||
46662756|NCT00477334|82875336|FG001|Overall Study|Adverse Event|2|||
46972122|NCT02031640|83215761|FG002|Screening Period|Exclusion criteria met|0|||
46662757|NCT00477334|82875335|FG000|Overall Study|Withdrawal by Subject|2|||
46783370|NCT00547378|83002099|FG000|All Implanted Cohort|Death|3|||
46972123|NCT02031640|83215762|FG003|Screening Period|Exclusion criteria met|0|||
46972124|NCT02031640|83215763|FG004|Screening Period|Exclusion criteria met|0|||
46662758|NCT00477334|82875336|FG001|Overall Study|Withdrawal by Subject|1|||
46662759|NCT00477334|82875335|FG000|Overall Study|Lost to Follow-up|15|||
46662760|NCT00477334|82875336|FG001|Overall Study|Lost to Follow-up|4|||
46662761|NCT00477334|82875335|FG000|Overall Study|Administrative Problems|39|||
46662762|NCT00477334|82875336|FG001|Overall Study|Administrative Problems|15|||
46662763|NCT00477334|82875335|FG000|Overall Study|Protocol Violation|7|||
46662764|NCT00477334|82875336|FG001|Overall Study|Protocol Violation|1|||
46662765|NCT04536727|82875441|FG000|Overall Study|Lost to Follow-up|1|||
46662766|NCT04536727|82875442|FG001|Overall Study|Lost to Follow-up|1|||
46662767|NCT04536727|82875441|FG000|Overall Study|Death|0|||
46662768|NCT04536727|82875442|FG001|Overall Study|Death|1|||
46662769|NCT04971967|82875503|FG000|Overall Study|Lost to Follow-up|6|||
46662770|NCT04971967|82875504|FG001|Overall Study|Lost to Follow-up|7|||
46662771|NCT04582266|82875531|FG000|Overall Study|Lost to Follow-up|7|||
46662772|NCT04582266|82875532|FG001|Overall Study|Lost to Follow-up|5|||
46662773|NCT04582266|82875531|FG000|Overall Study|Withdrawal by Subject|1|||
46662774|NCT04582266|82875532|FG001|Overall Study|Withdrawal by Subject|0|||
46851068|NCT03575806|83066830|FG000|Overall Study|Protocol Violation|0|||
46851069|NCT03575806|83066831|FG001|Overall Study|Protocol Violation|2|||
46851070|NCT03610048|83066837|FG000|Overall Study|Study terminated by sponsor|84|||
46851071|NCT03610048|83066837|FG000|Overall Study|Adverse Event|32|||
46851072|NCT03610048|83066837|FG000|Overall Study|Withdrawal by Subject|31|||
46851073|NCT03610048|83066837|FG000|Overall Study|Lost to Follow-up|8|||
46851074|NCT03610048|83066837|FG000|Overall Study|Other|4|||
46851075|NCT03610048|83066837|FG000|Overall Study|Physician Decision|1|||
46851076|NCT03610048|83066837|FG000|Overall Study|Pregnancy|1|||
46851077|NCT03608254|83066841|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
46851078|NCT03608254|83066841|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
46851079|NCT03606460|83066847|FG000|Overall Study|Lost to Follow-up|1|||
46851080|NCT03606460|83066848|FG001|Overall Study|Lost to Follow-up|8|||
46851081|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
46851082|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
46972125|NCT02031640|83215764|FG005|Screening Period|Exclusion criteria met|0|||
46972126|NCT02031640|83215759|FG000|Screening Period|Lost to Follow-up|14|||
46972127|NCT02031640|83215760|FG001|Screening Period|Lost to Follow-up|0|||
46972128|NCT02031640|83215761|FG002|Screening Period|Lost to Follow-up|0|||
46972129|NCT02031640|83215762|FG003|Screening Period|Lost to Follow-up|0|||
46783371|NCT00547378|83002100|FG001|All Implanted Cohort|Death|1|||
46783372|NCT00547378|83002101|FG002|All Implanted Cohort|Death|4|||
46783373|NCT00547378|83002099|FG000|All Implanted Cohort|Physician Decision|0|||
46972130|NCT02031640|83215763|FG004|Screening Period|Lost to Follow-up|0|||
46972131|NCT02031640|83215764|FG005|Screening Period|Lost to Follow-up|0|||
46972132|NCT02031640|83215759|FG000|Screening Period|Enrollment closed|26|||
46972133|NCT02031640|83215760|FG001|Screening Period|Enrollment closed|0|||
46972134|NCT02031640|83215761|FG002|Screening Period|Enrollment closed|0|||
47076262|NCT02335944|83370878|FG004|Treatment Phase|Physician Decision|0|||
46783374|NCT00547378|83002100|FG001|All Implanted Cohort|Physician Decision|2|||
46783375|NCT00547378|83002101|FG002|All Implanted Cohort|Physician Decision|6|||
46783376|NCT00547378|83002099|FG000|All Implanted Cohort|Site closure|2|||
46783377|NCT00547378|83002100|FG001|All Implanted Cohort|Site closure|0|||
47076263|NCT02335944|83370879|FG005|Treatment Phase|Physician Decision|6|||
47076264|NCT02335944|83370880|FG006|Treatment Phase|Physician Decision|1|||
46662775|NCT04582266|82875531|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
46662776|NCT04582266|82875532|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
46662777|NCT04459338|82875542|FG000|Overall Study|Loss of IV during study|1|||
46783378|NCT00547378|83002101|FG002|All Implanted Cohort|Site closure|1|||
46851083|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
46851084|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
46851085|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
46851086|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
46662778|NCT04459338|82875543|FG001|Overall Study|Loss of IV during study|0|||
46662779|NCT03740048|82875589|FG000|Overall Study|Withdrawal by Subject|1|||
46662780|NCT03740048|82875590|FG001|Overall Study|Withdrawal by Subject|1|||
46662781|NCT03740048|82875589|FG000|Overall Study|Death|1|||
46662782|NCT03740048|82875590|FG001|Overall Study|Death|6|||
46662783|NCT03740048|82875589|FG000|Overall Study|Switched to thrice-weekly HD|2|||
46662784|NCT03740048|82875590|FG001|Overall Study|Switched to thrice-weekly HD|0|||
46662785|NCT03740048|82875589|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
46662786|NCT03740048|82875590|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
46662787|NCT03740048|82875589|FG000|Overall Study|Lost to Follow-up|0|||
46662788|NCT03740048|82875590|FG001|Overall Study|Lost to Follow-up|1|||
46662789|NCT03740048|82875589|FG000|Overall Study|Non-compliance with HD|0|||
46662790|NCT03740048|82875590|FG001|Overall Study|Non-compliance with HD|1|||
46662791|NCT03373760|82875667|FG000|Overall Study|Adverse Event|8|||
46662792|NCT03373760|82875667|FG000|Overall Study|Disease Progression|46|||
46662793|NCT03373760|82875667|FG000|Overall Study|Death|4|||
46662794|NCT03324880|82875676|FG000|Overall Study|Adverse Event|0|||
46662795|NCT03324880|82875677|FG001|Overall Study|Adverse Event|2|||
46662796|NCT03324880|82875676|FG000|Overall Study|Withdrawal by Subject|2|||
46662797|NCT03324880|82875677|FG001|Overall Study|Withdrawal by Subject|2|||
46662798|NCT03324880|82875676|FG000|Overall Study|Lost to Follow-up|0|||
46662799|NCT03324880|82875677|FG001|Overall Study|Lost to Follow-up|1|||
46662800|NCT03324880|82875676|FG000|Overall Study|Product Recall|0|||
46662801|NCT03324880|82875677|FG001|Overall Study|Product Recall|1|||
46662802|NCT03053440|82875687|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
46662803|NCT03053440|82875688|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
46662804|NCT03053440|82875687|FG000|Overall Study|Death|18|||
46662805|NCT03053440|82875688|FG001|Overall Study|Death|14|||
46662806|NCT03053440|82875687|FG000|Overall Study|Withdrawal by Subject|9|||
46972135|NCT02031640|83215762|FG003|Screening Period|Enrollment closed|0|||
46972136|NCT02031640|83215763|FG004|Screening Period|Enrollment closed|0|||
46972137|NCT02031640|83215764|FG005|Screening Period|Enrollment closed|0|||
46972138|NCT02031640|83215759|FG000|Run-In Period|Adverse Event|4|||
46972139|NCT02031640|83215760|FG001|Run-In Period|Adverse Event|0|||
46972140|NCT02031640|83215761|FG002|Run-In Period|Adverse Event|0|||
46972141|NCT02031640|83215762|FG003|Run-In Period|Adverse Event|0|||
46972142|NCT02031640|83215763|FG004|Run-In Period|Adverse Event|0|||
46972143|NCT02031640|83215764|FG005|Run-In Period|Adverse Event|0|||
46972144|NCT02031640|83215759|FG000|Run-In Period|Withdrawal by Subject|17|||
46972145|NCT02031640|83215760|FG001|Run-In Period|Withdrawal by Subject|0|||
46972146|NCT02031640|83215761|FG002|Run-In Period|Withdrawal by Subject|0|||
46662807|NCT03053440|82875688|FG001|Overall Study|Withdrawal by Subject|8|||
46662808|NCT03053440|82875687|FG000|Overall Study|Lost to Follow-up|1|||
46662809|NCT03053440|82875688|FG001|Overall Study|Lost to Follow-up|0|||
46662810|NCT03053440|82875687|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
46662811|NCT03053440|82875688|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
46662812|NCT03053440|82875687|FG000|Overall Study|Physician Decision|2|||
46662813|NCT03053440|82875688|FG001|Overall Study|Physician Decision|1|||
46662814|NCT03053440|82875687|FG000|Overall Study|Participant Randomized but died before dosing|1|||
46662815|NCT03053440|82875688|FG001|Overall Study|Participant Randomized but died before dosing|0|||
46662816|NCT02985684|82875695|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
46662817|NCT02985684|82875695|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
46662818|NCT02985684|82875695|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
46662819|NCT02949934|82875734|FG000|Natural Drinking Period|Adverse Event|1|||
46662820|NCT02949934|82875735|FG001|Natural Drinking Period|Adverse Event|0|||
46662821|NCT02949934|82875736|FG002|Natural Drinking Period|Adverse Event|0|||
46662822|NCT02949934|82875737|FG003|Natural Drinking Period|Adverse Event|1|||
46662823|NCT02949934|82875738|FG004|Natural Drinking Period|Adverse Event|0|||
46662824|NCT02949934|82875739|FG005|Natural Drinking Period|Adverse Event|0|||
46972147|NCT02031640|83215762|FG003|Run-In Period|Withdrawal by Subject|0|||
46972148|NCT02031640|83215763|FG004|Run-In Period|Withdrawal by Subject|0|||
46972149|NCT02031640|83215764|FG005|Run-In Period|Withdrawal by Subject|0|||
47076265|NCT02335944|83370881|FG007|Treatment Phase|Physician Decision|2|||
47076266|NCT02335944|83370882|FG008|Treatment Phase|Physician Decision|1|||
47076267|NCT02335944|83370883|FG009|Treatment Phase|Physician Decision|0|||
47076268|NCT02335944|83370874|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
47076269|NCT02335944|83370875|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
47076270|NCT02335944|83370876|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
47076271|NCT02335944|83370877|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
46662825|NCT02949934|82875734|FG000|Natural Drinking Period|Lost to Follow-up|0|||
46662826|NCT02949934|82875735|FG001|Natural Drinking Period|Lost to Follow-up|0|||
46662827|NCT02949934|82875736|FG002|Natural Drinking Period|Lost to Follow-up|0|||
46662828|NCT02949934|82875737|FG003|Natural Drinking Period|Lost to Follow-up|0|||
46662829|NCT02949934|82875738|FG004|Natural Drinking Period|Lost to Follow-up|1|||
46662830|NCT02949934|82875739|FG005|Natural Drinking Period|Lost to Follow-up|0|||
46662831|NCT02949934|82875734|FG000|Neuroimaging|Protocol Violation|2|||
46662832|NCT02949934|82875735|FG001|Neuroimaging|Protocol Violation|0|||
46662833|NCT02949934|82875736|FG002|Neuroimaging|Protocol Violation|0|||
46662834|NCT02949934|82875737|FG003|Neuroimaging|Protocol Violation|0|||
46662835|NCT02949934|82875738|FG004|Neuroimaging|Protocol Violation|1|||
46662836|NCT02949934|82875739|FG005|Neuroimaging|Protocol Violation|0|||
46662837|NCT02949934|82875734|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
46662838|NCT02949934|82875735|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
46662839|NCT02949934|82875736|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
46662840|NCT02949934|82875737|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
46662841|NCT02949934|82875738|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
46783379|NCT00547378|83002099|FG000|All Implanted Cohort|Other reasons|1|||
46972150|NCT02031640|83215759|FG000|Run-In Period|Inclusion criteria not met|38|||
46972151|NCT02031640|83215760|FG001|Run-In Period|Inclusion criteria not met|0|||
46972152|NCT02031640|83215761|FG002|Run-In Period|Inclusion criteria not met|0|||
46972153|NCT02031640|83215762|FG003|Run-In Period|Inclusion criteria not met|0|||
46972154|NCT02031640|83215763|FG004|Run-In Period|Inclusion criteria not met|0|||
46972155|NCT02031640|83215764|FG005|Run-In Period|Inclusion criteria not met|0|||
46972156|NCT02031640|83215759|FG000|Run-In Period|Exclusion criteria met|8|||
46972157|NCT02031640|83215760|FG001|Run-In Period|Exclusion criteria met|0|||
46972158|NCT02031640|83215761|FG002|Run-In Period|Exclusion criteria met|0|||
46972159|NCT02031640|83215762|FG003|Run-In Period|Exclusion criteria met|0|||
46972160|NCT02031640|83215763|FG004|Run-In Period|Exclusion criteria met|0|||
46972161|NCT02031640|83215764|FG005|Run-In Period|Exclusion criteria met|0|||
46972162|NCT02031640|83215759|FG000|Run-In Period|Randomization criteria not met|85|||
46972163|NCT02031640|83215760|FG001|Run-In Period|Randomization criteria not met|0|||
46972164|NCT02031640|83215761|FG002|Run-In Period|Randomization criteria not met|0|||
46972165|NCT02031640|83215762|FG003|Run-In Period|Randomization criteria not met|0|||
46972166|NCT02031640|83215763|FG004|Run-In Period|Randomization criteria not met|0|||
46972167|NCT02031640|83215764|FG005|Run-In Period|Randomization criteria not met|0|||
46783380|NCT00547378|83002100|FG001|All Implanted Cohort|Other reasons|0|||
46972168|NCT02031640|83215759|FG000|Run-In Period|Various administrative reasons|17|||
46972169|NCT02031640|83215760|FG001|Run-In Period|Various administrative reasons|0|||
46972170|NCT02031640|83215761|FG002|Run-In Period|Various administrative reasons|0|||
46972171|NCT02031640|83215762|FG003|Run-In Period|Various administrative reasons|0|||
46662842|NCT02949934|82875739|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
46972172|NCT02031640|83215763|FG004|Run-In Period|Various administrative reasons|0|||
46783381|NCT00547378|83002101|FG002|All Implanted Cohort|Other reasons|1|||
46662843|NCT02949934|82875734|FG000|Neuroimaging|Not scanned|0|||
46662844|NCT02949934|82875735|FG001|Neuroimaging|Not scanned|0|||
46783382|NCT00381043|83002111|FG000|Overall Study|Lost to Follow-up|8|||
46783383|NCT00381043|83002112|FG001|Overall Study|Lost to Follow-up|6|||
47076272|NCT02335944|83370878|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
46662845|NCT02949934|82875736|FG002|Neuroimaging|Not scanned|1|||
46662846|NCT02949934|82875737|FG003|Neuroimaging|Not scanned|0|||
46662847|NCT02949934|82875738|FG004|Neuroimaging|Not scanned|0|||
46662848|NCT02949934|82875739|FG005|Neuroimaging|Not scanned|2|||
46662849|NCT02949934|82875734|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
46662850|NCT02949934|82875735|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
46662851|NCT02949934|82875736|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
46662852|NCT02949934|82875737|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
46662853|NCT02949934|82875738|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
46662854|NCT02949934|82875739|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
46662855|NCT02949934|82875734|FG000|Bar Laboratory|Adverse Event|1|||
46662856|NCT02949934|82875735|FG001|Bar Laboratory|Adverse Event|0|||
46662857|NCT02949934|82875736|FG002|Bar Laboratory|Adverse Event|2|||
46662858|NCT02949934|82875737|FG003|Bar Laboratory|Adverse Event|0|||
46662859|NCT02949934|82875738|FG004|Bar Laboratory|Adverse Event|1|||
46662860|NCT02949934|82875739|FG005|Bar Laboratory|Adverse Event|0|||
46662861|NCT02949934|82875734|FG000|Bar Laboratory|Protocol Violation|0|||
46662862|NCT02949934|82875735|FG001|Bar Laboratory|Protocol Violation|0|||
46662863|NCT02949934|82875736|FG002|Bar Laboratory|Protocol Violation|0|||
46662864|NCT02949934|82875737|FG003|Bar Laboratory|Protocol Violation|1|||
46662865|NCT02949934|82875738|FG004|Bar Laboratory|Protocol Violation|0|||
46662866|NCT02949934|82875739|FG005|Bar Laboratory|Protocol Violation|0|||
46662867|NCT02935634|82875771|FG000|Randomization|Participant withdrew consent|0|||
46662868|NCT02935634|82875772|FG001|Randomization|Participant withdrew consent|1|||
46662869|NCT02935634|82875773|FG002|Randomization|Participant withdrew consent|0|||
46662870|NCT02935634|82875774|FG003|Randomization|Participant withdrew consent|0|||
46662871|NCT02935634|82875775|FG004|Randomization|Participant withdrew consent|0|||
46783384|NCT00381043|83002111|FG000|Overall Study|Withdrawal by Subject|3|||
46783385|NCT00381043|83002112|FG001|Overall Study|Withdrawal by Subject|1|||
46783386|NCT00381043|83002111|FG000|Overall Study|wanted more care|0|||
46783387|NCT00381043|83002112|FG001|Overall Study|wanted more care|1|||
46783388|NCT00381043|83002111|FG000|Overall Study|incarcerated|1|||
46783389|NCT00381043|83002112|FG001|Overall Study|incarcerated|0|||
46783390|NCT00614991|83002124|FG000|Overall Study|Adverse Event|3|||
46783391|NCT00614991|83002125|FG001|Overall Study|Adverse Event|3|||
46783392|NCT00614991|83002126|FG002|Overall Study|Adverse Event|0|||
46783393|NCT00614991|83002127|FG003|Overall Study|Adverse Event|0|||
46783394|NCT00614991|83002128|FG004|Overall Study|Adverse Event|1|||
46783395|NCT00614991|83002129|FG005|Overall Study|Adverse Event|0|||
46783396|NCT00360529|83002151|FG000|Overall Study|Adverse Event|10|||
46783397|NCT00360529|83002152|FG001|Overall Study|Adverse Event|23|||
46783398|NCT00360529|83002153|FG002|Overall Study|Adverse Event|33|||
46783399|NCT00360529|83002151|FG000|Overall Study|Protocol Violation|3|||
46662872|NCT02935634|82875776|FG005|Randomization|Participant withdrew consent|0|||
46662873|NCT02935634|82875771|FG000|Randomization|Death|2|||
46662874|NCT02935634|82875772|FG001|Randomization|Death|1|||
46662875|NCT02935634|82875773|FG002|Randomization|Death|1|||
46662876|NCT02935634|82875774|FG003|Randomization|Death|0|||
46662877|NCT02935634|82875775|FG004|Randomization|Death|0|||
46662878|NCT02935634|82875776|FG005|Randomization|Death|0|||
46662879|NCT02935634|82875771|FG000|Randomization|Other reasons|0|||
46662880|NCT02935634|82875772|FG001|Randomization|Other reasons|2|||
46662881|NCT02935634|82875773|FG002|Randomization|Other reasons|2|||
46662882|NCT02935634|82875774|FG003|Randomization|Other reasons|0|||
46662883|NCT02935634|82875775|FG004|Randomization|Other reasons|0|||
46662884|NCT02935634|82875776|FG005|Randomization|Other reasons|0|||
46662885|NCT02935634|82875771|FG000|Treatment: Track 1|Disease progression|15|||
46662886|NCT02935634|82875772|FG001|Treatment: Track 1|Disease progression|17|||
46662887|NCT02935634|82875773|FG002|Treatment: Track 1|Disease progression|28|||
46662888|NCT02935634|82875774|FG003|Treatment: Track 1|Disease progression|4|||
46662889|NCT02935634|82875775|FG004|Treatment: Track 1|Disease progression|6|||
46783400|NCT00360529|83002152|FG001|Overall Study|Protocol Violation|3|||
47076273|NCT02335944|83370879|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
46662890|NCT02935634|82875776|FG005|Treatment: Track 1|Disease progression|2|||
46662891|NCT02935634|82875771|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
46662892|NCT02935634|82875772|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
46662893|NCT02935634|82875773|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
46783401|NCT00360529|83002153|FG002|Overall Study|Protocol Violation|11|||
46783402|NCT00360529|83002151|FG000|Overall Study|Lost to Follow-up|14|||
46783403|NCT00360529|83002152|FG001|Overall Study|Lost to Follow-up|10|||
46783404|NCT00360529|83002153|FG002|Overall Study|Lost to Follow-up|13|||
46662894|NCT02935634|82875774|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
46662895|NCT02935634|82875775|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
46662896|NCT02935634|82875776|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
46662897|NCT02935634|82875771|FG000|Treatment: Track 1|Lost to Follow-up|1|||
46783405|NCT00360529|83002151|FG000|Overall Study|Withdrawal by Subject|22|||
46662898|NCT02935634|82875772|FG001|Treatment: Track 1|Lost to Follow-up|0|||
46662899|NCT02935634|82875773|FG002|Treatment: Track 1|Lost to Follow-up|0|||
46662900|NCT02935634|82875774|FG003|Treatment: Track 1|Lost to Follow-up|0|||
46662901|NCT02935634|82875775|FG004|Treatment: Track 1|Lost to Follow-up|0|||
46662902|NCT02935634|82875776|FG005|Treatment: Track 1|Lost to Follow-up|0|||
46662903|NCT02935634|82875771|FG000|Treatment: Track 1|Study drug toxicity|2|||
46662904|NCT02935634|82875772|FG001|Treatment: Track 1|Study drug toxicity|1|||
46662905|NCT02935634|82875773|FG002|Treatment: Track 1|Study drug toxicity|3|||
46662906|NCT02935634|82875774|FG003|Treatment: Track 1|Study drug toxicity|0|||
46662907|NCT02935634|82875775|FG004|Treatment: Track 1|Study drug toxicity|0|||
46662908|NCT02935634|82875776|FG005|Treatment: Track 1|Study drug toxicity|1|||
46662909|NCT02935634|82875771|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
46662910|NCT02935634|82875772|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
46662911|NCT02935634|82875773|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
46662912|NCT02935634|82875774|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
46662913|NCT02935634|82875775|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
46662914|NCT02935634|82875776|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
46662915|NCT02935634|82875771|FG000|Treatment: Track 1|Participant withdrew consent|2|||
46662916|NCT02935634|82875772|FG001|Treatment: Track 1|Participant withdrew consent|0|||
46662917|NCT02935634|82875773|FG002|Treatment: Track 1|Participant withdrew consent|1|||
46662918|NCT02935634|82875774|FG003|Treatment: Track 1|Participant withdrew consent|0|||
46662919|NCT02935634|82875775|FG004|Treatment: Track 1|Participant withdrew consent|1|||
46662920|NCT02935634|82875776|FG005|Treatment: Track 1|Participant withdrew consent|0|||
46662921|NCT02935634|82875771|FG000|Treatment: Track 1|Other reasons|0|||
46662922|NCT02935634|82875772|FG001|Treatment: Track 1|Other reasons|0|||
46662923|NCT02935634|82875773|FG002|Treatment: Track 1|Other reasons|2|||
46662924|NCT02935634|82875774|FG003|Treatment: Track 1|Other reasons|0|||
46662925|NCT02935634|82875775|FG004|Treatment: Track 1|Other reasons|0|||
46662926|NCT02935634|82875776|FG005|Treatment: Track 1|Other reasons|0|||
46662927|NCT02935634|82875771|FG000|Treatment: Track 2|Disease progression|13|||
46662928|NCT02935634|82875772|FG001|Treatment: Track 2|Disease progression|26|||
46662929|NCT02935634|82875773|FG002|Treatment: Track 2|Disease progression|20|||
46662930|NCT02935634|82875774|FG003|Treatment: Track 2|Disease progression|5|||
46662931|NCT02935634|82875775|FG004|Treatment: Track 2|Disease progression|1|||
46662932|NCT02935634|82875776|FG005|Treatment: Track 2|Disease progression|4|||
46662933|NCT02935634|82875771|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
46662934|NCT02935634|82875772|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
46662935|NCT02935634|82875773|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
46662936|NCT02935634|82875774|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
46662937|NCT02935634|82875775|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
46662938|NCT02935634|82875776|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
46662939|NCT02935634|82875771|FG000|Treatment: Track 2|Study drug toxicity|7|||
46662940|NCT02935634|82875772|FG001|Treatment: Track 2|Study drug toxicity|3|||
46662941|NCT02935634|82875773|FG002|Treatment: Track 2|Study drug toxicity|0|||
46662942|NCT02935634|82875774|FG003|Treatment: Track 2|Study drug toxicity|0|||
46662943|NCT02935634|82875775|FG004|Treatment: Track 2|Study drug toxicity|0|||
46662944|NCT02935634|82875776|FG005|Treatment: Track 2|Study drug toxicity|0|||
46662945|NCT02935634|82875771|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
46662946|NCT02935634|82875772|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
46972173|NCT02031640|83215764|FG005|Run-In Period|Various administrative reasons|0|||
46662947|NCT02935634|82875773|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
46662948|NCT02935634|82875774|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
46662949|NCT02935634|82875775|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
46662950|NCT02935634|82875776|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
46662951|NCT02935634|82875771|FG000|Treatment: Track 2|Participant withdrew consent|0|||
46662952|NCT02935634|82875772|FG001|Treatment: Track 2|Participant withdrew consent|1|||
46662953|NCT02935634|82875773|FG002|Treatment: Track 2|Participant withdrew consent|1|||
46662954|NCT02935634|82875774|FG003|Treatment: Track 2|Participant withdrew consent|0|||
46662955|NCT02935634|82875775|FG004|Treatment: Track 2|Participant withdrew consent|1|||
46662956|NCT02935634|82875776|FG005|Treatment: Track 2|Participant withdrew consent|0|||
46662957|NCT02864992|82875805|FG000|Overall Study|still on treatment|15|||
46662958|NCT02864992|82875806|FG001|Overall Study|still on treatment|1|||
46662959|NCT02864992|82875807|FG002|Overall Study|still on treatment|33|||
46662960|NCT02684578|82875815|FG000|Overall Study|Withdrawal by Subject|10|||
46662961|NCT02684578|82875816|FG001|Overall Study|Withdrawal by Subject|7|||
46662962|NCT02684578|82875815|FG000|Overall Study|Lost to Follow-up|0|||
46662963|NCT02684578|82875816|FG001|Overall Study|Lost to Follow-up|3|||
46662964|NCT02684578|82875815|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
46662965|NCT02684578|82875816|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
46662966|NCT02684578|82875815|FG000|Overall Study|Missing follow-up data|0|||
46662967|NCT02684578|82875816|FG001|Overall Study|Missing follow-up data|1|||
46662968|NCT02612129|82875824|FG000|Single Dose Treatment Period|Screening Failure|1|||
46662969|NCT02612129|82875825|FG001|Single Dose Treatment Period|Screening Failure|0|||
46662970|NCT02612129|82875826|FG002|Single Dose Treatment Period|Screening Failure|0|||
46662971|NCT02612129|82875824|FG000|Continuous Treatment Period|Early Escape|0|||
46662972|NCT02612129|82875825|FG001|Continuous Treatment Period|Early Escape|2|||
46662973|NCT02612129|82875826|FG002|Continuous Treatment Period|Early Escape|0|||
46662974|NCT02612129|82875824|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
46662975|NCT02612129|82875825|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
46662976|NCT02612129|82875826|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
46662977|NCT02612129|82875824|FG000|Continuous Treatment Period|Safety Reasons|0|||
46662978|NCT02612129|82875825|FG001|Continuous Treatment Period|Safety Reasons|3|||
46662979|NCT02612129|82875826|FG002|Continuous Treatment Period|Safety Reasons|0|||
46662980|NCT02612129|82875824|FG000|Continuous Treatment Period|Death|0|||
46783406|NCT00360529|83002152|FG001|Overall Study|Withdrawal by Subject|14|||
46783407|NCT00360529|83002153|FG002|Overall Study|Withdrawal by Subject|18|||
46783408|NCT00360529|83002151|FG000|Overall Study|Lack of Efficacy|8|||
46783409|NCT00360529|83002152|FG001|Overall Study|Lack of Efficacy|6|||
46783410|NCT00360529|83002153|FG002|Overall Study|Lack of Efficacy|5|||
46662981|NCT02612129|82875825|FG001|Continuous Treatment Period|Death|1|||
46662982|NCT02612129|82875826|FG002|Continuous Treatment Period|Death|0|||
46662983|NCT02612129|82875824|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
46662984|NCT02612129|82875825|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
46662985|NCT02612129|82875826|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
46662986|NCT02580305|82875836|FG000|Overall Study|Adverse Event|15|||
46662987|NCT02580305|82875837|FG001|Overall Study|Adverse Event|19|||
46662988|NCT02580305|82875838|FG002|Overall Study|Adverse Event|10|||
46662989|NCT02580305|82875836|FG000|Overall Study|Lack of Efficacy|5|||
46662990|NCT02580305|82875837|FG001|Overall Study|Lack of Efficacy|0|||
46662991|NCT02580305|82875838|FG002|Overall Study|Lack of Efficacy|2|||
46783411|NCT00360529|83002151|FG000|Overall Study|Reason discontinued not explained above|4|||
46783412|NCT00360529|83002152|FG001|Overall Study|Reason discontinued not explained above|9|||
46783413|NCT00360529|83002153|FG002|Overall Study|Reason discontinued not explained above|11|||
46662992|NCT02580305|82875836|FG000|Overall Study|Protocol Violation|4|||
46851087|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
46662993|NCT02580305|82875837|FG001|Overall Study|Protocol Violation|9|||
46662994|NCT02580305|82875838|FG002|Overall Study|Protocol Violation|6|||
46662995|NCT02580305|82875836|FG000|Overall Study|Lost to Follow-up|4|||
46662996|NCT02580305|82875837|FG001|Overall Study|Lost to Follow-up|4|||
46662997|NCT02580305|82875838|FG002|Overall Study|Lost to Follow-up|2|||
46662998|NCT02580305|82875836|FG000|Overall Study|Withdrawal by Subject|11|||
46662999|NCT02580305|82875837|FG001|Overall Study|Withdrawal by Subject|9|||
46663000|NCT02580305|82875838|FG002|Overall Study|Withdrawal by Subject|7|||
46663001|NCT02580305|82875836|FG000|Overall Study|Randomized in error and never treated|4|||
46663002|NCT02580305|82875837|FG001|Overall Study|Randomized in error and never treated|8|||
46663003|NCT02580305|82875838|FG002|Overall Study|Randomized in error and never treated|5|||
46663004|NCT02054741|82875857|FG000|Overall Study|Protocol Violation|13|||
46783414|NCT00369577|83002164|FG000|Overall Study|Withdrawal by Subject|0|||
46972174|NCT02031640|83215759|FG000|Double-blind Treatment Period|Protocol deviation|0|||
46663005|NCT02054741|82875858|FG001|Overall Study|Protocol Violation|2|||
46663006|NCT02054741|82875857|FG000|Overall Study|Withdrawal by Subject|10|||
46663007|NCT02054741|82875858|FG001|Overall Study|Withdrawal by Subject|5|||
46663008|NCT02054741|82875857|FG000|Overall Study|Death|94|||
46663009|NCT02054741|82875858|FG001|Overall Study|Death|90|||
46663010|NCT02054741|82875857|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
46663011|NCT02054741|82875858|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
46663012|NCT01555463|82875866|FG000|Treatment|Adverse Event|6|||
46663013|NCT01555463|82875867|FG001|Treatment|Adverse Event|12|||
46663014|NCT01555463|82875866|FG000|Treatment|Withdrawal by Subject|24|||
46663015|NCT01555463|82875867|FG001|Treatment|Withdrawal by Subject|36|||
46663016|NCT01555463|82875866|FG000|Treatment|Lost to Follow-up|28|||
46663017|NCT01555463|82875867|FG001|Treatment|Lost to Follow-up|23|||
46663018|NCT01555463|82875866|FG000|Treatment|Protocol Violation|4|||
46663019|NCT01555463|82875867|FG001|Treatment|Protocol Violation|5|||
46663020|NCT01555463|82875866|FG000|Treatment|Other reason|2|||
46663021|NCT01555463|82875867|FG001|Treatment|Other reason|3|||
46663022|NCT01555463|82875866|FG000|Follow up|Adverse Event|2|||
46663023|NCT01555463|82875867|FG001|Follow up|Adverse Event|5|||
46663024|NCT01555463|82875866|FG000|Follow up|Death|0|||
46663025|NCT01555463|82875867|FG001|Follow up|Death|1|||
46663026|NCT01555463|82875866|FG000|Follow up|Withdrawal by Subject|22|||
46663027|NCT01555463|82875867|FG001|Follow up|Withdrawal by Subject|22|||
46663028|NCT01555463|82875866|FG000|Follow up|Lost to Follow-up|9|||
46663029|NCT01555463|82875867|FG001|Follow up|Lost to Follow-up|10|||
46663030|NCT01555463|82875866|FG000|Follow up|Protocol Violation|2|||
46663031|NCT01555463|82875867|FG001|Follow up|Protocol Violation|4|||
46663032|NCT01555463|82875866|FG000|Follow up|Other reason|3|||
46663033|NCT01555463|82875867|FG001|Follow up|Other reason|3|||
46663034|NCT02277106|82875943|FG000|Stage 2|Adverse Event|0|||
46663035|NCT02277106|82875944|FG001|Stage 2|Adverse Event|0|||
46663036|NCT02277106|82875945|FG002|Stage 2|Adverse Event|1|||
46663037|NCT02215096|82875968|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
46783415|NCT00369577|83002165|FG001|Overall Study|Withdrawal by Subject|0|||
46972175|NCT02031640|83215760|FG001|Double-blind Treatment Period|Protocol deviation|2|||
46663038|NCT02215096|82875969|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
46663039|NCT02215096|82875970|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
46663040|NCT02215096|82875971|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
46663041|NCT02215096|82875972|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
46663042|NCT02215096|82875968|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
46663043|NCT02215096|82875969|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
46663044|NCT02215096|82875970|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
46663045|NCT02215096|82875971|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
46663046|NCT02215096|82875972|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
46663047|NCT02215096|82875968|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
46663048|NCT02215096|82875969|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
46663049|NCT02215096|82875970|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
46663050|NCT02215096|82875971|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
46663051|NCT02215096|82875972|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
46663052|NCT02215096|82875968|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
46663053|NCT02215096|82875969|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
46663054|NCT02215096|82875970|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
46663055|NCT02215096|82875971|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
46663056|NCT02215096|82875972|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
46663057|NCT03189862|82876007|FG000|Overall Study|Withdrawal by Subject|1|||
46663058|NCT03189862|82876008|FG001|Overall Study|Withdrawal by Subject|0|||
46663059|NCT03189862|82876007|FG000|Overall Study|Lost to Follow-up|54|||
46663060|NCT03189862|82876008|FG001|Overall Study|Lost to Follow-up|62|||
46663061|NCT00107614|82876036|FG000|Overall Study|Physician Decision|10|||
46783416|NCT00369577|83002166|FG002|Overall Study|Withdrawal by Subject|1|||
46783417|NCT00678288|83002176|FG000|Overall Study|Adverse Event|0|||
46783418|NCT00678288|83002177|FG001|Overall Study|Adverse Event|2|||
46972176|NCT02031640|83215761|FG002|Double-blind Treatment Period|Protocol deviation|0|||
46972177|NCT02031640|83215762|FG003|Double-blind Treatment Period|Protocol deviation|1|||
46663062|NCT00107614|82876036|FG000|Overall Study|Death|2|||
46663063|NCT00107380|82876040|FG000|Overall Study|Adverse Event|7|||
46663064|NCT00107380|82876040|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
46663065|NCT00107380|82876040|FG000|Overall Study|Progression/relapse|4|||
46783419|NCT00678288|83002176|FG000|Overall Study|Withdrawal by Subject|1|||
46972178|NCT02031640|83215763|FG004|Double-blind Treatment Period|Protocol deviation|3|||
46783420|NCT00678288|83002177|FG001|Overall Study|Withdrawal by Subject|1|||
46663066|NCT00107380|82876040|FG000|Overall Study|Death|3|||
46663067|NCT00107380|82876040|FG000|Overall Study|Other - not protocol specified|7|||
46663068|NCT00107380|82876040|FG000|Overall Study|Ineligible|2|||
46663069|NCT05368831|82876049|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
46663070|NCT05213481|82876060|FG000|Overall Study|Adverse Event|3|||
46663071|NCT05213481|82876060|FG000|Overall Study|Lost to Follow-up|1|||
46663072|NCT04905563|82876070|FG000|Overall Study|Withdrawal by Subject|1|||
46663073|NCT04905563|82876071|FG001|Overall Study|Withdrawal by Subject|0|||
46663074|NCT04905563|82876070|FG000|Overall Study|Standard of care orders entered by resident|1|||
46663075|NCT04905563|82876071|FG001|Overall Study|Standard of care orders entered by resident|0|||
46663076|NCT04905563|82876070|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
46663077|NCT04905563|82876071|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
46663078|NCT04905563|82876070|FG000|Overall Study|Withdrawal by Subject|0|||
46663079|NCT04905563|82876071|FG001|Overall Study|Withdrawal by Subject|1|||
46663080|NCT04716894|82876086|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
46663081|NCT04716894|82876086|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
46663082|NCT04537897|82876119|FG000|Overall Study|Other than listed|0|||
46663083|NCT04537897|82876120|FG001|Overall Study|Other than listed|0|||
46972179|NCT02031640|83215764|FG005|Double-blind Treatment Period|Protocol deviation|1|||
46972180|NCT02031640|83215759|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
46972181|NCT02031640|83215760|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
46972182|NCT02031640|83215761|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
46663084|NCT04537897|82876121|FG002|Overall Study|Other than listed|0|||
46663085|NCT04537897|82876122|FG003|Overall Study|Other than listed|0|||
46663086|NCT04537897|82876123|FG004|Overall Study|Other than listed|0|||
46663087|NCT04537897|82876124|FG005|Overall Study|Other than listed|0|||
46663088|NCT04537897|82876125|FG006|Overall Study|Other than listed|1|||
46663089|NCT04537897|82876126|FG007|Overall Study|Other than listed|0|||
46663090|NCT04537897|82876127|FG008|Overall Study|Other than listed|0|||
46663091|NCT04537897|82876119|FG000|Overall Study|Adverse Event|0|||
46663092|NCT04537897|82876120|FG001|Overall Study|Adverse Event|0|||
46663093|NCT04537897|82876121|FG002|Overall Study|Adverse Event|0|||
46663094|NCT04537897|82876122|FG003|Overall Study|Adverse Event|1|||
46663095|NCT04537897|82876123|FG004|Overall Study|Adverse Event|0|||
46663096|NCT04537897|82876124|FG005|Overall Study|Adverse Event|0|||
46663097|NCT04537897|82876125|FG006|Overall Study|Adverse Event|0|||
46663098|NCT04537897|82876126|FG007|Overall Study|Adverse Event|0|||
46663099|NCT04537897|82876127|FG008|Overall Study|Adverse Event|0|||
46663100|NCT04537897|82876119|FG000|Overall Study|Withdrawal by Subject|0|||
46663101|NCT04537897|82876120|FG001|Overall Study|Withdrawal by Subject|1|||
46663102|NCT04537897|82876121|FG002|Overall Study|Withdrawal by Subject|0|||
46663103|NCT04537897|82876122|FG003|Overall Study|Withdrawal by Subject|0|||
46663104|NCT04537897|82876123|FG004|Overall Study|Withdrawal by Subject|0|||
46663105|NCT04537897|82876124|FG005|Overall Study|Withdrawal by Subject|0|||
46663106|NCT04537897|82876125|FG006|Overall Study|Withdrawal by Subject|0|||
46663107|NCT04537897|82876126|FG007|Overall Study|Withdrawal by Subject|0|||
46663108|NCT04537897|82876127|FG008|Overall Study|Withdrawal by Subject|0|||
46663109|NCT04478695|82876162|FG000|Overall Study|Death|1|||
46783421|NCT00678288|83002176|FG000|Overall Study|Study terminated by the sponsor|2|||
46783422|NCT00678288|83002177|FG001|Overall Study|Study terminated by the sponsor|0|||
46783423|NCT00678288|83002176|FG000|Overall Study|Not compliant with study medication|0|||
46783424|NCT00678288|83002177|FG001|Overall Study|Not compliant with study medication|1|||
46663110|NCT04478695|82876163|FG001|Overall Study|Death|0|||
46663111|NCT04356183|82876200|FG000|Overall Study|Lost to Follow-up|1|||
46663112|NCT04356183|82876201|FG001|Overall Study|Lost to Follow-up|0|||
46783425|NCT00678288|83002176|FG000|Overall Study|Switch to commercial drug|0|||
46663113|NCT04356183|82876200|FG000|Overall Study|Withdrawal by Subject|1|||
46663114|NCT04356183|82876201|FG001|Overall Study|Withdrawal by Subject|1|||
46663115|NCT04184622|82876211|FG000|Overall Study|Adverse Event|7|||
46783426|NCT00678288|83002177|FG001|Overall Study|Switch to commercial drug|1|||
46783427|NCT00678288|83002176|FG000|Overall Study|Reason not reported|1|||
46783428|NCT00678288|83002177|FG001|Overall Study|Reason not reported|0|||
46663116|NCT04184622|82876212|FG001|Overall Study|Adverse Event|7|||
46663117|NCT04184622|82876213|FG002|Overall Study|Adverse Event|11|||
46663118|NCT04184622|82876214|FG003|Overall Study|Adverse Event|8|||
46663119|NCT04184622|82876211|FG000|Overall Study|Death|4|||
46663120|NCT04184622|82876212|FG001|Overall Study|Death|4|||
46663121|NCT04184622|82876213|FG002|Overall Study|Death|2|||
46663122|NCT04184622|82876214|FG003|Overall Study|Death|1|||
46663123|NCT04184622|82876211|FG000|Overall Study|Lost to Follow-up|41|||
46663124|NCT04184622|82876212|FG001|Overall Study|Lost to Follow-up|19|||
46663125|NCT04184622|82876213|FG002|Overall Study|Lost to Follow-up|20|||
46663126|NCT04184622|82876214|FG003|Overall Study|Lost to Follow-up|15|||
46663127|NCT04184622|82876211|FG000|Overall Study|Missing Weight at Week 72|1|||
46663128|NCT04184622|82876212|FG001|Overall Study|Missing Weight at Week 72|0|||
46663129|NCT04184622|82876213|FG002|Overall Study|Missing Weight at Week 72|1|||
46663130|NCT04184622|82876214|FG003|Overall Study|Missing Weight at Week 72|0|||
46663131|NCT04184622|82876211|FG000|Overall Study|Other - as reported by the investigator|22|||
46663132|NCT04184622|82876212|FG001|Overall Study|Other - as reported by the investigator|7|||
46663133|NCT04184622|82876213|FG002|Overall Study|Other - as reported by the investigator|5|||
46663134|NCT04184622|82876214|FG003|Overall Study|Other - as reported by the investigator|12|||
46663135|NCT04184622|82876211|FG000|Overall Study|Physician Decision|0|||
46663136|NCT04184622|82876212|FG001|Overall Study|Physician Decision|0|||
47076274|NCT02335944|83370880|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
47076275|NCT02335944|83370881|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
47076276|NCT02335944|83370882|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
47076277|NCT02335944|83370883|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
46663137|NCT04184622|82876213|FG002|Overall Study|Physician Decision|3|||
46663138|NCT04184622|82876214|FG003|Overall Study|Physician Decision|1|||
46663139|NCT04184622|82876211|FG000|Overall Study|Pregnancy|4|||
46663140|NCT04184622|82876212|FG001|Overall Study|Pregnancy|4|||
46663141|NCT04184622|82876213|FG002|Overall Study|Pregnancy|3|||
46663142|NCT04184622|82876214|FG003|Overall Study|Pregnancy|5|||
46663143|NCT04184622|82876211|FG000|Overall Study|Protocol Deviation|1|||
46663144|NCT04184622|82876212|FG001|Overall Study|Protocol Deviation|0|||
46663145|NCT04184622|82876213|FG002|Overall Study|Protocol Deviation|0|||
46663146|NCT04184622|82876214|FG003|Overall Study|Protocol Deviation|0|||
46663147|NCT04184622|82876211|FG000|Overall Study|Withdrawal by Subject|68|||
46663148|NCT04184622|82876212|FG001|Overall Study|Withdrawal by Subject|28|||
46663149|NCT04184622|82876213|FG002|Overall Study|Withdrawal by Subject|29|||
46663150|NCT04184622|82876214|FG003|Overall Study|Withdrawal by Subject|22|||
46663151|NCT03945175|82876238|FG000|Overall Study|Did not meet inclusion criteria|31|||
46851088|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
46851089|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
46851090|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
46851091|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
46851092|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
46851093|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
46851094|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
46851095|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
46851096|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
46663152|NCT03945175|82876238|FG000|Overall Study|Withdrew consent|2|||
46663153|NCT03945175|82876238|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
46663154|NCT03945175|82876238|FG000|Overall Study|Early termination during Mydayis treatment|1|||
46663155|NCT03907878|82876242|FG000|Treatment Period|Withdrawal by Subject|5|||
46663156|NCT03907878|82876242|FG000|Treatment Period|Adverse Event|4|||
46663157|NCT03907878|82876242|FG000|Treatment Period|Lack of Efficacy|1|||
46663158|NCT03907878|82876242|FG000|Treatment Period|Protocol Violation|1|||
46663159|NCT03907878|82876242|FG000|Follow-up Period|Adverse Event|3|||
46663160|NCT03907878|82876242|FG000|Follow-up Period|Withdrawal by Subject|3|||
46663161|NCT03727139|82876257|FG000|Overall Study|Protocol Violation|60|||
46663162|NCT03579290|82876270|FG000|Overall Study|Lost to Follow-up|9|||
46663163|NCT03551496|82876276|FG000|Overall Study|Death|11|||
46663164|NCT03551496|82876277|FG001|Overall Study|Death|7|||
47076278|NCT02335944|83370874|FG000|Treatment Phase|Subject/Guardian Decision|0|||
46663165|NCT03551496|82876276|FG000|Overall Study|Withdrawal by Subject|4|||
46663166|NCT03551496|82876277|FG001|Overall Study|Withdrawal by Subject|3|||
46663167|NCT03551496|82876276|FG000|Overall Study|Other Reasons|1|||
46663168|NCT03551496|82876277|FG001|Overall Study|Other Reasons|0|||
46663169|NCT03382561|82876285|FG000|Overall Study|Disease progression|47|||
46663170|NCT03382561|82876286|FG001|Overall Study|Disease progression|6|||
46972183|NCT02031640|83215762|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
46663171|NCT03382561|82876285|FG000|Overall Study|Adverse Event|10|||
46663172|NCT03382561|82876286|FG001|Overall Study|Adverse Event|2|||
46663173|NCT03382561|82876285|FG000|Overall Study|Death|8|||
46663174|NCT03382561|82876286|FG001|Overall Study|Death|3|||
46663175|NCT03382561|82876285|FG000|Overall Study|Withdrawal by Subject|6|||
46851097|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
46663176|NCT03382561|82876286|FG001|Overall Study|Withdrawal by Subject|5|||
46663177|NCT03382561|82876285|FG000|Overall Study|Alternative therapy|2|||
46663178|NCT03382561|82876286|FG001|Overall Study|Alternative therapy|8|||
46663179|NCT03382561|82876285|FG000|Overall Study|Never started treatment|3|||
46663180|NCT03382561|82876286|FG001|Overall Study|Never started treatment|6|||
46663181|NCT03382561|82876285|FG000|Overall Study|Lack of Efficacy|0|||
46663182|NCT03382561|82876286|FG001|Overall Study|Lack of Efficacy|1|||
46663183|NCT03382561|82876285|FG000|Overall Study|Physician Decision|0|||
46663184|NCT03382561|82876286|FG001|Overall Study|Physician Decision|1|||
46663185|NCT03382561|82876285|FG000|Overall Study|Other complicating disease|0|||
46663186|NCT03382561|82876286|FG001|Overall Study|Other complicating disease|1|||
46663187|NCT03189446|82876305|FG000|Overall Study|Adverse Event|2|||
46663188|NCT03189446|82876305|FG000|Overall Study|Withdrawal by Subject|2|||
46663189|NCT03189446|82876305|FG000|Overall Study|Physician Decision|1|||
46663190|NCT03070392|82876311|FG000|Overall Study|Not Treated|7|||
46663191|NCT03070392|82876312|FG001|Overall Study|Not Treated|0|||
46663192|NCT03070392|82876313|FG002|Overall Study|Not Treated|3|||
46663193|NCT03070392|82876314|FG003|Overall Study|Not Treated|12|||
46663194|NCT03070392|82876311|FG000|Overall Study|Death|3|||
46663195|NCT03070392|82876312|FG001|Overall Study|Death|0|||
46783429|NCT00678288|83002176|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
46783430|NCT00678288|83002177|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
46783431|NCT00369343|83002185|FG000|Double-blind Phase|Adverse Event|19|||
46783432|NCT00369343|83002186|FG001|Double-blind Phase|Adverse Event|4|||
46783433|NCT00369343|83002185|FG000|Double-blind Phase|Failed to return|2|||
46783434|NCT00369343|83002186|FG001|Double-blind Phase|Failed to return|0|||
46783435|NCT00369343|83002185|FG000|Double-blind Phase|Lost to Follow-up|9|||
46783436|NCT00369343|83002186|FG001|Double-blind Phase|Lost to Follow-up|2|||
46783437|NCT00369343|83002185|FG000|Double-blind Phase|Protocol Violation|2|||
46783438|NCT00369343|83002186|FG001|Double-blind Phase|Protocol Violation|0|||
46783439|NCT00369343|83002185|FG000|Double-blind Phase|Withdrawal by Subject|8|||
46783440|NCT00369343|83002186|FG001|Double-blind Phase|Withdrawal by Subject|6|||
46783441|NCT00369343|83002185|FG000|Double-blind Phase|Lack of Efficacy|0|||
46783442|NCT00369343|83002186|FG001|Double-blind Phase|Lack of Efficacy|4|||
46783443|NCT00369343|83002185|FG000|Double-blind Phase|Protocol deviation|4|||
46783444|NCT00369343|83002186|FG001|Double-blind Phase|Protocol deviation|0|||
46783445|NCT00369343|83002185|FG000|Open-label Phase|Adverse Event|19|||
46783446|NCT00369343|83002186|FG001|Open-label Phase|Adverse Event|7|||
46783447|NCT00369343|83002185|FG000|Open-label Phase|Failed to return|4|||
46783448|NCT00369343|83002186|FG001|Open-label Phase|Failed to return|0|||
46783449|NCT00369343|83002185|FG000|Open-label Phase|Physician Decision|2|||
46783450|NCT00369343|83002186|FG001|Open-label Phase|Physician Decision|0|||
46783451|NCT00369343|83002185|FG000|Open-label Phase|Lost to Follow-up|5|||
46783452|NCT00369343|83002186|FG001|Open-label Phase|Lost to Follow-up|3|||
46783453|NCT00369343|83002185|FG000|Open-label Phase|inadvertently reported study completers|3|||
46783454|NCT00369343|83002186|FG001|Open-label Phase|inadvertently reported study completers|2|||
46783455|NCT00369343|83002185|FG000|Open-label Phase|Protocol Violation|1|||
46783456|NCT00369343|83002186|FG001|Open-label Phase|Protocol Violation|3|||
46783457|NCT00369343|83002185|FG000|Open-label Phase|Withdrawal by Subject|15|||
46783458|NCT00369343|83002186|FG001|Open-label Phase|Withdrawal by Subject|6|||
46783459|NCT00369343|83002185|FG000|Open-label Phase|Lack of Efficacy|4|||
46783460|NCT00369343|83002186|FG001|Open-label Phase|Lack of Efficacy|3|||
46783461|NCT00369343|83002185|FG000|Open-label Phase|Lack of continuance tolerability|3|||
46783462|NCT00369343|83002186|FG001|Open-label Phase|Lack of continuance tolerability|4|||
46851098|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
46851099|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
46851100|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
46851101|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
46851102|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
46851103|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
46851104|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
46851105|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
46851106|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
46972184|NCT02031640|83215763|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
46972185|NCT02031640|83215764|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
46972186|NCT02031640|83215759|FG000|Double-blind Treatment Period|Non-compliance|0|||
46972187|NCT02031640|83215760|FG001|Double-blind Treatment Period|Non-compliance|1|||
46972188|NCT02031640|83215761|FG002|Double-blind Treatment Period|Non-compliance|0|||
46663196|NCT03070392|82876313|FG002|Overall Study|Death|0|||
46663197|NCT03070392|82876314|FG003|Overall Study|Death|1|||
46663198|NCT03070392|82876311|FG000|Overall Study|Withdrawal by Subject|7|||
46663199|NCT03070392|82876312|FG001|Overall Study|Withdrawal by Subject|0|||
46663200|NCT03070392|82876313|FG002|Overall Study|Withdrawal by Subject|0|||
46663201|NCT03070392|82876314|FG003|Overall Study|Withdrawal by Subject|3|||
46663202|NCT03070392|82876311|FG000|Overall Study|Physician Decision|1|||
46663203|NCT03070392|82876312|FG001|Overall Study|Physician Decision|0|||
46663204|NCT03070392|82876313|FG002|Overall Study|Physician Decision|0|||
46783463|NCT00369343|83002185|FG000|Open-label Phase|did not take study drug|1|||
46783464|NCT00369343|83002186|FG001|Open-label Phase|did not take study drug|2|||
46663205|NCT03070392|82876314|FG003|Overall Study|Physician Decision|2|||
46663206|NCT03070392|82876311|FG000|Overall Study|Progressive Disease|154|||
46663207|NCT03070392|82876312|FG001|Overall Study|Progressive Disease|6|||
46663208|NCT03070392|82876313|FG002|Overall Study|Progressive Disease|2|||
46663209|NCT03070392|82876314|FG003|Overall Study|Progressive Disease|70|||
46663210|NCT03070392|82876311|FG000|Overall Study|Adverse Event|6|||
46663211|NCT03070392|82876312|FG001|Overall Study|Adverse Event|1|||
46663212|NCT03070392|82876313|FG002|Overall Study|Adverse Event|1|||
46663213|NCT03070392|82876314|FG003|Overall Study|Adverse Event|3|||
46663214|NCT03070392|82876311|FG000|Overall Study|Alternate anticancer treatment|1|||
46663215|NCT03070392|82876312|FG001|Overall Study|Alternate anticancer treatment|0|||
46663216|NCT03070392|82876313|FG002|Overall Study|Alternate anticancer treatment|0|||
46663217|NCT03070392|82876314|FG003|Overall Study|Alternate anticancer treatment|1|||
46663218|NCT03070392|82876311|FG000|Overall Study|Ongoing|73|||
46663219|NCT03070392|82876312|FG001|Overall Study|Ongoing|0|||
46663220|NCT03070392|82876313|FG002|Overall Study|Ongoing|0|||
46663221|NCT03070392|82876314|FG003|Overall Study|Ongoing|11|||
46663222|NCT02763566|82876357|FG000|Overall Study|Lost to Follow-up|1|||
46663223|NCT02763566|82876358|FG001|Overall Study|Lost to Follow-up|4|||
46663224|NCT02763566|82876359|FG002|Overall Study|Lost to Follow-up|0|||
46663225|NCT02763566|82876360|FG003|Overall Study|Lost to Follow-up|1|||
46663226|NCT02763566|82876357|FG000|Overall Study|On study treatment at study conclusion|114|||
46663227|NCT02763566|82876358|FG001|Overall Study|On study treatment at study conclusion|34|||
46663228|NCT02763566|82876359|FG002|Overall Study|On study treatment at study conclusion|54|||
46663229|NCT02763566|82876360|FG003|Overall Study|On study treatment at study conclusion|13|||
46663230|NCT02763566|82876357|FG000|Overall Study|Withdrawal by Subject|3|||
46663231|NCT02763566|82876358|FG001|Overall Study|Withdrawal by Subject|1|||
46663232|NCT02763566|82876359|FG002|Overall Study|Withdrawal by Subject|0|||
46663233|NCT02763566|82876360|FG003|Overall Study|Withdrawal by Subject|0|||
46663234|NCT02544074|82876395|FG000|Overall Study|Withdrawal by Subject|0|||
46663235|NCT02544074|82876396|FG001|Overall Study|Withdrawal by Subject|1|||
46663236|NCT02544074|82876397|FG002|Overall Study|Withdrawal by Subject|0|||
46663237|NCT02544074|82876398|FG003|Overall Study|Withdrawal by Subject|0|||
46663238|NCT02544074|82876399|FG004|Overall Study|Withdrawal by Subject|0|||
46663239|NCT02544074|82876400|FG005|Overall Study|Withdrawal by Subject|0|||
46663240|NCT02544074|82876401|FG006|Overall Study|Withdrawal by Subject|0|||
46663241|NCT02544074|82876402|FG007|Overall Study|Withdrawal by Subject|0|||
46663242|NCT02544074|82876403|FG008|Overall Study|Withdrawal by Subject|0|||
46663243|NCT02544074|82876404|FG009|Overall Study|Withdrawal by Subject|0|||
46663244|NCT02544074|82876405|FG010|Overall Study|Withdrawal by Subject|0|||
46663245|NCT02544074|82876406|FG011|Overall Study|Withdrawal by Subject|0|||
46663246|NCT02544074|82876407|FG012|Overall Study|Withdrawal by Subject|0|||
46663247|NCT02544074|82876408|FG013|Overall Study|Withdrawal by Subject|0|||
46783465|NCT00369265|83002201|FG000|Overall Study|Study terminated|4|||
46783466|NCT00369265|83002202|FG001|Overall Study|Study terminated|7|||
46783467|NCT00368875|83002208|FG000|Overall Study|Adverse Event|0|||
46783468|NCT00368875|83002209|FG001|Overall Study|Adverse Event|12|||
46783469|NCT00368875|83002208|FG000|Overall Study|Progressive disease|3|||
46783470|NCT00368875|83002209|FG001|Overall Study|Progressive disease|27|||
46783471|NCT00368875|83002208|FG000|Overall Study|Withdrawal by Subject|2|||
46783472|NCT00368875|83002209|FG001|Overall Study|Withdrawal by Subject|6|||
46783473|NCT00368875|83002208|FG000|Overall Study|Other Reason|0|||
46783474|NCT00368875|83002209|FG001|Overall Study|Other Reason|2|||
46663248|NCT02544074|82876409|FG014|Overall Study|Withdrawal by Subject|0|||
46663249|NCT02544074|82876410|FG015|Overall Study|Withdrawal by Subject|0|||
46663250|NCT02544074|82876411|FG016|Overall Study|Withdrawal by Subject|0|||
46663251|NCT02544074|82876412|FG017|Overall Study|Withdrawal by Subject|0|||
46783475|NCT00368875|83002208|FG000|Overall Study|Alternative Therapy|1|||
46851107|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
46851108|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
46851109|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
46851110|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
46851111|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
46663252|NCT02544074|82876413|FG018|Overall Study|Withdrawal by Subject|0|||
46663253|NCT02544074|82876414|FG019|Overall Study|Withdrawal by Subject|0|||
46663254|NCT02544074|82876415|FG020|Overall Study|Withdrawal by Subject|0|||
46783476|NCT00368875|83002209|FG001|Overall Study|Alternative Therapy|1|||
46851112|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
46663255|NCT02544074|82876395|FG000|Overall Study|Tablet error|0|||
46663256|NCT02544074|82876396|FG001|Overall Study|Tablet error|0|||
46663257|NCT02544074|82876397|FG002|Overall Study|Tablet error|0|||
46663258|NCT02544074|82876398|FG003|Overall Study|Tablet error|0|||
46783477|NCT00614055|83002218|FG000|Overall Study|Adverse Event|1|||
46663259|NCT02544074|82876399|FG004|Overall Study|Tablet error|0|||
46663260|NCT02544074|82876400|FG005|Overall Study|Tablet error|1|||
46783478|NCT00614055|83002219|FG001|Overall Study|Adverse Event|0|||
46663261|NCT02544074|82876401|FG006|Overall Study|Tablet error|0|||
46663262|NCT02544074|82876402|FG007|Overall Study|Tablet error|0|||
46663263|NCT02544074|82876403|FG008|Overall Study|Tablet error|0|||
46663264|NCT02544074|82876404|FG009|Overall Study|Tablet error|1|||
46663265|NCT02544074|82876405|FG010|Overall Study|Tablet error|0|||
46663266|NCT02544074|82876406|FG011|Overall Study|Tablet error|0|||
46663267|NCT02544074|82876407|FG012|Overall Study|Tablet error|0|||
46663268|NCT02544074|82876408|FG013|Overall Study|Tablet error|0|||
46663269|NCT02544074|82876409|FG014|Overall Study|Tablet error|0|||
46663270|NCT02544074|82876410|FG015|Overall Study|Tablet error|0|||
46663271|NCT02544074|82876411|FG016|Overall Study|Tablet error|0|||
46663272|NCT02544074|82876412|FG017|Overall Study|Tablet error|0|||
46663273|NCT02544074|82876413|FG018|Overall Study|Tablet error|0|||
46663274|NCT02544074|82876414|FG019|Overall Study|Tablet error|0|||
46663275|NCT02544074|82876415|FG020|Overall Study|Tablet error|0|||
46663276|NCT02367131|82876449|FG000|Overall Study|Adverse Event|64|||
46663277|NCT02367131|82876449|FG000|Overall Study|No visit since the first visit|3|||
46663278|NCT02367131|82876449|FG000|Overall Study|Request by patient|53|||
46663279|NCT02367131|82876449|FG000|Overall Study|Improvement/remission|2|||
46663280|NCT02367131|82876449|FG000|Overall Study|No change/progressive disease|78|||
46663281|NCT02367131|82876449|FG000|Overall Study|Other than stated above|20|||
46663282|NCT02367131|82876449|FG000|Overall Study|Not treated|2|||
46663283|NCT02282358|82876453|FG000|Overall Study|Nonevaluable|1|||
46663284|NCT02248259|82876459|FG000|Treatment Period 1|Adverse Event|0|||
46663285|NCT02248259|82876460|FG001|Treatment Period 1|Adverse Event|0|||
46663286|NCT02248259|82876461|FG002|Treatment Period 1|Adverse Event|1|||
46663287|NCT02248259|82876462|FG003|Treatment Period 1|Adverse Event|0|||
46663288|NCT02101775|82876481|FG000|Overall Study|Adverse Event|4|||
46663289|NCT02101775|82876482|FG001|Overall Study|Adverse Event|0|||
46663290|NCT02101775|82876483|FG002|Overall Study|Adverse Event|0|||
46663291|NCT02101775|82876481|FG000|Overall Study|Admission to Hospital|0|||
46663292|NCT02101775|82876482|FG001|Overall Study|Admission to Hospital|1|||
46663293|NCT02101775|82876483|FG002|Overall Study|Admission to Hospital|0|||
46663294|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
46663295|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
46663296|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
46663297|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
46663298|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
46663299|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
46663300|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
46663301|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
46663302|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
46663303|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
46663304|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
46783479|NCT00614055|83002220|FG002|Overall Study|Adverse Event|0|||
46783480|NCT00614055|83002218|FG000|Overall Study|Protocol Violation|2|||
46783481|NCT00614055|83002219|FG001|Overall Study|Protocol Violation|2|||
46783482|NCT00614055|83002220|FG002|Overall Study|Protocol Violation|1|||
46783483|NCT00614055|83002218|FG000|Overall Study|Lack of Efficacy|0|||
46783484|NCT00614055|83002219|FG001|Overall Study|Lack of Efficacy|0|||
46783485|NCT00614055|83002220|FG002|Overall Study|Lack of Efficacy|2|||
46783486|NCT00614055|83002218|FG000|Overall Study|Unclassified|1|||
46783487|NCT00614055|83002219|FG001|Overall Study|Unclassified|4|||
46783488|NCT00614055|83002220|FG002|Overall Study|Unclassified|2|||
46783489|NCT00613821|83002233|FG000|Overall Study|Withdrawal by Subject|1|||
46783490|NCT00613821|83002234|FG001|Overall Study|Withdrawal by Subject|0|||
46783491|NCT00613821|83002233|FG000|Overall Study|Physician Decision|1|||
46663305|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
46663306|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
46783492|NCT00613821|83002234|FG001|Overall Study|Physician Decision|1|||
46783493|NCT00548548|83002242|FG000|Overall Study|Death|345|||
46783494|NCT00548548|83002243|FG001|Overall Study|Death|348|||
46783495|NCT00548548|83002242|FG000|Overall Study|Lost to Follow-up|17|||
46783496|NCT00548548|83002243|FG001|Overall Study|Lost to Follow-up|18|||
46851113|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
46851114|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
46851115|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
46851116|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
46663307|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
46663308|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
46663309|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
46663310|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
46783497|NCT00613509|83002251|FG000|Cycle 1|Adverse Event|2|||
46783498|NCT00613509|83002252|FG001|Cycle 1|Adverse Event|1|||
46783499|NCT00613509|83002251|FG000|Cycle 1|Disease Progression|2|||
46851117|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
46783500|NCT00613509|83002252|FG001|Cycle 1|Disease Progression|6|||
46783501|NCT00613509|83002251|FG000|Cycle 1|Unacceptable Toxicity|1|||
46783502|NCT00613509|83002252|FG001|Cycle 1|Unacceptable Toxicity|0|||
46783503|NCT00613509|83002251|FG000|Cycle 1|Other administrative reason|0|||
46783504|NCT00613509|83002252|FG001|Cycle 1|Other administrative reason|1|||
46783505|NCT00547300|83002277|FG000|Overall Study|Study was Administratively Terminated|25|||
46783506|NCT00547300|83002278|FG001|Overall Study|Study was Administratively Terminated|24|||
46783507|NCT00547300|83002277|FG000|Overall Study|Did not Meet Entry Criteria|0|||
46851118|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
46851119|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
46851120|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
46851121|NCT03605836|83066859|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
46851122|NCT03605836|83066860|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
46783508|NCT00547300|83002278|FG001|Overall Study|Did not Meet Entry Criteria|2|||
46783509|NCT00612807|83002286|FG000|Overall Study|Withdrawal by Subject|2|||
46783510|NCT00612807|83002287|FG001|Overall Study|Withdrawal by Subject|0|||
46783511|NCT00678210|83002297|FG000|Overall Study|Adverse Event|1|||
46783512|NCT00678210|83002298|FG001|Overall Study|Adverse Event|2|||
46783513|NCT00678210|83002299|FG002|Overall Study|Adverse Event|3|||
46783514|NCT00678210|83002300|FG003|Overall Study|Adverse Event|3|||
46783515|NCT00678210|83002297|FG000|Overall Study|Lack of Efficacy|2|||
46783516|NCT00678210|83002298|FG001|Overall Study|Lack of Efficacy|3|||
46783517|NCT00678210|83002299|FG002|Overall Study|Lack of Efficacy|1|||
46783518|NCT00678210|83002300|FG003|Overall Study|Lack of Efficacy|9|||
46783519|NCT00678210|83002297|FG000|Overall Study|Lost to Follow-up|4|||
46783520|NCT00678210|83002298|FG001|Overall Study|Lost to Follow-up|2|||
46783521|NCT00678210|83002299|FG002|Overall Study|Lost to Follow-up|0|||
46783522|NCT00678210|83002300|FG003|Overall Study|Lost to Follow-up|1|||
46783523|NCT00678210|83002297|FG000|Overall Study|Withdrawal by Subject|3|||
46783524|NCT00678210|83002298|FG001|Overall Study|Withdrawal by Subject|4|||
46783525|NCT00678210|83002299|FG002|Overall Study|Withdrawal by Subject|1|||
46783526|NCT00678210|83002300|FG003|Overall Study|Withdrawal by Subject|7|||
46783527|NCT00678210|83002297|FG000|Overall Study|Other|1|||
46783528|NCT00678210|83002298|FG001|Overall Study|Other|0|||
46783529|NCT00678210|83002299|FG002|Overall Study|Other|1|||
46783530|NCT00678210|83002300|FG003|Overall Study|Other|0|||
46783531|NCT00611715|83002312|FG000|Overall Study|Disease Progression|24|||
46783532|NCT00611715|83002313|FG001|Overall Study|Disease Progression|4|||
46783533|NCT00611715|83002312|FG000|Overall Study|Withdrawal by Subject|5|||
46783534|NCT00611715|83002313|FG001|Overall Study|Withdrawal by Subject|1|||
46783535|NCT00611715|83002312|FG000|Overall Study|Adverse Event|9|||
46783536|NCT00611715|83002313|FG001|Overall Study|Adverse Event|1|||
46783537|NCT00611715|83002312|FG000|Overall Study|Death|1|||
46783538|NCT00611715|83002313|FG001|Overall Study|Death|0|||
46783539|NCT00611715|83002312|FG000|Overall Study|two patients are still on treatment|2|||
46783540|NCT00611715|83002313|FG001|Overall Study|two patients are still on treatment|0|||
46783541|NCT00677820|83002327|FG000|Overall Study|Lost to Follow-up|1|||
46783542|NCT00677820|83002328|FG001|Overall Study|Lost to Follow-up|0|||
46783543|NCT00611559|83002337|FG000|Overall Study|Lost to Follow-up|0|||
46783544|NCT00611559|83002338|FG001|Overall Study|Lost to Follow-up|1|||
46783545|NCT00611559|83002339|FG002|Overall Study|Lost to Follow-up|0|||
46783546|NCT00611559|83002337|FG000|Overall Study|Protocol Violation|1|||
46783547|NCT00611559|83002338|FG001|Overall Study|Protocol Violation|0|||
46783548|NCT00611559|83002339|FG002|Overall Study|Protocol Violation|1|||
46783549|NCT00611247|83002349|FG000|Overall Study|Death|1|||
46783550|NCT00611247|83002350|FG001|Overall Study|Death|5|||
46783551|NCT00611247|83002349|FG000|Overall Study|Lack of Efficacy|1|||
46783552|NCT00611247|83002350|FG001|Overall Study|Lack of Efficacy|16|||
46783553|NCT00675948|83002359|FG000|Overall Study|Adverse Event|23|||
46783554|NCT00675948|83002360|FG001|Overall Study|Adverse Event|1|||
46783555|NCT00675948|83002359|FG000|Overall Study|Lack of Efficacy|3|||
46783556|NCT00675948|83002360|FG001|Overall Study|Lack of Efficacy|0|||
46783557|NCT00675948|83002359|FG000|Overall Study|Withdrawal by Subject|7|||
46783558|NCT00675948|83002360|FG001|Overall Study|Withdrawal by Subject|0|||
46783559|NCT00675948|83002359|FG000|Overall Study|Lost to Follow-up|2|||
46783560|NCT00675948|83002360|FG001|Overall Study|Lost to Follow-up|0|||
46783561|NCT00675948|83002359|FG000|Overall Study|Protocol Violation|1|||
46783562|NCT00675948|83002360|FG001|Overall Study|Protocol Violation|0|||
46783563|NCT00675948|83002359|FG000|Overall Study|Pain under control|1|||
46783564|NCT00675948|83002360|FG001|Overall Study|Pain under control|0|||
46783565|NCT00675948|83002359|FG000|Overall Study|Sponsor decision|0|||
46851123|NCT03605836|83066861|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
46851124|NCT03605836|83066862|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
46851125|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
47076279|NCT02335944|83370875|FG001|Treatment Phase|Subject/Guardian Decision|0|||
47076280|NCT02335944|83370876|FG002|Treatment Phase|Subject/Guardian Decision|1|||
47076281|NCT02335944|83370877|FG003|Treatment Phase|Subject/Guardian Decision|0|||
47076282|NCT02335944|83370878|FG004|Treatment Phase|Subject/Guardian Decision|0|||
47076283|NCT02335944|83370879|FG005|Treatment Phase|Subject/Guardian Decision|1|||
47076284|NCT02335944|83370880|FG006|Treatment Phase|Subject/Guardian Decision|0|||
47076285|NCT02335944|83370881|FG007|Treatment Phase|Subject/Guardian Decision|4|||
47076286|NCT02335944|83370882|FG008|Treatment Phase|Subject/Guardian Decision|0|||
47076287|NCT02335944|83370883|FG009|Treatment Phase|Subject/Guardian Decision|0|||
46783566|NCT00675948|83002360|FG001|Overall Study|Sponsor decision|1|||
46783567|NCT00675948|83002359|FG000|Overall Study|Patient died|1|||
46783568|NCT00675948|83002360|FG001|Overall Study|Patient died|0|||
46783569|NCT00675948|83002359|FG000|Overall Study|Patient unable to comply with diaries|1|||
46783570|NCT00675948|83002360|FG001|Overall Study|Patient unable to comply with diaries|0|||
46783571|NCT00675948|83002359|FG000|Overall Study|Patient feels unable to take medication|0|||
46783572|NCT00675948|83002360|FG001|Overall Study|Patient feels unable to take medication|1|||
46783573|NCT00610935|83002369|FG000|Overall Study|Lost to Follow-up|0|||
46783574|NCT00610935|83002370|FG001|Overall Study|Lost to Follow-up|1|||
46783575|NCT00610935|83002369|FG000|Overall Study|Withdrawal by Subject|0|||
46663311|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
46663312|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
46663313|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
46663314|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
46663315|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
46663316|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
46663317|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
46663318|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
46663319|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
46663320|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
46663321|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
46663322|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
46663323|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
46663324|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
46663325|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
46663326|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
46663327|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
46663328|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
46663329|NCT01898494|82876501|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
46663330|NCT01898494|82876502|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
46663331|NCT01898494|82876503|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
46663332|NCT01898494|82876504|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
46663333|NCT01898494|82876505|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
46663334|NCT01898494|82876501|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
46663335|NCT01898494|82876502|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
46663336|NCT01898494|82876503|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
46663337|NCT01898494|82876504|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
46663338|NCT01898494|82876505|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
46663339|NCT01898494|82876501|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
46663340|NCT01898494|82876502|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
46663341|NCT01898494|82876503|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
46663342|NCT01898494|82876504|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
46663343|NCT01898494|82876505|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
46663344|NCT01898494|82876501|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
46663345|NCT01898494|82876502|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
46663346|NCT01898494|82876503|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
46663347|NCT01898494|82876504|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
46663348|NCT01898494|82876505|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
46663349|NCT01898494|82876501|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
46663350|NCT01898494|82876502|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
46663351|NCT01898494|82876503|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
46663352|NCT01898494|82876504|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
46663353|NCT01898494|82876505|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
46663354|NCT01898494|82876501|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
46663355|NCT01898494|82876502|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
46663356|NCT01898494|82876503|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
46663357|NCT01898494|82876504|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
46663358|NCT01898494|82876505|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
46663359|NCT01898494|82876501|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
46663360|NCT01898494|82876502|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
46663361|NCT01898494|82876503|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
46663362|NCT01898494|82876504|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
46663363|NCT01898494|82876505|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
46663364|NCT01892384|82876521|FG000|Overall Study|Withdrawal by Subject|1|||
46663365|NCT01892384|82876522|FG001|Overall Study|Withdrawal by Subject|1|||
46663366|NCT01892384|82876523|FG002|Overall Study|Withdrawal by Subject|0|||
46663367|NCT01892384|82876524|FG003|Overall Study|Withdrawal by Subject|0|||
46663368|NCT01616758|82876535|FG000|Overall Study|Adverse Event|1|||
46663369|NCT01616758|82876535|FG000|Overall Study|Withdrawal by Subject|2|||
46663370|NCT01616758|82876535|FG000|Overall Study|Disease progression|18|||
46663371|NCT01616758|82876535|FG000|Overall Study|Study termination by Sponsor|1|||
46663372|NCT01569568|82876570|FG000|Overall Study|Physician Decision|0|||
46663373|NCT01569568|82876571|FG001|Overall Study|Physician Decision|2|||
46663374|NCT01505894|82876586|FG000|Overall Study|Adverse Event|1|||
46663375|NCT01505894|82876587|FG001|Overall Study|Adverse Event|0|||
46663376|NCT01505894|82876588|FG002|Overall Study|Adverse Event|0|||
46663377|NCT01505894|82876589|FG003|Overall Study|Adverse Event|0|||
46663378|NCT01505894|82876590|FG004|Overall Study|Adverse Event|0|||
46663379|NCT01505894|82876591|FG005|Overall Study|Adverse Event|0|||
46663380|NCT01505894|82876592|FG006|Overall Study|Adverse Event|0|||
46663381|NCT01505894|82876593|FG007|Overall Study|Adverse Event|0|||
46663382|NCT01505894|82876594|FG008|Overall Study|Adverse Event|0|||
46663383|NCT01505894|82876586|FG000|Overall Study|Other than specified|0|||
46663384|NCT01505894|82876587|FG001|Overall Study|Other than specified|0|||
46663385|NCT01505894|82876588|FG002|Overall Study|Other than specified|0|||
46663386|NCT01505894|82876589|FG003|Overall Study|Other than specified|0|||
46663387|NCT01505894|82876590|FG004|Overall Study|Other than specified|1|||
46663388|NCT01505894|82876591|FG005|Overall Study|Other than specified|0|||
46663389|NCT01505894|82876592|FG006|Overall Study|Other than specified|0|||
46663390|NCT01505894|82876593|FG007|Overall Study|Other than specified|0|||
46663391|NCT01505894|82876594|FG008|Overall Study|Other than specified|0|||
46663392|NCT01416285|82876623|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
46663393|NCT01416285|82876624|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
46663394|NCT01412333|82876632|FG000|Overall Study|Adverse Event|40|||
46663395|NCT01412333|82876633|FG001|Overall Study|Adverse Event|42|||
46663396|NCT01412333|82876632|FG000|Overall Study|Death|5|||
46663397|NCT01412333|82876633|FG001|Overall Study|Death|6|||
46663398|NCT01412333|82876632|FG000|Overall Study|Lack of Efficacy|22|||
46783576|NCT00610935|83002370|FG001|Overall Study|Withdrawal by Subject|2|||
46783577|NCT00610935|83002369|FG000|Overall Study|Sponsor Discontinuation|1|||
46783578|NCT00610935|83002370|FG001|Overall Study|Sponsor Discontinuation|0|||
46783579|NCT00610857|83002385|FG000|Overall Study|Not evaluable for response|2|||
46783580|NCT00672984|83002392|FG000|First Intervention|Adverse Event|5|||
46783581|NCT00672984|83002393|FG001|First Intervention|Adverse Event|0|||
46783582|NCT00672984|83002394|FG002|First Intervention|Adverse Event|0|||
46783583|NCT00672984|83002392|FG000|First Intervention|Withdrawal by Subject|1|||
46783584|NCT00672984|83002393|FG001|First Intervention|Withdrawal by Subject|2|||
46783585|NCT00672984|83002394|FG002|First Intervention|Withdrawal by Subject|2|||
46783586|NCT00672984|83002392|FG000|First Intervention|Sponsor decision|3|||
46783587|NCT00672984|83002393|FG001|First Intervention|Sponsor decision|0|||
46783588|NCT00672984|83002394|FG002|First Intervention|Sponsor decision|0|||
46783589|NCT00672984|83002392|FG000|Second Intervention|Non-compliance with facility policies|0|||
46783590|NCT00672984|83002393|FG001|Second Intervention|Non-compliance with facility policies|2|||
46783591|NCT00672984|83002394|FG002|Second Intervention|Non-compliance with facility policies|0|||
46783592|NCT00672984|83002392|FG000|Second Intervention|Withdrawal by Subject|0|||
46783593|NCT00672984|83002393|FG001|Second Intervention|Withdrawal by Subject|3|||
46783594|NCT00672984|83002394|FG002|Second Intervention|Withdrawal by Subject|0|||
46783595|NCT00672984|83002392|FG000|Second Intervention|Protocol Violation|0|||
46783596|NCT00672984|83002393|FG001|Second Intervention|Protocol Violation|1|||
46783597|NCT00672984|83002394|FG002|Second Intervention|Protocol Violation|1|||
47076288|NCT02335944|83370874|FG000|Post-treatment Follow-up|Progressive Disease|0|||
46663399|NCT01412333|82876633|FG001|Overall Study|Lack of Efficacy|10|||
46663400|NCT01412333|82876632|FG000|Overall Study|Lost to Follow-up|15|||
46663401|NCT01412333|82876633|FG001|Overall Study|Lost to Follow-up|12|||
46783598|NCT00672984|83002392|FG000|Third Intervention|Adverse Event|1|||
46783599|NCT00672984|83002393|FG001|Third Intervention|Adverse Event|0|||
46783600|NCT00672984|83002394|FG002|Third Intervention|Adverse Event|1|||
46783601|NCT00546364|83002407|FG000|Overall Study|Disease progression|5|||
46783602|NCT00546364|83002408|FG001|Overall Study|Disease progression|11|||
46783603|NCT00546364|83002409|FG002|Overall Study|Disease progression|8|||
47076289|NCT02335944|83370875|FG001|Post-treatment Follow-up|Progressive Disease|0|||
47076290|NCT02335944|83370876|FG002|Post-treatment Follow-up|Progressive Disease|0|||
47076291|NCT02335944|83370877|FG003|Post-treatment Follow-up|Progressive Disease|1|||
47076292|NCT02335944|83370878|FG004|Post-treatment Follow-up|Progressive Disease|0|||
47076293|NCT02335944|83370879|FG005|Post-treatment Follow-up|Progressive Disease|9|||
47076294|NCT02335944|83370880|FG006|Post-treatment Follow-up|Progressive Disease|0|||
47076295|NCT02335944|83370881|FG007|Post-treatment Follow-up|Progressive Disease|2|||
47076296|NCT02335944|83370882|FG008|Post-treatment Follow-up|Progressive Disease|3|||
47076297|NCT02335944|83370883|FG009|Post-treatment Follow-up|Progressive Disease|0|||
47076298|NCT02335944|83370874|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
47076299|NCT02335944|83370875|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
47076300|NCT02335944|83370876|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
47076301|NCT02335944|83370877|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
47076302|NCT02335944|83370878|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
47076303|NCT02335944|83370879|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
46783604|NCT00546364|83002407|FG000|Overall Study|Completed and off treatment|1|||
46663402|NCT01412333|82876632|FG000|Overall Study|Non-Compliance|3|||
46663403|NCT01412333|82876633|FG001|Overall Study|Non-Compliance|7|||
46663404|NCT01412333|82876632|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46783605|NCT00546364|83002408|FG001|Overall Study|Completed and off treatment|0|||
47076304|NCT02335944|83370880|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
46783606|NCT00546364|83002409|FG002|Overall Study|Completed and off treatment|2|||
46783607|NCT00546364|83002407|FG000|Overall Study|Administrative reason by sponsor|1|||
46663405|NCT01412333|82876633|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46663406|NCT01412333|82876632|FG000|Overall Study|Other|30|||
46663407|NCT01412333|82876633|FG001|Overall Study|Other|33|||
46663408|NCT01412333|82876632|FG000|Overall Study|Physician Decision|11|||
46663409|NCT01412333|82876633|FG001|Overall Study|Physician Decision|16|||
46663410|NCT01412333|82876632|FG000|Overall Study|Pregnancy|6|||
46663411|NCT01412333|82876633|FG001|Overall Study|Pregnancy|4|||
46663412|NCT01412333|82876632|FG000|Overall Study|Protocol Violation|1|||
46663413|NCT01412333|82876633|FG001|Overall Study|Protocol Violation|2|||
46663414|NCT01412333|82876632|FG000|Overall Study|Study Terminated By Sponsor|3|||
46663415|NCT01412333|82876633|FG001|Overall Study|Study Terminated By Sponsor|2|||
46663416|NCT01412333|82876632|FG000|Overall Study|Withdrawal by Subject|51|||
46663417|NCT01412333|82876633|FG001|Overall Study|Withdrawal by Subject|54|||
46663418|NCT01412333|82876632|FG000|Overall Study|Missing|1|||
46663419|NCT01412333|82876633|FG001|Overall Study|Missing|3|||
46663420|NCT00861705|82876650|FG000|Overall Study|Never Began Treatment|7|||
46663421|NCT00861705|82876651|FG001|Overall Study|Never Began Treatment|3|||
46663422|NCT00861705|82876652|FG002|Overall Study|Never Began Treatment|0|||
46663423|NCT00861705|82876653|FG003|Overall Study|Never Began Treatment|1|||
46663424|NCT00602641|82876673|FG000|Overall Study|Never started protocol therapy|6|||
46663425|NCT00602641|82876674|FG001|Overall Study|Never started protocol therapy|2|||
46663426|NCT00602641|82876673|FG000|Overall Study|Still on treatment at time of analysis|8|||
46663427|NCT00602641|82876674|FG001|Overall Study|Still on treatment at time of analysis|15|||
46783608|NCT00546364|83002408|FG001|Overall Study|Administrative reason by sponsor|0|||
46783609|NCT00546364|83002409|FG002|Overall Study|Administrative reason by sponsor|0|||
46783610|NCT00546364|83002407|FG000|Overall Study|Poor compliance/noncompliance|0|||
46783611|NCT00546364|83002408|FG001|Overall Study|Poor compliance/noncompliance|0|||
46783612|NCT00546364|83002409|FG002|Overall Study|Poor compliance/noncompliance|1|||
46783613|NCT00546364|83002407|FG000|Overall Study|No longer meets study criteria|1|||
46783614|NCT00546364|83002408|FG001|Overall Study|No longer meets study criteria|1|||
46783615|NCT00546364|83002409|FG002|Overall Study|No longer meets study criteria|0|||
46783616|NCT00546364|83002407|FG000|Overall Study|Withdrawal by Subject|5|||
46783617|NCT00546364|83002408|FG001|Overall Study|Withdrawal by Subject|6|||
46783618|NCT00546364|83002409|FG002|Overall Study|Withdrawal by Subject|3|||
46783619|NCT00546364|83002407|FG000|Overall Study|Prior taxotere|1|||
46783620|NCT00546364|83002408|FG001|Overall Study|Prior taxotere|0|||
46783621|NCT00546364|83002409|FG002|Overall Study|Prior taxotere|0|||
46972189|NCT02031640|83215762|FG003|Double-blind Treatment Period|Non-compliance|1|||
46972190|NCT02031640|83215763|FG004|Double-blind Treatment Period|Non-compliance|1|||
46663428|NCT00602641|82876673|FG000|Overall Study|Adverse Event|62|||
46663429|NCT00602641|82876674|FG001|Overall Study|Adverse Event|53|||
46663430|NCT00602641|82876673|FG000|Overall Study|Disease progression|38|||
46663431|NCT00602641|82876674|FG001|Overall Study|Disease progression|55|||
46663432|NCT00602641|82876673|FG000|Overall Study|Death|6|||
46663433|NCT00602641|82876674|FG001|Overall Study|Death|5|||
46663434|NCT00602641|82876673|FG000|Overall Study|Withdrawal by Subject|15|||
46663435|NCT00602641|82876674|FG001|Overall Study|Withdrawal by Subject|12|||
46663436|NCT00602641|82876673|FG000|Overall Study|Alternative therapy|5|||
46663437|NCT00602641|82876674|FG001|Overall Study|Alternative therapy|2|||
46663438|NCT00602641|82876673|FG000|Overall Study|Other Complicating Disease|5|||
46663439|NCT00602641|82876674|FG001|Overall Study|Other Complicating Disease|2|||
46663440|NCT00602641|82876673|FG000|Overall Study|Physician Decision|5|||
46663441|NCT00602641|82876674|FG001|Overall Study|Physician Decision|4|||
46663442|NCT00602641|82876673|FG000|Overall Study|Administrative Closure|1|||
46663443|NCT00602641|82876674|FG001|Overall Study|Administrative Closure|1|||
46663444|NCT00602641|82876673|FG000|Overall Study|Other|3|||
46663445|NCT00602641|82876674|FG001|Overall Study|Other|1|||
46663446|NCT00588770|82876682|FG000|Overall Study|Disease progression|85|||
46663447|NCT00588770|82876683|FG001|Overall Study|Disease progression|68|||
46663448|NCT00588770|82876682|FG000|Overall Study|Adverse Event|29|||
46663449|NCT00588770|82876683|FG001|Overall Study|Adverse Event|58|||
46783622|NCT00546364|83002407|FG000|Overall Study|Mixed response|1|||
46663450|NCT00588770|82876682|FG000|Overall Study|Death|13|||
46783623|NCT00546364|83002408|FG001|Overall Study|Mixed response|0|||
46783624|NCT00546364|83002409|FG002|Overall Study|Mixed response|0|||
46783625|NCT00546364|83002407|FG000|Overall Study|Palliative treatment|1|||
46663451|NCT00588770|82876683|FG001|Overall Study|Death|22|||
46663452|NCT00588770|82876682|FG000|Overall Study|Withdrawal by Subject|15|||
46663453|NCT00588770|82876683|FG001|Overall Study|Withdrawal by Subject|25|||
46663454|NCT00588770|82876682|FG000|Overall Study|Alternative therapy|2|||
46663455|NCT00588770|82876683|FG001|Overall Study|Alternative therapy|4|||
46663456|NCT00588770|82876682|FG000|Overall Study|Other complicating disease|3|||
46663457|NCT00588770|82876683|FG001|Overall Study|Other complicating disease|2|||
46663458|NCT00588770|82876682|FG000|Overall Study|Not start protocol therapy|0|||
46783626|NCT00546364|83002408|FG001|Overall Study|Palliative treatment|0|||
46783627|NCT00546364|83002409|FG002|Overall Study|Palliative treatment|1|||
46783628|NCT00546364|83002407|FG000|Overall Study|Target lesions resected|1|||
46663459|NCT00588770|82876683|FG001|Overall Study|Not start protocol therapy|9|||
46663460|NCT00588770|82876682|FG000|Overall Study|Lack of Efficacy|8|||
46663461|NCT00588770|82876683|FG001|Overall Study|Lack of Efficacy|10|||
46851126|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
46851127|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
46851128|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
46851129|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
46851130|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
46851131|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
46851132|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
46851133|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
46663462|NCT00588770|82876682|FG000|Overall Study|Physician discretion|2|||
46663463|NCT00588770|82876683|FG001|Overall Study|Physician discretion|0|||
46663464|NCT00588770|82876682|FG000|Overall Study|Patient non-compliance|2|||
46663465|NCT00588770|82876683|FG001|Overall Study|Patient non-compliance|2|||
46663466|NCT00433511|82876692|FG000|Step 1|Adverse Event|50|||
46663467|NCT00433511|82876693|FG001|Step 1|Adverse Event|157|||
46663468|NCT00433511|82876694|FG002|Step 1|Adverse Event|153|||
46663469|NCT00433511|82876692|FG000|Step 1|Withdrawal by Subject|45|||
46663470|NCT00433511|82876693|FG001|Step 1|Withdrawal by Subject|143|||
46663471|NCT00433511|82876694|FG002|Step 1|Withdrawal by Subject|154|||
46663472|NCT00433511|82876692|FG000|Step 1|Death|3|||
46663473|NCT00433511|82876693|FG001|Step 1|Death|1|||
46783629|NCT00546364|83002408|FG001|Overall Study|Target lesions resected|0|||
46783630|NCT00546364|83002409|FG002|Overall Study|Target lesions resected|0|||
46783631|NCT00546364|83002407|FG000|Overall Study|Physician Decision|0|||
46783632|NCT00546364|83002408|FG001|Overall Study|Physician Decision|0|||
46783633|NCT00546364|83002409|FG002|Overall Study|Physician Decision|1|||
46851134|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
46851135|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
46851136|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
46851137|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
46851138|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
46851139|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
47076305|NCT02335944|83370881|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
47076306|NCT02335944|83370882|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
46663474|NCT00433511|82876694|FG002|Step 1|Death|1|||
46663475|NCT00433511|82876692|FG000|Step 1|Physician Decision|1|||
46663476|NCT00433511|82876693|FG001|Step 1|Physician Decision|4|||
46663477|NCT00433511|82876694|FG002|Step 1|Physician Decision|3|||
46663478|NCT00433511|82876692|FG000|Step 1|Never started protocol therapy|28|||
46663479|NCT00433511|82876693|FG001|Step 1|Never started protocol therapy|64|||
46663480|NCT00433511|82876694|FG002|Step 1|Never started protocol therapy|66|||
46663481|NCT00433511|82876692|FG000|Step 1|Alternative therapy|2|||
46663482|NCT00433511|82876693|FG001|Step 1|Alternative therapy|1|||
46663483|NCT00433511|82876694|FG002|Step 1|Alternative therapy|3|||
46663484|NCT00433511|82876692|FG000|Step 1|Disease progression, relapse|5|||
46663485|NCT00433511|82876693|FG001|Step 1|Disease progression, relapse|3|||
46663486|NCT00433511|82876694|FG002|Step 1|Disease progression, relapse|3|||
46663487|NCT00433511|82876692|FG000|Step 1|Other complicating disease|2|||
46663488|NCT00433511|82876693|FG001|Step 1|Other complicating disease|6|||
46663489|NCT00433511|82876694|FG002|Step 1|Other complicating disease|3|||
46663490|NCT00433511|82876692|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
46663491|NCT00433511|82876693|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
46663492|NCT00433511|82876694|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
46663493|NCT00433511|82876692|FG000|Step 1|Suspected recurrence|0|||
46663494|NCT00433511|82876693|FG001|Step 1|Suspected recurrence|1|||
46663495|NCT00433511|82876694|FG002|Step 1|Suspected recurrence|0|||
46663496|NCT00433511|82876692|FG000|Step 1|Insurance/drug distribution issues|0|||
46663497|NCT00433511|82876693|FG001|Step 1|Insurance/drug distribution issues|1|||
46663498|NCT00433511|82876694|FG002|Step 1|Insurance/drug distribution issues|2|||
46663499|NCT00433511|82876692|FG000|Step 1|Patient moved|0|||
46663500|NCT00433511|82876693|FG001|Step 1|Patient moved|0|||
46663501|NCT00433511|82876694|FG002|Step 1|Patient moved|1|||
46783634|NCT00546364|83002407|FG000|Overall Study|Sponsor decision|0|||
46783635|NCT00546364|83002408|FG001|Overall Study|Sponsor decision|0|||
46663502|NCT00433511|82876692|FG000|Step 2 (Arm D)|Adverse Event|0|||
46663503|NCT00433511|82876693|FG001|Step 2 (Arm D)|Adverse Event|0|||
46663504|NCT00433511|82876694|FG002|Step 2 (Arm D)|Adverse Event|135|||
46783636|NCT00546364|83002409|FG002|Overall Study|Sponsor decision|1|||
46783637|NCT05020327|83002428|FG000|Overall Study|Physician Decision|3|||
46663505|NCT00433511|82876692|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
46663506|NCT00433511|82876693|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
46663507|NCT00433511|82876694|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
46783638|NCT05020327|83002429|FG001|Overall Study|Physician Decision|0|||
46663508|NCT00433511|82876692|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
46663509|NCT00433511|82876693|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
46663510|NCT00433511|82876694|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
46663511|NCT00433511|82876692|FG000|Step 2 (Arm D)|Physician Decision|0|||
46663512|NCT00433511|82876693|FG001|Step 2 (Arm D)|Physician Decision|0|||
46663513|NCT00433511|82876694|FG002|Step 2 (Arm D)|Physician Decision|9|||
46663514|NCT00433511|82876692|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
46663515|NCT00433511|82876693|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
46663516|NCT00433511|82876694|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
46663517|NCT00433511|82876692|FG000|Step 2 (Arm D)|Other complicating disease|0|||
46663518|NCT00433511|82876693|FG001|Step 2 (Arm D)|Other complicating disease|0|||
46663519|NCT00433511|82876694|FG002|Step 2 (Arm D)|Other complicating disease|3|||
46663520|NCT00433511|82876692|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
46663521|NCT00433511|82876693|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
46663522|NCT00433511|82876694|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
46663523|NCT00433511|82876692|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
46663524|NCT00433511|82876693|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
46663525|NCT00433511|82876694|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
46663526|NCT00433511|82876692|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
46663527|NCT00433511|82876693|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
46663528|NCT00433511|82876694|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
46663529|NCT00433511|82876692|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
46663530|NCT00433511|82876693|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
46663531|NCT00433511|82876694|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
46663532|NCT00334815|82876707|FG000|Overall Study|Adverse Event|3|||
46663533|NCT00334815|82876708|FG001|Overall Study|Adverse Event|2|||
46663534|NCT00334815|82876707|FG000|Overall Study|Death|0|||
46663535|NCT00334815|82876708|FG001|Overall Study|Death|2|||
46663536|NCT00334815|82876707|FG000|Overall Study|Progression|1|||
46663537|NCT00334815|82876708|FG001|Overall Study|Progression|0|||
46663538|NCT00334815|82876707|FG000|Overall Study|ineligible|1|||
46663539|NCT00334815|82876708|FG001|Overall Study|ineligible|1|||
46663540|NCT00334815|82876707|FG000|Overall Study|patient refused treatment|0|||
46663541|NCT00334815|82876708|FG001|Overall Study|patient refused treatment|1|||
46663542|NCT00334815|82876707|FG000|Overall Study|Physician Decision|2|||
46783639|NCT05020327|83002430|FG002|Overall Study|Physician Decision|0|||
46783640|NCT05020327|83002428|FG000|Overall Study|Withdrawal by Subject|1|||
46783641|NCT05020327|83002429|FG001|Overall Study|Withdrawal by Subject|1|||
46783642|NCT05020327|83002430|FG002|Overall Study|Withdrawal by Subject|0|||
46783643|NCT05020327|83002428|FG000|Overall Study|personal/cultural, ineligible|12|||
46783644|NCT05020327|83002429|FG001|Overall Study|personal/cultural, ineligible|0|||
46783645|NCT05020327|83002430|FG002|Overall Study|personal/cultural, ineligible|0|||
46783646|NCT04907032|83002444|FG000|Overall Study|Withdrawal by Subject|7|||
46783647|NCT04907032|83002445|FG001|Overall Study|Withdrawal by Subject|1|||
46851140|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
46972191|NCT02031640|83215764|FG005|Double-blind Treatment Period|Non-compliance|0|||
46972192|NCT02031640|83215759|FG000|Double-blind Treatment Period|Adverse Event|0|||
47076307|NCT02335944|83370883|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
47076308|NCT02335944|83370874|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
46663543|NCT00334815|82876708|FG001|Overall Study|Physician Decision|4|||
46663544|NCT00070499|82876742|FG000|Overall Study|Adverse Event|6|||
46663545|NCT00070499|82876743|FG001|Overall Study|Adverse Event|6|||
46783648|NCT04739709|83002466|FG000|Overall Study|Physician Decision|1|||
47076309|NCT02335944|83370875|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
47076310|NCT02335944|83370876|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
47076311|NCT02335944|83370877|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
47076312|NCT02335944|83370878|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
47076313|NCT02335944|83370879|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
46663546|NCT00070499|82876744|FG002|Overall Study|Adverse Event|19|||
46783649|NCT04739709|83002467|FG001|Overall Study|Physician Decision|0|||
46783650|NCT04710927|83002484|FG000|Overall Study|Lost to Follow-up|7|||
46783651|NCT04710927|83002485|FG001|Overall Study|Lost to Follow-up|6|||
46783652|NCT04710927|83002486|FG002|Overall Study|Lost to Follow-up|5|||
46783653|NCT04657666|83002497|FG000|Period 1|Withdrawal of participant consent|2|||
46663547|NCT00070499|82876745|FG003|Overall Study|Adverse Event|15|||
46663548|NCT00070499|82876742|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
46663549|NCT00070499|82876743|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
46663550|NCT00070499|82876744|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
46851141|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
46851142|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
46851143|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
46851144|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
46851145|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
46851146|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
46851147|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
46851148|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
46663551|NCT00070499|82876745|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
46663552|NCT00070499|82876742|FG000|Overall Study|Progression/relapse|4|||
46663553|NCT00070499|82876743|FG001|Overall Study|Progression/relapse|2|||
46663554|NCT00070499|82876744|FG002|Overall Study|Progression/relapse|1|||
46663555|NCT00070499|82876745|FG003|Overall Study|Progression/relapse|4|||
46663556|NCT00070499|82876742|FG000|Overall Study|Death|1|||
46663557|NCT00070499|82876743|FG001|Overall Study|Death|1|||
46663558|NCT00070499|82876744|FG002|Overall Study|Death|1|||
46663559|NCT00070499|82876745|FG003|Overall Study|Death|2|||
46663560|NCT00070499|82876742|FG000|Overall Study|Other - not protocol specified|7|||
46663561|NCT00070499|82876743|FG001|Overall Study|Other - not protocol specified|3|||
46663562|NCT00070499|82876744|FG002|Overall Study|Other - not protocol specified|12|||
46663563|NCT00070499|82876745|FG003|Overall Study|Other - not protocol specified|20|||
46663564|NCT00070499|82876742|FG000|Overall Study|Still on protocol treatment|10|||
46663565|NCT00070499|82876743|FG001|Overall Study|Still on protocol treatment|4|||
46663566|NCT00070499|82876744|FG002|Overall Study|Still on protocol treatment|79|||
46663567|NCT00070499|82876745|FG003|Overall Study|Still on protocol treatment|57|||
46663568|NCT00070499|82876742|FG000|Overall Study|Did not start treatment|1|||
46663569|NCT00070499|82876743|FG001|Overall Study|Did not start treatment|0|||
46663570|NCT00070499|82876744|FG002|Overall Study|Did not start treatment|0|||
46663571|NCT00070499|82876745|FG003|Overall Study|Did not start treatment|2|||
46663572|NCT00070499|82876742|FG000|Overall Study|Not eligible|2|||
46663573|NCT00070499|82876743|FG001|Overall Study|Not eligible|5|||
46663574|NCT00070499|82876744|FG002|Overall Study|Not eligible|3|||
46663575|NCT00070499|82876745|FG003|Overall Study|Not eligible|2|||
46663576|NCT01340014|82876765|FG000|Period 1, First 7 Days|Adverse Event|1|||
46663577|NCT01340014|82876766|FG001|Period 1, First 7 Days|Adverse Event|0|||
46663578|NCT01340014|82876765|FG000|Period 1, First 7 Days|Personal Reasons|1|||
46783654|NCT04657666|83002498|FG001|Period 1|Withdrawal of participant consent|1|||
46783655|NCT04657666|83002497|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
46783656|NCT04657666|83002498|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
46783657|NCT04657666|83002497|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
46783658|NCT04657666|83002498|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
46783659|NCT04657666|83002497|FG000|Period 2|Other|2|||
46851149|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
46851150|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
46851151|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
46851152|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
46851153|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
46851154|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
46972193|NCT02031640|83215760|FG001|Double-blind Treatment Period|Adverse Event|0|||
46972194|NCT02031640|83215761|FG002|Double-blind Treatment Period|Adverse Event|0|||
47076314|NCT02335944|83370880|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
47076315|NCT02335944|83370881|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
46663579|NCT01340014|82876766|FG001|Period 1, First 7 Days|Personal Reasons|0|||
46663580|NCT01340014|82876765|FG000|Period 2, Second 7 Days|Adverse Event|0|||
46663581|NCT01340014|82876766|FG001|Period 2, Second 7 Days|Adverse Event|1|||
46663582|NCT01339897|82876776|FG000|Overall Study|Adverse Event|1|||
46663583|NCT01339897|82876777|FG001|Overall Study|Adverse Event|0|||
46663584|NCT01339897|82876778|FG002|Overall Study|Adverse Event|0|||
46663585|NCT01339897|82876779|FG003|Overall Study|Adverse Event|1|||
46663586|NCT01339429|82876791|FG000|Overall Study|Withdrawal by Subject|1|||
46663587|NCT01339429|82876791|FG000|Overall Study|Physician Decision|3|||
46663588|NCT01339390|82876797|FG000|Overall Study|Death|32|||
46783660|NCT04657666|83002498|FG001|Period 2|Other|0|||
47076316|NCT02335944|83370882|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
46663589|NCT01339390|82876798|FG001|Overall Study|Death|29|||
46663590|NCT01339390|82876797|FG000|Overall Study|Lost to Follow-up|125|||
46663591|NCT01339390|82876798|FG001|Overall Study|Lost to Follow-up|127|||
46663592|NCT01339273|82876806|FG000|Overall Study|Lost to Follow-up|8|||
46663593|NCT01339273|82876807|FG001|Overall Study|Lost to Follow-up|8|||
46663594|NCT01334866|82876813|FG000|Overall Study|Withdrawal by Subject|10|||
46663595|NCT01334866|82876813|FG000|Overall Study|Lost to Follow-up|3|||
46663596|NCT01334866|82876813|FG000|Overall Study|Physician Decision|3|||
46663597|NCT01334866|82876813|FG000|Overall Study|medically necessary prior to procedure|2|||
46663598|NCT01334866|82876813|FG000|Overall Study|medically necessary post-procedure|1|||
46663599|NCT01334710|82876819|FG000|Overall Study|Trial was terminated|3|||
46663600|NCT01334554|82876826|FG000|Overall Study|Adverse Event|4|||
46663601|NCT01334554|82876827|FG001|Overall Study|Adverse Event|2|||
46663602|NCT01332799|82876837|FG000|Overall Study|Insufficient funding|10|||
46663603|NCT01332799|82876838|FG001|Overall Study|Insufficient funding|10|||
46663604|NCT01332331|82876846|FG000|Overall Study|Lost to Follow-up|0|||
46663605|NCT01332331|82876847|FG001|Overall Study|Lost to Follow-up|1|||
46663606|NCT01332331|82876846|FG000|Overall Study|Adverse Event|1|||
46663607|NCT01332331|82876847|FG001|Overall Study|Adverse Event|1|||
46663608|NCT01332331|82876846|FG000|Overall Study|Physician Decision|1|||
46663609|NCT01332331|82876847|FG001|Overall Study|Physician Decision|0|||
46663610|NCT01332292|82876854|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
46663611|NCT01332292|82876855|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
46663612|NCT01332292|82876854|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
46663613|NCT01332292|82876855|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
46663614|NCT01332292|82876854|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
46663615|NCT01332292|82876855|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
46663616|NCT01332019|82876865|FG000|Overall Study|Was Not Dosed|1|||
46663617|NCT01332019|82876866|FG001|Overall Study|Was Not Dosed|0|||
46663618|NCT01332019|82876865|FG000|Overall Study|Other|16|||
46663619|NCT01332019|82876866|FG001|Overall Study|Other|18|||
46663620|NCT01332019|82876865|FG000|Overall Study|Death|2|||
46663621|NCT01332019|82876866|FG001|Overall Study|Death|1|||
46663622|NCT01332019|82876865|FG000|Overall Study|Physician Decision|4|||
46663623|NCT01332019|82876866|FG001|Overall Study|Physician Decision|3|||
46663624|NCT01332019|82876865|FG000|Overall Study|Withdrawal by Subject|73|||
46663625|NCT01332019|82876866|FG001|Overall Study|Withdrawal by Subject|71|||
46663626|NCT01332019|82876865|FG000|Overall Study|Lost to Follow-up|4|||
46663627|NCT01332019|82876866|FG001|Overall Study|Lost to Follow-up|7|||
46663628|NCT01332019|82876865|FG000|Overall Study|Adverse Event|13|||
46663629|NCT01332019|82876866|FG001|Overall Study|Adverse Event|22|||
46663630|NCT01331239|82876874|FG000|Part II: Core Study|Adverse Event|0|||
46663631|NCT01331239|82876875|FG001|Part II: Core Study|Adverse Event|3|||
46663632|NCT01331239|82876876|FG002|Part II: Core Study|Adverse Event|0|||
46663633|NCT01331239|82876874|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
46663634|NCT01331239|82876875|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
46663635|NCT01331239|82876876|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
46663636|NCT01331239|82876874|FG000|Part II: Core Study|Withdrawal by Subject|0|||
46663637|NCT01331239|82876875|FG001|Part II: Core Study|Withdrawal by Subject|2|||
46663638|NCT01331239|82876876|FG002|Part II: Core Study|Withdrawal by Subject|0|||
46663639|NCT01331239|82876874|FG000|Part II: Core Study|Administrative problems|0|||
46663640|NCT01331239|82876875|FG001|Part II: Core Study|Administrative problems|1|||
46663641|NCT01331239|82876876|FG002|Part II: Core Study|Administrative problems|0|||
46663642|NCT01331161|82876894|FG000|Overall Study|Physician Decision|1|||
46663643|NCT01331161|82876895|FG001|Overall Study|Physician Decision|0|||
46663644|NCT01331161|82876894|FG000|Overall Study|Lost to Follow-up|0|||
46663645|NCT01331161|82876895|FG001|Overall Study|Lost to Follow-up|1|||
46663646|NCT01331161|82876894|FG000|Overall Study|Pregnancy|0|||
46663647|NCT01331161|82876895|FG001|Overall Study|Pregnancy|1|||
46663648|NCT01331005|82876905|FG000|Overall Study|Lost to Follow-up|2|||
46663649|NCT01331005|82876906|FG001|Overall Study|Lost to Follow-up|1|||
46663650|NCT01331005|82876905|FG000|Overall Study|Withdrawal by Subject|2|||
46663651|NCT01331005|82876906|FG001|Overall Study|Withdrawal by Subject|3|||
46663652|NCT01330459|82876914|FG000|Overall Study|Physician Decision|0|||
46663653|NCT01330459|82876915|FG001|Overall Study|Physician Decision|2|||
46663654|NCT01330381|82876925|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
46663655|NCT01330381|82876926|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
46663656|NCT01330381|82876927|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
46663657|NCT01330381|82876925|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
46663658|NCT01330381|82876926|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
46663659|NCT01330381|82876927|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
46663660|NCT01330381|82876925|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
46663661|NCT01330381|82876926|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
46663662|NCT01330381|82876927|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
46663663|NCT01330381|82876925|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
46663664|NCT01330381|82876926|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
46663665|NCT01330381|82876927|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
46663666|NCT01330381|82876925|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
46663667|NCT01330381|82876926|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
46663668|NCT01330381|82876927|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
46663669|NCT01330381|82876925|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
46663670|NCT01330381|82876926|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
46663671|NCT01330381|82876927|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
46972195|NCT02031640|83215762|FG003|Double-blind Treatment Period|Adverse Event|2|||
46972196|NCT02031640|83215763|FG004|Double-blind Treatment Period|Adverse Event|0|||
46663672|NCT01330381|82876925|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
46663673|NCT01330381|82876926|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
46663674|NCT01330381|82876927|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
46663675|NCT01330381|82876925|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
46663676|NCT01330381|82876926|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
46663677|NCT01330381|82876927|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
46663678|NCT01330381|82876925|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
46663679|NCT01330381|82876926|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
46663680|NCT01330381|82876927|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
46663681|NCT01330381|82876925|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
46663682|NCT01330381|82876926|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
46663683|NCT01330381|82876927|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
46663684|NCT01330303|82876936|FG000|Period 1|Adverse Event|1|||
46663685|NCT01330303|82876937|FG001|Period 1|Adverse Event|0|||
46663686|NCT01330303|82876936|FG000|Period 1|Protocol Violation|0|||
46663687|NCT01330303|82876937|FG001|Period 1|Protocol Violation|1|||
46663688|NCT01330303|82876936|FG000|Period 1|Withdrawal by Subject|0|||
46663689|NCT01330303|82876937|FG001|Period 1|Withdrawal by Subject|1|||
46663690|NCT01330108|82876944|FG000|Overall Study|Withdrawal by Subject|4|||
46663691|NCT04849988|82876988|FG000|Overall Study|Lack of Efficacy|3|||
46663692|NCT04849988|82876989|FG001|Overall Study|Lack of Efficacy|4|||
46663693|NCT04849988|82876990|FG002|Overall Study|Lack of Efficacy|1|||
46663694|NCT04849988|82876991|FG003|Overall Study|Lack of Efficacy|4|||
46663695|NCT04849988|82876988|FG000|Overall Study|Other reasons|1|||
46663696|NCT04849988|82876989|FG001|Overall Study|Other reasons|2|||
46663697|NCT04849988|82876990|FG002|Overall Study|Other reasons|2|||
46663698|NCT04849988|82876991|FG003|Overall Study|Other reasons|1|||
46663699|NCT04678661|82877004|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
46663700|NCT04678661|82877005|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
46663701|NCT04678661|82877004|FG000|Overall Study|Protocol Violation|2|||
46663702|NCT04678661|82877005|FG001|Overall Study|Protocol Violation|0|||
46663703|NCT04678661|82877004|FG000|Overall Study|Withdrawal by Subject|1|||
46663704|NCT04678661|82877005|FG001|Overall Study|Withdrawal by Subject|0|||
46663705|NCT04678661|82877004|FG000|Overall Study|Lost to Follow-up|2|||
46663706|NCT04678661|82877005|FG001|Overall Study|Lost to Follow-up|0|||
46663707|NCT04678661|82877004|FG000|Overall Study|Death|2|||
46663708|NCT04678661|82877005|FG001|Overall Study|Death|0|||
46663709|NCT04478123|82877026|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
46663710|NCT04478123|82877026|FG000|Overall Study|NE|1|||
46663711|NCT04191135|82877037|FG000|Induction Treatment|Not Treated|2|||
46663712|NCT04191135|82877038|FG001|Induction Treatment|Not Treated|0|||
46783661|NCT04657666|83002497|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
46783662|NCT04657666|83002498|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
46783663|NCT04495829|83002517|FG000|Overall Study|Lost to Follow-up|2|||
46783664|NCT04495829|83002517|FG000|Overall Study|Inclusion criterion not met|3|||
46783665|NCT04101721|83002532|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
46783666|NCT04101721|83002533|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
46783667|NCT04101721|83002532|FG000|Overall Study|Death|0|||
46783668|NCT04101721|83002533|FG001|Overall Study|Death|1|||
46783669|NCT04101721|83002532|FG000|Overall Study|Lost to Follow-up|0|||
46783670|NCT04101721|83002533|FG001|Overall Study|Lost to Follow-up|3|||
46783671|NCT03864926|83002541|FG000|Overall Study|Death|0|||
46783672|NCT03864926|83002542|FG001|Overall Study|Death|2|||
46783673|NCT03623243|83002557|FG000|Overall Study|Adverse Event|15|||
46972197|NCT02031640|83215764|FG005|Double-blind Treatment Period|Adverse Event|0|||
46663713|NCT04191135|82877039|FG002|Induction Treatment|Not Treated|0|||
46663714|NCT04191135|82877037|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
46663715|NCT04191135|82877038|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
46663716|NCT04191135|82877039|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
46663717|NCT04191135|82877037|FG000|Induction Treatment|Adverse Event|25|||
46663718|NCT04191135|82877038|FG001|Induction Treatment|Adverse Event|0|||
46783674|NCT03623243|83002557|FG000|Overall Study|Guardian Decision|1|||
46783675|NCT03623243|83002557|FG000|Overall Study|New Therapy for Study Indication|1|||
46783676|NCT03623243|83002557|FG000|Overall Study|Protocol Deviation|3|||
46783677|NCT03623243|83002557|FG000|Overall Study|Physician Decision|4|||
46783678|NCT03623243|83002557|FG000|Overall Study|Patient Decision|15|||
46783679|NCT03258853|83002563|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
46783680|NCT03258853|83002564|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
46783681|NCT03006848|83002616|FG000|Overall Study|Adverse Event|1|||
46783682|NCT03006848|83002616|FG000|Overall Study|Physician Decision|1|||
46783683|NCT03006848|83002616|FG000|Overall Study|Lack of Efficacy|16|||
46783684|NCT02810444|83002654|FG000|Overall Study|Screen Failures|14|||
46783685|NCT02810444|83002654|FG000|Overall Study|Withdrawal by Subject|4|||
46783686|NCT02810444|83002654|FG000|Overall Study|Adverse Event|3|||
46783687|NCT02501096|83002680|FG000|Overall Study|Lost to Follow-up|0|||
46783688|NCT02501096|83002681|FG001|Overall Study|Lost to Follow-up|0|||
46783689|NCT02501096|83002682|FG002|Overall Study|Lost to Follow-up|0|||
46972198|NCT02031640|83215759|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
46783690|NCT02501096|83002683|FG003|Overall Study|Lost to Follow-up|0|||
46783691|NCT02501096|83002684|FG004|Overall Study|Lost to Follow-up|1|||
46783692|NCT02501096|83002685|FG005|Overall Study|Lost to Follow-up|1|||
46783693|NCT02501096|83002686|FG006|Overall Study|Lost to Follow-up|3|||
46783694|NCT02501096|83002687|FG007|Overall Study|Lost to Follow-up|0|||
46783695|NCT02501096|83002688|FG008|Overall Study|Lost to Follow-up|0|||
46972199|NCT02031640|83215760|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
46972200|NCT02031640|83215761|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
46663719|NCT04191135|82877039|FG002|Induction Treatment|Adverse Event|0|||
46663720|NCT04191135|82877037|FG000|Induction Treatment|Clinical Progression|8|||
46663721|NCT04191135|82877038|FG001|Induction Treatment|Clinical Progression|0|||
46663722|NCT04191135|82877039|FG002|Induction Treatment|Clinical Progression|0|||
46663723|NCT04191135|82877037|FG000|Induction Treatment|Excluded Medication|1|||
46663724|NCT04191135|82877038|FG001|Induction Treatment|Excluded Medication|0|||
46663725|NCT04191135|82877039|FG002|Induction Treatment|Excluded Medication|0|||
46663726|NCT04191135|82877037|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
46663727|NCT04191135|82877038|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
46663728|NCT04191135|82877039|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
46663729|NCT04191135|82877037|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
46663730|NCT04191135|82877038|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
46663731|NCT04191135|82877039|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
46663732|NCT04191135|82877037|FG000|Induction Treatment|Physician Decision|2|||
46663733|NCT04191135|82877038|FG001|Induction Treatment|Physician Decision|0|||
46663734|NCT04191135|82877039|FG002|Induction Treatment|Physician Decision|0|||
46663735|NCT04191135|82877037|FG000|Induction Treatment|Progressive Disease|135|||
46663736|NCT04191135|82877038|FG001|Induction Treatment|Progressive Disease|0|||
46663737|NCT04191135|82877039|FG002|Induction Treatment|Progressive Disease|0|||
46663738|NCT04191135|82877037|FG000|Induction Treatment|Protocol Violation|10|||
46663739|NCT04191135|82877038|FG001|Induction Treatment|Protocol Violation|0|||
46663740|NCT04191135|82877039|FG002|Induction Treatment|Protocol Violation|0|||
46663741|NCT04191135|82877037|FG000|Induction Treatment|Withdrawal by Subject|4|||
46663742|NCT04191135|82877038|FG001|Induction Treatment|Withdrawal by Subject|0|||
46663743|NCT04191135|82877039|FG002|Induction Treatment|Withdrawal by Subject|0|||
46663744|NCT04191135|82877037|FG000|Randomized Treatment|Death|0|||
46663745|NCT04191135|82877038|FG001|Randomized Treatment|Death|50|||
46663746|NCT04191135|82877039|FG002|Randomized Treatment|Death|54|||
46663747|NCT04191135|82877037|FG000|Randomized Treatment|Lost to Follow-up|0|||
46783696|NCT02501096|83002680|FG000|Overall Study|Withdrawal by Subject|1|||
46783697|NCT02501096|83002681|FG001|Overall Study|Withdrawal by Subject|0|||
46783698|NCT02501096|83002682|FG002|Overall Study|Withdrawal by Subject|7|||
46783699|NCT02501096|83002683|FG003|Overall Study|Withdrawal by Subject|13|||
46783700|NCT02501096|83002684|FG004|Overall Study|Withdrawal by Subject|2|||
46783701|NCT02501096|83002685|FG005|Overall Study|Withdrawal by Subject|2|||
46783702|NCT02501096|83002686|FG006|Overall Study|Withdrawal by Subject|2|||
46783703|NCT02501096|83002687|FG007|Overall Study|Withdrawal by Subject|3|||
46783704|NCT02501096|83002688|FG008|Overall Study|Withdrawal by Subject|0|||
46783705|NCT02501096|83002680|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
46783706|NCT02501096|83002681|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
46972201|NCT02031640|83215762|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
46663748|NCT04191135|82877038|FG001|Randomized Treatment|Lost to Follow-up|0|||
46783707|NCT02501096|83002682|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
46783708|NCT02501096|83002683|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
46783709|NCT02501096|83002684|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
46783710|NCT02501096|83002685|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
46783711|NCT02501096|83002686|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
46663749|NCT04191135|82877039|FG002|Randomized Treatment|Lost to Follow-up|1|||
46663750|NCT04191135|82877037|FG000|Randomized Treatment|Withdrawal by Subject|0|||
46663751|NCT04191135|82877038|FG001|Randomized Treatment|Withdrawal by Subject|2|||
46663752|NCT04191135|82877039|FG002|Randomized Treatment|Withdrawal by Subject|0|||
46663753|NCT04191135|82877037|FG000|Randomized Treatment|Ongoing in Trial|0|||
46663754|NCT04191135|82877038|FG001|Randomized Treatment|Ongoing in Trial|83|||
46663755|NCT04191135|82877039|FG002|Randomized Treatment|Ongoing in Trial|81|||
46663756|NCT03682848|82877072|FG000|Overall Study|Withdrawal by Subject|2|||
46663757|NCT03682848|82877072|FG000|Overall Study|Site closed|5|||
46663758|NCT03682848|82877072|FG000|Overall Study|Protocol Deviation|1|||
46663759|NCT03682848|82877072|FG000|Overall Study|Adverse Event|1|||
46663760|NCT03530124|82877113|FG000|Overall Study|Withdrawal by Subject|0|||
46663761|NCT03530124|82877114|FG001|Overall Study|Withdrawal by Subject|1|||
46663762|NCT03530124|82877113|FG000|Overall Study|Protocol Violation|1|||
46663763|NCT03530124|82877114|FG001|Overall Study|Protocol Violation|0|||
46663764|NCT03530124|82877113|FG000|Overall Study|Discharged prior to study completion|1|||
46663765|NCT03530124|82877114|FG001|Overall Study|Discharged prior to study completion|0|||
46663766|NCT03514017|82877120|FG000|Overall Study|Death|1|||
46663767|NCT03514017|82877120|FG000|Overall Study|Adverse Event|1|||
46663768|NCT03329404|82877135|FG000|Overall Study|The study was suspended.|1|||
46663769|NCT03329404|82877136|FG001|Overall Study|The study was suspended.|4|||
46663770|NCT03275064|82877149|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
46663771|NCT03275064|82877150|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
46663772|NCT03275064|82877151|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
46663773|NCT03275064|82877152|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
46663774|NCT03275064|82877153|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
46663775|NCT03275064|82877149|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
46663776|NCT03275064|82877150|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
46663777|NCT03275064|82877151|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
46663778|NCT03275064|82877152|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
46663779|NCT03275064|82877153|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
46663780|NCT03275064|82877149|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
46663781|NCT03275064|82877150|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
46663782|NCT03275064|82877151|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
46663783|NCT03275064|82877152|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
46663784|NCT03275064|82877153|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
46663785|NCT03275064|82877149|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
46663786|NCT03275064|82877150|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
46663787|NCT03275064|82877151|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
46663788|NCT03275064|82877152|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
46663789|NCT03275064|82877153|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
46663790|NCT03275064|82877149|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
46663791|NCT03275064|82877150|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
46663792|NCT03275064|82877151|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
46663793|NCT03275064|82877152|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
46663794|NCT03275064|82877153|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
46663795|NCT03238248|82877173|FG000|Overall Study|Death|5|||
46663796|NCT03238248|82877173|FG000|Overall Study|Withdrawal by Subject|7|||
46663797|NCT03238248|82877173|FG000|Overall Study|Participant proceeding to transplant|10|||
46663798|NCT03238248|82877173|FG000|Overall Study|Lack of Efficacy|4|||
46663799|NCT03238248|82877173|FG000|Overall Study|Physician Decision|3|||
46663800|NCT03238248|82877173|FG000|Overall Study|Transitioning to another study|1|||
46663801|NCT03238248|82877173|FG000|Overall Study|No longer benefiting|1|||
46663802|NCT03238248|82877173|FG000|Overall Study|Other complicating disease|1|||
46663803|NCT03238248|82877173|FG000|Overall Study|Adverse Event|5|||
46663804|NCT03238248|82877173|FG000|Overall Study|Disease progression|26|||
46663805|NCT03238248|82877173|FG000|Overall Study|N/A participant is still on treatment|1|||
46663806|NCT03238248|82877173|FG000|Overall Study|Decline in condition|1|||
46663807|NCT03238248|82877173|FG000|Overall Study|Alternative therapy|2|||
46663808|NCT03088605|82877188|FG000|Overall Study|Withdrawal by Subject|1|||
46663809|NCT03088605|82877189|FG001|Overall Study|Withdrawal by Subject|0|||
46663810|NCT02951052|82877197|FG000|Overall Study|Adverse Event|13|||
46663811|NCT02951052|82877198|FG001|Overall Study|Adverse Event|5|||
46663812|NCT02951052|82877197|FG000|Overall Study|Withdrawal by Subject|1|||
46663813|NCT02951052|82877198|FG001|Overall Study|Withdrawal by Subject|5|||
46783712|NCT02501096|83002687|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
46783713|NCT02501096|83002688|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
46663814|NCT02951052|82877197|FG000|Overall Study|Physician Decision|2|||
46663815|NCT02951052|82877198|FG001|Overall Study|Physician Decision|0|||
46663816|NCT02951052|82877197|FG000|Overall Study|Lost to Follow-up|1|||
46663817|NCT02951052|82877198|FG001|Overall Study|Lost to Follow-up|1|||
46663818|NCT02951052|82877197|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
46663819|NCT02951052|82877198|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
46663820|NCT02951052|82877197|FG000|Overall Study|Protocol Violation|5|||
46663821|NCT02951052|82877198|FG001|Overall Study|Protocol Violation|3|||
46663822|NCT02951052|82877197|FG000|Overall Study|Lack of Efficacy|3|||
46663823|NCT02951052|82877198|FG001|Overall Study|Lack of Efficacy|4|||
46663824|NCT02951052|82877197|FG000|Overall Study|Ongoing|1|||
46663825|NCT02951052|82877198|FG001|Overall Study|Ongoing|0|||
46663826|NCT02879383|82877212|FG000|First 24 Weeks|Physician Decision|0|||
46663827|NCT02879383|82877213|FG001|First 24 Weeks|Physician Decision|1|||
46663828|NCT02879383|82877214|FG002|First 24 Weeks|Physician Decision|0|||
46663829|NCT02879383|82877215|FG003|First 24 Weeks|Physician Decision|0|||
46663830|NCT02724878|82877227|FG000|Overall Study|Still on Active Therapy|15|||
46663831|NCT02724878|82877227|FG000|Overall Study|Disease Progression|31|||
46663832|NCT02724878|82877227|FG000|Overall Study|Toxicity|5|||
46663833|NCT02724878|82877227|FG000|Overall Study|Death|1|||
46663834|NCT02724878|82877227|FG000|Overall Study|Withdrawal by Subject|4|||
46663835|NCT02724878|82877227|FG000|Overall Study|Lost to Follow-up|2|||
46663836|NCT02724878|82877227|FG000|Overall Study|Protocol Violation|1|||
46663837|NCT02724878|82877227|FG000|Overall Study|Ineligible for Study Drug|5|||
46663838|NCT02724878|82877227|FG000|Overall Study|not started|1|||
46663839|NCT02542293|82877347|FG000|Overall Study|Death|367|||
46663840|NCT02542293|82877348|FG001|Overall Study|Death|377|||
46663841|NCT02542293|82877347|FG000|Overall Study|Withdrawal by Subject|8|||
46663842|NCT02542293|82877348|FG001|Overall Study|Withdrawal by Subject|19|||
46663843|NCT02447029|82877377|FG000|Overall Study|Withdrawal by Subject|3|||
46663844|NCT02447029|82877378|FG001|Overall Study|Withdrawal by Subject|2|||
46663845|NCT01927562|82877384|FG000|Overall Study|Lost to Follow-up|30|||
46663846|NCT01927562|82877384|FG000|Overall Study|Withdrawal by Subject|3|||
46663847|NCT01927562|82877384|FG000|Overall Study|Physician Decision|5|||
46663848|NCT01862991|82877391|FG000|Overall Study|Lost to Follow-up|2|||
46663849|NCT01862991|82877392|FG001|Overall Study|Lost to Follow-up|1|||
46783714|NCT02501096|83002680|FG000|Overall Study|Death|1|||
46783715|NCT02501096|83002681|FG001|Overall Study|Death|1|||
46783716|NCT02501096|83002682|FG002|Overall Study|Death|88|||
46783717|NCT02501096|83002683|FG003|Overall Study|Death|74|||
47076317|NCT02335944|83370883|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
46663850|NCT01862991|82877393|FG002|Overall Study|Lost to Follow-up|1|||
46663851|NCT01862991|82877391|FG000|Overall Study|Protocol Violation|1|||
46663852|NCT01862991|82877392|FG001|Overall Study|Protocol Violation|0|||
46663853|NCT01862991|82877393|FG002|Overall Study|Protocol Violation|0|||
46663854|NCT01701674|82877405|FG000|Overall Study|Unable to safely complete treatment|1|||
46663855|NCT04543409|82877444|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46663856|NCT04543409|82877445|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46663857|NCT04543409|82877444|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
46663858|NCT04543409|82877445|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
46663859|NCT04543409|82877444|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
47076318|NCT02335944|83370874|FG000|Post-treatment Follow-up|Adverse Event|0|||
46663860|NCT04543409|82877445|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
46663861|NCT04543409|82877444|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
46663862|NCT04543409|82877445|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
47076319|NCT02335944|83370875|FG001|Post-treatment Follow-up|Adverse Event|0|||
47076320|NCT02335944|83370876|FG002|Post-treatment Follow-up|Adverse Event|0|||
47076321|NCT02335944|83370877|FG003|Post-treatment Follow-up|Adverse Event|0|||
47076322|NCT02335944|83370878|FG004|Post-treatment Follow-up|Adverse Event|0|||
47076323|NCT02335944|83370879|FG005|Post-treatment Follow-up|Adverse Event|1|||
47076324|NCT02335944|83370880|FG006|Post-treatment Follow-up|Adverse Event|0|||
47076325|NCT02335944|83370881|FG007|Post-treatment Follow-up|Adverse Event|0|||
47076326|NCT02335944|83370882|FG008|Post-treatment Follow-up|Adverse Event|0|||
46663863|NCT04543409|82877444|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
46783718|NCT02501096|83002684|FG004|Overall Study|Death|15|||
46783719|NCT02501096|83002685|FG005|Overall Study|Death|16|||
46663864|NCT04543409|82877445|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
46663865|NCT04543409|82877444|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
46663866|NCT04543409|82877445|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
46663867|NCT04543409|82877444|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
47076327|NCT02335944|83370883|FG009|Post-treatment Follow-up|Adverse Event|0|||
47076328|NCT02335944|83370874|FG000|Post-treatment Follow-up|Death|0|||
47076329|NCT02335944|83370875|FG001|Post-treatment Follow-up|Death|0|||
46663868|NCT04543409|82877445|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
46663869|NCT04543409|82877444|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
46663870|NCT04543409|82877445|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
46663871|NCT04543409|82877444|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
46663872|NCT04543409|82877445|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
46663873|NCT04543409|82877444|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
46663874|NCT04543409|82877445|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
46663875|NCT04543409|82877444|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
46663876|NCT04543409|82877445|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
46663877|NCT04434937|82877452|FG000|Overall Study|Death|4|||
46663878|NCT04434937|82877452|FG000|Overall Study|Withdrawal by Subject|1|||
46663879|NCT04434937|82877452|FG000|Overall Study|"Captured as Other in Database"|1|||
46663880|NCT04434937|82877452|FG000|Overall Study|Ongoing|36|||
46663881|NCT04030143|82877488|FG000|Overall Study|Adverse Event|5|||
46663882|NCT04030143|82877489|FG001|Overall Study|Adverse Event|10|||
46663883|NCT04030143|82877488|FG000|Overall Study|Lost to Follow-up|3|||
46663884|NCT04030143|82877489|FG001|Overall Study|Lost to Follow-up|7|||
46663885|NCT04030143|82877488|FG000|Overall Study|Protocol Deviation|2|||
46663886|NCT04030143|82877489|FG001|Overall Study|Protocol Deviation|2|||
46783720|NCT02501096|83002686|FG006|Overall Study|Death|15|||
46663887|NCT04030143|82877488|FG000|Overall Study|Withdrawal by Subject|16|||
46663888|NCT04030143|82877489|FG001|Overall Study|Withdrawal by Subject|18|||
46663889|NCT04030143|82877488|FG000|Overall Study|Physician Decision|1|||
46663890|NCT04030143|82877489|FG001|Overall Study|Physician Decision|1|||
46663891|NCT04030143|82877488|FG000|Overall Study|Due to Covid-19|2|||
46663892|NCT04030143|82877489|FG001|Overall Study|Due to Covid-19|3|||
46663893|NCT04030143|82877488|FG000|Overall Study|Not Due to Covid-19|1|||
46663894|NCT04030143|82877489|FG001|Overall Study|Not Due to Covid-19|1|||
46663895|NCT03934931|82877504|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
46663896|NCT03934931|82877505|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
46663897|NCT03934931|82877506|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
46663898|NCT03927144|82877516|FG000|Core Phase|Adverse Event|9|||
46663899|NCT03927144|82877517|FG001|Core Phase|Adverse Event|5|||
46663900|NCT03927144|82877516|FG000|Core Phase|Lost to Follow-up|3|||
46783721|NCT02501096|83002687|FG007|Overall Study|Death|16|||
46783722|NCT02501096|83002688|FG008|Overall Study|Death|1|||
46783723|NCT01633541|83002722|FG000|Overall Study|Death|1|||
46783724|NCT01633541|83002723|FG001|Overall Study|Death|0|||
46783725|NCT01399372|83002733|FG000|Overall Study|Protocol Violation|3|||
46783726|NCT01399372|83002734|FG001|Overall Study|Protocol Violation|1|||
46783727|NCT01063517|83002742|FG000|Overall Study|Consent withdrawal|1|||
46783728|NCT01063517|83002743|FG001|Overall Study|Consent withdrawal|0|||
46783729|NCT01063517|83002742|FG000|Overall Study|Study reached data cut-off|19|||
46783730|NCT01063517|83002743|FG001|Overall Study|Study reached data cut-off|7|||
46783731|NCT01063517|83002742|FG000|Overall Study|Lost to Follow-up|4|||
46783732|NCT01063517|83002743|FG001|Overall Study|Lost to Follow-up|3|||
46783733|NCT01063517|83002742|FG000|Overall Study|Withdrawal by Subject|1|||
46783734|NCT01063517|83002743|FG001|Overall Study|Withdrawal by Subject|2|||
46783735|NCT01063517|83002742|FG000|Overall Study|Death|33|||
46783736|NCT01063517|83002743|FG001|Overall Study|Death|48|||
46783737|NCT00920621|83002753|FG000|Overall Study|Lost to Follow-up|16|||
46783738|NCT00920621|83002754|FG001|Overall Study|Lost to Follow-up|17|||
46783739|NCT00920621|83002755|FG002|Overall Study|Lost to Follow-up|19|||
46851155|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
46851156|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
46851157|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
46851158|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
46851159|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
46851160|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
46851161|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
47076330|NCT02335944|83370876|FG002|Post-treatment Follow-up|Death|0|||
47076331|NCT02335944|83370877|FG003|Post-treatment Follow-up|Death|1|||
47076332|NCT02335944|83370878|FG004|Post-treatment Follow-up|Death|0|||
47076333|NCT02335944|83370879|FG005|Post-treatment Follow-up|Death|1|||
47076334|NCT02335944|83370880|FG006|Post-treatment Follow-up|Death|0|||
47076335|NCT02335944|83370881|FG007|Post-treatment Follow-up|Death|0|||
47076336|NCT02335944|83370882|FG008|Post-treatment Follow-up|Death|0|||
47076337|NCT02335944|83370883|FG009|Post-treatment Follow-up|Death|0|||
47076338|NCT02335944|83370874|FG000|Post-treatment Follow-up|Physician Decision|1|||
47076339|NCT02335944|83370875|FG001|Post-treatment Follow-up|Physician Decision|0|||
47076340|NCT02335944|83370876|FG002|Post-treatment Follow-up|Physician Decision|0|||
46783740|NCT00920621|83002756|FG003|Overall Study|Lost to Follow-up|21|||
46783741|NCT00920621|83002753|FG000|Overall Study|Fetal/neonatal deaths|16|||
47076341|NCT02335944|83370877|FG003|Post-treatment Follow-up|Physician Decision|0|||
47076342|NCT02335944|83370878|FG004|Post-treatment Follow-up|Physician Decision|0|||
47076343|NCT02335944|83370879|FG005|Post-treatment Follow-up|Physician Decision|0|||
47076344|NCT02335944|83370880|FG006|Post-treatment Follow-up|Physician Decision|0|||
47076345|NCT02335944|83370881|FG007|Post-treatment Follow-up|Physician Decision|1|||
47076346|NCT02335944|83370882|FG008|Post-treatment Follow-up|Physician Decision|0|||
47076347|NCT02335944|83370883|FG009|Post-treatment Follow-up|Physician Decision|0|||
46663901|NCT03927144|82877517|FG001|Core Phase|Lost to Follow-up|2|||
46783742|NCT00920621|83002754|FG001|Overall Study|Fetal/neonatal deaths|14|||
46663902|NCT03927144|82877516|FG000|Core Phase|New Therapy for Study Indication|0|||
46663903|NCT03927144|82877517|FG001|Core Phase|New Therapy for Study Indication|1|||
46783743|NCT00920621|83002755|FG002|Overall Study|Fetal/neonatal deaths|16|||
47076348|NCT02200445|83370961|FG000|Overall Study|Lack of Efficacy|1|||
47076349|NCT02200445|83370962|FG001|Overall Study|Lack of Efficacy|2|||
46783744|NCT00920621|83002756|FG003|Overall Study|Fetal/neonatal deaths|14|||
46663904|NCT03927144|82877516|FG000|Core Phase|No Longer Clinically Benefiting|4|||
46663905|NCT03927144|82877517|FG001|Core Phase|No Longer Clinically Benefiting|4|||
46663906|NCT03927144|82877516|FG000|Core Phase|Physician Decision|2|||
46663907|NCT03927144|82877517|FG001|Core Phase|Physician Decision|8|||
46663908|NCT03927144|82877516|FG000|Core Phase|Protocol Violation|2|||
46663909|NCT03927144|82877517|FG001|Core Phase|Protocol Violation|2|||
46663910|NCT03927144|82877516|FG000|Core Phase|Withdrawal by Subject|16|||
46663911|NCT03927144|82877517|FG001|Core Phase|Withdrawal by Subject|40|||
46663912|NCT03927144|82877516|FG000|Extension Phase|Adverse Event|2|||
46663913|NCT03927144|82877517|FG001|Extension Phase|Adverse Event|1|||
46663914|NCT03927144|82877516|FG000|Extension Phase|No longer clinically benefiting|4|||
46663915|NCT03927144|82877517|FG001|Extension Phase|No longer clinically benefiting|5|||
46663916|NCT03927144|82877516|FG000|Extension Phase|Pregnancy|1|||
46663917|NCT03927144|82877517|FG001|Extension Phase|Pregnancy|0|||
46663918|NCT03927144|82877516|FG000|Extension Phase|Protocol Violation|0|||
46663919|NCT03927144|82877517|FG001|Extension Phase|Protocol Violation|1|||
46663920|NCT03927144|82877516|FG000|Extension Phase|Withdrawal by Subject|8|||
46663921|NCT03927144|82877517|FG001|Extension Phase|Withdrawal by Subject|3|||
46663922|NCT03859973|82877527|FG000|Overall Study|Other reason than listed|3|||
46663923|NCT03859973|82877528|FG001|Overall Study|Other reason than listed|2|||
46663924|NCT03859973|82877527|FG000|Overall Study|COVID-19 related, not due to AE|3|||
46663925|NCT03859973|82877528|FG001|Overall Study|COVID-19 related, not due to AE|4|||
46663926|NCT03859973|82877527|FG000|Overall Study|Withdrawal by Subject|8|||
46663927|NCT03859973|82877528|FG001|Overall Study|Withdrawal by Subject|9|||
46663928|NCT03859973|82877527|FG000|Overall Study|Lost to Follow-up|2|||
46663929|NCT03859973|82877528|FG001|Overall Study|Lost to Follow-up|3|||
46663930|NCT03859973|82877527|FG000|Overall Study|Protocol Violation|1|||
46663931|NCT03859973|82877528|FG001|Overall Study|Protocol Violation|3|||
46663932|NCT03859973|82877527|FG000|Overall Study|Adverse Event|3|||
46663933|NCT03859973|82877528|FG001|Overall Study|Adverse Event|5|||
46663934|NCT03761394|82877538|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
46783745|NCT00920621|83002753|FG000|Overall Study|Blood sample not collected|22|||
46783746|NCT00920621|83002754|FG001|Overall Study|Blood sample not collected|14|||
46783747|NCT00920621|83002755|FG002|Overall Study|Blood sample not collected|0|||
47076350|NCT02200445|83370963|FG002|Overall Study|Lack of Efficacy|2|||
47076351|NCT02200445|83370961|FG000|Overall Study|Adverse Event|0|||
47076352|NCT02200445|83370962|FG001|Overall Study|Adverse Event|2|||
47076353|NCT02200445|83370963|FG002|Overall Study|Adverse Event|0|||
47076354|NCT02058693|83370973|FG000|Phase 1|Withdrawal by Subject|3|||
47076355|NCT02058693|83370974|FG001|Phase 1|Withdrawal by Subject|2|||
47076356|NCT02058693|83370973|FG000|Phase 1|Adverse Event|0|||
47076357|NCT02058693|83370974|FG001|Phase 1|Adverse Event|1|||
47076358|NCT02058693|83370973|FG000|Phase 1|Lack of Efficacy|1|||
46663935|NCT03761394|82877539|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
46663936|NCT03761394|82877540|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
46663937|NCT03761394|82877541|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
46663938|NCT03761394|82877538|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
46663939|NCT03761394|82877539|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
46663940|NCT03761394|82877540|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
46783748|NCT00920621|83002756|FG003|Overall Study|Blood sample not collected|0|||
47076359|NCT02058693|83370974|FG001|Phase 1|Lack of Efficacy|0|||
47076360|NCT02058693|83370973|FG000|Phase 1|Physician Decision|1|||
47076361|NCT02058693|83370974|FG001|Phase 1|Physician Decision|1|||
46663941|NCT03761394|82877541|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
46663942|NCT03761394|82877538|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
46663943|NCT03761394|82877539|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
46663944|NCT03761394|82877540|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
46663945|NCT03761394|82877541|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
46663946|NCT03761394|82877538|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
46663947|NCT03761394|82877539|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
46663948|NCT03761394|82877540|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
46663949|NCT03761394|82877541|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
46663950|NCT03699020|82877553|FG000|Overall Study|Withdrawal by Subject|3|||
46663951|NCT03699020|82877554|FG001|Overall Study|Withdrawal by Subject|2|||
46663952|NCT03661723|82877592|FG000|Overall Study|Disease Progression|4|||
46663953|NCT03661723|82877593|FG001|Overall Study|Disease Progression|24|||
46663954|NCT03661723|82877594|FG002|Overall Study|Disease Progression|4|||
46663955|NCT03661723|82877595|FG003|Overall Study|Disease Progression|19|||
46663956|NCT03661723|82877592|FG000|Overall Study|Withdrawal by Subject|1|||
46663957|NCT03661723|82877593|FG001|Overall Study|Withdrawal by Subject|0|||
46663958|NCT03661723|82877594|FG002|Overall Study|Withdrawal by Subject|2|||
46663959|NCT03661723|82877595|FG003|Overall Study|Withdrawal by Subject|4|||
46663960|NCT03661723|82877592|FG000|Overall Study|Physician Decision|1|||
46663961|NCT03661723|82877593|FG001|Overall Study|Physician Decision|0|||
46663962|NCT03661723|82877594|FG002|Overall Study|Physician Decision|0|||
46663963|NCT03661723|82877595|FG003|Overall Study|Physician Decision|0|||
46663964|NCT03661723|82877592|FG000|Overall Study|Clinical Deterioration|0|||
46663965|NCT03661723|82877593|FG001|Overall Study|Clinical Deterioration|0|||
46663966|NCT03661723|82877594|FG002|Overall Study|Clinical Deterioration|0|||
46663967|NCT03661723|82877595|FG003|Overall Study|Clinical Deterioration|1|||
46663968|NCT03414983|82877616|FG000|Pre-Treatment|Other reasons|1|||
46663969|NCT03414983|82877617|FG001|Pre-Treatment|Other reasons|0|||
46663970|NCT03414983|82877616|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
46663971|NCT03414983|82877617|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
46663972|NCT03414983|82877616|FG000|Pre-Treatment|Participant withdrew consent|1|||
46663973|NCT03414983|82877617|FG001|Pre-Treatment|Participant withdrew consent|3|||
46663974|NCT03414983|82877616|FG000|Treatment|Participant withdrew consent|4|||
46663975|NCT03414983|82877617|FG001|Treatment|Participant withdrew consent|3|||
46663976|NCT03414983|82877616|FG000|Treatment|Participant request to discontinue study treatment|8|||
46663977|NCT03414983|82877617|FG001|Treatment|Participant request to discontinue study treatment|10|||
46663978|NCT03414983|82877616|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
46663979|NCT03414983|82877617|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
46663980|NCT03414983|82877616|FG000|Treatment|Death|0|||
46663981|NCT03414983|82877617|FG001|Treatment|Death|1|||
46663982|NCT03414983|82877616|FG000|Treatment|Study Drug Toxicity|10|||
46663983|NCT03414983|82877617|FG001|Treatment|Study Drug Toxicity|5|||
46663984|NCT03414983|82877616|FG000|Treatment|Disease Progression|75|||
46663985|NCT03414983|82877617|FG001|Treatment|Disease Progression|29|||
46663986|NCT03414983|82877616|FG000|Treatment|Not reported|1|||
46663987|NCT03414983|82877617|FG001|Treatment|Not reported|0|||
46663988|NCT03414983|82877616|FG000|Treatment|Other reasons|3|||
46663989|NCT03414983|82877617|FG001|Treatment|Other reasons|2|||
46663990|NCT03414983|82877616|FG000|Treatment|Poor/non-compliance|2|||
46663991|NCT03414983|82877617|FG001|Treatment|Poor/non-compliance|0|||
46663992|NCT03414983|82877616|FG000|Treatment|Maximum clinical benefit|5|||
46663993|NCT03414983|82877617|FG001|Treatment|Maximum clinical benefit|9|||
46663994|NCT03414983|82877616|FG000|Treatment|Lost to Follow-up|0|||
46783749|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
46783750|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
46783751|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
46783752|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
46783753|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
46783754|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
46783755|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
46783756|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
46783757|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
46663995|NCT03414983|82877617|FG001|Treatment|Lost to Follow-up|1|||
46663996|NCT03414983|82877616|FG000|Treatment|Administrative reasons by sponsor|1|||
46663997|NCT03414983|82877617|FG001|Treatment|Administrative reasons by sponsor|0|||
46663998|NCT02986659|82877651|FG000|First Intervention Period|Adverse Event|3|||
46663999|NCT02986659|82877652|FG001|First Intervention Period|Adverse Event|1|||
46664000|NCT02986659|82877651|FG000|First Intervention Period|Lost to Follow-up|1|||
46664001|NCT02986659|82877652|FG001|First Intervention Period|Lost to Follow-up|0|||
46664002|NCT02986659|82877651|FG000|First Intervention Period|Withdrawal by Subject|0|||
46664003|NCT02986659|82877652|FG001|First Intervention Period|Withdrawal by Subject|1|||
46664004|NCT02986659|82877651|FG000|Second Intervention Period|Adverse Event|0|||
46664005|NCT02986659|82877652|FG001|Second Intervention Period|Adverse Event|6|||
46664006|NCT02933489|82877660|FG000|Overall Study|Ineligible|3|||
46664007|NCT02933489|82877661|FG001|Overall Study|Ineligible|3|||
46664008|NCT02933489|82877660|FG000|Overall Study|Withdrawal by Subject|27|||
46664009|NCT02933489|82877661|FG001|Overall Study|Withdrawal by Subject|18|||
46664010|NCT02933489|82877660|FG000|Overall Study|Unable to complete exams (other)|14|||
46664011|NCT02933489|82877661|FG001|Overall Study|Unable to complete exams (other)|7|||
46664012|NCT02743806|82877679|FG000|Overall Study|Adverse Event|9|||
46664013|NCT02743806|82877679|FG000|Overall Study|Lost to Follow-up|8|||
46664014|NCT02743806|82877679|FG000|Overall Study|Voluntary Withdrawal|54|||
46664015|NCT02743806|82877679|FG000|Overall Study|Study Termination|65|||
46664016|NCT02743806|82877679|FG000|Overall Study|Pregnancy|6|||
46664017|NCT02743806|82877679|FG000|Overall Study|No Longer Clinically Benefiting|27|||
46664018|NCT02743806|82877679|FG000|Overall Study|Reason Not Specified|12|||
46664019|NCT02668653|82877685|FG000|Overall Study|Refractory disease|41|||
46664020|NCT02668653|82877686|FG001|Overall Study|Refractory disease|70|||
46664021|NCT02668653|82877685|FG000|Overall Study|Relapse|44|||
46664022|NCT02668653|82877686|FG001|Overall Study|Relapse|65|||
46664023|NCT02668653|82877685|FG000|Overall Study|Adverse Event|58|||
46664024|NCT02668653|82877686|FG001|Overall Study|Adverse Event|23|||
46664025|NCT02668653|82877685|FG000|Overall Study|Subject decision to stop study drug|25|||
46664026|NCT02668653|82877686|FG001|Overall Study|Subject decision to stop study drug|23|||
46664027|NCT02668653|82877685|FG000|Overall Study|Other reasons not specified|16|||
46664028|NCT02668653|82877686|FG001|Overall Study|Other reasons not specified|11|||
46664029|NCT02668653|82877685|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
46664030|NCT02668653|82877686|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
46664031|NCT02668653|82877685|FG000|Overall Study|Investigator decision|10|||
46664032|NCT02668653|82877686|FG001|Overall Study|Investigator decision|7|||
46664033|NCT02668653|82877685|FG000|Overall Study|Failure to meet continuation criteria|5|||
46664034|NCT02668653|82877686|FG001|Overall Study|Failure to meet continuation criteria|12|||
46664035|NCT02668653|82877685|FG000|Overall Study|Lost to Follow-up|1|||
46664036|NCT02668653|82877686|FG001|Overall Study|Lost to Follow-up|0|||
46664037|NCT02668653|82877685|FG000|Overall Study|Pregnancy|0|||
46664038|NCT02668653|82877686|FG001|Overall Study|Pregnancy|1|||
46664039|NCT02668653|82877685|FG000|Overall Study|Death|0|||
46664040|NCT02668653|82877686|FG001|Overall Study|Death|1|||
46664041|NCT02649972|82877692|FG000|Overall Study|Not treated|1|||
46664042|NCT02437318|82877707|FG000|Overall Study|Progressive disease|173|||
46664043|NCT02437318|82877708|FG001|Overall Study|Progressive disease|208|||
46664044|NCT02437318|82877707|FG000|Overall Study|Subject/guardian decision|22|||
46664045|NCT02437318|82877708|FG001|Overall Study|Subject/guardian decision|10|||
46664046|NCT02437318|82877707|FG000|Overall Study|Physician Decision|11|||
46664047|NCT02437318|82877708|FG001|Overall Study|Physician Decision|10|||
46664048|NCT02437318|82877707|FG000|Overall Study|Adverse Event|14|||
46664049|NCT02437318|82877708|FG001|Overall Study|Adverse Event|3|||
46664050|NCT02437318|82877707|FG000|Overall Study|Death|4|||
46664051|NCT02437318|82877708|FG001|Overall Study|Death|4|||
46664052|NCT02437318|82877707|FG000|Overall Study|Protocol Violation|5|||
46664053|NCT02437318|82877708|FG001|Overall Study|Protocol Violation|6|||
46664054|NCT02437318|82877707|FG000|Overall Study|Untreated|0|||
46664055|NCT02437318|82877708|FG001|Overall Study|Untreated|1|||
46664056|NCT02305238|82877717|FG000|Overall Study|Death|2|||
46664057|NCT02305238|82877718|FG001|Overall Study|Death|1|||
46664058|NCT02305238|82877719|FG002|Overall Study|Death|0|||
46664059|NCT02305238|82877717|FG000|Overall Study|Progressive disease|4|||
46664060|NCT02305238|82877718|FG001|Overall Study|Progressive disease|4|||
46664061|NCT02305238|82877719|FG002|Overall Study|Progressive disease|0|||
46664062|NCT02305238|82877717|FG000|Overall Study|Logistical difficulties|1|||
46664063|NCT02305238|82877718|FG001|Overall Study|Logistical difficulties|3|||
46664064|NCT02305238|82877719|FG002|Overall Study|Logistical difficulties|0|||
46664065|NCT02305238|82877717|FG000|Overall Study|Protocol Violation|0|||
46664066|NCT02305238|82877718|FG001|Overall Study|Protocol Violation|3|||
46664067|NCT02305238|82877719|FG002|Overall Study|Protocol Violation|0|||
46664068|NCT02305238|82877717|FG000|Overall Study|Physician Decision|2|||
46664069|NCT02305238|82877718|FG001|Overall Study|Physician Decision|1|||
46664070|NCT02305238|82877719|FG002|Overall Study|Physician Decision|0|||
46664071|NCT02305238|82877717|FG000|Overall Study|Adverse Event|4|||
46664072|NCT02305238|82877718|FG001|Overall Study|Adverse Event|2|||
46664073|NCT02305238|82877719|FG002|Overall Study|Adverse Event|0|||
46664074|NCT02305238|82877717|FG000|Overall Study|Withdrawal by Subject|3|||
46664075|NCT02305238|82877718|FG001|Overall Study|Withdrawal by Subject|4|||
46664076|NCT02305238|82877719|FG002|Overall Study|Withdrawal by Subject|0|||
46664077|NCT02305238|82877717|FG000|Overall Study|Randomized failure|0|||
46664078|NCT02305238|82877718|FG001|Overall Study|Randomized failure|0|||
46664079|NCT02305238|82877719|FG002|Overall Study|Randomized failure|8|||
46664080|NCT02305238|82877717|FG000|Overall Study|Required procedure failed|0|||
46664081|NCT02305238|82877718|FG001|Overall Study|Required procedure failed|1|||
46664082|NCT02305238|82877719|FG002|Overall Study|Required procedure failed|0|||
46664083|NCT02175004|82877728|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
46664084|NCT02175004|82877729|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
46664085|NCT02175004|82877728|FG000|Overall Study|Investigator Judgment|1|||
46664086|NCT02175004|82877729|FG001|Overall Study|Investigator Judgment|4|||
46664087|NCT02175004|82877728|FG000|Overall Study|Voluntary Withdrawal|6|||
46664088|NCT02175004|82877729|FG001|Overall Study|Voluntary Withdrawal|19|||
46664089|NCT02175004|82877728|FG000|Overall Study|Liver Transplant|1|||
46664090|NCT02175004|82877729|FG001|Overall Study|Liver Transplant|0|||
46664091|NCT02175004|82877728|FG000|Overall Study|Disease Progression|1|||
46664092|NCT02175004|82877729|FG001|Overall Study|Disease Progression|0|||
46664093|NCT02175004|82877728|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
46664094|NCT02175004|82877729|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
46664095|NCT01059825|82877741|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
46664096|NCT01059825|82877742|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
46664097|NCT01059825|82877743|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
46664098|NCT01059825|82877744|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
46664099|NCT01059825|82877745|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
46664100|NCT01059825|82877746|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
46664101|NCT01059825|82877747|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
46664102|NCT01059825|82877741|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
46664103|NCT01059825|82877742|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
46664104|NCT01059825|82877743|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
46664105|NCT01059825|82877744|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
46664106|NCT01059825|82877745|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
46664107|NCT01059825|82877746|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
46664108|NCT01059825|82877747|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
46664109|NCT01059825|82877741|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
46664110|NCT01059825|82877742|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
46664111|NCT01059825|82877743|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
46664112|NCT01059825|82877744|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
46664113|NCT01059825|82877745|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
46664114|NCT01059825|82877746|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
46664115|NCT01059825|82877747|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
46851162|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
46851163|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
46851164|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
46851165|NCT03605836|83066859|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
46851166|NCT03605836|83066860|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
46851167|NCT03605836|83066861|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
46851168|NCT03605836|83066862|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
46851169|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
46851170|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
46851171|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
46972202|NCT02031640|83215763|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
46972203|NCT02031640|83215764|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
46972204|NCT02031640|83215759|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
46664116|NCT01059825|82877741|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
46664117|NCT01059825|82877742|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
46664118|NCT01059825|82877743|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
46664119|NCT01059825|82877744|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
46664120|NCT01059825|82877745|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
46664121|NCT01059825|82877746|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
46664122|NCT01059825|82877747|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
46664123|NCT01059825|82877741|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
46664124|NCT01059825|82877742|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
46664125|NCT01059825|82877743|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
46664126|NCT01059825|82877744|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
46664127|NCT01059825|82877745|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
46664128|NCT01059825|82877746|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
46664129|NCT01059825|82877747|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
46664130|NCT01059825|82877741|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
46664131|NCT01059825|82877742|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
46664132|NCT01059825|82877743|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
46664133|NCT01059825|82877744|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
46664134|NCT01059825|82877745|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
46664135|NCT01059825|82877746|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
46851172|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
46851173|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
47076362|NCT02058693|83370973|FG000|Phase 2|Withdrawal by Subject|0|||
46664136|NCT01059825|82877747|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
46664137|NCT01059825|82877741|FG000|Treatment Period|Lost to Follow-up|2|||
46664138|NCT01059825|82877742|FG001|Treatment Period|Lost to Follow-up|1|||
46664139|NCT01059825|82877743|FG002|Treatment Period|Lost to Follow-up|0|||
46664140|NCT01059825|82877744|FG003|Treatment Period|Lost to Follow-up|1|||
46664141|NCT01059825|82877745|FG004|Treatment Period|Lost to Follow-up|2|||
46664142|NCT01059825|82877746|FG005|Treatment Period|Lost to Follow-up|0|||
46664143|NCT01059825|82877747|FG006|Treatment Period|Lost to Follow-up|0|||
46664144|NCT01059825|82877741|FG000|Treatment Period|Withdrawal by Subject|3|||
46664145|NCT01059825|82877742|FG001|Treatment Period|Withdrawal by Subject|0|||
46664146|NCT01059825|82877743|FG002|Treatment Period|Withdrawal by Subject|1|||
46664147|NCT01059825|82877744|FG003|Treatment Period|Withdrawal by Subject|5|||
46664148|NCT01059825|82877745|FG004|Treatment Period|Withdrawal by Subject|4|||
46664149|NCT01059825|82877746|FG005|Treatment Period|Withdrawal by Subject|1|||
46664150|NCT01059825|82877747|FG006|Treatment Period|Withdrawal by Subject|0|||
46664151|NCT01059825|82877741|FG000|Treatment Period|Other reason not specified|1|||
46664152|NCT01059825|82877742|FG001|Treatment Period|Other reason not specified|2|||
46664153|NCT01059825|82877743|FG002|Treatment Period|Other reason not specified|1|||
46664154|NCT01059825|82877744|FG003|Treatment Period|Other reason not specified|2|||
46664155|NCT01059825|82877745|FG004|Treatment Period|Other reason not specified|0|||
46664156|NCT01059825|82877746|FG005|Treatment Period|Other reason not specified|0|||
46664157|NCT01059825|82877747|FG006|Treatment Period|Other reason not specified|0|||
46664158|NCT01059825|82877741|FG000|Treatment Period|Protocol Violation|0|||
46664159|NCT01059825|82877742|FG001|Treatment Period|Protocol Violation|0|||
46664160|NCT01059825|82877743|FG002|Treatment Period|Protocol Violation|1|||
46664161|NCT01059825|82877744|FG003|Treatment Period|Protocol Violation|1|||
46664162|NCT01059825|82877745|FG004|Treatment Period|Protocol Violation|1|||
46664163|NCT01059825|82877746|FG005|Treatment Period|Protocol Violation|1|||
46664164|NCT01059825|82877747|FG006|Treatment Period|Protocol Violation|0|||
46664165|NCT01059825|82877741|FG000|Treatment Period|Adverse event related to study drug|1|||
46664166|NCT01059825|82877742|FG001|Treatment Period|Adverse event related to study drug|0|||
46664167|NCT01059825|82877743|FG002|Treatment Period|Adverse event related to study drug|1|||
46664168|NCT01059825|82877744|FG003|Treatment Period|Adverse event related to study drug|1|||
46664169|NCT01059825|82877745|FG004|Treatment Period|Adverse event related to study drug|0|||
46664170|NCT01059825|82877746|FG005|Treatment Period|Adverse event related to study drug|0|||
46664171|NCT01059825|82877747|FG006|Treatment Period|Adverse event related to study drug|0|||
46664172|NCT01059825|82877741|FG000|Treatment Period|Insufficient clinical response|3|||
46664173|NCT01059825|82877742|FG001|Treatment Period|Insufficient clinical response|0|||
46664174|NCT01059825|82877743|FG002|Treatment Period|Insufficient clinical response|0|||
46664175|NCT01059825|82877744|FG003|Treatment Period|Insufficient clinical response|0|||
46664176|NCT01059825|82877745|FG004|Treatment Period|Insufficient clinical response|0|||
46664177|NCT01059825|82877746|FG005|Treatment Period|Insufficient clinical response|0|||
46664178|NCT01059825|82877747|FG006|Treatment Period|Insufficient clinical response|0|||
46664179|NCT01059825|82877741|FG000|Treatment Period|Adverse event not related to study drug|0|||
46664180|NCT01059825|82877742|FG001|Treatment Period|Adverse event not related to study drug|1|||
46664181|NCT01059825|82877743|FG002|Treatment Period|Adverse event not related to study drug|2|||
46664182|NCT01059825|82877744|FG003|Treatment Period|Adverse event not related to study drug|1|||
46664183|NCT01059825|82877745|FG004|Treatment Period|Adverse event not related to study drug|1|||
46664184|NCT01059825|82877746|FG005|Treatment Period|Adverse event not related to study drug|1|||
46664185|NCT01059825|82877747|FG006|Treatment Period|Adverse event not related to study drug|0|||
46664186|NCT03439839|82877774|FG000|Overall Study|Death|3|||
46664187|NCT03439839|82877775|FG001|Overall Study|Death|0|||
46664188|NCT04618770|82877839|FG000|Overall Study|Censored from Analysis|12|||
46664189|NCT04618770|82877839|FG000|Overall Study|Early Termination|25|||
46664190|NCT04568603|82877843|FG000|Overall Study|Physician Decision|1|||
46664191|NCT04544709|82877848|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
46664192|NCT04528732|82877857|FG000|Overall Study|Death|1|||
46664193|NCT04528732|82877858|FG001|Overall Study|Death|0|||
46664194|NCT04528732|82877859|FG002|Overall Study|Death|1|||
46664195|NCT04528732|82877857|FG000|Overall Study|Lost to Follow-up|0|||
46664196|NCT04528732|82877858|FG001|Overall Study|Lost to Follow-up|1|||
46972205|NCT02031640|83215760|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
46972206|NCT02031640|83215761|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
46972207|NCT02031640|83215762|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
46664197|NCT04528732|82877859|FG002|Overall Study|Lost to Follow-up|2|||
46664198|NCT04505540|82877872|FG000|Baseline|Protocol Violation|10|||
46664199|NCT04505540|82877872|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
46664200|NCT04505540|82877872|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
46664201|NCT04505540|82877872|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
46664202|NCT04505540|82877872|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
46664203|NCT04505540|82877872|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
46972208|NCT02031640|83215763|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
46664204|NCT04505540|82877872|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
46664205|NCT04505540|82877872|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
46664206|NCT04505540|82877872|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
46664207|NCT04505540|82877872|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
46664208|NCT04505540|82877872|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
46664209|NCT04505540|82877872|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
46664210|NCT04505540|82877872|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
46664211|NCT04455815|82877878|FG000|Randomisation Phase|Adverse Event|1|||
46664212|NCT04455815|82877879|FG001|Randomisation Phase|Adverse Event|0|||
46664213|NCT04455815|82877878|FG000|Treatment Phase|Adverse Event|0|||
46664214|NCT04455815|82877879|FG001|Treatment Phase|Adverse Event|1|||
46664215|NCT04455815|82877878|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
46664216|NCT04455815|82877879|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
46664217|NCT04455815|82877878|FG000|Treatment Phase|Withdrawal by Subject|1|||
46664218|NCT04455815|82877879|FG001|Treatment Phase|Withdrawal by Subject|1|||
46664219|NCT04220411|82877889|FG000|Overall Study|Adverse Event|0|||
46664220|NCT04220411|82877890|FG001|Overall Study|Adverse Event|0|||
46664221|NCT04220411|82877891|FG002|Overall Study|Adverse Event|0|||
46664222|NCT04220411|82877892|FG003|Overall Study|Adverse Event|1|||
46664223|NCT04194489|82877904|FG000|Overall Study|Withdrawal by Subject|5|||
46664224|NCT04194489|82877904|FG000|Overall Study|Lost to Follow-up|48|||
46664225|NCT04194450|82877908|FG000|Overall Study|not eligible|1|||
46664226|NCT04194450|82877909|FG001|Overall Study|not eligible|0|||
46664227|NCT04188834|82877914|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
46664228|NCT04158739|82877920|FG000|Overall Study|Adverse Event|1|||
46664229|NCT04158739|82877921|FG001|Overall Study|Adverse Event|0|||
46664230|NCT04158739|82877920|FG000|Overall Study|Death|0|||
46664231|NCT04158739|82877921|FG001|Overall Study|Death|1|||
46664232|NCT04158739|82877920|FG000|Overall Study|Lack of Efficacy|3|||
46664233|NCT04158739|82877921|FG001|Overall Study|Lack of Efficacy|7|||
46664234|NCT04158739|82877920|FG000|Overall Study|Physician Decision|0|||
46664235|NCT04158739|82877921|FG001|Overall Study|Physician Decision|1|||
46664236|NCT04158739|82877920|FG000|Overall Study|Withdrawal by Subject|3|||
46664237|NCT04158739|82877921|FG001|Overall Study|Withdrawal by Subject|0|||
46664238|NCT04123093|82877931|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
46664239|NCT04123093|82877932|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
46664240|NCT04123093|82877931|FG000|Phase 2|Physician Decision|0|||
46664241|NCT04123093|82877932|FG001|Phase 2|Physician Decision|1|||
46664242|NCT04123093|82877931|FG000|Phase 2|Withdrawal by Subject|0|||
46664243|NCT04123093|82877932|FG001|Phase 2|Withdrawal by Subject|1|||
46664244|NCT03538301|82877994|FG000|Overall Study|Adverse Event|1|||
46664245|NCT03538301|82877995|FG001|Overall Study|Adverse Event|4|||
46664246|NCT03538301|82877996|FG002|Overall Study|Adverse Event|4|||
46664247|NCT03538301|82877994|FG000|Overall Study|Death|1|||
46664248|NCT03538301|82877995|FG001|Overall Study|Death|1|||
46664249|NCT03538301|82877996|FG002|Overall Study|Death|0|||
46664250|NCT03538301|82877994|FG000|Overall Study|Physician Decision|0|||
46664251|NCT03538301|82877995|FG001|Overall Study|Physician Decision|1|||
46664252|NCT03538301|82877996|FG002|Overall Study|Physician Decision|0|||
46664253|NCT03538301|82877994|FG000|Overall Study|Protocol Violation|0|||
46664254|NCT03538301|82877995|FG001|Overall Study|Protocol Violation|0|||
46783758|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
46783759|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
46783760|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
46783761|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
46783762|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
46783763|NCT00612105|83002769|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
46783764|NCT00612105|83002770|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
46783765|NCT00612105|83002769|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
46783766|NCT00612105|83002770|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
46783767|NCT00612105|83002769|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
46851174|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
46664255|NCT03538301|82877996|FG002|Overall Study|Protocol Violation|1|||
46664256|NCT03538301|82877994|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
46664257|NCT03538301|82877995|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
46664258|NCT03538301|82877996|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
46664259|NCT03485157|82878006|FG000|Double Blind Phase|Lost to Follow-up|4|||
46664260|NCT03485157|82878007|FG001|Double Blind Phase|Lost to Follow-up|4|||
46664261|NCT03485157|82878006|FG000|Double Blind Phase|Adverse Event|2|||
46664262|NCT03485157|82878007|FG001|Double Blind Phase|Adverse Event|1|||
46851175|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
46664263|NCT03485157|82878006|FG000|Double Blind Phase|Withdrawal by Subject|6|||
46664264|NCT03485157|82878007|FG001|Double Blind Phase|Withdrawal by Subject|9|||
46664265|NCT03485157|82878006|FG000|Double Blind Phase|Removal by PI|3|||
46664266|NCT03485157|82878007|FG001|Double Blind Phase|Removal by PI|7|||
46664267|NCT03485157|82878006|FG000|Open Label Phase|Lost to Follow-up|1|||
46664268|NCT03485157|82878007|FG001|Open Label Phase|Lost to Follow-up|2|||
46664269|NCT03485157|82878006|FG000|Open Label Phase|Adverse Event|0|||
46664270|NCT03485157|82878007|FG001|Open Label Phase|Adverse Event|1|||
46664271|NCT03485157|82878006|FG000|Open Label Phase|Withdrawal by Subject|1|||
46664272|NCT03485157|82878007|FG001|Open Label Phase|Withdrawal by Subject|2|||
46664273|NCT03485157|82878006|FG000|Open Label Phase|Removal by PI|2|||
46664274|NCT03485157|82878007|FG001|Open Label Phase|Removal by PI|0|||
46664275|NCT03383692|82878016|FG000|Overall Study|Progressive disease as per RECIST|3|||
46664276|NCT03383692|82878017|FG001|Overall Study|Progressive disease as per RECIST|3|||
46664277|NCT03383692|82878016|FG000|Overall Study|Clinical progression|0|||
46664278|NCT03383692|82878017|FG001|Overall Study|Clinical progression|1|||
46664279|NCT03383692|82878016|FG000|Overall Study|Adverse Event|3|||
46664280|NCT03383692|82878017|FG001|Overall Study|Adverse Event|0|||
46664281|NCT03048019|82878036|FG000|Overall Study|Adverse Event|1|||
46664282|NCT03048019|82878037|FG001|Overall Study|Adverse Event|0|||
46664283|NCT02998645|82878043|FG000|Treatment Period 1|Adverse Event|6|||
46664284|NCT02998645|82878043|FG000|Treatment Period 1|Death|5|||
46664285|NCT02998645|82878043|FG000|Treatment Period 1|Technical Problems|4|||
46664286|NCT02998645|82878043|FG000|Treatment Period 1|Lack of Efficacy|2|||
46664287|NCT02998645|82878043|FG000|Treatment Period 1|Progressive disease|1|||
46664288|NCT02998645|82878043|FG000|Treatment Period 1|Subject/guardian decision|1|||
46664289|NCT02998645|82878043|FG000|Treatment Period 2|Lack of Efficacy|5|||
46783768|NCT00612105|83002770|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
46783769|NCT00612105|83002769|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
46783770|NCT00612105|83002770|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
46783771|NCT00612105|83002769|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
46664290|NCT02998645|82878043|FG000|Treatment Period 2|Adverse Event|2|||
46664291|NCT02998645|82878043|FG000|Treatment Period 2|Progressive disease|2|||
46664292|NCT02998645|82878043|FG000|Treatment Period 2|Physician Decision|1|||
46664293|NCT02094261|82878056|FG000|Overall Study|Death|24|||
46664294|NCT02094261|82878056|FG000|Overall Study|Lost to Follow-up|1|||
46664295|NCT02094261|82878056|FG000|Overall Study|Withdrawal by Subject|4|||
46664296|NCT02094261|82878056|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
46664297|NCT02074553|82878067|FG000|Intervention Period 1|Family Emergency|0|||
46664298|NCT02074553|82878068|FG001|Intervention Period 1|Family Emergency|0|||
46664299|NCT02074553|82878069|FG002|Intervention Period 1|Family Emergency|0|||
46664300|NCT02074553|82878070|FG003|Intervention Period 1|Family Emergency|1|||
46664301|NCT02074553|82878071|FG004|Intervention Period 1|Family Emergency|0|||
46664302|NCT02074553|82878072|FG005|Intervention Period 1|Family Emergency|0|||
46664303|NCT02074553|82878073|FG006|Intervention Period 1|Family Emergency|0|||
46664304|NCT02074553|82878074|FG007|Intervention Period 1|Family Emergency|0|||
46664305|NCT02074553|82878067|FG000|Washout Period 1|Adverse Event|1|||
46664306|NCT02074553|82878068|FG001|Washout Period 1|Adverse Event|0|||
46664307|NCT02074553|82878069|FG002|Washout Period 1|Adverse Event|0|||
46664308|NCT02074553|82878070|FG003|Washout Period 1|Adverse Event|0|||
46664309|NCT02074553|82878071|FG004|Washout Period 1|Adverse Event|0|||
46664310|NCT02074553|82878072|FG005|Washout Period 1|Adverse Event|0|||
46664311|NCT02074553|82878073|FG006|Washout Period 1|Adverse Event|0|||
46664312|NCT02074553|82878074|FG007|Washout Period 1|Adverse Event|0|||
46664313|NCT02074553|82878067|FG000|Washout Period 1|Physician Decision|0|||
46783772|NCT00612105|83002770|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
46783773|NCT00546052|83002776|FG000|Overall Study|Adverse Event|47|||
46783774|NCT00546052|83002776|FG000|Overall Study|Lost to Follow-up|144|||
46783775|NCT00546052|83002776|FG000|Overall Study|Protocol Violation|9|||
46783776|NCT00546052|83002776|FG000|Overall Study|Withdrawal by Subject|20|||
46783777|NCT00546052|83002776|FG000|Overall Study|Non Compliance|7|||
46783778|NCT00673920|83002791|FG000|Baseline up to Week 48|Withdrew consent|1|||
46783779|NCT00673920|83002792|FG001|Baseline up to Week 48|Withdrew consent|0|||
46783780|NCT00673920|83002793|FG002|Baseline up to Week 48|Withdrew consent|2|||
46972209|NCT02031640|83215764|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
46972210|NCT02370173|83215785|FG000|Overall Study|Protocol Violation|1|||
46664314|NCT02074553|82878068|FG001|Washout Period 1|Physician Decision|0|||
46783781|NCT00673920|83002794|FG003|Baseline up to Week 48|Withdrew consent|0|||
46664315|NCT02074553|82878069|FG002|Washout Period 1|Physician Decision|0|||
46664316|NCT02074553|82878070|FG003|Washout Period 1|Physician Decision|1|||
46664317|NCT02074553|82878071|FG004|Washout Period 1|Physician Decision|0|||
46664318|NCT02074553|82878072|FG005|Washout Period 1|Physician Decision|0|||
46783782|NCT00673920|83002795|FG004|Baseline up to Week 48|Withdrew consent|0|||
46664319|NCT02074553|82878073|FG006|Washout Period 1|Physician Decision|0|||
46664320|NCT02074553|82878074|FG007|Washout Period 1|Physician Decision|0|||
46664321|NCT02074553|82878067|FG000|Washout Period 1|Other|0|||
46664322|NCT02074553|82878068|FG001|Washout Period 1|Other|0|||
46972211|NCT02370173|83215786|FG001|Overall Study|Protocol Violation|1|||
46783783|NCT00673920|83002796|FG005|Baseline up to Week 48|Withdrew consent|0|||
46783784|NCT00673920|83002797|FG006|Baseline up to Week 48|Withdrew consent|0|||
46783785|NCT00673920|83002798|FG007|Baseline up to Week 48|Withdrew consent|0|||
46783786|NCT00673920|83002791|FG000|Baseline up to Week 48|Refused treatment|1|||
46783787|NCT00673920|83002792|FG001|Baseline up to Week 48|Refused treatment|0|||
46972212|NCT02370173|83215785|FG000|Overall Study|Withdrawal by Subject|2|||
46972213|NCT02370173|83215786|FG001|Overall Study|Withdrawal by Subject|2|||
46972214|NCT02660489|83215796|FG000|Overall Study|Lost to Follow-up|1|||
46972215|NCT02660489|83215797|FG001|Overall Study|Lost to Follow-up|1|||
46664323|NCT02074553|82878069|FG002|Washout Period 1|Other|0|||
46664324|NCT02074553|82878070|FG003|Washout Period 1|Other|0|||
46664325|NCT02074553|82878071|FG004|Washout Period 1|Other|0|||
46664326|NCT02074553|82878072|FG005|Washout Period 1|Other|1|||
46664327|NCT02074553|82878073|FG006|Washout Period 1|Other|0|||
46664328|NCT02074553|82878074|FG007|Washout Period 1|Other|0|||
46664329|NCT02074553|82878067|FG000|Washout Period 2|Adverse Event|0|||
46664330|NCT02074553|82878068|FG001|Washout Period 2|Adverse Event|0|||
46664331|NCT02074553|82878069|FG002|Washout Period 2|Adverse Event|0|||
46664332|NCT02074553|82878070|FG003|Washout Period 2|Adverse Event|0|||
46664333|NCT02074553|82878071|FG004|Washout Period 2|Adverse Event|0|||
46664334|NCT02074553|82878072|FG005|Washout Period 2|Adverse Event|0|||
46664335|NCT02074553|82878073|FG006|Washout Period 2|Adverse Event|1|||
46664336|NCT02074553|82878074|FG007|Washout Period 2|Adverse Event|0|||
46664337|NCT02074553|82878067|FG000|Washout Period 2|Physician Decision|0|||
46664338|NCT02074553|82878068|FG001|Washout Period 2|Physician Decision|0|||
46664339|NCT02074553|82878069|FG002|Washout Period 2|Physician Decision|0|||
46972216|NCT02660489|83215796|FG000|Overall Study|Adverse Event|1|||
46664340|NCT02074553|82878070|FG003|Washout Period 2|Physician Decision|0|||
46972217|NCT02660489|83215797|FG001|Overall Study|Adverse Event|3|||
46972218|NCT02660489|83215796|FG000|Overall Study|no rhinovirus infection|4|||
46972219|NCT02660489|83215797|FG001|Overall Study|no rhinovirus infection|4|||
46972220|NCT02052310|83215805|FG000|Overall Study|Death|64|||
46972221|NCT02052310|83215806|FG001|Overall Study|Death|54|||
46972222|NCT02052310|83215805|FG000|Overall Study|Withdrawal by Subject|37|||
46972223|NCT02052310|83215806|FG001|Overall Study|Withdrawal by Subject|49|||
46972224|NCT02052310|83215805|FG000|Overall Study|Other than specified|32|||
46972225|NCT02052310|83215806|FG001|Overall Study|Other than specified|29|||
46972226|NCT02052310|83215805|FG000|Overall Study|Adverse Event|29|||
46972227|NCT02052310|83215806|FG001|Overall Study|Adverse Event|22|||
46972228|NCT02052310|83215805|FG000|Overall Study|Kidney Transplant|23|||
46972229|NCT02052310|83215806|FG001|Overall Study|Kidney Transplant|29|||
46972230|NCT02052310|83215805|FG000|Overall Study|Physician Decision|14|||
46972231|NCT02052310|83215806|FG001|Overall Study|Physician Decision|7|||
46972232|NCT02052310|83215805|FG000|Overall Study|Lack of Efficacy|6|||
46972233|NCT02052310|83215806|FG001|Overall Study|Lack of Efficacy|1|||
46972234|NCT02052310|83215805|FG000|Overall Study|Site Terminated by Sponsor|5|||
46972235|NCT02052310|83215806|FG001|Overall Study|Site Terminated by Sponsor|13|||
46972236|NCT02052310|83215805|FG000|Overall Study|Lost to Follow-up|4|||
46972237|NCT02052310|83215806|FG001|Overall Study|Lost to Follow-up|2|||
47076363|NCT02058693|83370974|FG001|Phase 2|Withdrawal by Subject|2|||
47076364|NCT02039856|83370984|FG000|Overall Study|Death|5|||
47076365|NCT02039856|83370985|FG001|Overall Study|Death|3|||
47076366|NCT02039856|83370984|FG000|Overall Study|Partial survey completion|61|||
47076367|NCT02039856|83370985|FG001|Overall Study|Partial survey completion|26|||
47076368|NCT02039856|83370984|FG000|Overall Study|Lost to Follow-up|388|||
47076369|NCT02039856|83370985|FG001|Overall Study|Lost to Follow-up|206|||
47076370|NCT02039856|83370984|FG000|Overall Study|Withdrawal by Subject|1573|||
47076371|NCT02039856|83370985|FG001|Overall Study|Withdrawal by Subject|618|||
47076372|NCT01796392|83370995|FG000|Overall Study|Withdrawal by Subject|2|||
47076373|NCT01796392|83370996|FG001|Overall Study|Withdrawal by Subject|0|||
46972238|NCT02052310|83215805|FG000|Overall Study|Protocol Violation|1|||
46972239|NCT02052310|83215806|FG001|Overall Study|Protocol Violation|6|||
47076374|NCT01796392|83370995|FG000|Overall Study|Death|5|||
46664341|NCT02074553|82878071|FG004|Washout Period 2|Physician Decision|0|||
46664342|NCT02074553|82878072|FG005|Washout Period 2|Physician Decision|1|||
46972240|NCT02051764|83215814|FG000|Overall Study|Study terminated by sponsor|0|||
46664343|NCT02074553|82878073|FG006|Washout Period 2|Physician Decision|0|||
46664344|NCT02074553|82878074|FG007|Washout Period 2|Physician Decision|0|||
46664345|NCT02074553|82878067|FG000|Washout Period 2|Lost to Follow-up|0|||
46664346|NCT02074553|82878068|FG001|Washout Period 2|Lost to Follow-up|0|||
46664347|NCT02074553|82878069|FG002|Washout Period 2|Lost to Follow-up|1|||
46972241|NCT02051764|83215815|FG001|Overall Study|Study terminated by sponsor|7|||
46972242|NCT02051296|83215823|FG000|Overall Study|Lost to Follow-up|1|||
47076375|NCT01796392|83370996|FG001|Overall Study|Death|1|||
47076376|NCT01796392|83370995|FG000|Overall Study|Excluded for medical reasons|1|||
47076377|NCT01796392|83370996|FG001|Overall Study|Excluded for medical reasons|2|||
46664348|NCT02074553|82878070|FG003|Washout Period 2|Lost to Follow-up|0|||
46664349|NCT02074553|82878071|FG004|Washout Period 2|Lost to Follow-up|0|||
46664350|NCT02074553|82878072|FG005|Washout Period 2|Lost to Follow-up|0|||
46664351|NCT02074553|82878073|FG006|Washout Period 2|Lost to Follow-up|0|||
46664352|NCT02074553|82878074|FG007|Washout Period 2|Lost to Follow-up|0|||
46664353|NCT02074553|82878067|FG000|Washout Period 3|Physician Decision|0|||
46664354|NCT02074553|82878068|FG001|Washout Period 3|Physician Decision|0|||
46664355|NCT02074553|82878069|FG002|Washout Period 3|Physician Decision|0|||
46664356|NCT02074553|82878070|FG003|Washout Period 3|Physician Decision|0|||
46664357|NCT02074553|82878071|FG004|Washout Period 3|Physician Decision|0|||
46664358|NCT02074553|82878072|FG005|Washout Period 3|Physician Decision|0|||
46664359|NCT02074553|82878073|FG006|Washout Period 3|Physician Decision|0|||
46664360|NCT02074553|82878074|FG007|Washout Period 3|Physician Decision|1|||
46664361|NCT01664598|82878092|FG000|Overall Study|Sponsor Decision|1|||
46664362|NCT01664598|82878092|FG000|Overall Study|Withdrawal of Informed Consent|4|||
46664363|NCT01664598|82878092|FG000|Overall Study|Adverse Event|1|||
46664364|NCT01280682|82878102|FG000|Overall Study|Lost to Follow-up|0|||
46664365|NCT01280682|82878103|FG001|Overall Study|Lost to Follow-up|6|||
46664366|NCT01280682|82878102|FG000|Overall Study|Withdrawal by Subject|0|||
46664367|NCT01280682|82878103|FG001|Overall Study|Withdrawal by Subject|7|||
46664368|NCT01050218|82878120|FG000|Overall Study|Adverse Event|37|||
46664369|NCT01050218|82878120|FG000|Overall Study|Lack of Efficacy|8|||
46664370|NCT01050218|82878120|FG000|Overall Study|Protocol Violation|3|||
46783788|NCT00673920|83002793|FG002|Baseline up to Week 48|Refused treatment|0|||
46783789|NCT00673920|83002794|FG003|Baseline up to Week 48|Refused treatment|0|||
46783790|NCT00673920|83002795|FG004|Baseline up to Week 48|Refused treatment|0|||
46783791|NCT00673920|83002796|FG005|Baseline up to Week 48|Refused treatment|0|||
46783792|NCT00673920|83002797|FG006|Baseline up to Week 48|Refused treatment|0|||
46783793|NCT00673920|83002798|FG007|Baseline up to Week 48|Refused treatment|0|||
46783794|NCT00673920|83002791|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
46783795|NCT00673920|83002792|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
46783796|NCT00673920|83002793|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
46783797|NCT00673920|83002794|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
46783798|NCT00673920|83002795|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
46783799|NCT00673920|83002796|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
46783800|NCT00673920|83002797|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
46783801|NCT00673920|83002798|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
46783802|NCT00673920|83002791|FG000|Baseline up to Week 48|Protocol Violation|0|||
46783803|NCT00673920|83002792|FG001|Baseline up to Week 48|Protocol Violation|0|||
46783804|NCT00673920|83002793|FG002|Baseline up to Week 48|Protocol Violation|1|||
46783805|NCT00673920|83002794|FG003|Baseline up to Week 48|Protocol Violation|0|||
46783806|NCT00673920|83002795|FG004|Baseline up to Week 48|Protocol Violation|0|||
46783807|NCT00673920|83002796|FG005|Baseline up to Week 48|Protocol Violation|0|||
46783808|NCT00673920|83002797|FG006|Baseline up to Week 48|Protocol Violation|0|||
46783809|NCT00673920|83002798|FG007|Baseline up to Week 48|Protocol Violation|0|||
46783810|NCT00673920|83002791|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
46783811|NCT00673920|83002792|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
46783812|NCT00673920|83002793|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
46783813|NCT00673920|83002794|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
46972243|NCT02051296|83215824|FG001|Overall Study|Lost to Follow-up|2|||
46972244|NCT02051296|83215823|FG000|Overall Study|withdraw prior to treatment|7|||
46972245|NCT02051296|83215824|FG001|Overall Study|withdraw prior to treatment|7|||
46972246|NCT02050048|83215832|FG000|Overall Study|Lost to Follow-up|0|||
46972247|NCT02050048|83215833|FG001|Overall Study|Lost to Follow-up|1|||
47076378|NCT01796392|83370995|FG000|Overall Study|Lost to Follow-up|1|||
47076379|NCT01796392|83370996|FG001|Overall Study|Lost to Follow-up|0|||
47076380|NCT01571635|83371007|FG000|Overall Study|Adverse Event|3|||
47076381|NCT01571635|83371008|FG001|Overall Study|Adverse Event|0|||
47076382|NCT01571635|83371009|FG002|Overall Study|Adverse Event|2|||
47076383|NCT01571635|83371010|FG003|Overall Study|Adverse Event|3|||
47076384|NCT01571635|83371011|FG004|Overall Study|Adverse Event|5|||
46664371|NCT01050218|82878120|FG000|Overall Study|Withdrawal by Subject|18|||
46783814|NCT00673920|83002795|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
46972248|NCT02050048|83215832|FG000|Overall Study|Death|1|||
47076385|NCT01571635|83371007|FG000|Overall Study|Other reasons|2|||
46664372|NCT01050218|82878120|FG000|Overall Study|Discontinued by sponsor|18|||
46664373|NCT01050218|82878120|FG000|Overall Study|Compliance|2|||
46972249|NCT02050048|83215833|FG001|Overall Study|Death|0|||
46972250|NCT02050048|83215832|FG000|Overall Study|Ineligible after ERCP|4|||
46664374|NCT01050218|82878120|FG000|Overall Study|Failed to return|7|||
46972251|NCT02050048|83215833|FG001|Overall Study|Ineligible after ERCP|1|||
47076386|NCT01571635|83371008|FG001|Overall Study|Other reasons|1|||
47076387|NCT01571635|83371009|FG002|Overall Study|Other reasons|2|||
46664375|NCT01050218|82878120|FG000|Overall Study|Serious Adverse Event|1|||
47076388|NCT01571635|83371010|FG003|Overall Study|Other reasons|2|||
46783815|NCT00673920|83002796|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
46783816|NCT00673920|83002797|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
46783817|NCT00673920|83002798|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
46783818|NCT00673920|83002791|FG000|Baseline up to Week 48|Administrative/Other|0|||
46783819|NCT00673920|83002792|FG001|Baseline up to Week 48|Administrative/Other|1|||
46783820|NCT00673920|83002793|FG002|Baseline up to Week 48|Administrative/Other|2|||
46783821|NCT00673920|83002794|FG003|Baseline up to Week 48|Administrative/Other|0|||
46783822|NCT00673920|83002795|FG004|Baseline up to Week 48|Administrative/Other|0|||
46783823|NCT00673920|83002796|FG005|Baseline up to Week 48|Administrative/Other|0|||
46783824|NCT00673920|83002797|FG006|Baseline up to Week 48|Administrative/Other|0|||
46783825|NCT00673920|83002798|FG007|Baseline up to Week 48|Administrative/Other|0|||
46783826|NCT00673920|83002791|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
46783827|NCT00673920|83002792|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
46783828|NCT00673920|83002793|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
46972252|NCT02049814|83215841|FG000|Overall Study|Reason not Specified|4|||
46972253|NCT02049814|83215842|FG001|Overall Study|Reason not Specified|3|||
46972254|NCT02049814|83215841|FG000|Overall Study|Pregnancy|1|||
46972255|NCT02049814|83215842|FG001|Overall Study|Pregnancy|0|||
46664376|NCT01050218|82878120|FG000|Overall Study|Family emergency|1|||
46664377|NCT00679029|82878124|FG000|Overall Study|Adverse Event|3|||
46664378|NCT00679029|82878124|FG000|Overall Study|Withdrawal by Subject|1|||
46664379|NCT00679029|82878124|FG000|Overall Study|Lost to Follow-up|1|||
46664380|NCT00195429|82878130|FG000|Overall Study|Adverse Event|2|||
46664381|NCT00195429|82878131|FG001|Overall Study|Adverse Event|4|||
46664382|NCT00195429|82878130|FG000|Overall Study|Lack of Efficacy|2|||
46664383|NCT00195429|82878131|FG001|Overall Study|Lack of Efficacy|1|||
46664384|NCT00195429|82878130|FG000|Overall Study|Lost to Follow-up|1|||
46664385|NCT00195429|82878131|FG001|Overall Study|Lost to Follow-up|0|||
46664386|NCT01059773|82878139|FG000|Overall Study|Adverse Event|2|||
46664387|NCT01059773|82878140|FG001|Overall Study|Adverse Event|2|||
46664388|NCT01059773|82878139|FG000|Overall Study|Withdrawal by Subject|1|||
46664389|NCT01059773|82878140|FG001|Overall Study|Withdrawal by Subject|5|||
46664390|NCT01059773|82878139|FG000|Overall Study|Lost to Follow-up|1|||
46664391|NCT01059773|82878140|FG001|Overall Study|Lost to Follow-up|1|||
46664392|NCT01059773|82878139|FG000|Overall Study|Pregnancy|1|||
46664393|NCT01059773|82878140|FG001|Overall Study|Pregnancy|1|||
46783829|NCT00673920|83002794|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
46783830|NCT00673920|83002795|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
46783831|NCT00673920|83002796|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
46783832|NCT00673920|83002797|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
46783833|NCT00673920|83002798|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
46783834|NCT00673920|83002791|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
46972256|NCT02049814|83215841|FG000|Overall Study|Lost to Follow-up|2|||
46972257|NCT02049814|83215842|FG001|Overall Study|Lost to Follow-up|3|||
46972258|NCT02049814|83215841|FG000|Overall Study|Serious Protocol Violation|5|||
46972259|NCT02049814|83215842|FG001|Overall Study|Serious Protocol Violation|7|||
46972260|NCT02049814|83215841|FG000|Overall Study|Study Termination|0|||
46972261|NCT02049814|83215842|FG001|Overall Study|Study Termination|1|||
46972262|NCT02049814|83215841|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
46972263|NCT02049814|83215842|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
46972264|NCT02049814|83215841|FG000|Overall Study|Voluntary withdrawal|9|||
46972265|NCT02049814|83215842|FG001|Overall Study|Voluntary withdrawal|8|||
46972266|NCT02079844|83215860|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
46972267|NCT02079844|83215861|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
46972268|NCT02079844|83215862|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
46972269|NCT02079844|83215860|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
46972270|NCT02079844|83215861|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
46972271|NCT02079844|83215862|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
46972272|NCT02048722|83215882|FG000|2 Cycles of Treatment|Adverse Event|2|||
46972273|NCT02048722|83215882|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
46972274|NCT02048722|83215882|FG000|2 Cycles of Treatment|Progressive Disease|2|||
46972275|NCT02048722|83215882|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
46972276|NCT02048722|83215882|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
47076389|NCT01571635|83371011|FG004|Overall Study|Other reasons|1|||
47076390|NCT01571635|83371007|FG000|Overall Study|Study terminated by sponsor|0|||
46783835|NCT00673920|83002792|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
46783836|NCT00673920|83002793|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
46783837|NCT00673920|83002794|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
46972277|NCT02048722|83215882|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
47076391|NCT01571635|83371008|FG001|Overall Study|Study terminated by sponsor|4|||
46664394|NCT01059773|82878139|FG000|Overall Study|Protocol Violation|6|||
46664395|NCT01059773|82878140|FG001|Overall Study|Protocol Violation|2|||
46664396|NCT01059773|82878139|FG000|Overall Study|Physician Decision|5|||
46664397|NCT01059773|82878140|FG001|Overall Study|Physician Decision|4|||
46664398|NCT01059773|82878139|FG000|Overall Study|Lack of Efficacy|3|||
46664399|NCT01059773|82878140|FG001|Overall Study|Lack of Efficacy|3|||
46664400|NCT01059773|82878139|FG000|Overall Study|Death|0|||
46664401|NCT01059773|82878140|FG001|Overall Study|Death|1|||
46664402|NCT01059773|82878139|FG000|Overall Study|Malignancy including squamous cell skin|0|||
46664403|NCT01059773|82878140|FG001|Overall Study|Malignancy including squamous cell skin|1|||
46664404|NCT01059773|82878139|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
46783838|NCT00673920|83002795|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
46783839|NCT00673920|83002796|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
46783840|NCT00673920|83002797|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
46783841|NCT00673920|83002798|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
46783842|NCT00673920|83002791|FG000|Week 24 to Week 48|Failure to return|0|||
46783843|NCT00673920|83002792|FG001|Week 24 to Week 48|Failure to return|0|||
46664405|NCT01059773|82878140|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
46664406|NCT01059773|82878139|FG000|Overall Study|Other|1|||
46664407|NCT01059773|82878140|FG001|Overall Study|Other|3|||
46664408|NCT01059318|82878151|FG000|Core Study (26 Week)|Adverse Event|3|||
46664409|NCT01059318|82878151|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
46664410|NCT01059318|82878151|FG000|Extension (36 Week)|Adverse Event|3|||
46783844|NCT00673920|83002793|FG002|Week 24 to Week 48|Failure to return|0|||
46783845|NCT00673920|83002794|FG003|Week 24 to Week 48|Failure to return|0|||
46783846|NCT00673920|83002795|FG004|Week 24 to Week 48|Failure to return|0|||
46783847|NCT00673920|83002796|FG005|Week 24 to Week 48|Failure to return|1|||
46783848|NCT00673920|83002797|FG006|Week 24 to Week 48|Failure to return|0|||
46783849|NCT00673920|83002798|FG007|Week 24 to Week 48|Failure to return|0|||
46783850|NCT00673920|83002791|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
46783851|NCT00673920|83002792|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
46783852|NCT00673920|83002793|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
46783853|NCT00673920|83002794|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
46783854|NCT00673920|83002795|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
46783855|NCT00673920|83002796|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
46783856|NCT00673920|83002797|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
46783857|NCT00673920|83002798|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
46783858|NCT00673920|83002791|FG000|Week 24 to Week 48|Death|0|||
46783859|NCT00673920|83002792|FG001|Week 24 to Week 48|Death|0|||
46664411|NCT01058655|82878162|FG000|Overall Study|Withdrawal by Subject|1|||
46664412|NCT01058655|82878163|FG001|Overall Study|Withdrawal by Subject|0|||
46664413|NCT01058655|82878164|FG002|Overall Study|Withdrawal by Subject|3|||
46664414|NCT01058655|82878165|FG003|Overall Study|Withdrawal by Subject|4|||
46664415|NCT01058655|82878162|FG000|Overall Study|Prolonged Treatment Delay|0|||
46664416|NCT01058655|82878163|FG001|Overall Study|Prolonged Treatment Delay|0|||
46664417|NCT01058655|82878164|FG002|Overall Study|Prolonged Treatment Delay|0|||
46664418|NCT01058655|82878165|FG003|Overall Study|Prolonged Treatment Delay|2|||
46664419|NCT01058655|82878162|FG000|Overall Study|Symptomatic Deterioration|0|||
46664420|NCT01058655|82878163|FG001|Overall Study|Symptomatic Deterioration|0|||
46664421|NCT01058655|82878164|FG002|Overall Study|Symptomatic Deterioration|0|||
46664422|NCT01058655|82878165|FG003|Overall Study|Symptomatic Deterioration|1|||
46664423|NCT01058655|82878162|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
46664424|NCT01058655|82878163|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
46664425|NCT01058655|82878164|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
46664426|NCT01058655|82878165|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
46783860|NCT00673920|83002793|FG002|Week 24 to Week 48|Death|0|||
46783861|NCT00673920|83002794|FG003|Week 24 to Week 48|Death|0|||
47076392|NCT01571635|83371009|FG002|Overall Study|Study terminated by sponsor|1|||
46664427|NCT01058655|82878162|FG000|Overall Study|Death|0|||
46664428|NCT01058655|82878163|FG001|Overall Study|Death|1|||
46664429|NCT01058655|82878164|FG002|Overall Study|Death|1|||
46783862|NCT00673920|83002795|FG004|Week 24 to Week 48|Death|0|||
46783863|NCT00673920|83002796|FG005|Week 24 to Week 48|Death|1|||
46783864|NCT00673920|83002797|FG006|Week 24 to Week 48|Death|0|||
46783865|NCT00673920|83002798|FG007|Week 24 to Week 48|Death|0|||
46783866|NCT00673920|83002791|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
47076393|NCT01571635|83371010|FG003|Overall Study|Study terminated by sponsor|3|||
47076394|NCT01571635|83371011|FG004|Overall Study|Study terminated by sponsor|1|||
47076395|NCT01571635|83371007|FG000|Overall Study|Withdrew consent|1|||
46664430|NCT01058655|82878165|FG003|Overall Study|Death|0|||
47076396|NCT01571635|83371008|FG001|Overall Study|Withdrew consent|1|||
47076397|NCT01571635|83371009|FG002|Overall Study|Withdrew consent|2|||
47076398|NCT01571635|83371010|FG003|Overall Study|Withdrew consent|3|||
47076399|NCT01571635|83371011|FG004|Overall Study|Withdrew consent|0|||
47076400|NCT01571635|83371007|FG000|Overall Study|Lack of Efficacy|0|||
47076401|NCT01571635|83371008|FG001|Overall Study|Lack of Efficacy|2|||
47076402|NCT01571635|83371009|FG002|Overall Study|Lack of Efficacy|0|||
46664431|NCT01058655|82878162|FG000|Overall Study|Disease Progression|1|||
46664432|NCT01058655|82878163|FG001|Overall Study|Disease Progression|2|||
46664433|NCT01058655|82878164|FG002|Overall Study|Disease Progression|4|||
46664434|NCT01058655|82878165|FG003|Overall Study|Disease Progression|24|||
46664435|NCT01058655|82878162|FG000|Overall Study|Other|0|||
46664436|NCT01058655|82878163|FG001|Overall Study|Other|0|||
46664437|NCT01058655|82878164|FG002|Overall Study|Other|0|||
46664438|NCT01058655|82878165|FG003|Overall Study|Other|4|||
46664439|NCT01058421|82878178|FG000|1 Month Outcomes|Death|10|||
46664440|NCT01058421|82878179|FG001|1 Month Outcomes|Death|6|||
46664441|NCT01058421|82878178|FG000|1 Month Outcomes|Lost to Follow-up|8|||
46664442|NCT01058421|82878179|FG001|1 Month Outcomes|Lost to Follow-up|7|||
46664443|NCT01058421|82878178|FG000|1 Month Outcomes|Remained in Hospital|5|||
46664444|NCT01058421|82878179|FG001|1 Month Outcomes|Remained in Hospital|12|||
46664445|NCT01058421|82878178|FG000|1 Month Outcomes|Remained in Other Facility|16|||
46664446|NCT01058421|82878179|FG001|1 Month Outcomes|Remained in Other Facility|17|||
46664447|NCT01058421|82878178|FG000|3 Month Outcomes|Death|3|||
46664448|NCT01058421|82878179|FG001|3 Month Outcomes|Death|5|||
46664449|NCT01058421|82878178|FG000|3 Month Outcomes|Lost to Follow-up|12|||
46664450|NCT01058421|82878179|FG001|3 Month Outcomes|Lost to Follow-up|11|||
46664451|NCT01058421|82878178|FG000|3 Month Outcomes|Remained in Hospital|0|||
46664452|NCT01058421|82878179|FG001|3 Month Outcomes|Remained in Hospital|2|||
46664453|NCT01058421|82878178|FG000|3 Month Outcomes|Remained in Other Facility|5|||
46664454|NCT01058421|82878179|FG001|3 Month Outcomes|Remained in Other Facility|8|||
46664455|NCT01058421|82878178|FG000|6 Month Outcomes|Death|2|||
46664456|NCT01058421|82878179|FG001|6 Month Outcomes|Death|2|||
46664457|NCT01058421|82878178|FG000|6 Month Outcomes|Lost to Follow-up|16|||
46664458|NCT01058421|82878179|FG001|6 Month Outcomes|Lost to Follow-up|21|||
46664459|NCT01058421|82878178|FG000|6 Month Outcomes|Remained in Other Facility|1|||
46664460|NCT01058421|82878179|FG001|6 Month Outcomes|Remained in Other Facility|3|||
46664461|NCT01058304|82878187|FG000|Overall Study|Withdrawal by Subject|8|||
46664462|NCT01058304|82878188|FG001|Overall Study|Withdrawal by Subject|5|||
46664463|NCT01058304|82878187|FG000|Overall Study|Lost to Follow-up|13|||
46664464|NCT01058304|82878188|FG001|Overall Study|Lost to Follow-up|16|||
46783867|NCT00673920|83002792|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
46783868|NCT00673920|83002793|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
46783869|NCT00673920|83002794|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
46783870|NCT00673920|83002795|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
46783871|NCT00673920|83002796|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
46783872|NCT00673920|83002797|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
46783873|NCT00673920|83002798|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
46783874|NCT00379795|83002825|FG000|Overall Study|Death|31|||
46783875|NCT00379795|83002826|FG001|Overall Study|Death|8|||
46783876|NCT00379795|83002827|FG002|Overall Study|Death|6|||
46783877|NCT00379795|83002828|FG003|Overall Study|Death|4|||
46783878|NCT00379795|83002829|FG004|Overall Study|Death|7|||
46783879|NCT00379795|83002825|FG000|Overall Study|Adverse Event|17|||
46783880|NCT00379795|83002826|FG001|Overall Study|Adverse Event|3|||
46783881|NCT00379795|83002827|FG002|Overall Study|Adverse Event|3|||
46783882|NCT00379795|83002828|FG003|Overall Study|Adverse Event|1|||
46783883|NCT00379795|83002829|FG004|Overall Study|Adverse Event|4|||
46783884|NCT00379795|83002825|FG000|Overall Study|Lost to Follow-up|8|||
46783885|NCT00379795|83002826|FG001|Overall Study|Lost to Follow-up|1|||
46783886|NCT00379795|83002827|FG002|Overall Study|Lost to Follow-up|2|||
47076403|NCT01571635|83371010|FG003|Overall Study|Lack of Efficacy|1|||
47076404|NCT01571635|83371011|FG004|Overall Study|Lack of Efficacy|2|||
46664465|NCT01058304|82878187|FG000|Overall Study|Developed exclusion criterion|6|||
46664466|NCT01058304|82878188|FG001|Overall Study|Developed exclusion criterion|12|||
46664467|NCT01058265|82878196|FG000|Overall Study|Lost to Follow-up|11|||
46783887|NCT00379795|83002828|FG003|Overall Study|Lost to Follow-up|1|||
46783888|NCT00379795|83002829|FG004|Overall Study|Lost to Follow-up|4|||
46783889|NCT00379795|83002825|FG000|Overall Study|Physician Decision|25|||
46783890|NCT00379795|83002826|FG001|Overall Study|Physician Decision|0|||
46783891|NCT00379795|83002827|FG002|Overall Study|Physician Decision|2|||
46783892|NCT00379795|83002828|FG003|Overall Study|Physician Decision|2|||
47076405|NCT01248715|83371025|FG000|Overall Study|Not influenza positive|501|||
47076406|NCT01248715|83371026|FG001|Overall Study|Not influenza positive|510|||
47076407|NCT00812214|83371078|FG000|Overall Study|Lost to Follow-up|3|||
47076408|NCT00812214|83371079|FG001|Overall Study|Lost to Follow-up|1|||
47076409|NCT00217425|83371086|FG000|Overall Study|Never started treatment|2|||
46664468|NCT01058265|82878197|FG001|Overall Study|Lost to Follow-up|12|||
46783893|NCT00379795|83002829|FG004|Overall Study|Physician Decision|2|||
46783894|NCT00379795|83002825|FG000|Overall Study|Withdrawal by Subject|94|||
46783895|NCT00379795|83002826|FG001|Overall Study|Withdrawal by Subject|11|||
46783896|NCT00379795|83002827|FG002|Overall Study|Withdrawal by Subject|19|||
46783897|NCT00379795|83002828|FG003|Overall Study|Withdrawal by Subject|7|||
46783898|NCT00379795|83002829|FG004|Overall Study|Withdrawal by Subject|14|||
47076410|NCT00217425|83371086|FG000|Overall Study|Patient ineligible|5|||
46664469|NCT01057251|82878205|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
46664470|NCT01057251|82878206|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
46664471|NCT01057251|82878205|FG000|Overall Study|Adverse Event|4|||
46664472|NCT01057251|82878206|FG001|Overall Study|Adverse Event|2|||
46664473|NCT01057251|82878205|FG000|Overall Study|Lack of Efficacy|2|||
46664474|NCT01057251|82878206|FG001|Overall Study|Lack of Efficacy|11|||
46664475|NCT01057251|82878205|FG000|Overall Study|Protocol Violation|6|||
46664476|NCT01057251|82878206|FG001|Overall Study|Protocol Violation|2|||
46664477|NCT01057251|82878205|FG000|Overall Study|Withdrawal by Subject|4|||
46664478|NCT01057251|82878206|FG001|Overall Study|Withdrawal by Subject|5|||
46664479|NCT01057251|82878205|FG000|Overall Study|Lost to Follow-up|7|||
46664480|NCT01057251|82878206|FG001|Overall Study|Lost to Follow-up|6|||
46664481|NCT01057251|82878205|FG000|Overall Study|Other Reason|1|||
46664482|NCT01057251|82878206|FG001|Overall Study|Other Reason|1|||
46664483|NCT01056822|82878214|FG000|Overall Study|Adverse Event|0|||
46664484|NCT01056822|82878215|FG001|Overall Study|Adverse Event|1|||
46664485|NCT01056822|82878214|FG000|Overall Study|Protocol Violation|6|||
46664486|NCT01056822|82878215|FG001|Overall Study|Protocol Violation|5|||
46664487|NCT01056822|82878214|FG000|Overall Study|Withdrawal by Subject|1|||
46783899|NCT00379795|83002825|FG000|Overall Study|Subject non-compliance|7|||
46783900|NCT00379795|83002826|FG001|Overall Study|Subject non-compliance|2|||
46783901|NCT00379795|83002827|FG002|Overall Study|Subject non-compliance|0|||
46783902|NCT00379795|83002828|FG003|Overall Study|Subject non-compliance|0|||
46783903|NCT00379795|83002829|FG004|Overall Study|Subject non-compliance|1|||
46783904|NCT00379795|83002825|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
46783905|NCT00379795|83002826|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
46783906|NCT00379795|83002827|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
46783907|NCT00379795|83002828|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
46783908|NCT00379795|83002829|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
46783909|NCT00379795|83002825|FG000|Overall Study|Subjects condition mandated intervention|34|||
46783910|NCT00379795|83002826|FG001|Overall Study|Subjects condition mandated intervention|9|||
46783911|NCT00379795|83002827|FG002|Overall Study|Subjects condition mandated intervention|7|||
46783912|NCT00379795|83002828|FG003|Overall Study|Subjects condition mandated intervention|5|||
46783913|NCT00379795|83002829|FG004|Overall Study|Subjects condition mandated intervention|7|||
46783914|NCT00379795|83002825|FG000|Overall Study|Sponsor's decision|257|||
46783915|NCT00379795|83002826|FG001|Overall Study|Sponsor's decision|17|||
46783916|NCT00379795|83002827|FG002|Overall Study|Sponsor's decision|54|||
46783917|NCT00379795|83002828|FG003|Overall Study|Sponsor's decision|47|||
46783918|NCT00379795|83002829|FG004|Overall Study|Sponsor's decision|10|||
46783919|NCT00610155|83002844|FG000|Period 1|Withdrawal by Subject|0|||
46664488|NCT01056822|82878215|FG001|Overall Study|Withdrawal by Subject|1|||
46664489|NCT01056822|82878214|FG000|Overall Study|Lost to Follow-up|1|||
46664490|NCT01056822|82878215|FG001|Overall Study|Lost to Follow-up|0|||
46664491|NCT01051791|82878222|FG000|Overall Study|Failed screening|3|||
46664492|NCT01051791|82878222|FG000|Overall Study|Withdrawal by Subject|1|||
46783920|NCT00610155|83002845|FG001|Period 1|Withdrawal by Subject|0|||
46783921|NCT00610155|83002846|FG002|Period 1|Withdrawal by Subject|1|||
46783922|NCT00610155|83002847|FG003|Period 1|Withdrawal by Subject|0|||
46783923|NCT00610155|83002848|FG004|Period 1|Withdrawal by Subject|0|||
46783924|NCT00610155|83002849|FG005|Period 1|Withdrawal by Subject|0|||
46783925|NCT00610155|83002844|FG000|Period 3|Adverse Event|1|||
46664493|NCT01056510|82878234|FG000|Overall Study|Dropout Before Start of Treatment|1|||
46664494|NCT01056510|82878235|FG001|Overall Study|Dropout Before Start of Treatment|1|||
46783926|NCT00610155|83002845|FG001|Period 3|Adverse Event|0|||
46783927|NCT00610155|83002846|FG002|Period 3|Adverse Event|0|||
46783928|NCT00610155|83002847|FG003|Period 3|Adverse Event|0|||
46783929|NCT00610155|83002848|FG004|Period 3|Adverse Event|0|||
46783930|NCT00610155|83002849|FG005|Period 3|Adverse Event|0|||
46783931|NCT00674700|83002860|FG000|Year 1|Adverse Event|17|||
46783932|NCT00674700|83002861|FG001|Year 1|Adverse Event|20|||
46783933|NCT00674700|83002862|FG002|Year 1|Adverse Event|5|||
46783934|NCT00674700|83002860|FG000|Year 1|Withdrawal by Subject|7|||
47076411|NCT00217425|83371086|FG000|Overall Study|Lack of Efficacy|13|||
47076412|NCT00217425|83371086|FG000|Overall Study|Adverse Event|8|||
47076413|NCT00217425|83371086|FG000|Overall Study|Withdrawal by Subject|4|||
47076414|NCT00217425|83371086|FG000|Overall Study|Other complicating disease|1|||
47076415|NCT00217425|83371086|FG000|Overall Study|Other|4|||
47076416|NCT03208231|83371105|FG000|Overall Study|Death|1|||
47076417|NCT03208231|83371106|FG001|Overall Study|Death|2|||
46664495|NCT01056510|82878234|FG000|Overall Study|Withdrawal by Subject|4|||
46664496|NCT01056510|82878235|FG001|Overall Study|Withdrawal by Subject|2|||
46664497|NCT01056510|82878234|FG000|Overall Study|Death|29|||
46664498|NCT01056510|82878235|FG001|Overall Study|Death|34|||
46664499|NCT01056510|82878234|FG000|Overall Study|Noncompliance|1|||
46664500|NCT01056510|82878235|FG001|Overall Study|Noncompliance|3|||
46664501|NCT01056510|82878234|FG000|Overall Study|Physician Decision|4|||
46664502|NCT01056510|82878235|FG001|Overall Study|Physician Decision|5|||
46664503|NCT01056510|82878234|FG000|Overall Study|Lost to Follow-up|5|||
46664504|NCT01056510|82878235|FG001|Overall Study|Lost to Follow-up|6|||
46664505|NCT01056510|82878234|FG000|Overall Study|Other|10|||
46664506|NCT01056510|82878235|FG001|Overall Study|Other|12|||
46664507|NCT01056510|82878234|FG000|Overall Study|Missing|0|||
46664508|NCT01056510|82878235|FG001|Overall Study|Missing|1|||
46664509|NCT01051323|82878243|FG000|Overall Study|Discontinuation of treatment|103|||
46664510|NCT01051323|82878243|FG000|Overall Study|Transplantation|28|||
46664511|NCT01051323|82878243|FG000|Overall Study|Dialysis dependency|22|||
46664512|NCT01051323|82878243|FG000|Overall Study|Withdrawal by Subject|13|||
46664513|NCT01051323|82878243|FG000|Overall Study|Lost to Follow-up|31|||
46664514|NCT01051323|82878243|FG000|Overall Study|Death|129|||
46664515|NCT01051323|82878243|FG000|Overall Study|Hospitalization|28|||
46664516|NCT01051323|82878243|FG000|Overall Study|Other|148|||
46664517|NCT01051323|82878243|FG000|Overall Study|Missing|37|||
46664518|NCT01056276|82878253|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
46664519|NCT01056276|82878254|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
46664520|NCT01056276|82878253|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
46664521|NCT01056276|82878254|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
46664522|NCT01056276|82878253|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
46664523|NCT01056276|82878254|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
46664524|NCT01056276|82878253|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
46972278|NCT02030002|83215886|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
46972279|NCT02030002|83215886|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
46972280|NCT02030002|83215886|FG000|Follow-up|Lost to Follow-up|2|||
46972281|NCT02079610|83215894|FG000|Overall Study|Withdrawal by Subject|1|||
46972282|NCT02079610|83215895|FG001|Overall Study|Withdrawal by Subject|1|||
46972283|NCT02079532|83215901|FG000|Overall Study|Adverse Event|7|||
46972284|NCT02079532|83215901|FG000|Overall Study|Additional or changed therapy|2|||
46664525|NCT01056276|82878254|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
46664526|NCT01056276|82878253|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
46664527|NCT01056276|82878254|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
46664528|NCT01056276|82878253|FG000|Treatment Period-Cycles 1-8|Death|3|||
46664529|NCT01056276|82878254|FG001|Treatment Period-Cycles 1-8|Death|1|||
46664530|NCT01056276|82878253|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
46664531|NCT01056276|82878254|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
46664532|NCT01056276|82878253|FG000|Maintenance Therapy|Toxicity|0|||
46664533|NCT01056276|82878254|FG001|Maintenance Therapy|Toxicity|2|||
46664534|NCT01056276|82878253|FG000|Maintenance Therapy|Progressive Disease|0|||
46664535|NCT01056276|82878254|FG001|Maintenance Therapy|Progressive Disease|9|||
46664536|NCT01056276|82878253|FG000|Maintenance Therapy|Physician Decision|0|||
46664537|NCT01056276|82878254|FG001|Maintenance Therapy|Physician Decision|1|||
47076418|NCT03208231|83371105|FG000|Overall Study|Moved and unable to get to clinic|1|||
47076419|NCT03208231|83371106|FG001|Overall Study|Moved and unable to get to clinic|0|||
46664538|NCT01056276|82878253|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
47076420|NCT03208231|83371105|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
46664539|NCT01056276|82878254|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
46664540|NCT01056276|82878253|FG000|Maintenance Therapy|Intercurrent Illness|0|||
46664541|NCT01056276|82878254|FG001|Maintenance Therapy|Intercurrent Illness|1|||
46664542|NCT01056276|82878253|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
46664543|NCT01056276|82878254|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
46664544|NCT01055886|82878267|FG000|Overall Study|Withdrawal by Subject|4|||
46664545|NCT01055886|82878268|FG001|Overall Study|Withdrawal by Subject|9|||
46664546|NCT01055886|82878267|FG000|Overall Study|Lost to Follow-up|1|||
46664547|NCT01055886|82878268|FG001|Overall Study|Lost to Follow-up|1|||
46664548|NCT01055886|82878267|FG000|Overall Study|Withdrawal by PI|0|||
46664549|NCT01055886|82878268|FG001|Overall Study|Withdrawal by PI|1|||
46664550|NCT01055613|82878276|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
46664551|NCT01055613|82878277|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46664552|NCT01055613|82878276|FG000|Overall Study|Unacceptable lens fit|1|||
46664553|NCT01055613|82878277|FG001|Overall Study|Unacceptable lens fit|0|||
46664554|NCT01055613|82878276|FG000|Overall Study|Discomfort|2|||
46664555|NCT01055613|82878277|FG001|Overall Study|Discomfort|1|||
46664556|NCT01055613|82878276|FG000|Overall Study|Lost to Follow-up|1|||
46664557|NCT01055613|82878277|FG001|Overall Study|Lost to Follow-up|1|||
46664558|NCT01055613|82878276|FG000|Overall Study|Protocol Violation|1|||
46664559|NCT01055613|82878277|FG001|Overall Study|Protocol Violation|1|||
46664560|NCT01055613|82878276|FG000|Overall Study|Subject Disinterest|1|||
46664561|NCT01055613|82878277|FG001|Overall Study|Subject Disinterest|1|||
46664562|NCT01055457|82878293|FG000|Overall Study|Lost to Follow-up|0|||
46664563|NCT01055457|82878294|FG001|Overall Study|Lost to Follow-up|1|||
46664564|NCT01055457|82878295|FG002|Overall Study|Lost to Follow-up|0|||
46664565|NCT01055457|82878296|FG003|Overall Study|Lost to Follow-up|0|||
46664566|NCT01055457|82878297|FG004|Overall Study|Lost to Follow-up|0|||
46664567|NCT01055457|82878298|FG005|Overall Study|Lost to Follow-up|1|||
46664568|NCT01055457|82878299|FG006|Overall Study|Lost to Follow-up|0|||
46664569|NCT01055457|82878300|FG007|Overall Study|Lost to Follow-up|0|||
46664570|NCT01055457|82878301|FG008|Overall Study|Lost to Follow-up|0|||
46664571|NCT01055457|82878302|FG009|Overall Study|Lost to Follow-up|0|||
46664572|NCT01055457|82878293|FG000|Overall Study|Protocol Violation|0|||
46664573|NCT01055457|82878294|FG001|Overall Study|Protocol Violation|0|||
46664574|NCT01055457|82878295|FG002|Overall Study|Protocol Violation|1|||
46664575|NCT01055457|82878296|FG003|Overall Study|Protocol Violation|1|||
46664576|NCT01055457|82878297|FG004|Overall Study|Protocol Violation|1|||
46664577|NCT01055457|82878298|FG005|Overall Study|Protocol Violation|2|||
46664578|NCT01055457|82878299|FG006|Overall Study|Protocol Violation|1|||
46664579|NCT01055457|82878300|FG007|Overall Study|Protocol Violation|0|||
46664580|NCT01055457|82878301|FG008|Overall Study|Protocol Violation|0|||
46664581|NCT01055457|82878302|FG009|Overall Study|Protocol Violation|1|||
46664582|NCT01055457|82878293|FG000|Overall Study|Subject Disinterest|0|||
46664583|NCT01055457|82878294|FG001|Overall Study|Subject Disinterest|0|||
46783935|NCT00674700|83002861|FG001|Year 1|Withdrawal by Subject|7|||
46783936|NCT00674700|83002862|FG002|Year 1|Withdrawal by Subject|6|||
46783937|NCT00674700|83002860|FG000|Year 1|Any other reason not above-mentioned|7|||
46783938|NCT00674700|83002861|FG001|Year 1|Any other reason not above-mentioned|7|||
46783939|NCT00674700|83002862|FG002|Year 1|Any other reason not above-mentioned|6|||
46664584|NCT01055457|82878295|FG002|Overall Study|Subject Disinterest|0|||
46664585|NCT01055457|82878296|FG003|Overall Study|Subject Disinterest|0|||
46664586|NCT01055457|82878297|FG004|Overall Study|Subject Disinterest|0|||
46664587|NCT01055457|82878298|FG005|Overall Study|Subject Disinterest|0|||
46664588|NCT01055457|82878299|FG006|Overall Study|Subject Disinterest|0|||
46664589|NCT01055457|82878300|FG007|Overall Study|Subject Disinterest|1|||
46664590|NCT01055457|82878301|FG008|Overall Study|Subject Disinterest|0|||
46664591|NCT01055457|82878302|FG009|Overall Study|Subject Disinterest|0|||
46664592|NCT01055457|82878293|FG000|Overall Study|Subject Ineligible|1|||
46664593|NCT01055457|82878294|FG001|Overall Study|Subject Ineligible|0|||
46664594|NCT01055457|82878295|FG002|Overall Study|Subject Ineligible|1|||
46664595|NCT01055457|82878296|FG003|Overall Study|Subject Ineligible|0|||
46664596|NCT01055457|82878297|FG004|Overall Study|Subject Ineligible|1|||
46664597|NCT01055457|82878298|FG005|Overall Study|Subject Ineligible|0|||
46664598|NCT01055457|82878299|FG006|Overall Study|Subject Ineligible|0|||
46664599|NCT01055457|82878300|FG007|Overall Study|Subject Ineligible|0|||
46783940|NCT00674700|83002860|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
46783941|NCT00674700|83002861|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
46783942|NCT00674700|83002862|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
46664600|NCT01055457|82878301|FG008|Overall Study|Subject Ineligible|0|||
46664601|NCT01055457|82878302|FG009|Overall Study|Subject Ineligible|0|||
46783943|NCT00674700|83002860|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
46664602|NCT01055457|82878293|FG000|Overall Study|Discomfort|0|||
46664603|NCT01055457|82878294|FG001|Overall Study|Discomfort|0|||
46664604|NCT01055457|82878295|FG002|Overall Study|Discomfort|0|||
46664605|NCT01055457|82878296|FG003|Overall Study|Discomfort|0|||
46664606|NCT01055457|82878297|FG004|Overall Study|Discomfort|1|||
46664607|NCT01055457|82878298|FG005|Overall Study|Discomfort|0|||
46664608|NCT01055457|82878299|FG006|Overall Study|Discomfort|0|||
46664609|NCT01055457|82878300|FG007|Overall Study|Discomfort|0|||
46664610|NCT01055457|82878301|FG008|Overall Study|Discomfort|0|||
46664611|NCT01055457|82878302|FG009|Overall Study|Discomfort|0|||
46664612|NCT01055457|82878293|FG000|Overall Study|Pregnancy|0|||
46664613|NCT01055457|82878294|FG001|Overall Study|Pregnancy|0|||
46664614|NCT01055457|82878295|FG002|Overall Study|Pregnancy|0|||
46664615|NCT01055457|82878296|FG003|Overall Study|Pregnancy|1|||
46664616|NCT01055457|82878297|FG004|Overall Study|Pregnancy|0|||
46664617|NCT01055457|82878298|FG005|Overall Study|Pregnancy|0|||
46664618|NCT01055457|82878299|FG006|Overall Study|Pregnancy|0|||
46664619|NCT01055457|82878300|FG007|Overall Study|Pregnancy|0|||
46664620|NCT01055457|82878301|FG008|Overall Study|Pregnancy|0|||
46664621|NCT01055457|82878302|FG009|Overall Study|Pregnancy|0|||
46664622|NCT01055457|82878293|FG000|Overall Study|Adverse Event|0|||
46664623|NCT01055457|82878294|FG001|Overall Study|Adverse Event|0|||
46664624|NCT01055457|82878295|FG002|Overall Study|Adverse Event|0|||
46664625|NCT01055457|82878296|FG003|Overall Study|Adverse Event|1|||
46664626|NCT01055457|82878297|FG004|Overall Study|Adverse Event|0|||
46664627|NCT01055457|82878298|FG005|Overall Study|Adverse Event|0|||
46664628|NCT01055457|82878299|FG006|Overall Study|Adverse Event|0|||
46664629|NCT01055457|82878300|FG007|Overall Study|Adverse Event|0|||
46664630|NCT01055457|82878301|FG008|Overall Study|Adverse Event|0|||
46664631|NCT01055457|82878302|FG009|Overall Study|Adverse Event|0|||
46664632|NCT01055028|82878326|FG000|Screening|Screen Failure|1|||
46664633|NCT01055028|82878327|FG001|Screening|Screen Failure|1|||
46664634|NCT01055028|82878326|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
46664635|NCT01055028|82878327|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
46664636|NCT01055028|82878326|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
46664637|NCT01055028|82878327|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
46664638|NCT01055028|82878326|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
46664639|NCT01055028|82878327|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
46664640|NCT01050816|82878359|FG000|Overall Study|Lost to Follow-up|2|||
46664641|NCT01050816|82878359|FG000|Overall Study|patient's refusal|2|||
46664642|NCT01054560|82878365|FG000|Overall Study|Death|10|||
46664643|NCT01054560|82878366|FG001|Overall Study|Death|21|||
46664644|NCT01054560|82878365|FG000|Overall Study|Lost to Follow-up|2|||
46664645|NCT01054560|82878366|FG001|Overall Study|Lost to Follow-up|5|||
46664646|NCT01054560|82878365|FG000|Overall Study|Withdrawal by Subject|0|||
46664647|NCT01054560|82878366|FG001|Overall Study|Withdrawal by Subject|2|||
46664648|NCT01054560|82878365|FG000|Overall Study|Physician Decision|1|||
46664649|NCT01054560|82878366|FG001|Overall Study|Physician Decision|0|||
46664650|NCT01054443|82878378|FG000|Overall Study|Withdrawal by Subject|0|||
46664651|NCT01054443|82878379|FG001|Overall Study|Withdrawal by Subject|0|||
46664652|NCT01054443|82878380|FG002|Overall Study|Withdrawal by Subject|0|||
46783944|NCT00674700|83002861|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
46783945|NCT00674700|83002862|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
46783946|NCT00674700|83002860|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
46783947|NCT00674700|83002861|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
46664653|NCT01054443|82878381|FG003|Overall Study|Withdrawal by Subject|1|||
46664654|NCT01050543|82878396|FG000|Overall Study|Withdrawal by Subject|0|||
46664655|NCT01050543|82878397|FG001|Overall Study|Withdrawal by Subject|2|||
46664656|NCT01050543|82878396|FG000|Overall Study|Protocol Violation|0|||
46664657|NCT01050543|82878397|FG001|Overall Study|Protocol Violation|1|||
46664658|NCT01050543|82878396|FG000|Overall Study|Administrative|4|||
46664659|NCT01050543|82878397|FG001|Overall Study|Administrative|1|||
46664660|NCT01051557|82878410|FG000|Overall Study|Physician Decision|1|||
46664661|NCT01051557|82878411|FG001|Overall Study|Physician Decision|0|||
46664662|NCT01051557|82878412|FG002|Overall Study|Physician Decision|0|||
46664663|NCT01051557|82878413|FG003|Overall Study|Physician Decision|0|||
46664664|NCT01051557|82878414|FG004|Overall Study|Physician Decision|0|||
46664665|NCT01051557|82878415|FG005|Overall Study|Physician Decision|0|||
46664666|NCT01051557|82878416|FG006|Overall Study|Physician Decision|0|||
46664667|NCT01051557|82878410|FG000|Overall Study|disease progression|3|||
46783948|NCT00674700|83002862|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
46783949|NCT00546910|83002872|FG000|Overall Study|Adverse Event|2|||
46783950|NCT00546910|83002873|FG001|Overall Study|Adverse Event|3|||
46783951|NCT00546910|83002872|FG000|Overall Study|Lack of Efficacy|5|||
46783952|NCT00546910|83002873|FG001|Overall Study|Lack of Efficacy|7|||
46664668|NCT01051557|82878411|FG001|Overall Study|disease progression|3|||
46664669|NCT01051557|82878412|FG002|Overall Study|disease progression|5|||
46664670|NCT01051557|82878413|FG003|Overall Study|disease progression|2|||
46664671|NCT01051557|82878414|FG004|Overall Study|disease progression|4|||
46664672|NCT01051557|82878415|FG005|Overall Study|disease progression|3|||
46783953|NCT00546910|83002872|FG000|Overall Study|Physician Decision|0|||
46664673|NCT01051557|82878416|FG006|Overall Study|disease progression|1|||
46664674|NCT01051557|82878410|FG000|Overall Study|Withdrawal by Subject|0|||
46664675|NCT01051557|82878411|FG001|Overall Study|Withdrawal by Subject|0|||
46664676|NCT01051557|82878412|FG002|Overall Study|Withdrawal by Subject|1|||
46664677|NCT01051557|82878413|FG003|Overall Study|Withdrawal by Subject|0|||
46664678|NCT01051557|82878414|FG004|Overall Study|Withdrawal by Subject|2|||
46664679|NCT01051557|82878415|FG005|Overall Study|Withdrawal by Subject|0|||
46664680|NCT01051557|82878416|FG006|Overall Study|Withdrawal by Subject|1|||
46783954|NCT00546910|83002873|FG001|Overall Study|Physician Decision|1|||
46783955|NCT00546910|83002872|FG000|Overall Study|Withdrawal by Subject|2|||
46783956|NCT00546910|83002873|FG001|Overall Study|Withdrawal by Subject|0|||
46783957|NCT00379639|83002884|FG000|Overall Study|Disease Progression|3|||
46783958|NCT00379639|83002885|FG001|Overall Study|Disease Progression|3|||
46783959|NCT00379639|83002886|FG002|Overall Study|Disease Progression|3|||
46783960|NCT00379639|83002887|FG003|Overall Study|Disease Progression|4|||
46783961|NCT00379639|83002888|FG004|Overall Study|Disease Progression|4|||
46783962|NCT00379639|83002884|FG000|Overall Study|Physician Decision|0|||
46783963|NCT00379639|83002885|FG001|Overall Study|Physician Decision|2|||
46783964|NCT00379639|83002886|FG002|Overall Study|Physician Decision|1|||
46783965|NCT00379639|83002887|FG003|Overall Study|Physician Decision|1|||
46851176|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
46851177|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
46851178|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
46851179|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
46851180|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
46972285|NCT02079532|83215901|FG000|Overall Study|Lack of Efficacy|9|||
46972286|NCT02079532|83215901|FG000|Overall Study|Protocol Violation|3|||
46664681|NCT01051557|82878410|FG000|Overall Study|Adverse Event|0|||
46664682|NCT01051557|82878411|FG001|Overall Study|Adverse Event|0|||
46664683|NCT01051557|82878412|FG002|Overall Study|Adverse Event|0|||
46664684|NCT01051557|82878413|FG003|Overall Study|Adverse Event|1|||
46664685|NCT01051557|82878414|FG004|Overall Study|Adverse Event|1|||
46664686|NCT01051557|82878415|FG005|Overall Study|Adverse Event|3|||
46664687|NCT01051557|82878416|FG006|Overall Study|Adverse Event|4|||
46783966|NCT00379639|83002888|FG004|Overall Study|Physician Decision|0|||
46783967|NCT00379639|83002884|FG000|Overall Study|Symptomatic Deterioration|0|||
46783968|NCT00379639|83002885|FG001|Overall Study|Symptomatic Deterioration|0|||
46783969|NCT00379639|83002886|FG002|Overall Study|Symptomatic Deterioration|1|||
46783970|NCT00379639|83002887|FG003|Overall Study|Symptomatic Deterioration|0|||
46783971|NCT00379639|83002888|FG004|Overall Study|Symptomatic Deterioration|1|||
46783972|NCT00379639|83002884|FG000|Overall Study|Adverse Event|0|||
46783973|NCT00379639|83002885|FG001|Overall Study|Adverse Event|0|||
46783974|NCT00379639|83002886|FG002|Overall Study|Adverse Event|1|||
46783975|NCT00379639|83002887|FG003|Overall Study|Adverse Event|0|||
46783976|NCT00379639|83002888|FG004|Overall Study|Adverse Event|1|||
46783977|NCT00379639|83002884|FG000|Overall Study|Lost to Follow-up|0|||
46783978|NCT00379639|83002885|FG001|Overall Study|Lost to Follow-up|0|||
46783979|NCT00379639|83002886|FG002|Overall Study|Lost to Follow-up|0|||
46783980|NCT00379639|83002887|FG003|Overall Study|Lost to Follow-up|1|||
46783981|NCT00379639|83002888|FG004|Overall Study|Lost to Follow-up|0|||
46783982|NCT00379639|83002884|FG000|Overall Study|Other|0|||
46783983|NCT00379639|83002885|FG001|Overall Study|Other|0|||
46783984|NCT00379639|83002886|FG002|Overall Study|Other|3|||
46783985|NCT00379639|83002887|FG003|Overall Study|Other|0|||
46664688|NCT01054170|82878435|FG000|Overall Study|Protocol Violation|1|||
46664689|NCT01054170|82878436|FG001|Overall Study|Protocol Violation|0|||
46664690|NCT01054170|82878435|FG000|Overall Study|Withdrawal by Subject|3|||
46664691|NCT01054170|82878436|FG001|Overall Study|Withdrawal by Subject|2|||
46664692|NCT01054170|82878435|FG000|Overall Study|Adverse Event|0|||
46664693|NCT01054170|82878436|FG001|Overall Study|Adverse Event|4|||
46664694|NCT01053741|82878444|FG000|2nd Study Intervention|Physician Decision|0|||
46664695|NCT01053741|82878445|FG001|2nd Study Intervention|Physician Decision|1|||
46664696|NCT01052493|82878451|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
46664697|NCT01052493|82878452|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
46783986|NCT00379639|83002888|FG004|Overall Study|Other|0|||
46783987|NCT03948334|83002902|FG000|Overall Study|Adverse Event|1|||
46783988|NCT03948334|83002903|FG001|Overall Study|Adverse Event|4|||
46972287|NCT02079532|83215901|FG000|Overall Study|Withdrawal by Subject|1|||
46783989|NCT03948334|83002902|FG000|Overall Study|Lack of Efficacy|2|||
46783990|NCT03948334|83002903|FG001|Overall Study|Lack of Efficacy|0|||
46783991|NCT03948334|83002902|FG000|Overall Study|Lost to Follow-up|1|||
46783992|NCT03948334|83002903|FG001|Overall Study|Lost to Follow-up|0|||
46783993|NCT03948334|83002902|FG000|Overall Study|Physician Decision|1|||
46783994|NCT03948334|83002903|FG001|Overall Study|Physician Decision|0|||
46783995|NCT03948334|83002902|FG000|Overall Study|Pregnancy|0|||
46783996|NCT03948334|83002903|FG001|Overall Study|Pregnancy|1|||
46783997|NCT03948334|83002902|FG000|Overall Study|Protocol Deviation|1|||
46851181|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
46664698|NCT01052493|82878453|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
46664699|NCT01052103|82878468|FG000|Overall Study|Adverse Event|10|||
46783998|NCT03948334|83002903|FG001|Overall Study|Protocol Deviation|0|||
46783999|NCT03948334|83002902|FG000|Overall Study|Study terminated by Sponsor|50|||
46784000|NCT03948334|83002903|FG001|Overall Study|Study terminated by Sponsor|51|||
46664700|NCT01052103|82878469|FG001|Overall Study|Adverse Event|6|||
46664701|NCT01052103|82878468|FG000|Overall Study|Entry Criteria Not Met|3|||
46664702|NCT01052103|82878469|FG001|Overall Study|Entry Criteria Not Met|1|||
46664703|NCT01052103|82878468|FG000|Overall Study|Lost to Follow-up|3|||
46664704|NCT01052103|82878469|FG001|Overall Study|Lost to Follow-up|5|||
46664705|NCT01052103|82878468|FG000|Overall Study|Protocol Violation|10|||
46664706|NCT01052103|82878469|FG001|Overall Study|Protocol Violation|4|||
46664707|NCT01052103|82878468|FG000|Overall Study|Scheduling conflict|2|||
46664708|NCT01052103|82878469|FG001|Overall Study|Scheduling conflict|1|||
46664709|NCT01052103|82878468|FG000|Overall Study|Sponsor Decision|2|||
46664710|NCT01052103|82878469|FG001|Overall Study|Sponsor Decision|0|||
46664711|NCT01052103|82878468|FG000|Overall Study|Withdrawal by Subject|3|||
46664712|NCT01052103|82878469|FG001|Overall Study|Withdrawal by Subject|6|||
46664713|NCT01052103|82878468|FG000|Overall Study|Perceived Lack of Efficacy|1|||
46664714|NCT01052103|82878469|FG001|Overall Study|Perceived Lack of Efficacy|0|||
46664715|NCT01051986|82878478|FG000|Overall Study|Death|1|||
46664716|NCT01051986|82878479|FG001|Overall Study|Death|0|||
46664717|NCT01051986|82878478|FG000|Overall Study|Withdrawal by Subject|2|||
46664718|NCT01051986|82878479|FG001|Overall Study|Withdrawal by Subject|1|||
46664719|NCT01051986|82878478|FG000|Overall Study|Protocol Violation|2|||
46664720|NCT01051986|82878479|FG001|Overall Study|Protocol Violation|3|||
46664721|NCT03279978|82878495|FG000|Overall Study|Withdrawal by Subject|0|||
46664722|NCT03279978|82878496|FG001|Overall Study|Withdrawal by Subject|1|||
46664723|NCT03279978|82878497|FG002|Overall Study|Withdrawal by Subject|0|||
46664724|NCT03279978|82878498|FG003|Overall Study|Withdrawal by Subject|0|||
46664725|NCT03279978|82878499|FG004|Overall Study|Withdrawal by Subject|0|||
46664726|NCT03279978|82878500|FG005|Overall Study|Withdrawal by Subject|0|||
46664727|NCT03279978|82878501|FG006|Overall Study|Withdrawal by Subject|0|||
46664728|NCT03279978|82878502|FG007|Overall Study|Withdrawal by Subject|0|||
46664729|NCT03279978|82878503|FG008|Overall Study|Withdrawal by Subject|0|||
46664730|NCT03279978|82878504|FG009|Overall Study|Withdrawal by Subject|1|||
46664731|NCT03279978|82878495|FG000|Overall Study|Lost to Follow-up|1|||
46664732|NCT03279978|82878496|FG001|Overall Study|Lost to Follow-up|0|||
46664733|NCT03279978|82878497|FG002|Overall Study|Lost to Follow-up|1|||
46664734|NCT03279978|82878498|FG003|Overall Study|Lost to Follow-up|0|||
46664735|NCT03279978|82878499|FG004|Overall Study|Lost to Follow-up|0|||
46664736|NCT03279978|82878500|FG005|Overall Study|Lost to Follow-up|0|||
46664737|NCT03279978|82878501|FG006|Overall Study|Lost to Follow-up|0|||
46664738|NCT03279978|82878502|FG007|Overall Study|Lost to Follow-up|0|||
46664739|NCT03279978|82878503|FG008|Overall Study|Lost to Follow-up|0|||
46664740|NCT03279978|82878504|FG009|Overall Study|Lost to Follow-up|0|||
46664741|NCT03279978|82878495|FG000|Overall Study|Other than stated above|0|||
46664742|NCT03279978|82878496|FG001|Overall Study|Other than stated above|0|||
46664743|NCT03279978|82878497|FG002|Overall Study|Other than stated above|0|||
46664744|NCT03279978|82878498|FG003|Overall Study|Other than stated above|0|||
46664745|NCT03279978|82878499|FG004|Overall Study|Other than stated above|0|||
46664746|NCT03279978|82878500|FG005|Overall Study|Other than stated above|0|||
46664747|NCT03279978|82878501|FG006|Overall Study|Other than stated above|1|||
46664748|NCT03279978|82878502|FG007|Overall Study|Other than stated above|0|||
46664749|NCT03279978|82878503|FG008|Overall Study|Other than stated above|0|||
46664750|NCT03279978|82878504|FG009|Overall Study|Other than stated above|0|||
46664751|NCT00105534|82878537|FG000|Overall Study|Adverse Event|2|||
46784001|NCT03948334|83002902|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
46784002|NCT03948334|83002903|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
46784003|NCT00609765|83002917|FG000|Overall Study|Study ended prior to 12 months|1|||
46784004|NCT00608829|83002921|FG000|Overall Study|Death|6|||
46784005|NCT00608829|83002921|FG000|Overall Study|Withdrawal by Subject|4|||
46784006|NCT00608829|83002921|FG000|Overall Study|Subject refuses to follow up or return.|5|||
46784007|NCT00545818|83002927|FG000|Overall Study|Protocol Violation|1|||
46784008|NCT00545818|83002928|FG001|Overall Study|Protocol Violation|0|||
46784009|NCT00545818|83002927|FG000|Overall Study|Adverse Event|1|||
46784010|NCT00545818|83002928|FG001|Overall Study|Adverse Event|1|||
46784011|NCT00545818|83002927|FG000|Overall Study|Lost to Follow-up|1|||
46784012|NCT00545818|83002928|FG001|Overall Study|Lost to Follow-up|6|||
46784013|NCT00674154|83002936|FG000|Overall Study|Withdrawal by Subject|3|||
46784014|NCT00674154|83002937|FG001|Overall Study|Withdrawal by Subject|1|||
46784015|NCT00674154|83002936|FG000|Overall Study|Did not want parathyroidectomy|0|||
46784016|NCT00674154|83002937|FG001|Overall Study|Did not want parathyroidectomy|2|||
46784017|NCT00608517|83002946|FG000|Overall Study|Death|1|||
46664752|NCT00105534|82878538|FG001|Overall Study|Adverse Event|5|||
46664753|NCT00105534|82878537|FG000|Overall Study|Protocol Violation|1|||
46664754|NCT00105534|82878538|FG001|Overall Study|Protocol Violation|4|||
46664755|NCT00105534|82878537|FG000|Overall Study|Withdrawal by Subject|6|||
46664756|NCT00105534|82878538|FG001|Overall Study|Withdrawal by Subject|6|||
46664757|NCT00105534|82878537|FG000|Overall Study|Lost to Follow-up|5|||
46664758|NCT00105534|82878538|FG001|Overall Study|Lost to Follow-up|1|||
46664759|NCT00105534|82878537|FG000|Overall Study|Lack of Efficacy|7|||
46664760|NCT00105534|82878538|FG001|Overall Study|Lack of Efficacy|15|||
46664761|NCT00105534|82878537|FG000|Overall Study|Treatment unmasked|1|||
46664762|NCT00105534|82878538|FG001|Overall Study|Treatment unmasked|0|||
46664763|NCT00105534|82878537|FG000|Overall Study|Other Reason|0|||
46664764|NCT00105534|82878538|FG001|Overall Study|Other Reason|2|||
46664765|NCT00105183|82878547|FG000|Overall Study|Death|19|||
46664766|NCT00105183|82878548|FG001|Overall Study|Death|13|||
46664767|NCT00105183|82878549|FG002|Overall Study|Death|15|||
46664768|NCT00105183|82878547|FG000|Overall Study|Withdrawal by Subject|1|||
46664769|NCT00105183|82878548|FG001|Overall Study|Withdrawal by Subject|1|||
46664770|NCT00105183|82878549|FG002|Overall Study|Withdrawal by Subject|4|||
46664771|NCT00105183|82878547|FG000|Overall Study|Physician Decision|1|||
46664772|NCT00105183|82878548|FG001|Overall Study|Physician Decision|2|||
46664773|NCT00105183|82878549|FG002|Overall Study|Physician Decision|3|||
46664774|NCT00105183|82878547|FG000|Overall Study|Lost to Follow-up|0|||
46664775|NCT00105183|82878548|FG001|Overall Study|Lost to Follow-up|1|||
46664776|NCT00105183|82878549|FG002|Overall Study|Lost to Follow-up|1|||
46664777|NCT00105183|82878547|FG000|Overall Study|Other reason|1|||
46664778|NCT00105183|82878548|FG001|Overall Study|Other reason|2|||
46664779|NCT00105183|82878549|FG002|Overall Study|Other reason|0|||
46664780|NCT01059617|82878561|FG000|Overall Study|Other|7|||
46664781|NCT01059617|82878562|FG001|Overall Study|Other|1|||
46664782|NCT01059617|82878563|FG002|Overall Study|Other|8|||
46664783|NCT01059617|82878564|FG003|Overall Study|Other|6|||
46664784|NCT01059344|82878584|FG000|Overall Study|Adverse Event|12|||
46664785|NCT01059344|82878585|FG001|Overall Study|Adverse Event|30|||
46664786|NCT01059344|82878584|FG000|Overall Study|Withdrawal by Subject|6|||
46664787|NCT01059344|82878585|FG001|Overall Study|Withdrawal by Subject|9|||
46664788|NCT01059344|82878584|FG000|Overall Study|Lost to Follow-up|1|||
46664789|NCT01059344|82878585|FG001|Overall Study|Lost to Follow-up|1|||
46664790|NCT01059344|82878584|FG000|Overall Study|Other|3|||
46664791|NCT01059344|82878585|FG001|Overall Study|Other|6|||
46664792|NCT01058369|82878593|FG000|Overall Study|Adverse Event|1|||
46664793|NCT01058369|82878593|FG000|Overall Study|Early termination study|1|||
46664794|NCT01057433|82878597|FG000|Overall Study|Adverse Event|1|||
46664795|NCT01057394|82878601|FG000|Overall Study|Not eligible|0|||
46664796|NCT01057394|82878602|FG001|Overall Study|Not eligible|2|||
46664797|NCT01058642|82878610|FG000|Treatment Period 1|Adverse Event|0|||
46664798|NCT01058642|82878611|FG001|Treatment Period 1|Adverse Event|1|||
46664799|NCT01058642|82878612|FG002|Treatment Period 1|Adverse Event|1|||
46664800|NCT01058642|82878613|FG003|Treatment Period 1|Adverse Event|0|||
46784018|NCT00608517|83002947|FG001|Overall Study|Death|0|||
46784019|NCT00608517|83002948|FG002|Overall Study|Death|0|||
46784020|NCT00608205|83002959|FG000|Overall Study|Adverse Event|3|||
46784021|NCT00608205|83002960|FG001|Overall Study|Adverse Event|2|||
46784022|NCT00608205|83002959|FG000|Overall Study|Patient non-compliant|0|||
46784023|NCT00608205|83002960|FG001|Overall Study|Patient non-compliant|1|||
46784024|NCT00670800|83002970|FG000|Overall Study|2 controls were insulin resistant|0|||
46784025|NCT00670800|83002971|FG001|Overall Study|2 controls were insulin resistant|2|||
46784026|NCT00607893|83002981|FG000|Overall Study|Lost to Follow-up|4|||
46784027|NCT00607893|83002982|FG001|Overall Study|Lost to Follow-up|0|||
46784028|NCT00607893|83002981|FG000|Overall Study|withdrew due to loss of interest|0|||
46784029|NCT00607893|83002982|FG001|Overall Study|withdrew due to loss of interest|1|||
46784030|NCT00607893|83002981|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
46784031|NCT00607893|83002982|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
46784032|NCT00607893|83002981|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
46784033|NCT00607893|83002982|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
46784034|NCT00607893|83002981|FG000|Overall Study|Declined to be treated|1|||
46784035|NCT00607893|83002982|FG001|Overall Study|Declined to be treated|0|||
46784036|NCT00607893|83002981|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
46784037|NCT00607893|83002982|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
46784038|NCT00571038|83002992|FG000|Overall Study|Lost to Follow-up|1|||
46784039|NCT00571038|83002993|FG001|Overall Study|Lost to Follow-up|4|||
46784040|NCT00571038|83002992|FG000|Overall Study|Death|7|||
46664801|NCT01058642|82878610|FG000|Treatment Period 1|Physician Decision|0|||
46664802|NCT01058642|82878611|FG001|Treatment Period 1|Physician Decision|0|||
46784041|NCT00571038|83002993|FG001|Overall Study|Death|5|||
46664803|NCT01058642|82878612|FG002|Treatment Period 1|Physician Decision|1|||
46664804|NCT01058642|82878613|FG003|Treatment Period 1|Physician Decision|0|||
46664805|NCT01058642|82878610|FG000|Treatment Period 1|Withdrawal by Subject|1|||
46784042|NCT00571038|83002992|FG000|Overall Study|Withdrawal by Subject|1|||
46784043|NCT00571038|83002993|FG001|Overall Study|Withdrawal by Subject|3|||
46784044|NCT00571038|83002992|FG000|Overall Study|Moved out of state|2|||
46784045|NCT00571038|83002993|FG001|Overall Study|Moved out of state|2|||
46784046|NCT00545740|83003003|FG000|Overall Study|Lack of Efficacy|34|||
46784047|NCT00545740|83003004|FG001|Overall Study|Lack of Efficacy|35|||
46664806|NCT01058642|82878611|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46664807|NCT01058642|82878612|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46664808|NCT01058642|82878613|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46784048|NCT00545740|83003005|FG002|Overall Study|Lack of Efficacy|47|||
46784049|NCT00545740|83003006|FG003|Overall Study|Lack of Efficacy|36|||
46784050|NCT00545740|83003003|FG000|Overall Study|Withdrawal by Subject|17|||
46784051|NCT00545740|83003004|FG001|Overall Study|Withdrawal by Subject|15|||
46784052|NCT00545740|83003005|FG002|Overall Study|Withdrawal by Subject|16|||
46784053|NCT00545740|83003006|FG003|Overall Study|Withdrawal by Subject|18|||
46784054|NCT00545740|83003003|FG000|Overall Study|Adverse Event|10|||
46784055|NCT00545740|83003004|FG001|Overall Study|Adverse Event|18|||
46784056|NCT00545740|83003005|FG002|Overall Study|Adverse Event|19|||
46784057|NCT00545740|83003006|FG003|Overall Study|Adverse Event|9|||
46784058|NCT00545740|83003003|FG000|Overall Study|Lost to Follow-up|7|||
46784059|NCT00545740|83003004|FG001|Overall Study|Lost to Follow-up|5|||
46784060|NCT00545740|83003005|FG002|Overall Study|Lost to Follow-up|5|||
46784061|NCT00545740|83003006|FG003|Overall Study|Lost to Follow-up|6|||
46784062|NCT00545740|83003003|FG000|Overall Study|Protocol Violation|1|||
47076421|NCT03208231|83371106|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
46784063|NCT00545740|83003004|FG001|Overall Study|Protocol Violation|3|||
46784064|NCT00545740|83003005|FG002|Overall Study|Protocol Violation|1|||
46784065|NCT00545740|83003006|FG003|Overall Study|Protocol Violation|0|||
46784066|NCT00545740|83003003|FG000|Overall Study|Non-compliance|0|||
46784067|NCT00545740|83003004|FG001|Overall Study|Non-compliance|2|||
46784068|NCT00545740|83003005|FG002|Overall Study|Non-compliance|1|||
46784069|NCT00545740|83003006|FG003|Overall Study|Non-compliance|0|||
46784070|NCT00545740|83003003|FG000|Overall Study|Moved|2|||
46784071|NCT00545740|83003004|FG001|Overall Study|Moved|0|||
46784072|NCT00545740|83003005|FG002|Overall Study|Moved|1|||
46784073|NCT00545740|83003006|FG003|Overall Study|Moved|0|||
46784074|NCT00545740|83003003|FG000|Overall Study|Diverticulitis attack|0|||
46784075|NCT00545740|83003004|FG001|Overall Study|Diverticulitis attack|0|||
46784076|NCT00545740|83003005|FG002|Overall Study|Diverticulitis attack|1|||
46784077|NCT00545740|83003006|FG003|Overall Study|Diverticulitis attack|1|||
46784078|NCT00545740|83003003|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
46784079|NCT00545740|83003004|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
46851182|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
46664809|NCT01058642|82878610|FG000|Treatment Period 1|Lack of Efficacy|0|||
46664810|NCT01058642|82878611|FG001|Treatment Period 1|Lack of Efficacy|0|||
46664811|NCT01058642|82878612|FG002|Treatment Period 1|Lack of Efficacy|0|||
46664812|NCT01058642|82878613|FG003|Treatment Period 1|Lack of Efficacy|1|||
46664813|NCT01058642|82878610|FG000|Treatment Period 1|Protocol Violation|0|||
46664814|NCT01058642|82878611|FG001|Treatment Period 1|Protocol Violation|0|||
46664815|NCT01058642|82878612|FG002|Treatment Period 1|Protocol Violation|0|||
46664816|NCT01058642|82878613|FG003|Treatment Period 1|Protocol Violation|1|||
46664817|NCT01058642|82878610|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
46664818|NCT01058642|82878611|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
46664819|NCT01058642|82878612|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
46664820|NCT01058642|82878613|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
46664821|NCT01056653|82878624|FG000|Overall Study|Lost to Follow-up|0|||
46664822|NCT01056653|82878625|FG001|Overall Study|Lost to Follow-up|0|||
46784080|NCT00545740|83003005|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
46784081|NCT00545740|83003006|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
46784082|NCT00545740|83003003|FG000|Overall Study|Site closure|1|||
46851183|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
46851184|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
47076422|NCT03102242|83371125|FG000|Overall Study|Adverse Event|2|||
47076423|NCT03097328|83371129|FG000|Overall Study|Still on Therapy|2|||
46784083|NCT00545740|83003004|FG001|Overall Study|Site closure|0|||
46784084|NCT00545740|83003005|FG002|Overall Study|Site closure|0|||
46784085|NCT00545740|83003006|FG003|Overall Study|Site closure|0|||
46784086|NCT00545740|83003003|FG000|Overall Study|Missed visit|1|||
47076424|NCT03097328|83371129|FG000|Overall Study|Progressive Disease|29|||
47076425|NCT03097328|83371129|FG000|Overall Study|Adverse Event|4|||
47076426|NCT03097328|83371129|FG000|Overall Study|Withdrawal by Subject|1|||
47076427|NCT03097328|83371129|FG000|Overall Study|Physician Decision|1|||
46664823|NCT01056653|82878626|FG002|Overall Study|Lost to Follow-up|2|||
46664824|NCT01056536|82878638|FG000|Overall Study|Lost to Follow-up|202|||
46664825|NCT01056536|82878639|FG001|Overall Study|Lost to Follow-up|116|||
46664826|NCT01056536|82878640|FG002|Overall Study|Lost to Follow-up|248|||
46664827|NCT01056380|82878650|FG000|Overall Study|Lost to Follow-up|2|||
46664828|NCT01056380|82878651|FG001|Overall Study|Lost to Follow-up|3|||
46664829|NCT01055834|82878661|FG000|Treatment Period I|Adverse Event|1|||
46664830|NCT01055834|82878662|FG001|Treatment Period I|Adverse Event|0|||
46664831|NCT01055639|82878673|FG000|Overall Study|Adverse Event|0|||
46664832|NCT01055639|82878674|FG001|Overall Study|Adverse Event|1|||
46664833|NCT01055639|82878673|FG000|Overall Study|Lack of Efficacy|0|||
46664834|NCT01055639|82878674|FG001|Overall Study|Lack of Efficacy|1|||
46664835|NCT01055639|82878673|FG000|Overall Study|Lost to Follow-up|8|||
46664836|NCT01055639|82878674|FG001|Overall Study|Lost to Follow-up|11|||
46664837|NCT01055639|82878673|FG000|Overall Study|Protocol Violation|5|||
46664838|NCT01055639|82878674|FG001|Overall Study|Protocol Violation|5|||
46664839|NCT01055639|82878673|FG000|Overall Study|Withdrawal by Subject|8|||
46664840|NCT01055639|82878674|FG001|Overall Study|Withdrawal by Subject|11|||
46664841|NCT01055132|82878689|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
46664842|NCT01055132|82878690|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
46664843|NCT01055132|82878689|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
46664844|NCT01055132|82878690|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
46664845|NCT01054976|82878700|FG000|Overall Study|Adverse Event|16|||
46664846|NCT01054976|82878700|FG000|Overall Study|Uncooperative participations to study|7|||
46664847|NCT01054976|82878700|FG000|Overall Study|Withdrawal by Subject|4|||
46664848|NCT01054976|82878700|FG000|Overall Study|Other|8|||
46664849|NCT05480514|82878734|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
46664850|NCT05480514|82878735|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
46664851|NCT05480514|82878734|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
46664852|NCT05480514|82878735|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
46664853|NCT05480514|82878734|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
46664854|NCT05480514|82878735|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
46664855|NCT05480514|82878734|FG000|Period 1|Covid-19 Related|1|||
46664856|NCT05480514|82878735|FG001|Period 1|Covid-19 Related|0|||
46664857|NCT05480514|82878734|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
46664858|NCT05480514|82878735|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
46664859|NCT05379920|82878745|FG000|Overall Study|Lost to Follow-up|0|||
46664860|NCT05379920|82878746|FG001|Overall Study|Lost to Follow-up|5|||
46664861|NCT05379920|82878747|FG002|Overall Study|Lost to Follow-up|0|||
46664862|NCT05379920|82878748|FG003|Overall Study|Lost to Follow-up|0|||
46664863|NCT05227027|82878758|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
46664864|NCT05227027|82878759|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
46664865|NCT05124210|82878780|FG000|Overall Study|Lost to Follow-up|1|||
46664866|NCT05124210|82878781|FG001|Overall Study|Lost to Follow-up|0|||
46664867|NCT05124210|82878780|FG000|Overall Study|Withdrawal by Subject|1|||
46664868|NCT05124210|82878781|FG001|Overall Study|Withdrawal by Subject|0|||
46664869|NCT05041062|82878796|FG000|Overall Study|Adverse Event|2|||
46664870|NCT04800315|82878844|FG000|Randomization|Did not receive study treatment|1|||
46664871|NCT04800315|82878845|FG001|Randomization|Did not receive study treatment|0|||
46664872|NCT04800315|82878846|FG002|Randomization|Did not receive study treatment|0|||
46664873|NCT04800315|82878847|FG003|Randomization|Did not receive study treatment|0|||
46664874|NCT04800315|82878844|FG000|Treatment Period|Adverse Event|4|||
46784087|NCT00545740|83003004|FG001|Overall Study|Missed visit|0|||
46784088|NCT00545740|83003005|FG002|Overall Study|Missed visit|0|||
46784089|NCT00545740|83003006|FG003|Overall Study|Missed visit|0|||
46784090|NCT00545740|83003003|FG000|Overall Study|Physician Decision|0|||
46784091|NCT00545740|83003004|FG001|Overall Study|Physician Decision|0|||
46784092|NCT00545740|83003005|FG002|Overall Study|Physician Decision|3|||
46784093|NCT00545740|83003006|FG003|Overall Study|Physician Decision|0|||
46664875|NCT04800315|82878845|FG001|Treatment Period|Adverse Event|2|||
46664876|NCT04800315|82878846|FG002|Treatment Period|Adverse Event|1|||
46664877|NCT04800315|82878847|FG003|Treatment Period|Adverse Event|2|||
46664878|NCT04800315|82878844|FG000|Treatment Period|Lack of Efficacy|1|||
46784094|NCT00545740|83003003|FG000|Overall Study|Accepted only monthly telephone calls|1|||
46784095|NCT00545740|83003004|FG001|Overall Study|Accepted only monthly telephone calls|0|||
46851185|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
46851186|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
47076428|NCT03097328|83371129|FG000|Overall Study|Patient Decision|1|||
46664879|NCT04800315|82878845|FG001|Treatment Period|Lack of Efficacy|0|||
46664880|NCT04800315|82878846|FG002|Treatment Period|Lack of Efficacy|0|||
46664881|NCT04800315|82878847|FG003|Treatment Period|Lack of Efficacy|3|||
46664882|NCT04800315|82878844|FG000|Treatment Period|Lost to Follow-up|0|||
46784096|NCT00545740|83003005|FG002|Overall Study|Accepted only monthly telephone calls|0|||
46851187|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
46664883|NCT04800315|82878845|FG001|Treatment Period|Lost to Follow-up|1|||
46664884|NCT04800315|82878846|FG002|Treatment Period|Lost to Follow-up|2|||
46664885|NCT04800315|82878847|FG003|Treatment Period|Lost to Follow-up|2|||
46664886|NCT04800315|82878844|FG000|Treatment Period|Withdrawal by participant|0|||
46664887|NCT04800315|82878845|FG001|Treatment Period|Withdrawal by participant|0|||
46664888|NCT04800315|82878846|FG002|Treatment Period|Withdrawal by participant|0|||
46664889|NCT04800315|82878847|FG003|Treatment Period|Withdrawal by participant|4|||
46664890|NCT04800315|82878844|FG000|Treatment Period|Other Reasons|0|||
46664891|NCT04800315|82878845|FG001|Treatment Period|Other Reasons|2|||
46664892|NCT04800315|82878846|FG002|Treatment Period|Other Reasons|0|||
46664893|NCT04800315|82878847|FG003|Treatment Period|Other Reasons|1|||
46664894|NCT04768114|82878859|FG000|Overall Study|Lost to Follow-up|5|||
46664895|NCT04768114|82878860|FG001|Overall Study|Lost to Follow-up|10|||
46664896|NCT04768114|82878859|FG000|Overall Study|Withdrawal by Subject|0|||
46664897|NCT04768114|82878860|FG001|Overall Study|Withdrawal by Subject|1|||
46664898|NCT04547192|82878893|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
46664899|NCT04547192|82878894|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
46664900|NCT04547192|82878895|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
46664901|NCT04547192|82878896|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
46664902|NCT04547192|82878893|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
46664903|NCT04547192|82878894|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
46664904|NCT04547192|82878895|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
46664905|NCT04547192|82878896|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
46664906|NCT04547192|82878893|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
46664907|NCT04547192|82878894|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
46664908|NCT04547192|82878895|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
46664909|NCT04547192|82878896|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
46664910|NCT04547192|82878893|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
46664911|NCT04547192|82878894|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
46664912|NCT04547192|82878895|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
46664913|NCT04547192|82878896|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
46664914|NCT04547192|82878893|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
46664915|NCT04547192|82878894|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
46664916|NCT04547192|82878895|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
46664917|NCT04547192|82878896|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
46664918|NCT04514510|82878906|FG000|Overall Study|Lost to Follow-up|0|||
46664919|NCT04514510|82878907|FG001|Overall Study|Lost to Follow-up|1|||
46664920|NCT04514510|82878906|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
46664921|NCT04514510|82878907|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
46664922|NCT04439123|82878923|FG000|Overall Study|Adverse Event|11|||
46664923|NCT04439123|82878923|FG000|Overall Study|Death|1|||
46664924|NCT04439123|82878923|FG000|Overall Study|Disease progression|19|||
46664925|NCT04439123|82878923|FG000|Overall Study|Withdrawal by Subject|2|||
46664926|NCT04439123|82878923|FG000|Overall Study|Still on treatment|2|||
46784097|NCT00545740|83003006|FG003|Overall Study|Accepted only monthly telephone calls|0|||
46784098|NCT00545740|83003003|FG000|Overall Study|Sponsor decision|0|||
46784099|NCT00545740|83003004|FG001|Overall Study|Sponsor decision|1|||
46784100|NCT00545740|83003005|FG002|Overall Study|Sponsor decision|0|||
46784101|NCT00545740|83003006|FG003|Overall Study|Sponsor decision|0|||
46784102|NCT00545740|83003003|FG000|Overall Study|Lack of time|0|||
47076429|NCT03097328|83371129|FG000|Overall Study|Ineligible for Study Drug|1|||
46664927|NCT04213079|82878964|FG000|Overall Study|Lost to Follow-up|0|||
46664928|NCT04213079|82878965|FG001|Overall Study|Lost to Follow-up|2|||
46664929|NCT04102189|82878995|FG000|Overall Study|Withdrawal by Subject|1|||
46664930|NCT04102189|82878996|FG001|Overall Study|Withdrawal by Subject|2|||
46664931|NCT04102189|82878995|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46664932|NCT04102189|82878996|FG001|Overall Study|Withdrawal by parent/guardian|1|||
46664933|NCT04102189|82878995|FG000|Overall Study|Lost to Follow-up|1|||
46664934|NCT04102189|82878996|FG001|Overall Study|Lost to Follow-up|0|||
46664935|NCT04034927|82879004|FG000|Overall Study|Adverse Event|4|||
46664936|NCT04034927|82879005|FG001|Overall Study|Adverse Event|9|||
46664937|NCT04034927|82879004|FG000|Overall Study|Death|0|||
46664938|NCT04034927|82879005|FG001|Overall Study|Death|1|||
46664939|NCT04034927|82879004|FG000|Overall Study|Withdrawal by Subject|0|||
46784103|NCT00545740|83003004|FG001|Overall Study|Lack of time|1|||
46784104|NCT00545740|83003005|FG002|Overall Study|Lack of time|0|||
46784105|NCT00545740|83003006|FG003|Overall Study|Lack of time|0|||
46784106|NCT00545740|83003003|FG000|Overall Study|Non-adherence to visits|0|||
47076430|NCT03033602|83371135|FG000|Overall Study|Withdrawal by Subject|11|||
46664940|NCT04034927|82879005|FG001|Overall Study|Withdrawal by Subject|3|||
46664941|NCT04034927|82879004|FG000|Overall Study|Still on Treatment|2|||
46664942|NCT04034927|82879005|FG001|Overall Study|Still on Treatment|1|||
46664943|NCT04034927|82879004|FG000|Overall Study|Other|1|||
46664944|NCT04034927|82879005|FG001|Overall Study|Other|1|||
46664945|NCT04025580|82879027|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
46784107|NCT00545740|83003004|FG001|Overall Study|Non-adherence to visits|1|||
46784108|NCT00545740|83003005|FG002|Overall Study|Non-adherence to visits|0|||
46664946|NCT04025580|82879028|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
46664947|NCT04025580|82879029|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
46664948|NCT03982368|82879039|FG000|Overall Study|Adverse Event|6|||
46664949|NCT03982368|82879040|FG001|Overall Study|Adverse Event|4|||
46664950|NCT03982368|82879041|FG002|Overall Study|Adverse Event|3|||
46664951|NCT03982368|82879039|FG000|Overall Study|Lost to Follow-up|2|||
46664952|NCT03982368|82879040|FG001|Overall Study|Lost to Follow-up|1|||
46664953|NCT03982368|82879041|FG002|Overall Study|Lost to Follow-up|0|||
46664954|NCT03982368|82879039|FG000|Overall Study|Withdrawal by Subject|1|||
46664955|NCT03982368|82879040|FG001|Overall Study|Withdrawal by Subject|2|||
46664956|NCT03982368|82879041|FG002|Overall Study|Withdrawal by Subject|0|||
46664957|NCT03982368|82879039|FG000|Overall Study|unknow|4|||
46664958|NCT03982368|82879040|FG001|Overall Study|unknow|0|||
46664959|NCT03982368|82879041|FG002|Overall Study|unknow|2|||
46664960|NCT03934684|82879054|FG000|Overall Study|Participants continuing in study|11|||
46664961|NCT03934684|82879055|FG001|Overall Study|Participants continuing in study|4|||
46664962|NCT03934684|82879054|FG000|Overall Study|Discontinuation of carfilzomib|20|||
46664963|NCT03934684|82879055|FG001|Overall Study|Discontinuation of carfilzomib|30|||
46664964|NCT03934684|82879054|FG000|Overall Study|Death|2|||
46664965|NCT03934684|82879055|FG001|Overall Study|Death|2|||
46664966|NCT03934684|82879054|FG000|Overall Study|Lost to Follow-up|2|||
46784109|NCT00545740|83003006|FG003|Overall Study|Non-adherence to visits|0|||
46784110|NCT00545740|83003003|FG000|Overall Study|Patient difficulties|0|||
46664967|NCT03934684|82879055|FG001|Overall Study|Lost to Follow-up|5|||
46784111|NCT00545740|83003004|FG001|Overall Study|Patient difficulties|1|||
46784112|NCT00545740|83003005|FG002|Overall Study|Patient difficulties|0|||
46784113|NCT00545740|83003006|FG003|Overall Study|Patient difficulties|0|||
46784114|NCT00545740|83003003|FG000|Overall Study|Husband against study|0|||
46784115|NCT00545740|83003004|FG001|Overall Study|Husband against study|0|||
46784116|NCT00545740|83003005|FG002|Overall Study|Husband against study|1|||
46784117|NCT00545740|83003006|FG003|Overall Study|Husband against study|0|||
46784118|NCT00609609|83003018|FG000|Overall Study|Withdrawal by Subject|2|||
46784119|NCT00609609|83003019|FG001|Overall Study|Withdrawal by Subject|0|||
46784120|NCT00609609|83003018|FG000|Overall Study|Progression|4|||
46784121|NCT00609609|83003019|FG001|Overall Study|Progression|2|||
46784122|NCT00673452|83003027|FG000|Acute Double-Blind Phase|Adverse Event|41|||
46784123|NCT00673452|83003028|FG001|Acute Double-Blind Phase|Adverse Event|24|||
46784124|NCT00673452|83003027|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
46784125|NCT00673452|83003028|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
46784126|NCT00673452|83003027|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
46784127|NCT00673452|83003028|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
46784128|NCT00673452|83003027|FG000|Acute Double-Blind Phase|Physician Decision|0|||
46784129|NCT00673452|83003028|FG001|Acute Double-Blind Phase|Physician Decision|6|||
46784130|NCT00673452|83003027|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
46784131|NCT00673452|83003028|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
46784132|NCT00673452|83003027|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
46784133|NCT00673452|83003028|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
46664968|NCT03934684|82879054|FG000|Overall Study|Withdrawal by Subject|7|||
46664969|NCT03934684|82879055|FG001|Overall Study|Withdrawal by Subject|8|||
46664970|NCT03880019|82879061|FG000|Overall Study|Competing disease|1|||
46664971|NCT03674112|82879067|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
46664972|NCT03674112|82879068|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
46664973|NCT03674112|82879067|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
46664974|NCT03674112|82879068|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
46664975|NCT03674112|82879067|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
46664976|NCT03674112|82879068|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
46664977|NCT03674112|82879067|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
46664978|NCT03674112|82879068|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
46784134|NCT00673452|83003027|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
46664979|NCT03674112|82879067|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
46664980|NCT03674112|82879068|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
46664981|NCT03674112|82879067|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
46664982|NCT03674112|82879068|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
46664983|NCT03674112|82879067|FG000|Follow-Up Period (≥3 Years)|Death|2|||
46784135|NCT00673452|83003028|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
47076431|NCT03033602|83371136|FG001|Overall Study|Withdrawal by Subject|21|||
46664984|NCT03674112|82879068|FG001|Follow-Up Period (≥3 Years)|Death|0|||
46784136|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
47076432|NCT03033602|83371135|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
46664985|NCT03674112|82879067|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
46664986|NCT03674112|82879068|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
46784137|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
46784138|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
46664987|NCT03673501|82879100|FG000|Overall Study|Participants ongoing.|36|||
46664988|NCT03673501|82879101|FG001|Overall Study|Participants ongoing.|24|||
46664989|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
46664990|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
46664991|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Death|0|||
46664992|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Death|4|||
46664993|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
46664994|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
47076433|NCT03033602|83371136|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
47076434|NCT02994784|83371147|FG000|6 Months Follow-up|Lost to Follow-up|3|||
47076435|NCT02617446|83371163|FG000|Overall Study|Withdrawal by Subject|0|||
47076436|NCT02617446|83371164|FG001|Overall Study|Withdrawal by Subject|2|||
47076437|NCT02617446|83371165|FG002|Overall Study|Withdrawal by Subject|0|||
47076438|NCT02617446|83371163|FG000|Overall Study|Adverse Event|1|||
47076439|NCT02617446|83371164|FG001|Overall Study|Adverse Event|0|||
47076440|NCT02617446|83371165|FG002|Overall Study|Adverse Event|5|||
47076441|NCT02617446|83371163|FG000|Overall Study|Lost to Follow-up|3|||
47076442|NCT02617446|83371164|FG001|Overall Study|Lost to Follow-up|0|||
47076443|NCT02617446|83371165|FG002|Overall Study|Lost to Follow-up|0|||
47076444|NCT02617446|83371163|FG000|Overall Study|Death|0|||
47076445|NCT02617446|83371164|FG001|Overall Study|Death|0|||
47076446|NCT02617446|83371165|FG002|Overall Study|Death|2|||
47076447|NCT02549170|83371179|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
47076448|NCT02549170|83371180|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
47076449|NCT02549170|83371181|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
47076450|NCT02549170|83371182|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
47076451|NCT02549170|83371183|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
47076452|NCT02549170|83371179|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
47076453|NCT02549170|83371180|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
47076454|NCT02549170|83371181|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
47076455|NCT02549170|83371182|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
47076456|NCT02549170|83371183|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
47076457|NCT02549170|83371179|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
47076458|NCT02549170|83371180|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
47076459|NCT02549170|83371181|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
47076460|NCT02549170|83371182|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
47076461|NCT02549170|83371183|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
47076462|NCT02410902|83371200|FG000|Overall Study|Adverse Event|2|||
47076463|NCT02410902|83371201|FG001|Overall Study|Adverse Event|3|||
47076464|NCT02410902|83371200|FG000|Overall Study|Lost to Follow-up|4|||
47076465|NCT02410902|83371201|FG001|Overall Study|Lost to Follow-up|1|||
46784139|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
46784140|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
46784141|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
46784142|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
46784143|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
47076466|NCT02410902|83371200|FG000|Overall Study|Protocol Violation|1|||
47076467|NCT02410902|83371201|FG001|Overall Study|Protocol Violation|4|||
47076468|NCT02410902|83371200|FG000|Overall Study|Withdrawal by Subject|6|||
47076469|NCT02410902|83371201|FG001|Overall Study|Withdrawal by Subject|8|||
47076470|NCT02410902|83371200|FG000|Overall Study|Non-Compliance|8|||
47076471|NCT02410902|83371201|FG001|Overall Study|Non-Compliance|2|||
47076472|NCT02101736|83371211|FG000|Overall Study|Protocol Violation|3|||
47076473|NCT02101736|83371212|FG001|Overall Study|Protocol Violation|0|||
47076474|NCT02101736|83371211|FG000|Overall Study|Withdrawal by Subject|1|||
47076475|NCT02101736|83371212|FG001|Overall Study|Withdrawal by Subject|1|||
47076476|NCT01918397|83371224|FG000|Overall Study|Never started treatment|2|||
46664995|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
46664996|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
46664997|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
46664998|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
46784144|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
46784145|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
46851188|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
46784146|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
46784147|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
46784148|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
46664999|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
46665000|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
46665001|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
46665002|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
46665003|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Other|4|||
46665004|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Other|3|||
46665005|NCT03517722|82879109|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
46665006|NCT03517722|82879110|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
46665007|NCT03517722|82879109|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
46665008|NCT03517722|82879110|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
46665009|NCT03517722|82879109|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
46665010|NCT03517722|82879110|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
46665011|NCT03517722|82879109|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
46665012|NCT03517722|82879110|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
46665013|NCT03517722|82879109|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
46665014|NCT03517722|82879110|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
46665015|NCT03258593|82879149|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
46665016|NCT03258593|82879150|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
46665017|NCT03258593|82879151|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
46665018|NCT03258593|82879152|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
46665019|NCT03258593|82879149|FG000|Run-In Maintenance Phase|Disease progression|3|||
46665020|NCT03258593|82879150|FG001|Run-In Maintenance Phase|Disease progression|0|||
46665021|NCT03258593|82879151|FG002|Run-In Maintenance Phase|Disease progression|0|||
46665022|NCT03258593|82879152|FG003|Run-In Maintenance Phase|Disease progression|0|||
46665023|NCT03258593|82879149|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
46665024|NCT03258593|82879150|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
46665025|NCT03258593|82879151|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
46665026|NCT03258593|82879152|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
46665027|NCT03258593|82879149|FG000|Expansion Maintenance Phase|Physician Decision|0|||
46665028|NCT03258593|82879150|FG001|Expansion Maintenance Phase|Physician Decision|1|||
46665029|NCT03258593|82879151|FG002|Expansion Maintenance Phase|Physician Decision|0|||
46665030|NCT03258593|82879152|FG003|Expansion Maintenance Phase|Physician Decision|0|||
46665031|NCT02924129|82879190|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
46665032|NCT02924129|82879191|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
46665033|NCT02924129|82879190|FG000|Overall Study|Withdrawal by Subject|2|||
46665034|NCT02924129|82879191|FG001|Overall Study|Withdrawal by Subject|2|||
46665035|NCT02924129|82879190|FG000|Overall Study|Physician Decision|1|||
46665036|NCT02924129|82879191|FG001|Overall Study|Physician Decision|0|||
46665037|NCT02924129|82879190|FG000|Overall Study|Missed Visit|0|||
46665038|NCT02924129|82879191|FG001|Overall Study|Missed Visit|1|||
46665039|NCT02824263|82879199|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
46665040|NCT02824263|82879200|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
46665041|NCT02824263|82879199|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
46665042|NCT02824263|82879200|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
46665043|NCT02814838|82879208|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
46665044|NCT02814838|82879209|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
46665045|NCT02814838|82879208|FG000|Overall Study|Consent withdrawal|1|||
46784149|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
46972288|NCT02079532|83215901|FG000|Overall Study|Administrative problems|1|||
46972289|NCT02079532|83215901|FG000|Overall Study|Inclusion into ReFIRST|3|||
46972290|NCT02079532|83215901|FG000|Overall Study|Other|3|||
46972291|NCT02357849|83215918|FG000|Overall Study|Withdrawal by Subject|2|||
46972292|NCT02357849|83215919|FG001|Overall Study|Withdrawal by Subject|3|||
46972293|NCT02709889|83215963|FG000|Overall Study|Withdrawal by Subject|11|||
46972294|NCT02709889|83215964|FG001|Overall Study|Withdrawal by Subject|10|||
46972295|NCT02709889|83215965|FG002|Overall Study|Withdrawal by Subject|2|||
46972296|NCT02709889|83215966|FG003|Overall Study|Withdrawal by Subject|12|||
46972297|NCT02709889|83215963|FG000|Overall Study|Death|25|||
46972298|NCT02709889|83215964|FG001|Overall Study|Death|38|||
46972299|NCT02709889|83215965|FG002|Overall Study|Death|4|||
46972300|NCT02709889|83215966|FG003|Overall Study|Death|44|||
46972301|NCT02709889|83215963|FG000|Overall Study|Physician Decision|1|||
46972302|NCT02709889|83215964|FG001|Overall Study|Physician Decision|2|||
47076477|NCT01918397|83371225|FG001|Overall Study|Never started treatment|1|||
47076478|NCT01918397|83371226|FG002|Overall Study|Never started treatment|0|||
47076479|NCT01918397|83371227|FG003|Overall Study|Never started treatment|0|||
46784150|NCT00673452|83003027|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
46972303|NCT02709889|83215965|FG002|Overall Study|Physician Decision|3|||
47076480|NCT01918397|83371224|FG000|Overall Study|Adverse Event|1|||
46972304|NCT02709889|83215966|FG003|Overall Study|Physician Decision|5|||
46972305|NCT02709889|83215963|FG000|Overall Study|Lost to Follow-up|2|||
47076481|NCT01918397|83371225|FG001|Overall Study|Adverse Event|1|||
47076482|NCT01918397|83371226|FG002|Overall Study|Adverse Event|1|||
47076483|NCT01918397|83371227|FG003|Overall Study|Adverse Event|0|||
47076484|NCT01918397|83371224|FG000|Overall Study|Lack of compliance|2|||
47076485|NCT01918397|83371225|FG001|Overall Study|Lack of compliance|2|||
47076486|NCT01918397|83371226|FG002|Overall Study|Lack of compliance|3|||
47076487|NCT01918397|83371227|FG003|Overall Study|Lack of compliance|0|||
47076488|NCT01918397|83371224|FG000|Overall Study|Pregnancy|0|||
47076489|NCT01918397|83371225|FG001|Overall Study|Pregnancy|1|||
47076490|NCT01918397|83371226|FG002|Overall Study|Pregnancy|0|||
47076491|NCT01918397|83371227|FG003|Overall Study|Pregnancy|0|||
47076492|NCT01918397|83371224|FG000|Overall Study|Rifampin susceptible|0|||
46784151|NCT00673452|83003028|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
46784152|NCT00545584|83003037|FG000|Overall Study|Only one reason for discontinuation|62|||
46784153|NCT00545584|83003038|FG001|Overall Study|Only one reason for discontinuation|61|||
46784154|NCT00545584|83003039|FG002|Overall Study|Only one reason for discontinuation|48|||
46784155|NCT00545584|83003037|FG000|Overall Study|Two or more reasons for discontinuation|17|||
46784156|NCT00545584|83003038|FG001|Overall Study|Two or more reasons for discontinuation|19|||
46784157|NCT00545584|83003039|FG002|Overall Study|Two or more reasons for discontinuation|8|||
47076493|NCT01918397|83371225|FG001|Overall Study|Rifampin susceptible|0|||
47076494|NCT01918397|83371226|FG002|Overall Study|Rifampin susceptible|0|||
47076495|NCT01918397|83371227|FG003|Overall Study|Rifampin susceptible|2|||
47076496|NCT01918397|83371224|FG000|Overall Study|Treatment failure|0|||
47076497|NCT01918397|83371225|FG001|Overall Study|Treatment failure|0|||
47076498|NCT01918397|83371226|FG002|Overall Study|Treatment failure|0|||
47076499|NCT01918397|83371227|FG003|Overall Study|Treatment failure|1|||
47076500|NCT01918397|83371224|FG000|Overall Study|Withdrawal by Subject|3|||
47076501|NCT01918397|83371225|FG001|Overall Study|Withdrawal by Subject|2|||
47076502|NCT01918397|83371226|FG002|Overall Study|Withdrawal by Subject|1|||
47076503|NCT01918397|83371227|FG003|Overall Study|Withdrawal by Subject|1|||
46851189|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
47076504|NCT01918397|83371224|FG000|Overall Study|XDR at baseline|0|||
47076505|NCT01918397|83371225|FG001|Overall Study|XDR at baseline|0|||
47076506|NCT01918397|83371226|FG002|Overall Study|XDR at baseline|1|||
47076507|NCT01918397|83371227|FG003|Overall Study|XDR at baseline|0|||
47076508|NCT01918397|83371224|FG000|Overall Study|Lost to Follow-up|2|||
46784158|NCT00378703|83003051|FG000|Overall Study|Disease progression|59|||
46784159|NCT00378703|83003052|FG001|Overall Study|Disease progression|43|||
46784160|NCT00378703|83003053|FG002|Overall Study|Disease progression|48|||
46784161|NCT00378703|83003054|FG003|Overall Study|Disease progression|49|||
46784162|NCT00378703|83003051|FG000|Overall Study|Adverse Event|11|||
46784163|NCT00378703|83003052|FG001|Overall Study|Adverse Event|17|||
46784164|NCT00378703|83003053|FG002|Overall Study|Adverse Event|20|||
46784165|NCT00378703|83003054|FG003|Overall Study|Adverse Event|18|||
46784166|NCT00378703|83003051|FG000|Overall Study|Death|2|||
46784167|NCT00378703|83003052|FG001|Overall Study|Death|2|||
46784168|NCT00378703|83003053|FG002|Overall Study|Death|4|||
46784169|NCT00378703|83003054|FG003|Overall Study|Death|3|||
46784170|NCT00378703|83003051|FG000|Overall Study|Withdrawal by Subject|4|||
46784171|NCT00378703|83003052|FG001|Overall Study|Withdrawal by Subject|8|||
46784172|NCT00378703|83003053|FG002|Overall Study|Withdrawal by Subject|5|||
46784173|NCT00378703|83003054|FG003|Overall Study|Withdrawal by Subject|7|||
46784174|NCT00378703|83003051|FG000|Overall Study|Physician Decision|1|||
46784175|NCT00378703|83003052|FG001|Overall Study|Physician Decision|4|||
46784176|NCT00378703|83003053|FG002|Overall Study|Physician Decision|1|||
46784177|NCT00378703|83003054|FG003|Overall Study|Physician Decision|0|||
46784178|NCT00378703|83003051|FG000|Overall Study|Alternative therapy|4|||
46784179|NCT00378703|83003052|FG001|Overall Study|Alternative therapy|2|||
46784180|NCT00378703|83003053|FG002|Overall Study|Alternative therapy|0|||
46784181|NCT00378703|83003054|FG003|Overall Study|Alternative therapy|0|||
46784182|NCT00378703|83003051|FG000|Overall Study|Other complicated disease|0|||
46784183|NCT00378703|83003052|FG001|Overall Study|Other complicated disease|2|||
46851190|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
46851191|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
46784184|NCT00378703|83003053|FG002|Overall Study|Other complicated disease|2|||
46851192|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
46972306|NCT02709889|83215964|FG001|Overall Study|Lost to Follow-up|0|||
47076509|NCT01918397|83371225|FG001|Overall Study|Lost to Follow-up|1|||
47076510|NCT01918397|83371226|FG002|Overall Study|Lost to Follow-up|1|||
47076511|NCT01918397|83371227|FG003|Overall Study|Lost to Follow-up|1|||
47076512|NCT01918397|83371224|FG000|Overall Study|Increased QTc|1|||
47076513|NCT01918397|83371225|FG001|Overall Study|Increased QTc|0|||
47076514|NCT01918397|83371226|FG002|Overall Study|Increased QTc|0|||
47076515|NCT01918397|83371227|FG003|Overall Study|Increased QTc|1|||
47076516|NCT01918397|83371224|FG000|Overall Study|Death|0|||
47076517|NCT01918397|83371225|FG001|Overall Study|Death|0|||
46784185|NCT00378703|83003054|FG003|Overall Study|Other complicated disease|0|||
47076518|NCT01918397|83371226|FG002|Overall Study|Death|1|||
46784186|NCT00378703|83003051|FG000|Overall Study|Symptomatic deterioration|0|||
46784187|NCT00378703|83003052|FG001|Overall Study|Symptomatic deterioration|1|||
46784188|NCT00378703|83003053|FG002|Overall Study|Symptomatic deterioration|0|||
46784189|NCT00378703|83003054|FG003|Overall Study|Symptomatic deterioration|2|||
46784190|NCT00378703|83003051|FG000|Overall Study|Surgery|1|||
46784191|NCT00378703|83003052|FG001|Overall Study|Surgery|0|||
46784192|NCT00378703|83003053|FG002|Overall Study|Surgery|0|||
46784193|NCT00378703|83003054|FG003|Overall Study|Surgery|1|||
46784194|NCT00378703|83003051|FG000|Overall Study|Joint decision of physician and patient|1|||
46784195|NCT00378703|83003052|FG001|Overall Study|Joint decision of physician and patient|0|||
46784196|NCT00378703|83003053|FG002|Overall Study|Joint decision of physician and patient|0|||
46784197|NCT00378703|83003054|FG003|Overall Study|Joint decision of physician and patient|0|||
46784198|NCT00378703|83003051|FG000|Overall Study|Adverse events and progressive disease|0|||
46784199|NCT00378703|83003052|FG001|Overall Study|Adverse events and progressive disease|0|||
46784200|NCT00378703|83003053|FG002|Overall Study|Adverse events and progressive disease|0|||
46784201|NCT00378703|83003054|FG003|Overall Study|Adverse events and progressive disease|1|||
46784202|NCT00378703|83003051|FG000|Overall Study|Relocation|0|||
46784203|NCT00378703|83003052|FG001|Overall Study|Relocation|0|||
46784204|NCT00378703|83003053|FG002|Overall Study|Relocation|1|||
46784205|NCT00378703|83003054|FG003|Overall Study|Relocation|0|||
46784206|NCT00378703|83003051|FG000|Overall Study|Ineligible|4|||
46784207|NCT00378703|83003052|FG001|Overall Study|Ineligible|7|||
46784208|NCT00378703|83003053|FG002|Overall Study|Ineligible|7|||
46784209|NCT00378703|83003054|FG003|Overall Study|Ineligible|7|||
46784210|NCT00378703|83003051|FG000|Overall Study|Never started treatment|1|||
46784211|NCT00378703|83003052|FG001|Overall Study|Never started treatment|4|||
46784212|NCT00378703|83003053|FG002|Overall Study|Never started treatment|0|||
46784213|NCT00378703|83003054|FG003|Overall Study|Never started treatment|0|||
46784214|NCT00378703|83003051|FG000|Overall Study|Other|1|||
46784215|NCT00378703|83003052|FG001|Overall Study|Other|1|||
46784216|NCT00378703|83003053|FG002|Overall Study|Other|2|||
46784217|NCT00378703|83003054|FG003|Overall Study|Other|3|||
46784218|NCT00368641|83003070|FG000|Overall Study|Adverse Event|2|||
46784219|NCT00368641|83003071|FG001|Overall Study|Adverse Event|1|||
46784220|NCT00368641|83003070|FG000|Overall Study|Death|1|||
46784221|NCT00368641|83003071|FG001|Overall Study|Death|0|||
46851193|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
46851194|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
46851195|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
46851196|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
46851197|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
46851198|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
46851199|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
46665046|NCT02814838|82879209|FG001|Overall Study|Consent withdrawal|1|||
46665047|NCT02661464|82879219|FG000|Overall Study|Lost to Follow-up|28|||
46665048|NCT02661464|82879220|FG001|Overall Study|Lost to Follow-up|0|||
46665049|NCT02661464|82879221|FG002|Overall Study|Lost to Follow-up|0|||
46665050|NCT02661464|82879222|FG003|Overall Study|Lost to Follow-up|0|||
46665051|NCT02661464|82879219|FG000|Overall Study|Withdrawal by Subject|3|||
46665052|NCT02661464|82879220|FG001|Overall Study|Withdrawal by Subject|1|||
46665053|NCT02661464|82879221|FG002|Overall Study|Withdrawal by Subject|0|||
46665054|NCT02661464|82879222|FG003|Overall Study|Withdrawal by Subject|0|||
46665055|NCT02661464|82879219|FG000|Overall Study|Participants terminated prematurely|288|||
46665056|NCT02661464|82879220|FG001|Overall Study|Participants terminated prematurely|52|||
46665057|NCT02661464|82879221|FG002|Overall Study|Participants terminated prematurely|1|||
46665058|NCT02661464|82879222|FG003|Overall Study|Participants terminated prematurely|1|||
46784222|NCT00368641|83003070|FG000|Overall Study|Withdrawal by Subject|1|||
46851200|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
46851201|NCT03605680|83066875|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
47076519|NCT01918397|83371227|FG003|Overall Study|Death|0|||
47076520|NCT01918397|83371224|FG000|Overall Study|Involved in another investigative trial|0|||
46784223|NCT00368641|83003071|FG001|Overall Study|Withdrawal by Subject|0|||
46784224|NCT00368641|83003070|FG000|Overall Study|Sponsor decision to terminate study|2|||
46851202|NCT03605680|83066876|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
46851203|NCT03605680|83066877|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
46972307|NCT02709889|83215965|FG002|Overall Study|Lost to Follow-up|0|||
46665059|NCT02661464|82879219|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
46665060|NCT02661464|82879220|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
46784225|NCT00368641|83003071|FG001|Overall Study|Sponsor decision to terminate study|5|||
46784226|NCT00608985|83003081|FG000|Overall Study|Adverse Event|2|||
46784227|NCT00608985|83003082|FG001|Overall Study|Adverse Event|7|||
46784228|NCT00608985|83003083|FG002|Overall Study|Adverse Event|4|||
46784229|NCT00608985|83003084|FG003|Overall Study|Adverse Event|6|||
46784230|NCT00608985|83003081|FG000|Overall Study|Administrative/Other|7|||
46784231|NCT00608985|83003082|FG001|Overall Study|Administrative/Other|4|||
46665061|NCT02661464|82879221|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
46665062|NCT02661464|82879222|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
46665063|NCT02618408|82879244|FG000|Overall Study|Withdrawal by Subject|1|||
46665064|NCT02618408|82879245|FG001|Overall Study|Withdrawal by Subject|0|||
46665065|NCT02618408|82879246|FG002|Overall Study|Withdrawal by Subject|4|||
46665066|NCT02618408|82879244|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
46665067|NCT02618408|82879245|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
46665068|NCT02618408|82879246|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
46665069|NCT02618408|82879244|FG000|Overall Study|Lost to Follow-up|4|||
46665070|NCT02618408|82879245|FG001|Overall Study|Lost to Follow-up|2|||
46665071|NCT02618408|82879246|FG002|Overall Study|Lost to Follow-up|6|||
46665072|NCT02618408|82879244|FG000|Overall Study|Adverse Event|4|||
46665073|NCT02618408|82879245|FG001|Overall Study|Adverse Event|0|||
46665074|NCT02618408|82879246|FG002|Overall Study|Adverse Event|10|||
46665075|NCT02618408|82879244|FG000|Overall Study|Physician Decision|1|||
46665076|NCT02618408|82879245|FG001|Overall Study|Physician Decision|1|||
46665077|NCT02618408|82879246|FG002|Overall Study|Physician Decision|2|||
46784232|NCT00608985|83003083|FG002|Overall Study|Administrative/Other|1|||
46784233|NCT00608985|83003084|FG003|Overall Study|Administrative/Other|2|||
46784234|NCT00608985|83003081|FG000|Overall Study|Withdrawal of Consent|5|||
46784235|NCT00608985|83003082|FG001|Overall Study|Withdrawal of Consent|1|||
46784236|NCT00608985|83003083|FG002|Overall Study|Withdrawal of Consent|1|||
46784237|NCT00608985|83003084|FG003|Overall Study|Withdrawal of Consent|1|||
46665078|NCT02618408|82879244|FG000|Overall Study|Protocol Violation|1|||
46665079|NCT02618408|82879245|FG001|Overall Study|Protocol Violation|1|||
46665080|NCT02618408|82879246|FG002|Overall Study|Protocol Violation|2|||
46665081|NCT02618408|82879244|FG000|Overall Study|Other, Multiple Categories|0|||
46665082|NCT02618408|82879245|FG001|Overall Study|Other, Multiple Categories|0|||
46665083|NCT02618408|82879246|FG002|Overall Study|Other, Multiple Categories|4|||
46665084|NCT02499172|82879261|FG000|Overall Study|Financial reason|0|||
46665085|NCT02499172|82879262|FG001|Overall Study|Financial reason|0|||
46665086|NCT02499172|82879263|FG002|Overall Study|Financial reason|523|||
46665087|NCT02499172|82879264|FG003|Overall Study|Financial reason|436|||
46665088|NCT02499172|82879261|FG000|Overall Study|Lost to Follow-up|65|||
46665089|NCT02499172|82879262|FG001|Overall Study|Lost to Follow-up|64|||
46665090|NCT02499172|82879263|FG002|Overall Study|Lost to Follow-up|0|||
46665091|NCT02499172|82879264|FG003|Overall Study|Lost to Follow-up|0|||
46665092|NCT02323880|82879286|FG000|Overall Study|Adverse Event|2|||
46665093|NCT02323880|82879287|FG001|Overall Study|Adverse Event|0|||
46665094|NCT02323880|82879288|FG002|Overall Study|Adverse Event|1|||
46665095|NCT02323880|82879289|FG003|Overall Study|Adverse Event|1|||
46665096|NCT02323880|82879290|FG004|Overall Study|Adverse Event|1|||
46665097|NCT02323880|82879291|FG005|Overall Study|Adverse Event|0|||
46665098|NCT02323880|82879292|FG006|Overall Study|Adverse Event|1|||
46665099|NCT02323880|82879293|FG007|Overall Study|Adverse Event|0|||
46665100|NCT02323880|82879286|FG000|Overall Study|Death|0|||
46665101|NCT02323880|82879287|FG001|Overall Study|Death|0|||
46665102|NCT02323880|82879288|FG002|Overall Study|Death|0|||
46665103|NCT02323880|82879289|FG003|Overall Study|Death|0|||
46665104|NCT02323880|82879290|FG004|Overall Study|Death|0|||
46665105|NCT02323880|82879291|FG005|Overall Study|Death|1|||
46665106|NCT02323880|82879292|FG006|Overall Study|Death|0|||
46665107|NCT02323880|82879293|FG007|Overall Study|Death|0|||
46784238|NCT00608985|83003081|FG000|Overall Study|Lost to Follow-up|2|||
46665108|NCT02323880|82879286|FG000|Overall Study|Lack of Efficacy|4|||
46665109|NCT02323880|82879287|FG001|Overall Study|Lack of Efficacy|11|||
46665110|NCT02323880|82879288|FG002|Overall Study|Lack of Efficacy|5|||
46665111|NCT02323880|82879289|FG003|Overall Study|Lack of Efficacy|5|||
46665112|NCT02323880|82879290|FG004|Overall Study|Lack of Efficacy|4|||
46784239|NCT00608985|83003082|FG001|Overall Study|Lost to Follow-up|1|||
46784240|NCT00608985|83003083|FG002|Overall Study|Lost to Follow-up|0|||
46784241|NCT00608985|83003084|FG003|Overall Study|Lost to Follow-up|0|||
46665113|NCT02323880|82879291|FG005|Overall Study|Lack of Efficacy|8|||
46665114|NCT02323880|82879292|FG006|Overall Study|Lack of Efficacy|4|||
46665115|NCT02323880|82879293|FG007|Overall Study|Lack of Efficacy|6|||
46665116|NCT02323880|82879286|FG000|Overall Study|Physician Decision|0|||
46665117|NCT02323880|82879287|FG001|Overall Study|Physician Decision|0|||
46665118|NCT02323880|82879288|FG002|Overall Study|Physician Decision|0|||
46665119|NCT02323880|82879289|FG003|Overall Study|Physician Decision|0|||
46784242|NCT00368251|83003097|FG000|Overall Study|SAE, non-fatal|1|||
46784243|NCT00368251|83003098|FG001|Overall Study|SAE, non-fatal|0|||
46665120|NCT02323880|82879290|FG004|Overall Study|Physician Decision|1|||
46665121|NCT02323880|82879291|FG005|Overall Study|Physician Decision|1|||
46665122|NCT02323880|82879292|FG006|Overall Study|Physician Decision|1|||
46665123|NCT02323880|82879293|FG007|Overall Study|Physician Decision|0|||
46665124|NCT02323880|82879286|FG000|Overall Study|Withdrawal by Subject|0|||
46665125|NCT02323880|82879287|FG001|Overall Study|Withdrawal by Subject|2|||
46784244|NCT00368251|83003099|FG002|Overall Study|SAE, non-fatal|0|||
46784245|NCT00368251|83003097|FG000|Overall Study|AE, non-serious non-fatal|0|||
46972308|NCT02709889|83215966|FG003|Overall Study|Lost to Follow-up|4|||
46784246|NCT00368251|83003098|FG001|Overall Study|AE, non-serious non-fatal|0|||
46784247|NCT00368251|83003099|FG002|Overall Study|AE, non-serious non-fatal|1|||
46784248|NCT00378079|83003110|FG000|Overall Study|Lost to Follow-up|6|||
46784249|NCT00378079|83003111|FG001|Overall Study|Lost to Follow-up|1|||
46784250|NCT00378079|83003112|FG002|Overall Study|Lost to Follow-up|0|||
46784251|NCT03936244|83003122|FG000|Overall Study|Lost to Follow-up|5|||
46665126|NCT02323880|82879288|FG002|Overall Study|Withdrawal by Subject|0|||
46665127|NCT02323880|82879289|FG003|Overall Study|Withdrawal by Subject|0|||
46665128|NCT02323880|82879290|FG004|Overall Study|Withdrawal by Subject|0|||
46665129|NCT02323880|82879291|FG005|Overall Study|Withdrawal by Subject|0|||
46665130|NCT02323880|82879292|FG006|Overall Study|Withdrawal by Subject|0|||
46665131|NCT02323880|82879293|FG007|Overall Study|Withdrawal by Subject|0|||
46665132|NCT02115282|82879333|FG000|Overall Study|Disease progression during treatment|216|||
46665133|NCT02115282|82879334|FG001|Overall Study|Disease progression during treatment|229|||
46665134|NCT02115282|82879333|FG000|Overall Study|Adverse Event|49|||
46665135|NCT02115282|82879334|FG001|Overall Study|Adverse Event|23|||
46665136|NCT02115282|82879333|FG000|Overall Study|Death|1|||
46665137|NCT02115282|82879334|FG001|Overall Study|Death|3|||
46665138|NCT02115282|82879333|FG000|Overall Study|Alternative therapy|1|||
46665139|NCT02115282|82879334|FG001|Overall Study|Alternative therapy|1|||
46665140|NCT02115282|82879333|FG000|Overall Study|Complicating disease|0|||
46665141|NCT02115282|82879334|FG001|Overall Study|Complicating disease|3|||
46665142|NCT02115282|82879333|FG000|Overall Study|Withdrawal by Subject|12|||
46665143|NCT02115282|82879334|FG001|Overall Study|Withdrawal by Subject|10|||
46665144|NCT02115282|82879333|FG000|Overall Study|Symptomatic progression/deterioration|7|||
46665145|NCT02115282|82879334|FG001|Overall Study|Symptomatic progression/deterioration|18|||
46665146|NCT02115282|82879333|FG000|Overall Study|Non-compliance|5|||
46665147|NCT02115282|82879334|FG001|Overall Study|Non-compliance|1|||
46665148|NCT02115282|82879333|FG000|Overall Study|Protocol Violation|2|||
46665149|NCT02115282|82879334|FG001|Overall Study|Protocol Violation|2|||
46665150|NCT02115282|82879333|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
46665151|NCT02115282|82879334|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
46665152|NCT02115282|82879333|FG000|Overall Study|Not start protocol therapy|9|||
46665153|NCT02115282|82879334|FG001|Overall Study|Not start protocol therapy|10|||
46665154|NCT01991977|82879342|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
46665155|NCT01991977|82879342|FG000|Overall Study|Withdrew after start of treatment|5|||
46665156|NCT01854554|82879354|FG000|Overall Study|Denial of Insurance Coverage|12|||
46665157|NCT01854554|82879355|FG001|Overall Study|Denial of Insurance Coverage|0|||
46665158|NCT01854554|82879354|FG000|Overall Study|Decided to get treatment locally|1|||
46665159|NCT01854554|82879355|FG001|Overall Study|Decided to get treatment locally|5|||
46665160|NCT01854554|82879354|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
46665161|NCT01854554|82879355|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
46665162|NCT01854554|82879354|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
46665163|NCT01854554|82879355|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
46665164|NCT01854554|82879354|FG000|Overall Study|Progression|0|||
46665165|NCT01854554|82879355|FG001|Overall Study|Progression|1|||
46665166|NCT01854554|82879354|FG000|Overall Study|Lost to Follow-up|0|||
46665167|NCT01854554|82879355|FG001|Overall Study|Lost to Follow-up|1|||
46665168|NCT01817959|82879363|FG000|Overall Study|Graft loss|1|||
46665169|NCT01817959|82879364|FG001|Overall Study|Graft loss|1|||
46665170|NCT01817959|82879363|FG000|Overall Study|forbidden medication|1|||
46665171|NCT01817959|82879364|FG001|Overall Study|forbidden medication|1|||
46784252|NCT03936244|83003123|FG001|Overall Study|Lost to Follow-up|1|||
46784253|NCT03936244|83003122|FG000|Overall Study|Physician Decision|7|||
46784254|NCT03936244|83003123|FG001|Overall Study|Physician Decision|3|||
46784255|NCT03923530|83003130|FG000|Overall Study|Withdrawal by Subject|1|||
46784256|NCT03923530|83003130|FG000|Overall Study|screen failure|3|||
46784257|NCT00608907|83003137|FG000|Overall Study|Adverse Event|6|||
46784258|NCT00608907|83003138|FG001|Overall Study|Adverse Event|0|||
46784259|NCT00608907|83003139|FG002|Overall Study|Adverse Event|1|||
46784260|NCT00608907|83003137|FG000|Overall Study|Death|1|||
47076521|NCT01918397|83371225|FG001|Overall Study|Involved in another investigative trial|0|||
46665172|NCT01817959|82879363|FG000|Overall Study|Adverse Event|1|||
46665173|NCT01817959|82879364|FG001|Overall Study|Adverse Event|0|||
46665174|NCT01817959|82879363|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
46665175|NCT01817959|82879364|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
46665176|NCT01755195|82879370|FG000|Overall Study|Participant noncompliance|2|||
46665177|NCT01755195|82879370|FG000|Overall Study|Switched to alternative treatment|4|||
46784261|NCT00608907|83003138|FG001|Overall Study|Death|0|||
46665178|NCT01755195|82879370|FG000|Overall Study|Withdrawal by Subject|1|||
46665179|NCT01755195|82879370|FG000|Overall Study|Participant refused to start treatment|1|||
46784262|NCT00608907|83003139|FG002|Overall Study|Death|0|||
46784263|NCT00608907|83003137|FG000|Overall Study|Withdrawal by Subject|4|||
46784264|NCT00608907|83003138|FG001|Overall Study|Withdrawal by Subject|0|||
46784265|NCT00608907|83003139|FG002|Overall Study|Withdrawal by Subject|0|||
46784266|NCT00608907|83003137|FG000|Overall Study|Progressive Disease|1|||
46784267|NCT00608907|83003138|FG001|Overall Study|Progressive Disease|0|||
46784268|NCT00608907|83003139|FG002|Overall Study|Progressive Disease|0|||
46784269|NCT00377611|83003149|FG000|Overall Study|Adverse Event|2|||
46784270|NCT00377611|83003150|FG001|Overall Study|Adverse Event|9|||
46784271|NCT00377611|83003149|FG000|Overall Study|Protocol Violation|2|||
46784272|NCT00377611|83003150|FG001|Overall Study|Protocol Violation|0|||
46784273|NCT00377611|83003149|FG000|Overall Study|Withdrawal by Subject|0|||
46784274|NCT00377611|83003150|FG001|Overall Study|Withdrawal by Subject|5|||
46784275|NCT00377611|83003149|FG000|Overall Study|Lost to Follow-up|18|||
46784276|NCT00377611|83003150|FG001|Overall Study|Lost to Follow-up|16|||
46784277|NCT00377611|83003149|FG000|Overall Study|Other|0|||
46665180|NCT01755195|82879370|FG000|Overall Study|Participant has been consented for another trial|1|||
46665181|NCT01755195|82879370|FG000|Overall Study|Refused further treatment|3|||
46784278|NCT00377611|83003150|FG001|Overall Study|Other|3|||
46784279|NCT00545272|83003163|FG000|Overall Study|Protocol deviation|0|||
46784280|NCT00545272|83003164|FG001|Overall Study|Protocol deviation|1|||
47076522|NCT01918397|83371226|FG002|Overall Study|Involved in another investigative trial|0|||
46665182|NCT01755195|82879370|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
46665183|NCT01263769|82879381|FG000|Overall Study|Non-Compliant with treatment|1|||
46784281|NCT00545272|83003165|FG002|Overall Study|Protocol deviation|0|||
46784282|NCT00545272|83003166|FG003|Overall Study|Protocol deviation|1|||
46784283|NCT00545272|83003167|FG004|Overall Study|Protocol deviation|0|||
46784284|NCT00545272|83003168|FG005|Overall Study|Protocol deviation|1|||
46784285|NCT00545272|83003163|FG000|Overall Study|Adverse Event|0|||
46784286|NCT00545272|83003164|FG001|Overall Study|Adverse Event|0|||
46784287|NCT00545272|83003165|FG002|Overall Study|Adverse Event|1|||
46784288|NCT00545272|83003166|FG003|Overall Study|Adverse Event|0|||
46784289|NCT00545272|83003167|FG004|Overall Study|Adverse Event|0|||
46784290|NCT00545272|83003168|FG005|Overall Study|Adverse Event|1|||
46784291|NCT00545272|83003163|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46784292|NCT00545272|83003164|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46784293|NCT00545272|83003165|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46784294|NCT00545272|83003166|FG003|Overall Study|Abnormal laboratory value(s)|0|||
46784295|NCT00545272|83003167|FG004|Overall Study|Abnormal laboratory value(s)|0|||
46784296|NCT00545272|83003168|FG005|Overall Study|Abnormal laboratory value(s)|1|||
46784297|NCT00545272|83003163|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46784298|NCT00545272|83003164|FG001|Overall Study|Abnormal test procedure result(s)|0|||
46784299|NCT00545272|83003165|FG002|Overall Study|Abnormal test procedure result(s)|0|||
46784300|NCT00545272|83003166|FG003|Overall Study|Abnormal test procedure result(s)|0|||
46784301|NCT00545272|83003167|FG004|Overall Study|Abnormal test procedure result(s)|1|||
46784302|NCT00545272|83003168|FG005|Overall Study|Abnormal test procedure result(s)|0|||
46784303|NCT00545272|83003163|FG000|Overall Study|Lost to Follow-up|0|||
46784304|NCT00545272|83003164|FG001|Overall Study|Lost to Follow-up|0|||
46784305|NCT00545272|83003165|FG002|Overall Study|Lost to Follow-up|0|||
46784306|NCT00545272|83003166|FG003|Overall Study|Lost to Follow-up|0|||
46784307|NCT00545272|83003167|FG004|Overall Study|Lost to Follow-up|1|||
46851204|NCT03605680|83066878|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
46851205|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
46851206|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
46851207|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
46851208|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
46851209|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
46851210|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
46851211|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
46851212|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
46851213|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
47076523|NCT01918397|83371227|FG003|Overall Study|Involved in another investigative trial|1|||
47076524|NCT00986921|83371261|FG000|Overall Study|Physician Decision|1|||
47076525|NCT00986921|83371262|FG001|Overall Study|Physician Decision|0|||
46784308|NCT00545272|83003168|FG005|Overall Study|Lost to Follow-up|0|||
46784309|NCT00377455|83003182|FG000|Overall Study|Withdrawal by Subject|1|||
46784310|NCT00377299|83003188|FG000|Overall Study|Lost to Follow-up|14|||
46784311|NCT00377299|83003189|FG001|Overall Study|Lost to Follow-up|19|||
46851214|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
46665184|NCT01004978|82879394|FG000|Overall Study|Disease progression|31|||
46784312|NCT00377299|83003188|FG000|Overall Study|Adverse Event|0|||
46784313|NCT00377299|83003189|FG001|Overall Study|Adverse Event|1|||
46784314|NCT00377299|83003188|FG000|Overall Study|Withdrawal by Subject|5|||
46784315|NCT00377299|83003189|FG001|Overall Study|Withdrawal by Subject|4|||
46784316|NCT00376675|83003207|FG000|Overall Study|Withdrawal by Subject|9|||
46784317|NCT00376675|83003208|FG001|Overall Study|Withdrawal by Subject|2|||
46784318|NCT00376675|83003207|FG000|Overall Study|Adverse Event|10|||
46784319|NCT00376675|83003208|FG001|Overall Study|Adverse Event|5|||
46784320|NCT00376675|83003207|FG000|Overall Study|Other Reason|1|||
46665185|NCT01004978|82879395|FG001|Overall Study|Disease progression|48|||
46665186|NCT01004978|82879394|FG000|Overall Study|Adverse Event|42|||
46665187|NCT01004978|82879395|FG001|Overall Study|Adverse Event|22|||
46665188|NCT01004978|82879394|FG000|Overall Study|Death|3|||
46665189|NCT01004978|82879395|FG001|Overall Study|Death|2|||
46665190|NCT01004978|82879394|FG000|Overall Study|Withdrawal by Subject|16|||
46665191|NCT01004978|82879395|FG001|Overall Study|Withdrawal by Subject|16|||
46665192|NCT01004978|82879394|FG000|Overall Study|Alternative therapy|4|||
46665193|NCT01004978|82879395|FG001|Overall Study|Alternative therapy|8|||
46665194|NCT01004978|82879394|FG000|Overall Study|Physician Decision|6|||
46665195|NCT01004978|82879395|FG001|Overall Study|Physician Decision|3|||
46665196|NCT01004978|82879394|FG000|Overall Study|Other complicating disease|2|||
46665197|NCT01004978|82879395|FG001|Overall Study|Other complicating disease|2|||
46665198|NCT01004978|82879394|FG000|Overall Study|Protocol Violation|2|||
46665199|NCT01004978|82879395|FG001|Overall Study|Protocol Violation|3|||
46665200|NCT01004978|82879394|FG000|Overall Study|Non-compliance|3|||
46665201|NCT01004978|82879395|FG001|Overall Study|Non-compliance|2|||
46784321|NCT00376675|83003208|FG001|Overall Study|Other Reason|7|||
46784322|NCT03931330|83003214|FG000|Overall Study|Physician Decision|1|||
46784323|NCT00367237|83003221|FG000|Overall Study|Adverse Event|7|||
46972309|NCT02709889|83215963|FG000|Overall Study|Study Terminated by Sponsor|4|||
46665202|NCT01004978|82879394|FG000|Overall Study|Ineligible|1|||
46665203|NCT01004978|82879395|FG001|Overall Study|Ineligible|0|||
46665204|NCT01004978|82879394|FG000|Overall Study|Unblinded|0|||
46665205|NCT01004978|82879395|FG001|Overall Study|Unblinded|1|||
46665206|NCT01004978|82879394|FG000|Overall Study|Performance status worsening|0|||
46665207|NCT01004978|82879395|FG001|Overall Study|Performance status worsening|1|||
46665208|NCT01004978|82879394|FG000|Overall Study|Never started treatment|8|||
46665209|NCT01004978|82879395|FG001|Overall Study|Never started treatment|9|||
46665210|NCT00643604|82879401|FG000|Overall Study|Death|1|||
46665211|NCT00447382|82879407|FG000|Overall Study|Adverse Event|1|||
46665212|NCT00447382|82879408|FG001|Overall Study|Adverse Event|1|||
46665213|NCT00447382|82879407|FG000|Overall Study|Lack of Efficacy|1|||
46665214|NCT00447382|82879408|FG001|Overall Study|Lack of Efficacy|0|||
46665215|NCT00447382|82879407|FG000|Overall Study|Protocol Violation|2|||
46665216|NCT00447382|82879408|FG001|Overall Study|Protocol Violation|0|||
46665217|NCT00447382|82879407|FG000|Overall Study|Unclassified|2|||
46665218|NCT00447382|82879408|FG001|Overall Study|Unclassified|5|||
46665219|NCT00135668|82879442|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
46665220|NCT00135668|82879443|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
46665221|NCT00135668|82879444|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
46665222|NCT00135668|82879445|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
46665223|NCT00066703|82879476|FG000|Overall Study|Adverse Event|80|||
46665224|NCT00066703|82879477|FG001|Overall Study|Adverse Event|111|||
46665225|NCT00066703|82879476|FG000|Overall Study|Death|3|||
46665226|NCT00066703|82879477|FG001|Overall Study|Death|0|||
46665227|NCT00066703|82879476|FG000|Overall Study|Lack of Efficacy|114|||
46665228|NCT00066703|82879477|FG001|Overall Study|Lack of Efficacy|69|||
46665229|NCT00066703|82879476|FG000|Overall Study|Lost to Follow-up|31|||
46665230|NCT00066703|82879477|FG001|Overall Study|Lost to Follow-up|28|||
46665231|NCT00066703|82879476|FG000|Overall Study|Withdrawal by Subject|38|||
46665232|NCT00066703|82879477|FG001|Overall Study|Withdrawal by Subject|63|||
46665233|NCT00066703|82879476|FG000|Overall Study|Treatment ongoing|346|||
46665234|NCT00066703|82879477|FG001|Overall Study|Treatment ongoing|311|||
46665235|NCT00066690|82879486|FG000|Overall Study|Adverse Event|145|||
46665236|NCT00066690|82879487|FG001|Overall Study|Adverse Event|58|||
46665237|NCT00066690|82879488|FG002|Overall Study|Adverse Event|126|||
46665238|NCT00066690|82879486|FG000|Overall Study|Death|3|||
46665239|NCT00066690|82879487|FG001|Overall Study|Death|0|||
46665240|NCT00066690|82879488|FG002|Overall Study|Death|2|||
46665241|NCT00066690|82879486|FG000|Overall Study|Lack of Efficacy|114|||
46665242|NCT00066690|82879487|FG001|Overall Study|Lack of Efficacy|110|||
46665243|NCT00066690|82879488|FG002|Overall Study|Lack of Efficacy|76|||
46665244|NCT00066690|82879486|FG000|Overall Study|Lost to Follow-up|40|||
46665245|NCT00066690|82879487|FG001|Overall Study|Lost to Follow-up|21|||
46665246|NCT00066690|82879488|FG002|Overall Study|Lost to Follow-up|29|||
46665247|NCT00066690|82879486|FG000|Overall Study|Withdrawal by Subject|50|||
46784324|NCT00367237|83003222|FG001|Overall Study|Adverse Event|2|||
46665248|NCT00066690|82879487|FG001|Overall Study|Withdrawal by Subject|55|||
46665249|NCT00066690|82879488|FG002|Overall Study|Withdrawal by Subject|49|||
46665250|NCT00066690|82879486|FG000|Overall Study|Treatment Ongoing|246|||
46784325|NCT00367237|83003221|FG000|Overall Study|Lost to Follow-up|1|||
46665251|NCT00066690|82879487|FG001|Overall Study|Treatment Ongoing|278|||
46665252|NCT00066690|82879488|FG002|Overall Study|Treatment Ongoing|282|||
46665253|NCT01053962|82879504|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
46665254|NCT01053962|82879505|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
46665255|NCT01053962|82879506|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
46665256|NCT01053962|82879507|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
46665257|NCT01053962|82879508|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
46665258|NCT01053962|82879504|FG000|Pretreatment Period|Venipuncture Failure|0|||
46665259|NCT01053962|82879505|FG001|Pretreatment Period|Venipuncture Failure|0|||
46665260|NCT01053962|82879506|FG002|Pretreatment Period|Venipuncture Failure|1|||
46665261|NCT01053962|82879507|FG003|Pretreatment Period|Venipuncture Failure|0|||
46665262|NCT01053962|82879508|FG004|Pretreatment Period|Venipuncture Failure|0|||
46665263|NCT01053962|82879504|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
46665264|NCT01053962|82879505|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
46665265|NCT01053962|82879506|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
46665266|NCT01053962|82879507|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
46665267|NCT01053962|82879508|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
46665268|NCT01053962|82879504|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
46665269|NCT01053962|82879505|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
46665270|NCT01053962|82879506|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
46665271|NCT01053962|82879507|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
46665272|NCT01053962|82879508|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
46665273|NCT01053962|82879504|FG000|Treatment Period|Lack of Efficacy|0|||
46665274|NCT01053962|82879505|FG001|Treatment Period|Lack of Efficacy|0|||
46665275|NCT01053962|82879506|FG002|Treatment Period|Lack of Efficacy|0|||
46665276|NCT01053962|82879507|FG003|Treatment Period|Lack of Efficacy|0|||
46665277|NCT01053962|82879508|FG004|Treatment Period|Lack of Efficacy|1|||
46665278|NCT01053962|82879504|FG000|Treatment Period|Adverse Event|0|||
46665279|NCT01053962|82879505|FG001|Treatment Period|Adverse Event|0|||
46665280|NCT01053962|82879506|FG002|Treatment Period|Adverse Event|0|||
46665281|NCT01053962|82879507|FG003|Treatment Period|Adverse Event|0|||
46665282|NCT01053962|82879508|FG004|Treatment Period|Adverse Event|1|||
46665283|NCT01053962|82879504|FG000|Treatment Period|Withdrawal by Subject|0|||
46665284|NCT01053962|82879505|FG001|Treatment Period|Withdrawal by Subject|0|||
46665285|NCT01053962|82879506|FG002|Treatment Period|Withdrawal by Subject|0|||
46665286|NCT01053962|82879507|FG003|Treatment Period|Withdrawal by Subject|0|||
46784326|NCT00367237|83003222|FG001|Overall Study|Lost to Follow-up|0|||
46784327|NCT00367237|83003221|FG000|Overall Study|Withdrawal by Subject|0|||
46784328|NCT00367237|83003222|FG001|Overall Study|Withdrawal by Subject|4|||
46784329|NCT00367237|83003221|FG000|Overall Study|Protocol Violation|2|||
46665287|NCT01053962|82879508|FG004|Treatment Period|Withdrawal by Subject|1|||
46665288|NCT01053962|82879504|FG000|Treatment Period|Noncompliance with protocol|1|||
46784330|NCT00367237|83003222|FG001|Overall Study|Protocol Violation|5|||
46784331|NCT00544882|83003230|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
46784332|NCT00544882|83003231|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
46784333|NCT00544882|83003232|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
46784334|NCT00544882|83003230|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
46665289|NCT01053962|82879505|FG001|Treatment Period|Noncompliance with protocol|0|||
46665290|NCT01053962|82879506|FG002|Treatment Period|Noncompliance with protocol|0|||
46665291|NCT01053962|82879507|FG003|Treatment Period|Noncompliance with protocol|0|||
46665292|NCT01053962|82879508|FG004|Treatment Period|Noncompliance with protocol|0|||
46665293|NCT01053221|82879527|FG000|Overall Study|The study was closed prematurely|5|||
46665294|NCT01053221|82879528|FG001|Overall Study|The study was closed prematurely|9|||
46665295|NCT01052012|82879540|FG000|Overall Study|Not treated|2|||
46665296|NCT01052012|82879541|FG001|Overall Study|Not treated|5|||
46784335|NCT00544882|83003231|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
46784336|NCT00544882|83003232|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
46784337|NCT00544882|83003230|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
46784338|NCT00544882|83003231|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
46784339|NCT00544882|83003232|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
46784340|NCT00544882|83003230|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
46784341|NCT00544882|83003231|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
46784342|NCT00544882|83003232|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
46784343|NCT00544882|83003230|FG000|Cycle 3: Follow-up|Noncompliance|0|||
46784344|NCT00544882|83003231|FG001|Cycle 3: Follow-up|Noncompliance|1|||
47076526|NCT01596972|83371273|FG000|Overall Study|Physician Decision|1|||
47076527|NCT01596972|83371274|FG001|Overall Study|Physician Decision|9|||
46665297|NCT01052012|82879542|FG002|Overall Study|Not treated|0|||
46665298|NCT01052012|82879543|FG003|Overall Study|Not treated|0|||
46665299|NCT01052012|82879544|FG004|Overall Study|Not treated|11|||
46665300|NCT01052012|82879545|FG005|Overall Study|Not treated|8|||
46665301|NCT01052012|82879540|FG000|Overall Study|Adverse Event|1|||
46665302|NCT01052012|82879541|FG001|Overall Study|Adverse Event|0|||
46665303|NCT01052012|82879542|FG002|Overall Study|Adverse Event|0|||
46784345|NCT00544882|83003232|FG002|Cycle 3: Follow-up|Noncompliance|0|||
46784346|NCT00544882|83003230|FG000|Cycle 3: Follow-up|Pregnancy|0|||
46784347|NCT00544882|83003231|FG001|Cycle 3: Follow-up|Pregnancy|1|||
47076528|NCT01596972|83371273|FG000|Overall Study|Lost to Follow-up|0|||
47076529|NCT01596972|83371274|FG001|Overall Study|Lost to Follow-up|4|||
47076530|NCT01596972|83371273|FG000|Overall Study|Withdrawal by Subject|0|||
46665304|NCT01052012|82879543|FG003|Overall Study|Adverse Event|1|||
46665305|NCT01052012|82879544|FG004|Overall Study|Adverse Event|0|||
46665306|NCT01052012|82879545|FG005|Overall Study|Adverse Event|0|||
46665307|NCT01052012|82879540|FG000|Overall Study|Lost to Follow-up|0|||
46665308|NCT01052012|82879541|FG001|Overall Study|Lost to Follow-up|0|||
46665309|NCT01052012|82879542|FG002|Overall Study|Lost to Follow-up|0|||
46665310|NCT01052012|82879543|FG003|Overall Study|Lost to Follow-up|0|||
46665311|NCT01052012|82879544|FG004|Overall Study|Lost to Follow-up|1|||
46665312|NCT01052012|82879545|FG005|Overall Study|Lost to Follow-up|0|||
46665313|NCT01052012|82879540|FG000|Overall Study|Withdrawal by Subject|1|||
46665314|NCT01052012|82879541|FG001|Overall Study|Withdrawal by Subject|1|||
46665315|NCT01052012|82879542|FG002|Overall Study|Withdrawal by Subject|0|||
46665316|NCT01052012|82879543|FG003|Overall Study|Withdrawal by Subject|0|||
46665317|NCT01052012|82879544|FG004|Overall Study|Withdrawal by Subject|3|||
46665318|NCT01052012|82879545|FG005|Overall Study|Withdrawal by Subject|1|||
46665319|NCT01052012|82879540|FG000|Overall Study|Physician Decision|0|||
46665320|NCT01052012|82879541|FG001|Overall Study|Physician Decision|0|||
46665321|NCT01052012|82879542|FG002|Overall Study|Physician Decision|0|||
46665322|NCT01052012|82879543|FG003|Overall Study|Physician Decision|0|||
46665323|NCT01052012|82879544|FG004|Overall Study|Physician Decision|0|||
46665324|NCT01052012|82879545|FG005|Overall Study|Physician Decision|1|||
46665325|NCT01052012|82879540|FG000|Overall Study|Other|0|||
46665326|NCT01052012|82879541|FG001|Overall Study|Other|0|||
46665327|NCT01052012|82879542|FG002|Overall Study|Other|0|||
46665328|NCT01052012|82879543|FG003|Overall Study|Other|0|||
46665329|NCT01052012|82879544|FG004|Overall Study|Other|1|||
46665330|NCT01052012|82879545|FG005|Overall Study|Other|0|||
46665331|NCT01051817|82879561|FG000|Overall Study|Adverse Event|0|||
46665332|NCT01051817|82879562|FG001|Overall Study|Adverse Event|2|||
46665333|NCT01051817|82879561|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
46784348|NCT00544882|83003232|FG002|Cycle 3: Follow-up|Pregnancy|0|||
46784349|NCT00606801|83003240|FG000|Intervention|Protocol Violation|3|||
46784350|NCT00606801|83003241|FG001|Intervention|Protocol Violation|3|||
46784351|NCT00606177|83003253|FG000|Overall Study|Adverse Event|9|||
46784352|NCT00606177|83003254|FG001|Overall Study|Adverse Event|5|||
46784353|NCT00606177|83003253|FG000|Overall Study|Lack of Efficacy|3|||
46784354|NCT00606177|83003254|FG001|Overall Study|Lack of Efficacy|7|||
46784355|NCT00606177|83003253|FG000|Overall Study|Physician Decision|1|||
46784356|NCT00606177|83003254|FG001|Overall Study|Physician Decision|0|||
46784357|NCT00606177|83003253|FG000|Overall Study|Protocol Violation|1|||
46784358|NCT00606177|83003254|FG001|Overall Study|Protocol Violation|4|||
46784359|NCT00606177|83003253|FG000|Overall Study|Withdrawal by Subject|5|||
46784360|NCT00606177|83003254|FG001|Overall Study|Withdrawal by Subject|6|||
46784361|NCT00606177|83003253|FG000|Overall Study|Progression to depressive phase|6|||
46784362|NCT00606177|83003254|FG001|Overall Study|Progression to depressive phase|1|||
46784363|NCT00606177|83003253|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
46784364|NCT00606177|83003254|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
46784365|NCT00606177|83003253|FG000|Overall Study|Change of residence or other commitments|1|||
46784366|NCT00606177|83003254|FG001|Overall Study|Change of residence or other commitments|1|||
46784367|NCT00359281|83003269|FG000|Overall Study|Adverse Event|1|||
46784368|NCT00359281|83003270|FG001|Overall Study|Adverse Event|0|||
46784369|NCT00359281|83003271|FG002|Overall Study|Adverse Event|0|||
46784370|NCT00359281|83003272|FG003|Overall Study|Adverse Event|0|||
47076531|NCT01596972|83371274|FG001|Overall Study|Withdrawal by Subject|1|||
47076532|NCT00985751|83371375|FG000|Overall Study|Adverse Event|0|||
47076533|NCT00985751|83371376|FG001|Overall Study|Adverse Event|0|||
47076534|NCT00985751|83371377|FG002|Overall Study|Adverse Event|0|||
47076535|NCT00985751|83371378|FG003|Overall Study|Adverse Event|0|||
47076536|NCT00985751|83371379|FG004|Overall Study|Adverse Event|1|||
47076537|NCT01596582|83371424|FG000|Overall Study|Deemed ineligible after study visit|3|||
47076538|NCT01596582|83371425|FG001|Overall Study|Deemed ineligible after study visit|6|||
47076539|NCT01596582|83371424|FG000|Overall Study|Missing all outcome data|1|||
46665334|NCT01051817|82879562|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
46665335|NCT01051817|82879561|FG000|Overall Study|Withdrawal by Subject|3|||
46784371|NCT00359281|83003273|FG004|Overall Study|Adverse Event|0|||
46784372|NCT00359281|83003274|FG005|Overall Study|Adverse Event|0|||
46784373|NCT00359281|83003275|FG006|Overall Study|Adverse Event|1|||
46784374|NCT00359281|83003276|FG007|Overall Study|Adverse Event|0|||
47076540|NCT01596582|83371425|FG001|Overall Study|Missing all outcome data|1|||
47076541|NCT01596504|83371441|FG000|Overall Study|Participant's Private Reason|0|||
46665336|NCT01051817|82879562|FG001|Overall Study|Withdrawal by Subject|5|||
46665337|NCT01051817|82879561|FG000|Overall Study|Protocol Violation|0|||
46665338|NCT01051817|82879562|FG001|Overall Study|Protocol Violation|1|||
46665339|NCT01327846|82879572|FG000|Core Phase|Subject decision (vital status: missing)|1|||
46665340|NCT01327846|82879573|FG001|Core Phase|Subject decision (vital status: missing)|2|||
46665341|NCT01327846|82879574|FG002|Core Phase|Subject decision (vital status: missing)|2|||
46784375|NCT00359281|83003277|FG008|Overall Study|Adverse Event|0|||
46784376|NCT00359281|83003269|FG000|Overall Study|Withdrawal by Subject|0|||
47076542|NCT01596504|83371442|FG001|Overall Study|Participant's Private Reason|1|||
47076543|NCT01596504|83371443|FG002|Overall Study|Participant's Private Reason|0|||
47076544|NCT01596504|83371441|FG000|Overall Study|Adverse Event|1|||
47076545|NCT01596504|83371442|FG001|Overall Study|Adverse Event|2|||
47076546|NCT01596504|83371443|FG002|Overall Study|Adverse Event|1|||
47076547|NCT01596504|83371441|FG000|Overall Study|Withdrawal by Subject|1|||
47076548|NCT01596504|83371442|FG001|Overall Study|Withdrawal by Subject|0|||
47076549|NCT01596504|83371443|FG002|Overall Study|Withdrawal by Subject|0|||
47076550|NCT02616900|83371485|FG000|Overall Study|Lack of Efficacy|7|||
47076551|NCT02616900|83371485|FG000|Overall Study|Lost to Follow-up|2|||
47076552|NCT02616900|83371485|FG000|Overall Study|Protocol Violation|5|||
47076553|NCT02616900|83371485|FG000|Overall Study|Withdrawal by Subject|3|||
47076554|NCT02616900|83371485|FG000|Overall Study|Incomplete data|6|||
47076555|NCT00985673|83371597|FG000|Overall Study|Lost to Follow-up|6|||
47076556|NCT00985673|83371598|FG001|Overall Study|Lost to Follow-up|7|||
46784377|NCT00359281|83003270|FG001|Overall Study|Withdrawal by Subject|0|||
46784378|NCT00359281|83003271|FG002|Overall Study|Withdrawal by Subject|0|||
46784379|NCT00359281|83003272|FG003|Overall Study|Withdrawal by Subject|0|||
46784380|NCT00359281|83003273|FG004|Overall Study|Withdrawal by Subject|0|||
47076557|NCT00985673|83371599|FG002|Overall Study|Lost to Follow-up|6|||
46665342|NCT01327846|82879575|FG003|Core Phase|Subject decision (vital status: missing)|1|||
46665343|NCT01327846|82879572|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
46665344|NCT01327846|82879573|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
46665345|NCT01327846|82879574|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
46665346|NCT01327846|82879575|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
46665347|NCT01327846|82879572|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
46665348|NCT01327846|82879573|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
46665349|NCT01327846|82879574|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
46665350|NCT01327846|82879575|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
46665351|NCT01327846|82879572|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
46665352|NCT01327846|82879573|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
46665353|NCT01327846|82879574|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
46665354|NCT01327846|82879575|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
46665355|NCT01327846|82879572|FG000|Core Phase|Lost to Follow-up|3|||
46665356|NCT01327846|82879573|FG001|Core Phase|Lost to Follow-up|3|||
46665357|NCT01327846|82879574|FG002|Core Phase|Lost to Follow-up|4|||
46665358|NCT01327846|82879575|FG003|Core Phase|Lost to Follow-up|5|||
46665359|NCT01327846|82879572|FG000|Extension Phase|Study terminated by sponsor|1073|||
46665360|NCT01327846|82879573|FG001|Extension Phase|Study terminated by sponsor|1124|||
46665361|NCT01327846|82879574|FG002|Extension Phase|Study terminated by sponsor|1067|||
46665362|NCT01327846|82879575|FG003|Extension Phase|Study terminated by sponsor|1660|||
46665363|NCT01327846|82879572|FG000|Extension Phase|Withdrawal by Subject|20|||
46665364|NCT01327846|82879573|FG001|Extension Phase|Withdrawal by Subject|13|||
46665365|NCT01327846|82879574|FG002|Extension Phase|Withdrawal by Subject|19|||
46665366|NCT01327846|82879575|FG003|Extension Phase|Withdrawal by Subject|37|||
46665367|NCT01327846|82879572|FG000|Extension Phase|Lost to Follow-up|4|||
46665368|NCT01327846|82879573|FG001|Extension Phase|Lost to Follow-up|3|||
46665369|NCT01327846|82879574|FG002|Extension Phase|Lost to Follow-up|4|||
46665370|NCT01327846|82879575|FG003|Extension Phase|Lost to Follow-up|7|||
46665371|NCT01327846|82879572|FG000|Extension Phase|Technical Problems|2|||
46665372|NCT01327846|82879573|FG001|Extension Phase|Technical Problems|4|||
46665373|NCT01327846|82879574|FG002|Extension Phase|Technical Problems|2|||
46665374|NCT01327846|82879575|FG003|Extension Phase|Technical Problems|2|||
46665375|NCT01051739|82879588|FG000|Overall Study|Death|3|||
46665376|NCT01051739|82879589|FG001|Overall Study|Death|3|||
46784381|NCT00359281|83003274|FG005|Overall Study|Withdrawal by Subject|0|||
46784382|NCT00359281|83003275|FG006|Overall Study|Withdrawal by Subject|1|||
46784383|NCT00359281|83003276|FG007|Overall Study|Withdrawal by Subject|0|||
46784384|NCT00359281|83003277|FG008|Overall Study|Withdrawal by Subject|0|||
46784385|NCT00366535|83003306|FG000|First Phase: 12 Weeks|Adverse Event|1|||
46784386|NCT00366535|83003307|FG001|First Phase: 12 Weeks|Adverse Event|3|||
46784387|NCT00366535|83003306|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
46784388|NCT00366535|83003307|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
46784389|NCT00366535|83003306|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
47076558|NCT00985673|83371600|FG003|Overall Study|Lost to Follow-up|10|||
47076559|NCT00985673|83371601|FG004|Overall Study|Lost to Follow-up|5|||
47076560|NCT00985673|83371602|FG005|Overall Study|Lost to Follow-up|3|||
47076561|NCT00985673|83371597|FG000|Overall Study|Withdrawal by Subject|0|||
46665377|NCT01051739|82879588|FG000|Overall Study|Withdrawal by Subject|25|||
47076562|NCT00985673|83371598|FG001|Overall Study|Withdrawal by Subject|4|||
47076563|NCT00985673|83371599|FG002|Overall Study|Withdrawal by Subject|5|||
46665378|NCT01051739|82879589|FG001|Overall Study|Withdrawal by Subject|10|||
46665379|NCT01051661|82879601|FG000|Overall Study|Adverse Event|1|||
46665380|NCT01051661|82879602|FG001|Overall Study|Adverse Event|1|||
47076564|NCT00985673|83371600|FG003|Overall Study|Withdrawal by Subject|2|||
47076565|NCT00985673|83371601|FG004|Overall Study|Withdrawal by Subject|2|||
46784390|NCT00366535|83003307|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
46784391|NCT00366535|83003306|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
46784392|NCT00366535|83003307|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
46784393|NCT00350545|83003321|FG000|Overall Study|Withdrawal by Subject|2|||
46784394|NCT00349921|83003329|FG000|First Spinal Injection|Physician Decision|1|||
46784395|NCT00349921|83003330|FG001|First Spinal Injection|Physician Decision|0|||
46784396|NCT00349921|83003331|FG002|First Spinal Injection|Physician Decision|0|||
46784397|NCT00349921|83003332|FG003|First Spinal Injection|Physician Decision|0|||
46784398|NCT00349921|83003329|FG000|First Spinal Injection|Adverse Event|0|||
46784399|NCT00349921|83003330|FG001|First Spinal Injection|Adverse Event|0|||
46784400|NCT00349921|83003331|FG002|First Spinal Injection|Adverse Event|1|||
46784401|NCT00349921|83003332|FG003|First Spinal Injection|Adverse Event|0|||
46784402|NCT00606021|83003343|FG000|Induction Phase|Death|73|||
46784403|NCT00606021|83003344|FG001|Induction Phase|Death|0|||
46665381|NCT01051661|82879603|FG002|Overall Study|Adverse Event|1|||
46665382|NCT01051661|82879604|FG003|Overall Study|Adverse Event|1|||
46665383|NCT01051661|82879605|FG004|Overall Study|Adverse Event|0|||
46665384|NCT01051661|82879606|FG005|Overall Study|Adverse Event|0|||
46665385|NCT01051661|82879601|FG000|Overall Study|Lost to Follow-up|13|||
46665386|NCT01051661|82879602|FG001|Overall Study|Lost to Follow-up|22|||
46665387|NCT01051661|82879603|FG002|Overall Study|Lost to Follow-up|15|||
46665388|NCT01051661|82879604|FG003|Overall Study|Lost to Follow-up|17|||
46665389|NCT01051661|82879605|FG004|Overall Study|Lost to Follow-up|10|||
46665390|NCT01051661|82879606|FG005|Overall Study|Lost to Follow-up|24|||
46665391|NCT01051661|82879601|FG000|Overall Study|Migrated/moved from study area|1|||
46665392|NCT01051661|82879602|FG001|Overall Study|Migrated/moved from study area|6|||
46665393|NCT01051661|82879603|FG002|Overall Study|Migrated/moved from study area|6|||
46665394|NCT01051661|82879604|FG003|Overall Study|Migrated/moved from study area|8|||
46665395|NCT01051661|82879605|FG004|Overall Study|Migrated/moved from study area|7|||
46665396|NCT01051661|82879606|FG005|Overall Study|Migrated/moved from study area|3|||
46665397|NCT01051661|82879601|FG000|Overall Study|Refused blood sampling|0|||
46665398|NCT01051661|82879602|FG001|Overall Study|Refused blood sampling|0|||
46665399|NCT01051661|82879603|FG002|Overall Study|Refused blood sampling|0|||
46665400|NCT01051661|82879604|FG003|Overall Study|Refused blood sampling|0|||
46665401|NCT01051661|82879605|FG004|Overall Study|Refused blood sampling|0|||
46665402|NCT01051661|82879606|FG005|Overall Study|Refused blood sampling|1|||
46665403|NCT01051661|82879601|FG000|Overall Study|Data not reliable|1|||
46665404|NCT01051661|82879602|FG001|Overall Study|Data not reliable|0|||
46665405|NCT01051661|82879603|FG002|Overall Study|Data not reliable|0|||
46665406|NCT01051661|82879604|FG003|Overall Study|Data not reliable|0|||
46665407|NCT01051661|82879605|FG004|Overall Study|Data not reliable|0|||
46665408|NCT01051661|82879606|FG005|Overall Study|Data not reliable|1|||
46665409|NCT01051661|82879601|FG000|Overall Study|Unable to attend visit(s)|2|||
46665410|NCT01051661|82879602|FG001|Overall Study|Unable to attend visit(s)|4|||
46665411|NCT01051661|82879603|FG002|Overall Study|Unable to attend visit(s)|2|||
46665412|NCT01051661|82879604|FG003|Overall Study|Unable to attend visit(s)|1|||
46665413|NCT01051661|82879605|FG004|Overall Study|Unable to attend visit(s)|3|||
46665414|NCT01051661|82879606|FG005|Overall Study|Unable to attend visit(s)|2|||
46665415|NCT01051661|82879601|FG000|Overall Study|Consent not received from both parents|0|||
46665416|NCT01051661|82879602|FG001|Overall Study|Consent not received from both parents|0|||
46665417|NCT01051661|82879603|FG002|Overall Study|Consent not received from both parents|0|||
46665418|NCT01051661|82879604|FG003|Overall Study|Consent not received from both parents|0|||
46665419|NCT01051661|82879605|FG004|Overall Study|Consent not received from both parents|0|||
46665420|NCT01051661|82879606|FG005|Overall Study|Consent not received from both parents|1|||
46665421|NCT01051661|82879601|FG000|Overall Study|Failure to comply with protocol|0|||
46665422|NCT01051661|82879602|FG001|Overall Study|Failure to comply with protocol|0|||
46665423|NCT01051661|82879603|FG002|Overall Study|Failure to comply with protocol|2|||
46665424|NCT01051661|82879604|FG003|Overall Study|Failure to comply with protocol|0|||
46665425|NCT01051661|82879605|FG004|Overall Study|Failure to comply with protocol|0|||
46665426|NCT01051661|82879606|FG005|Overall Study|Failure to comply with protocol|0|||
46665427|NCT01051661|82879601|FG000|Overall Study|Subject lost legal representation|0|||
46665428|NCT01051661|82879602|FG001|Overall Study|Subject lost legal representation|0|||
46665429|NCT01051661|82879603|FG002|Overall Study|Subject lost legal representation|0|||
46784404|NCT00606021|83003345|FG002|Induction Phase|Death|0|||
46784405|NCT00606021|83003343|FG000|Induction Phase|Physician Decision|2|||
46784406|NCT00606021|83003344|FG001|Induction Phase|Physician Decision|0|||
46784407|NCT00606021|83003345|FG002|Induction Phase|Physician Decision|0|||
46784408|NCT00606021|83003343|FG000|Induction Phase|Withdrawal by Subject|2|||
46665430|NCT01051661|82879604|FG003|Overall Study|Subject lost legal representation|0|||
46665431|NCT01051661|82879605|FG004|Overall Study|Subject lost legal representation|1|||
46665432|NCT01051661|82879606|FG005|Overall Study|Subject lost legal representation|0|||
46665433|NCT01051661|82879601|FG000|Overall Study|Protocol Violation|0|||
46665434|NCT01051661|82879602|FG001|Overall Study|Protocol Violation|0|||
46665435|NCT01051661|82879603|FG002|Overall Study|Protocol Violation|0|||
46784409|NCT00606021|83003344|FG001|Induction Phase|Withdrawal by Subject|0|||
46665436|NCT01051661|82879604|FG003|Overall Study|Protocol Violation|1|||
46665437|NCT01051661|82879605|FG004|Overall Study|Protocol Violation|2|||
47076566|NCT00985673|83371602|FG005|Overall Study|Withdrawal by Subject|3|||
47076567|NCT00985673|83371597|FG000|Overall Study|Other|1|||
46665438|NCT01051661|82879606|FG005|Overall Study|Protocol Violation|1|||
46665439|NCT01051661|82879601|FG000|Overall Study|Withdrawal by Subject|16|||
46665440|NCT01051661|82879602|FG001|Overall Study|Withdrawal by Subject|30|||
46665441|NCT01051661|82879603|FG002|Overall Study|Withdrawal by Subject|13|||
46665442|NCT01051661|82879604|FG003|Overall Study|Withdrawal by Subject|28|||
46665443|NCT01051661|82879605|FG004|Overall Study|Withdrawal by Subject|12|||
46665444|NCT01051661|82879606|FG005|Overall Study|Withdrawal by Subject|34|||
46665445|NCT01051466|82879643|FG000|Overall Study|Adverse Event|1|||
46665446|NCT01051466|82879644|FG001|Overall Study|Adverse Event|0|||
46665447|NCT01051466|82879643|FG000|Overall Study|Lost to Follow-up|1|||
46665448|NCT01051466|82879644|FG001|Overall Study|Lost to Follow-up|1|||
46665449|NCT01051466|82879643|FG000|Overall Study|Withdrawal by Subject|5|||
46665450|NCT01051466|82879644|FG001|Overall Study|Withdrawal by Subject|1|||
46665451|NCT01051466|82879643|FG000|Overall Study|Entry Criteria Not Met|0|||
46665452|NCT01051466|82879644|FG001|Overall Study|Entry Criteria Not Met|3|||
46665453|NCT01051466|82879643|FG000|Overall Study|Physician Decision|1|||
46665454|NCT01051466|82879644|FG001|Overall Study|Physician Decision|0|||
46665455|NCT01051349|82879658|FG000|Overall Study|Adverse Event|88|||
46665456|NCT01051349|82879658|FG000|Overall Study|Consent Withdrawn|54|||
46665457|NCT01051349|82879658|FG000|Overall Study|Investigator Decision|6|||
46665458|NCT01051349|82879658|FG000|Overall Study|Lost to Follow-up|6|||
46665459|NCT01051349|82879658|FG000|Overall Study|Subject non-compliance|7|||
46665460|NCT01051349|82879658|FG000|Overall Study|Reason not Specified|12|||
46665461|NCT01050998|82879670|FG000|Overall Study|Adverse Event|1|||
46665462|NCT01050998|82879671|FG001|Overall Study|Adverse Event|0|||
46665463|NCT01050998|82879672|FG002|Overall Study|Adverse Event|1|||
46665464|NCT01050998|82879673|FG003|Overall Study|Adverse Event|0|||
46665465|NCT01050998|82879674|FG004|Overall Study|Adverse Event|2|||
46665466|NCT01050998|82879670|FG000|Overall Study|Withdrawal by Subject|0|||
46665467|NCT01050998|82879671|FG001|Overall Study|Withdrawal by Subject|0|||
46665468|NCT01050998|82879672|FG002|Overall Study|Withdrawal by Subject|0|||
46665469|NCT01050998|82879673|FG003|Overall Study|Withdrawal by Subject|1|||
46665470|NCT01050998|82879674|FG004|Overall Study|Withdrawal by Subject|3|||
46665471|NCT01050998|82879670|FG000|Overall Study|Other|3|||
46665472|NCT01050998|82879671|FG001|Overall Study|Other|2|||
46665473|NCT01050998|82879672|FG002|Overall Study|Other|1|||
46665474|NCT01050998|82879673|FG003|Overall Study|Other|1|||
46665475|NCT01050998|82879674|FG004|Overall Study|Other|5|||
46665476|NCT01050998|82879670|FG000|Overall Study|Data integrity issues|0|||
46665477|NCT01050998|82879671|FG001|Overall Study|Data integrity issues|0|||
46665478|NCT01050998|82879672|FG002|Overall Study|Data integrity issues|1|||
46665479|NCT01050998|82879673|FG003|Overall Study|Data integrity issues|1|||
46665480|NCT01050998|82879674|FG004|Overall Study|Data integrity issues|4|||
46665481|NCT00106028|82879692|FG000|Overall Study|Adverse Event|3|||
46665482|NCT00106028|82879693|FG001|Overall Study|Adverse Event|2|||
46665483|NCT00106028|82879692|FG000|Overall Study|Protocol Violation|1|||
46665484|NCT00106028|82879693|FG001|Overall Study|Protocol Violation|1|||
46665485|NCT00106028|82879692|FG000|Overall Study|Withdrawal by Subject|2|||
46665486|NCT00106028|82879693|FG001|Overall Study|Withdrawal by Subject|8|||
46665487|NCT00106028|82879692|FG000|Overall Study|Lost to Follow-up|0|||
46665488|NCT00106028|82879693|FG001|Overall Study|Lost to Follow-up|1|||
46665489|NCT01050764|82879701|FG000|Overall Study|Death, before HSCT|1|||
46665490|NCT01050764|82879701|FG000|Overall Study|Donor mobilization failure, death|1|||
46665491|NCT01050764|82879701|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
46665492|NCT01050569|82879708|FG000|Overall Study|Lost to Follow-up|20|||
46665493|NCT01050569|82879709|FG001|Overall Study|Lost to Follow-up|14|||
46665494|NCT01050569|82879710|FG002|Overall Study|Lost to Follow-up|16|||
47076568|NCT00985673|83371598|FG001|Overall Study|Other|0|||
47076569|NCT00985673|83371599|FG002|Overall Study|Other|1|||
47076570|NCT00985673|83371600|FG003|Overall Study|Other|0|||
47076571|NCT00985673|83371601|FG004|Overall Study|Other|1|||
46665495|NCT01050569|82879708|FG000|Overall Study|Withdrawal by Subject|9|||
46665496|NCT01050569|82879709|FG001|Overall Study|Withdrawal by Subject|3|||
46665497|NCT01050569|82879710|FG002|Overall Study|Withdrawal by Subject|11|||
46665498|NCT01050569|82879708|FG000|Overall Study|Lack of Efficacy|5|||
46665499|NCT01050569|82879709|FG001|Overall Study|Lack of Efficacy|4|||
46665500|NCT01050569|82879710|FG002|Overall Study|Lack of Efficacy|3|||
46665501|NCT01050569|82879708|FG000|Overall Study|Adverse Event|1|||
46665502|NCT01050569|82879709|FG001|Overall Study|Adverse Event|0|||
46665503|NCT01050569|82879710|FG002|Overall Study|Adverse Event|0|||
46665504|NCT01050569|82879708|FG000|Overall Study|Physician Decision|3|||
46665505|NCT01050569|82879709|FG001|Overall Study|Physician Decision|3|||
46665506|NCT01050569|82879710|FG002|Overall Study|Physician Decision|3|||
46665507|NCT01050530|82879724|FG000|Overall Study|Adverse Event|6|||
47076572|NCT00985673|83371602|FG005|Overall Study|Other|0|||
46665508|NCT01050530|82879725|FG001|Overall Study|Adverse Event|3|||
46665509|NCT01050530|82879724|FG000|Overall Study|Lack of Efficacy|1|||
46665510|NCT01050530|82879725|FG001|Overall Study|Lack of Efficacy|4|||
46665511|NCT01050530|82879724|FG000|Overall Study|Withdrawal by Subject|0|||
46665512|NCT01050530|82879725|FG001|Overall Study|Withdrawal by Subject|3|||
46665513|NCT01050530|82879724|FG000|Overall Study|Protocol Violation|1|||
46665514|NCT01050530|82879725|FG001|Overall Study|Protocol Violation|0|||
46665515|NCT01050257|82879734|FG000|Overall Study|Adverse Event|4|||
46665516|NCT01050257|82879735|FG001|Overall Study|Adverse Event|4|||
46665517|NCT01050257|82879736|FG002|Overall Study|Adverse Event|2|||
46665518|NCT01050257|82879734|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
46665519|NCT01050257|82879735|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
46665520|NCT01050257|82879736|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
46665521|NCT01050257|82879734|FG000|Overall Study|Withdrawal by Subject|0|||
46665522|NCT01050257|82879735|FG001|Overall Study|Withdrawal by Subject|3|||
46665523|NCT01050257|82879736|FG002|Overall Study|Withdrawal by Subject|0|||
46665524|NCT01050257|82879734|FG000|Overall Study|No reason specified|0|||
46665525|NCT01050257|82879735|FG001|Overall Study|No reason specified|0|||
46665526|NCT01050257|82879736|FG002|Overall Study|No reason specified|2|||
46665527|NCT01050257|82879734|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
46665528|NCT01050257|82879735|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
46665529|NCT01050257|82879736|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
46665530|NCT01050257|82879734|FG000|Overall Study|Violation criteria|0|||
46665531|NCT01050257|82879735|FG001|Overall Study|Violation criteria|1|||
46665532|NCT01050257|82879736|FG002|Overall Study|Violation criteria|0|||
46665533|NCT01050257|82879734|FG000|Overall Study|Failure to return|0|||
46665534|NCT01050257|82879735|FG001|Overall Study|Failure to return|2|||
46665535|NCT01050257|82879736|FG002|Overall Study|Failure to return|0|||
46665536|NCT01050257|82879734|FG000|Overall Study|Death|0|||
46665537|NCT01050257|82879735|FG001|Overall Study|Death|0|||
46784410|NCT00606021|83003345|FG002|Induction Phase|Withdrawal by Subject|0|||
46784411|NCT00606021|83003343|FG000|Induction Phase|Lost to Follow-up|10|||
46784412|NCT00606021|83003344|FG001|Induction Phase|Lost to Follow-up|0|||
46784413|NCT00606021|83003345|FG002|Induction Phase|Lost to Follow-up|0|||
46784414|NCT00606021|83003343|FG000|Maintenance Phase|Death|0|||
46784415|NCT00606021|83003344|FG001|Maintenance Phase|Death|17|||
46784416|NCT00606021|83003345|FG002|Maintenance Phase|Death|15|||
46784417|NCT00606021|83003343|FG000|Maintenance Phase|Physician Decision|0|||
46784418|NCT00606021|83003344|FG001|Maintenance Phase|Physician Decision|1|||
46784419|NCT00606021|83003345|FG002|Maintenance Phase|Physician Decision|0|||
46784420|NCT00606021|83003343|FG000|Maintenance Phase|Lost to Follow-up|0|||
46784421|NCT00606021|83003344|FG001|Maintenance Phase|Lost to Follow-up|5|||
46784422|NCT00606021|83003345|FG002|Maintenance Phase|Lost to Follow-up|2|||
46665538|NCT01050257|82879736|FG002|Overall Study|Death|1|||
46665539|NCT01050062|82879746|FG000|Overall Study|Adverse Event|75|||
46665540|NCT01050062|82879747|FG001|Overall Study|Adverse Event|22|||
46665541|NCT01050062|82879746|FG000|Overall Study|Lost to Follow-up|83|||
46665542|NCT01050062|82879747|FG001|Overall Study|Lost to Follow-up|35|||
46665543|NCT01050062|82879746|FG000|Overall Study|Lack of Efficacy|22|||
46665544|NCT01050062|82879747|FG001|Overall Study|Lack of Efficacy|35|||
46665545|NCT01050062|82879746|FG000|Overall Study|Physician Decision|74|||
46665546|NCT01050062|82879747|FG001|Overall Study|Physician Decision|9|||
46665547|NCT01050062|82879746|FG000|Overall Study|Others|17|||
46784423|NCT00337675|83003356|FG000|Overall Study|Adverse Event|10|||
46784424|NCT00337675|83003357|FG001|Overall Study|Adverse Event|9|||
46665548|NCT01050062|82879747|FG001|Overall Study|Others|11|||
46784425|NCT00337675|83003358|FG002|Overall Study|Adverse Event|19|||
46784426|NCT00337675|83003356|FG000|Overall Study|Lack of Efficacy|10|||
46784427|NCT00337675|83003357|FG001|Overall Study|Lack of Efficacy|7|||
46784428|NCT00337675|83003358|FG002|Overall Study|Lack of Efficacy|9|||
46784429|NCT00337675|83003356|FG000|Overall Study|Lost to Follow-up|22|||
46784430|NCT00337675|83003357|FG001|Overall Study|Lost to Follow-up|19|||
46784431|NCT00337675|83003358|FG002|Overall Study|Lost to Follow-up|17|||
46665549|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
46784432|NCT00337675|83003356|FG000|Overall Study|Physician Decision|9|||
46665550|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
46665551|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
46665552|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
46665553|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
46665554|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
46665555|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
46665556|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
46665557|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
46665558|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
46784433|NCT00337675|83003357|FG001|Overall Study|Physician Decision|17|||
46784434|NCT00337675|83003358|FG002|Overall Study|Physician Decision|14|||
46784435|NCT00337675|83003356|FG000|Overall Study|Protocol Violation|21|||
46665559|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
46665560|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
46665561|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
46665562|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
46665563|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Death|1|||
46665564|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Death|0|||
46665565|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
46665566|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
46665567|NCT00105989|82879765|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
46665568|NCT00105989|82879766|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
46665569|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
46665570|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
46665571|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
46665572|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
46665573|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
46665574|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
46665575|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
46665576|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
46665577|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
46665578|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
46665579|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
46665580|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
46665581|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
46665582|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
46665583|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Death|0|||
46784436|NCT00337675|83003357|FG001|Overall Study|Protocol Violation|24|||
46784437|NCT00337675|83003358|FG002|Overall Study|Protocol Violation|19|||
46784438|NCT00337675|83003356|FG000|Overall Study|Withdrawal by Subject|25|||
46784439|NCT00337675|83003357|FG001|Overall Study|Withdrawal by Subject|25|||
46784440|NCT00337675|83003358|FG002|Overall Study|Withdrawal by Subject|19|||
46784441|NCT00337675|83003356|FG000|Overall Study|Progressive Disease|0|||
46784442|NCT00337675|83003357|FG001|Overall Study|Progressive Disease|2|||
46784443|NCT00337675|83003358|FG002|Overall Study|Progressive Disease|0|||
46784444|NCT00337675|83003356|FG000|Overall Study|Trial Terminated|0|||
46784445|NCT00337675|83003357|FG001|Overall Study|Trial Terminated|0|||
46784446|NCT00337675|83003358|FG002|Overall Study|Trial Terminated|2|||
46784447|NCT00337285|83003366|FG000|Overall Study|Withdrawal by Subject|42|||
46784448|NCT00337285|83003366|FG000|Overall Study|Lost to Follow-up|41|||
46784449|NCT00337285|83003366|FG000|Overall Study|Adverse Event|28|||
46665584|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Death|0|||
46784450|NCT00337285|83003366|FG000|Overall Study|Protocol Violation|27|||
46784451|NCT00337285|83003366|FG000|Overall Study|Lack of Efficacy|11|||
46784452|NCT00337285|83003366|FG000|Overall Study|Death|1|||
46784453|NCT00337285|83003366|FG000|Overall Study|Physician Decision|1|||
46665585|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
46665586|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
46665587|NCT00105989|82879765|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
46665588|NCT00105989|82879766|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
46665589|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
46665590|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
46665591|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
46665592|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
46665593|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
46665594|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
46665595|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
46665596|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
46665597|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
46665598|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
46665599|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
46665600|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
46665601|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
46784454|NCT00337285|83003366|FG000|Overall Study|Lack of protocol compliance|7|||
46784455|NCT00605865|83003370|FG000|Overall Study|Protocol Violation|115|||
46784456|NCT00348673|83003410|FG000|Stage 1|Randomized but not Treated|0|||
46784457|NCT00348673|83003411|FG001|Stage 1|Randomized but not Treated|0|||
46784458|NCT00348673|83003412|FG002|Stage 1|Randomized but not Treated|1|||
46784459|NCT00348673|83003413|FG003|Stage 1|Randomized but not Treated|0|||
46784460|NCT00348673|83003414|FG004|Stage 1|Randomized but not Treated|0|||
46784461|NCT00348673|83003415|FG005|Stage 1|Randomized but not Treated|0|||
46784462|NCT00348673|83003416|FG006|Stage 1|Randomized but not Treated|0|||
46784463|NCT00348673|83003417|FG007|Stage 1|Randomized but not Treated|0|||
46784464|NCT00348673|83003418|FG008|Stage 1|Randomized but not Treated|0|||
46784465|NCT00337207|83003436|FG000|Overall Study|Withdrawal by Subject|3|||
46784466|NCT00604695|83003443|FG000|Overall Study|Did not receive first bolus.|0|||
46784467|NCT00604695|83003444|FG001|Overall Study|Did not receive first bolus.|4|||
46784468|NCT00348595|83003452|FG000|Overall Study|Adverse Event|5|||
46784469|NCT00348595|83003453|FG001|Overall Study|Adverse Event|8|||
46784470|NCT00337129|83003459|FG000|Overall Study|Adverse Event|4|||
46784471|NCT00337129|83003459|FG000|Overall Study|Withdrawal by Subject|1|||
46784472|NCT00337129|83003459|FG000|Overall Study|Lack of Efficacy|32|||
46784473|NCT00337129|83003459|FG000|Overall Study|Death|2|||
46784474|NCT00337129|83003459|FG000|Overall Study|not protocol specified|1|||
46784475|NCT00348283|83003465|FG000|Induction|Adverse Event|0|||
46784476|NCT00348283|83003466|FG001|Induction|Adverse Event|2|||
46784477|NCT00348283|83003465|FG000|Induction|Protocol Violation|0|||
46784478|NCT00348283|83003466|FG001|Induction|Protocol Violation|4|||
46784479|NCT00348283|83003465|FG000|Double Blind|Adverse Event|2|||
46784480|NCT00348283|83003466|FG001|Double Blind|Adverse Event|5|||
46784481|NCT00348283|83003465|FG000|Double Blind|Withdrawal by Subject|1|||
46784482|NCT00348283|83003466|FG001|Double Blind|Withdrawal by Subject|1|||
46784483|NCT00348283|83003465|FG000|Double Blind|Protocol Violation|0|||
46851215|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
46851216|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
46851217|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
46851218|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
46851219|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
46851220|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
47076573|NCT00985439|83371648|FG000|Overall Study|Adverse Event|0|||
47076574|NCT00985439|83371649|FG001|Overall Study|Adverse Event|0|||
47076575|NCT00985439|83371650|FG002|Overall Study|Adverse Event|1|||
46665602|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
46665603|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
46665604|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
46665605|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
46665606|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
46665607|NCT00105989|82879765|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
46665608|NCT00105989|82879766|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
46665609|NCT03277248|82879784|FG000|Overall Study|Adverse Event|3|||
46665610|NCT03277248|82879785|FG001|Overall Study|Adverse Event|1|||
46665611|NCT03277248|82879784|FG000|Overall Study|Subject Withdrawal of Consent|6|||
46665612|NCT03277248|82879785|FG001|Overall Study|Subject Withdrawal of Consent|23|||
46665613|NCT03277248|82879784|FG000|Overall Study|Investigator/Sponsor Decision|2|||
46665614|NCT03277248|82879785|FG001|Overall Study|Investigator/Sponsor Decision|2|||
46665615|NCT03277248|82879784|FG000|Overall Study|Pregnancy|4|||
46665616|NCT03277248|82879785|FG001|Overall Study|Pregnancy|1|||
46665617|NCT03277248|82879784|FG000|Overall Study|Lost to Follow-up|0|||
46665618|NCT03277248|82879785|FG001|Overall Study|Lost to Follow-up|2|||
46665619|NCT03277248|82879784|FG000|Overall Study|Lack of Efficacy|0|||
46665620|NCT03277248|82879785|FG001|Overall Study|Lack of Efficacy|2|||
46665621|NCT03277248|82879784|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
46665622|NCT03277248|82879785|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
46665623|NCT03276780|82879793|FG000|Overall Study|Withdrawal by Subject|5|||
46665624|NCT03276780|82879794|FG001|Overall Study|Withdrawal by Subject|3|||
46665625|NCT03276780|82879793|FG000|Overall Study|Lost to Follow-up|3|||
46665626|NCT03276780|82879794|FG001|Overall Study|Lost to Follow-up|5|||
46665627|NCT03276780|82879793|FG000|Overall Study|Moved out of state|1|||
46665628|NCT03276780|82879794|FG001|Overall Study|Moved out of state|1|||
46665629|NCT03276780|82879793|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
47076576|NCT00985439|83371651|FG003|Overall Study|Adverse Event|0|||
47076577|NCT02618928|83371661|FG000|Overall Study|Failure to Return|28|||
47076578|NCT02618928|83371661|FG000|Overall Study|Insufficient Virological Response|1|||
47076579|NCT02618928|83371661|FG000|Overall Study|Withdrawal by Subject|2|||
46784484|NCT00348283|83003466|FG001|Double Blind|Protocol Violation|1|||
46784485|NCT00348283|83003465|FG000|Double Blind|Lack of Efficacy|2|||
47076580|NCT02618928|83371661|FG000|Overall Study|Death|3|||
47076581|NCT02618928|83371661|FG000|Overall Study|Other|11|||
46665630|NCT03276780|82879794|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
46707536|NCT01155570|82923117|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
46784486|NCT00348283|83003466|FG001|Double Blind|Lack of Efficacy|2|||
46784487|NCT00348283|83003465|FG000|Double Blind|Pregnancy|0|||
46851221|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
47076582|NCT02618928|83371661|FG000|Overall Study|Missing|6|||
47076583|NCT02618928|83371661|FG000|Overall Study|Treatment Never Started|7|||
46665631|NCT03276780|82879793|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
46665632|NCT03276780|82879794|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
46665633|NCT03271047|82879810|FG000|Phase 1b: Dose Finding Period|Death|8|||
46665634|NCT03271047|82879811|FG001|Phase 1b: Dose Finding Period|Death|8|||
46665635|NCT03271047|82879812|FG002|Phase 1b: Dose Finding Period|Death|0|||
46665636|NCT03271047|82879813|FG003|Phase 1b: Dose Finding Period|Death|0|||
46665637|NCT03271047|82879810|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
46665638|NCT03271047|82879811|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
46665639|NCT03271047|82879812|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
46665640|NCT03271047|82879813|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
46665641|NCT03271047|82879810|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
46665642|NCT03271047|82879811|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
46665643|NCT03271047|82879812|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
46784488|NCT00348283|83003466|FG001|Double Blind|Pregnancy|1|||
46784489|NCT00348283|83003465|FG000|Open Label|Adverse Event|0|||
46784490|NCT00348283|83003466|FG001|Open Label|Adverse Event|8|||
46784491|NCT00348283|83003465|FG000|Open Label|Withdrawal by Subject|0|||
46784492|NCT00348283|83003466|FG001|Open Label|Withdrawal by Subject|4|||
46784493|NCT00348283|83003465|FG000|Open Label|Lost to Follow-up|0|||
46784494|NCT00348283|83003466|FG001|Open Label|Lost to Follow-up|1|||
46784495|NCT00348283|83003465|FG000|Open Label|Lack of Efficacy|0|||
46784496|NCT00348283|83003466|FG001|Open Label|Lack of Efficacy|13|||
46784497|NCT00348283|83003465|FG000|Open Label|Administrative reasons|0|||
46784498|NCT00348283|83003466|FG001|Open Label|Administrative reasons|5|||
46784499|NCT00348283|83003465|FG000|Open Label|Subject moved to the United States|0|||
46784500|NCT00348283|83003466|FG001|Open Label|Subject moved to the United States|1|||
46784501|NCT00348283|83003465|FG000|Open Label|Pregnancy|0|||
46784502|NCT00348283|83003466|FG001|Open Label|Pregnancy|1|||
46784503|NCT00348283|83003465|FG000|Open Label|Sponsor decision|0|||
46784504|NCT00348283|83003466|FG001|Open Label|Sponsor decision|1|||
46784505|NCT00336895|83003472|FG000|Overall Study|diarrhea|1|||
46784506|NCT00336895|83003472|FG000|Overall Study|nausea and upset stomach|1|||
46784507|NCT00336895|83003472|FG000|Overall Study|Physician Decision|1|||
46784508|NCT00336895|83003472|FG000|Overall Study|screen failed|1|||
46784509|NCT00336583|83003476|FG000|Overall Study|Lost to Follow-up|1|||
46784510|NCT00336583|83003476|FG000|Overall Study|Death|1|||
46784511|NCT00336505|83003482|FG000|Overall Study|Adverse Event|10|||
46784512|NCT00336505|83003483|FG001|Overall Study|Adverse Event|9|||
46784513|NCT00336505|83003482|FG000|Overall Study|Lack of Efficacy|8|||
46784514|NCT00336505|83003483|FG001|Overall Study|Lack of Efficacy|4|||
46784515|NCT00336505|83003482|FG000|Overall Study|Lost to Follow-up|7|||
46784516|NCT00336505|83003483|FG001|Overall Study|Lost to Follow-up|4|||
46851222|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
46851223|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
46851224|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
46851225|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
46851226|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
46851227|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
46851228|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
46851229|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
46851230|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
46851231|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
46851232|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
46851233|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
46851234|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
46851235|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
46851236|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
46665644|NCT03271047|82879813|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
46665645|NCT03271047|82879810|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
46665646|NCT03271047|82879811|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
46665647|NCT03271047|82879812|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
46665648|NCT03271047|82879813|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
46784517|NCT00336505|83003482|FG000|Overall Study|Withdrawal by Subject|5|||
46784518|NCT00336505|83003483|FG001|Overall Study|Withdrawal by Subject|3|||
46784519|NCT00336505|83003482|FG000|Overall Study|Other|7|||
46851237|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
46784520|NCT00336505|83003483|FG001|Overall Study|Other|7|||
46784521|NCT00357877|83003491|FG000|Overall Study|Death|2|||
46784522|NCT00357877|83003492|FG001|Overall Study|Death|1|||
46784523|NCT00357877|83003491|FG000|Overall Study|Lost to Follow-up|20|||
46784524|NCT00357877|83003492|FG001|Overall Study|Lost to Follow-up|23|||
46784525|NCT00357877|83003491|FG000|Overall Study|Withdrawal by Subject|3|||
46665649|NCT03271047|82879810|FG000|Randomized Phase 2 Period|Other|0|||
46665650|NCT03271047|82879811|FG001|Randomized Phase 2 Period|Other|0|||
46665651|NCT03271047|82879812|FG002|Randomized Phase 2 Period|Other|0|||
46665652|NCT03271047|82879813|FG003|Randomized Phase 2 Period|Other|1|||
46665653|NCT03271047|82879810|FG000|Randomized Phase 2 Period|Death|0|||
46665654|NCT03271047|82879811|FG001|Randomized Phase 2 Period|Death|0|||
46665655|NCT03271047|82879812|FG002|Randomized Phase 2 Period|Death|20|||
46665656|NCT03271047|82879813|FG003|Randomized Phase 2 Period|Death|21|||
46665657|NCT03271047|82879810|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
46665658|NCT03271047|82879811|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
46665659|NCT03271047|82879812|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
46665660|NCT03271047|82879813|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
46665661|NCT03271047|82879810|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
46665662|NCT03271047|82879811|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
46665663|NCT03271047|82879812|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
46665664|NCT03271047|82879813|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
46665665|NCT03271047|82879810|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
46665666|NCT03271047|82879811|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
46665667|NCT03271047|82879812|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
46665668|NCT03271047|82879813|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
46665669|NCT03276936|82879827|FG000|Overall Study|Adverse Event|4|||
46665670|NCT03276936|82879828|FG001|Overall Study|Adverse Event|2|||
46665671|NCT03276936|82879827|FG000|Overall Study|Lost to Follow-up|16|||
46665672|NCT03276936|82879828|FG001|Overall Study|Lost to Follow-up|13|||
46665673|NCT03276936|82879827|FG000|Overall Study|Withdrawal by Subject|30|||
46665674|NCT03276936|82879828|FG001|Overall Study|Withdrawal by Subject|20|||
46665675|NCT03276936|82879827|FG000|Overall Study|Not mentioned|6|||
46665676|NCT03276936|82879828|FG001|Overall Study|Not mentioned|3|||
46665677|NCT00106002|82879834|FG000|Overall Study|Did not take any study drug|1|||
46665678|NCT00106002|82879834|FG000|Overall Study|Ineligible after Registration|1|||
46665679|NCT00105482|82879852|FG000|Overall Study|Adverse Event|1|||
46665680|NCT00105482|82879853|FG001|Overall Study|Adverse Event|1|||
46665681|NCT00105482|82879852|FG000|Overall Study|Lost to Follow-up|26|||
46784526|NCT00357877|83003492|FG001|Overall Study|Withdrawal by Subject|3|||
46784527|NCT00357877|83003491|FG000|Overall Study|Administrative withdrawal|1|||
46784528|NCT00357877|83003492|FG001|Overall Study|Administrative withdrawal|1|||
46784529|NCT00357877|83003491|FG000|Overall Study|Other|0|||
46784530|NCT00357877|83003492|FG001|Overall Study|Other|2|||
46784531|NCT00335959|83003500|FG000|Overall Study|Adverse Event|2|||
46784532|NCT00335959|83003500|FG000|Overall Study|Ineligible|1|||
46784533|NCT00670488|83003515|FG000|Overall Study|Adverse Event|0|||
46784534|NCT00670488|83003516|FG001|Overall Study|Adverse Event|7|||
46784535|NCT00670488|83003517|FG002|Overall Study|Adverse Event|0|||
46784536|NCT00670488|83003518|FG003|Overall Study|Adverse Event|3|||
46784537|NCT00670488|83003519|FG004|Overall Study|Adverse Event|1|||
46784538|NCT00670488|83003520|FG005|Overall Study|Adverse Event|1|||
46784539|NCT00670488|83003521|FG006|Overall Study|Adverse Event|5|||
46784540|NCT00670488|83003522|FG007|Overall Study|Adverse Event|1|||
46784541|NCT00670488|83003523|FG008|Overall Study|Adverse Event|0|||
46784542|NCT00670488|83003524|FG009|Overall Study|Adverse Event|1|||
46784543|NCT00670488|83003515|FG000|Overall Study|Physician Decision|1|||
46784544|NCT00670488|83003516|FG001|Overall Study|Physician Decision|9|||
46665682|NCT00105482|82879853|FG001|Overall Study|Lost to Follow-up|17|||
46665683|NCT00105482|82879852|FG000|Overall Study|Withdrawal by Subject|0|||
46665684|NCT00105482|82879853|FG001|Overall Study|Withdrawal by Subject|1|||
46665685|NCT00105482|82879852|FG000|Overall Study|Lost Interest|29|||
46665686|NCT00105482|82879853|FG001|Overall Study|Lost Interest|32|||
46665687|NCT00105482|82879852|FG000|Overall Study|Scheduling Conflict|2|||
46665688|NCT00105482|82879853|FG001|Overall Study|Scheduling Conflict|3|||
46665689|NCT00105482|82879852|FG000|Overall Study|Withdrawn by PI|1|||
47076584|NCT00983957|83371672|FG000|Overall Study|Adverse Event|1|||
46665690|NCT00105482|82879853|FG001|Overall Study|Withdrawn by PI|1|||
46665691|NCT01327651|82879868|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
46665692|NCT01327651|82879869|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
46784545|NCT00670488|83003517|FG002|Overall Study|Physician Decision|0|||
46784546|NCT00670488|83003518|FG003|Overall Study|Physician Decision|1|||
46784547|NCT00670488|83003519|FG004|Overall Study|Physician Decision|0|||
46784548|NCT00670488|83003520|FG005|Overall Study|Physician Decision|0|||
47076585|NCT00983957|83371672|FG000|Overall Study|Personal Reasons|1|||
47076586|NCT00981149|83371726|FG000|Overall Study|Lost to Follow-up|1|||
46784549|NCT00670488|83003521|FG006|Overall Study|Physician Decision|0|||
47076587|NCT00981149|83371727|FG001|Overall Study|Lost to Follow-up|2|||
47076588|NCT00981149|83371726|FG000|Overall Study|Withdrawal by Subject|1|||
46665693|NCT01327651|82879870|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
46665694|NCT01327651|82879871|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
46665695|NCT01327651|82879872|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
46665696|NCT01327651|82879873|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
46665697|NCT01327651|82879874|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
46665698|NCT01327651|82879875|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
46665699|NCT01327651|82879876|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
46665700|NCT01327651|82879868|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
46665701|NCT01327651|82879869|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665702|NCT01327651|82879870|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665703|NCT01327651|82879871|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665704|NCT01327651|82879872|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665705|NCT01327651|82879873|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665706|NCT01327651|82879874|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665707|NCT01327651|82879875|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665708|NCT01327651|82879876|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
46665709|NCT01327651|82879868|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
46665710|NCT01327651|82879869|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
46665711|NCT01327651|82879870|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
46665712|NCT01327651|82879871|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
46665713|NCT01327651|82879872|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
46665714|NCT01327651|82879873|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
46665715|NCT01327651|82879874|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
46665716|NCT01327651|82879875|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
46665717|NCT01327651|82879876|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
46665718|NCT01327651|82879868|FG000|Post Study Follow-up|Lost to Follow-up|0|||
46665719|NCT01327651|82879869|FG001|Post Study Follow-up|Lost to Follow-up|1|||
46665720|NCT01327651|82879870|FG002|Post Study Follow-up|Lost to Follow-up|1|||
46665721|NCT01327651|82879871|FG003|Post Study Follow-up|Lost to Follow-up|0|||
46665722|NCT01327651|82879872|FG004|Post Study Follow-up|Lost to Follow-up|0|||
46665723|NCT01327651|82879873|FG005|Post Study Follow-up|Lost to Follow-up|0|||
46665724|NCT01327651|82879874|FG006|Post Study Follow-up|Lost to Follow-up|4|||
46665725|NCT01327651|82879875|FG007|Post Study Follow-up|Lost to Follow-up|1|||
46665726|NCT01327651|82879876|FG008|Post Study Follow-up|Lost to Follow-up|2|||
46665727|NCT00105443|82879917|FG000|Double-Blind Treatment|Adverse Event|1|||
46665728|NCT00105443|82879918|FG001|Double-Blind Treatment|Adverse Event|0|||
46665729|NCT00105443|82879919|FG002|Double-Blind Treatment|Adverse Event|0|||
46665730|NCT00105443|82879920|FG003|Double-Blind Treatment|Adverse Event|0|||
46665731|NCT00105443|82879917|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
46665732|NCT00105443|82879918|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
46665733|NCT00105443|82879919|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
46665734|NCT00105443|82879920|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
46665735|NCT00105443|82879917|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
46665736|NCT00105443|82879918|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
46665737|NCT00105443|82879919|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
46665738|NCT00105443|82879920|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
46665739|NCT00105443|82879917|FG000|Double-Blind Treatment|Physician Decision|1|||
46665740|NCT00105443|82879918|FG001|Double-Blind Treatment|Physician Decision|0|||
46665741|NCT00105443|82879919|FG002|Double-Blind Treatment|Physician Decision|2|||
46665742|NCT00105443|82879920|FG003|Double-Blind Treatment|Physician Decision|0|||
46665743|NCT00105443|82879917|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
46665744|NCT00105443|82879918|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
46665745|NCT00105443|82879919|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
46665746|NCT00105443|82879920|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
46665747|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
46665748|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
46665749|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
46665750|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
46665751|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
46665752|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
46665753|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
46665754|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
46665755|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
46784550|NCT00670488|83003522|FG007|Overall Study|Physician Decision|0|||
47076589|NCT00981149|83371727|FG001|Overall Study|Withdrawal by Subject|1|||
47076590|NCT01595646|83371785|FG000|Overall Study|Withdrawal by Subject|1|||
47076591|NCT01595646|83371786|FG001|Overall Study|Withdrawal by Subject|0|||
47076592|NCT01595646|83371787|FG002|Overall Study|Withdrawal by Subject|0|||
47076593|NCT00981461|83371815|FG000|Overall Study|Lost to Follow-up|5|||
46665756|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
46665757|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
46665758|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
46784551|NCT00670488|83003523|FG008|Overall Study|Physician Decision|0|||
47076594|NCT00981461|83371816|FG001|Overall Study|Lost to Follow-up|2|||
46665759|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
46665760|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
46665761|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
46665762|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
46665763|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
46665764|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
46665765|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
46665766|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
46665767|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
46665768|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
46665769|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
46665770|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
46665771|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
46665772|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
46665773|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
46665774|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
46665775|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
46665776|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
46665777|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
46665778|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
46665779|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
46665780|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
46665781|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
46665782|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
46665783|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
46665784|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
46665785|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
46665786|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
46665787|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
46665788|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
46784552|NCT00670488|83003524|FG009|Overall Study|Physician Decision|0|||
46784553|NCT00670488|83003515|FG000|Overall Study|Progressive Disease|2|||
46784554|NCT00670488|83003516|FG001|Overall Study|Progressive Disease|41|||
46784555|NCT00670488|83003517|FG002|Overall Study|Progressive Disease|3|||
46784556|NCT00670488|83003518|FG003|Overall Study|Progressive Disease|2|||
46784557|NCT00670488|83003519|FG004|Overall Study|Progressive Disease|2|||
46665789|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
46665790|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
46665791|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
46665792|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
46665793|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
46665794|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
46665795|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
46665796|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
46665797|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
46665798|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
46665799|NCT00105443|82879917|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
46665800|NCT00105443|82879918|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
46665801|NCT00105443|82879919|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
46665802|NCT00105443|82879920|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
46665803|NCT01327612|82879936|FG000|Overall Study|Withdrawal by Subject|0|||
46784558|NCT00670488|83003520|FG005|Overall Study|Progressive Disease|4|||
46784559|NCT00670488|83003521|FG006|Overall Study|Progressive Disease|11|||
46784560|NCT00670488|83003522|FG007|Overall Study|Progressive Disease|2|||
46784561|NCT00670488|83003523|FG008|Overall Study|Progressive Disease|2|||
46784562|NCT00670488|83003524|FG009|Overall Study|Progressive Disease|1|||
46784563|NCT00670488|83003515|FG000|Overall Study|Withdrawal by Subject|0|||
47076595|NCT02618616|83371833|FG000|Overall Study|Lack of Efficacy|4|||
47076596|NCT02618616|83371834|FG001|Overall Study|Lack of Efficacy|0|||
47076597|NCT02618616|83371833|FG000|Overall Study|Pregnancy|0|||
47076598|NCT02618616|83371834|FG001|Overall Study|Pregnancy|1|||
47076599|NCT02618616|83371833|FG000|Overall Study|Adverse Event|8|||
47076600|NCT02618616|83371834|FG001|Overall Study|Adverse Event|0|||
47076601|NCT02618616|83371833|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
47076602|NCT02618616|83371834|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
47076603|NCT02618616|83371833|FG000|Overall Study|Consent withdrawn by subject|8|||
46665804|NCT01327612|82879937|FG001|Overall Study|Withdrawal by Subject|0|||
46665805|NCT01327612|82879938|FG002|Overall Study|Withdrawal by Subject|0|||
46665806|NCT01327612|82879939|FG003|Overall Study|Withdrawal by Subject|0|||
46665807|NCT01327612|82879940|FG004|Overall Study|Withdrawal by Subject|0|||
46665808|NCT01327612|82879941|FG005|Overall Study|Withdrawal by Subject|1|||
46665809|NCT01327612|82879942|FG006|Overall Study|Withdrawal by Subject|0|||
46665810|NCT01327612|82879936|FG000|Overall Study|Disease Progression|1|||
46665811|NCT01327612|82879937|FG001|Overall Study|Disease Progression|1|||
46665812|NCT01327612|82879938|FG002|Overall Study|Disease Progression|1|||
46665813|NCT01327612|82879939|FG003|Overall Study|Disease Progression|0|||
46665814|NCT01327612|82879940|FG004|Overall Study|Disease Progression|1|||
46665815|NCT01327612|82879941|FG005|Overall Study|Disease Progression|2|||
46665816|NCT01327612|82879942|FG006|Overall Study|Disease Progression|2|||
46665817|NCT01327612|82879936|FG000|Overall Study|Administrative Decision|0|||
46665818|NCT01327612|82879937|FG001|Overall Study|Administrative Decision|0|||
46665819|NCT01327612|82879938|FG002|Overall Study|Administrative Decision|0|||
46665820|NCT01327612|82879939|FG003|Overall Study|Administrative Decision|1|||
46665821|NCT01327612|82879940|FG004|Overall Study|Administrative Decision|0|||
46665822|NCT01327612|82879941|FG005|Overall Study|Administrative Decision|0|||
46665823|NCT01327612|82879942|FG006|Overall Study|Administrative Decision|0|||
46665824|NCT01327612|82879936|FG000|Overall Study|Death|0|||
46665825|NCT01327612|82879937|FG001|Overall Study|Death|0|||
46665826|NCT01327612|82879938|FG002|Overall Study|Death|0|||
46665827|NCT01327612|82879939|FG003|Overall Study|Death|0|||
46665828|NCT01327612|82879940|FG004|Overall Study|Death|1|||
46665829|NCT01327612|82879941|FG005|Overall Study|Death|0|||
46665830|NCT01327612|82879942|FG006|Overall Study|Death|0|||
46665831|NCT01327573|82879961|FG000|Overall Study|Physician Decision|3|||
46665832|NCT01327573|82879962|FG001|Overall Study|Physician Decision|1|||
46665833|NCT01327495|82879975|FG000|Overall Study|Adverse Event|2|||
46665834|NCT01327495|82879976|FG001|Overall Study|Adverse Event|1|||
46665835|NCT01327495|82879977|FG002|Overall Study|Adverse Event|1|||
46665836|NCT01327495|82879978|FG003|Overall Study|Adverse Event|0|||
46665837|NCT01327495|82879979|FG004|Overall Study|Adverse Event|0|||
46665838|NCT01327495|82879980|FG005|Overall Study|Adverse Event|2|||
46665839|NCT01327495|82879975|FG000|Overall Study|Withdrawal by Subject|0|||
46665840|NCT01327495|82879976|FG001|Overall Study|Withdrawal by Subject|1|||
46665841|NCT01327495|82879977|FG002|Overall Study|Withdrawal by Subject|1|||
46665842|NCT01327495|82879978|FG003|Overall Study|Withdrawal by Subject|0|||
46665843|NCT01327495|82879979|FG004|Overall Study|Withdrawal by Subject|1|||
46665844|NCT01327495|82879980|FG005|Overall Study|Withdrawal by Subject|0|||
46665845|NCT01327495|82879975|FG000|Overall Study|Physician Decision|0|||
46665846|NCT01327495|82879976|FG001|Overall Study|Physician Decision|0|||
46665847|NCT01327495|82879977|FG002|Overall Study|Physician Decision|0|||
46665848|NCT01327495|82879978|FG003|Overall Study|Physician Decision|0|||
46665849|NCT01327495|82879979|FG004|Overall Study|Physician Decision|2|||
46665850|NCT01327495|82879980|FG005|Overall Study|Physician Decision|0|||
46665851|NCT01327339|82880000|FG000|Overall Study|Protocol Violation|8|||
46665852|NCT01327300|82880004|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
46665853|NCT01327300|82880005|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
46665854|NCT01379521|82880023|FG000|Overall Study -Treatment Period|Adverse Event|3|||
46665855|NCT01379521|82880024|FG001|Overall Study -Treatment Period|Adverse Event|0|||
46665856|NCT01379521|82880023|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
46665857|NCT01379521|82880024|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
46665858|NCT01379521|82880023|FG000|Overall Study -Treatment Period|Disease Progression|23|||
46665859|NCT01379521|82880024|FG001|Overall Study -Treatment Period|Disease Progression|22|||
46665860|NCT01379521|82880023|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
46665861|NCT01379521|82880024|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
46665862|NCT01379521|82880023|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
46665863|NCT01379521|82880024|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
46665864|NCT01379521|82880023|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
46665865|NCT01379521|82880024|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
46665866|NCT01379521|82880023|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
46784564|NCT00670488|83003516|FG001|Overall Study|Withdrawal by Subject|1|||
46784565|NCT00670488|83003517|FG002|Overall Study|Withdrawal by Subject|0|||
46784566|NCT00670488|83003518|FG003|Overall Study|Withdrawal by Subject|1|||
46665867|NCT01379521|82880024|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
46784567|NCT00670488|83003519|FG004|Overall Study|Withdrawal by Subject|0|||
46665868|NCT01379521|82880023|FG000|Overall Study -Treatment Period|Death|2|||
46665869|NCT01379521|82880024|FG001|Overall Study -Treatment Period|Death|1|||
46665870|NCT01379521|82880023|FG000|Post-Treatment Evaluations|Disease Progression|22|||
46665871|NCT01379521|82880024|FG001|Post-Treatment Evaluations|Disease Progression|20|||
46665872|NCT01379521|82880023|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
46665873|NCT01379521|82880024|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
46665874|NCT01379521|82880023|FG000|Post-Treatment Evaluations|Death|1|||
46665875|NCT01379521|82880024|FG001|Post-Treatment Evaluations|Death|0|||
46665876|NCT01371994|82880032|FG000|Overall Study|Adverse Event|3|||
46665877|NCT01371994|82880033|FG001|Overall Study|Adverse Event|6|||
46665878|NCT01371994|82880032|FG000|Overall Study|Lack of Efficacy|3|||
46665879|NCT01371994|82880033|FG001|Overall Study|Lack of Efficacy|0|||
46665880|NCT01371994|82880032|FG000|Overall Study|Withdrawal by Subject|13|||
46665881|NCT01371994|82880033|FG001|Overall Study|Withdrawal by Subject|7|||
46665882|NCT01371994|82880032|FG000|Overall Study|Lost to Follow-up|1|||
46665883|NCT01371994|82880033|FG001|Overall Study|Lost to Follow-up|1|||
46665884|NCT01371994|82880032|FG000|Overall Study|Protocol Violation|24|||
46665885|NCT01371994|82880033|FG001|Overall Study|Protocol Violation|17|||
46665886|NCT01371994|82880032|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
46665887|NCT01371994|82880033|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
46665888|NCT01371994|82880032|FG000|Overall Study|Physician Decision|1|||
46665889|NCT01371994|82880033|FG001|Overall Study|Physician Decision|1|||
46665890|NCT01371994|82880032|FG000|Overall Study|Miscellaneous Reasons|6|||
46665891|NCT01371994|82880033|FG001|Overall Study|Miscellaneous Reasons|4|||
46784568|NCT00670488|83003520|FG005|Overall Study|Withdrawal by Subject|0|||
46784569|NCT00670488|83003521|FG006|Overall Study|Withdrawal by Subject|1|||
46784570|NCT00670488|83003522|FG007|Overall Study|Withdrawal by Subject|0|||
46784571|NCT00670488|83003523|FG008|Overall Study|Withdrawal by Subject|1|||
46784572|NCT00670488|83003524|FG009|Overall Study|Withdrawal by Subject|0|||
46784573|NCT00671658|83003546|FG000|Overall Study|Physician Decision|5|||
46784574|NCT00542386|83003556|FG000|Overall Study|Adverse Event|1|||
46784575|NCT00542386|83003557|FG001|Overall Study|Adverse Event|7|||
46784576|NCT00542386|83003558|FG002|Overall Study|Adverse Event|7|||
46784577|NCT00542386|83003559|FG003|Overall Study|Adverse Event|8|||
46784578|NCT00542386|83003560|FG004|Overall Study|Adverse Event|13|||
46784579|NCT00542386|83003561|FG005|Overall Study|Adverse Event|4|||
46972310|NCT02709889|83215964|FG001|Overall Study|Study Terminated by Sponsor|6|||
46972311|NCT02709889|83215965|FG002|Overall Study|Study Terminated by Sponsor|2|||
46972312|NCT02709889|83215966|FG003|Overall Study|Study Terminated by Sponsor|17|||
46972313|NCT02709889|83215963|FG000|Overall Study|Other, Not Specified|0|||
46972314|NCT02709889|83215964|FG001|Overall Study|Other, Not Specified|1|||
46972315|NCT02709889|83215965|FG002|Overall Study|Other, Not Specified|1|||
46972316|NCT02709889|83215966|FG003|Overall Study|Other, Not Specified|6|||
46972317|NCT02711995|83216011|FG000|Washout (90 Days)|Conflicting medication|1|||
46972318|NCT02514239|83216049|FG000|Overall Study|Refused to continue trial medication|0|||
46972319|NCT02514239|83216050|FG001|Overall Study|Refused to continue trial medication|0|||
46972320|NCT02514239|83216051|FG002|Overall Study|Refused to continue trial medication|0|||
46972321|NCT02514239|83216052|FG003|Overall Study|Refused to continue trial medication|0|||
46972322|NCT02514239|83216053|FG004|Overall Study|Refused to continue trial medication|0|||
46972323|NCT02514239|83216054|FG005|Overall Study|Refused to continue trial medication|0|||
46972324|NCT02514239|83216055|FG006|Overall Study|Refused to continue trial medication|0|||
46972325|NCT02514239|83216056|FG007|Overall Study|Refused to continue trial medication|0|||
46972326|NCT02514239|83216057|FG008|Overall Study|Refused to continue trial medication|0|||
46972327|NCT02514239|83216058|FG009|Overall Study|Refused to continue trial medication|1|||
46972328|NCT02514239|83216049|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972329|NCT02514239|83216050|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972330|NCT02514239|83216051|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972331|NCT02514239|83216052|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972332|NCT02514239|83216053|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972333|NCT02514239|83216054|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972334|NCT02514239|83216055|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972335|NCT02514239|83216056|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
46972336|NCT02514239|83216057|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
46972337|NCT02514239|83216058|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
46972338|NCT02514239|83216049|FG000|Overall Study|Not treated|0|||
47076604|NCT02618616|83371834|FG001|Overall Study|Consent withdrawn by subject|5|||
47076605|NCT02618616|83371833|FG000|Overall Study|Lost to Follow-up|0|||
46665892|NCT01371877|82880041|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
46784580|NCT00542386|83003556|FG000|Overall Study|Death|0|||
46784581|NCT00542386|83003557|FG001|Overall Study|Death|0|||
46784582|NCT00542386|83003558|FG002|Overall Study|Death|1|||
46784583|NCT00542386|83003559|FG003|Overall Study|Death|2|||
46784584|NCT00542386|83003560|FG004|Overall Study|Death|1|||
46784585|NCT00542386|83003561|FG005|Overall Study|Death|2|||
46784586|NCT00542386|83003556|FG000|Overall Study|Lack of Efficacy|32|||
46972339|NCT02514239|83216050|FG001|Overall Study|Not treated|1|||
46972340|NCT02514239|83216051|FG002|Overall Study|Not treated|0|||
46972341|NCT02514239|83216052|FG003|Overall Study|Not treated|0|||
46972342|NCT02514239|83216053|FG004|Overall Study|Not treated|0|||
47076606|NCT02618616|83371834|FG001|Overall Study|Lost to Follow-up|1|||
46665893|NCT01371877|82880042|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
46665894|NCT01371838|82880050|FG000|Overall Study|Withdrawal by Subject|27|||
46784587|NCT00542386|83003557|FG001|Overall Study|Lack of Efficacy|12|||
46665895|NCT01371838|82880051|FG001|Overall Study|Withdrawal by Subject|33|||
46665896|NCT01371838|82880050|FG000|Overall Study|Lost to Follow-up|10|||
46665897|NCT01371838|82880051|FG001|Overall Study|Lost to Follow-up|20|||
46665898|NCT01371838|82880050|FG000|Overall Study|Death|3|||
46665899|NCT01371838|82880051|FG001|Overall Study|Death|4|||
46665900|NCT01371838|82880050|FG000|Overall Study|Protocol Violation|3|||
46665901|NCT01371838|82880051|FG001|Overall Study|Protocol Violation|0|||
46665902|NCT01371838|82880050|FG000|Overall Study|Investigator Decision|3|||
46665903|NCT01371838|82880051|FG001|Overall Study|Investigator Decision|8|||
46665904|NCT01371838|82880050|FG000|Overall Study|Last follow-up visit not conducted|2|||
46665905|NCT01371838|82880051|FG001|Overall Study|Last follow-up visit not conducted|0|||
46665906|NCT01371838|82880050|FG000|Overall Study|Lack of therapeutic response|0|||
46665907|NCT01371838|82880051|FG001|Overall Study|Lack of therapeutic response|1|||
46665908|NCT01371838|82880050|FG000|Overall Study|Surgery|1|||
46665909|NCT01371838|82880051|FG001|Overall Study|Surgery|0|||
46665910|NCT01371721|82880060|FG000|Overall Study|Adverse Event|5|||
46665911|NCT01371721|82880061|FG001|Overall Study|Adverse Event|4|||
46665912|NCT01371721|82880062|FG002|Overall Study|Adverse Event|5|||
46665913|NCT01371721|82880060|FG000|Overall Study|Protocol Violation|6|||
46665914|NCT01371721|82880061|FG001|Overall Study|Protocol Violation|4|||
46665915|NCT01371721|82880062|FG002|Overall Study|Protocol Violation|5|||
46665916|NCT01371721|82880060|FG000|Overall Study|Lost to Follow-up|8|||
46665917|NCT01371721|82880061|FG001|Overall Study|Lost to Follow-up|2|||
46665918|NCT01371721|82880062|FG002|Overall Study|Lost to Follow-up|6|||
46665919|NCT01371721|82880060|FG000|Overall Study|Withdrawal by Subject|5|||
46665920|NCT01371721|82880061|FG001|Overall Study|Withdrawal by Subject|7|||
46665921|NCT01371721|82880062|FG002|Overall Study|Withdrawal by Subject|11|||
46665922|NCT01371721|82880060|FG000|Overall Study|Other|2|||
46665923|NCT01371721|82880061|FG001|Overall Study|Other|3|||
46665924|NCT01371721|82880062|FG002|Overall Study|Other|0|||
46665925|NCT01371721|82880060|FG000|Overall Study|Lack of Efficacy|2|||
46665926|NCT01371721|82880061|FG001|Overall Study|Lack of Efficacy|4|||
46665927|NCT01371721|82880062|FG002|Overall Study|Lack of Efficacy|3|||
46665928|NCT01371721|82880060|FG000|Overall Study|Randomized but not treated|1|||
46665929|NCT01371721|82880061|FG001|Overall Study|Randomized but not treated|0|||
46665930|NCT01371721|82880062|FG002|Overall Study|Randomized but not treated|0|||
46784588|NCT00542386|83003558|FG002|Overall Study|Lack of Efficacy|10|||
46784589|NCT00542386|83003559|FG003|Overall Study|Lack of Efficacy|13|||
46665931|NCT01366534|82880075|FG000|Overall Study|Lost to Follow-up|1|||
46665932|NCT01366534|82880076|FG001|Overall Study|Lost to Follow-up|0|||
46665933|NCT01366534|82880077|FG002|Overall Study|Lost to Follow-up|0|||
46665934|NCT01366534|82880075|FG000|Overall Study|Migrated|1|||
46665935|NCT01366534|82880076|FG001|Overall Study|Migrated|1|||
46665936|NCT01366534|82880077|FG002|Overall Study|Migrated|0|||
46665937|NCT01366534|82880075|FG000|Overall Study|Declined challenged|0|||
46665938|NCT01366534|82880076|FG001|Overall Study|Declined challenged|1|||
46665939|NCT01366534|82880077|FG002|Overall Study|Declined challenged|0|||
46665940|NCT01365910|82880085|FG000|Overall Study|Withdrawal by Subject|7|||
46665941|NCT01365910|82880085|FG000|Overall Study|disease progression|18|||
46665942|NCT01365910|82880085|FG000|Overall Study|Adverse Event|3|||
46665943|NCT01365910|82880085|FG000|Overall Study|other complicating disease|1|||
46665944|NCT01365910|82880085|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
46665945|NCT01365481|82880093|FG000|Overall Study|Adverse Event|6|||
46665946|NCT01365481|82880094|FG001|Overall Study|Adverse Event|9|||
46665947|NCT01365481|82880095|FG002|Overall Study|Adverse Event|0|||
46665948|NCT01365481|82880096|FG003|Overall Study|Adverse Event|2|||
46665949|NCT01365481|82880093|FG000|Overall Study|Withdrawal by Subject|0|||
46665950|NCT01365481|82880094|FG001|Overall Study|Withdrawal by Subject|2|||
46665951|NCT01365481|82880095|FG002|Overall Study|Withdrawal by Subject|1|||
46784590|NCT00542386|83003560|FG004|Overall Study|Lack of Efficacy|7|||
46665952|NCT01365481|82880096|FG003|Overall Study|Withdrawal by Subject|1|||
46665953|NCT01365481|82880093|FG000|Overall Study|Lost to Follow-up|1|||
46665954|NCT01365481|82880094|FG001|Overall Study|Lost to Follow-up|1|||
46665955|NCT01365481|82880095|FG002|Overall Study|Lost to Follow-up|2|||
46784591|NCT00542386|83003561|FG005|Overall Study|Lack of Efficacy|31|||
46665956|NCT01365481|82880096|FG003|Overall Study|Lost to Follow-up|3|||
46784592|NCT00542386|83003556|FG000|Overall Study|Physician Decision|1|||
46784593|NCT00542386|83003557|FG001|Overall Study|Physician Decision|0|||
47076607|NCT02618382|83371913|FG000|Overall Study|Physician Decision|1|||
46665957|NCT01365481|82880093|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46665958|NCT01365481|82880094|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46665959|NCT01365481|82880095|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46665960|NCT01365481|82880096|FG003|Overall Study|Abnormal laboratory value(s)|0|||
46665961|NCT01365481|82880093|FG000|Overall Study|Administrative problems|0|||
46665962|NCT01365481|82880094|FG001|Overall Study|Administrative problems|1|||
46665963|NCT01365481|82880095|FG002|Overall Study|Administrative problems|0|||
46665964|NCT01365481|82880096|FG003|Overall Study|Administrative problems|0|||
46665965|NCT01365481|82880093|FG000|Overall Study|Protocol deviation|0|||
46665966|NCT01365481|82880094|FG001|Overall Study|Protocol deviation|1|||
46784594|NCT00542386|83003558|FG002|Overall Study|Physician Decision|0|||
46784595|NCT00542386|83003559|FG003|Overall Study|Physician Decision|1|||
46784596|NCT00542386|83003560|FG004|Overall Study|Physician Decision|0|||
46784597|NCT00542386|83003561|FG005|Overall Study|Physician Decision|0|||
46784598|NCT00542386|83003556|FG000|Overall Study|Protocol Violation|0|||
46784599|NCT00542386|83003557|FG001|Overall Study|Protocol Violation|0|||
46784600|NCT00542386|83003558|FG002|Overall Study|Protocol Violation|1|||
46665967|NCT01365481|82880095|FG002|Overall Study|Protocol deviation|0|||
46665968|NCT01365481|82880096|FG003|Overall Study|Protocol deviation|1|||
46665969|NCT01365481|82880093|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46665970|NCT01365481|82880094|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46665971|NCT01365481|82880095|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
46665972|NCT01365481|82880096|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
46665973|NCT01357915|82880108|FG000|Overall Study|Lost to Follow-up|3|||
46665974|NCT01357915|82880109|FG001|Overall Study|Lost to Follow-up|0|||
46665975|NCT01350973|82880118|FG000|Overall Study|Adverse Event|4|||
46665976|NCT01350973|82880119|FG001|Overall Study|Adverse Event|7|||
46665977|NCT01350973|82880120|FG002|Overall Study|Adverse Event|7|||
46665978|NCT01350973|82880118|FG000|Overall Study|Voluntary Withdrawal|2|||
46665979|NCT01350973|82880119|FG001|Overall Study|Voluntary Withdrawal|1|||
46665980|NCT01350973|82880120|FG002|Overall Study|Voluntary Withdrawal|1|||
46665981|NCT01350544|82880130|FG000|Overall Study|Administrative Withdrawal|0|||
46665982|NCT01350544|82880131|FG001|Overall Study|Administrative Withdrawal|1|||
46665983|NCT01350544|82880130|FG000|Overall Study|Death|1|||
46665984|NCT01350544|82880131|FG001|Overall Study|Death|2|||
46665985|NCT01350544|82880130|FG000|Overall Study|Moved out of LA County|2|||
46665986|NCT01350544|82880131|FG001|Overall Study|Moved out of LA County|2|||
46784601|NCT00542386|83003559|FG003|Overall Study|Protocol Violation|0|||
46784602|NCT00542386|83003560|FG004|Overall Study|Protocol Violation|0|||
46784603|NCT00542386|83003561|FG005|Overall Study|Protocol Violation|4|||
46784604|NCT00542386|83003556|FG000|Overall Study|Withdrawal by Subject|5|||
46784605|NCT00542386|83003557|FG001|Overall Study|Withdrawal by Subject|8|||
46784606|NCT00542386|83003558|FG002|Overall Study|Withdrawal by Subject|10|||
46784607|NCT00542386|83003559|FG003|Overall Study|Withdrawal by Subject|11|||
46784608|NCT00542386|83003560|FG004|Overall Study|Withdrawal by Subject|15|||
46784609|NCT00542386|83003561|FG005|Overall Study|Withdrawal by Subject|7|||
46784610|NCT00542386|83003556|FG000|Overall Study|Other Reasons|4|||
46784611|NCT00542386|83003557|FG001|Overall Study|Other Reasons|1|||
46784612|NCT00542386|83003558|FG002|Overall Study|Other Reasons|4|||
46784613|NCT00542386|83003559|FG003|Overall Study|Other Reasons|3|||
46784614|NCT00542386|83003560|FG004|Overall Study|Other Reasons|4|||
46784615|NCT00542386|83003561|FG005|Overall Study|Other Reasons|2|||
46784616|NCT00604383|83003577|FG000|Overall Study|Withdrawal by Subject|33|||
46784617|NCT00604383|83003578|FG001|Overall Study|Withdrawal by Subject|31|||
46784618|NCT00604383|83003577|FG000|Overall Study|Lost to Follow-up|24|||
46784619|NCT00604383|83003578|FG001|Overall Study|Lost to Follow-up|19|||
46784620|NCT00604383|83003577|FG000|Overall Study|Death|14|||
46784621|NCT00604383|83003578|FG001|Overall Study|Death|22|||
46784622|NCT00604383|83003577|FG000|Overall Study|Adverse Event|16|||
46784623|NCT00604383|83003578|FG001|Overall Study|Adverse Event|9|||
46784624|NCT00604383|83003577|FG000|Overall Study|Physician Decision|0|||
46784625|NCT00604383|83003578|FG001|Overall Study|Physician Decision|3|||
46784626|NCT00333775|83003587|FG000|Overall Study|Death|144|||
46784627|NCT00333775|83003588|FG001|Overall Study|Death|149|||
46784628|NCT00333775|83003589|FG002|Overall Study|Death|143|||
46784629|NCT00333775|83003587|FG000|Overall Study|In Follow-up When Study Stopped|87|||
46784630|NCT00333775|83003588|FG001|Overall Study|In Follow-up When Study Stopped|92|||
46784631|NCT00333775|83003589|FG002|Overall Study|In Follow-up When Study Stopped|96|||
46784632|NCT00333775|83003587|FG000|Overall Study|Lost to Follow-up|10|||
46784633|NCT00333775|83003588|FG001|Overall Study|Lost to Follow-up|7|||
46784634|NCT00333775|83003589|FG002|Overall Study|Lost to Follow-up|8|||
46784635|NCT00605475|83003607|FG000|Overall Study|Abnormal Laboratory Values|0|||
46665987|NCT01350544|82880130|FG000|Overall Study|Medical Issues|1|||
46665988|NCT01350544|82880131|FG001|Overall Study|Medical Issues|1|||
46784636|NCT00605475|83003608|FG001|Overall Study|Abnormal Laboratory Values|0|||
46784637|NCT00605475|83003609|FG002|Overall Study|Abnormal Laboratory Values|0|||
46784638|NCT00605475|83003610|FG003|Overall Study|Abnormal Laboratory Values|0|||
46784639|NCT00605475|83003611|FG004|Overall Study|Abnormal Laboratory Values|0|||
46665989|NCT01350544|82880130|FG000|Overall Study|Withdrawal by Subject|0|||
46784640|NCT00605475|83003612|FG005|Overall Study|Abnormal Laboratory Values|0|||
47076608|NCT02618382|83371913|FG000|Overall Study|Withdrawal by Subject|1|||
46665990|NCT01350544|82880131|FG001|Overall Study|Withdrawal by Subject|1|||
46665991|NCT01350544|82880130|FG000|Overall Study|Incarceration|1|||
46665992|NCT01350544|82880131|FG001|Overall Study|Incarceration|0|||
46784641|NCT00605475|83003613|FG006|Overall Study|Abnormal Laboratory Values|0|||
46784642|NCT00605475|83003614|FG007|Overall Study|Abnormal Laboratory Values|0|||
46784643|NCT00605475|83003615|FG008|Overall Study|Abnormal Laboratory Values|1|||
46784644|NCT00605475|83003616|FG009|Overall Study|Abnormal Laboratory Values|0|||
46665993|NCT01350544|82880130|FG000|Overall Study|Lost to Follow-up|18|||
46665994|NCT01350544|82880131|FG001|Overall Study|Lost to Follow-up|15|||
46665995|NCT01350505|82880137|FG000|Overall Study|Lost to Follow-up|4|||
46665996|NCT01350271|82880144|FG000|Overall Study|Lost to Follow-up|21|||
46665997|NCT01350271|82880145|FG001|Overall Study|Lost to Follow-up|17|||
46665998|NCT01350271|82880146|FG002|Overall Study|Lost to Follow-up|26|||
46665999|NCT01348828|82880157|FG000|Overall Study|Death|20|||
46666000|NCT01348828|82880157|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
46666001|NCT01348828|82880157|FG000|Overall Study|Conversion|2|||
46666002|NCT01348828|82880157|FG000|Overall Study|missed visit|1|||
46666003|NCT01348789|82880161|FG000|Overall Study|Protocol Violation|2|||
46666004|NCT01348789|82880161|FG000|Overall Study|Withdrawal by Subject|2|||
46666005|NCT01342510|82880176|FG000|Overall Study|Protocol Violation|12|||
46666006|NCT01342510|82880177|FG001|Overall Study|Protocol Violation|6|||
46666007|NCT01342510|82880178|FG002|Overall Study|Protocol Violation|13|||
46666008|NCT01342510|82880179|FG003|Overall Study|Protocol Violation|11|||
46666009|NCT01340872|82880199|FG000|Double-blind Phase|Adverse Event|6|||
46666010|NCT01340872|82880200|FG001|Double-blind Phase|Adverse Event|4|||
46666011|NCT01340872|82880201|FG002|Double-blind Phase|Adverse Event|0|||
46666012|NCT01340872|82880202|FG003|Double-blind Phase|Adverse Event|0|||
46666013|NCT01340872|82880199|FG000|Double-blind Phase|Withdrawal by Subject|3|||
46666014|NCT01340872|82880200|FG001|Double-blind Phase|Withdrawal by Subject|5|||
46666015|NCT01340872|82880201|FG002|Double-blind Phase|Withdrawal by Subject|0|||
46666016|NCT01340872|82880202|FG003|Double-blind Phase|Withdrawal by Subject|0|||
46666017|NCT01340872|82880199|FG000|Double-blind Phase|Lost to Follow-up|0|||
46666018|NCT01340872|82880200|FG001|Double-blind Phase|Lost to Follow-up|1|||
46666019|NCT01340872|82880201|FG002|Double-blind Phase|Lost to Follow-up|0|||
46666020|NCT01340872|82880202|FG003|Double-blind Phase|Lost to Follow-up|0|||
46666021|NCT01340872|82880199|FG000|Double-blind Phase|Protocol Violation|0|||
46666022|NCT01340872|82880200|FG001|Double-blind Phase|Protocol Violation|1|||
46666023|NCT01340872|82880201|FG002|Double-blind Phase|Protocol Violation|0|||
46666024|NCT01340872|82880202|FG003|Double-blind Phase|Protocol Violation|0|||
46666025|NCT01340872|82880199|FG000|Open-label Phase|Physician Decision|0|||
46666026|NCT01340872|82880200|FG001|Open-label Phase|Physician Decision|0|||
46666027|NCT01340872|82880201|FG002|Open-label Phase|Physician Decision|2|||
46666028|NCT01340872|82880202|FG003|Open-label Phase|Physician Decision|1|||
46666029|NCT01340872|82880199|FG000|Open-label Phase|Pregnancy|0|||
46666030|NCT01340872|82880200|FG001|Open-label Phase|Pregnancy|0|||
46666031|NCT01340872|82880201|FG002|Open-label Phase|Pregnancy|1|||
46666032|NCT01340872|82880202|FG003|Open-label Phase|Pregnancy|0|||
46666033|NCT01340872|82880199|FG000|Open-label Phase|Adverse Event|0|||
46666034|NCT01340872|82880200|FG001|Open-label Phase|Adverse Event|0|||
46666035|NCT01340872|82880201|FG002|Open-label Phase|Adverse Event|8|||
46666036|NCT01340872|82880202|FG003|Open-label Phase|Adverse Event|4|||
46666037|NCT01340872|82880199|FG000|Open-label Phase|Withdrawal by Subject|0|||
46666038|NCT01340872|82880200|FG001|Open-label Phase|Withdrawal by Subject|0|||
46666039|NCT01340872|82880201|FG002|Open-label Phase|Withdrawal by Subject|1|||
46666040|NCT01340872|82880202|FG003|Open-label Phase|Withdrawal by Subject|6|||
46666041|NCT01340872|82880199|FG000|Open-label Phase|Worsening of IBD|0|||
46666042|NCT01340872|82880200|FG001|Open-label Phase|Worsening of IBD|0|||
46666043|NCT01340872|82880201|FG002|Open-label Phase|Worsening of IBD|1|||
46666044|NCT01340872|82880202|FG003|Open-label Phase|Worsening of IBD|0|||
46666045|NCT01340794|82880216|FG000|Overall Study|Withdrawal by Subject|0|||
46666046|NCT01340794|82880217|FG001|Overall Study|Withdrawal by Subject|1|||
46666047|NCT01340482|82880228|FG000|Overall Study|Adverse Event|2|||
46666048|NCT01340482|82880229|FG001|Overall Study|Adverse Event|0|||
46666049|NCT01340482|82880230|FG002|Overall Study|Adverse Event|0|||
46666050|NCT01340209|82880243|FG000|Overall Study|Adverse Event|1|||
47076609|NCT02618382|83371913|FG000|Overall Study|Protocol Violation|1|||
46666051|NCT01340209|82880244|FG001|Overall Study|Adverse Event|1|||
46666052|NCT01340209|82880245|FG002|Overall Study|Adverse Event|2|||
46666053|NCT01340209|82880243|FG000|Overall Study|Protocol Violation|1|||
46666054|NCT01340209|82880244|FG001|Overall Study|Protocol Violation|2|||
47076610|NCT00980057|83371957|FG000|Overall Study|Death|13|||
47076611|NCT00980057|83371958|FG001|Overall Study|Death|3|||
46666055|NCT01340209|82880245|FG002|Overall Study|Protocol Violation|1|||
46666056|NCT01340209|82880243|FG000|Overall Study|Withdrawal by Subject|0|||
46666057|NCT01340209|82880244|FG001|Overall Study|Withdrawal by Subject|0|||
46666058|NCT01340209|82880245|FG002|Overall Study|Withdrawal by Subject|1|||
46666059|NCT01340209|82880243|FG000|Overall Study|Other reason not defined above|3|||
46666060|NCT01340209|82880244|FG001|Overall Study|Other reason not defined above|5|||
46666061|NCT01340209|82880245|FG002|Overall Study|Other reason not defined above|4|||
46666062|NCT01326910|82880255|FG000|Overall Study|Withdrawal by Subject|3|||
46666063|NCT01326910|82880256|FG001|Overall Study|Withdrawal by Subject|2|||
46666064|NCT01326910|82880255|FG000|Overall Study|Protocol Violation|1|||
46666065|NCT01326910|82880256|FG001|Overall Study|Protocol Violation|1|||
46666066|NCT01326481|82880262|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
46666067|NCT01325701|82880270|FG000|Overall Study|Adverse Event|12|||
46666068|NCT01325701|82880271|FG001|Overall Study|Adverse Event|0|||
46666069|NCT01325701|82880270|FG000|Overall Study|Protocol Violation|1|||
46666070|NCT01325701|82880271|FG001|Overall Study|Protocol Violation|0|||
46666071|NCT01325701|82880270|FG000|Overall Study|Physician Decision|2|||
46666072|NCT01325701|82880271|FG001|Overall Study|Physician Decision|2|||
46666073|NCT01325701|82880270|FG000|Overall Study|Withdrawal by Subject|2|||
46666074|NCT01325701|82880271|FG001|Overall Study|Withdrawal by Subject|1|||
46666075|NCT01325701|82880270|FG000|Overall Study|Rollerover Extension Study|4|||
46666076|NCT01325701|82880271|FG001|Overall Study|Rollerover Extension Study|0|||
46666077|NCT01325623|82880278|FG000|Overall Study|Withdrawal by Subject|3|||
46666078|NCT01325584|82880315|FG000|Overall Study|Death|1|||
46666079|NCT01325428|82880319|FG000|Part A|Progressive disease according to RECIST|9|||
46666080|NCT01325428|82880319|FG000|Part A|Clinical signs, symptoms of progression|2|||
46784645|NCT00605475|83003607|FG000|Overall Study|Administrative problems|0|||
46784646|NCT00605475|83003608|FG001|Overall Study|Administrative problems|0|||
46784647|NCT00605475|83003609|FG002|Overall Study|Administrative problems|0|||
46784648|NCT00605475|83003610|FG003|Overall Study|Administrative problems|0|||
46784649|NCT00605475|83003611|FG004|Overall Study|Administrative problems|0|||
46784650|NCT00605475|83003612|FG005|Overall Study|Administrative problems|0|||
46784651|NCT00605475|83003613|FG006|Overall Study|Administrative problems|1|||
46784652|NCT00605475|83003614|FG007|Overall Study|Administrative problems|0|||
46784653|NCT00605475|83003615|FG008|Overall Study|Administrative problems|0|||
46784654|NCT00605475|83003616|FG009|Overall Study|Administrative problems|0|||
46784655|NCT00605475|83003607|FG000|Overall Study|Lost to Follow-up|0|||
46784656|NCT00605475|83003608|FG001|Overall Study|Lost to Follow-up|0|||
46784657|NCT00605475|83003609|FG002|Overall Study|Lost to Follow-up|0|||
46784658|NCT00605475|83003610|FG003|Overall Study|Lost to Follow-up|0|||
46784659|NCT00605475|83003611|FG004|Overall Study|Lost to Follow-up|0|||
46784660|NCT00605475|83003612|FG005|Overall Study|Lost to Follow-up|0|||
46784661|NCT00605475|83003613|FG006|Overall Study|Lost to Follow-up|0|||
46784662|NCT00605475|83003614|FG007|Overall Study|Lost to Follow-up|0|||
46784663|NCT00605475|83003615|FG008|Overall Study|Lost to Follow-up|1|||
46784664|NCT00605475|83003616|FG009|Overall Study|Lost to Follow-up|1|||
46784665|NCT00605475|83003607|FG000|Overall Study|Protocol Violation|0|||
47076612|NCT00980057|83371957|FG000|Overall Study|Adverse Event|0|||
46666081|NCT01325428|82880319|FG000|Part A|Other adverse event|1|||
46666082|NCT01325428|82880319|FG000|Part A|Refused continue taking trial medication|2|||
46666083|NCT01325428|82880319|FG000|Part A|Other reason not defined above|2|||
46666084|NCT01325428|82880319|FG000|Part B|Refused continue taking trial medication|2|||
46666085|NCT01325428|82880319|FG000|Part B|Other reason not defined above|1|||
46666086|NCT01325350|82880333|FG000|Overall Study|Adverse Event|3|||
46666087|NCT01325350|82880334|FG001|Overall Study|Adverse Event|3|||
46666088|NCT01325350|82880335|FG002|Overall Study|Adverse Event|3|||
46666089|NCT01325350|82880336|FG003|Overall Study|Adverse Event|1|||
46666090|NCT01325350|82880337|FG004|Overall Study|Adverse Event|2|||
46666091|NCT01325350|82880333|FG000|Overall Study|Pregnancy|0|||
46666092|NCT01325350|82880334|FG001|Overall Study|Pregnancy|0|||
46666093|NCT01325350|82880335|FG002|Overall Study|Pregnancy|1|||
46666094|NCT01325350|82880336|FG003|Overall Study|Pregnancy|0|||
46666095|NCT01325350|82880337|FG004|Overall Study|Pregnancy|1|||
46666096|NCT01325350|82880333|FG000|Overall Study|Lost to Follow-up|1|||
46666097|NCT01325350|82880334|FG001|Overall Study|Lost to Follow-up|0|||
46666098|NCT01325350|82880335|FG002|Overall Study|Lost to Follow-up|5|||
46666099|NCT01325350|82880336|FG003|Overall Study|Lost to Follow-up|1|||
46666100|NCT01325350|82880337|FG004|Overall Study|Lost to Follow-up|5|||
46666101|NCT01325350|82880333|FG000|Overall Study|Personal Reasons|2|||
46666102|NCT01325350|82880334|FG001|Overall Study|Personal Reasons|1|||
46666103|NCT01325350|82880335|FG002|Overall Study|Personal Reasons|6|||
46666104|NCT01325350|82880336|FG003|Overall Study|Personal Reasons|5|||
46666105|NCT01325350|82880337|FG004|Overall Study|Personal Reasons|3|||
46784666|NCT00605475|83003608|FG001|Overall Study|Protocol Violation|0|||
46784667|NCT00605475|83003609|FG002|Overall Study|Protocol Violation|0|||
46666106|NCT01325350|82880333|FG000|Overall Study|Protocol Violation|0|||
46784668|NCT00605475|83003610|FG003|Overall Study|Protocol Violation|0|||
46784669|NCT00605475|83003611|FG004|Overall Study|Protocol Violation|1|||
46784670|NCT00605475|83003612|FG005|Overall Study|Protocol Violation|0|||
46784671|NCT00605475|83003613|FG006|Overall Study|Protocol Violation|0|||
46784672|NCT00605475|83003614|FG007|Overall Study|Protocol Violation|0|||
46784673|NCT00605475|83003615|FG008|Overall Study|Protocol Violation|0|||
46666107|NCT01325350|82880334|FG001|Overall Study|Protocol Violation|0|||
46666108|NCT01325350|82880335|FG002|Overall Study|Protocol Violation|0|||
46666109|NCT01325350|82880336|FG003|Overall Study|Protocol Violation|1|||
46666110|NCT01325350|82880337|FG004|Overall Study|Protocol Violation|0|||
46666111|NCT01325350|82880333|FG000|Overall Study|Withdrawal by Subject|0|||
46666112|NCT01325350|82880334|FG001|Overall Study|Withdrawal by Subject|0|||
46666113|NCT01325350|82880335|FG002|Overall Study|Withdrawal by Subject|1|||
46666114|NCT01325350|82880336|FG003|Overall Study|Withdrawal by Subject|1|||
46666115|NCT01325350|82880337|FG004|Overall Study|Withdrawal by Subject|0|||
46666116|NCT01325350|82880333|FG000|Overall Study|Did Not Receive Treatment|0|||
46666117|NCT01325350|82880334|FG001|Overall Study|Did Not Receive Treatment|1|||
46666118|NCT01325350|82880335|FG002|Overall Study|Did Not Receive Treatment|1|||
46666119|NCT01325350|82880336|FG003|Overall Study|Did Not Receive Treatment|0|||
46666120|NCT01325350|82880337|FG004|Overall Study|Did Not Receive Treatment|1|||
46666121|NCT01324999|82880349|FG000|Overall Study|Adverse Event|3|||
46666122|NCT01324999|82880349|FG000|Overall Study|Withdrawal by Subject|2|||
46666123|NCT01324570|82880355|FG000|Overall Study|Adverse Event|4|||
46666124|NCT01324570|82880356|FG001|Overall Study|Adverse Event|7|||
46666125|NCT01324570|82880355|FG000|Overall Study|Withdrawal by Subject|0|||
46666126|NCT01324570|82880356|FG001|Overall Study|Withdrawal by Subject|3|||
46666127|NCT01324570|82880355|FG000|Overall Study|Lack of Efficacy|0|||
46666128|NCT01324570|82880356|FG001|Overall Study|Lack of Efficacy|1|||
46666129|NCT01324570|82880355|FG000|Overall Study|Confirmed or suspected diversion|0|||
46666130|NCT01324570|82880356|FG001|Overall Study|Confirmed or suspected diversion|1|||
46666131|NCT01324570|82880355|FG000|Overall Study|Administrative|0|||
46666132|NCT01324570|82880356|FG001|Overall Study|Administrative|2|||
46666133|NCT01324141|82880364|FG000|Overall Study|Declined to participate before treatment started|1|||
46666134|NCT01324141|82880364|FG000|Overall Study|Disease progression on study|1|||
46666135|NCT01324102|82880380|FG000|Overall Study|illness|1|||
46666136|NCT01324102|82880381|FG001|Overall Study|illness|6|||
46666137|NCT01324024|82880388|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
46666138|NCT01324024|82880389|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
46666139|NCT01323946|82880402|FG000|Overall Study|Lost to Follow-up|0|||
46666140|NCT01323946|82880403|FG001|Overall Study|Lost to Follow-up|1|||
46666141|NCT01323946|82880404|FG002|Overall Study|Lost to Follow-up|0|||
46666142|NCT01323946|82880402|FG000|Overall Study|Parents refused the last blood draw|1|||
46666143|NCT01323946|82880403|FG001|Overall Study|Parents refused the last blood draw|0|||
46666144|NCT01323946|82880404|FG002|Overall Study|Parents refused the last blood draw|0|||
46666145|NCT01323946|82880402|FG000|Overall Study|Withdrawal by Subject|2|||
46666146|NCT01323946|82880403|FG001|Overall Study|Withdrawal by Subject|2|||
46666147|NCT01323946|82880404|FG002|Overall Study|Withdrawal by Subject|0|||
46666148|NCT01323790|82880417|FG000|Overall Study|Other|3|||
46666149|NCT01323790|82880418|FG001|Overall Study|Other|2|||
46666150|NCT01323790|82880419|FG002|Overall Study|Other|1|||
46666151|NCT01323790|82880417|FG000|Overall Study|Lost to Follow-up|11|||
46666152|NCT01323790|82880418|FG001|Overall Study|Lost to Follow-up|9|||
46666153|NCT01323790|82880419|FG002|Overall Study|Lost to Follow-up|9|||
46666154|NCT01323790|82880417|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
46666155|NCT01323790|82880418|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
46666156|NCT01323790|82880419|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
46666157|NCT01323790|82880417|FG000|Overall Study|Lack of Efficacy|3|||
46666158|NCT01323790|82880418|FG001|Overall Study|Lack of Efficacy|0|||
46666159|NCT01323790|82880419|FG002|Overall Study|Lack of Efficacy|3|||
46666160|NCT01323790|82880417|FG000|Overall Study|Adverse Event|11|||
46666161|NCT01323790|82880418|FG001|Overall Study|Adverse Event|24|||
46666162|NCT01323790|82880419|FG002|Overall Study|Adverse Event|12|||
46666163|NCT01323790|82880417|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
46666164|NCT01323790|82880418|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
46666165|NCT01323790|82880419|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
46666166|NCT01323790|82880417|FG000|Overall Study|Withdrawal by Subject|23|||
46784674|NCT00605475|83003616|FG009|Overall Study|Protocol Violation|0|||
46784675|NCT00605475|83003607|FG000|Overall Study|Withdrawal by Subject|0|||
46784676|NCT00605475|83003608|FG001|Overall Study|Withdrawal by Subject|0|||
46784677|NCT00605475|83003609|FG002|Overall Study|Withdrawal by Subject|0|||
46784678|NCT00605475|83003610|FG003|Overall Study|Withdrawal by Subject|0|||
46784679|NCT00605475|83003611|FG004|Overall Study|Withdrawal by Subject|0|||
46784680|NCT00605475|83003612|FG005|Overall Study|Withdrawal by Subject|2|||
46784681|NCT00605475|83003613|FG006|Overall Study|Withdrawal by Subject|0|||
46784682|NCT00605475|83003614|FG007|Overall Study|Withdrawal by Subject|0|||
46784683|NCT00605475|83003615|FG008|Overall Study|Withdrawal by Subject|0|||
46784684|NCT00605475|83003616|FG009|Overall Study|Withdrawal by Subject|1|||
46666167|NCT01323790|82880418|FG001|Overall Study|Withdrawal by Subject|20|||
46666168|NCT01323790|82880419|FG002|Overall Study|Withdrawal by Subject|13|||
46784685|NCT00333619|83003661|FG000|Overall Study|Death|12|||
46784686|NCT00333619|83003662|FG001|Overall Study|Death|6|||
46666169|NCT01323790|82880417|FG000|Overall Study|Did Not Receive Treatment|2|||
46666170|NCT01323790|82880418|FG001|Overall Study|Did Not Receive Treatment|0|||
46666171|NCT01323790|82880419|FG002|Overall Study|Did Not Receive Treatment|1|||
46666172|NCT01323790|82880417|FG000|Overall Study|Severe non-compliance with protocol|2|||
46666173|NCT01323790|82880418|FG001|Overall Study|Severe non-compliance with protocol|2|||
46666174|NCT01323790|82880419|FG002|Overall Study|Severe non-compliance with protocol|2|||
46666175|NCT01323673|82880429|FG000|Overall Study|Adverse Event|0|||
46666176|NCT01323673|82880430|FG001|Overall Study|Adverse Event|1|||
46666177|NCT01323673|82880429|FG000|Overall Study|Lost to Follow-up|0|||
46666178|NCT01323673|82880430|FG001|Overall Study|Lost to Follow-up|1|||
46666179|NCT01323673|82880429|FG000|Overall Study|Protocol Violation|1|||
46666180|NCT01323673|82880430|FG001|Overall Study|Protocol Violation|0|||
46666181|NCT01323673|82880429|FG000|Overall Study|Withdrawal by Subject|2|||
46666182|NCT01323673|82880430|FG001|Overall Study|Withdrawal by Subject|3|||
46666183|NCT01323634|82880438|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
46666184|NCT01323634|82880439|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
46666185|NCT01323634|82880440|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
46666186|NCT01323634|82880438|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
46666187|NCT01323634|82880439|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
46666188|NCT01323634|82880440|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
46666189|NCT01323634|82880438|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
46666190|NCT01323634|82880439|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
46666191|NCT01323634|82880440|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
46666192|NCT01323634|82880438|FG000|2-week Run-in Period|Physician Decision|5|||
46666193|NCT01323634|82880439|FG001|2-week Run-in Period|Physician Decision|0|||
46666194|NCT01323634|82880440|FG002|2-week Run-in Period|Physician Decision|0|||
46784687|NCT00333619|83003661|FG000|Overall Study|Withdrawal by Subject|6|||
46784688|NCT00333619|83003662|FG001|Overall Study|Withdrawal by Subject|1|||
46784689|NCT00333619|83003661|FG000|Overall Study|Lost to Follow-up|3|||
46784690|NCT00333619|83003662|FG001|Overall Study|Lost to Follow-up|3|||
46784691|NCT00605319|83003670|FG000|Overall Study|Adverse Event|6|||
46784692|NCT00333229|83003682|FG000|Overall Study|Lack of Efficacy|0|||
46784693|NCT00333229|83003683|FG001|Overall Study|Lack of Efficacy|1|||
46784694|NCT00332839|83003691|FG000|Core (Months 0 - 12)|Administrative problems|1|||
46784695|NCT00332839|83003692|FG001|Core (Months 0 - 12)|Administrative problems|1|||
46784696|NCT00332839|83003691|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
46784697|NCT00332839|83003692|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
46784698|NCT00332839|83003691|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
46784699|NCT00332839|83003692|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
46784700|NCT00332839|83003691|FG000|Core (Months 0 - 12)|Adverse Event|5|||
46784701|NCT00332839|83003692|FG001|Core (Months 0 - 12)|Adverse Event|15|||
46784702|NCT00332839|83003691|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
46784703|NCT00332839|83003692|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
46784704|NCT00332839|83003691|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
46784705|NCT00332839|83003692|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
46784706|NCT00332839|83003691|FG000|Follow-up (Months 12 - 60)|Death|1|||
46784707|NCT00332839|83003692|FG001|Follow-up (Months 12 - 60)|Death|1|||
46784708|NCT00357097|83003700|FG000|Overall Study|Did not meet inclusion criteria|5|||
46784709|NCT00357097|83003701|FG001|Overall Study|Did not meet inclusion criteria|3|||
46784710|NCT00357097|83003700|FG000|Overall Study|Adverse Event|34|||
46784711|NCT00357097|83003701|FG001|Overall Study|Adverse Event|6|||
46784712|NCT00357097|83003700|FG000|Overall Study|Withdrawal by Subject|8|||
46784713|NCT00357097|83003701|FG001|Overall Study|Withdrawal by Subject|7|||
46784714|NCT00357097|83003700|FG000|Overall Study|Non-compliance|1|||
46784715|NCT00357097|83003701|FG001|Overall Study|Non-compliance|2|||
46784716|NCT00357097|83003700|FG000|Overall Study|Lack of Efficacy|2|||
46784717|NCT00357097|83003701|FG001|Overall Study|Lack of Efficacy|8|||
46784718|NCT00357097|83003700|FG000|Overall Study|Met Exclusion Criteria|3|||
46784719|NCT00357097|83003701|FG001|Overall Study|Met Exclusion Criteria|1|||
46784720|NCT00357097|83003700|FG000|Overall Study|Other|1|||
46784721|NCT00357097|83003701|FG001|Overall Study|Other|1|||
46784722|NCT00357097|83003700|FG000|Overall Study|Increase of RLS Symptoms|0|||
46784723|NCT00357097|83003701|FG001|Overall Study|Increase of RLS Symptoms|1|||
46784724|NCT00356863|83003709|FG000|Overall Study|Death|16|||
46784725|NCT00356863|83003710|FG001|Overall Study|Death|32|||
46784726|NCT00356863|83003709|FG000|Overall Study|Lost to Follow-up|76|||
46784727|NCT00356863|83003710|FG001|Overall Study|Lost to Follow-up|43|||
46784728|NCT00355615|83003733|FG000|Randomized Double Blind Period|Adverse Event|1|||
46784729|NCT00355615|83003734|FG001|Randomized Double Blind Period|Adverse Event|0|||
46784730|NCT00355615|83003735|FG002|Randomized Double Blind Period|Adverse Event|0|||
46784731|NCT00355615|83003736|FG003|Randomized Double Blind Period|Adverse Event|0|||
46784732|NCT00355615|83003737|FG004|Randomized Double Blind Period|Adverse Event|0|||
46784733|NCT00355615|83003733|FG000|Randomized Double Blind Period|Protocol Violation|0|||
46784734|NCT00355615|83003734|FG001|Randomized Double Blind Period|Protocol Violation|0|||
46784735|NCT00355615|83003735|FG002|Randomized Double Blind Period|Protocol Violation|1|||
46784736|NCT00355615|83003736|FG003|Randomized Double Blind Period|Protocol Violation|1|||
46784737|NCT00355615|83003737|FG004|Randomized Double Blind Period|Protocol Violation|0|||
46784738|NCT00355615|83003733|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
46784739|NCT00355615|83003734|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
46666195|NCT01323634|82880438|FG000|2-week Run-in Period|Protocol Violation|1|||
46666196|NCT01323634|82880439|FG001|2-week Run-in Period|Protocol Violation|0|||
46666197|NCT01323634|82880440|FG002|2-week Run-in Period|Protocol Violation|0|||
46784740|NCT00355615|83003735|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
46784741|NCT00355615|83003736|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
46784742|NCT00355615|83003737|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
46666198|NCT01323634|82880438|FG000|2-week Run-in Period|Adverse Event|1|||
46666199|NCT01323634|82880439|FG001|2-week Run-in Period|Adverse Event|0|||
46666200|NCT01323634|82880440|FG002|2-week Run-in Period|Adverse Event|0|||
46666201|NCT01323634|82880438|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
46666202|NCT01323634|82880439|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
46666203|NCT01323634|82880440|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
46666204|NCT01323634|82880438|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
46666205|NCT01323634|82880439|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
46784743|NCT00355615|83003733|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
46784744|NCT00355615|83003734|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
46784745|NCT00355615|83003735|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
46784746|NCT00355615|83003736|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
46784747|NCT00355615|83003737|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
46784748|NCT00355615|83003733|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
46784749|NCT00355615|83003734|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
46784750|NCT00355615|83003735|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
46784751|NCT00355615|83003736|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
46784752|NCT00355615|83003737|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
46784753|NCT00355615|83003733|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
46784754|NCT00355615|83003734|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
46784755|NCT00355615|83003735|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
46784756|NCT00355615|83003736|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
46784757|NCT00355615|83003737|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
46784758|NCT00347269|83003750|FG000|Overall Study|Lost to Follow-up|74|||
46666206|NCT01323634|82880440|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
46666207|NCT01323634|82880438|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
46666208|NCT01323634|82880439|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
46666209|NCT01323634|82880440|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
46666210|NCT01323634|82880438|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
46666211|NCT01323634|82880439|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
46666212|NCT01323634|82880440|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
46666213|NCT01323634|82880438|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
46666214|NCT01323634|82880439|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
46666215|NCT01323634|82880440|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
46666216|NCT01323634|82880438|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
46666217|NCT01323634|82880439|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
46666218|NCT01323634|82880440|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
46666219|NCT01323634|82880438|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
46666220|NCT01323634|82880439|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
46666221|NCT01323634|82880440|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
46666222|NCT01323478|82880446|FG000|Overall Study|Adverse Event|7|||
46666223|NCT01323478|82880446|FG000|Overall Study|Lack of Efficacy|4|||
46666224|NCT01323478|82880446|FG000|Overall Study|Non-compliance With Study Product|3|||
46666225|NCT01323478|82880446|FG000|Overall Study|Protocol Violation|1|||
46666226|NCT01323478|82880446|FG000|Overall Study|Withdrawal of Consent|1|||
46666227|NCT01323478|82880446|FG000|Overall Study|Administrative or Other Reasons|8|||
46666228|NCT01322386|82880452|FG000|Overall Study|Protocol Violation|0|||
46666229|NCT01322386|82880453|FG001|Overall Study|Protocol Violation|1|||
46784759|NCT00347269|83003751|FG001|Overall Study|Lost to Follow-up|65|||
46784760|NCT00347269|83003750|FG000|Overall Study|Withdrawal by Subject|18|||
46784761|NCT00347269|83003751|FG001|Overall Study|Withdrawal by Subject|38|||
46784762|NCT00347269|83003750|FG000|Overall Study|Death|2|||
46784763|NCT00347269|83003751|FG001|Overall Study|Death|3|||
46784764|NCT00544648|83003759|FG000|Overall Study|Withdrawal by Subject|1|||
46784765|NCT00544648|83003760|FG001|Overall Study|Withdrawal by Subject|0|||
46784766|NCT00544648|83003759|FG000|Overall Study|Adverse Event|1|||
46784767|NCT00544648|83003760|FG001|Overall Study|Adverse Event|1|||
46784768|NCT00544648|83003759|FG000|Overall Study|progression of disease|1|||
46784769|NCT00544648|83003760|FG001|Overall Study|progression of disease|0|||
46784770|NCT00346333|83003770|FG000|Overall Study|Death|1|||
46666230|NCT01322386|82880452|FG000|Overall Study|Physician Decision|0|||
46666231|NCT01322386|82880453|FG001|Overall Study|Physician Decision|1|||
46666232|NCT01322347|82880463|FG000|Overall Study|Adverse Event|7|||
46666233|NCT01322347|82880464|FG001|Overall Study|Adverse Event|2|||
46666234|NCT01322347|82880463|FG000|Overall Study|Death|5|||
46666235|NCT01322347|82880464|FG001|Overall Study|Death|3|||
46666236|NCT01322347|82880463|FG000|Overall Study|Physician Decision|2|||
46666237|NCT01322347|82880464|FG001|Overall Study|Physician Decision|1|||
46666238|NCT01322347|82880463|FG000|Overall Study|Protocol Violation|5|||
46666239|NCT01322347|82880464|FG001|Overall Study|Protocol Violation|2|||
46666240|NCT01322347|82880463|FG000|Overall Study|Withdrawal by Subject|1|||
46666241|NCT01322347|82880464|FG001|Overall Study|Withdrawal by Subject|4|||
46666242|NCT01322347|82880463|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
46666243|NCT01322347|82880464|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
46972343|NCT02514239|83216054|FG005|Overall Study|Not treated|0|||
46972344|NCT02514239|83216055|FG006|Overall Study|Not treated|0|||
46972345|NCT02514239|83216056|FG007|Overall Study|Not treated|0|||
46972346|NCT02514239|83216057|FG008|Overall Study|Not treated|0|||
46666244|NCT01322347|82880463|FG000|Overall Study|blood transfusion|5|||
46666245|NCT01322347|82880464|FG001|Overall Study|blood transfusion|5|||
46666246|NCT01322347|82880463|FG000|Overall Study|sponsor decision|1|||
46666247|NCT01322347|82880464|FG001|Overall Study|sponsor decision|3|||
46666248|NCT01322347|82880463|FG000|Overall Study|ineligible|6|||
46666249|NCT01322347|82880464|FG001|Overall Study|ineligible|3|||
46666250|NCT01322347|82880463|FG000|Overall Study|kidney transplant|3|||
46666251|NCT01322347|82880464|FG001|Overall Study|kidney transplant|1|||
46666252|NCT01322347|82880463|FG000|Overall Study|study drug withheld > 12 wks|0|||
46666253|NCT01322347|82880464|FG001|Overall Study|study drug withheld > 12 wks|1|||
46666254|NCT01322347|82880463|FG000|Overall Study|moved/changed dialysis|2|||
46666255|NCT01322347|82880464|FG001|Overall Study|moved/changed dialysis|4|||
46666256|NCT01321879|82880471|FG000|Overall Study|Lack of Efficacy|5|||
46666257|NCT01321879|82880471|FG000|Overall Study|Adverse Event|5|||
47076613|NCT00980057|83371958|FG001|Overall Study|Adverse Event|1|||
47076614|NCT00980057|83371957|FG000|Overall Study|Physician Decision|4|||
46666258|NCT01321879|82880471|FG000|Overall Study|Death|3|||
46666259|NCT01321879|82880471|FG000|Overall Study|Withdrawal by Subject|1|||
46666260|NCT01321723|82880478|FG000|Overall Study|Adverse Event|3|||
46666261|NCT01321723|82880479|FG001|Overall Study|Adverse Event|5|||
46666262|NCT01321723|82880480|FG002|Overall Study|Adverse Event|2|||
46666263|NCT01321723|82880478|FG000|Overall Study|Withdrawal by Subject|2|||
46666264|NCT01321723|82880479|FG001|Overall Study|Withdrawal by Subject|0|||
46666265|NCT01321723|82880480|FG002|Overall Study|Withdrawal by Subject|2|||
46666266|NCT01321606|82880490|FG000|Overall Study|Lost to Follow-up|0|||
46666267|NCT01321606|82880491|FG001|Overall Study|Lost to Follow-up|0|||
46666268|NCT01321606|82880492|FG002|Overall Study|Lost to Follow-up|0|||
46666269|NCT01321606|82880493|FG003|Overall Study|Lost to Follow-up|1|||
46666270|NCT01320943|82880505|FG000|Overall Study|Lost to Follow-up|1|||
46666271|NCT01320943|82880506|FG001|Overall Study|Lost to Follow-up|0|||
46666272|NCT01320943|82880505|FG000|Overall Study|Physician Decision|0|||
46666273|NCT01320943|82880506|FG001|Overall Study|Physician Decision|1|||
46666274|NCT01320943|82880505|FG000|Overall Study|Randomized but not Treated|0|||
46666275|NCT01320943|82880506|FG001|Overall Study|Randomized but not Treated|1|||
46666276|NCT02482233|82880521|FG000|Overall Study|Lost to Follow-up|1|||
46666277|NCT02482233|82880522|FG001|Overall Study|Lost to Follow-up|1|||
46666278|NCT01320202|82880532|FG000|Overall Study|Adverse Event|5|||
46666279|NCT01320202|82880533|FG001|Overall Study|Adverse Event|5|||
46972347|NCT02514239|83216058|FG009|Overall Study|Not treated|0|||
47076615|NCT00980057|83371958|FG001|Overall Study|Physician Decision|0|||
46666280|NCT01320202|82880532|FG000|Overall Study|Death|5|||
46666281|NCT01320202|82880533|FG001|Overall Study|Death|3|||
46784771|NCT00346333|83003771|FG001|Overall Study|Death|0|||
46784772|NCT00346333|83003770|FG000|Overall Study|unwilling or unable to continue|4|||
47076616|NCT00980057|83371957|FG000|Overall Study|Lost to Follow-up|1|||
47076617|NCT00980057|83371958|FG001|Overall Study|Lost to Follow-up|0|||
47076618|NCT00980057|83371957|FG000|Overall Study|Withdrawal by Subject|1|||
47076619|NCT00980057|83371958|FG001|Overall Study|Withdrawal by Subject|1|||
47076620|NCT04126733|83372079|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
47076621|NCT04126733|83372079|FG000|Treatment Period|Adverse Event|8|||
47076622|NCT04126733|83372079|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
46666282|NCT01320202|82880532|FG000|Overall Study|Lost to Follow-up|1|||
46666283|NCT01320202|82880533|FG001|Overall Study|Lost to Follow-up|0|||
46666284|NCT01320202|82880532|FG000|Overall Study|Physician Decision|3|||
46666285|NCT01320202|82880533|FG001|Overall Study|Physician Decision|1|||
46666286|NCT01320202|82880532|FG000|Overall Study|Protocol Violation|2|||
46666287|NCT01320202|82880533|FG001|Overall Study|Protocol Violation|1|||
46784773|NCT00346333|83003771|FG001|Overall Study|unwilling or unable to continue|8|||
47076623|NCT04126733|83372079|FG000|Treatment Period|Physician Decision|5|||
46666288|NCT01320202|82880532|FG000|Overall Study|Withdrawal by Subject|10|||
46666289|NCT01320202|82880533|FG001|Overall Study|Withdrawal by Subject|3|||
46666290|NCT01320202|82880532|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
46972348|NCT02514239|83216049|FG000|Overall Study|Other Adverse Events|2|||
47076624|NCT04126733|83372079|FG000|Treatment Period|Death|1|||
46666291|NCT01320202|82880533|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
46666292|NCT01320202|82880532|FG000|Overall Study|kidney transplant|1|||
46666293|NCT01320202|82880533|FG001|Overall Study|kidney transplant|2|||
46666294|NCT01320202|82880532|FG000|Overall Study|blood transfusion|1|||
46666295|NCT01320202|82880533|FG001|Overall Study|blood transfusion|7|||
46666296|NCT01320202|82880532|FG000|Overall Study|moved/changed dialysis|5|||
46666297|NCT01320202|82880533|FG001|Overall Study|moved/changed dialysis|2|||
46666298|NCT01320202|82880532|FG000|Overall Study|sponsor request|2|||
46666299|NCT01320202|82880533|FG001|Overall Study|sponsor request|0|||
46666300|NCT01320202|82880532|FG000|Overall Study|ineligible|3|||
46666301|NCT01320202|82880533|FG001|Overall Study|ineligible|0|||
46666302|NCT01320202|82880532|FG000|Overall Study|regained renal function|1|||
46666303|NCT01320202|82880533|FG001|Overall Study|regained renal function|0|||
46666304|NCT01319383|82880542|FG000|Overall Study|No ex vivo or in vivo response|4|||
46666305|NCT01319383|82880543|FG001|Overall Study|No ex vivo or in vivo response|0|||
46666306|NCT01319383|82880542|FG000|Overall Study|Physician Decision|3|||
46666307|NCT01319383|82880543|FG001|Overall Study|Physician Decision|0|||
46666308|NCT01319383|82880542|FG000|Overall Study|Lack of Efficacy|5|||
46666309|NCT01319383|82880543|FG001|Overall Study|Lack of Efficacy|9|||
46666310|NCT01319383|82880542|FG000|Overall Study|No in vivo response to interval doses|0|||
46666311|NCT01319383|82880543|FG001|Overall Study|No in vivo response to interval doses|1|||
46666312|NCT01316614|82880560|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
46666313|NCT01316614|82880560|FG000|Overall Study|Cytology slides not available for review|4|||
46666314|NCT01316614|82880560|FG000|Overall Study|Cystic lesion|5|||
46666315|NCT01316614|82880560|FG000|Overall Study|Inadequate number of passes|2|||
46666316|NCT01316614|82880560|FG000|Overall Study|Medically unstable|1|||
46666317|NCT01316575|82880567|FG000|Overall Study|Withdrawal by Subject|2|||
46666318|NCT01316575|82880568|FG001|Overall Study|Withdrawal by Subject|0|||
46666319|NCT01316575|82880567|FG000|Overall Study|Required alternate treatment|0|||
46666320|NCT01316575|82880568|FG001|Overall Study|Required alternate treatment|1|||
46784774|NCT00330967|83003781|FG000|Overall Study|Withdrawal by Subject|0|||
46784775|NCT00330967|83003782|FG001|Overall Study|Withdrawal by Subject|5|||
46784776|NCT00330967|83003781|FG000|Overall Study|Physician Decision|0|||
46784777|NCT00330967|83003782|FG001|Overall Study|Physician Decision|9|||
46784778|NCT00330343|83003788|FG000|Overall Study|Lost to Follow-up|5|||
46784779|NCT00330187|83003796|FG000|Overall Study|Lost to Follow-up|12|||
46784780|NCT00330187|83003797|FG001|Overall Study|Lost to Follow-up|13|||
46784781|NCT00330187|83003798|FG002|Overall Study|Lost to Follow-up|14|||
46784782|NCT00330187|83003799|FG003|Overall Study|Lost to Follow-up|10|||
46784783|NCT00330187|83003796|FG000|Overall Study|Withdrawal by Subject|8|||
46784784|NCT00330187|83003797|FG001|Overall Study|Withdrawal by Subject|5|||
46784785|NCT00330187|83003798|FG002|Overall Study|Withdrawal by Subject|4|||
46784786|NCT00330187|83003799|FG003|Overall Study|Withdrawal by Subject|4|||
46784787|NCT03914950|83003809|FG000|Overall Study|Physician Decision|54|||
46784788|NCT00329797|83003821|FG000|Overall Study|Protocol Violation|1|||
46784789|NCT00329797|83003822|FG001|Overall Study|Protocol Violation|0|||
46784790|NCT00329797|83003821|FG000|Overall Study|Withdrawal by Subject|6|||
46784791|NCT00329797|83003822|FG001|Overall Study|Withdrawal by Subject|6|||
46784792|NCT00541450|83003830|FG000|Phase A|Adverse Event|3|||
46784793|NCT00541450|83003831|FG001|Phase A|Adverse Event|0|||
46784794|NCT00541450|83003830|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
46784795|NCT00541450|83003831|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
46784796|NCT00541450|83003830|FG000|Phase A|Hyperglycemia|0|||
46784797|NCT00541450|83003831|FG001|Phase A|Hyperglycemia|1|||
46784798|NCT00541450|83003830|FG000|Phase A|Lost to Follow-up|6|||
46784799|NCT00541450|83003831|FG001|Phase A|Lost to Follow-up|4|||
46666321|NCT01315678|82880576|FG000|Overall Study|Withdrawal by Subject|7|||
46666322|NCT01315678|82880577|FG001|Overall Study|Withdrawal by Subject|3|||
46666323|NCT01315678|82880576|FG000|Overall Study|Adverse Event|3|||
46666324|NCT01315678|82880577|FG001|Overall Study|Adverse Event|1|||
46666325|NCT01315678|82880576|FG000|Overall Study|Lost to Follow-up|1|||
46666326|NCT01315678|82880577|FG001|Overall Study|Lost to Follow-up|0|||
46666327|NCT01315678|82880576|FG000|Overall Study|similar reason to those listed above|3|||
46666328|NCT01315678|82880577|FG001|Overall Study|similar reason to those listed above|2|||
46666329|NCT01315249|82880587|FG000|Overall Study|Adverse Event|22|||
46784800|NCT00541450|83003830|FG000|Phase A|Physician Decision|2|||
46784801|NCT00541450|83003831|FG001|Phase A|Physician Decision|0|||
46784802|NCT00541450|83003830|FG000|Phase A|Protocol Violation|2|||
46784803|NCT00541450|83003831|FG001|Phase A|Protocol Violation|3|||
46784804|NCT00541450|83003830|FG000|Phase A|Withdrawal by Subject|7|||
46666330|NCT01315249|82880588|FG001|Overall Study|Adverse Event|26|||
46666331|NCT01315249|82880587|FG000|Overall Study|Withdrawal by Subject|11|||
46666332|NCT01315249|82880588|FG001|Overall Study|Withdrawal by Subject|10|||
46666333|NCT01315249|82880587|FG000|Overall Study|Protocol Violation|8|||
46666334|NCT01315249|82880588|FG001|Overall Study|Protocol Violation|5|||
46666335|NCT01315249|82880587|FG000|Overall Study|Abnormal test results|1|||
46666336|NCT01315249|82880588|FG001|Overall Study|Abnormal test results|2|||
46784805|NCT00541450|83003831|FG001|Phase A|Withdrawal by Subject|7|||
46784806|NCT00541450|83003830|FG000|Phase B|Adverse Event|6|||
46784807|NCT00541450|83003831|FG001|Phase B|Adverse Event|6|||
46784808|NCT00541450|83003830|FG000|Phase B|Hyperglycemia|10|||
46784809|NCT00541450|83003831|FG001|Phase B|Hyperglycemia|9|||
46784810|NCT00541450|83003830|FG000|Phase B|Lost to Follow-up|6|||
46784811|NCT00541450|83003831|FG001|Phase B|Lost to Follow-up|4|||
46784812|NCT00541450|83003830|FG000|Phase B|Physician Decision|4|||
46784813|NCT00541450|83003831|FG001|Phase B|Physician Decision|2|||
47076625|NCT04126733|83372079|FG000|Treatment Period|Other Reasons|2|||
47076626|NCT04126733|83372079|FG000|Active Follow-up Period|Death|13|||
46666337|NCT01315249|82880587|FG000|Overall Study|Administrative problems|1|||
46666338|NCT01315249|82880588|FG001|Overall Study|Administrative problems|0|||
46666339|NCT01315249|82880587|FG000|Overall Study|inability to use device|1|||
46666340|NCT01315249|82880588|FG001|Overall Study|inability to use device|0|||
46666341|NCT01315249|82880587|FG000|Overall Study|Lack of Efficacy|0|||
46666342|NCT01315249|82880588|FG001|Overall Study|Lack of Efficacy|1|||
46666343|NCT01315249|82880587|FG000|Overall Study|Lost to Follow-up|0|||
46666344|NCT01315249|82880588|FG001|Overall Study|Lost to Follow-up|2|||
46666345|NCT01315249|82880587|FG000|Overall Study|Death|0|||
46666346|NCT01315249|82880588|FG001|Overall Study|Death|1|||
46666347|NCT01315132|82880594|FG000|Overall Study|not treated due to disease progression|1|||
46666348|NCT01313767|82880600|FG000|Overall Study|Adverse Event|1|||
46666349|NCT01313767|82880601|FG001|Overall Study|Adverse Event|0|||
46666350|NCT01313767|82880600|FG000|Overall Study|Lost to Follow-up|1|||
46666351|NCT01313767|82880601|FG001|Overall Study|Lost to Follow-up|0|||
46666352|NCT01313767|82880600|FG000|Overall Study|Withdrawal by Subject|2|||
46666353|NCT01313767|82880601|FG001|Overall Study|Withdrawal by Subject|1|||
46666354|NCT01313767|82880600|FG000|Overall Study|Protocol Violation|3|||
46666355|NCT01313767|82880601|FG001|Overall Study|Protocol Violation|1|||
46666356|NCT01313728|82880607|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
46666357|NCT01313650|82880616|FG000|Overall Study|Adverse Event|9|||
46666358|NCT01313650|82880617|FG001|Overall Study|Adverse Event|34|||
46666359|NCT01313650|82880618|FG002|Overall Study|Adverse Event|24|||
47076627|NCT04126733|83372079|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
47076628|NCT04126733|83372079|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
47076629|NCT04126733|83372079|FG000|Active Follow-up Period|Other Reasons|1|||
47076630|NCT04126733|83372079|FG000|Long-term Follow-up Period|Death|22|||
47076631|NCT04126733|83372079|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
47076632|NCT04126733|83372079|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
47076633|NCT00988247|83372114|FG000|Overall Study|Adverse Event|17|||
47076634|NCT00988247|83372115|FG001|Overall Study|Adverse Event|3|||
47076635|NCT00988247|83372114|FG000|Overall Study|Withdrawal by Subject|44|||
47076636|NCT00988247|83372115|FG001|Overall Study|Withdrawal by Subject|13|||
47076637|NCT00988247|83372114|FG000|Overall Study|Pregnancy|1|||
47076638|NCT00988247|83372115|FG001|Overall Study|Pregnancy|2|||
47076639|NCT00988247|83372114|FG000|Overall Study|Lost to Follow-up|11|||
47076640|NCT00988247|83372115|FG001|Overall Study|Lost to Follow-up|2|||
47076641|NCT00988247|83372114|FG000|Overall Study|Protocol Violation|4|||
47076642|NCT00988247|83372115|FG001|Overall Study|Protocol Violation|5|||
47076643|NCT00988247|83372114|FG000|Overall Study|Sponsor requested withdrawal|3|||
47076644|NCT00988247|83372115|FG001|Overall Study|Sponsor requested withdrawal|1|||
47076645|NCT00988247|83372114|FG000|Overall Study|Other|3|||
47076646|NCT00988247|83372115|FG001|Overall Study|Other|0|||
47076647|NCT00984659|83372125|FG000|2-week Run-in Period|Adverse Event|8|||
47076648|NCT00984659|83372126|FG001|2-week Run-in Period|Adverse Event|0|||
47076649|NCT00984659|83372127|FG002|2-week Run-in Period|Adverse Event|0|||
47076650|NCT00984659|83372128|FG003|2-week Run-in Period|Adverse Event|0|||
47076651|NCT00984659|83372125|FG000|2-week Run-in Period|Protocol Violation|5|||
46666360|NCT01313650|82880619|FG003|Overall Study|Adverse Event|23|||
46666361|NCT01313650|82880616|FG000|Overall Study|Lack of Efficacy|37|||
46666362|NCT01313650|82880617|FG001|Overall Study|Lack of Efficacy|20|||
46666363|NCT01313650|82880618|FG002|Overall Study|Lack of Efficacy|32|||
46666364|NCT01313650|82880619|FG003|Overall Study|Lack of Efficacy|20|||
46666365|NCT01313650|82880616|FG000|Overall Study|Lost to Follow-up|1|||
46666366|NCT01313650|82880617|FG001|Overall Study|Lost to Follow-up|0|||
46666367|NCT01313650|82880618|FG002|Overall Study|Lost to Follow-up|3|||
46666368|NCT01313650|82880619|FG003|Overall Study|Lost to Follow-up|2|||
46666369|NCT01313650|82880616|FG000|Overall Study|Withdrawal by Subject|16|||
46666370|NCT01313650|82880617|FG001|Overall Study|Withdrawal by Subject|20|||
46666371|NCT01313650|82880618|FG002|Overall Study|Withdrawal by Subject|15|||
46784814|NCT00541450|83003830|FG000|Phase B|Pregnancy|0|||
46666372|NCT01313650|82880619|FG003|Overall Study|Withdrawal by Subject|15|||
46784815|NCT00541450|83003831|FG001|Phase B|Pregnancy|1|||
46784816|NCT00541450|83003830|FG000|Phase B|Protocol Violation|3|||
46784817|NCT00541450|83003831|FG001|Phase B|Protocol Violation|3|||
46784818|NCT00541450|83003830|FG000|Phase B|Withdrawal by Subject|8|||
47076652|NCT00984659|83372126|FG001|2-week Run-in Period|Protocol Violation|0|||
47076653|NCT00984659|83372127|FG002|2-week Run-in Period|Protocol Violation|0|||
46666373|NCT01313650|82880616|FG000|Overall Study|Protocol Violation|4|||
46666374|NCT01313650|82880617|FG001|Overall Study|Protocol Violation|7|||
46666375|NCT01313650|82880618|FG002|Overall Study|Protocol Violation|5|||
46666376|NCT01313650|82880619|FG003|Overall Study|Protocol Violation|6|||
46666377|NCT01313650|82880616|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
46666378|NCT01313650|82880617|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
46666379|NCT01313650|82880618|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
46666380|NCT01313650|82880619|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
46666381|NCT01313299|82880632|FG000|Overall Study|Adverse Event|3|||
46666382|NCT01313299|82880633|FG001|Overall Study|Adverse Event|1|||
46666383|NCT01313299|82880634|FG002|Overall Study|Adverse Event|1|||
46666384|NCT01313299|82880632|FG000|Overall Study|Lost to Follow-up|1|||
46666385|NCT01313299|82880633|FG001|Overall Study|Lost to Follow-up|0|||
46666386|NCT01313299|82880634|FG002|Overall Study|Lost to Follow-up|0|||
46666387|NCT01313299|82880632|FG000|Overall Study|Protocol Violation|2|||
46666388|NCT01313299|82880633|FG001|Overall Study|Protocol Violation|0|||
46666389|NCT01313299|82880634|FG002|Overall Study|Protocol Violation|0|||
46666390|NCT01313299|82880632|FG000|Overall Study|Withdrawal by Subject|1|||
47076654|NCT00984659|83372128|FG003|2-week Run-in Period|Protocol Violation|0|||
47076655|NCT00984659|83372125|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
47076656|NCT00984659|83372126|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
47076657|NCT00984659|83372127|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
47076658|NCT00984659|83372128|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
47076659|NCT00984659|83372125|FG000|2-week Run-in Period|Lost to Follow-up|3|||
47076660|NCT00984659|83372126|FG001|2-week Run-in Period|Lost to Follow-up|0|||
47076661|NCT00984659|83372127|FG002|2-week Run-in Period|Lost to Follow-up|0|||
47076662|NCT00984659|83372128|FG003|2-week Run-in Period|Lost to Follow-up|0|||
47076663|NCT00984659|83372125|FG000|2-week Run-in Period|Physician Decision|10|||
47076664|NCT00984659|83372126|FG001|2-week Run-in Period|Physician Decision|0|||
47076665|NCT00984659|83372127|FG002|2-week Run-in Period|Physician Decision|0|||
47076666|NCT00984659|83372128|FG003|2-week Run-in Period|Physician Decision|0|||
47076667|NCT00984659|83372125|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
47076668|NCT00984659|83372126|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
47076669|NCT00984659|83372127|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
47076670|NCT00984659|83372128|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
47076671|NCT00984659|83372125|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
47076672|NCT00984659|83372126|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
47076673|NCT00984659|83372127|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
47076674|NCT00984659|83372128|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
47076675|NCT00984659|83372125|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
47076676|NCT00984659|83372126|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
47076677|NCT00984659|83372127|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
47076678|NCT00984659|83372128|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
47076679|NCT00984659|83372125|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
47076680|NCT00984659|83372126|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
47076681|NCT00984659|83372127|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
47076682|NCT00984659|83372128|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
47076683|NCT00984659|83372125|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
47076684|NCT00984659|83372126|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
47076685|NCT00984659|83372127|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
47076686|NCT00984659|83372128|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
47076687|NCT00984659|83372125|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
46666391|NCT01313299|82880633|FG001|Overall Study|Withdrawal by Subject|0|||
46666392|NCT01313299|82880634|FG002|Overall Study|Withdrawal by Subject|2|||
46666393|NCT01313299|82880632|FG000|Overall Study|Family reason and moved out of state|0|||
46666394|NCT01313299|82880633|FG001|Overall Study|Family reason and moved out of state|2|||
46666395|NCT01313299|82880634|FG002|Overall Study|Family reason and moved out of state|0|||
46666396|NCT01313299|82880632|FG000|Overall Study|Lack of subject compliance|0|||
47076688|NCT00984659|83372126|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
47076689|NCT00984659|83372127|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
47076690|NCT00984659|83372128|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
47076691|NCT00984659|83372125|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
47076692|NCT00984659|83372126|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
47076693|NCT00984659|83372127|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
47076694|NCT00984659|83372128|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
47076695|NCT00982319|83372137|FG000|Overall Study|Surgery date change|1|||
47076696|NCT00982319|83372138|FG001|Overall Study|Surgery date change|0|||
47076697|NCT00982319|83372137|FG000|Overall Study|Preop values out of acceptable range|1|||
47076698|NCT00982319|83372138|FG001|Overall Study|Preop values out of acceptable range|1|||
47076699|NCT00982319|83372137|FG000|Overall Study|Pregnancy|0|||
47076700|NCT00982319|83372138|FG001|Overall Study|Pregnancy|1|||
47076701|NCT02612064|83372150|FG000|Overall Study|Withdrawal by Subject|1|||
47076702|NCT02612064|83372151|FG001|Overall Study|Withdrawal by Subject|1|||
47076703|NCT02612064|83372150|FG000|Overall Study|Other|0|||
47076704|NCT02612064|83372151|FG001|Overall Study|Other|2|||
46666397|NCT01313299|82880633|FG001|Overall Study|Lack of subject compliance|0|||
46666398|NCT01313299|82880634|FG002|Overall Study|Lack of subject compliance|1|||
46666399|NCT01313221|82880645|FG000|Overall Study|Protocol Violation|0|||
46666400|NCT01313221|82880646|FG001|Overall Study|Protocol Violation|1|||
46666401|NCT01313221|82880647|FG002|Overall Study|Protocol Violation|1|||
46666402|NCT01313221|82880645|FG000|Overall Study|Non-compliance|3|||
46666403|NCT01313221|82880646|FG001|Overall Study|Non-compliance|0|||
46666404|NCT01313221|82880647|FG002|Overall Study|Non-compliance|2|||
46666405|NCT01313221|82880645|FG000|Overall Study|Withdrawal by Subject|2|||
46666406|NCT01313221|82880646|FG001|Overall Study|Withdrawal by Subject|3|||
46666407|NCT01313221|82880647|FG002|Overall Study|Withdrawal by Subject|5|||
46666408|NCT01313221|82880645|FG000|Overall Study|Requirement for alternative therapy|0|||
46666409|NCT01313221|82880646|FG001|Overall Study|Requirement for alternative therapy|1|||
46666410|NCT01313221|82880647|FG002|Overall Study|Requirement for alternative therapy|1|||
46666411|NCT01313221|82880645|FG000|Overall Study|Lost to Follow-up|6|||
46666412|NCT01313221|82880646|FG001|Overall Study|Lost to Follow-up|3|||
46666413|NCT01313221|82880647|FG002|Overall Study|Lost to Follow-up|1|||
46666414|NCT01313221|82880645|FG000|Overall Study|Other|1|||
46666415|NCT01313221|82880646|FG001|Overall Study|Other|0|||
46666416|NCT01313221|82880647|FG002|Overall Study|Other|0|||
46666417|NCT01313221|82880645|FG000|Overall Study|Adverse Event|0|||
46666418|NCT01313221|82880646|FG001|Overall Study|Adverse Event|0|||
46666419|NCT01313221|82880647|FG002|Overall Study|Adverse Event|7|||
46666420|NCT01313221|82880645|FG000|Overall Study|Disease progression|0|||
46666421|NCT01313221|82880646|FG001|Overall Study|Disease progression|0|||
46666422|NCT01313221|82880647|FG002|Overall Study|Disease progression|2|||
46666423|NCT01313221|82880645|FG000|Overall Study|Physician Decision|0|||
46666424|NCT01313221|82880646|FG001|Overall Study|Physician Decision|0|||
46666425|NCT01313221|82880647|FG002|Overall Study|Physician Decision|2|||
46666426|NCT01313221|82880645|FG000|Overall Study|Pregnancy|0|||
46666427|NCT01313221|82880646|FG001|Overall Study|Pregnancy|0|||
46666428|NCT01313221|82880647|FG002|Overall Study|Pregnancy|2|||
46666429|NCT01313182|82880657|FG000|Overall Study|Protocol Violation|66|||
46666430|NCT01313182|82880658|FG001|Overall Study|Protocol Violation|92|||
46666431|NCT01312909|82880667|FG000|Overall Study|Randomized but not treated|1|||
46666432|NCT01312909|82880668|FG001|Overall Study|Randomized but not treated|3|||
46666433|NCT01312909|82880669|FG002|Overall Study|Randomized but not treated|1|||
46666434|NCT01312909|82880667|FG000|Overall Study|Adverse Event|1|||
46666435|NCT01312909|82880668|FG001|Overall Study|Adverse Event|0|||
46666436|NCT01312909|82880669|FG002|Overall Study|Adverse Event|3|||
46666437|NCT01312909|82880667|FG000|Overall Study|Protocol Violation|2|||
47076705|NCT02614560|83372170|FG000|Overall Study|Death|6|||
46666438|NCT01312909|82880668|FG001|Overall Study|Protocol Violation|0|||
46666439|NCT01312909|82880669|FG002|Overall Study|Protocol Violation|2|||
47076706|NCT02614560|83372171|FG001|Overall Study|Death|2|||
46666440|NCT01312909|82880667|FG000|Overall Study|Other|9|||
47076707|NCT01669122|83372188|FG000|Period I|Lost to Follow-up|1|||
47076708|NCT01669122|83372188|FG000|Washout Period II|Protocol Violation|2|||
46666441|NCT01312909|82880668|FG001|Overall Study|Other|6|||
46666442|NCT01312909|82880669|FG002|Overall Study|Other|11|||
46666443|NCT01312909|82880667|FG000|Overall Study|Withdrawal by Subject|8|||
46666444|NCT01312909|82880668|FG001|Overall Study|Withdrawal by Subject|10|||
46666445|NCT01312909|82880669|FG002|Overall Study|Withdrawal by Subject|7|||
46666446|NCT01312909|82880667|FG000|Overall Study|Lost to Follow-up|21|||
46666447|NCT01312909|82880668|FG001|Overall Study|Lost to Follow-up|17|||
46666448|NCT01312909|82880669|FG002|Overall Study|Lost to Follow-up|20|||
46666449|NCT01312909|82880667|FG000|Overall Study|Insufficient clinical response|0|||
46784819|NCT00541450|83003831|FG001|Phase B|Withdrawal by Subject|6|||
47076709|NCT02611752|83372221|FG000|Overall Study|Adverse Event|0|||
47076710|NCT02611752|83372222|FG001|Overall Study|Adverse Event|1|||
46666450|NCT01312909|82880668|FG001|Overall Study|Insufficient clinical response|0|||
46666451|NCT01312909|82880669|FG002|Overall Study|Insufficient clinical response|1|||
46666452|NCT01312909|82880667|FG000|Overall Study|Entrance criteria not met|0|||
46666453|NCT01312909|82880668|FG001|Overall Study|Entrance criteria not met|0|||
46666454|NCT01312909|82880669|FG002|Overall Study|Entrance criteria not met|2|||
46666455|NCT01312129|82880679|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
46666456|NCT01312129|82880680|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
46666457|NCT01311661|82880686|FG000|Overall Study|Adverse Event|2|||
46666458|NCT01311661|82880686|FG000|Overall Study|Protocol Violation|3|||
46666459|NCT01311661|82880686|FG000|Overall Study|Withdrawal by Subject|2|||
46666460|NCT01311505|82880698|FG000|First Intervention Period|Protocol Violation|0|||
46666461|NCT01311505|82880699|FG001|First Intervention Period|Protocol Violation|1|||
46666462|NCT01310803|82880710|FG000|Overall Study|Subject terminated by Sponsor|1|||
46666463|NCT01310803|82880711|FG001|Overall Study|Subject terminated by Sponsor|0|||
46666464|NCT01310413|82880723|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
46666465|NCT01310413|82880724|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
46666466|NCT01310413|82880725|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
46666467|NCT01310413|82880726|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
46666468|NCT01310413|82880727|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
46666469|NCT01310413|82880728|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
46666470|NCT01310413|82880729|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
46666471|NCT01310413|82880723|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
46666472|NCT01310413|82880724|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
46666473|NCT01310413|82880725|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
46666474|NCT01310413|82880726|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
46666475|NCT01310413|82880727|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
46666476|NCT01310413|82880728|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
46666477|NCT01310413|82880729|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
46666478|NCT01310413|82880723|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
46666479|NCT01310413|82880724|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
46666480|NCT01310413|82880725|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
46666481|NCT01310413|82880726|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
46666482|NCT01310413|82880727|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
46666483|NCT01310413|82880728|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
46666484|NCT01310413|82880729|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
46666485|NCT01310413|82880723|FG000|Day 0 to Day 385|Other|1|||
46666486|NCT01310413|82880724|FG001|Day 0 to Day 385|Other|0|||
46666487|NCT01310413|82880725|FG002|Day 0 to Day 385|Other|3|||
46666488|NCT01310413|82880726|FG003|Day 0 to Day 385|Other|0|||
46666489|NCT01310413|82880727|FG004|Day 0 to Day 385|Other|0|||
46666490|NCT01310413|82880728|FG005|Day 0 to Day 385|Other|0|||
46666491|NCT01310413|82880729|FG006|Day 0 to Day 385|Other|0|||
46666492|NCT01310413|82880723|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
46666493|NCT01310413|82880724|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
46666494|NCT01310413|82880725|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
46666495|NCT01310413|82880726|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
46666496|NCT01310413|82880727|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
46666497|NCT01310413|82880728|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
46666498|NCT01310413|82880729|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
46666499|NCT01310413|82880723|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
46666500|NCT01310413|82880724|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
46666501|NCT01310413|82880725|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
46666502|NCT01310413|82880726|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
46666503|NCT01310413|82880727|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
46666504|NCT01310413|82880728|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
46666505|NCT01310413|82880729|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
46666506|NCT01309828|82880760|FG000|Overall Study|Adverse Event|10|||
46666507|NCT01309828|82880761|FG001|Overall Study|Adverse Event|11|||
46666508|NCT01309828|82880760|FG000|Overall Study|Voluntary Withdrawal|5|||
46666509|NCT01309828|82880761|FG001|Overall Study|Voluntary Withdrawal|4|||
46666510|NCT01309828|82880760|FG000|Overall Study|Major Protocol Deviation|0|||
46666511|NCT01309828|82880761|FG001|Overall Study|Major Protocol Deviation|1|||
46666512|NCT01309828|82880760|FG000|Overall Study|Other|1|||
46666513|NCT01309828|82880761|FG001|Overall Study|Other|0|||
46666514|NCT01309282|82880767|FG000|Overall Study|Lost to Follow-up|1|||
46666515|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
46666516|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
46666517|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
46666518|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
46666519|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Death|0|||
46666520|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Death|1|||
46666521|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
46666522|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
46666523|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
46666524|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
46666525|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
46666526|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
46666527|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
46666528|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
46666529|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
46666530|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
46666531|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
46666532|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
46666533|NCT01309243|82880773|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
46666534|NCT01309243|82880774|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
46666535|NCT01309243|82880773|FG000|Extension Phase|Lost to Follow-up|6|||
46666536|NCT01309243|82880774|FG001|Extension Phase|Lost to Follow-up|0|||
46666537|NCT01309204|82880782|FG000|Overall Study|Adverse Event|48|||
46666538|NCT01309204|82880783|FG001|Overall Study|Adverse Event|58|||
47076711|NCT02611362|83372243|FG000|Overall Study|Withdrawal by Subject|7|||
47076712|NCT02611362|83372244|FG001|Overall Study|Withdrawal by Subject|2|||
46666539|NCT01309204|82880782|FG000|Overall Study|Lost to Follow-up|2|||
46666540|NCT01309204|82880783|FG001|Overall Study|Lost to Follow-up|2|||
46666541|NCT01309204|82880782|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
46666542|NCT01309204|82880783|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
47076713|NCT02611362|83372243|FG000|Overall Study|Lost to Follow-up|2|||
47076714|NCT02611362|83372244|FG001|Overall Study|Lost to Follow-up|4|||
47076715|NCT01594476|83372264|FG000|Overall Study|Protocol Violation|1|||
47076716|NCT01594476|83372265|FG001|Overall Study|Protocol Violation|3|||
46972349|NCT02514239|83216050|FG001|Overall Study|Other Adverse Events|0|||
46972350|NCT02514239|83216051|FG002|Overall Study|Other Adverse Events|0|||
47076717|NCT01668966|83372279|FG000|Overall Study|Withdrawal by Subject|1|||
47076718|NCT01668966|83372279|FG000|Overall Study|Death|1|||
47076719|NCT01668966|83372279|FG000|Overall Study|Not treated|2|||
47076720|NCT02609724|83372286|FG000|Overall Study|Death|2|||
47076721|NCT02609724|83372287|FG001|Overall Study|Death|0|||
47076722|NCT02609724|83372288|FG002|Overall Study|Death|1|||
47076723|NCT02609724|83372286|FG000|Overall Study|Withdrawal by Subject|1|||
47076724|NCT02609724|83372287|FG001|Overall Study|Withdrawal by Subject|2|||
47076725|NCT02609724|83372288|FG002|Overall Study|Withdrawal by Subject|3|||
47076726|NCT02609724|83372286|FG000|Overall Study|Illness|2|||
47076727|NCT02609724|83372287|FG001|Overall Study|Illness|1|||
47076728|NCT02609724|83372288|FG002|Overall Study|Illness|0|||
47076729|NCT02610816|83372317|FG000|Phase 1|Withdrawal by Subject|2|||
47076730|NCT02610816|83372318|FG001|Phase 1|Withdrawal by Subject|6|||
46972351|NCT02514239|83216052|FG003|Overall Study|Other Adverse Events|1|||
46972352|NCT02514239|83216053|FG004|Overall Study|Other Adverse Events|0|||
46972353|NCT02514239|83216054|FG005|Overall Study|Other Adverse Events|1|||
46972354|NCT02514239|83216055|FG006|Overall Study|Other Adverse Events|0|||
46972355|NCT02514239|83216056|FG007|Overall Study|Other Adverse Events|1|||
46972356|NCT02514239|83216057|FG008|Overall Study|Other Adverse Events|2|||
46972357|NCT02514239|83216058|FG009|Overall Study|Other Adverse Events|0|||
47076731|NCT02610816|83372319|FG002|Phase 1|Withdrawal by Subject|0|||
47076732|NCT02610816|83372320|FG003|Phase 1|Withdrawal by Subject|0|||
46666543|NCT01309204|82880782|FG000|Overall Study|Inadequate control of IOP|4|||
46666544|NCT01309204|82880783|FG001|Overall Study|Inadequate control of IOP|4|||
46972358|NCT02514239|83216049|FG000|Overall Study|Progressive disease|3|||
46972359|NCT02514239|83216050|FG001|Overall Study|Progressive disease|3|||
46972360|NCT02514239|83216051|FG002|Overall Study|Progressive disease|2|||
47076733|NCT02610816|83372317|FG000|Phase 1|Lost to Follow-up|2|||
47076734|NCT02610816|83372318|FG001|Phase 1|Lost to Follow-up|1|||
47076735|NCT02610816|83372319|FG002|Phase 1|Lost to Follow-up|0|||
47076736|NCT02610816|83372320|FG003|Phase 1|Lost to Follow-up|0|||
47076737|NCT02610816|83372317|FG000|Phase 1|Physician Decision|0|||
47076738|NCT02610816|83372318|FG001|Phase 1|Physician Decision|1|||
47076739|NCT02610816|83372319|FG002|Phase 1|Physician Decision|0|||
47076740|NCT02610816|83372320|FG003|Phase 1|Physician Decision|0|||
47076741|NCT02610816|83372317|FG000|Phase 2|Withdrawal by Subject|0|||
47076742|NCT02610816|83372318|FG001|Phase 2|Withdrawal by Subject|0|||
47076743|NCT02610816|83372319|FG002|Phase 2|Withdrawal by Subject|9|||
47076744|NCT02610816|83372320|FG003|Phase 2|Withdrawal by Subject|3|||
47076745|NCT02610816|83372317|FG000|Phase 2|Lost to Follow-up|0|||
46972361|NCT02514239|83216052|FG003|Overall Study|Progressive disease|2|||
47076746|NCT02610816|83372318|FG001|Phase 2|Lost to Follow-up|0|||
46666545|NCT01309204|82880782|FG000|Overall Study|Other|4|||
46972362|NCT02514239|83216053|FG004|Overall Study|Progressive disease|3|||
46972363|NCT02514239|83216054|FG005|Overall Study|Progressive disease|3|||
46972364|NCT02514239|83216055|FG006|Overall Study|Progressive disease|4|||
47076747|NCT02610816|83372319|FG002|Phase 2|Lost to Follow-up|2|||
47076748|NCT02610816|83372320|FG003|Phase 2|Lost to Follow-up|0|||
47076749|NCT02610816|83372317|FG000|Phase 2|Physician Decision|0|||
47076750|NCT02610816|83372318|FG001|Phase 2|Physician Decision|0|||
46666546|NCT01309204|82880783|FG001|Overall Study|Other|1|||
46666547|NCT01309165|82880791|FG000|Overall Study|Lost to Follow-up|4|||
46666548|NCT01309165|82880792|FG001|Overall Study|Lost to Follow-up|3|||
46666549|NCT01309165|82880791|FG000|Overall Study|Return to work|1|||
46666550|NCT01309165|82880792|FG001|Overall Study|Return to work|2|||
46666551|NCT01309165|82880791|FG000|Overall Study|Left country|0|||
46666552|NCT01309165|82880792|FG001|Overall Study|Left country|1|||
47076751|NCT02610816|83372319|FG002|Phase 2|Physician Decision|0|||
47076752|NCT02610816|83372320|FG003|Phase 2|Physician Decision|2|||
47076753|NCT02610816|83372317|FG000|Phase 2|Pregnancy|0|||
47076754|NCT02610816|83372318|FG001|Phase 2|Pregnancy|0|||
47076755|NCT02610816|83372319|FG002|Phase 2|Pregnancy|0|||
47076756|NCT02610816|83372320|FG003|Phase 2|Pregnancy|1|||
47076757|NCT01896505|83372336|FG000|Overall Study|Adverse Event|1|||
47076758|NCT01896505|83372337|FG001|Overall Study|Adverse Event|0|||
47076759|NCT01896505|83372338|FG002|Overall Study|Adverse Event|2|||
47076760|NCT01896505|83372339|FG003|Overall Study|Adverse Event|1|||
47076761|NCT01896505|83372340|FG004|Overall Study|Adverse Event|1|||
47076762|NCT01896505|83372341|FG005|Overall Study|Adverse Event|0|||
47076763|NCT01896505|83372336|FG000|Overall Study|Physician Decision|1|||
47076764|NCT01896505|83372337|FG001|Overall Study|Physician Decision|3|||
47076765|NCT01896505|83372338|FG002|Overall Study|Physician Decision|2|||
47076766|NCT01896505|83372339|FG003|Overall Study|Physician Decision|0|||
47076767|NCT01896505|83372340|FG004|Overall Study|Physician Decision|0|||
47076768|NCT01896505|83372341|FG005|Overall Study|Physician Decision|1|||
47076769|NCT01896505|83372336|FG000|Overall Study|Withdrawal by Subject|1|||
47076770|NCT01896505|83372337|FG001|Overall Study|Withdrawal by Subject|0|||
47076771|NCT01896505|83372338|FG002|Overall Study|Withdrawal by Subject|3|||
47076772|NCT01896505|83372339|FG003|Overall Study|Withdrawal by Subject|1|||
47076773|NCT01896505|83372340|FG004|Overall Study|Withdrawal by Subject|0|||
47076774|NCT01896505|83372341|FG005|Overall Study|Withdrawal by Subject|0|||
46851238|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
47076775|NCT01896505|83372336|FG000|Overall Study|Disease Progression|7|||
47076776|NCT01896505|83372337|FG001|Overall Study|Disease Progression|5|||
47076777|NCT01896505|83372338|FG002|Overall Study|Disease Progression|8|||
47076778|NCT01896505|83372339|FG003|Overall Study|Disease Progression|4|||
47076779|NCT01896505|83372340|FG004|Overall Study|Disease Progression|4|||
47076780|NCT01896505|83372341|FG005|Overall Study|Disease Progression|4|||
46666553|NCT01309165|82880791|FG000|Overall Study|No transportation|0|||
46666554|NCT01309165|82880792|FG001|Overall Study|No transportation|1|||
46851239|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
46851240|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
46851241|NCT03605680|83066875|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
46851242|NCT03605680|83066876|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
46851243|NCT03605680|83066877|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
46851244|NCT03605680|83066878|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
46851245|NCT03572218|83066889|FG000|Overall Study|Lost to Follow-up|3|||
46851246|NCT03572218|83066890|FG001|Overall Study|Lost to Follow-up|2|||
46851247|NCT03572218|83066889|FG000|Overall Study|No longer available for study visits|2|||
46851248|NCT03572218|83066890|FG001|Overall Study|No longer available for study visits|1|||
46851249|NCT03572218|83066889|FG000|Overall Study|No longer interested|1|||
46851250|NCT03572218|83066890|FG001|Overall Study|No longer interested|2|||
46851251|NCT00111813|83066896|FG000|Overall Study|Adverse Event|1|||
46851252|NCT00111813|83066897|FG001|Overall Study|Adverse Event|2|||
46851253|NCT00111813|83066898|FG002|Overall Study|Adverse Event|4|||
46851254|NCT00111813|83066899|FG003|Overall Study|Adverse Event|2|||
46851255|NCT00111813|83066900|FG004|Overall Study|Adverse Event|2|||
46851256|NCT00111813|83066901|FG005|Overall Study|Adverse Event|2|||
46851257|NCT00111813|83066896|FG000|Overall Study|Progressive disease|2|||
46972365|NCT02514239|83216056|FG007|Overall Study|Progressive disease|2|||
46972366|NCT02514239|83216057|FG008|Overall Study|Progressive disease|5|||
46972367|NCT02514239|83216058|FG009|Overall Study|Progressive disease|0|||
46972368|NCT02709109|83216102|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
46972369|NCT02709109|83216103|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
46972370|NCT02709109|83216104|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
46972371|NCT02709109|83216105|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
46972372|NCT02709109|83216102|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
46972373|NCT02709109|83216103|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
46972374|NCT02709109|83216104|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
46972375|NCT02709109|83216105|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
47076781|NCT01896505|83372336|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
47076782|NCT01896505|83372337|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
47076783|NCT01896505|83372338|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
47076784|NCT01896505|83372339|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
46666555|NCT01309165|82880791|FG000|Overall Study|Admitted to hospital for second stroke|1|||
46851258|NCT00111813|83066897|FG001|Overall Study|Progressive disease|1|||
46851259|NCT00111813|83066898|FG002|Overall Study|Progressive disease|5|||
46851260|NCT00111813|83066899|FG003|Overall Study|Progressive disease|3|||
46666556|NCT01309165|82880792|FG001|Overall Study|Admitted to hospital for second stroke|0|||
46666557|NCT01308853|82880799|FG000|Overall Study|Adverse Event|1|||
46666558|NCT01308853|82880799|FG000|Overall Study|Lost to Follow-up|2|||
46666559|NCT01308853|82880799|FG000|Overall Study|Insertion of permanent implants|1|||
46666560|NCT01308736|82880805|FG000|Overall Study|Did not attend a single session|6|||
46666561|NCT01308736|82880806|FG001|Overall Study|Did not attend a single session|5|||
46666562|NCT01308580|82880814|FG000|Overall Study|Lost to Follow-up|12|||
46666563|NCT01308580|82880815|FG001|Overall Study|Lost to Follow-up|7|||
46666564|NCT01308463|82880822|FG000|Overall Study|Study Discontinued|23|||
46666565|NCT01308463|82880822|FG000|Overall Study|Death|4|||
46666566|NCT01308463|82880822|FG000|Overall Study|Revision|2|||
46666567|NCT01308424|82880828|FG000|Baseline Eligibility|Screen Failures|71|||
46666568|NCT01308424|82880829|FG001|Baseline Eligibility|Screen Failures|0|||
46666569|NCT01308424|82880830|FG002|Baseline Eligibility|Screen Failures|0|||
46666570|NCT01308424|82880828|FG000|Randomization|Adverse Event|0|||
46666571|NCT01308424|82880829|FG001|Randomization|Adverse Event|1|||
46666572|NCT01308424|82880830|FG002|Randomization|Adverse Event|1|||
46666573|NCT01308424|82880828|FG000|Randomization|Lost to Follow-up|0|||
46666574|NCT01308424|82880829|FG001|Randomization|Lost to Follow-up|1|||
46666575|NCT01308424|82880830|FG002|Randomization|Lost to Follow-up|0|||
46666576|NCT01308424|82880828|FG000|Randomization|Physician Decision|0|||
46851261|NCT00111813|83066900|FG004|Overall Study|Progressive disease|4|||
46851262|NCT00111813|83066901|FG005|Overall Study|Progressive disease|3|||
46851263|NCT00111813|83066896|FG000|Overall Study|Lack of Efficacy|0|||
46851264|NCT00111813|83066897|FG001|Overall Study|Lack of Efficacy|0|||
47076785|NCT01896505|83372340|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
46666577|NCT01308424|82880829|FG001|Randomization|Physician Decision|1|||
46666578|NCT01308424|82880830|FG002|Randomization|Physician Decision|1|||
46666579|NCT01307800|82880841|FG000|Overall Study|Adverse Event|9|||
46666580|NCT01307800|82880842|FG001|Overall Study|Adverse Event|8|||
46666581|NCT01307800|82880843|FG002|Overall Study|Adverse Event|10|||
46666582|NCT01307800|82880844|FG003|Overall Study|Adverse Event|14|||
46666583|NCT01307800|82880841|FG000|Overall Study|Entry Criteria Not Met|0|||
46666584|NCT01307800|82880842|FG001|Overall Study|Entry Criteria Not Met|0|||
46666585|NCT01307800|82880843|FG002|Overall Study|Entry Criteria Not Met|0|||
46666586|NCT01307800|82880844|FG003|Overall Study|Entry Criteria Not Met|2|||
46666587|NCT01307800|82880841|FG000|Overall Study|Lost to Follow-up|5|||
46666588|NCT01307800|82880842|FG001|Overall Study|Lost to Follow-up|6|||
46666589|NCT01307800|82880843|FG002|Overall Study|Lost to Follow-up|2|||
46666590|NCT01307800|82880844|FG003|Overall Study|Lost to Follow-up|8|||
46666591|NCT01307800|82880841|FG000|Overall Study|Perceived Lack of Efficacy|24|||
46666592|NCT01307800|82880842|FG001|Overall Study|Perceived Lack of Efficacy|23|||
47076786|NCT01896505|83372341|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
47076787|NCT01896505|83372336|FG000|Overall Study|Intercurrent illness|0|||
47076788|NCT01896505|83372337|FG001|Overall Study|Intercurrent illness|1|||
47076789|NCT01896505|83372338|FG002|Overall Study|Intercurrent illness|0|||
47076790|NCT01896505|83372339|FG003|Overall Study|Intercurrent illness|0|||
47076791|NCT01896505|83372340|FG004|Overall Study|Intercurrent illness|0|||
47076792|NCT01896505|83372341|FG005|Overall Study|Intercurrent illness|0|||
47076793|NCT01896505|83372336|FG000|Overall Study|Death|0|||
47076794|NCT01896505|83372337|FG001|Overall Study|Death|0|||
46666593|NCT01307800|82880843|FG002|Overall Study|Perceived Lack of Efficacy|20|||
46666594|NCT01307800|82880844|FG003|Overall Study|Perceived Lack of Efficacy|33|||
47076795|NCT01896505|83372338|FG002|Overall Study|Death|1|||
47076796|NCT01896505|83372339|FG003|Overall Study|Death|1|||
46666595|NCT01307800|82880841|FG000|Overall Study|Protocol Violation|0|||
46851265|NCT00111813|83066898|FG002|Overall Study|Lack of Efficacy|0|||
46666596|NCT01307800|82880842|FG001|Overall Study|Protocol Violation|3|||
46666597|NCT01307800|82880843|FG002|Overall Study|Protocol Violation|4|||
46666598|NCT01307800|82880844|FG003|Overall Study|Protocol Violation|5|||
47076797|NCT01896505|83372340|FG004|Overall Study|Death|0|||
46666599|NCT01307800|82880841|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
46851266|NCT00111813|83066899|FG003|Overall Study|Lack of Efficacy|0|||
46851267|NCT00111813|83066900|FG004|Overall Study|Lack of Efficacy|0|||
46851268|NCT00111813|83066901|FG005|Overall Study|Lack of Efficacy|1|||
46851269|NCT00111813|83066896|FG000|Overall Study|Other|0|||
46666600|NCT01307800|82880842|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
46666601|NCT01307800|82880843|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
46666602|NCT01307800|82880844|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
46666603|NCT01307800|82880841|FG000|Overall Study|Sponsor Decision|6|||
46666604|NCT01307800|82880842|FG001|Overall Study|Sponsor Decision|9|||
47076798|NCT01896505|83372341|FG005|Overall Study|Death|1|||
47076799|NCT02612610|83372462|FG000|Overall Study|Withdrawal by Subject|1|||
46666605|NCT01307800|82880843|FG002|Overall Study|Sponsor Decision|12|||
46851270|NCT00111813|83066897|FG001|Overall Study|Other|0|||
47076800|NCT02612610|83372463|FG001|Overall Study|Withdrawal by Subject|1|||
47076801|NCT02612610|83372464|FG002|Overall Study|Withdrawal by Subject|0|||
47076802|NCT02612610|83372465|FG003|Overall Study|Withdrawal by Subject|2|||
47076803|NCT02612610|83372462|FG000|Overall Study|Adverse Event|2|||
47076804|NCT02612610|83372463|FG001|Overall Study|Adverse Event|2|||
47076805|NCT02612610|83372464|FG002|Overall Study|Adverse Event|3|||
47076806|NCT02612610|83372465|FG003|Overall Study|Adverse Event|10|||
47076807|NCT02612610|83372462|FG000|Overall Study|Lost to Follow-up|0|||
47076808|NCT02612610|83372463|FG001|Overall Study|Lost to Follow-up|1|||
47076809|NCT02612610|83372464|FG002|Overall Study|Lost to Follow-up|0|||
47076810|NCT02612610|83372465|FG003|Overall Study|Lost to Follow-up|0|||
47076811|NCT02612610|83372462|FG000|Overall Study|Protocol Violation|0|||
47076812|NCT02612610|83372463|FG001|Overall Study|Protocol Violation|1|||
47076813|NCT02612610|83372464|FG002|Overall Study|Protocol Violation|1|||
47076814|NCT02612610|83372465|FG003|Overall Study|Protocol Violation|0|||
47076815|NCT02612610|83372462|FG000|Overall Study|Lack of Efficacy|1|||
47076816|NCT02612610|83372463|FG001|Overall Study|Lack of Efficacy|2|||
47076817|NCT02612610|83372464|FG002|Overall Study|Lack of Efficacy|0|||
47076818|NCT02612610|83372465|FG003|Overall Study|Lack of Efficacy|1|||
47076819|NCT02612610|83372462|FG000|Overall Study|Physician Decision|0|||
47076820|NCT02612610|83372463|FG001|Overall Study|Physician Decision|1|||
47076821|NCT02612610|83372464|FG002|Overall Study|Physician Decision|0|||
47076822|NCT02612610|83372465|FG003|Overall Study|Physician Decision|0|||
47076823|NCT02612610|83372462|FG000|Overall Study|Noncompliance|1|||
47076824|NCT02612610|83372463|FG001|Overall Study|Noncompliance|0|||
47076825|NCT02612610|83372464|FG002|Overall Study|Noncompliance|0|||
46666606|NCT01307800|82880844|FG003|Overall Study|Sponsor Decision|28|||
46666607|NCT01307800|82880841|FG000|Overall Study|Withdrawal by Subject|10|||
46666608|NCT01307800|82880842|FG001|Overall Study|Withdrawal by Subject|11|||
46666609|NCT01307800|82880843|FG002|Overall Study|Withdrawal by Subject|8|||
46666610|NCT01307800|82880844|FG003|Overall Study|Withdrawal by Subject|15|||
46666611|NCT01307800|82880841|FG000|Overall Study|Participant Moved|0|||
46666612|NCT01307800|82880842|FG001|Overall Study|Participant Moved|2|||
46666613|NCT01307800|82880843|FG002|Overall Study|Participant Moved|1|||
46666614|NCT01307800|82880844|FG003|Overall Study|Participant Moved|3|||
46666615|NCT01307449|82880858|FG000|Overall Study|Adverse Event|1|||
46666616|NCT01307449|82880859|FG001|Overall Study|Adverse Event|0|||
46666617|NCT01307449|82880860|FG002|Overall Study|Adverse Event|0|||
46666618|NCT01307449|82880861|FG003|Overall Study|Adverse Event|0|||
46666619|NCT01307020|82880881|FG000|Overall Study|Lost to Follow-up|0|||
46666620|NCT01307020|82880882|FG001|Overall Study|Lost to Follow-up|0|||
46666621|NCT01307020|82880883|FG002|Overall Study|Lost to Follow-up|1|||
46666622|NCT01307020|82880884|FG003|Overall Study|Lost to Follow-up|1|||
47076826|NCT02612610|83372465|FG003|Overall Study|Noncompliance|0|||
47076827|NCT02612610|83372462|FG000|Overall Study|Cough Improvement|0|||
47076828|NCT02612610|83372463|FG001|Overall Study|Cough Improvement|0|||
47076829|NCT02612610|83372464|FG002|Overall Study|Cough Improvement|1|||
47076830|NCT02612610|83372465|FG003|Overall Study|Cough Improvement|0|||
47076831|NCT02610192|83372678|FG000|Overall Study|Received other treatment|8|||
47076832|NCT02610192|83372678|FG000|Overall Study|Physician Decision|1|||
47076833|NCT02609178|83372806|FG000|First Crown|Withdrawal by Subject|0|||
47076834|NCT02609178|83372807|FG001|First Crown|Withdrawal by Subject|0|||
47076835|NCT02609178|83372808|FG002|First Crown|Withdrawal by Subject|1|||
47076836|NCT02609178|83372809|FG003|First Crown|Withdrawal by Subject|1|||
47076837|NCT02609178|83372810|FG004|First Crown|Withdrawal by Subject|0|||
47076838|NCT02609178|83372811|FG005|First Crown|Withdrawal by Subject|0|||
47076839|NCT02607228|83373035|FG000|Overall Study|Progressive Disease|4|||
47076840|NCT02607228|83373036|FG001|Overall Study|Progressive Disease|3|||
47076841|NCT02607228|83373037|FG002|Overall Study|Progressive Disease|1|||
47076842|NCT02607228|83373038|FG003|Overall Study|Progressive Disease|5|||
47076843|NCT02607228|83373039|FG004|Overall Study|Progressive Disease|4|||
46666623|NCT01307020|82880885|FG004|Overall Study|Lost to Follow-up|0|||
46666624|NCT01307020|82880886|FG005|Overall Study|Lost to Follow-up|0|||
46666625|NCT01307020|82880887|FG006|Overall Study|Lost to Follow-up|1|||
46666626|NCT01307020|82880888|FG007|Overall Study|Lost to Follow-up|0|||
47076844|NCT02607228|83373040|FG005|Overall Study|Progressive Disease|3|||
46666627|NCT01307020|82880889|FG008|Overall Study|Lost to Follow-up|0|||
46666628|NCT01307020|82880890|FG009|Overall Study|Lost to Follow-up|0|||
46784820|NCT00355147|83003843|FG000|Overall Study|Lost to Follow-up|10|||
46784821|NCT00355147|83003844|FG001|Overall Study|Lost to Follow-up|8|||
46784822|NCT00355147|83003843|FG000|Overall Study|Withdrawal by Subject|8|||
46851271|NCT00111813|83066898|FG002|Overall Study|Other|1|||
47076845|NCT02607228|83373041|FG006|Overall Study|Progressive Disease|1|||
47076846|NCT02607228|83373035|FG000|Overall Study|Adverse Event|1|||
47076847|NCT02607228|83373036|FG001|Overall Study|Adverse Event|0|||
47076848|NCT02607228|83373037|FG002|Overall Study|Adverse Event|1|||
47076849|NCT02607228|83373038|FG003|Overall Study|Adverse Event|0|||
47076850|NCT02607228|83373039|FG004|Overall Study|Adverse Event|1|||
47076851|NCT02607228|83373040|FG005|Overall Study|Adverse Event|1|||
47076852|NCT02607228|83373041|FG006|Overall Study|Adverse Event|1|||
46666629|NCT01307020|82880881|FG000|Overall Study|Electronic data capture failure|0|||
46666630|NCT01307020|82880882|FG001|Overall Study|Electronic data capture failure|1|||
46666631|NCT01307020|82880883|FG002|Overall Study|Electronic data capture failure|0|||
46666632|NCT01307020|82880884|FG003|Overall Study|Electronic data capture failure|0|||
46666633|NCT01307020|82880885|FG004|Overall Study|Electronic data capture failure|0|||
46666634|NCT01307020|82880886|FG005|Overall Study|Electronic data capture failure|0|||
46666635|NCT01307020|82880887|FG006|Overall Study|Electronic data capture failure|0|||
46666636|NCT01307020|82880888|FG007|Overall Study|Electronic data capture failure|0|||
46666637|NCT01307020|82880889|FG008|Overall Study|Electronic data capture failure|0|||
46666638|NCT01307020|82880890|FG009|Overall Study|Electronic data capture failure|0|||
46666639|NCT01306201|82880912|FG000|Overall Study|Arrhythmia|4|||
46666640|NCT01306201|82880912|FG000|Overall Study|Files could not be processed|3|||
46666641|NCT01306201|82880912|FG000|Overall Study|Files unreadable|3|||
46666642|NCT01306162|82880924|FG000|Period 1|Adverse Event|0|||
46666643|NCT01306162|82880925|FG001|Period 1|Adverse Event|0|||
46666644|NCT01306162|82880926|FG002|Period 1|Adverse Event|0|||
46666645|NCT01306162|82880927|FG003|Period 1|Adverse Event|1|||
46666646|NCT01306162|82880924|FG000|Washout 1|Non-compliance to protocol|0|||
46666647|NCT01306162|82880925|FG001|Washout 1|Non-compliance to protocol|1|||
46666648|NCT01306162|82880926|FG002|Washout 1|Non-compliance to protocol|0|||
47076853|NCT02607228|83373035|FG000|Overall Study|Investigator's Discretion|0|||
47076854|NCT02607228|83373036|FG001|Overall Study|Investigator's Discretion|0|||
47076855|NCT02607228|83373037|FG002|Overall Study|Investigator's Discretion|1|||
47076856|NCT02607228|83373038|FG003|Overall Study|Investigator's Discretion|0|||
47076857|NCT02607228|83373039|FG004|Overall Study|Investigator's Discretion|0|||
47076858|NCT02607228|83373040|FG005|Overall Study|Investigator's Discretion|1|||
47076859|NCT02607228|83373041|FG006|Overall Study|Investigator's Discretion|0|||
47076860|NCT02607228|83373035|FG000|Overall Study|Withdrew Consent|0|||
47076861|NCT02607228|83373036|FG001|Overall Study|Withdrew Consent|1|||
47076862|NCT02607228|83373037|FG002|Overall Study|Withdrew Consent|0|||
47076863|NCT02607228|83373038|FG003|Overall Study|Withdrew Consent|0|||
47076864|NCT02607228|83373039|FG004|Overall Study|Withdrew Consent|0|||
47076865|NCT02607228|83373040|FG005|Overall Study|Withdrew Consent|1|||
47076866|NCT02607228|83373041|FG006|Overall Study|Withdrew Consent|0|||
47076867|NCT02607228|83373035|FG000|Overall Study|Study Terminated by Sponsor|0|||
47076868|NCT02607228|83373036|FG001|Overall Study|Study Terminated by Sponsor|0|||
47076869|NCT02607228|83373037|FG002|Overall Study|Study Terminated by Sponsor|0|||
47076870|NCT02607228|83373038|FG003|Overall Study|Study Terminated by Sponsor|1|||
47076871|NCT02607228|83373039|FG004|Overall Study|Study Terminated by Sponsor|0|||
47076872|NCT02607228|83373040|FG005|Overall Study|Study Terminated by Sponsor|0|||
47076873|NCT02607228|83373041|FG006|Overall Study|Study Terminated by Sponsor|0|||
47076874|NCT01668654|83373083|FG000|Overall Study|Study Closed/Terminated|3|||
47076875|NCT01668654|83373083|FG000|Overall Study|Withdrawal by Subject|1|||
47076876|NCT02608476|83373177|FG000|Overall Study|Withdrawal by Subject|30|||
47076877|NCT02608476|83373178|FG001|Overall Study|Withdrawal by Subject|37|||
47076878|NCT02608476|83373177|FG000|Overall Study|Lost to Follow-up|24|||
47076879|NCT02608476|83373178|FG001|Overall Study|Lost to Follow-up|24|||
47076880|NCT02608476|83373177|FG000|Overall Study|Adverse Event|2|||
47076881|NCT02608476|83373178|FG001|Overall Study|Adverse Event|8|||
47076882|NCT02608476|83373177|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
47076883|NCT02608476|83373178|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
47076884|NCT02608476|83373177|FG000|Overall Study|Noncompliance with treatment|1|||
47076885|NCT02608476|83373178|FG001|Overall Study|Noncompliance with treatment|5|||
47076886|NCT02608476|83373177|FG000|Overall Study|Lack of Efficacy|3|||
47076887|NCT02608476|83373178|FG001|Overall Study|Lack of Efficacy|1|||
47076888|NCT02608476|83373177|FG000|Overall Study|Other|0|||
46851272|NCT00111813|83066899|FG003|Overall Study|Other|0|||
47076889|NCT02608476|83373178|FG001|Overall Study|Other|1|||
47076890|NCT02608476|83373177|FG000|Overall Study|Physician Decision|1|||
47076891|NCT02608476|83373178|FG001|Overall Study|Physician Decision|0|||
47076892|NCT02608476|83373177|FG000|Overall Study|Pregnancy|0|||
47076893|NCT02608476|83373178|FG001|Overall Study|Pregnancy|1|||
47076894|NCT02608476|83373177|FG000|Overall Study|Progressive disease|1|||
46666649|NCT01306162|82880927|FG003|Washout 1|Non-compliance to protocol|0|||
46666650|NCT01305577|82880943|FG000|Overall Study|Adverse Event|2|||
46666651|NCT01305577|82880944|FG001|Overall Study|Adverse Event|2|||
46666652|NCT01305577|82880945|FG002|Overall Study|Adverse Event|1|||
46666653|NCT01305577|82880943|FG000|Overall Study|Withdrawal by Subject|7|||
46666654|NCT01305577|82880944|FG001|Overall Study|Withdrawal by Subject|5|||
47076895|NCT02608476|83373178|FG001|Overall Study|Progressive disease|0|||
47076896|NCT02607306|83373307|FG000|Overall Study|Adverse Event|8|||
47076897|NCT02607306|83373308|FG001|Overall Study|Adverse Event|6|||
47076898|NCT02607306|83373309|FG002|Overall Study|Adverse Event|6|||
47076899|NCT02607306|83373307|FG000|Overall Study|Unclassified|1|||
47076900|NCT02607306|83373308|FG001|Overall Study|Unclassified|4|||
47076901|NCT02607306|83373309|FG002|Overall Study|Unclassified|0|||
47076902|NCT02607306|83373307|FG000|Overall Study|Withdrawal by Subject|8|||
47076903|NCT02607306|83373308|FG001|Overall Study|Withdrawal by Subject|10|||
46666655|NCT01305577|82880945|FG002|Overall Study|Withdrawal by Subject|6|||
46666656|NCT01305577|82880943|FG000|Overall Study|Lost to Follow-up|4|||
46666657|NCT01305577|82880944|FG001|Overall Study|Lost to Follow-up|3|||
46666658|NCT01305577|82880945|FG002|Overall Study|Lost to Follow-up|2|||
46666659|NCT01305577|82880943|FG000|Overall Study|Protocol Deviation|0|||
46666660|NCT01305577|82880944|FG001|Overall Study|Protocol Deviation|1|||
46666661|NCT01305577|82880945|FG002|Overall Study|Protocol Deviation|1|||
46666662|NCT01304329|82880953|FG000|Third Intervention (3 Days)|Adverse Event|0|||
46666663|NCT01304329|82880954|FG001|Third Intervention (3 Days)|Adverse Event|1|||
46666664|NCT01304329|82880955|FG002|Third Intervention (3 Days)|Adverse Event|0|||
46666665|NCT01304329|82880956|FG003|Third Intervention (3 Days)|Adverse Event|0|||
46666666|NCT01304329|82880957|FG004|Third Intervention (3 Days)|Adverse Event|0|||
46666667|NCT01304329|82880958|FG005|Third Intervention (3 Days)|Adverse Event|0|||
46666668|NCT01303861|82880971|FG000|Overall Study|Lost to Follow-up|34|||
46666669|NCT01303861|82880972|FG001|Overall Study|Lost to Follow-up|14|||
46666670|NCT01303861|82880973|FG002|Overall Study|Lost to Follow-up|27|||
46666671|NCT01303861|82880974|FG003|Overall Study|Lost to Follow-up|31|||
46666672|NCT01303861|82880971|FG000|Overall Study|Lack of Efficacy|3|||
46666673|NCT01303861|82880972|FG001|Overall Study|Lack of Efficacy|2|||
46666674|NCT01303861|82880973|FG002|Overall Study|Lack of Efficacy|1|||
46666675|NCT01303861|82880974|FG003|Overall Study|Lack of Efficacy|0|||
46666676|NCT01303861|82880971|FG000|Overall Study|Withdrawal by Subject|16|||
46666677|NCT01303861|82880972|FG001|Overall Study|Withdrawal by Subject|8|||
46666678|NCT01303861|82880973|FG002|Overall Study|Withdrawal by Subject|8|||
46666679|NCT01303861|82880974|FG003|Overall Study|Withdrawal by Subject|23|||
46666680|NCT01303861|82880971|FG000|Overall Study|Adverse Event|4|||
46666681|NCT01303861|82880972|FG001|Overall Study|Adverse Event|1|||
46666682|NCT01303861|82880973|FG002|Overall Study|Adverse Event|0|||
46666683|NCT01303861|82880974|FG003|Overall Study|Adverse Event|5|||
46666684|NCT01303861|82880971|FG000|Overall Study|Pregnancy|1|||
46666685|NCT01303861|82880972|FG001|Overall Study|Pregnancy|0|||
46666686|NCT01303861|82880973|FG002|Overall Study|Pregnancy|0|||
46666687|NCT01303861|82880974|FG003|Overall Study|Pregnancy|0|||
46666688|NCT01303627|82880987|FG000|Overall Study|the failure while performing URS|0|||
46666689|NCT01303627|82880988|FG001|Overall Study|the failure while performing URS|1|||
46666690|NCT01303510|82880996|FG000|Overall Study|Lost to Follow-up|1|||
46666691|NCT01303510|82880997|FG001|Overall Study|Lost to Follow-up|0|||
46666692|NCT01303159|82881003|FG000|Overall Study|Death|16|||
46666693|NCT01303159|82881003|FG000|Overall Study|Study Termination|7|||
46666694|NCT01302964|82881009|FG000|Overall Study|Adverse Event|1|||
46666695|NCT01302964|82881010|FG001|Overall Study|Adverse Event|0|||
46666696|NCT01302691|82881018|FG000|Overall Study|Adverse Event|2|||
46666697|NCT01302691|82881019|FG001|Overall Study|Adverse Event|0|||
46666698|NCT01302691|82881018|FG000|Overall Study|Death|0|||
46666699|NCT01302691|82881019|FG001|Overall Study|Death|1|||
46666700|NCT01302691|82881018|FG000|Overall Study|Lost to Follow-up|1|||
46666701|NCT01302691|82881019|FG001|Overall Study|Lost to Follow-up|0|||
46666702|NCT01302691|82881018|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
46666703|NCT01302691|82881019|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
46666704|NCT01302691|82881018|FG000|Overall Study|Physician Decision|0|||
46666705|NCT01302691|82881019|FG001|Overall Study|Physician Decision|1|||
46666706|NCT01302691|82881018|FG000|Overall Study|Protocol Violation|1|||
46666707|NCT01302691|82881019|FG001|Overall Study|Protocol Violation|0|||
46666708|NCT01302418|82881025|FG000|Overall Study|Protocol Violation|9|||
46666709|NCT01302418|82881025|FG000|Overall Study|Non-evaluable|9|||
46666710|NCT01302067|82881032|FG000|Overall Study|Death|0|||
46666711|NCT01302067|82881033|FG001|Overall Study|Death|0|||
47076904|NCT02607306|83373309|FG002|Overall Study|Withdrawal by Subject|2|||
47076905|NCT02607306|83373307|FG000|Overall Study|Lack of Efficacy|0|||
47076906|NCT02607306|83373308|FG001|Overall Study|Lack of Efficacy|1|||
46666712|NCT01302067|82881034|FG002|Overall Study|Death|1|||
46666713|NCT01302067|82881032|FG000|Overall Study|Physician Decision|9|||
46666714|NCT01302067|82881033|FG001|Overall Study|Physician Decision|5|||
46666715|NCT01302067|82881034|FG002|Overall Study|Physician Decision|14|||
46666716|NCT01302067|82881032|FG000|Overall Study|Lack of Efficacy|8|||
46666717|NCT01302067|82881033|FG001|Overall Study|Lack of Efficacy|4|||
46666718|NCT01302067|82881034|FG002|Overall Study|Lack of Efficacy|2|||
46666719|NCT01302067|82881032|FG000|Overall Study|Lost to Follow-up|9|||
46666720|NCT01302067|82881033|FG001|Overall Study|Lost to Follow-up|4|||
46666721|NCT01302067|82881034|FG002|Overall Study|Lost to Follow-up|15|||
46666722|NCT01302067|82881032|FG000|Overall Study|Withdrawal by Subject|13|||
46666723|NCT01302067|82881033|FG001|Overall Study|Withdrawal by Subject|6|||
46784823|NCT00355147|83003844|FG001|Overall Study|Withdrawal by Subject|12|||
46666724|NCT01302067|82881034|FG002|Overall Study|Withdrawal by Subject|10|||
46666725|NCT01302067|82881032|FG000|Overall Study|Other|1|||
46666726|NCT01302067|82881033|FG001|Overall Study|Other|1|||
46666727|NCT01302067|82881034|FG002|Overall Study|Other|3|||
46666728|NCT01302067|82881032|FG000|Overall Study|Protocol Violation|11|||
46666729|NCT01302067|82881033|FG001|Overall Study|Protocol Violation|0|||
46666730|NCT01302067|82881034|FG002|Overall Study|Protocol Violation|8|||
46666731|NCT01302067|82881032|FG000|Overall Study|Adverse Event|27|||
46666732|NCT01302067|82881033|FG001|Overall Study|Adverse Event|14|||
46666733|NCT01302067|82881034|FG002|Overall Study|Adverse Event|45|||
46666734|NCT01301950|82881044|FG000|Overall Study|Surgery was cancelled by patient|0|||
46666735|NCT01301950|82881045|FG001|Overall Study|Surgery was cancelled by patient|1|||
46666736|NCT01301833|82881055|FG000|Overall Study|Adverse Event|7|||
46666737|NCT01301833|82881056|FG001|Overall Study|Adverse Event|5|||
46666738|NCT01301833|82881057|FG002|Overall Study|Adverse Event|5|||
46666739|NCT01301833|82881058|FG003|Overall Study|Adverse Event|5|||
46666740|NCT01301833|82881055|FG000|Overall Study|Lack of Efficacy|1|||
46666741|NCT01301833|82881056|FG001|Overall Study|Lack of Efficacy|1|||
46666742|NCT01301833|82881057|FG002|Overall Study|Lack of Efficacy|0|||
46666743|NCT01301833|82881058|FG003|Overall Study|Lack of Efficacy|0|||
46666744|NCT01301833|82881055|FG000|Overall Study|Physician Decision|3|||
46666745|NCT01301833|82881056|FG001|Overall Study|Physician Decision|1|||
46666746|NCT01301833|82881057|FG002|Overall Study|Physician Decision|1|||
46666747|NCT01301833|82881058|FG003|Overall Study|Physician Decision|0|||
46666748|NCT01301833|82881055|FG000|Overall Study|Withdrawal by Subject|3|||
46666749|NCT01301833|82881056|FG001|Overall Study|Withdrawal by Subject|1|||
46666750|NCT01301833|82881057|FG002|Overall Study|Withdrawal by Subject|1|||
46666751|NCT01301833|82881058|FG003|Overall Study|Withdrawal by Subject|2|||
46666752|NCT01301833|82881055|FG000|Overall Study|Personal matter|1|||
46666753|NCT01301833|82881056|FG001|Overall Study|Personal matter|0|||
46851273|NCT00111813|83066900|FG004|Overall Study|Other|0|||
47076907|NCT02607306|83373309|FG002|Overall Study|Lack of Efficacy|1|||
47076908|NCT02607306|83373307|FG000|Overall Study|Protocol Violation|4|||
47076909|NCT02607306|83373308|FG001|Overall Study|Protocol Violation|2|||
46851274|NCT00111813|83066901|FG005|Overall Study|Other|0|||
47076910|NCT02607306|83373309|FG002|Overall Study|Protocol Violation|1|||
47076911|NCT01495689|83373358|FG000|Overall Study|Death|0|||
47076912|NCT01495689|83373359|FG001|Overall Study|Death|1|||
47076913|NCT01495689|83373358|FG000|Overall Study|Withdrawal by Subject|3|||
47076914|NCT01495689|83373359|FG001|Overall Study|Withdrawal by Subject|0|||
47076915|NCT01495689|83373358|FG000|Overall Study|Lost to Follow-up|7|||
47076916|NCT01495689|83373359|FG001|Overall Study|Lost to Follow-up|6|||
47076917|NCT02603952|83373632|FG000|Overall Study|Withdrawal by Subject|1|||
47076918|NCT02603952|83373633|FG001|Overall Study|Withdrawal by Subject|0|||
47076919|NCT02603952|83373634|FG002|Overall Study|Withdrawal by Subject|0|||
47076920|NCT02603952|83373635|FG003|Overall Study|Withdrawal by Subject|0|||
46851275|NCT00118287|83066916|FG000|Overall Study|Intracranial haemorrhage|1|||
46851276|NCT00118287|83066916|FG000|Overall Study|Muscle pain|1|||
46851277|NCT00130689|83066920|FG000|Overall Study|Progressive Disease|29|||
46851278|NCT00130689|83066920|FG000|Overall Study|Death|1|||
46851279|NCT00130689|83066920|FG000|Overall Study|Clinical Deterioration|4|||
46851280|NCT00130689|83066920|FG000|Overall Study|Withdrawal by Subject|3|||
46851281|NCT00130689|83066920|FG000|Overall Study|Ineligible|6|||
46851282|NCT03605212|83066929|FG000|Treatment Period|Adverse Event|1|||
46851283|NCT03605212|83066930|FG001|Treatment Period|Adverse Event|0|||
46851284|NCT03605212|83066931|FG002|Treatment Period|Adverse Event|0|||
46972376|NCT02709109|83216102|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
46972377|NCT02709109|83216103|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
46972378|NCT02709109|83216104|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
46972379|NCT02709109|83216105|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
46972380|NCT02709109|83216102|FG000|Washout Period (28 Days)|Other|2|||
46972381|NCT02709109|83216103|FG001|Washout Period (28 Days)|Other|2|||
46972382|NCT02709109|83216104|FG002|Washout Period (28 Days)|Other|3|||
46972383|NCT02709109|83216105|FG003|Washout Period (28 Days)|Other|0|||
46972384|NCT02709109|83216102|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
46972385|NCT02709109|83216103|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
46972386|NCT02709109|83216104|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
46972387|NCT02709109|83216105|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
46972388|NCT02709109|83216102|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
46972389|NCT02709109|83216103|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
46972390|NCT02709109|83216104|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
47076921|NCT02603952|83373632|FG000|Overall Study|Received oseltamivir by error|0|||
47076922|NCT02603952|83373633|FG001|Overall Study|Received oseltamivir by error|0|||
47076923|NCT02603952|83373634|FG002|Overall Study|Received oseltamivir by error|0|||
46666754|NCT01301833|82881057|FG002|Overall Study|Personal matter|0|||
46666755|NCT01301833|82881058|FG003|Overall Study|Personal matter|0|||
46666756|NCT01301092|82881071|FG000|Overall Study|Lost to Follow-up|0|||
46666757|NCT01301092|82881072|FG001|Overall Study|Lost to Follow-up|0|||
46666758|NCT01301092|82881073|FG002|Overall Study|Lost to Follow-up|1|||
46666759|NCT01300819|82881088|FG000|Overall Study|Adverse Event|9|||
46666760|NCT01300819|82881089|FG001|Overall Study|Adverse Event|27|||
46666761|NCT01300819|82881088|FG000|Overall Study|Lack of Efficacy|2|||
46851285|NCT03605212|83066932|FG003|Treatment Period|Adverse Event|0|||
46851286|NCT03605212|83066933|FG004|Treatment Period|Adverse Event|0|||
46666762|NCT01300819|82881089|FG001|Overall Study|Lack of Efficacy|1|||
46666763|NCT01300819|82881088|FG000|Overall Study|Withdrawal by Subject|10|||
46666764|NCT01300819|82881089|FG001|Overall Study|Withdrawal by Subject|12|||
46972391|NCT02709109|83216105|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
46972392|NCT02709109|83216102|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
46972393|NCT02709109|83216103|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
46972394|NCT02709109|83216104|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
46666765|NCT01300819|82881088|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
46666766|NCT01300819|82881089|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
46666767|NCT01300819|82881088|FG000|Overall Study|Refusal to down titrate study drug|0|||
46666768|NCT01300819|82881089|FG001|Overall Study|Refusal to down titrate study drug|1|||
46666769|NCT01300819|82881088|FG000|Overall Study|Administrative reason|0|||
46666770|NCT01300819|82881089|FG001|Overall Study|Administrative reason|1|||
46666771|NCT01300819|82881088|FG000|Overall Study|Safety follow up not done by mistake|0|||
46666772|NCT01300819|82881089|FG001|Overall Study|Safety follow up not done by mistake|1|||
46666773|NCT01300819|82881088|FG000|Overall Study|Follow up call was not done|1|||
46666774|NCT01300819|82881089|FG001|Overall Study|Follow up call was not done|0|||
46666775|NCT01300741|82881095|FG000|Overall Study|Lens deposits|1|||
46666776|NCT01300741|82881095|FG000|Overall Study|Lost to Follow-up|1|||
46666777|NCT01300741|82881095|FG000|Overall Study|Discomfort|1|||
46666778|NCT01300546|82881103|FG000|Overall Study|Withdrawal by Subject|1|||
46666779|NCT01300546|82881104|FG001|Overall Study|Withdrawal by Subject|0|||
46666780|NCT01300546|82881103|FG000|Overall Study|Lost to Follow-up|0|||
46666781|NCT01300546|82881104|FG001|Overall Study|Lost to Follow-up|2|||
46666782|NCT01300546|82881103|FG000|Overall Study|Lack of Efficacy|0|||
46666783|NCT01300546|82881104|FG001|Overall Study|Lack of Efficacy|3|||
46666784|NCT01300546|82881103|FG000|Overall Study|Adverse Event|0|||
46666785|NCT01300546|82881104|FG001|Overall Study|Adverse Event|1|||
46666786|NCT01300351|82881112|FG000|Overall Study|Did not receive treatment|2|||
46666787|NCT01300351|82881113|FG001|Overall Study|Did not receive treatment|0|||
46666788|NCT01300351|82881112|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
46666789|NCT01300351|82881113|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
46666790|NCT01300351|82881112|FG000|Overall Study|Lost to Follow-up|0|||
46666791|NCT01300351|82881113|FG001|Overall Study|Lost to Follow-up|1|||
46666792|NCT01300351|82881112|FG000|Overall Study|Adverse Event|0|||
46666793|NCT01300351|82881113|FG001|Overall Study|Adverse Event|4|||
46666794|NCT01300351|82881112|FG000|Overall Study|Withdrawal by Subject|7|||
46666795|NCT01300351|82881113|FG001|Overall Study|Withdrawal by Subject|10|||
46666796|NCT01300234|82881121|FG000|Overall Study|Adverse Event|1|||
46666797|NCT01300234|82881122|FG001|Overall Study|Adverse Event|1|||
46666798|NCT01300234|82881121|FG000|Overall Study|Protocol Violation|2|||
46666799|NCT01300234|82881122|FG001|Overall Study|Protocol Violation|3|||
46666800|NCT01300234|82881121|FG000|Overall Study|Withdrawal by Subject|5|||
46666801|NCT01300234|82881122|FG001|Overall Study|Withdrawal by Subject|9|||
46666802|NCT01300234|82881121|FG000|Overall Study|Lost to Follow-up|14|||
46666803|NCT01300234|82881122|FG001|Overall Study|Lost to Follow-up|12|||
47076924|NCT02603952|83373635|FG003|Overall Study|Received oseltamivir by error|1|||
46972395|NCT02709109|83216105|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
46851287|NCT03605212|83066929|FG000|Treatment Period|Physician Decision|0|||
46972396|NCT02709109|83216102|FG000|Treatment Period 2 (28 Days)|Other|0|||
46972397|NCT02709109|83216103|FG001|Treatment Period 2 (28 Days)|Other|0|||
46972398|NCT02709109|83216104|FG002|Treatment Period 2 (28 Days)|Other|1|||
46972399|NCT02709109|83216105|FG003|Treatment Period 2 (28 Days)|Other|0|||
47076925|NCT02603172|83374149|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
47076926|NCT02603172|83374150|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
47076927|NCT02603172|83374151|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
47076928|NCT02603172|83374152|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
47076929|NCT02603172|83374153|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
47076930|NCT02603172|83374154|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
47076931|NCT02603172|83374155|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
47076932|NCT02603172|83374156|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
46666804|NCT01300234|82881121|FG000|Overall Study|Pregnancy|2|||
46666805|NCT01300234|82881122|FG001|Overall Study|Pregnancy|1|||
46666806|NCT01300234|82881121|FG000|Overall Study|Participant reached stopping critera|2|||
46666807|NCT01300234|82881122|FG001|Overall Study|Participant reached stopping critera|0|||
46666808|NCT01300234|82881121|FG000|Overall Study|Participant stopped medication|1|||
46972400|NCT04289051|83216120|FG000|Overall Study|Lost to Follow-up|0|||
46972401|NCT04289051|83216121|FG001|Overall Study|Lost to Follow-up|0|||
47076933|NCT02605824|83374277|FG000|Overall Study|Physician Decision|1|||
46666809|NCT01300234|82881122|FG001|Overall Study|Participant stopped medication|1|||
46666810|NCT01300234|82881121|FG000|Overall Study|Participant refused return to hospital|1|||
46666811|NCT01300234|82881122|FG001|Overall Study|Participant refused return to hospital|0|||
46666812|NCT01299961|82881139|FG000|Overall Study|Adverse Event|3|||
46666813|NCT01299961|82881139|FG000|Overall Study|Lack of Efficacy|2|||
46666814|NCT01299961|82881139|FG000|Overall Study|Lost to Follow-up|1|||
46666815|NCT01299805|82881145|FG000|Overall Study|Adverse Event|2|||
46666816|NCT01299805|82881146|FG001|Overall Study|Adverse Event|0|||
46666817|NCT01299766|82881154|FG000|Overall Study|Death|5|||
46666818|NCT01299766|82881155|FG001|Overall Study|Death|4|||
46666819|NCT01299766|82881154|FG000|Overall Study|Withdrawal by Subject|29|||
46666820|NCT01299766|82881155|FG001|Overall Study|Withdrawal by Subject|19|||
46666821|NCT01299727|82881164|FG000|Overall Study|Withdrawal by Subject|1|||
46666822|NCT01299727|82881165|FG001|Overall Study|Withdrawal by Subject|0|||
46666823|NCT01299727|82881166|FG002|Overall Study|Withdrawal by Subject|0|||
46666824|NCT01299727|82881164|FG000|Overall Study|Adverse Event|0|||
46666825|NCT01299727|82881165|FG001|Overall Study|Adverse Event|0|||
46666826|NCT01299727|82881166|FG002|Overall Study|Adverse Event|1|||
46666827|NCT01299727|82881164|FG000|Overall Study|Completed the Treatment Period|3|||
46666828|NCT01299727|82881165|FG001|Overall Study|Completed the Treatment Period|4|||
46666829|NCT01299727|82881166|FG002|Overall Study|Completed the Treatment Period|3|||
46666830|NCT01299571|82881174|FG000|Overall Study|Protocol Violation|107|||
46666831|NCT01299376|82881181|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
46666832|NCT01299376|82881182|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
46666833|NCT01299376|82881181|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
46666834|NCT01299376|82881182|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
46666835|NCT01299376|82881181|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
46666836|NCT01299376|82881182|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
46666837|NCT01299376|82881181|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
46666838|NCT01299376|82881182|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
46666839|NCT01299376|82881181|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
46666840|NCT01299376|82881182|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
46666841|NCT01299376|82881181|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
46666842|NCT01299376|82881182|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
46666843|NCT01299376|82881181|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
46666844|NCT01299376|82881182|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
46666845|NCT01299376|82881181|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
46666846|NCT01299376|82881182|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
46972402|NCT04289051|83216122|FG002|Overall Study|Lost to Follow-up|2|||
46972403|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
46972404|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
46972405|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
46972406|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
46972407|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
46972408|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
46972409|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
46972410|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
46972411|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
46972412|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
46972413|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
46972414|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
46972415|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
46972416|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
46972417|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
46972418|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
46972419|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
46972420|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
46972421|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
46972422|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
46972423|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
46972424|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
46972425|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
46972426|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
46972427|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
46972428|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
46972429|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
46972430|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
46972431|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
46972432|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
46972433|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
46972434|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
46972435|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
46666847|NCT01299376|82881181|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
46666848|NCT01299376|82881182|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
46666849|NCT01299376|82881181|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
46666850|NCT01299376|82881182|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
46666851|NCT01299376|82881181|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
46666852|NCT01299376|82881182|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
46666853|NCT01299025|82881194|FG000|Overall Study|Withdrawal by Subject|2|||
46666854|NCT01299025|82881195|FG001|Overall Study|Withdrawal by Subject|1|||
46666855|NCT01299025|82881194|FG000|Overall Study|Lost to Follow-up|1|||
46666856|NCT01299025|82881195|FG001|Overall Study|Lost to Follow-up|0|||
46666857|NCT01298596|82881203|FG000|Overall Study|Withdrawal by Subject|1|||
46666858|NCT01298596|82881204|FG001|Overall Study|Withdrawal by Subject|1|||
46666859|NCT01298596|82881203|FG000|Overall Study|Death|5|||
46666860|NCT01298596|82881204|FG001|Overall Study|Death|3|||
46666861|NCT01298596|82881203|FG000|Overall Study|Lost to Follow-up|6|||
46666862|NCT01298596|82881204|FG001|Overall Study|Lost to Follow-up|14|||
46666863|NCT01298596|82881203|FG000|Overall Study|Referred for further management|16|||
46666864|NCT01298596|82881204|FG001|Overall Study|Referred for further management|15|||
46666865|NCT01298518|82881213|FG000|Overall Study|Withdrawal by Subject|0|||
46666866|NCT01298518|82881214|FG001|Overall Study|Withdrawal by Subject|0|||
46666867|NCT01298518|82881215|FG002|Overall Study|Withdrawal by Subject|1|||
46666868|NCT01298362|82881225|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
46666869|NCT01298362|82881226|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
46972436|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
46972437|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
46972438|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
46972439|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
46972440|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
47076934|NCT02605824|83374278|FG001|Overall Study|Physician Decision|0|||
47076935|NCT02605122|83374408|FG000|Overall Study|Withdrawal by Subject|4|||
46666870|NCT01297504|82881234|FG000|Overall Study|Invalid Consent|1|||
46666871|NCT01297504|82881234|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
46666872|NCT01297504|82881234|FG000|Overall Study|No Study Visits|4|||
46666873|NCT01297504|82881234|FG000|Overall Study|Death|3|||
46666874|NCT01297504|82881234|FG000|Overall Study|Lost to Follow-up|43|||
46666875|NCT01297504|82881234|FG000|Overall Study|Withdrawal by Subject|9|||
46666876|NCT01297504|82881234|FG000|Overall Study|Site Closure|3|||
46666877|NCT01297504|82881234|FG000|Overall Study|Protocol Violation|3|||
46666878|NCT01297465|82881244|FG000|Overall Study|Lack of Ovarian Response|1|||
46666879|NCT01297465|82881245|FG001|Overall Study|Lack of Ovarian Response|1|||
46666880|NCT01297465|82881244|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
46666881|NCT01297465|82881245|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
47076936|NCT02605122|83374409|FG001|Overall Study|Withdrawal by Subject|1|||
47076937|NCT02605122|83374408|FG000|Overall Study|Lost to Follow-up|1|||
47076938|NCT02605122|83374409|FG001|Overall Study|Lost to Follow-up|1|||
47076939|NCT01454102|83374460|FG000|Overall Study|Continuing in the treatment period|0|||
47076940|NCT01454102|83374461|FG001|Overall Study|Continuing in the treatment period|0|||
47076941|NCT01454102|83374462|FG002|Overall Study|Continuing in the treatment period|0|||
47076942|NCT01454102|83374463|FG003|Overall Study|Continuing in the treatment period|0|||
47076943|NCT01454102|83374464|FG004|Overall Study|Continuing in the treatment period|3|||
47076944|NCT01454102|83374465|FG005|Overall Study|Continuing in the treatment period|3|||
47076945|NCT01454102|83374466|FG006|Overall Study|Continuing in the treatment period|2|||
47076946|NCT01454102|83374467|FG007|Overall Study|Continuing in the treatment period|0|||
47076947|NCT01454102|83374468|FG008|Overall Study|Continuing in the treatment period|1|||
47076948|NCT01454102|83374469|FG009|Overall Study|Continuing in the treatment period|0|||
47076949|NCT01454102|83374470|FG010|Overall Study|Continuing in the treatment period|0|||
46666882|NCT01297465|82881244|FG000|Overall Study|No Oocytes Retrieved|1|||
46666883|NCT01297465|82881245|FG001|Overall Study|No Oocytes Retrieved|1|||
46666884|NCT01297465|82881244|FG000|Overall Study|Poor oocyte quality|0|||
46666885|NCT01297465|82881245|FG001|Overall Study|Poor oocyte quality|1|||
46666886|NCT01297465|82881244|FG000|Overall Study|No Fertilization|6|||
46666887|NCT01297465|82881245|FG001|Overall Study|No Fertilization|4|||
46666888|NCT01297465|82881244|FG000|Overall Study|All Embryos Discarded|0|||
46972441|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
47076950|NCT01454102|83374471|FG011|Overall Study|Continuing in the treatment period|4|||
47076951|NCT01454102|83374472|FG012|Overall Study|Continuing in the treatment period|7|||
47076952|NCT01454102|83374473|FG013|Overall Study|Continuing in the treatment period|4|||
46666889|NCT01297465|82881245|FG001|Overall Study|All Embryos Discarded|1|||
46666890|NCT01297465|82881244|FG000|Overall Study|Intention to Freeze all Embryos|0|||
46666891|NCT01297465|82881245|FG001|Overall Study|Intention to Freeze all Embryos|1|||
46666892|NCT01297309|82881251|FG000|Overall Study|Eligibility failure|2|||
46666893|NCT01297309|82881251|FG000|Overall Study|Screen failure|2|||
46666894|NCT01297309|82881251|FG000|Overall Study|Withdrawal by Subject|5|||
46666895|NCT01297309|82881251|FG000|Overall Study|Adverse Event|1|||
46666896|NCT01297309|82881251|FG000|Overall Study|Investigator Decision|2|||
46666897|NCT01297309|82881251|FG000|Overall Study|Death|1|||
46666898|NCT01297309|82881251|FG000|Overall Study|Participant not entering extensionperiod|1|||
46666899|NCT04518462|82881258|FG000|Overall Study|Withdrawal by Subject|0|||
46666900|NCT04518462|82881259|FG001|Overall Study|Withdrawal by Subject|0|||
46666901|NCT04518462|82881260|FG002|Overall Study|Withdrawal by Subject|1|||
46666902|NCT04518462|82881258|FG000|Overall Study|Physician Decision|1|||
46666903|NCT04518462|82881259|FG001|Overall Study|Physician Decision|1|||
46666904|NCT04518462|82881260|FG002|Overall Study|Physician Decision|0|||
46666905|NCT01297270|82881271|FG000|Overall Study|Adverse Event|19|||
46666906|NCT01297270|82881272|FG001|Overall Study|Adverse Event|32|||
46666907|NCT01297270|82881273|FG002|Overall Study|Adverse Event|5|||
46666908|NCT01297270|82881271|FG000|Overall Study|Lack of Efficacy|15|||
46666909|NCT01297270|82881272|FG001|Overall Study|Lack of Efficacy|17|||
46666910|NCT01297270|82881273|FG002|Overall Study|Lack of Efficacy|15|||
46666911|NCT01297270|82881271|FG000|Overall Study|Lost to Follow-up|1|||
46666912|NCT01297270|82881272|FG001|Overall Study|Lost to Follow-up|2|||
46666913|NCT01297270|82881273|FG002|Overall Study|Lost to Follow-up|1|||
46666914|NCT01297270|82881271|FG000|Overall Study|Protocol Violation|0|||
46666915|NCT01297270|82881272|FG001|Overall Study|Protocol Violation|2|||
46666916|NCT01297270|82881273|FG002|Overall Study|Protocol Violation|0|||
46666917|NCT01297270|82881271|FG000|Overall Study|Withdrawal by Subject|7|||
46666918|NCT01297270|82881272|FG001|Overall Study|Withdrawal by Subject|15|||
46666919|NCT01297270|82881273|FG002|Overall Study|Withdrawal by Subject|7|||
46666920|NCT01297270|82881271|FG000|Overall Study|Other reason not defined above|3|||
46666921|NCT01297270|82881272|FG001|Overall Study|Other reason not defined above|3|||
46666922|NCT01297270|82881273|FG002|Overall Study|Other reason not defined above|1|||
46666923|NCT01297270|82881271|FG000|Overall Study|Not treated|0|||
46666924|NCT01297270|82881272|FG001|Overall Study|Not treated|1|||
46666925|NCT01297270|82881273|FG002|Overall Study|Not treated|0|||
46666926|NCT01296568|82881281|FG000|Continued Access Phase|Lost to Follow-up|1|||
46666927|NCT01296568|82881281|FG000|Continued Access Phase|Withdrawal by Subject|1|||
46666928|NCT01296568|82881281|FG000|Continued Access Phase|Disease Progression|1|||
46666929|NCT01296412|82881289|FG000|Overall Study|Adverse Event|8|||
46666930|NCT01296412|82881290|FG001|Overall Study|Adverse Event|29|||
46666931|NCT01296412|82881289|FG000|Overall Study|Lack of Efficacy|1|||
46666932|NCT01296412|82881290|FG001|Overall Study|Lack of Efficacy|0|||
46666933|NCT01296412|82881289|FG000|Overall Study|Lost to Follow-up|10|||
46666934|NCT01296412|82881290|FG001|Overall Study|Lost to Follow-up|7|||
46666935|NCT01296412|82881289|FG000|Overall Study|Non-compliance with study drug|1|||
46666936|NCT01296412|82881290|FG001|Overall Study|Non-compliance with study drug|2|||
46666937|NCT01296412|82881289|FG000|Overall Study|Other reason not specified|20|||
46666938|NCT01296412|82881290|FG001|Overall Study|Other reason not specified|15|||
46666939|NCT01296412|82881289|FG000|Overall Study|Physician Decision|1|||
46666940|NCT01296412|82881290|FG001|Overall Study|Physician Decision|3|||
46666941|NCT01296412|82881289|FG000|Overall Study|Pregnancy|0|||
46666942|NCT01296412|82881290|FG001|Overall Study|Pregnancy|1|||
46666943|NCT01296412|82881289|FG000|Overall Study|Withdrawal by Subject|10|||
46666944|NCT01296412|82881290|FG001|Overall Study|Withdrawal by Subject|13|||
46666945|NCT01295905|82881298|FG000|Overall Study|Did not meet inclusion criteria|1|||
46666946|NCT01295905|82881299|FG001|Overall Study|Did not meet inclusion criteria|0|||
46666947|NCT01295905|82881298|FG000|Overall Study|Met exclusion criteria|1|||
46666948|NCT01295905|82881299|FG001|Overall Study|Met exclusion criteria|0|||
47076953|NCT01454102|83374474|FG014|Overall Study|Continuing in the treatment period|3|||
47076954|NCT01454102|83374475|FG015|Overall Study|Continuing in the treatment period|1|||
47076955|NCT02602080|83374569|FG000|Overall Study|Protocol Violation|6|||
47076956|NCT02602080|83374570|FG001|Overall Study|Protocol Violation|1|||
46666949|NCT02596035|82881308|FG000|Overall Study|Disease Progression|64|||
46972442|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
46972443|NCT02709655|83216130|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
46972444|NCT02709655|83216131|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
46972445|NCT02709655|83216132|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
47076957|NCT02602080|83374571|FG002|Overall Study|Protocol Violation|3|||
47076958|NCT02604342|83374655|FG000|Overall Study|Death|32|||
46666950|NCT02596035|82881309|FG001|Overall Study|Disease Progression|32|||
46666951|NCT02596035|82881310|FG002|Overall Study|Disease Progression|1|||
46666952|NCT02596035|82881308|FG000|Overall Study|study drug toxicity|12|||
46666953|NCT02596035|82881309|FG001|Overall Study|study drug toxicity|3|||
46666954|NCT02596035|82881310|FG002|Overall Study|study drug toxicity|0|||
46666955|NCT02596035|82881308|FG000|Overall Study|AE unrelated to study drug|5|||
46666956|NCT02596035|82881309|FG001|Overall Study|AE unrelated to study drug|2|||
46666957|NCT02596035|82881310|FG002|Overall Study|AE unrelated to study drug|0|||
46666958|NCT02596035|82881308|FG000|Overall Study|participant request to discontinue study treatment|2|||
46666959|NCT02596035|82881309|FG001|Overall Study|participant request to discontinue study treatment|0|||
46666960|NCT02596035|82881310|FG002|Overall Study|participant request to discontinue study treatment|0|||
46666961|NCT02596035|82881308|FG000|Overall Study|participant withdrew consent|2|||
46666962|NCT02596035|82881309|FG001|Overall Study|participant withdrew consent|2|||
46666963|NCT02596035|82881310|FG002|Overall Study|participant withdrew consent|0|||
46666964|NCT02596035|82881308|FG000|Overall Study|Poor/Non Comlpiance|0|||
46666965|NCT02596035|82881309|FG001|Overall Study|Poor/Non Comlpiance|1|||
46666966|NCT02596035|82881310|FG002|Overall Study|Poor/Non Comlpiance|0|||
46666967|NCT02596035|82881308|FG000|Overall Study|participant no longer meets study criteria|1|||
46666968|NCT02596035|82881309|FG001|Overall Study|participant no longer meets study criteria|0|||
46666969|NCT02596035|82881310|FG002|Overall Study|participant no longer meets study criteria|0|||
46666970|NCT02596035|82881308|FG000|Overall Study|other reasons|11|||
46666971|NCT02596035|82881309|FG001|Overall Study|other reasons|4|||
46666972|NCT02596035|82881310|FG002|Overall Study|other reasons|0|||
46666973|NCT02595372|82881319|FG000|Overall Study|Adverse Event|6|||
46666974|NCT02595372|82881319|FG000|Overall Study|Physician Decision|2|||
46666975|NCT02595372|82881319|FG000|Overall Study|Disease Progression|1|||
46666976|NCT04829916|82881356|FG000|Overall Study|Withdrawal by Subject|1|||
46666977|NCT04829916|82881357|FG001|Overall Study|Withdrawal by Subject|0|||
46666978|NCT04761822|82881369|FG000|Overall Study|Adverse Event|3|||
46666979|NCT04761822|82881370|FG001|Overall Study|Adverse Event|1|||
46666980|NCT04761822|82881371|FG002|Overall Study|Adverse Event|1|||
46666981|NCT04761822|82881372|FG003|Overall Study|Adverse Event|3|||
46666982|NCT04761822|82881369|FG000|Overall Study|Lost to Follow-up|1|||
46666983|NCT04761822|82881370|FG001|Overall Study|Lost to Follow-up|0|||
46666984|NCT04761822|82881371|FG002|Overall Study|Lost to Follow-up|2|||
46666985|NCT04761822|82881372|FG003|Overall Study|Lost to Follow-up|3|||
46666986|NCT04761822|82881369|FG000|Overall Study|Physician Decision|0|||
46666987|NCT04761822|82881370|FG001|Overall Study|Physician Decision|1|||
46666988|NCT04761822|82881371|FG002|Overall Study|Physician Decision|0|||
46666989|NCT04761822|82881372|FG003|Overall Study|Physician Decision|0|||
46666990|NCT04761822|82881369|FG000|Overall Study|Withdrawal by Subject|3|||
46666991|NCT04761822|82881370|FG001|Overall Study|Withdrawal by Subject|8|||
46666992|NCT04761822|82881371|FG002|Overall Study|Withdrawal by Subject|1|||
46666993|NCT04761822|82881372|FG003|Overall Study|Withdrawal by Subject|11|||
46666994|NCT04761822|82881369|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
46666995|NCT04761822|82881370|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
46666996|NCT04761822|82881371|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
46666997|NCT04761822|82881372|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
46666998|NCT04761822|82881369|FG000|Overall Study|Participant requested unblinding|0|||
46666999|NCT04761822|82881370|FG001|Overall Study|Participant requested unblinding|0|||
46667000|NCT04761822|82881371|FG002|Overall Study|Participant requested unblinding|0|||
46667001|NCT04761822|82881372|FG003|Overall Study|Participant requested unblinding|1|||
47076959|NCT02604342|83374656|FG001|Overall Study|Death|16|||
47076960|NCT02604342|83374655|FG000|Overall Study|Progression of disease|1|||
47076961|NCT02604342|83374656|FG001|Overall Study|Progression of disease|0|||
47076962|NCT02604342|83374655|FG000|Overall Study|Withdrawal by Subject|5|||
46667002|NCT04596267|82881410|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
47076963|NCT02604342|83374656|FG001|Overall Study|Withdrawal by Subject|6|||
47076964|NCT02604342|83374655|FG000|Overall Study|Other|1|||
47076965|NCT02604342|83374656|FG001|Overall Study|Other|0|||
47076966|NCT02604342|83374655|FG000|Overall Study|Study Termination by Sponsor|1|||
47076967|NCT02604342|83374656|FG001|Overall Study|Study Termination by Sponsor|0|||
47076968|NCT02604342|83374655|FG000|Overall Study|Lost to Follow-up|1|||
47076969|NCT02604342|83374656|FG001|Overall Study|Lost to Follow-up|1|||
47076970|NCT02604342|83374655|FG000|Overall Study|Physician Decision|2|||
47076971|NCT02604342|83374656|FG001|Overall Study|Physician Decision|0|||
46667003|NCT04596267|82881411|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
47076972|NCT02604264|83374685|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
47076973|NCT02604264|83374686|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
47076974|NCT02601300|83374723|FG000|Induction Phase|Lack of Efficacy|2|||
47076975|NCT02601300|83374723|FG000|Induction Phase|Protocol Violation|1|||
47076976|NCT02601300|83374723|FG000|Extension Phase|Withdrawal by Subject|3|||
47076977|NCT02601300|83374723|FG000|Extension Phase|Adverse Event|4|||
47076978|NCT02601300|83374723|FG000|Extension Phase|Lack of Efficacy|10|||
46667004|NCT04596267|82881410|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
46667005|NCT04596267|82881411|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
46667006|NCT04439903|82881434|FG000|Overall Study|Withdrawal by Subject|2|||
46667007|NCT04439903|82881434|FG000|Overall Study|Screen Failure|1|||
46667008|NCT04280783|82881440|FG000|Overall Study|Family issues unrelated to the study.|1|||
46667009|NCT04280783|82881441|FG001|Overall Study|Family issues unrelated to the study.|0|||
47076979|NCT01471340|83374762|FG000|Overall Study|Death|5|||
46667010|NCT04280783|82881440|FG000|Overall Study|Withdrawal by Subject|0|||
46851288|NCT03605212|83066930|FG001|Treatment Period|Physician Decision|0|||
46851289|NCT03605212|83066931|FG002|Treatment Period|Physician Decision|0|||
46851290|NCT03605212|83066932|FG003|Treatment Period|Physician Decision|0|||
46851291|NCT03605212|83066933|FG004|Treatment Period|Physician Decision|1|||
46851292|NCT03603652|83066946|FG000|Overall Study|Death|2|||
46851293|NCT00117507|83066950|FG000|Overall Study|Adverse Event|4|||
46851294|NCT00117507|83066950|FG000|Overall Study|Abnormal laboratory values|3|||
46851295|NCT00117507|83066950|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46851296|NCT00117507|83066950|FG000|Overall Study|Patient withdrew consent|4|||
46851297|NCT00117507|83066950|FG000|Overall Study|Death|3|||
46851298|NCT03603496|83066957|FG000|Overall Study|Death|19|||
46851299|NCT03603496|83066958|FG001|Overall Study|Death|24|||
46851300|NCT03603496|83066957|FG000|Overall Study|Lost to Follow-up|141|||
46851301|NCT03603496|83066958|FG001|Overall Study|Lost to Follow-up|141|||
46851302|NCT03603496|83066957|FG000|Overall Study|Withdrawal by Subject|26|||
46851303|NCT03603496|83066958|FG001|Overall Study|Withdrawal by Subject|20|||
46851304|NCT03603028|83066964|FG000|Overall Study|Withdrawal by Subject|1|||
46851305|NCT03602482|83066970|FG000|Overall Study|Withdrawal by Subject|6|||
46851306|NCT03602482|83066971|FG001|Overall Study|Withdrawal by Subject|7|||
46851307|NCT03602482|83066972|FG002|Overall Study|Withdrawal by Subject|0|||
46851308|NCT03602482|83066973|FG003|Overall Study|Withdrawal by Subject|0|||
46851309|NCT00096135|83066988|FG000|Overall Study|Physician Decision|20|||
46851310|NCT00096135|83066989|FG001|Overall Study|Physician Decision|4|||
46851311|NCT00096135|83066988|FG000|Overall Study|Refusal of further protocol therapy|4|||
46851312|NCT00096135|83066989|FG001|Overall Study|Refusal of further protocol therapy|1|||
46851313|NCT00096135|83066988|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
46851314|NCT00096135|83066989|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
46851315|NCT00096135|83066988|FG000|Overall Study|Other, specify|15|||
46851316|NCT00096135|83066989|FG001|Overall Study|Other, specify|3|||
46851317|NCT00096135|83066988|FG000|Overall Study|Ineligible|2|||
46851318|NCT00096135|83066989|FG001|Overall Study|Ineligible|0|||
46851319|NCT00116805|83066997|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
46851320|NCT00116805|83066998|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
46851321|NCT00116805|83066997|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
46851322|NCT00116805|83066998|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
46851323|NCT00116805|83066997|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
46851324|NCT00116805|83066998|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
46851325|NCT00116805|83066997|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
46851326|NCT00116805|83066998|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
46851327|NCT00116805|83066997|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
46851328|NCT00116805|83066998|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
46851329|NCT00116805|83066997|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
46851330|NCT00116805|83066998|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
46851331|NCT00116805|83066997|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
46851332|NCT00116805|83066998|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
46851333|NCT00116805|83066997|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
46851334|NCT00116805|83066998|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
46851335|NCT00116805|83066997|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
46851336|NCT00116805|83066998|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
46851337|NCT00116805|83066997|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
46851338|NCT00116805|83066998|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
46851339|NCT00116805|83066997|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
46851340|NCT00116805|83066998|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
46851341|NCT00116805|83066997|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
46851342|NCT00116805|83066998|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
46851343|NCT00116805|83066997|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
46851344|NCT00116805|83066998|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
46851345|NCT00116805|83066997|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
46851346|NCT00116805|83066998|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
46851347|NCT00116805|83066997|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
46851348|NCT00116805|83066998|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
46851349|NCT00116805|83066997|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
46851350|NCT00116805|83066998|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
46851351|NCT00116805|83066997|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
46851352|NCT00116805|83066998|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
46851353|NCT00116805|83066997|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
46851354|NCT00116805|83066998|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
46851355|NCT00116805|83066997|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
46972446|NCT02709655|83216133|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
46972447|NCT02709655|83216134|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
46972448|NCT02709655|83216130|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
46972449|NCT02709655|83216131|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
46972450|NCT02709655|83216132|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
46972451|NCT02709655|83216133|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
46972452|NCT02709655|83216134|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
46972453|NCT02709655|83216130|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
46972454|NCT02709655|83216131|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
46972455|NCT02709655|83216132|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
46972456|NCT02709655|83216133|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
46972457|NCT02709655|83216134|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
46972458|NCT02709655|83216130|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
46784824|NCT00540124|83003857|FG000|Overall Study|Adverse Event|0|||
46784825|NCT00540124|83003858|FG001|Overall Study|Adverse Event|2|||
46784826|NCT00540124|83003859|FG002|Overall Study|Adverse Event|1|||
46784827|NCT00540124|83003857|FG000|Overall Study|Entry Criteria Not Met|2|||
46784828|NCT00540124|83003858|FG001|Overall Study|Entry Criteria Not Met|0|||
46784829|NCT00540124|83003859|FG002|Overall Study|Entry Criteria Not Met|0|||
46667011|NCT04280783|82881441|FG001|Overall Study|Withdrawal by Subject|1|||
46667012|NCT04177095|82881448|FG000|Overall Study|Withdrawal by Subject|3|||
46667013|NCT04177095|82881448|FG000|Overall Study|Screen Failure|3|||
46667014|NCT04177095|82881448|FG000|Overall Study|Problems with the Trugraf assay|1|||
46667015|NCT03799718|82881470|FG000|Overall Study|Adverse Event|2|||
46667016|NCT03458728|82881505|FG000|Overall Study|Adverse Event|1|||
46784830|NCT00540124|83003857|FG000|Overall Study|Lack of Efficacy|1|||
46784831|NCT00540124|83003858|FG001|Overall Study|Lack of Efficacy|0|||
46784832|NCT00540124|83003859|FG002|Overall Study|Lack of Efficacy|0|||
46784833|NCT00540124|83003857|FG000|Overall Study|Withdrawal by Subject|1|||
46784834|NCT00540124|83003858|FG001|Overall Study|Withdrawal by Subject|1|||
46784835|NCT00540124|83003859|FG002|Overall Study|Withdrawal by Subject|0|||
46784836|NCT00540046|83003869|FG000|Overall Study|Lost to Follow-up|33|||
46784837|NCT00540046|83003870|FG001|Overall Study|Lost to Follow-up|23|||
46784838|NCT00689936|83003881|FG000|Active Treatment Phase|Adverse Event|68|||
46784839|NCT00689936|83003882|FG001|Active Treatment Phase|Adverse Event|71|||
46784840|NCT00689936|83003883|FG002|Active Treatment Phase|Adverse Event|76|||
46784841|NCT00689936|83003881|FG000|Active Treatment Phase|Disease Progression|273|||
46784842|NCT00689936|83003882|FG001|Active Treatment Phase|Disease Progression|362|||
46784843|NCT00689936|83003883|FG002|Active Treatment Phase|Disease Progression|339|||
46784844|NCT00689936|83003881|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
46784845|NCT00689936|83003882|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
46784846|NCT00689936|83003883|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
46784847|NCT00689936|83003881|FG000|Active Treatment Phase|Death|60|||
46784848|NCT00689936|83003882|FG001|Active Treatment Phase|Death|28|||
46784849|NCT00689936|83003883|FG002|Active Treatment Phase|Death|37|||
46784850|NCT00689936|83003881|FG000|Active Treatment Phase|Lost to Follow-up|0|||
46784851|NCT00689936|83003882|FG001|Active Treatment Phase|Lost to Follow-up|2|||
46784852|NCT00689936|83003883|FG002|Active Treatment Phase|Lost to Follow-up|2|||
46784853|NCT00689936|83003881|FG000|Active Treatment Phase|Protocol Violation|2|||
46784854|NCT00689936|83003882|FG001|Active Treatment Phase|Protocol Violation|2|||
46784855|NCT00689936|83003883|FG002|Active Treatment Phase|Protocol Violation|4|||
46784856|NCT00689936|83003881|FG000|Active Treatment Phase|Study Close Out|64|||
46784857|NCT00689936|83003882|FG001|Active Treatment Phase|Study Close Out|26|||
46784858|NCT00689936|83003883|FG002|Active Treatment Phase|Study Close Out|21|||
46784859|NCT00689936|83003881|FG000|Active Treatment Phase|Miscellaneous|52|||
46784860|NCT00689936|83003882|FG001|Active Treatment Phase|Miscellaneous|34|||
46784861|NCT00689936|83003883|FG002|Active Treatment Phase|Miscellaneous|47|||
46784862|NCT00689936|83003881|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
46972459|NCT02709655|83216131|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
46972460|NCT02709655|83216132|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
46972461|NCT02709655|83216133|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
46972462|NCT02709655|83216134|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
46972463|NCT02709655|83216130|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
46972464|NCT02709655|83216131|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
46667017|NCT03458728|82881506|FG001|Overall Study|Adverse Event|0|||
46667018|NCT03458728|82881505|FG000|Overall Study|Physician Decision|1|||
46784863|NCT00689936|83003882|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
46784864|NCT00689936|83003883|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
46784865|NCT00671034|83003894|FG000|Overall Study|Adverse Event|5|||
46784866|NCT00671034|83003895|FG001|Overall Study|Adverse Event|7|||
46784867|NCT00671034|83003896|FG002|Overall Study|Adverse Event|1|||
46784868|NCT00671034|83003894|FG000|Overall Study|Death|3|||
46784869|NCT00671034|83003895|FG001|Overall Study|Death|2|||
46784870|NCT00671034|83003896|FG002|Overall Study|Death|1|||
46784871|NCT00671034|83003894|FG000|Overall Study|Physician Decision|12|||
46667019|NCT03458728|82881506|FG001|Overall Study|Physician Decision|0|||
46667020|NCT03458728|82881505|FG000|Overall Study|Progressive disease - clinical assessment|1|||
46667021|NCT03458728|82881506|FG001|Overall Study|Progressive disease - clinical assessment|0|||
46667022|NCT03458728|82881505|FG000|Overall Study|Progressive disease - radiological progression|21|||
46667023|NCT03458728|82881506|FG001|Overall Study|Progressive disease - radiological progression|6|||
46667024|NCT03458728|82881505|FG000|Overall Study|Withdrawal by Subject|0|||
46667025|NCT03458728|82881506|FG001|Overall Study|Withdrawal by Subject|1|||
46667026|NCT03215706|82881516|FG000|Randomization|Adverse Event unrelated to study drug|1|||
46667027|NCT03215706|82881517|FG001|Randomization|Adverse Event unrelated to study drug|0|||
46667028|NCT03215706|82881516|FG000|Randomization|participant withdrew consent|1|||
46667029|NCT03215706|82881517|FG001|Randomization|participant withdrew consent|3|||
46667030|NCT03215706|82881516|FG000|Randomization|no longer meets study criteria|1|||
46667031|NCT03215706|82881517|FG001|Randomization|no longer meets study criteria|4|||
46667032|NCT03215706|82881516|FG000|Randomization|other reasons|0|||
46667033|NCT03215706|82881517|FG001|Randomization|other reasons|2|||
46667034|NCT03215706|82881516|FG000|Treatment Period|Disease Progression|150|||
46667035|NCT03215706|82881517|FG001|Treatment Period|Disease Progression|142|||
46667036|NCT03215706|82881516|FG000|Treatment Period|Study Drug Toxicity|53|||
46667037|NCT03215706|82881517|FG001|Treatment Period|Study Drug Toxicity|21|||
46667038|NCT03215706|82881516|FG000|Treatment Period|Death|2|||
46667039|NCT03215706|82881517|FG001|Treatment Period|Death|1|||
46667040|NCT03215706|82881516|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
46667041|NCT03215706|82881517|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
46667042|NCT03215706|82881516|FG000|Treatment Period|Request to D/C treatment|1|||
46667043|NCT03215706|82881517|FG001|Treatment Period|Request to D/C treatment|6|||
46667044|NCT03215706|82881516|FG000|Treatment Period|Participant withdrew consent|3|||
46667045|NCT03215706|82881517|FG001|Treatment Period|Participant withdrew consent|4|||
46667046|NCT03215706|82881516|FG000|Treatment Period|Lost to Follow-up|0|||
46667047|NCT03215706|82881517|FG001|Treatment Period|Lost to Follow-up|1|||
46667048|NCT03215706|82881516|FG000|Treatment Period|Other Reasons|4|||
46667049|NCT03215706|82881517|FG001|Treatment Period|Other Reasons|5|||
46667050|NCT03215706|82881516|FG000|Treatment Period|Ongoing in the treatment period|105|||
46667051|NCT03215706|82881517|FG001|Treatment Period|Ongoing in the treatment period|43|||
46667052|NCT03151005|82881525|FG000|Overall Study|Lost to Follow-up|5|||
46667053|NCT03151005|82881526|FG001|Overall Study|Lost to Follow-up|5|||
46667054|NCT03143153|82881535|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
46667055|NCT03143153|82881536|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
46667056|NCT03143153|82881537|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
46667057|NCT03143153|82881535|FG000|Pre-Treatment|Participant withdrew consent|0|||
46667058|NCT03143153|82881536|FG001|Pre-Treatment|Participant withdrew consent|1|||
46667059|NCT03143153|82881537|FG002|Pre-Treatment|Participant withdrew consent|12|||
46667060|NCT03143153|82881535|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
46667061|NCT03143153|82881536|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
46667062|NCT03143153|82881537|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
46667063|NCT03143153|82881535|FG000|Pre-Treatment|Other Reasons|1|||
46667064|NCT03143153|82881536|FG001|Pre-Treatment|Other Reasons|2|||
46667065|NCT03143153|82881537|FG002|Pre-Treatment|Other Reasons|1|||
46667066|NCT03143153|82881535|FG000|Pre-Treatment|Disease Progression|1|||
46667067|NCT03143153|82881536|FG001|Pre-Treatment|Disease Progression|1|||
46667068|NCT03143153|82881537|FG002|Pre-Treatment|Disease Progression|2|||
46667069|NCT03143153|82881535|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
46667070|NCT03143153|82881536|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
46667071|NCT03143153|82881537|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
46667072|NCT03143153|82881535|FG000|Treatment|Disease progression|174|||
46667073|NCT03143153|82881536|FG001|Treatment|Disease progression|184|||
46667074|NCT03143153|82881537|FG002|Treatment|Disease progression|193|||
46667075|NCT03143153|82881535|FG000|Treatment|Study drug toxicity|59|||
46667076|NCT03143153|82881536|FG001|Treatment|Study drug toxicity|33|||
46667077|NCT03143153|82881537|FG002|Treatment|Study drug toxicity|40|||
46667078|NCT03143153|82881535|FG000|Treatment|Death|5|||
46667079|NCT03143153|82881536|FG001|Treatment|Death|3|||
46667080|NCT03143153|82881537|FG002|Treatment|Death|4|||
46667081|NCT03143153|82881535|FG000|Treatment|Adverse event unrelated to study drug|19|||
46667082|NCT03143153|82881536|FG001|Treatment|Adverse event unrelated to study drug|28|||
46667083|NCT03143153|82881537|FG002|Treatment|Adverse event unrelated to study drug|12|||
46667084|NCT03143153|82881535|FG000|Treatment|Participant request to discontinue study treatment|13|||
46667085|NCT03143153|82881536|FG001|Treatment|Participant request to discontinue study treatment|15|||
46667086|NCT03143153|82881537|FG002|Treatment|Participant request to discontinue study treatment|20|||
46667087|NCT03143153|82881535|FG000|Treatment|Participant withdrew consent|3|||
46667088|NCT03143153|82881536|FG001|Treatment|Participant withdrew consent|4|||
46667089|NCT03143153|82881537|FG002|Treatment|Participant withdrew consent|12|||
46667090|NCT03143153|82881535|FG000|Treatment|Pregnancy|1|||
46667091|NCT03143153|82881536|FG001|Treatment|Pregnancy|0|||
46667092|NCT03143153|82881537|FG002|Treatment|Pregnancy|0|||
46667093|NCT03143153|82881535|FG000|Treatment|Maximum clinical benefit|1|||
46667094|NCT03143153|82881536|FG001|Treatment|Maximum clinical benefit|3|||
46667095|NCT03143153|82881537|FG002|Treatment|Maximum clinical benefit|4|||
46667096|NCT03143153|82881535|FG000|Treatment|Completed treatment as per Protocol|13|||
46667097|NCT03143153|82881536|FG001|Treatment|Completed treatment as per Protocol|8|||
46667098|NCT03143153|82881537|FG002|Treatment|Completed treatment as per Protocol|0|||
46667099|NCT03143153|82881535|FG000|Treatment|Other reasons|12|||
46667100|NCT03143153|82881536|FG001|Treatment|Other reasons|7|||
46667101|NCT03143153|82881537|FG002|Treatment|Other reasons|15|||
46667102|NCT03143153|82881535|FG000|Treatment|Not reported|1|||
46667103|NCT03143153|82881536|FG001|Treatment|Not reported|0|||
46667104|NCT03143153|82881537|FG002|Treatment|Not reported|0|||
46667105|NCT02872116|82881548|FG000|Pre-Treatment|Disease Progression|0|||
46667106|NCT02872116|82881549|FG001|Pre-Treatment|Disease Progression|1|||
46667107|NCT02872116|82881550|FG002|Pre-Treatment|Disease Progression|0|||
46667108|NCT02872116|82881548|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
46667109|NCT02872116|82881549|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
46667110|NCT02872116|82881550|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
46667111|NCT02872116|82881548|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
46667112|NCT02872116|82881549|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
46667113|NCT02872116|82881550|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
46667114|NCT02872116|82881548|FG000|Pre-Treatment|Participant withdrew consent|2|||
46667115|NCT02872116|82881549|FG001|Pre-Treatment|Participant withdrew consent|20|||
46667116|NCT02872116|82881550|FG002|Pre-Treatment|Participant withdrew consent|3|||
46667117|NCT02872116|82881548|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
46667118|NCT02872116|82881549|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
46667119|NCT02872116|82881550|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
46667120|NCT02872116|82881548|FG000|Pre-Treatment|Other reasons|1|||
46667121|NCT02872116|82881549|FG001|Pre-Treatment|Other reasons|2|||
46667122|NCT02872116|82881550|FG002|Pre-Treatment|Other reasons|2|||
46667123|NCT02872116|82881548|FG000|Treatment|Death|122|||
46667124|NCT02872116|82881549|FG001|Treatment|Death|94|||
46667125|NCT02872116|82881550|FG002|Treatment|Death|68|||
46667126|NCT02872116|82881548|FG000|Treatment|Lost to Follow-up|5|||
46667127|NCT02872116|82881549|FG001|Treatment|Lost to Follow-up|7|||
46667128|NCT02872116|82881550|FG002|Treatment|Lost to Follow-up|3|||
46667129|NCT02872116|82881548|FG000|Treatment|Participant withdrew consent|20|||
47076980|NCT01471340|83374763|FG001|Overall Study|Death|4|||
47076981|NCT01471340|83374762|FG000|Overall Study|Lost to Follow-up|0|||
47076982|NCT01471340|83374763|FG001|Overall Study|Lost to Follow-up|1|||
46667130|NCT02872116|82881549|FG001|Treatment|Participant withdrew consent|40|||
46784872|NCT00671034|83003895|FG001|Overall Study|Physician Decision|4|||
46784873|NCT00671034|83003896|FG002|Overall Study|Physician Decision|5|||
46784874|NCT00671034|83003894|FG000|Overall Study|VHR ALL feature|8|||
46784875|NCT00671034|83003895|FG001|Overall Study|VHR ALL feature|3|||
46784876|NCT00671034|83003896|FG002|Overall Study|VHR ALL feature|5|||
46784877|NCT00671034|83003894|FG000|Overall Study|Refusal|5|||
46784878|NCT00671034|83003895|FG001|Overall Study|Refusal|3|||
46784879|NCT00671034|83003896|FG002|Overall Study|Refusal|5|||
46784880|NCT00671034|83003894|FG000|Overall Study|includes Alternative therapy, etc.|6|||
46784881|NCT00671034|83003895|FG001|Overall Study|includes Alternative therapy, etc.|1|||
46784882|NCT00671034|83003896|FG002|Overall Study|includes Alternative therapy, etc.|7|||
46784883|NCT02679508|83003907|FG000|Healing Phase|Protocol Violation|1|||
46784884|NCT02679508|83003908|FG001|Healing Phase|Protocol Violation|1|||
46667131|NCT02872116|82881550|FG002|Treatment|Participant withdrew consent|8|||
46784885|NCT02679508|83003907|FG000|Healing Phase|Lost to Follow-up|1|||
46784886|NCT02679508|83003908|FG001|Healing Phase|Lost to Follow-up|0|||
47076983|NCT01471340|83374762|FG000|Overall Study|Investigational site closure|0|||
46667132|NCT02872116|82881548|FG000|Treatment|Other reasons|12|||
47076984|NCT01471340|83374763|FG001|Overall Study|Investigational site closure|1|||
47076985|NCT01471340|83374762|FG000|Overall Study|Invalid informed consent|1|||
46667133|NCT02872116|82881549|FG001|Treatment|Other reasons|12|||
46667134|NCT02872116|82881550|FG002|Treatment|Other reasons|5|||
46667135|NCT02592824|82881564|FG000|Overall Study|Protocol Violation|5|||
46667136|NCT02592824|82881565|FG001|Overall Study|Protocol Violation|3|||
46667137|NCT02592824|82881564|FG000|Overall Study|Lost to Follow-up|2|||
46784887|NCT02679508|83003907|FG000|Maintenance Phase|Adverse Event|12|||
46784888|NCT02679508|83003908|FG001|Maintenance Phase|Adverse Event|2|||
46784889|NCT02679508|83003907|FG000|Maintenance Phase|Lost to Follow-up|0|||
46784890|NCT02679508|83003908|FG001|Maintenance Phase|Lost to Follow-up|1|||
46667138|NCT02592824|82881565|FG001|Overall Study|Lost to Follow-up|1|||
46667139|NCT02348112|82881584|FG000|Overall Study|Withdrawal by Subject|32|||
46667140|NCT02348112|82881585|FG001|Overall Study|Withdrawal by Subject|29|||
46667141|NCT02348112|82881584|FG000|Overall Study|Lost to Follow-up|24|||
46667142|NCT02348112|82881585|FG001|Overall Study|Lost to Follow-up|20|||
46667143|NCT02348112|82881584|FG000|Overall Study|Physician Decision|17|||
46784891|NCT02679508|83003907|FG000|Maintenance Phase|Withdrawal by Subject|15|||
47076986|NCT01471340|83374763|FG001|Overall Study|Invalid informed consent|0|||
47076987|NCT01492400|83374785|FG000|Overall Study|Miscellaneous Reasons|2|||
47076988|NCT01492400|83374786|FG001|Overall Study|Miscellaneous Reasons|3|||
47076989|NCT01492400|83374785|FG000|Overall Study|Personal Reasons|0|||
47076990|NCT01492400|83374786|FG001|Overall Study|Personal Reasons|5|||
47076991|NCT01492400|83374785|FG000|Overall Study|Lost to Follow-up|3|||
46667144|NCT02348112|82881585|FG001|Overall Study|Physician Decision|15|||
46667145|NCT02348112|82881584|FG000|Overall Study|Site closed due to PI leaving|0|||
46667146|NCT02348112|82881585|FG001|Overall Study|Site closed due to PI leaving|30|||
46667147|NCT02348112|82881584|FG000|Overall Study|Sponsor withdrawal|0|||
46667148|NCT02348112|82881585|FG001|Overall Study|Sponsor withdrawal|7|||
46667149|NCT02348112|82881584|FG000|Overall Study|Death|0|||
46667150|NCT02348112|82881585|FG001|Overall Study|Death|1|||
46667151|NCT02004691|82881602|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
46667152|NCT02004691|82881603|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
46667153|NCT02004691|82881602|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
46667154|NCT02004691|82881603|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
46667155|NCT02004691|82881602|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
46667156|NCT02004691|82881603|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
46667157|NCT02004691|82881602|FG000|ETP: Ongoing From Week 52|Other|0|||
46667158|NCT02004691|82881603|FG001|ETP: Ongoing From Week 52|Other|1|||
46667159|NCT02004691|82881602|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
46667160|NCT02004691|82881603|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
46667161|NCT01248962|82881664|FG000|Overall Study|Withdrawal by Subject|1|||
46667162|NCT01248962|82881665|FG001|Overall Study|Withdrawal by Subject|1|||
46667163|NCT01248962|82881664|FG000|Overall Study|Adverse Event|2|||
46667164|NCT01248962|82881665|FG001|Overall Study|Adverse Event|1|||
46667165|NCT01248962|82881664|FG000|Overall Study|Complete Response after 4 Cycles|1|||
46667166|NCT01248962|82881665|FG001|Overall Study|Complete Response after 4 Cycles|0|||
46667167|NCT01248962|82881664|FG000|Overall Study|Complete Response after 3 Cycles|0|||
46667168|NCT01248962|82881665|FG001|Overall Study|Complete Response after 3 Cycles|1|||
46667169|NCT01248962|82881664|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
46667170|NCT01248962|82881665|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
46667171|NCT01248455|82881672|FG000|Overall Study|switched to alternate treatment|1|||
46667172|NCT01247090|82881679|FG000|Overall Study|Physician Decision|1|||
46667173|NCT01247090|82881680|FG001|Overall Study|Physician Decision|0|||
46667174|NCT01247090|82881681|FG002|Overall Study|Physician Decision|0|||
46667175|NCT01247090|82881679|FG000|Overall Study|Withdrawal by Subject|0|||
46667176|NCT01247090|82881680|FG001|Overall Study|Withdrawal by Subject|1|||
46667177|NCT01247090|82881681|FG002|Overall Study|Withdrawal by Subject|0|||
46667178|NCT01249664|82881691|FG000|Overall Study|Withdrawal by Subject|5|||
46667179|NCT01249664|82881692|FG001|Overall Study|Withdrawal by Subject|0|||
46667180|NCT01249664|82881691|FG000|Overall Study|Adverse Event|1|||
46667181|NCT01249664|82881692|FG001|Overall Study|Adverse Event|0|||
46667182|NCT01249274|82881702|FG000|Overall Study|Lost to Follow-up|3|||
46667183|NCT01249274|82881703|FG001|Overall Study|Lost to Follow-up|4|||
46667184|NCT01249274|82881702|FG000|Overall Study|Received inpatient substance treatment|1|||
46667185|NCT01249274|82881703|FG001|Overall Study|Received inpatient substance treatment|2|||
46667186|NCT01249157|82881711|FG000|Overall Study|Withdrawal by Subject|1|||
46667187|NCT01249118|82881715|FG000|First Washout Period|Physician Decision|0|||
46667188|NCT01249118|82881716|FG001|First Washout Period|Physician Decision|1|||
46667189|NCT01249118|82881717|FG002|First Washout Period|Physician Decision|0|||
46667190|NCT01248884|82881727|FG000|Overall Study|Withdrawal by Subject|1|||
46667191|NCT01248884|82881728|FG001|Overall Study|Withdrawal by Subject|3|||
47076992|NCT01492400|83374786|FG001|Overall Study|Lost to Follow-up|1|||
47076993|NCT01492400|83374785|FG000|Overall Study|Pregnancy|0|||
47076994|NCT01492400|83374786|FG001|Overall Study|Pregnancy|1|||
46667192|NCT01248884|82881729|FG002|Overall Study|Withdrawal by Subject|1|||
46667193|NCT01248884|82881727|FG000|Overall Study|Adverse Event|1|||
46667194|NCT01248884|82881728|FG001|Overall Study|Adverse Event|0|||
46667195|NCT01248884|82881729|FG002|Overall Study|Adverse Event|0|||
46667196|NCT01248728|82881741|FG000|Overall Study|Adverse Event|1|||
46667197|NCT01248728|82881742|FG001|Overall Study|Adverse Event|1|||
46667198|NCT01248728|82881741|FG000|Overall Study|Withdrawal by Subject|2|||
46667199|NCT01248728|82881742|FG001|Overall Study|Withdrawal by Subject|1|||
46667200|NCT01248728|82881741|FG000|Overall Study|Lack of Efficacy|1|||
46667201|NCT01248728|82881742|FG001|Overall Study|Lack of Efficacy|0|||
47076995|NCT01492400|83374785|FG000|Overall Study|Lack of Efficacy|1|||
47076996|NCT01492400|83374786|FG001|Overall Study|Lack of Efficacy|1|||
47076997|NCT01492400|83374785|FG000|Overall Study|Adverse Event|10|||
46667202|NCT01246973|82881752|FG000|Overall Study|Other|38|||
46667203|NCT01246973|82881753|FG001|Overall Study|Other|25|||
46667204|NCT01246973|82881752|FG000|Overall Study|Adverse Event|16|||
46667205|NCT01246973|82881753|FG001|Overall Study|Adverse Event|9|||
46667206|NCT01246973|82881752|FG000|Overall Study|Withdrawal by Subject|7|||
46667207|NCT01246973|82881753|FG001|Overall Study|Withdrawal by Subject|13|||
46667208|NCT01246466|82881759|FG000|Overall Study|Death|1|||
46667209|NCT01246466|82881759|FG000|Overall Study|Withdrawal by Subject|1|||
46667210|NCT01245764|82881768|FG000|Study Phase A|Other|3|||
46667211|NCT01245764|82881769|FG001|Study Phase A|Other|2|||
46667212|NCT01245764|82881770|FG002|Study Phase A|Other|3|||
46667213|NCT01245764|82881771|FG003|Study Phase A|Other|1|||
46667214|NCT01245764|82881768|FG000|Study Phase A|Protocol Violation|6|||
46667215|NCT01245764|82881769|FG001|Study Phase A|Protocol Violation|3|||
46667216|NCT01245764|82881770|FG002|Study Phase A|Protocol Violation|2|||
46667217|NCT01245764|82881771|FG003|Study Phase A|Protocol Violation|2|||
46972465|NCT02709655|83216132|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
46972466|NCT02709655|83216133|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
46667218|NCT01245764|82881768|FG000|Study Phase A|Lost to Follow-up|0|||
46667219|NCT01245764|82881769|FG001|Study Phase A|Lost to Follow-up|0|||
46667220|NCT01245764|82881770|FG002|Study Phase A|Lost to Follow-up|5|||
46667221|NCT01245764|82881771|FG003|Study Phase A|Lost to Follow-up|0|||
46667222|NCT01245140|82881791|FG000|Overall Study|Adverse Event|1|||
46667223|NCT01245140|82881792|FG001|Overall Study|Adverse Event|3|||
46667224|NCT01245140|82881791|FG000|Overall Study|Lack of Efficacy|2|||
46667225|NCT01245140|82881792|FG001|Overall Study|Lack of Efficacy|4|||
46667226|NCT01245140|82881791|FG000|Overall Study|Protocol Violation|0|||
46667227|NCT01245140|82881792|FG001|Overall Study|Protocol Violation|1|||
46667228|NCT01245140|82881791|FG000|Overall Study|Withdrawal by Subject|0|||
46667229|NCT01245140|82881792|FG001|Overall Study|Withdrawal by Subject|1|||
46667230|NCT01245140|82881791|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
46667231|NCT01245140|82881792|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
46667232|NCT01245101|82881800|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
46667233|NCT01245101|82881801|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
46667234|NCT01245101|82881800|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
46667235|NCT01245101|82881801|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
46667236|NCT01245101|82881800|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
46667237|NCT01245101|82881801|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
46667238|NCT01245062|82881809|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
46667239|NCT01245062|82881810|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
46667240|NCT01245062|82881811|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
46667241|NCT01245062|82881809|FG000|Randomization and Crossover Phase|Physician Decision|2|||
46667242|NCT01245062|82881810|FG001|Randomization and Crossover Phase|Physician Decision|4|||
46667243|NCT01245062|82881811|FG002|Randomization and Crossover Phase|Physician Decision|0|||
46667244|NCT01245062|82881809|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
46667245|NCT01245062|82881810|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
46667246|NCT01245062|82881811|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
46667247|NCT01245062|82881809|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
46667248|NCT01245062|82881810|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
46667249|NCT01245062|82881811|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
46667250|NCT01245062|82881809|FG000|Cross-over Phase|Lost to Follow-up|0|||
46667251|NCT01245062|82881810|FG001|Cross-over Phase|Lost to Follow-up|0|||
46667252|NCT01245062|82881811|FG002|Cross-over Phase|Lost to Follow-up|1|||
46667253|NCT01245062|82881809|FG000|Cross-over Phase|Physician Decision|0|||
46667254|NCT01245062|82881810|FG001|Cross-over Phase|Physician Decision|0|||
46667255|NCT01245062|82881811|FG002|Cross-over Phase|Physician Decision|1|||
46667256|NCT01245062|82881809|FG000|Cross-over Phase|Withdrew Consent|0|||
46667257|NCT01245062|82881810|FG001|Cross-over Phase|Withdrew Consent|0|||
46667258|NCT01245062|82881811|FG002|Cross-over Phase|Withdrew Consent|4|||
46667259|NCT01245062|82881809|FG000|Cross-over Phase|Study closed/ terminated|0|||
46667260|NCT01245062|82881810|FG001|Cross-over Phase|Study closed/ terminated|0|||
46667261|NCT01245062|82881811|FG002|Cross-over Phase|Study closed/ terminated|11|||
46667262|NCT01244984|82881822|FG000|Overall Study|Adverse Event|2|||
46667263|NCT01244984|82881823|FG001|Overall Study|Adverse Event|11|||
46667264|NCT01244984|82881824|FG002|Overall Study|Adverse Event|2|||
46667265|NCT01244984|82881822|FG000|Overall Study|Protocol Violation|1|||
46667266|NCT01244984|82881823|FG001|Overall Study|Protocol Violation|0|||
46667267|NCT01244984|82881824|FG002|Overall Study|Protocol Violation|0|||
46667268|NCT01244984|82881822|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
46667269|NCT01244984|82881823|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
46667270|NCT01244984|82881824|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
46667271|NCT01244984|82881822|FG000|Overall Study|Withdrawal by Subject|1|||
46667272|NCT01244984|82881823|FG001|Overall Study|Withdrawal by Subject|2|||
46784892|NCT02679508|83003908|FG001|Maintenance Phase|Withdrawal by Subject|8|||
46784893|NCT02679508|83003907|FG000|Maintenance Phase|Other|5|||
46667273|NCT01244984|82881824|FG002|Overall Study|Withdrawal by Subject|2|||
46667274|NCT01244516|82881836|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
46667275|NCT01244516|82881837|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
46667276|NCT01244516|82881838|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
46667277|NCT01244516|82881836|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
46667278|NCT01244516|82881837|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
46667279|NCT01244516|82881838|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
46667280|NCT01244516|82881836|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
46667281|NCT01244516|82881837|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
46667282|NCT01244516|82881838|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
46667283|NCT01244516|82881836|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
46667284|NCT01244516|82881837|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
46667285|NCT01244516|82881838|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
46667286|NCT01244516|82881836|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
46667287|NCT01244516|82881837|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
46667288|NCT01244516|82881838|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
46667289|NCT01244516|82881836|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
46667290|NCT01244516|82881837|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
46667291|NCT01244516|82881838|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
46667292|NCT01244516|82881836|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
46667293|NCT01244516|82881837|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
46667294|NCT01244516|82881838|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
46667295|NCT01244126|82881850|FG000|Overall Study|Protocol Violation|3|||
46667296|NCT01244126|82881851|FG001|Overall Study|Protocol Violation|3|||
46667297|NCT01244126|82881852|FG002|Overall Study|Protocol Violation|9|||
46667298|NCT01243892|82881862|FG000|Overall Study|Did not meet eligibility criteria|2|||
46667299|NCT01243892|82881863|FG001|Overall Study|Did not meet eligibility criteria|0|||
46784894|NCT02679508|83003908|FG001|Maintenance Phase|Other|4|||
46784895|NCT04404478|83003916|FG000|Overall Study|Withdrawal by Subject|1|||
46784896|NCT04404478|83003917|FG001|Overall Study|Withdrawal by Subject|3|||
46784897|NCT00539734|83003925|FG000|Overall Study|Protocol Violation|1|||
46784898|NCT03907072|83003932|FG000|Overall Study|Study Terminated by Sponsor|2|||
46784899|NCT03907072|83003933|FG001|Overall Study|Study Terminated by Sponsor|2|||
46784900|NCT03907072|83003934|FG002|Overall Study|Study Terminated by Sponsor|2|||
46784901|NCT00329719|83003959|FG000|Overall Study|Lost to Follow-up|0|||
46784902|NCT00329719|83003960|FG001|Overall Study|Lost to Follow-up|0|||
46784903|NCT00329719|83003961|FG002|Overall Study|Lost to Follow-up|0|||
46784904|NCT00329719|83003962|FG003|Overall Study|Lost to Follow-up|1|||
46784905|NCT00329641|83003972|FG000|Overall Study|Did not start treatment|1|||
46784906|NCT00329641|83003972|FG000|Overall Study|Not eligible|1|||
46784907|NCT00329641|83003972|FG000|Overall Study|Adverse Event|3|||
46784908|NCT00329641|83003972|FG000|Overall Study|Other reason, not protocol specified|1|||
46784909|NCT00329407|83003986|FG000|Overall Study|Withdrawal by Subject|1|||
46784910|NCT00328783|83003990|FG000|Overall Study|Could not tolerate ABC|21|||
46784911|NCT00328783|83003990|FG000|Overall Study|No heart in RT field|4|||
46784912|NCT00328783|83003990|FG000|Overall Study|Withdrawal by Subject|1|||
46784913|NCT00567489|83003998|FG000|Overall Study|Adverse Event|6|||
46784914|NCT00567489|83003999|FG001|Overall Study|Adverse Event|14|||
46784915|NCT00567489|83003998|FG000|Overall Study|Physician Decision|0|||
47076998|NCT01492400|83374786|FG001|Overall Study|Adverse Event|5|||
47076999|NCT02596854|83374911|FG000|Overall Study|Withdrawn|8|||
47077000|NCT02592876|83375048|FG000|Overall Study|Withdrawal by Subject|3|||
47077001|NCT02592876|83375049|FG001|Overall Study|Withdrawal by Subject|3|||
47077002|NCT02592876|83375048|FG000|Overall Study|Study Termination by Sponsor|32|||
47077003|NCT02592876|83375049|FG001|Overall Study|Study Termination by Sponsor|27|||
47077004|NCT02592876|83375048|FG000|Overall Study|Lost to Follow-up|0|||
47077005|NCT02592876|83375049|FG001|Overall Study|Lost to Follow-up|1|||
47077006|NCT02592876|83375048|FG000|Overall Study|Death|6|||
47077007|NCT02592876|83375049|FG001|Overall Study|Death|9|||
47077008|NCT01492088|83375066|FG000|Overall Study|Withdrawal by Patient|0|||
46667300|NCT01243775|82881869|FG000|Overall Study|Withdrawal by Subject|2|||
46667301|NCT01243268|82881873|FG000|Overall Study|Lost to Follow-up|4|||
46667302|NCT01243268|82881873|FG000|Overall Study|Protocol Violation|51|||
46667303|NCT01243268|82881873|FG000|Overall Study|Deviation with contract date|7|||
46667304|NCT01243268|82881873|FG000|Overall Study|Duplicate subject|2|||
46667305|NCT01242371|82881879|FG000|Overall Study|Withdrawal by Subject|2|||
46667306|NCT01242371|82881880|FG001|Overall Study|Withdrawal by Subject|2|||
46667307|NCT01242371|82881879|FG000|Overall Study|Protocol Violation|0|||
46667308|NCT01242371|82881880|FG001|Overall Study|Protocol Violation|3|||
46784916|NCT00567489|83003999|FG001|Overall Study|Physician Decision|4|||
46784917|NCT00567489|83003998|FG000|Overall Study|Withdrawal by Subject|0|||
46784918|NCT00567489|83003999|FG001|Overall Study|Withdrawal by Subject|2|||
46784919|NCT00567489|83003998|FG000|Overall Study|Renal Transplantation|0|||
46667309|NCT01242176|82881886|FG000|Washout Period of 7 Days|Adverse Event|0|||
46667310|NCT01242176|82881887|FG001|Washout Period of 7 Days|Adverse Event|2|||
46784920|NCT00567489|83003999|FG001|Overall Study|Renal Transplantation|3|||
46667311|NCT01242176|82881886|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
46667312|NCT01242176|82881887|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
47077009|NCT01492088|83375067|FG001|Overall Study|Withdrawal by Patient|2|||
47077010|NCT01492088|83375068|FG002|Overall Study|Withdrawal by Patient|0|||
46667313|NCT01242020|82881895|FG000|Overall Study|Withdrawal by Subject|2|||
46667314|NCT01242020|82881896|FG001|Overall Study|Withdrawal by Subject|0|||
46667315|NCT01242020|82881895|FG000|Overall Study|Failed screening|1|||
46667316|NCT01242020|82881896|FG001|Overall Study|Failed screening|0|||
46667317|NCT01241786|82881902|FG000|Overall Study|Lack of Efficacy|5|||
47077011|NCT01492088|83375066|FG000|Overall Study|Death|1|||
47077012|NCT01492088|83375067|FG001|Overall Study|Death|6|||
46667318|NCT01241318|82881909|FG000|Overall Study|Woman: false pregnancies|27|||
46784921|NCT00567489|83003998|FG000|Overall Study|Other|1|||
46784922|NCT00567489|83003999|FG001|Overall Study|Other|0|||
46784923|NCT00669942|83004017|FG000|Parts 2 and 3|Adverse Event|0|||
46784924|NCT00669942|83004018|FG001|Parts 2 and 3|Adverse Event|0|||
46784925|NCT00669942|83004019|FG002|Parts 2 and 3|Adverse Event|0|||
46784926|NCT00669942|83004020|FG003|Parts 2 and 3|Adverse Event|0|||
46784927|NCT00669942|83004021|FG004|Parts 2 and 3|Adverse Event|0|||
46784928|NCT00669942|83004022|FG005|Parts 2 and 3|Adverse Event|0|||
46784929|NCT00669942|83004023|FG006|Parts 2 and 3|Adverse Event|0|||
46784930|NCT00669942|83004024|FG007|Parts 2 and 3|Adverse Event|2|||
46784931|NCT00669942|83004025|FG008|Parts 2 and 3|Adverse Event|1|||
46784932|NCT00669942|83004026|FG009|Parts 2 and 3|Adverse Event|0|||
46784933|NCT00669942|83004027|FG010|Parts 2 and 3|Adverse Event|0|||
46784934|NCT00669942|83004028|FG011|Parts 2 and 3|Adverse Event|0|||
46784935|NCT00669942|83004017|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
46784936|NCT00669942|83004018|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
46784937|NCT00669942|83004019|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
46784938|NCT00669942|83004020|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
46784939|NCT00669942|83004021|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
46784940|NCT00669942|83004022|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
46784941|NCT00669942|83004023|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
46784942|NCT00669942|83004024|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
46784943|NCT00669942|83004025|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
46784944|NCT00669942|83004026|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
46784945|NCT00669942|83004027|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
46784946|NCT00669942|83004028|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
46784947|NCT00669942|83004017|FG000|Parts 2 and 3|Protocol Violation|0|||
46784948|NCT00669942|83004018|FG001|Parts 2 and 3|Protocol Violation|0|||
46784949|NCT00669942|83004019|FG002|Parts 2 and 3|Protocol Violation|0|||
46784950|NCT00669942|83004020|FG003|Parts 2 and 3|Protocol Violation|0|||
46784951|NCT00669942|83004021|FG004|Parts 2 and 3|Protocol Violation|0|||
46784952|NCT00669942|83004022|FG005|Parts 2 and 3|Protocol Violation|1|||
46784953|NCT00669942|83004023|FG006|Parts 2 and 3|Protocol Violation|0|||
46784954|NCT00669942|83004024|FG007|Parts 2 and 3|Protocol Violation|0|||
46784955|NCT00669942|83004025|FG008|Parts 2 and 3|Protocol Violation|0|||
46784956|NCT00669942|83004026|FG009|Parts 2 and 3|Protocol Violation|0|||
46784957|NCT00669942|83004027|FG010|Parts 2 and 3|Protocol Violation|0|||
46784958|NCT00669942|83004028|FG011|Parts 2 and 3|Protocol Violation|0|||
46784959|NCT00669864|83004051|FG000|Overall Study|Lost to Follow-up|2|||
46784960|NCT00669864|83004051|FG000|Overall Study|Protocol Violation|2|||
46784961|NCT00669864|83004051|FG000|Overall Study|Withdrawal by Subject|3|||
46784962|NCT00669864|83004051|FG000|Overall Study|Other|2|||
46784963|NCT00668148|83004055|FG000|Overall Study|Adverse Event|5|||
46784964|NCT00668148|83004055|FG000|Overall Study|Subject Non-compliance|1|||
46784965|NCT00668148|83004055|FG000|Overall Study|Progressive Disease Before Treatment|2|||
46784966|NCT00668148|83004055|FG000|Overall Study|Withdrawal of Consent|2|||
46784967|NCT00667992|83004072|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
46784968|NCT00667992|83004073|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
46784969|NCT00667992|83004072|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
46784970|NCT00667992|83004073|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
46784971|NCT00667992|83004072|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
46784972|NCT00667992|83004073|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
46972467|NCT02709655|83216134|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
46667319|NCT01241318|82881910|FG001|Overall Study|Woman: false pregnancies|15|||
46784973|NCT00667992|83004072|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
46784974|NCT00667992|83004073|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
46784975|NCT00667992|83004072|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
46784976|NCT00667992|83004073|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
46784977|NCT00667992|83004072|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
46784978|NCT00667992|83004073|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
46784979|NCT00667992|83004072|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
46784980|NCT00667992|83004073|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
46784981|NCT00667992|83004072|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
46972468|NCT02709655|83216130|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
46667320|NCT01241318|82881909|FG000|Overall Study|Woman: miscarriage/abortion|46|||
46667321|NCT01241318|82881910|FG001|Overall Study|Woman: miscarriage/abortion|38|||
46667322|NCT01241318|82881909|FG000|Overall Study|Withdrawal by Subject|175|||
46667323|NCT01241318|82881910|FG001|Overall Study|Withdrawal by Subject|46|||
46667324|NCT01241318|82881909|FG000|Overall Study|Lost to Follow-up|740|||
46667325|NCT01241318|82881910|FG001|Overall Study|Lost to Follow-up|455|||
46667326|NCT01241318|82881909|FG000|Overall Study|Death|2|||
46667327|NCT01241318|82881910|FG001|Overall Study|Death|4|||
46667328|NCT01241318|82881909|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
46667329|NCT01241318|82881910|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
46667330|NCT01241318|82881909|FG000|Overall Study|Woman: Stillborn infant|129|||
46667331|NCT01241318|82881910|FG001|Overall Study|Woman: Stillborn infant|146|||
46667332|NCT01241279|82881921|FG000|Overall Study|Lost to Follow-up|0|||
46667333|NCT01241279|82881922|FG001|Overall Study|Lost to Follow-up|1|||
46667334|NCT01241240|82881930|FG000|Overall Study|Adverse Event|5|||
46667335|NCT01241240|82881931|FG001|Overall Study|Adverse Event|4|||
46667336|NCT01241240|82881930|FG000|Overall Study|Lost to Follow-up|2|||
46667337|NCT01241240|82881931|FG001|Overall Study|Lost to Follow-up|4|||
46667338|NCT01241240|82881930|FG000|Overall Study|Personal Reasons|1|||
46667339|NCT01241240|82881931|FG001|Overall Study|Personal Reasons|1|||
46667340|NCT01240811|82881940|FG000|Overall Study|Physician Decision|0|||
46667341|NCT01240811|82881941|FG001|Overall Study|Physician Decision|1|||
46667342|NCT01240811|82881942|FG002|Overall Study|Physician Decision|0|||
46667343|NCT01240811|82881940|FG000|Overall Study|Withdrawal by Subject|0|||
46667344|NCT01240811|82881941|FG001|Overall Study|Withdrawal by Subject|0|||
46667345|NCT01240811|82881942|FG002|Overall Study|Withdrawal by Subject|1|||
46667346|NCT01240382|82881954|FG000|Overall Study|Adverse Event|2|||
46667347|NCT01240382|82881955|FG001|Overall Study|Adverse Event|1|||
46667348|NCT01240382|82881954|FG000|Overall Study|Lack of Efficacy|0|||
46667349|NCT01240382|82881955|FG001|Overall Study|Lack of Efficacy|2|||
46667350|NCT01240382|82881954|FG000|Overall Study|Fear of adverse events|0|||
46667351|NCT01240382|82881955|FG001|Overall Study|Fear of adverse events|1|||
46667352|NCT01244828|82881961|FG000|Overall Study|Adverse Event|37|||
46667353|NCT01244828|82881961|FG000|Overall Study|Withdrawal by Subject|31|||
46667354|NCT01244828|82881961|FG000|Overall Study|Lack of Efficacy|7|||
46667355|NCT01244828|82881961|FG000|Overall Study|Lost to Follow-up|2|||
46667356|NCT01244828|82881961|FG000|Overall Study|Other reason (not specified)|1|||
46667357|NCT01249833|82881967|FG000|Overall Study|Lost to Follow-up|0|||
46667358|NCT01249833|82881968|FG001|Overall Study|Lost to Follow-up|1|||
46784982|NCT00667992|83004073|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
46784983|NCT00667992|83004072|FG000|Wash-out|Not within one doubling dilution|4|||
46784984|NCT00667992|83004073|FG001|Wash-out|Not within one doubling dilution|3|||
46784985|NCT00667992|83004072|FG000|Wash-out|Failure to wash-out|2|||
46784986|NCT00667992|83004073|FG001|Wash-out|Failure to wash-out|2|||
46784987|NCT00667992|83004072|FG000|Wash-out|Withdrawal by Subject|1|||
46784988|NCT00667992|83004073|FG001|Wash-out|Withdrawal by Subject|0|||
46784989|NCT00667992|83004072|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
46784990|NCT00667992|83004073|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
46784991|NCT00667992|83004072|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
46784992|NCT00667992|83004073|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
46784993|NCT00669396|83004091|FG000|Overall Study|Lost to Follow-up|10|||
46784994|NCT00669396|83004092|FG001|Overall Study|Lost to Follow-up|12|||
46784995|NCT00669318|83004098|FG000|Overall Study|Withdrawal by Subject|2|||
46667359|NCT01249404|82881977|FG000|Overall Study|Study treatment not received|0|||
46784996|NCT00669240|83004102|FG000|Overall Study|Lack of Efficacy|33|||
46784997|NCT00669240|83004102|FG000|Overall Study|Withdrawal by Subject|42|||
46784998|NCT00669240|83004102|FG000|Overall Study|Lost to Follow-up|34|||
46784999|NCT00669240|83004102|FG000|Overall Study|Adverse Event|21|||
46851356|NCT00116805|83066998|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
46851357|NCT00116805|83066997|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
46851358|NCT00116805|83066998|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
46851359|NCT00116805|83066997|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
46851360|NCT00116805|83066998|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
46851361|NCT00116805|83066997|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
47077013|NCT01492088|83375068|FG002|Overall Study|Death|2|||
47077014|NCT01492088|83375066|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
47077015|NCT01492088|83375067|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
46667360|NCT01249404|82881978|FG001|Overall Study|Study treatment not received|1|||
46667361|NCT01249404|82881979|FG002|Overall Study|Study treatment not received|2|||
46667362|NCT01249404|82881977|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
46667363|NCT01249404|82881978|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
46667364|NCT01249404|82881979|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
46667365|NCT01249404|82881977|FG000|Overall Study|Adverse Event|2|||
46667366|NCT01249404|82881978|FG001|Overall Study|Adverse Event|2|||
46785000|NCT00669240|83004102|FG000|Overall Study|Other|19|||
46785001|NCT00669240|83004102|FG000|Overall Study|Enrolled but not treated|15|||
46785002|NCT00669240|83004102|FG000|Overall Study|Enrolled but no dosing record|1|||
46785003|NCT00669162|83004106|FG000|Overall Study|Withdrawal by Subject|1|||
46785004|NCT00666588|83004123|FG000|Overall Study|ineligible|2|||
46785005|NCT00666588|83004124|FG001|Overall Study|ineligible|0|||
46785006|NCT00666588|83004125|FG002|Overall Study|ineligible|0|||
46785007|NCT00666588|83004126|FG003|Overall Study|ineligible|2|||
46785008|NCT00666588|83004123|FG000|Overall Study|inevaluable|2|||
46785009|NCT00666588|83004124|FG001|Overall Study|inevaluable|0|||
46785010|NCT00666588|83004125|FG002|Overall Study|inevaluable|0|||
46785011|NCT00666588|83004126|FG003|Overall Study|inevaluable|0|||
46785012|NCT00689390|83004138|FG000|Overall Study|Adverse Event|19|||
46785013|NCT00689390|83004139|FG001|Overall Study|Adverse Event|0|||
46785014|NCT00689390|83004138|FG000|Overall Study|Lost to Follow-up|179|||
46785015|NCT00689390|83004139|FG001|Overall Study|Lost to Follow-up|7|||
46785016|NCT00689390|83004138|FG000|Overall Study|Withdrawal by Subject|117|||
46785017|NCT00689390|83004139|FG001|Overall Study|Withdrawal by Subject|3|||
46785018|NCT00689390|83004138|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
46785019|NCT00689390|83004139|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
46785020|NCT00689390|83004138|FG000|Overall Study|Non-Compliance With Protocol|21|||
46785021|NCT00689390|83004139|FG001|Overall Study|Non-Compliance With Protocol|0|||
46785022|NCT00689390|83004138|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
46785023|NCT00689390|83004139|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
46785024|NCT00689390|83004138|FG000|Overall Study|Administrative|37|||
46785025|NCT00689390|83004139|FG001|Overall Study|Administrative|0|||
46785026|NCT00567879|83004156|FG000|Overall Study|Adverse Event|2|||
46785027|NCT00567879|83004157|FG001|Overall Study|Adverse Event|0|||
46785028|NCT00567879|83004158|FG002|Overall Study|Adverse Event|1|||
46785029|NCT00567879|83004159|FG003|Overall Study|Adverse Event|0|||
46785030|NCT00567879|83004160|FG004|Overall Study|Adverse Event|1|||
46785031|NCT00567879|83004161|FG005|Overall Study|Adverse Event|0|||
46785032|NCT00567879|83004156|FG000|Overall Study|Abnormal test procedure(s)|0|||
46785033|NCT00567879|83004157|FG001|Overall Study|Abnormal test procedure(s)|0|||
46785034|NCT00567879|83004158|FG002|Overall Study|Abnormal test procedure(s)|1|||
46785035|NCT00567879|83004159|FG003|Overall Study|Abnormal test procedure(s)|0|||
46785036|NCT00567879|83004160|FG004|Overall Study|Abnormal test procedure(s)|0|||
46785037|NCT00567879|83004161|FG005|Overall Study|Abnormal test procedure(s)|0|||
46785038|NCT00567879|83004156|FG000|Overall Study|Withdrawal by Subject|0|||
46785039|NCT00567879|83004157|FG001|Overall Study|Withdrawal by Subject|0|||
46785040|NCT00567879|83004158|FG002|Overall Study|Withdrawal by Subject|3|||
46785041|NCT00567879|83004159|FG003|Overall Study|Withdrawal by Subject|1|||
46785042|NCT00567879|83004160|FG004|Overall Study|Withdrawal by Subject|0|||
46785043|NCT00567879|83004161|FG005|Overall Study|Withdrawal by Subject|0|||
46785044|NCT00567879|83004156|FG000|Overall Study|New cancer therapy|0|||
46785045|NCT00567879|83004157|FG001|Overall Study|New cancer therapy|0|||
46785046|NCT00567879|83004158|FG002|Overall Study|New cancer therapy|1|||
46785047|NCT00567879|83004159|FG003|Overall Study|New cancer therapy|0|||
46785048|NCT00567879|83004160|FG004|Overall Study|New cancer therapy|0|||
46785049|NCT00567879|83004161|FG005|Overall Study|New cancer therapy|0|||
46851362|NCT00116805|83066998|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
46851363|NCT00116805|83066997|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
46851364|NCT00116805|83066998|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
46851365|NCT00116805|83066997|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
46851366|NCT00116805|83066998|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
46851367|NCT00116805|83066997|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
46851368|NCT00116805|83066998|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
46851369|NCT00116805|83066997|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
46851370|NCT00116805|83066998|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
46851371|NCT00116805|83066997|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
46972469|NCT02709655|83216131|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
46972470|NCT02709655|83216132|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
46972471|NCT02709655|83216133|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
46972472|NCT02709655|83216134|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
46972473|NCT02709655|83216130|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
46972474|NCT02709655|83216131|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
46972475|NCT02709655|83216132|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
46667367|NCT01249404|82881979|FG002|Overall Study|Adverse Event|2|||
46667368|NCT01249404|82881977|FG000|Overall Study|Withdrawal by Subject|2|||
46667369|NCT01249404|82881978|FG001|Overall Study|Withdrawal by Subject|2|||
46667370|NCT01249404|82881979|FG002|Overall Study|Withdrawal by Subject|0|||
46785050|NCT00567879|83004156|FG000|Overall Study|Disease progression|5|||
46785051|NCT00567879|83004157|FG001|Overall Study|Disease progression|7|||
46785052|NCT00567879|83004158|FG002|Overall Study|Disease progression|15|||
46785053|NCT00567879|83004159|FG003|Overall Study|Disease progression|5|||
46785054|NCT00567879|83004160|FG004|Overall Study|Disease progression|11|||
46785055|NCT00567879|83004161|FG005|Overall Study|Disease progression|3|||
46785056|NCT00603915|83004179|FG000|Overall Study|Physician Decision|1|||
46972476|NCT02709655|83216133|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
46972477|NCT02709655|83216134|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
46972478|NCT02709655|83216130|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
46972479|NCT02709655|83216131|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
46972480|NCT02709655|83216132|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
46972481|NCT02709655|83216133|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
46667371|NCT01249404|82881977|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
46667372|NCT01249404|82881978|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
46667373|NCT01249404|82881979|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
46667374|NCT01249404|82881977|FG000|Overall Study|Non compliance to visit schedule|0|||
46667375|NCT01249404|82881978|FG001|Overall Study|Non compliance to visit schedule|1|||
46667376|NCT01249404|82881979|FG002|Overall Study|Non compliance to visit schedule|0|||
46667377|NCT01249365|82881987|FG000|Overall Study|Lost to Follow-up|1|||
46667378|NCT01249131|82881991|FG000|Washout Period of 10 Days|Adverse Event|0|||
46667379|NCT01249131|82881992|FG001|Washout Period of 10 Days|Adverse Event|0|||
46667380|NCT01249131|82881993|FG002|Washout Period of 10 Days|Adverse Event|0|||
46667381|NCT01249131|82881994|FG003|Washout Period of 10 Days|Adverse Event|0|||
46667382|NCT01249131|82881995|FG004|Washout Period of 10 Days|Adverse Event|1|||
46667383|NCT01249131|82881996|FG005|Washout Period of 10 Days|Adverse Event|0|||
46667384|NCT01249092|82882004|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
46667385|NCT01249092|82882004|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
46667386|NCT01248936|82882010|FG000|Overall Study|Sponsor Decision|259|||
46667387|NCT01248936|82882010|FG000|Overall Study|Progression of Disease|50|||
46667388|NCT01248936|82882010|FG000|Overall Study|Death|26|||
46667389|NCT01248936|82882010|FG000|Overall Study|Withdrawal of Consent|20|||
46667390|NCT01248936|82882010|FG000|Overall Study|Adverse Event|8|||
46667391|NCT01248936|82882010|FG000|Overall Study|Lost to Follow-up|7|||
46667392|NCT01248936|82882010|FG000|Overall Study|Refused Treatment|1|||
46667393|NCT01248936|82882010|FG000|Overall Study|Other reason|3|||
46667394|NCT01248780|82882017|FG000|Overall Study|Lack of Efficacy|2|||
46667395|NCT01248780|82882018|FG001|Overall Study|Lack of Efficacy|0|||
46667396|NCT01248780|82882017|FG000|Overall Study|Lost to Follow-up|0|||
46667397|NCT01248780|82882018|FG001|Overall Study|Lost to Follow-up|1|||
46667398|NCT01248780|82882017|FG000|Overall Study|Death|0|||
46667399|NCT01248780|82882018|FG001|Overall Study|Death|1|||
46667400|NCT01248780|82882017|FG000|Overall Study|Adverse Event|2|||
46667401|NCT01248780|82882018|FG001|Overall Study|Adverse Event|7|||
46667402|NCT01248780|82882017|FG000|Overall Study|Protocol Violation|1|||
46667403|NCT01248780|82882018|FG001|Overall Study|Protocol Violation|1|||
46667404|NCT01248780|82882017|FG000|Overall Study|Withdrawal by Subject|4|||
46667405|NCT01248780|82882018|FG001|Overall Study|Withdrawal by Subject|4|||
46667406|NCT01248780|82882017|FG000|Overall Study|Not treated|0|||
46667407|NCT01248780|82882018|FG001|Overall Study|Not treated|1|||
46667408|NCT01248468|82882027|FG000|Overall Study|Administrative problem|1|||
46667409|NCT01248468|82882028|FG001|Overall Study|Administrative problem|0|||
46667410|NCT01248468|82882029|FG002|Overall Study|Administrative problem|0|||
46667411|NCT01248468|82882027|FG000|Overall Study|Lost to Follow-up|9|||
46785057|NCT00603837|83004185|FG000|Overall Study|Physician Decision|3|||
46785058|NCT00603837|83004186|FG001|Overall Study|Physician Decision|0|||
46785059|NCT00667602|83004195|FG000|Overall Study|Withdrawal by Subject|4|||
46785060|NCT00667602|83004196|FG001|Overall Study|Withdrawal by Subject|9|||
46785061|NCT00667602|83004197|FG002|Overall Study|Withdrawal by Subject|10|||
46785062|NCT00667602|83004195|FG000|Overall Study|Lost to Follow-up|4|||
46785063|NCT00667602|83004196|FG001|Overall Study|Lost to Follow-up|5|||
46785064|NCT00667602|83004197|FG002|Overall Study|Lost to Follow-up|6|||
46785065|NCT00667602|83004195|FG000|Overall Study|Administrative reason|0|||
46785066|NCT00667602|83004196|FG001|Overall Study|Administrative reason|0|||
46785067|NCT00667602|83004197|FG002|Overall Study|Administrative reason|2|||
46785068|NCT00667602|83004195|FG000|Overall Study|Protocol Violation|0|||
46972482|NCT02709655|83216134|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
46972483|NCT02708485|83216148|FG000|Overall Study|Withdrawal by Subject|3|||
46667412|NCT01248468|82882028|FG001|Overall Study|Lost to Follow-up|12|||
46667413|NCT01248468|82882029|FG002|Overall Study|Lost to Follow-up|4|||
46667414|NCT01248468|82882027|FG000|Overall Study|Pregnancy|1|||
46667415|NCT01248468|82882028|FG001|Overall Study|Pregnancy|0|||
46667416|NCT01248468|82882029|FG002|Overall Study|Pregnancy|0|||
46667417|NCT01248468|82882027|FG000|Overall Study|Withdrawal by Subject|4|||
46667418|NCT01248468|82882028|FG001|Overall Study|Withdrawal by Subject|2|||
46667419|NCT01248468|82882029|FG002|Overall Study|Withdrawal by Subject|0|||
46667420|NCT01247922|82882037|FG000|Overall Study|Disease progression|4|||
46667421|NCT01246206|82882041|FG000|Overall Study|Patient did not receive study regiments.|1|||
46667422|NCT01246011|82882048|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
46667423|NCT01246011|82882049|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
46667424|NCT01246011|82882050|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
46667425|NCT01246011|82882048|FG000|Overall Study|Withdrawal by Subject|0|||
46785069|NCT00667602|83004196|FG001|Overall Study|Protocol Violation|1|||
46667426|NCT01246011|82882049|FG001|Overall Study|Withdrawal by Subject|0|||
46667427|NCT01246011|82882050|FG002|Overall Study|Withdrawal by Subject|1|||
46667428|NCT01244490|82882062|FG000|Overall Study|Lack of Efficacy|14|||
46667429|NCT01244490|82882063|FG001|Overall Study|Lack of Efficacy|5|||
46667430|NCT01244490|82882064|FG002|Overall Study|Lack of Efficacy|5|||
46667431|NCT01244490|82882062|FG000|Overall Study|Withdrawal by Subject|4|||
46667432|NCT01244490|82882063|FG001|Overall Study|Withdrawal by Subject|4|||
46667433|NCT01244490|82882064|FG002|Overall Study|Withdrawal by Subject|9|||
46667434|NCT01244490|82882062|FG000|Overall Study|Adverse Event|1|||
46667435|NCT01244490|82882063|FG001|Overall Study|Adverse Event|9|||
47077016|NCT01492088|83375068|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
46667436|NCT01244490|82882064|FG002|Overall Study|Adverse Event|5|||
46667437|NCT01244490|82882062|FG000|Overall Study|Lost to Follow-up|0|||
46667438|NCT01244490|82882063|FG001|Overall Study|Lost to Follow-up|6|||
46667439|NCT01244490|82882064|FG002|Overall Study|Lost to Follow-up|3|||
46667440|NCT01244490|82882062|FG000|Overall Study|Other|0|||
46667441|NCT01244490|82882063|FG001|Overall Study|Other|0|||
46667442|NCT01244490|82882064|FG002|Overall Study|Other|1|||
46667443|NCT01243944|82882074|FG000|Overall Study|Adverse Event|15|||
46667444|NCT01243944|82882075|FG001|Overall Study|Adverse Event|13|||
46667445|NCT01243944|82882074|FG000|Overall Study|Lost to Follow-up|2|||
46667446|NCT01243944|82882075|FG001|Overall Study|Lost to Follow-up|1|||
46667447|NCT01243944|82882074|FG000|Overall Study|Physician Decision|2|||
46667448|NCT01243944|82882075|FG001|Overall Study|Physician Decision|7|||
46667449|NCT01243944|82882074|FG000|Overall Study|Disease progression|12|||
46667450|NCT01243944|82882075|FG001|Overall Study|Disease progression|11|||
46667451|NCT01243944|82882074|FG000|Overall Study|Protocol deviation|1|||
46667452|NCT01243944|82882075|FG001|Overall Study|Protocol deviation|1|||
46667453|NCT01243944|82882074|FG000|Overall Study|Participant decision|10|||
46667454|NCT01243944|82882075|FG001|Overall Study|Participant decision|15|||
46667455|NCT01243944|82882074|FG000|Overall Study|Death|2|||
46667456|NCT01243944|82882075|FG001|Overall Study|Death|3|||
46667457|NCT01243944|82882074|FG000|Overall Study|Non-compliance with study treatment|1|||
46667458|NCT01243944|82882075|FG001|Overall Study|Non-compliance with study treatment|0|||
46667459|NCT01243242|82882084|FG000|Overall Study|Adverse Event|1|||
46667460|NCT01243242|82882085|FG001|Overall Study|Adverse Event|1|||
46667461|NCT01243242|82882084|FG000|Overall Study|Withdrawal by Subject|1|||
46667462|NCT01243242|82882085|FG001|Overall Study|Withdrawal by Subject|1|||
46667463|NCT01243242|82882084|FG000|Overall Study|Physician Decision|0|||
46667464|NCT01243242|82882085|FG001|Overall Study|Physician Decision|1|||
46667465|NCT01243242|82882084|FG000|Overall Study|sponsor decision|0|||
46667466|NCT01243242|82882085|FG001|Overall Study|sponsor decision|1|||
46667467|NCT01243242|82882084|FG000|Overall Study|non compliance|1|||
46667468|NCT01243242|82882085|FG001|Overall Study|non compliance|0|||
46667469|NCT01242813|82882091|FG000|Overall Study|Lost to Follow-up|2|||
46667470|NCT01242111|82882095|FG000|Overall Study|Adverse Event|1|||
46667471|NCT01242111|82882095|FG000|Overall Study|Withdrawal by Subject|1|||
46667472|NCT01242111|82882095|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
46667473|NCT01241604|82882099|FG000|Screening Period|Screen Failure|3|||
46667474|NCT01241604|82882100|FG001|Screening Period|Screen Failure|0|||
46667475|NCT01241604|82882101|FG002|Screening Period|Screen Failure|0|||
46667476|NCT01241292|82882110|FG000|Overall Study|Administrative Reason by Sponsor|1|||
46667477|NCT01241292|82882111|FG001|Overall Study|Administrative Reason by Sponsor|0|||
46667478|NCT01241292|82882110|FG000|Overall Study|Disease Progression|2|||
46667479|NCT01241292|82882111|FG001|Overall Study|Disease Progression|0|||
46667480|NCT01241292|82882110|FG000|Overall Study|Study Drug Toxicity|0|||
46667481|NCT01241292|82882111|FG001|Overall Study|Study Drug Toxicity|1|||
46667482|NCT01241292|82882110|FG000|Overall Study|Participant Discontinued Treatment|0|||
46667483|NCT01241292|82882111|FG001|Overall Study|Participant Discontinued Treatment|2|||
46667484|NCT01240863|82882123|FG000|Open-label Titration Period|Adverse Event|47|||
46667485|NCT01240863|82882124|FG001|Open-label Titration Period|Adverse Event|0|||
46785070|NCT00667602|83004197|FG002|Overall Study|Protocol Violation|0|||
46785071|NCT00691028|83004213|FG000|Open-label Period|Adverse Event|0|||
46785072|NCT00691028|83004214|FG001|Open-label Period|Adverse Event|0|||
46785073|NCT00691028|83004215|FG002|Open-label Period|Adverse Event|0|||
46785074|NCT00691028|83004216|FG003|Open-label Period|Adverse Event|16|||
46785075|NCT00691028|83004213|FG000|Open-label Period|Withdrawal by Subject|0|||
46785076|NCT00691028|83004214|FG001|Open-label Period|Withdrawal by Subject|0|||
46667486|NCT01240863|82882125|FG002|Open-label Titration Period|Adverse Event|0|||
46667487|NCT01240863|82882123|FG000|Open-label Titration Period|Lack of Efficacy|19|||
46785077|NCT00691028|83004215|FG002|Open-label Period|Withdrawal by Subject|0|||
46667488|NCT01240863|82882124|FG001|Open-label Titration Period|Lack of Efficacy|0|||
46785078|NCT00691028|83004216|FG003|Open-label Period|Withdrawal by Subject|3|||
46785079|NCT00691028|83004213|FG000|Open-label Period|not come to a hospital|0|||
46667489|NCT01240863|82882125|FG002|Open-label Titration Period|Lack of Efficacy|0|||
46667490|NCT01240863|82882123|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
47077017|NCT01492088|83375066|FG000|Overall Study|Alive at Last Follow-up|0|||
46785080|NCT00691028|83004214|FG001|Open-label Period|not come to a hospital|0|||
46667491|NCT01240863|82882124|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
46667492|NCT01240863|82882125|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
46667493|NCT01240863|82882123|FG000|Open-label Titration Period|Protocol Violation|7|||
46667494|NCT01240863|82882124|FG001|Open-label Titration Period|Protocol Violation|0|||
46667495|NCT01240863|82882125|FG002|Open-label Titration Period|Protocol Violation|0|||
46667496|NCT01240863|82882123|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
46667497|NCT01240863|82882124|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
46667498|NCT01240863|82882125|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
46667499|NCT01240863|82882123|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
46667500|NCT01240863|82882124|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
46667501|NCT01240863|82882125|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
46667502|NCT01240863|82882123|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
46667503|NCT01240863|82882124|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
46667504|NCT01240863|82882125|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
46667505|NCT01240863|82882123|FG000|Open-label Titration Period|Other|7|||
46667506|NCT01240863|82882124|FG001|Open-label Titration Period|Other|0|||
46667507|NCT01240863|82882125|FG002|Open-label Titration Period|Other|0|||
46667508|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
46667509|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
46667510|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
46667511|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
46667512|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
46667513|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
46667514|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
46667515|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
46667516|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
46667517|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
46667518|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
46667519|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
46667520|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
46667521|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
46667522|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
46667523|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
46667524|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
46667525|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
46667526|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
46667527|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
46667528|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
46667529|NCT01240863|82882123|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
46667530|NCT01240863|82882124|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
46667531|NCT01240863|82882125|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
46667532|NCT01240746|82882140|FG000|Overall Study|Adverse Event|2|||
46667533|NCT01240746|82882141|FG001|Overall Study|Adverse Event|0|||
46667534|NCT01240746|82882142|FG002|Overall Study|Adverse Event|10|||
46667535|NCT01240746|82882140|FG000|Overall Study|Lost to Follow-up|23|||
46667536|NCT01240746|82882141|FG001|Overall Study|Lost to Follow-up|20|||
46667537|NCT01240746|82882142|FG002|Overall Study|Lost to Follow-up|102|||
46667538|NCT01240746|82882140|FG000|Overall Study|Protocol Violation|24|||
46667539|NCT01240746|82882141|FG001|Overall Study|Protocol Violation|15|||
46667540|NCT01240746|82882142|FG002|Overall Study|Protocol Violation|72|||
46667541|NCT01240746|82882140|FG000|Overall Study|Withdrawal by Subject|10|||
46667542|NCT01240746|82882141|FG001|Overall Study|Withdrawal by Subject|13|||
46667543|NCT01240746|82882142|FG002|Overall Study|Withdrawal by Subject|59|||
46667544|NCT01240590|82882155|FG000|Phase I|Refused further treatment|0|||
46667545|NCT01240590|82882156|FG001|Phase I|Refused further treatment|0|||
46667546|NCT01240590|82882157|FG002|Phase I|Refused further treatment|3|||
46667547|NCT01240590|82882158|FG003|Phase I|Refused further treatment|0|||
46667548|NCT01240590|82882159|FG004|Phase I|Refused further treatment|0|||
46667549|NCT01240590|82882155|FG000|Phase II|Refused further treatment|0|||
46667550|NCT01240590|82882156|FG001|Phase II|Refused further treatment|0|||
46667551|NCT01240590|82882157|FG002|Phase II|Refused further treatment|0|||
46667552|NCT01240590|82882158|FG003|Phase II|Refused further treatment|2|||
46667553|NCT01240590|82882159|FG004|Phase II|Refused further treatment|1|||
46972484|NCT02708485|83216149|FG001|Overall Study|Withdrawal by Subject|2|||
46972485|NCT02709577|83216161|FG000|Overall Study|non-accommodating anatomy|0|||
46972486|NCT02709577|83216162|FG001|Overall Study|non-accommodating anatomy|1|||
46972487|NCT02709577|83216163|FG002|Overall Study|non-accommodating anatomy|0|||
46972488|NCT02709577|83216164|FG003|Overall Study|non-accommodating anatomy|0|||
46667554|NCT01240200|82882187|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
46667555|NCT01240200|82882188|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
46667556|NCT01356966|82882199|FG000|Overall Study|Withdrawal by Subject|1|||
46667557|NCT01356966|82882200|FG001|Overall Study|Withdrawal by Subject|2|||
46667558|NCT01356966|82882199|FG000|Overall Study|Physician Decision|1|||
46667559|NCT01356966|82882200|FG001|Overall Study|Physician Decision|0|||
46667560|NCT05289271|82882238|FG000|Overall Study|Mistakenly allocated, untreated|1|||
46667561|NCT05289271|82882239|FG001|Overall Study|Mistakenly allocated, untreated|0|||
46667562|NCT05080660|82882280|FG000|Overall Study|Adverse Event|4|||
46667563|NCT05080660|82882281|FG001|Overall Study|Adverse Event|0|||
46667564|NCT05080660|82882280|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
46667565|NCT05080660|82882281|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
46667566|NCT05080660|82882280|FG000|Overall Study|Physician Decision|1|||
46667567|NCT05080660|82882281|FG001|Overall Study|Physician Decision|0|||
46667568|NCT05080660|82882280|FG000|Overall Study|Protocol Deviation|2|||
46667569|NCT05080660|82882281|FG001|Overall Study|Protocol Deviation|0|||
46667570|NCT05080660|82882280|FG000|Overall Study|Withdrawal by Subject|5|||
46667571|NCT05080660|82882281|FG001|Overall Study|Withdrawal by Subject|2|||
46667572|NCT05005312|82882289|FG000|Overall Study|Enrolled, but not treated|0|||
46667573|NCT05005312|82882290|FG001|Overall Study|Enrolled, but not treated|1|||
46667574|NCT04867902|82882305|FG000|Overall Study|Lost to Follow-up|1|||
46667575|NCT04867902|82882305|FG000|Overall Study|Withdrawal by Subject|2|||
46667576|NCT04867902|82882305|FG000|Overall Study|Protocol Violation|1|||
46667577|NCT04677179|82882312|FG000|Induction Treatment Period|Adverse Event|1|||
46667578|NCT04677179|82882313|FG001|Induction Treatment Period|Adverse Event|0|||
46667579|NCT04677179|82882314|FG002|Induction Treatment Period|Adverse Event|0|||
46667580|NCT04677179|82882315|FG003|Induction Treatment Period|Adverse Event|0|||
46667581|NCT04677179|82882316|FG004|Induction Treatment Period|Adverse Event|0|||
46667582|NCT04677179|82882317|FG005|Induction Treatment Period|Adverse Event|0|||
46667583|NCT04677179|82882318|FG006|Induction Treatment Period|Adverse Event|0|||
46667584|NCT04677179|82882319|FG007|Induction Treatment Period|Adverse Event|0|||
46667585|NCT04677179|82882320|FG008|Induction Treatment Period|Adverse Event|0|||
46667586|NCT04677179|82882321|FG009|Induction Treatment Period|Adverse Event|0|||
46667587|NCT04677179|82882312|FG000|Induction Treatment Period|Physician Decision|1|||
46667588|NCT04677179|82882313|FG001|Induction Treatment Period|Physician Decision|0|||
46667589|NCT04677179|82882314|FG002|Induction Treatment Period|Physician Decision|1|||
46667590|NCT04677179|82882315|FG003|Induction Treatment Period|Physician Decision|0|||
46667591|NCT04677179|82882316|FG004|Induction Treatment Period|Physician Decision|0|||
46667592|NCT04677179|82882317|FG005|Induction Treatment Period|Physician Decision|0|||
46667593|NCT04677179|82882318|FG006|Induction Treatment Period|Physician Decision|0|||
46667594|NCT04677179|82882319|FG007|Induction Treatment Period|Physician Decision|0|||
46667595|NCT04677179|82882320|FG008|Induction Treatment Period|Physician Decision|0|||
46667596|NCT04677179|82882321|FG009|Induction Treatment Period|Physician Decision|0|||
46667597|NCT04677179|82882312|FG000|Induction Treatment Period|Protocol Violation|0|||
46667598|NCT04677179|82882313|FG001|Induction Treatment Period|Protocol Violation|1|||
46667599|NCT04677179|82882314|FG002|Induction Treatment Period|Protocol Violation|0|||
46972489|NCT02709577|83216161|FG000|Overall Study|procedural complication|0|||
46972490|NCT02709577|83216162|FG001|Overall Study|procedural complication|1|||
46972491|NCT02709577|83216163|FG002|Overall Study|procedural complication|0|||
46972492|NCT02709577|83216164|FG003|Overall Study|procedural complication|0|||
46972493|NCT02709577|83216161|FG000|Overall Study|Withdrawal by Subject|2|||
46972494|NCT02709577|83216162|FG001|Overall Study|Withdrawal by Subject|3|||
46972495|NCT02709577|83216163|FG002|Overall Study|Withdrawal by Subject|2|||
47077018|NCT01492088|83375067|FG001|Overall Study|Alive at Last Follow-up|6|||
47077019|NCT01492088|83375068|FG002|Overall Study|Alive at Last Follow-up|11|||
47077020|NCT02592798|83375310|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
47077021|NCT02592798|83375311|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
47077022|NCT02592798|83375310|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
47077023|NCT02592798|83375311|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
47077024|NCT02592798|83375310|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
47077025|NCT02592798|83375311|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
47077026|NCT02592798|83375310|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
47077027|NCT02592798|83375311|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
47077028|NCT02592798|83375310|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
47077029|NCT02592798|83375311|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
46667600|NCT04677179|82882315|FG003|Induction Treatment Period|Protocol Violation|0|||
46667601|NCT04677179|82882316|FG004|Induction Treatment Period|Protocol Violation|0|||
46667602|NCT04677179|82882317|FG005|Induction Treatment Period|Protocol Violation|0|||
46667603|NCT04677179|82882318|FG006|Induction Treatment Period|Protocol Violation|0|||
46667604|NCT04677179|82882319|FG007|Induction Treatment Period|Protocol Violation|0|||
46667605|NCT04677179|82882320|FG008|Induction Treatment Period|Protocol Violation|0|||
46972496|NCT02709577|83216164|FG003|Overall Study|Withdrawal by Subject|0|||
46667606|NCT04677179|82882321|FG009|Induction Treatment Period|Protocol Violation|0|||
46667607|NCT04677179|82882312|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
46667608|NCT04677179|82882313|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
46667609|NCT04677179|82882314|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
46667610|NCT04677179|82882315|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
46667611|NCT04677179|82882316|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
46667612|NCT04677179|82882317|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
46667613|NCT04677179|82882318|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
46667614|NCT04677179|82882319|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
46667615|NCT04677179|82882320|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
46667616|NCT04677179|82882321|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
46667617|NCT04677179|82882312|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
46667618|NCT04677179|82882313|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
46667619|NCT04677179|82882314|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
46667620|NCT04677179|82882315|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
46667621|NCT04677179|82882316|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
46667622|NCT04677179|82882317|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
46667623|NCT04677179|82882318|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
46667624|NCT04677179|82882319|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
46667625|NCT04677179|82882320|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
46667626|NCT04677179|82882321|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
46667627|NCT04677179|82882312|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
46667628|NCT04677179|82882313|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
46667629|NCT04677179|82882314|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
46667630|NCT04677179|82882315|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
46667631|NCT04677179|82882316|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
46667632|NCT04677179|82882317|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
46667633|NCT04677179|82882318|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
46667634|NCT04677179|82882319|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
46667635|NCT04677179|82882320|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
46667636|NCT04677179|82882321|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
46667637|NCT04677179|82882312|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667638|NCT04677179|82882313|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667639|NCT04677179|82882314|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667640|NCT04677179|82882315|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
46667641|NCT04677179|82882316|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667642|NCT04677179|82882317|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667643|NCT04677179|82882318|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667644|NCT04677179|82882319|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667645|NCT04677179|82882320|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667646|NCT04677179|82882321|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
46667647|NCT04677179|82882312|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
46667648|NCT04677179|82882313|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
46667649|NCT04677179|82882314|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
46667650|NCT04677179|82882315|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
46667651|NCT04677179|82882316|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
46667652|NCT04677179|82882317|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
46667653|NCT04677179|82882318|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
46667654|NCT04677179|82882319|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
46667655|NCT04677179|82882320|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
46667656|NCT04677179|82882321|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
46667657|NCT04677179|82882312|FG000|Extension Treatment Period|Lack of Efficacy|0|||
46785081|NCT00691028|83004215|FG002|Open-label Period|not come to a hospital|0|||
46785082|NCT00691028|83004216|FG003|Open-label Period|not come to a hospital|1|||
46785083|NCT00691028|83004213|FG000|Double-blind Period|Adverse Event|8|||
46785084|NCT00691028|83004214|FG001|Double-blind Period|Adverse Event|9|||
46785085|NCT00691028|83004215|FG002|Double-blind Period|Adverse Event|6|||
46785086|NCT00691028|83004216|FG003|Double-blind Period|Adverse Event|0|||
46785087|NCT00691028|83004213|FG000|Double-blind Period|Lack of Efficacy|4|||
46785088|NCT00691028|83004214|FG001|Double-blind Period|Lack of Efficacy|3|||
46785089|NCT00691028|83004215|FG002|Double-blind Period|Lack of Efficacy|2|||
46785090|NCT00691028|83004216|FG003|Double-blind Period|Lack of Efficacy|0|||
46972497|NCT02078752|83216185|FG000|Overall Study|Death|0|||
46972498|NCT02078752|83216186|FG001|Overall Study|Death|3|||
46667658|NCT04677179|82882313|FG001|Extension Treatment Period|Lack of Efficacy|0|||
46785091|NCT00691028|83004213|FG000|Double-blind Period|Withdrawal by Subject|1|||
46785092|NCT00691028|83004214|FG001|Double-blind Period|Withdrawal by Subject|0|||
46785093|NCT00691028|83004215|FG002|Double-blind Period|Withdrawal by Subject|1|||
46972499|NCT02078752|83216187|FG002|Overall Study|Death|0|||
46667659|NCT04677179|82882314|FG002|Extension Treatment Period|Lack of Efficacy|0|||
46667660|NCT04677179|82882315|FG003|Extension Treatment Period|Lack of Efficacy|0|||
46667661|NCT04677179|82882316|FG004|Extension Treatment Period|Lack of Efficacy|0|||
46667662|NCT04677179|82882317|FG005|Extension Treatment Period|Lack of Efficacy|0|||
46667663|NCT04677179|82882318|FG006|Extension Treatment Period|Lack of Efficacy|6|||
46667664|NCT04677179|82882319|FG007|Extension Treatment Period|Lack of Efficacy|0|||
46667665|NCT04677179|82882320|FG008|Extension Treatment Period|Lack of Efficacy|0|||
46667666|NCT04677179|82882321|FG009|Extension Treatment Period|Lack of Efficacy|0|||
46667667|NCT04677179|82882312|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
46667668|NCT04677179|82882313|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
46667669|NCT04677179|82882314|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
46667670|NCT04677179|82882315|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
46667671|NCT04677179|82882316|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
46667672|NCT04677179|82882317|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
46667673|NCT04677179|82882318|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
46667674|NCT04677179|82882319|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
46667675|NCT04677179|82882320|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
46667676|NCT04677179|82882321|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
46667677|NCT04677179|82882312|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
46667678|NCT04677179|82882313|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
46667679|NCT04677179|82882314|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
46667680|NCT04677179|82882315|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
46667681|NCT04677179|82882316|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
46667682|NCT04677179|82882317|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
46667683|NCT04677179|82882318|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
46667684|NCT04677179|82882319|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
46667685|NCT04677179|82882320|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
46667686|NCT04677179|82882321|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
46667687|NCT04677179|82882312|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
46667688|NCT04677179|82882313|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
46667689|NCT04677179|82882314|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
46667690|NCT04677179|82882315|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
46667691|NCT04677179|82882316|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
46667692|NCT04677179|82882317|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
46667693|NCT04677179|82882318|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
46667694|NCT04677179|82882319|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
46667695|NCT04677179|82882320|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
46667696|NCT04677179|82882321|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
46667697|NCT04677179|82882312|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
46667698|NCT04677179|82882313|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
46785094|NCT00691028|83004216|FG003|Double-blind Period|Withdrawal by Subject|0|||
46785095|NCT00691028|83004213|FG000|Double-blind Period|not come to a hospital.|0|||
46785096|NCT00691028|83004214|FG001|Double-blind Period|not come to a hospital.|1|||
46785097|NCT00691028|83004215|FG002|Double-blind Period|not come to a hospital.|0|||
46785098|NCT00691028|83004216|FG003|Double-blind Period|not come to a hospital.|0|||
46785099|NCT00690794|83004230|FG000|Overall Study|Adverse Event|12|||
46785100|NCT00690794|83004231|FG001|Overall Study|Adverse Event|10|||
46785101|NCT00690794|83004230|FG000|Overall Study|Lost to Follow-up|1|||
46785102|NCT00690794|83004231|FG001|Overall Study|Lost to Follow-up|4|||
46785103|NCT00690794|83004230|FG000|Overall Study|Withdrawal by Subject|0|||
46785104|NCT00690794|83004231|FG001|Overall Study|Withdrawal by Subject|9|||
46972500|NCT02078752|83216188|FG003|Overall Study|Death|0|||
46972501|NCT02078752|83216189|FG004|Overall Study|Death|0|||
46667699|NCT04677179|82882314|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
46667700|NCT04677179|82882315|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
46667701|NCT04677179|82882316|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
47077030|NCT02592798|83375310|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
47077031|NCT02592798|83375311|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
47077032|NCT02592798|83375310|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
46667702|NCT04677179|82882317|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
46667703|NCT04677179|82882318|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
46667704|NCT04677179|82882319|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
46785105|NCT00690794|83004230|FG000|Overall Study|Protocol Violation|6|||
46785106|NCT00690794|83004231|FG001|Overall Study|Protocol Violation|7|||
46972502|NCT02078752|83216190|FG005|Overall Study|Death|1|||
46667705|NCT04677179|82882320|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
46667706|NCT04677179|82882321|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
46667707|NCT04677179|82882312|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667708|NCT04677179|82882313|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667709|NCT04677179|82882314|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667710|NCT04677179|82882315|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46785107|NCT00690794|83004230|FG000|Overall Study|Noncompliance|1|||
46785108|NCT00690794|83004231|FG001|Overall Study|Noncompliance|2|||
46785109|NCT00690794|83004230|FG000|Overall Study|Other not specified|1|||
46785110|NCT00690794|83004231|FG001|Overall Study|Other not specified|3|||
46785111|NCT00666276|83004237|FG000|Overall Study|Protocol Violation|34|||
46785112|NCT00567255|83004262|FG000|Overall Study|Adverse Event|241|||
46785113|NCT00567255|83004263|FG001|Overall Study|Adverse Event|68|||
46785114|NCT00567255|83004262|FG000|Overall Study|Lost to Follow-up|77|||
46785115|NCT00567255|83004263|FG001|Overall Study|Lost to Follow-up|48|||
46785116|NCT00567255|83004262|FG000|Overall Study|Withdrawal by Subject|75|||
46785117|NCT00567255|83004263|FG001|Overall Study|Withdrawal by Subject|56|||
46785118|NCT00567255|83004262|FG000|Overall Study|Lack of Efficacy|19|||
46785119|NCT00567255|83004263|FG001|Overall Study|Lack of Efficacy|33|||
46785120|NCT00567255|83004262|FG000|Overall Study|Protocol Violation|20|||
46785121|NCT00567255|83004263|FG001|Overall Study|Protocol Violation|8|||
46785122|NCT00567255|83004262|FG000|Overall Study|Pregnancy|6|||
46785123|NCT00567255|83004263|FG001|Overall Study|Pregnancy|0|||
46785124|NCT00567255|83004262|FG000|Overall Study|Drug noncompliance,moved,other|25|||
46785125|NCT00567255|83004263|FG001|Overall Study|Drug noncompliance,moved,other|15|||
46785126|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
46785127|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
46785128|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Other|2|||
46785129|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Other|2|||
46785130|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Personal reasons|2|||
46785131|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Personal reasons|2|||
46785132|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
46785133|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
46785134|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
46785135|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
46785136|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
46785137|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
46785138|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
46785139|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
46785140|NCT00667446|83004271|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
46785141|NCT00667446|83004272|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
46785142|NCT00667446|83004271|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
46785143|NCT00667446|83004272|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
46785144|NCT00688844|83004278|FG000|Overall Study|Lost to Follow-up|10|||
46785145|NCT00667368|83004284|FG000|Overall Study|Lost to Follow-up|176|||
46785146|NCT00667368|83004285|FG001|Overall Study|Lost to Follow-up|155|||
46785147|NCT00667368|83004284|FG000|Overall Study|Discontinued early|24|||
46785148|NCT00667368|83004285|FG001|Overall Study|Discontinued early|17|||
46785149|NCT00567567|83004294|FG000|Overall Study|Adverse Event|0|||
46785150|NCT00567567|83004295|FG001|Overall Study|Adverse Event|2|||
46785151|NCT00567567|83004296|FG002|Overall Study|Adverse Event|5|||
47077033|NCT02592798|83375311|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
46667711|NCT04677179|82882316|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667712|NCT04677179|82882317|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667713|NCT04677179|82882318|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667714|NCT04677179|82882319|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
46667715|NCT04677179|82882320|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667716|NCT04677179|82882321|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46667717|NCT04677179|82882312|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667718|NCT04677179|82882313|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667719|NCT04677179|82882314|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667720|NCT04677179|82882315|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667721|NCT04677179|82882316|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667722|NCT04677179|82882317|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667723|NCT04677179|82882318|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667724|NCT04677179|82882319|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
46667725|NCT04677179|82882320|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
46667726|NCT04677179|82882321|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46667727|NCT04677179|82882312|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
47077034|NCT02592798|83375310|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
46667728|NCT04677179|82882313|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
46785152|NCT00567567|83004294|FG000|Overall Study|Death|8|||
46785153|NCT00567567|83004295|FG001|Overall Study|Death|1|||
46785154|NCT00567567|83004296|FG002|Overall Study|Death|5|||
46785155|NCT00567567|83004294|FG000|Overall Study|Lack of Efficacy|16|||
46785156|NCT00567567|83004295|FG001|Overall Study|Lack of Efficacy|17|||
46785157|NCT00567567|83004296|FG002|Overall Study|Lack of Efficacy|48|||
46785158|NCT00567567|83004294|FG000|Overall Study|Lost to Follow-up|0|||
46785159|NCT00567567|83004295|FG001|Overall Study|Lost to Follow-up|0|||
46785160|NCT00567567|83004296|FG002|Overall Study|Lost to Follow-up|1|||
46785161|NCT00567567|83004294|FG000|Overall Study|Physician Decision|16|||
46785162|NCT00567567|83004295|FG001|Overall Study|Physician Decision|18|||
46785163|NCT00567567|83004296|FG002|Overall Study|Physician Decision|84|||
46785164|NCT00567567|83004294|FG000|Overall Study|Withdrawal by Subject|0|||
46785165|NCT00567567|83004295|FG001|Overall Study|Withdrawal by Subject|0|||
46785166|NCT00567567|83004296|FG002|Overall Study|Withdrawal by Subject|2|||
46785167|NCT00567567|83004294|FG000|Overall Study|Ineligible|4|||
46785168|NCT00567567|83004295|FG001|Overall Study|Ineligible|0|||
46785169|NCT00567567|83004296|FG002|Overall Study|Ineligible|9|||
46785170|NCT00567567|83004294|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
46785171|NCT00567567|83004295|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
46785172|NCT00567567|83004296|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
46785173|NCT00567567|83004294|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
46785174|NCT00567567|83004295|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
46785175|NCT00567567|83004296|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
46785176|NCT00567567|83004294|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
46785177|NCT00567567|83004295|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
46785178|NCT00567567|83004296|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
46785179|NCT00666198|83004306|FG000|Overall Study|Protocol Violation|10|||
46785180|NCT00666198|83004306|FG000|Overall Study|No Visit After First Day of Treatment|13|||
46785181|NCT00666198|83004306|FG000|Overall Study|Safety Not Assessable|6|||
46785182|NCT00666198|83004306|FG000|Overall Study|No Drug Administration|4|||
46785183|NCT00664560|83004313|FG000|Overall Study|Adverse Event|19|||
46785184|NCT00664560|83004314|FG001|Overall Study|Adverse Event|16|||
46785185|NCT00664560|83004315|FG002|Overall Study|Adverse Event|7|||
46785186|NCT00664560|83004313|FG000|Overall Study|Withdrawal by Subject|9|||
46785187|NCT00664560|83004314|FG001|Overall Study|Withdrawal by Subject|13|||
46785188|NCT00664560|83004315|FG002|Overall Study|Withdrawal by Subject|7|||
46785189|NCT00664560|83004313|FG000|Overall Study|Lost to Follow-up|0|||
46785190|NCT00664560|83004314|FG001|Overall Study|Lost to Follow-up|2|||
46785191|NCT00664560|83004315|FG002|Overall Study|Lost to Follow-up|0|||
46785192|NCT00664560|83004313|FG000|Overall Study|Other|11|||
46785193|NCT00664560|83004314|FG001|Overall Study|Other|4|||
46785194|NCT00664560|83004315|FG002|Overall Study|Other|5|||
46785195|NCT00566709|83004325|FG000|Overall Study|Protocol Violation|5|||
46785196|NCT00566709|83004326|FG001|Overall Study|Protocol Violation|0|||
46785197|NCT00688688|83004335|FG000|Overall Study|Eligibility criterion not met|7|||
46785198|NCT00688688|83004336|FG001|Overall Study|Eligibility criterion not met|7|||
46785199|NCT00688688|83004337|FG002|Overall Study|Eligibility criterion not met|10|||
46785200|NCT00688688|83004335|FG000|Overall Study|Adverse Event|52|||
46785201|NCT00688688|83004336|FG001|Overall Study|Adverse Event|51|||
46785202|NCT00688688|83004337|FG002|Overall Study|Adverse Event|50|||
46785203|NCT00688688|83004335|FG000|Overall Study|Lack of Efficacy|34|||
46785204|NCT00688688|83004336|FG001|Overall Study|Lack of Efficacy|25|||
46785205|NCT00688688|83004337|FG002|Overall Study|Lack of Efficacy|45|||
46785206|NCT00688688|83004335|FG000|Overall Study|Withdrawal by Subject|66|||
46785207|NCT00688688|83004336|FG001|Overall Study|Withdrawal by Subject|75|||
46785208|NCT00688688|83004337|FG002|Overall Study|Withdrawal by Subject|65|||
46785209|NCT00688688|83004335|FG000|Overall Study|Lost to Follow-up|14|||
46785210|NCT00688688|83004336|FG001|Overall Study|Lost to Follow-up|7|||
46785211|NCT00688688|83004337|FG002|Overall Study|Lost to Follow-up|7|||
46785212|NCT00688688|83004335|FG000|Overall Study|Protocol Violation|6|||
46785213|NCT00688688|83004336|FG001|Overall Study|Protocol Violation|9|||
46785214|NCT00688688|83004337|FG002|Overall Study|Protocol Violation|11|||
46785215|NCT00688688|83004335|FG000|Overall Study|Randomized but never received study drug|1|||
46785216|NCT00688688|83004336|FG001|Overall Study|Randomized but never received study drug|0|||
46785217|NCT00688688|83004337|FG002|Overall Study|Randomized but never received study drug|0|||
46785218|NCT00688688|83004335|FG000|Overall Study|Non-compliance with study procedures|5|||
47077035|NCT02592798|83375311|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
47077036|NCT02592798|83375310|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
46785219|NCT00688688|83004336|FG001|Overall Study|Non-compliance with study procedures|3|||
46785220|NCT00688688|83004337|FG002|Overall Study|Non-compliance with study procedures|4|||
46785221|NCT00688688|83004335|FG000|Overall Study|Taking exclusionary medications|1|||
46785222|NCT00688688|83004336|FG001|Overall Study|Taking exclusionary medications|0|||
46785223|NCT00688688|83004337|FG002|Overall Study|Taking exclusionary medications|0|||
47077037|NCT02592798|83375311|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
46785224|NCT00688688|83004335|FG000|Overall Study|Site closure|0|||
46785225|NCT00688688|83004336|FG001|Overall Study|Site closure|1|||
46785226|NCT00688688|83004337|FG002|Overall Study|Site closure|0|||
46785227|NCT00688688|83004335|FG000|Overall Study|Violation of exclusion criterion|0|||
46785228|NCT00688688|83004336|FG001|Overall Study|Violation of exclusion criterion|1|||
46785229|NCT00688688|83004337|FG002|Overall Study|Violation of exclusion criterion|0|||
46785230|NCT00664326|83004345|FG000|Overall Study|Adverse Event|14|||
46972503|NCT02078752|83216191|FG006|Overall Study|Death|0|||
46785231|NCT00664326|83004345|FG000|Overall Study|Noncompliance with study medication|3|||
46785232|NCT00664326|83004345|FG000|Overall Study|Withdrawal by Subject|1|||
46785233|NCT00664326|83004345|FG000|Overall Study|Physician Decision|1|||
46785234|NCT00664326|83004345|FG000|Overall Study|Other Reasons|3|||
46785235|NCT00664326|83004345|FG000|Overall Study|Death|2|||
46785236|NCT00664326|83004345|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
46785237|NCT00686972|83004349|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
46785238|NCT00665652|83004353|FG000|Overall Study|Adverse Event|4|||
46785239|NCT00665652|83004353|FG000|Overall Study|Death|1|||
46785240|NCT00665652|83004353|FG000|Overall Study|No longer met inclusion criteria.|1|||
46785241|NCT00566631|83004357|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
46785242|NCT00566631|83004357|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
46785243|NCT00566631|83004357|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
46785244|NCT00566631|83004357|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
46785245|NCT00566631|83004357|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
46785246|NCT00566631|83004357|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
46785247|NCT00566631|83004357|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
46785248|NCT00566631|83004357|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
46785249|NCT00566631|83004357|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
46785250|NCT00566631|83004357|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
46785251|NCT00566631|83004357|FG000|Part 2: Extension Phase|Adverse Event|11|||
46785252|NCT00566631|83004357|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
46785253|NCT00566631|83004357|FG000|Part 2: Extension Phase|Death|1|||
46785254|NCT00566631|83004357|FG000|Part 2: Extension Phase|Other|5|||
46785255|NCT00661830|83004363|FG000|Overall Study|Death|37|||
46785256|NCT00661830|83004364|FG001|Overall Study|Death|33|||
46785257|NCT00661830|83004363|FG000|Overall Study|Lost to Follow-up|1|||
46851372|NCT00116805|83066998|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
46667729|NCT04677179|82882314|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
46667730|NCT04677179|82882315|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
46667731|NCT04677179|82882316|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
46667732|NCT04677179|82882317|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
46667733|NCT04677179|82882318|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
46667734|NCT04677179|82882319|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
46667735|NCT04677179|82882320|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
46667736|NCT04677179|82882321|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
46667737|NCT04590937|82882338|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
46667738|NCT04576897|82882352|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
46667739|NCT04166435|82882384|FG000|Overall Study|2 patients ineligible for response|2|||
46667740|NCT04124965|82882390|FG000|Overall Study|Adverse event, non-fatal|3|||
46667741|NCT04124965|82882391|FG001|Overall Study|Adverse event, non-fatal|1|||
46667742|NCT04124965|82882390|FG000|Overall Study|Withdrawal by Subject|1|||
46667743|NCT04124965|82882391|FG001|Overall Study|Withdrawal by Subject|1|||
46667744|NCT04124965|82882390|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
46667745|NCT04124965|82882391|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
46667746|NCT04124965|82882390|FG000|Overall Study|Pregnancy|1|||
46667747|NCT04124965|82882391|FG001|Overall Study|Pregnancy|0|||
46667748|NCT04124965|82882390|FG000|Overall Study|Sponsor and participant decision|0|||
46667749|NCT04124965|82882391|FG001|Overall Study|Sponsor and participant decision|1|||
46667750|NCT04124965|82882390|FG000|Overall Study|Personal surgery|0|||
46667751|NCT04124965|82882391|FG001|Overall Study|Personal surgery|1|||
46667752|NCT04124965|82882390|FG000|Overall Study|Physician Decision|0|||
46667753|NCT04124965|82882391|FG001|Overall Study|Physician Decision|1|||
46667754|NCT04021862|82882400|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
46667755|NCT04021862|82882401|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
46667756|NCT04021862|82882402|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
46667757|NCT04021862|82882403|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
46667758|NCT04021862|82882404|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
46667759|NCT04021862|82882405|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
46667760|NCT04021862|82882400|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
46785258|NCT00661830|83004364|FG001|Overall Study|Lost to Follow-up|3|||
46851373|NCT00116805|83066997|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
46851374|NCT00116805|83066998|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
46785259|NCT00661830|83004363|FG000|Overall Study|Withdrawal by Subject|1|||
46785260|NCT00661830|83004364|FG001|Overall Study|Withdrawal by Subject|1|||
46785261|NCT00661830|83004363|FG000|Overall Study|Other reason|1|||
46667761|NCT04021862|82882401|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
46785262|NCT00661830|83004364|FG001|Overall Study|Other reason|5|||
46785263|NCT00540592|83004380|FG000|Overall Study|Adverse Event|0|||
46851375|NCT00116805|83066997|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
46667762|NCT04021862|82882402|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
46667763|NCT04021862|82882403|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
46667764|NCT04021862|82882404|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
46667765|NCT04021862|82882405|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
46667766|NCT04021862|82882400|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
46667767|NCT04021862|82882401|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
46667768|NCT04021862|82882402|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
46667769|NCT04021862|82882403|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
46667770|NCT04021862|82882404|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
46667771|NCT04021862|82882405|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
46667772|NCT04021862|82882400|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
46667773|NCT04021862|82882401|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
46667774|NCT04021862|82882402|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
46667775|NCT04021862|82882403|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
46667776|NCT04021862|82882404|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
46667777|NCT04021862|82882405|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
46667778|NCT04021862|82882400|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
46667779|NCT04021862|82882401|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
46972504|NCT02078752|83216192|FG007|Overall Study|Death|1|||
46972505|NCT02078752|83216193|FG008|Overall Study|Death|0|||
46972506|NCT02078752|83216194|FG009|Overall Study|Death|4|||
46972507|NCT02078752|83216185|FG000|Overall Study|Lost to Follow-up|1|||
46972508|NCT02078752|83216186|FG001|Overall Study|Lost to Follow-up|0|||
46972509|NCT02078752|83216187|FG002|Overall Study|Lost to Follow-up|0|||
46972510|NCT02078752|83216188|FG003|Overall Study|Lost to Follow-up|1|||
46972511|NCT02078752|83216189|FG004|Overall Study|Lost to Follow-up|0|||
46972512|NCT02078752|83216190|FG005|Overall Study|Lost to Follow-up|0|||
46972513|NCT02078752|83216191|FG006|Overall Study|Lost to Follow-up|0|||
46972514|NCT02078752|83216192|FG007|Overall Study|Lost to Follow-up|0|||
46972515|NCT02078752|83216193|FG008|Overall Study|Lost to Follow-up|0|||
46972516|NCT02078752|83216194|FG009|Overall Study|Lost to Follow-up|0|||
46972517|NCT02078752|83216185|FG000|Overall Study|Withdrawal by Subject|1|||
46972518|NCT02078752|83216186|FG001|Overall Study|Withdrawal by Subject|1|||
46972519|NCT02078752|83216187|FG002|Overall Study|Withdrawal by Subject|1|||
46972520|NCT02078752|83216188|FG003|Overall Study|Withdrawal by Subject|1|||
46972521|NCT02078752|83216189|FG004|Overall Study|Withdrawal by Subject|0|||
46972522|NCT02078752|83216190|FG005|Overall Study|Withdrawal by Subject|3|||
46972523|NCT02078752|83216191|FG006|Overall Study|Withdrawal by Subject|2|||
46972524|NCT02078752|83216192|FG007|Overall Study|Withdrawal by Subject|1|||
46972525|NCT02078752|83216193|FG008|Overall Study|Withdrawal by Subject|0|||
46972526|NCT02078752|83216194|FG009|Overall Study|Withdrawal by Subject|1|||
46972527|NCT02078752|83216185|FG000|Overall Study|Other|0|||
46972528|NCT02078752|83216186|FG001|Overall Study|Other|3|||
46972529|NCT02078752|83216187|FG002|Overall Study|Other|0|||
46972530|NCT02078752|83216188|FG003|Overall Study|Other|0|||
46972531|NCT02078752|83216189|FG004|Overall Study|Other|1|||
46972532|NCT02078752|83216190|FG005|Overall Study|Other|0|||
46972533|NCT02078752|83216191|FG006|Overall Study|Other|0|||
46972534|NCT02078752|83216192|FG007|Overall Study|Other|1|||
46972535|NCT02078752|83216193|FG008|Overall Study|Other|0|||
46972536|NCT02078752|83216194|FG009|Overall Study|Other|0|||
46972537|NCT02078752|83216185|FG000|Overall Study|Study terminated by sponsor|0|||
46972538|NCT02078752|83216186|FG001|Overall Study|Study terminated by sponsor|0|||
46972539|NCT02078752|83216187|FG002|Overall Study|Study terminated by sponsor|0|||
46972540|NCT02078752|83216188|FG003|Overall Study|Study terminated by sponsor|0|||
46972541|NCT02078752|83216189|FG004|Overall Study|Study terminated by sponsor|0|||
46972542|NCT02078752|83216190|FG005|Overall Study|Study terminated by sponsor|0|||
46667780|NCT04021862|82882402|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
46667781|NCT04021862|82882403|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
46667782|NCT04021862|82882404|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
46972543|NCT02078752|83216191|FG006|Overall Study|Study terminated by sponsor|0|||
46972544|NCT02078752|83216192|FG007|Overall Study|Study terminated by sponsor|0|||
46972545|NCT02078752|83216193|FG008|Overall Study|Study terminated by sponsor|0|||
46972546|NCT02078752|83216194|FG009|Overall Study|Study terminated by sponsor|5|||
46972547|NCT02022748|83216227|FG000|Overall Study|Adverse Event|1|||
46972548|NCT02022748|83216228|FG001|Overall Study|Adverse Event|1|||
46972549|NCT02022748|83216229|FG002|Overall Study|Adverse Event|0|||
46972550|NCT02022748|83216227|FG000|Overall Study|Withdrawal by Subject|0|||
46667783|NCT04021862|82882405|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
46667784|NCT04003155|82882422|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
46667785|NCT04003155|82882423|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
46667786|NCT04003155|82882424|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
46667787|NCT04003155|82882425|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
46667788|NCT04003155|82882426|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
46667789|NCT04003155|82882422|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
46667790|NCT04003155|82882423|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
46667791|NCT04003155|82882424|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
46667792|NCT04003155|82882425|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
46667793|NCT04003155|82882426|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
46667794|NCT04003155|82882422|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
46667795|NCT04003155|82882423|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
46667796|NCT04003155|82882424|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
46667797|NCT04003155|82882425|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
46667798|NCT04003155|82882426|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
46667799|NCT04003155|82882422|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
46667800|NCT04003155|82882423|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
46667801|NCT04003155|82882424|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
46667802|NCT04003155|82882425|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
46667803|NCT04003155|82882426|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
46667804|NCT04003155|82882422|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
46667805|NCT04003155|82882423|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
46667806|NCT04003155|82882424|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
46667807|NCT04003155|82882425|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
46667808|NCT04003155|82882426|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
46667809|NCT04003155|82882422|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
46667810|NCT04003155|82882423|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
46667811|NCT04003155|82882424|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
46667812|NCT04003155|82882425|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
46667813|NCT04003155|82882426|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
46667814|NCT04003155|82882422|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
46667815|NCT04003155|82882423|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
46667816|NCT04003155|82882424|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
46667817|NCT04003155|82882425|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
46667818|NCT04003155|82882426|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
46667819|NCT04003155|82882422|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
46667820|NCT04003155|82882423|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
46667821|NCT04003155|82882424|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
46667822|NCT04003155|82882425|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
46667823|NCT04003155|82882426|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
46667824|NCT04003155|82882422|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
46667825|NCT04003155|82882423|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
46667826|NCT04003155|82882424|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
46785264|NCT00540592|83004381|FG001|Overall Study|Adverse Event|1|||
46785265|NCT00540592|83004382|FG002|Overall Study|Adverse Event|0|||
46785266|NCT00540592|83004383|FG003|Overall Study|Adverse Event|0|||
46785267|NCT00540592|83004384|FG004|Overall Study|Adverse Event|1|||
46785268|NCT00540592|83004385|FG005|Overall Study|Adverse Event|0|||
46785269|NCT00540592|83004386|FG006|Overall Study|Adverse Event|0|||
46785270|NCT00540592|83004387|FG007|Overall Study|Adverse Event|1|||
46785271|NCT00540592|83004388|FG008|Overall Study|Adverse Event|1|||
46785272|NCT00540592|83004389|FG009|Overall Study|Adverse Event|2|||
46785273|NCT00540592|83004380|FG000|Overall Study|Lost to Follow-up|2|||
46785274|NCT00540592|83004381|FG001|Overall Study|Lost to Follow-up|0|||
46785275|NCT00540592|83004382|FG002|Overall Study|Lost to Follow-up|0|||
46785276|NCT00540592|83004383|FG003|Overall Study|Lost to Follow-up|0|||
46851376|NCT00116805|83066998|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
46851377|NCT00116805|83066997|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
46851378|NCT00116805|83066998|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
47077038|NCT02592798|83375310|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
47077039|NCT02592798|83375311|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
46667827|NCT04003155|82882425|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
46785277|NCT00540592|83004384|FG004|Overall Study|Lost to Follow-up|0|||
46785278|NCT00540592|83004385|FG005|Overall Study|Lost to Follow-up|0|||
46972551|NCT02022748|83216228|FG001|Overall Study|Withdrawal by Subject|1|||
46667828|NCT04003155|82882426|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
46785279|NCT00540592|83004386|FG006|Overall Study|Lost to Follow-up|0|||
46785280|NCT00540592|83004387|FG007|Overall Study|Lost to Follow-up|0|||
46972552|NCT02022748|83216229|FG002|Overall Study|Withdrawal by Subject|0|||
47077040|NCT02592798|83375310|FG000|Transition From DB2 to OLE|Other reasons|1|||
46785281|NCT00540592|83004388|FG008|Overall Study|Lost to Follow-up|0|||
46785282|NCT00540592|83004389|FG009|Overall Study|Lost to Follow-up|0|||
46667829|NCT04003142|82882447|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
46667830|NCT04003142|82882448|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
46667831|NCT04003142|82882449|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
46667832|NCT04003142|82882450|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
46667833|NCT04003142|82882451|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
46667834|NCT04003142|82882447|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
46667835|NCT04003142|82882448|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
46667836|NCT04003142|82882449|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
46667837|NCT04003142|82882450|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
46667838|NCT04003142|82882451|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
46667839|NCT04003142|82882447|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
46667840|NCT04003142|82882448|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
46972553|NCT02022670|83216240|FG000|Overall Study|Adverse Event|1|||
46972554|NCT02022670|83216241|FG001|Overall Study|Adverse Event|0|||
46972555|NCT02022670|83216242|FG002|Overall Study|Adverse Event|1|||
46972556|NCT02076334|83216255|FG000|Overall Study|Protocol Violation|1|||
46972557|NCT02076334|83216256|FG001|Overall Study|Protocol Violation|0|||
46972558|NCT02076334|83216257|FG002|Overall Study|Protocol Violation|0|||
46972559|NCT02076334|83216258|FG003|Overall Study|Protocol Violation|0|||
46972560|NCT02076334|83216255|FG000|Overall Study|Lost to Follow-up|0|||
46972561|NCT02076334|83216256|FG001|Overall Study|Lost to Follow-up|1|||
46972562|NCT02076334|83216257|FG002|Overall Study|Lost to Follow-up|1|||
46972563|NCT02076334|83216258|FG003|Overall Study|Lost to Follow-up|0|||
46972564|NCT02076334|83216255|FG000|Overall Study|muscle soreness|0|||
46972565|NCT02076334|83216256|FG001|Overall Study|muscle soreness|0|||
46972566|NCT02076334|83216257|FG002|Overall Study|muscle soreness|0|||
46972567|NCT02076334|83216258|FG003|Overall Study|muscle soreness|1|||
46972568|NCT02021812|83216268|FG000|Overall Study|Death|8|||
46785283|NCT00540592|83004380|FG000|Overall Study|Withdrawal by Subject|0|||
46785284|NCT00540592|83004381|FG001|Overall Study|Withdrawal by Subject|0|||
46785285|NCT00540592|83004382|FG002|Overall Study|Withdrawal by Subject|1|||
46785286|NCT00540592|83004383|FG003|Overall Study|Withdrawal by Subject|1|||
46785287|NCT00540592|83004384|FG004|Overall Study|Withdrawal by Subject|0|||
46972569|NCT02021812|83216268|FG000|Overall Study|Withdrawal by Subject|3|||
46972570|NCT02021812|83216268|FG000|Overall Study|Lost to Follow-up|2|||
46972571|NCT02021812|83216268|FG000|Overall Study|Refuse to return, COVD 19|2|||
46972572|NCT02021656|83216272|FG000|Overall Study|Adverse Event|1|||
46972573|NCT02021656|83216272|FG000|Overall Study|Lack of Efficacy|2|||
46667841|NCT04003142|82882449|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
46667842|NCT04003142|82882450|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
46667843|NCT04003142|82882451|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
46667844|NCT04003142|82882447|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
46667845|NCT04003142|82882448|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
46667846|NCT04003142|82882449|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
46667847|NCT04003142|82882450|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
46667848|NCT04003142|82882451|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
46667849|NCT04003142|82882447|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
46667850|NCT04003142|82882448|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
46667851|NCT04003142|82882449|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
46667852|NCT04003142|82882450|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
46667853|NCT04003142|82882451|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
46667854|NCT04003142|82882447|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
46667855|NCT04003142|82882448|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
46667856|NCT04003142|82882449|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
46667857|NCT04003142|82882450|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
46667858|NCT04003142|82882451|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
46667859|NCT04003142|82882447|FG000|Extension Period (40 Weeks)|Death|0|||
46667860|NCT04003142|82882448|FG001|Extension Period (40 Weeks)|Death|0|||
46667861|NCT04003142|82882449|FG002|Extension Period (40 Weeks)|Death|0|||
46667862|NCT04003142|82882450|FG003|Extension Period (40 Weeks)|Death|0|||
46667863|NCT04003142|82882451|FG004|Extension Period (40 Weeks)|Death|1|||
46785288|NCT00540592|83004385|FG005|Overall Study|Withdrawal by Subject|0|||
46972574|NCT02021656|83216272|FG000|Overall Study|Lost to Follow-up|1|||
46972575|NCT02021656|83216272|FG000|Overall Study|Withdrew Consent|2|||
47077041|NCT02592798|83375311|FG001|Transition From DB2 to OLE|Other reasons|0|||
46667864|NCT04003142|82882447|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
46667865|NCT04003142|82882448|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
46785289|NCT00540592|83004386|FG006|Overall Study|Withdrawal by Subject|0|||
46785290|NCT00540592|83004387|FG007|Overall Study|Withdrawal by Subject|0|||
46972576|NCT02076022|83216282|FG000|Overall Study|Withdrawal by Subject|2|||
46972577|NCT02076022|83216283|FG001|Overall Study|Withdrawal by Subject|0|||
46972578|NCT02075632|83216291|FG000|Overall Study|Adverse Event|1|||
46785291|NCT00540592|83004388|FG008|Overall Study|Withdrawal by Subject|0|||
46667866|NCT04003142|82882449|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
46667867|NCT04003142|82882450|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
46667868|NCT04003142|82882451|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
46667869|NCT04003142|82882447|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
46667870|NCT04003142|82882448|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
46667871|NCT04003142|82882449|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
46667872|NCT04003142|82882450|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
46667873|NCT04003142|82882451|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
46667874|NCT04003142|82882447|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
46667875|NCT04003142|82882448|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
46667876|NCT04003142|82882449|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
46667877|NCT04003142|82882450|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
46667878|NCT04003142|82882451|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
46667879|NCT04003142|82882447|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
46667880|NCT04003142|82882448|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
46667881|NCT04003142|82882449|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
46667882|NCT04003142|82882450|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
46667883|NCT04003142|82882451|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
46667884|NCT03971422|82882472|FG000|Overall Study|Lost to Follow-up|0|||
46785292|NCT00540592|83004389|FG009|Overall Study|Withdrawal by Subject|0|||
46785293|NCT03970395|83004413|FG000|Overall Study|Withdrawal by Subject|3|||
46785294|NCT03970395|83004414|FG001|Overall Study|Withdrawal by Subject|4|||
46785295|NCT03970395|83004413|FG000|Overall Study|Lost to Follow-up|4|||
46785296|NCT03970395|83004414|FG001|Overall Study|Lost to Follow-up|8|||
46785297|NCT00565773|83004424|FG000|Overall Study|Withdrawal by Subject|1|||
46785298|NCT00565773|83004424|FG000|Overall Study|Physician Decision|1|||
46785299|NCT00570492|83004430|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
46785300|NCT00570492|83004431|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
46785301|NCT00570492|83004432|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
46785302|NCT00570492|83004430|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
46785303|NCT00570492|83004431|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
46785304|NCT00570492|83004432|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
46785305|NCT00570492|83004430|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
46785306|NCT00570492|83004431|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
46785307|NCT00570492|83004432|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
46785308|NCT00570492|83004430|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
46785309|NCT00570492|83004431|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
46785310|NCT00570492|83004432|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
46785311|NCT00570492|83004430|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
46785312|NCT00570492|83004431|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
46785313|NCT00570492|83004432|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
46785314|NCT00570492|83004430|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
46785315|NCT00570492|83004431|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
46785316|NCT00570492|83004432|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
46785317|NCT00570492|83004430|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
46785318|NCT00570492|83004431|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
46785319|NCT00570492|83004432|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
46785320|NCT00570492|83004430|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
46785321|NCT00570492|83004431|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
46785322|NCT00570492|83004432|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
46785323|NCT00570492|83004430|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
46785324|NCT00570492|83004431|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
46785325|NCT00570492|83004432|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
46785326|NCT00570492|83004430|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
46785327|NCT00570492|83004431|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
46785328|NCT00570492|83004432|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
46785329|NCT00570492|83004430|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
46785330|NCT00570492|83004431|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
46785331|NCT00570492|83004432|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
46785332|NCT00570492|83004430|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
46667885|NCT03971422|82882473|FG001|Overall Study|Lost to Follow-up|1|||
46667886|NCT03971422|82882474|FG002|Overall Study|Lost to Follow-up|0|||
47077042|NCT02592798|83375310|FG000|Open Label Period (OLE)|Other reasons|0|||
46667887|NCT03971422|82882472|FG000|Overall Study|Lack of Efficacy|5|||
46667888|NCT03971422|82882473|FG001|Overall Study|Lack of Efficacy|1|||
46667889|NCT03971422|82882474|FG002|Overall Study|Lack of Efficacy|1|||
46667890|NCT03971422|82882472|FG000|Overall Study|Adverse event, not fatal|2|||
46667891|NCT03971422|82882473|FG001|Overall Study|Adverse event, not fatal|2|||
46667892|NCT03971422|82882474|FG002|Overall Study|Adverse event, not fatal|5|||
46667893|NCT03971422|82882472|FG000|Overall Study|Worsening of MG Symptoms|1|||
46667894|NCT03971422|82882473|FG001|Overall Study|Worsening of MG Symptoms|4|||
46667895|NCT03971422|82882474|FG002|Overall Study|Worsening of MG Symptoms|2|||
46667896|NCT03971422|82882472|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
46667897|NCT03971422|82882473|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
46667898|NCT03971422|82882474|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
46667899|NCT03971422|82882472|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
46667900|NCT03971422|82882473|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
46667901|NCT03971422|82882474|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
46785333|NCT00570492|83004431|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
46785334|NCT00570492|83004432|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
46785335|NCT00570492|83004430|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
46785336|NCT00570492|83004431|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
46785337|NCT00570492|83004432|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
46785338|NCT00570492|83004430|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
46785339|NCT00570492|83004431|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
46785340|NCT00570492|83004432|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
46785341|NCT00571922|83004440|FG000|Overall Study|Completion unknown|36|||
46785342|NCT00571922|83004441|FG001|Overall Study|Completion unknown|36|||
46785343|NCT00686894|83004447|FG000|Overall Study|Relapse|2|||
46785344|NCT00686894|83004447|FG000|Overall Study|Protocol Violation|4|||
46785345|NCT00328627|83004463|FG000|Overall Study|Hyperglycemic Rescue|41|||
46785346|NCT00328627|83004464|FG001|Overall Study|Hyperglycemic Rescue|18|||
46785347|NCT00328627|83004465|FG002|Overall Study|Hyperglycemic Rescue|16|||
46785348|NCT00328627|83004466|FG003|Overall Study|Hyperglycemic Rescue|13|||
46785349|NCT00328627|83004467|FG004|Overall Study|Hyperglycemic Rescue|6|||
46785350|NCT00328627|83004468|FG005|Overall Study|Hyperglycemic Rescue|5|||
46785351|NCT00328627|83004469|FG006|Overall Study|Hyperglycemic Rescue|19|||
46785352|NCT00328627|83004470|FG007|Overall Study|Hyperglycemic Rescue|6|||
46785353|NCT00328627|83004471|FG008|Overall Study|Hyperglycemic Rescue|6|||
46785354|NCT00328627|83004472|FG009|Overall Study|Hyperglycemic Rescue|11|||
46785355|NCT00328627|83004473|FG010|Overall Study|Hyperglycemic Rescue|3|||
46785356|NCT00328627|83004474|FG011|Overall Study|Hyperglycemic Rescue|2|||
46785357|NCT00328627|83004463|FG000|Overall Study|Adverse Event|3|||
46785358|NCT00328627|83004464|FG001|Overall Study|Adverse Event|1|||
46785359|NCT00328627|83004465|FG002|Overall Study|Adverse Event|2|||
46785360|NCT00328627|83004466|FG003|Overall Study|Adverse Event|3|||
46785361|NCT00328627|83004467|FG004|Overall Study|Adverse Event|1|||
46785362|NCT00328627|83004468|FG005|Overall Study|Adverse Event|2|||
46785363|NCT00328627|83004469|FG006|Overall Study|Adverse Event|1|||
46785364|NCT00328627|83004470|FG007|Overall Study|Adverse Event|2|||
46785365|NCT00328627|83004471|FG008|Overall Study|Adverse Event|0|||
46785366|NCT00328627|83004472|FG009|Overall Study|Adverse Event|7|||
46785367|NCT00328627|83004473|FG010|Overall Study|Adverse Event|5|||
46785368|NCT00328627|83004474|FG011|Overall Study|Adverse Event|4|||
46785369|NCT00328627|83004463|FG000|Overall Study|Protocol Violation|2|||
46785370|NCT00328627|83004464|FG001|Overall Study|Protocol Violation|2|||
46785371|NCT00328627|83004465|FG002|Overall Study|Protocol Violation|2|||
46785372|NCT00328627|83004466|FG003|Overall Study|Protocol Violation|8|||
46785373|NCT00328627|83004467|FG004|Overall Study|Protocol Violation|5|||
46785374|NCT00328627|83004468|FG005|Overall Study|Protocol Violation|5|||
46785375|NCT00328627|83004469|FG006|Overall Study|Protocol Violation|6|||
46785376|NCT00328627|83004470|FG007|Overall Study|Protocol Violation|2|||
46785377|NCT00328627|83004471|FG008|Overall Study|Protocol Violation|1|||
46785378|NCT00328627|83004472|FG009|Overall Study|Protocol Violation|4|||
46785379|NCT00328627|83004473|FG010|Overall Study|Protocol Violation|6|||
46785380|NCT00328627|83004474|FG011|Overall Study|Protocol Violation|2|||
46785381|NCT00328627|83004463|FG000|Overall Study|Lost to Follow-up|4|||
46785382|NCT00328627|83004464|FG001|Overall Study|Lost to Follow-up|2|||
46785383|NCT00328627|83004465|FG002|Overall Study|Lost to Follow-up|2|||
46785384|NCT00328627|83004466|FG003|Overall Study|Lost to Follow-up|4|||
46785385|NCT00328627|83004467|FG004|Overall Study|Lost to Follow-up|0|||
46972579|NCT02075632|83216292|FG001|Overall Study|Adverse Event|1|||
46972580|NCT02075632|83216291|FG000|Overall Study|Lost to Follow-up|0|||
46785386|NCT00328627|83004468|FG005|Overall Study|Lost to Follow-up|2|||
46785387|NCT00328627|83004469|FG006|Overall Study|Lost to Follow-up|3|||
46785388|NCT00328627|83004470|FG007|Overall Study|Lost to Follow-up|0|||
46785389|NCT00328627|83004471|FG008|Overall Study|Lost to Follow-up|3|||
46785390|NCT00328627|83004472|FG009|Overall Study|Lost to Follow-up|2|||
46785391|NCT00328627|83004473|FG010|Overall Study|Lost to Follow-up|0|||
46785392|NCT00328627|83004474|FG011|Overall Study|Lost to Follow-up|1|||
46972581|NCT02075632|83216292|FG001|Overall Study|Lost to Follow-up|3|||
46785393|NCT00328627|83004463|FG000|Overall Study|Withdrawal by Subject|5|||
46667902|NCT03971422|82882472|FG000|Overall Study|Due to COVID-19 pandemic|0|||
46667903|NCT03971422|82882473|FG001|Overall Study|Due to COVID-19 pandemic|1|||
46667904|NCT03971422|82882474|FG002|Overall Study|Due to COVID-19 pandemic|1|||
46667905|NCT03770260|82882489|FG000|Overall Study|Disease progression|0|||
46667906|NCT03770260|82882490|FG001|Overall Study|Disease progression|1|||
46667907|NCT03770260|82882491|FG002|Overall Study|Disease progression|0|||
46667908|NCT03770260|82882492|FG003|Overall Study|Disease progression|0|||
46667909|NCT03737110|82882503|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
46667910|NCT03737110|82882504|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
46667911|NCT03737110|82882505|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
46667912|NCT03737110|82882506|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
46667913|NCT03737110|82882507|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
46667914|NCT03737110|82882508|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
46667915|NCT03737110|82882503|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
46667916|NCT03737110|82882504|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
46667917|NCT03737110|82882505|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
46667918|NCT03737110|82882506|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
46667919|NCT03737110|82882507|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
46667920|NCT03737110|82882508|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
46667921|NCT03737110|82882503|FG000|Run-in (RI) Period|Adverse Event|4|||
46667922|NCT03737110|82882504|FG001|Run-in (RI) Period|Adverse Event|0|||
46667923|NCT03737110|82882505|FG002|Run-in (RI) Period|Adverse Event|0|||
46667924|NCT03737110|82882506|FG003|Run-in (RI) Period|Adverse Event|0|||
46667925|NCT03737110|82882507|FG004|Run-in (RI) Period|Adverse Event|0|||
46667926|NCT03737110|82882508|FG005|Run-in (RI) Period|Adverse Event|0|||
46667927|NCT03737110|82882503|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
46667928|NCT03737110|82882504|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
46667929|NCT03737110|82882505|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
46667930|NCT03737110|82882506|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
46667931|NCT03737110|82882507|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
46667932|NCT03737110|82882508|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
46667933|NCT03737110|82882503|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
46667934|NCT03737110|82882504|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
46667935|NCT03737110|82882505|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
46667936|NCT03737110|82882506|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
46667937|NCT03737110|82882507|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
46667938|NCT03737110|82882508|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
46667939|NCT03737110|82882503|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
46667940|NCT03737110|82882504|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
46667941|NCT03737110|82882505|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
46667942|NCT03737110|82882506|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
46667943|NCT03737110|82882507|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
46667944|NCT03737110|82882508|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
46667945|NCT03737110|82882503|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
46667946|NCT03737110|82882504|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
46667947|NCT03737110|82882505|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
46667948|NCT03737110|82882506|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
46667949|NCT03737110|82882507|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
46667950|NCT03737110|82882508|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
46667951|NCT03737110|82882503|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
46667952|NCT03737110|82882504|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
46667953|NCT03737110|82882505|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
46667954|NCT03737110|82882506|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
46667955|NCT03737110|82882507|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
47077043|NCT02592798|83375311|FG001|Open Label Period (OLE)|Other reasons|2|||
47077044|NCT02592798|83375310|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
47077045|NCT02592798|83375311|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
47077046|NCT02592798|83375310|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
47077047|NCT02592798|83375311|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
47077048|NCT02592798|83375310|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
47077049|NCT02592798|83375311|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
47077050|NCT02592798|83375310|FG000|Open Label Period (OLE)|Adverse Event|0|||
47077051|NCT02592798|83375311|FG001|Open Label Period (OLE)|Adverse Event|1|||
47077052|NCT00081653|83375351|FG000|Overall Study|Adverse Event|23|||
47077053|NCT00081653|83375352|FG001|Overall Study|Adverse Event|17|||
46667956|NCT03737110|82882508|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
46667957|NCT03592771|82882543|FG000|Overall Study|Adverse Event|2|||
46667958|NCT03592771|82882544|FG001|Overall Study|Adverse Event|0|||
46667959|NCT03592771|82882545|FG002|Overall Study|Adverse Event|1|||
46667960|NCT03592771|82882543|FG000|Overall Study|Death|0|||
46667961|NCT03592771|82882544|FG001|Overall Study|Death|1|||
46667962|NCT03592771|82882545|FG002|Overall Study|Death|1|||
46667963|NCT03592771|82882543|FG000|Overall Study|Lost to Follow-up|5|||
46667964|NCT03592771|82882544|FG001|Overall Study|Lost to Follow-up|11|||
46667965|NCT03592771|82882545|FG002|Overall Study|Lost to Follow-up|15|||
46667966|NCT03592771|82882543|FG000|Overall Study|Withdrawal by Subject|0|||
46667967|NCT03592771|82882544|FG001|Overall Study|Withdrawal by Subject|2|||
46667968|NCT03592771|82882545|FG002|Overall Study|Withdrawal by Subject|0|||
46667969|NCT03495154|82882553|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
46667970|NCT03495154|82882553|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
46667971|NCT03495154|82882553|FG000|Overall Study|Screen Failures During Surgery|6|||
46667972|NCT03495154|82882553|FG000|Overall Study|Death|2|||
46667973|NCT03495154|82882553|FG000|Overall Study|Lost to Follow-up|16|||
46667974|NCT03495154|82882553|FG000|Overall Study|Withdrawal by Subject|2|||
46667975|NCT03495154|82882553|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
46667976|NCT03334253|82882593|FG000|Overall Study|Withdrawal by Subject|1|||
46667977|NCT03334253|82882594|FG001|Overall Study|Withdrawal by Subject|0|||
46667978|NCT03334253|82882593|FG000|Overall Study|Lost to Follow-up|4|||
46667979|NCT03334253|82882594|FG001|Overall Study|Lost to Follow-up|3|||
46667980|NCT03334253|82882593|FG000|Overall Study|Moved residence|2|||
46667981|NCT03334253|82882594|FG001|Overall Study|Moved residence|2|||
46667982|NCT03314857|82882600|FG000|Overall Study|Death|4|||
46667983|NCT03314857|82882600|FG000|Overall Study|Physician Decision|1|||
46667984|NCT03302156|82882606|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
46667985|NCT03302156|82882607|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
46667986|NCT03302156|82882608|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
46667987|NCT03235739|82882617|FG000|Overall Study|Withdrawal by Subject|2|||
46667988|NCT03235739|82882618|FG001|Overall Study|Withdrawal by Subject|2|||
46667989|NCT03235739|82882617|FG000|Overall Study|Physician Decision|0|||
46667990|NCT03235739|82882618|FG001|Overall Study|Physician Decision|1|||
46667991|NCT03176771|82882627|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
46667992|NCT03176771|82882628|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
46667993|NCT03176771|82882629|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
46667994|NCT03176771|82882630|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
46667995|NCT03176771|82882631|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
46667996|NCT03176771|82882627|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
46667997|NCT03176771|82882628|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
46667998|NCT03176771|82882629|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
46667999|NCT03176771|82882630|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
46668000|NCT03176771|82882631|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
46668001|NCT03176771|82882627|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
46668002|NCT03176771|82882628|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
46785394|NCT00328627|83004464|FG001|Overall Study|Withdrawal by Subject|4|||
46785395|NCT00328627|83004465|FG002|Overall Study|Withdrawal by Subject|5|||
46785396|NCT00328627|83004466|FG003|Overall Study|Withdrawal by Subject|6|||
46785397|NCT00328627|83004467|FG004|Overall Study|Withdrawal by Subject|2|||
46785398|NCT00328627|83004468|FG005|Overall Study|Withdrawal by Subject|5|||
46785399|NCT00328627|83004469|FG006|Overall Study|Withdrawal by Subject|4|||
46785400|NCT00328627|83004470|FG007|Overall Study|Withdrawal by Subject|4|||
46785401|NCT00328627|83004471|FG008|Overall Study|Withdrawal by Subject|4|||
46785402|NCT00328627|83004472|FG009|Overall Study|Withdrawal by Subject|5|||
46851379|NCT00116805|83066997|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
46851380|NCT00116805|83066998|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
46851381|NCT00116805|83066997|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
46851382|NCT00116805|83066998|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
46851383|NCT00116805|83066997|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
46668003|NCT03176771|82882629|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
46668004|NCT03176771|82882630|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
46668005|NCT03176771|82882631|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
46668006|NCT03176771|82882627|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
46668007|NCT03176771|82882628|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
46668008|NCT03176771|82882629|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
46668009|NCT03176771|82882630|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
46668010|NCT03176771|82882631|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
46668011|NCT03176771|82882627|FG000|Double-Blind Extension Period|Adverse Event|0|||
46785403|NCT00328627|83004473|FG010|Overall Study|Withdrawal by Subject|2|||
46851384|NCT00116805|83066998|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
46668012|NCT03176771|82882628|FG001|Double-Blind Extension Period|Adverse Event|0|||
46668013|NCT03176771|82882629|FG002|Double-Blind Extension Period|Adverse Event|0|||
46785404|NCT00328627|83004474|FG011|Overall Study|Withdrawal by Subject|7|||
46785405|NCT00328627|83004463|FG000|Overall Study|Pregnancy|0|||
46785406|NCT00328627|83004464|FG001|Overall Study|Pregnancy|1|||
46785407|NCT00328627|83004465|FG002|Overall Study|Pregnancy|0|||
46785408|NCT00328627|83004466|FG003|Overall Study|Pregnancy|0|||
46785409|NCT00328627|83004467|FG004|Overall Study|Pregnancy|0|||
46785410|NCT00328627|83004468|FG005|Overall Study|Pregnancy|0|||
46785411|NCT00328627|83004469|FG006|Overall Study|Pregnancy|0|||
46785412|NCT00328627|83004470|FG007|Overall Study|Pregnancy|0|||
46785413|NCT00328627|83004471|FG008|Overall Study|Pregnancy|0|||
46785414|NCT00328627|83004472|FG009|Overall Study|Pregnancy|0|||
46785415|NCT00328627|83004473|FG010|Overall Study|Pregnancy|0|||
46785416|NCT00328627|83004474|FG011|Overall Study|Pregnancy|0|||
46785417|NCT00328627|83004463|FG000|Overall Study|Physician Decision|4|||
46785418|NCT00328627|83004464|FG001|Overall Study|Physician Decision|3|||
46785419|NCT00328627|83004465|FG002|Overall Study|Physician Decision|1|||
46785420|NCT00328627|83004466|FG003|Overall Study|Physician Decision|2|||
46785421|NCT00328627|83004467|FG004|Overall Study|Physician Decision|1|||
46785422|NCT00328627|83004468|FG005|Overall Study|Physician Decision|1|||
46785423|NCT00328627|83004469|FG006|Overall Study|Physician Decision|1|||
46785424|NCT00328627|83004470|FG007|Overall Study|Physician Decision|0|||
46785425|NCT00328627|83004471|FG008|Overall Study|Physician Decision|3|||
46785426|NCT00328627|83004472|FG009|Overall Study|Physician Decision|2|||
46785427|NCT00328627|83004473|FG010|Overall Study|Physician Decision|1|||
46785428|NCT00328627|83004474|FG011|Overall Study|Physician Decision|0|||
46785429|NCT00328627|83004463|FG000|Overall Study|Other|0|||
46785430|NCT00328627|83004464|FG001|Overall Study|Other|0|||
46785431|NCT00328627|83004465|FG002|Overall Study|Other|0|||
46785432|NCT00328627|83004466|FG003|Overall Study|Other|1|||
46785433|NCT00328627|83004467|FG004|Overall Study|Other|0|||
46785434|NCT00328627|83004468|FG005|Overall Study|Other|0|||
46785435|NCT00328627|83004469|FG006|Overall Study|Other|1|||
46785436|NCT00328627|83004470|FG007|Overall Study|Other|0|||
46668014|NCT03176771|82882630|FG003|Double-Blind Extension Period|Adverse Event|15|||
46668015|NCT03176771|82882631|FG004|Double-Blind Extension Period|Adverse Event|18|||
46668016|NCT03176771|82882627|FG000|Double-Blind Extension Period|Death|0|||
46668017|NCT03176771|82882628|FG001|Double-Blind Extension Period|Death|0|||
46668018|NCT03176771|82882629|FG002|Double-Blind Extension Period|Death|0|||
46668019|NCT03176771|82882630|FG003|Double-Blind Extension Period|Death|3|||
46668020|NCT03176771|82882631|FG004|Double-Blind Extension Period|Death|4|||
46668021|NCT03176771|82882627|FG000|Double-Blind Extension Period|Physician Decision|0|||
46668022|NCT03176771|82882628|FG001|Double-Blind Extension Period|Physician Decision|0|||
46668023|NCT03176771|82882629|FG002|Double-Blind Extension Period|Physician Decision|0|||
46668024|NCT03176771|82882630|FG003|Double-Blind Extension Period|Physician Decision|3|||
46668025|NCT03176771|82882631|FG004|Double-Blind Extension Period|Physician Decision|1|||
46668026|NCT03176771|82882627|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
46668027|NCT03176771|82882628|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
46668028|NCT03176771|82882629|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
46668029|NCT03176771|82882630|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
46668030|NCT03176771|82882631|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
46668031|NCT02789020|82882647|FG000|Overall Study|Withdrawal by Subject|6|||
46785437|NCT00328627|83004471|FG008|Overall Study|Other|0|||
46785438|NCT00328627|83004472|FG009|Overall Study|Other|1|||
46785439|NCT00328627|83004473|FG010|Overall Study|Other|1|||
46785440|NCT00328627|83004474|FG011|Overall Study|Other|0|||
46785441|NCT03977727|83004510|FG000|Second Treatment|Lost to Follow-up|0|||
46785442|NCT03977727|83004511|FG001|Second Treatment|Lost to Follow-up|3|||
46785443|NCT00663858|83004520|FG000|Overall Study|Adverse Event|9|||
46785444|NCT00663858|83004521|FG001|Overall Study|Adverse Event|1|||
46785445|NCT00663858|83004522|FG002|Overall Study|Adverse Event|6|||
46785446|NCT00663858|83004520|FG000|Overall Study|Lack of Efficacy|5|||
46785447|NCT00663858|83004521|FG001|Overall Study|Lack of Efficacy|1|||
46785448|NCT00663858|83004522|FG002|Overall Study|Lack of Efficacy|3|||
46785449|NCT00663858|83004520|FG000|Overall Study|Withdrawal by Subject|7|||
46785450|NCT00663858|83004521|FG001|Overall Study|Withdrawal by Subject|3|||
46785451|NCT00663858|83004522|FG002|Overall Study|Withdrawal by Subject|3|||
46785452|NCT00663858|83004520|FG000|Overall Study|Protocol Violation|5|||
46785453|NCT00663858|83004521|FG001|Overall Study|Protocol Violation|3|||
46785454|NCT00663858|83004522|FG002|Overall Study|Protocol Violation|4|||
46668032|NCT02789020|82882648|FG001|Overall Study|Withdrawal by Subject|5|||
46785455|NCT00663858|83004520|FG000|Overall Study|Other|8|||
46785456|NCT00663858|83004521|FG001|Overall Study|Other|2|||
46785457|NCT00663858|83004522|FG002|Overall Study|Other|4|||
46785458|NCT00659880|83004530|FG000|Overall Study|Lost to Follow-up|5|||
46785459|NCT00683774|83004537|FG000|Overall Study|Withdrawal by Subject|0|||
46668033|NCT02427841|82882685|FG000|Overall Study|Lack of Efficacy|5|||
46785460|NCT00683774|83004538|FG001|Overall Study|Withdrawal by Subject|1|||
46785461|NCT00683774|83004537|FG000|Overall Study|Physician Decision|3|||
46785462|NCT00683774|83004538|FG001|Overall Study|Physician Decision|0|||
46785463|NCT00354679|83004544|FG000|Overall Study|Patient Not Treated|1|||
46785464|NCT00683696|83004550|FG000|Overall Study|Withdrawn due to study closure|337|||
46785465|NCT00683696|83004551|FG001|Overall Study|Withdrawn due to study closure|338|||
46785466|NCT00683696|83004550|FG000|Overall Study|Withdrawn prior to study closure|13|||
46785467|NCT00683696|83004551|FG001|Overall Study|Withdrawn prior to study closure|28|||
46785468|NCT00683696|83004550|FG000|Overall Study|Lost to Follow-up|5|||
46785469|NCT00683696|83004551|FG001|Overall Study|Lost to Follow-up|6|||
46785470|NCT00683696|83004550|FG000|Overall Study|Vital status follow-up only|3|||
46785471|NCT00683696|83004551|FG001|Overall Study|Vital status follow-up only|3|||
46785472|NCT00683696|83004550|FG000|Overall Study|Death|46|||
46785473|NCT00683696|83004551|FG001|Overall Study|Death|30|||
46785474|NCT00345631|83004561|FG000|Overall Study|Withdrawal by Subject|1|||
46785475|NCT00345631|83004562|FG001|Overall Study|Withdrawal by Subject|0|||
46785476|NCT00345631|83004563|FG002|Overall Study|Withdrawal by Subject|1|||
46785477|NCT00345631|83004561|FG000|Overall Study|Adverse Event|0|||
46785478|NCT00345631|83004562|FG001|Overall Study|Adverse Event|1|||
46785479|NCT00345631|83004563|FG002|Overall Study|Adverse Event|0|||
46785480|NCT00345631|83004561|FG000|Overall Study|Lost to Follow-up|3|||
46785481|NCT00345631|83004562|FG001|Overall Study|Lost to Follow-up|7|||
46785482|NCT00345631|83004563|FG002|Overall Study|Lost to Follow-up|4|||
46785483|NCT00345631|83004561|FG000|Overall Study|Other reasons|0|||
46785484|NCT00345631|83004562|FG001|Overall Study|Other reasons|0|||
46785485|NCT00345631|83004563|FG002|Overall Study|Other reasons|1|||
46785486|NCT00540514|83004575|FG000|Overall Study|Still on treatment|3|||
46785487|NCT00540514|83004576|FG001|Overall Study|Still on treatment|0|||
46785488|NCT00540514|83004575|FG000|Overall Study|Unacceptable Toxicity|61|||
46785489|NCT00540514|83004576|FG001|Overall Study|Unacceptable Toxicity|62|||
46785490|NCT00540514|83004575|FG000|Overall Study|Adverse Event|20|||
46785491|NCT00540514|83004576|FG001|Overall Study|Adverse Event|24|||
46785492|NCT00540514|83004575|FG000|Overall Study|Physician Decision|86|||
46785493|NCT00540514|83004576|FG001|Overall Study|Physician Decision|99|||
46785494|NCT00540514|83004575|FG000|Overall Study|Protocol Deviation|3|||
46785495|NCT00540514|83004576|FG001|Overall Study|Protocol Deviation|4|||
46785496|NCT00540514|83004575|FG000|Overall Study|Lost to Follow-up|1|||
46785497|NCT00540514|83004576|FG001|Overall Study|Lost to Follow-up|1|||
46785498|NCT00540514|83004575|FG000|Overall Study|Withdrawal by Subject|65|||
46785499|NCT00540514|83004576|FG001|Overall Study|Withdrawal by Subject|67|||
46785500|NCT00540514|83004575|FG000|Overall Study|Excluded prior to treatment|7|||
46785501|NCT00540514|83004576|FG001|Overall Study|Excluded prior to treatment|7|||
46785502|NCT00540514|83004575|FG000|Overall Study|Paclitaxel not available|0|||
46785503|NCT00540514|83004576|FG001|Overall Study|Paclitaxel not available|2|||
46785504|NCT00663702|83004585|FG000|Overall Study|Adverse Event|8|||
46785505|NCT00663702|83004586|FG001|Overall Study|Adverse Event|4|||
46851385|NCT00116805|83066997|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
46851386|NCT00116805|83066998|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
46851387|NCT00116805|83066997|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
46851388|NCT00116805|83066998|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
46851389|NCT00116805|83066997|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
46668034|NCT02427841|82882685|FG000|Overall Study|Physician Decision|2|||
46668035|NCT02427841|82882685|FG000|Overall Study|Withdrawal by Subject|1|||
46668036|NCT02348216|82882697|FG000|Overall Study|Death|4|||
46668037|NCT02348216|82882698|FG001|Overall Study|Death|27|||
46668038|NCT02348216|82882699|FG002|Overall Study|Death|3|||
46668039|NCT02348216|82882700|FG003|Overall Study|Death|18|||
46668040|NCT02348216|82882701|FG004|Overall Study|Death|9|||
46668041|NCT02348216|82882702|FG005|Overall Study|Death|23|||
46668042|NCT02348216|82882703|FG006|Overall Study|Death|6|||
46668043|NCT02348216|82882697|FG000|Overall Study|Full consent withdrawal|0|||
46668044|NCT02348216|82882698|FG001|Overall Study|Full consent withdrawal|0|||
46785506|NCT00663702|83004585|FG000|Overall Study|Withdrawal by Subject|3|||
46785507|NCT00663702|83004586|FG001|Overall Study|Withdrawal by Subject|1|||
46785508|NCT00663702|83004585|FG000|Overall Study|Pregnancy|0|||
46785509|NCT00663702|83004586|FG001|Overall Study|Pregnancy|1|||
46851390|NCT00116805|83066998|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
46785510|NCT00663702|83004585|FG000|Overall Study|Lost to Follow-up|3|||
46785511|NCT00663702|83004586|FG001|Overall Study|Lost to Follow-up|0|||
46785512|NCT00663702|83004585|FG000|Overall Study|Death|1|||
46785513|NCT00663702|83004586|FG001|Overall Study|Death|1|||
46785514|NCT00663702|83004585|FG000|Overall Study|Lack of Efficacy|3|||
46785515|NCT00663702|83004586|FG001|Overall Study|Lack of Efficacy|3|||
46785516|NCT00683618|83004595|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
46851391|NCT00116805|83066997|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
46972582|NCT02075632|83216291|FG000|Overall Study|Withdrawal by Subject|0|||
46668045|NCT02348216|82882699|FG002|Overall Study|Full consent withdrawal|0|||
46668046|NCT02348216|82882700|FG003|Overall Study|Full consent withdrawal|1|||
46785517|NCT00683618|83004596|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
46785518|NCT00683618|83004597|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
46785519|NCT00683618|83004595|FG000|Randomised Treatment Period|Protocol Violation|0|||
46668047|NCT02348216|82882701|FG004|Overall Study|Full consent withdrawal|0|||
46668048|NCT02348216|82882702|FG005|Overall Study|Full consent withdrawal|0|||
46668049|NCT02348216|82882703|FG006|Overall Study|Full consent withdrawal|1|||
46668050|NCT02348216|82882697|FG000|Overall Study|Lost to Follow-up|0|||
46668051|NCT02348216|82882698|FG001|Overall Study|Lost to Follow-up|0|||
46668052|NCT02348216|82882699|FG002|Overall Study|Lost to Follow-up|0|||
46668053|NCT02348216|82882700|FG003|Overall Study|Lost to Follow-up|0|||
46668054|NCT02348216|82882701|FG004|Overall Study|Lost to Follow-up|0|||
46668055|NCT02348216|82882702|FG005|Overall Study|Lost to Follow-up|0|||
46668056|NCT02348216|82882703|FG006|Overall Study|Lost to Follow-up|1|||
46668057|NCT02348216|82882697|FG000|Overall Study|Still on study|3|||
46668058|NCT02348216|82882698|FG001|Overall Study|Still on study|50|||
46668059|NCT02348216|82882699|FG002|Overall Study|Still on study|21|||
46668060|NCT02348216|82882700|FG003|Overall Study|Still on study|19|||
46668061|NCT02348216|82882701|FG004|Overall Study|Still on study|32|||
46668062|NCT02348216|82882702|FG005|Overall Study|Still on study|27|||
46668063|NCT02348216|82882703|FG006|Overall Study|Still on study|32|||
46668064|NCT02348216|82882697|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
46668065|NCT02348216|82882698|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
46668066|NCT02348216|82882699|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
46668067|NCT02348216|82882700|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
46668068|NCT02348216|82882701|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
46668069|NCT02348216|82882702|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
46668070|NCT02348216|82882703|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
46785520|NCT00683618|83004596|FG001|Randomised Treatment Period|Protocol Violation|1|||
46785521|NCT00683618|83004597|FG002|Randomised Treatment Period|Protocol Violation|0|||
46785522|NCT00683618|83004595|FG000|Randomised Treatment Period|Adverse Event|2|||
46785523|NCT00683618|83004596|FG001|Randomised Treatment Period|Adverse Event|0|||
46785524|NCT00683618|83004597|FG002|Randomised Treatment Period|Adverse Event|2|||
46668071|NCT02037529|82882743|FG000|Overall Study|Withdrawal by Subject|1|||
46668072|NCT02037529|82882744|FG001|Overall Study|Withdrawal by Subject|3|||
46668073|NCT02037529|82882743|FG000|Overall Study|Adverse Event|0|||
46668074|NCT02037529|82882744|FG001|Overall Study|Adverse Event|1|||
46668075|NCT02030028|82882751|FG000|Overall Study|Withdrawal by Subject|4|||
46668076|NCT02030028|82882751|FG000|Overall Study|lack of transportation|1|||
46668077|NCT01956123|82882757|FG000|COS Cycle 2|Protocol Violation|8|||
46668078|NCT01956123|82882758|FG001|COS Cycle 2|Protocol Violation|3|||
46668079|NCT01956123|82882759|FG002|COS Cycle 2|Protocol Violation|0|||
46785525|NCT00683618|83004595|FG000|Randomised Treatment Period|Reason not provided|0|||
46785526|NCT00683618|83004596|FG001|Randomised Treatment Period|Reason not provided|0|||
46785527|NCT00683618|83004597|FG002|Randomised Treatment Period|Reason not provided|2|||
46785528|NCT00683618|83004595|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
46785529|NCT00683618|83004596|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
46785530|NCT00683618|83004597|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
46785531|NCT00683618|83004595|FG000|Extension Treatment Period|Adverse Event|1|||
46785532|NCT00683618|83004596|FG001|Extension Treatment Period|Adverse Event|0|||
46785533|NCT00683618|83004597|FG002|Extension Treatment Period|Adverse Event|0|||
46785534|NCT00683618|83004595|FG000|Extension Treatment Period|Protocol Violation|1|||
46785535|NCT00683618|83004596|FG001|Extension Treatment Period|Protocol Violation|0|||
46785536|NCT00683618|83004597|FG002|Extension Treatment Period|Protocol Violation|0|||
46785537|NCT00688064|83004609|FG000|Overall Study|Protocol Violation|0|||
46785538|NCT00688064|83004610|FG001|Overall Study|Protocol Violation|1|||
46785539|NCT00688064|83004609|FG000|Overall Study|Adverse Event|2|||
46785540|NCT00688064|83004610|FG001|Overall Study|Adverse Event|4|||
46785541|NCT00688064|83004609|FG000|Overall Study|Withdrawal by Subject|7|||
46785542|NCT00688064|83004610|FG001|Overall Study|Withdrawal by Subject|7|||
46785543|NCT00688064|83004609|FG000|Overall Study|Lost to Follow-up|10|||
46785544|NCT00688064|83004610|FG001|Overall Study|Lost to Follow-up|10|||
46785545|NCT00688064|83004609|FG000|Overall Study|Lack of Efficacy|0|||
46785546|NCT00688064|83004610|FG001|Overall Study|Lack of Efficacy|1|||
46785547|NCT00688064|83004609|FG000|Overall Study|Pregnancy|1|||
46785548|NCT00688064|83004610|FG001|Overall Study|Pregnancy|0|||
46785549|NCT00688064|83004609|FG000|Overall Study|Any other reasons|1|||
46851392|NCT00116805|83066998|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
46851393|NCT00116805|83066997|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
46785550|NCT00688064|83004610|FG001|Overall Study|Any other reasons|3|||
46785551|NCT00663234|83004616|FG000|Overall Study|Not willing to adhere to requirements|1|||
46785552|NCT00683384|83004624|FG000|Overall Study|Death|1|||
46785553|NCT00683384|83004624|FG000|Overall Study|Adverse Event|1|||
47077054|NCT00081653|83375351|FG000|Overall Study|Lost to Follow-up|2|||
46785554|NCT00326911|83004630|FG000|Overall Study|Hospitalization prior to treatment|0|||
46785555|NCT00326911|83004631|FG001|Overall Study|Hospitalization prior to treatment|1|||
46785556|NCT00326911|83004630|FG000|Overall Study|Physician decision prior to treatment|1|||
46668080|NCT01956123|82882760|FG003|COS Cycle 2|Protocol Violation|0|||
46785557|NCT00326911|83004631|FG001|Overall Study|Physician decision prior to treatment|0|||
46785558|NCT00326911|83004630|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
46785559|NCT00326911|83004631|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
46785560|NCT00540436|83004637|FG000|First 12-Week Treatment Period|Adverse Event|1|||
46785561|NCT00540436|83004637|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
46785562|NCT00540436|83004637|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
46785563|NCT00540436|83004637|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
46785564|NCT00687440|83004641|FG000|Overall Study|Adverse Event|3|||
46785565|NCT00687440|83004641|FG000|Overall Study|Lost to Follow-up|3|||
46785566|NCT00687440|83004641|FG000|Overall Study|Lack of Efficacy|2|||
46785567|NCT00687440|83004641|FG000|Overall Study|Death|2|||
46785568|NCT00687440|83004641|FG000|Overall Study|Other|1|||
46785569|NCT00687440|83004641|FG000|Overall Study|Missing|1|||
46785570|NCT00659490|83004648|FG000|Overall Study|Lost to Follow-up|2|||
46785571|NCT00659490|83004649|FG001|Overall Study|Lost to Follow-up|0|||
46785572|NCT00659490|83004650|FG002|Overall Study|Lost to Follow-up|1|||
46785573|NCT00539500|83004658|FG000|Overall Study|Disease Progression|1|||
46785574|NCT00539500|83004658|FG000|Overall Study|Lost to Follow-up|2|||
46785575|NCT00662532|83004664|FG000|Overall Study|Adverse Event|0|||
46785576|NCT00662532|83004665|FG001|Overall Study|Adverse Event|1|||
46785577|NCT00662532|83004664|FG000|Overall Study|Lost to Follow-up|0|||
46785578|NCT00662532|83004665|FG001|Overall Study|Lost to Follow-up|1|||
46785579|NCT00686036|83004673|FG000|Overall Study|Adverse Event|3|||
46785580|NCT00686036|83004674|FG001|Overall Study|Adverse Event|0|||
46785581|NCT00686036|83004673|FG000|Overall Study|Withdrawal by Subject|3|||
46785582|NCT00686036|83004674|FG001|Overall Study|Withdrawal by Subject|1|||
46785583|NCT00686036|83004673|FG000|Overall Study|Study terminated by AstraZeneca|2|||
46851394|NCT00116805|83066998|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
46851395|NCT00116805|83066997|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
46851396|NCT00116805|83066998|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
46851397|NCT00116805|83066997|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
46851398|NCT00116805|83066998|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
46851399|NCT00116805|83066997|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
46851400|NCT00116805|83066998|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
46851401|NCT00116805|83066997|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
46851402|NCT00116805|83066998|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
46851403|NCT00116805|83066997|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
46851404|NCT00116805|83066998|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
46851405|NCT00116805|83066997|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
46851406|NCT00116805|83066998|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
46851407|NCT00116805|83066997|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
46851408|NCT00116805|83066998|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
46851409|NCT00116649|83067013|FG000|Overall Study|Adverse Event|20|||
46851410|NCT00116649|83067013|FG000|Overall Study|Lack of Efficacy|1|||
46851411|NCT00116649|83067013|FG000|Overall Study|Lost to Follow-up|32|||
46851412|NCT00116649|83067013|FG000|Overall Study|Withdrawal by Subject|68|||
46851413|NCT00116649|83067013|FG000|Overall Study|Local Skin Reaction|9|||
46851414|NCT00116649|83067013|FG000|Overall Study|Various Reasons|18|||
46851415|NCT00116649|83067013|FG000|Overall Study|Protocol Specified|7|||
46851416|NCT00083889|83067019|FG000|Overall Study|Adverse Event|76|||
46851417|NCT00083889|83067020|FG001|Overall Study|Adverse Event|86|||
46851418|NCT00083889|83067019|FG000|Overall Study|Protocol Violation|2|||
46851419|NCT00083889|83067020|FG001|Overall Study|Protocol Violation|2|||
46851420|NCT00083889|83067019|FG000|Overall Study|Withdrawal by Subject|22|||
46851421|NCT00083889|83067020|FG001|Overall Study|Withdrawal by Subject|24|||
46851422|NCT00083889|83067019|FG000|Overall Study|Lack of Efficacy|240|||
46851423|NCT00083889|83067020|FG001|Overall Study|Lack of Efficacy|219|||
47077055|NCT00081653|83375352|FG001|Overall Study|Lost to Follow-up|4|||
46668081|NCT01956123|82882757|FG000|COS Cycle 2|Adverse Event|3|||
46668082|NCT01956123|82882758|FG001|COS Cycle 2|Adverse Event|4|||
46668083|NCT01956123|82882759|FG002|COS Cycle 2|Adverse Event|0|||
46668084|NCT01956123|82882760|FG003|COS Cycle 2|Adverse Event|0|||
46668085|NCT01956123|82882757|FG000|COS Cycle 2|Personal Reasons|2|||
46668086|NCT01956123|82882758|FG001|COS Cycle 2|Personal Reasons|0|||
46668087|NCT01956123|82882759|FG002|COS Cycle 2|Personal Reasons|0|||
46668088|NCT01956123|82882760|FG003|COS Cycle 2|Personal Reasons|0|||
46668089|NCT01956123|82882757|FG000|COS Cycle 2|Withdrawal by Subject|1|||
46668090|NCT01956123|82882758|FG001|COS Cycle 2|Withdrawal by Subject|0|||
46785584|NCT00686036|83004674|FG001|Overall Study|Study terminated by AstraZeneca|1|||
46785585|NCT00686036|83004673|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
46785586|NCT00686036|83004674|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
46785587|NCT00686036|83004673|FG000|Overall Study|Other reasons not identified|0|||
46785588|NCT00686036|83004674|FG001|Overall Study|Other reasons not identified|4|||
46785589|NCT00682448|83004682|FG000|Overall Study|Adverse Event|1|||
46785590|NCT00682448|83004683|FG001|Overall Study|Adverse Event|2|||
46785591|NCT00682448|83004682|FG000|Overall Study|Lack of Efficacy|1|||
46785592|NCT00682448|83004683|FG001|Overall Study|Lack of Efficacy|0|||
46668091|NCT01956123|82882759|FG002|COS Cycle 2|Withdrawal by Subject|0|||
46668092|NCT01956123|82882760|FG003|COS Cycle 2|Withdrawal by Subject|0|||
46668093|NCT01956123|82882757|FG000|COS Cycle 3|Protocol Violation|0|||
46668094|NCT01956123|82882758|FG001|COS Cycle 3|Protocol Violation|0|||
46668095|NCT01956123|82882759|FG002|COS Cycle 3|Protocol Violation|2|||
46668096|NCT01956123|82882760|FG003|COS Cycle 3|Protocol Violation|1|||
46668097|NCT01956123|82882757|FG000|COS Cycle 3|Adverse Event|0|||
46668098|NCT01956123|82882758|FG001|COS Cycle 3|Adverse Event|0|||
46668099|NCT01956123|82882759|FG002|COS Cycle 3|Adverse Event|3|||
46668100|NCT01956123|82882760|FG003|COS Cycle 3|Adverse Event|0|||
46668101|NCT01956123|82882757|FG000|COS Cycle 3|Personal Reasons|0|||
46668102|NCT01956123|82882758|FG001|COS Cycle 3|Personal Reasons|0|||
46668103|NCT01956123|82882759|FG002|COS Cycle 3|Personal Reasons|1|||
46668104|NCT01956123|82882760|FG003|COS Cycle 3|Personal Reasons|0|||
46668105|NCT01956123|82882757|FG000|COS Cycle 3|Withdrawal by Subject|0|||
46668106|NCT01956123|82882758|FG001|COS Cycle 3|Withdrawal by Subject|0|||
46668107|NCT01956123|82882759|FG002|COS Cycle 3|Withdrawal by Subject|0|||
47077056|NCT00081653|83375351|FG000|Overall Study|Refused Treatment|18|||
46668108|NCT01956123|82882760|FG003|COS Cycle 3|Withdrawal by Subject|1|||
46668109|NCT01191697|82882780|FG000|Overall Study|Death|1|||
46668110|NCT01191697|82882780|FG000|Overall Study|Physician Decision|2|||
46668111|NCT01191697|82882780|FG000|Overall Study|Pursue chemoradiation|2|||
46668112|NCT01191697|82882780|FG000|Overall Study|Break from chemotherapy|2|||
46668113|NCT01191697|82882780|FG000|Overall Study|Withdrawal by Subject|1|||
46668114|NCT01191697|82882780|FG000|Overall Study|Surveillance|1|||
46668115|NCT01191697|82882780|FG000|Overall Study|Adverse Event|2|||
46668116|NCT01191697|82882780|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
46668117|NCT01191697|82882780|FG000|Overall Study|Not completed but analyzed|25|||
46668118|NCT01044745|82882784|FG000|Overall Study|Ineiligible|2|||
46668119|NCT01295827|82882801|FG000|Overall Study|Adverse Event|1|||
46668120|NCT01295827|82882802|FG001|Overall Study|Adverse Event|2|||
46668121|NCT01295827|82882803|FG002|Overall Study|Adverse Event|2|||
46668122|NCT01295827|82882804|FG003|Overall Study|Adverse Event|1|||
46668123|NCT01295827|82882805|FG004|Overall Study|Adverse Event|1|||
46668124|NCT01295827|82882806|FG005|Overall Study|Adverse Event|4|||
46668125|NCT01295827|82882807|FG006|Overall Study|Adverse Event|15|||
46668126|NCT01295827|82882808|FG007|Overall Study|Adverse Event|49|||
46668127|NCT01295827|82882809|FG008|Overall Study|Adverse Event|22|||
46668128|NCT01295827|82882810|FG009|Overall Study|Adverse Event|7|||
46668129|NCT01295827|82882811|FG010|Overall Study|Adverse Event|50|||
46668130|NCT01295827|82882812|FG011|Overall Study|Adverse Event|21|||
46668131|NCT01295827|82882813|FG012|Overall Study|Adverse Event|0|||
46668132|NCT01295827|82882814|FG013|Overall Study|Adverse Event|0|||
46668133|NCT01295827|82882815|FG014|Overall Study|Adverse Event|0|||
46668134|NCT01295827|82882801|FG000|Overall Study|Lost to Follow-up|0|||
46668135|NCT01295827|82882802|FG001|Overall Study|Lost to Follow-up|0|||
46668136|NCT01295827|82882803|FG002|Overall Study|Lost to Follow-up|3|||
46668137|NCT01295827|82882804|FG003|Overall Study|Lost to Follow-up|0|||
46668138|NCT01295827|82882805|FG004|Overall Study|Lost to Follow-up|1|||
46668139|NCT01295827|82882806|FG005|Overall Study|Lost to Follow-up|0|||
46785593|NCT00682448|83004682|FG000|Overall Study|Lost to Follow-up|1|||
46785594|NCT00682448|83004683|FG001|Overall Study|Lost to Follow-up|3|||
46785595|NCT00682448|83004682|FG000|Overall Study|Pregnancy|0|||
46785596|NCT00682448|83004683|FG001|Overall Study|Pregnancy|1|||
46785597|NCT00682448|83004682|FG000|Overall Study|Withdrawal by Subject|2|||
46785598|NCT00682448|83004683|FG001|Overall Study|Withdrawal by Subject|0|||
46785599|NCT00681824|83004692|FG000|Overall Study|withdrawn by investigator|0|||
46785600|NCT00681824|83004693|FG001|Overall Study|withdrawn by investigator|0|||
46785601|NCT00681824|83004694|FG002|Overall Study|withdrawn by investigator|1|||
46785602|NCT00681824|83004692|FG000|Overall Study|scheduling conflict|1|||
46785603|NCT00681824|83004693|FG001|Overall Study|scheduling conflict|0|||
46785604|NCT00681824|83004694|FG002|Overall Study|scheduling conflict|0|||
47077057|NCT00081653|83375352|FG001|Overall Study|Refused Treatment|14|||
46668140|NCT01295827|82882807|FG006|Overall Study|Lost to Follow-up|4|||
46668141|NCT01295827|82882808|FG007|Overall Study|Lost to Follow-up|8|||
46668142|NCT01295827|82882809|FG008|Overall Study|Lost to Follow-up|7|||
46668143|NCT01295827|82882810|FG009|Overall Study|Lost to Follow-up|4|||
46785605|NCT00681824|83004692|FG000|Overall Study|Death|0|||
47077058|NCT00081653|83375351|FG000|Overall Study|Low bone mineral density|1|||
46668144|NCT01295827|82882811|FG010|Overall Study|Lost to Follow-up|7|||
46668145|NCT01295827|82882812|FG011|Overall Study|Lost to Follow-up|3|||
46668146|NCT01295827|82882813|FG012|Overall Study|Lost to Follow-up|0|||
46668147|NCT01295827|82882814|FG013|Overall Study|Lost to Follow-up|0|||
46668148|NCT01295827|82882815|FG014|Overall Study|Lost to Follow-up|0|||
46668149|NCT01295827|82882801|FG000|Overall Study|Not Reported|0|||
46668150|NCT01295827|82882802|FG001|Overall Study|Not Reported|0|||
46785606|NCT00681824|83004693|FG001|Overall Study|Death|1|||
46785607|NCT00681824|83004694|FG002|Overall Study|Death|0|||
46785608|NCT00681668|83004702|FG000|Overall Study|Protocol Violation|1|||
46785609|NCT00681668|83004702|FG000|Overall Study|Withdrawal by Subject|1|||
46785610|NCT00539188|83004708|FG000|Overall Study|Withdrawal by Subject|1|||
46785611|NCT00539188|83004709|FG001|Overall Study|Withdrawal by Subject|0|||
46785612|NCT00539188|83004708|FG000|Overall Study|Lost to Follow-up|2|||
46785613|NCT00539188|83004709|FG001|Overall Study|Lost to Follow-up|1|||
46785614|NCT00681590|83004717|FG000|Overall Study|Withdrawal by Subject|2|||
46785615|NCT00681590|83004718|FG001|Overall Study|Withdrawal by Subject|12|||
46785616|NCT04980456|83004726|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
46785617|NCT04980456|83004727|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
46785618|NCT04980456|83004726|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
46668151|NCT01295827|82882803|FG002|Overall Study|Not Reported|0|||
46668152|NCT01295827|82882804|FG003|Overall Study|Not Reported|1|||
46668153|NCT01295827|82882805|FG004|Overall Study|Not Reported|0|||
46668154|NCT01295827|82882806|FG005|Overall Study|Not Reported|0|||
46668155|NCT01295827|82882807|FG006|Overall Study|Not Reported|24|||
46668156|NCT01295827|82882808|FG007|Overall Study|Not Reported|58|||
46668157|NCT01295827|82882809|FG008|Overall Study|Not Reported|41|||
46668158|NCT01295827|82882810|FG009|Overall Study|Not Reported|2|||
46668159|NCT01295827|82882811|FG010|Overall Study|Not Reported|23|||
47077059|NCT00081653|83375352|FG001|Overall Study|Low bone mineral density|0|||
47077060|NCT00081653|83375351|FG000|Overall Study|Bone loss|2|||
46668160|NCT01295827|82882812|FG011|Overall Study|Not Reported|13|||
46668161|NCT01295827|82882813|FG012|Overall Study|Not Reported|0|||
46668162|NCT01295827|82882814|FG013|Overall Study|Not Reported|0|||
46668163|NCT01295827|82882815|FG014|Overall Study|Not Reported|0|||
46668164|NCT01295827|82882801|FG000|Overall Study|Progressive Disease|2|||
46668165|NCT01295827|82882802|FG001|Overall Study|Progressive Disease|1|||
46668166|NCT01295827|82882803|FG002|Overall Study|Progressive Disease|5|||
46668167|NCT01295827|82882804|FG003|Overall Study|Progressive Disease|2|||
46668168|NCT01295827|82882805|FG004|Overall Study|Progressive Disease|0|||
46668169|NCT01295827|82882806|FG005|Overall Study|Progressive Disease|1|||
46668170|NCT01295827|82882807|FG006|Overall Study|Progressive Disease|87|||
46668171|NCT01295827|82882808|FG007|Overall Study|Progressive Disease|144|||
46668172|NCT01295827|82882809|FG008|Overall Study|Progressive Disease|85|||
46668173|NCT01295827|82882810|FG009|Overall Study|Progressive Disease|40|||
46668174|NCT01295827|82882811|FG010|Overall Study|Progressive Disease|175|||
46668175|NCT01295827|82882812|FG011|Overall Study|Progressive Disease|136|||
46668176|NCT01295827|82882813|FG012|Overall Study|Progressive Disease|0|||
46668177|NCT01295827|82882814|FG013|Overall Study|Progressive Disease|0|||
46668178|NCT01295827|82882815|FG014|Overall Study|Progressive Disease|0|||
46668179|NCT01295827|82882801|FG000|Overall Study|Screen Failure|0|||
46668180|NCT01295827|82882802|FG001|Overall Study|Screen Failure|0|||
46668181|NCT01295827|82882803|FG002|Overall Study|Screen Failure|0|||
46668182|NCT01295827|82882804|FG003|Overall Study|Screen Failure|0|||
46668183|NCT01295827|82882805|FG004|Overall Study|Screen Failure|0|||
46668184|NCT01295827|82882806|FG005|Overall Study|Screen Failure|0|||
46668185|NCT01295827|82882807|FG006|Overall Study|Screen Failure|2|||
46668186|NCT01295827|82882808|FG007|Overall Study|Screen Failure|2|||
46668187|NCT01295827|82882809|FG008|Overall Study|Screen Failure|2|||
46668188|NCT01295827|82882810|FG009|Overall Study|Screen Failure|0|||
46668189|NCT01295827|82882811|FG010|Overall Study|Screen Failure|1|||
46668190|NCT01295827|82882812|FG011|Overall Study|Screen Failure|0|||
46668191|NCT01295827|82882813|FG012|Overall Study|Screen Failure|0|||
46668192|NCT01295827|82882814|FG013|Overall Study|Screen Failure|0|||
46668193|NCT01295827|82882815|FG014|Overall Study|Screen Failure|0|||
46668194|NCT01295827|82882801|FG000|Overall Study|Withdrawal by Subject|1|||
46785619|NCT04980456|83004727|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
46785620|NCT04980456|83004726|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
46785621|NCT04980456|83004727|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
46785622|NCT04980456|83004726|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
46785623|NCT04980456|83004727|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
46785624|NCT00326599|83004740|FG000|Overall Study|Withdrawal by Subject|1|||
46851424|NCT00083889|83067019|FG000|Overall Study|Decision of sponsor|32|||
47077061|NCT00081653|83375352|FG001|Overall Study|Bone loss|0|||
47077062|NCT00081653|83375351|FG000|Overall Study|Participant leaving country|1|||
46668195|NCT01295827|82882802|FG001|Overall Study|Withdrawal by Subject|0|||
46668196|NCT01295827|82882803|FG002|Overall Study|Withdrawal by Subject|2|||
46668197|NCT01295827|82882804|FG003|Overall Study|Withdrawal by Subject|0|||
46785625|NCT00326599|83004741|FG001|Overall Study|Withdrawal by Subject|0|||
46785626|NCT00326599|83004742|FG002|Overall Study|Withdrawal by Subject|5|||
46785627|NCT00326599|83004743|FG003|Overall Study|Withdrawal by Subject|2|||
47077063|NCT00081653|83375352|FG001|Overall Study|Participant leaving country|0|||
46668198|NCT01295827|82882805|FG004|Overall Study|Withdrawal by Subject|0|||
46668199|NCT01295827|82882806|FG005|Overall Study|Withdrawal by Subject|1|||
46668200|NCT01295827|82882807|FG006|Overall Study|Withdrawal by Subject|13|||
46668201|NCT01295827|82882808|FG007|Overall Study|Withdrawal by Subject|35|||
46668202|NCT01295827|82882809|FG008|Overall Study|Withdrawal by Subject|11|||
46668203|NCT01295827|82882810|FG009|Overall Study|Withdrawal by Subject|2|||
46785628|NCT00326599|83004740|FG000|Overall Study|Adverse Event|1|||
46785629|NCT00326599|83004741|FG001|Overall Study|Adverse Event|0|||
46785630|NCT00326599|83004742|FG002|Overall Study|Adverse Event|32|||
46785631|NCT00326599|83004743|FG003|Overall Study|Adverse Event|3|||
46785632|NCT00326599|83004740|FG000|Overall Study|Disease Progression|3|||
46785633|NCT00326599|83004741|FG001|Overall Study|Disease Progression|1|||
46785634|NCT00326599|83004742|FG002|Overall Study|Disease Progression|13|||
46785635|NCT00326599|83004743|FG003|Overall Study|Disease Progression|11|||
46785636|NCT00326599|83004740|FG000|Overall Study|Alternate Treatment|1|||
46785637|NCT00326599|83004741|FG001|Overall Study|Alternate Treatment|0|||
46785638|NCT00326599|83004742|FG002|Overall Study|Alternate Treatment|0|||
46785639|NCT00326599|83004743|FG003|Overall Study|Alternate Treatment|0|||
46785640|NCT00326599|83004740|FG000|Overall Study|Death|0|||
46785641|NCT00326599|83004741|FG001|Overall Study|Death|0|||
46785642|NCT00326599|83004742|FG002|Overall Study|Death|1|||
46785643|NCT00326599|83004743|FG003|Overall Study|Death|2|||
46785644|NCT00326599|83004740|FG000|Overall Study|Other Unspecified Reason|0|||
46668204|NCT01295827|82882811|FG010|Overall Study|Withdrawal by Subject|18|||
46668205|NCT01295827|82882812|FG011|Overall Study|Withdrawal by Subject|13|||
46668206|NCT01295827|82882813|FG012|Overall Study|Withdrawal by Subject|0|||
46668207|NCT01295827|82882814|FG013|Overall Study|Withdrawal by Subject|0|||
46785645|NCT00326599|83004741|FG001|Overall Study|Other Unspecified Reason|0|||
46785646|NCT00326599|83004742|FG002|Overall Study|Other Unspecified Reason|2|||
46785647|NCT00326599|83004743|FG003|Overall Study|Other Unspecified Reason|1|||
46785648|NCT00539032|83004754|FG000|Overall Study|Withdrawal by Subject|2|||
46785649|NCT00539032|83004755|FG001|Overall Study|Withdrawal by Subject|1|||
46785650|NCT00685802|83004761|FG000|Washout Period of 7 Days|Protocol Violation|2|||
46785651|NCT00685802|83004762|FG001|Washout Period of 7 Days|Protocol Violation|0|||
46785652|NCT00685802|83004761|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
46785653|NCT00685802|83004762|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46785654|NCT00354601|83004768|FG000|Overall Study|Protocol Violation|1|||
46785655|NCT00354601|83004768|FG000|Overall Study|progression|1|||
46785656|NCT03827473|83004774|FG000|Overall Study|Withdrawal by Subject|1|||
46785657|NCT03827473|83004775|FG001|Overall Study|Withdrawal by Subject|0|||
46785658|NCT00345397|83004781|FG000|Overall Study|Death|1|||
46785659|NCT00326209|83004786|FG000|Overall Study|Adverse Event|28|||
46785660|NCT00326209|83004786|FG000|Overall Study|Withdrawal by Subject|22|||
46785661|NCT00326209|83004786|FG000|Overall Study|Lack of Efficacy|31|||
46785662|NCT00326209|83004786|FG000|Overall Study|Lost to Follow-up|18|||
46785663|NCT00326209|83004786|FG000|Overall Study|Participant non-compliant|6|||
46785664|NCT00326209|83004786|FG000|Overall Study|Sponsor closed study|173|||
46785665|NCT00326209|83004786|FG000|Overall Study|Prohibited medication use|1|||
46785666|NCT00326209|83004786|FG000|Overall Study|Violation of entry criteria|1|||
46785667|NCT00326209|83004786|FG000|Overall Study|Withdrawn in error|1|||
46785668|NCT00326209|83004786|FG000|Overall Study|Pregnancy|1|||
46785669|NCT00537940|83004792|FG000|Overall Study|Adverse Event|20|||
46785670|NCT00537940|83004793|FG001|Overall Study|Adverse Event|19|||
46785671|NCT00537940|83004792|FG000|Overall Study|Lack of Efficacy|8|||
46785672|NCT00537940|83004793|FG001|Overall Study|Lack of Efficacy|16|||
46785673|NCT00537940|83004792|FG000|Overall Study|Lost to Follow-up|23|||
46785674|NCT00537940|83004793|FG001|Overall Study|Lost to Follow-up|29|||
46785675|NCT00537940|83004792|FG000|Overall Study|Withdrawal by Subject|113|||
46785676|NCT00537940|83004793|FG001|Overall Study|Withdrawal by Subject|95|||
46785677|NCT00537940|83004792|FG000|Overall Study|Protocol Violation|6|||
46851425|NCT00083889|83067020|FG001|Overall Study|Decision of sponsor|4|||
46972583|NCT02075632|83216292|FG001|Overall Study|Withdrawal by Subject|1|||
46668208|NCT01295827|82882815|FG014|Overall Study|Withdrawal by Subject|0|||
46668209|NCT01295827|82882801|FG000|Overall Study|Other|0|||
46785678|NCT00537940|83004793|FG001|Overall Study|Protocol Violation|4|||
46785679|NCT00537940|83004792|FG000|Overall Study|Pregnancy|1|||
46785680|NCT00537940|83004793|FG001|Overall Study|Pregnancy|1|||
46785681|NCT00537940|83004792|FG000|Overall Study|Study terminated by sponsor|2|||
46785682|NCT00537940|83004793|FG001|Overall Study|Study terminated by sponsor|3|||
46785683|NCT00537940|83004792|FG000|Overall Study|Other|10|||
46785684|NCT00537940|83004793|FG001|Overall Study|Other|12|||
46785685|NCT00661362|83004801|FG000|Overall Study|Adverse Event|5|||
46668210|NCT01295827|82882802|FG001|Overall Study|Other|0|||
46785686|NCT00661362|83004802|FG001|Overall Study|Adverse Event|4|||
46785687|NCT00661362|83004801|FG000|Overall Study|Incorrect enrollment|2|||
46785688|NCT00661362|83004802|FG001|Overall Study|Incorrect enrollment|0|||
46785689|NCT00661362|83004801|FG000|Overall Study|Study specific discontinuation criteria|4|||
46851426|NCT00083889|83067019|FG000|Overall Study|Randomized: did not take study drug|0|||
46972584|NCT02075554|83216298|FG000|Overall Study|Lost to Follow-up|7|||
46668211|NCT01295827|82882803|FG002|Overall Study|Other|0|||
46785690|NCT00661362|83004802|FG001|Overall Study|Study specific discontinuation criteria|11|||
46785691|NCT00661362|83004801|FG000|Overall Study|Withdrawal by Subject|13|||
46785692|NCT00661362|83004802|FG001|Overall Study|Withdrawal by Subject|23|||
46785693|NCT00661362|83004801|FG000|Overall Study|Lost to Follow-up|3|||
46785694|NCT00661362|83004802|FG001|Overall Study|Lost to Follow-up|1|||
46668212|NCT01295827|82882804|FG003|Overall Study|Other|0|||
46668213|NCT01295827|82882805|FG004|Overall Study|Other|0|||
46668214|NCT01295827|82882806|FG005|Overall Study|Other|0|||
46668215|NCT01295827|82882807|FG006|Overall Study|Other|1|||
46668216|NCT01295827|82882808|FG007|Overall Study|Other|1|||
46668217|NCT01295827|82882809|FG008|Overall Study|Other|1|||
46668218|NCT01295827|82882810|FG009|Overall Study|Other|0|||
46668219|NCT01295827|82882811|FG010|Overall Study|Other|2|||
46668220|NCT01295827|82882812|FG011|Overall Study|Other|0|||
46668221|NCT01295827|82882813|FG012|Overall Study|Other|0|||
46668222|NCT01295827|82882814|FG013|Overall Study|Other|0|||
46668223|NCT01295827|82882815|FG014|Overall Study|Other|0|||
46668224|NCT01295671|82882871|FG000|Overall Study|Lost to Follow-up|4|||
46668225|NCT01295671|82882872|FG001|Overall Study|Lost to Follow-up|6|||
46668226|NCT01295671|82882873|FG002|Overall Study|Lost to Follow-up|3|||
46668227|NCT01295671|82882871|FG000|Overall Study|Withdrawal by Subject|3|||
46668228|NCT01295671|82882872|FG001|Overall Study|Withdrawal by Subject|1|||
46668229|NCT01295671|82882873|FG002|Overall Study|Withdrawal by Subject|0|||
46668230|NCT01295320|82882881|FG000|Overall Study|Adverse Event|2|||
46785695|NCT00661362|83004801|FG000|Overall Study|Severe non-compliance to protocol|0|||
46785696|NCT00661362|83004802|FG001|Overall Study|Severe non-compliance to protocol|1|||
46785697|NCT00661362|83004801|FG000|Overall Study|Safety reasons|1|||
46668231|NCT01295320|82882881|FG000|Overall Study|Lost to Follow-up|4|||
46668232|NCT01295320|82882881|FG000|Overall Study|Withdrawal by Subject|2|||
46668233|NCT01295320|82882881|FG000|Overall Study|Subject was bedridden|1|||
46668234|NCT01295320|82882881|FG000|Overall Study|Unable to travel|1|||
46668235|NCT01295281|82882887|FG000|First Intervention (7 Days)|Death|0|||
46668236|NCT01295281|82882888|FG001|First Intervention (7 Days)|Death|1|||
46785698|NCT00661362|83004802|FG001|Overall Study|Safety reasons|0|||
46785699|NCT00661362|83004801|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
46785700|NCT00661362|83004802|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
46785701|NCT00325897|83004810|FG000|Overall Study|Lost to Follow-up|12|||
46785702|NCT00325897|83004811|FG001|Overall Study|Lost to Follow-up|13|||
46785703|NCT00344773|83004820|FG000|Overall Study|Adverse Event|2|||
46785704|NCT00344773|83004820|FG000|Overall Study|Objective Disease Progression|16|||
46785705|NCT00344773|83004820|FG000|Overall Study|Withdrawal by Subject|1|||
46785706|NCT00344773|83004820|FG000|Overall Study|Not Eligible for the study|2|||
46785707|NCT00325819|83004826|FG000|Overall Study|Study product lost in mail|2|||
46785708|NCT00325819|83004827|FG001|Overall Study|Study product lost in mail|1|||
46785709|NCT00325819|83004826|FG000|Overall Study|Did not take a dose of study product|4|||
46668237|NCT01294696|82882896|FG000|Overall Study|Screening failures|7|||
46668238|NCT01294696|82882896|FG000|Overall Study|Protocol Violation|8|||
46668239|NCT01294696|82882896|FG000|Overall Study|Missing BPI Response|7|||
46668240|NCT01294696|82882896|FG000|Overall Study|Site closure|52|||
46668241|NCT01294579|82882901|FG000|Overall Study|Disease progression|12|||
46668242|NCT01294579|82882901|FG000|Overall Study|Adverse Event|11|||
46668243|NCT01294579|82882901|FG000|Overall Study|Study closed/terminated|3|||
46668244|NCT01294579|82882901|FG000|Overall Study|Lost to Follow-up|1|||
46668245|NCT01294579|82882901|FG000|Overall Study|Physician Decision|3|||
46668246|NCT01294579|82882901|FG000|Overall Study|Withdrawal by Subject|5|||
46668247|NCT01294462|82882907|FG000|Overall Study|Lost to Follow-up|1|||
46668248|NCT01294462|82882908|FG001|Overall Study|Lost to Follow-up|0|||
46668249|NCT01294462|82882907|FG000|Overall Study|Withdrawal by Subject|65|||
46668250|NCT01294462|82882908|FG001|Overall Study|Withdrawal by Subject|63|||
46668251|NCT01294423|82882917|FG000|Overall Study|Adverse Event|1|||
46668252|NCT01294423|82882918|FG001|Overall Study|Adverse Event|2|||
46668253|NCT01294423|82882919|FG002|Overall Study|Adverse Event|3|||
46668254|NCT01294423|82882917|FG000|Overall Study|Withdrawal by Subject|1|||
46668255|NCT01294423|82882918|FG001|Overall Study|Withdrawal by Subject|2|||
46668256|NCT01294423|82882919|FG002|Overall Study|Withdrawal by Subject|2|||
46851427|NCT00083889|83067020|FG001|Overall Study|Randomized: did not take study drug|15|||
46668257|NCT01294423|82882917|FG000|Overall Study|subject no longer meets study criteria|2|||
46668258|NCT01294423|82882918|FG001|Overall Study|subject no longer meets study criteria|5|||
46668259|NCT01294423|82882919|FG002|Overall Study|subject no longer meets study criteria|2|||
46668260|NCT01294423|82882917|FG000|Overall Study|poor/non-compliance|1|||
46851428|NCT00083889|83067019|FG000|Overall Study|Completed on marketed sunitinub|3|||
46668261|NCT01294423|82882918|FG001|Overall Study|poor/non-compliance|0|||
46668262|NCT01294423|82882919|FG002|Overall Study|poor/non-compliance|1|||
46668263|NCT01294150|82882929|FG000|Overall Study|Physician Decision|2|||
46668264|NCT01294150|82882930|FG001|Overall Study|Physician Decision|2|||
46668265|NCT01292473|82882942|FG000|Overall Study|Adverse Event|1|||
46668266|NCT01292473|82882943|FG001|Overall Study|Adverse Event|0|||
46785710|NCT00325819|83004827|FG001|Overall Study|Did not take a dose of study product|9|||
46668267|NCT01292473|82882944|FG002|Overall Study|Adverse Event|1|||
46785711|NCT00325819|83004826|FG000|Overall Study|Lost to Follow-up|3|||
46785712|NCT00325819|83004827|FG001|Overall Study|Lost to Follow-up|3|||
46785713|NCT00687362|83004835|FG000|Overall Study|Protocol Violation|2|||
46668268|NCT01292473|82882945|FG003|Overall Study|Adverse Event|1|||
46668269|NCT01292473|82882942|FG000|Overall Study|Lost to Follow-up|1|||
46668270|NCT01292473|82882943|FG001|Overall Study|Lost to Follow-up|1|||
46668271|NCT01292473|82882944|FG002|Overall Study|Lost to Follow-up|2|||
46668272|NCT01292473|82882945|FG003|Overall Study|Lost to Follow-up|2|||
46668273|NCT01292473|82882942|FG000|Overall Study|Withdrawal by Subject|3|||
46668274|NCT01292473|82882943|FG001|Overall Study|Withdrawal by Subject|4|||
46668275|NCT01292473|82882944|FG002|Overall Study|Withdrawal by Subject|3|||
46668276|NCT01292473|82882945|FG003|Overall Study|Withdrawal by Subject|3|||
46668277|NCT01292473|82882942|FG000|Overall Study|Physician Decision|0|||
46668278|NCT01292473|82882943|FG001|Overall Study|Physician Decision|1|||
46668279|NCT01292473|82882944|FG002|Overall Study|Physician Decision|0|||
46668280|NCT01292473|82882945|FG003|Overall Study|Physician Decision|0|||
46668281|NCT01292473|82882942|FG000|Overall Study|Disease Progression|0|||
46668282|NCT01292473|82882943|FG001|Overall Study|Disease Progression|1|||
46668283|NCT01292473|82882944|FG002|Overall Study|Disease Progression|3|||
46668284|NCT01292473|82882945|FG003|Overall Study|Disease Progression|6|||
46668285|NCT01292239|82882961|FG000|Overall Study|Other|1|||
46668286|NCT01292239|82882962|FG001|Overall Study|Other|1|||
46668287|NCT01292239|82882961|FG000|Overall Study|Withdrawal by Subject|3|||
46668288|NCT01292239|82882962|FG001|Overall Study|Withdrawal by Subject|6|||
46668289|NCT01291225|82882970|FG000|Overall Study|Lost to Follow-up|85|||
46668290|NCT01291225|82882971|FG001|Overall Study|Lost to Follow-up|39|||
46668291|NCT01290796|82882981|FG000|Overall Study|Lost to Follow-up|21|||
46668292|NCT01290796|82882981|FG000|Overall Study|Withdrawal by Subject|4|||
46668293|NCT01290796|82882981|FG000|Overall Study|Physician Decision|2|||
46668294|NCT01290796|82882981|FG000|Overall Study|Secondary Surgical Intervention|2|||
46668295|NCT01290796|82882981|FG000|Overall Study|Withdrawal by Sponsor|1|||
46668296|NCT01290757|82882987|FG000|Overall Study|Adverse Event|1|||
46668297|NCT01290757|82882988|FG001|Overall Study|Adverse Event|0|||
46668298|NCT01290757|82882987|FG000|Overall Study|Protocol Violation|1|||
46668299|NCT01290757|82882988|FG001|Overall Study|Protocol Violation|1|||
46668300|NCT01290757|82882987|FG000|Overall Study|Other|0|||
46668301|NCT01290757|82882988|FG001|Overall Study|Other|1|||
46668302|NCT01290718|82882994|FG000|Overall Study|Early termination of the study|4|||
46668303|NCT01290679|82883000|FG000|Overall Study|Adverse Event|2|||
46668304|NCT01290679|82883001|FG001|Overall Study|Adverse Event|0|||
46668305|NCT01290679|82883000|FG000|Overall Study|Lost to Follow-up|8|||
46668306|NCT01290679|82883001|FG001|Overall Study|Lost to Follow-up|10|||
46668307|NCT01290679|82883000|FG000|Overall Study|Protocol Violation|0|||
46668308|NCT01290679|82883001|FG001|Overall Study|Protocol Violation|1|||
46668309|NCT01290679|82883000|FG000|Overall Study|Withdrawal by Subject|6|||
46668310|NCT01290679|82883001|FG001|Overall Study|Withdrawal by Subject|5|||
46668311|NCT01290679|82883000|FG000|Overall Study|Subject Entered Another Trial|0|||
46668312|NCT01290679|82883001|FG001|Overall Study|Subject Entered Another Trial|5|||
46668313|NCT01290601|82883009|FG000|Overall Study|Adverse Event|0|||
46668314|NCT01290601|82883010|FG001|Overall Study|Adverse Event|2|||
46668315|NCT01290601|82883011|FG002|Overall Study|Adverse Event|0|||
46668316|NCT01290601|82883012|FG003|Overall Study|Adverse Event|0|||
46785714|NCT00687362|83004835|FG000|Overall Study|Withdrawal by Subject|1|||
46785715|NCT00325195|83004842|FG000|Randomized|Not dosed|5|||
46785716|NCT00325195|83004843|FG001|Randomized|Not dosed|5|||
46785717|NCT00325195|83004844|FG002|Randomized|Not dosed|3|||
46785718|NCT00325195|83004842|FG000|Received Intervention: ITT Population|Adverse Event|15|||
46785719|NCT00325195|83004843|FG001|Received Intervention: ITT Population|Adverse Event|17|||
46785720|NCT00325195|83004844|FG002|Received Intervention: ITT Population|Adverse Event|1|||
46668317|NCT01290601|82883009|FG000|Overall Study|Lack of Efficacy|2|||
46785721|NCT00325195|83004842|FG000|Received Intervention: ITT Population|Death|3|||
46972585|NCT02075554|83216298|FG000|Overall Study|Withdrawal by Subject|5|||
46972586|NCT02075554|83216298|FG000|Overall Study|Physician Decision|3|||
46972587|NCT02075476|83216304|FG000|Overall Study|Death|2|||
46972588|NCT02075476|83216305|FG001|Overall Study|Death|2|||
46972589|NCT02075476|83216304|FG000|Overall Study|Lost to Follow-up|1|||
46972590|NCT02075476|83216305|FG001|Overall Study|Lost to Follow-up|3|||
46972591|NCT02075320|83216311|FG000|Overall Study|Withdrawal by Subject|2|||
46668318|NCT01290601|82883010|FG001|Overall Study|Lack of Efficacy|1|||
46668319|NCT01290601|82883011|FG002|Overall Study|Lack of Efficacy|0|||
46668320|NCT01290601|82883012|FG003|Overall Study|Lack of Efficacy|0|||
46668321|NCT01290601|82883009|FG000|Overall Study|Lost to Follow-up|7|||
46785722|NCT00325195|83004843|FG001|Received Intervention: ITT Population|Death|1|||
46972592|NCT02708095|83216318|FG000|Overall Study|Adverse Event|4|||
46972593|NCT02708095|83216319|FG001|Overall Study|Adverse Event|10|||
46972594|NCT02708095|83216320|FG002|Overall Study|Adverse Event|11|||
46668322|NCT01290601|82883010|FG001|Overall Study|Lost to Follow-up|2|||
46668323|NCT01290601|82883011|FG002|Overall Study|Lost to Follow-up|0|||
46668324|NCT01290601|82883012|FG003|Overall Study|Lost to Follow-up|0|||
46668325|NCT01290601|82883009|FG000|Overall Study|Other|1|||
46668326|NCT01290601|82883010|FG001|Overall Study|Other|0|||
46972595|NCT02708095|83216318|FG000|Overall Study|Lack of Efficacy|9|||
46972596|NCT02708095|83216319|FG001|Overall Study|Lack of Efficacy|3|||
46972597|NCT02708095|83216320|FG002|Overall Study|Lack of Efficacy|0|||
46785723|NCT00325195|83004844|FG002|Received Intervention: ITT Population|Death|0|||
46785724|NCT00325195|83004842|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
46785725|NCT00325195|83004843|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
46785726|NCT00325195|83004844|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
46785727|NCT00325195|83004842|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
46785728|NCT00325195|83004843|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
46785729|NCT00325195|83004844|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
46785730|NCT00325195|83004842|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
46785731|NCT00325195|83004843|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
46785732|NCT00325195|83004844|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
46785733|NCT03976401|83004858|FG000|Overall Study|Adverse Event|2|||
46785734|NCT03976401|83004859|FG001|Overall Study|Adverse Event|0|||
46785735|NCT03976401|83004860|FG002|Overall Study|Adverse Event|4|||
46785736|NCT03976401|83004861|FG003|Overall Study|Adverse Event|1|||
46785737|NCT03976401|83004862|FG004|Overall Study|Adverse Event|1|||
46785738|NCT03976401|83004863|FG005|Overall Study|Adverse Event|0|||
46785739|NCT03976401|83004858|FG000|Overall Study|Withdrawal by Subject|0|||
46785740|NCT03976401|83004859|FG001|Overall Study|Withdrawal by Subject|1|||
46785741|NCT03976401|83004860|FG002|Overall Study|Withdrawal by Subject|0|||
46785742|NCT03976401|83004861|FG003|Overall Study|Withdrawal by Subject|0|||
46972598|NCT02708095|83216318|FG000|Overall Study|Lost to Follow-up|2|||
46668327|NCT01290601|82883011|FG002|Overall Study|Other|0|||
46668328|NCT01290601|82883012|FG003|Overall Study|Other|0|||
46668329|NCT01290601|82883009|FG000|Overall Study|Protocol Violation|1|||
46668330|NCT01290601|82883010|FG001|Overall Study|Protocol Violation|0|||
46668331|NCT01290601|82883011|FG002|Overall Study|Protocol Violation|0|||
46668332|NCT01290601|82883012|FG003|Overall Study|Protocol Violation|0|||
46668333|NCT01290523|82883018|FG000|Overall Study|Death|3|||
46668334|NCT01290094|82883022|FG000|Overall Study|Withdrawal by Subject|1|||
46668335|NCT01290094|82883022|FG000|Overall Study|Lost to Follow-up|5|||
46668336|NCT01289821|82883035|FG000|Treatment Period|Withdrawal by Subject|1|||
46668337|NCT01289821|82883035|FG000|Treatment Period|Physician Decision|3|||
46668338|NCT01289821|82883035|FG000|Treatment Period|Adverse Event|4|||
46668339|NCT01289821|82883035|FG000|Treatment Period|Radiological Progression|43|||
46668340|NCT01289821|82883035|FG000|Treatment Period|Clinical Progression|2|||
46668341|NCT01289821|82883035|FG000|Treatment Period|Therapeutic procedure required|1|||
46668342|NCT01289821|82883035|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
46668343|NCT01289821|82883035|FG000|Safety Follow-up Period|Protocol Violation|3|||
46668344|NCT01289821|82883035|FG000|Safety Follow-up Period|Unspecified reason|1|||
46668345|NCT01289821|82883035|FG000|Survival Follow-up Period|Protocol Violation|1|||
46668346|NCT01289821|82883035|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
46668347|NCT01289821|82883035|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
46668348|NCT01289782|82883041|FG000|Overall Study|Lost to Follow-up|14|||
46668349|NCT01289782|82883042|FG001|Overall Study|Lost to Follow-up|7|||
46785743|NCT03976401|83004862|FG004|Overall Study|Withdrawal by Subject|0|||
46785744|NCT03976401|83004863|FG005|Overall Study|Withdrawal by Subject|1|||
46785745|NCT03976401|83004858|FG000|Overall Study|Physician Decision|0|||
46785746|NCT03976401|83004859|FG001|Overall Study|Physician Decision|0|||
46785747|NCT03976401|83004860|FG002|Overall Study|Physician Decision|1|||
46785748|NCT03976401|83004861|FG003|Overall Study|Physician Decision|0|||
46785749|NCT03976401|83004862|FG004|Overall Study|Physician Decision|0|||
46785750|NCT03976401|83004863|FG005|Overall Study|Physician Decision|0|||
46785751|NCT03976401|83004858|FG000|Overall Study|Lost to Follow-up|1|||
46785752|NCT03976401|83004859|FG001|Overall Study|Lost to Follow-up|2|||
46785753|NCT03976401|83004860|FG002|Overall Study|Lost to Follow-up|0|||
46785754|NCT03976401|83004861|FG003|Overall Study|Lost to Follow-up|0|||
46785755|NCT03976401|83004862|FG004|Overall Study|Lost to Follow-up|0|||
46785756|NCT03976401|83004863|FG005|Overall Study|Lost to Follow-up|0|||
46785757|NCT03976401|83004858|FG000|Overall Study|Protocol Violation|0|||
46972599|NCT02708095|83216319|FG001|Overall Study|Lost to Follow-up|0|||
47077064|NCT00081653|83375351|FG000|Overall Study|Loss of bone mass|0|||
46668350|NCT01289782|82883041|FG000|Overall Study|Protocol Violation|1|||
46668351|NCT01289782|82883042|FG001|Overall Study|Protocol Violation|1|||
46668352|NCT01289782|82883041|FG000|Overall Study|Withdrawal by Subject|8|||
46668353|NCT01289782|82883042|FG001|Overall Study|Withdrawal by Subject|2|||
46785758|NCT03976401|83004859|FG001|Overall Study|Protocol Violation|1|||
46785759|NCT03976401|83004860|FG002|Overall Study|Protocol Violation|0|||
46785760|NCT03976401|83004861|FG003|Overall Study|Protocol Violation|0|||
46785761|NCT03976401|83004862|FG004|Overall Study|Protocol Violation|0|||
46668354|NCT01289782|82883041|FG000|Overall Study|Sponsor's Decision|1|||
46785762|NCT03976401|83004863|FG005|Overall Study|Protocol Violation|0|||
46972600|NCT02708095|83216320|FG002|Overall Study|Lost to Follow-up|0|||
46972601|NCT02708095|83216318|FG000|Overall Study|Physician Decision|2|||
46785763|NCT03976401|83004858|FG000|Overall Study|Withdrew Consent|0|||
46785764|NCT03976401|83004859|FG001|Overall Study|Withdrew Consent|0|||
46785765|NCT03976401|83004860|FG002|Overall Study|Withdrew Consent|0|||
46668355|NCT01289782|82883042|FG001|Overall Study|Sponsor's Decision|0|||
46668356|NCT01289782|82883041|FG000|Overall Study|Reason not specified|1|||
46668357|NCT01289782|82883042|FG001|Overall Study|Reason not specified|2|||
46668358|NCT01289353|82883048|FG000|Overall Study|Lost to Follow-up|2|||
46972602|NCT02708095|83216319|FG001|Overall Study|Physician Decision|3|||
46972603|NCT02708095|83216320|FG002|Overall Study|Physician Decision|2|||
46668359|NCT01289119|82883058|FG000|Overall Study|Adverse Event|2|||
46668360|NCT01289119|82883059|FG001|Overall Study|Adverse Event|1|||
46668361|NCT01289119|82883060|FG002|Overall Study|Adverse Event|0|||
46668362|NCT01289119|82883061|FG003|Overall Study|Adverse Event|2|||
46668363|NCT01289119|82883062|FG004|Overall Study|Adverse Event|1|||
46668364|NCT01289119|82883063|FG005|Overall Study|Adverse Event|0|||
46668365|NCT01289119|82883058|FG000|Overall Study|Major Protocol Deviation|2|||
46668366|NCT01289119|82883059|FG001|Overall Study|Major Protocol Deviation|1|||
46668367|NCT01289119|82883060|FG002|Overall Study|Major Protocol Deviation|3|||
46668368|NCT01289119|82883061|FG003|Overall Study|Major Protocol Deviation|0|||
46668369|NCT01289119|82883062|FG004|Overall Study|Major Protocol Deviation|2|||
46668370|NCT01289119|82883063|FG005|Overall Study|Major Protocol Deviation|1|||
46668371|NCT01289119|82883058|FG000|Overall Study|Lost to Follow-up|0|||
46668372|NCT01289119|82883059|FG001|Overall Study|Lost to Follow-up|3|||
46668373|NCT01289119|82883060|FG002|Overall Study|Lost to Follow-up|0|||
46668374|NCT01289119|82883061|FG003|Overall Study|Lost to Follow-up|0|||
46668375|NCT01289119|82883062|FG004|Overall Study|Lost to Follow-up|0|||
46668376|NCT01289119|82883063|FG005|Overall Study|Lost to Follow-up|1|||
46668377|NCT01289119|82883058|FG000|Overall Study|Withdrawal by Subject|4|||
46668378|NCT01289119|82883059|FG001|Overall Study|Withdrawal by Subject|2|||
46668379|NCT01289119|82883060|FG002|Overall Study|Withdrawal by Subject|4|||
46668380|NCT01289119|82883061|FG003|Overall Study|Withdrawal by Subject|3|||
46668381|NCT01289119|82883062|FG004|Overall Study|Withdrawal by Subject|1|||
46668382|NCT01289119|82883063|FG005|Overall Study|Withdrawal by Subject|1|||
46668383|NCT01289119|82883058|FG000|Overall Study|Pregnancy|0|||
46668384|NCT01289119|82883059|FG001|Overall Study|Pregnancy|1|||
46668385|NCT01289119|82883060|FG002|Overall Study|Pregnancy|0|||
46668386|NCT01289119|82883061|FG003|Overall Study|Pregnancy|0|||
46668387|NCT01289119|82883062|FG004|Overall Study|Pregnancy|0|||
46668388|NCT01289119|82883063|FG005|Overall Study|Pregnancy|0|||
46668389|NCT01289119|82883058|FG000|Overall Study|Lack of Efficacy|0|||
46668390|NCT01289119|82883059|FG001|Overall Study|Lack of Efficacy|1|||
46668391|NCT01289119|82883060|FG002|Overall Study|Lack of Efficacy|1|||
46668392|NCT01289119|82883061|FG003|Overall Study|Lack of Efficacy|1|||
46668393|NCT01289119|82883062|FG004|Overall Study|Lack of Efficacy|1|||
46668394|NCT01289119|82883063|FG005|Overall Study|Lack of Efficacy|1|||
46668395|NCT01289119|82883058|FG000|Overall Study|Other|1|||
46668396|NCT01289119|82883059|FG001|Overall Study|Other|0|||
46668397|NCT01289119|82883060|FG002|Overall Study|Other|1|||
46668398|NCT01289119|82883061|FG003|Overall Study|Other|0|||
46668399|NCT01289119|82883062|FG004|Overall Study|Other|0|||
46668400|NCT01289119|82883063|FG005|Overall Study|Other|0|||
46668401|NCT01289041|82883077|FG000|Overall Study|Adverse Event|24|||
46668402|NCT01289041|82883077|FG000|Overall Study|Physician Decision|1|||
46668403|NCT01289041|82883077|FG000|Overall Study|Progressive Disease|41|||
46668404|NCT01289041|82883077|FG000|Overall Study|Withdrawal by Subject|3|||
46668405|NCT01289041|82883077|FG000|Overall Study|Death|1|||
46668406|NCT01288729|82883085|FG000|Overall Study|Withdrawal by Subject|1|||
46668407|NCT01288729|82883086|FG001|Overall Study|Withdrawal by Subject|0|||
46785766|NCT03976401|83004861|FG003|Overall Study|Withdrew Consent|1|||
46785767|NCT03976401|83004862|FG004|Overall Study|Withdrew Consent|0|||
46785768|NCT03976401|83004863|FG005|Overall Study|Withdrew Consent|0|||
46785769|NCT00685334|83004879|FG000|Overall Study|Withdrawal by Subject|5|||
46668408|NCT01288612|82883095|FG000|Overall Study|Unable to contact|11|||
46668409|NCT01288612|82883096|FG001|Overall Study|Unable to contact|16|||
46668410|NCT01288612|82883097|FG002|Overall Study|Unable to contact|20|||
46668411|NCT01288612|82883095|FG000|Overall Study|Declined|78|||
46668412|NCT01288612|82883096|FG001|Overall Study|Declined|63|||
46668413|NCT01288612|82883097|FG002|Overall Study|Declined|62|||
46668414|NCT01288612|82883095|FG000|Overall Study|Unable to intubate|0|||
46668415|NCT01288612|82883096|FG001|Overall Study|Unable to intubate|3|||
46668416|NCT01288612|82883097|FG002|Overall Study|Unable to intubate|0|||
46668417|NCT01287832|82883107|FG000|Overall Study|Adverse Event|1|||
46785770|NCT00685334|83004880|FG001|Overall Study|Withdrawal by Subject|6|||
46972604|NCT02708095|83216318|FG000|Overall Study|Protocol Violation|0|||
46668418|NCT01287832|82883108|FG001|Overall Study|Adverse Event|0|||
46668419|NCT01287832|82883107|FG000|Overall Study|Death|0|||
46668420|NCT01287832|82883108|FG001|Overall Study|Death|1|||
46668421|NCT01287754|82883116|FG000|Overall Study|Death|2|||
46668422|NCT01287754|82883117|FG001|Overall Study|Death|12|||
46668423|NCT01287754|82883116|FG000|Overall Study|Lost to Follow-up|1|||
46668424|NCT01287754|82883117|FG001|Overall Study|Lost to Follow-up|6|||
46851429|NCT00083889|83067020|FG001|Overall Study|Completed on marketed sunitinub|0|||
46851430|NCT00083889|83067019|FG000|Overall Study|Crossover to SU011248|0|||
46851431|NCT00083889|83067020|FG001|Overall Study|Crossover to SU011248|25|||
46851432|NCT03572062|83067039|FG000|Overall Study|Adverse Event|0|||
46851433|NCT03572062|83067040|FG001|Overall Study|Adverse Event|0|||
46851434|NCT03572062|83067041|FG002|Overall Study|Adverse Event|0|||
46851435|NCT03572062|83067042|FG003|Overall Study|Adverse Event|0|||
46851436|NCT03572062|83067043|FG004|Overall Study|Adverse Event|0|||
46851437|NCT03572062|83067044|FG005|Overall Study|Adverse Event|0|||
46851438|NCT03572062|83067045|FG006|Overall Study|Adverse Event|0|||
46851439|NCT03572062|83067046|FG007|Overall Study|Adverse Event|0|||
47077065|NCT00081653|83375352|FG001|Overall Study|Loss of bone mass|2|||
46668425|NCT01287754|82883116|FG000|Overall Study|Protocol Violation|0|||
46668426|NCT01287754|82883117|FG001|Overall Study|Protocol Violation|3|||
46668427|NCT01287520|82883132|FG000|Overall Study|Adverse Event|2|||
46668428|NCT01287520|82883133|FG001|Overall Study|Adverse Event|2|||
46668429|NCT01287520|82883134|FG002|Overall Study|Adverse Event|2|||
46668430|NCT01287520|82883135|FG003|Overall Study|Adverse Event|1|||
46668431|NCT01287520|82883136|FG004|Overall Study|Adverse Event|1|||
46668432|NCT01287520|82883137|FG005|Overall Study|Adverse Event|2|||
46668433|NCT01287520|82883138|FG006|Overall Study|Adverse Event|0|||
46668434|NCT01287520|82883139|FG007|Overall Study|Adverse Event|2|||
46668435|NCT01287520|82883140|FG008|Overall Study|Adverse Event|0|||
46668436|NCT01287520|82883132|FG000|Overall Study|Physician Decision|1|||
46668437|NCT01287520|82883133|FG001|Overall Study|Physician Decision|1|||
46668438|NCT01287520|82883134|FG002|Overall Study|Physician Decision|2|||
46668439|NCT01287520|82883135|FG003|Overall Study|Physician Decision|0|||
46668440|NCT01287520|82883136|FG004|Overall Study|Physician Decision|1|||
46668441|NCT01287520|82883137|FG005|Overall Study|Physician Decision|1|||
46668442|NCT01287520|82883138|FG006|Overall Study|Physician Decision|0|||
46668443|NCT01287520|82883139|FG007|Overall Study|Physician Decision|1|||
46668444|NCT01287520|82883140|FG008|Overall Study|Physician Decision|0|||
46668445|NCT01287520|82883132|FG000|Overall Study|Progressive disease|0|||
46668446|NCT01287520|82883133|FG001|Overall Study|Progressive disease|4|||
46668447|NCT01287520|82883134|FG002|Overall Study|Progressive disease|1|||
46668448|NCT01287520|82883135|FG003|Overall Study|Progressive disease|6|||
46668449|NCT01287520|82883136|FG004|Overall Study|Progressive disease|1|||
46785771|NCT00685334|83004879|FG000|Overall Study|Lost to Follow-up|4|||
46785772|NCT00685334|83004880|FG001|Overall Study|Lost to Follow-up|0|||
46785773|NCT00685334|83004879|FG000|Overall Study|Chose to enter hospital|1|||
46785774|NCT00685334|83004880|FG001|Overall Study|Chose to enter hospital|1|||
46785775|NCT00325039|83004888|FG000|Overall Study|Lost to Follow-up|18|||
46785776|NCT00325039|83004889|FG001|Overall Study|Lost to Follow-up|14|||
46785777|NCT00344461|83004895|FG000|Overall Study|Adverse Event|6|||
46785778|NCT00344461|83004895|FG000|Overall Study|Death|1|||
46785779|NCT00344461|83004895|FG000|Overall Study|Lack of Efficacy|2|||
46785780|NCT00344461|83004895|FG000|Overall Study|Lost to Follow-up|2|||
46785781|NCT00344461|83004895|FG000|Overall Study|Physician Decision|2|||
46785782|NCT00344461|83004895|FG000|Overall Study|Protocol Violation|6|||
46785783|NCT00344461|83004895|FG000|Overall Study|Withdrawal by Subject|2|||
47077066|NCT02596620|83375413|FG000|Overall Study|Lost to Follow-up|1|||
46785784|NCT00685178|83004904|FG000|Overall Study|Adverse Event|1|||
46851440|NCT03572062|83067047|FG008|Overall Study|Adverse Event|1|||
46851441|NCT03572062|83067048|FG009|Overall Study|Adverse Event|3|||
47077067|NCT02596620|83375414|FG001|Overall Study|Lost to Follow-up|1|||
47077068|NCT02596230|83375570|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
47077069|NCT02596230|83375571|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
47077070|NCT02596230|83375572|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
47077071|NCT02596230|83375573|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
47077072|NCT02596230|83375574|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
47077073|NCT02596230|83375570|FG000|Objective 2, One Year|Lost to Follow-up|0|||
47077074|NCT02596230|83375571|FG001|Objective 2, One Year|Lost to Follow-up|41|||
47077075|NCT02596230|83375572|FG002|Objective 2, One Year|Lost to Follow-up|41|||
47077076|NCT02596230|83375573|FG003|Objective 2, One Year|Lost to Follow-up|32|||
47077077|NCT02596230|83375574|FG004|Objective 2, One Year|Lost to Follow-up|46|||
46668450|NCT01287520|82883137|FG005|Overall Study|Progressive disease|0|||
46668451|NCT01287520|82883138|FG006|Overall Study|Progressive disease|2|||
46668452|NCT01287520|82883139|FG007|Overall Study|Progressive disease|2|||
46785785|NCT00685178|83004905|FG001|Overall Study|Adverse Event|5|||
46785786|NCT00685178|83004906|FG002|Overall Study|Adverse Event|2|||
46785787|NCT00685178|83004907|FG003|Overall Study|Adverse Event|4|||
46851442|NCT03572062|83067039|FG000|Overall Study|Death|0|||
46851443|NCT03572062|83067040|FG001|Overall Study|Death|0|||
46668453|NCT01287520|82883140|FG008|Overall Study|Progressive disease|4|||
46668454|NCT01287520|82883132|FG000|Overall Study|Withdrawal by Subject|0|||
46668455|NCT01287520|82883133|FG001|Overall Study|Withdrawal by Subject|0|||
46851444|NCT03572062|83067041|FG002|Overall Study|Death|0|||
46851445|NCT03572062|83067042|FG003|Overall Study|Death|0|||
46668456|NCT01287520|82883134|FG002|Overall Study|Withdrawal by Subject|0|||
46668457|NCT01287520|82883135|FG003|Overall Study|Withdrawal by Subject|0|||
46668458|NCT01287520|82883136|FG004|Overall Study|Withdrawal by Subject|0|||
46668459|NCT01287520|82883137|FG005|Overall Study|Withdrawal by Subject|1|||
46668460|NCT01287520|82883138|FG006|Overall Study|Withdrawal by Subject|0|||
46668461|NCT01287520|82883139|FG007|Overall Study|Withdrawal by Subject|0|||
46668462|NCT01287520|82883140|FG008|Overall Study|Withdrawal by Subject|1|||
46668463|NCT01287403|82883189|FG000|1st Intervention (1 Day)|Adverse Event|1|||
46668464|NCT01287364|82883205|FG000|Overall Study|Adverse Event|0|||
46668465|NCT01287364|82883206|FG001|Overall Study|Adverse Event|3|||
46668466|NCT01287364|82883205|FG000|Overall Study|Protocol Violation|5|||
46785788|NCT00685178|83004904|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
46785789|NCT00685178|83004905|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
46785790|NCT00685178|83004906|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
46785791|NCT00685178|83004907|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
46785792|NCT00685178|83004904|FG000|Overall Study|voluntary study discharge|4|||
46785793|NCT00685178|83004905|FG001|Overall Study|voluntary study discharge|5|||
46785794|NCT00685178|83004906|FG002|Overall Study|voluntary study discharge|1|||
46785795|NCT00685178|83004907|FG003|Overall Study|voluntary study discharge|1|||
46785796|NCT00685178|83004904|FG000|Overall Study|incarcerated|1|||
46785797|NCT00685178|83004905|FG001|Overall Study|incarcerated|3|||
46972605|NCT02708095|83216319|FG001|Overall Study|Protocol Violation|0|||
46972606|NCT02708095|83216320|FG002|Overall Study|Protocol Violation|1|||
46972607|NCT02708095|83216318|FG000|Overall Study|Withdrawal by Subject|5|||
46972608|NCT02708095|83216319|FG001|Overall Study|Withdrawal by Subject|3|||
46972609|NCT02708095|83216320|FG002|Overall Study|Withdrawal by Subject|4|||
46972610|NCT02707861|83216332|FG000|Overall Study|Went onto commercial drug|30|||
46972611|NCT02707861|83216333|FG001|Overall Study|Went onto commercial drug|23|||
46972612|NCT02707861|83216332|FG000|Overall Study|Adverse Event|2|||
46972613|NCT02707861|83216333|FG001|Overall Study|Adverse Event|3|||
46972614|NCT02707861|83216332|FG000|Overall Study|Death|5|||
46972615|NCT02707861|83216333|FG001|Overall Study|Death|2|||
46972616|NCT02707861|83216332|FG000|Overall Study|Lack of Efficacy|0|||
46972617|NCT02707861|83216333|FG001|Overall Study|Lack of Efficacy|2|||
46972618|NCT02707861|83216332|FG000|Overall Study|Physician Decision|1|||
46972619|NCT02707861|83216333|FG001|Overall Study|Physician Decision|4|||
46972620|NCT02707861|83216332|FG000|Overall Study|Withdrawal by Subject|2|||
46972621|NCT02707861|83216333|FG001|Overall Study|Withdrawal by Subject|1|||
46972622|NCT02707861|83216332|FG000|Overall Study|Lost to Follow-up|1|||
46972623|NCT02707861|83216333|FG001|Overall Study|Lost to Follow-up|3|||
46972624|NCT02027428|83216341|FG000|Induction|Never treated|7|||
46972625|NCT02027428|83216342|FG001|Induction|Never treated|0|||
46972626|NCT02027428|83216343|FG002|Induction|Never treated|0|||
46972627|NCT02027428|83216341|FG000|Induction|Progressive disease|77|||
46972628|NCT02027428|83216342|FG001|Induction|Progressive disease|0|||
46972629|NCT02027428|83216343|FG002|Induction|Progressive disease|0|||
46972630|NCT02027428|83216341|FG000|Induction|Adverse Event|51|||
46972631|NCT02027428|83216342|FG001|Induction|Adverse Event|0|||
46972632|NCT02027428|83216343|FG002|Induction|Adverse Event|0|||
46972633|NCT02027428|83216341|FG000|Induction|Withdrawal by Subject|22|||
46972634|NCT02027428|83216342|FG001|Induction|Withdrawal by Subject|0|||
46972635|NCT02027428|83216343|FG002|Induction|Withdrawal by Subject|0|||
46972636|NCT02027428|83216341|FG000|Induction|Death|21|||
46972637|NCT02027428|83216342|FG001|Induction|Death|0|||
46972638|NCT02027428|83216343|FG002|Induction|Death|0|||
46972639|NCT02027428|83216341|FG000|Induction|Symptomatic deterioration|16|||
46972640|NCT02027428|83216342|FG001|Induction|Symptomatic deterioration|0|||
46972641|NCT02027428|83216343|FG002|Induction|Symptomatic deterioration|0|||
46972642|NCT02027428|83216341|FG000|Induction|Study terminated by sponsor|12|||
46972643|NCT02027428|83216342|FG001|Induction|Study terminated by sponsor|0|||
46972644|NCT02027428|83216343|FG002|Induction|Study terminated by sponsor|0|||
46972645|NCT02027428|83216341|FG000|Induction|Protocol Violation|1|||
46972646|NCT02027428|83216342|FG001|Induction|Protocol Violation|0|||
46972647|NCT02027428|83216343|FG002|Induction|Protocol Violation|0|||
46972648|NCT02027428|83216341|FG000|Induction|Miscellaneous|14|||
46972649|NCT02027428|83216342|FG001|Induction|Miscellaneous|0|||
46972650|NCT02027428|83216343|FG002|Induction|Miscellaneous|0|||
46972651|NCT02027428|83216341|FG000|Induction|Induction Treatment Ongoing|4|||
46972652|NCT02027428|83216342|FG001|Induction|Induction Treatment Ongoing|0|||
47077078|NCT02596230|83375570|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
46668467|NCT01287364|82883206|FG001|Overall Study|Protocol Violation|5|||
46668468|NCT01287364|82883205|FG000|Overall Study|Other Reason|4|||
46972653|NCT02027428|83216343|FG002|Induction|Induction Treatment Ongoing|0|||
46972654|NCT02027428|83216341|FG000|Maintenance|Death|0|||
46972655|NCT02027428|83216342|FG001|Maintenance|Death|3|||
46972656|NCT02027428|83216343|FG002|Maintenance|Death|2|||
46972657|NCT02027428|83216341|FG000|Maintenance|Adverse Event|0|||
46972658|NCT02027428|83216342|FG001|Maintenance|Adverse Event|21|||
46972659|NCT02027428|83216343|FG002|Maintenance|Adverse Event|1|||
46972660|NCT02027428|83216341|FG000|Maintenance|Progressive disease|0|||
46668469|NCT01287364|82883206|FG001|Overall Study|Other Reason|2|||
46668470|NCT02889835|82883225|FG000|Overall Study|Lost to Follow-up|13|||
46668471|NCT02889835|82883226|FG001|Overall Study|Lost to Follow-up|13|||
46668472|NCT02889835|82883227|FG002|Overall Study|Lost to Follow-up|13|||
46668473|NCT02889835|82883225|FG000|Overall Study|Withdrawal by Subject|2|||
46668474|NCT02889835|82883226|FG001|Overall Study|Withdrawal by Subject|2|||
46668475|NCT02889835|82883227|FG002|Overall Study|Withdrawal by Subject|2|||
46668476|NCT02889835|82883225|FG000|Overall Study|Protocol Violation|1|||
46668477|NCT02889835|82883226|FG001|Overall Study|Protocol Violation|1|||
46668478|NCT02889835|82883227|FG002|Overall Study|Protocol Violation|1|||
46668479|NCT02889835|82883225|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
46668480|NCT02889835|82883226|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
46668481|NCT02889835|82883227|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
46668482|NCT02889835|82883225|FG000|Overall Study|Death|1|||
46668483|NCT02889835|82883226|FG001|Overall Study|Death|1|||
46668484|NCT02889835|82883227|FG002|Overall Study|Death|1|||
46668485|NCT01287013|82883238|FG000|Overall Study|Non-evaluable|3|||
46668486|NCT01287013|82883239|FG001|Overall Study|Non-evaluable|5|||
46668487|NCT01287013|82883240|FG002|Overall Study|Non-evaluable|21|||
46668488|NCT01286779|82883248|FG000|Overall Study|Withdrawal by Subject|9|||
46668489|NCT01286779|82883248|FG000|Overall Study|Protocol Violation|5|||
46668490|NCT01286779|82883248|FG000|Overall Study|Physician Decision|2|||
46668491|NCT01286779|82883248|FG000|Overall Study|Participant had scheduled surgery|1|||
46668492|NCT01286779|82883248|FG000|Overall Study|Participant moved to another country|1|||
46668493|NCT01286779|82883248|FG000|Overall Study|Discontinued by sponsor|1|||
46668494|NCT01286740|82883262|FG000|Overall Study|Enrolled but not treated|1|||
46668495|NCT01286740|82883262|FG000|Overall Study|Protocol Violation|1|||
46668496|NCT01286311|82883268|FG000|Overall Study|Physician did not want outreach sent|14|||
46668497|NCT01286311|82883269|FG001|Overall Study|Physician did not want outreach sent|0|||
46668498|NCT01286077|82883277|FG000|Overall Study|Adverse Event|2|||
46668499|NCT01286077|82883278|FG001|Overall Study|Adverse Event|0|||
46668500|NCT01286077|82883277|FG000|Overall Study|Death|1|||
46668501|NCT01286077|82883278|FG001|Overall Study|Death|0|||
46668502|NCT01286077|82883277|FG000|Overall Study|Protocol Violation|1|||
46668503|NCT01286077|82883278|FG001|Overall Study|Protocol Violation|1|||
46668504|NCT01286077|82883277|FG000|Overall Study|Withdrawal by Subject|0|||
46668505|NCT01286077|82883278|FG001|Overall Study|Withdrawal by Subject|2|||
46668506|NCT01286077|82883277|FG000|Overall Study|Intercurrent illness|1|||
46668507|NCT01286077|82883278|FG001|Overall Study|Intercurrent illness|0|||
46668508|NCT01286077|82883277|FG000|Overall Study|Non-compliance|1|||
46668509|NCT01286077|82883278|FG001|Overall Study|Non-compliance|0|||
46668510|NCT01286077|82883277|FG000|Overall Study|The subject starts with alternative MMY|0|||
46668511|NCT01286077|82883278|FG001|Overall Study|The subject starts with alternative MMY|3|||
46668512|NCT01286077|82883277|FG000|Overall Study|Patient's decision to stop treatment|3|||
46668513|NCT01286077|82883278|FG001|Overall Study|Patient's decision to stop treatment|0|||
46668514|NCT01286077|82883277|FG000|Overall Study|Progression of disease|0|||
46668515|NCT01286077|82883278|FG001|Overall Study|Progression of disease|1|||
46668516|NCT01286077|82883277|FG000|Overall Study|refill medication not received in time|1|||
46668517|NCT01286077|82883278|FG001|Overall Study|refill medication not received in time|0|||
46668518|NCT01285960|82883284|FG000|Overall Study|Withdrawal by Subject|2|||
46668519|NCT01285960|82883284|FG000|Overall Study|Lost to Follow-up|2|||
46668520|NCT01285960|82883284|FG000|Overall Study|2 subjects received less 10 sonications|2|||
46668521|NCT01285609|82883295|FG000|Randomized|Progressive Disease|41|||
46668522|NCT01285609|82883296|FG001|Randomized|Progressive Disease|61|||
46668523|NCT01285609|82883295|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
46668524|NCT01285609|82883296|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
46668525|NCT01285609|82883295|FG000|Randomized|Study Drug Toxicity|13|||
46668526|NCT01285609|82883296|FG001|Randomized|Study Drug Toxicity|14|||
46668527|NCT01285609|82883295|FG000|Randomized|Death|5|||
46668528|NCT01285609|82883296|FG001|Randomized|Death|7|||
46785798|NCT00685178|83004906|FG002|Overall Study|incarcerated|7|||
46785799|NCT00685178|83004907|FG003|Overall Study|incarcerated|0|||
46668529|NCT01285609|82883295|FG000|Randomized|Withdrawal by Subject|8|||
46668530|NCT01285609|82883296|FG001|Randomized|Withdrawal by Subject|11|||
46668531|NCT01285609|82883295|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
46668532|NCT01285609|82883296|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
46668533|NCT01285609|82883295|FG000|Randomized|Undisclosed Reasons|1|||
46668534|NCT01285609|82883296|FG001|Randomized|Undisclosed Reasons|0|||
46785800|NCT00685178|83004904|FG000|Overall Study|administrative (disciplinary) discharge|0|||
46668535|NCT01285609|82883295|FG000|Randomized|Randomized but not Treated|4|||
46785801|NCT00685178|83004905|FG001|Overall Study|administrative (disciplinary) discharge|1|||
46668536|NCT01285609|82883296|FG001|Randomized|Randomized but not Treated|4|||
46668537|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
46668538|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
46668539|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
46668540|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
46668541|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
46668542|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
46668543|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
46668544|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
46668545|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Death|11|||
46668546|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Death|3|||
46668547|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
46668548|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
46668549|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Not Reported|0|||
46668550|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Not Reported|2|||
46668551|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
46668552|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
46668553|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
46668554|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
46668555|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
46668556|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
46668557|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
46668558|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
46668559|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
46668560|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
46668561|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
46668562|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
46668563|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
46668564|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
46668565|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
46668566|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
46668567|NCT01285609|82883295|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
46668568|NCT01285609|82883296|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
46668569|NCT01285609|82883295|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
46668570|NCT01285609|82883296|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
46668571|NCT01285492|82883306|FG000|Overall Study|Adverse Event|11|||
46668572|NCT01285492|82883307|FG001|Overall Study|Adverse Event|0|||
46668573|NCT01285492|82883306|FG000|Overall Study|Protocol Violation|3|||
46668574|NCT01285492|82883307|FG001|Overall Study|Protocol Violation|0|||
46668575|NCT01285492|82883306|FG000|Overall Study|Withdrawal by Subject|2|||
46668576|NCT01285492|82883307|FG001|Overall Study|Withdrawal by Subject|1|||
46668577|NCT01285492|82883306|FG000|Overall Study|Death|1|||
46668578|NCT01285492|82883307|FG001|Overall Study|Death|0|||
46668579|NCT01284634|82883317|FG000|Overall Study|Adverse Event|1|||
46668580|NCT01284634|82883318|FG001|Overall Study|Adverse Event|0|||
46668581|NCT01284634|82883319|FG002|Overall Study|Adverse Event|2|||
46668582|NCT01284634|82883320|FG003|Overall Study|Adverse Event|1|||
46668583|NCT01284361|82883330|FG000|Overall Study|Withdrawal by Subject|1|||
46668584|NCT01284361|82883330|FG000|Overall Study|Protocol Violation|5|||
46668585|NCT01284361|82883330|FG000|Overall Study|Adverse Event|1|||
46668586|NCT01284361|82883330|FG000|Overall Study|Lost to Follow-up|2|||
46668587|NCT01284127|82883337|FG000|Overall Study|Adverse Event|2|||
46668588|NCT01284127|82883337|FG000|Overall Study|Withdrawal by Subject|4|||
46668589|NCT01284127|82883337|FG000|Overall Study|Physician Decision|1|||
46668590|NCT01283971|82883343|FG000|Overall Study|Adverse Event|3|||
46668591|NCT01283971|82883344|FG001|Overall Study|Adverse Event|5|||
46668592|NCT01283971|82883343|FG000|Overall Study|Insufficient therapeutic responses|3|||
46668593|NCT01283971|82883344|FG001|Overall Study|Insufficient therapeutic responses|3|||
46668594|NCT01283971|82883343|FG000|Overall Study|Protocol Violation|5|||
46668595|NCT01283971|82883344|FG001|Overall Study|Protocol Violation|1|||
46668596|NCT01283971|82883343|FG000|Overall Study|Refused treatment|3|||
46668597|NCT01283971|82883344|FG001|Overall Study|Refused treatment|1|||
46668598|NCT01283971|82883343|FG000|Overall Study|Failure to return|0|||
46668599|NCT01283971|82883344|FG001|Overall Study|Failure to return|1|||
46668600|NCT01283971|82883343|FG000|Overall Study|Administrative reasons|1|||
46668601|NCT01283971|82883344|FG001|Overall Study|Administrative reasons|1|||
46668602|NCT01283581|82883353|FG000|Overall Study|Lost to Follow-up|8|||
47077079|NCT02596230|83375571|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
46785802|NCT00685178|83004906|FG002|Overall Study|administrative (disciplinary) discharge|0|||
47077080|NCT02596230|83375572|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
47077081|NCT02596230|83375573|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
47077082|NCT02596230|83375574|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
47077083|NCT02596230|83375570|FG000|Objective 2, One Year|Adverse drug reaction|0|||
46785803|NCT00685178|83004907|FG003|Overall Study|administrative (disciplinary) discharge|2|||
47077084|NCT02596230|83375571|FG001|Objective 2, One Year|Adverse drug reaction|1|||
46668603|NCT01283581|82883354|FG001|Overall Study|Lost to Follow-up|6|||
46668604|NCT01283581|82883355|FG002|Overall Study|Lost to Follow-up|8|||
46668605|NCT01283581|82883353|FG000|Overall Study|Withdrawal by Subject|2|||
46668606|NCT01283581|82883354|FG001|Overall Study|Withdrawal by Subject|5|||
46668607|NCT01283581|82883355|FG002|Overall Study|Withdrawal by Subject|2|||
46668608|NCT01283581|82883353|FG000|Overall Study|Adverse Event|1|||
46668609|NCT01283581|82883354|FG001|Overall Study|Adverse Event|1|||
46668610|NCT01283581|82883355|FG002|Overall Study|Adverse Event|4|||
46668611|NCT01283581|82883353|FG000|Overall Study|Physician Decision|0|||
46668612|NCT01283581|82883354|FG001|Overall Study|Physician Decision|1|||
46668613|NCT01283581|82883355|FG002|Overall Study|Physician Decision|2|||
46668614|NCT01283581|82883353|FG000|Overall Study|Protocol Violation|0|||
46668615|NCT01283581|82883354|FG001|Overall Study|Protocol Violation|1|||
46668616|NCT01283581|82883355|FG002|Overall Study|Protocol Violation|2|||
46668617|NCT01283581|82883353|FG000|Overall Study|Noncompliance|1|||
46668618|NCT01283581|82883354|FG001|Overall Study|Noncompliance|0|||
46668619|NCT01283581|82883355|FG002|Overall Study|Noncompliance|0|||
46668620|NCT01283581|82883353|FG000|Overall Study|Investigator unblinded|0|||
46668621|NCT01283581|82883354|FG001|Overall Study|Investigator unblinded|0|||
46785804|NCT00685178|83004904|FG000|Overall Study|Pregnancy|0|||
46785805|NCT00685178|83004905|FG001|Overall Study|Pregnancy|0|||
46785806|NCT00685178|83004906|FG002|Overall Study|Pregnancy|0|||
46785807|NCT00685178|83004907|FG003|Overall Study|Pregnancy|1|||
46785808|NCT00537394|83004920|FG000|First Year of Follow-up|Death|7|||
46668622|NCT01283581|82883355|FG002|Overall Study|Investigator unblinded|1|||
46668623|NCT01283581|82883353|FG000|Overall Study|"Early termination"|0|||
46668624|NCT01283581|82883354|FG001|Overall Study|"Early termination"|0|||
46668625|NCT01283581|82883355|FG002|Overall Study|"Early termination"|1|||
46668626|NCT01283542|82883366|FG000|Main Phase|Acute or progressive vision loss|1|||
46668627|NCT01283542|82883366|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
46668628|NCT01283542|82883366|FG000|Main Phase|abnormal laboratory values|5|||
46668629|NCT01283542|82883366|FG000|Extension Phase|Physician Decision|1|||
46668630|NCT01283542|82883366|FG000|Extension Phase|Adverse Event|1|||
46668631|NCT01283542|82883366|FG000|Extension Phase|Administrative problems|1|||
46668632|NCT01283386|82883390|FG000|Overall Study|Death|2|||
46668633|NCT01283386|82883391|FG001|Overall Study|Death|0|||
46668634|NCT01283386|82883390|FG000|Overall Study|Withdrawal by Subject|2|||
46668635|NCT01283386|82883391|FG001|Overall Study|Withdrawal by Subject|1|||
46668636|NCT01283386|82883390|FG000|Overall Study|Relapse of underlying disease|1|||
46668637|NCT01283386|82883391|FG001|Overall Study|Relapse of underlying disease|3|||
46668638|NCT01283386|82883390|FG000|Overall Study|Progression of underlying disease|2|||
46668639|NCT01283386|82883391|FG001|Overall Study|Progression of underlying disease|7|||
46668640|NCT01283386|82883390|FG000|Overall Study|Reason not specified|1|||
46668641|NCT01283386|82883391|FG001|Overall Study|Reason not specified|0|||
46668642|NCT01283386|82883390|FG000|Overall Study|Protocol Violation|0|||
46785809|NCT00537394|83004921|FG001|First Year of Follow-up|Death|0|||
46785810|NCT00537394|83004922|FG002|First Year of Follow-up|Death|0|||
46785811|NCT00537394|83004920|FG000|First Year of Follow-up|Severe debilitation|1|||
46851446|NCT03572062|83067043|FG004|Overall Study|Death|0|||
46851447|NCT03572062|83067044|FG005|Overall Study|Death|1|||
46851448|NCT03572062|83067045|FG006|Overall Study|Death|0|||
46851449|NCT03572062|83067046|FG007|Overall Study|Death|0|||
46851450|NCT03572062|83067047|FG008|Overall Study|Death|0|||
46851451|NCT03572062|83067048|FG009|Overall Study|Death|0|||
46851452|NCT03572062|83067039|FG000|Overall Study|Lost to Follow-up|0|||
46851453|NCT03572062|83067040|FG001|Overall Study|Lost to Follow-up|0|||
46851454|NCT03572062|83067041|FG002|Overall Study|Lost to Follow-up|0|||
46851455|NCT03572062|83067042|FG003|Overall Study|Lost to Follow-up|0|||
46851456|NCT03572062|83067043|FG004|Overall Study|Lost to Follow-up|0|||
46851457|NCT03572062|83067044|FG005|Overall Study|Lost to Follow-up|1|||
46668643|NCT01283386|82883391|FG001|Overall Study|Protocol Violation|1|||
46668644|NCT01283152|82883399|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
46668645|NCT01283152|82883400|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
46668646|NCT01283152|82883399|FG000|Overall Study|Refused HESA|1|||
46668647|NCT01283152|82883400|FG001|Overall Study|Refused HESA|0|||
46668648|NCT01283035|82883406|FG000|Overall Study|Subject later found ineligible|1|||
46668649|NCT01283464|82883412|FG000|Overall Study|Lost to Follow-up|0|||
46785812|NCT00537394|83004921|FG001|First Year of Follow-up|Severe debilitation|0|||
46668650|NCT01283464|82883413|FG001|Overall Study|Lost to Follow-up|1|||
46668651|NCT01283464|82883412|FG000|Overall Study|Withdrawal by Subject|1|||
46785813|NCT00537394|83004922|FG002|First Year of Follow-up|Severe debilitation|1|||
46785814|NCT00537394|83004920|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
46851458|NCT03572062|83067045|FG006|Overall Study|Lost to Follow-up|1|||
46851459|NCT03572062|83067046|FG007|Overall Study|Lost to Follow-up|0|||
46851460|NCT03572062|83067047|FG008|Overall Study|Lost to Follow-up|0|||
46668652|NCT01283464|82883413|FG001|Overall Study|Withdrawal by Subject|0|||
46785815|NCT00537394|83004921|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
46851461|NCT03572062|83067048|FG009|Overall Study|Lost to Follow-up|0|||
46972661|NCT02027428|83216342|FG001|Maintenance|Progressive disease|84|||
46785816|NCT00537394|83004922|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
46785817|NCT00537394|83004920|FG000|First Year of Follow-up|Lost to Follow-up|1|||
46785818|NCT00537394|83004921|FG001|First Year of Follow-up|Lost to Follow-up|5|||
46785819|NCT00537394|83004922|FG002|First Year of Follow-up|Lost to Follow-up|1|||
46785820|NCT00537394|83004920|FG000|2nd Year of Follow-up|Death|4|||
46785821|NCT00537394|83004921|FG001|2nd Year of Follow-up|Death|1|||
46668653|NCT01283464|82883412|FG000|Overall Study|Physician Decision|1|||
46668654|NCT01283464|82883413|FG001|Overall Study|Physician Decision|0|||
46668655|NCT01282801|82883421|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
46668656|NCT01282801|82883422|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
46668657|NCT01282372|82883428|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
46668658|NCT01282372|82883428|FG000|Overall Study|Lost to Follow-up|23|||
46668659|NCT01282372|82883428|FG000|Overall Study|Withdrawal by Subject|11|||
46668660|NCT01282372|82883428|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
46668661|NCT01282372|82883428|FG000|Overall Study|Death|1|||
46668662|NCT01282372|82883428|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
46668663|NCT01282372|82883428|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
46668664|NCT01282372|82883428|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
46972662|NCT02027428|83216343|FG002|Maintenance|Progressive disease|47|||
46972663|NCT02027428|83216341|FG000|Maintenance|Symptomatic deterioration|0|||
46972664|NCT02027428|83216342|FG001|Maintenance|Symptomatic deterioration|4|||
46972665|NCT02027428|83216343|FG002|Maintenance|Symptomatic deterioration|1|||
46972666|NCT02027428|83216341|FG000|Maintenance|Withdrawal by Subject|0|||
46972667|NCT02027428|83216342|FG001|Maintenance|Withdrawal by Subject|6|||
46972668|NCT02027428|83216343|FG002|Maintenance|Withdrawal by Subject|5|||
47077085|NCT02596230|83375572|FG002|Objective 2, One Year|Adverse drug reaction|0|||
46668665|NCT01282372|82883428|FG000|Overall Study|Adverse Event|12|||
46668666|NCT01282294|82883439|FG000|Overall Study|Lost to Follow-up|14|||
46668667|NCT01282294|82883439|FG000|Overall Study|Screening failure|1|||
46668668|NCT01282294|82883439|FG000|Overall Study|Adverse Event|1|||
46668669|NCT01282294|82883439|FG000|Overall Study|Patient non-compliance|2|||
46668670|NCT01282294|82883439|FG000|Overall Study|Physician Decision|1|||
46668671|NCT01282216|82883445|FG000|Overall Study|Graft failure|0|||
46668672|NCT01282216|82883446|FG001|Overall Study|Graft failure|0|||
46668673|NCT01282216|82883447|FG002|Overall Study|Graft failure|3|||
46668674|NCT01282216|82883448|FG003|Overall Study|Graft failure|2|||
46668675|NCT01282216|82883445|FG000|Overall Study|Physician Decision|0|||
46668676|NCT01282216|82883446|FG001|Overall Study|Physician Decision|0|||
46668677|NCT01282216|82883447|FG002|Overall Study|Physician Decision|11|||
46668678|NCT01282216|82883448|FG003|Overall Study|Physician Decision|0|||
46668679|NCT01282216|82883445|FG000|Overall Study|Relapse|0|||
46668680|NCT01282216|82883446|FG001|Overall Study|Relapse|0|||
46668681|NCT01282216|82883447|FG002|Overall Study|Relapse|17|||
46785822|NCT00537394|83004922|FG002|2nd Year of Follow-up|Death|2|||
46785823|NCT00537394|83004920|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
46785824|NCT00537394|83004921|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
46785825|NCT00537394|83004922|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
46785826|NCT00537394|83004920|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
46785827|NCT00537394|83004921|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
46785828|NCT00537394|83004922|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
46851462|NCT03572062|83067039|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851463|NCT03572062|83067040|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851464|NCT03572062|83067041|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851465|NCT03572062|83067042|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851466|NCT03572062|83067043|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851467|NCT03572062|83067044|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851468|NCT03572062|83067045|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851469|NCT03572062|83067046|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851470|NCT03572062|83067047|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
46668682|NCT01282216|82883448|FG003|Overall Study|Relapse|6|||
46668683|NCT01282216|82883445|FG000|Overall Study|Death|0|||
46668684|NCT01282216|82883446|FG001|Overall Study|Death|0|||
46668685|NCT01282216|82883447|FG002|Overall Study|Death|2|||
46668686|NCT01282216|82883448|FG003|Overall Study|Death|0|||
46668687|NCT01281865|82883456|FG000|Overall Study|Adverse Event|1|||
46668688|NCT01281865|82883457|FG001|Overall Study|Adverse Event|1|||
46668689|NCT01281865|82883456|FG000|Overall Study|Withdrawal by Subject|1|||
46668690|NCT01281865|82883457|FG001|Overall Study|Withdrawal by Subject|0|||
46668691|NCT01281865|82883456|FG000|Overall Study|Lack of Efficacy|1|||
46785829|NCT00537394|83004920|FG000|2nd Year of Follow-up|Clinic site closure|1|||
46785830|NCT00537394|83004921|FG001|2nd Year of Follow-up|Clinic site closure|0|||
46785831|NCT00537394|83004922|FG002|2nd Year of Follow-up|Clinic site closure|0|||
46785832|NCT00352885|83004930|FG000|Overall Study|Withdrawal by Subject|0|||
46785833|NCT00352885|83004931|FG001|Overall Study|Withdrawal by Subject|3|||
46972669|NCT02027428|83216341|FG000|Maintenance|Protocol Violation|0|||
46972670|NCT02027428|83216342|FG001|Maintenance|Protocol Violation|0|||
46785834|NCT00352885|83004930|FG000|Overall Study|Development of major depression|0|||
46785835|NCT00352885|83004931|FG001|Overall Study|Development of major depression|1|||
46785836|NCT00352885|83004930|FG000|Overall Study|Progression of metastatic melanoma|5|||
46785837|NCT00352885|83004931|FG001|Overall Study|Progression of metastatic melanoma|3|||
46785838|NCT00352885|83004930|FG000|Overall Study|Side effects of IL-2 administration|1|||
46785839|NCT00352885|83004931|FG001|Overall Study|Side effects of IL-2 administration|0|||
46785840|NCT00660660|83004939|FG000|Overall Study|Adverse Event|1|||
46785841|NCT00660660|83004940|FG001|Overall Study|Adverse Event|0|||
46785842|NCT00660660|83004939|FG000|Overall Study|Lost to Follow-up|0|||
46785843|NCT00660660|83004940|FG001|Overall Study|Lost to Follow-up|6|||
46972671|NCT02027428|83216343|FG002|Maintenance|Protocol Violation|1|||
46972672|NCT02027428|83216341|FG000|Maintenance|Other|0|||
46972673|NCT02027428|83216342|FG001|Maintenance|Other|6|||
46785844|NCT00660660|83004939|FG000|Overall Study|Lack of Efficacy|0|||
46785845|NCT00660660|83004940|FG001|Overall Study|Lack of Efficacy|2|||
46785846|NCT00660660|83004939|FG000|Overall Study|Withdrawal by Subject|3|||
46785847|NCT00660660|83004940|FG001|Overall Study|Withdrawal by Subject|0|||
46851471|NCT03572062|83067048|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
46851472|NCT03572062|83067039|FG000|Overall Study|Study Terminated By Sponsor|0|||
46851473|NCT03572062|83067040|FG001|Overall Study|Study Terminated By Sponsor|0|||
46851474|NCT03572062|83067041|FG002|Overall Study|Study Terminated By Sponsor|0|||
46851475|NCT03572062|83067042|FG003|Overall Study|Study Terminated By Sponsor|0|||
46851476|NCT03572062|83067043|FG004|Overall Study|Study Terminated By Sponsor|0|||
47077086|NCT02596230|83375573|FG003|Objective 2, One Year|Adverse drug reaction|0|||
47077087|NCT02596230|83375574|FG004|Objective 2, One Year|Adverse drug reaction|0|||
47077088|NCT02596230|83375570|FG000|Objective 2, One Year|Death|0|||
47077089|NCT02596230|83375571|FG001|Objective 2, One Year|Death|12|||
47077090|NCT02596230|83375572|FG002|Objective 2, One Year|Death|41|||
47077091|NCT02596230|83375573|FG003|Objective 2, One Year|Death|21|||
47077092|NCT02596230|83375574|FG004|Objective 2, One Year|Death|30|||
47077093|NCT02596230|83375570|FG000|Objective 2, One Year|Other|0|||
47077094|NCT02596230|83375571|FG001|Objective 2, One Year|Other|3|||
47077095|NCT02596230|83375572|FG002|Objective 2, One Year|Other|2|||
46851477|NCT03572062|83067044|FG005|Overall Study|Study Terminated By Sponsor|0|||
46972674|NCT02027428|83216343|FG002|Maintenance|Other|3|||
46972675|NCT02027428|83216341|FG000|Survival Follow-up|Death|0|||
46972676|NCT02027428|83216342|FG001|Survival Follow-up|Death|78|||
47077096|NCT02596230|83375573|FG003|Objective 2, One Year|Other|0|||
46668692|NCT01281865|82883457|FG001|Overall Study|Lack of Efficacy|0|||
46668693|NCT01281202|82883465|FG000|Overall Study|Adverse Event|2|||
46668694|NCT01281202|82883466|FG001|Overall Study|Adverse Event|0|||
46668695|NCT01281202|82883465|FG000|Overall Study|Withdrawal by Subject|2|||
46668696|NCT01281202|82883466|FG001|Overall Study|Withdrawal by Subject|2|||
46668697|NCT01281202|82883465|FG000|Overall Study|Protocol Violation|11|||
46668698|NCT01281202|82883466|FG001|Overall Study|Protocol Violation|10|||
46668699|NCT01281202|82883465|FG000|Overall Study|Administrative|2|||
46668700|NCT01281202|82883466|FG001|Overall Study|Administrative|8|||
46668701|NCT01281202|82883465|FG000|Overall Study|Lost to Follow-up|11|||
46668702|NCT01281202|82883466|FG001|Overall Study|Lost to Follow-up|13|||
46668703|NCT01281202|82883465|FG000|Overall Study|Incarceration|0|||
46668704|NCT01281202|82883466|FG001|Overall Study|Incarceration|3|||
46668705|NCT01281124|82883474|FG000|Overall Study|Death|1|||
46668706|NCT01280968|82883482|FG000|Overall Study|Lost to Follow-up|8|||
46668707|NCT01280968|82883483|FG001|Overall Study|Lost to Follow-up|2|||
46668708|NCT01280968|82883482|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
46668709|NCT01280968|82883483|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
46668710|NCT01280968|82883482|FG000|Overall Study|Commuting Problems|2|||
46668711|NCT01280968|82883483|FG001|Overall Study|Commuting Problems|0|||
46668712|NCT01280968|82883482|FG000|Overall Study|Anxiety|2|||
46668713|NCT01280968|82883483|FG001|Overall Study|Anxiety|0|||
46668714|NCT01280968|82883482|FG000|Overall Study|Adverse Event|1|||
46668715|NCT01280968|82883483|FG001|Overall Study|Adverse Event|0|||
46668716|NCT01280968|82883482|FG000|Overall Study|Scheduling Conflicts|1|||
46668717|NCT01280968|82883483|FG001|Overall Study|Scheduling Conflicts|1|||
46668718|NCT01280968|82883482|FG000|Overall Study|Pre-existing Neurological Condition|1|||
46668719|NCT01280968|82883483|FG001|Overall Study|Pre-existing Neurological Condition|0|||
46668720|NCT01280968|82883482|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
46668721|NCT01280968|82883483|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
46668722|NCT01280812|82883493|FG000|Overall Study|Withdrawal by Subject|2|||
46668723|NCT01280812|82883494|FG001|Overall Study|Withdrawal by Subject|1|||
46785848|NCT00660660|83004939|FG000|Overall Study|Incorrect enrollment and other|0|||
46785849|NCT00660660|83004940|FG001|Overall Study|Incorrect enrollment and other|1|||
46668724|NCT01280812|82883495|FG002|Overall Study|Withdrawal by Subject|0|||
46851478|NCT03572062|83067045|FG006|Overall Study|Study Terminated By Sponsor|0|||
46972677|NCT02027428|83216343|FG002|Survival Follow-up|Death|45|||
46972678|NCT02027428|83216341|FG000|Survival Follow-up|Lost to Follow-up|0|||
47077097|NCT02596230|83375574|FG004|Objective 2, One Year|Other|0|||
46851479|NCT03572062|83067046|FG007|Overall Study|Study Terminated By Sponsor|0|||
46851480|NCT03572062|83067047|FG008|Overall Study|Study Terminated By Sponsor|29|||
46851481|NCT03572062|83067048|FG009|Overall Study|Study Terminated By Sponsor|27|||
47077098|NCT01667562|83375623|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
47077099|NCT01667562|83375624|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
46851482|NCT03572062|83067039|FG000|Overall Study|Physician Decision|0|||
46785850|NCT00660660|83004939|FG000|Overall Study|New medication after randomization|1|||
46785851|NCT00660660|83004940|FG001|Overall Study|New medication after randomization|0|||
46785852|NCT00344305|83004948|FG000|Overall Study|Lost to Follow-up|2|||
46785853|NCT00344305|83004949|FG001|Overall Study|Lost to Follow-up|0|||
46851483|NCT03572062|83067040|FG001|Overall Study|Physician Decision|0|||
46851484|NCT03572062|83067041|FG002|Overall Study|Physician Decision|0|||
46851485|NCT03572062|83067042|FG003|Overall Study|Physician Decision|0|||
46851486|NCT03572062|83067043|FG004|Overall Study|Physician Decision|0|||
46851487|NCT03572062|83067044|FG005|Overall Study|Physician Decision|0|||
46851488|NCT03572062|83067045|FG006|Overall Study|Physician Decision|0|||
46851489|NCT03572062|83067046|FG007|Overall Study|Physician Decision|0|||
46851490|NCT03572062|83067047|FG008|Overall Study|Physician Decision|1|||
46851491|NCT03572062|83067048|FG009|Overall Study|Physician Decision|0|||
46851492|NCT03572062|83067039|FG000|Overall Study|Withdrawal by Subject|0|||
46851493|NCT03572062|83067040|FG001|Overall Study|Withdrawal by Subject|0|||
46851494|NCT03572062|83067041|FG002|Overall Study|Withdrawal by Subject|0|||
46851495|NCT03572062|83067042|FG003|Overall Study|Withdrawal by Subject|0|||
46851496|NCT03572062|83067043|FG004|Overall Study|Withdrawal by Subject|0|||
46851497|NCT03572062|83067044|FG005|Overall Study|Withdrawal by Subject|0|||
46851498|NCT03572062|83067045|FG006|Overall Study|Withdrawal by Subject|0|||
46851499|NCT03572062|83067046|FG007|Overall Study|Withdrawal by Subject|0|||
46851500|NCT03572062|83067047|FG008|Overall Study|Withdrawal by Subject|0|||
46851501|NCT03572062|83067048|FG009|Overall Study|Withdrawal by Subject|1|||
46851502|NCT03572062|83067039|FG000|Overall Study|Randomized But Not Treated|0|||
46851503|NCT03572062|83067040|FG001|Overall Study|Randomized But Not Treated|0|||
46851504|NCT03572062|83067041|FG002|Overall Study|Randomized But Not Treated|0|||
46851505|NCT03572062|83067042|FG003|Overall Study|Randomized But Not Treated|0|||
46851506|NCT03572062|83067043|FG004|Overall Study|Randomized But Not Treated|1|||
46851507|NCT03572062|83067044|FG005|Overall Study|Randomized But Not Treated|2|||
46851508|NCT03572062|83067045|FG006|Overall Study|Randomized But Not Treated|0|||
46851509|NCT03572062|83067046|FG007|Overall Study|Randomized But Not Treated|1|||
46851510|NCT03572062|83067047|FG008|Overall Study|Randomized But Not Treated|0|||
47077100|NCT01667562|83375623|FG000|Erlotinib Phase|Lost to Follow-up|0|||
47077101|NCT01667562|83375624|FG001|Erlotinib Phase|Lost to Follow-up|1|||
47077102|NCT01667562|83375623|FG000|Erlotinib Phase|Adverse Event|0|||
47077103|NCT01667562|83375624|FG001|Erlotinib Phase|Adverse Event|1|||
47077104|NCT01667562|83375623|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
47077105|NCT01667562|83375624|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
47077106|NCT02595528|83375661|FG000|Overall Study|Withdrawal by Subject|1|||
47077107|NCT02595528|83375662|FG001|Overall Study|Withdrawal by Subject|2|||
47077108|NCT02595528|83375663|FG002|Overall Study|Withdrawal by Subject|1|||
47077109|NCT02595528|83375664|FG003|Overall Study|Withdrawal by Subject|3|||
47077110|NCT02595528|83375661|FG000|Overall Study|Lost to Follow-up|1|||
47077111|NCT02595528|83375662|FG001|Overall Study|Lost to Follow-up|1|||
47077112|NCT02595528|83375663|FG002|Overall Study|Lost to Follow-up|0|||
47077113|NCT02595528|83375664|FG003|Overall Study|Lost to Follow-up|1|||
47077114|NCT02595450|83375692|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
47077115|NCT02595450|83375692|FG000|Overall Study|Enrolled, but not treated|8|||
46785854|NCT00344305|83004948|FG000|Overall Study|Participant was not contacted in window|0|||
46785855|NCT00344305|83004949|FG001|Overall Study|Participant was not contacted in window|1|||
46785856|NCT00660816|83004958|FG000|Overall Study|Adverse Event|1|||
46785857|NCT00660816|83004959|FG001|Overall Study|Adverse Event|2|||
46785858|NCT00660816|83004958|FG000|Overall Study|Withdrawal by Subject|1|||
46785859|NCT00660816|83004959|FG001|Overall Study|Withdrawal by Subject|0|||
46785860|NCT00660816|83004958|FG000|Overall Study|Death|0|||
46785861|NCT00660816|83004959|FG001|Overall Study|Death|2|||
46785862|NCT00660816|83004958|FG000|Overall Study|Lack of Efficacy|1|||
46785863|NCT00660816|83004959|FG001|Overall Study|Lack of Efficacy|0|||
46785864|NCT00660816|83004958|FG000|Overall Study|Physician Decision|0|||
46785865|NCT00660816|83004959|FG001|Overall Study|Physician Decision|2|||
46785866|NCT00660816|83004958|FG000|Overall Study|Protocol Violation|1|||
46785867|NCT00660816|83004959|FG001|Overall Study|Protocol Violation|0|||
46851511|NCT03572062|83067048|FG009|Overall Study|Randomized But Not Treated|0|||
46851512|NCT03571516|83067070|FG000|Overall Study|Severe diarrhea|1|||
46851513|NCT03571516|83067071|FG001|Overall Study|Severe diarrhea|0|||
46851514|NCT03571516|83067070|FG000|Overall Study|Withdrawal by Subject|0|||
46851515|NCT03571516|83067071|FG001|Overall Study|Withdrawal by Subject|1|||
46851516|NCT03600376|83067079|FG000|Overall Study|Adverse Event|1|||
47077116|NCT02592018|83375696|FG000|Overall Study|Adverse Event|1|||
47077117|NCT02592018|83375696|FG000|Overall Study|Lost to Follow-up|1|||
47077118|NCT02591238|83375704|FG000|Overall Study|Pregnancy|1|||
46668725|NCT01280812|82883493|FG000|Overall Study|Lost to Follow-up|1|||
46668726|NCT01280812|82883494|FG001|Overall Study|Lost to Follow-up|1|||
46668727|NCT01280812|82883495|FG002|Overall Study|Lost to Follow-up|1|||
46668728|NCT01280656|82883507|FG000|Overall Study|Adverse Event|1|||
46668729|NCT01280656|82883508|FG001|Overall Study|Adverse Event|14|||
46668730|NCT01280656|82883509|FG002|Overall Study|Adverse Event|13|||
46668731|NCT01280656|82883507|FG000|Overall Study|Lack of Efficacy|1|||
46668732|NCT01280656|82883508|FG001|Overall Study|Lack of Efficacy|22|||
46668733|NCT01280656|82883509|FG002|Overall Study|Lack of Efficacy|38|||
46668734|NCT01280656|82883507|FG000|Overall Study|Treatment shortening (RGT)|0|||
46668735|NCT01280656|82883508|FG001|Overall Study|Treatment shortening (RGT)|4|||
46668736|NCT01280656|82883509|FG002|Overall Study|Treatment shortening (RGT)|5|||
46668737|NCT01280656|82883507|FG000|Overall Study|Other|1|||
46668738|NCT01280656|82883508|FG001|Overall Study|Other|7|||
46668739|NCT01280656|82883509|FG002|Overall Study|Other|7|||
46668740|NCT01280617|82883519|FG000|Overall Study|Adverse Event|0|||
46668741|NCT01280617|82883520|FG001|Overall Study|Adverse Event|1|||
46668742|NCT01280266|82883528|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
46668743|NCT01280266|82883529|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
46668744|NCT01280266|82883528|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
46668745|NCT01280266|82883529|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
46668746|NCT01279447|82883541|FG000|Overall Study|Lost to Follow-up|3|||
46668747|NCT01279447|82883542|FG001|Overall Study|Lost to Follow-up|1|||
46668748|NCT01276639|82883564|FG000|Week 0 to 16|Death|1|||
46668749|NCT01276639|82883565|FG001|Week 0 to 16|Death|0|||
46668750|NCT01276639|82883566|FG002|Week 0 to 16|Death|0|||
46668751|NCT01276639|82883567|FG003|Week 0 to 16|Death|0|||
46668752|NCT01276639|82883568|FG004|Week 0 to 16|Death|0|||
46668753|NCT01276639|82883564|FG000|Week 0 to 16|Adverse Event|11|||
46668754|NCT01276639|82883565|FG001|Week 0 to 16|Adverse Event|8|||
46668755|NCT01276639|82883566|FG002|Week 0 to 16|Adverse Event|11|||
46668756|NCT01276639|82883567|FG003|Week 0 to 16|Adverse Event|0|||
46668757|NCT01276639|82883568|FG004|Week 0 to 16|Adverse Event|0|||
46668758|NCT01276639|82883564|FG000|Week 0 to 16|Lack of Efficacy|20|||
47077119|NCT02591238|83375705|FG001|Overall Study|Pregnancy|0|||
47077120|NCT02591238|83375706|FG002|Overall Study|Pregnancy|0|||
47077121|NCT02591238|83375707|FG003|Overall Study|Pregnancy|0|||
47077122|NCT02591238|83375704|FG000|Overall Study|Withdrawal by Subject|0|||
47077123|NCT02591238|83375705|FG001|Overall Study|Withdrawal by Subject|0|||
47077124|NCT02591238|83375706|FG002|Overall Study|Withdrawal by Subject|0|||
47077125|NCT02591238|83375707|FG003|Overall Study|Withdrawal by Subject|1|||
47077126|NCT02591238|83375704|FG000|Overall Study|influenza|0|||
46668759|NCT01276639|82883565|FG001|Week 0 to 16|Lack of Efficacy|15|||
46668760|NCT01276639|82883566|FG002|Week 0 to 16|Lack of Efficacy|25|||
46668761|NCT01276639|82883567|FG003|Week 0 to 16|Lack of Efficacy|0|||
46668762|NCT01276639|82883568|FG004|Week 0 to 16|Lack of Efficacy|0|||
46668763|NCT01276639|82883564|FG000|Week 0 to 16|Lost to Follow-up|3|||
46668764|NCT01276639|82883565|FG001|Week 0 to 16|Lost to Follow-up|5|||
46668765|NCT01276639|82883566|FG002|Week 0 to 16|Lost to Follow-up|3|||
46668766|NCT01276639|82883567|FG003|Week 0 to 16|Lost to Follow-up|0|||
46668767|NCT01276639|82883568|FG004|Week 0 to 16|Lost to Follow-up|0|||
46668768|NCT01276639|82883564|FG000|Week 0 to 16|Withdrawal by Subject|8|||
46668769|NCT01276639|82883565|FG001|Week 0 to 16|Withdrawal by Subject|5|||
46668770|NCT01276639|82883566|FG002|Week 0 to 16|Withdrawal by Subject|4|||
46668771|NCT01276639|82883567|FG003|Week 0 to 16|Withdrawal by Subject|0|||
46668772|NCT01276639|82883568|FG004|Week 0 to 16|Withdrawal by Subject|0|||
46668773|NCT01276639|82883564|FG000|Week 0 to 16|Other|7|||
46668774|NCT01276639|82883565|FG001|Week 0 to 16|Other|7|||
46668775|NCT01276639|82883566|FG002|Week 0 to 16|Other|2|||
46668776|NCT01276639|82883567|FG003|Week 0 to 16|Other|0|||
46668777|NCT01276639|82883568|FG004|Week 0 to 16|Other|0|||
47077127|NCT02591238|83375705|FG001|Overall Study|influenza|0|||
46668778|NCT01276639|82883564|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
46668779|NCT01276639|82883565|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
46668780|NCT01276639|82883566|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
46668781|NCT01276639|82883567|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
46785868|NCT00660816|83004958|FG000|Overall Study|Disease Progression|16|||
46785869|NCT00660816|83004959|FG001|Overall Study|Disease Progression|12|||
46785870|NCT00660816|83004958|FG000|Overall Study|Complicating Disease|0|||
46785871|NCT00660816|83004959|FG001|Overall Study|Complicating Disease|1|||
47077128|NCT02591238|83375706|FG002|Overall Study|influenza|0|||
47077129|NCT02591238|83375707|FG003|Overall Study|influenza|1|||
46668782|NCT01276639|82883568|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
46668783|NCT01276639|82883564|FG000|Week 16 to 52|Death|1|||
46668784|NCT01276639|82883565|FG001|Week 16 to 52|Death|0|||
46668785|NCT01276639|82883566|FG002|Week 16 to 52|Death|0|||
46668786|NCT01276639|82883567|FG003|Week 16 to 52|Death|0|||
46668787|NCT01276639|82883568|FG004|Week 16 to 52|Death|0|||
47077130|NCT02591238|83375704|FG000|Overall Study|personal circumstances|0|||
47077131|NCT02591238|83375705|FG001|Overall Study|personal circumstances|0|||
46668788|NCT01276639|82883564|FG000|Week 16 to 52|Adverse Event|10|||
46668789|NCT01276639|82883565|FG001|Week 16 to 52|Adverse Event|13|||
46668790|NCT01276639|82883566|FG002|Week 16 to 52|Adverse Event|0|||
46668791|NCT01276639|82883567|FG003|Week 16 to 52|Adverse Event|1|||
46668792|NCT01276639|82883568|FG004|Week 16 to 52|Adverse Event|3|||
46668793|NCT01276639|82883564|FG000|Week 16 to 52|Lack of Efficacy|99|||
46668794|NCT01276639|82883565|FG001|Week 16 to 52|Lack of Efficacy|71|||
46668795|NCT01276639|82883566|FG002|Week 16 to 52|Lack of Efficacy|0|||
46668796|NCT01276639|82883567|FG003|Week 16 to 52|Lack of Efficacy|14|||
46668797|NCT01276639|82883568|FG004|Week 16 to 52|Lack of Efficacy|13|||
46668798|NCT01276639|82883564|FG000|Week 16 to 52|Lost to Follow-up|3|||
46668799|NCT01276639|82883565|FG001|Week 16 to 52|Lost to Follow-up|1|||
46668800|NCT01276639|82883566|FG002|Week 16 to 52|Lost to Follow-up|0|||
46668801|NCT01276639|82883567|FG003|Week 16 to 52|Lost to Follow-up|0|||
46668802|NCT01276639|82883568|FG004|Week 16 to 52|Lost to Follow-up|1|||
46668803|NCT01276639|82883564|FG000|Week 16 to 52|Withdrawal by Subject|4|||
46668804|NCT01276639|82883565|FG001|Week 16 to 52|Withdrawal by Subject|4|||
46668805|NCT01276639|82883566|FG002|Week 16 to 52|Withdrawal by Subject|0|||
46668806|NCT01276639|82883567|FG003|Week 16 to 52|Withdrawal by Subject|0|||
46668807|NCT01276639|82883568|FG004|Week 16 to 52|Withdrawal by Subject|1|||
46668808|NCT01276639|82883564|FG000|Week 16 to 52|Other|10|||
46668809|NCT01276639|82883565|FG001|Week 16 to 52|Other|12|||
46668810|NCT01276639|82883566|FG002|Week 16 to 52|Other|0|||
46668811|NCT01276639|82883567|FG003|Week 16 to 52|Other|1|||
46668812|NCT01276639|82883568|FG004|Week 16 to 52|Other|3|||
46668813|NCT01275625|82883583|FG000|Overall Study|Death|1|||
46668814|NCT01275625|82883583|FG000|Overall Study|Lack of Efficacy|2|||
46668815|NCT01275625|82883583|FG000|Overall Study|Lost to Follow-up|1|||
46668816|NCT01275625|82883583|FG000|Overall Study|Withdrawal by Subject|3|||
46668817|NCT01275625|82883583|FG000|Overall Study|Protocol Violation|1|||
46668818|NCT01275625|82883583|FG000|Overall Study|Adverse Event|4|||
46668819|NCT01275625|82883583|FG000|Overall Study|Other|1|||
46668820|NCT01272193|82883589|FG000|Overall Study|Adverse Event|1|||
46668821|NCT01272193|82883590|FG001|Overall Study|Adverse Event|1|||
46668822|NCT01272193|82883589|FG000|Overall Study|Lack of Efficacy|0|||
46668823|NCT01272193|82883590|FG001|Overall Study|Lack of Efficacy|3|||
46668824|NCT01272193|82883589|FG000|Overall Study|Withdrawal Criteria|1|||
46668825|NCT01272193|82883590|FG001|Overall Study|Withdrawal Criteria|1|||
46668826|NCT01272193|82883589|FG000|Overall Study|Unclassified|8|||
46668827|NCT01272193|82883590|FG001|Overall Study|Unclassified|7|||
46668828|NCT01270828|82883602|FG000|Pregabalin CR SB|Reason Unspecified|0|||
46668829|NCT01270828|82883603|FG001|Pregabalin CR SB|Reason Unspecified|0|||
46668830|NCT01270828|82883604|FG002|Pregabalin CR SB|Reason Unspecified|8|||
46668831|NCT01270828|82883602|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
46668832|NCT01270828|82883603|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
46668833|NCT01270828|82883604|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
46668834|NCT01270828|82883602|FG000|Pregabalin CR SB|Related adverse event|0|||
46668835|NCT01270828|82883603|FG001|Pregabalin CR SB|Related adverse event|0|||
46668836|NCT01270828|82883604|FG002|Pregabalin CR SB|Related adverse event|46|||
46668837|NCT01270828|82883602|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
46668838|NCT01270828|82883603|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
46668839|NCT01270828|82883604|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
46668840|NCT01270828|82883602|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
46668841|NCT01270828|82883603|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
46668842|NCT01270828|82883604|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
46668843|NCT01270828|82883602|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
46668844|NCT01270828|82883603|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
46668845|NCT01270828|82883604|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
46668846|NCT01270828|82883602|FG000|Pregabalin CR SB|Unrelated AE|0|||
46668847|NCT01270828|82883603|FG001|Pregabalin CR SB|Unrelated AE|0|||
46668848|NCT01270828|82883604|FG002|Pregabalin CR SB|Unrelated AE|8|||
46668849|NCT01270828|82883602|FG000|Pregabalin CR SB|Protocol Violation|0|||
46668850|NCT01270828|82883603|FG001|Pregabalin CR SB|Protocol Violation|0|||
46668851|NCT01270828|82883604|FG002|Pregabalin CR SB|Protocol Violation|8|||
46668852|NCT01270828|82883602|FG000|Double Blind Phase|Death|0|||
46668853|NCT01270828|82883603|FG001|Double Blind Phase|Death|1|||
46668854|NCT01270828|82883604|FG002|Double Blind Phase|Death|0|||
46668855|NCT01270828|82883602|FG000|Double Blind Phase|Protocol Violation|0|||
46668856|NCT01270828|82883603|FG001|Double Blind Phase|Protocol Violation|1|||
46668857|NCT01270828|82883604|FG002|Double Blind Phase|Protocol Violation|0|||
46668858|NCT01270828|82883602|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
46785872|NCT00576056|83004965|FG000|Overall Study|Adverse Event|1|||
46668859|NCT01270828|82883603|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
46668860|NCT01270828|82883604|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
46668861|NCT01270828|82883602|FG000|Double Blind Phase|Reason Unspecified|7|||
46668862|NCT01270828|82883603|FG001|Double Blind Phase|Reason Unspecified|4|||
46668863|NCT01270828|82883604|FG002|Double Blind Phase|Reason Unspecified|0|||
46668864|NCT01270828|82883602|FG000|Double Blind Phase|Withdrawal by Subject|6|||
46668865|NCT01270828|82883603|FG001|Double Blind Phase|Withdrawal by Subject|15|||
46668866|NCT01270828|82883604|FG002|Double Blind Phase|Withdrawal by Subject|0|||
46668867|NCT01270828|82883602|FG000|Double Blind Phase|Lost to Follow-up|1|||
46668868|NCT01270828|82883603|FG001|Double Blind Phase|Lost to Follow-up|2|||
46668869|NCT01270828|82883604|FG002|Double Blind Phase|Lost to Follow-up|0|||
46668870|NCT01270828|82883602|FG000|Double Blind Phase|Lack of Efficacy|2|||
46668871|NCT01270828|82883603|FG001|Double Blind Phase|Lack of Efficacy|11|||
46668872|NCT01270828|82883604|FG002|Double Blind Phase|Lack of Efficacy|0|||
46668873|NCT01270828|82883602|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
46668874|NCT01270828|82883603|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
46668875|NCT01270828|82883604|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
46668876|NCT01270828|82883602|FG000|Double Blind Phase|Adverse event related to study drug|5|||
46668877|NCT01270828|82883603|FG001|Double Blind Phase|Adverse event related to study drug|7|||
46668878|NCT01270828|82883604|FG002|Double Blind Phase|Adverse event related to study drug|0|||
46668879|NCT01269385|82883612|FG000|Overall Study|Adverse Event|1|||
46668880|NCT01269385|82883613|FG001|Overall Study|Adverse Event|1|||
46668881|NCT01269385|82883614|FG002|Overall Study|Adverse Event|0|||
46668882|NCT01269385|82883615|FG003|Overall Study|Adverse Event|0|||
46668883|NCT01268683|82883625|FG000|Overall Study|Lost to Follow-up|1|||
46668884|NCT01268683|82883625|FG000|Overall Study|Death|1|||
46668885|NCT01268566|82883629|FG000|Overall Study|Lost to Follow-up|1|||
46668886|NCT01268566|82883629|FG000|Overall Study|Withdrawal by Subject|12|||
46668887|NCT01268566|82883629|FG000|Overall Study|Death|30|||
46668888|NCT01268488|82883633|FG000|Overall Study|Adverse Event|3|||
46668889|NCT01268488|82883633|FG000|Overall Study|Physician Decision|2|||
46668890|NCT01268098|82883640|FG000|Overall Study|Adverse Event|1|||
46668891|NCT01268098|82883641|FG001|Overall Study|Adverse Event|0|||
46668892|NCT01268059|82883651|FG000|Overall Study|Lost to Follow-up|0|||
46668893|NCT01268059|82883652|FG001|Overall Study|Lost to Follow-up|1|||
46668894|NCT01268059|82883653|FG002|Overall Study|Lost to Follow-up|0|||
46668895|NCT01268059|82883654|FG003|Overall Study|Lost to Follow-up|0|||
46668896|NCT01268059|82883651|FG000|Overall Study|Withdrawal by Subject|7|||
46668897|NCT01268059|82883652|FG001|Overall Study|Withdrawal by Subject|4|||
46668898|NCT01268059|82883653|FG002|Overall Study|Withdrawal by Subject|0|||
46668899|NCT01268059|82883654|FG003|Overall Study|Withdrawal by Subject|0|||
46668900|NCT01268059|82883651|FG000|Overall Study|Death|20|||
46668901|NCT01268059|82883652|FG001|Overall Study|Death|30|||
46668902|NCT01268059|82883653|FG002|Overall Study|Death|3|||
47077132|NCT02591238|83375706|FG002|Overall Study|personal circumstances|0|||
47077133|NCT02591238|83375707|FG003|Overall Study|personal circumstances|1|||
46668903|NCT01268059|82883654|FG003|Overall Study|Death|5|||
46668904|NCT01268059|82883651|FG000|Overall Study|Progression of disease|1|||
46668905|NCT01268059|82883652|FG001|Overall Study|Progression of disease|0|||
46785873|NCT00576056|83004965|FG000|Overall Study|Death|1|||
46785874|NCT00576056|83004965|FG000|Overall Study|Lack of Efficacy|1|||
46785875|NCT00576056|83004965|FG000|Overall Study|Withdrawal by Subject|2|||
46785876|NCT00576056|83004965|FG000|Overall Study|did not meet eligibility criteria|8|||
46785877|NCT00576056|83004965|FG000|Overall Study|Physician Decision|1|||
46785878|NCT00575510|83004972|FG000|Overall Study|Lost to Follow-up|4|||
46785879|NCT00575510|83004973|FG001|Overall Study|Lost to Follow-up|6|||
46785880|NCT00575510|83004974|FG002|Overall Study|Lost to Follow-up|9|||
46785881|NCT00575510|83004972|FG000|Overall Study|Withdrawal by Subject|1|||
46785882|NCT00575510|83004973|FG001|Overall Study|Withdrawal by Subject|0|||
46668906|NCT01268059|82883653|FG002|Overall Study|Progression of disease|0|||
46668907|NCT01268059|82883654|FG003|Overall Study|Progression of disease|0|||
46668908|NCT01267825|82883669|FG000|Overall Study|study terminated. no data collected.|1|||
46668909|NCT01267825|82883670|FG001|Overall Study|study terminated. no data collected.|0|||
46785883|NCT00575510|83004974|FG002|Overall Study|Withdrawal by Subject|0|||
46668910|NCT01260181|82883676|FG000|Overall Study|Decision of Investigator|1|||
46668911|NCT01260142|82883686|FG000|Treatment Period 1|Study on hold|1|||
46785884|NCT00575510|83004972|FG000|Overall Study|Clinic Called Patient|7|||
46668912|NCT01260142|82883687|FG001|Treatment Period 1|Study on hold|1|||
46785885|NCT00575510|83004973|FG001|Overall Study|Clinic Called Patient|7|||
46785886|NCT00575510|83004974|FG002|Overall Study|Clinic Called Patient|7|||
46785887|NCT00575510|83004972|FG000|Overall Study|Pregnancy|0|||
47077134|NCT02591238|83375704|FG000|Overall Study|personal circumstances|0|||
46668913|NCT01260142|82883688|FG002|Treatment Period 1|Study on hold|0|||
46668914|NCT01260142|82883689|FG003|Treatment Period 1|Study on hold|0|||
46668915|NCT01260142|82883690|FG004|Treatment Period 1|Study on hold|1|||
47077135|NCT02591238|83375705|FG001|Overall Study|personal circumstances|1|||
46668916|NCT01260142|82883691|FG005|Treatment Period 1|Study on hold|2|||
46668917|NCT01260142|82883686|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
46668918|NCT01260142|82883687|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
46785888|NCT00575510|83004973|FG001|Overall Study|Pregnancy|0|||
46785889|NCT00575510|83004974|FG002|Overall Study|Pregnancy|1|||
46785890|NCT02636439|83004985|FG000|Overall Study|Adverse Event|2|||
46785891|NCT02636439|83004986|FG001|Overall Study|Adverse Event|2|||
46785892|NCT02636439|83004985|FG000|Overall Study|Lost to Follow-up|1|||
46668919|NCT01260142|82883688|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
46668920|NCT01260142|82883689|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
46668921|NCT01260142|82883690|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
46668922|NCT01260142|82883691|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
46668923|NCT01260142|82883686|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46668924|NCT01260142|82883687|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46668925|NCT01260142|82883688|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46668926|NCT01260142|82883689|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46668927|NCT01260142|82883690|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46668928|NCT01260142|82883691|FG005|Treatment Period 1|Withdrawal by Subject|1|||
46668929|NCT01259869|82883711|FG000|Overall Study|Duplicated registration|1|||
46668930|NCT01259713|82883717|FG000|Overall Study|Adverse Event|54|||
46668931|NCT01259713|82883718|FG001|Overall Study|Adverse Event|23|||
46668932|NCT01259713|82883717|FG000|Overall Study|Death Not Related to IFI|8|||
46668933|NCT01259713|82883718|FG001|Overall Study|Death Not Related to IFI|1|||
46668934|NCT01259713|82883717|FG000|Overall Study|Investigators Discretion|14|||
46668935|NCT01259713|82883718|FG001|Overall Study|Investigators Discretion|6|||
46668936|NCT01259713|82883717|FG000|Overall Study|Lack of Efficacy|2|||
46668937|NCT01259713|82883718|FG001|Overall Study|Lack of Efficacy|0|||
46668938|NCT01259713|82883717|FG000|Overall Study|Protocol Violation|5|||
46668939|NCT01259713|82883718|FG001|Overall Study|Protocol Violation|4|||
46668940|NCT01259713|82883717|FG000|Overall Study|Subject Withdrew Consent|12|||
46668941|NCT01259713|82883718|FG001|Overall Study|Subject Withdrew Consent|7|||
46668942|NCT01259401|82883726|FG000|4-month Follow-up|Death|0|||
46668943|NCT01259401|82883727|FG001|4-month Follow-up|Death|1|||
46668944|NCT01259401|82883726|FG000|4-month Follow-up|Lost to Follow-up|0|||
46668945|NCT01259401|82883727|FG001|4-month Follow-up|Lost to Follow-up|1|||
46668946|NCT01313923|82883742|FG000|Overall Study|Physician Decision|3|||
46668947|NCT01313884|82883746|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
46668948|NCT01135459|82883752|FG000|Overall Study|Adverse Event|8|||
46668949|NCT01135459|82883753|FG001|Overall Study|Adverse Event|10|||
46668950|NCT01135459|82883752|FG000|Overall Study|Lack of Efficacy|3|||
46668951|NCT01135459|82883753|FG001|Overall Study|Lack of Efficacy|1|||
46668952|NCT01135459|82883752|FG000|Overall Study|Withdrawal by Subject|2|||
46668953|NCT01135459|82883753|FG001|Overall Study|Withdrawal by Subject|3|||
46668954|NCT01135459|82883752|FG000|Overall Study|Protocol Violation|5|||
46668955|NCT01135459|82883753|FG001|Overall Study|Protocol Violation|3|||
46668956|NCT01135459|82883752|FG000|Overall Study|Lost to Follow-up|2|||
46668957|NCT01135459|82883753|FG001|Overall Study|Lost to Follow-up|1|||
46668958|NCT01135459|82883752|FG000|Overall Study|Non-compliance to study procedures|0|||
46668959|NCT01135459|82883753|FG001|Overall Study|Non-compliance to study procedures|1|||
46668960|NCT01135459|82883752|FG000|Overall Study|Other than specified|1|||
46668961|NCT01135459|82883753|FG001|Overall Study|Other than specified|1|||
46668962|NCT01259284|82883762|FG000|Overall Study|Study Termination|2|||
46668963|NCT01259284|82883763|FG001|Overall Study|Study Termination|0|||
46668964|NCT01259284|82883764|FG002|Overall Study|Study Termination|0|||
46668965|NCT01259245|82883774|FG000|Overall Study|Withdrawal by Subject|27|||
46668966|NCT01259245|82883775|FG001|Overall Study|Withdrawal by Subject|24|||
46668967|NCT01259245|82883774|FG000|Overall Study|Death|1|||
46668968|NCT01259245|82883775|FG001|Overall Study|Death|2|||
46668969|NCT01259089|82883783|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
46668970|NCT01259089|82883784|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
46668971|NCT01259089|82883785|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
46668972|NCT01259089|82883786|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
46668973|NCT01259089|82883787|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
46785893|NCT02636439|83004986|FG001|Overall Study|Lost to Follow-up|0|||
46972679|NCT02027428|83216342|FG001|Survival Follow-up|Lost to Follow-up|1|||
46668974|NCT01259089|82883788|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
46668975|NCT01259089|82883783|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
46668976|NCT01259089|82883784|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
46668977|NCT01259089|82883785|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
46668978|NCT01259089|82883786|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
46668979|NCT01259089|82883787|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
46668980|NCT01259089|82883788|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
46668981|NCT01259089|82883783|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
46785894|NCT02636439|83004985|FG000|Overall Study|Non-compliance|1|||
46785895|NCT02636439|83004986|FG001|Overall Study|Non-compliance|1|||
46668982|NCT01259089|82883784|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
46668983|NCT01259089|82883785|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
46668984|NCT01259089|82883786|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
46668985|NCT01259089|82883787|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
46668986|NCT01259089|82883788|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
46668987|NCT01259089|82883783|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
46668988|NCT01259089|82883784|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
46668989|NCT01259089|82883785|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
46668990|NCT01259089|82883786|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
46668991|NCT01259089|82883787|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
46668992|NCT01259089|82883788|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
46668993|NCT01259089|82883783|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
46668994|NCT01259089|82883784|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
46668995|NCT01259089|82883785|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
46668996|NCT01259089|82883786|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
46668997|NCT01259089|82883787|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
46668998|NCT01259089|82883788|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
46668999|NCT01259089|82883783|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
46669000|NCT01259089|82883784|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
46669001|NCT01259089|82883785|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
46669002|NCT01259089|82883786|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
46669003|NCT01259089|82883787|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
46669004|NCT01259089|82883788|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
46669005|NCT01259089|82883783|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
46669006|NCT01259089|82883784|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
46669007|NCT01259089|82883785|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
46669008|NCT01259089|82883786|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
46669009|NCT01259089|82883787|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
46669010|NCT01259089|82883788|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
46669011|NCT01259089|82883783|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
46669012|NCT01259089|82883784|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
46669013|NCT01259089|82883785|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
46669014|NCT01259089|82883786|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
46669015|NCT01259089|82883787|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
46669016|NCT01259089|82883788|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
46669017|NCT01259089|82883783|FG000|Survival Follow up for Two Years|Death|3|||
46669018|NCT01259089|82883784|FG001|Survival Follow up for Two Years|Death|2|||
46669019|NCT01259089|82883785|FG002|Survival Follow up for Two Years|Death|2|||
46669020|NCT01259089|82883786|FG003|Survival Follow up for Two Years|Death|3|||
46669021|NCT01259089|82883787|FG004|Survival Follow up for Two Years|Death|6|||
46669022|NCT01259089|82883788|FG005|Survival Follow up for Two Years|Death|13|||
46669023|NCT01259089|82883783|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
46669024|NCT01259089|82883784|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
46669025|NCT01259089|82883785|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
46669026|NCT01259089|82883786|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
46669027|NCT01259089|82883787|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
46669028|NCT01259089|82883788|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
46669029|NCT01259089|82883783|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
46669030|NCT01259089|82883784|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
46669031|NCT01259089|82883785|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
46669032|NCT01259089|82883786|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
46669033|NCT01259089|82883787|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
46669034|NCT01259089|82883788|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
46669035|NCT01258738|82883804|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
46669036|NCT01258738|82883805|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
46669037|NCT01258738|82883804|FG000|Double-blind Period|Withdrawal by Subject|2|||
46669038|NCT01258738|82883805|FG001|Double-blind Period|Withdrawal by Subject|2|||
46785896|NCT02636439|83004985|FG000|Overall Study|Personal reasons|2|||
46785897|NCT02636439|83004986|FG001|Overall Study|Personal reasons|0|||
46785898|NCT00343915|83004994|FG000|Primary Study|Withdrawal by Subject|1|||
46785899|NCT00343915|83004995|FG001|Primary Study|Withdrawal by Subject|0|||
46785900|NCT00343915|83004994|FG000|Primary Study|Lost to Follow-up|2|||
46669039|NCT01258738|82883804|FG000|Double-blind Period|Protocol Violation|1|||
46669040|NCT01258738|82883805|FG001|Double-blind Period|Protocol Violation|1|||
46669041|NCT01258738|82883804|FG000|Double-blind Period|Adverse Event|3|||
46669042|NCT01258738|82883805|FG001|Double-blind Period|Adverse Event|1|||
46669043|NCT01258738|82883804|FG000|Open-label Period|Did not meet inclusion criteria|0|||
46785901|NCT00343915|83004995|FG001|Primary Study|Lost to Follow-up|3|||
46785902|NCT00343915|83004994|FG000|Primary Study|Other|1|||
46669044|NCT01258738|82883805|FG001|Open-label Period|Did not meet inclusion criteria|1|||
46669045|NCT01258738|82883804|FG000|Open-label Period|Insufficient clinical response|5|||
46669046|NCT01258738|82883805|FG001|Open-label Period|Insufficient clinical response|3|||
46669047|NCT01258738|82883804|FG000|Open-label Period|Lost to Follow-up|0|||
46669048|NCT01258738|82883805|FG001|Open-label Period|Lost to Follow-up|2|||
46669049|NCT01258738|82883804|FG000|Open-label Period|Withdrawal by Subject|5|||
46669050|NCT01258738|82883805|FG001|Open-label Period|Withdrawal by Subject|6|||
46669051|NCT01258738|82883804|FG000|Open-label Period|Protocol Violation|2|||
46669052|NCT01258738|82883805|FG001|Open-label Period|Protocol Violation|2|||
46669053|NCT01258738|82883804|FG000|Open-label Period|Adverse Event|4|||
46669054|NCT01258738|82883805|FG001|Open-label Period|Adverse Event|5|||
46669055|NCT01258738|82883804|FG000|Open-label Period|Other Reasons|0|||
46669056|NCT01258738|82883805|FG001|Open-label Period|Other Reasons|1|||
46669057|NCT01258738|82883804|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
46669058|NCT01258738|82883805|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
46669059|NCT01258660|82883813|FG000|Overall Study|Adverse Event|2|||
46669060|NCT01258660|82883814|FG001|Overall Study|Adverse Event|4|||
46669061|NCT01258660|82883813|FG000|Overall Study|Withdrawal by Subject|3|||
46669062|NCT01258660|82883814|FG001|Overall Study|Withdrawal by Subject|0|||
46669063|NCT01258660|82883813|FG000|Overall Study|due to relocation|2|||
46669064|NCT01258660|82883814|FG001|Overall Study|due to relocation|0|||
46669065|NCT01258660|82883813|FG000|Overall Study|Protocol Violation|0|||
46669066|NCT01258660|82883814|FG001|Overall Study|Protocol Violation|1|||
46669067|NCT01258660|82883813|FG000|Overall Study|Invalid for primary analysis data set|4|||
46669068|NCT01258660|82883814|FG001|Overall Study|Invalid for primary analysis data set|6|||
46669069|NCT01258348|82883821|FG000|Overall Study|Adverse Event|1|||
46669070|NCT01258348|82883822|FG001|Overall Study|Adverse Event|1|||
46669071|NCT01258348|82883823|FG002|Overall Study|Adverse Event|3|||
46669072|NCT01258348|82883824|FG003|Overall Study|Adverse Event|2|||
46669073|NCT01258348|82883825|FG004|Overall Study|Adverse Event|4|||
46669074|NCT01258348|82883821|FG000|Overall Study|Progressive Disease|0|||
46669075|NCT01258348|82883822|FG001|Overall Study|Progressive Disease|3|||
46669076|NCT01258348|82883823|FG002|Overall Study|Progressive Disease|0|||
46669077|NCT01258348|82883824|FG003|Overall Study|Progressive Disease|2|||
46669078|NCT01258348|82883825|FG004|Overall Study|Progressive Disease|2|||
46669079|NCT01258348|82883821|FG000|Overall Study|Physician Decision|0|||
46669080|NCT01258348|82883822|FG001|Overall Study|Physician Decision|0|||
46669081|NCT01258348|82883823|FG002|Overall Study|Physician Decision|0|||
46669082|NCT01258348|82883824|FG003|Overall Study|Physician Decision|2|||
46669083|NCT01258348|82883825|FG004|Overall Study|Physician Decision|0|||
46669084|NCT01258348|82883821|FG000|Overall Study|Withdrawal by Subject|0|||
46669085|NCT01258348|82883822|FG001|Overall Study|Withdrawal by Subject|1|||
46669086|NCT01258348|82883823|FG002|Overall Study|Withdrawal by Subject|0|||
46669087|NCT01258348|82883824|FG003|Overall Study|Withdrawal by Subject|0|||
46669088|NCT01258348|82883825|FG004|Overall Study|Withdrawal by Subject|0|||
46669089|NCT01258075|82883841|FG000|Overall Study|Adverse Event|8|||
46669090|NCT01258075|82883842|FG001|Overall Study|Adverse Event|3|||
46669091|NCT01258075|82883841|FG000|Overall Study|Lost to Follow-up|11|||
46669092|NCT01258075|82883842|FG001|Overall Study|Lost to Follow-up|6|||
46669093|NCT01258075|82883841|FG000|Overall Study|Withdrawal by Subject|10|||
46669094|NCT01258075|82883842|FG001|Overall Study|Withdrawal by Subject|7|||
46669095|NCT01258075|82883841|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
46669096|NCT01258075|82883842|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
46669097|NCT01258075|82883841|FG000|Overall Study|Other|12|||
46669098|NCT01258075|82883842|FG001|Overall Study|Other|5|||
46669099|NCT01257568|82883848|FG000|Overall Study|Lost to Follow-up|2|||
46669100|NCT01257568|82883848|FG000|Overall Study|Withdrawal by Subject|6|||
46669101|NCT01257568|82883848|FG000|Overall Study|Terminated|1|||
46669102|NCT01257568|82883848|FG000|Overall Study|Component Revision|24|||
46669103|NCT01256788|82883857|FG000|Overall Study|Lost to Follow-up|5|||
46669104|NCT01256788|82883858|FG001|Overall Study|Lost to Follow-up|8|||
46669105|NCT01256788|82883859|FG002|Overall Study|Lost to Follow-up|3|||
46669106|NCT01256671|82883867|FG000|Overall Study|Adverse Event|29|||
46669107|NCT01256671|82883867|FG000|Overall Study|Lost to Follow-up|16|||
46669108|NCT01256671|82883867|FG000|Overall Study|Withdrawal by Subject|31|||
46669109|NCT01256671|82883867|FG000|Overall Study|Physician Decision|3|||
46669110|NCT01256671|82883867|FG000|Overall Study|Lack of Efficacy|4|||
46669111|NCT01256671|82883867|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
46785903|NCT00343915|83004995|FG001|Primary Study|Other|0|||
46669112|NCT01256476|82883873|FG000|Overall Study|Adverse Event|2|||
46669113|NCT01256476|82883874|FG001|Overall Study|Adverse Event|1|||
46669114|NCT01256476|82883873|FG000|Overall Study|Withdrawal by Subject|2|||
46669115|NCT01256476|82883874|FG001|Overall Study|Withdrawal by Subject|1|||
46669116|NCT01256476|82883873|FG000|Overall Study|Lost to Follow-up|1|||
46669117|NCT01256476|82883874|FG001|Overall Study|Lost to Follow-up|2|||
46669118|NCT01256476|82883873|FG000|Overall Study|Persistent ALT or AST elevation|1|||
46669119|NCT01256476|82883874|FG001|Overall Study|Persistent ALT or AST elevation|0|||
46669120|NCT01256476|82883873|FG000|Overall Study|Physician Decision|0|||
46669121|NCT01256476|82883874|FG001|Overall Study|Physician Decision|1|||
46669122|NCT01256476|82883873|FG000|Overall Study|Subject non-compliance|0|||
46669123|NCT01256476|82883874|FG001|Overall Study|Subject non-compliance|1|||
46669124|NCT01256476|82883873|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
46669125|NCT01256476|82883874|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
46669126|NCT01256008|82883883|FG000|Overall Study|Lost to Follow-up|6|||
46669127|NCT01256008|82883884|FG001|Overall Study|Lost to Follow-up|4|||
46669128|NCT01256008|82883885|FG002|Overall Study|Lost to Follow-up|11|||
46669129|NCT01256008|82883883|FG000|Overall Study|Withdrawal by Subject|2|||
46669130|NCT01256008|82883884|FG001|Overall Study|Withdrawal by Subject|3|||
46669131|NCT01256008|82883885|FG002|Overall Study|Withdrawal by Subject|10|||
46669132|NCT01255423|82883897|FG000|Overall Study|Abnormal Laboratory value|3|||
46669133|NCT01255423|82883898|FG001|Overall Study|Abnormal Laboratory value|2|||
46669134|NCT01255423|82883897|FG000|Overall Study|Use of prohibited medications|0|||
46669135|NCT01255423|82883898|FG001|Overall Study|Use of prohibited medications|1|||
46669136|NCT01255306|82883906|FG000|Overall Study|Physician Decision|1|||
46972680|NCT02027428|83216343|FG002|Survival Follow-up|Lost to Follow-up|1|||
46972681|NCT01995136|83216366|FG000|Overall Study|Change in residence|1|||
46669137|NCT01255306|82883907|FG001|Overall Study|Physician Decision|1|||
46669138|NCT01254721|82883918|FG000|Overall Study|Lost to Follow-up|0|||
46669139|NCT01254721|82883919|FG001|Overall Study|Lost to Follow-up|4|||
46669140|NCT01254721|82883918|FG000|Overall Study|Lack of Efficacy|4|||
46669141|NCT01254721|82883919|FG001|Overall Study|Lack of Efficacy|2|||
46669142|NCT01254721|82883918|FG000|Overall Study|Death|0|||
46669143|NCT01254721|82883919|FG001|Overall Study|Death|1|||
46669144|NCT01254721|82883918|FG000|Overall Study|technical problum|1|||
46669145|NCT01254721|82883919|FG001|Overall Study|technical problum|0|||
46669146|NCT01254721|82883918|FG000|Overall Study|Adverse Event|2|||
46669147|NCT01254721|82883919|FG001|Overall Study|Adverse Event|3|||
46669148|NCT01254721|82883918|FG000|Overall Study|Withdrawal by Subject|8|||
46669149|NCT01254721|82883919|FG001|Overall Study|Withdrawal by Subject|11|||
46669150|NCT01254721|82883918|FG000|Overall Study|Wrongly randomization|0|||
46669151|NCT01254721|82883919|FG001|Overall Study|Wrongly randomization|1|||
46669152|NCT01254643|82883925|FG000|Overall Study|Withdrawal by Subject|1|||
46669153|NCT01254604|82883931|FG000|Overall Study|Lost to Follow-up|1|||
46669154|NCT01254604|82883932|FG001|Overall Study|Lost to Follow-up|1|||
46669155|NCT01254604|82883931|FG000|Overall Study|Protocol Violation|2|||
46669156|NCT01254604|82883932|FG001|Overall Study|Protocol Violation|2|||
46669157|NCT01254604|82883931|FG000|Overall Study|Withdrawal by Subject|2|||
46669158|NCT01254604|82883932|FG001|Overall Study|Withdrawal by Subject|4|||
46669159|NCT01254604|82883931|FG000|Overall Study|Adverse Event|3|||
46669160|NCT01254604|82883932|FG001|Overall Study|Adverse Event|2|||
46669161|NCT01254565|82883944|FG000|Overall Study|Non-compliance to Study Procedures|0|||
46669162|NCT01254565|82883945|FG001|Overall Study|Non-compliance to Study Procedures|0|||
46669163|NCT01254565|82883946|FG002|Overall Study|Non-compliance to Study Procedures|0|||
46669164|NCT01254565|82883947|FG003|Overall Study|Non-compliance to Study Procedures|0|||
46669165|NCT01254565|82883948|FG004|Overall Study|Non-compliance to Study Procedures|1|||
46669166|NCT01254565|82883949|FG005|Overall Study|Non-compliance to Study Procedures|0|||
46669167|NCT01254565|82883944|FG000|Overall Study|Did not Receive Treatment|1|||
46669168|NCT01254565|82883945|FG001|Overall Study|Did not Receive Treatment|1|||
46669169|NCT01254565|82883946|FG002|Overall Study|Did not Receive Treatment|0|||
46669170|NCT01254565|82883947|FG003|Overall Study|Did not Receive Treatment|0|||
46669171|NCT01254565|82883948|FG004|Overall Study|Did not Receive Treatment|3|||
46669172|NCT01254565|82883949|FG005|Overall Study|Did not Receive Treatment|4|||
46669173|NCT01254565|82883944|FG000|Overall Study|Other|0|||
46669174|NCT01254565|82883945|FG001|Overall Study|Other|0|||
46669175|NCT01254565|82883946|FG002|Overall Study|Other|0|||
46669176|NCT01254565|82883947|FG003|Overall Study|Other|1|||
46785904|NCT00575666|83005006|FG000|Overall Study|Withdrawal by Subject|3|||
46785905|NCT00575666|83005007|FG001|Overall Study|Withdrawal by Subject|2|||
46972682|NCT01994902|83216370|FG000|Test Period 1|Withdrawal by Subject|3|||
46669177|NCT01254565|82883948|FG004|Overall Study|Other|0|||
46669178|NCT01254565|82883949|FG005|Overall Study|Other|0|||
46669179|NCT01254409|82883967|FG000|Overall Study|Adverse Event|0|||
46669180|NCT01254409|82883968|FG001|Overall Study|Adverse Event|1|||
46669181|NCT01254409|82883969|FG002|Overall Study|Adverse Event|0|||
46669182|NCT01254409|82883970|FG003|Overall Study|Adverse Event|0|||
46785906|NCT00575666|83005006|FG000|Overall Study|Physician Decision|1|||
46785907|NCT00575666|83005007|FG001|Overall Study|Physician Decision|1|||
46669183|NCT01254331|82883983|FG000|Initial Phase|Adverse Event|3|||
46669184|NCT01254331|82883983|FG000|Initial Phase|Withdrawal by Subject|1|||
46669185|NCT01254331|82883983|FG000|Initial Phase|Pregnancy|1|||
46669186|NCT01254331|82883983|FG000|Extension Phase|Lack of Efficacy|1|||
46785908|NCT00658632|83005015|FG000|Overall Study|Adverse Event|13|||
46669187|NCT01254331|82883983|FG000|Extension Phase|Lost to Follow-up|3|||
46669188|NCT01254292|82883998|FG000|Comparative Phase|Adverse Event|25|||
46669189|NCT01254292|82883999|FG001|Comparative Phase|Adverse Event|25|||
46669190|NCT01254292|82883998|FG000|Comparative Phase|Lost to Follow-up|3|||
46669191|NCT01254292|82883999|FG001|Comparative Phase|Lost to Follow-up|21|||
46669192|NCT01254292|82883998|FG000|Comparative Phase|Pregnancy|2|||
46669193|NCT01254292|82883999|FG001|Comparative Phase|Pregnancy|6|||
46785909|NCT00658632|83005016|FG001|Overall Study|Adverse Event|11|||
46785910|NCT00658632|83005015|FG000|Overall Study|Lost to Follow-up|25|||
46669194|NCT01254292|82883998|FG000|Comparative Phase|Withdrawal by Subject|20|||
46669195|NCT01254292|82883999|FG001|Comparative Phase|Withdrawal by Subject|21|||
46669196|NCT01254292|82883998|FG000|Comparative Phase|Protocol Violation|1|||
46669197|NCT01254292|82883999|FG001|Comparative Phase|Protocol Violation|2|||
46669198|NCT01254292|82883998|FG000|Comparative Phase|Wish for pregnancy|4|||
46669199|NCT01254292|82883999|FG001|Comparative Phase|Wish for pregnancy|6|||
46669200|NCT01254292|82883998|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
46669201|NCT01254292|82883999|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
46669202|NCT01254292|82883998|FG000|LCS12 Extension Phase|Adverse Event|9|||
46669203|NCT01254292|82883999|FG001|LCS12 Extension Phase|Adverse Event|0|||
46669204|NCT01254292|82883998|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
46669205|NCT01254292|82883999|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
46785911|NCT00658632|83005016|FG001|Overall Study|Lost to Follow-up|23|||
46785912|NCT00658632|83005015|FG000|Overall Study|Withdrawal by Subject|10|||
46785913|NCT00658632|83005016|FG001|Overall Study|Withdrawal by Subject|7|||
46785914|NCT00658632|83005015|FG000|Overall Study|Lack of Efficacy|0|||
46785915|NCT00658632|83005016|FG001|Overall Study|Lack of Efficacy|1|||
46785916|NCT00658632|83005015|FG000|Overall Study|Withdrawal of consent|8|||
46785917|NCT00658632|83005016|FG001|Overall Study|Withdrawal of consent|14|||
46785918|NCT00658632|83005015|FG000|Overall Study|Pregnancy|1|||
46785919|NCT00658632|83005016|FG001|Overall Study|Pregnancy|1|||
46785920|NCT00658632|83005015|FG000|Overall Study|Other|7|||
46785921|NCT00658632|83005016|FG001|Overall Study|Other|8|||
46785922|NCT00677534|83005022|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
46785923|NCT00677534|83005022|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
46785924|NCT00677534|83005022|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
46785925|NCT00660348|83005028|FG000|Overall Study|Withdrawal by Subject|1|||
46785926|NCT00660348|83005029|FG001|Overall Study|Withdrawal by Subject|0|||
46785927|NCT00660192|83005037|FG000|Overall Study|Lost to Follow-up|2|||
46785928|NCT00660192|83005038|FG001|Overall Study|Lost to Follow-up|3|||
46785929|NCT00571688|83005046|FG000|Overall Study|Lost to Follow-up|3|||
46785930|NCT00571688|83005047|FG001|Overall Study|Lost to Follow-up|6|||
46785931|NCT00571688|83005046|FG000|Overall Study|subject did not tolerate Consta|1|||
46785932|NCT00571688|83005047|FG001|Overall Study|subject did not tolerate Consta|0|||
46669206|NCT01254292|82883998|FG000|LCS12 Extension Phase|Other unknown|4|||
46669207|NCT01254292|82883999|FG001|LCS12 Extension Phase|Other unknown|0|||
46669208|NCT01254292|82883998|FG000|LCS12 Extension Phase|Pregnancy|2|||
46669209|NCT01254292|82883999|FG001|LCS12 Extension Phase|Pregnancy|0|||
46669210|NCT01254292|82883998|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
46669211|NCT01254292|82883999|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
46669212|NCT01254019|82884008|FG000|Overall Study|Adverse Event|0|||
46669213|NCT01254019|82884009|FG001|Overall Study|Adverse Event|2|||
47077136|NCT02591238|83375706|FG002|Overall Study|personal circumstances|0|||
46669214|NCT01254019|82884008|FG000|Overall Study|Protocol Violation|1|||
46669215|NCT01254019|82884009|FG001|Overall Study|Protocol Violation|0|||
47077137|NCT02591238|83375707|FG003|Overall Study|personal circumstances|0|||
47077138|NCT02597946|83375789|FG000|Overall Study|Withdrawal by Subject|1|||
47077139|NCT02597946|83375789|FG000|Overall Study|Progressive disease|16|||
47077140|NCT02597946|83375789|FG000|Overall Study|Other than above|1|||
47077141|NCT02597712|83375795|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
47077142|NCT02597712|83375796|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
47077143|NCT02597712|83375795|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
47077144|NCT02597712|83375796|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
46669216|NCT01254019|82884008|FG000|Overall Study|Withdrawal by Subject|0|||
46669217|NCT01254019|82884009|FG001|Overall Study|Withdrawal by Subject|2|||
46669218|NCT01253317|82884018|FG000|Overall Study|Adverse Event|2|||
46669219|NCT01253200|82884031|FG000|Overall Study|Death|1|||
46669220|NCT01253200|82884032|FG001|Overall Study|Death|0|||
46669221|NCT01253200|82884033|FG002|Overall Study|Death|0|||
46669222|NCT01253200|82884034|FG003|Overall Study|Death|0|||
46669223|NCT01253200|82884035|FG004|Overall Study|Death|0|||
46785933|NCT00571688|83005046|FG000|Overall Study|subject moved out of the area|1|||
46669224|NCT01253200|82884031|FG000|Overall Study|Lost to Follow-up|1|||
46785934|NCT00571688|83005047|FG001|Overall Study|subject moved out of the area|0|||
46669225|NCT01253200|82884032|FG001|Overall Study|Lost to Follow-up|1|||
46669226|NCT01253200|82884033|FG002|Overall Study|Lost to Follow-up|0|||
46669227|NCT01253200|82884034|FG003|Overall Study|Lost to Follow-up|0|||
46785935|NCT00343291|83005055|FG000|Overall Study|Adverse Event|13|||
46785936|NCT00343291|83005056|FG001|Overall Study|Adverse Event|13|||
46669228|NCT01253200|82884035|FG004|Overall Study|Lost to Follow-up|0|||
46669229|NCT01253200|82884031|FG000|Overall Study|Withdrawal by Subject|2|||
46669230|NCT01253200|82884032|FG001|Overall Study|Withdrawal by Subject|0|||
46669231|NCT01253200|82884033|FG002|Overall Study|Withdrawal by Subject|0|||
46669232|NCT01253200|82884034|FG003|Overall Study|Withdrawal by Subject|0|||
46669233|NCT01253200|82884035|FG004|Overall Study|Withdrawal by Subject|0|||
46669234|NCT01253200|82884031|FG000|Overall Study|Protocol Violation|1|||
46669235|NCT01253200|82884032|FG001|Overall Study|Protocol Violation|4|||
46669236|NCT01253200|82884033|FG002|Overall Study|Protocol Violation|0|||
46669237|NCT01253200|82884034|FG003|Overall Study|Protocol Violation|0|||
46669238|NCT01253200|82884035|FG004|Overall Study|Protocol Violation|5|||
46669239|NCT01253200|82884031|FG000|Overall Study|intents|10|||
46669240|NCT01253200|82884032|FG001|Overall Study|intents|10|||
46669241|NCT01253200|82884033|FG002|Overall Study|intents|1|||
46669242|NCT01253200|82884034|FG003|Overall Study|intents|3|||
46669243|NCT01253200|82884035|FG004|Overall Study|intents|0|||
46669244|NCT01253200|82884031|FG000|Overall Study|Attempts|6|||
46669245|NCT01253200|82884032|FG001|Overall Study|Attempts|4|||
46669246|NCT01253200|82884033|FG002|Overall Study|Attempts|1|||
46669247|NCT01253200|82884034|FG003|Overall Study|Attempts|2|||
46669248|NCT01253200|82884035|FG004|Overall Study|Attempts|0|||
46669249|NCT01253044|82884046|FG000|Overall Study|Lost to Follow-up|38|||
46669250|NCT01253044|82884047|FG001|Overall Study|Lost to Follow-up|29|||
46669251|NCT01252966|82884055|FG000|Overall Study|Lost to Follow-up|16|||
46669252|NCT01252966|82884056|FG001|Overall Study|Lost to Follow-up|10|||
46669253|NCT01252966|82884055|FG000|Overall Study|Withdrawal by Subject|7|||
46669254|NCT01252966|82884056|FG001|Overall Study|Withdrawal by Subject|3|||
46669255|NCT01252810|82884066|FG000|Overall Study|Withdrawal by Subject|4|||
46669256|NCT01252810|82884067|FG001|Overall Study|Withdrawal by Subject|1|||
46669257|NCT01252810|82884066|FG000|Overall Study|Lost to Follow-up|0|||
46669258|NCT01252810|82884067|FG001|Overall Study|Lost to Follow-up|1|||
46669259|NCT01252810|82884066|FG000|Overall Study|Physician Decision|2|||
46669260|NCT01252810|82884067|FG001|Overall Study|Physician Decision|1|||
46669261|NCT01252810|82884066|FG000|Overall Study|Various reasons|8|||
46669262|NCT01252810|82884067|FG001|Overall Study|Various reasons|0|||
46669263|NCT01252186|82884076|FG000|Overall Study|Adverse Event|9|||
46669264|NCT01252186|82884077|FG001|Overall Study|Adverse Event|6|||
46669265|NCT01252186|82884078|FG002|Overall Study|Adverse Event|8|||
46669266|NCT01252186|82884076|FG000|Overall Study|Withdrawal by Subject|2|||
46669267|NCT01252186|82884077|FG001|Overall Study|Withdrawal by Subject|5|||
46669268|NCT01252186|82884078|FG002|Overall Study|Withdrawal by Subject|2|||
46669269|NCT01252186|82884076|FG000|Overall Study|Physician Decision|0|||
46669270|NCT01252186|82884077|FG001|Overall Study|Physician Decision|0|||
46669271|NCT01252186|82884078|FG002|Overall Study|Physician Decision|1|||
46669272|NCT01252186|82884076|FG000|Overall Study|Non-compliance|0|||
46669273|NCT01252186|82884077|FG001|Overall Study|Non-compliance|3|||
46669274|NCT01252186|82884078|FG002|Overall Study|Non-compliance|4|||
46669275|NCT01252186|82884076|FG000|Overall Study|Protocol Violation|0|||
46669276|NCT01252186|82884077|FG001|Overall Study|Protocol Violation|0|||
46669277|NCT01252186|82884078|FG002|Overall Study|Protocol Violation|1|||
46669278|NCT01252186|82884076|FG000|Overall Study|Pregnancy|2|||
46669279|NCT01252186|82884077|FG001|Overall Study|Pregnancy|2|||
46669280|NCT01252186|82884078|FG002|Overall Study|Pregnancy|0|||
46669281|NCT01252186|82884076|FG000|Overall Study|Sponsor Request|2|||
46669282|NCT01252186|82884077|FG001|Overall Study|Sponsor Request|1|||
46669283|NCT01252186|82884078|FG002|Overall Study|Sponsor Request|0|||
46669284|NCT01252186|82884076|FG000|Overall Study|Lost to Follow-up|10|||
46669285|NCT01252186|82884077|FG001|Overall Study|Lost to Follow-up|10|||
46669286|NCT01252186|82884078|FG002|Overall Study|Lost to Follow-up|11|||
46669287|NCT01252186|82884076|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
46669288|NCT01252186|82884077|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
46669289|NCT01252186|82884078|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
46669290|NCT01251952|82884113|FG000|Overall Study|Adverse Event|1|||
46669291|NCT01251367|82884117|FG000|Overall Study|Protocol Violation|1|||
46785937|NCT00343291|83005055|FG000|Overall Study|Death|3|||
46669292|NCT01251367|82884117|FG000|Overall Study|Lack of Efficacy|2|||
46669293|NCT01251367|82884117|FG000|Overall Study|Adverse Event|19|||
46669294|NCT01251367|82884117|FG000|Overall Study|Withdrawal by Subject|36|||
46669295|NCT01251367|82884117|FG000|Overall Study|Lost to Follow-up|5|||
46669296|NCT01251367|82884117|FG000|Overall Study|Subject Required Alternative Treatment|7|||
46669297|NCT01251367|82884117|FG000|Overall Study|No Study Drug Available|1|||
46669298|NCT01251367|82884117|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
46669299|NCT01251367|82884117|FG000|Overall Study|End of Study Visit Performed in Error|1|||
46669300|NCT01250509|82884123|FG000|Overall Study|Lost to Follow-up|5|||
46669301|NCT01250509|82884124|FG001|Overall Study|Lost to Follow-up|2|||
46669302|NCT01250119|82884132|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
46669303|NCT01250119|82884133|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
46785938|NCT00343291|83005056|FG001|Overall Study|Death|2|||
46669304|NCT01250119|82884132|FG000|Diagnostic Phase|Participants Not Tested|44|||
46785939|NCT00343291|83005055|FG000|Overall Study|Progressive disease|33|||
46669305|NCT01250119|82884133|FG001|Diagnostic Phase|Participants Not Tested|0|||
46669306|NCT01250119|82884132|FG000|Treatment Phase|Progressive Disease|0|||
46669307|NCT01250119|82884133|FG001|Treatment Phase|Progressive Disease|32|||
46669308|NCT01250119|82884132|FG000|Treatment Phase|Death|0|||
46669309|NCT01250119|82884133|FG001|Treatment Phase|Death|2|||
46669310|NCT01250119|82884132|FG000|Treatment Phase|Withdrawal by Subject|0|||
46669311|NCT01250119|82884133|FG001|Treatment Phase|Withdrawal by Subject|1|||
46669312|NCT01250119|82884132|FG000|Treatment Phase|Adverse Event|0|||
46669313|NCT01250119|82884133|FG001|Treatment Phase|Adverse Event|2|||
46669314|NCT01250119|82884132|FG000|Treatment Phase|Unknown reason|0|||
46669315|NCT01250119|82884133|FG001|Treatment Phase|Unknown reason|4|||
46669316|NCT01250002|82884142|FG000|Overall Study|Change to open surgical procedure|4|||
46669317|NCT01250002|82884143|FG001|Overall Study|Change to open surgical procedure|3|||
46669318|NCT01246960|82884151|FG000|Overall Study|Lost to Follow-up|3|||
46669319|NCT01246960|82884152|FG001|Overall Study|Lost to Follow-up|1|||
46669320|NCT01246960|82884151|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
46669321|NCT01246960|82884152|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
46669322|NCT01244620|82884158|FG000|Overall Study|Study terminated|4|||
46669323|NCT01244620|82884159|FG001|Overall Study|Study terminated|4|||
46669324|NCT01244620|82884160|FG002|Overall Study|Study terminated|4|||
46669325|NCT01244620|82884161|FG003|Overall Study|Study terminated|4|||
46669326|NCT01267201|82884171|FG000|First Intervention Period|Withdrawal by Subject|1|||
46669327|NCT01267201|82884172|FG001|First Intervention Period|Withdrawal by Subject|0|||
46669328|NCT01267201|82884173|FG002|First Intervention Period|Withdrawal by Subject|0|||
46669329|NCT01267201|82884174|FG003|First Intervention Period|Withdrawal by Subject|0|||
46669330|NCT01267201|82884175|FG004|First Intervention Period|Withdrawal by Subject|0|||
46669331|NCT01267201|82884176|FG005|First Intervention Period|Withdrawal by Subject|0|||
46669332|NCT01267201|82884171|FG000|Second Intervention Period|Withdrawal by Subject|0|||
46669333|NCT01267201|82884172|FG001|Second Intervention Period|Withdrawal by Subject|1|||
46669334|NCT01267201|82884173|FG002|Second Intervention Period|Withdrawal by Subject|0|||
46669335|NCT01267201|82884174|FG003|Second Intervention Period|Withdrawal by Subject|0|||
46669336|NCT01267201|82884175|FG004|Second Intervention Period|Withdrawal by Subject|0|||
46669337|NCT01267201|82884176|FG005|Second Intervention Period|Withdrawal by Subject|0|||
46669338|NCT01266967|82884186|FG000|Overall Study|Death|69|||
46669339|NCT01266967|82884187|FG001|Overall Study|Death|61|||
46669340|NCT01266967|82884186|FG000|Overall Study|Study Closed/Terminated|15|||
46669341|NCT01266967|82884187|FG001|Overall Study|Study Closed/Terminated|17|||
46669342|NCT01266967|82884186|FG000|Overall Study|Lost to Follow-up|2|||
46669343|NCT01266967|82884187|FG001|Overall Study|Lost to Follow-up|1|||
46669344|NCT01266967|82884186|FG000|Overall Study|Physician Decision|0|||
46669345|NCT01266967|82884187|FG001|Overall Study|Physician Decision|1|||
46669346|NCT01266967|82884186|FG000|Overall Study|Withdrawal by Subject|3|||
46669347|NCT01266967|82884187|FG001|Overall Study|Withdrawal by Subject|3|||
46669348|NCT01266850|82884201|FG000|Overall Study|Lost to Follow-up|19|||
46669349|NCT01266850|82884202|FG001|Overall Study|Lost to Follow-up|19|||
46669350|NCT01266850|82884203|FG002|Overall Study|Lost to Follow-up|13|||
46669351|NCT01266850|82884204|FG003|Overall Study|Lost to Follow-up|13|||
46669352|NCT01266850|82884205|FG004|Overall Study|Lost to Follow-up|12|||
46669353|NCT01266850|82884201|FG000|Overall Study|Withdrawal by Subject|8|||
46669354|NCT01266850|82884202|FG001|Overall Study|Withdrawal by Subject|9|||
46669355|NCT01266850|82884203|FG002|Overall Study|Withdrawal by Subject|6|||
46669356|NCT01266850|82884204|FG003|Overall Study|Withdrawal by Subject|9|||
46669357|NCT01266850|82884205|FG004|Overall Study|Withdrawal by Subject|12|||
46669358|NCT01266850|82884201|FG000|Overall Study|Physician Decision|3|||
46669359|NCT01266850|82884202|FG001|Overall Study|Physician Decision|6|||
46669360|NCT01266850|82884203|FG002|Overall Study|Physician Decision|4|||
46669361|NCT01266850|82884204|FG003|Overall Study|Physician Decision|4|||
46669362|NCT01266850|82884205|FG004|Overall Study|Physician Decision|3|||
46669363|NCT01266850|82884201|FG000|Overall Study|Protocol Violation|0|||
46669364|NCT01266850|82884202|FG001|Overall Study|Protocol Violation|1|||
46669365|NCT01266850|82884203|FG002|Overall Study|Protocol Violation|0|||
46669366|NCT01266850|82884204|FG003|Overall Study|Protocol Violation|1|||
46669367|NCT01266850|82884205|FG004|Overall Study|Protocol Violation|2|||
46669368|NCT01266850|82884201|FG000|Overall Study|Adverse Event|0|||
46669369|NCT01266850|82884202|FG001|Overall Study|Adverse Event|0|||
46669370|NCT01266850|82884203|FG002|Overall Study|Adverse Event|0|||
46669371|NCT01266850|82884204|FG003|Overall Study|Adverse Event|0|||
46669372|NCT01266850|82884205|FG004|Overall Study|Adverse Event|1|||
46669373|NCT01266850|82884201|FG000|Overall Study|Site Closure|0|||
46669374|NCT01266850|82884202|FG001|Overall Study|Site Closure|1|||
46669375|NCT01266850|82884203|FG002|Overall Study|Site Closure|1|||
46669376|NCT01266850|82884204|FG003|Overall Study|Site Closure|1|||
46669377|NCT01266850|82884205|FG004|Overall Study|Site Closure|0|||
46669378|NCT01266460|82884217|FG000|Overall Study|Adverse Event|3|||
46669379|NCT01266460|82884217|FG000|Overall Study|Withdrawal by Subject|5|||
46669380|NCT01266460|82884217|FG000|Overall Study|Disease Progression|18|||
46669381|NCT01266460|82884217|FG000|Overall Study|Not otherwise specified|8|||
46669382|NCT01266265|82884223|FG000|Overall Study|Death|95|||
46669383|NCT01266265|82884224|FG001|Overall Study|Death|73|||
46669384|NCT01266265|82884223|FG000|Overall Study|Lost to Follow-up|23|||
46669385|NCT01266265|82884224|FG001|Overall Study|Lost to Follow-up|28|||
46669386|NCT01266265|82884223|FG000|Overall Study|Withdrawal by Subject|13|||
46669387|NCT01266265|82884224|FG001|Overall Study|Withdrawal by Subject|11|||
46669388|NCT01266265|82884223|FG000|Overall Study|Respiratory-related adverse event|2|||
46669389|NCT01266265|82884224|FG001|Overall Study|Respiratory-related adverse event|1|||
46669390|NCT01266265|82884223|FG000|Overall Study|Transferred care to another provider|22|||
46669391|NCT01266265|82884224|FG001|Overall Study|Transferred care to another provider|28|||
46669392|NCT01266265|82884223|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
46669393|NCT01266265|82884224|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
46669394|NCT01266265|82884223|FG000|Overall Study|Enrolled in another clinical study|15|||
46669395|NCT01266265|82884224|FG001|Overall Study|Enrolled in another clinical study|26|||
46669396|NCT01266265|82884223|FG000|Overall Study|Non-compliance|8|||
46669397|NCT01266265|82884224|FG001|Overall Study|Non-compliance|5|||
46669398|NCT01266265|82884223|FG000|Overall Study|Lung transplant|6|||
46669399|NCT01266265|82884224|FG001|Overall Study|Lung transplant|5|||
46669400|NCT01266265|82884223|FG000|Overall Study|Site closed early|4|||
46669401|NCT01266265|82884224|FG001|Overall Study|Site closed early|3|||
46669402|NCT01266265|82884223|FG000|Overall Study|Clinical worsening|1|||
46669403|NCT01266265|82884224|FG001|Overall Study|Clinical worsening|1|||
46669404|NCT01266148|82884232|FG000|Overall Study|Adverse Event|2|||
46669405|NCT01266148|82884233|FG001|Overall Study|Adverse Event|0|||
46669406|NCT01266148|82884232|FG000|Overall Study|Ongoing rejection|1|||
46669407|NCT01266148|82884233|FG001|Overall Study|Ongoing rejection|0|||
46669408|NCT01266148|82884232|FG000|Overall Study|2 2R rejections|1|||
46669409|NCT01266148|82884233|FG001|Overall Study|2 2R rejections|0|||
46669410|NCT01266148|82884232|FG000|Overall Study|Death|2|||
46669411|NCT01266148|82884233|FG001|Overall Study|Death|3|||
46669412|NCT01266148|82884232|FG000|Overall Study|missing mGFR value + AE|1|||
46669413|NCT01266148|82884233|FG001|Overall Study|missing mGFR value + AE|0|||
46669414|NCT01266070|82884239|FG000|Overall Study|Adverse Event|3|||
46669415|NCT01266070|82884239|FG000|Overall Study|Protocol Violation|1|||
46669416|NCT01265992|82884243|FG000|Overall Study|Lost to Follow-up|1|||
46669417|NCT01265992|82884243|FG000|Overall Study|Withdrawal by Subject|1|||
46669418|NCT01265992|82884243|FG000|Overall Study|Adverse Event|1|||
46669419|NCT01265992|82884243|FG000|Overall Study|Administrative reasons|2|||
46669420|NCT01265992|82884243|FG000|Overall Study|Stopped treatment|3|||
46669421|NCT01265992|82884243|FG000|Overall Study|Did not receive treatment|1|||
46669422|NCT01265953|82884249|FG000|Overall Study|Non compliance|5|||
46669423|NCT01265953|82884250|FG001|Overall Study|Non compliance|3|||
46669424|NCT01265875|82884256|FG000|Overall Study|Uncooperative/unreliable|1|||
46669425|NCT01265797|82884263|FG000|Run-in Month|Withdrawal by Subject|0|||
46669426|NCT01265797|82884264|FG001|Run-in Month|Withdrawal by Subject|4|||
46669427|NCT01265797|82884263|FG000|Run-in Month|1st seizure during run-in month|0|||
46669428|NCT01265797|82884264|FG001|Run-in Month|1st seizure during run-in month|1|||
46669429|NCT01265797|82884263|FG000|Blinded Month|Lack of Efficacy|5|||
46669430|NCT01265797|82884264|FG001|Blinded Month|Lack of Efficacy|0|||
46669431|NCT01265797|82884263|FG000|Blinded Month|Lost to Follow-up|1|||
46669432|NCT01265797|82884264|FG001|Blinded Month|Lost to Follow-up|0|||
46669433|NCT01265797|82884263|FG000|Blinded Month|Protocol Violation|2|||
46669434|NCT01265797|82884264|FG001|Blinded Month|Protocol Violation|1|||
46669435|NCT01265797|82884263|FG000|Blinded Month|Adverse Event|2|||
46669436|NCT01265797|82884264|FG001|Blinded Month|Adverse Event|0|||
46669437|NCT01265797|82884263|FG000|Blinded Month|Diary data incomplete|0|||
46669438|NCT01265797|82884264|FG001|Blinded Month|Diary data incomplete|1|||
46669439|NCT01265797|82884263|FG000|Open Label Month|Lost to Follow-up|0|||
46669440|NCT01265797|82884264|FG001|Open Label Month|Lost to Follow-up|1|||
46669441|NCT01265719|82884274|FG000|Overall Study|Does not meet entrance criteria|0|||
46669442|NCT01265719|82884275|FG001|Overall Study|Does not meet entrance criteria|3|||
46669443|NCT01265719|82884274|FG000|Overall Study|Other reasons|2|||
46669444|NCT01265719|82884275|FG001|Overall Study|Other reasons|0|||
46669445|NCT01265719|82884274|FG000|Overall Study|Withdrawal by Subject|8|||
46669446|NCT01265719|82884275|FG001|Overall Study|Withdrawal by Subject|3|||
46669447|NCT01265719|82884274|FG000|Overall Study|Lost to Follow-up|2|||
46669448|NCT01265719|82884275|FG001|Overall Study|Lost to Follow-up|7|||
46669449|NCT01265719|82884274|FG000|Overall Study|Adverse Event|2|||
46669450|NCT01265719|82884275|FG001|Overall Study|Adverse Event|0|||
46785940|NCT00343291|83005056|FG001|Overall Study|Progressive disease|34|||
46669451|NCT01265563|82884307|FG000|Overall Study|Withdrawal by Subject|0|||
46669452|NCT01265563|82884308|FG001|Overall Study|Withdrawal by Subject|1|||
46669453|NCT01265563|82884309|FG002|Overall Study|Withdrawal by Subject|1|||
46669454|NCT01265563|82884310|FG003|Overall Study|Withdrawal by Subject|0|||
46669455|NCT01265563|82884311|FG004|Overall Study|Withdrawal by Subject|2|||
46669456|NCT01265056|82884330|FG000|Initial Study Period|Withdrawal by Subject|1|||
46669457|NCT01265056|82884331|FG001|Initial Study Period|Withdrawal by Subject|1|||
46669458|NCT01265056|82884330|FG000|Initial Study Period|Withdrawal by Subject|1|||
46669459|NCT01265056|82884331|FG001|Initial Study Period|Withdrawal by Subject|1|||
46669460|NCT01265056|82884330|FG000|Follow up|Lost to Follow-up|7|||
46669461|NCT01265056|82884331|FG001|Follow up|Lost to Follow-up|3|||
46669462|NCT01264939|82884339|FG000|Overall Study|Adverse Event|1|||
46669463|NCT01264939|82884340|FG001|Overall Study|Adverse Event|3|||
46669464|NCT01264939|82884339|FG000|Overall Study|Lost to Follow-up|0|||
46669465|NCT01264939|82884340|FG001|Overall Study|Lost to Follow-up|3|||
46669466|NCT01264939|82884339|FG000|Overall Study|Physician Decision|1|||
46669467|NCT01264939|82884340|FG001|Overall Study|Physician Decision|1|||
46972683|NCT01994902|83216371|FG001|Test Period 1|Withdrawal by Subject|0|||
46972684|NCT01994902|83216370|FG000|Test Period 1|device deficiency with adverse event|0|||
46972685|NCT01994902|83216371|FG001|Test Period 1|device deficiency with adverse event|1|||
46972686|NCT01994902|83216370|FG000|Test Period 1|Adverse Event|2|||
46972687|NCT01994902|83216371|FG001|Test Period 1|Adverse Event|1|||
46972688|NCT01994902|83216370|FG000|Test Period 1|Lack of Efficacy|0|||
46972689|NCT01994902|83216371|FG001|Test Period 1|Lack of Efficacy|1|||
46972690|NCT01994902|83216370|FG000|Test Period 1|bag too small|1|||
46972691|NCT01994902|83216371|FG001|Test Period 1|bag too small|0|||
46972692|NCT01994902|83216370|FG000|Test Period 2|Withdrawal by Subject|0|||
47077145|NCT02597712|83375795|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
47077146|NCT02597712|83375796|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
46669468|NCT01264939|82884339|FG000|Overall Study|Patient/Guardian Decision|8|||
46669469|NCT01264939|82884340|FG001|Overall Study|Patient/Guardian Decision|10|||
46669470|NCT01264939|82884339|FG000|Overall Study|Disease Progression|8|||
46669471|NCT01264939|82884340|FG001|Overall Study|Disease Progression|11|||
46669472|NCT01264081|82884346|FG000|Participants Screened|Screening failures|30|||
46669473|NCT01264081|82884346|FG000|Started Treatment|Withdrawal by Subject|1|||
46669474|NCT01264081|82884346|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
46669475|NCT01263925|82884352|FG000|Overall Study|Protocol Violation|1|||
46669476|NCT01263925|82884353|FG001|Overall Study|Protocol Violation|0|||
46669477|NCT01263925|82884352|FG000|Overall Study|Lack of Efficacy|0|||
46669478|NCT01263925|82884353|FG001|Overall Study|Lack of Efficacy|1|||
46669479|NCT01263925|82884352|FG000|Overall Study|Adverse Event|23|||
46669480|NCT01263925|82884353|FG001|Overall Study|Adverse Event|22|||
46669481|NCT01263925|82884352|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
46669482|NCT01263925|82884353|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
46669483|NCT01263925|82884352|FG000|Overall Study|Withdrawal by Subject|6|||
46669484|NCT01263925|82884353|FG001|Overall Study|Withdrawal by Subject|8|||
46669485|NCT01263925|82884352|FG000|Overall Study|Other|4|||
46669486|NCT01263925|82884353|FG001|Overall Study|Other|4|||
46669487|NCT01263925|82884352|FG000|Overall Study|Lost to Follow-up|3|||
46669488|NCT01263925|82884353|FG001|Overall Study|Lost to Follow-up|1|||
46669489|NCT01263925|82884352|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
46669490|NCT01263925|82884353|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
46669491|NCT01263925|82884352|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
46669492|NCT01263925|82884353|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
46669493|NCT01263925|82884352|FG000|Overall Study|AE/ Withdrawal|1|||
46669494|NCT01263925|82884353|FG001|Overall Study|AE/ Withdrawal|4|||
46669495|NCT01263925|82884352|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
46669496|NCT01263925|82884353|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
46669497|NCT01263925|82884352|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
46669498|NCT01263925|82884353|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
46669499|NCT01263925|82884352|FG000|Overall Study|Withdrawal/ Not specified|0|||
46669500|NCT01263925|82884353|FG001|Overall Study|Withdrawal/ Not specified|1|||
46669501|NCT01263496|82884392|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
46785941|NCT00343291|83005055|FG000|Overall Study|Withdrawal by Subject|0|||
46972693|NCT01994902|83216371|FG001|Test Period 2|Withdrawal by Subject|2|||
47077147|NCT02597478|83375804|FG000|Overall Study|Withdrawal by Subject|2|||
47077148|NCT02597478|83375805|FG001|Overall Study|Withdrawal by Subject|0|||
47077149|NCT02597478|83375804|FG000|Overall Study|Change of opioid dose|1|||
46785942|NCT00343291|83005056|FG001|Overall Study|Withdrawal by Subject|2|||
46785943|NCT00343291|83005055|FG000|Overall Study|Other|8|||
46785944|NCT00343291|83005056|FG001|Overall Study|Other|5|||
46785945|NCT00658788|83005062|FG000|Overall Study|Adverse Event|11|||
46785946|NCT00658788|83005062|FG000|Overall Study|Withdrawal by Subject|13|||
46785947|NCT00658788|83005062|FG000|Overall Study|Lost to Follow-up|18|||
46785948|NCT00658788|83005062|FG000|Overall Study|Treatment Discontinuation|32|||
46785949|NCT04829214|83005077|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
46785950|NCT04829214|83005078|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
46669502|NCT01263496|82884393|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46669503|NCT01263496|82884394|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46669504|NCT01263496|82884395|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46972694|NCT01994902|83216370|FG000|Test Period 2|Lack of Efficacy|0|||
47077150|NCT02597478|83375805|FG001|Overall Study|Change of opioid dose|0|||
46972695|NCT01994902|83216371|FG001|Test Period 2|Lack of Efficacy|1|||
46972696|NCT01994902|83216370|FG000|Test Period 2|Other|0|||
46972697|NCT01994902|83216371|FG001|Test Period 2|Other|3|||
46972698|NCT02026258|83216379|FG000|Randomized|Did not start treatment|2|||
46972699|NCT02026258|83216380|FG001|Randomized|Did not start treatment|1|||
46972700|NCT02026258|83216379|FG000|Randomized|Change in treatment plan|1|||
46972701|NCT02026258|83216380|FG001|Randomized|Change in treatment plan|0|||
46972702|NCT02026258|83216379|FG000|Randomized|Presence of periodontal disease|1|||
46972703|NCT02026258|83216380|FG001|Randomized|Presence of periodontal disease|1|||
46972704|NCT02026258|83216379|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
46972705|NCT02026258|83216380|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
46972706|NCT02026258|83216379|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
46972707|NCT02026258|83216380|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
46972708|NCT01994590|83216387|FG000|Overall Study|Adverse Event|1|||
46972709|NCT01994590|83216387|FG000|Overall Study|Trial Terminated|1|||
46972710|NCT02019550|83216393|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
46972711|NCT02019550|83216394|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
46972712|NCT02019472|83216405|FG000|Overall Study|Adverse Event|14|||
46972713|NCT02019472|83216406|FG001|Overall Study|Adverse Event|23|||
46972714|NCT02019472|83216407|FG002|Overall Study|Adverse Event|17|||
46972715|NCT02019472|83216405|FG000|Overall Study|Death|0|||
46972716|NCT02019472|83216406|FG001|Overall Study|Death|1|||
46972717|NCT02019472|83216407|FG002|Overall Study|Death|1|||
46972718|NCT02019472|83216405|FG000|Overall Study|Lack of Efficacy|7|||
46972719|NCT02019472|83216406|FG001|Overall Study|Lack of Efficacy|4|||
46972720|NCT02019472|83216407|FG002|Overall Study|Lack of Efficacy|4|||
46972721|NCT02019472|83216405|FG000|Overall Study|Lost to Follow-up|0|||
46972722|NCT02019472|83216406|FG001|Overall Study|Lost to Follow-up|2|||
46972723|NCT02019472|83216407|FG002|Overall Study|Lost to Follow-up|1|||
46972724|NCT02019472|83216405|FG000|Overall Study|Physician Decision|1|||
46972725|NCT02019472|83216406|FG001|Overall Study|Physician Decision|2|||
46972726|NCT02019472|83216407|FG002|Overall Study|Physician Decision|0|||
46972727|NCT02019472|83216405|FG000|Overall Study|Pregnancy|1|||
46972728|NCT02019472|83216406|FG001|Overall Study|Pregnancy|2|||
46972729|NCT02019472|83216407|FG002|Overall Study|Pregnancy|2|||
46972730|NCT02019472|83216405|FG000|Overall Study|Withdrawal by Subject|11|||
46972731|NCT02019472|83216406|FG001|Overall Study|Withdrawal by Subject|10|||
46972732|NCT02019472|83216407|FG002|Overall Study|Withdrawal by Subject|11|||
46972733|NCT02019472|83216405|FG000|Overall Study|Other|3|||
46972734|NCT02019472|83216406|FG001|Overall Study|Other|8|||
46972735|NCT02019472|83216407|FG002|Overall Study|Other|6|||
46972736|NCT02705755|83216419|FG000|Part A (6 Days)|Adverse Event|1|||
46972737|NCT02705755|83216420|FG001|Part A (6 Days)|Adverse Event|0|||
46972738|NCT02705755|83216421|FG002|Part A (6 Days)|Adverse Event|0|||
46972739|NCT02705755|83216422|FG003|Part A (6 Days)|Adverse Event|0|||
46972740|NCT02705755|83216419|FG000|Part A (6 Days)|Physician Decision|3|||
46972741|NCT02705755|83216420|FG001|Part A (6 Days)|Physician Decision|0|||
46972742|NCT02705755|83216421|FG002|Part A (6 Days)|Physician Decision|0|||
46972743|NCT02705755|83216422|FG003|Part A (6 Days)|Physician Decision|0|||
46972744|NCT02705755|83216419|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
46972745|NCT02705755|83216420|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
46972746|NCT02705755|83216421|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
46972747|NCT02705755|83216422|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
46972748|NCT02705755|83216419|FG000|Part C (20 Weeks)|Physician Decision|0|||
46972749|NCT02705755|83216420|FG001|Part C (20 Weeks)|Physician Decision|0|||
46972750|NCT02705755|83216421|FG002|Part C (20 Weeks)|Physician Decision|0|||
46972751|NCT02705755|83216422|FG003|Part C (20 Weeks)|Physician Decision|2|||
46972752|NCT02705755|83216419|FG000|Part C (20 Weeks)|Adverse Event|0|||
46972753|NCT02705755|83216420|FG001|Part C (20 Weeks)|Adverse Event|0|||
46972754|NCT02705755|83216421|FG002|Part C (20 Weeks)|Adverse Event|0|||
46972755|NCT02705755|83216422|FG003|Part C (20 Weeks)|Adverse Event|6|||
46972756|NCT02705755|83216419|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
46972757|NCT02705755|83216420|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
46972758|NCT02705755|83216421|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
46972759|NCT02705755|83216422|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
46972760|NCT02024932|83216455|FG000|Overall Study|Adverse Event|2|||
46972761|NCT02024932|83216456|FG001|Overall Study|Adverse Event|3|||
46972762|NCT02024932|83216457|FG002|Overall Study|Adverse Event|0|||
46972763|NCT02024932|83216458|FG003|Overall Study|Adverse Event|0|||
46972764|NCT02024932|83216459|FG004|Overall Study|Adverse Event|2|||
47077151|NCT02597478|83375804|FG000|Overall Study|Insufficient exertional dyspnea|0|||
47077152|NCT02597478|83375805|FG001|Overall Study|Insufficient exertional dyspnea|1|||
47077153|NCT01471028|83375900|FG000|VTI-208|Adverse Event|39|||
47077154|NCT01471028|83375901|FG001|VTI-208|Adverse Event|41|||
47077155|NCT01471028|83375900|FG000|VTI-208|Withdrawal by Subject|0|||
47077156|NCT01471028|83375901|FG001|VTI-208|Withdrawal by Subject|2|||
47077157|NCT01471028|83375900|FG000|VTI-208|Lost to Follow-up|1|||
47077158|NCT01471028|83375901|FG001|VTI-208|Lost to Follow-up|1|||
47077159|NCT01471028|83375900|FG000|VTI-208E|Death|7|||
47077160|NCT01471028|83375901|FG001|VTI-208E|Death|10|||
46972765|NCT02024932|83216460|FG005|Overall Study|Adverse Event|0|||
46972766|NCT02024932|83216455|FG000|Overall Study|Abnormal laboratory value|0|||
46972767|NCT02024932|83216456|FG001|Overall Study|Abnormal laboratory value|0|||
46972768|NCT02024932|83216457|FG002|Overall Study|Abnormal laboratory value|0|||
46972769|NCT02024932|83216458|FG003|Overall Study|Abnormal laboratory value|2|||
46972770|NCT02024932|83216459|FG004|Overall Study|Abnormal laboratory value|0|||
46972771|NCT02024932|83216460|FG005|Overall Study|Abnormal laboratory value|0|||
46972772|NCT01993888|83216491|FG000|Overall Study|Death|1|||
46972773|NCT01993888|83216492|FG001|Overall Study|Death|1|||
46785951|NCT04829214|83005077|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
46785952|NCT04829214|83005078|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
46785953|NCT00562965|83005088|FG000|Overall Study|Withdrawal by Subject|0|||
46972774|NCT01993888|83216491|FG000|Overall Study|Lost to Follow-up|1|||
46972775|NCT01993888|83216492|FG001|Overall Study|Lost to Follow-up|1|||
46972776|NCT01993888|83216491|FG000|Overall Study|Withdrawal by Subject|0|||
46972777|NCT01993888|83216492|FG001|Overall Study|Withdrawal by Subject|1|||
46785954|NCT00562965|83005089|FG001|Overall Study|Withdrawal by Subject|1|||
46785955|NCT00562965|83005088|FG000|Overall Study|Death|2|||
46785956|NCT00562965|83005089|FG001|Overall Study|Death|4|||
46785957|NCT00562965|83005088|FG000|Overall Study|Lost to Follow-up|1|||
46785958|NCT00562965|83005089|FG001|Overall Study|Lost to Follow-up|0|||
46785959|NCT00562965|83005088|FG000|Overall Study|Other|0|||
46785960|NCT00562965|83005089|FG001|Overall Study|Other|1|||
46972778|NCT02024698|83216498|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
46972779|NCT02024698|83216499|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
46972780|NCT02018458|83216505|FG000|Overall Study|Death|4|||
46972781|NCT02017522|83216509|FG000|Overall Study|Withdrawal by Subject|1|||
46972782|NCT02017444|83216516|FG000|Overall Study|Physician Decision|1|||
46972783|NCT02017444|83216517|FG001|Overall Study|Physician Decision|0|||
46972784|NCT02017444|83216516|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
46972785|NCT02017444|83216517|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
46972786|NCT01993186|83216525|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
46972787|NCT01993186|83216526|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
46972788|NCT01993186|83216525|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
46972789|NCT01993186|83216526|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
46972790|NCT01993186|83216525|FG000|Open-Label Extension Period|Other, Not Specified|0|||
46972791|NCT01993186|83216526|FG001|Open-Label Extension Period|Other, Not Specified|1|||
46785961|NCT00537082|83005098|FG000|Overall Study|Adverse Event|6|||
46785962|NCT00537082|83005099|FG001|Overall Study|Adverse Event|6|||
46785963|NCT00537082|83005100|FG002|Overall Study|Adverse Event|3|||
46785964|NCT00537082|83005098|FG000|Overall Study|Protocol Violation|0|||
46785965|NCT00537082|83005099|FG001|Overall Study|Protocol Violation|2|||
46785966|NCT00537082|83005100|FG002|Overall Study|Protocol Violation|1|||
46785967|NCT00537082|83005098|FG000|Overall Study|Lack of Efficacy|0|||
46785968|NCT00537082|83005099|FG001|Overall Study|Lack of Efficacy|0|||
46785969|NCT00537082|83005100|FG002|Overall Study|Lack of Efficacy|2|||
46785970|NCT00537082|83005098|FG000|Overall Study|Withdrawal by Subject|0|||
46785971|NCT00537082|83005099|FG001|Overall Study|Withdrawal by Subject|1|||
46785972|NCT00537082|83005100|FG002|Overall Study|Withdrawal by Subject|0|||
46785973|NCT00537082|83005098|FG000|Overall Study|Discontinued before initiating treatment|3|||
46785974|NCT00537082|83005099|FG001|Overall Study|Discontinued before initiating treatment|0|||
46785975|NCT00537082|83005100|FG002|Overall Study|Discontinued before initiating treatment|0|||
46785976|NCT03828487|83005108|FG000|Overall Study|Physician Decision|1|||
46785977|NCT00324961|83005112|FG000|Overall Study|Adverse Event|5|||
46785978|NCT00324961|83005112|FG000|Overall Study|Consent Withdrawn|11|||
46785979|NCT00324961|83005112|FG000|Overall Study|Lost to Follow-up|22|||
46785980|NCT00324961|83005112|FG000|Overall Study|Protocol Violation|3|||
46785981|NCT00324961|83005112|FG000|Overall Study|Other|2|||
46785982|NCT00324649|83005120|FG000|Overall Study|Adverse Event|1|||
46785983|NCT00324649|83005121|FG001|Overall Study|Adverse Event|4|||
46785984|NCT00324649|83005120|FG000|Overall Study|Withdrawal by Subject|0|||
46785985|NCT00324649|83005121|FG001|Overall Study|Withdrawal by Subject|1|||
46785986|NCT00324649|83005120|FG000|Overall Study|Noncompliance|1|||
46972792|NCT01993186|83216525|FG000|Open-Label Extension Period|Adverse Event|1|||
46972793|NCT01993186|83216526|FG001|Open-Label Extension Period|Adverse Event|0|||
46972794|NCT01993186|83216525|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
46972795|NCT01993186|83216526|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
46972796|NCT01993186|83216525|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
46972797|NCT01993186|83216526|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
46972798|NCT01993186|83216525|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
46972799|NCT01993186|83216526|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
46972800|NCT02016898|83216535|FG000|Overall Study|Death|1|||
46785987|NCT00324649|83005121|FG001|Overall Study|Noncompliance|0|||
46785988|NCT00656370|83005127|FG000|Overall Study|Screen Failures|7|||
47077161|NCT01471028|83375900|FG000|VTI-208E|Withdrawal by Subject|1|||
47077162|NCT01471028|83375901|FG001|VTI-208E|Withdrawal by Subject|0|||
47077163|NCT01471028|83375900|FG000|VTI-208E|Lost to Follow-up|0|||
47077164|NCT01471028|83375901|FG001|VTI-208E|Lost to Follow-up|2|||
47077165|NCT01491854|83375915|FG000|Overall Study|mainly due to premature termination|93|||
47077166|NCT01491854|83375915|FG000|Overall Study|Death|1|||
47077167|NCT01491854|83375915|FG000|Overall Study|Withdrawal by Subject|3|||
47077168|NCT01491854|83375915|FG000|Overall Study|Lost to Follow-up|33|||
47077169|NCT01470248|83375923|FG000|Overall Study|Withdrawal by Subject|1|||
47077170|NCT01490918|83375943|FG000|Overall Study|Lost to Follow-up|2|||
47077171|NCT01490918|83375944|FG001|Overall Study|Lost to Follow-up|1|||
47077172|NCT01490918|83375945|FG002|Overall Study|Lost to Follow-up|0|||
47077173|NCT01490918|83375943|FG000|Overall Study|Withdrawal by Subject|7|||
47077174|NCT01490918|83375944|FG001|Overall Study|Withdrawal by Subject|8|||
47077175|NCT01490918|83375945|FG002|Overall Study|Withdrawal by Subject|3|||
47077176|NCT01490918|83375943|FG000|Overall Study|Adverse Event|0|||
47077177|NCT01490918|83375944|FG001|Overall Study|Adverse Event|0|||
47077178|NCT01490918|83375945|FG002|Overall Study|Adverse Event|1|||
47077179|NCT01490918|83375943|FG000|Overall Study|other cause|4|||
47077180|NCT01490918|83375944|FG001|Overall Study|other cause|5|||
47077181|NCT01490918|83375945|FG002|Overall Study|other cause|8|||
47077182|NCT01490840|83375977|FG000|Phase 1|Lost to Follow-up|1|||
47077183|NCT01490840|83375978|FG001|Phase 1|Lost to Follow-up|0|||
47077184|NCT01490840|83375977|FG000|Phase 1|Adverse Event|2|||
47077185|NCT01490840|83375978|FG001|Phase 1|Adverse Event|1|||
47077186|NCT01490840|83375977|FG000|Phase 1|Withdrawal by Subject|6|||
47077187|NCT01490840|83375978|FG001|Phase 1|Withdrawal by Subject|5|||
47077188|NCT01490840|83375977|FG000|Phase 1|Visit 6a omitted|1|||
47077189|NCT01490840|83375978|FG001|Phase 1|Visit 6a omitted|0|||
47077190|NCT01490840|83375977|FG000|Phase 2|Withdrawal by Subject|4|||
47077191|NCT01490840|83375978|FG001|Phase 2|Withdrawal by Subject|3|||
47077192|NCT01490840|83375977|FG000|Phase 2|Permanent interruption of fingolimod|0|||
47077193|NCT01490840|83375978|FG001|Phase 2|Permanent interruption of fingolimod|1|||
47077194|NCT01490840|83375977|FG000|Phase 2|Lost to Follow-up|1|||
46669505|NCT01263496|82884396|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46669506|NCT01263496|82884397|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46669507|NCT01263496|82884398|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46669508|NCT01263496|82884399|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46669509|NCT01263496|82884400|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
46669510|NCT01263496|82884392|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46669511|NCT01263496|82884393|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46669512|NCT01263496|82884394|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46669513|NCT01263496|82884395|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
46669514|NCT01263496|82884396|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
46669515|NCT01263496|82884397|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46669516|NCT01263496|82884398|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46669517|NCT01263496|82884399|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46669518|NCT01263496|82884400|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
46669519|NCT01263496|82884392|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
46669520|NCT01263496|82884393|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
46669521|NCT01263496|82884394|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
46669522|NCT01263496|82884395|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
46669523|NCT01263496|82884396|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
46669524|NCT01263496|82884397|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
46669525|NCT01263496|82884398|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
46669526|NCT01263496|82884399|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
46669527|NCT01263496|82884400|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
46669528|NCT01263496|82884392|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46669529|NCT01263496|82884393|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
46669530|NCT01263496|82884394|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46669531|NCT01263496|82884395|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46669532|NCT01263496|82884396|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46972801|NCT02016898|83216536|FG001|Overall Study|Death|1|||
46972802|NCT02016898|83216535|FG000|Overall Study|Lost to Follow-up|4|||
47077195|NCT01490840|83375978|FG001|Phase 2|Lost to Follow-up|1|||
47077196|NCT01490840|83375977|FG000|Phase 2|Adverse Event|1|||
47077197|NCT01490840|83375978|FG001|Phase 2|Adverse Event|1|||
47077198|NCT01490450|83376010|FG000|Period 1|Lack of Efficacy|2|||
47077199|NCT01490450|83376011|FG001|Period 1|Lack of Efficacy|0|||
47077200|NCT01490450|83376012|FG002|Period 1|Lack of Efficacy|3|||
47077201|NCT01490450|83376013|FG003|Period 1|Lack of Efficacy|0|||
47077202|NCT01490450|83376010|FG000|Period 1|Adverse Event|0|||
47077203|NCT01490450|83376011|FG001|Period 1|Adverse Event|0|||
47077204|NCT01490450|83376012|FG002|Period 1|Adverse Event|0|||
47077205|NCT01490450|83376013|FG003|Period 1|Adverse Event|5|||
46669533|NCT01263496|82884397|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46669534|NCT01263496|82884398|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46669535|NCT01263496|82884399|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46669536|NCT01263496|82884400|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
46669537|NCT01263496|82884392|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46669538|NCT01263496|82884393|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46669539|NCT01263496|82884394|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
46669540|NCT01263496|82884395|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46669541|NCT01263496|82884396|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
46669542|NCT01263496|82884397|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46669543|NCT01263496|82884398|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46669544|NCT01263496|82884399|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
46669545|NCT01263496|82884400|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46669546|NCT01263496|82884392|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
46669547|NCT01263496|82884393|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
46669548|NCT01263496|82884394|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
46669549|NCT01263496|82884395|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
46669550|NCT01263496|82884396|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
46669551|NCT01263496|82884397|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
46669552|NCT01263496|82884398|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
46669553|NCT01263496|82884399|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
46669554|NCT01263496|82884400|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
46669555|NCT01263496|82884392|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669556|NCT01263496|82884393|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669557|NCT01263496|82884394|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669558|NCT01263496|82884395|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669559|NCT01263496|82884396|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669560|NCT01263496|82884397|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669561|NCT01263496|82884398|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669562|NCT01263496|82884399|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
46669563|NCT01263496|82884400|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46669564|NCT01263223|82884412|FG000|Period 2|Withdrawal by Subject|0|||
46669565|NCT01263223|82884413|FG001|Period 2|Withdrawal by Subject|1|||
46669566|NCT01263223|82884412|FG000|7-day Follow-up|Withdrawal by Subject|0|||
46669567|NCT01263223|82884413|FG001|7-day Follow-up|Withdrawal by Subject|1|||
46669568|NCT01263223|82884412|FG000|7-day Follow-up|Lost to Follow-up|1|||
46669569|NCT01263223|82884413|FG001|7-day Follow-up|Lost to Follow-up|0|||
46669570|NCT01263106|82884422|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
46669571|NCT01263106|82884423|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
46669572|NCT01263028|82884432|FG000|Overall Study|Withdrawal by Subject|1|||
46669573|NCT01263028|82884432|FG000|Overall Study|Adverse Event|1|||
46669574|NCT01263028|82884432|FG000|Overall Study|Study terminated due to low enrollment.|4|||
46669575|NCT01262989|82884436|FG000|Period 1|Lost to Follow-up|1|||
46669576|NCT01262989|82884437|FG001|Period 1|Lost to Follow-up|1|||
46669577|NCT01262989|82884436|FG000|Period 1|Intercurrent disease|0|||
46669578|NCT01262989|82884437|FG001|Period 1|Intercurrent disease|1|||
46669579|NCT01262989|82884436|FG000|Period 1|Positive answer for exclusion criteria|0|||
46669580|NCT01262989|82884437|FG001|Period 1|Positive answer for exclusion criteria|1|||
46669581|NCT01262989|82884436|FG000|Period 2|Intercurrent disease|0|||
46669582|NCT01262989|82884437|FG001|Period 2|Intercurrent disease|1|||
46669583|NCT01262872|82884451|FG000|Step 2|Death|0|||
46669584|NCT01262872|82884452|FG001|Step 2|Death|0|||
46669585|NCT01262872|82884453|FG002|Step 2|Death|0|||
46669586|NCT01262872|82884454|FG003|Step 2|Death|1|||
46669587|NCT01262872|82884455|FG004|Step 2|Death|0|||
46785989|NCT00656370|83005127|FG000|Overall Study|Alternates|3|||
46785990|NCT00680186|83005135|FG000|Overall Study|Adverse Event|47|||
46785991|NCT00680186|83005136|FG001|Overall Study|Adverse Event|44|||
46785992|NCT00680186|83005135|FG000|Overall Study|Protocol Violation|31|||
46785993|NCT00680186|83005136|FG001|Overall Study|Protocol Violation|26|||
46669588|NCT01262872|82884456|FG005|Step 2|Death|2|||
46669589|NCT01262872|82884457|FG006|Step 2|Death|2|||
46669590|NCT01262872|82884458|FG007|Step 2|Death|1|||
46669591|NCT01262872|82884451|FG000|Step 2|Protocol Violation|0|||
46669592|NCT01262872|82884452|FG001|Step 2|Protocol Violation|0|||
46785994|NCT00680186|83005135|FG000|Overall Study|Lost to Follow-up|11|||
46785995|NCT00680186|83005136|FG001|Overall Study|Lost to Follow-up|6|||
46785996|NCT00680186|83005135|FG000|Overall Study|Withdrawal by Subject|32|||
46669593|NCT01262872|82884453|FG002|Step 2|Protocol Violation|1|||
46669594|NCT01262872|82884454|FG003|Step 2|Protocol Violation|0|||
46669595|NCT01262872|82884455|FG004|Step 2|Protocol Violation|0|||
46669596|NCT01262872|82884456|FG005|Step 2|Protocol Violation|0|||
46785997|NCT00680186|83005136|FG001|Overall Study|Withdrawal by Subject|39|||
46785998|NCT00680186|83005135|FG000|Overall Study|Other|4|||
46669597|NCT01262872|82884457|FG006|Step 2|Protocol Violation|3|||
46669598|NCT01262872|82884458|FG007|Step 2|Protocol Violation|1|||
46669599|NCT01262872|82884451|FG000|Step 2|Withdrawal by Subject|0|||
46669600|NCT01262872|82884452|FG001|Step 2|Withdrawal by Subject|0|||
46669601|NCT01262872|82884453|FG002|Step 2|Withdrawal by Subject|4|||
46669602|NCT01262872|82884454|FG003|Step 2|Withdrawal by Subject|6|||
46669603|NCT01262872|82884455|FG004|Step 2|Withdrawal by Subject|3|||
46669604|NCT01262872|82884456|FG005|Step 2|Withdrawal by Subject|1|||
46669605|NCT01262872|82884457|FG006|Step 2|Withdrawal by Subject|2|||
46669606|NCT01262872|82884458|FG007|Step 2|Withdrawal by Subject|1|||
46669607|NCT01262872|82884451|FG000|Step 2|Migrated/moved from study area|0|||
46669608|NCT01262872|82884452|FG001|Step 2|Migrated/moved from study area|0|||
46669609|NCT01262872|82884453|FG002|Step 2|Migrated/moved from study area|4|||
46669610|NCT01262872|82884454|FG003|Step 2|Migrated/moved from study area|3|||
46669611|NCT01262872|82884455|FG004|Step 2|Migrated/moved from study area|2|||
46669612|NCT01262872|82884456|FG005|Step 2|Migrated/moved from study area|6|||
46669613|NCT01262872|82884457|FG006|Step 2|Migrated/moved from study area|2|||
46669614|NCT01262872|82884458|FG007|Step 2|Migrated/moved from study area|3|||
46669615|NCT01262677|82884495|FG000|Overall Study|Does not meet entrance criteria|0|||
46669616|NCT01262677|82884496|FG001|Overall Study|Does not meet entrance criteria|2|||
46669617|NCT01262677|82884497|FG002|Overall Study|Does not meet entrance criteria|0|||
46669618|NCT01262677|82884495|FG000|Overall Study|Insufficient clinical response|0|||
46785999|NCT00680186|83005136|FG001|Overall Study|Other|1|||
46786000|NCT00656292|83005144|FG000|Overall Study|Withdrawal by Subject|2|||
46786001|NCT00656292|83005145|FG001|Overall Study|Withdrawal by Subject|3|||
46786002|NCT00656292|83005144|FG000|Overall Study|Screen failure|1|||
46786003|NCT00656292|83005145|FG001|Overall Study|Screen failure|2|||
46786004|NCT00352417|83005153|FG000|Overall Study|Adverse Event|1|||
46786005|NCT00352417|83005154|FG001|Overall Study|Adverse Event|0|||
46786006|NCT00352417|83005153|FG000|Overall Study|Protocol Violation|0|||
46786007|NCT00352417|83005154|FG001|Overall Study|Protocol Violation|2|||
46786008|NCT00352417|83005153|FG000|Overall Study|Withdrawal by Subject|1|||
47077206|NCT01490450|83376010|FG000|Period 1|Request to discontinue treatment|1|||
47077207|NCT01490450|83376011|FG001|Period 1|Request to discontinue treatment|0|||
47077208|NCT01490450|83376012|FG002|Period 1|Request to discontinue treatment|0|||
47077209|NCT01490450|83376013|FG003|Period 1|Request to discontinue treatment|0|||
47077210|NCT01490450|83376010|FG000|Period 1|Withdrawal by Subject|0|||
47077211|NCT01490450|83376011|FG001|Period 1|Withdrawal by Subject|0|||
47077212|NCT01490450|83376012|FG002|Period 1|Withdrawal by Subject|0|||
47077213|NCT01490450|83376013|FG003|Period 1|Withdrawal by Subject|3|||
47077214|NCT01490450|83376010|FG000|Period 1|No longer met study criteria|0|||
47077215|NCT01490450|83376011|FG001|Period 1|No longer met study criteria|1|||
46786009|NCT00352417|83005154|FG001|Overall Study|Withdrawal by Subject|2|||
46786010|NCT00352417|83005153|FG000|Overall Study|Lost to Follow-up|1|||
46786011|NCT00352417|83005154|FG001|Overall Study|Lost to Follow-up|0|||
46786012|NCT00352417|83005153|FG000|Overall Study|Schedule Change|2|||
46786013|NCT00352417|83005154|FG001|Overall Study|Schedule Change|1|||
46786014|NCT00323869|83005160|FG000|Overall Study|Death|1|||
47077216|NCT01490450|83376012|FG002|Period 1|No longer met study criteria|1|||
47077217|NCT01490450|83376013|FG003|Period 1|No longer met study criteria|0|||
47077218|NCT01490450|83376010|FG000|Period 2|Lack of Efficacy|0|||
46786015|NCT00323557|83005166|FG000|Overall Study|Physician Decision|1|||
46786016|NCT00323557|83005167|FG001|Overall Study|Physician Decision|0|||
46786017|NCT00558363|83005176|FG000|Overall Study|Physician Decision|18|||
47077219|NCT01490450|83376011|FG001|Period 2|Lack of Efficacy|0|||
47077220|NCT01490450|83376012|FG002|Period 2|Lack of Efficacy|0|||
46669619|NCT01262677|82884496|FG001|Overall Study|Insufficient clinical response|0|||
46669620|NCT01262677|82884497|FG002|Overall Study|Insufficient clinical response|1|||
46669621|NCT01262677|82884495|FG000|Overall Study|Lost to Follow-up|1|||
46669622|NCT01262677|82884496|FG001|Overall Study|Lost to Follow-up|0|||
46786018|NCT00558363|83005177|FG001|Overall Study|Physician Decision|4|||
46786019|NCT00558363|83005176|FG000|Overall Study|Withdrawal by Subject|11|||
46786020|NCT00558363|83005177|FG001|Overall Study|Withdrawal by Subject|4|||
46972803|NCT02016898|83216536|FG001|Overall Study|Lost to Follow-up|4|||
46972804|NCT01993030|83216544|FG000|Overall Study|Adverse Event|0|||
46972805|NCT01993030|83216545|FG001|Overall Study|Adverse Event|4|||
46972806|NCT01992094|83216554|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
46972807|NCT01992094|83216555|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
46972808|NCT01992094|83216556|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
46972809|NCT01992094|83216554|FG000|Overall Study|Adverse Event|1|||
46972810|NCT01992094|83216555|FG001|Overall Study|Adverse Event|0|||
46972811|NCT01992094|83216556|FG002|Overall Study|Adverse Event|0|||
46972812|NCT01992094|83216554|FG000|Overall Study|Death|5|||
47077221|NCT01490450|83376013|FG003|Period 2|Lack of Efficacy|1|||
47077222|NCT01490450|83376010|FG000|Period 2|Adverse Event|1|||
47077223|NCT01490450|83376011|FG001|Period 2|Adverse Event|1|||
47077224|NCT01490450|83376012|FG002|Period 2|Adverse Event|0|||
47077225|NCT01490450|83376013|FG003|Period 2|Adverse Event|1|||
47077226|NCT01490450|83376010|FG000|Period 2|Withdrawal by Subject|1|||
47077227|NCT01490450|83376011|FG001|Period 2|Withdrawal by Subject|0|||
47077228|NCT01490450|83376012|FG002|Period 2|Withdrawal by Subject|0|||
47077229|NCT01490450|83376013|FG003|Period 2|Withdrawal by Subject|0|||
47077230|NCT01490450|83376010|FG000|Period 2|Lost to Follow-up|0|||
47077231|NCT01490450|83376011|FG001|Period 2|Lost to Follow-up|0|||
47077232|NCT01490450|83376012|FG002|Period 2|Lost to Follow-up|0|||
47077233|NCT01490450|83376013|FG003|Period 2|Lost to Follow-up|2|||
47077234|NCT01469546|83376057|FG000|Received 5 mg Dose|Adverse Event|13|||
47077235|NCT01469546|83376057|FG000|Received 5 mg Dose|Death|2|||
47077236|NCT01469546|83376057|FG000|Received 5 mg Dose|Protocol Violation|2|||
46669623|NCT01262677|82884497|FG002|Overall Study|Lost to Follow-up|2|||
46669624|NCT01262677|82884495|FG000|Overall Study|No longer willing to participate|3|||
46669625|NCT01262677|82884496|FG001|Overall Study|No longer willing to participate|3|||
46669626|NCT01262677|82884497|FG002|Overall Study|No longer willing to participate|2|||
46669627|NCT01262677|82884495|FG000|Overall Study|Reason not provided|2|||
46669628|NCT01262677|82884496|FG001|Overall Study|Reason not provided|1|||
46669629|NCT01262677|82884497|FG002|Overall Study|Reason not provided|3|||
46669630|NCT01262677|82884495|FG000|Overall Study|Protocol Violation|0|||
46669631|NCT01262677|82884496|FG001|Overall Study|Protocol Violation|1|||
46669632|NCT01262677|82884497|FG002|Overall Study|Protocol Violation|1|||
46669633|NCT01262677|82884495|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
46669634|NCT01262677|82884496|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
46669635|NCT01262677|82884497|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
46669636|NCT01262638|82884509|FG000|Overall Study|Adverse Event|3|||
46669637|NCT01262638|82884510|FG001|Overall Study|Adverse Event|4|||
46669638|NCT01262638|82884511|FG002|Overall Study|Adverse Event|3|||
46669639|NCT01262638|82884512|FG003|Overall Study|Adverse Event|4|||
46669640|NCT01262638|82884509|FG000|Overall Study|Protocol Violation|1|||
46669641|NCT01262638|82884510|FG001|Overall Study|Protocol Violation|0|||
46669642|NCT01262638|82884511|FG002|Overall Study|Protocol Violation|0|||
46669643|NCT01262638|82884512|FG003|Overall Study|Protocol Violation|1|||
46669644|NCT01262638|82884509|FG000|Overall Study|Withdrawal by Subject|2|||
46669645|NCT01262638|82884510|FG001|Overall Study|Withdrawal by Subject|1|||
46669646|NCT01262638|82884511|FG002|Overall Study|Withdrawal by Subject|0|||
46669647|NCT01262638|82884512|FG003|Overall Study|Withdrawal by Subject|1|||
46669648|NCT01262638|82884509|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
46669649|NCT01262638|82884510|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
46669650|NCT01262638|82884511|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
46669651|NCT01262638|82884512|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
46669652|NCT01262638|82884509|FG000|Overall Study|Lost to Follow-up|1|||
46669653|NCT01262638|82884510|FG001|Overall Study|Lost to Follow-up|1|||
46669654|NCT01262638|82884511|FG002|Overall Study|Lost to Follow-up|1|||
46669655|NCT01262638|82884512|FG003|Overall Study|Lost to Follow-up|1|||
46669656|NCT01262638|82884509|FG000|Overall Study|Participant Went Out of Town|0|||
46669657|NCT01262638|82884510|FG001|Overall Study|Participant Went Out of Town|0|||
46669658|NCT01262638|82884511|FG002|Overall Study|Participant Went Out of Town|1|||
46669659|NCT01262638|82884512|FG003|Overall Study|Participant Went Out of Town|0|||
46669660|NCT01262560|82884528|FG000|Overall Study|Protocol Violation|0|||
46669661|NCT01262560|82884529|FG001|Overall Study|Protocol Violation|1|||
46669662|NCT01262560|82884530|FG002|Overall Study|Protocol Violation|2|||
46669663|NCT01262365|82884541|FG000|Overall Study|Lack of Efficacy|35|||
46669664|NCT01262365|82884542|FG001|Overall Study|Lack of Efficacy|30|||
46669665|NCT01262365|82884543|FG002|Overall Study|Lack of Efficacy|47|||
46669666|NCT01262365|82884541|FG000|Overall Study|Protocol Violation|3|||
46669667|NCT01262365|82884542|FG001|Overall Study|Protocol Violation|1|||
46669668|NCT01262365|82884543|FG002|Overall Study|Protocol Violation|1|||
46669669|NCT01262365|82884541|FG000|Overall Study|Lost to Follow-up|3|||
46669670|NCT01262365|82884542|FG001|Overall Study|Lost to Follow-up|7|||
46669671|NCT01262365|82884543|FG002|Overall Study|Lost to Follow-up|6|||
46669672|NCT01262365|82884541|FG000|Overall Study|Withdrawal by Subject|17|||
46669673|NCT01262365|82884542|FG001|Overall Study|Withdrawal by Subject|22|||
46669674|NCT01262365|82884543|FG002|Overall Study|Withdrawal by Subject|22|||
46669675|NCT01262365|82884541|FG000|Overall Study|Death|1|||
46669676|NCT01262365|82884542|FG001|Overall Study|Death|2|||
46669677|NCT01262365|82884543|FG002|Overall Study|Death|1|||
46669678|NCT01262365|82884541|FG000|Overall Study|Adverse Event|26|||
46669679|NCT01262365|82884542|FG001|Overall Study|Adverse Event|16|||
46669680|NCT01262365|82884543|FG002|Overall Study|Adverse Event|11|||
46669681|NCT01262365|82884541|FG000|Overall Study|sponsor decision|1|||
47077237|NCT01469546|83376057|FG000|Received 5 mg Dose|Progressive Disease|3|||
47077238|NCT01469546|83376057|FG000|Received 5 mg Dose|Physician Decision|3|||
46669682|NCT01262365|82884542|FG001|Overall Study|sponsor decision|1|||
46669683|NCT01262365|82884543|FG002|Overall Study|sponsor decision|0|||
46669684|NCT01262365|82884541|FG000|Overall Study|Randomization error|1|||
47077239|NCT00081497|83376063|FG000|Overall Study|Adverse Event|2|||
47077240|NCT00081497|83376064|FG001|Overall Study|Adverse Event|0|||
46669685|NCT01262365|82884542|FG001|Overall Study|Randomization error|0|||
46669686|NCT01262365|82884543|FG002|Overall Study|Randomization error|2|||
46669687|NCT01262365|82884541|FG000|Overall Study|Non-compliance|1|||
46669688|NCT01262365|82884542|FG001|Overall Study|Non-compliance|0|||
46669689|NCT01262365|82884543|FG002|Overall Study|Non-compliance|2|||
46669690|NCT01262365|82884541|FG000|Overall Study|Suspected pregnancy|1|||
46669691|NCT01262365|82884542|FG001|Overall Study|Suspected pregnancy|0|||
46669692|NCT01262365|82884543|FG002|Overall Study|Suspected pregnancy|0|||
46669693|NCT01262365|82884541|FG000|Overall Study|Patient pregnant|1|||
46669694|NCT01262365|82884542|FG001|Overall Study|Patient pregnant|0|||
46669695|NCT01262365|82884543|FG002|Overall Study|Patient pregnant|1|||
46669696|NCT01262365|82884541|FG000|Overall Study|Toxicity related to study drug|0|||
46669697|NCT01262365|82884542|FG001|Overall Study|Toxicity related to study drug|1|||
46669698|NCT01262365|82884543|FG002|Overall Study|Toxicity related to study drug|0|||
46669699|NCT01262365|82884541|FG000|Overall Study|Cannot tolerate the protocol|0|||
46669700|NCT01262365|82884542|FG001|Overall Study|Cannot tolerate the protocol|1|||
46786021|NCT00558363|83005176|FG000|Overall Study|Adverse Event|5|||
46972813|NCT01992094|83216555|FG001|Overall Study|Death|5|||
46669701|NCT01262365|82884543|FG002|Overall Study|Cannot tolerate the protocol|0|||
46669702|NCT01262365|82884541|FG000|Overall Study|Patient unavailable|0|||
46669703|NCT01262365|82884542|FG001|Overall Study|Patient unavailable|0|||
46669704|NCT01262365|82884543|FG002|Overall Study|Patient unavailable|1|||
46669705|NCT03932812|82884553|FG000|Overall Study|Lost to Follow-up|12|||
46669706|NCT03932812|82884554|FG001|Overall Study|Lost to Follow-up|14|||
46669707|NCT03932812|82884553|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
46669708|NCT03932812|82884554|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
46669709|NCT01262287|82884563|FG000|Overall Study|Lost to Follow-up|2|||
46669710|NCT01262287|82884564|FG001|Overall Study|Lost to Follow-up|1|||
46669711|NCT01262092|82884576|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
46669712|NCT01262092|82884577|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
46669713|NCT01262092|82884576|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
46669714|NCT01262092|82884577|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
46669715|NCT01262092|82884576|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
46669716|NCT01262092|82884577|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
46669717|NCT01262092|82884576|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
46669718|NCT01262092|82884577|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
46669719|NCT01261975|82884583|FG000|Overall Study|Surgical complication|1|||
46669720|NCT01261780|82884592|FG000|Overall Study|Withdrawal by Subject|1|||
46669721|NCT01261780|82884593|FG001|Overall Study|Withdrawal by Subject|0|||
46669722|NCT01261780|82884592|FG000|Overall Study|Event not related to subject|1|||
46669723|NCT01261780|82884593|FG001|Overall Study|Event not related to subject|2|||
46669724|NCT01261624|82884601|FG000|Week 0 to Week 12|Disease Progression|1|||
46669725|NCT01261624|82884602|FG001|Week 0 to Week 12|Disease Progression|1|||
46669726|NCT01261624|82884601|FG000|Week 0 to Week 12|Insufficient Response|0|||
46669727|NCT01261624|82884602|FG001|Week 0 to Week 12|Insufficient Response|2|||
46669728|NCT01261624|82884601|FG000|Week 13 to Week 24|Insufficient Response|0|||
46669729|NCT01261624|82884602|FG001|Week 13 to Week 24|Insufficient Response|1|||
46669730|NCT01261390|82884618|FG000|Overall Study|Significant Concurrent Illness|1|||
46669731|NCT01261390|82884619|FG001|Overall Study|Significant Concurrent Illness|0|||
46669732|NCT01261390|82884620|FG002|Overall Study|Significant Concurrent Illness|1|||
46669733|NCT01261390|82884621|FG003|Overall Study|Significant Concurrent Illness|0|||
46669734|NCT01261390|82884618|FG000|Overall Study|Dissatisfaction with Treatment|2|||
46669735|NCT01261390|82884619|FG001|Overall Study|Dissatisfaction with Treatment|1|||
46669736|NCT01261390|82884620|FG002|Overall Study|Dissatisfaction with Treatment|1|||
46669737|NCT01261390|82884621|FG003|Overall Study|Dissatisfaction with Treatment|2|||
46669738|NCT01261390|82884618|FG000|Overall Study|Relocation|0|||
46669739|NCT01261390|82884619|FG001|Overall Study|Relocation|1|||
46669740|NCT01261390|82884620|FG002|Overall Study|Relocation|0|||
46669741|NCT01261390|82884621|FG003|Overall Study|Relocation|0|||
46669742|NCT01261390|82884618|FG000|Overall Study|Loss of Interest in the Study|3|||
46669743|NCT01261390|82884619|FG001|Overall Study|Loss of Interest in the Study|1|||
46669744|NCT01261390|82884620|FG002|Overall Study|Loss of Interest in the Study|0|||
46669745|NCT01261390|82884621|FG003|Overall Study|Loss of Interest in the Study|0|||
46669746|NCT01261390|82884618|FG000|Overall Study|Lost to Follow-up|1|||
46669747|NCT01261390|82884619|FG001|Overall Study|Lost to Follow-up|6|||
46669748|NCT01261390|82884620|FG002|Overall Study|Lost to Follow-up|5|||
46669749|NCT01261390|82884621|FG003|Overall Study|Lost to Follow-up|6|||
46669750|NCT03391882|82884642|FG000|Study Overall|Adverse Event|3|||
46669751|NCT03391882|82884643|FG001|Study Overall|Adverse Event|6|||
46669752|NCT03391882|82884644|FG002|Study Overall|Adverse Event|1|||
46669753|NCT03391882|82884645|FG003|Study Overall|Adverse Event|1|||
46669754|NCT03391882|82884646|FG004|Study Overall|Adverse Event|3|||
46669755|NCT03391882|82884647|FG005|Study Overall|Adverse Event|1|||
46786022|NCT00558363|83005177|FG001|Overall Study|Adverse Event|5|||
46669756|NCT03391882|82884642|FG000|Study Overall|Lack of Efficacy|13|||
46669757|NCT03391882|82884643|FG001|Study Overall|Lack of Efficacy|9|||
46669758|NCT03391882|82884644|FG002|Study Overall|Lack of Efficacy|0|||
46669759|NCT03391882|82884645|FG003|Study Overall|Lack of Efficacy|0|||
46669760|NCT03391882|82884646|FG004|Study Overall|Lack of Efficacy|0|||
46669761|NCT03391882|82884647|FG005|Study Overall|Lack of Efficacy|0|||
46669762|NCT03391882|82884642|FG000|Study Overall|Withdrawal by Subject|3|||
46669763|NCT03391882|82884643|FG001|Study Overall|Withdrawal by Subject|3|||
46669764|NCT03391882|82884644|FG002|Study Overall|Withdrawal by Subject|2|||
46669765|NCT03391882|82884645|FG003|Study Overall|Withdrawal by Subject|2|||
46669766|NCT03391882|82884646|FG004|Study Overall|Withdrawal by Subject|1|||
46786023|NCT00558363|83005176|FG000|Overall Study|Lack of Efficacy|2|||
46786024|NCT00558363|83005177|FG001|Overall Study|Lack of Efficacy|2|||
46786025|NCT00558363|83005176|FG000|Overall Study|Protocol Violation|2|||
46786026|NCT00558363|83005177|FG001|Overall Study|Protocol Violation|1|||
46786027|NCT00558363|83005176|FG000|Overall Study|Lost to Follow-up|0|||
46786028|NCT00558363|83005177|FG001|Overall Study|Lost to Follow-up|1|||
46786029|NCT00558363|83005176|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
46786030|NCT00558363|83005177|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
46786031|NCT00558363|83005176|FG000|Overall Study|Randomized in Error|1|||
46786032|NCT00558363|83005177|FG001|Overall Study|Randomized in Error|2|||
47077241|NCT00081497|83376063|FG000|Overall Study|Death|0|||
46669767|NCT03391882|82884647|FG005|Study Overall|Withdrawal by Subject|3|||
46669768|NCT03391882|82884642|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
46669769|NCT03391882|82884643|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
46669770|NCT03391882|82884644|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
46669771|NCT03391882|82884645|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
46669772|NCT03391882|82884646|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
46669773|NCT03391882|82884647|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
46669774|NCT03391882|82884642|FG000|Study Overall|Protocol Violation|1|||
46669775|NCT03391882|82884643|FG001|Study Overall|Protocol Violation|0|||
46669776|NCT03391882|82884644|FG002|Study Overall|Protocol Violation|0|||
46669777|NCT03391882|82884645|FG003|Study Overall|Protocol Violation|0|||
46669778|NCT03391882|82884646|FG004|Study Overall|Protocol Violation|0|||
46669779|NCT03391882|82884647|FG005|Study Overall|Protocol Violation|0|||
46669780|NCT03391882|82884642|FG000|Part A - Titration Phase|Adverse Event|3|||
46669781|NCT03391882|82884643|FG001|Part A - Titration Phase|Adverse Event|6|||
46669782|NCT03391882|82884644|FG002|Part A - Titration Phase|Adverse Event|0|||
46669783|NCT03391882|82884645|FG003|Part A - Titration Phase|Adverse Event|0|||
46669784|NCT03391882|82884646|FG004|Part A - Titration Phase|Adverse Event|0|||
46669785|NCT03391882|82884647|FG005|Part A - Titration Phase|Adverse Event|0|||
46669786|NCT03391882|82884642|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
46669787|NCT03391882|82884643|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
46669788|NCT03391882|82884644|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
46669789|NCT03391882|82884645|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
46669790|NCT03391882|82884646|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
46669791|NCT03391882|82884647|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
46669792|NCT03391882|82884642|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
46669793|NCT03391882|82884643|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
46669794|NCT03391882|82884644|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
46669795|NCT03391882|82884645|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
46669796|NCT03391882|82884646|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
46669797|NCT03391882|82884647|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
46669798|NCT03391882|82884642|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
46669799|NCT03391882|82884643|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
46669800|NCT03391882|82884644|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
46669801|NCT03391882|82884645|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
46669802|NCT03391882|82884646|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
46669803|NCT03391882|82884647|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
46786033|NCT00558363|83005176|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
47077242|NCT00081497|83376064|FG001|Overall Study|Death|1|||
47077243|NCT00081497|83376063|FG000|Overall Study|Withdrawal by Subject|1|||
47077244|NCT00081497|83376064|FG001|Overall Study|Withdrawal by Subject|0|||
46669804|NCT03391882|82884642|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
46669805|NCT03391882|82884643|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
46786034|NCT00558363|83005177|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
46786035|NCT00323479|83005183|FG000|Overall Study|Adverse Event|2|||
46786036|NCT00323479|83005183|FG000|Overall Study|Withdrawal by Subject|2|||
47077245|NCT00081497|83376063|FG000|Overall Study|Non-compliance|0|||
47077246|NCT00081497|83376064|FG001|Overall Study|Non-compliance|1|||
47077247|NCT00081263|83376078|FG000|Overall Study|clerical error|1|||
47077248|NCT00081263|83376079|FG001|Overall Study|clerical error|0|||
46669806|NCT03391882|82884644|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
46669807|NCT03391882|82884645|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
47077249|NCT00081263|83376078|FG000|Overall Study|wrong cell type|7|||
46669808|NCT03391882|82884646|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
46669809|NCT03391882|82884647|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
46669810|NCT03391882|82884642|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
46669811|NCT03391882|82884643|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
46669812|NCT03391882|82884644|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
46669813|NCT03391882|82884645|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
46669814|NCT03391882|82884646|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
46669815|NCT03391882|82884647|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
46669816|NCT03391882|82884642|FG000|Part B - Treatment Phase|Adverse Event|0|||
46669817|NCT03391882|82884643|FG001|Part B - Treatment Phase|Adverse Event|0|||
46669818|NCT03391882|82884644|FG002|Part B - Treatment Phase|Adverse Event|1|||
46669819|NCT03391882|82884645|FG003|Part B - Treatment Phase|Adverse Event|1|||
46669820|NCT03391882|82884646|FG004|Part B - Treatment Phase|Adverse Event|3|||
46669821|NCT03391882|82884647|FG005|Part B - Treatment Phase|Adverse Event|1|||
46669822|NCT03391882|82884642|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
46669823|NCT03391882|82884643|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
46669824|NCT03391882|82884644|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
46669825|NCT03391882|82884645|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
46669826|NCT03391882|82884646|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
46669827|NCT03391882|82884647|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
46669828|NCT01261000|82884657|FG000|Overall Study|Screen failure|1|||
46669829|NCT01234402|82884690|FG000|Overall Study|Lost to Follow-up|0|||
46669830|NCT01234402|82884691|FG001|Overall Study|Lost to Follow-up|1|||
46669831|NCT01234402|82884692|FG002|Overall Study|Lost to Follow-up|3|||
46669832|NCT01234402|82884690|FG000|Overall Study|Withdrawal by Subject|1|||
46669833|NCT01234402|82884691|FG001|Overall Study|Withdrawal by Subject|3|||
46669834|NCT01234402|82884692|FG002|Overall Study|Withdrawal by Subject|4|||
46669835|NCT01234402|82884690|FG000|Overall Study|Never treated: Death|0|||
46669836|NCT01234402|82884691|FG001|Overall Study|Never treated: Death|0|||
46669837|NCT01234402|82884692|FG002|Overall Study|Never treated: Death|1|||
46669838|NCT01234402|82884690|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
46669839|NCT01234402|82884691|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
46669840|NCT01234402|82884692|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
46669841|NCT01234402|82884690|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
46669842|NCT01234402|82884691|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
46669843|NCT01234402|82884692|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
46669844|NCT01260922|82884704|FG000|First Intervention|Withdrawal by Subject|0|||
46669845|NCT01260922|82884705|FG001|First Intervention|Withdrawal by Subject|1|||
46669846|NCT01260922|82884704|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
46669847|NCT01260922|82884705|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
46669848|NCT01260922|82884704|FG000|Second Intervention|Emesis|0|||
46669849|NCT01260922|82884705|FG001|Second Intervention|Emesis|2|||
46669850|NCT01233817|82884711|FG000|Overall Study|Lost to Follow-up|1|||
46669851|NCT01233817|82884711|FG000|Overall Study|Withdrawal by Subject|2|||
46669852|NCT01233232|82884718|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
46669853|NCT01233232|82884719|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
46669854|NCT01233232|82884720|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
46669855|NCT01233076|82884730|FG000|Period 2, One Week|Lost to Follow-up|1|||
46669856|NCT01233076|82884731|FG001|Period 2, One Week|Lost to Follow-up|0|||
46669857|NCT01212094|82884740|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
46669858|NCT01212094|82884741|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
46669859|NCT01212094|82884742|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
46669860|NCT01212094|82884740|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
46669861|NCT01212094|82884741|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
46669862|NCT01212094|82884742|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
46669863|NCT01212094|82884740|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
46669864|NCT01212094|82884741|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
46669865|NCT01212094|82884742|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
46669866|NCT01212094|82884740|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
46669867|NCT01212094|82884741|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
46669868|NCT01212094|82884742|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
46669869|NCT01212094|82884740|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
46669870|NCT01212094|82884741|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
46669871|NCT01212094|82884742|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
46669872|NCT01212094|82884740|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
46786037|NCT00323479|83005183|FG000|Overall Study|Protocol Violation|3|||
46786038|NCT00323479|83005183|FG000|Overall Study|house moving|1|||
46669873|NCT01212094|82884741|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
46669874|NCT01212094|82884742|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
46786039|NCT00352105|83005187|FG000|Overall Study|Death|5|||
46786040|NCT00352105|83005187|FG000|Overall Study|Withdrawal by Subject|5|||
46786041|NCT00352105|83005187|FG000|Overall Study|Lack of Efficacy|9|||
46669875|NCT01232569|82884751|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
46669876|NCT01232569|82884752|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
46669877|NCT01232569|82884753|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46669878|NCT01232569|82884754|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
46669879|NCT01232569|82884751|FG000|Double-blind Treatment Period|Escape|2|||
46669880|NCT01232569|82884752|FG001|Double-blind Treatment Period|Escape|2|||
46669881|NCT01232569|82884753|FG002|Double-blind Treatment Period|Escape|0|||
46669882|NCT01232569|82884754|FG003|Double-blind Treatment Period|Escape|0|||
46669883|NCT01232569|82884751|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
46669884|NCT01232569|82884752|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
46669885|NCT01232569|82884753|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
46669886|NCT01232569|82884754|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
46669887|NCT01232569|82884751|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
46669888|NCT01232569|82884752|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
46669889|NCT01232569|82884753|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
46669890|NCT01232569|82884754|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
46669891|NCT01232569|82884751|FG000|Double-blind Treatment Period|Physician Decision|1|||
46669892|NCT01232569|82884752|FG001|Double-blind Treatment Period|Physician Decision|0|||
46669893|NCT01232569|82884753|FG002|Double-blind Treatment Period|Physician Decision|0|||
46669894|NCT01232569|82884754|FG003|Double-blind Treatment Period|Physician Decision|0|||
46669895|NCT01232569|82884751|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
46669896|NCT01232569|82884752|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
46669897|NCT01232569|82884753|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
46669898|NCT01232569|82884754|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
46669899|NCT01232569|82884751|FG000|Double-blind Treatment Period|Death|2|||
46669900|NCT01232569|82884752|FG001|Double-blind Treatment Period|Death|0|||
46669901|NCT01232569|82884753|FG002|Double-blind Treatment Period|Death|0|||
46669902|NCT01232569|82884754|FG003|Double-blind Treatment Period|Death|0|||
46669903|NCT01211665|82884765|FG000|Overall Study|Withdrawal by Subject|1|||
46669904|NCT01211665|82884766|FG001|Overall Study|Withdrawal by Subject|0|||
46669905|NCT01211665|82884765|FG000|Overall Study|Death|1|||
46669906|NCT01211665|82884766|FG001|Overall Study|Death|0|||
46669907|NCT01232491|82884774|FG000|Overall Study|Adverse Event|13|||
46669908|NCT01232491|82884775|FG001|Overall Study|Adverse Event|8|||
46669909|NCT01232491|82884774|FG000|Overall Study|Lack of Efficacy|1|||
46669910|NCT01232491|82884775|FG001|Overall Study|Lack of Efficacy|5|||
46669911|NCT01232491|82884774|FG000|Overall Study|Protocol Violation|13|||
46669912|NCT01232491|82884775|FG001|Overall Study|Protocol Violation|11|||
46669913|NCT01232491|82884774|FG000|Overall Study|Withdrawal Criteria|12|||
46669914|NCT01232491|82884775|FG001|Overall Study|Withdrawal Criteria|21|||
46669915|NCT01232491|82884774|FG000|Overall Study|Other|21|||
46669916|NCT01232491|82884775|FG001|Overall Study|Other|18|||
46669917|NCT01232452|82884783|FG000|Overall Study|Adverse Event|17|||
46669918|NCT01232452|82884784|FG001|Overall Study|Adverse Event|15|||
46669919|NCT01232452|82884783|FG000|Overall Study|Withdrawal by Subject|11|||
46669920|NCT01232452|82884784|FG001|Overall Study|Withdrawal by Subject|8|||
46669921|NCT01232452|82884783|FG000|Overall Study|Physician Decision|8|||
46669922|NCT01232452|82884784|FG001|Overall Study|Physician Decision|12|||
46669923|NCT01232452|82884783|FG000|Overall Study|Protocol entry criterion not met|0|||
46669924|NCT01232452|82884784|FG001|Overall Study|Protocol entry criterion not met|2|||
46669925|NCT01232452|82884783|FG000|Overall Study|Sponsor Decision|3|||
46669926|NCT01232452|82884784|FG001|Overall Study|Sponsor Decision|1|||
46669927|NCT01232452|82884783|FG000|Overall Study|Protocol Violation|0|||
46669928|NCT01232452|82884784|FG001|Overall Study|Protocol Violation|1|||
46669929|NCT01211197|82884790|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46669930|NCT01211197|82884791|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46669931|NCT01211197|82884792|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
46669932|NCT01211197|82884793|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46669933|NCT01211197|82884794|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46669934|NCT01211197|82884795|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46669935|NCT01211197|82884790|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
46669936|NCT01211197|82884791|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
46669937|NCT01211197|82884792|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
46669938|NCT01211197|82884793|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
46669939|NCT01211197|82884794|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
46669940|NCT01211197|82884795|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
46669941|NCT01232296|82884805|FG000|Overall Study|Adverse Event|24|||
46669942|NCT01232296|82884806|FG001|Overall Study|Adverse Event|12|||
46669943|NCT01232296|82884805|FG000|Overall Study|Physician Decision|1|||
46669944|NCT01232296|82884806|FG001|Overall Study|Physician Decision|1|||
46669945|NCT01232296|82884805|FG000|Overall Study|Progressive disease|43|||
46669946|NCT01232296|82884806|FG001|Overall Study|Progressive disease|61|||
46669947|NCT01232296|82884805|FG000|Overall Study|Study terminated by sponsor|0|||
46786042|NCT00352105|83005187|FG000|Overall Study|Adverse Event|19|||
46669948|NCT01232296|82884806|FG001|Overall Study|Study terminated by sponsor|1|||
46669949|NCT01232296|82884805|FG000|Overall Study|Technical problems|3|||
46669950|NCT01232296|82884806|FG001|Overall Study|Technical problems|0|||
46669951|NCT01232296|82884805|FG000|Overall Study|Subject/guardian decision|10|||
46669952|NCT01232296|82884806|FG001|Overall Study|Subject/guardian decision|2|||
46669953|NCT01232296|82884805|FG000|Overall Study|Death|1|||
46669954|NCT01232296|82884806|FG001|Overall Study|Death|6|||
46669955|NCT01231984|82884814|FG000|Study Period 1|Withdrawal by Subject|0|||
46669956|NCT01231984|82884815|FG001|Study Period 1|Withdrawal by Subject|0|||
46669957|NCT01231984|82884816|FG002|Study Period 1|Withdrawal by Subject|0|||
46669958|NCT01231984|82884817|FG003|Study Period 1|Withdrawal by Subject|1|||
46669959|NCT01231984|82884814|FG000|Study Period 1|Lost to Follow-up|1|||
46669960|NCT01231984|82884815|FG001|Study Period 1|Lost to Follow-up|1|||
46669961|NCT01231984|82884816|FG002|Study Period 1|Lost to Follow-up|1|||
46669962|NCT01231984|82884817|FG003|Study Period 1|Lost to Follow-up|0|||
46669963|NCT01231984|82884814|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
46669964|NCT01231984|82884815|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
46669965|NCT01231984|82884816|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
46669966|NCT01231984|82884817|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
46669967|NCT01231984|82884814|FG000|Study Period 1|Screen Failure|0|||
46669968|NCT01231984|82884815|FG001|Study Period 1|Screen Failure|0|||
46669969|NCT01231984|82884816|FG002|Study Period 1|Screen Failure|0|||
46669970|NCT01231984|82884817|FG003|Study Period 1|Screen Failure|1|||
46669971|NCT01231984|82884814|FG000|Study Period 1|Non-compliance with study requirements|5|||
46669972|NCT01231984|82884815|FG001|Study Period 1|Non-compliance with study requirements|0|||
46669973|NCT01231984|82884816|FG002|Study Period 1|Non-compliance with study requirements|2|||
46669974|NCT01231984|82884817|FG003|Study Period 1|Non-compliance with study requirements|1|||
46669975|NCT01231984|82884814|FG000|Study Period 1|Protocol Violation|3|||
46669976|NCT01231984|82884815|FG001|Study Period 1|Protocol Violation|4|||
46669977|NCT01231984|82884816|FG002|Study Period 1|Protocol Violation|2|||
46669978|NCT01231984|82884817|FG003|Study Period 1|Protocol Violation|3|||
46669979|NCT01231984|82884814|FG000|Study Period 1|Adverse Event|1|||
46669980|NCT01231984|82884815|FG001|Study Period 1|Adverse Event|0|||
46669981|NCT01231984|82884816|FG002|Study Period 1|Adverse Event|0|||
46669982|NCT01231984|82884817|FG003|Study Period 1|Adverse Event|0|||
46669983|NCT01231984|82884814|FG000|Study Period 1|Other|0|||
46669984|NCT01231984|82884815|FG001|Study Period 1|Other|0|||
46669985|NCT01231984|82884816|FG002|Study Period 1|Other|0|||
46669986|NCT01231984|82884817|FG003|Study Period 1|Other|1|||
46669987|NCT01231984|82884814|FG000|Study Period 2|Withdrawal by Subject|1|||
46669988|NCT01231984|82884815|FG001|Study Period 2|Withdrawal by Subject|1|||
46669989|NCT01231984|82884816|FG002|Study Period 2|Withdrawal by Subject|0|||
46669990|NCT01231984|82884817|FG003|Study Period 2|Withdrawal by Subject|0|||
46669991|NCT01231984|82884814|FG000|Study Period 2|Lost to Follow-up|1|||
46669992|NCT01231984|82884815|FG001|Study Period 2|Lost to Follow-up|0|||
46669993|NCT01231984|82884816|FG002|Study Period 2|Lost to Follow-up|0|||
46669994|NCT01231984|82884817|FG003|Study Period 2|Lost to Follow-up|3|||
46669995|NCT01231984|82884814|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
46669996|NCT01231984|82884815|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
46669997|NCT01231984|82884816|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
46669998|NCT01231984|82884817|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
46669999|NCT01210807|82884837|FG000|Overall Study|Lost to Follow-up|1|||
46670000|NCT01210807|82884838|FG001|Overall Study|Lost to Follow-up|2|||
46670001|NCT01210807|82884837|FG000|Overall Study|Not implanted bilaterally|2|||
46670002|NCT01210807|82884838|FG001|Overall Study|Not implanted bilaterally|1|||
46670003|NCT01231555|82884847|FG000|Overall Study|Study terminated|8|||
46670004|NCT01231555|82884848|FG001|Overall Study|Study terminated|5|||
46670005|NCT01231555|82884849|FG002|Overall Study|Study terminated|8|||
46670006|NCT01231555|82884847|FG000|Overall Study|Withdrawal by Subject|0|||
46670007|NCT01231555|82884848|FG001|Overall Study|Withdrawal by Subject|2|||
46670008|NCT01231555|82884849|FG002|Overall Study|Withdrawal by Subject|0|||
46670009|NCT01210690|82884857|FG000|Overall Study|Adverse Event|7|||
46670010|NCT01210690|82884857|FG000|Overall Study|Lack of Efficacy|12|||
46670011|NCT01210690|82884857|FG000|Overall Study|Lost to Follow-up|3|||
46670012|NCT01210690|82884857|FG000|Overall Study|Disease Remission|1|||
46670013|NCT01210690|82884857|FG000|Overall Study|Withdrawal by Subject|1|||
46670014|NCT01210690|82884857|FG000|Overall Study|Patient refused to swallow|1|||
46670015|NCT01210690|82884857|FG000|Overall Study|Patient could not take glucose|1|||
46670016|NCT01210651|82884864|FG000|Overall Study|Lost to Follow-up|1|||
46670017|NCT01210651|82884865|FG001|Overall Study|Lost to Follow-up|1|||
46670018|NCT01210651|82884864|FG000|Overall Study|schedule conflicts|1|||
46670019|NCT01210651|82884865|FG001|Overall Study|schedule conflicts|5|||
46670020|NCT01210651|82884864|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
46670021|NCT01210651|82884865|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
46670022|NCT01210651|82884864|FG000|Overall Study|Withdrawal by Subject|1|||
46670023|NCT01210651|82884865|FG001|Overall Study|Withdrawal by Subject|1|||
46786043|NCT00352105|83005187|FG000|Overall Study|Protocol Violation|2|||
46670024|NCT01210651|82884864|FG000|Overall Study|Injury outside study|2|||
46670025|NCT01210651|82884865|FG001|Overall Study|Injury outside study|0|||
46670026|NCT01210495|82884944|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
46670027|NCT01210495|82884945|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
46786044|NCT00350779|83005193|FG000|Overall Study|Adverse Event|4|||
46786045|NCT00350779|83005194|FG001|Overall Study|Adverse Event|2|||
46786046|NCT00350779|83005193|FG000|Overall Study|Lack of Efficacy|0|||
46786047|NCT00350779|83005194|FG001|Overall Study|Lack of Efficacy|4|||
46786048|NCT00350779|83005193|FG000|Overall Study|Lost to Follow-up|2|||
46670028|NCT01210495|82884946|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
46670029|NCT01210495|82884947|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
46670030|NCT01210495|82884944|FG000|Overall Study|Death|14|||
46786049|NCT00350779|83005194|FG001|Overall Study|Lost to Follow-up|0|||
46786050|NCT00350779|83005193|FG000|Overall Study|Physician Decision|2|||
46786051|NCT00350779|83005194|FG001|Overall Study|Physician Decision|4|||
46786052|NCT00350779|83005193|FG000|Overall Study|Protocol Violation|3|||
46786053|NCT00350779|83005194|FG001|Overall Study|Protocol Violation|1|||
46786054|NCT00350779|83005193|FG000|Overall Study|Withdrawal by Subject|9|||
46786055|NCT00350779|83005194|FG001|Overall Study|Withdrawal by Subject|8|||
46786056|NCT00350779|83005193|FG000|Overall Study|Patient Moved|2|||
47077250|NCT00081263|83376079|FG001|Overall Study|wrong cell type|5|||
46851517|NCT03600376|83067080|FG001|Overall Study|Adverse Event|1|||
47077251|NCT00081263|83376078|FG000|Overall Study|improper pre-protocol therapy|0|||
46670031|NCT01210495|82884945|FG001|Overall Study|Death|7|||
46670032|NCT01210495|82884946|FG002|Overall Study|Death|112|||
46670033|NCT01210495|82884947|FG003|Overall Study|Death|54|||
46670034|NCT01210495|82884944|FG000|Overall Study|Study Terminated by Sponsor|0|||
46670035|NCT01210495|82884945|FG001|Overall Study|Study Terminated by Sponsor|0|||
46670036|NCT01210495|82884946|FG002|Overall Study|Study Terminated by Sponsor|4|||
46670037|NCT01210495|82884947|FG003|Overall Study|Study Terminated by Sponsor|11|||
46670038|NCT01210495|82884944|FG000|Overall Study|Lost to Follow-up|0|||
46670039|NCT01210495|82884945|FG001|Overall Study|Lost to Follow-up|0|||
46670040|NCT01210495|82884946|FG002|Overall Study|Lost to Follow-up|1|||
46670041|NCT01210495|82884947|FG003|Overall Study|Lost to Follow-up|1|||
46670042|NCT01210495|82884944|FG000|Overall Study|Other unspecified|0|||
46670043|NCT01210495|82884945|FG001|Overall Study|Other unspecified|0|||
46670044|NCT01210495|82884946|FG002|Overall Study|Other unspecified|6|||
46670045|NCT01210495|82884947|FG003|Overall Study|Other unspecified|0|||
46670046|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
46670047|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
46670048|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
46670049|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
46670050|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
46670051|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
46670052|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
46670053|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
46670054|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
46670055|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
46670056|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
46786057|NCT00350779|83005194|FG001|Overall Study|Patient Moved|1|||
46786058|NCT00350779|83005193|FG000|Overall Study|Non-compliance with study procedures|0|||
46786059|NCT00350779|83005194|FG001|Overall Study|Non-compliance with study procedures|1|||
46786060|NCT00350623|83005205|FG000|Overall Study|Lost to Follow-up|8|||
46972814|NCT01992094|83216556|FG002|Overall Study|Death|2|||
47077252|NCT00081263|83376079|FG001|Overall Study|improper pre-protocol therapy|1|||
47077253|NCT00081263|83376078|FG000|Overall Study|Inadequate pathology|0|||
47077254|NCT00081263|83376079|FG001|Overall Study|Inadequate pathology|1|||
47077255|NCT00081263|83376078|FG000|Overall Study|Never treated|4|||
47077256|NCT00081263|83376079|FG001|Overall Study|Never treated|5|||
47077257|NCT00081263|83376078|FG000|Overall Study|Inadequate data|5|||
47077258|NCT00081263|83376079|FG001|Overall Study|Inadequate data|10|||
47077259|NCT01490294|83376089|FG000|Overall Study|Prematurely discontinuation|4|||
47077260|NCT01490294|83376090|FG001|Overall Study|Prematurely discontinuation|0|||
47077261|NCT01490294|83376091|FG002|Overall Study|Prematurely discontinuation|1|||
47077262|NCT01490294|83376092|FG003|Overall Study|Prematurely discontinuation|1|||
47077263|NCT01490294|83376089|FG000|Overall Study|Adverse Event|1|||
47077264|NCT01490294|83376090|FG001|Overall Study|Adverse Event|0|||
47077265|NCT01490294|83376091|FG002|Overall Study|Adverse Event|0|||
47077266|NCT01490294|83376092|FG003|Overall Study|Adverse Event|0|||
47077267|NCT00080483|83376119|FG000|Overall Study|Lost to Follow-up|1|||
46670057|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
46670058|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
46670059|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
46670060|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
46670061|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
46670062|NCT01231516|82884959|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
46670063|NCT01231516|82884960|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
46670064|NCT01231516|82884959|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
46851518|NCT03600376|83067079|FG000|Overall Study|Transferred to other facility|1|||
46851519|NCT03600376|83067080|FG001|Overall Study|Transferred to other facility|0|||
46851520|NCT03600376|83067079|FG000|Overall Study|Investigator Decision|0|||
46851521|NCT03600376|83067080|FG001|Overall Study|Investigator Decision|4|||
46851522|NCT03600376|83067079|FG000|Overall Study|Determined to be ineligible for study|0|||
46851523|NCT03600376|83067080|FG001|Overall Study|Determined to be ineligible for study|1|||
46851524|NCT03599362|83067086|FG000|Overall Study|Screen Failure|3|||
46851525|NCT03598036|83067092|FG000|Overall Study|Withdrawal by Subject|1|||
46851526|NCT03598036|83067093|FG001|Overall Study|Withdrawal by Subject|0|||
46851527|NCT00082407|83067103|FG000|Overall Study|Adverse Event|20|||
46851528|NCT00082407|83067104|FG001|Overall Study|Adverse Event|0|||
46851529|NCT00082407|83067103|FG000|Overall Study|Protocol Violation|14|||
46851530|NCT00082407|83067104|FG001|Overall Study|Protocol Violation|12|||
46851531|NCT00082407|83067103|FG000|Overall Study|Patient Decision|13|||
46851532|NCT00082407|83067104|FG001|Overall Study|Patient Decision|6|||
46851533|NCT00082407|83067103|FG000|Overall Study|Physician Decision|5|||
46851534|NCT00082407|83067104|FG001|Overall Study|Physician Decision|3|||
46851535|NCT00082407|83067103|FG000|Overall Study|Loss of Glucose Control|2|||
46851536|NCT00082407|83067104|FG001|Overall Study|Loss of Glucose Control|2|||
46851537|NCT00082407|83067103|FG000|Overall Study|Death|2|||
46851538|NCT00082407|83067104|FG001|Overall Study|Death|1|||
46851539|NCT00082407|83067103|FG000|Overall Study|Lost to Follow-up|0|||
46851540|NCT00082407|83067104|FG001|Overall Study|Lost to Follow-up|3|||
46851541|NCT03643432|83067112|FG000|Overall Study|Lost to Follow-up|1|||
46851542|NCT03643432|83067113|FG001|Overall Study|Lost to Follow-up|0|||
46851543|NCT03810183|83067121|FG000|Overall Study|Study terminated by Sponsor|2|||
46851544|NCT03810183|83067122|FG001|Overall Study|Study terminated by Sponsor|1|||
46851545|NCT03597022|83067132|FG000|Overall Study|Premature termination of the study|7|||
46851546|NCT03597022|83067133|FG001|Overall Study|Premature termination of the study|7|||
46851547|NCT03597022|83067134|FG002|Overall Study|Premature termination of the study|8|||
46851548|NCT03597022|83067132|FG000|Overall Study|Serious adverse event|1|||
46851549|NCT03597022|83067133|FG001|Overall Study|Serious adverse event|1|||
47077268|NCT00080483|83376120|FG001|Overall Study|Lost to Follow-up|1|||
46670065|NCT01231516|82884960|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
46670066|NCT01231516|82884959|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
46670067|NCT01231516|82884960|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
46670068|NCT01231516|82884959|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
46670069|NCT01231516|82884960|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
46670070|NCT01231516|82884959|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
46670071|NCT01231516|82884960|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
46670072|NCT01231516|82884959|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
46670073|NCT01231516|82884960|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
46670074|NCT01231516|82884959|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
46670075|NCT01231516|82884960|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
46670076|NCT01231516|82884959|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
46670077|NCT01231516|82884960|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
46851550|NCT03597022|83067134|FG002|Overall Study|Serious adverse event|0|||
46851551|NCT03571204|83067145|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
46851552|NCT03571204|83067146|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
46851553|NCT03571204|83067147|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
46851554|NCT03571204|83067145|FG000|Overall Study|Physician Decision|0|||
47077269|NCT00080483|83376119|FG000|Overall Study|Physician Decision|1|||
47077270|NCT00080483|83376120|FG001|Overall Study|Physician Decision|1|||
47077271|NCT00089141|83376141|FG000|Overall Study|Termination of trial|18|||
47077272|NCT00089141|83376142|FG001|Overall Study|Termination of trial|24|||
47077273|NCT02588664|83376188|FG000|Overall Study|Death|56|||
47077274|NCT02588664|83376189|FG001|Overall Study|Death|55|||
47077275|NCT02588664|83376188|FG000|Overall Study|Lost to Follow-up|1305|||
47077276|NCT02588664|83376189|FG001|Overall Study|Lost to Follow-up|990|||
46786061|NCT00350623|83005206|FG001|Overall Study|Lost to Follow-up|3|||
46786062|NCT00350623|83005207|FG002|Overall Study|Lost to Follow-up|4|||
46786063|NCT00350623|83005205|FG000|Overall Study|Withdrawal by Subject|0|||
46786064|NCT00350623|83005206|FG001|Overall Study|Withdrawal by Subject|1|||
46786065|NCT00350623|83005207|FG002|Overall Study|Withdrawal by Subject|1|||
46786066|NCT00350623|83005205|FG000|Overall Study|patient traveling outside the country|0|||
46786067|NCT00350623|83005206|FG001|Overall Study|patient traveling outside the country|0|||
46786068|NCT00350623|83005207|FG002|Overall Study|patient traveling outside the country|1|||
46786069|NCT00656136|83005217|FG000|Overall Study|Progressive disease|177|||
46786070|NCT00656136|83005218|FG001|Overall Study|Progressive disease|322|||
46786071|NCT00656136|83005217|FG000|Overall Study|Other Adverse Event|5|||
46786072|NCT00656136|83005218|FG001|Overall Study|Other Adverse Event|51|||
46786073|NCT00656136|83005217|FG000|Overall Study|Protocol Violation|2|||
46786074|NCT00656136|83005218|FG001|Overall Study|Protocol Violation|3|||
46786075|NCT00656136|83005217|FG000|Overall Study|Patient refused to take study medication|7|||
46786076|NCT00656136|83005218|FG001|Overall Study|Patient refused to take study medication|10|||
46670078|NCT01231321|82884966|FG000|Overall Study|Adverse Event|3|||
46670079|NCT01231321|82884966|FG000|Overall Study|Lack of Efficacy|2|||
46670080|NCT01210222|82884976|FG000|Overall Study|Ineligible|2|||
46670081|NCT01210222|82884976|FG000|Overall Study|Never treated|1|||
46670082|NCT01210144|82884988|FG000|Overall Study|Lack of ovarian response|1|||
46670083|NCT01210144|82884989|FG001|Overall Study|Lack of ovarian response|0|||
46670084|NCT01210144|82884988|FG000|Overall Study|No fertilization|1|||
46670085|NCT01210144|82884989|FG001|Overall Study|No fertilization|0|||
46670086|NCT01210144|82884988|FG000|Overall Study|No transfer|1|||
46670087|NCT01210144|82884989|FG001|Overall Study|No transfer|0|||
46670088|NCT01209949|82884996|FG000|Overall Study|Lost to Follow-up|3|||
46670089|NCT01209832|82885000|FG000|Period 1|Sponsor Decision and was not dosed|1|||
46670090|NCT01209832|82885000|FG000|Period 2|Sponsor Decision|1|||
46670091|NCT01230892|82885013|FG000|Overall Study|Withdrawal by Subject|1|||
46670092|NCT01230892|82885014|FG001|Overall Study|Withdrawal by Subject|1|||
46670093|NCT01230892|82885013|FG000|Overall Study|Lost to Follow-up|2|||
46670094|NCT01230892|82885014|FG001|Overall Study|Lost to Follow-up|0|||
46670095|NCT01230814|82885022|FG000|Overall Study|Lost to Follow-up|11|||
46670096|NCT01230814|82885023|FG001|Overall Study|Lost to Follow-up|3|||
46670097|NCT01230814|82885022|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
46670098|NCT01230814|82885023|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
46670099|NCT01230307|82885031|FG000|Overall Study|LVAD Placement|0|||
46670100|NCT01230307|82885032|FG001|Overall Study|LVAD Placement|2|||
46786077|NCT00656136|83005217|FG000|Overall Study|Unknown and others|4|||
46786078|NCT00656136|83005218|FG001|Overall Study|Unknown and others|4|||
46786079|NCT00676520|83005224|FG000|Overall Study|Withdrawal by Subject|163|||
46786080|NCT00676520|83005224|FG000|Overall Study|Lost to Follow-up|162|||
46786081|NCT00676520|83005224|FG000|Overall Study|Death|159|||
46786082|NCT00676520|83005224|FG000|Overall Study|Physician Decision|20|||
46786083|NCT00676520|83005224|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
46786084|NCT00676520|83005224|FG000|Overall Study|Other Reason|18|||
46786085|NCT00652938|83005236|FG000|Overall Study|Adverse Event|1|||
46786086|NCT00652938|83005237|FG001|Overall Study|Adverse Event|0|||
46786087|NCT00652938|83005238|FG002|Overall Study|Adverse Event|2|||
46786088|NCT00652938|83005236|FG000|Overall Study|Withdrawal by Subject|0|||
46786089|NCT00652938|83005237|FG001|Overall Study|Withdrawal by Subject|6|||
46786090|NCT00652938|83005238|FG002|Overall Study|Withdrawal by Subject|1|||
46786091|NCT00652938|83005236|FG000|Overall Study|Lost to Follow-up|0|||
46786092|NCT00652938|83005237|FG001|Overall Study|Lost to Follow-up|0|||
46786093|NCT00652938|83005238|FG002|Overall Study|Lost to Follow-up|2|||
46786094|NCT00652938|83005236|FG000|Overall Study|fear of blood sampling|0|||
46786095|NCT00652938|83005237|FG001|Overall Study|fear of blood sampling|1|||
46786096|NCT00652938|83005238|FG002|Overall Study|fear of blood sampling|0|||
46786097|NCT00322621|83005246|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
46786098|NCT00322621|83005247|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
46786099|NCT00322621|83005248|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
46786100|NCT00322621|83005246|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
46786101|NCT00322621|83005247|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
46786102|NCT00322621|83005248|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
46786103|NCT00322621|83005246|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
46786104|NCT00322621|83005247|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
46786105|NCT00322621|83005248|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
46786106|NCT00322621|83005246|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
46786107|NCT00322621|83005247|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
46670101|NCT01209598|82885040|FG000|Overall Study|Withdrawal by Subject|1|||
46670102|NCT01209598|82885041|FG001|Overall Study|Withdrawal by Subject|0|||
46670103|NCT01209520|82885048|FG000|Overall Study|Withdrawal by Subject|3|||
46670104|NCT01209325|82885052|FG000|Overall Study|Lost to Follow-up|24|||
46670105|NCT01209325|82885052|FG000|Overall Study|Adverse Event|1|||
46670106|NCT01209325|82885052|FG000|Overall Study|Relocated|3|||
46786108|NCT00322621|83005248|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
46786109|NCT00322621|83005246|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
46670107|NCT01209325|82885052|FG000|Overall Study|Refusal after starting therapy|8|||
46670108|NCT01209325|82885052|FG000|Overall Study|Protocol Violation|4|||
46670109|NCT01209325|82885052|FG000|Overall Study|Refusal prior to therapy|1|||
46786110|NCT00322621|83005247|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
46786111|NCT00322621|83005248|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
46786112|NCT00322621|83005246|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
46786113|NCT00322621|83005247|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
46786114|NCT00322621|83005248|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
46786115|NCT00322621|83005246|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
46786116|NCT00322621|83005247|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
46786117|NCT00322621|83005248|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
46786118|NCT00322621|83005246|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
46786119|NCT00322621|83005247|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
46786120|NCT00322621|83005248|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
46786121|NCT00322621|83005246|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
46786122|NCT00322621|83005247|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
46786123|NCT00322621|83005248|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
46786124|NCT00322621|83005246|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
46786125|NCT00322621|83005247|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
46786126|NCT00322621|83005248|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
46786127|NCT00322621|83005246|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
46786128|NCT00322621|83005247|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
46786129|NCT00322621|83005248|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
46786130|NCT00575042|83005261|FG000|Overall Study|Adverse Event|2|||
46786131|NCT00575042|83005261|FG000|Overall Study|Lost to Follow-up|1|||
46786132|NCT00676208|83005268|FG000|Overall Study|Lost to Follow-up|0|||
46786133|NCT00676208|83005269|FG001|Overall Study|Lost to Follow-up|2|||
46786134|NCT00676208|83005268|FG000|Overall Study|Incomplete data|2|||
46786135|NCT00676208|83005269|FG001|Overall Study|Incomplete data|4|||
46786136|NCT00656058|83005277|FG000|Overall Study|Withdrawal by Subject|2|||
46786137|NCT00656058|83005277|FG000|Overall Study|Withdrawal by Subject|4|||
46786138|NCT00537316|83005287|FG000|Part 1|Adverse Event|7|||
46786139|NCT00537316|83005288|FG001|Part 1|Adverse Event|11|||
46786140|NCT00537316|83005289|FG002|Part 1|Adverse Event|8|||
46786141|NCT00537316|83005290|FG003|Part 1|Adverse Event|0|||
46670110|NCT01209325|82885052|FG000|Overall Study|Incarceration|2|||
46670111|NCT01209286|82885090|FG000|Overall Study|Adverse Event|4|||
46670112|NCT01209286|82885091|FG001|Overall Study|Adverse Event|3|||
46670113|NCT01209286|82885092|FG002|Overall Study|Adverse Event|1|||
46670114|NCT01209286|82885090|FG000|Overall Study|Hematological Relapse After Remission|0|||
46670115|NCT01209286|82885091|FG001|Overall Study|Hematological Relapse After Remission|1|||
46670116|NCT01209286|82885092|FG002|Overall Study|Hematological Relapse After Remission|1|||
46670117|NCT01209286|82885090|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
46670118|NCT01209286|82885091|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
46670119|NCT01209286|82885092|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
46670120|NCT01209286|82885090|FG000|Overall Study|Physician Decision|0|||
46670121|NCT01209286|82885091|FG001|Overall Study|Physician Decision|2|||
46670122|NCT01209286|82885092|FG002|Overall Study|Physician Decision|0|||
46670123|NCT01209286|82885090|FG000|Overall Study|Other|0|||
46670124|NCT01209286|82885091|FG001|Overall Study|Other|1|||
46670125|NCT01209286|82885092|FG002|Overall Study|Other|0|||
46670126|NCT05048719|82885125|FG000|Overall Study|Withdrawal by Subject|2|||
46670127|NCT05048719|82885126|FG001|Overall Study|Withdrawal by Subject|1|||
46670128|NCT05048719|82885127|FG002|Overall Study|Withdrawal by Subject|3|||
46670129|NCT05048719|82885128|FG003|Overall Study|Withdrawal by Subject|1|||
46670130|NCT05048719|82885129|FG004|Overall Study|Withdrawal by Subject|0|||
46670131|NCT05048719|82885130|FG005|Overall Study|Withdrawal by Subject|2|||
46670132|NCT05048719|82885131|FG006|Overall Study|Withdrawal by Subject|1|||
46670133|NCT05048719|82885132|FG007|Overall Study|Withdrawal by Subject|1|||
46670134|NCT05048719|82885133|FG008|Overall Study|Withdrawal by Subject|0|||
46670135|NCT05048719|82885125|FG000|Overall Study|Death|1|||
46670136|NCT05048719|82885126|FG001|Overall Study|Death|0|||
46786142|NCT00537316|83005291|FG004|Part 1|Adverse Event|0|||
46786143|NCT00537316|83005292|FG005|Part 1|Adverse Event|0|||
46786144|NCT00537316|83005293|FG006|Part 1|Adverse Event|0|||
46786145|NCT00537316|83005287|FG000|Part 1|Protocol defined clinical event|1|||
46670137|NCT05048719|82885127|FG002|Overall Study|Death|0|||
46670138|NCT05048719|82885128|FG003|Overall Study|Death|0|||
46670139|NCT05048719|82885129|FG004|Overall Study|Death|0|||
46670140|NCT05048719|82885130|FG005|Overall Study|Death|0|||
46670141|NCT05048719|82885131|FG006|Overall Study|Death|0|||
46670142|NCT05048719|82885132|FG007|Overall Study|Death|0|||
46670143|NCT05048719|82885133|FG008|Overall Study|Death|0|||
46670144|NCT05048719|82885125|FG000|Overall Study|Adverse Event|0|||
46670145|NCT05048719|82885126|FG001|Overall Study|Adverse Event|1|||
46670146|NCT05048719|82885127|FG002|Overall Study|Adverse Event|2|||
46670147|NCT05048719|82885128|FG003|Overall Study|Adverse Event|0|||
46670148|NCT05048719|82885129|FG004|Overall Study|Adverse Event|1|||
46670149|NCT05048719|82885130|FG005|Overall Study|Adverse Event|0|||
46670150|NCT05048719|82885131|FG006|Overall Study|Adverse Event|0|||
46670151|NCT05048719|82885132|FG007|Overall Study|Adverse Event|0|||
47077277|NCT00083759|83376252|FG000|Overall Study|Adverse Event|5|||
47077278|NCT00083759|83376253|FG001|Overall Study|Adverse Event|3|||
47077279|NCT00083759|83376252|FG000|Overall Study|Lost to Follow-up|1|||
47077280|NCT00083759|83376253|FG001|Overall Study|Lost to Follow-up|0|||
47077281|NCT00083759|83376252|FG000|Overall Study|Death|1|||
47077282|NCT00083759|83376253|FG001|Overall Study|Death|1|||
47077283|NCT00083759|83376252|FG000|Overall Study|Inadequate Therapeutic Response|32|||
47077284|NCT00083759|83376253|FG001|Overall Study|Inadequate Therapeutic Response|35|||
47077285|NCT00083759|83376252|FG000|Overall Study|Subject Withdrew Consent|2|||
47077286|NCT00083759|83376253|FG001|Overall Study|Subject Withdrew Consent|2|||
46670152|NCT05048719|82885133|FG008|Overall Study|Adverse Event|0|||
46670153|NCT05048719|82885125|FG000|Overall Study|Lost to Follow-up|0|||
46670154|NCT05048719|82885126|FG001|Overall Study|Lost to Follow-up|0|||
46670155|NCT05048719|82885127|FG002|Overall Study|Lost to Follow-up|1|||
46670156|NCT05048719|82885128|FG003|Overall Study|Lost to Follow-up|3|||
46670157|NCT05048719|82885129|FG004|Overall Study|Lost to Follow-up|1|||
46670158|NCT05048719|82885130|FG005|Overall Study|Lost to Follow-up|1|||
46670159|NCT05048719|82885131|FG006|Overall Study|Lost to Follow-up|1|||
46670160|NCT05048719|82885132|FG007|Overall Study|Lost to Follow-up|1|||
46670161|NCT05048719|82885133|FG008|Overall Study|Lost to Follow-up|0|||
46670162|NCT05048719|82885125|FG000|Overall Study|Physician Decision|0|||
46670163|NCT05048719|82885126|FG001|Overall Study|Physician Decision|0|||
46670164|NCT05048719|82885127|FG002|Overall Study|Physician Decision|0|||
46670165|NCT05048719|82885128|FG003|Overall Study|Physician Decision|0|||
46670166|NCT05048719|82885129|FG004|Overall Study|Physician Decision|0|||
46670167|NCT05048719|82885130|FG005|Overall Study|Physician Decision|0|||
46670168|NCT05048719|82885131|FG006|Overall Study|Physician Decision|0|||
46670169|NCT05048719|82885132|FG007|Overall Study|Physician Decision|1|||
46670170|NCT05048719|82885133|FG008|Overall Study|Physician Decision|1|||
46670171|NCT05048719|82885125|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
46670172|NCT05048719|82885126|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670173|NCT05048719|82885127|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670174|NCT05048719|82885128|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670175|NCT05048719|82885129|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670176|NCT05048719|82885130|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670177|NCT05048719|82885131|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670178|NCT05048719|82885132|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670179|NCT05048719|82885133|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
46670180|NCT05048719|82885125|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
46670181|NCT05048719|82885126|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
46670182|NCT05048719|82885127|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
46670183|NCT05048719|82885128|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
46670184|NCT05048719|82885129|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
46670185|NCT05048719|82885130|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
46670186|NCT05048719|82885131|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
46786146|NCT00537316|83005288|FG001|Part 1|Protocol defined clinical event|0|||
46786147|NCT00537316|83005289|FG002|Part 1|Protocol defined clinical event|0|||
47077287|NCT00083759|83376252|FG000|Overall Study|Non-Compliance|1|||
47077288|NCT00083759|83376253|FG001|Overall Study|Non-Compliance|0|||
47077289|NCT00083759|83376252|FG000|Overall Study|Sponsor's Discretion|28|||
47077290|NCT00083759|83376253|FG001|Overall Study|Sponsor's Discretion|29|||
47077291|NCT00083759|83376252|FG000|Overall Study|Other|14|||
47077292|NCT00083759|83376253|FG001|Overall Study|Other|13|||
47077293|NCT00089609|83376379|FG000|Overall Study|Withdrawal by Subject|3|||
47077294|NCT00089609|83376380|FG001|Overall Study|Withdrawal by Subject|1|||
47077295|NCT02440581|83376521|FG000|Overall Study|Death|0|||
47077296|NCT02440581|83376522|FG001|Overall Study|Death|0|||
46786148|NCT00537316|83005290|FG003|Part 1|Protocol defined clinical event|0|||
47077297|NCT02440581|83376523|FG002|Overall Study|Death|7|||
46851555|NCT03571204|83067146|FG001|Overall Study|Physician Decision|1|||
47077298|NCT02440581|83376524|FG003|Overall Study|Death|5|||
46670187|NCT05048719|82885132|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
46670188|NCT05048719|82885133|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
47077299|NCT02440581|83376521|FG000|Overall Study|Transplanted|1|||
46670189|NCT05048719|82885125|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670190|NCT05048719|82885126|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
46670191|NCT05048719|82885127|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670192|NCT05048719|82885128|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670193|NCT05048719|82885129|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670194|NCT05048719|82885130|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670195|NCT05048719|82885131|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670196|NCT05048719|82885132|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670197|NCT05048719|82885133|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
46670198|NCT05048719|82885125|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670199|NCT05048719|82885126|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670200|NCT05048719|82885127|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670201|NCT05048719|82885128|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
46670202|NCT05048719|82885129|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670203|NCT05048719|82885130|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670204|NCT05048719|82885131|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670205|NCT05048719|82885132|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670206|NCT05048719|82885133|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
46670207|NCT05048719|82885125|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
46670208|NCT05048719|82885126|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
46670209|NCT05048719|82885127|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
46670210|NCT05048719|82885128|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
46670211|NCT05048719|82885129|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
46670212|NCT05048719|82885130|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
46670213|NCT05048719|82885131|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
46670214|NCT05048719|82885132|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
47077300|NCT02440581|83376522|FG001|Overall Study|Transplanted|0|||
47077301|NCT02440581|83376523|FG002|Overall Study|Transplanted|3|||
46670215|NCT05048719|82885133|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
46670216|NCT04949802|82885158|FG000|Overall Study|Lost to Follow-up|3|||
46670217|NCT04626297|82885174|FG000|Overall Study|Adverse Event|5|||
46670218|NCT04626297|82885175|FG001|Overall Study|Adverse Event|3|||
46670219|NCT04626297|82885174|FG000|Overall Study|Lost to Follow-up|7|||
46670220|NCT04626297|82885175|FG001|Overall Study|Lost to Follow-up|3|||
46670221|NCT04626297|82885174|FG000|Overall Study|Protocol Violation|5|||
46670222|NCT04626297|82885175|FG001|Overall Study|Protocol Violation|1|||
46670223|NCT04626297|82885174|FG000|Overall Study|Withdrawal by Subject|20|||
46670224|NCT04626297|82885175|FG001|Overall Study|Withdrawal by Subject|6|||
46670225|NCT04626297|82885174|FG000|Overall Study|Sponsor decision|2|||
46670226|NCT04626297|82885175|FG001|Overall Study|Sponsor decision|1|||
46670227|NCT04154189|82885187|FG000|Overall Study|Death|16|||
46670228|NCT04154189|82885188|FG001|Overall Study|Death|15|||
46670229|NCT04154189|82885187|FG000|Overall Study|Withdrawal by Subject|4|||
46670230|NCT04154189|82885188|FG001|Overall Study|Withdrawal by Subject|6|||
46670231|NCT04154189|82885187|FG000|Overall Study|Ongoing|20|||
46670232|NCT04154189|82885188|FG001|Overall Study|Ongoing|20|||
46670233|NCT03905512|82885211|FG000|Overall Study|Withdrawal by Subject|9|||
46670234|NCT03905512|82885212|FG001|Overall Study|Withdrawal by Subject|8|||
46670235|NCT03905512|82885211|FG000|Overall Study|Adverse Event|1|||
46670236|NCT03905512|82885212|FG001|Overall Study|Adverse Event|2|||
46670237|NCT03905512|82885211|FG000|Overall Study|Lost to Follow-up|4|||
46670238|NCT03905512|82885212|FG001|Overall Study|Lost to Follow-up|3|||
46670239|NCT03905512|82885211|FG000|Overall Study|Other than Specified|7|||
46670240|NCT03905512|82885212|FG001|Overall Study|Other than Specified|4|||
46670241|NCT03891875|82885221|FG000|Overall Study|Withdrawal by Subject|20|||
46670242|NCT03891875|82885222|FG001|Overall Study|Withdrawal by Subject|3|||
46670243|NCT03891875|82885221|FG000|Overall Study|Adverse Event|10|||
46670244|NCT03891875|82885222|FG001|Overall Study|Adverse Event|4|||
46786149|NCT00537316|83005291|FG004|Part 1|Protocol defined clinical event|0|||
46972815|NCT01992094|83216554|FG000|Overall Study|Lost to Follow-up|26|||
47077302|NCT02440581|83376524|FG003|Overall Study|Transplanted|2|||
46670245|NCT03891875|82885221|FG000|Overall Study|Physician Decision|1|||
46670246|NCT03891875|82885222|FG001|Overall Study|Physician Decision|1|||
46670247|NCT03891875|82885221|FG000|Overall Study|Protocol Violation|1|||
46972816|NCT01992094|83216555|FG001|Overall Study|Lost to Follow-up|9|||
46972817|NCT01992094|83216556|FG002|Overall Study|Lost to Follow-up|13|||
46972818|NCT01992094|83216554|FG000|Overall Study|OTHER|4|||
47077303|NCT02440581|83376521|FG000|Overall Study|Withdrawal by Subject|4|||
46670248|NCT03891875|82885222|FG001|Overall Study|Protocol Violation|0|||
46670249|NCT03891875|82885221|FG000|Overall Study|Lost to Follow-up|1|||
46670250|NCT03891875|82885222|FG001|Overall Study|Lost to Follow-up|0|||
46670251|NCT03891875|82885221|FG000|Overall Study|COVID-19 infection|1|||
46670252|NCT03891875|82885222|FG001|Overall Study|COVID-19 infection|0|||
46670253|NCT03830164|82885231|FG000|Overall Study|Adverse Event|0|||
46670254|NCT03830164|82885232|FG001|Overall Study|Adverse Event|2|||
46670255|NCT03830164|82885233|FG002|Overall Study|Adverse Event|0|||
46670256|NCT03830164|82885231|FG000|Overall Study|Lack of Efficacy|1|||
46670257|NCT03830164|82885232|FG001|Overall Study|Lack of Efficacy|5|||
46670258|NCT03830164|82885233|FG002|Overall Study|Lack of Efficacy|0|||
46670259|NCT03830164|82885231|FG000|Overall Study|Lost to Follow-up|0|||
46670260|NCT03830164|82885232|FG001|Overall Study|Lost to Follow-up|1|||
46670261|NCT03830164|82885233|FG002|Overall Study|Lost to Follow-up|0|||
46670262|NCT03830164|82885231|FG000|Overall Study|Withdrawal by Subject|1|||
46670263|NCT03830164|82885232|FG001|Overall Study|Withdrawal by Subject|0|||
46670264|NCT03830164|82885233|FG002|Overall Study|Withdrawal by Subject|0|||
46670265|NCT03769181|82885245|FG000|Overall Study|Adverse Event|1|||
46670266|NCT03769181|82885246|FG001|Overall Study|Adverse Event|0|||
46670267|NCT03769181|82885247|FG002|Overall Study|Adverse Event|2|||
46670268|NCT03769181|82885248|FG003|Overall Study|Adverse Event|4|||
46670269|NCT03769181|82885245|FG000|Overall Study|Withdrawal by Subject|1|||
46670270|NCT03769181|82885246|FG001|Overall Study|Withdrawal by Subject|0|||
46670271|NCT03769181|82885247|FG002|Overall Study|Withdrawal by Subject|2|||
46670272|NCT03769181|82885248|FG003|Overall Study|Withdrawal by Subject|1|||
46670273|NCT03769181|82885245|FG000|Overall Study|Progressive disease|9|||
46670274|NCT03769181|82885246|FG001|Overall Study|Progressive disease|7|||
46670275|NCT03769181|82885247|FG002|Overall Study|Progressive disease|13|||
46670276|NCT03769181|82885248|FG003|Overall Study|Progressive disease|6|||
46670277|NCT03769181|82885245|FG000|Overall Study|Other - Unspecified|2|||
46670278|NCT03769181|82885246|FG001|Overall Study|Other - Unspecified|1|||
46670279|NCT03769181|82885247|FG002|Overall Study|Other - Unspecified|0|||
46670280|NCT03769181|82885248|FG003|Overall Study|Other - Unspecified|0|||
46670281|NCT03621696|82885287|FG000|Overall Study|Not eligible|0|||
46670282|NCT03621696|82885288|FG001|Overall Study|Not eligible|0|||
46670283|NCT03621696|82885289|FG002|Overall Study|Not eligible|0|||
46670284|NCT03621696|82885290|FG003|Overall Study|Not eligible|5|||
46670285|NCT03621696|82885287|FG000|Overall Study|Withdrawal by Subject|1|||
46670286|NCT03621696|82885288|FG001|Overall Study|Withdrawal by Subject|1|||
46670287|NCT03621696|82885289|FG002|Overall Study|Withdrawal by Subject|1|||
46670288|NCT03621696|82885290|FG003|Overall Study|Withdrawal by Subject|0|||
46670289|NCT03621696|82885287|FG000|Overall Study|Physician Decision|0|||
46670290|NCT03621696|82885288|FG001|Overall Study|Physician Decision|0|||
46670291|NCT03621696|82885289|FG002|Overall Study|Physician Decision|1|||
46786150|NCT00537316|83005292|FG005|Part 1|Protocol defined clinical event|0|||
46786151|NCT00537316|83005293|FG006|Part 1|Protocol defined clinical event|0|||
46786152|NCT00537316|83005287|FG000|Part 1|Lost to Follow-up|1|||
46786153|NCT00537316|83005288|FG001|Part 1|Lost to Follow-up|0|||
46786154|NCT00537316|83005289|FG002|Part 1|Lost to Follow-up|0|||
46786155|NCT00537316|83005290|FG003|Part 1|Lost to Follow-up|0|||
46786156|NCT00537316|83005291|FG004|Part 1|Lost to Follow-up|0|||
46786157|NCT00537316|83005292|FG005|Part 1|Lost to Follow-up|0|||
46786158|NCT00537316|83005293|FG006|Part 1|Lost to Follow-up|0|||
46786159|NCT00537316|83005287|FG000|Part 1|Withdrawal by Subject|3|||
46786160|NCT00537316|83005288|FG001|Part 1|Withdrawal by Subject|8|||
46786161|NCT00537316|83005289|FG002|Part 1|Withdrawal by Subject|4|||
46670292|NCT03621696|82885290|FG003|Overall Study|Physician Decision|0|||
46670293|NCT03592641|82885298|FG000|Overall Study|Withdrawal by Subject|1|||
46670294|NCT03468985|82885306|FG000|Overall Study|Adverse Event|0|||
46670295|NCT03468985|82885307|FG001|Overall Study|Adverse Event|2|||
46670296|NCT03468985|82885308|FG002|Overall Study|Adverse Event|0|||
46670297|NCT03468985|82885309|FG003|Overall Study|Adverse Event|0|||
46670298|NCT03468985|82885306|FG000|Overall Study|Withdrawal by Subject|0|||
46670299|NCT03468985|82885307|FG001|Overall Study|Withdrawal by Subject|0|||
46670300|NCT03468985|82885308|FG002|Overall Study|Withdrawal by Subject|0|||
46786162|NCT00537316|83005290|FG003|Part 1|Withdrawal by Subject|0|||
46786163|NCT00537316|83005291|FG004|Part 1|Withdrawal by Subject|0|||
46786164|NCT00537316|83005292|FG005|Part 1|Withdrawal by Subject|0|||
46786165|NCT00537316|83005293|FG006|Part 1|Withdrawal by Subject|0|||
46670301|NCT03468985|82885309|FG003|Overall Study|Withdrawal by Subject|1|||
46670302|NCT03434418|82885328|FG000|Overall Study|Disease Progression|11|||
46670303|NCT03434418|82885328|FG000|Overall Study|Adverse Event|2|||
46670304|NCT03434418|82885328|FG000|Overall Study|Physician Decision|1|||
46670305|NCT03434418|82885328|FG000|Overall Study|Decline in Performance Status (PS)|1|||
46670306|NCT03366103|82885335|FG000|Overall Study|Disease Progression|3|||
46670307|NCT03366103|82885336|FG001|Overall Study|Disease Progression|1|||
46670308|NCT03366103|82885337|FG002|Overall Study|Disease Progression|0|||
46670309|NCT03366103|82885335|FG000|Overall Study|Adverse Event|0|||
46670310|NCT03366103|82885336|FG001|Overall Study|Adverse Event|1|||
46786166|NCT00537316|83005287|FG000|Part 1|Protocol Violation|1|||
46670311|NCT03366103|82885337|FG002|Overall Study|Adverse Event|0|||
46670312|NCT03253679|82885348|FG000|Overall Study|Screen Failure|1|||
46670313|NCT03099148|82885352|FG000|Wash-out|scheduling conflict|0|||
46670314|NCT03099148|82885353|FG001|Wash-out|scheduling conflict|1|||
46670315|NCT03099148|82885354|FG002|Wash-out|scheduling conflict|0|||
46670316|NCT03099148|82885355|FG003|Wash-out|scheduling conflict|0|||
46670317|NCT03099148|82885352|FG000|Wash-out|Adverse Event|0|||
46670318|NCT03099148|82885353|FG001|Wash-out|Adverse Event|1|||
46670319|NCT03099148|82885354|FG002|Wash-out|Adverse Event|0|||
46670320|NCT03099148|82885355|FG003|Wash-out|Adverse Event|0|||
46670321|NCT03088813|82885370|FG000|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
46670322|NCT03088813|82885371|FG001|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|1|||
46670323|NCT03088813|82885372|FG002|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
46670324|NCT03088813|82885373|FG003|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
46670325|NCT03088813|82885370|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
46670326|NCT03088813|82885371|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
46670327|NCT03088813|82885372|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
46670328|NCT03088813|82885373|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
46670329|NCT03088813|82885370|FG000|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
46670330|NCT03088813|82885371|FG001|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
46670331|NCT03088813|82885372|FG002|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
46670332|NCT03088813|82885373|FG003|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
46670333|NCT03088813|82885370|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
46670334|NCT03088813|82885371|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
46670335|NCT03088813|82885372|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
46670336|NCT03088813|82885373|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
46670337|NCT03088813|82885370|FG000|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
46670338|NCT03088813|82885371|FG001|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
46786167|NCT00537316|83005288|FG001|Part 1|Protocol Violation|5|||
46786168|NCT00537316|83005289|FG002|Part 1|Protocol Violation|1|||
46786169|NCT00537316|83005290|FG003|Part 1|Protocol Violation|0|||
46786170|NCT00537316|83005291|FG004|Part 1|Protocol Violation|0|||
46786171|NCT00537316|83005292|FG005|Part 1|Protocol Violation|0|||
46786172|NCT00537316|83005293|FG006|Part 1|Protocol Violation|0|||
46786173|NCT00537316|83005287|FG000|Part 1|Did not meet protocol eligibility|1|||
46786174|NCT00537316|83005288|FG001|Part 1|Did not meet protocol eligibility|3|||
46786175|NCT00537316|83005289|FG002|Part 1|Did not meet protocol eligibility|2|||
46786176|NCT00537316|83005290|FG003|Part 1|Did not meet protocol eligibility|0|||
46786177|NCT00537316|83005291|FG004|Part 1|Did not meet protocol eligibility|0|||
46786178|NCT00537316|83005292|FG005|Part 1|Did not meet protocol eligibility|0|||
46786179|NCT00537316|83005293|FG006|Part 1|Did not meet protocol eligibility|0|||
46786180|NCT00537316|83005287|FG000|Part 1|Administrative|0|||
46786181|NCT00537316|83005288|FG001|Part 1|Administrative|0|||
46786182|NCT00537316|83005289|FG002|Part 1|Administrative|2|||
46786183|NCT00537316|83005290|FG003|Part 1|Administrative|0|||
46786184|NCT00537316|83005291|FG004|Part 1|Administrative|0|||
46786185|NCT00537316|83005292|FG005|Part 1|Administrative|0|||
46786186|NCT00537316|83005293|FG006|Part 1|Administrative|0|||
46786187|NCT00537316|83005287|FG000|Part 2|Never entered follow-up|0|||
46786188|NCT00537316|83005288|FG001|Part 2|Never entered follow-up|0|||
46786189|NCT00537316|83005289|FG002|Part 2|Never entered follow-up|0|||
46786190|NCT00537316|83005290|FG003|Part 2|Never entered follow-up|0|||
46786191|NCT00537316|83005291|FG004|Part 2|Never entered follow-up|0|||
46786192|NCT00537316|83005292|FG005|Part 2|Never entered follow-up|0|||
46786193|NCT00537316|83005293|FG006|Part 2|Never entered follow-up|1|||
46786194|NCT00537316|83005287|FG000|Part 2|Adverse Event|4|||
46786195|NCT00537316|83005288|FG001|Part 2|Adverse Event|0|||
46786196|NCT00537316|83005289|FG002|Part 2|Adverse Event|2|||
46786197|NCT00537316|83005290|FG003|Part 2|Adverse Event|0|||
46786198|NCT00537316|83005291|FG004|Part 2|Adverse Event|0|||
46972819|NCT01992094|83216555|FG001|Overall Study|OTHER|0|||
46972820|NCT01992094|83216556|FG002|Overall Study|OTHER|0|||
46786199|NCT00537316|83005292|FG005|Part 2|Adverse Event|0|||
46786200|NCT00537316|83005293|FG006|Part 2|Adverse Event|0|||
46670339|NCT03088813|82885372|FG002|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
46670340|NCT03088813|82885373|FG003|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
46670341|NCT03088813|82885370|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
46670342|NCT03088813|82885371|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
46786201|NCT00537316|83005287|FG000|Part 2|Lost to Follow-up|1|||
46786202|NCT00537316|83005288|FG001|Part 2|Lost to Follow-up|0|||
46972821|NCT01992094|83216554|FG000|Overall Study|Protocol Violation|1|||
46786203|NCT00537316|83005289|FG002|Part 2|Lost to Follow-up|2|||
46786204|NCT00537316|83005290|FG003|Part 2|Lost to Follow-up|0|||
46786205|NCT00537316|83005291|FG004|Part 2|Lost to Follow-up|0|||
46786206|NCT00537316|83005292|FG005|Part 2|Lost to Follow-up|0|||
46786207|NCT00537316|83005293|FG006|Part 2|Lost to Follow-up|0|||
46972822|NCT01992094|83216555|FG001|Overall Study|Protocol Violation|0|||
46972823|NCT01992094|83216556|FG002|Overall Study|Protocol Violation|1|||
46786208|NCT00537316|83005287|FG000|Part 2|Withdrawal by Subject|5|||
46786209|NCT00537316|83005288|FG001|Part 2|Withdrawal by Subject|1|||
46786210|NCT00537316|83005289|FG002|Part 2|Withdrawal by Subject|4|||
46786211|NCT00537316|83005290|FG003|Part 2|Withdrawal by Subject|0|||
46786212|NCT00537316|83005291|FG004|Part 2|Withdrawal by Subject|0|||
46786213|NCT00537316|83005292|FG005|Part 2|Withdrawal by Subject|0|||
46670343|NCT03088813|82885372|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|2|||
46670344|NCT03088813|82885373|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
46670345|NCT03088813|82885370|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
46670346|NCT03088813|82885371|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
46670347|NCT03088813|82885372|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
46670348|NCT03088813|82885373|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|12|||
46670349|NCT03088813|82885370|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
46670350|NCT03088813|82885371|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
46670351|NCT03088813|82885372|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|20|||
46670352|NCT03088813|82885373|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|37|||
46670353|NCT03088813|82885370|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
46670354|NCT03088813|82885371|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
46670355|NCT03088813|82885372|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|7|||
46670356|NCT03088813|82885373|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|3|||
46670357|NCT03088813|82885370|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
46670358|NCT03088813|82885371|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
46670359|NCT03088813|82885372|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
46670360|NCT03088813|82885373|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
46670361|NCT03061474|82885386|FG000|Overall Study|Adverse Event|2|||
46670362|NCT03061474|82885387|FG001|Overall Study|Adverse Event|0|||
46670363|NCT03061474|82885386|FG000|Overall Study|Safety Risk|0|||
46670364|NCT03061474|82885387|FG001|Overall Study|Safety Risk|1|||
46670365|NCT03061474|82885386|FG000|Overall Study|Participant unwilling or unable to participate|0|||
46670366|NCT03061474|82885387|FG001|Overall Study|Participant unwilling or unable to participate|2|||
46670367|NCT03061474|82885386|FG000|Overall Study|Lost to Follow-up|0|||
46670368|NCT03061474|82885387|FG001|Overall Study|Lost to Follow-up|1|||
46670369|NCT03040726|82885395|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
46670370|NCT03040726|82885396|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
46670371|NCT03040726|82885395|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
46670372|NCT03040726|82885396|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
46670373|NCT03040726|82885395|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
46670374|NCT03040726|82885396|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
46670375|NCT03040726|82885395|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
46670376|NCT03040726|82885396|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
46670377|NCT03040726|82885395|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
46670378|NCT03040726|82885396|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
46670379|NCT02899728|82885405|FG000|Overall Study|Withdrawal by Subject|1|||
46670380|NCT02899728|82885406|FG001|Overall Study|Withdrawal by Subject|1|||
46670381|NCT02899065|82885414|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
46670382|NCT02899065|82885415|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
46670383|NCT02899065|82885414|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
46670384|NCT02899065|82885415|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
46670385|NCT02899065|82885414|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
46786214|NCT00537316|83005293|FG006|Part 2|Withdrawal by Subject|0|||
46786215|NCT00537316|83005287|FG000|Part 2|Administrative|16|||
46786216|NCT00537316|83005288|FG001|Part 2|Administrative|8|||
46786217|NCT00537316|83005289|FG002|Part 2|Administrative|24|||
46786218|NCT00537316|83005290|FG003|Part 2|Administrative|3|||
46786219|NCT00537316|83005291|FG004|Part 2|Administrative|1|||
46786220|NCT00537316|83005292|FG005|Part 2|Administrative|4|||
46786221|NCT00537316|83005293|FG006|Part 2|Administrative|1|||
46786222|NCT03827395|83005314|FG000|Overall Study|Lost to Follow-up|1|||
46972824|NCT01992094|83216554|FG000|Overall Study|Withdrawal by Subject|7|||
46670386|NCT02899065|82885415|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
46670387|NCT02893930|82885421|FG000|Overall Study|Adverse Event|3|||
46670388|NCT02893930|82885421|FG000|Overall Study|Death|1|||
46670389|NCT02893930|82885421|FG000|Overall Study|Disease progression|5|||
46670390|NCT02893930|82885421|FG000|Overall Study|Withdrawal by Subject|2|||
46670391|NCT02893930|82885421|FG000|Overall Study|Physician Decision|1|||
46670392|NCT02893930|82885421|FG000|Overall Study|Ineligible|1|||
46670393|NCT02780804|82885428|FG000|Overall Study|Death|1|||
46670394|NCT02780804|82885429|FG001|Overall Study|Death|0|||
46670395|NCT02780804|82885430|FG002|Overall Study|Death|0|||
46670396|NCT02780804|82885428|FG000|Overall Study|Lack of Efficacy|5|||
46670397|NCT02780804|82885429|FG001|Overall Study|Lack of Efficacy|8|||
46670398|NCT02780804|82885430|FG002|Overall Study|Lack of Efficacy|4|||
46670399|NCT02780804|82885428|FG000|Overall Study|Physician Decision|0|||
46670400|NCT02780804|82885429|FG001|Overall Study|Physician Decision|0|||
46670401|NCT02780804|82885430|FG002|Overall Study|Physician Decision|2|||
46670402|NCT02780804|82885428|FG000|Overall Study|Withdrawal by Subject|0|||
46670403|NCT02780804|82885429|FG001|Overall Study|Withdrawal by Subject|1|||
46670404|NCT02780804|82885430|FG002|Overall Study|Withdrawal by Subject|0|||
46670405|NCT02629393|82885439|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
46670406|NCT02629393|82885439|FG000|Overall Study|Physician Decision|1|||
46670407|NCT02500797|82885471|FG000|Overall Study|Cancel (rapid disease progression)|0|||
46670408|NCT02500797|82885472|FG001|Overall Study|Cancel (rapid disease progression)|0|||
46670409|NCT02500797|82885473|FG002|Overall Study|Cancel (rapid disease progression)|0|||
46670410|NCT02500797|82885474|FG003|Overall Study|Cancel (rapid disease progression)|0|||
46670411|NCT02500797|82885475|FG004|Overall Study|Cancel (rapid disease progression)|1|||
46670412|NCT02500797|82885476|FG005|Overall Study|Cancel (rapid disease progression)|1|||
46670413|NCT02500797|82885477|FG006|Overall Study|Cancel (rapid disease progression)|0|||
46670414|NCT02500797|82885478|FG007|Overall Study|Cancel (rapid disease progression)|0|||
46670415|NCT02500797|82885471|FG000|Overall Study|Withdrawal by Subject|1|||
46670416|NCT02500797|82885472|FG001|Overall Study|Withdrawal by Subject|0|||
46670417|NCT02500797|82885473|FG002|Overall Study|Withdrawal by Subject|0|||
46670418|NCT02500797|82885474|FG003|Overall Study|Withdrawal by Subject|0|||
46670419|NCT02500797|82885475|FG004|Overall Study|Withdrawal by Subject|0|||
46670420|NCT02500797|82885476|FG005|Overall Study|Withdrawal by Subject|0|||
46670421|NCT02500797|82885477|FG006|Overall Study|Withdrawal by Subject|0|||
46670422|NCT02500797|82885478|FG007|Overall Study|Withdrawal by Subject|0|||
46670423|NCT02017704|82885511|FG000|Overall Study|Withdrawal by Subject|2|||
46670424|NCT02017704|82885512|FG001|Overall Study|Withdrawal by Subject|0|||
46670425|NCT02005471|82885522|FG000|Main Study|Adverse Event|0|||
46670426|NCT02005471|82885523|FG001|Main Study|Adverse Event|1|||
46670427|NCT02005471|82885524|FG002|Main Study|Adverse Event|0|||
46670428|NCT02005471|82885525|FG003|Main Study|Adverse Event|0|||
46670429|NCT02005471|82885522|FG000|Main Study|Death|83|||
46670430|NCT02005471|82885523|FG001|Main Study|Death|52|||
46670431|NCT02005471|82885524|FG002|Main Study|Death|0|||
46670432|NCT02005471|82885525|FG003|Main Study|Death|0|||
46670433|NCT02005471|82885522|FG000|Main Study|Lost to Follow-up|4|||
46670434|NCT02005471|82885523|FG001|Main Study|Lost to Follow-up|5|||
46670435|NCT02005471|82885524|FG002|Main Study|Lost to Follow-up|0|||
46670436|NCT02005471|82885525|FG003|Main Study|Lost to Follow-up|0|||
46670437|NCT02005471|82885522|FG000|Main Study|Physician Decision|3|||
46670438|NCT02005471|82885523|FG001|Main Study|Physician Decision|1|||
46670439|NCT02005471|82885524|FG002|Main Study|Physician Decision|0|||
46670440|NCT02005471|82885525|FG003|Main Study|Physician Decision|0|||
46670441|NCT02005471|82885522|FG000|Main Study|Withdrawal by Subject|26|||
46670442|NCT02005471|82885523|FG001|Main Study|Withdrawal by Subject|11|||
46670443|NCT02005471|82885524|FG002|Main Study|Withdrawal by Subject|0|||
46670444|NCT02005471|82885525|FG003|Main Study|Withdrawal by Subject|0|||
46670445|NCT02005471|82885522|FG000|Main Study|Reason not Specified|0|||
46670446|NCT02005471|82885523|FG001|Main Study|Reason not Specified|6|||
46670447|NCT02005471|82885524|FG002|Main Study|Reason not Specified|0|||
46670448|NCT02005471|82885525|FG003|Main Study|Reason not Specified|0|||
46670449|NCT02005471|82885522|FG000|Main Study|Randomized but not Dosed|8|||
46670450|NCT02005471|82885523|FG001|Main Study|Randomized but not Dosed|0|||
46670451|NCT02005471|82885524|FG002|Main Study|Randomized but not Dosed|0|||
46670452|NCT02005471|82885525|FG003|Main Study|Randomized but not Dosed|0|||
46670453|NCT02005471|82885522|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
46670454|NCT02005471|82885523|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
46670455|NCT02005471|82885524|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
46670456|NCT02005471|82885525|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
46670457|NCT02005471|82885522|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
46670458|NCT02005471|82885523|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
46670459|NCT02005471|82885524|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
46670460|NCT02005471|82885525|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
46670461|NCT02005471|82885522|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
46670462|NCT02005471|82885523|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
46670463|NCT02005471|82885524|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
46670464|NCT02005471|82885525|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
46670465|NCT01977651|82885536|FG000|4 Month Treatment Period|Adverse Event|34|||
46670466|NCT01977651|82885536|FG000|4 Month Treatment Period|Death|3|||
46670467|NCT01977651|82885536|FG000|4 Month Treatment Period|Progressive Disease|43|||
46670468|NCT01977651|82885536|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
46670469|NCT01977651|82885536|FG000|4 Month Treatment Period|Physician Decision|4|||
46670470|NCT01977651|82885536|FG000|1 Year Extension Period|Adverse Event|14|||
46670471|NCT01977651|82885536|FG000|1 Year Extension Period|Death|10|||
46670472|NCT01977651|82885536|FG000|1 Year Extension Period|Lost to Follow-up|2|||
46670473|NCT01977651|82885536|FG000|1 Year Extension Period|Progressive Disease|86|||
46670474|NCT01977651|82885536|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
46670475|NCT01977651|82885536|FG000|1 Year Extension Period|Physician Decision|6|||
46670476|NCT01977651|82885536|FG000|1 Year Extension Period|Miscellaneous|1|||
46670477|NCT01977651|82885536|FG000|Post 1 Year Extension Period|Adverse Event|5|||
46670478|NCT01977651|82885536|FG000|Post 1 Year Extension Period|Death|13|||
46670479|NCT01977651|82885536|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
46670480|NCT01977651|82885536|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
46670481|NCT01977651|82885536|FG000|Post 1 Year Extension Period|Physician Decision|4|||
46670482|NCT01977651|82885536|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
46670483|NCT01949311|82885540|FG000|Overall Study|Lost to Follow-up|73|||
46670484|NCT01949311|82885540|FG000|Overall Study|Terminated by Sponsor|708|||
46670485|NCT01949311|82885540|FG000|Overall Study|Withdrawal by Subject|375|||
46670486|NCT01949311|82885540|FG000|Overall Study|Lack of Efficacy|50|||
46670487|NCT01949311|82885540|FG000|Overall Study|Protocol Deviation|34|||
46670488|NCT01949311|82885540|FG000|Overall Study|Pregnancy|20|||
46670489|NCT01949311|82885540|FG000|Overall Study|Physician Decision|9|||
46670490|NCT01949311|82885540|FG000|Overall Study|Other|4|||
46670491|NCT01949311|82885540|FG000|Overall Study|Adverse Event|107|||
46670492|NCT01933932|82885547|FG000|Overall Study|Death|173|||
46670493|NCT01933932|82885548|FG001|Overall Study|Death|163|||
46670494|NCT01933932|82885547|FG000|Overall Study|Withdrawal by Subject|11|||
46670495|NCT01933932|82885548|FG001|Overall Study|Withdrawal by Subject|14|||
46670496|NCT01933932|82885547|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46670497|NCT01933932|82885548|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
46670498|NCT01698008|82885566|FG000|Overall Study|Withdrawal by Subject|1|||
46670499|NCT01698008|82885567|FG001|Overall Study|Withdrawal by Subject|2|||
46670500|NCT01622868|82885575|FG000|Overall Study|Protocol Violation|7|||
46670501|NCT01622868|82885576|FG001|Overall Study|Protocol Violation|0|||
46670502|NCT01208233|82885605|FG000|Overall Study|Adverse Event|0|||
46670503|NCT01208233|82885606|FG001|Overall Study|Adverse Event|1|||
46670504|NCT01208233|82885607|FG002|Overall Study|Adverse Event|2|||
46670505|NCT01208233|82885608|FG003|Overall Study|Adverse Event|0|||
46670506|NCT01208233|82885609|FG004|Overall Study|Adverse Event|3|||
46670507|NCT01208233|82885610|FG005|Overall Study|Adverse Event|5|||
46670508|NCT01208233|82885605|FG000|Overall Study|Death|0|||
46670509|NCT01208233|82885606|FG001|Overall Study|Death|0|||
46670510|NCT01208233|82885607|FG002|Overall Study|Death|0|||
46670511|NCT01208233|82885608|FG003|Overall Study|Death|0|||
46670512|NCT01208233|82885609|FG004|Overall Study|Death|3|||
46670513|NCT01208233|82885610|FG005|Overall Study|Death|5|||
46670514|NCT01208233|82885605|FG000|Overall Study|Did not meet entrance criteria|2|||
46670515|NCT01208233|82885606|FG001|Overall Study|Did not meet entrance criteria|1|||
46670516|NCT01208233|82885607|FG002|Overall Study|Did not meet entrance criteria|1|||
46670517|NCT01208233|82885608|FG003|Overall Study|Did not meet entrance criteria|0|||
46670518|NCT01208233|82885609|FG004|Overall Study|Did not meet entrance criteria|1|||
46670519|NCT01208233|82885610|FG005|Overall Study|Did not meet entrance criteria|0|||
46670520|NCT01208233|82885605|FG000|Overall Study|Medication error without adverse event|0|||
46851556|NCT03571204|83067147|FG002|Overall Study|Physician Decision|0|||
46851557|NCT03569098|83067159|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
46851558|NCT03569098|83067160|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
46851559|NCT03569098|83067161|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
46972825|NCT01992094|83216555|FG001|Overall Study|Withdrawal by Subject|3|||
47077304|NCT02440581|83376522|FG001|Overall Study|Withdrawal by Subject|11|||
47077305|NCT02440581|83376523|FG002|Overall Study|Withdrawal by Subject|3|||
47077306|NCT02440581|83376524|FG003|Overall Study|Withdrawal by Subject|7|||
47077307|NCT01359150|83376536|FG000|Overall Study|Lack of Efficacy|1|||
46670521|NCT01208233|82885606|FG001|Overall Study|Medication error without adverse event|0|||
46670522|NCT01208233|82885607|FG002|Overall Study|Medication error without adverse event|0|||
46670523|NCT01208233|82885608|FG003|Overall Study|Medication error without adverse event|0|||
46670524|NCT01208233|82885609|FG004|Overall Study|Medication error without adverse event|0|||
46670525|NCT01208233|82885610|FG005|Overall Study|Medication error without adverse event|1|||
47077308|NCT01359150|83376537|FG001|Overall Study|Lack of Efficacy|1|||
46670526|NCT01208233|82885605|FG000|Overall Study|Study terminated by sponsor|0|||
46670527|NCT01208233|82885606|FG001|Overall Study|Study terminated by sponsor|0|||
46670528|NCT01208233|82885607|FG002|Overall Study|Study terminated by sponsor|0|||
46670529|NCT01208233|82885608|FG003|Overall Study|Study terminated by sponsor|0|||
46670530|NCT01208233|82885609|FG004|Overall Study|Study terminated by sponsor|10|||
46670531|NCT01208233|82885610|FG005|Overall Study|Study terminated by sponsor|7|||
46670532|NCT01208233|82885605|FG000|Overall Study|Protocol Violation|0|||
46670533|NCT01208233|82885606|FG001|Overall Study|Protocol Violation|0|||
46670534|NCT01208233|82885607|FG002|Overall Study|Protocol Violation|0|||
46670535|NCT01208233|82885608|FG003|Overall Study|Protocol Violation|0|||
46670536|NCT01208233|82885609|FG004|Overall Study|Protocol Violation|3|||
46670537|NCT01208233|82885610|FG005|Overall Study|Protocol Violation|0|||
46670538|NCT01208233|82885605|FG000|Overall Study|Other|2|||
46670539|NCT01208233|82885606|FG001|Overall Study|Other|1|||
46670540|NCT01208233|82885607|FG002|Overall Study|Other|0|||
46670541|NCT01208233|82885608|FG003|Overall Study|Other|0|||
46670542|NCT01208233|82885609|FG004|Overall Study|Other|0|||
46670543|NCT01208233|82885610|FG005|Overall Study|Other|1|||
46670544|NCT01208233|82885605|FG000|Overall Study|Withdrawal by Subject|1|||
46670545|NCT01208233|82885606|FG001|Overall Study|Withdrawal by Subject|0|||
46670546|NCT01208233|82885607|FG002|Overall Study|Withdrawal by Subject|1|||
46670547|NCT01208233|82885608|FG003|Overall Study|Withdrawal by Subject|1|||
46670548|NCT01208233|82885609|FG004|Overall Study|Withdrawal by Subject|4|||
46670549|NCT01208233|82885610|FG005|Overall Study|Withdrawal by Subject|2|||
46670550|NCT01208038|82885630|FG000|Overall Study|Withdrawal by Subject|1|||
46670551|NCT01207687|82885634|FG000|Overall Study|Adverse Event|1|||
46670552|NCT01207687|82885634|FG000|Overall Study|Withdrawal by Subject|1|||
46670553|NCT01207453|82885646|FG000|First Intervention|Adverse Event|2|||
46670554|NCT01207453|82885647|FG001|First Intervention|Adverse Event|1|||
46670555|NCT01207453|82885646|FG000|Washout|Adverse Event|1|||
46670556|NCT01207453|82885647|FG001|Washout|Adverse Event|0|||
46670557|NCT01207453|82885646|FG000|Washout|Lost to Follow-up|1|||
46670558|NCT01207453|82885647|FG001|Washout|Lost to Follow-up|0|||
46670559|NCT01207453|82885646|FG000|2nd Intervention|Adverse Event|1|||
46670560|NCT01207453|82885647|FG001|2nd Intervention|Adverse Event|2|||
46670561|NCT01207453|82885646|FG000|2nd Intervention|Lost to Follow-up|1|||
46670562|NCT01207453|82885647|FG001|2nd Intervention|Lost to Follow-up|0|||
46670563|NCT01207414|82885658|FG000|Overall Study|Adverse Event|25|||
46670564|NCT01207414|82885659|FG001|Overall Study|Adverse Event|39|||
46670565|NCT01207414|82885658|FG000|Overall Study|Abnormal test procedure results|0|||
46670566|NCT01207414|82885659|FG001|Overall Study|Abnormal test procedure results|1|||
46670567|NCT01207414|82885658|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
46670568|NCT01207414|82885659|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
46670569|NCT01207414|82885658|FG000|Overall Study|Patient withdrew consent|14|||
46670570|NCT01207414|82885659|FG001|Overall Study|Patient withdrew consent|11|||
46670571|NCT01207414|82885658|FG000|Overall Study|Lost to Follow-up|15|||
46670572|NCT01207414|82885659|FG001|Overall Study|Lost to Follow-up|17|||
46670573|NCT01207414|82885658|FG000|Overall Study|Administrative problems|1|||
46670574|NCT01207414|82885659|FG001|Overall Study|Administrative problems|1|||
46670575|NCT01207414|82885658|FG000|Overall Study|Protocol deviation|12|||
46670576|NCT01207414|82885659|FG001|Overall Study|Protocol deviation|9|||
46670577|NCT01207414|82885658|FG000|Overall Study|Randomized in error|1|||
46670578|NCT01207414|82885659|FG001|Overall Study|Randomized in error|0|||
46670579|NCT01207219|82885668|FG000|Overall Study|changed diagnosis during study period|5|||
46670580|NCT01207219|82885669|FG001|Overall Study|changed diagnosis during study period|3|||
46670581|NCT01207219|82885670|FG002|Overall Study|changed diagnosis during study period|1|||
46786223|NCT03827395|83005315|FG001|Overall Study|Lost to Follow-up|0|||
46972826|NCT01992094|83216556|FG002|Overall Study|Withdrawal by Subject|4|||
46972827|NCT02706691|83216580|FG000|Overall Study|Adverse Event|1|||
46972828|NCT01991470|83216585|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
46670582|NCT01207219|82885668|FG000|Overall Study|Lost to Follow-up|6|||
46670583|NCT01207219|82885669|FG001|Overall Study|Lost to Follow-up|8|||
46670584|NCT01207219|82885670|FG002|Overall Study|Lost to Follow-up|6|||
46670585|NCT01206517|82885684|FG000|Overall Study|Withdrawal by Subject|0|||
46670586|NCT01206517|82885685|FG001|Overall Study|Withdrawal by Subject|0|||
46670587|NCT01206517|82885686|FG002|Overall Study|Withdrawal by Subject|2|||
46670588|NCT01206517|82885687|FG003|Overall Study|Withdrawal by Subject|0|||
46670589|NCT01206517|82885688|FG004|Overall Study|Withdrawal by Subject|1|||
46786224|NCT03827395|83005314|FG000|Overall Study|Protocol Violation|1|||
46670590|NCT01206517|82885689|FG005|Overall Study|Withdrawal by Subject|0|||
46670591|NCT01206439|82885700|FG000|Overall Study|subject did not meet inclusion criteria|1|||
46670592|NCT01206322|82885706|FG000|Overall Study|Adverse Event|0|||
46670593|NCT01206322|82885707|FG001|Overall Study|Adverse Event|0|||
46670594|NCT01206322|82885708|FG002|Overall Study|Adverse Event|0|||
46786225|NCT03827395|83005315|FG001|Overall Study|Protocol Violation|0|||
46972829|NCT01991470|83216585|FG000|Enlite 1 Period|Adverse Event|1|||
46972830|NCT01991470|83216585|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
46670595|NCT01206322|82885709|FG003|Overall Study|Adverse Event|1|||
46670596|NCT01206166|82885721|FG000|Overall Study|No evaluable data|2|||
46670597|NCT01206166|82885722|FG001|Overall Study|No evaluable data|3|||
46670598|NCT01207102|82885731|FG000|Overall Study|Withdrawal by Subject|5|||
46670599|NCT01207102|82885731|FG000|Overall Study|Adverse Event|2|||
46670600|NCT01207102|82885731|FG000|Overall Study|progression|2|||
46670601|NCT01207102|82885731|FG000|Overall Study|Withdrawal by Treating Physician|1|||
46670602|NCT01205776|82885747|FG000|Overall Study|Lost to Follow-up|53|||
46670603|NCT01205776|82885748|FG001|Overall Study|Lost to Follow-up|61|||
46670604|NCT01205776|82885747|FG000|Overall Study|Withdrawal by Subject|11|||
46670605|NCT01205776|82885748|FG001|Overall Study|Withdrawal by Subject|34|||
46670606|NCT01205581|82885760|FG000|Overall Study|Withdrawal by Subject|1|||
46670607|NCT01205581|82885761|FG001|Overall Study|Withdrawal by Subject|0|||
46670608|NCT01205581|82885762|FG002|Overall Study|Withdrawal by Subject|0|||
46670609|NCT01205581|82885763|FG003|Overall Study|Withdrawal by Subject|0|||
46670610|NCT01205581|82885764|FG004|Overall Study|Withdrawal by Subject|0|||
46670611|NCT01205581|82885765|FG005|Overall Study|Withdrawal by Subject|0|||
46972831|NCT01991470|83216585|FG000|Enlite 3 Period|Lost to Follow-up|1|||
46972832|NCT01991470|83216585|FG000|Enlite 3 Period|Physician Decision|2|||
46972833|NCT01991470|83216585|FG000|Enlite 3 Period|Physician Decision|8|||
46972834|NCT01991470|83216585|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
46972835|NCT01991314|83216599|FG000|Overall Study|Adverse Event|5|||
46972836|NCT01991314|83216600|FG001|Overall Study|Adverse Event|1|||
46972837|NCT01991314|83216599|FG000|Overall Study|Lost to Follow-up|6|||
46786226|NCT03827395|83005314|FG000|Overall Study|Became ineligible after enrollment|1|||
46786227|NCT03827395|83005315|FG001|Overall Study|Became ineligible after enrollment|2|||
46786228|NCT00655980|83005324|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
46786229|NCT00655980|83005325|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
46786230|NCT00655980|83005326|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
46786231|NCT00679172|83005342|FG000|Overall Study|Non-compliance|1|||
46786232|NCT00679172|83005343|FG001|Overall Study|Non-compliance|1|||
46786233|NCT00679172|83005344|FG002|Overall Study|Non-compliance|0|||
46786234|NCT00679172|83005345|FG003|Overall Study|Non-compliance|1|||
46786235|NCT00679172|83005346|FG004|Overall Study|Non-compliance|0|||
46786236|NCT00679172|83005342|FG000|Overall Study|Other not specified|0|||
46786237|NCT00679172|83005343|FG001|Overall Study|Other not specified|0|||
46972838|NCT01991314|83216600|FG001|Overall Study|Lost to Follow-up|10|||
46972839|NCT01990768|83216609|FG000|Intervention Started|Found to be ineligible|14|||
46972840|NCT01990768|83216610|FG001|Intervention Started|Found to be ineligible|13|||
46972841|NCT01990768|83216611|FG002|Intervention Started|Found to be ineligible|11|||
46972842|NCT01990768|83216609|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
46972843|NCT01990768|83216610|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
46972844|NCT01990768|83216611|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
46972845|NCT01990768|83216609|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
46972846|NCT01990768|83216610|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
46670612|NCT01205269|82885796|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
46670613|NCT01205269|82885797|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
46670614|NCT01205269|82885798|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
46670615|NCT01205269|82885799|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
46670616|NCT01205269|82885800|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
46670617|NCT01205269|82885801|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
46670618|NCT01240915|82885826|FG000|Overall Study|Adverse Event|0|||
46670619|NCT01240915|82885827|FG001|Overall Study|Adverse Event|0|||
46670620|NCT01240915|82885828|FG002|Overall Study|Adverse Event|0|||
46670621|NCT01240915|82885829|FG003|Overall Study|Adverse Event|1|||
46670622|NCT01240915|82885830|FG004|Overall Study|Adverse Event|0|||
46670623|NCT01240915|82885831|FG005|Overall Study|Adverse Event|2|||
46670624|NCT01240915|82885832|FG006|Overall Study|Adverse Event|0|||
46670625|NCT01240915|82885833|FG007|Overall Study|Adverse Event|0|||
46670626|NCT01240915|82885834|FG008|Overall Study|Adverse Event|1|||
46670627|NCT01240915|82885826|FG000|Overall Study|Lost to Follow-up|0|||
46670628|NCT01240915|82885827|FG001|Overall Study|Lost to Follow-up|0|||
46670629|NCT01240915|82885828|FG002|Overall Study|Lost to Follow-up|0|||
46670630|NCT01240915|82885829|FG003|Overall Study|Lost to Follow-up|0|||
46670631|NCT01240915|82885830|FG004|Overall Study|Lost to Follow-up|1|||
46670632|NCT01240915|82885831|FG005|Overall Study|Lost to Follow-up|1|||
46972847|NCT01990768|83216611|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
46670633|NCT01240915|82885832|FG006|Overall Study|Lost to Follow-up|0|||
46670634|NCT01240915|82885833|FG007|Overall Study|Lost to Follow-up|1|||
46670635|NCT01240915|82885834|FG008|Overall Study|Lost to Follow-up|1|||
46670636|NCT01240915|82885826|FG000|Overall Study|Withdrawal by Subject|2|||
46670637|NCT01240915|82885827|FG001|Overall Study|Withdrawal by Subject|1|||
46786238|NCT00679172|83005344|FG002|Overall Study|Other not specified|1|||
46972848|NCT01990768|83216609|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
46670638|NCT01240915|82885828|FG002|Overall Study|Withdrawal by Subject|0|||
46670639|NCT01240915|82885829|FG003|Overall Study|Withdrawal by Subject|2|||
46786239|NCT00679172|83005345|FG003|Overall Study|Other not specified|0|||
46670640|NCT01240915|82885830|FG004|Overall Study|Withdrawal by Subject|0|||
46670641|NCT01240915|82885831|FG005|Overall Study|Withdrawal by Subject|4|||
46670642|NCT01240915|82885832|FG006|Overall Study|Withdrawal by Subject|2|||
46670643|NCT01240915|82885833|FG007|Overall Study|Withdrawal by Subject|3|||
46670644|NCT01240915|82885834|FG008|Overall Study|Withdrawal by Subject|3|||
46670645|NCT01240915|82885826|FG000|Overall Study|Other|0|||
46670646|NCT01240915|82885827|FG001|Overall Study|Other|0|||
46670647|NCT01240915|82885828|FG002|Overall Study|Other|0|||
46670648|NCT01240915|82885829|FG003|Overall Study|Other|0|||
46670649|NCT01240915|82885830|FG004|Overall Study|Other|2|||
46670650|NCT01240915|82885831|FG005|Overall Study|Other|0|||
46670651|NCT01240915|82885832|FG006|Overall Study|Other|0|||
46670652|NCT01240915|82885833|FG007|Overall Study|Other|0|||
46670653|NCT01240915|82885834|FG008|Overall Study|Other|0|||
46670654|NCT01240915|82885826|FG000|Overall Study|Insufficient Clinical Response|0|||
46670655|NCT01240915|82885827|FG001|Overall Study|Insufficient Clinical Response|0|||
46670656|NCT01240915|82885828|FG002|Overall Study|Insufficient Clinical Response|0|||
46670657|NCT01240915|82885829|FG003|Overall Study|Insufficient Clinical Response|0|||
46670658|NCT01240915|82885830|FG004|Overall Study|Insufficient Clinical Response|1|||
46670659|NCT01240915|82885831|FG005|Overall Study|Insufficient Clinical Response|3|||
46670660|NCT01240915|82885832|FG006|Overall Study|Insufficient Clinical Response|6|||
46670661|NCT01240915|82885833|FG007|Overall Study|Insufficient Clinical Response|0|||
46670662|NCT01240915|82885834|FG008|Overall Study|Insufficient Clinical Response|3|||
46670663|NCT01239745|82885856|FG000|Overall Study|Study terminated by sponsor|45|||
46670664|NCT01239745|82885856|FG000|Overall Study|Adverse Event|1|||
46670665|NCT01239472|82885862|FG000|Overall Study|Withdrawal by Subject|5|||
46670666|NCT01239472|82885863|FG001|Overall Study|Withdrawal by Subject|1|||
46670667|NCT01239472|82885862|FG000|Overall Study|Adverse Event|0|||
46670668|NCT01239472|82885863|FG001|Overall Study|Adverse Event|1|||
46670669|NCT01239472|82885862|FG000|Overall Study|Lack of Efficacy|0|||
46670670|NCT01239472|82885863|FG001|Overall Study|Lack of Efficacy|1|||
46670671|NCT01229449|82885876|FG000|Overall Study|Withdrawal by Subject|0|||
46670672|NCT01229449|82885877|FG001|Overall Study|Withdrawal by Subject|3|||
46670673|NCT01229449|82885878|FG002|Overall Study|Withdrawal by Subject|0|||
46670674|NCT01229449|82885879|FG003|Overall Study|Withdrawal by Subject|1|||
46670675|NCT01229449|82885880|FG004|Overall Study|Withdrawal by Subject|1|||
46670676|NCT01229449|82885876|FG000|Overall Study|Lost to Follow-up|1|||
46670677|NCT01229449|82885877|FG001|Overall Study|Lost to Follow-up|1|||
46670678|NCT01229449|82885878|FG002|Overall Study|Lost to Follow-up|1|||
46670679|NCT01229449|82885879|FG003|Overall Study|Lost to Follow-up|0|||
46670680|NCT01229449|82885880|FG004|Overall Study|Lost to Follow-up|0|||
46670681|NCT01229449|82885876|FG000|Overall Study|Physician Decision|0|||
46670682|NCT01229449|82885877|FG001|Overall Study|Physician Decision|0|||
46670683|NCT01229449|82885878|FG002|Overall Study|Physician Decision|1|||
46670684|NCT01229449|82885879|FG003|Overall Study|Physician Decision|0|||
46670685|NCT01229449|82885880|FG004|Overall Study|Physician Decision|0|||
46670686|NCT01239316|82885892|FG000|Overall Study|Progression/Relapse|11|||
46972849|NCT01990768|83216610|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
46972850|NCT01990768|83216611|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
46972851|NCT01990768|83216609|FG000|Intervention Started|Patient care priority|1|||
46972852|NCT01990768|83216610|FG001|Intervention Started|Patient care priority|2|||
46972853|NCT01990768|83216611|FG002|Intervention Started|Patient care priority|3|||
46670687|NCT01239316|82885892|FG000|Overall Study|Adverse Event|1|||
46670688|NCT01239160|82885898|FG000|Overall Study|Lost to Follow-up|3|||
46670689|NCT01239160|82885899|FG001|Overall Study|Lost to Follow-up|5|||
46670690|NCT01239160|82885900|FG002|Overall Study|Lost to Follow-up|0|||
46670691|NCT01239160|82885898|FG000|Overall Study|Withdrawal by Subject|17|||
46670692|NCT01239160|82885899|FG001|Overall Study|Withdrawal by Subject|6|||
46670693|NCT01239160|82885900|FG002|Overall Study|Withdrawal by Subject|2|||
46670694|NCT01239160|82885898|FG000|Overall Study|Physician Decision|5|||
46670695|NCT01239160|82885899|FG001|Overall Study|Physician Decision|7|||
46670696|NCT01239160|82885900|FG002|Overall Study|Physician Decision|2|||
46670697|NCT01239160|82885898|FG000|Overall Study|Early Termination Due to Study Closure|0|||
46670698|NCT01239160|82885899|FG001|Overall Study|Early Termination Due to Study Closure|1|||
46670699|NCT01239160|82885900|FG002|Overall Study|Early Termination Due to Study Closure|6|||
46670700|NCT01239121|82885909|FG000|Overall Study|Withdrawal by Subject|2|||
46670701|NCT01239121|82885910|FG001|Overall Study|Withdrawal by Subject|4|||
46670702|NCT01239121|82885911|FG002|Overall Study|Withdrawal by Subject|0|||
46670703|NCT01239043|82885921|FG000|Overall Study|Protocol Violation|2|||
46670704|NCT01239043|82885922|FG001|Overall Study|Protocol Violation|1|||
46670705|NCT01238848|82885930|FG000|Overall Study|Physician Decision|13|||
46670706|NCT01238848|82885931|FG001|Overall Study|Physician Decision|5|||
46972854|NCT01990768|83216609|FG000|Intervention Started|IV lost|2|||
46670707|NCT01238575|82885939|FG000|Overall Study|Lack of Efficacy|2|||
46786240|NCT00679172|83005346|FG004|Overall Study|Other not specified|0|||
46972855|NCT01990768|83216610|FG001|Intervention Started|IV lost|2|||
46670708|NCT01238575|82885940|FG001|Overall Study|Lack of Efficacy|4|||
46670709|NCT01238575|82885939|FG000|Overall Study|Adverse Event|2|||
46670710|NCT01238575|82885940|FG001|Overall Study|Adverse Event|0|||
46670711|NCT05376215|82885948|FG000|Overall Study|Withdrawal by Subject|2|||
46670712|NCT05376215|82885949|FG001|Overall Study|Withdrawal by Subject|1|||
46670713|NCT05376215|82885948|FG000|Overall Study|Lost to Follow-up|0|||
46670714|NCT05376215|82885949|FG001|Overall Study|Lost to Follow-up|1|||
46670715|NCT04447794|82885978|FG000|Overall Study|Lost to Follow-up|2|||
46670716|NCT04447794|82885979|FG001|Overall Study|Lost to Follow-up|3|||
46670717|NCT04447794|82885980|FG002|Overall Study|Lost to Follow-up|8|||
46670718|NCT04447794|82885978|FG000|Overall Study|Withdrawal by Subject|1|||
46670719|NCT04447794|82885979|FG001|Overall Study|Withdrawal by Subject|1|||
46670720|NCT04447794|82885980|FG002|Overall Study|Withdrawal by Subject|0|||
46670721|NCT04138576|82885993|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
46670722|NCT04009291|82886007|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
46670723|NCT04009291|82886008|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
46670724|NCT04009291|82886009|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
46670725|NCT04009291|82886010|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
46670726|NCT04009291|82886011|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
46670727|NCT04009291|82886007|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
46670728|NCT04009291|82886008|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
46670729|NCT04009291|82886009|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
46670730|NCT04009291|82886010|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
46670731|NCT04009291|82886011|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
46670732|NCT03811340|82886022|FG000|Overall Study|subjects did not complete the survey.|90|||
46670733|NCT03668119|82886037|FG000|Pre-treatment|Disease Progression|1|||
46670734|NCT03668119|82886038|FG001|Pre-treatment|Disease Progression|0|||
46670735|NCT03668119|82886037|FG000|Treatment|Disease Progression|75|||
46670736|NCT03668119|82886038|FG001|Treatment|Disease Progression|55|||
46670737|NCT03668119|82886037|FG000|Treatment|Study drug toxicity|19|||
46670738|NCT03668119|82886038|FG001|Treatment|Study drug toxicity|1|||
46670739|NCT03668119|82886037|FG000|Treatment|Death|3|||
46670740|NCT03668119|82886038|FG001|Treatment|Death|0|||
46670741|NCT03668119|82886037|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
46670742|NCT03668119|82886038|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
46670743|NCT03668119|82886037|FG000|Treatment|Withdrawal by Subject|2|||
46670744|NCT03668119|82886038|FG001|Treatment|Withdrawal by Subject|1|||
46670745|NCT03668119|82886037|FG000|Treatment|Participant request to discontinue study treatment|3|||
46670746|NCT03668119|82886038|FG001|Treatment|Participant request to discontinue study treatment|1|||
46670747|NCT03668119|82886037|FG000|Treatment|Maximum Clinical Benefit|0|||
46670748|NCT03668119|82886038|FG001|Treatment|Maximum Clinical Benefit|1|||
46670749|NCT03668119|82886037|FG000|Treatment|Participants completed treatment|20|||
46670750|NCT03668119|82886038|FG001|Treatment|Participants completed treatment|8|||
46670751|NCT03668119|82886037|FG000|Treatment|Other reasons|1|||
46670752|NCT03668119|82886038|FG001|Treatment|Other reasons|2|||
46670753|NCT03224819|82886064|FG000|Overall Study|Withdrawal by Subject|0|||
46670754|NCT03224819|82886065|FG001|Overall Study|Withdrawal by Subject|0|||
46670755|NCT03224819|82886066|FG002|Overall Study|Withdrawal by Subject|0|||
46670756|NCT03224819|82886067|FG003|Overall Study|Withdrawal by Subject|0|||
46670757|NCT03224819|82886068|FG004|Overall Study|Withdrawal by Subject|0|||
46670758|NCT03224819|82886069|FG005|Overall Study|Withdrawal by Subject|0|||
46670759|NCT03224819|82886070|FG006|Overall Study|Withdrawal by Subject|0|||
46670760|NCT03224819|82886071|FG007|Overall Study|Withdrawal by Subject|0|||
46670761|NCT03224819|82886072|FG008|Overall Study|Withdrawal by Subject|0|||
46670762|NCT03224819|82886073|FG009|Overall Study|Withdrawal by Subject|0|||
46670763|NCT03224819|82886074|FG010|Overall Study|Withdrawal by Subject|0|||
46670764|NCT03224819|82886075|FG011|Overall Study|Withdrawal by Subject|0|||
46670765|NCT03224819|82886076|FG012|Overall Study|Withdrawal by Subject|1|||
46670766|NCT03224819|82886077|FG013|Overall Study|Withdrawal by Subject|0|||
46670767|NCT03224819|82886064|FG000|Overall Study|Sponsor Decision|0|||
46670768|NCT03224819|82886065|FG001|Overall Study|Sponsor Decision|0|||
46670769|NCT03224819|82886066|FG002|Overall Study|Sponsor Decision|0|||
46670770|NCT03224819|82886067|FG003|Overall Study|Sponsor Decision|1|||
46670771|NCT03224819|82886068|FG004|Overall Study|Sponsor Decision|1|||
46670772|NCT03224819|82886069|FG005|Overall Study|Sponsor Decision|2|||
46670773|NCT03224819|82886070|FG006|Overall Study|Sponsor Decision|1|||
46670774|NCT03224819|82886071|FG007|Overall Study|Sponsor Decision|1|||
46670775|NCT03224819|82886072|FG008|Overall Study|Sponsor Decision|1|||
46670776|NCT03224819|82886073|FG009|Overall Study|Sponsor Decision|2|||
46670777|NCT03224819|82886074|FG010|Overall Study|Sponsor Decision|1|||
46670778|NCT03224819|82886075|FG011|Overall Study|Sponsor Decision|1|||
46670779|NCT03224819|82886076|FG012|Overall Study|Sponsor Decision|1|||
46670780|NCT03224819|82886077|FG013|Overall Study|Sponsor Decision|0|||
46670781|NCT03224819|82886064|FG000|Overall Study|Lost to Follow-up|0|||
46670782|NCT03224819|82886065|FG001|Overall Study|Lost to Follow-up|0|||
46670783|NCT03224819|82886066|FG002|Overall Study|Lost to Follow-up|0|||
46670784|NCT03224819|82886067|FG003|Overall Study|Lost to Follow-up|0|||
46670785|NCT03224819|82886068|FG004|Overall Study|Lost to Follow-up|0|||
46972856|NCT01990768|83216611|FG002|Intervention Started|IV lost|2|||
46972857|NCT01990768|83216609|FG000|Intervention Started|Required CPR|1|||
46972858|NCT01990768|83216610|FG001|Intervention Started|Required CPR|1|||
46670786|NCT03224819|82886069|FG005|Overall Study|Lost to Follow-up|0|||
46670787|NCT03224819|82886070|FG006|Overall Study|Lost to Follow-up|0|||
46670788|NCT03224819|82886071|FG007|Overall Study|Lost to Follow-up|0|||
46670789|NCT03224819|82886072|FG008|Overall Study|Lost to Follow-up|1|||
46670790|NCT03224819|82886073|FG009|Overall Study|Lost to Follow-up|0|||
46670791|NCT03224819|82886074|FG010|Overall Study|Lost to Follow-up|0|||
46670792|NCT03224819|82886075|FG011|Overall Study|Lost to Follow-up|0|||
46670793|NCT03224819|82886076|FG012|Overall Study|Lost to Follow-up|0|||
46670794|NCT03224819|82886077|FG013|Overall Study|Lost to Follow-up|0|||
46670795|NCT03224819|82886064|FG000|Overall Study|Death|0|||
46670796|NCT03224819|82886065|FG001|Overall Study|Death|1|||
46670797|NCT03224819|82886066|FG002|Overall Study|Death|0|||
46670798|NCT03224819|82886067|FG003|Overall Study|Death|0|||
46670799|NCT03224819|82886068|FG004|Overall Study|Death|0|||
46670800|NCT03224819|82886069|FG005|Overall Study|Death|0|||
46670801|NCT03224819|82886070|FG006|Overall Study|Death|0|||
46670802|NCT03224819|82886071|FG007|Overall Study|Death|1|||
46670803|NCT03224819|82886072|FG008|Overall Study|Death|0|||
46670804|NCT03224819|82886073|FG009|Overall Study|Death|0|||
46670805|NCT03224819|82886074|FG010|Overall Study|Death|0|||
46670806|NCT03224819|82886075|FG011|Overall Study|Death|1|||
46670807|NCT03224819|82886076|FG012|Overall Study|Death|0|||
46670808|NCT03224819|82886077|FG013|Overall Study|Death|0|||
46670809|NCT02549573|82886120|FG000|Overall Study|Withdrawal by Subject|0|||
46670810|NCT02549573|82886121|FG001|Overall Study|Withdrawal by Subject|2|||
46670811|NCT02549573|82886120|FG000|Overall Study|Protocol Violation|0|||
46670812|NCT02549573|82886121|FG001|Overall Study|Protocol Violation|1|||
46670813|NCT02378181|82886129|FG000|Overall Study|Lost to Follow-up|2|||
46670814|NCT02378181|82886130|FG001|Overall Study|Lost to Follow-up|5|||
46670815|NCT02378181|82886129|FG000|Overall Study|Withdrawal by Subject|1|||
46670816|NCT02378181|82886130|FG001|Overall Study|Withdrawal by Subject|1|||
46670817|NCT02378181|82886129|FG000|Overall Study|Incarcerated|0|||
46670818|NCT02378181|82886130|FG001|Overall Study|Incarcerated|1|||
46670819|NCT02201108|82886138|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
46670820|NCT02201108|82886139|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
46670821|NCT02201108|82886138|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
46670822|NCT02201108|82886139|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
46670823|NCT02201108|82886138|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
46670824|NCT02201108|82886139|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
46670825|NCT02201108|82886138|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
46670826|NCT02201108|82886139|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
46670827|NCT02201108|82886138|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
46670828|NCT02201108|82886139|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
46972859|NCT01990768|83216611|FG002|Intervention Started|Required CPR|0|||
46972860|NCT01990768|83216609|FG000|Intervention Started|Seizure or hx of seizure|0|||
46972861|NCT01990768|83216610|FG001|Intervention Started|Seizure or hx of seizure|0|||
46972862|NCT01990768|83216611|FG002|Intervention Started|Seizure or hx of seizure|2|||
46972863|NCT01990768|83216609|FG000|Intervention Started|Discovered to be pregnant|0|||
46972864|NCT01990768|83216610|FG001|Intervention Started|Discovered to be pregnant|1|||
46972865|NCT01990768|83216611|FG002|Intervention Started|Discovered to be pregnant|0|||
46670829|NCT02201108|82886138|FG000|Open Label Period (up to Week 192)|Other reason|4|||
46670830|NCT02201108|82886139|FG001|Open Label Period (up to Week 192)|Other reason|7|||
46670831|NCT02201108|82886138|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
46851560|NCT03569098|83067159|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
46851561|NCT03569098|83067160|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
46851562|NCT03569098|83067161|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
46851563|NCT03569098|83067159|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
46851564|NCT03569098|83067160|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
46851565|NCT03569098|83067161|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
46851566|NCT03569098|83067159|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
46851567|NCT03569098|83067160|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
46851568|NCT03569098|83067161|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
46851569|NCT03569098|83067159|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
46851570|NCT03569098|83067160|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
46851571|NCT03569098|83067161|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
46972866|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
46972867|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
46670832|NCT02201108|82886139|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
46670833|NCT02180243|82886160|FG000|Overall Study|Withdrawal by Subject|12|||
46670834|NCT02180243|82886161|FG001|Overall Study|Withdrawal by Subject|12|||
46786241|NCT00676130|83005363|FG000|Overall Study|Lost to Follow-up|0|||
46786242|NCT00676130|83005364|FG001|Overall Study|Lost to Follow-up|1|||
46670835|NCT02180243|82886160|FG000|Overall Study|Lost to Follow-up|12|||
46670836|NCT02180243|82886161|FG001|Overall Study|Lost to Follow-up|2|||
46670837|NCT01772563|82886168|FG000|Cycle 1|Dose limiting toxicity|2|||
46670838|NCT01772563|82886168|FG000|Cycle 1|Progressive disease|2|||
46670839|NCT01772563|82886168|FG000|Cycle 2 and Beyond|Progressive disease|17|||
46670840|NCT01772563|82886168|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
46670841|NCT01772563|82886168|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
46670842|NCT01445171|82886174|FG000|Overall Study|Lost to Follow-up|11|||
46670843|NCT01445171|82886174|FG000|Overall Study|Withdrawal by Subject|16|||
46670844|NCT01445171|82886174|FG000|Overall Study|Death|51|||
46670845|NCT01445171|82886174|FG000|Overall Study|Subjects declined to return for followup|9|||
47077309|NCT01359150|83376536|FG000|Overall Study|Withdrawal by Subject|1|||
47077310|NCT01359150|83376537|FG001|Overall Study|Withdrawal by Subject|1|||
47077311|NCT01359150|83376536|FG000|Overall Study|Adverse Event|4|||
47077312|NCT01359150|83376537|FG001|Overall Study|Adverse Event|3|||
47077313|NCT01359150|83376536|FG000|Overall Study|Other|1|||
47077314|NCT01359150|83376537|FG001|Overall Study|Other|0|||
46670846|NCT01445171|82886174|FG000|Overall Study|Consented but did not receive device|8|||
46670847|NCT01237951|82886180|FG000|Overall Study|Death|1|||
46670848|NCT01239394|82886184|FG000|Overall Study|Adverse Event|1|||
46670849|NCT01237678|82886191|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
46670850|NCT01237678|82886192|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
46670851|NCT01237678|82886193|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
46670852|NCT01237678|82886191|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
46670853|NCT01237678|82886192|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
46670854|NCT01237678|82886193|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
46670855|NCT01237678|82886191|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
46670856|NCT01237678|82886192|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
46670857|NCT01237678|82886193|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
46670858|NCT01237678|82886191|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
46670859|NCT01237678|82886192|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
46670860|NCT01237678|82886193|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
46670861|NCT01237678|82886191|FG000|Phase II|Adverse Event|0|||
46670862|NCT01237678|82886192|FG001|Phase II|Adverse Event|39|||
46670863|NCT01237678|82886193|FG002|Phase II|Adverse Event|9|||
46670864|NCT01237678|82886191|FG000|Phase II|Death|0|||
46670865|NCT01237678|82886192|FG001|Phase II|Death|0|||
46670866|NCT01237678|82886193|FG002|Phase II|Death|2|||
46670867|NCT01237678|82886191|FG000|Phase II|Lack of Efficacy|0|||
46670868|NCT01237678|82886192|FG001|Phase II|Lack of Efficacy|25|||
46670869|NCT01237678|82886193|FG002|Phase II|Lack of Efficacy|3|||
46670870|NCT01237678|82886191|FG000|Phase II|Withdrawal by Subject|0|||
46670871|NCT01237678|82886192|FG001|Phase II|Withdrawal by Subject|1|||
46670872|NCT01237678|82886193|FG002|Phase II|Withdrawal by Subject|5|||
46670873|NCT01237678|82886191|FG000|Phase II|Completed Cycles 4-6|0|||
46670874|NCT01237678|82886192|FG001|Phase II|Completed Cycles 4-6|11|||
46670875|NCT01237678|82886193|FG002|Phase II|Completed Cycles 4-6|21|||
46670876|NCT01237678|82886191|FG000|Phase II|Sponsor Decision/Study Closed|0|||
46670877|NCT01237678|82886192|FG001|Phase II|Sponsor Decision/Study Closed|18|||
46670878|NCT01237678|82886193|FG002|Phase II|Sponsor Decision/Study Closed|7|||
46670879|NCT01237678|82886191|FG000|Phase II|Randomized but were not treated|0|||
46670880|NCT01237678|82886192|FG001|Phase II|Randomized but were not treated|4|||
46670881|NCT01237678|82886193|FG002|Phase II|Randomized but were not treated|3|||
46670882|NCT01229371|82886216|FG000|Overall Study|Withdrawal by Subject|0|||
46786243|NCT00676130|83005363|FG000|Overall Study|Found ineligible|3|||
46786244|NCT00676130|83005364|FG001|Overall Study|Found ineligible|2|||
46786245|NCT00676130|83005363|FG000|Overall Study|Withdrawal by Subject|0|||
46786246|NCT00676130|83005364|FG001|Overall Study|Withdrawal by Subject|1|||
46786247|NCT00676052|83005376|FG000|Overall Study|Adverse Event|0|||
46786248|NCT00676052|83005377|FG001|Overall Study|Adverse Event|1|||
46786249|NCT00676052|83005378|FG002|Overall Study|Adverse Event|1|||
46786250|NCT00676052|83005379|FG003|Overall Study|Adverse Event|2|||
46786251|NCT00676052|83005380|FG004|Overall Study|Adverse Event|2|||
47077315|NCT01469000|83376598|FG000|Overall Study|Withdrawal by Subject|16|||
47077316|NCT01469000|83376599|FG001|Overall Study|Withdrawal by Subject|3|||
46786252|NCT00676052|83005381|FG005|Overall Study|Adverse Event|2|||
47077317|NCT01469000|83376598|FG000|Overall Study|Sponsor Decision|4|||
47077318|NCT01469000|83376599|FG001|Overall Study|Sponsor Decision|1|||
47077319|NCT01490060|83376612|FG000|Cycle 1|Change of Treatment|0|||
47077320|NCT01490060|83376613|FG001|Cycle 1|Change of Treatment|1|||
46670883|NCT01229371|82886217|FG001|Overall Study|Withdrawal by Subject|1|||
46670884|NCT01229371|82886218|FG002|Overall Study|Withdrawal by Subject|0|||
46670885|NCT01229371|82886219|FG003|Overall Study|Withdrawal by Subject|0|||
46786253|NCT00676052|83005376|FG000|Overall Study|Lack of Efficacy|2|||
47077321|NCT01490060|83376614|FG002|Cycle 1|Change of Treatment|1|||
46670886|NCT01237327|82886231|FG000|Overall Study|Protocol Violation: Core Study|1|||
46670887|NCT01237327|82886232|FG001|Overall Study|Protocol Violation: Core Study|0|||
46786254|NCT00676052|83005377|FG001|Overall Study|Lack of Efficacy|2|||
46786255|NCT00676052|83005378|FG002|Overall Study|Lack of Efficacy|1|||
46786256|NCT00676052|83005379|FG003|Overall Study|Lack of Efficacy|1|||
46786257|NCT00676052|83005380|FG004|Overall Study|Lack of Efficacy|2|||
46786258|NCT00676052|83005381|FG005|Overall Study|Lack of Efficacy|1|||
46786259|NCT00676052|83005376|FG000|Overall Study|Protocol Violation|5|||
46786260|NCT00676052|83005377|FG001|Overall Study|Protocol Violation|3|||
46786261|NCT00676052|83005378|FG002|Overall Study|Protocol Violation|2|||
46786262|NCT00676052|83005379|FG003|Overall Study|Protocol Violation|2|||
46786263|NCT00676052|83005380|FG004|Overall Study|Protocol Violation|1|||
46786264|NCT00676052|83005381|FG005|Overall Study|Protocol Violation|2|||
46786265|NCT00676052|83005376|FG000|Overall Study|Lost to Follow-up|0|||
46851572|NCT03569098|83067159|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
46851573|NCT03569098|83067160|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
46851574|NCT03569098|83067161|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
46851575|NCT03569098|83067159|FG000|Double-Blind Treatment Cycle 1|Other|1|||
46851576|NCT03569098|83067160|FG001|Double-Blind Treatment Cycle 1|Other|0|||
46851577|NCT03569098|83067161|FG002|Double-Blind Treatment Cycle 1|Other|1|||
46972868|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
46972869|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
46972870|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
46972871|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
46972872|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
46972873|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
46972874|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
46972875|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
46972876|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
46972877|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
46972878|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Death|3|||
46972879|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Death|1|||
46972880|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Death|1|||
46972881|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Discharged|2|||
46972882|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Discharged|1|||
46972883|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Discharged|0|||
46972884|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
46972885|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
46972886|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
46972887|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
46972888|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
46972889|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
46972890|NCT01990768|83216609|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
46972891|NCT01990768|83216610|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
46972892|NCT01990768|83216611|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
46972893|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
46972894|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
46972895|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
46972896|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
46972897|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
46972898|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
46972899|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
46972900|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
46972901|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
46972902|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
46972903|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
46972904|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
46972905|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
46972906|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
46972907|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
46972908|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
46972909|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
47077322|NCT01490060|83376615|FG003|Cycle 1|Change of Treatment|1|||
46786266|NCT00676052|83005377|FG001|Overall Study|Lost to Follow-up|0|||
46851578|NCT03569098|83067159|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
47077323|NCT01490060|83376612|FG000|Cycle 1|Insurance Denied|0|||
47077324|NCT01490060|83376613|FG001|Cycle 1|Insurance Denied|0|||
47077325|NCT01490060|83376614|FG002|Cycle 1|Insurance Denied|2|||
47077326|NCT01490060|83376615|FG003|Cycle 1|Insurance Denied|0|||
47077327|NCT01490060|83376612|FG000|Cycle 1|Withdrawal by Subject|0|||
47077328|NCT01490060|83376613|FG001|Cycle 1|Withdrawal by Subject|0|||
47077329|NCT01490060|83376614|FG002|Cycle 1|Withdrawal by Subject|0|||
47077330|NCT01490060|83376615|FG003|Cycle 1|Withdrawal by Subject|1|||
47077331|NCT01490060|83376612|FG000|Cycle 1|Treatment at Another Facility|0|||
47077332|NCT01490060|83376613|FG001|Cycle 1|Treatment at Another Facility|0|||
47077333|NCT01490060|83376614|FG002|Cycle 1|Treatment at Another Facility|0|||
47077334|NCT01490060|83376615|FG003|Cycle 1|Treatment at Another Facility|1|||
47077335|NCT01490060|83376612|FG000|Cycle 2|Change of Treatment|1|||
47077336|NCT01490060|83376613|FG001|Cycle 2|Change of Treatment|1|||
46670888|NCT01237327|82886231|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
46670889|NCT01237327|82886232|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
46670890|NCT01237327|82886231|FG000|Overall Study|Progression of Disease: Core Study|18|||
46670891|NCT01237327|82886232|FG001|Overall Study|Progression of Disease: Core Study|22|||
46670892|NCT01237327|82886231|FG000|Overall Study|Progression of Disease: Extension Study|15|||
46670893|NCT01237327|82886232|FG001|Overall Study|Progression of Disease: Extension Study|13|||
46670894|NCT01237327|82886231|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
46972910|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
46972911|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
46670895|NCT01237327|82886232|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
46670896|NCT01237327|82886231|FG000|Overall Study|Withdrawal by Subject|1|||
46670897|NCT01237327|82886232|FG001|Overall Study|Withdrawal by Subject|3|||
46670898|NCT01237327|82886231|FG000|Overall Study|Lost to Follow-up|3|||
46670899|NCT01237327|82886232|FG001|Overall Study|Lost to Follow-up|0|||
46670900|NCT01237054|82886238|FG000|Overall Study|imaging 10C0096|1|||
46670901|NCT05333289|82886263|FG000|Overall Study|Other|1|||
46670902|NCT05333289|82886264|FG001|Overall Study|Other|0|||
46670903|NCT05333289|82886265|FG002|Overall Study|Other|0|||
46670904|NCT05333289|82886266|FG003|Overall Study|Other|1|||
46670905|NCT05333289|82886267|FG004|Overall Study|Other|1|||
46670906|NCT05333289|82886268|FG005|Overall Study|Other|2|||
46670907|NCT05333289|82886269|FG006|Overall Study|Other|2|||
46670908|NCT05333289|82886270|FG007|Overall Study|Other|0|||
46670909|NCT05333289|82886263|FG000|Overall Study|Withdrawal by Subject|1|||
46670910|NCT05333289|82886264|FG001|Overall Study|Withdrawal by Subject|2|||
46670911|NCT05333289|82886265|FG002|Overall Study|Withdrawal by Subject|2|||
46670912|NCT05333289|82886266|FG003|Overall Study|Withdrawal by Subject|1|||
46670913|NCT05333289|82886267|FG004|Overall Study|Withdrawal by Subject|1|||
46670914|NCT05333289|82886268|FG005|Overall Study|Withdrawal by Subject|2|||
46670915|NCT05333289|82886269|FG006|Overall Study|Withdrawal by Subject|1|||
46670916|NCT05333289|82886270|FG007|Overall Study|Withdrawal by Subject|3|||
46670917|NCT05333289|82886263|FG000|Overall Study|Protocol Violation|1|||
46670918|NCT05333289|82886264|FG001|Overall Study|Protocol Violation|0|||
46670919|NCT05333289|82886265|FG002|Overall Study|Protocol Violation|0|||
46670920|NCT05333289|82886266|FG003|Overall Study|Protocol Violation|0|||
46670921|NCT05333289|82886267|FG004|Overall Study|Protocol Violation|0|||
46670922|NCT05333289|82886268|FG005|Overall Study|Protocol Violation|0|||
46786267|NCT00676052|83005378|FG002|Overall Study|Lost to Follow-up|0|||
46786268|NCT00676052|83005379|FG003|Overall Study|Lost to Follow-up|0|||
46786269|NCT00676052|83005380|FG004|Overall Study|Lost to Follow-up|1|||
46786270|NCT00676052|83005381|FG005|Overall Study|Lost to Follow-up|0|||
46786271|NCT00676052|83005376|FG000|Overall Study|Physician Decision|1|||
46786272|NCT00676052|83005377|FG001|Overall Study|Physician Decision|1|||
46972912|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
47077337|NCT01490060|83376614|FG002|Cycle 2|Change of Treatment|0|||
47077338|NCT01490060|83376615|FG003|Cycle 2|Change of Treatment|0|||
47077339|NCT01490060|83376612|FG000|Cycle 2|Non-Compliance|0|||
47077340|NCT01490060|83376613|FG001|Cycle 2|Non-Compliance|0|||
46972913|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
46972914|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
46972915|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
46972916|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
46670923|NCT05333289|82886269|FG006|Overall Study|Protocol Violation|0|||
46670924|NCT05333289|82886270|FG007|Overall Study|Protocol Violation|0|||
46670925|NCT05333289|82886263|FG000|Overall Study|Physician Decision|0|||
46670926|NCT05333289|82886264|FG001|Overall Study|Physician Decision|0|||
46670927|NCT05333289|82886265|FG002|Overall Study|Physician Decision|1|||
46670928|NCT05333289|82886266|FG003|Overall Study|Physician Decision|0|||
47077341|NCT01490060|83376614|FG002|Cycle 2|Non-Compliance|1|||
46670929|NCT05333289|82886267|FG004|Overall Study|Physician Decision|0|||
46786273|NCT00676052|83005378|FG002|Overall Study|Physician Decision|1|||
46670930|NCT05333289|82886268|FG005|Overall Study|Physician Decision|2|||
47077342|NCT01490060|83376615|FG003|Cycle 2|Non-Compliance|0|||
46972917|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
46972918|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
46972919|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
46972920|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
46972921|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
46972922|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
46972923|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
46972924|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
46972925|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
46972926|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
46972927|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
46972928|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
46972929|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
46972930|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
46972931|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
46972932|NCT01990768|83216609|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
46972933|NCT01990768|83216610|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
46972934|NCT01990768|83216611|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
46972935|NCT01990768|83216609|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
46972936|NCT01990768|83216610|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
46972937|NCT01990768|83216611|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
46972938|NCT01990768|83216609|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
47077343|NCT01490060|83376612|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
47077344|NCT01490060|83376613|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
46670931|NCT05333289|82886269|FG006|Overall Study|Physician Decision|0|||
46670932|NCT05333289|82886270|FG007|Overall Study|Physician Decision|0|||
46670933|NCT05333289|82886263|FG000|Overall Study|Lost to Follow-up|6|||
46670934|NCT05333289|82886264|FG001|Overall Study|Lost to Follow-up|0|||
46670935|NCT05333289|82886265|FG002|Overall Study|Lost to Follow-up|1|||
46670936|NCT05333289|82886266|FG003|Overall Study|Lost to Follow-up|6|||
46670937|NCT05333289|82886267|FG004|Overall Study|Lost to Follow-up|3|||
46670938|NCT05333289|82886268|FG005|Overall Study|Lost to Follow-up|3|||
46670939|NCT05333289|82886269|FG006|Overall Study|Lost to Follow-up|2|||
46670940|NCT05333289|82886270|FG007|Overall Study|Lost to Follow-up|1|||
46670941|NCT05333289|82886263|FG000|Overall Study|Death|1|||
46670942|NCT05333289|82886264|FG001|Overall Study|Death|0|||
46670943|NCT05333289|82886265|FG002|Overall Study|Death|0|||
46670944|NCT05333289|82886266|FG003|Overall Study|Death|0|||
46670945|NCT05333289|82886267|FG004|Overall Study|Death|0|||
46670946|NCT05333289|82886268|FG005|Overall Study|Death|0|||
46670947|NCT05333289|82886269|FG006|Overall Study|Death|0|||
46670948|NCT05333289|82886270|FG007|Overall Study|Death|0|||
46670949|NCT04749914|82886294|FG000|Period 1|Adverse Event|1|||
46670950|NCT04749914|82886295|FG001|Period 1|Adverse Event|0|||
46670951|NCT04749914|82886296|FG002|Period 1|Adverse Event|0|||
46670952|NCT04749914|82886297|FG003|Period 1|Adverse Event|0|||
46670953|NCT04749914|82886294|FG000|Period 1|Withdrawal by Subject|1|||
46670954|NCT04749914|82886295|FG001|Period 1|Withdrawal by Subject|0|||
46670955|NCT04749914|82886296|FG002|Period 1|Withdrawal by Subject|1|||
46670956|NCT04749914|82886297|FG003|Period 1|Withdrawal by Subject|0|||
46670957|NCT04608773|82886312|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
46786274|NCT00676052|83005379|FG003|Overall Study|Physician Decision|0|||
46786275|NCT00676052|83005380|FG004|Overall Study|Physician Decision|0|||
46670958|NCT04608773|82886313|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
46670959|NCT04608773|82886312|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
46670960|NCT04608773|82886313|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
46670961|NCT04608773|82886312|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
46670962|NCT04608773|82886313|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
46670963|NCT04608773|82886312|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
46670964|NCT04608773|82886313|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
46670965|NCT04608773|82886312|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
46786276|NCT00676052|83005381|FG005|Overall Study|Physician Decision|1|||
46786277|NCT00676052|83005376|FG000|Overall Study|Withdrawal by Subject|1|||
46786278|NCT00676052|83005377|FG001|Overall Study|Withdrawal by Subject|0|||
46786279|NCT00676052|83005378|FG002|Overall Study|Withdrawal by Subject|1|||
46786280|NCT00676052|83005379|FG003|Overall Study|Withdrawal by Subject|0|||
46786281|NCT00676052|83005380|FG004|Overall Study|Withdrawal by Subject|0|||
46786282|NCT00676052|83005381|FG005|Overall Study|Withdrawal by Subject|0|||
46786283|NCT00535288|83005400|FG000|Overall Study|Adverse Event|20|||
46786284|NCT00535288|83005401|FG001|Overall Study|Adverse Event|19|||
46670966|NCT04608773|82886313|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
46670967|NCT04601532|82886329|FG000|Overall Study|Lost to Follow-up|1|||
46670968|NCT04601532|82886330|FG001|Overall Study|Lost to Follow-up|2|||
46670969|NCT04601532|82886329|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
46670970|NCT04601532|82886330|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
46670971|NCT04114539|82886363|FG000|Overall Study|Adverse Event|14|||
46670972|NCT04114539|82886363|FG000|Overall Study|Lost to Follow-up|2|||
46670973|NCT04114539|82886363|FG000|Overall Study|Non-compliance with Protocol|2|||
46670974|NCT04114539|82886363|FG000|Overall Study|Non-compliance with Study Drug|1|||
46670975|NCT04114539|82886363|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
46670976|NCT04114539|82886363|FG000|Overall Study|Withdrew consent|10|||
46670977|NCT04114539|82886363|FG000|Overall Study|Others not specified|5|||
46670978|NCT04114539|82886363|FG000|Overall Study|Investigator Decision|2|||
46670979|NCT03768505|82886385|FG000|Overall Study|sponsor decision|76|||
46670980|NCT03768505|82886385|FG000|Overall Study|Death|35|||
46670981|NCT03768505|82886385|FG000|Overall Study|Other -Various|30|||
46670982|NCT03768505|82886385|FG000|Overall Study|Withdrawal by Subject|22|||
46670983|NCT03768505|82886385|FG000|Overall Study|Lost to Follow-up|6|||
46670984|NCT03563716|82886403|FG000|Overall Study|Death|20|||
46670985|NCT03563716|82886404|FG001|Overall Study|Death|14|||
46670986|NCT03563716|82886403|FG000|Overall Study|Withdrawal by Subject|3|||
46670987|NCT03563716|82886404|FG001|Overall Study|Withdrawal by Subject|3|||
46670988|NCT03563716|82886403|FG000|Overall Study|Still on Study|45|||
46670989|NCT03563716|82886404|FG001|Overall Study|Still on Study|50|||
46670990|NCT03538626|82886418|FG000|Overall Study|Withdrawal by Subject|0|||
46670991|NCT03538626|82886419|FG001|Overall Study|Withdrawal by Subject|1|||
46670992|NCT03538626|82886420|FG002|Overall Study|Withdrawal by Subject|0|||
46670993|NCT03538626|82886421|FG003|Overall Study|Withdrawal by Subject|0|||
46670994|NCT03538626|82886422|FG004|Overall Study|Withdrawal by Subject|0|||
46670995|NCT03538626|82886423|FG005|Overall Study|Withdrawal by Subject|0|||
46670996|NCT03538626|82886424|FG006|Overall Study|Withdrawal by Subject|0|||
46670997|NCT03538626|82886425|FG007|Overall Study|Withdrawal by Subject|0|||
46670998|NCT03538626|82886418|FG000|Overall Study|Lost to Follow-up|0|||
46670999|NCT03538626|82886419|FG001|Overall Study|Lost to Follow-up|0|||
46671000|NCT03538626|82886420|FG002|Overall Study|Lost to Follow-up|0|||
46671001|NCT03538626|82886421|FG003|Overall Study|Lost to Follow-up|0|||
46671002|NCT03538626|82886422|FG004|Overall Study|Lost to Follow-up|0|||
46671003|NCT03538626|82886423|FG005|Overall Study|Lost to Follow-up|0|||
46671004|NCT03538626|82886424|FG006|Overall Study|Lost to Follow-up|1|||
46671005|NCT03538626|82886425|FG007|Overall Study|Lost to Follow-up|0|||
46671006|NCT03276221|82886446|FG000|Overall Study|Lost to Follow-up|6|||
46671007|NCT03276221|82886447|FG001|Overall Study|Lost to Follow-up|2|||
46671008|NCT03276221|82886448|FG002|Overall Study|Lost to Follow-up|0|||
46671009|NCT03276221|82886446|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
46671010|NCT03276221|82886447|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
46671011|NCT03276221|82886448|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
46671012|NCT03266770|82886456|FG000|Overall Study|Physician Decision|3|||
46671013|NCT03266770|82886456|FG000|Overall Study|Insufficient study supplies|1|||
46671014|NCT03266770|82886456|FG000|Overall Study|Adverse Event|1|||
46671015|NCT03243422|82886462|FG000|Overall Study|Death|20|||
46671016|NCT03243422|82886463|FG001|Overall Study|Death|21|||
46671017|NCT03243422|82886462|FG000|Overall Study|Lost to Follow-up|9|||
46671018|NCT03243422|82886463|FG001|Overall Study|Lost to Follow-up|21|||
46671019|NCT03243422|82886462|FG000|Overall Study|Withdrawal by Subject|22|||
46671020|NCT03243422|82886463|FG001|Overall Study|Withdrawal by Subject|8|||
46671021|NCT03238196|82886477|FG000|Overall Study|Adverse Event|3|||
46671022|NCT03238196|82886478|FG001|Overall Study|Adverse Event|0|||
46671023|NCT03238196|82886479|FG002|Overall Study|Adverse Event|2|||
46671024|NCT03238196|82886480|FG003|Overall Study|Adverse Event|2|||
46671025|NCT03238196|82886477|FG000|Overall Study|Withdrawal by Subject|4|||
46671026|NCT03238196|82886478|FG001|Overall Study|Withdrawal by Subject|1|||
46671027|NCT03238196|82886479|FG002|Overall Study|Withdrawal by Subject|1|||
46671028|NCT03238196|82886480|FG003|Overall Study|Withdrawal by Subject|0|||
46671029|NCT03238196|82886477|FG000|Overall Study|Disease progression|14|||
46671030|NCT03238196|82886478|FG001|Overall Study|Disease progression|2|||
46671031|NCT03238196|82886479|FG002|Overall Study|Disease progression|3|||
46671032|NCT03238196|82886480|FG003|Overall Study|Disease progression|2|||
46671033|NCT03238196|82886477|FG000|Overall Study|Still on treatment|1|||
46671034|NCT03238196|82886478|FG001|Overall Study|Still on treatment|0|||
46671035|NCT03238196|82886479|FG002|Overall Study|Still on treatment|0|||
46671036|NCT03238196|82886480|FG003|Overall Study|Still on treatment|0|||
46671037|NCT03173560|82886491|FG000|Overall Study|Ongoing on Treatment|38|||
46671038|NCT03173560|82886492|FG001|Overall Study|Ongoing on Treatment|50|||
46671039|NCT03173560|82886491|FG000|Overall Study|Ongoing Survival Follow-up|56|||
46671040|NCT03173560|82886492|FG001|Overall Study|Ongoing Survival Follow-up|57|||
46671041|NCT03173560|82886491|FG000|Overall Study|Lost to Follow-up|1|||
46671042|NCT03173560|82886492|FG001|Overall Study|Lost to Follow-up|4|||
46671043|NCT03173560|82886491|FG000|Overall Study|Withdrawal by Subject|10|||
46671044|NCT03173560|82886492|FG001|Overall Study|Withdrawal by Subject|5|||
46671045|NCT03173560|82886491|FG000|Overall Study|Other|0|||
46671046|NCT03173560|82886492|FG001|Overall Study|Other|1|||
46671047|NCT03052127|82886550|FG000|Overall Study|Withdrawal by Subject|0|||
46671048|NCT03052127|82886551|FG001|Overall Study|Withdrawal by Subject|0|||
46671049|NCT03052127|82886552|FG002|Overall Study|Withdrawal by Subject|0|||
46671050|NCT03052127|82886553|FG003|Overall Study|Withdrawal by Subject|0|||
46671051|NCT03052127|82886554|FG004|Overall Study|Withdrawal by Subject|0|||
46671052|NCT03052127|82886555|FG005|Overall Study|Withdrawal by Subject|0|||
46671053|NCT03052127|82886556|FG006|Overall Study|Withdrawal by Subject|0|||
46786285|NCT00535288|83005402|FG002|Overall Study|Adverse Event|25|||
46786286|NCT00535288|83005403|FG003|Overall Study|Adverse Event|20|||
46786287|NCT00535288|83005404|FG004|Overall Study|Adverse Event|30|||
46786288|NCT00535288|83005400|FG000|Overall Study|Lost to Follow-up|0|||
46786289|NCT00535288|83005401|FG001|Overall Study|Lost to Follow-up|3|||
46786290|NCT00535288|83005402|FG002|Overall Study|Lost to Follow-up|0|||
47077345|NCT01490060|83376614|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
47077346|NCT01490060|83376615|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
46671054|NCT03052127|82886557|FG007|Overall Study|Withdrawal by Subject|1|||
46671055|NCT03052127|82886558|FG008|Overall Study|Withdrawal by Subject|1|||
46671056|NCT03052127|82886559|FG009|Overall Study|Withdrawal by Subject|1|||
46671057|NCT03052127|82886560|FG010|Overall Study|Withdrawal by Subject|0|||
46671058|NCT03052127|82886561|FG011|Overall Study|Withdrawal by Subject|0|||
46671059|NCT03052127|82886550|FG000|Overall Study|Discontinuation by Sponsor|0|||
46671060|NCT03052127|82886551|FG001|Overall Study|Discontinuation by Sponsor|0|||
46671061|NCT03052127|82886552|FG002|Overall Study|Discontinuation by Sponsor|0|||
46671062|NCT03052127|82886553|FG003|Overall Study|Discontinuation by Sponsor|0|||
46671063|NCT03052127|82886554|FG004|Overall Study|Discontinuation by Sponsor|0|||
46671064|NCT03052127|82886555|FG005|Overall Study|Discontinuation by Sponsor|0|||
46671065|NCT03052127|82886556|FG006|Overall Study|Discontinuation by Sponsor|0|||
46671066|NCT03052127|82886557|FG007|Overall Study|Discontinuation by Sponsor|0|||
46671067|NCT03052127|82886558|FG008|Overall Study|Discontinuation by Sponsor|4|||
46671068|NCT03052127|82886559|FG009|Overall Study|Discontinuation by Sponsor|2|||
46671069|NCT03052127|82886560|FG010|Overall Study|Discontinuation by Sponsor|5|||
46671070|NCT03052127|82886561|FG011|Overall Study|Discontinuation by Sponsor|13|||
46671071|NCT03052127|82886550|FG000|Overall Study|Inability to comply with trial requirements|0|||
46671072|NCT03052127|82886551|FG001|Overall Study|Inability to comply with trial requirements|0|||
46671073|NCT03052127|82886552|FG002|Overall Study|Inability to comply with trial requirements|1|||
46671074|NCT03052127|82886553|FG003|Overall Study|Inability to comply with trial requirements|0|||
46671075|NCT03052127|82886554|FG004|Overall Study|Inability to comply with trial requirements|0|||
46671076|NCT03052127|82886555|FG005|Overall Study|Inability to comply with trial requirements|0|||
46671077|NCT03052127|82886556|FG006|Overall Study|Inability to comply with trial requirements|0|||
46671078|NCT03052127|82886557|FG007|Overall Study|Inability to comply with trial requirements|0|||
46671079|NCT03052127|82886558|FG008|Overall Study|Inability to comply with trial requirements|0|||
46671080|NCT03052127|82886559|FG009|Overall Study|Inability to comply with trial requirements|0|||
46671081|NCT03052127|82886560|FG010|Overall Study|Inability to comply with trial requirements|0|||
46671082|NCT03052127|82886561|FG011|Overall Study|Inability to comply with trial requirements|0|||
46671083|NCT03052127|82886550|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
46671084|NCT03052127|82886551|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
46671085|NCT03052127|82886552|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
46671086|NCT03052127|82886553|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
46671087|NCT03052127|82886554|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
46671088|NCT03052127|82886555|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
46671089|NCT03052127|82886556|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
46671090|NCT03052127|82886557|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
47077347|NCT01452152|83376667|FG000|Overall Study|Study termination by sponsor|5|||
46671091|NCT03052127|82886558|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
46671092|NCT03052127|82886559|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
46671093|NCT03052127|82886560|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
46671094|NCT03052127|82886561|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
46671095|NCT02967692|82886593|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
46786291|NCT00535288|83005403|FG003|Overall Study|Lost to Follow-up|0|||
46786292|NCT00535288|83005404|FG004|Overall Study|Lost to Follow-up|0|||
46786293|NCT00535288|83005400|FG000|Overall Study|Lack of Efficacy|26|||
46671096|NCT02967692|82886594|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
46707537|NCT01155570|82923117|FG000|Overall Study|Adverse Event + Other Reasons|7|||
46671097|NCT02967692|82886595|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
46671098|NCT02967692|82886596|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
46671099|NCT02967692|82886593|FG000|Overall Study|Progressive disease|3|||
46671100|NCT02967692|82886594|FG001|Overall Study|Progressive disease|15|||
46671101|NCT02967692|82886595|FG002|Overall Study|Progressive disease|99|||
46671102|NCT02967692|82886596|FG003|Overall Study|Progressive disease|128|||
46671103|NCT02967692|82886593|FG000|Overall Study|Subject/guardian decision|1|||
46671104|NCT02967692|82886594|FG001|Overall Study|Subject/guardian decision|1|||
46671105|NCT02967692|82886595|FG002|Overall Study|Subject/guardian decision|6|||
46671106|NCT02967692|82886596|FG003|Overall Study|Subject/guardian decision|13|||
46671107|NCT02967692|82886593|FG000|Overall Study|Death|0|||
46671108|NCT02967692|82886594|FG001|Overall Study|Death|1|||
46671109|NCT02967692|82886595|FG002|Overall Study|Death|10|||
46671110|NCT02967692|82886596|FG003|Overall Study|Death|9|||
46671111|NCT02967692|82886593|FG000|Overall Study|Protocol deviation|1|||
46671112|NCT02967692|82886594|FG001|Overall Study|Protocol deviation|0|||
46671113|NCT02967692|82886595|FG002|Overall Study|Protocol deviation|1|||
46671114|NCT02967692|82886596|FG003|Overall Study|Protocol deviation|1|||
46671115|NCT02967692|82886593|FG000|Overall Study|Lost to Follow-up|0|||
46671116|NCT02967692|82886594|FG001|Overall Study|Lost to Follow-up|0|||
46671117|NCT02967692|82886595|FG002|Overall Study|Lost to Follow-up|1|||
46671118|NCT02967692|82886596|FG003|Overall Study|Lost to Follow-up|0|||
46671119|NCT02967692|82886593|FG000|Overall Study|Physician Decision|0|||
46671120|NCT02967692|82886594|FG001|Overall Study|Physician Decision|0|||
46671121|NCT02967692|82886595|FG002|Overall Study|Physician Decision|13|||
46671122|NCT02967692|82886596|FG003|Overall Study|Physician Decision|9|||
46671123|NCT02967692|82886593|FG000|Overall Study|Adverse Event|1|||
46671124|NCT02967692|82886594|FG001|Overall Study|Adverse Event|9|||
46671125|NCT02967692|82886595|FG002|Overall Study|Adverse Event|51|||
46671126|NCT02967692|82886596|FG003|Overall Study|Adverse Event|23|||
46671127|NCT02925416|82886632|FG000|Overall Study|Adverse Event|2|||
46671128|NCT02925416|82886633|FG001|Overall Study|Adverse Event|0|||
46671129|NCT02564978|82886648|FG000|Overall Study|Adverse Event|8|||
46671130|NCT02564978|82886648|FG000|Overall Study|Death|1|||
46671131|NCT02564978|82886648|FG000|Overall Study|Lost to Follow-up|1|||
46671132|NCT02564978|82886648|FG000|Overall Study|Withdrawal by Subject|15|||
46671133|NCT02564978|82886648|FG000|Overall Study|Early Study Closure|2|||
46671134|NCT02564978|82886648|FG000|Overall Study|Other Reason|5|||
46671135|NCT02561962|82886661|FG000|Overall Study|Withdrawal by Subject|1|||
46671136|NCT02561962|82886662|FG001|Overall Study|Withdrawal by Subject|0|||
46671137|NCT02561962|82886663|FG002|Overall Study|Withdrawal by Subject|0|||
46671138|NCT02561962|82886664|FG003|Overall Study|Withdrawal by Subject|0|||
46671139|NCT02561962|82886665|FG004|Overall Study|Withdrawal by Subject|1|||
47077348|NCT01452152|83376668|FG001|Overall Study|Study termination by sponsor|0|||
47077349|NCT01452152|83376669|FG002|Overall Study|Study termination by sponsor|4|||
47077350|NCT01451762|83376680|FG000|Overall Study|Lost to Follow-up|3|||
47077351|NCT01451762|83376681|FG001|Overall Study|Lost to Follow-up|6|||
47077352|NCT01451762|83376682|FG002|Overall Study|Lost to Follow-up|6|||
47077353|NCT01468844|83376717|FG000|Overall Study|Adverse Event|1|||
47077354|NCT01468844|83376718|FG001|Overall Study|Adverse Event|0|||
47077355|NCT01468844|83376717|FG000|Overall Study|Withdrawal by Subject|1|||
47077356|NCT01468844|83376718|FG001|Overall Study|Withdrawal by Subject|0|||
47077357|NCT01451606|83376742|FG000|Overall Study|Withdrawal by Subject|4|||
46671140|NCT02561962|82886666|FG005|Overall Study|Withdrawal by Subject|1|||
47077358|NCT01451606|83376743|FG001|Overall Study|Withdrawal by Subject|3|||
47077359|NCT00473343|83376798|FG000|Overall Study|Adverse Event|9|||
46671141|NCT02561962|82886667|FG006|Overall Study|Withdrawal by Subject|2|||
46671142|NCT02561962|82886668|FG007|Overall Study|Withdrawal by Subject|1|||
46671143|NCT02561962|82886669|FG008|Overall Study|Withdrawal by Subject|0|||
46671144|NCT02561962|82886661|FG000|Overall Study|Decision by sponsor|0|||
46671145|NCT02561962|82886662|FG001|Overall Study|Decision by sponsor|0|||
46671146|NCT02561962|82886663|FG002|Overall Study|Decision by sponsor|0|||
47077360|NCT00473343|83376798|FG000|Overall Study|Lost to Follow-up|8|||
47077361|NCT00473343|83376798|FG000|Overall Study|Treatment failure|27|||
46671147|NCT02561962|82886664|FG003|Overall Study|Decision by sponsor|0|||
46671148|NCT02561962|82886665|FG004|Overall Study|Decision by sponsor|1|||
46671149|NCT02561962|82886666|FG005|Overall Study|Decision by sponsor|1|||
46671150|NCT02561962|82886667|FG006|Overall Study|Decision by sponsor|0|||
46671151|NCT02561962|82886668|FG007|Overall Study|Decision by sponsor|3|||
46671152|NCT02561962|82886669|FG008|Overall Study|Decision by sponsor|0|||
46671153|NCT02561962|82886661|FG000|Overall Study|Lost to Follow-up|0|||
46671154|NCT02561962|82886662|FG001|Overall Study|Lost to Follow-up|0|||
46671155|NCT02561962|82886663|FG002|Overall Study|Lost to Follow-up|0|||
46671156|NCT02561962|82886664|FG003|Overall Study|Lost to Follow-up|0|||
46671157|NCT02561962|82886665|FG004|Overall Study|Lost to Follow-up|0|||
46671158|NCT02561962|82886666|FG005|Overall Study|Lost to Follow-up|1|||
46671159|NCT02561962|82886667|FG006|Overall Study|Lost to Follow-up|0|||
46671160|NCT02561962|82886668|FG007|Overall Study|Lost to Follow-up|0|||
46671161|NCT02561962|82886669|FG008|Overall Study|Lost to Follow-up|0|||
46671162|NCT02519348|82886699|FG000|Overall Study|Death|31|||
46671163|NCT02519348|82886700|FG001|Overall Study|Death|74|||
46671164|NCT02519348|82886701|FG002|Overall Study|Death|47|||
46671165|NCT02519348|82886702|FG003|Overall Study|Death|54|||
46671166|NCT02519348|82886703|FG004|Overall Study|Death|63|||
46671167|NCT02519348|82886704|FG005|Overall Study|Death|18|||
46671168|NCT02519348|82886705|FG006|Overall Study|Death|2|||
46671169|NCT02519348|82886706|FG007|Overall Study|Death|5|||
46671170|NCT02519348|82886707|FG008|Overall Study|Death|5|||
46671171|NCT02519348|82886699|FG000|Overall Study|Withdrawal by Subject|4|||
46671172|NCT02519348|82886700|FG001|Overall Study|Withdrawal by Subject|7|||
46671173|NCT02519348|82886701|FG002|Overall Study|Withdrawal by Subject|4|||
46671174|NCT02519348|82886702|FG003|Overall Study|Withdrawal by Subject|3|||
46671175|NCT02519348|82886703|FG004|Overall Study|Withdrawal by Subject|3|||
46671176|NCT02519348|82886704|FG005|Overall Study|Withdrawal by Subject|2|||
46671177|NCT02519348|82886705|FG006|Overall Study|Withdrawal by Subject|0|||
46671178|NCT02519348|82886706|FG007|Overall Study|Withdrawal by Subject|0|||
46671179|NCT02519348|82886707|FG008|Overall Study|Withdrawal by Subject|1|||
46671180|NCT02519348|82886699|FG000|Overall Study|Lost to Follow-up|0|||
46671181|NCT02519348|82886700|FG001|Overall Study|Lost to Follow-up|0|||
46671182|NCT02519348|82886701|FG002|Overall Study|Lost to Follow-up|1|||
46786294|NCT00535288|83005401|FG001|Overall Study|Lack of Efficacy|3|||
46786295|NCT00535288|83005402|FG002|Overall Study|Lack of Efficacy|4|||
46786296|NCT00535288|83005403|FG003|Overall Study|Lack of Efficacy|4|||
46786297|NCT00535288|83005404|FG004|Overall Study|Lack of Efficacy|7|||
46972939|NCT01990768|83216610|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
46972940|NCT01990768|83216611|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
46972941|NCT01990768|83216609|FG000|6-Month Follow-up|No contact information|5|||
46972942|NCT01990768|83216610|FG001|6-Month Follow-up|No contact information|6|||
46972943|NCT01990768|83216611|FG002|6-Month Follow-up|No contact information|5|||
46972944|NCT01990768|83216609|FG000|6-Month Follow-up|Homeless|4|||
46972945|NCT01990768|83216610|FG001|6-Month Follow-up|Homeless|3|||
46972946|NCT01990768|83216611|FG002|6-Month Follow-up|Homeless|6|||
46972947|NCT01990768|83216609|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
46972948|NCT01990768|83216610|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
47077362|NCT00473343|83376798|FG000|Overall Study|Withdrew consent|3|||
47077363|NCT00473343|83376798|FG000|Overall Study|Other un-specified reason|3|||
47077364|NCT02587962|83377255|FG000|Overall Study|Adverse Event|0|||
47077365|NCT02587962|83377256|FG001|Overall Study|Adverse Event|0|||
47077366|NCT02587962|83377257|FG002|Overall Study|Adverse Event|1|||
47077367|NCT02587962|83377258|FG003|Overall Study|Adverse Event|0|||
47077368|NCT02587962|83377259|FG004|Overall Study|Adverse Event|0|||
47077369|NCT02587962|83377255|FG000|Overall Study|Withdrawal by Subject|0|||
47077370|NCT02587962|83377256|FG001|Overall Study|Withdrawal by Subject|0|||
47077371|NCT02587962|83377257|FG002|Overall Study|Withdrawal by Subject|1|||
47077372|NCT02587962|83377258|FG003|Overall Study|Withdrawal by Subject|1|||
47077373|NCT02587962|83377259|FG004|Overall Study|Withdrawal by Subject|4|||
47077374|NCT02587962|83377255|FG000|Overall Study|Radiological progression|2|||
47077375|NCT02587962|83377256|FG001|Overall Study|Radiological progression|2|||
47077376|NCT02587962|83377257|FG002|Overall Study|Radiological progression|2|||
47077377|NCT02587962|83377258|FG003|Overall Study|Radiological progression|5|||
47077378|NCT02587962|83377259|FG004|Overall Study|Radiological progression|10|||
47077379|NCT02587962|83377255|FG000|Overall Study|Clinical progression|0|||
46671183|NCT02519348|82886702|FG003|Overall Study|Lost to Follow-up|0|||
46671184|NCT02519348|82886703|FG004|Overall Study|Lost to Follow-up|2|||
46671185|NCT02519348|82886704|FG005|Overall Study|Lost to Follow-up|1|||
46671186|NCT02519348|82886705|FG006|Overall Study|Lost to Follow-up|1|||
46671187|NCT02519348|82886706|FG007|Overall Study|Lost to Follow-up|0|||
46671188|NCT02519348|82886707|FG008|Overall Study|Lost to Follow-up|0|||
46671189|NCT02519348|82886699|FG000|Overall Study|Other|0|||
46671190|NCT02519348|82886700|FG001|Overall Study|Other|3|||
46671191|NCT02519348|82886701|FG002|Overall Study|Other|0|||
46671192|NCT02519348|82886702|FG003|Overall Study|Other|0|||
46671193|NCT02519348|82886703|FG004|Overall Study|Other|1|||
46972949|NCT01990768|83216611|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
46972950|NCT01990768|83216609|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
46972951|NCT01990768|83216610|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
46972952|NCT01990768|83216611|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
46972953|NCT01990768|83216609|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
46972954|NCT01990768|83216610|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
46972955|NCT01990768|83216611|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
46972956|NCT01990612|83216622|FG000|Overall Study|Lost to Follow-up|2|||
46671194|NCT02519348|82886704|FG005|Overall Study|Other|0|||
46671195|NCT02519348|82886705|FG006|Overall Study|Other|0|||
46671196|NCT02519348|82886706|FG007|Overall Study|Other|0|||
46671197|NCT02519348|82886707|FG008|Overall Study|Other|0|||
46671198|NCT02519348|82886699|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
46671199|NCT02519348|82886700|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
46671200|NCT02519348|82886701|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
46671201|NCT02519348|82886702|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
46671202|NCT02519348|82886703|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
46671203|NCT02519348|82886704|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
46671204|NCT02519348|82886705|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
46671205|NCT02519348|82886706|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
46671206|NCT02519348|82886707|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
46671207|NCT02496156|82886730|FG000|Overall Study|Lost to Follow-up|5|||
46671208|NCT02496156|82886731|FG001|Overall Study|Lost to Follow-up|0|||
46671209|NCT02496156|82886730|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
46671210|NCT02496156|82886731|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
46671211|NCT02477696|82886739|FG000|Overall Study|Death|89|||
46671212|NCT02477696|82886740|FG001|Overall Study|Death|106|||
46671213|NCT02477696|82886739|FG000|Overall Study|Lost to Follow-up|7|||
46671214|NCT02477696|82886740|FG001|Overall Study|Lost to Follow-up|5|||
46671215|NCT02477696|82886739|FG000|Overall Study|Withdrawal by Subject|37|||
46671216|NCT02477696|82886740|FG001|Overall Study|Withdrawal by Subject|34|||
46671217|NCT02477696|82886739|FG000|Overall Study|Physician Decision|7|||
46671218|NCT02477696|82886740|FG001|Overall Study|Physician Decision|9|||
46671219|NCT02477696|82886739|FG000|Overall Study|Study terminated by sponsor|103|||
46671220|NCT02477696|82886740|FG001|Overall Study|Study terminated by sponsor|99|||
46671221|NCT02477696|82886739|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
46671222|NCT02477696|82886740|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
46671223|NCT02477696|82886739|FG000|Overall Study|Missing/Unknown|2|||
46671224|NCT02477696|82886740|FG001|Overall Study|Missing/Unknown|0|||
46671225|NCT02361944|82886748|FG000|Overall Study|surgery cancellation|0|||
46671226|NCT02361944|82886749|FG001|Overall Study|surgery cancellation|1|||
46671227|NCT01575834|82886757|FG000|Overall Study|Withdrawal by Subject|352|||
46786298|NCT00535288|83005400|FG000|Overall Study|Unwilling to cooperate|6|||
46786299|NCT00535288|83005401|FG001|Overall Study|Unwilling to cooperate|6|||
46786300|NCT00535288|83005402|FG002|Overall Study|Unwilling to cooperate|3|||
46786301|NCT00535288|83005403|FG003|Overall Study|Unwilling to cooperate|3|||
46786302|NCT00535288|83005404|FG004|Overall Study|Unwilling to cooperate|4|||
46786303|NCT00535288|83005400|FG000|Overall Study|Other|2|||
46786304|NCT00535288|83005401|FG001|Overall Study|Other|1|||
46786305|NCT00535288|83005402|FG002|Overall Study|Other|1|||
46786306|NCT00535288|83005403|FG003|Overall Study|Other|2|||
46786307|NCT00535288|83005404|FG004|Overall Study|Other|1|||
46786308|NCT03904420|83005423|FG000|Overall Study|Study terminated|2|||
46786309|NCT03904420|83005424|FG001|Overall Study|Study terminated|2|||
46786310|NCT00675506|83005432|FG000|Overall Study|Lost to Follow-up|1|||
46671228|NCT01575834|82886758|FG001|Overall Study|Withdrawal by Subject|390|||
46671229|NCT01575834|82886757|FG000|Overall Study|Death|81|||
46671230|NCT01575834|82886758|FG001|Overall Study|Death|74|||
46671231|NCT01575834|82886757|FG000|Overall Study|Other|70|||
46786311|NCT00675506|83005433|FG001|Overall Study|Lost to Follow-up|5|||
46786312|NCT00675506|83005432|FG000|Overall Study|Lost interest|3|||
46786313|NCT00675506|83005433|FG001|Overall Study|Lost interest|5|||
46786314|NCT00675506|83005432|FG000|Overall Study|Elevated fasting glucose|2|||
46786315|NCT00675506|83005433|FG001|Overall Study|Elevated fasting glucose|1|||
46786316|NCT00675506|83005432|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
46786317|NCT00675506|83005433|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
46786318|NCT00675506|83005432|FG000|Overall Study|Elevated IGF-1|2|||
46972957|NCT01990612|83216623|FG001|Overall Study|Lost to Follow-up|1|||
46671232|NCT01575834|82886758|FG001|Overall Study|Other|70|||
46671233|NCT01575834|82886757|FG000|Overall Study|Adverse Event|63|||
46671234|NCT01575834|82886758|FG001|Overall Study|Adverse Event|61|||
46671235|NCT01575834|82886757|FG000|Overall Study|Lost to Follow-up|55|||
46671236|NCT01575834|82886758|FG001|Overall Study|Lost to Follow-up|68|||
46671237|NCT01575834|82886757|FG000|Overall Study|Noncompliance|52|||
46671238|NCT01575834|82886758|FG001|Overall Study|Noncompliance|27|||
46671239|NCT01575834|82886757|FG000|Overall Study|Administrative decision|15|||
46671240|NCT01575834|82886758|FG001|Overall Study|Administrative decision|33|||
46671241|NCT01575834|82886757|FG000|Overall Study|Ineligibility Determined|5|||
46671242|NCT01575834|82886758|FG001|Overall Study|Ineligibility Determined|8|||
46671243|NCT01575834|82886757|FG000|Overall Study|Protocol Deviation|4|||
46671244|NCT01575834|82886758|FG001|Overall Study|Protocol Deviation|3|||
46671245|NCT01575834|82886757|FG000|Overall Study|Requirement for Alternative Therapy|2|||
46671246|NCT01575834|82886758|FG001|Overall Study|Requirement for Alternative Therapy|4|||
46671247|NCT01385176|82886770|FG000|Randomization Phase|Death|1|||
46671248|NCT01385176|82886771|FG001|Randomization Phase|Death|2|||
46671249|NCT01385176|82886770|FG000|6-18 Month All VNS Active|Death|1|||
46671250|NCT01385176|82886771|FG001|6-18 Month All VNS Active|Death|2|||
46671251|NCT01385176|82886770|FG000|6-18 Month All VNS Active|Physician Decision|0|||
46671252|NCT01385176|82886771|FG001|6-18 Month All VNS Active|Physician Decision|1|||
46671253|NCT01385176|82886770|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
46972958|NCT01990612|83216622|FG000|Overall Study|Withdrawal by Subject|5|||
46671254|NCT01385176|82886771|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
46671255|NCT01385176|82886770|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
46671256|NCT01385176|82886771|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
46671257|NCT01186328|82886782|FG000|Overall Study|Death|1|||
46671258|NCT01186328|82886783|FG001|Overall Study|Death|0|||
46671259|NCT01186328|82886784|FG002|Overall Study|Death|0|||
46671260|NCT00455858|82886825|FG000|Overall Study|Lost to Follow-up|2|||
46671261|NCT00455858|82886825|FG000|Overall Study|Protocol Violation|1|||
46671262|NCT00455858|82886825|FG000|Overall Study|Lack of Efficacy|1|||
46671263|NCT00455858|82886825|FG000|Overall Study|Well controlled FPG without insulin|1|||
46671264|NCT00455858|82886825|FG000|Overall Study|Withdrawal|1|||
46671265|NCT00408005|82886831|FG000|Induction|Adverse Event|19|||
46671266|NCT00408005|82886832|FG001|Induction|Adverse Event|3|||
46671267|NCT00408005|82886833|FG002|Induction|Adverse Event|0|||
46671268|NCT00408005|82886834|FG003|Induction|Adverse Event|0|||
46671269|NCT00408005|82886835|FG004|Induction|Adverse Event|0|||
46671270|NCT00408005|82886836|FG005|Induction|Adverse Event|0|||
46671271|NCT00408005|82886837|FG006|Induction|Adverse Event|0|||
46671272|NCT00408005|82886838|FG007|Induction|Adverse Event|0|||
46671273|NCT00408005|82886831|FG000|Induction|Death|6|||
46671274|NCT00408005|82886832|FG001|Induction|Death|0|||
46671275|NCT00408005|82886833|FG002|Induction|Death|0|||
46671276|NCT00408005|82886834|FG003|Induction|Death|0|||
46671277|NCT00408005|82886835|FG004|Induction|Death|0|||
46671278|NCT00408005|82886836|FG005|Induction|Death|0|||
46671279|NCT00408005|82886837|FG006|Induction|Death|0|||
46671280|NCT00408005|82886838|FG007|Induction|Death|0|||
46671281|NCT00408005|82886831|FG000|Induction|Physician Decision|83|||
46671282|NCT00408005|82886832|FG001|Induction|Physician Decision|9|||
46671283|NCT00408005|82886833|FG002|Induction|Physician Decision|0|||
46671284|NCT00408005|82886834|FG003|Induction|Physician Decision|0|||
46671285|NCT00408005|82886835|FG004|Induction|Physician Decision|0|||
46671286|NCT00408005|82886836|FG005|Induction|Physician Decision|0|||
46671287|NCT00408005|82886837|FG006|Induction|Physician Decision|0|||
46671288|NCT00408005|82886838|FG007|Induction|Physician Decision|0|||
46671289|NCT00408005|82886831|FG000|Induction|Withdrawal by Subject|2|||
46671290|NCT00408005|82886832|FG001|Induction|Withdrawal by Subject|4|||
46671291|NCT00408005|82886833|FG002|Induction|Withdrawal by Subject|0|||
46786319|NCT00675506|83005433|FG001|Overall Study|Elevated IGF-1|0|||
46786320|NCT00675506|83005432|FG000|Overall Study|Hypersensitivity Reaction|1|||
46786321|NCT00675506|83005433|FG001|Overall Study|Hypersensitivity Reaction|0|||
46786322|NCT00675506|83005432|FG000|Overall Study|Disclosed history of cancer|1|||
46786323|NCT00675506|83005433|FG001|Overall Study|Disclosed history of cancer|0|||
46786324|NCT00675506|83005432|FG000|Overall Study|Declined participation|1|||
46786325|NCT00675506|83005433|FG001|Overall Study|Declined participation|0|||
46972959|NCT01990612|83216623|FG001|Overall Study|Withdrawal by Subject|2|||
46972960|NCT01990534|83216629|FG000|Overall Study|Death|22|||
46972961|NCT01990534|83216629|FG000|Overall Study|Progressive disease|3|||
46972962|NCT01990534|83216629|FG000|Overall Study|Protocol Violation|1|||
46671292|NCT00408005|82886834|FG003|Induction|Withdrawal by Subject|0|||
46671293|NCT00408005|82886835|FG004|Induction|Withdrawal by Subject|0|||
46671294|NCT00408005|82886836|FG005|Induction|Withdrawal by Subject|0|||
46786326|NCT00675506|83005432|FG000|Overall Study|Schedule conflict|0|||
46786327|NCT00675506|83005433|FG001|Overall Study|Schedule conflict|1|||
46972963|NCT01990534|83216629|FG000|Overall Study|Withdrawal of Informed Consent|2|||
46671295|NCT00408005|82886837|FG006|Induction|Withdrawal by Subject|0|||
46671296|NCT00408005|82886838|FG007|Induction|Withdrawal by Subject|0|||
46671297|NCT00408005|82886831|FG000|Induction|Ineligible|33|||
46671298|NCT00408005|82886832|FG001|Induction|Ineligible|14|||
46671299|NCT00408005|82886833|FG002|Induction|Ineligible|0|||
46671300|NCT00408005|82886834|FG003|Induction|Ineligible|0|||
46671301|NCT00408005|82886835|FG004|Induction|Ineligible|0|||
46671302|NCT00408005|82886836|FG005|Induction|Ineligible|0|||
46671303|NCT00408005|82886837|FG006|Induction|Ineligible|0|||
46786328|NCT03895840|83005440|FG000|Overall Study|Withdrawal by Subject|21|||
46671304|NCT00408005|82886838|FG007|Induction|Ineligible|0|||
46671305|NCT00408005|82886831|FG000|Induction|Refusal of Further Protocol Therapy|225|||
46671306|NCT00408005|82886832|FG001|Induction|Refusal of Further Protocol Therapy|44|||
46671307|NCT00408005|82886833|FG002|Induction|Refusal of Further Protocol Therapy|0|||
46671308|NCT00408005|82886834|FG003|Induction|Refusal of Further Protocol Therapy|0|||
46671309|NCT00408005|82886835|FG004|Induction|Refusal of Further Protocol Therapy|0|||
46671310|NCT00408005|82886836|FG005|Induction|Refusal of Further Protocol Therapy|0|||
46671311|NCT00408005|82886837|FG006|Induction|Refusal of Further Protocol Therapy|0|||
46671312|NCT00408005|82886838|FG007|Induction|Refusal of Further Protocol Therapy|0|||
46671313|NCT00408005|82886831|FG000|Induction|Entered another COG therapeutic protocol|4|||
46671314|NCT00408005|82886832|FG001|Induction|Entered another COG therapeutic protocol|0|||
46671315|NCT00408005|82886833|FG002|Induction|Entered another COG therapeutic protocol|0|||
46671316|NCT00408005|82886834|FG003|Induction|Entered another COG therapeutic protocol|0|||
46972964|NCT01990534|83216629|FG000|Overall Study|Symptomatic Deterioration|1|||
47077380|NCT02587962|83377256|FG001|Overall Study|Clinical progression|1|||
46671317|NCT00408005|82886835|FG004|Induction|Entered another COG therapeutic protocol|0|||
46671318|NCT00408005|82886836|FG005|Induction|Entered another COG therapeutic protocol|0|||
46671319|NCT00408005|82886837|FG006|Induction|Entered another COG therapeutic protocol|0|||
46671320|NCT00408005|82886838|FG007|Induction|Entered another COG therapeutic protocol|0|||
46671321|NCT00408005|82886831|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
46671322|NCT00408005|82886832|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
46671323|NCT00408005|82886833|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
46671324|NCT00408005|82886834|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
46671325|NCT00408005|82886835|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
46671326|NCT00408005|82886836|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
46671327|NCT00408005|82886837|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
46671328|NCT00408005|82886838|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
46671329|NCT00408005|82886831|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
46671330|NCT00408005|82886832|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
46671331|NCT00408005|82886833|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
46671332|NCT00408005|82886834|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
46671333|NCT00408005|82886835|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
46671334|NCT00408005|82886836|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
46671335|NCT00408005|82886837|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
46671336|NCT00408005|82886838|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
46671337|NCT00408005|82886831|FG000|Induction|Progressive Disease|0|||
46671338|NCT00408005|82886832|FG001|Induction|Progressive Disease|1|||
46671339|NCT00408005|82886833|FG002|Induction|Progressive Disease|0|||
46671340|NCT00408005|82886834|FG003|Induction|Progressive Disease|0|||
46671341|NCT00408005|82886835|FG004|Induction|Progressive Disease|0|||
46671342|NCT00408005|82886836|FG005|Induction|Progressive Disease|0|||
46671343|NCT00408005|82886837|FG006|Induction|Progressive Disease|0|||
46671344|NCT00408005|82886838|FG007|Induction|Progressive Disease|0|||
46671345|NCT00408005|82886831|FG000|Induction|Inevaluable|18|||
46671346|NCT00408005|82886832|FG001|Induction|Inevaluable|14|||
46671347|NCT00408005|82886833|FG002|Induction|Inevaluable|0|||
46671348|NCT00408005|82886834|FG003|Induction|Inevaluable|0|||
46671349|NCT00408005|82886835|FG004|Induction|Inevaluable|0|||
46671350|NCT00408005|82886836|FG005|Induction|Inevaluable|0|||
46671351|NCT00408005|82886837|FG006|Induction|Inevaluable|0|||
46671352|NCT00408005|82886838|FG007|Induction|Inevaluable|0|||
46671353|NCT00408005|82886831|FG000|Induction|Failed to Complete Randomization|3|||
46671354|NCT00408005|82886832|FG001|Induction|Failed to Complete Randomization|2|||
46671355|NCT00408005|82886833|FG002|Induction|Failed to Complete Randomization|0|||
46671356|NCT00408005|82886834|FG003|Induction|Failed to Complete Randomization|0|||
46671357|NCT00408005|82886835|FG004|Induction|Failed to Complete Randomization|0|||
46671358|NCT00408005|82886836|FG005|Induction|Failed to Complete Randomization|0|||
46671359|NCT00408005|82886837|FG006|Induction|Failed to Complete Randomization|0|||
46671360|NCT00408005|82886838|FG007|Induction|Failed to Complete Randomization|0|||
46671361|NCT00408005|82886831|FG000|Induction|Protocol Deviation|3|||
47077381|NCT02587962|83377257|FG002|Overall Study|Clinical progression|2|||
47077382|NCT02587962|83377258|FG003|Overall Study|Clinical progression|0|||
47077383|NCT02587962|83377259|FG004|Overall Study|Clinical progression|1|||
46671362|NCT00408005|82886832|FG001|Induction|Protocol Deviation|1|||
46671363|NCT00408005|82886833|FG002|Induction|Protocol Deviation|0|||
46671364|NCT00408005|82886834|FG003|Induction|Protocol Deviation|0|||
46671365|NCT00408005|82886835|FG004|Induction|Protocol Deviation|0|||
46671366|NCT00408005|82886836|FG005|Induction|Protocol Deviation|0|||
46671367|NCT00408005|82886837|FG006|Induction|Protocol Deviation|0|||
46671368|NCT00408005|82886838|FG007|Induction|Protocol Deviation|0|||
46671369|NCT00408005|82886831|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
46671370|NCT00408005|82886832|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
46671371|NCT00408005|82886833|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
46671372|NCT00408005|82886834|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
46671373|NCT00408005|82886835|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
46671374|NCT00408005|82886836|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
46671375|NCT00408005|82886837|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
46671376|NCT00408005|82886838|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
46671377|NCT00408005|82886831|FG000|Induction|Recurrent leukemia|1|||
46671378|NCT00408005|82886832|FG001|Induction|Recurrent leukemia|0|||
46671379|NCT00408005|82886833|FG002|Induction|Recurrent leukemia|0|||
46671380|NCT00408005|82886834|FG003|Induction|Recurrent leukemia|0|||
46671381|NCT00408005|82886835|FG004|Induction|Recurrent leukemia|0|||
46671382|NCT00408005|82886836|FG005|Induction|Recurrent leukemia|0|||
46671383|NCT00408005|82886837|FG006|Induction|Recurrent leukemia|0|||
46786329|NCT00310375|83005446|FG000|Primary Reporting Phase|Adverse Event|28|||
46786330|NCT00310375|83005447|FG001|Primary Reporting Phase|Adverse Event|22|||
46786331|NCT00310375|83005448|FG002|Primary Reporting Phase|Adverse Event|0|||
46786332|NCT00310375|83005446|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
46786333|NCT00310375|83005447|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
46786334|NCT00310375|83005448|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
46786335|NCT00310375|83005446|FG000|Primary Reporting Phase|Pregnancy|2|||
46786336|NCT00310375|83005447|FG001|Primary Reporting Phase|Pregnancy|2|||
46786337|NCT00310375|83005448|FG002|Primary Reporting Phase|Pregnancy|0|||
46786338|NCT00310375|83005446|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
46786339|NCT00310375|83005447|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
46786340|NCT00310375|83005448|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
46786341|NCT00310375|83005446|FG000|Primary Reporting Phase|Protocol Violation|8|||
46786342|NCT00310375|83005447|FG001|Primary Reporting Phase|Protocol Violation|5|||
46786343|NCT00310375|83005448|FG002|Primary Reporting Phase|Protocol Violation|0|||
46786344|NCT00310375|83005446|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
46786345|NCT00310375|83005447|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
46786346|NCT00310375|83005448|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
46786347|NCT00310375|83005446|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
46786348|NCT00310375|83005447|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
46786349|NCT00310375|83005448|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
46786350|NCT00310375|83005446|FG000|Primary Reporting Phase|Physician Decision|5|||
46786351|NCT00310375|83005447|FG001|Primary Reporting Phase|Physician Decision|3|||
46786352|NCT00310375|83005448|FG002|Primary Reporting Phase|Physician Decision|0|||
46786353|NCT00310375|83005446|FG000|Primary Reporting Phase|Request of the sponsor|2|||
46786354|NCT00310375|83005447|FG001|Primary Reporting Phase|Request of the sponsor|2|||
46786355|NCT00310375|83005448|FG002|Primary Reporting Phase|Request of the sponsor|0|||
46786356|NCT00310375|83005446|FG000|Primary Reporting Phase|Failed to return|1|||
46786357|NCT00310375|83005447|FG001|Primary Reporting Phase|Failed to return|3|||
46786358|NCT00310375|83005448|FG002|Primary Reporting Phase|Failed to return|0|||
46851579|NCT03569098|83067160|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
47077384|NCT01440374|83377404|FG000|Part 1: Open-label Phase|Adverse Event|5|||
47077385|NCT01440374|83377405|FG001|Part 1: Open-label Phase|Adverse Event|0|||
47077386|NCT01440374|83377406|FG002|Part 1: Open-label Phase|Adverse Event|0|||
47077387|NCT01440374|83377407|FG003|Part 1: Open-label Phase|Adverse Event|0|||
47077388|NCT01440374|83377404|FG000|Part 1: Open-label Phase|Physician Decision|1|||
47077389|NCT01440374|83377405|FG001|Part 1: Open-label Phase|Physician Decision|0|||
46851580|NCT03569098|83067161|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
46851581|NCT03569098|83067159|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
46851582|NCT03569098|83067160|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
46851583|NCT03569098|83067161|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
46671384|NCT00408005|82886838|FG007|Induction|Recurrent leukemia|0|||
46671385|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
46786359|NCT00310375|83005446|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
46786360|NCT00310375|83005447|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
46786361|NCT00310375|83005448|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
46786362|NCT00310375|83005446|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
46786363|NCT00310375|83005447|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
46786364|NCT00310375|83005448|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
46786365|NCT00310375|83005446|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
46786366|NCT00310375|83005447|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
46786367|NCT00310375|83005448|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
46851584|NCT03569098|83067159|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
46851585|NCT03569098|83067160|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
47077390|NCT01440374|83377406|FG002|Part 1: Open-label Phase|Physician Decision|0|||
46786368|NCT00310375|83005446|FG000|Primary Reporting Phase|Site closure|3|||
46786369|NCT00310375|83005447|FG001|Primary Reporting Phase|Site closure|0|||
46851586|NCT03569098|83067161|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
46671386|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
46851587|NCT03569098|83067159|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
46851588|NCT03569098|83067160|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
46786370|NCT00310375|83005448|FG002|Primary Reporting Phase|Site closure|0|||
46786371|NCT00310375|83005446|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
46786372|NCT00310375|83005447|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
46786373|NCT00310375|83005448|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
46851589|NCT03569098|83067161|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
46786374|NCT00310375|83005446|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
46786375|NCT00310375|83005447|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
46786376|NCT00310375|83005448|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
46786377|NCT00310375|83005446|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
46786378|NCT00310375|83005447|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
46786379|NCT00310375|83005448|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
46786380|NCT00310375|83005446|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
46786381|NCT00310375|83005447|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
46786382|NCT00310375|83005448|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
46786383|NCT00309907|83005457|FG000|Overall Study|Death|4|||
46786384|NCT00309907|83005457|FG000|Overall Study|Physician Decision|1|||
46786385|NCT00309907|83005457|FG000|Overall Study|Ineligible|11|||
46786386|NCT00309907|83005457|FG000|Overall Study|Major infectious event|4|||
46786387|NCT00655824|83005462|FG000|Overall Study|Adverse Event|3|||
46786388|NCT00655824|83005462|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
46786389|NCT00655824|83005462|FG000|Overall Study|Protocol Violation|1|||
46786390|NCT00655824|83005462|FG000|Overall Study|Withdrawal by Subject|4|||
46786391|NCT00655824|83005462|FG000|Overall Study|Deterioration of Trial Disease|2|||
46786392|NCT00575588|83005468|FG000|Overall Study|Adverse Event|11|||
46786393|NCT00575588|83005469|FG001|Overall Study|Adverse Event|13|||
46786394|NCT00575588|83005468|FG000|Overall Study|Withdrawal by Subject|27|||
46786395|NCT00575588|83005469|FG001|Overall Study|Withdrawal by Subject|31|||
47077391|NCT01440374|83377407|FG003|Part 1: Open-label Phase|Physician Decision|0|||
47077392|NCT01440374|83377404|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
47077393|NCT01440374|83377405|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
46786396|NCT00575588|83005468|FG000|Overall Study|Lost to Follow-up|1|||
46786397|NCT00575588|83005469|FG001|Overall Study|Lost to Follow-up|3|||
46786398|NCT00575588|83005468|FG000|Overall Study|Death|4|||
46786399|NCT00575588|83005469|FG001|Overall Study|Death|2|||
46786400|NCT00575588|83005468|FG000|Overall Study|Incorrect enrollment|8|||
46786401|NCT00575588|83005469|FG001|Overall Study|Incorrect enrollment|4|||
46786402|NCT00575588|83005468|FG000|Overall Study|Study specific discontinuation criteria|203|||
46786403|NCT00575588|83005469|FG001|Overall Study|Study specific discontinuation criteria|218|||
46786404|NCT00575588|83005468|FG000|Overall Study|Severe non-compliance to protocol|5|||
46786405|NCT00575588|83005469|FG001|Overall Study|Severe non-compliance to protocol|7|||
46786406|NCT00575588|83005468|FG000|Overall Study|Safety reasons|2|||
46786407|NCT00575588|83005469|FG001|Overall Study|Safety reasons|1|||
46786408|NCT00575588|83005468|FG000|Overall Study|Elevated triglyceride|1|||
46786409|NCT00575588|83005469|FG001|Overall Study|Elevated triglyceride|0|||
46786410|NCT00575588|83005468|FG000|Overall Study|Patient moved|1|||
46786411|NCT00575588|83005469|FG001|Overall Study|Patient moved|3|||
46786412|NCT00575588|83005468|FG000|Overall Study|Impossible to determine HbA1c|0|||
46786413|NCT00575588|83005469|FG001|Overall Study|Impossible to determine HbA1c|1|||
46786414|NCT00675428|83005477|FG000|Overall Study|Disease Progression|2|||
46851590|NCT03569098|83067159|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
46851591|NCT03569098|83067160|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
47077394|NCT01440374|83377406|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
46671387|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
46786415|NCT00675428|83005478|FG001|Overall Study|Disease Progression|2|||
46786416|NCT00675428|83005477|FG000|Overall Study|No Disease Response After Cycle 6|0|||
46786417|NCT00675428|83005478|FG001|Overall Study|No Disease Response After Cycle 6|1|||
46786418|NCT00675428|83005477|FG000|Overall Study|Physician Decision|1|||
46786419|NCT00675428|83005478|FG001|Overall Study|Physician Decision|0|||
46786420|NCT00557505|83005502|FG000|Overall Study|Death|0|||
46786421|NCT00557505|83005503|FG001|Overall Study|Death|0|||
46786422|NCT00557505|83005504|FG002|Overall Study|Death|0|||
46786423|NCT00557505|83005505|FG003|Overall Study|Death|0|||
46786424|NCT00557505|83005506|FG004|Overall Study|Death|0|||
46786425|NCT00557505|83005507|FG005|Overall Study|Death|0|||
46786426|NCT00557505|83005508|FG006|Overall Study|Death|0|||
46786427|NCT00557505|83005509|FG007|Overall Study|Death|0|||
46786428|NCT00557505|83005510|FG008|Overall Study|Death|1|||
46786429|NCT00557505|83005502|FG000|Overall Study|Adverse Event|0|||
46786430|NCT00557505|83005503|FG001|Overall Study|Adverse Event|0|||
46786431|NCT00557505|83005504|FG002|Overall Study|Adverse Event|1|||
46786432|NCT00557505|83005505|FG003|Overall Study|Adverse Event|0|||
46786433|NCT00557505|83005506|FG004|Overall Study|Adverse Event|0|||
46671388|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
46671389|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
46671390|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
46671391|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
46671392|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
46671393|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
46671394|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
46671395|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
46671396|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
46671397|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
46671398|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
46671399|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
46671400|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
46972965|NCT01990534|83216629|FG000|Overall Study|Withdrawal by Subject|3|||
46972966|NCT01990534|83216629|FG000|Overall Study|Reason not Specified|2|||
46972967|NCT01990534|83216629|FG000|Overall Study|Lost to Follow-up|1|||
46972968|NCT01967134|83216636|FG000|Overall Study|Lost to Follow-up|0|||
46671401|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
46671402|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
46671403|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
46671404|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
46671405|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
46671406|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
46671407|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
46671408|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
46671409|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
46671410|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
46671411|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
46671412|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
46671413|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
46671414|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
46671415|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
46671416|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
46671417|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
46671418|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
46671419|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
46671420|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
46671421|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
47077395|NCT01440374|83377407|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
47077396|NCT01440374|83377404|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
46671422|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
46671423|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
46671424|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
46671425|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
46786434|NCT00557505|83005507|FG005|Overall Study|Adverse Event|0|||
46786435|NCT00557505|83005508|FG006|Overall Study|Adverse Event|1|||
46786436|NCT00557505|83005509|FG007|Overall Study|Adverse Event|0|||
46786437|NCT00557505|83005510|FG008|Overall Study|Adverse Event|0|||
46786438|NCT00557505|83005502|FG000|Overall Study|Global deterioration of health|1|||
46786439|NCT00557505|83005503|FG001|Overall Study|Global deterioration of health|0|||
46786440|NCT00557505|83005504|FG002|Overall Study|Global deterioration of health|0|||
46786441|NCT00557505|83005505|FG003|Overall Study|Global deterioration of health|0|||
46671426|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
46671427|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
46671428|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
46671429|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
46671430|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
46671431|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
46671432|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
46972969|NCT01967134|83216637|FG001|Overall Study|Lost to Follow-up|1|||
47077397|NCT01440374|83377405|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
47077398|NCT01440374|83377406|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
46972970|NCT01967134|83216638|FG002|Overall Study|Lost to Follow-up|0|||
46786442|NCT00557505|83005506|FG004|Overall Study|Global deterioration of health|0|||
46786443|NCT00557505|83005507|FG005|Overall Study|Global deterioration of health|0|||
46972971|NCT01966432|83216649|FG000|Overall Study|Lost to Follow-up|3|||
46671433|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
46671434|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
46671435|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
46671436|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
46671437|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
46671438|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
46671439|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
46671440|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
46671441|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
46671442|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
46671443|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
46671444|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
46671445|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
46671446|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
46671447|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
46671448|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
46671449|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
46671450|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
46671451|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
46671452|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
46671453|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
46671454|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
46671455|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
46671456|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
46671457|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
46671458|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
46671459|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
46671460|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
46671461|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
46671462|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
46671463|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
46786444|NCT00557505|83005508|FG006|Overall Study|Global deterioration of health|0|||
46786445|NCT00557505|83005509|FG007|Overall Study|Global deterioration of health|0|||
46786446|NCT00557505|83005510|FG008|Overall Study|Global deterioration of health|0|||
46671464|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
46671465|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
46671466|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
46671467|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
46671468|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
46671469|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
46671470|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
46671471|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
46671472|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
46671473|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
46671474|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
46671475|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
46786447|NCT00557505|83005502|FG000|Overall Study|Objective progression or relapse|2|||
46786448|NCT00557505|83005503|FG001|Overall Study|Objective progression or relapse|3|||
46786449|NCT00557505|83005504|FG002|Overall Study|Objective progression or relapse|3|||
46786450|NCT00557505|83005505|FG003|Overall Study|Objective progression or relapse|2|||
46786451|NCT00557505|83005506|FG004|Overall Study|Objective progression or relapse|2|||
46786452|NCT00557505|83005507|FG005|Overall Study|Objective progression or relapse|3|||
46786453|NCT00557505|83005508|FG006|Overall Study|Objective progression or relapse|2|||
46786454|NCT00557505|83005509|FG007|Overall Study|Objective progression or relapse|5|||
46786455|NCT00557505|83005510|FG008|Overall Study|Objective progression or relapse|15|||
47077399|NCT01440374|83377407|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
47077400|NCT01440374|83377404|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
47077401|NCT01440374|83377405|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
47077402|NCT01440374|83377406|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
47077403|NCT01440374|83377407|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
47077404|NCT01440374|83377404|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
47077405|NCT01440374|83377405|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
46671476|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
46671477|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
46671478|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
46671479|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
46671480|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
46671481|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
46671482|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
46671483|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
46671484|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
46671485|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
46786456|NCT00557505|83005502|FG000|Overall Study|Withdrawal by Subject|0|||
46786457|NCT00557505|83005503|FG001|Overall Study|Withdrawal by Subject|0|||
46786458|NCT00557505|83005504|FG002|Overall Study|Withdrawal by Subject|0|||
46786459|NCT00557505|83005505|FG003|Overall Study|Withdrawal by Subject|1|||
46786460|NCT00557505|83005506|FG004|Overall Study|Withdrawal by Subject|0|||
46786461|NCT00557505|83005507|FG005|Overall Study|Withdrawal by Subject|0|||
46786462|NCT00557505|83005508|FG006|Overall Study|Withdrawal by Subject|0|||
46786463|NCT00557505|83005509|FG007|Overall Study|Withdrawal by Subject|0|||
46786464|NCT00557505|83005510|FG008|Overall Study|Withdrawal by Subject|1|||
46786465|NCT00674570|83005536|FG000|Overall Study|Withdrawal by Subject|0|||
46786466|NCT00674570|83005537|FG001|Overall Study|Withdrawal by Subject|2|||
46786467|NCT00674570|83005538|FG002|Overall Study|Withdrawal by Subject|0|||
46786468|NCT00561951|83005549|FG000|Overall Study|Adverse Event|11|||
46786469|NCT00561951|83005550|FG001|Overall Study|Adverse Event|14|||
46786470|NCT00561951|83005551|FG002|Overall Study|Adverse Event|14|||
46786471|NCT00561951|83005549|FG000|Overall Study|Lack of Efficacy|5|||
46786472|NCT00561951|83005550|FG001|Overall Study|Lack of Efficacy|3|||
46786473|NCT00561951|83005551|FG002|Overall Study|Lack of Efficacy|2|||
46786474|NCT00561951|83005549|FG000|Overall Study|Lost to Follow-up|1|||
46786475|NCT00561951|83005550|FG001|Overall Study|Lost to Follow-up|1|||
46786476|NCT00561951|83005551|FG002|Overall Study|Lost to Follow-up|0|||
46786477|NCT00561951|83005549|FG000|Overall Study|Withdrawal by Subject|10|||
46786478|NCT00561951|83005550|FG001|Overall Study|Withdrawal by Subject|9|||
46786479|NCT00561951|83005551|FG002|Overall Study|Withdrawal by Subject|10|||
46786480|NCT00561951|83005549|FG000|Overall Study|Protocol Violation|4|||
46671486|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
46671487|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
46671488|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
46671489|NCT00408005|82886831|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
46671490|NCT00408005|82886832|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
46671491|NCT00408005|82886833|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
46671492|NCT00408005|82886834|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
46671493|NCT00408005|82886835|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
46671494|NCT00408005|82886836|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
46851592|NCT03569098|83067161|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
46851593|NCT03569098|83067159|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
46671495|NCT00408005|82886837|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
46671496|NCT00408005|82886838|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
46671497|NCT00075946|82886862|FG000|Overall Study|Path ineligible: undetermined histology|0|||
46671498|NCT00075946|82886863|FG001|Overall Study|Path ineligible: undetermined histology|0|||
46671499|NCT00075946|82886864|FG002|Overall Study|Path ineligible: undetermined histology|0|||
46671500|NCT00075946|82886865|FG003|Overall Study|Path ineligible: undetermined histology|0|||
46671501|NCT00075946|82886866|FG004|Overall Study|Path ineligible: undetermined histology|6|||
46671502|NCT00075946|82886862|FG000|Overall Study|Did not achieve response after induction|0|||
46671503|NCT00075946|82886863|FG001|Overall Study|Did not achieve response after induction|0|||
46671504|NCT00075946|82886864|FG002|Overall Study|Did not achieve response after induction|0|||
46786481|NCT00561951|83005550|FG001|Overall Study|Protocol Violation|3|||
46786482|NCT00561951|83005551|FG002|Overall Study|Protocol Violation|4|||
46786483|NCT00561951|83005549|FG000|Overall Study|Physician Decision|1|||
46786484|NCT00561951|83005550|FG001|Overall Study|Physician Decision|0|||
46786485|NCT00561951|83005551|FG002|Overall Study|Physician Decision|0|||
46786486|NCT00561951|83005549|FG000|Overall Study|Pregnancy|0|||
46786487|NCT00561951|83005550|FG001|Overall Study|Pregnancy|1|||
46786488|NCT00561951|83005551|FG002|Overall Study|Pregnancy|0|||
46786489|NCT00561951|83005549|FG000|Overall Study|Meet Withdrawal Criterion|0|||
46786490|NCT00561951|83005550|FG001|Overall Study|Meet Withdrawal Criterion|1|||
46851594|NCT03569098|83067160|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
46671505|NCT00075946|82886865|FG003|Overall Study|Did not achieve response after induction|0|||
46671506|NCT00075946|82886866|FG004|Overall Study|Did not achieve response after induction|182|||
46671507|NCT00075946|82886862|FG000|Overall Study|Incorrectly randomized (no response)|5|||
46671508|NCT00075946|82886863|FG001|Overall Study|Incorrectly randomized (no response)|5|||
46671509|NCT00075946|82886864|FG002|Overall Study|Incorrectly randomized (no response)|5|||
46671510|NCT00075946|82886865|FG003|Overall Study|Incorrectly randomized (no response)|1|||
46671511|NCT00075946|82886866|FG004|Overall Study|Incorrectly randomized (no response)|0|||
46671512|NCT00075946|82886862|FG000|Overall Study|Adverse Event|2|||
46671513|NCT00075946|82886863|FG001|Overall Study|Adverse Event|10|||
46671514|NCT00075946|82886864|FG002|Overall Study|Adverse Event|0|||
46671515|NCT00075946|82886865|FG003|Overall Study|Adverse Event|2|||
46671516|NCT00075946|82886866|FG004|Overall Study|Adverse Event|0|||
46671517|NCT00075946|82886862|FG000|Overall Study|Death|0|||
46671518|NCT00075946|82886863|FG001|Overall Study|Death|1|||
46671519|NCT00075946|82886864|FG002|Overall Study|Death|0|||
46671520|NCT00075946|82886865|FG003|Overall Study|Death|0|||
46671521|NCT00075946|82886866|FG004|Overall Study|Death|0|||
46671522|NCT00075946|82886862|FG000|Overall Study|Withdrawal by Subject|23|||
46671523|NCT00075946|82886863|FG001|Overall Study|Withdrawal by Subject|58|||
46671524|NCT00075946|82886864|FG002|Overall Study|Withdrawal by Subject|4|||
46671525|NCT00075946|82886865|FG003|Overall Study|Withdrawal by Subject|9|||
46671526|NCT00075946|82886866|FG004|Overall Study|Withdrawal by Subject|0|||
46671527|NCT00075946|82886862|FG000|Overall Study|Alternative therapy|16|||
46671528|NCT00075946|82886863|FG001|Overall Study|Alternative therapy|2|||
46671529|NCT00075946|82886864|FG002|Overall Study|Alternative therapy|5|||
46671530|NCT00075946|82886865|FG003|Overall Study|Alternative therapy|0|||
46671531|NCT00075946|82886866|FG004|Overall Study|Alternative therapy|0|||
46671532|NCT00075946|82886862|FG000|Overall Study|Other complicating disease|7|||
46671533|NCT00075946|82886863|FG001|Overall Study|Other complicating disease|13|||
46671534|NCT00075946|82886864|FG002|Overall Study|Other complicating disease|1|||
46786491|NCT00561951|83005551|FG002|Overall Study|Meet Withdrawal Criterion|1|||
46786492|NCT00561951|83005549|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
46786493|NCT00561951|83005550|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
46786494|NCT00561951|83005551|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
46786495|NCT00322387|83005561|FG000|Treatment Period|Adverse Event|0|||
46786496|NCT00322387|83005562|FG001|Treatment Period|Adverse Event|1|||
46786497|NCT00322387|83005561|FG000|Follow-up Period|Final assessment not done|1|||
46786498|NCT00322387|83005562|FG001|Follow-up Period|Final assessment not done|3|||
46786499|NCT00322387|83005561|FG000|Follow-up Period|Death|1|||
46786500|NCT00322387|83005562|FG001|Follow-up Period|Death|0|||
46786501|NCT00561015|83005585|FG000|Overall Study|Adverse Event|0|||
46786502|NCT00561015|83005586|FG001|Overall Study|Adverse Event|0|||
46786503|NCT00561015|83005587|FG002|Overall Study|Adverse Event|0|||
46972972|NCT01966432|83216650|FG001|Overall Study|Lost to Follow-up|2|||
46972973|NCT01966432|83216651|FG002|Overall Study|Lost to Follow-up|5|||
46972974|NCT01966432|83216649|FG000|Overall Study|Withdrawal by Subject|1|||
46786504|NCT00561015|83005588|FG003|Overall Study|Adverse Event|0|||
46786505|NCT00561015|83005589|FG004|Overall Study|Adverse Event|1|||
46786506|NCT00561015|83005590|FG005|Overall Study|Adverse Event|0|||
46786507|NCT00561015|83005585|FG000|Overall Study|Lost to Follow-up|2|||
46786508|NCT00561015|83005586|FG001|Overall Study|Lost to Follow-up|0|||
46786509|NCT00561015|83005587|FG002|Overall Study|Lost to Follow-up|0|||
46786510|NCT00561015|83005588|FG003|Overall Study|Lost to Follow-up|1|||
46786511|NCT00561015|83005589|FG004|Overall Study|Lost to Follow-up|0|||
46786512|NCT00561015|83005590|FG005|Overall Study|Lost to Follow-up|3|||
46786513|NCT00561015|83005585|FG000|Overall Study|Participant non-compliance|2|||
46851595|NCT03569098|83067161|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
46851596|NCT03568942|83067172|FG000|Overall Study|Family emergency|1|||
46851597|NCT03568942|83067172|FG000|Overall Study|Lost to Follow-up|1|||
46786514|NCT00561015|83005586|FG001|Overall Study|Participant non-compliance|0|||
46786515|NCT00561015|83005587|FG002|Overall Study|Participant non-compliance|0|||
46786516|NCT00561015|83005588|FG003|Overall Study|Participant non-compliance|0|||
46786517|NCT00561015|83005589|FG004|Overall Study|Participant non-compliance|0|||
46786518|NCT00561015|83005590|FG005|Overall Study|Participant non-compliance|0|||
46786519|NCT00560937|83005610|FG000|Overall Study|Withdrawal by Subject|0|||
46786520|NCT00560937|83005611|FG001|Overall Study|Withdrawal by Subject|1|||
46786521|NCT00560937|83005610|FG000|Overall Study|Physician Decision|1|||
46851598|NCT00110019|83067178|FG000|Overall Study|Lack of Efficacy|253|||
46671535|NCT00075946|82886865|FG003|Overall Study|Other complicating disease|4|||
46671536|NCT00075946|82886866|FG004|Overall Study|Other complicating disease|0|||
46786522|NCT00560937|83005611|FG001|Overall Study|Physician Decision|1|||
46786523|NCT00561795|83005619|FG000|Overall Study|Adverse Event|3|||
46786524|NCT00561795|83005620|FG001|Overall Study|Adverse Event|3|||
46786525|NCT00561795|83005621|FG002|Overall Study|Adverse Event|0|||
46851599|NCT00110019|83067179|FG001|Overall Study|Lack of Efficacy|285|||
46671537|NCT00075946|82886862|FG000|Overall Study|No response to retreatment|23|||
46671538|NCT00075946|82886863|FG001|Overall Study|No response to retreatment|0|||
46671539|NCT00075946|82886864|FG002|Overall Study|No response to retreatment|2|||
46671540|NCT00075946|82886865|FG003|Overall Study|No response to retreatment|0|||
46671541|NCT00075946|82886866|FG004|Overall Study|No response to retreatment|0|||
46671542|NCT00075946|82886862|FG000|Overall Study|Time to progression less than 6 months|15|||
46671543|NCT00075946|82886863|FG001|Overall Study|Time to progression less than 6 months|30|||
46671544|NCT00075946|82886864|FG002|Overall Study|Time to progression less than 6 months|8|||
46671545|NCT00075946|82886865|FG003|Overall Study|Time to progression less than 6 months|3|||
46671546|NCT00075946|82886866|FG004|Overall Study|Time to progression less than 6 months|0|||
46671547|NCT00075946|82886862|FG000|Overall Study|Other|57|||
46671548|NCT00075946|82886863|FG001|Overall Study|Other|32|||
46671549|NCT00075946|82886864|FG002|Overall Study|Other|3|||
46671550|NCT00075946|82886865|FG003|Overall Study|Other|11|||
46671551|NCT00075946|82886866|FG004|Overall Study|Other|0|||
46671552|NCT01236352|82886907|FG000|Overall Study|Death|0|||
46671553|NCT01236352|82886908|FG001|Overall Study|Death|0|||
46671554|NCT01236352|82886909|FG002|Overall Study|Death|0|||
46671555|NCT01236352|82886910|FG003|Overall Study|Death|0|||
46671556|NCT01236352|82886911|FG004|Overall Study|Death|0|||
46671557|NCT01236352|82886912|FG005|Overall Study|Death|0|||
46671558|NCT01236352|82886913|FG006|Overall Study|Death|0|||
46671559|NCT01236352|82886914|FG007|Overall Study|Death|1|||
46671560|NCT01236352|82886915|FG008|Overall Study|Death|0|||
46671561|NCT01236352|82886916|FG009|Overall Study|Death|0|||
46671562|NCT01236352|82886917|FG010|Overall Study|Death|0|||
46671563|NCT01236352|82886907|FG000|Overall Study|Withdrawal by Subject|0|||
46671564|NCT01236352|82886908|FG001|Overall Study|Withdrawal by Subject|0|||
46671565|NCT01236352|82886909|FG002|Overall Study|Withdrawal by Subject|0|||
46671566|NCT01236352|82886910|FG003|Overall Study|Withdrawal by Subject|0|||
46671567|NCT01236352|82886911|FG004|Overall Study|Withdrawal by Subject|0|||
46671568|NCT01236352|82886912|FG005|Overall Study|Withdrawal by Subject|0|||
46671569|NCT01236352|82886913|FG006|Overall Study|Withdrawal by Subject|0|||
46671570|NCT01236352|82886914|FG007|Overall Study|Withdrawal by Subject|0|||
46671571|NCT01236352|82886915|FG008|Overall Study|Withdrawal by Subject|0|||
46671572|NCT01236352|82886916|FG009|Overall Study|Withdrawal by Subject|2|||
46671573|NCT01236352|82886917|FG010|Overall Study|Withdrawal by Subject|1|||
46671574|NCT01236352|82886907|FG000|Overall Study|Adverse Event|0|||
46671575|NCT01236352|82886908|FG001|Overall Study|Adverse Event|0|||
46671576|NCT01236352|82886909|FG002|Overall Study|Adverse Event|0|||
46671577|NCT01236352|82886910|FG003|Overall Study|Adverse Event|0|||
46671578|NCT01236352|82886911|FG004|Overall Study|Adverse Event|0|||
46671579|NCT01236352|82886912|FG005|Overall Study|Adverse Event|0|||
46671580|NCT01236352|82886913|FG006|Overall Study|Adverse Event|2|||
46671581|NCT01236352|82886914|FG007|Overall Study|Adverse Event|0|||
46671582|NCT01236352|82886915|FG008|Overall Study|Adverse Event|0|||
46671583|NCT01236352|82886916|FG009|Overall Study|Adverse Event|4|||
46671584|NCT01236352|82886917|FG010|Overall Study|Adverse Event|1|||
46671585|NCT01236352|82886907|FG000|Overall Study|Study drug toxicity|0|||
46671586|NCT01236352|82886908|FG001|Overall Study|Study drug toxicity|0|||
46671587|NCT01236352|82886909|FG002|Overall Study|Study drug toxicity|0|||
46671588|NCT01236352|82886910|FG003|Overall Study|Study drug toxicity|0|||
46671589|NCT01236352|82886911|FG004|Overall Study|Study drug toxicity|0|||
46671590|NCT01236352|82886912|FG005|Overall Study|Study drug toxicity|1|||
46671591|NCT01236352|82886913|FG006|Overall Study|Study drug toxicity|1|||
46671592|NCT01236352|82886914|FG007|Overall Study|Study drug toxicity|0|||
46671593|NCT01236352|82886915|FG008|Overall Study|Study drug toxicity|0|||
46671594|NCT01236352|82886916|FG009|Overall Study|Study drug toxicity|2|||
46671595|NCT01236352|82886917|FG010|Overall Study|Study drug toxicity|2|||
46671596|NCT01236352|82886907|FG000|Overall Study|Disease progression|1|||
46671597|NCT01236352|82886908|FG001|Overall Study|Disease progression|2|||
46671598|NCT01236352|82886909|FG002|Overall Study|Disease progression|1|||
46671599|NCT01236352|82886910|FG003|Overall Study|Disease progression|2|||
46671600|NCT01236352|82886911|FG004|Overall Study|Disease progression|2|||
46671601|NCT01236352|82886912|FG005|Overall Study|Disease progression|2|||
46671602|NCT01236352|82886913|FG006|Overall Study|Disease progression|1|||
46671603|NCT01236352|82886914|FG007|Overall Study|Disease progression|3|||
46671604|NCT01236352|82886915|FG008|Overall Study|Disease progression|2|||
46671605|NCT01236352|82886916|FG009|Overall Study|Disease progression|2|||
46671606|NCT01236352|82886917|FG010|Overall Study|Disease progression|2|||
46671607|NCT01236352|82886907|FG000|Overall Study|Poor/Non-compliance|1|||
46972975|NCT01966432|83216650|FG001|Overall Study|Withdrawal by Subject|3|||
46671608|NCT01236352|82886908|FG001|Overall Study|Poor/Non-compliance|0|||
46671609|NCT01236352|82886909|FG002|Overall Study|Poor/Non-compliance|0|||
46671610|NCT01236352|82886910|FG003|Overall Study|Poor/Non-compliance|0|||
46671611|NCT01236352|82886911|FG004|Overall Study|Poor/Non-compliance|0|||
46671612|NCT01236352|82886912|FG005|Overall Study|Poor/Non-compliance|0|||
46671613|NCT01236352|82886913|FG006|Overall Study|Poor/Non-compliance|0|||
46671614|NCT01236352|82886914|FG007|Overall Study|Poor/Non-compliance|0|||
46671615|NCT01236352|82886915|FG008|Overall Study|Poor/Non-compliance|0|||
46671616|NCT01236352|82886916|FG009|Overall Study|Poor/Non-compliance|0|||
46671617|NCT01236352|82886917|FG010|Overall Study|Poor/Non-compliance|0|||
46671618|NCT01236352|82886907|FG000|Overall Study|Maximum clinical benefit|1|||
46671619|NCT01236352|82886908|FG001|Overall Study|Maximum clinical benefit|1|||
47077406|NCT01440374|83377406|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
47077407|NCT01440374|83377407|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
47077408|NCT01440374|83377404|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
47077409|NCT01440374|83377405|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
47077410|NCT01440374|83377406|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
47077411|NCT01440374|83377407|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
47077412|NCT01440374|83377404|FG000|Part 2; Double-blind Phase|Not treated|0|||
46671620|NCT01236352|82886909|FG002|Overall Study|Maximum clinical benefit|1|||
46671621|NCT01236352|82886910|FG003|Overall Study|Maximum clinical benefit|0|||
46671622|NCT01236352|82886911|FG004|Overall Study|Maximum clinical benefit|2|||
46671623|NCT01236352|82886912|FG005|Overall Study|Maximum clinical benefit|0|||
46671624|NCT01236352|82886913|FG006|Overall Study|Maximum clinical benefit|3|||
46671625|NCT01236352|82886914|FG007|Overall Study|Maximum clinical benefit|1|||
46671626|NCT01236352|82886915|FG008|Overall Study|Maximum clinical benefit|1|||
46671627|NCT01236352|82886916|FG009|Overall Study|Maximum clinical benefit|4|||
46671628|NCT01236352|82886917|FG010|Overall Study|Maximum clinical benefit|2|||
46671629|NCT01236352|82886907|FG000|Overall Study|Subject request to discontinue treatment|0|||
46671630|NCT01236352|82886908|FG001|Overall Study|Subject request to discontinue treatment|0|||
46671631|NCT01236352|82886909|FG002|Overall Study|Subject request to discontinue treatment|1|||
46671632|NCT01236352|82886910|FG003|Overall Study|Subject request to discontinue treatment|1|||
46671633|NCT01236352|82886911|FG004|Overall Study|Subject request to discontinue treatment|0|||
46671634|NCT01236352|82886912|FG005|Overall Study|Subject request to discontinue treatment|1|||
46671635|NCT01236352|82886913|FG006|Overall Study|Subject request to discontinue treatment|0|||
46671636|NCT01236352|82886914|FG007|Overall Study|Subject request to discontinue treatment|0|||
46671637|NCT01236352|82886915|FG008|Overall Study|Subject request to discontinue treatment|0|||
46671638|NCT01236352|82886916|FG009|Overall Study|Subject request to discontinue treatment|1|||
46671639|NCT01236352|82886917|FG010|Overall Study|Subject request to discontinue treatment|4|||
46671640|NCT01236352|82886907|FG000|Overall Study|Subject to receive drug via EAP|1|||
46671641|NCT01236352|82886908|FG001|Overall Study|Subject to receive drug via EAP|1|||
46671642|NCT01236352|82886909|FG002|Overall Study|Subject to receive drug via EAP|1|||
46671643|NCT01236352|82886910|FG003|Overall Study|Subject to receive drug via EAP|0|||
46671644|NCT01236352|82886911|FG004|Overall Study|Subject to receive drug via EAP|0|||
46671645|NCT01236352|82886912|FG005|Overall Study|Subject to receive drug via EAP|0|||
46671646|NCT01236352|82886913|FG006|Overall Study|Subject to receive drug via EAP|0|||
46671647|NCT01236352|82886914|FG007|Overall Study|Subject to receive drug via EAP|2|||
46671648|NCT01236352|82886915|FG008|Overall Study|Subject to receive drug via EAP|0|||
46671649|NCT01236352|82886916|FG009|Overall Study|Subject to receive drug via EAP|4|||
46671650|NCT01236352|82886917|FG010|Overall Study|Subject to receive drug via EAP|0|||
46671651|NCT01236352|82886907|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
46671652|NCT01236352|82886908|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
46671653|NCT01236352|82886909|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
46671654|NCT01236352|82886910|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
46671655|NCT01236352|82886911|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
46671656|NCT01236352|82886912|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
46671657|NCT01236352|82886913|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
46671658|NCT01236352|82886914|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
46671659|NCT01236352|82886915|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
46671660|NCT01236352|82886916|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
46671661|NCT01236352|82886917|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
46671662|NCT01236352|82886907|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671663|NCT01236352|82886908|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671664|NCT01236352|82886909|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671665|NCT01236352|82886910|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671666|NCT01236352|82886911|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671667|NCT01236352|82886912|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671668|NCT01236352|82886913|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671669|NCT01236352|82886914|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671670|NCT01236352|82886915|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671671|NCT01236352|82886916|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
46671672|NCT01236352|82886917|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
46671673|NCT01236352|82886907|FG000|Overall Study|Lack of response to drug|0|||
46671674|NCT01236352|82886908|FG001|Overall Study|Lack of response to drug|0|||
46671675|NCT01236352|82886909|FG002|Overall Study|Lack of response to drug|0|||
46786526|NCT00561795|83005622|FG003|Overall Study|Adverse Event|0|||
47077413|NCT01440374|83377405|FG001|Part 2; Double-blind Phase|Not treated|0|||
47077414|NCT01440374|83377406|FG002|Part 2; Double-blind Phase|Not treated|1|||
46671676|NCT01236352|82886910|FG003|Overall Study|Lack of response to drug|0|||
46671677|NCT01236352|82886911|FG004|Overall Study|Lack of response to drug|0|||
46671678|NCT01236352|82886912|FG005|Overall Study|Lack of response to drug|0|||
46671679|NCT01236352|82886913|FG006|Overall Study|Lack of response to drug|0|||
46671680|NCT01236352|82886914|FG007|Overall Study|Lack of response to drug|0|||
46671681|NCT01236352|82886915|FG008|Overall Study|Lack of response to drug|0|||
46671682|NCT01236352|82886916|FG009|Overall Study|Lack of response to drug|1|||
46671683|NCT01236352|82886917|FG010|Overall Study|Lack of response to drug|1|||
46671684|NCT01236352|82886907|FG000|Overall Study|Patient transferred to IST|0|||
46671685|NCT01236352|82886908|FG001|Overall Study|Patient transferred to IST|0|||
46671686|NCT01236352|82886909|FG002|Overall Study|Patient transferred to IST|0|||
46671687|NCT01236352|82886910|FG003|Overall Study|Patient transferred to IST|0|||
46671688|NCT01236352|82886911|FG004|Overall Study|Patient transferred to IST|0|||
46671689|NCT01236352|82886912|FG005|Overall Study|Patient transferred to IST|0|||
46671690|NCT01236352|82886913|FG006|Overall Study|Patient transferred to IST|0|||
46671691|NCT01236352|82886914|FG007|Overall Study|Patient transferred to IST|0|||
46671692|NCT01236352|82886915|FG008|Overall Study|Patient transferred to IST|0|||
46671693|NCT01236352|82886916|FG009|Overall Study|Patient transferred to IST|2|||
46671694|NCT01236352|82886917|FG010|Overall Study|Patient transferred to IST|6|||
46671695|NCT01236118|82886944|FG000|Overall Study|Adverse Event|2|||
46671696|NCT01236118|82886945|FG001|Overall Study|Adverse Event|0|||
46786527|NCT00561795|83005619|FG000|Overall Study|Study Closed/Terminated|0|||
46786528|NCT00561795|83005620|FG001|Overall Study|Study Closed/Terminated|3|||
46786529|NCT00561795|83005621|FG002|Overall Study|Study Closed/Terminated|0|||
46786530|NCT00561795|83005622|FG003|Overall Study|Study Closed/Terminated|0|||
46786531|NCT00561795|83005619|FG000|Overall Study|Physician Decision|1|||
46786532|NCT00561795|83005620|FG001|Overall Study|Physician Decision|0|||
46786533|NCT00561795|83005621|FG002|Overall Study|Physician Decision|0|||
46786534|NCT00561795|83005622|FG003|Overall Study|Physician Decision|0|||
46786535|NCT00652626|83005637|FG000|Initial Treatment Phase|Adverse Event|0|||
46786536|NCT00652626|83005638|FG001|Initial Treatment Phase|Adverse Event|0|||
46786537|NCT00652626|83005639|FG002|Initial Treatment Phase|Adverse Event|0|||
46786538|NCT00652626|83005640|FG003|Initial Treatment Phase|Adverse Event|0|||
46786539|NCT00652626|83005641|FG004|Initial Treatment Phase|Adverse Event|1|||
46786540|NCT00652626|83005642|FG005|Initial Treatment Phase|Adverse Event|0|||
46786541|NCT00652626|83005643|FG006|Initial Treatment Phase|Adverse Event|0|||
46786542|NCT00652626|83005637|FG000|Initial Treatment Phase|Protocol Violation|0|||
46786543|NCT00652626|83005638|FG001|Initial Treatment Phase|Protocol Violation|0|||
46786544|NCT00652626|83005639|FG002|Initial Treatment Phase|Protocol Violation|0|||
46786545|NCT00652626|83005640|FG003|Initial Treatment Phase|Protocol Violation|1|||
46786546|NCT00652626|83005641|FG004|Initial Treatment Phase|Protocol Violation|0|||
46786547|NCT00652626|83005642|FG005|Initial Treatment Phase|Protocol Violation|0|||
46786548|NCT00652626|83005643|FG006|Initial Treatment Phase|Protocol Violation|0|||
46786549|NCT00652626|83005637|FG000|Initial Treatment Phase|Physician Decision|0|||
46786550|NCT00652626|83005638|FG001|Initial Treatment Phase|Physician Decision|0|||
46786551|NCT00652626|83005639|FG002|Initial Treatment Phase|Physician Decision|0|||
46786552|NCT00652626|83005640|FG003|Initial Treatment Phase|Physician Decision|0|||
46786553|NCT00652626|83005641|FG004|Initial Treatment Phase|Physician Decision|1|||
46786554|NCT00652626|83005642|FG005|Initial Treatment Phase|Physician Decision|0|||
46786555|NCT00652626|83005643|FG006|Initial Treatment Phase|Physician Decision|0|||
46786556|NCT00652626|83005637|FG000|Initial Treatment Phase|Sponsor Request|0|||
46786557|NCT00652626|83005638|FG001|Initial Treatment Phase|Sponsor Request|0|||
46671697|NCT01236118|82886946|FG002|Overall Study|Adverse Event|2|||
46671698|NCT01236118|82886944|FG000|Overall Study|Physician Decision|0|||
46671699|NCT01236118|82886945|FG001|Overall Study|Physician Decision|1|||
46671700|NCT01236118|82886946|FG002|Overall Study|Physician Decision|0|||
46671701|NCT01236118|82886944|FG000|Overall Study|Withdrawal by Subject|0|||
46671702|NCT01236118|82886945|FG001|Overall Study|Withdrawal by Subject|0|||
46786558|NCT00652626|83005639|FG002|Initial Treatment Phase|Sponsor Request|1|||
46786559|NCT00652626|83005640|FG003|Initial Treatment Phase|Sponsor Request|0|||
46786560|NCT00652626|83005641|FG004|Initial Treatment Phase|Sponsor Request|0|||
46786561|NCT00652626|83005642|FG005|Initial Treatment Phase|Sponsor Request|0|||
46786562|NCT00652626|83005643|FG006|Initial Treatment Phase|Sponsor Request|0|||
46786563|NCT00652626|83005637|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
46786564|NCT00652626|83005638|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
46786565|NCT00652626|83005639|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
46851600|NCT00110019|83067178|FG000|Overall Study|Adverse Event|61|||
46671703|NCT01236118|82886946|FG002|Overall Study|Withdrawal by Subject|1|||
46671704|NCT01236001|82886956|FG000|Overall Study|Adverse Event|5|||
46786566|NCT00652626|83005640|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
46786567|NCT00652626|83005641|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
46786568|NCT00652626|83005642|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
46786569|NCT00652626|83005643|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
46851601|NCT00110019|83067179|FG001|Overall Study|Adverse Event|40|||
46786570|NCT00652626|83005637|FG000|Extension Phase|Withdrawal by Subject|0|||
46786571|NCT00652626|83005638|FG001|Extension Phase|Withdrawal by Subject|0|||
46786572|NCT00652626|83005639|FG002|Extension Phase|Withdrawal by Subject|0|||
46972976|NCT01966432|83216651|FG002|Overall Study|Withdrawal by Subject|0|||
46972977|NCT01966432|83216649|FG000|Overall Study|Subject Incarcerated|0|||
46972978|NCT01966432|83216650|FG001|Overall Study|Subject Incarcerated|0|||
46972979|NCT01966432|83216651|FG002|Overall Study|Subject Incarcerated|1|||
46972980|NCT01966432|83216649|FG000|Overall Study|SBIRT program ended|1|||
46972981|NCT01966432|83216650|FG001|Overall Study|SBIRT program ended|8|||
46972982|NCT01966432|83216651|FG002|Overall Study|SBIRT program ended|20|||
46972983|NCT02702401|83216663|FG000|Overall Study|Death|242|||
46972984|NCT02702401|83216664|FG001|Overall Study|Death|125|||
46972985|NCT02702401|83216663|FG000|Overall Study|Withdrawal by Subject|15|||
46972986|NCT02702401|83216664|FG001|Overall Study|Withdrawal by Subject|5|||
46972987|NCT02702401|83216663|FG000|Overall Study|Sponsor Decision|19|||
46972988|NCT02702401|83216664|FG001|Overall Study|Sponsor Decision|3|||
46972989|NCT02702401|83216663|FG000|Overall Study|Physician Decision|1|||
46972990|NCT02702401|83216664|FG001|Overall Study|Physician Decision|2|||
46972991|NCT02702401|83216663|FG000|Overall Study|Lost to Follow-up|1|||
46972992|NCT02702401|83216664|FG001|Overall Study|Lost to Follow-up|0|||
46972993|NCT02703337|83216671|FG000|Period One (Part A)|Withdrawal by Subject|0|||
46972994|NCT02703337|83216672|FG001|Period One (Part A)|Withdrawal by Subject|0|||
46972995|NCT02703337|83216673|FG002|Period One (Part A)|Withdrawal by Subject|0|||
46972996|NCT02703337|83216674|FG003|Period One (Part A)|Withdrawal by Subject|0|||
46972997|NCT02703337|83216675|FG004|Period One (Part A)|Withdrawal by Subject|1|||
46972998|NCT02703337|83216676|FG005|Period One (Part A)|Withdrawal by Subject|0|||
46972999|NCT02703337|83216677|FG006|Period One (Part A)|Withdrawal by Subject|0|||
46973000|NCT02703337|83216678|FG007|Period One (Part A)|Withdrawal by Subject|0|||
46973001|NCT01680497|83216696|FG000|Overall Study|Lost to Follow-up|2|||
46973002|NCT01680341|83216702|FG000|Overall Study|Adverse Event|3|||
46973003|NCT01680341|83216703|FG001|Overall Study|Adverse Event|2|||
46973004|NCT01680341|83216702|FG000|Overall Study|Unclassified|18|||
46973005|NCT01680341|83216703|FG001|Overall Study|Unclassified|15|||
46973006|NCT01679405|83216711|FG000|Overall Study|Death|2|||
46973007|NCT01679405|83216712|FG001|Overall Study|Death|5|||
46973008|NCT01603355|83216718|FG000|Overall Study|Lack of Efficacy|2|||
46973009|NCT02703259|83216724|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
46973010|NCT02703259|83216725|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
46973011|NCT02703259|83216724|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
46973012|NCT02703259|83216725|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
46973013|NCT02703259|83216724|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
46973014|NCT02703259|83216725|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
46973015|NCT00701701|83216733|FG000|Overall Study|Withdrawal by Subject|0|||
46973016|NCT00701701|83216734|FG001|Overall Study|Withdrawal by Subject|1|||
46973017|NCT00701701|83216733|FG000|Overall Study|Adverse Event|0|||
46973018|NCT00701701|83216734|FG001|Overall Study|Adverse Event|1|||
46973019|NCT01989754|83216743|FG000|Overall Study|Withdrawal by Subject|10|||
46973020|NCT01989754|83216744|FG001|Overall Study|Withdrawal by Subject|14|||
46973021|NCT01989754|83216743|FG000|Overall Study|Lost to Follow-up|28|||
46973022|NCT01989754|83216744|FG001|Overall Study|Lost to Follow-up|20|||
46973023|NCT01989754|83216743|FG000|Overall Study|Closed Site|1|||
46973024|NCT01989754|83216744|FG001|Overall Study|Closed Site|1|||
46973025|NCT01619878|83216750|FG000|6 Week Follow-up Phase|Adverse Event|1|||
46973026|NCT01619878|83216750|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
46973027|NCT01619878|83216750|FG000|Follow-up at 12 Months of Age|Death|2|||
46973028|NCT02015104|83216756|FG000|Overall Study|Withdrew consent after first dose drug|1|||
46973029|NCT02015104|83216757|FG001|Overall Study|Withdrew consent after first dose drug|0|||
46973030|NCT02015104|83216756|FG000|Overall Study|Withdrew consent prior to treatment|0|||
46973031|NCT02015104|83216757|FG001|Overall Study|Withdrew consent prior to treatment|1|||
46973032|NCT01619800|83216768|FG000|Overall Study|study terminated|2|||
47077415|NCT01440374|83377407|FG003|Part 2; Double-blind Phase|Not treated|0|||
47077416|NCT01440374|83377404|FG000|Part 3: Extension|Withdrawal by Subject|0|||
46973033|NCT01619800|83216769|FG001|Overall Study|study terminated|0|||
47077417|NCT01440374|83377405|FG001|Part 3: Extension|Withdrawal by Subject|0|||
46973034|NCT01989208|83216777|FG000|200 mg (7 Days)|Protocol Violation|0|||
46973035|NCT01989208|83216778|FG001|200 mg (7 Days)|Protocol Violation|1|||
46973036|NCT01619410|83216798|FG000|Overall Study|Lost to Follow-up|7|||
46973037|NCT01619410|83216799|FG001|Overall Study|Lost to Follow-up|4|||
47077418|NCT01440374|83377406|FG002|Part 3: Extension|Withdrawal by Subject|0|||
46786573|NCT00652626|83005640|FG003|Extension Phase|Withdrawal by Subject|0|||
46973038|NCT01966042|83216805|FG000|Overall Study|Death|2|||
46973039|NCT02014480|83216809|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
47077419|NCT01440374|83377407|FG003|Part 3: Extension|Withdrawal by Subject|5|||
46973040|NCT02014480|83216810|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
46973041|NCT02014480|83216811|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
46973042|NCT02014480|83216812|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
46786574|NCT00652626|83005641|FG004|Extension Phase|Withdrawal by Subject|0|||
46786575|NCT00652626|83005642|FG005|Extension Phase|Withdrawal by Subject|2|||
46786576|NCT00652626|83005643|FG006|Extension Phase|Withdrawal by Subject|0|||
46851602|NCT00110019|83067178|FG000|Overall Study|Death|13|||
46851603|NCT00110019|83067179|FG001|Overall Study|Death|15|||
46851604|NCT00110019|83067178|FG000|Overall Study|Withdrawal by Subject|21|||
46851605|NCT00110019|83067179|FG001|Overall Study|Withdrawal by Subject|9|||
46851606|NCT00110019|83067178|FG000|Overall Study|alternative therapy|5|||
46851607|NCT00110019|83067179|FG001|Overall Study|alternative therapy|1|||
46851608|NCT00110019|83067178|FG000|Overall Study|complicating disease|1|||
46851609|NCT00110019|83067179|FG001|Overall Study|complicating disease|1|||
46671705|NCT01236001|82886957|FG001|Overall Study|Adverse Event|14|||
46671706|NCT01236001|82886956|FG000|Overall Study|Lack of Efficacy|6|||
46671707|NCT01236001|82886957|FG001|Overall Study|Lack of Efficacy|6|||
46671708|NCT01236001|82886956|FG000|Overall Study|Lost to Follow-up|6|||
46671709|NCT01236001|82886957|FG001|Overall Study|Lost to Follow-up|1|||
46786577|NCT00652626|83005637|FG000|Extension Phase|Adverse Event|0|||
46786578|NCT00652626|83005638|FG001|Extension Phase|Adverse Event|0|||
46786579|NCT00652626|83005639|FG002|Extension Phase|Adverse Event|0|||
46786580|NCT00652626|83005640|FG003|Extension Phase|Adverse Event|0|||
46786581|NCT00652626|83005641|FG004|Extension Phase|Adverse Event|0|||
46786582|NCT00652626|83005642|FG005|Extension Phase|Adverse Event|2|||
46786583|NCT00652626|83005643|FG006|Extension Phase|Adverse Event|1|||
46786584|NCT00652626|83005637|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
46671710|NCT01236001|82886956|FG000|Overall Study|Incompliance|1|||
46671711|NCT01236001|82886957|FG001|Overall Study|Incompliance|0|||
46671712|NCT01236001|82886956|FG000|Overall Study|Planned Visit After End of Study|0|||
46671713|NCT01236001|82886957|FG001|Overall Study|Planned Visit After End of Study|1|||
46671714|NCT01229254|82886967|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
46671715|NCT01229254|82886968|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
46671716|NCT01229254|82886969|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
46671717|NCT01229254|82886967|FG000|Overall Study|Adverse Event|4|||
46671718|NCT01229254|82886968|FG001|Overall Study|Adverse Event|5|||
46671719|NCT01229254|82886969|FG002|Overall Study|Adverse Event|3|||
46671720|NCT01229254|82886967|FG000|Overall Study|Lost to Follow-up|3|||
46671721|NCT01229254|82886968|FG001|Overall Study|Lost to Follow-up|0|||
46786585|NCT00652626|83005638|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
46786586|NCT00652626|83005639|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
46786587|NCT00652626|83005640|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
46786588|NCT00652626|83005641|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
46786589|NCT00652626|83005642|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
46786590|NCT00652626|83005643|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
46671722|NCT01229254|82886969|FG002|Overall Study|Lost to Follow-up|1|||
46671723|NCT01229254|82886967|FG000|Overall Study|Physician Decision|0|||
46671724|NCT01229254|82886968|FG001|Overall Study|Physician Decision|3|||
46671725|NCT01229254|82886969|FG002|Overall Study|Physician Decision|0|||
46671726|NCT01229254|82886967|FG000|Overall Study|Protocol Violation|4|||
46671727|NCT01229254|82886968|FG001|Overall Study|Protocol Violation|6|||
46671728|NCT01229254|82886969|FG002|Overall Study|Protocol Violation|5|||
46671729|NCT01229254|82886967|FG000|Overall Study|Withdrawal by Subject|1|||
46671730|NCT01229254|82886968|FG001|Overall Study|Withdrawal by Subject|0|||
46671731|NCT01229254|82886969|FG002|Overall Study|Withdrawal by Subject|1|||
46671732|NCT01229254|82886967|FG000|Overall Study|Non-compliance with Study Drug|0|||
46671733|NCT01229254|82886968|FG001|Overall Study|Non-compliance with Study Drug|1|||
46671734|NCT01229254|82886969|FG002|Overall Study|Non-compliance with Study Drug|1|||
46786591|NCT00652626|83005637|FG000|Extension Phase|Physician Decision|0|||
46786592|NCT00652626|83005638|FG001|Extension Phase|Physician Decision|0|||
46786593|NCT00652626|83005639|FG002|Extension Phase|Physician Decision|0|||
46786594|NCT00652626|83005640|FG003|Extension Phase|Physician Decision|0|||
46786595|NCT00652626|83005641|FG004|Extension Phase|Physician Decision|0|||
46786596|NCT00652626|83005642|FG005|Extension Phase|Physician Decision|1|||
46851610|NCT00110019|83067178|FG000|Overall Study|symptom deterioration|13|||
46671735|NCT01235728|82886978|FG000|Overall Study|Protocol Violation|0|||
46671736|NCT01235728|82886979|FG001|Overall Study|Protocol Violation|0|||
46671737|NCT01235728|82886980|FG002|Overall Study|Protocol Violation|0|||
46671738|NCT01235728|82886981|FG003|Overall Study|Protocol Violation|1|||
46786597|NCT00652626|83005643|FG006|Extension Phase|Physician Decision|1|||
46786598|NCT00652626|83005637|FG000|Extension Phase|Death|0|||
46786599|NCT00652626|83005638|FG001|Extension Phase|Death|0|||
46786600|NCT00652626|83005639|FG002|Extension Phase|Death|0|||
46786601|NCT00652626|83005640|FG003|Extension Phase|Death|0|||
46851611|NCT00110019|83067179|FG001|Overall Study|symptom deterioration|16|||
46671739|NCT01235728|82886982|FG004|Overall Study|Protocol Violation|0|||
46671740|NCT01235728|82886983|FG005|Overall Study|Protocol Violation|0|||
46671741|NCT01235728|82886984|FG006|Overall Study|Protocol Violation|0|||
46671742|NCT01235728|82886985|FG007|Overall Study|Protocol Violation|0|||
46671743|NCT01235689|82886995|FG000|Overall Study|Adverse Event|12|||
46671744|NCT01235689|82886996|FG001|Overall Study|Adverse Event|16|||
46671745|NCT01235689|82886995|FG000|Overall Study|Lack of Efficacy|12|||
46671746|NCT01235689|82886996|FG001|Overall Study|Lack of Efficacy|5|||
46671747|NCT01235689|82886995|FG000|Overall Study|Withdrawal by Subject|3|||
46671748|NCT01235689|82886996|FG001|Overall Study|Withdrawal by Subject|4|||
46671749|NCT01235689|82886995|FG000|Overall Study|Lost to Follow-up|1|||
46671750|NCT01235689|82886996|FG001|Overall Study|Lost to Follow-up|2|||
46671751|NCT01235689|82886995|FG000|Overall Study|Miscellaneous|1|||
46671752|NCT01235689|82886996|FG001|Overall Study|Miscellaneous|5|||
46671753|NCT01229176|82887010|FG000|Overall Study|Withdrawal by Subject|0|||
46671754|NCT01229176|82887011|FG001|Overall Study|Withdrawal by Subject|0|||
46671755|NCT01229176|82887012|FG002|Overall Study|Withdrawal by Subject|0|||
46671756|NCT01229176|82887013|FG003|Overall Study|Withdrawal by Subject|1|||
46671757|NCT01229176|82887014|FG004|Overall Study|Withdrawal by Subject|1|||
46671758|NCT01229176|82887015|FG005|Overall Study|Withdrawal by Subject|1|||
46671759|NCT01229176|82887016|FG006|Overall Study|Withdrawal by Subject|0|||
46671760|NCT01229176|82887017|FG007|Overall Study|Withdrawal by Subject|1|||
46671761|NCT01229176|82887010|FG000|Overall Study|Lost to Follow-up|0|||
46671762|NCT01229176|82887011|FG001|Overall Study|Lost to Follow-up|3|||
46671763|NCT01229176|82887012|FG002|Overall Study|Lost to Follow-up|0|||
46671764|NCT01229176|82887013|FG003|Overall Study|Lost to Follow-up|0|||
46671765|NCT01229176|82887014|FG004|Overall Study|Lost to Follow-up|1|||
46671766|NCT01229176|82887015|FG005|Overall Study|Lost to Follow-up|1|||
46671767|NCT01229176|82887016|FG006|Overall Study|Lost to Follow-up|0|||
46671768|NCT01229176|82887017|FG007|Overall Study|Lost to Follow-up|2|||
46671769|NCT01228747|82887037|FG000|Overall Study|Adverse Event|8|||
46671770|NCT01228747|82887038|FG001|Overall Study|Adverse Event|4|||
46671771|NCT01228747|82887037|FG000|Overall Study|Lack of Efficacy|40|||
46671772|NCT01228747|82887038|FG001|Overall Study|Lack of Efficacy|27|||
46786602|NCT00652626|83005641|FG004|Extension Phase|Death|0|||
47077420|NCT01440374|83377404|FG000|Part 3: Extension|Adverse Event|0|||
47077421|NCT01440374|83377405|FG001|Part 3: Extension|Adverse Event|0|||
47077422|NCT01440374|83377406|FG002|Part 3: Extension|Adverse Event|0|||
47077423|NCT01440374|83377407|FG003|Part 3: Extension|Adverse Event|13|||
47077424|NCT01440374|83377404|FG000|Part 3: Extension|Physician Decision|0|||
47077425|NCT01440374|83377405|FG001|Part 3: Extension|Physician Decision|0|||
47077426|NCT01440374|83377406|FG002|Part 3: Extension|Physician Decision|0|||
47077427|NCT01440374|83377407|FG003|Part 3: Extension|Physician Decision|14|||
47077428|NCT01666782|83377555|FG000|Overall Study|Received 2 doses of vaccine|0|||
47077429|NCT01666782|83377556|FG001|Overall Study|Received 2 doses of vaccine|1|||
47077430|NCT01666782|83377555|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
47077431|NCT01666782|83377556|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
47077432|NCT01439360|83377572|FG000|Overall Study|Adverse Event|4|||
47077433|NCT01439360|83377573|FG001|Overall Study|Adverse Event|16|||
47077434|NCT01439360|83377572|FG000|Overall Study|Lost to Follow-up|43|||
47077435|NCT01439360|83377573|FG001|Overall Study|Lost to Follow-up|58|||
46671773|NCT01228747|82887037|FG000|Overall Study|Protocol Violation|6|||
46671774|NCT01228747|82887038|FG001|Overall Study|Protocol Violation|5|||
46671775|NCT01228747|82887037|FG000|Overall Study|Lost to Follow-up|4|||
46671776|NCT01228747|82887038|FG001|Overall Study|Lost to Follow-up|3|||
46671777|NCT01228747|82887037|FG000|Overall Study|Withdrawal by Subject|5|||
46671778|NCT01228747|82887038|FG001|Overall Study|Withdrawal by Subject|1|||
46671779|NCT01228747|82887037|FG000|Overall Study|Other Reason|2|||
46671780|NCT01228747|82887038|FG001|Overall Study|Other Reason|5|||
46671781|NCT01228591|82887044|FG000|Baseline|Lack of Efficacy|1|||
46671782|NCT01228591|82887045|FG001|Baseline|Lack of Efficacy|2|||
47077436|NCT01439360|83377572|FG000|Overall Study|Others|10|||
46671783|NCT01235338|82887057|FG000|Overall Study|Adverse Event|3|||
46671784|NCT01235338|82887058|FG001|Overall Study|Adverse Event|2|||
46671785|NCT01235338|82887057|FG000|Overall Study|Protocol Violation|1|||
46671786|NCT01235338|82887058|FG001|Overall Study|Protocol Violation|1|||
46671787|NCT01235338|82887057|FG000|Overall Study|Withdrawal by Subject|5|||
46671788|NCT01235338|82887058|FG001|Overall Study|Withdrawal by Subject|0|||
46671789|NCT01235338|82887057|FG000|Overall Study|Exclusion criteria violations|1|||
46671790|NCT01235338|82887058|FG001|Overall Study|Exclusion criteria violations|1|||
46671791|NCT01235338|82887057|FG000|Overall Study|Positive drug screen|0|||
46671792|NCT01235338|82887058|FG001|Overall Study|Positive drug screen|1|||
46671793|NCT01235338|82887057|FG000|Overall Study|Prohibited meds|1|||
46671794|NCT01235338|82887058|FG001|Overall Study|Prohibited meds|0|||
46671795|NCT01234675|82887066|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
46671796|NCT01234675|82887067|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
46671797|NCT01234675|82887066|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
46671798|NCT01234675|82887067|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
46671799|NCT01228318|82887075|FG000|Overall Study|Clinic no show to receive intervention|1|||
46671800|NCT01228318|82887076|FG001|Overall Study|Clinic no show to receive intervention|0|||
46671801|NCT01228318|82887075|FG000|Overall Study|Unable to contact|2|||
46671802|NCT01228318|82887076|FG001|Overall Study|Unable to contact|5|||
46671803|NCT01228318|82887075|FG000|Overall Study|Moved|0|||
46671804|NCT01228318|82887076|FG001|Overall Study|Moved|2|||
46671805|NCT01228318|82887075|FG000|Overall Study|Incarcerated|1|||
46671806|NCT01228318|82887076|FG001|Overall Study|Incarcerated|0|||
46671807|NCT01227967|82887084|FG000|Overall Study|Protocol Violation|3|||
46671808|NCT01227967|82887085|FG001|Overall Study|Protocol Violation|1|||
46671809|NCT01227967|82887084|FG000|Overall Study|Death|0|||
46671810|NCT01227967|82887085|FG001|Overall Study|Death|1|||
46671811|NCT01227967|82887084|FG000|Overall Study|Lost to Follow-up|8|||
46671812|NCT01227967|82887085|FG001|Overall Study|Lost to Follow-up|3|||
46671813|NCT01227967|82887084|FG000|Overall Study|Withdrawal by Subject|4|||
46671814|NCT01227967|82887085|FG001|Overall Study|Withdrawal by Subject|3|||
46671815|NCT01227967|82887084|FG000|Overall Study|Physician Decision|0|||
46671816|NCT01227967|82887085|FG001|Overall Study|Physician Decision|1|||
46671817|NCT01227967|82887084|FG000|Overall Study|Never Started Treatment|0|||
46671818|NCT01227967|82887085|FG001|Overall Study|Never Started Treatment|4|||
46671819|NCT01227967|82887084|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
46671820|NCT01227967|82887085|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
46671821|NCT01227928|82887093|FG000|Overall Study|Lost to Follow-up|4|||
46671822|NCT01227928|82887094|FG001|Overall Study|Lost to Follow-up|2|||
46671823|NCT01227928|82887093|FG000|Overall Study|Withdrawal by Subject|4|||
46671824|NCT01227928|82887094|FG001|Overall Study|Withdrawal by Subject|3|||
46786603|NCT00652626|83005642|FG005|Extension Phase|Death|1|||
46786604|NCT00652626|83005643|FG006|Extension Phase|Death|1|||
46786605|NCT00560703|83005663|FG000|Overall Study|Adverse Event|0|||
46786606|NCT00560703|83005664|FG001|Overall Study|Adverse Event|2|||
46786607|NCT00560703|83005663|FG000|Overall Study|Protocol Violation|0|||
46786608|NCT00560703|83005664|FG001|Overall Study|Protocol Violation|2|||
46786609|NCT00560703|83005663|FG000|Overall Study|Withdrawal by Subject|0|||
46786610|NCT00560703|83005664|FG001|Overall Study|Withdrawal by Subject|1|||
46786611|NCT00560703|83005663|FG000|Overall Study|non-compliance|0|||
46786612|NCT00560703|83005664|FG001|Overall Study|non-compliance|1|||
46786613|NCT00308737|83005673|FG000|Overall Study|Adverse Event|104|||
46786614|NCT00308737|83005674|FG001|Overall Study|Adverse Event|9|||
46786615|NCT00308737|83005675|FG002|Overall Study|Adverse Event|0|||
46973043|NCT02014480|83216813|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
46671825|NCT01227928|82887093|FG000|Overall Study|Death|14|||
46671826|NCT01227928|82887094|FG001|Overall Study|Death|12|||
46671827|NCT01227889|82887102|FG000|Randomized Phase (RP)|Adverse Event|13|||
46671828|NCT01227889|82887103|FG001|Randomized Phase (RP)|Adverse Event|0|||
46671829|NCT01227889|82887102|FG000|Randomized Phase (RP)|Physician Decision|13|||
46786616|NCT00308737|83005673|FG000|Overall Study|Death|4|||
46786617|NCT00308737|83005674|FG001|Overall Study|Death|3|||
46786618|NCT00308737|83005675|FG002|Overall Study|Death|0|||
46786619|NCT00308737|83005673|FG000|Overall Study|Lost to Follow-up|56|||
46786620|NCT00308737|83005674|FG001|Overall Study|Lost to Follow-up|80|||
46786621|NCT00308737|83005675|FG002|Overall Study|Lost to Follow-up|5|||
46786622|NCT00308737|83005673|FG000|Overall Study|Physician Decision|15|||
46671830|NCT01227889|82887103|FG001|Randomized Phase (RP)|Physician Decision|5|||
46786623|NCT00308737|83005674|FG001|Overall Study|Physician Decision|2|||
46671831|NCT01227889|82887102|FG000|Randomized Phase (RP)|Progressive Disease|135|||
46671832|NCT01227889|82887103|FG001|Randomized Phase (RP)|Progressive Disease|52|||
46671833|NCT01227889|82887102|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
46671834|NCT01227889|82887103|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
46671835|NCT01227889|82887102|FG000|Randomized Phase (RP)|Missing|1|||
46671836|NCT01227889|82887103|FG001|Randomized Phase (RP)|Missing|3|||
46671837|NCT01227889|82887102|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
46671838|NCT01227889|82887103|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
46786624|NCT00308737|83005675|FG002|Overall Study|Physician Decision|1|||
46786625|NCT00308737|83005673|FG000|Overall Study|Protocol Violation|34|||
46786626|NCT00308737|83005674|FG001|Overall Study|Protocol Violation|9|||
46786627|NCT00308737|83005675|FG002|Overall Study|Protocol Violation|5|||
46786628|NCT00308737|83005673|FG000|Overall Study|Withdrawal by Subject|218|||
46786629|NCT00308737|83005674|FG001|Overall Study|Withdrawal by Subject|166|||
46786630|NCT00308737|83005675|FG002|Overall Study|Withdrawal by Subject|18|||
46786631|NCT00308737|83005673|FG000|Overall Study|Various|32|||
46786632|NCT00308737|83005674|FG001|Overall Study|Various|20|||
46786633|NCT00308737|83005675|FG002|Overall Study|Various|8|||
46786634|NCT00655746|83005683|FG000|Overall Study|Withdrawal by Subject|1|||
47077437|NCT01439360|83377573|FG001|Overall Study|Others|5|||
47077438|NCT01439360|83377572|FG000|Overall Study|Protocol Violation|1|||
46671839|NCT01227889|82887102|FG000|Crossover Phase|Adverse Event|0|||
47077439|NCT01439360|83377573|FG001|Overall Study|Protocol Violation|0|||
47077440|NCT01439360|83377572|FG000|Overall Study|Withdrawal by Subject|140|||
46671840|NCT01227889|82887103|FG001|Crossover Phase|Adverse Event|1|||
46671841|NCT01227889|82887102|FG000|Crossover Phase|Physician Decision|0|||
46671842|NCT01227889|82887103|FG001|Crossover Phase|Physician Decision|3|||
46671843|NCT01227889|82887102|FG000|Crossover Phase|Progressive Disease|0|||
46671844|NCT01227889|82887103|FG001|Crossover Phase|Progressive Disease|31|||
46671845|NCT01227889|82887102|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
46671846|NCT01227889|82887103|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
46671847|NCT01227889|82887102|FG000|Crossover Phase|Withdrawal by Subject|0|||
46671848|NCT01227889|82887103|FG001|Crossover Phase|Withdrawal by Subject|1|||
46671849|NCT01227577|82887117|FG000|Overall Study|Protocol deviation|3|||
46671850|NCT01227577|82887117|FG000|Overall Study|Death|3|||
46671851|NCT01227577|82887117|FG000|Overall Study|Administrative problems|2|||
46671852|NCT01227577|82887117|FG000|Overall Study|Lost to Follow-up|1|||
46671853|NCT01227577|82887117|FG000|Overall Study|Withdrawal by Subject|4|||
46671854|NCT01227577|82887117|FG000|Overall Study|Lack of Efficacy|5|||
46671855|NCT01227577|82887117|FG000|Overall Study|Adverse Event|17|||
46671856|NCT01227421|82887137|FG000|Overall Study|Lost to Follow-up|6|||
46671857|NCT01227421|82887138|FG001|Overall Study|Lost to Follow-up|7|||
46671858|NCT01227421|82887139|FG002|Overall Study|Lost to Follow-up|5|||
46671859|NCT01227421|82887137|FG000|Overall Study|Adverse Event|2|||
46671860|NCT01227421|82887138|FG001|Overall Study|Adverse Event|7|||
46671861|NCT01227421|82887139|FG002|Overall Study|Adverse Event|2|||
46671862|NCT01227421|82887137|FG000|Overall Study|Withdrawal by Subject|1|||
46671863|NCT01227421|82887138|FG001|Overall Study|Withdrawal by Subject|2|||
46671864|NCT01227421|82887139|FG002|Overall Study|Withdrawal by Subject|1|||
46671865|NCT01227421|82887137|FG000|Overall Study|Protocol Violation|1|||
46671866|NCT01227421|82887138|FG001|Overall Study|Protocol Violation|1|||
46671867|NCT01227421|82887139|FG002|Overall Study|Protocol Violation|2|||
46671868|NCT01227421|82887137|FG000|Overall Study|Randomized in error|1|||
46671869|NCT01227421|82887138|FG001|Overall Study|Randomized in error|1|||
46671870|NCT01227421|82887139|FG002|Overall Study|Randomized in error|0|||
46671871|NCT01227265|82887150|FG000|Overall Study|Did Not Receive Treatment|1|||
46671872|NCT01227265|82887151|FG001|Overall Study|Did Not Receive Treatment|2|||
46671873|NCT01227265|82887152|FG002|Overall Study|Did Not Receive Treatment|0|||
46671874|NCT01227265|82887150|FG000|Overall Study|Administrative|1|||
46671875|NCT01227265|82887151|FG001|Overall Study|Administrative|0|||
46671876|NCT01227265|82887152|FG002|Overall Study|Administrative|2|||
46671877|NCT01227265|82887150|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
46671878|NCT01227265|82887151|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
46671879|NCT01227265|82887152|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
46671880|NCT01227265|82887150|FG000|Overall Study|Protocol Violation|2|||
46671881|NCT01227265|82887151|FG001|Overall Study|Protocol Violation|1|||
46671882|NCT01227265|82887152|FG002|Overall Study|Protocol Violation|0|||
46671883|NCT01227265|82887150|FG000|Overall Study|Withdrawal by Subject|7|||
46671884|NCT01227265|82887151|FG001|Overall Study|Withdrawal by Subject|7|||
46671885|NCT01227265|82887152|FG002|Overall Study|Withdrawal by Subject|3|||
46671886|NCT01227265|82887150|FG000|Overall Study|Lost to Follow-up|2|||
46671887|NCT01227265|82887151|FG001|Overall Study|Lost to Follow-up|0|||
46671888|NCT01227265|82887152|FG002|Overall Study|Lost to Follow-up|3|||
46786635|NCT00338455|83005693|FG000|Overall Study|Death|2|||
46786636|NCT00338455|83005694|FG001|Overall Study|Death|1|||
46786637|NCT00338455|83005693|FG000|Overall Study|Physician Decision|1|||
46786638|NCT00338455|83005694|FG001|Overall Study|Physician Decision|0|||
46671889|NCT01227265|82887150|FG000|Overall Study|Adverse Event|6|||
46671890|NCT01227265|82887151|FG001|Overall Study|Adverse Event|10|||
46671891|NCT01227265|82887152|FG002|Overall Study|Adverse Event|5|||
46671892|NCT01226095|82887160|FG000|Overall Study|Poor compliance|1|||
46671893|NCT01225822|82887176|FG000|Overall Study|Adverse Event|13|||
46671894|NCT01225822|82887177|FG001|Overall Study|Adverse Event|31|||
46671895|NCT01225822|82887178|FG002|Overall Study|Adverse Event|18|||
46671896|NCT01225822|82887179|FG003|Overall Study|Adverse Event|23|||
47077441|NCT01439360|83377573|FG001|Overall Study|Withdrawal by Subject|129|||
46671897|NCT01225822|82887180|FG004|Overall Study|Adverse Event|14|||
47077442|NCT01439204|83377750|FG000|Overall Study|Withdrawal by Subject|0|||
47077443|NCT01439204|83377751|FG001|Overall Study|Withdrawal by Subject|1|||
47077444|NCT01439204|83377750|FG000|Overall Study|Lost to Follow-up|0|||
47077445|NCT01439204|83377751|FG001|Overall Study|Lost to Follow-up|2|||
47077446|NCT01439204|83377750|FG000|Overall Study|No longer meets study criteria|1|||
47077447|NCT01439204|83377751|FG001|Overall Study|No longer meets study criteria|0|||
47077448|NCT01439204|83377750|FG000|Overall Study|poor/non-compliance|3|||
47077449|NCT01439204|83377751|FG001|Overall Study|poor/non-compliance|0|||
47077450|NCT01439126|83377797|FG000|Overall Study|Adverse Event|2|||
47077451|NCT01439126|83377798|FG001|Overall Study|Adverse Event|0|||
47077452|NCT01439126|83377797|FG000|Overall Study|Withdrawal by Subject|5|||
47077453|NCT01439126|83377798|FG001|Overall Study|Withdrawal by Subject|21|||
47077454|NCT01439126|83377797|FG000|Overall Study|Protocol Violation|6|||
46786639|NCT00651924|83005702|FG000|Overall Study|Withdrawal by PI|0|||
46786640|NCT00651924|83005703|FG001|Overall Study|Withdrawal by PI|2|||
46786641|NCT00651924|83005702|FG000|Overall Study|Withdrawal by Subject|0|||
46786642|NCT00651924|83005703|FG001|Overall Study|Withdrawal by Subject|5|||
46786643|NCT00678392|83005711|FG000|Overall Study|Adverse Event|0|||
46786644|NCT00678392|83005712|FG001|Overall Study|Adverse Event|6|||
46786645|NCT00678392|83005711|FG000|Overall Study|Death|280|||
46786646|NCT00678392|83005712|FG001|Overall Study|Death|269|||
46786647|NCT00678392|83005711|FG000|Overall Study|Lost to Follow-up|15|||
46786648|NCT00678392|83005712|FG001|Overall Study|Lost to Follow-up|13|||
46786649|NCT00678392|83005711|FG000|Overall Study|Objective Progression or Relapse|3|||
46786650|NCT00678392|83005712|FG001|Overall Study|Objective Progression or Relapse|8|||
46786651|NCT00678392|83005711|FG000|Overall Study|Sponsor's Decision|1|||
46786652|NCT00678392|83005712|FG001|Overall Study|Sponsor's Decision|2|||
46786653|NCT00678392|83005711|FG000|Overall Study|Withdrawal by Subject|4|||
46851612|NCT00110019|83067178|FG000|Overall Study|Not start protocol therapy|17|||
46851613|NCT00110019|83067179|FG001|Overall Study|Not start protocol therapy|16|||
46851614|NCT00110019|83067178|FG000|Overall Study|other reasons|22|||
46851615|NCT00110019|83067179|FG001|Overall Study|other reasons|30|||
46851616|NCT03595618|83067189|FG000|Overall Study|Adverse Event|16|||
46851617|NCT03595618|83067190|FG001|Overall Study|Adverse Event|17|||
46851618|NCT03595618|83067191|FG002|Overall Study|Adverse Event|20|||
46851619|NCT03595618|83067192|FG003|Overall Study|Adverse Event|8|||
46786654|NCT00678392|83005712|FG001|Overall Study|Withdrawal by Subject|4|||
46786655|NCT00678392|83005711|FG000|Overall Study|Randomized But Not Treated|2|||
46786656|NCT00678392|83005712|FG001|Overall Study|Randomized But Not Treated|7|||
46786657|NCT00678392|83005711|FG000|Overall Study|Other|56|||
46786658|NCT00678392|83005712|FG001|Overall Study|Other|53|||
46786659|NCT00308581|83005718|FG000|Induction Phase|Adverse Event|0|||
46786660|NCT00308581|83005719|FG001|Induction Phase|Adverse Event|0|||
46786661|NCT00308581|83005720|FG002|Induction Phase|Adverse Event|37|||
46786662|NCT00308581|83005718|FG000|Induction Phase|Lack of Efficacy|0|||
46786663|NCT00308581|83005719|FG001|Induction Phase|Lack of Efficacy|0|||
46786664|NCT00308581|83005720|FG002|Induction Phase|Lack of Efficacy|121|||
46786665|NCT00308581|83005718|FG000|Induction Phase|Withdrawal by Subject|0|||
46786666|NCT00308581|83005719|FG001|Induction Phase|Withdrawal by Subject|0|||
46786667|NCT00308581|83005720|FG002|Induction Phase|Withdrawal by Subject|5|||
46786668|NCT00308581|83005718|FG000|Induction Phase|Unknown reason|0|||
46851620|NCT03595618|83067189|FG000|Overall Study|Withdrawal by Subject|12|||
46851621|NCT03595618|83067190|FG001|Overall Study|Withdrawal by Subject|14|||
46786669|NCT00308581|83005719|FG001|Induction Phase|Unknown reason|0|||
46786670|NCT00308581|83005720|FG002|Induction Phase|Unknown reason|3|||
46786671|NCT00308581|83005718|FG000|Randomized Maintenance Phase|Adverse Event|10|||
46851622|NCT03595618|83067191|FG002|Overall Study|Withdrawal by Subject|14|||
47077455|NCT01439126|83377798|FG001|Overall Study|Protocol Violation|4|||
47077456|NCT01439126|83377797|FG000|Overall Study|Lost to Follow-up|6|||
47077457|NCT01439126|83377798|FG001|Overall Study|Lost to Follow-up|3|||
47077458|NCT01439126|83377797|FG000|Overall Study|Other-Use of prohibited treatment|0|||
47077459|NCT01439126|83377798|FG001|Overall Study|Other-Use of prohibited treatment|2|||
47077460|NCT01439126|83377797|FG000|Overall Study|Other-Miscellaneous|12|||
47077461|NCT01439126|83377798|FG001|Overall Study|Other-Miscellaneous|12|||
47077462|NCT01449812|83377824|FG000|Overall Study|Migrated/moved from study area|1|||
47077463|NCT01449812|83377825|FG001|Overall Study|Migrated/moved from study area|0|||
47077464|NCT01449812|83377826|FG002|Overall Study|Migrated/moved from study area|0|||
47077465|NCT01449812|83377824|FG000|Overall Study|Withdrawal by Subject|0|||
47077466|NCT01449812|83377825|FG001|Overall Study|Withdrawal by Subject|0|||
47077467|NCT01449812|83377826|FG002|Overall Study|Withdrawal by Subject|1|||
47077468|NCT01449812|83377824|FG000|Overall Study|Lost to Follow-up|1|||
46671898|NCT01225822|82887176|FG000|Overall Study|Protocol Violation|6|||
46671899|NCT01225822|82887177|FG001|Overall Study|Protocol Violation|8|||
46671900|NCT01225822|82887178|FG002|Overall Study|Protocol Violation|6|||
46671901|NCT01225822|82887179|FG003|Overall Study|Protocol Violation|7|||
46671902|NCT01225822|82887180|FG004|Overall Study|Protocol Violation|4|||
46671903|NCT01225822|82887176|FG000|Overall Study|Lost to Follow-up|0|||
46671904|NCT01225822|82887177|FG001|Overall Study|Lost to Follow-up|0|||
46671905|NCT01225822|82887178|FG002|Overall Study|Lost to Follow-up|0|||
46671906|NCT01225822|82887179|FG003|Overall Study|Lost to Follow-up|1|||
46671907|NCT01225822|82887180|FG004|Overall Study|Lost to Follow-up|0|||
46671908|NCT01225822|82887176|FG000|Overall Study|Withdrawal by Subject|6|||
46671909|NCT01225822|82887177|FG001|Overall Study|Withdrawal by Subject|7|||
46671910|NCT01225822|82887178|FG002|Overall Study|Withdrawal by Subject|7|||
46671911|NCT01225822|82887179|FG003|Overall Study|Withdrawal by Subject|11|||
46671912|NCT01225822|82887180|FG004|Overall Study|Withdrawal by Subject|6|||
46671913|NCT01225822|82887176|FG000|Overall Study|Other|13|||
46671914|NCT01225822|82887177|FG001|Overall Study|Other|10|||
46671915|NCT01225822|82887178|FG002|Overall Study|Other|7|||
46671916|NCT01225822|82887179|FG003|Overall Study|Other|10|||
46671917|NCT01225822|82887180|FG004|Overall Study|Other|7|||
46671918|NCT01225549|82887195|FG000|Period 4 - Washout|Disallowed medication|0|||
46786672|NCT00308581|83005719|FG001|Randomized Maintenance Phase|Adverse Event|17|||
46786673|NCT00308581|83005720|FG002|Randomized Maintenance Phase|Adverse Event|0|||
46786674|NCT00308581|83005718|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
46786675|NCT00308581|83005719|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
46786676|NCT00308581|83005720|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
46786677|NCT00308581|83005718|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
46786678|NCT00308581|83005719|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
46786679|NCT00308581|83005720|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
46786680|NCT00308581|83005718|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
46786681|NCT00308581|83005719|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
47077469|NCT01449812|83377825|FG001|Overall Study|Lost to Follow-up|0|||
46671919|NCT01225549|82887196|FG001|Period 4 - Washout|Disallowed medication|1|||
46671920|NCT01225549|82887197|FG002|Period 4 - Washout|Disallowed medication|0|||
46671921|NCT01225549|82887198|FG003|Period 4 - Washout|Disallowed medication|0|||
46671922|NCT01225549|82887199|FG004|Period 4 - Washout|Disallowed medication|0|||
46671923|NCT01225549|82887200|FG005|Period 4 - Washout|Disallowed medication|0|||
46671924|NCT01225549|82887201|FG006|Period 4 - Washout|Disallowed medication|0|||
46671925|NCT01225549|82887202|FG007|Period 4 - Washout|Disallowed medication|0|||
46671926|NCT01225549|82887203|FG008|Period 4 - Washout|Disallowed medication|0|||
46671927|NCT01225549|82887204|FG009|Period 4 - Washout|Disallowed medication|0|||
46671928|NCT01225549|82887195|FG000|Period 6 - Washout|Disallowed medication|0|||
46671929|NCT01225549|82887196|FG001|Period 6 - Washout|Disallowed medication|0|||
46671930|NCT01225549|82887197|FG002|Period 6 - Washout|Disallowed medication|0|||
46671931|NCT01225549|82887198|FG003|Period 6 - Washout|Disallowed medication|1|||
46671932|NCT01225549|82887199|FG004|Period 6 - Washout|Disallowed medication|0|||
46671933|NCT01225549|82887200|FG005|Period 6 - Washout|Disallowed medication|0|||
46786682|NCT00308581|83005720|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
46786683|NCT00308581|83005718|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
46786684|NCT00308581|83005719|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
46786685|NCT00308581|83005720|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
46786686|NCT00308581|83005718|FG000|Randomized Maintenance Phase|Unknown reason|3|||
47077470|NCT01449812|83377826|FG002|Overall Study|Lost to Follow-up|0|||
47077471|NCT01466660|83377997|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
46671934|NCT01225549|82887201|FG006|Period 6 - Washout|Disallowed medication|0|||
47077472|NCT01466660|83377998|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
46671935|NCT01225549|82887202|FG007|Period 6 - Washout|Disallowed medication|0|||
46671936|NCT01225549|82887203|FG008|Period 6 - Washout|Disallowed medication|0|||
46671937|NCT01225549|82887204|FG009|Period 6 - Washout|Disallowed medication|0|||
46671938|NCT01225159|82887216|FG000|Overall Study|Change operation|1|||
46671939|NCT01225159|82887217|FG001|Overall Study|Change operation|0|||
46671940|NCT01224925|82887225|FG000|Overall Study|Lost to Follow-up|3|||
46671941|NCT01224925|82887226|FG001|Overall Study|Lost to Follow-up|2|||
46671942|NCT01223404|82887234|FG000|First Intervention (1 Day)|Adverse Event|0|||
46671943|NCT01223404|82887235|FG001|First Intervention (1 Day)|Adverse Event|0|||
46671944|NCT01223404|82887236|FG002|First Intervention (1 Day)|Adverse Event|0|||
46786687|NCT00308581|83005719|FG001|Randomized Maintenance Phase|Unknown reason|0|||
46786688|NCT00308581|83005720|FG002|Randomized Maintenance Phase|Unknown reason|0|||
46786689|NCT00678080|83005730|FG000|Overall Study|Physician Decision|2|||
47077473|NCT01466660|83377997|FG000|Overall Study|Worsening of underlying cancer disease|5|||
47077474|NCT01466660|83377998|FG001|Overall Study|Worsening of underlying cancer disease|2|||
47077475|NCT01466660|83377997|FG000|Overall Study|Other adverse event|19|||
46671945|NCT01223404|82887237|FG003|First Intervention (1 Day)|Adverse Event|1|||
46671946|NCT01223404|82887238|FG004|First Intervention (1 Day)|Adverse Event|0|||
46671947|NCT01223404|82887239|FG005|First Intervention (1 Day)|Adverse Event|0|||
46671948|NCT01223404|82887234|FG000|Second Intervention (1 Day)|Adverse Event|1|||
46671949|NCT01223404|82887235|FG001|Second Intervention (1 Day)|Adverse Event|0|||
46671950|NCT01223404|82887236|FG002|Second Intervention (1 Day)|Adverse Event|0|||
46671951|NCT01223404|82887237|FG003|Second Intervention (1 Day)|Adverse Event|0|||
46671952|NCT01223404|82887238|FG004|Second Intervention (1 Day)|Adverse Event|0|||
46671953|NCT01223404|82887239|FG005|Second Intervention (1 Day)|Adverse Event|0|||
46671954|NCT01223404|82887234|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
46671955|NCT01223404|82887235|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
46671956|NCT01223404|82887236|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
46671957|NCT01223404|82887237|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
46671958|NCT01223404|82887238|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
46671959|NCT01223404|82887239|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
46671960|NCT01223365|82887287|FG000|Open-label Titration Period|Enrolled but not treated|1|||
46671961|NCT01223365|82887287|FG000|Open-label Titration Period|Adverse Event|23|||
46671962|NCT01223365|82887287|FG000|Open-label Titration Period|Lack of Efficacy|3|||
46671963|NCT01223365|82887287|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
46671964|NCT01223365|82887287|FG000|Open-label Titration Period|Protocol Violation|1|||
46671965|NCT01223365|82887287|FG000|Open-label Titration Period|Lost to Follow-up|2|||
46671966|NCT01223365|82887287|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
46671967|NCT01223365|82887287|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
46671968|NCT01223365|82887287|FG000|Open-label Titration Period|Starting physical therapy|1|||
46671969|NCT01223365|82887287|FG000|Open-label Treatment Period|Adverse Event|39|||
46671970|NCT01223365|82887287|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
46671971|NCT01223365|82887287|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
46671972|NCT01223365|82887287|FG000|Open-label Treatment Period|Protocol Violation|15|||
46671973|NCT01223365|82887287|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
46671974|NCT01223365|82887287|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
46671975|NCT01223365|82887287|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
46671976|NCT01223365|82887287|FG000|Open-label Treatment Period|Moved out of area|2|||
46671977|NCT01223365|82887287|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
46671978|NCT01223365|82887287|FG000|Open-label Treatment Period|"Out of window"|1|||
46671979|NCT01223365|82887287|FG000|Open-label Treatment Period|Starting physical therapy|1|||
46671980|NCT01223365|82887287|FG000|Open-label Treatment Period|Physician Decision|2|||
46671981|NCT01222507|82887296|FG000|Overall Study|Physician Decision|1|||
46671982|NCT01222507|82887296|FG000|Overall Study|Withdrawal by Subject|1|||
46671983|NCT01222078|82887300|FG000|Overall Study|Early termination of the study|1|||
46671984|NCT01221727|82887307|FG000|Overall Study|Physician Decision|2|||
46671985|NCT01221727|82887308|FG001|Overall Study|Physician Decision|0|||
46671986|NCT01221727|82887307|FG000|Overall Study|Withdrawal by Subject|1|||
46671987|NCT01221727|82887308|FG001|Overall Study|Withdrawal by Subject|1|||
46671988|NCT01221181|82887320|FG000|Overall Study|Lost to Follow-up|1|||
46671989|NCT01220557|82887326|FG000|Overall Study|Lost to Follow-up|5|||
46671990|NCT01220557|82887327|FG001|Overall Study|Lost to Follow-up|3|||
46671991|NCT01220557|82887326|FG000|Overall Study|attended less than 6 lessons|1|||
46786690|NCT00678080|83005731|FG001|Overall Study|Physician Decision|0|||
46786691|NCT00678080|83005730|FG000|Overall Study|Lost to Follow-up|1|||
46786692|NCT00678080|83005731|FG001|Overall Study|Lost to Follow-up|0|||
46786693|NCT00678080|83005730|FG000|Overall Study|Withdrawal by Subject|0|||
46786694|NCT00678080|83005731|FG001|Overall Study|Withdrawal by Subject|1|||
47077476|NCT01466660|83377998|FG001|Overall Study|Other adverse event|18|||
47077477|NCT01466660|83377997|FG000|Overall Study|Protocol Violation|2|||
47077478|NCT01466660|83377998|FG001|Overall Study|Protocol Violation|1|||
47077479|NCT01466660|83377997|FG000|Overall Study|Refused continuation of trial medication|4|||
47077480|NCT01466660|83377998|FG001|Overall Study|Refused continuation of trial medication|3|||
47077481|NCT01466660|83377997|FG000|Overall Study|Other reason not defined above|10|||
47077482|NCT01466660|83377998|FG001|Overall Study|Other reason not defined above|8|||
47077483|NCT01466348|83378008|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
47077484|NCT01466348|83378009|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
47077485|NCT01466270|83378032|FG000|Overall Study|Withdrawal by Subject|4|||
47077486|NCT01466270|83378033|FG001|Overall Study|Withdrawal by Subject|1|||
46671992|NCT01220557|82887327|FG001|Overall Study|attended less than 6 lessons|2|||
46786695|NCT00658320|83005739|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
46786696|NCT00658320|83005740|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
46786697|NCT00658320|83005739|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
46786698|NCT00658320|83005740|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
46786699|NCT00658320|83005739|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
46786700|NCT00658320|83005740|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
46786701|NCT00658320|83005739|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
46786702|NCT00658320|83005740|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
46786703|NCT00322153|83005750|FG000|Overall Study|Adverse Event|21|||
46786704|NCT00322153|83005751|FG001|Overall Study|Adverse Event|34|||
46786705|NCT00322153|83005750|FG000|Overall Study|Protocol Violation|6|||
46786706|NCT00322153|83005751|FG001|Overall Study|Protocol Violation|14|||
46786707|NCT00322153|83005750|FG000|Overall Study|Withdrawal by Subject|18|||
46786708|NCT00322153|83005751|FG001|Overall Study|Withdrawal by Subject|10|||
46851623|NCT03595618|83067192|FG003|Overall Study|Withdrawal by Subject|10|||
46671993|NCT01220401|82887333|FG000|Overall Study|Withdrawal by Subject|2|||
46671994|NCT01220401|82887333|FG000|Overall Study|Protocol Violation|1|||
46671995|NCT01220167|82887340|FG000|Period 3|Urine positive for substance abuse|0|||
46671996|NCT01220167|82887341|FG001|Period 3|Urine positive for substance abuse|1|||
46671997|NCT01220167|82887342|FG002|Period 3|Urine positive for substance abuse|0|||
46671998|NCT01220128|82887355|FG000|Overall Study|Progressive disease|0|||
46671999|NCT01220128|82887356|FG001|Overall Study|Progressive disease|0|||
46672000|NCT01220128|82887357|FG002|Overall Study|Progressive disease|2|||
46672001|NCT01220128|82887358|FG003|Overall Study|Progressive disease|0|||
46672002|NCT01220128|82887359|FG004|Overall Study|Progressive disease|0|||
46672003|NCT01220128|82887360|FG005|Overall Study|Progressive disease|0|||
46672004|NCT01220128|82887361|FG006|Overall Study|Progressive disease|0|||
46672005|NCT01220128|82887355|FG000|Overall Study|Sponsor study termination|0|||
46672006|NCT01220128|82887356|FG001|Overall Study|Sponsor study termination|1|||
46672007|NCT01220128|82887357|FG002|Overall Study|Sponsor study termination|0|||
46672008|NCT01220128|82887358|FG003|Overall Study|Sponsor study termination|0|||
46672009|NCT01220128|82887359|FG004|Overall Study|Sponsor study termination|0|||
46672010|NCT01220128|82887360|FG005|Overall Study|Sponsor study termination|0|||
46672011|NCT01220128|82887361|FG006|Overall Study|Sponsor study termination|1|||
46672012|NCT01220128|82887355|FG000|Overall Study|Adverse event, serious fatal|2|||
46672013|NCT01220128|82887356|FG001|Overall Study|Adverse event, serious fatal|0|||
46672014|NCT01220128|82887357|FG002|Overall Study|Adverse event, serious fatal|0|||
46672015|NCT01220128|82887358|FG003|Overall Study|Adverse event, serious fatal|0|||
46672016|NCT01220128|82887359|FG004|Overall Study|Adverse event, serious fatal|0|||
46672017|NCT01220128|82887360|FG005|Overall Study|Adverse event, serious fatal|0|||
46672018|NCT01220128|82887361|FG006|Overall Study|Adverse event, serious fatal|1|||
46672019|NCT01220128|82887355|FG000|Overall Study|Adverse event, non-fatal|1|||
46672020|NCT01220128|82887356|FG001|Overall Study|Adverse event, non-fatal|0|||
46672021|NCT01220128|82887357|FG002|Overall Study|Adverse event, non-fatal|0|||
46672022|NCT01220128|82887358|FG003|Overall Study|Adverse event, non-fatal|0|||
46672023|NCT01220128|82887359|FG004|Overall Study|Adverse event, non-fatal|0|||
46672024|NCT01220128|82887360|FG005|Overall Study|Adverse event, non-fatal|0|||
46672025|NCT01220128|82887361|FG006|Overall Study|Adverse event, non-fatal|3|||
46672026|NCT01220128|82887355|FG000|Overall Study|Other|0|||
46672027|NCT01220128|82887356|FG001|Overall Study|Other|0|||
46672028|NCT01220128|82887357|FG002|Overall Study|Other|1|||
46672029|NCT01220128|82887358|FG003|Overall Study|Other|0|||
46672030|NCT01220128|82887359|FG004|Overall Study|Other|0|||
46672031|NCT01220128|82887360|FG005|Overall Study|Other|0|||
46672032|NCT01220128|82887361|FG006|Overall Study|Other|0|||
46672033|NCT01220128|82887355|FG000|Overall Study|Consent withdrawn by subject|1|||
46672034|NCT01220128|82887356|FG001|Overall Study|Consent withdrawn by subject|0|||
46672035|NCT01220128|82887357|FG002|Overall Study|Consent withdrawn by subject|0|||
46672036|NCT01220128|82887358|FG003|Overall Study|Consent withdrawn by subject|0|||
46672037|NCT01220128|82887359|FG004|Overall Study|Consent withdrawn by subject|0|||
46672038|NCT01220128|82887360|FG005|Overall Study|Consent withdrawn by subject|0|||
46672039|NCT01220128|82887361|FG006|Overall Study|Consent withdrawn by subject|0|||
46851624|NCT03595618|83067189|FG000|Overall Study|Lost to Follow-up|6|||
46672040|NCT01219933|82887378|FG000|Overall Study|Adverse Event|8|||
46672041|NCT01219933|82887378|FG000|Overall Study|No LDA reached|5|||
46672042|NCT01219933|82887378|FG000|Overall Study|No LDA maintained|7|||
46672043|NCT01219933|82887378|FG000|Overall Study|Lost to Follow-up|3|||
46851625|NCT03595618|83067190|FG001|Overall Study|Lost to Follow-up|4|||
46851626|NCT03595618|83067191|FG002|Overall Study|Lost to Follow-up|5|||
46672044|NCT01219933|82887378|FG000|Overall Study|GC free|1|||
46672045|NCT01219933|82887378|FG000|Overall Study|Withdrawal by Subject|5|||
46672046|NCT01219933|82887378|FG000|Overall Study|Protocol Violation|8|||
46672047|NCT01219933|82887378|FG000|Overall Study|Lack of Efficacy|1|||
46672048|NCT01218802|82887385|FG000|Overall Study|Lost to Follow-up|5|||
46672049|NCT01218802|82887386|FG001|Overall Study|Lost to Follow-up|6|||
46786709|NCT00322153|83005750|FG000|Overall Study|Lack of Efficacy|8|||
46786710|NCT00322153|83005751|FG001|Overall Study|Lack of Efficacy|3|||
46786711|NCT00322153|83005750|FG000|Overall Study|Lost to Follow-up|5|||
46786712|NCT00322153|83005751|FG001|Overall Study|Lost to Follow-up|4|||
47077487|NCT01466270|83378032|FG000|Overall Study|Physician Decision|1|||
47077488|NCT01466270|83378033|FG001|Overall Study|Physician Decision|0|||
47077489|NCT01466270|83378032|FG000|Overall Study|Lost to Follow-up|1|||
47077490|NCT01466270|83378033|FG001|Overall Study|Lost to Follow-up|3|||
46786713|NCT00322153|83005750|FG000|Overall Study|Withdrawn for other reasons|5|||
46786714|NCT00322153|83005751|FG001|Overall Study|Withdrawn for other reasons|4|||
46786715|NCT00657618|83005757|FG000|Overall Study|Adverse Event|32|||
46786716|NCT00657618|83005757|FG000|Overall Study|Withdrawal by Subject|8|||
46786717|NCT00657618|83005757|FG000|Overall Study|negative for leishmaniasis|2|||
46786718|NCT00657618|83005757|FG000|Overall Study|didn't start due to schedule conflicts|1|||
46786719|NCT00657540|83005763|FG000|Overall Study|Lost to Follow-up|1|||
46786720|NCT00657540|83005764|FG001|Overall Study|Lost to Follow-up|4|||
46786721|NCT00672620|83005774|FG000|Overall Study|Adverse Event|7|||
46786722|NCT00672620|83005775|FG001|Overall Study|Adverse Event|7|||
46786723|NCT00672620|83005776|FG002|Overall Study|Adverse Event|12|||
46786724|NCT00672620|83005777|FG003|Overall Study|Adverse Event|17|||
46786725|NCT00672620|83005774|FG000|Overall Study|Lack of Efficacy|1|||
46786726|NCT00672620|83005775|FG001|Overall Study|Lack of Efficacy|2|||
46786727|NCT00672620|83005776|FG002|Overall Study|Lack of Efficacy|2|||
46786728|NCT00672620|83005777|FG003|Overall Study|Lack of Efficacy|0|||
46786729|NCT00672620|83005774|FG000|Overall Study|Noncompliance with Study Drug|3|||
46786730|NCT00672620|83005775|FG001|Overall Study|Noncompliance with Study Drug|4|||
46786731|NCT00672620|83005776|FG002|Overall Study|Noncompliance with Study Drug|0|||
46786732|NCT00672620|83005777|FG003|Overall Study|Noncompliance with Study Drug|2|||
46786733|NCT00672620|83005774|FG000|Overall Study|Protocol Deviations|5|||
46786734|NCT00672620|83005775|FG001|Overall Study|Protocol Deviations|7|||
46786735|NCT00672620|83005776|FG002|Overall Study|Protocol Deviations|2|||
46786736|NCT00672620|83005777|FG003|Overall Study|Protocol Deviations|5|||
46786737|NCT00672620|83005774|FG000|Overall Study|Withdrawal of Consent|6|||
46786738|NCT00672620|83005775|FG001|Overall Study|Withdrawal of Consent|12|||
46786739|NCT00672620|83005776|FG002|Overall Study|Withdrawal of Consent|5|||
46786740|NCT00672620|83005777|FG003|Overall Study|Withdrawal of Consent|6|||
46786741|NCT00672620|83005774|FG000|Overall Study|Lost to Follow-up|8|||
46786742|NCT00672620|83005775|FG001|Overall Study|Lost to Follow-up|19|||
46786743|NCT00672620|83005776|FG002|Overall Study|Lost to Follow-up|8|||
46786744|NCT00672620|83005777|FG003|Overall Study|Lost to Follow-up|11|||
46786745|NCT00672620|83005774|FG000|Overall Study|Reason not Specified|3|||
46786746|NCT00672620|83005775|FG001|Overall Study|Reason not Specified|3|||
46786747|NCT00672620|83005776|FG002|Overall Study|Reason not Specified|2|||
46786748|NCT00672620|83005777|FG003|Overall Study|Reason not Specified|1|||
46786749|NCT00673790|83005790|FG000|Overall Study|Adverse Event|23|||
46786750|NCT00673790|83005791|FG001|Overall Study|Adverse Event|14|||
46786751|NCT00673790|83005792|FG002|Overall Study|Adverse Event|2|||
46786752|NCT00673790|83005790|FG000|Overall Study|Lack of Efficacy|2|||
46786753|NCT00673790|83005791|FG001|Overall Study|Lack of Efficacy|2|||
46786754|NCT00673790|83005792|FG002|Overall Study|Lack of Efficacy|2|||
46786755|NCT00673790|83005790|FG000|Overall Study|Protocol Violation|6|||
46786756|NCT00673790|83005791|FG001|Overall Study|Protocol Violation|9|||
46851627|NCT03595618|83067192|FG003|Overall Study|Lost to Follow-up|6|||
46851628|NCT03595618|83067189|FG000|Overall Study|Protocol Violation|2|||
46851629|NCT03595618|83067190|FG001|Overall Study|Protocol Violation|0|||
46973044|NCT02014480|83216814|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
46973045|NCT02014480|83216809|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
46973046|NCT02014480|83216810|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
46973047|NCT02014480|83216811|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
46973048|NCT02014480|83216812|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
47077491|NCT01466270|83378032|FG000|Overall Study|Progression|1|||
46786757|NCT00673790|83005792|FG002|Overall Study|Protocol Violation|1|||
46786758|NCT00673790|83005790|FG000|Overall Study|Withdrawal by Subject|7|||
46786759|NCT00673790|83005791|FG001|Overall Study|Withdrawal by Subject|4|||
46786760|NCT00673790|83005792|FG002|Overall Study|Withdrawal by Subject|1|||
46786761|NCT00673790|83005790|FG000|Overall Study|Lost to Follow-up|6|||
46786762|NCT00673790|83005791|FG001|Overall Study|Lost to Follow-up|6|||
46786763|NCT00673790|83005792|FG002|Overall Study|Lost to Follow-up|5|||
46786764|NCT00673790|83005790|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
47077492|NCT01466270|83378033|FG001|Overall Study|Progression|0|||
47077493|NCT01466270|83378032|FG000|Overall Study|Toxicity|4|||
46786765|NCT00673790|83005791|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
46786766|NCT00673790|83005792|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
46786767|NCT00673790|83005790|FG000|Overall Study|Poor compliance|1|||
46786768|NCT00673790|83005791|FG001|Overall Study|Poor compliance|0|||
47077494|NCT01466270|83378033|FG001|Overall Study|Toxicity|1|||
47077495|NCT01466270|83378032|FG000|Overall Study|Multiple|1|||
47077496|NCT01466270|83378033|FG001|Overall Study|Multiple|1|||
47077497|NCT01466192|83378066|FG000|Overall Study|Physician Decision|1|||
47077498|NCT01466192|83378066|FG000|Overall Study|Withdrawal by Subject|3|||
47077499|NCT01438814|83378086|FG000|Overall Study|Adverse Event|3|||
47077500|NCT01438814|83378087|FG001|Overall Study|Adverse Event|3|||
47077501|NCT01438814|83378086|FG000|Overall Study|Protocol Violation|1|||
47077502|NCT01438814|83378087|FG001|Overall Study|Protocol Violation|2|||
47077503|NCT01438814|83378086|FG000|Overall Study|Lost to Follow-up|4|||
47077504|NCT01438814|83378087|FG001|Overall Study|Lost to Follow-up|3|||
47077505|NCT01438814|83378086|FG000|Overall Study|Withdrawal by Subject|4|||
47077506|NCT01438814|83378087|FG001|Overall Study|Withdrawal by Subject|2|||
46672050|NCT01218802|82887385|FG000|Overall Study|Withdrawal by Subject|3|||
46672051|NCT01218802|82887386|FG001|Overall Study|Withdrawal by Subject|10|||
46672052|NCT01218802|82887385|FG000|Overall Study|Adverse Event|0|||
46851630|NCT03595618|83067191|FG002|Overall Study|Protocol Violation|6|||
46851631|NCT03595618|83067192|FG003|Overall Study|Protocol Violation|2|||
46851632|NCT03595618|83067189|FG000|Overall Study|Physician Decision|0|||
46851633|NCT03595618|83067190|FG001|Overall Study|Physician Decision|0|||
46851634|NCT03595618|83067191|FG002|Overall Study|Physician Decision|1|||
47077507|NCT01438814|83378086|FG000|Overall Study|Other|2|||
47077508|NCT01438814|83378087|FG001|Overall Study|Other|4|||
47077509|NCT02851797|83378696|FG000|Overall Study|Withdrawal by Subject|4|||
47077510|NCT02851797|83378697|FG001|Overall Study|Withdrawal by Subject|2|||
46672053|NCT01218802|82887386|FG001|Overall Study|Adverse Event|2|||
46672054|NCT01218802|82887385|FG000|Overall Study|Incarcerated|2|||
46672055|NCT01218802|82887386|FG001|Overall Study|Incarcerated|0|||
46672056|NCT01218646|82887396|FG000|Overall Study|Adverse Event|0|||
46672057|NCT01218646|82887397|FG001|Overall Study|Adverse Event|0|||
46672058|NCT01218646|82887398|FG002|Overall Study|Adverse Event|1|||
46672059|NCT01218646|82887399|FG003|Overall Study|Adverse Event|0|||
46672060|NCT01218646|82887396|FG000|Overall Study|Lost to Follow-up|1|||
46672061|NCT01218646|82887397|FG001|Overall Study|Lost to Follow-up|0|||
46672062|NCT01218646|82887398|FG002|Overall Study|Lost to Follow-up|0|||
46672063|NCT01218646|82887399|FG003|Overall Study|Lost to Follow-up|0|||
46672064|NCT01218646|82887396|FG000|Overall Study|Protocol Violation|0|||
46672065|NCT01218646|82887397|FG001|Overall Study|Protocol Violation|0|||
46672066|NCT01218646|82887398|FG002|Overall Study|Protocol Violation|1|||
46672067|NCT01218646|82887399|FG003|Overall Study|Protocol Violation|1|||
46672068|NCT01188772|82887413|FG000|Overall Study|Randomized but Not Treated|0|||
46672069|NCT01188772|82887414|FG001|Overall Study|Randomized but Not Treated|1|||
46672070|NCT01188772|82887415|FG002|Overall Study|Randomized but Not Treated|0|||
46672071|NCT01188772|82887416|FG003|Overall Study|Randomized but Not Treated|0|||
46672072|NCT01188772|82887413|FG000|Overall Study|Adverse Event|0|||
46672073|NCT01188772|82887414|FG001|Overall Study|Adverse Event|1|||
46672074|NCT01188772|82887415|FG002|Overall Study|Adverse Event|2|||
46672075|NCT01188772|82887416|FG003|Overall Study|Adverse Event|0|||
46672076|NCT01188772|82887413|FG000|Overall Study|Lost to Follow-up|4|||
46672077|NCT01188772|82887414|FG001|Overall Study|Lost to Follow-up|1|||
46672078|NCT01188772|82887415|FG002|Overall Study|Lost to Follow-up|1|||
46672079|NCT01188772|82887416|FG003|Overall Study|Lost to Follow-up|1|||
46672080|NCT01188772|82887413|FG000|Overall Study|Non-responder|0|||
46672081|NCT01188772|82887414|FG001|Overall Study|Non-responder|0|||
46672082|NCT01188772|82887415|FG002|Overall Study|Non-responder|3|||
46672083|NCT01188772|82887416|FG003|Overall Study|Non-responder|0|||
46672084|NCT01188772|82887413|FG000|Overall Study|Physician Decision|0|||
46672085|NCT01188772|82887414|FG001|Overall Study|Physician Decision|0|||
46672086|NCT01188772|82887415|FG002|Overall Study|Physician Decision|1|||
46672087|NCT01188772|82887416|FG003|Overall Study|Physician Decision|0|||
46851635|NCT03595618|83067192|FG003|Overall Study|Physician Decision|2|||
47077511|NCT02851797|83378696|FG000|Overall Study|Adverse Event|3|||
47077512|NCT02851797|83378697|FG001|Overall Study|Adverse Event|0|||
46672088|NCT01188772|82887413|FG000|Overall Study|Terminated by Sponsor|0|||
46672089|NCT01188772|82887414|FG001|Overall Study|Terminated by Sponsor|0|||
46672090|NCT01188772|82887415|FG002|Overall Study|Terminated by Sponsor|1|||
46672091|NCT01188772|82887416|FG003|Overall Study|Terminated by Sponsor|0|||
46672092|NCT01188772|82887413|FG000|Overall Study|Treatment Failure|0|||
46672093|NCT01188772|82887414|FG001|Overall Study|Treatment Failure|0|||
46672094|NCT01188772|82887415|FG002|Overall Study|Treatment Failure|1|||
46672095|NCT01188772|82887416|FG003|Overall Study|Treatment Failure|0|||
46672096|NCT01188772|82887413|FG000|Overall Study|Virologic Failure|1|||
46672097|NCT01188772|82887414|FG001|Overall Study|Virologic Failure|0|||
46672098|NCT01188772|82887415|FG002|Overall Study|Virologic Failure|0|||
46672099|NCT01188772|82887416|FG003|Overall Study|Virologic Failure|0|||
46672100|NCT01188772|82887413|FG000|Overall Study|Withdrawal by Subject|0|||
46672101|NCT01188772|82887414|FG001|Overall Study|Withdrawal by Subject|0|||
46672102|NCT01188772|82887415|FG002|Overall Study|Withdrawal by Subject|2|||
46672103|NCT01188772|82887416|FG003|Overall Study|Withdrawal by Subject|0|||
46672104|NCT01188655|82887429|FG000|Overall Study|Lack of Efficacy|1|||
46672105|NCT01188655|82887429|FG000|Overall Study|Lost to Follow-up|1|||
46672106|NCT01188655|82887429|FG000|Overall Study|Other|11|||
46672107|NCT01188538|82887435|FG000|Overall Study|Lost to Follow-up|0|||
46672108|NCT01188538|82887436|FG001|Overall Study|Lost to Follow-up|1|||
46672109|NCT01188343|82887447|FG000|Overall Study|Not vaccinated|0|||
46672110|NCT01188343|82887448|FG001|Overall Study|Not vaccinated|2|||
46672111|NCT01188343|82887449|FG002|Overall Study|Not vaccinated|1|||
46672112|NCT01188343|82887447|FG000|Overall Study|Withdrawal by Subject|1|||
46786769|NCT00673790|83005792|FG002|Overall Study|Poor compliance|0|||
46786770|NCT00673790|83005790|FG000|Overall Study|Participated in two Nebivolol studies|0|||
46786771|NCT00673790|83005791|FG001|Overall Study|Participated in two Nebivolol studies|0|||
46786772|NCT00673790|83005792|FG002|Overall Study|Participated in two Nebivolol studies|1|||
46786773|NCT00673790|83005790|FG000|Overall Study|Unconfirmed pregnancy|0|||
46786774|NCT00673790|83005791|FG001|Overall Study|Unconfirmed pregnancy|1|||
46786775|NCT00673790|83005792|FG002|Overall Study|Unconfirmed pregnancy|0|||
46786776|NCT00673790|83005790|FG000|Overall Study|Randomization criteria not met|0|||
46786777|NCT00673790|83005791|FG001|Overall Study|Randomization criteria not met|1|||
46786778|NCT00673790|83005792|FG002|Overall Study|Randomization criteria not met|0|||
46851636|NCT03595618|83067189|FG000|Overall Study|Miscellaneous|7|||
46851637|NCT03595618|83067190|FG001|Overall Study|Miscellaneous|5|||
46851638|NCT03595618|83067191|FG002|Overall Study|Miscellaneous|10|||
46851639|NCT03595618|83067192|FG003|Overall Study|Miscellaneous|6|||
46851640|NCT02954848|83067204|FG000|Overall Study|Randomized but Not Treated|0|||
46851641|NCT02954848|83067205|FG001|Overall Study|Randomized but Not Treated|1|||
46851642|NCT02954848|83067204|FG000|Overall Study|Adverse Event|2|||
46851643|NCT02954848|83067205|FG001|Overall Study|Adverse Event|3|||
46851644|NCT02954848|83067204|FG000|Overall Study|Withdrawal by Participant|0|||
46851645|NCT02954848|83067205|FG001|Overall Study|Withdrawal by Participant|1|||
46851646|NCT03642262|83067211|FG000|Period 1|Withdrawal by Subject|1|||
46851647|NCT03642262|83067212|FG001|Period 1|Withdrawal by Subject|1|||
46851648|NCT03642262|83067211|FG000|Period 1|Adverse Event|0|||
46851649|NCT03642262|83067212|FG001|Period 1|Adverse Event|1|||
46851650|NCT00109707|83067222|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
46851651|NCT00109707|83067223|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
46851652|NCT00109707|83067224|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
46851653|NCT00109707|83067222|FG000|Overall Study|Abnormal laboratory values|1|||
46851654|NCT00109707|83067223|FG001|Overall Study|Abnormal laboratory values|0|||
46851655|NCT00109707|83067224|FG002|Overall Study|Abnormal laboratory values|0|||
46851656|NCT00109707|83067222|FG000|Overall Study|Administrative problems|2|||
46851657|NCT00109707|83067223|FG001|Overall Study|Administrative problems|0|||
46851658|NCT00109707|83067224|FG002|Overall Study|Administrative problems|1|||
46851659|NCT00109707|83067222|FG000|Overall Study|Adverse Event|10|||
46851660|NCT00109707|83067223|FG001|Overall Study|Adverse Event|2|||
46851661|NCT00109707|83067224|FG002|Overall Study|Adverse Event|3|||
46672113|NCT01188343|82887448|FG001|Overall Study|Withdrawal by Subject|24|||
46672114|NCT01188343|82887449|FG002|Overall Study|Withdrawal by Subject|0|||
46672115|NCT01188226|82887460|FG000|Overall Study|Withdrawal by Subject|4|||
46672116|NCT01218100|82887478|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
46672117|NCT01218100|82887479|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
46851662|NCT00109707|83067222|FG000|Overall Study|Death|4|||
46851663|NCT00109707|83067223|FG001|Overall Study|Death|0|||
46672118|NCT01218100|82887480|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
46672119|NCT01218100|82887481|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
46851664|NCT00109707|83067224|FG002|Overall Study|Death|0|||
46851665|NCT00109707|83067222|FG000|Overall Study|Disease progression|12|||
46672120|NCT01218100|82887478|FG000|Overall Study|Adverse Event|4|||
46672121|NCT01218100|82887479|FG001|Overall Study|Adverse Event|6|||
46851666|NCT00109707|83067223|FG001|Overall Study|Disease progression|4|||
46851667|NCT00109707|83067224|FG002|Overall Study|Disease progression|3|||
46786779|NCT00657150|83005803|FG000|Overall Study|Adverse Event|19|||
46786780|NCT00657150|83005804|FG001|Overall Study|Adverse Event|10|||
46786781|NCT00657150|83005803|FG000|Overall Study|Non-compliant with protocol|5|||
46672122|NCT01218100|82887480|FG002|Overall Study|Adverse Event|6|||
46672123|NCT01218100|82887481|FG003|Overall Study|Adverse Event|7|||
46672124|NCT01218100|82887478|FG000|Overall Study|Lack of Efficacy|9|||
46672125|NCT01218100|82887479|FG001|Overall Study|Lack of Efficacy|6|||
46672126|NCT01218100|82887480|FG002|Overall Study|Lack of Efficacy|5|||
46672127|NCT01218100|82887481|FG003|Overall Study|Lack of Efficacy|12|||
46672128|NCT01218100|82887478|FG000|Overall Study|Protocol Violation|0|||
46672129|NCT01218100|82887479|FG001|Overall Study|Protocol Violation|0|||
46672130|NCT01218100|82887480|FG002|Overall Study|Protocol Violation|1|||
46672131|NCT01218100|82887481|FG003|Overall Study|Protocol Violation|1|||
46672132|NCT01218100|82887478|FG000|Overall Study|Withdrawal by Subject|5|||
46672133|NCT01218100|82887479|FG001|Overall Study|Withdrawal by Subject|2|||
46672134|NCT01218100|82887480|FG002|Overall Study|Withdrawal by Subject|6|||
46672135|NCT01218100|82887481|FG003|Overall Study|Withdrawal by Subject|7|||
46672136|NCT01218100|82887478|FG000|Overall Study|Lost to Follow-up|3|||
46672137|NCT01218100|82887479|FG001|Overall Study|Lost to Follow-up|8|||
46672138|NCT01218100|82887480|FG002|Overall Study|Lost to Follow-up|2|||
46672139|NCT01218100|82887481|FG003|Overall Study|Lost to Follow-up|1|||
46672140|NCT01218100|82887478|FG000|Overall Study|Other Reason|2|||
46672141|NCT01218100|82887479|FG001|Overall Study|Other Reason|2|||
46672142|NCT01218100|82887480|FG002|Overall Study|Other Reason|6|||
46672143|NCT01218100|82887481|FG003|Overall Study|Other Reason|4|||
46672144|NCT02956850|82887509|FG000|Overall Study|Withdrawal by Subject|0|||
46672145|NCT02956850|82887510|FG001|Overall Study|Withdrawal by Subject|0|||
46672146|NCT02956850|82887511|FG002|Overall Study|Withdrawal by Subject|0|||
46672147|NCT02956850|82887512|FG003|Overall Study|Withdrawal by Subject|0|||
46672148|NCT02956850|82887513|FG004|Overall Study|Withdrawal by Subject|0|||
46672149|NCT02956850|82887514|FG005|Overall Study|Withdrawal by Subject|0|||
46786782|NCT00657150|83005804|FG001|Overall Study|Non-compliant with protocol|9|||
46786783|NCT00657150|83005803|FG000|Overall Study|Lost to Follow-up|2|||
46672150|NCT02956850|82887515|FG006|Overall Study|Withdrawal by Subject|0|||
46672151|NCT02956850|82887516|FG007|Overall Study|Withdrawal by Subject|0|||
46672152|NCT02956850|82887517|FG008|Overall Study|Withdrawal by Subject|0|||
46786784|NCT00657150|83005804|FG001|Overall Study|Lost to Follow-up|0|||
46786785|NCT00657150|83005803|FG000|Overall Study|Withdrawal by Subject|51|||
46672153|NCT02956850|82887518|FG009|Overall Study|Withdrawal by Subject|0|||
46672154|NCT02956850|82887519|FG010|Overall Study|Withdrawal by Subject|0|||
46672155|NCT02956850|82887520|FG011|Overall Study|Withdrawal by Subject|0|||
46672156|NCT02956850|82887521|FG012|Overall Study|Withdrawal by Subject|0|||
46786786|NCT00657150|83005804|FG001|Overall Study|Withdrawal by Subject|36|||
46786787|NCT00657150|83005803|FG000|Overall Study|Other|38|||
46786788|NCT00657150|83005804|FG001|Overall Study|Other|38|||
46786789|NCT00657150|83005803|FG000|Treatment|Adverse Event|60|||
46786790|NCT00657150|83005804|FG001|Treatment|Adverse Event|53|||
46786791|NCT00657150|83005803|FG000|Treatment|Non-compliant with protocol|10|||
46786792|NCT00657150|83005804|FG001|Treatment|Non-compliant with protocol|9|||
46786793|NCT00657150|83005803|FG000|Treatment|Lost to Follow-up|1|||
46786794|NCT00657150|83005804|FG001|Treatment|Lost to Follow-up|0|||
46786795|NCT00657150|83005803|FG000|Treatment|Withdrawal by Subject|23|||
46786796|NCT00657150|83005804|FG001|Treatment|Withdrawal by Subject|20|||
46786797|NCT00657150|83005803|FG000|Treatment|Other|13|||
46786798|NCT00657150|83005804|FG001|Treatment|Other|15|||
46786799|NCT00670748|83005814|FG000|Overall Study|Death during treatment|1|||
46786800|NCT00670748|83005815|FG001|Overall Study|Death during treatment|1|||
46786801|NCT00670748|83005816|FG002|Overall Study|Death during treatment|1|||
46786802|NCT00670748|83005817|FG003|Overall Study|Death during treatment|0|||
47077513|NCT01666314|83378912|FG000|Overall Study|Adverse Event|3|||
46672157|NCT02956850|82887522|FG013|Overall Study|Withdrawal by Subject|0|||
46672158|NCT02956850|82887523|FG014|Overall Study|Withdrawal by Subject|0|||
46672159|NCT02956850|82887524|FG015|Overall Study|Withdrawal by Subject|0|||
47077514|NCT01666314|83378913|FG001|Overall Study|Adverse Event|13|||
47077515|NCT01666314|83378914|FG002|Overall Study|Adverse Event|7|||
47077516|NCT01666314|83378915|FG003|Overall Study|Adverse Event|7|||
47077517|NCT01666314|83378912|FG000|Overall Study|Progressive Disease|11|||
47077518|NCT01666314|83378913|FG001|Overall Study|Progressive Disease|9|||
46672160|NCT02956850|82887525|FG016|Overall Study|Withdrawal by Subject|0|||
46672161|NCT02956850|82887526|FG017|Overall Study|Withdrawal by Subject|1|||
46672162|NCT01187953|82887636|FG000|Overall Study|Death|11|||
46786803|NCT00670748|83005814|FG000|Overall Study|Not off study|2|||
46786804|NCT00670748|83005815|FG001|Overall Study|Not off study|1|||
46786805|NCT00670748|83005816|FG002|Overall Study|Not off study|1|||
46786806|NCT00670748|83005817|FG003|Overall Study|Not off study|1|||
47077519|NCT01666314|83378914|FG002|Overall Study|Progressive Disease|19|||
46672163|NCT01187953|82887637|FG001|Overall Study|Death|13|||
46786807|NCT00646776|83005829|FG000|Overall Study|Adverse Event|1|||
46786808|NCT00646776|83005830|FG001|Overall Study|Adverse Event|9|||
46672164|NCT01187953|82887636|FG000|Overall Study|Adverse Event|1|||
46672165|NCT01187953|82887637|FG001|Overall Study|Adverse Event|2|||
46672166|NCT01187953|82887636|FG000|Overall Study|Lost to Follow-up|0|||
46672167|NCT01187953|82887637|FG001|Overall Study|Lost to Follow-up|3|||
46672168|NCT01187953|82887636|FG000|Overall Study|Withdrawal by Subject|3|||
46672169|NCT01187953|82887637|FG001|Overall Study|Withdrawal by Subject|3|||
46672170|NCT01217944|82887653|FG000|Overall Study|Protocol Violation|1|||
46672171|NCT01217944|82887654|FG001|Overall Study|Protocol Violation|1|||
46672172|NCT01217944|82887655|FG002|Overall Study|Protocol Violation|0|||
46672173|NCT01217944|82887653|FG000|Overall Study|Lost to Follow-up|3|||
46672174|NCT01217944|82887654|FG001|Overall Study|Lost to Follow-up|1|||
46672175|NCT01217944|82887655|FG002|Overall Study|Lost to Follow-up|0|||
46672176|NCT01217944|82887653|FG000|Overall Study|Withdrawal by Subject|1|||
46672177|NCT01217944|82887654|FG001|Overall Study|Withdrawal by Subject|2|||
46672178|NCT01217944|82887655|FG002|Overall Study|Withdrawal by Subject|0|||
46672179|NCT01217944|82887653|FG000|Overall Study|Lack of Efficacy|1|||
46672180|NCT01217944|82887654|FG001|Overall Study|Lack of Efficacy|0|||
46672181|NCT01217944|82887655|FG002|Overall Study|Lack of Efficacy|0|||
46672182|NCT01187446|82887667|FG000|Overall Study|Patient started non-protocol therapy|0|||
46672183|NCT01187446|82887668|FG001|Overall Study|Patient started non-protocol therapy|1|||
46672184|NCT01187407|82887678|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
46672185|NCT01187407|82887679|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46672186|NCT01187407|82887680|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46672187|NCT01187407|82887681|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46672188|NCT01187407|82887682|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46672189|NCT01187407|82887678|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
46672190|NCT01187407|82887679|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46672191|NCT01187407|82887680|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46672192|NCT01187407|82887681|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46672193|NCT01187407|82887682|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46672194|NCT01187407|82887678|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
46672195|NCT01187407|82887679|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46672196|NCT01187407|82887680|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46672197|NCT01187407|82887681|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46672198|NCT01187407|82887682|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46672199|NCT01187407|82887678|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
46672200|NCT01187407|82887679|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46672201|NCT01187407|82887680|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46672202|NCT01187407|82887681|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46672203|NCT01187407|82887682|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46672204|NCT01187407|82887678|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
46672205|NCT01187407|82887679|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46672206|NCT01187407|82887680|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46672207|NCT01187407|82887681|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46672208|NCT01187407|82887682|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46672209|NCT01187407|82887678|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
46672210|NCT01187407|82887679|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46786809|NCT00646776|83005829|FG000|Overall Study|Investigator discretion|0|||
46786810|NCT00646776|83005830|FG001|Overall Study|Investigator discretion|4|||
46786811|NCT00655668|83005839|FG000|Overall Study|Adverse Event|6|||
46786812|NCT00655668|83005839|FG000|Overall Study|Death|5|||
46786813|NCT00655668|83005839|FG000|Overall Study|Disease Progression|27|||
46786814|NCT00655668|83005839|FG000|Overall Study|Study Terminated|9|||
46786815|NCT00655668|83005839|FG000|Overall Study|Other|1|||
46786816|NCT00655668|83005839|FG000|Overall Study|New Lymphoma Treatment Started|4|||
46786817|NCT00655668|83005839|FG000|Overall Study|Withdrawal by Subject|2|||
46973049|NCT02014480|83216813|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
46973050|NCT02014480|83216814|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
46973051|NCT02014480|83216809|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
46973052|NCT02014480|83216810|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
46672211|NCT01187407|82887680|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46672212|NCT01187407|82887681|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46786818|NCT00569166|83005846|FG000|Overall Study|Withdrawal by Subject|7|||
46672213|NCT01187407|82887682|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46672214|NCT01187407|82887678|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
46672215|NCT01187407|82887679|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46786819|NCT00569166|83005847|FG001|Overall Study|Withdrawal by Subject|5|||
46786820|NCT00569166|83005848|FG002|Overall Study|Withdrawal by Subject|3|||
46786821|NCT00569166|83005846|FG000|Overall Study|Lost to Follow-up|2|||
46973053|NCT02014480|83216811|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
46672216|NCT01187407|82887680|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46672217|NCT01187407|82887681|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46672218|NCT01187407|82887682|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46672219|NCT01187407|82887678|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
46672220|NCT01187407|82887679|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
46672221|NCT01187407|82887680|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
46672222|NCT01187407|82887681|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
46672223|NCT01187407|82887682|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
46786822|NCT00569166|83005847|FG001|Overall Study|Lost to Follow-up|1|||
46786823|NCT00569166|83005848|FG002|Overall Study|Lost to Follow-up|1|||
46672224|NCT01187407|82887678|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
46672225|NCT01187407|82887679|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
46672226|NCT01187407|82887680|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
46672227|NCT01187407|82887681|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
46672228|NCT01187407|82887682|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
46672229|NCT01187407|82887678|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
46672230|NCT01187407|82887679|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
46672231|NCT01187407|82887680|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
46786824|NCT00655356|83005858|FG000|Overall Study|Withdrawal by Subject|3|||
46786825|NCT00655356|83005859|FG001|Overall Study|Withdrawal by Subject|4|||
46786826|NCT00655356|83005858|FG000|Overall Study|Sponsor Request|10|||
46786827|NCT00655356|83005859|FG001|Overall Study|Sponsor Request|4|||
46786828|NCT00655356|83005858|FG000|Overall Study|Adverse Event|1|||
46786829|NCT00655356|83005859|FG001|Overall Study|Adverse Event|1|||
46786830|NCT00655356|83005858|FG000|Overall Study|Protocol Violation|2|||
46786831|NCT00655356|83005859|FG001|Overall Study|Protocol Violation|1|||
46786832|NCT00655356|83005858|FG000|Overall Study|Other Reason|1|||
46786833|NCT00655356|83005859|FG001|Overall Study|Other Reason|0|||
46786834|NCT00571064|83005865|FG000|Overall Study|Adverse Event|13|||
46786835|NCT00571064|83005865|FG000|Overall Study|Protocol Violation|4|||
46786836|NCT00571064|83005865|FG000|Overall Study|Withdrawal by Subject|2|||
46786837|NCT00571064|83005865|FG000|Overall Study|Other|2|||
46786838|NCT03895372|83005878|FG000|Investigational Treatment Period|Adverse Event|1|||
46786839|NCT03895372|83005879|FG001|Investigational Treatment Period|Adverse Event|0|||
46786840|NCT03895372|83005880|FG002|Investigational Treatment Period|Adverse Event|0|||
46786841|NCT03895372|83005881|FG003|Investigational Treatment Period|Adverse Event|0|||
46786842|NCT03895372|83005882|FG004|Investigational Treatment Period|Adverse Event|0|||
46786843|NCT03895372|83005883|FG005|Investigational Treatment Period|Adverse Event|0|||
46786844|NCT03895372|83005884|FG006|Investigational Treatment Period|Adverse Event|4|||
46786845|NCT03895372|83005885|FG007|Investigational Treatment Period|Adverse Event|3|||
46786846|NCT03895372|83005878|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
46973054|NCT02014480|83216812|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
46672232|NCT01187407|82887681|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
46672233|NCT01187407|82887682|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
46672234|NCT01187407|82887678|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
46672235|NCT01187407|82887679|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
46672236|NCT01187407|82887680|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
46672237|NCT01187407|82887681|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
46672238|NCT01187407|82887682|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
46672239|NCT01187407|82887678|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
46672240|NCT01187407|82887679|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
46672241|NCT01187407|82887680|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
46672242|NCT01187407|82887681|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
46672243|NCT01187407|82887682|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
46672244|NCT01187407|82887678|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
46672245|NCT01187407|82887679|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
46672246|NCT01187407|82887680|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
46786847|NCT03895372|83005879|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
46786848|NCT03895372|83005880|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
46786849|NCT03895372|83005881|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
46786850|NCT03895372|83005882|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
46973055|NCT02014480|83216813|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
46973056|NCT02014480|83216814|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
46786851|NCT03895372|83005883|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
46786852|NCT03895372|83005884|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
46786853|NCT03895372|83005885|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
46786854|NCT03895372|83005878|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
46973057|NCT02014480|83216809|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
46973058|NCT02014480|83216810|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
46973059|NCT02014480|83216811|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
46672247|NCT01187407|82887681|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
46672248|NCT01187407|82887682|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
46672249|NCT01187407|82887678|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
46672250|NCT01187407|82887679|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
46672251|NCT01187407|82887680|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
46672252|NCT01187407|82887681|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
46672253|NCT01187407|82887682|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
46672254|NCT01186978|82887699|FG000|Overall Study|Withdrawal by Subject|1|||
46672255|NCT01186939|82887703|FG000|Overall Study|Death|7|||
46672256|NCT01186939|82887703|FG000|Overall Study|Withdrawal by Subject|2|||
46672257|NCT01186939|82887703|FG000|Overall Study|No longer receiving clinical benefit|17|||
46672258|NCT01186939|82887703|FG000|Overall Study|Program closed|5|||
46672259|NCT01186939|82887703|FG000|Overall Study|Sponsor decision|4|||
46672260|NCT01186939|82887703|FG000|Overall Study|Started additional treatment|1|||
46672261|NCT01186939|82887703|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
46672262|NCT01186939|82887703|FG000|Overall Study|Myocardial infarction|1|||
46672263|NCT01186939|82887703|FG000|Overall Study|Bone marrow transplant|1|||
46672264|NCT01186939|82887703|FG000|Overall Study|Transformation to AML|1|||
46672265|NCT04938648|82887728|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
46672266|NCT04938648|82887729|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
46672267|NCT04938648|82887728|FG000|Overall Study|Patient too ill|0|||
46672268|NCT04938648|82887729|FG001|Overall Study|Patient too ill|1|||
46672269|NCT04938648|82887728|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
46672270|NCT04938648|82887729|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
46672271|NCT04938648|82887728|FG000|Overall Study|Patient did not have memory problems|1|||
46672272|NCT04938648|82887729|FG001|Overall Study|Patient did not have memory problems|1|||
46672273|NCT04938648|82887728|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
46672274|NCT04938648|82887729|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
46672275|NCT04938648|82887728|FG000|Overall Study|Care partner could not be reached|0|||
46672276|NCT04938648|82887729|FG001|Overall Study|Care partner could not be reached|1|||
46672277|NCT04938648|82887728|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
46672278|NCT04938648|82887729|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
46672279|NCT04938648|82887728|FG000|Overall Study|Withdrawal by Subject|2|||
46672280|NCT04938648|82887729|FG001|Overall Study|Withdrawal by Subject|1|||
46672281|NCT04564092|82887736|FG000|Overall Study|Withdrawal by Subject|1|||
46672282|NCT01658826|82887777|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
46672283|NCT01658826|82887778|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
46672284|NCT01658826|82887777|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
46672285|NCT01658826|82887778|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
46672286|NCT01658826|82887777|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
46672287|NCT01658826|82887778|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
46672288|NCT01658826|82887777|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
46672289|NCT01658826|82887778|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
46672290|NCT01658826|82887777|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
46672291|NCT01658826|82887778|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
46672292|NCT01658826|82887777|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
46672293|NCT01658826|82887778|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
46672294|NCT01658826|82887777|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
46672295|NCT01658826|82887778|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
46672296|NCT01658826|82887777|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
46672297|NCT01658826|82887778|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
46672298|NCT01658826|82887777|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
46672299|NCT01658826|82887778|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
46672300|NCT01186744|82887794|FG000|Overall Study|Lack of Efficacy|156|||
46672301|NCT01186744|82887795|FG001|Overall Study|Lack of Efficacy|99|||
46672302|NCT01186744|82887796|FG002|Overall Study|Lack of Efficacy|0|||
46672303|NCT01186744|82887797|FG003|Overall Study|Lack of Efficacy|2|||
46672304|NCT01186744|82887798|FG004|Overall Study|Lack of Efficacy|2|||
46672305|NCT01186744|82887799|FG005|Overall Study|Lack of Efficacy|5|||
46672306|NCT01186744|82887794|FG000|Overall Study|Protocol Violation|1|||
46672307|NCT01186744|82887795|FG001|Overall Study|Protocol Violation|2|||
46672308|NCT01186744|82887796|FG002|Overall Study|Protocol Violation|0|||
46672309|NCT01186744|82887797|FG003|Overall Study|Protocol Violation|1|||
46672310|NCT01186744|82887798|FG004|Overall Study|Protocol Violation|1|||
46973060|NCT02014480|83216812|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
46672311|NCT01186744|82887799|FG005|Overall Study|Protocol Violation|2|||
46672312|NCT01186744|82887794|FG000|Overall Study|Lost to Follow-up|15|||
46672313|NCT01186744|82887795|FG001|Overall Study|Lost to Follow-up|16|||
46672314|NCT01186744|82887796|FG002|Overall Study|Lost to Follow-up|2|||
46672315|NCT01186744|82887797|FG003|Overall Study|Lost to Follow-up|1|||
46672316|NCT01186744|82887798|FG004|Overall Study|Lost to Follow-up|1|||
46672317|NCT01186744|82887799|FG005|Overall Study|Lost to Follow-up|4|||
46672318|NCT01186744|82887794|FG000|Overall Study|Screen failure|1|||
46672319|NCT01186744|82887795|FG001|Overall Study|Screen failure|1|||
46672320|NCT01186744|82887796|FG002|Overall Study|Screen failure|0|||
46672321|NCT01186744|82887797|FG003|Overall Study|Screen failure|1|||
46672322|NCT01186744|82887798|FG004|Overall Study|Screen failure|0|||
46672323|NCT01186744|82887799|FG005|Overall Study|Screen failure|0|||
46672324|NCT01186744|82887794|FG000|Overall Study|Withdrawal by Subject|14|||
46672325|NCT01186744|82887795|FG001|Overall Study|Withdrawal by Subject|10|||
46672326|NCT01186744|82887796|FG002|Overall Study|Withdrawal by Subject|2|||
46672327|NCT01186744|82887797|FG003|Overall Study|Withdrawal by Subject|5|||
46672328|NCT01186744|82887798|FG004|Overall Study|Withdrawal by Subject|0|||
46672329|NCT01186744|82887799|FG005|Overall Study|Withdrawal by Subject|6|||
46672330|NCT01186744|82887794|FG000|Overall Study|Study terminated by Sponsor|1|||
46672331|NCT01186744|82887795|FG001|Overall Study|Study terminated by Sponsor|0|||
46672332|NCT01186744|82887796|FG002|Overall Study|Study terminated by Sponsor|0|||
46672333|NCT01186744|82887797|FG003|Overall Study|Study terminated by Sponsor|0|||
46672334|NCT01186744|82887798|FG004|Overall Study|Study terminated by Sponsor|0|||
47077520|NCT01666314|83378915|FG003|Overall Study|Progressive Disease|20|||
47077521|NCT01666314|83378912|FG000|Overall Study|Symptomatic Deterioration|1|||
47077522|NCT01666314|83378913|FG001|Overall Study|Symptomatic Deterioration|0|||
47077523|NCT01666314|83378914|FG002|Overall Study|Symptomatic Deterioration|2|||
47077524|NCT01666314|83378915|FG003|Overall Study|Symptomatic Deterioration|0|||
47077525|NCT01666314|83378912|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
47077526|NCT01666314|83378913|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
47077527|NCT01666314|83378914|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
47077528|NCT01666314|83378915|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
47077529|NCT01666314|83378912|FG000|Overall Study|Withdrawal by Subject|1|||
47077530|NCT01666314|83378913|FG001|Overall Study|Withdrawal by Subject|1|||
47077531|NCT01666314|83378914|FG002|Overall Study|Withdrawal by Subject|2|||
47077532|NCT01666314|83378915|FG003|Overall Study|Withdrawal by Subject|3|||
47077533|NCT01666314|83378912|FG000|Overall Study|Reason not Specified|10|||
47077534|NCT01666314|83378913|FG001|Overall Study|Reason not Specified|7|||
46672335|NCT01186744|82887799|FG005|Overall Study|Study terminated by Sponsor|0|||
46672336|NCT01186744|82887794|FG000|Overall Study|Other|9|||
46672337|NCT01186744|82887795|FG001|Overall Study|Other|10|||
46672338|NCT01186744|82887796|FG002|Overall Study|Other|1|||
46672339|NCT01186744|82887797|FG003|Overall Study|Other|2|||
46672340|NCT01186744|82887798|FG004|Overall Study|Other|1|||
46672341|NCT01186744|82887799|FG005|Overall Study|Other|5|||
46672342|NCT01186744|82887794|FG000|Overall Study|Adverse Event|10|||
46672343|NCT01186744|82887795|FG001|Overall Study|Adverse Event|14|||
46672344|NCT01186744|82887796|FG002|Overall Study|Adverse Event|1|||
46672345|NCT01186744|82887797|FG003|Overall Study|Adverse Event|0|||
46672346|NCT01186744|82887798|FG004|Overall Study|Adverse Event|1|||
46786855|NCT03895372|83005879|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
46786856|NCT03895372|83005880|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
46786857|NCT03895372|83005881|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
46786858|NCT03895372|83005882|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
46786859|NCT03895372|83005883|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
46786860|NCT03895372|83005884|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
46786861|NCT03895372|83005885|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
46672347|NCT01186744|82887799|FG005|Overall Study|Adverse Event|4|||
46672348|NCT01186744|82887794|FG000|Overall Study|Death|1|||
46672349|NCT01186744|82887795|FG001|Overall Study|Death|0|||
47077535|NCT01666314|83378914|FG002|Overall Study|Reason not Specified|5|||
47077536|NCT01666314|83378915|FG003|Overall Study|Reason not Specified|5|||
47077537|NCT01666002|83378946|FG000|Overall Study|Lost to Follow-up|5|||
46672350|NCT01186744|82887796|FG002|Overall Study|Death|0|||
46672351|NCT01186744|82887797|FG003|Overall Study|Death|0|||
46672352|NCT01186744|82887798|FG004|Overall Study|Death|0|||
46672353|NCT01186744|82887799|FG005|Overall Study|Death|0|||
46672354|NCT01185964|82887837|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
46672355|NCT01185964|82887838|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
46672356|NCT01185964|82887839|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
46672357|NCT01185964|82887840|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
46672358|NCT01185964|82887837|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
46672359|NCT01185964|82887838|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
46672360|NCT01185964|82887839|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
46672361|NCT01185964|82887840|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
46672362|NCT01185964|82887837|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
46672363|NCT01185964|82887838|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
46672364|NCT01185964|82887839|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
46672365|NCT01185964|82887840|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
46672366|NCT01185964|82887837|FG000|Phase 1b and Phase 2|Adverse Event|1|||
46672367|NCT01185964|82887838|FG001|Phase 1b and Phase 2|Adverse Event|0|||
46672368|NCT01185964|82887839|FG002|Phase 1b and Phase 2|Adverse Event|2|||
46672369|NCT01185964|82887840|FG003|Phase 1b and Phase 2|Adverse Event|0|||
46672370|NCT01185964|82887837|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
46672371|NCT01185964|82887838|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
46672372|NCT01185964|82887839|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
46672373|NCT01185964|82887840|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
46672374|NCT01185964|82887837|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
46672375|NCT01185964|82887838|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
46672376|NCT01185964|82887839|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
46672377|NCT01185964|82887840|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
46672378|NCT01185964|82887837|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
46672379|NCT01185964|82887838|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
46672380|NCT01185964|82887839|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
46672381|NCT01185964|82887840|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
46672382|NCT01185964|82887837|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
46672383|NCT01185964|82887838|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
46672384|NCT01185964|82887839|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
46672385|NCT01185964|82887840|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
46672386|NCT01217476|82887858|FG000|Overall Study|Adverse Event|6|||
46672387|NCT01217476|82887859|FG001|Overall Study|Adverse Event|1|||
46672388|NCT01217476|82887858|FG000|Overall Study|Physician Decision|0|||
46672389|NCT01217476|82887859|FG001|Overall Study|Physician Decision|1|||
46672390|NCT01217476|82887858|FG000|Overall Study|Withdrawal by Subject|3|||
46672391|NCT01217476|82887859|FG001|Overall Study|Withdrawal by Subject|3|||
46672392|NCT01217476|82887858|FG000|Overall Study|Surgery on the Target Limb|0|||
46672393|NCT01217476|82887859|FG001|Overall Study|Surgery on the Target Limb|2|||
46672394|NCT01217476|82887858|FG000|Overall Study|Protocol Deviation|1|||
46672395|NCT01217476|82887859|FG001|Overall Study|Protocol Deviation|0|||
46672396|NCT01217476|82887858|FG000|Overall Study|Other|2|||
46672397|NCT01217476|82887859|FG001|Overall Study|Other|0|||
46672398|NCT01217437|82887880|FG000|Overall Study|Adverse Event|0|||
46672399|NCT01217437|82887881|FG001|Overall Study|Adverse Event|8|||
46672400|NCT01217437|82887880|FG000|Overall Study|Death|5|||
46672401|NCT01217437|82887881|FG001|Overall Study|Death|0|||
46672402|NCT01217437|82887880|FG000|Overall Study|Lack of Efficacy|29|||
46672403|NCT01217437|82887881|FG001|Overall Study|Lack of Efficacy|25|||
46672404|NCT01217437|82887880|FG000|Overall Study|Physician Decision|8|||
46672405|NCT01217437|82887881|FG001|Overall Study|Physician Decision|5|||
46672406|NCT01217437|82887880|FG000|Overall Study|Withdrawal by Subject|0|||
46672407|NCT01217437|82887881|FG001|Overall Study|Withdrawal by Subject|2|||
46672408|NCT01217437|82887880|FG000|Overall Study|Ineligible|1|||
46672409|NCT01217437|82887881|FG001|Overall Study|Ineligible|1|||
46672410|NCT04531904|82887905|FG000|Overall Study|Lost to Follow-up|1|||
46672411|NCT04531904|82887905|FG000|Overall Study|Death|14|||
46672412|NCT04137380|82887916|FG000|Overall Study|Physician Decision|0|||
46672413|NCT04137380|82887917|FG001|Overall Study|Physician Decision|0|||
46672414|NCT04137380|82887918|FG002|Overall Study|Physician Decision|0|||
46672415|NCT04137380|82887919|FG003|Overall Study|Physician Decision|1|||
46672416|NCT04137380|82887920|FG004|Overall Study|Physician Decision|0|||
46672417|NCT04137380|82887921|FG005|Overall Study|Physician Decision|0|||
46672418|NCT04137380|82887922|FG006|Overall Study|Physician Decision|0|||
46786862|NCT03895372|83005878|FG000|Investigational Treatment Period|Other|0|||
46786863|NCT03895372|83005879|FG001|Investigational Treatment Period|Other|0|||
46973061|NCT02014480|83216813|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
46672419|NCT02927301|82887946|FG000|Overall Study|Adverse Event|7|||
46672420|NCT02927301|82887946|FG000|Overall Study|Withdrawal by Subject|1|||
46672421|NCT02927301|82887946|FG000|Overall Study|Physician Decision|2|||
46672422|NCT02653976|82887950|FG000|Overall Study|Withdrawal by Subject|5|||
46672423|NCT02653976|82887950|FG000|Overall Study|Death|4|||
46672424|NCT02611037|82887954|FG000|Overall Study|Withdrawal prior to treatment|2|||
46672425|NCT02611037|82887955|FG001|Overall Study|Withdrawal prior to treatment|0|||
46672426|NCT01566695|82887962|FG000|Overall Study|Lack of Efficacy|18|||
46672427|NCT01566695|82887963|FG001|Overall Study|Lack of Efficacy|45|||
46672428|NCT01566695|82887962|FG000|Overall Study|Adverse Event|28|||
46672429|NCT01566695|82887963|FG001|Overall Study|Adverse Event|27|||
46672430|NCT01566695|82887962|FG000|Overall Study|Death|20|||
46672431|NCT01566695|82887963|FG001|Overall Study|Death|8|||
46672432|NCT01566695|82887962|FG000|Overall Study|Withdrawal by Subject|14|||
46672433|NCT01566695|82887963|FG001|Overall Study|Withdrawal by Subject|7|||
46672434|NCT01566695|82887962|FG000|Overall Study|Progressive Disease|11|||
46672435|NCT01566695|82887963|FG001|Overall Study|Progressive Disease|6|||
46672436|NCT01566695|82887962|FG000|Overall Study|Miscellaneous|4|||
46672437|NCT01566695|82887963|FG001|Overall Study|Miscellaneous|6|||
46672438|NCT01081951|82887971|FG000|Overall Study|Death|54|||
46672439|NCT01081951|82887972|FG001|Overall Study|Death|47|||
46672440|NCT01081951|82887971|FG000|Overall Study|Withdrawal by Subject|2|||
46672441|NCT01081951|82887972|FG001|Overall Study|Withdrawal by Subject|6|||
46672442|NCT01081951|82887971|FG000|Overall Study|Allocated treatment but did not take it|0|||
46672443|NCT01081951|82887972|FG001|Overall Study|Allocated treatment but did not take it|1|||
46672444|NCT01081951|82887971|FG000|Overall Study|Lost to Follow-up|0|||
46672445|NCT01081951|82887972|FG001|Overall Study|Lost to Follow-up|1|||
46672446|NCT00736385|82887980|FG000|Overall Study|Withdrawal by Subject|2|||
46672447|NCT00736385|82887981|FG001|Overall Study|Withdrawal by Subject|2|||
46672448|NCT00736385|82887980|FG000|Overall Study|Adverse Event|0|||
46672449|NCT00736385|82887981|FG001|Overall Study|Adverse Event|1|||
46672450|NCT00392327|82887995|FG000|Overall Study|Death|1|||
46672451|NCT00392327|82887996|FG001|Overall Study|Death|0|||
46672452|NCT00392327|82887997|FG002|Overall Study|Death|1|||
46672453|NCT00392327|82887998|FG003|Overall Study|Death|0|||
46672454|NCT00392327|82887999|FG004|Overall Study|Death|0|||
46672455|NCT00392327|82888000|FG005|Overall Study|Death|0|||
46672456|NCT00392327|82888001|FG006|Overall Study|Death|0|||
46672457|NCT00392327|82888002|FG007|Overall Study|Death|0|||
46672458|NCT00392327|82887995|FG000|Overall Study|Lack of Efficacy|8|||
46672459|NCT00392327|82887996|FG001|Overall Study|Lack of Efficacy|8|||
46672460|NCT00392327|82887997|FG002|Overall Study|Lack of Efficacy|9|||
46672461|NCT00392327|82887998|FG003|Overall Study|Lack of Efficacy|6|||
46672462|NCT00392327|82887999|FG004|Overall Study|Lack of Efficacy|3|||
46672463|NCT00392327|82888000|FG005|Overall Study|Lack of Efficacy|3|||
46672464|NCT00392327|82888001|FG006|Overall Study|Lack of Efficacy|3|||
46672465|NCT00392327|82888002|FG007|Overall Study|Lack of Efficacy|3|||
46672466|NCT00392327|82887995|FG000|Overall Study|Physician Decision|3|||
46672467|NCT00392327|82887996|FG001|Overall Study|Physician Decision|5|||
46672468|NCT00392327|82887997|FG002|Overall Study|Physician Decision|2|||
46672469|NCT00392327|82887998|FG003|Overall Study|Physician Decision|2|||
46672470|NCT00392327|82887999|FG004|Overall Study|Physician Decision|0|||
46672471|NCT00392327|82888000|FG005|Overall Study|Physician Decision|1|||
46672472|NCT00392327|82888001|FG006|Overall Study|Physician Decision|5|||
46672473|NCT00392327|82888002|FG007|Overall Study|Physician Decision|3|||
46672474|NCT00392327|82887995|FG000|Overall Study|Protocol Violation|0|||
46672475|NCT00392327|82887996|FG001|Overall Study|Protocol Violation|0|||
46672476|NCT00392327|82887997|FG002|Overall Study|Protocol Violation|1|||
46672477|NCT00392327|82887998|FG003|Overall Study|Protocol Violation|0|||
46672478|NCT00392327|82887999|FG004|Overall Study|Protocol Violation|0|||
46672479|NCT00392327|82888000|FG005|Overall Study|Protocol Violation|0|||
46672480|NCT00392327|82888001|FG006|Overall Study|Protocol Violation|0|||
46672481|NCT00392327|82888002|FG007|Overall Study|Protocol Violation|0|||
46786864|NCT03895372|83005880|FG002|Investigational Treatment Period|Other|0|||
46786865|NCT03895372|83005881|FG003|Investigational Treatment Period|Other|0|||
46786866|NCT03895372|83005882|FG004|Investigational Treatment Period|Other|0|||
46786867|NCT03895372|83005883|FG005|Investigational Treatment Period|Other|1|||
46786868|NCT03895372|83005884|FG006|Investigational Treatment Period|Other|0|||
47077538|NCT01666002|83378947|FG001|Overall Study|Lost to Follow-up|0|||
46672482|NCT00392327|82887995|FG000|Overall Study|Withdrawal by Subject|3|||
46672483|NCT00392327|82887996|FG001|Overall Study|Withdrawal by Subject|2|||
46672484|NCT00392327|82887997|FG002|Overall Study|Withdrawal by Subject|4|||
46672485|NCT00392327|82887998|FG003|Overall Study|Withdrawal by Subject|6|||
46786869|NCT03895372|83005885|FG007|Investigational Treatment Period|Other|2|||
46786870|NCT03895372|83005878|FG000|Investigational Treatment Period|Protocol Violation|0|||
47077539|NCT01665768|83379019|FG000|Overall Study|Adverse Event|3|||
46786871|NCT03895372|83005879|FG001|Investigational Treatment Period|Protocol Violation|0|||
47077540|NCT01665768|83379019|FG000|Overall Study|Lack of Efficacy|19|||
47077541|NCT01665768|83379019|FG000|Overall Study|Withdrawal by Subject|1|||
46672486|NCT00392327|82887999|FG004|Overall Study|Withdrawal by Subject|0|||
46672487|NCT00392327|82888000|FG005|Overall Study|Withdrawal by Subject|1|||
46672488|NCT00392327|82888001|FG006|Overall Study|Withdrawal by Subject|1|||
46672489|NCT00392327|82888002|FG007|Overall Study|Withdrawal by Subject|5|||
46786872|NCT03895372|83005880|FG002|Investigational Treatment Period|Protocol Violation|0|||
47077542|NCT02584452|83379227|FG000|Overall Study|Physician Decision|1|||
46672490|NCT00392327|82887995|FG000|Overall Study|Ineligible|0|||
46672491|NCT00392327|82887996|FG001|Overall Study|Ineligible|4|||
46672492|NCT00392327|82887997|FG002|Overall Study|Ineligible|3|||
46672493|NCT00392327|82887998|FG003|Overall Study|Ineligible|2|||
46672494|NCT00392327|82887999|FG004|Overall Study|Ineligible|0|||
46672495|NCT00392327|82888000|FG005|Overall Study|Ineligible|0|||
46672496|NCT00392327|82888001|FG006|Overall Study|Ineligible|0|||
46672497|NCT00392327|82888002|FG007|Overall Study|Ineligible|0|||
46672498|NCT00352534|82888022|FG000|Initial Staging|Ineligible|8|||
46672499|NCT00352534|82888023|FG001|Initial Staging|Ineligible|9|||
46672500|NCT00352534|82888024|FG002|Initial Staging|Ineligible|0|||
46672501|NCT00352534|82888025|FG003|Initial Staging|Ineligible|0|||
46672502|NCT00352534|82888026|FG004|Initial Staging|Ineligible|0|||
46672503|NCT00352534|82888027|FG005|Initial Staging|Ineligible|0|||
46672504|NCT00352534|82888028|FG006|Initial Staging|Ineligible|0|||
46672505|NCT00352534|82888022|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
46672506|NCT00352534|82888023|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
46672507|NCT00352534|82888024|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
46672508|NCT00352534|82888025|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
46672509|NCT00352534|82888026|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
46672510|NCT00352534|82888027|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
46672511|NCT00352534|82888028|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
46672512|NCT00352534|82888022|FG000|Final Risk Group Assignment|Physician Decision|0|||
46672513|NCT00352534|82888023|FG001|Final Risk Group Assignment|Physician Decision|0|||
46672514|NCT00352534|82888024|FG002|Final Risk Group Assignment|Physician Decision|0|||
46672515|NCT00352534|82888025|FG003|Final Risk Group Assignment|Physician Decision|0|||
46672516|NCT00352534|82888026|FG004|Final Risk Group Assignment|Physician Decision|0|||
46672517|NCT00352534|82888027|FG005|Final Risk Group Assignment|Physician Decision|8|||
46672518|NCT00352534|82888028|FG006|Final Risk Group Assignment|Physician Decision|0|||
46672519|NCT00352534|82888022|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
46672520|NCT00352534|82888023|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
46672521|NCT00352534|82888024|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
46672522|NCT00352534|82888025|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
46672523|NCT00352534|82888026|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
46672524|NCT00352534|82888027|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
46672525|NCT00352534|82888028|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
46672526|NCT00352534|82888022|FG000|Final Risk Group Assignment|Ineligible|0|||
46672527|NCT00352534|82888023|FG001|Final Risk Group Assignment|Ineligible|0|||
46672528|NCT00352534|82888024|FG002|Final Risk Group Assignment|Ineligible|3|||
46672529|NCT00352534|82888025|FG003|Final Risk Group Assignment|Ineligible|1|||
46672530|NCT00352534|82888026|FG004|Final Risk Group Assignment|Ineligible|0|||
46672531|NCT00352534|82888027|FG005|Final Risk Group Assignment|Ineligible|13|||
46672532|NCT00352534|82888028|FG006|Final Risk Group Assignment|Ineligible|0|||
46672533|NCT00352534|82888022|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
46672534|NCT00352534|82888023|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
46672535|NCT00352534|82888024|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
46672536|NCT00352534|82888025|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
46672537|NCT00352534|82888026|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
46672538|NCT00352534|82888027|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
46672539|NCT00352534|82888028|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
46672540|NCT00352534|82888022|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
46672541|NCT00352534|82888023|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
46672542|NCT00352534|82888024|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
46672543|NCT00352534|82888025|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
46672544|NCT00352534|82888026|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
46672545|NCT00352534|82888027|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
46672546|NCT00352534|82888028|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
46672547|NCT00352534|82888022|FG000|Final Risk Group Assignment|Death|0|||
46672548|NCT00352534|82888023|FG001|Final Risk Group Assignment|Death|0|||
46672549|NCT00352534|82888024|FG002|Final Risk Group Assignment|Death|0|||
46672550|NCT00352534|82888025|FG003|Final Risk Group Assignment|Death|0|||
46672551|NCT00352534|82888026|FG004|Final Risk Group Assignment|Death|0|||
46672552|NCT00352534|82888027|FG005|Final Risk Group Assignment|Death|2|||
46672553|NCT00352534|82888028|FG006|Final Risk Group Assignment|Death|0|||
46672554|NCT01217047|82888042|FG000|Overall Study|Lost to Follow-up|0|||
46672555|NCT01217047|82888043|FG001|Overall Study|Lost to Follow-up|1|||
46672556|NCT01217047|82888044|FG002|Overall Study|Lost to Follow-up|0|||
46672557|NCT01185340|82888056|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
46672558|NCT01185340|82888057|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46672559|NCT01185340|82888058|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46672560|NCT01185340|82888059|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46672561|NCT01185340|82888056|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
46851668|NCT00109707|83067222|FG000|Overall Study|Lost to Follow-up|3|||
46973062|NCT02014480|83216814|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
46672562|NCT01185340|82888057|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46672563|NCT01185340|82888058|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46973063|NCT02014480|83216809|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
46672564|NCT01185340|82888059|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46672565|NCT01185340|82888056|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
46672566|NCT01185340|82888057|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46672567|NCT01185340|82888058|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46672568|NCT01185340|82888059|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46672569|NCT01185340|82888056|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
46672570|NCT01185340|82888057|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46672571|NCT01185340|82888058|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46672572|NCT01185340|82888059|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46672573|NCT01185340|82888056|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
46672574|NCT01185340|82888057|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46672575|NCT01185340|82888058|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46672576|NCT01185340|82888059|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46672577|NCT01185340|82888056|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
46672578|NCT01185340|82888057|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46672579|NCT01185340|82888058|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46672580|NCT01185340|82888059|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46672581|NCT01185340|82888056|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
46672582|NCT01185340|82888057|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46672583|NCT01185340|82888058|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46672584|NCT01185340|82888059|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46672585|NCT01185340|82888056|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
46672586|NCT01185340|82888057|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
46672587|NCT01185340|82888058|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
46672588|NCT01185340|82888059|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
46672589|NCT01185340|82888056|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
46672590|NCT01185340|82888057|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
46672591|NCT01185340|82888058|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
46672592|NCT01185340|82888059|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
46672593|NCT01185340|82888056|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
46672594|NCT01185340|82888057|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
46672595|NCT01185340|82888058|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
46672596|NCT01185340|82888059|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
46672597|NCT01185340|82888056|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
46672598|NCT01185340|82888057|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
46672599|NCT01185340|82888058|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
46672600|NCT01185340|82888059|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
46672601|NCT01185340|82888056|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
46672602|NCT01185340|82888057|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
46672603|NCT01185340|82888058|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
46672604|NCT01185340|82888059|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
46672605|NCT01185340|82888056|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
46672606|NCT01185340|82888057|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
46672607|NCT01185340|82888058|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
46672608|NCT01185340|82888059|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
46672609|NCT01185340|82888056|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
46672610|NCT01185340|82888057|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
46672611|NCT01185340|82888058|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
46672612|NCT01185340|82888059|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
46672613|NCT01216189|82888073|FG000|Overall Study|Lost to Follow-up|21|||
46672614|NCT01216189|82888074|FG001|Overall Study|Lost to Follow-up|3|||
46672615|NCT01216189|82888073|FG000|Overall Study|Death|4|||
46672616|NCT01216189|82888074|FG001|Overall Study|Death|2|||
46672617|NCT01185301|82888084|FG000|Overall Study|Adverse Event|3|||
46672618|NCT01185301|82888085|FG001|Overall Study|Adverse Event|0|||
46672619|NCT01185301|82888086|FG002|Overall Study|Adverse Event|2|||
46672620|NCT01185301|82888087|FG003|Overall Study|Adverse Event|3|||
46672621|NCT01185301|82888084|FG000|Overall Study|Withdrawal by Subject|7|||
46973064|NCT02014480|83216810|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
46973065|NCT02014480|83216811|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
46973066|NCT02014480|83216812|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
46672622|NCT01185301|82888085|FG001|Overall Study|Withdrawal by Subject|5|||
46786873|NCT03895372|83005881|FG003|Investigational Treatment Period|Protocol Violation|1|||
46973067|NCT02014480|83216813|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
46672623|NCT01185301|82888086|FG002|Overall Study|Withdrawal by Subject|2|||
46973068|NCT02014480|83216814|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
46973069|NCT02014480|83216809|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
46672624|NCT01185301|82888087|FG003|Overall Study|Withdrawal by Subject|3|||
46672625|NCT01185301|82888084|FG000|Overall Study|Lost to Follow-up|2|||
46672626|NCT01185301|82888085|FG001|Overall Study|Lost to Follow-up|0|||
46672627|NCT01185301|82888086|FG002|Overall Study|Lost to Follow-up|0|||
46672628|NCT01185301|82888087|FG003|Overall Study|Lost to Follow-up|1|||
46672629|NCT01185301|82888084|FG000|Overall Study|Other Reason|3|||
46672630|NCT01185301|82888085|FG001|Overall Study|Other Reason|2|||
46672631|NCT01185301|82888086|FG002|Overall Study|Other Reason|2|||
46672632|NCT01185301|82888087|FG003|Overall Study|Other Reason|2|||
46672633|NCT01216072|82888099|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
46672634|NCT01216072|82888100|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
46672635|NCT01216072|82888099|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
46672636|NCT01216072|82888100|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
46672637|NCT01216072|82888099|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
46672638|NCT01216072|82888100|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
46672639|NCT01216072|82888099|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
46672640|NCT01216072|82888100|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
46672641|NCT01216072|82888099|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
46672642|NCT01216072|82888100|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
46672643|NCT01216072|82888099|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
46672644|NCT01216072|82888100|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
46672645|NCT01216072|82888099|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
46786874|NCT03895372|83005882|FG004|Investigational Treatment Period|Protocol Violation|0|||
46786875|NCT03895372|83005883|FG005|Investigational Treatment Period|Protocol Violation|0|||
46786876|NCT03895372|83005884|FG006|Investigational Treatment Period|Protocol Violation|0|||
46786877|NCT03895372|83005885|FG007|Investigational Treatment Period|Protocol Violation|0|||
46786878|NCT03895372|83005878|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
46786879|NCT03895372|83005879|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
46786880|NCT03895372|83005880|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
46786881|NCT03895372|83005881|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
46786882|NCT03895372|83005882|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
46786883|NCT03895372|83005883|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
46672646|NCT01216072|82888100|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
46672647|NCT01216072|82888099|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
46672648|NCT01216072|82888100|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
46672649|NCT01216072|82888099|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
46672650|NCT01216072|82888100|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
46672651|NCT01216072|82888099|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
46672652|NCT01216072|82888100|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
46672653|NCT01184989|82888109|FG000|Overall Study|Adverse Event|11|||
46672654|NCT01184989|82888109|FG000|Overall Study|Withdrawal by Subject|1|||
46672655|NCT01215955|82888117|FG000|Overall Study|Adverse Event|1|||
46672656|NCT01215955|82888118|FG001|Overall Study|Adverse Event|4|||
46672657|NCT01215955|82888119|FG002|Overall Study|Adverse Event|2|||
46672658|NCT01215955|82888120|FG003|Overall Study|Adverse Event|3|||
46672659|NCT01215955|82888117|FG000|Overall Study|Death|2|||
46672660|NCT01215955|82888118|FG001|Overall Study|Death|0|||
46672661|NCT01215955|82888119|FG002|Overall Study|Death|1|||
46672662|NCT01215955|82888120|FG003|Overall Study|Death|3|||
46672663|NCT01215955|82888117|FG000|Overall Study|Entry Criteria Not Met|1|||
46672664|NCT01215955|82888118|FG001|Overall Study|Entry Criteria Not Met|3|||
46672665|NCT01215955|82888119|FG002|Overall Study|Entry Criteria Not Met|4|||
46672666|NCT01215955|82888120|FG003|Overall Study|Entry Criteria Not Met|7|||
46672667|NCT01215955|82888117|FG000|Overall Study|Lack of Efficacy|1|||
46786884|NCT03895372|83005884|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
46786885|NCT03895372|83005885|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
46786886|NCT03895372|83005878|FG000|Extension Treatment Period|Adverse Event|0|||
46786887|NCT03895372|83005879|FG001|Extension Treatment Period|Adverse Event|1|||
46786888|NCT03895372|83005880|FG002|Extension Treatment Period|Adverse Event|0|||
46851669|NCT00109707|83067223|FG001|Overall Study|Lost to Follow-up|0|||
46851670|NCT00109707|83067224|FG002|Overall Study|Lost to Follow-up|0|||
46672668|NCT01215955|82888118|FG001|Overall Study|Lack of Efficacy|2|||
46672669|NCT01215955|82888119|FG002|Overall Study|Lack of Efficacy|1|||
46672670|NCT01215955|82888120|FG003|Overall Study|Lack of Efficacy|0|||
46786889|NCT03895372|83005881|FG003|Extension Treatment Period|Adverse Event|1|||
46973070|NCT02014480|83216810|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
46672671|NCT01215955|82888117|FG000|Overall Study|Lost to Follow-up|4|||
46672672|NCT01215955|82888118|FG001|Overall Study|Lost to Follow-up|4|||
46786890|NCT03895372|83005882|FG004|Extension Treatment Period|Adverse Event|0|||
46851671|NCT00109707|83067222|FG000|Overall Study|Protocol Violation|1|||
46672673|NCT01215955|82888119|FG002|Overall Study|Lost to Follow-up|8|||
46672674|NCT01215955|82888120|FG003|Overall Study|Lost to Follow-up|9|||
46672675|NCT01215955|82888117|FG000|Overall Study|Physician Decision|4|||
46786891|NCT03895372|83005883|FG005|Extension Treatment Period|Adverse Event|0|||
47077543|NCT02584452|83379228|FG001|Overall Study|Physician Decision|1|||
47077544|NCT02584452|83379227|FG000|Overall Study|Lost to Follow-up|1|||
47077545|NCT02584452|83379228|FG001|Overall Study|Lost to Follow-up|1|||
47077546|NCT02586012|83379275|FG000|Overall Study|Withdrawal by Subject|1|||
47077547|NCT02586012|83379276|FG001|Overall Study|Withdrawal by Subject|1|||
47077548|NCT02586012|83379277|FG002|Overall Study|Withdrawal by Subject|0|||
47077549|NCT02586012|83379278|FG003|Overall Study|Withdrawal by Subject|1|||
47077550|NCT02586012|83379279|FG004|Overall Study|Withdrawal by Subject|0|||
47077551|NCT02586012|83379280|FG005|Overall Study|Withdrawal by Subject|2|||
47077552|NCT02586012|83379275|FG000|Overall Study|Protocol Violation|0|||
47077553|NCT02586012|83379276|FG001|Overall Study|Protocol Violation|0|||
47077554|NCT02586012|83379277|FG002|Overall Study|Protocol Violation|0|||
47077555|NCT02586012|83379278|FG003|Overall Study|Protocol Violation|0|||
47077556|NCT02586012|83379279|FG004|Overall Study|Protocol Violation|0|||
47077557|NCT02586012|83379280|FG005|Overall Study|Protocol Violation|1|||
47077558|NCT02586012|83379275|FG000|Overall Study|study terminated|0|||
47077559|NCT02586012|83379276|FG001|Overall Study|study terminated|2|||
47077560|NCT02586012|83379277|FG002|Overall Study|study terminated|1|||
47077561|NCT02586012|83379278|FG003|Overall Study|study terminated|1|||
47077562|NCT02586012|83379279|FG004|Overall Study|study terminated|1|||
47077563|NCT02586012|83379280|FG005|Overall Study|study terminated|0|||
47077564|NCT02582814|83379291|FG000|Overall Study|Study-specific withdrawal criteria|1|||
47077565|NCT02582814|83379292|FG001|Overall Study|Study-specific withdrawal criteria|0|||
47077566|NCT02582814|83379291|FG000|Overall Study|Withdrawal by Subject|4|||
47077567|NCT02582814|83379292|FG001|Overall Study|Withdrawal by Subject|3|||
47077568|NCT02582814|83379291|FG000|Overall Study|Adverse Event|4|||
47077569|NCT02582814|83379292|FG001|Overall Study|Adverse Event|4|||
47077570|NCT02585934|83379440|FG000|Overall Study|Lost to Follow-up|2|||
47077571|NCT02585934|83379441|FG001|Overall Study|Lost to Follow-up|2|||
47077572|NCT02585934|83379440|FG000|Overall Study|Protocol Violation|14|||
47077573|NCT02585934|83379441|FG001|Overall Study|Protocol Violation|11|||
47077574|NCT02585934|83379440|FG000|Overall Study|Adverse Event|21|||
47077575|NCT02585934|83379441|FG001|Overall Study|Adverse Event|22|||
47077576|NCT02585934|83379440|FG000|Overall Study|Physician Decision|3|||
47077577|NCT02585934|83379441|FG001|Overall Study|Physician Decision|2|||
46786892|NCT03895372|83005884|FG006|Extension Treatment Period|Adverse Event|3|||
46786893|NCT03895372|83005885|FG007|Extension Treatment Period|Adverse Event|3|||
46786894|NCT03895372|83005878|FG000|Extension Treatment Period|Other|1|||
46786895|NCT03895372|83005879|FG001|Extension Treatment Period|Other|3|||
46786896|NCT03895372|83005880|FG002|Extension Treatment Period|Other|0|||
46786897|NCT03895372|83005881|FG003|Extension Treatment Period|Other|0|||
47077578|NCT02585934|83379440|FG000|Overall Study|Withdrawal by Subject|7|||
47077579|NCT02585934|83379441|FG001|Overall Study|Withdrawal by Subject|21|||
47077580|NCT02585934|83379440|FG000|Overall Study|Lack of Efficacy|2|||
46672676|NCT01215955|82888118|FG001|Overall Study|Physician Decision|10|||
46672677|NCT01215955|82888119|FG002|Overall Study|Physician Decision|8|||
46672678|NCT01215955|82888120|FG003|Overall Study|Physician Decision|11|||
46672679|NCT01215955|82888117|FG000|Overall Study|Protocol Violation|17|||
46786898|NCT03895372|83005882|FG004|Extension Treatment Period|Other|1|||
46786899|NCT03895372|83005883|FG005|Extension Treatment Period|Other|0|||
46786900|NCT03895372|83005884|FG006|Extension Treatment Period|Other|0|||
46786901|NCT03895372|83005885|FG007|Extension Treatment Period|Other|2|||
46786902|NCT03895372|83005878|FG000|Extension Treatment Period|Pregnancy|0|||
46786903|NCT03895372|83005879|FG001|Extension Treatment Period|Pregnancy|0|||
46786904|NCT03895372|83005880|FG002|Extension Treatment Period|Pregnancy|0|||
46786905|NCT03895372|83005881|FG003|Extension Treatment Period|Pregnancy|0|||
46786906|NCT03895372|83005882|FG004|Extension Treatment Period|Pregnancy|1|||
46786907|NCT03895372|83005883|FG005|Extension Treatment Period|Pregnancy|0|||
46786908|NCT03895372|83005884|FG006|Extension Treatment Period|Pregnancy|0|||
46786909|NCT03895372|83005885|FG007|Extension Treatment Period|Pregnancy|0|||
47077581|NCT02585934|83379441|FG001|Overall Study|Lack of Efficacy|1|||
47077582|NCT02585934|83379440|FG000|Overall Study|Death|2|||
47077583|NCT02585934|83379441|FG001|Overall Study|Death|0|||
47077584|NCT02585934|83379440|FG000|Overall Study|Caregiver Withdrew Consent|7|||
47077585|NCT02585934|83379441|FG001|Overall Study|Caregiver Withdrew Consent|7|||
47077586|NCT02585934|83379440|FG000|Overall Study|Sponsor Termination|1|||
47077587|NCT02585934|83379441|FG001|Overall Study|Sponsor Termination|2|||
47077588|NCT02585934|83379440|FG000|Overall Study|Another Reason|10|||
46672680|NCT01215955|82888118|FG001|Overall Study|Protocol Violation|13|||
46786910|NCT03895372|83005878|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
47077589|NCT02585934|83379441|FG001|Overall Study|Another Reason|5|||
47077590|NCT02582658|83379470|FG000|Overall Study|Failure to Return|10|||
47077591|NCT02582658|83379470|FG000|Overall Study|Insufficient Virological Response|2|||
46672681|NCT01215955|82888119|FG002|Overall Study|Protocol Violation|8|||
46786911|NCT03895372|83005879|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
46786912|NCT03895372|83005880|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
47077592|NCT02582658|83379470|FG000|Overall Study|Withdrawn Consent|1|||
47077593|NCT02582658|83379470|FG000|Overall Study|Death|1|||
47077594|NCT02582658|83379470|FG000|Overall Study|Not further specified|11|||
47077595|NCT02585778|83379572|FG000|Overall Study|Adverse Event|17|||
46672682|NCT01215955|82888120|FG003|Overall Study|Protocol Violation|8|||
46672683|NCT01215955|82888117|FG000|Overall Study|Sponsor Decision|1|||
46672684|NCT01215955|82888118|FG001|Overall Study|Sponsor Decision|2|||
46672685|NCT01215955|82888119|FG002|Overall Study|Sponsor Decision|0|||
46672686|NCT01215955|82888120|FG003|Overall Study|Sponsor Decision|1|||
46672687|NCT01215955|82888117|FG000|Overall Study|Withdrawal by Subject|14|||
46672688|NCT01215955|82888118|FG001|Overall Study|Withdrawal by Subject|15|||
46672689|NCT01215955|82888119|FG002|Overall Study|Withdrawal by Subject|13|||
46672690|NCT01215955|82888120|FG003|Overall Study|Withdrawal by Subject|9|||
46672691|NCT01215955|82888117|FG000|Overall Study|Quality Issues|0|||
46672692|NCT01215955|82888118|FG001|Overall Study|Quality Issues|0|||
46672693|NCT01215955|82888119|FG002|Overall Study|Quality Issues|3|||
46672694|NCT01215955|82888120|FG003|Overall Study|Quality Issues|2|||
46672695|NCT04676763|82888149|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
46672696|NCT04676763|82888150|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
46672697|NCT04676763|82888151|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
46672698|NCT04676763|82888149|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
46672699|NCT04676763|82888150|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
46672700|NCT04676763|82888151|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
46672701|NCT04676763|82888149|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
46672702|NCT04676763|82888150|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
46672703|NCT04676763|82888151|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
46672704|NCT01215916|82888166|FG000|Overall Study|Progressive Disease|0|||
46672705|NCT01215916|82888167|FG001|Overall Study|Progressive Disease|2|||
46672706|NCT01215916|82888168|FG002|Overall Study|Progressive Disease|1|||
46672707|NCT01215916|82888169|FG003|Overall Study|Progressive Disease|2|||
46672708|NCT01215916|82888170|FG004|Overall Study|Progressive Disease|5|||
46672709|NCT01215916|82888171|FG005|Overall Study|Progressive Disease|4|||
46672710|NCT01215916|82888172|FG006|Overall Study|Progressive Disease|5|||
46672711|NCT01215916|82888173|FG007|Overall Study|Progressive Disease|3|||
46672712|NCT01215916|82888174|FG008|Overall Study|Progressive Disease|1|||
46672713|NCT01215916|82888166|FG000|Overall Study|Adverse Event|1|||
46672714|NCT01215916|82888167|FG001|Overall Study|Adverse Event|1|||
46672715|NCT01215916|82888168|FG002|Overall Study|Adverse Event|0|||
46672716|NCT01215916|82888169|FG003|Overall Study|Adverse Event|1|||
46672717|NCT01215916|82888170|FG004|Overall Study|Adverse Event|0|||
46672718|NCT01215916|82888171|FG005|Overall Study|Adverse Event|0|||
46672719|NCT01215916|82888172|FG006|Overall Study|Adverse Event|3|||
46672720|NCT01215916|82888173|FG007|Overall Study|Adverse Event|0|||
46672721|NCT01215916|82888174|FG008|Overall Study|Adverse Event|0|||
46672722|NCT01215916|82888166|FG000|Overall Study|Withdrawal by Subject|0|||
46672723|NCT01215916|82888167|FG001|Overall Study|Withdrawal by Subject|1|||
46672724|NCT01215916|82888168|FG002|Overall Study|Withdrawal by Subject|1|||
46672725|NCT01215916|82888169|FG003|Overall Study|Withdrawal by Subject|2|||
46672726|NCT01215916|82888170|FG004|Overall Study|Withdrawal by Subject|0|||
46672727|NCT01215916|82888171|FG005|Overall Study|Withdrawal by Subject|0|||
46672728|NCT01215916|82888172|FG006|Overall Study|Withdrawal by Subject|1|||
46672729|NCT01215916|82888173|FG007|Overall Study|Withdrawal by Subject|0|||
46672730|NCT01215916|82888174|FG008|Overall Study|Withdrawal by Subject|0|||
46672731|NCT01215916|82888166|FG000|Overall Study|Death|0|||
46672732|NCT01215916|82888167|FG001|Overall Study|Death|1|||
46672733|NCT01215916|82888168|FG002|Overall Study|Death|0|||
46672734|NCT01215916|82888169|FG003|Overall Study|Death|0|||
46672735|NCT01215916|82888170|FG004|Overall Study|Death|1|||
46672736|NCT01215916|82888171|FG005|Overall Study|Death|0|||
46672737|NCT01215916|82888172|FG006|Overall Study|Death|0|||
46672738|NCT01215916|82888173|FG007|Overall Study|Death|0|||
46973071|NCT02014480|83216811|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
47077596|NCT02585778|83379573|FG001|Overall Study|Adverse Event|4|||
47077597|NCT02585778|83379572|FG000|Overall Study|Participant did not wish to continue|9|||
47077598|NCT02585778|83379573|FG001|Overall Study|Participant did not wish to continue|4|||
46672739|NCT01215916|82888174|FG008|Overall Study|Death|1|||
46672740|NCT01215916|82888166|FG000|Overall Study|Physician Decision|0|||
46672741|NCT01215916|82888167|FG001|Overall Study|Physician Decision|0|||
46672742|NCT01215916|82888168|FG002|Overall Study|Physician Decision|1|||
46672743|NCT01215916|82888169|FG003|Overall Study|Physician Decision|1|||
46672744|NCT01215916|82888170|FG004|Overall Study|Physician Decision|0|||
46672745|NCT01215916|82888171|FG005|Overall Study|Physician Decision|0|||
46672746|NCT01215916|82888172|FG006|Overall Study|Physician Decision|0|||
46672747|NCT01215916|82888173|FG007|Overall Study|Physician Decision|0|||
46672748|NCT01215916|82888174|FG008|Overall Study|Physician Decision|0|||
47077599|NCT02585778|83379572|FG000|Overall Study|Poor compliance to study protocol|0|||
46672749|NCT01184872|82888200|FG000|Overall Study|Adverse Event|3|||
46672750|NCT01184872|82888201|FG001|Overall Study|Adverse Event|4|||
46672751|NCT01184872|82888200|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
46672752|NCT01184872|82888201|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46672753|NCT01184872|82888200|FG000|Overall Study|Withdrawal by Subject|2|||
46672754|NCT01184872|82888201|FG001|Overall Study|Withdrawal by Subject|0|||
46672755|NCT01184872|82888200|FG000|Overall Study|Lost to Follow-up|0|||
46672756|NCT01184872|82888201|FG001|Overall Study|Lost to Follow-up|1|||
46672757|NCT01184872|82888200|FG000|Overall Study|Administrative problems|1|||
46672758|NCT01184872|82888201|FG001|Overall Study|Administrative problems|1|||
46672759|NCT01184872|82888200|FG000|Overall Study|Protocol deviation|1|||
46672760|NCT01184872|82888201|FG001|Overall Study|Protocol deviation|0|||
46672761|NCT01215721|82888207|FG000|Overall Study|Adverse Event|2|||
46672762|NCT01184326|82888214|FG000|Overall Study|Adverse Event|1|||
46672763|NCT01184326|82888215|FG001|Overall Study|Adverse Event|2|||
46672764|NCT01184326|82888216|FG002|Overall Study|Adverse Event|0|||
46672765|NCT01184326|82888214|FG000|Overall Study|Death|0|||
46672766|NCT01184326|82888215|FG001|Overall Study|Death|0|||
46672767|NCT01184326|82888216|FG002|Overall Study|Death|1|||
46672768|NCT01184326|82888214|FG000|Overall Study|Withdrawal by Subject|0|||
46672769|NCT01184326|82888215|FG001|Overall Study|Withdrawal by Subject|0|||
46672770|NCT01184326|82888216|FG002|Overall Study|Withdrawal by Subject|1|||
46672771|NCT01184326|82888214|FG000|Overall Study|Physician Decision|1|||
46672772|NCT01184326|82888215|FG001|Overall Study|Physician Decision|1|||
46672773|NCT01184326|82888216|FG002|Overall Study|Physician Decision|0|||
46672774|NCT01184326|82888214|FG000|Overall Study|Disease Progression|1|||
46672775|NCT01184326|82888215|FG001|Overall Study|Disease Progression|3|||
46672776|NCT01184326|82888216|FG002|Overall Study|Disease Progression|12|||
46672777|NCT01215253|82888229|FG000|Overall Study|Withdrawal by Subject|57|||
46672778|NCT01215253|82888230|FG001|Overall Study|Withdrawal by Subject|35|||
46672779|NCT01215253|82888229|FG000|Overall Study|Physician Decision|9|||
46672780|NCT01215253|82888230|FG001|Overall Study|Physician Decision|12|||
46672781|NCT01215253|82888229|FG000|Overall Study|Lost to Follow-up|6|||
46672782|NCT01215253|82888230|FG001|Overall Study|Lost to Follow-up|4|||
46786913|NCT03895372|83005881|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
46786914|NCT03895372|83005882|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
46786915|NCT03895372|83005883|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
46786916|NCT03895372|83005884|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
46786917|NCT03895372|83005885|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
46786918|NCT00669110|83005910|FG000|Overall Study|Adverse Event|4|||
46786919|NCT00669110|83005911|FG001|Overall Study|Adverse Event|3|||
46786920|NCT00669110|83005910|FG000|Overall Study|Caregiver request|3|||
46786921|NCT00669110|83005911|FG001|Overall Study|Caregiver request|2|||
46786922|NCT00669110|83005910|FG000|Overall Study|Physician Decision|0|||
46786923|NCT00669110|83005911|FG001|Overall Study|Physician Decision|1|||
46786924|NCT00669110|83005910|FG000|Overall Study|Lost to Follow-up|1|||
46786925|NCT00669110|83005911|FG001|Overall Study|Lost to Follow-up|0|||
46786926|NCT00669110|83005910|FG000|Overall Study|Protocol Violation|0|||
46786927|NCT00669110|83005911|FG001|Overall Study|Protocol Violation|5|||
46786928|NCT00669110|83005910|FG000|Overall Study|Withdrawal by Subject|0|||
46786929|NCT00669110|83005911|FG001|Overall Study|Withdrawal by Subject|2|||
46786930|NCT00654732|83005919|FG000|Overall Study|Adverse Event|4|||
46786931|NCT00654732|83005920|FG001|Overall Study|Adverse Event|6|||
46786932|NCT00649428|83005928|FG000|Overall Study|Adverse Event|2|||
46786933|NCT00649428|83005929|FG001|Overall Study|Adverse Event|2|||
46786934|NCT00649428|83005928|FG000|Overall Study|Withdrawal by Subject|6|||
46786935|NCT00649428|83005929|FG001|Overall Study|Withdrawal by Subject|6|||
46786936|NCT00649428|83005928|FG000|Overall Study|Lost to Follow-up|1|||
46786937|NCT00649428|83005929|FG001|Overall Study|Lost to Follow-up|3|||
46786938|NCT00649428|83005928|FG000|Overall Study|Insufficient manufacturing yield|5|||
46973072|NCT02014480|83216812|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
46672783|NCT01215253|82888229|FG000|Overall Study|Other|14|||
46672784|NCT01215253|82888230|FG001|Overall Study|Other|12|||
46672785|NCT01184053|82888237|FG000|Overall Study|progression while on treatment|3|||
46672786|NCT01183975|82888242|FG000|Overall Study|Lost to Follow-up|73|||
46672787|NCT01183858|82888248|FG000|Overall Study|Death not related to Progressive Disease|5|||
46672788|NCT01183858|82888249|FG001|Overall Study|Death not related to Progressive Disease|6|||
46672789|NCT01183858|82888248|FG000|Overall Study|Adverse Event|14|||
46672790|NCT01183858|82888249|FG001|Overall Study|Adverse Event|11|||
46672791|NCT01183858|82888248|FG000|Overall Study|Investigator's Decision|0|||
46672792|NCT01183858|82888249|FG001|Overall Study|Investigator's Decision|3|||
46786939|NCT00649428|83005929|FG001|Overall Study|Insufficient manufacturing yield|1|||
46672793|NCT01183858|82888248|FG000|Overall Study|Insufficient Therapeutic Response|2|||
46672794|NCT01183858|82888249|FG001|Overall Study|Insufficient Therapeutic Response|0|||
46672795|NCT01183858|82888248|FG000|Overall Study|Refused Treatment|1|||
46672796|NCT01183858|82888249|FG001|Overall Study|Refused Treatment|4|||
46786940|NCT00649428|83005928|FG000|Overall Study|Protocol Violation|6|||
46786941|NCT00649428|83005929|FG001|Overall Study|Protocol Violation|2|||
46786942|NCT00649428|83005928|FG000|Overall Study|Physician Decision|0|||
46786943|NCT00649428|83005929|FG001|Overall Study|Physician Decision|1|||
46786944|NCT00669032|83005938|FG000|Overall Study|Lost to Follow-up|6|||
46786945|NCT00669032|83005939|FG001|Overall Study|Lost to Follow-up|5|||
46786946|NCT00669032|83005938|FG000|Overall Study|Lack of Efficacy|8|||
46786947|NCT00669032|83005939|FG001|Overall Study|Lack of Efficacy|19|||
46672797|NCT01183858|82888248|FG000|Overall Study|Withdrew Consent|4|||
46672798|NCT01183858|82888249|FG001|Overall Study|Withdrew Consent|4|||
46672799|NCT01183858|82888248|FG000|Overall Study|Discontinued Smoking|3|||
46672800|NCT01183858|82888249|FG001|Overall Study|Discontinued Smoking|1|||
46672801|NCT01183858|82888248|FG000|Overall Study|Protocol Violation|1|||
46672802|NCT01183858|82888249|FG001|Overall Study|Protocol Violation|0|||
46672803|NCT01183858|82888248|FG000|Overall Study|Administrative/Other|6|||
46672804|NCT01183858|82888249|FG001|Overall Study|Administrative/Other|6|||
46672805|NCT01183858|82888248|FG000|Overall Study|Progressive Disease|112|||
46672806|NCT01183858|82888249|FG001|Overall Study|Progressive Disease|115|||
46672807|NCT01183858|82888248|FG000|Overall Study|Death related to Progressive Disease|4|||
46672808|NCT01183858|82888249|FG001|Overall Study|Death related to Progressive Disease|5|||
46672809|NCT01183858|82888248|FG000|Overall Study|Lost to Follow-up|1|||
46672810|NCT01183858|82888249|FG001|Overall Study|Lost to Follow-up|1|||
46672811|NCT01215175|82888260|FG000|Overall Study|Lost to Follow-up|0|||
46672812|NCT01215175|82888261|FG001|Overall Study|Lost to Follow-up|1|||
46672813|NCT01215175|82888262|FG002|Overall Study|Lost to Follow-up|0|||
46672814|NCT01215175|82888263|FG003|Overall Study|Lost to Follow-up|1|||
46672815|NCT01215175|82888264|FG004|Overall Study|Lost to Follow-up|0|||
46672816|NCT01215097|82888278|FG000|Overall Study|Adverse Event|1|||
46672817|NCT01215097|82888279|FG001|Overall Study|Adverse Event|3|||
46672818|NCT01215097|82888278|FG000|Overall Study|Protocol Violation|0|||
46672819|NCT01215097|82888279|FG001|Overall Study|Protocol Violation|2|||
46672820|NCT01215097|82888278|FG000|Overall Study|Lost to Follow-up|2|||
46672821|NCT01215097|82888279|FG001|Overall Study|Lost to Follow-up|0|||
46672822|NCT01215097|82888278|FG000|Overall Study|Withdrawal by Subject|6|||
46672823|NCT01215097|82888279|FG001|Overall Study|Withdrawal by Subject|3|||
46672824|NCT01215097|82888278|FG000|Overall Study|Lack of Efficacy|0|||
46672825|NCT01215097|82888279|FG001|Overall Study|Lack of Efficacy|3|||
46672826|NCT01215097|82888278|FG000|Overall Study|patient's refusal to come|2|||
46672827|NCT01215097|82888279|FG001|Overall Study|patient's refusal to come|2|||
46672828|NCT01215097|82888278|FG000|Overall Study|patient's private reason|1|||
46672829|NCT01215097|82888279|FG001|Overall Study|patient's private reason|1|||
46672830|NCT03303339|82888297|FG000|Overall Study|Death|2|||
46672831|NCT03303339|82888298|FG001|Overall Study|Death|2|||
46672832|NCT03303339|82888299|FG002|Overall Study|Death|2|||
46672833|NCT03303339|82888300|FG003|Overall Study|Death|1|||
46672834|NCT03303339|82888301|FG004|Overall Study|Death|4|||
46672835|NCT03303339|82888302|FG005|Overall Study|Death|2|||
46672836|NCT03303339|82888303|FG006|Overall Study|Death|2|||
46672837|NCT03303339|82888304|FG007|Overall Study|Death|2|||
46672838|NCT03303339|82888305|FG008|Overall Study|Death|3|||
46672839|NCT03303339|82888306|FG009|Overall Study|Death|3|||
46672840|NCT03303339|82888307|FG010|Overall Study|Death|4|||
46672841|NCT03303339|82888308|FG011|Overall Study|Death|24|||
46672842|NCT03303339|82888297|FG000|Overall Study|Study Terminated by Sponsor|0|||
46672843|NCT03303339|82888298|FG001|Overall Study|Study Terminated by Sponsor|0|||
46672844|NCT03303339|82888299|FG002|Overall Study|Study Terminated by Sponsor|0|||
46672845|NCT03303339|82888300|FG003|Overall Study|Study Terminated by Sponsor|0|||
46786948|NCT00669032|83005938|FG000|Overall Study|Withdrawal by Subject|12|||
46786949|NCT00669032|83005939|FG001|Overall Study|Withdrawal by Subject|13|||
46786950|NCT00669032|83005938|FG000|Overall Study|Adverse Event|12|||
46786951|NCT00669032|83005939|FG001|Overall Study|Adverse Event|16|||
46786952|NCT00669032|83005938|FG000|Overall Study|Physician Decision|1|||
46973073|NCT02014480|83216813|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
46973074|NCT02014480|83216814|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
46973075|NCT02014480|83216809|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47077600|NCT02585778|83379573|FG001|Overall Study|Poor compliance to study protocol|2|||
46672846|NCT03303339|82888301|FG004|Overall Study|Study Terminated by Sponsor|0|||
46672847|NCT03303339|82888302|FG005|Overall Study|Study Terminated by Sponsor|0|||
46973076|NCT02014480|83216810|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
46672848|NCT03303339|82888303|FG006|Overall Study|Study Terminated by Sponsor|0|||
46672849|NCT03303339|82888304|FG007|Overall Study|Study Terminated by Sponsor|0|||
46672850|NCT03303339|82888305|FG008|Overall Study|Study Terminated by Sponsor|1|||
46672851|NCT03303339|82888306|FG009|Overall Study|Study Terminated by Sponsor|0|||
46672852|NCT03303339|82888307|FG010|Overall Study|Study Terminated by Sponsor|1|||
46672853|NCT03303339|82888308|FG011|Overall Study|Study Terminated by Sponsor|1|||
46672854|NCT03303339|82888297|FG000|Overall Study|Withdrawal by Subject|1|||
46672855|NCT03303339|82888298|FG001|Overall Study|Withdrawal by Subject|0|||
46672856|NCT03303339|82888299|FG002|Overall Study|Withdrawal by Subject|0|||
46672857|NCT03303339|82888300|FG003|Overall Study|Withdrawal by Subject|0|||
46672858|NCT03303339|82888301|FG004|Overall Study|Withdrawal by Subject|0|||
46786953|NCT00669032|83005939|FG001|Overall Study|Physician Decision|1|||
46973077|NCT02014480|83216811|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
47077601|NCT02585778|83379572|FG000|Overall Study|Death|0|||
47077602|NCT02585778|83379573|FG001|Overall Study|Death|1|||
46672859|NCT03303339|82888302|FG005|Overall Study|Withdrawal by Subject|1|||
46672860|NCT03303339|82888303|FG006|Overall Study|Withdrawal by Subject|1|||
46672861|NCT03303339|82888304|FG007|Overall Study|Withdrawal by Subject|0|||
46672862|NCT03303339|82888305|FG008|Overall Study|Withdrawal by Subject|0|||
46672863|NCT03303339|82888306|FG009|Overall Study|Withdrawal by Subject|0|||
46672864|NCT03303339|82888307|FG010|Overall Study|Withdrawal by Subject|0|||
46672865|NCT03303339|82888308|FG011|Overall Study|Withdrawal by Subject|2|||
46672866|NCT03303339|82888297|FG000|Overall Study|Physician Decision|0|||
47077603|NCT02585778|83379572|FG000|Overall Study|Randomized but not treated|1|||
47077604|NCT02585778|83379573|FG001|Overall Study|Randomized but not treated|2|||
46672867|NCT03303339|82888298|FG001|Overall Study|Physician Decision|0|||
46672868|NCT03303339|82888299|FG002|Overall Study|Physician Decision|0|||
46672869|NCT03303339|82888300|FG003|Overall Study|Physician Decision|0|||
46672870|NCT03303339|82888301|FG004|Overall Study|Physician Decision|1|||
46672871|NCT03303339|82888302|FG005|Overall Study|Physician Decision|0|||
46672872|NCT03303339|82888303|FG006|Overall Study|Physician Decision|0|||
46672873|NCT03303339|82888304|FG007|Overall Study|Physician Decision|0|||
46672874|NCT03303339|82888305|FG008|Overall Study|Physician Decision|0|||
46672875|NCT03303339|82888306|FG009|Overall Study|Physician Decision|0|||
46672876|NCT03303339|82888307|FG010|Overall Study|Physician Decision|0|||
46672877|NCT03303339|82888308|FG011|Overall Study|Physician Decision|0|||
46672878|NCT03303339|82888297|FG000|Overall Study|Safety/Non-compliance|0|||
46672879|NCT03303339|82888298|FG001|Overall Study|Safety/Non-compliance|0|||
46672880|NCT03303339|82888299|FG002|Overall Study|Safety/Non-compliance|0|||
46672881|NCT03303339|82888300|FG003|Overall Study|Safety/Non-compliance|0|||
46672882|NCT03303339|82888301|FG004|Overall Study|Safety/Non-compliance|0|||
46672883|NCT03303339|82888302|FG005|Overall Study|Safety/Non-compliance|0|||
46672884|NCT03303339|82888303|FG006|Overall Study|Safety/Non-compliance|0|||
46672885|NCT03303339|82888304|FG007|Overall Study|Safety/Non-compliance|0|||
46672886|NCT03303339|82888305|FG008|Overall Study|Safety/Non-compliance|0|||
46672887|NCT03303339|82888306|FG009|Overall Study|Safety/Non-compliance|0|||
46672888|NCT03303339|82888307|FG010|Overall Study|Safety/Non-compliance|0|||
46672889|NCT03303339|82888308|FG011|Overall Study|Safety/Non-compliance|1|||
46672890|NCT01183780|82888353|FG000|Overall Study|Withdrawal by Subject|25|||
46672891|NCT01183780|82888354|FG001|Overall Study|Withdrawal by Subject|14|||
46672892|NCT01183780|82888353|FG000|Overall Study|Lost to Follow-up|6|||
46672893|NCT01183780|82888354|FG001|Overall Study|Lost to Follow-up|11|||
46672894|NCT01183468|82888364|FG000|Overall Study|Lost to Follow-up|2|||
46672895|NCT01183468|82888365|FG001|Overall Study|Lost to Follow-up|1|||
46672896|NCT01183468|82888366|FG002|Overall Study|Lost to Follow-up|0|||
46672897|NCT01183468|82888367|FG003|Overall Study|Lost to Follow-up|0|||
46672898|NCT01183468|82888364|FG000|Overall Study|Physician Decision|1|||
46672899|NCT01183468|82888365|FG001|Overall Study|Physician Decision|0|||
46672900|NCT01183468|82888366|FG002|Overall Study|Physician Decision|0|||
46672901|NCT01183468|82888367|FG003|Overall Study|Physician Decision|0|||
46672902|NCT01183468|82888364|FG000|Overall Study|Withdrawal by Subject|0|||
46672903|NCT01183468|82888365|FG001|Overall Study|Withdrawal by Subject|1|||
46672904|NCT01183468|82888366|FG002|Overall Study|Withdrawal by Subject|0|||
46672905|NCT01183468|82888367|FG003|Overall Study|Withdrawal by Subject|0|||
46672906|NCT01183390|82888377|FG000|First Intervention|Adverse Event|0|||
46672907|NCT01183390|82888378|FG001|First Intervention|Adverse Event|1|||
46672908|NCT01214668|82888390|FG000|Overall Study|Adverse Event|0|||
46672909|NCT01214668|82888391|FG001|Overall Study|Adverse Event|1|||
46672910|NCT01214668|82888392|FG002|Overall Study|Adverse Event|0|||
46672911|NCT01214668|82888393|FG003|Overall Study|Adverse Event|2|||
46672912|NCT01214668|82888394|FG004|Overall Study|Adverse Event|1|||
46672913|NCT01214668|82888395|FG005|Overall Study|Adverse Event|1|||
46672914|NCT01214668|82888390|FG000|Overall Study|Death|0|||
46786954|NCT00669032|83005938|FG000|Overall Study|No fulfilment of the selection criteria|5|||
46672915|NCT01214668|82888391|FG001|Overall Study|Death|0|||
46672916|NCT01214668|82888392|FG002|Overall Study|Death|1|||
46672917|NCT01214668|82888393|FG003|Overall Study|Death|0|||
46672918|NCT01214668|82888394|FG004|Overall Study|Death|0|||
46672919|NCT01214668|82888395|FG005|Overall Study|Death|0|||
46672920|NCT01214668|82888390|FG000|Overall Study|Progressive Disease|4|||
46672921|NCT01214668|82888391|FG001|Overall Study|Progressive Disease|2|||
46672922|NCT01214668|82888392|FG002|Overall Study|Progressive Disease|5|||
46672923|NCT01214668|82888393|FG003|Overall Study|Progressive Disease|4|||
46672924|NCT01214668|82888394|FG004|Overall Study|Progressive Disease|4|||
46672925|NCT01214668|82888395|FG005|Overall Study|Progressive Disease|5|||
46672926|NCT01214668|82888390|FG000|Overall Study|Withdrawal by Subject|0|||
46672927|NCT01214668|82888391|FG001|Overall Study|Withdrawal by Subject|0|||
46672928|NCT01214668|82888392|FG002|Overall Study|Withdrawal by Subject|0|||
46672929|NCT01214668|82888393|FG003|Overall Study|Withdrawal by Subject|0|||
46672930|NCT01214668|82888394|FG004|Overall Study|Withdrawal by Subject|1|||
47077605|NCT02585778|83379572|FG000|Overall Study|Other than specified above|6|||
46672931|NCT01214668|82888395|FG005|Overall Study|Withdrawal by Subject|0|||
46672932|NCT03456713|82888414|FG000|Overall Study|Lost to Follow-up|1|||
46672933|NCT03456713|82888415|FG001|Overall Study|Lost to Follow-up|0|||
46672934|NCT03456713|82888416|FG002|Overall Study|Lost to Follow-up|0|||
46672935|NCT03456713|82888417|FG003|Overall Study|Lost to Follow-up|0|||
46672936|NCT01191268|82888436|FG000|Overall Study|Withdrawal by Subject|19|||
46672937|NCT01191268|82888437|FG001|Overall Study|Withdrawal by Subject|25|||
46672938|NCT01191268|82888438|FG002|Overall Study|Withdrawal by Subject|21|||
46851672|NCT00109707|83067223|FG001|Overall Study|Protocol Violation|0|||
46851673|NCT00109707|83067224|FG002|Overall Study|Protocol Violation|0|||
46672939|NCT01191268|82888436|FG000|Overall Study|Adverse Event|21|||
46672940|NCT01191268|82888437|FG001|Overall Study|Adverse Event|13|||
46672941|NCT01191268|82888438|FG002|Overall Study|Adverse Event|8|||
46786955|NCT00669032|83005939|FG001|Overall Study|No fulfilment of the selection criteria|5|||
46786956|NCT00654498|83005947|FG000|Overall Study|Not Treated|1|||
46786957|NCT00654498|83005948|FG001|Overall Study|Not Treated|0|||
46786958|NCT00654498|83005947|FG000|Overall Study|Adverse Event|6|||
46786959|NCT00654498|83005948|FG001|Overall Study|Adverse Event|1|||
46786960|NCT00654498|83005947|FG000|Overall Study|Protocol Violation|1|||
46786961|NCT00654498|83005948|FG001|Overall Study|Protocol Violation|1|||
46786962|NCT00654498|83005947|FG000|Overall Study|Lost to Follow-up|1|||
46786963|NCT00654498|83005948|FG001|Overall Study|Lost to Follow-up|5|||
46786964|NCT00654498|83005947|FG000|Overall Study|Withdrawal by Subject|1|||
46786965|NCT00654498|83005948|FG001|Overall Study|Withdrawal by Subject|0|||
46786966|NCT00654498|83005947|FG000|Overall Study|Other reason not defined above|4|||
46786967|NCT00654498|83005948|FG001|Overall Study|Other reason not defined above|5|||
46786968|NCT00670046|83005956|FG000|Overall Study|Lost to Follow-up|1|||
46786969|NCT00670046|83005957|FG001|Overall Study|Lost to Follow-up|1|||
46786970|NCT00670046|83005956|FG000|Overall Study|Withdrawal by Subject|0|||
46786971|NCT00670046|83005957|FG001|Overall Study|Withdrawal by Subject|1|||
46786972|NCT00560391|83005968|FG000|Overall Study|Still on treatment|0|||
46786973|NCT00560391|83005969|FG001|Overall Study|Still on treatment|0|||
46786974|NCT00560391|83005970|FG002|Overall Study|Still on treatment|0|||
46851674|NCT00109707|83067222|FG000|Overall Study|Patient withdrew consent|6|||
46851675|NCT00109707|83067223|FG001|Overall Study|Patient withdrew consent|1|||
46851676|NCT00109707|83067224|FG002|Overall Study|Patient withdrew consent|0|||
46851677|NCT00095979|83067236|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
46851678|NCT00082173|83067247|FG000|Overall Study|Withdrawal by Subject|3|||
46851679|NCT00082173|83067248|FG001|Overall Study|Withdrawal by Subject|5|||
46851680|NCT00082173|83067247|FG000|Overall Study|Lost to Follow-up|1|||
46851681|NCT00082173|83067248|FG001|Overall Study|Lost to Follow-up|0|||
46851682|NCT00082173|83067247|FG000|Overall Study|Adverse Event|1|||
46851683|NCT00082173|83067248|FG001|Overall Study|Adverse Event|0|||
46851684|NCT00082173|83067247|FG000|Overall Study|Culture negative or resistant at baselin|5|||
46851685|NCT00082173|83067248|FG001|Overall Study|Culture negative or resistant at baselin|6|||
46851686|NCT00108069|83067256|FG000|Overall Study|Never rec'd study drug|0|||
46851687|NCT00108069|83067257|FG001|Overall Study|Never rec'd study drug|1|||
46851688|NCT00108069|83067256|FG000|Overall Study|Adverse Event|1|||
46851689|NCT00108069|83067257|FG001|Overall Study|Adverse Event|1|||
46851690|NCT00108069|83067256|FG000|Overall Study|Withdrawal by Subject|1|||
46851691|NCT00108069|83067257|FG001|Overall Study|Withdrawal by Subject|0|||
46851692|NCT00108069|83067256|FG000|Overall Study|Death|1|||
46851693|NCT00108069|83067257|FG001|Overall Study|Death|0|||
46851694|NCT00108069|83067256|FG000|Overall Study|Progessive disease|27|||
46851695|NCT00108069|83067257|FG001|Overall Study|Progessive disease|11|||
46851696|NCT00079274|83067276|FG000|Overall Study|Withdrawal by Subject|111|||
46851697|NCT00079274|83067277|FG001|Overall Study|Withdrawal by Subject|10|||
46851698|NCT00079274|83067278|FG002|Overall Study|Withdrawal by Subject|12|||
46851699|NCT00079274|83067279|FG003|Overall Study|Withdrawal by Subject|163|||
46851700|NCT00079274|83067280|FG004|Overall Study|Withdrawal by Subject|7|||
47077606|NCT02585778|83379573|FG001|Overall Study|Other than specified above|2|||
47077607|NCT01438424|83379596|FG000|Overall Study|Continuing treatment|29|||
46672942|NCT01191268|82888436|FG000|Overall Study|Physician Decision|6|||
47077608|NCT01438424|83379596|FG000|Overall Study|Minimal virologic response|95|||
47077609|NCT01438424|83379596|FG000|Overall Study|Not identified|55|||
47077610|NCT01438424|83379596|FG000|Overall Study|Withdrawal by Subject|104|||
47077611|NCT01438424|83379596|FG000|Overall Study|Progression of chronic hepatitis B|22|||
46672943|NCT01191268|82888437|FG001|Overall Study|Physician Decision|8|||
46672944|NCT01191268|82888438|FG002|Overall Study|Physician Decision|9|||
46786975|NCT00560391|83005971|FG003|Overall Study|Still on treatment|1|||
46786976|NCT00560391|83005972|FG004|Overall Study|Still on treatment|2|||
46786977|NCT00537238|83005987|FG000|Overall Study|Death|1|||
46786978|NCT00537238|83005988|FG001|Overall Study|Death|2|||
46786979|NCT00537238|83005987|FG000|Overall Study|Adverse Event|31|||
46786980|NCT00537238|83005988|FG001|Overall Study|Adverse Event|22|||
46851701|NCT00079274|83067281|FG005|Overall Study|Withdrawal by Subject|8|||
46851702|NCT00079274|83067282|FG006|Overall Study|Withdrawal by Subject|0|||
46851703|NCT00079274|83067276|FG000|Overall Study|Adverse Event|130|||
46851704|NCT00079274|83067277|FG001|Overall Study|Adverse Event|8|||
46672945|NCT01191268|82888436|FG000|Overall Study|Lost to Follow-up|8|||
46672946|NCT01191268|82888437|FG001|Overall Study|Lost to Follow-up|5|||
46672947|NCT01191268|82888438|FG002|Overall Study|Lost to Follow-up|9|||
46672948|NCT01191268|82888436|FG000|Overall Study|Entry Criteria Not Met|3|||
46672949|NCT01191268|82888437|FG001|Overall Study|Entry Criteria Not Met|1|||
46672950|NCT01191268|82888438|FG002|Overall Study|Entry Criteria Not Met|1|||
46672951|NCT01191268|82888436|FG000|Overall Study|Death|0|||
47077612|NCT01438424|83379596|FG000|Overall Study|Death|22|||
46672952|NCT01191268|82888437|FG001|Overall Study|Death|1|||
46672953|NCT01191268|82888438|FG002|Overall Study|Death|3|||
46672954|NCT01191268|82888436|FG000|Overall Study|Protocol Violation|1|||
46672955|NCT01191268|82888437|FG001|Overall Study|Protocol Violation|0|||
46672956|NCT01191268|82888438|FG002|Overall Study|Protocol Violation|1|||
46672957|NCT01191268|82888436|FG000|Overall Study|Sponsor Decision|0|||
46672958|NCT01191268|82888437|FG001|Overall Study|Sponsor Decision|2|||
46672959|NCT01191268|82888438|FG002|Overall Study|Sponsor Decision|0|||
46672960|NCT01191190|82888447|FG000|Overall Study|Withdrawal by Subject|1|||
46672961|NCT05751629|82888451|FG000|Overall Study|Withdrawal by Subject|6|||
46672962|NCT05751629|82888451|FG000|Overall Study|Death|25|||
46672963|NCT05751629|82888451|FG000|Overall Study|Study Site Closed|9|||
46672964|NCT05751629|82888451|FG000|Overall Study|Physician Decision|1|||
46672965|NCT05306977|82888455|FG000|Overall Study|Withdrawal by Subject|1|||
46672966|NCT05086276|82888461|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
46672967|NCT05086276|82888462|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
46672968|NCT04870710|82888468|FG000|Overall Study|Lost to Follow-up|3|||
46672969|NCT04858802|82888474|FG000|Overall Study|Lost to Follow-up|1|||
46672970|NCT04858802|82888475|FG001|Overall Study|Lost to Follow-up|1|||
46672971|NCT04858802|82888474|FG000|Overall Study|Withdrawal by Subject|1|||
46672972|NCT04858802|82888475|FG001|Overall Study|Withdrawal by Subject|1|||
46672973|NCT04562090|82888493|FG000|Overall Study|Withdrawal by Subject|3|||
46672974|NCT04562090|82888494|FG001|Overall Study|Withdrawal by Subject|4|||
46672975|NCT04562090|82888493|FG000|Overall Study|Protocol Violation|2|||
46672976|NCT04562090|82888494|FG001|Overall Study|Protocol Violation|0|||
46672977|NCT04562090|82888493|FG000|Overall Study|Lack of Efficacy|0|||
46672978|NCT04562090|82888494|FG001|Overall Study|Lack of Efficacy|1|||
46672979|NCT04562090|82888493|FG000|Overall Study|Adverse Event|1|||
46672980|NCT04562090|82888494|FG001|Overall Study|Adverse Event|4|||
46672981|NCT04562090|82888493|FG000|Overall Study|Miscellaneous|0|||
46672982|NCT04562090|82888494|FG001|Overall Study|Miscellaneous|3|||
46672983|NCT04557189|82888505|FG000|Overall Study|Adverse Event|0|||
46672984|NCT04557189|82888506|FG001|Overall Study|Adverse Event|1|||
46851705|NCT00079274|83067278|FG002|Overall Study|Adverse Event|8|||
46851706|NCT00079274|83067279|FG003|Overall Study|Adverse Event|184|||
46851707|NCT00079274|83067280|FG004|Overall Study|Adverse Event|7|||
46851708|NCT00079274|83067281|FG005|Overall Study|Adverse Event|8|||
46851709|NCT00079274|83067282|FG006|Overall Study|Adverse Event|0|||
46851710|NCT00079274|83067276|FG000|Overall Study|Recurrence|21|||
46851711|NCT00079274|83067277|FG001|Overall Study|Recurrence|0|||
46851712|NCT00079274|83067278|FG002|Overall Study|Recurrence|1|||
46851713|NCT00079274|83067279|FG003|Overall Study|Recurrence|15|||
46851714|NCT00079274|83067280|FG004|Overall Study|Recurrence|0|||
46851715|NCT00079274|83067281|FG005|Overall Study|Recurrence|2|||
46851716|NCT00079274|83067282|FG006|Overall Study|Recurrence|0|||
46851717|NCT00079274|83067276|FG000|Overall Study|Alternate Treatment|6|||
46851718|NCT00079274|83067277|FG001|Overall Study|Alternate Treatment|1|||
46851719|NCT00079274|83067278|FG002|Overall Study|Alternate Treatment|0|||
46851720|NCT00079274|83067279|FG003|Overall Study|Alternate Treatment|3|||
46851721|NCT00079274|83067280|FG004|Overall Study|Alternate Treatment|0|||
46851722|NCT00079274|83067281|FG005|Overall Study|Alternate Treatment|0|||
46851723|NCT00079274|83067282|FG006|Overall Study|Alternate Treatment|0|||
46851724|NCT00079274|83067276|FG000|Overall Study|Other Medical Problems|6|||
46851725|NCT00079274|83067277|FG001|Overall Study|Other Medical Problems|1|||
47077613|NCT01438424|83379596|FG000|Overall Study|Adverse Event|17|||
47077614|NCT01438424|83379596|FG000|Overall Study|Lost to Follow-up|17|||
47077615|NCT01438424|83379596|FG000|Overall Study|Abnormal laboratory test result|14|||
46672985|NCT04557189|82888505|FG000|Overall Study|Lost to Follow-up|1|||
46672986|NCT04557189|82888506|FG001|Overall Study|Lost to Follow-up|1|||
46672987|NCT04557189|82888505|FG000|Overall Study|Withdrawal by Subject|2|||
46672988|NCT04557189|82888506|FG001|Overall Study|Withdrawal by Subject|1|||
46851726|NCT00079274|83067278|FG002|Overall Study|Other Medical Problems|0|||
46672989|NCT04557189|82888505|FG000|Overall Study|Reason not Specified|3|||
46672990|NCT04557189|82888506|FG001|Overall Study|Reason not Specified|6|||
46672991|NCT04530838|82888519|FG000|Overall Study|Other|2|||
46672992|NCT04530838|82888520|FG001|Overall Study|Other|1|||
46672993|NCT04530838|82888521|FG002|Overall Study|Other|0|||
46672994|NCT04530838|82888519|FG000|Overall Study|Physician Decision|0|||
46672995|NCT04530838|82888520|FG001|Overall Study|Physician Decision|0|||
46672996|NCT04530838|82888521|FG002|Overall Study|Physician Decision|1|||
46672997|NCT04530838|82888519|FG000|Overall Study|Death|0|||
46851727|NCT00079274|83067279|FG003|Overall Study|Other Medical Problems|7|||
46672998|NCT04530838|82888520|FG001|Overall Study|Death|0|||
46672999|NCT04530838|82888521|FG002|Overall Study|Death|1|||
46673000|NCT04530838|82888519|FG000|Overall Study|Adverse Event|0|||
46673001|NCT04530838|82888520|FG001|Overall Study|Adverse Event|1|||
46673002|NCT04530838|82888521|FG002|Overall Study|Adverse Event|0|||
46673003|NCT04530838|82888519|FG000|Overall Study|No longer meets eligibility criteria|1|||
46673004|NCT04530838|82888520|FG001|Overall Study|No longer meets eligibility criteria|0|||
46673005|NCT04530838|82888521|FG002|Overall Study|No longer meets eligibility criteria|2|||
46673006|NCT04530838|82888519|FG000|Overall Study|Withdrawal by parent/guardian|5|||
46673007|NCT04530838|82888520|FG001|Overall Study|Withdrawal by parent/guardian|2|||
46673008|NCT04530838|82888521|FG002|Overall Study|Withdrawal by parent/guardian|2|||
46673009|NCT04424901|82888535|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
46673010|NCT04424901|82888536|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
46673011|NCT04410445|82888544|FG000|Overall Study|Lost to Follow-up|3|||
47077616|NCT01438424|83379596|FG000|Overall Study|Need for drug prohibited by protocol|14|||
47077617|NCT01438424|83379596|FG000|Overall Study|Pregnancy|7|||
46673012|NCT04410445|82888545|FG001|Overall Study|Lost to Follow-up|9|||
46673013|NCT04410445|82888544|FG000|Overall Study|Withdrawal by Subject|27|||
46673014|NCT04410445|82888545|FG001|Overall Study|Withdrawal by Subject|15|||
46673015|NCT03970733|82888572|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
46673016|NCT03970733|82888573|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
46673017|NCT03970733|82888574|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
46673018|NCT03970733|82888575|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
46673019|NCT03970733|82888576|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
46673020|NCT03970733|82888572|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
46673021|NCT03970733|82888573|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
46673022|NCT03970733|82888574|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
46673023|NCT03970733|82888575|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
46673024|NCT03970733|82888576|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
46673025|NCT03970733|82888572|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
46673026|NCT03970733|82888573|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
46673027|NCT03970733|82888574|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
46673028|NCT03970733|82888575|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
46673029|NCT03970733|82888576|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
46673030|NCT03970733|82888572|FG000|Main Study Phase (18 Months)|Other|1|||
46673031|NCT03970733|82888573|FG001|Main Study Phase (18 Months)|Other|1|||
46673032|NCT03970733|82888574|FG002|Main Study Phase (18 Months)|Other|0|||
46673033|NCT03970733|82888575|FG003|Main Study Phase (18 Months)|Other|0|||
46673034|NCT03970733|82888576|FG004|Main Study Phase (18 Months)|Other|0|||
46673035|NCT03970733|82888572|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
46673036|NCT03970733|82888573|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
46673037|NCT03970733|82888574|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
46673038|NCT03970733|82888575|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
46673039|NCT03970733|82888576|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
46673040|NCT03921411|82888588|FG000|Overall Study|Withdrawal by Subject|1|||
46673041|NCT03921411|82888588|FG000|Overall Study|Protocol Deviation|2|||
46673042|NCT03921411|82888588|FG000|Overall Study|Enrolled, but never treated|2|||
46673043|NCT03728582|82888592|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
46673044|NCT03728582|82888593|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
46673045|NCT03728582|82888592|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
46673046|NCT03728582|82888593|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
46673047|NCT03416179|82888612|FG000|Overall Study|Death|90|||
46673048|NCT03416179|82888613|FG001|Overall Study|Death|87|||
46673049|NCT03416179|82888614|FG002|Overall Study|Death|117|||
46673050|NCT03416179|82888615|FG003|Overall Study|Death|113|||
46673051|NCT03416179|82888612|FG000|Overall Study|Withdrawal by Subject|15|||
46673052|NCT03416179|82888613|FG001|Overall Study|Withdrawal by Subject|20|||
46673053|NCT03416179|82888614|FG002|Overall Study|Withdrawal by Subject|6|||
46673054|NCT03416179|82888615|FG003|Overall Study|Withdrawal by Subject|9|||
46673055|NCT03416179|82888612|FG000|Overall Study|Lost to Follow-up|1|||
46673056|NCT03416179|82888613|FG001|Overall Study|Lost to Follow-up|1|||
46673057|NCT03416179|82888614|FG002|Overall Study|Lost to Follow-up|0|||
46673058|NCT03416179|82888615|FG003|Overall Study|Lost to Follow-up|3|||
46673059|NCT03416179|82888612|FG000|Overall Study|Study participation terminated by Sponsor|93|||
46673060|NCT03416179|82888613|FG001|Overall Study|Study participation terminated by Sponsor|91|||
46786981|NCT00537238|83005987|FG000|Overall Study|Lack of Efficacy|20|||
46673061|NCT03416179|82888614|FG002|Overall Study|Study participation terminated by Sponsor|26|||
46673062|NCT03416179|82888615|FG003|Overall Study|Study participation terminated by Sponsor|31|||
46786982|NCT00537238|83005988|FG001|Overall Study|Lack of Efficacy|21|||
46673063|NCT03416179|82888612|FG000|Overall Study|Other|2|||
47077618|NCT01438424|83379596|FG000|Overall Study|No longer met inclusion criteria|1|||
46673064|NCT03416179|82888613|FG001|Overall Study|Other|3|||
46673065|NCT03416179|82888614|FG002|Overall Study|Other|1|||
46673066|NCT03416179|82888615|FG003|Overall Study|Other|0|||
46673067|NCT02932332|82888642|FG000|Overall Study|Withdrawal by Subject|1|||
46673068|NCT02932332|82888643|FG001|Overall Study|Withdrawal by Subject|1|||
46673069|NCT02932332|82888644|FG002|Overall Study|Withdrawal by Subject|0|||
46673070|NCT02932332|82888645|FG003|Overall Study|Withdrawal by Subject|1|||
46673071|NCT02932332|82888642|FG000|Overall Study|Chest pain|0|||
46673072|NCT02932332|82888643|FG001|Overall Study|Chest pain|0|||
46673073|NCT02932332|82888644|FG002|Overall Study|Chest pain|0|||
46673074|NCT02932332|82888645|FG003|Overall Study|Chest pain|1|||
46673075|NCT02932332|82888642|FG000|Overall Study|Not Dyspneic cough|1|||
46673076|NCT02932332|82888643|FG001|Overall Study|Not Dyspneic cough|2|||
46673077|NCT02932332|82888644|FG002|Overall Study|Not Dyspneic cough|1|||
46673078|NCT02932332|82888645|FG003|Overall Study|Not Dyspneic cough|0|||
46673079|NCT02820623|82888679|FG000|Overall Study|Withdrawal by Subject|1|||
46673080|NCT02820623|82888680|FG001|Overall Study|Withdrawal by Subject|3|||
46673081|NCT02820623|82888681|FG002|Overall Study|Withdrawal by Subject|3|||
46673082|NCT02820623|82888679|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
46673083|NCT02820623|82888680|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
46673084|NCT02820623|82888681|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
46673085|NCT02820623|82888679|FG000|Overall Study|Therapist unable to enroll clients|1|||
46673086|NCT02820623|82888680|FG001|Overall Study|Therapist unable to enroll clients|1|||
46673087|NCT02820623|82888681|FG002|Overall Study|Therapist unable to enroll clients|3|||
46673088|NCT02820623|82888679|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
46673089|NCT02820623|82888680|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
46673090|NCT02820623|82888681|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
46673091|NCT02774005|82888689|FG000|Overall Study|Adverse Event|8|||
46673092|NCT02774005|82888689|FG000|Overall Study|Withdrawal by Subject|23|||
46673093|NCT02774005|82888689|FG000|Overall Study|Lost to Follow-up|7|||
46673094|NCT02774005|82888689|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
46786983|NCT00537238|83005987|FG000|Overall Study|Lost to Follow-up|12|||
46786984|NCT00537238|83005988|FG001|Overall Study|Lost to Follow-up|8|||
46786985|NCT00537238|83005987|FG000|Overall Study|Withdrawal by Subject|51|||
46786986|NCT00537238|83005988|FG001|Overall Study|Withdrawal by Subject|47|||
46786987|NCT00537238|83005987|FG000|Overall Study|Protocol Violation|15|||
46786988|NCT00537238|83005988|FG001|Overall Study|Protocol Violation|19|||
46786989|NCT00537238|83005987|FG000|Overall Study|Does not meet entrance criteria|0|||
46786990|NCT00537238|83005988|FG001|Overall Study|Does not meet entrance criteria|2|||
46786991|NCT00537238|83005987|FG000|Overall Study|Other|44|||
46786992|NCT00537238|83005988|FG001|Overall Study|Other|52|||
46851728|NCT00079274|83067280|FG004|Overall Study|Other Medical Problems|0|||
46851729|NCT00079274|83067281|FG005|Overall Study|Other Medical Problems|0|||
46851730|NCT00079274|83067282|FG006|Overall Study|Other Medical Problems|0|||
46851731|NCT00079274|83067276|FG000|Overall Study|Death|4|||
46851732|NCT00079274|83067277|FG001|Overall Study|Death|0|||
46851733|NCT00079274|83067278|FG002|Overall Study|Death|1|||
46851734|NCT00079274|83067279|FG003|Overall Study|Death|15|||
46851735|NCT00079274|83067280|FG004|Overall Study|Death|0|||
46851736|NCT00079274|83067281|FG005|Overall Study|Death|0|||
46851737|NCT00079274|83067282|FG006|Overall Study|Death|0|||
46851738|NCT00079274|83067276|FG000|Overall Study|Cytogenetic resistance|0|||
46851739|NCT00079274|83067277|FG001|Overall Study|Cytogenetic resistance|0|||
46851740|NCT00079274|83067278|FG002|Overall Study|Cytogenetic resistance|0|||
46851741|NCT00079274|83067279|FG003|Overall Study|Cytogenetic resistance|2|||
46851742|NCT00079274|83067280|FG004|Overall Study|Cytogenetic resistance|0|||
46851743|NCT00079274|83067281|FG005|Overall Study|Cytogenetic resistance|0|||
47077619|NCT01438424|83379596|FG000|Overall Study|Participant noncompliance|20|||
47077620|NCT02580240|83379612|FG000|Overall Study|Physician Decision|2|||
47077621|NCT02580240|83379613|FG001|Overall Study|Physician Decision|0|||
47077622|NCT01465958|83379619|FG000|Run-in Phase|Protocol Violation|1|||
46673095|NCT02774005|82888689|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
46673096|NCT02774005|82888689|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
46673097|NCT02774005|82888689|FG000|Overall Study|Death|1|||
46673098|NCT02774005|82888689|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
46673099|NCT02774005|82888689|FG000|Overall Study|Lack of compliance with study medication|4|||
46673100|NCT02774005|82888689|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
46673101|NCT02774005|82888689|FG000|Overall Study|another study|1|||
46673102|NCT02774005|82888689|FG000|Overall Study|cardiologist imposed travel restriction|1|||
46673103|NCT01975428|82888719|FG000|Overall Study|Lost to Follow-up|17|||
46786993|NCT03966885|83005996|FG000|Overall Study|Death|1|||
46786994|NCT03966885|83005997|FG001|Overall Study|Death|0|||
46786995|NCT03966885|83005996|FG000|Overall Study|Lost to Follow-up|1|||
46851744|NCT00079274|83067282|FG006|Overall Study|Cytogenetic resistance|0|||
47077623|NCT01465958|83379620|FG001|Run-in Phase|Protocol Violation|0|||
47077624|NCT01465958|83379619|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
46851745|NCT00079274|83067276|FG000|Overall Study|Other|43|||
46786996|NCT03966885|83005997|FG001|Overall Study|Lost to Follow-up|2|||
46786997|NCT03966885|83005996|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
46786998|NCT03966885|83005997|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
46786999|NCT03966885|83005996|FG000|Overall Study|Moved from study area.|0|||
47077625|NCT01465958|83379620|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
47077626|NCT02581488|83379833|FG000|Overall Study|Adverse Event|6|||
47077627|NCT02581488|83379834|FG001|Overall Study|Adverse Event|7|||
47077628|NCT02581488|83379833|FG000|Overall Study|Lost to Follow-up|1|||
47077629|NCT02581488|83379834|FG001|Overall Study|Lost to Follow-up|0|||
47077630|NCT02581488|83379833|FG000|Overall Study|Withdrawal by Subject|1|||
47077631|NCT02581488|83379834|FG001|Overall Study|Withdrawal by Subject|0|||
47077632|NCT02581488|83379833|FG000|Overall Study|Non-Compliance|1|||
46787000|NCT03966885|83005997|FG001|Overall Study|Moved from study area.|2|||
46787001|NCT03965403|83006004|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
47077633|NCT02581488|83379834|FG001|Overall Study|Non-Compliance|0|||
47077634|NCT02581488|83379833|FG000|Overall Study|Protocol Violation|0|||
46787002|NCT00552669|83006010|FG000|Overall Study|Death|3|||
46673104|NCT01975428|82888720|FG001|Overall Study|Lost to Follow-up|4|||
46673105|NCT01975428|82888719|FG000|Overall Study|Withdrawal by Subject|3|||
46673106|NCT01975428|82888720|FG001|Overall Study|Withdrawal by Subject|10|||
46673107|NCT01047540|82888761|FG000|Overall Study|Protocol Violation|1|||
46673108|NCT01047540|82888762|FG001|Overall Study|Protocol Violation|0|||
46673109|NCT01047540|82888763|FG002|Overall Study|Protocol Violation|0|||
46673110|NCT01047540|82888764|FG003|Overall Study|Protocol Violation|0|||
46673111|NCT01047540|82888765|FG004|Overall Study|Protocol Violation|0|||
46673112|NCT01047540|82888761|FG000|Overall Study|Lost to Follow-up|1|||
46673113|NCT01047540|82888762|FG001|Overall Study|Lost to Follow-up|0|||
46673114|NCT01047540|82888763|FG002|Overall Study|Lost to Follow-up|0|||
46673115|NCT01047540|82888764|FG003|Overall Study|Lost to Follow-up|0|||
46673116|NCT01047540|82888765|FG004|Overall Study|Lost to Follow-up|0|||
46673117|NCT01047540|82888761|FG000|Overall Study|Withdrawal by Subject|1|||
46673118|NCT01047540|82888762|FG001|Overall Study|Withdrawal by Subject|0|||
46673119|NCT01047540|82888763|FG002|Overall Study|Withdrawal by Subject|3|||
46673120|NCT01047540|82888764|FG003|Overall Study|Withdrawal by Subject|0|||
46673121|NCT01047540|82888765|FG004|Overall Study|Withdrawal by Subject|1|||
46787003|NCT00552669|83006011|FG001|Overall Study|Death|7|||
46787004|NCT00552513|83006019|FG000|Overall Study|Lost to Follow-up|5|||
46787005|NCT00552513|83006020|FG001|Overall Study|Lost to Follow-up|1|||
47077635|NCT02581488|83379834|FG001|Overall Study|Protocol Violation|4|||
47077636|NCT02581410|83379877|FG000|Vaccination Phase|Adverse Event|2|||
47077637|NCT02581410|83379878|FG001|Vaccination Phase|Adverse Event|1|||
47077638|NCT02581410|83379877|FG000|Vaccination Phase|Withdrawal by Subject|0|||
47077639|NCT02581410|83379878|FG001|Vaccination Phase|Withdrawal by Subject|1|||
47077640|NCT02581410|83379877|FG000|Vaccination Phase|Migrated/moved from study area|0|||
47077641|NCT02581410|83379878|FG001|Vaccination Phase|Migrated/moved from study area|1|||
47077642|NCT02581410|83379877|FG000|End of Study Phase|Adverse Event|4|||
47077643|NCT02581410|83379878|FG001|End of Study Phase|Adverse Event|3|||
47077644|NCT02581410|83379877|FG000|End of Study Phase|Withdrawal by Subject|1|||
47077645|NCT02581410|83379878|FG001|End of Study Phase|Withdrawal by Subject|2|||
47077646|NCT02581410|83379877|FG000|End of Study Phase|Migrated/moved from study area|0|||
47077647|NCT02581410|83379878|FG001|End of Study Phase|Migrated/moved from study area|3|||
47077648|NCT02581410|83379877|FG000|End of Study Phase|Lost to Follow-up|0|||
47077649|NCT02581410|83379878|FG001|End of Study Phase|Lost to Follow-up|2|||
46851746|NCT00079274|83067277|FG001|Overall Study|Other|7|||
47077650|NCT02581410|83379877|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
47077651|NCT02581410|83379878|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
47077652|NCT01664130|83379937|FG000|Overall Study|competing secondary disease|2|||
47077653|NCT02579928|83379968|FG000|Overall Study|Withdrawal by Subject|1|||
47077654|NCT02579928|83379969|FG001|Overall Study|Withdrawal by Subject|0|||
47077655|NCT00551460|83380063|FG000|Overall Study|Adverse Event|1|||
46787006|NCT00560313|83006028|FG000|Overall Study|Adverse Events or Death|2|||
46787007|NCT00560313|83006028|FG000|Overall Study|Withdrawal by Subject|2|||
46787008|NCT00560313|83006028|FG000|Overall Study|Lost to Follow-up|1|||
46787009|NCT00560313|83006028|FG000|Overall Study|Protocol Violation|1|||
46851747|NCT00079274|83067278|FG002|Overall Study|Other|5|||
46851748|NCT00079274|83067279|FG003|Overall Study|Other|55|||
47077656|NCT00551460|83380063|FG000|Overall Study|Withdrawal by Subject|1|||
47077657|NCT00551460|83380063|FG000|Overall Study|Physician Decision|1|||
47077658|NCT00551460|83380063|FG000|Overall Study|Death|7|||
47077659|NCT00551460|83380063|FG000|Overall Study|Ineligible|4|||
47077660|NCT00551460|83380063|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
47077661|NCT02579772|83380124|FG000|Overall Study|Withdrawal by Subject|0|||
46673122|NCT01047540|82888761|FG000|Overall Study|Pregnancy|1|||
46673123|NCT01047540|82888762|FG001|Overall Study|Pregnancy|0|||
46673124|NCT01047540|82888763|FG002|Overall Study|Pregnancy|0|||
46787010|NCT00667862|83006047|FG000|Overall Study|Adverse Event|9|||
46787011|NCT00667862|83006047|FG000|Overall Study|Death|1|||
46787012|NCT00667862|83006047|FG000|Overall Study|Disease Progression|22|||
46787013|NCT00667862|83006047|FG000|Overall Study|Withdrawal by Subject|3|||
46787014|NCT00535132|83006053|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
46787015|NCT00535132|83006054|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
46787016|NCT00535132|83006053|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
46851749|NCT00079274|83067280|FG004|Overall Study|Other|1|||
46851750|NCT00079274|83067281|FG005|Overall Study|Other|2|||
46851751|NCT00079274|83067282|FG006|Overall Study|Other|0|||
46851752|NCT00079040|83067295|FG000|Overall Study|Withdrew before treatment|1|||
46851753|NCT00079040|83067295|FG000|Overall Study|Ineligible|1|||
46851754|NCT00078806|83067299|FG000|Part 1A|Adverse Event|2|||
46851755|NCT00078806|83067300|FG001|Part 1A|Adverse Event|0|||
46851756|NCT00078806|83067301|FG002|Part 1A|Adverse Event|0|||
46851757|NCT00078806|83067302|FG003|Part 1A|Adverse Event|0|||
46851758|NCT00078806|83067299|FG000|Part 1A|Lack of Efficacy|7|||
46787017|NCT00535132|83006054|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
46787018|NCT00570908|83006062|FG000|Overall Study|Adverse Event|5|||
46787019|NCT00570908|83006062|FG000|Overall Study|Withdrawal by Subject|2|||
46787020|NCT00321919|83006068|FG000|Overall Study|Adverse Event|17|||
46787021|NCT00321919|83006069|FG001|Overall Study|Adverse Event|10|||
46851759|NCT00078806|83067300|FG001|Part 1A|Lack of Efficacy|0|||
46851760|NCT00078806|83067301|FG002|Part 1A|Lack of Efficacy|0|||
46851761|NCT00078806|83067302|FG003|Part 1A|Lack of Efficacy|0|||
46851762|NCT00078806|83067299|FG000|Part 1A|Other|1|||
46787022|NCT00321919|83006068|FG000|Overall Study|Death|21|||
46787023|NCT00321919|83006069|FG001|Overall Study|Death|17|||
46787024|NCT00321919|83006068|FG000|Overall Study|Insufficient Therapeutic Response|1|||
46787025|NCT00321919|83006069|FG001|Overall Study|Insufficient Therapeutic Response|0|||
46787026|NCT00321919|83006068|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
46787027|NCT00321919|83006069|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
46787028|NCT00321919|83006068|FG000|Overall Study|Refused Treatment|23|||
46787029|NCT00321919|83006069|FG001|Overall Study|Refused Treatment|14|||
46787030|NCT00321919|83006068|FG000|Overall Study|Other Protocol Violation|2|||
46787031|NCT00321919|83006069|FG001|Overall Study|Other Protocol Violation|3|||
46787032|NCT00321919|83006068|FG000|Overall Study|Failure to Return|3|||
46787033|NCT00321919|83006069|FG001|Overall Study|Failure to Return|1|||
46787034|NCT00321919|83006068|FG000|Overall Study|Other withdrawal reason|7|||
46787035|NCT00321919|83006069|FG001|Overall Study|Other withdrawal reason|6|||
46851763|NCT00078806|83067300|FG001|Part 1A|Other|0|||
46851764|NCT00078806|83067301|FG002|Part 1A|Other|0|||
46851765|NCT00078806|83067302|FG003|Part 1A|Other|0|||
46851766|NCT00078806|83067299|FG000|Part 1B|Adverse Event|1|||
46851767|NCT00078806|83067300|FG001|Part 1B|Adverse Event|0|||
46851768|NCT00078806|83067301|FG002|Part 1B|Adverse Event|0|||
46851769|NCT00078806|83067302|FG003|Part 1B|Adverse Event|0|||
46973078|NCT02014480|83216812|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
46787036|NCT00781391|83006079|FG000|Overall Study|never received study drug|24|||
46787037|NCT00781391|83006080|FG001|Overall Study|never received study drug|23|||
46787038|NCT00781391|83006081|FG002|Overall Study|never received study drug|32|||
46787039|NCT00781391|83006079|FG000|Overall Study|Protocol Violation|19|||
46787040|NCT00781391|83006080|FG001|Overall Study|Protocol Violation|17|||
46787041|NCT00781391|83006081|FG002|Overall Study|Protocol Violation|20|||
46787042|NCT00781391|83006079|FG000|Overall Study|Death|789|||
46787043|NCT00781391|83006080|FG001|Overall Study|Death|730|||
46787044|NCT00781391|83006081|FG002|Overall Study|Death|706|||
46787045|NCT00781391|83006079|FG000|Overall Study|Withdrawal by Subject|47|||
46787046|NCT00781391|83006080|FG001|Overall Study|Withdrawal by Subject|37|||
46787047|NCT00781391|83006081|FG002|Overall Study|Withdrawal by Subject|25|||
46787048|NCT00781391|83006079|FG000|Overall Study|Lost to Follow-up|0|||
46787049|NCT00781391|83006080|FG001|Overall Study|Lost to Follow-up|0|||
46787050|NCT00781391|83006081|FG002|Overall Study|Lost to Follow-up|1|||
46787051|NCT00534976|83006091|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
46787052|NCT00534976|83006092|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
46787053|NCT00534976|83006091|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
46787054|NCT00534976|83006092|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
46787055|NCT00534976|83006091|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
46787056|NCT00534976|83006092|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
46851770|NCT00078806|83067299|FG000|Part 1B|Lack of Efficacy|7|||
46851771|NCT00078806|83067300|FG001|Part 1B|Lack of Efficacy|0|||
46851772|NCT00078806|83067301|FG002|Part 1B|Lack of Efficacy|0|||
46787057|NCT00321763|83006102|FG000|Overall Study|Adverse Event|1|||
46787058|NCT00321763|83006103|FG001|Overall Study|Adverse Event|1|||
46787059|NCT00321763|83006104|FG002|Overall Study|Adverse Event|0|||
46787060|NCT00321763|83006105|FG003|Overall Study|Adverse Event|1|||
46851773|NCT00078806|83067302|FG003|Part 1B|Lack of Efficacy|0|||
46851774|NCT00078806|83067299|FG000|Part 2|Adverse Event|0|||
46851775|NCT00078806|83067300|FG001|Part 2|Adverse Event|1|||
46851776|NCT00078806|83067301|FG002|Part 2|Adverse Event|0|||
46787061|NCT00321763|83006102|FG000|Overall Study|Withdrawal by Subject|2|||
46787062|NCT00321763|83006103|FG001|Overall Study|Withdrawal by Subject|0|||
46787063|NCT00321763|83006104|FG002|Overall Study|Withdrawal by Subject|1|||
46787064|NCT00321763|83006105|FG003|Overall Study|Withdrawal by Subject|0|||
46787065|NCT00321763|83006102|FG000|Overall Study|Lost to Follow-up|3|||
46787066|NCT00321763|83006103|FG001|Overall Study|Lost to Follow-up|1|||
46787067|NCT00321763|83006104|FG002|Overall Study|Lost to Follow-up|5|||
46787068|NCT00321763|83006105|FG003|Overall Study|Lost to Follow-up|4|||
46787069|NCT00308113|83006121|FG000|Overall Study|Protocol closure|0|||
46787070|NCT00308113|83006122|FG001|Overall Study|Protocol closure|0|||
46787071|NCT00308113|83006123|FG002|Overall Study|Protocol closure|0|||
46787072|NCT00308113|83006124|FG003|Overall Study|Protocol closure|1|||
46787073|NCT00307801|83006140|FG000|Overall Study|Adverse Event|12|||
46787074|NCT00307801|83006141|FG001|Overall Study|Adverse Event|4|||
46787075|NCT00307801|83006140|FG000|Overall Study|Withdrawal by Subject|9|||
46787076|NCT00307801|83006141|FG001|Overall Study|Withdrawal by Subject|4|||
46787077|NCT00307801|83006140|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
46787078|NCT00307801|83006141|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
46787079|NCT00307801|83006140|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
46787080|NCT00307801|83006141|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
46787081|NCT00307801|83006140|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
46787082|NCT00307801|83006141|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
46787083|NCT00307801|83006140|FG000|Overall Study|Wrong Randomization|1|||
46787084|NCT00307801|83006141|FG001|Overall Study|Wrong Randomization|0|||
46787085|NCT00307801|83006140|FG000|Overall Study|Lack of Efficacy|0|||
46787086|NCT00307801|83006141|FG001|Overall Study|Lack of Efficacy|2|||
46787087|NCT00307801|83006140|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
46787088|NCT00307801|83006141|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
46787089|NCT00307801|83006140|FG000|Overall Study|Frustration with e-diary|1|||
46787090|NCT00307801|83006141|FG001|Overall Study|Frustration with e-diary|0|||
46787091|NCT00307801|83006140|FG000|Overall Study|Protocol Violation|3|||
46787092|NCT00307801|83006141|FG001|Overall Study|Protocol Violation|2|||
46787093|NCT00307801|83006140|FG000|Overall Study|No reason specified|2|||
46787094|NCT00307801|83006141|FG001|Overall Study|No reason specified|0|||
46787095|NCT00307801|83006140|FG000|Overall Study|Pregnancy|0|||
46787096|NCT00307801|83006141|FG001|Overall Study|Pregnancy|1|||
46787097|NCT00671060|83006150|FG000|Overall Study|Protocol Violation|1|||
46787098|NCT00671060|83006151|FG001|Overall Study|Protocol Violation|0|||
46787099|NCT00671060|83006150|FG000|Overall Study|Physician Decision|0|||
46787100|NCT00671060|83006151|FG001|Overall Study|Physician Decision|1|||
46787101|NCT00654420|83006161|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
46787102|NCT00654420|83006162|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
46787103|NCT00654420|83006163|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
46787104|NCT00654420|83006164|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
46787105|NCT00654420|83006161|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
46787106|NCT00654420|83006162|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
46787107|NCT00654420|83006163|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
46787108|NCT00654420|83006164|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
46787109|NCT00654420|83006161|FG000|Phase II|Adverse Event|0|||
46787110|NCT00654420|83006162|FG001|Phase II|Adverse Event|0|||
46787111|NCT00654420|83006163|FG002|Phase II|Adverse Event|3|||
46787112|NCT00654420|83006164|FG003|Phase II|Adverse Event|3|||
46787113|NCT00654420|83006161|FG000|Phase II|Lost to Follow-up|0|||
46787114|NCT00654420|83006162|FG001|Phase II|Lost to Follow-up|0|||
46787115|NCT00654420|83006163|FG002|Phase II|Lost to Follow-up|0|||
46787116|NCT00654420|83006164|FG003|Phase II|Lost to Follow-up|1|||
46787117|NCT00654420|83006161|FG000|Phase II|Physician Decision|0|||
46787118|NCT00654420|83006162|FG001|Phase II|Physician Decision|0|||
46787119|NCT00654420|83006163|FG002|Phase II|Physician Decision|0|||
46787120|NCT00654420|83006164|FG003|Phase II|Physician Decision|4|||
47077662|NCT02579772|83380125|FG001|Overall Study|Withdrawal by Subject|1|||
47077663|NCT02579772|83380124|FG000|Overall Study|Usage of additional antioxidants|1|||
47077664|NCT02579772|83380125|FG001|Overall Study|Usage of additional antioxidants|0|||
46787121|NCT00654420|83006161|FG000|Phase II|Progressive Disease|0|||
46787122|NCT00654420|83006162|FG001|Phase II|Progressive Disease|0|||
46787123|NCT00654420|83006163|FG002|Phase II|Progressive Disease|29|||
46787124|NCT00654420|83006164|FG003|Phase II|Progressive Disease|29|||
46787125|NCT00654420|83006161|FG000|Phase II|Withdrawal by Subject|0|||
46787126|NCT00654420|83006162|FG001|Phase II|Withdrawal by Subject|0|||
46787127|NCT00654420|83006163|FG002|Phase II|Withdrawal by Subject|4|||
46787128|NCT00654420|83006164|FG003|Phase II|Withdrawal by Subject|1|||
46787129|NCT00654420|83006161|FG000|Phase II|Missing Disposition Record|0|||
46787130|NCT00654420|83006162|FG001|Phase II|Missing Disposition Record|0|||
46787131|NCT00654420|83006163|FG002|Phase II|Missing Disposition Record|1|||
46787132|NCT00654420|83006164|FG003|Phase II|Missing Disposition Record|0|||
46787133|NCT00307489|83006176|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
46787134|NCT00307489|83006177|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
46787135|NCT00307489|83006176|FG000|Baseline Through Week 48|Physician Decision|1|||
46787136|NCT00307489|83006177|FG001|Baseline Through Week 48|Physician Decision|0|||
46787137|NCT00307489|83006176|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
46787138|NCT00307489|83006177|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
46787139|NCT00307489|83006176|FG000|Week 48 Through Week 168|Adverse Event|1|||
46787140|NCT00307489|83006177|FG001|Week 48 Through Week 168|Adverse Event|0|||
46787141|NCT00307489|83006176|FG000|Week 48 Through Week 168|Physician Decision|1|||
46787142|NCT00307489|83006177|FG001|Week 48 Through Week 168|Physician Decision|0|||
46787143|NCT00307489|83006176|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
46787144|NCT00307489|83006177|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
46787145|NCT00307489|83006176|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
46787146|NCT00307489|83006177|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
46787147|NCT00307489|83006176|FG000|Week 48 Through Week 168|Death|0|||
46787148|NCT00307489|83006177|FG001|Week 48 Through Week 168|Death|1|||
46787149|NCT00307489|83006176|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
46787150|NCT00307489|83006177|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
46787151|NCT00307489|83006176|FG000|Week 48 Through Week 168|Seroconversion|1|||
46787152|NCT00307489|83006177|FG001|Week 48 Through Week 168|Seroconversion|0|||
46787153|NCT00645840|83006183|FG000|Overall Study|Protocol Violation|3|||
46787154|NCT00307333|83006189|FG000|Overall Study|Lost to Follow-up|11|||
46787155|NCT00307333|83006190|FG001|Overall Study|Lost to Follow-up|3|||
46787156|NCT00762359|83006198|FG000|Overall Study|Adverse Event|20|||
46787157|NCT00762359|83006199|FG001|Overall Study|Adverse Event|23|||
46787158|NCT00762359|83006198|FG000|Overall Study|Protocol Violation|21|||
46787159|NCT00762359|83006199|FG001|Overall Study|Protocol Violation|13|||
46787160|NCT00762359|83006198|FG000|Overall Study|Withdrawal by Subject|13|||
46787161|NCT00762359|83006199|FG001|Overall Study|Withdrawal by Subject|10|||
46787162|NCT00762359|83006198|FG000|Overall Study|Lack of Efficacy|0|||
46787163|NCT00762359|83006199|FG001|Overall Study|Lack of Efficacy|4|||
46787164|NCT00762359|83006198|FG000|Overall Study|Institution closed|2|||
46787165|NCT00762359|83006199|FG001|Overall Study|Institution closed|3|||
46787166|NCT00762359|83006198|FG000|Overall Study|Physician Decision|2|||
46787167|NCT00762359|83006199|FG001|Overall Study|Physician Decision|3|||
46787168|NCT00762359|83006198|FG000|Overall Study|Removal|0|||
46787169|NCT00762359|83006199|FG001|Overall Study|Removal|1|||
46787170|NCT00762359|83006198|FG000|Overall Study|Withdrew consent|1|||
46787171|NCT00762359|83006199|FG001|Overall Study|Withdrew consent|0|||
46787172|NCT00654186|83006205|FG000|Overall Study|Withdrawal by Subject|5|||
46787173|NCT00761969|83006211|FG000|Overall Study|Death|112|||
46787174|NCT00761969|83006212|FG001|Overall Study|Death|47|||
46787175|NCT00761969|83006211|FG000|Overall Study|Lost to Follow-up|88|||
46787176|NCT00761969|83006212|FG001|Overall Study|Lost to Follow-up|93|||
46787177|NCT00761891|83006223|FG000|Overall Study|Withdrawal by Subject|10|||
46787178|NCT00321685|83006228|FG000|Overall Study|Adverse Event|18|||
46787179|NCT00321685|83006228|FG000|Overall Study|Death|2|||
46787180|NCT00321685|83006228|FG000|Overall Study|Withdrawal by Subject|8|||
46787181|NCT00321685|83006228|FG000|Overall Study|Alternative therapy|1|||
46787182|NCT00321685|83006228|FG000|Overall Study|Complicating disese|1|||
46787183|NCT00321685|83006228|FG000|Overall Study|Other|5|||
46973079|NCT02014480|83216813|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
46973080|NCT02014480|83216814|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
46787184|NCT00321685|83006228|FG000|Overall Study|Not start protocol therapy|2|||
46787185|NCT00321685|83006228|FG000|Overall Study|Ineligible|2|||
46787186|NCT03902392|83006234|FG000|Overall Study|Lost to Follow-up|7|||
46787187|NCT03902392|83006235|FG001|Overall Study|Lost to Follow-up|7|||
46787188|NCT00306787|83006243|FG000|Overall Study|Discontinued without taking study drug|208|||
46787189|NCT00306787|83006244|FG001|Overall Study|Discontinued without taking study drug|215|||
46787190|NCT00306787|83006243|FG000|Overall Study|Adverse Event|1|||
46787191|NCT00306787|83006244|FG001|Overall Study|Adverse Event|1|||
46787192|NCT00306787|83006243|FG000|Overall Study|Lack of Efficacy|1|||
46787193|NCT00306787|83006244|FG001|Overall Study|Lack of Efficacy|0|||
46787194|NCT00306787|83006243|FG000|Overall Study|Protocol Violation|8|||
46787195|NCT00306787|83006244|FG001|Overall Study|Protocol Violation|10|||
46787196|NCT00306787|83006243|FG000|Overall Study|Withdrawal by Subject|2|||
46787197|NCT00306787|83006244|FG001|Overall Study|Withdrawal by Subject|9|||
46787198|NCT00306787|83006243|FG000|Overall Study|Lost to Follow-up|9|||
46973081|NCT01261247|83216822|FG000|Overall Study|Ineligible|2|||
46973082|NCT01677767|83216826|FG000|Overall Study|Adverse Event|1|||
46787199|NCT00306787|83006244|FG001|Overall Study|Lost to Follow-up|6|||
46787200|NCT00306787|83006243|FG000|Overall Study|Administrative problems|4|||
46787201|NCT00306787|83006244|FG001|Overall Study|Administrative problems|0|||
46787202|NCT00306787|83006243|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46787203|NCT00306787|83006244|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46787204|NCT00769067|83006252|FG000|Overall Study|Death|89|||
46787205|NCT00769067|83006253|FG001|Overall Study|Death|86|||
46787206|NCT00769067|83006252|FG000|Overall Study|Lost to Follow-up|3|||
46787207|NCT00769067|83006253|FG001|Overall Study|Lost to Follow-up|1|||
46787208|NCT00769067|83006252|FG000|Overall Study|Study terminated by sponsor|1|||
46787209|NCT00769067|83006253|FG001|Overall Study|Study terminated by sponsor|3|||
46787210|NCT00769067|83006252|FG000|Overall Study|Other|1|||
46787211|NCT00769067|83006253|FG001|Overall Study|Other|3|||
46787212|NCT00769067|83006252|FG000|Overall Study|Withdrawal by Subject|0|||
46787213|NCT00769067|83006253|FG001|Overall Study|Withdrawal by Subject|1|||
46787214|NCT00321373|83006263|FG000|Overall Study|Adverse Event|0|||
46787215|NCT00321373|83006264|FG001|Overall Study|Adverse Event|0|||
46787216|NCT00321373|83006265|FG002|Overall Study|Adverse Event|1|||
46787217|NCT00321373|83006263|FG000|Overall Study|Lost to Follow-up|1|||
46787218|NCT00321373|83006264|FG001|Overall Study|Lost to Follow-up|0|||
46851777|NCT00078806|83067302|FG003|Part 2|Adverse Event|0|||
46851778|NCT00078338|83067319|FG000|Overall Study|Adverse Event|31|||
46851779|NCT00078338|83067320|FG001|Overall Study|Adverse Event|24|||
46851780|NCT00078338|83067319|FG000|Overall Study|Lost to Follow-up|17|||
46851781|NCT00078338|83067320|FG001|Overall Study|Lost to Follow-up|2|||
46787219|NCT00321373|83006265|FG002|Overall Study|Lost to Follow-up|1|||
46787220|NCT00321373|83006263|FG000|Overall Study|Withdrawal by Subject|1|||
46787221|NCT00321373|83006264|FG001|Overall Study|Withdrawal by Subject|0|||
46787222|NCT00321373|83006265|FG002|Overall Study|Withdrawal by Subject|0|||
46787223|NCT00321373|83006263|FG000|Overall Study|Other|0|||
46787224|NCT00321373|83006264|FG001|Overall Study|Other|0|||
46787225|NCT00321373|83006265|FG002|Overall Study|Other|1|||
46787226|NCT00667394|83006275|FG000|Overall Study|Adverse Event|3|||
46787227|NCT00667394|83006276|FG001|Overall Study|Adverse Event|0|||
46787228|NCT00667394|83006275|FG000|Overall Study|Progressive disease|1|||
46787229|NCT00667394|83006276|FG001|Overall Study|Progressive disease|0|||
46787230|NCT00761735|83006282|FG000|Overall Study|Lost to Follow-up|6|||
46787231|NCT00761735|83006282|FG000|Overall Study|Withdrawal by Subject|6|||
46787232|NCT00761735|83006282|FG000|Overall Study|Non-compliance with protocol|1|||
46787233|NCT00761735|83006282|FG000|Overall Study|Administrative|1|||
46787234|NCT00569946|83006290|FG000|Overall Study|Adverse Event|16|||
46787235|NCT00569946|83006290|FG000|Overall Study|Objective Progression or Relapse|42|||
46787236|NCT00569946|83006290|FG000|Overall Study|Global Deterioration of Health Status|1|||
46787237|NCT00645528|83006294|FG000|Overall Study|Did not show up for Visit 2|7|||
46851782|NCT00078338|83067319|FG000|Overall Study|Protocol Violation|2|||
46851783|NCT00078338|83067320|FG001|Overall Study|Protocol Violation|2|||
46851784|NCT00078338|83067319|FG000|Overall Study|Disease Progression|4|||
46851785|NCT00078338|83067320|FG001|Overall Study|Disease Progression|7|||
46851786|NCT00078338|83067319|FG000|Overall Study|Other|28|||
46851787|NCT00078338|83067320|FG001|Overall Study|Other|16|||
46851788|NCT00078338|83067319|FG000|Overall Study|Subjects randomized, but not treated|3|||
46851789|NCT00078338|83067320|FG001|Overall Study|Subjects randomized, but not treated|3|||
46851790|NCT03808688|83067328|FG000|Overall Study|Adverse Event|13|||
46851791|NCT03808688|83067329|FG001|Overall Study|Adverse Event|17|||
46851792|NCT03808688|83067328|FG000|Overall Study|Lack of Efficacy|2|||
47077665|NCT02579772|83380124|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
46787238|NCT00295633|83006301|FG000|Overall Study|Lack of Efficacy|19|||
46787239|NCT00295633|83006302|FG001|Overall Study|Lack of Efficacy|7|||
46787240|NCT00295633|83006303|FG002|Overall Study|Lack of Efficacy|16|||
46787241|NCT00295633|83006301|FG000|Overall Study|Withdrawal of consent by subject|16|||
46787242|NCT00295633|83006302|FG001|Overall Study|Withdrawal of consent by subject|16|||
46787243|NCT00295633|83006303|FG002|Overall Study|Withdrawal of consent by subject|26|||
46787244|NCT00295633|83006301|FG000|Overall Study|Adverse Event|9|||
46787245|NCT00295633|83006302|FG001|Overall Study|Adverse Event|17|||
46787246|NCT00295633|83006303|FG002|Overall Study|Adverse Event|9|||
46787247|NCT00295633|83006301|FG000|Overall Study|Lost to Follow-up|6|||
46787248|NCT00295633|83006302|FG001|Overall Study|Lost to Follow-up|11|||
46787249|NCT00295633|83006303|FG002|Overall Study|Lost to Follow-up|7|||
46787250|NCT00295633|83006301|FG000|Overall Study|Physician Decision|9|||
46787251|NCT00295633|83006302|FG001|Overall Study|Physician Decision|10|||
47077666|NCT02579772|83380125|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
47077667|NCT02579616|83380198|FG000|Overall Study|Participants did not receive treatment|3|||
47077668|NCT04027608|83380258|FG000|Overall Study|Withdrawal by Subject|13|||
47077669|NCT04027608|83380259|FG001|Overall Study|Withdrawal by Subject|2|||
47077670|NCT04027608|83380258|FG000|Overall Study|Protocol Violation|2|||
47077671|NCT04027608|83380259|FG001|Overall Study|Protocol Violation|1|||
46787252|NCT00295633|83006303|FG002|Overall Study|Physician Decision|8|||
46787253|NCT00295633|83006301|FG000|Overall Study|Poor/Noncompliance|2|||
46851793|NCT03808688|83067329|FG001|Overall Study|Lack of Efficacy|0|||
46787254|NCT00295633|83006302|FG001|Overall Study|Poor/Noncompliance|2|||
46851794|NCT03808688|83067328|FG000|Overall Study|Lost to Follow-up|0|||
46851795|NCT03808688|83067329|FG001|Overall Study|Lost to Follow-up|2|||
46851796|NCT03808688|83067328|FG000|Overall Study|Withdrawal by Subject|1|||
46787255|NCT00295633|83006303|FG002|Overall Study|Poor/Noncompliance|6|||
46851797|NCT03808688|83067329|FG001|Overall Study|Withdrawal by Subject|0|||
46787256|NCT00295633|83006301|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
46787257|NCT00295633|83006302|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
46851798|NCT03808688|83067328|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
46851799|NCT03808688|83067329|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
46851800|NCT03808688|83067328|FG000|Overall Study|IOP Too High|1|||
46851801|NCT03808688|83067329|FG001|Overall Study|IOP Too High|1|||
46851802|NCT03808688|83067328|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
46851803|NCT03808688|83067329|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
46851804|NCT03808688|83067328|FG000|Overall Study|Visit Out of Window|0|||
46851805|NCT03808688|83067329|FG001|Overall Study|Visit Out of Window|1|||
46851806|NCT03808688|83067328|FG000|Overall Study|Medication Non-Compliance|0|||
46851807|NCT03808688|83067329|FG001|Overall Study|Medication Non-Compliance|1|||
46851808|NCT03808298|83067337|FG000|Overall Study|Adverse Event|3|||
46851809|NCT03808298|83067337|FG000|Overall Study|Physician Decision|1|||
46851810|NCT03808298|83067337|FG000|Overall Study|Withdrawal by Subject|1|||
46851811|NCT03808298|83067337|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
46851812|NCT00077636|83067368|FG000|Overall Study|Refused Treatment|9|||
46851813|NCT00077636|83067369|FG001|Overall Study|Refused Treatment|31|||
46851814|NCT00077636|83067368|FG000|Overall Study|Admin|3|||
46851815|NCT00077636|83067369|FG001|Overall Study|Admin|3|||
46851816|NCT00077636|83067368|FG000|Overall Study|Withdrawal by Subject|2|||
46851817|NCT00077636|83067369|FG001|Overall Study|Withdrawal by Subject|2|||
46851818|NCT00077636|83067368|FG000|Overall Study|Adverse Event|17|||
46673125|NCT01047540|82888764|FG003|Overall Study|Pregnancy|0|||
46673126|NCT01047540|82888765|FG004|Overall Study|Pregnancy|0|||
46673127|NCT01047540|82888761|FG000|Overall Study|Adverse Event|1|||
46787258|NCT00295633|83006303|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
46787259|NCT00295633|83006301|FG000|Overall Study|Death|1|||
46787260|NCT00295633|83006302|FG001|Overall Study|Death|1|||
46787261|NCT00295633|83006303|FG002|Overall Study|Death|0|||
46787262|NCT00295633|83006301|FG000|Overall Study|Administrative reason by sponsor|0|||
46787263|NCT00295633|83006302|FG001|Overall Study|Administrative reason by sponsor|0|||
46787264|NCT00295633|83006303|FG002|Overall Study|Administrative reason by sponsor|1|||
46787265|NCT00570674|83006311|FG000|Overall Study|Withdrawal by Subject|0|||
46787266|NCT00570674|83006312|FG001|Overall Study|Withdrawal by Subject|0|||
46787267|NCT00570674|83006313|FG002|Overall Study|Withdrawal by Subject|1|||
46787268|NCT00570674|83006314|FG003|Overall Study|Withdrawal by Subject|0|||
46787269|NCT00570674|83006315|FG004|Overall Study|Withdrawal by Subject|0|||
46787270|NCT00570674|83006316|FG005|Overall Study|Withdrawal by Subject|0|||
46787271|NCT00570674|83006317|FG006|Overall Study|Withdrawal by Subject|0|||
46673128|NCT01047540|82888762|FG001|Overall Study|Adverse Event|0|||
46673129|NCT01047540|82888763|FG002|Overall Study|Adverse Event|0|||
46673130|NCT01047540|82888764|FG003|Overall Study|Adverse Event|0|||
46673131|NCT01047540|82888765|FG004|Overall Study|Adverse Event|0|||
46673132|NCT00521222|82888781|FG000|Overall Study|Lost to Follow-up|0|||
46673133|NCT00521222|82888782|FG001|Overall Study|Lost to Follow-up|0|||
46673134|NCT00521222|82888783|FG002|Overall Study|Lost to Follow-up|1|||
46673135|NCT00521222|82888784|FG003|Overall Study|Lost to Follow-up|1|||
46673136|NCT00521222|82888781|FG000|Overall Study|Withdrawal by Subject|0|||
46673137|NCT00521222|82888782|FG001|Overall Study|Withdrawal by Subject|0|||
46673138|NCT00521222|82888783|FG002|Overall Study|Withdrawal by Subject|2|||
46673139|NCT00521222|82888784|FG003|Overall Study|Withdrawal by Subject|0|||
46673140|NCT00521222|82888781|FG000|Overall Study|Physician Decision|0|||
46673141|NCT00521222|82888782|FG001|Overall Study|Physician Decision|1|||
46673142|NCT00521222|82888783|FG002|Overall Study|Physician Decision|0|||
46673143|NCT00521222|82888784|FG003|Overall Study|Physician Decision|1|||
46673144|NCT01214629|82888818|FG000|Overall Study|Progressive Disease|1|||
46673145|NCT01214629|82888819|FG001|Overall Study|Progressive Disease|1|||
46673146|NCT01214629|82888820|FG002|Overall Study|Progressive Disease|0|||
46673147|NCT01214629|82888821|FG003|Overall Study|Progressive Disease|1|||
46673148|NCT01214629|82888822|FG004|Overall Study|Progressive Disease|2|||
46673149|NCT01214629|82888823|FG005|Overall Study|Progressive Disease|3|||
46673150|NCT01214629|82888824|FG006|Overall Study|Progressive Disease|1|||
46673151|NCT01214629|82888825|FG007|Overall Study|Progressive Disease|1|||
46673152|NCT01214629|82888826|FG008|Overall Study|Progressive Disease|1|||
46673153|NCT01214629|82888827|FG009|Overall Study|Progressive Disease|5|||
46673154|NCT01214629|82888828|FG010|Overall Study|Progressive Disease|1|||
46851819|NCT00077636|83067369|FG001|Overall Study|Adverse Event|34|||
46851820|NCT00077636|83067368|FG000|Overall Study|Protocol Violation|0|||
46673155|NCT01214629|82888818|FG000|Overall Study|Adverse Event|0|||
46787272|NCT00768989|83006330|FG000|Prior to Week 24|Withdrawal by Subject|1|||
46787273|NCT00768989|83006331|FG001|Prior to Week 24|Withdrawal by Subject|0|||
46851821|NCT00077636|83067369|FG001|Overall Study|Protocol Violation|2|||
46973083|NCT01677767|83216826|FG000|Overall Study|Death|4|||
46787274|NCT00768989|83006330|FG000|Prior to Week 24|Adverse Event|3|||
46673156|NCT01214629|82888819|FG001|Overall Study|Adverse Event|0|||
46673157|NCT01214629|82888820|FG002|Overall Study|Adverse Event|0|||
46673158|NCT01214629|82888821|FG003|Overall Study|Adverse Event|1|||
46673159|NCT01214629|82888822|FG004|Overall Study|Adverse Event|0|||
46673160|NCT01214629|82888823|FG005|Overall Study|Adverse Event|1|||
46673161|NCT01214629|82888824|FG006|Overall Study|Adverse Event|0|||
46673162|NCT01214629|82888825|FG007|Overall Study|Adverse Event|0|||
46673163|NCT01214629|82888826|FG008|Overall Study|Adverse Event|0|||
46673164|NCT01214629|82888827|FG009|Overall Study|Adverse Event|1|||
46787275|NCT00768989|83006331|FG001|Prior to Week 24|Adverse Event|0|||
46787276|NCT00768989|83006330|FG000|Prior to Week 24|Lost to Follow-up|0|||
46787277|NCT00768989|83006331|FG001|Prior to Week 24|Lost to Follow-up|1|||
46787278|NCT00768989|83006330|FG000|Prior to Week 24|Protocol Violation|0|||
46787279|NCT00768989|83006331|FG001|Prior to Week 24|Protocol Violation|2|||
46787280|NCT00768989|83006330|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
46787281|NCT00768989|83006331|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
46787282|NCT00768989|83006330|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
46787283|NCT00768989|83006331|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
46787284|NCT00768989|83006330|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
46787285|NCT00768989|83006331|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
46787286|NCT00768989|83006330|FG000|On or After Week 36|Lack of Efficacy|1|||
46787287|NCT00768989|83006331|FG001|On or After Week 36|Lack of Efficacy|0|||
46787288|NCT00768989|83006330|FG000|On or After Week 36|Adverse Event|0|||
46787289|NCT00768989|83006331|FG001|On or After Week 36|Adverse Event|1|||
46787290|NCT00768989|83006330|FG000|On or After Week 36|Lost to Follow-up|1|||
46787291|NCT00768989|83006331|FG001|On or After Week 36|Lost to Follow-up|0|||
46787292|NCT00768989|83006330|FG000|On or After Week 36|Poor Compliance|1|||
46787293|NCT00768989|83006331|FG001|On or After Week 36|Poor Compliance|0|||
46787294|NCT00768989|83006330|FG000|On or After Week 36|Protocol Violation|1|||
46787295|NCT00768989|83006331|FG001|On or After Week 36|Protocol Violation|0|||
46787296|NCT00768989|83006330|FG000|On or After Week 36|Did not attend termination visit|2|||
46787297|NCT00768989|83006331|FG001|On or After Week 36|Did not attend termination visit|0|||
46787298|NCT00768989|83006330|FG000|On or After Week 36|Sponsor Termination|45|||
46787299|NCT00768989|83006331|FG001|On or After Week 36|Sponsor Termination|26|||
46787300|NCT00305773|83006341|FG000|Overall Study|Death|3|||
46787301|NCT00305773|83006342|FG001|Overall Study|Death|2|||
46787302|NCT00305773|83006341|FG000|Overall Study|Adverse Event|1|||
46787303|NCT00305773|83006342|FG001|Overall Study|Adverse Event|2|||
46787304|NCT00305773|83006341|FG000|Overall Study|Alternative Treatment|4|||
46787305|NCT00305773|83006342|FG001|Overall Study|Alternative Treatment|4|||
46787306|NCT00305773|83006341|FG000|Overall Study|Physician Decision|1|||
46787307|NCT00305773|83006342|FG001|Overall Study|Physician Decision|1|||
46787308|NCT00305773|83006341|FG000|Overall Study|Withdrawal by Subject|1|||
46787309|NCT00305773|83006342|FG001|Overall Study|Withdrawal by Subject|4|||
46787310|NCT00305773|83006341|FG000|Overall Study|Disease Progression|1|||
46787311|NCT00305773|83006342|FG001|Overall Study|Disease Progression|3|||
46787312|NCT00305773|83006341|FG000|Overall Study|All other reasons|3|||
46787313|NCT00305773|83006342|FG001|Overall Study|All other reasons|2|||
46787314|NCT00305695|83006350|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
46787315|NCT00305695|83006351|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
46787316|NCT00305695|83006350|FG000|Overall Study|Did not have baseline scan|1|||
46787317|NCT00305695|83006351|FG001|Overall Study|Did not have baseline scan|1|||
46787318|NCT00647556|83006359|FG000|Overall Study|Adverse Event|0|||
46787319|NCT00647556|83006360|FG001|Overall Study|Adverse Event|1|||
46787320|NCT00647556|83006359|FG000|Overall Study|Lost to Follow-up|1|||
46787321|NCT00647556|83006360|FG001|Overall Study|Lost to Follow-up|0|||
46787322|NCT00647556|83006359|FG000|Overall Study|Protocol Violation|0|||
46787323|NCT00647556|83006360|FG001|Overall Study|Protocol Violation|1|||
46787324|NCT00647556|83006359|FG000|Overall Study|Withdrawal by Subject|1|||
46787325|NCT00647556|83006360|FG001|Overall Study|Withdrawal by Subject|0|||
46787326|NCT00647556|83006359|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
46787327|NCT00647556|83006360|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
46787328|NCT00320593|83006368|FG000|Overall Study|Lost to Follow-up|3|||
46851822|NCT00077636|83067368|FG000|Overall Study|Lost to Follow-up|10|||
46973084|NCT01677767|83216826|FG000|Overall Study|Protocol Violation|4|||
46787329|NCT00320593|83006369|FG001|Overall Study|Lost to Follow-up|0|||
46787330|NCT00320593|83006368|FG000|Overall Study|Moved to another state|1|||
46787331|NCT00320593|83006369|FG001|Overall Study|Moved to another state|0|||
46787332|NCT00320593|83006368|FG000|Overall Study|Withdrawal by Subject|2|||
46787333|NCT00320593|83006369|FG001|Overall Study|Withdrawal by Subject|1|||
46787334|NCT00320593|83006368|FG000|Overall Study|Withdrawal by clinical center|1|||
46787335|NCT00320593|83006369|FG001|Overall Study|Withdrawal by clinical center|0|||
46787336|NCT00320515|83006375|FG000|Overall Study|Death|33|||
46787337|NCT00320515|83006375|FG000|Overall Study|Lost to Follow-up|6|||
46787338|NCT00320515|83006375|FG000|Overall Study|Physician Decision|2|||
46787339|NCT00320515|83006375|FG000|Overall Study|Withdrawal by Subject|8|||
46787340|NCT00662012|83006379|FG000|Overall Study|Lost to Follow-up|85|||
46851823|NCT00077636|83067369|FG001|Overall Study|Lost to Follow-up|18|||
46787341|NCT00662012|83006379|FG000|Overall Study|Death|1|||
46787342|NCT00662012|83006379|FG000|Overall Study|Withdrawal by Subject|1|||
46673165|NCT01214629|82888828|FG010|Overall Study|Adverse Event|0|||
46787343|NCT00661778|83006383|FG000|Overall Study|Disease Progression|23|||
46787344|NCT00661778|83006383|FG000|Overall Study|Adverse Event|18|||
46787345|NCT00661778|83006383|FG000|Overall Study|Reason not Specified|6|||
46787346|NCT00661778|83006383|FG000|Overall Study|Protocol Violation|2|||
46787347|NCT00661778|83006383|FG000|Overall Study|Withdrawal of Consent|1|||
46787348|NCT00319735|83006387|FG000|Overall Study|Death|2|||
46787349|NCT00653328|83006392|FG000|Overall Study|Withdrawal by Subject|1|||
46787350|NCT00653328|83006392|FG000|Overall Study|Adverse Event|2|||
46787351|NCT00653328|83006392|FG000|Overall Study|Disease progression|10|||
46787352|NCT00653328|83006392|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
46787353|NCT00642642|83006405|FG000|Treatment & Follow Up|Adverse Event|2|||
46787354|NCT00642642|83006405|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
46787355|NCT00642642|83006405|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
46787356|NCT00534352|83006415|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
46787357|NCT00534352|83006415|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
46787358|NCT00534352|83006415|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
46787359|NCT00534352|83006415|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
46787360|NCT00534352|83006415|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
46787361|NCT00534352|83006415|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
46787362|NCT00642174|83006430|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
46787363|NCT00642174|83006431|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
46787364|NCT00665366|83006439|FG000|Overall Study|Lack of Efficacy|11|||
46851824|NCT00077636|83067368|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
46851825|NCT00077636|83067369|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
46851826|NCT00095199|83067380|FG000|Overall Study|Adverse Event|40|||
46851827|NCT00095199|83067381|FG001|Overall Study|Adverse Event|22|||
46851828|NCT00095199|83067382|FG002|Overall Study|Adverse Event|26|||
46851829|NCT00095199|83067383|FG003|Overall Study|Adverse Event|11|||
46851830|NCT00095199|83067380|FG000|Overall Study|Progressive disease|213|||
46851831|NCT00095199|83067381|FG001|Overall Study|Progressive disease|179|||
46851832|NCT00095199|83067382|FG002|Overall Study|Progressive disease|105|||
46851833|NCT00095199|83067383|FG003|Overall Study|Progressive disease|98|||
46851834|NCT00095199|83067380|FG000|Overall Study|Death|10|||
46851835|NCT00095199|83067381|FG001|Overall Study|Death|6|||
46851836|NCT00095199|83067382|FG002|Overall Study|Death|11|||
46851837|NCT00095199|83067383|FG003|Overall Study|Death|9|||
46851838|NCT00095199|83067380|FG000|Overall Study|Withdrawal by Subject|21|||
46851839|NCT00095199|83067381|FG001|Overall Study|Withdrawal by Subject|16|||
46851840|NCT00095199|83067382|FG002|Overall Study|Withdrawal by Subject|13|||
46851841|NCT00095199|83067383|FG003|Overall Study|Withdrawal by Subject|22|||
46851842|NCT00095199|83067380|FG000|Overall Study|Protocol Violation|4|||
46851843|NCT00095199|83067381|FG001|Overall Study|Protocol Violation|4|||
46851844|NCT00095199|83067382|FG002|Overall Study|Protocol Violation|2|||
46851845|NCT00095199|83067383|FG003|Overall Study|Protocol Violation|0|||
46851846|NCT00095199|83067380|FG000|Overall Study|Liver function test results elevated|0|||
46851847|NCT00095199|83067381|FG001|Overall Study|Liver function test results elevated|0|||
46851848|NCT00095199|83067382|FG002|Overall Study|Liver function test results elevated|1|||
46851849|NCT00095199|83067383|FG003|Overall Study|Liver function test results elevated|1|||
46851850|NCT00095199|83067380|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
46851851|NCT00095199|83067381|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
46851852|NCT00095199|83067382|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
46851853|NCT00095199|83067383|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
46851854|NCT00095199|83067380|FG000|Overall Study|Physician Decision|5|||
46851855|NCT00095199|83067381|FG001|Overall Study|Physician Decision|6|||
46851856|NCT00095199|83067382|FG002|Overall Study|Physician Decision|1|||
46851857|NCT00095199|83067383|FG003|Overall Study|Physician Decision|1|||
46851858|NCT00095199|83067380|FG000|Overall Study|Not eligible|1|||
46851859|NCT00095199|83067381|FG001|Overall Study|Not eligible|7|||
46851860|NCT00095199|83067382|FG002|Overall Study|Not eligible|0|||
46973085|NCT01677767|83216826|FG000|Overall Study|Withdrawal by Subject|10|||
46787365|NCT00665366|83006440|FG001|Overall Study|Lack of Efficacy|10|||
46787366|NCT00665366|83006439|FG000|Overall Study|Adverse Event|25|||
46787367|NCT00665366|83006440|FG001|Overall Study|Adverse Event|23|||
46787368|NCT00665366|83006439|FG000|Overall Study|Withdrawal by Subject|11|||
46787369|NCT00665366|83006440|FG001|Overall Study|Withdrawal by Subject|14|||
46787370|NCT00665366|83006439|FG000|Overall Study|Lost to Follow-up|3|||
46851861|NCT00095199|83067383|FG003|Overall Study|Not eligible|1|||
46851862|NCT00095199|83067380|FG000|Overall Study|Started Palliative Radiotherapy|1|||
46851863|NCT00095199|83067381|FG001|Overall Study|Started Palliative Radiotherapy|0|||
46851864|NCT00095199|83067382|FG002|Overall Study|Started Palliative Radiotherapy|0|||
46851865|NCT00095199|83067383|FG003|Overall Study|Started Palliative Radiotherapy|0|||
46851866|NCT00095199|83067380|FG000|Overall Study|Started radiotherapy regimen|0|||
46851867|NCT00095199|83067381|FG001|Overall Study|Started radiotherapy regimen|1|||
46851868|NCT00095199|83067382|FG002|Overall Study|Started radiotherapy regimen|0|||
46851869|NCT00095199|83067383|FG003|Overall Study|Started radiotherapy regimen|0|||
46787371|NCT00665366|83006440|FG001|Overall Study|Lost to Follow-up|5|||
46787372|NCT00665366|83006439|FG000|Overall Study|Poor compliance/noncompliance|3|||
46787373|NCT00665366|83006440|FG001|Overall Study|Poor compliance/noncompliance|5|||
46787374|NCT00665366|83006439|FG000|Overall Study|Pregnancy|1|||
46787375|NCT00665366|83006440|FG001|Overall Study|Pregnancy|0|||
46787376|NCT00665366|83006439|FG000|Overall Study|No longer meets study criteria|0|||
46787377|NCT00665366|83006440|FG001|Overall Study|No longer meets study criteria|1|||
46787378|NCT00665366|83006439|FG000|Overall Study|Other reasons|4|||
46973086|NCT01677767|83216826|FG000|Overall Study|Non-compliance by the participants|3|||
46851870|NCT00095199|83067380|FG000|Overall Study|Primary tumor removed in other surgery|0|||
46851871|NCT00095199|83067381|FG001|Overall Study|Primary tumor removed in other surgery|1|||
46851872|NCT00095199|83067382|FG002|Overall Study|Primary tumor removed in other surgery|0|||
46851873|NCT00095199|83067383|FG003|Overall Study|Primary tumor removed in other surgery|0|||
46851874|NCT00095199|83067380|FG000|Overall Study|Data inadvertently lost by site|1|||
46851875|NCT00095199|83067381|FG001|Overall Study|Data inadvertently lost by site|0|||
46973087|NCT01603277|83216847|FG000|Overall Study|Adverse Event|1|||
46973088|NCT01603277|83216848|FG001|Overall Study|Adverse Event|2|||
46973089|NCT01603277|83216847|FG000|Overall Study|Physician Decision|0|||
46973090|NCT01603277|83216848|FG001|Overall Study|Physician Decision|1|||
46973091|NCT01603277|83216847|FG000|Overall Study|Protocol Violation|6|||
46973092|NCT01603277|83216848|FG001|Overall Study|Protocol Violation|10|||
46973093|NCT01603277|83216847|FG000|Overall Study|Withdrawal by Subject|5|||
46973094|NCT01603277|83216848|FG001|Overall Study|Withdrawal by Subject|4|||
46973095|NCT01603277|83216847|FG000|Overall Study|Non-Compliance|2|||
46973096|NCT01603277|83216848|FG001|Overall Study|Non-Compliance|1|||
46851876|NCT00095199|83067382|FG002|Overall Study|Data inadvertently lost by site|0|||
46973097|NCT01678313|83216856|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
46973098|NCT01678313|83216857|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
46973099|NCT01678313|83216856|FG000|Completed the 3-month Therapy|Physician Decision|3|||
46973100|NCT01678313|83216857|FG001|Completed the 3-month Therapy|Physician Decision|4|||
46973101|NCT01678313|83216856|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
46973102|NCT01678313|83216857|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
46973103|NCT01678313|83216856|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
46973104|NCT01678313|83216857|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
46973105|NCT01603121|83216863|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
46973106|NCT01603121|83216864|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
46973107|NCT01603043|83216872|FG000|Overall Study|Study Futility|7|||
46973108|NCT01603043|83216873|FG001|Overall Study|Study Futility|3|||
46973109|NCT02014402|83216883|FG000|Overall Study|Adverse Event|1|||
46973110|NCT02014402|83216884|FG001|Overall Study|Adverse Event|0|||
46973111|NCT02014402|83216885|FG002|Overall Study|Adverse Event|0|||
46973112|NCT02014402|83216886|FG003|Overall Study|Adverse Event|0|||
46851877|NCT00095199|83067383|FG003|Overall Study|Data inadvertently lost by site|0|||
46851878|NCT00075764|83067400|FG000|Overall Study|Adverse Event|5|||
46851879|NCT00075764|83067401|FG001|Overall Study|Adverse Event|12|||
46973113|NCT02014402|83216883|FG000|Overall Study|Withdrawal by Subject|1|||
46973114|NCT02014402|83216884|FG001|Overall Study|Withdrawal by Subject|2|||
46973115|NCT02014402|83216885|FG002|Overall Study|Withdrawal by Subject|2|||
46973116|NCT02014402|83216886|FG003|Overall Study|Withdrawal by Subject|1|||
46973117|NCT02014402|83216883|FG000|Overall Study|Subject did not have transportation|0|||
46973118|NCT02014402|83216884|FG001|Overall Study|Subject did not have transportation|1|||
46787379|NCT00665366|83006440|FG001|Overall Study|Other reasons|1|||
46851880|NCT00075764|83067400|FG000|Overall Study|Death|4|||
46851881|NCT00075764|83067401|FG001|Overall Study|Death|8|||
46851882|NCT00075764|83067400|FG000|Overall Study|Withdrawal by Subject|28|||
46851883|NCT00075764|83067401|FG001|Overall Study|Withdrawal by Subject|18|||
46851884|NCT00075764|83067400|FG000|Overall Study|Progression|269|||
46851885|NCT00075764|83067401|FG001|Overall Study|Progression|274|||
46787380|NCT00642018|83006470|FG000|Overall Study|Adverse Event|11|||
46787381|NCT00642018|83006471|FG001|Overall Study|Adverse Event|36|||
46973119|NCT02014402|83216885|FG002|Overall Study|Subject did not have transportation|0|||
46973120|NCT02014402|83216886|FG003|Overall Study|Subject did not have transportation|0|||
46973121|NCT02014402|83216883|FG000|Overall Study|Lost to Follow-up|0|||
46973122|NCT02014402|83216884|FG001|Overall Study|Lost to Follow-up|0|||
46973123|NCT02014402|83216885|FG002|Overall Study|Lost to Follow-up|1|||
46973124|NCT02014402|83216886|FG003|Overall Study|Lost to Follow-up|2|||
46973125|NCT01988662|83216905|FG000|Overall Study|Subject/guardian decision|1|||
46973126|NCT01988662|83216906|FG001|Overall Study|Subject/guardian decision|1|||
46973127|NCT01988662|83216905|FG000|Overall Study|Adverse Event|3|||
46973128|NCT01988662|83216906|FG001|Overall Study|Adverse Event|1|||
46973129|NCT02839343|83216915|FG000|Overall Study|Withdrawal by Subject|3|||
46973130|NCT02839343|83216916|FG001|Overall Study|Withdrawal by Subject|1|||
46973131|NCT02839343|83216915|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
46973132|NCT02839343|83216916|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
46851886|NCT00075764|83067400|FG000|Overall Study|Still on treatment|8|||
46851887|NCT00075764|83067401|FG001|Overall Study|Still on treatment|15|||
46787382|NCT00642018|83006470|FG000|Overall Study|Withdrawal by Subject|4|||
46787383|NCT00642018|83006471|FG001|Overall Study|Withdrawal by Subject|10|||
46787384|NCT00642018|83006470|FG000|Overall Study|Progressive Disease|13|||
46787385|NCT00642018|83006471|FG001|Overall Study|Progressive Disease|18|||
46787386|NCT00642018|83006470|FG000|Overall Study|Physician Decision|0|||
46787387|NCT00642018|83006471|FG001|Overall Study|Physician Decision|10|||
46787388|NCT00642018|83006470|FG000|Overall Study|Protocol Violation|0|||
46787389|NCT00642018|83006471|FG001|Overall Study|Protocol Violation|1|||
46787390|NCT00642018|83006470|FG000|Overall Study|Death|0|||
46787391|NCT00642018|83006471|FG001|Overall Study|Death|3|||
46787392|NCT00642018|83006470|FG000|Overall Study|Entry Criteria Not Met|0|||
46787393|NCT00642018|83006471|FG001|Overall Study|Entry Criteria Not Met|1|||
46787394|NCT00532948|83006481|FG000|Overall Study|Protocol Violation|1|||
46787395|NCT00532948|83006482|FG001|Overall Study|Protocol Violation|0|||
46787396|NCT00532948|83006483|FG002|Overall Study|Protocol Violation|0|||
46787397|NCT00532948|83006481|FG000|Overall Study|Death|3|||
46787398|NCT00532948|83006482|FG001|Overall Study|Death|3|||
46787399|NCT00532948|83006483|FG002|Overall Study|Death|4|||
46787400|NCT00532948|83006481|FG000|Overall Study|Violation of selection criteria at entry|0|||
46787401|NCT00532948|83006482|FG001|Overall Study|Violation of selection criteria at entry|1|||
46787402|NCT00532948|83006483|FG002|Overall Study|Violation of selection criteria at entry|0|||
46787403|NCT00532948|83006481|FG000|Overall Study|Failure to return|0|||
46787404|NCT00532948|83006482|FG001|Overall Study|Failure to return|1|||
46787405|NCT00532948|83006483|FG002|Overall Study|Failure to return|0|||
46787406|NCT00641706|83006497|FG000|Overall Study|Adverse Event|2|||
46787407|NCT00641706|83006498|FG001|Overall Study|Adverse Event|1|||
46787408|NCT00641706|83006497|FG000|Overall Study|Withdrawal by Subject|6|||
46787409|NCT00641706|83006498|FG001|Overall Study|Withdrawal by Subject|1|||
46787410|NCT00641706|83006497|FG000|Overall Study|Clinical Decline|1|||
46787411|NCT00641706|83006498|FG001|Overall Study|Clinical Decline|0|||
46787412|NCT00641706|83006497|FG000|Overall Study|Lead Investigator Decision|0|||
46787413|NCT00641706|83006498|FG001|Overall Study|Lead Investigator Decision|1|||
46787414|NCT00644358|83006504|FG000|Overall Study|Adverse Event|124|||
46787415|NCT00644358|83006504|FG000|Overall Study|Lost to Follow-up|105|||
46787416|NCT00644358|83006504|FG000|Overall Study|Consent Withdrawal|64|||
46787417|NCT00644358|83006504|FG000|Overall Study|Lack of Effectiveness|39|||
46787418|NCT00644358|83006504|FG000|Overall Study|Protocol Violation|5|||
46787419|NCT00644358|83006504|FG000|Overall Study|Noncompliance|14|||
46787420|NCT00644358|83006504|FG000|Overall Study|Other Unspecified|11|||
46787421|NCT00640926|83006511|FG000|Overall Study|Adverse Event|2|||
46787422|NCT00640926|83006512|FG001|Overall Study|Adverse Event|3|||
46787423|NCT00640926|83006513|FG002|Overall Study|Adverse Event|2|||
46787424|NCT00640926|83006511|FG000|Overall Study|Lack of Efficacy|0|||
46787425|NCT00640926|83006512|FG001|Overall Study|Lack of Efficacy|2|||
46787426|NCT00640926|83006513|FG002|Overall Study|Lack of Efficacy|1|||
46787427|NCT00640926|83006511|FG000|Overall Study|Protocol Violation|2|||
46787428|NCT00640926|83006512|FG001|Overall Study|Protocol Violation|0|||
46787429|NCT00640926|83006513|FG002|Overall Study|Protocol Violation|2|||
46787430|NCT00640926|83006511|FG000|Overall Study|Lost to Follow-up|3|||
46787431|NCT00640926|83006512|FG001|Overall Study|Lost to Follow-up|1|||
46787432|NCT00640926|83006513|FG002|Overall Study|Lost to Follow-up|2|||
46787433|NCT00640926|83006511|FG000|Overall Study|Withdrawal by Subject|1|||
46787434|NCT00640926|83006512|FG001|Overall Study|Withdrawal by Subject|0|||
46787435|NCT00640926|83006513|FG002|Overall Study|Withdrawal by Subject|1|||
46787436|NCT03892564|83006521|FG000|Overall Study|Withdrawal by Subject|2|||
46787437|NCT03891862|83006528|FG000|Open-label Period|Adverse Event|2|||
46787438|NCT03891862|83006529|FG001|Open-label Period|Adverse Event|0|||
46787439|NCT03891862|83006530|FG002|Open-label Period|Adverse Event|0|||
46787440|NCT03891862|83006528|FG000|Open-label Period|Protocol Violation|5|||
46787441|NCT03891862|83006529|FG001|Open-label Period|Protocol Violation|0|||
46787442|NCT03891862|83006530|FG002|Open-label Period|Protocol Violation|0|||
46787443|NCT03891862|83006528|FG000|Open-label Period|Withdrawal by Subject|6|||
46787444|NCT03891862|83006529|FG001|Open-label Period|Withdrawal by Subject|0|||
46787445|NCT03891862|83006530|FG002|Open-label Period|Withdrawal by Subject|0|||
46787446|NCT03891862|83006528|FG000|Open-label Period|Death|1|||
46787447|NCT03891862|83006529|FG001|Open-label Period|Death|0|||
46973133|NCT02839343|83216915|FG000|Overall Study|Adverse Event|1|||
46787448|NCT03891862|83006530|FG002|Open-label Period|Death|0|||
46787449|NCT03891862|83006528|FG000|Open-label Period|Lost to Follow-up|2|||
46787450|NCT03891862|83006529|FG001|Open-label Period|Lost to Follow-up|0|||
46787451|NCT03891862|83006530|FG002|Open-label Period|Lost to Follow-up|0|||
46787452|NCT03891862|83006528|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
46787453|NCT03891862|83006529|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
46787454|NCT03891862|83006530|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
46787455|NCT03891862|83006528|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
46787456|NCT03891862|83006529|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
46787457|NCT03891862|83006530|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
46673166|NCT01214629|82888818|FG000|Overall Study|Physician Decision|0|||
46673167|NCT01214629|82888819|FG001|Overall Study|Physician Decision|0|||
46673168|NCT01214629|82888820|FG002|Overall Study|Physician Decision|0|||
46673169|NCT01214629|82888821|FG003|Overall Study|Physician Decision|0|||
46673170|NCT01214629|82888822|FG004|Overall Study|Physician Decision|0|||
46673171|NCT01214629|82888823|FG005|Overall Study|Physician Decision|0|||
46673172|NCT01214629|82888824|FG006|Overall Study|Physician Decision|0|||
46673173|NCT01214629|82888825|FG007|Overall Study|Physician Decision|0|||
46673174|NCT01214629|82888826|FG008|Overall Study|Physician Decision|0|||
46673175|NCT01214629|82888827|FG009|Overall Study|Physician Decision|0|||
46673176|NCT01214629|82888828|FG010|Overall Study|Physician Decision|1|||
46673177|NCT01214629|82888818|FG000|Overall Study|Withdrawal by Subject|0|||
46673178|NCT01214629|82888819|FG001|Overall Study|Withdrawal by Subject|0|||
46787458|NCT03891862|83006528|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
46787459|NCT03891862|83006529|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
46787460|NCT03891862|83006530|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
46787461|NCT03891862|83006528|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
46787462|NCT03891862|83006529|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
46787463|NCT03891862|83006530|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
46787464|NCT00640614|83006539|FG000|Overall Study|Lost to Follow-up|1|||
46787465|NCT00640614|83006540|FG001|Overall Study|Lost to Follow-up|0|||
46787466|NCT00761657|83006578|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
46787467|NCT00761657|83006579|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
46787468|NCT00761657|83006580|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
46787469|NCT00761657|83006581|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
46787470|NCT00761657|83006582|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
46787471|NCT00761657|83006583|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
46787472|NCT00761657|83006584|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
46787473|NCT00761657|83006585|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
46787474|NCT00761657|83006586|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
46787475|NCT00761657|83006578|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
46787476|NCT00761657|83006579|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
46787477|NCT00761657|83006580|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
46787478|NCT00761657|83006581|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
46787479|NCT00761657|83006582|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
46787480|NCT00761657|83006583|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
46851888|NCT00075764|83067400|FG000|Overall Study|Delinquent|4|||
46851889|NCT00075764|83067401|FG001|Overall Study|Delinquent|2|||
46851890|NCT00075764|83067400|FG000|Overall Study|Not protocol specified|27|||
46851891|NCT00075764|83067401|FG001|Overall Study|Not protocol specified|19|||
46851892|NCT00075764|83067400|FG000|Overall Study|Under review|0|||
46851893|NCT00075764|83067401|FG001|Overall Study|Under review|1|||
46851894|NCT03568162|83067415|FG000|Overall Study|Adverse Event|0|||
46851895|NCT03568162|83067416|FG001|Overall Study|Adverse Event|1|||
46851896|NCT03568162|83067417|FG002|Overall Study|Adverse Event|2|||
46851897|NCT03568162|83067418|FG003|Overall Study|Adverse Event|0|||
46851898|NCT03568162|83067419|FG004|Overall Study|Adverse Event|0|||
46851899|NCT03568162|83067420|FG005|Overall Study|Adverse Event|1|||
46851900|NCT03568162|83067415|FG000|Overall Study|Death|0|||
46851901|NCT03568162|83067416|FG001|Overall Study|Death|0|||
46973134|NCT02839343|83216916|FG001|Overall Study|Adverse Event|0|||
46673179|NCT01214629|82888820|FG002|Overall Study|Withdrawal by Subject|0|||
46673180|NCT01214629|82888821|FG003|Overall Study|Withdrawal by Subject|0|||
46673181|NCT01214629|82888822|FG004|Overall Study|Withdrawal by Subject|0|||
46673182|NCT01214629|82888823|FG005|Overall Study|Withdrawal by Subject|0|||
46673183|NCT01214629|82888824|FG006|Overall Study|Withdrawal by Subject|0|||
46673184|NCT01214629|82888825|FG007|Overall Study|Withdrawal by Subject|0|||
46673185|NCT01214629|82888826|FG008|Overall Study|Withdrawal by Subject|0|||
46673186|NCT01214629|82888827|FG009|Overall Study|Withdrawal by Subject|1|||
46673187|NCT01214629|82888828|FG010|Overall Study|Withdrawal by Subject|0|||
46673188|NCT01214434|82888868|FG000|Overall Study|Withdrawal by Subject|1|||
46673189|NCT01214434|82888869|FG001|Overall Study|Withdrawal by Subject|0|||
46673190|NCT01214434|82888868|FG000|Overall Study|Lost to Follow-up|2|||
46673191|NCT01214434|82888869|FG001|Overall Study|Lost to Follow-up|2|||
46787481|NCT00761657|83006584|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
46787482|NCT00761657|83006585|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
46787483|NCT00761657|83006586|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
46851902|NCT03568162|83067417|FG002|Overall Study|Death|0|||
46851903|NCT03568162|83067418|FG003|Overall Study|Death|0|||
46851904|NCT03568162|83067419|FG004|Overall Study|Death|1|||
46851905|NCT03568162|83067420|FG005|Overall Study|Death|0|||
46851906|NCT03568162|83067415|FG000|Overall Study|Lost to Follow-up|3|||
46851907|NCT03568162|83067416|FG001|Overall Study|Lost to Follow-up|2|||
46973135|NCT01965652|83216945|FG000|Overall Study|Adverse Event|40|||
46973136|NCT01965652|83216946|FG001|Overall Study|Adverse Event|37|||
46673192|NCT01214434|82888868|FG000|Overall Study|Site error|1|||
46851908|NCT03568162|83067417|FG002|Overall Study|Lost to Follow-up|4|||
46851909|NCT03568162|83067418|FG003|Overall Study|Lost to Follow-up|2|||
46851910|NCT03568162|83067419|FG004|Overall Study|Lost to Follow-up|3|||
46851911|NCT03568162|83067420|FG005|Overall Study|Lost to Follow-up|2|||
46851912|NCT03568162|83067415|FG000|Overall Study|Physician Decision|0|||
46851913|NCT03568162|83067416|FG001|Overall Study|Physician Decision|1|||
46851914|NCT03568162|83067417|FG002|Overall Study|Physician Decision|1|||
46851915|NCT03568162|83067418|FG003|Overall Study|Physician Decision|0|||
46851916|NCT03568162|83067419|FG004|Overall Study|Physician Decision|1|||
46851917|NCT03568162|83067420|FG005|Overall Study|Physician Decision|0|||
46851918|NCT03568162|83067415|FG000|Overall Study|Pregnancy|0|||
46851919|NCT03568162|83067416|FG001|Overall Study|Pregnancy|0|||
46851920|NCT03568162|83067417|FG002|Overall Study|Pregnancy|0|||
46851921|NCT03568162|83067418|FG003|Overall Study|Pregnancy|1|||
46851922|NCT03568162|83067419|FG004|Overall Study|Pregnancy|0|||
46851923|NCT03568162|83067420|FG005|Overall Study|Pregnancy|0|||
46851924|NCT03568162|83067415|FG000|Overall Study|Protocol Violation|1|||
46851925|NCT03568162|83067416|FG001|Overall Study|Protocol Violation|0|||
46851926|NCT03568162|83067417|FG002|Overall Study|Protocol Violation|1|||
46851927|NCT03568162|83067418|FG003|Overall Study|Protocol Violation|1|||
46851928|NCT03568162|83067419|FG004|Overall Study|Protocol Violation|1|||
46851929|NCT03568162|83067420|FG005|Overall Study|Protocol Violation|1|||
46851930|NCT03568162|83067415|FG000|Overall Study|Withdrawal by Subject|15|||
46851931|NCT03568162|83067416|FG001|Overall Study|Withdrawal by Subject|15|||
46851932|NCT03568162|83067417|FG002|Overall Study|Withdrawal by Subject|26|||
46851933|NCT03568162|83067418|FG003|Overall Study|Withdrawal by Subject|22|||
46851934|NCT03568162|83067419|FG004|Overall Study|Withdrawal by Subject|6|||
46851935|NCT03568162|83067420|FG005|Overall Study|Withdrawal by Subject|9|||
46851936|NCT03568162|83067415|FG000|Overall Study|Others|3|||
46851937|NCT03568162|83067416|FG001|Overall Study|Others|4|||
46851938|NCT03568162|83067417|FG002|Overall Study|Others|1|||
46973137|NCT01965652|83216945|FG000|Overall Study|Withdrawal by Subject|62|||
46673193|NCT01214434|82888869|FG001|Overall Study|Site error|0|||
46673194|NCT01214395|82888875|FG000|Overall Study|All patients had infection|5|||
46673195|NCT01214239|82888882|FG000|Overall Study|Adverse Event|3|||
46673196|NCT01214239|82888883|FG001|Overall Study|Adverse Event|4|||
46673197|NCT01214239|82888882|FG000|Overall Study|Protocol Violation|2|||
46673198|NCT01214239|82888883|FG001|Overall Study|Protocol Violation|1|||
46673199|NCT01214239|82888882|FG000|Overall Study|Lost to Follow-up|1|||
46673200|NCT01214239|82888883|FG001|Overall Study|Lost to Follow-up|1|||
46673201|NCT01214239|82888882|FG000|Overall Study|Withdrawal by Subject|4|||
46673202|NCT01214239|82888883|FG001|Overall Study|Withdrawal by Subject|9|||
46673203|NCT01214239|82888882|FG000|Overall Study|Lack of Efficacy|1|||
46673204|NCT01214239|82888883|FG001|Overall Study|Lack of Efficacy|2|||
46673205|NCT01214239|82888882|FG000|Overall Study|patient's private reason|1|||
46673206|NCT01214239|82888883|FG001|Overall Study|patient's private reason|1|||
46673207|NCT01214200|82888889|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
46673208|NCT01214200|82888889|FG000|Overall Study|Withdrawal by Subject|2|||
46673209|NCT01214044|82888895|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
46673210|NCT01214044|82888895|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
46673211|NCT01214044|82888895|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
46673212|NCT01214044|82888895|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
46673213|NCT01214044|82888895|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
46673214|NCT01214044|82888895|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
46673215|NCT01213966|82888907|FG000|Overall Study|Protocol Violation|1|||
46673216|NCT01213966|82888908|FG001|Overall Study|Protocol Violation|0|||
46673217|NCT01213966|82888909|FG002|Overall Study|Protocol Violation|3|||
46973138|NCT01965652|83216946|FG001|Overall Study|Withdrawal by Subject|69|||
46851939|NCT03568162|83067418|FG003|Overall Study|Others|4|||
46851940|NCT03568162|83067419|FG004|Overall Study|Others|2|||
46851941|NCT03568162|83067420|FG005|Overall Study|Others|1|||
46851942|NCT03567616|83067439|FG000|Overall Study|Disease progression|4|||
46851943|NCT03567616|83067439|FG000|Overall Study|Withdrawal by Subject|1|||
46851944|NCT03567616|83067439|FG000|Overall Study|Physician Decision|1|||
46851945|NCT03567616|83067439|FG000|Overall Study|Death|1|||
46851946|NCT03567616|83067439|FG000|Overall Study|Adverse Event|1|||
46851947|NCT03567382|83067448|FG000|Overall Study|Lost to Follow-up|1|||
46673218|NCT01213966|82888910|FG003|Overall Study|Protocol Violation|1|||
46851948|NCT03567382|83067449|FG001|Overall Study|Lost to Follow-up|21|||
46851949|NCT03567382|83067450|FG002|Overall Study|Lost to Follow-up|1|||
46851950|NCT03567382|83067451|FG003|Overall Study|Lost to Follow-up|21|||
46851951|NCT03567382|83067448|FG000|Overall Study|Withdrawal by Subject|2|||
46851952|NCT03567382|83067449|FG001|Overall Study|Withdrawal by Subject|14|||
46851953|NCT03567382|83067450|FG002|Overall Study|Withdrawal by Subject|1|||
46851954|NCT03567382|83067451|FG003|Overall Study|Withdrawal by Subject|12|||
46851955|NCT03595384|83067462|FG000|Overall Study|Other time commitments|8|||
46851956|NCT03595384|83067462|FG000|Overall Study|Changes to session time|7|||
46851957|NCT03595384|83067462|FG000|Overall Study|Relocation out of country|1|||
46851958|NCT03591874|83067468|FG000|Overall Study|Adverse Event|4|||
46851959|NCT03591874|83067469|FG001|Overall Study|Adverse Event|0|||
46851960|NCT03591874|83067468|FG000|Overall Study|Withdrawal by Subject|2|||
46851961|NCT03591874|83067469|FG001|Overall Study|Withdrawal by Subject|1|||
46851962|NCT03591874|83067468|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
46851963|NCT03591874|83067469|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
46851964|NCT03591874|83067468|FG000|Overall Study|On Study at Time of Study Termination|12|||
46851965|NCT03591874|83067469|FG001|Overall Study|On Study at Time of Study Termination|6|||
46851966|NCT03566680|83067475|FG000|Overall Study|Pregnancy|1|||
46851967|NCT03566680|83067475|FG000|Overall Study|Lost to Follow-up|13|||
46851968|NCT03566680|83067475|FG000|Overall Study|Withdrawal by Subject|3|||
47077672|NCT04027608|83380258|FG000|Overall Study|Physician Decision|1|||
47077673|NCT04027608|83380259|FG001|Overall Study|Physician Decision|0|||
47077674|NCT04027608|83380258|FG000|Overall Study|Lost to Follow-up|20|||
47077675|NCT04027608|83380259|FG001|Overall Study|Lost to Follow-up|4|||
46673219|NCT01213264|82888923|FG000|Overall Study|Adverse Event|1|||
46673220|NCT01213264|82888924|FG001|Overall Study|Adverse Event|0|||
46673221|NCT01213264|82888925|FG002|Overall Study|Adverse Event|0|||
46673222|NCT01213264|82888923|FG000|Overall Study|Lost to Follow-up|1|||
46673223|NCT01213264|82888924|FG001|Overall Study|Lost to Follow-up|2|||
46673224|NCT01213264|82888925|FG002|Overall Study|Lost to Follow-up|6|||
46673225|NCT01212991|82888938|FG000|Double-blind|Lost to Follow-up|8|||
46673226|NCT01212991|82888939|FG001|Double-blind|Lost to Follow-up|4|||
46673227|NCT01212991|82888940|FG002|Double-blind|Lost to Follow-up|0|||
46673228|NCT01212991|82888938|FG000|Double-blind|Death|699|||
46673229|NCT01212991|82888939|FG001|Double-blind|Death|550|||
46673230|NCT01212991|82888940|FG002|Double-blind|Death|0|||
46673231|NCT01212991|82888938|FG000|Double-blind|Withdrawal by Subject|16|||
46673232|NCT01212991|82888939|FG001|Double-blind|Withdrawal by Subject|19|||
46673233|NCT01212991|82888940|FG002|Double-blind|Withdrawal by Subject|0|||
46673234|NCT01212991|82888938|FG000|Double-blind|Other|7|||
46673235|NCT01212991|82888939|FG001|Double-blind|Other|0|||
46673236|NCT01212991|82888940|FG002|Double-blind|Other|0|||
46673237|NCT01212991|82888938|FG000|Double-blind|Sponsor decision|142|||
46673238|NCT01212991|82888939|FG001|Double-blind|Sponsor decision|38|||
46787484|NCT00761657|83006578|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
46787485|NCT00761657|83006579|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
46787486|NCT00761657|83006580|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
46787487|NCT00761657|83006581|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
46787488|NCT00761657|83006582|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
46787489|NCT00761657|83006583|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
46787490|NCT00761657|83006584|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
46787491|NCT00761657|83006585|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
46787492|NCT00761657|83006586|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
46787493|NCT00761657|83006578|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
46787494|NCT00761657|83006579|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
46787495|NCT00761657|83006580|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
46787496|NCT00761657|83006581|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
46787497|NCT00761657|83006582|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
46787498|NCT00761657|83006583|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
46787499|NCT00761657|83006584|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
46787500|NCT00761657|83006585|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
46787501|NCT00761657|83006586|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
46787502|NCT00319501|83006618|FG000|Double-blind Period|Withdrawal by Subject|0|||
46787503|NCT00319501|83006619|FG001|Double-blind Period|Withdrawal by Subject|3|||
46787504|NCT00319501|83006618|FG000|Double-blind Period|Sponsor Request|1|||
46787505|NCT00319501|83006619|FG001|Double-blind Period|Sponsor Request|0|||
46787506|NCT00319501|83006618|FG000|Double-blind Period|Did not receive treatment|42|||
46787507|NCT00319501|83006619|FG001|Double-blind Period|Did not receive treatment|29|||
46787508|NCT00319501|83006618|FG000|Open-label Period|Adverse Event|5|||
46787509|NCT00319501|83006619|FG001|Open-label Period|Adverse Event|0|||
46787510|NCT00319501|83006618|FG000|Open-label Period|Protocol Violation|6|||
46787511|NCT00319501|83006619|FG001|Open-label Period|Protocol Violation|0|||
46787512|NCT00319501|83006618|FG000|Open-label Period|Withdrawal by Subject|38|||
46787513|NCT00319501|83006619|FG001|Open-label Period|Withdrawal by Subject|0|||
46851969|NCT00106353|83067481|FG000|Part 1|Disease progression|3|||
47077676|NCT01664052|83380350|FG000|Phase 1|No device placement|6|||
46673239|NCT01212991|82888940|FG002|Double-blind|Sponsor decision|0|||
46673240|NCT01212991|82888938|FG000|Open-label|Death|0|||
46851970|NCT00106353|83067482|FG001|Part 1|Disease progression|4|||
47077677|NCT01664052|83380351|FG001|Phase 1|No device placement|0|||
46851971|NCT00106353|83067483|FG002|Part 1|Disease progression|1|||
46851972|NCT00106353|83067484|FG003|Part 1|Disease progression|3|||
46851973|NCT00106353|83067485|FG004|Part 1|Disease progression|0|||
46851974|NCT00106353|83067486|FG005|Part 1|Disease progression|0|||
46851975|NCT00106353|83067487|FG006|Part 1|Disease progression|0|||
46851976|NCT00106353|83067481|FG000|Part 1|Withdrawal by Subject|0|||
46851977|NCT00106353|83067482|FG001|Part 1|Withdrawal by Subject|0|||
46851978|NCT00106353|83067483|FG002|Part 1|Withdrawal by Subject|1|||
46851979|NCT00106353|83067484|FG003|Part 1|Withdrawal by Subject|2|||
46851980|NCT00106353|83067485|FG004|Part 1|Withdrawal by Subject|0|||
46851981|NCT00106353|83067486|FG005|Part 1|Withdrawal by Subject|0|||
46851982|NCT00106353|83067487|FG006|Part 1|Withdrawal by Subject|0|||
46851983|NCT00106353|83067481|FG000|Part 1|Symptomatic deterioration|0|||
46851984|NCT00106353|83067482|FG001|Part 1|Symptomatic deterioration|0|||
46851985|NCT00106353|83067483|FG002|Part 1|Symptomatic deterioration|1|||
46851986|NCT00106353|83067484|FG003|Part 1|Symptomatic deterioration|0|||
46851987|NCT00106353|83067485|FG004|Part 1|Symptomatic deterioration|0|||
46851988|NCT00106353|83067486|FG005|Part 1|Symptomatic deterioration|0|||
46851989|NCT00106353|83067487|FG006|Part 1|Symptomatic deterioration|0|||
46851990|NCT00106353|83067481|FG000|Part 1|Entered follow-up phase|1|||
46851991|NCT00106353|83067482|FG001|Part 1|Entered follow-up phase|1|||
46851992|NCT00106353|83067483|FG002|Part 1|Entered follow-up phase|0|||
46851993|NCT00106353|83067484|FG003|Part 1|Entered follow-up phase|1|||
46851994|NCT00106353|83067485|FG004|Part 1|Entered follow-up phase|0|||
46851995|NCT00106353|83067486|FG005|Part 1|Entered follow-up phase|0|||
46851996|NCT00106353|83067487|FG006|Part 1|Entered follow-up phase|0|||
46851997|NCT00106353|83067481|FG000|Part 1|Adverse Event|0|||
46851998|NCT00106353|83067482|FG001|Part 1|Adverse Event|0|||
46851999|NCT00106353|83067483|FG002|Part 1|Adverse Event|0|||
46852000|NCT00106353|83067484|FG003|Part 1|Adverse Event|1|||
46852001|NCT00106353|83067485|FG004|Part 1|Adverse Event|0|||
46852002|NCT00106353|83067486|FG005|Part 1|Adverse Event|0|||
46852003|NCT00106353|83067487|FG006|Part 1|Adverse Event|0|||
46852004|NCT00106353|83067481|FG000|Part 2|Disease progression|0|||
46852005|NCT00106353|83067482|FG001|Part 2|Disease progression|0|||
46852006|NCT00106353|83067483|FG002|Part 2|Disease progression|0|||
46852007|NCT00106353|83067484|FG003|Part 2|Disease progression|0|||
46852008|NCT00106353|83067485|FG004|Part 2|Disease progression|8|||
46852009|NCT00106353|83067486|FG005|Part 2|Disease progression|14|||
46852010|NCT00106353|83067487|FG006|Part 2|Disease progression|13|||
46852011|NCT00106353|83067481|FG000|Part 2|Death|0|||
46852012|NCT00106353|83067482|FG001|Part 2|Death|0|||
46852013|NCT00106353|83067483|FG002|Part 2|Death|0|||
46852014|NCT00106353|83067484|FG003|Part 2|Death|0|||
46852015|NCT00106353|83067485|FG004|Part 2|Death|3|||
46852016|NCT00106353|83067486|FG005|Part 2|Death|0|||
46852017|NCT00106353|83067487|FG006|Part 2|Death|1|||
46852018|NCT00106353|83067481|FG000|Part 2|Symptomatic deterioration|0|||
46852019|NCT00106353|83067482|FG001|Part 2|Symptomatic deterioration|0|||
46852020|NCT00106353|83067483|FG002|Part 2|Symptomatic deterioration|0|||
46852021|NCT00106353|83067484|FG003|Part 2|Symptomatic deterioration|0|||
46852022|NCT00106353|83067485|FG004|Part 2|Symptomatic deterioration|3|||
46852023|NCT00106353|83067486|FG005|Part 2|Symptomatic deterioration|0|||
46852024|NCT00106353|83067487|FG006|Part 2|Symptomatic deterioration|0|||
46852025|NCT00106353|83067481|FG000|Part 2|Adverse Event|0|||
46852026|NCT00106353|83067482|FG001|Part 2|Adverse Event|0|||
46852027|NCT00106353|83067483|FG002|Part 2|Adverse Event|0|||
46852028|NCT00106353|83067484|FG003|Part 2|Adverse Event|0|||
46852029|NCT00106353|83067485|FG004|Part 2|Adverse Event|0|||
46852030|NCT00106353|83067486|FG005|Part 2|Adverse Event|2|||
46973139|NCT01965652|83216945|FG000|Overall Study|Lost to Follow-up|53|||
46852031|NCT00106353|83067487|FG006|Part 2|Adverse Event|1|||
46852032|NCT00106353|83067481|FG000|Part 2|Other|0|||
46852033|NCT00106353|83067482|FG001|Part 2|Other|0|||
46852034|NCT00106353|83067483|FG002|Part 2|Other|0|||
46852035|NCT00106353|83067484|FG003|Part 2|Other|0|||
46852036|NCT00106353|83067485|FG004|Part 2|Other|1|||
46673241|NCT01212991|82888939|FG001|Open-label|Death|0|||
46852037|NCT00106353|83067486|FG005|Part 2|Other|1|||
46852038|NCT00106353|83067487|FG006|Part 2|Other|1|||
46852039|NCT00106353|83067481|FG000|Part 2|Withdrawal by Subject|0|||
46852040|NCT00106353|83067482|FG001|Part 2|Withdrawal by Subject|0|||
46852041|NCT00106353|83067483|FG002|Part 2|Withdrawal by Subject|0|||
46852042|NCT00106353|83067484|FG003|Part 2|Withdrawal by Subject|0|||
46852043|NCT00106353|83067485|FG004|Part 2|Withdrawal by Subject|1|||
46852044|NCT00106353|83067486|FG005|Part 2|Withdrawal by Subject|0|||
46852045|NCT00106353|83067487|FG006|Part 2|Withdrawal by Subject|0|||
46852046|NCT00106353|83067481|FG000|Part 2|Physician Decision|0|||
46852047|NCT00106353|83067482|FG001|Part 2|Physician Decision|0|||
46852048|NCT00106353|83067483|FG002|Part 2|Physician Decision|0|||
46852049|NCT00106353|83067484|FG003|Part 2|Physician Decision|0|||
46852050|NCT00106353|83067485|FG004|Part 2|Physician Decision|0|||
46852051|NCT00106353|83067486|FG005|Part 2|Physician Decision|1|||
46852052|NCT00106353|83067487|FG006|Part 2|Physician Decision|0|||
46852053|NCT00080301|83067510|FG000|Overall Study|Randomized but Never Treated|5|||
46852054|NCT00080301|83067511|FG001|Overall Study|Randomized but Never Treated|10|||
46852055|NCT00080301|83067510|FG000|Overall Study|Still on Treatment as of CSR date|0|||
46852056|NCT00080301|83067511|FG001|Overall Study|Still on Treatment as of CSR date|1|||
46852057|NCT00079677|83067520|FG000|Overall Study|Adverse Event|5|||
46852058|NCT00079677|83067521|FG001|Overall Study|Adverse Event|6|||
46852059|NCT00079677|83067520|FG000|Overall Study|Lack of Efficacy|1|||
46852060|NCT00079677|83067521|FG001|Overall Study|Lack of Efficacy|0|||
46852061|NCT00079677|83067520|FG000|Overall Study|Lost to Follow-up|2|||
46852062|NCT00079677|83067521|FG001|Overall Study|Lost to Follow-up|2|||
46852063|NCT00079677|83067520|FG000|Overall Study|Physician Decision|3|||
46852064|NCT00079677|83067521|FG001|Overall Study|Physician Decision|0|||
46852065|NCT00079677|83067520|FG000|Overall Study|Protocol Violation|2|||
46852066|NCT00079677|83067521|FG001|Overall Study|Protocol Violation|3|||
46852067|NCT00079677|83067520|FG000|Overall Study|Withdrawal by Subject|5|||
46852068|NCT00079677|83067521|FG001|Overall Study|Withdrawal by Subject|3|||
46852069|NCT00079677|83067520|FG000|Overall Study|Miscellaneous|2|||
46852070|NCT00079677|83067521|FG001|Overall Study|Miscellaneous|0|||
46852071|NCT00095121|83067529|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
46852072|NCT00095121|83067530|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
46852073|NCT00095121|83067529|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
46852074|NCT00095121|83067530|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
46852075|NCT00094809|83067548|FG000|Overall Study|Protocol deviation|2|||
46852076|NCT00094809|83067549|FG001|Overall Study|Protocol deviation|2|||
46852077|NCT00094809|83067548|FG000|Overall Study|Noncompliance|1|||
46852078|NCT00094809|83067549|FG001|Overall Study|Noncompliance|0|||
46852079|NCT00094809|83067548|FG000|Overall Study|Adverse Event|3|||
46852080|NCT00094809|83067549|FG001|Overall Study|Adverse Event|1|||
46852081|NCT00094809|83067548|FG000|Overall Study|Withdrawal by Subject|8|||
46852082|NCT00094809|83067549|FG001|Overall Study|Withdrawal by Subject|9|||
46852083|NCT00094809|83067548|FG000|Overall Study|Disease progression|3|||
46852084|NCT00094809|83067549|FG001|Overall Study|Disease progression|3|||
46852085|NCT00094809|83067548|FG000|Overall Study|Physician Decision|3|||
46852086|NCT00094809|83067549|FG001|Overall Study|Physician Decision|5|||
46852087|NCT00094809|83067548|FG000|Overall Study|Lost to Follow-up|6|||
46852088|NCT00094809|83067549|FG001|Overall Study|Lost to Follow-up|6|||
46973140|NCT01965652|83216946|FG001|Overall Study|Lost to Follow-up|40|||
47077678|NCT01664052|83380350|FG000|Phase 1|No HSG 1 hr post placement|1|||
46787514|NCT00319501|83006618|FG000|Open-label Period|Principal Investigator decision|6|||
46787515|NCT00319501|83006619|FG001|Open-label Period|Principal Investigator decision|0|||
46787516|NCT00319501|83006618|FG000|Open-label Period|Sponsor request|12|||
46787517|NCT00319501|83006619|FG001|Open-label Period|Sponsor request|0|||
46787518|NCT00319501|83006618|FG000|Open-label Period|Lost to Follow-up|5|||
46787519|NCT00319501|83006619|FG001|Open-label Period|Lost to Follow-up|0|||
46787520|NCT00319501|83006618|FG000|Open-label Period|Did not receive treatment|33|||
46787521|NCT00319501|83006619|FG001|Open-label Period|Did not receive treatment|0|||
46787522|NCT00319501|83006618|FG000|Open-label Period|Other|11|||
46787523|NCT00319501|83006619|FG001|Open-label Period|Other|0|||
46787524|NCT00319501|83006618|FG000|Open-label Extension Period|Adverse Event|2|||
46787525|NCT00319501|83006619|FG001|Open-label Extension Period|Adverse Event|0|||
46787526|NCT00319501|83006618|FG000|Open-label Extension Period|Did not receive treatment|18|||
46787527|NCT00319501|83006619|FG001|Open-label Extension Period|Did not receive treatment|0|||
46787528|NCT00319501|83006618|FG000|Open-label Extension Period|Other|1|||
46787529|NCT00319501|83006619|FG001|Open-label Extension Period|Other|0|||
46973141|NCT01965652|83216945|FG000|Overall Study|Protocol Violation|34|||
47077679|NCT01664052|83380351|FG001|Phase 1|No HSG 1 hr post placement|0|||
47077680|NCT01664052|83380350|FG000|Phase 2|No device placement|0|||
47077681|NCT01664052|83380351|FG001|Phase 2|No device placement|4|||
47077682|NCT01465802|83380398|FG000|Overall Study|Study terminated by sponsor|1|||
47077683|NCT01465802|83380399|FG001|Overall Study|Study terminated by sponsor|0|||
46787530|NCT00319501|83006618|FG000|Open-label Extension Period|Principal investigator decision|2|||
46787531|NCT00319501|83006619|FG001|Open-label Extension Period|Principal investigator decision|0|||
46852089|NCT00094809|83067548|FG000|Overall Study|Death|19|||
46787532|NCT00319501|83006618|FG000|Open-label Extension Period|Sponsor request|26|||
46852090|NCT00094809|83067549|FG001|Overall Study|Death|25|||
46852091|NCT00094809|83067548|FG000|Overall Study|Protocol-specified criteria|1|||
46852092|NCT00094809|83067549|FG001|Overall Study|Protocol-specified criteria|1|||
46852093|NCT00094809|83067548|FG000|Overall Study|Other|2|||
46852094|NCT00094809|83067549|FG001|Overall Study|Other|4|||
46852095|NCT00094809|83067548|FG000|Overall Study|Informed consent signed after treatment|1|||
46973142|NCT01965652|83216946|FG001|Overall Study|Protocol Violation|38|||
46973143|NCT01965652|83216945|FG000|Overall Study|Death|3|||
47077684|NCT01465802|83380400|FG002|Overall Study|Study terminated by sponsor|0|||
46973144|NCT01965652|83216946|FG001|Overall Study|Death|4|||
46852096|NCT00094809|83067549|FG001|Overall Study|Informed consent signed after treatment|0|||
46852097|NCT00094809|83067548|FG000|Overall Study|Study drug not received|2|||
46852098|NCT00094809|83067549|FG001|Overall Study|Study drug not received|8|||
46852099|NCT00094809|83067548|FG000|Overall Study|Other|1|||
46852100|NCT00094809|83067549|FG001|Overall Study|Other|1|||
46852101|NCT00075218|83067557|FG000|Double-Blind Treatment|Adverse Event|23|||
46852102|NCT00075218|83067558|FG001|Double-Blind Treatment|Adverse Event|4|||
46852103|NCT00075218|83067559|FG002|Double-Blind Treatment|Adverse Event|0|||
46852104|NCT00075218|83067557|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
46852105|NCT00075218|83067558|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
46852106|NCT00075218|83067559|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
46852107|NCT00075218|83067557|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
46852108|NCT00075218|83067558|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
46852109|NCT00075218|83067559|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
46852110|NCT00075218|83067557|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
46852111|NCT00075218|83067558|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
46673242|NCT01212991|82888940|FG002|Open-label|Death|166|||
46673243|NCT01212991|82888938|FG000|Open-label|Lost to Follow-up|0|||
46673244|NCT01212991|82888939|FG001|Open-label|Lost to Follow-up|0|||
46673245|NCT01212991|82888940|FG002|Open-label|Lost to Follow-up|5|||
46673246|NCT01212991|82888938|FG000|Open-label|Withdrawal by Subject|0|||
46673247|NCT01212991|82888939|FG001|Open-label|Withdrawal by Subject|0|||
46673248|NCT01212991|82888940|FG002|Open-label|Withdrawal by Subject|7|||
46673249|NCT01212991|82888938|FG000|Open-label|Sponsor decision|0|||
46673250|NCT01212991|82888939|FG001|Open-label|Sponsor decision|0|||
46673251|NCT01212991|82888940|FG002|Open-label|Sponsor decision|53|||
46852112|NCT00075218|83067559|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
46852113|NCT00075218|83067557|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
46852114|NCT00075218|83067558|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
46852115|NCT00075218|83067559|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
46673252|NCT01212991|82888938|FG000|Open-label|Other|0|||
46673253|NCT01212991|82888939|FG001|Open-label|Other|0|||
46673254|NCT01212991|82888940|FG002|Open-label|Other|3|||
46673255|NCT01212757|82888951|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
46673256|NCT01212757|82888952|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
46673257|NCT01212757|82888953|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
46673258|NCT01212757|82888954|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46673259|NCT01212757|82888955|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46673260|NCT01212757|82888956|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46673261|NCT01212757|82888957|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46973145|NCT01965652|83216945|FG000|Overall Study|Other - Miscellaneous|18|||
46973146|NCT01965652|83216946|FG001|Overall Study|Other - Miscellaneous|21|||
46973147|NCT01965652|83216945|FG000|Overall Study|Pregnancy|0|||
46973148|NCT01965652|83216946|FG001|Overall Study|Pregnancy|1|||
46973149|NCT01602965|83216954|FG000|Overall Study|Lost to Follow-up|4|||
46973150|NCT01602965|83216955|FG001|Overall Study|Lost to Follow-up|2|||
46973151|NCT01987960|83216963|FG000|Period 1|Adverse Event|24|||
46973152|NCT01987960|83216964|FG001|Period 1|Adverse Event|0|||
46973153|NCT01987960|83216965|FG002|Period 1|Adverse Event|0|||
46973154|NCT01987960|83216966|FG003|Period 1|Adverse Event|0|||
46973155|NCT01987960|83216963|FG000|Period 1|Lack of Efficacy|4|||
46973156|NCT01987960|83216964|FG001|Period 1|Lack of Efficacy|0|||
46973157|NCT01987960|83216965|FG002|Period 1|Lack of Efficacy|0|||
47077685|NCT01465802|83380401|FG003|Overall Study|Study terminated by sponsor|1|||
47077686|NCT01465802|83380402|FG004|Overall Study|Study terminated by sponsor|7|||
46673262|NCT01212757|82888958|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46673263|NCT01212757|82888959|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
46673264|NCT01212757|82888951|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
46673265|NCT01212757|82888952|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
46673266|NCT01212757|82888953|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
46673267|NCT01212757|82888954|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46673268|NCT01212757|82888955|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46673269|NCT01212757|82888956|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46673270|NCT01212757|82888957|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46673271|NCT01212757|82888958|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46973158|NCT01987960|83216966|FG003|Period 1|Lack of Efficacy|0|||
46973159|NCT01987960|83216963|FG000|Period 1|Non-compliance with IMP|6|||
46973160|NCT01987960|83216964|FG001|Period 1|Non-compliance with IMP|0|||
46973161|NCT01987960|83216965|FG002|Period 1|Non-compliance with IMP|0|||
46673272|NCT01212757|82888959|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
46852116|NCT00075218|83067557|FG000|Double-Blind Treatment|No study medication taken|2|||
46852117|NCT00075218|83067558|FG001|Double-Blind Treatment|No study medication taken|0|||
46852118|NCT00075218|83067559|FG002|Double-Blind Treatment|No study medication taken|0|||
46973162|NCT01987960|83216966|FG003|Period 1|Non-compliance with IMP|0|||
46973163|NCT01987960|83216963|FG000|Period 1|Protocol Violation|12|||
46973164|NCT01987960|83216964|FG001|Period 1|Protocol Violation|0|||
46673273|NCT01212757|82888951|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
46673274|NCT01212757|82888952|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
46673275|NCT01212757|82888953|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
46673276|NCT01212757|82888954|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46673277|NCT01212757|82888955|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46673278|NCT01212757|82888956|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46673279|NCT01212757|82888957|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46673280|NCT01212757|82888958|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46673281|NCT01212757|82888959|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
46852119|NCT00075218|83067557|FG000|Open-Label Treatment|Lack of Efficacy|0|||
46852120|NCT00075218|83067558|FG001|Open-Label Treatment|Lack of Efficacy|0|||
46852121|NCT00075218|83067559|FG002|Open-Label Treatment|Lack of Efficacy|174|||
46852122|NCT00075218|83067557|FG000|Open-Label Treatment|Adverse Event|0|||
46852123|NCT00075218|83067558|FG001|Open-Label Treatment|Adverse Event|0|||
46852124|NCT00075218|83067559|FG002|Open-Label Treatment|Adverse Event|51|||
46852125|NCT00075218|83067557|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
46852126|NCT00075218|83067558|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
46852127|NCT00075218|83067559|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
46673282|NCT01212757|82888951|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
46673283|NCT01212757|82888952|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46673284|NCT01212757|82888953|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
46673285|NCT01212757|82888954|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46673286|NCT01212757|82888955|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46673287|NCT01212757|82888956|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46673288|NCT01212757|82888957|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46673289|NCT01212757|82888958|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46673290|NCT01212757|82888959|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
46673291|NCT01212757|82888951|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
46673292|NCT01212757|82888952|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
46673293|NCT01212757|82888953|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
46673294|NCT01212757|82888954|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46673295|NCT01212757|82888955|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46673296|NCT01212757|82888956|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46673297|NCT01212757|82888957|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46673298|NCT01212757|82888958|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46673299|NCT01212757|82888959|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
46673300|NCT01212757|82888951|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46673301|NCT01212757|82888952|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
46673302|NCT01212757|82888953|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
46673303|NCT01212757|82888954|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46673304|NCT01212757|82888955|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46673305|NCT01212757|82888956|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46673306|NCT01212757|82888957|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46673307|NCT01212757|82888958|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46673308|NCT01212757|82888959|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
46673309|NCT01212757|82888951|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
46673310|NCT01212757|82888952|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
46673311|NCT01212757|82888953|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46673312|NCT01212757|82888954|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46673313|NCT01212757|82888955|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46673314|NCT01212757|82888956|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46787533|NCT00319501|83006619|FG001|Open-label Extension Period|Sponsor request|0|||
46787534|NCT00319501|83006618|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
46787535|NCT00319501|83006619|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
46787536|NCT00761579|83006630|FG000|Overall Study|Adverse Event|10|||
46787537|NCT00761579|83006630|FG000|Overall Study|Death|2|||
46787538|NCT00761579|83006630|FG000|Overall Study|Lack of Efficacy|21|||
46787539|NCT00761579|83006630|FG000|Overall Study|Lost to Follow-up|16|||
46787540|NCT00761579|83006630|FG000|Overall Study|Pregnancy|1|||
46787541|NCT00761579|83006630|FG000|Overall Study|Withdrawal by Subject|34|||
46787542|NCT00761579|83006630|FG000|Overall Study|Lack of compliance|2|||
46787543|NCT00761579|83006630|FG000|Overall Study|Protocol deviation|1|||
46787544|NCT00761579|83006630|FG000|Overall Study|Drug overdose|1|||
46787545|NCT00761579|83006630|FG000|Overall Study|Aggravation of depression|1|||
46852128|NCT00075218|83067557|FG000|Open-Label Treatment|Decision of Sponsor|0|||
46852129|NCT00075218|83067558|FG001|Open-Label Treatment|Decision of Sponsor|0|||
47077687|NCT01465802|83380398|FG000|Overall Study|Withdrawal by Subject|7|||
47077688|NCT01465802|83380399|FG001|Overall Study|Withdrawal by Subject|7|||
46673315|NCT01212757|82888957|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46673316|NCT01212757|82888958|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46673317|NCT01212757|82888959|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
46673318|NCT01212757|82888951|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
46673319|NCT01212757|82888952|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
46673320|NCT01212757|82888953|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
46673321|NCT01212757|82888954|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
46673322|NCT01212757|82888955|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
46673323|NCT01212757|82888956|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
46673324|NCT01212757|82888957|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
46673325|NCT01212757|82888958|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
46673326|NCT01212757|82888959|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
46673327|NCT01212757|82888951|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
46673328|NCT01212757|82888952|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
46673329|NCT01212757|82888953|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
46673330|NCT01212757|82888954|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
46673331|NCT01212757|82888955|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
46673332|NCT01212757|82888956|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
46673333|NCT01212757|82888957|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
46673334|NCT01212757|82888958|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
46673335|NCT01212757|82888959|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
46673336|NCT01212757|82888951|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673337|NCT01212757|82888952|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673338|NCT01212757|82888953|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
46673339|NCT01212757|82888954|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673340|NCT01212757|82888955|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673341|NCT01212757|82888956|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673342|NCT01212757|82888957|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673343|NCT01212757|82888958|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673344|NCT01212757|82888959|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
46673345|NCT01212757|82888951|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
46673346|NCT01212757|82888952|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
46673347|NCT01212757|82888953|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
46673348|NCT01212757|82888954|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
46673349|NCT01212757|82888955|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
46673350|NCT01212757|82888956|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
46673351|NCT01212757|82888957|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
46673352|NCT01212757|82888958|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
46673353|NCT01212757|82888959|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
46673354|NCT01212757|82888951|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46673355|NCT01212757|82888952|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
46673356|NCT01212757|82888953|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46673357|NCT01212757|82888954|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46673358|NCT01212757|82888955|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
46673359|NCT01212757|82888956|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46673360|NCT01212757|82888957|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46673361|NCT01212757|82888958|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46787546|NCT00761579|83006630|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
46787547|NCT00761579|83006630|FG000|Overall Study|Lost survey form|1|||
46787548|NCT00761579|83006630|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
46787549|NCT00627042|83006636|FG000|Overall Study|Withdrawal by Subject|2|||
46787550|NCT00319111|83006640|FG000|Overall Study|Adverse Event|20|||
46787551|NCT00319111|83006640|FG000|Overall Study|Withdrawal of consent|11|||
46852130|NCT00075218|83067559|FG002|Open-Label Treatment|Decision of Sponsor|8|||
46852131|NCT00075218|83067557|FG000|Open-Label Treatment|Protocol Violation|0|||
46852132|NCT00075218|83067558|FG001|Open-Label Treatment|Protocol Violation|0|||
46852133|NCT00075218|83067559|FG002|Open-Label Treatment|Protocol Violation|1|||
46673362|NCT01212757|82888959|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
46673363|NCT01212757|82888951|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
46787552|NCT00319111|83006640|FG000|Overall Study|Death|9|||
46787553|NCT00319111|83006640|FG000|Overall Study|Lack of clinical improvement|4|||
46787554|NCT00319111|83006640|FG000|Overall Study|Administrative|2|||
46852134|NCT00075218|83067557|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
46787555|NCT00319111|83006640|FG000|Overall Study|Treatment failure|1|||
46787556|NCT00640224|83006648|FG000|Overall Study|Lost to Follow-up|5|||
46787557|NCT00640224|83006649|FG001|Overall Study|Lost to Follow-up|2|||
46787558|NCT00640224|83006650|FG002|Overall Study|Lost to Follow-up|0|||
46787559|NCT00640224|83006651|FG003|Overall Study|Lost to Follow-up|0|||
46787560|NCT00640224|83006648|FG000|Overall Study|Withdrawal by Subject|1|||
46787561|NCT00640224|83006649|FG001|Overall Study|Withdrawal by Subject|0|||
46787562|NCT00640224|83006650|FG002|Overall Study|Withdrawal by Subject|0|||
46787563|NCT00640224|83006651|FG003|Overall Study|Withdrawal by Subject|0|||
46787564|NCT00640224|83006648|FG000|Overall Study|Headaches|0|||
46787565|NCT00640224|83006649|FG001|Overall Study|Headaches|1|||
46787566|NCT00640224|83006650|FG002|Overall Study|Headaches|0|||
46787567|NCT00640224|83006651|FG003|Overall Study|Headaches|0|||
46787568|NCT00318643|83006666|FG000|Overall Study|Adverse Event|0|||
46787569|NCT00318643|83006667|FG001|Overall Study|Adverse Event|0|||
46787570|NCT00318643|83006668|FG002|Overall Study|Adverse Event|0|||
46787571|NCT00318643|83006669|FG003|Overall Study|Adverse Event|0|||
46787572|NCT00318643|83006670|FG004|Overall Study|Adverse Event|1|||
46787573|NCT00318643|83006666|FG000|Overall Study|Participant's Decision|0|||
46787574|NCT00318643|83006667|FG001|Overall Study|Participant's Decision|0|||
46787575|NCT00318643|83006668|FG002|Overall Study|Participant's Decision|0|||
46787576|NCT00318643|83006669|FG003|Overall Study|Participant's Decision|0|||
46787577|NCT00318643|83006670|FG004|Overall Study|Participant's Decision|1|||
46787578|NCT00318643|83006666|FG000|Overall Study|Investigator's Decision|0|||
46852135|NCT00075218|83067558|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
46852136|NCT00075218|83067559|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
46852137|NCT00094653|83067569|FG000|Overall Study|Death|306|||
46787579|NCT00318643|83006667|FG001|Overall Study|Investigator's Decision|0|||
46787580|NCT00318643|83006668|FG002|Overall Study|Investigator's Decision|0|||
46852138|NCT00094653|83067570|FG001|Overall Study|Death|100|||
46852139|NCT00094653|83067571|FG002|Overall Study|Death|119|||
46852140|NCT00094653|83067569|FG000|Overall Study|Subject Withdrew Consent|10|||
46852141|NCT00094653|83067570|FG001|Overall Study|Subject Withdrew Consent|2|||
46973165|NCT01987960|83216965|FG002|Period 1|Protocol Violation|0|||
46973166|NCT01987960|83216966|FG003|Period 1|Protocol Violation|0|||
46973167|NCT01987960|83216963|FG000|Period 1|Withdrawal by Subject|21|||
46973168|NCT01987960|83216964|FG001|Period 1|Withdrawal by Subject|0|||
46973169|NCT01987960|83216965|FG002|Period 1|Withdrawal by Subject|0|||
46973170|NCT01987960|83216966|FG003|Period 1|Withdrawal by Subject|0|||
46973171|NCT01987960|83216963|FG000|Period 1|Lost to Follow-up|40|||
46973172|NCT01987960|83216964|FG001|Period 1|Lost to Follow-up|0|||
46973173|NCT01987960|83216965|FG002|Period 1|Lost to Follow-up|0|||
46973174|NCT01987960|83216966|FG003|Period 1|Lost to Follow-up|0|||
46973175|NCT01987960|83216963|FG000|Period 1|administrative or other reason|75|||
46973176|NCT01987960|83216964|FG001|Period 1|administrative or other reason|0|||
46973177|NCT01987960|83216965|FG002|Period 1|administrative or other reason|0|||
46787581|NCT00318643|83006669|FG003|Overall Study|Investigator's Decision|0|||
46787582|NCT00318643|83006670|FG004|Overall Study|Investigator's Decision|1|||
46852142|NCT00094653|83067571|FG002|Overall Study|Subject Withdrew Consent|3|||
46852143|NCT00094653|83067569|FG000|Overall Study|Other|2|||
46852144|NCT00094653|83067570|FG001|Overall Study|Other|2|||
46852145|NCT00094653|83067571|FG002|Overall Study|Other|2|||
46852146|NCT00094653|83067569|FG000|Overall Study|Lost to Follow-up|3|||
46852147|NCT00094653|83067570|FG001|Overall Study|Lost to Follow-up|2|||
46852148|NCT00094653|83067571|FG002|Overall Study|Lost to Follow-up|1|||
46852149|NCT00094653|83067569|FG000|Overall Study|Protocol Violation|0|||
46852150|NCT00094653|83067570|FG001|Overall Study|Protocol Violation|0|||
46973178|NCT01987960|83216966|FG003|Period 1|administrative or other reason|0|||
46973179|NCT01987960|83216963|FG000|Period 1|Withdrawal of consent before treatment|4|||
46973180|NCT01987960|83216964|FG001|Period 1|Withdrawal of consent before treatment|0|||
46787583|NCT00318565|83006683|FG000|Overall Study|Excluded per protocol|24|||
46787584|NCT00304915|83006689|FG000|Overall Study|Lost to Follow-up|11|||
46787585|NCT00304915|83006690|FG001|Overall Study|Lost to Follow-up|11|||
46852151|NCT00094653|83067571|FG002|Overall Study|Protocol Violation|1|||
46973181|NCT01987960|83216965|FG002|Period 1|Withdrawal of consent before treatment|0|||
46852152|NCT00104247|83067582|FG000|Overall Study|Withdrawal by Subject|1|||
46852153|NCT00104247|83067583|FG001|Overall Study|Withdrawal by Subject|0|||
46973182|NCT01987960|83216966|FG003|Period 1|Withdrawal of consent before treatment|0|||
46973183|NCT01987960|83216963|FG000|Period 2|Adverse Event|0|||
46973184|NCT01987960|83216964|FG001|Period 2|Adverse Event|0|||
46973185|NCT01987960|83216965|FG002|Period 2|Adverse Event|1|||
46973186|NCT01987960|83216966|FG003|Period 2|Adverse Event|0|||
46973187|NCT01987960|83216963|FG000|Period 2|Withdrawal by Subject|0|||
46852154|NCT00104247|83067582|FG000|Overall Study|Noncompliant with dosing|0|||
46973188|NCT01987960|83216964|FG001|Period 2|Withdrawal by Subject|0|||
46973189|NCT01987960|83216965|FG002|Period 2|Withdrawal by Subject|1|||
46973190|NCT01987960|83216966|FG003|Period 2|Withdrawal by Subject|0|||
46973191|NCT01987960|83216963|FG000|Period 2|Administrative or other reason|0|||
46973192|NCT01987960|83216964|FG001|Period 2|Administrative or other reason|5|||
46787586|NCT00304915|83006689|FG000|Overall Study|Death|4|||
46787587|NCT00304915|83006690|FG001|Overall Study|Death|5|||
46787588|NCT00304915|83006689|FG000|Overall Study|Withdrawal by Subject|3|||
46787589|NCT00304915|83006690|FG001|Overall Study|Withdrawal by Subject|0|||
46787590|NCT03687970|83006698|FG000|Overall Study|visit scheduling conflicts|2|||
46787591|NCT03687970|83006699|FG001|Overall Study|visit scheduling conflicts|0|||
46787592|NCT00530920|83006710|FG000|Overall Study|Randomized but not treated|0|||
46787593|NCT00530920|83006711|FG001|Overall Study|Randomized but not treated|2|||
46787594|NCT00530920|83006712|FG002|Overall Study|Randomized but not treated|0|||
46787595|NCT00530920|83006710|FG000|Overall Study|Adverse Event|0|||
46787596|NCT00530920|83006711|FG001|Overall Study|Adverse Event|0|||
46787597|NCT00530920|83006712|FG002|Overall Study|Adverse Event|3|||
46787598|NCT00530920|83006710|FG000|Overall Study|Withdrawal by Subject|0|||
46787599|NCT00530920|83006711|FG001|Overall Study|Withdrawal by Subject|0|||
46787600|NCT00530920|83006712|FG002|Overall Study|Withdrawal by Subject|1|||
46787601|NCT03878758|83006721|FG000|Overall Study|Withdrawal by Subject|1|||
46787602|NCT03878758|83006721|FG000|Overall Study|Protocol defined|2|||
46787603|NCT03878758|83006721|FG000|Overall Study|Improper consent documentation|1|||
46787604|NCT03878602|83006736|FG000|Overall Study|cord blood donation|7|||
46787605|NCT03878602|83006737|FG001|Overall Study|cord blood donation|1|||
46787606|NCT03878602|83006736|FG000|Overall Study|incomplete data collection|2|||
46787607|NCT03878602|83006737|FG001|Overall Study|incomplete data collection|0|||
46787608|NCT00768755|83006749|FG000|Phase 1|Death|6|||
46787609|NCT00768755|83006750|FG001|Phase 1|Death|0|||
46787610|NCT00768755|83006751|FG002|Phase 1|Death|0|||
46787611|NCT00768755|83006752|FG003|Phase 1|Death|0|||
46787612|NCT00768755|83006749|FG000|Phase 1|Other|4|||
46787613|NCT00768755|83006750|FG001|Phase 1|Other|0|||
46787614|NCT00768755|83006751|FG002|Phase 1|Other|0|||
46787615|NCT00768755|83006752|FG003|Phase 1|Other|0|||
46787616|NCT00768755|83006749|FG000|Phase 2|Death|0|||
46787617|NCT00768755|83006750|FG001|Phase 2|Death|37|||
46787618|NCT00768755|83006751|FG002|Phase 2|Death|48|||
46787619|NCT00768755|83006752|FG003|Phase 2|Death|31|||
46787620|NCT00768755|83006749|FG000|Phase 2|Protocol Violation|0|||
46787621|NCT00768755|83006750|FG001|Phase 2|Protocol Violation|2|||
46787622|NCT00768755|83006751|FG002|Phase 2|Protocol Violation|0|||
46787623|NCT00768755|83006752|FG003|Phase 2|Protocol Violation|1|||
46787624|NCT00768755|83006749|FG000|Phase 2|Lost to Follow-up|0|||
46787625|NCT00768755|83006750|FG001|Phase 2|Lost to Follow-up|1|||
46787626|NCT00768755|83006751|FG002|Phase 2|Lost to Follow-up|1|||
46787627|NCT00768755|83006752|FG003|Phase 2|Lost to Follow-up|4|||
46787628|NCT00768755|83006749|FG000|Phase 2|Withdrawal by Subject|0|||
46787629|NCT00768755|83006750|FG001|Phase 2|Withdrawal by Subject|1|||
46787630|NCT00768755|83006751|FG002|Phase 2|Withdrawal by Subject|0|||
46787631|NCT00768755|83006752|FG003|Phase 2|Withdrawal by Subject|1|||
46787632|NCT00768755|83006749|FG000|Phase 2|Other|0|||
46787633|NCT00768755|83006750|FG001|Phase 2|Other|1|||
46787634|NCT00768755|83006751|FG002|Phase 2|Other|2|||
46787635|NCT00768755|83006752|FG003|Phase 2|Other|4|||
46787636|NCT00768755|83006749|FG000|Phase 2|Study Terminated by Sponsor|0|||
46787637|NCT00768755|83006750|FG001|Phase 2|Study Terminated by Sponsor|13|||
46787638|NCT00768755|83006751|FG002|Phase 2|Study Terminated by Sponsor|7|||
46787639|NCT00768755|83006752|FG003|Phase 2|Study Terminated by Sponsor|14|||
46787640|NCT00768755|83006749|FG000|Phase 2|Randomized but not treated|0|||
46787641|NCT00768755|83006750|FG001|Phase 2|Randomized but not treated|0|||
46787642|NCT00768755|83006751|FG002|Phase 2|Randomized but not treated|0|||
46787643|NCT00768755|83006752|FG003|Phase 2|Randomized but not treated|2|||
46852155|NCT00104247|83067583|FG001|Overall Study|Noncompliant with dosing|1|||
46852156|NCT03591406|83067591|FG000|Overall Study|Adverse Event|5|||
46852157|NCT03591406|83067592|FG001|Overall Study|Adverse Event|3|||
46852158|NCT03591406|83067591|FG000|Overall Study|Protocol Violation|2|||
46852159|NCT03591406|83067592|FG001|Overall Study|Protocol Violation|1|||
46787644|NCT00530842|83006763|FG000|Overall Study|Adverse Event|10|||
46852160|NCT03591406|83067591|FG000|Overall Study|Withdrawal by Subject|0|||
47077689|NCT01465802|83380400|FG002|Overall Study|Withdrawal by Subject|0|||
46787645|NCT00530842|83006764|FG001|Overall Study|Adverse Event|6|||
46787646|NCT00530842|83006763|FG000|Overall Study|Lack of Efficacy|2|||
46787647|NCT00530842|83006764|FG001|Overall Study|Lack of Efficacy|1|||
46787648|NCT00530842|83006763|FG000|Overall Study|Lost to Follow-up|0|||
46787649|NCT00530842|83006764|FG001|Overall Study|Lost to Follow-up|4|||
46787650|NCT00530842|83006763|FG000|Overall Study|Protocol Violation|3|||
46787651|NCT00530842|83006764|FG001|Overall Study|Protocol Violation|2|||
46787652|NCT00530842|83006763|FG000|Overall Study|Withdrawal by Subject|4|||
47077690|NCT01465802|83380401|FG003|Overall Study|Withdrawal by Subject|8|||
47077691|NCT01465802|83380402|FG004|Overall Study|Withdrawal by Subject|1|||
47077692|NCT01465802|83380398|FG000|Overall Study|Lost to Follow-up|1|||
47077693|NCT01465802|83380399|FG001|Overall Study|Lost to Follow-up|1|||
47077694|NCT01465802|83380400|FG002|Overall Study|Lost to Follow-up|0|||
47077695|NCT01465802|83380401|FG003|Overall Study|Lost to Follow-up|0|||
47077696|NCT01465802|83380402|FG004|Overall Study|Lost to Follow-up|0|||
47077697|NCT01465802|83380398|FG000|Overall Study|Reason not specified|9|||
46787653|NCT00530842|83006764|FG001|Overall Study|Withdrawal by Subject|5|||
46787654|NCT00530842|83006763|FG000|Overall Study|Individual different reasons|4|||
46787655|NCT00530842|83006764|FG001|Overall Study|Individual different reasons|3|||
46787656|NCT00530842|83006763|FG000|Period 1|Adverse Event|7|||
46787657|NCT00530842|83006764|FG001|Period 1|Adverse Event|3|||
46787658|NCT00530842|83006763|FG000|Period 1|Lack of Efficacy|1|||
46787659|NCT00530842|83006764|FG001|Period 1|Lack of Efficacy|1|||
46787660|NCT00530842|83006763|FG000|Period 1|Protocol Violation|2|||
46787661|NCT00530842|83006764|FG001|Period 1|Protocol Violation|1|||
46787662|NCT00530842|83006763|FG000|Period 1|Withdrawal by Subject|2|||
46787663|NCT00530842|83006764|FG001|Period 1|Withdrawal by Subject|3|||
46787664|NCT00530842|83006763|FG000|Period 1|Individual different reasons|2|||
46787665|NCT00530842|83006764|FG001|Period 1|Individual different reasons|3|||
46787666|NCT00530842|83006763|FG000|Period 2|Adverse Event|3|||
46787667|NCT00530842|83006764|FG001|Period 2|Adverse Event|3|||
46787668|NCT00530842|83006763|FG000|Period 2|Lack of Efficacy|1|||
46787669|NCT00530842|83006764|FG001|Period 2|Lack of Efficacy|0|||
46787670|NCT00530842|83006763|FG000|Period 2|Lost to Follow-up|0|||
46787671|NCT00530842|83006764|FG001|Period 2|Lost to Follow-up|4|||
46787672|NCT00530842|83006763|FG000|Period 2|Protocol Violation|1|||
46787673|NCT00530842|83006764|FG001|Period 2|Protocol Violation|0|||
46787674|NCT00530842|83006763|FG000|Period 2|Withdrawal by Subject|1|||
46787675|NCT00530842|83006764|FG001|Period 2|Withdrawal by Subject|2|||
46787676|NCT00530842|83006763|FG000|Period 2|Individual different reasons|2|||
46787677|NCT00530842|83006764|FG001|Period 2|Individual different reasons|0|||
46787678|NCT03882424|83006775|FG000|Overall Study|Lost to Follow-up|3|||
46787679|NCT03882424|83006776|FG001|Overall Study|Lost to Follow-up|0|||
46787680|NCT03882424|83006777|FG002|Overall Study|Lost to Follow-up|0|||
46787681|NCT03882424|83006775|FG000|Overall Study|schedule conflict|1|||
46787682|NCT03882424|83006776|FG001|Overall Study|schedule conflict|0|||
46787683|NCT03882424|83006777|FG002|Overall Study|schedule conflict|0|||
46787684|NCT03879772|83006790|FG000|Overall Study|Adverse Event|2|||
46787685|NCT03879772|83006791|FG001|Overall Study|Adverse Event|2|||
46787686|NCT03879772|83006792|FG002|Overall Study|Adverse Event|3|||
46787687|NCT03879772|83006793|FG003|Overall Study|Adverse Event|4|||
46787688|NCT03879772|83006794|FG004|Overall Study|Adverse Event|3|||
46787689|NCT03879772|83006790|FG000|Overall Study|Treatment Failure|1|||
46787690|NCT03879772|83006791|FG001|Overall Study|Treatment Failure|0|||
46787691|NCT03879772|83006792|FG002|Overall Study|Treatment Failure|0|||
46787692|NCT03879772|83006793|FG003|Overall Study|Treatment Failure|2|||
46787693|NCT03879772|83006794|FG004|Overall Study|Treatment Failure|1|||
46787694|NCT03879772|83006790|FG000|Overall Study|Lost to Follow-up|0|||
46787695|NCT03879772|83006791|FG001|Overall Study|Lost to Follow-up|0|||
46787696|NCT03879772|83006792|FG002|Overall Study|Lost to Follow-up|0|||
46787697|NCT03879772|83006793|FG003|Overall Study|Lost to Follow-up|0|||
46787698|NCT03879772|83006794|FG004|Overall Study|Lost to Follow-up|1|||
46787699|NCT03879772|83006790|FG000|Overall Study|Withdrawal by Subject|0|||
46787700|NCT03879772|83006791|FG001|Overall Study|Withdrawal by Subject|1|||
46787701|NCT03879772|83006792|FG002|Overall Study|Withdrawal by Subject|3|||
46787702|NCT03879772|83006793|FG003|Overall Study|Withdrawal by Subject|1|||
46787703|NCT03879772|83006794|FG004|Overall Study|Withdrawal by Subject|1|||
46787704|NCT03879772|83006790|FG000|Overall Study|Protocol Violation|0|||
46787705|NCT03879772|83006791|FG001|Overall Study|Protocol Violation|0|||
46787706|NCT03879772|83006792|FG002|Overall Study|Protocol Violation|3|||
46787707|NCT03879772|83006793|FG003|Overall Study|Protocol Violation|1|||
46787708|NCT03879772|83006794|FG004|Overall Study|Protocol Violation|2|||
46787709|NCT03879772|83006790|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
46787710|NCT03879772|83006791|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
46787711|NCT03879772|83006792|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
46787712|NCT03879772|83006793|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
46787713|NCT03879772|83006794|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
46787714|NCT00642954|83006811|FG000|Overall Study|Progressive Disease|3|||
46787715|NCT00642954|83006812|FG001|Overall Study|Progressive Disease|3|||
46787716|NCT00642954|83006813|FG002|Overall Study|Progressive Disease|3|||
46787717|NCT00642954|83006814|FG003|Overall Study|Progressive Disease|3|||
46787718|NCT00642954|83006815|FG004|Overall Study|Progressive Disease|9|||
46787719|NCT00642954|83006811|FG000|Overall Study|Withdrawal by Subject|0|||
46787720|NCT00642954|83006812|FG001|Overall Study|Withdrawal by Subject|0|||
46787721|NCT00642954|83006813|FG002|Overall Study|Withdrawal by Subject|0|||
46787722|NCT00642954|83006814|FG003|Overall Study|Withdrawal by Subject|0|||
46787723|NCT00642954|83006815|FG004|Overall Study|Withdrawal by Subject|1|||
46787724|NCT00642954|83006811|FG000|Overall Study|Adverse Event|1|||
46787725|NCT00642954|83006812|FG001|Overall Study|Adverse Event|1|||
46787726|NCT00642954|83006813|FG002|Overall Study|Adverse Event|0|||
46787727|NCT00642954|83006814|FG003|Overall Study|Adverse Event|0|||
46787728|NCT00642954|83006815|FG004|Overall Study|Adverse Event|6|||
46787729|NCT00640146|83006829|FG000|Overall Study|Adverse Event|2|||
46787730|NCT00640146|83006830|FG001|Overall Study|Adverse Event|0|||
46787731|NCT00640146|83006829|FG000|Overall Study|Lost to Follow-up|0|||
46787732|NCT00640146|83006830|FG001|Overall Study|Lost to Follow-up|1|||
46787733|NCT00640146|83006829|FG000|Overall Study|Lack of Efficacy|0|||
46787734|NCT00640146|83006830|FG001|Overall Study|Lack of Efficacy|1|||
46787735|NCT00640146|83006829|FG000|Overall Study|Withdrawal by Subject|1|||
46787736|NCT00640146|83006830|FG001|Overall Study|Withdrawal by Subject|1|||
46673364|NCT01212757|82888952|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
46673365|NCT01212757|82888953|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
46673366|NCT01212757|82888954|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
46787737|NCT00640146|83006829|FG000|Overall Study|Randomized but not treated|1|||
46787738|NCT00640146|83006830|FG001|Overall Study|Randomized but not treated|3|||
46787739|NCT00317473|83006842|FG000|Overall Study|Withdrawal by Subject|2|||
46787740|NCT00317473|83006843|FG001|Overall Study|Withdrawal by Subject|1|||
46787741|NCT00317473|83006844|FG002|Overall Study|Withdrawal by Subject|2|||
46787742|NCT00317473|83006845|FG003|Overall Study|Withdrawal by Subject|1|||
46787743|NCT00317473|83006846|FG004|Overall Study|Withdrawal by Subject|3|||
46787744|NCT00317473|83006847|FG005|Overall Study|Withdrawal by Subject|1|||
46787745|NCT00317473|83006842|FG000|Overall Study|Relocation|1|||
46787746|NCT00317473|83006843|FG001|Overall Study|Relocation|0|||
46787747|NCT00317473|83006844|FG002|Overall Study|Relocation|1|||
46787748|NCT00317473|83006845|FG003|Overall Study|Relocation|1|||
46787749|NCT00317473|83006846|FG004|Overall Study|Relocation|5|||
46787750|NCT00317473|83006847|FG005|Overall Study|Relocation|2|||
46787751|NCT00317473|83006842|FG000|Overall Study|Death|1|||
46787752|NCT00317473|83006843|FG001|Overall Study|Death|0|||
46787753|NCT00317473|83006844|FG002|Overall Study|Death|0|||
46787754|NCT00317473|83006845|FG003|Overall Study|Death|0|||
46787755|NCT00317473|83006846|FG004|Overall Study|Death|0|||
46787756|NCT00317473|83006847|FG005|Overall Study|Death|0|||
46787757|NCT00317473|83006842|FG000|Overall Study|Other|0|||
46787758|NCT00317473|83006843|FG001|Overall Study|Other|2|||
46787759|NCT00317473|83006844|FG002|Overall Study|Other|0|||
46787760|NCT00317473|83006845|FG003|Overall Study|Other|0|||
46787761|NCT00317473|83006846|FG004|Overall Study|Other|0|||
46787762|NCT00317473|83006847|FG005|Overall Study|Other|0|||
46787763|NCT00530218|83006871|FG000|Overall Study|CMV Not Detected|13|||
46787764|NCT00530218|83006871|FG000|Overall Study|Death|12|||
46787765|NCT00761267|83006881|FG000|Overall Study|Death|1|||
46787766|NCT00761267|83006882|FG001|Overall Study|Death|2|||
46787767|NCT00761267|83006883|FG002|Overall Study|Death|5|||
46787768|NCT00761267|83006881|FG000|Overall Study|Lost to Follow-up|0|||
46787769|NCT00761267|83006882|FG001|Overall Study|Lost to Follow-up|0|||
46787770|NCT00761267|83006883|FG002|Overall Study|Lost to Follow-up|1|||
46787771|NCT00761267|83006881|FG000|Overall Study|Randomized but not treated|1|||
46787772|NCT00761267|83006882|FG001|Overall Study|Randomized but not treated|1|||
46787773|NCT00761267|83006883|FG002|Overall Study|Randomized but not treated|0|||
46787774|NCT00761267|83006881|FG000|Overall Study|Withdrawal by Subject|0|||
46787775|NCT00761267|83006882|FG001|Overall Study|Withdrawal by Subject|1|||
47077698|NCT01465802|83380399|FG001|Overall Study|Reason not specified|4|||
47077699|NCT01465802|83380400|FG002|Overall Study|Reason not specified|0|||
46673367|NCT01212757|82888955|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
46673368|NCT01212757|82888956|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
46673369|NCT01212757|82888957|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
46673370|NCT01212757|82888958|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
46673371|NCT01212757|82888959|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
46673372|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673373|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673374|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673375|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673376|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673377|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673378|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673379|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
46673380|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
47077700|NCT01465802|83380401|FG003|Overall Study|Reason not specified|10|||
46673381|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
46673382|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
46787776|NCT00761267|83006883|FG002|Overall Study|Withdrawal by Subject|0|||
46787777|NCT00303667|83006904|FG000|Overall Study|Death|0|||
46787778|NCT00303667|83006905|FG001|Overall Study|Death|4|||
47077701|NCT01465802|83380402|FG004|Overall Study|Reason not specified|2|||
46787779|NCT00761189|83006911|FG000|Overall Study|Adverse Event|42|||
46787780|NCT00761189|83006911|FG000|Overall Study|Lack of Efficacy|45|||
46787781|NCT00761189|83006911|FG000|Overall Study|Lost to Follow-up|36|||
46787782|NCT00761189|83006911|FG000|Overall Study|Withdrawal by Subject|49|||
46787783|NCT00761189|83006911|FG000|Overall Study|Other|13|||
46787784|NCT00529516|83006918|FG000|Overall Study|Adverse Event|2|||
46787785|NCT00529516|83006919|FG001|Overall Study|Adverse Event|1|||
46787786|NCT00529516|83006920|FG002|Overall Study|Adverse Event|0|||
46787787|NCT00529516|83006918|FG000|Overall Study|Withdrawal by Subject|1|||
46787788|NCT00529516|83006919|FG001|Overall Study|Withdrawal by Subject|1|||
46787789|NCT00529516|83006920|FG002|Overall Study|Withdrawal by Subject|0|||
46787790|NCT00529516|83006918|FG000|Overall Study|Lost to Follow-up|0|||
46787791|NCT00529516|83006919|FG001|Overall Study|Lost to Follow-up|0|||
46787792|NCT00529516|83006920|FG002|Overall Study|Lost to Follow-up|1|||
46787793|NCT00316693|83006930|FG000|Overall Study|Adverse Event|6|||
46787794|NCT00316693|83006931|FG001|Overall Study|Adverse Event|1|||
46787795|NCT00316693|83006930|FG000|Overall Study|Protocol Violation|1|||
46787796|NCT00316693|83006931|FG001|Overall Study|Protocol Violation|0|||
46787797|NCT00316693|83006930|FG000|Overall Study|Withdrawal by Subject|6|||
46787798|NCT00316693|83006931|FG001|Overall Study|Withdrawal by Subject|6|||
46787799|NCT00316693|83006930|FG000|Overall Study|Lost to Follow-up|26|||
46787800|NCT00316693|83006931|FG001|Overall Study|Lost to Follow-up|34|||
46787801|NCT00316693|83006930|FG000|Overall Study|Other|38|||
46787802|NCT00316693|83006931|FG001|Overall Study|Other|44|||
46787803|NCT00316303|83006939|FG000|Overall Study|Lost to Follow-up|11|||
46787804|NCT00316303|83006940|FG001|Overall Study|Lost to Follow-up|16|||
46787805|NCT00760877|83006951|FG000|Overall Study|Protocol Violation|1|||
46787806|NCT00760877|83006952|FG001|Overall Study|Protocol Violation|0|||
46787807|NCT00760877|83006951|FG000|Overall Study|Non-compliance with protocol treatment|2|||
46787808|NCT00760877|83006952|FG001|Overall Study|Non-compliance with protocol treatment|1|||
46787809|NCT00760877|83006951|FG000|Overall Study|Pregnancy|1|||
46787810|NCT00760877|83006952|FG001|Overall Study|Pregnancy|4|||
46787811|NCT00760877|83006951|FG000|Overall Study|Death|2|||
46787812|NCT00760877|83006952|FG001|Overall Study|Death|1|||
46787813|NCT00760877|83006951|FG000|Overall Study|Withdrawal by Subject|7|||
46787814|NCT00760877|83006952|FG001|Overall Study|Withdrawal by Subject|3|||
46787815|NCT00760877|83006951|FG000|Overall Study|Adverse Event|19|||
46787816|NCT00760877|83006952|FG001|Overall Study|Adverse Event|12|||
46787817|NCT00760877|83006951|FG000|Overall Study|Participant diagnosed with AML|0|||
46787818|NCT00760877|83006952|FG001|Overall Study|Participant diagnosed with AML|1|||
46787819|NCT00760877|83006951|FG000|Overall Study|Participant not eligible to cross-over|0|||
46787820|NCT00760877|83006952|FG001|Overall Study|Participant not eligible to cross-over|1|||
46787821|NCT00760877|83006951|FG000|Overall Study|Physician Decision|1|||
46787822|NCT00760877|83006952|FG001|Overall Study|Physician Decision|2|||
46787823|NCT00760877|83006951|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
46787824|NCT00760877|83006952|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
46787825|NCT00760877|83006951|FG000|Overall Study|Treatment failure|1|||
46787826|NCT00760877|83006952|FG001|Overall Study|Treatment failure|0|||
46787827|NCT00302731|83006963|FG000|Overall Study|Lost to Follow-up|1|||
46787828|NCT00302731|83006964|FG001|Overall Study|Lost to Follow-up|2|||
46787829|NCT00302731|83006965|FG002|Overall Study|Lost to Follow-up|0|||
46787830|NCT00302731|83006966|FG003|Overall Study|Lost to Follow-up|0|||
46787831|NCT00302731|83006963|FG000|Overall Study|Adverse Event|0|||
46787832|NCT00302731|83006964|FG001|Overall Study|Adverse Event|2|||
46787833|NCT00302731|83006965|FG002|Overall Study|Adverse Event|2|||
46787834|NCT00302731|83006966|FG003|Overall Study|Adverse Event|0|||
46787835|NCT00302731|83006963|FG000|Overall Study|Withdrawal by Subject|1|||
46787836|NCT00302731|83006964|FG001|Overall Study|Withdrawal by Subject|1|||
46787837|NCT00302731|83006965|FG002|Overall Study|Withdrawal by Subject|0|||
46787838|NCT00302731|83006966|FG003|Overall Study|Withdrawal by Subject|0|||
46787839|NCT00302731|83006963|FG000|Overall Study|Protocol Violation|1|||
46787840|NCT00302731|83006964|FG001|Overall Study|Protocol Violation|0|||
46787841|NCT00302731|83006965|FG002|Overall Study|Protocol Violation|0|||
46787842|NCT00302731|83006966|FG003|Overall Study|Protocol Violation|0|||
46787843|NCT00302731|83006963|FG000|Overall Study|cancer unrelated to study discovered|1|||
46787844|NCT00302731|83006964|FG001|Overall Study|cancer unrelated to study discovered|0|||
46787845|NCT00302731|83006965|FG002|Overall Study|cancer unrelated to study discovered|1|||
46787846|NCT00302731|83006966|FG003|Overall Study|cancer unrelated to study discovered|0|||
46787847|NCT00780143|83006976|FG000|Overall Study|Progressive disease|1|||
46852161|NCT03591406|83067592|FG001|Overall Study|Withdrawal by Subject|5|||
46852162|NCT03560986|83067600|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
46852163|NCT03560986|83067601|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
46852164|NCT03560986|83067600|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
47077702|NCT01465802|83380398|FG000|Overall Study|Death|15|||
46787848|NCT00780143|83006976|FG000|Overall Study|Toxicity|1|||
46787849|NCT00780143|83006976|FG000|Overall Study|Adverse Event|1|||
46787850|NCT00779909|83006984|FG000|Overall Study|Lost to Follow-up|1|||
46787851|NCT00779909|83006985|FG001|Overall Study|Lost to Follow-up|0|||
46787852|NCT00779909|83006986|FG002|Overall Study|Lost to Follow-up|0|||
46787853|NCT00779909|83006987|FG003|Overall Study|Lost to Follow-up|1|||
46787854|NCT00779909|83006984|FG000|Overall Study|Withdrawal by Subject|0|||
46787855|NCT00779909|83006985|FG001|Overall Study|Withdrawal by Subject|1|||
46787856|NCT00779909|83006986|FG002|Overall Study|Withdrawal by Subject|0|||
46787857|NCT00779909|83006987|FG003|Overall Study|Withdrawal by Subject|0|||
46787858|NCT00302107|83007006|FG000|Overall Study|Lost to Follow-up|6|||
46787859|NCT00302107|83007007|FG001|Overall Study|Lost to Follow-up|5|||
46787860|NCT00302107|83007006|FG000|Overall Study|Protocol Violation|1|||
46787861|NCT00302107|83007007|FG001|Overall Study|Protocol Violation|0|||
46787862|NCT00302107|83007006|FG000|Overall Study|Relocation|0|||
46787863|NCT00302107|83007007|FG001|Overall Study|Relocation|1|||
46787864|NCT00302107|83007006|FG000|Overall Study|Withdrawal by Subject|0|||
46787865|NCT00302107|83007007|FG001|Overall Study|Withdrawal by Subject|3|||
46787866|NCT00302107|83007006|FG000|Overall Study|Adverse Event|1|||
46787867|NCT00302107|83007007|FG001|Overall Study|Adverse Event|0|||
46787868|NCT00760487|83007013|FG000|Overall Study|Unilateral implantation|3|||
46787869|NCT00316225|83007017|FG000|Overall Study|Adverse Event|2|||
46787870|NCT00316225|83007017|FG000|Overall Study|Physician Decision|3|||
46787871|NCT00316225|83007017|FG000|Overall Study|Progressive Disease|15|||
46787872|NCT00316225|83007017|FG000|Overall Study|Withdrawal by Subject|3|||
46787873|NCT00316225|83007017|FG000|Overall Study|Death|2|||
46787874|NCT00586703|83007021|FG000|Overall Study|Death|12|||
46787875|NCT00586625|83007027|FG000|Overall Study|Adverse Event|6|||
46787876|NCT00586625|83007028|FG001|Overall Study|Adverse Event|6|||
46787877|NCT00586625|83007027|FG000|Overall Study|Protocol Violation|3|||
46787878|NCT00586625|83007028|FG001|Overall Study|Protocol Violation|0|||
46787879|NCT00586625|83007027|FG000|Overall Study|Withdrawal by Subject|32|||
46787880|NCT00586625|83007028|FG001|Overall Study|Withdrawal by Subject|10|||
46787881|NCT00586625|83007027|FG000|Overall Study|Subject non-compliance|0|||
46787882|NCT00586625|83007028|FG001|Overall Study|Subject non-compliance|1|||
46787883|NCT00586625|83007027|FG000|Overall Study|Subject unable to return for visit|2|||
46787884|NCT00586625|83007028|FG001|Overall Study|Subject unable to return for visit|0|||
46787885|NCT00636168|83007036|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
46787886|NCT00636168|83007037|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
46787887|NCT00636168|83007036|FG000|Randomized to Study Drug|Adverse Event|1|||
46787888|NCT00636168|83007037|FG001|Randomized to Study Drug|Adverse Event|0|||
46787889|NCT00636168|83007036|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
46787890|NCT00636168|83007037|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
46787891|NCT00636168|83007036|FG000|Treated With Study Drug|Recurrence of disease|135|||
46787892|NCT00636168|83007037|FG001|Treated With Study Drug|Recurrence of disease|282|||
46787893|NCT00636168|83007036|FG000|Treated With Study Drug|Adverse Event|250|||
46787894|NCT00636168|83007037|FG001|Treated With Study Drug|Adverse Event|22|||
46787895|NCT00636168|83007036|FG000|Treated With Study Drug|Participant withdrew consent|16|||
46787896|NCT00636168|83007037|FG001|Treated With Study Drug|Participant withdrew consent|21|||
46787897|NCT00636168|83007036|FG000|Treated With Study Drug|Poor/non-compliance|1|||
46787898|NCT00636168|83007037|FG001|Treated With Study Drug|Poor/non-compliance|3|||
46787899|NCT00636168|83007036|FG000|Treated With Study Drug|Death|3|||
46787900|NCT00636168|83007037|FG001|Treated With Study Drug|Death|0|||
46787901|NCT00636168|83007036|FG000|Treated With Study Drug|Pregnancy|1|||
46787902|NCT00636168|83007037|FG001|Treated With Study Drug|Pregnancy|0|||
46787903|NCT00636168|83007036|FG000|Treated With Study Drug|No longer meets study criteria|1|||
46787904|NCT00636168|83007037|FG001|Treated With Study Drug|No longer meets study criteria|0|||
46787905|NCT00636168|83007036|FG000|Treated With Study Drug|Other reason|1|||
46973193|NCT01987960|83216965|FG002|Period 2|Administrative or other reason|7|||
46973194|NCT01987960|83216966|FG003|Period 2|Administrative or other reason|0|||
46973195|NCT01987960|83216963|FG000|Period 3|Adverse Event|0|||
46973196|NCT01987960|83216964|FG001|Period 3|Adverse Event|0|||
46973197|NCT01987960|83216965|FG002|Period 3|Adverse Event|0|||
46973198|NCT01987960|83216966|FG003|Period 3|Adverse Event|7|||
46973199|NCT01987960|83216963|FG000|Period 3|Non-compliance with IMP|0|||
46973200|NCT01987960|83216964|FG001|Period 3|Non-compliance with IMP|0|||
46973201|NCT01987960|83216965|FG002|Period 3|Non-compliance with IMP|0|||
46973202|NCT01987960|83216966|FG003|Period 3|Non-compliance with IMP|1|||
46973203|NCT01987960|83216963|FG000|Period 3|Protocol Violation|0|||
46973204|NCT01987960|83216964|FG001|Period 3|Protocol Violation|0|||
46973205|NCT01987960|83216965|FG002|Period 3|Protocol Violation|0|||
46973206|NCT01987960|83216966|FG003|Period 3|Protocol Violation|6|||
46973207|NCT01987960|83216963|FG000|Period 3|Withdrawal by Subject|0|||
46973208|NCT01987960|83216964|FG001|Period 3|Withdrawal by Subject|0|||
46973209|NCT01987960|83216965|FG002|Period 3|Withdrawal by Subject|0|||
46973210|NCT01987960|83216966|FG003|Period 3|Withdrawal by Subject|9|||
46973211|NCT01987960|83216963|FG000|Period 3|Lost to Follow-up|0|||
46973212|NCT01987960|83216964|FG001|Period 3|Lost to Follow-up|0|||
46973213|NCT01987960|83216965|FG002|Period 3|Lost to Follow-up|0|||
46973214|NCT01987960|83216966|FG003|Period 3|Lost to Follow-up|5|||
46973215|NCT01987960|83216963|FG000|Period 3|Administrative or other reason|0|||
46787906|NCT00636168|83007037|FG001|Treated With Study Drug|Other reason|3|||
46787907|NCT00636168|83007036|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
46787908|NCT00636168|83007037|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
46787909|NCT00636168|83007036|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
46787910|NCT00636168|83007037|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
46787911|NCT00636168|83007036|FG000|Long Term Follow-Up|Death|8|||
46973216|NCT01987960|83216964|FG001|Period 3|Administrative or other reason|0|||
46973217|NCT01987960|83216965|FG002|Period 3|Administrative or other reason|0|||
46787912|NCT00636168|83007037|FG001|Long Term Follow-Up|Death|9|||
46787913|NCT00759941|83007045|FG000|Overall Study|Use of medication|1|||
46787914|NCT00759941|83007046|FG001|Overall Study|Use of medication|0|||
46787915|NCT00759941|83007045|FG000|Overall Study|Adverse Event|1|||
46787916|NCT00759941|83007046|FG001|Overall Study|Adverse Event|0|||
46787917|NCT00759941|83007045|FG000|Overall Study|Exited in error by site|1|||
46787918|NCT00759941|83007046|FG001|Overall Study|Exited in error by site|1|||
46787919|NCT00528424|83007052|FG000|Overall Study|Lost to Follow-up|13|||
46787920|NCT00528424|83007052|FG000|Overall Study|Withdrew consent|2|||
46787921|NCT00528424|83007052|FG000|Overall Study|Administrative reason|2|||
46787922|NCT00528424|83007052|FG000|Overall Study|Other|12|||
46787923|NCT00315445|83007059|FG000|Overall Study|Adverse Event|7|||
46787924|NCT00315445|83007060|FG001|Overall Study|Adverse Event|12|||
46787925|NCT00315445|83007061|FG002|Overall Study|Adverse Event|15|||
46673383|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
46673384|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
46673385|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
46673386|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
46673387|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
46673388|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
46673389|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
46673390|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
46673391|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
46673392|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
46673393|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
46673394|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
46673395|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
46787926|NCT00315445|83007059|FG000|Overall Study|Lack of Efficacy|16|||
46787927|NCT00315445|83007060|FG001|Overall Study|Lack of Efficacy|1|||
46787928|NCT00315445|83007061|FG002|Overall Study|Lack of Efficacy|7|||
46787929|NCT00315445|83007059|FG000|Overall Study|Lost to Follow-up|1|||
46787930|NCT00315445|83007060|FG001|Overall Study|Lost to Follow-up|0|||
46787931|NCT00315445|83007061|FG002|Overall Study|Lost to Follow-up|1|||
46787932|NCT00315445|83007059|FG000|Overall Study|Protocol Violation|2|||
46787933|NCT00315445|83007060|FG001|Overall Study|Protocol Violation|0|||
46787934|NCT00315445|83007061|FG002|Overall Study|Protocol Violation|1|||
46787935|NCT00315445|83007059|FG000|Overall Study|Other|1|||
46787936|NCT00315445|83007060|FG001|Overall Study|Other|3|||
46787937|NCT00315445|83007061|FG002|Overall Study|Other|0|||
46787938|NCT03687736|83007069|FG000|Overall Study|Lost to Follow-up|7|||
46787939|NCT03687736|83007069|FG000|Overall Study|Withdrawal by Subject|3|||
46787940|NCT00779675|83007075|FG000|Treatment Period|Adverse Event|87|||
46787941|NCT00779675|83007075|FG000|Treatment Period|Treatment Failure|80|||
46787942|NCT00779675|83007075|FG000|Treatment Period|Transferred to Another Study|38|||
46787943|NCT00779675|83007075|FG000|Treatment Period|Lost to Follow-up|23|||
46787944|NCT00779675|83007075|FG000|Treatment Period|Withdrawal by Subject|46|||
46787945|NCT00779675|83007075|FG000|Treatment Period|Protocol Violation|54|||
46787946|NCT00779675|83007075|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
46787947|NCT00779675|83007075|FG000|Treatment Period|Administrative|3|||
46787948|NCT00779675|83007075|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
46787949|NCT00779675|83007075|FG000|Extended Treatment Period|Protocol Violation|13|||
46787950|NCT00779675|83007075|FG000|Extended Treatment Period|Adverse Event|6|||
46973218|NCT01987960|83216966|FG003|Period 3|Administrative or other reason|43|||
46973219|NCT02013778|83216976|FG000|Overall Study|Death|4|||
46973220|NCT02013778|83216976|FG000|Overall Study|Withdrawal by Subject|1|||
46973221|NCT02013778|83216976|FG000|Overall Study|Physician Decision|1|||
46973222|NCT02013778|83216976|FG000|Overall Study|Adverse Event|1|||
46973223|NCT02013622|83216980|FG000|Overall Study|Lost to Follow-up|10|||
46973224|NCT02013622|83216980|FG000|Overall Study|Adverse Event|3|||
46973225|NCT02013622|83216980|FG000|Overall Study|Met Withdrawal Criteria|3|||
46973226|NCT02013622|83216980|FG000|Overall Study|Withdrawal by Subject|6|||
46973227|NCT02013622|83216980|FG000|Overall Study|Protocol Deviation|1|||
46973228|NCT02013622|83216980|FG000|Overall Study|Lack of Efficacy|1|||
46973229|NCT01987102|83216986|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
47077703|NCT01465802|83380399|FG001|Overall Study|Death|12|||
47077704|NCT01465802|83380400|FG002|Overall Study|Death|0|||
47077705|NCT01465802|83380401|FG003|Overall Study|Death|10|||
47077706|NCT01465802|83380402|FG004|Overall Study|Death|2|||
47077707|NCT01437878|83380447|FG000|Overall Study|Withdrawal by Subject|1|||
47077708|NCT01437878|83380448|FG001|Overall Study|Withdrawal by Subject|0|||
47077709|NCT01465178|83380474|FG000|Overall Study|Withdrawal by Subject|1|||
46787951|NCT00779675|83007075|FG000|Extended Treatment Period|Treatment Failure|11|||
46787952|NCT00779675|83007075|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
46787953|NCT00779675|83007075|FG000|Extended Treatment Period|Lost to Follow-up|6|||
46787954|NCT00759863|83007085|FG000|Overall Study|Death, moved, or lost contact|20|||
46787955|NCT00759863|83007086|FG001|Overall Study|Death, moved, or lost contact|18|||
47077710|NCT01465178|83380475|FG001|Overall Study|Withdrawal by Subject|0|||
46787956|NCT00759785|83007094|FG000|Overall Study|Participant sample not evaluable|11|||
46787957|NCT00759785|83007095|FG001|Overall Study|Participant sample not evaluable|2|||
46787958|NCT00759785|83007094|FG000|Overall Study|Participant sample lost|0|||
46787959|NCT00759785|83007095|FG001|Overall Study|Participant sample lost|1|||
46787960|NCT00759785|83007094|FG000|Overall Study|Protocol Violation|1|||
46787961|NCT00759785|83007095|FG001|Overall Study|Protocol Violation|0|||
46787962|NCT00759785|83007094|FG000|Overall Study|Physician Decision|0|||
46787963|NCT00759785|83007095|FG001|Overall Study|Physician Decision|1|||
46973230|NCT01987102|83216987|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
46973231|NCT01987102|83216986|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
46973232|NCT01987102|83216987|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
46973233|NCT01987102|83216986|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
46973234|NCT01987102|83216987|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
46673396|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
46787964|NCT00759785|83007094|FG000|Overall Study|Withdrawal by Subject|0|||
46787965|NCT00759785|83007095|FG001|Overall Study|Withdrawal by Subject|1|||
46787966|NCT00300781|83007103|FG000|Overall Study|Disease Progression|55|||
46787967|NCT00300781|83007104|FG001|Overall Study|Disease Progression|52|||
46787968|NCT00300781|83007103|FG000|Overall Study|Adverse Event|5|||
46787969|NCT00300781|83007104|FG001|Overall Study|Adverse Event|6|||
46787970|NCT00300781|83007103|FG000|Overall Study|Withdrawal by Subject|1|||
46787971|NCT00300781|83007104|FG001|Overall Study|Withdrawal by Subject|2|||
46787972|NCT00300781|83007103|FG000|Overall Study|Physician Decision|1|||
46787973|NCT00300781|83007104|FG001|Overall Study|Physician Decision|0|||
46787974|NCT00300781|83007103|FG000|Overall Study|Not Recorded|0|||
46787975|NCT00300781|83007104|FG001|Overall Study|Not Recorded|1|||
46787976|NCT00300781|83007103|FG000|Overall Study|Symptomatic Deterioration|1|||
46787977|NCT00300781|83007104|FG001|Overall Study|Symptomatic Deterioration|0|||
46787978|NCT00300781|83007103|FG000|Overall Study|Lost to Follow-up|0|||
46787979|NCT00300781|83007104|FG001|Overall Study|Lost to Follow-up|1|||
46787980|NCT00315055|83007112|FG000|Overall Study|Protocol Violation|2|||
46787981|NCT00315055|83007113|FG001|Overall Study|Protocol Violation|4|||
47077711|NCT01445678|83380581|FG000|Overall Study|Adverse Event|12|||
47077712|NCT01445678|83380582|FG001|Overall Study|Adverse Event|8|||
47077713|NCT01445678|83380581|FG000|Overall Study|Lack of Efficacy|0|||
46673397|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
46673398|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
46673399|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46673400|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
46673401|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
46673402|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46673403|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46673404|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46673405|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
46673406|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
46673407|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
46673408|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673409|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673410|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
46673411|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673412|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673413|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673414|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673415|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673416|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
46673417|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
46673418|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
46673419|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
46673420|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
46673421|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
46673422|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
46673423|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
46787982|NCT00315055|83007112|FG000|Overall Study|Lost to Follow-up|1|||
46787983|NCT00315055|83007113|FG001|Overall Study|Lost to Follow-up|1|||
46787984|NCT00528970|83007125|FG000|Overall Study|Adverse Event|6|||
46787985|NCT00528970|83007126|FG001|Overall Study|Adverse Event|8|||
46787986|NCT00528970|83007127|FG002|Overall Study|Adverse Event|5|||
46787987|NCT00528970|83007125|FG000|Overall Study|Lost to Follow-up|0|||
46787988|NCT00528970|83007126|FG001|Overall Study|Lost to Follow-up|0|||
46787989|NCT00528970|83007127|FG002|Overall Study|Lost to Follow-up|1|||
46673424|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
46787990|NCT00528970|83007125|FG000|Overall Study|Other than specified|2|||
46787991|NCT00528970|83007126|FG001|Overall Study|Other than specified|3|||
46673425|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
46673426|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
46673427|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
46673428|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
46673429|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
46673430|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
46787992|NCT00528970|83007127|FG002|Overall Study|Other than specified|3|||
46787993|NCT00528970|83007125|FG000|Overall Study|Protocol Violation|2|||
46787994|NCT00528970|83007126|FG001|Overall Study|Protocol Violation|1|||
46787995|NCT00528970|83007127|FG002|Overall Study|Protocol Violation|4|||
46787996|NCT00528970|83007125|FG000|Overall Study|Lack of Efficacy|0|||
46787997|NCT00528970|83007126|FG001|Overall Study|Lack of Efficacy|0|||
46787998|NCT00528970|83007127|FG002|Overall Study|Lack of Efficacy|1|||
46787999|NCT00528970|83007125|FG000|Overall Study|Withdrawal by Subject|4|||
46788000|NCT00528970|83007126|FG001|Overall Study|Withdrawal by Subject|3|||
46788001|NCT00528970|83007127|FG002|Overall Study|Withdrawal by Subject|5|||
46788002|NCT00528970|83007125|FG000|Overall Study|Randomized but not treated|0|||
46788003|NCT00528970|83007126|FG001|Overall Study|Randomized but not treated|0|||
46788004|NCT00528970|83007127|FG002|Overall Study|Randomized but not treated|1|||
46788005|NCT00759395|83007137|FG000|Overall Study|Adverse Event|1|||
46788006|NCT00759395|83007138|FG001|Overall Study|Adverse Event|0|||
46788007|NCT00759395|83007137|FG000|Overall Study|Withdrawal by Subject|1|||
46788008|NCT00759395|83007138|FG001|Overall Study|Withdrawal by Subject|0|||
46788009|NCT00759395|83007137|FG000|Overall Study|Lack of Efficacy|0|||
46788010|NCT00759395|83007138|FG001|Overall Study|Lack of Efficacy|2|||
46788011|NCT00293293|83007146|FG000|Overall Study|Withdrawal by Subject|1|||
46788012|NCT00293293|83007147|FG001|Overall Study|Withdrawal by Subject|1|||
46788013|NCT00293293|83007146|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
46788014|NCT00293293|83007147|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
46788015|NCT00293293|83007146|FG000|Overall Study|Patient discontinued chemotherapy|0|||
46788016|NCT00293293|83007147|FG001|Overall Study|Patient discontinued chemotherapy|1|||
46788017|NCT04864639|83007154|FG000|Overall Study|Death|1|||
46788018|NCT04864639|83007154|FG000|Overall Study|Lost to Follow-up|1|||
46788019|NCT04245449|83007180|FG000|Overall Study|COVID shutdown|7|||
46673431|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
46673432|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
46673433|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
46673434|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
46788020|NCT03887221|83007190|FG000|Overall Study|Protocol Violation|1|||
46788021|NCT03887221|83007191|FG001|Overall Study|Protocol Violation|0|||
47077714|NCT01445678|83380582|FG001|Overall Study|Lack of Efficacy|2|||
47077715|NCT01445678|83380581|FG000|Overall Study|Lost to Follow-up|8|||
47077716|NCT01445678|83380582|FG001|Overall Study|Lost to Follow-up|5|||
47077717|NCT01445678|83380581|FG000|Overall Study|Protocol Violation|1|||
47077718|NCT01445678|83380582|FG001|Overall Study|Protocol Violation|1|||
47077719|NCT01445678|83380581|FG000|Overall Study|Withdrawal by Subject|9|||
47077720|NCT01445678|83380582|FG001|Overall Study|Withdrawal by Subject|5|||
47077721|NCT03769194|83380601|FG000|Overall Study|Withdrawal by Subject|0|||
47077722|NCT03769194|83380602|FG001|Overall Study|Withdrawal by Subject|7|||
46788022|NCT03604445|83007212|FG000|Overall Study|Death|0|||
46788023|NCT03604445|83007213|FG001|Overall Study|Death|0|||
46788024|NCT03604445|83007214|FG002|Overall Study|Death|0|||
46788025|NCT03604445|83007215|FG003|Overall Study|Death|0|||
46788026|NCT03604445|83007216|FG004|Overall Study|Death|0|||
46788027|NCT03604445|83007217|FG005|Overall Study|Death|0|||
46852165|NCT03560986|83067601|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
46973235|NCT01987102|83216986|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
46788028|NCT03604445|83007218|FG006|Overall Study|Death|0|||
47077723|NCT03769194|83380603|FG002|Overall Study|Withdrawal by Subject|4|||
46788029|NCT03604445|83007219|FG007|Overall Study|Death|0|||
46788030|NCT03604445|83007220|FG008|Overall Study|Death|1|||
46788031|NCT03604445|83007212|FG000|Overall Study|Withdrawal by Subject|0|||
46673435|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46788032|NCT03604445|83007213|FG001|Overall Study|Withdrawal by Subject|0|||
46788033|NCT03604445|83007214|FG002|Overall Study|Withdrawal by Subject|0|||
47077724|NCT03769194|83380604|FG003|Overall Study|Withdrawal by Subject|1|||
46788034|NCT03604445|83007215|FG003|Overall Study|Withdrawal by Subject|0|||
46788035|NCT03604445|83007216|FG004|Overall Study|Withdrawal by Subject|0|||
46788036|NCT03604445|83007217|FG005|Overall Study|Withdrawal by Subject|0|||
46788037|NCT03604445|83007218|FG006|Overall Study|Withdrawal by Subject|1|||
46788038|NCT03604445|83007219|FG007|Overall Study|Withdrawal by Subject|0|||
46788039|NCT03604445|83007220|FG008|Overall Study|Withdrawal by Subject|0|||
46788040|NCT03604445|83007212|FG000|Overall Study|Missing visit|0|||
46788041|NCT03604445|83007213|FG001|Overall Study|Missing visit|0|||
46788042|NCT03604445|83007214|FG002|Overall Study|Missing visit|0|||
46788043|NCT03604445|83007215|FG003|Overall Study|Missing visit|0|||
46852166|NCT03560986|83067600|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
46852167|NCT03560986|83067601|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
47077725|NCT03769194|83380601|FG000|Overall Study|moved from study area|0|||
47077726|NCT03769194|83380602|FG001|Overall Study|moved from study area|2|||
47077727|NCT03769194|83380603|FG002|Overall Study|moved from study area|1|||
47077728|NCT03769194|83380604|FG003|Overall Study|moved from study area|1|||
47077729|NCT03769194|83380601|FG000|Overall Study|Lost to Follow-up|3|||
47077730|NCT03769194|83380602|FG001|Overall Study|Lost to Follow-up|6|||
47077731|NCT03769194|83380603|FG002|Overall Study|Lost to Follow-up|3|||
47077732|NCT03769194|83380604|FG003|Overall Study|Lost to Follow-up|6|||
47077733|NCT03769194|83380601|FG000|Overall Study|other|1|||
47077734|NCT03769194|83380602|FG001|Overall Study|other|3|||
47077735|NCT03769194|83380603|FG002|Overall Study|other|0|||
47077736|NCT03769194|83380604|FG003|Overall Study|other|1|||
47077737|NCT01465022|83380630|FG000|Overall Study|Lost to Follow-up|15|||
47077738|NCT01465022|83380631|FG001|Overall Study|Lost to Follow-up|14|||
47077739|NCT01465022|83380632|FG002|Overall Study|Lost to Follow-up|0|||
47077740|NCT01465022|83380630|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
47077741|NCT01465022|83380631|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
47077742|NCT01465022|83380632|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
47077743|NCT01465022|83380630|FG000|Overall Study|Not Randomized|0|||
47077744|NCT01465022|83380631|FG001|Overall Study|Not Randomized|0|||
47077745|NCT01465022|83380632|FG002|Overall Study|Not Randomized|70|||
47077746|NCT01464788|83380676|FG000|Overall Study|Lost to Follow-up|0|||
47077747|NCT01464788|83380677|FG001|Overall Study|Lost to Follow-up|1|||
47077748|NCT01464788|83380678|FG002|Overall Study|Lost to Follow-up|0|||
47077749|NCT01464788|83380676|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
47077750|NCT01464788|83380677|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
47077751|NCT01464788|83380678|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
47077752|NCT01444898|83380688|FG000|Overall Study|Withdrawal by Subject|1|||
46852168|NCT03560986|83067600|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
46852169|NCT03560986|83067601|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
47077753|NCT01419626|83380706|FG000|Overall Study|Protocol Violation|3|||
46673436|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46673437|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
46673438|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46673439|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46673440|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46673441|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46673442|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46673443|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
46673444|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46673445|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
46673446|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
46673447|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46673448|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46673449|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46673450|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
46673451|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
46852170|NCT03560986|83067600|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
47077754|NCT01419626|83380707|FG001|Overall Study|Protocol Violation|2|||
47077755|NCT01419626|83380708|FG002|Overall Study|Protocol Violation|2|||
47077756|NCT01419626|83380706|FG000|Overall Study|Withdrawal by Subject|1|||
47077757|NCT01419626|83380707|FG001|Overall Study|Withdrawal by Subject|0|||
47077758|NCT01419626|83380708|FG002|Overall Study|Withdrawal by Subject|0|||
47077759|NCT01419626|83380706|FG000|Overall Study|Lost to Follow-up|0|||
47077760|NCT01419626|83380707|FG001|Overall Study|Lost to Follow-up|1|||
47077761|NCT01419626|83380708|FG002|Overall Study|Lost to Follow-up|1|||
46788044|NCT03604445|83007216|FG004|Overall Study|Missing visit|0|||
46788045|NCT03604445|83007217|FG005|Overall Study|Missing visit|1|||
46788046|NCT03604445|83007218|FG006|Overall Study|Missing visit|0|||
47077762|NCT01444742|83380747|FG000|Overall Study|Death|1|||
46788047|NCT03604445|83007219|FG007|Overall Study|Missing visit|1|||
46788048|NCT03604445|83007220|FG008|Overall Study|Missing visit|0|||
46788049|NCT03604445|83007212|FG000|Overall Study|Adverse Event|0|||
46788050|NCT03604445|83007213|FG001|Overall Study|Adverse Event|0|||
46788051|NCT03604445|83007214|FG002|Overall Study|Adverse Event|0|||
46852171|NCT03560986|83067601|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
47077763|NCT01444430|83380947|FG000|Overall Study|Withdrawal by Subject|53|||
47077764|NCT01444430|83380948|FG001|Overall Study|Withdrawal by Subject|72|||
47077765|NCT01444430|83380947|FG000|Overall Study|Death|6|||
47077766|NCT01444430|83380948|FG001|Overall Study|Death|8|||
47077767|NCT01444430|83380947|FG000|Overall Study|Lost to Follow-up|2|||
47077768|NCT01444430|83380948|FG001|Overall Study|Lost to Follow-up|0|||
47077769|NCT01444430|83380947|FG000|Overall Study|CRF termination module not completed.|0|||
47077770|NCT01444430|83380948|FG001|Overall Study|CRF termination module not completed.|1|||
47077771|NCT01436162|83381024|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
47077772|NCT01436162|83381025|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
47077773|NCT01436162|83381026|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
47077774|NCT01436162|83381024|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
47077775|NCT01436162|83381025|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
47077776|NCT01436162|83381026|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
47077777|NCT01436162|83381024|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
47077778|NCT01436162|83381025|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
47077779|NCT01436162|83381026|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
47077780|NCT01436162|83381024|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
47077781|NCT01436162|83381025|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
47077782|NCT01436162|83381026|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
47077783|NCT01436162|83381024|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
47077784|NCT01436162|83381025|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
47077785|NCT01436162|83381026|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
47077786|NCT01436162|83381024|FG000|Single-blind Lead-in Phase|Other|107|||
47077787|NCT01436162|83381025|FG001|Single-blind Lead-in Phase|Other|0|||
47077788|NCT01436162|83381026|FG002|Single-blind Lead-in Phase|Other|0|||
47077789|NCT01436162|83381024|FG000|Randomized Phase|Adverse Event|1|||
47077790|NCT01436162|83381025|FG001|Randomized Phase|Adverse Event|5|||
47077791|NCT01436162|83381026|FG002|Randomized Phase|Adverse Event|6|||
47077792|NCT01436162|83381024|FG000|Randomized Phase|Protocol Violation|4|||
47077793|NCT01436162|83381025|FG001|Randomized Phase|Protocol Violation|4|||
47077794|NCT01436162|83381026|FG002|Randomized Phase|Protocol Violation|2|||
47077795|NCT01436162|83381024|FG000|Randomized Phase|Withdrawal by Subject|16|||
47077796|NCT01436162|83381025|FG001|Randomized Phase|Withdrawal by Subject|9|||
47077797|NCT01436162|83381026|FG002|Randomized Phase|Withdrawal by Subject|8|||
47077798|NCT01436162|83381024|FG000|Randomized Phase|Lost to Follow-up|17|||
47077799|NCT01436162|83381025|FG001|Randomized Phase|Lost to Follow-up|5|||
47077800|NCT01436162|83381026|FG002|Randomized Phase|Lost to Follow-up|4|||
47077801|NCT01436162|83381024|FG000|Randomized Phase|Lack of Efficacy|0|||
47077802|NCT01436162|83381025|FG001|Randomized Phase|Lack of Efficacy|1|||
47077803|NCT01436162|83381026|FG002|Randomized Phase|Lack of Efficacy|1|||
47077804|NCT01436162|83381024|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
47077805|NCT01436162|83381025|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
47077806|NCT01436162|83381026|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
47077807|NCT01436162|83381024|FG000|Randomized Phase|Other|2|||
47077808|NCT01436162|83381025|FG001|Randomized Phase|Other|5|||
47077809|NCT01436162|83381026|FG002|Randomized Phase|Other|4|||
47077810|NCT02579382|83381038|FG000|Main Study Phase|Lost to Follow-up|0|||
47077811|NCT02579382|83381039|FG001|Main Study Phase|Lost to Follow-up|0|||
47077812|NCT02579382|83381040|FG002|Main Study Phase|Lost to Follow-up|2|||
47077813|NCT02579382|83381041|FG003|Main Study Phase|Lost to Follow-up|0|||
47077814|NCT02579382|83381038|FG000|Main Study Phase|Withdrew Consent|0|||
47077815|NCT02579382|83381039|FG001|Main Study Phase|Withdrew Consent|0|||
46788052|NCT03604445|83007215|FG003|Overall Study|Adverse Event|1|||
46788053|NCT03604445|83007216|FG004|Overall Study|Adverse Event|0|||
47077816|NCT02579382|83381040|FG002|Main Study Phase|Withdrew Consent|0|||
47077817|NCT02579382|83381041|FG003|Main Study Phase|Withdrew Consent|2|||
47077818|NCT02579382|83381038|FG000|Main Study Phase|Lack of Efficacy|0|||
47077819|NCT02579382|83381039|FG001|Main Study Phase|Lack of Efficacy|0|||
47077820|NCT02579382|83381040|FG002|Main Study Phase|Lack of Efficacy|0|||
46788054|NCT03604445|83007217|FG005|Overall Study|Adverse Event|0|||
46788055|NCT03604445|83007218|FG006|Overall Study|Adverse Event|0|||
47077821|NCT02579382|83381041|FG003|Main Study Phase|Lack of Efficacy|1|||
47077822|NCT02579382|83381038|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
47077823|NCT02579382|83381039|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
47077824|NCT02579382|83381040|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
47077825|NCT02579382|83381041|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
47077826|NCT02579382|83381038|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
47077827|NCT02579382|83381039|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
47077828|NCT02579382|83381040|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
47077829|NCT02579382|83381041|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
47077830|NCT02579382|83381038|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
47077831|NCT02579382|83381039|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
47077832|NCT02579382|83381040|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
47077833|NCT02579382|83381041|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
47077834|NCT02579382|83381038|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
47077835|NCT02579382|83381039|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
47077836|NCT02579382|83381040|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
47077837|NCT02579382|83381041|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
47077838|NCT02579382|83381038|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
47077839|NCT02579382|83381039|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
47077840|NCT02579382|83381040|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
47077841|NCT02579382|83381041|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
47077842|NCT02579382|83381038|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
47077843|NCT02579382|83381039|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
47077844|NCT02579382|83381040|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
47077845|NCT02579382|83381041|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
47077846|NCT01436084|83381068|FG000|Overall Study|Disease Progression|2|||
47077847|NCT01436084|83381068|FG000|Overall Study|Withdrawal by Subject|1|||
47077848|NCT01436084|83381068|FG000|Overall Study|Early Closure of Study|1|||
47077849|NCT01419314|83381083|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
47077850|NCT01419314|83381084|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
47077851|NCT01419314|83381083|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
47077852|NCT01419314|83381084|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
47077853|NCT01419314|83381083|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
47077854|NCT01419314|83381084|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
47077855|NCT01419236|83381141|FG000|Overall Study|Adverse Event|1|||
47077856|NCT01419236|83381142|FG001|Overall Study|Adverse Event|0|||
47077857|NCT01419236|83381141|FG000|Overall Study|Lack of Efficacy|0|||
47077858|NCT01419236|83381142|FG001|Overall Study|Lack of Efficacy|1|||
47077859|NCT01419236|83381141|FG000|Overall Study|Lost to Follow-up|1|||
47077860|NCT01419236|83381142|FG001|Overall Study|Lost to Follow-up|0|||
47077861|NCT01419236|83381141|FG000|Overall Study|Physician Decision|1|||
47077862|NCT01419236|83381142|FG001|Overall Study|Physician Decision|0|||
47077863|NCT01419236|83381141|FG000|Overall Study|Withdrawal by Subject|1|||
47077864|NCT01419236|83381142|FG001|Overall Study|Withdrawal by Subject|4|||
47077865|NCT01419236|83381141|FG000|Overall Study|Entry Criteria Not Met|1|||
47077866|NCT01419236|83381142|FG001|Overall Study|Entry Criteria Not Met|0|||
47077867|NCT03323658|83381155|FG000|Overall Study|Adverse Event|0|||
47077868|NCT03323658|83381156|FG001|Overall Study|Adverse Event|1|||
47077869|NCT03323658|83381157|FG002|Overall Study|Adverse Event|0|||
47077870|NCT01443026|83381182|FG000|Overall Study|Physician Decision|1|||
47077871|NCT01443026|83381183|FG001|Overall Study|Physician Decision|0|||
47077872|NCT01443026|83381182|FG000|Overall Study|Death|0|||
47077873|NCT01443026|83381183|FG001|Overall Study|Death|1|||
47077874|NCT01443026|83381182|FG000|Overall Study|Withdrawal by Subject|0|||
47077875|NCT01443026|83381183|FG001|Overall Study|Withdrawal by Subject|3|||
47077876|NCT01443026|83381182|FG000|Overall Study|Lost to Follow-up|2|||
47077877|NCT01443026|83381183|FG001|Overall Study|Lost to Follow-up|1|||
47077878|NCT01442714|83381217|FG000|Overall Study|Death|11|||
47077879|NCT01442714|83381217|FG000|Overall Study|Withdrawal by Subject|1|||
47077880|NCT01418378|83381230|FG000|Overall Study|Death|1|||
47077881|NCT01418378|83381231|FG001|Overall Study|Death|2|||
47077882|NCT01418378|83381230|FG000|Overall Study|Physician Decision|0|||
46788056|NCT03604445|83007219|FG007|Overall Study|Adverse Event|0|||
47077883|NCT01418378|83381231|FG001|Overall Study|Physician Decision|1|||
47077884|NCT01418378|83381230|FG000|Overall Study|ligament imbalance|0|||
47077885|NCT01418378|83381231|FG001|Overall Study|ligament imbalance|1|||
47077886|NCT01418378|83381230|FG000|Overall Study|developed chronic myopathy|0|||
47077887|NCT01418378|83381231|FG001|Overall Study|developed chronic myopathy|1|||
47077888|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
47077889|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
47077890|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
47077891|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
47077892|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
47077893|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
47077894|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
47077895|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
47077896|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
47077897|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
47077898|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
47077899|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
47077900|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
47077901|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
47077902|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
47077903|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
46673452|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
46673453|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46673454|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46673455|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46973236|NCT01987102|83216987|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
46973237|NCT01987102|83216986|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
46973238|NCT01987102|83216987|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
46973239|NCT01987102|83216986|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
46973240|NCT01987102|83216987|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
46973241|NCT02013544|83216996|FG000|Overall Study|Adverse Event|5|||
46973242|NCT02013544|83216997|FG001|Overall Study|Adverse Event|5|||
46973243|NCT02013544|83216996|FG000|Overall Study|Lost to Follow-up|2|||
46973244|NCT02013544|83216997|FG001|Overall Study|Lost to Follow-up|3|||
46973245|NCT02013544|83216996|FG000|Overall Study|Withdrawal by Subject|2|||
46973246|NCT02013544|83216997|FG001|Overall Study|Withdrawal by Subject|8|||
46973247|NCT02013544|83216996|FG000|Overall Study|Physician Decision|0|||
46973248|NCT02013544|83216997|FG001|Overall Study|Physician Decision|1|||
46973249|NCT02013544|83216996|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
46973250|NCT02013544|83216997|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
46973251|NCT02013388|83217011|FG000|Overall Study|work emergency|1|||
46973252|NCT02013388|83217012|FG001|Overall Study|work emergency|0|||
46973253|NCT02013388|83217013|FG002|Overall Study|work emergency|0|||
46973254|NCT02013388|83217014|FG003|Overall Study|work emergency|0|||
46973255|NCT02013388|83217015|FG004|Overall Study|work emergency|1|||
46973256|NCT02013388|83217016|FG005|Overall Study|work emergency|0|||
46973257|NCT02013388|83217017|FG006|Overall Study|work emergency|0|||
46973258|NCT02013388|83217018|FG007|Overall Study|work emergency|0|||
46973259|NCT02012686|83217042|FG000|Overall Study|muscle contraction|0|||
46973260|NCT02012686|83217043|FG001|Overall Study|muscle contraction|1|||
46973261|NCT02012686|83217042|FG000|Overall Study|electrocardiography monitoring noise|0|||
46973262|NCT02012686|83217043|FG001|Overall Study|electrocardiography monitoring noise|1|||
46973263|NCT02012452|83217051|FG000|Overall Study|Lost to Follow-up|2|||
46973264|NCT02012452|83217052|FG001|Overall Study|Lost to Follow-up|1|||
46973265|NCT02012452|83217051|FG000|Overall Study|Withdrawal by Subject|4|||
46973266|NCT02012452|83217052|FG001|Overall Study|Withdrawal by Subject|0|||
47077904|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
46788057|NCT03604445|83007220|FG008|Overall Study|Adverse Event|1|||
46788058|NCT02782741|83007248|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
46673456|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46673457|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46673458|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46673459|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46673460|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
46673461|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
46673462|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673463|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
46788059|NCT02782741|83007249|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
46788060|NCT02782741|83007248|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
46788061|NCT02782741|83007249|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
46788062|NCT02782741|83007248|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
46788063|NCT02782741|83007249|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
46788064|NCT02782741|83007248|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
46788065|NCT02782741|83007249|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
46788066|NCT02782741|83007248|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
46788067|NCT02782741|83007249|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
46788068|NCT02771626|83007265|FG000|Overall Study|Adverse Event|1|||
46788069|NCT02771626|83007266|FG001|Overall Study|Adverse Event|5|||
46788070|NCT02771626|83007267|FG002|Overall Study|Adverse Event|3|||
47077905|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
46788071|NCT02771626|83007268|FG003|Overall Study|Adverse Event|0|||
46788072|NCT02771626|83007269|FG004|Overall Study|Adverse Event|1|||
46788073|NCT02771626|83007270|FG005|Overall Study|Adverse Event|1|||
46788074|NCT02771626|83007265|FG000|Overall Study|Radiologic Disease Progression|6|||
46788075|NCT02771626|83007266|FG001|Overall Study|Radiologic Disease Progression|13|||
46788076|NCT02771626|83007267|FG002|Overall Study|Radiologic Disease Progression|10|||
46788077|NCT02771626|83007268|FG003|Overall Study|Radiologic Disease Progression|7|||
46852172|NCT03560986|83067600|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
46852173|NCT03560986|83067601|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
46852174|NCT03560986|83067600|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
46852175|NCT03560986|83067601|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
46852176|NCT03560518|83067616|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
46852177|NCT03560518|83067617|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
46852178|NCT03560518|83067618|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
46852179|NCT03560518|83067616|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
46973267|NCT01676909|83217060|FG000|Overall Study|Withdrawal by Subject|3|||
46973268|NCT01676909|83217061|FG001|Overall Study|Withdrawal by Subject|5|||
46973269|NCT01676909|83217060|FG000|Overall Study|Lost to Follow-up|15|||
46973270|NCT01676909|83217061|FG001|Overall Study|Lost to Follow-up|9|||
46973271|NCT02012296|83217072|FG000|Overall Study|Lack of Efficacy|0|||
46973272|NCT02012296|83217073|FG001|Overall Study|Lack of Efficacy|0|||
46852180|NCT03560518|83067617|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
46852181|NCT03560518|83067618|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
46852182|NCT03560518|83067616|FG000|Double Blind Treatment Period|Protocol Violation|1|||
46852183|NCT03560518|83067617|FG001|Double Blind Treatment Period|Protocol Violation|2|||
46852184|NCT03560518|83067618|FG002|Double Blind Treatment Period|Protocol Violation|0|||
46852185|NCT03560518|83067616|FG000|Double Blind Treatment Period|Pregnancy|0|||
46973273|NCT02012296|83217074|FG002|Overall Study|Lack of Efficacy|15|||
46973274|NCT02012296|83217072|FG000|Overall Study|Adverse Event|0|||
46973275|NCT02012296|83217073|FG001|Overall Study|Adverse Event|0|||
46973276|NCT02012296|83217074|FG002|Overall Study|Adverse Event|2|||
46973277|NCT02012296|83217072|FG000|Overall Study|Early study closure|0|||
46973278|NCT02012296|83217073|FG001|Overall Study|Early study closure|0|||
46973279|NCT02012296|83217074|FG002|Overall Study|Early study closure|5|||
46973280|NCT02012296|83217072|FG000|Overall Study|Protocol Violation|0|||
46973281|NCT02012296|83217073|FG001|Overall Study|Protocol Violation|1|||
46973282|NCT02012296|83217074|FG002|Overall Study|Protocol Violation|0|||
46973283|NCT02012218|83217091|FG000|Overall Study|Withdrawal by Subject|1|||
46973284|NCT02012218|83217092|FG001|Overall Study|Withdrawal by Subject|0|||
46973285|NCT02012218|83217093|FG002|Overall Study|Withdrawal by Subject|1|||
46973286|NCT02012218|83217094|FG003|Overall Study|Withdrawal by Subject|1|||
46973287|NCT02012218|83217095|FG004|Overall Study|Withdrawal by Subject|1|||
46973288|NCT02012218|83217091|FG000|Overall Study|Adverse Event|1|||
46973289|NCT02012218|83217092|FG001|Overall Study|Adverse Event|0|||
46973290|NCT02012218|83217093|FG002|Overall Study|Adverse Event|0|||
46973291|NCT02012218|83217094|FG003|Overall Study|Adverse Event|1|||
46973292|NCT02012218|83217095|FG004|Overall Study|Adverse Event|0|||
46973293|NCT02012218|83217091|FG000|Overall Study|Lost to Follow-up|0|||
46973294|NCT02012218|83217092|FG001|Overall Study|Lost to Follow-up|1|||
46973295|NCT02012218|83217093|FG002|Overall Study|Lost to Follow-up|1|||
46973296|NCT02012218|83217094|FG003|Overall Study|Lost to Follow-up|0|||
46973297|NCT02012218|83217095|FG004|Overall Study|Lost to Follow-up|0|||
47077906|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
47077907|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
47077908|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
46788078|NCT02771626|83007269|FG004|Overall Study|Radiologic Disease Progression|28|||
46788079|NCT02771626|83007270|FG005|Overall Study|Radiologic Disease Progression|15|||
46788080|NCT02771626|83007265|FG000|Overall Study|Symptomatic Deterioration|0|||
46788081|NCT02771626|83007266|FG001|Overall Study|Symptomatic Deterioration|4|||
46852186|NCT03560518|83067617|FG001|Double Blind Treatment Period|Pregnancy|2|||
46852187|NCT03560518|83067618|FG002|Double Blind Treatment Period|Pregnancy|0|||
46852188|NCT03560518|83067616|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
46852189|NCT03560518|83067617|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
46788082|NCT02771626|83007267|FG002|Overall Study|Symptomatic Deterioration|2|||
46852190|NCT03560518|83067618|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
46973298|NCT02012218|83217091|FG000|Overall Study|Protocol Specified|1|||
46973299|NCT02012218|83217092|FG001|Overall Study|Protocol Specified|0|||
46973300|NCT02012218|83217093|FG002|Overall Study|Protocol Specified|0|||
46973301|NCT02012218|83217094|FG003|Overall Study|Protocol Specified|0|||
46973302|NCT02012218|83217095|FG004|Overall Study|Protocol Specified|0|||
46973303|NCT02012218|83217091|FG000|Overall Study|Protocol Deviation|1|||
46973304|NCT02012218|83217092|FG001|Overall Study|Protocol Deviation|0|||
46973305|NCT02012218|83217093|FG002|Overall Study|Protocol Deviation|0|||
46788083|NCT02771626|83007268|FG003|Overall Study|Symptomatic Deterioration|0|||
46788084|NCT02771626|83007269|FG004|Overall Study|Symptomatic Deterioration|5|||
46788085|NCT02771626|83007270|FG005|Overall Study|Symptomatic Deterioration|2|||
46788086|NCT02771626|83007265|FG000|Overall Study|Participant Request|0|||
46788087|NCT02771626|83007266|FG001|Overall Study|Participant Request|1|||
46788088|NCT02771626|83007267|FG002|Overall Study|Participant Request|0|||
46788089|NCT02771626|83007268|FG003|Overall Study|Participant Request|2|||
46788090|NCT02771626|83007269|FG004|Overall Study|Participant Request|0|||
46788091|NCT02771626|83007270|FG005|Overall Study|Participant Request|1|||
46788092|NCT02771626|83007265|FG000|Overall Study|Investigator Decision|0|||
46788093|NCT02771626|83007266|FG001|Overall Study|Investigator Decision|1|||
46788094|NCT02771626|83007267|FG002|Overall Study|Investigator Decision|0|||
46788095|NCT02771626|83007268|FG003|Overall Study|Investigator Decision|0|||
46788096|NCT02771626|83007269|FG004|Overall Study|Investigator Decision|1|||
46788097|NCT02771626|83007270|FG005|Overall Study|Investigator Decision|0|||
46788098|NCT02771626|83007265|FG000|Overall Study|Study Termination by Sponsor|0|||
46788099|NCT02771626|83007266|FG001|Overall Study|Study Termination by Sponsor|2|||
46788100|NCT02771626|83007267|FG002|Overall Study|Study Termination by Sponsor|1|||
46788101|NCT02771626|83007268|FG003|Overall Study|Study Termination by Sponsor|0|||
46788102|NCT02771626|83007269|FG004|Overall Study|Study Termination by Sponsor|1|||
46788103|NCT02771626|83007270|FG005|Overall Study|Study Termination by Sponsor|0|||
46788104|NCT02771626|83007265|FG000|Overall Study|Informed Consent Withdrawn|0|||
46788105|NCT02771626|83007266|FG001|Overall Study|Informed Consent Withdrawn|0|||
46788106|NCT02771626|83007267|FG002|Overall Study|Informed Consent Withdrawn|1|||
46788107|NCT02771626|83007268|FG003|Overall Study|Informed Consent Withdrawn|0|||
46788108|NCT02771626|83007269|FG004|Overall Study|Informed Consent Withdrawn|1|||
46788109|NCT02771626|83007270|FG005|Overall Study|Informed Consent Withdrawn|1|||
46788110|NCT02771626|83007265|FG000|Overall Study|Other, Not Specified|1|||
46973306|NCT02012218|83217094|FG003|Overall Study|Protocol Deviation|0|||
46973307|NCT02012218|83217095|FG004|Overall Study|Protocol Deviation|0|||
46852191|NCT03560518|83067616|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
46852192|NCT03560518|83067617|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
46852193|NCT03560518|83067618|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
46852194|NCT03560518|83067616|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
46973308|NCT01965262|83217107|FG000|Second Intervention (7 Days)|Discontinued|0|||
46973309|NCT01965262|83217108|FG001|Second Intervention (7 Days)|Discontinued|1|||
47077909|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
46788111|NCT02771626|83007266|FG001|Overall Study|Other, Not Specified|0|||
46788112|NCT02771626|83007267|FG002|Overall Study|Other, Not Specified|0|||
46788113|NCT02771626|83007268|FG003|Overall Study|Other, Not Specified|0|||
46788114|NCT02771626|83007269|FG004|Overall Study|Other, Not Specified|0|||
46788115|NCT02771626|83007270|FG005|Overall Study|Other, Not Specified|1|||
46852195|NCT03560518|83067617|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
46852196|NCT03560518|83067618|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
46852197|NCT03560518|83067616|FG000|Double Blind Treatment Period|Adverse Event|0|||
46852198|NCT03560518|83067617|FG001|Double Blind Treatment Period|Adverse Event|3|||
46852199|NCT03560518|83067618|FG002|Double Blind Treatment Period|Adverse Event|1|||
46852200|NCT03560206|83067628|FG000|Overall Study|Lost to Follow-up|19|||
46852201|NCT03560206|83067629|FG001|Overall Study|Lost to Follow-up|11|||
46852202|NCT03560206|83067628|FG000|Overall Study|Withdrawal by Subject|2|||
46852203|NCT03560206|83067629|FG001|Overall Study|Withdrawal by Subject|4|||
46852204|NCT03560206|83067628|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
46852205|NCT03560206|83067629|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
46852206|NCT03560206|83067628|FG000|Overall Study|Busy schedule|14|||
46852207|NCT03560206|83067629|FG001|Overall Study|Busy schedule|2|||
46852208|NCT03560206|83067628|FG000|Overall Study|patients' new health condition such as cancer|10|||
46852209|NCT03560206|83067629|FG001|Overall Study|patients' new health condition such as cancer|1|||
46852210|NCT02892760|83067635|FG000|Overall Study|Withdrawal by Subject|3|||
46852211|NCT03635086|83067644|FG000|Overall Study|Withdrawal of consent|0|||
46852212|NCT03635086|83067645|FG001|Overall Study|Withdrawal of consent|0|||
46852213|NCT03635086|83067646|FG002|Overall Study|Withdrawal of consent|1|||
46852214|NCT03635086|83067647|FG003|Overall Study|Withdrawal of consent|0|||
46852215|NCT03635086|83067648|FG004|Overall Study|Withdrawal of consent|0|||
46852216|NCT03635086|83067644|FG000|Overall Study|Adverse Event|0|||
46852217|NCT03635086|83067645|FG001|Overall Study|Adverse Event|1|||
46788116|NCT01464164|83007291|FG000|Overall Study|Screen failure|0|||
46788117|NCT01464164|83007292|FG001|Overall Study|Screen failure|1|||
46788118|NCT01464164|83007293|FG002|Overall Study|Screen failure|2|||
46788119|NCT01464164|83007294|FG003|Overall Study|Screen failure|0|||
46852218|NCT03635086|83067646|FG002|Overall Study|Adverse Event|0|||
46973310|NCT01965262|83217107|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
46973311|NCT01965262|83217108|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
46788120|NCT01464164|83007295|FG004|Overall Study|Screen failure|0|||
46788121|NCT01464164|83007296|FG005|Overall Study|Screen failure|0|||
46788122|NCT01464164|83007297|FG006|Overall Study|Screen failure|0|||
46788123|NCT01464164|83007291|FG000|Overall Study|Physician Decision|0|||
46788124|NCT01464164|83007292|FG001|Overall Study|Physician Decision|1|||
46788125|NCT01464164|83007293|FG002|Overall Study|Physician Decision|0|||
46788126|NCT01464164|83007294|FG003|Overall Study|Physician Decision|0|||
46788127|NCT01464164|83007295|FG004|Overall Study|Physician Decision|0|||
46788128|NCT01464164|83007296|FG005|Overall Study|Physician Decision|0|||
46788129|NCT01464164|83007297|FG006|Overall Study|Physician Decision|2|||
46788130|NCT00568776|83007340|FG000|Overall Study|Adverse Event|8|||
46788131|NCT00568776|83007341|FG001|Overall Study|Adverse Event|8|||
46788132|NCT00568776|83007342|FG002|Overall Study|Adverse Event|10|||
46788133|NCT00568776|83007343|FG003|Overall Study|Adverse Event|8|||
46788134|NCT00568776|83007340|FG000|Overall Study|Death|0|||
46788135|NCT00568776|83007341|FG001|Overall Study|Death|1|||
46788136|NCT00568776|83007342|FG002|Overall Study|Death|4|||
46788137|NCT00568776|83007343|FG003|Overall Study|Death|3|||
46788138|NCT00568776|83007340|FG000|Overall Study|Physician Decision|0|||
46788139|NCT00568776|83007341|FG001|Overall Study|Physician Decision|2|||
46788140|NCT00568776|83007342|FG002|Overall Study|Physician Decision|0|||
46788141|NCT00568776|83007343|FG003|Overall Study|Physician Decision|0|||
46788142|NCT00568776|83007340|FG000|Overall Study|Lack of Efficacy|2|||
46788143|NCT00568776|83007341|FG001|Overall Study|Lack of Efficacy|2|||
46788144|NCT00568776|83007342|FG002|Overall Study|Lack of Efficacy|2|||
46788145|NCT00568776|83007343|FG003|Overall Study|Lack of Efficacy|4|||
46788146|NCT00568776|83007340|FG000|Overall Study|Lost to Follow-up|1|||
46788147|NCT00568776|83007341|FG001|Overall Study|Lost to Follow-up|1|||
46788148|NCT00568776|83007342|FG002|Overall Study|Lost to Follow-up|1|||
46788149|NCT00568776|83007343|FG003|Overall Study|Lost to Follow-up|1|||
46788150|NCT00568776|83007340|FG000|Overall Study|Protocol Violation|1|||
46788151|NCT00568776|83007341|FG001|Overall Study|Protocol Violation|0|||
46788152|NCT00568776|83007342|FG002|Overall Study|Protocol Violation|1|||
46788153|NCT00568776|83007343|FG003|Overall Study|Protocol Violation|1|||
46788154|NCT00568776|83007340|FG000|Overall Study|Withdrawal by Subject|13|||
46788155|NCT00568776|83007341|FG001|Overall Study|Withdrawal by Subject|15|||
46788156|NCT00568776|83007342|FG002|Overall Study|Withdrawal by Subject|13|||
46788157|NCT00568776|83007343|FG003|Overall Study|Withdrawal by Subject|7|||
46788158|NCT00568776|83007340|FG000|Overall Study|Loss of Caregiver|0|||
46788159|NCT00568776|83007341|FG001|Overall Study|Loss of Caregiver|2|||
46788160|NCT00568776|83007342|FG002|Overall Study|Loss of Caregiver|1|||
46788161|NCT00568776|83007343|FG003|Overall Study|Loss of Caregiver|2|||
46788162|NCT00568776|83007340|FG000|Overall Study|Sponsor Decision|2|||
46788163|NCT00568776|83007341|FG001|Overall Study|Sponsor Decision|2|||
46788164|NCT00568776|83007342|FG002|Overall Study|Sponsor Decision|41|||
46852219|NCT03635086|83067647|FG003|Overall Study|Adverse Event|0|||
46852220|NCT03635086|83067648|FG004|Overall Study|Adverse Event|0|||
46973312|NCT01965262|83217107|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
46973313|NCT01965262|83217108|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
46973314|NCT01677377|83217117|FG000|Overall Study|Protocol Violation|1|||
46673464|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673465|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673466|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673467|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673468|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673469|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673470|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
46673471|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
46673472|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
46673473|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
46673474|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
46673475|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
46673476|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
46673477|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
46673478|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
46673479|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
46673480|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
46673481|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
46673482|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
46673483|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
46673484|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
46673485|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
46673486|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
46673487|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
46673488|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
46788165|NCT00568776|83007343|FG003|Overall Study|Sponsor Decision|42|||
46788166|NCT00568776|83007340|FG000|Overall Study|Miscellaeneous|3|||
46788167|NCT00568776|83007341|FG001|Overall Study|Miscellaeneous|3|||
46788168|NCT00568776|83007342|FG002|Overall Study|Miscellaeneous|1|||
46788169|NCT00568776|83007343|FG003|Overall Study|Miscellaeneous|4|||
46788170|NCT00758771|83007355|FG000|Overall Study|Withdrawal by Subject|1|||
46788171|NCT00758771|83007356|FG001|Overall Study|Withdrawal by Subject|1|||
46788172|NCT00758771|83007355|FG000|Overall Study|Did not meet eligibility criteria|2|||
46788173|NCT00758771|83007356|FG001|Overall Study|Did not meet eligibility criteria|4|||
46788174|NCT00635154|83007362|FG000|Overall Study|Alternative Treatment|8|||
46788175|NCT00635154|83007362|FG000|Overall Study|Other|4|||
46973315|NCT01677377|83217118|FG001|Overall Study|Protocol Violation|0|||
46973316|NCT01677377|83217119|FG002|Overall Study|Protocol Violation|0|||
46973317|NCT01677377|83217117|FG000|Overall Study|Lost to Follow-up|0|||
46973318|NCT01677377|83217118|FG001|Overall Study|Lost to Follow-up|1|||
46973319|NCT01677377|83217119|FG002|Overall Study|Lost to Follow-up|1|||
46973320|NCT01677377|83217117|FG000|Overall Study|Withdrawal by Subject|0|||
46973321|NCT01677377|83217118|FG001|Overall Study|Withdrawal by Subject|0|||
46973322|NCT01677377|83217119|FG002|Overall Study|Withdrawal by Subject|3|||
46973323|NCT01677377|83217117|FG000|Overall Study|Lack of Efficacy|0|||
46973324|NCT01677377|83217118|FG001|Overall Study|Lack of Efficacy|0|||
46973325|NCT01677377|83217119|FG002|Overall Study|Lack of Efficacy|1|||
46973326|NCT01677377|83217117|FG000|Overall Study|Pregnancy|0|||
46973327|NCT01677377|83217118|FG001|Overall Study|Pregnancy|0|||
46973328|NCT01677377|83217119|FG002|Overall Study|Pregnancy|1|||
46973329|NCT01964950|83217129|FG000|Overall Study|Protocol Violation|25|||
46788176|NCT00635154|83007362|FG000|Overall Study|Still on treatment|21|||
46788177|NCT00778895|83007371|FG000|Active Phase|Adverse Event|3|||
46788178|NCT00778895|83007372|FG001|Active Phase|Adverse Event|1|||
46788179|NCT00778895|83007373|FG002|Active Phase|Adverse Event|0|||
46788180|NCT00778895|83007371|FG000|Active Phase|Withdrawal by Subject|1|||
46788181|NCT00778895|83007372|FG001|Active Phase|Withdrawal by Subject|4|||
46788182|NCT00778895|83007373|FG002|Active Phase|Withdrawal by Subject|0|||
46788183|NCT00778895|83007371|FG000|Active Phase|Lost to Follow-up|1|||
46788184|NCT00778895|83007372|FG001|Active Phase|Lost to Follow-up|1|||
46788185|NCT00778895|83007373|FG002|Active Phase|Lost to Follow-up|0|||
46788186|NCT00778895|83007371|FG000|Active Phase|Other|2|||
46788187|NCT00778895|83007372|FG001|Active Phase|Other|0|||
46788188|NCT00778895|83007373|FG002|Active Phase|Other|0|||
46788189|NCT00778895|83007371|FG000|ESFU Phase|Adverse Event|2|||
46788190|NCT00778895|83007372|FG001|ESFU Phase|Adverse Event|1|||
46788191|NCT00778895|83007373|FG002|ESFU Phase|Adverse Event|0|||
46788192|NCT00778895|83007371|FG000|ESFU Phase|Withdrawal by Subject|1|||
46788193|NCT00778895|83007372|FG001|ESFU Phase|Withdrawal by Subject|4|||
46788194|NCT00778895|83007373|FG002|ESFU Phase|Withdrawal by Subject|0|||
46788195|NCT00778895|83007371|FG000|ESFU Phase|Lost to Follow-up|6|||
46973330|NCT01964716|83217138|FG000|Overall Study|Withdrawal by Subject|2|||
46973331|NCT01964716|83217139|FG001|Overall Study|Withdrawal by Subject|3|||
46973332|NCT01964716|83217138|FG000|Overall Study|Lost to Follow-up|1|||
46973333|NCT01964716|83217139|FG001|Overall Study|Lost to Follow-up|2|||
46973334|NCT01964716|83217138|FG000|Overall Study|No longer met eligibility criteria|1|||
46973335|NCT01964716|83217139|FG001|Overall Study|No longer met eligibility criteria|1|||
46973336|NCT01964716|83217138|FG000|Overall Study|Death|1|||
46788196|NCT00778895|83007372|FG001|ESFU Phase|Lost to Follow-up|7|||
46788197|NCT00778895|83007373|FG002|ESFU Phase|Lost to Follow-up|2|||
46788198|NCT00778895|83007371|FG000|ESFU Phase|Other|2|||
46788199|NCT00778895|83007372|FG001|ESFU Phase|Other|0|||
46788200|NCT00778895|83007373|FG002|ESFU Phase|Other|0|||
46788201|NCT00293215|83007384|FG000|Overall Study|Progressive disease|3|||
46788202|NCT00293215|83007385|FG001|Overall Study|Progressive disease|1|||
46788203|NCT00293215|83007384|FG000|Overall Study|Adverse Event|2|||
46788204|NCT00293215|83007385|FG001|Overall Study|Adverse Event|2|||
46788205|NCT00778817|83007391|FG000|Overall Study|Adverse Event|2|||
46788206|NCT00778817|83007391|FG000|Overall Study|Withdrawal by Subject|2|||
46788207|NCT00293059|83007397|FG000|Overall Study|Adverse Event|12|||
46788208|NCT00293059|83007398|FG001|Overall Study|Adverse Event|4|||
46973337|NCT01964716|83217139|FG001|Overall Study|Death|0|||
46973338|NCT01964560|83217153|FG000|Overall Study|Adverse Event|23|||
46973339|NCT01964560|83217153|FG000|Overall Study|Lack of Efficacy|46|||
46788209|NCT00293059|83007397|FG000|Overall Study|Lack of Efficacy|2|||
46788210|NCT00293059|83007398|FG001|Overall Study|Lack of Efficacy|0|||
46788211|NCT00293059|83007397|FG000|Overall Study|Lost to Follow-up|2|||
46788212|NCT00293059|83007398|FG001|Overall Study|Lost to Follow-up|3|||
46788213|NCT00293059|83007397|FG000|Overall Study|Pregnancy|1|||
46788214|NCT00293059|83007398|FG001|Overall Study|Pregnancy|1|||
46788215|NCT00293059|83007397|FG000|Overall Study|Protocol Violation|2|||
46788216|NCT00293059|83007398|FG001|Overall Study|Protocol Violation|0|||
46973340|NCT01964560|83217153|FG000|Overall Study|Protocol deviation|2|||
46973341|NCT01964560|83217153|FG000|Overall Study|Lost to Follow-up|4|||
46973342|NCT01964560|83217153|FG000|Overall Study|Withdrawal by Subject|64|||
46973343|NCT01964560|83217153|FG000|Overall Study|Surgery-hemispherotomy|1|||
46973344|NCT01964560|83217153|FG000|Overall Study|Surgery|1|||
46973345|NCT01964560|83217153|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
46973346|NCT01964560|83217153|FG000|Overall Study|Patient and Investigator choice|1|||
46788217|NCT00293059|83007397|FG000|Overall Study|Withdrawal by Subject|11|||
46788218|NCT00293059|83007398|FG001|Overall Study|Withdrawal by Subject|5|||
46788219|NCT00293059|83007397|FG000|Overall Study|Participant moved out of state|1|||
46788220|NCT00293059|83007398|FG001|Overall Study|Participant moved out of state|0|||
46973347|NCT01964560|83217153|FG000|Overall Study|Patient was prescribed CBD|1|||
46973348|NCT01964560|83217153|FG000|Overall Study|Participant moved to another country|1|||
46973349|NCT02659943|83217164|FG000|Overall Study|Switched to alternative treatment|1|||
46973350|NCT02659943|83217165|FG001|Overall Study|Switched to alternative treatment|1|||
46973351|NCT02659943|83217166|FG002|Overall Study|Switched to alternative treatment|0|||
46973352|NCT02659943|83217167|FG003|Overall Study|Switched to alternative treatment|2|||
46973353|NCT02659943|83217168|FG004|Overall Study|Switched to alternative treatment|1|||
46973354|NCT02659943|83217169|FG005|Overall Study|Switched to alternative treatment|0|||
46973355|NCT02659943|83217170|FG006|Overall Study|Switched to alternative treatment|1|||
46973356|NCT02659943|83217164|FG000|Overall Study|Disease progression on study|0|||
46788221|NCT00293059|83007397|FG000|Overall Study|Participant stopped study drug|1|||
46788222|NCT00293059|83007398|FG001|Overall Study|Participant stopped study drug|0|||
46788223|NCT00293059|83007397|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
46788224|NCT00293059|83007398|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
46788225|NCT00293059|83007397|FG000|Overall Study|missing|3|||
46788226|NCT00293059|83007398|FG001|Overall Study|missing|5|||
46788227|NCT00756275|83007406|FG000|Overall Study|Lost to Follow-up|25|||
46788228|NCT00756275|83007407|FG001|Overall Study|Lost to Follow-up|21|||
46788229|NCT00756275|83007406|FG000|Overall Study|Withdrawal by Subject|4|||
46788230|NCT00756275|83007407|FG001|Overall Study|Withdrawal by Subject|7|||
46788231|NCT00758459|83007415|FG000|Overall Study|Adverse Event|3|||
46788232|NCT00758459|83007416|FG001|Overall Study|Adverse Event|2|||
46788233|NCT00758459|83007415|FG000|Overall Study|Protocol Violation|0|||
46788234|NCT00758459|83007416|FG001|Overall Study|Protocol Violation|1|||
46788235|NCT00758459|83007415|FG000|Overall Study|Withdrawal by Subject|0|||
46788236|NCT00758459|83007416|FG001|Overall Study|Withdrawal by Subject|1|||
46788237|NCT00298831|83007422|FG000|Overall Study|Adverse Event|1|||
46788238|NCT00298831|83007422|FG000|Overall Study|Lost to Follow-up|3|||
46788239|NCT00298831|83007422|FG000|Overall Study|Withdrawal by Subject|1|||
46788240|NCT00298831|83007422|FG000|Overall Study|Participants did not receive treatment|27|||
46788241|NCT00758069|83007429|FG000|Overall Study|Lack of Efficacy|0|||
46788242|NCT00758069|83007430|FG001|Overall Study|Lack of Efficacy|0|||
46788243|NCT00758069|83007431|FG002|Overall Study|Lack of Efficacy|1|||
46788244|NCT00758069|83007429|FG000|Overall Study|Incorrect Study Drug|1|||
46788245|NCT00758069|83007430|FG001|Overall Study|Incorrect Study Drug|0|||
46788246|NCT00758069|83007431|FG002|Overall Study|Incorrect Study Drug|0|||
46788247|NCT00311623|83007442|FG000|Overall Study|Physician Decision|0|||
46973357|NCT02659943|83217165|FG001|Overall Study|Disease progression on study|1|||
46973358|NCT02659943|83217166|FG002|Overall Study|Disease progression on study|1|||
46973359|NCT02659943|83217167|FG003|Overall Study|Disease progression on study|1|||
46673489|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
46673490|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
46673491|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
46673492|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
46673493|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
46673494|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
46673495|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
46788248|NCT00311623|83007443|FG001|Overall Study|Physician Decision|0|||
46788249|NCT00311623|83007444|FG002|Overall Study|Physician Decision|2|||
46788250|NCT00528112|83007455|FG000|Treatment up to 3 Years|Adverse Event|313|||
46788251|NCT00528112|83007456|FG001|Treatment up to 3 Years|Adverse Event|278|||
46788252|NCT00528112|83007455|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
46788253|NCT00528112|83007456|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
46788254|NCT00528112|83007455|FG000|Treatment up to 3 Years|Protocol Violation|16|||
46788255|NCT00528112|83007456|FG001|Treatment up to 3 Years|Protocol Violation|16|||
46788256|NCT00528112|83007455|FG000|Treatment up to 3 Years|Death|0|||
46788257|NCT00528112|83007456|FG001|Treatment up to 3 Years|Death|1|||
46788258|NCT00528112|83007455|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
46973360|NCT02659943|83217168|FG004|Overall Study|Disease progression on study|1|||
46973361|NCT02659943|83217169|FG005|Overall Study|Disease progression on study|4|||
46973362|NCT02659943|83217170|FG006|Overall Study|Disease progression on study|0|||
46973363|NCT02659943|83217164|FG000|Overall Study|Patient's condition per principal investigator|0|||
47077910|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
46788259|NCT00528112|83007456|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
46788260|NCT00528112|83007455|FG000|Treatment up to 3 Years|Pregnancy|9|||
46788261|NCT00528112|83007456|FG001|Treatment up to 3 Years|Pregnancy|10|||
46788262|NCT00528112|83007455|FG000|Treatment up to 3 Years|Other reasons|186|||
46852221|NCT03635086|83067644|FG000|Overall Study|Lost to Follow-up|1|||
46973364|NCT02659943|83217165|FG001|Overall Study|Patient's condition per principal investigator|0|||
46788263|NCT00528112|83007456|FG001|Treatment up to 3 Years|Other reasons|186|||
46788264|NCT00528112|83007455|FG000|Extension Phase|Withdrawal by Subject|0|||
46788265|NCT00528112|83007456|FG001|Extension Phase|Withdrawal by Subject|3|||
46788266|NCT00528112|83007455|FG000|Extension Phase|Other reasons|0|||
46788267|NCT00528112|83007456|FG001|Extension Phase|Other reasons|100|||
46788268|NCT00528112|83007455|FG000|Extension Phase|Pregnancy|0|||
46788269|NCT00528112|83007456|FG001|Extension Phase|Pregnancy|3|||
46788270|NCT00528112|83007455|FG000|Extension Phase|Lost to Follow-up|0|||
46788271|NCT00528112|83007456|FG001|Extension Phase|Lost to Follow-up|12|||
46788272|NCT00528112|83007455|FG000|Extension Phase|Death|0|||
46788273|NCT00528112|83007456|FG001|Extension Phase|Death|1|||
46788274|NCT00528112|83007455|FG000|Extension Phase|Adverse Event|0|||
46788275|NCT00528112|83007456|FG001|Extension Phase|Adverse Event|36|||
46788276|NCT00528112|83007455|FG000|Extension Phase|Protocol Violation|0|||
46788277|NCT00528112|83007456|FG001|Extension Phase|Protocol Violation|2|||
46788278|NCT00633594|83007467|FG000|Overall Study|Adverse Event|0|||
46788279|NCT00633594|83007468|FG001|Overall Study|Adverse Event|4|||
46788280|NCT00633594|83007469|FG002|Overall Study|Adverse Event|7|||
46788281|NCT00633594|83007467|FG000|Overall Study|Death|0|||
46788282|NCT00633594|83007468|FG001|Overall Study|Death|1|||
46788283|NCT00633594|83007469|FG002|Overall Study|Death|2|||
46788284|NCT00633594|83007467|FG000|Overall Study|Disease Progression|0|||
46788285|NCT00633594|83007468|FG001|Overall Study|Disease Progression|0|||
46788286|NCT00633594|83007469|FG002|Overall Study|Disease Progression|1|||
46788287|NCT00755807|83007482|FG000|Acute Phase|Adverse Event|16|||
46788288|NCT00755807|83007483|FG001|Acute Phase|Adverse Event|5|||
46788289|NCT00755807|83007482|FG000|Acute Phase|Protocol Violation|1|||
46788290|NCT00755807|83007483|FG001|Acute Phase|Protocol Violation|3|||
46788291|NCT00755807|83007482|FG000|Acute Phase|Withdrawal by Subject|1|||
46788292|NCT00755807|83007483|FG001|Acute Phase|Withdrawal by Subject|2|||
46788293|NCT00755807|83007482|FG000|Acute Phase|Lack of Efficacy|0|||
46788294|NCT00755807|83007483|FG001|Acute Phase|Lack of Efficacy|1|||
46788295|NCT00755807|83007482|FG000|Acute Phase|Physician Decision|0|||
46788296|NCT00755807|83007483|FG001|Acute Phase|Physician Decision|1|||
46788297|NCT00755807|83007482|FG000|Open-label Extension Phase|Adverse Event|7|||
46788298|NCT00755807|83007483|FG001|Open-label Extension Phase|Adverse Event|7|||
46788299|NCT00755807|83007482|FG000|Open-label Extension Phase|Protocol Violation|5|||
46788300|NCT00755807|83007483|FG001|Open-label Extension Phase|Protocol Violation|2|||
46788301|NCT00755807|83007482|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
46788302|NCT00755807|83007483|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
46788303|NCT00755807|83007482|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
46788304|NCT00755807|83007483|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
46788305|NCT00755807|83007482|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
46788306|NCT00755807|83007483|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
46788307|NCT00755807|83007482|FG000|Open-label Extension Phase|Sponsor Decision|0|||
46788308|NCT00755807|83007483|FG001|Open-label Extension Phase|Sponsor Decision|1|||
46852222|NCT03635086|83067645|FG001|Overall Study|Lost to Follow-up|0|||
46852223|NCT03635086|83067646|FG002|Overall Study|Lost to Follow-up|0|||
46852224|NCT03635086|83067647|FG003|Overall Study|Lost to Follow-up|0|||
46852225|NCT03635086|83067648|FG004|Overall Study|Lost to Follow-up|0|||
46852226|NCT03588910|83067663|FG000|Overall Study|Withdrawal by Subject|1|||
46852227|NCT03588910|83067664|FG001|Overall Study|Withdrawal by Subject|0|||
46852228|NCT03588910|83067663|FG000|Overall Study|Allergy|2|||
46852229|NCT03588910|83067664|FG001|Overall Study|Allergy|0|||
46852230|NCT03588910|83067663|FG000|Overall Study|Protocol Violation|0|||
46852231|NCT03588910|83067664|FG001|Overall Study|Protocol Violation|3|||
46852232|NCT03588910|83067663|FG000|Overall Study|Did not complete Day 1 Survey|5|||
46973365|NCT02659943|83217166|FG002|Overall Study|Patient's condition per principal investigator|0|||
46788309|NCT00631410|83007495|FG000|Overall Study|Adverse Event|1|||
46788310|NCT00631410|83007496|FG001|Overall Study|Adverse Event|3|||
46852233|NCT03588910|83067664|FG001|Overall Study|Did not complete Day 1 Survey|10|||
46973366|NCT02659943|83217167|FG003|Overall Study|Patient's condition per principal investigator|0|||
46788311|NCT00631410|83007495|FG000|Overall Study|Objective Progression or Relapse|4|||
46788312|NCT00631410|83007496|FG001|Overall Study|Objective Progression or Relapse|3|||
46788313|NCT00631410|83007495|FG000|Overall Study|Surgery|1|||
46788314|NCT00631410|83007496|FG001|Overall Study|Surgery|0|||
46852234|NCT03588910|83067663|FG000|Overall Study|Did not complete Day 7 Survey|5|||
46852235|NCT03588910|83067664|FG001|Overall Study|Did not complete Day 7 Survey|2|||
46788315|NCT03686176|83007508|FG000|Overall Study|Procedure cancelled|1|||
46852236|NCT03587974|83067672|FG000|Overall Study|caregiver demented, care recipient died|3|||
46852237|NCT03587974|83067673|FG001|Overall Study|caregiver demented, care recipient died|3|||
46852238|NCT03587974|83067672|FG000|Overall Study|Withdrawal by Subject|2|||
46852239|NCT03587974|83067673|FG001|Overall Study|Withdrawal by Subject|1|||
46788316|NCT03686176|83007509|FG001|Overall Study|Procedure cancelled|0|||
46788317|NCT03686176|83007510|FG002|Overall Study|Procedure cancelled|0|||
46788318|NCT03686176|83007508|FG000|Overall Study|VR Malfunction|1|||
46788319|NCT03686176|83007509|FG001|Overall Study|VR Malfunction|0|||
46788320|NCT03686176|83007510|FG002|Overall Study|VR Malfunction|0|||
46788321|NCT00755417|83007521|FG000|Overall Study|Adverse Event|28|||
46788322|NCT00755417|83007522|FG001|Overall Study|Adverse Event|20|||
46788323|NCT00755417|83007523|FG002|Overall Study|Adverse Event|7|||
46788324|NCT00755417|83007521|FG000|Overall Study|Lack of Efficacy|8|||
46788325|NCT00755417|83007522|FG001|Overall Study|Lack of Efficacy|4|||
46788326|NCT00755417|83007523|FG002|Overall Study|Lack of Efficacy|9|||
46788327|NCT00755417|83007521|FG000|Overall Study|Protocol Violation|2|||
46788328|NCT00755417|83007522|FG001|Overall Study|Protocol Violation|1|||
46788329|NCT00755417|83007523|FG002|Overall Study|Protocol Violation|1|||
46788330|NCT00755417|83007521|FG000|Overall Study|Lost to Follow-up|3|||
46973367|NCT02659943|83217168|FG004|Overall Study|Patient's condition per principal investigator|0|||
46973368|NCT02659943|83217169|FG005|Overall Study|Patient's condition per principal investigator|1|||
46973369|NCT02659943|83217170|FG006|Overall Study|Patient's condition per principal investigator|0|||
46973370|NCT02659943|83217164|FG000|Overall Study|Ineligible|0|||
46973371|NCT02659943|83217165|FG001|Overall Study|Ineligible|0|||
46973372|NCT02659943|83217166|FG002|Overall Study|Ineligible|0|||
46973373|NCT02659943|83217167|FG003|Overall Study|Ineligible|0|||
46973374|NCT02659943|83217168|FG004|Overall Study|Ineligible|0|||
46973375|NCT02659943|83217169|FG005|Overall Study|Ineligible|0|||
46973376|NCT02659943|83217170|FG006|Overall Study|Ineligible|1|||
46973377|NCT02659943|83217164|FG000|Overall Study|No longer meets eligibility|0|||
46973378|NCT02659943|83217165|FG001|Overall Study|No longer meets eligibility|0|||
46973379|NCT02659943|83217166|FG002|Overall Study|No longer meets eligibility|0|||
46973380|NCT02659943|83217167|FG003|Overall Study|No longer meets eligibility|0|||
46973381|NCT02659943|83217168|FG004|Overall Study|No longer meets eligibility|0|||
46973382|NCT02659943|83217169|FG005|Overall Study|No longer meets eligibility|0|||
46973383|NCT02659943|83217170|FG006|Overall Study|No longer meets eligibility|1|||
46973384|NCT02659943|83217164|FG000|Overall Study|No treatment, per protocol|0|||
46973385|NCT02659943|83217165|FG001|Overall Study|No treatment, per protocol|0|||
46973386|NCT02659943|83217166|FG002|Overall Study|No treatment, per protocol|0|||
46973387|NCT02659943|83217167|FG003|Overall Study|No treatment, per protocol|0|||
47077911|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
46788331|NCT00755417|83007522|FG001|Overall Study|Lost to Follow-up|0|||
46788332|NCT00755417|83007523|FG002|Overall Study|Lost to Follow-up|1|||
46788333|NCT00755417|83007521|FG000|Overall Study|Withdrawal by Subject|12|||
46788334|NCT00755417|83007522|FG001|Overall Study|Withdrawal by Subject|12|||
46788335|NCT00755417|83007523|FG002|Overall Study|Withdrawal by Subject|12|||
46788336|NCT00755417|83007521|FG000|Overall Study|Not specified or missing data|9|||
46788337|NCT00755417|83007522|FG001|Overall Study|Not specified or missing data|18|||
46788338|NCT00755417|83007523|FG002|Overall Study|Not specified or missing data|12|||
46788339|NCT03685708|83007534|FG000|Overall Study|Withdrawal by Subject|0|||
46788340|NCT03685708|83007535|FG001|Overall Study|Withdrawal by Subject|0|||
46788341|NCT03685708|83007536|FG002|Overall Study|Withdrawal by Subject|1|||
46788342|NCT03685708|83007534|FG000|Overall Study|Screen Fail|0|||
46788343|NCT03685708|83007535|FG001|Overall Study|Screen Fail|1|||
46788344|NCT03685708|83007536|FG002|Overall Study|Screen Fail|1|||
46788345|NCT03685708|83007534|FG000|Overall Study|COVID 19 Pandemic|1|||
46788346|NCT03685708|83007535|FG001|Overall Study|COVID 19 Pandemic|1|||
46788347|NCT03685708|83007536|FG002|Overall Study|COVID 19 Pandemic|6|||
46788348|NCT03685708|83007534|FG000|Overall Study|Disease Progression|0|||
46788349|NCT03685708|83007535|FG001|Overall Study|Disease Progression|0|||
46788350|NCT03685708|83007536|FG002|Overall Study|Disease Progression|1|||
46788351|NCT03684928|83007544|FG000|First Intervention|Lost to Follow-up|0|||
46788352|NCT03684928|83007545|FG001|First Intervention|Lost to Follow-up|1|||
46788353|NCT03684928|83007544|FG000|First Intervention|Withdrawal by Subject|0|||
46788354|NCT03684928|83007545|FG001|First Intervention|Withdrawal by Subject|2|||
46788355|NCT03684928|83007544|FG000|Second Intervention|Soft Tissue Injury|1|||
46788356|NCT03684928|83007545|FG001|Second Intervention|Soft Tissue Injury|0|||
46788357|NCT00777803|83007553|FG000|Overall Study|Lost to Follow-up|12|||
46788358|NCT00777803|83007554|FG001|Overall Study|Lost to Follow-up|5|||
46788359|NCT00777803|83007553|FG000|Overall Study|Adverse Event|1|||
46852240|NCT00103857|83067686|FG000|54-Week Base Study|Adverse Event|12|||
46852241|NCT00103857|83067687|FG001|54-Week Base Study|Adverse Event|9|||
46852242|NCT00103857|83067688|FG002|54-Week Base Study|Adverse Event|11|||
46973388|NCT02659943|83217168|FG004|Overall Study|No treatment, per protocol|0|||
46973389|NCT02659943|83217169|FG005|Overall Study|No treatment, per protocol|0|||
46973390|NCT02659943|83217170|FG006|Overall Study|No treatment, per protocol|3|||
46973391|NCT01677299|83217195|FG000|Overall Study|Adverse Event|0|||
47077912|NCT01435928|83381252|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
46788360|NCT00777803|83007554|FG001|Overall Study|Adverse Event|0|||
46788361|NCT00777803|83007553|FG000|Overall Study|Non-compliance|2|||
46788362|NCT00777803|83007554|FG001|Overall Study|Non-compliance|2|||
46973392|NCT01677299|83217196|FG001|Overall Study|Adverse Event|2|||
46973393|NCT01677299|83217197|FG002|Overall Study|Adverse Event|1|||
46973394|NCT01677299|83217198|FG003|Overall Study|Adverse Event|0|||
46973395|NCT01677299|83217195|FG000|Overall Study|Withdrawal by Subject|0|||
46973396|NCT01677299|83217196|FG001|Overall Study|Withdrawal by Subject|1|||
46973397|NCT01677299|83217197|FG002|Overall Study|Withdrawal by Subject|0|||
46788363|NCT00527488|83007564|FG000|Overall Study|Withdrawn prior to dosing|0|||
46788364|NCT00527488|83007565|FG001|Overall Study|Withdrawn prior to dosing|1|||
46788365|NCT00527488|83007566|FG002|Overall Study|Withdrawn prior to dosing|1|||
46788366|NCT00527488|83007567|FG003|Overall Study|Withdrawn prior to dosing|0|||
46788367|NCT00527332|83007579|FG000|Overall Study|Protocol Violation|4|||
46788368|NCT00527332|83007580|FG001|Overall Study|Protocol Violation|8|||
46788369|NCT00527332|83007579|FG000|Overall Study|Withdrew consent|5|||
46788370|NCT00527332|83007580|FG001|Overall Study|Withdrew consent|1|||
46673496|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
46673497|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
46673498|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
46673499|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
46673500|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
46673501|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
46788371|NCT00752609|83007588|FG000|Overall Study|Adverse Event|2|||
46788372|NCT00752609|83007589|FG001|Overall Study|Adverse Event|2|||
46788373|NCT00752609|83007588|FG000|Overall Study|Withdrawal by Subject|3|||
46788374|NCT00752609|83007589|FG001|Overall Study|Withdrawal by Subject|0|||
46788375|NCT00752609|83007588|FG000|Overall Study|Physician Decision|1|||
46788376|NCT00752609|83007589|FG001|Overall Study|Physician Decision|0|||
46788377|NCT00752609|83007588|FG000|Overall Study|Death|1|||
46788378|NCT00752609|83007589|FG001|Overall Study|Death|0|||
46788379|NCT00752609|83007588|FG000|Overall Study|Met exclusion criteria|1|||
46788380|NCT00752609|83007589|FG001|Overall Study|Met exclusion criteria|0|||
46788381|NCT00752609|83007588|FG000|Overall Study|Received Aranesp in error|1|||
46788382|NCT00752609|83007589|FG001|Overall Study|Received Aranesp in error|0|||
46788383|NCT03684304|83007600|FG000|Overall Study|Lost to Follow-up|19|||
46788384|NCT03684304|83007601|FG001|Overall Study|Lost to Follow-up|17|||
46788385|NCT00629772|83007609|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
46788386|NCT00629772|83007610|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
46788387|NCT00629772|83007609|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
46788388|NCT00629772|83007610|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
46788389|NCT00526630|83007617|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
46788390|NCT00526630|83007618|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
46788391|NCT00526630|83007617|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
46788392|NCT00526630|83007618|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
46788393|NCT00755183|83007628|FG000|Overall Study|Adverse Event|5|||
46852243|NCT00103857|83067689|FG003|54-Week Base Study|Adverse Event|6|||
46973398|NCT01677299|83217198|FG003|Overall Study|Withdrawal by Subject|1|||
46973399|NCT01964326|83217212|FG000|Overall Study|Adverse Event|48|||
46973400|NCT01964326|83217212|FG000|Overall Study|Death|2|||
46973401|NCT01964326|83217212|FG000|Overall Study|Protocol Violation|4|||
46973402|NCT01964326|83217212|FG000|Overall Study|Lost to Follow-up|88|||
46973403|NCT01964326|83217212|FG000|Overall Study|Withdrawal by Subject|87|||
46973404|NCT01964326|83217212|FG000|Overall Study|Pregnancy|1|||
46673502|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
46788394|NCT00755183|83007629|FG001|Overall Study|Adverse Event|2|||
46852244|NCT00103857|83067690|FG004|54-Week Base Study|Adverse Event|5|||
46852245|NCT00103857|83067691|FG005|54-Week Base Study|Adverse Event|11|||
46852246|NCT00103857|83067692|FG006|54-Week Base Study|Adverse Event|3|||
46852247|NCT00103857|83067686|FG000|54-Week Base Study|Death|0|||
46852248|NCT00103857|83067687|FG001|54-Week Base Study|Death|0|||
46852249|NCT00103857|83067688|FG002|54-Week Base Study|Death|0|||
46852250|NCT00103857|83067689|FG003|54-Week Base Study|Death|0|||
46852251|NCT00103857|83067690|FG004|54-Week Base Study|Death|1|||
46852252|NCT00103857|83067691|FG005|54-Week Base Study|Death|1|||
46852253|NCT00103857|83067692|FG006|54-Week Base Study|Death|0|||
46852254|NCT00103857|83067686|FG000|54-Week Base Study|Lack of Efficacy|11|||
46852255|NCT00103857|83067687|FG001|54-Week Base Study|Lack of Efficacy|14|||
46852256|NCT00103857|83067688|FG002|54-Week Base Study|Lack of Efficacy|8|||
46852257|NCT00103857|83067689|FG003|54-Week Base Study|Lack of Efficacy|4|||
46852258|NCT00103857|83067690|FG004|54-Week Base Study|Lack of Efficacy|3|||
46973405|NCT01964326|83217212|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
46973406|NCT01964326|83217212|FG000|Overall Study|Physician Decision|55|||
46973407|NCT01964326|83217212|FG000|Overall Study|Investigator Discretion|1|||
46973408|NCT01964326|83217212|FG000|Overall Study|Other|9|||
46788395|NCT00755183|83007628|FG000|Overall Study|Protocol Violation|0|||
46788396|NCT00755183|83007629|FG001|Overall Study|Protocol Violation|1|||
46788397|NCT00755183|83007628|FG000|Overall Study|Withdrawal by Subject|0|||
46788398|NCT00755183|83007629|FG001|Overall Study|Withdrawal by Subject|2|||
46788399|NCT00755183|83007628|FG000|Overall Study|Administrative|2|||
46788400|NCT00755183|83007629|FG001|Overall Study|Administrative|1|||
46852259|NCT00103857|83067691|FG005|54-Week Base Study|Lack of Efficacy|14|||
46973409|NCT01964326|83217212|FG000|Overall Study|Did not meet eligibility criteria|1|||
46673503|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
46788401|NCT00755105|83007640|FG000|Overall Study|Withdrawal by Subject|9|||
46973410|NCT02699749|83217230|FG000|Overall Study|Other|0|||
46788402|NCT00755105|83007641|FG001|Overall Study|Withdrawal by Subject|11|||
46788403|NCT00755105|83007642|FG002|Overall Study|Withdrawal by Subject|4|||
46788404|NCT00526162|83007650|FG000|Overall Study|Device not implanted|3|||
46788405|NCT03875482|83007660|FG000|Overall Study|Adverse Event|0|||
46788406|NCT03875482|83007661|FG001|Overall Study|Adverse Event|1|||
46788407|NCT03875482|83007660|FG000|Overall Study|Withdrew consent|5|||
46788408|NCT03875482|83007661|FG001|Overall Study|Withdrew consent|6|||
46788409|NCT03875482|83007660|FG000|Overall Study|Lost to Follow-up|8|||
46788410|NCT03875482|83007661|FG001|Overall Study|Lost to Follow-up|2|||
46788411|NCT03875482|83007660|FG000|Overall Study|Lack of Efficacy|0|||
46788412|NCT03875482|83007661|FG001|Overall Study|Lack of Efficacy|11|||
46788413|NCT00754793|83007669|FG000|Overall Study|voluntary withdrawn from study|0|||
46788414|NCT00754793|83007670|FG001|Overall Study|voluntary withdrawn from study|1|||
46788415|NCT00586469|83007678|FG000|Overall Study|Adverse Event|0|||
46788416|NCT00586469|83007679|FG001|Overall Study|Adverse Event|1|||
46673504|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
46673505|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
46673506|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
46788417|NCT00626028|83007687|FG000|Overall Study|Adverse Event|1|||
46788418|NCT00626028|83007688|FG001|Overall Study|Adverse Event|1|||
46788419|NCT00626028|83007687|FG000|Overall Study|Device Failure|0|||
46788420|NCT00626028|83007688|FG001|Overall Study|Device Failure|1|||
46788421|NCT00626028|83007687|FG000|Overall Study|Physician Decision|2|||
46788422|NCT00626028|83007688|FG001|Overall Study|Physician Decision|1|||
46788423|NCT00626028|83007687|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
46788424|NCT00626028|83007688|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
46788425|NCT00777257|83007697|FG000|Overall Study|Adverse Event|3|||
46788426|NCT00777257|83007698|FG001|Overall Study|Adverse Event|1|||
46788427|NCT00777257|83007699|FG002|Overall Study|Adverse Event|0|||
46788428|NCT00777257|83007697|FG000|Overall Study|Lost to Follow-up|3|||
46788429|NCT00777257|83007698|FG001|Overall Study|Lost to Follow-up|3|||
46788430|NCT00777257|83007699|FG002|Overall Study|Lost to Follow-up|2|||
46788431|NCT00777257|83007697|FG000|Overall Study|Protocol Violation|2|||
46788432|NCT00777257|83007698|FG001|Overall Study|Protocol Violation|2|||
46788433|NCT00777257|83007699|FG002|Overall Study|Protocol Violation|2|||
46788434|NCT00777257|83007697|FG000|Overall Study|Withdrawal by Subject|3|||
46788435|NCT00777257|83007698|FG001|Overall Study|Withdrawal by Subject|6|||
46788436|NCT00777257|83007699|FG002|Overall Study|Withdrawal by Subject|5|||
46788437|NCT00628758|83007709|FG000|Overall Study|Adverse Event|2|||
46788438|NCT00628758|83007710|FG001|Overall Study|Adverse Event|3|||
46788439|NCT00628758|83007709|FG000|Overall Study|Withdrawal by Subject|6|||
46788440|NCT00628758|83007710|FG001|Overall Study|Withdrawal by Subject|3|||
46788441|NCT00628758|83007709|FG000|Overall Study|Death|1|||
46788442|NCT00628758|83007710|FG001|Overall Study|Death|0|||
46788443|NCT00628758|83007709|FG000|Overall Study|Protocol Violation|5|||
46788444|NCT00628758|83007710|FG001|Overall Study|Protocol Violation|1|||
46788445|NCT00628758|83007709|FG000|Overall Study|Lost to Follow-up|25|||
46788446|NCT00628758|83007710|FG001|Overall Study|Lost to Follow-up|31|||
46673507|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46673508|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
46673509|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
46673510|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46673511|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46673512|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46673513|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
46673514|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
46673515|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
46673516|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
46673517|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
46673518|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
46673519|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
46788447|NCT00628758|83007709|FG000|Overall Study|Pregnancy|2|||
46788448|NCT00628758|83007710|FG001|Overall Study|Pregnancy|2|||
46788449|NCT00628758|83007709|FG000|Overall Study|Investigator Moved|3|||
46788450|NCT00628758|83007710|FG001|Overall Study|Investigator Moved|0|||
46788451|NCT00628758|83007709|FG000|Overall Study|Treatment Failure|0|||
46788452|NCT00628758|83007710|FG001|Overall Study|Treatment Failure|2|||
46788453|NCT04491604|83007718|FG000|Overall Study|Withdrawal by Subject|3|||
46788454|NCT00628446|83007723|FG000|Overall Study|Lost to Follow-up|3|||
46788455|NCT00628446|83007723|FG000|Overall Study|Withdrawal by Subject|1|||
46673520|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
46673521|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
46788456|NCT00628446|83007723|FG000|Overall Study|Protocol Violation|3|||
46788457|NCT00754559|83007728|FG000|Overall Study|Adverse Event|15|||
46788458|NCT00754559|83007728|FG000|Overall Study|Protocol Violation|11|||
46788459|NCT00754559|83007728|FG000|Overall Study|Lack of Efficacy|10|||
46788460|NCT00754559|83007728|FG000|Overall Study|Lost to Follow-up|2|||
46788461|NCT00754559|83007728|FG000|Overall Study|Administrative reason|1|||
46788462|NCT00754559|83007728|FG000|Overall Study|Other|5|||
46788463|NCT00754559|83007728|FG000|Overall Study|Withdrawal by Subject|3|||
46788464|NCT00525148|83007739|FG000|Overall Study|Other Adverse Event|3|||
46788465|NCT00525148|83007740|FG001|Overall Study|Other Adverse Event|5|||
46788466|NCT00525148|83007741|FG002|Overall Study|Other Adverse Event|1|||
46788467|NCT00525148|83007742|FG003|Overall Study|Other Adverse Event|8|||
46788468|NCT00525148|83007739|FG000|Overall Study|Progressive disease|18|||
46788469|NCT00525148|83007740|FG001|Overall Study|Progressive disease|30|||
46788470|NCT00525148|83007741|FG002|Overall Study|Progressive disease|6|||
46788471|NCT00525148|83007742|FG003|Overall Study|Progressive disease|49|||
46788472|NCT00525148|83007739|FG000|Overall Study|Refused continuation of study medication|0|||
46788473|NCT00525148|83007740|FG001|Overall Study|Refused continuation of study medication|2|||
46788474|NCT00525148|83007741|FG002|Overall Study|Refused continuation of study medication|0|||
46788475|NCT00525148|83007742|FG003|Overall Study|Refused continuation of study medication|1|||
46788476|NCT00525148|83007739|FG000|Overall Study|Other than stated|2|||
46788477|NCT00525148|83007740|FG001|Overall Study|Other than stated|1|||
46788478|NCT00525148|83007741|FG002|Overall Study|Other than stated|0|||
46788479|NCT00525148|83007742|FG003|Overall Study|Other than stated|3|||
46788480|NCT00754325|83007754|FG000|Initial Treatment|Continuing Active Treatment|4|||
46788481|NCT00754325|83007755|FG001|Initial Treatment|Continuing Active Treatment|5|||
46788482|NCT00754325|83007754|FG000|Initial Treatment|Adverse Event|7|||
46973411|NCT02699749|83217231|FG001|Overall Study|Other|0|||
46973412|NCT02699749|83217232|FG002|Overall Study|Other|2|||
46973413|NCT02699749|83217233|FG003|Overall Study|Other|0|||
46973414|NCT02699749|83217234|FG004|Overall Study|Other|0|||
46973415|NCT02699749|83217235|FG005|Overall Study|Other|1|||
46973416|NCT02699749|83217236|FG006|Overall Study|Other|1|||
46673522|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
46673523|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
46673524|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
46973417|NCT02699749|83217237|FG007|Overall Study|Other|0|||
46973418|NCT02699749|83217238|FG008|Overall Study|Other|0|||
46973419|NCT02699749|83217239|FG009|Overall Study|Other|0|||
46973420|NCT02699749|83217240|FG010|Overall Study|Other|1|||
46973421|NCT02699749|83217241|FG011|Overall Study|Other|0|||
46973422|NCT02699749|83217242|FG012|Overall Study|Other|0|||
46973423|NCT02699749|83217243|FG013|Overall Study|Other|0|||
46973424|NCT02699749|83217230|FG000|Overall Study|Progressive Disease|3|||
46973425|NCT02699749|83217231|FG001|Overall Study|Progressive Disease|3|||
46973426|NCT02699749|83217232|FG002|Overall Study|Progressive Disease|14|||
46973427|NCT02699749|83217233|FG003|Overall Study|Progressive Disease|3|||
46973428|NCT02699749|83217234|FG004|Overall Study|Progressive Disease|3|||
46973429|NCT02699749|83217235|FG005|Overall Study|Progressive Disease|7|||
46673525|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673526|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673527|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673528|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673529|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673530|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673531|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673532|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
46673533|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
46673534|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46673535|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
46673536|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
46673537|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46673538|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46788483|NCT00754325|83007755|FG001|Initial Treatment|Adverse Event|6|||
46788484|NCT00754325|83007754|FG000|Initial Treatment|Withdrawal by Subject|2|||
46788485|NCT00754325|83007755|FG001|Initial Treatment|Withdrawal by Subject|2|||
46973430|NCT02699749|83217236|FG006|Overall Study|Progressive Disease|5|||
46673539|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46788486|NCT00754325|83007754|FG000|Initial Treatment|Physician Decision|2|||
46788487|NCT00754325|83007755|FG001|Initial Treatment|Physician Decision|0|||
46788488|NCT00754325|83007754|FG000|Initial Treatment|Sponsor Request|0|||
46788489|NCT00754325|83007755|FG001|Initial Treatment|Sponsor Request|1|||
46788490|NCT00754325|83007754|FG000|Initial Treatment|Disease Progression|35|||
46788491|NCT00754325|83007755|FG001|Initial Treatment|Disease Progression|35|||
46788492|NCT00524680|83007766|FG000|Overall Study|progression|0|||
46673540|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
46788493|NCT00524680|83007767|FG001|Overall Study|progression|0|||
46973431|NCT02699749|83217237|FG007|Overall Study|Progressive Disease|5|||
46973432|NCT02699749|83217238|FG008|Overall Study|Progressive Disease|6|||
46973433|NCT02699749|83217239|FG009|Overall Study|Progressive Disease|6|||
46973434|NCT02699749|83217240|FG010|Overall Study|Progressive Disease|5|||
46973435|NCT02699749|83217241|FG011|Overall Study|Progressive Disease|4|||
46788494|NCT00524680|83007768|FG002|Overall Study|progression|0|||
46788495|NCT00524680|83007769|FG003|Overall Study|progression|1|||
46788496|NCT00524680|83007766|FG000|Overall Study|Adverse Event|2|||
46788497|NCT00524680|83007767|FG001|Overall Study|Adverse Event|0|||
46788498|NCT00524680|83007768|FG002|Overall Study|Adverse Event|0|||
46788499|NCT00524680|83007769|FG003|Overall Study|Adverse Event|1|||
46788500|NCT00524680|83007766|FG000|Overall Study|Other|0|||
46788501|NCT00524680|83007767|FG001|Overall Study|Other|1|||
46788502|NCT00524680|83007768|FG002|Overall Study|Other|2|||
46973436|NCT02699749|83217242|FG012|Overall Study|Progressive Disease|3|||
46973437|NCT02699749|83217243|FG013|Overall Study|Progressive Disease|5|||
46973438|NCT02699749|83217230|FG000|Overall Study|Death|0|||
46973439|NCT02699749|83217231|FG001|Overall Study|Death|0|||
46973440|NCT02699749|83217232|FG002|Overall Study|Death|0|||
46973441|NCT02699749|83217233|FG003|Overall Study|Death|0|||
46973442|NCT02699749|83217234|FG004|Overall Study|Death|0|||
46973443|NCT02699749|83217235|FG005|Overall Study|Death|0|||
46973444|NCT02699749|83217236|FG006|Overall Study|Death|0|||
46973445|NCT02699749|83217237|FG007|Overall Study|Death|0|||
46973446|NCT02699749|83217238|FG008|Overall Study|Death|0|||
46788503|NCT00524680|83007769|FG003|Overall Study|Other|3|||
46788504|NCT00524680|83007766|FG000|Overall Study|Withdrawal by Subject|1|||
46788505|NCT00524680|83007767|FG001|Overall Study|Withdrawal by Subject|0|||
46973447|NCT02699749|83217239|FG009|Overall Study|Death|0|||
46973448|NCT02699749|83217240|FG010|Overall Study|Death|0|||
46973449|NCT02699749|83217241|FG011|Overall Study|Death|0|||
46973450|NCT02699749|83217242|FG012|Overall Study|Death|0|||
46973451|NCT02699749|83217243|FG013|Overall Study|Death|1|||
46973452|NCT02699749|83217230|FG000|Overall Study|Lost to Follow-up|0|||
46973453|NCT02699749|83217231|FG001|Overall Study|Lost to Follow-up|0|||
46973454|NCT02699749|83217232|FG002|Overall Study|Lost to Follow-up|0|||
46973455|NCT02699749|83217233|FG003|Overall Study|Lost to Follow-up|0|||
46973456|NCT02699749|83217234|FG004|Overall Study|Lost to Follow-up|0|||
46973457|NCT02699749|83217235|FG005|Overall Study|Lost to Follow-up|1|||
46973458|NCT02699749|83217236|FG006|Overall Study|Lost to Follow-up|0|||
46973459|NCT02699749|83217237|FG007|Overall Study|Lost to Follow-up|1|||
46973460|NCT02699749|83217238|FG008|Overall Study|Lost to Follow-up|0|||
46973461|NCT02699749|83217239|FG009|Overall Study|Lost to Follow-up|0|||
46973462|NCT02699749|83217240|FG010|Overall Study|Lost to Follow-up|0|||
46973463|NCT02699749|83217241|FG011|Overall Study|Lost to Follow-up|0|||
47077913|NCT01435928|83381253|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
46788506|NCT00524680|83007768|FG002|Overall Study|Withdrawal by Subject|1|||
46788507|NCT00524680|83007769|FG003|Overall Study|Withdrawal by Subject|1|||
46788508|NCT00628212|83007783|FG000|Overall Study|Adverse Event|2|||
46788509|NCT00628212|83007784|FG001|Overall Study|Adverse Event|0|||
46788510|NCT00628212|83007785|FG002|Overall Study|Adverse Event|1|||
46788511|NCT00628212|83007786|FG003|Overall Study|Adverse Event|2|||
46788512|NCT00628212|83007783|FG000|Overall Study|Physician Decision|1|||
46788513|NCT00628212|83007784|FG001|Overall Study|Physician Decision|1|||
46852260|NCT00103857|83067692|FG006|54-Week Base Study|Lack of Efficacy|19|||
46852261|NCT00103857|83067686|FG000|54-Week Base Study|Lost to Follow-up|5|||
46852262|NCT00103857|83067687|FG001|54-Week Base Study|Lost to Follow-up|4|||
46852263|NCT00103857|83067688|FG002|54-Week Base Study|Lost to Follow-up|7|||
46852264|NCT00103857|83067689|FG003|54-Week Base Study|Lost to Follow-up|5|||
46788514|NCT00628212|83007785|FG002|Overall Study|Physician Decision|2|||
46788515|NCT00628212|83007786|FG003|Overall Study|Physician Decision|3|||
46852265|NCT00103857|83067690|FG004|54-Week Base Study|Lost to Follow-up|10|||
46852266|NCT00103857|83067691|FG005|54-Week Base Study|Lost to Follow-up|9|||
46973464|NCT02699749|83217242|FG012|Overall Study|Lost to Follow-up|0|||
46973465|NCT02699749|83217243|FG013|Overall Study|Lost to Follow-up|0|||
47077914|NCT01435928|83381254|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
47077915|NCT01435928|83381252|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
47077916|NCT01435928|83381253|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
46788516|NCT00298363|83007799|FG000|Overall Study|Lost to Follow-up|0|||
46788517|NCT00298363|83007800|FG001|Overall Study|Lost to Follow-up|0|||
46788518|NCT00298363|83007801|FG002|Overall Study|Lost to Follow-up|1|||
46788519|NCT00298363|83007799|FG000|Overall Study|Physician Decision|4|||
46788520|NCT00298363|83007800|FG001|Overall Study|Physician Decision|1|||
46973466|NCT02699593|83217273|FG000|Period 1|Unsatisfactory Visual Response|0|||
46973467|NCT02699593|83217274|FG001|Period 1|Unsatisfactory Visual Response|1|||
46852267|NCT00103857|83067692|FG006|54-Week Base Study|Lost to Follow-up|3|||
46973468|NCT02699593|83217273|FG000|Period 1|Torn Contact Len|4|||
46973469|NCT02699593|83217274|FG001|Period 1|Torn Contact Len|3|||
46973470|NCT02699593|83217273|FG000|Period 1|Protocol Violation|0|||
46973471|NCT02699593|83217274|FG001|Period 1|Protocol Violation|1|||
46852268|NCT00103857|83067686|FG000|54-Week Base Study|Physician Decision|1|||
46852269|NCT00103857|83067687|FG001|54-Week Base Study|Physician Decision|1|||
46973472|NCT02699593|83217273|FG000|Period 1|Withdrawal by Subject|0|||
46973473|NCT02699593|83217274|FG001|Period 1|Withdrawal by Subject|1|||
46973474|NCT02699593|83217273|FG000|Period 1|Adverse Event|1|||
46973475|NCT02699593|83217274|FG001|Period 1|Adverse Event|1|||
46973476|NCT02699593|83217273|FG000|Period 2|Adverse Event|1|||
46973477|NCT02699593|83217274|FG001|Period 2|Adverse Event|1|||
46973478|NCT02699593|83217273|FG000|Period 2|Lost Contact Lens|0|||
46973479|NCT02699593|83217274|FG001|Period 2|Lost Contact Lens|1|||
46973480|NCT02699593|83217273|FG000|Period 2|Torn Contact Lens|1|||
46788521|NCT00298363|83007801|FG002|Overall Study|Physician Decision|0|||
46788522|NCT00298363|83007799|FG000|Overall Study|Protocol Violation|1|||
46788523|NCT00298363|83007800|FG001|Overall Study|Protocol Violation|1|||
46788524|NCT00298363|83007801|FG002|Overall Study|Protocol Violation|0|||
46788525|NCT00298363|83007799|FG000|Overall Study|Withdrawal by Subject|5|||
46788526|NCT00298363|83007800|FG001|Overall Study|Withdrawal by Subject|1|||
46788527|NCT00298363|83007801|FG002|Overall Study|Withdrawal by Subject|3|||
46788528|NCT00298363|83007799|FG000|Overall Study|Adverse Event|5|||
46788529|NCT00298363|83007800|FG001|Overall Study|Adverse Event|2|||
46788530|NCT00298363|83007801|FG002|Overall Study|Adverse Event|2|||
46788531|NCT00298363|83007799|FG000|Overall Study|Lack of Efficacy|2|||
46788532|NCT00298363|83007800|FG001|Overall Study|Lack of Efficacy|3|||
46788533|NCT00298363|83007801|FG002|Overall Study|Lack of Efficacy|0|||
46788534|NCT00524368|83007817|FG000|Overall Study|Adverse Event|10|||
46788535|NCT00524368|83007818|FG001|Overall Study|Adverse Event|12|||
46788536|NCT00524368|83007817|FG000|Overall Study|Lost to Follow-up|9|||
46788537|NCT00524368|83007818|FG001|Overall Study|Lost to Follow-up|13|||
46788538|NCT00524368|83007817|FG000|Overall Study|Withdrawal by Subject|4|||
46788539|NCT00524368|83007818|FG001|Overall Study|Withdrawal by Subject|5|||
46852270|NCT00103857|83067688|FG002|54-Week Base Study|Physician Decision|0|||
46852271|NCT00103857|83067689|FG003|54-Week Base Study|Physician Decision|0|||
46852272|NCT00103857|83067690|FG004|54-Week Base Study|Physician Decision|1|||
46852273|NCT00103857|83067691|FG005|54-Week Base Study|Physician Decision|0|||
46852274|NCT00103857|83067692|FG006|54-Week Base Study|Physician Decision|0|||
46852275|NCT00103857|83067686|FG000|54-Week Base Study|Pregnancy|1|||
46852276|NCT00103857|83067687|FG001|54-Week Base Study|Pregnancy|0|||
46852277|NCT00103857|83067688|FG002|54-Week Base Study|Pregnancy|0|||
46852278|NCT00103857|83067689|FG003|54-Week Base Study|Pregnancy|0|||
46852279|NCT00103857|83067690|FG004|54-Week Base Study|Pregnancy|1|||
46852280|NCT00103857|83067691|FG005|54-Week Base Study|Pregnancy|0|||
46852281|NCT00103857|83067692|FG006|54-Week Base Study|Pregnancy|1|||
46852282|NCT00103857|83067686|FG000|54-Week Base Study|Protocol Violation|6|||
46852283|NCT00103857|83067687|FG001|54-Week Base Study|Protocol Violation|4|||
46852284|NCT00103857|83067688|FG002|54-Week Base Study|Protocol Violation|2|||
46852285|NCT00103857|83067689|FG003|54-Week Base Study|Protocol Violation|4|||
46852286|NCT00103857|83067690|FG004|54-Week Base Study|Protocol Violation|0|||
46852287|NCT00103857|83067691|FG005|54-Week Base Study|Protocol Violation|3|||
46852288|NCT00103857|83067692|FG006|54-Week Base Study|Protocol Violation|3|||
46852289|NCT00103857|83067686|FG000|54-Week Base Study|Withdrawal by Subject|17|||
46852290|NCT00103857|83067687|FG001|54-Week Base Study|Withdrawal by Subject|16|||
46852291|NCT00103857|83067688|FG002|54-Week Base Study|Withdrawal by Subject|16|||
46852292|NCT00103857|83067689|FG003|54-Week Base Study|Withdrawal by Subject|15|||
46852293|NCT00103857|83067690|FG004|54-Week Base Study|Withdrawal by Subject|10|||
46852294|NCT00103857|83067691|FG005|54-Week Base Study|Withdrawal by Subject|15|||
46852295|NCT00103857|83067692|FG006|54-Week Base Study|Withdrawal by Subject|4|||
46852296|NCT00103857|83067686|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
46852297|NCT00103857|83067687|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
46852298|NCT00103857|83067688|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
46788540|NCT00524368|83007817|FG000|Overall Study|Non-compliant|8|||
46788541|NCT00524368|83007818|FG001|Overall Study|Non-compliant|9|||
46788542|NCT00524368|83007817|FG000|Overall Study|Reached a Virologic Endpoint|3|||
46788543|NCT00524368|83007818|FG001|Overall Study|Reached a Virologic Endpoint|2|||
46788544|NCT00524368|83007817|FG000|Overall Study|Sponsor's Decision|2|||
46788545|NCT00524368|83007818|FG001|Overall Study|Sponsor's Decision|0|||
46852299|NCT00103857|83067689|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
46788546|NCT00524368|83007817|FG000|Overall Study|Ineligible to Continue the study|2|||
46788547|NCT00524368|83007818|FG001|Overall Study|Ineligible to Continue the study|5|||
46788548|NCT00524368|83007817|FG000|Overall Study|Other|3|||
46788549|NCT00524368|83007818|FG001|Overall Study|Other|2|||
46852300|NCT00103857|83067690|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
46973481|NCT02699593|83217274|FG001|Period 2|Torn Contact Lens|0|||
46788550|NCT00777101|83007826|FG000|Overall Study|Death|48|||
46788551|NCT00777101|83007827|FG001|Overall Study|Death|43|||
46973482|NCT00708097|83217280|FG000|Period 1|Protocol Violation|0|||
46788552|NCT00777101|83007826|FG000|Overall Study|Withdrawal by Subject|11|||
46788553|NCT00777101|83007827|FG001|Overall Study|Withdrawal by Subject|6|||
46852301|NCT00103857|83067691|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
46852302|NCT00103857|83067692|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
46852303|NCT00103857|83067686|FG000|54-Week Base Study|patient moved|0|||
46852304|NCT00103857|83067687|FG001|54-Week Base Study|patient moved|1|||
46852305|NCT00103857|83067688|FG002|54-Week Base Study|patient moved|1|||
46788554|NCT00777101|83007826|FG000|Overall Study|Lost to Follow-up|2|||
46788555|NCT00777101|83007827|FG001|Overall Study|Lost to Follow-up|1|||
46788556|NCT00777101|83007826|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
46788557|NCT00777101|83007827|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
46788558|NCT00777101|83007826|FG000|Overall Study|Failed to Return|0|||
46788559|NCT00777101|83007827|FG001|Overall Study|Failed to Return|1|||
46788560|NCT00297427|83007836|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
46788561|NCT00297427|83007837|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
46788562|NCT00297427|83007836|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
46788563|NCT00297427|83007837|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
46788564|NCT00297427|83007836|FG000|Phase 1: Initial Intervention|Death|0|||
46788565|NCT00297427|83007837|FG001|Phase 1: Initial Intervention|Death|1|||
46788566|NCT00297427|83007836|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
46788567|NCT00297427|83007837|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
46788568|NCT00297427|83007836|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
46788569|NCT00297427|83007837|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
46788570|NCT00297427|83007836|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
46788571|NCT00297427|83007837|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
46788572|NCT00297427|83007836|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
46788573|NCT00297427|83007837|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
46788574|NCT00297427|83007836|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
46788575|NCT00297427|83007837|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
46788576|NCT00524134|83007851|FG000|Overall Study|Withdrawal by Subject|1|||
46788577|NCT00524134|83007851|FG000|Overall Study|Physician Decision|1|||
46788578|NCT00777023|83007858|FG000|Overall Study|Adverse Event|15|||
46788579|NCT00777023|83007859|FG001|Overall Study|Adverse Event|21|||
46788580|NCT00777023|83007860|FG002|Overall Study|Adverse Event|8|||
46788581|NCT00777023|83007858|FG000|Overall Study|Lack of Efficacy|1|||
46788582|NCT00777023|83007859|FG001|Overall Study|Lack of Efficacy|0|||
46788583|NCT00777023|83007860|FG002|Overall Study|Lack of Efficacy|14|||
46788584|NCT00777023|83007858|FG000|Overall Study|Protocol Violation|2|||
46788585|NCT00777023|83007859|FG001|Overall Study|Protocol Violation|1|||
46788586|NCT00777023|83007860|FG002|Overall Study|Protocol Violation|1|||
46788587|NCT00777023|83007858|FG000|Overall Study|Lost to Follow-up|2|||
46788588|NCT00777023|83007859|FG001|Overall Study|Lost to Follow-up|3|||
46788589|NCT00777023|83007860|FG002|Overall Study|Lost to Follow-up|3|||
46788590|NCT00777023|83007858|FG000|Overall Study|Death|0|||
46788591|NCT00777023|83007859|FG001|Overall Study|Death|1|||
46788592|NCT00777023|83007860|FG002|Overall Study|Death|0|||
46788593|NCT00777023|83007858|FG000|Overall Study|Withdrawal by Subject|7|||
46788594|NCT00777023|83007859|FG001|Overall Study|Withdrawal by Subject|7|||
46788595|NCT00777023|83007860|FG002|Overall Study|Withdrawal by Subject|8|||
46788596|NCT00777023|83007858|FG000|Overall Study|Missing data|1|||
46788597|NCT00777023|83007859|FG001|Overall Study|Missing data|1|||
46788598|NCT00777023|83007860|FG002|Overall Study|Missing data|0|||
46788599|NCT00777023|83007858|FG000|Overall Study|Reasons not specified|4|||
46788600|NCT00777023|83007859|FG001|Overall Study|Reasons not specified|4|||
46788601|NCT00777023|83007860|FG002|Overall Study|Reasons not specified|2|||
46788602|NCT00777023|83007858|FG000|Overall Study|Last dose date unknown|3|||
46788603|NCT00777023|83007859|FG001|Overall Study|Last dose date unknown|3|||
46673541|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
46673542|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
46673543|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
46673544|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
46673545|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
46673546|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
46673547|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
46673548|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
46673549|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
46673550|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
46673551|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
46673552|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
46788604|NCT00777023|83007860|FG002|Overall Study|Last dose date unknown|1|||
46788605|NCT00297037|83007870|FG000|Overall Study|Withdrawal by Subject|2|||
46788606|NCT00297037|83007871|FG001|Overall Study|Withdrawal by Subject|0|||
46788607|NCT00292981|83007879|FG000|Overall Study|Adverse Event|1|||
46852306|NCT00103857|83067689|FG003|54-Week Base Study|patient moved|2|||
46788608|NCT00292981|83007879|FG000|Overall Study|Lost to Follow-up|13|||
46788609|NCT00292981|83007879|FG000|Overall Study|Withdrawal by Subject|22|||
46788610|NCT00292981|83007879|FG000|Overall Study|Other|3|||
46788611|NCT00296725|83007883|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
46852307|NCT00103857|83067690|FG004|54-Week Base Study|patient moved|3|||
46673553|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
46788612|NCT00296725|83007883|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
46788613|NCT00296725|83007883|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
46788614|NCT00625872|83007891|FG000|Overall Study|Withdrawal by Subject|1|||
46788615|NCT00625872|83007892|FG001|Overall Study|Withdrawal by Subject|0|||
46788616|NCT00625872|83007891|FG000|Overall Study|Does not meet inclusion criteria|1|||
46788617|NCT00625872|83007892|FG001|Overall Study|Does not meet inclusion criteria|0|||
46788618|NCT00625872|83007891|FG000|Overall Study|Terminated by sponsor|2|||
46788619|NCT00625872|83007892|FG001|Overall Study|Terminated by sponsor|5|||
46788620|NCT00625872|83007891|FG000|Overall Study|Randomized but not treated|0|||
46788621|NCT00625872|83007892|FG001|Overall Study|Randomized but not treated|1|||
46788622|NCT00523978|83007900|FG000|Overall Study|Withdrawal by Subject|3|||
46788623|NCT00523978|83007901|FG001|Overall Study|Withdrawal by Subject|7|||
46788624|NCT00523978|83007900|FG000|Overall Study|Screen Failures|5|||
46788625|NCT00523978|83007901|FG001|Overall Study|Screen Failures|1|||
46788626|NCT00523978|83007900|FG000|Overall Study|Death|1|||
46788627|NCT00523978|83007901|FG001|Overall Study|Death|0|||
46788628|NCT00296647|83007913|FG000|Overall Study|Death|4|||
46788629|NCT00296647|83007914|FG001|Overall Study|Death|1|||
46788630|NCT00296647|83007915|FG002|Overall Study|Death|2|||
46788631|NCT00296647|83007916|FG003|Overall Study|Death|1|||
46788632|NCT00296647|83007917|FG004|Overall Study|Death|1|||
46788633|NCT00296647|83007913|FG000|Overall Study|Withdrawal by Subject|28|||
46788634|NCT00296647|83007914|FG001|Overall Study|Withdrawal by Subject|27|||
46788635|NCT00296647|83007915|FG002|Overall Study|Withdrawal by Subject|32|||
46788636|NCT00296647|83007916|FG003|Overall Study|Withdrawal by Subject|16|||
46788637|NCT00296647|83007917|FG004|Overall Study|Withdrawal by Subject|19|||
46788638|NCT00754013|83007931|FG000|Overall Study|Lost to Follow-up|1|||
46788639|NCT00754013|83007932|FG001|Overall Study|Lost to Follow-up|1|||
46788640|NCT00754013|83007931|FG000|Overall Study|didn't return after study termed|3|||
46788641|NCT00754013|83007932|FG001|Overall Study|didn't return after study termed|4|||
46788642|NCT00523744|83007938|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
46788643|NCT00523744|83007938|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
46788644|NCT00523744|83007938|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
46788645|NCT00523744|83007938|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
46973483|NCT00708097|83217281|FG001|Period 1|Protocol Violation|1|||
46973484|NCT00708097|83217282|FG002|Period 1|Protocol Violation|0|||
46973485|NCT00708097|83217283|FG003|Period 1|Protocol Violation|2|||
46973486|NCT00708097|83217284|FG004|Period 1|Protocol Violation|0|||
46973487|NCT00708097|83217280|FG000|Period 1|Other Reason|0|||
46973488|NCT00708097|83217281|FG001|Period 1|Other Reason|0|||
46973489|NCT00708097|83217282|FG002|Period 1|Other Reason|0|||
46973490|NCT00708097|83217283|FG003|Period 1|Other Reason|0|||
46788646|NCT00523744|83007938|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
46788647|NCT00523744|83007938|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
46788648|NCT00752219|83007956|FG000|Overall Study|Clinical failure|0|||
46788649|NCT00752219|83007957|FG001|Overall Study|Clinical failure|1|||
46788650|NCT00752219|83007956|FG000|Overall Study|Adverse Event|5|||
46788651|NCT00752219|83007957|FG001|Overall Study|Adverse Event|3|||
46788652|NCT00752219|83007956|FG000|Overall Study|Protocol deviation|1|||
46788653|NCT00752219|83007957|FG001|Overall Study|Protocol deviation|0|||
46788654|NCT00752219|83007956|FG000|Overall Study|Lost to Follow-up|1|||
46788655|NCT00752219|83007957|FG001|Overall Study|Lost to Follow-up|2|||
46788656|NCT00752219|83007956|FG000|Overall Study|Randomized but not treated|1|||
46788657|NCT00752219|83007957|FG001|Overall Study|Randomized but not treated|0|||
46788658|NCT00752219|83007956|FG000|Overall Study|Other|3|||
46788659|NCT00752219|83007957|FG001|Overall Study|Other|0|||
46852308|NCT00103857|83067691|FG005|54-Week Base Study|patient moved|1|||
46852309|NCT00103857|83067692|FG006|54-Week Base Study|patient moved|0|||
46852310|NCT00103857|83067686|FG000|54-Week Base Study|non-compliance with study procedures|1|||
46852311|NCT00103857|83067687|FG001|54-Week Base Study|non-compliance with study procedures|2|||
46852312|NCT00103857|83067688|FG002|54-Week Base Study|non-compliance with study procedures|0|||
46852313|NCT00103857|83067689|FG003|54-Week Base Study|non-compliance with study procedures|0|||
46852314|NCT00103857|83067690|FG004|54-Week Base Study|non-compliance with study procedures|0|||
46852315|NCT00103857|83067691|FG005|54-Week Base Study|non-compliance with study procedures|2|||
46852316|NCT00103857|83067692|FG006|54-Week Base Study|non-compliance with study procedures|0|||
46852317|NCT00103857|83067686|FG000|54-Week Base Study|patient incarcerated|0|||
46973491|NCT00708097|83217284|FG004|Period 1|Other Reason|1|||
46788660|NCT00622908|83007965|FG000|Overall Study|Protocol Violation|1|||
46788661|NCT00622908|83007966|FG001|Overall Study|Protocol Violation|0|||
46788662|NCT00622908|83007965|FG000|Overall Study|Adverse Event|0|||
46788663|NCT00622908|83007966|FG001|Overall Study|Adverse Event|1|||
46788664|NCT00622908|83007965|FG000|Overall Study|Lack of Efficacy|1|||
46788665|NCT00622908|83007966|FG001|Overall Study|Lack of Efficacy|7|||
46788666|NCT00622908|83007965|FG000|Overall Study|Lost to Follow-up|1|||
46852318|NCT00103857|83067687|FG001|54-Week Base Study|patient incarcerated|0|||
46852319|NCT00103857|83067688|FG002|54-Week Base Study|patient incarcerated|0|||
46973492|NCT00708097|83217280|FG000|Period 2|Protocol Violation|0|||
46788667|NCT00622908|83007966|FG001|Overall Study|Lost to Follow-up|0|||
46788668|NCT00622908|83007965|FG000|Overall Study|Refusal|0|||
46788669|NCT00622908|83007966|FG001|Overall Study|Refusal|1|||
46788670|NCT00622908|83007965|FG000|Overall Study|Termination by study sponser|0|||
46788671|NCT00622908|83007966|FG001|Overall Study|Termination by study sponser|1|||
46788672|NCT00296491|83007976|FG000|Overall Study|Low Pollen Counts|18|||
46788673|NCT00296491|83007977|FG001|Overall Study|Low Pollen Counts|26|||
46788674|NCT00296491|83007978|FG002|Overall Study|Low Pollen Counts|25|||
46788675|NCT00296491|83007979|FG003|Overall Study|Low Pollen Counts|16|||
46788676|NCT00296491|83007976|FG000|Overall Study|Protocol Violation|4|||
46788677|NCT00296491|83007977|FG001|Overall Study|Protocol Violation|6|||
46788678|NCT00296491|83007978|FG002|Overall Study|Protocol Violation|2|||
46788679|NCT00296491|83007979|FG003|Overall Study|Protocol Violation|3|||
46788680|NCT00296491|83007976|FG000|Overall Study|Adverse Event|1|||
46788681|NCT00296491|83007977|FG001|Overall Study|Adverse Event|3|||
46788682|NCT00296491|83007978|FG002|Overall Study|Adverse Event|1|||
46788683|NCT00296491|83007979|FG003|Overall Study|Adverse Event|4|||
46788684|NCT00296491|83007976|FG000|Overall Study|Withdrawn due to Asthma|0|||
46673554|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
46673555|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
46673556|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
46788685|NCT00296491|83007977|FG001|Overall Study|Withdrawn due to Asthma|0|||
46788686|NCT00296491|83007978|FG002|Overall Study|Withdrawn due to Asthma|0|||
46788687|NCT00296491|83007979|FG003|Overall Study|Withdrawn due to Asthma|4|||
46788688|NCT00296491|83007976|FG000|Overall Study|Withdrawal by Subject|7|||
46788689|NCT00296491|83007977|FG001|Overall Study|Withdrawal by Subject|3|||
46788690|NCT00296491|83007978|FG002|Overall Study|Withdrawal by Subject|3|||
46788691|NCT00296491|83007979|FG003|Overall Study|Withdrawal by Subject|2|||
46788692|NCT00296491|83007976|FG000|Overall Study|Non-Compliance|12|||
46788693|NCT00296491|83007977|FG001|Overall Study|Non-Compliance|13|||
46788694|NCT00296491|83007978|FG002|Overall Study|Non-Compliance|10|||
46788695|NCT00296491|83007979|FG003|Overall Study|Non-Compliance|14|||
46788696|NCT00296491|83007976|FG000|Overall Study|Lost to Follow-up|0|||
46852320|NCT00103857|83067689|FG003|54-Week Base Study|patient incarcerated|0|||
46852321|NCT00103857|83067690|FG004|54-Week Base Study|patient incarcerated|1|||
46852322|NCT00103857|83067691|FG005|54-Week Base Study|patient incarcerated|1|||
46852323|NCT00103857|83067692|FG006|54-Week Base Study|patient incarcerated|0|||
46852324|NCT00103857|83067686|FG000|54-Week Base Study|laboratory reporting error|0|||
46852325|NCT00103857|83067687|FG001|54-Week Base Study|laboratory reporting error|0|||
46973493|NCT00708097|83217281|FG001|Period 2|Protocol Violation|1|||
46852326|NCT00103857|83067688|FG002|54-Week Base Study|laboratory reporting error|0|||
46852327|NCT00103857|83067689|FG003|54-Week Base Study|laboratory reporting error|0|||
46852328|NCT00103857|83067690|FG004|54-Week Base Study|laboratory reporting error|1|||
46852329|NCT00103857|83067691|FG005|54-Week Base Study|laboratory reporting error|0|||
46852330|NCT00103857|83067692|FG006|54-Week Base Study|laboratory reporting error|0|||
46852331|NCT00103857|83067686|FG000|54-Week Base Study|site error|0|||
46852332|NCT00103857|83067687|FG001|54-Week Base Study|site error|0|||
46852333|NCT00103857|83067688|FG002|54-Week Base Study|site error|0|||
46852334|NCT00103857|83067689|FG003|54-Week Base Study|site error|0|||
46852335|NCT00103857|83067690|FG004|54-Week Base Study|site error|0|||
46852336|NCT00103857|83067691|FG005|54-Week Base Study|site error|1|||
46852337|NCT00103857|83067692|FG006|54-Week Base Study|site error|0|||
46852338|NCT00103857|83067686|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
46973494|NCT00708097|83217282|FG002|Period 2|Protocol Violation|1|||
46973495|NCT00708097|83217283|FG003|Period 2|Protocol Violation|1|||
46973496|NCT00708097|83217284|FG004|Period 2|Protocol Violation|0|||
46973497|NCT02659631|83217311|FG000|Overall Study|Lost to Follow-up|0|||
46973498|NCT02659631|83217312|FG001|Overall Study|Lost to Follow-up|0|||
46973499|NCT02659631|83217313|FG002|Overall Study|Lost to Follow-up|2|||
46973500|NCT02659631|83217314|FG003|Overall Study|Lost to Follow-up|0|||
46673557|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
46973501|NCT02659631|83217315|FG004|Overall Study|Lost to Follow-up|0|||
46973502|NCT02659631|83217316|FG005|Overall Study|Lost to Follow-up|1|||
46973503|NCT02659631|83217317|FG006|Overall Study|Lost to Follow-up|0|||
46788697|NCT00296491|83007977|FG001|Overall Study|Lost to Follow-up|2|||
46788698|NCT00296491|83007978|FG002|Overall Study|Lost to Follow-up|2|||
46788699|NCT00296491|83007979|FG003|Overall Study|Lost to Follow-up|0|||
46973504|NCT02659631|83217318|FG007|Overall Study|Lost to Follow-up|0|||
46973505|NCT02659631|83217319|FG008|Overall Study|Lost to Follow-up|0|||
46788700|NCT00747617|83007998|FG000|Overall Study|Lost to Follow-up|3|||
46788701|NCT00747617|83007999|FG001|Overall Study|Lost to Follow-up|1|||
46788702|NCT00296335|83008007|FG000|Overall Study|Recurrence|3|||
46788703|NCT00296335|83008008|FG001|Overall Study|Recurrence|51|||
46788704|NCT00296335|83008007|FG000|Overall Study|Adverse Event|17|||
46852339|NCT00103857|83067687|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
46852340|NCT00103857|83067688|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
46973506|NCT02659631|83217320|FG009|Overall Study|Lost to Follow-up|0|||
46973507|NCT02659631|83217311|FG000|Overall Study|Withdrawal prior to treatment|0|||
46973508|NCT02659631|83217312|FG001|Overall Study|Withdrawal prior to treatment|0|||
46973509|NCT02659631|83217313|FG002|Overall Study|Withdrawal prior to treatment|0|||
46973510|NCT02659631|83217314|FG003|Overall Study|Withdrawal prior to treatment|0|||
46973511|NCT02659631|83217315|FG004|Overall Study|Withdrawal prior to treatment|1|||
46973512|NCT02659631|83217316|FG005|Overall Study|Withdrawal prior to treatment|0|||
46973513|NCT02659631|83217317|FG006|Overall Study|Withdrawal prior to treatment|0|||
46973514|NCT02659631|83217318|FG007|Overall Study|Withdrawal prior to treatment|0|||
46973515|NCT02659631|83217319|FG008|Overall Study|Withdrawal prior to treatment|0|||
46973516|NCT02659631|83217320|FG009|Overall Study|Withdrawal prior to treatment|0|||
46973517|NCT02659631|83217311|FG000|Overall Study|Participant refused further follow-up|0|||
46973518|NCT02659631|83217312|FG001|Overall Study|Participant refused further follow-up|0|||
46973519|NCT02659631|83217313|FG002|Overall Study|Participant refused further follow-up|0|||
46788705|NCT00296335|83008008|FG001|Overall Study|Adverse Event|27|||
46788706|NCT00296335|83008007|FG000|Overall Study|Lost to Follow-up|7|||
46788707|NCT00296335|83008008|FG001|Overall Study|Lost to Follow-up|33|||
46788708|NCT00296335|83008007|FG000|Overall Study|Physician Decision|3|||
46788709|NCT00296335|83008008|FG001|Overall Study|Physician Decision|11|||
46788710|NCT00747461|83008016|FG000|Overall Study|study terminated by sponsor|5|||
46788711|NCT03683758|83008023|FG000|Overall Study|Non-study commitment conflict|1|||
46788712|NCT03683758|83008024|FG001|Overall Study|Non-study commitment conflict|3|||
46788713|NCT03683758|83008023|FG000|Overall Study|Illness preventing participation|1|||
46788714|NCT03683758|83008024|FG001|Overall Study|Illness preventing participation|0|||
46788715|NCT03683758|83008023|FG000|Overall Study|Adverse Event|1|||
46788716|NCT03683758|83008024|FG001|Overall Study|Adverse Event|0|||
46788717|NCT00522418|83008032|FG000|Overall Study|Local IRB Consent Violation|5|||
46788718|NCT00522418|83008033|FG001|Overall Study|Local IRB Consent Violation|5|||
46788719|NCT00522418|83008032|FG000|Overall Study|Early Study Termination|46|||
46788720|NCT00522418|83008033|FG001|Overall Study|Early Study Termination|47|||
46788721|NCT00522418|83008032|FG000|Overall Study|Noncompliance|2|||
46788722|NCT00522418|83008033|FG001|Overall Study|Noncompliance|2|||
46788723|NCT00522418|83008032|FG000|Overall Study|Reason Not Specified|3|||
46788724|NCT00522418|83008033|FG001|Overall Study|Reason Not Specified|1|||
46788725|NCT00522418|83008032|FG000|Overall Study|Consent Withdraw|1|||
46788726|NCT00522418|83008033|FG001|Overall Study|Consent Withdraw|2|||
46788727|NCT00522418|83008032|FG000|Overall Study|Lack of Efficacy|0|||
46788728|NCT00522418|83008033|FG001|Overall Study|Lack of Efficacy|1|||
46788729|NCT00624780|83008047|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
46788730|NCT00624780|83008048|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
46788731|NCT00624780|83008049|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
46788732|NCT00624780|83008050|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
46788733|NCT00624780|83008051|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
46788734|NCT00624780|83008052|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
46788735|NCT00624780|83008047|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
46788736|NCT00624780|83008048|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
46788737|NCT00624780|83008049|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
46788738|NCT00624780|83008050|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
46788739|NCT00624780|83008051|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
46788740|NCT00624780|83008052|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
46788741|NCT00624780|83008047|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
46788742|NCT00624780|83008048|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
46973520|NCT02659631|83217314|FG003|Overall Study|Participant refused further follow-up|1|||
46788743|NCT00624780|83008049|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
46788744|NCT00624780|83008050|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
46788745|NCT00624780|83008051|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
46852341|NCT00103857|83067689|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
46852342|NCT00103857|83067690|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
46852343|NCT00103857|83067691|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
46852344|NCT00103857|83067692|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
46852345|NCT00103857|83067686|FG000|50-Week Extension Study|Adverse Event|2|||
46852346|NCT00103857|83067687|FG001|50-Week Extension Study|Adverse Event|3|||
46852347|NCT00103857|83067688|FG002|50-Week Extension Study|Adverse Event|2|||
46852348|NCT00103857|83067689|FG003|50-Week Extension Study|Adverse Event|0|||
46852349|NCT00103857|83067690|FG004|50-Week Extension Study|Adverse Event|1|||
46852350|NCT00103857|83067691|FG005|50-Week Extension Study|Adverse Event|1|||
46852351|NCT00103857|83067692|FG006|50-Week Extension Study|Adverse Event|0|||
46973521|NCT02659631|83217315|FG004|Overall Study|Participant refused further follow-up|0|||
46973522|NCT02659631|83217316|FG005|Overall Study|Participant refused further follow-up|0|||
46788746|NCT00624780|83008052|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
46788747|NCT00624780|83008047|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
46788748|NCT00624780|83008048|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
46788749|NCT00624780|83008049|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
46788750|NCT00624780|83008050|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
46788751|NCT00624780|83008051|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
46788752|NCT00624780|83008052|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
46788753|NCT00624780|83008047|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
46788754|NCT00624780|83008048|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
46788755|NCT00624780|83008049|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
46788756|NCT00624780|83008050|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
46788757|NCT00624780|83008051|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
46788758|NCT00624780|83008052|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
46788759|NCT00624780|83008047|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
46788760|NCT00624780|83008048|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
46788761|NCT00624780|83008049|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
46788762|NCT00624780|83008050|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
46788763|NCT00624780|83008051|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
46788764|NCT00624780|83008052|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
46788765|NCT00624780|83008047|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
46788766|NCT00624780|83008048|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
46788767|NCT00624780|83008049|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
46788768|NCT00624780|83008050|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
46788769|NCT00624780|83008051|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
46788770|NCT00624780|83008052|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
46788771|NCT00624780|83008047|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
46788772|NCT00624780|83008048|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
46788773|NCT00624780|83008049|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
46788774|NCT00624780|83008050|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
46788775|NCT00624780|83008051|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
46788776|NCT00624780|83008052|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
46788777|NCT00624780|83008047|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
46788778|NCT00624780|83008048|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
46788779|NCT00624780|83008049|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
46788780|NCT00624780|83008050|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
46788781|NCT00624780|83008051|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
46788782|NCT00624780|83008052|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
46788783|NCT00624780|83008047|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
46788784|NCT00624780|83008048|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
46788785|NCT00624780|83008049|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
46788786|NCT00624780|83008050|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
46788787|NCT00624780|83008051|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
46788788|NCT00624780|83008052|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
46788789|NCT00624780|83008047|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
46788790|NCT00624780|83008048|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
46788791|NCT00624780|83008049|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
46788792|NCT00624780|83008050|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
46788793|NCT00624780|83008051|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
46788794|NCT00624780|83008052|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
46788795|NCT00624780|83008047|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
46788796|NCT00624780|83008048|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
46788797|NCT00624780|83008049|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
46788798|NCT00624780|83008050|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
46788799|NCT00624780|83008051|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
46788800|NCT00624780|83008052|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
46788801|NCT00624780|83008047|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
46788802|NCT00624780|83008048|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
46788803|NCT00624780|83008049|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
46788804|NCT00624780|83008050|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
46788805|NCT00624780|83008051|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
46788806|NCT00624780|83008052|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
46788807|NCT00624780|83008047|FG000|Follow-up (Week 26)|Death|0|||
46788808|NCT00624780|83008048|FG001|Follow-up (Week 26)|Death|0|||
46852352|NCT00103857|83067686|FG000|50-Week Extension Study|Death|0|||
46673558|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
46788809|NCT00624780|83008049|FG002|Follow-up (Week 26)|Death|1|||
46788810|NCT00624780|83008050|FG003|Follow-up (Week 26)|Death|0|||
46788811|NCT00624780|83008051|FG004|Follow-up (Week 26)|Death|0|||
46788812|NCT00624780|83008052|FG005|Follow-up (Week 26)|Death|0|||
46788813|NCT00624780|83008047|FG000|Follow-up (Week 26)|Adverse Event|0|||
46852353|NCT00103857|83067687|FG001|50-Week Extension Study|Death|0|||
46788814|NCT00624780|83008048|FG001|Follow-up (Week 26)|Adverse Event|0|||
46788815|NCT00624780|83008049|FG002|Follow-up (Week 26)|Adverse Event|0|||
46788816|NCT00624780|83008050|FG003|Follow-up (Week 26)|Adverse Event|0|||
46788817|NCT00624780|83008051|FG004|Follow-up (Week 26)|Adverse Event|1|||
46788818|NCT00624780|83008052|FG005|Follow-up (Week 26)|Adverse Event|0|||
46788819|NCT00624780|83008047|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
46788820|NCT00624780|83008048|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
46788821|NCT00624780|83008049|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
46788822|NCT00624780|83008050|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
46788823|NCT00624780|83008051|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
46788824|NCT00624780|83008052|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
46788825|NCT00624780|83008047|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
46788826|NCT00624780|83008048|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
46788827|NCT00624780|83008049|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
46788828|NCT00624780|83008050|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
46788829|NCT00624780|83008051|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
46788830|NCT00624780|83008052|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
46788831|NCT00624780|83008047|FG000|Follow-up (Week 26)|Other|1|||
46788832|NCT00624780|83008048|FG001|Follow-up (Week 26)|Other|1|||
46788833|NCT00624780|83008049|FG002|Follow-up (Week 26)|Other|0|||
46788834|NCT00624780|83008050|FG003|Follow-up (Week 26)|Other|0|||
46788835|NCT00624780|83008051|FG004|Follow-up (Week 26)|Other|0|||
46788836|NCT00624780|83008052|FG005|Follow-up (Week 26)|Other|0|||
46788837|NCT00750893|83008069|FG000|Overall Study|Adverse Event|5|||
46788838|NCT00750893|83008069|FG000|Overall Study|Withdrawal by Subject|10|||
46788839|NCT00750893|83008069|FG000|Overall Study|Lost to Follow-up|510|||
46788840|NCT00750893|83008069|FG000|Overall Study|Other|17|||
46788841|NCT00753623|83008075|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
46788842|NCT00753623|83008076|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
46788843|NCT00753623|83008075|FG000|Phase I (14 Days)|Physician Decision|1|||
46788844|NCT00753623|83008076|FG001|Phase I (14 Days)|Physician Decision|2|||
46788845|NCT00753623|83008075|FG000|Phase I (14 Days)|Adverse Event|0|||
46788846|NCT00753623|83008076|FG001|Phase I (14 Days)|Adverse Event|1|||
46788847|NCT00753623|83008075|FG000|Washout (7 Days)|Physician Decision|1|||
46788848|NCT00753623|83008076|FG001|Washout (7 Days)|Physician Decision|0|||
46788849|NCT00753623|83008075|FG000|Phase II (14 Days)|Physician Decision|0|||
46788850|NCT00753623|83008076|FG001|Phase II (14 Days)|Physician Decision|1|||
46788851|NCT00750737|83008084|FG000|Overall Study|Withdrawal by Subject|3|||
46788852|NCT00750737|83008085|FG001|Overall Study|Withdrawal by Subject|3|||
46788853|NCT00622440|83008093|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
46788854|NCT00622440|83008094|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
46788855|NCT00622440|83008093|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
46788856|NCT00622440|83008094|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
46788857|NCT00622440|83008093|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
46788858|NCT00622440|83008094|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
46788859|NCT00622440|83008093|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
46788860|NCT00622440|83008094|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
46788861|NCT00744653|83008100|FG000|Overall Study|antineoplastic treatment|11|||
46788862|NCT00744653|83008100|FG000|Overall Study|Death|1|||
46788863|NCT00744653|83008100|FG000|Overall Study|Lost to Follow-up|1|||
46788864|NCT00744653|83008100|FG000|Overall Study|Physician Decision|3|||
46788865|NCT00311311|83008107|FG000|Overall Study|Adverse Event|3|||
46788866|NCT00311311|83008108|FG001|Overall Study|Adverse Event|2|||
46788867|NCT00311311|83008107|FG000|Overall Study|Withdrawal by Subject|1|||
46788868|NCT00311311|83008108|FG001|Overall Study|Withdrawal by Subject|1|||
46788869|NCT00311311|83008107|FG000|Overall Study|Noncompliance|0|||
46788870|NCT00311311|83008108|FG001|Overall Study|Noncompliance|1|||
46788871|NCT00311311|83008107|FG000|Overall Study|Study Termination by Sponsor|3|||
46788872|NCT00311311|83008108|FG001|Overall Study|Study Termination by Sponsor|4|||
46788873|NCT00311311|83008107|FG000|Overall Study|Death|1|||
46673559|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
46673560|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
46673561|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46788874|NCT00311311|83008108|FG001|Overall Study|Death|0|||
46788875|NCT00311311|83008107|FG000|Overall Study|Lack of ancillary assistance|0|||
46788876|NCT00311311|83008108|FG001|Overall Study|Lack of ancillary assistance|1|||
46788877|NCT00521404|83008114|FG000|Overall Study|Adverse Event|13|||
46788878|NCT00521404|83008114|FG000|Overall Study|Disease Progression|33|||
46788879|NCT00521404|83008114|FG000|Overall Study|Investigator decision|5|||
46788880|NCT00521404|83008114|FG000|Overall Study|Withdrawal of consent|3|||
46788881|NCT00521404|83008114|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
46788882|NCT00521404|83008114|FG000|Overall Study|Other|7|||
46788883|NCT00311155|83008118|FG000|Overall Study|Adverse Event|21|||
46788884|NCT00311155|83008118|FG000|Overall Study|Withdrawal by Subject|17|||
46788885|NCT00311155|83008118|FG000|Overall Study|Did not meet entry criteria|55|||
46788886|NCT00274651|83008124|FG000|Overall Study|Adverse Event|6|||
46788887|NCT00274651|83008125|FG001|Overall Study|Adverse Event|3|||
46788888|NCT00274651|83008124|FG000|Overall Study|Lack of Efficacy|13|||
46788889|NCT00274651|83008125|FG001|Overall Study|Lack of Efficacy|6|||
46788890|NCT00274651|83008124|FG000|Overall Study|Death|1|||
46788891|NCT00274651|83008125|FG001|Overall Study|Death|3|||
46788892|NCT00274651|83008124|FG000|Overall Study|Withdrawal by Subject|0|||
46788893|NCT00274651|83008125|FG001|Overall Study|Withdrawal by Subject|1|||
46788894|NCT00274651|83008124|FG000|Overall Study|Physician Decision|8|||
46788895|NCT00274651|83008125|FG001|Overall Study|Physician Decision|7|||
46788896|NCT00274261|83008134|FG000|Overall Study|Adverse Event|19|||
46788897|NCT00274261|83008135|FG001|Overall Study|Adverse Event|11|||
46788898|NCT00274261|83008134|FG000|Overall Study|Pregnancy|114|||
46788899|NCT00274261|83008135|FG001|Overall Study|Pregnancy|83|||
46852354|NCT00103857|83067688|FG002|50-Week Extension Study|Death|0|||
46852355|NCT00103857|83067689|FG003|50-Week Extension Study|Death|1|||
46852356|NCT00103857|83067690|FG004|50-Week Extension Study|Death|0|||
46852357|NCT00103857|83067691|FG005|50-Week Extension Study|Death|1|||
46852358|NCT00103857|83067692|FG006|50-Week Extension Study|Death|0|||
46852359|NCT00103857|83067686|FG000|50-Week Extension Study|Lack of Efficacy|26|||
46852360|NCT00103857|83067687|FG001|50-Week Extension Study|Lack of Efficacy|15|||
46852361|NCT00103857|83067688|FG002|50-Week Extension Study|Lack of Efficacy|13|||
46852362|NCT00103857|83067689|FG003|50-Week Extension Study|Lack of Efficacy|16|||
46852363|NCT00103857|83067690|FG004|50-Week Extension Study|Lack of Efficacy|8|||
46852364|NCT00103857|83067691|FG005|50-Week Extension Study|Lack of Efficacy|8|||
46852365|NCT00103857|83067692|FG006|50-Week Extension Study|Lack of Efficacy|0|||
46852366|NCT00103857|83067686|FG000|50-Week Extension Study|Lost to Follow-up|4|||
46852367|NCT00103857|83067687|FG001|50-Week Extension Study|Lost to Follow-up|0|||
46852368|NCT00103857|83067688|FG002|50-Week Extension Study|Lost to Follow-up|1|||
46852369|NCT00103857|83067689|FG003|50-Week Extension Study|Lost to Follow-up|4|||
46852370|NCT00103857|83067690|FG004|50-Week Extension Study|Lost to Follow-up|3|||
46852371|NCT00103857|83067691|FG005|50-Week Extension Study|Lost to Follow-up|3|||
46852372|NCT00103857|83067692|FG006|50-Week Extension Study|Lost to Follow-up|0|||
46852373|NCT00103857|83067686|FG000|50-Week Extension Study|Physician Decision|0|||
46852374|NCT00103857|83067687|FG001|50-Week Extension Study|Physician Decision|1|||
46852375|NCT00103857|83067688|FG002|50-Week Extension Study|Physician Decision|1|||
46852376|NCT00103857|83067689|FG003|50-Week Extension Study|Physician Decision|0|||
46852377|NCT00103857|83067690|FG004|50-Week Extension Study|Physician Decision|0|||
46852378|NCT00103857|83067691|FG005|50-Week Extension Study|Physician Decision|0|||
46852379|NCT00103857|83067692|FG006|50-Week Extension Study|Physician Decision|0|||
46852380|NCT00103857|83067686|FG000|50-Week Extension Study|Pregnancy|0|||
46852381|NCT00103857|83067687|FG001|50-Week Extension Study|Pregnancy|0|||
46852382|NCT00103857|83067688|FG002|50-Week Extension Study|Pregnancy|1|||
46852383|NCT00103857|83067689|FG003|50-Week Extension Study|Pregnancy|0|||
46852384|NCT00103857|83067690|FG004|50-Week Extension Study|Pregnancy|1|||
46852385|NCT00103857|83067691|FG005|50-Week Extension Study|Pregnancy|0|||
46852386|NCT00103857|83067692|FG006|50-Week Extension Study|Pregnancy|0|||
46852387|NCT00103857|83067686|FG000|50-Week Extension Study|Protocol Violation|1|||
46852388|NCT00103857|83067687|FG001|50-Week Extension Study|Protocol Violation|1|||
46852389|NCT00103857|83067688|FG002|50-Week Extension Study|Protocol Violation|1|||
46852390|NCT00103857|83067689|FG003|50-Week Extension Study|Protocol Violation|2|||
46852391|NCT00103857|83067690|FG004|50-Week Extension Study|Protocol Violation|0|||
46852392|NCT00103857|83067691|FG005|50-Week Extension Study|Protocol Violation|1|||
46852393|NCT00103857|83067692|FG006|50-Week Extension Study|Protocol Violation|0|||
46852394|NCT00103857|83067686|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
46852395|NCT00103857|83067687|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
46852396|NCT00103857|83067688|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
46852397|NCT00103857|83067689|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
46852398|NCT00103857|83067690|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
46852399|NCT00103857|83067691|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
46852400|NCT00103857|83067692|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
46788900|NCT00274261|83008134|FG000|Overall Study|Withdrawal by Subject|179|||
46852401|NCT00103857|83067686|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
46788901|NCT00274261|83008135|FG001|Overall Study|Withdrawal by Subject|126|||
46788902|NCT00274261|83008134|FG000|Overall Study|Protocol Violation|71|||
46852402|NCT00103857|83067687|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
46852403|NCT00103857|83067688|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
46852404|NCT00103857|83067689|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
46852405|NCT00103857|83067690|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
46852406|NCT00103857|83067691|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
46852407|NCT00103857|83067692|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
46788903|NCT00274261|83008135|FG001|Overall Study|Protocol Violation|42|||
46788904|NCT00274261|83008134|FG000|Overall Study|Lost to Follow-up|106|||
46788905|NCT00274261|83008135|FG001|Overall Study|Lost to Follow-up|75|||
46788906|NCT00624468|83008145|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
46788907|NCT00624468|83008146|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
46788908|NCT00624468|83008147|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
46788909|NCT00624468|83008148|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
46788910|NCT00624468|83008145|FG000|Double-blind Period|Withdrew Prematurely|1|||
46788911|NCT00624468|83008146|FG001|Double-blind Period|Withdrew Prematurely|1|||
46788912|NCT00624468|83008147|FG002|Double-blind Period|Withdrew Prematurely|0|||
46788913|NCT00624468|83008148|FG003|Double-blind Period|Withdrew Prematurely|0|||
46788914|NCT00624468|83008145|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
46788915|NCT00624468|83008146|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
46788916|NCT00624468|83008147|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
46788917|NCT00624468|83008148|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
46788918|NCT00624468|83008145|FG000|Safety Follow-up (SFU) Period|Other|0|||
46788919|NCT00624468|83008146|FG001|Safety Follow-up (SFU) Period|Other|0|||
46788920|NCT00624468|83008147|FG002|Safety Follow-up (SFU) Period|Other|1|||
46852408|NCT00103857|83067686|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
46852409|NCT00103857|83067687|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
46852410|NCT00103857|83067688|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
46852411|NCT00103857|83067689|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
46852412|NCT00103857|83067690|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
46852413|NCT00103857|83067691|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
46852414|NCT00103857|83067692|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
46852415|NCT00103857|83067686|FG000|50-Week Extension Study|patient moved|0|||
46852416|NCT00103857|83067687|FG001|50-Week Extension Study|patient moved|0|||
46852417|NCT00103857|83067688|FG002|50-Week Extension Study|patient moved|1|||
46852418|NCT00103857|83067689|FG003|50-Week Extension Study|patient moved|2|||
46852419|NCT00103857|83067690|FG004|50-Week Extension Study|patient moved|0|||
46852420|NCT00103857|83067691|FG005|50-Week Extension Study|patient moved|0|||
46852421|NCT00103857|83067692|FG006|50-Week Extension Study|patient moved|0|||
46852422|NCT00103857|83067686|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
46852423|NCT00103857|83067687|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
46852424|NCT00103857|83067688|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
46852425|NCT00103857|83067689|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
46852426|NCT00103857|83067690|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
46852427|NCT00103857|83067691|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
46852428|NCT00103857|83067692|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
46852429|NCT00103857|83067686|FG000|50-Week Extension Study|reason unspecified|0|||
46852430|NCT00103857|83067687|FG001|50-Week Extension Study|reason unspecified|0|||
46852431|NCT00103857|83067688|FG002|50-Week Extension Study|reason unspecified|0|||
46852432|NCT00103857|83067689|FG003|50-Week Extension Study|reason unspecified|0|||
46852433|NCT00103857|83067690|FG004|50-Week Extension Study|reason unspecified|1|||
46852434|NCT00103857|83067691|FG005|50-Week Extension Study|reason unspecified|0|||
46852435|NCT00103857|83067692|FG006|50-Week Extension Study|reason unspecified|0|||
46852436|NCT03587584|83067709|FG000|Overall Study|SOC deviations|4|||
46852437|NCT03587584|83067710|FG001|Overall Study|SOC deviations|6|||
46852438|NCT03587584|83067709|FG000|Overall Study|Incomplete data|0|||
46852439|NCT03587584|83067710|FG001|Overall Study|Incomplete data|3|||
46852440|NCT03586726|83067716|FG000|Overall Study|Withdrawal by Subject|1|||
46852441|NCT03586648|83067720|FG000|Period 1|Withdrawal by Subject|0|||
46852442|NCT03586648|83067721|FG001|Period 1|Withdrawal by Subject|1|||
46852443|NCT03586648|83067720|FG000|Period 1|Lost to Follow-up|1|||
46852444|NCT03586648|83067721|FG001|Period 1|Lost to Follow-up|1|||
46852445|NCT03586648|83067720|FG000|Period 1|Adverse Event|1|||
46852446|NCT03586648|83067721|FG001|Period 1|Adverse Event|0|||
46852447|NCT03586648|83067720|FG000|Period 1|Study related symptoms or complaints|2|||
46852448|NCT03586648|83067721|FG001|Period 1|Study related symptoms or complaints|1|||
46852449|NCT03586648|83067720|FG000|Period 1|Physician Decision|0|||
46852450|NCT03586648|83067721|FG001|Period 1|Physician Decision|1|||
46852451|NCT03586648|83067720|FG000|Period 2|Adverse Event|1|||
46852452|NCT03586648|83067721|FG001|Period 2|Adverse Event|0|||
46852453|NCT02892448|83067730|FG000|Overall Study|Screening failure|2|||
46852454|NCT02892448|83067731|FG001|Overall Study|Screening failure|2|||
46852455|NCT02892448|83067732|FG002|Overall Study|Screening failure|1|||
46852456|NCT03585712|83067740|FG000|Treatment Period 1|Protocol Violation|1|||
46852457|NCT03585712|83067741|FG001|Treatment Period 1|Protocol Violation|0|||
46852458|NCT03585712|83067742|FG002|Treatment Period 1|Protocol Violation|0|||
46852459|NCT03585712|83067740|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
46852460|NCT03585712|83067741|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
46788921|NCT00624468|83008148|FG003|Safety Follow-up (SFU) Period|Other|1|||
46788922|NCT00521014|83008156|FG000|Overall Study|Inevaluable, not treated|1|||
46788923|NCT00560235|83008163|FG000|Phase 1|Discontinued|8|||
46788924|NCT00560235|83008164|FG001|Phase 1|Discontinued|0|||
46788925|NCT00560235|83008165|FG002|Phase 1|Discontinued|0|||
46788926|NCT00560235|83008163|FG000|Phase 1B|Discontinued|0|||
46788927|NCT00560235|83008164|FG001|Phase 1B|Discontinued|19|||
46788928|NCT00560235|83008165|FG002|Phase 1B|Discontinued|0|||
46788929|NCT00560235|83008163|FG000|Phase 2|Discontinued|0|||
46788930|NCT00560235|83008164|FG001|Phase 2|Discontinued|0|||
46788931|NCT00560235|83008165|FG002|Phase 2|Discontinued|96|||
46788932|NCT00560235|83008163|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
46788933|NCT00560235|83008164|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
46788934|NCT00560235|83008165|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
46788935|NCT00291577|83008183|FG000|Overall Study|Adverse Event|1|||
46788936|NCT00291577|83008183|FG000|Overall Study|Other|4|||
46788937|NCT00291577|83008183|FG000|Overall Study|Withdrawal by Subject|2|||
46788938|NCT00291577|83008183|FG000|Overall Study|Lack of Efficacy|14|||
46788939|NCT00520936|83008195|FG000|Overall Study|Physician Decision|0|||
46788940|NCT00520936|83008196|FG001|Overall Study|Physician Decision|2|||
46788941|NCT00520936|83008197|FG002|Overall Study|Physician Decision|1|||
46788942|NCT00520936|83008198|FG003|Overall Study|Physician Decision|0|||
46788943|NCT00520936|83008199|FG004|Overall Study|Physician Decision|0|||
46788944|NCT00520936|83008200|FG005|Overall Study|Physician Decision|0|||
46788945|NCT00520936|83008201|FG006|Overall Study|Physician Decision|0|||
46788946|NCT00520936|83008202|FG007|Overall Study|Physician Decision|0|||
46788947|NCT00520936|83008195|FG000|Overall Study|Withdrawal by Subject|0|||
46788948|NCT00520936|83008196|FG001|Overall Study|Withdrawal by Subject|0|||
46788949|NCT00520936|83008197|FG002|Overall Study|Withdrawal by Subject|0|||
46788950|NCT00520936|83008198|FG003|Overall Study|Withdrawal by Subject|0|||
46788951|NCT00520936|83008199|FG004|Overall Study|Withdrawal by Subject|0|||
46788952|NCT00520936|83008200|FG005|Overall Study|Withdrawal by Subject|0|||
46788953|NCT00520936|83008201|FG006|Overall Study|Withdrawal by Subject|0|||
46788954|NCT00520936|83008202|FG007|Overall Study|Withdrawal by Subject|1|||
46788955|NCT00520936|83008195|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
46788956|NCT00520936|83008196|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
46788957|NCT00520936|83008197|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
46788958|NCT00520936|83008198|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
46788959|NCT00520936|83008199|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
46788960|NCT00520936|83008200|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
46788961|NCT00520936|83008201|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
46788962|NCT00520936|83008202|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
46788963|NCT00520936|83008195|FG000|Overall Study|Death|0|||
46788964|NCT00520936|83008196|FG001|Overall Study|Death|0|||
46788965|NCT00520936|83008197|FG002|Overall Study|Death|0|||
46788966|NCT00520936|83008198|FG003|Overall Study|Death|0|||
46788967|NCT00520936|83008199|FG004|Overall Study|Death|0|||
46788968|NCT00520936|83008200|FG005|Overall Study|Death|0|||
46788969|NCT00520936|83008201|FG006|Overall Study|Death|1|||
46788970|NCT00520936|83008202|FG007|Overall Study|Death|0|||
46788971|NCT00520936|83008195|FG000|Overall Study|Protocol Violation|0|||
46673562|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
46673563|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46673564|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46673565|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46788972|NCT00520936|83008196|FG001|Overall Study|Protocol Violation|1|||
46788973|NCT00520936|83008197|FG002|Overall Study|Protocol Violation|1|||
46788974|NCT00520936|83008198|FG003|Overall Study|Protocol Violation|0|||
46788975|NCT00520936|83008199|FG004|Overall Study|Protocol Violation|1|||
46788976|NCT00520936|83008200|FG005|Overall Study|Protocol Violation|0|||
46788977|NCT00520936|83008201|FG006|Overall Study|Protocol Violation|1|||
46788978|NCT00520936|83008202|FG007|Overall Study|Protocol Violation|0|||
46788979|NCT03867760|83008215|FG000|Overall Study|Lost to Follow-up|2|||
46788980|NCT03867760|83008216|FG001|Overall Study|Lost to Follow-up|3|||
46788981|NCT03867760|83008215|FG000|Overall Study|Withdrawal by Subject|1|||
46788982|NCT03867760|83008216|FG001|Overall Study|Withdrawal by Subject|2|||
46788983|NCT03867760|83008215|FG000|Overall Study|subject could not meet study logistics|3|||
46788984|NCT03867760|83008216|FG001|Overall Study|subject could not meet study logistics|3|||
46788985|NCT03865732|83008226|FG000|Overall Study|Adverse Event|0|||
46788986|NCT03865732|83008227|FG001|Overall Study|Adverse Event|1|||
46788987|NCT00520546|83008234|FG000|Overall Study|Withdrawal by Subject|1|||
46788988|NCT00520546|83008234|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
46788989|NCT00555009|83008245|FG000|Overall Study|Withdrawal by Subject|0|||
46788990|NCT00555009|83008246|FG001|Overall Study|Withdrawal by Subject|1|||
46788991|NCT00555009|83008245|FG000|Overall Study|Terminated by Sponsor|2|||
46788992|NCT00555009|83008246|FG001|Overall Study|Terminated by Sponsor|5|||
46788993|NCT00623766|83008254|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
46788994|NCT00623766|83008255|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
46788995|NCT00623766|83008254|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
46788996|NCT00623766|83008255|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
46788997|NCT00623766|83008254|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
46788998|NCT00623766|83008255|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
46788999|NCT00623766|83008254|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
46789000|NCT00623766|83008255|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
46789001|NCT00623766|83008254|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
46789002|NCT00623766|83008255|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
46789003|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
46789004|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
46789005|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
46789006|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
46789007|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
46789008|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
46789009|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
46789010|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
46789011|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
46789012|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
46789013|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
46789014|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
46789015|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
46789016|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
46789017|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
46789018|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
46789019|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
46789020|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
46789021|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
46789022|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
46789023|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
46789024|NCT00550407|83008267|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
46789025|NCT00550407|83008268|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
46789026|NCT00550407|83008269|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
46789027|NCT00550407|83008267|FG000|26-Week Randomized Phase|Adverse Event|0|||
46789028|NCT00550407|83008268|FG001|26-Week Randomized Phase|Adverse Event|5|||
46789029|NCT00550407|83008269|FG002|26-Week Randomized Phase|Adverse Event|2|||
46789030|NCT00550407|83008267|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
46789031|NCT00550407|83008268|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
46789032|NCT00550407|83008269|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
46789033|NCT00550407|83008267|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
46789034|NCT00550407|83008268|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
46789035|NCT00550407|83008269|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
46789036|NCT00550407|83008267|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
46789037|NCT00550407|83008268|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
46789038|NCT00550407|83008269|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
46789039|NCT00531934|83008279|FG000|Overall Study|Adverse Event|4|||
46789040|NCT00531934|83008280|FG001|Overall Study|Adverse Event|8|||
46789041|NCT00531934|83008279|FG000|Overall Study|Progression|52|||
46789042|NCT00531934|83008280|FG001|Overall Study|Progression|42|||
46789043|NCT00531934|83008279|FG000|Overall Study|Death|7|||
46789044|NCT00531934|83008280|FG001|Overall Study|Death|10|||
46789045|NCT00531934|83008279|FG000|Overall Study|Withdrawal by Subject|1|||
46789046|NCT00531934|83008280|FG001|Overall Study|Withdrawal by Subject|1|||
46789047|NCT00531934|83008279|FG000|Overall Study|Other|2|||
47077917|NCT01435928|83381254|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
46789048|NCT00531934|83008280|FG001|Overall Study|Other|2|||
46789049|NCT00549939|83008289|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
46789050|NCT00549939|83008290|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
46789051|NCT00549939|83008291|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
46789052|NCT00549939|83008289|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
46789053|NCT00549939|83008290|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
46789054|NCT00549939|83008291|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
46789055|NCT00549939|83008289|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
46789056|NCT00549939|83008290|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
46789057|NCT00549939|83008291|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
46789058|NCT00549939|83008289|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
46789059|NCT00549939|83008290|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
46789060|NCT00549939|83008291|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
47077918|NCT01435928|83381252|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
46789061|NCT00549939|83008289|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
46789062|NCT00549939|83008290|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
46789063|NCT00549939|83008291|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
46789064|NCT00549939|83008289|FG000|40-week Open Label Treatment Period|Other|0|||
46789065|NCT00549939|83008290|FG001|40-week Open Label Treatment Period|Other|1|||
46789066|NCT00549939|83008291|FG002|40-week Open Label Treatment Period|Other|4|||
46789067|NCT00272779|83008303|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
46789068|NCT00272779|83008304|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
46852461|NCT03585712|83067742|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
46852462|NCT03585712|83067740|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
46852463|NCT03585712|83067741|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
46852464|NCT03585712|83067742|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
46852465|NCT03585712|83067740|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
46789069|NCT00272779|83008303|FG000|Baseline Through Week 48|Death before Week 48|4|||
46789070|NCT00272779|83008304|FG001|Baseline Through Week 48|Death before Week 48|4|||
46789071|NCT00272779|83008303|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
46789072|NCT00272779|83008304|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
46789073|NCT00272779|83008303|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
46789074|NCT00272779|83008304|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
46789075|NCT00272779|83008303|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
46789076|NCT00272779|83008304|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
46789077|NCT00272779|83008303|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
46789078|NCT00272779|83008304|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
46789079|NCT00272779|83008303|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
46789080|NCT00272779|83008304|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
46789081|NCT00272779|83008303|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
46789082|NCT00272779|83008304|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
46789083|NCT00272779|83008303|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
46789084|NCT00272779|83008304|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
46789085|NCT00272779|83008303|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
46789086|NCT00272779|83008304|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
46789087|NCT00272779|83008303|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
46789088|NCT00272779|83008304|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
46789089|NCT00272779|83008303|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
46789090|NCT00272779|83008304|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
46789091|NCT00272779|83008303|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
46789092|NCT00272779|83008304|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
46789093|NCT00272779|83008303|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
46789094|NCT00272779|83008304|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
46789095|NCT00272779|83008303|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
46789096|NCT00272779|83008304|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
46789097|NCT00272779|83008303|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
46789098|NCT00272779|83008304|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
46789099|NCT00272779|83008303|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
46789100|NCT00272779|83008304|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
46789101|NCT00272779|83008303|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
46789102|NCT00272779|83008304|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
46789103|NCT00272779|83008303|FG000|Baseline Through Week 48|Continuing treatment|385|||
46789104|NCT00272779|83008304|FG001|Baseline Through Week 48|Continuing treatment|368|||
46789105|NCT00272779|83008303|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
46852466|NCT03585712|83067741|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
46852467|NCT03585712|83067742|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
47077919|NCT01435928|83381253|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
47077920|NCT01435928|83381254|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
47077921|NCT01435928|83381252|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
47077922|NCT01435928|83381253|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
47077923|NCT01435928|83381254|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
47077924|NCT01435928|83381252|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
47077925|NCT01435928|83381253|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
47077926|NCT01435928|83381254|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
47077927|NCT01435928|83381252|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
46852468|NCT03585244|83067759|FG000|Overall Study|Withdrawal by Subject|15|||
46789106|NCT00272779|83008304|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
46789107|NCT00272779|83008303|FG000|Baseline Through Week 48|Never treated|2|||
46789108|NCT00272779|83008304|FG001|Baseline Through Week 48|Never treated|3|||
46789109|NCT00272779|83008303|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
46789110|NCT00272779|83008304|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
46789111|NCT00272779|83008303|FG000|Baseline Through Week 96|Death before Week 96|6|||
46789112|NCT00272779|83008304|FG001|Baseline Through Week 96|Death before Week 96|5|||
46789113|NCT00272779|83008303|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
46789114|NCT00272779|83008304|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
46789115|NCT00272779|83008303|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
46789116|NCT00272779|83008304|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
46789117|NCT00272779|83008303|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
46789118|NCT00272779|83008304|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
46789119|NCT00272779|83008303|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
46789120|NCT00272779|83008304|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
46789121|NCT00272779|83008303|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
46789122|NCT00272779|83008304|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
46789123|NCT00272779|83008303|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
46789124|NCT00272779|83008304|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
46789125|NCT00272779|83008303|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
46789126|NCT00272779|83008304|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
46789127|NCT00272779|83008303|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
46789128|NCT00272779|83008304|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
46789129|NCT00272779|83008303|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
46789130|NCT00272779|83008304|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
46789131|NCT00272779|83008303|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
46789132|NCT00272779|83008304|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
46789133|NCT00272779|83008303|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
46789134|NCT00272779|83008304|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
46789135|NCT00272779|83008303|FG000|Baseline Through Week 96|Never treated|2|||
46789136|NCT00272779|83008304|FG001|Baseline Through Week 96|Never treated|3|||
46789137|NCT00272779|83008303|FG000|Baseline Through Week 96|Continuing on treatment|61|||
46789138|NCT00272779|83008304|FG001|Baseline Through Week 96|Continuing on treatment|38|||
46789139|NCT00511810|83008313|FG000|Overall Study|Lost to Follow-up|1|||
46789140|NCT00511810|83008314|FG001|Overall Study|Lost to Follow-up|2|||
46789141|NCT00511810|83008313|FG000|Overall Study|Lack of Efficacy|0|||
46789142|NCT00511810|83008314|FG001|Overall Study|Lack of Efficacy|2|||
46789143|NCT00511810|83008313|FG000|Overall Study|Refused second scn|0|||
46789144|NCT00511810|83008314|FG001|Overall Study|Refused second scn|1|||
46789145|NCT00291499|83008322|FG000|Overall Study|Adverse Event|3|||
46789146|NCT00291499|83008323|FG001|Overall Study|Adverse Event|8|||
46789147|NCT00291499|83008322|FG000|Overall Study|Change to other therapy|2|||
46789148|NCT00291499|83008323|FG001|Overall Study|Change to other therapy|1|||
46789149|NCT00291499|83008322|FG000|Overall Study|Intercurrent illness|1|||
46789150|NCT00291499|83008323|FG001|Overall Study|Intercurrent illness|0|||
46852469|NCT00074984|83067765|FG000|Overall Study|Death|1|||
46852470|NCT00074984|83067766|FG001|Overall Study|Death|2|||
46852471|NCT00074984|83067765|FG000|Overall Study|Withdrawal by Subject|2|||
46852472|NCT00074984|83067766|FG001|Overall Study|Withdrawal by Subject|3|||
46852473|NCT00074984|83067765|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
46852474|NCT00074984|83067766|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
46852475|NCT03583450|83067775|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
46789151|NCT00291499|83008322|FG000|Overall Study|Protocol Violation|2|||
46852476|NCT03583450|83067776|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
46852477|NCT03583372|83067788|FG000|Overall Study|Withdrawal by Subject|6|||
46973523|NCT02659631|83217317|FG006|Overall Study|Participant refused further follow-up|0|||
46973524|NCT02659631|83217318|FG007|Overall Study|Participant refused further follow-up|0|||
46973525|NCT02659631|83217319|FG008|Overall Study|Participant refused further follow-up|1|||
46973526|NCT02659631|83217320|FG009|Overall Study|Participant refused further follow-up|0|||
46789152|NCT00291499|83008323|FG001|Overall Study|Protocol Violation|2|||
46973527|NCT02659631|83217311|FG000|Overall Study|Death (follow-up phase)|1|||
46789153|NCT00291499|83008322|FG000|Overall Study|Other reasons|1|||
46852478|NCT03583372|83067789|FG001|Overall Study|Withdrawal by Subject|11|||
46852479|NCT03583372|83067790|FG002|Overall Study|Withdrawal by Subject|7|||
46973528|NCT02659631|83217312|FG001|Overall Study|Death (follow-up phase)|2|||
46973529|NCT02659631|83217313|FG002|Overall Study|Death (follow-up phase)|1|||
47077928|NCT01435928|83381253|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
47077929|NCT01435928|83381254|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
47077930|NCT01435928|83381252|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
46973530|NCT02659631|83217314|FG003|Overall Study|Death (follow-up phase)|1|||
46973531|NCT02659631|83217315|FG004|Overall Study|Death (follow-up phase)|3|||
46973532|NCT02659631|83217316|FG005|Overall Study|Death (follow-up phase)|2|||
46973533|NCT02659631|83217317|FG006|Overall Study|Death (follow-up phase)|0|||
46973534|NCT02659631|83217318|FG007|Overall Study|Death (follow-up phase)|3|||
46852480|NCT03583372|83067791|FG003|Overall Study|Withdrawal by Subject|8|||
46673566|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46673567|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46673568|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46673569|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
46973535|NCT02659631|83217319|FG008|Overall Study|Death (follow-up phase)|1|||
46852481|NCT03583372|83067788|FG000|Overall Study|Lost to Follow-up|4|||
46852482|NCT03583372|83067789|FG001|Overall Study|Lost to Follow-up|6|||
46852483|NCT03583372|83067790|FG002|Overall Study|Lost to Follow-up|3|||
46852484|NCT03583372|83067791|FG003|Overall Study|Lost to Follow-up|2|||
46852485|NCT03583372|83067788|FG000|Overall Study|Adverse Event|1|||
46852486|NCT03583372|83067789|FG001|Overall Study|Adverse Event|3|||
46852487|NCT03583372|83067790|FG002|Overall Study|Adverse Event|4|||
46852488|NCT03583372|83067791|FG003|Overall Study|Adverse Event|4|||
46852489|NCT03583372|83067788|FG000|Overall Study|Physician Decision|0|||
46852490|NCT03583372|83067789|FG001|Overall Study|Physician Decision|1|||
46852491|NCT03583372|83067790|FG002|Overall Study|Physician Decision|1|||
46852492|NCT03583372|83067791|FG003|Overall Study|Physician Decision|1|||
46852493|NCT03583372|83067788|FG000|Overall Study|Lack of Efficacy|0|||
46852494|NCT03583372|83067789|FG001|Overall Study|Lack of Efficacy|1|||
46852495|NCT03583372|83067790|FG002|Overall Study|Lack of Efficacy|0|||
46852496|NCT03583372|83067791|FG003|Overall Study|Lack of Efficacy|1|||
46973536|NCT02659631|83217320|FG009|Overall Study|Death (follow-up phase)|0|||
46973537|NCT02659631|83217311|FG000|Overall Study|Death (treatment phase)|0|||
46973538|NCT02659631|83217312|FG001|Overall Study|Death (treatment phase)|0|||
46973539|NCT02659631|83217313|FG002|Overall Study|Death (treatment phase)|0|||
46673570|NCT01212757|82888951|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
46673571|NCT01212757|82888952|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
46673572|NCT01212757|82888953|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
46673573|NCT01212757|82888954|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
46673574|NCT01212757|82888955|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
46673575|NCT01212757|82888956|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
46673576|NCT01212757|82888957|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
46673577|NCT01212757|82888958|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
46673578|NCT01212757|82888959|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
46673579|NCT01190410|82888979|FG000|Overall Study|Adverse Event|0|||
46673580|NCT01190410|82888980|FG001|Overall Study|Adverse Event|3|||
46673581|NCT01190410|82888979|FG000|Overall Study|Lack of Efficacy|0|||
46789154|NCT00291499|83008323|FG001|Overall Study|Other reasons|4|||
46789155|NCT00553605|83008331|FG000|Overall Study|Did not meet entrance criteria|1|||
46789156|NCT00553605|83008332|FG001|Overall Study|Did not meet entrance criteria|3|||
46789157|NCT00553605|83008331|FG000|Overall Study|Did not receive full dose|1|||
46789158|NCT00553605|83008332|FG001|Overall Study|Did not receive full dose|0|||
46973540|NCT02659631|83217314|FG003|Overall Study|Death (treatment phase)|0|||
46973541|NCT02659631|83217315|FG004|Overall Study|Death (treatment phase)|1|||
46973542|NCT02659631|83217316|FG005|Overall Study|Death (treatment phase)|0|||
46789159|NCT00553605|83008331|FG000|Overall Study|Randomized but not treated|2|||
46789160|NCT00553605|83008332|FG001|Overall Study|Randomized but not treated|0|||
46789161|NCT00621582|83008338|FG000|Overall Study|Adverse Event|7|||
46789162|NCT00621582|83008338|FG000|Overall Study|Protocol Violation|57|||
46973543|NCT02659631|83217317|FG006|Overall Study|Death (treatment phase)|1|||
46973544|NCT02659631|83217318|FG007|Overall Study|Death (treatment phase)|0|||
46973545|NCT02659631|83217319|FG008|Overall Study|Death (treatment phase)|0|||
46973546|NCT02659631|83217320|FG009|Overall Study|Death (treatment phase)|0|||
46973547|NCT02699125|83217344|FG000|Placebo|Lost to Follow-up|2|||
46789163|NCT00621582|83008338|FG000|Overall Study|Lost to Follow-up|24|||
46789164|NCT00621582|83008338|FG000|Overall Study|issues not identified by investigators|18|||
46789165|NCT00744497|83008344|FG000|Overall Study|Withdrawal by Subject|21|||
46789166|NCT00744497|83008345|FG001|Overall Study|Withdrawal by Subject|18|||
46852497|NCT03583372|83067788|FG000|Overall Study|Death|1|||
46852498|NCT03583372|83067789|FG001|Overall Study|Death|0|||
46852499|NCT03583372|83067790|FG002|Overall Study|Death|0|||
46852500|NCT03583372|83067791|FG003|Overall Study|Death|0|||
46973548|NCT02699125|83217345|FG001|Placebo|Lost to Follow-up|0|||
46673582|NCT01190410|82888980|FG001|Overall Study|Lack of Efficacy|2|||
46789167|NCT00744497|83008344|FG000|Overall Study|Death|11|||
46789168|NCT00744497|83008345|FG001|Overall Study|Death|9|||
46852501|NCT03583372|83067788|FG000|Overall Study|Protocol Violation|0|||
46852502|NCT03583372|83067789|FG001|Overall Study|Protocol Violation|1|||
46973549|NCT02699125|83217344|FG000|Placebo|Protocol Violation|1|||
46973550|NCT02699125|83217345|FG001|Placebo|Protocol Violation|0|||
46973551|NCT02699125|83217344|FG000|Placebo|Withdrawal by Subject|0|||
46852503|NCT03583372|83067790|FG002|Overall Study|Protocol Violation|0|||
46852504|NCT03583372|83067791|FG003|Overall Study|Protocol Violation|0|||
46852505|NCT03583372|83067788|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
46852506|NCT03583372|83067789|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
46852507|NCT03583372|83067790|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
46852508|NCT03583372|83067791|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
46852509|NCT03583372|83067788|FG000|Overall Study|Did Not Receive Study Drug|0|||
46852510|NCT03583372|83067789|FG001|Overall Study|Did Not Receive Study Drug|1|||
46852511|NCT03583372|83067790|FG002|Overall Study|Did Not Receive Study Drug|0|||
46852512|NCT03583372|83067791|FG003|Overall Study|Did Not Receive Study Drug|0|||
46852513|NCT03583372|83067788|FG000|Overall Study|Captured as Other in the Database|1|||
46852514|NCT03583372|83067789|FG001|Overall Study|Captured as Other in the Database|2|||
46852515|NCT03583372|83067790|FG002|Overall Study|Captured as Other in the Database|4|||
46852516|NCT03583372|83067791|FG003|Overall Study|Captured as Other in the Database|1|||
46852517|NCT03582826|83067803|FG000|Overall Study|Lost to Follow-up|39|||
46789169|NCT00744497|83008344|FG000|Overall Study|Lost to Follow-up|4|||
46673583|NCT01190410|82888979|FG000|Overall Study|Withdrawal by Subject|0|||
46673584|NCT01190410|82888980|FG001|Overall Study|Withdrawal by Subject|2|||
46673585|NCT01190410|82888979|FG000|Overall Study|Administrative decision|1|||
46673586|NCT01190410|82888980|FG001|Overall Study|Administrative decision|0|||
46789170|NCT00744497|83008345|FG001|Overall Study|Lost to Follow-up|2|||
46789171|NCT00744497|83008344|FG000|Overall Study|Poor compliance/noncompliance|9|||
46789172|NCT00744497|83008345|FG001|Overall Study|Poor compliance/noncompliance|5|||
46789173|NCT00744497|83008344|FG000|Overall Study|No longer meets study criteria|7|||
46789174|NCT00744497|83008345|FG001|Overall Study|No longer meets study criteria|3|||
46789175|NCT00744497|83008344|FG000|Overall Study|Administrative Reason By Sponsor|25|||
46789176|NCT00744497|83008345|FG001|Overall Study|Administrative Reason By Sponsor|8|||
46789177|NCT00744497|83008344|FG000|Overall Study|Disease progression|312|||
46789178|NCT00744497|83008345|FG001|Overall Study|Disease progression|219|||
46789179|NCT00744497|83008344|FG000|Overall Study|Study drug toxicity|68|||
46789180|NCT00744497|83008345|FG001|Overall Study|Study drug toxicity|141|||
46789181|NCT00744497|83008344|FG000|Overall Study|Adverse event unrelated to study drug|78|||
46789182|NCT00744497|83008345|FG001|Overall Study|Adverse event unrelated to study drug|122|||
46789183|NCT00744497|83008344|FG000|Overall Study|Patient requested to stop study drug|65|||
46789184|NCT00744497|83008345|FG001|Overall Study|Patient requested to stop study drug|80|||
46789185|NCT00744497|83008344|FG000|Overall Study|Maximum clinical benefit|141|||
46789186|NCT00744497|83008345|FG001|Overall Study|Maximum clinical benefit|142|||
46789187|NCT00744497|83008344|FG000|Overall Study|Not defined|19|||
46789188|NCT00744497|83008345|FG001|Overall Study|Not defined|13|||
46789189|NCT00747227|83008353|FG000|Overall Study|Death|3|||
46789190|NCT00747227|83008354|FG001|Overall Study|Death|1|||
46789191|NCT00747227|83008353|FG000|Overall Study|Withdrawal by Subject|1|||
46789192|NCT00747227|83008354|FG001|Overall Study|Withdrawal by Subject|0|||
46789193|NCT00747227|83008353|FG000|Overall Study|Lost to Follow-up|1|||
46789194|NCT00747227|83008354|FG001|Overall Study|Lost to Follow-up|2|||
46789195|NCT00747227|83008353|FG000|Overall Study|Illness|1|||
46789196|NCT00747227|83008354|FG001|Overall Study|Illness|1|||
46789197|NCT00747149|83008362|FG000|Overall Study|Adverse Event|0|||
46789198|NCT00747149|83008363|FG001|Overall Study|Adverse Event|15|||
46789199|NCT00747149|83008362|FG000|Overall Study|Lost to Follow-up|0|||
46789200|NCT00747149|83008363|FG001|Overall Study|Lost to Follow-up|10|||
46789201|NCT00747149|83008362|FG000|Overall Study|Withdrawal by Subject|0|||
46789202|NCT00747149|83008363|FG001|Overall Study|Withdrawal by Subject|6|||
46789203|NCT00747149|83008362|FG000|Overall Study|Did not receive treatment|0|||
46673587|NCT01190410|82888979|FG000|Overall Study|PI discretion|0|||
46673588|NCT01190410|82888980|FG001|Overall Study|PI discretion|2|||
46673589|NCT01190254|82888995|FG000|Overall Study|Adverse Event|3|||
46789204|NCT00747149|83008363|FG001|Overall Study|Did not receive treatment|1|||
46789205|NCT00747149|83008362|FG000|Overall Study|Incorrect enrollment|0|||
46789206|NCT00747149|83008363|FG001|Overall Study|Incorrect enrollment|6|||
46789207|NCT00747149|83008362|FG000|Overall Study|Severe non-compliance to protocol|0|||
46789208|NCT00747149|83008363|FG001|Overall Study|Severe non-compliance to protocol|1|||
46789209|NCT00747149|83008362|FG000|Overall Study|Not reported|1|||
46789210|NCT00747149|83008363|FG001|Overall Study|Not reported|4|||
46789211|NCT00271609|83008377|FG000|Overall Study|Adverse Event|11|||
46789212|NCT00271609|83008378|FG001|Overall Study|Adverse Event|3|||
46789213|NCT00271609|83008377|FG000|Overall Study|Withdrawal by Subject|2|||
46789214|NCT00271609|83008378|FG001|Overall Study|Withdrawal by Subject|0|||
46789215|NCT00548847|83008384|FG000|Overall Study|Disease progression|7|||
46789216|NCT00290407|83008388|FG000|Overall Study|Physician Decision|2|||
46789217|NCT00749411|83008394|FG000|Overall Study|Adverse Event|0|||
46789218|NCT00749411|83008395|FG001|Overall Study|Adverse Event|2|||
46852518|NCT03582826|83067804|FG001|Overall Study|Lost to Follow-up|0|||
46673590|NCT01190254|82888996|FG001|Overall Study|Adverse Event|6|||
46673591|NCT01190254|82888997|FG002|Overall Study|Adverse Event|8|||
46789219|NCT00749411|83008394|FG000|Overall Study|Lack of Efficacy|0|||
46973552|NCT02699125|83217345|FG001|Placebo|Withdrawal by Subject|4|||
46789220|NCT00749411|83008395|FG001|Overall Study|Lack of Efficacy|1|||
46789221|NCT00749411|83008394|FG000|Overall Study|Protocol Violation|1|||
46789222|NCT00749411|83008395|FG001|Overall Study|Protocol Violation|1|||
46789223|NCT00749411|83008394|FG000|Overall Study|Protocol-defined stopping criteria|0|||
46789224|NCT00749411|83008395|FG001|Overall Study|Protocol-defined stopping criteria|1|||
46789225|NCT03958149|83008403|FG000|Overall Study|Withdrawal by Subject|0|||
46852519|NCT03582826|83067803|FG000|Overall Study|Withdrawal by Subject|2|||
46852520|NCT03582826|83067804|FG001|Overall Study|Withdrawal by Subject|0|||
46852521|NCT03518008|83067819|FG000|Period 2, Second Week of Wear|Family emergency|0|||
46852522|NCT03518008|83067820|FG001|Period 2, Second Week of Wear|Family emergency|1|||
46852523|NCT03810014|83067830|FG000|Overall Study|Pregnancy|2|||
46852524|NCT03810014|83067831|FG001|Overall Study|Pregnancy|2|||
46852525|NCT03810014|83067832|FG002|Overall Study|Pregnancy|0|||
46852526|NCT03810014|83067833|FG003|Overall Study|Pregnancy|2|||
46852527|NCT04978363|83067858|FG000|Overall Study|Other medical issues unrelated to the study|0|||
46852528|NCT04978363|83067859|FG001|Overall Study|Other medical issues unrelated to the study|0|||
46852529|NCT04978363|83067860|FG002|Overall Study|Other medical issues unrelated to the study|0|||
46852530|NCT04978363|83067861|FG003|Overall Study|Other medical issues unrelated to the study|0|||
46852531|NCT04978363|83067862|FG004|Overall Study|Other medical issues unrelated to the study|1|||
46852532|NCT04978363|83067863|FG005|Overall Study|Other medical issues unrelated to the study|0|||
46852533|NCT04978363|83067864|FG006|Overall Study|Other medical issues unrelated to the study|0|||
46852534|NCT04978363|83067865|FG007|Overall Study|Other medical issues unrelated to the study|0|||
46852535|NCT04978363|83067866|FG008|Overall Study|Other medical issues unrelated to the study|0|||
46852536|NCT04978363|83067867|FG009|Overall Study|Other medical issues unrelated to the study|0|||
46852537|NCT04978363|83067868|FG010|Overall Study|Other medical issues unrelated to the study|0|||
46852538|NCT04978363|83067858|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
46852539|NCT04978363|83067859|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
46852540|NCT04978363|83067860|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
46852541|NCT04978363|83067861|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
46852542|NCT04978363|83067862|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
46852543|NCT04978363|83067863|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
46852544|NCT04978363|83067864|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
46852545|NCT04978363|83067865|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
46852546|NCT04978363|83067866|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
46852547|NCT04978363|83067867|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
46852548|NCT04978363|83067868|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
46852549|NCT04978363|83067858|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852550|NCT04978363|83067859|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
46852551|NCT04978363|83067860|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852552|NCT04978363|83067861|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852553|NCT04978363|83067862|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852554|NCT04978363|83067863|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852555|NCT04978363|83067864|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852556|NCT04978363|83067865|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852557|NCT04978363|83067866|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852558|NCT04978363|83067867|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852559|NCT04978363|83067868|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
46852560|NCT04101422|83067948|FG000|Overall Study|Ineligible|1|||
46852561|NCT04101422|83067949|FG001|Overall Study|Ineligible|0|||
46852562|NCT04101422|83067950|FG002|Overall Study|Ineligible|9|||
46852563|NCT04101422|83067951|FG003|Overall Study|Ineligible|0|||
46852564|NCT04101422|83067948|FG000|Overall Study|Withdrawal by Subject|0|||
46852565|NCT04101422|83067949|FG001|Overall Study|Withdrawal by Subject|0|||
46852566|NCT04101422|83067950|FG002|Overall Study|Withdrawal by Subject|1|||
46852567|NCT04101422|83067951|FG003|Overall Study|Withdrawal by Subject|0|||
46852568|NCT04101422|83067948|FG000|Overall Study|Not attending to the stimuli|0|||
46852569|NCT04101422|83067949|FG001|Overall Study|Not attending to the stimuli|0|||
46852570|NCT04101422|83067950|FG002|Overall Study|Not attending to the stimuli|4|||
46852571|NCT04101422|83067951|FG003|Overall Study|Not attending to the stimuli|0|||
46852572|NCT04101422|83067948|FG000|Overall Study|Did not download app|0|||
46973553|NCT02699125|83217344|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
46973554|NCT02699125|83217345|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
46973555|NCT02698891|83217355|FG000|Overall Study|Withdrawal by Subject|2|||
46973556|NCT02698891|83217355|FG000|Overall Study|deemed ineligible|1|||
46973557|NCT02698891|83217355|FG000|Overall Study|Adverse Event|9|||
46973558|NCT02698423|83217361|FG000|Overall Study|Lost to Follow-up|19|||
46789226|NCT03958149|83008404|FG001|Overall Study|Withdrawal by Subject|1|||
46789227|NCT00549549|83008418|FG000|Overall Study|Adverse Event|5|||
46789228|NCT00549549|83008419|FG001|Overall Study|Adverse Event|3|||
46789229|NCT00549549|83008420|FG002|Overall Study|Adverse Event|1|||
46789230|NCT00549549|83008421|FG003|Overall Study|Adverse Event|9|||
46789231|NCT00549549|83008418|FG000|Overall Study|Lack of Efficacy|9|||
46789232|NCT00549549|83008419|FG001|Overall Study|Lack of Efficacy|6|||
46789233|NCT00549549|83008420|FG002|Overall Study|Lack of Efficacy|4|||
46789234|NCT00549549|83008421|FG003|Overall Study|Lack of Efficacy|2|||
46789235|NCT00549549|83008418|FG000|Overall Study|Lost to Follow-up|1|||
46789236|NCT00549549|83008419|FG001|Overall Study|Lost to Follow-up|0|||
46789237|NCT00549549|83008420|FG002|Overall Study|Lost to Follow-up|1|||
46789238|NCT00549549|83008421|FG003|Overall Study|Lost to Follow-up|2|||
46789239|NCT00549549|83008418|FG000|Overall Study|Withdrawal by Subject|0|||
46789240|NCT00549549|83008419|FG001|Overall Study|Withdrawal by Subject|4|||
46789241|NCT00549549|83008420|FG002|Overall Study|Withdrawal by Subject|1|||
46852573|NCT04101422|83067949|FG001|Overall Study|Did not download app|0|||
46852574|NCT04101422|83067950|FG002|Overall Study|Did not download app|0|||
46852575|NCT04101422|83067951|FG003|Overall Study|Did not download app|17|||
46852576|NCT04101422|83067948|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
46852577|NCT04101422|83067949|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
46852578|NCT04101422|83067950|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
46852579|NCT04101422|83067951|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
46852580|NCT03841604|83067963|FG000|Overall Study|Withdrawal by Subject|3|||
46789242|NCT00549549|83008421|FG003|Overall Study|Withdrawal by Subject|0|||
46789243|NCT00549549|83008418|FG000|Overall Study|Other|9|||
46789244|NCT00549549|83008419|FG001|Overall Study|Other|9|||
46789245|NCT00549549|83008420|FG002|Overall Study|Other|9|||
46789246|NCT00549549|83008421|FG003|Overall Study|Other|11|||
46789247|NCT00549549|83008418|FG000|Overall Study|Randomized but not treated|0|||
46789248|NCT00549549|83008419|FG001|Overall Study|Randomized but not treated|0|||
46789249|NCT00549549|83008420|FG002|Overall Study|Randomized but not treated|1|||
46789250|NCT00549549|83008421|FG003|Overall Study|Randomized but not treated|1|||
46789251|NCT00270205|83008435|FG000|Overall Study|Lost to Follow-up|1|||
46789252|NCT00270205|83008436|FG001|Overall Study|Lost to Follow-up|0|||
46852581|NCT03841604|83067964|FG001|Overall Study|Withdrawal by Subject|1|||
46852582|NCT03841604|83067963|FG000|Overall Study|Adverse Event|4|||
46789253|NCT00270205|83008437|FG002|Overall Study|Lost to Follow-up|0|||
46789254|NCT00270205|83008438|FG003|Overall Study|Lost to Follow-up|1|||
46789255|NCT00622284|83008450|FG000|Overall Study|Lack of Efficacy|45|||
46789256|NCT00622284|83008451|FG001|Overall Study|Lack of Efficacy|15|||
46789257|NCT00622284|83008450|FG000|Overall Study|Adverse Event|61|||
46789258|NCT00622284|83008451|FG001|Overall Study|Adverse Event|90|||
46789259|NCT00622284|83008450|FG000|Overall Study|Protocol Violation|12|||
46789260|NCT00622284|83008451|FG001|Overall Study|Protocol Violation|5|||
46789261|NCT00622284|83008450|FG000|Overall Study|Lost to Follow-up|11|||
46852583|NCT03841604|83067964|FG001|Overall Study|Adverse Event|2|||
46852584|NCT03841604|83067963|FG000|Overall Study|Physician Decision|1|||
46852585|NCT03841604|83067964|FG001|Overall Study|Physician Decision|0|||
46852586|NCT03541187|83067981|FG000|Overall Study|Lost to Follow-up|2|||
46852587|NCT03541187|83067982|FG001|Overall Study|Lost to Follow-up|6|||
47077931|NCT01435928|83381253|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
47077932|NCT01435928|83381254|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
47077933|NCT01435928|83381252|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
46673592|NCT01190254|82888995|FG000|Overall Study|Lack of Efficacy|7|||
46673593|NCT01190254|82888996|FG001|Overall Study|Lack of Efficacy|4|||
46673594|NCT01190254|82888997|FG002|Overall Study|Lack of Efficacy|5|||
46673595|NCT01190254|82888995|FG000|Overall Study|Lost to Follow-up|4|||
46789262|NCT00622284|83008451|FG001|Overall Study|Lost to Follow-up|13|||
46789263|NCT00622284|83008450|FG000|Overall Study|Withdrawal by Subject|27|||
46789264|NCT00622284|83008451|FG001|Overall Study|Withdrawal by Subject|24|||
46789265|NCT00622284|83008450|FG000|Overall Study|Other reason (not specified)|33|||
46789266|NCT00622284|83008451|FG001|Overall Study|Other reason (not specified)|24|||
46789267|NCT00269113|83008459|FG000|Overall Study|Adverse Event|14|||
46673596|NCT01190254|82888996|FG001|Overall Study|Lost to Follow-up|2|||
46789268|NCT00269113|83008460|FG001|Overall Study|Adverse Event|7|||
46789269|NCT00269113|83008459|FG000|Overall Study|Lack of Efficacy|35|||
46789270|NCT00269113|83008460|FG001|Overall Study|Lack of Efficacy|18|||
46789271|NCT00269113|83008459|FG000|Overall Study|Early Improvement|2|||
46789272|NCT00269113|83008460|FG001|Overall Study|Early Improvement|0|||
46789273|NCT00269113|83008459|FG000|Overall Study|Withdrawal by Subject|0|||
46789274|NCT00269113|83008460|FG001|Overall Study|Withdrawal by Subject|2|||
46789275|NCT00269113|83008459|FG000|Overall Study|Death|6|||
46852588|NCT03541187|83067981|FG000|Overall Study|Pregnancy|0|||
46852589|NCT03541187|83067982|FG001|Overall Study|Pregnancy|1|||
46852590|NCT03541187|83067981|FG000|Overall Study|Withdrawal by Subject|6|||
46852591|NCT03541187|83067982|FG001|Overall Study|Withdrawal by Subject|2|||
46852592|NCT03541187|83067981|FG000|Overall Study|Moved out of town|1|||
46789276|NCT00269113|83008460|FG001|Overall Study|Death|2|||
46789277|NCT00269113|83008459|FG000|Overall Study|Lost to Follow-up|2|||
46673597|NCT01190254|82888997|FG002|Overall Study|Lost to Follow-up|0|||
46673598|NCT01190254|82888995|FG000|Overall Study|Withdrawal by Subject|4|||
46673599|NCT01190254|82888996|FG001|Overall Study|Withdrawal by Subject|5|||
46673600|NCT01190254|82888997|FG002|Overall Study|Withdrawal by Subject|7|||
46673601|NCT01190254|82888995|FG000|Overall Study|Protocol Violation|2|||
46673602|NCT01190254|82888996|FG001|Overall Study|Protocol Violation|0|||
46673603|NCT01190254|82888997|FG002|Overall Study|Protocol Violation|2|||
46673604|NCT01190254|82888995|FG000|Overall Study|Did not meet protocol eligibility|1|||
46789278|NCT00269113|83008460|FG001|Overall Study|Lost to Follow-up|1|||
46789279|NCT00269113|83008459|FG000|Overall Study|Protocol Violation|15|||
46789280|NCT00269113|83008460|FG001|Overall Study|Protocol Violation|5|||
46789281|NCT00269113|83008459|FG000|Overall Study|Other|0|||
46789282|NCT00269113|83008460|FG001|Overall Study|Other|2|||
46789283|NCT00291187|83008470|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
46852593|NCT03541187|83067982|FG001|Overall Study|Moved out of town|0|||
46852594|NCT03541187|83067981|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
46852595|NCT03541187|83067982|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
46852596|NCT03541187|83067981|FG000|Overall Study|Did not meet randomization criteria|1|||
46852597|NCT03541187|83067982|FG001|Overall Study|Did not meet randomization criteria|1|||
46852598|NCT03541187|83067981|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
46852599|NCT03541187|83067982|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
46852600|NCT03541187|83067981|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
46852601|NCT03541187|83067982|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
46852602|NCT03240081|83067999|FG000|Overall Study|Withdrawal by Subject|0|||
46852603|NCT03240081|83068000|FG001|Overall Study|Withdrawal by Subject|2|||
46852604|NCT03240081|83067999|FG000|Overall Study|Lost to Follow-up|0|||
46852605|NCT03240081|83068000|FG001|Overall Study|Lost to Follow-up|1|||
46852606|NCT03003520|83068021|FG000|Overall Study|Adverse Event|9|||
46852607|NCT03003520|83068022|FG001|Overall Study|Adverse Event|0|||
46852608|NCT03003520|83068021|FG000|Overall Study|Death|1|||
46852609|NCT03003520|83068022|FG001|Overall Study|Death|0|||
46852610|NCT03003520|83068021|FG000|Overall Study|Other reasons|4|||
46852611|NCT03003520|83068022|FG001|Overall Study|Other reasons|0|||
46852612|NCT03003520|83068021|FG000|Overall Study|Withdrawal by Subject|6|||
46852613|NCT03003520|83068022|FG001|Overall Study|Withdrawal by Subject|0|||
46789284|NCT00291187|83008471|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
46789285|NCT00291187|83008472|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
46852614|NCT03003520|83068021|FG000|Overall Study|Progressive disease|9|||
46852615|NCT03003520|83068022|FG001|Overall Study|Progressive disease|1|||
46852616|NCT02958527|83068045|FG000|Overall Study|Not collected CRFs|12|||
46852617|NCT02586025|83068067|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
46852618|NCT02586025|83068068|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
46852619|NCT02586025|83068067|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
46852620|NCT02586025|83068068|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
46852621|NCT02586025|83068067|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
46852622|NCT02586025|83068068|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
46852623|NCT02586025|83068067|FG000|Neoadjuvant Treatment|Death|1|||
46852624|NCT02586025|83068068|FG001|Neoadjuvant Treatment|Death|0|||
46852625|NCT02586025|83068067|FG000|Neoadjuvant Treatment|Adverse Event|1|||
46852626|NCT02586025|83068068|FG001|Neoadjuvant Treatment|Adverse Event|0|||
46852627|NCT02586025|83068067|FG000|Neoadjuvant Treatment|Physician Decision|2|||
46789286|NCT00291187|83008473|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
46789287|NCT00546819|83008489|FG000|Overall Study|Adverse Event|2|||
46789288|NCT00546819|83008490|FG001|Overall Study|Adverse Event|3|||
46789289|NCT00546819|83008489|FG000|Overall Study|Lost to Follow-up|2|||
46789290|NCT00546819|83008490|FG001|Overall Study|Lost to Follow-up|1|||
46789291|NCT00546819|83008489|FG000|Overall Study|Withdrawal by Subject|4|||
46789292|NCT00546819|83008490|FG001|Overall Study|Withdrawal by Subject|2|||
46789293|NCT00621504|83008498|FG000|Overall Study|Adverse Event|1|||
46789294|NCT00621504|83008499|FG001|Overall Study|Adverse Event|3|||
46852628|NCT02586025|83068068|FG001|Neoadjuvant Treatment|Physician Decision|1|||
46852629|NCT02586025|83068067|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
46789295|NCT00621504|83008498|FG000|Overall Study|At the request of sponsor/investigator|1|||
46789296|NCT00621504|83008499|FG001|Overall Study|At the request of sponsor/investigator|0|||
46852630|NCT02586025|83068068|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
46852631|NCT02586025|83068067|FG000|Adjuvant Treatment|Recurrent Disease|4|||
46852632|NCT02586025|83068068|FG001|Adjuvant Treatment|Recurrent Disease|5|||
46973559|NCT02698423|83217362|FG001|Overall Study|Lost to Follow-up|24|||
46673605|NCT01190254|82888996|FG001|Overall Study|Did not meet protocol eligibility|0|||
46789297|NCT00621504|83008498|FG000|Overall Study|Withdrew consent|9|||
46789298|NCT00621504|83008499|FG001|Overall Study|Withdrew consent|6|||
46789299|NCT00621504|83008498|FG000|Overall Study|Lost to Follow-up|8|||
46789300|NCT00621504|83008499|FG001|Overall Study|Lost to Follow-up|10|||
46789301|NCT00621504|83008498|FG000|Overall Study|Other|1|||
46789302|NCT00621504|83008499|FG001|Overall Study|Other|0|||
46789303|NCT00621504|83008498|FG000|Overall Study|Death|6|||
46789304|NCT00621504|83008499|FG001|Overall Study|Death|6|||
46789305|NCT00548145|83008507|FG000|Overall Study|Death|0|||
46789306|NCT00548145|83008508|FG001|Overall Study|Death|1|||
46789307|NCT00548145|83008507|FG000|Overall Study|Withdrawal by Subject|0|||
46789308|NCT00548145|83008508|FG001|Overall Study|Withdrawal by Subject|2|||
46789309|NCT00548145|83008507|FG000|Overall Study|Physician Decision|1|||
46789310|NCT00548145|83008508|FG001|Overall Study|Physician Decision|1|||
46789311|NCT00547911|83008518|FG000|Overall Study|Adverse Event|0|||
46789312|NCT00547911|83008519|FG001|Overall Study|Adverse Event|0|||
46789313|NCT00547911|83008520|FG002|Overall Study|Adverse Event|0|||
46789314|NCT00547911|83008521|FG003|Overall Study|Adverse Event|1|||
46789315|NCT00547911|83008522|FG004|Overall Study|Adverse Event|0|||
46789316|NCT00547911|83008523|FG005|Overall Study|Adverse Event|0|||
46789317|NCT00289783|83008538|FG000|Primary Phase|Adverse Event|10|||
46789318|NCT00289783|83008539|FG001|Primary Phase|Adverse Event|1|||
46789319|NCT00289783|83008538|FG000|Primary Phase|Protocol Violation|27|||
46789320|NCT00289783|83008539|FG001|Primary Phase|Protocol Violation|6|||
46789321|NCT00289783|83008538|FG000|Primary Phase|Withdrawal by Subject|93|||
46789322|NCT00289783|83008539|FG001|Primary Phase|Withdrawal by Subject|40|||
46789323|NCT00289783|83008538|FG000|Primary Phase|Lost to Follow-up|60|||
46789324|NCT00289783|83008539|FG001|Primary Phase|Lost to Follow-up|14|||
46789325|NCT00289783|83008538|FG000|Primary Phase|Migration from the study area|26|||
46789326|NCT00289783|83008539|FG001|Primary Phase|Migration from the study area|10|||
46789327|NCT00289783|83008538|FG000|Primary Phase|Other|32|||
46789328|NCT00289783|83008539|FG001|Primary Phase|Other|12|||
46789329|NCT00289783|83008538|FG000|Fourth Dose Phase|Adverse Event|1|||
46789330|NCT00289783|83008539|FG001|Fourth Dose Phase|Adverse Event|0|||
46789331|NCT00289783|83008538|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
46789332|NCT00289783|83008539|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
46789333|NCT00289783|83008538|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
46852633|NCT02586025|83068067|FG000|Adjuvant Treatment|Physician Decision|0|||
46852634|NCT02586025|83068068|FG001|Adjuvant Treatment|Physician Decision|1|||
46852635|NCT02586025|83068067|FG000|Adjuvant Treatment|Pregnancy|1|||
46852636|NCT02586025|83068068|FG001|Adjuvant Treatment|Pregnancy|0|||
46852637|NCT02586025|83068067|FG000|Treatment-Free Follow-Up|Death|11|||
46852638|NCT02586025|83068068|FG001|Treatment-Free Follow-Up|Death|11|||
46852639|NCT02586025|83068067|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
46852640|NCT02586025|83068068|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
46852641|NCT02586025|83068067|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
46852642|NCT02586025|83068068|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
46852643|NCT02586025|83068067|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
46852644|NCT02586025|83068068|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
46852645|NCT02586025|83068067|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
46852646|NCT02586025|83068068|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
46852647|NCT01721577|83068086|FG000|Overall Study|Lack of Efficacy|1|||
46852648|NCT01721577|83068087|FG001|Overall Study|Lack of Efficacy|0|||
46852649|NCT01721577|83068086|FG000|Overall Study|Death|1|||
46852650|NCT01721577|83068087|FG001|Overall Study|Death|0|||
46852651|NCT01721577|83068086|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
46852652|NCT01721577|83068087|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
46852653|NCT01721577|83068086|FG000|Overall Study|Adverse Event|0|||
46852654|NCT01721577|83068087|FG001|Overall Study|Adverse Event|2|||
46852655|NCT01411332|83068104|FG000|Enrollment|Protocol Violation|0|||
46852656|NCT01411332|83068105|FG001|Enrollment|Protocol Violation|1|||
46852657|NCT01411332|83068104|FG000|Enrollment|Withdrawal by Subject|0|||
46852658|NCT01411332|83068105|FG001|Enrollment|Withdrawal by Subject|1|||
46852659|NCT01411332|83068104|FG000|Treatment|Lost to Follow-up|1|||
46852660|NCT01411332|83068105|FG001|Treatment|Lost to Follow-up|0|||
46789334|NCT00289783|83008539|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
46852661|NCT04881747|83068132|FG000|Period 2 Washout|Adverse Event|1|||
46789335|NCT00289783|83008538|FG000|Fourth Dose Phase|Migration from the study area|1|||
46852662|NCT04881747|83068133|FG001|Period 2 Washout|Adverse Event|0|||
46852663|NCT04881747|83068134|FG002|Period 2 Washout|Adverse Event|0|||
46789336|NCT00289783|83008539|FG001|Fourth Dose Phase|Migration from the study area|1|||
46852664|NCT04881747|83068135|FG003|Period 2 Washout|Adverse Event|0|||
46852665|NCT04881747|83068136|FG004|Period 2 Washout|Adverse Event|1|||
46852666|NCT04881747|83068137|FG005|Period 2 Washout|Adverse Event|0|||
46789337|NCT00289783|83008538|FG000|Fourth Dose Phase|Other|22|||
46789338|NCT00289783|83008539|FG001|Fourth Dose Phase|Other|10|||
46789339|NCT00574080|83008555|FG000|Overall Study|Death|10|||
46789340|NCT00574080|83008556|FG001|Overall Study|Death|10|||
46789341|NCT00267865|83008562|FG000|Induction Treatment|Died before completing.|2|||
46789342|NCT00267865|83008562|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
46789343|NCT00546117|83008568|FG000|Overall Study|Withdrawal by Subject|3|||
46789344|NCT00546117|83008569|FG001|Overall Study|Withdrawal by Subject|0|||
46789345|NCT00546117|83008568|FG000|Overall Study|Inability to schedule follow-up visit|1|||
46789346|NCT00546117|83008569|FG001|Overall Study|Inability to schedule follow-up visit|0|||
46852667|NCT04881747|83068132|FG000|Period 2 Washout|Withdrawal by Subject|1|||
46852668|NCT04881747|83068133|FG001|Period 2 Washout|Withdrawal by Subject|0|||
46852669|NCT04881747|83068134|FG002|Period 2 Washout|Withdrawal by Subject|0|||
46852670|NCT04881747|83068135|FG003|Period 2 Washout|Withdrawal by Subject|1|||
46852671|NCT04881747|83068136|FG004|Period 2 Washout|Withdrawal by Subject|0|||
46852672|NCT04881747|83068137|FG005|Period 2 Washout|Withdrawal by Subject|0|||
46852673|NCT04795622|83068147|FG000|Overall Study|Adverse Event|1|||
46852674|NCT04795622|83068148|FG001|Overall Study|Adverse Event|0|||
46852675|NCT04795622|83068147|FG000|Overall Study|Withdrawal by Subject|3|||
46852676|NCT04795622|83068148|FG001|Overall Study|Withdrawal by Subject|3|||
46852677|NCT04795622|83068147|FG000|Overall Study|Protocol Violation|0|||
46852678|NCT04795622|83068148|FG001|Overall Study|Protocol Violation|2|||
46852679|NCT04795622|83068147|FG000|Overall Study|Lost to Follow-up|2|||
46852680|NCT04795622|83068148|FG001|Overall Study|Lost to Follow-up|3|||
46852681|NCT04795622|83068147|FG000|Overall Study|Other|7|||
46852682|NCT04795622|83068148|FG001|Overall Study|Other|8|||
46852683|NCT04652245|83068169|FG000|Wash-Out Period|Adverse Event|0|||
46852684|NCT04652245|83068170|FG001|Wash-Out Period|Adverse Event|2|||
46852685|NCT04652245|83068169|FG000|Wash-Out Period|Withdrawal by Subject|0|||
46852686|NCT04652245|83068170|FG001|Wash-Out Period|Withdrawal by Subject|2|||
46852687|NCT04405739|83068187|FG000|Overall Study|Adverse Event|0|||
46852688|NCT04405739|83068188|FG001|Overall Study|Adverse Event|1|||
46852689|NCT04405739|83068189|FG002|Overall Study|Adverse Event|0|||
46852690|NCT04405739|83068190|FG003|Overall Study|Adverse Event|0|||
46973560|NCT02700997|83217370|FG000|Overall Study|Did not undergo CT imaging|1|||
46973561|NCT02700997|83217370|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
46973562|NCT02658149|83217376|FG000|Overall Study|Physician Decision|1|||
46973563|NCT02658149|83217377|FG001|Overall Study|Physician Decision|0|||
46973564|NCT02698189|83217385|FG000|Overall Study|Physician Decision|3|||
46973565|NCT02698189|83217386|FG001|Overall Study|Physician Decision|0|||
46973566|NCT02698189|83217385|FG000|Overall Study|Progressive disease|0|||
46973567|NCT02698189|83217386|FG001|Overall Study|Progressive disease|5|||
46973568|NCT02698189|83217385|FG000|Overall Study|Study terminated by sponsor|0|||
46973569|NCT02698189|83217386|FG001|Overall Study|Study terminated by sponsor|1|||
46973570|NCT02702011|83217398|FG000|Overall Study|Withdrawal by Subject|0|||
46973571|NCT02702011|83217399|FG001|Overall Study|Withdrawal by Subject|1|||
46673606|NCT01190254|82888997|FG002|Overall Study|Did not meet protocol eligibility|0|||
46673607|NCT01190839|82889007|FG000|Overall Study|Adverse Event|32|||
46673608|NCT01190839|82889008|FG001|Overall Study|Adverse Event|41|||
46673609|NCT01190839|82889007|FG000|Overall Study|Protocol Violation|2|||
46673610|NCT01190839|82889008|FG001|Overall Study|Protocol Violation|2|||
46673611|NCT01190839|82889007|FG000|Overall Study|Lost to Follow-up|7|||
46673612|NCT01190839|82889008|FG001|Overall Study|Lost to Follow-up|1|||
46673613|NCT01190839|82889007|FG000|Overall Study|Death|1|||
46673614|NCT01190839|82889008|FG001|Overall Study|Death|0|||
46673615|NCT01190839|82889007|FG000|Overall Study|Trial stopped by Sponsor|71|||
46673616|NCT01190839|82889008|FG001|Overall Study|Trial stopped by Sponsor|68|||
46673617|NCT01190839|82889007|FG000|Overall Study|Undefined|35|||
46673618|NCT01190839|82889008|FG001|Overall Study|Undefined|31|||
46673619|NCT01190839|82889007|FG000|Overall Study|Randomized but not treated|2|||
46673620|NCT01190839|82889008|FG001|Overall Study|Randomized but not treated|4|||
46789347|NCT00251719|83008580|FG000|Overall Study|Adverse Event|14|||
46852691|NCT04405739|83068187|FG000|Overall Study|Lost to Follow-up|0|||
46852692|NCT04405739|83068188|FG001|Overall Study|Lost to Follow-up|2|||
46852693|NCT04405739|83068189|FG002|Overall Study|Lost to Follow-up|1|||
46852694|NCT04405739|83068190|FG003|Overall Study|Lost to Follow-up|3|||
46973572|NCT02702011|83217400|FG002|Overall Study|Withdrawal by Subject|0|||
46973573|NCT02702011|83217401|FG003|Overall Study|Withdrawal by Subject|0|||
46973574|NCT02657369|83217411|FG000|Overall Study|Death|27|||
46673621|NCT01190215|82889018|FG000|Up to Month 6|Lost to Follow-up|2|||
46673622|NCT01190215|82889019|FG001|Up to Month 6|Lost to Follow-up|0|||
46789348|NCT00251719|83008581|FG001|Overall Study|Adverse Event|8|||
46852695|NCT04405739|83068187|FG000|Overall Study|Withdrawal by Subject|0|||
46852696|NCT04405739|83068188|FG001|Overall Study|Withdrawal by Subject|2|||
46852697|NCT04405739|83068189|FG002|Overall Study|Withdrawal by Subject|1|||
46852698|NCT04405739|83068190|FG003|Overall Study|Withdrawal by Subject|1|||
46852699|NCT04405739|83068187|FG000|Overall Study|Death|0|||
46973575|NCT02657369|83217411|FG000|Overall Study|Study terminated by sponsor|7|||
46973576|NCT02701777|83217419|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
46789349|NCT00251719|83008582|FG002|Overall Study|Adverse Event|7|||
46789350|NCT00251719|83008580|FG000|Overall Study|Protocol Violation|1|||
46789351|NCT00251719|83008581|FG001|Overall Study|Protocol Violation|1|||
46789352|NCT00251719|83008582|FG002|Overall Study|Protocol Violation|1|||
46789353|NCT00251719|83008580|FG000|Overall Study|Lost to Follow-up|5|||
46789354|NCT00251719|83008581|FG001|Overall Study|Lost to Follow-up|11|||
46789355|NCT00251719|83008582|FG002|Overall Study|Lost to Follow-up|8|||
46789356|NCT00251719|83008580|FG000|Overall Study|Withdrawal by Subject|14|||
46789357|NCT00251719|83008581|FG001|Overall Study|Withdrawal by Subject|12|||
46789358|NCT00251719|83008582|FG002|Overall Study|Withdrawal by Subject|11|||
46789359|NCT00251719|83008580|FG000|Overall Study|Lack of Efficacy|2|||
46789360|NCT00251719|83008581|FG001|Overall Study|Lack of Efficacy|1|||
46789361|NCT00251719|83008582|FG002|Overall Study|Lack of Efficacy|0|||
46789362|NCT00251719|83008580|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
46789363|NCT00251719|83008581|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
46789364|NCT00251719|83008582|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
46789365|NCT00251719|83008580|FG000|Overall Study|Investigator decision|1|||
46789366|NCT00251719|83008581|FG001|Overall Study|Investigator decision|1|||
46789367|NCT00251719|83008582|FG002|Overall Study|Investigator decision|0|||
46789368|NCT00251719|83008580|FG000|Overall Study|Noncompliance|2|||
46789369|NCT00251719|83008581|FG001|Overall Study|Noncompliance|3|||
46789370|NCT00251719|83008582|FG002|Overall Study|Noncompliance|1|||
46789371|NCT00251719|83008580|FG000|Overall Study|Barrett's esophagus|2|||
46789372|NCT00251719|83008581|FG001|Overall Study|Barrett's esophagus|2|||
46789373|NCT00251719|83008582|FG002|Overall Study|Barrett's esophagus|0|||
46789374|NCT03952143|83008592|FG000|Lead-In Period|Adverse Event|2|||
46789375|NCT03952143|83008593|FG001|Lead-In Period|Adverse Event|0|||
46789376|NCT03952143|83008594|FG002|Lead-In Period|Adverse Event|0|||
46789377|NCT03952143|83008592|FG000|Lead-In Period|Lack of Efficacy|2|||
46789378|NCT03952143|83008593|FG001|Lead-In Period|Lack of Efficacy|0|||
46789379|NCT03952143|83008594|FG002|Lead-In Period|Lack of Efficacy|0|||
46789380|NCT03952143|83008592|FG000|Lead-In Period|Physician Decision|5|||
46789381|NCT03952143|83008593|FG001|Lead-In Period|Physician Decision|0|||
46789382|NCT03952143|83008594|FG002|Lead-In Period|Physician Decision|0|||
46789383|NCT03952143|83008592|FG000|Lead-In Period|Protocol Violation|5|||
46789384|NCT03952143|83008593|FG001|Lead-In Period|Protocol Violation|0|||
46789385|NCT03952143|83008594|FG002|Lead-In Period|Protocol Violation|0|||
46789386|NCT03952143|83008592|FG000|Lead-In Period|Withdrawal by Subject|19|||
46789387|NCT03952143|83008593|FG001|Lead-In Period|Withdrawal by Subject|0|||
46789388|NCT03952143|83008594|FG002|Lead-In Period|Withdrawal by Subject|0|||
46789389|NCT03952143|83008592|FG000|Treatment Period|Adverse Event|0|||
46789390|NCT03952143|83008593|FG001|Treatment Period|Adverse Event|0|||
46789391|NCT03952143|83008594|FG002|Treatment Period|Adverse Event|1|||
46789392|NCT03952143|83008592|FG000|Treatment Period|Lost to Follow-up|0|||
46789393|NCT03952143|83008593|FG001|Treatment Period|Lost to Follow-up|2|||
46789394|NCT03952143|83008594|FG002|Treatment Period|Lost to Follow-up|0|||
46789395|NCT03952143|83008592|FG000|Treatment Period|Physician Decision|0|||
46673623|NCT01190449|82889027|FG000|Overall Study|Ineligible|0|||
46673624|NCT01190449|82889028|FG001|Overall Study|Ineligible|4|||
46673625|NCT01190176|82889034|FG000|Overall Study|Withdrawal by Subject|1|||
46673626|NCT01190176|82889034|FG000|Overall Study|Lost to Follow-up|1|||
46673627|NCT01190098|82889040|FG000|Overall Study|Adverse Event|2|||
46673628|NCT01190098|82889041|FG001|Overall Study|Adverse Event|0|||
46673629|NCT01190098|82889040|FG000|Overall Study|Patient coomorbidity|0|||
46673630|NCT01190098|82889041|FG001|Overall Study|Patient coomorbidity|1|||
46673631|NCT01190098|82889040|FG000|Overall Study|Lack of transportation|1|||
46673632|NCT01190098|82889041|FG001|Overall Study|Lack of transportation|0|||
46673633|NCT01190098|82889040|FG000|Overall Study|Other|0|||
46673634|NCT01190098|82889041|FG001|Overall Study|Other|1|||
46673635|NCT01190020|82889049|FG000|Overall Study|Adverse Event|2|||
46673636|NCT01190020|82889050|FG001|Overall Study|Adverse Event|0|||
46789396|NCT03952143|83008593|FG001|Treatment Period|Physician Decision|0|||
46789397|NCT03952143|83008594|FG002|Treatment Period|Physician Decision|2|||
46789398|NCT03952143|83008592|FG000|Treatment Period|Protocol Violation|0|||
46789399|NCT03952143|83008593|FG001|Treatment Period|Protocol Violation|0|||
46789400|NCT03952143|83008594|FG002|Treatment Period|Protocol Violation|1|||
46789401|NCT03952143|83008592|FG000|Treatment Period|Withdrawal by Subject|0|||
46789402|NCT03952143|83008593|FG001|Treatment Period|Withdrawal by Subject|5|||
46789403|NCT03952143|83008594|FG002|Treatment Period|Withdrawal by Subject|26|||
46789404|NCT03952143|83008592|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
46789405|NCT03952143|83008593|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
46789406|NCT03952143|83008594|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
46673637|NCT01190020|82889049|FG000|Overall Study|Lost to Follow-up|2|||
46673638|NCT01190020|82889050|FG001|Overall Study|Lost to Follow-up|0|||
46673639|NCT01190020|82889049|FG000|Overall Study|Withdrawal by Subject|3|||
46673640|NCT01190020|82889050|FG001|Overall Study|Withdrawal by Subject|0|||
46673641|NCT01189435|82889056|FG000|Overall Study|Withdrawal by Subject|1|||
46789407|NCT03952143|83008592|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
46789408|NCT03952143|83008593|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
46789409|NCT03952143|83008594|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
46789410|NCT00267007|83008603|FG000|Overall Study|Withdrawal by Subject|6|||
46789411|NCT00267007|83008604|FG001|Overall Study|Withdrawal by Subject|0|||
46789412|NCT00267007|83008603|FG000|Overall Study|Lost to Follow-up|1|||
46789413|NCT00267007|83008604|FG001|Overall Study|Lost to Follow-up|0|||
46789414|NCT00267007|83008603|FG000|Overall Study|Non-compliance|0|||
46789415|NCT00267007|83008604|FG001|Overall Study|Non-compliance|1|||
46789416|NCT00267007|83008603|FG000|Overall Study|Adverse Event|1|||
46789417|NCT00267007|83008604|FG001|Overall Study|Adverse Event|0|||
46789418|NCT03943095|83008612|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
46789419|NCT03943095|83008613|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
46789420|NCT03943095|83008612|FG000|Overall Study|Withdrawal by Subject|1|||
46789421|NCT03943095|83008613|FG001|Overall Study|Withdrawal by Subject|0|||
46789422|NCT00251641|83008622|FG000|Overall Study|Adverse Event|80|||
46789423|NCT00251641|83008623|FG001|Overall Study|Adverse Event|8|||
46789424|NCT00251641|83008622|FG000|Overall Study|Lack of Efficacy|2|||
46789425|NCT00251641|83008623|FG001|Overall Study|Lack of Efficacy|1|||
46789426|NCT00251641|83008622|FG000|Overall Study|Progression of Disease|0|||
46789427|NCT00251641|83008623|FG001|Overall Study|Progression of Disease|2|||
46789428|NCT00251641|83008622|FG000|Overall Study|Lost to Follow-up|3|||
46789429|NCT00251641|83008623|FG001|Overall Study|Lost to Follow-up|3|||
46789430|NCT00251641|83008622|FG000|Overall Study|Withdrawal by Subject|6|||
46789431|NCT00251641|83008623|FG001|Overall Study|Withdrawal by Subject|8|||
46789432|NCT00251641|83008622|FG000|Overall Study|Protocol Violation|10|||
46789433|NCT00251641|83008623|FG001|Overall Study|Protocol Violation|2|||
46789434|NCT00251641|83008622|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
46789435|NCT00251641|83008623|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
46789436|NCT00251641|83008622|FG000|Overall Study|Switched Treatment|9|||
46789437|NCT00251641|83008623|FG001|Overall Study|Switched Treatment|63|||
46789438|NCT00250705|83008631|FG000|Overall Study|Lack of Efficacy|2|||
46789439|NCT00266695|83008637|FG000|Overall Study|Adverse Event|1|||
46789440|NCT00266695|83008637|FG000|Overall Study|Death|9|||
46789441|NCT00266695|83008637|FG000|Overall Study|Physician Decision|1|||
46789442|NCT00266695|83008637|FG000|Overall Study|Lost to Follow-up|3|||
46789443|NCT00266695|83008637|FG000|Overall Study|Withdrawal by Subject|15|||
46789444|NCT00620022|83008641|FG000|Treatment Period 1|Adverse Event|4|||
46789445|NCT00620022|83008642|FG001|Treatment Period 1|Adverse Event|6|||
46789446|NCT00620022|83008641|FG000|Treatment Period 1|Subject withdrew consent|1|||
46789447|NCT00620022|83008642|FG001|Treatment Period 1|Subject withdrew consent|0|||
46789448|NCT00620022|83008641|FG000|Treatment Period 2|Adverse Event|2|||
46789449|NCT00620022|83008642|FG001|Treatment Period 2|Adverse Event|2|||
46789450|NCT00547521|83008650|FG000|Short Term Study (4 Months)|Adverse Event|1|||
46789451|NCT00547521|83008651|FG001|Short Term Study (4 Months)|Adverse Event|0|||
46789452|NCT00547521|83008650|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
46789453|NCT00547521|83008651|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
46789454|NCT00547521|83008650|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
46673642|NCT01189435|82889056|FG000|Overall Study|Physician Decision|1|||
46673643|NCT01165996|82889060|FG000|Overall Study|Death|1|||
46673644|NCT01165996|82889060|FG000|Overall Study|Physician Decision|1|||
46673645|NCT01165684|82889067|FG000|Overall Study|Adverse Event|1|||
46673646|NCT01165684|82889068|FG001|Overall Study|Adverse Event|1|||
46673647|NCT01165684|82889067|FG000|Overall Study|Lack of Efficacy|2|||
46673648|NCT01165684|82889068|FG001|Overall Study|Lack of Efficacy|1|||
46673649|NCT01165684|82889067|FG000|Overall Study|Protocol Violation|7|||
46673650|NCT01165684|82889068|FG001|Overall Study|Protocol Violation|15|||
46673651|NCT01165684|82889067|FG000|Overall Study|Withdrawal Criteria|2|||
46673652|NCT01165684|82889068|FG001|Overall Study|Withdrawal Criteria|13|||
46789455|NCT00547521|83008651|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
46789456|NCT00547521|83008650|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
46789457|NCT00547521|83008651|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
46789458|NCT00547521|83008650|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
46789459|NCT00547521|83008651|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
46973577|NCT02701777|83217420|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
46789460|NCT00547521|83008650|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
46789461|NCT00547521|83008651|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
46973578|NCT02701777|83217421|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
46673653|NCT01165684|82889067|FG000|Overall Study|Unclassified|16|||
46673654|NCT01165684|82889068|FG001|Overall Study|Unclassified|22|||
46673655|NCT01189201|82889074|FG000|Overall Study|Adverse Event|1|||
46673656|NCT01188967|82889091|FG000|Overall Study|Withdrawal by Subject|1|||
46673657|NCT01188967|82889092|FG001|Overall Study|Withdrawal by Subject|1|||
46673658|NCT01188967|82889091|FG000|Overall Study|Physician Decision|1|||
46673659|NCT01188967|82889092|FG001|Overall Study|Physician Decision|1|||
46789462|NCT00547521|83008650|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
46789463|NCT00547521|83008651|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
46789464|NCT00547521|83008650|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
46789465|NCT00547521|83008651|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
46789466|NCT00547521|83008650|FG000|Long Term Extension (LTE) Study|Other|0|||
46789467|NCT00547521|83008651|FG001|Long Term Extension (LTE) Study|Other|2|||
46789468|NCT00547521|83008650|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
46789469|NCT00547521|83008651|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
46789470|NCT00266227|83008666|FG000|Initial Treatment|Adverse Event|0|||
46789471|NCT00266227|83008667|FG001|Initial Treatment|Adverse Event|0|||
46789472|NCT00266227|83008668|FG002|Initial Treatment|Adverse Event|13|||
46789473|NCT00266227|83008666|FG000|Initial Treatment|Lost to Follow-up|0|||
46789474|NCT00266227|83008667|FG001|Initial Treatment|Lost to Follow-up|0|||
46789475|NCT00266227|83008668|FG002|Initial Treatment|Lost to Follow-up|6|||
46789476|NCT00266227|83008666|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
46789477|NCT00266227|83008667|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
46789478|NCT00266227|83008668|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
46789479|NCT00266227|83008666|FG000|Initial Treatment|Physician decision to withdraw|0|||
46789480|NCT00266227|83008667|FG001|Initial Treatment|Physician decision to withdraw|0|||
46789481|NCT00266227|83008668|FG002|Initial Treatment|Physician decision to withdraw|12|||
46789482|NCT00266227|83008666|FG000|Initial Treatment|Pregnancy|0|||
46789483|NCT00266227|83008667|FG001|Initial Treatment|Pregnancy|0|||
46789484|NCT00266227|83008668|FG002|Initial Treatment|Pregnancy|1|||
46789485|NCT00266227|83008666|FG000|Retreatment: Up to Week 48|Death|1|||
46789486|NCT00266227|83008667|FG001|Retreatment: Up to Week 48|Death|0|||
46789487|NCT00266227|83008668|FG002|Retreatment: Up to Week 48|Death|0|||
46789488|NCT00266227|83008666|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
46789489|NCT00266227|83008667|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
46789490|NCT00266227|83008668|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
46789491|NCT00266227|83008666|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
46789492|NCT00266227|83008667|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
46789493|NCT00266227|83008668|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
46789494|NCT00266227|83008666|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
46789495|NCT00266227|83008667|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
46789496|NCT00266227|83008668|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
46789497|NCT00266227|83008666|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
46789498|NCT00266227|83008667|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
46789499|NCT00266227|83008668|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
46789500|NCT00266227|83008666|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
46789501|NCT00266227|83008667|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
46789502|NCT00266227|83008668|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
46789503|NCT00266227|83008666|FG000|Retreatment: Week 48 to Week 72|Death|1|||
46789504|NCT00266227|83008667|FG001|Retreatment: Week 48 to Week 72|Death|1|||
46789505|NCT00266227|83008668|FG002|Retreatment: Week 48 to Week 72|Death|0|||
46673660|NCT01188967|82889091|FG000|Overall Study|Lost to Follow-up|3|||
46673661|NCT01188967|82889092|FG001|Overall Study|Lost to Follow-up|2|||
46673662|NCT01188811|82889102|FG000|Overall Study|Withdrawal by Subject|0|||
46673663|NCT01188811|82889103|FG001|Overall Study|Withdrawal by Subject|2|||
46673664|NCT01188811|82889102|FG000|Overall Study|Adverse Event|6|||
46673665|NCT01188811|82889103|FG001|Overall Study|Adverse Event|0|||
46673666|NCT01183234|82889111|FG000|First Intervention|Adverse Event|1|||
46673667|NCT01183234|82889112|FG001|First Intervention|Adverse Event|0|||
46673668|NCT01165216|82889120|FG000|Overall Study|Adverse Event|6|||
46673669|NCT01165216|82889121|FG001|Overall Study|Adverse Event|3|||
46673670|NCT01165216|82889120|FG000|Overall Study|Withdrawal by Subject|1|||
46673671|NCT01165216|82889121|FG001|Overall Study|Withdrawal by Subject|1|||
46673672|NCT01165216|82889120|FG000|Overall Study|Disease progression|1|||
46673673|NCT01165216|82889121|FG001|Overall Study|Disease progression|3|||
46673674|NCT04545476|82889146|FG000|Overall Study|Lost to Follow-up|1|||
46673675|NCT04545476|82889147|FG001|Overall Study|Lost to Follow-up|1|||
46673676|NCT04545476|82889148|FG002|Overall Study|Lost to Follow-up|0|||
46673677|NCT04545476|82889149|FG003|Overall Study|Lost to Follow-up|0|||
46673678|NCT01969838|82889164|FG000|Double-blind Phase|Adverse Event|10|||
46673679|NCT01969838|82889165|FG001|Double-blind Phase|Adverse Event|4|||
46673680|NCT01969838|82889166|FG002|Double-blind Phase|Adverse Event|0|||
46789506|NCT00266227|83008666|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
46789507|NCT00266227|83008667|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
46789508|NCT00266227|83008668|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
46673681|NCT01969838|82889167|FG003|Double-blind Phase|Adverse Event|0|||
46673682|NCT01969838|82889164|FG000|Double-blind Phase|Death|5|||
46852700|NCT04405739|83068188|FG001|Overall Study|Death|0|||
46673683|NCT01969838|82889165|FG001|Double-blind Phase|Death|2|||
46673684|NCT01969838|82889166|FG002|Double-blind Phase|Death|0|||
46673685|NCT01969838|82889167|FG003|Double-blind Phase|Death|0|||
46673686|NCT01969838|82889164|FG000|Double-blind Phase|Physician Decision|5|||
46673687|NCT01969838|82889165|FG001|Double-blind Phase|Physician Decision|1|||
46673688|NCT01969838|82889166|FG002|Double-blind Phase|Physician Decision|0|||
46673689|NCT01969838|82889167|FG003|Double-blind Phase|Physician Decision|0|||
46673690|NCT01969838|82889164|FG000|Double-blind Phase|Subject Decision|4|||
46673691|NCT01969838|82889165|FG001|Double-blind Phase|Subject Decision|2|||
46673692|NCT01969838|82889166|FG002|Double-blind Phase|Subject Decision|0|||
46673693|NCT01969838|82889167|FG003|Double-blind Phase|Subject Decision|0|||
46673694|NCT01969838|82889164|FG000|Double-blind Phase|Disease Progression|2|||
46673695|NCT01969838|82889165|FG001|Double-blind Phase|Disease Progression|0|||
46789509|NCT00266227|83008666|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
46789510|NCT00266227|83008667|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
46789511|NCT00266227|83008668|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
46789512|NCT00266227|83008666|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
46789513|NCT00266227|83008667|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
46789514|NCT00266227|83008668|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
46789515|NCT00266227|83008666|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
46852701|NCT04405739|83068189|FG002|Overall Study|Death|1|||
46852702|NCT04405739|83068190|FG003|Overall Study|Death|0|||
46852703|NCT04405739|83068187|FG000|Overall Study|Transferred to rehab|0|||
46852704|NCT04405739|83068188|FG001|Overall Study|Transferred to rehab|0|||
46852705|NCT04405739|83068189|FG002|Overall Study|Transferred to rehab|0|||
46852706|NCT04405739|83068190|FG003|Overall Study|Transferred to rehab|1|||
46852707|NCT04405739|83068187|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
46852708|NCT04405739|83068188|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
46852709|NCT04405739|83068189|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
46673696|NCT01969838|82889166|FG002|Double-blind Phase|Disease Progression|0|||
46673697|NCT01969838|82889167|FG003|Double-blind Phase|Disease Progression|0|||
46673698|NCT01969838|82889164|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
46673699|NCT01969838|82889165|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
46673700|NCT01969838|82889166|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
46673701|NCT01969838|82889167|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
46673702|NCT01969838|82889164|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
46673703|NCT01969838|82889165|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
46673704|NCT01969838|82889166|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
46673705|NCT01969838|82889167|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
46673706|NCT01969838|82889164|FG000|Open-label Phase|Adverse Event|0|||
46673707|NCT01969838|82889165|FG001|Open-label Phase|Adverse Event|0|||
46673708|NCT01969838|82889166|FG002|Open-label Phase|Adverse Event|37|||
46673709|NCT01969838|82889167|FG003|Open-label Phase|Adverse Event|49|||
46673710|NCT01969838|82889164|FG000|Open-label Phase|Disease Progression|0|||
46673711|NCT01969838|82889165|FG001|Open-label Phase|Disease Progression|0|||
46852710|NCT04405739|83068190|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
46852711|NCT04954326|83068223|FG000|Overall Study|Protocol Violation|0|||
46673712|NCT01969838|82889166|FG002|Open-label Phase|Disease Progression|26|||
47077934|NCT01435928|83381253|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
47077935|NCT01435928|83381254|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
47077936|NCT01416272|83381266|FG000|Overall Study|Unacceptable distance visual acuity|2|||
47077937|NCT01416272|83381266|FG000|Overall Study|Lost to Follow-up|1|||
47077938|NCT01416272|83381266|FG000|Overall Study|Study related complaints|1|||
47077939|NCT01435772|83381756|FG000|Overall Study|Adverse Event|1|||
47077940|NCT01435772|83381757|FG001|Overall Study|Adverse Event|0|||
47077941|NCT01435772|83381758|FG002|Overall Study|Adverse Event|2|||
47077942|NCT01435772|83381756|FG000|Overall Study|Withdrawal by Subject|0|||
47077943|NCT01435772|83381757|FG001|Overall Study|Withdrawal by Subject|1|||
46852712|NCT04954326|83068224|FG001|Overall Study|Protocol Violation|1|||
47077944|NCT01435772|83381758|FG002|Overall Study|Withdrawal by Subject|3|||
47077945|NCT01435772|83381756|FG000|Overall Study|Other - study termination|2|||
47077946|NCT01435772|83381757|FG001|Overall Study|Other - study termination|2|||
47077947|NCT01435772|83381758|FG002|Overall Study|Other - study termination|10|||
47077948|NCT01435616|83381977|FG000|Overall Study|Adverse Event|39|||
47077949|NCT01435616|83381978|FG001|Overall Study|Adverse Event|21|||
47077950|NCT01435616|83381977|FG000|Overall Study|Death|7|||
47077951|NCT01435616|83381978|FG001|Overall Study|Death|2|||
46852713|NCT04954326|83068223|FG000|Overall Study|Death|0|||
46852714|NCT04954326|83068224|FG001|Overall Study|Death|2|||
46852715|NCT04954326|83068223|FG000|Overall Study|Physician Decision|0|||
46852716|NCT04954326|83068224|FG001|Overall Study|Physician Decision|1|||
46852717|NCT04914819|83068232|FG000|Overall Study|Pregnancy|3|||
47077952|NCT01435616|83381977|FG000|Overall Study|Lost to Follow-up|22|||
47077953|NCT01435616|83381978|FG001|Overall Study|Lost to Follow-up|13|||
47077954|NCT01435616|83381977|FG000|Overall Study|Protocol Violation|16|||
47077955|NCT01435616|83381978|FG001|Overall Study|Protocol Violation|13|||
46789516|NCT00266227|83008667|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
46789517|NCT00266227|83008668|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
46852718|NCT04914819|83068233|FG001|Overall Study|Pregnancy|1|||
46852719|NCT04914819|83068232|FG000|Overall Study|Discontinued study|4|||
46852720|NCT04914819|83068233|FG001|Overall Study|Discontinued study|1|||
46673713|NCT01969838|82889167|FG003|Open-label Phase|Disease Progression|27|||
46789518|NCT00287365|83008677|FG000|Overall Study|sample not acquired|13|||
46789519|NCT00573768|83008685|FG000|Overall Study|Adverse Event|1|||
46789520|NCT00573768|83008686|FG001|Overall Study|Adverse Event|1|||
46789521|NCT00573768|83008687|FG002|Overall Study|Adverse Event|2|||
46789522|NCT00573768|83008685|FG000|Overall Study|Protocol Violation|1|||
46789523|NCT00573768|83008686|FG001|Overall Study|Protocol Violation|0|||
46789524|NCT00573768|83008687|FG002|Overall Study|Protocol Violation|1|||
46789525|NCT00573768|83008685|FG000|Overall Study|Withdrawal by Subject|0|||
46789526|NCT00573768|83008686|FG001|Overall Study|Withdrawal by Subject|1|||
46789527|NCT00573768|83008687|FG002|Overall Study|Withdrawal by Subject|0|||
46789528|NCT00573768|83008685|FG000|Overall Study|Lost to Follow-up|0|||
46673714|NCT01969838|82889164|FG000|Open-label Phase|Lack of Efficacy|0|||
46673715|NCT01969838|82889165|FG001|Open-label Phase|Lack of Efficacy|0|||
46673716|NCT01969838|82889166|FG002|Open-label Phase|Lack of Efficacy|17|||
46673717|NCT01969838|82889167|FG003|Open-label Phase|Lack of Efficacy|19|||
46789529|NCT00573768|83008686|FG001|Overall Study|Lost to Follow-up|0|||
46852721|NCT04914819|83068232|FG000|Overall Study|Lost to Follow-up|7|||
46673718|NCT01969838|82889164|FG000|Open-label Phase|Subject Decision|0|||
46673719|NCT01969838|82889165|FG001|Open-label Phase|Subject Decision|0|||
47077956|NCT01435616|83381977|FG000|Overall Study|Withdrawal by Subject|66|||
47077957|NCT01435616|83381978|FG001|Overall Study|Withdrawal by Subject|24|||
46789530|NCT00573768|83008687|FG002|Overall Study|Lost to Follow-up|1|||
46852722|NCT04914819|83068233|FG001|Overall Study|Lost to Follow-up|0|||
47077958|NCT01435616|83381977|FG000|Overall Study|Physician Decision|20|||
47077959|NCT01435616|83381978|FG001|Overall Study|Physician Decision|7|||
47077960|NCT01435616|83381977|FG000|Overall Study|Sponsor Decision|1|||
47077961|NCT01435616|83381978|FG001|Overall Study|Sponsor Decision|0|||
47077962|NCT01435460|83382037|FG000|Overall Study|Adverse Event|2|||
46852723|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Adverse Event|1|||
46852724|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Adverse Event|2|||
46852725|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Adverse Event|0|||
46673720|NCT01969838|82889166|FG002|Open-label Phase|Subject Decision|14|||
46673721|NCT01969838|82889167|FG003|Open-label Phase|Subject Decision|15|||
46852726|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Adverse Event|3|||
46673722|NCT01969838|82889164|FG000|Open-label Phase|Death|0|||
46673723|NCT01969838|82889165|FG001|Open-label Phase|Death|0|||
46789531|NCT00547365|83008695|FG000|Overall Study|Physician Decision|1|||
47077963|NCT01435460|83382038|FG001|Overall Study|Adverse Event|1|||
47077964|NCT01435460|83382037|FG000|Overall Study|Lost to Follow-up|6|||
47077965|NCT01435460|83382038|FG001|Overall Study|Lost to Follow-up|1|||
47077966|NCT01435460|83382037|FG000|Overall Study|Withdrawal by Subject|1|||
47077967|NCT01435460|83382038|FG001|Overall Study|Withdrawal by Subject|3|||
47077968|NCT01435460|83382037|FG000|Overall Study|Protocol Violation|0|||
46789532|NCT00547365|83008695|FG000|Overall Study|Lost to Follow-up|1|||
46789533|NCT00547365|83008695|FG000|Overall Study|Protocol Violation|2|||
46789534|NCT00547365|83008695|FG000|Overall Study|death (not related to study)|4|||
46789535|NCT00619866|83008703|FG000|Weeks 1 - 12|Adverse Event|0|||
46789536|NCT00619866|83008704|FG001|Weeks 1 - 12|Adverse Event|1|||
46789537|NCT00619866|83008705|FG002|Weeks 1 - 12|Adverse Event|2|||
46789538|NCT00619866|83008706|FG003|Weeks 1 - 12|Adverse Event|0|||
46789539|NCT00619866|83008707|FG004|Weeks 1 - 12|Adverse Event|0|||
46789540|NCT00619866|83008703|FG000|Weeks 1 - 12|Non-compliance|0|||
46789541|NCT00619866|83008704|FG001|Weeks 1 - 12|Non-compliance|0|||
46789542|NCT00619866|83008705|FG002|Weeks 1 - 12|Non-compliance|1|||
46789543|NCT00619866|83008706|FG003|Weeks 1 - 12|Non-compliance|0|||
46789544|NCT00619866|83008707|FG004|Weeks 1 - 12|Non-compliance|0|||
46789545|NCT00619866|83008703|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
46789546|NCT00619866|83008704|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
46789547|NCT00619866|83008705|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
46789548|NCT00619866|83008706|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
46789549|NCT00619866|83008707|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
46789550|NCT00619866|83008703|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
46789551|NCT00619866|83008704|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
46789552|NCT00619866|83008705|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
46789553|NCT00619866|83008706|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
46852727|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
46852728|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Lost to Follow-up|2|||
46852729|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
46852730|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Lost to Follow-up|1|||
46852731|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Physician Decision|1|||
46852732|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Physician Decision|0|||
46852733|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Physician Decision|0|||
46789554|NCT00619866|83008707|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
46789555|NCT00619866|83008703|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
46789556|NCT00619866|83008704|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
46789557|NCT00619866|83008705|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
46789558|NCT00619866|83008706|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
46789559|NCT00619866|83008707|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
46789560|NCT00619866|83008703|FG000|Weeks 1 - 12|Sponsor Decision|0|||
46789561|NCT00619866|83008704|FG001|Weeks 1 - 12|Sponsor Decision|1|||
46789562|NCT00619866|83008705|FG002|Weeks 1 - 12|Sponsor Decision|0|||
46789563|NCT00619866|83008706|FG003|Weeks 1 - 12|Sponsor Decision|0|||
46789564|NCT00619866|83008707|FG004|Weeks 1 - 12|Sponsor Decision|0|||
46789565|NCT00619866|83008703|FG000|Weeks 13 - 24|Adverse Event|0|||
46789566|NCT00619866|83008704|FG001|Weeks 13 - 24|Adverse Event|0|||
46789567|NCT00619866|83008705|FG002|Weeks 13 - 24|Adverse Event|2|||
46789568|NCT00619866|83008706|FG003|Weeks 13 - 24|Adverse Event|1|||
46789569|NCT00619866|83008707|FG004|Weeks 13 - 24|Adverse Event|0|||
46789570|NCT00619866|83008703|FG000|Weeks 13 - 24|Protocol Deviation|0|||
46789571|NCT00619866|83008704|FG001|Weeks 13 - 24|Protocol Deviation|0|||
46852734|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Physician Decision|0|||
46852735|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Protocol Violation|0|||
46852736|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Protocol Violation|0|||
46852737|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Protocol Violation|1|||
46852738|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Protocol Violation|1|||
46852739|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
46852740|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
46852741|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Withdrawal by Subject|6|||
46852742|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Withdrawal by Subject|2|||
46852743|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|1|||
46852744|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
46852745|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
46852746|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
46852747|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
46852748|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
46973579|NCT02701777|83217422|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
46973580|NCT02701777|83217419|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
46973581|NCT02701777|83217420|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
46973582|NCT02701777|83217421|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
46673724|NCT01969838|82889166|FG002|Open-label Phase|Death|13|||
46673725|NCT01969838|82889167|FG003|Open-label Phase|Death|11|||
46789572|NCT00619866|83008705|FG002|Weeks 13 - 24|Protocol Deviation|0|||
46789573|NCT00619866|83008706|FG003|Weeks 13 - 24|Protocol Deviation|1|||
46789574|NCT00619866|83008707|FG004|Weeks 13 - 24|Protocol Deviation|0|||
46789575|NCT00619866|83008703|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
46789576|NCT00619866|83008704|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
46789577|NCT00619866|83008705|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
46789578|NCT00619866|83008706|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
46789579|NCT00619866|83008707|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
46789580|NCT00619866|83008703|FG000|Weeks 13 - 24|Non-compliance|0|||
46789581|NCT00619866|83008704|FG001|Weeks 13 - 24|Non-compliance|1|||
46789582|NCT00619866|83008705|FG002|Weeks 13 - 24|Non-compliance|1|||
46789583|NCT00619866|83008706|FG003|Weeks 13 - 24|Non-compliance|0|||
46789584|NCT00619866|83008707|FG004|Weeks 13 - 24|Non-compliance|0|||
46789585|NCT00619866|83008703|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
46789586|NCT00619866|83008704|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
46789587|NCT00619866|83008705|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
46789588|NCT00619866|83008706|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
46789589|NCT00619866|83008707|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
46789590|NCT03937479|83008735|FG000|Overall Study|Adverse Event|2|||
46789591|NCT03937479|83008736|FG001|Overall Study|Adverse Event|3|||
46789592|NCT03937479|83008737|FG002|Overall Study|Adverse Event|0|||
46789593|NCT03937479|83008738|FG003|Overall Study|Adverse Event|0|||
46789594|NCT03937479|83008739|FG004|Overall Study|Adverse Event|1|||
46789595|NCT03937479|83008735|FG000|Overall Study|Withdrawal by Subject|3|||
46789596|NCT03937479|83008736|FG001|Overall Study|Withdrawal by Subject|5|||
46789597|NCT03937479|83008737|FG002|Overall Study|Withdrawal by Subject|2|||
46789598|NCT03937479|83008738|FG003|Overall Study|Withdrawal by Subject|2|||
46789599|NCT03937479|83008739|FG004|Overall Study|Withdrawal by Subject|1|||
46789600|NCT03937479|83008735|FG000|Overall Study|Protocol Violation|5|||
46789601|NCT03937479|83008736|FG001|Overall Study|Protocol Violation|6|||
46789602|NCT03937479|83008737|FG002|Overall Study|Protocol Violation|4|||
46789603|NCT03937479|83008738|FG003|Overall Study|Protocol Violation|3|||
46789604|NCT03937479|83008739|FG004|Overall Study|Protocol Violation|2|||
46789605|NCT03937479|83008735|FG000|Overall Study|Lost to Follow-up|0|||
46789606|NCT03937479|83008736|FG001|Overall Study|Lost to Follow-up|1|||
46789607|NCT03937479|83008737|FG002|Overall Study|Lost to Follow-up|0|||
46789608|NCT03937479|83008738|FG003|Overall Study|Lost to Follow-up|1|||
46789609|NCT03937479|83008739|FG004|Overall Study|Lost to Follow-up|0|||
46789610|NCT03937479|83008735|FG000|Overall Study|Physician Decision|0|||
46789611|NCT03937479|83008736|FG001|Overall Study|Physician Decision|0|||
46789612|NCT03937479|83008737|FG002|Overall Study|Physician Decision|1|||
46789613|NCT03937479|83008738|FG003|Overall Study|Physician Decision|0|||
46789614|NCT03937479|83008739|FG004|Overall Study|Physician Decision|1|||
46789615|NCT00619476|83008755|FG000|Overall Study|Adverse Event|12|||
46789616|NCT00619476|83008756|FG001|Overall Study|Adverse Event|6|||
46789617|NCT00619476|83008757|FG002|Overall Study|Adverse Event|12|||
46789618|NCT00619476|83008758|FG003|Overall Study|Adverse Event|16|||
46789619|NCT00619476|83008755|FG000|Overall Study|Lack of Efficacy|6|||
46789620|NCT00619476|83008756|FG001|Overall Study|Lack of Efficacy|1|||
46789621|NCT00619476|83008757|FG002|Overall Study|Lack of Efficacy|1|||
46789622|NCT00619476|83008758|FG003|Overall Study|Lack of Efficacy|4|||
46789623|NCT00619476|83008755|FG000|Overall Study|Protocol Violation|5|||
46789624|NCT00619476|83008756|FG001|Overall Study|Protocol Violation|4|||
46789625|NCT00619476|83008757|FG002|Overall Study|Protocol Violation|4|||
46789626|NCT00619476|83008758|FG003|Overall Study|Protocol Violation|9|||
46789627|NCT00619476|83008755|FG000|Overall Study|Lost to Follow-up|1|||
46973583|NCT02701777|83217422|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
46973584|NCT04604015|83217436|FG000|Overall Study|Incomplete Data Collection|33|||
46973585|NCT01675661|83217452|FG000|Overall Study|Lost to Follow-up|22|||
46973586|NCT01675661|83217453|FG001|Overall Study|Lost to Follow-up|23|||
46973587|NCT01675661|83217452|FG000|Overall Study|Practical problems|9|||
46973588|NCT01675661|83217453|FG001|Overall Study|Practical problems|5|||
46973589|NCT01675661|83217452|FG000|Overall Study|Moved away|5|||
46973590|NCT01675661|83217453|FG001|Overall Study|Moved away|6|||
46789628|NCT00619476|83008756|FG001|Overall Study|Lost to Follow-up|2|||
46789629|NCT00619476|83008757|FG002|Overall Study|Lost to Follow-up|0|||
46973591|NCT01675661|83217452|FG000|Overall Study|Withdrawal by Subject|3|||
46973592|NCT01675661|83217453|FG001|Overall Study|Withdrawal by Subject|7|||
46973593|NCT01675661|83217452|FG000|Overall Study|Physician Decision|0|||
46973594|NCT01675661|83217453|FG001|Overall Study|Physician Decision|2|||
46973595|NCT01675661|83217452|FG000|Overall Study|Death|0|||
46973596|NCT01675661|83217453|FG001|Overall Study|Death|1|||
46789630|NCT00619476|83008758|FG003|Overall Study|Lost to Follow-up|1|||
46789631|NCT00619476|83008755|FG000|Overall Study|Investigator Discretion|2|||
46789632|NCT00619476|83008756|FG001|Overall Study|Investigator Discretion|2|||
46789633|NCT00619476|83008757|FG002|Overall Study|Investigator Discretion|2|||
46789634|NCT00619476|83008758|FG003|Overall Study|Investigator Discretion|0|||
46789635|NCT00619476|83008755|FG000|Overall Study|Withdrawal by Subject|5|||
46789636|NCT00619476|83008756|FG001|Overall Study|Withdrawal by Subject|7|||
46789637|NCT00619476|83008757|FG002|Overall Study|Withdrawal by Subject|5|||
46789638|NCT00619476|83008758|FG003|Overall Study|Withdrawal by Subject|4|||
46789639|NCT00618072|83008771|FG000|Overall Study|Lost to Follow-up|2|||
46789640|NCT00618072|83008772|FG001|Overall Study|Lost to Follow-up|0|||
46973597|NCT01675661|83217452|FG000|Overall Study|Other reason|1|||
46789641|NCT00618072|83008773|FG002|Overall Study|Lost to Follow-up|3|||
46789642|NCT00618072|83008771|FG000|Overall Study|Physician Decision|0|||
46789643|NCT00618072|83008772|FG001|Overall Study|Physician Decision|1|||
46789644|NCT00618072|83008773|FG002|Overall Study|Physician Decision|1|||
46789645|NCT00666926|83008781|FG000|Overall Study|Adverse Event|0|||
46789646|NCT00666926|83008782|FG001|Overall Study|Adverse Event|0|||
46789647|NCT00666926|83008783|FG002|Overall Study|Adverse Event|0|||
46789648|NCT00666926|83008784|FG003|Overall Study|Adverse Event|0|||
46789649|NCT00666926|83008785|FG004|Overall Study|Adverse Event|0|||
46789650|NCT00666926|83008786|FG005|Overall Study|Adverse Event|0|||
46789651|NCT00666926|83008787|FG006|Overall Study|Adverse Event|0|||
46789652|NCT00666926|83008788|FG007|Overall Study|Adverse Event|0|||
46789653|NCT00666926|83008789|FG008|Overall Study|Adverse Event|0|||
46789654|NCT00666926|83008790|FG009|Overall Study|Adverse Event|2|||
46789655|NCT00666926|83008791|FG010|Overall Study|Adverse Event|2|||
46789656|NCT00666926|83008792|FG011|Overall Study|Adverse Event|2|||
46789657|NCT00666926|83008793|FG012|Overall Study|Adverse Event|0|||
46789658|NCT00666926|83008794|FG013|Overall Study|Adverse Event|1|||
46789659|NCT00666926|83008795|FG014|Overall Study|Adverse Event|0|||
46789660|NCT00666926|83008796|FG015|Overall Study|Adverse Event|0|||
46789661|NCT00666926|83008781|FG000|Overall Study|Laboratory abnormality|0|||
46789662|NCT00666926|83008782|FG001|Overall Study|Laboratory abnormality|0|||
46789663|NCT00666926|83008783|FG002|Overall Study|Laboratory abnormality|0|||
46789664|NCT00666926|83008784|FG003|Overall Study|Laboratory abnormality|0|||
46789665|NCT00666926|83008785|FG004|Overall Study|Laboratory abnormality|0|||
46789666|NCT00666926|83008786|FG005|Overall Study|Laboratory abnormality|0|||
46789667|NCT00666926|83008787|FG006|Overall Study|Laboratory abnormality|0|||
46789668|NCT00666926|83008788|FG007|Overall Study|Laboratory abnormality|0|||
46789669|NCT00666926|83008789|FG008|Overall Study|Laboratory abnormality|0|||
46789670|NCT00666926|83008790|FG009|Overall Study|Laboratory abnormality|0|||
46789671|NCT00666926|83008791|FG010|Overall Study|Laboratory abnormality|1|||
46789672|NCT00666926|83008792|FG011|Overall Study|Laboratory abnormality|0|||
46789673|NCT00666926|83008793|FG012|Overall Study|Laboratory abnormality|0|||
46789674|NCT00666926|83008794|FG013|Overall Study|Laboratory abnormality|0|||
46789675|NCT00666926|83008795|FG014|Overall Study|Laboratory abnormality|0|||
46789676|NCT00666926|83008796|FG015|Overall Study|Laboratory abnormality|1|||
46789677|NCT00666926|83008781|FG000|Overall Study|Lack of Efficacy|0|||
46789678|NCT00666926|83008782|FG001|Overall Study|Lack of Efficacy|0|||
46789679|NCT00666926|83008783|FG002|Overall Study|Lack of Efficacy|0|||
46789680|NCT00666926|83008784|FG003|Overall Study|Lack of Efficacy|0|||
46789681|NCT00666926|83008785|FG004|Overall Study|Lack of Efficacy|0|||
46789682|NCT00666926|83008786|FG005|Overall Study|Lack of Efficacy|1|||
46789683|NCT00666926|83008787|FG006|Overall Study|Lack of Efficacy|0|||
46789684|NCT00666926|83008788|FG007|Overall Study|Lack of Efficacy|0|||
46789685|NCT00666926|83008789|FG008|Overall Study|Lack of Efficacy|0|||
46789686|NCT00666926|83008790|FG009|Overall Study|Lack of Efficacy|0|||
46789687|NCT00666926|83008791|FG010|Overall Study|Lack of Efficacy|0|||
46789688|NCT00666926|83008792|FG011|Overall Study|Lack of Efficacy|1|||
46789689|NCT00666926|83008793|FG012|Overall Study|Lack of Efficacy|0|||
46789690|NCT00666926|83008794|FG013|Overall Study|Lack of Efficacy|0|||
46789691|NCT00666926|83008795|FG014|Overall Study|Lack of Efficacy|0|||
46789692|NCT00666926|83008796|FG015|Overall Study|Lack of Efficacy|0|||
46789693|NCT00666926|83008781|FG000|Overall Study|Lost to Follow-up|0|||
46789694|NCT00666926|83008782|FG001|Overall Study|Lost to Follow-up|0|||
46789695|NCT00666926|83008783|FG002|Overall Study|Lost to Follow-up|0|||
46789696|NCT00666926|83008784|FG003|Overall Study|Lost to Follow-up|1|||
46789697|NCT00666926|83008785|FG004|Overall Study|Lost to Follow-up|0|||
46789698|NCT00666926|83008786|FG005|Overall Study|Lost to Follow-up|0|||
46789699|NCT00666926|83008787|FG006|Overall Study|Lost to Follow-up|0|||
46789700|NCT00666926|83008788|FG007|Overall Study|Lost to Follow-up|0|||
47077969|NCT01435460|83382038|FG001|Overall Study|Protocol Violation|1|||
47077970|NCT01435460|83382037|FG000|Overall Study|Did not meet eligibility criteria|2|||
47077971|NCT01435460|83382038|FG001|Overall Study|Did not meet eligibility criteria|0|||
46789701|NCT00666926|83008789|FG008|Overall Study|Lost to Follow-up|0|||
46789702|NCT00666926|83008790|FG009|Overall Study|Lost to Follow-up|0|||
46789703|NCT00666926|83008791|FG010|Overall Study|Lost to Follow-up|0|||
46789704|NCT00666926|83008792|FG011|Overall Study|Lost to Follow-up|0|||
46789705|NCT00666926|83008793|FG012|Overall Study|Lost to Follow-up|0|||
46789706|NCT00666926|83008794|FG013|Overall Study|Lost to Follow-up|0|||
46789707|NCT00666926|83008795|FG014|Overall Study|Lost to Follow-up|0|||
46789708|NCT00666926|83008796|FG015|Overall Study|Lost to Follow-up|0|||
47077972|NCT01435382|83382124|FG000|Overall Study|Lost to Follow-up|1|||
47077973|NCT01435382|83382125|FG001|Overall Study|Lost to Follow-up|0|||
46789709|NCT00666926|83008781|FG000|Overall Study|Other|2|||
46789710|NCT00666926|83008782|FG001|Overall Study|Other|4|||
46789711|NCT00666926|83008783|FG002|Overall Study|Other|3|||
46789712|NCT00666926|83008784|FG003|Overall Study|Other|3|||
46789713|NCT00666926|83008785|FG004|Overall Study|Other|3|||
46789714|NCT00666926|83008786|FG005|Overall Study|Other|3|||
46789715|NCT00666926|83008787|FG006|Overall Study|Other|4|||
46789716|NCT00666926|83008788|FG007|Overall Study|Other|0|||
46789717|NCT00666926|83008789|FG008|Overall Study|Other|3|||
46789718|NCT00666926|83008790|FG009|Overall Study|Other|5|||
46789719|NCT00666926|83008791|FG010|Overall Study|Other|3|||
46789720|NCT00666926|83008792|FG011|Overall Study|Other|26|||
46789721|NCT00666926|83008793|FG012|Overall Study|Other|3|||
46789722|NCT00666926|83008794|FG013|Overall Study|Other|2|||
46789723|NCT00666926|83008795|FG014|Overall Study|Other|4|||
46789724|NCT00666926|83008796|FG015|Overall Study|Other|4|||
46789725|NCT00666926|83008781|FG000|Overall Study|Withdrawal by Subject|0|||
46789726|NCT00666926|83008782|FG001|Overall Study|Withdrawal by Subject|0|||
46789727|NCT00666926|83008783|FG002|Overall Study|Withdrawal by Subject|0|||
46789728|NCT00666926|83008784|FG003|Overall Study|Withdrawal by Subject|0|||
46789729|NCT00666926|83008785|FG004|Overall Study|Withdrawal by Subject|0|||
46789730|NCT00666926|83008786|FG005|Overall Study|Withdrawal by Subject|0|||
46789731|NCT00666926|83008787|FG006|Overall Study|Withdrawal by Subject|0|||
46789732|NCT00666926|83008788|FG007|Overall Study|Withdrawal by Subject|1|||
46789733|NCT00666926|83008789|FG008|Overall Study|Withdrawal by Subject|0|||
46789734|NCT00666926|83008790|FG009|Overall Study|Withdrawal by Subject|3|||
46789735|NCT00666926|83008791|FG010|Overall Study|Withdrawal by Subject|0|||
46789736|NCT00666926|83008792|FG011|Overall Study|Withdrawal by Subject|3|||
46789737|NCT00666926|83008793|FG012|Overall Study|Withdrawal by Subject|0|||
46789738|NCT00666926|83008794|FG013|Overall Study|Withdrawal by Subject|1|||
46789739|NCT00666926|83008795|FG014|Overall Study|Withdrawal by Subject|3|||
46789740|NCT00666926|83008796|FG015|Overall Study|Withdrawal by Subject|3|||
46789741|NCT00666926|83008781|FG000|Overall Study|Death|0|||
46789742|NCT00666926|83008782|FG001|Overall Study|Death|0|||
46789743|NCT00666926|83008783|FG002|Overall Study|Death|0|||
46789744|NCT00666926|83008784|FG003|Overall Study|Death|0|||
46789745|NCT00666926|83008785|FG004|Overall Study|Death|0|||
46789746|NCT00666926|83008786|FG005|Overall Study|Death|0|||
46789747|NCT00666926|83008787|FG006|Overall Study|Death|0|||
46789748|NCT00666926|83008788|FG007|Overall Study|Death|0|||
46789749|NCT00666926|83008789|FG008|Overall Study|Death|0|||
46789750|NCT00666926|83008790|FG009|Overall Study|Death|0|||
46789751|NCT00666926|83008791|FG010|Overall Study|Death|0|||
46789752|NCT00666926|83008792|FG011|Overall Study|Death|1|||
46789753|NCT00666926|83008793|FG012|Overall Study|Death|0|||
46789754|NCT00666926|83008794|FG013|Overall Study|Death|0|||
46789755|NCT00666926|83008795|FG014|Overall Study|Death|0|||
46789756|NCT00666926|83008796|FG015|Overall Study|Death|0|||
46789757|NCT03861052|83008851|FG000|Overall Study|Adverse Event|1|||
46789758|NCT03861052|83008852|FG001|Overall Study|Adverse Event|1|||
46789759|NCT03861052|83008853|FG002|Overall Study|Adverse Event|2|||
46789760|NCT03861052|83008854|FG003|Overall Study|Adverse Event|4|||
46789761|NCT03861052|83008851|FG000|Overall Study|Lost to Follow-up|0|||
46789762|NCT03861052|83008852|FG001|Overall Study|Lost to Follow-up|0|||
46789763|NCT03861052|83008853|FG002|Overall Study|Lost to Follow-up|0|||
46789764|NCT03861052|83008854|FG003|Overall Study|Lost to Follow-up|1|||
46789765|NCT03861052|83008851|FG000|Overall Study|Physician Decision|0|||
46789766|NCT03861052|83008852|FG001|Overall Study|Physician Decision|1|||
46789767|NCT03861052|83008853|FG002|Overall Study|Physician Decision|0|||
46852749|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
46973598|NCT01675661|83217453|FG001|Overall Study|Other reason|2|||
46789768|NCT03861052|83008854|FG003|Overall Study|Physician Decision|0|||
46789769|NCT03861052|83008851|FG000|Overall Study|Withdrawal by Subject|2|||
46789770|NCT03861052|83008852|FG001|Overall Study|Withdrawal by Subject|5|||
46789771|NCT03861052|83008853|FG002|Overall Study|Withdrawal by Subject|3|||
47077974|NCT01435382|83382126|FG002|Overall Study|Lost to Follow-up|1|||
47077975|NCT01435382|83382127|FG003|Overall Study|Lost to Follow-up|0|||
47077976|NCT01435382|83382124|FG000|Overall Study|Withdrawal by Subject|0|||
47077977|NCT01435382|83382125|FG001|Overall Study|Withdrawal by Subject|2|||
47077978|NCT01435382|83382126|FG002|Overall Study|Withdrawal by Subject|0|||
47077979|NCT01435382|83382127|FG003|Overall Study|Withdrawal by Subject|1|||
47077980|NCT01414166|83382192|FG000|Overall Study|Adverse Event|10|||
47077981|NCT01414166|83382193|FG001|Overall Study|Adverse Event|2|||
47077982|NCT01414166|83382192|FG000|Overall Study|Lost to Follow-up|4|||
47077983|NCT01414166|83382193|FG001|Overall Study|Lost to Follow-up|1|||
47077984|NCT01414166|83382192|FG000|Overall Study|Non-compliance with study drug|2|||
47077985|NCT01414166|83382193|FG001|Overall Study|Non-compliance with study drug|0|||
47077986|NCT01414166|83382192|FG000|Overall Study|Physician Decision|2|||
46789772|NCT03861052|83008854|FG003|Overall Study|Withdrawal by Subject|0|||
46789773|NCT03861052|83008851|FG000|Overall Study|Relocation to other city|1|||
46789774|NCT03861052|83008852|FG001|Overall Study|Relocation to other city|0|||
46789775|NCT03861052|83008853|FG002|Overall Study|Relocation to other city|0|||
46789776|NCT03861052|83008854|FG003|Overall Study|Relocation to other city|0|||
47077987|NCT01414166|83382193|FG001|Overall Study|Physician Decision|0|||
46789777|NCT00664742|83008869|FG000|Overall Study|Withdrawn due to adverse events|3|||
46852750|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
46852751|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
46852752|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
46852753|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|1|||
46852754|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
46852755|NCT04818346|83068248|FG000|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
46852756|NCT04818346|83068249|FG001|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
46852757|NCT04818346|83068250|FG002|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
46852758|NCT04818346|83068251|FG003|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
46852759|NCT04723394|83068263|FG000|Overall Study|Adverse Event|0|||
46789778|NCT00664742|83008869|FG000|Overall Study|Withdrawal by Subject|31|||
46789779|NCT00664742|83008869|FG000|Overall Study|Lost to Follow-up|92|||
46789780|NCT00511342|83008875|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
46789781|NCT00511342|83008876|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
46789782|NCT00511342|83008875|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
46789783|NCT00511342|83008876|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
46789784|NCT00511342|83008875|FG000|Overall Study|Pregnancy|0|||
46789785|NCT00511342|83008876|FG001|Overall Study|Pregnancy|1|||
46789786|NCT00511342|83008875|FG000|Overall Study|Pregnancy wish|0|||
46789787|NCT00511342|83008876|FG001|Overall Study|Pregnancy wish|1|||
46789788|NCT00511342|83008875|FG000|Overall Study|Lost to Follow-up|1|||
46789789|NCT00511342|83008876|FG001|Overall Study|Lost to Follow-up|5|||
46789790|NCT00511342|83008875|FG000|Overall Study|Other Reason|2|||
46789791|NCT00511342|83008876|FG001|Overall Study|Other Reason|2|||
46789792|NCT03931785|83008886|FG000|Overall Study|Lost to Follow-up|4|||
46789793|NCT03931785|83008887|FG001|Overall Study|Lost to Follow-up|1|||
46789794|NCT03931785|83008888|FG002|Overall Study|Lost to Follow-up|4|||
46789795|NCT03931785|83008889|FG003|Overall Study|Lost to Follow-up|3|||
46789796|NCT03931785|83008886|FG000|Overall Study|Adverse Event|1|||
46789797|NCT03931785|83008887|FG001|Overall Study|Adverse Event|0|||
46789798|NCT03931785|83008888|FG002|Overall Study|Adverse Event|3|||
46789799|NCT03931785|83008889|FG003|Overall Study|Adverse Event|4|||
46789800|NCT03931785|83008886|FG000|Overall Study|Protocol Violation|0|||
46789801|NCT03931785|83008887|FG001|Overall Study|Protocol Violation|1|||
46789802|NCT03931785|83008888|FG002|Overall Study|Protocol Violation|0|||
46789803|NCT03931785|83008889|FG003|Overall Study|Protocol Violation|0|||
46789804|NCT03931785|83008886|FG000|Overall Study|Noncompliance With Study drug|0|||
46789805|NCT03931785|83008887|FG001|Overall Study|Noncompliance With Study drug|1|||
46789806|NCT03931785|83008888|FG002|Overall Study|Noncompliance With Study drug|0|||
46852760|NCT04723394|83068264|FG001|Overall Study|Adverse Event|3|||
46852761|NCT04723394|83068263|FG000|Overall Study|Death|8|||
46852762|NCT04723394|83068264|FG001|Overall Study|Death|8|||
46852763|NCT04723394|83068263|FG000|Overall Study|Lost to Follow-up|20|||
46852764|NCT04723394|83068264|FG001|Overall Study|Lost to Follow-up|17|||
46852765|NCT04723394|83068263|FG000|Overall Study|Physician Decision|1|||
46852766|NCT04723394|83068264|FG001|Overall Study|Physician Decision|0|||
46852767|NCT04723394|83068263|FG000|Overall Study|Withdrawal by Subject|20|||
46852768|NCT04723394|83068264|FG001|Overall Study|Withdrawal by Subject|34|||
46852769|NCT04723394|83068263|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
46852770|NCT04723394|83068264|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
46852771|NCT04409002|83068274|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
46852772|NCT04289363|83068280|FG000|Overall Study|Lost to Follow-up|14|||
46852773|NCT04289363|83068281|FG001|Overall Study|Lost to Follow-up|0|||
46852774|NCT04235959|83068290|FG000|Overall Study|Protocol Violation|0|||
46852775|NCT04235959|83068291|FG001|Overall Study|Protocol Violation|1|||
46852776|NCT04235959|83068292|FG002|Overall Study|Protocol Violation|0|||
46852777|NCT04235959|83068290|FG000|Overall Study|Adverse Event|1|||
46852778|NCT04235959|83068291|FG001|Overall Study|Adverse Event|0|||
46852779|NCT04235959|83068292|FG002|Overall Study|Adverse Event|0|||
46852780|NCT03525613|83068327|FG000|Overall Study|Adverse Event|11|||
46973599|NCT01602341|83217461|FG000|Overall Study|Adverse Event|0|||
46789807|NCT03931785|83008889|FG003|Overall Study|Noncompliance With Study drug|0|||
46789808|NCT03931785|83008886|FG000|Overall Study|Other Not specified|0|||
46852781|NCT03525613|83068328|FG001|Overall Study|Adverse Event|8|||
46852782|NCT03525613|83068329|FG002|Overall Study|Adverse Event|3|||
46852783|NCT03525613|83068330|FG003|Overall Study|Adverse Event|3|||
46789809|NCT03931785|83008887|FG001|Overall Study|Other Not specified|2|||
46789810|NCT03931785|83008888|FG002|Overall Study|Other Not specified|2|||
46789811|NCT03931785|83008889|FG003|Overall Study|Other Not specified|2|||
46789812|NCT03931785|83008886|FG000|Overall Study|Withdrawal by Subject|0|||
46789813|NCT03931785|83008887|FG001|Overall Study|Withdrawal by Subject|2|||
46789814|NCT03931785|83008888|FG002|Overall Study|Withdrawal by Subject|4|||
46789815|NCT03931785|83008889|FG003|Overall Study|Withdrawal by Subject|1|||
46789816|NCT03931785|83008886|FG000|Overall Study|Pregnancy|0|||
46789817|NCT03931785|83008887|FG001|Overall Study|Pregnancy|0|||
46789818|NCT03931785|83008888|FG002|Overall Study|Pregnancy|0|||
46789819|NCT03931785|83008889|FG003|Overall Study|Pregnancy|1|||
46789820|NCT00666536|83008901|FG000|Overall Study|Adverse Event|9|||
46789821|NCT00666536|83008902|FG001|Overall Study|Adverse Event|19|||
46789822|NCT00666536|83008901|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46789823|NCT00666536|83008902|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46789824|NCT00666536|83008901|FG000|Overall Study|Protocol deviation(s)|8|||
46789825|NCT00666536|83008902|FG001|Overall Study|Protocol deviation(s)|6|||
46789826|NCT00666536|83008901|FG000|Overall Study|Withdrawal by Subject|10|||
46789827|NCT00666536|83008902|FG001|Overall Study|Withdrawal by Subject|9|||
46789828|NCT00666536|83008901|FG000|Overall Study|Lost to Follow-up|4|||
46789829|NCT00666536|83008902|FG001|Overall Study|Lost to Follow-up|3|||
46789830|NCT00519532|83008908|FG000|Overall Study|Adverse Event|11|||
46789831|NCT00519532|83008908|FG000|Overall Study|Withdrawal by Subject|5|||
46789832|NCT00519532|83008908|FG000|Overall Study|Lost to Follow-up|2|||
46789833|NCT00666458|83008914|FG000|Overall Study|Adverse Event|8|||
46789834|NCT00666458|83008915|FG001|Overall Study|Adverse Event|7|||
46789835|NCT00666458|83008914|FG000|Overall Study|Withdrawal by Subject|5|||
46789836|NCT00666458|83008915|FG001|Overall Study|Withdrawal by Subject|4|||
46789837|NCT00666458|83008914|FG000|Overall Study|Lost to Follow-up|0|||
46789838|NCT00666458|83008915|FG001|Overall Study|Lost to Follow-up|3|||
46789839|NCT00666458|83008914|FG000|Overall Study|Administrative reason by sponsor|1|||
46789840|NCT00666458|83008915|FG001|Overall Study|Administrative reason by sponsor|1|||
46789841|NCT00666458|83008914|FG000|Overall Study|Incorrect enrollment|7|||
46789842|NCT00666458|83008915|FG001|Overall Study|Incorrect enrollment|1|||
46789843|NCT00666458|83008914|FG000|Overall Study|Study specific discontinuation criteria|14|||
46789844|NCT00666458|83008915|FG001|Overall Study|Study specific discontinuation criteria|7|||
46789845|NCT00666458|83008914|FG000|Overall Study|Severe non-compliance to the protocol|1|||
46789846|NCT00666458|83008915|FG001|Overall Study|Severe non-compliance to the protocol|1|||
46789847|NCT00666458|83008914|FG000|Overall Study|Safety reasons|1|||
46789848|NCT00666458|83008915|FG001|Overall Study|Safety reasons|0|||
46789849|NCT00666458|83008914|FG000|Overall Study|Medical history of anemia|1|||
46789850|NCT00666458|83008915|FG001|Overall Study|Medical history of anemia|0|||
46789851|NCT00511108|83008925|FG000|Overall Study|Adverse Event|2|||
46852784|NCT03525613|83068327|FG000|Overall Study|Lost to Follow-up|4|||
46852785|NCT03525613|83068328|FG001|Overall Study|Lost to Follow-up|5|||
46789852|NCT00511108|83008926|FG001|Overall Study|Adverse Event|0|||
46789853|NCT00511108|83008927|FG002|Overall Study|Adverse Event|1|||
46789854|NCT00511108|83008928|FG003|Overall Study|Adverse Event|2|||
46789855|NCT00511108|83008925|FG000|Overall Study|Lost to Follow-up|0|||
46789856|NCT00511108|83008926|FG001|Overall Study|Lost to Follow-up|2|||
46789857|NCT00511108|83008927|FG002|Overall Study|Lost to Follow-up|1|||
46789858|NCT00511108|83008928|FG003|Overall Study|Lost to Follow-up|0|||
46789859|NCT00511108|83008925|FG000|Overall Study|Physician Decision|0|||
46789860|NCT00511108|83008926|FG001|Overall Study|Physician Decision|0|||
46789861|NCT00511108|83008927|FG002|Overall Study|Physician Decision|0|||
46789862|NCT00511108|83008928|FG003|Overall Study|Physician Decision|1|||
46789863|NCT00511108|83008925|FG000|Overall Study|Withdrawal by Subject|4|||
46789864|NCT00511108|83008926|FG001|Overall Study|Withdrawal by Subject|0|||
46789865|NCT00511108|83008927|FG002|Overall Study|Withdrawal by Subject|3|||
46789866|NCT00511108|83008928|FG003|Overall Study|Withdrawal by Subject|2|||
46789867|NCT00510952|83008940|FG000|Overall Study|Adverse Event|1|||
46789868|NCT00510952|83008941|FG001|Overall Study|Adverse Event|0|||
46789869|NCT00510952|83008940|FG000|Overall Study|Entry Criteria Not Met|3|||
46789870|NCT00510952|83008941|FG001|Overall Study|Entry Criteria Not Met|1|||
46789871|NCT00510952|83008940|FG000|Overall Study|Lost to Follow-up|5|||
46852786|NCT03525613|83068329|FG002|Overall Study|Lost to Follow-up|3|||
46852787|NCT03525613|83068330|FG003|Overall Study|Lost to Follow-up|2|||
46852788|NCT03525613|83068327|FG000|Overall Study|Physician Decision|0|||
46852789|NCT03525613|83068328|FG001|Overall Study|Physician Decision|1|||
46852790|NCT03525613|83068329|FG002|Overall Study|Physician Decision|0|||
46852791|NCT03525613|83068330|FG003|Overall Study|Physician Decision|1|||
46852792|NCT03525613|83068327|FG000|Overall Study|Consent Withdrawal|25|||
46852793|NCT03525613|83068328|FG001|Overall Study|Consent Withdrawal|16|||
46852794|NCT03525613|83068329|FG002|Overall Study|Consent Withdrawal|12|||
46789872|NCT00510952|83008941|FG001|Overall Study|Lost to Follow-up|3|||
46789873|NCT00510952|83008940|FG000|Overall Study|Physician Decision|1|||
46852795|NCT03525613|83068330|FG003|Overall Study|Consent Withdrawal|9|||
46789874|NCT00510952|83008941|FG001|Overall Study|Physician Decision|1|||
46789875|NCT00510952|83008940|FG000|Overall Study|Protocol Violation|7|||
46789876|NCT00510952|83008941|FG001|Overall Study|Protocol Violation|4|||
46789877|NCT00510952|83008940|FG000|Overall Study|Sponsor Decision|1|||
46852796|NCT03525613|83068327|FG000|Overall Study|Death|20|||
46852797|NCT03525613|83068328|FG001|Overall Study|Death|9|||
46852798|NCT03525613|83068329|FG002|Overall Study|Death|7|||
46852799|NCT03525613|83068330|FG003|Overall Study|Death|1|||
46789878|NCT00510952|83008941|FG001|Overall Study|Sponsor Decision|0|||
46789879|NCT00510952|83008940|FG000|Overall Study|Withdrawal by Subject|6|||
46789880|NCT00510952|83008941|FG001|Overall Study|Withdrawal by Subject|7|||
46789881|NCT00510952|83008940|FG000|Overall Study|Did Not Receive Study Drug|2|||
46789882|NCT00510952|83008941|FG001|Overall Study|Did Not Receive Study Drug|0|||
46789883|NCT00617604|83008949|FG000|Overall Study|Death|2|||
46789884|NCT00617604|83008950|FG001|Overall Study|Death|1|||
46789885|NCT00617604|83008949|FG000|Overall Study|Lost to Follow-up|1|||
46789886|NCT00617604|83008950|FG001|Overall Study|Lost to Follow-up|0|||
46789887|NCT00617604|83008949|FG000|Overall Study|Miscellaneous Reasons|8|||
46789888|NCT00617604|83008950|FG001|Overall Study|Miscellaneous Reasons|10|||
46789889|NCT00617604|83008949|FG000|Overall Study|Withdrawal by Subject|4|||
46789890|NCT00617604|83008950|FG001|Overall Study|Withdrawal by Subject|6|||
46789891|NCT00617604|83008949|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
46789892|NCT00617604|83008950|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
46789893|NCT00661622|83008958|FG000|Overall Study|Protocol Violation|1|||
46789894|NCT00661622|83008959|FG001|Overall Study|Protocol Violation|0|||
46789895|NCT04093752|83008970|FG000|Overall Study|Adverse Event|7|||
46789896|NCT04093752|83008971|FG001|Overall Study|Adverse Event|19|||
46789897|NCT04093752|83008972|FG002|Overall Study|Adverse Event|18|||
46789898|NCT04093752|83008973|FG003|Overall Study|Adverse Event|4|||
46789899|NCT04093752|83008970|FG000|Overall Study|Withdrawal by Subject|6|||
46789900|NCT04093752|83008971|FG001|Overall Study|Withdrawal by Subject|6|||
46789901|NCT04093752|83008972|FG002|Overall Study|Withdrawal by Subject|8|||
46789902|NCT04093752|83008973|FG003|Overall Study|Withdrawal by Subject|20|||
46789903|NCT04093752|83008970|FG000|Overall Study|Lost to Follow-up|2|||
46789904|NCT04093752|83008971|FG001|Overall Study|Lost to Follow-up|1|||
46789905|NCT04093752|83008972|FG002|Overall Study|Lost to Follow-up|1|||
46789906|NCT04093752|83008973|FG003|Overall Study|Lost to Follow-up|1|||
46789907|NCT04093752|83008970|FG000|Overall Study|Death|0|||
46789908|NCT04093752|83008971|FG001|Overall Study|Death|0|||
46852800|NCT03525613|83068327|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
46852801|NCT03525613|83068328|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
46852802|NCT03525613|83068329|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
46852803|NCT03525613|83068330|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
46852804|NCT03500692|83068344|FG000|Overall Study|Death|163|||
46852805|NCT03500692|83068344|FG000|Overall Study|Lost to Follow-up|76|||
46852806|NCT03500692|83068344|FG000|Overall Study|Termination Reasons|3|||
46852807|NCT03264404|83068357|FG000|Overall Study|Death|2|||
46852808|NCT03264404|83068357|FG000|Overall Study|Physician Decision|1|||
46852809|NCT03264404|83068357|FG000|Overall Study|Disease Progression|28|||
46852810|NCT03264404|83068357|FG000|Overall Study|Adverse Event|1|||
46852811|NCT03264404|83068357|FG000|Overall Study|Off study prior to treatment|2|||
46852812|NCT03118570|83068375|FG000|Overall Study|Adverse Event|2|||
46852813|NCT03118570|83068376|FG001|Overall Study|Adverse Event|0|||
46852814|NCT03118570|83068377|FG002|Overall Study|Adverse Event|0|||
46852815|NCT03118570|83068378|FG003|Overall Study|Adverse Event|0|||
46852816|NCT03118570|83068379|FG004|Overall Study|Adverse Event|3|||
46852817|NCT03118570|83068375|FG000|Overall Study|Withdrawal by Subject|0|||
46852818|NCT03118570|83068376|FG001|Overall Study|Withdrawal by Subject|1|||
46852819|NCT03118570|83068377|FG002|Overall Study|Withdrawal by Subject|4|||
46973600|NCT01602341|83217462|FG001|Overall Study|Adverse Event|1|||
46973601|NCT02700919|83217475|FG000|Overall Study|Physician Decision|1|||
46973602|NCT02700919|83217476|FG001|Overall Study|Physician Decision|0|||
46973603|NCT02700919|83217477|FG002|Overall Study|Physician Decision|0|||
46973604|NCT02700919|83217475|FG000|Overall Study|Protocol Violation|1|||
46973605|NCT02700919|83217476|FG001|Overall Study|Protocol Violation|0|||
46973606|NCT02700919|83217477|FG002|Overall Study|Protocol Violation|0|||
46973607|NCT02700919|83217475|FG000|Overall Study|Adverse Event|1|||
46973608|NCT02700919|83217476|FG001|Overall Study|Adverse Event|3|||
47077988|NCT01414166|83382192|FG000|Overall Study|Protocol Violation|2|||
47077989|NCT01414166|83382193|FG001|Overall Study|Protocol Violation|0|||
46852820|NCT03118570|83068378|FG003|Overall Study|Withdrawal by Subject|0|||
46852821|NCT03118570|83068379|FG004|Overall Study|Withdrawal by Subject|1|||
46852822|NCT03118570|83068375|FG000|Overall Study|Lost to Follow-up|2|||
46852823|NCT03118570|83068376|FG001|Overall Study|Lost to Follow-up|3|||
46789909|NCT04093752|83008972|FG002|Overall Study|Death|1|||
46789910|NCT04093752|83008973|FG003|Overall Study|Death|2|||
46789911|NCT04093752|83008970|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
46789912|NCT04093752|83008971|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
46789913|NCT04093752|83008972|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
46852824|NCT03118570|83068377|FG002|Overall Study|Lost to Follow-up|1|||
46852825|NCT03118570|83068378|FG003|Overall Study|Lost to Follow-up|0|||
46852826|NCT03118570|83068379|FG004|Overall Study|Lost to Follow-up|1|||
46852827|NCT03118570|83068375|FG000|Overall Study|Other, Not Specified|1|||
46973609|NCT02700919|83217477|FG002|Overall Study|Adverse Event|1|||
46973610|NCT02700919|83217475|FG000|Overall Study|Withdrawal by Subject|5|||
46789914|NCT04093752|83008973|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
46789915|NCT04093752|83008970|FG000|Overall Study|Covid 19|0|||
46789916|NCT04093752|83008971|FG001|Overall Study|Covid 19|0|||
46789917|NCT04093752|83008972|FG002|Overall Study|Covid 19|0|||
46673726|NCT01969838|82889164|FG000|Open-label Phase|Physician Decision|0|||
46673727|NCT01969838|82889165|FG001|Open-label Phase|Physician Decision|0|||
46673728|NCT01969838|82889166|FG002|Open-label Phase|Physician Decision|9|||
46673729|NCT01969838|82889167|FG003|Open-label Phase|Physician Decision|14|||
46673730|NCT01969838|82889164|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
46789918|NCT04093752|83008973|FG003|Overall Study|Covid 19|1|||
46852828|NCT03118570|83068376|FG001|Overall Study|Other, Not Specified|3|||
46852829|NCT03118570|83068377|FG002|Overall Study|Other, Not Specified|0|||
46852830|NCT03118570|83068378|FG003|Overall Study|Other, Not Specified|0|||
46852831|NCT03118570|83068379|FG004|Overall Study|Other, Not Specified|0|||
46852832|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
46852833|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
46852834|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
46852835|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
46852836|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
46852837|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
46852838|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
46852839|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
46973611|NCT02700919|83217476|FG001|Overall Study|Withdrawal by Subject|8|||
46973612|NCT02700919|83217477|FG002|Overall Study|Withdrawal by Subject|2|||
46973613|NCT02700919|83217475|FG000|Overall Study|Lost to Follow-up|2|||
46973614|NCT02700919|83217476|FG001|Overall Study|Lost to Follow-up|0|||
46973615|NCT02700919|83217477|FG002|Overall Study|Lost to Follow-up|0|||
46973616|NCT02700919|83217475|FG000|Overall Study|Other|2|||
46973617|NCT02700919|83217476|FG001|Overall Study|Other|1|||
46973618|NCT02700919|83217477|FG002|Overall Study|Other|1|||
46973619|NCT01986010|83217502|FG000|Overall Study|Adverse Event|0|||
46973620|NCT01986010|83217503|FG001|Overall Study|Adverse Event|1|||
46973621|NCT01986010|83217504|FG002|Overall Study|Adverse Event|0|||
46973622|NCT01986010|83217505|FG003|Overall Study|Adverse Event|0|||
46789919|NCT04093752|83008970|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
46789920|NCT04093752|83008971|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
46789921|NCT04093752|83008972|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
46789922|NCT04093752|83008973|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
46789923|NCT04093752|83008970|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
46789924|NCT04093752|83008971|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
46973623|NCT01986010|83217506|FG004|Overall Study|Adverse Event|0|||
46973624|NCT01986010|83217507|FG005|Overall Study|Adverse Event|0|||
46973625|NCT01986010|83217508|FG006|Overall Study|Adverse Event|0|||
46973626|NCT01986010|83217509|FG007|Overall Study|Adverse Event|0|||
46973627|NCT01986010|83217510|FG008|Overall Study|Adverse Event|0|||
46973628|NCT01986010|83217511|FG009|Overall Study|Adverse Event|0|||
46973629|NCT01986010|83217512|FG010|Overall Study|Adverse Event|0|||
46973630|NCT01986010|83217513|FG011|Overall Study|Adverse Event|0|||
46973631|NCT01986010|83217514|FG012|Overall Study|Adverse Event|0|||
46973632|NCT01986010|83217515|FG013|Overall Study|Adverse Event|0|||
46973633|NCT01986010|83217516|FG014|Overall Study|Adverse Event|0|||
46973634|NCT01986010|83217517|FG015|Overall Study|Adverse Event|1|||
46973635|NCT01986010|83217518|FG016|Overall Study|Adverse Event|0|||
46973636|NCT01986010|83217502|FG000|Overall Study|Lost to Follow-up|2|||
46973637|NCT01986010|83217503|FG001|Overall Study|Lost to Follow-up|1|||
46973638|NCT01986010|83217504|FG002|Overall Study|Lost to Follow-up|2|||
46973639|NCT01986010|83217505|FG003|Overall Study|Lost to Follow-up|2|||
46973640|NCT01986010|83217506|FG004|Overall Study|Lost to Follow-up|2|||
46973641|NCT01986010|83217507|FG005|Overall Study|Lost to Follow-up|2|||
46973642|NCT01986010|83217508|FG006|Overall Study|Lost to Follow-up|0|||
47077990|NCT01414166|83382192|FG000|Overall Study|Study terminated by Sponsor|68|||
47077991|NCT01414166|83382193|FG001|Overall Study|Study terminated by Sponsor|75|||
46789925|NCT04093752|83008972|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
46789926|NCT04093752|83008973|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
46789927|NCT04093752|83008970|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
46973643|NCT01986010|83217509|FG007|Overall Study|Lost to Follow-up|0|||
46673731|NCT01969838|82889165|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
46973644|NCT01986010|83217510|FG008|Overall Study|Lost to Follow-up|4|||
46673732|NCT01969838|82889166|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
46673733|NCT01969838|82889167|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
46789928|NCT04093752|83008971|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
46852840|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
46973645|NCT01986010|83217511|FG009|Overall Study|Lost to Follow-up|2|||
46973646|NCT01986010|83217512|FG010|Overall Study|Lost to Follow-up|0|||
46973647|NCT01986010|83217513|FG011|Overall Study|Lost to Follow-up|1|||
46852841|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
46852842|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
46852843|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
46852844|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
46852845|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
46852846|NCT02971683|83068394|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
46852847|NCT02971683|83068395|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
46852848|NCT02971683|83068394|FG000|Open-Label|Lost to Follow-up|1|||
46852849|NCT02971683|83068395|FG001|Open-Label|Lost to Follow-up|0|||
46852850|NCT02971683|83068394|FG000|Open-Label|Participants withdrew consent|0|||
46852851|NCT02971683|83068395|FG001|Open-Label|Participants withdrew consent|2|||
46852852|NCT02971683|83068394|FG000|Open-Label|Participant request to discontinue study treatment|1|||
46852853|NCT02971683|83068395|FG001|Open-Label|Participant request to discontinue study treatment|0|||
46852854|NCT02971683|83068394|FG000|Open-Label|Lack of Efficacy|2|||
46852855|NCT02971683|83068395|FG001|Open-Label|Lack of Efficacy|0|||
46852856|NCT02971683|83068394|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
46852857|NCT02971683|83068395|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
46852858|NCT02971683|83068394|FG000|Long-Term Open Label|Participant withdrew consent|1|||
46852859|NCT02971683|83068395|FG001|Long-Term Open Label|Participant withdrew consent|0|||
46852860|NCT02971683|83068394|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
46852861|NCT02971683|83068395|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
46852862|NCT02971683|83068394|FG000|Long-Term Open Label|Adverse Event|1|||
46852863|NCT02971683|83068395|FG001|Long-Term Open Label|Adverse Event|2|||
46852864|NCT02971683|83068394|FG000|Long-Term Open Label|Lack of Efficacy|1|||
46852865|NCT02971683|83068395|FG001|Long-Term Open Label|Lack of Efficacy|1|||
46852866|NCT02899299|83068403|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
46852867|NCT02899299|83068404|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
46852868|NCT02899299|83068403|FG000|Pre-treatment|Participant withdrew consent|1|||
46852869|NCT02899299|83068404|FG001|Pre-treatment|Participant withdrew consent|11|||
46852870|NCT02899299|83068403|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
46852871|NCT02899299|83068404|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
46852872|NCT02899299|83068403|FG000|Pre-treatment|Not reported|0|||
46852873|NCT02899299|83068404|FG001|Pre-treatment|Not reported|1|||
46852874|NCT02899299|83068403|FG000|Treatment|Disease Progression|182|||
46852875|NCT02899299|83068404|FG001|Treatment|Disease Progression|44|||
46852876|NCT02899299|83068403|FG000|Treatment|Study Drug Toxicity|59|||
46852877|NCT02899299|83068404|FG001|Treatment|Study Drug Toxicity|24|||
47077992|NCT01414166|83382192|FG000|Overall Study|Withdrawal by Subject|3|||
46852878|NCT02899299|83068403|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
46852879|NCT02899299|83068404|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
46852880|NCT02899299|83068403|FG000|Treatment|Participant request to discontinue Study treatment|4|||
46852881|NCT02899299|83068404|FG001|Treatment|Participant request to discontinue Study treatment|10|||
46852882|NCT02899299|83068403|FG000|Treatment|Participant withdrew consent|6|||
46852883|NCT02899299|83068404|FG001|Treatment|Participant withdrew consent|3|||
46852884|NCT02899299|83068403|FG000|Treatment|Lost to Follow-up|0|||
46852885|NCT02899299|83068404|FG001|Treatment|Lost to Follow-up|1|||
46852886|NCT02899299|83068403|FG000|Treatment|Maximum Clinical Benefit|10|||
46852887|NCT02899299|83068404|FG001|Treatment|Maximum Clinical Benefit|2|||
46852888|NCT02899299|83068403|FG000|Treatment|Poor/Non-compliance|1|||
46852889|NCT02899299|83068404|FG001|Treatment|Poor/Non-compliance|0|||
46852890|NCT02899299|83068403|FG000|Treatment|Participant no longer meets Study criteria|4|||
46852891|NCT02899299|83068404|FG001|Treatment|Participant no longer meets Study criteria|0|||
46852892|NCT02899299|83068403|FG000|Treatment|Administrative reason by Sponsor|2|||
46852893|NCT02899299|83068404|FG001|Treatment|Administrative reason by Sponsor|0|||
46852894|NCT02899299|83068403|FG000|Treatment|Other reasons|11|||
47077993|NCT01414166|83382193|FG001|Overall Study|Withdrawal by Subject|5|||
47077994|NCT01434680|83382203|FG000|Overall Study|Withdrawal by Subject|1|||
47077995|NCT01434680|83382204|FG001|Overall Study|Withdrawal by Subject|0|||
47077996|NCT01434680|83382205|FG002|Overall Study|Withdrawal by Subject|2|||
47077997|NCT01434680|83382206|FG003|Overall Study|Withdrawal by Subject|0|||
47077998|NCT01434680|83382203|FG000|Overall Study|Lost to Follow-up|1|||
47077999|NCT01434680|83382204|FG001|Overall Study|Lost to Follow-up|1|||
46673734|NCT01165177|82889178|FG000|Overall Study|Serious Adverse Event|227|||
46673735|NCT01165177|82889179|FG001|Overall Study|Serious Adverse Event|235|||
46852895|NCT02899299|83068404|FG001|Treatment|Other reasons|2|||
46852896|NCT02899299|83068403|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
46852897|NCT02899299|83068404|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
46852898|NCT02899195|83068410|FG000|Concurrent Durvalumab|Adverse Event|4|||
46852899|NCT02899195|83068410|FG000|Concurrent Durvalumab|Physician Decision|1|||
46852900|NCT02899195|83068410|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
47078000|NCT01434680|83382205|FG002|Overall Study|Lost to Follow-up|0|||
46852901|NCT02899195|83068410|FG000|Concurrent Durvalumab|Progressive Disease|5|||
46852902|NCT02899195|83068410|FG000|Maintenance Durvalumab|Adverse Event|1|||
46852903|NCT02899195|83068410|FG000|Maintenance Durvalumab|Physician Decision|1|||
46852904|NCT02899195|83068410|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
46852905|NCT02899195|83068410|FG000|Maintenance Durvalumab|Progressive Disease|31|||
46852906|NCT02581943|83068479|FG000|Overall Study|Death|5|||
46852907|NCT02581943|83068480|FG001|Overall Study|Death|2|||
46852908|NCT02581943|83068479|FG000|Overall Study|Disease Progression|12|||
46852909|NCT02581943|83068480|FG001|Overall Study|Disease Progression|15|||
46852910|NCT02581943|83068479|FG000|Overall Study|Withdrawal by Subject|1|||
46852911|NCT02581943|83068480|FG001|Overall Study|Withdrawal by Subject|2|||
46852912|NCT02527200|83068495|FG000|Overall Study|Withdrawal by Subject|3|||
46852913|NCT02527200|83068496|FG001|Overall Study|Withdrawal by Subject|2|||
46852914|NCT02527200|83068497|FG002|Overall Study|Withdrawal by Subject|1|||
46852915|NCT02527200|83068498|FG003|Overall Study|Withdrawal by Subject|0|||
46852916|NCT02527200|83068495|FG000|Overall Study|Unclassified|0|||
46852917|NCT02527200|83068496|FG001|Overall Study|Unclassified|1|||
46852918|NCT02527200|83068497|FG002|Overall Study|Unclassified|0|||
46852919|NCT02527200|83068498|FG003|Overall Study|Unclassified|0|||
46852920|NCT02527200|83068495|FG000|Overall Study|Lost to Follow-up|0|||
46852921|NCT02527200|83068496|FG001|Overall Study|Lost to Follow-up|0|||
46852922|NCT02527200|83068497|FG002|Overall Study|Lost to Follow-up|1|||
46852923|NCT02527200|83068498|FG003|Overall Study|Lost to Follow-up|0|||
46852924|NCT02510040|83068515|FG000|Overall Study|Deemed no longer eligible|18|||
46852925|NCT02510040|83068516|FG001|Overall Study|Deemed no longer eligible|3|||
46852926|NCT02510040|83068517|FG002|Overall Study|Deemed no longer eligible|1|||
46852927|NCT01935089|83068543|FG000|Overall Study|Adverse Event|2|||
46852928|NCT01935089|83068543|FG000|Overall Study|Withdrawal by Subject|1|||
46852929|NCT00571727|83068579|FG000|Overall Study|Did not enter in this study|1|||
46852930|NCT00571727|83068579|FG000|Overall Study|Non-compliance|4|||
46852931|NCT00571727|83068579|FG000|Overall Study|Lost to Follow-up|30|||
46852932|NCT00571727|83068579|FG000|Overall Study|Poor growth|1|||
46852933|NCT00571727|83068579|FG000|Overall Study|Parent/patient decision|2|||
46852934|NCT00571727|83068579|FG000|Overall Study|Participant transferred to commercial drug|14|||
46852935|NCT00571727|83068579|FG000|Overall Study|Unable to provide study drug|6|||
46852936|NCT00571727|83068579|FG000|Overall Study|On-treatment at end of study|8|||
46852937|NCT00427349|83068583|FG000|Overall Study|Lack of Efficacy|23|||
46852938|NCT00427349|83068583|FG000|Overall Study|Adverse Event|14|||
46852939|NCT00427349|83068583|FG000|Overall Study|Death|1|||
46852940|NCT00427349|83068583|FG000|Overall Study|Withdrawal by Subject|3|||
46852941|NCT00427349|83068583|FG000|Overall Study|Alternative therapy|1|||
46852942|NCT00427349|83068583|FG000|Overall Study|Other|2|||
46852943|NCT00427349|83068583|FG000|Overall Study|Ineligible|1|||
46852944|NCT00427349|83068583|FG000|Overall Study|Never started therapy|1|||
46852945|NCT00098787|83068590|FG000|Overall Study|Never started treatment|3|||
46852946|NCT00098787|83068591|FG001|Overall Study|Never started treatment|2|||
46852947|NCT00098787|83068592|FG002|Overall Study|Never started treatment|1|||
46852948|NCT00098787|83068590|FG000|Overall Study|Ineligible|9|||
46852949|NCT00098787|83068591|FG001|Overall Study|Ineligible|7|||
46852950|NCT00098787|83068592|FG002|Overall Study|Ineligible|3|||
46852951|NCT00098787|83068590|FG000|Overall Study|Disease progression|28|||
46852952|NCT00098787|83068591|FG001|Overall Study|Disease progression|17|||
46852953|NCT00098787|83068592|FG002|Overall Study|Disease progression|23|||
46852954|NCT00098787|83068590|FG000|Overall Study|Adverse Event|8|||
46852955|NCT00098787|83068591|FG001|Overall Study|Adverse Event|17|||
46852956|NCT00098787|83068592|FG002|Overall Study|Adverse Event|8|||
46852957|NCT00098787|83068590|FG000|Overall Study|Death|6|||
46852958|NCT00098787|83068591|FG001|Overall Study|Death|1|||
46852959|NCT00098787|83068592|FG002|Overall Study|Death|0|||
46852960|NCT00098787|83068590|FG000|Overall Study|Withdrawal by Subject|4|||
46852961|NCT00098787|83068591|FG001|Overall Study|Withdrawal by Subject|12|||
46852962|NCT00098787|83068592|FG002|Overall Study|Withdrawal by Subject|6|||
46852963|NCT00098787|83068590|FG000|Overall Study|Alternative therapy|8|||
46852964|NCT00098787|83068591|FG001|Overall Study|Alternative therapy|13|||
46852965|NCT00098787|83068592|FG002|Overall Study|Alternative therapy|13|||
46852966|NCT00098787|83068590|FG000|Overall Study|Other|7|||
46852967|NCT00098787|83068591|FG001|Overall Study|Other|6|||
46852968|NCT00098787|83068592|FG002|Overall Study|Other|9|||
46852969|NCT00091169|83068602|FG000|Overall Study|Disease progression|3|||
46852970|NCT00091169|83068603|FG001|Overall Study|Disease progression|1|||
46852971|NCT00091169|83068602|FG000|Overall Study|Adverse Event|11|||
46852972|NCT00091169|83068603|FG001|Overall Study|Adverse Event|17|||
46852973|NCT00091169|83068602|FG000|Overall Study|Death|4|||
46852974|NCT00091169|83068603|FG001|Overall Study|Death|1|||
46852975|NCT00091169|83068602|FG000|Overall Study|Withdrawal by Subject|10|||
46852976|NCT00091169|83068603|FG001|Overall Study|Withdrawal by Subject|13|||
46852977|NCT00091169|83068602|FG000|Overall Study|Other|3|||
46852978|NCT00091169|83068603|FG001|Overall Study|Other|4|||
46852979|NCT00091169|83068602|FG000|Overall Study|Not start protocol therapy|26|||
46852980|NCT00091169|83068603|FG001|Overall Study|Not start protocol therapy|17|||
46852981|NCT00057876|83068617|FG000|Overall Study|Adverse Event|8|||
46852982|NCT00057876|83068618|FG001|Overall Study|Adverse Event|8|||
46852983|NCT00057876|83068617|FG000|Overall Study|Death|2|||
46852984|NCT00057876|83068618|FG001|Overall Study|Death|1|||
46852985|NCT00057876|83068617|FG000|Overall Study|Withdrawal by Subject|5|||
46852986|NCT00057876|83068618|FG001|Overall Study|Withdrawal by Subject|6|||
46852987|NCT00057876|83068617|FG000|Overall Study|Lack of Efficacy|10|||
46852988|NCT00057876|83068618|FG001|Overall Study|Lack of Efficacy|8|||
46852989|NCT00057876|83068617|FG000|Overall Study|Ineligible|1|||
46852990|NCT00057876|83068618|FG001|Overall Study|Ineligible|2|||
46852991|NCT00057876|83068617|FG000|Overall Study|other reason|2|||
46852992|NCT00057876|83068618|FG001|Overall Study|other reason|2|||
46852993|NCT00057876|83068617|FG000|Overall Study|other complicating disease|1|||
46852994|NCT00057876|83068618|FG001|Overall Study|other complicating disease|0|||
46852995|NCT00057837|83068626|FG000|Overall Study|Progression/relapse|12|||
46852996|NCT00057837|83068627|FG001|Overall Study|Progression/relapse|14|||
46852997|NCT00057837|83068626|FG000|Overall Study|Adverse Event|2|||
46852998|NCT00057837|83068627|FG001|Overall Study|Adverse Event|12|||
46852999|NCT00057837|83068626|FG000|Overall Study|Death|5|||
46853000|NCT00057837|83068627|FG001|Overall Study|Death|4|||
46853001|NCT00057837|83068626|FG000|Overall Study|Withdrawal by Subject|5|||
46853002|NCT00057837|83068627|FG001|Overall Study|Withdrawal by Subject|3|||
46853003|NCT00057837|83068626|FG000|Overall Study|Alternative therapy|0|||
46853004|NCT00057837|83068627|FG001|Overall Study|Alternative therapy|1|||
46853005|NCT00057837|83068626|FG000|Overall Study|Other complicating disease|2|||
46853006|NCT00057837|83068627|FG001|Overall Study|Other complicating disease|1|||
46853007|NCT00057837|83068626|FG000|Overall Study|Physician Decision|1|||
46853008|NCT00057837|83068627|FG001|Overall Study|Physician Decision|0|||
46853009|NCT00057837|83068626|FG000|Overall Study|Ineligible|3|||
46853010|NCT00057837|83068627|FG001|Overall Study|Ineligible|3|||
46853011|NCT00057837|83068626|FG000|Overall Study|Never started treatment|1|||
46853012|NCT00057837|83068627|FG001|Overall Study|Never started treatment|1|||
46853013|NCT00046930|83068635|FG000|Overall Study|Ineligible|12|||
46853014|NCT00046930|83068636|FG001|Overall Study|Ineligible|4|||
46853015|NCT00042939|83068647|FG000|Overall Study|Adverse Event|6|||
46853016|NCT00042939|83068648|FG001|Overall Study|Adverse Event|7|||
46853017|NCT00042939|83068647|FG000|Overall Study|Death|3|||
46853018|NCT00042939|83068648|FG001|Overall Study|Death|2|||
46853019|NCT00042939|83068647|FG000|Overall Study|Withdrawal by Subject|3|||
46853020|NCT00042939|83068648|FG001|Overall Study|Withdrawal by Subject|4|||
46853021|NCT00042939|83068647|FG000|Overall Study|Other disease|1|||
46853022|NCT00042939|83068648|FG001|Overall Study|Other disease|0|||
46853023|NCT00042939|83068647|FG000|Overall Study|Ineligible|2|||
46853024|NCT00042939|83068648|FG001|Overall Study|Ineligible|2|||
46853025|NCT00042939|83068647|FG000|Overall Study|Deterioration of health|3|||
46853026|NCT00042939|83068648|FG001|Overall Study|Deterioration of health|4|||
46853027|NCT00042939|83068647|FG000|Overall Study|QOL diminished|1|||
46853028|NCT00042939|83068648|FG001|Overall Study|QOL diminished|0|||
46973648|NCT01986010|83217514|FG012|Overall Study|Lost to Follow-up|1|||
46789929|NCT04093752|83008972|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
46789930|NCT04093752|83008973|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
46789931|NCT03928821|83008991|FG000|Overall Study|Death|0|||
46789932|NCT03928821|83008992|FG001|Overall Study|Death|1|||
46789933|NCT03928821|83008993|FG002|Overall Study|Death|0|||
46789934|NCT03928821|83008994|FG003|Overall Study|Death|0|||
46789935|NCT03928821|83008991|FG000|Overall Study|Lost to Follow-up|0|||
46789936|NCT03928821|83008992|FG001|Overall Study|Lost to Follow-up|2|||
46789937|NCT03928821|83008993|FG002|Overall Study|Lost to Follow-up|3|||
46789938|NCT03928821|83008994|FG003|Overall Study|Lost to Follow-up|0|||
46789939|NCT03928821|83008991|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
46789940|NCT03928821|83008992|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
46789941|NCT03928821|83008993|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
46789942|NCT03928821|83008994|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
46853029|NCT00042939|83068647|FG000|Overall Study|Rising ca 19-9|1|||
46853030|NCT00042939|83068648|FG001|Overall Study|Rising ca 19-9|0|||
46853031|NCT00042939|83068647|FG000|Overall Study|Patient non-compliance|1|||
46853032|NCT00042939|83068648|FG001|Overall Study|Patient non-compliance|0|||
46789943|NCT00666224|83009006|FG000|Double-Blind|Adverse Event|15|||
46789944|NCT00666224|83009007|FG001|Double-Blind|Adverse Event|5|||
46853033|NCT00042939|83068647|FG000|Overall Study|Still on treatment|1|||
46853034|NCT00042939|83068648|FG001|Overall Study|Still on treatment|0|||
46853035|NCT00042939|83068647|FG000|Overall Study|Treatment break > 4 weeks|0|||
46853036|NCT00042939|83068648|FG001|Overall Study|Treatment break > 4 weeks|1|||
46853037|NCT00042939|83068647|FG000|Overall Study|Did not start treatment|2|||
46853038|NCT00042939|83068648|FG001|Overall Study|Did not start treatment|1|||
46789945|NCT00666224|83009006|FG000|Double-Blind|Lost to Follow-up|2|||
46853039|NCT00008385|83068656|FG000|Overall Study|Off treatment reasons not reported|79|||
46853040|NCT00008385|83068657|FG001|Overall Study|Off treatment reasons not reported|70|||
46853041|NCT00008385|83068656|FG000|Overall Study|Progressive disease|52|||
46853042|NCT00008385|83068657|FG001|Overall Study|Progressive disease|117|||
46853043|NCT00008385|83068656|FG000|Overall Study|Adverse Event|8|||
46853044|NCT00008385|83068657|FG001|Overall Study|Adverse Event|20|||
46853045|NCT00008385|83068656|FG000|Overall Study|Death|12|||
46853046|NCT00008385|83068657|FG001|Overall Study|Death|18|||
46853047|NCT00008385|83068656|FG000|Overall Study|Withdrawal by Subject|67|||
46853048|NCT00008385|83068657|FG001|Overall Study|Withdrawal by Subject|157|||
46853049|NCT00008385|83068656|FG000|Overall Study|Start non-protocol therapy|3|||
46853050|NCT00008385|83068657|FG001|Overall Study|Start non-protocol therapy|1|||
46853051|NCT00008385|83068656|FG000|Overall Study|Other complicating disease|17|||
46853052|NCT00008385|83068657|FG001|Overall Study|Other complicating disease|30|||
46853053|NCT00008385|83068656|FG000|Overall Study|Maximum dose reached|0|||
46853054|NCT00008385|83068657|FG001|Overall Study|Maximum dose reached|2|||
46853055|NCT00008385|83068656|FG000|Overall Study|Other|105|||
46853056|NCT00008385|83068657|FG001|Overall Study|Other|212|||
46853057|NCT00008385|83068656|FG000|Overall Study|Not start protocol therapy|44|||
46853058|NCT00008385|83068657|FG001|Overall Study|Not start protocol therapy|175|||
46853059|NCT00003907|83068672|FG000|Overall Study|Adverse Event|2|||
46853060|NCT00003907|83068673|FG001|Overall Study|Adverse Event|11|||
46853061|NCT00003907|83068672|FG000|Overall Study|Death|2|||
46853062|NCT00003907|83068673|FG001|Overall Study|Death|0|||
46853063|NCT00003907|83068672|FG000|Overall Study|Withdrawal by Subject|1|||
46853064|NCT00003907|83068673|FG001|Overall Study|Withdrawal by Subject|3|||
47078001|NCT01434680|83382206|FG003|Overall Study|Lost to Follow-up|0|||
46789946|NCT00666224|83009007|FG001|Double-Blind|Lost to Follow-up|2|||
46789947|NCT00666224|83009006|FG000|Double-Blind|Withdrawal by Subject|18|||
46789948|NCT00666224|83009007|FG001|Double-Blind|Withdrawal by Subject|14|||
46789949|NCT00666224|83009006|FG000|Double-Blind|Physician Decision|0|||
46789950|NCT00666224|83009007|FG001|Double-Blind|Physician Decision|3|||
46789951|NCT00666224|83009006|FG000|Double-Blind|Sponsor decision|1|||
46789952|NCT00666224|83009007|FG001|Double-Blind|Sponsor decision|0|||
46789953|NCT00666224|83009006|FG000|Double-Blind|Pregnancy|3|||
46789954|NCT00666224|83009007|FG001|Double-Blind|Pregnancy|2|||
46789955|NCT00666224|83009006|FG000|Double-Blind|Noncompliance|1|||
46789956|NCT00666224|83009007|FG001|Double-Blind|Noncompliance|0|||
46789957|NCT00666224|83009006|FG000|Double-Blind|Death|1|||
46789958|NCT00666224|83009007|FG001|Double-Blind|Death|0|||
46789959|NCT00666224|83009006|FG000|Double-Blind|Undefined/Unknown|4|||
46789960|NCT00666224|83009007|FG001|Double-Blind|Undefined/Unknown|1|||
46789961|NCT00666224|83009006|FG000|Open-Label|Adverse Event|8|||
46789962|NCT00666224|83009007|FG001|Open-Label|Adverse Event|43|||
46789963|NCT00666224|83009006|FG000|Open-Label|Lost to Follow-up|4|||
46789964|NCT00666224|83009007|FG001|Open-Label|Lost to Follow-up|5|||
46789965|NCT00666224|83009006|FG000|Open-Label|Withdrawal by Subject|12|||
46789966|NCT00666224|83009007|FG001|Open-Label|Withdrawal by Subject|25|||
46789967|NCT00666224|83009006|FG000|Open-Label|Physician Decision|7|||
46789968|NCT00666224|83009007|FG001|Open-Label|Physician Decision|5|||
46789969|NCT00666224|83009006|FG000|Open-Label|Pregnancy|1|||
46789970|NCT00666224|83009007|FG001|Open-Label|Pregnancy|5|||
46789971|NCT00666224|83009006|FG000|Open-Label|Noncompliance|2|||
46789972|NCT00666224|83009007|FG001|Open-Label|Noncompliance|1|||
46789973|NCT00666224|83009006|FG000|Open-Label|Undefined/Unknown|1|||
46789974|NCT00666224|83009007|FG001|Open-Label|Undefined/Unknown|1|||
46789975|NCT00663962|83009016|FG000|Overall Study|somnolence|1|||
46789976|NCT00663962|83009017|FG001|Overall Study|somnolence|0|||
46789977|NCT00265759|83009029|FG000|Overall Study|Withdrawal by Subject|0|||
46789978|NCT00265759|83009030|FG001|Overall Study|Withdrawal by Subject|1|||
46853065|NCT00003907|83068672|FG000|Overall Study|Progressive disease|4|||
46853066|NCT00003907|83068673|FG001|Overall Study|Progressive disease|4|||
46853067|NCT00003907|83068672|FG000|Overall Study|Complicating disease|1|||
47078002|NCT01434680|83382203|FG000|Overall Study|Protocol Violation|1|||
47078003|NCT01434680|83382204|FG001|Overall Study|Protocol Violation|1|||
46789979|NCT00265759|83009031|FG002|Overall Study|Withdrawal by Subject|2|||
46789980|NCT00265759|83009032|FG003|Overall Study|Withdrawal by Subject|2|||
46853068|NCT00003907|83068673|FG001|Overall Study|Complicating disease|0|||
46853069|NCT00003907|83068672|FG000|Overall Study|Other|1|||
46853070|NCT00003907|83068673|FG001|Overall Study|Other|3|||
46853071|NCT00003907|83068672|FG000|Overall Study|ineligible or not treated|2|||
47078004|NCT01434680|83382205|FG002|Overall Study|Protocol Violation|0|||
46789981|NCT00265759|83009029|FG000|Overall Study|Cancel|0|||
46853072|NCT00003907|83068673|FG001|Overall Study|ineligible or not treated|2|||
46853073|NCT04241315|83068681|FG000|Overall Study|Withdrawal by Subject|0|||
46853074|NCT04241315|83068682|FG001|Overall Study|Withdrawal by Subject|1|||
46853075|NCT04225026|83068688|FG000|Overall Study|Withdrawal by Subject|4|||
46853076|NCT04225026|83068688|FG000|Overall Study|Adverse Event|1|||
46789982|NCT00265759|83009030|FG001|Overall Study|Cancel|0|||
46789983|NCT00265759|83009031|FG002|Overall Study|Cancel|0|||
46789984|NCT00265759|83009032|FG003|Overall Study|Cancel|3|||
46789985|NCT00265759|83009029|FG000|Overall Study|Ineligible|0|||
46789986|NCT00265759|83009030|FG001|Overall Study|Ineligible|0|||
46789987|NCT00265759|83009031|FG002|Overall Study|Ineligible|0|||
46789988|NCT00265759|83009032|FG003|Overall Study|Ineligible|1|||
46673736|NCT01165177|82889178|FG000|Overall Study|Withdrawal by Subject|368|||
46673737|NCT01165177|82889179|FG001|Overall Study|Withdrawal by Subject|354|||
46673738|NCT01165177|82889178|FG000|Overall Study|Protocol Violation|19|||
46673739|NCT01165177|82889179|FG001|Overall Study|Protocol Violation|21|||
46673740|NCT01165177|82889178|FG000|Overall Study|Non-serious adverse event|30|||
46673741|NCT01165177|82889179|FG001|Overall Study|Non-serious adverse event|18|||
46673742|NCT01165177|82889178|FG000|Overall Study|Other unspecified reasons|47|||
46673743|NCT01165177|82889179|FG001|Overall Study|Other unspecified reasons|35|||
46673744|NCT01165177|82889178|FG000|Overall Study|Suspected HZ episode|0|||
46673745|NCT01165177|82889179|FG001|Overall Study|Suspected HZ episode|2|||
46673746|NCT01165177|82889178|FG000|Overall Study|Lost to Follow-up|183|||
46673747|NCT01165177|82889179|FG001|Overall Study|Lost to Follow-up|194|||
46673748|NCT01165177|82889178|FG000|Overall Study|Migrated/ moved from study area|48|||
46673749|NCT01165177|82889179|FG001|Overall Study|Migrated/ moved from study area|43|||
46673750|NCT01165138|82889196|FG000|Overall Study|Adverse Event|0|||
46673751|NCT01165138|82889197|FG001|Overall Study|Adverse Event|1|||
46673752|NCT01165138|82889198|FG002|Overall Study|Adverse Event|0|||
46673753|NCT01165138|82889199|FG003|Overall Study|Adverse Event|2|||
46673754|NCT01165138|82889196|FG000|Overall Study|Lack of Efficacy|0|||
46673755|NCT01165138|82889197|FG001|Overall Study|Lack of Efficacy|32|||
46673756|NCT01165138|82889198|FG002|Overall Study|Lack of Efficacy|6|||
46673757|NCT01165138|82889199|FG003|Overall Study|Lack of Efficacy|7|||
46673758|NCT01165138|82889196|FG000|Overall Study|Protocol Violation|0|||
46673759|NCT01165138|82889197|FG001|Overall Study|Protocol Violation|7|||
46673760|NCT01165138|82889198|FG002|Overall Study|Protocol Violation|0|||
46673761|NCT01165138|82889199|FG003|Overall Study|Protocol Violation|2|||
46673762|NCT01165138|82889196|FG000|Overall Study|Lost to Follow-up|0|||
46673763|NCT01165138|82889197|FG001|Overall Study|Lost to Follow-up|0|||
46673764|NCT01165138|82889198|FG002|Overall Study|Lost to Follow-up|1|||
46673765|NCT01165138|82889199|FG003|Overall Study|Lost to Follow-up|2|||
46673766|NCT01165138|82889196|FG000|Overall Study|Physician Decision|0|||
46673767|NCT01165138|82889197|FG001|Overall Study|Physician Decision|6|||
46673768|NCT01165138|82889198|FG002|Overall Study|Physician Decision|7|||
46673769|NCT01165138|82889199|FG003|Overall Study|Physician Decision|6|||
46673770|NCT01165138|82889196|FG000|Overall Study|Withdrawal by Subject|0|||
46673771|NCT01165138|82889197|FG001|Overall Study|Withdrawal by Subject|6|||
46673772|NCT01165138|82889198|FG002|Overall Study|Withdrawal by Subject|6|||
46673773|NCT01165138|82889199|FG003|Overall Study|Withdrawal by Subject|3|||
46673774|NCT01165021|82889207|FG000|Overall Study|Death|1|||
46673775|NCT01182844|82889213|FG000|Overall Study|Withdrawal by Subject|0|||
46673776|NCT01182844|82889214|FG001|Overall Study|Withdrawal by Subject|2|||
46673777|NCT01164865|82889222|FG000|Overall Study|Lost to Follow-up|2|||
46673778|NCT01164865|82889223|FG001|Overall Study|Lost to Follow-up|1|||
46673779|NCT01164475|82889231|FG000|Overall Study|Lack of Efficacy|1|||
46673780|NCT01164475|82889232|FG001|Overall Study|Lack of Efficacy|0|||
46673781|NCT01164475|82889231|FG000|Overall Study|Other|0|||
46673782|NCT01164475|82889232|FG001|Overall Study|Other|1|||
46673783|NCT01164475|82889231|FG000|Overall Study|Progressive disease|0|||
46673784|NCT01164475|82889232|FG001|Overall Study|Progressive disease|1|||
46673785|NCT01164475|82889231|FG000|Overall Study|Protocol Violation|1|||
46673786|NCT01164475|82889232|FG001|Overall Study|Protocol Violation|0|||
46673787|NCT01164007|82889238|FG000|Overall Study|Adverse Event|5|||
46673788|NCT01164007|82889238|FG000|Overall Study|Progression of Disease|30|||
46673789|NCT01164007|82889238|FG000|Overall Study|Protocol Violation|1|||
46673790|NCT01164007|82889238|FG000|Overall Study|Withdrawal by Subject|1|||
46673791|NCT01164007|82889238|FG000|Overall Study|Medical Decision|3|||
46673792|NCT01163851|82889244|FG000|Overall Study|Site Closure|0|||
46673793|NCT01163851|82889245|FG001|Overall Study|Site Closure|1|||
46673794|NCT01163851|82889244|FG000|Overall Study|Enrolled but not treated|1|||
46673795|NCT01163851|82889245|FG001|Overall Study|Enrolled but not treated|0|||
46789989|NCT00265759|83009029|FG000|Overall Study|Bilateral disease|0|||
46789990|NCT00265759|83009030|FG001|Overall Study|Bilateral disease|0|||
46789991|NCT00265759|83009031|FG002|Overall Study|Bilateral disease|0|||
46789992|NCT00265759|83009032|FG003|Overall Study|Bilateral disease|2|||
46673796|NCT01163617|82889251|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
46673797|NCT01163617|82889252|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
46673798|NCT01163617|82889253|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
46673799|NCT01163617|82889254|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
46673800|NCT01163617|82889255|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
46673801|NCT01163617|82889256|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
46673802|NCT01163617|82889257|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
46673803|NCT01163617|82889258|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
46673804|NCT01163617|82889251|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
46673805|NCT01163617|82889252|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
46707538|NCT01155570|82923117|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
46853077|NCT04225026|83068688|FG000|Overall Study|Other|1|||
46789993|NCT00265759|83009029|FG000|Overall Study|Discontinued due to intolerability|0|||
46789994|NCT00265759|83009030|FG001|Overall Study|Discontinued due to intolerability|0|||
46789995|NCT00265759|83009031|FG002|Overall Study|Discontinued due to intolerability|0|||
46789996|NCT00265759|83009032|FG003|Overall Study|Discontinued due to intolerability|1|||
46789997|NCT00744263|83009045|FG000|Overall Study|Death|3006|||
46789998|NCT00744263|83009046|FG001|Overall Study|Death|3005|||
46789999|NCT00744263|83009045|FG000|Overall Study|Lost to Follow-up|2038|||
46790000|NCT00744263|83009046|FG001|Overall Study|Lost to Follow-up|2135|||
46790001|NCT00744263|83009045|FG000|Overall Study|Withdrawal by Subject|166|||
46790002|NCT00744263|83009046|FG001|Overall Study|Withdrawal by Subject|150|||
46790003|NCT00744263|83009045|FG000|Overall Study|Physician Decision|20|||
46853078|NCT04225026|83068688|FG000|Overall Study|Death|11|||
46853079|NCT04225026|83068688|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
46853080|NCT03493958|83069094|FG000|Overall Study|Withdrawal by Subject|6|||
46853081|NCT03493958|83069094|FG000|Overall Study|Lost to Follow-up|7|||
46853082|NCT03493958|83069094|FG000|Overall Study|Did not complete all required study procedures|2|||
46853083|NCT03486223|83069100|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
46853084|NCT03486223|83069101|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
46853085|NCT03482024|83069112|FG000|Overall Study|Physician Decision|1|||
46790004|NCT00744263|83009046|FG001|Overall Study|Physician Decision|23|||
46790005|NCT00744263|83009045|FG000|Overall Study|Protocol Violation|3|||
46790006|NCT00744263|83009046|FG001|Overall Study|Protocol Violation|5|||
46790007|NCT00744263|83009045|FG000|Overall Study|Adverse Event|1|||
46790008|NCT00744263|83009046|FG001|Overall Study|Adverse Event|0|||
46790009|NCT00744263|83009045|FG000|Overall Study|Other|2|||
46790010|NCT00744263|83009046|FG001|Overall Study|Other|2|||
46790011|NCT00618774|83009056|FG000|Overall Study|Adverse Event|5|||
46790012|NCT00618774|83009057|FG001|Overall Study|Adverse Event|3|||
46790013|NCT00618774|83009056|FG000|Overall Study|Withdrawal by Subject|1|||
46790014|NCT00618774|83009057|FG001|Overall Study|Withdrawal by Subject|0|||
46790015|NCT00545571|83009063|FG000|Overall Study|Administrative Reasons|1|||
46790016|NCT00545571|83009063|FG000|Overall Study|Adverse Event|2|||
46790017|NCT00545571|83009063|FG000|Overall Study|Death|5|||
46790018|NCT00545571|83009063|FG000|Overall Study|Lack of Efficacy|1|||
46790019|NCT00545571|83009063|FG000|Overall Study|Protocol Violation|2|||
46790020|NCT00545571|83009063|FG000|Overall Study|Refused Treatment|1|||
46790021|NCT00545571|83009063|FG000|Overall Study|Screen Failure|16|||
46790022|NCT00545571|83009063|FG000|Overall Study|Transfusion|12|||
46790023|NCT00545571|83009063|FG000|Overall Study|Early Termination of Study|24|||
46790024|NCT00545571|83009063|FG000|Overall Study|Kidney Transplantation|3|||
46790025|NCT00748709|83009067|FG000|Overall Study|Progressive disease|15|||
46790026|NCT00748709|83009067|FG000|Overall Study|Drug reducing Toxity|2|||
46790027|NCT00748709|83009067|FG000|Overall Study|Other Adverse Event|1|||
46790028|NCT00748709|83009067|FG000|Overall Study|Withdrawal by Subject|1|||
46790029|NCT00748709|83009067|FG000|Overall Study|Other Reasons|1|||
46790030|NCT00263887|83009073|FG000|Overall Study|Withdrawal by Subject|1|||
46790031|NCT00263887|83009074|FG001|Overall Study|Withdrawal by Subject|1|||
46790032|NCT00263887|83009073|FG000|Overall Study|Lung transplantation|1|||
46790033|NCT00263887|83009074|FG001|Overall Study|Lung transplantation|2|||
46790034|NCT00263887|83009073|FG000|Overall Study|Too ill to attend visit|1|||
46790035|NCT00263887|83009074|FG001|Overall Study|Too ill to attend visit|0|||
46790036|NCT00263887|83009073|FG000|Overall Study|Adverse Event|0|||
46790037|NCT00263887|83009074|FG001|Overall Study|Adverse Event|2|||
46790038|NCT00263887|83009073|FG000|Overall Study|Disease progression|0|||
46853086|NCT03482024|83069113|FG001|Overall Study|Physician Decision|0|||
46853087|NCT03482024|83069114|FG002|Overall Study|Physician Decision|0|||
46853088|NCT03482024|83069115|FG003|Overall Study|Physician Decision|0|||
46853089|NCT03482024|83069116|FG004|Overall Study|Physician Decision|0|||
46853090|NCT03468309|83069128|FG000|Overall Study|Lost to Follow-up|4|||
46853091|NCT03468309|83069128|FG000|Overall Study|Withdrawal by Subject|2|||
46853092|NCT03423147|83069134|FG000|Overall Study|Lost to Follow-up|5|||
46853093|NCT03423147|83069135|FG001|Overall Study|Lost to Follow-up|8|||
46853094|NCT03423147|83069134|FG000|Overall Study|Withdrawal by Subject|1|||
46853095|NCT03423147|83069135|FG001|Overall Study|Withdrawal by Subject|0|||
46853096|NCT03423147|83069134|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
46853097|NCT03423147|83069135|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
46853098|NCT03423147|83069134|FG000|Overall Study|Age < 18|1|||
46853099|NCT03423147|83069135|FG001|Overall Study|Age < 18|0|||
46790039|NCT00263887|83009074|FG001|Overall Study|Disease progression|1|||
46790040|NCT00263887|83009073|FG000|Overall Study|Lack of Efficacy|0|||
46853100|NCT03423147|83069134|FG000|Overall Study|No Trial of Labor|0|||
47078005|NCT01434680|83382206|FG003|Overall Study|Protocol Violation|0|||
46790041|NCT00263887|83009074|FG001|Overall Study|Lack of Efficacy|1|||
46790042|NCT00748553|83009082|FG000|Overall Study|Adverse Event|0|||
46790043|NCT00748553|83009083|FG001|Overall Study|Adverse Event|1|||
46853101|NCT03423147|83069135|FG001|Overall Study|No Trial of Labor|1|||
46853102|NCT03322631|83069145|FG000|Overall Study|Withdrawal by Subject|0|||
46853103|NCT03322631|83069146|FG001|Overall Study|Withdrawal by Subject|1|||
46853104|NCT03322631|83069147|FG002|Overall Study|Withdrawal by Subject|0|||
46790044|NCT00748553|83009082|FG000|Overall Study|disease progression|2|||
46790045|NCT00748553|83009083|FG001|Overall Study|disease progression|0|||
46790046|NCT00748553|83009082|FG000|Overall Study|noncompliance|1|||
46790047|NCT00748553|83009083|FG001|Overall Study|noncompliance|0|||
46790048|NCT00661388|83009088|FG000|Overall Study|Adverse Event|14|||
46853105|NCT03322631|83069148|FG003|Overall Study|Withdrawal by Subject|0|||
46853106|NCT03322631|83069145|FG000|Overall Study|Adverse Event|0|||
46853107|NCT03322631|83069146|FG001|Overall Study|Adverse Event|0|||
46853108|NCT03322631|83069147|FG002|Overall Study|Adverse Event|1|||
46853109|NCT03322631|83069148|FG003|Overall Study|Adverse Event|0|||
46853110|NCT03018704|83069167|FG000|Overall Study|Lost to Follow-up|1|||
46853111|NCT03018704|83069168|FG001|Overall Study|Lost to Follow-up|1|||
46853112|NCT02663349|83069174|FG000|Overall Study|Withdrawal by Subject|6|||
46853113|NCT02558491|83069178|FG000|First Invention|Withdrawal by Subject|3|||
46853114|NCT02558491|83069179|FG001|First Invention|Withdrawal by Subject|1|||
46853115|NCT02558491|83069178|FG000|First Invention|Data collection issues|1|||
46853116|NCT02558491|83069179|FG001|First Invention|Data collection issues|0|||
46853117|NCT02558491|83069178|FG000|First Invention|Stopping criteria|0|||
46853118|NCT02558491|83069179|FG001|First Invention|Stopping criteria|1|||
46853119|NCT02558491|83069178|FG000|First Invention|Changed parameters during trial|1|||
46853120|NCT02558491|83069179|FG001|First Invention|Changed parameters during trial|0|||
46853121|NCT02558491|83069178|FG000|Second Intervention|Withdrawal by Subject|1|||
46853122|NCT02558491|83069179|FG001|Second Intervention|Withdrawal by Subject|0|||
46853123|NCT02558491|83069178|FG000|Second Intervention|Stopping Criteria|1|||
46853124|NCT02558491|83069179|FG001|Second Intervention|Stopping Criteria|0|||
46853125|NCT02490878|83069188|FG000|Overall Study|deemed ineligible|0|||
46853126|NCT02490878|83069189|FG001|Overall Study|deemed ineligible|1|||
46853127|NCT02490878|83069188|FG000|Overall Study|progression prior to treatment|0|||
46853128|NCT02490878|83069189|FG001|Overall Study|progression prior to treatment|1|||
46853129|NCT02490878|83069188|FG000|Overall Study|only submitted baseline QOL|0|||
46853130|NCT02490878|83069189|FG001|Overall Study|only submitted baseline QOL|1|||
46853131|NCT02421601|83069195|FG000|Overall Study|Adverse Event|4|||
46853132|NCT02421601|83069195|FG000|Overall Study|Lack of Efficacy|5|||
46853133|NCT02421601|83069195|FG000|Overall Study|Physician Decision|1|||
46853134|NCT02421601|83069195|FG000|Overall Study|Withdrawal by Subject|31|||
46853135|NCT02421601|83069195|FG000|Overall Study|Others|41|||
46853136|NCT01934218|83069201|FG000|Double-blind Phase|Adverse Event|8|||
46853137|NCT01934218|83069202|FG001|Double-blind Phase|Adverse Event|8|||
46853138|NCT01934218|83069201|FG000|Double-blind Phase|Lack of Efficacy|6|||
46853139|NCT01934218|83069202|FG001|Double-blind Phase|Lack of Efficacy|7|||
46853140|NCT01934218|83069201|FG000|Double-blind Phase|Lost to Follow-up|7|||
46853141|NCT01934218|83069202|FG001|Double-blind Phase|Lost to Follow-up|14|||
46853142|NCT01934218|83069201|FG000|Double-blind Phase|Physician Decision|1|||
46853143|NCT01934218|83069202|FG001|Double-blind Phase|Physician Decision|2|||
46853144|NCT01934218|83069201|FG000|Double-blind Phase|Protocol Violation|4|||
46853145|NCT01934218|83069202|FG001|Double-blind Phase|Protocol Violation|0|||
46853146|NCT01934218|83069201|FG000|Double-blind Phase|Withdrawal by Subject|16|||
46853147|NCT01934218|83069202|FG001|Double-blind Phase|Withdrawal by Subject|13|||
46853148|NCT01934218|83069201|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
46790049|NCT00661388|83009088|FG000|Overall Study|Protocol Violation|7|||
46790050|NCT00661388|83009088|FG000|Overall Study|Renal transplantation|1|||
46790051|NCT00661388|83009088|FG000|Overall Study|Dialysis initiation|1|||
46790052|NCT00661388|83009088|FG000|Overall Study|Administrative reasons|1|||
46790053|NCT00743483|83009092|FG000|Baseline Period|Physician Decision|1|||
46790054|NCT00743483|83009092|FG000|Treatment Period|Adverse Event|1|||
46790055|NCT00263575|83009096|FG000|Titration Period|Adverse Event|14|||
46790056|NCT00263575|83009096|FG000|Titration Period|Withdrawal by Subject|10|||
46790057|NCT00263575|83009096|FG000|Titration Period|Protocol Violation|9|||
46790058|NCT00263575|83009096|FG000|Titration Period|Sponsor Decision|2|||
46790059|NCT00263575|83009096|FG000|Titration Period|Other|2|||
46790060|NCT00263575|83009096|FG000|Titration Period|Lack of Efficacy|6|||
46790061|NCT00263575|83009096|FG000|Maintence Period|Adverse Event|23|||
46790062|NCT00263575|83009096|FG000|Maintence Period|Withdrawal by Subject|8|||
46790063|NCT00263575|83009096|FG000|Maintence Period|Protocol Violation|4|||
46790064|NCT00263575|83009096|FG000|Maintence Period|Lack of Efficacy|4|||
46790065|NCT00263575|83009096|FG000|Maintence Period|Physician Decision|6|||
46790066|NCT00263575|83009096|FG000|Maintence Period|Lost to Follow-up|1|||
46853149|NCT01934218|83069202|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
46853150|NCT01934218|83069201|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
46853151|NCT01934218|83069202|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
46853152|NCT01934218|83069201|FG000|Open-Label Phase|Adverse Event|2|||
46790067|NCT00263575|83009096|FG000|Maintence Period|Sponsor Decision|24|||
46790068|NCT00263575|83009096|FG000|Maintence Period|Other|7|||
46790069|NCT00748241|83009102|FG000|Overall Study|Implant failure|1|||
46853153|NCT01934218|83069202|FG001|Open-Label Phase|Adverse Event|4|||
46790070|NCT00748241|83009102|FG000|Overall Study|Lost to Follow-up|5|||
46790071|NCT00748241|83009102|FG000|Overall Study|Death|2|||
46790072|NCT00570128|83009108|FG000|Overall Study|Adverse Event|1|||
46790073|NCT00570128|83009109|FG001|Overall Study|Adverse Event|0|||
46790074|NCT00570128|83009108|FG000|Overall Study|Lost to Follow-up|1|||
46790075|NCT00570128|83009109|FG001|Overall Study|Lost to Follow-up|0|||
46790076|NCT00570128|83009108|FG000|Overall Study|Withdrawal by Subject|2|||
46790077|NCT00570128|83009109|FG001|Overall Study|Withdrawal by Subject|0|||
46790078|NCT00743249|83009117|FG000|Overall Study|Adverse Event|0|||
46790079|NCT00743249|83009118|FG001|Overall Study|Adverse Event|4|||
46790080|NCT00743249|83009117|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
46790081|NCT00743249|83009118|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
46790082|NCT00743249|83009117|FG000|Overall Study|Unsuccessful insertion of stent|2|||
46790083|NCT00743249|83009118|FG001|Overall Study|Unsuccessful insertion of stent|1|||
46790084|NCT00262951|83009124|FG000|Overall Study|Progressive disease/relapse|3|||
46790085|NCT00262951|83009124|FG000|Overall Study|Adverse Event|7|||
46790086|NCT00262951|83009124|FG000|Overall Study|Death|1|||
46790087|NCT00262951|83009124|FG000|Overall Study|Withdrawal by Subject|1|||
46790088|NCT00262951|83009124|FG000|Overall Study|Alternative treatment|3|||
46790089|NCT00262951|83009124|FG000|Overall Study|Off treatment for other disease|1|||
46790090|NCT00262873|83009128|FG000|Overall Study|Adverse Event|3|||
46790091|NCT00262873|83009128|FG000|Overall Study|Withdrawal by Subject|5|||
46790092|NCT00573534|83009132|FG000|Overall Study|oppositional behavior|3|||
46790093|NCT00260533|83009139|FG000|Overall Study|Other|3|||
46790094|NCT00260533|83009140|FG001|Overall Study|Other|3|||
46790095|NCT03945981|83009146|FG000|Overall Study|Lost to Follow-up|12|||
46790096|NCT03945981|83009146|FG000|Overall Study|Physician Decision|4|||
46790097|NCT03945981|83009146|FG000|Overall Study|Withdrawal by Subject|6|||
46790098|NCT03945981|83009146|FG000|Overall Study|Protocol Violation|1|||
46790099|NCT00745901|83009173|FG000|Overall Study|Adverse Event|3|||
46790100|NCT00745901|83009174|FG001|Overall Study|Adverse Event|4|||
46790101|NCT00745901|83009173|FG000|Overall Study|Protocol Violation|0|||
46790102|NCT00745901|83009174|FG001|Overall Study|Protocol Violation|1|||
46790103|NCT00745901|83009173|FG000|Overall Study|Withdrawal by Subject|1|||
46790104|NCT00745901|83009174|FG001|Overall Study|Withdrawal by Subject|0|||
46790105|NCT00745901|83009173|FG000|Overall Study|Lost to Follow-up|7|||
46790106|NCT00745901|83009174|FG001|Overall Study|Lost to Follow-up|4|||
46790107|NCT00745901|83009173|FG000|Overall Study|Pregnancy|2|||
46790108|NCT00745901|83009174|FG001|Overall Study|Pregnancy|4|||
46790109|NCT00745901|83009173|FG000|Overall Study|Lack of compliance|2|||
46790110|NCT00745901|83009174|FG001|Overall Study|Lack of compliance|2|||
46790111|NCT00745901|83009173|FG000|Overall Study|Patient's next menses did not start with|1|||
46790112|NCT00745901|83009174|FG001|Overall Study|Patient's next menses did not start with|0|||
46790113|NCT00745901|83009173|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
46790114|NCT00745901|83009174|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
46790115|NCT00745901|83009173|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
46790116|NCT00745901|83009174|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
46790117|NCT00745901|83009173|FG000|Overall Study|Patient didn't take any study medication|7|||
46790118|NCT00745901|83009174|FG001|Overall Study|Patient didn't take any study medication|3|||
46790119|NCT00286429|83009183|FG000|Overall Study|Adverse Event|4|||
46790120|NCT00286429|83009184|FG001|Overall Study|Adverse Event|1|||
46790121|NCT00286429|83009185|FG002|Overall Study|Adverse Event|6|||
46790122|NCT00286429|83009183|FG000|Overall Study|Lack of Efficacy|52|||
46790123|NCT00286429|83009184|FG001|Overall Study|Lack of Efficacy|27|||
46790124|NCT00286429|83009185|FG002|Overall Study|Lack of Efficacy|25|||
46790125|NCT00286429|83009183|FG000|Overall Study|Lost to Follow-up|2|||
46790126|NCT00286429|83009184|FG001|Overall Study|Lost to Follow-up|4|||
46790127|NCT00286429|83009185|FG002|Overall Study|Lost to Follow-up|3|||
46790128|NCT00286429|83009183|FG000|Overall Study|Physician Decision|10|||
46790129|NCT00286429|83009184|FG001|Overall Study|Physician Decision|7|||
46790130|NCT00286429|83009185|FG002|Overall Study|Physician Decision|7|||
46790131|NCT00286429|83009183|FG000|Overall Study|Protocol Violation|3|||
47078006|NCT01433978|83382339|FG000|Core Study|Adverse Event, Non-Fatal|0|||
46790132|NCT00286429|83009184|FG001|Overall Study|Protocol Violation|5|||
46790133|NCT00286429|83009185|FG002|Overall Study|Protocol Violation|4|||
46790134|NCT00286429|83009183|FG000|Overall Study|Withdrawal by Subject|3|||
46790135|NCT00286429|83009184|FG001|Overall Study|Withdrawal by Subject|2|||
47078007|NCT01433978|83382340|FG001|Core Study|Adverse Event, Non-Fatal|1|||
47078008|NCT01433978|83382341|FG002|Core Study|Adverse Event, Non-Fatal|0|||
47078009|NCT01433978|83382339|FG000|Core Study|Lack of Efficacy|5|||
47078010|NCT01433978|83382340|FG001|Core Study|Lack of Efficacy|1|||
47078011|NCT01433978|83382341|FG002|Core Study|Lack of Efficacy|0|||
46790136|NCT00286429|83009185|FG002|Overall Study|Withdrawal by Subject|6|||
46790137|NCT00286429|83009183|FG000|Overall Study|Administrative Error|1|||
46790138|NCT00286429|83009184|FG001|Overall Study|Administrative Error|1|||
46790139|NCT00286429|83009185|FG002|Overall Study|Administrative Error|1|||
46790140|NCT00286429|83009183|FG000|Overall Study|Administrative Decision|0|||
46790141|NCT00286429|83009184|FG001|Overall Study|Administrative Decision|1|||
46790142|NCT00286429|83009185|FG002|Overall Study|Administrative Decision|0|||
46790143|NCT00665444|83009193|FG000|Overall Study|Physician Decision|1|||
46790144|NCT00665444|83009193|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
46790145|NCT03926169|83009200|FG000|Period A|Adverse Event|2|||
46790146|NCT03926169|83009201|FG001|Period A|Adverse Event|2|||
46790147|NCT03926169|83009202|FG002|Period A|Adverse Event|1|||
46790148|NCT03926169|83009200|FG000|Period A|Withdrawal by Subject|2|||
46790149|NCT03926169|83009201|FG001|Period A|Withdrawal by Subject|2|||
46790150|NCT03926169|83009202|FG002|Period A|Withdrawal by Subject|2|||
46790151|NCT03926169|83009200|FG000|Period A|Lost to Follow-up|3|||
46790152|NCT03926169|83009201|FG001|Period A|Lost to Follow-up|1|||
46790153|NCT03926169|83009202|FG002|Period A|Lost to Follow-up|0|||
46790154|NCT03926169|83009200|FG000|Period A|Lack of Efficacy|0|||
46790155|NCT03926169|83009201|FG001|Period A|Lack of Efficacy|2|||
46853154|NCT01934218|83069201|FG000|Open-Label Phase|Lack of Efficacy|1|||
46853155|NCT01934218|83069202|FG001|Open-Label Phase|Lack of Efficacy|4|||
46853156|NCT01934218|83069201|FG000|Open-Label Phase|Lost to Follow-up|4|||
46853157|NCT01934218|83069202|FG001|Open-Label Phase|Lost to Follow-up|2|||
46853158|NCT01934218|83069201|FG000|Open-Label Phase|Physician Decision|1|||
46853159|NCT01934218|83069202|FG001|Open-Label Phase|Physician Decision|0|||
46790156|NCT03926169|83009202|FG002|Period A|Lack of Efficacy|2|||
46790157|NCT03926169|83009200|FG000|Period A|COVID-19 Infection|0|||
46790158|NCT03926169|83009201|FG001|Period A|COVID-19 Infection|1|||
46790159|NCT03926169|83009202|FG002|Period A|COVID-19 Infection|0|||
46790160|NCT03926169|83009200|FG000|Period A|COVID-19 Logistical Restrictions|0|||
46790161|NCT03926169|83009201|FG001|Period A|COVID-19 Logistical Restrictions|2|||
46790162|NCT03926169|83009202|FG002|Period A|COVID-19 Logistical Restrictions|1|||
46790163|NCT03926169|83009200|FG000|Period A|Other, Not Specified|1|||
46790164|NCT03926169|83009201|FG001|Period A|Other, Not Specified|0|||
46790165|NCT03926169|83009202|FG002|Period A|Other, Not Specified|0|||
46790166|NCT03926169|83009200|FG000|Period B|Adverse Event|3|||
46790167|NCT03926169|83009201|FG001|Period B|Adverse Event|1|||
46790168|NCT03926169|83009202|FG002|Period B|Adverse Event|1|||
46853160|NCT01934218|83069201|FG000|Open-Label Phase|Protocol Violation|1|||
46853161|NCT01934218|83069202|FG001|Open-Label Phase|Protocol Violation|0|||
46853162|NCT01934218|83069201|FG000|Open-Label Phase|Withdrawal by Subject|13|||
46853163|NCT01934218|83069202|FG001|Open-Label Phase|Withdrawal by Subject|11|||
46853164|NCT01934218|83069201|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
46853165|NCT01934218|83069202|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
46973649|NCT01986010|83217515|FG013|Overall Study|Lost to Follow-up|1|||
46973650|NCT01986010|83217516|FG014|Overall Study|Lost to Follow-up|2|||
47078012|NCT01433978|83382339|FG000|Core Study|Study Terminated by Sponsor|6|||
47078013|NCT01433978|83382340|FG001|Core Study|Study Terminated by Sponsor|9|||
46790169|NCT03926169|83009200|FG000|Period B|Withdrawal by Subject|1|||
46790170|NCT03926169|83009201|FG001|Period B|Withdrawal by Subject|3|||
46790171|NCT03926169|83009202|FG002|Period B|Withdrawal by Subject|0|||
46790172|NCT03926169|83009200|FG000|Period B|Lack of Efficacy|3|||
46790173|NCT03926169|83009201|FG001|Period B|Lack of Efficacy|1|||
46790174|NCT03926169|83009202|FG002|Period B|Lack of Efficacy|1|||
46790175|NCT03926169|83009200|FG000|Period B|Lost to Follow-up|1|||
46790176|NCT03926169|83009201|FG001|Period B|Lost to Follow-up|1|||
46790177|NCT03926169|83009202|FG002|Period B|Lost to Follow-up|4|||
46790178|NCT03926169|83009200|FG000|Period B|Other, Not Specified|62|||
46790179|NCT03926169|83009201|FG001|Period B|Other, Not Specified|57|||
46790180|NCT03926169|83009202|FG002|Period B|Other, Not Specified|65|||
46790181|NCT00285649|83009216|FG000|Overall Study|Lost to Follow-up|6|||
46790182|NCT00285649|83009217|FG001|Overall Study|Lost to Follow-up|4|||
46790183|NCT00285649|83009218|FG002|Overall Study|Lost to Follow-up|4|||
47078014|NCT01433978|83382341|FG002|Core Study|Study Terminated by Sponsor|0|||
46790184|NCT00285649|83009216|FG000|Overall Study|Withdrawal by Subject|3|||
46790185|NCT00285649|83009217|FG001|Overall Study|Withdrawal by Subject|2|||
46790186|NCT00285649|83009218|FG002|Overall Study|Withdrawal by Subject|2|||
46790187|NCT00745823|83009228|FG000|Overall Study|Adverse Event|5|||
46790188|NCT00745823|83009229|FG001|Overall Study|Adverse Event|3|||
46790189|NCT00745823|83009228|FG000|Overall Study|Lack of Efficacy|20|||
46790190|NCT00745823|83009229|FG001|Overall Study|Lack of Efficacy|6|||
46790191|NCT00745823|83009228|FG000|Overall Study|Lost to Follow-up|10|||
46790192|NCT00745823|83009229|FG001|Overall Study|Lost to Follow-up|11|||
46790193|NCT00745823|83009228|FG000|Overall Study|Physician Decision|10|||
46853166|NCT01934218|83069201|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
46853167|NCT01934218|83069202|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
46853168|NCT00097370|83069212|FG000|Stage 1|Adverse Event|3|||
47078015|NCT01433978|83382339|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
46790194|NCT00745823|83009229|FG001|Overall Study|Physician Decision|5|||
46790195|NCT00745823|83009228|FG000|Overall Study|Pregnancy|0|||
46790196|NCT00745823|83009229|FG001|Overall Study|Pregnancy|4|||
46790197|NCT00745823|83009228|FG000|Overall Study|Withdrawal by Subject|14|||
46790198|NCT00745823|83009229|FG001|Overall Study|Withdrawal by Subject|8|||
46790199|NCT00745823|83009228|FG000|Overall Study|Study Terminated by Sponsor|326|||
46790200|NCT00745823|83009229|FG001|Overall Study|Study Terminated by Sponsor|349|||
46790201|NCT00663260|83009240|FG000|Overall Study|Lack of Efficacy|2|||
46790202|NCT00663260|83009241|FG001|Overall Study|Lack of Efficacy|0|||
46790203|NCT00663260|83009242|FG002|Overall Study|Lack of Efficacy|0|||
46790204|NCT00663260|83009240|FG000|Overall Study|Adverse Event|12|||
46790205|NCT00663260|83009241|FG001|Overall Study|Adverse Event|7|||
46790206|NCT00663260|83009242|FG002|Overall Study|Adverse Event|6|||
46790207|NCT00663260|83009240|FG000|Overall Study|Withdrawal by Subject|3|||
46790208|NCT00663260|83009241|FG001|Overall Study|Withdrawal by Subject|1|||
46790209|NCT00663260|83009242|FG002|Overall Study|Withdrawal by Subject|6|||
46790210|NCT00663260|83009240|FG000|Overall Study|Death|1|||
46790211|NCT00663260|83009241|FG001|Overall Study|Death|0|||
46790212|NCT00663260|83009242|FG002|Overall Study|Death|1|||
46790213|NCT00663260|83009240|FG000|Overall Study|Lost to Follow-up|0|||
46790214|NCT00663260|83009241|FG001|Overall Study|Lost to Follow-up|1|||
46790215|NCT00663260|83009242|FG002|Overall Study|Lost to Follow-up|0|||
46790216|NCT00663260|83009240|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
46790217|NCT00663260|83009241|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
46790218|NCT00663260|83009242|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
46853169|NCT00097370|83069212|FG000|Stage 1|Withdrawal by Subject|1|||
46853170|NCT00097370|83069212|FG000|Stage 1|Lack of Efficacy|2|||
46853171|NCT00097370|83069212|FG000|Stage 2|Adverse Event|5|||
46853172|NCT00097370|83069212|FG000|Stage 2|Withdrawal by Subject|1|||
46853173|NCT00097370|83069212|FG000|Stage 2|Lack of Efficacy|3|||
46853174|NCT00097370|83069212|FG000|Stage 2|Pregnancy|1|||
46853175|NCT00097370|83069212|FG000|Stage 2|Sponsor Terminated Study|2|||
46853176|NCT00097370|83069212|FG000|Stage 2|Lost to Follow-up|1|||
46853177|NCT00097370|83069212|FG000|Stage 3|Adverse Event|2|||
46853178|NCT00097370|83069212|FG000|Stage 3|Withdrawal by Subject|3|||
46853179|NCT00097370|83069212|FG000|Stage 3|Lack of Efficacy|1|||
46853180|NCT00097370|83069212|FG000|Stage 3|Sponsor Terminated Study|52|||
46853181|NCT00097370|83069212|FG000|Stage 3|Lost to Follow-up|1|||
46853182|NCT03515824|83069219|FG000|Overall Study|Death|3|||
46853183|NCT03515824|83069220|FG001|Overall Study|Death|2|||
46853184|NCT03515824|83069221|FG002|Overall Study|Death|6|||
46853185|NCT03515824|83069222|FG003|Overall Study|Death|0|||
46853186|NCT03515824|83069219|FG000|Overall Study|Lost to Follow-up|0|||
46853187|NCT03515824|83069220|FG001|Overall Study|Lost to Follow-up|1|||
46853188|NCT03515824|83069221|FG002|Overall Study|Lost to Follow-up|1|||
46853189|NCT03515824|83069222|FG003|Overall Study|Lost to Follow-up|0|||
46853190|NCT03515824|83069219|FG000|Overall Study|Study terminated by sponsor|0|||
46853191|NCT03515824|83069220|FG001|Overall Study|Study terminated by sponsor|1|||
46853192|NCT03515824|83069221|FG002|Overall Study|Study terminated by sponsor|6|||
46853193|NCT03515824|83069222|FG003|Overall Study|Study terminated by sponsor|0|||
46853194|NCT03515824|83069219|FG000|Overall Study|Status not recorded|0|||
46853195|NCT03515824|83069220|FG001|Overall Study|Status not recorded|0|||
46853196|NCT03515824|83069221|FG002|Overall Study|Status not recorded|2|||
46853197|NCT03515824|83069222|FG003|Overall Study|Status not recorded|0|||
46853198|NCT01089374|83069232|FG000|Overall Study|Lost to Follow-up|3|||
46853199|NCT01089374|83069233|FG001|Overall Study|Lost to Follow-up|0|||
46853200|NCT01089374|83069232|FG000|Overall Study|Withdrawal by Subject|1|||
46973651|NCT01986010|83217517|FG015|Overall Study|Lost to Follow-up|0|||
46673806|NCT01163617|82889253|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
46790219|NCT00740597|83009250|FG000|Overall Study|insurance would not cover treatment|1|||
46853201|NCT01089374|83069233|FG001|Overall Study|Withdrawal by Subject|0|||
46853202|NCT01089374|83069232|FG000|Overall Study|Study closed early - low accrual|6|||
46853203|NCT01089374|83069233|FG001|Overall Study|Study closed early - low accrual|0|||
46853204|NCT03511378|83069240|FG000|Overall Study|Withdrawal by Subject|2|||
46853205|NCT03511378|83069241|FG001|Overall Study|Withdrawal by Subject|2|||
46853206|NCT03511378|83069240|FG000|Overall Study|Patient not coming or schedule visit|1|||
46853207|NCT03511378|83069241|FG001|Overall Study|Patient not coming or schedule visit|0|||
46853208|NCT03511066|83069250|FG000|Overall Study|Withdrawal by Subject|1|||
46853209|NCT03511066|83069251|FG001|Overall Study|Withdrawal by Subject|2|||
46853210|NCT03511066|83069252|FG002|Overall Study|Withdrawal by Subject|3|||
46853211|NCT03511066|83069250|FG000|Overall Study|Lost to Follow-up|2|||
46853212|NCT03511066|83069251|FG001|Overall Study|Lost to Follow-up|3|||
46853213|NCT03511066|83069252|FG002|Overall Study|Lost to Follow-up|0|||
46853214|NCT03510910|83069262|FG000|Overall Study|Incomplete Survey|2|||
46853215|NCT03510910|83069263|FG001|Overall Study|Incomplete Survey|3|||
46853216|NCT03509350|83069271|FG000|Overall Study|Withdrawal by Subject|0|||
46853217|NCT03509350|83069272|FG001|Overall Study|Withdrawal by Subject|2|||
46973652|NCT01986010|83217518|FG016|Overall Study|Lost to Follow-up|0|||
46790220|NCT00284089|83009258|FG000|Multiple Dose Phase|Adverse Event|1|||
46790221|NCT00284089|83009259|FG001|Multiple Dose Phase|Adverse Event|0|||
46790222|NCT00284089|83009260|FG002|Multiple Dose Phase|Adverse Event|1|||
46790223|NCT00284089|83009261|FG003|Multiple Dose Phase|Adverse Event|1|||
46853218|NCT03478696|83069280|FG000|Overall Study|Adverse Event|1|||
46853219|NCT03478696|83069281|FG001|Overall Study|Adverse Event|5|||
46790224|NCT00284089|83009258|FG000|Multiple Dose Phase|Protocol Violation|0|||
46790225|NCT00284089|83009259|FG001|Multiple Dose Phase|Protocol Violation|0|||
46790226|NCT00284089|83009260|FG002|Multiple Dose Phase|Protocol Violation|1|||
46790227|NCT00284089|83009261|FG003|Multiple Dose Phase|Protocol Violation|0|||
46790228|NCT00284089|83009258|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
46790229|NCT00284089|83009259|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
46790230|NCT00284089|83009260|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
46790231|NCT00284089|83009261|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
46790232|NCT00284089|83009258|FG000|Multiple Dose Phase|Death|0|||
46790233|NCT00284089|83009259|FG001|Multiple Dose Phase|Death|0|||
46790234|NCT00284089|83009260|FG002|Multiple Dose Phase|Death|1|||
46790235|NCT00284089|83009261|FG003|Multiple Dose Phase|Death|1|||
46790236|NCT00284089|83009258|FG000|Extension Phase|Adverse Event|0|||
46790237|NCT00284089|83009259|FG001|Extension Phase|Adverse Event|0|||
46790238|NCT00284089|83009260|FG002|Extension Phase|Adverse Event|2|||
46790239|NCT00284089|83009261|FG003|Extension Phase|Adverse Event|2|||
46790240|NCT00284089|83009258|FG000|Extension Phase|condition no longer requires study drug|2|||
46790241|NCT00284089|83009259|FG001|Extension Phase|condition no longer requires study drug|0|||
46790242|NCT00284089|83009260|FG002|Extension Phase|condition no longer requires study drug|2|||
46790243|NCT00284089|83009261|FG003|Extension Phase|condition no longer requires study drug|7|||
46790244|NCT00284089|83009258|FG000|Extension Phase|Protocol Violation|0|||
46790245|NCT00284089|83009259|FG001|Extension Phase|Protocol Violation|0|||
46790246|NCT00284089|83009260|FG002|Extension Phase|Protocol Violation|1|||
46673807|NCT01163617|82889254|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
46673808|NCT01163617|82889255|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
46673809|NCT01163617|82889256|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
46673810|NCT01163617|82889257|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
46790247|NCT00284089|83009261|FG003|Extension Phase|Protocol Violation|0|||
46790248|NCT00284089|83009258|FG000|Extension Phase|Withdrawal by Subject|0|||
46790249|NCT00284089|83009259|FG001|Extension Phase|Withdrawal by Subject|0|||
46790250|NCT00284089|83009260|FG002|Extension Phase|Withdrawal by Subject|1|||
46790251|NCT00284089|83009261|FG003|Extension Phase|Withdrawal by Subject|3|||
46790252|NCT00659984|83009271|FG000|Overall Study|Adverse Event|1|||
46790253|NCT00283387|83009285|FG000|First Intervention|Subject non-compliant|1|||
46790254|NCT00283387|83009286|FG001|First Intervention|Subject non-compliant|1|||
46790255|NCT00283387|83009285|FG000|First Intervention|Withdrawal by Subject|0|||
46790256|NCT00283387|83009286|FG001|First Intervention|Withdrawal by Subject|1|||
46790257|NCT00282919|83009292|FG000|Overall Study|Lack of Efficacy|4|||
46790258|NCT00282919|83009292|FG000|Overall Study|Withdrawal by Subject|1|||
46790259|NCT00282919|83009292|FG000|Overall Study|Asymptomatic Parasitemia|2|||
46790260|NCT00282295|83009299|FG000|Overall Study|Adverse Event|0|||
46790261|NCT00282295|83009300|FG001|Overall Study|Adverse Event|1|||
46790262|NCT00282295|83009301|FG002|Overall Study|Adverse Event|0|||
46790263|NCT00282295|83009299|FG000|Overall Study|Serious Adverse Events|0|||
46790264|NCT00282295|83009300|FG001|Overall Study|Serious Adverse Events|0|||
46790265|NCT00282295|83009301|FG002|Overall Study|Serious Adverse Events|1|||
46790266|NCT00282295|83009299|FG000|Overall Study|Protocol Violation|0|||
46790267|NCT00282295|83009300|FG001|Overall Study|Protocol Violation|2|||
46790268|NCT00282295|83009301|FG002|Overall Study|Protocol Violation|1|||
46790269|NCT00282295|83009299|FG000|Overall Study|Withdrawal by Subject|2|||
46790270|NCT00282295|83009300|FG001|Overall Study|Withdrawal by Subject|6|||
46790271|NCT00282295|83009301|FG002|Overall Study|Withdrawal by Subject|4|||
46790272|NCT00282295|83009299|FG000|Overall Study|Lost to Follow-up|1|||
46790273|NCT00282295|83009300|FG001|Overall Study|Lost to Follow-up|7|||
46790274|NCT00282295|83009301|FG002|Overall Study|Lost to Follow-up|2|||
46790275|NCT00282295|83009299|FG000|Overall Study|Other|0|||
46790276|NCT00282295|83009300|FG001|Overall Study|Other|1|||
46790277|NCT00282295|83009301|FG002|Overall Study|Other|0|||
46790278|NCT00742781|83009314|FG000|Overall Study|Withdrawal by Subject|3|||
46853220|NCT03478696|83069280|FG000|Overall Study|Lost to Follow-up|1|||
46673811|NCT01163617|82889258|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
46673812|NCT01163617|82889251|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
46790279|NCT00663026|83009322|FG000|Overall Study|Lost to Follow-up|1|||
46790280|NCT00663026|83009323|FG001|Overall Study|Lost to Follow-up|0|||
46790281|NCT00663026|83009324|FG002|Overall Study|Lost to Follow-up|0|||
46790282|NCT00663026|83009322|FG000|Overall Study|Other|1|||
46790283|NCT00663026|83009323|FG001|Overall Study|Other|2|||
46790284|NCT00663026|83009324|FG002|Overall Study|Other|0|||
46790285|NCT00663026|83009322|FG000|Overall Study|Adverse Event|0|||
46790286|NCT00663026|83009323|FG001|Overall Study|Adverse Event|2|||
46790287|NCT00663026|83009324|FG002|Overall Study|Adverse Event|3|||
46790288|NCT00663026|83009322|FG000|Overall Study|Caregiver Request|0|||
46790289|NCT00663026|83009323|FG001|Overall Study|Caregiver Request|2|||
46790290|NCT00663026|83009324|FG002|Overall Study|Caregiver Request|0|||
46790291|NCT00663026|83009322|FG000|Overall Study|Withdrawal by Subject|0|||
46790292|NCT00663026|83009323|FG001|Overall Study|Withdrawal by Subject|0|||
46790293|NCT00663026|83009324|FG002|Overall Study|Withdrawal by Subject|1|||
46790294|NCT00280735|83009334|FG000|Overall Study|Adverse Event|5|||
46790295|NCT00280735|83009334|FG000|Overall Study|Lack of Efficacy|3|||
46790296|NCT00280735|83009334|FG000|Overall Study|Withdrawal by Subject|8|||
46790297|NCT00280735|83009334|FG000|Overall Study|Intercurrent Illness|2|||
46673813|NCT01163617|82889252|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
46673814|NCT01163617|82889253|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
46673815|NCT01163617|82889254|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
46673816|NCT01163617|82889255|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
46673817|NCT01163617|82889256|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
46673818|NCT01163617|82889257|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
46673819|NCT01163617|82889258|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
46673820|NCT01182337|82889280|FG000|Overall Study|Withdrawal by Subject|3|||
46790298|NCT00260065|83009342|FG000|Overall Study|Progressive Disease|22|||
46790299|NCT00260065|83009342|FG000|Overall Study|Adverse Event|17|||
46790300|NCT00260065|83009342|FG000|Overall Study|Death|13|||
46790301|NCT00260065|83009342|FG000|Overall Study|Withdrawal by Subject|13|||
46790302|NCT00260065|83009342|FG000|Overall Study|Physician Decision|19|||
46790303|NCT00260065|83009342|FG000|Overall Study|Not otherwise specified|8|||
46973653|NCT01986010|83217502|FG000|Overall Study|Physician Decision|0|||
46973654|NCT01986010|83217503|FG001|Overall Study|Physician Decision|0|||
46973655|NCT01986010|83217504|FG002|Overall Study|Physician Decision|0|||
46973656|NCT01986010|83217505|FG003|Overall Study|Physician Decision|0|||
46973657|NCT01986010|83217506|FG004|Overall Study|Physician Decision|0|||
46973658|NCT01986010|83217507|FG005|Overall Study|Physician Decision|0|||
46973659|NCT01986010|83217508|FG006|Overall Study|Physician Decision|0|||
46973660|NCT01986010|83217509|FG007|Overall Study|Physician Decision|0|||
47078016|NCT01433978|83382340|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
47078017|NCT01433978|83382341|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
47078018|NCT01433978|83382339|FG000|Extension Phase|Lack of Efficacy|0|||
47078019|NCT01433978|83382340|FG001|Extension Phase|Lack of Efficacy|0|||
47078020|NCT01433978|83382341|FG002|Extension Phase|Lack of Efficacy|1|||
46790304|NCT00260065|83009342|FG000|Overall Study|Medication Noncompliance|1|||
46790305|NCT00506350|83009355|FG000|Overall Study|Serious Adverse Event|1|||
46790306|NCT00506350|83009356|FG001|Overall Study|Serious Adverse Event|0|||
46790307|NCT00506350|83009357|FG002|Overall Study|Serious Adverse Event|0|||
46790308|NCT00506350|83009358|FG003|Overall Study|Serious Adverse Event|0|||
46790309|NCT00506350|83009359|FG004|Overall Study|Serious Adverse Event|0|||
47078021|NCT01433978|83382339|FG000|Extension Phase|Study Terminated by Sponsor|0|||
47078022|NCT01433978|83382340|FG001|Extension Phase|Study Terminated by Sponsor|0|||
47078023|NCT01433978|83382341|FG002|Extension Phase|Study Terminated by Sponsor|4|||
47078024|NCT01433354|83382390|FG000|Overall Study|Adverse Event|6|||
47078025|NCT01433354|83382390|FG000|Overall Study|Lost to Follow-up|1|||
46673821|NCT01182337|82889281|FG001|Overall Study|Withdrawal by Subject|1|||
46790310|NCT00506350|83009360|FG005|Overall Study|Serious Adverse Event|0|||
46790311|NCT00506350|83009361|FG006|Overall Study|Serious Adverse Event|0|||
46790312|NCT00506350|83009362|FG007|Overall Study|Serious Adverse Event|0|||
46790313|NCT00506350|83009363|FG008|Overall Study|Serious Adverse Event|0|||
46790314|NCT00506350|83009355|FG000|Overall Study|Adverse Event|0|||
46790315|NCT00506350|83009356|FG001|Overall Study|Adverse Event|0|||
46790316|NCT00506350|83009357|FG002|Overall Study|Adverse Event|0|||
46790317|NCT00506350|83009358|FG003|Overall Study|Adverse Event|0|||
46790318|NCT00506350|83009359|FG004|Overall Study|Adverse Event|0|||
46853221|NCT03478696|83069281|FG001|Overall Study|Lost to Follow-up|0|||
46853222|NCT03478696|83069280|FG000|Overall Study|Physician Decision|6|||
46853223|NCT03478696|83069281|FG001|Overall Study|Physician Decision|3|||
46853224|NCT03478696|83069280|FG000|Overall Study|Withdrawal by Subject|9|||
46853225|NCT03478696|83069281|FG001|Overall Study|Withdrawal by Subject|4|||
46853226|NCT03477838|83069287|FG000|Overall Study|Lost to Follow-up|14|||
46973661|NCT01986010|83217510|FG008|Overall Study|Physician Decision|0|||
46973662|NCT01986010|83217511|FG009|Overall Study|Physician Decision|0|||
46973663|NCT01986010|83217512|FG010|Overall Study|Physician Decision|0|||
46790319|NCT00506350|83009360|FG005|Overall Study|Adverse Event|0|||
46973664|NCT01986010|83217513|FG011|Overall Study|Physician Decision|0|||
46673822|NCT01182337|82889280|FG000|Overall Study|Lost to Follow-up|0|||
46853227|NCT00072176|83069293|FG000|Overall Study|Withdrawal by Subject|1|||
46853228|NCT00072176|83069294|FG001|Overall Study|Withdrawal by Subject|0|||
46973665|NCT01986010|83217514|FG012|Overall Study|Physician Decision|0|||
46790320|NCT00506350|83009361|FG006|Overall Study|Adverse Event|0|||
46790321|NCT00506350|83009362|FG007|Overall Study|Adverse Event|1|||
46790322|NCT00506350|83009363|FG008|Overall Study|Adverse Event|1|||
46790323|NCT00506350|83009355|FG000|Overall Study|Protocol Violation|0|||
46790324|NCT00506350|83009356|FG001|Overall Study|Protocol Violation|0|||
46853229|NCT00072176|83069293|FG000|Overall Study|Protocol Violation|0|||
47078026|NCT01433354|83382390|FG000|Overall Study|Administrative problems|90|||
47078027|NCT01433354|83382390|FG000|Overall Study|Protocol Violation|2|||
46790325|NCT00506350|83009357|FG002|Overall Study|Protocol Violation|1|||
46790326|NCT00506350|83009358|FG003|Overall Study|Protocol Violation|0|||
46790327|NCT00506350|83009359|FG004|Overall Study|Protocol Violation|0|||
46790328|NCT00506350|83009360|FG005|Overall Study|Protocol Violation|0|||
46790329|NCT00506350|83009361|FG006|Overall Study|Protocol Violation|1|||
46790330|NCT00506350|83009362|FG007|Overall Study|Protocol Violation|0|||
46790331|NCT00506350|83009363|FG008|Overall Study|Protocol Violation|0|||
46790332|NCT00506350|83009355|FG000|Overall Study|Withdrawal by Subject|0|||
46790333|NCT00506350|83009356|FG001|Overall Study|Withdrawal by Subject|1|||
46790334|NCT00506350|83009357|FG002|Overall Study|Withdrawal by Subject|1|||
46790335|NCT00506350|83009358|FG003|Overall Study|Withdrawal by Subject|1|||
46790336|NCT00506350|83009359|FG004|Overall Study|Withdrawal by Subject|4|||
46790337|NCT00506350|83009360|FG005|Overall Study|Withdrawal by Subject|1|||
46790338|NCT00506350|83009361|FG006|Overall Study|Withdrawal by Subject|1|||
46790339|NCT00506350|83009362|FG007|Overall Study|Withdrawal by Subject|2|||
46790340|NCT00506350|83009363|FG008|Overall Study|Withdrawal by Subject|0|||
46790341|NCT00506350|83009355|FG000|Overall Study|Lost to Follow-up|1|||
46790342|NCT00506350|83009356|FG001|Overall Study|Lost to Follow-up|1|||
46790343|NCT00506350|83009357|FG002|Overall Study|Lost to Follow-up|1|||
46790344|NCT00506350|83009358|FG003|Overall Study|Lost to Follow-up|1|||
46790345|NCT00506350|83009359|FG004|Overall Study|Lost to Follow-up|2|||
46853230|NCT00072176|83069294|FG001|Overall Study|Protocol Violation|1|||
46853231|NCT00071396|83069300|FG000|Overall Study|Withdrawal by Subject|1|||
46853232|NCT00071396|83069300|FG000|Overall Study|Physician Decision|2|||
46853233|NCT03473236|83069314|FG000|Overall Study|Withdrawal by Subject|0|||
46853234|NCT03473236|83069315|FG001|Overall Study|Withdrawal by Subject|0|||
46853235|NCT03473236|83069316|FG002|Overall Study|Withdrawal by Subject|0|||
46853236|NCT03473236|83069317|FG003|Overall Study|Withdrawal by Subject|0|||
46853237|NCT03473236|83069318|FG004|Overall Study|Withdrawal by Subject|0|||
46853238|NCT03473236|83069319|FG005|Overall Study|Withdrawal by Subject|1|||
46853239|NCT03473236|83069320|FG006|Overall Study|Withdrawal by Subject|0|||
46853240|NCT03473236|83069321|FG007|Overall Study|Withdrawal by Subject|0|||
46853241|NCT03473236|83069322|FG008|Overall Study|Withdrawal by Subject|1|||
46853242|NCT03473236|83069323|FG009|Overall Study|Withdrawal by Subject|0|||
46853243|NCT03550378|83069355|FG000|Overall Study|Death|0|||
46853244|NCT03550378|83069356|FG001|Overall Study|Death|1|||
46853245|NCT03472534|83069363|FG000|Overall Study|Withdrawal by Subject|9|||
46853246|NCT03472534|83069363|FG000|Overall Study|Adverse Event|2|||
46853247|NCT03549130|83069369|FG000|Overall Study|Adverse Event|0|||
46853248|NCT03549130|83069370|FG001|Overall Study|Adverse Event|1|||
46853249|NCT03549130|83069369|FG000|Overall Study|Lost to Follow-up|0|||
46853250|NCT03549130|83069370|FG001|Overall Study|Lost to Follow-up|1|||
46853251|NCT03470194|83069380|FG000|Overall Study|Lost to Follow-up|11|||
46853252|NCT03470194|83069381|FG001|Overall Study|Lost to Follow-up|17|||
46853253|NCT03469336|83069387|FG000|Overall Study|Adverse Event|1|||
46853254|NCT03469258|83069397|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
46853255|NCT03503188|83069403|FG000|Overall Study|Non eligible in the sub study|0|||
46853256|NCT03503188|83069404|FG001|Overall Study|Non eligible in the sub study|1|||
46853257|NCT03502798|83069412|FG000|Overall Study|equipment failure|0|||
46853258|NCT03502798|83069413|FG001|Overall Study|equipment failure|7|||
46853259|NCT00066170|83069423|FG000|Overall Study|Adverse Event|2|||
46853260|NCT00066170|83069424|FG001|Overall Study|Adverse Event|4|||
46853261|NCT00066170|83069425|FG002|Overall Study|Adverse Event|1|||
46853262|NCT00066170|83069426|FG003|Overall Study|Adverse Event|7|||
46853263|NCT00066170|83069423|FG000|Overall Study|Serious Adverse Event|0|||
46853264|NCT00066170|83069424|FG001|Overall Study|Serious Adverse Event|0|||
46853265|NCT00066170|83069425|FG002|Overall Study|Serious Adverse Event|1|||
46853266|NCT00066170|83069426|FG003|Overall Study|Serious Adverse Event|1|||
46853267|NCT00066170|83069423|FG000|Overall Study|Lost to Follow-up|0|||
46853268|NCT00066170|83069424|FG001|Overall Study|Lost to Follow-up|1|||
46853269|NCT00066170|83069425|FG002|Overall Study|Lost to Follow-up|0|||
46853270|NCT00066170|83069426|FG003|Overall Study|Lost to Follow-up|0|||
46853271|NCT00066170|83069423|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
46853272|NCT00066170|83069424|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
46790346|NCT00506350|83009360|FG005|Overall Study|Lost to Follow-up|1|||
46853273|NCT00066170|83069425|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
46790347|NCT00506350|83009361|FG006|Overall Study|Lost to Follow-up|0|||
46790348|NCT00506350|83009362|FG007|Overall Study|Lost to Follow-up|0|||
46790349|NCT00506350|83009363|FG008|Overall Study|Lost to Follow-up|2|||
46790350|NCT00506350|83009355|FG000|Overall Study|Medical Reason|0|||
46790351|NCT00506350|83009356|FG001|Overall Study|Medical Reason|0|||
46790352|NCT00506350|83009357|FG002|Overall Study|Medical Reason|0|||
46853274|NCT00066170|83069426|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
46853275|NCT00066170|83069423|FG000|Overall Study|Protocol Violation|3|||
46853276|NCT00066170|83069424|FG001|Overall Study|Protocol Violation|0|||
46853277|NCT00066170|83069425|FG002|Overall Study|Protocol Violation|0|||
46853278|NCT00066170|83069426|FG003|Overall Study|Protocol Violation|0|||
46853279|NCT00066170|83069423|FG000|Overall Study|Other|1|||
46790353|NCT00506350|83009358|FG003|Overall Study|Medical Reason|0|||
46790354|NCT00506350|83009359|FG004|Overall Study|Medical Reason|1|||
46790355|NCT00506350|83009360|FG005|Overall Study|Medical Reason|0|||
46790356|NCT00506350|83009361|FG006|Overall Study|Medical Reason|0|||
46790357|NCT00506350|83009362|FG007|Overall Study|Medical Reason|0|||
46790358|NCT00506350|83009363|FG008|Overall Study|Medical Reason|0|||
46790359|NCT00506350|83009355|FG000|Overall Study|Other|1|||
46790360|NCT00506350|83009356|FG001|Overall Study|Other|1|||
46790361|NCT00506350|83009357|FG002|Overall Study|Other|3|||
46790362|NCT00506350|83009358|FG003|Overall Study|Other|0|||
46790363|NCT00506350|83009359|FG004|Overall Study|Other|3|||
46790364|NCT00506350|83009360|FG005|Overall Study|Other|0|||
46790365|NCT00506350|83009361|FG006|Overall Study|Other|0|||
46790366|NCT00506350|83009362|FG007|Overall Study|Other|2|||
46790367|NCT00506350|83009363|FG008|Overall Study|Other|2|||
46790368|NCT00258895|83009392|FG000|Overall Study|Lost to Follow-up|3|||
46790369|NCT00258895|83009393|FG001|Overall Study|Lost to Follow-up|1|||
46790370|NCT00258895|83009392|FG000|Overall Study|Protocol Violation|6|||
46790371|NCT00258895|83009393|FG001|Overall Study|Protocol Violation|2|||
46790372|NCT00258895|83009392|FG000|Overall Study|Withdrawal by Subject|1|||
46790373|NCT00258895|83009393|FG001|Overall Study|Withdrawal by Subject|0|||
46790374|NCT00742625|83009399|FG000|Remission Induction|Progression|6|||
46790375|NCT00742625|83009399|FG000|Remission Induction|Failed induction|8|||
46790376|NCT00742625|83009399|FG000|Remission Induction|Adverse Event|3|||
46790377|NCT00742625|83009399|FG000|Remission Induction|Death|10|||
46790378|NCT00742625|83009399|FG000|Remission Induction|Refusal|5|||
46790379|NCT00742625|83009399|FG000|Remission Induction|Non protocol treatment|17|||
46790380|NCT00742625|83009399|FG000|Remission Induction|Other, not specified|5|||
46790381|NCT00742625|83009399|FG000|Consolidation|Progression|5|||
46790382|NCT00742625|83009399|FG000|Consolidation|Adverse Event|1|||
46790383|NCT00742625|83009399|FG000|Consolidation|Death|1|||
46790384|NCT00742625|83009399|FG000|Consolidation|Refused|1|||
46790385|NCT00742625|83009399|FG000|Consolidation|Non protocol therapy|13|||
46790386|NCT00618618|83009410|FG000|Overall Study|Patient Request|0|||
46790387|NCT00618618|83009411|FG001|Overall Study|Patient Request|0|||
46790388|NCT00618618|83009412|FG002|Overall Study|Patient Request|2|||
46790389|NCT00618618|83009413|FG003|Overall Study|Patient Request|0|||
46790390|NCT00618618|83009410|FG000|Overall Study|Inability to Complete Study Procedures|0|||
46790391|NCT00618618|83009411|FG001|Overall Study|Inability to Complete Study Procedures|1|||
46790392|NCT00618618|83009412|FG002|Overall Study|Inability to Complete Study Procedures|0|||
46790393|NCT00618618|83009413|FG003|Overall Study|Inability to Complete Study Procedures|0|||
46790394|NCT00618618|83009410|FG000|Overall Study|Lost to Follow-up|3|||
46790395|NCT00618618|83009411|FG001|Overall Study|Lost to Follow-up|0|||
46790396|NCT00618618|83009412|FG002|Overall Study|Lost to Follow-up|0|||
46790397|NCT00618618|83009413|FG003|Overall Study|Lost to Follow-up|1|||
46790398|NCT00618618|83009410|FG000|Overall Study|Non-compliance|1|||
46790399|NCT00618618|83009411|FG001|Overall Study|Non-compliance|1|||
46790400|NCT00618618|83009412|FG002|Overall Study|Non-compliance|0|||
46790401|NCT00618618|83009413|FG003|Overall Study|Non-compliance|0|||
46790402|NCT00618618|83009410|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
46790403|NCT00618618|83009411|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
46790404|NCT00618618|83009412|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
46790405|NCT00618618|83009413|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
46790406|NCT00618618|83009410|FG000|Overall Study|Death|0|||
46790407|NCT00618618|83009411|FG001|Overall Study|Death|1|||
46790408|NCT00618618|83009412|FG002|Overall Study|Death|0|||
46853280|NCT00066170|83069424|FG001|Overall Study|Other|5|||
46853281|NCT00066170|83069425|FG002|Overall Study|Other|2|||
46853282|NCT00066170|83069426|FG003|Overall Study|Other|0|||
47078028|NCT01433354|83382390|FG000|Overall Study|Lack of Efficacy|17|||
47078029|NCT01433354|83382390|FG000|Overall Study|Subject Withdrew Consent|3|||
47078030|NCT05209360|83382925|FG000|Overall Study|Withdrawal by Subject|0|||
47078031|NCT05209360|83382926|FG001|Overall Study|Withdrawal by Subject|0|||
46790409|NCT00618618|83009413|FG003|Overall Study|Death|0|||
46790410|NCT00246805|83009426|FG000|Phase 1|Lost to Follow-up|1|||
46790411|NCT00246805|83009427|FG001|Phase 1|Lost to Follow-up|0|||
46790412|NCT00519376|83009433|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790413|NCT00519376|83009434|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790414|NCT00519376|83009435|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790415|NCT00519376|83009436|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790416|NCT00519376|83009437|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790417|NCT00519376|83009438|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790418|NCT00519376|83009439|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790419|NCT00519376|83009440|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790420|NCT00519376|83009441|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46853283|NCT00065468|83069439|FG000|Overall Study|Death|172|||
46853284|NCT00065468|83069440|FG001|Overall Study|Death|169|||
46790421|NCT00519376|83009442|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790422|NCT00519376|83009443|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790423|NCT00519376|83009444|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790424|NCT00519376|83009445|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
46790425|NCT00519376|83009446|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790426|NCT00519376|83009447|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790427|NCT00519376|83009448|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
46790428|NCT00519376|83009433|FG000|Treatment Period 4|Lost to Follow-up|0|||
46790429|NCT00519376|83009434|FG001|Treatment Period 4|Lost to Follow-up|0|||
46790430|NCT00519376|83009435|FG002|Treatment Period 4|Lost to Follow-up|1|||
46790431|NCT00519376|83009436|FG003|Treatment Period 4|Lost to Follow-up|0|||
46790432|NCT00519376|83009437|FG004|Treatment Period 4|Lost to Follow-up|0|||
46790433|NCT00519376|83009438|FG005|Treatment Period 4|Lost to Follow-up|0|||
46790434|NCT00519376|83009439|FG006|Treatment Period 4|Lost to Follow-up|0|||
46790435|NCT00519376|83009440|FG007|Treatment Period 4|Lost to Follow-up|0|||
46790436|NCT00519376|83009441|FG008|Treatment Period 4|Lost to Follow-up|0|||
46790437|NCT00519376|83009442|FG009|Treatment Period 4|Lost to Follow-up|0|||
46790438|NCT00519376|83009443|FG010|Treatment Period 4|Lost to Follow-up|0|||
46790439|NCT00519376|83009444|FG011|Treatment Period 4|Lost to Follow-up|0|||
46790440|NCT00519376|83009445|FG012|Treatment Period 4|Lost to Follow-up|0|||
46790441|NCT00519376|83009446|FG013|Treatment Period 4|Lost to Follow-up|0|||
46790442|NCT00519376|83009447|FG014|Treatment Period 4|Lost to Follow-up|0|||
46790443|NCT00519376|83009448|FG015|Treatment Period 4|Lost to Follow-up|0|||
46790444|NCT00745121|83009462|FG000|Overall Study|Death|3|||
46790445|NCT00745121|83009463|FG001|Overall Study|Death|0|||
46790446|NCT00745121|83009462|FG000|Overall Study|Adverse Event|1|||
46790447|NCT00745121|83009463|FG001|Overall Study|Adverse Event|0|||
46790448|NCT00745121|83009462|FG000|Overall Study|Lost to Follow-up|1|||
46790449|NCT00745121|83009463|FG001|Overall Study|Lost to Follow-up|0|||
46790450|NCT00745121|83009462|FG000|Overall Study|Withdrawal by Subject|4|||
46790451|NCT00745121|83009463|FG001|Overall Study|Withdrawal by Subject|2|||
46790452|NCT00740051|83009471|FG000|Overall Study|Lack of Efficacy|2|||
46790453|NCT00740051|83009472|FG001|Overall Study|Lack of Efficacy|5|||
46790454|NCT00740051|83009471|FG000|Overall Study|Adverse Event|1|||
46790455|NCT00740051|83009472|FG001|Overall Study|Adverse Event|4|||
46790456|NCT00740051|83009471|FG000|Overall Study|Protocol Violation|2|||
46790457|NCT00740051|83009472|FG001|Overall Study|Protocol Violation|6|||
46853285|NCT00065468|83069441|FG002|Overall Study|Death|171|||
46853286|NCT00065468|83069439|FG000|Overall Study|Withdrawal by Subject|3|||
46853287|NCT00065468|83069440|FG001|Overall Study|Withdrawal by Subject|4|||
46853288|NCT00065468|83069441|FG002|Overall Study|Withdrawal by Subject|5|||
46853289|NCT00065468|83069439|FG000|Overall Study|Lost to Follow-up|5|||
46853290|NCT00065468|83069440|FG001|Overall Study|Lost to Follow-up|3|||
46853291|NCT00065468|83069441|FG002|Overall Study|Lost to Follow-up|2|||
46853292|NCT00065468|83069439|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
46853293|NCT00065468|83069440|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
46853294|NCT00065468|83069441|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
46853295|NCT00065468|83069439|FG000|Overall Study|Disease progression|0|||
46853296|NCT00065468|83069440|FG001|Overall Study|Disease progression|0|||
46853297|NCT00065468|83069441|FG002|Overall Study|Disease progression|1|||
46853298|NCT00065468|83069439|FG000|Overall Study|Other|14|||
46853299|NCT00065468|83069440|FG001|Overall Study|Other|24|||
46853300|NCT00065468|83069441|FG002|Overall Study|Other|18|||
46853301|NCT00071006|83069449|FG000|Overall Study|Lack of Efficacy|7|||
46853302|NCT00071006|83069449|FG000|Overall Study|Adverse Event|1|||
46853303|NCT00071006|83069449|FG000|Overall Study|Withdrawal by Subject|1|||
46853304|NCT00071006|83069449|FG000|Overall Study|Other|3|||
46853305|NCT00094575|83069455|FG000|Overall Study|Death|146|||
46853306|NCT00094575|83069456|FG001|Overall Study|Death|146|||
46853307|NCT00057746|83069467|FG000|Overall Study|Withdrawal by Subject|0|||
46790458|NCT00740051|83009471|FG000|Overall Study|Lost to Follow-up|3|||
46790459|NCT00740051|83009472|FG001|Overall Study|Lost to Follow-up|8|||
46790460|NCT00740051|83009471|FG000|Overall Study|Withdrawal by Subject|6|||
46853308|NCT00057746|83069468|FG001|Overall Study|Withdrawal by Subject|0|||
46853309|NCT00057746|83069469|FG002|Overall Study|Withdrawal by Subject|1|||
46853310|NCT00094107|83069477|FG000|Overall Study|Lack of Efficacy|23|||
46853311|NCT00094107|83069477|FG000|Overall Study|Death|5|||
46790461|NCT00740051|83009472|FG001|Overall Study|Withdrawal by Subject|8|||
46790462|NCT00740051|83009471|FG000|Overall Study|Other reason (not specified)|4|||
46790463|NCT00740051|83009472|FG001|Overall Study|Other reason (not specified)|1|||
46853312|NCT00094107|83069477|FG000|Overall Study|Adverse Event|3|||
46790464|NCT00518986|83009481|FG000|Overall Study|Adverse Event|12|||
46790465|NCT00518986|83009482|FG001|Overall Study|Adverse Event|7|||
46790466|NCT00518986|83009481|FG000|Overall Study|Lack of Efficacy|0|||
46853313|NCT00094107|83069477|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
46973666|NCT01986010|83217515|FG013|Overall Study|Physician Decision|0|||
46973667|NCT01986010|83217516|FG014|Overall Study|Physician Decision|1|||
46790467|NCT00518986|83009482|FG001|Overall Study|Lack of Efficacy|2|||
46790468|NCT00518986|83009481|FG000|Overall Study|Lost to Follow-up|3|||
46790469|NCT00518986|83009482|FG001|Overall Study|Lost to Follow-up|2|||
46790470|NCT00518986|83009481|FG000|Overall Study|Physician Decision|0|||
46790471|NCT00518986|83009482|FG001|Overall Study|Physician Decision|3|||
46790472|NCT00518986|83009481|FG000|Overall Study|Protocol Violation|5|||
46790473|NCT00518986|83009482|FG001|Overall Study|Protocol Violation|7|||
46790474|NCT00518986|83009481|FG000|Overall Study|Withdrawal by Subject|4|||
46790475|NCT00518986|83009482|FG001|Overall Study|Withdrawal by Subject|4|||
46790476|NCT00518986|83009481|FG000|Overall Study|Non-Specific|2|||
46790477|NCT00518986|83009482|FG001|Overall Study|Non-Specific|1|||
46790478|NCT00742391|83009490|FG000|Overall Study|Adverse Event|2|||
46790479|NCT00742391|83009491|FG001|Overall Study|Adverse Event|1|||
46790480|NCT00742391|83009490|FG000|Overall Study|Lost to Follow-up|1|||
46790481|NCT00742391|83009491|FG001|Overall Study|Lost to Follow-up|0|||
46790482|NCT00742391|83009490|FG000|Overall Study|Protocol Violation|1|||
46790483|NCT00742391|83009491|FG001|Overall Study|Protocol Violation|0|||
46790484|NCT00742235|83009499|FG000|Overall Study|Lost to Follow-up|0|||
46790485|NCT00742235|83009500|FG001|Overall Study|Lost to Follow-up|31|||
46790486|NCT00742079|83009508|FG000|Overall Study|Lost to Follow-up|0|||
46790487|NCT00742079|83009509|FG001|Overall Study|Lost to Follow-up|1|||
46790488|NCT00662792|83009515|FG000|Period 1|Personal Reasons|0|||
46790489|NCT00662792|83009516|FG001|Period 1|Personal Reasons|0|||
46790490|NCT00662792|83009517|FG002|Period 1|Personal Reasons|1|||
46790491|NCT00662792|83009518|FG003|Period 1|Personal Reasons|0|||
46790492|NCT00662792|83009515|FG000|Period 1|Refused continuing medication|0|||
46790493|NCT00662792|83009516|FG001|Period 1|Refused continuing medication|1|||
46790494|NCT00662792|83009517|FG002|Period 1|Refused continuing medication|1|||
46790495|NCT00662792|83009518|FG003|Period 1|Refused continuing medication|0|||
46790496|NCT00662792|83009515|FG000|Period 1|Lost to Follow-up|1|||
46790497|NCT00662792|83009516|FG001|Period 1|Lost to Follow-up|0|||
46790498|NCT00662792|83009517|FG002|Period 1|Lost to Follow-up|0|||
46790499|NCT00662792|83009518|FG003|Period 1|Lost to Follow-up|0|||
46790500|NCT00662792|83009515|FG000|Period 1|Other adverse event (AE)|0|||
46790501|NCT00662792|83009516|FG001|Period 1|Other adverse event (AE)|2|||
46790502|NCT00662792|83009517|FG002|Period 1|Other adverse event (AE)|0|||
46790503|NCT00662792|83009518|FG003|Period 1|Other adverse event (AE)|0|||
46790504|NCT00662792|83009515|FG000|Period 1|Worsening of disease under study (AE)|1|||
46790505|NCT00662792|83009516|FG001|Period 1|Worsening of disease under study (AE)|3|||
46790506|NCT00662792|83009517|FG002|Period 1|Worsening of disease under study (AE)|2|||
46790507|NCT00662792|83009518|FG003|Period 1|Worsening of disease under study (AE)|0|||
46790508|NCT00662792|83009515|FG000|Period 1|Not treated|0|||
46790509|NCT00662792|83009516|FG001|Period 1|Not treated|1|||
46790510|NCT00662792|83009517|FG002|Period 1|Not treated|0|||
46790511|NCT00662792|83009518|FG003|Period 1|Not treated|0|||
46790512|NCT00662792|83009515|FG000|Period 2|Worsening of disease under study|1|||
46790513|NCT00662792|83009516|FG001|Period 2|Worsening of disease under study|0|||
46790514|NCT00662792|83009517|FG002|Period 2|Worsening of disease under study|0|||
46790515|NCT00662792|83009518|FG003|Period 2|Worsening of disease under study|3|||
46790516|NCT00662792|83009515|FG000|Period 3|Refused continuing medication|1|||
46790517|NCT00662792|83009516|FG001|Period 3|Refused continuing medication|0|||
46790518|NCT00662792|83009517|FG002|Period 3|Refused continuing medication|1|||
46790519|NCT00662792|83009518|FG003|Period 3|Refused continuing medication|0|||
46790520|NCT00662792|83009515|FG000|Period 3|Other adverse event (AE)|0|||
46790521|NCT00662792|83009516|FG001|Period 3|Other adverse event (AE)|0|||
46790522|NCT00662792|83009517|FG002|Period 3|Other adverse event (AE)|1|||
46790523|NCT00662792|83009518|FG003|Period 3|Other adverse event (AE)|1|||
46790524|NCT00662792|83009515|FG000|Period 4|Refused continuing medication|0|||
46790525|NCT00662792|83009516|FG001|Period 4|Refused continuing medication|1|||
46790526|NCT00662792|83009517|FG002|Period 4|Refused continuing medication|0|||
46790527|NCT00662792|83009518|FG003|Period 4|Refused continuing medication|0|||
46790528|NCT00662792|83009515|FG000|Period 4|Other adverse event (AE)|1|||
46790529|NCT00662792|83009516|FG001|Period 4|Other adverse event (AE)|0|||
46790530|NCT00662792|83009517|FG002|Period 4|Other adverse event (AE)|0|||
46790531|NCT00662792|83009518|FG003|Period 4|Other adverse event (AE)|0|||
46790532|NCT00662792|83009515|FG000|Period 4|Worsening of disease under study (AE)|0|||
46790533|NCT00662792|83009516|FG001|Period 4|Worsening of disease under study (AE)|0|||
46790534|NCT00662792|83009517|FG002|Period 4|Worsening of disease under study (AE)|0|||
46790535|NCT00662792|83009518|FG003|Period 4|Worsening of disease under study (AE)|1|||
46790536|NCT00742001|83009533|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
46790537|NCT00742001|83009534|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
46790538|NCT00742001|83009535|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
46790539|NCT00616902|83009548|FG000|Overall Study|Termination of study|6|||
46790540|NCT00616902|83009549|FG001|Overall Study|Termination of study|6|||
46790541|NCT00741611|83009558|FG000|Overall Study|Death|0|||
46790542|NCT00741611|83009559|FG001|Overall Study|Death|0|||
46790543|NCT00741611|83009560|FG002|Overall Study|Death|1|||
46790544|NCT00741611|83009558|FG000|Overall Study|Withdrawal by Subject|0|||
46790545|NCT00741611|83009559|FG001|Overall Study|Withdrawal by Subject|2|||
46790546|NCT00741611|83009560|FG002|Overall Study|Withdrawal by Subject|2|||
46790547|NCT00662558|83009571|FG000|Overall Study|Adverse Event|21|||
46790548|NCT00662558|83009572|FG001|Overall Study|Adverse Event|59|||
46790549|NCT00662558|83009571|FG000|Overall Study|Lack of Efficacy|4|||
46790550|NCT00662558|83009572|FG001|Overall Study|Lack of Efficacy|7|||
46790551|NCT00662558|83009571|FG000|Overall Study|Lost to Follow-up|13|||
46790552|NCT00662558|83009572|FG001|Overall Study|Lost to Follow-up|10|||
46790553|NCT00662558|83009571|FG000|Overall Study|Other|9|||
46790554|NCT00662558|83009572|FG001|Overall Study|Other|14|||
46673823|NCT01182337|82889281|FG001|Overall Study|Lost to Follow-up|1|||
46673824|NCT01182298|82889288|FG000|Overall Study|Lack of Efficacy|4|||
46673825|NCT01182298|82889288|FG000|Overall Study|Withdrawal by Subject|2|||
46673826|NCT01163266|82889295|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
46673827|NCT01163266|82889296|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
46673828|NCT01163266|82889297|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
46673829|NCT01163266|82889295|FG000|Overall Study|Lack of Efficacy|1|||
46673830|NCT01163266|82889296|FG001|Overall Study|Lack of Efficacy|3|||
46673831|NCT01163266|82889297|FG002|Overall Study|Lack of Efficacy|1|||
46673832|NCT01163266|82889295|FG000|Overall Study|Noncompliance with Study Drug|0|||
46790555|NCT00662558|83009571|FG000|Overall Study|Withdrawal by Subject|7|||
46790556|NCT00662558|83009572|FG001|Overall Study|Withdrawal by Subject|12|||
46790557|NCT00662558|83009571|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
46790558|NCT00662558|83009572|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
46790559|NCT00739973|83009587|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
46790560|NCT00739973|83009588|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46790561|NCT00739973|83009589|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46790562|NCT00739973|83009590|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46790563|NCT00739973|83009591|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46790564|NCT00739973|83009592|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46853314|NCT00102063|83069484|FG000|Overall Study|Lack of Efficacy|5|||
46853315|NCT00102063|83069485|FG001|Overall Study|Lack of Efficacy|1|||
46853316|NCT00102063|83069486|FG002|Overall Study|Lack of Efficacy|1|||
46853317|NCT00102063|83069484|FG000|Overall Study|Adverse Event|7|||
46853318|NCT00102063|83069485|FG001|Overall Study|Adverse Event|4|||
46853319|NCT00102063|83069486|FG002|Overall Study|Adverse Event|2|||
46853320|NCT00102063|83069484|FG000|Overall Study|Withdrawal by Subject|4|||
46853321|NCT00102063|83069485|FG001|Overall Study|Withdrawal by Subject|12|||
46853322|NCT00102063|83069486|FG002|Overall Study|Withdrawal by Subject|5|||
46853323|NCT00102063|83069484|FG000|Overall Study|Lost to Follow-up|0|||
46853324|NCT00102063|83069485|FG001|Overall Study|Lost to Follow-up|0|||
46853325|NCT00102063|83069486|FG002|Overall Study|Lost to Follow-up|1|||
46853326|NCT00102063|83069484|FG000|Overall Study|Protocol Violation|0|||
46853327|NCT00102063|83069485|FG001|Overall Study|Protocol Violation|1|||
46853328|NCT00102063|83069486|FG002|Overall Study|Protocol Violation|1|||
46853329|NCT00065156|83069494|FG000|Overall Study|Adverse Event|37|||
46853330|NCT00065156|83069494|FG000|Overall Study|Lack of Efficacy|52|||
46853331|NCT00065156|83069494|FG000|Overall Study|Withdrawal by Subject|8|||
46853332|NCT00065156|83069494|FG000|Overall Study|Lost to Follow-up|1|||
46853333|NCT00065156|83069494|FG000|Overall Study|Death|11|||
46853334|NCT00065156|83069494|FG000|Overall Study|Study Closed by Sponsor|2|||
46853335|NCT00065156|83069494|FG000|Overall Study|Disease Progression|7|||
46853336|NCT00065156|83069494|FG000|Overall Study|Investigator Decision|2|||
46853337|NCT00065156|83069494|FG000|Overall Study|Non-Compliance|2|||
46853338|NCT00065156|83069494|FG000|Overall Study|Loss of Response|1|||
46853339|NCT00065156|83069494|FG000|Overall Study|Secondary Malign Disease|1|||
46853340|NCT00064298|83069500|FG000|Overall Study|Withdrawal by Subject|2|||
46853341|NCT00064298|83069501|FG001|Overall Study|Withdrawal by Subject|1|||
46673833|NCT01163266|82889296|FG001|Overall Study|Noncompliance with Study Drug|2|||
46673834|NCT01163266|82889297|FG002|Overall Study|Noncompliance with Study Drug|0|||
46673835|NCT01163266|82889295|FG000|Overall Study|Protocol Deviations|2|||
46673836|NCT01163266|82889296|FG001|Overall Study|Protocol Deviations|2|||
46673837|NCT01163266|82889297|FG002|Overall Study|Protocol Deviations|5|||
46673838|NCT01163266|82889295|FG000|Overall Study|Withdrawal of Consent|5|||
46673839|NCT01163266|82889296|FG001|Overall Study|Withdrawal of Consent|7|||
46673840|NCT01163266|82889297|FG002|Overall Study|Withdrawal of Consent|3|||
46673841|NCT01163266|82889295|FG000|Overall Study|Lost to Follow-up|7|||
46853342|NCT00064298|83069500|FG000|Overall Study|Lost to Follow-up|2|||
46853343|NCT00064298|83069501|FG001|Overall Study|Lost to Follow-up|2|||
46673842|NCT01163266|82889296|FG001|Overall Study|Lost to Follow-up|7|||
46673843|NCT01163266|82889297|FG002|Overall Study|Lost to Follow-up|10|||
46673844|NCT01163266|82889295|FG000|Overall Study|Other|1|||
46853344|NCT00064298|83069500|FG000|Overall Study|Death|0|||
46853345|NCT00064298|83069501|FG001|Overall Study|Death|1|||
46673845|NCT01163266|82889296|FG001|Overall Study|Other|1|||
46673846|NCT01163266|82889297|FG002|Overall Study|Other|2|||
46790565|NCT00739973|83009593|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46790566|NCT00739973|83009594|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46790567|NCT00739973|83009595|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
46790568|NCT00739973|83009587|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
46790569|NCT00739973|83009588|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790570|NCT00739973|83009589|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790571|NCT00739973|83009590|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790572|NCT00739973|83009591|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790573|NCT00739973|83009592|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790574|NCT00739973|83009593|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790575|NCT00739973|83009594|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790576|NCT00739973|83009595|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
46790577|NCT00739973|83009587|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
46790578|NCT00739973|83009588|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790579|NCT00739973|83009589|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790580|NCT00739973|83009590|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790581|NCT00739973|83009591|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790582|NCT00739973|83009592|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790583|NCT00739973|83009593|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790584|NCT00739973|83009594|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790585|NCT00739973|83009595|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
46790586|NCT00739973|83009587|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
46790587|NCT00739973|83009588|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790588|NCT00739973|83009589|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790589|NCT00739973|83009590|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790590|NCT00739973|83009591|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790591|NCT00739973|83009592|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790592|NCT00739973|83009593|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790593|NCT00739973|83009594|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790594|NCT00739973|83009595|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
46790595|NCT00739973|83009587|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
46790596|NCT00739973|83009588|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790597|NCT00739973|83009589|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790598|NCT00739973|83009590|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790599|NCT00739973|83009591|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790600|NCT00739973|83009592|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790601|NCT00739973|83009593|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790602|NCT00739973|83009594|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790603|NCT00739973|83009595|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
46790604|NCT00739973|83009587|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
46790605|NCT00739973|83009588|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790606|NCT00739973|83009589|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790607|NCT00739973|83009590|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790608|NCT00739973|83009591|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790609|NCT00739973|83009592|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790610|NCT00739973|83009593|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790611|NCT00739973|83009594|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790612|NCT00739973|83009595|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
46790613|NCT00739973|83009587|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
46790614|NCT00739973|83009588|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790615|NCT00739973|83009589|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790616|NCT00739973|83009590|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790617|NCT00739973|83009591|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790618|NCT00739973|83009592|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790619|NCT00739973|83009593|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790620|NCT00739973|83009594|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790621|NCT00739973|83009595|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
46790622|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
46790623|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
46790624|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
46790625|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
46790626|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
47078032|NCT05209360|83382927|FG002|Overall Study|Withdrawal by Subject|1|||
46790627|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
46790628|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
46790629|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
46790630|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
46790631|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
46790632|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
46790633|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
46790634|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
46790635|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
46790636|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
46790637|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
46790638|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
46790639|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
46790640|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
46790641|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
46790642|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
46790643|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
46790644|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
46790645|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
46790646|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
46790647|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
46790648|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
46790649|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
46790650|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
46790651|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
46790652|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
46790653|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
46790654|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
46790655|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
46790656|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
46790657|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
46790658|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790659|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790660|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
46790661|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790662|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790663|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790664|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790665|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790666|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
46790667|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
46790668|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
46790669|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
46790670|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
46790671|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
46790672|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
46790673|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
46790674|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
46790675|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
46790676|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
46790677|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
46790678|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
46790679|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
46790680|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
46790681|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
46790682|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
46790683|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
46790684|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
46790685|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790686|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790687|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790688|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790689|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790690|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790691|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
46790692|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790693|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
46790694|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
46790695|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
46790696|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
46790697|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
46790698|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
46790699|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
46790700|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
46790701|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
46790702|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
46790703|NCT00739973|83009587|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
46790704|NCT00739973|83009588|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
46790705|NCT00739973|83009589|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
46790706|NCT00739973|83009590|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
46790707|NCT00739973|83009591|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
46790708|NCT00739973|83009592|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
46790709|NCT00739973|83009593|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
46790710|NCT00739973|83009594|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
46790711|NCT00739973|83009595|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
46790712|NCT00510874|83009630|FG000|Overall Study|Withdrawal by Subject|1|||
46790713|NCT00510874|83009631|FG001|Overall Study|Withdrawal by Subject|1|||
46790714|NCT00510874|83009632|FG002|Overall Study|Withdrawal by Subject|0|||
46790715|NCT00510874|83009633|FG003|Overall Study|Withdrawal by Subject|0|||
46790716|NCT00510874|83009634|FG004|Overall Study|Withdrawal by Subject|3|||
46790717|NCT00510874|83009635|FG005|Overall Study|Withdrawal by Subject|0|||
46790718|NCT00510874|83009636|FG006|Overall Study|Withdrawal by Subject|0|||
46790719|NCT00510874|83009630|FG000|Overall Study|Lost to Follow-up|2|||
46790720|NCT00510874|83009631|FG001|Overall Study|Lost to Follow-up|3|||
46790721|NCT00510874|83009632|FG002|Overall Study|Lost to Follow-up|1|||
46790722|NCT00510874|83009633|FG003|Overall Study|Lost to Follow-up|3|||
46790723|NCT00510874|83009634|FG004|Overall Study|Lost to Follow-up|4|||
46790724|NCT00510874|83009635|FG005|Overall Study|Lost to Follow-up|0|||
46790725|NCT00510874|83009636|FG006|Overall Study|Lost to Follow-up|1|||
46790726|NCT00739661|83009655|FG000|Overall Study|Adverse Event|2|||
46790727|NCT00739661|83009656|FG001|Overall Study|Adverse Event|0|||
46790728|NCT00739661|83009655|FG000|Overall Study|Physician decision to withdraw patient|1|||
46790729|NCT00739661|83009656|FG001|Overall Study|Physician decision to withdraw patient|0|||
46790730|NCT00739661|83009655|FG000|Overall Study|Patient decision to withdraw|9|||
46790731|NCT00739661|83009656|FG001|Overall Study|Patient decision to withdraw|4|||
46790732|NCT00739661|83009655|FG000|Overall Study|Disease progression, radiographic|33|||
46853346|NCT00064298|83069500|FG000|Overall Study|Disease Progression|2|||
46853347|NCT00064298|83069501|FG001|Overall Study|Disease Progression|1|||
46790733|NCT00739661|83009656|FG001|Overall Study|Disease progression, radiographic|37|||
46790734|NCT00739661|83009655|FG000|Overall Study|Reason for discontinuation not available|1|||
46790735|NCT00739661|83009656|FG001|Overall Study|Reason for discontinuation not available|1|||
46790736|NCT00615030|83009662|FG000|Period I|Administrative problem|0|||
46790737|NCT00615030|83009663|FG001|Period I|Administrative problem|0|||
46853348|NCT00078819|83069509|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
46853349|NCT00078819|83069510|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
46853350|NCT00078819|83069511|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
46853351|NCT00078819|83069512|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
46853352|NCT00078819|83069509|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
46853353|NCT00078819|83069510|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
46790738|NCT00615030|83009664|FG002|Period I|Administrative problem|0|||
46853354|NCT00078819|83069511|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
46853355|NCT00078819|83069512|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
46790739|NCT00615030|83009665|FG003|Period I|Administrative problem|0|||
46790740|NCT00615030|83009666|FG004|Period I|Administrative problem|1|||
46790741|NCT00615030|83009667|FG005|Period I|Administrative problem|0|||
46790742|NCT00615030|83009668|FG006|Period I|Administrative problem|0|||
46790743|NCT00615030|83009669|FG007|Period I|Administrative problem|0|||
46790744|NCT00615030|83009670|FG008|Period I|Administrative problem|0|||
46790745|NCT00615030|83009671|FG009|Period I|Administrative problem|0|||
46853356|NCT00078819|83069509|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
46853357|NCT00078819|83069510|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
46853358|NCT00078819|83069511|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
46853359|NCT00078819|83069512|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
46853360|NCT00078819|83069509|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
46853361|NCT00078819|83069510|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
46853362|NCT00078819|83069511|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
46853363|NCT00078819|83069512|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
46853364|NCT00078819|83069509|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
46853365|NCT00078819|83069510|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
46853366|NCT00078819|83069511|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
46853367|NCT00078819|83069512|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
46853368|NCT00078819|83069509|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
46853369|NCT00078819|83069510|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
46853370|NCT00078819|83069511|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
46853371|NCT00078819|83069512|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
46853372|NCT00078819|83069509|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
46853373|NCT00078819|83069510|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
46853374|NCT00078819|83069511|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
46853375|NCT00078819|83069512|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
46853376|NCT00078819|83069509|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
46853377|NCT00078819|83069510|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
46853378|NCT00078819|83069511|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
46973668|NCT01986010|83217517|FG015|Overall Study|Physician Decision|0|||
46973669|NCT01986010|83217518|FG016|Overall Study|Physician Decision|0|||
46973670|NCT01986010|83217502|FG000|Overall Study|Withdrawal by Subject|2|||
46973671|NCT01986010|83217503|FG001|Overall Study|Withdrawal by Subject|2|||
46973672|NCT01986010|83217504|FG002|Overall Study|Withdrawal by Subject|3|||
46973673|NCT01986010|83217505|FG003|Overall Study|Withdrawal by Subject|0|||
46973674|NCT01986010|83217506|FG004|Overall Study|Withdrawal by Subject|2|||
46973675|NCT01986010|83217507|FG005|Overall Study|Withdrawal by Subject|4|||
46973676|NCT01986010|83217508|FG006|Overall Study|Withdrawal by Subject|0|||
46973677|NCT01986010|83217509|FG007|Overall Study|Withdrawal by Subject|0|||
46973678|NCT01986010|83217510|FG008|Overall Study|Withdrawal by Subject|0|||
46973679|NCT01986010|83217511|FG009|Overall Study|Withdrawal by Subject|0|||
46973680|NCT01986010|83217512|FG010|Overall Study|Withdrawal by Subject|0|||
46973681|NCT01986010|83217513|FG011|Overall Study|Withdrawal by Subject|2|||
46973682|NCT01986010|83217514|FG012|Overall Study|Withdrawal by Subject|0|||
46973683|NCT01986010|83217515|FG013|Overall Study|Withdrawal by Subject|1|||
46973684|NCT01986010|83217516|FG014|Overall Study|Withdrawal by Subject|2|||
46973685|NCT01986010|83217517|FG015|Overall Study|Withdrawal by Subject|0|||
46973686|NCT01986010|83217518|FG016|Overall Study|Withdrawal by Subject|0|||
46973687|NCT01986010|83217502|FG000|Overall Study|Status Not Recorded|2|||
46973688|NCT01986010|83217503|FG001|Overall Study|Status Not Recorded|4|||
46973689|NCT01986010|83217504|FG002|Overall Study|Status Not Recorded|2|||
46973690|NCT01986010|83217505|FG003|Overall Study|Status Not Recorded|0|||
46973691|NCT01986010|83217506|FG004|Overall Study|Status Not Recorded|1|||
46973692|NCT01986010|83217507|FG005|Overall Study|Status Not Recorded|2|||
46973693|NCT01986010|83217508|FG006|Overall Study|Status Not Recorded|0|||
46973694|NCT01986010|83217509|FG007|Overall Study|Status Not Recorded|0|||
46973695|NCT01986010|83217510|FG008|Overall Study|Status Not Recorded|2|||
46973696|NCT01986010|83217511|FG009|Overall Study|Status Not Recorded|1|||
46973697|NCT01986010|83217512|FG010|Overall Study|Status Not Recorded|7|||
46790746|NCT00615030|83009672|FG010|Period I|Administrative problem|0|||
46790747|NCT00615030|83009673|FG011|Period I|Administrative problem|0|||
46790748|NCT00615030|83009662|FG000|Period I|Protocol deviation|1|||
46790749|NCT00615030|83009663|FG001|Period I|Protocol deviation|0|||
46790750|NCT00615030|83009664|FG002|Period I|Protocol deviation|0|||
46790751|NCT00615030|83009665|FG003|Period I|Protocol deviation|0|||
46790752|NCT00615030|83009666|FG004|Period I|Protocol deviation|0|||
46973698|NCT01986010|83217513|FG011|Overall Study|Status Not Recorded|7|||
46973699|NCT01986010|83217514|FG012|Overall Study|Status Not Recorded|9|||
46973700|NCT01986010|83217515|FG013|Overall Study|Status Not Recorded|9|||
46973701|NCT01986010|83217516|FG014|Overall Study|Status Not Recorded|5|||
46973702|NCT01986010|83217517|FG015|Overall Study|Status Not Recorded|10|||
46790753|NCT00615030|83009667|FG005|Period I|Protocol deviation|0|||
46790754|NCT00615030|83009668|FG006|Period I|Protocol deviation|0|||
46790755|NCT00615030|83009669|FG007|Period I|Protocol deviation|0|||
46790756|NCT00615030|83009670|FG008|Period I|Protocol deviation|0|||
46790757|NCT00615030|83009671|FG009|Period I|Protocol deviation|0|||
46790758|NCT00615030|83009672|FG010|Period I|Protocol deviation|0|||
46790759|NCT00615030|83009673|FG011|Period I|Protocol deviation|0|||
46790760|NCT00615030|83009662|FG000|Period I|Subject withdrew consent|0|||
46790761|NCT00615030|83009663|FG001|Period I|Subject withdrew consent|0|||
46790762|NCT00615030|83009664|FG002|Period I|Subject withdrew consent|0|||
46790763|NCT00615030|83009665|FG003|Period I|Subject withdrew consent|0|||
46790764|NCT00615030|83009666|FG004|Period I|Subject withdrew consent|0|||
46790765|NCT00615030|83009667|FG005|Period I|Subject withdrew consent|0|||
46790766|NCT00615030|83009668|FG006|Period I|Subject withdrew consent|0|||
46790767|NCT00615030|83009669|FG007|Period I|Subject withdrew consent|0|||
46853379|NCT00078819|83069512|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
46853380|NCT00098865|83069529|FG000|Overall Study|Progressive Disease|6|||
46973703|NCT01986010|83217518|FG016|Overall Study|Status Not Recorded|4|||
46973704|NCT01963780|83217564|FG000|Overall Study|Death|7|||
46973705|NCT02009878|83217571|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
46973706|NCT02009878|83217572|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
46973707|NCT02009878|83217573|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
46973708|NCT02009722|83217583|FG000|Overall Study|Protocol Violation|1|||
46973709|NCT02009722|83217584|FG001|Overall Study|Protocol Violation|2|||
46973710|NCT02009722|83217583|FG000|Overall Study|Did not receive intervention|0|||
46973711|NCT02009722|83217584|FG001|Overall Study|Did not receive intervention|1|||
46973712|NCT02655419|83217592|FG000|Overall Study|Enrolled but not treated|1|||
46973713|NCT02655419|83217593|FG001|Overall Study|Enrolled but not treated|5|||
46973714|NCT02655419|83217592|FG000|Overall Study|Withdrawal by Subject|4|||
46973715|NCT02655419|83217593|FG001|Overall Study|Withdrawal by Subject|1|||
46973716|NCT02655419|83217592|FG000|Overall Study|Other|0|||
46973717|NCT02655419|83217593|FG001|Overall Study|Other|1|||
46853381|NCT00098865|83069529|FG000|Overall Study|Adverse Event|2|||
46853382|NCT00098865|83069529|FG000|Overall Study|Alternative Therapy|1|||
46853383|NCT02954458|83069537|FG000|Overall Study|Adverse Event|0|||
46973718|NCT01962922|83217605|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
46973719|NCT01962922|83217606|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
46853384|NCT02954458|83069538|FG001|Overall Study|Adverse Event|0|||
46973720|NCT01962922|83217605|FG000|PK Portion Day 7|non-compliance|1|||
46973721|NCT01962922|83217606|FG001|PK Portion Day 7|non-compliance|0|||
46973722|NCT01962922|83217605|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
46973723|NCT01962922|83217606|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
46973724|NCT01962922|83217605|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
46973725|NCT01962922|83217606|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
46973726|NCT01984684|83217614|FG000|Overall Study|Lost to Follow-up|25|||
46973727|NCT01984684|83217615|FG001|Overall Study|Lost to Follow-up|24|||
46973728|NCT01984684|83217614|FG000|Overall Study|Adverse Event|8|||
46973729|NCT01984684|83217615|FG001|Overall Study|Adverse Event|12|||
46973730|NCT01984684|83217614|FG000|Overall Study|Withdrawal by Subject|9|||
46973731|NCT01984684|83217615|FG001|Overall Study|Withdrawal by Subject|9|||
46973732|NCT01984684|83217614|FG000|Overall Study|Lack of Efficacy|3|||
46973733|NCT01984684|83217615|FG001|Overall Study|Lack of Efficacy|6|||
46973734|NCT01984684|83217614|FG000|Overall Study|Physician Decision|4|||
46973735|NCT01984684|83217615|FG001|Overall Study|Physician Decision|2|||
46973736|NCT01984684|83217614|FG000|Overall Study|Protocol Violation|4|||
46973737|NCT01984684|83217615|FG001|Overall Study|Protocol Violation|2|||
47078033|NCT05209360|83382928|FG003|Overall Study|Withdrawal by Subject|0|||
47078034|NCT05209360|83382929|FG004|Overall Study|Withdrawal by Subject|0|||
47078035|NCT05209360|83382930|FG005|Overall Study|Withdrawal by Subject|0|||
47078036|NCT04594733|83382991|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
46853385|NCT02954458|83069539|FG002|Overall Study|Adverse Event|0|||
46973738|NCT01984684|83217614|FG000|Overall Study|Death|0|||
46973739|NCT01984684|83217615|FG001|Overall Study|Death|1|||
46973740|NCT01984684|83217614|FG000|Overall Study|Noncompliance with study drug|2|||
46973741|NCT01984684|83217615|FG001|Overall Study|Noncompliance with study drug|1|||
46973742|NCT01984684|83217614|FG000|Overall Study|Subject incarcerated|1|||
46790768|NCT00615030|83009670|FG008|Period I|Subject withdrew consent|1|||
46790769|NCT00615030|83009671|FG009|Period I|Subject withdrew consent|0|||
46790770|NCT00615030|83009672|FG010|Period I|Subject withdrew consent|1|||
46790771|NCT00615030|83009673|FG011|Period I|Subject withdrew consent|1|||
47078037|NCT04594733|83382992|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
46853386|NCT02954458|83069540|FG003|Overall Study|Adverse Event|1|||
46853387|NCT02954458|83069537|FG000|Overall Study|Withdrawal by Subject|0|||
46973743|NCT01984684|83217615|FG001|Overall Study|Subject incarcerated|0|||
46973744|NCT01984684|83217614|FG000|Overall Study|Study drug not available at site|1|||
46973745|NCT01984684|83217615|FG001|Overall Study|Study drug not available at site|1|||
46973746|NCT01984684|83217614|FG000|Overall Study|Subject had inadequate IV access|0|||
46790772|NCT00615030|83009662|FG000|Period I|Abnormal laboratory value(s)|0|||
46790773|NCT00615030|83009663|FG001|Period I|Abnormal laboratory value(s)|0|||
46790774|NCT00615030|83009664|FG002|Period I|Abnormal laboratory value(s)|0|||
46790775|NCT00615030|83009665|FG003|Period I|Abnormal laboratory value(s)|0|||
46790776|NCT00615030|83009666|FG004|Period I|Abnormal laboratory value(s)|0|||
46790777|NCT00615030|83009667|FG005|Period I|Abnormal laboratory value(s)|1|||
46790778|NCT00615030|83009668|FG006|Period I|Abnormal laboratory value(s)|0|||
46790779|NCT00615030|83009669|FG007|Period I|Abnormal laboratory value(s)|0|||
46790780|NCT00615030|83009670|FG008|Period I|Abnormal laboratory value(s)|0|||
46973747|NCT01984684|83217615|FG001|Overall Study|Subject had inadequate IV access|1|||
46973748|NCT02694523|83217623|FG000|Part A|Adverse Event|7|||
46973749|NCT02694523|83217624|FG001|Part A|Adverse Event|3|||
46973750|NCT02694523|83217625|FG002|Part A|Adverse Event|0|||
46973751|NCT02694523|83217626|FG003|Part A|Adverse Event|0|||
46973752|NCT02694523|83217627|FG004|Part A|Adverse Event|0|||
46973753|NCT02694523|83217628|FG005|Part A|Adverse Event|0|||
46973754|NCT02694523|83217629|FG006|Part A|Adverse Event|0|||
46973755|NCT02694523|83217623|FG000|Part A|Protocol Violation|1|||
46973756|NCT02694523|83217624|FG001|Part A|Protocol Violation|0|||
46973757|NCT02694523|83217625|FG002|Part A|Protocol Violation|0|||
46973758|NCT02694523|83217626|FG003|Part A|Protocol Violation|0|||
46973759|NCT02694523|83217627|FG004|Part A|Protocol Violation|0|||
46973760|NCT02694523|83217628|FG005|Part A|Protocol Violation|0|||
46973761|NCT02694523|83217629|FG006|Part A|Protocol Violation|0|||
46973762|NCT02694523|83217623|FG000|Part A|Lost to Follow-up|1|||
46973763|NCT02694523|83217624|FG001|Part A|Lost to Follow-up|2|||
46973764|NCT02694523|83217625|FG002|Part A|Lost to Follow-up|0|||
46973765|NCT02694523|83217626|FG003|Part A|Lost to Follow-up|0|||
46973766|NCT02694523|83217627|FG004|Part A|Lost to Follow-up|0|||
46973767|NCT02694523|83217628|FG005|Part A|Lost to Follow-up|0|||
46973768|NCT02694523|83217629|FG006|Part A|Lost to Follow-up|0|||
46973769|NCT02694523|83217623|FG000|Part A|Withdrawal by Subject|3|||
46973770|NCT02694523|83217624|FG001|Part A|Withdrawal by Subject|1|||
46973771|NCT02694523|83217625|FG002|Part A|Withdrawal by Subject|0|||
46973772|NCT02694523|83217626|FG003|Part A|Withdrawal by Subject|0|||
46973773|NCT02694523|83217627|FG004|Part A|Withdrawal by Subject|0|||
46973774|NCT02694523|83217628|FG005|Part A|Withdrawal by Subject|0|||
46973775|NCT02694523|83217629|FG006|Part A|Withdrawal by Subject|0|||
46973776|NCT02694523|83217623|FG000|Part A|Other|1|||
46973777|NCT02694523|83217624|FG001|Part A|Other|1|||
46973778|NCT02694523|83217625|FG002|Part A|Other|0|||
46973779|NCT02694523|83217626|FG003|Part A|Other|0|||
46973780|NCT02694523|83217627|FG004|Part A|Other|0|||
46973781|NCT02694523|83217628|FG005|Part A|Other|0|||
46973782|NCT02694523|83217629|FG006|Part A|Other|0|||
46973783|NCT02694523|83217623|FG000|Part B|Adverse Event|0|||
46973784|NCT02694523|83217624|FG001|Part B|Adverse Event|0|||
46973785|NCT02694523|83217625|FG002|Part B|Adverse Event|7|||
46973786|NCT02694523|83217626|FG003|Part B|Adverse Event|1|||
46973787|NCT02694523|83217627|FG004|Part B|Adverse Event|1|||
46973788|NCT02694523|83217628|FG005|Part B|Adverse Event|2|||
46973789|NCT02694523|83217629|FG006|Part B|Adverse Event|0|||
46973790|NCT02694523|83217623|FG000|Part B|Protocol Violation|0|||
46973791|NCT02694523|83217624|FG001|Part B|Protocol Violation|0|||
46973792|NCT02694523|83217625|FG002|Part B|Protocol Violation|1|||
46973793|NCT02694523|83217626|FG003|Part B|Protocol Violation|0|||
46973794|NCT02694523|83217627|FG004|Part B|Protocol Violation|0|||
46973795|NCT02694523|83217628|FG005|Part B|Protocol Violation|0|||
46973796|NCT02694523|83217629|FG006|Part B|Protocol Violation|0|||
46973797|NCT02694523|83217623|FG000|Part B|Lost to Follow-up|0|||
46973798|NCT02694523|83217624|FG001|Part B|Lost to Follow-up|0|||
46973799|NCT02694523|83217625|FG002|Part B|Lost to Follow-up|2|||
46973800|NCT02694523|83217626|FG003|Part B|Lost to Follow-up|3|||
46973801|NCT02694523|83217627|FG004|Part B|Lost to Follow-up|2|||
46973802|NCT02694523|83217628|FG005|Part B|Lost to Follow-up|0|||
46973803|NCT02694523|83217629|FG006|Part B|Lost to Follow-up|1|||
46790781|NCT00615030|83009671|FG009|Period I|Abnormal laboratory value(s)|0|||
46973804|NCT02694523|83217623|FG000|Part B|Withdrawal by Subject|0|||
46973805|NCT02694523|83217624|FG001|Part B|Withdrawal by Subject|0|||
46973806|NCT02694523|83217625|FG002|Part B|Withdrawal by Subject|9|||
46973807|NCT02694523|83217626|FG003|Part B|Withdrawal by Subject|0|||
46973808|NCT02694523|83217627|FG004|Part B|Withdrawal by Subject|1|||
46790782|NCT00615030|83009672|FG010|Period I|Abnormal laboratory value(s)|0|||
46973809|NCT02694523|83217628|FG005|Part B|Withdrawal by Subject|3|||
46973810|NCT02694523|83217629|FG006|Part B|Withdrawal by Subject|0|||
46973811|NCT02694523|83217623|FG000|Part B|Other|0|||
46973812|NCT02694523|83217624|FG001|Part B|Other|0|||
46973813|NCT02694523|83217625|FG002|Part B|Other|1|||
46973814|NCT02694523|83217626|FG003|Part B|Other|0|||
46973815|NCT02694523|83217627|FG004|Part B|Other|0|||
46973816|NCT02694523|83217628|FG005|Part B|Other|0|||
46973817|NCT02694523|83217629|FG006|Part B|Other|1|||
46973818|NCT01353703|83217643|FG000|Overall Study|Migrated/moved from study area|1|||
46973819|NCT01353703|83217644|FG001|Overall Study|Migrated/moved from study area|0|||
46973820|NCT02009332|83217658|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
46973821|NCT02009332|83217659|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
46973822|NCT02009332|83217660|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
46973823|NCT02009332|83217661|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
46973824|NCT02009332|83217662|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
46973825|NCT02009332|83217663|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
46973826|NCT02009332|83217658|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
46973827|NCT02009332|83217659|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
46973828|NCT02009332|83217660|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
46973829|NCT02009332|83217661|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
46973830|NCT02009332|83217662|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
46973831|NCT02009332|83217663|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
46973832|NCT02009332|83217658|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
46973833|NCT02009332|83217659|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
46973834|NCT02009332|83217660|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
46973835|NCT02009332|83217661|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
46973836|NCT02009332|83217662|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
46973837|NCT02009332|83217663|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
46973838|NCT01984294|83217680|FG000|Overall Study|Randomized but Never Treated|0|||
46973839|NCT01984294|83217681|FG001|Overall Study|Randomized but Never Treated|0|||
46973840|NCT01984294|83217682|FG002|Overall Study|Randomized but Never Treated|1|||
46973841|NCT01984294|83217680|FG000|Overall Study|Lack of Efficacy|4|||
46973842|NCT01984294|83217681|FG001|Overall Study|Lack of Efficacy|2|||
46790783|NCT00615030|83009673|FG011|Period I|Abnormal laboratory value(s)|0|||
46790784|NCT00615030|83009662|FG000|Period II|Adverse Event|0|||
46790785|NCT00615030|83009663|FG001|Period II|Adverse Event|0|||
46790786|NCT00615030|83009664|FG002|Period II|Adverse Event|1|||
46790787|NCT00615030|83009665|FG003|Period II|Adverse Event|0|||
46790788|NCT00615030|83009666|FG004|Period II|Adverse Event|0|||
46790789|NCT00615030|83009667|FG005|Period II|Adverse Event|0|||
46790790|NCT00615030|83009668|FG006|Period II|Adverse Event|0|||
46790791|NCT00615030|83009669|FG007|Period II|Adverse Event|0|||
46790792|NCT00615030|83009670|FG008|Period II|Adverse Event|1|||
46790793|NCT00615030|83009671|FG009|Period II|Adverse Event|0|||
46853388|NCT02954458|83069538|FG001|Overall Study|Withdrawal by Subject|0|||
46853389|NCT02954458|83069539|FG002|Overall Study|Withdrawal by Subject|0|||
46853390|NCT02954458|83069540|FG003|Overall Study|Withdrawal by Subject|1|||
46853391|NCT02954458|83069537|FG000|Overall Study|Physician Decision|0|||
46853392|NCT02954458|83069538|FG001|Overall Study|Physician Decision|0|||
46853393|NCT02954458|83069539|FG002|Overall Study|Physician Decision|1|||
46853394|NCT02954458|83069540|FG003|Overall Study|Physician Decision|1|||
46853395|NCT02954458|83069537|FG000|Overall Study|Lost to Follow-up|1|||
46853396|NCT02954458|83069538|FG001|Overall Study|Lost to Follow-up|0|||
46853397|NCT02954458|83069539|FG002|Overall Study|Lost to Follow-up|0|||
46853398|NCT02954458|83069540|FG003|Overall Study|Lost to Follow-up|1|||
46853399|NCT02954458|83069537|FG000|Overall Study|Death|0|||
46853400|NCT02954458|83069538|FG001|Overall Study|Death|0|||
46853401|NCT02954458|83069539|FG002|Overall Study|Death|0|||
46853402|NCT02954458|83069540|FG003|Overall Study|Death|1|||
46853403|NCT02954458|83069537|FG000|Overall Study|Other|0|||
46973843|NCT01984294|83217682|FG002|Overall Study|Lack of Efficacy|6|||
46973844|NCT01984294|83217680|FG000|Overall Study|Adverse Event|0|||
46973845|NCT01984294|83217681|FG001|Overall Study|Adverse Event|1|||
46973846|NCT01984294|83217682|FG002|Overall Study|Adverse Event|0|||
46973847|NCT01962298|83217695|FG000|Overall Study|Protocol Violation|1|||
46973848|NCT01962298|83217696|FG001|Overall Study|Protocol Violation|0|||
46973849|NCT01962298|83217697|FG002|Overall Study|Protocol Violation|1|||
46973850|NCT01962298|83217698|FG003|Overall Study|Protocol Violation|1|||
46973851|NCT01962298|83217699|FG004|Overall Study|Protocol Violation|0|||
46973852|NCT01962298|83217695|FG000|Overall Study|Data quality insufficient|2|||
47078038|NCT04594733|83382991|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
46973853|NCT01962298|83217696|FG001|Overall Study|Data quality insufficient|0|||
47078039|NCT04594733|83382992|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
47078040|NCT04594733|83382991|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
47078041|NCT04594733|83382992|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
46853404|NCT02954458|83069538|FG001|Overall Study|Other|0|||
46853405|NCT02954458|83069539|FG002|Overall Study|Other|0|||
46853406|NCT02954458|83069540|FG003|Overall Study|Other|7|||
46853407|NCT03500224|83069554|FG000|Overall Study|Withdrawal by Subject|2|||
46707539|NCT01155570|82923117|FG000|Overall Study|Other Reasons|23|||
46790794|NCT00615030|83009672|FG010|Period II|Adverse Event|0|||
46790795|NCT00615030|83009673|FG011|Period II|Adverse Event|0|||
46790796|NCT00615030|83009662|FG000|Period II|Subject withdrew consent|0|||
46853408|NCT00077649|83069562|FG000|Overall Study|Adverse Event|5|||
46853409|NCT00077649|83069563|FG001|Overall Study|Adverse Event|1|||
46853410|NCT00077649|83069564|FG002|Overall Study|Adverse Event|7|||
46973854|NCT01962298|83217697|FG002|Overall Study|Data quality insufficient|3|||
46973855|NCT01962298|83217698|FG003|Overall Study|Data quality insufficient|1|||
46973856|NCT01962298|83217699|FG004|Overall Study|Data quality insufficient|4|||
46790797|NCT00615030|83009663|FG001|Period II|Subject withdrew consent|0|||
46790798|NCT00615030|83009664|FG002|Period II|Subject withdrew consent|0|||
46790799|NCT00615030|83009665|FG003|Period II|Subject withdrew consent|1|||
46790800|NCT00615030|83009666|FG004|Period II|Subject withdrew consent|0|||
46790801|NCT00615030|83009667|FG005|Period II|Subject withdrew consent|0|||
46790802|NCT00615030|83009668|FG006|Period II|Subject withdrew consent|1|||
46853411|NCT00077649|83069565|FG003|Overall Study|Adverse Event|9|||
46973857|NCT01962298|83217695|FG000|Overall Study|Insufficient data|0|||
46973858|NCT01962298|83217696|FG001|Overall Study|Insufficient data|2|||
46973859|NCT01962298|83217697|FG002|Overall Study|Insufficient data|1|||
46973860|NCT01962298|83217698|FG003|Overall Study|Insufficient data|0|||
46973861|NCT01962298|83217699|FG004|Overall Study|Insufficient data|1|||
46973862|NCT01962298|83217695|FG000|Overall Study|Incorrect data recorded|0|||
46973863|NCT01962298|83217696|FG001|Overall Study|Incorrect data recorded|1|||
46973864|NCT01962298|83217697|FG002|Overall Study|Incorrect data recorded|0|||
46973865|NCT01962298|83217698|FG003|Overall Study|Incorrect data recorded|0|||
46973866|NCT01962298|83217699|FG004|Overall Study|Incorrect data recorded|0|||
46973867|NCT01962298|83217695|FG000|Overall Study|Physician Decision|0|||
46973868|NCT01962298|83217696|FG001|Overall Study|Physician Decision|1|||
46973869|NCT01962298|83217697|FG002|Overall Study|Physician Decision|0|||
46973870|NCT01962298|83217698|FG003|Overall Study|Physician Decision|0|||
46973871|NCT01962298|83217699|FG004|Overall Study|Physician Decision|1|||
46973872|NCT02693743|83217713|FG000|Overall Study|Physician Decision|1|||
46973873|NCT02693743|83217714|FG001|Overall Study|Physician Decision|0|||
46973874|NCT02655887|83217720|FG000|Overall Study|Lost to Follow-up|3|||
46973875|NCT02655887|83217720|FG000|Overall Study|Death|4|||
46973876|NCT02655887|83217720|FG000|Overall Study|Withdrawal by Subject|3|||
46973877|NCT02655887|83217720|FG000|Overall Study|Missed 12-month follow-up visit|4|||
46973878|NCT02008318|83217726|FG000|Overall Study|Adverse Event|4|||
46973879|NCT02008318|83217727|FG001|Overall Study|Adverse Event|0|||
46973880|NCT02008318|83217726|FG000|Overall Study|Physician Decision|2|||
46973881|NCT02008318|83217727|FG001|Overall Study|Physician Decision|0|||
46973882|NCT02008318|83217726|FG000|Overall Study|Progressive Disease|2|||
46973883|NCT02008318|83217727|FG001|Overall Study|Progressive Disease|0|||
46973884|NCT02008318|83217726|FG000|Overall Study|Protocol Violation|1|||
46973885|NCT02008318|83217727|FG001|Overall Study|Protocol Violation|1|||
46973886|NCT02008318|83217726|FG000|Overall Study|Withdrawal by Subject|3|||
46973887|NCT02008318|83217727|FG001|Overall Study|Withdrawal by Subject|0|||
46973888|NCT01982812|83217738|FG000|Overall Study|Death|1|||
46973889|NCT01982812|83217739|FG001|Overall Study|Death|5|||
46973890|NCT01982812|83217738|FG000|Overall Study|Adverse Event|0|||
46673847|NCT01163149|82889355|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
46673848|NCT01163149|82889356|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
46673849|NCT01163149|82889357|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
46673850|NCT01163149|82889355|FG000|Extension Treatment Period|Adverse Event|0|||
46673851|NCT01163149|82889356|FG001|Extension Treatment Period|Adverse Event|1|||
46673852|NCT01163149|82889357|FG002|Extension Treatment Period|Adverse Event|0|||
46673853|NCT01163149|82889355|FG000|Extension Treatment Period|Noncompliance|0|||
46673854|NCT01163149|82889356|FG001|Extension Treatment Period|Noncompliance|0|||
46673855|NCT01163149|82889357|FG002|Extension Treatment Period|Noncompliance|1|||
46673856|NCT01163032|82889382|FG000|Randomization Phase|Withdrawal by Subject|2|||
46673857|NCT01163032|82889383|FG001|Randomization Phase|Withdrawal by Subject|3|||
46673858|NCT01163032|82889384|FG002|Randomization Phase|Withdrawal by Subject|0|||
46673859|NCT01163032|82889382|FG000|Randomization Phase|Adverse Event|3|||
46673860|NCT01163032|82889383|FG001|Randomization Phase|Adverse Event|3|||
46673861|NCT01163032|82889384|FG002|Randomization Phase|Adverse Event|0|||
46673862|NCT01163032|82889382|FG000|Randomization Phase|Protocol Violation|0|||
46673863|NCT01163032|82889383|FG001|Randomization Phase|Protocol Violation|1|||
46673864|NCT01163032|82889384|FG002|Randomization Phase|Protocol Violation|0|||
46673865|NCT01163032|82889382|FG000|Randomization Phase|Various*|5|||
46673866|NCT01163032|82889383|FG001|Randomization Phase|Various*|4|||
46673867|NCT01163032|82889384|FG002|Randomization Phase|Various*|0|||
46673868|NCT01163032|82889382|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
46673869|NCT01163032|82889383|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
46673870|NCT01163032|82889384|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
46673871|NCT01163032|82889382|FG000|Open Label Extension Phase|Adverse Event|0|||
46673872|NCT01163032|82889383|FG001|Open Label Extension Phase|Adverse Event|0|||
46673873|NCT01163032|82889384|FG002|Open Label Extension Phase|Adverse Event|3|||
46673874|NCT01163032|82889382|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
46673875|NCT01163032|82889383|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
46673876|NCT01163032|82889384|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
46973891|NCT01982812|83217739|FG001|Overall Study|Adverse Event|5|||
46973892|NCT02007070|83217745|FG000|Overall Study|Adverse Event|4|||
46973893|NCT02007070|83217745|FG000|Overall Study|Clinical Progression|4|||
46790803|NCT00615030|83009669|FG007|Period II|Subject withdrew consent|0|||
46853412|NCT00077649|83069562|FG000|Overall Study|Lack of Efficacy|5|||
46973894|NCT02007070|83217745|FG000|Overall Study|Death|1|||
46973895|NCT02007070|83217745|FG000|Overall Study|Protocol Violation|2|||
46973896|NCT02007070|83217745|FG000|Overall Study|Physician Decision|1|||
46790804|NCT00615030|83009670|FG008|Period II|Subject withdrew consent|0|||
46790805|NCT00615030|83009671|FG009|Period II|Subject withdrew consent|0|||
46973897|NCT02007070|83217745|FG000|Overall Study|Progressive Disease|21|||
46973898|NCT02006758|83217749|FG000|Overall Study|Protocol Violation|1|||
46973899|NCT02006758|83217749|FG000|Overall Study|Death|1|||
46973900|NCT02006758|83217749|FG000|Overall Study|Lost to Follow-up|4|||
46973901|NCT02006758|83217749|FG000|Overall Study|Withdrawal by Subject|4|||
46973902|NCT02006758|83217749|FG000|Overall Study|Procedurally excluded|1|||
46973903|NCT02006758|83217749|FG000|Overall Study|Other|2|||
46973904|NCT01960816|83217754|FG000|Overall Study|Lost to Follow-up|1|||
46973905|NCT01602419|83217758|FG000|Overall Study|Not treated with Wilate|9|||
46973906|NCT01602419|83217758|FG000|Overall Study|Adverse Drug Reaction|4|||
46973907|NCT01602419|83217758|FG000|Overall Study|Insurance issues|3|||
46973908|NCT01602419|83217758|FG000|Overall Study|Changed treatment centre|1|||
46973909|NCT01602419|83217758|FG000|Overall Study|Treatment centre closed|1|||
46973910|NCT01602419|83217758|FG000|Overall Study|Withdrawal by Subject|5|||
46973911|NCT01602419|83217758|FG000|Overall Study|Lost to Follow-up|6|||
46973912|NCT01981954|83217803|FG000|Titration Period|Protocol Deviation|1|||
46973913|NCT01981954|83217803|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
46973914|NCT02693119|83217809|FG000|Open-Label Period|Withdrawal by Subject|0|||
46973915|NCT02693119|83217810|FG001|Open-Label Period|Withdrawal by Subject|1|||
46973916|NCT05641311|83217848|FG000|Dosing Period 1|Adverse Event|1|||
46973917|NCT05641311|83217849|FG001|Dosing Period 1|Adverse Event|0|||
46973918|NCT05502289|83217862|FG000|Period 1|Out Of Window|1|||
46973919|NCT05502289|83217863|FG001|Period 1|Out Of Window|0|||
46973920|NCT04778592|83217875|FG000|Overall Study|Adverse Event|1|||
46973921|NCT04778592|83217876|FG001|Overall Study|Adverse Event|2|||
46973922|NCT04778592|83217875|FG000|Overall Study|Withdrawal by Subject|1|||
46973923|NCT04778592|83217876|FG001|Overall Study|Withdrawal by Subject|2|||
46973924|NCT04688671|83217884|FG000|Overall Study|Adverse Event|3|||
46973925|NCT04688671|83217885|FG001|Overall Study|Adverse Event|1|||
46973926|NCT04688671|83217884|FG000|Overall Study|Withdrawal by Subject|3|||
46973927|NCT04688671|83217885|FG001|Overall Study|Withdrawal by Subject|1|||
46973928|NCT04688671|83217884|FG000|Overall Study|Lack of Efficacy|1|||
46973929|NCT04688671|83217885|FG001|Overall Study|Lack of Efficacy|1|||
46973930|NCT04688671|83217884|FG000|Overall Study|Protocol Violation|1|||
46973931|NCT04688671|83217885|FG001|Overall Study|Protocol Violation|0|||
46973932|NCT04688671|83217884|FG000|Overall Study|Lost to Follow-up|0|||
46973933|NCT04688671|83217885|FG001|Overall Study|Lost to Follow-up|1|||
46973934|NCT04668209|83217893|FG000|Overall Study|Withdrawal by Subject|2|||
47078042|NCT04570657|83383002|FG000|Overall Study|Adverse Event|0|||
47078043|NCT04570657|83383003|FG001|Overall Study|Adverse Event|0|||
47078044|NCT04570657|83383004|FG002|Overall Study|Adverse Event|1|||
47078045|NCT04570657|83383002|FG000|Overall Study|Lost to Follow-up|0|||
47078046|NCT04570657|83383003|FG001|Overall Study|Lost to Follow-up|0|||
46790806|NCT00615030|83009672|FG010|Period II|Subject withdrew consent|0|||
46973935|NCT04668209|83217894|FG001|Overall Study|Withdrawal by Subject|2|||
46973936|NCT04668209|83217893|FG000|Overall Study|Lost to Follow-up|3|||
46973937|NCT04668209|83217894|FG001|Overall Study|Lost to Follow-up|4|||
46973938|NCT04668209|83217893|FG000|Overall Study|Subject Expired|2|||
46973939|NCT04668209|83217894|FG001|Overall Study|Subject Expired|0|||
46973940|NCT04668209|83217893|FG000|Overall Study|Withdrawn from study|0|||
47078047|NCT04570657|83383004|FG002|Overall Study|Lost to Follow-up|1|||
46790807|NCT00615030|83009673|FG011|Period II|Subject withdrew consent|0|||
46790808|NCT00615030|83009662|FG000|Period III|Administrative problems|1|||
46790809|NCT00615030|83009663|FG001|Period III|Administrative problems|0|||
46790810|NCT00615030|83009664|FG002|Period III|Administrative problems|0|||
46790811|NCT00615030|83009665|FG003|Period III|Administrative problems|1|||
46790812|NCT00615030|83009666|FG004|Period III|Administrative problems|0|||
46790813|NCT00615030|83009667|FG005|Period III|Administrative problems|0|||
46790814|NCT00615030|83009668|FG006|Period III|Administrative problems|0|||
46790815|NCT00615030|83009669|FG007|Period III|Administrative problems|0|||
46790816|NCT00615030|83009670|FG008|Period III|Administrative problems|0|||
46790817|NCT00615030|83009671|FG009|Period III|Administrative problems|0|||
46790818|NCT00615030|83009672|FG010|Period III|Administrative problems|0|||
46790819|NCT00615030|83009673|FG011|Period III|Administrative problems|0|||
46973941|NCT04668209|83217894|FG001|Overall Study|Withdrawn from study|1|||
46973942|NCT04668209|83217893|FG000|Overall Study|Adverse Event|0|||
46973943|NCT04668209|83217894|FG001|Overall Study|Adverse Event|1|||
46973944|NCT04456998|83217904|FG000|Overall Study|Adverse Event|0|||
46973945|NCT04456998|83217905|FG001|Overall Study|Adverse Event|4|||
47078048|NCT04570657|83383002|FG000|Overall Study|Physician Decision|0|||
47078049|NCT04570657|83383003|FG001|Overall Study|Physician Decision|1|||
46790820|NCT00518284|83009691|FG000|Overall Study|Adverse Event|0|||
46790821|NCT00518284|83009692|FG001|Overall Study|Adverse Event|1|||
46973946|NCT04456998|83217904|FG000|Overall Study|Protocol Deviation|0|||
47078050|NCT04570657|83383004|FG002|Overall Study|Physician Decision|0|||
46973947|NCT04456998|83217905|FG001|Overall Study|Protocol Deviation|1|||
46973948|NCT04456998|83217904|FG000|Overall Study|Withdrawal by Subject|0|||
46973949|NCT04456998|83217905|FG001|Overall Study|Withdrawal by Subject|1|||
46973950|NCT04251221|83217934|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
46973951|NCT04251221|83217935|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
47078051|NCT04570657|83383002|FG000|Overall Study|Withdrawal by Subject|1|||
47078052|NCT04570657|83383003|FG001|Overall Study|Withdrawal by Subject|2|||
47078053|NCT04570657|83383004|FG002|Overall Study|Withdrawal by Subject|2|||
47078054|NCT04566601|83383017|FG000|Overall Study|Other than listed|13|||
47078055|NCT04566601|83383018|FG001|Overall Study|Other than listed|4|||
47078056|NCT04566601|83383019|FG002|Overall Study|Other than listed|2|||
47078057|NCT04566601|83383020|FG003|Overall Study|Other than listed|1|||
47078058|NCT04566601|83383021|FG004|Overall Study|Other than listed|4|||
47078059|NCT04566601|83383017|FG000|Overall Study|Protocol deviation|3|||
47078060|NCT04566601|83383018|FG001|Overall Study|Protocol deviation|0|||
47078061|NCT04566601|83383019|FG002|Overall Study|Protocol deviation|1|||
47078062|NCT04566601|83383020|FG003|Overall Study|Protocol deviation|1|||
47078063|NCT04566601|83383021|FG004|Overall Study|Protocol deviation|1|||
47078064|NCT04566601|83383017|FG000|Overall Study|Technical problems|0|||
47078065|NCT04566601|83383018|FG001|Overall Study|Technical problems|0|||
47078066|NCT04566601|83383019|FG002|Overall Study|Technical problems|1|||
47078067|NCT04566601|83383020|FG003|Overall Study|Technical problems|0|||
47078068|NCT04566601|83383021|FG004|Overall Study|Technical problems|0|||
47078069|NCT04566601|83383017|FG000|Overall Study|No reason available|3|||
46853413|NCT00077649|83069563|FG001|Overall Study|Lack of Efficacy|3|||
46853414|NCT00077649|83069564|FG002|Overall Study|Lack of Efficacy|3|||
46853415|NCT00077649|83069565|FG003|Overall Study|Lack of Efficacy|2|||
46853416|NCT00077649|83069562|FG000|Overall Study|Withdrawal by Subject|0|||
46853417|NCT00077649|83069563|FG001|Overall Study|Withdrawal by Subject|1|||
46853418|NCT00077649|83069564|FG002|Overall Study|Withdrawal by Subject|1|||
47078070|NCT04566601|83383018|FG001|Overall Study|No reason available|2|||
47078071|NCT04566601|83383019|FG002|Overall Study|No reason available|7|||
47078072|NCT04566601|83383020|FG003|Overall Study|No reason available|1|||
46673877|NCT01163032|82889382|FG000|Open Label Extension Phase|Protocol Violation|0|||
46853419|NCT00077649|83069565|FG003|Overall Study|Withdrawal by Subject|2|||
46853420|NCT00077649|83069562|FG000|Overall Study|Lost to Follow-up|2|||
47078073|NCT04566601|83383021|FG004|Overall Study|No reason available|5|||
47078074|NCT04566601|83383017|FG000|Overall Study|Burden of study procedures|3|||
47078075|NCT04566601|83383018|FG001|Overall Study|Burden of study procedures|0|||
47078076|NCT04566601|83383019|FG002|Overall Study|Burden of study procedures|0|||
47078077|NCT04566601|83383020|FG003|Overall Study|Burden of study procedures|3|||
47078078|NCT04566601|83383021|FG004|Overall Study|Burden of study procedures|1|||
46673878|NCT01163032|82889383|FG001|Open Label Extension Phase|Protocol Violation|0|||
46790822|NCT00518284|83009693|FG002|Overall Study|Adverse Event|0|||
46790823|NCT00518284|83009694|FG003|Overall Study|Adverse Event|0|||
46790824|NCT00518284|83009691|FG000|Overall Study|Study Termination|0|||
46790825|NCT00518284|83009692|FG001|Overall Study|Study Termination|2|||
46790826|NCT00518284|83009693|FG002|Overall Study|Study Termination|1|||
46790827|NCT00518284|83009694|FG003|Overall Study|Study Termination|2|||
46790828|NCT00614874|83009704|FG000|Overall Study|Protocol Violation|1|||
46790829|NCT00614874|83009704|FG000|Overall Study|Withdrawal by Subject|1|||
46790830|NCT00727415|83009708|FG000|Phase I|Dose Limiting Toxicity|2|||
46790831|NCT00544557|83009712|FG000|Overall Study|Adverse Event|140|||
46790832|NCT00544557|83009712|FG000|Overall Study|Lack of Efficacy|196|||
46790833|NCT00544557|83009712|FG000|Overall Study|Other|98|||
46790834|NCT00727259|83009716|FG000|Overall Study|Not all questionnaires completed|1055|||
46790835|NCT00735371|83009725|FG000|Overall Study|Adverse Event|3|||
46790836|NCT00735371|83009726|FG001|Overall Study|Adverse Event|3|||
46790837|NCT00735371|83009727|FG002|Overall Study|Adverse Event|4|||
46790838|NCT00735371|83009728|FG003|Overall Study|Adverse Event|1|||
46790839|NCT00735371|83009725|FG000|Overall Study|Protocol Violation|2|||
46790840|NCT00735371|83009726|FG001|Overall Study|Protocol Violation|2|||
46790841|NCT00735371|83009727|FG002|Overall Study|Protocol Violation|0|||
46790842|NCT00735371|83009728|FG003|Overall Study|Protocol Violation|3|||
46790843|NCT00735371|83009725|FG000|Overall Study|Withdrawal by Subject|0|||
46790844|NCT00735371|83009726|FG001|Overall Study|Withdrawal by Subject|2|||
46790845|NCT00735371|83009727|FG002|Overall Study|Withdrawal by Subject|2|||
46853421|NCT00077649|83069563|FG001|Overall Study|Lost to Follow-up|2|||
46853422|NCT00077649|83069564|FG002|Overall Study|Lost to Follow-up|3|||
47078079|NCT04566601|83383017|FG000|Overall Study|Change of residence|2|||
47078080|NCT04566601|83383018|FG001|Overall Study|Change of residence|2|||
46790846|NCT00735371|83009728|FG003|Overall Study|Withdrawal by Subject|0|||
46790847|NCT00735371|83009725|FG000|Overall Study|Lost to Follow-up|1|||
46790848|NCT00735371|83009726|FG001|Overall Study|Lost to Follow-up|1|||
46790849|NCT00735371|83009727|FG002|Overall Study|Lost to Follow-up|3|||
46853423|NCT00077649|83069565|FG003|Overall Study|Lost to Follow-up|2|||
46853424|NCT00077649|83069562|FG000|Overall Study|Abnormality of Laboratory Test|1|||
46973952|NCT04203238|83217943|FG000|Overall Study|Withdrawal by Subject|1|||
46973953|NCT04203238|83217944|FG001|Overall Study|Withdrawal by Subject|1|||
46973954|NCT04203238|83217943|FG000|Overall Study|Covid-19|3|||
46973955|NCT04203238|83217944|FG001|Overall Study|Covid-19|0|||
46973956|NCT04055844|83217982|FG000|Overall Study|Adverse Event|12|||
46790850|NCT00735371|83009728|FG003|Overall Study|Lost to Follow-up|1|||
46790851|NCT00735371|83009725|FG000|Overall Study|Lack of Efficacy|4|||
46790852|NCT00735371|83009726|FG001|Overall Study|Lack of Efficacy|2|||
46790853|NCT00735371|83009727|FG002|Overall Study|Lack of Efficacy|0|||
46790854|NCT00735371|83009728|FG003|Overall Study|Lack of Efficacy|4|||
46853425|NCT00077649|83069563|FG001|Overall Study|Abnormality of Laboratory Test|2|||
46853426|NCT00077649|83069564|FG002|Overall Study|Abnormality of Laboratory Test|1|||
46853427|NCT00077649|83069565|FG003|Overall Study|Abnormality of Laboratory Test|2|||
46853428|NCT00077649|83069562|FG000|Overall Study|Randomized but never dosed|1|||
46853429|NCT00077649|83069563|FG001|Overall Study|Randomized but never dosed|0|||
46853430|NCT00077649|83069564|FG002|Overall Study|Randomized but never dosed|0|||
46853431|NCT00077649|83069565|FG003|Overall Study|Randomized but never dosed|0|||
46853432|NCT00038948|83069581|FG000|Overall Study|Adverse Event|131|||
46853433|NCT00038948|83069582|FG001|Overall Study|Adverse Event|43|||
46853434|NCT00038948|83069581|FG000|Overall Study|Lost to Follow-up|4|||
46853435|NCT00038948|83069582|FG001|Overall Study|Lost to Follow-up|4|||
46853436|NCT00038948|83069581|FG000|Overall Study|Nonmedical event|5|||
46853437|NCT00038948|83069582|FG001|Overall Study|Nonmedical event|7|||
46853438|NCT00038948|83069581|FG000|Overall Study|Withdrawal by Subject|23|||
46853439|NCT00038948|83069582|FG001|Overall Study|Withdrawal by Subject|10|||
46853440|NCT00038948|83069581|FG000|Overall Study|Protocol Violation|3|||
46790855|NCT00735371|83009725|FG000|Overall Study|Sponsor Decision|3|||
46790856|NCT00735371|83009726|FG001|Overall Study|Sponsor Decision|1|||
46853441|NCT00038948|83069582|FG001|Overall Study|Protocol Violation|7|||
46853442|NCT00038948|83069581|FG000|Overall Study|Lack of Efficacy|3|||
46853443|NCT00038948|83069582|FG001|Overall Study|Lack of Efficacy|6|||
46853444|NCT00054704|83069596|FG000|Overall Study|Lack of Efficacy|2|||
46853445|NCT00054704|83069597|FG001|Overall Study|Lack of Efficacy|3|||
46853446|NCT00054704|83069596|FG000|Overall Study|Adverse Event|3|||
46853447|NCT00054704|83069597|FG001|Overall Study|Adverse Event|1|||
46853448|NCT00054704|83069596|FG000|Overall Study|Lost to Follow-up|0|||
46853449|NCT00054704|83069597|FG001|Overall Study|Lost to Follow-up|1|||
46853450|NCT00031694|83069603|FG000|Overall Study|Adverse Event|12|||
46853451|NCT00031694|83069603|FG000|Overall Study|Death|2|||
46853452|NCT00031694|83069603|FG000|Overall Study|Withdrawal by Subject|5|||
46853453|NCT00093795|83069611|FG000|Overall Study|No follow up data|20|||
46853454|NCT00093795|83069612|FG001|Overall Study|No follow up data|16|||
46853455|NCT00093795|83069613|FG002|Overall Study|No follow up data|17|||
46853456|NCT03467152|83069623|FG000|Overall Study|Adverse Event|4|||
46853457|NCT03467152|83069624|FG001|Overall Study|Adverse Event|5|||
46790857|NCT00735371|83009727|FG002|Overall Study|Sponsor Decision|0|||
46790858|NCT00735371|83009728|FG003|Overall Study|Sponsor Decision|1|||
46790859|NCT00735371|83009725|FG000|Overall Study|Protocol Violation|0|||
46790860|NCT00735371|83009726|FG001|Overall Study|Protocol Violation|1|||
46790861|NCT00735371|83009727|FG002|Overall Study|Protocol Violation|2|||
46790862|NCT00735371|83009728|FG003|Overall Study|Protocol Violation|0|||
46790863|NCT00735371|83009725|FG000|Overall Study|Prior Vyvanse Exposure|1|||
46790864|NCT00735371|83009726|FG001|Overall Study|Prior Vyvanse Exposure|1|||
46853458|NCT03467152|83069625|FG002|Overall Study|Adverse Event|0|||
46853459|NCT03467152|83069623|FG000|Overall Study|Subject Choice|1|||
46853460|NCT03467152|83069624|FG001|Overall Study|Subject Choice|3|||
46973957|NCT04055844|83217982|FG000|Overall Study|Poor Performance|1|||
46853461|NCT03467152|83069625|FG002|Overall Study|Subject Choice|0|||
46853462|NCT03467152|83069623|FG000|Overall Study|Lost to Follow-up|1|||
46853463|NCT03467152|83069624|FG001|Overall Study|Lost to Follow-up|0|||
46853464|NCT03467152|83069625|FG002|Overall Study|Lost to Follow-up|0|||
46853465|NCT03467152|83069623|FG000|Overall Study|Withdrawal by Subject|4|||
46853466|NCT03467152|83069624|FG001|Overall Study|Withdrawal by Subject|2|||
46853467|NCT03467152|83069625|FG002|Overall Study|Withdrawal by Subject|0|||
46853468|NCT03467152|83069623|FG000|Overall Study|Others|3|||
46853469|NCT03467152|83069624|FG001|Overall Study|Others|0|||
46790865|NCT00735371|83009727|FG002|Overall Study|Prior Vyvanse Exposure|0|||
46853470|NCT03467152|83069625|FG002|Overall Study|Others|0|||
46853471|NCT03467152|83069623|FG000|Overall Study|Not treated|3|||
46853472|NCT03467152|83069624|FG001|Overall Study|Not treated|1|||
46973958|NCT04055844|83217982|FG000|Overall Study|Death|1|||
46790866|NCT00735371|83009728|FG003|Overall Study|Prior Vyvanse Exposure|0|||
46790867|NCT00735371|83009725|FG000|Overall Study|Exclusion criteria|1|||
46790868|NCT00735371|83009726|FG001|Overall Study|Exclusion criteria|0|||
46790869|NCT00735371|83009727|FG002|Overall Study|Exclusion criteria|0|||
46790870|NCT00735371|83009728|FG003|Overall Study|Exclusion criteria|0|||
46790871|NCT00518206|83009740|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
46790872|NCT00518206|83009741|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
46790873|NCT00518206|83009740|FG000|Overall Study|Withdrawal by Subject|2|||
46973959|NCT03905655|83218004|FG000|Overall Study|Adverse Event|1|||
46973960|NCT03905655|83218005|FG001|Overall Study|Adverse Event|0|||
46973961|NCT03905655|83218006|FG002|Overall Study|Adverse Event|1|||
46973962|NCT03905655|83218007|FG003|Overall Study|Adverse Event|1|||
46973963|NCT03555149|83218038|FG000|Overall Study|Death|18|||
47078081|NCT04566601|83383019|FG002|Overall Study|Change of residence|0|||
47078082|NCT04566601|83383020|FG003|Overall Study|Change of residence|1|||
47078083|NCT04566601|83383021|FG004|Overall Study|Change of residence|2|||
47078084|NCT04566601|83383017|FG000|Overall Study|Perceived lack of efficacy|2|||
47078085|NCT04566601|83383018|FG001|Overall Study|Perceived lack of efficacy|0|||
47078086|NCT04566601|83383019|FG002|Overall Study|Perceived lack of efficacy|1|||
47078087|NCT04566601|83383020|FG003|Overall Study|Perceived lack of efficacy|1|||
47078088|NCT04566601|83383021|FG004|Overall Study|Perceived lack of efficacy|2|||
47078089|NCT04566601|83383017|FG000|Overall Study|Adverse Event|7|||
47078090|NCT04566601|83383018|FG001|Overall Study|Adverse Event|4|||
47078091|NCT04566601|83383019|FG002|Overall Study|Adverse Event|6|||
47078092|NCT04566601|83383020|FG003|Overall Study|Adverse Event|5|||
47078093|NCT04566601|83383021|FG004|Overall Study|Adverse Event|12|||
47078094|NCT04168112|83383075|FG000|Overall Study|Lost to Follow-up|1|||
47078095|NCT04168112|83383076|FG001|Overall Study|Lost to Follow-up|0|||
47078096|NCT04168112|83383075|FG000|Overall Study|Withdrawal by Subject|1|||
47078097|NCT04168112|83383076|FG001|Overall Study|Withdrawal by Subject|0|||
47078098|NCT04005352|83383084|FG000|Overall Study|Adverse Event|4|||
47078099|NCT04005352|83383085|FG001|Overall Study|Adverse Event|5|||
47078100|NCT04005352|83383084|FG000|Overall Study|Death|4|||
47078101|NCT04005352|83383085|FG001|Overall Study|Death|2|||
47078102|NCT04005352|83383084|FG000|Overall Study|Lost to Follow-up|6|||
47078103|NCT04005352|83383085|FG001|Overall Study|Lost to Follow-up|2|||
47078104|NCT04005352|83383084|FG000|Overall Study|Physician Decision|7|||
47078105|NCT04005352|83383085|FG001|Overall Study|Physician Decision|13|||
47078106|NCT04005352|83383084|FG000|Overall Study|Protocol Violation|0|||
47078107|NCT04005352|83383085|FG001|Overall Study|Protocol Violation|1|||
47078108|NCT04005352|83383084|FG000|Overall Study|Withdrawal by Subject|28|||
47078109|NCT04005352|83383085|FG001|Overall Study|Withdrawal by Subject|38|||
47078110|NCT03952039|83383098|FG000|Overall Study|Adverse Event|22|||
47078111|NCT03952039|83383099|FG001|Overall Study|Adverse Event|8|||
47078112|NCT03952039|83383098|FG000|Overall Study|Withdrawal by Participant|17|||
47078113|NCT03952039|83383099|FG001|Overall Study|Withdrawal by Participant|12|||
47078114|NCT03952039|83383098|FG000|Overall Study|Death|13|||
47078115|NCT03952039|83383099|FG001|Overall Study|Death|6|||
47078116|NCT03952039|83383098|FG000|Overall Study|Lack of Efficacy|12|||
47078117|NCT03952039|83383099|FG001|Overall Study|Lack of Efficacy|2|||
47078118|NCT03952039|83383098|FG000|Overall Study|Physician Decision|9|||
46853473|NCT03467152|83069625|FG002|Overall Study|Not treated|6|||
46853474|NCT03466060|83069634|FG000|Period 1|Test Lens Damage|0|||
46853475|NCT03466060|83069635|FG001|Period 1|Test Lens Damage|2|||
46853476|NCT03466060|83069636|FG002|Period 1|Test Lens Damage|0|||
46853477|NCT03466060|83069637|FG003|Period 1|Test Lens Damage|0|||
46853478|NCT03466060|83069638|FG004|Period 1|Test Lens Damage|0|||
46853479|NCT03466060|83069639|FG005|Period 1|Test Lens Damage|0|||
46853480|NCT03466060|83069634|FG000|Period 1|Withdrawal by Subject|0|||
46853481|NCT03466060|83069635|FG001|Period 1|Withdrawal by Subject|0|||
47078119|NCT03952039|83383099|FG001|Overall Study|Physician Decision|3|||
47078120|NCT03952039|83383098|FG000|Overall Study|Progressive Disease|6|||
47078121|NCT03952039|83383099|FG001|Overall Study|Progressive Disease|4|||
47078122|NCT03952039|83383098|FG000|Overall Study|Other Reasons|12|||
47078123|NCT03952039|83383099|FG001|Overall Study|Other Reasons|4|||
47078124|NCT03940586|83383118|FG000|Overall Study|Death|3|||
47078125|NCT03940586|83383119|FG001|Overall Study|Death|2|||
46853482|NCT03466060|83069636|FG002|Period 1|Withdrawal by Subject|2|||
46853483|NCT03466060|83069637|FG003|Period 1|Withdrawal by Subject|0|||
47078126|NCT03940586|83383120|FG002|Overall Study|Death|0|||
47078127|NCT03940586|83383118|FG000|Overall Study|Physician Decision|1|||
46853484|NCT03466060|83069638|FG004|Period 1|Withdrawal by Subject|0|||
46853485|NCT03466060|83069639|FG005|Period 1|Withdrawal by Subject|0|||
46853486|NCT03466060|83069634|FG000|Period 1|Lost to Follow-up|0|||
46973964|NCT03555149|83218039|FG001|Overall Study|Death|15|||
47078128|NCT03940586|83383119|FG001|Overall Study|Physician Decision|0|||
47078129|NCT03940586|83383120|FG002|Overall Study|Physician Decision|1|||
47078130|NCT03940586|83383118|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
47078131|NCT03940586|83383119|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
47078132|NCT03940586|83383120|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
47078133|NCT03940586|83383118|FG000|Overall Study|Not Treated|0|||
46790874|NCT00518206|83009741|FG001|Overall Study|Withdrawal by Subject|0|||
46790875|NCT00518206|83009740|FG000|Overall Study|Drug Supply Issue|1|||
46790876|NCT00518206|83009741|FG001|Overall Study|Drug Supply Issue|0|||
46790877|NCT00518206|83009740|FG000|Overall Study|Reason Unknown|1|||
46790878|NCT00518206|83009741|FG001|Overall Study|Reason Unknown|0|||
46790879|NCT00518206|83009740|FG000|Overall Study|Completion Status Unknown|1|||
46790880|NCT00518206|83009741|FG001|Overall Study|Completion Status Unknown|0|||
46790881|NCT00586313|83009747|FG000|Overall Study|Lack of Efficacy|2|||
46790882|NCT00734747|83009751|FG000|SRS Procedure|No staples placed|3|||
46790883|NCT00734747|83009751|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
46790884|NCT00726557|83009755|FG000|Overall Study|Screening failure|4|||
46790885|NCT00726557|83009755|FG000|Overall Study|No end of treatment documentation|37|||
46790886|NCT00726557|83009755|FG000|Overall Study|No follow-up documentation available|55|||
46790887|NCT00726557|83009755|FG000|Overall Study|Treatment less than 3 months|17|||
46790888|NCT00726557|83009755|FG000|Overall Study|Inclusion criteria not met|15|||
46790889|NCT00738881|83009762|FG000|Overall Study|Withdrawal by Subject|0|||
46790890|NCT00738881|83009763|FG001|Overall Study|Withdrawal by Subject|2|||
46790891|NCT00657020|83009769|FG000|PERIOD 1|Adverse Event|0|||
46790892|NCT00657020|83009770|FG001|PERIOD 1|Adverse Event|1|||
46790893|NCT03921723|83009782|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
46790894|NCT03921723|83009782|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
46790895|NCT00544167|83009790|FG000|Overall Study|Adverse Event|21|||
46790896|NCT00544167|83009790|FG000|Overall Study|Physician Decision|8|||
46790897|NCT00659438|83009796|FG000|Overall Study|Withdrawal by Subject|2|||
46790898|NCT00659438|83009797|FG001|Overall Study|Withdrawal by Subject|2|||
46790899|NCT00659438|83009796|FG000|Overall Study|Death|11|||
46790900|NCT00659438|83009797|FG001|Overall Study|Death|6|||
46790901|NCT00659438|83009796|FG000|Overall Study|Lost to Follow-up|1|||
46790902|NCT00659438|83009797|FG001|Overall Study|Lost to Follow-up|0|||
46790903|NCT00543855|83009807|FG000|Overall Study|Adverse Event|3|||
46790904|NCT00543855|83009808|FG001|Overall Study|Adverse Event|1|||
46790905|NCT00543855|83009809|FG002|Overall Study|Adverse Event|3|||
46973965|NCT03555149|83218040|FG002|Overall Study|Death|15|||
46973966|NCT03555149|83218041|FG003|Overall Study|Death|4|||
46973967|NCT03555149|83218042|FG004|Overall Study|Death|4|||
46973968|NCT03555149|83218043|FG005|Overall Study|Death|11|||
46973969|NCT03555149|83218044|FG006|Overall Study|Death|12|||
47078134|NCT03940586|83383119|FG001|Overall Study|Not Treated|2|||
46790906|NCT00543855|83009810|FG003|Overall Study|Adverse Event|4|||
46790907|NCT00543855|83009807|FG000|Overall Study|Lost to Follow-up|0|||
46790908|NCT00543855|83009808|FG001|Overall Study|Lost to Follow-up|0|||
46853487|NCT03466060|83069635|FG001|Period 1|Lost to Follow-up|0|||
46853488|NCT03466060|83069636|FG002|Period 1|Lost to Follow-up|0|||
46853489|NCT03466060|83069637|FG003|Period 1|Lost to Follow-up|1|||
46853490|NCT03466060|83069638|FG004|Period 1|Lost to Follow-up|0|||
46853491|NCT03466060|83069639|FG005|Period 1|Lost to Follow-up|0|||
46853492|NCT03466060|83069634|FG000|Period 1|Grade 2 Conjunctivitis|0|||
46853493|NCT03466060|83069635|FG001|Period 1|Grade 2 Conjunctivitis|0|||
47078135|NCT03940586|83383120|FG002|Overall Study|Not Treated|0|||
47078136|NCT03782974|83383163|FG000|Overall Study|Withdrawal by Subject|7|||
47078137|NCT03782974|83383164|FG001|Overall Study|Withdrawal by Subject|7|||
46853494|NCT03466060|83069636|FG002|Period 1|Grade 2 Conjunctivitis|1|||
46853495|NCT03466060|83069637|FG003|Period 1|Grade 2 Conjunctivitis|0|||
46853496|NCT03466060|83069638|FG004|Period 1|Grade 2 Conjunctivitis|0|||
46853497|NCT03466060|83069639|FG005|Period 1|Grade 2 Conjunctivitis|0|||
46853498|NCT03466060|83069634|FG000|Period 2|Lens Handling Difficulties|0|||
46853499|NCT03466060|83069635|FG001|Period 2|Lens Handling Difficulties|0|||
46853500|NCT03466060|83069636|FG002|Period 2|Lens Handling Difficulties|1|||
46853501|NCT03466060|83069637|FG003|Period 2|Lens Handling Difficulties|0|||
46853502|NCT03466060|83069638|FG004|Period 2|Lens Handling Difficulties|0|||
46853503|NCT03466060|83069639|FG005|Period 2|Lens Handling Difficulties|0|||
46853504|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
46853505|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
46853506|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
46973970|NCT03555149|83218045|FG007|Overall Study|Death|1|||
47078138|NCT03782974|83383163|FG000|Overall Study|Pregnancy|1|||
46790909|NCT00543855|83009809|FG002|Overall Study|Lost to Follow-up|1|||
46790910|NCT00543855|83009810|FG003|Overall Study|Lost to Follow-up|0|||
46790911|NCT00543855|83009807|FG000|Overall Study|Withdrawal by Subject|0|||
46790912|NCT00543855|83009808|FG001|Overall Study|Withdrawal by Subject|1|||
46790913|NCT00543855|83009809|FG002|Overall Study|Withdrawal by Subject|2|||
46790914|NCT00543855|83009810|FG003|Overall Study|Withdrawal by Subject|0|||
46790915|NCT00543855|83009807|FG000|Overall Study|Protocol Violation|1|||
46790916|NCT00543855|83009808|FG001|Overall Study|Protocol Violation|0|||
46790917|NCT00543855|83009809|FG002|Overall Study|Protocol Violation|0|||
46790918|NCT00543855|83009810|FG003|Overall Study|Protocol Violation|0|||
46790919|NCT00656474|83009820|FG000|Overall Study|Other Reason|1|||
46853507|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
46973971|NCT03555149|83218038|FG000|Overall Study|Lost to Follow-up|1|||
46790920|NCT00656084|83009825|FG000|Overall Study|Adverse Event|4|||
46790921|NCT00656084|83009825|FG000|Overall Study|Withdrawal by Subject|1|||
46790922|NCT00656084|83009825|FG000|Overall Study|Patient Request|1|||
46790923|NCT00656084|83009825|FG000|Overall Study|Investigator Request|1|||
46790924|NCT00613938|83009833|FG000|Overall Study|Withdrawal by Subject|2|||
46790925|NCT00613938|83009834|FG001|Overall Study|Withdrawal by Subject|4|||
46790926|NCT00613938|83009835|FG002|Overall Study|Withdrawal by Subject|9|||
46790927|NCT00613938|83009836|FG003|Overall Study|Withdrawal by Subject|9|||
46790928|NCT00613938|83009833|FG000|Overall Study|Adverse Event|1|||
46790929|NCT00613938|83009834|FG001|Overall Study|Adverse Event|4|||
46790930|NCT00613938|83009835|FG002|Overall Study|Adverse Event|8|||
46790931|NCT00613938|83009836|FG003|Overall Study|Adverse Event|5|||
46790932|NCT00613938|83009833|FG000|Overall Study|Lack of Efficacy|16|||
46790933|NCT00613938|83009834|FG001|Overall Study|Lack of Efficacy|18|||
46790934|NCT00613938|83009835|FG002|Overall Study|Lack of Efficacy|5|||
46790935|NCT00613938|83009836|FG003|Overall Study|Lack of Efficacy|9|||
46790936|NCT00613938|83009833|FG000|Overall Study|Other|1|||
46973972|NCT03555149|83218039|FG001|Overall Study|Lost to Follow-up|0|||
46973973|NCT03555149|83218040|FG002|Overall Study|Lost to Follow-up|0|||
46973974|NCT03555149|83218041|FG003|Overall Study|Lost to Follow-up|0|||
46973975|NCT03555149|83218042|FG004|Overall Study|Lost to Follow-up|0|||
46973976|NCT03555149|83218043|FG005|Overall Study|Lost to Follow-up|1|||
46973977|NCT03555149|83218044|FG006|Overall Study|Lost to Follow-up|0|||
46790937|NCT00613938|83009834|FG001|Overall Study|Other|2|||
46790938|NCT00613938|83009835|FG002|Overall Study|Other|1|||
46790939|NCT00613938|83009836|FG003|Overall Study|Other|3|||
46790940|NCT00655928|83009848|FG000|Overall Study|Withdrawal by Subject|2|||
46790941|NCT00655928|83009849|FG001|Overall Study|Withdrawal by Subject|1|||
46790942|NCT00655928|83009848|FG000|Overall Study|Physician Decision|1|||
46790943|NCT00655928|83009849|FG001|Overall Study|Physician Decision|1|||
46790944|NCT00655850|83009855|FG000|Overall Study|Death|2|||
46790945|NCT00655850|83009855|FG000|Overall Study|Withdrawal by Subject|1|||
46790946|NCT00726323|83009863|FG000|Overall Study|Withdrawal by Subject|3|||
46790947|NCT00726323|83009864|FG001|Overall Study|Withdrawal by Subject|1|||
46790948|NCT00726323|83009863|FG000|Overall Study|Physician Decision|1|||
46790949|NCT00726323|83009864|FG001|Overall Study|Physician Decision|0|||
46790950|NCT00726323|83009863|FG000|Overall Study|Progressive disease|23|||
46790951|NCT00726323|83009864|FG001|Overall Study|Progressive disease|16|||
46790952|NCT00726323|83009863|FG000|Overall Study|Clinical progression|0|||
46790953|NCT00726323|83009864|FG001|Overall Study|Clinical progression|3|||
46790954|NCT00726323|83009863|FG000|Overall Study|Adverse Event|9|||
46790955|NCT00726323|83009864|FG001|Overall Study|Adverse Event|9|||
46790956|NCT00726323|83009863|FG000|Overall Study|Death|1|||
46853508|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
46853509|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
46853510|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
46853511|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
46853512|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
46853513|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
46853514|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
46853515|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
46973978|NCT03555149|83218045|FG007|Overall Study|Lost to Follow-up|0|||
46973979|NCT03555149|83218038|FG000|Overall Study|Physician Decision|1|||
46973980|NCT03555149|83218039|FG001|Overall Study|Physician Decision|0|||
46973981|NCT03555149|83218040|FG002|Overall Study|Physician Decision|0|||
46973982|NCT03555149|83218041|FG003|Overall Study|Physician Decision|0|||
46973983|NCT03555149|83218042|FG004|Overall Study|Physician Decision|0|||
46973984|NCT03555149|83218043|FG005|Overall Study|Physician Decision|0|||
46973985|NCT03555149|83218044|FG006|Overall Study|Physician Decision|0|||
46973986|NCT03555149|83218045|FG007|Overall Study|Physician Decision|0|||
46973987|NCT03555149|83218038|FG000|Overall Study|Study Terminated By Sponsor|1|||
46973988|NCT03555149|83218039|FG001|Overall Study|Study Terminated By Sponsor|0|||
46973989|NCT03555149|83218040|FG002|Overall Study|Study Terminated By Sponsor|0|||
46973990|NCT03555149|83218041|FG003|Overall Study|Study Terminated By Sponsor|0|||
46973991|NCT03555149|83218042|FG004|Overall Study|Study Terminated By Sponsor|0|||
46973992|NCT03555149|83218043|FG005|Overall Study|Study Terminated By Sponsor|2|||
46790957|NCT00726323|83009864|FG001|Overall Study|Death|0|||
46790958|NCT00726323|83009863|FG000|Overall Study|Participant wished to discontinue|0|||
46973993|NCT03555149|83218044|FG006|Overall Study|Study Terminated By Sponsor|3|||
46973994|NCT03555149|83218045|FG007|Overall Study|Study Terminated By Sponsor|1|||
46973995|NCT03555149|83218038|FG000|Overall Study|Withdrawal by Subject|3|||
46790959|NCT00726323|83009864|FG001|Overall Study|Participant wished to discontinue|1|||
46790960|NCT00726323|83009863|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
46790961|NCT00726323|83009864|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
46790962|NCT00246571|83009872|FG000|Overall Study|Adverse Event|7|||
46790963|NCT00246571|83009873|FG001|Overall Study|Adverse Event|0|||
46790964|NCT00246571|83009872|FG000|Overall Study|Protocol Violation|0|||
46973996|NCT03555149|83218039|FG001|Overall Study|Withdrawal by Subject|0|||
46973997|NCT03555149|83218040|FG002|Overall Study|Withdrawal by Subject|0|||
46973998|NCT03555149|83218041|FG003|Overall Study|Withdrawal by Subject|2|||
46973999|NCT03555149|83218042|FG004|Overall Study|Withdrawal by Subject|0|||
46974000|NCT03555149|83218043|FG005|Overall Study|Withdrawal by Subject|1|||
46974001|NCT03555149|83218044|FG006|Overall Study|Withdrawal by Subject|0|||
46853516|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
46853517|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
46974002|NCT03555149|83218045|FG007|Overall Study|Withdrawal by Subject|0|||
46974003|NCT03515811|83218065|FG000|Overall Study|Lost to Follow-up|2|||
46974004|NCT03515811|83218066|FG001|Overall Study|Lost to Follow-up|1|||
46974005|NCT03515811|83218065|FG000|Overall Study|Protocol Violation|1|||
46974006|NCT03515811|83218066|FG001|Overall Study|Protocol Violation|1|||
46974007|NCT03515811|83218065|FG000|Overall Study|Death|1|||
46974008|NCT03515811|83218066|FG001|Overall Study|Death|1|||
46974009|NCT03515811|83218065|FG000|Overall Study|Withdrawal by Subject|0|||
46974010|NCT03515811|83218066|FG001|Overall Study|Withdrawal by Subject|2|||
46974011|NCT03515811|83218065|FG000|Overall Study|Technical Problems|1|||
46974012|NCT03515811|83218066|FG001|Overall Study|Technical Problems|0|||
46974013|NCT03515811|83218065|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
46974014|NCT03515811|83218066|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
46974015|NCT03515811|83218065|FG000|Overall Study|COVID-19|0|||
46974016|NCT03515811|83218066|FG001|Overall Study|COVID-19|1|||
46974017|NCT02847598|83218140|FG000|Overall Study|Adverse Event|0|||
46974018|NCT02847598|83218141|FG001|Overall Study|Adverse Event|0|||
46974019|NCT02847598|83218142|FG002|Overall Study|Adverse Event|0|||
46974020|NCT02847598|83218143|FG003|Overall Study|Adverse Event|0|||
46974021|NCT02847598|83218144|FG004|Overall Study|Adverse Event|0|||
46974022|NCT02847598|83218145|FG005|Overall Study|Adverse Event|0|||
46974023|NCT02847598|83218146|FG006|Overall Study|Adverse Event|0|||
46974024|NCT02847598|83218147|FG007|Overall Study|Adverse Event|1|||
46974025|NCT02847598|83218140|FG000|Overall Study|Consent withdrawn|2|||
46974026|NCT02847598|83218141|FG001|Overall Study|Consent withdrawn|0|||
46974027|NCT02847598|83218142|FG002|Overall Study|Consent withdrawn|0|||
46790965|NCT00246571|83009873|FG001|Overall Study|Protocol Violation|1|||
46974028|NCT02847598|83218143|FG003|Overall Study|Consent withdrawn|4|||
46974029|NCT02847598|83218144|FG004|Overall Study|Consent withdrawn|3|||
46974030|NCT02847598|83218145|FG005|Overall Study|Consent withdrawn|2|||
46974031|NCT02847598|83218146|FG006|Overall Study|Consent withdrawn|1|||
46974032|NCT02847598|83218147|FG007|Overall Study|Consent withdrawn|3|||
46974033|NCT02847598|83218140|FG000|Overall Study|Death|3|||
46974034|NCT02847598|83218141|FG001|Overall Study|Death|0|||
46974035|NCT02847598|83218142|FG002|Overall Study|Death|0|||
46974036|NCT02847598|83218143|FG003|Overall Study|Death|0|||
46974037|NCT02847598|83218144|FG004|Overall Study|Death|0|||
46974038|NCT02847598|83218145|FG005|Overall Study|Death|0|||
46974039|NCT02847598|83218146|FG006|Overall Study|Death|0|||
46974040|NCT02847598|83218147|FG007|Overall Study|Death|0|||
46974041|NCT02847598|83218140|FG000|Overall Study|Lost to Follow-up|0|||
46974042|NCT02847598|83218141|FG001|Overall Study|Lost to Follow-up|0|||
46974043|NCT02847598|83218142|FG002|Overall Study|Lost to Follow-up|0|||
46974044|NCT02847598|83218143|FG003|Overall Study|Lost to Follow-up|0|||
46974045|NCT02847598|83218144|FG004|Overall Study|Lost to Follow-up|0|||
46974046|NCT02847598|83218145|FG005|Overall Study|Lost to Follow-up|1|||
46974047|NCT02847598|83218146|FG006|Overall Study|Lost to Follow-up|1|||
46974048|NCT02847598|83218147|FG007|Overall Study|Lost to Follow-up|0|||
46974049|NCT02834975|83218171|FG000|Overall Study|Physician Decision|2|||
46974050|NCT02834975|83218171|FG000|Overall Study|Adverse Event|1|||
46974051|NCT02834975|83218171|FG000|Overall Study|Withdrawal by Subject|1|||
47078139|NCT03782974|83383164|FG001|Overall Study|Pregnancy|0|||
46790966|NCT00246571|83009872|FG000|Overall Study|Withdrawal by Subject|2|||
46790967|NCT00246571|83009873|FG001|Overall Study|Withdrawal by Subject|3|||
46790968|NCT00246571|83009872|FG000|Overall Study|Lack of Efficacy|84|||
46790969|NCT00246571|83009873|FG001|Overall Study|Lack of Efficacy|21|||
46790970|NCT00246571|83009872|FG000|Overall Study|Death|17|||
46853518|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
46853519|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
46974052|NCT02834975|83218171|FG000|Overall Study|Lack of Efficacy|1|||
46974053|NCT02684123|83218194|FG000|Phase 1|Lack of Efficacy|5|||
46974054|NCT02684123|83218195|FG001|Phase 1|Lack of Efficacy|0|||
46974055|NCT02684123|83218194|FG000|Phase 1|Adverse Event|3|||
46974056|NCT02684123|83218195|FG001|Phase 1|Adverse Event|0|||
46974057|NCT02684123|83218194|FG000|Phase 1|Lost to Follow-up|0|||
46974058|NCT02684123|83218195|FG001|Phase 1|Lost to Follow-up|1|||
46974059|NCT02684123|83218194|FG000|Phase 2|Lack of Efficacy|1|||
46974060|NCT02684123|83218195|FG001|Phase 2|Lack of Efficacy|8|||
46673879|NCT01163032|82889384|FG002|Open Label Extension Phase|Protocol Violation|1|||
46974061|NCT02203331|83218273|FG000|Overall Study|Pregnancy|1|||
46790971|NCT00246571|83009873|FG001|Overall Study|Death|3|||
46790972|NCT00246571|83009872|FG000|Overall Study|Sponsor|0|||
46790973|NCT00246571|83009873|FG001|Overall Study|Sponsor|1|||
46974062|NCT02203331|83218274|FG001|Overall Study|Pregnancy|0|||
46974063|NCT02203331|83218275|FG002|Overall Study|Pregnancy|0|||
46974064|NCT02203331|83218276|FG003|Overall Study|Pregnancy|0|||
46974065|NCT02203331|83218277|FG004|Overall Study|Pregnancy|2|||
46974066|NCT02203331|83218278|FG005|Overall Study|Pregnancy|0|||
46974067|NCT02203331|83218273|FG000|Overall Study|Withdrawal by Subject|1|||
46974068|NCT02203331|83218274|FG001|Overall Study|Withdrawal by Subject|0|||
46974069|NCT02203331|83218275|FG002|Overall Study|Withdrawal by Subject|1|||
46974070|NCT02203331|83218276|FG003|Overall Study|Withdrawal by Subject|0|||
46974071|NCT02203331|83218277|FG004|Overall Study|Withdrawal by Subject|0|||
46974072|NCT02203331|83218278|FG005|Overall Study|Withdrawal by Subject|3|||
46974073|NCT02203331|83218273|FG000|Overall Study|Adverse Event|4|||
46974074|NCT02203331|83218274|FG001|Overall Study|Adverse Event|8|||
46974075|NCT02203331|83218275|FG002|Overall Study|Adverse Event|3|||
46974076|NCT02203331|83218276|FG003|Overall Study|Adverse Event|4|||
46974077|NCT02203331|83218277|FG004|Overall Study|Adverse Event|3|||
46974078|NCT02203331|83218278|FG005|Overall Study|Adverse Event|3|||
46974079|NCT02203331|83218273|FG000|Overall Study|Other Reasons|1|||
46974080|NCT02203331|83218274|FG001|Overall Study|Other Reasons|2|||
46974081|NCT02203331|83218275|FG002|Overall Study|Other Reasons|0|||
46974082|NCT02203331|83218276|FG003|Overall Study|Other Reasons|2|||
46974083|NCT02203331|83218277|FG004|Overall Study|Other Reasons|0|||
46853520|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
46853521|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
46853522|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
46853523|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
46853524|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
46853525|NCT00092547|83069655|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
46853526|NCT00092547|83069656|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
46853527|NCT00092547|83069657|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
46853528|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
46853529|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
46853530|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
46853531|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
46853532|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
46853533|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
46853534|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
46853535|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
46853536|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
46853537|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
46853538|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
46974084|NCT02203331|83218278|FG005|Overall Study|Other Reasons|0|||
46974085|NCT02203331|83218273|FG000|Overall Study|Lack of Efficacy|0|||
46974086|NCT02203331|83218274|FG001|Overall Study|Lack of Efficacy|2|||
46974087|NCT02203331|83218275|FG002|Overall Study|Lack of Efficacy|1|||
46974088|NCT02203331|83218276|FG003|Overall Study|Lack of Efficacy|0|||
46974089|NCT02203331|83218277|FG004|Overall Study|Lack of Efficacy|0|||
46790974|NCT00246571|83009872|FG000|Overall Study|Did not meet entrance criteria|2|||
46790975|NCT00246571|83009873|FG001|Overall Study|Did not meet entrance criteria|1|||
46790976|NCT00246571|83009872|FG000|Overall Study|Laboratory abnormalities|1|||
46790977|NCT00246571|83009873|FG001|Overall Study|Laboratory abnormalities|0|||
46974090|NCT02203331|83218278|FG005|Overall Study|Lack of Efficacy|1|||
46974091|NCT02203331|83218273|FG000|Overall Study|Protocol Violation|0|||
46974092|NCT02203331|83218274|FG001|Overall Study|Protocol Violation|2|||
46974093|NCT02203331|83218275|FG002|Overall Study|Protocol Violation|0|||
46790978|NCT00246571|83009872|FG000|Overall Study|Crossover participants|0|||
46790979|NCT00246571|83009873|FG001|Overall Study|Crossover participants|74|||
46790980|NCT00734591|83009881|FG000|Screening for Prospective Period|Site did not participate|1604|||
46790981|NCT00734591|83009882|FG001|Screening for Prospective Period|Site did not participate|1488|||
46790982|NCT00734591|83009881|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
46790983|NCT00734591|83009882|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
46790984|NCT00734591|83009881|FG000|Prospective Period|Withdrawal by Subject|11|||
46790985|NCT00734591|83009882|FG001|Prospective Period|Withdrawal by Subject|9|||
46974094|NCT02203331|83218276|FG003|Overall Study|Protocol Violation|1|||
46974095|NCT02203331|83218277|FG004|Overall Study|Protocol Violation|1|||
46974096|NCT02203331|83218278|FG005|Overall Study|Protocol Violation|0|||
46974097|NCT02203331|83218273|FG000|Overall Study|Lost to Follow-up|0|||
46974098|NCT02203331|83218274|FG001|Overall Study|Lost to Follow-up|0|||
46974099|NCT02203331|83218275|FG002|Overall Study|Lost to Follow-up|0|||
46974100|NCT02203331|83218276|FG003|Overall Study|Lost to Follow-up|0|||
46974101|NCT02203331|83218277|FG004|Overall Study|Lost to Follow-up|1|||
46790986|NCT00734591|83009881|FG000|Prospective Period|Lost to Follow-up|37|||
46790987|NCT00734591|83009882|FG001|Prospective Period|Lost to Follow-up|33|||
46853539|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
46853540|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
46853541|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
46853542|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
46853543|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
46673880|NCT01163032|82889382|FG000|Open Label Extension Phase|Study Termination|0|||
46673881|NCT01163032|82889383|FG001|Open Label Extension Phase|Study Termination|0|||
46673882|NCT01163032|82889384|FG002|Open Label Extension Phase|Study Termination|7|||
46673883|NCT01163032|82889382|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
46673884|NCT01163032|82889383|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
46673885|NCT01163032|82889384|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
46673886|NCT01162486|82889397|FG000|Overall Study|low ANC|1|||
46673887|NCT01162486|82889398|FG001|Overall Study|low ANC|0|||
46673888|NCT01162486|82889399|FG002|Overall Study|low ANC|0|||
46790988|NCT00734591|83009881|FG000|Prospective Period|Study Terminated|1|||
46974102|NCT02203331|83218278|FG005|Overall Study|Lost to Follow-up|0|||
46974103|NCT02170025|83218307|FG000|Overall Study|Adverse Event|2|||
46853544|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
46853545|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
46853546|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
46853547|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
46853548|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
46974104|NCT02170025|83218308|FG001|Overall Study|Adverse Event|0|||
46974105|NCT02164578|83218316|FG000|Treatment Period|Withdrawal by Subject|3|||
46974106|NCT02164578|83218317|FG001|Treatment Period|Withdrawal by Subject|3|||
46974107|NCT02164578|83218316|FG000|Treatment Period|Adverse Event|13|||
46974108|NCT02164578|83218317|FG001|Treatment Period|Adverse Event|6|||
46974109|NCT02164578|83218316|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
46974110|NCT02164578|83218317|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
46974111|NCT02164578|83218316|FG000|Treatment Period|Protocol Violation|0|||
46974112|NCT02164578|83218317|FG001|Treatment Period|Protocol Violation|2|||
46853549|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
46853550|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
46853551|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
46853552|NCT00092547|83069655|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
46853553|NCT00092547|83069656|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
46853554|NCT00092547|83069657|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
46853555|NCT00092547|83069655|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
46853556|NCT00092547|83069656|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
46853557|NCT00092547|83069657|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
46853558|NCT00092547|83069655|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
46853559|NCT00092547|83069656|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
46853560|NCT00092547|83069657|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
46853561|NCT00092547|83069655|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
46853562|NCT00092547|83069656|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
46853563|NCT00092547|83069657|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
46853564|NCT00092547|83069655|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
46853565|NCT00092547|83069656|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
46853566|NCT00092547|83069657|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
46853567|NCT03802994|83069673|FG000|Overall Study|Lost to Follow-up|0|||
46853568|NCT03802994|83069674|FG001|Overall Study|Lost to Follow-up|2|||
46974113|NCT02164578|83218316|FG000|Extension Period|Withdrawal by Subject|2|||
46974114|NCT02164578|83218317|FG001|Extension Period|Withdrawal by Subject|0|||
46974115|NCT02164578|83218316|FG000|Extension Period|Adverse Event|4|||
46974116|NCT02164578|83218317|FG001|Extension Period|Adverse Event|0|||
46974117|NCT02164578|83218316|FG000|Extension Period|Expiry of study medication|1|||
46974118|NCT02164578|83218317|FG001|Extension Period|Expiry of study medication|0|||
46974119|NCT02164578|83218316|FG000|Extension Period|Protocol Violation|0|||
46974120|NCT02164578|83218317|FG001|Extension Period|Protocol Violation|1|||
46974121|NCT01823198|83218343|FG000|Overall Study|Physician Decision|0|||
46790989|NCT00734591|83009882|FG001|Prospective Period|Study Terminated|0|||
46790990|NCT00734591|83009881|FG000|Prospective Period|Other|2|||
46790991|NCT00734591|83009882|FG001|Prospective Period|Other|2|||
46790992|NCT00569270|83009888|FG000|Period: First Intervention|Protocol Violation|0|||
46790993|NCT00569270|83009889|FG001|Period: First Intervention|Protocol Violation|1|||
46790994|NCT00545103|83009908|FG000|Overall Study|Lack of Efficacy|48|||
46974122|NCT01823198|83218344|FG001|Overall Study|Physician Decision|1|||
46673889|NCT01162486|82889400|FG003|Overall Study|low ANC|0|||
46673890|NCT01162486|82889401|FG004|Overall Study|low ANC|0|||
46790995|NCT00545103|83009909|FG001|Overall Study|Lack of Efficacy|45|||
46790996|NCT00545103|83009910|FG002|Overall Study|Lack of Efficacy|31|||
46853569|NCT03802994|83069675|FG002|Overall Study|Lost to Follow-up|3|||
46853570|NCT03802994|83069676|FG003|Overall Study|Lost to Follow-up|2|||
46853571|NCT03802994|83069677|FG004|Overall Study|Lost to Follow-up|2|||
46853572|NCT03465904|83069702|FG000|Overall Study|Withdrawal by Subject|9|||
46853573|NCT03465904|83069703|FG001|Overall Study|Withdrawal by Subject|5|||
46853574|NCT03465904|83069702|FG000|Overall Study|Lost to Follow-up|10|||
46853575|NCT03465904|83069703|FG001|Overall Study|Lost to Follow-up|9|||
46853576|NCT03465904|83069702|FG000|Overall Study|Protocol Violation|8|||
46853577|NCT03465904|83069703|FG001|Overall Study|Protocol Violation|5|||
46853578|NCT03465904|83069702|FG000|Overall Study|Ineligible for mITT analysis|62|||
46853579|NCT03465904|83069703|FG001|Overall Study|Ineligible for mITT analysis|47|||
46853580|NCT03802916|83069711|FG000|Overall Study|Adverse Event|0|||
46853581|NCT03802916|83069712|FG001|Overall Study|Adverse Event|1|||
46853582|NCT03802916|83069711|FG000|Overall Study|Withdrawal by Subject|0|||
46853583|NCT03802916|83069712|FG001|Overall Study|Withdrawal by Subject|1|||
46853584|NCT00076011|83069720|FG000|Overall Study|Death|1|||
46853585|NCT00076011|83069720|FG000|Overall Study|Adverse Event|10|||
46853586|NCT00076011|83069720|FG000|Overall Study|Lack of Efficacy|25|||
46853587|NCT00076011|83069720|FG000|Overall Study|Withdrawal by Subject|1|||
46853588|NCT00076011|83069720|FG000|Overall Study|Study terminated by sponsor|3|||
46853589|NCT00076011|83069720|FG000|Overall Study|Other|11|||
46974123|NCT01823198|83218345|FG002|Overall Study|Physician Decision|0|||
46974124|NCT01823198|83218346|FG003|Overall Study|Physician Decision|0|||
46974125|NCT01823198|83218347|FG004|Overall Study|Physician Decision|0|||
46974126|NCT01823198|83218348|FG005|Overall Study|Physician Decision|3|||
46974127|NCT01823198|83218349|FG006|Overall Study|Physician Decision|3|||
46974128|NCT01761292|83218367|FG000|Part 1|Adverse Event|1|||
46974129|NCT01761292|83218367|FG000|Part 1|not receiving treatment in Part 1|1|||
46974130|NCT01761292|83218367|FG000|Extension 1|Withdrawal by Subject|1|||
46974131|NCT01725113|83218378|FG000|Overall Study|Kidney Transplant|1|||
46974132|NCT01725113|83218379|FG001|Overall Study|Kidney Transplant|1|||
46974133|NCT01725113|83218378|FG000|Overall Study|Withdrawal by Subject|0|||
46974134|NCT01725113|83218379|FG001|Overall Study|Withdrawal by Subject|1|||
46974135|NCT01580293|83218392|FG000|Part A_Main Trial|Adverse Event|0|||
46974136|NCT01580293|83218393|FG001|Part A_Main Trial|Adverse Event|2|||
46974137|NCT01580293|83218394|FG002|Part A_Main Trial|Adverse Event|0|||
46853590|NCT00076011|83069720|FG000|Overall Study|Ongoing|1|||
46853591|NCT03465436|83069728|FG000|Period 1|Protocol Violation|0|||
46853592|NCT03465436|83069729|FG001|Period 1|Protocol Violation|0|||
46853593|NCT03465436|83069730|FG002|Period 1|Protocol Violation|1|||
46853594|NCT03465436|83069731|FG003|Period 1|Protocol Violation|0|||
46853595|NCT03465436|83069728|FG000|Period 2|Protocol Violation|0|||
46853596|NCT03465436|83069729|FG001|Period 2|Protocol Violation|1|||
46853597|NCT03465436|83069730|FG002|Period 2|Protocol Violation|0|||
46853598|NCT03465436|83069731|FG003|Period 2|Protocol Violation|0|||
46853599|NCT03465436|83069728|FG000|Period 3|Protocol Violation|1|||
46853600|NCT03465436|83069729|FG001|Period 3|Protocol Violation|1|||
46853601|NCT03465436|83069730|FG002|Period 3|Protocol Violation|0|||
46853602|NCT03465436|83069731|FG003|Period 3|Protocol Violation|0|||
46853603|NCT03465436|83069728|FG000|Period 4|Protocol Violation|0|||
46853604|NCT03465436|83069729|FG001|Period 4|Protocol Violation|0|||
46853605|NCT03465436|83069730|FG002|Period 4|Protocol Violation|1|||
46853606|NCT03465436|83069731|FG003|Period 4|Protocol Violation|0|||
46853607|NCT00053846|83069745|FG000|Overall Study|Changed mind|8|||
46853608|NCT00053846|83069746|FG001|Overall Study|Changed mind|13|||
46853609|NCT00053846|83069745|FG000|Overall Study|Became too ill|8|||
46974138|NCT01580293|83218392|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
46974139|NCT01580293|83218393|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
46974140|NCT01580293|83218394|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
46974141|NCT01580293|83218392|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
46974142|NCT01580293|83218393|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
46974143|NCT01580293|83218394|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
47078140|NCT03674411|83383186|FG000|Overall Study|Non-treatment|4|||
47078141|NCT03655470|83383192|FG000|Overall Study|Lost to Follow-up|6|||
47078142|NCT03655470|83383193|FG001|Overall Study|Lost to Follow-up|7|||
46853610|NCT00053846|83069746|FG001|Overall Study|Became too ill|7|||
46853611|NCT00053846|83069745|FG000|Overall Study|Expired|5|||
46853612|NCT00053846|83069746|FG001|Overall Study|Expired|0|||
46853613|NCT00053846|83069745|FG000|Overall Study|Became ineligible|3|||
46853614|NCT00053846|83069746|FG001|Overall Study|Became ineligible|1|||
47078143|NCT03570619|83383202|FG000|Overall Study|Adverse Event|2|||
46853615|NCT00053846|83069745|FG000|Overall Study|Did not return data|1|||
46853616|NCT00053846|83069746|FG001|Overall Study|Did not return data|2|||
46853617|NCT00053846|83069745|FG000|Overall Study|Quit due to side effects|1|||
46853618|NCT00053846|83069746|FG001|Overall Study|Quit due to side effects|3|||
46853619|NCT00053846|83069745|FG000|Overall Study|Pills too large|0|||
46853620|NCT00053846|83069746|FG001|Overall Study|Pills too large|1|||
46853621|NCT00090987|83069752|FG000|Overall Study|Adverse Event|5|||
46974144|NCT01580293|83218392|FG000|Part A_Extension|Adverse Event|0|||
46974145|NCT01580293|83218393|FG001|Part A_Extension|Adverse Event|2|||
46974146|NCT01580293|83218394|FG002|Part A_Extension|Adverse Event|0|||
46974147|NCT01580293|83218392|FG000|Part A_Extension|Withdrawal by Subject|0|||
46974148|NCT01580293|83218393|FG001|Part A_Extension|Withdrawal by Subject|3|||
46974149|NCT01580293|83218394|FG002|Part A_Extension|Withdrawal by Subject|0|||
46974150|NCT01580293|83218392|FG000|Part A_Extension|Lost to Follow-up|0|||
46853622|NCT00090987|83069752|FG000|Overall Study|Lack of Efficacy|7|||
46853623|NCT00090987|83069752|FG000|Overall Study|Withdrawal by Subject|3|||
46853624|NCT00090987|83069752|FG000|Overall Study|alternative therapy|1|||
46853625|NCT00090987|83069752|FG000|Overall Study|Non-compliance|4|||
46974151|NCT01580293|83218393|FG001|Part A_Extension|Lost to Follow-up|1|||
46974152|NCT01580293|83218394|FG002|Part A_Extension|Lost to Follow-up|0|||
46974153|NCT01580293|83218392|FG000|Part A_Extension|Other Reason|0|||
46974154|NCT01580293|83218393|FG001|Part A_Extension|Other Reason|1|||
46974155|NCT01580293|83218394|FG002|Part A_Extension|Other Reason|0|||
46974156|NCT01580293|83218392|FG000|Part A_Extension|Completed Japan only|0|||
46974157|NCT01580293|83218393|FG001|Part A_Extension|Completed Japan only|5|||
46974158|NCT01580293|83218394|FG002|Part A_Extension|Completed Japan only|0|||
46974159|NCT01580293|83218392|FG000|Part B|Withdrawal by Subject|0|||
46974160|NCT01580293|83218393|FG001|Part B|Withdrawal by Subject|0|||
46974161|NCT01580293|83218394|FG002|Part B|Withdrawal by Subject|1|||
46974162|NCT01580293|83218392|FG000|Part B|Other reason|0|||
46974163|NCT01580293|83218393|FG001|Part B|Other reason|0|||
46853626|NCT00090987|83069752|FG000|Overall Study|Incarcerated|1|||
46853627|NCT03464422|83069756|FG000|Overall Study|Lost to Follow-up|2|||
46853628|NCT03464422|83069756|FG000|Overall Study|Withdrawal by Subject|2|||
46853629|NCT03489304|83069762|FG000|Overall Study|Lost to Follow-up|4|||
46853630|NCT03543358|83069766|FG000|Overall Study|Death|1|||
46853631|NCT03543358|83069767|FG001|Overall Study|Death|0|||
46853632|NCT03543358|83069766|FG000|Overall Study|Disease Progression|1|||
46853633|NCT03543358|83069767|FG001|Overall Study|Disease Progression|0|||
46853634|NCT03543358|83069766|FG000|Overall Study|Parent Study Closure|1|||
46853635|NCT03543358|83069767|FG001|Overall Study|Parent Study Closure|0|||
46853636|NCT03485950|83069773|FG000|Overall Study|Adverse Event|1|||
46853637|NCT03485950|83069774|FG001|Overall Study|Adverse Event|0|||
46853638|NCT03485950|83069773|FG000|Overall Study|Death|3|||
46853639|NCT03485950|83069774|FG001|Overall Study|Death|2|||
46853640|NCT03485950|83069773|FG000|Overall Study|Withdrawal by Subject|3|||
46853641|NCT03485950|83069774|FG001|Overall Study|Withdrawal by Subject|0|||
46853642|NCT00060944|83069782|FG000|Overall Study|Adverse Event|12|||
46853643|NCT00060944|83069783|FG001|Overall Study|Adverse Event|10|||
46853644|NCT00060944|83069782|FG000|Overall Study|Death|2|||
46853645|NCT00060944|83069783|FG001|Overall Study|Death|3|||
46853646|NCT00060944|83069782|FG000|Overall Study|Withdrawal by Subject|18|||
46853647|NCT00060944|83069783|FG001|Overall Study|Withdrawal by Subject|5|||
46974164|NCT01580293|83218394|FG002|Part B|Other reason|1|||
46974165|NCT01960348|83218447|FG000|Overall Study|Adverse event, not serious|2|||
46974166|NCT01960348|83218448|FG001|Overall Study|Adverse event, not serious|2|||
46974167|NCT01960348|83218447|FG000|Overall Study|Adverse event, serious fatal|6|||
46974168|NCT01960348|83218448|FG001|Overall Study|Adverse event, serious fatal|5|||
46790997|NCT00545103|83009911|FG003|Overall Study|Lack of Efficacy|27|||
46790998|NCT00545103|83009908|FG000|Overall Study|Withdrawal by Subject|6|||
46790999|NCT00545103|83009909|FG001|Overall Study|Withdrawal by Subject|10|||
46853648|NCT00060944|83069782|FG000|Overall Study|Disease Progression|93|||
46853649|NCT00060944|83069783|FG001|Overall Study|Disease Progression|94|||
46853650|NCT00060944|83069782|FG000|Overall Study|Lost to Follow-up|1|||
46853651|NCT00060944|83069783|FG001|Overall Study|Lost to Follow-up|0|||
46853652|NCT00060944|83069782|FG000|Overall Study|Subject Ineligible To Continue|2|||
46853653|NCT00060944|83069783|FG001|Overall Study|Subject Ineligible To Continue|1|||
46853654|NCT00060944|83069782|FG000|Overall Study|Treatment Switch|0|||
46853655|NCT00060944|83069783|FG001|Overall Study|Treatment Switch|13|||
46853656|NCT00060944|83069782|FG000|Overall Study|Other|2|||
46791000|NCT00545103|83009910|FG002|Overall Study|Withdrawal by Subject|18|||
46791001|NCT00545103|83009911|FG003|Overall Study|Withdrawal by Subject|22|||
46791002|NCT00545103|83009908|FG000|Overall Study|Adverse Event|11|||
46791003|NCT00545103|83009909|FG001|Overall Study|Adverse Event|12|||
46791004|NCT00545103|83009910|FG002|Overall Study|Adverse Event|17|||
46791005|NCT00545103|83009911|FG003|Overall Study|Adverse Event|10|||
46791006|NCT00545103|83009908|FG000|Overall Study|Lost to Follow-up|4|||
46791007|NCT00545103|83009909|FG001|Overall Study|Lost to Follow-up|6|||
46791008|NCT00545103|83009910|FG002|Overall Study|Lost to Follow-up|3|||
46791009|NCT00545103|83009911|FG003|Overall Study|Lost to Follow-up|4|||
46791010|NCT00545103|83009908|FG000|Overall Study|Protocol Violation|1|||
46791011|NCT00545103|83009909|FG001|Overall Study|Protocol Violation|2|||
46791012|NCT00545103|83009910|FG002|Overall Study|Protocol Violation|3|||
46791013|NCT00545103|83009911|FG003|Overall Study|Protocol Violation|0|||
46974169|NCT01960348|83218447|FG000|Overall Study|Adverse event, serious non-fatal|0|||
46791014|NCT00545103|83009908|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
46791015|NCT00545103|83009909|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
46791016|NCT00545103|83009910|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
46974170|NCT01960348|83218448|FG001|Overall Study|Adverse event, serious non-fatal|3|||
46974171|NCT01960348|83218447|FG000|Overall Study|Withdrawal by Subject|1|||
46974172|NCT01960348|83218448|FG001|Overall Study|Withdrawal by Subject|11|||
46974173|NCT01960348|83218447|FG000|Overall Study|Physician Decision|0|||
46974174|NCT01960348|83218448|FG001|Overall Study|Physician Decision|1|||
46974175|NCT01960348|83218447|FG000|Overall Study|Protocol Violation|1|||
46974176|NCT01960348|83218448|FG001|Overall Study|Protocol Violation|0|||
46974177|NCT02653625|83218454|FG000|Overall Study|Adverse Event|1|||
46974178|NCT02653625|83218454|FG000|Overall Study|Non-compliance with Study Drug|1|||
46974179|NCT02653625|83218454|FG000|Overall Study|Protocol Violation|1|||
46974180|NCT02653625|83218454|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
46974181|NCT01981096|83218460|FG000|Overall Study|Parent illness|1|||
46974182|NCT01981096|83218461|FG001|Overall Study|Parent illness|0|||
46974183|NCT01981096|83218460|FG000|Overall Study|Withdrawal by Subject|0|||
46974184|NCT01981096|83218461|FG001|Overall Study|Withdrawal by Subject|1|||
46974185|NCT01981096|83218460|FG000|Overall Study|Lost to Follow-up|2|||
46974186|NCT01981096|83218461|FG001|Overall Study|Lost to Follow-up|0|||
46974187|NCT02652767|83218467|FG000|Overall Study|Death|2|||
46974188|NCT02652767|83218467|FG000|Overall Study|Lost to Follow-up|1|||
46974189|NCT02652767|83218467|FG000|Overall Study|Withdrawal by Subject|1|||
46974190|NCT01980940|83218481|FG000|Overall Study|Protocol Violation|0|||
46974191|NCT01980940|83218482|FG001|Overall Study|Protocol Violation|0|||
46974192|NCT01980940|83218483|FG002|Overall Study|Protocol Violation|0|||
46974193|NCT01980940|83218484|FG003|Overall Study|Protocol Violation|0|||
46974194|NCT01980940|83218485|FG004|Overall Study|Protocol Violation|0|||
46974195|NCT01980940|83218486|FG005|Overall Study|Protocol Violation|2|||
46974196|NCT01980940|83218487|FG006|Overall Study|Protocol Violation|0|||
46974197|NCT01980940|83218488|FG007|Overall Study|Protocol Violation|0|||
46974198|NCT02699983|83218514|FG000|Overall Study|Withdrawal by Subject|1|||
46974199|NCT02699983|83218515|FG001|Overall Study|Withdrawal by Subject|0|||
46974200|NCT01960114|83218527|FG000|Overall Study|Adverse Event|1|||
46974201|NCT01960114|83218528|FG001|Overall Study|Adverse Event|0|||
46974202|NCT01960114|83218527|FG000|Overall Study|Could not swallow study medication|0|||
46974203|NCT01960114|83218528|FG001|Overall Study|Could not swallow study medication|1|||
46974204|NCT02005276|83218538|FG000|Overall Study|No longer interested|5|||
46974205|NCT02005276|83218539|FG001|Overall Study|No longer interested|2|||
46974206|NCT02005276|83218540|FG002|Overall Study|No longer interested|3|||
46974207|NCT02005276|83218541|FG003|Overall Study|No longer interested|3|||
46974208|NCT01980706|83218556|FG000|Overall Study|Withdrawal by Subject|9|||
46974209|NCT01980706|83218557|FG001|Overall Study|Withdrawal by Subject|6|||
46974210|NCT01980706|83218558|FG002|Overall Study|Withdrawal by Subject|2|||
46974211|NCT01980706|83218556|FG000|Overall Study|Adverse Event|1|||
46974212|NCT01980706|83218557|FG001|Overall Study|Adverse Event|2|||
46974213|NCT01980706|83218558|FG002|Overall Study|Adverse Event|5|||
46974214|NCT01980706|83218556|FG000|Overall Study|Lost to Follow-up|3|||
46974215|NCT01980706|83218557|FG001|Overall Study|Lost to Follow-up|4|||
46974216|NCT01980706|83218558|FG002|Overall Study|Lost to Follow-up|3|||
46974217|NCT01980706|83218556|FG000|Overall Study|miscellaneous|4|||
46974218|NCT01980706|83218557|FG001|Overall Study|miscellaneous|5|||
46974219|NCT01980706|83218558|FG002|Overall Study|miscellaneous|3|||
46974220|NCT02692417|83218568|FG000|Overall Study|Withdrawal by Subject|5|||
46673891|NCT01162486|82889397|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
46974221|NCT02692417|83218569|FG001|Overall Study|Withdrawal by Subject|1|||
46974222|NCT02692417|83218568|FG000|Overall Study|Adverse Event|1|||
46974223|NCT02692417|83218569|FG001|Overall Study|Adverse Event|0|||
46974224|NCT02004886|83218579|FG000|Overall Study|Adverse Event|0|||
46974225|NCT02004886|83218580|FG001|Overall Study|Adverse Event|1|||
46791017|NCT00545103|83009911|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
46791018|NCT00545103|83009908|FG000|Overall Study|Difficult to open package|0|||
46791019|NCT00545103|83009909|FG001|Overall Study|Difficult to open package|0|||
46791020|NCT00545103|83009910|FG002|Overall Study|Difficult to open package|0|||
46791021|NCT00545103|83009911|FG003|Overall Study|Difficult to open package|1|||
46791022|NCT00545103|83009908|FG000|Overall Study|Investigational product not taken|1|||
46791023|NCT00545103|83009909|FG001|Overall Study|Investigational product not taken|0|||
46791024|NCT00545103|83009910|FG002|Overall Study|Investigational product not taken|0|||
46791025|NCT00545103|83009911|FG003|Overall Study|Investigational product not taken|1|||
46791026|NCT00545103|83009908|FG000|Overall Study|Wish to start a family|0|||
46974226|NCT02004886|83218581|FG002|Overall Study|Adverse Event|0|||
46974227|NCT02004886|83218582|FG003|Overall Study|Adverse Event|0|||
46974228|NCT02004886|83218579|FG000|Overall Study|Unable to attend future visits|1|||
46974229|NCT02004886|83218580|FG001|Overall Study|Unable to attend future visits|0|||
46974230|NCT02004886|83218581|FG002|Overall Study|Unable to attend future visits|0|||
46974231|NCT02004886|83218582|FG003|Overall Study|Unable to attend future visits|0|||
46974232|NCT01959880|83218596|FG000|Overall Study|Withdrawal by Subject|11|||
46974233|NCT01959880|83218597|FG001|Overall Study|Withdrawal by Subject|13|||
46974234|NCT01959880|83218598|FG002|Overall Study|Withdrawal by Subject|8|||
46974235|NCT01959880|83218599|FG003|Overall Study|Withdrawal by Subject|7|||
46791027|NCT00545103|83009909|FG001|Overall Study|Wish to start a family|0|||
46791028|NCT00545103|83009910|FG002|Overall Study|Wish to start a family|0|||
46974236|NCT01959880|83218596|FG000|Overall Study|Death|1|||
46974237|NCT01959880|83218597|FG001|Overall Study|Death|10|||
46974238|NCT01959880|83218598|FG002|Overall Study|Death|1|||
46974239|NCT01959880|83218599|FG003|Overall Study|Death|2|||
46974240|NCT01959880|83218596|FG000|Overall Study|Lost to Follow-up|95|||
46853657|NCT00060944|83069783|FG001|Overall Study|Other|4|||
46853658|NCT00060944|83069782|FG000|Overall Study|randomized but not treated|6|||
46853659|NCT00060944|83069783|FG001|Overall Study|randomized but not treated|4|||
46853660|NCT03462082|83069789|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
46853661|NCT03462082|83069790|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
46853662|NCT03462082|83069791|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
46853663|NCT03462082|83069792|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
46853664|NCT03462082|83069793|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
46853665|NCT03462082|83069794|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
46853666|NCT03462082|83069795|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
46853667|NCT03462082|83069796|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
46853668|NCT03541252|83069806|FG000|Overall Study|Withdrawal by Subject|1|||
46853669|NCT00031460|83069812|FG000|Overall Study|Lost to Follow-up|0|||
46853670|NCT00031460|83069813|FG001|Overall Study|Lost to Follow-up|1|||
46853671|NCT00031460|83069812|FG000|Overall Study|Withdrawal by Subject|1|||
46853672|NCT00031460|83069813|FG001|Overall Study|Withdrawal by Subject|1|||
46853673|NCT00031460|83069812|FG000|Overall Study|Non-Compliant|1|||
46853674|NCT00031460|83069813|FG001|Overall Study|Non-Compliant|1|||
46974241|NCT01959880|83218597|FG001|Overall Study|Lost to Follow-up|18|||
46974242|NCT01959880|83218598|FG002|Overall Study|Lost to Follow-up|15|||
46974243|NCT01959880|83218599|FG003|Overall Study|Lost to Follow-up|8|||
46974244|NCT01959880|83218596|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
46974245|NCT01959880|83218597|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
46974246|NCT01959880|83218598|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
46974247|NCT01959880|83218599|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
46791029|NCT00545103|83009911|FG003|Overall Study|Wish to start a family|1|||
46791030|NCT00545103|83009908|FG000|Overall Study|Diverticulitis crisis|0|||
46791031|NCT00545103|83009909|FG001|Overall Study|Diverticulitis crisis|0|||
46791032|NCT00545103|83009910|FG002|Overall Study|Diverticulitis crisis|0|||
46791033|NCT00545103|83009911|FG003|Overall Study|Diverticulitis crisis|1|||
46791034|NCT00545103|83009908|FG000|Overall Study|Personal reasons|1|||
46791035|NCT00545103|83009909|FG001|Overall Study|Personal reasons|0|||
46791036|NCT00545103|83009910|FG002|Overall Study|Personal reasons|0|||
46791037|NCT00545103|83009911|FG003|Overall Study|Personal reasons|0|||
46791038|NCT00545103|83009908|FG000|Overall Study|Subject's decision|1|||
46791039|NCT00545103|83009909|FG001|Overall Study|Subject's decision|0|||
46791040|NCT00545103|83009910|FG002|Overall Study|Subject's decision|0|||
46853675|NCT00031460|83069812|FG000|Overall Study|Death|0|||
46853676|NCT00031460|83069813|FG001|Overall Study|Death|1|||
46853677|NCT00031460|83069812|FG000|Overall Study|Reactivation of Disease|5|||
46853678|NCT00031460|83069813|FG001|Overall Study|Reactivation of Disease|9|||
46853679|NCT00031460|83069812|FG000|Overall Study|Disruption of blinded drug supply|2|||
46853680|NCT00031460|83069813|FG001|Overall Study|Disruption of blinded drug supply|0|||
46853681|NCT00031460|83069812|FG000|Overall Study|Confirmed unevaluable|0|||
46853682|NCT00031460|83069813|FG001|Overall Study|Confirmed unevaluable|1|||
46853683|NCT03540160|83069819|FG000|Overall Study|Protocol Violation|1|||
46853684|NCT03540160|83069819|FG000|Overall Study|Physician Decision|8|||
46853685|NCT03540160|83069819|FG000|Overall Study|Lack of Efficacy|60|||
46853686|NCT03540160|83069819|FG000|Overall Study|Pregnancy|1|||
46853687|NCT03540160|83069819|FG000|Overall Study|Adverse Event|20|||
46853688|NCT03540160|83069819|FG000|Overall Study|Withdrawal by Subject|68|||
46853689|NCT03540160|83069819|FG000|Overall Study|COVID-19|2|||
46853690|NCT03540160|83069819|FG000|Overall Study|Study Closure|10|||
46853691|NCT03540160|83069819|FG000|Overall Study|Lost to Follow-up|18|||
46853692|NCT03540160|83069819|FG000|Overall Study|Sponsor decision|191|||
46853693|NCT03459196|83069823|FG000|Overall Study|Subject didn't receive study catheter|2|||
46853694|NCT03459040|83069827|FG000|Overall Study|Death|8|||
46853695|NCT03459040|83069827|FG000|Overall Study|Withdrawal by Subject|1|||
46853696|NCT03457636|83069832|FG000|Overall Study|Lost to Follow-up|2|||
46853697|NCT03481816|83069838|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
46853698|NCT03481816|83069839|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
46974248|NCT01959880|83218596|FG000|Overall Study|Study completed early-FDA approved|1003|||
46974249|NCT01959880|83218597|FG001|Overall Study|Study completed early-FDA approved|311|||
46853699|NCT03481816|83069838|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
46853700|NCT03481816|83069839|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
46974250|NCT01959880|83218598|FG002|Overall Study|Study completed early-FDA approved|179|||
46791041|NCT00545103|83009911|FG003|Overall Study|Subject's decision|0|||
46791042|NCT00545103|83009908|FG000|Overall Study|Noncompliance|0|||
46974251|NCT01959880|83218599|FG003|Overall Study|Study completed early-FDA approved|152|||
46791043|NCT00545103|83009909|FG001|Overall Study|Noncompliance|1|||
46791044|NCT00545103|83009910|FG002|Overall Study|Noncompliance|0|||
46791045|NCT00545103|83009911|FG003|Overall Study|Noncompliance|0|||
46791046|NCT00545103|83009908|FG000|Overall Study|Investigator decision|0|||
46791047|NCT00545103|83009909|FG001|Overall Study|Investigator decision|0|||
46791048|NCT00545103|83009910|FG002|Overall Study|Investigator decision|1|||
46853701|NCT03481816|83069838|FG000|Dose Expansion|Withdrawal by Subject|0|||
46853702|NCT03481816|83069839|FG001|Dose Expansion|Withdrawal by Subject|2|||
46853703|NCT03481816|83069838|FG000|Dose Expansion|Physician Decision|0|||
46853704|NCT03481816|83069839|FG001|Dose Expansion|Physician Decision|5|||
46853705|NCT03538054|83069847|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
46853706|NCT03538054|83069847|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
46853707|NCT03538054|83069847|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
46853708|NCT03480802|83069855|FG000|Overall Study|Lost to Follow-up|5|||
46853709|NCT03480802|83069856|FG001|Overall Study|Lost to Follow-up|1|||
46853710|NCT03480802|83069855|FG000|Overall Study|Withdrawal by Subject|2|||
46853711|NCT03480802|83069856|FG001|Overall Study|Withdrawal by Subject|1|||
46853712|NCT03480802|83069855|FG000|Overall Study|Relocated|0|||
46853713|NCT03480802|83069856|FG001|Overall Study|Relocated|1|||
46853714|NCT00050960|83069866|FG000|Overall Study|Progressive Disease|137|||
46853715|NCT00050960|83069867|FG001|Overall Study|Progressive Disease|93|||
46853716|NCT00050960|83069866|FG000|Overall Study|Stable Disease|19|||
46853717|NCT00050960|83069867|FG001|Overall Study|Stable Disease|48|||
46791049|NCT00545103|83009911|FG003|Overall Study|Investigator decision|0|||
46791050|NCT00545103|83009908|FG000|Overall Study|Subject moved|0|||
46853718|NCT00050960|83069866|FG000|Overall Study|Partial Response|14|||
46974252|NCT01980628|83218609|FG000|Overall Study|Adverse Event|12|||
46974253|NCT01980628|83218609|FG000|Overall Study|Physician Decision|5|||
46974254|NCT01980628|83218609|FG000|Overall Study|Withdrawal by Subject|4|||
46974255|NCT01980628|83218609|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
46974256|NCT01979614|83218616|FG000|Overall Study|Adverse Event|1|||
46974257|NCT01979614|83218617|FG001|Overall Study|Adverse Event|1|||
46974258|NCT02654717|83218625|FG000|Overall Study|Adverse Event|2|||
46974259|NCT02654717|83218626|FG001|Overall Study|Adverse Event|2|||
46974260|NCT02654717|83218625|FG000|Overall Study|Protocol Violation|1|||
46974261|NCT02654717|83218626|FG001|Overall Study|Protocol Violation|2|||
46974262|NCT02654717|83218625|FG000|Overall Study|Withdrawal by Subject|0|||
46974263|NCT02654717|83218626|FG001|Overall Study|Withdrawal by Subject|1|||
46974264|NCT02654717|83218625|FG000|Overall Study|Non-permitted medication|3|||
46974265|NCT02654717|83218626|FG001|Overall Study|Non-permitted medication|0|||
46974266|NCT02696785|83218636|FG000|Blinded Treatment Period|Adverse Event|0|||
46974267|NCT02696785|83218637|FG001|Blinded Treatment Period|Adverse Event|1|||
46974268|NCT02696785|83218638|FG002|Blinded Treatment Period|Adverse Event|3|||
46974269|NCT02696785|83218639|FG003|Blinded Treatment Period|Adverse Event|0|||
46974270|NCT02696785|83218636|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
46791051|NCT00545103|83009909|FG001|Overall Study|Subject moved|1|||
46791052|NCT00545103|83009910|FG002|Overall Study|Subject moved|0|||
46853719|NCT00050960|83069867|FG001|Overall Study|Partial Response|19|||
46853720|NCT00050960|83069866|FG000|Overall Study|Complete Response|0|||
46853721|NCT00050960|83069867|FG001|Overall Study|Complete Response|2|||
46853722|NCT00050960|83069866|FG000|Overall Study|Adverse Event|62|||
46853723|NCT00050960|83069867|FG001|Overall Study|Adverse Event|61|||
46853724|NCT00050960|83069866|FG000|Overall Study|Lost to Follow-up|0|||
46853725|NCT00050960|83069867|FG001|Overall Study|Lost to Follow-up|1|||
46853726|NCT00050960|83069866|FG000|Overall Study|Withdrawal by Subject|23|||
46853727|NCT00050960|83069867|FG001|Overall Study|Withdrawal by Subject|18|||
46853728|NCT00050960|83069866|FG000|Overall Study|Administrative|31|||
46853729|NCT00050960|83069867|FG001|Overall Study|Administrative|46|||
46853730|NCT00050960|83069866|FG000|Overall Study|Non-compliance|3|||
46853731|NCT00050960|83069867|FG001|Overall Study|Non-compliance|1|||
46853732|NCT00050960|83069866|FG000|Overall Study|Death|13|||
46853733|NCT00050960|83069867|FG001|Overall Study|Death|15|||
46853734|NCT03456856|83069873|FG000|Overall Study|Lost to Follow-up|2|||
46853735|NCT03456856|83069873|FG000|Overall Study|Withdrawal by Subject|1|||
46853736|NCT00058214|83069877|FG000|Overall Study|Adverse Event|1|||
46853737|NCT00097773|83069885|FG000|Overall Study|Lost to Follow-up|2|||
46853738|NCT00097773|83069886|FG001|Overall Study|Lost to Follow-up|2|||
46853739|NCT00097773|83069887|FG002|Overall Study|Lost to Follow-up|0|||
46974271|NCT02696785|83218637|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
46974272|NCT02696785|83218638|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
46974273|NCT02696785|83218639|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
46853740|NCT00097773|83069888|FG003|Overall Study|Lost to Follow-up|1|||
46853741|NCT00097773|83069885|FG000|Overall Study|Physician Decision|2|||
46853742|NCT00097773|83069886|FG001|Overall Study|Physician Decision|2|||
46853743|NCT00097773|83069887|FG002|Overall Study|Physician Decision|3|||
46853744|NCT00097773|83069888|FG003|Overall Study|Physician Decision|1|||
46791053|NCT00545103|83009911|FG003|Overall Study|Subject moved|0|||
46791054|NCT00545103|83009908|FG000|Overall Study|Use of prohibited medication|0|||
46791055|NCT00545103|83009909|FG001|Overall Study|Use of prohibited medication|0|||
46791056|NCT00545103|83009910|FG002|Overall Study|Use of prohibited medication|1|||
46791057|NCT00545103|83009911|FG003|Overall Study|Use of prohibited medication|0|||
46791058|NCT00545103|83009908|FG000|Overall Study|Does not want to take study drug anymore|1|||
46791059|NCT00545103|83009909|FG001|Overall Study|Does not want to take study drug anymore|0|||
46791060|NCT00545103|83009910|FG002|Overall Study|Does not want to take study drug anymore|1|||
46791061|NCT00545103|83009911|FG003|Overall Study|Does not want to take study drug anymore|0|||
46853745|NCT00097773|83069885|FG000|Overall Study|Withdrawal by Subject|3|||
46853746|NCT00097773|83069886|FG001|Overall Study|Withdrawal by Subject|3|||
46853747|NCT00097773|83069887|FG002|Overall Study|Withdrawal by Subject|3|||
46853748|NCT00097773|83069888|FG003|Overall Study|Withdrawal by Subject|1|||
46853749|NCT00097773|83069885|FG000|Overall Study|Adverse Event|0|||
46853750|NCT00097773|83069886|FG001|Overall Study|Adverse Event|1|||
46853751|NCT00097773|83069887|FG002|Overall Study|Adverse Event|0|||
46853752|NCT00097773|83069888|FG003|Overall Study|Adverse Event|0|||
46853753|NCT00097773|83069885|FG000|Overall Study|Other|1|||
46853754|NCT00097773|83069886|FG001|Overall Study|Other|0|||
46853755|NCT00097773|83069887|FG002|Overall Study|Other|2|||
46853756|NCT00097773|83069888|FG003|Overall Study|Other|0|||
46853757|NCT03480022|83069905|FG000|Overall Study|Pregnancy|2|||
46853758|NCT03480022|83069906|FG001|Overall Study|Pregnancy|0|||
46974274|NCT02696785|83218636|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
46974275|NCT02696785|83218637|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
46974276|NCT02696785|83218638|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
46974277|NCT02696785|83218639|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
46974278|NCT02696785|83218636|FG000|Blinded Treatment Period|Screen Failure|1|||
46853759|NCT03480022|83069905|FG000|Overall Study|Adverse Event|6|||
46853760|NCT03480022|83069906|FG001|Overall Study|Adverse Event|0|||
46974279|NCT02696785|83218637|FG001|Blinded Treatment Period|Screen Failure|0|||
46974280|NCT02696785|83218638|FG002|Blinded Treatment Period|Screen Failure|0|||
46974281|NCT02696785|83218639|FG003|Blinded Treatment Period|Screen Failure|0|||
46974282|NCT02696785|83218636|FG000|Washout Period|Withdrawal by Subject|0|||
46974283|NCT02696785|83218637|FG001|Washout Period|Withdrawal by Subject|1|||
46974284|NCT02696785|83218638|FG002|Washout Period|Withdrawal by Subject|0|||
46974285|NCT02696785|83218639|FG003|Washout Period|Withdrawal by Subject|0|||
46974286|NCT02696785|83218636|FG000|Washout Period|Lack of Efficacy|0|||
46974287|NCT02696785|83218637|FG001|Washout Period|Lack of Efficacy|1|||
46974288|NCT02696785|83218638|FG002|Washout Period|Lack of Efficacy|0|||
46974289|NCT02696785|83218639|FG003|Washout Period|Lack of Efficacy|0|||
46974290|NCT02696785|83218636|FG000|Extended Treatment Period|Adverse Event|2|||
46974291|NCT02696785|83218637|FG001|Extended Treatment Period|Adverse Event|3|||
46974292|NCT02696785|83218638|FG002|Extended Treatment Period|Adverse Event|2|||
46974293|NCT02696785|83218639|FG003|Extended Treatment Period|Adverse Event|1|||
46974294|NCT02696785|83218636|FG000|Extended Treatment Period|Lack of Efficacy|0|||
46974295|NCT02696785|83218637|FG001|Extended Treatment Period|Lack of Efficacy|1|||
46974296|NCT02696785|83218638|FG002|Extended Treatment Period|Lack of Efficacy|0|||
46974297|NCT02696785|83218639|FG003|Extended Treatment Period|Lack of Efficacy|0|||
46974298|NCT02696785|83218636|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
46974299|NCT02696785|83218637|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
46791062|NCT00545103|83009908|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
46791063|NCT00545103|83009909|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
46791064|NCT00545103|83009910|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
46853761|NCT03480022|83069905|FG000|Overall Study|Lack of Efficacy|0|||
46974300|NCT02696785|83218638|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
46853762|NCT03480022|83069906|FG001|Overall Study|Lack of Efficacy|2|||
46853763|NCT03480022|83069905|FG000|Overall Study|Physician Decision|0|||
46974301|NCT02696785|83218639|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
46974302|NCT02696785|83218636|FG000|Follow-up Period|Adverse Event|0|||
46974303|NCT02696785|83218637|FG001|Follow-up Period|Adverse Event|0|||
46791065|NCT00545103|83009911|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
46791066|NCT00545103|83009908|FG000|Overall Study|Death|0|||
46853764|NCT03480022|83069906|FG001|Overall Study|Physician Decision|1|||
46853765|NCT03480022|83069905|FG000|Overall Study|Withdrawal by Subject|2|||
46791067|NCT00545103|83009909|FG001|Overall Study|Death|1|||
46791068|NCT00545103|83009910|FG002|Overall Study|Death|0|||
46791069|NCT00545103|83009911|FG003|Overall Study|Death|0|||
46791070|NCT00586157|83009921|FG000|First Intervention|Worsening behavior|1|||
46791071|NCT00586157|83009922|FG001|First Intervention|Worsening behavior|0|||
46791072|NCT00586157|83009921|FG000|Second Intervention|Withdrawal by Subject|1|||
46791073|NCT00586157|83009922|FG001|Second Intervention|Withdrawal by Subject|0|||
46791074|NCT00586157|83009921|FG000|Second Intervention|Worsening behavior|1|||
46791075|NCT00586157|83009922|FG001|Second Intervention|Worsening behavior|0|||
46791076|NCT00586157|83009921|FG000|Second Intervention|Adverse Event|0|||
46791077|NCT00586157|83009922|FG001|Second Intervention|Adverse Event|1|||
46791078|NCT00246337|83009937|FG000|Overall Study|Lost to Follow-up|3|||
46791079|NCT00246337|83009938|FG001|Overall Study|Lost to Follow-up|0|||
46791080|NCT00246337|83009939|FG002|Overall Study|Lost to Follow-up|0|||
46791081|NCT00246337|83009940|FG003|Overall Study|Lost to Follow-up|0|||
46791082|NCT00246337|83009941|FG004|Overall Study|Lost to Follow-up|2|||
46791083|NCT00246337|83009942|FG005|Overall Study|Lost to Follow-up|2|||
46791084|NCT00246337|83009943|FG006|Overall Study|Lost to Follow-up|1|||
46791085|NCT00246337|83009944|FG007|Overall Study|Lost to Follow-up|2|||
46791086|NCT00246337|83009945|FG008|Overall Study|Lost to Follow-up|0|||
46791087|NCT00246337|83009937|FG000|Overall Study|Protocol Violation|1|||
46791088|NCT00246337|83009938|FG001|Overall Study|Protocol Violation|0|||
46791089|NCT00246337|83009939|FG002|Overall Study|Protocol Violation|0|||
46791090|NCT00246337|83009940|FG003|Overall Study|Protocol Violation|0|||
46791091|NCT00246337|83009941|FG004|Overall Study|Protocol Violation|1|||
46791092|NCT00246337|83009942|FG005|Overall Study|Protocol Violation|0|||
46791093|NCT00246337|83009943|FG006|Overall Study|Protocol Violation|1|||
46791094|NCT00246337|83009944|FG007|Overall Study|Protocol Violation|1|||
46791095|NCT00246337|83009945|FG008|Overall Study|Protocol Violation|0|||
46791096|NCT00246337|83009937|FG000|Overall Study|Withdrawal by Subject|2|||
46791097|NCT00246337|83009938|FG001|Overall Study|Withdrawal by Subject|0|||
46791098|NCT00246337|83009939|FG002|Overall Study|Withdrawal by Subject|0|||
46791099|NCT00246337|83009940|FG003|Overall Study|Withdrawal by Subject|0|||
46791100|NCT00246337|83009941|FG004|Overall Study|Withdrawal by Subject|0|||
46791101|NCT00246337|83009942|FG005|Overall Study|Withdrawal by Subject|0|||
46791102|NCT00246337|83009943|FG006|Overall Study|Withdrawal by Subject|1|||
46791103|NCT00246337|83009944|FG007|Overall Study|Withdrawal by Subject|1|||
46791104|NCT00246337|83009945|FG008|Overall Study|Withdrawal by Subject|0|||
46791105|NCT00246337|83009937|FG000|Overall Study|Lack of Qualifying Event|8|||
46791106|NCT00246337|83009938|FG001|Overall Study|Lack of Qualifying Event|2|||
46791107|NCT00246337|83009939|FG002|Overall Study|Lack of Qualifying Event|1|||
46791108|NCT00246337|83009940|FG003|Overall Study|Lack of Qualifying Event|1|||
46791109|NCT00246337|83009941|FG004|Overall Study|Lack of Qualifying Event|1|||
46791110|NCT00246337|83009942|FG005|Overall Study|Lack of Qualifying Event|3|||
46791111|NCT00246337|83009943|FG006|Overall Study|Lack of Qualifying Event|3|||
46791112|NCT00246337|83009944|FG007|Overall Study|Lack of Qualifying Event|2|||
46791113|NCT00246337|83009945|FG008|Overall Study|Lack of Qualifying Event|5|||
46791114|NCT00246337|83009937|FG000|Overall Study|Site Terminated|10|||
46791115|NCT00246337|83009938|FG001|Overall Study|Site Terminated|0|||
46791116|NCT00246337|83009939|FG002|Overall Study|Site Terminated|0|||
46791117|NCT00246337|83009940|FG003|Overall Study|Site Terminated|0|||
46791118|NCT00246337|83009941|FG004|Overall Study|Site Terminated|0|||
46791119|NCT00246337|83009942|FG005|Overall Study|Site Terminated|7|||
46791120|NCT00246337|83009943|FG006|Overall Study|Site Terminated|1|||
46791121|NCT00246337|83009944|FG007|Overall Study|Site Terminated|6|||
46791122|NCT00246337|83009945|FG008|Overall Study|Site Terminated|2|||
46791123|NCT00246337|83009937|FG000|Overall Study|Abnormal baseline lab values|7|||
46791124|NCT00246337|83009938|FG001|Overall Study|Abnormal baseline lab values|0|||
46791125|NCT00246337|83009939|FG002|Overall Study|Abnormal baseline lab values|2|||
46974304|NCT02696785|83218638|FG002|Follow-up Period|Adverse Event|8|||
46974305|NCT02696785|83218639|FG003|Follow-up Period|Adverse Event|2|||
46791126|NCT00246337|83009940|FG003|Overall Study|Abnormal baseline lab values|0|||
46791127|NCT00246337|83009941|FG004|Overall Study|Abnormal baseline lab values|0|||
47078144|NCT03570619|83383203|FG001|Overall Study|Adverse Event|0|||
46791128|NCT00246337|83009942|FG005|Overall Study|Abnormal baseline lab values|2|||
47078145|NCT03570619|83383204|FG002|Overall Study|Adverse Event|1|||
47078146|NCT03570619|83383202|FG000|Overall Study|new diagnosis of new malignancy|1|||
47078147|NCT03570619|83383203|FG001|Overall Study|new diagnosis of new malignancy|0|||
46791129|NCT00246337|83009943|FG006|Overall Study|Abnormal baseline lab values|2|||
47078148|NCT03570619|83383204|FG002|Overall Study|new diagnosis of new malignancy|0|||
47078149|NCT03570619|83383202|FG000|Overall Study|Physician Decision|1|||
46791130|NCT00246337|83009944|FG007|Overall Study|Abnormal baseline lab values|0|||
46791131|NCT00246337|83009945|FG008|Overall Study|Abnormal baseline lab values|4|||
46791132|NCT00246337|83009937|FG000|Overall Study|Overwhelmed|0|||
46791133|NCT00246337|83009938|FG001|Overall Study|Overwhelmed|0|||
46791134|NCT00246337|83009939|FG002|Overall Study|Overwhelmed|0|||
46791135|NCT00246337|83009940|FG003|Overall Study|Overwhelmed|0|||
46791136|NCT00246337|83009941|FG004|Overall Study|Overwhelmed|0|||
47078150|NCT03570619|83383203|FG001|Overall Study|Physician Decision|1|||
46791137|NCT00246337|83009942|FG005|Overall Study|Overwhelmed|1|||
46791138|NCT00246337|83009943|FG006|Overall Study|Overwhelmed|0|||
46791139|NCT00246337|83009944|FG007|Overall Study|Overwhelmed|0|||
46791140|NCT00246337|83009945|FG008|Overall Study|Overwhelmed|0|||
46791141|NCT00246337|83009937|FG000|Overall Study|Protocol Violator|1|||
46791142|NCT00246337|83009938|FG001|Overall Study|Protocol Violator|0|||
46791143|NCT00246337|83009939|FG002|Overall Study|Protocol Violator|0|||
46791144|NCT00246337|83009940|FG003|Overall Study|Protocol Violator|0|||
46791145|NCT00246337|83009941|FG004|Overall Study|Protocol Violator|0|||
46791146|NCT00246337|83009942|FG005|Overall Study|Protocol Violator|0|||
46791147|NCT00246337|83009943|FG006|Overall Study|Protocol Violator|0|||
46791148|NCT00246337|83009944|FG007|Overall Study|Protocol Violator|0|||
46791149|NCT00246337|83009945|FG008|Overall Study|Protocol Violator|0|||
46791150|NCT00246337|83009937|FG000|Overall Study|Reported as completing trial in error|0|||
46791151|NCT00246337|83009938|FG001|Overall Study|Reported as completing trial in error|0|||
46791152|NCT00246337|83009939|FG002|Overall Study|Reported as completing trial in error|0|||
46791153|NCT00246337|83009940|FG003|Overall Study|Reported as completing trial in error|0|||
46791154|NCT00246337|83009941|FG004|Overall Study|Reported as completing trial in error|0|||
46791155|NCT00246337|83009942|FG005|Overall Study|Reported as completing trial in error|0|||
46791156|NCT00246337|83009943|FG006|Overall Study|Reported as completing trial in error|0|||
46791157|NCT00246337|83009944|FG007|Overall Study|Reported as completing trial in error|1|||
46791158|NCT00246337|83009945|FG008|Overall Study|Reported as completing trial in error|0|||
46791159|NCT00243919|83009968|FG000|Overall Study|Death|3|||
46791160|NCT00243919|83009969|FG001|Overall Study|Death|4|||
46791161|NCT00243919|83009970|FG002|Overall Study|Death|6|||
46791162|NCT00243919|83009968|FG000|Overall Study|Withdrawal by Subject|6|||
46791163|NCT00243919|83009969|FG001|Overall Study|Withdrawal by Subject|6|||
46791164|NCT00243919|83009970|FG002|Overall Study|Withdrawal by Subject|2|||
46791165|NCT00243919|83009968|FG000|Overall Study|Lost to Follow-up|6|||
46791166|NCT00243919|83009969|FG001|Overall Study|Lost to Follow-up|7|||
46791167|NCT00243919|83009970|FG002|Overall Study|Lost to Follow-up|3|||
46791168|NCT00243919|83009968|FG000|Overall Study|Administrative Error|1|||
46791169|NCT00243919|83009969|FG001|Overall Study|Administrative Error|0|||
46791170|NCT00243919|83009970|FG002|Overall Study|Administrative Error|0|||
46791171|NCT00243919|83009968|FG000|Overall Study|Physician Decision|1|||
46791172|NCT00243919|83009969|FG001|Overall Study|Physician Decision|1|||
46791173|NCT00243919|83009970|FG002|Overall Study|Physician Decision|0|||
46791174|NCT00725621|83009978|FG000|Overall Study|Adverse Event|25|||
46791175|NCT00725621|83009978|FG000|Overall Study|Lack of Efficacy|46|||
47078151|NCT03570619|83383204|FG002|Overall Study|Physician Decision|0|||
46791176|NCT00725621|83009978|FG000|Overall Study|Withdrawal by Subject|57|||
46791177|NCT00725621|83009978|FG000|Overall Study|Physician Decision|19|||
46791178|NCT00725621|83009978|FG000|Overall Study|Lost to Follow-up|52|||
46853766|NCT03480022|83069906|FG001|Overall Study|Withdrawal by Subject|0|||
46853767|NCT03480022|83069905|FG000|Overall Study|Medication concerns|1|||
47078152|NCT03570619|83383202|FG000|Overall Study|Withdrawal by Subject|0|||
47078153|NCT03570619|83383203|FG001|Overall Study|Withdrawal by Subject|2|||
47078154|NCT03570619|83383204|FG002|Overall Study|Withdrawal by Subject|0|||
47078155|NCT03568461|83383212|FG000|Overall Study|Death|7|||
47078156|NCT03568461|83383212|FG000|Overall Study|Physician Decision|5|||
47078157|NCT03568461|83383212|FG000|Overall Study|Subject decision|5|||
47078158|NCT03568461|83383212|FG000|Overall Study|Lost to Follow-up|1|||
47078159|NCT03543254|83383216|FG000|Overall Study|Lost to Follow-up|1|||
47078160|NCT03447769|83383227|FG000|Overall Study|Progressive disease|138|||
47078161|NCT03447769|83383228|FG001|Overall Study|Progressive disease|148|||
47078162|NCT03447769|83383227|FG000|Overall Study|Study terminated by Sponsor|60|||
47078163|NCT03447769|83383228|FG001|Overall Study|Study terminated by Sponsor|44|||
47078164|NCT03447769|83383227|FG000|Overall Study|Adverse Event|34|||
47078165|NCT03447769|83383228|FG001|Overall Study|Adverse Event|31|||
46791179|NCT00725621|83009978|FG000|Overall Study|Non-compliance|8|||
46791180|NCT00725621|83009978|FG000|Overall Study|Continued treatment by other physician|6|||
46791181|NCT00725621|83009978|FG000|Overall Study|Switched to other study|1|||
46791182|NCT00725621|83009978|FG000|Overall Study|Switched to other drug|1|||
46791183|NCT00725621|83009978|FG000|Overall Study|Prepared for elective surgery|1|||
46974306|NCT02696785|83218636|FG000|Follow-up Period|Lost to Follow-up|0|||
46974307|NCT02696785|83218637|FG001|Follow-up Period|Lost to Follow-up|0|||
46974308|NCT02696785|83218638|FG002|Follow-up Period|Lost to Follow-up|0|||
46974309|NCT02696785|83218639|FG003|Follow-up Period|Lost to Follow-up|1|||
46974310|NCT02696785|83218636|FG000|Follow-up Period|Lack of Efficacy|0|||
46974311|NCT02696785|83218637|FG001|Follow-up Period|Lack of Efficacy|0|||
46974312|NCT02696785|83218638|FG002|Follow-up Period|Lack of Efficacy|0|||
46974313|NCT02696785|83218639|FG003|Follow-up Period|Lack of Efficacy|1|||
46974314|NCT02696785|83218636|FG000|Follow-up Period|Withdrawal by Subject|1|||
46974315|NCT02696785|83218637|FG001|Follow-up Period|Withdrawal by Subject|0|||
46974316|NCT02696785|83218638|FG002|Follow-up Period|Withdrawal by Subject|5|||
46974317|NCT02696785|83218639|FG003|Follow-up Period|Withdrawal by Subject|4|||
46791184|NCT00725621|83009978|FG000|Overall Study|Reason not specified|55|||
46974318|NCT02004262|83218673|FG000|Overall Study|Death|67|||
46974319|NCT02004262|83218674|FG001|Overall Study|Death|64|||
46974320|NCT02004262|83218675|FG002|Overall Study|Death|66|||
46974321|NCT02004262|83218676|FG003|Overall Study|Death|28|||
46974322|NCT02004262|83218677|FG004|Overall Study|Death|29|||
46974323|NCT02004262|83218678|FG005|Overall Study|Death|22|||
46974324|NCT02004262|83218673|FG000|Overall Study|Withdrawal by Subject|1|||
46974325|NCT02004262|83218674|FG001|Overall Study|Withdrawal by Subject|0|||
46974326|NCT02004262|83218675|FG002|Overall Study|Withdrawal by Subject|4|||
46974327|NCT02004262|83218676|FG003|Overall Study|Withdrawal by Subject|0|||
46974328|NCT02004262|83218677|FG004|Overall Study|Withdrawal by Subject|1|||
46974329|NCT02004262|83218678|FG005|Overall Study|Withdrawal by Subject|3|||
46974330|NCT02004262|83218673|FG000|Overall Study|Lost to Follow-up|1|||
46974331|NCT02004262|83218674|FG001|Overall Study|Lost to Follow-up|1|||
46974332|NCT02004262|83218675|FG002|Overall Study|Lost to Follow-up|0|||
46974333|NCT02004262|83218676|FG003|Overall Study|Lost to Follow-up|0|||
46974334|NCT02004262|83218677|FG004|Overall Study|Lost to Follow-up|0|||
46974335|NCT02004262|83218678|FG005|Overall Study|Lost to Follow-up|0|||
46974336|NCT02004262|83218673|FG000|Overall Study|Study Terminated by Sponsor|4|||
46974337|NCT02004262|83218674|FG001|Overall Study|Study Terminated by Sponsor|3|||
46974338|NCT02004262|83218675|FG002|Overall Study|Study Terminated by Sponsor|2|||
46791185|NCT00613626|83009989|FG000|Overall Study|Ineligible|0|||
46791186|NCT00613626|83009990|FG001|Overall Study|Ineligible|1|||
46791187|NCT00613626|83009991|FG002|Overall Study|Ineligible|0|||
46791188|NCT00725543|83009998|FG000|Overall Study|Adverse Event|10|||
46791189|NCT00725543|83009998|FG000|Overall Study|Lack of Efficacy|3|||
46791190|NCT00725543|83009998|FG000|Overall Study|Withdrawal by Subject|10|||
46974339|NCT02004262|83218676|FG003|Overall Study|Study Terminated by Sponsor|1|||
46974340|NCT02004262|83218677|FG004|Overall Study|Study Terminated by Sponsor|1|||
46974341|NCT02004262|83218678|FG005|Overall Study|Study Terminated by Sponsor|5|||
46974342|NCT01675427|83218692|FG000|Overall Study|Withdrawal by Subject|7|||
46974343|NCT01675427|83218692|FG000|Overall Study|Participant Refused Sample Collection|18|||
46974344|NCT01675427|83218692|FG000|Overall Study|Sample not Collected by Mistake|2|||
46791191|NCT00725543|83009998|FG000|Overall Study|Physician Decision|5|||
46791192|NCT00725543|83009998|FG000|Overall Study|Lost to Follow-up|4|||
46791193|NCT00725543|83009998|FG000|Overall Study|Non-compliance|2|||
46791194|NCT00725543|83009998|FG000|Overall Study|Other|119|||
46791195|NCT00239005|83010004|FG000|Overall Study|Adverse Event|6|||
46791196|NCT00239005|83010005|FG001|Overall Study|Adverse Event|6|||
46791197|NCT00239005|83010004|FG000|Overall Study|Withdrawal by Subject|3|||
46791198|NCT00239005|83010005|FG001|Overall Study|Withdrawal by Subject|4|||
46791199|NCT00239005|83010004|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
46791200|NCT00239005|83010005|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
46791201|NCT00239005|83010004|FG000|Overall Study|Protocol Violation|1|||
46791202|NCT00239005|83010005|FG001|Overall Study|Protocol Violation|0|||
46791203|NCT00239005|83010004|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
46791204|NCT00239005|83010005|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
46791205|NCT00239005|83010004|FG000|Overall Study|Lost to Follow-up|0|||
46791206|NCT00239005|83010005|FG001|Overall Study|Lost to Follow-up|1|||
46791207|NCT00616434|83010013|FG000|Overall Study|Adverse Event|5|||
46791208|NCT00616434|83010014|FG001|Overall Study|Adverse Event|2|||
46791209|NCT00616434|83010013|FG000|Overall Study|Physician Decision|0|||
46791210|NCT00616434|83010014|FG001|Overall Study|Physician Decision|4|||
46791211|NCT00616434|83010013|FG000|Overall Study|Withdrawal by Subject|1|||
46791212|NCT00616434|83010014|FG001|Overall Study|Withdrawal by Subject|1|||
46791213|NCT00616434|83010013|FG000|Overall Study|Protocol deviation|0|||
46791214|NCT00616434|83010014|FG001|Overall Study|Protocol deviation|1|||
46791215|NCT00652340|83010022|FG000|Overall Study|Had not progressed.|4|||
46791216|NCT00652340|83010023|FG001|Overall Study|Had not progressed.|3|||
46791217|NCT00613314|83010029|FG000|Overall Study|Adverse Event|5|||
46791218|NCT00613314|83010029|FG000|Overall Study|Protocol Violation|14|||
46791219|NCT00613314|83010029|FG000|Overall Study|Lost to Follow-up|46|||
46791220|NCT00613314|83010029|FG000|Overall Study|Other reason not defined above|90|||
46791221|NCT00257725|83010033|FG000|Overall Study|Adverse Event|3|||
46791222|NCT00544869|83010041|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
46791223|NCT00544869|83010042|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
46791224|NCT00544869|83010043|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
46791225|NCT00544869|83010041|FG000|Overall Study|Adverse Event|6|||
46974345|NCT01675427|83218692|FG000|Overall Study|Lost to Follow-up|5|||
46791226|NCT00544869|83010042|FG001|Overall Study|Adverse Event|1|||
46791227|NCT00544869|83010043|FG002|Overall Study|Adverse Event|0|||
46791228|NCT00544869|83010041|FG000|Overall Study|Lack of Efficacy|1|||
46791229|NCT00544869|83010042|FG001|Overall Study|Lack of Efficacy|1|||
46791230|NCT00544869|83010043|FG002|Overall Study|Lack of Efficacy|0|||
46791231|NCT00544869|83010041|FG000|Overall Study|Physician Decision|2|||
46791232|NCT00544869|83010042|FG001|Overall Study|Physician Decision|0|||
46791233|NCT00544869|83010043|FG002|Overall Study|Physician Decision|0|||
46791234|NCT00725075|83010054|FG000|Overall Study|Use of Excluded Medication|0|||
46791235|NCT00725075|83010055|FG001|Overall Study|Use of Excluded Medication|1|||
46791236|NCT00725075|83010056|FG002|Overall Study|Use of Excluded Medication|0|||
46791237|NCT00725075|83010054|FG000|Overall Study|Protocol Violation|0|||
46791238|NCT00725075|83010055|FG001|Overall Study|Protocol Violation|0|||
46791239|NCT00725075|83010056|FG002|Overall Study|Protocol Violation|1|||
46791240|NCT00725075|83010054|FG000|Overall Study|Lost to Follow-up|1|||
46791241|NCT00725075|83010055|FG001|Overall Study|Lost to Follow-up|0|||
46791242|NCT00725075|83010056|FG002|Overall Study|Lost to Follow-up|0|||
46791243|NCT00725075|83010054|FG000|Overall Study|Withdrawal by Subject|4|||
46791244|NCT00725075|83010055|FG001|Overall Study|Withdrawal by Subject|5|||
46791245|NCT00725075|83010056|FG002|Overall Study|Withdrawal by Subject|4|||
46791246|NCT00725075|83010054|FG000|Overall Study|Adverse Event|2|||
46791247|NCT00725075|83010055|FG001|Overall Study|Adverse Event|1|||
46791248|NCT00725075|83010056|FG002|Overall Study|Adverse Event|1|||
46974346|NCT01675427|83218692|FG000|Overall Study|Other|2|||
46791249|NCT00725075|83010054|FG000|Overall Study|Worsening of Disease|2|||
46974347|NCT01978912|83218730|FG000|Overall Study|Adverse Event|0|||
47078166|NCT03447769|83383227|FG000|Overall Study|Patient decision|27|||
47078167|NCT03447769|83383228|FG001|Overall Study|Patient decision|27|||
47078168|NCT03447769|83383227|FG000|Overall Study|Protocol deviation|4|||
47078169|NCT03447769|83383228|FG001|Overall Study|Protocol deviation|6|||
47078170|NCT03447769|83383227|FG000|Overall Study|Death|2|||
47078171|NCT03447769|83383228|FG001|Overall Study|Death|7|||
47078172|NCT03447769|83383227|FG000|Overall Study|Technical problems|1|||
47078173|NCT03447769|83383228|FG001|Overall Study|Technical problems|0|||
47078174|NCT03447769|83383227|FG000|Overall Study|Lost to Follow-up|0|||
47078175|NCT03447769|83383228|FG001|Overall Study|Lost to Follow-up|1|||
46791250|NCT00725075|83010055|FG001|Overall Study|Worsening of Disease|1|||
46974348|NCT01978912|83218731|FG001|Overall Study|Adverse Event|1|||
47078176|NCT03447769|83383227|FG000|Overall Study|Physician Decision|13|||
47078177|NCT03447769|83383228|FG001|Overall Study|Physician Decision|5|||
46791251|NCT00725075|83010056|FG002|Overall Study|Worsening of Disease|2|||
46974349|NCT01978912|83218732|FG002|Overall Study|Adverse Event|0|||
47078178|NCT03446651|83383239|FG000|Overall Study|Lost to Follow-up|4|||
46791252|NCT00725075|83010054|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
46791253|NCT00725075|83010055|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
46791254|NCT00725075|83010056|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
46791255|NCT00725075|83010054|FG000|Overall Study|Other|1|||
46791256|NCT00725075|83010055|FG001|Overall Study|Other|0|||
46791257|NCT00725075|83010056|FG002|Overall Study|Other|0|||
46791258|NCT00733499|83010066|FG000|Pre-operative|Protocol Violation|0|||
46791259|NCT00733499|83010067|FG001|Pre-operative|Protocol Violation|1|||
46791260|NCT00733499|83010066|FG000|3 Months Follow-up|Death|1|||
46791261|NCT00733499|83010067|FG001|3 Months Follow-up|Death|2|||
46791262|NCT00733499|83010066|FG000|6 Months Follow-up|Death|0|||
46791263|NCT00733499|83010067|FG001|6 Months Follow-up|Death|2|||
46791264|NCT00733499|83010066|FG000|6 Months Follow-up|Adverse Event|0|||
46791265|NCT00733499|83010067|FG001|6 Months Follow-up|Adverse Event|1|||
46791266|NCT00733499|83010066|FG000|12 Months Follow-up|Death|2|||
46791267|NCT00733499|83010067|FG001|12 Months Follow-up|Death|1|||
46791268|NCT00733499|83010066|FG000|24 Months Follow-up|Death|0|||
46791269|NCT00733499|83010067|FG001|24 Months Follow-up|Death|1|||
46791270|NCT00733499|83010066|FG000|5 Year Followup|Adverse Event|2|||
46791271|NCT00733499|83010067|FG001|5 Year Followup|Adverse Event|2|||
46791272|NCT00733499|83010066|FG000|5 Year Followup|Non device related AE|0|||
46791273|NCT00733499|83010067|FG001|5 Year Followup|Non device related AE|1|||
46791274|NCT00733499|83010066|FG000|5 Year Followup|Revision of Study Implant|0|||
46791275|NCT00733499|83010067|FG001|5 Year Followup|Revision of Study Implant|1|||
46791276|NCT00733499|83010066|FG000|5 Year Followup|Lost to Follow-up|2|||
46673892|NCT01162486|82889398|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
46791277|NCT00733499|83010067|FG001|5 Year Followup|Lost to Follow-up|0|||
46791278|NCT00733499|83010066|FG000|5 Year Followup|Death|13|||
46791279|NCT00733499|83010067|FG001|5 Year Followup|Death|19|||
46791280|NCT00733499|83010066|FG000|5 Year Followup|missing, unable to locate|0|||
46791281|NCT00733499|83010067|FG001|5 Year Followup|missing, unable to locate|1|||
46791282|NCT00733499|83010066|FG000|5 Year Followup|Withdrawal by Subject|4|||
46791283|NCT00733499|83010067|FG001|5 Year Followup|Withdrawal by Subject|1|||
46791284|NCT00733499|83010066|FG000|10 Year Followup|Death|9|||
46791285|NCT00733499|83010067|FG001|10 Year Followup|Death|7|||
46791286|NCT00733499|83010066|FG000|10 Year Followup|Adverse Event|3|||
46791287|NCT00733499|83010067|FG001|10 Year Followup|Adverse Event|3|||
46791288|NCT00733499|83010066|FG000|10 Year Followup|Lost to Follow-up|3|||
46791289|NCT00733499|83010067|FG001|10 Year Followup|Lost to Follow-up|2|||
46791290|NCT00733499|83010066|FG000|10 Year Followup|Withdrawal by Subject|5|||
46791291|NCT00733499|83010067|FG001|10 Year Followup|Withdrawal by Subject|5|||
46791292|NCT00733499|83010066|FG000|10 Year Followup|missing, unable to locate|0|||
46791293|NCT00733499|83010067|FG001|10 Year Followup|missing, unable to locate|2|||
46791294|NCT00652028|83010077|FG000|Overall Study|Adverse Event|1|||
46791295|NCT00652028|83010078|FG001|Overall Study|Adverse Event|0|||
46791296|NCT00652028|83010079|FG002|Overall Study|Adverse Event|0|||
46853768|NCT03480022|83069906|FG001|Overall Study|Medication concerns|0|||
47078179|NCT03446651|83383240|FG001|Overall Study|Lost to Follow-up|0|||
47078180|NCT03446651|83383239|FG000|Overall Study|Open Label Participants|5|||
47078181|NCT03446651|83383240|FG001|Overall Study|Open Label Participants|0|||
46791297|NCT00652028|83010080|FG003|Overall Study|Adverse Event|0|||
46791298|NCT00652028|83010077|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
46791299|NCT00652028|83010078|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
46853769|NCT03480022|83069905|FG000|Overall Study|Family member COVID exposure|0|||
46853770|NCT03480022|83069906|FG001|Overall Study|Family member COVID exposure|1|||
47078182|NCT03442751|83383248|FG000|Overall Study|Withdrawal by Subject|3|||
47078183|NCT03442751|83383249|FG001|Overall Study|Withdrawal by Subject|1|||
47078184|NCT03442751|83383248|FG000|Overall Study|Lost to Follow-up|3|||
47078185|NCT03442751|83383249|FG001|Overall Study|Lost to Follow-up|0|||
47078186|NCT03255967|83383262|FG000|Overall Study|Adverse Event|26|||
47078187|NCT03255967|83383263|FG001|Overall Study|Adverse Event|30|||
47078188|NCT03255967|83383262|FG000|Overall Study|Withdrawal by Subject|6|||
47078189|NCT03255967|83383263|FG001|Overall Study|Withdrawal by Subject|6|||
47078190|NCT03255967|83383262|FG000|Overall Study|Schedule conflict|6|||
47078191|NCT03255967|83383263|FG001|Overall Study|Schedule conflict|4|||
47078192|NCT03255967|83383262|FG000|Overall Study|POA did not sign consent form|2|||
47078193|NCT03255967|83383263|FG001|Overall Study|POA did not sign consent form|0|||
47078194|NCT03151811|83383273|FG000|Overall Study|Randomized But Not Treated|18|||
47078195|NCT03151811|83383274|FG001|Overall Study|Randomized But Not Treated|3|||
46673893|NCT01162486|82889399|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
46791300|NCT00652028|83010079|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
46791301|NCT00652028|83010080|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
46791302|NCT00652028|83010077|FG000|Overall Study|Physician Decision|0|||
47078196|NCT03151811|83383273|FG000|Overall Study|Progressive Disease|130|||
47078197|NCT03151811|83383274|FG001|Overall Study|Progressive Disease|170|||
47078198|NCT03151811|83383273|FG000|Overall Study|Adverse Event|49|||
47078199|NCT03151811|83383274|FG001|Overall Study|Adverse Event|40|||
46791303|NCT00652028|83010078|FG001|Overall Study|Physician Decision|0|||
46673894|NCT01162486|82889400|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
46791304|NCT00652028|83010079|FG002|Overall Study|Physician Decision|1|||
46791305|NCT00652028|83010080|FG003|Overall Study|Physician Decision|0|||
46791306|NCT00738101|83010090|FG000|Overall Study|Physician Decision|5|||
46791307|NCT00738101|83010090|FG000|Overall Study|Death|1|||
46791308|NCT00738101|83010090|FG000|Overall Study|Repeat enrollment|1|||
46791309|NCT00733421|83010096|FG000|Overall Study|Withdrawal by Subject|1|||
46791310|NCT00733421|83010097|FG001|Overall Study|Withdrawal by Subject|1|||
46791311|NCT00613080|83010103|FG000|Overall Study|Ineligible / no protocol treatment|11|||
46791312|NCT00732875|83010107|FG000|Overall Study|Adverse Event|16|||
46791313|NCT00732875|83010107|FG000|Overall Study|Withdrawal by Subject|6|||
46791314|NCT00732875|83010107|FG000|Overall Study|Lack of Efficacy|13|||
46791315|NCT00615264|83010117|FG000|Overall Study|Withdrawal by Subject|17|||
46791316|NCT00615264|83010118|FG001|Overall Study|Withdrawal by Subject|19|||
46791317|NCT00615264|83010117|FG000|Overall Study|Lost to Follow-up|6|||
46791318|NCT00615264|83010118|FG001|Overall Study|Lost to Follow-up|13|||
46791319|NCT00615264|83010117|FG000|Overall Study|Adverse Event|8|||
46791320|NCT00615264|83010118|FG001|Overall Study|Adverse Event|5|||
46791321|NCT00615264|83010117|FG000|Overall Study|Death|1|||
46791322|NCT00615264|83010118|FG001|Overall Study|Death|1|||
46791323|NCT00615264|83010117|FG000|Overall Study|Protocol Violation|11|||
46853771|NCT03533608|83069912|FG000|Overall Study|Withdrawal by Subject|3|||
46853772|NCT03533608|83069912|FG000|Overall Study|Physician Decision|2|||
46853773|NCT00049322|83069919|FG000|Overall Study|disease burden|0|||
46853774|NCT00049322|83069920|FG001|Overall Study|disease burden|3|||
46853775|NCT00049322|83069919|FG000|Overall Study|Adverse Event|1|||
46853776|NCT00049322|83069920|FG001|Overall Study|Adverse Event|0|||
46853777|NCT00049322|83069919|FG000|Overall Study|refused angio|0|||
46853778|NCT00049322|83069920|FG001|Overall Study|refused angio|3|||
46853779|NCT03437512|83069930|FG000|Randomized|Withdrawal by Subject|0|||
46853780|NCT03437512|83069931|FG001|Randomized|Withdrawal by Subject|2|||
47078200|NCT03151811|83383273|FG000|Overall Study|Lack of Efficacy|6|||
46673895|NCT01162486|82889401|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
46673896|NCT01162486|82889397|FG000|Overall Study|elevated LFTs|0|||
46673897|NCT01162486|82889398|FG001|Overall Study|elevated LFTs|0|||
46673898|NCT01162486|82889399|FG002|Overall Study|elevated LFTs|1|||
46673899|NCT01162486|82889400|FG003|Overall Study|elevated LFTs|0|||
46791324|NCT00615264|83010118|FG001|Overall Study|Protocol Violation|7|||
46791325|NCT00615264|83010117|FG000|Overall Study|Not defined|7|||
46791326|NCT00615264|83010118|FG001|Overall Study|Not defined|4|||
46791327|NCT00615264|83010117|FG000|Overall Study|Dermal Hypersensitivity|0|||
46673900|NCT01162486|82889401|FG004|Overall Study|elevated LFTs|0|||
46673901|NCT01162486|82889397|FG000|Overall Study|Pregnancy|0|||
46673902|NCT01162486|82889398|FG001|Overall Study|Pregnancy|0|||
46791328|NCT00615264|83010118|FG001|Overall Study|Dermal Hypersensitivity|3|||
46791329|NCT00732641|83010126|FG000|Overall Study|Relapse or Progressive Disease|65|||
46791330|NCT00732641|83010127|FG001|Overall Study|Relapse or Progressive Disease|101|||
47078201|NCT03151811|83383274|FG001|Overall Study|Lack of Efficacy|8|||
47078202|NCT03151811|83383273|FG000|Overall Study|Physician Decision|21|||
46791331|NCT00732641|83010126|FG000|Overall Study|Serious Adverse Events|12|||
46791332|NCT00732641|83010127|FG001|Overall Study|Serious Adverse Events|3|||
46791333|NCT00732641|83010126|FG000|Overall Study|Physician Decision|6|||
46791334|NCT00732641|83010127|FG001|Overall Study|Physician Decision|0|||
47078203|NCT03151811|83383274|FG001|Overall Study|Physician Decision|9|||
47078204|NCT03151811|83383273|FG000|Overall Study|Withdrawal by Subject|17|||
47078205|NCT03151811|83383274|FG001|Overall Study|Withdrawal by Subject|7|||
47078206|NCT03151811|83383273|FG000|Overall Study|Lost to Follow-up|0|||
47078207|NCT03151811|83383274|FG001|Overall Study|Lost to Follow-up|1|||
47078208|NCT03151811|83383273|FG000|Overall Study|Study Terminated by Sponsor|5|||
46853781|NCT03437512|83069930|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
46791335|NCT00732641|83010126|FG000|Overall Study|Withdrawal by Subject|4|||
46853782|NCT03437512|83069931|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
46853783|NCT00058058|83069937|FG000|Overall Study|Withdrawal by Subject|4|||
46853784|NCT00058058|83069937|FG000|Overall Study|Ineligible|20|||
46853785|NCT00058058|83069937|FG000|Overall Study|Claustrophobic|5|||
46791336|NCT00732641|83010127|FG001|Overall Study|Withdrawal by Subject|2|||
47078209|NCT03151811|83383274|FG001|Overall Study|Study Terminated by Sponsor|11|||
47078210|NCT02706951|83383311|FG000|Period 1|Adverse Event|1|||
47078211|NCT02706951|83383312|FG001|Period 1|Adverse Event|5|||
47078212|NCT02706951|83383313|FG002|Period 1|Adverse Event|3|||
47078213|NCT02706951|83383314|FG003|Period 1|Adverse Event|0|||
46791337|NCT00732641|83010126|FG000|Overall Study|Unable to Complete|1|||
46791338|NCT00732641|83010127|FG001|Overall Study|Unable to Complete|1|||
46791339|NCT00732641|83010126|FG000|Overall Study|Other|18|||
46791340|NCT00732641|83010127|FG001|Overall Study|Other|5|||
46853786|NCT00058058|83069937|FG000|Overall Study|technical issues|6|||
46853787|NCT00058058|83069937|FG000|Overall Study|Poor positioning, illness,pain|3|||
46673903|NCT01162486|82889399|FG002|Overall Study|Pregnancy|0|||
46791341|NCT00737711|83010133|FG000|Overall Study|Adverse Event|2|||
46791342|NCT00737711|83010133|FG000|Overall Study|Death|8|||
46791343|NCT00737711|83010133|FG000|Overall Study|Failure to return|4|||
46791344|NCT00737711|83010133|FG000|Overall Study|Protocol Violation|1|||
46791345|NCT00737711|83010133|FG000|Overall Study|Withdrawal by Subject|5|||
46791346|NCT00737711|83010133|FG000|Overall Study|Blood transfusion|6|||
46791347|NCT00737711|83010133|FG000|Overall Study|Other|5|||
46791348|NCT00615108|83010137|FG000|Overall Study|Adverse Event|122|||
46791349|NCT00615108|83010137|FG000|Overall Study|Other|370|||
46791350|NCT00615108|83010137|FG000|Overall Study|Lost to Follow-up|15|||
46791351|NCT00238303|83010146|FG000|Overall Study|Withdrawal by Subject|11|||
46791352|NCT00238303|83010147|FG001|Overall Study|Withdrawal by Subject|1|||
46853788|NCT03532048|83069944|FG000|Overall Study|Lost to Follow-up|12|||
46853789|NCT03532048|83069945|FG001|Overall Study|Lost to Follow-up|17|||
46853790|NCT03532048|83069944|FG000|Overall Study|Withdrawal by Subject|7|||
46853791|NCT03532048|83069945|FG001|Overall Study|Withdrawal by Subject|0|||
46853792|NCT00008138|83069951|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
46853793|NCT00008138|83069951|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
46853794|NCT00008138|83069951|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
46853795|NCT00008138|83069951|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
46853796|NCT00008138|83069951|FG000|Interval Debulking|Withdrawal by Subject|2|||
46853797|NCT00008138|83069951|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
46853798|NCT00008138|83069951|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
46791353|NCT00238303|83010148|FG002|Overall Study|Withdrawal by Subject|2|||
46853799|NCT00008138|83069951|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
46853800|NCT03436732|83069958|FG000|Overall Study|Not treated-enrolled in different study|1|||
46853801|NCT03436732|83069959|FG001|Overall Study|Not treated-enrolled in different study|0|||
46853802|NCT03436732|83069958|FG000|Overall Study|Off study after cycle 1|1|||
46853803|NCT03436732|83069959|FG001|Overall Study|Off study after cycle 1|0|||
46853804|NCT03436732|83069958|FG000|Overall Study|Adverse Event|2|||
46853805|NCT03436732|83069959|FG001|Overall Study|Adverse Event|0|||
46853806|NCT03436732|83069958|FG000|Overall Study|Death|0|||
46853807|NCT03436732|83069959|FG001|Overall Study|Death|1|||
46853808|NCT03436420|83069966|FG000|Overall Study|Lack of Efficacy|3|||
46853809|NCT00027560|83069970|FG000|Overall Study|Withdrawal by Subject|1|||
46853810|NCT03451084|83069980|FG000|Overall Study|Withdrawal by Subject|2|||
46853811|NCT03451084|83069981|FG001|Overall Study|Withdrawal by Subject|1|||
46853812|NCT03451084|83069982|FG002|Overall Study|Withdrawal by Subject|2|||
46853813|NCT03451084|83069983|FG003|Overall Study|Withdrawal by Subject|1|||
46853814|NCT03451084|83069980|FG000|Overall Study|Disease recurrence|0|||
46853815|NCT03451084|83069981|FG001|Overall Study|Disease recurrence|2|||
46853816|NCT03451084|83069982|FG002|Overall Study|Disease recurrence|0|||
46853817|NCT03451084|83069983|FG003|Overall Study|Disease recurrence|0|||
46853818|NCT03451084|83069980|FG000|Overall Study|Lack of Efficacy|0|||
46853819|NCT03451084|83069981|FG001|Overall Study|Lack of Efficacy|3|||
46853820|NCT03451084|83069982|FG002|Overall Study|Lack of Efficacy|0|||
46853821|NCT03451084|83069983|FG003|Overall Study|Lack of Efficacy|1|||
46853822|NCT03451084|83069980|FG000|Overall Study|Death|1|||
46853823|NCT03451084|83069981|FG001|Overall Study|Death|0|||
46853824|NCT03451084|83069982|FG002|Overall Study|Death|2|||
46853825|NCT03451084|83069983|FG003|Overall Study|Death|0|||
46791354|NCT00238303|83010146|FG000|Overall Study|Death|1|||
46791355|NCT00238303|83010147|FG001|Overall Study|Death|0|||
46791356|NCT00238303|83010148|FG002|Overall Study|Death|1|||
46791357|NCT00238303|83010146|FG000|Overall Study|Other Medical Problems|2|||
46791358|NCT00238303|83010147|FG001|Overall Study|Other Medical Problems|0|||
46791359|NCT00238303|83010148|FG002|Overall Study|Other Medical Problems|2|||
46791360|NCT00238303|83010146|FG000|Overall Study|Poor tolerance of study treatment|1|||
46791361|NCT00238303|83010147|FG001|Overall Study|Poor tolerance of study treatment|0|||
46791362|NCT00238303|83010148|FG002|Overall Study|Poor tolerance of study treatment|1|||
46791363|NCT00238303|83010146|FG000|Overall Study|Adverse Event|0|||
46791364|NCT00238303|83010147|FG001|Overall Study|Adverse Event|1|||
46791365|NCT00238303|83010148|FG002|Overall Study|Adverse Event|3|||
46791366|NCT00737633|83010159|FG000|Overall Study|Study terminated by sponsor|44|||
46791367|NCT00737633|83010160|FG001|Overall Study|Study terminated by sponsor|55|||
46791368|NCT00737633|83010159|FG000|Overall Study|Lost to Follow-up|0|||
46853826|NCT03451084|83069980|FG000|Overall Study|Physician Decision|0|||
46791369|NCT00737633|83010160|FG001|Overall Study|Lost to Follow-up|1|||
46853827|NCT03451084|83069981|FG001|Overall Study|Physician Decision|0|||
46853828|NCT03451084|83069982|FG002|Overall Study|Physician Decision|2|||
46853829|NCT03451084|83069983|FG003|Overall Study|Physician Decision|2|||
46791370|NCT00737633|83010159|FG000|Overall Study|protocol non-compliance|0|||
46791371|NCT00737633|83010160|FG001|Overall Study|protocol non-compliance|1|||
46853830|NCT03451084|83069980|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
46853831|NCT03451084|83069981|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
46853832|NCT03451084|83069982|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
46791372|NCT00732251|83010166|FG000|Overall Study|Lost to Follow-up|3|||
46791373|NCT00732251|83010166|FG000|Overall Study|Withdrawal by Subject|3|||
46791374|NCT00732251|83010166|FG000|Overall Study|Early Term due to Site Closure|1|||
46791375|NCT00737477|83010170|FG000|Overall Study|Adverse Event|9|||
46791376|NCT00737477|83010170|FG000|Overall Study|Death|9|||
46791377|NCT00737477|83010170|FG000|Overall Study|Treatment Refusal|1|||
46791378|NCT00737477|83010170|FG000|Overall Study|Withdrawal by Subject|1|||
46791379|NCT00737477|83010170|FG000|Overall Study|Renal Transplantation|10|||
46791380|NCT00737477|83010170|FG000|Overall Study|Other|4|||
46791381|NCT00256867|83010182|FG000|Overall Study|Adverse Event|0|||
46791382|NCT00256867|83010183|FG001|Overall Study|Adverse Event|1|||
46791383|NCT00256867|83010184|FG002|Overall Study|Adverse Event|1|||
46791384|NCT00256867|83010185|FG003|Overall Study|Adverse Event|1|||
46791385|NCT00256867|83010186|FG004|Overall Study|Adverse Event|2|||
46791386|NCT00256867|83010187|FG005|Overall Study|Adverse Event|2|||
46791387|NCT00256867|83010188|FG006|Overall Study|Adverse Event|1|||
46791388|NCT00256867|83010189|FG007|Overall Study|Adverse Event|4|||
46791389|NCT00256867|83010182|FG000|Overall Study|Lost to Follow-up|2|||
46791390|NCT00256867|83010183|FG001|Overall Study|Lost to Follow-up|2|||
46791391|NCT00256867|83010184|FG002|Overall Study|Lost to Follow-up|2|||
46791392|NCT00256867|83010185|FG003|Overall Study|Lost to Follow-up|3|||
46791393|NCT00256867|83010186|FG004|Overall Study|Lost to Follow-up|2|||
46791394|NCT00256867|83010187|FG005|Overall Study|Lost to Follow-up|0|||
46791395|NCT00256867|83010188|FG006|Overall Study|Lost to Follow-up|1|||
46791396|NCT00256867|83010189|FG007|Overall Study|Lost to Follow-up|2|||
46791397|NCT00256867|83010182|FG000|Overall Study|Protocol Violation|0|||
46791398|NCT00256867|83010183|FG001|Overall Study|Protocol Violation|0|||
46791399|NCT00256867|83010184|FG002|Overall Study|Protocol Violation|0|||
46791400|NCT00256867|83010185|FG003|Overall Study|Protocol Violation|1|||
46791401|NCT00256867|83010186|FG004|Overall Study|Protocol Violation|0|||
46791402|NCT00256867|83010187|FG005|Overall Study|Protocol Violation|1|||
46791403|NCT00256867|83010188|FG006|Overall Study|Protocol Violation|0|||
46791404|NCT00256867|83010189|FG007|Overall Study|Protocol Violation|1|||
46791405|NCT00256867|83010182|FG000|Overall Study|Withdrawal by Subject|0|||
46791406|NCT00256867|83010183|FG001|Overall Study|Withdrawal by Subject|0|||
46853833|NCT03451084|83069983|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
46853834|NCT03451006|83069995|FG000|Overall Study|Withdrawal by Subject|2|||
46853835|NCT03451006|83069996|FG001|Overall Study|Withdrawal by Subject|2|||
46853836|NCT03450070|83070002|FG000|Overall Study|Withdrawal by Subject|8|||
46853837|NCT03449758|83070006|FG000|Overall Study|Major protocol deviation|1|||
46853838|NCT03449758|83070006|FG000|Overall Study|Treatment inefficacy|5|||
46853839|NCT03449758|83070006|FG000|Overall Study|Adverse Event|9|||
46853840|NCT03449758|83070006|FG000|Overall Study|Consent withdrawal|1|||
46974350|NCT01978912|83218733|FG003|Overall Study|Adverse Event|0|||
46974351|NCT01978912|83218730|FG000|Overall Study|Lost to Follow-up|1|||
46974352|NCT01978912|83218731|FG001|Overall Study|Lost to Follow-up|1|||
46791407|NCT00256867|83010184|FG002|Overall Study|Withdrawal by Subject|1|||
46791408|NCT00256867|83010185|FG003|Overall Study|Withdrawal by Subject|1|||
46791409|NCT00256867|83010186|FG004|Overall Study|Withdrawal by Subject|2|||
46791410|NCT00256867|83010187|FG005|Overall Study|Withdrawal by Subject|2|||
46791411|NCT00256867|83010188|FG006|Overall Study|Withdrawal by Subject|3|||
46791412|NCT00256867|83010189|FG007|Overall Study|Withdrawal by Subject|2|||
46791413|NCT00256867|83010182|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
46791414|NCT00256867|83010183|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
46791415|NCT00256867|83010184|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
46791416|NCT00256867|83010185|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
46791417|NCT00256867|83010186|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
46791418|NCT00256867|83010187|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
46853841|NCT03449758|83070006|FG000|Overall Study|Other unspecified reason|3|||
46974353|NCT01978912|83218732|FG002|Overall Study|Lost to Follow-up|0|||
46974354|NCT01978912|83218733|FG003|Overall Study|Lost to Follow-up|1|||
46974355|NCT01978912|83218730|FG000|Overall Study|Withdrawal by Subject|1|||
46974356|NCT01978912|83218731|FG001|Overall Study|Withdrawal by Subject|0|||
46974357|NCT01978912|83218732|FG002|Overall Study|Withdrawal by Subject|2|||
46791419|NCT00256867|83010188|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
46791420|NCT00256867|83010189|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
46791421|NCT00256867|83010182|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
46791422|NCT00256867|83010183|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
46791423|NCT00256867|83010184|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
46791424|NCT00256867|83010185|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
46791425|NCT00256867|83010186|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
46791426|NCT00256867|83010187|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
46791427|NCT00256867|83010188|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
46791428|NCT00256867|83010189|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
46791429|NCT00256867|83010182|FG000|Overall Study|Investigator's Decision|0|||
46974358|NCT01978912|83218733|FG003|Overall Study|Withdrawal by Subject|2|||
46791430|NCT00256867|83010183|FG001|Overall Study|Investigator's Decision|0|||
46791431|NCT00256867|83010184|FG002|Overall Study|Investigator's Decision|0|||
46791432|NCT00256867|83010185|FG003|Overall Study|Investigator's Decision|0|||
46791433|NCT00256867|83010186|FG004|Overall Study|Investigator's Decision|1|||
46791434|NCT00256867|83010187|FG005|Overall Study|Investigator's Decision|0|||
46791435|NCT00256867|83010188|FG006|Overall Study|Investigator's Decision|0|||
46791436|NCT00256867|83010189|FG007|Overall Study|Investigator's Decision|0|||
46791437|NCT00256867|83010182|FG000|Overall Study|Non-compliance with study medication|0|||
46791438|NCT00256867|83010183|FG001|Overall Study|Non-compliance with study medication|0|||
46791439|NCT00256867|83010184|FG002|Overall Study|Non-compliance with study medication|0|||
46791440|NCT00256867|83010185|FG003|Overall Study|Non-compliance with study medication|0|||
46853842|NCT03449446|83070018|FG000|Overall Study|Randomized but Never Treated|0|||
46853843|NCT03449446|83070019|FG001|Overall Study|Randomized but Never Treated|0|||
46853844|NCT03449446|83070020|FG002|Overall Study|Randomized but Never Treated|1|||
46853845|NCT03449446|83070021|FG003|Overall Study|Randomized but Never Treated|1|||
46853846|NCT03449446|83070022|FG004|Overall Study|Randomized but Never Treated|1|||
46853847|NCT03449446|83070023|FG005|Overall Study|Randomized but Never Treated|0|||
46791441|NCT00256867|83010186|FG004|Overall Study|Non-compliance with study medication|0|||
46791442|NCT00256867|83010187|FG005|Overall Study|Non-compliance with study medication|0|||
46791443|NCT00256867|83010188|FG006|Overall Study|Non-compliance with study medication|0|||
46791444|NCT00256867|83010189|FG007|Overall Study|Non-compliance with study medication|1|||
46791445|NCT00256867|83010182|FG000|Overall Study|Participant travelled Overseas|0|||
46791446|NCT00256867|83010183|FG001|Overall Study|Participant travelled Overseas|1|||
46791447|NCT00256867|83010184|FG002|Overall Study|Participant travelled Overseas|0|||
46791448|NCT00256867|83010185|FG003|Overall Study|Participant travelled Overseas|0|||
46791449|NCT00256867|83010186|FG004|Overall Study|Participant travelled Overseas|0|||
46791450|NCT00256867|83010187|FG005|Overall Study|Participant travelled Overseas|0|||
46791451|NCT00256867|83010188|FG006|Overall Study|Participant travelled Overseas|0|||
46791452|NCT00256867|83010189|FG007|Overall Study|Participant travelled Overseas|0|||
46791453|NCT00256867|83010182|FG000|Overall Study|Participant out of assessment window|0|||
46791454|NCT00256867|83010183|FG001|Overall Study|Participant out of assessment window|0|||
46791455|NCT00256867|83010184|FG002|Overall Study|Participant out of assessment window|1|||
46791456|NCT00256867|83010185|FG003|Overall Study|Participant out of assessment window|0|||
46791457|NCT00256867|83010186|FG004|Overall Study|Participant out of assessment window|0|||
46791458|NCT00256867|83010187|FG005|Overall Study|Participant out of assessment window|0|||
46853848|NCT03449446|83070024|FG006|Overall Study|Randomized but Never Treated|0|||
46853849|NCT03449446|83070018|FG000|Overall Study|Unknown Reason|33|||
46853850|NCT03449446|83070019|FG001|Overall Study|Unknown Reason|1|||
46853851|NCT03449446|83070020|FG002|Overall Study|Unknown Reason|1|||
46853852|NCT03449446|83070021|FG003|Overall Study|Unknown Reason|1|||
46853853|NCT03449446|83070022|FG004|Overall Study|Unknown Reason|2|||
46791459|NCT00256867|83010188|FG006|Overall Study|Participant out of assessment window|0|||
46853854|NCT03449446|83070023|FG005|Overall Study|Unknown Reason|2|||
46853855|NCT03449446|83070024|FG006|Overall Study|Unknown Reason|0|||
46853856|NCT03449446|83070018|FG000|Overall Study|Withdrew Consent|1|||
46853857|NCT03449446|83070019|FG001|Overall Study|Withdrew Consent|3|||
46791460|NCT00256867|83010189|FG007|Overall Study|Participant out of assessment window|0|||
46791461|NCT00256867|83010182|FG000|Overall Study|Withdrawal by participant|0|||
46791462|NCT00256867|83010183|FG001|Overall Study|Withdrawal by participant|0|||
46791463|NCT00256867|83010184|FG002|Overall Study|Withdrawal by participant|0|||
46791464|NCT00256867|83010185|FG003|Overall Study|Withdrawal by participant|0|||
46791465|NCT00256867|83010186|FG004|Overall Study|Withdrawal by participant|0|||
46791466|NCT00256867|83010187|FG005|Overall Study|Withdrawal by participant|1|||
46791467|NCT00256867|83010188|FG006|Overall Study|Withdrawal by participant|0|||
46791468|NCT00256867|83010189|FG007|Overall Study|Withdrawal by participant|0|||
46791469|NCT00731939|83010212|FG000|Overall Study|Adverse Event|6|||
46791470|NCT00731939|83010212|FG000|Overall Study|Lost to Follow-up|15|||
46791471|NCT00731939|83010212|FG000|Overall Study|Not implanted with study device|9|||
46791472|NCT00731939|83010212|FG000|Overall Study|Withdrawal by Subject|2|||
46791473|NCT00731939|83010212|FG000|Overall Study|Did not meet enrollment criteria|2|||
46791474|NCT00731783|83010218|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
46791475|NCT00731783|83010219|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
46791476|NCT00731783|83010218|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
46791477|NCT00731783|83010219|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
46673904|NCT01162486|82889400|FG003|Overall Study|Pregnancy|1|||
46791478|NCT00731783|83010218|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
46791479|NCT00731783|83010219|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
46853858|NCT03449446|83070020|FG002|Overall Study|Withdrew Consent|1|||
46853859|NCT03449446|83070021|FG003|Overall Study|Withdrew Consent|4|||
46853860|NCT03449446|83070022|FG004|Overall Study|Withdrew Consent|4|||
46853861|NCT03449446|83070023|FG005|Overall Study|Withdrew Consent|4|||
46853862|NCT03449446|83070024|FG006|Overall Study|Withdrew Consent|1|||
46853863|NCT03449446|83070018|FG000|Overall Study|Adverse Event|1|||
46853864|NCT03449446|83070019|FG001|Overall Study|Adverse Event|2|||
46791480|NCT00731783|83010218|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
46791481|NCT00731783|83010219|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
46791482|NCT00724451|83010225|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
46791483|NCT00724451|83010225|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
46791484|NCT00724451|83010225|FG000|Overall Study|Not Eligible for Treatment|431|||
46791485|NCT00724451|83010225|FG000|Overall Study|Participant Refused Treatment|89|||
46791486|NCT00724451|83010225|FG000|Overall Study|Never Started Treatment|89|||
46791487|NCT00724451|83010225|FG000|Overall Study|Unknown; No Data Sources Available|9|||
46791488|NCT00724451|83010225|FG000|Overall Study|Physician Decision|116|||
46791489|NCT00724451|83010225|FG000|Overall Study|Withdrawal by Subject|45|||
46791490|NCT00724451|83010225|FG000|Overall Study|Investigator + Participant Decision|13|||
46791491|NCT00724373|83010229|FG000|Overall Study|Adverse Event|41|||
46791492|NCT00724373|83010229|FG000|Overall Study|Lack of Efficacy|82|||
46791493|NCT00724373|83010229|FG000|Overall Study|Lost to Follow-up|7|||
46791494|NCT00724373|83010229|FG000|Overall Study|Non-compliance|2|||
46791495|NCT00724373|83010229|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
46791496|NCT00724373|83010229|FG000|Overall Study|Participant moved away|1|||
46791497|NCT00724373|83010229|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
46791498|NCT00724373|83010229|FG000|Overall Study|Only to have 24 week regimen|1|||
46791499|NCT00724373|83010229|FG000|Overall Study|Viral Relapse|1|||
46791500|NCT00724373|83010229|FG000|Overall Study|Acute HCV infection|1|||
46791501|NCT00724373|83010229|FG000|Overall Study|Drug Relapse|1|||
46791502|NCT00724373|83010229|FG000|Overall Study|Tolerability|23|||
46791503|NCT00724061|83010233|FG000|Dose Escalation Phase|Adverse Event|2|||
46791504|NCT00724061|83010233|FG000|Dose Escalation Phase|Disease Progression|3|||
46791505|NCT00731549|83010237|FG000|Overall Study|Lost to Follow-up|19|||
46791506|NCT00731549|83010237|FG000|Overall Study|Met withdrawal criteria|24|||
46791507|NCT00731549|83010237|FG000|Overall Study|Physician Decision|16|||
46791508|NCT00731549|83010237|FG000|Overall Study|Withdrawal by Subject|89|||
46791509|NCT00731549|83010237|FG000|Overall Study|Protocol deviation|1|||
46853865|NCT03449446|83070020|FG002|Overall Study|Adverse Event|1|||
46853866|NCT03449446|83070021|FG003|Overall Study|Adverse Event|0|||
46853867|NCT03449446|83070022|FG004|Overall Study|Adverse Event|0|||
46853868|NCT03449446|83070023|FG005|Overall Study|Adverse Event|2|||
46853869|NCT03449446|83070024|FG006|Overall Study|Adverse Event|0|||
46853870|NCT03449446|83070018|FG000|Overall Study|Lost to Follow-up|0|||
46853871|NCT03449446|83070019|FG001|Overall Study|Lost to Follow-up|0|||
46853872|NCT03449446|83070020|FG002|Overall Study|Lost to Follow-up|2|||
46853873|NCT03449446|83070021|FG003|Overall Study|Lost to Follow-up|1|||
46853874|NCT03449446|83070022|FG004|Overall Study|Lost to Follow-up|3|||
46853875|NCT03449446|83070023|FG005|Overall Study|Lost to Follow-up|0|||
46853876|NCT03449446|83070024|FG006|Overall Study|Lost to Follow-up|0|||
46853877|NCT03449446|83070018|FG000|Overall Study|Investigator's Discretion|0|||
46853878|NCT03449446|83070019|FG001|Overall Study|Investigator's Discretion|1|||
46853879|NCT03449446|83070020|FG002|Overall Study|Investigator's Discretion|1|||
46853880|NCT03449446|83070021|FG003|Overall Study|Investigator's Discretion|2|||
46853881|NCT03449446|83070022|FG004|Overall Study|Investigator's Discretion|0|||
46853882|NCT03449446|83070023|FG005|Overall Study|Investigator's Discretion|0|||
46853883|NCT03449446|83070024|FG006|Overall Study|Investigator's Discretion|0|||
46853884|NCT03449446|83070018|FG000|Overall Study|Non Compliance with Study Drug|1|||
46853885|NCT03449446|83070019|FG001|Overall Study|Non Compliance with Study Drug|0|||
46853886|NCT03449446|83070020|FG002|Overall Study|Non Compliance with Study Drug|0|||
46853887|NCT03449446|83070021|FG003|Overall Study|Non Compliance with Study Drug|0|||
46853888|NCT03449446|83070022|FG004|Overall Study|Non Compliance with Study Drug|0|||
46853889|NCT03449446|83070023|FG005|Overall Study|Non Compliance with Study Drug|0|||
46974359|NCT01978912|83218730|FG000|Overall Study|Lumbar Surgery|1|||
46974360|NCT01978912|83218731|FG001|Overall Study|Lumbar Surgery|0|||
46974361|NCT01978912|83218732|FG002|Overall Study|Lumbar Surgery|1|||
47078214|NCT02706951|83383315|FG004|Period 1|Adverse Event|0|||
46791510|NCT00731549|83010237|FG000|Overall Study|Adverse Event|31|||
46791511|NCT00731549|83010237|FG000|Overall Study|Lack of efficacy with AE|37|||
46974362|NCT01978912|83218733|FG003|Overall Study|Lumbar Surgery|0|||
46791512|NCT00731549|83010237|FG000|Overall Study|Lack of efficacy without AE|6|||
46791513|NCT00730925|83010282|FG000|Overall Study|Progressive Disease|21|||
46791514|NCT00730925|83010282|FG000|Overall Study|Dose reducing Event|2|||
46853890|NCT03449446|83070024|FG006|Overall Study|Non Compliance with Study Drug|0|||
46853891|NCT03449446|83070018|FG000|Overall Study|Protocol Violation|0|||
46853892|NCT03449446|83070019|FG001|Overall Study|Protocol Violation|0|||
46853893|NCT03449446|83070020|FG002|Overall Study|Protocol Violation|0|||
46974363|NCT01978912|83218730|FG000|Overall Study|Intradiscal Steroid Injection|0|||
46791515|NCT00730925|83010282|FG000|Overall Study|Other Averse Event|7|||
46791516|NCT00730925|83010282|FG000|Overall Study|Protocol Violation|1|||
46853894|NCT03449446|83070021|FG003|Overall Study|Protocol Violation|0|||
46791517|NCT00730925|83010282|FG000|Overall Study|Withdrawal by Subject|1|||
46853895|NCT03449446|83070022|FG004|Overall Study|Protocol Violation|1|||
47078215|NCT02706951|83383311|FG000|Period 1|Withdrawal by Subject|10|||
47078216|NCT02706951|83383312|FG001|Period 1|Withdrawal by Subject|6|||
46791518|NCT00730925|83010282|FG000|Overall Study|Switch to combination therapy|8|||
46791519|NCT00730925|83010282|FG000|Overall Study|Other|1|||
46791520|NCT00236899|83010290|FG000|Overall Study|Adverse Event (Study Related)|1|||
46791521|NCT00236899|83010291|FG001|Overall Study|Adverse Event (Study Related)|1|||
46791522|NCT00236899|83010292|FG002|Overall Study|Adverse Event (Study Related)|2|||
46791523|NCT00236899|83010293|FG003|Overall Study|Adverse Event (Study Related)|1|||
46791524|NCT00236899|83010290|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
46791525|NCT00236899|83010291|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
46853896|NCT03449446|83070023|FG005|Overall Study|Protocol Violation|1|||
46853897|NCT03449446|83070024|FG006|Overall Study|Protocol Violation|0|||
46853898|NCT03449446|83070018|FG000|Overall Study|Death|0|||
46853899|NCT03449446|83070019|FG001|Overall Study|Death|0|||
46853900|NCT03449446|83070020|FG002|Overall Study|Death|0|||
46853901|NCT03449446|83070021|FG003|Overall Study|Death|0|||
46853902|NCT03449446|83070022|FG004|Overall Study|Death|1|||
46853903|NCT03449446|83070023|FG005|Overall Study|Death|0|||
46853904|NCT03449446|83070024|FG006|Overall Study|Death|0|||
46853905|NCT03449134|83070043|FG000|52-Week Treatment Period|Death|2|||
46853906|NCT03449134|83070044|FG001|52-Week Treatment Period|Death|1|||
46853907|NCT03449134|83070045|FG002|52-Week Treatment Period|Death|0|||
46853908|NCT03449134|83070043|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
46853909|NCT03449134|83070044|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
46853910|NCT03449134|83070045|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
46853911|NCT03449134|83070043|FG000|52-Week Treatment Period|Physician Decision|2|||
46853912|NCT03449134|83070044|FG001|52-Week Treatment Period|Physician Decision|3|||
46853913|NCT03449134|83070045|FG002|52-Week Treatment Period|Physician Decision|3|||
46853914|NCT03449134|83070043|FG000|52-Week Treatment Period|Screen Failure|1|||
46853915|NCT03449134|83070044|FG001|52-Week Treatment Period|Screen Failure|0|||
46853916|NCT03449134|83070045|FG002|52-Week Treatment Period|Screen Failure|1|||
46853917|NCT03449134|83070043|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
46853918|NCT03449134|83070044|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
46853919|NCT03449134|83070045|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
46853920|NCT03449134|83070043|FG000|52-Week Treatment Period|Site Closure|1|||
46853921|NCT03449134|83070044|FG001|52-Week Treatment Period|Site Closure|0|||
46853922|NCT03449134|83070045|FG002|52-Week Treatment Period|Site Closure|0|||
46853923|NCT03529162|83070058|FG000|Overall Study|Lost to Follow-up|2|||
46853924|NCT03529162|83070059|FG001|Overall Study|Lost to Follow-up|2|||
46853925|NCT03447730|83070070|FG000|Overall Study|Adverse Event|0|||
46853926|NCT03447730|83070071|FG001|Overall Study|Adverse Event|2|||
46853927|NCT03447730|83070072|FG002|Overall Study|Adverse Event|0|||
46853928|NCT03429556|83070084|FG000|Overall Study|Lost to Follow-up|0|||
46853929|NCT03429556|83070085|FG001|Overall Study|Lost to Follow-up|1|||
46853930|NCT03429556|83070086|FG002|Overall Study|Lost to Follow-up|0|||
46853931|NCT03429556|83070087|FG003|Overall Study|Lost to Follow-up|0|||
46853932|NCT03444766|83070097|FG000|Overall Study|Other Reasons|2|||
46853933|NCT03444766|83070097|FG000|Overall Study|Participant Withdrew Consent|5|||
46974364|NCT01978912|83218731|FG001|Overall Study|Intradiscal Steroid Injection|1|||
46974365|NCT01978912|83218732|FG002|Overall Study|Intradiscal Steroid Injection|0|||
46974366|NCT01978912|83218733|FG003|Overall Study|Intradiscal Steroid Injection|0|||
46974367|NCT01977898|83218745|FG000|Overall Study|Non functioning catheter|1|||
46853934|NCT03444766|83070097|FG000|Overall Study|Lost to Follow-up|2|||
46853935|NCT03444766|83070097|FG000|Overall Study|Death|2|||
46853936|NCT03444766|83070097|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
46853937|NCT03444766|83070097|FG000|Overall Study|Disease Progression|49|||
46853938|NCT03426436|83070101|FG000|Overall Study|Incorrect lead placement|12|||
46853939|NCT03426436|83070101|FG000|Overall Study|Withdrawal by Subject|2|||
46974368|NCT01977898|83218746|FG001|Overall Study|Non functioning catheter|1|||
46974369|NCT02003638|83218754|FG000|Overall Study|Withdrawal by Subject|1|||
47078217|NCT02706951|83383313|FG002|Period 1|Withdrawal by Subject|6|||
47078218|NCT02706951|83383314|FG003|Period 1|Withdrawal by Subject|0|||
47078219|NCT02706951|83383315|FG004|Period 1|Withdrawal by Subject|0|||
47078220|NCT02706951|83383311|FG000|Period 1|Lost to Follow-up|0|||
46853940|NCT03426436|83070101|FG000|Overall Study|Consent issue|1|||
46853941|NCT03426436|83070101|FG000|Overall Study|ECGs not saved|4|||
46853942|NCT03425188|83070105|FG000|Overall Study|Withdrawal by Subject|1|||
46853943|NCT03423238|83070112|FG000|Overall Study|Lost to Follow-up|1|||
46853944|NCT03423238|83070113|FG001|Overall Study|Lost to Follow-up|0|||
46853945|NCT03423238|83070112|FG000|Overall Study|Withdrawal by Subject|1|||
46974370|NCT02003638|83218755|FG001|Overall Study|Withdrawal by Subject|0|||
46853946|NCT03423238|83070113|FG001|Overall Study|Withdrawal by Subject|0|||
46853947|NCT02953678|83070120|FG000|Overall Study|Adverse Event|20|||
46853948|NCT02953678|83070120|FG000|Overall Study|Death|7|||
46853949|NCT02953678|83070120|FG000|Overall Study|Physician Decision|23|||
46853950|NCT02953678|83070120|FG000|Overall Study|Progressive Disease of GVHD|7|||
46853951|NCT02953678|83070120|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
47078221|NCT02706951|83383312|FG001|Period 1|Lost to Follow-up|4|||
47078222|NCT02706951|83383313|FG002|Period 1|Lost to Follow-up|1|||
46853952|NCT02953678|83070120|FG000|Overall Study|Withdrawal by participant|3|||
46853953|NCT02953678|83070120|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
46853954|NCT02953678|83070120|FG000|Overall Study|Participants were transferred to commercial product.|3|||
46853955|NCT03412084|83070127|FG000|Overall Study|Withdrawal by Subject|2|||
46853956|NCT03412084|83070128|FG001|Overall Study|Withdrawal by Subject|0|||
46853957|NCT03412084|83070127|FG000|Overall Study|Participant moved|1|||
46853958|NCT03412084|83070128|FG001|Overall Study|Participant moved|0|||
46853959|NCT03412084|83070127|FG000|Overall Study|Lost to Follow-up|1|||
46853960|NCT03412084|83070128|FG001|Overall Study|Lost to Follow-up|1|||
46853961|NCT00090753|83070136|FG000|First Treatment Period|Adverse Event|20|||
46853962|NCT00090753|83070137|FG001|First Treatment Period|Adverse Event|8|||
46974371|NCT02696317|83218761|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
46974372|NCT02696317|83218762|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
46974373|NCT02696317|83218761|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
46974374|NCT02696317|83218762|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
46974375|NCT01959412|83218770|FG000|Overall Study|Protocol deviation|1|||
46974376|NCT01959412|83218771|FG001|Overall Study|Protocol deviation|1|||
46974377|NCT01959412|83218772|FG002|Overall Study|Protocol deviation|0|||
46974378|NCT01959412|83218773|FG003|Overall Study|Protocol deviation|1|||
46974379|NCT01959412|83218774|FG004|Overall Study|Protocol deviation|3|||
46974380|NCT01959412|83218775|FG005|Overall Study|Protocol deviation|0|||
46791526|NCT00236899|83010292|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
46974381|NCT01959412|83218770|FG000|Overall Study|Adverse Event|0|||
46974382|NCT01959412|83218771|FG001|Overall Study|Adverse Event|0|||
46974383|NCT01959412|83218772|FG002|Overall Study|Adverse Event|0|||
46974384|NCT01959412|83218773|FG003|Overall Study|Adverse Event|1|||
46974385|NCT01959412|83218774|FG004|Overall Study|Adverse Event|0|||
46974386|NCT01959412|83218775|FG005|Overall Study|Adverse Event|0|||
46974387|NCT01977820|83218791|FG000|Overall Study|Sponsor terminated the study|1|||
46974388|NCT01977820|83218792|FG001|Overall Study|Sponsor terminated the study|1|||
46974389|NCT02003014|83218798|FG000|Overall Study|Case report forms uncollected|9|||
46974390|NCT02003014|83218798|FG000|Overall Study|Treatment started after contract period|1|||
46974391|NCT02003014|83218798|FG000|Overall Study|Patient did not visit the study site|5|||
46974392|NCT02003014|83218798|FG000|Overall Study|Investigator's transfer|4|||
46974393|NCT01977352|83218804|FG000|Overall Study|Lost to Follow-up|1|||
46974394|NCT01977352|83218805|FG001|Overall Study|Lost to Follow-up|2|||
46974395|NCT02001688|83218814|FG000|Overall Study|Withdrawal by Subject|0|||
46974396|NCT02001688|83218815|FG001|Overall Study|Withdrawal by Subject|0|||
46974397|NCT02001688|83218816|FG002|Overall Study|Withdrawal by Subject|1|||
46974398|NCT02001688|83218814|FG000|Overall Study|Adverse Event|0|||
46974399|NCT02001688|83218815|FG001|Overall Study|Adverse Event|1|||
46791527|NCT00236899|83010293|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
46791528|NCT00236899|83010290|FG000|Overall Study|Death (Study Disease)|1|||
46791529|NCT00236899|83010291|FG001|Overall Study|Death (Study Disease)|4|||
46791530|NCT00236899|83010292|FG002|Overall Study|Death (Study Disease)|0|||
46791531|NCT00236899|83010293|FG003|Overall Study|Death (Study Disease)|0|||
46791532|NCT00236899|83010290|FG000|Overall Study|Death (Not Study Related)|2|||
46791533|NCT00236899|83010291|FG001|Overall Study|Death (Not Study Related)|0|||
46791534|NCT00236899|83010292|FG002|Overall Study|Death (Not Study Related)|0|||
46791535|NCT00236899|83010293|FG003|Overall Study|Death (Not Study Related)|0|||
46791536|NCT00236899|83010290|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
46791537|NCT00236899|83010291|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
46791538|NCT00236899|83010292|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
46791539|NCT00236899|83010293|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
46791540|NCT00236899|83010290|FG000|Overall Study|Lost to Follow-up|0|||
46791541|NCT00236899|83010291|FG001|Overall Study|Lost to Follow-up|1|||
46791542|NCT00236899|83010292|FG002|Overall Study|Lost to Follow-up|0|||
46791543|NCT00236899|83010293|FG003|Overall Study|Lost to Follow-up|0|||
46791544|NCT00236899|83010290|FG000|Overall Study|Entry Criteria Exclusion|0|||
46853963|NCT00090753|83070136|FG000|First Treatment Period|Death|88|||
46853964|NCT00090753|83070137|FG001|First Treatment Period|Death|62|||
46853965|NCT00090753|83070136|FG000|First Treatment Period|Lack of Efficacy|2|||
46853966|NCT00090753|83070137|FG001|First Treatment Period|Lack of Efficacy|1|||
46791545|NCT00236899|83010291|FG001|Overall Study|Entry Criteria Exclusion|1|||
46791546|NCT00236899|83010292|FG002|Overall Study|Entry Criteria Exclusion|1|||
46791547|NCT00236899|83010293|FG003|Overall Study|Entry Criteria Exclusion|0|||
46853967|NCT00090753|83070136|FG000|First Treatment Period|Refused Treatment|32|||
46853968|NCT00090753|83070137|FG001|First Treatment Period|Refused Treatment|25|||
46853969|NCT00090753|83070136|FG000|First Treatment Period|Lost to Follow-up|4|||
46853970|NCT00090753|83070137|FG001|First Treatment Period|Lost to Follow-up|4|||
46974400|NCT02001688|83218816|FG002|Overall Study|Adverse Event|0|||
46974401|NCT02001064|83218827|FG000|Overall Study|Withdrawal by Subject|2|||
46974402|NCT02001064|83218828|FG001|Overall Study|Withdrawal by Subject|1|||
46974403|NCT02000752|83218836|FG000|Overall Study|Dystocic delivery|19|||
46791548|NCT00236899|83010290|FG000|Overall Study|Protocol Violation|1|||
46791549|NCT00236899|83010291|FG001|Overall Study|Protocol Violation|0|||
46791550|NCT00236899|83010292|FG002|Overall Study|Protocol Violation|0|||
46791551|NCT00236899|83010293|FG003|Overall Study|Protocol Violation|0|||
46791552|NCT00236899|83010290|FG000|Overall Study|Withdrawal by Subject|6|||
46791553|NCT00236899|83010291|FG001|Overall Study|Withdrawal by Subject|4|||
46791554|NCT00236899|83010292|FG002|Overall Study|Withdrawal by Subject|5|||
46791555|NCT00236899|83010293|FG003|Overall Study|Withdrawal by Subject|2|||
46791556|NCT00236899|83010290|FG000|Overall Study|Physician Decision|7|||
46791557|NCT00236899|83010291|FG001|Overall Study|Physician Decision|8|||
46791558|NCT00236899|83010292|FG002|Overall Study|Physician Decision|7|||
46791559|NCT00236899|83010293|FG003|Overall Study|Physician Decision|6|||
46791560|NCT00236899|83010290|FG000|Overall Study|Satisfactory Response|2|||
46791561|NCT00236899|83010291|FG001|Overall Study|Satisfactory Response|0|||
46791562|NCT00236899|83010292|FG002|Overall Study|Satisfactory Response|0|||
46791563|NCT00236899|83010293|FG003|Overall Study|Satisfactory Response|1|||
46791564|NCT00236899|83010290|FG000|Overall Study|Lack of Efficacy|18|||
46791565|NCT00236899|83010291|FG001|Overall Study|Lack of Efficacy|18|||
46791566|NCT00236899|83010292|FG002|Overall Study|Lack of Efficacy|25|||
46791567|NCT00236899|83010293|FG003|Overall Study|Lack of Efficacy|23|||
46791568|NCT00611130|83010312|FG000|Overall Study|Lost to Follow-up|25|||
46791569|NCT00611130|83010313|FG001|Overall Study|Lost to Follow-up|29|||
46791570|NCT00611130|83010312|FG000|Overall Study|Protocol noncompliance|7|||
46791571|NCT00611130|83010313|FG001|Overall Study|Protocol noncompliance|6|||
46791572|NCT00611130|83010312|FG000|Overall Study|Withdrawal by Subject|6|||
46791573|NCT00611130|83010313|FG001|Overall Study|Withdrawal by Subject|5|||
46853971|NCT00090753|83070136|FG000|First Treatment Period|Renal Transplant|70|||
46853972|NCT00090753|83070137|FG001|First Treatment Period|Renal Transplant|50|||
46853973|NCT00090753|83070136|FG000|First Treatment Period|Mircera Commercialization|1|||
46853974|NCT00090753|83070137|FG001|First Treatment Period|Mircera Commercialization|0|||
46791574|NCT00611130|83010312|FG000|Overall Study|Other|5|||
46791575|NCT00611130|83010313|FG001|Overall Study|Other|4|||
46791576|NCT00611130|83010312|FG000|Overall Study|Incarceration|3|||
46853975|NCT00090753|83070136|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
46853976|NCT00090753|83070137|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
46853977|NCT00090753|83070136|FG000|Extended Treatment Period|Adverse Event|11|||
46853978|NCT00090753|83070137|FG001|Extended Treatment Period|Adverse Event|0|||
46853979|NCT00090753|83070136|FG000|Extended Treatment Period|Death|58|||
46974404|NCT02000752|83218837|FG001|Overall Study|Dystocic delivery|8|||
46791577|NCT00611130|83010313|FG001|Overall Study|Incarceration|2|||
46791578|NCT00611130|83010312|FG000|Overall Study|Administrative|1|||
46791579|NCT00611130|83010313|FG001|Overall Study|Administrative|1|||
46791580|NCT00611130|83010312|FG000|Overall Study|Adverse Event|1|||
46791581|NCT00611130|83010313|FG001|Overall Study|Adverse Event|0|||
46791582|NCT00611130|83010312|FG000|Overall Study|Death|1|||
46791583|NCT00611130|83010313|FG001|Overall Study|Death|0|||
46791584|NCT00256243|83010320|FG000|Overall Study|Lost to Follow-up|2|||
46791585|NCT00256243|83010320|FG000|Overall Study|Death|7|||
46791586|NCT00256243|83010320|FG000|Overall Study|Not treated|1|||
46791587|NCT00236197|83010327|FG000|Overall Study|Withdrawal by Subject|3|||
46791588|NCT00236197|83010328|FG001|Overall Study|Withdrawal by Subject|2|||
46974405|NCT02000752|83218836|FG000|Overall Study|Shift Changes|12|||
46974406|NCT02000752|83218837|FG001|Overall Study|Shift Changes|5|||
46974407|NCT02000440|83218843|FG000|Overall Study|Adverse Event|3|||
46974408|NCT02000440|83218843|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
46974409|NCT02687815|83218849|FG000|Overall Study|Lost to Follow-up|2|||
46974410|NCT02687815|83218850|FG001|Overall Study|Lost to Follow-up|4|||
46974411|NCT02687815|83218849|FG000|Overall Study|Withdrawal by Subject|2|||
46974412|NCT02687815|83218850|FG001|Overall Study|Withdrawal by Subject|4|||
46853980|NCT00090753|83070137|FG001|Extended Treatment Period|Death|30|||
46791589|NCT00236197|83010327|FG000|Overall Study|Lost to Follow-up|1|||
46791590|NCT00236197|83010328|FG001|Overall Study|Lost to Follow-up|5|||
46853981|NCT00090753|83070136|FG000|Extended Treatment Period|Lack of Efficacy|1|||
46853982|NCT00090753|83070137|FG001|Extended Treatment Period|Lack of Efficacy|0|||
46853983|NCT00090753|83070136|FG000|Extended Treatment Period|Refused Treatment|18|||
46974413|NCT01959334|83218858|FG000|Second Dose|Adverse Event|1|||
46791591|NCT00236197|83010327|FG000|Overall Study|Protocol Violation|0|||
46791592|NCT00236197|83010328|FG001|Overall Study|Protocol Violation|3|||
46974414|NCT01959334|83218859|FG001|Second Dose|Adverse Event|0|||
46791593|NCT00236197|83010327|FG000|Overall Study|Medication non-compliance|1|||
46791594|NCT00236197|83010328|FG001|Overall Study|Medication non-compliance|2|||
46673905|NCT01162486|82889401|FG004|Overall Study|Pregnancy|0|||
46791595|NCT00236197|83010327|FG000|Overall Study|Other|0|||
46791596|NCT00236197|83010328|FG001|Overall Study|Other|2|||
46853984|NCT00090753|83070137|FG001|Extended Treatment Period|Refused Treatment|12|||
46974415|NCT01959334|83218858|FG000|Third Dose|Adverse Event|0|||
46974416|NCT01959334|83218859|FG001|Third Dose|Adverse Event|1|||
46791597|NCT00278629|83010334|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
46791598|NCT00612690|83010341|FG000|Overall Study|Lost to Follow-up|72|||
46791599|NCT00612690|83010342|FG001|Overall Study|Lost to Follow-up|98|||
46791600|NCT00612690|83010341|FG000|Overall Study|Withdrawal by Subject|32|||
46974417|NCT02687581|83218869|FG000|Overall Study|Withdrawal by Subject|1|||
46974418|NCT02687581|83218870|FG001|Overall Study|Withdrawal by Subject|0|||
46974419|NCT02687581|83218871|FG002|Overall Study|Withdrawal by Subject|0|||
46974420|NCT02687581|83218872|FG003|Overall Study|Withdrawal by Subject|1|||
46974421|NCT02687581|83218869|FG000|Overall Study|Lost to Follow-up|2|||
46974422|NCT02687581|83218870|FG001|Overall Study|Lost to Follow-up|2|||
46974423|NCT02687581|83218871|FG002|Overall Study|Lost to Follow-up|0|||
46974424|NCT02687581|83218872|FG003|Overall Study|Lost to Follow-up|0|||
46974425|NCT02687581|83218869|FG000|Overall Study|the device is too small for the patient.|1|||
46974426|NCT02687581|83218870|FG001|Overall Study|the device is too small for the patient.|0|||
46974427|NCT02687581|83218871|FG002|Overall Study|the device is too small for the patient.|0|||
46974428|NCT02687581|83218872|FG003|Overall Study|the device is too small for the patient.|0|||
46974429|NCT01977040|83218882|FG000|Overall Study|Vasa previa not confirmed|2|||
46974430|NCT01958476|83218892|FG000|Overall Study|Parent requested exclusion from analysis|1|||
46974431|NCT01958476|83218893|FG001|Overall Study|Parent requested exclusion from analysis|0|||
46974432|NCT02695537|83218929|FG000|Overall Study|Adverse Event|3|||
46974433|NCT02695537|83218929|FG000|Overall Study|Lack of Efficacy|28|||
46974434|NCT02695537|83218929|FG000|Overall Study|Withdrawal by Subject|4|||
46974435|NCT02695537|83218929|FG000|Overall Study|Protocol Violation|3|||
46974436|NCT02691247|83218936|FG000|Overall Study|Withdrawal by Subject|1|||
46974437|NCT02691247|83218937|FG001|Overall Study|Withdrawal by Subject|2|||
46974438|NCT02691247|83218938|FG002|Overall Study|Withdrawal by Subject|2|||
46974439|NCT02691247|83218936|FG000|Overall Study|Lost to Follow-up|2|||
46974440|NCT02691247|83218937|FG001|Overall Study|Lost to Follow-up|0|||
46974441|NCT02691247|83218938|FG002|Overall Study|Lost to Follow-up|1|||
46974442|NCT01362491|83218949|FG000|Overall Study|Ineligible|1|||
46974443|NCT01362491|83218950|FG001|Overall Study|Ineligible|0|||
46974444|NCT01362491|83218951|FG002|Overall Study|Ineligible|0|||
46974445|NCT02687191|83218966|FG000|Overall Study|Death|0|||
46974446|NCT02687191|83218967|FG001|Overall Study|Death|1|||
46974447|NCT02687191|83218968|FG002|Overall Study|Death|1|||
46974448|NCT02687191|83218969|FG003|Overall Study|Death|0|||
46974449|NCT02687191|83218970|FG004|Overall Study|Death|1|||
46974450|NCT02687191|83218971|FG005|Overall Study|Death|1|||
46974451|NCT02687191|83218966|FG000|Overall Study|Withdrawal by Subject|0|||
46974452|NCT02687191|83218967|FG001|Overall Study|Withdrawal by Subject|0|||
46974453|NCT02687191|83218968|FG002|Overall Study|Withdrawal by Subject|0|||
46974454|NCT02687191|83218969|FG003|Overall Study|Withdrawal by Subject|1|||
46974455|NCT02687191|83218970|FG004|Overall Study|Withdrawal by Subject|0|||
46974456|NCT02687191|83218971|FG005|Overall Study|Withdrawal by Subject|0|||
46974457|NCT02687035|83218985|FG000|Overall Study|Withdrawal by Subject|1|||
46974458|NCT02687035|83218985|FG000|Overall Study|Death|87|||
46974459|NCT02687035|83218985|FG000|Overall Study|Lost to Follow-up|1|||
46974460|NCT02687035|83218985|FG000|Overall Study|Missed Visit|87|||
46974461|NCT02687035|83218985|FG000|Overall Study|Did not receive Study Device|8|||
46791601|NCT00612690|83010342|FG001|Overall Study|Withdrawal by Subject|20|||
46791602|NCT00612690|83010341|FG000|Overall Study|Withdrawal by Site|11|||
46791603|NCT00612690|83010342|FG001|Overall Study|Withdrawal by Site|0|||
46791604|NCT00278473|83010352|FG000|Overall Study|drop out|4|||
46791605|NCT00278473|83010353|FG001|Overall Study|drop out|3|||
46791606|NCT00278395|83010359|FG000|Overall Study|Adverse Event|2|||
46791607|NCT00278395|83010359|FG000|Overall Study|Nonevaluable|1|||
46791608|NCT00612534|83010370|FG000|Overall Study|Adverse Event|0|||
46791609|NCT00612534|83010371|FG001|Overall Study|Adverse Event|4|||
46791610|NCT00612534|83010372|FG002|Overall Study|Adverse Event|2|||
46791611|NCT00612534|83010373|FG003|Overall Study|Adverse Event|1|||
46791612|NCT00612534|83010370|FG000|Overall Study|Lack of Efficacy|13|||
46791613|NCT00612534|83010371|FG001|Overall Study|Lack of Efficacy|12|||
46791614|NCT00612534|83010372|FG002|Overall Study|Lack of Efficacy|5|||
46791615|NCT00612534|83010373|FG003|Overall Study|Lack of Efficacy|16|||
46791616|NCT00612534|83010370|FG000|Overall Study|Other Reason|0|||
46791617|NCT00612534|83010371|FG001|Overall Study|Other Reason|1|||
46791618|NCT00612534|83010372|FG002|Overall Study|Other Reason|0|||
46791619|NCT00612534|83010373|FG003|Overall Study|Other Reason|0|||
46974462|NCT02691013|83218991|FG000|Overall Study|Withdrawal by Subject|3|||
46974463|NCT02691013|83218992|FG001|Overall Study|Withdrawal by Subject|0|||
46974464|NCT02690701|83219002|FG000|Treatment Period 1|Adverse Event|2|||
46974465|NCT02690701|83219003|FG001|Treatment Period 1|Adverse Event|2|||
46974466|NCT02690701|83219002|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46974467|NCT02690701|83219003|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46974468|NCT02690701|83219002|FG000|Treatment Period 2|Adverse Event|2|||
46791620|NCT00736853|83010383|FG000|Open-Label Period|Physician Decision|2|||
46791621|NCT00736853|83010384|FG001|Open-Label Period|Physician Decision|0|||
46791622|NCT00736853|83010385|FG002|Open-Label Period|Physician Decision|0|||
46974469|NCT02690701|83219003|FG001|Treatment Period 2|Adverse Event|0|||
47078223|NCT02706951|83383314|FG003|Period 1|Lost to Follow-up|0|||
46791623|NCT00736853|83010383|FG000|Open-Label Period|Adverse Event|31|||
46791624|NCT00736853|83010384|FG001|Open-Label Period|Adverse Event|0|||
46791625|NCT00736853|83010385|FG002|Open-Label Period|Adverse Event|0|||
46791626|NCT00736853|83010383|FG000|Open-Label Period|Withdrawal by Subject|16|||
46791627|NCT00736853|83010384|FG001|Open-Label Period|Withdrawal by Subject|0|||
46791628|NCT00736853|83010385|FG002|Open-Label Period|Withdrawal by Subject|0|||
46791629|NCT00736853|83010383|FG000|Open-Label Period|Started but not treated|42|||
46791630|NCT00736853|83010384|FG001|Open-Label Period|Started but not treated|0|||
46791631|NCT00736853|83010385|FG002|Open-Label Period|Started but not treated|0|||
46791632|NCT00736853|83010383|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
46791633|NCT00736853|83010384|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
46791634|NCT00736853|83010385|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
46791635|NCT00736853|83010383|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
46791636|NCT00736853|83010384|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
46791637|NCT00736853|83010385|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
46791638|NCT00736853|83010383|FG000|Double-Blind Period|Lack of Efficacy|0|||
46791639|NCT00736853|83010384|FG001|Double-Blind Period|Lack of Efficacy|19|||
46791640|NCT00736853|83010385|FG002|Double-Blind Period|Lack of Efficacy|42|||
46791641|NCT00736853|83010383|FG000|Double-Blind Period|Adverse Event|0|||
46791642|NCT00736853|83010384|FG001|Double-Blind Period|Adverse Event|3|||
46791643|NCT00736853|83010385|FG002|Double-Blind Period|Adverse Event|2|||
46853985|NCT00090753|83070136|FG000|Extended Treatment Period|Lost to Follow-up|3|||
46853986|NCT00090753|83070137|FG001|Extended Treatment Period|Lost to Follow-up|1|||
46853987|NCT00090753|83070136|FG000|Extended Treatment Period|Renal Transplant|15|||
46853988|NCT00090753|83070137|FG001|Extended Treatment Period|Renal Transplant|12|||
46853989|NCT00090753|83070136|FG000|Extended Treatment Period|Mircera Commercialization|188|||
46853990|NCT00090753|83070137|FG001|Extended Treatment Period|Mircera Commercialization|93|||
46853991|NCT00090753|83070136|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
46853992|NCT00090753|83070137|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
46791644|NCT00736853|83010383|FG000|Double-Blind Period|Withdrawal by Subject|0|||
46791645|NCT00736853|83010384|FG001|Double-Blind Period|Withdrawal by Subject|1|||
46791646|NCT00736853|83010385|FG002|Double-Blind Period|Withdrawal by Subject|4|||
46791647|NCT00736853|83010383|FG000|Double-Blind Period|Ineligible to participate the study|0|||
46791648|NCT00736853|83010384|FG001|Double-Blind Period|Ineligible to participate the study|1|||
46791649|NCT00736853|83010385|FG002|Double-Blind Period|Ineligible to participate the study|0|||
46791650|NCT00730847|83010394|FG000|Overall Study|Adverse Event|1|||
46791651|NCT00730847|83010394|FG000|Overall Study|Protocol Violation|2|||
46791652|NCT00730847|83010394|FG000|Overall Study|Withdrawal by Subject|16|||
46791653|NCT00730847|83010394|FG000|Overall Study|Lost to Follow-up|67|||
46791654|NCT00730847|83010394|FG000|Overall Study|Unknown completion status|21|||
46791655|NCT00730847|83010394|FG000|Overall Study|Other|24|||
46791656|NCT00573066|83010398|FG000|Overall Study|Exclusion criteria|18|||
46791657|NCT00573066|83010398|FG000|Overall Study|IV malfunction|1|||
46791658|NCT00573066|83010398|FG000|Overall Study|Postoperative bleeding|1|||
46853993|NCT00048932|83070145|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
46853994|NCT00048932|83070146|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
47078224|NCT02706951|83383315|FG004|Period 1|Lost to Follow-up|0|||
47078225|NCT02706951|83383311|FG000|Period 1|Other|2|||
47078226|NCT02706951|83383312|FG001|Period 1|Other|1|||
47078227|NCT02706951|83383313|FG002|Period 1|Other|0|||
46791659|NCT00612456|83010405|FG000|Overall Study|Adverse Event|1|||
47078228|NCT02706951|83383314|FG003|Period 1|Other|0|||
46791660|NCT00612456|83010406|FG001|Overall Study|Adverse Event|0|||
46791661|NCT00612456|83010407|FG002|Overall Study|Adverse Event|0|||
46791662|NCT00612456|83010405|FG000|Overall Study|Lack of Efficacy|1|||
46791663|NCT00612456|83010406|FG001|Overall Study|Lack of Efficacy|1|||
46791664|NCT00612456|83010407|FG002|Overall Study|Lack of Efficacy|0|||
46791665|NCT00612456|83010405|FG000|Overall Study|Withdrawal by Subject|0|||
46791666|NCT00612456|83010406|FG001|Overall Study|Withdrawal by Subject|1|||
46791667|NCT00612456|83010407|FG002|Overall Study|Withdrawal by Subject|0|||
46791668|NCT00730691|83010422|FG000|Overall Study|Adverse Event|4|||
46791669|NCT00730691|83010423|FG001|Overall Study|Adverse Event|8|||
46791670|NCT00730691|83010424|FG002|Overall Study|Adverse Event|11|||
46791671|NCT00730691|83010425|FG003|Overall Study|Adverse Event|11|||
46791672|NCT00730691|83010426|FG004|Overall Study|Adverse Event|23|||
46791673|NCT00730691|83010422|FG000|Overall Study|Lack of Efficacy|4|||
47078229|NCT02706951|83383315|FG004|Period 1|Other|0|||
46791674|NCT00730691|83010423|FG001|Overall Study|Lack of Efficacy|4|||
47078230|NCT02706951|83383311|FG000|Period 2|Adverse Event|0|||
46791675|NCT00730691|83010424|FG002|Overall Study|Lack of Efficacy|2|||
46791676|NCT00730691|83010425|FG003|Overall Study|Lack of Efficacy|1|||
46853995|NCT00048932|83070147|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
47078231|NCT02706951|83383312|FG001|Period 2|Adverse Event|0|||
47078232|NCT02706951|83383313|FG002|Period 2|Adverse Event|0|||
47078233|NCT02706951|83383314|FG003|Period 2|Adverse Event|25|||
46791677|NCT00730691|83010426|FG004|Overall Study|Lack of Efficacy|1|||
46974470|NCT02690701|83219002|FG000|Treatment Period 2|Lack of Efficacy|1|||
46974471|NCT02690701|83219003|FG001|Treatment Period 2|Lack of Efficacy|0|||
46974472|NCT02690701|83219002|FG000|Treatment Period 2|Lost to Follow-up|0|||
46974473|NCT02690701|83219003|FG001|Treatment Period 2|Lost to Follow-up|2|||
46974474|NCT02690701|83219002|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46974475|NCT02690701|83219003|FG001|Treatment Period 2|Withdrawal by Subject|2|||
46974476|NCT02690701|83219002|FG000|Treatment Period 2|Protocol Violation|0|||
46974477|NCT02690701|83219003|FG001|Treatment Period 2|Protocol Violation|1|||
46974478|NCT02694757|83219010|FG000|Overall Study|Lack of Efficacy|3|||
46974479|NCT03805841|83219017|FG000|Overall Study|Clinical Progression|2|||
46974480|NCT03805841|83219018|FG001|Overall Study|Clinical Progression|0|||
46974481|NCT03805841|83219019|FG002|Overall Study|Clinical Progression|0|||
46974482|NCT03805841|83219017|FG000|Overall Study|Death|0|||
46974483|NCT03805841|83219018|FG001|Overall Study|Death|3|||
46974484|NCT03805841|83219019|FG002|Overall Study|Death|1|||
46974485|NCT03805841|83219017|FG000|Overall Study|Lost to Follow-up|0|||
46974486|NCT03805841|83219018|FG001|Overall Study|Lost to Follow-up|0|||
46974487|NCT03805841|83219019|FG002|Overall Study|Lost to Follow-up|1|||
46974488|NCT03805841|83219017|FG000|Overall Study|Withdrawal by Subject|2|||
46974489|NCT03805841|83219018|FG001|Overall Study|Withdrawal by Subject|3|||
46974490|NCT03805841|83219019|FG002|Overall Study|Withdrawal by Subject|0|||
46974491|NCT03805841|83219017|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
46974492|NCT03805841|83219018|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
46974493|NCT03805841|83219019|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
46974494|NCT02684617|83219030|FG000|Overall Study|Adverse Event|1|||
46974495|NCT02684617|83219031|FG001|Overall Study|Adverse Event|0|||
46974496|NCT02684617|83219032|FG002|Overall Study|Adverse Event|1|||
46974497|NCT02684617|83219030|FG000|Overall Study|Death|8|||
46974498|NCT02684617|83219031|FG001|Overall Study|Death|16|||
46974499|NCT02684617|83219032|FG002|Overall Study|Death|28|||
46974500|NCT02684617|83219030|FG000|Overall Study|Withdrawal by Subject|2|||
46974501|NCT02684617|83219031|FG001|Overall Study|Withdrawal by Subject|0|||
46974502|NCT02684617|83219032|FG002|Overall Study|Withdrawal by Subject|4|||
46974503|NCT02684617|83219030|FG000|Overall Study|Screen Failure|1|||
46974504|NCT02684617|83219031|FG001|Overall Study|Screen Failure|0|||
46974505|NCT02684617|83219032|FG002|Overall Study|Screen Failure|2|||
46974506|NCT02684617|83219030|FG000|Overall Study|Study Terminated by Sponsor|6|||
46974507|NCT02684617|83219031|FG001|Overall Study|Study Terminated by Sponsor|1|||
46974508|NCT02684617|83219032|FG002|Overall Study|Study Terminated by Sponsor|5|||
46974509|NCT01999972|83219046|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
46974510|NCT01999972|83219047|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
46974511|NCT01999972|83219048|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
46974512|NCT01999972|83219049|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
46974513|NCT01999972|83219050|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
46974514|NCT01999972|83219051|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
46974515|NCT01999972|83219046|FG000|Dose Escalation Part|Death|0|||
46974516|NCT01999972|83219047|FG001|Dose Escalation Part|Death|1|||
46974517|NCT01999972|83219048|FG002|Dose Escalation Part|Death|0|||
46974518|NCT01999972|83219049|FG003|Dose Escalation Part|Death|0|||
46974519|NCT01999972|83219050|FG004|Dose Escalation Part|Death|0|||
46974520|NCT01999972|83219051|FG005|Dose Escalation Part|Death|0|||
46974521|NCT01999972|83219046|FG000|Dose Escalation Part|Enrolled but not treated|0|||
46974522|NCT01999972|83219047|FG001|Dose Escalation Part|Enrolled but not treated|0|||
46974523|NCT01999972|83219048|FG002|Dose Escalation Part|Enrolled but not treated|1|||
46974524|NCT01999972|83219049|FG003|Dose Escalation Part|Enrolled but not treated|1|||
46974525|NCT01999972|83219050|FG004|Dose Escalation Part|Enrolled but not treated|0|||
46974526|NCT01999972|83219051|FG005|Dose Escalation Part|Enrolled but not treated|0|||
46974527|NCT01999972|83219046|FG000|Dose Escalation Part|Disease progression|3|||
47078234|NCT02706951|83383315|FG004|Period 2|Adverse Event|34|||
47078235|NCT02706951|83383311|FG000|Period 2|Withdrawal by Subject|0|||
47078236|NCT02706951|83383312|FG001|Period 2|Withdrawal by Subject|0|||
47078237|NCT02706951|83383313|FG002|Period 2|Withdrawal by Subject|0|||
46673906|NCT01162135|82889417|FG000|Overall Study|Withdrawal by Subject|1|||
46974528|NCT01999972|83219047|FG001|Dose Escalation Part|Disease progression|2|||
46974529|NCT01999972|83219048|FG002|Dose Escalation Part|Disease progression|3|||
46974530|NCT01999972|83219049|FG003|Dose Escalation Part|Disease progression|6|||
46974531|NCT01999972|83219050|FG004|Dose Escalation Part|Disease progression|0|||
46974532|NCT01999972|83219051|FG005|Dose Escalation Part|Disease progression|0|||
46974533|NCT01999972|83219046|FG000|Dose Escalation Part|Adverse Event|0|||
46974534|NCT01999972|83219047|FG001|Dose Escalation Part|Adverse Event|0|||
46974535|NCT01999972|83219048|FG002|Dose Escalation Part|Adverse Event|0|||
47078238|NCT02706951|83383314|FG003|Period 2|Withdrawal by Subject|38|||
47078239|NCT02706951|83383315|FG004|Period 2|Withdrawal by Subject|44|||
47078240|NCT02706951|83383311|FG000|Period 2|Lost to Follow-up|0|||
46673907|NCT01162135|82889417|FG000|Overall Study|Severe back pain|1|||
46791678|NCT00730691|83010422|FG000|Overall Study|Non-compliance with Study Drug|6|||
46791679|NCT00730691|83010423|FG001|Overall Study|Non-compliance with Study Drug|1|||
46791680|NCT00730691|83010424|FG002|Overall Study|Non-compliance with Study Drug|6|||
46791681|NCT00730691|83010425|FG003|Overall Study|Non-compliance with Study Drug|3|||
46791682|NCT00730691|83010426|FG004|Overall Study|Non-compliance with Study Drug|3|||
46853996|NCT00048932|83070145|FG000|Double Blind Period (DB)|Adverse Event|51|||
46853997|NCT00048932|83070146|FG001|Double Blind Period (DB)|Adverse Event|19|||
46853998|NCT00048932|83070147|FG002|Double Blind Period (DB)|Adverse Event|0|||
46791683|NCT00730691|83010422|FG000|Overall Study|Protocol Deviations|3|||
46791684|NCT00730691|83010423|FG001|Overall Study|Protocol Deviations|5|||
46791685|NCT00730691|83010424|FG002|Overall Study|Protocol Deviations|3|||
46791686|NCT00730691|83010425|FG003|Overall Study|Protocol Deviations|7|||
46791687|NCT00730691|83010426|FG004|Overall Study|Protocol Deviations|5|||
46791688|NCT00730691|83010422|FG000|Overall Study|Withdrawal of Consent|7|||
46791689|NCT00730691|83010423|FG001|Overall Study|Withdrawal of Consent|9|||
46791690|NCT00730691|83010424|FG002|Overall Study|Withdrawal of Consent|3|||
46791691|NCT00730691|83010425|FG003|Overall Study|Withdrawal of Consent|6|||
46853999|NCT00048932|83070145|FG000|Double Blind Period (DB)|Death|5|||
46854000|NCT00048932|83070146|FG001|Double Blind Period (DB)|Death|3|||
46854001|NCT00048932|83070147|FG002|Double Blind Period (DB)|Death|0|||
46854002|NCT00048932|83070145|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
46854003|NCT00048932|83070146|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
46854004|NCT00048932|83070147|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
46854005|NCT00048932|83070145|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
46854006|NCT00048932|83070146|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
46854007|NCT00048932|83070147|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
46854008|NCT00048932|83070145|FG000|Double Blind Period (DB)|Relocation|1|||
46854009|NCT00048932|83070146|FG001|Double Blind Period (DB)|Relocation|0|||
46854010|NCT00048932|83070147|FG002|Double Blind Period (DB)|Relocation|0|||
46854011|NCT00048932|83070145|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
46854012|NCT00048932|83070146|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
46791692|NCT00730691|83010426|FG004|Overall Study|Withdrawal of Consent|3|||
46791693|NCT00730691|83010422|FG000|Overall Study|Lost to Follow-up|11|||
46791694|NCT00730691|83010423|FG001|Overall Study|Lost to Follow-up|8|||
46791695|NCT00730691|83010424|FG002|Overall Study|Lost to Follow-up|13|||
46791696|NCT00730691|83010425|FG003|Overall Study|Lost to Follow-up|15|||
46791697|NCT00730691|83010426|FG004|Overall Study|Lost to Follow-up|13|||
46791698|NCT00730691|83010422|FG000|Overall Study|Other|1|||
46791699|NCT00730691|83010423|FG001|Overall Study|Other|1|||
46791700|NCT00730691|83010424|FG002|Overall Study|Other|1|||
46791701|NCT00730691|83010425|FG003|Overall Study|Other|2|||
46854013|NCT00048932|83070147|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
46974536|NCT01999972|83219049|FG003|Dose Escalation Part|Adverse Event|2|||
46974537|NCT01999972|83219050|FG004|Dose Escalation Part|Adverse Event|0|||
46974538|NCT01999972|83219051|FG005|Dose Escalation Part|Adverse Event|0|||
46974539|NCT01999972|83219046|FG000|Dose Escalation Part|Global deterioration of health status|1|||
46974540|NCT01999972|83219047|FG001|Dose Escalation Part|Global deterioration of health status|0|||
46974541|NCT01999972|83219048|FG002|Dose Escalation Part|Global deterioration of health status|0|||
46974542|NCT01999972|83219049|FG003|Dose Escalation Part|Global deterioration of health status|1|||
46974543|NCT01999972|83219050|FG004|Dose Escalation Part|Global deterioration of health status|0|||
46974544|NCT01999972|83219051|FG005|Dose Escalation Part|Global deterioration of health status|0|||
46974545|NCT01999972|83219046|FG000|Dose Expansion Part|Death|0|||
46974546|NCT01999972|83219047|FG001|Dose Expansion Part|Death|0|||
46974547|NCT01999972|83219048|FG002|Dose Expansion Part|Death|0|||
46974548|NCT01999972|83219049|FG003|Dose Expansion Part|Death|0|||
46974549|NCT01999972|83219050|FG004|Dose Expansion Part|Death|2|||
46974550|NCT01999972|83219051|FG005|Dose Expansion Part|Death|1|||
46974551|NCT01999972|83219046|FG000|Dose Expansion Part|Disease progression|0|||
46974552|NCT01999972|83219047|FG001|Dose Expansion Part|Disease progression|0|||
46974553|NCT01999972|83219048|FG002|Dose Expansion Part|Disease progression|0|||
46974554|NCT01999972|83219049|FG003|Dose Expansion Part|Disease progression|0|||
46974555|NCT01999972|83219050|FG004|Dose Expansion Part|Disease progression|9|||
46974556|NCT01999972|83219051|FG005|Dose Expansion Part|Disease progression|3|||
46791702|NCT00730691|83010426|FG004|Overall Study|Other|2|||
46854014|NCT00048932|83070145|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
46974557|NCT01999972|83219046|FG000|Dose Expansion Part|Sponsor decision|0|||
46974558|NCT01999972|83219047|FG001|Dose Expansion Part|Sponsor decision|0|||
46974559|NCT01999972|83219048|FG002|Dose Expansion Part|Sponsor decision|0|||
46791703|NCT00235495|83010440|FG000|Overall Study|Death|52|||
46791704|NCT00235495|83010441|FG001|Overall Study|Death|42|||
46791705|NCT00235495|83010440|FG000|Overall Study|Withdrawal by Subject|5|||
46791706|NCT00235495|83010441|FG001|Overall Study|Withdrawal by Subject|3|||
46791707|NCT00235495|83010440|FG000|Overall Study|Lost to Follow-up|11|||
46791708|NCT00235495|83010441|FG001|Overall Study|Lost to Follow-up|13|||
46791709|NCT00235495|83010440|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
46854015|NCT00048932|83070146|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
46854016|NCT00048932|83070147|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
46854017|NCT00048932|83070145|FG000|Double Blind Period (DB)|Pregnancy|1|||
46854018|NCT00048932|83070146|FG001|Double Blind Period (DB)|Pregnancy|0|||
46854019|NCT00048932|83070147|FG002|Double Blind Period (DB)|Pregnancy|0|||
46854020|NCT00048932|83070145|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
46854021|NCT00048932|83070146|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
46854022|NCT00048932|83070147|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
46791710|NCT00235495|83010441|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
46791711|NCT00278161|83010447|FG000|Overall Study|Death|11|||
46791712|NCT00255151|83010454|FG000|Overall Study|Adverse Event|10|||
46791713|NCT00255151|83010455|FG001|Overall Study|Adverse Event|6|||
46791714|NCT00255151|83010456|FG002|Overall Study|Adverse Event|9|||
46791715|NCT00255151|83010454|FG000|Overall Study|Lost to Follow-up|4|||
46791716|NCT00255151|83010455|FG001|Overall Study|Lost to Follow-up|3|||
46854023|NCT00048932|83070145|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
46854024|NCT00048932|83070146|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
46854025|NCT00048932|83070147|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
46854026|NCT00048932|83070145|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
46854027|NCT00048932|83070146|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
46854028|NCT00048932|83070147|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
46854029|NCT00048932|83070145|FG000|Open Label Period (OL)|Death|0|||
46854030|NCT00048932|83070146|FG001|Open Label Period (OL)|Death|0|||
46854031|NCT00048932|83070147|FG002|Open Label Period (OL)|Death|25|||
46854032|NCT00048932|83070145|FG000|Open Label Period (OL)|Adverse Event|0|||
46854033|NCT00048932|83070146|FG001|Open Label Period (OL)|Adverse Event|0|||
46854034|NCT00048932|83070147|FG002|Open Label Period (OL)|Adverse Event|103|||
46854035|NCT00048932|83070145|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
46854036|NCT00048932|83070146|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
46854037|NCT00048932|83070147|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
46854038|NCT00048932|83070145|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
46854039|NCT00048932|83070146|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
46854040|NCT00048932|83070147|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
46854041|NCT00048932|83070145|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
46854042|NCT00048932|83070146|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
46854043|NCT00048932|83070147|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
46854044|NCT00048932|83070145|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
46974560|NCT01999972|83219049|FG003|Dose Expansion Part|Sponsor decision|0|||
46854045|NCT00048932|83070146|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
46974561|NCT01999972|83219050|FG004|Dose Expansion Part|Sponsor decision|1|||
46974562|NCT01999972|83219051|FG005|Dose Expansion Part|Sponsor decision|0|||
46974563|NCT01999972|83219046|FG000|Dose Expansion Part|Adverse Event|0|||
46974564|NCT01999972|83219047|FG001|Dose Expansion Part|Adverse Event|0|||
46974565|NCT01999972|83219048|FG002|Dose Expansion Part|Adverse Event|0|||
46974566|NCT01999972|83219049|FG003|Dose Expansion Part|Adverse Event|0|||
46974567|NCT01999972|83219050|FG004|Dose Expansion Part|Adverse Event|4|||
46974568|NCT01999972|83219051|FG005|Dose Expansion Part|Adverse Event|2|||
46974569|NCT01999972|83219046|FG000|Dose Expansion Part|Participant's non-compliance|0|||
46974570|NCT01999972|83219047|FG001|Dose Expansion Part|Participant's non-compliance|0|||
46974571|NCT01999972|83219048|FG002|Dose Expansion Part|Participant's non-compliance|0|||
46974572|NCT01999972|83219049|FG003|Dose Expansion Part|Participant's non-compliance|0|||
46974573|NCT01999972|83219050|FG004|Dose Expansion Part|Participant's non-compliance|0|||
46974574|NCT01999972|83219051|FG005|Dose Expansion Part|Participant's non-compliance|1|||
46974575|NCT01999972|83219046|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
46974576|NCT01999972|83219047|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
46974577|NCT01999972|83219048|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
46974578|NCT01999972|83219049|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
46974579|NCT01999972|83219050|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
46974580|NCT01999972|83219051|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
46974581|NCT01999972|83219046|FG000|Dose Expansion Part|Changed to standard of care|0|||
46854046|NCT00048932|83070147|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
46854047|NCT00048932|83070145|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
46854048|NCT00048932|83070146|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
46854049|NCT00048932|83070147|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
47078241|NCT02706951|83383312|FG001|Period 2|Lost to Follow-up|0|||
46974582|NCT01999972|83219047|FG001|Dose Expansion Part|Changed to standard of care|0|||
46974583|NCT01999972|83219048|FG002|Dose Expansion Part|Changed to standard of care|0|||
47078242|NCT02706951|83383313|FG002|Period 2|Lost to Follow-up|0|||
47078243|NCT02706951|83383314|FG003|Period 2|Lost to Follow-up|17|||
47078244|NCT02706951|83383315|FG004|Period 2|Lost to Follow-up|9|||
46673908|NCT01162135|82889417|FG000|Overall Study|Ineligible|1|||
46791717|NCT00255151|83010456|FG002|Overall Study|Lost to Follow-up|4|||
46791718|NCT00255151|83010454|FG000|Overall Study|Withdrawal by Subject|18|||
46791719|NCT00255151|83010455|FG001|Overall Study|Withdrawal by Subject|17|||
46791720|NCT00255151|83010456|FG002|Overall Study|Withdrawal by Subject|8|||
46791721|NCT00255151|83010454|FG000|Overall Study|Noncompliance|0|||
46791722|NCT00255151|83010455|FG001|Overall Study|Noncompliance|1|||
46791723|NCT00255151|83010456|FG002|Overall Study|Noncompliance|2|||
46791724|NCT00255151|83010454|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
46974584|NCT01999972|83219049|FG003|Dose Expansion Part|Changed to standard of care|0|||
46974585|NCT01999972|83219050|FG004|Dose Expansion Part|Changed to standard of care|1|||
46974586|NCT01999972|83219051|FG005|Dose Expansion Part|Changed to standard of care|0|||
46974587|NCT01999894|83219067|FG000|Overall Study|Adverse Event|9|||
46974588|NCT01999894|83219067|FG000|Overall Study|Lack of Efficacy|5|||
46974589|NCT01999894|83219067|FG000|Overall Study|Protocol Violation|1|||
46974590|NCT01999894|83219067|FG000|Overall Study|Withdrawal by Subject|7|||
46974591|NCT01999894|83219067|FG000|Overall Study|Lost to Follow-up|10|||
46974592|NCT01999894|83219067|FG000|Overall Study|Other Reason|3|||
46974593|NCT01999894|83219067|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
46974594|NCT02679235|83219072|FG000|Overall Study|Withdrawal by Subject|3|||
46974595|NCT02679235|83219072|FG000|Overall Study|Adverse Event|1|||
46974596|NCT01976806|83219078|FG000|Overall Study|Lost to Follow-up|1|||
46974597|NCT01976806|83219079|FG001|Overall Study|Lost to Follow-up|4|||
46974598|NCT01976806|83219078|FG000|Overall Study|Adverse Event|1|||
46974599|NCT01976806|83219079|FG001|Overall Study|Adverse Event|1|||
46974600|NCT01976806|83219078|FG000|Overall Study|Withdrawal by Subject|1|||
46974601|NCT01976806|83219079|FG001|Overall Study|Withdrawal by Subject|1|||
46974602|NCT02679079|83219088|FG000|Overall Study|Adverse Event|2|||
46974603|NCT02679079|83219089|FG001|Overall Study|Adverse Event|0|||
46974604|NCT02679079|83219090|FG002|Overall Study|Adverse Event|2|||
46974605|NCT02679079|83219088|FG000|Overall Study|Protocol Violation|0|||
46974606|NCT02679079|83219089|FG001|Overall Study|Protocol Violation|1|||
46974607|NCT02679079|83219090|FG002|Overall Study|Protocol Violation|0|||
46974608|NCT02679079|83219088|FG000|Overall Study|Withdrawal by Subject|2|||
46974609|NCT02679079|83219089|FG001|Overall Study|Withdrawal by Subject|1|||
46974610|NCT02679079|83219090|FG002|Overall Study|Withdrawal by Subject|0|||
46974611|NCT02678923|83219100|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
46974612|NCT02678923|83219101|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
46974613|NCT02678923|83219100|FG000|Overall Study|Withdrawal by Subject|3|||
46974614|NCT02678923|83219101|FG001|Overall Study|Withdrawal by Subject|2|||
46974615|NCT02678923|83219100|FG000|Overall Study|Lost to Follow-up|1|||
46974616|NCT02678923|83219101|FG001|Overall Study|Lost to Follow-up|0|||
46974617|NCT02678923|83219100|FG000|Overall Study|Did Not Return for Study Visits|1|||
46974618|NCT02678923|83219101|FG001|Overall Study|Did Not Return for Study Visits|0|||
46974619|NCT01976728|83219111|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
46974620|NCT01976728|83219112|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
46974621|NCT01976728|83219113|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
46974622|NCT01976728|83219114|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
46974623|NCT02689219|83219142|FG000|Overall Study|Death|1|||
46974624|NCT02689219|83219143|FG001|Overall Study|Death|1|||
46974625|NCT02689219|83219142|FG000|Overall Study|Disease Progression|10|||
46974626|NCT02689219|83219143|FG001|Overall Study|Disease Progression|6|||
46974627|NCT02683525|83219149|FG000|Overall Study|Lost to Follow-up|1|||
46974628|NCT02683525|83219149|FG000|Overall Study|Physician Decision|1|||
46974629|NCT02683525|83219149|FG000|Overall Study|Disease Progression|6|||
46974630|NCT01976338|83219155|FG000|Overall Study|Physician Decision|0|||
46974631|NCT01976338|83219156|FG001|Overall Study|Physician Decision|1|||
46974632|NCT01976338|83219155|FG000|Overall Study|Lost to Follow-up|3|||
46974633|NCT01976338|83219156|FG001|Overall Study|Lost to Follow-up|0|||
46974634|NCT01976338|83219155|FG000|Overall Study|Withdrawal by Subject|5|||
46974635|NCT01976338|83219156|FG001|Overall Study|Withdrawal by Subject|2|||
46974636|NCT01976338|83219155|FG000|Overall Study|Adverse Event|5|||
46974637|NCT01976338|83219156|FG001|Overall Study|Adverse Event|1|||
46974638|NCT02674633|83219165|FG000|Overall Study|Lost to Follow-up|3|||
46974639|NCT02674633|83219166|FG001|Overall Study|Lost to Follow-up|2|||
46974640|NCT02674633|83219165|FG000|Overall Study|Physician Decision|1|||
46791725|NCT00255151|83010455|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
46974641|NCT02674633|83219166|FG001|Overall Study|Physician Decision|0|||
46974642|NCT02674633|83219165|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
46974643|NCT02674633|83219166|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
46974644|NCT02651987|83219174|FG000|Overall Study|Adverse Event|2|||
46974645|NCT02651987|83219175|FG001|Overall Study|Adverse Event|2|||
46974646|NCT02651987|83219174|FG000|Overall Study|Consent Withdrawn|2|||
46974647|NCT02651987|83219175|FG001|Overall Study|Consent Withdrawn|0|||
46974648|NCT02651987|83219174|FG000|Overall Study|Local PD|0|||
46974649|NCT02651987|83219175|FG001|Overall Study|Local PD|2|||
46974650|NCT02651987|83219174|FG000|Overall Study|Investigator Decision|1|||
46974651|NCT02651987|83219175|FG001|Overall Study|Investigator Decision|1|||
46974652|NCT02677987|83219186|FG000|Overall Study|Withdrawal by Subject|3|||
46974653|NCT02677987|83219187|FG001|Overall Study|Withdrawal by Subject|0|||
46854050|NCT00048932|83070145|FG000|Open Label Period (OL)|Pregnancy|0|||
46974654|NCT02677987|83219186|FG000|Overall Study|Lost to Follow-up|1|||
46974655|NCT02677987|83219187|FG001|Overall Study|Lost to Follow-up|0|||
46974656|NCT01999114|83219206|FG000|Overall Study|Adverse Event|8|||
46974657|NCT01999114|83219207|FG001|Overall Study|Adverse Event|7|||
46974658|NCT01999114|83219208|FG002|Overall Study|Adverse Event|2|||
46974659|NCT01999114|83219209|FG003|Overall Study|Adverse Event|2|||
46974660|NCT01999114|83219210|FG004|Overall Study|Adverse Event|1|||
47078245|NCT02706951|83383311|FG000|Period 2|COVID-19 Related|0|||
47078246|NCT02706951|83383312|FG001|Period 2|COVID-19 Related|0|||
47078247|NCT02706951|83383313|FG002|Period 2|COVID-19 Related|0|||
47078248|NCT02706951|83383314|FG003|Period 2|COVID-19 Related|1|||
47078249|NCT02706951|83383315|FG004|Period 2|COVID-19 Related|2|||
46791726|NCT00255151|83010456|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
46974661|NCT01999114|83219206|FG000|Overall Study|Withdrawal by Subject|0|||
46974662|NCT01999114|83219207|FG001|Overall Study|Withdrawal by Subject|0|||
46974663|NCT01999114|83219208|FG002|Overall Study|Withdrawal by Subject|1|||
46974664|NCT01999114|83219209|FG003|Overall Study|Withdrawal by Subject|0|||
46974665|NCT01999114|83219210|FG004|Overall Study|Withdrawal by Subject|1|||
46974666|NCT01999114|83219206|FG000|Overall Study|Lost to Follow-up|0|||
46974667|NCT01999114|83219207|FG001|Overall Study|Lost to Follow-up|0|||
46974668|NCT01999114|83219208|FG002|Overall Study|Lost to Follow-up|1|||
46974669|NCT01999114|83219209|FG003|Overall Study|Lost to Follow-up|0|||
46974670|NCT01999114|83219210|FG004|Overall Study|Lost to Follow-up|0|||
46974671|NCT01999114|83219206|FG000|Overall Study|Administrative|0|||
46974672|NCT01999114|83219207|FG001|Overall Study|Administrative|0|||
46974673|NCT01999114|83219208|FG002|Overall Study|Administrative|1|||
46974674|NCT01999114|83219209|FG003|Overall Study|Administrative|1|||
46974675|NCT01999114|83219210|FG004|Overall Study|Administrative|2|||
46974676|NCT02682823|83219241|FG000|Overall Study|Withdrawal by Subject|0|||
46974677|NCT02682823|83219242|FG001|Overall Study|Withdrawal by Subject|0|||
46974678|NCT02682823|83219243|FG002|Overall Study|Withdrawal by Subject|1|||
46974679|NCT02682823|83219244|FG003|Overall Study|Withdrawal by Subject|0|||
46974680|NCT02682823|83219245|FG004|Overall Study|Withdrawal by Subject|1|||
46974681|NCT02682823|83219241|FG000|Overall Study|Protocol Deviation|0|||
46974682|NCT02682823|83219242|FG001|Overall Study|Protocol Deviation|1|||
46974683|NCT02682823|83219243|FG002|Overall Study|Protocol Deviation|0|||
46974684|NCT02682823|83219244|FG003|Overall Study|Protocol Deviation|0|||
46974685|NCT02682823|83219245|FG004|Overall Study|Protocol Deviation|0|||
46974686|NCT02682823|83219241|FG000|Overall Study|Adverse Event|0|||
46974687|NCT02682823|83219242|FG001|Overall Study|Adverse Event|0|||
46974688|NCT02682823|83219243|FG002|Overall Study|Adverse Event|0|||
46974689|NCT02682823|83219244|FG003|Overall Study|Adverse Event|1|||
46974690|NCT02682823|83219245|FG004|Overall Study|Adverse Event|0|||
46974691|NCT01374451|83219259|FG000|Overall Study|Administrative problems|1|||
46974692|NCT01374451|83219260|FG001|Overall Study|Administrative problems|0|||
46974693|NCT02674477|83219268|FG000|Overall Study|Protocol Violation|8|||
46974694|NCT02674477|83219269|FG001|Overall Study|Protocol Violation|2|||
47078250|NCT02706951|83383311|FG000|Period 2|Other|0|||
46791727|NCT00255151|83010454|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
46791728|NCT00255151|83010455|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
46791729|NCT00255151|83010456|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
46791730|NCT00255151|83010454|FG000|Overall Study|Possible Barrett's Esophagus|1|||
46791731|NCT00255151|83010455|FG001|Overall Study|Possible Barrett's Esophagus|3|||
46791732|NCT00255151|83010456|FG002|Overall Study|Possible Barrett's Esophagus|8|||
46791733|NCT00255151|83010454|FG000|Overall Study|Esophageal Stricture|0|||
46791734|NCT00255151|83010455|FG001|Overall Study|Esophageal Stricture|0|||
46791735|NCT00255151|83010456|FG002|Overall Study|Esophageal Stricture|1|||
46854051|NCT00048932|83070146|FG001|Open Label Period (OL)|Pregnancy|0|||
46791736|NCT00255151|83010454|FG000|Overall Study|Therapeutic Failure|11|||
46854052|NCT00048932|83070147|FG002|Open Label Period (OL)|Pregnancy|6|||
46854053|NCT00048932|83070145|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
46854054|NCT00048932|83070146|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
46854055|NCT00048932|83070147|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
46854056|NCT00048932|83070145|FG000|Open Label Period (OL)|Investigator Retiring|0|||
46854057|NCT00048932|83070146|FG001|Open Label Period (OL)|Investigator Retiring|0|||
46974695|NCT01352845|83219277|FG000|Overall Study|Lost to Follow-up|313|||
46974696|NCT01352845|83219278|FG001|Overall Study|Lost to Follow-up|92|||
46974697|NCT01352845|83219277|FG000|Overall Study|No Longer Willing to Participate|205|||
46974698|NCT01352845|83219278|FG001|Overall Study|No Longer Willing to Participate|58|||
47078251|NCT02706951|83383312|FG001|Period 2|Other|0|||
46791737|NCT00255151|83010455|FG001|Overall Study|Therapeutic Failure|2|||
46854058|NCT00048932|83070147|FG002|Open Label Period (OL)|Investigator Retiring|2|||
46974699|NCT01352845|83219277|FG000|Overall Study|Withdrawal by Subject|48|||
47078252|NCT02706951|83383313|FG002|Period 2|Other|0|||
46974700|NCT01352845|83219278|FG001|Overall Study|Withdrawal by Subject|16|||
46974701|NCT01352845|83219277|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
46974702|NCT01352845|83219278|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
46791738|NCT00255151|83010456|FG002|Overall Study|Therapeutic Failure|3|||
46791739|NCT00658658|83010469|FG000|Overall Study|Withdrawal by Subject|0|||
46791740|NCT00658658|83010470|FG001|Overall Study|Withdrawal by Subject|1|||
46791741|NCT00658658|83010471|FG002|Overall Study|Withdrawal by Subject|0|||
46791742|NCT00658658|83010472|FG003|Overall Study|Withdrawal by Subject|0|||
46854059|NCT00048932|83070145|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
46791743|NCT00658658|83010473|FG004|Overall Study|Withdrawal by Subject|0|||
46791744|NCT00658658|83010469|FG000|Overall Study|Death|4|||
46791745|NCT00658658|83010470|FG001|Overall Study|Death|0|||
46791746|NCT00658658|83010471|FG002|Overall Study|Death|0|||
46791747|NCT00658658|83010472|FG003|Overall Study|Death|1|||
46791748|NCT00658658|83010473|FG004|Overall Study|Death|1|||
46791749|NCT00658658|83010469|FG000|Overall Study|Disease Progression|0|||
46791750|NCT00658658|83010470|FG001|Overall Study|Disease Progression|1|||
46791751|NCT00658658|83010471|FG002|Overall Study|Disease Progression|0|||
46791752|NCT00658658|83010472|FG003|Overall Study|Disease Progression|1|||
46791753|NCT00658658|83010473|FG004|Overall Study|Disease Progression|3|||
46791754|NCT00658658|83010469|FG000|Overall Study|Protocol-specified Criteria|1|||
46791755|NCT00658658|83010470|FG001|Overall Study|Protocol-specified Criteria|0|||
46791756|NCT00658658|83010471|FG002|Overall Study|Protocol-specified Criteria|0|||
46854060|NCT00048932|83070146|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
46854061|NCT00048932|83070147|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
46854062|NCT00048932|83070145|FG000|Open Label Period (OL)|Participant Relocated|0|||
46854063|NCT00048932|83070146|FG001|Open Label Period (OL)|Participant Relocated|0|||
46854064|NCT00048932|83070147|FG002|Open Label Period (OL)|Participant Relocated|6|||
46854065|NCT00048932|83070145|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
46854066|NCT00048932|83070146|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
46974703|NCT01352845|83219277|FG000|Overall Study|Pregnancy|27|||
46791757|NCT00658658|83010472|FG003|Overall Study|Protocol-specified Criteria|0|||
46791758|NCT00658658|83010473|FG004|Overall Study|Protocol-specified Criteria|0|||
46854067|NCT00048932|83070147|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
46854068|NCT00048932|83070145|FG000|Open Label Period (OL)|Site Closure|0|||
46854069|NCT00048932|83070146|FG001|Open Label Period (OL)|Site Closure|0|||
46854070|NCT00048932|83070147|FG002|Open Label Period (OL)|Site Closure|3|||
46854071|NCT00048932|83070145|FG000|Open Label Period (OL)|Trial Terminated|0|||
46854072|NCT00048932|83070146|FG001|Open Label Period (OL)|Trial Terminated|0|||
46854073|NCT00048932|83070147|FG002|Open Label Period (OL)|Trial Terminated|1|||
46854074|NCT00048932|83070145|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
46854075|NCT00048932|83070146|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
46854076|NCT00048932|83070147|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
46854077|NCT00048932|83070145|FG000|Open Label Period (OL)|Patient Decision|0|||
46854078|NCT00048932|83070146|FG001|Open Label Period (OL)|Patient Decision|0|||
46854079|NCT00048932|83070147|FG002|Open Label Period (OL)|Patient Decision|4|||
46854080|NCT00048932|83070145|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
46854081|NCT00048932|83070146|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
46854082|NCT00048932|83070147|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
46854083|NCT00048932|83070145|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
46854084|NCT00048932|83070146|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
46854085|NCT00048932|83070147|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
46854086|NCT00048932|83070145|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
46854087|NCT00048932|83070146|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
46854088|NCT00048932|83070147|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
46854089|NCT00048932|83070145|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
46854090|NCT00048932|83070146|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
46854091|NCT00048932|83070147|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
46854092|NCT00048932|83070145|FG000|Open Label Period (OL)|Investigator Decision|0|||
46854093|NCT00048932|83070146|FG001|Open Label Period (OL)|Investigator Decision|0|||
46854094|NCT00048932|83070147|FG002|Open Label Period (OL)|Investigator Decision|4|||
46854095|NCT00048932|83070145|FG000|Open Label Period (OL)|Site Staff Issues|0|||
46854096|NCT00048932|83070146|FG001|Open Label Period (OL)|Site Staff Issues|0|||
46854097|NCT00048932|83070147|FG002|Open Label Period (OL)|Site Staff Issues|2|||
46854098|NCT00048932|83070145|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
46854099|NCT00048932|83070146|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
46854100|NCT00048932|83070147|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
46854101|NCT00048932|83070145|FG000|Open Label Period (OL)|Participant Surgery|0|||
46854102|NCT00048932|83070146|FG001|Open Label Period (OL)|Participant Surgery|0|||
46974704|NCT01352845|83219278|FG001|Overall Study|Pregnancy|7|||
46791759|NCT00658658|83010469|FG000|Overall Study|Other|0|||
46974705|NCT01352845|83219277|FG000|Overall Study|Adverse Event|22|||
46791760|NCT00658658|83010470|FG001|Overall Study|Other|0|||
46791761|NCT00658658|83010471|FG002|Overall Study|Other|0|||
46791762|NCT00658658|83010472|FG003|Overall Study|Other|0|||
46791763|NCT00658658|83010473|FG004|Overall Study|Other|1|||
46791764|NCT00723203|83010485|FG000|Overall Study|Withdrawal by Subject|3|||
46791765|NCT00233389|83010491|FG000|Overall Study|Adverse Event|5|||
46791766|NCT00233389|83010492|FG001|Overall Study|Adverse Event|5|||
46791767|NCT00233389|83010491|FG000|Overall Study|Lack of Efficacy|11|||
46791768|NCT00233389|83010492|FG001|Overall Study|Lack of Efficacy|8|||
46791769|NCT00233389|83010491|FG000|Overall Study|Lost to Follow-up|1|||
46791770|NCT00233389|83010492|FG001|Overall Study|Lost to Follow-up|1|||
46791771|NCT00233389|83010491|FG000|Overall Study|Physician Decision|1|||
46791772|NCT00233389|83010492|FG001|Overall Study|Physician Decision|0|||
46791773|NCT00233389|83010491|FG000|Overall Study|Protocol Violation|0|||
46791774|NCT00233389|83010492|FG001|Overall Study|Protocol Violation|1|||
46791775|NCT00233389|83010491|FG000|Overall Study|Withdrawal by Subject|0|||
46791776|NCT00233389|83010492|FG001|Overall Study|Withdrawal by Subject|1|||
46791777|NCT00649220|83010498|FG000|Overall Study|Adverse Event|2|||
46791778|NCT00649220|83010498|FG000|Overall Study|Withdrawal by Subject|1|||
46791779|NCT00654368|83010505|FG000|Overall Study|Ineligibility determined|6|||
46791780|NCT00654368|83010506|FG001|Overall Study|Ineligibility determined|0|||
46791781|NCT00654368|83010507|FG002|Overall Study|Ineligibility determined|0|||
46791782|NCT00654368|83010505|FG000|Overall Study|Protocol deviation|3|||
46791783|NCT00654368|83010506|FG001|Overall Study|Protocol deviation|2|||
46791784|NCT00654368|83010507|FG002|Overall Study|Protocol deviation|1|||
46791785|NCT00654368|83010505|FG000|Overall Study|Non-compliance|2|||
46791786|NCT00654368|83010506|FG001|Overall Study|Non-compliance|1|||
46791787|NCT00654368|83010507|FG002|Overall Study|Non-compliance|2|||
46791788|NCT00654368|83010505|FG000|Overall Study|Withdrawal by Subject|5|||
46791789|NCT00654368|83010506|FG001|Overall Study|Withdrawal by Subject|2|||
46791790|NCT00654368|83010507|FG002|Overall Study|Withdrawal by Subject|2|||
46791791|NCT00654368|83010505|FG000|Overall Study|Disease progression|21|||
46791792|NCT00654368|83010506|FG001|Overall Study|Disease progression|31|||
46791793|NCT00654368|83010507|FG002|Overall Study|Disease progression|13|||
46854103|NCT00048932|83070147|FG002|Open Label Period (OL)|Participant Surgery|1|||
46854104|NCT00073983|83070156|FG000|Overall Study|not evaluable|1|||
46854105|NCT03812679|83070162|FG000|Overall Study|Adverse Event|2|||
46854106|NCT03812679|83070162|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
46791794|NCT00654368|83010505|FG000|Overall Study|Requirement for alternative therapy|1|||
46791795|NCT00654368|83010506|FG001|Overall Study|Requirement for alternative therapy|1|||
46791796|NCT00654368|83010507|FG002|Overall Study|Requirement for alternative therapy|1|||
46791797|NCT00654368|83010505|FG000|Overall Study|Physician Decision|0|||
46791798|NCT00654368|83010506|FG001|Overall Study|Physician Decision|0|||
46791799|NCT00654368|83010507|FG002|Overall Study|Physician Decision|2|||
46791800|NCT00654368|83010505|FG000|Overall Study|Death|1|||
46791801|NCT00654368|83010506|FG001|Overall Study|Death|0|||
46791802|NCT00654368|83010507|FG002|Overall Study|Death|0|||
46791803|NCT00654368|83010505|FG000|Overall Study|Pregnancy|0|||
46791804|NCT00654368|83010506|FG001|Overall Study|Pregnancy|0|||
46791805|NCT00654368|83010507|FG002|Overall Study|Pregnancy|2|||
46791806|NCT00654368|83010505|FG000|Overall Study|Other|0|||
46791807|NCT00654368|83010506|FG001|Overall Study|Other|2|||
46791808|NCT00654368|83010507|FG002|Overall Study|Other|3|||
46791809|NCT00654368|83010505|FG000|Overall Study|Adverse Event|14|||
46854107|NCT03812679|83070162|FG000|Overall Study|Renal transplant|1|||
46854108|NCT03812679|83070162|FG000|Overall Study|Withdrawal by Subject|1|||
46854109|NCT03812679|83070162|FG000|Overall Study|Termination of study|2|||
46854110|NCT03812679|83070162|FG000|Overall Study|Water device replacement|1|||
46854111|NCT02952820|83070169|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
46854112|NCT02952820|83070170|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
46854113|NCT02952820|83070171|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
46854114|NCT02952820|83070169|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
46854115|NCT02952820|83070170|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
46854116|NCT02952820|83070171|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
46791810|NCT00654368|83010506|FG001|Overall Study|Adverse Event|9|||
46791811|NCT00654368|83010507|FG002|Overall Study|Adverse Event|6|||
46791812|NCT00647426|83010514|FG000|Overall Study|Withdrawal by Subject|2|||
46791813|NCT00647348|83010521|FG000|Overall Study|Lost to Follow-up|3|||
46854117|NCT02952820|83070169|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
46974706|NCT01352845|83219278|FG001|Overall Study|Adverse Event|6|||
46974707|NCT01352845|83219277|FG000|Overall Study|Other|17|||
46791814|NCT00647348|83010522|FG001|Overall Study|Lost to Follow-up|6|||
46791815|NCT00647270|83010531|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
46791816|NCT00647270|83010532|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
46791817|NCT00647270|83010533|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
46791818|NCT00647270|83010531|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
46974708|NCT01352845|83219278|FG001|Overall Study|Other|7|||
46791819|NCT00647270|83010532|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
46791820|NCT00647270|83010533|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
46791821|NCT00647270|83010531|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
46854118|NCT02952820|83070170|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
46854119|NCT02952820|83070171|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
46854120|NCT02952820|83070169|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
46854121|NCT02952820|83070170|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
46854122|NCT02952820|83070171|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
46791822|NCT00647270|83010532|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
46854123|NCT02952820|83070169|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
46854124|NCT02952820|83070170|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
46854125|NCT02952820|83070171|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
46854126|NCT02952820|83070169|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
46854127|NCT02952820|83070170|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
46854128|NCT02952820|83070171|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
46854129|NCT02952820|83070169|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
46854130|NCT02952820|83070170|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
46974709|NCT01352845|83219277|FG000|Overall Study|Protocol Violation|12|||
46974710|NCT01352845|83219278|FG001|Overall Study|Protocol Violation|6|||
46974711|NCT01352845|83219277|FG000|Overall Study|Death|3|||
46974712|NCT01352845|83219278|FG001|Overall Study|Death|0|||
46974713|NCT02674399|83219286|FG000|Overall Study|Lost to Follow-up|2|||
46974714|NCT02674399|83219287|FG001|Overall Study|Lost to Follow-up|0|||
46974715|NCT02676895|83219296|FG000|Overall Study|Administrative reason|1|||
46974716|NCT02676895|83219297|FG001|Overall Study|Administrative reason|0|||
46974717|NCT02676895|83219298|FG002|Overall Study|Administrative reason|0|||
46791823|NCT00647270|83010533|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
46791824|NCT00647270|83010531|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
46974718|NCT02676895|83219296|FG000|Overall Study|Protocol Violation|1|||
46974719|NCT02676895|83219297|FG001|Overall Study|Protocol Violation|0|||
46974720|NCT02676895|83219298|FG002|Overall Study|Protocol Violation|0|||
46974721|NCT02676895|83219296|FG000|Overall Study|Adverse Event|0|||
46974722|NCT02676895|83219297|FG001|Overall Study|Adverse Event|3|||
46974723|NCT02676895|83219298|FG002|Overall Study|Adverse Event|1|||
46974724|NCT02676895|83219296|FG000|Overall Study|Lost to Follow-up|0|||
46974725|NCT02676895|83219297|FG001|Overall Study|Lost to Follow-up|0|||
46974726|NCT02676895|83219298|FG002|Overall Study|Lost to Follow-up|1|||
46974727|NCT02676895|83219296|FG000|Overall Study|Withdrawal by Subject|0|||
46974728|NCT02676895|83219297|FG001|Overall Study|Withdrawal by Subject|0|||
46974729|NCT02676895|83219298|FG002|Overall Study|Withdrawal by Subject|1|||
46974730|NCT02673697|83219309|FG000|Overall Study|Adverse Event|2|||
46974731|NCT02673697|83219310|FG001|Overall Study|Adverse Event|0|||
46974732|NCT02673697|83219309|FG000|Overall Study|Death|32|||
46974733|NCT02673697|83219310|FG001|Overall Study|Death|24|||
46974734|NCT02673697|83219309|FG000|Overall Study|Lost to Follow-up|5|||
46974735|NCT02673697|83219310|FG001|Overall Study|Lost to Follow-up|2|||
46974736|NCT02673697|83219309|FG000|Overall Study|Physician Decision|2|||
46974737|NCT02673697|83219310|FG001|Overall Study|Physician Decision|1|||
46974738|NCT02673697|83219309|FG000|Overall Study|Withdrawal by Subject|10|||
46974739|NCT02673697|83219310|FG001|Overall Study|Withdrawal by Subject|7|||
46974740|NCT02673697|83219309|FG000|Overall Study|Change subj medical status|1|||
46974741|NCT02673697|83219310|FG001|Overall Study|Change subj medical status|2|||
46974742|NCT02673697|83219309|FG000|Overall Study|Explant|10|||
46974743|NCT02673697|83219310|FG001|Overall Study|Explant|5|||
46974744|NCT02673697|83219309|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
46791825|NCT00647270|83010532|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
46791826|NCT00647270|83010533|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
46791827|NCT00647270|83010531|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
46791828|NCT00647270|83010532|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
46791829|NCT00647270|83010533|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
46791830|NCT00647270|83010531|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
46791831|NCT00647270|83010532|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
46791832|NCT00647270|83010533|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
46791833|NCT00647270|83010531|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
46791834|NCT00647270|83010532|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
46791835|NCT00647270|83010533|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
46974745|NCT02673697|83219310|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
46974746|NCT05168579|83219318|FG000|Overall Study|Lack of Consent|1|||
46974747|NCT05168579|83219319|FG001|Overall Study|Lack of Consent|0|||
46974748|NCT05168579|83219318|FG000|Overall Study|Conflicts with time|2|||
47078253|NCT02706951|83383314|FG003|Period 2|Other|37|||
47078254|NCT02706951|83383315|FG004|Period 2|Other|31|||
46974749|NCT05168579|83219319|FG001|Overall Study|Conflicts with time|0|||
46974750|NCT05168579|83219318|FG000|Overall Study|Time slots were full|3|||
46974751|NCT05168579|83219319|FG001|Overall Study|Time slots were full|0|||
46974752|NCT05168579|83219318|FG000|Overall Study|Lost to Follow-up|0|||
46791836|NCT00645944|83010546|FG000|Randomized|Withdrawal by Subject|1|||
46791837|NCT00645944|83010547|FG001|Randomized|Withdrawal by Subject|2|||
46791838|NCT00645944|83010546|FG000|Received Medication|Adverse Event|2|||
46854131|NCT02952820|83070171|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
46854132|NCT02952820|83070169|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
46854133|NCT02952820|83070170|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
46854134|NCT02952820|83070171|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
46854135|NCT02952820|83070169|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
46854136|NCT02952820|83070170|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
46791839|NCT00645944|83010547|FG001|Received Medication|Adverse Event|1|||
46974753|NCT05168579|83219319|FG001|Overall Study|Lost to Follow-up|15|||
46974754|NCT02673619|83219332|FG000|Overall Study|Lost to Follow-up|1|||
46974755|NCT02673619|83219333|FG001|Overall Study|Lost to Follow-up|0|||
46854137|NCT02952820|83070171|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
46854138|NCT02952820|83070169|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
46854139|NCT02952820|83070170|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
46854140|NCT02952820|83070171|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
46854141|NCT02952820|83070169|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
46854142|NCT02952820|83070170|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
46854143|NCT02952820|83070171|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
46854144|NCT02952820|83070169|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
46854145|NCT02952820|83070170|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
46854146|NCT02952820|83070171|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
46974756|NCT02673619|83219334|FG002|Overall Study|Lost to Follow-up|0|||
46791840|NCT00645944|83010546|FG000|Received Medication|Withdrawal by Subject|1|||
46791841|NCT00645944|83010547|FG001|Received Medication|Withdrawal by Subject|1|||
46854147|NCT02952820|83070169|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
46854148|NCT02952820|83070170|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
46854149|NCT02952820|83070171|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
46854150|NCT02952820|83070169|FG000|Active Treatment Period (6 Months)|Not treated|0|||
46854151|NCT02952820|83070170|FG001|Active Treatment Period (6 Months)|Not treated|0|||
46854152|NCT02952820|83070171|FG002|Active Treatment Period (6 Months)|Not treated|1|||
46854153|NCT00006392|83070186|FG000|Overall Study|Ineligible|11|||
46854154|NCT00006392|83070187|FG001|Overall Study|Ineligible|3|||
46854155|NCT00006392|83070188|FG002|Overall Study|Ineligible|5|||
46854156|NCT00006392|83070189|FG003|Overall Study|Ineligible|5|||
46854157|NCT00006392|83070186|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
46854158|NCT00006392|83070187|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
46854159|NCT00006392|83070188|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
46854160|NCT00006392|83070189|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
46974757|NCT02673619|83219335|FG003|Overall Study|Lost to Follow-up|0|||
46974758|NCT02673619|83219332|FG000|Overall Study|Withdrawal by Subject|1|||
46974759|NCT02673619|83219333|FG001|Overall Study|Withdrawal by Subject|1|||
46974760|NCT02673619|83219334|FG002|Overall Study|Withdrawal by Subject|1|||
46974761|NCT02673619|83219335|FG003|Overall Study|Withdrawal by Subject|0|||
46974762|NCT02673619|83219332|FG000|Overall Study|Adverse Event|0|||
46974763|NCT02673619|83219333|FG001|Overall Study|Adverse Event|0|||
46974764|NCT02673619|83219334|FG002|Overall Study|Adverse Event|1|||
46974765|NCT02673619|83219335|FG003|Overall Study|Adverse Event|0|||
46974766|NCT02673619|83219332|FG000|Overall Study|Lack of Efficacy|0|||
46974767|NCT02673619|83219333|FG001|Overall Study|Lack of Efficacy|0|||
46974768|NCT02673619|83219334|FG002|Overall Study|Lack of Efficacy|1|||
46974769|NCT02673619|83219335|FG003|Overall Study|Lack of Efficacy|0|||
46974770|NCT02680639|83219357|FG000|Screening Period|Screen Failure|7|||
46974771|NCT02680639|83219358|FG001|Screening Period|Screen Failure|0|||
46974772|NCT02680639|83219359|FG002|Screening Period|Screen Failure|0|||
46974773|NCT01674725|83219371|FG000|Overall Study|Adverse Event|1|||
46974774|NCT01674725|83219372|FG001|Overall Study|Adverse Event|0|||
46974775|NCT01674725|83219371|FG000|Overall Study|Did not receive study drug|1|||
46791842|NCT00645944|83010546|FG000|Received Medication|Lost to Follow-up|1|||
46791843|NCT00645944|83010547|FG001|Received Medication|Lost to Follow-up|0|||
46854161|NCT00379769|83070203|FG000|Main Study|Death|57|||
46854162|NCT00379769|83070204|FG001|Main Study|Death|67|||
46854163|NCT00379769|83070205|FG002|Main Study|Death|54|||
46974776|NCT01674725|83219372|FG001|Overall Study|Did not receive study drug|0|||
46974777|NCT01674725|83219371|FG000|Overall Study|Withdrawal by Subject|1|||
46974778|NCT01674725|83219372|FG001|Overall Study|Withdrawal by Subject|0|||
46974779|NCT01674725|83219371|FG000|Overall Study|Lost to Follow-up|0|||
46974780|NCT01674725|83219372|FG001|Overall Study|Lost to Follow-up|1|||
47078255|NCT02609386|83383328|FG000|Overall Study|Withdrawal by Subject|6|||
47078256|NCT02609386|83383329|FG001|Overall Study|Withdrawal by Subject|1|||
46791844|NCT00645944|83010546|FG000|Received Medication|Protocol Violation|2|||
46854164|NCT00379769|83070206|FG003|Main Study|Death|72|||
46854165|NCT00379769|83070207|FG004|Main Study|Death|0|||
46974781|NCT01674569|83219378|FG000|Overall Study|Adverse Event|0|||
46791845|NCT00645944|83010547|FG001|Received Medication|Protocol Violation|1|||
46791846|NCT00646958|83010556|FG000|Overall Study|Lack of Efficacy|1|||
46791847|NCT00646958|83010557|FG001|Overall Study|Lack of Efficacy|0|||
46791848|NCT00646958|83010558|FG002|Overall Study|Lack of Efficacy|0|||
46791849|NCT00646958|83010556|FG000|Overall Study|Adverse Event|4|||
46791850|NCT00646958|83010557|FG001|Overall Study|Adverse Event|0|||
46791851|NCT00646958|83010558|FG002|Overall Study|Adverse Event|0|||
46791852|NCT00646958|83010556|FG000|Overall Study|Lost to Follow-up|1|||
46974782|NCT01674569|83219379|FG001|Overall Study|Adverse Event|2|||
46974783|NCT01674569|83219380|FG002|Overall Study|Adverse Event|0|||
46974784|NCT01674569|83219381|FG003|Overall Study|Adverse Event|1|||
46974785|NCT01674569|83219382|FG004|Overall Study|Adverse Event|2|||
46974786|NCT01674569|83219383|FG005|Overall Study|Adverse Event|2|||
46974787|NCT01674569|83219378|FG000|Overall Study|Protocol Violation|0|||
46974788|NCT01674569|83219379|FG001|Overall Study|Protocol Violation|1|||
46974789|NCT01674569|83219380|FG002|Overall Study|Protocol Violation|1|||
46974790|NCT01674569|83219381|FG003|Overall Study|Protocol Violation|0|||
46974791|NCT01674569|83219382|FG004|Overall Study|Protocol Violation|0|||
46974792|NCT01674569|83219383|FG005|Overall Study|Protocol Violation|0|||
46974793|NCT01674569|83219378|FG000|Overall Study|Withdrawal by Subject|0|||
46974794|NCT01674569|83219379|FG001|Overall Study|Withdrawal by Subject|0|||
46974795|NCT01674569|83219380|FG002|Overall Study|Withdrawal by Subject|1|||
46974796|NCT01674569|83219381|FG003|Overall Study|Withdrawal by Subject|0|||
46974797|NCT01674569|83219382|FG004|Overall Study|Withdrawal by Subject|0|||
46974798|NCT01674569|83219383|FG005|Overall Study|Withdrawal by Subject|0|||
46974799|NCT01374217|83219387|FG000|Overall Study|Lack of Efficacy|13|||
46974800|NCT01674647|83219393|FG000|Treatment Period|Death|4|||
46974801|NCT01674647|83219394|FG001|Treatment Period|Death|1|||
46974802|NCT01674647|83219393|FG000|Treatment Period|Efficacy outcome reached|0|||
46974803|NCT01674647|83219394|FG001|Treatment Period|Efficacy outcome reached|1|||
46974804|NCT01674647|83219393|FG000|Treatment Period|Physician Decision|3|||
46974805|NCT01674647|83219394|FG001|Treatment Period|Physician Decision|1|||
46974806|NCT01674647|83219393|FG000|Treatment Period|Adverse Event|60|||
46974807|NCT01674647|83219394|FG001|Treatment Period|Adverse Event|22|||
46974808|NCT01674647|83219393|FG000|Treatment Period|Non-compliance with study drug|3|||
46791853|NCT00646958|83010557|FG001|Overall Study|Lost to Follow-up|5|||
46791854|NCT00646958|83010558|FG002|Overall Study|Lost to Follow-up|7|||
46791855|NCT00646958|83010556|FG000|Overall Study|Protocol Violation|1|||
46791856|NCT00646958|83010557|FG001|Overall Study|Protocol Violation|1|||
46791857|NCT00646958|83010558|FG002|Overall Study|Protocol Violation|0|||
46791858|NCT00646958|83010556|FG000|Overall Study|Abnormal screening lab tests|1|||
46791859|NCT00646958|83010557|FG001|Overall Study|Abnormal screening lab tests|1|||
46791860|NCT00646958|83010558|FG002|Overall Study|Abnormal screening lab tests|0|||
46791861|NCT00646958|83010556|FG000|Overall Study|Withdrawal by Subject|1|||
46791862|NCT00646958|83010557|FG001|Overall Study|Withdrawal by Subject|2|||
46791863|NCT00646958|83010558|FG002|Overall Study|Withdrawal by Subject|0|||
46673909|NCT01161628|82889421|FG000|Overall Study|Death|6|||
46791864|NCT00646958|83010556|FG000|Overall Study|Did not receive study drug|2|||
46791865|NCT00646958|83010557|FG001|Overall Study|Did not receive study drug|0|||
46791866|NCT00646958|83010558|FG002|Overall Study|Did not receive study drug|2|||
46791867|NCT00642746|83010568|FG000|Overall Study|Patient unevaluable|1|||
46791868|NCT00642746|83010569|FG001|Overall Study|Patient unevaluable|0|||
46791869|NCT00642668|83010575|FG000|Overall Study|Lost to Follow-up|1|||
46791870|NCT00642668|83010575|FG000|Overall Study|Adverse Event|2|||
46791871|NCT00642668|83010575|FG000|Overall Study|Death|2|||
46791872|NCT00642668|83010575|FG000|Overall Study|Insufficient Therapeutic Response|1|||
46791873|NCT00642668|83010575|FG000|Overall Study|Failure to Return|1|||
46791874|NCT00642668|83010575|FG000|Overall Study|Dialysis Initiation|5|||
46791875|NCT00642668|83010575|FG000|Overall Study|Blood Transfusion|2|||
46791876|NCT00729833|83010579|FG000|Overall Study|Death|5|||
46791877|NCT00729833|83010580|FG001|Overall Study|Death|1|||
46791878|NCT00729833|83010581|FG002|Overall Study|Death|3|||
46791879|NCT00729833|83010582|FG003|Overall Study|Death|5|||
46791880|NCT00729833|83010579|FG000|Overall Study|Study Terminated by Sponsor|0|||
46791881|NCT00729833|83010580|FG001|Overall Study|Study Terminated by Sponsor|0|||
46791882|NCT00729833|83010581|FG002|Overall Study|Study Terminated by Sponsor|1|||
46791883|NCT00729833|83010582|FG003|Overall Study|Study Terminated by Sponsor|0|||
46791884|NCT00729833|83010579|FG000|Overall Study|Lost to Follow-up|1|||
46791885|NCT00729833|83010580|FG001|Overall Study|Lost to Follow-up|0|||
46791886|NCT00729833|83010581|FG002|Overall Study|Lost to Follow-up|0|||
46974809|NCT01674647|83219394|FG001|Treatment Period|Non-compliance with study drug|0|||
46974810|NCT01674647|83219393|FG000|Treatment Period|Lost to Follow-up|1|||
46854166|NCT00379769|83070208|FG005|Main Study|Death|0|||
46974811|NCT01674647|83219394|FG001|Treatment Period|Lost to Follow-up|1|||
46974812|NCT01674647|83219393|FG000|Treatment Period|Withdrawal by Subject|19|||
46791887|NCT00729833|83010582|FG003|Overall Study|Lost to Follow-up|0|||
46974813|NCT01674647|83219394|FG001|Treatment Period|Withdrawal by Subject|16|||
46791888|NCT00729833|83010579|FG000|Overall Study|Withdrawal by Subject|3|||
46791889|NCT00729833|83010580|FG001|Overall Study|Withdrawal by Subject|1|||
46791890|NCT00729833|83010581|FG002|Overall Study|Withdrawal by Subject|3|||
46791891|NCT00729833|83010582|FG003|Overall Study|Withdrawal by Subject|0|||
46791892|NCT00729833|83010579|FG000|Overall Study|Unspecified Reasons|11|||
46791893|NCT00729833|83010580|FG001|Overall Study|Unspecified Reasons|5|||
46791894|NCT00729833|83010581|FG002|Overall Study|Unspecified Reasons|5|||
46854167|NCT00379769|83070203|FG000|Main Study|Adverse Event|5|||
46854168|NCT00379769|83070204|FG001|Main Study|Adverse Event|8|||
46854169|NCT00379769|83070205|FG002|Main Study|Adverse Event|10|||
46854170|NCT00379769|83070206|FG003|Main Study|Adverse Event|11|||
46854171|NCT00379769|83070207|FG004|Main Study|Adverse Event|0|||
46854172|NCT00379769|83070208|FG005|Main Study|Adverse Event|0|||
46854173|NCT00379769|83070203|FG000|Main Study|Lost to Follow-up|29|||
46854174|NCT00379769|83070204|FG001|Main Study|Lost to Follow-up|29|||
46854175|NCT00379769|83070205|FG002|Main Study|Lost to Follow-up|25|||
46854176|NCT00379769|83070206|FG003|Main Study|Lost to Follow-up|26|||
46854177|NCT00379769|83070207|FG004|Main Study|Lost to Follow-up|0|||
46854178|NCT00379769|83070208|FG005|Main Study|Lost to Follow-up|0|||
46854179|NCT00379769|83070203|FG000|Main Study|Withdrawal by Subject|46|||
46854180|NCT00379769|83070204|FG001|Main Study|Withdrawal by Subject|56|||
46791895|NCT00729833|83010582|FG003|Overall Study|Unspecified Reasons|1|||
46791896|NCT00645788|83010597|FG000|Overall Study|Did not receive study drug|1|||
46791897|NCT00645788|83010598|FG001|Overall Study|Did not receive study drug|1|||
46854181|NCT00379769|83070205|FG002|Main Study|Withdrawal by Subject|72|||
46854182|NCT00379769|83070206|FG003|Main Study|Withdrawal by Subject|70|||
46854183|NCT00379769|83070207|FG004|Main Study|Withdrawal by Subject|0|||
46854184|NCT00379769|83070208|FG005|Main Study|Withdrawal by Subject|0|||
46854185|NCT00379769|83070203|FG000|Main Study|Moved to survival status follow-up only|27|||
46854186|NCT00379769|83070204|FG001|Main Study|Moved to survival status follow-up only|25|||
46854187|NCT00379769|83070205|FG002|Main Study|Moved to survival status follow-up only|32|||
46854188|NCT00379769|83070206|FG003|Main Study|Moved to survival status follow-up only|36|||
46854189|NCT00379769|83070207|FG004|Main Study|Moved to survival status follow-up only|0|||
46854190|NCT00379769|83070208|FG005|Main Study|Moved to survival status follow-up only|0|||
46854191|NCT00379769|83070203|FG000|Main Study|Participant moved|3|||
46854192|NCT00379769|83070204|FG001|Main Study|Participant moved|2|||
46854193|NCT00379769|83070205|FG002|Main Study|Participant moved|3|||
46854194|NCT00379769|83070206|FG003|Main Study|Participant moved|3|||
46854195|NCT00379769|83070207|FG004|Main Study|Participant moved|0|||
46854196|NCT00379769|83070208|FG005|Main Study|Participant moved|0|||
46854197|NCT00379769|83070203|FG000|Main Study|Poor compliance|3|||
46854198|NCT00379769|83070204|FG001|Main Study|Poor compliance|2|||
46854199|NCT00379769|83070205|FG002|Main Study|Poor compliance|2|||
46854200|NCT00379769|83070206|FG003|Main Study|Poor compliance|1|||
46854201|NCT00379769|83070207|FG004|Main Study|Poor compliance|0|||
46854202|NCT00379769|83070208|FG005|Main Study|Poor compliance|0|||
46854203|NCT00379769|83070203|FG000|Main Study|Prohibited glucose lowering medication|0|||
46854204|NCT00379769|83070204|FG001|Main Study|Prohibited glucose lowering medication|3|||
46854205|NCT00379769|83070205|FG002|Main Study|Prohibited glucose lowering medication|0|||
46854206|NCT00379769|83070206|FG003|Main Study|Prohibited glucose lowering medication|1|||
46854207|NCT00379769|83070207|FG004|Main Study|Prohibited glucose lowering medication|0|||
46974814|NCT01674647|83219393|FG000|Treatment Period|Switching to other therapy|5|||
46974815|NCT01674647|83219394|FG001|Treatment Period|Switching to other therapy|2|||
46974816|NCT01674647|83219393|FG000|Treatment Period|Logistical difficulties|5|||
46974817|NCT01674647|83219394|FG001|Treatment Period|Logistical difficulties|8|||
47078257|NCT02609386|83383328|FG000|Overall Study|Lost to Follow-up|3|||
47078258|NCT02609386|83383329|FG001|Overall Study|Lost to Follow-up|5|||
47078259|NCT02609386|83383328|FG000|Overall Study|Death|19|||
46791898|NCT00645788|83010599|FG002|Overall Study|Did not receive study drug|0|||
46791899|NCT00645788|83010600|FG003|Overall Study|Did not receive study drug|0|||
46791900|NCT00645788|83010597|FG000|Overall Study|Adverse Event|4|||
46791901|NCT00645788|83010598|FG001|Overall Study|Adverse Event|9|||
46854208|NCT00379769|83070208|FG005|Main Study|Prohibited glucose lowering medication|0|||
47078260|NCT02609386|83383329|FG001|Overall Study|Death|9|||
46673910|NCT01161628|82889421|FG000|Overall Study|Lack of Efficacy|2|||
46854209|NCT00379769|83070203|FG000|Main Study|Site closed|4|||
46854210|NCT00379769|83070204|FG001|Main Study|Site closed|4|||
46854211|NCT00379769|83070205|FG002|Main Study|Site closed|4|||
46854212|NCT00379769|83070206|FG003|Main Study|Site closed|8|||
46854213|NCT00379769|83070207|FG004|Main Study|Site closed|0|||
46854214|NCT00379769|83070208|FG005|Main Study|Site closed|0|||
46854215|NCT00379769|83070203|FG000|Main Study|Entry criteria violation|0|||
46854216|NCT00379769|83070204|FG001|Main Study|Entry criteria violation|0|||
46854217|NCT00379769|83070205|FG002|Main Study|Entry criteria violation|1|||
46854218|NCT00379769|83070206|FG003|Main Study|Entry criteria violation|1|||
46854219|NCT00379769|83070207|FG004|Main Study|Entry criteria violation|0|||
47078261|NCT02609386|83383328|FG000|Overall Study|Physician Decision|0|||
46791902|NCT00645788|83010599|FG002|Overall Study|Adverse Event|5|||
46791903|NCT00645788|83010600|FG003|Overall Study|Adverse Event|3|||
46791904|NCT00645788|83010597|FG000|Overall Study|Lost to Follow-up|1|||
46791905|NCT00645788|83010598|FG001|Overall Study|Lost to Follow-up|0|||
46791906|NCT00645788|83010599|FG002|Overall Study|Lost to Follow-up|0|||
46791907|NCT00645788|83010600|FG003|Overall Study|Lost to Follow-up|0|||
46791908|NCT00645788|83010597|FG000|Overall Study|Protocol Violation|1|||
46791909|NCT00645788|83010598|FG001|Overall Study|Protocol Violation|0|||
46791910|NCT00645788|83010599|FG002|Overall Study|Protocol Violation|2|||
46791911|NCT00645788|83010600|FG003|Overall Study|Protocol Violation|0|||
46791912|NCT00645788|83010597|FG000|Overall Study|Withdrawal by Subject|0|||
46791913|NCT00645788|83010598|FG001|Overall Study|Withdrawal by Subject|1|||
46791914|NCT00645788|83010599|FG002|Overall Study|Withdrawal by Subject|0|||
46791915|NCT00645788|83010600|FG003|Overall Study|Withdrawal by Subject|2|||
46791916|NCT00645788|83010597|FG000|Overall Study|Pulmonary exacerbation|13|||
46791917|NCT00645788|83010598|FG001|Overall Study|Pulmonary exacerbation|16|||
46791918|NCT00645788|83010599|FG002|Overall Study|Pulmonary exacerbation|11|||
46791919|NCT00645788|83010600|FG003|Overall Study|Pulmonary exacerbation|9|||
46791920|NCT00642356|83010612|FG000|Overall Study|Adverse Event|1|||
46791921|NCT00642356|83010613|FG001|Overall Study|Adverse Event|0|||
46791922|NCT00642356|83010612|FG000|Overall Study|Protocol Violation|0|||
46791923|NCT00642356|83010613|FG001|Overall Study|Protocol Violation|3|||
46791924|NCT00642356|83010612|FG000|Overall Study|Lack of Efficacy|1|||
46791925|NCT00642356|83010613|FG001|Overall Study|Lack of Efficacy|0|||
46791926|NCT00642278|83010626|FG000|Overall Study|Adverse Event|2|||
46791927|NCT00642278|83010627|FG001|Overall Study|Adverse Event|1|||
46791928|NCT00642278|83010628|FG002|Overall Study|Adverse Event|3|||
46791929|NCT00642278|83010629|FG003|Overall Study|Adverse Event|1|||
46791930|NCT00642278|83010630|FG004|Overall Study|Adverse Event|2|||
46791931|NCT00642278|83010631|FG005|Overall Study|Adverse Event|2|||
46854220|NCT00379769|83070208|FG005|Main Study|Entry criteria violation|0|||
46854221|NCT00379769|83070203|FG000|Main Study|Participant did not take study drug|0|||
46854222|NCT00379769|83070204|FG001|Main Study|Participant did not take study drug|0|||
46854223|NCT00379769|83070205|FG002|Main Study|Participant did not take study drug|1|||
46854224|NCT00379769|83070206|FG003|Main Study|Participant did not take study drug|0|||
46854225|NCT00379769|83070207|FG004|Main Study|Participant did not take study drug|0|||
46854226|NCT00379769|83070208|FG005|Main Study|Participant did not take study drug|0|||
46854227|NCT00379769|83070203|FG000|Main Study|Physician Decision|2|||
46974818|NCT01674647|83219393|FG000|Treatment Period|Treatment failure|0|||
46974819|NCT01674647|83219394|FG001|Treatment Period|Treatment failure|14|||
46974820|NCT01674647|83219393|FG000|Treatment Period|Protocol Violation|56|||
46974821|NCT01674647|83219394|FG001|Treatment Period|Protocol Violation|36|||
46974822|NCT01674647|83219393|FG000|30-day Safety Follow-up Period|Death|3|||
46974823|NCT01674647|83219394|FG001|30-day Safety Follow-up Period|Death|2|||
46974824|NCT01674647|83219393|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
46974825|NCT01674647|83219394|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
46974826|NCT01674647|83219393|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
46974827|NCT01674647|83219394|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
46974828|NCT01674647|83219393|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
46974829|NCT01674647|83219394|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
46974830|NCT01674647|83219393|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
46974831|NCT01674647|83219394|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
46974832|NCT01674647|83219393|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
46974833|NCT01674647|83219394|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
46974834|NCT02669407|83219400|FG000|Overall Study|Physician Decision|3|||
46974835|NCT02667457|83219406|FG000|Overall Study|Withdrawal by Subject|1|||
46974836|NCT02667457|83219407|FG001|Overall Study|Withdrawal by Subject|0|||
46974837|NCT02667457|83219406|FG000|Overall Study|Other Reason|0|||
46974838|NCT02667457|83219407|FG001|Overall Study|Other Reason|2|||
46974839|NCT02669095|83219416|FG000|Overall Study|Adverse Event|1|||
46974840|NCT02669095|83219417|FG001|Overall Study|Adverse Event|0|||
46974841|NCT02669095|83219416|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
46974842|NCT02669095|83219417|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
46791932|NCT00642278|83010632|FG006|Overall Study|Adverse Event|0|||
46791933|NCT00642278|83010626|FG000|Overall Study|Lack of Efficacy|0|||
46791934|NCT00642278|83010627|FG001|Overall Study|Lack of Efficacy|1|||
46791935|NCT00642278|83010628|FG002|Overall Study|Lack of Efficacy|0|||
46791936|NCT00642278|83010629|FG003|Overall Study|Lack of Efficacy|0|||
46974843|NCT02669095|83219416|FG000|Overall Study|Torn Lens|0|||
46974844|NCT02669095|83219417|FG001|Overall Study|Torn Lens|1|||
46974845|NCT02669095|83219416|FG000|Overall Study|Visit 5 assessments not completed|0|||
46974846|NCT02669095|83219417|FG001|Overall Study|Visit 5 assessments not completed|1|||
46791937|NCT00642278|83010630|FG004|Overall Study|Lack of Efficacy|0|||
46791938|NCT00642278|83010631|FG005|Overall Study|Lack of Efficacy|0|||
46791939|NCT00642278|83010632|FG006|Overall Study|Lack of Efficacy|0|||
46791940|NCT00642278|83010626|FG000|Overall Study|Lost to Follow-up|5|||
46854228|NCT00379769|83070204|FG001|Main Study|Physician Decision|2|||
46791941|NCT00642278|83010627|FG001|Overall Study|Lost to Follow-up|1|||
46791942|NCT00642278|83010628|FG002|Overall Study|Lost to Follow-up|0|||
46791943|NCT00642278|83010629|FG003|Overall Study|Lost to Follow-up|1|||
46791944|NCT00642278|83010630|FG004|Overall Study|Lost to Follow-up|0|||
46791945|NCT00642278|83010631|FG005|Overall Study|Lost to Follow-up|1|||
46791946|NCT00642278|83010632|FG006|Overall Study|Lost to Follow-up|1|||
46791947|NCT00642278|83010626|FG000|Overall Study|Physician Decision|0|||
46791948|NCT00642278|83010627|FG001|Overall Study|Physician Decision|0|||
46854229|NCT00379769|83070205|FG002|Main Study|Physician Decision|1|||
46974847|NCT02667301|83219423|FG000|Overall Study|Adverse Event|1|||
46974848|NCT02667301|83219423|FG000|Overall Study|Lack of Efficacy|1|||
46974849|NCT05274165|83219431|FG000|Overall Study|Withdrawal by Subject|3|||
46974850|NCT05274165|83219432|FG001|Overall Study|Withdrawal by Subject|3|||
46974851|NCT04510090|83219474|FG000|FE-HS|Withdrawal by Subject|0|||
46974852|NCT04510090|83219475|FG001|FE-HS|Withdrawal by Subject|0|||
46974853|NCT04510090|83219476|FG002|FE-HS|Withdrawal by Subject|0|||
46974854|NCT04510090|83219477|FG003|FE-HS|Withdrawal by Subject|0|||
46974855|NCT04510090|83219478|FG004|FE-HS|Withdrawal by Subject|1|||
46974856|NCT04510090|83219479|FG005|FE-HS|Withdrawal by Subject|0|||
46974857|NCT04510090|83219480|FG006|FE-HS|Withdrawal by Subject|0|||
46974858|NCT04510090|83219481|FG007|FE-HS|Withdrawal by Subject|0|||
46974859|NCT04491006|83219511|FG000|Overall Study|Adverse Event|0|||
46974860|NCT04491006|83219512|FG001|Overall Study|Adverse Event|3|||
46974861|NCT04491006|83219513|FG002|Overall Study|Adverse Event|5|||
46974862|NCT04491006|83219511|FG000|Overall Study|Withdrawal by Subject|1|||
46974863|NCT04491006|83219512|FG001|Overall Study|Withdrawal by Subject|0|||
46974864|NCT04491006|83219513|FG002|Overall Study|Withdrawal by Subject|2|||
46974865|NCT04162470|83219556|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
46974866|NCT04122625|83219566|FG000|Part A (up to 2.92 Years)|Death|2|||
46974867|NCT04122625|83219567|FG001|Part A (up to 2.92 Years)|Death|4|||
46974868|NCT04122625|83219568|FG002|Part A (up to 2.92 Years)|Death|0|||
46974869|NCT04122625|83219569|FG003|Part A (up to 2.92 Years)|Death|0|||
46974870|NCT04122625|83219570|FG004|Part A (up to 2.92 Years)|Death|0|||
46974871|NCT04122625|83219571|FG005|Part A (up to 2.92 Years)|Death|0|||
46974872|NCT04122625|83219566|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
46974873|NCT04122625|83219567|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
46974874|NCT04122625|83219568|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
46974875|NCT04122625|83219569|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
46974876|NCT04122625|83219570|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
46974877|NCT04122625|83219571|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
46974878|NCT04122625|83219566|FG000|Part B (up to 2.33 Years)|Death|0|||
46974879|NCT04122625|83219567|FG001|Part B (up to 2.33 Years)|Death|0|||
46974880|NCT04122625|83219568|FG002|Part B (up to 2.33 Years)|Death|5|||
46974881|NCT04122625|83219569|FG003|Part B (up to 2.33 Years)|Death|7|||
46974882|NCT04122625|83219570|FG004|Part B (up to 2.33 Years)|Death|6|||
46974883|NCT04122625|83219571|FG005|Part B (up to 2.33 Years)|Death|7|||
46974884|NCT03824704|83219589|FG000|Overall Study|Study Terminated by Sponsor|1|||
46974885|NCT03766581|83219605|FG000|Randomization|Other reasons|2|||
46974886|NCT03766581|83219606|FG001|Randomization|Other reasons|1|||
46974887|NCT03766581|83219607|FG002|Randomization|Other reasons|0|||
46974888|NCT03766581|83219608|FG003|Randomization|Other reasons|1|||
46974889|NCT03766581|83219609|FG004|Randomization|Other reasons|0|||
46673911|NCT01161472|82889425|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
46791949|NCT00642278|83010628|FG002|Overall Study|Physician Decision|0|||
46791950|NCT00642278|83010629|FG003|Overall Study|Physician Decision|1|||
46791951|NCT00642278|83010630|FG004|Overall Study|Physician Decision|0|||
46791952|NCT00642278|83010631|FG005|Overall Study|Physician Decision|0|||
46791953|NCT00642278|83010632|FG006|Overall Study|Physician Decision|0|||
46791954|NCT00642278|83010626|FG000|Overall Study|Protocol Violation|0|||
46791955|NCT00642278|83010627|FG001|Overall Study|Protocol Violation|0|||
46791956|NCT00642278|83010628|FG002|Overall Study|Protocol Violation|1|||
46974890|NCT03766581|83219610|FG005|Randomization|Other reasons|0|||
46791957|NCT00642278|83010629|FG003|Overall Study|Protocol Violation|1|||
46791958|NCT00642278|83010630|FG004|Overall Study|Protocol Violation|0|||
46854230|NCT00379769|83070206|FG003|Main Study|Physician Decision|1|||
46974891|NCT03766581|83219611|FG006|Randomization|Other reasons|0|||
46974892|NCT03766581|83219612|FG007|Randomization|Other reasons|0|||
46974893|NCT03766581|83219605|FG000|Randomization|Participant no longer meets study criteria|5|||
46974894|NCT03766581|83219606|FG001|Randomization|Participant no longer meets study criteria|3|||
46974895|NCT03766581|83219607|FG002|Randomization|Participant no longer meets study criteria|4|||
46974896|NCT03766581|83219608|FG003|Randomization|Participant no longer meets study criteria|0|||
46974897|NCT03766581|83219609|FG004|Randomization|Participant no longer meets study criteria|2|||
46974898|NCT03766581|83219610|FG005|Randomization|Participant no longer meets study criteria|3|||
46974899|NCT03766581|83219611|FG006|Randomization|Participant no longer meets study criteria|0|||
46974900|NCT03766581|83219612|FG007|Randomization|Participant no longer meets study criteria|1|||
46791959|NCT00642278|83010631|FG005|Overall Study|Protocol Violation|1|||
46791960|NCT00642278|83010632|FG006|Overall Study|Protocol Violation|2|||
46791961|NCT00642278|83010626|FG000|Overall Study|Withdrawal by Subject|1|||
46791962|NCT00642278|83010627|FG001|Overall Study|Withdrawal by Subject|1|||
46854231|NCT00379769|83070207|FG004|Main Study|Physician Decision|0|||
46854232|NCT00379769|83070208|FG005|Main Study|Physician Decision|0|||
46854233|NCT00379769|83070203|FG000|Main Study|Participant completed study at visit 27|1|||
46854234|NCT00379769|83070204|FG001|Main Study|Participant completed study at visit 27|0|||
46854235|NCT00379769|83070205|FG002|Main Study|Participant completed study at visit 27|0|||
46854236|NCT00379769|83070206|FG003|Main Study|Participant completed study at visit 27|0|||
46854237|NCT00379769|83070207|FG004|Main Study|Participant completed study at visit 27|0|||
46854238|NCT00379769|83070208|FG005|Main Study|Participant completed study at visit 27|0|||
46854239|NCT00379769|83070203|FG000|Main Study|Personal reasons|1|||
46854240|NCT00379769|83070204|FG001|Main Study|Personal reasons|0|||
46854241|NCT00379769|83070205|FG002|Main Study|Personal reasons|0|||
46854242|NCT00379769|83070206|FG003|Main Study|Personal reasons|0|||
46974901|NCT03766581|83219605|FG000|Randomization|Participant request to discontinue study treatment|1|||
46974902|NCT03766581|83219606|FG001|Randomization|Participant request to discontinue study treatment|0|||
46974903|NCT03766581|83219607|FG002|Randomization|Participant request to discontinue study treatment|0|||
46974904|NCT03766581|83219608|FG003|Randomization|Participant request to discontinue study treatment|0|||
46974905|NCT03766581|83219609|FG004|Randomization|Participant request to discontinue study treatment|1|||
46974906|NCT03766581|83219610|FG005|Randomization|Participant request to discontinue study treatment|2|||
46974907|NCT03766581|83219611|FG006|Randomization|Participant request to discontinue study treatment|0|||
46974908|NCT03766581|83219612|FG007|Randomization|Participant request to discontinue study treatment|0|||
46974909|NCT03766581|83219605|FG000|Randomization|Participant withdrew consent|1|||
46974910|NCT03766581|83219606|FG001|Randomization|Participant withdrew consent|0|||
46974911|NCT03766581|83219607|FG002|Randomization|Participant withdrew consent|1|||
46974912|NCT03766581|83219608|FG003|Randomization|Participant withdrew consent|2|||
46974913|NCT03766581|83219609|FG004|Randomization|Participant withdrew consent|1|||
46974914|NCT03766581|83219610|FG005|Randomization|Participant withdrew consent|1|||
46974915|NCT03766581|83219611|FG006|Randomization|Participant withdrew consent|0|||
46974916|NCT03766581|83219612|FG007|Randomization|Participant withdrew consent|0|||
46974917|NCT03766581|83219605|FG000|Treatment|Adverse Event|82|||
46974918|NCT03766581|83219606|FG001|Treatment|Adverse Event|44|||
46974919|NCT03766581|83219607|FG002|Treatment|Adverse Event|47|||
46974920|NCT03766581|83219608|FG003|Treatment|Adverse Event|46|||
46974921|NCT03766581|83219609|FG004|Treatment|Adverse Event|50|||
46974922|NCT03766581|83219610|FG005|Treatment|Adverse Event|77|||
46974923|NCT03766581|83219611|FG006|Treatment|Adverse Event|5|||
46974924|NCT03766581|83219612|FG007|Treatment|Adverse Event|2|||
46974925|NCT03766581|83219605|FG000|Treatment|Participant request to discontinue treatment|34|||
46974926|NCT03766581|83219606|FG001|Treatment|Participant request to discontinue treatment|6|||
46974927|NCT03766581|83219607|FG002|Treatment|Participant request to discontinue treatment|10|||
46974928|NCT03766581|83219608|FG003|Treatment|Participant request to discontinue treatment|10|||
46974929|NCT03766581|83219609|FG004|Treatment|Participant request to discontinue treatment|14|||
46974930|NCT03766581|83219610|FG005|Treatment|Participant request to discontinue treatment|15|||
46974931|NCT03766581|83219611|FG006|Treatment|Participant request to discontinue treatment|0|||
46974932|NCT03766581|83219612|FG007|Treatment|Participant request to discontinue treatment|1|||
46974933|NCT03766581|83219605|FG000|Treatment|Participant withdrew consent|11|||
46974934|NCT03766581|83219606|FG001|Treatment|Participant withdrew consent|4|||
46974935|NCT03766581|83219607|FG002|Treatment|Participant withdrew consent|5|||
46974936|NCT03766581|83219608|FG003|Treatment|Participant withdrew consent|5|||
46791963|NCT00642278|83010628|FG002|Overall Study|Withdrawal by Subject|1|||
46791964|NCT00642278|83010629|FG003|Overall Study|Withdrawal by Subject|3|||
46791965|NCT00642278|83010630|FG004|Overall Study|Withdrawal by Subject|6|||
46791966|NCT00642278|83010631|FG005|Overall Study|Withdrawal by Subject|2|||
46791967|NCT00642278|83010632|FG006|Overall Study|Withdrawal by Subject|2|||
46791968|NCT00642278|83010626|FG000|Overall Study|Noncompliance with study drug regimen|0|||
46791969|NCT00642278|83010627|FG001|Overall Study|Noncompliance with study drug regimen|0|||
46791970|NCT00642278|83010628|FG002|Overall Study|Noncompliance with study drug regimen|0|||
46791971|NCT00642278|83010629|FG003|Overall Study|Noncompliance with study drug regimen|1|||
46854243|NCT00379769|83070207|FG004|Main Study|Personal reasons|0|||
46854244|NCT00379769|83070208|FG005|Main Study|Personal reasons|0|||
46974937|NCT03766581|83219609|FG004|Treatment|Participant withdrew consent|4|||
46974938|NCT03766581|83219610|FG005|Treatment|Participant withdrew consent|4|||
46673912|NCT01161472|82889426|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
46854245|NCT00379769|83070203|FG000|Main Study|Risk of heart failure|0|||
46974939|NCT03766581|83219611|FG006|Treatment|Participant withdrew consent|0|||
46974940|NCT03766581|83219612|FG007|Treatment|Participant withdrew consent|0|||
46974941|NCT03766581|83219605|FG000|Treatment|Death|1|||
46974942|NCT03766581|83219606|FG001|Treatment|Death|0|||
46974943|NCT03766581|83219607|FG002|Treatment|Death|0|||
46854246|NCT00379769|83070204|FG001|Main Study|Risk of heart failure|1|||
46854247|NCT00379769|83070205|FG002|Main Study|Risk of heart failure|0|||
46854248|NCT00379769|83070206|FG003|Main Study|Risk of heart failure|0|||
46974944|NCT03766581|83219608|FG003|Treatment|Death|0|||
46974945|NCT03766581|83219609|FG004|Treatment|Death|0|||
46854249|NCT00379769|83070207|FG004|Main Study|Risk of heart failure|0|||
46854250|NCT00379769|83070208|FG005|Main Study|Risk of heart failure|0|||
46854251|NCT00379769|83070203|FG000|Main Study|Investigator refused to log temperature|0|||
46854252|NCT00379769|83070204|FG001|Main Study|Investigator refused to log temperature|0|||
46854253|NCT00379769|83070205|FG002|Main Study|Investigator refused to log temperature|1|||
46854254|NCT00379769|83070206|FG003|Main Study|Investigator refused to log temperature|0|||
46854255|NCT00379769|83070207|FG004|Main Study|Investigator refused to log temperature|0|||
46854256|NCT00379769|83070208|FG005|Main Study|Investigator refused to log temperature|0|||
46854257|NCT00379769|83070203|FG000|Main Study|Reason unspecified|0|||
46854258|NCT00379769|83070204|FG001|Main Study|Reason unspecified|0|||
46854259|NCT00379769|83070205|FG002|Main Study|Reason unspecified|1|||
46854260|NCT00379769|83070206|FG003|Main Study|Reason unspecified|0|||
46854261|NCT00379769|83070207|FG004|Main Study|Reason unspecified|0|||
46854262|NCT00379769|83070208|FG005|Main Study|Reason unspecified|0|||
46854263|NCT00379769|83070203|FG000|Observational Follow-up|Death|0|||
46854264|NCT00379769|83070204|FG001|Observational Follow-up|Death|0|||
46854265|NCT00379769|83070205|FG002|Observational Follow-up|Death|0|||
46854266|NCT00379769|83070206|FG003|Observational Follow-up|Death|0|||
46854267|NCT00379769|83070207|FG004|Observational Follow-up|Death|78|||
46791972|NCT00642278|83010630|FG004|Overall Study|Noncompliance with study drug regimen|0|||
46791973|NCT00642278|83010631|FG005|Overall Study|Noncompliance with study drug regimen|0|||
46791974|NCT00642278|83010632|FG006|Overall Study|Noncompliance with study drug regimen|0|||
46791975|NCT00642278|83010626|FG000|Overall Study|Other|2|||
46791976|NCT00642278|83010627|FG001|Overall Study|Other|1|||
46791977|NCT00642278|83010628|FG002|Overall Study|Other|0|||
46791978|NCT00642278|83010629|FG003|Overall Study|Other|1|||
46791979|NCT00642278|83010630|FG004|Overall Study|Other|0|||
46791980|NCT00642278|83010631|FG005|Overall Study|Other|1|||
46791981|NCT00642278|83010632|FG006|Overall Study|Other|0|||
46791982|NCT00543543|83010652|FG000|Base Study|Adverse Event|1|||
46791983|NCT00543543|83010653|FG001|Base Study|Adverse Event|11|||
46791984|NCT00543543|83010654|FG002|Base Study|Adverse Event|0|||
46791985|NCT00543543|83010655|FG003|Base Study|Adverse Event|5|||
46791986|NCT00543543|83010652|FG000|Base Study|Lost to Follow-up|12|||
46791987|NCT00543543|83010653|FG001|Base Study|Lost to Follow-up|749|||
46791988|NCT00543543|83010654|FG002|Base Study|Lost to Follow-up|9|||
46791989|NCT00543543|83010655|FG003|Base Study|Lost to Follow-up|701|||
46791990|NCT00543543|83010652|FG000|Base Study|Physician Decision|0|||
46791991|NCT00543543|83010653|FG001|Base Study|Physician Decision|4|||
46791992|NCT00543543|83010654|FG002|Base Study|Physician Decision|0|||
46791993|NCT00543543|83010655|FG003|Base Study|Physician Decision|7|||
46791994|NCT00543543|83010652|FG000|Base Study|Protocol Violation|0|||
46791995|NCT00543543|83010653|FG001|Base Study|Protocol Violation|6|||
46791996|NCT00543543|83010654|FG002|Base Study|Protocol Violation|0|||
46791997|NCT00543543|83010655|FG003|Base Study|Protocol Violation|6|||
46791998|NCT00543543|83010652|FG000|Base Study|Withdrawal by Subject|7|||
46791999|NCT00543543|83010653|FG001|Base Study|Withdrawal by Subject|482|||
46792000|NCT00543543|83010654|FG002|Base Study|Withdrawal by Subject|5|||
46792001|NCT00543543|83010655|FG003|Base Study|Withdrawal by Subject|503|||
46792002|NCT00543543|83010652|FG000|Extension Study|Adverse Event|0|||
46792003|NCT00543543|83010653|FG001|Extension Study|Adverse Event|0|||
46792004|NCT00543543|83010654|FG002|Extension Study|Adverse Event|0|||
46792005|NCT00543543|83010655|FG003|Extension Study|Adverse Event|5|||
46792006|NCT00543543|83010652|FG000|Extension Study|Lost to Follow-up|0|||
46792007|NCT00543543|83010653|FG001|Extension Study|Lost to Follow-up|0|||
46792008|NCT00543543|83010654|FG002|Extension Study|Lost to Follow-up|0|||
46792009|NCT00543543|83010655|FG003|Extension Study|Lost to Follow-up|77|||
46792010|NCT00543543|83010652|FG000|Extension Study|Physician Decision|0|||
46792011|NCT00543543|83010653|FG001|Extension Study|Physician Decision|0|||
46792012|NCT00543543|83010654|FG002|Extension Study|Physician Decision|0|||
46854268|NCT00379769|83070208|FG005|Observational Follow-up|Death|70|||
46854269|NCT00379769|83070203|FG000|Observational Follow-up|Adverse Event|0|||
46854270|NCT00379769|83070204|FG001|Observational Follow-up|Adverse Event|0|||
46854271|NCT00379769|83070205|FG002|Observational Follow-up|Adverse Event|0|||
46974946|NCT03766581|83219610|FG005|Treatment|Death|0|||
46974947|NCT03766581|83219611|FG006|Treatment|Death|0|||
46792013|NCT00543543|83010655|FG003|Extension Study|Physician Decision|7|||
46792014|NCT00543543|83010652|FG000|Extension Study|Pregnancy|0|||
46792015|NCT00543543|83010653|FG001|Extension Study|Pregnancy|0|||
46792016|NCT00543543|83010654|FG002|Extension Study|Pregnancy|0|||
46854272|NCT00379769|83070206|FG003|Observational Follow-up|Adverse Event|0|||
46854273|NCT00379769|83070207|FG004|Observational Follow-up|Adverse Event|1|||
46854274|NCT00379769|83070208|FG005|Observational Follow-up|Adverse Event|0|||
46854275|NCT00379769|83070203|FG000|Observational Follow-up|Lost to Follow-up|0|||
46974948|NCT03766581|83219612|FG007|Treatment|Death|0|||
46792017|NCT00543543|83010655|FG003|Extension Study|Pregnancy|6|||
46974949|NCT03766581|83219605|FG000|Treatment|Lost to Follow-up|1|||
46792018|NCT00543543|83010652|FG000|Extension Study|Protocol Violation|0|||
46792019|NCT00543543|83010653|FG001|Extension Study|Protocol Violation|0|||
46792020|NCT00543543|83010654|FG002|Extension Study|Protocol Violation|0|||
46854276|NCT00379769|83070204|FG001|Observational Follow-up|Lost to Follow-up|0|||
46854277|NCT00379769|83070205|FG002|Observational Follow-up|Lost to Follow-up|0|||
46854278|NCT00379769|83070206|FG003|Observational Follow-up|Lost to Follow-up|0|||
46854279|NCT00379769|83070207|FG004|Observational Follow-up|Lost to Follow-up|25|||
46854280|NCT00379769|83070208|FG005|Observational Follow-up|Lost to Follow-up|27|||
46854281|NCT00379769|83070203|FG000|Observational Follow-up|Withdrawal by Subject|0|||
46854282|NCT00379769|83070204|FG001|Observational Follow-up|Withdrawal by Subject|0|||
46854283|NCT00379769|83070205|FG002|Observational Follow-up|Withdrawal by Subject|0|||
46792021|NCT00543543|83010655|FG003|Extension Study|Protocol Violation|11|||
46792022|NCT00543543|83010652|FG000|Extension Study|Withdrawal by Subject|0|||
46792023|NCT00543543|83010653|FG001|Extension Study|Withdrawal by Subject|0|||
46792024|NCT00543543|83010654|FG002|Extension Study|Withdrawal by Subject|0|||
46792025|NCT00543543|83010655|FG003|Extension Study|Withdrawal by Subject|120|||
46792026|NCT00645164|83010670|FG000|Overall Study|Lost to Follow-up|2|||
46792027|NCT00645164|83010670|FG000|Overall Study|Withdrawal by Subject|4|||
46792028|NCT00645164|83010670|FG000|Overall Study|Protocol Violation|1|||
46792029|NCT00723125|83010676|FG000|Overall Study|Met Dx|1|||
46792030|NCT00723125|83010677|FG001|Overall Study|Met Dx|0|||
46792031|NCT00723125|83010676|FG000|Overall Study|Withdrawal by Subject|15|||
46792032|NCT00723125|83010677|FG001|Overall Study|Withdrawal by Subject|6|||
46792033|NCT00723125|83010676|FG000|Overall Study|Adverse Event|2|||
46792034|NCT00723125|83010677|FG001|Overall Study|Adverse Event|0|||
46792035|NCT00722423|83010691|FG000|Overall Study|Protocol Violation|0|||
46792036|NCT00722423|83010692|FG001|Overall Study|Protocol Violation|1|||
46792037|NCT00640562|83010702|FG000|Overall Study|Adverse Event|8|||
46854284|NCT00379769|83070206|FG003|Observational Follow-up|Withdrawal by Subject|0|||
46854285|NCT00379769|83070207|FG004|Observational Follow-up|Withdrawal by Subject|12|||
46854286|NCT00379769|83070208|FG005|Observational Follow-up|Withdrawal by Subject|12|||
46854287|NCT00379769|83070203|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
46854288|NCT00379769|83070204|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
46854289|NCT00379769|83070205|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
46854290|NCT00379769|83070206|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
46854291|NCT00379769|83070207|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
46854292|NCT00379769|83070208|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
46854293|NCT00379769|83070203|FG000|Observational Follow-up|Physician Decision|0|||
46854294|NCT00379769|83070204|FG001|Observational Follow-up|Physician Decision|0|||
46854295|NCT00379769|83070205|FG002|Observational Follow-up|Physician Decision|0|||
46854296|NCT00379769|83070206|FG003|Observational Follow-up|Physician Decision|0|||
46854297|NCT00379769|83070207|FG004|Observational Follow-up|Physician Decision|8|||
46854298|NCT00379769|83070208|FG005|Observational Follow-up|Physician Decision|8|||
46854299|NCT00379769|83070203|FG000|Observational Follow-up|Site Closed Early|0|||
46974950|NCT03766581|83219606|FG001|Treatment|Lost to Follow-up|0|||
46974951|NCT03766581|83219607|FG002|Treatment|Lost to Follow-up|0|||
46974952|NCT03766581|83219608|FG003|Treatment|Lost to Follow-up|1|||
46974953|NCT03766581|83219609|FG004|Treatment|Lost to Follow-up|0|||
46974954|NCT03766581|83219610|FG005|Treatment|Lost to Follow-up|0|||
46974955|NCT03766581|83219611|FG006|Treatment|Lost to Follow-up|0|||
46974956|NCT03766581|83219612|FG007|Treatment|Lost to Follow-up|0|||
46974957|NCT03766581|83219605|FG000|Treatment|Poor/Non compliance|2|||
46974958|NCT03766581|83219606|FG001|Treatment|Poor/Non compliance|2|||
46974959|NCT03766581|83219607|FG002|Treatment|Poor/Non compliance|1|||
46974960|NCT03766581|83219608|FG003|Treatment|Poor/Non compliance|1|||
46974961|NCT03766581|83219609|FG004|Treatment|Poor/Non compliance|1|||
46974962|NCT03766581|83219610|FG005|Treatment|Poor/Non compliance|1|||
46974963|NCT03766581|83219611|FG006|Treatment|Poor/Non compliance|0|||
46974964|NCT03766581|83219612|FG007|Treatment|Poor/Non compliance|0|||
46974965|NCT03766581|83219605|FG000|Treatment|Participant no longer meets study criteria|9|||
46974966|NCT03766581|83219606|FG001|Treatment|Participant no longer meets study criteria|1|||
46974967|NCT03766581|83219607|FG002|Treatment|Participant no longer meets study criteria|5|||
46974968|NCT03766581|83219608|FG003|Treatment|Participant no longer meets study criteria|4|||
46792038|NCT00640562|83010703|FG001|Overall Study|Adverse Event|5|||
46792039|NCT00640562|83010702|FG000|Overall Study|Lack of Efficacy|1|||
46792040|NCT00640562|83010703|FG001|Overall Study|Lack of Efficacy|4|||
46792041|NCT00640562|83010702|FG000|Overall Study|Protocol Violation|2|||
46974969|NCT03766581|83219609|FG004|Treatment|Participant no longer meets study criteria|4|||
46854300|NCT00379769|83070204|FG001|Observational Follow-up|Site Closed Early|0|||
46974970|NCT03766581|83219610|FG005|Treatment|Participant no longer meets study criteria|4|||
46974971|NCT03766581|83219611|FG006|Treatment|Participant no longer meets study criteria|2|||
46792042|NCT00640562|83010703|FG001|Overall Study|Protocol Violation|4|||
46792043|NCT00640562|83010702|FG000|Overall Study|Withdrawal by Subject|6|||
46792044|NCT00640562|83010703|FG001|Overall Study|Withdrawal by Subject|10|||
46854301|NCT00379769|83070205|FG002|Observational Follow-up|Site Closed Early|0|||
46792045|NCT00640562|83010702|FG000|Overall Study|Known risperidone intolerance|0|||
46792046|NCT00640562|83010703|FG001|Overall Study|Known risperidone intolerance|1|||
46792047|NCT00640562|83010702|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
46792048|NCT00640562|83010703|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
46792049|NCT00640562|83010702|FG000|Overall Study|Low study drug dose|0|||
46792050|NCT00640562|83010703|FG001|Overall Study|Low study drug dose|1|||
46792051|NCT00640562|83010702|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
46792052|NCT00640562|83010703|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
46792053|NCT00585923|83010711|FG000|Overall Study|Physician decided not to continue|31|||
46854302|NCT00379769|83070206|FG003|Observational Follow-up|Site Closed Early|0|||
46854303|NCT00379769|83070207|FG004|Observational Follow-up|Site Closed Early|6|||
46854304|NCT00379769|83070208|FG005|Observational Follow-up|Site Closed Early|7|||
46854305|NCT00379769|83070203|FG000|Observational Follow-up|Participant Moved|0|||
46792054|NCT00585923|83010712|FG001|Overall Study|Physician decided not to continue|33|||
46792055|NCT00721955|83010721|FG000|Overall Study|Adverse Event|0|||
46792056|NCT00721955|83010722|FG001|Overall Study|Adverse Event|0|||
46792057|NCT00721955|83010723|FG002|Overall Study|Adverse Event|2|||
46792058|NCT00585689|83010731|FG000|Overall Study|Received different ABI-007 schedule|3|||
46792059|NCT00585689|83010731|FG000|Overall Study|Adverse Event|1|||
46792060|NCT00585689|83010731|FG000|Overall Study|Patient Declined Surgery|1|||
46792061|NCT00585689|83010731|FG000|Overall Study|Patient had unresectable disease|1|||
46792062|NCT00585689|83010731|FG000|Overall Study|Death|1|||
46792063|NCT00721799|83010735|FG000|Overall Study|Withdrawal by Subject|7|||
46854306|NCT00379769|83070204|FG001|Observational Follow-up|Participant Moved|0|||
46854307|NCT00379769|83070205|FG002|Observational Follow-up|Participant Moved|0|||
46854308|NCT00379769|83070206|FG003|Observational Follow-up|Participant Moved|0|||
46854309|NCT00379769|83070207|FG004|Observational Follow-up|Participant Moved|0|||
46854310|NCT00379769|83070208|FG005|Observational Follow-up|Participant Moved|1|||
46854311|NCT00379769|83070203|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
46792064|NCT00721799|83010735|FG000|Overall Study|withdraw by subject after scan 1|1|||
46792065|NCT00729365|83010742|FG000|Overall Study|Physician Decision|33|||
46792066|NCT00729365|83010743|FG001|Overall Study|Physician Decision|6|||
46792067|NCT00729365|83010744|FG002|Overall Study|Physician Decision|7|||
46854312|NCT00379769|83070204|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
46854313|NCT00379769|83070205|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
46854314|NCT00379769|83070206|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
46854315|NCT00379769|83070207|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
46854316|NCT00379769|83070208|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
46854317|NCT00006164|83070237|FG000|Overall Study|Withdrew or lost to follow-up|70|||
46974972|NCT03766581|83219612|FG007|Treatment|Participant no longer meets study criteria|0|||
46974973|NCT03766581|83219605|FG000|Treatment|Other reasons|13|||
46974974|NCT03766581|83219606|FG001|Treatment|Other reasons|8|||
46792068|NCT00254293|83010760|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
46854318|NCT00006164|83070238|FG001|Overall Study|Withdrew or lost to follow-up|81|||
46854319|NCT00378599|83070244|FG000|Overall Study|Adverse Event|38|||
46854320|NCT00378599|83070244|FG000|Overall Study|Protocol Violation|2|||
46854321|NCT00378599|83070244|FG000|Overall Study|Treatment failure|7|||
46854322|NCT00378599|83070244|FG000|Overall Study|Withdrawal by Subject|5|||
46854323|NCT00378209|83070248|FG000|Overall Study|Progressive disease|11|||
46854324|NCT00378209|83070248|FG000|Overall Study|Adverse Event|3|||
46854325|NCT00378209|83070248|FG000|Overall Study|Initiation of non-protocol therapy|3|||
46854326|NCT00378209|83070248|FG000|Overall Study|Physician Decision|3|||
46854327|NCT00378209|83070248|FG000|Overall Study|Death|1|||
46854328|NCT00378209|83070248|FG000|Overall Study|Treatment delay|1|||
46854329|NCT00377819|83070255|FG000|Overall Study|Adverse Event|2|||
46854330|NCT00377819|83070256|FG001|Overall Study|Adverse Event|3|||
46854331|NCT00377819|83070255|FG000|Overall Study|Withdrawal by Subject|10|||
46854332|NCT00377819|83070256|FG001|Overall Study|Withdrawal by Subject|4|||
46854333|NCT00377819|83070255|FG000|Overall Study|Death|0|||
46854334|NCT00377819|83070256|FG001|Overall Study|Death|1|||
46854335|NCT00377819|83070255|FG000|Overall Study|Lost to Follow-up|0|||
46854336|NCT00377819|83070256|FG001|Overall Study|Lost to Follow-up|1|||
46854337|NCT00377819|83070255|FG000|Overall Study|Protocol Violation|1|||
46854338|NCT00377819|83070256|FG001|Overall Study|Protocol Violation|1|||
46854339|NCT03419962|83070262|FG000|Overall Study|Change to other medication|1|||
46854340|NCT03419962|83070262|FG000|Overall Study|Refusal of continuing with trial drug|1|||
46854341|NCT03419962|83070262|FG000|Overall Study|Lost to Follow-up|3|||
46854342|NCT03419962|83070262|FG000|Overall Study|Difficulty in inhaling the doses|1|||
46974975|NCT03766581|83219607|FG002|Treatment|Other reasons|3|||
46974976|NCT03766581|83219608|FG003|Treatment|Other reasons|7|||
46974977|NCT03766581|83219609|FG004|Treatment|Other reasons|3|||
46792069|NCT00254293|83010761|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
46792070|NCT00254293|83010762|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
46854343|NCT03419962|83070262|FG000|Overall Study|Missing completion data|31|||
46854344|NCT00377429|83070266|FG000|Overall Study|Withdrawal by Subject|5|||
46974978|NCT03766581|83219610|FG005|Treatment|Other reasons|3|||
46792071|NCT00254293|83010763|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
46792072|NCT00254293|83010764|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
46792073|NCT00254293|83010765|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
46792074|NCT00254293|83010766|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
46792075|NCT00254293|83010760|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
46792076|NCT00254293|83010761|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
46792077|NCT00254293|83010762|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
46792078|NCT00254293|83010763|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
46792079|NCT00254293|83010764|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
46854345|NCT00377429|83070266|FG000|Overall Study|Adverse Event|8|||
46854346|NCT00377429|83070266|FG000|Overall Study|Physician Decision|1|||
46854347|NCT00377429|83070266|FG000|Overall Study|Patient non-compliance|1|||
46792080|NCT00254293|83010765|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
46792081|NCT00254293|83010766|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
46792082|NCT00254293|83010760|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
46792083|NCT00254293|83010761|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
46792084|NCT00254293|83010762|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
46792085|NCT00254293|83010763|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
46792086|NCT00254293|83010764|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
46792087|NCT00254293|83010765|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
46792088|NCT00254293|83010766|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
46792089|NCT00254293|83010760|FG000|LTE Open Label Variable SC Dosing|Death|0|||
46792090|NCT00254293|83010761|FG001|LTE Open Label Variable SC Dosing|Death|0|||
46792091|NCT00254293|83010762|FG002|LTE Open Label Variable SC Dosing|Death|1|||
46792092|NCT00254293|83010763|FG003|LTE Open Label Variable SC Dosing|Death|0|||
46792093|NCT00254293|83010764|FG004|LTE Open Label Variable SC Dosing|Death|0|||
46792094|NCT00254293|83010765|FG005|LTE Open Label Variable SC Dosing|Death|0|||
46792095|NCT00254293|83010766|FG006|LTE Open Label Variable SC Dosing|Death|0|||
46792096|NCT00254293|83010760|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
46792097|NCT00254293|83010761|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
46792098|NCT00254293|83010762|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
46854348|NCT00376961|83070270|FG000|Initial Registration|Adverse Event|1|||
46854349|NCT00376961|83070271|FG001|Initial Registration|Adverse Event|0|||
46854350|NCT00376961|83070270|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
46854351|NCT00376961|83070271|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
46854352|NCT00376961|83070270|FG000|Initial Registration|Progression/relapse|1|||
46854353|NCT00376961|83070271|FG001|Initial Registration|Progression/relapse|0|||
46854354|NCT00376961|83070270|FG000|Initial Registration|Ineligible|3|||
46854355|NCT00376961|83070271|FG001|Initial Registration|Ineligible|0|||
46854356|NCT00376961|83070270|FG000|Maintenance|Adverse Event|0|||
46854357|NCT00376961|83070271|FG001|Maintenance|Adverse Event|1|||
46974979|NCT03766581|83219611|FG006|Treatment|Other reasons|0|||
46974980|NCT03766581|83219612|FG007|Treatment|Other reasons|0|||
46974981|NCT03675321|83219637|FG000|Overall Study|Lack of Efficacy|2|||
46974982|NCT03675321|83219638|FG001|Overall Study|Lack of Efficacy|2|||
46974983|NCT03675321|83219637|FG000|Overall Study|Withdrawal by Subject|1|||
46974984|NCT03675321|83219638|FG001|Overall Study|Withdrawal by Subject|3|||
46974985|NCT03527745|83219684|FG000|Overall Study|Lost to Follow-up|3|||
46974986|NCT03527745|83219685|FG001|Overall Study|Lost to Follow-up|6|||
46974987|NCT03527745|83219686|FG002|Overall Study|Lost to Follow-up|7|||
46974988|NCT03527745|83219687|FG003|Overall Study|Lost to Follow-up|9|||
46974989|NCT03527745|83219688|FG004|Overall Study|Lost to Follow-up|0|||
46974990|NCT03527745|83219689|FG005|Overall Study|Lost to Follow-up|2|||
46974991|NCT03527745|83219690|FG006|Overall Study|Lost to Follow-up|3|||
46974992|NCT03527745|83219691|FG007|Overall Study|Lost to Follow-up|2|||
46974993|NCT03527745|83219692|FG008|Overall Study|Lost to Follow-up|3|||
46974994|NCT03527745|83219693|FG009|Overall Study|Lost to Follow-up|2|||
46974995|NCT03527745|83219694|FG010|Overall Study|Lost to Follow-up|1|||
46974996|NCT03527745|83219695|FG011|Overall Study|Lost to Follow-up|1|||
46974997|NCT03527745|83219696|FG012|Overall Study|Lost to Follow-up|0|||
46974998|NCT03527745|83219697|FG013|Overall Study|Lost to Follow-up|0|||
46974999|NCT03527745|83219698|FG014|Overall Study|Lost to Follow-up|0|||
46975000|NCT03527745|83219699|FG015|Overall Study|Lost to Follow-up|0|||
46975001|NCT03527745|83219700|FG016|Overall Study|Lost to Follow-up|1|||
46792099|NCT00254293|83010763|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
46792100|NCT00254293|83010764|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
46854358|NCT00376961|83070270|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
46975002|NCT03527745|83219701|FG017|Overall Study|Lost to Follow-up|0|||
46975003|NCT03527745|83219702|FG018|Overall Study|Lost to Follow-up|0|||
46975004|NCT03527745|83219703|FG019|Overall Study|Lost to Follow-up|1|||
46792101|NCT00254293|83010765|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
46854359|NCT00376961|83070271|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
46975005|NCT03527745|83219704|FG020|Overall Study|Lost to Follow-up|1|||
46792102|NCT00254293|83010766|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
46792103|NCT00254293|83010760|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
46792104|NCT00254293|83010761|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
46792105|NCT00254293|83010762|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
46975006|NCT03527745|83219705|FG021|Overall Study|Lost to Follow-up|5|||
46975007|NCT03527745|83219706|FG022|Overall Study|Lost to Follow-up|6|||
46975008|NCT03527745|83219707|FG023|Overall Study|Lost to Follow-up|8|||
46854360|NCT00376961|83070270|FG000|Maintenance|Progression/relapse|0|||
46854361|NCT00376961|83070271|FG001|Maintenance|Progression/relapse|18|||
46854362|NCT00376961|83070270|FG000|Maintenance|Ineligible|0|||
46854363|NCT00376961|83070271|FG001|Maintenance|Ineligible|3|||
46854364|NCT03418324|83070281|FG000|Overall Study|Death|0|||
46854365|NCT03418324|83070282|FG001|Overall Study|Death|1|||
46854366|NCT03418324|83070281|FG000|Overall Study|Physician Decision|1|||
46854367|NCT03418324|83070282|FG001|Overall Study|Physician Decision|1|||
46854368|NCT00376259|83070290|FG000|Overall Study|Sponsor request - study termination|21|||
46975009|NCT03527745|83219708|FG024|Overall Study|Lost to Follow-up|1|||
46975010|NCT03527745|83219709|FG025|Overall Study|Lost to Follow-up|3|||
46975011|NCT03174782|83219791|FG000|Overall Study|Protocol Violation|1|||
46975012|NCT03174782|83219792|FG001|Overall Study|Protocol Violation|0|||
46975013|NCT03174782|83219791|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
46975014|NCT03174782|83219792|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
46975015|NCT02919969|83219798|FG000|Overall Study|Lack of Efficacy|22|||
46792106|NCT00254293|83010763|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
46792107|NCT00254293|83010764|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
46792108|NCT00254293|83010765|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
46792109|NCT00254293|83010766|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
46792110|NCT00254293|83010760|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
46792111|NCT00254293|83010761|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
46792112|NCT00254293|83010762|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
46854369|NCT00376259|83070291|FG001|Overall Study|Sponsor request - study termination|21|||
46854370|NCT00376259|83070290|FG000|Overall Study|Patient request|1|||
46854371|NCT00376259|83070291|FG001|Overall Study|Patient request|0|||
46854372|NCT03410056|83070301|FG000|Overall Study|Decision by Sponsor|0|||
46854373|NCT03410056|83070302|FG001|Overall Study|Decision by Sponsor|0|||
46854374|NCT03410056|83070303|FG002|Overall Study|Decision by Sponsor|3|||
46854375|NCT03410056|83070304|FG003|Overall Study|Decision by Sponsor|0|||
46854376|NCT03410056|83070305|FG004|Overall Study|Decision by Sponsor|0|||
46854377|NCT03410056|83070306|FG005|Overall Study|Decision by Sponsor|0|||
46854378|NCT03410056|83070307|FG006|Overall Study|Decision by Sponsor|0|||
46854379|NCT03410056|83070301|FG000|Overall Study|Withdrawal by Subject|0|||
46854380|NCT03410056|83070302|FG001|Overall Study|Withdrawal by Subject|2|||
46854381|NCT03410056|83070303|FG002|Overall Study|Withdrawal by Subject|5|||
46854382|NCT03410056|83070304|FG003|Overall Study|Withdrawal by Subject|5|||
46854383|NCT03410056|83070305|FG004|Overall Study|Withdrawal by Subject|0|||
46854384|NCT03410056|83070306|FG005|Overall Study|Withdrawal by Subject|0|||
46854385|NCT03410056|83070307|FG006|Overall Study|Withdrawal by Subject|0|||
46854386|NCT03409666|83070325|FG000|Overall Study|Physician Decision|0|||
46854387|NCT03409666|83070326|FG001|Overall Study|Physician Decision|1|||
46854388|NCT03409666|83070325|FG000|Overall Study|Protocol Violation|0|||
46854389|NCT03409666|83070326|FG001|Overall Study|Protocol Violation|3|||
46854390|NCT03440944|83070334|FG000|Overall Study|Physician Decision|1|||
46854391|NCT03440944|83070335|FG001|Overall Study|Physician Decision|0|||
46854392|NCT03440944|83070334|FG000|Overall Study|No Acceptable Vasculature|0|||
46854393|NCT03440944|83070335|FG001|Overall Study|No Acceptable Vasculature|1|||
46854394|NCT00365105|83070344|FG000|Overall Study|Protocol Violation|5|||
46854395|NCT00365105|83070345|FG001|Overall Study|Protocol Violation|8|||
46854396|NCT00399893|83070353|FG000|Overall Study|Withdrawal by Subject|1|||
46854397|NCT00399893|83070354|FG001|Overall Study|Withdrawal by Subject|0|||
46854398|NCT00048542|83070364|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
46854399|NCT00048542|83070365|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
46854400|NCT00048542|83070366|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
46854401|NCT00048542|83070367|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
46854402|NCT00048542|83070368|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
46854403|NCT00048542|83070369|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
46975016|NCT02919969|83219798|FG000|Overall Study|Death|4|||
46854404|NCT00048542|83070370|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
46854405|NCT00048542|83070371|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
46854406|NCT00048542|83070364|FG000|Double-Blind Phase|Protocol Violation|0|||
46975017|NCT02919969|83219798|FG000|Overall Study|Physician Decision|3|||
46792113|NCT00254293|83010763|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
46975018|NCT02919969|83219798|FG000|Overall Study|Withdrawal by Subject|2|||
46975019|NCT01891344|83219820|FG000|Overall Study|Ongoing|6|||
46854407|NCT00048542|83070365|FG001|Double-Blind Phase|Protocol Violation|0|||
46854408|NCT00048542|83070366|FG002|Double-Blind Phase|Protocol Violation|1|||
46854409|NCT00048542|83070367|FG003|Double-Blind Phase|Protocol Violation|0|||
46792114|NCT00254293|83010764|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
46792115|NCT00254293|83010765|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
46792116|NCT00254293|83010766|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
46792117|NCT00254293|83010760|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
46792118|NCT00254293|83010761|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
46792119|NCT00254293|83010762|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
46792120|NCT00254293|83010763|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
46792121|NCT00254293|83010764|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
46792122|NCT00254293|83010765|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
46792123|NCT00254293|83010766|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
46792124|NCT00254293|83010760|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
46792125|NCT00254293|83010761|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
46792126|NCT00254293|83010762|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
46792127|NCT00254293|83010763|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
46792128|NCT00254293|83010764|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
46792129|NCT00254293|83010765|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
46792130|NCT00254293|83010766|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
46792131|NCT00254293|83010760|FG000|LTE Open Label Variable SC Dosing|Other|0|||
46792132|NCT00254293|83010761|FG001|LTE Open Label Variable SC Dosing|Other|0|||
46792133|NCT00254293|83010762|FG002|LTE Open Label Variable SC Dosing|Other|2|||
46792134|NCT00254293|83010763|FG003|LTE Open Label Variable SC Dosing|Other|0|||
46792135|NCT00254293|83010764|FG004|LTE Open Label Variable SC Dosing|Other|0|||
46792136|NCT00254293|83010765|FG005|LTE Open Label Variable SC Dosing|Other|0|||
46792137|NCT00254293|83010766|FG006|LTE Open Label Variable SC Dosing|Other|0|||
46792138|NCT00254293|83010760|FG000|LTE Open Label Fixed Dosing|Death|0|||
46792139|NCT00254293|83010761|FG001|LTE Open Label Fixed Dosing|Death|0|||
46792140|NCT00254293|83010762|FG002|LTE Open Label Fixed Dosing|Death|0|||
46792141|NCT00254293|83010763|FG003|LTE Open Label Fixed Dosing|Death|0|||
46792142|NCT00254293|83010764|FG004|LTE Open Label Fixed Dosing|Death|0|||
46792143|NCT00254293|83010765|FG005|LTE Open Label Fixed Dosing|Death|0|||
46792144|NCT00254293|83010766|FG006|LTE Open Label Fixed Dosing|Death|3|||
46792145|NCT00254293|83010760|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
46792146|NCT00254293|83010761|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
46792147|NCT00254293|83010762|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
46792148|NCT00254293|83010763|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
46792149|NCT00254293|83010764|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
46792150|NCT00254293|83010765|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
46792151|NCT00254293|83010766|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
46792152|NCT00254293|83010760|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
46792153|NCT00254293|83010761|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
46792154|NCT00254293|83010762|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
46792155|NCT00254293|83010763|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
46792156|NCT00254293|83010764|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
46792157|NCT00254293|83010765|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
46792158|NCT00254293|83010766|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
46792159|NCT00254293|83010760|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
46792160|NCT00254293|83010761|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
46792161|NCT00254293|83010762|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
46792162|NCT00254293|83010763|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
46854410|NCT00048542|83070368|FG004|Double-Blind Phase|Protocol Violation|0|||
46854411|NCT00048542|83070369|FG005|Double-Blind Phase|Protocol Violation|0|||
46854412|NCT00048542|83070370|FG006|Double-Blind Phase|Protocol Violation|0|||
46854413|NCT00048542|83070371|FG007|Double-Blind Phase|Protocol Violation|0|||
46854414|NCT00048542|83070364|FG000|Double-Blind Phase|Sponsor request or decision|2|||
46854415|NCT00048542|83070365|FG001|Double-Blind Phase|Sponsor request or decision|0|||
46854416|NCT00048542|83070366|FG002|Double-Blind Phase|Sponsor request or decision|0|||
46854417|NCT00048542|83070367|FG003|Double-Blind Phase|Sponsor request or decision|0|||
46854418|NCT00048542|83070368|FG004|Double-Blind Phase|Sponsor request or decision|0|||
46854419|NCT00048542|83070369|FG005|Double-Blind Phase|Sponsor request or decision|0|||
46854420|NCT00048542|83070370|FG006|Double-Blind Phase|Sponsor request or decision|0|||
46854421|NCT00048542|83070371|FG007|Double-Blind Phase|Sponsor request or decision|0|||
46854422|NCT00048542|83070364|FG000|Double-Blind Phase|Randomized in error|1|||
46854423|NCT00048542|83070365|FG001|Double-Blind Phase|Randomized in error|0|||
46792163|NCT00254293|83010764|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
46792164|NCT00254293|83010765|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
46854424|NCT00048542|83070366|FG002|Double-Blind Phase|Randomized in error|0|||
46854425|NCT00048542|83070367|FG003|Double-Blind Phase|Randomized in error|0|||
46854426|NCT00048542|83070368|FG004|Double-Blind Phase|Randomized in error|0|||
46792165|NCT00254293|83010766|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
46792166|NCT00254293|83010760|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
46792167|NCT00254293|83010761|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
46792168|NCT00254293|83010762|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
46792169|NCT00254293|83010763|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
46792170|NCT00254293|83010764|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
46792171|NCT00254293|83010765|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
46792172|NCT00254293|83010766|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
46792173|NCT00254293|83010760|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
46792174|NCT00254293|83010761|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
46854427|NCT00048542|83070369|FG005|Double-Blind Phase|Randomized in error|0|||
46854428|NCT00048542|83070370|FG006|Double-Blind Phase|Randomized in error|0|||
46854429|NCT00048542|83070371|FG007|Double-Blind Phase|Randomized in error|0|||
46854430|NCT00048542|83070364|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
46854431|NCT00048542|83070365|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
46854432|NCT00048542|83070366|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
46854433|NCT00048542|83070367|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
46975020|NCT01891344|83219821|FG001|Overall Study|Ongoing|2|||
46975021|NCT01891344|83219822|FG002|Overall Study|Ongoing|0|||
46975022|NCT01891344|83219823|FG003|Overall Study|Ongoing|1|||
46975023|NCT01891344|83219824|FG004|Overall Study|Ongoing|4|||
46975024|NCT01891344|83219825|FG005|Overall Study|Ongoing|1|||
46975025|NCT01891344|83219826|FG006|Overall Study|Ongoing|0|||
46975026|NCT01891344|83219827|FG007|Overall Study|Ongoing|0|||
46975027|NCT01188096|83219845|FG000|Overall Study|progression of disease|4|||
46975028|NCT01188096|83219845|FG000|Overall Study|Withdrawal by Subject|2|||
46975029|NCT00579826|83219865|FG000|Overall Study|Withdrawal by Subject|5|||
46975030|NCT00579826|83219866|FG001|Overall Study|Withdrawal by Subject|3|||
46975031|NCT00106691|83219874|FG000|Overall Study|Adverse Event|60|||
46975032|NCT00106691|83219875|FG001|Overall Study|Adverse Event|64|||
46975033|NCT00106691|83219874|FG000|Overall Study|Lost to Follow-up|23|||
46975034|NCT00106691|83219875|FG001|Overall Study|Lost to Follow-up|18|||
46975035|NCT00106691|83219874|FG000|Overall Study|Physician Decision|18|||
46975036|NCT00106691|83219875|FG001|Overall Study|Physician Decision|21|||
46975037|NCT00106691|83219874|FG000|Overall Study|Protocol Violation|13|||
46975038|NCT00106691|83219875|FG001|Overall Study|Protocol Violation|18|||
46975039|NCT00106691|83219874|FG000|Overall Study|Withdrawal by Subject|75|||
46975040|NCT00106691|83219875|FG001|Overall Study|Withdrawal by Subject|70|||
46975041|NCT00106691|83219874|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
46975042|NCT00106691|83219875|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
46975043|NCT00106691|83219874|FG000|Overall Study|QTc>480|3|||
46975044|NCT00106691|83219875|FG001|Overall Study|QTc>480|1|||
46975045|NCT00106691|83219874|FG000|Overall Study|mililtary deployment|2|||
46975046|NCT00106691|83219875|FG001|Overall Study|mililtary deployment|0|||
46975047|NCT00106691|83219874|FG000|Overall Study|Study Site Closing/PI Moved|1|||
46975048|NCT00106691|83219875|FG001|Overall Study|Study Site Closing/PI Moved|2|||
46975049|NCT00106691|83219874|FG000|Overall Study|Cardiologist recommendation|1|||
46975050|NCT00106691|83219875|FG001|Overall Study|Cardiologist recommendation|0|||
46975051|NCT00106691|83219874|FG000|Overall Study|Pt. moved to another state|1|||
46975052|NCT00106691|83219875|FG001|Overall Study|Pt. moved to another state|0|||
46854434|NCT00048542|83070368|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
46854435|NCT00048542|83070369|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
46854436|NCT00048542|83070370|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
46975053|NCT00106691|83219874|FG000|Overall Study|Taking exclusionary avodart|1|||
46975054|NCT00106691|83219875|FG001|Overall Study|Taking exclusionary avodart|0|||
46975055|NCT00106691|83219874|FG000|Overall Study|Not able to discontinue plavix|0|||
46975056|NCT00106691|83219875|FG001|Overall Study|Not able to discontinue plavix|1|||
46975057|NCT02644967|83219964|FG000|Overall Study|Death|26|||
46975058|NCT02644967|83219964|FG000|Overall Study|Physician Decision|1|||
46975059|NCT02644967|83219964|FG000|Overall Study|Withdrawal by Subject|2|||
46975060|NCT02644967|83219964|FG000|Overall Study|Protocol Violation|1|||
46975061|NCT02644967|83219964|FG000|Overall Study|Progressive Disease|1|||
46975062|NCT02644967|83219964|FG000|Overall Study|Study Terminated by Sponsor|4|||
46792175|NCT00254293|83010762|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
46792176|NCT00254293|83010763|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
46975063|NCT02644343|83219968|FG000|Overall Study|Withdrawal by Subject|1|||
46975064|NCT02644109|83219974|FG000|Overall Study|Adverse Event|0|||
46975065|NCT02644109|83219975|FG001|Overall Study|Adverse Event|4|||
46975066|NCT02642159|83219983|FG000|Overall Study|Randomized but not treated|1|||
46975067|NCT02642159|83219984|FG001|Overall Study|Randomized but not treated|0|||
46975068|NCT02642159|83219983|FG000|Overall Study|Adverse Event|10|||
46975069|NCT02642159|83219984|FG001|Overall Study|Adverse Event|4|||
46975070|NCT02642159|83219983|FG000|Overall Study|Withdrawal by Subject|9|||
46975071|NCT02642159|83219984|FG001|Overall Study|Withdrawal by Subject|1|||
46975072|NCT02642159|83219983|FG000|Overall Study|Poor compliance to study protocol|1|||
46792177|NCT00254293|83010764|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
46792178|NCT00254293|83010765|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
46854437|NCT00048542|83070371|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
46854438|NCT00048542|83070364|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
46854439|NCT00048542|83070365|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
46854440|NCT00048542|83070366|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
46854441|NCT00048542|83070367|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
46854442|NCT00048542|83070368|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
46854443|NCT00048542|83070369|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
46854444|NCT00048542|83070370|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
46792179|NCT00254293|83010766|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
46854445|NCT00048542|83070371|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
46854446|NCT00048542|83070364|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
46854447|NCT00048542|83070365|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
46854448|NCT00048542|83070366|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
46792180|NCT00254293|83010760|FG000|LTE Open Label Fixed Dosing|Other|0|||
46792181|NCT00254293|83010761|FG001|LTE Open Label Fixed Dosing|Other|0|||
46792182|NCT00254293|83010762|FG002|LTE Open Label Fixed Dosing|Other|0|||
46792183|NCT00254293|83010763|FG003|LTE Open Label Fixed Dosing|Other|0|||
46792184|NCT00254293|83010764|FG004|LTE Open Label Fixed Dosing|Other|0|||
46792185|NCT00254293|83010765|FG005|LTE Open Label Fixed Dosing|Other|0|||
46792186|NCT00254293|83010766|FG006|LTE Open Label Fixed Dosing|Other|1|||
46792187|NCT00585221|83010809|FG000|Overall Study|Protocol Violation|8|||
46792188|NCT00253747|83010815|FG000|Overall Study|Lost to Follow-up|13|||
46792189|NCT00253747|83010816|FG001|Overall Study|Lost to Follow-up|14|||
46792190|NCT00253747|83010815|FG000|Overall Study|Withdrawal by Subject|10|||
46792191|NCT00253747|83010816|FG001|Overall Study|Withdrawal by Subject|11|||
46792192|NCT00253747|83010815|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
46792193|NCT00253747|83010816|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
46792194|NCT00252733|83010834|FG000|Overall Study|Withdrawal by Subject|73|||
46792195|NCT00252733|83010835|FG001|Overall Study|Withdrawal by Subject|67|||
46792196|NCT00252733|83010834|FG000|Overall Study|Death|7|||
46792197|NCT00252733|83010835|FG001|Overall Study|Death|5|||
46792198|NCT00252733|83010834|FG000|Overall Study|Lost to Follow-up|12|||
46792199|NCT00252733|83010835|FG001|Overall Study|Lost to Follow-up|6|||
46792200|NCT00252733|83010834|FG000|Overall Study|Multiple Reasons|14|||
46792201|NCT00252733|83010835|FG001|Overall Study|Multiple Reasons|14|||
46792202|NCT00275821|83010844|FG000|Overall Study|Adverse Event|4|||
46792203|NCT00275821|83010845|FG001|Overall Study|Adverse Event|12|||
47078262|NCT02609386|83383329|FG001|Overall Study|Physician Decision|2|||
47078263|NCT02576717|83383339|FG000|Overall Study|Other Reasons|16|||
47078264|NCT02576717|83383340|FG001|Overall Study|Other Reasons|18|||
46673913|NCT01161472|82889427|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
46792204|NCT00275821|83010846|FG002|Overall Study|Adverse Event|5|||
46792205|NCT00275821|83010844|FG000|Overall Study|Administrative problems|3|||
46792206|NCT00275821|83010845|FG001|Overall Study|Administrative problems|4|||
46792207|NCT00275821|83010846|FG002|Overall Study|Administrative problems|4|||
46792208|NCT00275821|83010844|FG000|Overall Study|Withdrawal by Subject|0|||
46792209|NCT00275821|83010845|FG001|Overall Study|Withdrawal by Subject|2|||
46792210|NCT00275821|83010846|FG002|Overall Study|Withdrawal by Subject|1|||
46975073|NCT02642159|83219984|FG001|Overall Study|Poor compliance to study protocol|0|||
46854449|NCT00048542|83070367|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
46854450|NCT00048542|83070368|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
46975074|NCT02642159|83219983|FG000|Overall Study|Other than specified above|10|||
46975075|NCT02642159|83219984|FG001|Overall Study|Other than specified above|3|||
46975076|NCT02669017|83220000|FG000|Overall Study|Death|1|||
46975077|NCT02669017|83220001|FG001|Overall Study|Death|2|||
46975078|NCT02669017|83220002|FG002|Overall Study|Death|2|||
46975079|NCT02669017|83220003|FG003|Overall Study|Death|3|||
46792211|NCT00275821|83010844|FG000|Overall Study|Lost to Follow-up|0|||
46792212|NCT00275821|83010845|FG001|Overall Study|Lost to Follow-up|1|||
46792213|NCT00275821|83010846|FG002|Overall Study|Lost to Follow-up|1|||
46854451|NCT00048542|83070369|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
46975080|NCT02669017|83220004|FG004|Overall Study|Death|8|||
46975081|NCT02669017|83220005|FG005|Overall Study|Death|18|||
46792214|NCT00275821|83010844|FG000|Overall Study|Death|0|||
46792215|NCT00275821|83010845|FG001|Overall Study|Death|2|||
46792216|NCT00275821|83010846|FG002|Overall Study|Death|1|||
46792217|NCT00275821|83010844|FG000|Overall Study|Lack of Efficacy|2|||
46975082|NCT02669017|83220006|FG006|Overall Study|Death|10|||
46792218|NCT00275821|83010845|FG001|Overall Study|Lack of Efficacy|1|||
46792219|NCT00275821|83010846|FG002|Overall Study|Lack of Efficacy|0|||
46792220|NCT00275821|83010844|FG000|Overall Study|Protocol Violation|5|||
46792221|NCT00275821|83010845|FG001|Overall Study|Protocol Violation|1|||
46792222|NCT00275821|83010846|FG002|Overall Study|Protocol Violation|0|||
47078265|NCT02576717|83383341|FG002|Overall Study|Other Reasons|15|||
46792223|NCT00275509|83010856|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
46792224|NCT00275509|83010857|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
46792225|NCT00252577|83010863|FG000|Overall Study|Lost to Follow-up|20|||
46792226|NCT00252499|83010870|FG000|Overall Study|Lost to Follow-up|1|||
46792227|NCT00252499|83010871|FG001|Overall Study|Lost to Follow-up|0|||
46792228|NCT00252499|83010872|FG002|Overall Study|Lost to Follow-up|0|||
46792229|NCT00252187|83010882|FG000|Overall Study|Adverse Event|3|||
46792230|NCT00252187|83010883|FG001|Overall Study|Adverse Event|1|||
46792231|NCT00252187|83010882|FG000|Overall Study|Withdrawal by Subject|1|||
46792232|NCT00252187|83010883|FG001|Overall Study|Withdrawal by Subject|0|||
46792233|NCT00572910|83010895|FG000|Overall Study|Adverse Event|1|||
46792234|NCT00572910|83010896|FG001|Overall Study|Adverse Event|2|||
46792235|NCT00572910|83010897|FG002|Overall Study|Adverse Event|0|||
46792236|NCT00572910|83010898|FG003|Overall Study|Adverse Event|2|||
46792237|NCT00572910|83010899|FG004|Overall Study|Adverse Event|0|||
46792238|NCT00572910|83010900|FG005|Overall Study|Adverse Event|0|||
46792239|NCT00572910|83010901|FG006|Overall Study|Adverse Event|4|||
46792240|NCT00572910|83010902|FG007|Overall Study|Adverse Event|2|||
46792241|NCT00572910|83010903|FG008|Overall Study|Adverse Event|1|||
46792242|NCT00572910|83010904|FG009|Overall Study|Adverse Event|3|||
46792243|NCT00572910|83010905|FG010|Overall Study|Adverse Event|2|||
46792244|NCT00572910|83010895|FG000|Overall Study|Lost to Follow-up|0|||
46792245|NCT00572910|83010896|FG001|Overall Study|Lost to Follow-up|1|||
46792246|NCT00572910|83010897|FG002|Overall Study|Lost to Follow-up|1|||
46792247|NCT00572910|83010898|FG003|Overall Study|Lost to Follow-up|2|||
46792248|NCT00572910|83010899|FG004|Overall Study|Lost to Follow-up|1|||
46792249|NCT00572910|83010900|FG005|Overall Study|Lost to Follow-up|0|||
46792250|NCT00572910|83010901|FG006|Overall Study|Lost to Follow-up|0|||
46792251|NCT00572910|83010902|FG007|Overall Study|Lost to Follow-up|0|||
46792252|NCT00572910|83010903|FG008|Overall Study|Lost to Follow-up|0|||
46792253|NCT00572910|83010904|FG009|Overall Study|Lost to Follow-up|1|||
46792254|NCT00572910|83010905|FG010|Overall Study|Lost to Follow-up|0|||
46792255|NCT00572910|83010895|FG000|Overall Study|Withdrawal by Subject|3|||
46792256|NCT00572910|83010896|FG001|Overall Study|Withdrawal by Subject|0|||
46792257|NCT00572910|83010897|FG002|Overall Study|Withdrawal by Subject|1|||
46792258|NCT00572910|83010898|FG003|Overall Study|Withdrawal by Subject|0|||
46792259|NCT00572910|83010899|FG004|Overall Study|Withdrawal by Subject|1|||
46792260|NCT00572910|83010900|FG005|Overall Study|Withdrawal by Subject|3|||
46792261|NCT00572910|83010901|FG006|Overall Study|Withdrawal by Subject|0|||
46792262|NCT00572910|83010902|FG007|Overall Study|Withdrawal by Subject|2|||
46792263|NCT00572910|83010903|FG008|Overall Study|Withdrawal by Subject|2|||
46792264|NCT00572910|83010904|FG009|Overall Study|Withdrawal by Subject|2|||
46792265|NCT00572910|83010905|FG010|Overall Study|Withdrawal by Subject|1|||
46792266|NCT00163657|83010943|FG000|Overall Study|Death|12|||
46792267|NCT00163657|83010944|FG001|Overall Study|Death|14|||
46792268|NCT00163657|83010945|FG002|Overall Study|Death|19|||
46792269|NCT00163657|83010943|FG000|Overall Study|graft loss|4|||
46792270|NCT00163657|83010944|FG001|Overall Study|graft loss|1|||
46792271|NCT00163657|83010945|FG002|Overall Study|graft loss|2|||
46792272|NCT00163657|83010943|FG000|Overall Study|Withdrawal by Subject|2|||
46792273|NCT00163657|83010944|FG001|Overall Study|Withdrawal by Subject|3|||
46792274|NCT00163657|83010945|FG002|Overall Study|Withdrawal by Subject|2|||
46854452|NCT00048542|83070370|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
46854453|NCT00048542|83070371|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
46854454|NCT00048542|83070364|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
46854455|NCT00048542|83070365|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
46854456|NCT00048542|83070366|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
46854457|NCT00048542|83070367|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
46854458|NCT00048542|83070368|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
46854459|NCT00048542|83070369|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
46854460|NCT00048542|83070370|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
47078266|NCT02576717|83383339|FG000|Overall Study|Covid-19 Pandemic|0|||
47078267|NCT02576717|83383340|FG001|Overall Study|Covid-19 Pandemic|1|||
47078268|NCT02576717|83383341|FG002|Overall Study|Covid-19 Pandemic|1|||
46792275|NCT00163657|83010943|FG000|Overall Study|Physician Decision|0|||
47078269|NCT02576717|83383339|FG000|Overall Study|Sponsor Decision|0|||
47078270|NCT02576717|83383340|FG001|Overall Study|Sponsor Decision|0|||
46792276|NCT00163657|83010944|FG001|Overall Study|Physician Decision|1|||
46792277|NCT00163657|83010945|FG002|Overall Study|Physician Decision|1|||
46854461|NCT00048542|83070371|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
46854462|NCT00048542|83070364|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
46792278|NCT00163657|83010943|FG000|Overall Study|Non Compliance|1|||
46792279|NCT00163657|83010944|FG001|Overall Study|Non Compliance|0|||
46792280|NCT00163657|83010945|FG002|Overall Study|Non Compliance|0|||
46792281|NCT00163657|83010943|FG000|Overall Study|Lost to Follow-up|1|||
46792282|NCT00163657|83010944|FG001|Overall Study|Lost to Follow-up|3|||
46792283|NCT00163657|83010945|FG002|Overall Study|Lost to Follow-up|10|||
47078271|NCT02576717|83383341|FG002|Overall Study|Sponsor Decision|1|||
46792284|NCT00163657|83010943|FG000|Overall Study|Other reason|0|||
46792285|NCT00163657|83010944|FG001|Overall Study|Other reason|1|||
46792286|NCT00163657|83010945|FG002|Overall Study|Other reason|3|||
46792287|NCT00609492|83010956|FG000|Overall Study|Withdrawal by Subject|0|||
46792288|NCT00609492|83010957|FG001|Overall Study|Withdrawal by Subject|2|||
46792289|NCT00609492|83010958|FG002|Overall Study|Withdrawal by Subject|3|||
46792290|NCT00609492|83010956|FG000|Overall Study|Lost to Follow-up|1|||
46792291|NCT00609492|83010957|FG001|Overall Study|Lost to Follow-up|1|||
46792292|NCT00609492|83010958|FG002|Overall Study|Lost to Follow-up|4|||
46792293|NCT00230971|83010970|FG000|Randomization|No study drug administered|3|||
46792294|NCT00230971|83010971|FG001|Randomization|No study drug administered|3|||
46792295|NCT00230971|83010970|FG000|Baseline Participants|Lost to Follow-up|5|||
46792296|NCT00230971|83010971|FG001|Baseline Participants|Lost to Follow-up|12|||
46792297|NCT00230971|83010970|FG000|Baseline Participants|Death|6|||
46792298|NCT00230971|83010971|FG001|Baseline Participants|Death|5|||
46792299|NCT00230971|83010970|FG000|Baseline Participants|Withdrawal by Subject|7|||
46792300|NCT00230971|83010971|FG001|Baseline Participants|Withdrawal by Subject|1|||
46792301|NCT00230971|83010970|FG000|Baseline Participants|Adverse Event|1|||
46792302|NCT00230971|83010971|FG001|Baseline Participants|Adverse Event|0|||
46792303|NCT00230971|83010970|FG000|Baseline Participants|No bacteria observed|1|||
46792304|NCT00230971|83010971|FG001|Baseline Participants|No bacteria observed|0|||
46854463|NCT00048542|83070365|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
46854464|NCT00048542|83070366|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
46854465|NCT00048542|83070367|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
46854466|NCT00048542|83070368|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
46975083|NCT02669017|83220007|FG007|Overall Study|Death|47|||
46975084|NCT02669017|83220008|FG008|Overall Study|Death|20|||
46975085|NCT02669017|83220000|FG000|Overall Study|Withdrawal by Subject|0|||
46975086|NCT02669017|83220001|FG001|Overall Study|Withdrawal by Subject|0|||
46975087|NCT02669017|83220002|FG002|Overall Study|Withdrawal by Subject|0|||
46975088|NCT02669017|83220003|FG003|Overall Study|Withdrawal by Subject|1|||
46975089|NCT02669017|83220004|FG004|Overall Study|Withdrawal by Subject|2|||
46854467|NCT00048542|83070369|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
46854468|NCT00048542|83070370|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
46854469|NCT00048542|83070371|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
46854470|NCT00048542|83070364|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
46854471|NCT00048542|83070365|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
46854472|NCT00048542|83070366|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
46854473|NCT00048542|83070367|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
46854474|NCT00048542|83070368|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
46854475|NCT00048542|83070369|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
46854476|NCT00048542|83070370|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
46854477|NCT00048542|83070371|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
46854478|NCT00048542|83070364|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
46854479|NCT00048542|83070365|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
46854480|NCT00048542|83070366|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
46854481|NCT00048542|83070367|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
46854482|NCT00048542|83070368|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
46975090|NCT02669017|83220005|FG005|Overall Study|Withdrawal by Subject|0|||
46975091|NCT02669017|83220006|FG006|Overall Study|Withdrawal by Subject|0|||
46975092|NCT02669017|83220007|FG007|Overall Study|Withdrawal by Subject|2|||
46975093|NCT02669017|83220008|FG008|Overall Study|Withdrawal by Subject|2|||
46975094|NCT02669017|83220000|FG000|Overall Study|Lost to Follow-up|0|||
46975095|NCT02669017|83220001|FG001|Overall Study|Lost to Follow-up|0|||
46975096|NCT02669017|83220002|FG002|Overall Study|Lost to Follow-up|0|||
46975097|NCT02669017|83220003|FG003|Overall Study|Lost to Follow-up|0|||
46975098|NCT02669017|83220004|FG004|Overall Study|Lost to Follow-up|0|||
46792305|NCT00230971|83010970|FG000|Baseline Participants|Failure to return|1|||
46792306|NCT00230971|83010971|FG001|Baseline Participants|Failure to return|1|||
46792307|NCT00230971|83010970|FG000|Baseline Participants|Reintervention|1|||
46792308|NCT00230971|83010971|FG001|Baseline Participants|Reintervention|0|||
46792309|NCT00211081|83010977|FG000|Overall Study|Withdrawal by Subject|2|||
46854483|NCT00048542|83070369|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
46975099|NCT02669017|83220005|FG005|Overall Study|Lost to Follow-up|0|||
47078272|NCT02576717|83383339|FG000|Overall Study|Physician Decision|3|||
47078273|NCT02576717|83383340|FG001|Overall Study|Physician Decision|8|||
46792310|NCT00609336|83010981|FG000|Overall Study|Protocol Violation|3|||
46975100|NCT02669017|83220006|FG006|Overall Study|Lost to Follow-up|0|||
46975101|NCT02669017|83220007|FG007|Overall Study|Lost to Follow-up|0|||
46975102|NCT02669017|83220008|FG008|Overall Study|Lost to Follow-up|1|||
46975103|NCT02669017|83220000|FG000|Overall Study|Miscellaneous|0|||
47078274|NCT02576717|83383341|FG002|Overall Study|Physician Decision|9|||
46792311|NCT00609336|83010981|FG000|Overall Study|Death|1|||
46792312|NCT00609336|83010981|FG000|Overall Study|LA or Met at Surgery|9|||
46792313|NCT00612066|83010986|FG000|Overall Study|Adverse Event|1|||
46792314|NCT00573144|83010992|FG000|Overall Study|Withdrawal by Subject|2|||
46792315|NCT00573144|83010993|FG001|Overall Study|Withdrawal by Subject|3|||
46792316|NCT00640328|83011005|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
46792317|NCT00640328|83011006|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
46792318|NCT00640328|83011007|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
46792319|NCT00640328|83011008|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
46792320|NCT00640328|83011009|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
46854484|NCT00048542|83070370|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
46854485|NCT00048542|83070371|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
46854486|NCT00048542|83070364|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
46854487|NCT00048542|83070365|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
46854488|NCT00048542|83070366|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
46854489|NCT00048542|83070367|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
46854490|NCT00048542|83070368|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
46854491|NCT00048542|83070369|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
46854492|NCT00048542|83070370|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
46854493|NCT00048542|83070371|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
46854494|NCT00048542|83070364|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
46854495|NCT00048542|83070365|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
46854496|NCT00048542|83070366|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
46854497|NCT00048542|83070367|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
46854498|NCT00048542|83070368|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
47078275|NCT02576717|83383339|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
47078276|NCT02576717|83383340|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
47078277|NCT02576717|83383341|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
47078278|NCT02576717|83383339|FG000|Overall Study|Death|3|||
47078279|NCT02576717|83383340|FG001|Overall Study|Death|5|||
47078280|NCT02576717|83383341|FG002|Overall Study|Death|3|||
47078281|NCT02576717|83383339|FG000|Overall Study|Lost to Follow-up|9|||
47078282|NCT02576717|83383340|FG001|Overall Study|Lost to Follow-up|10|||
47078283|NCT02576717|83383341|FG002|Overall Study|Lost to Follow-up|19|||
47078284|NCT02576717|83383339|FG000|Overall Study|Protocol Violation|4|||
47078285|NCT02576717|83383340|FG001|Overall Study|Protocol Violation|0|||
47078286|NCT02576717|83383341|FG002|Overall Study|Protocol Violation|5|||
47078287|NCT02576717|83383339|FG000|Overall Study|Lack of Efficacy|24|||
47078288|NCT02576717|83383340|FG001|Overall Study|Lack of Efficacy|28|||
46854499|NCT00048542|83070369|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
46854500|NCT00048542|83070370|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
46854501|NCT00048542|83070371|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
46854502|NCT00048542|83070364|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
46854503|NCT00048542|83070365|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
46854504|NCT00048542|83070366|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
46854505|NCT00048542|83070367|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
46854506|NCT00048542|83070368|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
46854507|NCT00048542|83070369|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
46854508|NCT00048542|83070370|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
47078289|NCT02576717|83383341|FG002|Overall Study|Lack of Efficacy|20|||
47078290|NCT02576717|83383339|FG000|Overall Study|Adverse Event|26|||
47078291|NCT02576717|83383340|FG001|Overall Study|Adverse Event|32|||
47078292|NCT02576717|83383341|FG002|Overall Study|Adverse Event|26|||
47078293|NCT02554474|83383354|FG000|Overall Study|Protocol Violation|1|||
47078294|NCT02554474|83383355|FG001|Overall Study|Protocol Violation|1|||
47078295|NCT02554474|83383354|FG000|Overall Study|Health issue not related to the study|1|||
46673914|NCT01161472|82889428|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
46854509|NCT00048542|83070371|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
46854510|NCT00048542|83070364|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
46854511|NCT00048542|83070365|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
46854512|NCT00048542|83070366|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
46854513|NCT00048542|83070367|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
46975104|NCT02669017|83220001|FG001|Overall Study|Miscellaneous|0|||
47078296|NCT02554474|83383355|FG001|Overall Study|Health issue not related to the study|0|||
47078297|NCT02554474|83383354|FG000|Overall Study|Withdrawal by Subject|1|||
47078298|NCT02554474|83383355|FG001|Overall Study|Withdrawal by Subject|1|||
47078299|NCT02517307|83383384|FG000|Overall Study|Withdrawal by Subject|1|||
47078300|NCT02517307|83383385|FG001|Overall Study|Withdrawal by Subject|0|||
47078301|NCT02517307|83383386|FG002|Overall Study|Withdrawal by Subject|1|||
46673915|NCT01161043|82889438|FG000|Overall Study|Withdrawal by Subject|3|||
46792321|NCT00640328|83011010|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
46792322|NCT00640328|83011005|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
46792323|NCT00640328|83011006|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
46792324|NCT00640328|83011007|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
46792325|NCT00640328|83011008|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
46792326|NCT00640328|83011009|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
46792327|NCT00640328|83011010|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
46792328|NCT00640328|83011005|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
46792329|NCT00640328|83011006|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
47078302|NCT02517307|83383387|FG003|Overall Study|Withdrawal by Subject|0|||
46975105|NCT02669017|83220002|FG002|Overall Study|Miscellaneous|0|||
46975106|NCT02669017|83220003|FG003|Overall Study|Miscellaneous|0|||
46975107|NCT02669017|83220004|FG004|Overall Study|Miscellaneous|2|||
46975108|NCT02669017|83220005|FG005|Overall Study|Miscellaneous|1|||
46975109|NCT02669017|83220006|FG006|Overall Study|Miscellaneous|1|||
46975110|NCT02669017|83220007|FG007|Overall Study|Miscellaneous|13|||
46975111|NCT02669017|83220008|FG008|Overall Study|Miscellaneous|2|||
46975112|NCT02668393|83220038|FG000|Overall Study|Progressive disease|6|||
46975113|NCT02668393|83220039|FG001|Overall Study|Progressive disease|3|||
46975114|NCT02668393|83220038|FG000|Overall Study|Adverse Event|0|||
46975115|NCT02668393|83220039|FG001|Overall Study|Adverse Event|2|||
46975116|NCT02668393|83220038|FG000|Overall Study|Withdrawal from the trial|0|||
46975117|NCT02668393|83220039|FG001|Overall Study|Withdrawal from the trial|1|||
46975118|NCT02668393|83220038|FG000|Overall Study|Lack of benefit and side effects|1|||
46975119|NCT02668393|83220039|FG001|Overall Study|Lack of benefit and side effects|0|||
46854514|NCT00048542|83070368|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
46854515|NCT00048542|83070369|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
46854516|NCT00048542|83070370|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
46854517|NCT00048542|83070371|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
46854518|NCT03814590|83070414|FG000|Overall Study|Adverse Event|0|||
46854519|NCT03814590|83070415|FG001|Overall Study|Adverse Event|0|||
46854520|NCT03814590|83070416|FG002|Overall Study|Adverse Event|0|||
46854521|NCT03814590|83070417|FG003|Overall Study|Adverse Event|0|||
46854522|NCT03814590|83070418|FG004|Overall Study|Adverse Event|0|||
46854523|NCT03814590|83070419|FG005|Overall Study|Adverse Event|1|||
46854524|NCT03814590|83070420|FG006|Overall Study|Adverse Event|1|||
46854525|NCT03814590|83070421|FG007|Overall Study|Adverse Event|1|||
46975120|NCT01998958|83220053|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
47078303|NCT02517307|83383384|FG000|Overall Study|Protocol Violation|0|||
47078304|NCT02517307|83383385|FG001|Overall Study|Protocol Violation|0|||
46854526|NCT03814590|83070422|FG008|Overall Study|Adverse Event|0|||
46854527|NCT03814590|83070423|FG009|Overall Study|Adverse Event|0|||
46854528|NCT03814590|83070424|FG010|Overall Study|Adverse Event|1|||
46854529|NCT03814590|83070425|FG011|Overall Study|Adverse Event|0|||
46854530|NCT03814590|83070426|FG012|Overall Study|Adverse Event|3|||
46854531|NCT03814590|83070427|FG013|Overall Study|Adverse Event|0|||
46854532|NCT03814590|83070414|FG000|Overall Study|Lost to Follow-up|0|||
46854533|NCT03814590|83070415|FG001|Overall Study|Lost to Follow-up|2|||
46854534|NCT03814590|83070416|FG002|Overall Study|Lost to Follow-up|1|||
46854535|NCT03814590|83070417|FG003|Overall Study|Lost to Follow-up|0|||
46854536|NCT03814590|83070418|FG004|Overall Study|Lost to Follow-up|1|||
46854537|NCT03814590|83070419|FG005|Overall Study|Lost to Follow-up|1|||
46854538|NCT03814590|83070420|FG006|Overall Study|Lost to Follow-up|1|||
46854539|NCT03814590|83070421|FG007|Overall Study|Lost to Follow-up|1|||
46854540|NCT03814590|83070422|FG008|Overall Study|Lost to Follow-up|0|||
46854541|NCT03814590|83070423|FG009|Overall Study|Lost to Follow-up|0|||
46854542|NCT03814590|83070424|FG010|Overall Study|Lost to Follow-up|1|||
46854543|NCT03814590|83070425|FG011|Overall Study|Lost to Follow-up|0|||
46854544|NCT03814590|83070426|FG012|Overall Study|Lost to Follow-up|0|||
46854545|NCT03814590|83070427|FG013|Overall Study|Lost to Follow-up|1|||
46854546|NCT03814590|83070414|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
47078305|NCT02517307|83383386|FG002|Overall Study|Protocol Violation|1|||
47078306|NCT02517307|83383387|FG003|Overall Study|Protocol Violation|1|||
47078307|NCT02499354|83383399|FG000|Overall Study|Withdrawal by Subject|1|||
47078308|NCT02499354|83383400|FG001|Overall Study|Withdrawal by Subject|0|||
46792330|NCT00640328|83011007|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
46854547|NCT03814590|83070415|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854548|NCT03814590|83070416|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854549|NCT03814590|83070417|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854550|NCT03814590|83070418|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46975121|NCT01998958|83220054|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
46975122|NCT01998958|83220055|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975123|NCT01998958|83220056|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975124|NCT01998958|83220057|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
47078309|NCT02362503|83383422|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
47078310|NCT02362503|83383423|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
47078311|NCT02362503|83383424|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
47078312|NCT02362503|83383422|FG000|Double-blind Period-Up to 8 Days|Death|1|||
47078313|NCT02362503|83383423|FG001|Double-blind Period-Up to 8 Days|Death|0|||
47078314|NCT02362503|83383424|FG002|Double-blind Period-Up to 8 Days|Death|0|||
47078315|NCT02362503|83383422|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
47078316|NCT02362503|83383423|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
47078317|NCT02362503|83383424|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
47078318|NCT02362503|83383422|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
47078319|NCT02362503|83383423|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
47078320|NCT02362503|83383424|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
47078321|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
47078322|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
47078323|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
47078324|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
47078325|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
47078326|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
47078327|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
47078328|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
46792331|NCT00640328|83011008|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
46792332|NCT00640328|83011009|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
46792333|NCT00640328|83011010|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
46792334|NCT00640328|83011005|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
46854551|NCT03814590|83070419|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854552|NCT03814590|83070420|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854553|NCT03814590|83070421|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854554|NCT03814590|83070422|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854555|NCT03814590|83070423|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
46854556|NCT03814590|83070424|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854557|NCT03814590|83070425|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854558|NCT03814590|83070426|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854559|NCT03814590|83070427|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
46854560|NCT03814590|83070414|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
46854561|NCT03814590|83070415|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
46854562|NCT03814590|83070416|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
46792335|NCT00640328|83011006|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
46792336|NCT00640328|83011007|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
46792337|NCT00640328|83011008|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
46854563|NCT03814590|83070417|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
47078329|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
47078330|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
46854564|NCT03814590|83070418|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
46854565|NCT03814590|83070419|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
46854566|NCT03814590|83070420|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
46854567|NCT03814590|83070421|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
46854568|NCT03814590|83070422|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
46854569|NCT03814590|83070423|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
46854570|NCT03814590|83070424|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
46792338|NCT00640328|83011009|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
46792339|NCT00640328|83011010|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
46792340|NCT00163189|83011031|FG000|Overall Study|Other|6|||
46792341|NCT00163189|83011031|FG000|Overall Study|Lost to Follow-up|1|||
46792342|NCT00163189|83011031|FG000|Overall Study|Protocol Violation|2|||
46792343|NCT00163189|83011031|FG000|Overall Study|Death|3|||
46792344|NCT00163189|83011031|FG000|Overall Study|Adverse Event|6|||
46792345|NCT00163189|83011031|FG000|Overall Study|Lack of Efficacy|7|||
46792346|NCT00163189|83011031|FG000|Overall Study|Study terminated by sponsor|11|||
46792347|NCT00163189|83011031|FG000|Overall Study|Withdrawal by Subject|11|||
46792348|NCT00163189|83011031|FG000|Overall Study|Did not meet continuation criterion|16|||
46792349|NCT00162097|83011039|FG000|Overall Study|Participant no longer met study criteria|0|||
46792350|NCT00162097|83011040|FG001|Overall Study|Participant no longer met study criteria|0|||
46792351|NCT00162097|83011041|FG002|Overall Study|Participant no longer met study criteria|0|||
46792352|NCT00162097|83011042|FG003|Overall Study|Participant no longer met study criteria|1|||
46792353|NCT00640016|83011062|FG000|Overall Study|Withdrawal by Subject|0|||
46854571|NCT03814590|83070425|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
46854572|NCT03814590|83070426|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
46854573|NCT03814590|83070427|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
46854574|NCT03814590|83070414|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46975125|NCT01998958|83220058|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975126|NCT01998958|83220059|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975127|NCT01998958|83220060|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975128|NCT01998958|83220061|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975129|NCT01998958|83220062|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975130|NCT01998958|83220063|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975131|NCT01998958|83220064|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975132|NCT01998958|83220065|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975133|NCT01998958|83220066|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975134|NCT01998958|83220067|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975135|NCT01998958|83220068|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975136|NCT01998958|83220069|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975137|NCT01998958|83220070|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975138|NCT01998958|83220071|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975139|NCT01998958|83220072|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975140|NCT01998958|83220073|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975141|NCT01998958|83220074|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975142|NCT01998958|83220075|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975143|NCT01998958|83220076|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975144|NCT01998958|83220077|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975145|NCT01998958|83220078|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975146|NCT01998958|83220079|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975147|NCT01998958|83220080|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975148|NCT01998958|83220081|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975149|NCT01998958|83220082|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975150|NCT01998958|83220083|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975151|NCT01998958|83220084|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
46975152|NCT01998958|83220053|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
47078331|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
47078332|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
47078333|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
47078334|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
47078335|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
47078336|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
46975153|NCT01998958|83220054|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
47078337|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
47078338|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
46792354|NCT00640016|83011063|FG001|Overall Study|Withdrawal by Subject|1|||
47078339|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
46792355|NCT00640016|83011064|FG002|Overall Study|Withdrawal by Subject|0|||
46975154|NCT01998958|83220055|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46792356|NCT00640016|83011065|FG003|Overall Study|Withdrawal by Subject|0|||
46792357|NCT00640016|83011062|FG000|Overall Study|Study termination|2|||
46792358|NCT00640016|83011063|FG001|Overall Study|Study termination|1|||
46792359|NCT00640016|83011064|FG002|Overall Study|Study termination|3|||
46792360|NCT00640016|83011065|FG003|Overall Study|Study termination|2|||
46792361|NCT00640016|83011062|FG000|Overall Study|Adverse Event|0|||
46792362|NCT00640016|83011063|FG001|Overall Study|Adverse Event|0|||
46792363|NCT00640016|83011064|FG002|Overall Study|Adverse Event|0|||
46792364|NCT00640016|83011065|FG003|Overall Study|Adverse Event|1|||
46792365|NCT00608868|83011082|FG000|Overall Study|Withdrawal by Subject|7|||
46792366|NCT00608868|83011082|FG000|Overall Study|Protocol Violation|3|||
46792367|NCT00608868|83011082|FG000|Overall Study|Lost to Follow-up|2|||
46792368|NCT00608868|83011082|FG000|Overall Study|Adverse Event|1|||
46792369|NCT00608868|83011082|FG000|Overall Study|Physician Decision|2|||
46792370|NCT00608322|83011088|FG000|Overall Study|Death|2|||
46792371|NCT00608322|83011089|FG001|Overall Study|Death|1|||
46792372|NCT00608244|83011095|FG000|Overall Study|Adverse Event|1|||
46792373|NCT00608244|83011095|FG000|Overall Study|Low trough levels|1|||
46792374|NCT00605280|83011105|FG000|Year 1|Protocol Violation|0|||
46792375|NCT00605280|83011106|FG001|Year 1|Protocol Violation|0|||
46792376|NCT00605280|83011107|FG002|Year 1|Protocol Violation|0|||
46792377|NCT00605280|83011108|FG003|Year 1|Protocol Violation|1|||
46792378|NCT00605280|83011105|FG000|Year 1|Adverse Event|3|||
46792379|NCT00605280|83011106|FG001|Year 1|Adverse Event|1|||
46792380|NCT00605280|83011107|FG002|Year 1|Adverse Event|1|||
46792381|NCT00605280|83011108|FG003|Year 1|Adverse Event|5|||
46792382|NCT00605280|83011105|FG000|Year 1|Physician Decision|7|||
46792383|NCT00605280|83011106|FG001|Year 1|Physician Decision|4|||
46792384|NCT00605280|83011107|FG002|Year 1|Physician Decision|0|||
46792385|NCT00605280|83011108|FG003|Year 1|Physician Decision|6|||
46792386|NCT00605280|83011105|FG000|Year 1|Withdrawal by Subject|2|||
46792387|NCT00605280|83011106|FG001|Year 1|Withdrawal by Subject|4|||
46792388|NCT00605280|83011107|FG002|Year 1|Withdrawal by Subject|0|||
46792389|NCT00605280|83011108|FG003|Year 1|Withdrawal by Subject|4|||
46792390|NCT00605280|83011105|FG000|Year 1|Other|2|||
46792391|NCT00605280|83011106|FG001|Year 1|Other|1|||
46792392|NCT00605280|83011107|FG002|Year 1|Other|0|||
46792393|NCT00605280|83011108|FG003|Year 1|Other|1|||
46792394|NCT00605280|83011105|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
46792395|NCT00605280|83011106|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
46792396|NCT00605280|83011107|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
46792397|NCT00605280|83011108|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
46792398|NCT00605280|83011105|FG000|Year 2|Adverse Event|4|||
46792399|NCT00605280|83011106|FG001|Year 2|Adverse Event|0|||
46792400|NCT00605280|83011107|FG002|Year 2|Adverse Event|2|||
46792401|NCT00605280|83011108|FG003|Year 2|Adverse Event|4|||
46792402|NCT00605280|83011105|FG000|Year 2|Physician Decision|11|||
46792403|NCT00605280|83011106|FG001|Year 2|Physician Decision|6|||
46792404|NCT00605280|83011107|FG002|Year 2|Physician Decision|4|||
46792405|NCT00605280|83011108|FG003|Year 2|Physician Decision|11|||
46792406|NCT00605280|83011105|FG000|Year 2|Withdrawal by Subject|4|||
46792407|NCT00605280|83011106|FG001|Year 2|Withdrawal by Subject|0|||
46792408|NCT00605280|83011107|FG002|Year 2|Withdrawal by Subject|0|||
46792409|NCT00605280|83011108|FG003|Year 2|Withdrawal by Subject|4|||
46792410|NCT00605280|83011105|FG000|Year 2|Other|1|||
46792411|NCT00605280|83011106|FG001|Year 2|Other|0|||
46792412|NCT00605280|83011107|FG002|Year 2|Other|0|||
46792413|NCT00605280|83011108|FG003|Year 2|Other|1|||
46792414|NCT00605280|83011105|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
46975155|NCT01998958|83220056|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975156|NCT01998958|83220057|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46792415|NCT00605280|83011106|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
46792416|NCT00605280|83011107|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
46792417|NCT00605280|83011108|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
46792418|NCT00605280|83011105|FG000|Year 3 Extension|Adverse Event|2|||
46792419|NCT00605280|83011106|FG001|Year 3 Extension|Adverse Event|0|||
46792420|NCT00605280|83011107|FG002|Year 3 Extension|Adverse Event|0|||
46792421|NCT00605280|83011108|FG003|Year 3 Extension|Adverse Event|2|||
46792422|NCT00605280|83011105|FG000|Year 3 Extension|Physician Decision|0|||
46792423|NCT00605280|83011106|FG001|Year 3 Extension|Physician Decision|0|||
46792424|NCT00605280|83011107|FG002|Year 3 Extension|Physician Decision|0|||
46792425|NCT00605280|83011108|FG003|Year 3 Extension|Physician Decision|2|||
46792426|NCT00605280|83011105|FG000|Year 3 Extension|Withdrawal by Subject|2|||
46792427|NCT00605280|83011106|FG001|Year 3 Extension|Withdrawal by Subject|0|||
46792428|NCT00605280|83011107|FG002|Year 3 Extension|Withdrawal by Subject|0|||
46792429|NCT00605280|83011108|FG003|Year 3 Extension|Withdrawal by Subject|5|||
46792430|NCT00605280|83011105|FG000|Year 3 Extension|Other|2|||
46792431|NCT00605280|83011106|FG001|Year 3 Extension|Other|0|||
46792432|NCT00605280|83011107|FG002|Year 3 Extension|Other|0|||
46792433|NCT00605280|83011108|FG003|Year 3 Extension|Other|0|||
46792434|NCT00605280|83011105|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
46792435|NCT00605280|83011106|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
46792436|NCT00605280|83011107|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
46792437|NCT00605280|83011108|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
46792438|NCT00607386|83011118|FG000|Overall Study|Physician Decision|1|||
46792439|NCT00638690|83011124|FG000|Overall Study|Death|655|||
46854575|NCT03814590|83070415|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46792440|NCT00638690|83011125|FG001|Overall Study|Death|335|||
46792441|NCT00638690|83011124|FG000|Overall Study|Withdrawal by Subject|22|||
46792442|NCT00638690|83011125|FG001|Overall Study|Withdrawal by Subject|5|||
46792443|NCT00638690|83011124|FG000|Overall Study|Lost to Follow-up|4|||
46854576|NCT03814590|83070416|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854577|NCT03814590|83070417|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854578|NCT03814590|83070418|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854579|NCT03814590|83070419|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854580|NCT03814590|83070420|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854581|NCT03814590|83070421|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46792444|NCT00638690|83011125|FG001|Overall Study|Lost to Follow-up|2|||
46792445|NCT00543387|83011141|FG000|Panel 1 + Panel 2|Adverse Event|0|||
46792446|NCT00543387|83011142|FG001|Panel 1 + Panel 2|Adverse Event|1|||
46792447|NCT00543387|83011143|FG002|Panel 1 + Panel 2|Adverse Event|0|||
46792448|NCT00543387|83011144|FG003|Panel 1 + Panel 2|Adverse Event|0|||
46792449|NCT00543387|83011145|FG004|Panel 1 + Panel 2|Adverse Event|0|||
46792450|NCT00543387|83011146|FG005|Panel 1 + Panel 2|Adverse Event|0|||
46792451|NCT00543387|83011147|FG006|Panel 1 + Panel 2|Adverse Event|0|||
46792452|NCT00543387|83011148|FG007|Panel 1 + Panel 2|Adverse Event|1|||
46792453|NCT00543387|83011149|FG008|Panel 1 + Panel 2|Adverse Event|1|||
46792454|NCT00543387|83011150|FG009|Panel 1 + Panel 2|Adverse Event|0|||
46792455|NCT00543387|83011151|FG010|Panel 1 + Panel 2|Adverse Event|0|||
46792456|NCT00543387|83011141|FG000|Panel 1 + Panel 2|Physician Decision|0|||
46792457|NCT00543387|83011142|FG001|Panel 1 + Panel 2|Physician Decision|0|||
46854582|NCT03814590|83070422|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854583|NCT03814590|83070423|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
46854584|NCT03814590|83070424|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854585|NCT03814590|83070425|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854586|NCT03814590|83070426|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854587|NCT03814590|83070427|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46854588|NCT03814590|83070414|FG000|Overall Study|UNKNOWN REASON|0|||
46854589|NCT03814590|83070415|FG001|Overall Study|UNKNOWN REASON|0|||
46854590|NCT03814590|83070416|FG002|Overall Study|UNKNOWN REASON|0|||
46854591|NCT03814590|83070417|FG003|Overall Study|UNKNOWN REASON|0|||
46975157|NCT01998958|83220058|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975158|NCT01998958|83220059|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975159|NCT01998958|83220060|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975160|NCT01998958|83220061|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975161|NCT01998958|83220062|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975162|NCT01998958|83220063|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975163|NCT01998958|83220064|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975164|NCT01998958|83220065|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975165|NCT01998958|83220066|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975166|NCT01998958|83220067|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975167|NCT01998958|83220068|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975168|NCT01998958|83220069|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975169|NCT01998958|83220070|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975170|NCT01998958|83220071|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
47078340|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
46854592|NCT03814590|83070418|FG004|Overall Study|UNKNOWN REASON|0|||
46975171|NCT01998958|83220072|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975172|NCT01998958|83220073|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975173|NCT01998958|83220074|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975174|NCT01998958|83220075|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975175|NCT01998958|83220076|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46792458|NCT00543387|83011143|FG002|Panel 1 + Panel 2|Physician Decision|1|||
46792459|NCT00543387|83011144|FG003|Panel 1 + Panel 2|Physician Decision|0|||
46792460|NCT00543387|83011145|FG004|Panel 1 + Panel 2|Physician Decision|0|||
46792461|NCT00543387|83011146|FG005|Panel 1 + Panel 2|Physician Decision|0|||
46792462|NCT00543387|83011147|FG006|Panel 1 + Panel 2|Physician Decision|0|||
46792463|NCT00543387|83011148|FG007|Panel 1 + Panel 2|Physician Decision|1|||
46792464|NCT00543387|83011149|FG008|Panel 1 + Panel 2|Physician Decision|0|||
46792465|NCT00543387|83011150|FG009|Panel 1 + Panel 2|Physician Decision|0|||
46792466|NCT00543387|83011151|FG010|Panel 1 + Panel 2|Physician Decision|0|||
46792467|NCT00543387|83011141|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
46792468|NCT00543387|83011142|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
46854593|NCT03814590|83070419|FG005|Overall Study|UNKNOWN REASON|0|||
46975176|NCT01998958|83220077|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975177|NCT01998958|83220078|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975178|NCT01998958|83220079|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975179|NCT01998958|83220080|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975180|NCT01998958|83220081|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975181|NCT01998958|83220082|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975182|NCT01998958|83220083|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975183|NCT01998958|83220084|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
46975184|NCT01998958|83220053|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
46975185|NCT01998958|83220054|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
46975186|NCT01998958|83220055|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
46975187|NCT01998958|83220056|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
46975188|NCT01998958|83220057|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
46975189|NCT01998958|83220058|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
46975190|NCT01998958|83220059|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
46975191|NCT01998958|83220060|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
46975192|NCT01998958|83220061|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
46975193|NCT01998958|83220062|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
47078341|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
47078342|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
47078343|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
47078344|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
47078345|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
47078346|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
47078347|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
47078348|NCT02362503|83383422|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
47078349|NCT02362503|83383423|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
47078350|NCT02362503|83383424|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
47078351|NCT02224924|83383437|FG000|Overall Study|Withdrawal by Subject|7|||
47078352|NCT02224924|83383438|FG001|Overall Study|Withdrawal by Subject|6|||
47078353|NCT02224924|83383437|FG000|Overall Study|Biopsy cancelled|20|||
47078354|NCT02224924|83383438|FG001|Overall Study|Biopsy cancelled|14|||
47078355|NCT02224924|83383437|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
47078356|NCT02224924|83383438|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
46792469|NCT00543387|83011143|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
46792470|NCT00543387|83011144|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
46792471|NCT00543387|83011145|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
46792472|NCT00543387|83011146|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
46792473|NCT00543387|83011147|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
46792474|NCT00543387|83011148|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
46792475|NCT00543387|83011149|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
46792476|NCT00543387|83011150|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
46792477|NCT00543387|83011151|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
46792478|NCT00543387|83011141|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46854594|NCT03814590|83070420|FG006|Overall Study|UNKNOWN REASON|0|||
46854595|NCT03814590|83070421|FG007|Overall Study|UNKNOWN REASON|1|||
46854596|NCT03814590|83070422|FG008|Overall Study|UNKNOWN REASON|0|||
46854597|NCT03814590|83070423|FG009|Overall Study|UNKNOWN REASON|0|||
46854598|NCT03814590|83070424|FG010|Overall Study|UNKNOWN REASON|0|||
46854599|NCT03814590|83070425|FG011|Overall Study|UNKNOWN REASON|0|||
46854600|NCT03814590|83070426|FG012|Overall Study|UNKNOWN REASON|0|||
46854601|NCT03814590|83070427|FG013|Overall Study|UNKNOWN REASON|0|||
46854602|NCT00048074|83070470|FG000|Overall Study|Adverse Event|46|||
46854603|NCT00048074|83070471|FG001|Overall Study|Adverse Event|41|||
46854604|NCT00048074|83070472|FG002|Overall Study|Adverse Event|53|||
46854605|NCT00048074|83070470|FG000|Overall Study|Death|3|||
46854606|NCT00048074|83070471|FG001|Overall Study|Death|3|||
46854607|NCT00048074|83070472|FG002|Overall Study|Death|2|||
46975194|NCT01998958|83220063|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
46975195|NCT01998958|83220064|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
46975196|NCT01998958|83220065|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
46975197|NCT01998958|83220066|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
47078357|NCT02224924|83383437|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
47078358|NCT02224924|83383438|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
47078359|NCT02152956|83383457|FG000|Overall Study|Adverse Event|0|||
47078360|NCT02152956|83383458|FG001|Overall Study|Adverse Event|0|||
47078361|NCT02152956|83383459|FG002|Overall Study|Adverse Event|0|||
47078362|NCT02152956|83383460|FG003|Overall Study|Adverse Event|0|||
47078363|NCT02152956|83383461|FG004|Overall Study|Adverse Event|0|||
47078364|NCT02152956|83383462|FG005|Overall Study|Adverse Event|0|||
46673916|NCT01160770|82889442|FG000|Overall Study|Adverse Event|10|||
46673917|NCT01160770|82889442|FG000|Overall Study|Protocol Violation|2|||
46792479|NCT00543387|83011142|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792480|NCT00543387|83011143|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792481|NCT00543387|83011144|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792482|NCT00543387|83011145|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792483|NCT00543387|83011146|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792484|NCT00543387|83011147|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
46792485|NCT00543387|83011148|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792486|NCT00543387|83011149|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792487|NCT00543387|83011150|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792488|NCT00543387|83011151|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
46792489|NCT00543387|83011141|FG000|Crossover Participants|Progressive Disease|0|||
46792490|NCT00543387|83011142|FG001|Crossover Participants|Progressive Disease|0|||
46854608|NCT00048074|83070470|FG000|Overall Study|Lost to Follow-up|2|||
46854609|NCT00048074|83070471|FG001|Overall Study|Lost to Follow-up|6|||
46854610|NCT00048074|83070472|FG002|Overall Study|Lost to Follow-up|6|||
46854611|NCT00048074|83070470|FG000|Overall Study|Withdrawal by Subject|28|||
46854612|NCT00048074|83070471|FG001|Overall Study|Withdrawal by Subject|30|||
46975198|NCT01998958|83220067|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
46975199|NCT01998958|83220068|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
46975200|NCT01998958|83220069|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
46975201|NCT01998958|83220070|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
46975202|NCT01998958|83220071|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
46975203|NCT01998958|83220072|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
46975204|NCT01998958|83220073|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
46975205|NCT01998958|83220074|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
46975206|NCT01998958|83220075|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
46975207|NCT01998958|83220076|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
46975208|NCT01998958|83220077|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
46975209|NCT01998958|83220078|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
46673918|NCT01160770|82889442|FG000|Overall Study|Subject/parent/caregiver request|33|||
46854613|NCT00048074|83070472|FG002|Overall Study|Withdrawal by Subject|35|||
46854614|NCT00048074|83070470|FG000|Overall Study|Protocol Violation|1|||
46854615|NCT00048074|83070471|FG001|Overall Study|Protocol Violation|3|||
46854616|NCT00048074|83070472|FG002|Overall Study|Protocol Violation|0|||
46854617|NCT00048074|83070470|FG000|Overall Study|Study participation was terminated|0|||
46854618|NCT00048074|83070471|FG001|Overall Study|Study participation was terminated|1|||
46854619|NCT00048074|83070472|FG002|Overall Study|Study participation was terminated|0|||
46854620|NCT00048074|83070470|FG000|Overall Study|Husband ill|0|||
46854621|NCT00048074|83070471|FG001|Overall Study|Husband ill|1|||
46854622|NCT00048074|83070472|FG002|Overall Study|Husband ill|0|||
46854623|NCT00048074|83070470|FG000|Overall Study|Poor compliance|0|||
46854624|NCT00048074|83070471|FG001|Overall Study|Poor compliance|1|||
46854625|NCT00048074|83070472|FG002|Overall Study|Poor compliance|0|||
46854626|NCT00048074|83070470|FG000|Overall Study|Out of station|0|||
46854627|NCT00048074|83070471|FG001|Overall Study|Out of station|1|||
46854628|NCT00048074|83070472|FG002|Overall Study|Out of station|1|||
46854629|NCT00048074|83070470|FG000|Overall Study|Social reasons|1|||
46854630|NCT00048074|83070471|FG001|Overall Study|Social reasons|0|||
46854631|NCT00048074|83070472|FG002|Overall Study|Social reasons|0|||
46854632|NCT03831191|83070484|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
46854633|NCT03831191|83070485|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
46854634|NCT03831191|83070486|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
46854635|NCT03831191|83070487|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
46854636|NCT03831191|83070488|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
46854637|NCT03831191|83070489|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
46854638|NCT03831191|83070490|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
46854639|NCT03831191|83070491|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
46854640|NCT03831191|83070492|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
46854641|NCT03831191|83070493|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
46854642|NCT03831191|83070494|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
46854643|NCT03831191|83070495|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
46854644|NCT03831191|83070496|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
46854645|NCT03831191|83070497|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
46854646|NCT03831191|83070498|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
46854647|NCT03831191|83070484|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
46854648|NCT03831191|83070485|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
46854649|NCT03831191|83070486|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854650|NCT03831191|83070487|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46975210|NCT01998958|83220079|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
46975211|NCT01998958|83220080|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
46854651|NCT03831191|83070488|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46975212|NCT01998958|83220081|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
46673919|NCT01160770|82889442|FG000|Overall Study|Physician Decision|1|||
46673920|NCT01160770|82889442|FG000|Overall Study|Lost to Follow-up|7|||
46792491|NCT00543387|83011143|FG002|Crossover Participants|Progressive Disease|0|||
46792492|NCT00543387|83011144|FG003|Crossover Participants|Progressive Disease|0|||
46792493|NCT00543387|83011145|FG004|Crossover Participants|Progressive Disease|0|||
46792494|NCT00543387|83011146|FG005|Crossover Participants|Progressive Disease|0|||
46792495|NCT00543387|83011147|FG006|Crossover Participants|Progressive Disease|0|||
46792496|NCT00543387|83011148|FG007|Crossover Participants|Progressive Disease|0|||
46792497|NCT00543387|83011149|FG008|Crossover Participants|Progressive Disease|0|||
46792498|NCT00543387|83011150|FG009|Crossover Participants|Progressive Disease|1|||
46792499|NCT00543387|83011151|FG010|Crossover Participants|Progressive Disease|2|||
46792500|NCT00543387|83011141|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
46792501|NCT00543387|83011142|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
46792502|NCT00543387|83011143|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
46792503|NCT00543387|83011144|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
46792504|NCT00543387|83011145|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
46792505|NCT00543387|83011146|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
46792506|NCT00543387|83011147|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
46792507|NCT00543387|83011148|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
46792508|NCT00543387|83011149|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
46792509|NCT00543387|83011150|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
46792510|NCT00543387|83011151|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
46792511|NCT00635570|83011181|FG000|Overall Study|Lost to Follow-up|8|||
46792512|NCT00635570|83011182|FG001|Overall Study|Lost to Follow-up|8|||
46792513|NCT00635570|83011181|FG000|Overall Study|Withdrawal by Subject|1|||
46854652|NCT03831191|83070489|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854653|NCT03831191|83070490|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854654|NCT03831191|83070491|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854655|NCT03831191|83070492|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854656|NCT03831191|83070493|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854657|NCT03831191|83070494|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854658|NCT03831191|83070495|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854659|NCT03831191|83070496|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854660|NCT03831191|83070497|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854661|NCT03831191|83070498|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
46854662|NCT03831191|83070484|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
46854663|NCT03831191|83070485|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
46854664|NCT03831191|83070486|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
46854665|NCT03831191|83070487|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
46854666|NCT03831191|83070488|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
46854667|NCT03831191|83070489|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
46854668|NCT03831191|83070490|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
46854669|NCT03831191|83070491|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
47078365|NCT02152956|83383463|FG006|Overall Study|Adverse Event|0|||
47078366|NCT02152956|83383464|FG007|Overall Study|Adverse Event|0|||
47078367|NCT02152956|83383465|FG008|Overall Study|Adverse Event|0|||
47078368|NCT02152956|83383466|FG009|Overall Study|Adverse Event|0|||
47078369|NCT02152956|83383467|FG010|Overall Study|Adverse Event|0|||
47078370|NCT02152956|83383468|FG011|Overall Study|Adverse Event|4|||
47078371|NCT02152956|83383469|FG012|Overall Study|Adverse Event|0|||
47078372|NCT02152956|83383457|FG000|Overall Study|Death|0|||
47078373|NCT02152956|83383458|FG001|Overall Study|Death|3|||
47078374|NCT02152956|83383459|FG002|Overall Study|Death|3|||
47078375|NCT02152956|83383460|FG003|Overall Study|Death|4|||
47078376|NCT02152956|83383461|FG004|Overall Study|Death|1|||
47078377|NCT02152956|83383462|FG005|Overall Study|Death|2|||
47078378|NCT02152956|83383463|FG006|Overall Study|Death|6|||
47078379|NCT02152956|83383464|FG007|Overall Study|Death|6|||
46792514|NCT00635570|83011182|FG001|Overall Study|Withdrawal by Subject|1|||
46792515|NCT00635570|83011181|FG000|Overall Study|Adverse Event|2|||
46854670|NCT03831191|83070492|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
46854671|NCT03831191|83070493|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
46854672|NCT03831191|83070494|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
46854673|NCT03831191|83070495|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
46854674|NCT03831191|83070496|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
46854675|NCT03831191|83070497|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
46854676|NCT03831191|83070498|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
47078380|NCT02152956|83383465|FG008|Overall Study|Death|4|||
47078381|NCT02152956|83383466|FG009|Overall Study|Death|5|||
47078382|NCT02152956|83383467|FG010|Overall Study|Death|3|||
47078383|NCT02152956|83383468|FG011|Overall Study|Death|143|||
47078384|NCT02152956|83383469|FG012|Overall Study|Death|12|||
47078385|NCT02152956|83383457|FG000|Overall Study|Lost to Follow-up|0|||
47078386|NCT02152956|83383458|FG001|Overall Study|Lost to Follow-up|1|||
47078387|NCT02152956|83383459|FG002|Overall Study|Lost to Follow-up|0|||
47078388|NCT02152956|83383460|FG003|Overall Study|Lost to Follow-up|0|||
46792516|NCT00635570|83011182|FG001|Overall Study|Adverse Event|0|||
46792517|NCT00635570|83011181|FG000|Overall Study|Physician Decision|1|||
46792518|NCT00635570|83011182|FG001|Overall Study|Physician Decision|0|||
46792519|NCT00635570|83011181|FG000|Overall Study|Did not complete survey|2|||
46792520|NCT00635570|83011182|FG001|Overall Study|Did not complete survey|1|||
46792521|NCT00635570|83011181|FG000|Overall Study|Early termination(No sexual activity)|1|||
46975213|NCT01998958|83220082|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
46975214|NCT01998958|83220083|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
46975215|NCT01998958|83220084|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
46975216|NCT01998958|83220053|FG000|Period 1 (Panel A and B)|Other|1|||
46975217|NCT01998958|83220054|FG001|Period 1 (Panel A and B)|Other|0|||
46975218|NCT01998958|83220055|FG002|Period 1 (Panel A and B)|Other|0|||
46975219|NCT01998958|83220056|FG003|Period 1 (Panel A and B)|Other|0|||
46975220|NCT01998958|83220057|FG004|Period 1 (Panel A and B)|Other|0|||
46975221|NCT01998958|83220058|FG005|Period 1 (Panel A and B)|Other|0|||
46975222|NCT01998958|83220059|FG006|Period 1 (Panel A and B)|Other|0|||
46975223|NCT01998958|83220060|FG007|Period 1 (Panel A and B)|Other|0|||
46975224|NCT01998958|83220061|FG008|Period 1 (Panel A and B)|Other|0|||
46975225|NCT01998958|83220062|FG009|Period 1 (Panel A and B)|Other|0|||
46975226|NCT01998958|83220063|FG010|Period 1 (Panel A and B)|Other|0|||
46975227|NCT01998958|83220064|FG011|Period 1 (Panel A and B)|Other|0|||
46975228|NCT01998958|83220065|FG012|Period 1 (Panel A and B)|Other|0|||
46975229|NCT01998958|83220066|FG013|Period 1 (Panel A and B)|Other|0|||
46975230|NCT01998958|83220067|FG014|Period 1 (Panel A and B)|Other|0|||
46975231|NCT01998958|83220068|FG015|Period 1 (Panel A and B)|Other|0|||
46975232|NCT01998958|83220069|FG016|Period 1 (Panel A and B)|Other|0|||
46975233|NCT01998958|83220070|FG017|Period 1 (Panel A and B)|Other|0|||
46975234|NCT01998958|83220071|FG018|Period 1 (Panel A and B)|Other|0|||
46975235|NCT01998958|83220072|FG019|Period 1 (Panel A and B)|Other|0|||
46975236|NCT01998958|83220073|FG020|Period 1 (Panel A and B)|Other|0|||
46975237|NCT01998958|83220074|FG021|Period 1 (Panel A and B)|Other|0|||
46975238|NCT01998958|83220075|FG022|Period 1 (Panel A and B)|Other|0|||
46975239|NCT01998958|83220076|FG023|Period 1 (Panel A and B)|Other|0|||
46975240|NCT01998958|83220077|FG024|Period 1 (Panel A and B)|Other|0|||
46975241|NCT01998958|83220078|FG025|Period 1 (Panel A and B)|Other|0|||
46975242|NCT01998958|83220079|FG026|Period 1 (Panel A and B)|Other|0|||
46975243|NCT01998958|83220080|FG027|Period 1 (Panel A and B)|Other|0|||
46975244|NCT01998958|83220081|FG028|Period 1 (Panel A and B)|Other|0|||
46975245|NCT01998958|83220082|FG029|Period 1 (Panel A and B)|Other|0|||
46975246|NCT01998958|83220083|FG030|Period 1 (Panel A and B)|Other|0|||
46975247|NCT01998958|83220084|FG031|Period 1 (Panel A and B)|Other|0|||
46975248|NCT01998958|83220053|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
46975249|NCT01998958|83220054|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
46975250|NCT01998958|83220055|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
46975251|NCT01998958|83220056|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
46975252|NCT01998958|83220057|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
46975253|NCT01998958|83220058|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
46975254|NCT01998958|83220059|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
46975255|NCT01998958|83220060|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
46975256|NCT01998958|83220061|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
46975257|NCT01998958|83220062|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
46975258|NCT01998958|83220063|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
46975259|NCT01998958|83220064|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
47078389|NCT02152956|83383461|FG004|Overall Study|Lost to Follow-up|0|||
47078390|NCT02152956|83383462|FG005|Overall Study|Lost to Follow-up|0|||
47078391|NCT02152956|83383463|FG006|Overall Study|Lost to Follow-up|0|||
47078392|NCT02152956|83383464|FG007|Overall Study|Lost to Follow-up|0|||
47078393|NCT02152956|83383465|FG008|Overall Study|Lost to Follow-up|0|||
47078394|NCT02152956|83383466|FG009|Overall Study|Lost to Follow-up|0|||
46975260|NCT01998958|83220065|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
46975261|NCT01998958|83220066|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
46975262|NCT01998958|83220067|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
46975263|NCT01998958|83220068|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
46975264|NCT01998958|83220069|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
47078395|NCT02152956|83383467|FG010|Overall Study|Lost to Follow-up|0|||
46792522|NCT00635570|83011182|FG001|Overall Study|Early termination(No sexual activity)|1|||
46975265|NCT01998958|83220070|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
46975266|NCT01998958|83220071|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
46975267|NCT01998958|83220072|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
46975268|NCT01998958|83220073|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
46975269|NCT01998958|83220074|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
46792523|NCT00635492|83011190|FG000|Overall Study|Death|12|||
46792524|NCT00635492|83011191|FG001|Overall Study|Death|40|||
46792525|NCT00635492|83011190|FG000|Overall Study|Lost to Follow-up|151|||
46975270|NCT01998958|83220075|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
46975271|NCT01998958|83220076|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
46975272|NCT01998958|83220077|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
47078396|NCT02152956|83383468|FG011|Overall Study|Lost to Follow-up|3|||
46854677|NCT03831191|83070484|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
46854678|NCT03831191|83070485|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
46854679|NCT03831191|83070486|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
46854680|NCT03831191|83070487|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
46854681|NCT03831191|83070488|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
46854682|NCT03831191|83070489|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
46854683|NCT03831191|83070490|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
46854684|NCT03831191|83070491|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
46854685|NCT03831191|83070492|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
46854686|NCT03831191|83070493|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
46854687|NCT03831191|83070494|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
46854688|NCT03831191|83070495|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
46854689|NCT03831191|83070496|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
46854690|NCT03831191|83070497|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
46854691|NCT03831191|83070498|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
46975273|NCT01998958|83220078|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
46975274|NCT01998958|83220079|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
46975275|NCT01998958|83220080|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
47078397|NCT02152956|83383469|FG012|Overall Study|Lost to Follow-up|0|||
47078398|NCT02152956|83383457|FG000|Overall Study|Withdrawal by Subject|1|||
47078399|NCT02152956|83383458|FG001|Overall Study|Withdrawal by Subject|0|||
47078400|NCT02152956|83383459|FG002|Overall Study|Withdrawal by Subject|1|||
47078401|NCT02152956|83383460|FG003|Overall Study|Withdrawal by Subject|0|||
47078402|NCT02152956|83383461|FG004|Overall Study|Withdrawal by Subject|2|||
47078403|NCT02152956|83383462|FG005|Overall Study|Withdrawal by Subject|2|||
47078404|NCT02152956|83383463|FG006|Overall Study|Withdrawal by Subject|0|||
47078405|NCT02152956|83383464|FG007|Overall Study|Withdrawal by Subject|0|||
47078406|NCT02152956|83383465|FG008|Overall Study|Withdrawal by Subject|1|||
47078407|NCT02152956|83383466|FG009|Overall Study|Withdrawal by Subject|0|||
47078408|NCT02152956|83383467|FG010|Overall Study|Withdrawal by Subject|0|||
47078409|NCT02152956|83383468|FG011|Overall Study|Withdrawal by Subject|4|||
47078410|NCT02152956|83383469|FG012|Overall Study|Withdrawal by Subject|0|||
47078411|NCT02152956|83383457|FG000|Overall Study|Physician Decision|0|||
47078412|NCT02152956|83383458|FG001|Overall Study|Physician Decision|0|||
47078413|NCT02152956|83383459|FG002|Overall Study|Physician Decision|0|||
47078414|NCT02152956|83383460|FG003|Overall Study|Physician Decision|0|||
47078415|NCT02152956|83383461|FG004|Overall Study|Physician Decision|0|||
47078416|NCT02152956|83383462|FG005|Overall Study|Physician Decision|0|||
47078417|NCT02152956|83383463|FG006|Overall Study|Physician Decision|0|||
47078418|NCT02152956|83383464|FG007|Overall Study|Physician Decision|0|||
47078419|NCT02152956|83383465|FG008|Overall Study|Physician Decision|0|||
47078420|NCT02152956|83383466|FG009|Overall Study|Physician Decision|0|||
47078421|NCT02152956|83383467|FG010|Overall Study|Physician Decision|0|||
47078422|NCT02152956|83383468|FG011|Overall Study|Physician Decision|1|||
47078423|NCT02152956|83383469|FG012|Overall Study|Physician Decision|0|||
47078424|NCT02152956|83383457|FG000|Overall Study|Study terminated by sponsor|0|||
47078425|NCT02152956|83383458|FG001|Overall Study|Study terminated by sponsor|0|||
47078426|NCT02152956|83383459|FG002|Overall Study|Study terminated by sponsor|0|||
47078427|NCT02152956|83383460|FG003|Overall Study|Study terminated by sponsor|0|||
47078428|NCT02152956|83383461|FG004|Overall Study|Study terminated by sponsor|0|||
47078429|NCT02152956|83383462|FG005|Overall Study|Study terminated by sponsor|0|||
47078430|NCT02152956|83383463|FG006|Overall Study|Study terminated by sponsor|0|||
47078431|NCT02152956|83383464|FG007|Overall Study|Study terminated by sponsor|0|||
47078432|NCT02152956|83383465|FG008|Overall Study|Study terminated by sponsor|0|||
47078433|NCT02152956|83383466|FG009|Overall Study|Study terminated by sponsor|0|||
47078434|NCT02152956|83383467|FG010|Overall Study|Study terminated by sponsor|0|||
47078435|NCT02152956|83383468|FG011|Overall Study|Study terminated by sponsor|29|||
47078436|NCT02152956|83383469|FG012|Overall Study|Study terminated by sponsor|0|||
47078437|NCT02152956|83383457|FG000|Overall Study|progressive disease|0|||
47078438|NCT02152956|83383458|FG001|Overall Study|progressive disease|0|||
47078439|NCT02152956|83383459|FG002|Overall Study|progressive disease|0|||
46854692|NCT03831191|83070484|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
46854693|NCT03831191|83070485|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
46975276|NCT01998958|83220081|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
47078440|NCT02152956|83383460|FG003|Overall Study|progressive disease|0|||
47078441|NCT02152956|83383461|FG004|Overall Study|progressive disease|0|||
47078442|NCT02152956|83383462|FG005|Overall Study|progressive disease|0|||
47078443|NCT02152956|83383463|FG006|Overall Study|progressive disease|0|||
47078444|NCT02152956|83383464|FG007|Overall Study|progressive disease|0|||
47078445|NCT02152956|83383465|FG008|Overall Study|progressive disease|1|||
47078446|NCT02152956|83383466|FG009|Overall Study|progressive disease|0|||
47078447|NCT02152956|83383467|FG010|Overall Study|progressive disease|0|||
47078448|NCT02152956|83383468|FG011|Overall Study|progressive disease|1|||
47078449|NCT02152956|83383469|FG012|Overall Study|progressive disease|0|||
47078450|NCT01553149|83383549|FG000|Overall Study|Adverse Event|0|||
46792526|NCT00635492|83011191|FG001|Overall Study|Lost to Follow-up|172|||
46792527|NCT00635492|83011190|FG000|Overall Study|Physician Decision|32|||
46792528|NCT00635492|83011191|FG001|Overall Study|Physician Decision|22|||
46792529|NCT00635492|83011190|FG000|Overall Study|Sponsor decision|2|||
46792530|NCT00635492|83011191|FG001|Overall Study|Sponsor decision|3|||
46792531|NCT00635492|83011190|FG000|Overall Study|Withdrawal by Subject|82|||
46792532|NCT00635492|83011191|FG001|Overall Study|Withdrawal by Subject|45|||
46792533|NCT00543309|83011204|FG000|Overall Study|Physician Decision|0|||
46792534|NCT00543309|83011205|FG001|Overall Study|Physician Decision|1|||
46792535|NCT00543309|83011206|FG002|Overall Study|Physician Decision|0|||
46975277|NCT01998958|83220082|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
46975278|NCT01998958|83220083|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
46975279|NCT01998958|83220084|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
46975280|NCT01998958|83220053|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975281|NCT01998958|83220054|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975282|NCT01998958|83220055|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975283|NCT01998958|83220056|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975284|NCT01998958|83220057|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975285|NCT01998958|83220058|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975286|NCT01998958|83220059|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975287|NCT01998958|83220060|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975288|NCT01998958|83220061|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975289|NCT01998958|83220062|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975290|NCT01998958|83220063|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975291|NCT01998958|83220064|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975292|NCT01998958|83220065|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975293|NCT01998958|83220066|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975294|NCT01998958|83220067|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
46975295|NCT01998958|83220068|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975296|NCT01998958|83220069|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975297|NCT01998958|83220070|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975298|NCT01998958|83220071|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
46975299|NCT01998958|83220072|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975300|NCT01998958|83220073|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975301|NCT01998958|83220074|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975302|NCT01998958|83220075|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975303|NCT01998958|83220076|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975304|NCT01998958|83220077|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
47078451|NCT01553149|83383550|FG001|Overall Study|Adverse Event|9|||
47078452|NCT01553149|83383549|FG000|Overall Study|Physician Decision|5|||
47078453|NCT01553149|83383550|FG001|Overall Study|Physician Decision|10|||
47078454|NCT01553149|83383549|FG000|Overall Study|Ineligible|0|||
47078455|NCT01553149|83383550|FG001|Overall Study|Ineligible|1|||
47078456|NCT01437189|83383573|FG000|Overall Study|Adverse Event|3|||
47078457|NCT01437189|83383573|FG000|Overall Study|Lack of Efficacy|4|||
47078458|NCT01437189|83383573|FG000|Overall Study|Withdrawal by Subject|8|||
47078459|NCT01311713|83383597|FG000|Overall Study|Death|0|||
47078460|NCT01311713|83383598|FG001|Overall Study|Death|0|||
47078461|NCT01311713|83383599|FG002|Overall Study|Death|1|||
47078462|NCT01311713|83383600|FG003|Overall Study|Death|1|||
47078463|NCT01311713|83383601|FG004|Overall Study|Death|0|||
46792536|NCT00569582|83011215|FG000|Overall Study|Withdrawal by Subject|5|||
46792537|NCT00569582|83011215|FG000|Overall Study|Death|2|||
46792538|NCT00569582|83011215|FG000|Overall Study|Adverse Event|7|||
46792539|NCT00569582|83011215|FG000|Overall Study|Subject was too ill to travel.|1|||
46792540|NCT00569582|83011215|FG000|Overall Study|Subject was non-compliant.|1|||
46792541|NCT00721409|83011222|FG000|Overall Study|Global deterioration of health status|2|||
46975305|NCT01998958|83220078|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46792542|NCT00721409|83011223|FG001|Overall Study|Global deterioration of health status|6|||
47078464|NCT01311713|83383602|FG005|Overall Study|Death|1|||
46975306|NCT01998958|83220079|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975307|NCT01998958|83220080|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975308|NCT01998958|83220081|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
47078465|NCT01311713|83383603|FG006|Overall Study|Death|0|||
47078466|NCT01311713|83383597|FG000|Overall Study|Adverse Event|0|||
47078467|NCT01311713|83383598|FG001|Overall Study|Adverse Event|1|||
47078468|NCT01311713|83383599|FG002|Overall Study|Adverse Event|0|||
46975309|NCT01998958|83220082|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975310|NCT01998958|83220083|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975311|NCT01998958|83220084|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
46975312|NCT01998958|83220053|FG000|Open Label Phase (Optional)|Adverse Event|0|||
46975313|NCT01998958|83220054|FG001|Open Label Phase (Optional)|Adverse Event|0|||
46854694|NCT03831191|83070486|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
46854695|NCT03831191|83070487|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
46854696|NCT03831191|83070488|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46975314|NCT01998958|83220055|FG002|Open Label Phase (Optional)|Adverse Event|0|||
46975315|NCT01998958|83220056|FG003|Open Label Phase (Optional)|Adverse Event|0|||
46975316|NCT01998958|83220057|FG004|Open Label Phase (Optional)|Adverse Event|0|||
46975317|NCT01998958|83220058|FG005|Open Label Phase (Optional)|Adverse Event|0|||
46854697|NCT03831191|83070489|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854698|NCT03831191|83070490|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854699|NCT03831191|83070491|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854700|NCT03831191|83070492|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46975318|NCT01998958|83220059|FG006|Open Label Phase (Optional)|Adverse Event|0|||
46975319|NCT01998958|83220060|FG007|Open Label Phase (Optional)|Adverse Event|0|||
46975320|NCT01998958|83220061|FG008|Open Label Phase (Optional)|Adverse Event|0|||
46975321|NCT01998958|83220062|FG009|Open Label Phase (Optional)|Adverse Event|0|||
46975322|NCT01998958|83220063|FG010|Open Label Phase (Optional)|Adverse Event|0|||
46975323|NCT01998958|83220064|FG011|Open Label Phase (Optional)|Adverse Event|0|||
46975324|NCT01998958|83220065|FG012|Open Label Phase (Optional)|Adverse Event|0|||
46975325|NCT01998958|83220066|FG013|Open Label Phase (Optional)|Adverse Event|0|||
46975326|NCT01998958|83220067|FG014|Open Label Phase (Optional)|Adverse Event|0|||
46975327|NCT01998958|83220068|FG015|Open Label Phase (Optional)|Adverse Event|0|||
46975328|NCT01998958|83220069|FG016|Open Label Phase (Optional)|Adverse Event|0|||
46975329|NCT01998958|83220070|FG017|Open Label Phase (Optional)|Adverse Event|0|||
46975330|NCT01998958|83220071|FG018|Open Label Phase (Optional)|Adverse Event|0|||
46975331|NCT01998958|83220072|FG019|Open Label Phase (Optional)|Adverse Event|0|||
46975332|NCT01998958|83220073|FG020|Open Label Phase (Optional)|Adverse Event|0|||
46975333|NCT01998958|83220074|FG021|Open Label Phase (Optional)|Adverse Event|0|||
46975334|NCT01998958|83220075|FG022|Open Label Phase (Optional)|Adverse Event|0|||
46975335|NCT01998958|83220076|FG023|Open Label Phase (Optional)|Adverse Event|1|||
46975336|NCT01998958|83220077|FG024|Open Label Phase (Optional)|Adverse Event|0|||
46975337|NCT01998958|83220078|FG025|Open Label Phase (Optional)|Adverse Event|0|||
46975338|NCT01998958|83220079|FG026|Open Label Phase (Optional)|Adverse Event|0|||
46975339|NCT01998958|83220080|FG027|Open Label Phase (Optional)|Adverse Event|0|||
46975340|NCT01998958|83220081|FG028|Open Label Phase (Optional)|Adverse Event|0|||
46975341|NCT01998958|83220082|FG029|Open Label Phase (Optional)|Adverse Event|0|||
46975342|NCT01998958|83220083|FG030|Open Label Phase (Optional)|Adverse Event|0|||
46975343|NCT01998958|83220084|FG031|Open Label Phase (Optional)|Adverse Event|0|||
46975344|NCT01998958|83220053|FG000|Open Label Phase (Optional)|Other|0|||
46975345|NCT01998958|83220054|FG001|Open Label Phase (Optional)|Other|0|||
46975346|NCT01998958|83220055|FG002|Open Label Phase (Optional)|Other|0|||
46975347|NCT01998958|83220056|FG003|Open Label Phase (Optional)|Other|0|||
46975348|NCT01998958|83220057|FG004|Open Label Phase (Optional)|Other|0|||
46975349|NCT01998958|83220058|FG005|Open Label Phase (Optional)|Other|0|||
46975350|NCT01998958|83220059|FG006|Open Label Phase (Optional)|Other|0|||
46975351|NCT01998958|83220060|FG007|Open Label Phase (Optional)|Other|0|||
46975352|NCT01998958|83220061|FG008|Open Label Phase (Optional)|Other|0|||
46975353|NCT01998958|83220062|FG009|Open Label Phase (Optional)|Other|0|||
46975354|NCT01998958|83220063|FG010|Open Label Phase (Optional)|Other|0|||
46975355|NCT01998958|83220064|FG011|Open Label Phase (Optional)|Other|0|||
46975356|NCT01998958|83220065|FG012|Open Label Phase (Optional)|Other|0|||
46975357|NCT01998958|83220066|FG013|Open Label Phase (Optional)|Other|0|||
46975358|NCT01998958|83220067|FG014|Open Label Phase (Optional)|Other|0|||
46975359|NCT01998958|83220068|FG015|Open Label Phase (Optional)|Other|0|||
46975360|NCT01998958|83220069|FG016|Open Label Phase (Optional)|Other|0|||
46975361|NCT01998958|83220070|FG017|Open Label Phase (Optional)|Other|0|||
46975362|NCT01998958|83220071|FG018|Open Label Phase (Optional)|Other|0|||
46975363|NCT01998958|83220072|FG019|Open Label Phase (Optional)|Other|0|||
46975364|NCT01998958|83220073|FG020|Open Label Phase (Optional)|Other|0|||
47078469|NCT01311713|83383600|FG003|Overall Study|Adverse Event|2|||
46975365|NCT01998958|83220074|FG021|Open Label Phase (Optional)|Other|0|||
46975366|NCT01998958|83220075|FG022|Open Label Phase (Optional)|Other|5|||
46975367|NCT01998958|83220076|FG023|Open Label Phase (Optional)|Other|1|||
47078470|NCT01311713|83383601|FG004|Overall Study|Adverse Event|0|||
46975368|NCT01998958|83220077|FG024|Open Label Phase (Optional)|Other|0|||
46975369|NCT01998958|83220078|FG025|Open Label Phase (Optional)|Other|0|||
47078471|NCT01311713|83383602|FG005|Overall Study|Adverse Event|0|||
46975370|NCT01998958|83220079|FG026|Open Label Phase (Optional)|Other|0|||
46975371|NCT01998958|83220080|FG027|Open Label Phase (Optional)|Other|0|||
46975372|NCT01998958|83220081|FG028|Open Label Phase (Optional)|Other|0|||
46975373|NCT01998958|83220082|FG029|Open Label Phase (Optional)|Other|0|||
46975374|NCT01998958|83220083|FG030|Open Label Phase (Optional)|Other|0|||
47078472|NCT01311713|83383603|FG006|Overall Study|Adverse Event|2|||
46975375|NCT01998958|83220084|FG031|Open Label Phase (Optional)|Other|0|||
46975376|NCT01998958|83220053|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975377|NCT01998958|83220054|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975378|NCT01998958|83220055|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975379|NCT01998958|83220056|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975380|NCT01998958|83220057|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975381|NCT01998958|83220058|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
47078473|NCT01311713|83383597|FG000|Overall Study|Withdrawal by Subject|0|||
46673921|NCT01160770|82889442|FG000|Overall Study|Study termination or sponsor request|1|||
46792543|NCT00721409|83011224|FG002|Overall Study|Global deterioration of health status|3|||
46792544|NCT00721409|83011222|FG000|Overall Study|Death|0|||
46792545|NCT00721409|83011223|FG001|Overall Study|Death|1|||
46792546|NCT00721409|83011224|FG002|Overall Study|Death|0|||
46792547|NCT00721409|83011222|FG000|Overall Study|Randomized not Treated|0|||
46792548|NCT00721409|83011223|FG001|Overall Study|Randomized not Treated|1|||
46792549|NCT00721409|83011224|FG002|Overall Study|Randomized not Treated|4|||
46792550|NCT00721409|83011222|FG000|Overall Study|Reason not specified|1|||
46792551|NCT00721409|83011223|FG001|Overall Study|Reason not specified|0|||
46792552|NCT00721409|83011224|FG002|Overall Study|Reason not specified|2|||
46792553|NCT00721409|83011222|FG000|Overall Study|Adverse Event|0|||
46854701|NCT03831191|83070493|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854702|NCT03831191|83070494|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854703|NCT03831191|83070495|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854704|NCT03831191|83070496|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854705|NCT03831191|83070497|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854706|NCT03831191|83070498|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
46854707|NCT03831191|83070484|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
46854708|NCT03831191|83070485|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
46854709|NCT03831191|83070486|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
46854710|NCT03831191|83070487|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
46975382|NCT01998958|83220059|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
47078474|NCT01311713|83383598|FG001|Overall Study|Withdrawal by Subject|1|||
47078475|NCT01311713|83383599|FG002|Overall Study|Withdrawal by Subject|1|||
47078476|NCT01311713|83383600|FG003|Overall Study|Withdrawal by Subject|0|||
46792554|NCT00721409|83011223|FG001|Overall Study|Adverse Event|13|||
47078477|NCT01311713|83383601|FG004|Overall Study|Withdrawal by Subject|0|||
47078478|NCT01311713|83383602|FG005|Overall Study|Withdrawal by Subject|1|||
47078479|NCT01311713|83383603|FG006|Overall Study|Withdrawal by Subject|2|||
47078480|NCT01311713|83383597|FG000|Overall Study|Disease progression|3|||
47078481|NCT01311713|83383598|FG001|Overall Study|Disease progression|4|||
46792555|NCT00721409|83011224|FG002|Overall Study|Adverse Event|2|||
46792556|NCT00721409|83011222|FG000|Overall Study|Lost to Follow-up|0|||
47078482|NCT01311713|83383599|FG002|Overall Study|Disease progression|3|||
46792557|NCT00721409|83011223|FG001|Overall Study|Lost to Follow-up|0|||
47078483|NCT01311713|83383600|FG003|Overall Study|Disease progression|2|||
47078484|NCT01311713|83383601|FG004|Overall Study|Disease progression|4|||
47078485|NCT01311713|83383602|FG005|Overall Study|Disease progression|4|||
46792558|NCT00721409|83011224|FG002|Overall Study|Lost to Follow-up|1|||
46792559|NCT00721409|83011222|FG000|Overall Study|Withdrawal by Subject|1|||
46673922|NCT01160770|82889442|FG000|Overall Study|Death|9|||
46975383|NCT01998958|83220060|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975384|NCT01998958|83220061|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975385|NCT01998958|83220062|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975386|NCT01998958|83220063|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975387|NCT01998958|83220064|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975388|NCT01998958|83220065|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975389|NCT01998958|83220066|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975390|NCT01998958|83220067|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975391|NCT01998958|83220068|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975392|NCT01998958|83220069|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975393|NCT01998958|83220070|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975394|NCT01998958|83220071|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975395|NCT01998958|83220072|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975396|NCT01998958|83220073|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975397|NCT01998958|83220074|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975398|NCT01998958|83220075|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
46975399|NCT01998958|83220076|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975400|NCT01998958|83220077|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975401|NCT01998958|83220078|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
47078486|NCT01311713|83383603|FG006|Overall Study|Disease progression|5|||
47078487|NCT01311713|83383597|FG000|Overall Study|Lost to Follow-up|0|||
47078488|NCT01311713|83383598|FG001|Overall Study|Lost to Follow-up|0|||
47078489|NCT01311713|83383599|FG002|Overall Study|Lost to Follow-up|1|||
47078490|NCT01311713|83383600|FG003|Overall Study|Lost to Follow-up|0|||
47078491|NCT01311713|83383601|FG004|Overall Study|Lost to Follow-up|0|||
47078492|NCT01311713|83383602|FG005|Overall Study|Lost to Follow-up|0|||
47078493|NCT01311713|83383603|FG006|Overall Study|Lost to Follow-up|0|||
47078494|NCT01311713|83383597|FG000|Overall Study|Stopped taking study medication|0|||
47078495|NCT01311713|83383598|FG001|Overall Study|Stopped taking study medication|0|||
47078496|NCT01311713|83383599|FG002|Overall Study|Stopped taking study medication|0|||
47078497|NCT01311713|83383600|FG003|Overall Study|Stopped taking study medication|1|||
47078498|NCT01311713|83383601|FG004|Overall Study|Stopped taking study medication|1|||
47078499|NCT01311713|83383602|FG005|Overall Study|Stopped taking study medication|0|||
47078500|NCT01311713|83383603|FG006|Overall Study|Stopped taking study medication|0|||
47078501|NCT01311713|83383597|FG000|Overall Study|Enrolled but not treated|0|||
46854711|NCT03831191|83070488|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854712|NCT03831191|83070489|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854713|NCT03831191|83070490|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854714|NCT03831191|83070491|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854715|NCT03831191|83070492|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854716|NCT03831191|83070493|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854717|NCT03831191|83070494|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854718|NCT03831191|83070495|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854719|NCT03831191|83070496|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854720|NCT03831191|83070497|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46854721|NCT03831191|83070498|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
46975402|NCT01998958|83220079|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975403|NCT01998958|83220080|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975404|NCT01998958|83220081|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975405|NCT01998958|83220082|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975406|NCT01998958|83220083|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975407|NCT01998958|83220084|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
46975408|NCT01998958|83220053|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975409|NCT01998958|83220054|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975410|NCT01998958|83220055|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975411|NCT01998958|83220056|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975412|NCT01998958|83220057|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975413|NCT01998958|83220058|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975414|NCT01998958|83220059|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975415|NCT01998958|83220060|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975416|NCT01998958|83220061|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975417|NCT01998958|83220062|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975418|NCT01998958|83220063|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975419|NCT01998958|83220064|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975420|NCT01998958|83220065|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975421|NCT01998958|83220066|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975422|NCT01998958|83220067|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975423|NCT01998958|83220068|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975424|NCT01998958|83220069|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975425|NCT01998958|83220070|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975426|NCT01998958|83220071|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975427|NCT01998958|83220072|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975428|NCT01998958|83220073|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975429|NCT01998958|83220074|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
46975430|NCT01998958|83220075|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
46975431|NCT01998958|83220076|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975432|NCT01998958|83220077|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975433|NCT01998958|83220078|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975434|NCT01998958|83220079|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975435|NCT01998958|83220080|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975436|NCT01998958|83220081|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975437|NCT01998958|83220082|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975438|NCT01998958|83220083|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975439|NCT01998958|83220084|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
46975440|NCT01998958|83220053|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975441|NCT01998958|83220054|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975442|NCT01998958|83220055|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975443|NCT01998958|83220056|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975444|NCT01998958|83220057|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975445|NCT01998958|83220058|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975446|NCT01998958|83220059|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975447|NCT01998958|83220060|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975448|NCT01998958|83220061|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975449|NCT01998958|83220062|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975450|NCT01998958|83220063|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975451|NCT01998958|83220064|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975452|NCT01998958|83220065|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975453|NCT01998958|83220066|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975454|NCT01998958|83220067|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975455|NCT01998958|83220068|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
47078502|NCT01311713|83383598|FG001|Overall Study|Enrolled but not treated|0|||
46792560|NCT00721409|83011223|FG001|Overall Study|Withdrawal by Subject|6|||
46792561|NCT00721409|83011224|FG002|Overall Study|Withdrawal by Subject|5|||
46792562|NCT00721409|83011222|FG000|Overall Study|Objective progression or relapse|8|||
46792563|NCT00721409|83011223|FG001|Overall Study|Objective progression or relapse|55|||
46792564|NCT00721409|83011224|FG002|Overall Study|Objective progression or relapse|62|||
46792565|NCT00542997|83011248|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
46792566|NCT00542997|83011248|FG000|Wash in / Wash Out Period|Adverse Event|3|||
46792567|NCT00542997|83011248|FG000|Efficacy Period|Adverse Event|3|||
46792568|NCT00572832|83011257|FG000|Overall Study|Lost to Follow-up|0|||
46792569|NCT00572832|83011258|FG001|Overall Study|Lost to Follow-up|11|||
46792570|NCT00572832|83011257|FG000|Overall Study|Pregnancy|0|||
47078503|NCT01311713|83383599|FG002|Overall Study|Enrolled but not treated|1|||
47078504|NCT01311713|83383600|FG003|Overall Study|Enrolled but not treated|0|||
47078505|NCT01311713|83383601|FG004|Overall Study|Enrolled but not treated|0|||
47078506|NCT01311713|83383602|FG005|Overall Study|Enrolled but not treated|0|||
46792571|NCT00572832|83011258|FG001|Overall Study|Pregnancy|1|||
46975456|NCT01998958|83220069|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975457|NCT01998958|83220070|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975458|NCT01998958|83220071|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975459|NCT01998958|83220072|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975460|NCT01998958|83220073|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975461|NCT01998958|83220074|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
46975462|NCT01998958|83220075|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
46975463|NCT01998958|83220076|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
46975464|NCT01998958|83220077|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975465|NCT01998958|83220078|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975466|NCT01998958|83220079|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975467|NCT01998958|83220080|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975468|NCT01998958|83220081|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975469|NCT01998958|83220082|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975470|NCT01998958|83220083|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975471|NCT01998958|83220084|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
46975472|NCT01958164|83220136|FG000|Overall Study|Adverse Event|0|||
46975473|NCT01958164|83220137|FG001|Overall Study|Adverse Event|2|||
46975474|NCT01958164|83220136|FG000|Overall Study|Lost to Follow-up|2|||
46975475|NCT01958164|83220137|FG001|Overall Study|Lost to Follow-up|3|||
46975476|NCT01976104|83220147|FG000|Overall Study|Adverse Event|0|||
46975477|NCT01976104|83220148|FG001|Overall Study|Adverse Event|0|||
46975478|NCT01976104|83220149|FG002|Overall Study|Adverse Event|1|||
46975479|NCT01976104|83220150|FG003|Overall Study|Adverse Event|0|||
46975480|NCT01976104|83220147|FG000|Overall Study|Lost to Follow-up|3|||
46975481|NCT01976104|83220148|FG001|Overall Study|Lost to Follow-up|0|||
46975482|NCT01976104|83220149|FG002|Overall Study|Lost to Follow-up|1|||
46975483|NCT01976104|83220150|FG003|Overall Study|Lost to Follow-up|1|||
46975484|NCT01976104|83220147|FG000|Overall Study|Subject Choice|0|||
46975485|NCT01976104|83220148|FG001|Overall Study|Subject Choice|1|||
46975486|NCT01976104|83220149|FG002|Overall Study|Subject Choice|0|||
46975487|NCT01976104|83220150|FG003|Overall Study|Subject Choice|1|||
46975488|NCT01976104|83220147|FG000|Overall Study|Withdrawal by Subject|3|||
46975489|NCT01976104|83220148|FG001|Overall Study|Withdrawal by Subject|0|||
46975490|NCT01976104|83220149|FG002|Overall Study|Withdrawal by Subject|0|||
46975491|NCT01976104|83220150|FG003|Overall Study|Withdrawal by Subject|1|||
46792572|NCT03917823|83011266|FG000|Overall Study|Lost to Follow-up|1|||
46854722|NCT03831191|83070484|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854723|NCT03831191|83070485|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854724|NCT03831191|83070486|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854725|NCT03831191|83070487|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
46854726|NCT03831191|83070488|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
46975492|NCT01976104|83220147|FG000|Overall Study|Other|0|||
46975493|NCT01976104|83220148|FG001|Overall Study|Other|1|||
46975494|NCT01976104|83220149|FG002|Overall Study|Other|0|||
46975495|NCT01976104|83220150|FG003|Overall Study|Other|0|||
46975496|NCT01372501|83220161|FG000|Overall Study|Adverse Event|4|||
46975497|NCT01372501|83220161|FG000|Overall Study|Device migration|1|||
46975498|NCT01958008|83220170|FG000|Overall Study|Worsening of disease under study|0|||
46975499|NCT01958008|83220171|FG001|Overall Study|Worsening of disease under study|0|||
46975500|NCT01958008|83220172|FG002|Overall Study|Worsening of disease under study|1|||
46975501|NCT01958008|83220173|FG003|Overall Study|Worsening of disease under study|0|||
46975502|NCT01958008|83220170|FG000|Overall Study|Other adverse event|1|||
46975503|NCT01958008|83220171|FG001|Overall Study|Other adverse event|0|||
46975504|NCT01958008|83220172|FG002|Overall Study|Other adverse event|0|||
46975505|NCT01958008|83220173|FG003|Overall Study|Other adverse event|0|||
46975506|NCT01998880|83220201|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
46975507|NCT01998880|83220202|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
46975508|NCT01998880|83220201|FG000|Overall Study|Disease Progression|1|||
46975509|NCT01998880|83220202|FG001|Overall Study|Disease Progression|8|||
47078507|NCT01311713|83383603|FG006|Overall Study|Enrolled but not treated|0|||
47078508|NCT01311713|83383597|FG000|Overall Study|Other than specified|0|||
47078509|NCT01311713|83383598|FG001|Overall Study|Other than specified|1|||
47078510|NCT01311713|83383599|FG002|Overall Study|Other than specified|2|||
47078511|NCT01311713|83383600|FG003|Overall Study|Other than specified|0|||
47078512|NCT01311713|83383601|FG004|Overall Study|Other than specified|0|||
47078513|NCT01311713|83383602|FG005|Overall Study|Other than specified|0|||
46792573|NCT03917823|83011267|FG001|Overall Study|Lost to Follow-up|1|||
46792574|NCT03917823|83011266|FG000|Overall Study|Withdrawal by Subject|0|||
46792575|NCT03917823|83011267|FG001|Overall Study|Withdrawal by Subject|1|||
46975510|NCT01998880|83220201|FG000|Overall Study|Withdrew Consent|2|||
46975511|NCT01998880|83220202|FG001|Overall Study|Withdrew Consent|1|||
46975512|NCT01998880|83220201|FG000|Overall Study|Death|3|||
46975513|NCT01998880|83220202|FG001|Overall Study|Death|6|||
46975514|NCT01998880|83220201|FG000|Overall Study|Insufficient Therapeutic Response|1|||
46975515|NCT01998880|83220202|FG001|Overall Study|Insufficient Therapeutic Response|5|||
46975516|NCT01998880|83220201|FG000|Overall Study|Administrative/Other|1|||
46975517|NCT01998880|83220202|FG001|Overall Study|Administrative/Other|1|||
46975518|NCT01998880|83220201|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
46975519|NCT01998880|83220202|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
46975520|NCT01998880|83220201|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
46975521|NCT01998880|83220202|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
46975522|NCT01998880|83220201|FG000|Overall Study|Did Not Receive Treatment|3|||
46975523|NCT01998880|83220202|FG001|Overall Study|Did Not Receive Treatment|2|||
46975524|NCT01975948|83220212|FG000|Overall Study|Withdrawal by Subject|17|||
46975525|NCT01975948|83220213|FG001|Overall Study|Withdrawal by Subject|21|||
46975526|NCT01975948|83220214|FG002|Overall Study|Withdrawal by Subject|7|||
46975527|NCT01975948|83220215|FG003|Overall Study|Withdrawal by Subject|6|||
46975528|NCT01975246|83220227|FG000|Overall Study|Adverse Event|2|||
46975529|NCT01975246|83220228|FG001|Overall Study|Adverse Event|1|||
46975530|NCT01975246|83220227|FG000|Overall Study|Lack of Efficacy|1|||
46975531|NCT01975246|83220228|FG001|Overall Study|Lack of Efficacy|0|||
46975532|NCT01975246|83220227|FG000|Overall Study|Protocol Violation|1|||
46975533|NCT01975246|83220228|FG001|Overall Study|Protocol Violation|0|||
46975534|NCT01975246|83220227|FG000|Overall Study|Other than stated|0|||
46975535|NCT01975246|83220228|FG001|Overall Study|Other than stated|1|||
46854727|NCT03831191|83070489|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854728|NCT03831191|83070490|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854729|NCT03831191|83070491|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854730|NCT03831191|83070492|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854731|NCT03831191|83070493|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854732|NCT03831191|83070494|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854733|NCT03831191|83070495|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854734|NCT03831191|83070496|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854735|NCT03831191|83070497|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
46792576|NCT00229723|83011280|FG000|Concomitant Phase|Adverse Event|4|||
46792577|NCT00229723|83011281|FG001|Concomitant Phase|Adverse Event|2|||
46854736|NCT03831191|83070498|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
46854737|NCT03831191|83070484|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
46854738|NCT03831191|83070485|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
46854739|NCT03831191|83070486|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
46854740|NCT03831191|83070487|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
46854741|NCT03831191|83070488|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
46975536|NCT01621126|83220234|FG000|Overall Study|Physician Decision|6|||
46792578|NCT00229723|83011282|FG002|Concomitant Phase|Adverse Event|5|||
46792579|NCT00229723|83011283|FG003|Concomitant Phase|Adverse Event|2|||
46792580|NCT00229723|83011284|FG004|Concomitant Phase|Adverse Event|0|||
46792581|NCT00229723|83011285|FG005|Concomitant Phase|Adverse Event|1|||
46792582|NCT00229723|83011286|FG006|Concomitant Phase|Adverse Event|2|||
46792583|NCT00229723|83011280|FG000|Concomitant Phase|Objective disease progression|0|||
46792584|NCT00229723|83011281|FG001|Concomitant Phase|Objective disease progression|0|||
46792585|NCT00229723|83011282|FG002|Concomitant Phase|Objective disease progression|0|||
46792586|NCT00229723|83011283|FG003|Concomitant Phase|Objective disease progression|0|||
46792587|NCT00229723|83011284|FG004|Concomitant Phase|Objective disease progression|0|||
46792588|NCT00229723|83011285|FG005|Concomitant Phase|Objective disease progression|0|||
46792589|NCT00229723|83011286|FG006|Concomitant Phase|Objective disease progression|0|||
46854742|NCT03831191|83070489|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
46854743|NCT03831191|83070490|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
46854744|NCT03831191|83070491|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
46854745|NCT03831191|83070492|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
46792590|NCT00229723|83011280|FG000|Concomitant Phase|Clinical progression|0|||
46792591|NCT00229723|83011281|FG001|Concomitant Phase|Clinical progression|0|||
46975537|NCT01973998|83220240|FG000|Overall Study|Death|2|||
46975538|NCT01973998|83220241|FG001|Overall Study|Death|2|||
46975539|NCT02664415|83220249|FG000|Overall Study|Adverse Event|1|||
46975540|NCT02664415|83220250|FG001|Overall Study|Adverse Event|0|||
46975541|NCT02661061|83220258|FG000|Overall Study|Lack of Efficacy|1|||
46975542|NCT02661061|83220259|FG001|Overall Study|Lack of Efficacy|1|||
46975543|NCT02661061|83220258|FG000|Overall Study|Withdrawal by Subject|1|||
46975544|NCT02661061|83220259|FG001|Overall Study|Withdrawal by Subject|1|||
46975545|NCT01995838|83220272|FG000|Overall Study|Lost to Follow-up|0|||
46975546|NCT01995838|83220273|FG001|Overall Study|Lost to Follow-up|1|||
46975547|NCT01995838|83220274|FG002|Overall Study|Lost to Follow-up|0|||
46975548|NCT01995838|83220275|FG003|Overall Study|Lost to Follow-up|0|||
46975549|NCT01995838|83220276|FG004|Overall Study|Lost to Follow-up|0|||
46975550|NCT01995838|83220277|FG005|Overall Study|Lost to Follow-up|0|||
46975551|NCT01995838|83220278|FG006|Overall Study|Lost to Follow-up|1|||
46975552|NCT01995838|83220272|FG000|Overall Study|Participant choice|2|||
46975553|NCT01995838|83220273|FG001|Overall Study|Participant choice|0|||
46975554|NCT01995838|83220274|FG002|Overall Study|Participant choice|0|||
46975555|NCT01995838|83220275|FG003|Overall Study|Participant choice|0|||
46975556|NCT01995838|83220276|FG004|Overall Study|Participant choice|0|||
46975557|NCT01995838|83220277|FG005|Overall Study|Participant choice|1|||
46975558|NCT01995838|83220278|FG006|Overall Study|Participant choice|1|||
46975559|NCT01995838|83220272|FG000|Overall Study|Adverse Event|0|||
46975560|NCT01995838|83220273|FG001|Overall Study|Adverse Event|0|||
46975561|NCT01995838|83220274|FG002|Overall Study|Adverse Event|0|||
46975562|NCT01995838|83220275|FG003|Overall Study|Adverse Event|0|||
46975563|NCT01995838|83220276|FG004|Overall Study|Adverse Event|0|||
46975564|NCT01995838|83220277|FG005|Overall Study|Adverse Event|0|||
46792592|NCT00229723|83011282|FG002|Concomitant Phase|Clinical progression|0|||
46792593|NCT00229723|83011283|FG003|Concomitant Phase|Clinical progression|0|||
46792594|NCT00229723|83011284|FG004|Concomitant Phase|Clinical progression|0|||
46792595|NCT00229723|83011285|FG005|Concomitant Phase|Clinical progression|0|||
46975565|NCT01995838|83220278|FG006|Overall Study|Adverse Event|1|||
46975566|NCT01995838|83220272|FG000|Overall Study|Withdrawal by Subject|0|||
46975567|NCT01995838|83220273|FG001|Overall Study|Withdrawal by Subject|0|||
46975568|NCT01995838|83220274|FG002|Overall Study|Withdrawal by Subject|0|||
46975569|NCT01995838|83220275|FG003|Overall Study|Withdrawal by Subject|0|||
46975570|NCT01995838|83220276|FG004|Overall Study|Withdrawal by Subject|1|||
46975571|NCT01995838|83220277|FG005|Overall Study|Withdrawal by Subject|0|||
46975572|NCT01995838|83220278|FG006|Overall Study|Withdrawal by Subject|0|||
46975573|NCT01995838|83220272|FG000|Overall Study|Other|3|||
46975574|NCT01995838|83220273|FG001|Overall Study|Other|1|||
46975575|NCT01995838|83220274|FG002|Overall Study|Other|0|||
46975576|NCT01995838|83220275|FG003|Overall Study|Other|2|||
46975577|NCT01995838|83220276|FG004|Overall Study|Other|1|||
46975578|NCT01995838|83220277|FG005|Overall Study|Other|1|||
46975579|NCT01995838|83220278|FG006|Overall Study|Other|2|||
46975580|NCT01957462|83220295|FG000|Test Period 1|Withdrawal by Subject|1|||
46975581|NCT01957462|83220296|FG001|Test Period 1|Withdrawal by Subject|0|||
46975582|NCT01957462|83220295|FG000|Test Period 1|Adverse Event|1|||
46975583|NCT01957462|83220296|FG001|Test Period 1|Adverse Event|0|||
46975584|NCT01957150|83220304|FG000|Overall Study|Adverse Event|23|||
46975585|NCT01957150|83220305|FG001|Overall Study|Adverse Event|20|||
46975586|NCT01957150|83220304|FG000|Overall Study|Withdrawal by Subject|13|||
46975587|NCT01957150|83220305|FG001|Overall Study|Withdrawal by Subject|17|||
46975588|NCT01957150|83220304|FG000|Overall Study|Physician Decision|3|||
46975589|NCT01957150|83220305|FG001|Overall Study|Physician Decision|6|||
46975590|NCT01957150|83220304|FG000|Overall Study|Lost to Follow-up|4|||
46975591|NCT01957150|83220305|FG001|Overall Study|Lost to Follow-up|4|||
46975592|NCT01957150|83220304|FG000|Overall Study|Protocol Violation|1|||
46975593|NCT01957150|83220305|FG001|Overall Study|Protocol Violation|0|||
46975594|NCT01957150|83220304|FG000|Overall Study|Lack of Efficacy|11|||
46975595|NCT01957150|83220305|FG001|Overall Study|Lack of Efficacy|11|||
47078514|NCT01311713|83383603|FG006|Overall Study|Other than specified|0|||
46792596|NCT00229723|83011286|FG006|Concomitant Phase|Clinical progression|1|||
46792597|NCT00229723|83011280|FG000|Concomitant Phase|Lost to Follow-up|0|||
46792598|NCT00229723|83011281|FG001|Concomitant Phase|Lost to Follow-up|0|||
46792599|NCT00229723|83011282|FG002|Concomitant Phase|Lost to Follow-up|0|||
46854746|NCT03831191|83070493|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
47078515|NCT00728884|83383656|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
46975596|NCT01955122|83220313|FG000|Overall Study|Physician Decision|5|||
47078516|NCT00728884|83383656|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
46792600|NCT00229723|83011283|FG003|Concomitant Phase|Lost to Follow-up|0|||
46792601|NCT00229723|83011284|FG004|Concomitant Phase|Lost to Follow-up|1|||
46792602|NCT00229723|83011285|FG005|Concomitant Phase|Lost to Follow-up|0|||
46975597|NCT01955122|83220314|FG001|Overall Study|Physician Decision|5|||
46975598|NCT01995526|83220326|FG000|Overall Study|Physician Decision|1|||
46975599|NCT01955044|83220333|FG000|Overall Study|Death|1|||
47078517|NCT00659776|83383663|FG000|Overall Study|Withdrawal by Subject|12|||
46975600|NCT01955044|83220334|FG001|Overall Study|Death|1|||
46975601|NCT01955044|83220335|FG002|Overall Study|Death|0|||
46975602|NCT01973218|83220345|FG000|Overall Study|Adverse Event|1|||
46975603|NCT01973218|83220346|FG001|Overall Study|Adverse Event|0|||
46975604|NCT01973218|83220345|FG000|Overall Study|Withdrawal by Subject|1|||
46975605|NCT01973218|83220346|FG001|Overall Study|Withdrawal by Subject|0|||
46975606|NCT01954342|83220358|FG000|Overall Study|Missing data from 13-16week study visit|0|||
46975607|NCT01954342|83220359|FG001|Overall Study|Missing data from 13-16week study visit|0|||
46975608|NCT01954342|83220360|FG002|Overall Study|Missing data from 13-16week study visit|0|||
46975609|NCT01954342|83220361|FG003|Overall Study|Missing data from 13-16week study visit|1|||
46975610|NCT01954342|83220358|FG000|Overall Study|Miscarriage|0|||
46975611|NCT01954342|83220359|FG001|Overall Study|Miscarriage|0|||
46975612|NCT01954342|83220360|FG002|Overall Study|Miscarriage|0|||
46975613|NCT01954342|83220361|FG003|Overall Study|Miscarriage|3|||
46975614|NCT01954342|83220358|FG000|Overall Study|Lost to Follow-up|0|||
46975615|NCT01954342|83220359|FG001|Overall Study|Lost to Follow-up|0|||
46975616|NCT01954342|83220360|FG002|Overall Study|Lost to Follow-up|0|||
46975617|NCT01954342|83220361|FG003|Overall Study|Lost to Follow-up|5|||
46975618|NCT01954342|83220358|FG000|Overall Study|Preterm delivery|0|||
46975619|NCT01954342|83220359|FG001|Overall Study|Preterm delivery|0|||
46975620|NCT01954342|83220360|FG002|Overall Study|Preterm delivery|0|||
46975621|NCT01954342|83220361|FG003|Overall Study|Preterm delivery|3|||
46975622|NCT01954342|83220358|FG000|Overall Study|Pre-eclampsia|0|||
46975623|NCT01954342|83220359|FG001|Overall Study|Pre-eclampsia|0|||
46975624|NCT01954342|83220360|FG002|Overall Study|Pre-eclampsia|0|||
46975625|NCT01954342|83220361|FG003|Overall Study|Pre-eclampsia|4|||
46975626|NCT01954342|83220358|FG000|Overall Study|Unreliable Data|0|||
46975627|NCT01954342|83220359|FG001|Overall Study|Unreliable Data|0|||
46975628|NCT01954342|83220360|FG002|Overall Study|Unreliable Data|0|||
46975629|NCT01954342|83220361|FG003|Overall Study|Unreliable Data|2|||
46975630|NCT01972438|83220373|FG000|Baseline-Month 3 Crossover Period|Death|1|||
46975631|NCT01972438|83220374|FG001|Baseline-Month 3 Crossover Period|Death|0|||
46975632|NCT01972438|83220373|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
46975633|NCT01972438|83220374|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
46975634|NCT01972438|83220373|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
46975635|NCT01972438|83220374|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
46975636|NCT01972438|83220373|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
46975637|NCT01972438|83220374|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
46975638|NCT01972438|83220373|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
46975639|NCT01972438|83220374|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
46975640|NCT01972438|83220373|FG000|Months 6-12 Study Period|Death|1|||
46975641|NCT01972438|83220374|FG001|Months 6-12 Study Period|Death|0|||
46975642|NCT01972438|83220373|FG000|Months 6-12 Study Period|Early Study Closure|2|||
46975643|NCT01972438|83220374|FG001|Months 6-12 Study Period|Early Study Closure|2|||
46975644|NCT01972438|83220373|FG000|Post Month 12 Study Period|Early Study Closure|3|||
46975645|NCT01972438|83220374|FG001|Post Month 12 Study Period|Early Study Closure|4|||
46975646|NCT01946152|83220386|FG000|Overall Study|Adverse Event|1|||
46975647|NCT01946152|83220387|FG001|Overall Study|Adverse Event|0|||
46975648|NCT01946152|83220388|FG002|Overall Study|Adverse Event|0|||
46975649|NCT01946152|83220389|FG003|Overall Study|Adverse Event|0|||
46975650|NCT01946152|83220386|FG000|Overall Study|Withdrawal by Subject|0|||
46975651|NCT01946152|83220387|FG001|Overall Study|Withdrawal by Subject|2|||
46975652|NCT01946152|83220388|FG002|Overall Study|Withdrawal by Subject|0|||
46975653|NCT01946152|83220389|FG003|Overall Study|Withdrawal by Subject|0|||
46975654|NCT01946152|83220386|FG000|Overall Study|Progression|0|||
46975655|NCT01946152|83220387|FG001|Overall Study|Progression|1|||
46975656|NCT01946152|83220388|FG002|Overall Study|Progression|4|||
46975657|NCT01946152|83220389|FG003|Overall Study|Progression|7|||
46975658|NCT01946152|83220386|FG000|Overall Study|Physician Decision|0|||
46975659|NCT01946152|83220387|FG001|Overall Study|Physician Decision|0|||
46975660|NCT01946152|83220388|FG002|Overall Study|Physician Decision|1|||
46975661|NCT01946152|83220389|FG003|Overall Study|Physician Decision|0|||
46975662|NCT01946152|83220386|FG000|Overall Study|Second malignancy|0|||
46975663|NCT01946152|83220387|FG001|Overall Study|Second malignancy|0|||
46975664|NCT01946152|83220388|FG002|Overall Study|Second malignancy|1|||
46975665|NCT01946152|83220389|FG003|Overall Study|Second malignancy|0|||
46975666|NCT01946152|83220386|FG000|Overall Study|Adverse Event|0|||
46673923|NCT01160770|82889442|FG000|Overall Study|Lack of Efficacy|15|||
46673924|NCT01160770|82889442|FG000|Overall Study|Other Reasons|1|||
47078518|NCT00659776|83383664|FG001|Overall Study|Withdrawal by Subject|2|||
47078519|NCT00659776|83383665|FG002|Overall Study|Withdrawal by Subject|0|||
46673925|NCT01160614|82889448|FG000|Overall Study|Withdrawal by Subject|0|||
46975667|NCT01946152|83220387|FG001|Overall Study|Adverse Event|0|||
46975668|NCT01946152|83220388|FG002|Overall Study|Adverse Event|0|||
46975669|NCT01946152|83220389|FG003|Overall Study|Adverse Event|1|||
46975670|NCT01945996|83220403|FG000|Overall Study|Lost to Follow-up|3|||
46975671|NCT01945996|83220404|FG001|Overall Study|Lost to Follow-up|5|||
46975672|NCT01971346|83220412|FG000|Overall Study|Protocol Violation|3|||
46673926|NCT01160614|82889449|FG001|Overall Study|Withdrawal by Subject|2|||
46673927|NCT01159912|82889476|FG000|Overall Study|Adverse Event|2|||
46975673|NCT01971346|83220412|FG000|Overall Study|Lost to Follow-up|2|||
46975674|NCT01971346|83220412|FG000|Overall Study|Withdrawal by Subject|2|||
46975675|NCT01971346|83220412|FG000|Overall Study|Physician Decision|1|||
46975676|NCT01945216|83220427|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
46975677|NCT01945216|83220427|FG000|Overall Study|Protocol Violation|42|||
46975678|NCT01945216|83220427|FG000|Overall Study|CRF not assured by investigators|5|||
46975679|NCT02641379|83220446|FG000|Overall Study|Exclusion criterion during screening|1|||
46975680|NCT02641379|83220447|FG001|Overall Study|Exclusion criterion during screening|0|||
46975681|NCT02641379|83220448|FG002|Overall Study|Exclusion criterion during screening|0|||
46975682|NCT02641379|83220449|FG003|Overall Study|Exclusion criterion during screening|1|||
46975683|NCT02641379|83220450|FG004|Overall Study|Exclusion criterion during screening|2|||
46975684|NCT02641379|83220451|FG005|Overall Study|Exclusion criterion during screening|0|||
46975685|NCT02641379|83220452|FG006|Overall Study|Exclusion criterion during screening|0|||
46975686|NCT02641379|83220453|FG007|Overall Study|Exclusion criterion during screening|0|||
46975687|NCT02641379|83220454|FG008|Overall Study|Exclusion criterion during screening|0|||
46975688|NCT02641379|83220455|FG009|Overall Study|Exclusion criterion during screening|0|||
46975689|NCT02641379|83220456|FG010|Overall Study|Exclusion criterion during screening|0|||
46975690|NCT02641379|83220446|FG000|Overall Study|Withdrawal of informed consent|0|||
46975691|NCT02641379|83220447|FG001|Overall Study|Withdrawal of informed consent|1|||
46975692|NCT02641379|83220448|FG002|Overall Study|Withdrawal of informed consent|0|||
46975693|NCT02641379|83220449|FG003|Overall Study|Withdrawal of informed consent|0|||
46975694|NCT02641379|83220450|FG004|Overall Study|Withdrawal of informed consent|0|||
46975695|NCT02641379|83220451|FG005|Overall Study|Withdrawal of informed consent|0|||
46975696|NCT02641379|83220452|FG006|Overall Study|Withdrawal of informed consent|0|||
46975697|NCT02641379|83220453|FG007|Overall Study|Withdrawal of informed consent|1|||
46975698|NCT02641379|83220454|FG008|Overall Study|Withdrawal of informed consent|0|||
46975699|NCT02641379|83220455|FG009|Overall Study|Withdrawal of informed consent|0|||
46975700|NCT02641379|83220456|FG010|Overall Study|Withdrawal of informed consent|0|||
46975701|NCT02641379|83220446|FG000|Overall Study|Adverse Event|7|||
46975702|NCT02641379|83220447|FG001|Overall Study|Adverse Event|8|||
46975703|NCT02641379|83220448|FG002|Overall Study|Adverse Event|2|||
46975704|NCT02641379|83220449|FG003|Overall Study|Adverse Event|2|||
46975705|NCT02641379|83220450|FG004|Overall Study|Adverse Event|5|||
46975706|NCT02641379|83220451|FG005|Overall Study|Adverse Event|1|||
46975707|NCT02641379|83220452|FG006|Overall Study|Adverse Event|5|||
46975708|NCT02641379|83220453|FG007|Overall Study|Adverse Event|0|||
46975709|NCT02641379|83220454|FG008|Overall Study|Adverse Event|1|||
46854747|NCT03831191|83070494|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
46854748|NCT03831191|83070495|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
46975710|NCT02641379|83220455|FG009|Overall Study|Adverse Event|1|||
46975711|NCT02641379|83220456|FG010|Overall Study|Adverse Event|5|||
46975712|NCT02641379|83220446|FG000|Overall Study|Lack of Efficacy|0|||
46975713|NCT02641379|83220447|FG001|Overall Study|Lack of Efficacy|0|||
46975714|NCT02641379|83220448|FG002|Overall Study|Lack of Efficacy|2|||
46975715|NCT02641379|83220449|FG003|Overall Study|Lack of Efficacy|0|||
46975716|NCT02641379|83220450|FG004|Overall Study|Lack of Efficacy|0|||
46854749|NCT03831191|83070496|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
46854750|NCT03831191|83070497|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
46854751|NCT03831191|83070498|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
46854752|NCT03831191|83070484|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46975717|NCT02641379|83220451|FG005|Overall Study|Lack of Efficacy|2|||
46975718|NCT02641379|83220452|FG006|Overall Study|Lack of Efficacy|0|||
46975719|NCT02641379|83220453|FG007|Overall Study|Lack of Efficacy|5|||
46975720|NCT02641379|83220454|FG008|Overall Study|Lack of Efficacy|0|||
46975721|NCT02641379|83220455|FG009|Overall Study|Lack of Efficacy|0|||
46975722|NCT02641379|83220456|FG010|Overall Study|Lack of Efficacy|0|||
46975723|NCT02641379|83220446|FG000|Overall Study|Participant unable to attend study visit|4|||
47078520|NCT00617656|83383675|FG000|Overall Study|Inclusion error|4|||
47078521|NCT00617656|83383676|FG001|Overall Study|Inclusion error|4|||
46792603|NCT00229723|83011286|FG006|Concomitant Phase|Lost to Follow-up|0|||
46792604|NCT00229723|83011280|FG000|Concomitant Phase|Informed consent withdrawn|3|||
46792605|NCT00229723|83011281|FG001|Concomitant Phase|Informed consent withdrawn|2|||
46792606|NCT00229723|83011282|FG002|Concomitant Phase|Informed consent withdrawn|0|||
46792607|NCT00229723|83011283|FG003|Concomitant Phase|Informed consent withdrawn|2|||
46792608|NCT00229723|83011284|FG004|Concomitant Phase|Informed consent withdrawn|0|||
46792609|NCT00229723|83011285|FG005|Concomitant Phase|Informed consent withdrawn|0|||
46792610|NCT00229723|83011286|FG006|Concomitant Phase|Informed consent withdrawn|0|||
46792611|NCT00229723|83011280|FG000|Concomitant Phase|Severe non-compliance|0|||
47078522|NCT00617656|83383677|FG002|Overall Study|Inclusion error|0|||
46792612|NCT00229723|83011281|FG001|Concomitant Phase|Severe non-compliance|1|||
46792613|NCT00229723|83011282|FG002|Concomitant Phase|Severe non-compliance|0|||
46975724|NCT02641379|83220447|FG001|Overall Study|Participant unable to attend study visit|10|||
46975725|NCT02641379|83220448|FG002|Overall Study|Participant unable to attend study visit|1|||
46975726|NCT02641379|83220449|FG003|Overall Study|Participant unable to attend study visit|2|||
46975727|NCT02641379|83220450|FG004|Overall Study|Participant unable to attend study visit|5|||
46975728|NCT02641379|83220451|FG005|Overall Study|Participant unable to attend study visit|1|||
46975729|NCT02641379|83220452|FG006|Overall Study|Participant unable to attend study visit|1|||
46975730|NCT02641379|83220453|FG007|Overall Study|Participant unable to attend study visit|1|||
46975731|NCT02641379|83220454|FG008|Overall Study|Participant unable to attend study visit|0|||
46975732|NCT02641379|83220455|FG009|Overall Study|Participant unable to attend study visit|2|||
46975733|NCT02641379|83220456|FG010|Overall Study|Participant unable to attend study visit|0|||
46975734|NCT02641379|83220446|FG000|Overall Study|Participant's compliance|0|||
46975735|NCT02641379|83220447|FG001|Overall Study|Participant's compliance|1|||
46975736|NCT02641379|83220448|FG002|Overall Study|Participant's compliance|0|||
46975737|NCT02641379|83220449|FG003|Overall Study|Participant's compliance|1|||
46792614|NCT00229723|83011283|FG003|Concomitant Phase|Severe non-compliance|0|||
46792615|NCT00229723|83011284|FG004|Concomitant Phase|Severe non-compliance|1|||
46792616|NCT00229723|83011285|FG005|Concomitant Phase|Severe non-compliance|0|||
46792617|NCT00229723|83011286|FG006|Concomitant Phase|Severe non-compliance|0|||
46792618|NCT00229723|83011280|FG000|Concomitant Phase|Other|3|||
46792619|NCT00229723|83011281|FG001|Concomitant Phase|Other|0|||
46792620|NCT00229723|83011282|FG002|Concomitant Phase|Other|1|||
46792621|NCT00229723|83011283|FG003|Concomitant Phase|Other|1|||
46792622|NCT00229723|83011284|FG004|Concomitant Phase|Other|0|||
46975738|NCT02641379|83220450|FG004|Overall Study|Participant's compliance|0|||
46975739|NCT02641379|83220451|FG005|Overall Study|Participant's compliance|2|||
46975740|NCT02641379|83220452|FG006|Overall Study|Participant's compliance|0|||
46975741|NCT02641379|83220453|FG007|Overall Study|Participant's compliance|0|||
46975742|NCT02641379|83220454|FG008|Overall Study|Participant's compliance|1|||
46975743|NCT02641379|83220455|FG009|Overall Study|Participant's compliance|1|||
46975744|NCT02641379|83220456|FG010|Overall Study|Participant's compliance|1|||
46975745|NCT02641379|83220446|FG000|Overall Study|Participant cannot be reached|4|||
46975746|NCT02641379|83220447|FG001|Overall Study|Participant cannot be reached|4|||
46975747|NCT02641379|83220448|FG002|Overall Study|Participant cannot be reached|0|||
46975748|NCT02641379|83220449|FG003|Overall Study|Participant cannot be reached|8|||
46975749|NCT02641379|83220450|FG004|Overall Study|Participant cannot be reached|2|||
46975750|NCT02641379|83220451|FG005|Overall Study|Participant cannot be reached|1|||
46975751|NCT02641379|83220452|FG006|Overall Study|Participant cannot be reached|0|||
46975752|NCT02641379|83220453|FG007|Overall Study|Participant cannot be reached|1|||
46975753|NCT02641379|83220454|FG008|Overall Study|Participant cannot be reached|0|||
46975754|NCT02641379|83220455|FG009|Overall Study|Participant cannot be reached|2|||
46975755|NCT02641379|83220456|FG010|Overall Study|Participant cannot be reached|1|||
46975756|NCT02641379|83220446|FG000|Overall Study|PCR positive at Week 24|15|||
46975757|NCT02641379|83220447|FG001|Overall Study|PCR positive at Week 24|21|||
46975758|NCT02641379|83220448|FG002|Overall Study|PCR positive at Week 24|62|||
46975759|NCT02641379|83220449|FG003|Overall Study|PCR positive at Week 24|0|||
46975760|NCT02641379|83220450|FG004|Overall Study|PCR positive at Week 24|0|||
46975761|NCT02641379|83220451|FG005|Overall Study|PCR positive at Week 24|6|||
46975762|NCT02641379|83220452|FG006|Overall Study|PCR positive at Week 24|3|||
46975763|NCT02641379|83220453|FG007|Overall Study|PCR positive at Week 24|8|||
46975764|NCT02641379|83220454|FG008|Overall Study|PCR positive at Week 24|0|||
46975765|NCT02641379|83220455|FG009|Overall Study|PCR positive at Week 24|1|||
46975766|NCT02641379|83220456|FG010|Overall Study|PCR positive at Week 24|0|||
46975767|NCT02641379|83220446|FG000|Overall Study|PCR positive at follow up 2|1|||
46975768|NCT02641379|83220447|FG001|Overall Study|PCR positive at follow up 2|0|||
46975769|NCT02641379|83220448|FG002|Overall Study|PCR positive at follow up 2|0|||
46975770|NCT02641379|83220449|FG003|Overall Study|PCR positive at follow up 2|0|||
46975771|NCT02641379|83220450|FG004|Overall Study|PCR positive at follow up 2|0|||
46975772|NCT02641379|83220451|FG005|Overall Study|PCR positive at follow up 2|0|||
46975773|NCT02641379|83220452|FG006|Overall Study|PCR positive at follow up 2|0|||
47078523|NCT00617656|83383678|FG003|Overall Study|Inclusion error|0|||
46975774|NCT02641379|83220453|FG007|Overall Study|PCR positive at follow up 2|0|||
46975775|NCT02641379|83220454|FG008|Overall Study|PCR positive at follow up 2|0|||
46975776|NCT02641379|83220455|FG009|Overall Study|PCR positive at follow up 2|0|||
46975777|NCT02641379|83220456|FG010|Overall Study|PCR positive at follow up 2|0|||
46975778|NCT02641379|83220446|FG000|Overall Study|Participant showed relapse|1|||
47078524|NCT00617656|83383675|FG000|Overall Study|Missing data|44|||
46975779|NCT02641379|83220447|FG001|Overall Study|Participant showed relapse|0|||
47078525|NCT00617656|83383676|FG001|Overall Study|Missing data|30|||
47078526|NCT00617656|83383677|FG002|Overall Study|Missing data|13|||
47078527|NCT00617656|83383678|FG003|Overall Study|Missing data|6|||
47078528|NCT00617656|83383675|FG000|Overall Study|Withdrawal by Subject|0|||
46975780|NCT02641379|83220448|FG002|Overall Study|Participant showed relapse|0|||
46975781|NCT02641379|83220449|FG003|Overall Study|Participant showed relapse|0|||
46975782|NCT02641379|83220450|FG004|Overall Study|Participant showed relapse|0|||
47078529|NCT00617656|83383676|FG001|Overall Study|Withdrawal by Subject|2|||
47078530|NCT00617656|83383677|FG002|Overall Study|Withdrawal by Subject|0|||
47078531|NCT00617656|83383678|FG003|Overall Study|Withdrawal by Subject|0|||
46792623|NCT00229723|83011285|FG005|Concomitant Phase|Other|2|||
46792624|NCT00229723|83011286|FG006|Concomitant Phase|Other|0|||
46975783|NCT02641379|83220451|FG005|Overall Study|Participant showed relapse|0|||
46975784|NCT02641379|83220452|FG006|Overall Study|Participant showed relapse|1|||
46975785|NCT02641379|83220453|FG007|Overall Study|Participant showed relapse|0|||
46975786|NCT02641379|83220454|FG008|Overall Study|Participant showed relapse|0|||
46975787|NCT02641379|83220455|FG009|Overall Study|Participant showed relapse|0|||
46975788|NCT02641379|83220456|FG010|Overall Study|Participant showed relapse|0|||
46975789|NCT02641379|83220446|FG000|Overall Study|Participant stopped study/treatment|1|||
46975790|NCT02641379|83220447|FG001|Overall Study|Participant stopped study/treatment|3|||
46975791|NCT02641379|83220448|FG002|Overall Study|Participant stopped study/treatment|1|||
46854753|NCT03831191|83070485|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854754|NCT03831191|83070486|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854755|NCT03831191|83070487|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854756|NCT03831191|83070488|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46975792|NCT02641379|83220449|FG003|Overall Study|Participant stopped study/treatment|0|||
46975793|NCT02641379|83220450|FG004|Overall Study|Participant stopped study/treatment|0|||
46975794|NCT02641379|83220451|FG005|Overall Study|Participant stopped study/treatment|1|||
46975795|NCT02641379|83220452|FG006|Overall Study|Participant stopped study/treatment|2|||
46975796|NCT02641379|83220453|FG007|Overall Study|Participant stopped study/treatment|0|||
46975797|NCT02641379|83220454|FG008|Overall Study|Participant stopped study/treatment|1|||
46975798|NCT02641379|83220455|FG009|Overall Study|Participant stopped study/treatment|0|||
46975799|NCT02641379|83220456|FG010|Overall Study|Participant stopped study/treatment|0|||
46975800|NCT02641379|83220446|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
46975801|NCT02641379|83220447|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
46975802|NCT02641379|83220448|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
46975803|NCT02641379|83220449|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
46975804|NCT02641379|83220450|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
46975805|NCT02641379|83220451|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
46975806|NCT02641379|83220452|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
47078532|NCT04508023|83383692|FG000|Overall Study|Withdrawal by Subject|1|||
47078533|NCT04508023|83383693|FG001|Overall Study|Withdrawal by Subject|2|||
47078534|NCT04187144|83383701|FG000|Overall Study|Lost to Follow-up|12|||
47078535|NCT04187144|83383702|FG001|Overall Study|Lost to Follow-up|11|||
47078536|NCT04187144|83383701|FG000|Overall Study|Withdrawal by Subject|20|||
47078537|NCT04187144|83383702|FG001|Overall Study|Withdrawal by Subject|18|||
47078538|NCT04187144|83383701|FG000|Overall Study|Adverse Event|19|||
47078539|NCT04187144|83383702|FG001|Overall Study|Adverse Event|4|||
47078540|NCT04187144|83383701|FG000|Overall Study|Physician Decision|5|||
47078541|NCT04187144|83383702|FG001|Overall Study|Physician Decision|3|||
47078542|NCT04187144|83383701|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
47078543|NCT04187144|83383702|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
47078544|NCT04187144|83383701|FG000|Overall Study|Protocol Deviation|1|||
46975807|NCT02641379|83220453|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
47078545|NCT04187144|83383702|FG001|Overall Study|Protocol Deviation|4|||
47078546|NCT03856047|83383719|FG000|Overall Study|Withdrawal by Subject|0|||
47078547|NCT03856047|83383720|FG001|Overall Study|Withdrawal by Subject|1|||
47078548|NCT03856047|83383721|FG002|Overall Study|Withdrawal by Subject|1|||
47078549|NCT03856047|83383722|FG003|Overall Study|Withdrawal by Subject|0|||
47078550|NCT03856047|83383723|FG004|Overall Study|Withdrawal by Subject|3|||
47078551|NCT03856047|83383724|FG005|Overall Study|Withdrawal by Subject|0|||
47078552|NCT03856047|83383725|FG006|Overall Study|Withdrawal by Subject|2|||
47078553|NCT03856047|83383719|FG000|Overall Study|Lost to Follow-up|4|||
47078554|NCT03856047|83383720|FG001|Overall Study|Lost to Follow-up|2|||
47078555|NCT03856047|83383721|FG002|Overall Study|Lost to Follow-up|3|||
47078556|NCT03856047|83383722|FG003|Overall Study|Lost to Follow-up|1|||
47078557|NCT03856047|83383723|FG004|Overall Study|Lost to Follow-up|4|||
47078558|NCT03856047|83383724|FG005|Overall Study|Lost to Follow-up|4|||
47078559|NCT03856047|83383725|FG006|Overall Study|Lost to Follow-up|4|||
46854757|NCT03831191|83070489|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
47078560|NCT03112603|83383776|FG000|End of Randomization Period|Lost to Follow-up|3|||
46975808|NCT02641379|83220454|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
47078561|NCT03112603|83383777|FG001|End of Randomization Period|Lost to Follow-up|0|||
47078562|NCT03112603|83383778|FG002|End of Randomization Period|Lost to Follow-up|0|||
46854758|NCT03831191|83070490|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46975809|NCT02641379|83220455|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
46975810|NCT02641379|83220456|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
46792625|NCT00229723|83011280|FG000|Maintenance Phase|Adverse Event|7|||
46792626|NCT00229723|83011281|FG001|Maintenance Phase|Adverse Event|2|||
46792627|NCT00229723|83011282|FG002|Maintenance Phase|Adverse Event|1|||
46792628|NCT00229723|83011283|FG003|Maintenance Phase|Adverse Event|4|||
46792629|NCT00229723|83011284|FG004|Maintenance Phase|Adverse Event|7|||
46792630|NCT00229723|83011285|FG005|Maintenance Phase|Adverse Event|5|||
46792631|NCT00229723|83011286|FG006|Maintenance Phase|Adverse Event|2|||
46792632|NCT00229723|83011280|FG000|Maintenance Phase|Objective disease progression|5|||
46792633|NCT00229723|83011281|FG001|Maintenance Phase|Objective disease progression|5|||
46854759|NCT03831191|83070491|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854760|NCT03831191|83070492|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854761|NCT03831191|83070493|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854762|NCT03831191|83070494|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854763|NCT03831191|83070495|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854764|NCT03831191|83070496|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854765|NCT03831191|83070497|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
46854766|NCT03831191|83070498|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
46854767|NCT03831191|83070484|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854768|NCT03831191|83070485|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854769|NCT03831191|83070486|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854770|NCT03831191|83070487|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854771|NCT03831191|83070488|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854772|NCT03831191|83070489|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854773|NCT03831191|83070490|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854774|NCT03831191|83070491|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854775|NCT03831191|83070492|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854776|NCT03831191|83070493|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854777|NCT03831191|83070494|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854778|NCT03831191|83070495|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854779|NCT03831191|83070496|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854780|NCT03831191|83070497|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
46854781|NCT03831191|83070498|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
46854782|NCT00005906|83070531|FG000|Overall Study|Lack of Efficacy|3|||
46854783|NCT03409276|83070540|FG000|Overall Study|Withdrawal by Subject|0|||
46854784|NCT03409276|83070541|FG001|Overall Study|Withdrawal by Subject|0|||
46854785|NCT03409276|83070542|FG002|Overall Study|Withdrawal by Subject|0|||
46854786|NCT03409276|83070543|FG003|Overall Study|Withdrawal by Subject|0|||
46854787|NCT03409276|83070544|FG004|Overall Study|Withdrawal by Subject|1|||
46854788|NCT03409276|83070540|FG000|Overall Study|Lost to Follow-up|0|||
46975811|NCT02641379|83220446|FG000|Overall Study|Financial problems|0|||
46854789|NCT03409276|83070541|FG001|Overall Study|Lost to Follow-up|0|||
46792634|NCT00229723|83011282|FG002|Maintenance Phase|Objective disease progression|3|||
46975812|NCT02641379|83220447|FG001|Overall Study|Financial problems|1|||
46975813|NCT02641379|83220448|FG002|Overall Study|Financial problems|0|||
46975814|NCT02641379|83220449|FG003|Overall Study|Financial problems|0|||
46975815|NCT02641379|83220450|FG004|Overall Study|Financial problems|0|||
46975816|NCT02641379|83220451|FG005|Overall Study|Financial problems|0|||
46975817|NCT02641379|83220452|FG006|Overall Study|Financial problems|0|||
46975818|NCT02641379|83220453|FG007|Overall Study|Financial problems|0|||
46975819|NCT02641379|83220454|FG008|Overall Study|Financial problems|0|||
46975820|NCT02641379|83220455|FG009|Overall Study|Financial problems|0|||
46975821|NCT02641379|83220456|FG010|Overall Study|Financial problems|0|||
46975822|NCT02641379|83220446|FG000|Overall Study|PCR positive at Week 68|0|||
46975823|NCT02641379|83220447|FG001|Overall Study|PCR positive at Week 68|1|||
46975824|NCT02641379|83220448|FG002|Overall Study|PCR positive at Week 68|0|||
46975825|NCT02641379|83220449|FG003|Overall Study|PCR positive at Week 68|0|||
46975826|NCT02641379|83220450|FG004|Overall Study|PCR positive at Week 68|0|||
46975827|NCT02641379|83220451|FG005|Overall Study|PCR positive at Week 68|0|||
46975828|NCT02641379|83220452|FG006|Overall Study|PCR positive at Week 68|0|||
46975829|NCT02641379|83220453|FG007|Overall Study|PCR positive at Week 68|0|||
46975830|NCT02641379|83220454|FG008|Overall Study|PCR positive at Week 68|0|||
46975831|NCT02641379|83220455|FG009|Overall Study|PCR positive at Week 68|0|||
46975832|NCT02641379|83220456|FG010|Overall Study|PCR positive at Week 68|0|||
46975833|NCT02641379|83220446|FG000|Overall Study|PCR positive at Week 48|0|||
46975834|NCT02641379|83220447|FG001|Overall Study|PCR positive at Week 48|1|||
46975835|NCT02641379|83220448|FG002|Overall Study|PCR positive at Week 48|0|||
46975836|NCT02641379|83220449|FG003|Overall Study|PCR positive at Week 48|0|||
46975837|NCT02641379|83220450|FG004|Overall Study|PCR positive at Week 48|0|||
46975838|NCT02641379|83220451|FG005|Overall Study|PCR positive at Week 48|0|||
46975839|NCT02641379|83220452|FG006|Overall Study|PCR positive at Week 48|0|||
46975840|NCT02641379|83220453|FG007|Overall Study|PCR positive at Week 48|0|||
46975841|NCT02641379|83220454|FG008|Overall Study|PCR positive at Week 48|0|||
46975842|NCT02641379|83220455|FG009|Overall Study|PCR positive at Week 48|0|||
46975843|NCT02641379|83220456|FG010|Overall Study|PCR positive at Week 48|0|||
46975844|NCT02641379|83220446|FG000|Overall Study|PCR not performed at Week 12|0|||
46975845|NCT02641379|83220447|FG001|Overall Study|PCR not performed at Week 12|0|||
46792635|NCT00229723|83011283|FG003|Maintenance Phase|Objective disease progression|6|||
46792636|NCT00229723|83011284|FG004|Maintenance Phase|Objective disease progression|2|||
46792637|NCT00229723|83011285|FG005|Maintenance Phase|Objective disease progression|9|||
46792638|NCT00229723|83011286|FG006|Maintenance Phase|Objective disease progression|5|||
46792639|NCT00229723|83011280|FG000|Maintenance Phase|Clinical progression|4|||
46792640|NCT00229723|83011281|FG001|Maintenance Phase|Clinical progression|1|||
46792641|NCT00229723|83011282|FG002|Maintenance Phase|Clinical progression|2|||
46792642|NCT00229723|83011283|FG003|Maintenance Phase|Clinical progression|2|||
46792643|NCT00229723|83011284|FG004|Maintenance Phase|Clinical progression|1|||
46792644|NCT00229723|83011285|FG005|Maintenance Phase|Clinical progression|1|||
46792645|NCT00229723|83011286|FG006|Maintenance Phase|Clinical progression|1|||
46792646|NCT00229723|83011280|FG000|Maintenance Phase|Lost to Follow-up|0|||
46792647|NCT00229723|83011281|FG001|Maintenance Phase|Lost to Follow-up|1|||
46792648|NCT00229723|83011282|FG002|Maintenance Phase|Lost to Follow-up|2|||
46792649|NCT00229723|83011283|FG003|Maintenance Phase|Lost to Follow-up|2|||
46792650|NCT00229723|83011284|FG004|Maintenance Phase|Lost to Follow-up|0|||
46792651|NCT00229723|83011285|FG005|Maintenance Phase|Lost to Follow-up|0|||
46792652|NCT00229723|83011286|FG006|Maintenance Phase|Lost to Follow-up|1|||
46792653|NCT00229723|83011280|FG000|Maintenance Phase|Informed consent withdrawn|1|||
46792654|NCT00229723|83011281|FG001|Maintenance Phase|Informed consent withdrawn|0|||
46792655|NCT00229723|83011282|FG002|Maintenance Phase|Informed consent withdrawn|0|||
46792656|NCT00229723|83011283|FG003|Maintenance Phase|Informed consent withdrawn|1|||
46792657|NCT00229723|83011284|FG004|Maintenance Phase|Informed consent withdrawn|1|||
46792658|NCT00229723|83011285|FG005|Maintenance Phase|Informed consent withdrawn|1|||
46792659|NCT00229723|83011286|FG006|Maintenance Phase|Informed consent withdrawn|0|||
46792660|NCT00229723|83011280|FG000|Maintenance Phase|Severe non-compliance|3|||
46792661|NCT00229723|83011281|FG001|Maintenance Phase|Severe non-compliance|1|||
46792662|NCT00229723|83011282|FG002|Maintenance Phase|Severe non-compliance|0|||
46975846|NCT02641379|83220448|FG002|Overall Study|PCR not performed at Week 12|1|||
46975847|NCT02641379|83220449|FG003|Overall Study|PCR not performed at Week 12|0|||
46975848|NCT02641379|83220450|FG004|Overall Study|PCR not performed at Week 12|0|||
46975849|NCT02641379|83220451|FG005|Overall Study|PCR not performed at Week 12|0|||
46792663|NCT00229723|83011283|FG003|Maintenance Phase|Severe non-compliance|0|||
46792664|NCT00229723|83011284|FG004|Maintenance Phase|Severe non-compliance|1|||
46792665|NCT00229723|83011285|FG005|Maintenance Phase|Severe non-compliance|0|||
46792666|NCT00229723|83011286|FG006|Maintenance Phase|Severe non-compliance|0|||
46975850|NCT02641379|83220452|FG006|Overall Study|PCR not performed at Week 12|0|||
46975851|NCT02641379|83220453|FG007|Overall Study|PCR not performed at Week 12|0|||
46975852|NCT02641379|83220454|FG008|Overall Study|PCR not performed at Week 12|0|||
46792667|NCT00229723|83011280|FG000|Maintenance Phase|Other|5|||
46975853|NCT02641379|83220455|FG009|Overall Study|PCR not performed at Week 12|0|||
46673928|NCT01159912|82889477|FG001|Overall Study|Adverse Event|2|||
46673929|NCT01159912|82889478|FG002|Overall Study|Adverse Event|3|||
46673930|NCT01159912|82889476|FG000|Overall Study|Lack of Efficacy|23|||
46673931|NCT01159912|82889477|FG001|Overall Study|Lack of Efficacy|15|||
46673932|NCT01159912|82889478|FG002|Overall Study|Lack of Efficacy|14|||
46673933|NCT01159912|82889476|FG000|Overall Study|Protocol Violation|1|||
46792668|NCT00229723|83011281|FG001|Maintenance Phase|Other|4|||
46792669|NCT00229723|83011282|FG002|Maintenance Phase|Other|1|||
46975854|NCT02641379|83220456|FG010|Overall Study|PCR not performed at Week 12|0|||
46975855|NCT02641379|83220446|FG000|Overall Study|No PCR at baseline|0|||
46975856|NCT02641379|83220447|FG001|Overall Study|No PCR at baseline|0|||
46975857|NCT02641379|83220448|FG002|Overall Study|No PCR at baseline|1|||
46975858|NCT02641379|83220449|FG003|Overall Study|No PCR at baseline|0|||
46975859|NCT02641379|83220450|FG004|Overall Study|No PCR at baseline|0|||
46975860|NCT02641379|83220451|FG005|Overall Study|No PCR at baseline|0|||
46975861|NCT02641379|83220452|FG006|Overall Study|No PCR at baseline|0|||
46975862|NCT02641379|83220453|FG007|Overall Study|No PCR at baseline|0|||
46975863|NCT02641379|83220454|FG008|Overall Study|No PCR at baseline|0|||
46975864|NCT02641379|83220455|FG009|Overall Study|No PCR at baseline|0|||
46975865|NCT02641379|83220456|FG010|Overall Study|No PCR at baseline|0|||
46975866|NCT02641379|83220446|FG000|Overall Study|PCR positive at Week 28|0|||
46975867|NCT02641379|83220447|FG001|Overall Study|PCR positive at Week 28|0|||
46975868|NCT02641379|83220448|FG002|Overall Study|PCR positive at Week 28|1|||
46975869|NCT02641379|83220449|FG003|Overall Study|PCR positive at Week 28|0|||
46975870|NCT02641379|83220450|FG004|Overall Study|PCR positive at Week 28|0|||
46975871|NCT02641379|83220451|FG005|Overall Study|PCR positive at Week 28|0|||
46975872|NCT02641379|83220452|FG006|Overall Study|PCR positive at Week 28|0|||
46975873|NCT02641379|83220453|FG007|Overall Study|PCR positive at Week 28|0|||
46975874|NCT02641379|83220454|FG008|Overall Study|PCR positive at Week 28|0|||
46975875|NCT02641379|83220455|FG009|Overall Study|PCR positive at Week 28|0|||
46975876|NCT02641379|83220456|FG010|Overall Study|PCR positive at Week 28|0|||
46975877|NCT02641379|83220446|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
46975878|NCT02641379|83220447|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
46975879|NCT02641379|83220448|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
46975880|NCT02641379|83220449|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
46975881|NCT02641379|83220450|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
46975882|NCT02641379|83220451|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
46975883|NCT02641379|83220452|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
46975884|NCT02641379|83220453|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
46975885|NCT02641379|83220454|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
46975886|NCT02641379|83220455|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
46975887|NCT02641379|83220456|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
47078563|NCT03112603|83383776|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
47078564|NCT03112603|83383777|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
47078565|NCT03112603|83383778|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
47078566|NCT03112603|83383776|FG000|End of Randomization Period|Physician Decision|43|||
47078567|NCT03112603|83383777|FG001|End of Randomization Period|Physician Decision|18|||
46792670|NCT00229723|83011283|FG003|Maintenance Phase|Other|2|||
46792671|NCT00229723|83011284|FG004|Maintenance Phase|Other|3|||
46792672|NCT00229723|83011285|FG005|Maintenance Phase|Other|3|||
46792673|NCT00229723|83011286|FG006|Maintenance Phase|Other|1|||
46792674|NCT00606684|83011308|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
46792675|NCT00606684|83011309|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
46792676|NCT00606684|83011310|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
46975888|NCT02641379|83220446|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
47078568|NCT03112603|83383778|FG002|End of Randomization Period|Physician Decision|0|||
46975889|NCT02641379|83220447|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
47078569|NCT03112603|83383776|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
47078570|NCT03112603|83383777|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
46673934|NCT01159912|82889477|FG001|Overall Study|Protocol Violation|2|||
46673935|NCT01159912|82889478|FG002|Overall Study|Protocol Violation|3|||
46673936|NCT01159912|82889476|FG000|Overall Study|Lost to Follow-up|4|||
46792677|NCT00606684|83011311|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
46975890|NCT02641379|83220448|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
46975891|NCT02641379|83220449|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
46975892|NCT02641379|83220450|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
46792678|NCT00606684|83011312|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
46792679|NCT00606684|83011313|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
46792680|NCT00606684|83011314|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
46792681|NCT00606684|83011308|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
46792682|NCT00606684|83011309|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
46792683|NCT00606684|83011310|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
46792684|NCT00606684|83011311|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
46792685|NCT00606684|83011312|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
46792686|NCT00606684|83011313|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
46792687|NCT00606684|83011314|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
46792688|NCT00606684|83011308|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
46792689|NCT00606684|83011309|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
46792690|NCT00606684|83011310|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
46792691|NCT00606684|83011311|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
46792692|NCT00606684|83011312|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
46792693|NCT00606684|83011313|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
47078571|NCT03112603|83383778|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
47078572|NCT03112603|83383776|FG000|End of Randomization Period|Death|10|||
47078573|NCT03112603|83383777|FG001|End of Randomization Period|Death|7|||
47078574|NCT03112603|83383778|FG002|End of Randomization Period|Death|0|||
47078575|NCT03112603|83383776|FG000|End of Randomization Period|Disease Relapse|12|||
47078576|NCT03112603|83383777|FG001|End of Randomization Period|Disease Relapse|7|||
47078577|NCT03112603|83383778|FG002|End of Randomization Period|Disease Relapse|0|||
47078578|NCT03112603|83383776|FG000|End of Randomization Period|Lack of Efficacy|25|||
47078579|NCT03112603|83383777|FG001|End of Randomization Period|Lack of Efficacy|77|||
47078580|NCT03112603|83383778|FG002|End of Randomization Period|Lack of Efficacy|0|||
46792694|NCT00606684|83011314|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
46975893|NCT02641379|83220451|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
46975894|NCT02641379|83220452|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
46975895|NCT02641379|83220453|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
46975896|NCT02641379|83220454|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
46975897|NCT02641379|83220455|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
46975898|NCT02641379|83220456|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
46975899|NCT02641379|83220446|FG000|Overall Study|Baseline viral load unavailable|0|||
46975900|NCT02641379|83220447|FG001|Overall Study|Baseline viral load unavailable|0|||
46975901|NCT02641379|83220448|FG002|Overall Study|Baseline viral load unavailable|0|||
46975902|NCT02641379|83220449|FG003|Overall Study|Baseline viral load unavailable|1|||
46975903|NCT02641379|83220450|FG004|Overall Study|Baseline viral load unavailable|0|||
46792695|NCT00606684|83011308|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
46792696|NCT00606684|83011309|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
46792697|NCT00606684|83011310|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
46792698|NCT00606684|83011311|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
46792699|NCT00606684|83011312|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
46975904|NCT02641379|83220451|FG005|Overall Study|Baseline viral load unavailable|0|||
46975905|NCT02641379|83220452|FG006|Overall Study|Baseline viral load unavailable|0|||
46975906|NCT02641379|83220453|FG007|Overall Study|Baseline viral load unavailable|0|||
46975907|NCT02641379|83220454|FG008|Overall Study|Baseline viral load unavailable|0|||
46975908|NCT02641379|83220455|FG009|Overall Study|Baseline viral load unavailable|0|||
46975909|NCT02641379|83220456|FG010|Overall Study|Baseline viral load unavailable|0|||
46975910|NCT02641379|83220446|FG000|Overall Study|Blood could not be drawn|0|||
46975911|NCT02641379|83220447|FG001|Overall Study|Blood could not be drawn|0|||
46975912|NCT02641379|83220448|FG002|Overall Study|Blood could not be drawn|0|||
46792700|NCT00606684|83011313|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
46792701|NCT00606684|83011314|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
46792702|NCT00606684|83011308|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
46975913|NCT02641379|83220449|FG003|Overall Study|Blood could not be drawn|0|||
46975914|NCT02641379|83220450|FG004|Overall Study|Blood could not be drawn|1|||
46975915|NCT02641379|83220451|FG005|Overall Study|Blood could not be drawn|0|||
46975916|NCT02641379|83220452|FG006|Overall Study|Blood could not be drawn|0|||
46975917|NCT02641379|83220453|FG007|Overall Study|Blood could not be drawn|0|||
46975918|NCT02641379|83220454|FG008|Overall Study|Blood could not be drawn|0|||
46975919|NCT02641379|83220455|FG009|Overall Study|Blood could not be drawn|0|||
46975920|NCT02641379|83220456|FG010|Overall Study|Blood could not be drawn|0|||
46975921|NCT02641379|83220446|FG000|Overall Study|Protocol Violation|0|||
46975922|NCT02641379|83220447|FG001|Overall Study|Protocol Violation|0|||
46975923|NCT02641379|83220448|FG002|Overall Study|Protocol Violation|0|||
46975924|NCT02641379|83220449|FG003|Overall Study|Protocol Violation|0|||
46975925|NCT02641379|83220450|FG004|Overall Study|Protocol Violation|2|||
46975926|NCT02641379|83220451|FG005|Overall Study|Protocol Violation|0|||
46975927|NCT02641379|83220452|FG006|Overall Study|Protocol Violation|0|||
46975928|NCT02641379|83220453|FG007|Overall Study|Protocol Violation|0|||
46975929|NCT02641379|83220454|FG008|Overall Study|Protocol Violation|1|||
46975930|NCT02641379|83220455|FG009|Overall Study|Protocol Violation|0|||
47078581|NCT03112603|83383776|FG000|End of Randomization Period|Adverse Event|32|||
47078582|NCT03112603|83383777|FG001|End of Randomization Period|Adverse Event|12|||
47078583|NCT03112603|83383778|FG002|End of Randomization Period|Adverse Event|0|||
47078584|NCT03112603|83383776|FG000|End of Cross Over Period|Death|0|||
46792703|NCT00606684|83011309|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
46975931|NCT02641379|83220456|FG010|Overall Study|Protocol Violation|0|||
46975932|NCT02641379|83220446|FG000|Overall Study|Participation in sili rescue study|0|||
46975933|NCT02641379|83220447|FG001|Overall Study|Participation in sili rescue study|0|||
46975934|NCT02641379|83220448|FG002|Overall Study|Participation in sili rescue study|0|||
46975935|NCT02641379|83220449|FG003|Overall Study|Participation in sili rescue study|0|||
47078585|NCT03112603|83383777|FG001|End of Cross Over Period|Death|0|||
46975936|NCT02641379|83220450|FG004|Overall Study|Participation in sili rescue study|0|||
46975937|NCT02641379|83220451|FG005|Overall Study|Participation in sili rescue study|1|||
47078586|NCT03112603|83383778|FG002|End of Cross Over Period|Death|2|||
47078587|NCT03112603|83383776|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
47078588|NCT03112603|83383777|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
47078589|NCT03112603|83383778|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
47078590|NCT03112603|83383776|FG000|End of Cross Over Period|Physician Decision|0|||
47078591|NCT03112603|83383777|FG001|End of Cross Over Period|Physician Decision|0|||
47078592|NCT03112603|83383778|FG002|End of Cross Over Period|Physician Decision|29|||
47078593|NCT03112603|83383776|FG000|End of Cross Over Period|Lack of Efficacy|0|||
47078594|NCT03112603|83383777|FG001|End of Cross Over Period|Lack of Efficacy|0|||
47078595|NCT03112603|83383778|FG002|End of Cross Over Period|Lack of Efficacy|8|||
47078596|NCT03112603|83383776|FG000|End of Cross Over Period|Adverse Event|0|||
46975938|NCT02641379|83220452|FG006|Overall Study|Participation in sili rescue study|0|||
46975939|NCT02641379|83220453|FG007|Overall Study|Participation in sili rescue study|0|||
46975940|NCT02641379|83220454|FG008|Overall Study|Participation in sili rescue study|0|||
46975941|NCT02641379|83220455|FG009|Overall Study|Participation in sili rescue study|0|||
46975942|NCT02641379|83220456|FG010|Overall Study|Participation in sili rescue study|0|||
46975943|NCT02641379|83220446|FG000|Overall Study|Lost to Follow-up|0|||
46975944|NCT02641379|83220447|FG001|Overall Study|Lost to Follow-up|0|||
46975945|NCT02641379|83220448|FG002|Overall Study|Lost to Follow-up|0|||
46975946|NCT02641379|83220449|FG003|Overall Study|Lost to Follow-up|0|||
46975947|NCT02641379|83220450|FG004|Overall Study|Lost to Follow-up|0|||
46975948|NCT02641379|83220451|FG005|Overall Study|Lost to Follow-up|0|||
46975949|NCT02641379|83220452|FG006|Overall Study|Lost to Follow-up|0|||
46975950|NCT02641379|83220453|FG007|Overall Study|Lost to Follow-up|0|||
46975951|NCT02641379|83220454|FG008|Overall Study|Lost to Follow-up|1|||
46975952|NCT02641379|83220455|FG009|Overall Study|Lost to Follow-up|0|||
46975953|NCT02641379|83220456|FG010|Overall Study|Lost to Follow-up|0|||
46975954|NCT02641379|83220446|FG000|Overall Study|Source data not found|0|||
46975955|NCT02641379|83220447|FG001|Overall Study|Source data not found|0|||
46975956|NCT02641379|83220448|FG002|Overall Study|Source data not found|0|||
46975957|NCT02641379|83220449|FG003|Overall Study|Source data not found|0|||
46975958|NCT02641379|83220450|FG004|Overall Study|Source data not found|0|||
46975959|NCT02641379|83220451|FG005|Overall Study|Source data not found|1|||
46975960|NCT02641379|83220452|FG006|Overall Study|Source data not found|0|||
46975961|NCT02641379|83220453|FG007|Overall Study|Source data not found|0|||
46975962|NCT02641379|83220454|FG008|Overall Study|Source data not found|0|||
46975963|NCT02641379|83220455|FG009|Overall Study|Source data not found|0|||
46975964|NCT02641379|83220456|FG010|Overall Study|Source data not found|0|||
46975965|NCT02641379|83220446|FG000|Overall Study|Participant showed weight reduction|0|||
46975966|NCT02641379|83220447|FG001|Overall Study|Participant showed weight reduction|0|||
46975967|NCT02641379|83220448|FG002|Overall Study|Participant showed weight reduction|0|||
46975968|NCT02641379|83220449|FG003|Overall Study|Participant showed weight reduction|0|||
46975969|NCT02641379|83220450|FG004|Overall Study|Participant showed weight reduction|0|||
46975970|NCT02641379|83220451|FG005|Overall Study|Participant showed weight reduction|0|||
46975971|NCT02641379|83220452|FG006|Overall Study|Participant showed weight reduction|0|||
46975972|NCT02641379|83220453|FG007|Overall Study|Participant showed weight reduction|1|||
46975973|NCT02641379|83220454|FG008|Overall Study|Participant showed weight reduction|0|||
46975974|NCT02641379|83220455|FG009|Overall Study|Participant showed weight reduction|0|||
46975975|NCT02641379|83220456|FG010|Overall Study|Participant showed weight reduction|0|||
46975976|NCT02641379|83220446|FG000|Overall Study|Non-response Week 12|0|||
46975977|NCT02641379|83220447|FG001|Overall Study|Non-response Week 12|0|||
46975978|NCT02641379|83220448|FG002|Overall Study|Non-response Week 12|0|||
46975979|NCT02641379|83220449|FG003|Overall Study|Non-response Week 12|0|||
46975980|NCT02641379|83220450|FG004|Overall Study|Non-response Week 12|0|||
46975981|NCT02641379|83220451|FG005|Overall Study|Non-response Week 12|0|||
46975982|NCT02641379|83220452|FG006|Overall Study|Non-response Week 12|0|||
46975983|NCT02641379|83220453|FG007|Overall Study|Non-response Week 12|1|||
46975984|NCT02641379|83220454|FG008|Overall Study|Non-response Week 12|0|||
46975985|NCT02641379|83220455|FG009|Overall Study|Non-response Week 12|0|||
46975986|NCT02641379|83220456|FG010|Overall Study|Non-response Week 12|0|||
46975987|NCT02641379|83220446|FG000|Overall Study|No 2 Log drop at Week 12|0|||
46975988|NCT02641379|83220447|FG001|Overall Study|No 2 Log drop at Week 12|0|||
46975989|NCT02641379|83220448|FG002|Overall Study|No 2 Log drop at Week 12|0|||
46975990|NCT02641379|83220449|FG003|Overall Study|No 2 Log drop at Week 12|0|||
46975991|NCT02641379|83220450|FG004|Overall Study|No 2 Log drop at Week 12|0|||
46975992|NCT02641379|83220451|FG005|Overall Study|No 2 Log drop at Week 12|0|||
46975993|NCT02641379|83220452|FG006|Overall Study|No 2 Log drop at Week 12|0|||
46975994|NCT02641379|83220453|FG007|Overall Study|No 2 Log drop at Week 12|0|||
46975995|NCT02641379|83220454|FG008|Overall Study|No 2 Log drop at Week 12|0|||
46975996|NCT02641379|83220455|FG009|Overall Study|No 2 Log drop at Week 12|0|||
46975997|NCT02641379|83220456|FG010|Overall Study|No 2 Log drop at Week 12|1|||
46975998|NCT02641379|83220446|FG000|Overall Study|Negative PCR result|0|||
47078597|NCT03112603|83383777|FG001|End of Cross Over Period|Adverse Event|0|||
47078598|NCT03112603|83383778|FG002|End of Cross Over Period|Adverse Event|6|||
46975999|NCT02641379|83220447|FG001|Overall Study|Negative PCR result|0|||
46976000|NCT02641379|83220448|FG002|Overall Study|Negative PCR result|0|||
46976001|NCT02641379|83220449|FG003|Overall Study|Negative PCR result|0|||
46976002|NCT02641379|83220450|FG004|Overall Study|Negative PCR result|0|||
46976003|NCT02641379|83220451|FG005|Overall Study|Negative PCR result|0|||
46976004|NCT02641379|83220452|FG006|Overall Study|Negative PCR result|0|||
46976005|NCT02641379|83220453|FG007|Overall Study|Negative PCR result|0|||
46976006|NCT02641379|83220454|FG008|Overall Study|Negative PCR result|0|||
47078599|NCT03112603|83383776|FG000|End of Cross Over Period|Disease Relapse|0|||
47078600|NCT03112603|83383777|FG001|End of Cross Over Period|Disease Relapse|0|||
46976007|NCT02641379|83220455|FG009|Overall Study|Negative PCR result|1|||
46976008|NCT02641379|83220456|FG010|Overall Study|Negative PCR result|0|||
46976009|NCT02641379|83220446|FG000|Overall Study|Participant's PCR high|0|||
46976010|NCT02641379|83220447|FG001|Overall Study|Participant's PCR high|0|||
46976011|NCT02641379|83220448|FG002|Overall Study|Participant's PCR high|0|||
46976012|NCT02641379|83220449|FG003|Overall Study|Participant's PCR high|0|||
46976013|NCT02641379|83220450|FG004|Overall Study|Participant's PCR high|0|||
46976014|NCT02641379|83220451|FG005|Overall Study|Participant's PCR high|0|||
46976015|NCT02641379|83220452|FG006|Overall Study|Participant's PCR high|0|||
46976016|NCT02641379|83220453|FG007|Overall Study|Participant's PCR high|1|||
46976017|NCT02641379|83220454|FG008|Overall Study|Participant's PCR high|0|||
46976018|NCT02641379|83220455|FG009|Overall Study|Participant's PCR high|0|||
46976019|NCT02641379|83220456|FG010|Overall Study|Participant's PCR high|0|||
46976020|NCT02641379|83220446|FG000|Overall Study|Participant treated after Week 24|0|||
46976021|NCT02641379|83220447|FG001|Overall Study|Participant treated after Week 24|0|||
46976022|NCT02641379|83220448|FG002|Overall Study|Participant treated after Week 24|0|||
46976023|NCT02641379|83220449|FG003|Overall Study|Participant treated after Week 24|0|||
46976024|NCT02641379|83220450|FG004|Overall Study|Participant treated after Week 24|0|||
46976025|NCT02641379|83220451|FG005|Overall Study|Participant treated after Week 24|0|||
46976026|NCT02641379|83220452|FG006|Overall Study|Participant treated after Week 24|0|||
46976027|NCT02641379|83220453|FG007|Overall Study|Participant treated after Week 24|0|||
46976028|NCT02641379|83220454|FG008|Overall Study|Participant treated after Week 24|1|||
46976029|NCT02641379|83220455|FG009|Overall Study|Participant treated after Week 24|0|||
46976030|NCT02641379|83220456|FG010|Overall Study|Participant treated after Week 24|0|||
46976031|NCT02641379|83220446|FG000|Overall Study|Missing PCR result at Week 8|0|||
46976032|NCT02641379|83220447|FG001|Overall Study|Missing PCR result at Week 8|0|||
46976033|NCT02641379|83220448|FG002|Overall Study|Missing PCR result at Week 8|0|||
46976034|NCT02641379|83220449|FG003|Overall Study|Missing PCR result at Week 8|0|||
46976035|NCT02641379|83220450|FG004|Overall Study|Missing PCR result at Week 8|0|||
46976036|NCT02641379|83220451|FG005|Overall Study|Missing PCR result at Week 8|0|||
46976037|NCT02641379|83220452|FG006|Overall Study|Missing PCR result at Week 8|0|||
46976038|NCT02641379|83220453|FG007|Overall Study|Missing PCR result at Week 8|0|||
46976039|NCT02641379|83220454|FG008|Overall Study|Missing PCR result at Week 8|0|||
46976040|NCT02641379|83220455|FG009|Overall Study|Missing PCR result at Week 8|1|||
46976041|NCT02641379|83220456|FG010|Overall Study|Missing PCR result at Week 8|0|||
46976042|NCT02641379|83220446|FG000|Overall Study|PCR positive|0|||
46976043|NCT02641379|83220447|FG001|Overall Study|PCR positive|0|||
46976044|NCT02641379|83220448|FG002|Overall Study|PCR positive|0|||
46976045|NCT02641379|83220449|FG003|Overall Study|PCR positive|0|||
46976046|NCT02641379|83220450|FG004|Overall Study|PCR positive|0|||
46976047|NCT02641379|83220451|FG005|Overall Study|PCR positive|0|||
46976048|NCT02641379|83220452|FG006|Overall Study|PCR positive|1|||
46673937|NCT01159912|82889477|FG001|Overall Study|Lost to Follow-up|0|||
46673938|NCT01159912|82889478|FG002|Overall Study|Lost to Follow-up|0|||
46673939|NCT01159912|82889476|FG000|Overall Study|Physician Decision|0|||
46792704|NCT00606684|83011310|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
46792705|NCT00606684|83011311|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
46792706|NCT00606684|83011312|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
46792707|NCT00606684|83011313|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
46976049|NCT02641379|83220453|FG007|Overall Study|PCR positive|0|||
46976050|NCT02641379|83220454|FG008|Overall Study|PCR positive|0|||
46976051|NCT02641379|83220455|FG009|Overall Study|PCR positive|0|||
46976052|NCT02641379|83220456|FG010|Overall Study|PCR positive|0|||
46976053|NCT02660983|83220487|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
46976054|NCT02660983|83220488|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
46976055|NCT02660983|83220487|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
46976056|NCT02660983|83220488|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
46976057|NCT02660983|83220487|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
46673940|NCT01159912|82889477|FG001|Overall Study|Physician Decision|0|||
46673941|NCT01159912|82889478|FG002|Overall Study|Physician Decision|3|||
46673942|NCT01159912|82889476|FG000|Overall Study|Withdrawal by Subject|10|||
46673943|NCT01159912|82889477|FG001|Overall Study|Withdrawal by Subject|3|||
46976058|NCT02660983|83220488|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
46976059|NCT02660983|83220487|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
46976060|NCT02660983|83220488|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
46976061|NCT02660983|83220487|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
46976062|NCT02660983|83220488|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
46976063|NCT02660983|83220487|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
46976064|NCT02660983|83220488|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
46673944|NCT01159912|82889478|FG002|Overall Study|Withdrawal by Subject|3|||
46673945|NCT01159600|82889494|FG000|Overall Study|Not treated|0|||
46854790|NCT03409276|83070542|FG002|Overall Study|Lost to Follow-up|0|||
46854791|NCT03409276|83070543|FG003|Overall Study|Lost to Follow-up|2|||
46854792|NCT03409276|83070544|FG004|Overall Study|Lost to Follow-up|2|||
46854793|NCT00004562|83070562|FG000|Overall Study|Lost to Follow-up|102|||
46854794|NCT00004562|83070563|FG001|Overall Study|Lost to Follow-up|91|||
46854795|NCT00004412|83070572|FG000|Randomized Period|Moved to Crossover Period|3|||
46854796|NCT00004412|83070573|FG001|Randomized Period|Moved to Crossover Period|0|||
46854797|NCT00004412|83070574|FG002|Randomized Period|Moved to Crossover Period|0|||
46854798|NCT03440320|83070584|FG000|Overall Study|Withdrawal by Subject|0|||
46854799|NCT03440320|83070585|FG001|Overall Study|Withdrawal by Subject|1|||
46854800|NCT00004088|83070593|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
46854801|NCT00004088|83070593|FG000|Overall Study|Withdrawal by Subject|1|||
46854802|NCT00004088|83070593|FG000|Overall Study|Protocol Violation|3|||
46854803|NCT00004088|83070593|FG000|Overall Study|Physician Decision|1|||
46854804|NCT03439072|83070597|FG000|Overall Study|Withdrawal by Subject|2|||
46854805|NCT03439072|83070598|FG001|Overall Study|Withdrawal by Subject|3|||
46854806|NCT03439072|83070597|FG000|Overall Study|Physician Decision|0|||
46854807|NCT03439072|83070598|FG001|Overall Study|Physician Decision|1|||
46854808|NCT00078312|83070604|FG000|Overall Study|Adverse Event|43|||
46976065|NCT02660983|83220487|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
46976066|NCT02660983|83220488|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
46976067|NCT01953328|83220503|FG000|Overall Study|Withdrawal by Subject|0|||
46976068|NCT01953328|83220504|FG001|Overall Study|Withdrawal by Subject|0|||
47078601|NCT03112603|83383778|FG002|End of Cross Over Period|Disease Relapse|2|||
47078602|NCT02725528|83383793|FG000|Overall Study|Lost to Follow-up|1|||
47078603|NCT02725528|83383794|FG001|Overall Study|Lost to Follow-up|4|||
47078604|NCT02725528|83383793|FG000|Overall Study|Withdrawal by Subject|0|||
47078605|NCT02725528|83383794|FG001|Overall Study|Withdrawal by Subject|1|||
47078606|NCT02627963|83383811|FG000|Overall Study|Randomized but not treated|2|||
47078607|NCT02627963|83383812|FG001|Overall Study|Randomized but not treated|6|||
47078608|NCT02585258|83383820|FG000|Overall Study|Adverse Event|28|||
47078609|NCT02585258|83383821|FG001|Overall Study|Adverse Event|29|||
47078610|NCT02585258|83383820|FG000|Overall Study|Death|3|||
47078611|NCT02585258|83383821|FG001|Overall Study|Death|2|||
47078612|NCT02585258|83383820|FG000|Overall Study|Lack of Efficacy|7|||
47078613|NCT02585258|83383821|FG001|Overall Study|Lack of Efficacy|9|||
47078614|NCT02585258|83383820|FG000|Overall Study|includes covid-related access problems|42|||
47078615|NCT02585258|83383821|FG001|Overall Study|includes covid-related access problems|46|||
47078616|NCT02585258|83383820|FG000|Overall Study|Lost to Follow-up|5|||
47078617|NCT02585258|83383821|FG001|Overall Study|Lost to Follow-up|2|||
47078618|NCT02132611|83383838|FG000|Overall Study|Death|2|||
47078619|NCT01941030|83383844|FG000|Overall Study|Death|3|||
47078620|NCT01941030|83383845|FG001|Overall Study|Death|2|||
47078621|NCT01941030|83383844|FG000|Overall Study|Lost to Follow-up|6|||
47078622|NCT01941030|83383845|FG001|Overall Study|Lost to Follow-up|5|||
47078623|NCT01941030|83383844|FG000|Overall Study|Withdrawal by Subject|4|||
47078624|NCT01941030|83383845|FG001|Overall Study|Withdrawal by Subject|6|||
46673946|NCT01159600|82889495|FG001|Overall Study|Not treated|0|||
46854809|NCT00078312|83070604|FG000|Overall Study|Lack of Efficacy|15|||
46976069|NCT01953328|83220505|FG002|Overall Study|Withdrawal by Subject|0|||
47078625|NCT01092416|83383856|FG000|Enrollment|Atherectomy device not inserted|3|||
47078626|NCT01092416|83383856|FG000|30-Day Follow-up|Death|2|||
47078627|NCT01092416|83383856|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
47078628|NCT01092416|83383856|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
47078629|NCT01092416|83383856|FG000|12-Month Follow-up|Death|16|||
47078630|NCT01092416|83383856|FG000|12-Month Follow-up|Lost to Follow-up|4|||
47078631|NCT01092416|83383856|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
47078632|NCT01092416|83383856|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
47078633|NCT01092416|83383856|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
47078634|NCT00701220|83383865|FG000|Overall Study|Withdrawal by Subject|0|||
47078635|NCT00701220|83383866|FG001|Overall Study|Withdrawal by Subject|2|||
46673947|NCT01159600|82889496|FG002|Overall Study|Not treated|1|||
46673948|NCT01159600|82889497|FG003|Overall Study|Not treated|0|||
46673949|NCT01159600|82889498|FG004|Overall Study|Not treated|0|||
46673950|NCT01159600|82889499|FG005|Overall Study|Not treated|1|||
46673951|NCT01159600|82889500|FG006|Overall Study|Not treated|2|||
46792708|NCT00606684|83011314|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
46792709|NCT00606684|83011308|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
46792710|NCT00606684|83011309|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
46792711|NCT00606684|83011310|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
46792712|NCT00606684|83011311|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
46792713|NCT00606684|83011312|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
46792714|NCT00606684|83011313|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
46792715|NCT00606684|83011314|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
46792716|NCT00606684|83011308|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
46792717|NCT00606684|83011309|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
46792718|NCT00606684|83011310|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
46792719|NCT00606684|83011311|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
46792720|NCT00606684|83011312|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
46792721|NCT00606684|83011313|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
47078636|NCT00701220|83383865|FG000|Overall Study|Protocol Violation|2|||
47078637|NCT00701220|83383866|FG001|Overall Study|Protocol Violation|0|||
47078638|NCT00559845|83383940|FG000|Overall Study|Withdrew Consent|1|||
47078639|NCT00559845|83383940|FG000|Overall Study|Disease Progression|1|||
46976070|NCT01953328|83220506|FG003|Overall Study|Withdrawal by Subject|0|||
46976071|NCT01953328|83220507|FG004|Overall Study|Withdrawal by Subject|1|||
46976072|NCT01953328|83220508|FG005|Overall Study|Withdrawal by Subject|0|||
46976073|NCT01953328|83220509|FG006|Overall Study|Withdrawal by Subject|0|||
46976074|NCT01953328|83220510|FG007|Overall Study|Withdrawal by Subject|0|||
46976075|NCT01953328|83220503|FG000|Overall Study|Lost to Follow-up|0|||
46976076|NCT01953328|83220504|FG001|Overall Study|Lost to Follow-up|0|||
46976077|NCT01953328|83220505|FG002|Overall Study|Lost to Follow-up|0|||
46976078|NCT01953328|83220506|FG003|Overall Study|Lost to Follow-up|0|||
46976079|NCT01953328|83220507|FG004|Overall Study|Lost to Follow-up|1|||
46976080|NCT01953328|83220508|FG005|Overall Study|Lost to Follow-up|0|||
46976081|NCT01953328|83220509|FG006|Overall Study|Lost to Follow-up|0|||
46976082|NCT01953328|83220510|FG007|Overall Study|Lost to Follow-up|0|||
46976083|NCT02640755|83220530|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
46976084|NCT02640755|83220531|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
46976085|NCT02640755|83220530|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
46976086|NCT02640755|83220531|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
46976087|NCT02640755|83220530|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
46976088|NCT02640755|83220531|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
46976089|NCT02640677|83220538|FG000|Overall Study|Lost to Follow-up|1|||
46976090|NCT02640677|83220538|FG000|Overall Study|Withdrawal by Subject|1|||
46976091|NCT02643251|83220544|FG000|Overall Study|Adverse Event|3|||
46976092|NCT02643251|83220545|FG001|Overall Study|Adverse Event|1|||
46976093|NCT02643251|83220544|FG000|Overall Study|Withdrawal by Subject|2|||
46976094|NCT02643251|83220545|FG001|Overall Study|Withdrawal by Subject|0|||
46976095|NCT02643251|83220544|FG000|Overall Study|Lost to Follow-up|4|||
46976096|NCT02643251|83220545|FG001|Overall Study|Lost to Follow-up|1|||
46976097|NCT02643251|83220544|FG000|Overall Study|Protocol Violation|1|||
46976098|NCT02643251|83220545|FG001|Overall Study|Protocol Violation|0|||
46976099|NCT02643251|83220544|FG000|Overall Study|PI Decision to terminate patient|1|||
46976100|NCT02643251|83220545|FG001|Overall Study|PI Decision to terminate patient|0|||
46976101|NCT01970878|83220555|FG000|Overall Study|Withdrawal by Subject|11|||
47078640|NCT00559845|83383940|FG000|Overall Study|Adverse Event|3|||
47078641|NCT00559845|83383940|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
47078642|NCT00559845|83383940|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
47078643|NCT01393964|83384043|FG000|Overall Study|Disease Progression|4|||
47078644|NCT01393964|83384044|FG001|Overall Study|Disease Progression|3|||
47078645|NCT01393964|83384045|FG002|Overall Study|Disease Progression|5|||
47078646|NCT01393964|83384043|FG000|Overall Study|Study drug toxicity|1|||
47078647|NCT01393964|83384044|FG001|Overall Study|Study drug toxicity|0|||
46792722|NCT00606684|83011314|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
46792723|NCT00606684|83011308|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46792724|NCT00606684|83011309|FG001|Double-Blind Treatment Period|Adverse Event|3|||
46792725|NCT00606684|83011310|FG002|Double-Blind Treatment Period|Adverse Event|2|||
46792726|NCT00606684|83011311|FG003|Double-Blind Treatment Period|Adverse Event|4|||
46792727|NCT00606684|83011312|FG004|Double-Blind Treatment Period|Adverse Event|2|||
46792728|NCT00606684|83011313|FG005|Double-Blind Treatment Period|Adverse Event|0|||
46792729|NCT00606684|83011314|FG006|Double-Blind Treatment Period|Adverse Event|1|||
46792730|NCT00606684|83011308|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
46792731|NCT00606684|83011309|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
46792732|NCT00606684|83011310|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
46792733|NCT00606684|83011311|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
46792734|NCT00606684|83011312|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
46792735|NCT00606684|83011313|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
46792736|NCT00606684|83011314|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
46792737|NCT00606684|83011308|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
46792738|NCT00606684|83011309|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
46792739|NCT00606684|83011310|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
46792740|NCT00606684|83011311|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
46792741|NCT00606684|83011312|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
46792742|NCT00606684|83011313|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
46792743|NCT00606684|83011314|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
46976102|NCT01970878|83220556|FG001|Overall Study|Withdrawal by Subject|10|||
46976103|NCT01970878|83220557|FG002|Overall Study|Withdrawal by Subject|14|||
46976104|NCT01970878|83220558|FG003|Overall Study|Withdrawal by Subject|7|||
46976105|NCT01970878|83220555|FG000|Overall Study|Lost to Follow-up|1|||
47078648|NCT01393964|83384045|FG002|Overall Study|Study drug toxicity|0|||
46792744|NCT00606684|83011308|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
47078649|NCT01393964|83384043|FG000|Overall Study|Withdrawal by Subject|0|||
46854810|NCT00078312|83070604|FG000|Overall Study|Lost to Follow-up|41|||
46854811|NCT00078312|83070604|FG000|Overall Study|Physician Decision|9|||
46792745|NCT00606684|83011309|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
46792746|NCT00606684|83011310|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
46792747|NCT00606684|83011311|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
46792748|NCT00606684|83011312|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
46792749|NCT00606684|83011313|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
46792750|NCT00606684|83011314|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
46854812|NCT00078312|83070604|FG000|Overall Study|Protocol Violation|3|||
46854813|NCT00078312|83070604|FG000|Overall Study|Withdrawal by Subject|33|||
46976106|NCT01970878|83220556|FG001|Overall Study|Lost to Follow-up|3|||
46792751|NCT00606684|83011308|FG000|Double-Blind Treatment Period|Physician Decision|0|||
46792752|NCT00606684|83011309|FG001|Double-Blind Treatment Period|Physician Decision|5|||
46854814|NCT00078312|83070604|FG000|Overall Study|Miscellaneous|33|||
46854815|NCT00003896|83070608|FG000|Overall Study|Adverse Event|16|||
46854816|NCT00003896|83070608|FG000|Overall Study|Withdrawal by Subject|1|||
46854817|NCT00003896|83070608|FG000|Overall Study|Lack of Efficacy|1|||
46854818|NCT00003896|83070608|FG000|Overall Study|Death|3|||
46854819|NCT00003896|83070608|FG000|Overall Study|not protocol specified|3|||
46854820|NCT00003896|83070608|FG000|Overall Study|ineligible|5|||
46854821|NCT00003830|83070615|FG000|Overall Study|No follow up data|3|||
46854822|NCT00003830|83070616|FG001|Overall Study|No follow up data|0|||
46854823|NCT00003830|83070615|FG000|Overall Study|Sentinel node positive patients|829|||
46854824|NCT00003830|83070616|FG001|Overall Study|Sentinel node positive patients|793|||
46854825|NCT03407482|83070624|FG000|Overall Study|Adverse Event|12|||
46854826|NCT03407482|83070624|FG000|Overall Study|Disease Relapse|1|||
46854827|NCT03407482|83070624|FG000|Overall Study|Lost to Follow-up|1|||
46854828|NCT03407482|83070624|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46854829|NCT03407482|83070624|FG000|Overall Study|Pregnancy|2|||
46976107|NCT01970878|83220557|FG002|Overall Study|Lost to Follow-up|2|||
46976108|NCT01970878|83220558|FG003|Overall Study|Lost to Follow-up|4|||
46976109|NCT01970878|83220555|FG000|Overall Study|Administrative Reasons|1|||
46976110|NCT01970878|83220556|FG001|Overall Study|Administrative Reasons|0|||
46976111|NCT01970878|83220557|FG002|Overall Study|Administrative Reasons|0|||
46976112|NCT01970878|83220558|FG003|Overall Study|Administrative Reasons|4|||
46976113|NCT01970878|83220555|FG000|Overall Study|Lack of Efficacy|2|||
46976114|NCT01970878|83220556|FG001|Overall Study|Lack of Efficacy|1|||
46976115|NCT01970878|83220557|FG002|Overall Study|Lack of Efficacy|2|||
46976116|NCT01970878|83220558|FG003|Overall Study|Lack of Efficacy|0|||
46976117|NCT01970878|83220555|FG000|Overall Study|Adverse Event|12|||
46976118|NCT01970878|83220556|FG001|Overall Study|Adverse Event|7|||
46976119|NCT01970878|83220557|FG002|Overall Study|Adverse Event|4|||
46976120|NCT01970878|83220558|FG003|Overall Study|Adverse Event|3|||
46976121|NCT01970878|83220555|FG000|Overall Study|Protocol Specified Criteria|10|||
46976122|NCT01970878|83220556|FG001|Overall Study|Protocol Specified Criteria|4|||
46976123|NCT01970878|83220557|FG002|Overall Study|Protocol Specified Criteria|3|||
46976124|NCT01970878|83220558|FG003|Overall Study|Protocol Specified Criteria|6|||
47078650|NCT01393964|83384044|FG001|Overall Study|Withdrawal by Subject|0|||
46673952|NCT01159600|82889501|FG007|Overall Study|Not treated|2|||
46673953|NCT01159600|82889494|FG000|Overall Study|Adverse Event|7|||
46673954|NCT01159600|82889495|FG001|Overall Study|Adverse Event|2|||
47078651|NCT01393964|83384045|FG002|Overall Study|Withdrawal by Subject|1|||
47078652|NCT01393964|83384043|FG000|Overall Study|Adverse event unrelated to study drug|0|||
47078653|NCT01393964|83384044|FG001|Overall Study|Adverse event unrelated to study drug|3|||
47078654|NCT01393964|83384045|FG002|Overall Study|Adverse event unrelated to study drug|0|||
47078655|NCT01393964|83384043|FG000|Overall Study|Subject request stop study treatment|0|||
47078656|NCT01393964|83384044|FG001|Overall Study|Subject request stop study treatment|1|||
47078657|NCT01393964|83384045|FG002|Overall Study|Subject request stop study treatment|0|||
47078658|NCT01393964|83384043|FG000|Overall Study|Subject decided to move to transplant|1|||
47078659|NCT01393964|83384044|FG001|Overall Study|Subject decided to move to transplant|0|||
47078660|NCT01393964|83384045|FG002|Overall Study|Subject decided to move to transplant|0|||
47078661|NCT01393964|83384043|FG000|Overall Study|Subject switched to commercial supply|1|||
47078662|NCT01393964|83384044|FG001|Overall Study|Subject switched to commercial supply|0|||
47078663|NCT01393964|83384045|FG002|Overall Study|Subject switched to commercial supply|2|||
47078664|NCT01393964|83384043|FG000|Overall Study|Subject plateaued in terms of effect|1|||
47078665|NCT01393964|83384044|FG001|Overall Study|Subject plateaued in terms of effect|0|||
46792753|NCT00606684|83011310|FG002|Double-Blind Treatment Period|Physician Decision|1|||
46792754|NCT00606684|83011311|FG003|Double-Blind Treatment Period|Physician Decision|0|||
46792755|NCT00606684|83011312|FG004|Double-Blind Treatment Period|Physician Decision|3|||
46792756|NCT00606684|83011313|FG005|Double-Blind Treatment Period|Physician Decision|1|||
46792757|NCT00606684|83011314|FG006|Double-Blind Treatment Period|Physician Decision|2|||
46792758|NCT00606684|83011308|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46792759|NCT00606684|83011309|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46792760|NCT00606684|83011310|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46792761|NCT00606684|83011311|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
46792762|NCT00606684|83011312|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46792763|NCT00606684|83011313|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
46792764|NCT00606684|83011314|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46792765|NCT00627926|83011331|FG000|Overall Study|Adverse Event|26|||
46792766|NCT00627926|83011332|FG001|Overall Study|Adverse Event|37|||
46792767|NCT00627926|83011333|FG002|Overall Study|Adverse Event|36|||
46792768|NCT00627926|83011331|FG000|Overall Study|Death|1|||
46792769|NCT00627926|83011332|FG001|Overall Study|Death|0|||
46792770|NCT00627926|83011333|FG002|Overall Study|Death|0|||
46792771|NCT00627926|83011331|FG000|Overall Study|Lost to Follow-up|4|||
46792772|NCT00627926|83011332|FG001|Overall Study|Lost to Follow-up|3|||
46792773|NCT00627926|83011333|FG002|Overall Study|Lost to Follow-up|4|||
46792774|NCT00627926|83011331|FG000|Overall Study|Withdrawal by Subject|2|||
46792775|NCT00627926|83011332|FG001|Overall Study|Withdrawal by Subject|1|||
46792776|NCT00627926|83011333|FG002|Overall Study|Withdrawal by Subject|0|||
46792777|NCT00627926|83011331|FG000|Overall Study|Lack of Efficacy|118|||
46792778|NCT00627926|83011332|FG001|Overall Study|Lack of Efficacy|40|||
46792779|NCT00627926|83011333|FG002|Overall Study|Lack of Efficacy|38|||
46792780|NCT00627926|83011331|FG000|Overall Study|Noncompliance/unspecified|8|||
46792781|NCT00627926|83011332|FG001|Overall Study|Noncompliance/unspecified|23|||
46792782|NCT00627926|83011333|FG002|Overall Study|Noncompliance/unspecified|17|||
46792783|NCT00228553|83011341|FG000|Overall Study|Adverse Event|112|||
46792784|NCT00228553|83011341|FG000|Overall Study|Lack of Efficacy|34|||
46792785|NCT00228553|83011341|FG000|Overall Study|Lost to Follow-up|67|||
46792786|NCT00228553|83011341|FG000|Overall Study|Physician Decision|48|||
46792787|NCT00228553|83011341|FG000|Overall Study|Protocol Violation|6|||
46792788|NCT00228553|83011341|FG000|Overall Study|Withdrawal by Subject|115|||
46792789|NCT00228553|83011341|FG000|Overall Study|Pregnancy|2|||
46854830|NCT03407482|83070624|FG000|Overall Study|Protocol Violation|1|||
46792790|NCT00228553|83011341|FG000|Overall Study|Miscellaneous|46|||
46976125|NCT01970878|83220555|FG000|Overall Study|Physician Decision|0|||
46976126|NCT01970878|83220556|FG001|Overall Study|Physician Decision|1|||
46976127|NCT01970878|83220557|FG002|Overall Study|Physician Decision|1|||
46976128|NCT01970878|83220558|FG003|Overall Study|Physician Decision|0|||
46976129|NCT01970878|83220555|FG000|Overall Study|No Completion Status|0|||
46976130|NCT01970878|83220556|FG001|Overall Study|No Completion Status|1|||
46976131|NCT01970878|83220557|FG002|Overall Study|No Completion Status|0|||
46976132|NCT01970878|83220558|FG003|Overall Study|No Completion Status|0|||
47078666|NCT01393964|83384045|FG002|Overall Study|Subject plateaued in terms of effect|0|||
47078667|NCT01393964|83384043|FG000|Overall Study|Investigator removed subject from study|0|||
47078668|NCT01393964|83384044|FG001|Overall Study|Investigator removed subject from study|1|||
47078669|NCT01393964|83384045|FG002|Overall Study|Investigator removed subject from study|0|||
47078670|NCT01393964|83384043|FG000|Overall Study|Subject converted to roll-over study|0|||
47078671|NCT01393964|83384044|FG001|Overall Study|Subject converted to roll-over study|1|||
47078672|NCT01393964|83384045|FG002|Overall Study|Subject converted to roll-over study|0|||
47078673|NCT01393964|83384043|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
47078674|NCT01393964|83384044|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
47078675|NCT01393964|83384045|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
47078676|NCT01393730|83384133|FG000|Overall Study|Withdrawal by Subject|3|||
47078677|NCT01393730|83384133|FG000|Overall Study|Other|2|||
47078678|NCT01393730|83384133|FG000|Overall Study|Adverse Event|1|||
47078679|NCT01393106|83384152|FG000|Overall Study|Adverse Event|3|||
47078680|NCT01393106|83384152|FG000|Overall Study|Withdrawal by Subject|1|||
47078681|NCT01393106|83384152|FG000|Overall Study|Lack of Efficacy|1|||
47078682|NCT00553059|83384158|FG000|Overall Study|Deemed ineligible|1|||
47078683|NCT00553059|83384159|FG001|Overall Study|Deemed ineligible|1|||
47078684|NCT00553059|83384158|FG000|Overall Study|Drug supply not available|0|||
47078685|NCT00553059|83384159|FG001|Overall Study|Drug supply not available|1|||
47078686|NCT01413542|83384181|FG000|Overall Study|Physician Decision|1|||
47078687|NCT01413542|83384182|FG001|Overall Study|Physician Decision|0|||
47078688|NCT01413542|83384183|FG002|Overall Study|Physician Decision|3|||
47078689|NCT01413542|83384184|FG003|Overall Study|Physician Decision|0|||
47078690|NCT01413542|83384181|FG000|Overall Study|Adverse Event|0|||
47078691|NCT01413542|83384182|FG001|Overall Study|Adverse Event|0|||
47078692|NCT01413542|83384183|FG002|Overall Study|Adverse Event|0|||
47078693|NCT01413542|83384184|FG003|Overall Study|Adverse Event|1|||
47078694|NCT01432730|83384216|FG000|Period 1|Adverse Event|2|||
47078695|NCT01432730|83384217|FG001|Period 1|Adverse Event|0|||
47078696|NCT01432730|83384216|FG000|Period 2|Adverse Event|0|||
47078697|NCT01432730|83384217|FG001|Period 2|Adverse Event|4|||
47078698|NCT01432574|83384232|FG000|Overall Study|Moved|2|||
47078699|NCT01432574|83384232|FG000|Overall Study|Not interested|1|||
47078700|NCT01392560|83384265|FG000|Overall Study|Adverse Event|2|||
47078701|NCT01392560|83384265|FG000|Overall Study|not entered|8|||
47078702|NCT01392560|83384265|FG000|Overall Study|discontinued during placebo run-in|2|||
47078703|NCT00552279|83384322|FG000|Overall Study|Adverse Event|0|||
47078704|NCT00552279|83384323|FG001|Overall Study|Adverse Event|1|||
47078705|NCT00552279|83384322|FG000|Overall Study|Withdrawal by Subject|12|||
47078706|NCT00552279|83384323|FG001|Overall Study|Withdrawal by Subject|1|||
46976133|NCT01970488|83220570|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
46976134|NCT01970488|83220571|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
46976135|NCT01970488|83220572|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
46976136|NCT01970488|83220573|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
46976137|NCT01970488|83220574|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
46976138|NCT01970488|83220570|FG000|Part 1: Through Week 16|Protocol Violation|1|||
46976139|NCT01970488|83220571|FG001|Part 1: Through Week 16|Protocol Violation|2|||
46976140|NCT01970488|83220572|FG002|Part 1: Through Week 16|Protocol Violation|0|||
46976141|NCT01970488|83220573|FG003|Part 1: Through Week 16|Protocol Violation|0|||
46976142|NCT01970488|83220574|FG004|Part 1: Through Week 16|Protocol Violation|0|||
46976143|NCT01970488|83220570|FG000|Part 1: Through Week 16|Adverse Event|6|||
47078707|NCT00552279|83384322|FG000|Overall Study|Lost to Follow-up|1|||
47078708|NCT00552279|83384323|FG001|Overall Study|Lost to Follow-up|0|||
46673955|NCT01159600|82889496|FG002|Overall Study|Adverse Event|5|||
46673956|NCT01159600|82889497|FG003|Overall Study|Adverse Event|1|||
46673957|NCT01159600|82889498|FG004|Overall Study|Adverse Event|8|||
46673958|NCT01159600|82889499|FG005|Overall Study|Adverse Event|6|||
47078709|NCT00552279|83384322|FG000|Overall Study|Other|1|||
47078710|NCT00552279|83384323|FG001|Overall Study|Other|1|||
46673959|NCT01159600|82889500|FG006|Overall Study|Adverse Event|7|||
46673960|NCT01159600|82889501|FG007|Overall Study|Adverse Event|5|||
46976144|NCT01970488|83220571|FG001|Part 1: Through Week 16|Adverse Event|5|||
46976145|NCT01970488|83220572|FG002|Part 1: Through Week 16|Adverse Event|0|||
46976146|NCT01970488|83220573|FG003|Part 1: Through Week 16|Adverse Event|0|||
47078711|NCT00559377|83384364|FG000|Overall Study|Withdrawal by Subject|9|||
47078712|NCT01412060|83384371|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
47078713|NCT01412060|83384372|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
46673961|NCT01159600|82889494|FG000|Overall Study|Lack of Efficacy|0|||
46673962|NCT01159600|82889495|FG001|Overall Study|Lack of Efficacy|0|||
46673963|NCT01159600|82889496|FG002|Overall Study|Lack of Efficacy|0|||
46673964|NCT01159600|82889497|FG003|Overall Study|Lack of Efficacy|0|||
46673965|NCT01159600|82889498|FG004|Overall Study|Lack of Efficacy|2|||
46673966|NCT01159600|82889499|FG005|Overall Study|Lack of Efficacy|0|||
46673967|NCT01159600|82889500|FG006|Overall Study|Lack of Efficacy|0|||
46673968|NCT01159600|82889501|FG007|Overall Study|Lack of Efficacy|1|||
46673969|NCT01159600|82889494|FG000|Overall Study|Non compliant with protocol|2|||
46673970|NCT01159600|82889495|FG001|Overall Study|Non compliant with protocol|1|||
46673971|NCT01159600|82889496|FG002|Overall Study|Non compliant with protocol|0|||
46673972|NCT01159600|82889497|FG003|Overall Study|Non compliant with protocol|0|||
46673973|NCT01159600|82889498|FG004|Overall Study|Non compliant with protocol|2|||
46673974|NCT01159600|82889499|FG005|Overall Study|Non compliant with protocol|0|||
46673975|NCT01159600|82889500|FG006|Overall Study|Non compliant with protocol|2|||
46673976|NCT01159600|82889501|FG007|Overall Study|Non compliant with protocol|0|||
46673977|NCT01159600|82889494|FG000|Overall Study|Lost to Follow-up|2|||
46673978|NCT01159600|82889495|FG001|Overall Study|Lost to Follow-up|3|||
46976147|NCT01970488|83220574|FG004|Part 1: Through Week 16|Adverse Event|0|||
46976148|NCT01970488|83220570|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
46976149|NCT01970488|83220571|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
46976150|NCT01970488|83220572|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
46976151|NCT01970488|83220573|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
46976152|NCT01970488|83220574|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
46976153|NCT01970488|83220570|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
46976154|NCT01970488|83220571|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
46976155|NCT01970488|83220572|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
46976156|NCT01970488|83220573|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
46976157|NCT01970488|83220574|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
46976158|NCT01970488|83220570|FG000|Part 2: Post Week 16|Physician Decision|0|||
46976159|NCT01970488|83220571|FG001|Part 2: Post Week 16|Physician Decision|0|||
46976160|NCT01970488|83220572|FG002|Part 2: Post Week 16|Physician Decision|0|||
46976161|NCT01970488|83220573|FG003|Part 2: Post Week 16|Physician Decision|0|||
46976162|NCT01970488|83220574|FG004|Part 2: Post Week 16|Physician Decision|1|||
46976163|NCT01970488|83220570|FG000|Part 2: Post Week 16|Non-compliance|0|||
46976164|NCT01970488|83220571|FG001|Part 2: Post Week 16|Non-compliance|0|||
46976165|NCT01970488|83220572|FG002|Part 2: Post Week 16|Non-compliance|1|||
46976166|NCT01970488|83220573|FG003|Part 2: Post Week 16|Non-compliance|0|||
46976167|NCT01970488|83220574|FG004|Part 2: Post Week 16|Non-compliance|0|||
46976168|NCT01970488|83220570|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
46976169|NCT01970488|83220571|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
46976170|NCT01970488|83220572|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
46976171|NCT01970488|83220573|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
46976172|NCT01970488|83220574|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
46976173|NCT01970488|83220570|FG000|Part 2: Post Week 16|Adverse Event|0|||
46976174|NCT01970488|83220571|FG001|Part 2: Post Week 16|Adverse Event|0|||
46673979|NCT01159600|82889496|FG002|Overall Study|Lost to Follow-up|4|||
46673980|NCT01159600|82889497|FG003|Overall Study|Lost to Follow-up|3|||
46673981|NCT01159600|82889498|FG004|Overall Study|Lost to Follow-up|3|||
46673982|NCT01159600|82889499|FG005|Overall Study|Lost to Follow-up|0|||
46673983|NCT01159600|82889500|FG006|Overall Study|Lost to Follow-up|3|||
46976175|NCT01970488|83220572|FG002|Part 2: Post Week 16|Adverse Event|5|||
46976176|NCT01970488|83220573|FG003|Part 2: Post Week 16|Adverse Event|1|||
46976177|NCT01970488|83220574|FG004|Part 2: Post Week 16|Adverse Event|1|||
46976178|NCT01970488|83220570|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
46976179|NCT01970488|83220571|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
46976180|NCT01970488|83220572|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
46976181|NCT01970488|83220573|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
46976182|NCT01970488|83220574|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
46976183|NCT01970488|83220570|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
46976184|NCT01970488|83220571|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
46976185|NCT01970488|83220572|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
46976186|NCT01970488|83220573|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
46976187|NCT01970488|83220574|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
46976188|NCT02661217|83220591|FG000|Overall Study|Physician Decision|12|||
46976189|NCT02661217|83220592|FG001|Overall Study|Physician Decision|15|||
46976190|NCT02661217|83220591|FG000|Overall Study|Lost to Follow-up|1|||
46976191|NCT02661217|83220592|FG001|Overall Study|Lost to Follow-up|4|||
46976192|NCT02661217|83220591|FG000|Overall Study|Protocol Deviation|0|||
46976193|NCT02661217|83220592|FG001|Overall Study|Protocol Deviation|4|||
46976194|NCT02661217|83220591|FG000|Overall Study|Non-compliance with study treatment|5|||
46976195|NCT02661217|83220592|FG001|Overall Study|Non-compliance with study treatment|5|||
46976196|NCT02661217|83220591|FG000|Overall Study|Death|21|||
46976197|NCT02661217|83220592|FG001|Overall Study|Death|15|||
46976198|NCT02661217|83220591|FG000|Overall Study|Adverse Event|10|||
46976199|NCT02661217|83220592|FG001|Overall Study|Adverse Event|8|||
46976200|NCT02661217|83220591|FG000|Overall Study|Withdrawal by Subject|15|||
46976201|NCT02661217|83220592|FG001|Overall Study|Withdrawal by Subject|19|||
46976202|NCT02661217|83220591|FG000|Overall Study|Did not enter follow-up epoch|7|||
46976203|NCT02661217|83220592|FG001|Overall Study|Did not enter follow-up epoch|10|||
46976204|NCT02661217|83220591|FG000|Overall Study|Death - no study drug received|1|||
46976205|NCT02661217|83220592|FG001|Overall Study|Death - no study drug received|2|||
46976206|NCT02661217|83220591|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
46976207|NCT02661217|83220592|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
46976208|NCT01952080|83220603|FG000|Overall Study|Withdrawal by Subject|0|||
46976209|NCT01952080|83220604|FG001|Overall Study|Withdrawal by Subject|0|||
46976210|NCT01952080|83220605|FG002|Overall Study|Withdrawal by Subject|0|||
46976211|NCT01952080|83220606|FG003|Overall Study|Withdrawal by Subject|1|||
46976212|NCT01952080|83220603|FG000|Overall Study|Protocol Non-compliance|0|||
46976213|NCT01952080|83220604|FG001|Overall Study|Protocol Non-compliance|1|||
46976214|NCT01952080|83220605|FG002|Overall Study|Protocol Non-compliance|0|||
46976215|NCT01952080|83220606|FG003|Overall Study|Protocol Non-compliance|0|||
46976216|NCT01951378|83220618|FG000|Overall Study|Study Terminated-Not completed|23|||
46976217|NCT01951378|83220619|FG001|Overall Study|Study Terminated-Not completed|17|||
46976218|NCT01944670|83220625|FG000|Overall Study|Lost to Follow-up|2|||
46976219|NCT01361009|83220629|FG000|Overall Study|Protocol Violation|116|||
46976220|NCT01944046|83220635|FG000|Randomized to DB|Adverse Event|5|||
46976221|NCT01944046|83220636|FG001|Randomized to DB|Adverse Event|2|||
46976222|NCT01944046|83220635|FG000|Randomized to DB|Clinical Worsening|3|||
46976223|NCT01944046|83220636|FG001|Randomized to DB|Clinical Worsening|2|||
46976224|NCT01944046|83220635|FG000|Randomized to DB|Lost to Follow-up|3|||
46673984|NCT01159600|82889501|FG007|Overall Study|Lost to Follow-up|2|||
46673985|NCT01159600|82889494|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
46673986|NCT01159600|82889495|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
46792791|NCT00643916|83011351|FG000|Overall Study|Protocol Violation|0|||
46792792|NCT00643916|83011352|FG001|Overall Study|Protocol Violation|1|||
46792793|NCT00643916|83011353|FG002|Overall Study|Protocol Violation|1|||
46792794|NCT00643916|83011354|FG003|Overall Study|Protocol Violation|1|||
46792795|NCT00643916|83011355|FG004|Overall Study|Protocol Violation|0|||
46792796|NCT00643916|83011356|FG005|Overall Study|Protocol Violation|0|||
46792797|NCT00643916|83011351|FG000|Overall Study|Lost to Follow-up|0|||
46792798|NCT00643916|83011352|FG001|Overall Study|Lost to Follow-up|1|||
46792799|NCT00643916|83011353|FG002|Overall Study|Lost to Follow-up|0|||
46976225|NCT01944046|83220636|FG001|Randomized to DB|Lost to Follow-up|3|||
46976226|NCT01944046|83220635|FG000|Randomized to DB|Withdrawal by Subject|2|||
46976227|NCT01944046|83220636|FG001|Randomized to DB|Withdrawal by Subject|4|||
46976228|NCT01944046|83220635|FG000|Randomized to DB|Physician Decision|1|||
46976229|NCT01944046|83220636|FG001|Randomized to DB|Physician Decision|2|||
47078714|NCT01412060|83384373|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
47078715|NCT01412060|83384371|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
47078716|NCT01412060|83384372|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
47078717|NCT01412060|83384373|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
46792800|NCT00643916|83011354|FG003|Overall Study|Lost to Follow-up|0|||
46976230|NCT01944046|83220635|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
46976231|NCT01944046|83220636|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
46976232|NCT01944046|83220635|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
46976233|NCT01944046|83220636|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
46976234|NCT01944046|83220635|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
46976235|NCT01944046|83220636|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
46976236|NCT01944046|83220635|FG000|Open Label Eligible and Consented|Adverse Event|6|||
46976237|NCT01944046|83220636|FG001|Open Label Eligible and Consented|Adverse Event|1|||
46976238|NCT01944046|83220635|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
46976239|NCT01944046|83220636|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
47078718|NCT01412060|83384371|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
47078719|NCT01412060|83384372|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
47078720|NCT01412060|83384373|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
47078721|NCT01412060|83384371|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
47078722|NCT01412060|83384372|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
47078723|NCT01412060|83384373|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
47078724|NCT01412060|83384371|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
46673987|NCT01159600|82889496|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
46673988|NCT01159600|82889497|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
46792801|NCT00643916|83011355|FG004|Overall Study|Lost to Follow-up|0|||
46792802|NCT00643916|83011356|FG005|Overall Study|Lost to Follow-up|0|||
46792803|NCT00643916|83011351|FG000|Overall Study|Withdrawal by Subject|2|||
46792804|NCT00643916|83011352|FG001|Overall Study|Withdrawal by Subject|2|||
46792805|NCT00643916|83011353|FG002|Overall Study|Withdrawal by Subject|2|||
46792806|NCT00643916|83011354|FG003|Overall Study|Withdrawal by Subject|1|||
46792807|NCT00643916|83011355|FG004|Overall Study|Withdrawal by Subject|0|||
46792808|NCT00643916|83011356|FG005|Overall Study|Withdrawal by Subject|1|||
46792809|NCT00643916|83011351|FG000|Overall Study|Not Vaccinated|2|||
46792810|NCT00643916|83011352|FG001|Overall Study|Not Vaccinated|2|||
46792811|NCT00643916|83011353|FG002|Overall Study|Not Vaccinated|3|||
46792812|NCT00643916|83011354|FG003|Overall Study|Not Vaccinated|0|||
46792813|NCT00643916|83011355|FG004|Overall Study|Not Vaccinated|2|||
46792814|NCT00643916|83011356|FG005|Overall Study|Not Vaccinated|0|||
46792815|NCT00160693|83011370|FG000|Overall Study|Adverse Event|97|||
46976240|NCT01944046|83220635|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
46976241|NCT01944046|83220636|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
46976242|NCT01969084|83220648|FG000|Overall Study|Adverse Event|0|||
46976243|NCT01969084|83220649|FG001|Overall Study|Adverse Event|1|||
46976244|NCT01942486|83220659|FG000|Overall Study|Lost to Follow-up|27|||
46976245|NCT01941940|83220663|FG000|Overall Study|Adverse Event|11|||
46976246|NCT01941940|83220663|FG000|Overall Study|Lost to Follow-up|2|||
46976247|NCT01941940|83220663|FG000|Overall Study|Physician Decision|2|||
46976248|NCT01941940|83220663|FG000|Overall Study|Withdrawal by Subject|15|||
46976249|NCT01941940|83220663|FG000|Overall Study|Death|1|||
46792816|NCT00160693|83011370|FG000|Overall Study|Lack of Efficacy|30|||
46792817|NCT00160693|83011370|FG000|Overall Study|Protocol Violation|24|||
46792818|NCT00160693|83011370|FG000|Overall Study|Lost to Follow-up|15|||
46792819|NCT00160693|83011370|FG000|Overall Study|Withdrawal by Subject|54|||
46792820|NCT00160693|83011370|FG000|Overall Study|Study terminated by sponsor|15|||
46976250|NCT01941940|83220663|FG000|Overall Study|Other|1|||
46976251|NCT01941940|83220663|FG000|Overall Study|Other|1|||
46976252|NCT01968694|83220669|FG000|Washout (1 Month)|Lost to Follow-up|0|||
46976253|NCT01968694|83220670|FG001|Washout (1 Month)|Lost to Follow-up|1|||
46976254|NCT01968226|83220678|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
46976255|NCT02640053|83220684|FG000|Overall Study|Withdrawal by Subject|2|||
46976256|NCT02640053|83220685|FG001|Overall Study|Withdrawal by Subject|1|||
46976257|NCT02640053|83220684|FG000|Overall Study|Adverse Event|1|||
46976258|NCT02640053|83220685|FG001|Overall Study|Adverse Event|1|||
46976259|NCT02640053|83220684|FG000|Overall Study|Alternative Therapy|1|||
46976260|NCT02640053|83220685|FG001|Overall Study|Alternative Therapy|1|||
46976261|NCT02640053|83220684|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
46976262|NCT02640053|83220685|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
46976263|NCT01950364|83220693|FG000|Overall Study|Adverse Event|3|||
47078725|NCT01412060|83384372|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
46854831|NCT03407482|83070624|FG000|Overall Study|Study Terminated By Sponsor|106|||
46976264|NCT01950364|83220694|FG001|Overall Study|Adverse Event|0|||
47078726|NCT01412060|83384373|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
47078727|NCT01412060|83384371|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
47078728|NCT01412060|83384372|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
47078729|NCT01412060|83384373|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
47078730|NCT01412060|83384371|FG000|Period Between RIP and SP|Adverse Event|4|||
47078731|NCT01412060|83384372|FG001|Period Between RIP and SP|Adverse Event|0|||
47078732|NCT01412060|83384373|FG002|Period Between RIP and SP|Adverse Event|0|||
47078733|NCT01412060|83384371|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
47078734|NCT01412060|83384372|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
47078735|NCT01412060|83384373|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
47078736|NCT01412060|83384371|FG000|Period Between RIP and SP|Protocol Violation|2|||
47078737|NCT01412060|83384372|FG001|Period Between RIP and SP|Protocol Violation|0|||
47078738|NCT01412060|83384373|FG002|Period Between RIP and SP|Protocol Violation|0|||
47078739|NCT01412060|83384371|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
47078740|NCT01412060|83384372|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
47078741|NCT01412060|83384373|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
47078742|NCT01412060|83384371|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
47078743|NCT01412060|83384372|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
47078744|NCT01412060|83384373|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
47078745|NCT01412060|83384371|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
47078746|NCT01412060|83384372|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
47078747|NCT01412060|83384373|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
47078748|NCT01412060|83384371|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
47078749|NCT01412060|83384372|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
46673989|NCT01159600|82889498|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
46673990|NCT01159600|82889499|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
46673991|NCT01159600|82889500|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
47078750|NCT01412060|83384373|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
47078751|NCT01412060|83384371|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
47078752|NCT01412060|83384372|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
47078753|NCT01412060|83384373|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
47078754|NCT01412060|83384371|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
47078755|NCT01412060|83384372|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
47078756|NCT01412060|83384373|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
47078757|NCT01412060|83384371|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
47078758|NCT01412060|83384372|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
47078759|NCT01412060|83384373|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
47078760|NCT01412060|83384371|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
47078761|NCT01412060|83384372|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
47078762|NCT01412060|83384373|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
47078763|NCT01412060|83384371|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
47078764|NCT01412060|83384372|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
47078765|NCT01412060|83384373|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
47078766|NCT01412060|83384371|FG000|Period Between SP and DBP|Protocol Violation|2|||
47078767|NCT01412060|83384372|FG001|Period Between SP and DBP|Protocol Violation|0|||
47078768|NCT01412060|83384373|FG002|Period Between SP and DBP|Protocol Violation|0|||
47078769|NCT01412060|83384371|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
47078770|NCT01412060|83384372|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
47078771|NCT01412060|83384373|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
47078772|NCT01412060|83384371|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
47078773|NCT01412060|83384372|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
47078774|NCT01412060|83384373|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
47078775|NCT01412060|83384371|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
47078776|NCT01412060|83384372|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
47078777|NCT01412060|83384373|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
47078778|NCT01412060|83384371|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
47078779|NCT01412060|83384372|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
47078780|NCT01412060|83384373|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
47078781|NCT01412060|83384371|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
47078782|NCT01412060|83384372|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
47078783|NCT01412060|83384373|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
47078784|NCT01412060|83384371|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
47078785|NCT01412060|83384372|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
46673992|NCT01159600|82889501|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
47078786|NCT01412060|83384373|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
47078787|NCT01412060|83384371|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
47078788|NCT01412060|83384372|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
47078789|NCT01412060|83384373|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
47078790|NCT01412060|83384371|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
47078791|NCT01412060|83384372|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
47078792|NCT01412060|83384373|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
47078793|NCT01412060|83384371|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
47078794|NCT01412060|83384372|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
47078795|NCT01412060|83384373|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
47078796|NCT01412060|83384371|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
47078797|NCT01412060|83384372|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
47078798|NCT01412060|83384373|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
47078799|NCT00551421|83384404|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
47078800|NCT01891643|83384424|FG000|Overall Study|Adverse event unrelated to study drug|2|||
47078801|NCT01891643|83384425|FG001|Overall Study|Adverse event unrelated to study drug|5|||
47078802|NCT01891643|83384424|FG000|Overall Study|Disease Progression|4|||
47078803|NCT01891643|83384425|FG001|Overall Study|Disease Progression|3|||
47078804|NCT01891643|83384424|FG000|Overall Study|Study Drug Toxicity|3|||
47078805|NCT01891643|83384425|FG001|Overall Study|Study Drug Toxicity|0|||
47078806|NCT01891643|83384424|FG000|Overall Study|Maximum Clinical Benefit|0|||
47078807|NCT01891643|83384425|FG001|Overall Study|Maximum Clinical Benefit|1|||
47078808|NCT01891643|83384424|FG000|Overall Study|Poor/Non-compliance|0|||
47078809|NCT01891643|83384425|FG001|Overall Study|Poor/Non-compliance|1|||
47078810|NCT01891643|83384424|FG000|Overall Study|Participant request to discontinue|1|||
47078811|NCT01891643|83384425|FG001|Overall Study|Participant request to discontinue|0|||
47078812|NCT01392326|83384559|FG000|Overall Study|Death|2|||
47078813|NCT01392326|83384560|FG001|Overall Study|Death|0|||
47078814|NCT01392326|83384561|FG002|Overall Study|Death|0|||
47078815|NCT01392326|83384559|FG000|Overall Study|Withdrawal by Subject|12|||
47078816|NCT01392326|83384560|FG001|Overall Study|Withdrawal by Subject|11|||
47078817|NCT01392326|83384561|FG002|Overall Study|Withdrawal by Subject|15|||
47078818|NCT01392326|83384559|FG000|Overall Study|Protocol Violation|2|||
47078819|NCT01392326|83384560|FG001|Overall Study|Protocol Violation|0|||
47078820|NCT01392326|83384561|FG002|Overall Study|Protocol Violation|0|||
47078821|NCT01392326|83384559|FG000|Overall Study|Pregnancy|0|||
47078822|NCT01392326|83384560|FG001|Overall Study|Pregnancy|0|||
47078823|NCT01392326|83384561|FG002|Overall Study|Pregnancy|1|||
47078824|NCT01392326|83384559|FG000|Overall Study|Physician Decision|7|||
47078825|NCT01392326|83384560|FG001|Overall Study|Physician Decision|5|||
47078826|NCT01392326|83384561|FG002|Overall Study|Physician Decision|2|||
47078827|NCT01392326|83384559|FG000|Overall Study|Lost to Follow-up|1|||
47078828|NCT01392326|83384560|FG001|Overall Study|Lost to Follow-up|3|||
47078829|NCT01392326|83384561|FG002|Overall Study|Lost to Follow-up|4|||
47078830|NCT01392326|83384559|FG000|Overall Study|Lack of Efficacy|14|||
47078831|NCT01392326|83384560|FG001|Overall Study|Lack of Efficacy|10|||
47078832|NCT01392326|83384561|FG002|Overall Study|Lack of Efficacy|15|||
47078833|NCT01392326|83384559|FG000|Overall Study|Adverse Event|9|||
47078834|NCT01392326|83384560|FG001|Overall Study|Adverse Event|6|||
47078835|NCT01392326|83384561|FG002|Overall Study|Adverse Event|11|||
47078836|NCT01432262|83384604|FG000|Overall Study|Withdrawal by Subject|2|||
47078837|NCT01432262|83384605|FG001|Overall Study|Withdrawal by Subject|1|||
47078838|NCT01410890|83384625|FG000|Overall Study|Withdrawal by Subject|0|||
47078839|NCT01410890|83384626|FG001|Overall Study|Withdrawal by Subject|1|||
47078840|NCT01431950|83384636|FG000|Overall Study|Study Site Closed/Terminated|7|||
47078841|NCT01431950|83384637|FG001|Overall Study|Study Site Closed/Terminated|3|||
47078842|NCT01431950|83384636|FG000|Overall Study|Withdrawal by Subject|4|||
47078843|NCT01431950|83384637|FG001|Overall Study|Withdrawal by Subject|3|||
47078844|NCT01431950|83384636|FG000|Overall Study|Protocol Violation|2|||
47078845|NCT01431950|83384637|FG001|Overall Study|Protocol Violation|3|||
47078846|NCT01431950|83384636|FG000|Overall Study|Adverse Event|2|||
47078847|NCT01431950|83384637|FG001|Overall Study|Adverse Event|2|||
47078848|NCT01431950|83384636|FG000|Overall Study|Physician Decision|2|||
47078849|NCT01431950|83384637|FG001|Overall Study|Physician Decision|1|||
47078850|NCT01431950|83384636|FG000|Overall Study|Lack of Efficacy|2|||
47078851|NCT01431950|83384637|FG001|Overall Study|Lack of Efficacy|1|||
47078852|NCT01431950|83384636|FG000|Overall Study|Lost to Follow-up|0|||
47078853|NCT01431950|83384637|FG001|Overall Study|Lost to Follow-up|1|||
47078854|NCT01431950|83384636|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
47078855|NCT01431950|83384637|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
47078856|NCT00551031|83384648|FG000|Overall Study|Adverse Event|0|||
47078857|NCT00551031|83384649|FG001|Overall Study|Adverse Event|1|||
47078858|NCT00551031|83384650|FG002|Overall Study|Adverse Event|0|||
47078859|NCT00551031|83384651|FG003|Overall Study|Adverse Event|0|||
47078860|NCT00551031|83384652|FG004|Overall Study|Adverse Event|0|||
47078861|NCT00551031|83384648|FG000|Overall Study|Protocol Violation|1|||
47078862|NCT00551031|83384649|FG001|Overall Study|Protocol Violation|1|||
47078863|NCT00551031|83384650|FG002|Overall Study|Protocol Violation|0|||
47078864|NCT00551031|83384651|FG003|Overall Study|Protocol Violation|0|||
47078865|NCT00551031|83384652|FG004|Overall Study|Protocol Violation|0|||
46792821|NCT00643760|83011379|FG000|Overall Study|Adverse Event|11|||
46792822|NCT00643760|83011380|FG001|Overall Study|Adverse Event|5|||
46792823|NCT00643760|83011381|FG002|Overall Study|Adverse Event|12|||
46792824|NCT00643760|83011382|FG003|Overall Study|Adverse Event|21|||
46976265|NCT01950364|83220693|FG000|Overall Study|Stem Cell Transplant|2|||
46976266|NCT01950364|83220694|FG001|Overall Study|Stem Cell Transplant|6|||
46976267|NCT01950364|83220693|FG000|Overall Study|Disease Progression|5|||
46976268|NCT01950364|83220694|FG001|Overall Study|Disease Progression|2|||
46976269|NCT01950364|83220693|FG000|Overall Study|Withdrawal by Subject|0|||
46976270|NCT01950364|83220694|FG001|Overall Study|Withdrawal by Subject|1|||
46792825|NCT00643760|83011383|FG004|Overall Study|Adverse Event|6|||
46792826|NCT00643760|83011379|FG000|Overall Study|Lack of Efficacy|3|||
46792827|NCT00643760|83011380|FG001|Overall Study|Lack of Efficacy|1|||
46792828|NCT00643760|83011381|FG002|Overall Study|Lack of Efficacy|0|||
46792829|NCT00643760|83011382|FG003|Overall Study|Lack of Efficacy|4|||
46792830|NCT00643760|83011383|FG004|Overall Study|Lack of Efficacy|3|||
46792831|NCT00643760|83011379|FG000|Overall Study|Protocol Violation|7|||
46792832|NCT00643760|83011380|FG001|Overall Study|Protocol Violation|6|||
46792833|NCT00643760|83011381|FG002|Overall Study|Protocol Violation|4|||
46792834|NCT00643760|83011382|FG003|Overall Study|Protocol Violation|4|||
46976271|NCT01950364|83220693|FG000|Overall Study|Protocol Violation|0|||
46976272|NCT01950364|83220694|FG001|Overall Study|Protocol Violation|1|||
46976273|NCT01968070|83220718|FG000|Period 1|Withdrawal by Subject|0|||
46976274|NCT01968070|83220719|FG001|Period 1|Withdrawal by Subject|1|||
46854832|NCT03407482|83070624|FG000|Overall Study|Withdrawal by Subject|6|||
46854833|NCT03407482|83070624|FG000|Overall Study|Data Entry Error|1|||
46976275|NCT01968070|83220720|FG002|Period 1|Withdrawal by Subject|0|||
46976276|NCT01968070|83220721|FG003|Period 1|Withdrawal by Subject|0|||
46976277|NCT01968070|83220722|FG004|Period 1|Withdrawal by Subject|0|||
46976278|NCT01968070|83220723|FG005|Period 1|Withdrawal by Subject|0|||
46854834|NCT00003782|83070631|FG000|Overall Study|No follow up data|30|||
46854835|NCT00003782|83070632|FG001|Overall Study|No follow up data|31|||
46854836|NCT00003782|83070633|FG002|Overall Study|No follow up data|26|||
46854837|NCT03389308|83070641|FG000|Overall Study|Withdrawal by Subject|5|||
46854838|NCT03389308|83070641|FG000|Overall Study|Lost to Follow-up|3|||
46854839|NCT03389308|83070641|FG000|Overall Study|Adverse Event|2|||
46854840|NCT03389308|83070641|FG000|Overall Study|Sponsor Request|2|||
46976279|NCT01968070|83220724|FG006|Period 1|Withdrawal by Subject|1|||
46976280|NCT01968070|83220725|FG007|Period 1|Withdrawal by Subject|0|||
46976281|NCT01968070|83220726|FG008|Period 1|Withdrawal by Subject|0|||
46976282|NCT01968070|83220727|FG009|Period 1|Withdrawal by Subject|0|||
46976283|NCT01968070|83220728|FG010|Period 1|Withdrawal by Subject|0|||
46976284|NCT01968070|83220729|FG011|Period 1|Withdrawal by Subject|0|||
47078866|NCT00551031|83384648|FG000|Overall Study|Lost to Follow-up|0|||
46854841|NCT03407170|83070645|FG000|Overall Study|Adverse Event|1|||
46854842|NCT03406858|83070649|FG000|Overall Study|Failure to receive treatment drug.|1|||
46854843|NCT03406858|83070649|FG000|Overall Study|ineligible|1|||
46854844|NCT03406702|83070653|FG000|Overall Study|Missed Day 27 Dosing|1|||
47078867|NCT00551031|83384649|FG001|Overall Study|Lost to Follow-up|1|||
47078868|NCT00551031|83384650|FG002|Overall Study|Lost to Follow-up|0|||
47078869|NCT00551031|83384651|FG003|Overall Study|Lost to Follow-up|1|||
47078870|NCT00551031|83384652|FG004|Overall Study|Lost to Follow-up|1|||
47078871|NCT00551031|83384648|FG000|Overall Study|Withdrawal by Subject|0|||
47078872|NCT00551031|83384649|FG001|Overall Study|Withdrawal by Subject|4|||
47078873|NCT00551031|83384650|FG002|Overall Study|Withdrawal by Subject|1|||
47078874|NCT00551031|83384651|FG003|Overall Study|Withdrawal by Subject|2|||
47078875|NCT00551031|83384652|FG004|Overall Study|Withdrawal by Subject|0|||
47078876|NCT00551031|83384648|FG000|Overall Study|Serious Adverse Event|0|||
47078877|NCT00551031|83384649|FG001|Overall Study|Serious Adverse Event|2|||
47078878|NCT00551031|83384650|FG002|Overall Study|Serious Adverse Event|1|||
47078879|NCT00551031|83384651|FG003|Overall Study|Serious Adverse Event|0|||
47078880|NCT00551031|83384652|FG004|Overall Study|Serious Adverse Event|0|||
46854845|NCT00003656|83070671|FG000|Overall Study|Adverse Event|0|||
46792835|NCT00643760|83011383|FG004|Overall Study|Protocol Violation|6|||
46792836|NCT00643760|83011379|FG000|Overall Study|Lost to Follow-up|6|||
46792837|NCT00643760|83011380|FG001|Overall Study|Lost to Follow-up|2|||
46854846|NCT00003656|83070672|FG001|Overall Study|Adverse Event|1|||
46976285|NCT01968070|83220730|FG012|Period 1|Withdrawal by Subject|0|||
46976286|NCT01968070|83220731|FG013|Period 1|Withdrawal by Subject|0|||
47078881|NCT00551031|83384648|FG000|Overall Study|Did not receive vaccine|1|||
47078882|NCT00551031|83384649|FG001|Overall Study|Did not receive vaccine|2|||
47078883|NCT00551031|83384650|FG002|Overall Study|Did not receive vaccine|0|||
46854847|NCT00003590|83070679|FG000|Overall Study|Ineligible Patient|1|||
46976287|NCT01968070|83220732|FG014|Period 1|Withdrawal by Subject|0|||
46976288|NCT01968070|83220733|FG015|Period 1|Withdrawal by Subject|1|||
46976289|NCT01968070|83220734|FG016|Period 1|Withdrawal by Subject|0|||
46976290|NCT01968070|83220735|FG017|Period 1|Withdrawal by Subject|0|||
46976291|NCT01968070|83220718|FG000|Period 1|Protocol Violation|0|||
47078884|NCT00551031|83384651|FG003|Overall Study|Did not receive vaccine|0|||
47078885|NCT00551031|83384652|FG004|Overall Study|Did not receive vaccine|0|||
47078886|NCT01431716|83384664|FG000|Overall Study|Withdrawal of consent|1|||
47078887|NCT00550953|83384670|FG000|Overall Study|Adverse Event|4|||
47078888|NCT00550953|83384671|FG001|Overall Study|Adverse Event|3|||
47078889|NCT00550953|83384670|FG000|Overall Study|Not able to visit the site|2|||
47078890|NCT00550953|83384671|FG001|Overall Study|Not able to visit the site|3|||
47078891|NCT00558831|83384706|FG000|Overall Study|Lost to Follow-up|1|||
47078892|NCT01431638|83384715|FG000|Overall Study|Adverse Event|1|||
47078893|NCT01431638|83384716|FG001|Overall Study|Adverse Event|3|||
47078894|NCT01431638|83384717|FG002|Overall Study|Adverse Event|1|||
47078895|NCT01431638|83384715|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
47078896|NCT01431638|83384716|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
47078897|NCT01431638|83384717|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
46792838|NCT00643760|83011381|FG002|Overall Study|Lost to Follow-up|1|||
46792839|NCT00643760|83011382|FG003|Overall Study|Lost to Follow-up|3|||
46792840|NCT00643760|83011383|FG004|Overall Study|Lost to Follow-up|3|||
46792841|NCT00643760|83011379|FG000|Overall Study|Investigator Discretion|0|||
46854848|NCT00003590|83070679|FG000|Overall Study|Adverse Event|7|||
46854849|NCT00003590|83070679|FG000|Overall Study|Withdrawal by Subject|1|||
46976292|NCT01968070|83220719|FG001|Period 1|Protocol Violation|0|||
46976293|NCT01968070|83220720|FG002|Period 1|Protocol Violation|0|||
46976294|NCT01968070|83220721|FG003|Period 1|Protocol Violation|1|||
46976295|NCT01968070|83220722|FG004|Period 1|Protocol Violation|1|||
46976296|NCT01968070|83220723|FG005|Period 1|Protocol Violation|0|||
46976297|NCT01968070|83220724|FG006|Period 1|Protocol Violation|0|||
46854850|NCT00003590|83070679|FG000|Overall Study|Lack of Efficacy|11|||
46854851|NCT00003590|83070679|FG000|Overall Study|Death|1|||
46854852|NCT00003590|83070679|FG000|Overall Study|Physician Decision|1|||
46854853|NCT03416374|83070685|FG000|Between Treatment Period I and II|Other|0|||
46854854|NCT03416374|83070686|FG001|Between Treatment Period I and II|Other|9|||
46854855|NCT03416374|83070685|FG000|Treatment Period II|Lack of Efficacy|3|||
46854856|NCT03416374|83070686|FG001|Treatment Period II|Lack of Efficacy|11|||
47078898|NCT01431638|83384715|FG000|Overall Study|Participants condition no longer requires study drug|0|||
47078899|NCT01431638|83384716|FG001|Overall Study|Participants condition no longer requires study drug|1|||
47078900|NCT01431638|83384717|FG002|Overall Study|Participants condition no longer requires study drug|0|||
47078901|NCT01431638|83384715|FG000|Overall Study|Participant withdrew consent|14|||
47078902|NCT01431638|83384716|FG001|Overall Study|Participant withdrew consent|5|||
47078903|NCT01431638|83384717|FG002|Overall Study|Participant withdrew consent|8|||
47078904|NCT01431638|83384715|FG000|Overall Study|Lost to Follow-up|7|||
47078905|NCT01431638|83384716|FG001|Overall Study|Lost to Follow-up|9|||
47078906|NCT01431638|83384717|FG002|Overall Study|Lost to Follow-up|7|||
47078907|NCT01431638|83384715|FG000|Overall Study|Administrative problems|1|||
47078908|NCT01431638|83384716|FG001|Overall Study|Administrative problems|4|||
47078909|NCT01431638|83384717|FG002|Overall Study|Administrative problems|6|||
47078910|NCT01431638|83384715|FG000|Overall Study|Death|1|||
47078911|NCT01431638|83384716|FG001|Overall Study|Death|0|||
47078912|NCT01431638|83384717|FG002|Overall Study|Death|0|||
47078913|NCT01431638|83384715|FG000|Overall Study|Protocol deviation|1|||
46792842|NCT00643760|83011380|FG001|Overall Study|Investigator Discretion|0|||
46792843|NCT00643760|83011381|FG002|Overall Study|Investigator Discretion|0|||
46792844|NCT00643760|83011382|FG003|Overall Study|Investigator Discretion|2|||
46854857|NCT03416374|83070685|FG000|Treatment Period II|Adverse Event|1|||
46854858|NCT03416374|83070686|FG001|Treatment Period II|Adverse Event|4|||
46854859|NCT03416374|83070685|FG000|Treatment Period II|Death|0|||
46854860|NCT03416374|83070686|FG001|Treatment Period II|Death|1|||
46976298|NCT01968070|83220725|FG007|Period 1|Protocol Violation|0|||
46976299|NCT01968070|83220726|FG008|Period 1|Protocol Violation|0|||
46976300|NCT01968070|83220727|FG009|Period 1|Protocol Violation|0|||
47078914|NCT01431638|83384716|FG001|Overall Study|Protocol deviation|1|||
47078915|NCT01431638|83384717|FG002|Overall Study|Protocol deviation|4|||
46792845|NCT00643760|83011383|FG004|Overall Study|Investigator Discretion|0|||
46854861|NCT03416374|83070685|FG000|Treatment Period II|Other|0|||
46854862|NCT03416374|83070686|FG001|Treatment Period II|Other|2|||
46976301|NCT01968070|83220728|FG010|Period 1|Protocol Violation|0|||
46976302|NCT01968070|83220729|FG011|Period 1|Protocol Violation|0|||
46976303|NCT01968070|83220730|FG012|Period 1|Protocol Violation|0|||
47078916|NCT01431638|83384715|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
47078917|NCT01431638|83384716|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
46854863|NCT03799952|83070697|FG000|Overall Study|Program was too easy, discontinued|1|||
46976304|NCT01968070|83220731|FG013|Period 1|Protocol Violation|0|||
46976305|NCT01968070|83220732|FG014|Period 1|Protocol Violation|0|||
46976306|NCT01968070|83220733|FG015|Period 1|Protocol Violation|0|||
46976307|NCT01968070|83220734|FG016|Period 1|Protocol Violation|0|||
46976308|NCT01968070|83220735|FG017|Period 1|Protocol Violation|0|||
46976309|NCT01968070|83220718|FG000|Period 1|Lost to Follow-up|0|||
46976310|NCT01968070|83220719|FG001|Period 1|Lost to Follow-up|0|||
46976311|NCT01968070|83220720|FG002|Period 1|Lost to Follow-up|0|||
46976312|NCT01968070|83220721|FG003|Period 1|Lost to Follow-up|1|||
46976313|NCT01968070|83220722|FG004|Period 1|Lost to Follow-up|0|||
46976314|NCT01968070|83220723|FG005|Period 1|Lost to Follow-up|0|||
46976315|NCT01968070|83220724|FG006|Period 1|Lost to Follow-up|0|||
46976316|NCT01968070|83220725|FG007|Period 1|Lost to Follow-up|0|||
46976317|NCT01968070|83220726|FG008|Period 1|Lost to Follow-up|0|||
47078918|NCT01431638|83384717|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
47078919|NCT01392170|83384725|FG000|Overall Study|Withdrawal by Subject|1|||
47078920|NCT01392170|83384725|FG000|Overall Study|Ineligible|1|||
47078921|NCT00558753|83384731|FG000|Overall Study|Lost to Follow-up|5|||
46976318|NCT01968070|83220727|FG009|Period 1|Lost to Follow-up|0|||
46976319|NCT01968070|83220728|FG010|Period 1|Lost to Follow-up|0|||
46976320|NCT01968070|83220729|FG011|Period 1|Lost to Follow-up|0|||
46976321|NCT01968070|83220730|FG012|Period 1|Lost to Follow-up|0|||
46976322|NCT01968070|83220731|FG013|Period 1|Lost to Follow-up|0|||
46976323|NCT01968070|83220732|FG014|Period 1|Lost to Follow-up|0|||
46976324|NCT01968070|83220733|FG015|Period 1|Lost to Follow-up|0|||
46976325|NCT01968070|83220734|FG016|Period 1|Lost to Follow-up|0|||
46976326|NCT01968070|83220735|FG017|Period 1|Lost to Follow-up|0|||
46976327|NCT01968070|83220718|FG000|Period 1|Adverse Event|0|||
46976328|NCT01968070|83220719|FG001|Period 1|Adverse Event|0|||
46976329|NCT01968070|83220720|FG002|Period 1|Adverse Event|0|||
46976330|NCT01968070|83220721|FG003|Period 1|Adverse Event|0|||
46976331|NCT01968070|83220722|FG004|Period 1|Adverse Event|0|||
46976332|NCT01968070|83220723|FG005|Period 1|Adverse Event|0|||
46976333|NCT01968070|83220724|FG006|Period 1|Adverse Event|1|||
46976334|NCT01968070|83220725|FG007|Period 1|Adverse Event|0|||
46976335|NCT01968070|83220726|FG008|Period 1|Adverse Event|0|||
46976336|NCT01968070|83220727|FG009|Period 1|Adverse Event|0|||
47078922|NCT00558753|83384732|FG001|Overall Study|Lost to Follow-up|7|||
47078923|NCT01391546|83384740|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
46792846|NCT00643760|83011379|FG000|Overall Study|Withdrawal by Subject|3|||
46792847|NCT00643760|83011380|FG001|Overall Study|Withdrawal by Subject|1|||
46976337|NCT01968070|83220728|FG010|Period 1|Adverse Event|0|||
46976338|NCT01968070|83220729|FG011|Period 1|Adverse Event|0|||
46976339|NCT01968070|83220730|FG012|Period 1|Adverse Event|0|||
46976340|NCT01968070|83220731|FG013|Period 1|Adverse Event|0|||
46976341|NCT01968070|83220732|FG014|Period 1|Adverse Event|0|||
46976342|NCT01968070|83220733|FG015|Period 1|Adverse Event|0|||
46976343|NCT01968070|83220734|FG016|Period 1|Adverse Event|0|||
46976344|NCT01968070|83220735|FG017|Period 1|Adverse Event|0|||
47078924|NCT01391546|83384741|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
46792848|NCT00643760|83011381|FG002|Overall Study|Withdrawal by Subject|2|||
46792849|NCT00643760|83011382|FG003|Overall Study|Withdrawal by Subject|4|||
46792850|NCT00643760|83011383|FG004|Overall Study|Withdrawal by Subject|1|||
46792851|NCT00643682|83011397|FG000|Overall Study|did not keep appointment|522|||
46792852|NCT00643682|83011398|FG001|Overall Study|did not keep appointment|509|||
46792853|NCT00603798|83011407|FG000|Overall Study|Adverse Event|4|||
46792854|NCT00603798|83011408|FG001|Overall Study|Adverse Event|2|||
46792855|NCT00603798|83011409|FG002|Overall Study|Adverse Event|1|||
46976345|NCT01968070|83220718|FG000|Period 1|Physician Decision|0|||
46976346|NCT01968070|83220719|FG001|Period 1|Physician Decision|0|||
46976347|NCT01968070|83220720|FG002|Period 1|Physician Decision|0|||
46976348|NCT01968070|83220721|FG003|Period 1|Physician Decision|0|||
46976349|NCT01968070|83220722|FG004|Period 1|Physician Decision|0|||
46976350|NCT01968070|83220723|FG005|Period 1|Physician Decision|0|||
46976351|NCT01968070|83220724|FG006|Period 1|Physician Decision|0|||
46792856|NCT00603798|83011407|FG000|Overall Study|Withdrawal by Subject|4|||
46792857|NCT00603798|83011408|FG001|Overall Study|Withdrawal by Subject|3|||
46976352|NCT01968070|83220725|FG007|Period 1|Physician Decision|0|||
46976353|NCT01968070|83220726|FG008|Period 1|Physician Decision|0|||
46976354|NCT01968070|83220727|FG009|Period 1|Physician Decision|0|||
46976355|NCT01968070|83220728|FG010|Period 1|Physician Decision|0|||
46976356|NCT01968070|83220729|FG011|Period 1|Physician Decision|1|||
46976357|NCT01968070|83220730|FG012|Period 1|Physician Decision|0|||
46976358|NCT01968070|83220731|FG013|Period 1|Physician Decision|0|||
46976359|NCT01968070|83220732|FG014|Period 1|Physician Decision|0|||
46976360|NCT01968070|83220733|FG015|Period 1|Physician Decision|0|||
46976361|NCT01968070|83220734|FG016|Period 1|Physician Decision|0|||
47078925|NCT01410110|83384750|FG000|Overall Study|Withdrawal by Subject|4|||
46976362|NCT01968070|83220735|FG017|Period 1|Physician Decision|0|||
46976363|NCT01968070|83220718|FG000|Period 2|Withdrawal by Subject|0|||
46976364|NCT01968070|83220719|FG001|Period 2|Withdrawal by Subject|0|||
46976365|NCT01968070|83220720|FG002|Period 2|Withdrawal by Subject|0|||
47078926|NCT01410110|83384751|FG001|Overall Study|Withdrawal by Subject|2|||
46976366|NCT01968070|83220721|FG003|Period 2|Withdrawal by Subject|0|||
46976367|NCT01968070|83220722|FG004|Period 2|Withdrawal by Subject|1|||
47078927|NCT01391000|83384759|FG000|Overall Study|Lost to Follow-up|2|||
47078928|NCT01391000|83384760|FG001|Overall Study|Lost to Follow-up|0|||
47078929|NCT01390844|83384835|FG000|Treatment Phase|Adverse Event|12|||
47078930|NCT01390844|83384836|FG001|Treatment Phase|Adverse Event|2|||
47078931|NCT01390844|83384837|FG002|Treatment Phase|Adverse Event|3|||
47078932|NCT01390844|83384838|FG003|Treatment Phase|Adverse Event|2|||
47078933|NCT01390844|83384835|FG000|Treatment Phase|Treatment Failure|23|||
47078934|NCT01390844|83384836|FG001|Treatment Phase|Treatment Failure|25|||
46792858|NCT00603798|83011409|FG002|Overall Study|Withdrawal by Subject|4|||
46792859|NCT00603798|83011407|FG000|Overall Study|Lost to Follow-up|1|||
46792860|NCT00603798|83011408|FG001|Overall Study|Lost to Follow-up|0|||
46792861|NCT00603798|83011409|FG002|Overall Study|Lost to Follow-up|1|||
46792862|NCT00603798|83011407|FG000|Overall Study|Non-compliance with study procedures|0|||
46792863|NCT00603798|83011408|FG001|Overall Study|Non-compliance with study procedures|1|||
46976368|NCT01968070|83220723|FG005|Period 2|Withdrawal by Subject|0|||
46976369|NCT01968070|83220724|FG006|Period 2|Withdrawal by Subject|0|||
46976370|NCT01968070|83220725|FG007|Period 2|Withdrawal by Subject|0|||
46976371|NCT01968070|83220726|FG008|Period 2|Withdrawal by Subject|0|||
46976372|NCT01968070|83220727|FG009|Period 2|Withdrawal by Subject|0|||
46976373|NCT01968070|83220728|FG010|Period 2|Withdrawal by Subject|0|||
46976374|NCT01968070|83220729|FG011|Period 2|Withdrawal by Subject|0|||
46976375|NCT01968070|83220730|FG012|Period 2|Withdrawal by Subject|0|||
46976376|NCT01968070|83220731|FG013|Period 2|Withdrawal by Subject|0|||
46976377|NCT01968070|83220732|FG014|Period 2|Withdrawal by Subject|0|||
46976378|NCT01968070|83220733|FG015|Period 2|Withdrawal by Subject|0|||
46976379|NCT01968070|83220734|FG016|Period 2|Withdrawal by Subject|0|||
46976380|NCT01968070|83220735|FG017|Period 2|Withdrawal by Subject|0|||
46976381|NCT01918774|83220773|FG000|Overall Study|Lost prior to first CBTw session|4|||
46976382|NCT01918774|83220773|FG000|Overall Study|Lost to Follow-up|1|||
46976383|NCT01949116|83220779|FG000|Overall Study|Death|2|||
46976384|NCT01949116|83220780|FG001|Overall Study|Death|0|||
46976385|NCT01949116|83220779|FG000|Overall Study|Lost to Follow-up|1|||
46976386|NCT01949116|83220780|FG001|Overall Study|Lost to Follow-up|3|||
46976387|NCT01949116|83220779|FG000|Overall Study|Withdrawal by Subject|5|||
46976388|NCT01949116|83220780|FG001|Overall Study|Withdrawal by Subject|3|||
46976389|NCT01673009|83220790|FG000|Overall Study|Physician Decision|5|||
46976390|NCT01673009|83220790|FG000|Overall Study|Withdrawal by Subject|8|||
46976391|NCT01939366|83220799|FG000|Overall Study|Adverse Event|8|||
46976392|NCT01939366|83220800|FG001|Overall Study|Adverse Event|17|||
46976393|NCT01939366|83220801|FG002|Overall Study|Adverse Event|30|||
46976394|NCT01939366|83220802|FG003|Overall Study|Adverse Event|8|||
46976395|NCT01939366|83220803|FG004|Overall Study|Adverse Event|5|||
46976396|NCT01939366|83220799|FG000|Overall Study|Lack of Efficacy|2|||
46976397|NCT01939366|83220800|FG001|Overall Study|Lack of Efficacy|1|||
46976398|NCT01939366|83220801|FG002|Overall Study|Lack of Efficacy|1|||
46976399|NCT01939366|83220802|FG003|Overall Study|Lack of Efficacy|1|||
46976400|NCT01939366|83220803|FG004|Overall Study|Lack of Efficacy|3|||
46976401|NCT01939366|83220799|FG000|Overall Study|Lost to Follow-up|1|||
46976402|NCT01939366|83220800|FG001|Overall Study|Lost to Follow-up|1|||
46976403|NCT01939366|83220801|FG002|Overall Study|Lost to Follow-up|0|||
46976404|NCT01939366|83220802|FG003|Overall Study|Lost to Follow-up|0|||
46976405|NCT01939366|83220803|FG004|Overall Study|Lost to Follow-up|0|||
46976406|NCT01939366|83220799|FG000|Overall Study|Withdrawal by Subject|1|||
46976407|NCT01939366|83220800|FG001|Overall Study|Withdrawal by Subject|0|||
46976408|NCT01939366|83220801|FG002|Overall Study|Withdrawal by Subject|2|||
46976409|NCT01939366|83220802|FG003|Overall Study|Withdrawal by Subject|2|||
46976410|NCT01939366|83220803|FG004|Overall Study|Withdrawal by Subject|3|||
46976411|NCT01939366|83220799|FG000|Overall Study|Inclusion criteria not met|0|||
46976412|NCT01939366|83220800|FG001|Overall Study|Inclusion criteria not met|1|||
46976413|NCT01939366|83220801|FG002|Overall Study|Inclusion criteria not met|1|||
46976414|NCT01939366|83220802|FG003|Overall Study|Inclusion criteria not met|0|||
46976415|NCT01939366|83220803|FG004|Overall Study|Inclusion criteria not met|1|||
46976416|NCT01939366|83220799|FG000|Overall Study|Other|0|||
46976417|NCT01939366|83220800|FG001|Overall Study|Other|0|||
46976418|NCT01939366|83220801|FG002|Overall Study|Other|2|||
46976419|NCT01939366|83220802|FG003|Overall Study|Other|2|||
46976420|NCT01939366|83220803|FG004|Overall Study|Other|1|||
46976421|NCT01939366|83220799|FG000|Overall Study|Protocol Violation|0|||
47078935|NCT01390844|83384837|FG002|Treatment Phase|Treatment Failure|10|||
46976422|NCT01939366|83220800|FG001|Overall Study|Protocol Violation|0|||
46976423|NCT01939366|83220801|FG002|Overall Study|Protocol Violation|0|||
46976424|NCT01939366|83220802|FG003|Overall Study|Protocol Violation|1|||
46976425|NCT01939366|83220803|FG004|Overall Study|Protocol Violation|0|||
46976426|NCT01939366|83220799|FG000|Overall Study|Sponsor decision|0|||
46976427|NCT01939366|83220800|FG001|Overall Study|Sponsor decision|0|||
47078936|NCT01390844|83384838|FG003|Treatment Phase|Treatment Failure|13|||
46976428|NCT01939366|83220801|FG002|Overall Study|Sponsor decision|0|||
46976429|NCT01939366|83220802|FG003|Overall Study|Sponsor decision|0|||
46976430|NCT01939366|83220803|FG004|Overall Study|Sponsor decision|2|||
46976431|NCT01939366|83220799|FG000|Overall Study|GCP non-compliance at site|2|||
46976432|NCT01939366|83220800|FG001|Overall Study|GCP non-compliance at site|3|||
46976433|NCT01939366|83220801|FG002|Overall Study|GCP non-compliance at site|2|||
46976434|NCT01939366|83220802|FG003|Overall Study|GCP non-compliance at site|3|||
46976435|NCT01939366|83220803|FG004|Overall Study|GCP non-compliance at site|3|||
46976436|NCT01918306|83220817|FG000|Overall Study|progresive disease|4|||
46976437|NCT01918306|83220818|FG001|Overall Study|progresive disease|0|||
46976438|NCT01918306|83220819|FG002|Overall Study|progresive disease|1|||
46976439|NCT01918306|83220820|FG003|Overall Study|progresive disease|1|||
46976440|NCT01918306|83220817|FG000|Overall Study|Withdrawal by Subject|0|||
46976441|NCT01918306|83220818|FG001|Overall Study|Withdrawal by Subject|0|||
46976442|NCT01918306|83220819|FG002|Overall Study|Withdrawal by Subject|0|||
47078937|NCT01390844|83384835|FG000|Treatment Phase|Non-Medical Reasons|5|||
47078938|NCT01390844|83384836|FG001|Treatment Phase|Non-Medical Reasons|1|||
47078939|NCT01390844|83384837|FG002|Treatment Phase|Non-Medical Reasons|8|||
46673993|NCT01159600|82889494|FG000|Overall Study|Other reason not defined above|3|||
46673994|NCT01159600|82889495|FG001|Overall Study|Other reason not defined above|0|||
46792864|NCT00603798|83011409|FG002|Overall Study|Non-compliance with study procedures|0|||
46792865|NCT00603798|83011407|FG000|Overall Study|Not due to AE|1|||
46792866|NCT00603798|83011408|FG001|Overall Study|Not due to AE|1|||
46792867|NCT00603798|83011409|FG002|Overall Study|Not due to AE|4|||
46792868|NCT00630812|83011419|FG000|Randomisation to First Dose|Adverse Event|1|||
46792869|NCT00630812|83011420|FG001|Randomisation to First Dose|Adverse Event|1|||
46792870|NCT00630812|83011419|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
46854864|NCT03799952|83070698|FG001|Overall Study|Program was too easy, discontinued|0|||
46854865|NCT03799952|83070697|FG000|Overall Study|Lost to Follow-up|0|||
47078940|NCT01390844|83384838|FG003|Treatment Phase|Non-Medical Reasons|1|||
47078941|NCT01390844|83384835|FG000|Treatment Phase|Non-GCP Compliant|0|||
47078942|NCT01390844|83384836|FG001|Treatment Phase|Non-GCP Compliant|0|||
46854866|NCT03799952|83070698|FG001|Overall Study|Lost to Follow-up|2|||
46854867|NCT00077766|83070706|FG000|Overall Study|Adverse Event|1|||
46854868|NCT00077766|83070707|FG001|Overall Study|Adverse Event|1|||
46854869|NCT00077766|83070706|FG000|Overall Study|Withdrawal by Subject|4|||
46854870|NCT00077766|83070707|FG001|Overall Study|Withdrawal by Subject|3|||
46854871|NCT00077766|83070706|FG000|Overall Study|Death|12|||
46854872|NCT00077766|83070707|FG001|Overall Study|Death|10|||
46854873|NCT00077766|83070706|FG000|Overall Study|Lost to Follow-up|2|||
46854874|NCT00077766|83070707|FG001|Overall Study|Lost to Follow-up|0|||
46854875|NCT00077766|83070706|FG000|Overall Study|Protocol Violation|1|||
46854876|NCT00077766|83070707|FG001|Overall Study|Protocol Violation|0|||
46854877|NCT00077766|83070706|FG000|Overall Study|Kidney Transplantation|9|||
46854878|NCT00077766|83070707|FG001|Overall Study|Kidney Transplantation|5|||
46854879|NCT00077766|83070706|FG000|Overall Study|Transplantation|5|||
47078943|NCT01390844|83384837|FG002|Treatment Phase|Non-GCP Compliant|10|||
47078944|NCT01390844|83384838|FG003|Treatment Phase|Non-GCP Compliant|3|||
47078945|NCT01390844|83384835|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
47078946|NCT01390844|83384836|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
46854880|NCT00077766|83070707|FG001|Overall Study|Transplantation|1|||
46854881|NCT00077766|83070706|FG000|Overall Study|Investigators Discretion|1|||
46854882|NCT00077766|83070707|FG001|Overall Study|Investigators Discretion|0|||
46854883|NCT00077766|83070706|FG000|Overall Study|Participant's decision|1|||
46854884|NCT00077766|83070707|FG001|Overall Study|Participant's decision|0|||
46976443|NCT01918306|83220820|FG003|Overall Study|Withdrawal by Subject|2|||
46976444|NCT01918306|83220817|FG000|Overall Study|neutropenia|1|||
46976445|NCT01918306|83220818|FG001|Overall Study|neutropenia|0|||
47078947|NCT01390844|83384837|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
47078948|NCT01390844|83384838|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
47078949|NCT01430624|83384851|FG000|Overall Study|Lost to Follow-up|23|||
47078950|NCT01430624|83384852|FG001|Overall Study|Lost to Follow-up|29|||
47078951|NCT01430624|83384853|FG002|Overall Study|Lost to Follow-up|27|||
47078952|NCT01430624|83384851|FG000|Overall Study|technical or eligibility|5|||
47078953|NCT01430624|83384852|FG001|Overall Study|technical or eligibility|5|||
47078954|NCT01430624|83384853|FG002|Overall Study|technical or eligibility|2|||
46976446|NCT01918306|83220819|FG002|Overall Study|neutropenia|0|||
46792871|NCT00630812|83011420|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
46854885|NCT00077766|83070706|FG000|Overall Study|Dialysis Discontinued|1|||
46854886|NCT00077766|83070707|FG001|Overall Study|Dialysis Discontinued|0|||
46976447|NCT01918306|83220820|FG003|Overall Study|neutropenia|0|||
47078955|NCT01430468|83384878|FG000|Overall Study|Physician Decision|2|||
47078956|NCT01430468|83384879|FG001|Overall Study|Physician Decision|1|||
47078957|NCT01430468|83384878|FG000|Overall Study|Withdrawal by Subject|5|||
46976448|NCT01918306|83220817|FG000|Overall Study|Lack of Efficacy|1|||
46976449|NCT01918306|83220818|FG001|Overall Study|Lack of Efficacy|0|||
47078958|NCT01430468|83384879|FG001|Overall Study|Withdrawal by Subject|5|||
47078959|NCT01409564|83384900|FG000|Overall Study|low medication compliance|4|||
46792872|NCT00630812|83011419|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
46792873|NCT00630812|83011420|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
46792874|NCT00630812|83011419|FG000|Randomisation to First Dose|Protocol Violation|4|||
46792875|NCT00630812|83011420|FG001|Randomisation to First Dose|Protocol Violation|1|||
46792876|NCT00630812|83011419|FG000|Double Blind Treatment Period|Adverse Event|13|||
46792877|NCT00630812|83011420|FG001|Double Blind Treatment Period|Adverse Event|5|||
46792878|NCT00630812|83011419|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
46792879|NCT00630812|83011420|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
47078960|NCT01409564|83384901|FG001|Overall Study|low medication compliance|3|||
47078961|NCT01409564|83384900|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
47078962|NCT01409564|83384901|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
47078963|NCT01390298|83384911|FG000|Overall Study|Death|1|||
47078964|NCT01390298|83384911|FG000|Overall Study|long term ICU admission|1|||
47078965|NCT01390298|83384911|FG000|Overall Study|Withdrawal by Subject|14|||
47078966|NCT01390298|83384911|FG000|Overall Study|Lost to Follow-up|7|||
47078967|NCT01390298|83384911|FG000|Overall Study|Surgery cancelled|1|||
47078968|NCT01390220|83384929|FG000|Test Dose Phase|Adverse Event|17|||
47078969|NCT01390220|83384930|FG001|Test Dose Phase|Adverse Event|0|||
47078970|NCT01390220|83384931|FG002|Test Dose Phase|Adverse Event|0|||
46673995|NCT01159600|82889496|FG002|Overall Study|Other reason not defined above|4|||
46673996|NCT01159600|82889497|FG003|Overall Study|Other reason not defined above|2|||
46673997|NCT01159600|82889498|FG004|Overall Study|Other reason not defined above|5|||
46673998|NCT01159600|82889499|FG005|Overall Study|Other reason not defined above|7|||
46673999|NCT01159600|82889500|FG006|Overall Study|Other reason not defined above|3|||
46792880|NCT00630812|83011419|FG000|Double Blind Treatment Period|Physician Decision|2|||
46976450|NCT01918306|83220819|FG002|Overall Study|Lack of Efficacy|0|||
46976451|NCT01918306|83220820|FG003|Overall Study|Lack of Efficacy|0|||
46976452|NCT01918306|83220817|FG000|Overall Study|progress disease, crossover|0|||
46976453|NCT01918306|83220818|FG001|Overall Study|progress disease, crossover|0|||
46976454|NCT01918306|83220819|FG002|Overall Study|progress disease, crossover|1|||
46976455|NCT01918306|83220820|FG003|Overall Study|progress disease, crossover|0|||
46976456|NCT01917526|83220842|FG000|Overall Study|Protocol Violation|1|||
46976457|NCT01917526|83220843|FG001|Overall Study|Protocol Violation|1|||
46976458|NCT01948258|83220849|FG000|Overall Study|Pregnancy|41|||
46976459|NCT01948258|83220849|FG000|Overall Study|Did not complete by cut-off date|35|||
46976460|NCT01948258|83220849|FG000|Overall Study|Lost to Follow-up|27|||
46976461|NCT01948258|83220849|FG000|Overall Study|Withdrawal by SPD|8|||
46976462|NCT01948258|83220849|FG000|Overall Study|Withdrawal by Subject|6|||
46976463|NCT01948258|83220849|FG000|Overall Study|Health Care Professional|43|||
46976464|NCT01948258|83220849|FG000|Overall Study|Removed from statistical analysis|2|||
46976465|NCT01916980|83220855|FG000|Overall Study|Adverse Event|4|||
46976466|NCT01916980|83220856|FG001|Overall Study|Adverse Event|2|||
46976467|NCT01916980|83220855|FG000|Overall Study|Lack of Efficacy|2|||
46976468|NCT01916980|83220856|FG001|Overall Study|Lack of Efficacy|2|||
46976469|NCT01916980|83220855|FG000|Overall Study|Withdrawal by Subject|1|||
46976470|NCT01916980|83220856|FG001|Overall Study|Withdrawal by Subject|0|||
46976471|NCT05940077|83220862|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
46976472|NCT05011513|83220876|FG000|Overall Study|Death|0|||
47078971|NCT01390220|83384929|FG000|Test Dose Phase|Withdrawal by Subject|8|||
46792881|NCT00630812|83011420|FG001|Double Blind Treatment Period|Physician Decision|1|||
46792882|NCT00630812|83011419|FG000|Double Blind Treatment Period|Protocol Violation|1|||
46976473|NCT05011513|83220877|FG001|Overall Study|Death|1|||
47078972|NCT01390220|83384930|FG001|Test Dose Phase|Withdrawal by Subject|0|||
46976474|NCT05011513|83220876|FG000|Overall Study|Lost to Follow-up|4|||
46976475|NCT05011513|83220877|FG001|Overall Study|Lost to Follow-up|0|||
46976476|NCT05011513|83220876|FG000|Overall Study|Withdrawal by Subject|18|||
46976477|NCT05011513|83220877|FG001|Overall Study|Withdrawal by Subject|17|||
47078973|NCT01390220|83384931|FG002|Test Dose Phase|Withdrawal by Subject|0|||
47078974|NCT01390220|83384929|FG000|Test Dose Phase|Lost to Follow-up|2|||
47078975|NCT01390220|83384930|FG001|Test Dose Phase|Lost to Follow-up|0|||
47078976|NCT01390220|83384931|FG002|Test Dose Phase|Lost to Follow-up|0|||
47078977|NCT01390220|83384929|FG000|Test Dose Phase|Protocol Violation|8|||
47078978|NCT01390220|83384930|FG001|Test Dose Phase|Protocol Violation|0|||
47078979|NCT01390220|83384931|FG002|Test Dose Phase|Protocol Violation|0|||
47078980|NCT01390220|83384929|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
47078981|NCT01390220|83384930|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
47078982|NCT01390220|83384931|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
47078983|NCT01390220|83384929|FG000|Test Dose Phase|Study/Site closure|6|||
47078984|NCT01390220|83384930|FG001|Test Dose Phase|Study/Site closure|0|||
47078985|NCT01390220|83384931|FG002|Test Dose Phase|Study/Site closure|0|||
47078986|NCT01390220|83384929|FG000|Test Dose Phase|Caregiver no longer available|5|||
46976478|NCT05011513|83220876|FG000|Overall Study|Other|4|||
47078987|NCT01390220|83384930|FG001|Test Dose Phase|Caregiver no longer available|0|||
47078988|NCT01390220|83384931|FG002|Test Dose Phase|Caregiver no longer available|0|||
47078989|NCT01390220|83384929|FG000|Test Dose Phase|Noncompliance|2|||
47078990|NCT01390220|83384930|FG001|Test Dose Phase|Noncompliance|0|||
47078991|NCT01390220|83384931|FG002|Test Dose Phase|Noncompliance|0|||
46976479|NCT05011513|83220877|FG001|Overall Study|Other|2|||
46976480|NCT04750239|83220883|FG000|Overall Study|Withdrawal by Subject|2|||
46976481|NCT04750239|83220883|FG000|Overall Study|Trial terminated by sponsor|1|||
46976482|NCT04590248|83220888|FG000|Overall Study|Lost to Follow-up|1|||
46976483|NCT04590248|83220888|FG000|Overall Study|Withdrawal by Subject|16|||
46976484|NCT04590248|83220888|FG000|Overall Study|Other|2|||
46976485|NCT04560816|83220892|FG000|Overall Study|Withdrawal by Subject|1|||
46976486|NCT04560816|83220893|FG001|Overall Study|Withdrawal by Subject|1|||
46976487|NCT04560816|83220894|FG002|Overall Study|Withdrawal by Subject|1|||
46976488|NCT04560816|83220895|FG003|Overall Study|Withdrawal by Subject|0|||
46976489|NCT04560816|83220896|FG004|Overall Study|Withdrawal by Subject|3|||
46976490|NCT04560816|83220897|FG005|Overall Study|Withdrawal by Subject|0|||
46976491|NCT04560816|83220892|FG000|Overall Study|Lost to Follow-up|1|||
46976492|NCT04560816|83220893|FG001|Overall Study|Lost to Follow-up|0|||
46976493|NCT04560816|83220894|FG002|Overall Study|Lost to Follow-up|0|||
46976494|NCT04560816|83220895|FG003|Overall Study|Lost to Follow-up|0|||
46976495|NCT04560816|83220896|FG004|Overall Study|Lost to Follow-up|0|||
46976496|NCT04560816|83220897|FG005|Overall Study|Lost to Follow-up|0|||
46976497|NCT04560816|83220892|FG000|Overall Study|Protocol Violation|1|||
46976498|NCT04560816|83220893|FG001|Overall Study|Protocol Violation|0|||
46976499|NCT04560816|83220894|FG002|Overall Study|Protocol Violation|0|||
46976500|NCT04560816|83220895|FG003|Overall Study|Protocol Violation|0|||
46976501|NCT04560816|83220896|FG004|Overall Study|Protocol Violation|0|||
46976502|NCT04560816|83220897|FG005|Overall Study|Protocol Violation|0|||
46976503|NCT04092582|83220911|FG000|Overall Study|Death|1|||
46976504|NCT04092582|83220912|FG001|Overall Study|Death|1|||
46976505|NCT04092582|83220911|FG000|Overall Study|Withdrawal by Subject|4|||
46976506|NCT04092582|83220912|FG001|Overall Study|Withdrawal by Subject|1|||
46976507|NCT04092582|83220911|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
46976508|NCT04092582|83220912|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
46976509|NCT04011384|83220930|FG000|Overall Study|Withdrawal by Subject|2|||
46976510|NCT04011384|83220931|FG001|Overall Study|Withdrawal by Subject|0|||
46674000|NCT01159600|82889501|FG007|Overall Study|Other reason not defined above|3|||
46976511|NCT03636256|83220957|FG000|Overall Study|Lost to Follow-up|3|||
46674001|NCT01159171|82889520|FG000|Overall Study|Adverse Event|11|||
46976512|NCT03636256|83220958|FG001|Overall Study|Lost to Follow-up|0|||
46976513|NCT03636256|83220959|FG002|Overall Study|Lost to Follow-up|2|||
46976514|NCT03636256|83220960|FG003|Overall Study|Lost to Follow-up|1|||
46976515|NCT03636256|83220961|FG004|Overall Study|Lost to Follow-up|0|||
46976516|NCT03636256|83220962|FG005|Overall Study|Lost to Follow-up|4|||
47078992|NCT01390220|83384929|FG000|Test Dose Phase|Logistical|6|||
47078993|NCT01390220|83384930|FG001|Test Dose Phase|Logistical|0|||
47078994|NCT01390220|83384931|FG002|Test Dose Phase|Logistical|0|||
47078995|NCT01390220|83384929|FG000|Comparative Phase|Withdrawal by Subject|0|||
47078996|NCT01390220|83384930|FG001|Comparative Phase|Withdrawal by Subject|1|||
47078997|NCT01390220|83384931|FG002|Comparative Phase|Withdrawal by Subject|0|||
47078998|NCT00550173|83384961|FG000|Overall Study|Death|45|||
47078999|NCT00550173|83384962|FG001|Overall Study|Death|38|||
47079000|NCT00550173|83384963|FG002|Overall Study|Death|50|||
47079001|NCT00550173|83384961|FG000|Overall Study|Physician Decision|1|||
47079002|NCT00550173|83384962|FG001|Overall Study|Physician Decision|2|||
47079003|NCT00550173|83384963|FG002|Overall Study|Physician Decision|2|||
47079004|NCT00550173|83384961|FG000|Overall Study|Withdrawal by Subject|9|||
47079005|NCT00550173|83384962|FG001|Overall Study|Withdrawal by Subject|12|||
47079006|NCT00550173|83384963|FG002|Overall Study|Withdrawal by Subject|17|||
47079007|NCT00550173|83384961|FG000|Overall Study|Sponsor Decision|13|||
47079008|NCT00550173|83384962|FG001|Overall Study|Sponsor Decision|7|||
46674002|NCT01159171|82889520|FG000|Overall Study|Progression of Disease|28|||
46976517|NCT03636256|83220963|FG006|Overall Study|Lost to Follow-up|2|||
46976518|NCT03636256|83220964|FG007|Overall Study|Lost to Follow-up|0|||
47079009|NCT00550173|83384963|FG002|Overall Study|Sponsor Decision|1|||
46976519|NCT03636256|83220965|FG008|Overall Study|Lost to Follow-up|4|||
46976520|NCT03636256|83220957|FG000|Overall Study|Withdrawal by Subject|0|||
46976521|NCT03636256|83220958|FG001|Overall Study|Withdrawal by Subject|0|||
46976522|NCT03636256|83220959|FG002|Overall Study|Withdrawal by Subject|0|||
46976523|NCT03636256|83220960|FG003|Overall Study|Withdrawal by Subject|0|||
46976524|NCT03636256|83220961|FG004|Overall Study|Withdrawal by Subject|0|||
46976525|NCT03636256|83220962|FG005|Overall Study|Withdrawal by Subject|0|||
46976526|NCT03636256|83220963|FG006|Overall Study|Withdrawal by Subject|0|||
46976527|NCT03636256|83220964|FG007|Overall Study|Withdrawal by Subject|0|||
46976528|NCT03636256|83220965|FG008|Overall Study|Withdrawal by Subject|1|||
46976529|NCT03614676|83220996|FG000|Overall Study|Delivery before planned visit|2|||
46976530|NCT03614676|83220997|FG001|Overall Study|Delivery before planned visit|0|||
46674003|NCT01159171|82889520|FG000|Overall Study|Protocol Violation|1|||
46674004|NCT01159171|82889520|FG000|Overall Study|Need for Surgery|5|||
46674005|NCT01159171|82889520|FG000|Overall Study|Medical Decision|4|||
46674006|NCT01159171|82889520|FG000|Overall Study|Death|1|||
46674007|NCT01158118|82889527|FG000|Overall Study|Screen failure|1|||
46674008|NCT01158118|82889528|FG001|Overall Study|Screen failure|0|||
46674009|NCT01158118|82889527|FG000|Overall Study|Donor match was a screen failure|0|||
46674010|NCT01158118|82889528|FG001|Overall Study|Donor match was a screen failure|1|||
46674011|NCT01158118|82889527|FG000|Overall Study|Suffered stroke prior to transplant|0|||
46674012|NCT01158118|82889528|FG001|Overall Study|Suffered stroke prior to transplant|1|||
46674013|NCT01158118|82889527|FG000|Overall Study|Death|0|||
46674014|NCT01158118|82889528|FG001|Overall Study|Death|1|||
46674015|NCT01157845|82889534|FG000|Overall Study|Lost to Follow-up|5|||
46792883|NCT00630812|83011420|FG001|Double Blind Treatment Period|Protocol Violation|0|||
46792884|NCT00630812|83011419|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
46792885|NCT00630812|83011420|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
46976531|NCT03614676|83220996|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
46976532|NCT03614676|83220997|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
46976533|NCT03614676|83220996|FG000|Overall Study|Migrated / moved from the study area|30|||
46976534|NCT03614676|83220997|FG001|Overall Study|Migrated / moved from the study area|22|||
46976535|NCT03614676|83220996|FG000|Overall Study|Lost to Follow-up|17|||
46976536|NCT03614676|83220997|FG001|Overall Study|Lost to Follow-up|42|||
46976537|NCT03614676|83220996|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
46976538|NCT03614676|83220997|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
46976539|NCT03614676|83220996|FG000|Overall Study|Other|16|||
46976540|NCT03614676|83220997|FG001|Overall Study|Other|47|||
46976541|NCT03614676|83220996|FG000|Overall Study|Protocol Violation|0|||
46976542|NCT03614676|83220997|FG001|Overall Study|Protocol Violation|2|||
46976543|NCT03614676|83220996|FG000|Overall Study|Neonatal event of interest|0|||
46976544|NCT03614676|83220997|FG001|Overall Study|Neonatal event of interest|6|||
46976545|NCT03614676|83220996|FG000|Overall Study|Death in infant greater than 28 days old|0|||
46976546|NCT03614676|83220997|FG001|Overall Study|Death in infant greater than 28 days old|12|||
46976547|NCT03614676|83220996|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
46976548|NCT03614676|83220997|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
46976549|NCT02727478|83221009|FG000|Overall Study|Withdrawal by Subject|8|||
46976550|NCT02727478|83221010|FG001|Overall Study|Withdrawal by Subject|10|||
46976551|NCT02614794|83221018|FG000|Overall Study|Death|258|||
46976552|NCT02614794|83221019|FG001|Overall Study|Death|151|||
46976553|NCT02614794|83221018|FG000|Overall Study|Study closure by Sponsor|119|||
46792886|NCT00630812|83011419|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
46792887|NCT00630812|83011420|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
46792888|NCT00630812|83011419|FG000|Double Blind Treatment Period|Non-compliance|0|||
46792889|NCT00630812|83011420|FG001|Double Blind Treatment Period|Non-compliance|1|||
46792890|NCT00629798|83011426|FG000|Overall Study|Not Treated|4|||
46976554|NCT02614794|83221019|FG001|Overall Study|Study closure by Sponsor|45|||
46976555|NCT02614794|83221018|FG000|Overall Study|Withdrawal by Subject|24|||
46976556|NCT02614794|83221019|FG001|Overall Study|Withdrawal by Subject|5|||
46976557|NCT02614794|83221018|FG000|Overall Study|Lost to Follow-up|7|||
46976558|NCT02614794|83221019|FG001|Overall Study|Lost to Follow-up|0|||
46976559|NCT02614794|83221018|FG000|Overall Study|Physician Decision|1|||
46976560|NCT02614794|83221019|FG001|Overall Study|Physician Decision|1|||
46976561|NCT02614794|83221018|FG000|Overall Study|Hospital closure|1|||
46976562|NCT02614794|83221019|FG001|Overall Study|Hospital closure|0|||
46976563|NCT01649232|83221032|FG000|Overall Study|Physician Decision|2|||
46976564|NCT01649232|83221033|FG001|Overall Study|Physician Decision|0|||
46976565|NCT00955968|83221047|FG000|Overall Study|Death|2|||
46976566|NCT00955968|83221048|FG001|Overall Study|Death|4|||
46976567|NCT00955968|83221047|FG000|Overall Study|Withdrawal by Subject|35|||
46674016|NCT01157845|82889534|FG000|Overall Study|Withdrawal by Subject|12|||
46674017|NCT01157845|82889534|FG000|Overall Study|Physician Decision|3|||
46674018|NCT01157845|82889534|FG000|Overall Study|Protocol Violation|13|||
46674019|NCT01157845|82889534|FG000|Overall Study|Study was ended|1|||
46674020|NCT01157845|82889534|FG000|Overall Study|Device malfunction|1|||
46674021|NCT01157377|82889545|FG000|Overall Study|Lost to Follow-up|0|||
46674022|NCT01157377|82889546|FG001|Overall Study|Lost to Follow-up|0|||
46674023|NCT01157377|82889547|FG002|Overall Study|Lost to Follow-up|1|||
46674024|NCT01157377|82889548|FG003|Overall Study|Lost to Follow-up|0|||
46674025|NCT01157377|82889549|FG004|Overall Study|Lost to Follow-up|1|||
46674026|NCT01157377|82889550|FG005|Overall Study|Lost to Follow-up|1|||
46674027|NCT01157377|82889551|FG006|Overall Study|Lost to Follow-up|0|||
46674028|NCT01157377|82889545|FG000|Overall Study|Personal Reasons|2|||
46674029|NCT01157377|82889546|FG001|Overall Study|Personal Reasons|1|||
46674030|NCT01157377|82889547|FG002|Overall Study|Personal Reasons|0|||
46674031|NCT01157377|82889548|FG003|Overall Study|Personal Reasons|1|||
46674032|NCT01157377|82889549|FG004|Overall Study|Personal Reasons|0|||
46674033|NCT01157377|82889550|FG005|Overall Study|Personal Reasons|0|||
46674034|NCT01157377|82889551|FG006|Overall Study|Personal Reasons|0|||
46792891|NCT00160615|83011432|FG000|Overall Study|Adverse Event|5|||
46792892|NCT00160615|83011433|FG001|Overall Study|Adverse Event|12|||
46792893|NCT00160615|83011432|FG000|Overall Study|Withdrawal by Subject|0|||
46792894|NCT00160615|83011433|FG001|Overall Study|Withdrawal by Subject|2|||
46792895|NCT00160615|83011432|FG000|Overall Study|Lack of Efficacy|11|||
46792896|NCT00160615|83011433|FG001|Overall Study|Lack of Efficacy|23|||
46792897|NCT00160615|83011432|FG000|Overall Study|Patient decision|1|||
46792898|NCT00160615|83011433|FG001|Overall Study|Patient decision|2|||
46674035|NCT01157377|82889545|FG000|Overall Study|Protocol Violation|0|||
46674036|NCT01157377|82889546|FG001|Overall Study|Protocol Violation|0|||
46674037|NCT01157377|82889547|FG002|Overall Study|Protocol Violation|0|||
46674038|NCT01157377|82889548|FG003|Overall Study|Protocol Violation|0|||
46674039|NCT01157377|82889549|FG004|Overall Study|Protocol Violation|0|||
46674040|NCT01157377|82889550|FG005|Overall Study|Protocol Violation|1|||
46674041|NCT01157377|82889551|FG006|Overall Study|Protocol Violation|0|||
46792899|NCT00160615|83011432|FG000|Overall Study|Investigator decision|1|||
46792900|NCT00160615|83011433|FG001|Overall Study|Investigator decision|1|||
46792901|NCT00160615|83011432|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
46792902|NCT00160615|83011433|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
46792903|NCT00160615|83011432|FG000|Overall Study|Switch to surgical treatment|0|||
46674042|NCT01157377|82889545|FG000|Overall Study|Lack of Efficacy|0|||
46792904|NCT00160615|83011433|FG001|Overall Study|Switch to surgical treatment|2|||
46674043|NCT01157377|82889546|FG001|Overall Study|Lack of Efficacy|0|||
46674044|NCT01157377|82889547|FG002|Overall Study|Lack of Efficacy|0|||
46674045|NCT01157377|82889548|FG003|Overall Study|Lack of Efficacy|0|||
46976568|NCT00955968|83221048|FG001|Overall Study|Withdrawal by Subject|31|||
46976569|NCT00955968|83221047|FG000|Overall Study|Lost to Follow-up|45|||
46976570|NCT00955968|83221048|FG001|Overall Study|Lost to Follow-up|39|||
46976571|NCT00955968|83221047|FG000|Overall Study|Site closed|55|||
46976572|NCT00955968|83221048|FG001|Overall Study|Site closed|52|||
46976573|NCT05062759|83221072|FG000|Overall Study|Death|0|||
46976574|NCT05062759|83221073|FG001|Overall Study|Death|1|||
46976575|NCT05062759|83221072|FG000|Overall Study|Lost to Follow-up|1|||
46976576|NCT05062759|83221073|FG001|Overall Study|Lost to Follow-up|0|||
46976577|NCT05033262|83221092|FG000|Overall Study|Lost to Follow-up|1|||
46674046|NCT01157377|82889549|FG004|Overall Study|Lack of Efficacy|0|||
46674047|NCT01157377|82889550|FG005|Overall Study|Lack of Efficacy|0|||
46792905|NCT00160615|83011432|FG000|Overall Study|Non-compliance was suspected|0|||
46792906|NCT00160615|83011433|FG001|Overall Study|Non-compliance was suspected|1|||
46792907|NCT00160615|83011432|FG000|Overall Study|Poor compliance|0|||
46792908|NCT00160615|83011433|FG001|Overall Study|Poor compliance|1|||
46792909|NCT00643448|83011444|FG000|Overall Study|Lack of Efficacy|2|||
46792910|NCT00643448|83011445|FG001|Overall Study|Lack of Efficacy|0|||
46792911|NCT00643448|83011446|FG002|Overall Study|Lack of Efficacy|4|||
46792912|NCT00643448|83011444|FG000|Overall Study|Adverse Event|2|||
46792913|NCT00643448|83011445|FG001|Overall Study|Adverse Event|2|||
46674048|NCT01157377|82889551|FG006|Overall Study|Lack of Efficacy|1|||
46792914|NCT00643448|83011446|FG002|Overall Study|Adverse Event|2|||
46792915|NCT00643448|83011444|FG000|Overall Study|QTcF>550 ms|0|||
46792916|NCT00643448|83011445|FG001|Overall Study|QTcF>550 ms|3|||
46976578|NCT05033262|83221093|FG001|Overall Study|Lost to Follow-up|0|||
46976579|NCT05033262|83221094|FG002|Overall Study|Lost to Follow-up|0|||
46976580|NCT05033262|83221095|FG003|Overall Study|Lost to Follow-up|1|||
46976581|NCT04963062|83221109|FG000|Overall Study|withdrew by the study team|4|||
46976582|NCT04963062|83221110|FG001|Overall Study|withdrew by the study team|2|||
46976583|NCT04900220|83221122|FG000|Overall Study|Lost to Follow-up|1|||
46976584|NCT04900220|83221123|FG001|Overall Study|Lost to Follow-up|1|||
46792917|NCT00643448|83011446|FG002|Overall Study|QTcF>550 ms|0|||
46976585|NCT04599062|83221135|FG000|Overall Study|Physician Decision|1|||
46976586|NCT04599062|83221136|FG001|Overall Study|Physician Decision|0|||
46792918|NCT00604500|83011456|FG000|Overall Study|Adverse Event|2|||
46792919|NCT00604500|83011456|FG000|Overall Study|Protocol Violation|2|||
46792920|NCT00604500|83011456|FG000|Overall Study|Treatment Failure|1|||
46792921|NCT00604500|83011456|FG000|Overall Study|Withdrawal by Subject|4|||
46792922|NCT00604500|83011456|FG000|Overall Study|Administrative|1|||
46792923|NCT00604500|83011456|FG000|Overall Study|Did not meet protocol eligibility|1|||
46792924|NCT00627458|83011463|FG000|Overall Study|Migrated from study area|1|||
46792925|NCT00627458|83011464|FG001|Overall Study|Migrated from study area|0|||
46854887|NCT00077766|83070706|FG000|Overall Study|Dialysis|0|||
46854888|NCT00077766|83070707|FG001|Overall Study|Dialysis|1|||
46854889|NCT00077766|83070706|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
46854890|NCT00077766|83070707|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
46854891|NCT00077766|83070706|FG000|Overall Study|Started Nocturnal Dialysis|0|||
46854892|NCT00077766|83070707|FG001|Overall Study|Started Nocturnal Dialysis|1|||
46854893|NCT00077766|83070706|FG000|Overall Study|Stop Dialysis|0|||
46854894|NCT00077766|83070707|FG001|Overall Study|Stop Dialysis|1|||
46854895|NCT00077766|83070706|FG000|Overall Study|Participants Vacation|2|||
46854896|NCT00077766|83070707|FG001|Overall Study|Participants Vacation|1|||
46854897|NCT03388138|83070716|FG000|Overall Study|Protocol Violation|1|||
46854898|NCT03388138|83070717|FG001|Overall Study|Protocol Violation|0|||
46854899|NCT02952898|83070726|FG000|Overall Study|Withdrawal by Subject|10|||
46976587|NCT04537208|83221153|FG000|Overall Study|Adverse Event|0|||
46976588|NCT04537208|83221154|FG001|Overall Study|Adverse Event|0|||
46976589|NCT04537208|83221155|FG002|Overall Study|Adverse Event|0|||
46976590|NCT04537208|83221156|FG003|Overall Study|Adverse Event|0|||
46976591|NCT04537208|83221157|FG004|Overall Study|Adverse Event|0|||
46976592|NCT04537208|83221158|FG005|Overall Study|Adverse Event|0|||
46976593|NCT04537208|83221159|FG006|Overall Study|Adverse Event|0|||
46792926|NCT00627458|83011465|FG002|Overall Study|Migrated from study area|1|||
46792927|NCT00627458|83011463|FG000|Overall Study|Withdrawal by Subject|2|||
46792928|NCT00627458|83011464|FG001|Overall Study|Withdrawal by Subject|6|||
46792929|NCT00627458|83011465|FG002|Overall Study|Withdrawal by Subject|5|||
46792930|NCT00627458|83011463|FG000|Overall Study|Lost to Follow-up|1|||
46792931|NCT00627458|83011464|FG001|Overall Study|Lost to Follow-up|1|||
46792932|NCT00627458|83011465|FG002|Overall Study|Lost to Follow-up|0|||
46792933|NCT00542919|83011477|FG000|Overall Study|Adverse Event|1|||
46792934|NCT00542919|83011478|FG001|Overall Study|Adverse Event|5|||
46792935|NCT00542919|83011479|FG002|Overall Study|Adverse Event|1|||
46792936|NCT00542919|83011477|FG000|Overall Study|Withdrawal by Subject|1|||
46854900|NCT02952898|83070727|FG001|Overall Study|Withdrawal by Subject|8|||
46854901|NCT02952898|83070728|FG002|Overall Study|Withdrawal by Subject|8|||
46854902|NCT02952898|83070726|FG000|Overall Study|Adverse Event|8|||
46854903|NCT02952898|83070727|FG001|Overall Study|Adverse Event|8|||
46854904|NCT02952898|83070728|FG002|Overall Study|Adverse Event|3|||
46854905|NCT02952898|83070726|FG000|Overall Study|Lost to Follow-up|3|||
46854906|NCT02952898|83070727|FG001|Overall Study|Lost to Follow-up|2|||
46854907|NCT02952898|83070728|FG002|Overall Study|Lost to Follow-up|2|||
46854908|NCT02952898|83070726|FG000|Overall Study|Non-compliance with study drug|1|||
46854909|NCT02952898|83070727|FG001|Overall Study|Non-compliance with study drug|1|||
46854910|NCT02952898|83070728|FG002|Overall Study|Non-compliance with study drug|2|||
46854911|NCT00045734|83070736|FG000|Overall Study|Protocol Violation|1|||
46854912|NCT03387046|83070742|FG000|Overall Study|Adverse Event|1|||
46854913|NCT03387046|83070743|FG001|Overall Study|Adverse Event|1|||
46854914|NCT00045110|83070752|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
46854915|NCT00045110|83070753|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
46854916|NCT00045110|83070754|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
46854917|NCT00045110|83070752|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
46854918|NCT00045110|83070753|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
46976594|NCT04537208|83221160|FG007|Overall Study|Adverse Event|0|||
46976595|NCT04537208|83221161|FG008|Overall Study|Adverse Event|1|||
47079010|NCT00550173|83384961|FG000|Overall Study|Lost to Follow-up|4|||
47079011|NCT00550173|83384962|FG001|Overall Study|Lost to Follow-up|4|||
47079012|NCT00550173|83384963|FG002|Overall Study|Lost to Follow-up|3|||
47079013|NCT01429298|83384974|FG000|Overall Study|Protocol Violation|4|||
47079014|NCT01429298|83384975|FG001|Overall Study|Protocol Violation|6|||
47079015|NCT01408706|83384987|FG000|Overall Study|Physician Decision|1|||
47079016|NCT01408706|83384988|FG001|Overall Study|Physician Decision|0|||
47079017|NCT01408628|83384996|FG000|Consented|Withdrawal by Subject|12|||
46792937|NCT00542919|83011478|FG001|Overall Study|Withdrawal by Subject|0|||
47079018|NCT01408628|83384996|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
46792938|NCT00542919|83011479|FG002|Overall Study|Withdrawal by Subject|3|||
46792939|NCT00542919|83011477|FG000|Overall Study|Physician Decision|2|||
46792940|NCT00542919|83011478|FG001|Overall Study|Physician Decision|2|||
46976596|NCT04537208|83221162|FG009|Overall Study|Adverse Event|0|||
46976597|NCT04537208|83221163|FG010|Overall Study|Adverse Event|0|||
46976598|NCT04537208|83221153|FG000|Overall Study|Protocol deviation|0|||
46976599|NCT04537208|83221154|FG001|Overall Study|Protocol deviation|0|||
46976600|NCT04537208|83221155|FG002|Overall Study|Protocol deviation|2|||
46976601|NCT04537208|83221156|FG003|Overall Study|Protocol deviation|0|||
46976602|NCT04537208|83221157|FG004|Overall Study|Protocol deviation|0|||
46976603|NCT04537208|83221158|FG005|Overall Study|Protocol deviation|2|||
46976604|NCT04537208|83221159|FG006|Overall Study|Protocol deviation|4|||
46854919|NCT00045110|83070754|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
46854920|NCT00045110|83070752|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
46854921|NCT00045110|83070753|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
46854922|NCT00045110|83070754|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
46854923|NCT03353740|83070771|FG000|Overall Study|Images for these participants not viable|52|||
46854924|NCT00003476|83070775|FG000|Overall Study|Not evaluable|1|||
46854925|NCT00003470|83070779|FG000|Overall Study|Not evaluable|6|||
46854926|NCT03386344|83070786|FG000|Overall Study|Adverse Event|6|||
46854927|NCT03386344|83070787|FG001|Overall Study|Adverse Event|3|||
46854928|NCT03386344|83070788|FG002|Overall Study|Adverse Event|1|||
46854929|NCT03386344|83070786|FG000|Overall Study|Poor Compliance to Protocol|0|||
46854930|NCT03386344|83070787|FG001|Overall Study|Poor Compliance to Protocol|1|||
46854931|NCT03386344|83070788|FG002|Overall Study|Poor Compliance to Protocol|0|||
46854932|NCT03386344|83070786|FG000|Overall Study|Study Terminated by Sponsor|101|||
46854933|NCT03386344|83070787|FG001|Overall Study|Study Terminated by Sponsor|102|||
46854934|NCT03386344|83070788|FG002|Overall Study|Study Terminated by Sponsor|106|||
46854935|NCT03386344|83070786|FG000|Overall Study|Lost to Follow-up|3|||
46976605|NCT04537208|83221160|FG007|Overall Study|Protocol deviation|0|||
46976606|NCT04537208|83221161|FG008|Overall Study|Protocol deviation|1|||
46976607|NCT04537208|83221162|FG009|Overall Study|Protocol deviation|0|||
46976608|NCT04537208|83221163|FG010|Overall Study|Protocol deviation|2|||
46976609|NCT04537208|83221153|FG000|Overall Study|Withdrawal by Subject|4|||
46976610|NCT04537208|83221154|FG001|Overall Study|Withdrawal by Subject|2|||
46976611|NCT04537208|83221155|FG002|Overall Study|Withdrawal by Subject|1|||
46976612|NCT04537208|83221156|FG003|Overall Study|Withdrawal by Subject|3|||
46976613|NCT04537208|83221157|FG004|Overall Study|Withdrawal by Subject|5|||
46976614|NCT04537208|83221158|FG005|Overall Study|Withdrawal by Subject|1|||
46976615|NCT04537208|83221159|FG006|Overall Study|Withdrawal by Subject|6|||
46976616|NCT04537208|83221160|FG007|Overall Study|Withdrawal by Subject|1|||
46976617|NCT04537208|83221161|FG008|Overall Study|Withdrawal by Subject|7|||
46976618|NCT04537208|83221162|FG009|Overall Study|Withdrawal by Subject|2|||
46976619|NCT04537208|83221163|FG010|Overall Study|Withdrawal by Subject|4|||
46976620|NCT04537208|83221153|FG000|Overall Study|Lost to Follow-up|4|||
46976621|NCT04537208|83221154|FG001|Overall Study|Lost to Follow-up|1|||
46976622|NCT04537208|83221155|FG002|Overall Study|Lost to Follow-up|3|||
46976623|NCT04537208|83221156|FG003|Overall Study|Lost to Follow-up|4|||
46976624|NCT04537208|83221157|FG004|Overall Study|Lost to Follow-up|3|||
46976625|NCT04537208|83221158|FG005|Overall Study|Lost to Follow-up|2|||
46976626|NCT04537208|83221159|FG006|Overall Study|Lost to Follow-up|3|||
46976627|NCT04537208|83221160|FG007|Overall Study|Lost to Follow-up|2|||
46976628|NCT04537208|83221161|FG008|Overall Study|Lost to Follow-up|7|||
46976629|NCT04537208|83221162|FG009|Overall Study|Lost to Follow-up|2|||
46976630|NCT04537208|83221163|FG010|Overall Study|Lost to Follow-up|2|||
46976631|NCT04502433|83221192|FG000|Overall Study|Death|2|||
46976632|NCT04502433|83221193|FG001|Overall Study|Death|4|||
46976633|NCT04502433|83221192|FG000|Overall Study|Lost to Follow-up|1|||
46792941|NCT00542919|83011479|FG002|Overall Study|Physician Decision|1|||
46792942|NCT00542919|83011477|FG000|Overall Study|Sponsor Decision|1|||
46792943|NCT00542919|83011478|FG001|Overall Study|Sponsor Decision|0|||
46792944|NCT00542919|83011479|FG002|Overall Study|Sponsor Decision|0|||
46792945|NCT00542919|83011477|FG000|Overall Study|Lost to Follow-up|2|||
46792946|NCT00542919|83011478|FG001|Overall Study|Lost to Follow-up|0|||
46792947|NCT00542919|83011479|FG002|Overall Study|Lost to Follow-up|1|||
46792948|NCT00159913|83011506|FG000|Overall Study|Adverse Event|1|||
46792949|NCT00159913|83011507|FG001|Overall Study|Adverse Event|0|||
46854936|NCT03386344|83070787|FG001|Overall Study|Lost to Follow-up|2|||
46854937|NCT03386344|83070788|FG002|Overall Study|Lost to Follow-up|1|||
46854938|NCT03386344|83070786|FG000|Overall Study|At the Participant's own Request|7|||
46976634|NCT04502433|83221193|FG001|Overall Study|Lost to Follow-up|0|||
46976635|NCT04502433|83221192|FG000|Overall Study|Physician Decision|0|||
46976636|NCT04502433|83221193|FG001|Overall Study|Physician Decision|1|||
46976637|NCT04411914|83221201|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
46976638|NCT04411914|83221202|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
46792950|NCT00159913|83011508|FG002|Overall Study|Adverse Event|1|||
46792951|NCT00159913|83011509|FG003|Overall Study|Adverse Event|0|||
46976639|NCT04389671|83221221|FG000|Overall Study|Death|7|||
46976640|NCT04381494|83221225|FG000|Overall Study|Early termination of trial|19|||
46976641|NCT04381494|83221225|FG000|Overall Study|Investigator's discretion|1|||
46792952|NCT00159913|83011506|FG000|Overall Study|Withdrawal by Subject|0|||
46792953|NCT00159913|83011507|FG001|Overall Study|Withdrawal by Subject|0|||
46976642|NCT04381494|83221225|FG000|Overall Study|Withdrawal by Subject|9|||
46976643|NCT04381494|83221225|FG000|Overall Study|NSCLC disease progression|4|||
46976644|NCT04381494|83221225|FG000|Overall Study|Device-Related Adverse Event|2|||
46976645|NCT04094584|83221280|FG000|Overall Study|No interest in study|88|||
46976646|NCT04094584|83221280|FG000|Overall Study|Unwilling to undergo screening tests|36|||
46976647|NCT04094584|83221280|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
46976648|NCT04094584|83221280|FG000|Overall Study|Opioid use|7|||
46976649|NCT04094584|83221280|FG000|Overall Study|Need for major surgery in study period|4|||
46976650|NCT04094584|83221280|FG000|Overall Study|eligible but declined enrollment|4|||
46976651|NCT04094584|83221280|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
46976652|NCT04094584|83221280|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
46976653|NCT04094584|83221280|FG000|Overall Study|Lost to Follow-up|3|||
46976654|NCT04094584|83221280|FG000|Overall Study|Withdrawal by Subject|2|||
46976655|NCT04020341|83221295|FG000|Overall Study|Adverse Event|8|||
46792954|NCT00159913|83011508|FG002|Overall Study|Withdrawal by Subject|0|||
46792955|NCT00159913|83011509|FG003|Overall Study|Withdrawal by Subject|1|||
46976656|NCT04020341|83221296|FG001|Overall Study|Adverse Event|6|||
46976657|NCT04020341|83221295|FG000|Overall Study|Lost to Follow-up|8|||
46976658|NCT04020341|83221296|FG001|Overall Study|Lost to Follow-up|2|||
46976659|NCT04020341|83221295|FG000|Overall Study|Withdrawal by Subject|16|||
46976660|NCT04020341|83221296|FG001|Overall Study|Withdrawal by Subject|16|||
46976661|NCT04020341|83221295|FG000|Overall Study|Participant not able to swallow the tablet|1|||
46976662|NCT04020341|83221296|FG001|Overall Study|Participant not able to swallow the tablet|0|||
46976663|NCT04020341|83221295|FG000|Overall Study|Physician Decision|0|||
46976664|NCT04020341|83221296|FG001|Overall Study|Physician Decision|2|||
46976665|NCT04020341|83221295|FG000|Overall Study|Protocol Deviation|0|||
46976666|NCT04020341|83221296|FG001|Overall Study|Protocol Deviation|2|||
46976667|NCT03868891|83221318|FG000|Overall Study|Adverse Event|1|||
46976668|NCT03868891|83221319|FG001|Overall Study|Adverse Event|0|||
46792956|NCT00159913|83011506|FG000|Overall Study|Lost to Follow-up|0|||
46792957|NCT00159913|83011507|FG001|Overall Study|Lost to Follow-up|0|||
46792958|NCT00159913|83011508|FG002|Overall Study|Lost to Follow-up|0|||
46792959|NCT00159913|83011509|FG003|Overall Study|Lost to Follow-up|1|||
46792960|NCT00159913|83011506|FG000|Overall Study|Protocol Violation|1|||
46792961|NCT00159913|83011507|FG001|Overall Study|Protocol Violation|0|||
46792962|NCT00159913|83011508|FG002|Overall Study|Protocol Violation|1|||
46792963|NCT00159913|83011509|FG003|Overall Study|Protocol Violation|0|||
46792964|NCT00604188|83011523|FG000|Overall Study|Adverse Event|1|||
46792965|NCT00604188|83011524|FG001|Overall Study|Adverse Event|4|||
46792966|NCT00604188|83011523|FG000|Overall Study|Lost to Follow-up|17|||
46792967|NCT00604188|83011524|FG001|Overall Study|Lost to Follow-up|15|||
46792968|NCT00604188|83011523|FG000|Overall Study|Withdrawal by Subject|5|||
46792969|NCT00604188|83011524|FG001|Overall Study|Withdrawal by Subject|1|||
46792970|NCT00604188|83011523|FG000|Overall Study|Non-compliance with protocol|4|||
46792971|NCT00604188|83011524|FG001|Overall Study|Non-compliance with protocol|4|||
46792972|NCT00604188|83011523|FG000|Overall Study|Did not receive study drug|0|||
46792973|NCT00604188|83011524|FG001|Overall Study|Did not receive study drug|1|||
46792974|NCT03913377|83011532|FG000|Period 1|Test Article no longer available|0|||
46792975|NCT03913377|83011533|FG001|Period 1|Test Article no longer available|1|||
46976669|NCT03868891|83221318|FG000|Overall Study|Lost to Follow-up|2|||
46976670|NCT03868891|83221319|FG001|Overall Study|Lost to Follow-up|1|||
47079019|NCT01408628|83384996|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
47079020|NCT01408628|83384996|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
47079021|NCT01389752|83385001|FG000|Study Period 1|Sponsor decision|0|||
47079022|NCT01389752|83385002|FG001|Study Period 1|Sponsor decision|2|||
47079023|NCT01389752|83385001|FG000|Study Period 2|Sponsor decision|1|||
47079024|NCT01389752|83385002|FG001|Study Period 2|Sponsor decision|0|||
47079025|NCT01428128|83385009|FG000|Overall Study|Withdrawal by Subject|4|||
47079026|NCT01428128|83385009|FG000|Overall Study|Screen failure by p53|10|||
47079027|NCT01428128|83385009|FG000|Overall Study|Received Neulasta in one cycle|2|||
47079028|NCT01428128|83385009|FG000|Overall Study|Adverse Event|1|||
47079029|NCT01407926|83385014|FG000|Overall Study|Lost to Follow-up|55|||
47079030|NCT01427972|83385041|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079031|NCT01427972|83385042|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
46792976|NCT03913377|83011534|FG002|Period 1|Test Article no longer available|0|||
46792977|NCT03913377|83011532|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
46792978|NCT03913377|83011533|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
46792979|NCT03913377|83011534|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
46792980|NCT00227539|83011541|FG000|Overall Study|Protocol Violation|1|||
46792981|NCT00227305|83011545|FG000|Overall Study|Adverse Event|40|||
46792982|NCT00227305|83011545|FG000|Overall Study|Withdrawal by Subject|42|||
46976671|NCT03868891|83221318|FG000|Overall Study|COVID-19 Restrictions|1|||
46976672|NCT03868891|83221319|FG001|Overall Study|COVID-19 Restrictions|2|||
46976673|NCT03827655|83221330|FG000|Overall Study|Death|0|||
46976674|NCT03827655|83221331|FG001|Overall Study|Death|0|||
46976675|NCT03827655|83221332|FG002|Overall Study|Death|0|||
46976676|NCT03827655|83221333|FG003|Overall Study|Death|0|||
46976677|NCT03827655|83221334|FG004|Overall Study|Death|1|||
46976678|NCT03827655|83221330|FG000|Overall Study|Protocol Deviation|1|||
46976679|NCT03827655|83221331|FG001|Overall Study|Protocol Deviation|0|||
46976680|NCT03827655|83221332|FG002|Overall Study|Protocol Deviation|1|||
46976681|NCT03827655|83221333|FG003|Overall Study|Protocol Deviation|1|||
46976682|NCT03827655|83221334|FG004|Overall Study|Protocol Deviation|0|||
46976683|NCT03827655|83221330|FG000|Overall Study|Withdrawal by Subject|3|||
46976684|NCT03827655|83221331|FG001|Overall Study|Withdrawal by Subject|2|||
46976685|NCT03827655|83221332|FG002|Overall Study|Withdrawal by Subject|2|||
46976686|NCT03827655|83221333|FG003|Overall Study|Withdrawal by Subject|0|||
46976687|NCT03827655|83221334|FG004|Overall Study|Withdrawal by Subject|1|||
46976688|NCT03827655|83221330|FG000|Overall Study|Reason not Specified|3|||
46976689|NCT03827655|83221331|FG001|Overall Study|Reason not Specified|1|||
46976690|NCT03827655|83221332|FG002|Overall Study|Reason not Specified|1|||
46976691|NCT03827655|83221333|FG003|Overall Study|Reason not Specified|1|||
46976692|NCT03827655|83221334|FG004|Overall Study|Reason not Specified|1|||
46976693|NCT03782064|83221369|FG000|Overall Study|Lack of Efficacy|2|||
46976694|NCT03782064|83221369|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
46976695|NCT03772522|83221375|FG000|Pre-intervention|Withdrawal by Subject|3|||
46976696|NCT03772522|83221376|FG001|Pre-intervention|Withdrawal by Subject|4|||
46976697|NCT03772522|83221375|FG000|Intervention|Withdrawal by Subject|1|||
46976698|NCT03772522|83221376|FG001|Intervention|Withdrawal by Subject|0|||
46976699|NCT03772522|83221375|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
46976700|NCT03772522|83221376|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
46976701|NCT03755518|83221386|FG000|Overall Study|Adverse Event|6|||
46976702|NCT03755518|83221386|FG000|Overall Study|Lack of Efficacy|6|||
46976703|NCT03755518|83221386|FG000|Overall Study|Bone Marrow Transplant|4|||
46976704|NCT03755518|83221386|FG000|Overall Study|Withdrawal by participant|4|||
46976705|NCT03755518|83221386|FG000|Overall Study|Progressive Disease|2|||
46976706|NCT03755518|83221386|FG000|Overall Study|Death|1|||
46976707|NCT03755518|83221386|FG000|Overall Study|Physician Decision|1|||
46976708|NCT03755518|83221386|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
46976709|NCT03739112|83221392|FG000|Overall Study|Adverse Event|2|||
46976710|NCT03739112|83221393|FG001|Overall Study|Adverse Event|2|||
46976711|NCT03739112|83221392|FG000|Overall Study|Withdrawal by Subject|38|||
46976712|NCT03739112|83221393|FG001|Overall Study|Withdrawal by Subject|19|||
46976713|NCT03739112|83221392|FG000|Overall Study|Lost to Follow-up|31|||
46976714|NCT03739112|83221393|FG001|Overall Study|Lost to Follow-up|33|||
46976715|NCT03739112|83221392|FG000|Overall Study|Protocol Deviation|12|||
46976716|NCT03739112|83221393|FG001|Overall Study|Protocol Deviation|9|||
46976717|NCT03739112|83221392|FG000|Overall Study|Physician Decision|1|||
46976718|NCT03739112|83221393|FG001|Overall Study|Physician Decision|0|||
46976719|NCT03739112|83221392|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
46976720|NCT03739112|83221393|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
46976721|NCT03739112|83221392|FG000|Overall Study|Site went on hold|65|||
46976722|NCT03739112|83221393|FG001|Overall Study|Site went on hold|67|||
46976723|NCT03739112|83221392|FG000|Overall Study|Other than specified|8|||
46976724|NCT03739112|83221393|FG001|Overall Study|Other than specified|5|||
46976725|NCT03739112|83221392|FG000|Overall Study|Randomized but not vaccinated|31|||
46976726|NCT03739112|83221393|FG001|Overall Study|Randomized but not vaccinated|25|||
46976727|NCT03622593|83221402|FG000|Overall Study|Withdrawal by Subject|11|||
47079032|NCT01427972|83385043|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079033|NCT01427972|83385044|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079034|NCT01427972|83385045|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079035|NCT01427972|83385046|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079036|NCT01427972|83385047|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079037|NCT01427972|83385048|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
47079038|NCT01427972|83385049|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079039|NCT01427972|83385050|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079040|NCT01427972|83385051|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
47079041|NCT01427972|83385052|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
46674049|NCT01157377|82889545|FG000|Overall Study|Other Miscellaneous Reasons|0|||
46674050|NCT01157377|82889546|FG001|Overall Study|Other Miscellaneous Reasons|2|||
46976728|NCT03622593|83221403|FG001|Overall Study|Withdrawal by Subject|9|||
46976729|NCT03622593|83221404|FG002|Overall Study|Withdrawal by Subject|13|||
46976730|NCT03622593|83221402|FG000|Overall Study|Death|12|||
46976731|NCT03622593|83221403|FG001|Overall Study|Death|9|||
46976732|NCT03622593|83221404|FG002|Overall Study|Death|10|||
46976733|NCT03622593|83221402|FG000|Overall Study|Lost to Follow-up|11|||
46976734|NCT03622593|83221403|FG001|Overall Study|Lost to Follow-up|5|||
46976735|NCT03622593|83221404|FG002|Overall Study|Lost to Follow-up|8|||
46976736|NCT03622593|83221402|FG000|Overall Study|Adverse Event|4|||
46976737|NCT03622593|83221403|FG001|Overall Study|Adverse Event|5|||
46976738|NCT03622593|83221404|FG002|Overall Study|Adverse Event|6|||
46976739|NCT03622593|83221402|FG000|Overall Study|Physician Decision|2|||
46976740|NCT03622593|83221403|FG001|Overall Study|Physician Decision|1|||
46976741|NCT03622593|83221404|FG002|Overall Study|Physician Decision|6|||
46976742|NCT03622593|83221402|FG000|Overall Study|Other|2|||
46976743|NCT03622593|83221403|FG001|Overall Study|Other|2|||
46976744|NCT03622593|83221404|FG002|Overall Study|Other|3|||
46976745|NCT03622593|83221402|FG000|Overall Study|Protocol Violation|0|||
46976746|NCT03622593|83221403|FG001|Overall Study|Protocol Violation|0|||
46976747|NCT03622593|83221404|FG002|Overall Study|Protocol Violation|1|||
47079042|NCT01427972|83385041|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
46792983|NCT00227305|83011545|FG000|Overall Study|Lost to Follow-up|33|||
46792984|NCT00227305|83011545|FG000|Overall Study|Study specific discontinuation|13|||
46792985|NCT00227305|83011545|FG000|Overall Study|MOVED OUT OF AREA|3|||
46792986|NCT00227305|83011545|FG000|Overall Study|Lack of Efficacy|7|||
46792987|NCT00227305|83011545|FG000|Overall Study|Physician Decision|3|||
46792988|NCT00227305|83011545|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
46792989|NCT00227305|83011545|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
46792990|NCT00227305|83011545|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
46976748|NCT03622593|83221402|FG000|Overall Study|Pregnancy|0|||
47079043|NCT01427972|83385042|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079044|NCT01427972|83385043|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079045|NCT01427972|83385044|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079046|NCT01427972|83385045|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079047|NCT01427972|83385046|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
47079048|NCT01427972|83385047|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079049|NCT01427972|83385048|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
46792991|NCT00720941|83011551|FG000|Overall Study|Death|334|||
46976749|NCT03622593|83221403|FG001|Overall Study|Pregnancy|0|||
46976750|NCT03622593|83221404|FG002|Overall Study|Pregnancy|1|||
46976751|NCT03593655|83221415|FG000|First Product Use Period|Withdrawal by Subject|1|||
46976752|NCT03593655|83221416|FG001|First Product Use Period|Withdrawal by Subject|1|||
46674051|NCT01157377|82889547|FG002|Overall Study|Other Miscellaneous Reasons|0|||
46674052|NCT01157377|82889548|FG003|Overall Study|Other Miscellaneous Reasons|0|||
46674053|NCT01157377|82889549|FG004|Overall Study|Other Miscellaneous Reasons|1|||
46674054|NCT01157377|82889550|FG005|Overall Study|Other Miscellaneous Reasons|1|||
46674055|NCT01157377|82889551|FG006|Overall Study|Other Miscellaneous Reasons|1|||
46674056|NCT01157182|82889569|FG000|Washout of 28 Days|Adverse Event|2|||
46674057|NCT01157182|82889570|FG001|Washout of 28 Days|Adverse Event|0|||
46674058|NCT01157065|82889578|FG000|Overall Study|Death|0|||
46976753|NCT03593655|83221415|FG000|First Product Use Period|Lost to Follow-up|1|||
46976754|NCT03593655|83221416|FG001|First Product Use Period|Lost to Follow-up|3|||
46976755|NCT03593655|83221415|FG000|Second Product Use Period|Withdrawal by Subject|1|||
46976756|NCT03593655|83221416|FG001|Second Product Use Period|Withdrawal by Subject|1|||
46976757|NCT03593655|83221415|FG000|Second Product Use Period|Lost to Follow-up|1|||
46976758|NCT03593655|83221416|FG001|Second Product Use Period|Lost to Follow-up|0|||
46976759|NCT03593655|83221415|FG000|Third Product Use Period|Lost to Follow-up|1|||
46976760|NCT03593655|83221416|FG001|Third Product Use Period|Lost to Follow-up|2|||
46976761|NCT03593655|83221415|FG000|Third Product Use Period|Physician Decision|0|||
46976762|NCT03593655|83221416|FG001|Third Product Use Period|Physician Decision|1|||
46674059|NCT01157065|82889579|FG001|Overall Study|Death|1|||
46674060|NCT01156792|82889585|FG000|Overall Study|Adverse Event|1|||
46674061|NCT01156792|82889585|FG000|Overall Study|Lack of Efficacy|36|||
46674062|NCT01156792|82889585|FG000|Overall Study|Protocol Violation|6|||
46674063|NCT01156792|82889585|FG000|Overall Study|Lost to Follow-up|3|||
46674064|NCT01156792|82889585|FG000|Overall Study|Physician Decision|3|||
46674065|NCT01156792|82889585|FG000|Overall Study|Withdrawal by Subject|9|||
46674066|NCT01156792|82889585|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
46854939|NCT03386344|83070787|FG001|Overall Study|At the Participant's own Request|7|||
46854940|NCT03386344|83070788|FG002|Overall Study|At the Participant's own Request|8|||
46976763|NCT03593655|83221415|FG000|Third Product Use Period|Withdrawal by Subject|0|||
46976764|NCT03593655|83221416|FG001|Third Product Use Period|Withdrawal by Subject|1|||
46976765|NCT03577106|83221425|FG000|Overall Study|Withdrawal by Subject|3|||
47079050|NCT01427972|83385049|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079051|NCT01427972|83385050|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079052|NCT01427972|83385051|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079053|NCT01427972|83385052|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
47079054|NCT01427972|83385041|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079055|NCT01427972|83385042|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
47079056|NCT01427972|83385043|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079057|NCT01427972|83385044|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079058|NCT01427972|83385045|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079059|NCT01427972|83385046|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079060|NCT01427972|83385047|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079061|NCT01427972|83385048|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079062|NCT01427972|83385049|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079063|NCT01427972|83385050|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079064|NCT01427972|83385051|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079065|NCT01427972|83385052|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
47079066|NCT01427738|83385089|FG000|Overall Study|Death|12|||
47079067|NCT01427738|83385090|FG001|Overall Study|Death|9|||
47079068|NCT01427738|83385089|FG000|Overall Study|Severe debilitation, unable to continue|0|||
47079069|NCT01427738|83385090|FG001|Overall Study|Severe debilitation, unable to continue|1|||
47079070|NCT01427738|83385089|FG000|Overall Study|Subject unable to get to clinic|5|||
47079071|NCT01427738|83385090|FG001|Overall Study|Subject unable to get to clinic|2|||
47079072|NCT01427738|83385089|FG000|Overall Study|Withdrawal by Subject|0|||
47079073|NCT01427738|83385090|FG001|Overall Study|Withdrawal by Subject|2|||
46792992|NCT00720941|83011552|FG001|Overall Study|Death|335|||
46792993|NCT00720941|83011551|FG000|Overall Study|Protocol Violation|0|||
46792994|NCT00720941|83011552|FG001|Overall Study|Protocol Violation|2|||
46792995|NCT00720941|83011551|FG000|Overall Study|Lost to Follow-up|17|||
46792996|NCT00720941|83011552|FG001|Overall Study|Lost to Follow-up|15|||
46792997|NCT00720941|83011551|FG000|Overall Study|Physician Decision|1|||
46792998|NCT00720941|83011552|FG001|Overall Study|Physician Decision|5|||
46792999|NCT00720941|83011551|FG000|Overall Study|Withdrawal by Subject|27|||
46976766|NCT03364231|83221435|FG000|Overall Study|Adverse Event|1|||
46976767|NCT03364231|83221436|FG001|Overall Study|Adverse Event|4|||
46976768|NCT03364231|83221435|FG000|Overall Study|Death|1|||
46976769|NCT03364231|83221436|FG001|Overall Study|Death|0|||
46976770|NCT03364231|83221435|FG000|Overall Study|Investigator Decision|2|||
46976771|NCT03364231|83221436|FG001|Overall Study|Investigator Decision|2|||
46976772|NCT03364231|83221435|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
46976773|NCT03364231|83221436|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
46976774|NCT03364231|83221435|FG000|Overall Study|Withdrawal of Subject Consent|1|||
46976775|NCT03364231|83221436|FG001|Overall Study|Withdrawal of Subject Consent|0|||
46976776|NCT03364231|83221435|FG000|Overall Study|Reason Not Specified|1|||
46976777|NCT03364231|83221436|FG001|Overall Study|Reason Not Specified|0|||
46976778|NCT03364231|83221435|FG000|Overall Study|Disease Progression|0|||
46976779|NCT03364231|83221436|FG001|Overall Study|Disease Progression|6|||
46976780|NCT03303625|83221447|FG000|Overall Study|Withdrawal by Subject|2|||
46976781|NCT03303625|83221448|FG001|Overall Study|Withdrawal by Subject|0|||
46976782|NCT03303625|83221449|FG002|Overall Study|Withdrawal by Subject|0|||
46976783|NCT03303625|83221450|FG003|Overall Study|Withdrawal by Subject|0|||
46976784|NCT03299816|83221462|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
46976785|NCT03299816|83221463|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
46976786|NCT03299816|83221462|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
46976787|NCT03299816|83221463|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
46976788|NCT03299816|83221462|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
46976789|NCT03299816|83221463|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
46976790|NCT03238300|83221471|FG000|Baseline (Before Intervention)|Physician Decision|0|||
46976791|NCT03238300|83221472|FG001|Baseline (Before Intervention)|Physician Decision|1|||
46976792|NCT03238300|83221471|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
46976793|NCT03238300|83221472|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
46976794|NCT03238300|83221471|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
46976795|NCT03238300|83221472|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
46976796|NCT03238300|83221471|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
46976797|NCT03238300|83221472|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
46976798|NCT03178045|83221484|FG000|Overall Study|Withdrawal by Subject|5|||
46976799|NCT03178045|83221485|FG001|Overall Study|Withdrawal by Subject|7|||
46976800|NCT03178045|83221484|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
46976801|NCT03178045|83221485|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
46976802|NCT03178045|83221484|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
46793000|NCT00720941|83011552|FG001|Overall Study|Withdrawal by Subject|35|||
46793001|NCT00720941|83011551|FG000|Overall Study|Ongoing|34|||
46793002|NCT00720941|83011552|FG001|Overall Study|Ongoing|23|||
46793003|NCT00585533|83011558|FG000|Overall Study|objective or symptomatic progression|9|||
46793004|NCT00628862|83011565|FG000|Overall Study|Adverse Event|6|||
46793005|NCT00628862|83011566|FG001|Overall Study|Adverse Event|8|||
46793006|NCT00628862|83011567|FG002|Overall Study|Adverse Event|10|||
46793007|NCT00628862|83011565|FG000|Overall Study|Withdrawal by Subject|4|||
46793008|NCT00628862|83011566|FG001|Overall Study|Withdrawal by Subject|6|||
46793009|NCT00628862|83011567|FG002|Overall Study|Withdrawal by Subject|11|||
46793010|NCT00628862|83011565|FG000|Overall Study|Lost to Follow-up|0|||
46976803|NCT03178045|83221485|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
46793011|NCT00628862|83011566|FG001|Overall Study|Lost to Follow-up|2|||
46793012|NCT00628862|83011567|FG002|Overall Study|Lost to Follow-up|1|||
46976804|NCT02924727|83221526|FG000|Overall Study|Withdrawal by Subject|2|||
46976805|NCT02924727|83221527|FG001|Overall Study|Withdrawal by Subject|4|||
46976806|NCT02924727|83221526|FG000|Overall Study|Lost to Follow-up|2|||
46976807|NCT02924727|83221527|FG001|Overall Study|Lost to Follow-up|5|||
46793013|NCT00628862|83011565|FG000|Overall Study|Protocol Violation|1|||
46976808|NCT02924727|83221526|FG000|Overall Study|Death|221|||
46976809|NCT02924727|83221527|FG001|Overall Study|Death|247|||
46976810|NCT02924727|83221526|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
46674067|NCT01156714|82889603|FG000|Overall Study|Withdrawal by Subject|9|||
46674068|NCT01156714|82889604|FG001|Overall Study|Withdrawal by Subject|4|||
46674069|NCT01156714|82889605|FG002|Overall Study|Withdrawal by Subject|3|||
46674070|NCT01156675|82889619|FG000|Overall Study|Death|5|||
46793014|NCT00628862|83011566|FG001|Overall Study|Protocol Violation|0|||
46793015|NCT00628862|83011567|FG002|Overall Study|Protocol Violation|0|||
46793016|NCT00628862|83011565|FG000|Overall Study|COPD Exacerbation|0|||
46793017|NCT00628862|83011566|FG001|Overall Study|COPD Exacerbation|1|||
46793018|NCT00628862|83011567|FG002|Overall Study|COPD Exacerbation|0|||
46793019|NCT00584987|83011579|FG000|Overall Study|Protocol Violation|1|||
46793020|NCT00584987|83011580|FG001|Overall Study|Protocol Violation|1|||
46793021|NCT00584987|83011581|FG002|Overall Study|Protocol Violation|1|||
46793022|NCT00584987|83011582|FG003|Overall Study|Protocol Violation|0|||
46793023|NCT00584987|83011579|FG000|Overall Study|Adverse Event|0|||
46793024|NCT00584987|83011580|FG001|Overall Study|Adverse Event|0|||
46793025|NCT00584987|83011581|FG002|Overall Study|Adverse Event|0|||
46674071|NCT01156675|82889620|FG001|Overall Study|Death|3|||
46674072|NCT01156675|82889621|FG002|Overall Study|Death|0|||
46674073|NCT01156675|82889619|FG000|Overall Study|No data|29|||
46674074|NCT01156675|82889620|FG001|Overall Study|No data|22|||
46674075|NCT01156675|82889621|FG002|Overall Study|No data|2|||
46674076|NCT01156480|82889632|FG000|Overall Study|change in diagnosis|0|||
46674077|NCT01156480|82889633|FG001|Overall Study|change in diagnosis|1|||
46674078|NCT01156363|82889641|FG000|Overall Study|Adverse Event|6|||
46674079|NCT01156363|82889641|FG000|Overall Study|Insufficient Therapeutic Response|5|||
46674080|NCT01156363|82889641|FG000|Overall Study|Failure to Return|1|||
46674081|NCT01156363|82889641|FG000|Overall Study|Refused Treatment|4|||
46674082|NCT01156363|82889641|FG000|Overall Study|Other|6|||
46674083|NCT01156051|82889654|FG000|Overall Study|Lost to Follow-up|1|||
46674084|NCT01156051|82889655|FG001|Overall Study|Lost to Follow-up|0|||
46674085|NCT01156051|82889654|FG000|Overall Study|patient not compliant with protocol|0|||
46674086|NCT01156051|82889655|FG001|Overall Study|patient not compliant with protocol|1|||
46674087|NCT01156012|82889663|FG000|Overall Study|Adverse Event|3|||
46674088|NCT01156012|82889664|FG001|Overall Study|Adverse Event|1|||
46674089|NCT01156012|82889663|FG000|Overall Study|Lost to Follow-up|1|||
46674090|NCT01156012|82889664|FG001|Overall Study|Lost to Follow-up|0|||
46674091|NCT01156012|82889663|FG000|Overall Study|Withdrawal by Subject|1|||
46674092|NCT01156012|82889664|FG001|Overall Study|Withdrawal by Subject|0|||
46674093|NCT01156012|82889663|FG000|Overall Study|use of commercial drug instead of study|0|||
46674094|NCT01156012|82889664|FG001|Overall Study|use of commercial drug instead of study|1|||
46674095|NCT01156012|82889663|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
46674096|NCT01156012|82889664|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
46674097|NCT01155661|82889670|FG000|Overall Study|Adverse Event|101|||
46674098|NCT01155661|82889670|FG000|Overall Study|Death|1|||
46674099|NCT01155661|82889670|FG000|Overall Study|Lack of Efficacy|32|||
46674100|NCT01155661|82889670|FG000|Overall Study|Lost to Follow-up|22|||
46674101|NCT01155661|82889670|FG000|Overall Study|Physician Decision|3|||
46674102|NCT01155661|82889670|FG000|Overall Study|Protocol Violation|35|||
46674103|NCT01155661|82889670|FG000|Overall Study|Withdrawal by Subject|73|||
46674104|NCT01155661|82889670|FG000|Overall Study|Sponsor Decision|13|||
46674105|NCT01155583|82889685|FG000|Phase I|Screen failure - did not start treatment|0|||
46674106|NCT01155583|82889686|FG001|Phase I|Screen failure - did not start treatment|0|||
46674107|NCT01155583|82889687|FG002|Phase I|Screen failure - did not start treatment|0|||
46674108|NCT01155583|82889688|FG003|Phase I|Screen failure - did not start treatment|0|||
46674109|NCT01155583|82889689|FG004|Phase I|Screen failure - did not start treatment|1|||
46674110|NCT01155583|82889690|FG005|Phase I|Screen failure - did not start treatment|0|||
46674111|NCT01155583|82889691|FG006|Phase I|Screen failure - did not start treatment|0|||
46674112|NCT01155583|82889692|FG007|Phase I|Screen failure - did not start treatment|2|||
46674113|NCT01155583|82889693|FG008|Phase I|Screen failure - did not start treatment|0|||
46674114|NCT01155583|82889685|FG000|Phase I|Withdrawal by Subject|0|||
46793026|NCT00584987|83011582|FG003|Overall Study|Adverse Event|1|||
46793027|NCT00727961|83011592|FG000|Overall Study|Lost to Follow-up|1|||
46854941|NCT03386344|83070786|FG000|Overall Study|Reason not Specified|0|||
46854942|NCT03386344|83070787|FG001|Overall Study|Reason not Specified|1|||
46793028|NCT00727961|83011592|FG000|Overall Study|Adverse Event|4|||
46674115|NCT01155583|82889686|FG001|Phase I|Withdrawal by Subject|0|||
46674116|NCT01155583|82889687|FG002|Phase I|Withdrawal by Subject|0|||
46674117|NCT01155583|82889688|FG003|Phase I|Withdrawal by Subject|0|||
46674118|NCT01155583|82889689|FG004|Phase I|Withdrawal by Subject|0|||
46793029|NCT00727961|83011592|FG000|Overall Study|Patient's refusal|2|||
46793030|NCT00727961|83011592|FG000|Overall Study|Progression|30|||
46793031|NCT00568958|83011598|FG000|Allocation|Withdrawal by Subject|7|||
46793032|NCT00568958|83011599|FG001|Allocation|Withdrawal by Subject|3|||
46976811|NCT02924727|83221527|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
46976812|NCT02901626|83221537|FG000|Overall Study|Lost to Follow-up|1|||
46976813|NCT02901626|83221538|FG001|Overall Study|Lost to Follow-up|1|||
46976814|NCT02720692|83221573|FG000|Overall Study|Withdrawal by Subject|3|||
46976815|NCT02720692|83221574|FG001|Overall Study|Withdrawal by Subject|0|||
46976816|NCT02720692|83221573|FG000|Overall Study|Physician Decision|1|||
46976817|NCT02720692|83221574|FG001|Overall Study|Physician Decision|0|||
46976818|NCT02720692|83221573|FG000|Overall Study|Lost to Follow-up|8|||
46976819|NCT02720692|83221574|FG001|Overall Study|Lost to Follow-up|3|||
46976820|NCT02720692|83221573|FG000|Overall Study|Subject unable to return for visit|1|||
46976821|NCT02720692|83221574|FG001|Overall Study|Subject unable to return for visit|0|||
46976822|NCT02656303|83221583|FG000|Overall Study|Adverse Event|3|||
46976823|NCT02656303|83221584|FG001|Overall Study|Adverse Event|2|||
46976824|NCT02656303|83221585|FG002|Overall Study|Adverse Event|0|||
46976825|NCT02656303|83221583|FG000|Overall Study|Death|12|||
46674119|NCT01155583|82889690|FG005|Phase I|Withdrawal by Subject|0|||
46674120|NCT01155583|82889691|FG006|Phase I|Withdrawal by Subject|0|||
46674121|NCT01155583|82889692|FG007|Phase I|Withdrawal by Subject|1|||
46674122|NCT01155583|82889693|FG008|Phase I|Withdrawal by Subject|0|||
46674123|NCT01155466|82889714|FG000|Overall Study|Adverse Event|13|||
46674124|NCT01155466|82889715|FG001|Overall Study|Adverse Event|15|||
46674125|NCT01155466|82889716|FG002|Overall Study|Adverse Event|6|||
46674126|NCT01155466|82889717|FG003|Overall Study|Adverse Event|17|||
46674127|NCT01155466|82889718|FG004|Overall Study|Adverse Event|18|||
46674128|NCT01155466|82889714|FG000|Overall Study|Lost to Follow-up|0|||
46674129|NCT01155466|82889715|FG001|Overall Study|Lost to Follow-up|0|||
46674130|NCT01155466|82889716|FG002|Overall Study|Lost to Follow-up|0|||
46674131|NCT01155466|82889717|FG003|Overall Study|Lost to Follow-up|0|||
46674132|NCT01155466|82889718|FG004|Overall Study|Lost to Follow-up|2|||
46674133|NCT01155466|82889714|FG000|Overall Study|Withdrawal by Subject|7|||
46674134|NCT01155466|82889715|FG001|Overall Study|Withdrawal by Subject|5|||
46674135|NCT01155466|82889716|FG002|Overall Study|Withdrawal by Subject|9|||
46674136|NCT01155466|82889717|FG003|Overall Study|Withdrawal by Subject|4|||
46674137|NCT01155466|82889718|FG004|Overall Study|Withdrawal by Subject|4|||
46674138|NCT01155466|82889714|FG000|Overall Study|Protocol Violation|0|||
46674139|NCT01155466|82889715|FG001|Overall Study|Protocol Violation|0|||
46674140|NCT01155466|82889716|FG002|Overall Study|Protocol Violation|2|||
46674141|NCT01155466|82889717|FG003|Overall Study|Protocol Violation|0|||
46854943|NCT03386344|83070788|FG002|Overall Study|Reason not Specified|0|||
46854944|NCT00399035|83070799|FG000|Overall Study|Death|289|||
46854945|NCT00399035|83070800|FG001|Overall Study|Death|141|||
46854946|NCT00399035|83070801|FG002|Overall Study|Death|234|||
46854947|NCT00399035|83070799|FG000|Overall Study|Lost to Follow-up|2|||
46854948|NCT00399035|83070800|FG001|Overall Study|Lost to Follow-up|1|||
46854949|NCT00399035|83070801|FG002|Overall Study|Lost to Follow-up|5|||
46854950|NCT00399035|83070799|FG000|Overall Study|Withdrawal by Subject|19|||
46854951|NCT00399035|83070800|FG001|Overall Study|Withdrawal by Subject|15|||
46854952|NCT00399035|83070801|FG002|Overall Study|Withdrawal by Subject|12|||
46854953|NCT00399035|83070799|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
46854954|NCT00399035|83070800|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
46976826|NCT02656303|83221584|FG001|Overall Study|Death|4|||
46976827|NCT02656303|83221585|FG002|Overall Study|Death|1|||
46674142|NCT01155466|82889718|FG004|Overall Study|Protocol Violation|1|||
46793033|NCT00568958|83011598|FG000|Allocation|Physician Decision|2|||
46793034|NCT00568958|83011599|FG001|Allocation|Physician Decision|0|||
46793035|NCT00568958|83011598|FG000|Follow-Up|Withdrawal by Subject|6|||
46793036|NCT00568958|83011599|FG001|Follow-Up|Withdrawal by Subject|6|||
46793037|NCT00568958|83011598|FG000|Follow-Up|Physician Decision|1|||
46854955|NCT00399035|83070801|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
46854956|NCT00399035|83070799|FG000|Overall Study|Severe non-compliance with protocol|2|||
46854957|NCT00399035|83070800|FG001|Overall Study|Severe non-compliance with protocol|1|||
46854958|NCT00399035|83070801|FG002|Overall Study|Severe non-compliance with protocol|0|||
46854959|NCT00073749|83070815|FG000|Overall Study|Disease Progression|2|||
46854960|NCT00073749|83070816|FG001|Overall Study|Disease Progression|0|||
46854961|NCT00073749|83070817|FG002|Overall Study|Disease Progression|3|||
46854962|NCT00073749|83070818|FG003|Overall Study|Disease Progression|2|||
46854963|NCT00073749|83070819|FG004|Overall Study|Disease Progression|3|||
46854964|NCT00073749|83070820|FG005|Overall Study|Disease Progression|1|||
46854965|NCT00073749|83070821|FG006|Overall Study|Disease Progression|3|||
46854966|NCT00073749|83070815|FG000|Overall Study|Death|0|||
46854967|NCT00073749|83070816|FG001|Overall Study|Death|1|||
46854968|NCT00073749|83070817|FG002|Overall Study|Death|1|||
46854969|NCT00073749|83070818|FG003|Overall Study|Death|0|||
46854970|NCT00073749|83070819|FG004|Overall Study|Death|0|||
46854971|NCT00073749|83070820|FG005|Overall Study|Death|0|||
46793038|NCT00568958|83011599|FG001|Follow-Up|Physician Decision|1|||
46793039|NCT00568958|83011598|FG000|Follow-Up|Family Emergency|1|||
46793040|NCT00568958|83011599|FG001|Follow-Up|Family Emergency|0|||
46793041|NCT00568958|83011598|FG000|Follow-Up|Adverse Event|1|||
46793042|NCT00568958|83011599|FG001|Follow-Up|Adverse Event|0|||
46854972|NCT00073749|83070821|FG006|Overall Study|Death|29|||
46854973|NCT00073749|83070815|FG000|Overall Study|Adverse Event|0|||
46854974|NCT00073749|83070816|FG001|Overall Study|Adverse Event|3|||
46854975|NCT00073749|83070817|FG002|Overall Study|Adverse Event|6|||
46854976|NCT00073749|83070818|FG003|Overall Study|Adverse Event|4|||
46854977|NCT00073749|83070819|FG004|Overall Study|Adverse Event|2|||
46854978|NCT00073749|83070820|FG005|Overall Study|Adverse Event|1|||
46854979|NCT00073749|83070821|FG006|Overall Study|Adverse Event|0|||
46793043|NCT00727649|83011607|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
46793044|NCT00727649|83011608|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
46793045|NCT00727649|83011607|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
46793046|NCT00727649|83011608|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
46793047|NCT00727649|83011607|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
46793048|NCT00727649|83011608|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
46793049|NCT00727649|83011607|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
46793050|NCT00727649|83011608|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
46793051|NCT00727649|83011607|FG000|Second Intervention (4-weeks)|Death|1|||
46793052|NCT00727649|83011608|FG001|Second Intervention (4-weeks)|Death|0|||
46793053|NCT00727649|83011607|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
46793054|NCT00727649|83011608|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
46793055|NCT00727649|83011607|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
46793056|NCT00727649|83011608|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
46793057|NCT00568334|83011618|FG000|Overall Study|Withdrawal by Subject|0|||
46793058|NCT00568334|83011619|FG001|Overall Study|Withdrawal by Subject|1|||
46793059|NCT00568334|83011618|FG000|Overall Study|Lost to Follow-up|1|||
46793060|NCT00568334|83011619|FG001|Overall Study|Lost to Follow-up|0|||
46793061|NCT00727571|83011629|FG000|Overall Study|Ineligibility determined|1|||
46793062|NCT00727571|83011630|FG001|Overall Study|Ineligibility determined|1|||
46793063|NCT00727571|83011631|FG002|Overall Study|Ineligibility determined|1|||
46793064|NCT00727571|83011632|FG003|Overall Study|Ineligibility determined|0|||
46793065|NCT00727571|83011629|FG000|Overall Study|Death|0|||
46793066|NCT00727571|83011630|FG001|Overall Study|Death|19|||
46793067|NCT00727571|83011631|FG002|Overall Study|Death|5|||
46793068|NCT00727571|83011632|FG003|Overall Study|Death|1|||
46793069|NCT00727571|83011629|FG000|Overall Study|Physician Decision|0|||
46793070|NCT00727571|83011630|FG001|Overall Study|Physician Decision|5|||
46793071|NCT00727571|83011631|FG002|Overall Study|Physician Decision|0|||
46793072|NCT00727571|83011632|FG003|Overall Study|Physician Decision|0|||
46793073|NCT00727571|83011629|FG000|Overall Study|Withdrawal by Subject|0|||
46793074|NCT00727571|83011630|FG001|Overall Study|Withdrawal by Subject|10|||
46793075|NCT00727571|83011631|FG002|Overall Study|Withdrawal by Subject|11|||
46793076|NCT00727571|83011632|FG003|Overall Study|Withdrawal by Subject|0|||
46793077|NCT00727571|83011629|FG000|Overall Study|Subject Non Compliance|0|||
46793078|NCT00727571|83011630|FG001|Overall Study|Subject Non Compliance|6|||
46793079|NCT00727571|83011631|FG002|Overall Study|Subject Non Compliance|0|||
46793080|NCT00727571|83011632|FG003|Overall Study|Subject Non Compliance|4|||
46793081|NCT00727571|83011629|FG000|Overall Study|Dismissed from nursing home|0|||
46793082|NCT00727571|83011630|FG001|Overall Study|Dismissed from nursing home|9|||
46793083|NCT00727571|83011631|FG002|Overall Study|Dismissed from nursing home|5|||
46793084|NCT00727571|83011632|FG003|Overall Study|Dismissed from nursing home|0|||
46793085|NCT00727571|83011629|FG000|Overall Study|Hospitalization|0|||
46793086|NCT00727571|83011630|FG001|Overall Study|Hospitalization|1|||
46793087|NCT00727571|83011631|FG002|Overall Study|Hospitalization|0|||
46793088|NCT00727571|83011632|FG003|Overall Study|Hospitalization|1|||
46793089|NCT00727571|83011629|FG000|Overall Study|AE not leading to hospitalization|0|||
46793090|NCT00727571|83011630|FG001|Overall Study|AE not leading to hospitalization|0|||
46793091|NCT00727571|83011631|FG002|Overall Study|AE not leading to hospitalization|2|||
46793092|NCT00727571|83011632|FG003|Overall Study|AE not leading to hospitalization|0|||
46793093|NCT00727571|83011629|FG000|Overall Study|Other|0|||
46793094|NCT00727571|83011630|FG001|Overall Study|Other|4|||
46793095|NCT00727571|83011631|FG002|Overall Study|Other|6|||
46793096|NCT00727571|83011632|FG003|Overall Study|Other|0|||
46793097|NCT00225277|83011644|FG000|Overall Study|Adverse Event|30|||
46793098|NCT00225277|83011645|FG001|Overall Study|Adverse Event|34|||
46793099|NCT00225277|83011644|FG000|Overall Study|Lack of Efficacy|4|||
46793100|NCT00225277|83011645|FG001|Overall Study|Lack of Efficacy|1|||
46793101|NCT00225277|83011644|FG000|Overall Study|Lost to Follow-up|4|||
46793102|NCT00225277|83011645|FG001|Overall Study|Lost to Follow-up|6|||
46793103|NCT00225277|83011644|FG000|Overall Study|Physician Decision|6|||
46793104|NCT00225277|83011645|FG001|Overall Study|Physician Decision|8|||
46793105|NCT00225277|83011644|FG000|Overall Study|Protocol Violation|6|||
46793106|NCT00225277|83011645|FG001|Overall Study|Protocol Violation|3|||
46976828|NCT02656303|83221583|FG000|Overall Study|Lack of Efficacy|1|||
46976829|NCT02656303|83221584|FG001|Overall Study|Lack of Efficacy|0|||
46976830|NCT02656303|83221585|FG002|Overall Study|Lack of Efficacy|0|||
46976831|NCT02656303|83221583|FG000|Overall Study|Non-Compliance with Study|1|||
46976832|NCT02656303|83221584|FG001|Overall Study|Non-Compliance with Study|1|||
46976833|NCT02656303|83221585|FG002|Overall Study|Non-Compliance with Study|0|||
46976834|NCT02656303|83221583|FG000|Overall Study|Investigator Decision|2|||
46976835|NCT02656303|83221584|FG001|Overall Study|Investigator Decision|1|||
46793107|NCT00225277|83011644|FG000|Overall Study|Withdrawal by Subject|40|||
46976836|NCT02656303|83221585|FG002|Overall Study|Investigator Decision|0|||
46976837|NCT02656303|83221583|FG000|Overall Study|Progressive Disease|25|||
46793108|NCT00225277|83011645|FG001|Overall Study|Withdrawal by Subject|34|||
46793109|NCT00225277|83011644|FG000|Overall Study|Other|7|||
46793110|NCT00225277|83011645|FG001|Overall Study|Other|9|||
46793111|NCT00567996|83011654|FG000|Overall Study|Adverse Event|18|||
46793112|NCT00567996|83011655|FG001|Overall Study|Adverse Event|16|||
46793113|NCT00567996|83011656|FG002|Overall Study|Adverse Event|13|||
46793114|NCT00567996|83011654|FG000|Overall Study|Protocol Deviation|9|||
46793115|NCT00567996|83011655|FG001|Overall Study|Protocol Deviation|11|||
46793116|NCT00567996|83011656|FG002|Overall Study|Protocol Deviation|13|||
46976838|NCT02656303|83221584|FG001|Overall Study|Progressive Disease|14|||
46976839|NCT02656303|83221585|FG002|Overall Study|Progressive Disease|10|||
46976840|NCT02656303|83221583|FG000|Overall Study|Study Terminated by Sponsor|20|||
46976841|NCT02656303|83221584|FG001|Overall Study|Study Terminated by Sponsor|7|||
46976842|NCT02656303|83221585|FG002|Overall Study|Study Terminated by Sponsor|5|||
47079074|NCT01427738|83385089|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
47079075|NCT01427738|83385090|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
47079076|NCT01427738|83385089|FG000|Overall Study|Lost to Follow-up|1|||
47079077|NCT01427738|83385090|FG001|Overall Study|Lost to Follow-up|5|||
46854980|NCT00073749|83070815|FG000|Overall Study|Physician Decision|0|||
46854981|NCT00073749|83070816|FG001|Overall Study|Physician Decision|0|||
46854982|NCT00073749|83070817|FG002|Overall Study|Physician Decision|1|||
46854983|NCT00073749|83070818|FG003|Overall Study|Physician Decision|0|||
46854984|NCT00073749|83070819|FG004|Overall Study|Physician Decision|0|||
46854985|NCT00073749|83070820|FG005|Overall Study|Physician Decision|2|||
46854986|NCT00073749|83070821|FG006|Overall Study|Physician Decision|0|||
46854987|NCT00073749|83070815|FG000|Overall Study|Withdrawal by Subject|0|||
46854988|NCT00073749|83070816|FG001|Overall Study|Withdrawal by Subject|1|||
46854989|NCT00073749|83070817|FG002|Overall Study|Withdrawal by Subject|0|||
46854990|NCT00073749|83070818|FG003|Overall Study|Withdrawal by Subject|0|||
46854991|NCT00073749|83070819|FG004|Overall Study|Withdrawal by Subject|1|||
46854992|NCT00073749|83070820|FG005|Overall Study|Withdrawal by Subject|0|||
46854993|NCT00073749|83070821|FG006|Overall Study|Withdrawal by Subject|2|||
46854994|NCT00073749|83070815|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
46854995|NCT00073749|83070816|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
46976843|NCT02656303|83221583|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
47079078|NCT01426958|83385096|FG000|Overall Study|Adverse Event|2|||
47079079|NCT02578992|83385274|FG000|Overall Study|equipment not available or malfunction|3|||
47079080|NCT02578992|83385275|FG001|Overall Study|equipment not available or malfunction|3|||
47079081|NCT00558519|83385339|FG000|Overall Study|Ph+|20|||
46793117|NCT00567996|83011654|FG000|Overall Study|Withdrawal by Subject|8|||
46793118|NCT00567996|83011655|FG001|Overall Study|Withdrawal by Subject|12|||
46793119|NCT00567996|83011656|FG002|Overall Study|Withdrawal by Subject|22|||
46793120|NCT00567996|83011654|FG000|Overall Study|Abnormal Lab value(s)|2|||
47079082|NCT00558519|83385339|FG000|Overall Study|Ineligible|1|||
47079083|NCT00558519|83385339|FG000|Overall Study|Insufficient data|1|||
47079084|NCT00558519|83385339|FG000|Overall Study|Never received treatment|1|||
47079085|NCT00558285|83385383|FG000|Overall Study|Adverse Event|1|||
47079086|NCT00558285|83385384|FG001|Overall Study|Adverse Event|1|||
47079087|NCT00558285|83385385|FG002|Overall Study|Adverse Event|4|||
47079088|NCT00558285|83385386|FG003|Overall Study|Adverse Event|1|||
47079089|NCT00558285|83385387|FG004|Overall Study|Adverse Event|2|||
47079090|NCT00558285|83385383|FG000|Overall Study|Abnormal test procedure result(s)|1|||
47079091|NCT00558285|83385384|FG001|Overall Study|Abnormal test procedure result(s)|0|||
47079092|NCT00558285|83385385|FG002|Overall Study|Abnormal test procedure result(s)|0|||
47079093|NCT00558285|83385386|FG003|Overall Study|Abnormal test procedure result(s)|0|||
47079094|NCT00558285|83385387|FG004|Overall Study|Abnormal test procedure result(s)|0|||
46793121|NCT00567996|83011655|FG001|Overall Study|Abnormal Lab value(s)|1|||
46793122|NCT00567996|83011656|FG002|Overall Study|Abnormal Lab value(s)|2|||
46793123|NCT00567996|83011654|FG000|Overall Study|Abnormal test procedure result(s)|2|||
46793124|NCT00567996|83011655|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46793125|NCT00567996|83011656|FG002|Overall Study|Abnormal test procedure result(s)|1|||
46793126|NCT00567996|83011654|FG000|Overall Study|Lost to Follow-up|2|||
46854996|NCT00073749|83070817|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
46976844|NCT02656303|83221584|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
46854997|NCT00073749|83070818|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
46854998|NCT00073749|83070819|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
46854999|NCT00073749|83070820|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
46855000|NCT00073749|83070821|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
46855001|NCT00073749|83070815|FG000|Overall Study|Lost to Follow-up|0|||
46855002|NCT00073749|83070816|FG001|Overall Study|Lost to Follow-up|0|||
46855003|NCT00073749|83070817|FG002|Overall Study|Lost to Follow-up|0|||
46855004|NCT00073749|83070818|FG003|Overall Study|Lost to Follow-up|0|||
46855005|NCT00073749|83070819|FG004|Overall Study|Lost to Follow-up|0|||
46855006|NCT00073749|83070820|FG005|Overall Study|Lost to Follow-up|0|||
46855007|NCT00073749|83070821|FG006|Overall Study|Lost to Follow-up|2|||
46855008|NCT00073749|83070815|FG000|Overall Study|Other|0|||
46855009|NCT00073749|83070816|FG001|Overall Study|Other|0|||
46855010|NCT00073749|83070817|FG002|Overall Study|Other|0|||
46855011|NCT00073749|83070818|FG003|Overall Study|Other|0|||
46855012|NCT00073749|83070819|FG004|Overall Study|Other|0|||
46855013|NCT00073749|83070820|FG005|Overall Study|Other|2|||
46855014|NCT00073749|83070821|FG006|Overall Study|Other|0|||
46855015|NCT00398567|83070843|FG000|Overall Study|Disease Progression|3|||
46855016|NCT00398567|83070844|FG001|Overall Study|Disease Progression|4|||
46855017|NCT00398567|83070845|FG002|Overall Study|Disease Progression|27|||
46855018|NCT00398567|83070843|FG000|Overall Study|Withdrawal by Subject|1|||
46855019|NCT00398567|83070844|FG001|Overall Study|Withdrawal by Subject|0|||
46855020|NCT00398567|83070845|FG002|Overall Study|Withdrawal by Subject|4|||
46855021|NCT00398567|83070843|FG000|Overall Study|Adverse Event|0|||
46855022|NCT00398567|83070844|FG001|Overall Study|Adverse Event|0|||
46855023|NCT00398567|83070845|FG002|Overall Study|Adverse Event|2|||
46855024|NCT00398567|83070843|FG000|Overall Study|Protocol Violation|0|||
46855025|NCT00398567|83070844|FG001|Overall Study|Protocol Violation|0|||
46855026|NCT00398567|83070845|FG002|Overall Study|Protocol Violation|1|||
46855027|NCT05249569|83070851|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
46855028|NCT04779879|83070874|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
46855029|NCT04779879|83070875|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
46855030|NCT04779879|83070876|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
46855031|NCT04779879|83070877|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
46674143|NCT01155466|82889714|FG000|Overall Study|Administrative|0|||
46793127|NCT00567996|83011655|FG001|Overall Study|Lost to Follow-up|5|||
46793128|NCT00567996|83011656|FG002|Overall Study|Lost to Follow-up|2|||
46793129|NCT00567996|83011654|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46793130|NCT00567996|83011655|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46793131|NCT00567996|83011656|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
46793132|NCT00567996|83011654|FG000|Overall Study|Administrative problems|1|||
46793133|NCT00567996|83011655|FG001|Overall Study|Administrative problems|1|||
46793134|NCT00567996|83011656|FG002|Overall Study|Administrative problems|0|||
46855032|NCT04779879|83070878|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
46855033|NCT04779879|83070879|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
46855034|NCT04779879|83070874|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
46674144|NCT01155466|82889715|FG001|Overall Study|Administrative|3|||
46674145|NCT01155466|82889716|FG002|Overall Study|Administrative|0|||
46674146|NCT01155466|82889717|FG003|Overall Study|Administrative|0|||
46674147|NCT01155466|82889718|FG004|Overall Study|Administrative|0|||
46674148|NCT01155466|82889714|FG000|Overall Study|Randomized not treated|2|||
46793135|NCT00567996|83011654|FG000|Overall Study|Death|1|||
46674149|NCT01155466|82889715|FG001|Overall Study|Randomized not treated|2|||
46674150|NCT01155466|82889716|FG002|Overall Study|Randomized not treated|3|||
46674151|NCT01155466|82889717|FG003|Overall Study|Randomized not treated|0|||
46674152|NCT01155466|82889718|FG004|Overall Study|Randomized not treated|2|||
46674153|NCT01155388|82889732|FG000|Overall Study|Adverse Event|1|||
46674154|NCT01155388|82889733|FG001|Overall Study|Adverse Event|0|||
46855035|NCT04779879|83070875|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
46855036|NCT04779879|83070876|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
46855037|NCT04779879|83070877|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
46855038|NCT04779879|83070878|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
46855039|NCT04779879|83070879|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
46855040|NCT04779879|83070874|FG000|Part C: Up to Week 36|Death|0|||
46855041|NCT04779879|83070875|FG001|Part C: Up to Week 36|Death|0|||
46855042|NCT04779879|83070876|FG002|Part C: Up to Week 36|Death|0|||
46855043|NCT04779879|83070877|FG003|Part C: Up to Week 36|Death|0|||
46674155|NCT01154452|82889744|FG000|Phase Ib|Not Treated|1|||
46674156|NCT01154452|82889745|FG001|Phase Ib|Not Treated|0|||
46674157|NCT01154452|82889746|FG002|Phase Ib|Not Treated|0|||
46674158|NCT01154452|82889747|FG003|Phase Ib|Not Treated|0|||
46674159|NCT01154452|82889744|FG000|Phase Ib|Adverse Event|2|||
46976845|NCT02656303|83221585|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
46976846|NCT02656303|83221583|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
46976847|NCT02656303|83221584|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
46976848|NCT02656303|83221585|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
46976849|NCT02656303|83221583|FG000|Overall Study|Reason not Specified|1|||
46976850|NCT02656303|83221584|FG001|Overall Study|Reason not Specified|1|||
46976851|NCT02656303|83221585|FG002|Overall Study|Reason not Specified|2|||
46976852|NCT02628626|83221595|FG000|Overall Study|Withdrawal by Subject|2|||
46976853|NCT02628626|83221596|FG001|Overall Study|Withdrawal by Subject|2|||
46976854|NCT02527707|83221628|FG000|Overall Study|Adverse Event|1|||
46976855|NCT02527707|83221628|FG000|Overall Study|Adverse Event|1|||
46976856|NCT02453191|83221639|FG000|Overall Study|Withdrawal by Subject|1|||
46976857|NCT02352090|83221647|FG000|Overall Study|general malaise|1|||
46976858|NCT02352090|83221648|FG001|Overall Study|general malaise|0|||
46976859|NCT02352090|83221649|FG002|Overall Study|general malaise|0|||
46976860|NCT02352090|83221647|FG000|Overall Study|non-specified mild side-effects|0|||
46674160|NCT01154452|82889745|FG001|Phase Ib|Adverse Event|1|||
46674161|NCT01154452|82889746|FG002|Phase Ib|Adverse Event|0|||
46674162|NCT01154452|82889747|FG003|Phase Ib|Adverse Event|0|||
46674163|NCT01154452|82889744|FG000|Phase II|Withdrawal by Subject|0|||
46674164|NCT01154452|82889745|FG001|Phase II|Withdrawal by Subject|0|||
46674165|NCT01154452|82889746|FG002|Phase II|Withdrawal by Subject|1|||
46674166|NCT01154452|82889747|FG003|Phase II|Withdrawal by Subject|2|||
46674167|NCT01154452|82889744|FG000|Phase II|Adverse Event|0|||
46674168|NCT01154452|82889745|FG001|Phase II|Adverse Event|0|||
46793136|NCT00567996|83011655|FG001|Overall Study|Death|0|||
46793137|NCT00567996|83011656|FG002|Overall Study|Death|2|||
46793138|NCT00567996|83011654|FG000|Overall Study|Patient's inability to use the device|0|||
46976861|NCT02352090|83221648|FG001|Overall Study|non-specified mild side-effects|0|||
46793139|NCT00567996|83011655|FG001|Overall Study|Patient's inability to use the device|1|||
46793140|NCT00567996|83011656|FG002|Overall Study|Patient's inability to use the device|0|||
46793141|NCT00224887|83011670|FG000|Overall Study|Pregnancy|6|||
46793142|NCT00224887|83011671|FG001|Overall Study|Pregnancy|6|||
46793143|NCT00148759|83011679|FG000|Overall Study|Withdrawal by Subject|1|||
46976862|NCT02352090|83221649|FG002|Overall Study|non-specified mild side-effects|2|||
46793144|NCT00148759|83011680|FG001|Overall Study|Withdrawal by Subject|1|||
46793145|NCT00148759|83011679|FG000|Overall Study|Lost to Follow-up|1|||
46855044|NCT04779879|83070878|FG004|Part C: Up to Week 36|Death|0|||
46855045|NCT04779879|83070879|FG005|Part C: Up to Week 36|Death|1|||
46855046|NCT04779879|83070874|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
46855047|NCT04779879|83070875|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
46976863|NCT02135107|83221659|FG000|Treatment Period|Withdrawal by Subject|11|||
46976864|NCT02135107|83221660|FG001|Treatment Period|Withdrawal by Subject|0|||
46976865|NCT02135107|83221661|FG002|Treatment Period|Withdrawal by Subject|0|||
46674169|NCT01154452|82889746|FG002|Phase II|Adverse Event|4|||
46674170|NCT01154452|82889747|FG003|Phase II|Adverse Event|4|||
46793146|NCT00148759|83011680|FG001|Overall Study|Lost to Follow-up|0|||
46855048|NCT04779879|83070876|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
46976866|NCT02135107|83221662|FG003|Treatment Period|Withdrawal by Subject|0|||
46976867|NCT02135107|83221659|FG000|Treatment Period|Adverse Event|5|||
46976868|NCT02135107|83221660|FG001|Treatment Period|Adverse Event|2|||
46976869|NCT02135107|83221661|FG002|Treatment Period|Adverse Event|0|||
46976870|NCT02135107|83221662|FG003|Treatment Period|Adverse Event|0|||
46674171|NCT01154296|82889762|FG000|Randomization and Intervention|Decided to decline|1|||
46793147|NCT00717275|83011686|FG000|Overall Study|Premature study termination.|3|||
46674172|NCT01154296|82889763|FG001|Randomization and Intervention|Decided to decline|1|||
46674173|NCT01154296|82889762|FG000|Randomization and Intervention|Declined by staff|1|||
46855049|NCT04779879|83070877|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
46855050|NCT04779879|83070878|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
46855051|NCT04779879|83070879|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
46855052|NCT04535167|83070920|FG000|Treatment|Adverse Event|0|||
46855053|NCT04535167|83070921|FG001|Treatment|Adverse Event|0|||
46855054|NCT04535167|83070922|FG002|Treatment|Adverse Event|0|||
46855055|NCT04535167|83070923|FG003|Treatment|Adverse Event|0|||
46855056|NCT04535167|83070924|FG004|Treatment|Adverse Event|0|||
46855057|NCT04535167|83070925|FG005|Treatment|Adverse Event|0|||
46855058|NCT04535167|83070926|FG006|Treatment|Adverse Event|1|||
46855059|NCT04535167|83070920|FG000|Follow-Up|Death|0|||
46855060|NCT04535167|83070921|FG001|Follow-Up|Death|0|||
46855061|NCT04535167|83070922|FG002|Follow-Up|Death|0|||
46855062|NCT04535167|83070923|FG003|Follow-Up|Death|0|||
46855063|NCT04535167|83070924|FG004|Follow-Up|Death|0|||
46855064|NCT04535167|83070925|FG005|Follow-Up|Death|0|||
46855065|NCT04535167|83070926|FG006|Follow-Up|Death|1|||
46855066|NCT04535167|83070920|FG000|Follow-Up|Lost to Follow-up|0|||
46855067|NCT04535167|83070921|FG001|Follow-Up|Lost to Follow-up|0|||
46855068|NCT04535167|83070922|FG002|Follow-Up|Lost to Follow-up|0|||
46855069|NCT04535167|83070923|FG003|Follow-Up|Lost to Follow-up|1|||
46855070|NCT04535167|83070924|FG004|Follow-Up|Lost to Follow-up|0|||
46855071|NCT04535167|83070925|FG005|Follow-Up|Lost to Follow-up|0|||
46855072|NCT04535167|83070926|FG006|Follow-Up|Lost to Follow-up|0|||
46855073|NCT04223791|83070944|FG000|Overall Study|Lost to Follow-up|0|||
46855074|NCT04223791|83070945|FG001|Overall Study|Lost to Follow-up|4|||
46855075|NCT04223791|83070944|FG000|Overall Study|Physician Decision|5|||
46855076|NCT04223791|83070945|FG001|Overall Study|Physician Decision|1|||
46855077|NCT04223791|83070944|FG000|Overall Study|Protocol Violation|1|||
46855078|NCT04223791|83070945|FG001|Overall Study|Protocol Violation|1|||
46855079|NCT04223791|83070944|FG000|Overall Study|Withdrawal by Subject|10|||
46855080|NCT04223791|83070945|FG001|Overall Study|Withdrawal by Subject|12|||
46855081|NCT04223791|83070944|FG000|Overall Study|Pregnancy|1|||
46855082|NCT04223791|83070945|FG001|Overall Study|Pregnancy|1|||
46855083|NCT04223791|83070944|FG000|Overall Study|Ongoing in Study|305|||
46855084|NCT04223791|83070945|FG001|Overall Study|Ongoing in Study|302|||
46855085|NCT04115293|83070953|FG000|Overall Study|Adverse Event|0|||
46855086|NCT04115293|83070954|FG001|Overall Study|Adverse Event|2|||
46855087|NCT04115293|83070953|FG000|Overall Study|Withdrawal by Subject|2|||
46855088|NCT04115293|83070954|FG001|Overall Study|Withdrawal by Subject|1|||
46855089|NCT04115293|83070953|FG000|Overall Study|Physician Decision|1|||
46855090|NCT04115293|83070954|FG001|Overall Study|Physician Decision|0|||
46855091|NCT04115293|83070953|FG000|Overall Study|Death|1|||
46855092|NCT04115293|83070954|FG001|Overall Study|Death|1|||
46855093|NCT04035499|83070960|FG000|Overall Study|Death|2|||
46855094|NCT04035499|83070960|FG000|Overall Study|Withdrawal by Subject|1|||
46855095|NCT03915067|83070967|FG000|Overall Study|Adverse Event|0|||
46855096|NCT03915067|83070968|FG001|Overall Study|Adverse Event|0|||
46855097|NCT03915067|83070969|FG002|Overall Study|Adverse Event|1|||
46855098|NCT03915067|83070967|FG000|Overall Study|Withdrawal by Subject|4|||
46855099|NCT03915067|83070968|FG001|Overall Study|Withdrawal by Subject|3|||
46674174|NCT01154296|82889763|FG001|Randomization and Intervention|Declined by staff|0|||
46674175|NCT01154296|82889762|FG000|Randomization and Intervention|Did not return|1|||
46674176|NCT01154296|82889763|FG001|Randomization and Intervention|Did not return|0|||
46793148|NCT00584909|83011690|FG000|Overall Study|Adverse Event|4|||
46793149|NCT00147823|83011696|FG000|Overall Study|Lost to Follow-up|6|||
46793150|NCT00147823|83011697|FG001|Overall Study|Lost to Follow-up|12|||
46793151|NCT00147823|83011696|FG000|Overall Study|Physician Decision|1|||
46793152|NCT00147823|83011697|FG001|Overall Study|Physician Decision|0|||
46793153|NCT00147823|83011696|FG000|Overall Study|Withdrawal by Subject|0|||
46793154|NCT00147823|83011697|FG001|Overall Study|Withdrawal by Subject|1|||
46793155|NCT00147823|83011696|FG000|Overall Study|Did not receive vitoss due to infection|6|||
46855100|NCT03915067|83070969|FG002|Overall Study|Withdrawal by Subject|0|||
46855101|NCT03915067|83070967|FG000|Overall Study|Lost to Follow-up|3|||
46793156|NCT00147823|83011697|FG001|Overall Study|Did not receive vitoss due to infection|2|||
46793157|NCT00717197|83011703|FG000|Overall Study|Unable to purchase study drug|5|||
46793158|NCT00717197|83011703|FG000|Overall Study|Tumor Progression|1|||
46793159|NCT00717197|83011703|FG000|Overall Study|Physician Decision|1|||
46855102|NCT03915067|83070968|FG001|Overall Study|Lost to Follow-up|2|||
46855103|NCT03915067|83070969|FG002|Overall Study|Lost to Follow-up|0|||
46855104|NCT03915067|83070967|FG000|Overall Study|Protocol Deviation|0|||
46855105|NCT03915067|83070968|FG001|Overall Study|Protocol Deviation|0|||
46855106|NCT03915067|83070969|FG002|Overall Study|Protocol Deviation|1|||
46793160|NCT00147745|83011710|FG000|Overall Study|Withdrawal by Subject|1|||
46855107|NCT03915067|83070967|FG000|Overall Study|Covid-19 Related Issues|2|||
46855108|NCT03915067|83070968|FG001|Overall Study|Covid-19 Related Issues|4|||
46855109|NCT03915067|83070969|FG002|Overall Study|Covid-19 Related Issues|4|||
46855110|NCT03915067|83070967|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
46855111|NCT03915067|83070968|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
46855112|NCT03915067|83070969|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
46976871|NCT02135107|83221659|FG000|Treatment Period|Pregnancy|1|||
46976872|NCT02135107|83221660|FG001|Treatment Period|Pregnancy|0|||
46976873|NCT02135107|83221661|FG002|Treatment Period|Pregnancy|0|||
46976874|NCT02135107|83221662|FG003|Treatment Period|Pregnancy|0|||
46976875|NCT02135107|83221659|FG000|Treatment Period|Other|115|||
46976876|NCT02135107|83221660|FG001|Treatment Period|Other|24|||
46976877|NCT02135107|83221661|FG002|Treatment Period|Other|0|||
46976878|NCT02135107|83221662|FG003|Treatment Period|Other|0|||
46976879|NCT02135107|83221659|FG000|Maintenance Therapy Period|Adverse Event|0|||
46976880|NCT02135107|83221660|FG001|Maintenance Therapy Period|Adverse Event|0|||
46976881|NCT02135107|83221661|FG002|Maintenance Therapy Period|Adverse Event|3|||
46976882|NCT02135107|83221662|FG003|Maintenance Therapy Period|Adverse Event|7|||
46976883|NCT02135107|83221659|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
46976884|NCT02135107|83221660|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
46976885|NCT02135107|83221661|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
46976886|NCT02135107|83221662|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
46976887|NCT02135107|83221659|FG000|Maintenance Therapy Period|Pregnancy|0|||
46976888|NCT02135107|83221660|FG001|Maintenance Therapy Period|Pregnancy|0|||
46976889|NCT02135107|83221661|FG002|Maintenance Therapy Period|Pregnancy|0|||
46976890|NCT02135107|83221662|FG003|Maintenance Therapy Period|Pregnancy|1|||
46976891|NCT02135107|83221659|FG000|Maintenance Therapy Period|Other|0|||
46976892|NCT02135107|83221660|FG001|Maintenance Therapy Period|Other|0|||
46976893|NCT02135107|83221661|FG002|Maintenance Therapy Period|Other|7|||
46976894|NCT02135107|83221662|FG003|Maintenance Therapy Period|Other|8|||
46976895|NCT02030847|83221674|FG000|Overall Study|Death|10|||
46976896|NCT02030847|83221674|FG000|Overall Study|Disease Progression|15|||
46976897|NCT02030847|83221674|FG000|Overall Study|New Cancer Therapy|8|||
46976898|NCT02030847|83221674|FG000|Overall Study|Physician Decision|3|||
46976899|NCT02030847|83221674|FG000|Overall Study|Withdrawal by Subject|1|||
46976900|NCT02030834|83221682|FG000|Overall Study|Death|4|||
46976901|NCT02030834|83221683|FG001|Overall Study|Death|0|||
46976902|NCT02030834|83221684|FG002|Overall Study|Death|0|||
46976903|NCT02030834|83221682|FG000|Overall Study|Manufacturing failure|2|||
46976904|NCT02030834|83221683|FG001|Overall Study|Manufacturing failure|0|||
46976905|NCT02030834|83221684|FG002|Overall Study|Manufacturing failure|1|||
46976906|NCT02030834|83221682|FG000|Overall Study|Disease progression|2|||
46976907|NCT02030834|83221683|FG001|Overall Study|Disease progression|0|||
46976908|NCT02030834|83221684|FG002|Overall Study|Disease progression|2|||
46976909|NCT02030834|83221682|FG000|Overall Study|Lost to Follow-up|1|||
46976910|NCT02030834|83221683|FG001|Overall Study|Lost to Follow-up|0|||
46976911|NCT02030834|83221684|FG002|Overall Study|Lost to Follow-up|0|||
46976912|NCT02030834|83221682|FG000|Overall Study|Withdrawal by Subject|1|||
46976913|NCT02030834|83221683|FG001|Overall Study|Withdrawal by Subject|0|||
46976914|NCT02030834|83221684|FG002|Overall Study|Withdrawal by Subject|0|||
46976915|NCT02030834|83221682|FG000|Overall Study|Lack of funding|1|||
46976916|NCT02030834|83221683|FG001|Overall Study|Lack of funding|0|||
46976917|NCT02030834|83221684|FG002|Overall Study|Lack of funding|0|||
46976918|NCT01982448|83221694|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
46976919|NCT01982448|83221695|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
46976920|NCT01982448|83221694|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
46976921|NCT01982448|83221695|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
46976922|NCT01982448|83221694|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
46976923|NCT01982448|83221695|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
46976924|NCT01982448|83221694|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
46976925|NCT01982448|83221695|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
46976926|NCT01773421|83221709|FG000|Treatment Phase|Other|0|||
46976927|NCT01773421|83221710|FG001|Treatment Phase|Other|0|||
46976928|NCT01773421|83221711|FG002|Treatment Phase|Other|2|||
46976929|NCT01773421|83221712|FG003|Treatment Phase|Other|0|||
47079095|NCT00558285|83385383|FG000|Overall Study|Subject withdrew consent|2|||
47079096|NCT00558285|83385384|FG001|Overall Study|Subject withdrew consent|0|||
47079097|NCT00558285|83385385|FG002|Overall Study|Subject withdrew consent|1|||
47079098|NCT00558285|83385386|FG003|Overall Study|Subject withdrew consent|1|||
47079099|NCT00558285|83385387|FG004|Overall Study|Subject withdrew consent|1|||
46855113|NCT03654404|83070977|FG000|Overall Study|Death|1|||
46976930|NCT01773421|83221713|FG004|Treatment Phase|Other|0|||
46976931|NCT01773421|83221714|FG005|Treatment Phase|Other|0|||
46976932|NCT01773421|83221715|FG006|Treatment Phase|Other|0|||
46976933|NCT01773421|83221709|FG000|Treatment Phase|Adverse Event|0|||
46976934|NCT01773421|83221710|FG001|Treatment Phase|Adverse Event|0|||
46976935|NCT01773421|83221711|FG002|Treatment Phase|Adverse Event|3|||
46976936|NCT01773421|83221712|FG003|Treatment Phase|Adverse Event|1|||
46976937|NCT01773421|83221713|FG004|Treatment Phase|Adverse Event|0|||
46976938|NCT01773421|83221714|FG005|Treatment Phase|Adverse Event|0|||
46976939|NCT01773421|83221715|FG006|Treatment Phase|Adverse Event|0|||
46976940|NCT01773421|83221709|FG000|Treatment Phase|Withdrawal by Subject|0|||
47079100|NCT00558285|83385383|FG000|Overall Study|Lost to Follow-up|1|||
46976941|NCT01773421|83221710|FG001|Treatment Phase|Withdrawal by Subject|0|||
46976942|NCT01773421|83221711|FG002|Treatment Phase|Withdrawal by Subject|1|||
46976943|NCT01773421|83221712|FG003|Treatment Phase|Withdrawal by Subject|1|||
46976944|NCT01773421|83221713|FG004|Treatment Phase|Withdrawal by Subject|0|||
46976945|NCT01773421|83221714|FG005|Treatment Phase|Withdrawal by Subject|0|||
46976946|NCT01773421|83221715|FG006|Treatment Phase|Withdrawal by Subject|0|||
46976947|NCT01773421|83221709|FG000|Extension Phase|Other|0|||
46976948|NCT01773421|83221710|FG001|Extension Phase|Other|0|||
46976949|NCT01773421|83221711|FG002|Extension Phase|Other|0|||
46976950|NCT01773421|83221712|FG003|Extension Phase|Other|0|||
46976951|NCT01773421|83221713|FG004|Extension Phase|Other|1|||
46976952|NCT01773421|83221714|FG005|Extension Phase|Other|2|||
46976953|NCT01773421|83221715|FG006|Extension Phase|Other|0|||
46976954|NCT01773421|83221709|FG000|Extension Phase|Adverse Event|0|||
46976955|NCT01773421|83221710|FG001|Extension Phase|Adverse Event|0|||
46976956|NCT01773421|83221711|FG002|Extension Phase|Adverse Event|0|||
46976957|NCT01773421|83221712|FG003|Extension Phase|Adverse Event|0|||
46976958|NCT01773421|83221713|FG004|Extension Phase|Adverse Event|2|||
46976959|NCT01773421|83221714|FG005|Extension Phase|Adverse Event|0|||
46976960|NCT01773421|83221715|FG006|Extension Phase|Adverse Event|0|||
46976961|NCT01747486|83221733|FG000|Stage 1|Physician Decision|3|||
46976962|NCT01747486|83221734|FG001|Stage 1|Physician Decision|0|||
46976963|NCT01747486|83221733|FG000|Stage 1|Withdrawal by Subject|4|||
46976964|NCT01747486|83221734|FG001|Stage 1|Withdrawal by Subject|3|||
46976965|NCT01747486|83221733|FG000|Stage 1|Disease progression|4|||
46976966|NCT01747486|83221734|FG001|Stage 1|Disease progression|9|||
46976967|NCT01747486|83221733|FG000|Stage 1|Death|1|||
46976968|NCT01747486|83221734|FG001|Stage 1|Death|1|||
46976969|NCT01747486|83221733|FG000|Stage 2|Physician Decision|2|||
46976970|NCT01747486|83221734|FG001|Stage 2|Physician Decision|0|||
46976971|NCT01747486|83221733|FG000|Stage 2|Withdrawal by Subject|1|||
46976972|NCT01747486|83221734|FG001|Stage 2|Withdrawal by Subject|0|||
46976973|NCT01747486|83221733|FG000|Stage 2|New Cancer Therapy|3|||
46976974|NCT01747486|83221734|FG001|Stage 2|New Cancer Therapy|0|||
46976975|NCT01747486|83221733|FG000|Stage 2|Disease Progression|3|||
46976976|NCT01747486|83221734|FG001|Stage 2|Disease Progression|0|||
46976977|NCT01593254|83221746|FG000|Overall Study|Disease progression|2|||
46976978|NCT01593254|83221747|FG001|Overall Study|Disease progression|7|||
46976979|NCT01593254|83221746|FG000|Overall Study|Study drug toxicity|6|||
46793161|NCT00147745|83011711|FG001|Overall Study|Withdrawal by Subject|0|||
46793162|NCT00147745|83011712|FG002|Overall Study|Withdrawal by Subject|0|||
46793163|NCT00642902|83011724|FG000|Overall Study|Adverse Event|0|||
46793164|NCT00642902|83011725|FG001|Overall Study|Adverse Event|1|||
46793165|NCT00642902|83011726|FG002|Overall Study|Adverse Event|3|||
46793166|NCT00642902|83011727|FG003|Overall Study|Adverse Event|1|||
46793167|NCT00642902|83011724|FG000|Overall Study|Lost to Follow-up|1|||
46793168|NCT00642902|83011725|FG001|Overall Study|Lost to Follow-up|1|||
46793169|NCT00642902|83011726|FG002|Overall Study|Lost to Follow-up|0|||
46793170|NCT00642902|83011727|FG003|Overall Study|Lost to Follow-up|0|||
46976980|NCT01593254|83221747|FG001|Overall Study|Study drug toxicity|20|||
46976981|NCT01593254|83221746|FG000|Overall Study|Death|3|||
46976982|NCT01593254|83221747|FG001|Overall Study|Death|3|||
46976983|NCT01593254|83221746|FG000|Overall Study|AE unrelated to study drug|0|||
46976984|NCT01593254|83221747|FG001|Overall Study|AE unrelated to study drug|1|||
46976985|NCT01593254|83221746|FG000|Overall Study|participant request to discontinue study treatment|1|||
46976986|NCT01593254|83221747|FG001|Overall Study|participant request to discontinue study treatment|3|||
46976987|NCT01593254|83221746|FG000|Overall Study|participant withdrew consent|0|||
46976988|NCT01593254|83221747|FG001|Overall Study|participant withdrew consent|9|||
46793171|NCT00642902|83011724|FG000|Overall Study|Lack of Efficacy|0|||
46793172|NCT00642902|83011725|FG001|Overall Study|Lack of Efficacy|3|||
46793173|NCT00642902|83011726|FG002|Overall Study|Lack of Efficacy|3|||
46976989|NCT01593254|83221746|FG000|Overall Study|lost to follow up|1|||
46976990|NCT01593254|83221747|FG001|Overall Study|lost to follow up|6|||
46855114|NCT03654404|83070977|FG000|Overall Study|Lost to Follow-up|2|||
46855115|NCT03654404|83070977|FG000|Overall Study|Withdrawal by Subject|5|||
46976991|NCT01593254|83221746|FG000|Overall Study|maximum clinical benefit|1|||
46976992|NCT01593254|83221747|FG001|Overall Study|maximum clinical benefit|2|||
46976993|NCT01593254|83221746|FG000|Overall Study|Poor/non compliance|1|||
46976994|NCT01593254|83221747|FG001|Overall Study|Poor/non compliance|1|||
46976995|NCT01593254|83221746|FG000|Overall Study|Pregnancy|0|||
46976996|NCT01593254|83221747|FG001|Overall Study|Pregnancy|3|||
46976997|NCT01593254|83221746|FG000|Overall Study|participant no longer meets study criteria|1|||
46976998|NCT01593254|83221747|FG001|Overall Study|participant no longer meets study criteria|1|||
46976999|NCT01593254|83221746|FG000|Overall Study|Admin reason by sponsor|7|||
46977000|NCT01593254|83221747|FG001|Overall Study|Admin reason by sponsor|3|||
46977001|NCT01593254|83221746|FG000|Overall Study|Imatinib treatment failure|2|||
46977002|NCT01593254|83221747|FG001|Overall Study|Imatinib treatment failure|0|||
46977003|NCT01593254|83221746|FG000|Overall Study|Other Reasons|61|||
46977004|NCT01593254|83221747|FG001|Overall Study|Other Reasons|115|||
46977005|NCT01559818|83221754|FG000|Overall Study|Physician Decision|1|||
46977006|NCT01559818|83221754|FG000|Overall Study|Pregnancy|1|||
46977007|NCT01559818|83221754|FG000|Overall Study|Study terminated by Sponsor|4|||
46977008|NCT01559818|83221754|FG000|Overall Study|Withdrawal by Subject|1|||
46977009|NCT01454934|83221761|FG000|Overall Study|Clinical progression|28|||
46977010|NCT01454934|83221762|FG001|Overall Study|Clinical progression|25|||
46977011|NCT01454934|83221761|FG000|Overall Study|Other|6|||
46977012|NCT01454934|83221762|FG001|Overall Study|Other|17|||
46977013|NCT01454934|83221761|FG000|Overall Study|Adverse Event|28|||
46977014|NCT01454934|83221762|FG001|Overall Study|Adverse Event|24|||
46977015|NCT01454934|83221761|FG000|Overall Study|Withdrawn consent|2|||
46977016|NCT01454934|83221762|FG001|Overall Study|Withdrawn consent|5|||
46793174|NCT00642902|83011727|FG003|Overall Study|Lack of Efficacy|0|||
46793175|NCT00642902|83011724|FG000|Overall Study|Death|1|||
46793176|NCT00642902|83011725|FG001|Overall Study|Death|0|||
46793177|NCT00642902|83011726|FG002|Overall Study|Death|0|||
46793178|NCT00642902|83011727|FG003|Overall Study|Death|0|||
46793179|NCT00642902|83011724|FG000|Overall Study|Premature termination of clinical trial|37|||
46793180|NCT00642902|83011725|FG001|Overall Study|Premature termination of clinical trial|32|||
46793181|NCT00642902|83011726|FG002|Overall Study|Premature termination of clinical trial|35|||
46793182|NCT00642902|83011727|FG003|Overall Study|Premature termination of clinical trial|35|||
46793183|NCT00642902|83011724|FG000|Overall Study|Randomized, but not treated|0|||
46793184|NCT00642902|83011725|FG001|Overall Study|Randomized, but not treated|0|||
46793185|NCT00642902|83011726|FG002|Overall Study|Randomized, but not treated|1|||
46793186|NCT00642902|83011727|FG003|Overall Study|Randomized, but not treated|0|||
46793187|NCT00642902|83011724|FG000|Overall Study|Other|1|||
46793188|NCT00642902|83011725|FG001|Overall Study|Other|5|||
46793189|NCT00642902|83011726|FG002|Overall Study|Other|1|||
46793190|NCT00642902|83011727|FG003|Overall Study|Other|4|||
46793191|NCT00224107|83011739|FG000|Overall Study|Adverse Event|20|||
46793192|NCT00224107|83011740|FG001|Overall Study|Adverse Event|6|||
46793193|NCT00224107|83011739|FG000|Overall Study|Protocol Violation|2|||
46793194|NCT00224107|83011740|FG001|Overall Study|Protocol Violation|3|||
46793195|NCT00224107|83011739|FG000|Overall Study|Withdrawal by Subject|1|||
46793196|NCT00224107|83011740|FG001|Overall Study|Withdrawal by Subject|4|||
46793197|NCT00224107|83011739|FG000|Overall Study|Lack of Efficacy|2|||
46793198|NCT00224107|83011740|FG001|Overall Study|Lack of Efficacy|0|||
46793199|NCT00224107|83011739|FG000|Overall Study|Lost to Follow-up|4|||
46793200|NCT00224107|83011740|FG001|Overall Study|Lost to Follow-up|0|||
46793201|NCT00224107|83011739|FG000|Overall Study|Physician Decision|1|||
46793202|NCT00224107|83011740|FG001|Overall Study|Physician Decision|0|||
46793203|NCT00224107|83011739|FG000|Overall Study|Other|1|||
46793204|NCT00224107|83011740|FG001|Overall Study|Other|1|||
46793205|NCT00720083|83011748|FG000|Overall Study|Ineligible|1|||
46793206|NCT00720083|83011749|FG001|Overall Study|Ineligible|2|||
46793207|NCT00209131|83011757|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
46977017|NCT01454934|83221761|FG000|Overall Study|Withdrawal by Subject|11|||
46977018|NCT01454934|83221762|FG001|Overall Study|Withdrawal by Subject|15|||
46977019|NCT01454934|83221761|FG000|Overall Study|Disease progression|194|||
46977020|NCT01454934|83221762|FG001|Overall Study|Disease progression|181|||
46977021|NCT01454934|83221761|FG000|Overall Study|Lost to Follow-up|0|||
46977022|NCT01454934|83221762|FG001|Overall Study|Lost to Follow-up|1|||
46977023|NCT01454934|83221761|FG000|Overall Study|Not treated|1|||
46977024|NCT01454934|83221762|FG001|Overall Study|Not treated|2|||
46977025|NCT01439282|83221770|FG000|Overall Study|Adverse Event|5|||
46977026|NCT01439282|83221771|FG001|Overall Study|Adverse Event|0|||
46977027|NCT01439282|83221770|FG000|Overall Study|Withdrawal by Subject|2|||
47079101|NCT00558285|83385384|FG001|Overall Study|Lost to Follow-up|1|||
47079102|NCT00558285|83385385|FG002|Overall Study|Lost to Follow-up|0|||
47079103|NCT00558285|83385386|FG003|Overall Study|Lost to Follow-up|0|||
46793208|NCT00209131|83011758|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
46793209|NCT00224029|83011764|FG000|Overall Study|Lost to Follow-up|1|||
46793210|NCT00224029|83011764|FG000|Overall Study|Withdrawal by Subject|4|||
46793211|NCT00224029|83011764|FG000|Overall Study|Other|1|||
46793212|NCT00223795|83011768|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
46793213|NCT00223795|83011769|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
46793214|NCT00223795|83011768|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
46793215|NCT00223795|83011769|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
46793216|NCT00719849|83011778|FG000|Overall Study|Death|0|||
46793217|NCT00719849|83011779|FG001|Overall Study|Death|1|||
47079104|NCT00558285|83385387|FG004|Overall Study|Lost to Follow-up|0|||
47079105|NCT00558285|83385383|FG000|Overall Study|Administrative problems|0|||
47079106|NCT00558285|83385384|FG001|Overall Study|Administrative problems|0|||
47079107|NCT00558285|83385385|FG002|Overall Study|Administrative problems|0|||
47079108|NCT00558285|83385386|FG003|Overall Study|Administrative problems|1|||
47079109|NCT00558285|83385387|FG004|Overall Study|Administrative problems|1|||
47079110|NCT00558285|83385383|FG000|Overall Study|Protocol deviation|1|||
47079111|NCT00558285|83385384|FG001|Overall Study|Protocol deviation|1|||
47079112|NCT00558285|83385385|FG002|Overall Study|Protocol deviation|0|||
47079113|NCT00558285|83385386|FG003|Overall Study|Protocol deviation|1|||
47079114|NCT00558285|83385387|FG004|Overall Study|Protocol deviation|0|||
46793218|NCT03907683|83011785|FG000|Overall Study|Pregnancy|1|||
46793219|NCT03907683|83011785|FG000|Overall Study|Withdrawal by Subject|1|||
46674177|NCT01154296|82889762|FG000|Randomization and Intervention|Left before test|0|||
46793220|NCT00626522|83011795|FG000|Overall Study|Protocol Violation|0|||
46793221|NCT00626522|83011796|FG001|Overall Study|Protocol Violation|0|||
46977028|NCT01439282|83221771|FG001|Overall Study|Withdrawal by Subject|0|||
46977029|NCT01439282|83221770|FG000|Overall Study|Other|1|||
46977030|NCT01439282|83221771|FG001|Overall Study|Other|1|||
47079115|NCT01389596|83385402|FG000|Overall Study|Protocol Violation|3|||
46977031|NCT01326312|83221781|FG000|Overall Study|Adverse Event|11|||
46977032|NCT01326312|83221782|FG001|Overall Study|Adverse Event|11|||
46977033|NCT01326312|83221783|FG002|Overall Study|Adverse Event|1|||
46977034|NCT01326312|83221781|FG000|Overall Study|Withdrawal by Subject|1|||
46977035|NCT01326312|83221782|FG001|Overall Study|Withdrawal by Subject|2|||
46977036|NCT01326312|83221783|FG002|Overall Study|Withdrawal by Subject|1|||
46977037|NCT01326312|83221781|FG000|Overall Study|Protocol Violation|0|||
46977038|NCT01326312|83221782|FG001|Overall Study|Protocol Violation|1|||
46977039|NCT01326312|83221783|FG002|Overall Study|Protocol Violation|0|||
46977040|NCT01326312|83221781|FG000|Overall Study|Lack of Efficacy|13|||
46977041|NCT01326312|83221782|FG001|Overall Study|Lack of Efficacy|7|||
46977042|NCT01326312|83221783|FG002|Overall Study|Lack of Efficacy|1|||
46977043|NCT01326312|83221781|FG000|Overall Study|Death|1|||
46977044|NCT01326312|83221782|FG001|Overall Study|Death|0|||
46977045|NCT01326312|83221783|FG002|Overall Study|Death|1|||
46977046|NCT01326312|83221781|FG000|Overall Study|progressive disease|0|||
46977047|NCT01326312|83221782|FG001|Overall Study|progressive disease|1|||
46977048|NCT01326312|83221783|FG002|Overall Study|progressive disease|1|||
46977049|NCT01326312|83221781|FG000|Overall Study|Study terminated by Sponsor|8|||
46977050|NCT01326312|83221782|FG001|Overall Study|Study terminated by Sponsor|32|||
46977051|NCT01326312|83221783|FG002|Overall Study|Study terminated by Sponsor|46|||
46977052|NCT01326312|83221781|FG000|Overall Study|Treatment arm terminated|19|||
46977053|NCT01326312|83221782|FG001|Overall Study|Treatment arm terminated|0|||
46977054|NCT01326312|83221783|FG002|Overall Study|Treatment arm terminated|0|||
46977055|NCT01326312|83221781|FG000|Overall Study|QTc > 500|0|||
46977056|NCT01326312|83221782|FG001|Overall Study|QTc > 500|1|||
46977057|NCT01326312|83221783|FG002|Overall Study|QTc > 500|0|||
46977058|NCT01269346|83221805|FG000|Treatment Phase|Disease progression|3|||
46977059|NCT01269346|83221805|FG000|Treatment Phase|Adverse Event|3|||
46977060|NCT01269346|83221805|FG000|Treatment Phase|Withdrawal by Subject|1|||
46977061|NCT01269346|83221805|FG000|Treatment Phase|Other|2|||
46977062|NCT01269346|83221805|FG000|Extension Phase|Adverse Event|6|||
46793222|NCT00626522|83011797|FG002|Overall Study|Protocol Violation|0|||
46793223|NCT00626522|83011798|FG003|Overall Study|Protocol Violation|0|||
46793224|NCT00626522|83011799|FG004|Overall Study|Protocol Violation|1|||
46793225|NCT00626522|83011800|FG005|Overall Study|Protocol Violation|0|||
46793226|NCT00626522|83011795|FG000|Overall Study|Adverse Event|2|||
46793227|NCT00626522|83011796|FG001|Overall Study|Adverse Event|1|||
46793228|NCT00626522|83011797|FG002|Overall Study|Adverse Event|2|||
46793229|NCT00626522|83011798|FG003|Overall Study|Adverse Event|0|||
46793230|NCT00626522|83011799|FG004|Overall Study|Adverse Event|1|||
46793231|NCT00626522|83011800|FG005|Overall Study|Adverse Event|1|||
46793232|NCT00626522|83011795|FG000|Overall Study|Withdrawal by Subject|2|||
46793233|NCT00626522|83011796|FG001|Overall Study|Withdrawal by Subject|5|||
46793234|NCT00626522|83011797|FG002|Overall Study|Withdrawal by Subject|5|||
46793235|NCT00626522|83011798|FG003|Overall Study|Withdrawal by Subject|0|||
46793236|NCT00626522|83011799|FG004|Overall Study|Withdrawal by Subject|4|||
46793237|NCT00626522|83011800|FG005|Overall Study|Withdrawal by Subject|1|||
46793238|NCT00626522|83011795|FG000|Overall Study|COPD exacerbation|0|||
46793239|NCT00626522|83011796|FG001|Overall Study|COPD exacerbation|0|||
46793240|NCT00626522|83011797|FG002|Overall Study|COPD exacerbation|0|||
46793241|NCT00626522|83011798|FG003|Overall Study|COPD exacerbation|1|||
46793242|NCT00626522|83011799|FG004|Overall Study|COPD exacerbation|1|||
46793243|NCT00626522|83011800|FG005|Overall Study|COPD exacerbation|0|||
46977063|NCT01269346|83221805|FG000|Extension Phase|Withdrawal by Subject|4|||
46793244|NCT00626522|83011795|FG000|Overall Study|Lost to Follow-up|0|||
46793245|NCT00626522|83011796|FG001|Overall Study|Lost to Follow-up|1|||
46793246|NCT00626522|83011797|FG002|Overall Study|Lost to Follow-up|0|||
46793247|NCT00626522|83011798|FG003|Overall Study|Lost to Follow-up|0|||
46793248|NCT00626522|83011799|FG004|Overall Study|Lost to Follow-up|0|||
46793249|NCT00626522|83011800|FG005|Overall Study|Lost to Follow-up|0|||
46793250|NCT00626522|83011795|FG000|Overall Study|Inconsistent reason reported|1|||
46793251|NCT00626522|83011796|FG001|Overall Study|Inconsistent reason reported|0|||
46793252|NCT00626522|83011797|FG002|Overall Study|Inconsistent reason reported|0|||
46793253|NCT00626522|83011798|FG003|Overall Study|Inconsistent reason reported|0|||
46793254|NCT00626522|83011799|FG004|Overall Study|Inconsistent reason reported|0|||
46793255|NCT00626522|83011800|FG005|Overall Study|Inconsistent reason reported|0|||
46793256|NCT00626522|83011795|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
46793257|NCT00626522|83011796|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
46977064|NCT01269346|83221805|FG000|Extension Phase|Disease progression|22|||
46977065|NCT01269346|83221805|FG000|Extension Phase|Physician decision or participant choice|9|||
46977066|NCT01269346|83221805|FG000|Extension Phase|Clinical progression|1|||
46977067|NCT01269346|83221805|FG000|Extension Phase|Started a prohibited con med|1|||
46977068|NCT01268293|83221810|FG000|Overall Study|Disease progression|7|||
46977069|NCT01268293|83221810|FG000|Overall Study|Adverse Event|1|||
46977070|NCT01268293|83221810|FG000|Overall Study|Subject choice|1|||
46977071|NCT01268150|83221814|FG000|Treatment Phase|Progression of disease|18|||
46977072|NCT01268150|83221814|FG000|Treatment Phase|Adverse Event|3|||
46977073|NCT01268150|83221814|FG000|Treatment Phase|Withdrawal by Subject|3|||
46977074|NCT01268150|83221814|FG000|Treatment Phase|Other|4|||
46793258|NCT00626522|83011797|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
46793259|NCT00626522|83011798|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
46793260|NCT00626522|83011799|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
46793261|NCT00626522|83011800|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
46793262|NCT00540423|83011825|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46793263|NCT00540423|83011826|FG001|Double-Blind Treatment Period|Adverse Event|1|||
46793264|NCT00540423|83011827|FG002|Double-Blind Treatment Period|Adverse Event|0|||
46793265|NCT00540423|83011825|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
46793266|NCT00540423|83011826|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
46793267|NCT00540423|83011827|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
46793268|NCT00566982|83011847|FG000|Overall Study|Adverse Event|6|||
46793269|NCT00566982|83011848|FG001|Overall Study|Adverse Event|48|||
46793270|NCT00566982|83011847|FG000|Overall Study|Withdrawal by Subject|1|||
46793271|NCT00566982|83011848|FG001|Overall Study|Withdrawal by Subject|14|||
46793272|NCT00566982|83011847|FG000|Overall Study|Protocol Violation|1|||
46793273|NCT00566982|83011848|FG001|Overall Study|Protocol Violation|4|||
46793274|NCT00566982|83011847|FG000|Overall Study|Lost to Follow-up|0|||
46793275|NCT00566982|83011848|FG001|Overall Study|Lost to Follow-up|1|||
46793276|NCT00566982|83011847|FG000|Overall Study|Other-family problems & doctor's request|0|||
46793277|NCT00566982|83011848|FG001|Overall Study|Other-family problems & doctor's request|2|||
46793278|NCT00624338|83011860|FG000|Overall Study|Adverse Event|14|||
46793279|NCT00624338|83011861|FG001|Overall Study|Adverse Event|14|||
46793280|NCT00624338|83011862|FG002|Overall Study|Adverse Event|18|||
46793281|NCT00624338|83011860|FG000|Overall Study|Lost to Follow-up|1|||
46793282|NCT00624338|83011861|FG001|Overall Study|Lost to Follow-up|0|||
46793283|NCT00624338|83011862|FG002|Overall Study|Lost to Follow-up|0|||
46793284|NCT00624338|83011860|FG000|Overall Study|Lack of Efficacy|11|||
46793285|NCT00624338|83011861|FG001|Overall Study|Lack of Efficacy|3|||
46855116|NCT03447314|83071042|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
46855117|NCT03447314|83071043|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
46855118|NCT03447314|83071044|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
46793286|NCT00624338|83011862|FG002|Overall Study|Lack of Efficacy|14|||
46855119|NCT03447314|83071045|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
46855120|NCT03447314|83071046|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
46855121|NCT03447314|83071047|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
46855122|NCT03447314|83071048|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
46977075|NCT01268150|83221814|FG000|Extension Phase|Adverse Event|3|||
46977076|NCT01268150|83221814|FG000|Extension Phase|Disease progression|18|||
46977077|NCT01268150|83221814|FG000|Extension Phase|Other|6|||
46977078|NCT01267175|83221818|FG000|Overall Study|Withdrawal by Subject|1|||
46793287|NCT00624338|83011860|FG000|Overall Study|Protocol Violation|3|||
46793288|NCT00624338|83011861|FG001|Overall Study|Protocol Violation|3|||
46793289|NCT00624338|83011862|FG002|Overall Study|Protocol Violation|2|||
46793290|NCT00624338|83011860|FG000|Overall Study|Death|0|||
46793291|NCT00624338|83011861|FG001|Overall Study|Death|2|||
46793292|NCT00624338|83011862|FG002|Overall Study|Death|0|||
46793293|NCT00624338|83011860|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
46793294|NCT00624338|83011861|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
46855123|NCT03447314|83071049|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46977079|NCT01267175|83221818|FG000|Overall Study|Lost to Follow-up|1|||
46977080|NCT01133756|83221829|FG000|Overall Study|Adverse Event|1|||
46977081|NCT01133756|83221830|FG001|Overall Study|Adverse Event|2|||
46977082|NCT01133756|83221831|FG002|Overall Study|Adverse Event|1|||
46977083|NCT01133756|83221829|FG000|Overall Study|Investigator Decision|1|||
46977084|NCT01133756|83221830|FG001|Overall Study|Investigator Decision|0|||
46977085|NCT01133756|83221831|FG002|Overall Study|Investigator Decision|0|||
46977086|NCT01133756|83221829|FG000|Overall Study|Withdrawal by Subject|0|||
46977087|NCT01133756|83221830|FG001|Overall Study|Withdrawal by Subject|1|||
46977088|NCT01133756|83221831|FG002|Overall Study|Withdrawal by Subject|0|||
46977089|NCT01133756|83221829|FG000|Overall Study|Progression of Disease|0|||
46977090|NCT01133756|83221830|FG001|Overall Study|Progression of Disease|0|||
46977091|NCT01133756|83221831|FG002|Overall Study|Progression of Disease|1|||
46977092|NCT01126736|83221844|FG000|Overall Study|Death|2|||
46977093|NCT01126736|83221845|FG001|Overall Study|Death|2|||
46977094|NCT01126736|83221846|FG002|Overall Study|Death|1|||
46977095|NCT01126736|83221847|FG003|Overall Study|Death|19|||
46977096|NCT01126736|83221848|FG004|Overall Study|Death|19|||
46977097|NCT01126736|83221844|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
46977098|NCT01126736|83221845|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
46977099|NCT01126736|83221846|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
46674178|NCT01154296|82889763|FG001|Randomization and Intervention|Left before test|1|||
46674179|NCT01154296|82889762|FG000|Randomization and Intervention|Left clinic early|2|||
46977100|NCT01126736|83221847|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
46977101|NCT01126736|83221848|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
46977102|NCT01126736|83221844|FG000|Overall Study|Lost to Follow-up|0|||
46977103|NCT01126736|83221845|FG001|Overall Study|Lost to Follow-up|0|||
46977104|NCT01126736|83221846|FG002|Overall Study|Lost to Follow-up|0|||
46977105|NCT01126736|83221847|FG003|Overall Study|Lost to Follow-up|1|||
46977106|NCT01126736|83221848|FG004|Overall Study|Lost to Follow-up|1|||
46977107|NCT01126736|83221844|FG000|Overall Study|Administrative reasons|0|||
46977108|NCT01126736|83221845|FG001|Overall Study|Administrative reasons|0|||
46977109|NCT01126736|83221846|FG002|Overall Study|Administrative reasons|0|||
46977110|NCT01126736|83221847|FG003|Overall Study|Administrative reasons|0|||
46977111|NCT01126736|83221848|FG004|Overall Study|Administrative reasons|1|||
46977112|NCT01126736|83221844|FG000|Overall Study|Progressive disease|0|||
46977113|NCT01126736|83221845|FG001|Overall Study|Progressive disease|0|||
46977114|NCT01126736|83221846|FG002|Overall Study|Progressive disease|0|||
46977115|NCT01126736|83221847|FG003|Overall Study|Progressive disease|2|||
46977116|NCT01126736|83221848|FG004|Overall Study|Progressive disease|1|||
46977117|NCT01126736|83221844|FG000|Overall Study|Withdrawal by Subject|0|||
46674180|NCT01154296|82889763|FG001|Randomization and Intervention|Left clinic early|0|||
46674181|NCT01154296|82889762|FG000|6-month Follow-up|Lost contact|269|||
46674182|NCT01154296|82889763|FG001|6-month Follow-up|Lost contact|275|||
46674183|NCT01154296|82889762|FG000|6-month Follow-up|Incarcerated|37|||
46977118|NCT01126736|83221845|FG001|Overall Study|Withdrawal by Subject|0|||
46977119|NCT01126736|83221846|FG002|Overall Study|Withdrawal by Subject|0|||
46977120|NCT01126736|83221847|FG003|Overall Study|Withdrawal by Subject|1|||
46977121|NCT01126736|83221848|FG004|Overall Study|Withdrawal by Subject|1|||
46977122|NCT01126736|83221844|FG000|Overall Study|Other|2|||
46977123|NCT01126736|83221845|FG001|Overall Study|Other|4|||
46977124|NCT01126736|83221846|FG002|Overall Study|Other|4|||
46977125|NCT01126736|83221847|FG003|Overall Study|Other|16|||
46674184|NCT01154296|82889763|FG001|6-month Follow-up|Incarcerated|32|||
46674185|NCT01154296|82889762|FG000|6-month Follow-up|Withdrew consent|14|||
46674186|NCT01154296|82889763|FG001|6-month Follow-up|Withdrew consent|15|||
46674187|NCT01154296|82889762|FG000|6-month Follow-up|Death|3|||
46674188|NCT01154296|82889763|FG001|6-month Follow-up|Death|2|||
46793295|NCT00624338|83011862|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
46793296|NCT00624338|83011860|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
46793297|NCT00624338|83011861|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
46793298|NCT00624338|83011862|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
46793299|NCT00624338|83011860|FG000|Overall Study|Other|15|||
46793300|NCT00624338|83011861|FG001|Overall Study|Other|5|||
46793301|NCT00624338|83011862|FG002|Overall Study|Other|9|||
46793302|NCT00624338|83011860|FG000|Overall Study|Randomized but not treated|2|||
46977126|NCT01126736|83221848|FG004|Overall Study|Other|15|||
46674189|NCT01154296|82889762|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
46674190|NCT01154296|82889763|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
46793303|NCT00624338|83011861|FG001|Overall Study|Randomized but not treated|1|||
46977127|NCT01111461|83221860|FG000|Overall Study|Adverse Event|32|||
46977128|NCT01111461|83221860|FG000|Overall Study|Participant choice|11|||
46977129|NCT01111461|83221860|FG000|Overall Study|Lost to Follow-up|1|||
46977130|NCT01111461|83221860|FG000|Overall Study|Withdrawal by Subject|1|||
46977131|NCT01111461|83221860|FG000|Overall Study|Other|6|||
46977132|NCT01104155|83221866|FG000|Overall Study|Adverse Event|15|||
46977133|NCT01104155|83221867|FG001|Overall Study|Adverse Event|8|||
46977134|NCT01104155|83221866|FG000|Overall Study|Participant choice|6|||
46977135|NCT01104155|83221867|FG001|Overall Study|Participant choice|5|||
46977136|NCT01104155|83221866|FG000|Overall Study|Withdrawal of consent|1|||
46674191|NCT01154218|82889769|FG000|Third Intervention Period|Adverse Event|0|||
46674192|NCT01154218|82889770|FG001|Third Intervention Period|Adverse Event|1|||
46674193|NCT01154218|82889771|FG002|Third Intervention Period|Adverse Event|0|||
46674194|NCT01154218|82889772|FG003|Third Intervention Period|Adverse Event|0|||
46674195|NCT01154218|82889769|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
46674196|NCT01154218|82889770|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
46674197|NCT01154218|82889771|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
46674198|NCT01154218|82889772|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
46674199|NCT01154218|82889769|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
46674200|NCT01154218|82889770|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
46674201|NCT01154218|82889771|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
46674202|NCT01154218|82889772|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
46674203|NCT01154140|82889797|FG000|Overall Study|Death|71|||
46674204|NCT01154140|82889798|FG001|Overall Study|Death|81|||
46977137|NCT01104155|83221867|FG001|Overall Study|Withdrawal of consent|1|||
46977138|NCT01104155|83221866|FG000|Overall Study|Other|3|||
46977139|NCT01104155|83221867|FG001|Overall Study|Other|4|||
46977140|NCT01065597|83221873|FG000|Overall Study|Adverse Event|1|||
46977141|NCT01051856|83221879|FG000|Overall Study|Withdrawal by Subject|1|||
46977142|NCT01051856|83221880|FG001|Overall Study|Withdrawal by Subject|0|||
46977143|NCT01029366|83221888|FG000|Overall Study|Withdrawal by Subject|1|||
46977144|NCT01029366|83221889|FG001|Overall Study|Withdrawal by Subject|0|||
46977145|NCT01029366|83221888|FG000|Overall Study|Death|1|||
46977146|NCT01029366|83221889|FG001|Overall Study|Death|1|||
46977147|NCT01029366|83221888|FG000|Overall Study|disease progression|2|||
46977148|NCT01029366|83221889|FG001|Overall Study|disease progression|0|||
46977149|NCT01029366|83221888|FG000|Overall Study|manufacturing failure|0|||
46977150|NCT01029366|83221889|FG001|Overall Study|manufacturing failure|1|||
46977151|NCT00879086|83221898|FG000|Overall Study|Adverse Event|3|||
46977152|NCT00879086|83221899|FG001|Overall Study|Adverse Event|15|||
46977153|NCT00879086|83221898|FG000|Overall Study|Participant choice|2|||
46977154|NCT00879086|83221899|FG001|Overall Study|Participant choice|2|||
46674205|NCT01154140|82889797|FG000|Overall Study|Lost to Follow-up|4|||
46674206|NCT01154140|82889798|FG001|Overall Study|Lost to Follow-up|5|||
46674207|NCT01154140|82889797|FG000|Overall Study|Withdrawal by Subject|12|||
46674208|NCT01154140|82889798|FG001|Overall Study|Withdrawal by Subject|13|||
46674209|NCT01154140|82889797|FG000|Overall Study|Other|3|||
46793304|NCT00624338|83011862|FG002|Overall Study|Randomized but not treated|3|||
46793305|NCT03977454|83011872|FG000|Overall Study|immediate postoperative revision|2|||
46793306|NCT03977454|83011873|FG001|Overall Study|immediate postoperative revision|2|||
46793307|NCT00538785|83011881|FG000|Overall Study|Death|9|||
46793308|NCT00538785|83011882|FG001|Overall Study|Death|10|||
46855124|NCT03447314|83071050|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46855125|NCT03447314|83071051|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46793309|NCT00538785|83011881|FG000|Overall Study|Withdrawal of consent|9|||
46793310|NCT00538785|83011882|FG001|Overall Study|Withdrawal of consent|7|||
46793311|NCT00538785|83011881|FG000|Overall Study|Lost to Follow-up|1|||
46793312|NCT00538785|83011882|FG001|Overall Study|Lost to Follow-up|0|||
46793313|NCT00538629|83011888|FG000|Overall Study|At subject's request|1|||
46793314|NCT00538629|83011888|FG000|Overall Study|Adverse Event|2|||
46855126|NCT03447314|83071052|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
46855127|NCT03447314|83071053|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
46855128|NCT03447314|83071054|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46855129|NCT03447314|83071055|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46855130|NCT03447314|83071056|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46855131|NCT03447314|83071057|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46855132|NCT03447314|83071058|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46855133|NCT03447314|83071059|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
46855134|NCT03447314|83071042|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
46855135|NCT03447314|83071043|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855136|NCT03447314|83071044|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
46855137|NCT03447314|83071045|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855138|NCT03447314|83071046|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46674210|NCT01154140|82889798|FG001|Overall Study|Other|1|||
46674211|NCT01154140|82889797|FG000|Overall Study|Randomized but not treated|1|||
46793315|NCT00538629|83011888|FG000|Overall Study|Lack of Efficacy|12|||
46855139|NCT03447314|83071047|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
46855140|NCT03447314|83071048|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
46977155|NCT00879086|83221898|FG000|Overall Study|Progression of disease|40|||
46674212|NCT01154140|82889798|FG001|Overall Study|Randomized but not treated|2|||
46793316|NCT00538629|83011888|FG000|Overall Study|Lost to Follow-up|6|||
46977156|NCT00879086|83221899|FG001|Overall Study|Progression of disease|26|||
46977157|NCT00879086|83221898|FG000|Overall Study|Withdrawal of consent|2|||
46977158|NCT00879086|83221899|FG001|Overall Study|Withdrawal of consent|1|||
46977159|NCT00879086|83221898|FG000|Overall Study|Other|4|||
46977160|NCT00879086|83221899|FG001|Overall Study|Other|6|||
46977161|NCT00879086|83221898|FG000|Overall Study|Death|1|||
46977162|NCT00879086|83221899|FG001|Overall Study|Death|2|||
46977163|NCT00244933|83221915|FG000|Overall Study|Not response evaluable|2|||
46855141|NCT03447314|83071049|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855142|NCT03447314|83071050|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855143|NCT03447314|83071051|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855144|NCT03447314|83071052|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855145|NCT03447314|83071053|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855146|NCT03447314|83071054|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855147|NCT03447314|83071055|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855148|NCT03447314|83071056|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855149|NCT03447314|83071057|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855150|NCT03447314|83071058|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855151|NCT03447314|83071059|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
46855152|NCT03447314|83071042|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855153|NCT03447314|83071043|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855154|NCT03447314|83071044|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
46855155|NCT03447314|83071045|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855156|NCT03447314|83071046|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855157|NCT03447314|83071047|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46977164|NCT02637557|83221996|FG000|Overall Study|Adverse Event|3|||
46977165|NCT02637557|83221997|FG001|Overall Study|Adverse Event|1|||
46977166|NCT02637557|83221998|FG002|Overall Study|Adverse Event|3|||
46977167|NCT02637557|83221999|FG003|Overall Study|Adverse Event|3|||
46977168|NCT02637557|83221996|FG000|Overall Study|Lost to Follow-up|1|||
46977169|NCT02637557|83221997|FG001|Overall Study|Lost to Follow-up|1|||
46977170|NCT02637557|83221998|FG002|Overall Study|Lost to Follow-up|0|||
46977171|NCT02637557|83221999|FG003|Overall Study|Lost to Follow-up|1|||
46977172|NCT02637557|83221996|FG000|Overall Study|Physician Decision|1|||
46977173|NCT02637557|83221997|FG001|Overall Study|Physician Decision|0|||
46977174|NCT02637557|83221998|FG002|Overall Study|Physician Decision|0|||
46977175|NCT02637557|83221999|FG003|Overall Study|Physician Decision|0|||
46977176|NCT02637557|83221996|FG000|Overall Study|Protocol Violation|2|||
46977177|NCT02637557|83221997|FG001|Overall Study|Protocol Violation|0|||
46977178|NCT02637557|83221998|FG002|Overall Study|Protocol Violation|2|||
46977179|NCT02637557|83221999|FG003|Overall Study|Protocol Violation|1|||
46977180|NCT02637557|83221996|FG000|Overall Study|Withdrawal by Subject|1|||
46977181|NCT02637557|83221997|FG001|Overall Study|Withdrawal by Subject|3|||
46977182|NCT02637557|83221998|FG002|Overall Study|Withdrawal by Subject|4|||
46977183|NCT02637557|83221999|FG003|Overall Study|Withdrawal by Subject|2|||
46977184|NCT02638493|83222012|FG000|Overall Study|Inability to provide semen samples|2|||
46977185|NCT02638493|83222013|FG001|Overall Study|Inability to provide semen samples|0|||
46977186|NCT02638493|83222014|FG002|Overall Study|Inability to provide semen samples|0|||
46793317|NCT00538629|83011888|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
46793318|NCT00622700|83011895|FG000|Core Treatment Period|Randomized but Not Treated|0|||
46793319|NCT00622700|83011896|FG001|Core Treatment Period|Randomized but Not Treated|2|||
46793320|NCT00622700|83011897|FG002|Core Treatment Period|Randomized but Not Treated|2|||
46793321|NCT00622700|83011898|FG003|Core Treatment Period|Randomized but Not Treated|0|||
46793322|NCT00622700|83011899|FG004|Core Treatment Period|Randomized but Not Treated|0|||
46793323|NCT00622700|83011900|FG005|Core Treatment Period|Randomized but Not Treated|0|||
46793324|NCT00622700|83011901|FG006|Core Treatment Period|Randomized but Not Treated|0|||
46793325|NCT00622700|83011895|FG000|Core Treatment Period|Adverse Event|18|||
46793326|NCT00622700|83011896|FG001|Core Treatment Period|Adverse Event|25|||
46793327|NCT00622700|83011897|FG002|Core Treatment Period|Adverse Event|18|||
46793328|NCT00622700|83011898|FG003|Core Treatment Period|Adverse Event|0|||
46793329|NCT00622700|83011899|FG004|Core Treatment Period|Adverse Event|0|||
46855158|NCT03447314|83071048|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855159|NCT03447314|83071049|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46977187|NCT02638337|83222024|FG000|Overall Study|Adverse Event|6|||
46793330|NCT00622700|83011900|FG005|Core Treatment Period|Adverse Event|0|||
46793331|NCT00622700|83011901|FG006|Core Treatment Period|Adverse Event|0|||
46977188|NCT02638337|83222025|FG001|Overall Study|Adverse Event|10|||
46977189|NCT02638337|83222024|FG000|Overall Study|Protocol Violation|3|||
46977190|NCT02638337|83222025|FG001|Overall Study|Protocol Violation|0|||
46977191|NCT02638337|83222024|FG000|Overall Study|Withdrawal by Subject|13|||
46977192|NCT02638337|83222025|FG001|Overall Study|Withdrawal by Subject|16|||
46977193|NCT02638337|83222024|FG000|Overall Study|Lost to Follow-up|7|||
46977194|NCT02638337|83222025|FG001|Overall Study|Lost to Follow-up|7|||
46977195|NCT02638337|83222024|FG000|Overall Study|Other - Miscellaneous|4|||
46977196|NCT02638337|83222025|FG001|Overall Study|Other - Miscellaneous|3|||
46977197|NCT02638259|83222033|FG000|Treatment Period 1|Adverse Event|1|||
46977198|NCT02638259|83222034|FG001|Treatment Period 1|Adverse Event|5|||
46977199|NCT02638259|83222033|FG000|Treatment Period 1|Death|0|||
46977200|NCT02638259|83222034|FG001|Treatment Period 1|Death|1|||
46977201|NCT02638259|83222033|FG000|Treatment Period 1|Lack of Efficacy|0|||
46977202|NCT02638259|83222034|FG001|Treatment Period 1|Lack of Efficacy|1|||
46977203|NCT02638259|83222033|FG000|Treatment Period 1|Protocol Violation|0|||
46977204|NCT02638259|83222034|FG001|Treatment Period 1|Protocol Violation|3|||
46855160|NCT03447314|83071050|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855161|NCT03447314|83071051|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855162|NCT03447314|83071052|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855163|NCT03447314|83071053|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46977205|NCT02638259|83222033|FG000|Treatment Period 1|Withdrawal by Subject|4|||
46977206|NCT02638259|83222034|FG001|Treatment Period 1|Withdrawal by Subject|6|||
46977207|NCT02638259|83222033|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
46674213|NCT01154101|82889809|FG000|Overall Study|Adverse Event|0|||
46674214|NCT01154101|82889810|FG001|Overall Study|Adverse Event|2|||
46674215|NCT01154101|82889811|FG002|Overall Study|Adverse Event|1|||
46793332|NCT00622700|83011895|FG000|Core Treatment Period|Lack of Efficacy|19|||
46855164|NCT03447314|83071054|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855165|NCT03447314|83071055|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46977208|NCT02638259|83222034|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
46674216|NCT01154101|82889812|FG003|Overall Study|Adverse Event|1|||
46674217|NCT01154101|82889813|FG004|Overall Study|Adverse Event|0|||
46674218|NCT01154101|82889809|FG000|Overall Study|Lost to Follow-up|0|||
46674219|NCT01154101|82889810|FG001|Overall Study|Lost to Follow-up|1|||
46674220|NCT01154101|82889811|FG002|Overall Study|Lost to Follow-up|0|||
46674221|NCT01154101|82889812|FG003|Overall Study|Lost to Follow-up|1|||
46674222|NCT01154101|82889813|FG004|Overall Study|Lost to Follow-up|0|||
46674223|NCT01154101|82889809|FG000|Overall Study|Withdrawal by Subject|0|||
46793333|NCT00622700|83011896|FG001|Core Treatment Period|Lack of Efficacy|6|||
46793334|NCT00622700|83011897|FG002|Core Treatment Period|Lack of Efficacy|12|||
46793335|NCT00622700|83011898|FG003|Core Treatment Period|Lack of Efficacy|0|||
46793336|NCT00622700|83011899|FG004|Core Treatment Period|Lack of Efficacy|0|||
46674224|NCT01154101|82889810|FG001|Overall Study|Withdrawal by Subject|1|||
46674225|NCT01154101|82889811|FG002|Overall Study|Withdrawal by Subject|2|||
46674226|NCT01154101|82889812|FG003|Overall Study|Withdrawal by Subject|0|||
46674227|NCT01154101|82889813|FG004|Overall Study|Withdrawal by Subject|1|||
46674228|NCT01153984|82889830|FG000|Overall Study|Withdrawal by Subject|1|||
46674229|NCT01153984|82889830|FG000|Overall Study|Adverse Event|1|||
46674230|NCT01153633|82889836|FG000|Overall Study|Protocol Violation|1|||
46674231|NCT01153633|82889837|FG001|Overall Study|Protocol Violation|1|||
46674232|NCT01153633|82889836|FG000|Overall Study|Therapeutic failure|3|||
46674233|NCT01153633|82889837|FG001|Overall Study|Therapeutic failure|3|||
46674234|NCT01153516|82889847|FG000|Overall Study|Both subjects refused surgery|2|||
46674235|NCT01153516|82889848|FG001|Overall Study|Both subjects refused surgery|0|||
46674236|NCT01153321|82889856|FG000|Overall Study|Development of study withdrawal criteria|0|||
46793337|NCT00622700|83011900|FG005|Core Treatment Period|Lack of Efficacy|0|||
46793338|NCT00622700|83011901|FG006|Core Treatment Period|Lack of Efficacy|0|||
46793339|NCT00622700|83011895|FG000|Core Treatment Period|Lost to Follow-up|1|||
46793340|NCT00622700|83011896|FG001|Core Treatment Period|Lost to Follow-up|1|||
46793341|NCT00622700|83011897|FG002|Core Treatment Period|Lost to Follow-up|1|||
46793342|NCT00622700|83011898|FG003|Core Treatment Period|Lost to Follow-up|0|||
46793343|NCT00622700|83011899|FG004|Core Treatment Period|Lost to Follow-up|0|||
46793344|NCT00622700|83011900|FG005|Core Treatment Period|Lost to Follow-up|0|||
46855166|NCT03447314|83071056|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46977209|NCT02638259|83222033|FG000|Treatment Period 2|Adverse Event|5|||
46977210|NCT02638259|83222034|FG001|Treatment Period 2|Adverse Event|4|||
46977211|NCT02638259|83222033|FG000|Treatment Period 2|Withdrawal by Subject|1|||
47079116|NCT01389596|83385403|FG001|Overall Study|Protocol Violation|4|||
47079117|NCT01389596|83385404|FG002|Overall Study|Protocol Violation|3|||
46674237|NCT01153321|82889857|FG001|Overall Study|Development of study withdrawal criteria|1|||
46674238|NCT01153321|82889856|FG000|Overall Study|Withdrawal by Subject|0|||
46674239|NCT01153321|82889857|FG001|Overall Study|Withdrawal by Subject|1|||
46793345|NCT00622700|83011901|FG006|Core Treatment Period|Lost to Follow-up|0|||
46977212|NCT02638259|83222034|FG001|Treatment Period 2|Withdrawal by Subject|7|||
46977213|NCT02637323|83222046|FG000|Overall Study|Lost to Follow-up|2|||
47079118|NCT01389596|83385402|FG000|Overall Study|Withdrawal by Subject|1|||
47079119|NCT01389596|83385403|FG001|Overall Study|Withdrawal by Subject|2|||
46793346|NCT00622700|83011895|FG000|Core Treatment Period|Death|1|||
46793347|NCT00622700|83011896|FG001|Core Treatment Period|Death|0|||
46855167|NCT03447314|83071057|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46977214|NCT02637323|83222047|FG001|Overall Study|Lost to Follow-up|0|||
46977215|NCT02637323|83222046|FG000|Overall Study|Protocol Violation|0|||
46977216|NCT02637323|83222047|FG001|Overall Study|Protocol Violation|1|||
46977217|NCT05446142|83222071|FG000|Period 2|Adverse Event|1|||
46977218|NCT05446142|83222072|FG001|Period 2|Adverse Event|0|||
46977219|NCT05446142|83222073|FG002|Period 2|Adverse Event|0|||
46977220|NCT05446142|83222074|FG003|Period 2|Adverse Event|0|||
46977221|NCT05446142|83222075|FG004|Period 2|Adverse Event|0|||
47079120|NCT01389596|83385404|FG002|Overall Study|Withdrawal by Subject|2|||
46674240|NCT01153321|82889856|FG000|Overall Study|Adverse Event|1|||
46674241|NCT01153321|82889857|FG001|Overall Study|Adverse Event|1|||
46674242|NCT01153009|82889867|FG000|Overall Study|Adverse Event|4|||
46674243|NCT01153009|82889868|FG001|Overall Study|Adverse Event|14|||
46674244|NCT01153009|82889869|FG002|Overall Study|Adverse Event|14|||
46674245|NCT01153009|82889870|FG003|Overall Study|Adverse Event|10|||
46674246|NCT01153009|82889867|FG000|Overall Study|Lack of Efficacy|9|||
46855168|NCT03447314|83071058|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855169|NCT03447314|83071059|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
46855170|NCT03447314|83071042|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855171|NCT03447314|83071043|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855172|NCT03447314|83071044|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
46855173|NCT03447314|83071045|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855174|NCT03447314|83071046|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855175|NCT03447314|83071047|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855176|NCT03447314|83071048|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
47079121|NCT01389596|83385402|FG000|Overall Study|Insufficient Clinical Response|3|||
47079122|NCT01389596|83385403|FG001|Overall Study|Insufficient Clinical Response|4|||
47079123|NCT01389596|83385404|FG002|Overall Study|Insufficient Clinical Response|5|||
47079124|NCT01389596|83385402|FG000|Overall Study|Adverse Event|1|||
47079125|NCT01389596|83385403|FG001|Overall Study|Adverse Event|4|||
47079126|NCT01389596|83385404|FG002|Overall Study|Adverse Event|0|||
47079127|NCT01389596|83385402|FG000|Overall Study|Death|0|||
47079128|NCT01389596|83385403|FG001|Overall Study|Death|1|||
47079129|NCT01389596|83385404|FG002|Overall Study|Death|0|||
47079130|NCT01389596|83385402|FG000|Overall Study|Other Unspecified|2|||
47079131|NCT01389596|83385403|FG001|Overall Study|Other Unspecified|1|||
47079132|NCT01389596|83385404|FG002|Overall Study|Other Unspecified|0|||
47079133|NCT01405898|83385440|FG000|Overall Study|Withdrawal by Subject|2|||
47079134|NCT01405898|83385441|FG001|Overall Study|Withdrawal by Subject|2|||
47079135|NCT01389128|83385467|FG000|Overall Study|Fetal distress|1|||
47079136|NCT01389128|83385468|FG001|Overall Study|Fetal distress|0|||
47079137|NCT01389128|83385467|FG000|Overall Study|Cervix dilation stop|1|||
47079138|NCT01389128|83385468|FG001|Overall Study|Cervix dilation stop|2|||
47079139|NCT01389128|83385467|FG000|Overall Study|Rapid labor evolution|3|||
47079140|NCT01389128|83385468|FG001|Overall Study|Rapid labor evolution|2|||
47079141|NCT01389128|83385467|FG000|Overall Study|Intolerance to procedure|0|||
47079142|NCT01389128|83385468|FG001|Overall Study|Intolerance to procedure|2|||
47079143|NCT01388816|83385499|FG000|Overall Study|Adverse Event|0|||
47079144|NCT01388816|83385500|FG001|Overall Study|Adverse Event|2|||
47079145|NCT01388816|83385501|FG002|Overall Study|Adverse Event|0|||
47079146|NCT01388816|83385502|FG003|Overall Study|Adverse Event|0|||
47079147|NCT01388816|83385499|FG000|Overall Study|Lost to Follow-up|0|||
47079148|NCT01388816|83385500|FG001|Overall Study|Lost to Follow-up|1|||
47079149|NCT01388816|83385501|FG002|Overall Study|Lost to Follow-up|0|||
47079150|NCT01388816|83385502|FG003|Overall Study|Lost to Follow-up|0|||
47079151|NCT01388816|83385499|FG000|Overall Study|Withdrawal by Subject|2|||
47079152|NCT01388816|83385500|FG001|Overall Study|Withdrawal by Subject|1|||
47079153|NCT01388816|83385501|FG002|Overall Study|Withdrawal by Subject|1|||
47079154|NCT01388816|83385502|FG003|Overall Study|Withdrawal by Subject|0|||
47079155|NCT01388816|83385499|FG000|Overall Study|Protocol Violation|0|||
47079156|NCT01388816|83385500|FG001|Overall Study|Protocol Violation|0|||
47079157|NCT01388816|83385501|FG002|Overall Study|Protocol Violation|2|||
47079158|NCT01388816|83385502|FG003|Overall Study|Protocol Violation|0|||
47079159|NCT00555477|83385656|FG000|Overall Study|Adverse Event|0|||
47079160|NCT00555477|83385657|FG001|Overall Study|Adverse Event|9|||
47079161|NCT00555477|83385656|FG000|Overall Study|Withdrawal by Subject|1|||
47079162|NCT00555477|83385657|FG001|Overall Study|Withdrawal by Subject|2|||
47079163|NCT00555477|83385656|FG000|Overall Study|Physician Decision|1|||
47079164|NCT00555477|83385657|FG001|Overall Study|Physician Decision|2|||
47079165|NCT00554619|83385674|FG000|Overall Study|Adverse Event|1|||
47079166|NCT00554619|83385674|FG000|Overall Study|Physician Decision|1|||
47079167|NCT00554619|83385674|FG000|Overall Study|Liver Function Test Abnormality|1|||
47079168|NCT01426412|83385734|FG000|Overall Study|Withdrawal by Subject|1|||
47079169|NCT01426412|83385735|FG001|Overall Study|Withdrawal by Subject|0|||
47079170|NCT01426412|83385736|FG002|Overall Study|Withdrawal by Subject|0|||
47079171|NCT01426412|83385737|FG003|Overall Study|Withdrawal by Subject|0|||
47079172|NCT01426412|83385738|FG004|Overall Study|Withdrawal by Subject|1|||
46977222|NCT05446142|83222076|FG005|Period 2|Adverse Event|0|||
46977223|NCT04748445|83222088|FG000|Overall Study|No longer met eligibility criteria|12|||
47079173|NCT01426412|83385739|FG005|Overall Study|Withdrawal by Subject|0|||
47079174|NCT01426412|83385740|FG006|Overall Study|Withdrawal by Subject|0|||
46793348|NCT00622700|83011897|FG002|Core Treatment Period|Death|0|||
46793349|NCT00622700|83011898|FG003|Core Treatment Period|Death|0|||
46793350|NCT00622700|83011899|FG004|Core Treatment Period|Death|0|||
46793351|NCT00622700|83011900|FG005|Core Treatment Period|Death|0|||
46793352|NCT00622700|83011901|FG006|Core Treatment Period|Death|0|||
46793353|NCT00622700|83011895|FG000|Core Treatment Period|Progressive Disease|3|||
46793354|NCT00622700|83011896|FG001|Core Treatment Period|Progressive Disease|1|||
46793355|NCT00622700|83011897|FG002|Core Treatment Period|Progressive Disease|0|||
46793356|NCT00622700|83011898|FG003|Core Treatment Period|Progressive Disease|0|||
46855177|NCT03447314|83071049|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855178|NCT03447314|83071050|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855179|NCT03447314|83071051|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855180|NCT03447314|83071052|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855181|NCT03447314|83071053|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855182|NCT03447314|83071054|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855183|NCT03447314|83071055|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855184|NCT03447314|83071056|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855185|NCT03447314|83071057|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855186|NCT03447314|83071058|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855187|NCT03447314|83071059|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
46855188|NCT03447314|83071042|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855189|NCT03447314|83071043|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855190|NCT03447314|83071044|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855191|NCT03447314|83071045|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855192|NCT03447314|83071046|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855193|NCT03447314|83071047|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855194|NCT03447314|83071048|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855195|NCT03447314|83071049|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855196|NCT03447314|83071050|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855197|NCT03447314|83071051|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855198|NCT03447314|83071052|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
46855199|NCT03447314|83071053|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855200|NCT03447314|83071054|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855201|NCT03447314|83071055|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855202|NCT03447314|83071056|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855203|NCT03447314|83071057|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855204|NCT03447314|83071058|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855205|NCT03447314|83071059|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
46855206|NCT03447314|83071042|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855207|NCT03447314|83071043|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855208|NCT03447314|83071044|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855209|NCT03447314|83071045|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
46977224|NCT04748445|83222088|FG000|Overall Study|Other|36|||
46977225|NCT04748445|83222088|FG000|Overall Study|Withdrawal by Subject|553|||
46977226|NCT04748445|83222088|FG000|Overall Study|Lost to Follow-up|30|||
46977227|NCT04716881|83222092|FG000|Overall Study|Adverse Event|1|||
46977228|NCT04716881|83222092|FG000|Overall Study|Lost to Follow-up|1|||
46977229|NCT04666922|83222103|FG000|Overall Study|Withdrawal by Subject|1|||
46977230|NCT04666922|83222104|FG001|Overall Study|Withdrawal by Subject|0|||
46977231|NCT04666922|83222105|FG002|Overall Study|Withdrawal by Subject|0|||
46977232|NCT04666922|83222106|FG003|Overall Study|Withdrawal by Subject|0|||
46977233|NCT04666922|83222107|FG004|Overall Study|Withdrawal by Subject|0|||
46793357|NCT00622700|83011899|FG004|Core Treatment Period|Progressive Disease|0|||
46793358|NCT00622700|83011900|FG005|Core Treatment Period|Progressive Disease|0|||
46793359|NCT00622700|83011901|FG006|Core Treatment Period|Progressive Disease|0|||
46977234|NCT04666922|83222108|FG005|Overall Study|Withdrawal by Subject|0|||
46977235|NCT04666922|83222109|FG006|Overall Study|Withdrawal by Subject|0|||
46977236|NCT04435366|83222139|FG000|Overall Study|Adverse Event|3|||
46977237|NCT04435366|83222140|FG001|Overall Study|Adverse Event|2|||
46977238|NCT04435366|83222139|FG000|Overall Study|Death|2|||
46977239|NCT04435366|83222140|FG001|Overall Study|Death|1|||
46793360|NCT00622700|83011895|FG000|Core Treatment Period|Withdrawal by Subject|12|||
46793361|NCT00622700|83011896|FG001|Core Treatment Period|Withdrawal by Subject|18|||
46855210|NCT03447314|83071046|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855211|NCT03447314|83071047|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
46855212|NCT03447314|83071048|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855213|NCT03447314|83071049|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46977240|NCT04435366|83222139|FG000|Overall Study|Lost to Follow-up|2|||
46977241|NCT04435366|83222140|FG001|Overall Study|Lost to Follow-up|1|||
46977242|NCT04435366|83222139|FG000|Overall Study|Withdrawal by Subject|17|||
46977243|NCT04435366|83222140|FG001|Overall Study|Withdrawal by Subject|13|||
46977244|NCT04435366|83222139|FG000|Overall Study|Patient non-compliance|1|||
46977245|NCT04435366|83222140|FG001|Overall Study|Patient non-compliance|0|||
46977246|NCT03734679|83222191|FG000|Overall Study|Missed Visit|1|||
46977247|NCT03709706|83222201|FG000|Overall Study|Adverse Event|0|||
46977248|NCT03709706|83222202|FG001|Overall Study|Adverse Event|1|||
46977249|NCT03709706|83222201|FG000|Overall Study|Physician Decision|14|||
46977250|NCT03709706|83222202|FG001|Overall Study|Physician Decision|8|||
46977251|NCT03709706|83222201|FG000|Overall Study|Withdrawal by Subject|2|||
46977252|NCT03709706|83222202|FG001|Overall Study|Withdrawal by Subject|1|||
46977253|NCT03709706|83222201|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
46977254|NCT03709706|83222202|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
46977255|NCT03429543|83222233|FG000|Overall Study|Adverse Event|1|||
46977256|NCT03429543|83222234|FG001|Overall Study|Adverse Event|1|||
46977257|NCT03429543|83222235|FG002|Overall Study|Adverse Event|0|||
46977258|NCT03429543|83222236|FG003|Overall Study|Adverse Event|0|||
46977259|NCT03429543|83222237|FG004|Overall Study|Adverse Event|0|||
46977260|NCT03429543|83222238|FG005|Overall Study|Adverse Event|2|||
46977261|NCT03429543|83222239|FG006|Overall Study|Adverse Event|0|||
46977262|NCT03429543|83222233|FG000|Overall Study|Lost to Follow-up|1|||
46977263|NCT03429543|83222234|FG001|Overall Study|Lost to Follow-up|0|||
46977264|NCT03429543|83222235|FG002|Overall Study|Lost to Follow-up|0|||
46977265|NCT03429543|83222236|FG003|Overall Study|Lost to Follow-up|0|||
46977266|NCT03429543|83222237|FG004|Overall Study|Lost to Follow-up|1|||
46977267|NCT03429543|83222238|FG005|Overall Study|Lost to Follow-up|0|||
46977268|NCT03429543|83222239|FG006|Overall Study|Lost to Follow-up|0|||
46977269|NCT03429543|83222233|FG000|Overall Study|Withdrawal by Subject|5|||
46977270|NCT03429543|83222234|FG001|Overall Study|Withdrawal by Subject|0|||
46977271|NCT03429543|83222235|FG002|Overall Study|Withdrawal by Subject|1|||
46977272|NCT03429543|83222236|FG003|Overall Study|Withdrawal by Subject|2|||
46793362|NCT00622700|83011897|FG002|Core Treatment Period|Withdrawal by Subject|15|||
46793363|NCT00622700|83011898|FG003|Core Treatment Period|Withdrawal by Subject|0|||
46793364|NCT00622700|83011899|FG004|Core Treatment Period|Withdrawal by Subject|0|||
46793365|NCT00622700|83011900|FG005|Core Treatment Period|Withdrawal by Subject|0|||
46977273|NCT03429543|83222237|FG004|Overall Study|Withdrawal by Subject|6|||
47079175|NCT01426412|83385741|FG007|Overall Study|Withdrawal by Subject|3|||
47079176|NCT01426412|83385742|FG008|Overall Study|Withdrawal by Subject|1|||
47079177|NCT00554229|83385937|FG000|Overall Study|Lost to Follow-up|3|||
47079178|NCT00554229|83385938|FG001|Overall Study|Lost to Follow-up|6|||
47079179|NCT00554229|83385937|FG000|Overall Study|Withdrawal by Subject|29|||
46793366|NCT00622700|83011901|FG006|Core Treatment Period|Withdrawal by Subject|0|||
46793367|NCT00622700|83011895|FG000|Core Treatment Period|Other than specified above|2|||
46793368|NCT00622700|83011896|FG001|Core Treatment Period|Other than specified above|2|||
46793369|NCT00622700|83011897|FG002|Core Treatment Period|Other than specified above|5|||
46793370|NCT00622700|83011898|FG003|Core Treatment Period|Other than specified above|0|||
46855214|NCT03447314|83071050|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855215|NCT03447314|83071051|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855216|NCT03447314|83071052|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855217|NCT03447314|83071053|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46977274|NCT03429543|83222238|FG005|Overall Study|Withdrawal by Subject|3|||
46977275|NCT03429543|83222239|FG006|Overall Study|Withdrawal by Subject|1|||
46977276|NCT03429543|83222233|FG000|Overall Study|Other reason than listed|0|||
46977277|NCT03429543|83222234|FG001|Overall Study|Other reason than listed|1|||
46977278|NCT03429543|83222235|FG002|Overall Study|Other reason than listed|0|||
46977279|NCT03429543|83222236|FG003|Overall Study|Other reason than listed|0|||
46977280|NCT03429543|83222237|FG004|Overall Study|Other reason than listed|4|||
46977281|NCT03429543|83222238|FG005|Overall Study|Other reason than listed|4|||
46977282|NCT03429543|83222239|FG006|Overall Study|Other reason than listed|0|||
46977283|NCT03429543|83222233|FG000|Overall Study|Not treated|0|||
46977284|NCT03429543|83222234|FG001|Overall Study|Not treated|0|||
46977285|NCT03429543|83222235|FG002|Overall Study|Not treated|0|||
46977286|NCT03429543|83222236|FG003|Overall Study|Not treated|0|||
46977287|NCT03429543|83222237|FG004|Overall Study|Not treated|1|||
47079180|NCT00554229|83385938|FG001|Overall Study|Withdrawal by Subject|37|||
46793371|NCT00622700|83011899|FG004|Core Treatment Period|Other than specified above|0|||
46977288|NCT03429543|83222238|FG005|Overall Study|Not treated|0|||
46793372|NCT00622700|83011900|FG005|Core Treatment Period|Other than specified above|0|||
47079181|NCT00554229|83385937|FG000|Overall Study|Adverse Event|71|||
46855218|NCT03447314|83071054|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855219|NCT03447314|83071055|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855220|NCT03447314|83071056|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855221|NCT03447314|83071057|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855222|NCT03447314|83071058|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46977289|NCT03429543|83222239|FG006|Overall Study|Not treated|0|||
46977290|NCT03362190|83222269|FG000|Overall Study|Adverse Event|0|||
46793373|NCT00622700|83011901|FG006|Core Treatment Period|Other than specified above|0|||
46793374|NCT00622700|83011895|FG000|Extension Treatment Period|Adverse Event|0|||
46793375|NCT00622700|83011896|FG001|Extension Treatment Period|Adverse Event|0|||
46793376|NCT00622700|83011897|FG002|Extension Treatment Period|Adverse Event|0|||
46793377|NCT00622700|83011898|FG003|Extension Treatment Period|Adverse Event|5|||
46793378|NCT00622700|83011899|FG004|Extension Treatment Period|Adverse Event|9|||
46793379|NCT00622700|83011900|FG005|Extension Treatment Period|Adverse Event|6|||
46793380|NCT00622700|83011901|FG006|Extension Treatment Period|Adverse Event|8|||
46793381|NCT00622700|83011895|FG000|Extension Treatment Period|Lack of Efficacy|0|||
46793382|NCT00622700|83011896|FG001|Extension Treatment Period|Lack of Efficacy|0|||
46793383|NCT00622700|83011897|FG002|Extension Treatment Period|Lack of Efficacy|0|||
46793384|NCT00622700|83011898|FG003|Extension Treatment Period|Lack of Efficacy|2|||
46793385|NCT00622700|83011899|FG004|Extension Treatment Period|Lack of Efficacy|8|||
46793386|NCT00622700|83011900|FG005|Extension Treatment Period|Lack of Efficacy|1|||
46793387|NCT00622700|83011901|FG006|Extension Treatment Period|Lack of Efficacy|9|||
46793388|NCT00622700|83011895|FG000|Extension Treatment Period|Protocol Violation|0|||
46793389|NCT00622700|83011896|FG001|Extension Treatment Period|Protocol Violation|0|||
46793390|NCT00622700|83011897|FG002|Extension Treatment Period|Protocol Violation|0|||
46977291|NCT03362190|83222270|FG001|Overall Study|Adverse Event|0|||
46977292|NCT03362190|83222271|FG002|Overall Study|Adverse Event|0|||
46977293|NCT03362190|83222272|FG003|Overall Study|Adverse Event|1|||
46977294|NCT03362190|83222269|FG000|Overall Study|Withdrawal by Subject|0|||
46977295|NCT03362190|83222270|FG001|Overall Study|Withdrawal by Subject|0|||
46977296|NCT03362190|83222271|FG002|Overall Study|Withdrawal by Subject|0|||
46793391|NCT00622700|83011898|FG003|Extension Treatment Period|Protocol Violation|0|||
46793392|NCT00622700|83011899|FG004|Extension Treatment Period|Protocol Violation|0|||
46793393|NCT00622700|83011900|FG005|Extension Treatment Period|Protocol Violation|2|||
46793394|NCT00622700|83011901|FG006|Extension Treatment Period|Protocol Violation|0|||
46855223|NCT03447314|83071059|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
46855224|NCT03423121|83071102|FG000|Overall Study|Lost to Follow-up|2|||
46855225|NCT03423121|83071103|FG001|Overall Study|Lost to Follow-up|6|||
46977297|NCT03362190|83222272|FG003|Overall Study|Withdrawal by Subject|1|||
46855226|NCT03423121|83071102|FG000|Overall Study|Adverse Event|1|||
46855227|NCT03423121|83071103|FG001|Overall Study|Adverse Event|0|||
46855228|NCT03335475|83071111|FG000|Overall Study|Did not wear accelerometer|4|||
46855229|NCT03335475|83071112|FG001|Overall Study|Did not wear accelerometer|0|||
46855230|NCT03335475|83071111|FG000|Overall Study|Withdrawal by Subject|0|||
46855231|NCT03335475|83071112|FG001|Overall Study|Withdrawal by Subject|1|||
46855232|NCT03252756|83071120|FG000|Overall Study|Protocol Violation|2|||
46855233|NCT03252756|83071121|FG001|Overall Study|Protocol Violation|4|||
46855234|NCT03252756|83071120|FG000|Overall Study|COVID-19 Pandemic|1|||
46855235|NCT03252756|83071121|FG001|Overall Study|COVID-19 Pandemic|1|||
46855236|NCT03252756|83071120|FG000|Overall Study|Study Drug Expiration|0|||
46855237|NCT03252756|83071121|FG001|Overall Study|Study Drug Expiration|1|||
46855238|NCT03164356|83071133|FG000|Overall Study|Lost to Follow-up|1|||
46855239|NCT03164356|83071134|FG001|Overall Study|Lost to Follow-up|1|||
46855240|NCT03164356|83071135|FG002|Overall Study|Lost to Follow-up|2|||
46855241|NCT03164356|83071136|FG003|Overall Study|Lost to Follow-up|1|||
46855242|NCT03164356|83071133|FG000|Overall Study|Physician Decision|0|||
46855243|NCT03164356|83071134|FG001|Overall Study|Physician Decision|0|||
46855244|NCT03164356|83071135|FG002|Overall Study|Physician Decision|3|||
46855245|NCT03164356|83071136|FG003|Overall Study|Physician Decision|0|||
46977298|NCT03246061|83222287|FG000|Overall Study|Still in follow-up|15|||
46977299|NCT03246061|83222288|FG001|Overall Study|Still in follow-up|21|||
46977300|NCT02788006|83222326|FG000|Overall Study|Patient not treated|1|||
46977301|NCT02686658|83222337|FG000|Overall Study|Adverse Event|0|||
46977302|NCT02686658|83222338|FG001|Overall Study|Adverse Event|0|||
46977303|NCT02686658|83222339|FG002|Overall Study|Adverse Event|1|||
46977304|NCT02686658|83222340|FG003|Overall Study|Adverse Event|1|||
46977305|NCT02686658|83222341|FG004|Overall Study|Adverse Event|2|||
46977306|NCT02686658|83222342|FG005|Overall Study|Adverse Event|1|||
47079182|NCT00554229|83385938|FG001|Overall Study|Adverse Event|39|||
47079183|NCT00554229|83385937|FG000|Overall Study|Protocol Violation|3|||
46793395|NCT00622700|83011895|FG000|Extension Treatment Period|Lost to Follow-up|0|||
46793396|NCT00622700|83011896|FG001|Extension Treatment Period|Lost to Follow-up|0|||
46855246|NCT03164356|83071133|FG000|Overall Study|Protocol Violation|2|||
46855247|NCT03164356|83071134|FG001|Overall Study|Protocol Violation|1|||
46855248|NCT03164356|83071135|FG002|Overall Study|Protocol Violation|0|||
46855249|NCT03164356|83071136|FG003|Overall Study|Protocol Violation|0|||
46855250|NCT03164356|83071133|FG000|Overall Study|Withdrawal by Subject|1|||
46793397|NCT00622700|83011897|FG002|Extension Treatment Period|Lost to Follow-up|0|||
46793398|NCT00622700|83011898|FG003|Extension Treatment Period|Lost to Follow-up|0|||
46793399|NCT00622700|83011899|FG004|Extension Treatment Period|Lost to Follow-up|1|||
46793400|NCT00622700|83011900|FG005|Extension Treatment Period|Lost to Follow-up|0|||
46793401|NCT00622700|83011901|FG006|Extension Treatment Period|Lost to Follow-up|0|||
46793402|NCT00622700|83011895|FG000|Extension Treatment Period|Progressive Disease|0|||
46793403|NCT00622700|83011896|FG001|Extension Treatment Period|Progressive Disease|0|||
46855251|NCT03164356|83071134|FG001|Overall Study|Withdrawal by Subject|0|||
46855252|NCT03164356|83071135|FG002|Overall Study|Withdrawal by Subject|0|||
46855253|NCT03164356|83071136|FG003|Overall Study|Withdrawal by Subject|0|||
46855254|NCT03164356|83071133|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
46855255|NCT03164356|83071134|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
46855256|NCT03164356|83071135|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
46977307|NCT02686658|83222337|FG000|Overall Study|Investigator decision|0|||
47079184|NCT00554229|83385938|FG001|Overall Study|Protocol Violation|3|||
47079185|NCT00554229|83385937|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
47079186|NCT00554229|83385938|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
47079187|NCT00554229|83385937|FG000|Overall Study|Randomised but no treatment received|1|||
47079188|NCT00554229|83385938|FG001|Overall Study|Randomised but no treatment received|0|||
47079189|NCT01405820|83386048|FG000|Randomized Treatment Period|Adverse Event|3|||
47079190|NCT01405820|83386049|FG001|Randomized Treatment Period|Adverse Event|3|||
47079191|NCT01405820|83386050|FG002|Randomized Treatment Period|Adverse Event|3|||
46977308|NCT02686658|83222338|FG001|Overall Study|Investigator decision|0|||
47079192|NCT01405820|83386051|FG003|Randomized Treatment Period|Adverse Event|0|||
46855257|NCT03164356|83071136|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
46855258|NCT03164356|83071133|FG000|Overall Study|Subject Incarcerated|0|||
47079193|NCT01405820|83386052|FG004|Randomized Treatment Period|Adverse Event|2|||
46855259|NCT03164356|83071134|FG001|Overall Study|Subject Incarcerated|1|||
47079194|NCT01405820|83386053|FG005|Randomized Treatment Period|Adverse Event|1|||
46855260|NCT03164356|83071135|FG002|Overall Study|Subject Incarcerated|0|||
46855261|NCT03164356|83071136|FG003|Overall Study|Subject Incarcerated|0|||
46855262|NCT03164356|83071133|FG000|Overall Study|Prosthetist unable to participate|0|||
46855263|NCT03164356|83071134|FG001|Overall Study|Prosthetist unable to participate|2|||
46855264|NCT03164356|83071135|FG002|Overall Study|Prosthetist unable to participate|1|||
46855265|NCT03164356|83071136|FG003|Overall Study|Prosthetist unable to participate|0|||
46855266|NCT01925131|83071171|FG000|Overall Study|Death|0|||
46855267|NCT01925131|83071172|FG001|Overall Study|Death|0|||
46855268|NCT01925131|83071173|FG002|Overall Study|Death|1|||
46855269|NCT01925131|83071174|FG003|Overall Study|Death|0|||
46855270|NCT01925131|83071175|FG004|Overall Study|Death|0|||
46855271|NCT01925131|83071176|FG005|Overall Study|Death|0|||
46855272|NCT01925131|83071171|FG000|Overall Study|Progression/Relapse|1|||
46855273|NCT01925131|83071172|FG001|Overall Study|Progression/Relapse|1|||
46855274|NCT01925131|83071173|FG002|Overall Study|Progression/Relapse|4|||
46855275|NCT01925131|83071174|FG003|Overall Study|Progression/Relapse|0|||
46855276|NCT01925131|83071175|FG004|Overall Study|Progression/Relapse|0|||
46855277|NCT01925131|83071176|FG005|Overall Study|Progression/Relapse|1|||
46855278|NCT01925131|83071171|FG000|Overall Study|Patient Refusal|1|||
46855279|NCT01925131|83071172|FG001|Overall Study|Patient Refusal|0|||
46855280|NCT01925131|83071173|FG002|Overall Study|Patient Refusal|0|||
46855281|NCT01925131|83071174|FG003|Overall Study|Patient Refusal|0|||
46855282|NCT01925131|83071175|FG004|Overall Study|Patient Refusal|0|||
46855283|NCT01925131|83071176|FG005|Overall Study|Patient Refusal|0|||
46855284|NCT01925131|83071171|FG000|Overall Study|Adverse Event|0|||
46977309|NCT02686658|83222339|FG002|Overall Study|Investigator decision|0|||
46977310|NCT02686658|83222340|FG003|Overall Study|Investigator decision|1|||
46977311|NCT02686658|83222341|FG004|Overall Study|Investigator decision|2|||
46977312|NCT02686658|83222342|FG005|Overall Study|Investigator decision|1|||
46977313|NCT02686658|83222337|FG000|Overall Study|Sponsor decision|1|||
46977314|NCT02686658|83222338|FG001|Overall Study|Sponsor decision|2|||
46977315|NCT02686658|83222339|FG002|Overall Study|Sponsor decision|1|||
46977316|NCT02686658|83222340|FG003|Overall Study|Sponsor decision|5|||
46977317|NCT02686658|83222341|FG004|Overall Study|Sponsor decision|13|||
46977318|NCT02686658|83222342|FG005|Overall Study|Sponsor decision|2|||
46977319|NCT02686658|83222337|FG000|Overall Study|Lost to Follow-up|0|||
46977320|NCT02686658|83222338|FG001|Overall Study|Lost to Follow-up|0|||
46977321|NCT02686658|83222339|FG002|Overall Study|Lost to Follow-up|2|||
46977322|NCT02686658|83222340|FG003|Overall Study|Lost to Follow-up|0|||
46977323|NCT02686658|83222341|FG004|Overall Study|Lost to Follow-up|0|||
46977324|NCT02686658|83222342|FG005|Overall Study|Lost to Follow-up|1|||
46977325|NCT02686658|83222337|FG000|Overall Study|Death|1|||
46977326|NCT02686658|83222338|FG001|Overall Study|Death|0|||
46977327|NCT02686658|83222339|FG002|Overall Study|Death|0|||
46793404|NCT00622700|83011897|FG002|Extension Treatment Period|Progressive Disease|0|||
46793405|NCT00622700|83011898|FG003|Extension Treatment Period|Progressive Disease|1|||
46793406|NCT00622700|83011899|FG004|Extension Treatment Period|Progressive Disease|2|||
46793407|NCT00622700|83011900|FG005|Extension Treatment Period|Progressive Disease|0|||
46793408|NCT00622700|83011901|FG006|Extension Treatment Period|Progressive Disease|2|||
46793409|NCT00622700|83011895|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
46793410|NCT00622700|83011896|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
46793411|NCT00622700|83011897|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
46793412|NCT00622700|83011898|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
46793413|NCT00622700|83011899|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
46793414|NCT00622700|83011900|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
46793415|NCT00622700|83011901|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
46793416|NCT00622700|83011895|FG000|Extension Treatment Period|Missing|0|||
46855285|NCT01925131|83071172|FG001|Overall Study|Adverse Event|0|||
46855286|NCT01925131|83071173|FG002|Overall Study|Adverse Event|2|||
46855287|NCT01925131|83071174|FG003|Overall Study|Adverse Event|0|||
46977328|NCT02686658|83222340|FG003|Overall Study|Death|1|||
46977329|NCT02686658|83222341|FG004|Overall Study|Death|1|||
46977330|NCT02686658|83222342|FG005|Overall Study|Death|1|||
46855288|NCT01925131|83071175|FG004|Overall Study|Adverse Event|1|||
46855289|NCT01925131|83071176|FG005|Overall Study|Adverse Event|3|||
46977331|NCT02686658|83222337|FG000|Overall Study|Withdrawal by Subject|2|||
46977332|NCT02686658|83222338|FG001|Overall Study|Withdrawal by Subject|5|||
46977333|NCT02686658|83222339|FG002|Overall Study|Withdrawal by Subject|4|||
46793417|NCT00622700|83011896|FG001|Extension Treatment Period|Missing|0|||
46793418|NCT00622700|83011897|FG002|Extension Treatment Period|Missing|0|||
46793419|NCT00622700|83011898|FG003|Extension Treatment Period|Missing|2|||
46855290|NCT01925131|83071171|FG000|Overall Study|Other - Not Protocol Specified|3|||
46855291|NCT01925131|83071172|FG001|Overall Study|Other - Not Protocol Specified|1|||
46855292|NCT01925131|83071173|FG002|Overall Study|Other - Not Protocol Specified|2|||
46855293|NCT01925131|83071174|FG003|Overall Study|Other - Not Protocol Specified|5|||
46855294|NCT01925131|83071175|FG004|Overall Study|Other - Not Protocol Specified|10|||
46977334|NCT02686658|83222340|FG003|Overall Study|Withdrawal by Subject|4|||
46977335|NCT02686658|83222341|FG004|Overall Study|Withdrawal by Subject|17|||
46977336|NCT02686658|83222342|FG005|Overall Study|Withdrawal by Subject|8|||
46977337|NCT02686658|83222337|FG000|Overall Study|Placed in hospice care|0|||
46977338|NCT02686658|83222338|FG001|Overall Study|Placed in hospice care|0|||
46977339|NCT02686658|83222339|FG002|Overall Study|Placed in hospice care|1|||
46977340|NCT02686658|83222340|FG003|Overall Study|Placed in hospice care|0|||
46977341|NCT02686658|83222341|FG004|Overall Study|Placed in hospice care|0|||
46977342|NCT02686658|83222342|FG005|Overall Study|Placed in hospice care|0|||
46977343|NCT02686658|83222337|FG000|Overall Study|Participant non-compliance|0|||
46977344|NCT02686658|83222338|FG001|Overall Study|Participant non-compliance|0|||
46977345|NCT02686658|83222339|FG002|Overall Study|Participant non-compliance|0|||
46977346|NCT02686658|83222340|FG003|Overall Study|Participant non-compliance|0|||
46977347|NCT02686658|83222341|FG004|Overall Study|Participant non-compliance|0|||
46977348|NCT02686658|83222342|FG005|Overall Study|Participant non-compliance|1|||
46977349|NCT02686658|83222337|FG000|Overall Study|Concern over coronavirus disease care|0|||
46793420|NCT00622700|83011899|FG004|Extension Treatment Period|Missing|3|||
46793421|NCT00622700|83011900|FG005|Extension Treatment Period|Missing|1|||
46793422|NCT00622700|83011901|FG006|Extension Treatment Period|Missing|0|||
46793423|NCT00622700|83011895|FG000|Extension Treatment Period|Other than specified above|0|||
46793424|NCT00622700|83011896|FG001|Extension Treatment Period|Other than specified above|0|||
46793425|NCT00622700|83011897|FG002|Extension Treatment Period|Other than specified above|0|||
46793426|NCT00622700|83011898|FG003|Extension Treatment Period|Other than specified above|0|||
46793427|NCT00622700|83011899|FG004|Extension Treatment Period|Other than specified above|0|||
46793428|NCT00622700|83011900|FG005|Extension Treatment Period|Other than specified above|1|||
46793429|NCT00622700|83011901|FG006|Extension Treatment Period|Other than specified above|1|||
46793430|NCT00538473|83011920|FG000|Overall Study|Adverse Event|1|||
46793431|NCT00538473|83011921|FG001|Overall Study|Adverse Event|0|||
46793432|NCT00622466|83011927|FG000|Overall Study|Death|1|||
46793433|NCT00622466|83011927|FG000|Overall Study|Adverse Event|1|||
46793434|NCT00622466|83011927|FG000|Overall Study|Withdrawal by Subject|2|||
46793435|NCT00537771|83011933|FG000|Overall Study|Withdrawal by Subject|6|||
46793436|NCT00537771|83011934|FG001|Overall Study|Withdrawal by Subject|23|||
46793437|NCT00537771|83011933|FG000|Overall Study|Adverse Event|8|||
46793438|NCT00537771|83011934|FG001|Overall Study|Adverse Event|15|||
46793439|NCT00537771|83011933|FG000|Overall Study|Lost to Follow-up|9|||
46793440|NCT00537771|83011934|FG001|Overall Study|Lost to Follow-up|15|||
46793441|NCT00537771|83011933|FG000|Overall Study|Protocol Violation|2|||
46793442|NCT00537771|83011934|FG001|Overall Study|Protocol Violation|6|||
46793443|NCT00537771|83011933|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
46793444|NCT00537771|83011934|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
46793445|NCT00623480|83011942|FG000|Overall Study|Lost to Follow-up|0|||
46793446|NCT00623480|83011943|FG001|Overall Study|Lost to Follow-up|1|||
46793447|NCT00623480|83011942|FG000|Overall Study|Withdrawal by Subject|2|||
46793448|NCT00623480|83011943|FG001|Overall Study|Withdrawal by Subject|4|||
46793449|NCT00623480|83011942|FG000|Overall Study|Lack of Efficacy|1|||
46793450|NCT00623480|83011943|FG001|Overall Study|Lack of Efficacy|0|||
46793451|NCT00623480|83011942|FG000|Overall Study|Non-compliant with study medication|4|||
46793452|NCT00623480|83011943|FG001|Overall Study|Non-compliant with study medication|0|||
46793453|NCT00623480|83011942|FG000|Overall Study|Protocol Violation|0|||
46793454|NCT00623480|83011943|FG001|Overall Study|Protocol Violation|1|||
46793455|NCT00623480|83011942|FG000|Overall Study|Site closed by sponsor|0|||
46793456|NCT00623480|83011943|FG001|Overall Study|Site closed by sponsor|1|||
46793457|NCT02513667|83011951|FG000|Overall Study|Withdrawal by Subject|0|||
46793458|NCT02513667|83011952|FG001|Overall Study|Withdrawal by Subject|1|||
46793459|NCT03823911|83011961|FG000|Overall Study|Lost to Follow-up|1|||
46793460|NCT03823911|83011962|FG001|Overall Study|Lost to Follow-up|5|||
46793461|NCT03823911|83011963|FG002|Overall Study|Lost to Follow-up|2|||
46793462|NCT03823911|83011961|FG000|Overall Study|Did not meet eligibility criteria|13|||
46793463|NCT03823911|83011962|FG001|Overall Study|Did not meet eligibility criteria|7|||
46793464|NCT03823911|83011963|FG002|Overall Study|Did not meet eligibility criteria|4|||
46793465|NCT03823911|83011961|FG000|Overall Study|Death|0|||
46793466|NCT03823911|83011962|FG001|Overall Study|Death|1|||
46793467|NCT03823911|83011963|FG002|Overall Study|Death|0|||
46855295|NCT01925131|83071176|FG005|Overall Study|Other - Not Protocol Specified|6|||
46855296|NCT01698918|83071192|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
46855297|NCT01698918|83071192|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
46855298|NCT01698918|83071192|FG000|First Line Treatment (Core+Extension)|Death|2|||
46855299|NCT01698918|83071192|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
46793468|NCT00621764|83011974|FG000|Overall Study|Protocol Violation|0|||
46793469|NCT00621764|83011975|FG001|Overall Study|Protocol Violation|0|||
46855300|NCT01698918|83071192|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
46977350|NCT02686658|83222338|FG001|Overall Study|Concern over coronavirus disease care|0|||
46793470|NCT00621764|83011976|FG002|Overall Study|Protocol Violation|0|||
46793471|NCT00621764|83011977|FG003|Overall Study|Protocol Violation|1|||
46793472|NCT00510718|83011995|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
46977351|NCT02686658|83222339|FG002|Overall Study|Concern over coronavirus disease care|0|||
46977352|NCT02686658|83222340|FG003|Overall Study|Concern over coronavirus disease care|0|||
46977353|NCT02686658|83222341|FG004|Overall Study|Concern over coronavirus disease care|2|||
46977354|NCT02686658|83222342|FG005|Overall Study|Concern over coronavirus disease care|1|||
46977355|NCT02387957|83222385|FG000|Overall Study|The study was discontinued|21|||
46977356|NCT02387957|83222386|FG001|Overall Study|The study was discontinued|21|||
46977357|NCT02387957|83222387|FG002|Overall Study|The study was discontinued|20|||
46977358|NCT02163694|83222408|FG000|Overall Study|Adverse event- related to progression|3|||
46977359|NCT02163694|83222409|FG001|Overall Study|Adverse event- related to progression|8|||
46977360|NCT02163694|83222408|FG000|Overall Study|Adverse event- not related to progression|7|||
46977361|NCT02163694|83222409|FG001|Overall Study|Adverse event- not related to progression|17|||
46977362|NCT02163694|83222408|FG000|Overall Study|Withdrew consent|8|||
46977363|NCT02163694|83222409|FG001|Overall Study|Withdrew consent|21|||
46977364|NCT02163694|83222408|FG000|Overall Study|Lost to Follow-up|1|||
46977365|NCT02163694|83222409|FG001|Overall Study|Lost to Follow-up|2|||
46977366|NCT02163694|83222408|FG000|Overall Study|Progressive disease per protocol|122|||
46977367|NCT02163694|83222409|FG001|Overall Study|Progressive disease per protocol|197|||
46977368|NCT02163694|83222408|FG000|Overall Study|Other, not specified|13|||
46977369|NCT02163694|83222409|FG001|Overall Study|Other, not specified|22|||
46977370|NCT01944839|83222428|FG000|Overall Study|Physician Decision|2|||
46977371|NCT01944839|83222429|FG001|Overall Study|Physician Decision|2|||
46977372|NCT01944839|83222428|FG000|Overall Study|Protocol Violation|0|||
46977373|NCT01944839|83222429|FG001|Overall Study|Protocol Violation|1|||
46977374|NCT01944839|83222428|FG000|Overall Study|Adverse Event|10|||
46977375|NCT01944839|83222429|FG001|Overall Study|Adverse Event|5|||
46977376|NCT01944839|83222428|FG000|Overall Study|Withdrawal by Subject|9|||
46977377|NCT01944839|83222429|FG001|Overall Study|Withdrawal by Subject|17|||
46977378|NCT01944839|83222428|FG000|Overall Study|Lost to Follow-up|1|||
46977379|NCT01944839|83222429|FG001|Overall Study|Lost to Follow-up|0|||
46977380|NCT01944839|83222428|FG000|Overall Study|Subject non-compliance|0|||
46977381|NCT01944839|83222429|FG001|Overall Study|Subject non-compliance|3|||
46977382|NCT01940900|83222437|FG000|Overall Study|Physician Decision|4|||
46977383|NCT01940900|83222438|FG001|Overall Study|Physician Decision|0|||
46977384|NCT01940900|83222437|FG000|Overall Study|Adverse Event|10|||
46977385|NCT01940900|83222438|FG001|Overall Study|Adverse Event|15|||
46977386|NCT01940900|83222437|FG000|Overall Study|Withdrawal by Subject|11|||
46977387|NCT01940900|83222438|FG001|Overall Study|Withdrawal by Subject|15|||
46977388|NCT01940900|83222437|FG000|Overall Study|Lost to Follow-up|1|||
46977389|NCT01940900|83222438|FG001|Overall Study|Lost to Follow-up|0|||
46977390|NCT01940900|83222437|FG000|Overall Study|Sponsor Decision|1|||
46977391|NCT01940900|83222438|FG001|Overall Study|Sponsor Decision|0|||
46977392|NCT01940900|83222437|FG000|Overall Study|subject non-compliance|1|||
46977393|NCT01940900|83222438|FG001|Overall Study|subject non-compliance|1|||
46977394|NCT01940900|83222437|FG000|Overall Study|other|1|||
46977395|NCT01940900|83222438|FG001|Overall Study|other|0|||
46977396|NCT01940887|83222446|FG000|Year 1|Protocol Violation|0|||
46977397|NCT01940887|83222447|FG001|Year 1|Protocol Violation|1|||
46977398|NCT01940887|83222446|FG000|Year 1|Physician Decision|7|||
46977399|NCT01940887|83222447|FG001|Year 1|Physician Decision|3|||
46977400|NCT01940887|83222446|FG000|Year 1|Death|5|||
46977401|NCT01940887|83222447|FG001|Year 1|Death|3|||
46977402|NCT01940887|83222446|FG000|Year 1|Adverse Event|7|||
46977403|NCT01940887|83222447|FG001|Year 1|Adverse Event|6|||
46977404|NCT01940887|83222446|FG000|Year 1|Withdrawal by Subject|18|||
46977405|NCT01940887|83222447|FG001|Year 1|Withdrawal by Subject|9|||
46977406|NCT01940887|83222446|FG000|Year 1|Lost to Follow-up|2|||
46977407|NCT01940887|83222447|FG001|Year 1|Lost to Follow-up|1|||
46977408|NCT01940887|83222446|FG000|Year 2|Physician Decision|8|||
46977409|NCT01940887|83222447|FG001|Year 2|Physician Decision|1|||
46977410|NCT01940887|83222446|FG000|Year 2|Death|0|||
46977411|NCT01940887|83222447|FG001|Year 2|Death|2|||
46977412|NCT01940887|83222446|FG000|Year 2|Sponsor Decision, early termination|192|||
46977413|NCT01940887|83222447|FG001|Year 2|Sponsor Decision, early termination|203|||
46977414|NCT01940887|83222446|FG000|Year 2|Adverse Event|8|||
46977415|NCT01940887|83222447|FG001|Year 2|Adverse Event|2|||
46977416|NCT01940887|83222446|FG000|Year 2|Withdrawal by Subject|8|||
46977417|NCT01940887|83222447|FG001|Year 2|Withdrawal by Subject|8|||
46977418|NCT01940887|83222446|FG000|Year 2|Lost to Follow-up|1|||
46977419|NCT01940887|83222447|FG001|Year 2|Lost to Follow-up|6|||
46977420|NCT01326104|83222455|FG000|Overall Study|progressed prior to vaccine|0|||
46977421|NCT01326104|83222456|FG001|Overall Study|progressed prior to vaccine|2|||
46977422|NCT01326104|83222455|FG000|Overall Study|unable to make vaccine|0|||
46977423|NCT01326104|83222456|FG001|Overall Study|unable to make vaccine|2|||
46977424|NCT00712881|83222464|FG000|Overall Study|Adverse Event|3|||
46977425|NCT00712881|83222465|FG001|Overall Study|Adverse Event|3|||
46674247|NCT01153009|82889868|FG001|Overall Study|Lack of Efficacy|0|||
46977426|NCT00712881|83222464|FG000|Overall Study|Withdrawal by Subject|1|||
46977427|NCT00712881|83222465|FG001|Overall Study|Withdrawal by Subject|1|||
46977428|NCT00712881|83222464|FG000|Overall Study|Disease Progression|2|||
46977429|NCT00712881|83222465|FG001|Overall Study|Disease Progression|1|||
46855301|NCT01698918|83071192|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
46977430|NCT00712881|83222464|FG000|Overall Study|Lost to Follow-up|1|||
46977431|NCT00712881|83222465|FG001|Overall Study|Lost to Follow-up|1|||
46977432|NCT00712881|83222464|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
46977433|NCT00712881|83222465|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
46977434|NCT00712881|83222464|FG000|Overall Study|Protocol Violation|1|||
46977435|NCT00712881|83222465|FG001|Overall Study|Protocol Violation|1|||
46977436|NCT00712881|83222464|FG000|Overall Study|Randomized but not treated|1|||
46793473|NCT00510718|83011996|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
46793474|NCT00510718|83011995|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
46793475|NCT00510718|83011996|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
46793476|NCT00510718|83011995|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
46793477|NCT00510718|83011996|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
46793478|NCT00510718|83011995|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
46793479|NCT00510718|83011996|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
46793480|NCT00510718|83011995|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
46793481|NCT00510718|83011996|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
46793482|NCT00510718|83011995|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
46793483|NCT00510718|83011996|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
46855302|NCT01698918|83071192|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
46855303|NCT01698918|83071192|FG000|Second Line Treatment (Core+Extension)|Death|1|||
46855304|NCT01698918|83071192|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
46855305|NCT01698918|83071192|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
46855306|NCT01208974|83071205|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
46855307|NCT01208974|83071206|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
46855308|NCT01208974|83071207|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
46855309|NCT01208974|83071208|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
46855310|NCT01208974|83071205|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
46855311|NCT01208974|83071206|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
46855312|NCT01208974|83071207|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
46855313|NCT01208974|83071208|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
46855314|NCT01208974|83071205|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
46855315|NCT01208974|83071206|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
46855316|NCT01208974|83071207|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
46855317|NCT01208974|83071208|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
46855318|NCT00840177|83071218|FG000|Overall Study|Adverse Event|5|||
46855319|NCT00840177|83071219|FG001|Overall Study|Adverse Event|1|||
46855320|NCT00840177|83071220|FG002|Overall Study|Adverse Event|1|||
46855321|NCT00840177|83071218|FG000|Overall Study|Refusal unrelated to adverse events|1|||
46855322|NCT00840177|83071219|FG001|Overall Study|Refusal unrelated to adverse events|0|||
46855323|NCT00840177|83071220|FG002|Overall Study|Refusal unrelated to adverse events|1|||
46855324|NCT00840177|83071218|FG000|Overall Study|Progression/relapse|2|||
46855325|NCT00840177|83071219|FG001|Overall Study|Progression/relapse|0|||
46855326|NCT00840177|83071220|FG002|Overall Study|Progression/relapse|0|||
46855327|NCT00840177|83071218|FG000|Overall Study|Death|4|||
46855328|NCT00840177|83071219|FG001|Overall Study|Death|5|||
46855329|NCT00840177|83071220|FG002|Overall Study|Death|5|||
46855330|NCT00840177|83071218|FG000|Overall Study|not protocol specified|6|||
46855331|NCT00840177|83071219|FG001|Overall Study|not protocol specified|3|||
46855332|NCT00840177|83071220|FG002|Overall Study|not protocol specified|0|||
46855333|NCT00840177|83071218|FG000|Overall Study|Ineligible|0|||
46855334|NCT00840177|83071219|FG001|Overall Study|Ineligible|0|||
46977437|NCT00712881|83222465|FG001|Overall Study|Randomized but not treated|0|||
46855335|NCT00840177|83071220|FG002|Overall Study|Ineligible|3|||
46855336|NCT00840177|83071218|FG000|Overall Study|Did not start treatment|0|||
46855337|NCT00840177|83071219|FG001|Overall Study|Did not start treatment|0|||
46977438|NCT03573817|83222473|FG000|Overall Study|Adverse Event|0|||
46855338|NCT00840177|83071220|FG002|Overall Study|Did not start treatment|1|||
46855339|NCT01347580|83071230|FG000|Overall Study|Withdrawal by Subject|13|||
46855340|NCT01347580|83071231|FG001|Overall Study|Withdrawal by Subject|23|||
46855341|NCT01347580|83071230|FG000|Overall Study|Death|30|||
46855342|NCT01347580|83071231|FG001|Overall Study|Death|19|||
46977439|NCT03573817|83222474|FG001|Overall Study|Adverse Event|2|||
46977440|NCT03573817|83222473|FG000|Overall Study|Protocol Violation|0|||
46977441|NCT03573817|83222474|FG001|Overall Study|Protocol Violation|1|||
46977442|NCT03573817|83222473|FG000|Overall Study|Withdrawal by Subject|1|||
46977443|NCT03573817|83222474|FG001|Overall Study|Withdrawal by Subject|1|||
46855343|NCT01347580|83071230|FG000|Overall Study|Protocol Violation|10|||
46855344|NCT01347580|83071231|FG001|Overall Study|Protocol Violation|7|||
46855345|NCT01347580|83071230|FG000|Overall Study|Lost to Follow-up|3|||
46977444|NCT02638103|83222489|FG000|Overall Study|Adverse Event|13|||
46977445|NCT02638103|83222490|FG001|Overall Study|Adverse Event|12|||
46977446|NCT02638103|83222491|FG002|Overall Study|Adverse Event|19|||
46977447|NCT02638103|83222492|FG003|Overall Study|Adverse Event|12|||
46855346|NCT01347580|83071231|FG001|Overall Study|Lost to Follow-up|1|||
46855347|NCT01347580|83071230|FG000|Overall Study|Had other reason|9|||
46855348|NCT01347580|83071231|FG001|Overall Study|Had other reason|6|||
46855349|NCT00398411|83071239|FG000|Overall Study|Death|0|||
46855350|NCT00398411|83071240|FG001|Overall Study|Death|1|||
46855351|NCT03352414|83071248|FG000|Overall Study|Ineligible by operative criteria|12|||
46977448|NCT02638103|83222489|FG000|Overall Study|Withdrawal by Subject|43|||
46977449|NCT02638103|83222490|FG001|Overall Study|Withdrawal by Subject|53|||
46977450|NCT02638103|83222491|FG002|Overall Study|Withdrawal by Subject|30|||
46977451|NCT02638103|83222492|FG003|Overall Study|Withdrawal by Subject|61|||
46977452|NCT02638103|83222489|FG000|Overall Study|Protocol Violation|1|||
46977453|NCT02638103|83222490|FG001|Overall Study|Protocol Violation|2|||
46977454|NCT02638103|83222491|FG002|Overall Study|Protocol Violation|1|||
46977455|NCT02638103|83222492|FG003|Overall Study|Protocol Violation|4|||
46977456|NCT02638103|83222489|FG000|Overall Study|Pregnancy|2|||
46977457|NCT02638103|83222490|FG001|Overall Study|Pregnancy|3|||
46977458|NCT02638103|83222491|FG002|Overall Study|Pregnancy|0|||
46977459|NCT02638103|83222492|FG003|Overall Study|Pregnancy|1|||
46977460|NCT02638103|83222489|FG000|Overall Study|Non-compliance to Study Procedures|2|||
46977461|NCT02638103|83222490|FG001|Overall Study|Non-compliance to Study Procedures|1|||
46855352|NCT03352414|83071249|FG001|Overall Study|Ineligible by operative criteria|10|||
46855353|NCT00364793|83071261|FG000|Overall Study|Adverse Event|2|||
46855354|NCT00364793|83071262|FG001|Overall Study|Adverse Event|0|||
46855355|NCT00364793|83071263|FG002|Overall Study|Adverse Event|0|||
46855356|NCT00364793|83071264|FG003|Overall Study|Adverse Event|0|||
46855357|NCT00364793|83071261|FG000|Overall Study|Death|1|||
46977462|NCT02638103|83222491|FG002|Overall Study|Non-compliance to Study Procedures|1|||
46977463|NCT02638103|83222492|FG003|Overall Study|Non-compliance to Study Procedures|1|||
46977464|NCT02638103|83222489|FG000|Overall Study|Lost to Follow-up|26|||
46977465|NCT02638103|83222490|FG001|Overall Study|Lost to Follow-up|33|||
46855358|NCT00364793|83071262|FG001|Overall Study|Death|0|||
46977466|NCT02638103|83222491|FG002|Overall Study|Lost to Follow-up|20|||
46977467|NCT02638103|83222492|FG003|Overall Study|Lost to Follow-up|37|||
46977468|NCT02638103|83222489|FG000|Overall Study|Lack of Efficacy|14|||
46977469|NCT02638103|83222490|FG001|Overall Study|Lack of Efficacy|10|||
46793484|NCT00537381|83012017|FG000|Overall Study|Adverse Event|13|||
46793485|NCT00537381|83012018|FG001|Overall Study|Adverse Event|9|||
46793486|NCT00537381|83012017|FG000|Overall Study|Death|3|||
46793487|NCT00537381|83012018|FG001|Overall Study|Death|3|||
46793488|NCT00537381|83012017|FG000|Overall Study|Withdrawal by Subject|5|||
46793489|NCT00537381|83012018|FG001|Overall Study|Withdrawal by Subject|14|||
46793490|NCT00537381|83012017|FG000|Overall Study|Physician Decision|7|||
46793491|NCT00537381|83012018|FG001|Overall Study|Physician Decision|6|||
46793492|NCT00537381|83012017|FG000|Overall Study|Disease Progression|9|||
46793493|NCT00537381|83012018|FG001|Overall Study|Disease Progression|18|||
46793494|NCT00537381|83012017|FG000|Overall Study|Sponsor decision|14|||
46793495|NCT00537381|83012018|FG001|Overall Study|Sponsor decision|9|||
46793496|NCT00537381|83012017|FG000|Overall Study|Other|5|||
46793497|NCT00537381|83012018|FG001|Overall Study|Other|3|||
46793498|NCT03791398|83012029|FG000|Overall Study|Progression of Disease Under Study|2|||
46793499|NCT03791398|83012030|FG001|Overall Study|Progression of Disease Under Study|0|||
46793500|NCT03791398|83012031|FG002|Overall Study|Progression of Disease Under Study|0|||
46793501|NCT00517192|83012037|FG000|Overall Study|Adverse Event|1|||
46793502|NCT00517192|83012038|FG001|Overall Study|Adverse Event|1|||
46793503|NCT00517192|83012037|FG000|Overall Study|Lost to Follow-up|1|||
46793504|NCT00517192|83012038|FG001|Overall Study|Lost to Follow-up|1|||
46855359|NCT00364793|83071263|FG002|Overall Study|Death|1|||
46855360|NCT00364793|83071264|FG003|Overall Study|Death|0|||
46977470|NCT02638103|83222491|FG002|Overall Study|Lack of Efficacy|12|||
46977471|NCT02638103|83222492|FG003|Overall Study|Lack of Efficacy|22|||
46977472|NCT02638103|83222489|FG000|Overall Study|Other than specified|5|||
46977473|NCT02638103|83222490|FG001|Overall Study|Other than specified|4|||
46977474|NCT02638103|83222491|FG002|Overall Study|Other than specified|2|||
46977475|NCT02638103|83222492|FG003|Overall Study|Other than specified|4|||
46674248|NCT01153009|82889869|FG002|Overall Study|Lack of Efficacy|2|||
46793505|NCT00517192|83012037|FG000|Overall Study|Withdrawal by Subject|1|||
46793506|NCT00517192|83012038|FG001|Overall Study|Withdrawal by Subject|0|||
46793507|NCT00517192|83012037|FG000|Overall Study|Early termination of the trial|16|||
46855361|NCT00364793|83071261|FG000|Overall Study|Lack of Efficacy|3|||
46855362|NCT00364793|83071262|FG001|Overall Study|Lack of Efficacy|3|||
46855363|NCT00364793|83071263|FG002|Overall Study|Lack of Efficacy|1|||
46855364|NCT00364793|83071264|FG003|Overall Study|Lack of Efficacy|1|||
46793508|NCT00517192|83012038|FG001|Overall Study|Early termination of the trial|18|||
46977476|NCT03551743|83222514|FG000|Overall Study|Adverse Event|1|||
46977477|NCT03551743|83222515|FG001|Overall Study|Adverse Event|0|||
46977478|NCT03551743|83222516|FG002|Overall Study|Adverse Event|0|||
46977479|NCT03551743|83222517|FG003|Overall Study|Adverse Event|0|||
46977480|NCT03551743|83222514|FG000|Overall Study|Withdrawal by Subject|1|||
46977481|NCT03551743|83222515|FG001|Overall Study|Withdrawal by Subject|0|||
46977482|NCT03551743|83222516|FG002|Overall Study|Withdrawal by Subject|0|||
46977483|NCT03551743|83222517|FG003|Overall Study|Withdrawal by Subject|0|||
46855365|NCT00364793|83071261|FG000|Overall Study|Lost to Follow-up|1|||
46855366|NCT00364793|83071262|FG001|Overall Study|Lost to Follow-up|0|||
46855367|NCT00364793|83071263|FG002|Overall Study|Lost to Follow-up|2|||
46855368|NCT00364793|83071264|FG003|Overall Study|Lost to Follow-up|0|||
46855369|NCT00364793|83071261|FG000|Overall Study|Poor or non-compliance|1|||
46855370|NCT00364793|83071262|FG001|Overall Study|Poor or non-compliance|1|||
46977484|NCT02636699|83222529|FG000|Overall Study|Adverse Event|4|||
46977485|NCT02636699|83222530|FG001|Overall Study|Adverse Event|0|||
46977486|NCT02636699|83222529|FG000|Overall Study|Lost to Follow-up|3|||
46977487|NCT02636699|83222530|FG001|Overall Study|Lost to Follow-up|3|||
46977488|NCT02636699|83222529|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
46977489|NCT02636699|83222530|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
46977490|NCT02636699|83222529|FG000|Overall Study|Physician Decision|0|||
46977491|NCT02636699|83222530|FG001|Overall Study|Physician Decision|1|||
46977492|NCT02636699|83222529|FG000|Overall Study|Withdrawal by Subject|13|||
46977493|NCT02636699|83222530|FG001|Overall Study|Withdrawal by Subject|6|||
46977494|NCT02636699|83222529|FG000|Overall Study|Other|3|||
46977495|NCT02636699|83222530|FG001|Overall Study|Other|1|||
46977496|NCT02634983|83222536|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
46977497|NCT02634983|83222537|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
46977498|NCT02633501|83222549|FG000|Overall Study|Adverse Event|0|||
46977499|NCT02633501|83222550|FG001|Overall Study|Adverse Event|0|||
46977500|NCT02633501|83222551|FG002|Overall Study|Adverse Event|1|||
46977501|NCT02633501|83222552|FG003|Overall Study|Adverse Event|0|||
46977502|NCT02633501|83222553|FG004|Overall Study|Adverse Event|1|||
46977503|NCT02633501|83222554|FG005|Overall Study|Adverse Event|1|||
46977504|NCT02633501|83222549|FG000|Overall Study|Withdrawal by Subject|2|||
46977505|NCT02633501|83222550|FG001|Overall Study|Withdrawal by Subject|1|||
46977506|NCT02633501|83222551|FG002|Overall Study|Withdrawal by Subject|2|||
46977507|NCT02633501|83222552|FG003|Overall Study|Withdrawal by Subject|2|||
46977508|NCT02633501|83222553|FG004|Overall Study|Withdrawal by Subject|1|||
46977509|NCT02633501|83222554|FG005|Overall Study|Withdrawal by Subject|3|||
46977510|NCT02633501|83222549|FG000|Overall Study|Various other reasons|0|||
46977511|NCT02633501|83222550|FG001|Overall Study|Various other reasons|2|||
46674249|NCT01153009|82889870|FG003|Overall Study|Lack of Efficacy|1|||
46674250|NCT01153009|82889867|FG000|Overall Study|Noncompliance with Study Medication|1|||
46793509|NCT00625820|83012044|FG000|Overall Study|Withdrawal by Subject|1|||
46793510|NCT00145327|83012052|FG000|Overall Study|Withdrawal by Subject|77|||
46793511|NCT00145327|83012053|FG001|Overall Study|Withdrawal by Subject|72|||
46793512|NCT00145327|83012054|FG002|Overall Study|Withdrawal by Subject|164|||
46793513|NCT00145327|83012052|FG000|Overall Study|Death|26|||
46793514|NCT00145327|83012053|FG001|Overall Study|Death|18|||
46855371|NCT00364793|83071263|FG002|Overall Study|Poor or non-compliance|0|||
46855372|NCT00364793|83071264|FG003|Overall Study|Poor or non-compliance|1|||
46855373|NCT00364793|83071261|FG000|Overall Study|No longer meets criteria|0|||
46855374|NCT00364793|83071262|FG001|Overall Study|No longer meets criteria|0|||
46855375|NCT00364793|83071263|FG002|Overall Study|No longer meets criteria|0|||
46855376|NCT00364793|83071264|FG003|Overall Study|No longer meets criteria|1|||
46855377|NCT00364793|83071261|FG000|Overall Study|Withdrawal by Subject|0|||
46855378|NCT00364793|83071262|FG001|Overall Study|Withdrawal by Subject|1|||
46855379|NCT00364793|83071263|FG002|Overall Study|Withdrawal by Subject|0|||
46855380|NCT00364793|83071264|FG003|Overall Study|Withdrawal by Subject|0|||
46977512|NCT02633501|83222551|FG002|Overall Study|Various other reasons|4|||
46977513|NCT02633501|83222552|FG003|Overall Study|Various other reasons|1|||
46793515|NCT00145327|83012054|FG002|Overall Study|Death|30|||
46793516|NCT00145327|83012052|FG000|Overall Study|Adverse Event|14|||
46793517|NCT00145327|83012053|FG001|Overall Study|Adverse Event|11|||
46977514|NCT02633501|83222553|FG004|Overall Study|Various other reasons|7|||
46977515|NCT02633501|83222554|FG005|Overall Study|Various other reasons|11|||
46977516|NCT02633501|83222549|FG000|Overall Study|Lost to Follow-up|0|||
46977517|NCT02633501|83222550|FG001|Overall Study|Lost to Follow-up|0|||
46977518|NCT02633501|83222551|FG002|Overall Study|Lost to Follow-up|0|||
46977519|NCT02633501|83222552|FG003|Overall Study|Lost to Follow-up|1|||
46977520|NCT02633501|83222553|FG004|Overall Study|Lost to Follow-up|2|||
46977521|NCT02633501|83222554|FG005|Overall Study|Lost to Follow-up|0|||
46977522|NCT03591107|83222575|FG000|Overall Study|Same patient in both arms|1|||
46977523|NCT03591107|83222576|FG001|Overall Study|Same patient in both arms|1|||
46793518|NCT00145327|83012054|FG002|Overall Study|Adverse Event|22|||
46793519|NCT00145327|83012052|FG000|Overall Study|Lost to Follow-up|9|||
46855381|NCT03351478|83071280|FG000|Overall Study|At the subject's own request|11|||
46855382|NCT03351478|83071281|FG001|Overall Study|At the subject's own request|12|||
46855383|NCT03351478|83071282|FG002|Overall Study|At the subject's own request|5|||
46977524|NCT03591107|83222575|FG000|Overall Study|Sought care at other clinics|0|||
46977525|NCT03591107|83222576|FG001|Overall Study|Sought care at other clinics|2|||
46977526|NCT03591107|83222575|FG000|Overall Study|Discharged from clinic|0|||
46977527|NCT03591107|83222576|FG001|Overall Study|Discharged from clinic|1|||
46977528|NCT03591107|83222575|FG000|Overall Study|Withdrawal by Subject|0|||
46977529|NCT03591107|83222576|FG001|Overall Study|Withdrawal by Subject|1|||
46977530|NCT02922023|83222589|FG000|Overall Study|Lost to Follow-up|2|||
46977531|NCT02922023|83222590|FG001|Overall Study|Lost to Follow-up|0|||
46977532|NCT01672853|83222599|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
46977533|NCT01672853|83222600|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
46977534|NCT01672853|83222601|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
46977535|NCT01672853|83222599|FG000|Overall Study|Pregnancy|0|||
46674251|NCT01153009|82889868|FG001|Overall Study|Noncompliance with Study Medication|3|||
46674252|NCT01153009|82889869|FG002|Overall Study|Noncompliance with Study Medication|4|||
46674253|NCT01153009|82889870|FG003|Overall Study|Noncompliance with Study Medication|1|||
46674254|NCT01153009|82889867|FG000|Overall Study|Protocol Deviations|4|||
46674255|NCT01153009|82889868|FG001|Overall Study|Protocol Deviations|3|||
46674256|NCT01153009|82889869|FG002|Overall Study|Protocol Deviations|3|||
46674257|NCT01153009|82889870|FG003|Overall Study|Protocol Deviations|2|||
46674258|NCT01153009|82889867|FG000|Overall Study|Withdrawal of Consent|5|||
46674259|NCT01153009|82889868|FG001|Overall Study|Withdrawal of Consent|5|||
46674260|NCT01153009|82889869|FG002|Overall Study|Withdrawal of Consent|4|||
46674261|NCT01153009|82889870|FG003|Overall Study|Withdrawal of Consent|6|||
46674262|NCT01153009|82889867|FG000|Overall Study|Lost to Follow-up|8|||
46793520|NCT00145327|83012053|FG001|Overall Study|Lost to Follow-up|14|||
46793521|NCT00145327|83012054|FG002|Overall Study|Lost to Follow-up|14|||
46793522|NCT00145327|83012052|FG000|Overall Study|Administrative problems|12|||
46793523|NCT00145327|83012053|FG001|Overall Study|Administrative problems|9|||
46793524|NCT00145327|83012054|FG002|Overall Study|Administrative problems|13|||
46793525|NCT00145327|83012052|FG000|Overall Study|Protocol Violation|2|||
46793526|NCT00145327|83012053|FG001|Overall Study|Protocol Violation|0|||
46793527|NCT00145327|83012054|FG002|Overall Study|Protocol Violation|2|||
46793528|NCT00145327|83012052|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46855384|NCT03351478|83071280|FG000|Overall Study|Adverse Event|1|||
46855385|NCT03351478|83071281|FG001|Overall Study|Adverse Event|2|||
46855386|NCT03351478|83071282|FG002|Overall Study|Adverse Event|1|||
46855387|NCT03351478|83071280|FG000|Overall Study|Poor compliance to protocol|1|||
46855388|NCT03351478|83071281|FG001|Overall Study|Poor compliance to protocol|0|||
46855389|NCT03351478|83071282|FG002|Overall Study|Poor compliance to protocol|0|||
46855390|NCT03351478|83071280|FG000|Overall Study|Reason not Specified|1|||
46855391|NCT03351478|83071281|FG001|Overall Study|Reason not Specified|3|||
46855392|NCT03351478|83071282|FG002|Overall Study|Reason not Specified|0|||
46855393|NCT03351478|83071280|FG000|Overall Study|Lost to Follow-up|0|||
46855394|NCT03351478|83071281|FG001|Overall Study|Lost to Follow-up|0|||
46855395|NCT03351478|83071282|FG002|Overall Study|Lost to Follow-up|1|||
46855396|NCT00363545|83071292|FG000|Overall Study|Serious Adverse Event|0|||
46855397|NCT00363545|83071293|FG001|Overall Study|Serious Adverse Event|1|||
46855398|NCT00363545|83071292|FG000|Overall Study|Withdrawal by Subject|12|||
46855399|NCT00363545|83071293|FG001|Overall Study|Withdrawal by Subject|15|||
46855400|NCT00363545|83071292|FG000|Overall Study|Migrated/moved from study area|3|||
46855401|NCT00363545|83071293|FG001|Overall Study|Migrated/moved from study area|6|||
46855402|NCT00363545|83071292|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
46855403|NCT00363545|83071293|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
46855404|NCT00363545|83071292|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
46855405|NCT00363545|83071293|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
46855406|NCT00363545|83071292|FG000|Overall Study|Others|1|||
46855407|NCT00363545|83071293|FG001|Overall Study|Others|0|||
46855408|NCT03351244|83071302|FG000|Overall Study|Adverse Event|7|||
46855409|NCT03351244|83071303|FG001|Overall Study|Adverse Event|11|||
46855410|NCT03351244|83071304|FG002|Overall Study|Adverse Event|12|||
46855411|NCT03351244|83071302|FG000|Overall Study|Investigator's decision|0|||
46855412|NCT03351244|83071303|FG001|Overall Study|Investigator's decision|0|||
46855413|NCT03351244|83071304|FG002|Overall Study|Investigator's decision|2|||
46855414|NCT03351244|83071302|FG000|Overall Study|System error|0|||
46855415|NCT03351244|83071303|FG001|Overall Study|System error|0|||
46855416|NCT03351244|83071304|FG002|Overall Study|System error|2|||
46855417|NCT03351244|83071302|FG000|Overall Study|COVID-19 restrictions|3|||
46855418|NCT03351244|83071303|FG001|Overall Study|COVID-19 restrictions|0|||
46855419|NCT03351244|83071304|FG002|Overall Study|COVID-19 restrictions|1|||
46855420|NCT03351244|83071302|FG000|Overall Study|Non-compliance|2|||
46855421|NCT03351244|83071303|FG001|Overall Study|Non-compliance|5|||
46977536|NCT01672853|83222600|FG001|Overall Study|Pregnancy|1|||
46855422|NCT03351244|83071304|FG002|Overall Study|Non-compliance|0|||
46977537|NCT01672853|83222601|FG002|Overall Study|Pregnancy|0|||
46674263|NCT01153009|82889868|FG001|Overall Study|Lost to Follow-up|8|||
46793529|NCT00145327|83012053|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46793530|NCT00145327|83012054|FG002|Overall Study|Abnormal laboratory value(s)|2|||
46855423|NCT03351244|83071302|FG000|Overall Study|Withdrawal by Subject|11|||
46977538|NCT01672853|83222599|FG000|Overall Study|Investigator's Discretion|1|||
46977539|NCT01672853|83222600|FG001|Overall Study|Investigator's Discretion|0|||
46977540|NCT01672853|83222601|FG002|Overall Study|Investigator's Discretion|0|||
46977541|NCT01672853|83222599|FG000|Overall Study|Withdrew Consent|5|||
46793531|NCT00145327|83012052|FG000|Overall Study|Missing - not stated|1|||
46855424|NCT03351244|83071303|FG001|Overall Study|Withdrawal by Subject|16|||
46855425|NCT03351244|83071304|FG002|Overall Study|Withdrawal by Subject|13|||
46855426|NCT03351244|83071302|FG000|Overall Study|Lost to Follow-up|2|||
46855427|NCT03351244|83071303|FG001|Overall Study|Lost to Follow-up|6|||
46855428|NCT03351244|83071304|FG002|Overall Study|Lost to Follow-up|4|||
46855429|NCT03351244|83071302|FG000|Overall Study|Protocol Violation|2|||
46855430|NCT03351244|83071303|FG001|Overall Study|Protocol Violation|2|||
46793532|NCT00145327|83012053|FG001|Overall Study|Missing - not stated|0|||
46793533|NCT00145327|83012054|FG002|Overall Study|Missing - not stated|1|||
46793534|NCT00510484|83012064|FG000|Wash-out Period|Adverse Event|0|||
46793535|NCT00510484|83012065|FG001|Wash-out Period|Adverse Event|1|||
46793536|NCT00622388|83012071|FG000|Overall Study|Disease Progression|47|||
46793537|NCT00622388|83012071|FG000|Overall Study|Adverse Event|6|||
46793538|NCT00622388|83012071|FG000|Overall Study|Protocol Violation|3|||
46793539|NCT00622388|83012071|FG000|Overall Study|Participant Refusal|1|||
46793540|NCT00622388|83012071|FG000|Overall Study|Death|3|||
46855431|NCT03351244|83071304|FG002|Overall Study|Protocol Violation|0|||
46855432|NCT03386032|83071317|FG000|Overall Study|Lack of Efficacy|6|||
46855433|NCT03386032|83071318|FG001|Overall Study|Lack of Efficacy|2|||
46855434|NCT03386032|83071319|FG002|Overall Study|Lack of Efficacy|0|||
46855435|NCT03386032|83071317|FG000|Overall Study|Adverse Event|2|||
46855436|NCT03386032|83071318|FG001|Overall Study|Adverse Event|2|||
46855437|NCT03386032|83071319|FG002|Overall Study|Adverse Event|0|||
46977542|NCT01672853|83222600|FG001|Overall Study|Withdrew Consent|5|||
46793541|NCT00622388|83012071|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
46793542|NCT00622388|83012071|FG000|Overall Study|Took Prohibited Medication|2|||
46793543|NCT00622388|83012071|FG000|Overall Study|Withdrew Consent|1|||
46793544|NCT00622388|83012071|FG000|Overall Study|Insurance Expired|1|||
46793545|NCT01156389|83012078|FG000|Overall Study|Elevated liver enzymes|4|||
46793546|NCT01156389|83012079|FG001|Overall Study|Elevated liver enzymes|0|||
46793547|NCT01156389|83012078|FG000|Overall Study|Vomiting|0|||
46793548|NCT01156389|83012079|FG001|Overall Study|Vomiting|1|||
46793549|NCT01105767|83012088|FG000|Overall Study|Lost to Follow-up|1160|||
46793550|NCT01105767|83012089|FG001|Overall Study|Lost to Follow-up|1614|||
46793551|NCT01105767|83012090|FG002|Overall Study|Lost to Follow-up|1184|||
46793552|NCT03693430|83012100|FG000|Overall Study|Lost to Follow-up|3|||
46793553|NCT03693430|83012101|FG001|Overall Study|Lost to Follow-up|14|||
46793554|NCT03693430|83012100|FG000|Overall Study|Death|1|||
46793555|NCT03693430|83012101|FG001|Overall Study|Death|0|||
46793556|NCT03693430|83012100|FG000|Overall Study|Withdrawal by Subject|0|||
46793557|NCT03693430|83012101|FG001|Overall Study|Withdrawal by Subject|4|||
46793558|NCT00625742|83012107|FG000|Overall Study|Disease Progression|2|||
46793559|NCT00625742|83012107|FG000|Overall Study|Withdrawal by Subject|1|||
46793560|NCT00625742|83012107|FG000|Overall Study|Adverse Event|4|||
46793561|NCT00625742|83012107|FG000|Overall Study|Lost to Follow-up|4|||
46793562|NCT00625742|83012107|FG000|Overall Study|Ineligible|1|||
46793563|NCT00621296|83012120|FG000|Overall Study|Adverse Event|2|||
46793564|NCT00621296|83012120|FG000|Overall Study|Lack of Efficacy|1|||
46855438|NCT03386032|83071317|FG000|Overall Study|Withdrawal by Subject|1|||
46977543|NCT01672853|83222601|FG002|Overall Study|Withdrew Consent|5|||
46977544|NCT01672853|83222599|FG000|Overall Study|Adverse Event|4|||
46977545|NCT01672853|83222600|FG001|Overall Study|Adverse Event|6|||
46977546|NCT01672853|83222601|FG002|Overall Study|Adverse Event|8|||
46977547|NCT01672853|83222599|FG000|Overall Study|Lost to Follow-up|0|||
46977548|NCT01672853|83222600|FG001|Overall Study|Lost to Follow-up|1|||
46977549|NCT01672853|83222601|FG002|Overall Study|Lost to Follow-up|0|||
46977550|NCT01672853|83222599|FG000|Overall Study|Randomized but Never Treated|0|||
46977551|NCT01672853|83222600|FG001|Overall Study|Randomized but Never Treated|0|||
46977552|NCT01672853|83222601|FG002|Overall Study|Randomized but Never Treated|1|||
46977553|NCT01603459|83222609|FG000|Overall Study|Adverse Event|5|||
46977554|NCT01603459|83222609|FG000|Overall Study|Withdrawal by Subject|5|||
46793565|NCT00621296|83012120|FG000|Overall Study|Physician Decision|7|||
46793566|NCT00621296|83012120|FG000|Overall Study|Unmatch Criteria|1|||
46793567|NCT00621296|83012120|FG000|Overall Study|Stopping Criteria|3|||
46793568|NCT00537303|83012126|FG000|Overall Study|Adverse Event|1|||
46793569|NCT00537303|83012127|FG001|Overall Study|Adverse Event|4|||
46793570|NCT00537303|83012126|FG000|Overall Study|Lack of Efficacy|6|||
46793571|NCT00537303|83012127|FG001|Overall Study|Lack of Efficacy|7|||
46793572|NCT00537303|83012126|FG000|Overall Study|Protocol Violation|8|||
46793573|NCT00537303|83012127|FG001|Overall Study|Protocol Violation|4|||
46793574|NCT00537303|83012126|FG000|Overall Study|Withdrawal criteria|3|||
46793575|NCT00537303|83012127|FG001|Overall Study|Withdrawal criteria|3|||
46855439|NCT03386032|83071318|FG001|Overall Study|Withdrawal by Subject|0|||
46855440|NCT03386032|83071319|FG002|Overall Study|Withdrawal by Subject|0|||
46855441|NCT03386032|83071317|FG000|Overall Study|Lost to Follow-up|9|||
46855442|NCT03386032|83071318|FG001|Overall Study|Lost to Follow-up|3|||
46855443|NCT03386032|83071319|FG002|Overall Study|Lost to Follow-up|0|||
46855444|NCT00077610|83071330|FG000|Overall Study|Adverse Event|9|||
46855445|NCT00077610|83071331|FG001|Overall Study|Adverse Event|7|||
46855446|NCT00077610|83071332|FG002|Overall Study|Adverse Event|1|||
46855447|NCT00077610|83071330|FG000|Overall Study|Lost to Follow-up|0|||
46855448|NCT00077610|83071331|FG001|Overall Study|Lost to Follow-up|1|||
46855449|NCT00077610|83071332|FG002|Overall Study|Lost to Follow-up|2|||
46855450|NCT00077610|83071330|FG000|Overall Study|Withdrawal by Subject|4|||
46855451|NCT00077610|83071331|FG001|Overall Study|Withdrawal by Subject|10|||
46855452|NCT00077610|83071332|FG002|Overall Study|Withdrawal by Subject|6|||
46977555|NCT01603459|83222609|FG000|Overall Study|Lost to Follow-up|3|||
46977556|NCT01603459|83222609|FG000|Overall Study|Predefined discontinuation criteria|3|||
46977557|NCT01603459|83222609|FG000|Overall Study|Non-compliance|1|||
46977558|NCT01603459|83222609|FG000|Overall Study|Administrative reason|1|||
46977559|NCT01678807|83222648|FG000|Overall Study|Adverse Event|4|||
46977560|NCT01678807|83222649|FG001|Overall Study|Adverse Event|4|||
46977561|NCT01678807|83222650|FG002|Overall Study|Adverse Event|0|||
46977562|NCT01678807|83222648|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
46977563|NCT01678807|83222649|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
46977564|NCT01678807|83222650|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
46977565|NCT03073525|83222661|FG000|Overall Study|Withdrawal by Subject|0|||
46793576|NCT00537303|83012126|FG000|Overall Study|Unclassified|8|||
46793577|NCT00537303|83012127|FG001|Overall Study|Unclassified|7|||
46793578|NCT00505414|83012135|FG000|Titration Phase|Adverse Event|0|||
46793579|NCT00505414|83012136|FG001|Titration Phase|Adverse Event|0|||
46793580|NCT00505414|83012137|FG002|Titration Phase|Adverse Event|0|||
46793581|NCT00505414|83012138|FG003|Titration Phase|Adverse Event|8|||
46793582|NCT00505414|83012139|FG004|Titration Phase|Adverse Event|3|||
46793583|NCT00505414|83012135|FG000|Titration Phase|Death|0|||
46793584|NCT00505414|83012136|FG001|Titration Phase|Death|0|||
46793585|NCT00505414|83012137|FG002|Titration Phase|Death|0|||
46793586|NCT00505414|83012138|FG003|Titration Phase|Death|2|||
46793587|NCT00505414|83012139|FG004|Titration Phase|Death|0|||
46793588|NCT00505414|83012135|FG000|Titration Phase|Lack of Efficacy|0|||
46793589|NCT00505414|83012136|FG001|Titration Phase|Lack of Efficacy|0|||
46793590|NCT00505414|83012137|FG002|Titration Phase|Lack of Efficacy|0|||
46793591|NCT00505414|83012138|FG003|Titration Phase|Lack of Efficacy|10|||
46793592|NCT00505414|83012139|FG004|Titration Phase|Lack of Efficacy|1|||
46793593|NCT00505414|83012135|FG000|Titration Phase|Protocol Violation|0|||
46793594|NCT00505414|83012136|FG001|Titration Phase|Protocol Violation|0|||
46793595|NCT00505414|83012137|FG002|Titration Phase|Protocol Violation|0|||
46793596|NCT00505414|83012138|FG003|Titration Phase|Protocol Violation|0|||
46793597|NCT00505414|83012139|FG004|Titration Phase|Protocol Violation|1|||
46793598|NCT00505414|83012135|FG000|Titration Phase|Withdrawal by Subject|0|||
46793599|NCT00505414|83012136|FG001|Titration Phase|Withdrawal by Subject|0|||
46793600|NCT00505414|83012137|FG002|Titration Phase|Withdrawal by Subject|0|||
46793601|NCT00505414|83012138|FG003|Titration Phase|Withdrawal by Subject|3|||
46793602|NCT00505414|83012139|FG004|Titration Phase|Withdrawal by Subject|4|||
46793603|NCT00505414|83012135|FG000|Titration Phase|Underlying disease and therapy required|0|||
46793604|NCT00505414|83012136|FG001|Titration Phase|Underlying disease and therapy required|0|||
46793605|NCT00505414|83012137|FG002|Titration Phase|Underlying disease and therapy required|0|||
46793606|NCT00505414|83012138|FG003|Titration Phase|Underlying disease and therapy required|7|||
46793607|NCT00505414|83012139|FG004|Titration Phase|Underlying disease and therapy required|3|||
46793608|NCT00505414|83012135|FG000|Maintenance Phase|Adverse Event|2|||
46793609|NCT00505414|83012136|FG001|Maintenance Phase|Adverse Event|2|||
46793610|NCT00505414|83012137|FG002|Maintenance Phase|Adverse Event|3|||
46793611|NCT00505414|83012138|FG003|Maintenance Phase|Adverse Event|0|||
46793612|NCT00505414|83012139|FG004|Maintenance Phase|Adverse Event|0|||
46793613|NCT00505414|83012135|FG000|Maintenance Phase|Death|2|||
46793614|NCT00505414|83012136|FG001|Maintenance Phase|Death|0|||
46793615|NCT00505414|83012137|FG002|Maintenance Phase|Death|1|||
46793616|NCT00505414|83012138|FG003|Maintenance Phase|Death|0|||
46793617|NCT00505414|83012139|FG004|Maintenance Phase|Death|0|||
46793618|NCT00505414|83012135|FG000|Maintenance Phase|Lack of Efficacy|2|||
46793619|NCT00505414|83012136|FG001|Maintenance Phase|Lack of Efficacy|1|||
46793620|NCT00505414|83012137|FG002|Maintenance Phase|Lack of Efficacy|1|||
46793621|NCT00505414|83012138|FG003|Maintenance Phase|Lack of Efficacy|0|||
46793622|NCT00505414|83012139|FG004|Maintenance Phase|Lack of Efficacy|0|||
46793623|NCT00505414|83012135|FG000|Maintenance Phase|Withdrawal by Subject|0|||
46793624|NCT00505414|83012136|FG001|Maintenance Phase|Withdrawal by Subject|0|||
46793625|NCT00505414|83012137|FG002|Maintenance Phase|Withdrawal by Subject|1|||
46793626|NCT00505414|83012138|FG003|Maintenance Phase|Withdrawal by Subject|0|||
46793627|NCT00505414|83012139|FG004|Maintenance Phase|Withdrawal by Subject|0|||
46855453|NCT00077610|83071330|FG000|Overall Study|Death|17|||
46855454|NCT00077610|83071331|FG001|Overall Study|Death|13|||
46977566|NCT03073525|83222662|FG001|Overall Study|Withdrawal by Subject|0|||
46977567|NCT03073525|83222663|FG002|Overall Study|Withdrawal by Subject|3|||
46977568|NCT02631551|83222684|FG000|Overall Study|Adverse Event|1|||
46977569|NCT02631551|83222685|FG001|Overall Study|Adverse Event|2|||
46977570|NCT02631551|83222686|FG002|Overall Study|Adverse Event|4|||
46977571|NCT02631551|83222687|FG003|Overall Study|Adverse Event|0|||
46855455|NCT00077610|83071332|FG002|Overall Study|Death|13|||
46855456|NCT00077610|83071330|FG000|Overall Study|Renal transplant|12|||
46855457|NCT00077610|83071331|FG001|Overall Study|Renal transplant|15|||
46855458|NCT00077610|83071332|FG002|Overall Study|Renal transplant|11|||
46855459|NCT00077610|83071330|FG000|Overall Study|Withdrew from dialysis care|5|||
46855460|NCT00077610|83071331|FG001|Overall Study|Withdrew from dialysis care|0|||
46855461|NCT00077610|83071332|FG002|Overall Study|Withdrew from dialysis care|3|||
46855462|NCT00077610|83071330|FG000|Overall Study|Insufficient Therapeutic Response|1|||
46855463|NCT00077610|83071331|FG001|Overall Study|Insufficient Therapeutic Response|0|||
46855464|NCT00077610|83071332|FG002|Overall Study|Insufficient Therapeutic Response|0|||
46855465|NCT00077610|83071330|FG000|Overall Study|Multiple blood transfusions|0|||
46977572|NCT02631551|83222684|FG000|Overall Study|Lack of Efficacy|0|||
46977573|NCT02631551|83222685|FG001|Overall Study|Lack of Efficacy|0|||
46977574|NCT02631551|83222686|FG002|Overall Study|Lack of Efficacy|1|||
46977575|NCT02631551|83222687|FG003|Overall Study|Lack of Efficacy|0|||
46977576|NCT02631551|83222684|FG000|Overall Study|Lost to Follow-up|1|||
46977577|NCT02631551|83222685|FG001|Overall Study|Lost to Follow-up|2|||
46977578|NCT02631551|83222686|FG002|Overall Study|Lost to Follow-up|0|||
46977579|NCT02631551|83222687|FG003|Overall Study|Lost to Follow-up|3|||
46977580|NCT02631551|83222684|FG000|Overall Study|Withdrawal by Subject|2|||
46977581|NCT02631551|83222685|FG001|Overall Study|Withdrawal by Subject|2|||
46977582|NCT02631551|83222686|FG002|Overall Study|Withdrawal by Subject|0|||
46977583|NCT02631551|83222687|FG003|Overall Study|Withdrawal by Subject|5|||
46977584|NCT02631551|83222684|FG000|Overall Study|Protocol deviation|3|||
46977585|NCT02631551|83222685|FG001|Overall Study|Protocol deviation|6|||
46977586|NCT02631551|83222686|FG002|Overall Study|Protocol deviation|3|||
46977587|NCT02631551|83222687|FG003|Overall Study|Protocol deviation|0|||
46977588|NCT02631551|83222684|FG000|Overall Study|Non-compliance with study procedures|0|||
46977589|NCT02631551|83222685|FG001|Overall Study|Non-compliance with study procedures|0|||
46977590|NCT02631551|83222686|FG002|Overall Study|Non-compliance with study procedures|1|||
46977591|NCT02631551|83222687|FG003|Overall Study|Non-compliance with study procedures|1|||
46977592|NCT02631551|83222684|FG000|Overall Study|Non-compliance with study drug|1|||
46977593|NCT02631551|83222685|FG001|Overall Study|Non-compliance with study drug|0|||
46977594|NCT02631551|83222686|FG002|Overall Study|Non-compliance with study drug|0|||
46977595|NCT02631551|83222687|FG003|Overall Study|Non-compliance with study drug|0|||
46977596|NCT02631551|83222684|FG000|Overall Study|Other, specific reasons not collected|5|||
46977597|NCT02631551|83222685|FG001|Overall Study|Other, specific reasons not collected|7|||
46977598|NCT02631551|83222686|FG002|Overall Study|Other, specific reasons not collected|2|||
46977599|NCT02631551|83222687|FG003|Overall Study|Other, specific reasons not collected|2|||
46977600|NCT01680991|83222700|FG000|Overall Study|Adverse Event|1|||
46977601|NCT01680991|83222701|FG001|Overall Study|Adverse Event|0|||
46977602|NCT01680991|83222702|FG002|Overall Study|Adverse Event|0|||
46977603|NCT01680991|83222700|FG000|Overall Study|Death|1|||
46977604|NCT01680991|83222701|FG001|Overall Study|Death|0|||
46977605|NCT01680991|83222702|FG002|Overall Study|Death|1|||
46977606|NCT01680991|83222700|FG000|Overall Study|Protocol Violation|0|||
46977607|NCT01680991|83222701|FG001|Overall Study|Protocol Violation|1|||
46977608|NCT01680991|83222702|FG002|Overall Study|Protocol Violation|0|||
46793628|NCT00505414|83012135|FG000|Maintenance Phase|underlying disease and therapy required|0|||
46793629|NCT00505414|83012136|FG001|Maintenance Phase|underlying disease and therapy required|2|||
46793630|NCT00505414|83012137|FG002|Maintenance Phase|underlying disease and therapy required|2|||
46793631|NCT00505414|83012138|FG003|Maintenance Phase|underlying disease and therapy required|0|||
46793632|NCT00505414|83012139|FG004|Maintenance Phase|underlying disease and therapy required|0|||
46793633|NCT00144781|83012173|FG000|Overall Study|Adverse Event|0|||
46793634|NCT00144781|83012174|FG001|Overall Study|Adverse Event|1|||
46793635|NCT00144781|83012175|FG002|Overall Study|Adverse Event|0|||
46977609|NCT01680991|83222700|FG000|Overall Study|Withdrawal by Subject|5|||
46977610|NCT01680991|83222701|FG001|Overall Study|Withdrawal by Subject|1|||
46977611|NCT01680991|83222702|FG002|Overall Study|Withdrawal by Subject|0|||
46977612|NCT01680991|83222700|FG000|Overall Study|Progressive disease (PD)|0|||
46855466|NCT00077610|83071331|FG001|Overall Study|Multiple blood transfusions|0|||
46977613|NCT01680991|83222701|FG001|Overall Study|Progressive disease (PD)|10|||
46793636|NCT00144781|83012176|FG003|Overall Study|Adverse Event|0|||
46793637|NCT00144781|83012173|FG000|Overall Study|Non-compliant|0|||
46855467|NCT00077610|83071332|FG002|Overall Study|Multiple blood transfusions|1|||
46855468|NCT00077610|83071330|FG000|Overall Study|Principal Investigator's decision|1|||
46977614|NCT01680991|83222702|FG002|Overall Study|Progressive disease (PD)|0|||
46977615|NCT01680991|83222700|FG000|Overall Study|Physician Decision|0|||
46977616|NCT01680991|83222701|FG001|Overall Study|Physician Decision|7|||
46977617|NCT01680991|83222702|FG002|Overall Study|Physician Decision|2|||
46977618|NCT01680991|83222700|FG000|Overall Study|Bad physical condition|0|||
46977619|NCT01680991|83222701|FG001|Overall Study|Bad physical condition|0|||
46977620|NCT01680991|83222702|FG002|Overall Study|Bad physical condition|1|||
46977621|NCT01680991|83222700|FG000|Overall Study|PD confirmed in other hospital|1|||
46977622|NCT01680991|83222701|FG001|Overall Study|PD confirmed in other hospital|0|||
46977623|NCT01680991|83222702|FG002|Overall Study|PD confirmed in other hospital|0|||
46977624|NCT02819479|83222712|FG000|Overall Study|Adverse Event|2|||
46977625|NCT04064411|83222719|FG000|Overall Study|Adverse Event|29|||
46977626|NCT04064411|83222720|FG001|Overall Study|Adverse Event|19|||
46977627|NCT04064411|83222719|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
46977628|NCT04064411|83222720|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
46977629|NCT04064411|83222719|FG000|Overall Study|Protocol Deviation|0|||
46977630|NCT04064411|83222720|FG001|Overall Study|Protocol Deviation|2|||
46977631|NCT04064411|83222719|FG000|Overall Study|Withdrawal by Subject|25|||
46977632|NCT04064411|83222720|FG001|Overall Study|Withdrawal by Subject|29|||
46977633|NCT04064411|83222719|FG000|Overall Study|Lost to Follow-up|5|||
46977634|NCT04064411|83222720|FG001|Overall Study|Lost to Follow-up|2|||
46977635|NCT04064411|83222719|FG000|Overall Study|Other than Specified|4|||
46977636|NCT04064411|83222720|FG001|Overall Study|Other than Specified|1|||
46977637|NCT04064411|83222719|FG000|Overall Study|Death|1|||
46977638|NCT04064411|83222720|FG001|Overall Study|Death|0|||
46977639|NCT02629133|83222728|FG000|Overall Study|Lost to Follow-up|3|||
46977640|NCT02629133|83222729|FG001|Overall Study|Lost to Follow-up|1|||
46977641|NCT02629133|83222728|FG000|Overall Study|Withdrawal by Subject|1|||
46977642|NCT02629133|83222729|FG001|Overall Study|Withdrawal by Subject|1|||
46977643|NCT02660359|83222738|FG000|Overall Study|Protocol Deviation|0|||
46977644|NCT02660359|83222739|FG001|Overall Study|Protocol Deviation|0|||
46855469|NCT00077610|83071331|FG001|Overall Study|Principal Investigator's decision|0|||
46855470|NCT00077610|83071332|FG002|Overall Study|Principal Investigator's decision|1|||
46855471|NCT00077610|83071330|FG000|Overall Study|Worsening of health condition|1|||
46855472|NCT00077610|83071331|FG001|Overall Study|Worsening of health condition|1|||
46977645|NCT02660359|83222740|FG002|Overall Study|Protocol Deviation|1|||
46674264|NCT01153009|82889869|FG002|Overall Study|Lost to Follow-up|11|||
46674265|NCT01153009|82889870|FG003|Overall Study|Lost to Follow-up|15|||
46674266|NCT01153009|82889867|FG000|Overall Study|Other|1|||
46674267|NCT01153009|82889868|FG001|Overall Study|Other|1|||
46674268|NCT01153009|82889869|FG002|Overall Study|Other|3|||
46674269|NCT01153009|82889870|FG003|Overall Study|Other|2|||
46674270|NCT01152814|82889880|FG000|Overall Study|Lost to Follow-up|2|||
46674271|NCT01152580|82889886|FG000|Overall Study|Withdrawal by Subject|0|||
46977646|NCT02660359|83222738|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
46977647|NCT02660359|83222739|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
46793638|NCT00144781|83012174|FG001|Overall Study|Non-compliant|1|||
46793639|NCT00144781|83012175|FG002|Overall Study|Non-compliant|0|||
46793640|NCT00144781|83012176|FG003|Overall Study|Non-compliant|0|||
46793641|NCT00621140|83012192|FG000|Overall Study|Adverse Event|4|||
46793642|NCT00621140|83012193|FG001|Overall Study|Adverse Event|5|||
46793643|NCT00621140|83012192|FG000|Overall Study|Lost to Follow-up|1|||
46793644|NCT00621140|83012193|FG001|Overall Study|Lost to Follow-up|2|||
46855473|NCT00077610|83071332|FG002|Overall Study|Worsening of health condition|0|||
46855474|NCT00077610|83071330|FG000|Overall Study|Given Epogen in hospital|1|||
46855475|NCT00077610|83071331|FG001|Overall Study|Given Epogen in hospital|0|||
46855476|NCT00077610|83071332|FG002|Overall Study|Given Epogen in hospital|0|||
46855477|NCT00077610|83071330|FG000|Overall Study|Transferred to other unit|0|||
46855478|NCT00077610|83071331|FG001|Overall Study|Transferred to other unit|0|||
46855479|NCT00077610|83071332|FG002|Overall Study|Transferred to other unit|1|||
46855480|NCT00077610|83071330|FG000|Overall Study|Transferred to nursing home|0|||
46855481|NCT00077610|83071331|FG001|Overall Study|Transferred to nursing home|0|||
46977648|NCT02660359|83222740|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
46977649|NCT02660359|83222738|FG000|Overall Study|Lack of Efficacy|1|||
46977650|NCT02660359|83222739|FG001|Overall Study|Lack of Efficacy|1|||
46855482|NCT00077610|83071332|FG002|Overall Study|Transferred to nursing home|1|||
46855483|NCT00077610|83071330|FG000|Overall Study|Transfer to satellite unit|1|||
46855484|NCT00077610|83071331|FG001|Overall Study|Transfer to satellite unit|0|||
46977651|NCT02660359|83222740|FG002|Overall Study|Lack of Efficacy|1|||
46977652|NCT02660359|83222738|FG000|Overall Study|Adverse Event|0|||
46977653|NCT02660359|83222739|FG001|Overall Study|Adverse Event|1|||
46977654|NCT02660359|83222740|FG002|Overall Study|Adverse Event|0|||
46793645|NCT00621140|83012192|FG000|Overall Study|Withdrawal by Subject|4|||
46977655|NCT02660359|83222738|FG000|Overall Study|Other|2|||
46977656|NCT02660359|83222739|FG001|Overall Study|Other|1|||
46674272|NCT01152580|82889887|FG001|Overall Study|Withdrawal by Subject|1|||
46674273|NCT01152385|82889897|FG000|Overall Study|Withdrawal by Subject|3|||
46674274|NCT01152385|82889898|FG001|Overall Study|Withdrawal by Subject|1|||
46793646|NCT00621140|83012193|FG001|Overall Study|Withdrawal by Subject|6|||
46793647|NCT00621140|83012192|FG000|Overall Study|Other incl. lack of efficacy|6|||
46855485|NCT00077610|83071332|FG002|Overall Study|Transfer to satellite unit|0|||
46855486|NCT00077610|83071330|FG000|Overall Study|Transfer to other center for surgery|1|||
46855487|NCT00077610|83071331|FG001|Overall Study|Transfer to other center for surgery|0|||
46855488|NCT00077610|83071332|FG002|Overall Study|Transfer to other center for surgery|0|||
46855489|NCT00077610|83071330|FG000|Overall Study|Change in dialysis modality|1|||
46855490|NCT00077610|83071331|FG001|Overall Study|Change in dialysis modality|0|||
46855491|NCT00077610|83071332|FG002|Overall Study|Change in dialysis modality|0|||
46855492|NCT00077610|83071330|FG000|Overall Study|Relocation|0|||
46855493|NCT00077610|83071331|FG001|Overall Study|Relocation|8|||
46855494|NCT00077610|83071332|FG002|Overall Study|Relocation|5|||
46855495|NCT00077610|83071330|FG000|Overall Study|Financial issues|0|||
46855496|NCT00077610|83071331|FG001|Overall Study|Financial issues|1|||
46855497|NCT00077610|83071332|FG002|Overall Study|Financial issues|0|||
46855498|NCT00077610|83071330|FG000|Overall Study|Sponsors decision to withdraw|0|||
46855499|NCT00077610|83071331|FG001|Overall Study|Sponsors decision to withdraw|0|||
46855500|NCT00077610|83071332|FG002|Overall Study|Sponsors decision to withdraw|1|||
46855501|NCT03385564|83071349|FG000|Overall Study|Adverse Event|0|||
46855502|NCT03385564|83071350|FG001|Overall Study|Adverse Event|0|||
46855503|NCT03385564|83071351|FG002|Overall Study|Adverse Event|3|||
46855504|NCT03385564|83071352|FG003|Overall Study|Adverse Event|3|||
46855505|NCT03385564|83071349|FG000|Overall Study|Other than listed|0|||
46855506|NCT03385564|83071350|FG001|Overall Study|Other than listed|0|||
46855507|NCT03385564|83071351|FG002|Overall Study|Other than listed|0|||
46855508|NCT03385564|83071352|FG003|Overall Study|Other than listed|5|||
46855509|NCT03385564|83071349|FG000|Overall Study|Withdrawal by Subject|0|||
46793648|NCT00621140|83012193|FG001|Overall Study|Other incl. lack of efficacy|5|||
46793649|NCT00207727|83012204|FG000|Overall Study|Withdrawal by Subject|0|||
46793650|NCT00207727|83012205|FG001|Overall Study|Withdrawal by Subject|0|||
46793651|NCT00207727|83012206|FG002|Overall Study|Withdrawal by Subject|0|||
46793652|NCT00207727|83012207|FG003|Overall Study|Withdrawal by Subject|0|||
46855510|NCT03385564|83071350|FG001|Overall Study|Withdrawal by Subject|1|||
46674275|NCT01152385|82889899|FG002|Overall Study|Withdrawal by Subject|1|||
46793653|NCT00207727|83012208|FG004|Overall Study|Withdrawal by Subject|1|||
46793654|NCT00207727|83012204|FG000|Overall Study|Lost to Follow-up|0|||
46793655|NCT00207727|83012205|FG001|Overall Study|Lost to Follow-up|1|||
46793656|NCT00207727|83012206|FG002|Overall Study|Lost to Follow-up|0|||
46793657|NCT00207727|83012207|FG003|Overall Study|Lost to Follow-up|0|||
46793658|NCT00207727|83012208|FG004|Overall Study|Lost to Follow-up|0|||
46793659|NCT00207727|83012204|FG000|Overall Study|Other|38|||
46793660|NCT00207727|83012205|FG001|Overall Study|Other|41|||
46793661|NCT00207727|83012206|FG002|Overall Study|Other|41|||
46793662|NCT00207727|83012207|FG003|Overall Study|Other|37|||
46793663|NCT00207727|83012208|FG004|Overall Study|Other|33|||
46793664|NCT00504556|83012225|FG000|Overall Study|Adverse Event|11|||
46793665|NCT00504556|83012226|FG001|Overall Study|Adverse Event|11|||
46793666|NCT00504556|83012227|FG002|Overall Study|Adverse Event|14|||
46793667|NCT00504556|83012228|FG003|Overall Study|Adverse Event|13|||
46793668|NCT00504556|83012229|FG004|Overall Study|Adverse Event|5|||
46793669|NCT00504556|83012225|FG000|Overall Study|Death|3|||
46793670|NCT00504556|83012226|FG001|Overall Study|Death|3|||
46793671|NCT00504556|83012227|FG002|Overall Study|Death|1|||
46793672|NCT00504556|83012228|FG003|Overall Study|Death|0|||
46793673|NCT00504556|83012229|FG004|Overall Study|Death|2|||
46793674|NCT00504556|83012225|FG000|Overall Study|Protocol Violation|1|||
46793675|NCT00504556|83012226|FG001|Overall Study|Protocol Violation|3|||
46793676|NCT00504556|83012227|FG002|Overall Study|Protocol Violation|2|||
46793677|NCT00504556|83012228|FG003|Overall Study|Protocol Violation|1|||
46793678|NCT00504556|83012229|FG004|Overall Study|Protocol Violation|2|||
46793679|NCT00504556|83012225|FG000|Overall Study|Lost to Follow-up|0|||
46855511|NCT03385564|83071351|FG002|Overall Study|Withdrawal by Subject|1|||
46855512|NCT03385564|83071352|FG003|Overall Study|Withdrawal by Subject|0|||
46855513|NCT03385564|83071349|FG000|Overall Study|Lack of Efficacy|0|||
46855514|NCT03385564|83071350|FG001|Overall Study|Lack of Efficacy|0|||
46855515|NCT03385564|83071351|FG002|Overall Study|Lack of Efficacy|0|||
46674276|NCT01152385|82889900|FG003|Overall Study|Withdrawal by Subject|1|||
46674277|NCT01152385|82889897|FG000|Overall Study|Protocol Violation|0|||
46855516|NCT03385564|83071352|FG003|Overall Study|Lack of Efficacy|1|||
46793680|NCT00504556|83012226|FG001|Overall Study|Lost to Follow-up|0|||
46793681|NCT00504556|83012227|FG002|Overall Study|Lost to Follow-up|1|||
46793682|NCT00504556|83012228|FG003|Overall Study|Lost to Follow-up|1|||
46793683|NCT00504556|83012229|FG004|Overall Study|Lost to Follow-up|1|||
46855517|NCT03385564|83071349|FG000|Overall Study|Death|0|||
46855518|NCT03385564|83071350|FG001|Overall Study|Death|0|||
46855519|NCT03385564|83071351|FG002|Overall Study|Death|1|||
46674278|NCT01152385|82889898|FG001|Overall Study|Protocol Violation|0|||
46793684|NCT00504556|83012225|FG000|Overall Study|Withdrawal by Subject|16|||
46793685|NCT00504556|83012226|FG001|Overall Study|Withdrawal by Subject|16|||
46793686|NCT00504556|83012227|FG002|Overall Study|Withdrawal by Subject|7|||
46793687|NCT00504556|83012228|FG003|Overall Study|Withdrawal by Subject|8|||
46855520|NCT03385564|83071352|FG003|Overall Study|Death|0|||
46855521|NCT00066222|83071362|FG000|Overall Study|No protocol treatment received|1|||
46855522|NCT00397943|83071371|FG000|Overall Study|Unspecified reasons|12|||
46855523|NCT00397943|83071372|FG001|Overall Study|Unspecified reasons|9|||
46855524|NCT00397943|83071373|FG002|Overall Study|Unspecified reasons|0|||
46855525|NCT00397943|83071374|FG003|Overall Study|Unspecified reasons|0|||
46793688|NCT00504556|83012229|FG004|Overall Study|Withdrawal by Subject|12|||
46793689|NCT00504556|83012225|FG000|Overall Study|administrative reasons|0|||
46793690|NCT00504556|83012226|FG001|Overall Study|administrative reasons|2|||
46793691|NCT00504556|83012227|FG002|Overall Study|administrative reasons|2|||
46793692|NCT00504556|83012228|FG003|Overall Study|administrative reasons|1|||
46793693|NCT00504556|83012229|FG004|Overall Study|administrative reasons|2|||
46793694|NCT00504556|83012225|FG000|Overall Study|did not meet entry criteria|2|||
46793695|NCT00504556|83012226|FG001|Overall Study|did not meet entry criteria|0|||
46793696|NCT00504556|83012227|FG002|Overall Study|did not meet entry criteria|1|||
46793697|NCT00504556|83012228|FG003|Overall Study|did not meet entry criteria|1|||
46793698|NCT00504556|83012229|FG004|Overall Study|did not meet entry criteria|0|||
46793699|NCT00504556|83012225|FG000|Overall Study|data monitor committee decision|0|||
46793700|NCT00504556|83012226|FG001|Overall Study|data monitor committee decision|0|||
46793701|NCT00504556|83012227|FG002|Overall Study|data monitor committee decision|0|||
46793702|NCT00504556|83012228|FG003|Overall Study|data monitor committee decision|100|||
46793703|NCT00504556|83012229|FG004|Overall Study|data monitor committee decision|0|||
46793704|NCT00504556|83012225|FG000|Overall Study|Other|2|||
46793705|NCT00504556|83012226|FG001|Overall Study|Other|2|||
46793706|NCT00504556|83012227|FG002|Overall Study|Other|2|||
46793707|NCT00504556|83012228|FG003|Overall Study|Other|3|||
46793708|NCT00504556|83012229|FG004|Overall Study|Other|0|||
46793709|NCT00504556|83012225|FG000|Overall Study|not in safety analysis set|0|||
46793710|NCT00504556|83012226|FG001|Overall Study|not in safety analysis set|1|||
46793711|NCT00504556|83012227|FG002|Overall Study|not in safety analysis set|1|||
46793712|NCT00504556|83012228|FG003|Overall Study|not in safety analysis set|0|||
46793713|NCT00504556|83012229|FG004|Overall Study|not in safety analysis set|1|||
46793714|NCT00206323|83012243|FG000|Overall Study|Lack of Efficacy|4|||
46793715|NCT00206323|83012244|FG001|Overall Study|Lack of Efficacy|1|||
46793716|NCT00206323|83012243|FG000|Overall Study|Adverse Event|1|||
46793717|NCT00206323|83012244|FG001|Overall Study|Adverse Event|1|||
46793718|NCT00206323|83012243|FG000|Overall Study|Lost to Follow-up|1|||
46793719|NCT00206323|83012244|FG001|Overall Study|Lost to Follow-up|1|||
46793720|NCT03903159|83012250|FG000|Overall Study|Discharged with Staff Approval|2|||
46793721|NCT03903159|83012250|FG000|Overall Study|Discharged at Staff Request|2|||
46793722|NCT03903159|83012250|FG000|Overall Study|Discharged Against Staff Advice|1|||
46793723|NCT00205855|83012254|FG000|Overall Study|Only received temporary implants|16|||
46793724|NCT00205855|83012254|FG000|Overall Study|Withdrawal by Subject|5|||
46793725|NCT00536991|83012258|FG000|Overall Study|Withdrawal by Subject|10|||
46793726|NCT00536991|83012258|FG000|Overall Study|Physician Decision|1|||
46793727|NCT00536991|83012258|FG000|Overall Study|patient ineligible|2|||
46855526|NCT00397943|83071375|FG004|Overall Study|Unspecified reasons|0|||
46855527|NCT00066066|83071390|FG000|Overall Study|Lost to Follow-up|6|||
46855528|NCT00066066|83071391|FG001|Overall Study|Lost to Follow-up|4|||
46855529|NCT00066066|83071392|FG002|Overall Study|Lost to Follow-up|7|||
46855530|NCT00066066|83071393|FG003|Overall Study|Lost to Follow-up|4|||
46855531|NCT00066066|83071394|FG004|Overall Study|Lost to Follow-up|3|||
46855532|NCT00066066|83071395|FG005|Overall Study|Lost to Follow-up|5|||
46855533|NCT00363467|83071409|FG000|Overall Study|Physician Decision|1|||
46855534|NCT00397631|83071415|FG000|Overall Study|Adverse Event|5|||
46855535|NCT00397631|83071416|FG001|Overall Study|Adverse Event|6|||
46855536|NCT00397631|83071415|FG000|Overall Study|Lack of Efficacy|7|||
46977657|NCT02660359|83222740|FG002|Overall Study|Other|3|||
46977658|NCT02660359|83222738|FG000|Overall Study|Withdrawal by Subject|7|||
46977659|NCT02660359|83222739|FG001|Overall Study|Withdrawal by Subject|5|||
46977660|NCT02660359|83222740|FG002|Overall Study|Withdrawal by Subject|8|||
46977661|NCT02660359|83222738|FG000|Overall Study|Lost to Follow-up|3|||
46977662|NCT02660359|83222739|FG001|Overall Study|Lost to Follow-up|3|||
46977663|NCT02660359|83222740|FG002|Overall Study|Lost to Follow-up|0|||
46674279|NCT01152385|82889899|FG002|Overall Study|Protocol Violation|0|||
46793728|NCT00504166|83012265|FG000|Overall Study|Adverse Event|1|||
46793729|NCT00504166|83012266|FG001|Overall Study|Adverse Event|4|||
46793730|NCT00504166|83012265|FG000|Overall Study|Withdrawal by Subject|3|||
46793731|NCT00504166|83012266|FG001|Overall Study|Withdrawal by Subject|6|||
46793732|NCT00504166|83012265|FG000|Overall Study|Physician Decision|1|||
46793733|NCT00504166|83012266|FG001|Overall Study|Physician Decision|1|||
46793734|NCT00504166|83012265|FG000|Overall Study|Lost to Follow-up|1|||
46793735|NCT00504166|83012266|FG001|Overall Study|Lost to Follow-up|3|||
46793736|NCT00509236|83012274|FG000|Overall Study|Adverse Event|7|||
46793737|NCT00509236|83012275|FG001|Overall Study|Adverse Event|9|||
46793738|NCT00509236|83012274|FG000|Overall Study|Withdrawal by Subject|5|||
46793739|NCT00509236|83012275|FG001|Overall Study|Withdrawal by Subject|10|||
46855537|NCT00397631|83071416|FG001|Overall Study|Lack of Efficacy|10|||
46977664|NCT02628743|83222748|FG000|Overall Study|Other|3|||
46855538|NCT00397631|83071415|FG000|Overall Study|Lost to Follow-up|8|||
46855539|NCT00397631|83071416|FG001|Overall Study|Lost to Follow-up|9|||
46855540|NCT00397631|83071415|FG000|Overall Study|Physician Decision|2|||
46855541|NCT00397631|83071416|FG001|Overall Study|Physician Decision|0|||
46855542|NCT00397631|83071415|FG000|Overall Study|Protocol Violation|0|||
46855543|NCT00397631|83071416|FG001|Overall Study|Protocol Violation|1|||
46855544|NCT00397631|83071415|FG000|Overall Study|Withdrawal by Subject|7|||
46855545|NCT00397631|83071416|FG001|Overall Study|Withdrawal by Subject|14|||
46855546|NCT00397631|83071415|FG000|Overall Study|protocol discontinuation criteria|1|||
46855547|NCT00397631|83071416|FG001|Overall Study|protocol discontinuation criteria|4|||
46855548|NCT00077376|83071422|FG000|Overall Study|Adverse Event|8|||
46855549|NCT00077376|83071422|FG000|Overall Study|Withdrawal by Subject|2|||
46855550|NCT00077376|83071422|FG000|Overall Study|Death|1|||
46855551|NCT00077376|83071422|FG000|Overall Study|Physician Decision|1|||
46855552|NCT00077376|83071422|FG000|Overall Study|Alternative therapy|5|||
46855553|NCT00077376|83071422|FG000|Overall Study|Complicating disease|1|||
46855554|NCT00077376|83071422|FG000|Overall Study|Still on treatment|1|||
46855555|NCT00077376|83071422|FG000|Overall Study|Symptomatic deterioration|1|||
46855556|NCT00077376|83071422|FG000|Overall Study|Surgery|1|||
46855557|NCT00077376|83071422|FG000|Overall Study|Insurance ran out|1|||
46855558|NCT00363311|83071428|FG000|Overall Study|Adverse Event|6|||
46855559|NCT00363311|83071429|FG001|Overall Study|Adverse Event|4|||
46855560|NCT00363311|83071428|FG000|Overall Study|Lost to Follow-up|3|||
46855561|NCT00363311|83071429|FG001|Overall Study|Lost to Follow-up|0|||
46855562|NCT00363311|83071428|FG000|Overall Study|Protocol Violation|1|||
46855563|NCT00363311|83071429|FG001|Overall Study|Protocol Violation|2|||
46855564|NCT00363311|83071428|FG000|Overall Study|Withdrawal by Subject|12|||
46855565|NCT00363311|83071429|FG001|Overall Study|Withdrawal by Subject|6|||
46855566|NCT00363311|83071428|FG000|Overall Study|Physician Decision|1|||
46855567|NCT00363311|83071429|FG001|Overall Study|Physician Decision|1|||
46855568|NCT00363311|83071428|FG000|Overall Study|Sponsor Terminated Study|2|||
46855569|NCT00363311|83071429|FG001|Overall Study|Sponsor Terminated Study|2|||
46855570|NCT00363311|83071428|FG000|Overall Study|Disease Progression|46|||
46855571|NCT00363311|83071429|FG001|Overall Study|Disease Progression|26|||
46855572|NCT00363311|83071428|FG000|Overall Study|Non-Compliance|1|||
46855573|NCT00363311|83071429|FG001|Overall Study|Non-Compliance|1|||
46855574|NCT00363311|83071428|FG000|Overall Study|Participant Refused Biopsy|1|||
46855575|NCT00363311|83071429|FG001|Overall Study|Participant Refused Biopsy|0|||
46855576|NCT00363311|83071428|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
46855577|NCT00363311|83071429|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
46855578|NCT00363311|83071428|FG000|Overall Study|Participant Opted for Treatment|1|||
46977665|NCT02628743|83222748|FG000|Overall Study|Withdrawal by Subject|50|||
46977666|NCT02628743|83222748|FG000|Overall Study|Study Terminated by Sponsor|76|||
46793740|NCT00509236|83012274|FG000|Overall Study|Protocol Violation|3|||
46793741|NCT00509236|83012275|FG001|Overall Study|Protocol Violation|0|||
46793742|NCT00509236|83012274|FG000|Overall Study|Excluded Medication|1|||
46793743|NCT00509236|83012275|FG001|Overall Study|Excluded Medication|1|||
46793744|NCT00509236|83012274|FG000|Overall Study|Scheduled Kidney Transplant|1|||
46793745|NCT00509236|83012275|FG001|Overall Study|Scheduled Kidney Transplant|0|||
46793746|NCT00508924|83012285|FG000|Overall Study|Protocol Violation|0|||
46793747|NCT00508924|83012286|FG001|Overall Study|Protocol Violation|0|||
46793748|NCT00508924|83012287|FG002|Overall Study|Protocol Violation|1|||
46793749|NCT00508924|83012288|FG003|Overall Study|Protocol Violation|1|||
46793750|NCT00620750|83012298|FG000|Overall Study|Lost to Follow-up|25|||
46793751|NCT00508144|83012302|FG000|Overall Study|Not eligible|6|||
46793752|NCT00508144|83012302|FG000|Overall Study|Death|5|||
46793753|NCT00621842|83012306|FG000|Overall Study|Adverse Event|6|||
46793754|NCT00621842|83012306|FG000|Overall Study|Withdrawal by Subject|7|||
46793755|NCT00621842|83012306|FG000|Overall Study|Protocol Violation|4|||
46793756|NCT00621842|83012306|FG000|Overall Study|Lack of Efficacy|2|||
46793757|NCT00503776|83012314|FG000|Overall Study|Withdrawal by Subject|1|||
46855579|NCT00363311|83071429|FG001|Overall Study|Participant Opted for Treatment|0|||
46855580|NCT00363311|83071428|FG000|Overall Study|Participant Moved to Another Country|1|||
46855581|NCT00363311|83071429|FG001|Overall Study|Participant Moved to Another Country|0|||
46855582|NCT00363311|83071428|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
46855583|NCT00363311|83071429|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
46855584|NCT00363311|83071428|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
46855585|NCT00363311|83071429|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
46977667|NCT02628743|83222748|FG000|Overall Study|Physician Decision|2|||
46793758|NCT00503776|83012315|FG001|Overall Study|Withdrawal by Subject|0|||
46855586|NCT00363311|83071428|FG000|Overall Study|Participant Moved to Louisiana|0|||
46793759|NCT00503776|83012316|FG002|Overall Study|Withdrawal by Subject|1|||
46793760|NCT00503776|83012317|FG003|Overall Study|Withdrawal by Subject|1|||
46793761|NCT00503776|83012314|FG000|Overall Study|Physician Decision|0|||
46793762|NCT00503776|83012315|FG001|Overall Study|Physician Decision|0|||
46793763|NCT00503776|83012316|FG002|Overall Study|Physician Decision|1|||
46855587|NCT00363311|83071429|FG001|Overall Study|Participant Moved to Louisiana|1|||
46977668|NCT05059301|83222755|FG000|Overall Study|Adverse Event|0|||
46977669|NCT05059301|83222756|FG001|Overall Study|Adverse Event|2|||
46977670|NCT05059301|83222757|FG002|Overall Study|Adverse Event|2|||
46977671|NCT05059301|83222755|FG000|Overall Study|Lost to Follow-up|2|||
46977672|NCT05059301|83222756|FG001|Overall Study|Lost to Follow-up|3|||
46977673|NCT05059301|83222757|FG002|Overall Study|Lost to Follow-up|3|||
46977674|NCT01938430|83222783|FG000|Overall Study|Randomized but Not Treated|0|||
46977675|NCT01938430|83222784|FG001|Overall Study|Randomized but Not Treated|0|||
46977676|NCT01938430|83222785|FG002|Overall Study|Randomized but Not Treated|0|||
46977677|NCT01938430|83222786|FG003|Overall Study|Randomized but Not Treated|0|||
46977678|NCT01938430|83222787|FG004|Overall Study|Randomized but Not Treated|0|||
46977679|NCT01938430|83222788|FG005|Overall Study|Randomized but Not Treated|0|||
46977680|NCT01938430|83222789|FG006|Overall Study|Randomized but Not Treated|0|||
46977681|NCT01938430|83222790|FG007|Overall Study|Randomized but Not Treated|0|||
46977682|NCT01938430|83222791|FG008|Overall Study|Randomized but Not Treated|0|||
46977683|NCT01938430|83222792|FG009|Overall Study|Randomized but Not Treated|0|||
46977684|NCT01938430|83222793|FG010|Overall Study|Randomized but Not Treated|1|||
46977685|NCT01938430|83222794|FG011|Overall Study|Randomized but Not Treated|0|||
46674280|NCT01152385|82889900|FG003|Overall Study|Protocol Violation|1|||
46674281|NCT01152385|82889897|FG000|Overall Study|Adverse Event|1|||
46674282|NCT01152385|82889898|FG001|Overall Study|Adverse Event|1|||
46977686|NCT01938430|83222795|FG012|Overall Study|Randomized but Not Treated|0|||
46977687|NCT01938430|83222796|FG013|Overall Study|Randomized but Not Treated|1|||
46977688|NCT01938430|83222783|FG000|Overall Study|Adverse Event|0|||
46977689|NCT01938430|83222784|FG001|Overall Study|Adverse Event|0|||
46977690|NCT01938430|83222785|FG002|Overall Study|Adverse Event|0|||
46977691|NCT01938430|83222786|FG003|Overall Study|Adverse Event|0|||
46977692|NCT01938430|83222787|FG004|Overall Study|Adverse Event|0|||
46977693|NCT01938430|83222788|FG005|Overall Study|Adverse Event|0|||
46977694|NCT01938430|83222789|FG006|Overall Study|Adverse Event|1|||
46977695|NCT01938430|83222790|FG007|Overall Study|Adverse Event|0|||
46977696|NCT01938430|83222791|FG008|Overall Study|Adverse Event|0|||
46977697|NCT01938430|83222792|FG009|Overall Study|Adverse Event|0|||
46977698|NCT01938430|83222793|FG010|Overall Study|Adverse Event|0|||
46674283|NCT01152385|82889899|FG002|Overall Study|Adverse Event|0|||
46674284|NCT01152385|82889900|FG003|Overall Study|Adverse Event|0|||
46674285|NCT01152385|82889897|FG000|Overall Study|Study-specific withdrawal criteria|1|||
46793764|NCT00503776|83012317|FG003|Overall Study|Physician Decision|1|||
46793765|NCT00619112|83012334|FG000|Overall Study|Adverse Event|1|||
46793766|NCT00619112|83012335|FG001|Overall Study|Adverse Event|2|||
46793767|NCT00619502|83012346|FG000|Overall Study|Lost to Follow-up|8|||
46793768|NCT00619502|83012347|FG001|Overall Study|Lost to Follow-up|10|||
46793769|NCT00618956|83012357|FG000|Overall Study|Adverse Event|10|||
46793770|NCT00618956|83012358|FG001|Overall Study|Adverse Event|34|||
46793771|NCT00618956|83012357|FG000|Overall Study|Lack of Efficacy|2|||
46793772|NCT00618956|83012358|FG001|Overall Study|Lack of Efficacy|1|||
46674286|NCT01152385|82889898|FG001|Overall Study|Study-specific withdrawal criteria|1|||
46674287|NCT01152385|82889899|FG002|Overall Study|Study-specific withdrawal criteria|2|||
46793773|NCT00618956|83012357|FG000|Overall Study|Withdrawal by Subject|5|||
46793774|NCT00618956|83012358|FG001|Overall Study|Withdrawal by Subject|7|||
46793775|NCT00618956|83012357|FG000|Overall Study|Lost to Follow-up|4|||
46793776|NCT00618956|83012358|FG001|Overall Study|Lost to Follow-up|5|||
46793777|NCT00618956|83012357|FG000|Overall Study|Protocol Violation|2|||
46793778|NCT00618956|83012358|FG001|Overall Study|Protocol Violation|2|||
46793779|NCT00618956|83012357|FG000|Overall Study|did not meet criteria, non-compliance|2|||
46793780|NCT00618956|83012358|FG001|Overall Study|did not meet criteria, non-compliance|1|||
46793781|NCT00716417|83012380|FG000|Overall Study|Adverse Event|0|||
46793782|NCT00716417|83012381|FG001|Overall Study|Adverse Event|0|||
46793783|NCT00716417|83012382|FG002|Overall Study|Adverse Event|2|||
46793784|NCT00716417|83012383|FG003|Overall Study|Adverse Event|1|||
46793785|NCT00716417|83012384|FG004|Overall Study|Adverse Event|0|||
46793786|NCT00716417|83012385|FG005|Overall Study|Adverse Event|0|||
46793787|NCT00716417|83012386|FG006|Overall Study|Adverse Event|3|||
46977699|NCT01938430|83222794|FG011|Overall Study|Adverse Event|0|||
46977700|NCT01938430|83222795|FG012|Overall Study|Adverse Event|0|||
46977701|NCT01938430|83222796|FG013|Overall Study|Adverse Event|0|||
46977702|NCT01938430|83222783|FG000|Overall Study|Death|1|||
46977703|NCT01938430|83222784|FG001|Overall Study|Death|2|||
46977704|NCT01938430|83222785|FG002|Overall Study|Death|2|||
46793788|NCT00716417|83012387|FG007|Overall Study|Adverse Event|1|||
46793789|NCT00716417|83012388|FG008|Overall Study|Adverse Event|0|||
46793790|NCT00716417|83012389|FG009|Overall Study|Adverse Event|3|||
46793791|NCT00716417|83012380|FG000|Overall Study|Withdrawal by Subject|0|||
46793792|NCT00716417|83012381|FG001|Overall Study|Withdrawal by Subject|1|||
46793793|NCT00716417|83012382|FG002|Overall Study|Withdrawal by Subject|0|||
46977705|NCT01938430|83222786|FG003|Overall Study|Death|1|||
46977706|NCT01938430|83222787|FG004|Overall Study|Death|0|||
46977707|NCT01938430|83222788|FG005|Overall Study|Death|0|||
46977708|NCT01938430|83222789|FG006|Overall Study|Death|1|||
46977709|NCT01938430|83222790|FG007|Overall Study|Death|1|||
46977710|NCT01938430|83222791|FG008|Overall Study|Death|2|||
46977711|NCT01938430|83222792|FG009|Overall Study|Death|3|||
46977712|NCT01938430|83222793|FG010|Overall Study|Death|0|||
46977713|NCT01938430|83222794|FG011|Overall Study|Death|0|||
46977714|NCT01938430|83222795|FG012|Overall Study|Death|0|||
46977715|NCT01938430|83222796|FG013|Overall Study|Death|0|||
46977716|NCT01938430|83222783|FG000|Overall Study|Investigator's Discretion|0|||
46977717|NCT01938430|83222784|FG001|Overall Study|Investigator's Discretion|0|||
46977718|NCT01938430|83222785|FG002|Overall Study|Investigator's Discretion|1|||
46977719|NCT01938430|83222786|FG003|Overall Study|Investigator's Discretion|0|||
46977720|NCT01938430|83222787|FG004|Overall Study|Investigator's Discretion|0|||
46977721|NCT01938430|83222788|FG005|Overall Study|Investigator's Discretion|0|||
46977722|NCT01938430|83222789|FG006|Overall Study|Investigator's Discretion|0|||
46977723|NCT01938430|83222790|FG007|Overall Study|Investigator's Discretion|0|||
46977724|NCT01938430|83222791|FG008|Overall Study|Investigator's Discretion|0|||
46977725|NCT01938430|83222792|FG009|Overall Study|Investigator's Discretion|0|||
46977726|NCT01938430|83222793|FG010|Overall Study|Investigator's Discretion|0|||
46977727|NCT01938430|83222794|FG011|Overall Study|Investigator's Discretion|0|||
46793794|NCT00716417|83012383|FG003|Overall Study|Withdrawal by Subject|2|||
46793795|NCT00716417|83012384|FG004|Overall Study|Withdrawal by Subject|0|||
46977728|NCT01938430|83222795|FG012|Overall Study|Investigator's Discretion|0|||
46977729|NCT01938430|83222796|FG013|Overall Study|Investigator's Discretion|0|||
46977730|NCT01938430|83222783|FG000|Overall Study|Lack of Efficacy|3|||
46977731|NCT01938430|83222784|FG001|Overall Study|Lack of Efficacy|1|||
46977732|NCT01938430|83222785|FG002|Overall Study|Lack of Efficacy|1|||
46977733|NCT01938430|83222786|FG003|Overall Study|Lack of Efficacy|1|||
46977734|NCT01938430|83222787|FG004|Overall Study|Lack of Efficacy|0|||
46977735|NCT01938430|83222788|FG005|Overall Study|Lack of Efficacy|0|||
46977736|NCT01938430|83222789|FG006|Overall Study|Lack of Efficacy|0|||
46977737|NCT01938430|83222790|FG007|Overall Study|Lack of Efficacy|0|||
46977738|NCT01938430|83222791|FG008|Overall Study|Lack of Efficacy|1|||
46977739|NCT01938430|83222792|FG009|Overall Study|Lack of Efficacy|0|||
46977740|NCT01938430|83222793|FG010|Overall Study|Lack of Efficacy|2|||
46977741|NCT01938430|83222794|FG011|Overall Study|Lack of Efficacy|1|||
46977742|NCT01938430|83222795|FG012|Overall Study|Lack of Efficacy|0|||
46977743|NCT01938430|83222796|FG013|Overall Study|Lack of Efficacy|0|||
46977744|NCT01938430|83222783|FG000|Overall Study|Lost to Follow-up|0|||
46977745|NCT01938430|83222784|FG001|Overall Study|Lost to Follow-up|0|||
46977746|NCT01938430|83222785|FG002|Overall Study|Lost to Follow-up|1|||
46977747|NCT01938430|83222786|FG003|Overall Study|Lost to Follow-up|0|||
46977748|NCT01938430|83222787|FG004|Overall Study|Lost to Follow-up|0|||
46977749|NCT01938430|83222788|FG005|Overall Study|Lost to Follow-up|1|||
46977750|NCT01938430|83222789|FG006|Overall Study|Lost to Follow-up|0|||
46977751|NCT01938430|83222790|FG007|Overall Study|Lost to Follow-up|0|||
46977752|NCT01938430|83222791|FG008|Overall Study|Lost to Follow-up|0|||
46977753|NCT01938430|83222792|FG009|Overall Study|Lost to Follow-up|0|||
46977754|NCT01938430|83222793|FG010|Overall Study|Lost to Follow-up|0|||
46977755|NCT01938430|83222794|FG011|Overall Study|Lost to Follow-up|0|||
46977756|NCT01938430|83222795|FG012|Overall Study|Lost to Follow-up|0|||
46977757|NCT01938430|83222796|FG013|Overall Study|Lost to Follow-up|0|||
46977758|NCT01938430|83222783|FG000|Overall Study|Withdrew Consent|0|||
46977759|NCT01938430|83222784|FG001|Overall Study|Withdrew Consent|0|||
46977760|NCT01938430|83222785|FG002|Overall Study|Withdrew Consent|0|||
46977761|NCT01938430|83222786|FG003|Overall Study|Withdrew Consent|0|||
46977762|NCT01938430|83222787|FG004|Overall Study|Withdrew Consent|0|||
46977763|NCT01938430|83222788|FG005|Overall Study|Withdrew Consent|0|||
46977764|NCT01938430|83222789|FG006|Overall Study|Withdrew Consent|0|||
46977765|NCT01938430|83222790|FG007|Overall Study|Withdrew Consent|0|||
46977766|NCT01938430|83222791|FG008|Overall Study|Withdrew Consent|1|||
46977767|NCT01938430|83222792|FG009|Overall Study|Withdrew Consent|0|||
46977768|NCT01938430|83222793|FG010|Overall Study|Withdrew Consent|0|||
46977769|NCT01938430|83222794|FG011|Overall Study|Withdrew Consent|0|||
46977770|NCT01938430|83222795|FG012|Overall Study|Withdrew Consent|0|||
46977771|NCT01938430|83222796|FG013|Overall Study|Withdrew Consent|0|||
46977772|NCT01937884|83222853|FG000|Overall Study|Withdrawal by Subject|1|||
46977773|NCT01937884|83222854|FG001|Overall Study|Withdrawal by Subject|0|||
46977774|NCT01916824|83222864|FG000|Overall Study|Lost to Follow-up|3|||
46977775|NCT01916824|83222865|FG001|Overall Study|Lost to Follow-up|6|||
46977776|NCT01916824|83222864|FG000|Overall Study|Physician Decision|2|||
46977777|NCT01916824|83222865|FG001|Overall Study|Physician Decision|0|||
46977778|NCT01916824|83222864|FG000|Overall Study|Withdrawal by Subject|2|||
46977779|NCT01916824|83222865|FG001|Overall Study|Withdrawal by Subject|3|||
46793796|NCT00716417|83012385|FG005|Overall Study|Withdrawal by Subject|0|||
46977780|NCT01915732|83222873|FG000|Overall Study|Withdrawal by Subject|18|||
46977781|NCT01915732|83222874|FG001|Overall Study|Withdrawal by Subject|18|||
46977782|NCT01915732|83222873|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
46977783|NCT01915732|83222874|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
46977784|NCT01915732|83222873|FG000|Overall Study|Adverse Event|12|||
46977785|NCT01915732|83222874|FG001|Overall Study|Adverse Event|4|||
46977786|NCT01915732|83222873|FG000|Overall Study|Protocol Violation|5|||
46977787|NCT01915732|83222874|FG001|Overall Study|Protocol Violation|5|||
46977788|NCT01915732|83222873|FG000|Overall Study|Lack of Efficacy|6|||
46977789|NCT01915732|83222874|FG001|Overall Study|Lack of Efficacy|11|||
46977790|NCT01915732|83222873|FG000|Overall Study|Lost to Follow-up|22|||
46977791|NCT01915732|83222874|FG001|Overall Study|Lost to Follow-up|26|||
46977792|NCT01915732|83222873|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
46977793|NCT01915732|83222874|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
46977794|NCT01915732|83222873|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
46977795|NCT01915732|83222874|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
46977796|NCT01915732|83222873|FG000|Overall Study|Drug Release Error|1|||
46977797|NCT01915732|83222874|FG001|Overall Study|Drug Release Error|0|||
46977798|NCT01915732|83222873|FG000|Overall Study|Recovered|1|||
46977799|NCT01915732|83222874|FG001|Overall Study|Recovered|0|||
46977800|NCT01915732|83222873|FG000|Overall Study|Pregnancy|1|||
46977801|NCT01915732|83222874|FG001|Overall Study|Pregnancy|0|||
46977802|NCT01915732|83222873|FG000|Overall Study|Poor Perceived Efficacy|1|||
46977803|NCT01915732|83222874|FG001|Overall Study|Poor Perceived Efficacy|0|||
46977804|NCT01915732|83222873|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
46977805|NCT01915732|83222874|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
46977806|NCT01915732|83222873|FG000|Overall Study|Got Well|0|||
46977807|NCT01915732|83222874|FG001|Overall Study|Got Well|1|||
46977808|NCT01915732|83222873|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
46977809|NCT01915732|83222874|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
46977810|NCT01915732|83222873|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
46977811|NCT01915732|83222874|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
46977812|NCT01915732|83222873|FG000|Overall Study|Job Transfer|0|||
46977813|NCT01915732|83222874|FG001|Overall Study|Job Transfer|1|||
46977814|NCT01915732|83222873|FG000|Overall Study|Improper Facial Procedure|0|||
46977815|NCT01915732|83222874|FG001|Overall Study|Improper Facial Procedure|1|||
46977816|NCT01915732|83222873|FG000|Overall Study|Poor Conscious Effect|0|||
46977817|NCT01915732|83222874|FG001|Overall Study|Poor Conscious Effect|1|||
46977818|NCT01936948|83222884|FG000|Overall Study|no 30-day follow-up data|0|||
46977819|NCT01936948|83222885|FG001|Overall Study|no 30-day follow-up data|3|||
46977820|NCT01936948|83222886|FG002|Overall Study|no 30-day follow-up data|3|||
46977821|NCT01936948|83222887|FG003|Overall Study|no 30-day follow-up data|3|||
46674288|NCT01152385|82889900|FG003|Overall Study|Study-specific withdrawal criteria|0|||
46674289|NCT01152385|82889897|FG000|Overall Study|Other|4|||
46674290|NCT01152385|82889898|FG001|Overall Study|Other|3|||
46793797|NCT00716417|83012386|FG006|Overall Study|Withdrawal by Subject|1|||
46793798|NCT00716417|83012387|FG007|Overall Study|Withdrawal by Subject|0|||
46793799|NCT00716417|83012388|FG008|Overall Study|Withdrawal by Subject|0|||
46793800|NCT00716417|83012389|FG009|Overall Study|Withdrawal by Subject|0|||
46977822|NCT01936870|83222895|FG000|Overall Study|No Visit After Treatment|176|||
46674291|NCT01152385|82889899|FG002|Overall Study|Other|2|||
46793801|NCT00716417|83012380|FG000|Overall Study|Progressive disease|3|||
46977823|NCT01936870|83222895|FG000|Overall Study|Protocol Violation|12|||
46977824|NCT01936870|83222895|FG000|Overall Study|No Drug Administration|1|||
46977825|NCT01618864|83222899|FG000|Overall Study|Withdrawal by Subject|2|||
46977826|NCT01618864|83222899|FG000|Overall Study|Lost to Follow-up|2|||
46977827|NCT01618708|83222910|FG000|Overall Study|Adverse Event|10|||
46977828|NCT01618708|83222911|FG001|Overall Study|Adverse Event|10|||
46793802|NCT00716417|83012381|FG001|Overall Study|Progressive disease|5|||
46793803|NCT00716417|83012382|FG002|Overall Study|Progressive disease|3|||
46793804|NCT00716417|83012383|FG003|Overall Study|Progressive disease|8|||
46793805|NCT00716417|83012384|FG004|Overall Study|Progressive disease|0|||
46793806|NCT00716417|83012385|FG005|Overall Study|Progressive disease|3|||
46793807|NCT00716417|83012386|FG006|Overall Study|Progressive disease|3|||
46793808|NCT00716417|83012387|FG007|Overall Study|Progressive disease|1|||
46793809|NCT00716417|83012388|FG008|Overall Study|Progressive disease|5|||
46977829|NCT01618708|83222910|FG000|Overall Study|Lost to Follow-up|3|||
46977830|NCT01618708|83222911|FG001|Overall Study|Lost to Follow-up|3|||
46977831|NCT01618708|83222910|FG000|Overall Study|Withdrawal by Subject|17|||
46977832|NCT01618708|83222911|FG001|Overall Study|Withdrawal by Subject|22|||
46977833|NCT01618708|83222910|FG000|Overall Study|Lack of Efficacy|8|||
46977834|NCT01618708|83222911|FG001|Overall Study|Lack of Efficacy|8|||
46977835|NCT01618708|83222910|FG000|Overall Study|Technical problems|2|||
46674292|NCT01152385|82889900|FG003|Overall Study|Other|3|||
46793810|NCT00716417|83012389|FG009|Overall Study|Progressive disease|0|||
46793811|NCT00716417|83012380|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
46977836|NCT01618708|83222911|FG001|Overall Study|Technical problems|0|||
46977837|NCT01618708|83222910|FG000|Overall Study|Other than specified above|1|||
46977838|NCT01618708|83222911|FG001|Overall Study|Other than specified above|1|||
46977839|NCT01618708|83222910|FG000|Overall Study|Randomized but not treated|3|||
46793812|NCT00716417|83012381|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
46977840|NCT01618708|83222911|FG001|Overall Study|Randomized but not treated|2|||
46674293|NCT01152190|82889916|FG000|Overall Study|Adverse Event|2|||
46977841|NCT03315455|83222922|FG000|Overall Study|Ongoing in the Study|13|||
46977842|NCT03315455|83222923|FG001|Overall Study|Ongoing in the Study|24|||
46977843|NCT03315455|83222924|FG002|Overall Study|Ongoing in the Study|17|||
46977844|NCT03315455|83222925|FG003|Overall Study|Ongoing in the Study|15|||
46977845|NCT03315455|83222922|FG000|Overall Study|Withdrawal by Subject|0|||
46977846|NCT03315455|83222923|FG001|Overall Study|Withdrawal by Subject|1|||
46977847|NCT03315455|83222924|FG002|Overall Study|Withdrawal by Subject|0|||
46977848|NCT03315455|83222925|FG003|Overall Study|Withdrawal by Subject|0|||
46977849|NCT00790933|83222948|FG000|Overall Study|Adverse Event|94|||
46977850|NCT00790933|83222949|FG001|Overall Study|Adverse Event|119|||
46977851|NCT00790933|83222950|FG002|Overall Study|Adverse Event|65|||
46977852|NCT00790933|83222951|FG003|Overall Study|Adverse Event|5|||
46977853|NCT00790933|83222952|FG004|Overall Study|Adverse Event|69|||
46977854|NCT00790933|83222948|FG000|Overall Study|Protocol Violation(s)|8|||
46977855|NCT00790933|83222949|FG001|Overall Study|Protocol Violation(s)|18|||
46977856|NCT00790933|83222950|FG002|Overall Study|Protocol Violation(s)|7|||
46977857|NCT00790933|83222951|FG003|Overall Study|Protocol Violation(s)|0|||
46977858|NCT00790933|83222952|FG004|Overall Study|Protocol Violation(s)|12|||
46977859|NCT00790933|83222948|FG000|Overall Study|Lack of Efficacy|192|||
46977860|NCT00790933|83222949|FG001|Overall Study|Lack of Efficacy|176|||
46977861|NCT00790933|83222950|FG002|Overall Study|Lack of Efficacy|130|||
46977862|NCT00790933|83222951|FG003|Overall Study|Lack of Efficacy|1|||
46977863|NCT00790933|83222952|FG004|Overall Study|Lack of Efficacy|121|||
46977864|NCT00790933|83222948|FG000|Overall Study|Study Terminated by Sponsor|0|||
46977865|NCT00790933|83222949|FG001|Overall Study|Study Terminated by Sponsor|0|||
46977866|NCT00790933|83222950|FG002|Overall Study|Study Terminated by Sponsor|1|||
46977867|NCT00790933|83222951|FG003|Overall Study|Study Terminated by Sponsor|0|||
46977868|NCT00790933|83222952|FG004|Overall Study|Study Terminated by Sponsor|0|||
46977869|NCT00790933|83222948|FG000|Overall Study|Withdrawal by Subject|123|||
46977870|NCT00790933|83222949|FG001|Overall Study|Withdrawal by Subject|120|||
46977871|NCT00790933|83222950|FG002|Overall Study|Withdrawal by Subject|52|||
46977872|NCT00790933|83222951|FG003|Overall Study|Withdrawal by Subject|6|||
46977873|NCT00790933|83222952|FG004|Overall Study|Withdrawal by Subject|50|||
46977874|NCT00790933|83222948|FG000|Overall Study|Lost to Follow-up|13|||
46977875|NCT00790933|83222949|FG001|Overall Study|Lost to Follow-up|31|||
46977876|NCT00790933|83222950|FG002|Overall Study|Lost to Follow-up|10|||
46977877|NCT00790933|83222951|FG003|Overall Study|Lost to Follow-up|1|||
46977878|NCT00790933|83222952|FG004|Overall Study|Lost to Follow-up|15|||
46977879|NCT00790933|83222948|FG000|Overall Study|Reason Not Specified|8|||
46977880|NCT00790933|83222949|FG001|Overall Study|Reason Not Specified|16|||
46977881|NCT00790933|83222950|FG002|Overall Study|Reason Not Specified|4|||
46977882|NCT00790933|83222951|FG003|Overall Study|Reason Not Specified|1|||
46977883|NCT00790933|83222952|FG004|Overall Study|Reason Not Specified|9|||
46977884|NCT02161211|83222971|FG000|Overall Study|Lost to Follow-up|21|||
46977885|NCT02161211|83222972|FG001|Overall Study|Lost to Follow-up|27|||
46977886|NCT02161211|83222973|FG002|Overall Study|Lost to Follow-up|21|||
46977887|NCT02161211|83222971|FG000|Overall Study|Dropped|12|||
46977888|NCT02161211|83222972|FG001|Overall Study|Dropped|5|||
46977889|NCT02161211|83222973|FG002|Overall Study|Dropped|9|||
46977890|NCT01676701|83222983|FG000|Overall Study|Protocol Violation|1|||
46977891|NCT01676701|83222984|FG001|Overall Study|Protocol Violation|0|||
46977892|NCT01676701|83222983|FG000|Overall Study|Sponsor Decision|3|||
46855588|NCT00362609|83071437|FG000|Overall Study|Withdrawal by Subject|0|||
46855589|NCT00362609|83071438|FG001|Overall Study|Withdrawal by Subject|1|||
46855590|NCT00362609|83071437|FG000|Overall Study|Protocol Violation|0|||
46855591|NCT00362609|83071438|FG001|Overall Study|Protocol Violation|1|||
46855592|NCT00362375|83071446|FG000|Overall Study|Lost to Follow-up|40|||
46855593|NCT00362375|83071447|FG001|Overall Study|Lost to Follow-up|35|||
46855594|NCT00362297|83071455|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
46977893|NCT01676701|83222984|FG001|Overall Study|Sponsor Decision|4|||
46977894|NCT01670279|83222995|FG000|Overall Study|Adverse Event|0|||
46855595|NCT00362297|83071456|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
46855596|NCT00065442|83071464|FG000|Overall Study|Lost to Follow-up|1|||
46977895|NCT01670279|83222996|FG001|Overall Study|Adverse Event|1|||
46977896|NCT01670279|83222997|FG002|Overall Study|Adverse Event|0|||
46977897|NCT01670279|83222998|FG003|Overall Study|Adverse Event|0|||
46977898|NCT01670279|83222995|FG000|Overall Study|Physician Decision|0|||
46855597|NCT00065442|83071465|FG001|Overall Study|Lost to Follow-up|1|||
46855598|NCT00065442|83071464|FG000|Overall Study|Death|121|||
46977899|NCT01670279|83222996|FG001|Overall Study|Physician Decision|1|||
46977900|NCT01670279|83222997|FG002|Overall Study|Physician Decision|0|||
46977901|NCT01670279|83222998|FG003|Overall Study|Physician Decision|0|||
46977902|NCT01670279|83222995|FG000|Overall Study|Participant met withdrawal criteria|0|||
46977903|NCT01670279|83222996|FG001|Overall Study|Participant met withdrawal criteria|0|||
46977904|NCT01670279|83222997|FG002|Overall Study|Participant met withdrawal criteria|0|||
46977905|NCT01670279|83222998|FG003|Overall Study|Participant met withdrawal criteria|1|||
46977906|NCT02627495|83223006|FG000|Overall Study|Withdrawal by Subject|4|||
46977907|NCT01670045|83223010|FG000|Overall Study|Withdrawal by Subject|3|||
46977908|NCT01670045|83223010|FG000|Overall Study|Adverse Event|1|||
46977909|NCT01670045|83223010|FG000|Overall Study|Death|1|||
46977910|NCT01670045|83223010|FG000|Overall Study|Lost to Follow-up|11|||
46977911|NCT01669421|83223014|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
46977912|NCT01669421|83223014|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
46977913|NCT01671059|83223028|FG000|Overall Study|Adverse Event|4|||
46977914|NCT01671059|83223028|FG000|Overall Study|Lack of Efficacy|1|||
46977915|NCT01669811|83223044|FG000|Overall Study|Investigator decision|0|||
46977916|NCT01669811|83223045|FG001|Overall Study|Investigator decision|1|||
46977917|NCT01669811|83223044|FG000|Overall Study|Withdrawal by Subject|1|||
46977918|NCT01669811|83223045|FG001|Overall Study|Withdrawal by Subject|2|||
46977919|NCT01669811|83223044|FG000|Overall Study|Adverse Event|2|||
46977920|NCT01669811|83223045|FG001|Overall Study|Adverse Event|6|||
46977921|NCT01669811|83223044|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
46977922|NCT01669811|83223045|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
46977923|NCT01669577|83223051|FG000|Overall Study|Death|22|||
46977924|NCT01669577|83223051|FG000|Overall Study|Lost to Follow-up|78|||
46977925|NCT01669577|83223051|FG000|Overall Study|Physician Decision|34|||
46977926|NCT02658175|83223058|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
46793813|NCT00716417|83012382|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
46793814|NCT00716417|83012383|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
46793815|NCT00716417|83012384|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
46793816|NCT00716417|83012385|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
46977927|NCT02658175|83223059|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
46977928|NCT02658175|83223060|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
46977929|NCT02658175|83223058|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
46977930|NCT02658175|83223059|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
46977931|NCT02658175|83223060|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
46977932|NCT02658175|83223058|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
46977933|NCT02658175|83223059|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
46977934|NCT02658175|83223060|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
46977935|NCT02658175|83223058|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
46977936|NCT02658175|83223059|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
46977937|NCT02658175|83223060|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
46977938|NCT02658175|83223058|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
46977939|NCT02658175|83223059|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
46977940|NCT02658175|83223060|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
46977941|NCT02658175|83223058|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
46977942|NCT02658175|83223059|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
46977943|NCT02658175|83223060|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
46977944|NCT02658175|83223058|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
46977945|NCT02658175|83223059|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
46977946|NCT02658175|83223060|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
46977947|NCT02658175|83223058|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
46977948|NCT02658175|83223059|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
46977949|NCT02658175|83223060|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
46977950|NCT02658175|83223058|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
46977951|NCT02658175|83223059|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
46977952|NCT02658175|83223060|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
46977953|NCT02658175|83223058|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
46977954|NCT02658175|83223059|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
46977955|NCT02658175|83223060|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
46977956|NCT02625623|83223070|FG000|Overall Study|Participants randomized but not treated|9|||
46977957|NCT02625623|83223071|FG001|Overall Study|Participants randomized but not treated|1|||
46977958|NCT02658019|83223079|FG000|Overall Study|Adverse Event|1|||
46977959|NCT02624687|83223085|FG000|Overall Study|Withdrawal by Subject|1|||
46977960|NCT02624687|83223086|FG001|Overall Study|Withdrawal by Subject|1|||
46977961|NCT02624687|83223085|FG000|Overall Study|medical leave from work|0|||
46977962|NCT02624687|83223086|FG001|Overall Study|medical leave from work|1|||
46977963|NCT01675765|83223094|FG000|Overall Study|Progressive disease|4|||
46793817|NCT00716417|83012386|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
46977964|NCT01675765|83223095|FG001|Overall Study|Progressive disease|4|||
46977965|NCT01675765|83223094|FG000|Overall Study|Adverse Event|1|||
46977966|NCT01675765|83223095|FG001|Overall Study|Adverse Event|2|||
46977967|NCT01675765|83223094|FG000|Overall Study|Withdrawal by Subject|2|||
46977968|NCT01675765|83223095|FG001|Overall Study|Withdrawal by Subject|0|||
46977969|NCT01675765|83223094|FG000|Overall Study|Death|1|||
46793818|NCT00716417|83012387|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
46977970|NCT01675765|83223095|FG001|Overall Study|Death|0|||
46977971|NCT01675765|83223094|FG000|Overall Study|Clinical progression|3|||
46977972|NCT01675765|83223095|FG001|Overall Study|Clinical progression|2|||
46977973|NCT02625233|83223103|FG000|Overall Study|Adverse Event|2|||
46977974|NCT02625233|83223104|FG001|Overall Study|Adverse Event|0|||
46977975|NCT02656693|83223113|FG000|Overall Study|Pregnancy|1|||
46977976|NCT02656693|83223114|FG001|Overall Study|Pregnancy|1|||
46977977|NCT02656693|83223115|FG002|Overall Study|Pregnancy|1|||
46977978|NCT02656693|83223113|FG000|Overall Study|Bariatric surgery|0|||
46977979|NCT02656693|83223114|FG001|Overall Study|Bariatric surgery|1|||
46977980|NCT02656693|83223115|FG002|Overall Study|Bariatric surgery|2|||
46977981|NCT02633293|83223123|FG000|Overall Study|Death|56|||
46977982|NCT02633293|83223123|FG000|Overall Study|Progressive Disease|12|||
46977983|NCT02633293|83223123|FG000|Overall Study|Adverse Event|29|||
46977984|NCT02633293|83223123|FG000|Overall Study|Withdrawal by Subject|41|||
46977985|NCT02633293|83223123|FG000|Overall Study|Protocol Violation|1|||
46977986|NCT02633293|83223123|FG000|Overall Study|Lost to Follow-up|1|||
46977987|NCT02633293|83223123|FG000|Overall Study|Study Terminated by Sponsor|24|||
46977988|NCT02633293|83223123|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
46977989|NCT02633293|83223123|FG000|Overall Study|Lung Transplant|5|||
46977990|NCT02633293|83223123|FG000|Overall Study|Lack of Efficacy|2|||
46977991|NCT02633293|83223123|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
46977992|NCT02623829|83223129|FG000|Overall Study|Lost to Follow-up|1|||
46977993|NCT02623829|83223130|FG001|Overall Study|Lost to Follow-up|1|||
46977994|NCT02655679|83223141|FG000|Overall Study|Adverse Event|0|||
46977995|NCT02655679|83223142|FG001|Overall Study|Adverse Event|1|||
46977996|NCT02655679|83223143|FG002|Overall Study|Adverse Event|0|||
46977997|NCT02655679|83223144|FG003|Overall Study|Adverse Event|0|||
46977998|NCT02655679|83223145|FG004|Overall Study|Adverse Event|0|||
46977999|NCT02655679|83223141|FG000|Overall Study|Withdrawal by Subject|1|||
46978000|NCT02655679|83223142|FG001|Overall Study|Withdrawal by Subject|1|||
46978001|NCT02655679|83223143|FG002|Overall Study|Withdrawal by Subject|0|||
46978002|NCT02655679|83223144|FG003|Overall Study|Withdrawal by Subject|3|||
46978003|NCT02655679|83223145|FG004|Overall Study|Withdrawal by Subject|1|||
46978004|NCT02655679|83223141|FG000|Overall Study|Inability to Comply with the Protocol|1|||
46978005|NCT02655679|83223142|FG001|Overall Study|Inability to Comply with the Protocol|0|||
46674294|NCT01152190|82889917|FG001|Overall Study|Adverse Event|4|||
46793819|NCT00716417|83012388|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
46793820|NCT00716417|83012389|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
46793821|NCT00716417|83012380|FG000|Overall Study|On patient request due to toxicities|0|||
46793822|NCT00716417|83012381|FG001|Overall Study|On patient request due to toxicities|0|||
46793823|NCT00716417|83012382|FG002|Overall Study|On patient request due to toxicities|0|||
46793824|NCT00716417|83012383|FG003|Overall Study|On patient request due to toxicities|0|||
46793825|NCT00716417|83012384|FG004|Overall Study|On patient request due to toxicities|0|||
46793826|NCT00716417|83012385|FG005|Overall Study|On patient request due to toxicities|0|||
46793827|NCT00716417|83012386|FG006|Overall Study|On patient request due to toxicities|0|||
46793828|NCT00716417|83012387|FG007|Overall Study|On patient request due to toxicities|1|||
46793829|NCT00716417|83012388|FG008|Overall Study|On patient request due to toxicities|0|||
46793830|NCT00716417|83012389|FG009|Overall Study|On patient request due to toxicities|0|||
46793831|NCT00719537|83012415|FG000|Overall Study|Withdrawal by Subject|1|||
46793832|NCT00719537|83012416|FG001|Overall Study|Withdrawal by Subject|0|||
46793833|NCT00719537|83012415|FG000|Overall Study|Lost to Follow-up|0|||
46793834|NCT00719537|83012416|FG001|Overall Study|Lost to Follow-up|1|||
46793835|NCT00715949|83012422|FG000|Overall Study|could not finish first test|4|||
46793836|NCT00503698|83012428|FG000|Overall Study|Protocol Violation|5|||
46978006|NCT02655679|83223143|FG002|Overall Study|Inability to Comply with the Protocol|0|||
46978007|NCT02655679|83223144|FG003|Overall Study|Inability to Comply with the Protocol|0|||
46978008|NCT02655679|83223145|FG004|Overall Study|Inability to Comply with the Protocol|0|||
46978009|NCT02655679|83223141|FG000|Overall Study|Lost to Follow-up|0|||
46978010|NCT02655679|83223142|FG001|Overall Study|Lost to Follow-up|1|||
46978011|NCT02655679|83223143|FG002|Overall Study|Lost to Follow-up|1|||
46978012|NCT02655679|83223144|FG003|Overall Study|Lost to Follow-up|1|||
46978013|NCT02655679|83223145|FG004|Overall Study|Lost to Follow-up|0|||
46978014|NCT02655679|83223141|FG000|Overall Study|Other Miscellaneous Reasons|1|||
46978015|NCT02655679|83223142|FG001|Overall Study|Other Miscellaneous Reasons|0|||
46978016|NCT02655679|83223143|FG002|Overall Study|Other Miscellaneous Reasons|0|||
46978017|NCT02655679|83223144|FG003|Overall Study|Other Miscellaneous Reasons|0|||
46978018|NCT02655679|83223145|FG004|Overall Study|Other Miscellaneous Reasons|0|||
46855599|NCT00065442|83071465|FG001|Overall Study|Death|210|||
46855600|NCT00065442|83071464|FG000|Overall Study|Withdrawal by Subject|3|||
46855601|NCT00065442|83071465|FG001|Overall Study|Withdrawal by Subject|9|||
46855602|NCT00090402|83071474|FG000|Overall Study|Death|1|||
46855603|NCT00090402|83071475|FG001|Overall Study|Death|1|||
46855604|NCT00090402|83071476|FG002|Overall Study|Death|0|||
46855605|NCT00090402|83071474|FG000|Overall Study|subject moved|0|||
46855606|NCT00090402|83071475|FG001|Overall Study|subject moved|1|||
46855607|NCT00090402|83071476|FG002|Overall Study|subject moved|0|||
46855608|NCT00090402|83071474|FG000|Overall Study|stopped taking study medication|1|||
46855609|NCT00090402|83071475|FG001|Overall Study|stopped taking study medication|0|||
46855610|NCT00090402|83071476|FG002|Overall Study|stopped taking study medication|1|||
46855611|NCT00361283|83071487|FG000|Overall Study|Lost to Follow-up|27|||
46855612|NCT00077064|83071493|FG000|Overall Study|Adverse Event|0|||
46855613|NCT00077064|83071494|FG001|Overall Study|Adverse Event|4|||
46855614|NCT00077064|83071493|FG000|Overall Study|Patient refusal|0|||
46855615|NCT00077064|83071494|FG001|Overall Study|Patient refusal|2|||
46855616|NCT00396383|83071501|FG000|Overall Study|Death|2|||
46855617|NCT00396383|83071501|FG000|Overall Study|Lost to Follow-up|1|||
46978019|NCT02623361|83223160|FG000|Overall Study|Protocol Violation|0|||
46978020|NCT02623361|83223161|FG001|Overall Study|Protocol Violation|1|||
46978021|NCT02623361|83223160|FG000|Overall Study|Withdrawal by Subject|0|||
46793837|NCT00503698|83012429|FG001|Overall Study|Protocol Violation|6|||
46793838|NCT00503698|83012428|FG000|Overall Study|Adverse Event|52|||
46793839|NCT00503698|83012429|FG001|Overall Study|Adverse Event|41|||
46793840|NCT00503698|83012428|FG000|Overall Study|Death|1|||
46793841|NCT00503698|83012429|FG001|Overall Study|Death|0|||
46793842|NCT00503698|83012428|FG000|Overall Study|Lack of Efficacy|3|||
46793843|NCT00503698|83012429|FG001|Overall Study|Lack of Efficacy|4|||
46793844|NCT00503698|83012428|FG000|Overall Study|Trial terminated|216|||
46793845|NCT00503698|83012429|FG001|Overall Study|Trial terminated|253|||
46793846|NCT00503698|83012428|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
46793847|NCT00503698|83012429|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
46793848|NCT00503698|83012428|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
46793849|NCT00503698|83012429|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
46793850|NCT00503698|83012428|FG000|Overall Study|Any condition in exclusion criteria|4|||
46793851|NCT00503698|83012429|FG001|Overall Study|Any condition in exclusion criteria|6|||
46793852|NCT00503698|83012428|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
46793853|NCT00503698|83012429|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
46793854|NCT00503698|83012428|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
46793855|NCT00503698|83012429|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
46793856|NCT00503698|83012428|FG000|Overall Study|Critically ill|2|||
46793857|NCT00503698|83012429|FG001|Overall Study|Critically ill|0|||
46793858|NCT00503698|83012428|FG000|Overall Study|Unclassified|48|||
46793859|NCT00503698|83012429|FG001|Overall Study|Unclassified|32|||
46793860|NCT00503698|83012428|FG000|Overall Study|Not exposed to trial drug|11|||
46793861|NCT00503698|83012429|FG001|Overall Study|Not exposed to trial drug|6|||
46793862|NCT00573794|83012444|FG000|Overall Study|Adverse Event|81|||
46793863|NCT00573794|83012444|FG000|Overall Study|Withdrew Consent|90|||
46793864|NCT00573794|83012444|FG000|Overall Study|Lost to Follow-up|13|||
46793865|NCT00573794|83012444|FG000|Overall Study|Protocol Violation|6|||
46793866|NCT00573794|83012444|FG000|Overall Study|Lack of Efficacy|94|||
46793867|NCT00573794|83012444|FG000|Overall Study|Other|46|||
46793868|NCT00715793|83012448|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
46793869|NCT00715793|83012449|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
46793870|NCT00715793|83012448|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
46793871|NCT00715793|83012449|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
46793872|NCT00718523|83012458|FG000|Overall Study|Withdrawal by Subject|5|||
46793873|NCT00718523|83012459|FG001|Overall Study|Withdrawal by Subject|7|||
46793874|NCT00718523|83012458|FG000|Overall Study|Death|13|||
46793875|NCT00718523|83012459|FG001|Overall Study|Death|17|||
46793876|NCT00715559|83012465|FG000|Overall Study|medication not tolerated - nausea|1|||
46855618|NCT00395447|83071507|FG000|Overall Study|Death|37|||
46978022|NCT02623361|83223161|FG001|Overall Study|Withdrawal by Subject|1|||
46978023|NCT01675531|83223208|FG000|Overall Study|Adverse Event|9|||
46978024|NCT01675531|83223208|FG000|Overall Study|Withdrawal by Subject|7|||
46978025|NCT01675531|83223208|FG000|Overall Study|Lack of Efficacy|1|||
46978026|NCT01675531|83223208|FG000|Overall Study|Protocol Violation|8|||
46978027|NCT02532543|83223217|FG000|Overall Study|Lost to Follow-up|0|||
46978028|NCT02532543|83223218|FG001|Overall Study|Lost to Follow-up|0|||
46978029|NCT02532543|83223219|FG002|Overall Study|Lost to Follow-up|1|||
46978030|NCT02532543|83223220|FG003|Overall Study|Lost to Follow-up|0|||
46978031|NCT02532465|83223232|FG000|Overall Study|Protocol Violation|1|||
46978032|NCT02532465|83223233|FG001|Overall Study|Protocol Violation|0|||
46978033|NCT02532465|83223232|FG000|Overall Study|Lack of Efficacy|0|||
46978034|NCT02532465|83223233|FG001|Overall Study|Lack of Efficacy|1|||
46978035|NCT02528331|83223239|FG000|Overall Study|Withdrawal by Subject|2|||
46978036|NCT02654977|83223243|FG000|Overall Study|Death|1|||
46978037|NCT02654977|83223243|FG000|Overall Study|Lost to Follow-up|1|||
46978038|NCT02654977|83223243|FG000|Overall Study|Adverse Event|1|||
46978039|NCT02654977|83223243|FG000|Overall Study|Withdrawal by Subject|1|||
46978040|NCT02654977|83223243|FG000|Overall Study|Lack of Efficacy|3|||
46978041|NCT01362517|83223247|FG000|Overall Study|Protocol Violation|1|||
46978042|NCT01362517|83223247|FG000|Overall Study|Lost to Follow-up|1|||
46978043|NCT01362439|83223254|FG000|Overall Study|Adverse Event|1|||
46978044|NCT01362439|83223254|FG000|Overall Study|Lack of Efficacy|3|||
46978045|NCT01362439|83223254|FG000|Overall Study|Lost to Follow-up|2|||
46978046|NCT01362439|83223254|FG000|Overall Study|Study medication non-compliant|1|||
46978047|NCT01362439|83223254|FG000|Overall Study|Participant who withdrew consent|8|||
46978048|NCT02653495|83223261|FG000|Overall Study|Lost to Follow-up|2|||
46978049|NCT02653495|83223262|FG001|Overall Study|Lost to Follow-up|0|||
46978050|NCT02653495|83223261|FG000|Overall Study|Screening Failure|10|||
46978051|NCT02653495|83223262|FG001|Overall Study|Screening Failure|0|||
46978052|NCT01675141|83223268|FG000|Overall Study|Lenalidomide outside NIH|3|||
46978053|NCT01675141|83223268|FG000|Overall Study|Withdrawal by Subject|3|||
46978054|NCT01675141|83223268|FG000|Overall Study|Physician Decision|4|||
46978055|NCT01675141|83223268|FG000|Overall Study|No treatment, per protocol|1|||
46978056|NCT03367819|83223290|FG000|Overall Study|Adverse Event|4|||
46978057|NCT03367819|83223291|FG001|Overall Study|Adverse Event|4|||
46793877|NCT00620282|83012472|FG000|Overall Study|Adverse Event|0|||
46793878|NCT00620282|83012473|FG001|Overall Study|Adverse Event|1|||
46793879|NCT00620282|83012474|FG002|Overall Study|Adverse Event|0|||
46793880|NCT00620282|83012472|FG000|Overall Study|Arterial line unable to be placed|0|||
46793881|NCT00620282|83012473|FG001|Overall Study|Arterial line unable to be placed|0|||
46793882|NCT00620282|83012474|FG002|Overall Study|Arterial line unable to be placed|1|||
46793883|NCT00620282|83012472|FG000|Overall Study|Withdrawal by Subject|0|||
46978058|NCT03367819|83223290|FG000|Overall Study|Progressive Disease|15|||
46978059|NCT03367819|83223291|FG001|Overall Study|Progressive Disease|13|||
46793884|NCT00620282|83012473|FG001|Overall Study|Withdrawal by Subject|1|||
46978060|NCT03367819|83223290|FG000|Overall Study|Withdrawal by Subject|1|||
46674295|NCT01152190|82889916|FG000|Overall Study|Death|1|||
46674296|NCT01152190|82889917|FG001|Overall Study|Death|0|||
46674297|NCT01152190|82889916|FG000|Overall Study|Protocol Violation|1|||
46674298|NCT01152190|82889917|FG001|Overall Study|Protocol Violation|1|||
46674299|NCT01152190|82889916|FG000|Overall Study|Withdrawal by Subject|1|||
46793885|NCT00620282|83012474|FG002|Overall Study|Withdrawal by Subject|0|||
46793886|NCT00515086|83012486|FG000|Overall Study|Adverse Event|1|||
46793887|NCT00515086|83012487|FG001|Overall Study|Adverse Event|1|||
46674300|NCT01152190|82889917|FG001|Overall Study|Withdrawal by Subject|3|||
46674301|NCT01151410|82889925|FG000|Overall Study|Withdrawal by Subject|3|||
46674302|NCT01151410|82889926|FG001|Overall Study|Withdrawal by Subject|5|||
46674303|NCT01151410|82889925|FG000|Overall Study|Lost to Follow-up|3|||
46674304|NCT01151410|82889926|FG001|Overall Study|Lost to Follow-up|4|||
46674305|NCT01151410|82889925|FG000|Overall Study|Adverse Event|1|||
46674306|NCT01151410|82889926|FG001|Overall Study|Adverse Event|2|||
46674307|NCT01151410|82889925|FG000|Overall Study|Protocol deviation|2|||
46674308|NCT01151410|82889926|FG001|Overall Study|Protocol deviation|1|||
46674309|NCT01151410|82889925|FG000|Overall Study|Administrative problems|1|||
46674310|NCT01151410|82889926|FG001|Overall Study|Administrative problems|1|||
46674311|NCT01151410|82889925|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46674312|NCT01151410|82889926|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46978061|NCT03367819|83223291|FG001|Overall Study|Withdrawal by Subject|0|||
46978062|NCT03367819|83223290|FG000|Overall Study|Other|4|||
46978063|NCT03367819|83223291|FG001|Overall Study|Other|2|||
46978064|NCT01597193|83223334|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
46978065|NCT01597193|83223335|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
46978066|NCT01597193|83223336|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
46978067|NCT01597193|83223337|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
46978068|NCT01597193|83223338|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
46855619|NCT00395447|83071508|FG001|Overall Study|Death|32|||
46855620|NCT00395447|83071507|FG000|Overall Study|Lost to Follow-up|52|||
46855621|NCT00395447|83071508|FG001|Overall Study|Lost to Follow-up|43|||
46855622|NCT00395447|83071507|FG000|Overall Study|Withdrawal by Subject|24|||
46855623|NCT00395447|83071508|FG001|Overall Study|Withdrawal by Subject|19|||
46855624|NCT00395447|83071507|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
46978069|NCT01597193|83223339|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
46978070|NCT01597193|83223340|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
46978071|NCT01597193|83223334|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
46978072|NCT01597193|83223335|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
46978073|NCT01597193|83223336|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
46978074|NCT01597193|83223337|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
46978075|NCT01597193|83223338|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
46978076|NCT01597193|83223339|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
46978077|NCT01597193|83223340|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
46978078|NCT01597193|83223334|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
46978079|NCT01597193|83223335|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
46978080|NCT01597193|83223336|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
46978081|NCT01597193|83223337|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
46978082|NCT01597193|83223338|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
46978083|NCT01597193|83223339|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
46978084|NCT01597193|83223340|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
46978085|NCT01597193|83223334|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
46978086|NCT01597193|83223335|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
46978087|NCT01597193|83223336|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
46978088|NCT01597193|83223337|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
46978089|NCT01597193|83223338|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
46978090|NCT01597193|83223339|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
46978091|NCT01597193|83223340|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
46978092|NCT01597193|83223334|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
46978093|NCT01597193|83223335|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
46978094|NCT01597193|83223336|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
46978095|NCT01597193|83223337|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
46978096|NCT01597193|83223338|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
46978097|NCT01597193|83223339|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
46978098|NCT01597193|83223340|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
46978099|NCT02649439|83223363|FG000|Overall Study|Switched to alternative treatment|6|||
46978100|NCT02649439|83223364|FG001|Overall Study|Switched to alternative treatment|4|||
46978101|NCT02649439|83223363|FG000|Overall Study|Patient decision|1|||
46978102|NCT02649439|83223364|FG001|Overall Study|Patient decision|0|||
46978103|NCT02649439|83223363|FG000|Overall Study|Patient going out of country|1|||
46978104|NCT02649439|83223364|FG001|Overall Study|Patient going out of country|0|||
46978105|NCT02649439|83223363|FG000|Overall Study|To start finasteride|1|||
46978106|NCT02649439|83223364|FG001|Overall Study|To start finasteride|0|||
46978107|NCT02649439|83223363|FG000|Overall Study|Physician Decision|1|||
46978108|NCT02649439|83223364|FG001|Overall Study|Physician Decision|0|||
46978109|NCT02649439|83223363|FG000|Overall Study|Disease progression on study|12|||
46793888|NCT00515086|83012488|FG002|Overall Study|Adverse Event|2|||
46978110|NCT02649439|83223364|FG001|Overall Study|Disease progression on study|13|||
46793889|NCT00515086|83012489|FG003|Overall Study|Adverse Event|3|||
46793890|NCT00515086|83012486|FG000|Overall Study|Administrative|1|||
46978111|NCT02649439|83223363|FG000|Overall Study|Refused further treatment|1|||
46978112|NCT02649439|83223364|FG001|Overall Study|Refused further treatment|0|||
46978113|NCT02649439|83223363|FG000|Overall Study|Refused further follow up|2|||
46978114|NCT02649439|83223364|FG001|Overall Study|Refused further follow up|7|||
46978115|NCT02649439|83223363|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
46978116|NCT02649439|83223364|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
46978117|NCT02649439|83223363|FG000|Overall Study|No treatment, per protocol|1|||
46978118|NCT02649439|83223364|FG001|Overall Study|No treatment, per protocol|0|||
46978119|NCT02649439|83223363|FG000|Overall Study|PSA DT makes ineligible|0|||
46978120|NCT02649439|83223364|FG001|Overall Study|PSA DT makes ineligible|1|||
46978121|NCT02649439|83223363|FG000|Overall Study|Rising PSA No Mets|0|||
46978122|NCT02649439|83223364|FG001|Overall Study|Rising PSA No Mets|1|||
46978123|NCT02649439|83223363|FG000|Overall Study|Rising PSA|0|||
46978124|NCT02649439|83223364|FG001|Overall Study|Rising PSA|1|||
46978125|NCT02649439|83223363|FG000|Overall Study|Signed follow up protocol|0|||
46978126|NCT02649439|83223364|FG001|Overall Study|Signed follow up protocol|1|||
46978127|NCT02622113|83223379|FG000|Overall Study|Adverse Event|4|||
46978128|NCT02622113|83223380|FG001|Overall Study|Adverse Event|4|||
46978129|NCT02622113|83223379|FG000|Overall Study|Physician Decision|0|||
46978130|NCT02622113|83223380|FG001|Overall Study|Physician Decision|1|||
46978131|NCT02622113|83223379|FG000|Overall Study|Withdrawal by Subject|0|||
46978132|NCT02622113|83223380|FG001|Overall Study|Withdrawal by Subject|2|||
46978133|NCT02622113|83223379|FG000|Overall Study|Stopping Criteria|1|||
46978134|NCT02622113|83223380|FG001|Overall Study|Stopping Criteria|3|||
46978135|NCT02651467|83223389|FG000|Overall Study|Withdrawal by Subject|0|||
46978136|NCT02651467|83223390|FG001|Overall Study|Withdrawal by Subject|0|||
46978137|NCT02651467|83223391|FG002|Overall Study|Withdrawal by Subject|2|||
46978138|NCT02651467|83223389|FG000|Overall Study|Other (Not specified)|1|||
46978139|NCT02651467|83223390|FG001|Overall Study|Other (Not specified)|0|||
46978140|NCT02651467|83223391|FG002|Overall Study|Other (Not specified)|2|||
46978141|NCT02620787|83223420|FG000|Overall Study|Adverse Event|1|||
46978142|NCT02620787|83223421|FG001|Overall Study|Adverse Event|0|||
46978143|NCT02620787|83223420|FG000|Overall Study|Eligibility Criteria Not Met|1|||
46978144|NCT02620787|83223421|FG001|Overall Study|Eligibility Criteria Not Met|0|||
46855625|NCT00395447|83071508|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
46855626|NCT03404674|83071520|FG000|Overall Study|Inability to Attend Future Visits|0|||
46978145|NCT02651155|83223429|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
46978146|NCT02651155|83223430|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
46978147|NCT02651155|83223429|FG000|Overall Study|Voluntary Withdrawal|5|||
46978148|NCT02651155|83223430|FG001|Overall Study|Voluntary Withdrawal|0|||
46978149|NCT02619617|83223436|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
46978150|NCT02619617|83223437|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
46978151|NCT02619617|83223436|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
46978152|NCT02619617|83223437|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
46978153|NCT02650921|83223458|FG000|Overall Study|Withdrawal by Subject|4|||
46978154|NCT02650921|83223458|FG000|Overall Study|Lost to Follow-up|2|||
46793891|NCT00515086|83012487|FG001|Overall Study|Administrative|1|||
46793892|NCT00515086|83012488|FG002|Overall Study|Administrative|0|||
46793893|NCT00515086|83012489|FG003|Overall Study|Administrative|0|||
46793894|NCT00515086|83012486|FG000|Overall Study|Withdrawal by Subject|1|||
46793895|NCT00515086|83012487|FG001|Overall Study|Withdrawal by Subject|0|||
46793896|NCT00515086|83012488|FG002|Overall Study|Withdrawal by Subject|0|||
46793897|NCT00515086|83012489|FG003|Overall Study|Withdrawal by Subject|1|||
46978155|NCT02650921|83223458|FG000|Overall Study|Adverse Event|1|||
46978156|NCT02650921|83223458|FG000|Overall Study|Due to Medical Condition|1|||
46793898|NCT00515086|83012486|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
46793899|NCT00515086|83012487|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
46793900|NCT00515086|83012488|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
46978157|NCT01596335|83223466|FG000|Overall Study|exacerbation of primary disease|5|||
46978158|NCT01596335|83223467|FG001|Overall Study|exacerbation of primary disease|9|||
46978159|NCT02618759|83223475|FG000|Overall Study|Lost to Follow-up|0|||
46978160|NCT02618759|83223476|FG001|Overall Study|Lost to Follow-up|1|||
46978161|NCT02618759|83223475|FG000|Overall Study|Withdrawal by Subject|1|||
46978162|NCT02618759|83223476|FG001|Overall Study|Withdrawal by Subject|0|||
46978163|NCT02618759|83223475|FG000|Overall Study|Other Reasons|1|||
46978164|NCT02618759|83223476|FG001|Overall Study|Other Reasons|4|||
46978165|NCT02614079|83223491|FG000|Overall Study|Withdrawal by Subject|1|||
46978166|NCT02616029|83223497|FG000|Overall Study|Adverse Event|1|||
46978167|NCT02616029|83223498|FG001|Overall Study|Adverse Event|0|||
46793901|NCT00515086|83012489|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
46978168|NCT02616029|83223497|FG000|Overall Study|Death|0|||
46978169|NCT02616029|83223498|FG001|Overall Study|Death|1|||
46978170|NCT02616029|83223497|FG000|Overall Study|Protocol Violation|1|||
46855627|NCT03404674|83071521|FG001|Overall Study|Inability to Attend Future Visits|1|||
46855628|NCT03404674|83071522|FG002|Overall Study|Inability to Attend Future Visits|1|||
46855629|NCT03404674|83071523|FG003|Overall Study|Inability to Attend Future Visits|0|||
46855630|NCT03404674|83071524|FG004|Overall Study|Inability to Attend Future Visits|0|||
46855631|NCT03404674|83071525|FG005|Overall Study|Inability to Attend Future Visits|0|||
46978171|NCT02616029|83223498|FG001|Overall Study|Protocol Violation|0|||
46978172|NCT02616029|83223497|FG000|Overall Study|Withdrew Consent|1|||
46978173|NCT02616029|83223498|FG001|Overall Study|Withdrew Consent|0|||
46978174|NCT02616029|83223497|FG000|Overall Study|Enrolled and Never Treated|1|||
46978175|NCT02616029|83223498|FG001|Overall Study|Enrolled and Never Treated|1|||
46978176|NCT02614859|83223506|FG000|Overall Study|Physician Decision|0|||
46978177|NCT02614859|83223507|FG001|Overall Study|Physician Decision|1|||
46978178|NCT02615249|83223515|FG000|Overall Study|Withdrawal by Subject|1|||
46978179|NCT02615171|83223522|FG000|Overall Study|Lost to Follow-up|2|||
46978180|NCT02615171|83223523|FG001|Overall Study|Lost to Follow-up|1|||
46978181|NCT02648347|83223531|FG000|Overall Study|Death|174|||
46978182|NCT02648347|83223532|FG001|Overall Study|Death|167|||
46978183|NCT02648347|83223531|FG000|Overall Study|Withdrawal by Subject|16|||
46978184|NCT02648347|83223532|FG001|Overall Study|Withdrawal by Subject|9|||
46978185|NCT02648347|83223531|FG000|Overall Study|Lost to Follow-up|18|||
46978186|NCT02648347|83223532|FG001|Overall Study|Lost to Follow-up|21|||
46978187|NCT02648347|83223531|FG000|Overall Study|Missing|1|||
46978188|NCT02648347|83223532|FG001|Overall Study|Missing|0|||
46978189|NCT02614703|83223540|FG000|Overall Study|Withdrawal by Subject|7|||
46978190|NCT02614703|83223541|FG001|Overall Study|Withdrawal by Subject|1|||
46978191|NCT01669343|83223547|FG000|Part A: All Patients|Withdrawal by Subject|7|||
46978192|NCT01669343|83223547|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
46978193|NCT01669343|83223547|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
46978194|NCT01669343|83223547|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
46978195|NCT01669343|83223547|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
46978196|NCT01594931|83223557|FG000|Overall Study|Adverse Event|3|||
46978197|NCT01594931|83223558|FG001|Overall Study|Adverse Event|1|||
46978198|NCT01594931|83223559|FG002|Overall Study|Adverse Event|1|||
46978199|NCT01594931|83223557|FG000|Overall Study|Withdrawal by Subject|2|||
46978200|NCT01594931|83223558|FG001|Overall Study|Withdrawal by Subject|1|||
46978201|NCT01594931|83223559|FG002|Overall Study|Withdrawal by Subject|1|||
46978202|NCT01594931|83223557|FG000|Overall Study|Lack of Efficacy|7|||
46978203|NCT01594931|83223558|FG001|Overall Study|Lack of Efficacy|2|||
46978204|NCT01594931|83223559|FG002|Overall Study|Lack of Efficacy|2|||
46978205|NCT01594931|83223557|FG000|Overall Study|Lost to Follow-up|4|||
46978206|NCT01594931|83223558|FG001|Overall Study|Lost to Follow-up|3|||
46793902|NCT00515086|83012486|FG000|Overall Study|Lost to Follow-up|1|||
46793903|NCT00515086|83012487|FG001|Overall Study|Lost to Follow-up|0|||
46793904|NCT00515086|83012488|FG002|Overall Study|Lost to Follow-up|0|||
46793905|NCT00515086|83012489|FG003|Overall Study|Lost to Follow-up|0|||
46793906|NCT00515086|83012486|FG000|Overall Study|Study drug no longer required|0|||
46793907|NCT00515086|83012487|FG001|Overall Study|Study drug no longer required|1|||
46793908|NCT00515086|83012488|FG002|Overall Study|Study drug no longer required|0|||
46793909|NCT00515086|83012489|FG003|Overall Study|Study drug no longer required|0|||
46793910|NCT00515086|83012486|FG000|Overall Study|Death|2|||
46855632|NCT03404674|83071520|FG000|Overall Study|Behavioral Problems|0|||
46855633|NCT03404674|83071521|FG001|Overall Study|Behavioral Problems|0|||
46855634|NCT03404674|83071522|FG002|Overall Study|Behavioral Problems|1|||
46793911|NCT00515086|83012487|FG001|Overall Study|Death|0|||
46855635|NCT03404674|83071523|FG003|Overall Study|Behavioral Problems|0|||
46855636|NCT03404674|83071524|FG004|Overall Study|Behavioral Problems|0|||
46855637|NCT03404674|83071525|FG005|Overall Study|Behavioral Problems|0|||
46978207|NCT01594931|83223559|FG002|Overall Study|Lost to Follow-up|3|||
46978208|NCT01594931|83223557|FG000|Overall Study|Protocol Violation|2|||
46978209|NCT01594931|83223558|FG001|Overall Study|Protocol Violation|1|||
46978210|NCT01594931|83223559|FG002|Overall Study|Protocol Violation|0|||
46978211|NCT01594931|83223557|FG000|Overall Study|No defiined|11|||
46978212|NCT01594931|83223558|FG001|Overall Study|No defiined|4|||
46978213|NCT01594931|83223559|FG002|Overall Study|No defiined|7|||
46978214|NCT01594853|83223569|FG000|Overall Study|Withdrawal by Subject|1|||
46978215|NCT01594853|83223570|FG001|Overall Study|Withdrawal by Subject|1|||
46978216|NCT01594853|83223569|FG000|Overall Study|Lost to Follow-up|1|||
46978217|NCT01594853|83223570|FG001|Overall Study|Lost to Follow-up|1|||
46978218|NCT01594853|83223569|FG000|Overall Study|noncompliance with exercise|0|||
46978219|NCT01594853|83223570|FG001|Overall Study|noncompliance with exercise|1|||
46978220|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
46978221|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
46978222|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
46978223|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
46978224|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
46978225|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
46978226|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
46978227|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
46978228|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
46978229|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
46978230|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
46978231|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
46978232|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
46978233|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
46978234|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
46978235|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
46978236|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
46978237|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
46978238|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
46978239|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
46978240|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
46978241|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
46978242|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
46978243|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
46978244|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
46978245|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
46978246|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
46978247|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
46978248|NCT01668797|83223587|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
46978249|NCT01668797|83223588|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
46978250|NCT01668797|83223589|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
47079195|NCT01405820|83386048|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
47079196|NCT01405820|83386049|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
47079197|NCT01405820|83386050|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
47079198|NCT01405820|83386051|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
47079199|NCT01405820|83386052|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
47079200|NCT01405820|83386053|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
47079201|NCT01405820|83386048|FG000|Randomized Treatment Period|Other|2|||
47079202|NCT01405820|83386049|FG001|Randomized Treatment Period|Other|2|||
47079203|NCT01405820|83386050|FG002|Randomized Treatment Period|Other|1|||
47079204|NCT01405820|83386051|FG003|Randomized Treatment Period|Other|1|||
47079205|NCT01405820|83386052|FG004|Randomized Treatment Period|Other|0|||
47079206|NCT01405820|83386053|FG005|Randomized Treatment Period|Other|0|||
47079207|NCT01405820|83386048|FG000|Randomized Treatment Period|Physician Decision|0|||
47079208|NCT01405820|83386049|FG001|Randomized Treatment Period|Physician Decision|2|||
47079209|NCT01405820|83386050|FG002|Randomized Treatment Period|Physician Decision|1|||
47079210|NCT01405820|83386051|FG003|Randomized Treatment Period|Physician Decision|0|||
47079211|NCT01405820|83386052|FG004|Randomized Treatment Period|Physician Decision|0|||
47079212|NCT01405820|83386053|FG005|Randomized Treatment Period|Physician Decision|0|||
47079213|NCT01405820|83386048|FG000|Randomized Treatment Period|Rescue|0|||
46978251|NCT01668797|83223590|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
46978252|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
46978253|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
46674313|NCT01151410|82889925|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46674314|NCT01151410|82889926|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46793912|NCT00515086|83012488|FG002|Overall Study|Death|0|||
46793913|NCT00515086|83012489|FG003|Overall Study|Death|0|||
46793914|NCT00618410|83012505|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
46793915|NCT00618410|83012506|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
46793916|NCT00618722|83012516|FG000|Overall Study|Refusal of Treatment|0|||
46793917|NCT00618722|83012517|FG001|Overall Study|Refusal of Treatment|0|||
46793918|NCT00618722|83012518|FG002|Overall Study|Refusal of Treatment|1|||
46793919|NCT00618722|83012519|FG003|Overall Study|Refusal of Treatment|0|||
46793920|NCT00618722|83012516|FG000|Overall Study|Patient Request|1|||
46793921|NCT00618722|83012517|FG001|Overall Study|Patient Request|1|||
46793922|NCT00618722|83012518|FG002|Overall Study|Patient Request|1|||
46793923|NCT00618722|83012519|FG003|Overall Study|Patient Request|1|||
46793924|NCT00618722|83012516|FG000|Overall Study|Inability to Complete Study Procedure|0|||
46793925|NCT00618722|83012517|FG001|Overall Study|Inability to Complete Study Procedure|1|||
46793926|NCT00618722|83012518|FG002|Overall Study|Inability to Complete Study Procedure|0|||
46978254|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
46978255|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
46674315|NCT01151215|82889935|FG000|Overall Study|Worsening of condition under study|1|||
46674316|NCT01151215|82889936|FG001|Overall Study|Worsening of condition under study|1|||
46674317|NCT01151215|82889937|FG002|Overall Study|Worsening of condition under study|1|||
46793927|NCT00618722|83012519|FG003|Overall Study|Inability to Complete Study Procedure|0|||
46978256|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
46978257|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
46978258|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
46978259|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
46978260|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
46978261|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
46978262|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
46978263|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
46978264|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
46978265|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
46978266|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
46978267|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
46978268|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
46978269|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
46978270|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
46978271|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
46978272|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
46978273|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
46978274|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
46978275|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
46978276|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
46978277|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
46978278|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
46978279|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
46978280|NCT01668797|83223587|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
46978281|NCT01668797|83223588|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
46978282|NCT01668797|83223589|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
47079214|NCT01405820|83386049|FG001|Randomized Treatment Period|Rescue|1|||
46793928|NCT00618722|83012516|FG000|Overall Study|Lost to Follow-up|2|||
46793929|NCT00618722|83012517|FG001|Overall Study|Lost to Follow-up|0|||
46793930|NCT00618722|83012518|FG002|Overall Study|Lost to Follow-up|0|||
46793931|NCT00618722|83012519|FG003|Overall Study|Lost to Follow-up|2|||
46855638|NCT03404674|83071520|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
46855639|NCT03404674|83071521|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
46855640|NCT03404674|83071522|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
46855641|NCT03404674|83071523|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
46855642|NCT03404674|83071524|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
46855643|NCT03404674|83071525|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
46855644|NCT00064662|83071542|FG000|Overall Study|Death|1|||
46855645|NCT00064662|83071543|FG001|Overall Study|Death|1|||
46855646|NCT00064662|83071542|FG000|Overall Study|Lost to Follow-up|57|||
46855647|NCT00064662|83071543|FG001|Overall Study|Lost to Follow-up|44|||
46855648|NCT00064662|83071542|FG000|Overall Study|Withdrawal by Subject|14|||
46855649|NCT00064662|83071543|FG001|Overall Study|Withdrawal by Subject|14|||
46855650|NCT00064662|83071542|FG000|Overall Study|Administratively withdrawn|2|||
46855651|NCT00064662|83071543|FG001|Overall Study|Administratively withdrawn|2|||
46793932|NCT00618722|83012516|FG000|Overall Study|Miscellaneous Reasons|0|||
46793933|NCT00618722|83012517|FG001|Overall Study|Miscellaneous Reasons|0|||
46793934|NCT00618722|83012518|FG002|Overall Study|Miscellaneous Reasons|1|||
46793935|NCT00618722|83012519|FG003|Overall Study|Miscellaneous Reasons|1|||
46793936|NCT00507442|83012533|FG000|Overall Study|Adverse Event|8|||
46793937|NCT00507442|83012534|FG001|Overall Study|Adverse Event|11|||
46793938|NCT00507442|83012535|FG002|Overall Study|Adverse Event|4|||
46793939|NCT00507442|83012536|FG003|Overall Study|Adverse Event|1|||
46793940|NCT00507442|83012533|FG000|Overall Study|Protocol Violation|0|||
46793941|NCT00507442|83012534|FG001|Overall Study|Protocol Violation|1|||
46793942|NCT00507442|83012535|FG002|Overall Study|Protocol Violation|0|||
46793943|NCT00507442|83012536|FG003|Overall Study|Protocol Violation|0|||
46793944|NCT00507442|83012533|FG000|Overall Study|Lost to Follow-up|0|||
46793945|NCT00507442|83012534|FG001|Overall Study|Lost to Follow-up|0|||
46793946|NCT00507442|83012535|FG002|Overall Study|Lost to Follow-up|1|||
46793947|NCT00507442|83012536|FG003|Overall Study|Lost to Follow-up|0|||
46855652|NCT03404518|83071551|FG000|Overall Study|Lost to Follow-up|28|||
46855653|NCT03404518|83071552|FG001|Overall Study|Lost to Follow-up|30|||
46855654|NCT03404518|83071551|FG000|Overall Study|Protocol Violation|13|||
46855655|NCT03404518|83071552|FG001|Overall Study|Protocol Violation|6|||
47079215|NCT01405820|83386050|FG002|Randomized Treatment Period|Rescue|13|||
46793948|NCT00507442|83012533|FG000|Overall Study|Physician Decision|0|||
46793949|NCT00507442|83012534|FG001|Overall Study|Physician Decision|2|||
46793950|NCT00507442|83012535|FG002|Overall Study|Physician Decision|4|||
46793951|NCT00507442|83012536|FG003|Overall Study|Physician Decision|1|||
46855656|NCT03404206|83071561|FG000|Overall Study|Withdrawal by Subject|1|||
46855657|NCT03404206|83071562|FG001|Overall Study|Withdrawal by Subject|1|||
46855658|NCT03404206|83071563|FG002|Overall Study|Withdrawal by Subject|0|||
46855659|NCT03404206|83071561|FG000|Overall Study|Lost to Follow-up|3|||
46855660|NCT03404206|83071562|FG001|Overall Study|Lost to Follow-up|1|||
46855661|NCT03404206|83071563|FG002|Overall Study|Lost to Follow-up|0|||
46855662|NCT03403426|83071571|FG000|Overall Study|Death|1|||
46855663|NCT03403426|83071571|FG000|Overall Study|Lost to Follow-up|2|||
46855664|NCT00394901|83071579|FG000|Baseline Phase|Protocol Violation|0|||
46855665|NCT00394901|83071580|FG001|Baseline Phase|Protocol Violation|0|||
46855666|NCT00394901|83071581|FG002|Baseline Phase|Protocol Violation|1|||
46855667|NCT00394901|83071582|FG003|Baseline Phase|Protocol Violation|0|||
46855668|NCT00394901|83071579|FG000|Double-blind Phase|Adverse Event|5|||
46855669|NCT00394901|83071580|FG001|Double-blind Phase|Adverse Event|7|||
46855670|NCT00394901|83071581|FG002|Double-blind Phase|Adverse Event|16|||
46855671|NCT00394901|83071582|FG003|Double-blind Phase|Adverse Event|20|||
46855672|NCT00394901|83071579|FG000|Double-blind Phase|Lack of Efficacy|6|||
46855673|NCT00394901|83071580|FG001|Double-blind Phase|Lack of Efficacy|4|||
46855674|NCT00394901|83071581|FG002|Double-blind Phase|Lack of Efficacy|1|||
46855675|NCT00394901|83071582|FG003|Double-blind Phase|Lack of Efficacy|3|||
46855676|NCT00394901|83071579|FG000|Double-blind Phase|Withdrawal by Subject|2|||
46855677|NCT00394901|83071580|FG001|Double-blind Phase|Withdrawal by Subject|0|||
46855678|NCT00394901|83071581|FG002|Double-blind Phase|Withdrawal by Subject|0|||
46855679|NCT00394901|83071582|FG003|Double-blind Phase|Withdrawal by Subject|0|||
46793952|NCT00507442|83012533|FG000|Overall Study|Progressive Disease|2|||
46793953|NCT00507442|83012534|FG001|Overall Study|Progressive Disease|4|||
46793954|NCT00507442|83012535|FG002|Overall Study|Progressive Disease|2|||
46793955|NCT00507442|83012536|FG003|Overall Study|Progressive Disease|0|||
46793956|NCT00507442|83012533|FG000|Overall Study|Withdrawal by Subject|4|||
46793957|NCT00507442|83012534|FG001|Overall Study|Withdrawal by Subject|4|||
46793958|NCT00507442|83012535|FG002|Overall Study|Withdrawal by Subject|2|||
46793959|NCT00507442|83012536|FG003|Overall Study|Withdrawal by Subject|1|||
46793960|NCT00507442|83012533|FG000|Overall Study|Other|2|||
46793961|NCT00507442|83012534|FG001|Overall Study|Other|5|||
46793962|NCT00507442|83012535|FG002|Overall Study|Other|2|||
46793963|NCT00507442|83012536|FG003|Overall Study|Other|2|||
46793964|NCT00619892|83012552|FG000|Overall Study|Adverse Event|3|||
46793965|NCT00619892|83012553|FG001|Overall Study|Adverse Event|0|||
46793966|NCT00619892|83012552|FG000|Overall Study|Lost to Follow-up|0|||
46793967|NCT00619892|83012553|FG001|Overall Study|Lost to Follow-up|1|||
46793968|NCT00619892|83012552|FG000|Overall Study|Intercurrent illness|0|||
46793969|NCT00619892|83012553|FG001|Overall Study|Intercurrent illness|1|||
46793970|NCT00507130|83012565|FG000|Overall Study|Lost to Follow-up|0|||
46793971|NCT00507130|83012566|FG001|Overall Study|Lost to Follow-up|0|||
46793972|NCT00507130|83012567|FG002|Overall Study|Lost to Follow-up|1|||
46793973|NCT00507130|83012568|FG003|Overall Study|Lost to Follow-up|1|||
46793974|NCT00507130|83012565|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
46793975|NCT00507130|83012566|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
46793976|NCT00507130|83012567|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
46793977|NCT00507130|83012568|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
46793978|NCT00503308|83012580|FG000|Overall Study|Protocol Violation|2|||
46793979|NCT00503308|83012581|FG001|Overall Study|Protocol Violation|1|||
46793980|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
46793981|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
46793982|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
46793983|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
46793984|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
46793985|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
46793986|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
46855680|NCT00394901|83071579|FG000|Double-blind Phase|Lost to Follow-up|0|||
46855681|NCT00394901|83071580|FG001|Double-blind Phase|Lost to Follow-up|0|||
46855682|NCT00394901|83071581|FG002|Double-blind Phase|Lost to Follow-up|0|||
46855683|NCT00394901|83071582|FG003|Double-blind Phase|Lost to Follow-up|1|||
46793987|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
46793988|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
46793989|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46793990|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
46855684|NCT00394901|83071579|FG000|Double-blind Phase|Protocol Violation|0|||
46793991|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46793992|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46793993|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46793994|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46855685|NCT00394901|83071580|FG001|Double-blind Phase|Protocol Violation|0|||
46855686|NCT00394901|83071581|FG002|Double-blind Phase|Protocol Violation|0|||
46855687|NCT00394901|83071582|FG003|Double-blind Phase|Protocol Violation|1|||
46855688|NCT00394901|83071579|FG000|Double-blind Phase|Death|1|||
46855689|NCT00394901|83071580|FG001|Double-blind Phase|Death|0|||
46855690|NCT00394901|83071581|FG002|Double-blind Phase|Death|0|||
46855691|NCT00394901|83071582|FG003|Double-blind Phase|Death|0|||
46855692|NCT00394901|83071579|FG000|Double-blind Phase|Subject's Personal Reason|1|||
46855693|NCT00394901|83071580|FG001|Double-blind Phase|Subject's Personal Reason|0|||
46855694|NCT00394901|83071581|FG002|Double-blind Phase|Subject's Personal Reason|0|||
46855695|NCT00394901|83071582|FG003|Double-blind Phase|Subject's Personal Reason|1|||
46855696|NCT00394901|83071579|FG000|Double-blind Phase|Lack of Compliance|0|||
46855697|NCT00394901|83071580|FG001|Double-blind Phase|Lack of Compliance|3|||
46978283|NCT01668797|83223590|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
46978284|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
46978285|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
46855698|NCT00394901|83071581|FG002|Double-blind Phase|Lack of Compliance|0|||
46978286|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
46978287|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
46855699|NCT00394901|83071582|FG003|Double-blind Phase|Lack of Compliance|0|||
46855700|NCT00394901|83071579|FG000|Double-blind Phase|Entry into another study was found|0|||
46978288|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
46978289|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
46978290|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
46978291|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
46978292|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
46978293|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
46978294|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
46978295|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
46978296|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
46978297|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
46978298|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
46978299|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
46978300|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
46978301|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
46978302|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
46978303|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
46978304|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
46978305|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
46978306|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
46978307|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
46978308|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
46978309|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
46978310|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
46978311|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
46978312|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
46978313|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
46978314|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
46855701|NCT00394901|83071580|FG001|Double-blind Phase|Entry into another study was found|0|||
46855702|NCT00394901|83071581|FG002|Double-blind Phase|Entry into another study was found|1|||
46855703|NCT00394901|83071582|FG003|Double-blind Phase|Entry into another study was found|0|||
46855704|NCT00394901|83071579|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
46855705|NCT00394901|83071580|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
46855706|NCT00394901|83071581|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
46855707|NCT00394901|83071582|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
46855708|NCT03349060|83071598|FG000|Overall Study|Adverse Event|9|||
46855709|NCT03349060|83071599|FG001|Overall Study|Adverse Event|9|||
46855710|NCT03349060|83071600|FG002|Overall Study|Adverse Event|7|||
46855711|NCT03349060|83071598|FG000|Overall Study|Lack of Efficacy|1|||
46855712|NCT03349060|83071599|FG001|Overall Study|Lack of Efficacy|0|||
46855713|NCT03349060|83071600|FG002|Overall Study|Lack of Efficacy|2|||
46855714|NCT03349060|83071598|FG000|Overall Study|Lost to Follow-up|2|||
46855715|NCT03349060|83071599|FG001|Overall Study|Lost to Follow-up|1|||
46855716|NCT03349060|83071600|FG002|Overall Study|Lost to Follow-up|1|||
46855717|NCT03349060|83071598|FG000|Overall Study|Protocol Violation|2|||
46855718|NCT03349060|83071599|FG001|Overall Study|Protocol Violation|2|||
46855719|NCT03349060|83071600|FG002|Overall Study|Protocol Violation|1|||
46855720|NCT03349060|83071598|FG000|Overall Study|Withdrawal by Subject|5|||
46855721|NCT03349060|83071599|FG001|Overall Study|Withdrawal by Subject|3|||
46855722|NCT03349060|83071600|FG002|Overall Study|Withdrawal by Subject|4|||
46855723|NCT03349060|83071598|FG000|Overall Study|Medication error,no linked adverse event|0|||
46855724|NCT03349060|83071599|FG001|Overall Study|Medication error,no linked adverse event|0|||
46855725|NCT03349060|83071600|FG002|Overall Study|Medication error,no linked adverse event|1|||
46855726|NCT03349060|83071598|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
46855727|NCT03349060|83071599|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
46855728|NCT03349060|83071600|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
46855729|NCT03349060|83071598|FG000|Overall Study|Other|2|||
46855730|NCT03349060|83071599|FG001|Overall Study|Other|1|||
46855731|NCT03349060|83071600|FG002|Overall Study|Other|0|||
46793995|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46793996|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46793997|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
46793998|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46793999|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
46794000|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794001|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
46794002|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794003|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794004|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794005|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46855732|NCT03348904|83071611|FG000|Overall Study|Administrative reason by the sponsor|0|||
46855733|NCT03348904|83071612|FG001|Overall Study|Administrative reason by the sponsor|1|||
46855734|NCT03348904|83071613|FG002|Overall Study|Administrative reason by the sponsor|0|||
46855735|NCT00359021|83071623|FG000|Overall Study|Adverse Event|26|||
46855736|NCT00359021|83071624|FG001|Overall Study|Adverse Event|8|||
46855737|NCT00359021|83071623|FG000|Overall Study|Subject Non-Compliant|1|||
46855738|NCT00359021|83071624|FG001|Overall Study|Subject Non-Compliant|2|||
46855739|NCT00359021|83071623|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
46855740|NCT00359021|83071624|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
46855741|NCT00359021|83071623|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
46855742|NCT00359021|83071624|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
46855743|NCT00359021|83071623|FG000|Overall Study|Withdrawal by Subject|2|||
46855744|NCT00359021|83071624|FG001|Overall Study|Withdrawal by Subject|9|||
46855745|NCT00359021|83071623|FG000|Overall Study|Lost to Follow-up|1|||
46855746|NCT00359021|83071624|FG001|Overall Study|Lost to Follow-up|0|||
46855747|NCT00359021|83071623|FG000|Overall Study|Other|4|||
46855748|NCT00359021|83071624|FG001|Overall Study|Other|1|||
46855749|NCT00359021|83071623|FG000|Overall Study|Pregnancy|1|||
46855750|NCT00359021|83071624|FG001|Overall Study|Pregnancy|0|||
46855751|NCT00360269|83071634|FG000|Overall Study|Lost to Follow-up|7|||
46855752|NCT00360269|83071635|FG001|Overall Study|Lost to Follow-up|9|||
46855753|NCT00360269|83071634|FG000|Overall Study|Physician Decision|1|||
46855754|NCT00360269|83071635|FG001|Overall Study|Physician Decision|2|||
46855755|NCT00360269|83071634|FG000|Overall Study|Adverse Event|1|||
46855756|NCT00360269|83071635|FG001|Overall Study|Adverse Event|0|||
46855757|NCT00360269|83071634|FG000|Overall Study|Withdrawal by Subject|1|||
46855758|NCT00360269|83071635|FG001|Overall Study|Withdrawal by Subject|1|||
46855759|NCT00076752|83071641|FG000|Overall Study|Death|2|||
46855760|NCT00076752|83071641|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
46855761|NCT03384940|83071649|FG000|Overall Study|Progressive disease|36|||
46855762|NCT03384940|83071650|FG001|Overall Study|Progressive disease|11|||
46794006|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794007|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
46794008|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
46794009|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
46794010|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
46855763|NCT03384940|83071651|FG002|Overall Study|Progressive disease|13|||
46794011|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
46794012|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
46794013|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
46794014|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
46855764|NCT03384940|83071649|FG000|Overall Study|Clinical progression|4|||
46855765|NCT03384940|83071650|FG001|Overall Study|Clinical progression|0|||
46855766|NCT03384940|83071651|FG002|Overall Study|Clinical progression|3|||
46855767|NCT03384940|83071649|FG000|Overall Study|Adverse Event|7|||
46855768|NCT03384940|83071650|FG001|Overall Study|Adverse Event|1|||
46855769|NCT03384940|83071651|FG002|Overall Study|Adverse Event|1|||
46855770|NCT03384940|83071649|FG000|Overall Study|Withdrawal by Subject|3|||
46855771|NCT03384940|83071650|FG001|Overall Study|Withdrawal by Subject|1|||
46855772|NCT03384940|83071651|FG002|Overall Study|Withdrawal by Subject|0|||
46855773|NCT03384940|83071649|FG000|Overall Study|Physician Decision|1|||
46855774|NCT03384940|83071650|FG001|Overall Study|Physician Decision|1|||
46855775|NCT03384940|83071651|FG002|Overall Study|Physician Decision|0|||
46855776|NCT03384940|83071649|FG000|Overall Study|Death|2|||
46855777|NCT03384940|83071650|FG001|Overall Study|Death|1|||
46855778|NCT03384940|83071651|FG002|Overall Study|Death|0|||
46674318|NCT01151215|82889935|FG000|Overall Study|Death|16|||
46674319|NCT01151215|82889936|FG001|Overall Study|Death|20|||
46674320|NCT01151215|82889937|FG002|Overall Study|Death|11|||
46674321|NCT01151215|82889935|FG000|Overall Study|Lost to Follow-up|0|||
46674322|NCT01151215|82889936|FG001|Overall Study|Lost to Follow-up|0|||
46674323|NCT01151215|82889937|FG002|Overall Study|Lost to Follow-up|3|||
46674324|NCT01151215|82889935|FG000|Overall Study|Withdrawal by Subject|3|||
46674325|NCT01151215|82889936|FG001|Overall Study|Withdrawal by Subject|1|||
46674326|NCT01151215|82889937|FG002|Overall Study|Withdrawal by Subject|2|||
46674327|NCT01151215|82889935|FG000|Overall Study|Disease progression|0|||
46674328|NCT01151215|82889936|FG001|Overall Study|Disease progression|1|||
46674329|NCT01151215|82889937|FG002|Overall Study|Disease progression|1|||
46674330|NCT01151215|82889935|FG000|Overall Study|Safety as judged by the investigator|0|||
46674331|NCT01151215|82889936|FG001|Overall Study|Safety as judged by the investigator|0|||
46674332|NCT01151215|82889937|FG002|Overall Study|Safety as judged by the investigator|1|||
46674333|NCT01151137|82889947|FG000|Overall Study|Death|15|||
46674334|NCT01151137|82889948|FG001|Overall Study|Death|27|||
46674335|NCT01151137|82889947|FG000|Overall Study|Lost to Follow-up|1|||
46674336|NCT01151137|82889948|FG001|Overall Study|Lost to Follow-up|1|||
46674337|NCT01151098|82889954|FG000|Overall Study|Adverse Event|82|||
46794015|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
46794016|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
46794017|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
46794018|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
46794019|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794020|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
46794021|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46855779|NCT03384940|83071649|FG000|Overall Study|Other|0|||
46855780|NCT03384940|83071650|FG001|Overall Study|Other|0|||
46855781|NCT03384940|83071651|FG002|Overall Study|Other|1|||
46855782|NCT00075582|83071661|FG000|Overall Study|Adverse Event|3|||
46855783|NCT00075582|83071662|FG001|Overall Study|Adverse Event|1|||
46855784|NCT00075582|83071661|FG000|Overall Study|Lack of Efficacy|4|||
46855785|NCT00075582|83071662|FG001|Overall Study|Lack of Efficacy|8|||
46855786|NCT00075582|83071661|FG000|Overall Study|Physician Decision|5|||
46855787|NCT00075582|83071662|FG001|Overall Study|Physician Decision|8|||
46855788|NCT00075582|83071661|FG000|Overall Study|Withdrawal by Subject|2|||
46855789|NCT00075582|83071662|FG001|Overall Study|Withdrawal by Subject|2|||
46855790|NCT00075582|83071661|FG000|Overall Study|Ineligible for study|36|||
46855791|NCT00075582|83071662|FG001|Overall Study|Ineligible for study|16|||
46855792|NCT00063258|83071674|FG000|Overall Study|Physician Decision|2|||
46855793|NCT00063258|83071675|FG001|Overall Study|Physician Decision|0|||
46855794|NCT00063258|83071674|FG000|Overall Study|Lack of Efficacy|2|||
46855795|NCT00063258|83071675|FG001|Overall Study|Lack of Efficacy|0|||
46855796|NCT00088530|83071683|FG000|Overall Study|Progressive/Relapsed Disease|28|||
46855797|NCT00088530|83071684|FG001|Overall Study|Progressive/Relapsed Disease|39|||
46855798|NCT00088530|83071683|FG000|Overall Study|Adverse Event|15|||
46855799|NCT00088530|83071684|FG001|Overall Study|Adverse Event|9|||
46855800|NCT00088530|83071683|FG000|Overall Study|Withdrawal by Subject|2|||
47079216|NCT01405820|83386051|FG003|Randomized Treatment Period|Rescue|10|||
47079217|NCT01405820|83386052|FG004|Randomized Treatment Period|Rescue|8|||
47079218|NCT01405820|83386053|FG005|Randomized Treatment Period|Rescue|8|||
47079219|NCT01405820|83386048|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
47079220|NCT01405820|83386049|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
47079221|NCT01405820|83386050|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
47079222|NCT01405820|83386051|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
47079223|NCT01405820|83386052|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
47079224|NCT01405820|83386053|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
47079225|NCT01405820|83386048|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
47079226|NCT01405820|83386049|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
46674338|NCT01151098|82889954|FG000|Overall Study|Lost to Follow-up|6|||
46674339|NCT01151098|82889954|FG000|Overall Study|Lack of Efficacy|15|||
46674340|NCT01151098|82889954|FG000|Overall Study|Protocol Violation|1|||
46674341|NCT01151098|82889954|FG000|Overall Study|Miscellaneous|13|||
46855801|NCT00088530|83071684|FG001|Overall Study|Withdrawal by Subject|5|||
46855802|NCT00088530|83071683|FG000|Overall Study|Lost to Follow-up|2|||
46855803|NCT00088530|83071684|FG001|Overall Study|Lost to Follow-up|0|||
46855804|NCT00088530|83071683|FG000|Overall Study|Physician Decision|2|||
46855805|NCT00088530|83071684|FG001|Overall Study|Physician Decision|0|||
46674342|NCT01151020|82889958|FG000|Overall Study|Death|25|||
46674343|NCT01151020|82889958|FG000|Overall Study|Conversion to open repair|1|||
46674344|NCT01151020|82889958|FG000|Overall Study|Lost to Follow-up|4|||
46674345|NCT01151020|82889958|FG000|Overall Study|Withdrawal by Subject|22|||
46674346|NCT01151020|82889958|FG000|Overall Study|Patients did not receive the device|2|||
46674347|NCT01150474|82889964|FG000|Overall Study|Withdrawal by Subject|5|||
46674348|NCT01150474|82889965|FG001|Overall Study|Withdrawal by Subject|2|||
46794022|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794023|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46855806|NCT00088530|83071683|FG000|Overall Study|Sponsor decision|0|||
46794024|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794025|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794026|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
46855807|NCT00088530|83071684|FG001|Overall Study|Sponsor decision|1|||
46855808|NCT00088530|83071683|FG000|Overall Study|Patient never treated|1|||
46855809|NCT00088530|83071684|FG001|Overall Study|Patient never treated|0|||
46855810|NCT00359801|83071692|FG000|Overall Study|Lost to Follow-up|72|||
46855811|NCT00359801|83071693|FG001|Overall Study|Lost to Follow-up|58|||
46855812|NCT00359801|83071692|FG000|Overall Study|Withdrawal by Subject|143|||
46855813|NCT00359801|83071693|FG001|Overall Study|Withdrawal by Subject|96|||
46855814|NCT00359801|83071692|FG000|Overall Study|Other|66|||
46855815|NCT00359801|83071693|FG001|Overall Study|Other|46|||
46855816|NCT00359801|83071692|FG000|Overall Study|Final Status Unknown: missing data|7|||
46794027|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794028|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794029|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794030|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794031|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794032|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794033|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
46794034|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794035|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794036|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794037|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
46794038|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794039|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794040|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794041|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794042|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794043|NCT03893565|83012592|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
46794044|NCT03893565|83012593|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
46794045|NCT03893565|83012594|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
46794046|NCT03893565|83012595|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
46794047|NCT03893565|83012596|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
46794048|NCT03893565|83012597|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
46794049|NCT03893565|83012598|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
46855817|NCT00359801|83071693|FG001|Overall Study|Final Status Unknown: missing data|4|||
46855818|NCT00359801|83071692|FG000|Overall Study|Sponsor Decision|17|||
46855819|NCT00359801|83071693|FG001|Overall Study|Sponsor Decision|16|||
46855820|NCT00045032|83071702|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
46855821|NCT00045032|83071703|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
46855822|NCT00045032|83071704|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
46855823|NCT00045032|83071702|FG000|Overall Study|Death|22|||
46855824|NCT00045032|83071703|FG001|Overall Study|Death|24|||
46674349|NCT01150474|82889964|FG000|Overall Study|Cancer found|1|||
46978315|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
46674350|NCT01150474|82889965|FG001|Overall Study|Cancer found|0|||
46855825|NCT00045032|83071704|FG002|Overall Study|Death|17|||
46855826|NCT00045032|83071702|FG000|Overall Study|Insufficient Therapeutic Response|542|||
46855827|NCT00045032|83071703|FG001|Overall Study|Insufficient Therapeutic Response|437|||
46855828|NCT00045032|83071704|FG002|Overall Study|Insufficient Therapeutic Response|445|||
46855829|NCT00045032|83071702|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
46855830|NCT00045032|83071703|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
46855831|NCT00045032|83071704|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
46855832|NCT00045032|83071702|FG000|Overall Study|Other Protocol Violation|2|||
46855833|NCT00045032|83071703|FG001|Overall Study|Other Protocol Violation|0|||
46674351|NCT01150474|82889964|FG000|Overall Study|Multiple Studies|0|||
46674352|NCT01150474|82889965|FG001|Overall Study|Multiple Studies|1|||
46855834|NCT00045032|83071704|FG002|Overall Study|Other Protocol Violation|1|||
46855835|NCT00045032|83071702|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
46855836|NCT00045032|83071703|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
46855837|NCT00045032|83071704|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
46855838|NCT00045032|83071702|FG000|Overall Study|Failure to Return|57|||
46855839|NCT00045032|83071703|FG001|Overall Study|Failure to Return|62|||
46855840|NCT00045032|83071704|FG002|Overall Study|Failure to Return|61|||
46855841|NCT00045032|83071702|FG000|Overall Study|Other|93|||
46855842|NCT00045032|83071703|FG001|Overall Study|Other|84|||
46855843|NCT00045032|83071704|FG002|Overall Study|Other|105|||
46855844|NCT00356915|83071717|FG000|Overall Study|Non compliance|1|||
46855845|NCT00356915|83071718|FG001|Overall Study|Non compliance|2|||
46855846|NCT00356915|83071719|FG002|Overall Study|Non compliance|1|||
46855847|NCT00356915|83071717|FG000|Overall Study|Protocol Violation|2|||
46855848|NCT00356915|83071718|FG001|Overall Study|Protocol Violation|3|||
46794050|NCT03893565|83012599|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
46794051|NCT03893565|83012600|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
46794052|NCT03893565|83012592|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
46794053|NCT03893565|83012593|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
46794054|NCT03893565|83012594|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
46794055|NCT03893565|83012595|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
46794056|NCT03893565|83012596|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
46794057|NCT03893565|83012597|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
46794058|NCT03893565|83012598|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
46794059|NCT03893565|83012599|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
46794060|NCT03893565|83012600|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
46794061|NCT03893565|83012592|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794062|NCT03893565|83012593|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794063|NCT03893565|83012594|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794064|NCT03893565|83012595|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794065|NCT03893565|83012596|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794066|NCT03893565|83012597|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794067|NCT03893565|83012598|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
46794068|NCT03893565|83012599|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794069|NCT03893565|83012600|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
46794070|NCT03893565|83012592|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
46794071|NCT03893565|83012593|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
46794072|NCT03893565|83012594|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
46794073|NCT03893565|83012595|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
46855849|NCT00356915|83071719|FG002|Overall Study|Protocol Violation|2|||
46855850|NCT00356915|83071717|FG000|Overall Study|Withdrawal by Subject|14|||
46855851|NCT00356915|83071718|FG001|Overall Study|Withdrawal by Subject|14|||
46855852|NCT00356915|83071719|FG002|Overall Study|Withdrawal by Subject|10|||
46855853|NCT00356915|83071717|FG000|Overall Study|Lack of Efficacy|0|||
46855854|NCT00356915|83071718|FG001|Overall Study|Lack of Efficacy|0|||
46855855|NCT00356915|83071719|FG002|Overall Study|Lack of Efficacy|3|||
46855856|NCT00356915|83071717|FG000|Overall Study|Lost to Follow-up|27|||
46978316|NCT01668797|83223587|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
46978317|NCT01668797|83223588|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
46978318|NCT01668797|83223589|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
46978319|NCT01668797|83223590|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
46978320|NCT02613221|83223597|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
46794074|NCT03893565|83012596|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
46794075|NCT03893565|83012597|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
46794076|NCT03893565|83012598|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
46794077|NCT03893565|83012599|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
46794078|NCT03893565|83012600|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
46794079|NCT03893565|83012592|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
46794080|NCT03893565|83012593|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
46794081|NCT03893565|83012594|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
46794082|NCT03893565|83012595|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
46794083|NCT03893565|83012596|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
46794084|NCT03893565|83012597|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
46794085|NCT03893565|83012598|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
46794086|NCT03893565|83012599|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
46794087|NCT03893565|83012600|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
46794088|NCT03893565|83012592|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794089|NCT03893565|83012593|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794090|NCT03893565|83012594|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794091|NCT03893565|83012595|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794092|NCT03893565|83012596|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794093|NCT03893565|83012597|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794094|NCT03893565|83012598|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794095|NCT03893565|83012599|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
46794096|NCT03893565|83012600|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
46794097|NCT03893565|83012592|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794098|NCT03893565|83012593|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794099|NCT03893565|83012594|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794100|NCT03893565|83012595|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794101|NCT03893565|83012596|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794102|NCT03893565|83012597|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794103|NCT03893565|83012598|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794104|NCT03893565|83012599|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
46794105|NCT03893565|83012600|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
46794106|NCT03893565|83012592|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794107|NCT03893565|83012593|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794108|NCT03893565|83012594|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794109|NCT03893565|83012595|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794110|NCT03893565|83012596|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794111|NCT03893565|83012597|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794112|NCT03893565|83012598|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794113|NCT03893565|83012599|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
46794114|NCT03893565|83012600|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
46794115|NCT03893565|83012592|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46794116|NCT03893565|83012593|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46794117|NCT03893565|83012594|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46978321|NCT02613221|83223597|FG000|Overall Study|Adverse Event|2|||
46978322|NCT02613221|83223597|FG000|Overall Study|Voluntary Discontinuation|1|||
46978323|NCT02613221|83223597|FG000|Overall Study|Delayed Treatment|1|||
46978324|NCT02613221|83223597|FG000|Overall Study|Enrolled but Not Treated|1|||
46978325|NCT01362049|83223605|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
46978326|NCT01362049|83223606|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
46978327|NCT01362049|83223607|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
46978328|NCT01362049|83223608|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
46978329|NCT01362049|83223605|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
46978330|NCT01362049|83223606|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
46978331|NCT01362049|83223607|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
46978332|NCT01362049|83223608|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
46978333|NCT02612909|83223640|FG000|Phase 2|Withdrawal by Subject|2|||
46978334|NCT02612909|83223641|FG001|Phase 2|Withdrawal by Subject|5|||
46978335|NCT02612909|83223642|FG002|Phase 2|Withdrawal by Subject|0|||
46978336|NCT02612909|83223643|FG003|Phase 2|Withdrawal by Subject|0|||
46978337|NCT02612909|83223644|FG004|Phase 2|Withdrawal by Subject|0|||
46978338|NCT02612909|83223640|FG000|Phase 2|Pregnancy|0|||
46978339|NCT02612909|83223641|FG001|Phase 2|Pregnancy|0|||
46978340|NCT02612909|83223642|FG002|Phase 2|Pregnancy|1|||
46794118|NCT03893565|83012595|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46794119|NCT03893565|83012596|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46794120|NCT03893565|83012597|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46794121|NCT03893565|83012598|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46794122|NCT03893565|83012599|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
46855857|NCT00356915|83071718|FG001|Overall Study|Lost to Follow-up|34|||
46855858|NCT00356915|83071719|FG002|Overall Study|Lost to Follow-up|14|||
46978341|NCT02612909|83223643|FG003|Phase 2|Pregnancy|0|||
46978342|NCT02612909|83223644|FG004|Phase 2|Pregnancy|0|||
46978343|NCT02612909|83223640|FG000|Phase 3|Withdrawal by Subject|0|||
46978344|NCT02612909|83223641|FG001|Phase 3|Withdrawal by Subject|0|||
46978345|NCT02612909|83223642|FG002|Phase 3|Withdrawal by Subject|0|||
46978346|NCT02612909|83223643|FG003|Phase 3|Withdrawal by Subject|1|||
46978347|NCT02612909|83223644|FG004|Phase 3|Withdrawal by Subject|0|||
46978348|NCT02612285|83223658|FG000|Overall Study|Withdrawal by Subject|1|||
46978349|NCT02609633|83223664|FG000|Overall Study|Consent Withdrawn|0|||
46978350|NCT02609633|83223665|FG001|Overall Study|Consent Withdrawn|1|||
46978351|NCT02609633|83223664|FG000|Overall Study|Protocol Deviation|1|||
46978352|NCT02609633|83223665|FG001|Overall Study|Protocol Deviation|0|||
46978353|NCT02609633|83223664|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
46794123|NCT03893565|83012600|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
46794124|NCT00502996|83012619|FG000|Overall Study|Lost to Follow-up|9|||
46794125|NCT00502996|83012619|FG000|Overall Study|Protocol Violation|2|||
46855859|NCT00356915|83071717|FG000|Overall Study|Administrative Decision|0|||
46855860|NCT00356915|83071718|FG001|Overall Study|Administrative Decision|0|||
46855861|NCT00356915|83071719|FG002|Overall Study|Administrative Decision|1|||
46855862|NCT00356915|83071717|FG000|Overall Study|Physician Decision|0|||
46855863|NCT00356915|83071718|FG001|Overall Study|Physician Decision|2|||
46855864|NCT00356915|83071719|FG002|Overall Study|Physician Decision|0|||
46855865|NCT00356915|83071717|FG000|Overall Study|Adverse Event|21|||
46794126|NCT00502996|83012619|FG000|Overall Study|Treatment failure|25|||
46794127|NCT00502996|83012619|FG000|Overall Study|Withdrawal Informed Consent|6|||
46794128|NCT00502996|83012619|FG000|Overall Study|Adverse Event|2|||
46855866|NCT00356915|83071718|FG001|Overall Study|Adverse Event|31|||
46855867|NCT00356915|83071719|FG002|Overall Study|Adverse Event|8|||
46978354|NCT02609633|83223665|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
46978355|NCT02609633|83223664|FG000|Overall Study|Reason not Specified|2|||
46978356|NCT02609633|83223665|FG001|Overall Study|Reason not Specified|1|||
46978357|NCT01597375|83223687|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
46978358|NCT01597375|83223688|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
46855868|NCT00356915|83071717|FG000|Overall Study|Miscellaneous reasons|11|||
46978359|NCT01597375|83223687|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
46978360|NCT01597375|83223688|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
46978361|NCT01597375|83223687|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
46978362|NCT01597375|83223688|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
46978363|NCT01597375|83223687|FG000|Washout (2 Weeks)|Adverse Event|1|||
46978364|NCT01597375|83223688|FG001|Washout (2 Weeks)|Adverse Event|0|||
46978365|NCT01597375|83223687|FG000|Second Intervention|Failed to react at both Aspirin|1|||
46978366|NCT01597375|83223688|FG001|Second Intervention|Failed to react at both Aspirin|1|||
46978367|NCT02527161|83223695|FG000|Overall Study|Failed MRI|52|||
46978368|NCT02527161|83223695|FG000|Overall Study|Withdrawal by Subject|19|||
46978369|NCT02527161|83223695|FG000|Overall Study|Delay in or unfit for surgery|16|||
46978370|NCT02527161|83223695|FG000|Overall Study|MRI contraindication|6|||
46794129|NCT00715403|83012630|FG000|Overall Study|Progressive disease|0|||
46794130|NCT00715403|83012631|FG001|Overall Study|Progressive disease|1|||
46794131|NCT00715403|83012632|FG002|Overall Study|Progressive disease|3|||
46794132|NCT00715403|83012633|FG003|Overall Study|Progressive disease|9|||
46794133|NCT00715403|83012634|FG004|Overall Study|Progressive disease|5|||
46794134|NCT00715403|83012635|FG005|Overall Study|Progressive disease|14|||
46794135|NCT00715403|83012636|FG006|Overall Study|Progressive disease|1|||
46794136|NCT00715403|83012630|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
46794137|NCT00715403|83012631|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
46794138|NCT00715403|83012632|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
46794139|NCT00715403|83012633|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
46794140|NCT00715403|83012634|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
46794141|NCT00715403|83012635|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
46794142|NCT00715403|83012636|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
46794143|NCT00715403|83012630|FG000|Overall Study|Other Adverse Event than DLT|1|||
46794144|NCT00715403|83012631|FG001|Overall Study|Other Adverse Event than DLT|0|||
46794145|NCT00715403|83012632|FG002|Overall Study|Other Adverse Event than DLT|0|||
46794146|NCT00715403|83012633|FG003|Overall Study|Other Adverse Event than DLT|0|||
46794147|NCT00715403|83012634|FG004|Overall Study|Other Adverse Event than DLT|0|||
46794148|NCT00715403|83012635|FG005|Overall Study|Other Adverse Event than DLT|2|||
46794149|NCT00715403|83012636|FG006|Overall Study|Other Adverse Event than DLT|0|||
46794150|NCT00715403|83012630|FG000|Overall Study|Protocol Violation|0|||
46855869|NCT00356915|83071718|FG001|Overall Study|Miscellaneous reasons|8|||
46855870|NCT00356915|83071719|FG002|Overall Study|Miscellaneous reasons|3|||
46855871|NCT00356759|83071735|FG000|Overall Study|Death|5|||
46855872|NCT00356759|83071736|FG001|Overall Study|Death|2|||
46855873|NCT00356759|83071735|FG000|Overall Study|Withdrawal by Subject|2|||
46855874|NCT00356759|83071736|FG001|Overall Study|Withdrawal by Subject|2|||
46855875|NCT00356759|83071735|FG000|Overall Study|Adverse Event|1|||
46855876|NCT00356759|83071736|FG001|Overall Study|Adverse Event|3|||
46855877|NCT00356759|83071735|FG000|Overall Study|Lost to Follow-up|1|||
46855878|NCT00356759|83071736|FG001|Overall Study|Lost to Follow-up|1|||
46855879|NCT00356759|83071735|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
46855880|NCT00356759|83071736|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
46855881|NCT03804710|83071744|FG000|Overall Study|Adverse Event|0|||
46855882|NCT03804710|83071745|FG001|Overall Study|Adverse Event|3|||
46855883|NCT03804710|83071744|FG000|Overall Study|Withdrawal by Subject|2|||
46855884|NCT03804710|83071745|FG001|Overall Study|Withdrawal by Subject|1|||
46794151|NCT00715403|83012631|FG001|Overall Study|Protocol Violation|0|||
46794152|NCT00715403|83012632|FG002|Overall Study|Protocol Violation|0|||
46794153|NCT00715403|83012633|FG003|Overall Study|Protocol Violation|0|||
46794154|NCT00715403|83012634|FG004|Overall Study|Protocol Violation|0|||
46794155|NCT00715403|83012635|FG005|Overall Study|Protocol Violation|1|||
46794156|NCT00715403|83012636|FG006|Overall Study|Protocol Violation|0|||
46794157|NCT00715403|83012630|FG000|Overall Study|Other reason not defined above|0|||
46794158|NCT00715403|83012631|FG001|Overall Study|Other reason not defined above|0|||
46794159|NCT00715403|83012632|FG002|Overall Study|Other reason not defined above|1|||
46855885|NCT03804710|83071744|FG000|Overall Study|Other|0|||
46794160|NCT00715403|83012633|FG003|Overall Study|Other reason not defined above|0|||
46855886|NCT03804710|83071745|FG001|Overall Study|Other|1|||
46855887|NCT00356603|83071757|FG000|Overall Study|Other|6|||
46855888|NCT00356603|83071758|FG001|Overall Study|Other|3|||
46855889|NCT00002558|83071768|FG000|Overall Study|Withdrawal by Subject|0|||
46855890|NCT00002558|83071769|FG001|Overall Study|Withdrawal by Subject|1|||
46855891|NCT00001880|83071775|FG000|Overall Study|Death|14|||
46855892|NCT00043550|83071782|FG000|Overall Study|Withdrawal by Subject|22|||
46855893|NCT00043550|83071783|FG001|Overall Study|Withdrawal by Subject|12|||
46855894|NCT00043550|83071784|FG002|Overall Study|Withdrawal by Subject|20|||
46855895|NCT00041756|83071797|FG000|Overall Study|Adverse Event|4|||
46978371|NCT02527161|83223695|FG000|Overall Study|Consent violation|4|||
46978372|NCT02527161|83223695|FG000|Overall Study|Only Recruited to Part A|27|||
46794161|NCT00715403|83012634|FG004|Overall Study|Other reason not defined above|1|||
46794162|NCT00715403|83012635|FG005|Overall Study|Other reason not defined above|1|||
46855896|NCT00041756|83071798|FG001|Overall Study|Adverse Event|10|||
46855897|NCT00041756|83071799|FG002|Overall Study|Adverse Event|6|||
46855898|NCT00041756|83071800|FG003|Overall Study|Adverse Event|11|||
46855899|NCT00041756|83071801|FG004|Overall Study|Adverse Event|34|||
46855900|NCT00041756|83071797|FG000|Overall Study|Protocol Violation|1|||
46855901|NCT00041756|83071798|FG001|Overall Study|Protocol Violation|1|||
46855902|NCT00041756|83071799|FG002|Overall Study|Protocol Violation|2|||
46855903|NCT00041756|83071800|FG003|Overall Study|Protocol Violation|2|||
46855904|NCT00041756|83071801|FG004|Overall Study|Protocol Violation|1|||
46855905|NCT00041756|83071797|FG000|Overall Study|Withdrawal by Subject|3|||
46855906|NCT00041756|83071798|FG001|Overall Study|Withdrawal by Subject|3|||
46855907|NCT00041756|83071799|FG002|Overall Study|Withdrawal by Subject|4|||
46855908|NCT00041756|83071800|FG003|Overall Study|Withdrawal by Subject|2|||
46855909|NCT00041756|83071801|FG004|Overall Study|Withdrawal by Subject|3|||
46855910|NCT00041756|83071797|FG000|Overall Study|Lost to Follow-up|0|||
46855911|NCT00041756|83071798|FG001|Overall Study|Lost to Follow-up|1|||
46855912|NCT00041756|83071799|FG002|Overall Study|Lost to Follow-up|0|||
46855913|NCT00041756|83071800|FG003|Overall Study|Lost to Follow-up|1|||
46855914|NCT00041756|83071801|FG004|Overall Study|Lost to Follow-up|0|||
46855915|NCT00041756|83071797|FG000|Overall Study|Unable to meet protocol criteria|0|||
46978373|NCT02527161|83223695|FG000|Overall Study|Physician Decision|1|||
46978374|NCT02527161|83223695|FG000|Overall Study|Adverse Event|1|||
46978375|NCT02527161|83223695|FG000|Overall Study|Lost to Follow-up|6|||
46978376|NCT02609399|83223702|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
46978377|NCT02609399|83223703|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
46978378|NCT02609399|83223702|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
46855916|NCT00041756|83071798|FG001|Overall Study|Unable to meet protocol criteria|0|||
46855917|NCT00041756|83071799|FG002|Overall Study|Unable to meet protocol criteria|1|||
46855918|NCT00041756|83071800|FG003|Overall Study|Unable to meet protocol criteria|0|||
46978379|NCT02609399|83223703|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
46978380|NCT02609399|83223702|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
46794163|NCT00715403|83012636|FG006|Overall Study|Other reason not defined above|0|||
46855919|NCT00041756|83071801|FG004|Overall Study|Unable to meet protocol criteria|1|||
46855920|NCT00041756|83071797|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
46855921|NCT00041756|83071798|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
46855922|NCT00041756|83071799|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
46855923|NCT00041756|83071800|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
46855924|NCT00041756|83071801|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
46855925|NCT00041132|83071813|FG000|Overall Study|Adverse Event|19|||
46855926|NCT00041132|83071813|FG000|Overall Study|Death|1|||
46855927|NCT00041132|83071813|FG000|Overall Study|Not Eligible|7|||
46855928|NCT00041132|83071813|FG000|Overall Study|Withdrawal by Subject|1|||
46855929|NCT00041132|83071813|FG000|Overall Study|Physician Decision|2|||
46855930|NCT00040742|83071821|FG000|Overall Study|Death|0|||
46855931|NCT00040742|83071822|FG001|Overall Study|Death|0|||
46855932|NCT00040742|83071823|FG002|Overall Study|Death|1|||
46855933|NCT00040742|83071824|FG003|Overall Study|Death|0|||
46978381|NCT02609399|83223703|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
46978382|NCT02720185|83223711|FG000|Overall Study|Lost to Follow-up|1|||
46978383|NCT02526693|83223734|FG000|Overall Study|Physician Decision|3|||
46794164|NCT00502840|83012652|FG000|Overall Study|Adverse Event|5|||
46794165|NCT00502840|83012652|FG000|Overall Study|Additional or changed therapy|48|||
46794166|NCT00502840|83012652|FG000|Overall Study|Lack of Efficacy|11|||
46794167|NCT00502840|83012652|FG000|Overall Study|Protocol Violation|4|||
46794168|NCT00502840|83012652|FG000|Overall Study|Withdrawal by Subject|5|||
46794169|NCT00502840|83012652|FG000|Overall Study|Lost to Follow-up|6|||
46794170|NCT00502840|83012652|FG000|Overall Study|Administrative problems|1|||
46794171|NCT00502840|83012652|FG000|Overall Study|Other|20|||
46794172|NCT00515008|83012659|FG000|Overall Study|Lost to Follow-up|1|||
46794173|NCT00515008|83012660|FG001|Overall Study|Lost to Follow-up|0|||
46794174|NCT00515008|83012659|FG000|Overall Study|Declined|0|||
46794175|NCT00515008|83012660|FG001|Overall Study|Declined|3|||
46794176|NCT00515008|83012659|FG000|Overall Study|Left the Boston Area|1|||
46794177|NCT00515008|83012660|FG001|Overall Study|Left the Boston Area|1|||
46794178|NCT00515008|83012659|FG000|Overall Study|Scheduling conflict|1|||
46855934|NCT00040742|83071821|FG000|Overall Study|Adverse Event|15|||
46855935|NCT00040742|83071822|FG001|Overall Study|Adverse Event|16|||
46855936|NCT00040742|83071823|FG002|Overall Study|Adverse Event|21|||
46855937|NCT00040742|83071824|FG003|Overall Study|Adverse Event|9|||
46855938|NCT00040742|83071821|FG000|Overall Study|Withdrawal by Subject|7|||
46855939|NCT00040742|83071822|FG001|Overall Study|Withdrawal by Subject|15|||
46855940|NCT00040742|83071823|FG002|Overall Study|Withdrawal by Subject|10|||
46855941|NCT00040742|83071824|FG003|Overall Study|Withdrawal by Subject|13|||
46855942|NCT00040742|83071821|FG000|Overall Study|Chemotoxicity|4|||
46855943|NCT00040742|83071822|FG001|Overall Study|Chemotoxicity|3|||
46855944|NCT00040742|83071823|FG002|Overall Study|Chemotoxicity|5|||
46978384|NCT02526693|83223735|FG001|Overall Study|Physician Decision|1|||
46978385|NCT02710669|83223753|FG000|Overall Study|Physician Decision|2|||
46978386|NCT02710669|83223754|FG001|Overall Study|Physician Decision|1|||
46978387|NCT02710669|83223755|FG002|Overall Study|Physician Decision|0|||
46978388|NCT02710669|83223753|FG000|Overall Study|Institutional delays (including COVID)|2|||
46978389|NCT02710669|83223754|FG001|Overall Study|Institutional delays (including COVID)|2|||
46978390|NCT02710669|83223755|FG002|Overall Study|Institutional delays (including COVID)|0|||
46978391|NCT02710669|83223753|FG000|Overall Study|arrived in afib/aflutter|10|||
46978392|NCT02710669|83223754|FG001|Overall Study|arrived in afib/aflutter|8|||
46978393|NCT02710669|83223755|FG002|Overall Study|arrived in afib/aflutter|2|||
46978394|NCT02610725|83223763|FG000|Overall Study|Lost to Follow-up|197|||
46978395|NCT02610725|83223763|FG000|Overall Study|self-reported contraindication|9|||
46978396|NCT02684461|83223770|FG000|Overall Study|Adverse Event|1|||
46978397|NCT02684461|83223771|FG001|Overall Study|Adverse Event|0|||
46978398|NCT02684461|83223772|FG002|Overall Study|Adverse Event|0|||
46978399|NCT02684461|83223770|FG000|Overall Study|Lack of Efficacy|1|||
46978400|NCT02684461|83223771|FG001|Overall Study|Lack of Efficacy|2|||
46978401|NCT02684461|83223772|FG002|Overall Study|Lack of Efficacy|0|||
46794179|NCT00515008|83012660|FG001|Overall Study|Scheduling conflict|0|||
46794180|NCT00514540|83012669|FG000|First-Line Chemo|Withdrawal by Subject|1|||
46794181|NCT00514540|83012669|FG000|First-Line Chemo|Protocol Violation|7|||
46794182|NCT00514540|83012669|FG000|Second-Line|Physician/Patient Decision|31|||
46794183|NCT00713609|83012687|FG000|Overall Study|Adverse Event|2|||
46794184|NCT00713609|83012688|FG001|Overall Study|Adverse Event|0|||
46794185|NCT00713609|83012689|FG002|Overall Study|Adverse Event|2|||
46794186|NCT00713609|83012690|FG003|Overall Study|Adverse Event|2|||
46794187|NCT00713609|83012691|FG004|Overall Study|Adverse Event|3|||
46794188|NCT00713609|83012692|FG005|Overall Study|Adverse Event|1|||
46794189|NCT00713609|83012687|FG000|Overall Study|Lost to Follow-up|5|||
46794190|NCT00713609|83012688|FG001|Overall Study|Lost to Follow-up|7|||
46794191|NCT00713609|83012689|FG002|Overall Study|Lost to Follow-up|5|||
46855945|NCT00040742|83071824|FG003|Overall Study|Chemotoxicity|2|||
46855946|NCT00040742|83071821|FG000|Overall Study|Incomplete Forms|6|||
46855947|NCT00040742|83071822|FG001|Overall Study|Incomplete Forms|10|||
46855948|NCT00040742|83071823|FG002|Overall Study|Incomplete Forms|4|||
46855949|NCT00040742|83071824|FG003|Overall Study|Incomplete Forms|5|||
46855950|NCT00040742|83071821|FG000|Overall Study|Other medical|7|||
46855951|NCT00040742|83071822|FG001|Overall Study|Other medical|5|||
46855952|NCT00040742|83071823|FG002|Overall Study|Other medical|5|||
46855953|NCT00040742|83071824|FG003|Overall Study|Other medical|5|||
46855954|NCT00040664|83071834|FG000|Overall Study|Adverse Event|12|||
46855955|NCT00040664|83071835|FG001|Overall Study|Adverse Event|3|||
46855956|NCT00040664|83071836|FG002|Overall Study|Adverse Event|2|||
46855957|NCT00040664|83071837|FG003|Overall Study|Adverse Event|7|||
46855958|NCT00040664|83071834|FG000|Overall Study|Lack of Efficacy|9|||
46855959|NCT00040664|83071835|FG001|Overall Study|Lack of Efficacy|2|||
46855960|NCT00040664|83071836|FG002|Overall Study|Lack of Efficacy|3|||
46855961|NCT00040664|83071837|FG003|Overall Study|Lack of Efficacy|4|||
46978402|NCT02647645|83223797|FG000|Overall Study|Lost to Follow-up|2|||
46794192|NCT00713609|83012690|FG003|Overall Study|Lost to Follow-up|5|||
46794193|NCT00713609|83012691|FG004|Overall Study|Lost to Follow-up|7|||
46794194|NCT00713609|83012692|FG005|Overall Study|Lost to Follow-up|0|||
46794195|NCT00713609|83012687|FG000|Overall Study|Lack of Efficacy|1|||
46794196|NCT00713609|83012688|FG001|Overall Study|Lack of Efficacy|3|||
46794197|NCT00713609|83012689|FG002|Overall Study|Lack of Efficacy|0|||
46794198|NCT00713609|83012690|FG003|Overall Study|Lack of Efficacy|0|||
46794199|NCT00713609|83012691|FG004|Overall Study|Lack of Efficacy|1|||
46794200|NCT00713609|83012692|FG005|Overall Study|Lack of Efficacy|0|||
46794201|NCT00713609|83012687|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
46794202|NCT00713609|83012688|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
46794203|NCT00713609|83012689|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
46855962|NCT00040664|83071834|FG000|Overall Study|Insufficient CD4 response|1|||
46978403|NCT02647645|83223798|FG001|Overall Study|Lost to Follow-up|1|||
46978404|NCT02531373|83223813|FG000|Overall Study|Lack of Efficacy|0|||
46794204|NCT00713609|83012690|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
46855963|NCT00040664|83071835|FG001|Overall Study|Insufficient CD4 response|0|||
46855964|NCT00040664|83071836|FG002|Overall Study|Insufficient CD4 response|1|||
46855965|NCT00040664|83071837|FG003|Overall Study|Insufficient CD4 response|0|||
47079227|NCT01405820|83386050|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
47079228|NCT01405820|83386051|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
47079229|NCT01405820|83386052|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
47079230|NCT01405820|83386053|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
47079231|NCT01405820|83386048|FG000|Randomized Treatment Period|Death|0|||
47079232|NCT01405820|83386049|FG001|Randomized Treatment Period|Death|0|||
47079233|NCT01405820|83386050|FG002|Randomized Treatment Period|Death|0|||
47079234|NCT01405820|83386051|FG003|Randomized Treatment Period|Death|1|||
47079235|NCT01405820|83386052|FG004|Randomized Treatment Period|Death|0|||
46978405|NCT02531373|83223814|FG001|Overall Study|Lack of Efficacy|0|||
46978406|NCT02531373|83223815|FG002|Overall Study|Lack of Efficacy|0|||
46978407|NCT02531373|83223816|FG003|Overall Study|Lack of Efficacy|0|||
46978408|NCT02531373|83223817|FG004|Overall Study|Lack of Efficacy|3|||
46978409|NCT02531373|83223818|FG005|Overall Study|Lack of Efficacy|2|||
46978410|NCT02531373|83223819|FG006|Overall Study|Lack of Efficacy|4|||
46855966|NCT00040664|83071834|FG000|Overall Study|Lost to Follow-up|4|||
46978411|NCT02531373|83223820|FG007|Overall Study|Lack of Efficacy|8|||
46978412|NCT02531373|83223821|FG008|Overall Study|Lack of Efficacy|5|||
46674353|NCT01150474|82889964|FG000|Overall Study|Rectotomy|1|||
46978413|NCT02531373|83223813|FG000|Overall Study|Lost to Follow-up|0|||
46978414|NCT02531373|83223814|FG001|Overall Study|Lost to Follow-up|0|||
46978415|NCT02531373|83223815|FG002|Overall Study|Lost to Follow-up|0|||
46978416|NCT02531373|83223816|FG003|Overall Study|Lost to Follow-up|0|||
46978417|NCT02531373|83223817|FG004|Overall Study|Lost to Follow-up|0|||
46978418|NCT02531373|83223818|FG005|Overall Study|Lost to Follow-up|2|||
46978419|NCT02531373|83223819|FG006|Overall Study|Lost to Follow-up|2|||
46978420|NCT02531373|83223820|FG007|Overall Study|Lost to Follow-up|0|||
46978421|NCT02531373|83223821|FG008|Overall Study|Lost to Follow-up|0|||
46978422|NCT02531373|83223813|FG000|Overall Study|Physician Decision|0|||
46978423|NCT02531373|83223814|FG001|Overall Study|Physician Decision|0|||
46978424|NCT02531373|83223815|FG002|Overall Study|Physician Decision|0|||
46978425|NCT02531373|83223816|FG003|Overall Study|Physician Decision|0|||
46978426|NCT02531373|83223817|FG004|Overall Study|Physician Decision|2|||
46978427|NCT02531373|83223818|FG005|Overall Study|Physician Decision|1|||
46855967|NCT00040664|83071835|FG001|Overall Study|Lost to Follow-up|2|||
46855968|NCT00040664|83071836|FG002|Overall Study|Lost to Follow-up|0|||
46855969|NCT00040664|83071837|FG003|Overall Study|Lost to Follow-up|2|||
46855970|NCT00040664|83071834|FG000|Overall Study|Protocol Violation|2|||
46855971|NCT00040664|83071835|FG001|Overall Study|Protocol Violation|1|||
46855972|NCT00040664|83071836|FG002|Overall Study|Protocol Violation|0|||
46978428|NCT02531373|83223819|FG006|Overall Study|Physician Decision|0|||
46978429|NCT02531373|83223820|FG007|Overall Study|Physician Decision|0|||
46978430|NCT02531373|83223821|FG008|Overall Study|Physician Decision|0|||
46978431|NCT02531373|83223813|FG000|Overall Study|Protocol Violation|0|||
46978432|NCT02531373|83223814|FG001|Overall Study|Protocol Violation|0|||
46978433|NCT02531373|83223815|FG002|Overall Study|Protocol Violation|0|||
46978434|NCT02531373|83223816|FG003|Overall Study|Protocol Violation|0|||
46978435|NCT02531373|83223817|FG004|Overall Study|Protocol Violation|0|||
46978436|NCT02531373|83223818|FG005|Overall Study|Protocol Violation|1|||
46978437|NCT02531373|83223819|FG006|Overall Study|Protocol Violation|1|||
46978438|NCT02531373|83223820|FG007|Overall Study|Protocol Violation|0|||
46978439|NCT02531373|83223821|FG008|Overall Study|Protocol Violation|1|||
46978440|NCT02531373|83223813|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46978441|NCT02531373|83223814|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46978442|NCT02531373|83223815|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
46978443|NCT02531373|83223816|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
46978444|NCT02531373|83223817|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
46978445|NCT02531373|83223818|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
46978446|NCT02531373|83223819|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
46978447|NCT02531373|83223820|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
46978448|NCT02531373|83223821|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
46978449|NCT02531373|83223813|FG000|Overall Study|Withdrawal by Subject|0|||
46978450|NCT02531373|83223814|FG001|Overall Study|Withdrawal by Subject|0|||
46978451|NCT02531373|83223815|FG002|Overall Study|Withdrawal by Subject|0|||
46978452|NCT02531373|83223816|FG003|Overall Study|Withdrawal by Subject|0|||
46978453|NCT02531373|83223817|FG004|Overall Study|Withdrawal by Subject|3|||
46978454|NCT02531373|83223818|FG005|Overall Study|Withdrawal by Subject|0|||
46978455|NCT02531373|83223819|FG006|Overall Study|Withdrawal by Subject|0|||
46978456|NCT02531373|83223820|FG007|Overall Study|Withdrawal by Subject|0|||
46978457|NCT02531373|83223821|FG008|Overall Study|Withdrawal by Subject|0|||
46674354|NCT01150474|82889965|FG001|Overall Study|Rectotomy|0|||
46978458|NCT02606279|83223844|FG000|Overall Study|Lost to Follow-up|0|||
46674355|NCT01150474|82889964|FG000|Overall Study|Drug did not arrive in time|1|||
46674356|NCT01150474|82889965|FG001|Overall Study|Drug did not arrive in time|0|||
46674357|NCT01150474|82889964|FG000|Overall Study|Drug not administered|1|||
46978459|NCT02606279|83223845|FG001|Overall Study|Lost to Follow-up|1|||
46978460|NCT02643355|83223859|FG000|Overall Study|Withdrawal by Subject|1|||
46674358|NCT01150474|82889965|FG001|Overall Study|Drug not administered|0|||
46978461|NCT02643355|83223860|FG001|Overall Study|Withdrawal by Subject|3|||
46855973|NCT00040664|83071837|FG003|Overall Study|Protocol Violation|1|||
46978462|NCT02643355|83223859|FG000|Overall Study|Protocol Violation|0|||
46978463|NCT02643355|83223860|FG001|Overall Study|Protocol Violation|2|||
46978464|NCT02604017|83223868|FG000|Overall Study|Withdrew Consent|0|||
46978465|NCT02604017|83223869|FG001|Overall Study|Withdrew Consent|2|||
46855974|NCT00040664|83071834|FG000|Overall Study|Withdrawal by Subject|7|||
46855975|NCT00040664|83071835|FG001|Overall Study|Withdrawal by Subject|0|||
46855976|NCT00040664|83071836|FG002|Overall Study|Withdrawal by Subject|3|||
46855977|NCT00040664|83071837|FG003|Overall Study|Withdrawal by Subject|4|||
46855978|NCT00040664|83071834|FG000|Overall Study|Pregnancy|3|||
46855979|NCT00040664|83071835|FG001|Overall Study|Pregnancy|0|||
46855980|NCT00040664|83071836|FG002|Overall Study|Pregnancy|0|||
46855981|NCT00040664|83071837|FG003|Overall Study|Pregnancy|3|||
46674359|NCT01150474|82889964|FG000|Overall Study|Surgery Changed|1|||
46855982|NCT00040664|83071834|FG000|Overall Study|Medication adherence/compliance problems|8|||
46855983|NCT00040664|83071835|FG001|Overall Study|Medication adherence/compliance problems|2|||
46855984|NCT00040664|83071836|FG002|Overall Study|Medication adherence/compliance problems|1|||
46855985|NCT00040664|83071837|FG003|Overall Study|Medication adherence/compliance problems|5|||
46855986|NCT00040664|83071834|FG000|Overall Study|Poor taste|2|||
46855987|NCT00040664|83071835|FG001|Overall Study|Poor taste|0|||
46855988|NCT00040664|83071836|FG002|Overall Study|Poor taste|2|||
46855989|NCT00040664|83071837|FG003|Overall Study|Poor taste|0|||
46855990|NCT00040664|83071834|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
46855991|NCT00040664|83071835|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
46855992|NCT00040664|83071836|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
46674360|NCT01150474|82889965|FG001|Overall Study|Surgery Changed|0|||
46674361|NCT01150357|82889974|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
46674362|NCT01150357|82889975|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
46674363|NCT01150357|82889976|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
46674364|NCT01150357|82889974|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
46855993|NCT00040664|83071837|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
46978466|NCT02604017|83223868|FG000|Overall Study|Lost to Follow-up|5|||
46978467|NCT02604017|83223869|FG001|Overall Study|Lost to Follow-up|6|||
46978468|NCT02604017|83223868|FG000|Overall Study|Other|1|||
46978469|NCT02604017|83223869|FG001|Overall Study|Other|0|||
46978470|NCT02640547|83223875|FG000|Overall Study|Failure to Return|1|||
46978471|NCT02640547|83223875|FG000|Overall Study|Withdrawal by Subject|1|||
46978472|NCT02640547|83223875|FG000|Overall Study|Death|6|||
46978473|NCT02640547|83223875|FG000|Overall Study|Miscellaneous|3|||
46978474|NCT02530905|83223889|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
46978475|NCT02530905|83223890|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
46978476|NCT02530905|83223891|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
46978477|NCT02530671|83223915|FG000|Overall Study|Lost to Follow-up|2|||
46978478|NCT02530671|83223916|FG001|Overall Study|Lost to Follow-up|0|||
46978479|NCT02530671|83223915|FG000|Overall Study|Withdrawal by Subject|1|||
46978480|NCT02530671|83223916|FG001|Overall Study|Withdrawal by Subject|0|||
46978481|NCT02603393|83223924|FG000|Overall Study|Patient/guardian decision|32|||
46978482|NCT02603393|83223925|FG001|Overall Study|Patient/guardian decision|18|||
46978483|NCT02603393|83223924|FG000|Overall Study|Adverse Event|17|||
46978484|NCT02603393|83223925|FG001|Overall Study|Adverse Event|15|||
46978485|NCT02603393|83223924|FG000|Overall Study|Technical problems|4|||
46978486|NCT02603393|83223925|FG001|Overall Study|Technical problems|7|||
46978487|NCT02603393|83223924|FG000|Overall Study|Lack of Efficacy|7|||
46978488|NCT02603393|83223925|FG001|Overall Study|Lack of Efficacy|2|||
46978489|NCT02603393|83223924|FG000|Overall Study|Death|3|||
46855994|NCT00040664|83071834|FG000|Overall Study|Change of formulation|2|||
46855995|NCT00040664|83071835|FG001|Overall Study|Change of formulation|2|||
46978490|NCT02603393|83223925|FG001|Overall Study|Death|4|||
46978491|NCT02603393|83223924|FG000|Overall Study|Physician Decision|3|||
46978492|NCT02603393|83223925|FG001|Overall Study|Physician Decision|3|||
46978493|NCT02603393|83223924|FG000|Overall Study|Protocol deviation|2|||
46978494|NCT02603393|83223925|FG001|Overall Study|Protocol deviation|3|||
46978495|NCT02603393|83223924|FG000|Overall Study|Lost to Follow-up|1|||
46978496|NCT02603393|83223925|FG001|Overall Study|Lost to Follow-up|2|||
46978497|NCT02603393|83223924|FG000|Overall Study|Non-compliance with study treatment|1|||
46978498|NCT02603393|83223925|FG001|Overall Study|Non-compliance with study treatment|0|||
46978499|NCT02603393|83223924|FG000|Overall Study|Sponsor decision|1|||
46978500|NCT02603393|83223925|FG001|Overall Study|Sponsor decision|0|||
46978501|NCT02642653|83223933|FG000|Overall Study|Adverse Event|2|||
46978502|NCT02642653|83223934|FG001|Overall Study|Adverse Event|0|||
46978503|NCT01659567|83223940|FG000|Overall Study|Lack of Efficacy|22|||
46978504|NCT01659567|83223940|FG000|Overall Study|Switched to Pegferon|6|||
46978505|NCT01659567|83223940|FG000|Overall Study|Adverse Event|12|||
46978506|NCT01659567|83223940|FG000|Overall Study|Good result at early stage of treatment|5|||
46978507|NCT01659567|83223940|FG000|Overall Study|Withdrawal by Subject|64|||
46978508|NCT01659567|83223940|FG000|Overall Study|Progression of the main disease|1|||
46978509|NCT01659567|83223940|FG000|Overall Study|Other|13|||
46978510|NCT02605967|83223956|FG000|Overall Study|subject / guardian decision|1|||
46855996|NCT00040664|83071836|FG002|Overall Study|Change of formulation|0|||
46855997|NCT00040664|83071837|FG003|Overall Study|Change of formulation|0|||
46978511|NCT02605967|83223957|FG001|Overall Study|subject / guardian decision|2|||
46978512|NCT02605967|83223956|FG000|Overall Study|Physician Decision|10|||
46978513|NCT02605967|83223957|FG001|Overall Study|Physician Decision|1|||
46855998|NCT00040664|83071834|FG000|Overall Study|Non-viability of oral suspension|1|||
46855999|NCT00040664|83071835|FG001|Overall Study|Non-viability of oral suspension|0|||
46856000|NCT00040664|83071836|FG002|Overall Study|Non-viability of oral suspension|1|||
46978514|NCT02605967|83223956|FG000|Overall Study|Death|4|||
46978515|NCT02605967|83223957|FG001|Overall Study|Death|2|||
46978516|NCT02605967|83223956|FG000|Overall Study|Adverse Event|1|||
46856001|NCT00040664|83071837|FG003|Overall Study|Non-viability of oral suspension|0|||
46856002|NCT02952586|83071857|FG000|Lead-In Phase (7 Days)|Death|0|||
46856003|NCT02952586|83071858|FG001|Lead-In Phase (7 Days)|Death|1|||
46978517|NCT02605967|83223957|FG001|Overall Study|Adverse Event|0|||
46978518|NCT02605967|83223956|FG000|Overall Study|progressive disease|66|||
46978519|NCT02605967|83223957|FG001|Overall Study|progressive disease|35|||
46856004|NCT02952586|83071857|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
46978520|NCT01668173|83223967|FG000|Overall Study|Adverse Event|3|||
46978521|NCT01668173|83223967|FG000|Overall Study|Trial suspension|4|||
46978522|NCT02600351|83223984|FG000|Overall Study|Lack of Efficacy|3|||
46856005|NCT02952586|83071858|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
46978523|NCT02600351|83223985|FG001|Overall Study|Lack of Efficacy|0|||
46978524|NCT02600351|83223986|FG002|Overall Study|Lack of Efficacy|5|||
46978525|NCT02600351|83223987|FG003|Overall Study|Lack of Efficacy|2|||
46856006|NCT02952586|83071857|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
46856007|NCT02952586|83071858|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
46856008|NCT02952586|83071857|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
46978526|NCT02600351|83223984|FG000|Overall Study|Lost to Follow-up|1|||
46978527|NCT02600351|83223985|FG001|Overall Study|Lost to Follow-up|0|||
46978528|NCT02600351|83223986|FG002|Overall Study|Lost to Follow-up|0|||
46978529|NCT02600351|83223987|FG003|Overall Study|Lost to Follow-up|0|||
46978530|NCT02600351|83223984|FG000|Overall Study|Randomized but Not Treated|1|||
46794205|NCT00713609|83012691|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
46794206|NCT00713609|83012692|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
46794207|NCT00713609|83012687|FG000|Overall Study|Withdrawal by Subject|6|||
46794208|NCT00713609|83012688|FG001|Overall Study|Withdrawal by Subject|1|||
46794209|NCT00713609|83012689|FG002|Overall Study|Withdrawal by Subject|5|||
46794210|NCT00713609|83012690|FG003|Overall Study|Withdrawal by Subject|1|||
46794211|NCT00713609|83012691|FG004|Overall Study|Withdrawal by Subject|5|||
46794212|NCT00713609|83012692|FG005|Overall Study|Withdrawal by Subject|7|||
46794213|NCT00713609|83012687|FG000|Overall Study|Protocol Violation|6|||
46794214|NCT00713609|83012688|FG001|Overall Study|Protocol Violation|3|||
46978531|NCT02600351|83223985|FG001|Overall Study|Randomized but Not Treated|0|||
46978532|NCT02600351|83223986|FG002|Overall Study|Randomized but Not Treated|1|||
47079236|NCT01405820|83386053|FG005|Randomized Treatment Period|Death|0|||
46794215|NCT00713609|83012689|FG002|Overall Study|Protocol Violation|1|||
46794216|NCT00713609|83012690|FG003|Overall Study|Protocol Violation|1|||
46794217|NCT00713609|83012691|FG004|Overall Study|Protocol Violation|2|||
46794218|NCT00713609|83012692|FG005|Overall Study|Protocol Violation|0|||
46856009|NCT02952586|83071858|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
46978533|NCT02600351|83223987|FG003|Overall Study|Randomized but Not Treated|3|||
47079237|NCT01405820|83386048|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
47079238|NCT01405820|83386049|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
47079239|NCT01405820|83386050|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
47079240|NCT01405820|83386051|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
47079241|NCT01405820|83386052|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
47079242|NCT01405820|83386053|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
47079243|NCT01405820|83386048|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
47079244|NCT01405820|83386049|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
47079245|NCT01405820|83386050|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
47079246|NCT01405820|83386051|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
47079247|NCT01405820|83386052|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
47079248|NCT01405820|83386053|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
47079249|NCT01405820|83386048|FG000|Open-Label Treatment Period|Other|1|||
46794219|NCT00513682|83012706|FG000|Washout Phase|Adverse Event|2|||
46794220|NCT00493012|83012715|FG000|Overall Study|Lost to Follow-up|18|||
46794221|NCT00493012|83012716|FG001|Overall Study|Lost to Follow-up|17|||
46794222|NCT05144477|83012724|FG000|Overall Study|Withdrawal by Subject|1|||
46794223|NCT05144477|83012725|FG001|Overall Study|Withdrawal by Subject|1|||
46794224|NCT00617708|83012741|FG000|Overall Study|Adverse Event|0|||
46794225|NCT00617708|83012742|FG001|Overall Study|Adverse Event|6|||
46794226|NCT00617708|83012743|FG002|Overall Study|Adverse Event|9|||
46794227|NCT00617708|83012741|FG000|Overall Study|Withdrawal by Subject|1|||
46978534|NCT02640235|83224001|FG000|Overall Study|Withdrawal by Subject|7|||
46978535|NCT02640235|83224002|FG001|Overall Study|Withdrawal by Subject|6|||
46978536|NCT02640235|83224001|FG000|Overall Study|Lost to Follow-up|4|||
46978537|NCT02640235|83224002|FG001|Overall Study|Lost to Follow-up|3|||
46978538|NCT02640235|83224001|FG000|Overall Study|Death|2|||
46978539|NCT02640235|83224002|FG001|Overall Study|Death|3|||
46794228|NCT00617708|83012742|FG001|Overall Study|Withdrawal by Subject|1|||
46794229|NCT00617708|83012743|FG002|Overall Study|Withdrawal by Subject|7|||
46794230|NCT00617708|83012741|FG000|Overall Study|Death|0|||
46794231|NCT00617708|83012742|FG001|Overall Study|Death|6|||
46856010|NCT02952586|83071857|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
46856011|NCT02952586|83071858|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
46856012|NCT02952586|83071857|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
46856013|NCT02952586|83071858|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
46856014|NCT02952586|83071857|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
46856015|NCT02952586|83071858|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
46856016|NCT02952586|83071857|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
46856017|NCT02952586|83071858|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
46856018|NCT02952586|83071857|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
46794232|NCT00617708|83012743|FG002|Overall Study|Death|5|||
46794233|NCT00617708|83012741|FG000|Overall Study|Progression/Relapse|7|||
46794234|NCT00617708|83012742|FG001|Overall Study|Progression/Relapse|40|||
46794235|NCT00617708|83012743|FG002|Overall Study|Progression/Relapse|36|||
46794236|NCT00617708|83012741|FG000|Overall Study|Not protocol specified|1|||
46856019|NCT02952586|83071858|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
46856020|NCT02952586|83071857|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
46794237|NCT00617708|83012742|FG001|Overall Study|Not protocol specified|4|||
46794238|NCT00617708|83012743|FG002|Overall Study|Not protocol specified|2|||
46794239|NCT00617708|83012741|FG000|Overall Study|Not eligible|1|||
46856021|NCT02952586|83071858|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
46856022|NCT02952586|83071857|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
46978540|NCT02640235|83224001|FG000|Overall Study|Other|1|||
46978541|NCT02640235|83224002|FG001|Overall Study|Other|2|||
46978542|NCT02599961|83224008|FG000|Overall Study|Withdrawal by Subject|1|||
46978543|NCT02599961|83224008|FG000|Overall Study|Subject Non-Compliance|2|||
46978544|NCT02599961|83224008|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
46978545|NCT02599961|83224008|FG000|Overall Study|Other, Not Specified|3|||
46978546|NCT02640157|83224033|FG000|Overall Study|Adverse Event|2|||
46978547|NCT02640157|83224034|FG001|Overall Study|Adverse Event|2|||
46978548|NCT02640157|83224035|FG002|Overall Study|Adverse Event|1|||
46978549|NCT02640157|83224033|FG000|Overall Study|Withdrew consent|2|||
46978550|NCT02640157|83224034|FG001|Overall Study|Withdrew consent|0|||
46978551|NCT02640157|83224035|FG002|Overall Study|Withdrew consent|2|||
46978552|NCT02640157|83224033|FG000|Overall Study|Lost to Follow-up|9|||
46978553|NCT02640157|83224034|FG001|Overall Study|Lost to Follow-up|2|||
46978554|NCT02640157|83224035|FG002|Overall Study|Lost to Follow-up|7|||
46978555|NCT02640157|83224033|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
46978556|NCT02640157|83224034|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
46978557|NCT02640157|83224035|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
46978558|NCT01673347|83224044|FG000|Overall Study|failure of allograft|7|||
46978559|NCT02528253|83224053|FG000|Overall Study|Adverse Event|3|||
46978560|NCT02528253|83224054|FG001|Overall Study|Adverse Event|4|||
46856023|NCT02952586|83071858|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
46856024|NCT02952586|83071857|FG000|CRT for Cisplatin (63 Days)|Death|3|||
46856025|NCT02952586|83071858|FG001|CRT for Cisplatin (63 Days)|Death|8|||
46856026|NCT02952586|83071857|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
46856027|NCT02952586|83071858|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
46856028|NCT02952586|83071857|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
46856029|NCT02952586|83071858|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
46856030|NCT02952586|83071857|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
46856031|NCT02952586|83071858|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
46856032|NCT02952586|83071857|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
46978561|NCT02528253|83224055|FG002|Overall Study|Adverse Event|4|||
46978562|NCT02528253|83224056|FG003|Overall Study|Adverse Event|8|||
46978563|NCT02528253|83224057|FG004|Overall Study|Adverse Event|18|||
46978564|NCT02528253|83224053|FG000|Overall Study|Death|2|||
46794240|NCT00617708|83012742|FG001|Overall Study|Not eligible|3|||
46794241|NCT00617708|83012743|FG002|Overall Study|Not eligible|5|||
46794242|NCT03894969|83012758|FG000|Overall Study|Adverse Event|0|||
46794243|NCT03894969|83012759|FG001|Overall Study|Adverse Event|2|||
46794244|NCT03894969|83012760|FG002|Overall Study|Adverse Event|0|||
46794245|NCT03894969|83012761|FG003|Overall Study|Adverse Event|1|||
46794246|NCT03894969|83012762|FG004|Overall Study|Adverse Event|2|||
46794247|NCT03894969|83012758|FG000|Overall Study|Lost to Follow-up|3|||
46794248|NCT03894969|83012759|FG001|Overall Study|Lost to Follow-up|1|||
46794249|NCT03894969|83012760|FG002|Overall Study|Lost to Follow-up|1|||
46856033|NCT02952586|83071858|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
46978565|NCT02528253|83224054|FG001|Overall Study|Death|2|||
46856034|NCT02952586|83071857|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
46856035|NCT02952586|83071858|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
46978566|NCT02528253|83224055|FG002|Overall Study|Death|1|||
46794250|NCT03894969|83012761|FG003|Overall Study|Lost to Follow-up|0|||
46794251|NCT03894969|83012762|FG004|Overall Study|Lost to Follow-up|0|||
46794252|NCT03894969|83012758|FG000|Overall Study|Withdrawal by Subject|2|||
46794253|NCT03894969|83012759|FG001|Overall Study|Withdrawal by Subject|1|||
46794254|NCT03894969|83012760|FG002|Overall Study|Withdrawal by Subject|3|||
46856036|NCT02952586|83071857|FG000|CRT for Cisplatin (63 Days)|Other|1|||
46978567|NCT02528253|83224056|FG003|Overall Study|Death|0|||
46978568|NCT02528253|83224057|FG004|Overall Study|Death|1|||
46978569|NCT02528253|83224053|FG000|Overall Study|Insufficient clinical response|7|||
46978570|NCT02528253|83224054|FG001|Overall Study|Insufficient clinical response|10|||
46978571|NCT02528253|83224055|FG002|Overall Study|Insufficient clinical response|13|||
46978572|NCT02528253|83224056|FG003|Overall Study|Insufficient clinical response|12|||
46978573|NCT02528253|83224057|FG004|Overall Study|Insufficient clinical response|16|||
46978574|NCT02528253|83224053|FG000|Overall Study|Lost to Follow-up|16|||
46978575|NCT02528253|83224054|FG001|Overall Study|Lost to Follow-up|9|||
46978576|NCT02528253|83224055|FG002|Overall Study|Lost to Follow-up|31|||
46978577|NCT02528253|83224056|FG003|Overall Study|Lost to Follow-up|16|||
46978578|NCT02528253|83224057|FG004|Overall Study|Lost to Follow-up|34|||
46978579|NCT02528253|83224053|FG000|Overall Study|Other|21|||
46978580|NCT02528253|83224054|FG001|Overall Study|Other|22|||
46978581|NCT02528253|83224055|FG002|Overall Study|Other|58|||
46978582|NCT02528253|83224056|FG003|Overall Study|Other|52|||
46978583|NCT02528253|83224057|FG004|Overall Study|Other|76|||
46978584|NCT02528253|83224053|FG000|Overall Study|Withdrawal by Subject|25|||
46978585|NCT02528253|83224054|FG001|Overall Study|Withdrawal by Subject|20|||
46978586|NCT02528253|83224055|FG002|Overall Study|Withdrawal by Subject|29|||
46978587|NCT02528253|83224056|FG003|Overall Study|Withdrawal by Subject|48|||
46978588|NCT02528253|83224057|FG004|Overall Study|Withdrawal by Subject|73|||
46978589|NCT02528253|83224053|FG000|Overall Study|Protocol Violation|1|||
46978590|NCT02528253|83224054|FG001|Overall Study|Protocol Violation|2|||
46978591|NCT02528253|83224055|FG002|Overall Study|Protocol Violation|4|||
46978592|NCT02528253|83224056|FG003|Overall Study|Protocol Violation|0|||
46978593|NCT02528253|83224057|FG004|Overall Study|Protocol Violation|4|||
46978594|NCT02528253|83224053|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
46978595|NCT02528253|83224054|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
46978596|NCT02528253|83224055|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
46978597|NCT02528253|83224056|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
46978598|NCT02528253|83224057|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
46978599|NCT01672957|83224088|FG000|Overall Study|Protocol Violation|48|||
46978600|NCT01672957|83224088|FG000|Overall Study|Death|2|||
46978601|NCT01672957|83224088|FG000|Overall Study|ICF Signed After Transplantation|5|||
46978602|NCT02525133|83224094|FG000|Overall Study|Adverse Event|0|||
46978603|NCT02525133|83224095|FG001|Overall Study|Adverse Event|1|||
46978604|NCT02525133|83224094|FG000|Overall Study|Death|0|||
46978605|NCT02525133|83224095|FG001|Overall Study|Death|1|||
46794255|NCT03894969|83012761|FG003|Overall Study|Withdrawal by Subject|4|||
46794256|NCT03894969|83012762|FG004|Overall Study|Withdrawal by Subject|8|||
46794257|NCT03894969|83012758|FG000|Overall Study|Other|0|||
46794258|NCT03894969|83012759|FG001|Overall Study|Other|0|||
46794259|NCT03894969|83012760|FG002|Overall Study|Other|0|||
46794260|NCT03894969|83012761|FG003|Overall Study|Other|0|||
46794261|NCT03894969|83012762|FG004|Overall Study|Other|3|||
46794262|NCT03894969|83012758|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
46794263|NCT03894969|83012759|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
46794264|NCT03894969|83012760|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
46794265|NCT03894969|83012761|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
46794266|NCT03894969|83012762|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
46794267|NCT03894969|83012758|FG000|Overall Study|Solicited Adverse Event|0|||
46794268|NCT03894969|83012759|FG001|Overall Study|Solicited Adverse Event|1|||
46794269|NCT03894969|83012760|FG002|Overall Study|Solicited Adverse Event|0|||
46794270|NCT03894969|83012761|FG003|Overall Study|Solicited Adverse Event|0|||
46794271|NCT03894969|83012762|FG004|Overall Study|Solicited Adverse Event|0|||
46978606|NCT02525133|83224094|FG000|Overall Study|did not meet randomization criteria|1|||
46978607|NCT02525133|83224095|FG001|Overall Study|did not meet randomization criteria|0|||
46978608|NCT02525133|83224094|FG000|Overall Study|Lost to Follow-up|5|||
46978609|NCT02525133|83224095|FG001|Overall Study|Lost to Follow-up|1|||
46978610|NCT02525133|83224094|FG000|Overall Study|randomized not enrolled|3|||
46794272|NCT03894813|83012778|FG000|Overall Study|Adverse Event|1|||
46794273|NCT03894813|83012779|FG001|Overall Study|Adverse Event|1|||
46856037|NCT02952586|83071858|FG001|CRT for Cisplatin (63 Days)|Other|1|||
46978611|NCT02525133|83224095|FG001|Overall Study|randomized not enrolled|0|||
46674365|NCT01150357|82889975|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
46674366|NCT01150357|82889976|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
46674367|NCT01150357|82889974|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
46794274|NCT03894813|83012778|FG000|Overall Study|Lack of Efficacy|3|||
46794275|NCT03894813|83012779|FG001|Overall Study|Lack of Efficacy|3|||
46794276|NCT03894813|83012778|FG000|Overall Study|Lost to Follow-up|1|||
46794277|NCT03894813|83012779|FG001|Overall Study|Lost to Follow-up|0|||
46856038|NCT02952586|83071857|FG000|CRT for IMRT (63 Days)|Death|5|||
46856039|NCT02952586|83071858|FG001|CRT for IMRT (63 Days)|Death|8|||
46856040|NCT02952586|83071857|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
46856041|NCT02952586|83071858|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
46856042|NCT02952586|83071857|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
46856043|NCT02952586|83071858|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
46856044|NCT02952586|83071857|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
46856045|NCT02952586|83071858|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
46856046|NCT02952586|83071857|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
46856047|NCT02952586|83071858|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
46856048|NCT02952586|83071857|FG000|CRT for IMRT (63 Days)|Other|1|||
46856049|NCT02952586|83071858|FG001|CRT for IMRT (63 Days)|Other|0|||
46856050|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Death|17|||
46856051|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Death|11|||
46856052|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
46856053|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
46856054|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
46856055|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
46856056|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
46856057|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
46856058|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
46856059|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
46856060|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
46856061|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
46856062|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
46856063|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
46856064|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
46856065|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
46856066|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Other|2|||
46856067|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Other|1|||
46856068|NCT02952586|83071857|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
46856069|NCT02952586|83071858|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
46856070|NCT02952586|83071857|FG000|Follow-Up Phase (90 Days)|Death|12|||
46856071|NCT02952586|83071858|FG001|Follow-Up Phase (90 Days)|Death|10|||
46856072|NCT02952586|83071857|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
46856073|NCT02952586|83071858|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
46856074|NCT02952586|83071857|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
46856075|NCT02952586|83071858|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
46856076|NCT02952586|83071857|FG000|Follow-Up Phase (90 Days)|Other|7|||
46794278|NCT03894813|83012778|FG000|Overall Study|Pregnancy|2|||
46794279|NCT03894813|83012779|FG001|Overall Study|Pregnancy|1|||
46794280|NCT03894813|83012778|FG000|Overall Study|Protocol Violation|3|||
46794281|NCT03894813|83012779|FG001|Overall Study|Protocol Violation|7|||
46794282|NCT03894813|83012778|FG000|Overall Study|Withdrawal by Subject|1|||
46794283|NCT03894813|83012779|FG001|Overall Study|Withdrawal by Subject|3|||
46856077|NCT02952586|83071858|FG001|Follow-Up Phase (90 Days)|Other|5|||
46856078|NCT02952586|83071857|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
46856079|NCT02952586|83071858|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
46856080|NCT02952586|83071857|FG000|LT Follow-up (up to 45 Months)|Death|51|||
46856081|NCT02952586|83071858|FG001|LT Follow-up (up to 45 Months)|Death|31|||
46856082|NCT02952586|83071857|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
46856083|NCT02952586|83071858|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
46978612|NCT02525133|83224094|FG000|Overall Study|Withdrawal by Subject|1|||
46794284|NCT03894813|83012778|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
46794285|NCT03894813|83012779|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
46856084|NCT02952586|83071857|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
46856085|NCT02952586|83071858|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
46856086|NCT02952586|83071857|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
46856087|NCT02952586|83071858|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
46978613|NCT02525133|83224095|FG001|Overall Study|Withdrawal by Subject|0|||
47079250|NCT01405820|83386049|FG001|Open-Label Treatment Period|Other|1|||
46794286|NCT00615992|83012785|FG000|Overall Study|Protocol Violation|67|||
46794287|NCT03892707|83012791|FG000|Overall Study|Screen failure|6|||
46794288|NCT03892707|83012792|FG001|Overall Study|Screen failure|0|||
46856088|NCT03384316|83071867|FG000|Overall Study|Screen failure|0|||
46856089|NCT03384316|83071868|FG001|Overall Study|Screen failure|1|||
46856090|NCT03403192|83071880|FG000|Overall Study|Lost to Follow-up|1|||
46856091|NCT03403192|83071881|FG001|Overall Study|Lost to Follow-up|2|||
46856092|NCT03403192|83071882|FG002|Overall Study|Lost to Follow-up|0|||
46856093|NCT03403192|83071883|FG003|Overall Study|Lost to Follow-up|0|||
46856094|NCT03403192|83071880|FG000|Overall Study|Unable to respond|0|||
46856095|NCT03403192|83071881|FG001|Overall Study|Unable to respond|1|||
46856096|NCT03403192|83071882|FG002|Overall Study|Unable to respond|0|||
46856097|NCT03403192|83071883|FG003|Overall Study|Unable to respond|0|||
46856098|NCT03403192|83071880|FG000|Overall Study|Incomplete|3|||
46856099|NCT03403192|83071881|FG001|Overall Study|Incomplete|1|||
46856100|NCT03403192|83071882|FG002|Overall Study|Incomplete|3|||
46674368|NCT01150357|82889975|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
46674369|NCT01150357|82889976|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
46674370|NCT01150357|82889974|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
46674371|NCT01150357|82889975|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
46674372|NCT01150357|82889976|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
46674373|NCT01150357|82889974|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
46674374|NCT01150357|82889975|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
46674375|NCT01150357|82889976|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
46856101|NCT03403192|83071883|FG003|Overall Study|Incomplete|6|||
46856102|NCT00356525|83071897|FG000|Overall Study|Progressive Disease|8|||
46856103|NCT00356525|83071898|FG001|Overall Study|Progressive Disease|5|||
46856104|NCT00356525|83071899|FG002|Overall Study|Progressive Disease|4|||
46856105|NCT00356525|83071900|FG003|Overall Study|Progressive Disease|2|||
46856106|NCT00356525|83071897|FG000|Overall Study|Adverse Event|1|||
46856107|NCT00356525|83071898|FG001|Overall Study|Adverse Event|3|||
46978614|NCT01659255|83224122|FG000|Overall Study|Adverse Event|0|||
46978615|NCT01659255|83224123|FG001|Overall Study|Adverse Event|0|||
46978616|NCT01659255|83224124|FG002|Overall Study|Adverse Event|0|||
46794289|NCT03892707|83012791|FG000|Overall Study|Pain resolution|0|||
46674376|NCT01150357|82889974|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
46674377|NCT01150357|82889975|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
46674378|NCT01150357|82889976|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
46674379|NCT01150357|82889974|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
46674380|NCT01150357|82889975|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
46674381|NCT01150357|82889976|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
46674382|NCT01150123|82890026|FG000|Overall Study|Withdrawal by Subject|1|||
46674383|NCT01150123|82890027|FG001|Overall Study|Withdrawal by Subject|1|||
46794290|NCT03892707|83012792|FG001|Overall Study|Pain resolution|4|||
46794291|NCT03892707|83012791|FG000|Overall Study|Withdrawal by Subject|0|||
46794292|NCT03892707|83012792|FG001|Overall Study|Withdrawal by Subject|1|||
46794293|NCT03892707|83012791|FG000|Overall Study|Other (long business trip)|0|||
46794294|NCT03892707|83012792|FG001|Overall Study|Other (long business trip)|1|||
46794295|NCT00615914|83012799|FG000|Overall Study|Adverse Event|274|||
46794296|NCT00615914|83012799|FG000|Overall Study|Death|20|||
46794297|NCT00615914|83012799|FG000|Overall Study|Lack of Efficacy|59|||
46794298|NCT00615914|83012799|FG000|Overall Study|Lost to Follow-up|187|||
46794299|NCT00615914|83012799|FG000|Overall Study|Withdrawal by Subject|16|||
46794300|NCT00615914|83012799|FG000|Overall Study|Physician Decision|4|||
46794301|NCT00615914|83012799|FG000|Overall Study|No data was collected.|65|||
46856108|NCT00356525|83071899|FG002|Overall Study|Adverse Event|1|||
46856109|NCT00356525|83071900|FG003|Overall Study|Adverse Event|1|||
46794302|NCT00615914|83012799|FG000|Overall Study|No treatment|2|||
46856110|NCT00356525|83071897|FG000|Overall Study|Lost to Follow-up|1|||
46856111|NCT00356525|83071898|FG001|Overall Study|Lost to Follow-up|0|||
46856112|NCT00356525|83071899|FG002|Overall Study|Lost to Follow-up|0|||
46856113|NCT00356525|83071900|FG003|Overall Study|Lost to Follow-up|0|||
46978617|NCT01659255|83224125|FG003|Overall Study|Adverse Event|0|||
46794303|NCT00615914|83012799|FG000|Overall Study|Irregularly enrolled patients|10|||
46794304|NCT00513604|83012809|FG000|Overall Study|Not treated|2|||
46794305|NCT00513604|83012810|FG001|Overall Study|Not treated|0|||
46794306|NCT00513604|83012811|FG002|Overall Study|Not treated|1|||
46794307|NCT00513604|83012812|FG003|Overall Study|Not treated|0|||
46794308|NCT00513604|83012813|FG004|Overall Study|Not treated|0|||
46794309|NCT00513604|83012809|FG000|Overall Study|Death during treatment|0|||
46794310|NCT00513604|83012810|FG001|Overall Study|Death during treatment|3|||
46794311|NCT00513604|83012811|FG002|Overall Study|Death during treatment|2|||
46794312|NCT00513604|83012812|FG003|Overall Study|Death during treatment|0|||
46794313|NCT00513604|83012813|FG004|Overall Study|Death during treatment|0|||
47079251|NCT01405820|83386050|FG002|Open-Label Treatment Period|Other|1|||
47079252|NCT01405820|83386051|FG003|Open-Label Treatment Period|Other|1|||
47079253|NCT01405820|83386052|FG004|Open-Label Treatment Period|Other|1|||
47079254|NCT01405820|83386053|FG005|Open-Label Treatment Period|Other|1|||
47079255|NCT01405820|83386048|FG000|Open-Label Treatment Period|Physician Decision|0|||
47079256|NCT01405820|83386049|FG001|Open-Label Treatment Period|Physician Decision|0|||
47079257|NCT01405820|83386050|FG002|Open-Label Treatment Period|Physician Decision|1|||
47079258|NCT01405820|83386051|FG003|Open-Label Treatment Period|Physician Decision|2|||
47079259|NCT01405820|83386052|FG004|Open-Label Treatment Period|Physician Decision|1|||
47079260|NCT01405820|83386053|FG005|Open-Label Treatment Period|Physician Decision|0|||
47079261|NCT01405820|83386048|FG000|Open-Label Treatment Period|Adverse Event|0|||
47079262|NCT01405820|83386049|FG001|Open-Label Treatment Period|Adverse Event|0|||
47079263|NCT01405820|83386050|FG002|Open-Label Treatment Period|Adverse Event|0|||
47079264|NCT01405820|83386051|FG003|Open-Label Treatment Period|Adverse Event|1|||
47079265|NCT01405820|83386052|FG004|Open-Label Treatment Period|Adverse Event|0|||
46794314|NCT00534105|83012827|FG000|Overall Study|Lost to Follow-up|23|||
46794315|NCT00534105|83012828|FG001|Overall Study|Lost to Follow-up|39|||
46794316|NCT00573248|83012843|FG000|Overall Study|scheduling conflicts|15|||
47079266|NCT01405820|83386053|FG005|Open-Label Treatment Period|Adverse Event|0|||
46794317|NCT00573248|83012844|FG001|Overall Study|scheduling conflicts|11|||
46794318|NCT00532935|83012852|FG000|Overall Study|Adverse Event|11|||
46856114|NCT00356525|83071897|FG000|Overall Study|Physician Decision|2|||
46856115|NCT00356525|83071898|FG001|Overall Study|Physician Decision|2|||
46856116|NCT00356525|83071899|FG002|Overall Study|Physician Decision|2|||
46856117|NCT00356525|83071900|FG003|Overall Study|Physician Decision|1|||
46856118|NCT00356525|83071897|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
46856119|NCT00356525|83071898|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
46856120|NCT00356525|83071899|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
46856121|NCT00356525|83071900|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
46856122|NCT00356525|83071897|FG000|Overall Study|Withdrawal by Subject|1|||
46856123|NCT00356525|83071898|FG001|Overall Study|Withdrawal by Subject|1|||
46856124|NCT00356525|83071899|FG002|Overall Study|Withdrawal by Subject|0|||
46856125|NCT00356525|83071900|FG003|Overall Study|Withdrawal by Subject|3|||
46856126|NCT00356525|83071897|FG000|Overall Study|Death|0|||
46856127|NCT00356525|83071898|FG001|Overall Study|Death|0|||
46856128|NCT00356525|83071899|FG002|Overall Study|Death|0|||
46856129|NCT00356525|83071900|FG003|Overall Study|Death|1|||
46856130|NCT00356525|83071897|FG000|Overall Study|Sponsor Decision|0|||
46856131|NCT00356525|83071898|FG001|Overall Study|Sponsor Decision|0|||
46856132|NCT00356525|83071899|FG002|Overall Study|Sponsor Decision|0|||
46856133|NCT00356525|83071900|FG003|Overall Study|Sponsor Decision|1|||
46856134|NCT00356369|83071912|FG000|Active Phase|Withdrawal by Subject|2|||
46856135|NCT00356369|83071913|FG001|Active Phase|Withdrawal by Subject|1|||
46856136|NCT03383614|83071923|FG000|Overall Study|Withdrawal by Subject|0|||
46856137|NCT03383614|83071924|FG001|Overall Study|Withdrawal by Subject|1|||
46856138|NCT03383614|83071925|FG002|Overall Study|Withdrawal by Subject|0|||
46856139|NCT03383614|83071926|FG003|Overall Study|Withdrawal by Subject|0|||
46794319|NCT00532935|83012853|FG001|Overall Study|Adverse Event|12|||
46794320|NCT00532935|83012852|FG000|Overall Study|Lack of Efficacy|0|||
46794321|NCT00532935|83012853|FG001|Overall Study|Lack of Efficacy|3|||
46794322|NCT00532935|83012852|FG000|Overall Study|Lost to Follow-up|10|||
46794323|NCT00532935|83012853|FG001|Overall Study|Lost to Follow-up|6|||
46794324|NCT00532935|83012852|FG000|Overall Study|Physician Decision|4|||
46794325|NCT00532935|83012853|FG001|Overall Study|Physician Decision|5|||
46794326|NCT00532935|83012852|FG000|Overall Study|Pregnancy|1|||
46794327|NCT00532935|83012853|FG001|Overall Study|Pregnancy|0|||
46794328|NCT00532935|83012852|FG000|Overall Study|Protocol Violation|4|||
46794329|NCT00532935|83012853|FG001|Overall Study|Protocol Violation|2|||
46794330|NCT00532935|83012852|FG000|Overall Study|Withdrawal by Subject|10|||
46794331|NCT00532935|83012853|FG001|Overall Study|Withdrawal by Subject|9|||
46794332|NCT00532935|83012852|FG000|Overall Study|Protocol Specific Criteria|11|||
46794333|NCT00532935|83012853|FG001|Overall Study|Protocol Specific Criteria|15|||
46794334|NCT03016312|83012861|FG000|Overall Study|Death|194|||
46794335|NCT03016312|83012862|FG001|Overall Study|Death|164|||
46794336|NCT03016312|83012861|FG000|Overall Study|Lost to Follow-up|11|||
46794337|NCT03016312|83012862|FG001|Overall Study|Lost to Follow-up|12|||
46794338|NCT03016312|83012861|FG000|Overall Study|Started new therapy, loss of contact|2|||
46794339|NCT03016312|83012862|FG001|Overall Study|Started new therapy, loss of contact|1|||
46794340|NCT03016312|83012861|FG000|Overall Study|Physician Decision|0|||
46794341|NCT03016312|83012862|FG001|Overall Study|Physician Decision|2|||
46794342|NCT03016312|83012861|FG000|Overall Study|Withdrawal by Subject|34|||
46794343|NCT03016312|83012862|FG001|Overall Study|Withdrawal by Subject|39|||
46794344|NCT00512902|83012868|FG000|Overall Study|Adverse Event|7|||
46794345|NCT00512902|83012868|FG000|Overall Study|Lost to Follow-up|1|||
46794346|NCT00492232|83012874|FG000|Placebo Run-in|Adverse Event|0|||
46794347|NCT00492232|83012875|FG001|Placebo Run-in|Adverse Event|2|||
46794348|NCT00492232|83012874|FG000|Placebo Run-in|Protocol Violation|0|||
46794349|NCT00492232|83012875|FG001|Placebo Run-in|Protocol Violation|3|||
46794350|NCT00492232|83012874|FG000|Placebo Run-in|Lost to Follow-up|0|||
46794351|NCT00492232|83012875|FG001|Placebo Run-in|Lost to Follow-up|3|||
46794352|NCT00492232|83012874|FG000|Placebo Run-in|Withdrawal by Subject|0|||
46856140|NCT03403036|83071941|FG000|Overall Study|Lack of Efficacy|5|||
46856141|NCT00356135|83071948|FG000|Overall Study|Protocol Violation|1|||
46856142|NCT00356135|83071949|FG001|Overall Study|Protocol Violation|0|||
46856143|NCT00356135|83071950|FG002|Overall Study|Protocol Violation|0|||
46856144|NCT00356135|83071948|FG000|Overall Study|Adverse Event|1|||
46794353|NCT00492232|83012875|FG001|Placebo Run-in|Withdrawal by Subject|8|||
46794354|NCT00492232|83012874|FG000|Placebo Run-in|Pregnancy|0|||
46794355|NCT00492232|83012875|FG001|Placebo Run-in|Pregnancy|1|||
46794356|NCT00492232|83012874|FG000|Placebo Run-in|Entrance criteria not met|0|||
46856145|NCT00356135|83071949|FG001|Overall Study|Adverse Event|0|||
46794357|NCT00492232|83012875|FG001|Placebo Run-in|Entrance criteria not met|45|||
46856146|NCT00356135|83071950|FG002|Overall Study|Adverse Event|0|||
46794358|NCT00492232|83012874|FG000|Placebo Run-in|Other|0|||
46794359|NCT00492232|83012875|FG001|Placebo Run-in|Other|6|||
46794360|NCT00492232|83012874|FG000|Placebo Run-in|Missing|0|||
46794361|NCT00492232|83012875|FG001|Placebo Run-in|Missing|2|||
46794362|NCT00492232|83012874|FG000|Double-Blind Treatment|Adverse Event|1|||
46794363|NCT00492232|83012875|FG001|Double-Blind Treatment|Adverse Event|2|||
46794364|NCT00492232|83012874|FG000|Double-Blind Treatment|Protocol Violation|3|||
46794365|NCT00492232|83012875|FG001|Double-Blind Treatment|Protocol Violation|7|||
46794366|NCT00492232|83012874|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
46794367|NCT00492232|83012875|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
46856147|NCT00356135|83071948|FG000|Overall Study|Lost to Follow-up|0|||
46794368|NCT00492232|83012874|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
46794369|NCT00492232|83012875|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
46794370|NCT00492232|83012874|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
46794371|NCT00492232|83012875|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
46794372|NCT00492232|83012874|FG000|Double-Blind Treatment|Other|6|||
46794373|NCT00492232|83012875|FG001|Double-Blind Treatment|Other|5|||
46794374|NCT00492232|83012874|FG000|Double-Blind Treatment|Randomized not treated|1|||
46794375|NCT00492232|83012875|FG001|Double-Blind Treatment|Randomized not treated|0|||
46794376|NCT00492232|83012874|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
46794377|NCT00492232|83012875|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
46794378|NCT00491764|83012887|FG000|Overall Study|Adverse Event|1|||
46794379|NCT00491764|83012888|FG001|Overall Study|Adverse Event|2|||
46794380|NCT00491764|83012889|FG002|Overall Study|Adverse Event|4|||
46794381|NCT00491764|83012890|FG003|Overall Study|Adverse Event|4|||
46978618|NCT01659255|83224126|FG004|Overall Study|Adverse Event|0|||
46978619|NCT01659255|83224127|FG005|Overall Study|Adverse Event|1|||
46978620|NCT01659255|83224128|FG006|Overall Study|Adverse Event|1|||
46978621|NCT01659255|83224129|FG007|Overall Study|Adverse Event|0|||
46978622|NCT01659255|83224130|FG008|Overall Study|Adverse Event|0|||
46978623|NCT01659255|83224131|FG009|Overall Study|Adverse Event|1|||
46978624|NCT01659255|83224132|FG010|Overall Study|Adverse Event|0|||
46978625|NCT01659255|83224133|FG011|Overall Study|Adverse Event|1|||
46978626|NCT01659255|83224134|FG012|Overall Study|Adverse Event|0|||
46978627|NCT01659255|83224135|FG013|Overall Study|Adverse Event|2|||
46794382|NCT00491764|83012891|FG004|Overall Study|Adverse Event|0|||
46794383|NCT00491764|83012892|FG005|Overall Study|Adverse Event|1|||
46794384|NCT00491764|83012887|FG000|Overall Study|Lost to Follow-up|0|||
46794385|NCT00491764|83012888|FG001|Overall Study|Lost to Follow-up|1|||
46794386|NCT00491764|83012889|FG002|Overall Study|Lost to Follow-up|0|||
46794387|NCT00491764|83012890|FG003|Overall Study|Lost to Follow-up|1|||
46794388|NCT00491764|83012891|FG004|Overall Study|Lost to Follow-up|0|||
46794389|NCT00491764|83012892|FG005|Overall Study|Lost to Follow-up|3|||
46978628|NCT01659255|83224136|FG014|Overall Study|Adverse Event|0|||
46978629|NCT01659255|83224137|FG015|Overall Study|Adverse Event|1|||
46856148|NCT00356135|83071949|FG001|Overall Study|Lost to Follow-up|0|||
46978630|NCT01659255|83224138|FG016|Overall Study|Adverse Event|0|||
46978631|NCT01659255|83224122|FG000|Overall Study|Death|0|||
46978632|NCT01659255|83224123|FG001|Overall Study|Death|1|||
46794390|NCT00491764|83012887|FG000|Overall Study|Withdrawal by Subject|2|||
46978633|NCT01659255|83224124|FG002|Overall Study|Death|0|||
46978634|NCT01659255|83224125|FG003|Overall Study|Death|0|||
46674384|NCT01150123|82890028|FG002|Overall Study|Withdrawal by Subject|2|||
46674385|NCT01150123|82890029|FG003|Overall Study|Withdrawal by Subject|1|||
46674386|NCT01150123|82890030|FG004|Overall Study|Withdrawal by Subject|1|||
46674387|NCT01150123|82890031|FG005|Overall Study|Withdrawal by Subject|1|||
46674388|NCT01150123|82890032|FG006|Overall Study|Withdrawal by Subject|0|||
46674389|NCT01150123|82890033|FG007|Overall Study|Withdrawal by Subject|3|||
46674390|NCT01150123|82890034|FG008|Overall Study|Withdrawal by Subject|2|||
46674391|NCT01150123|82890035|FG009|Overall Study|Withdrawal by Subject|0|||
46674392|NCT01150123|82890036|FG010|Overall Study|Withdrawal by Subject|1|||
46674393|NCT01150123|82890037|FG011|Overall Study|Withdrawal by Subject|0|||
46794391|NCT00491764|83012888|FG001|Overall Study|Withdrawal by Subject|3|||
46794392|NCT00491764|83012889|FG002|Overall Study|Withdrawal by Subject|1|||
46794393|NCT00491764|83012890|FG003|Overall Study|Withdrawal by Subject|2|||
46794394|NCT00491764|83012891|FG004|Overall Study|Withdrawal by Subject|2|||
46794395|NCT00491764|83012892|FG005|Overall Study|Withdrawal by Subject|4|||
46794396|NCT00491764|83012887|FG000|Overall Study|Non Compliance with the Protocol|1|||
46794397|NCT00491764|83012888|FG001|Overall Study|Non Compliance with the Protocol|0|||
46794398|NCT00491764|83012889|FG002|Overall Study|Non Compliance with the Protocol|0|||
46794399|NCT00491764|83012890|FG003|Overall Study|Non Compliance with the Protocol|0|||
46978635|NCT01659255|83224126|FG004|Overall Study|Death|0|||
46978636|NCT01659255|83224127|FG005|Overall Study|Death|0|||
47079267|NCT01405742|83386082|FG000|Overall Study|Lost to Follow-up|1|||
47079268|NCT01405742|83386083|FG001|Overall Study|Lost to Follow-up|0|||
47079269|NCT01425632|83386112|FG000|Overall Study|Adverse Event|0|||
47079270|NCT01425632|83386113|FG001|Overall Study|Adverse Event|1|||
47079271|NCT01425632|83386114|FG002|Overall Study|Adverse Event|1|||
47079272|NCT01425632|83386112|FG000|Overall Study|Physician Decision|1|||
47079273|NCT01425632|83386113|FG001|Overall Study|Physician Decision|0|||
47079274|NCT01425632|83386114|FG002|Overall Study|Physician Decision|0|||
47079275|NCT01425632|83386112|FG000|Overall Study|Protocol Violation|0|||
47079276|NCT01425632|83386113|FG001|Overall Study|Protocol Violation|0|||
47079277|NCT01425632|83386114|FG002|Overall Study|Protocol Violation|2|||
46674394|NCT01150123|82890038|FG012|Overall Study|Withdrawal by Subject|1|||
46794400|NCT00491764|83012891|FG004|Overall Study|Non Compliance with the Protocol|0|||
46978637|NCT01659255|83224128|FG006|Overall Study|Death|0|||
47079278|NCT01425632|83386112|FG000|Overall Study|Withdrawal by Subject|0|||
47079279|NCT01425632|83386113|FG001|Overall Study|Withdrawal by Subject|0|||
47079280|NCT01425632|83386114|FG002|Overall Study|Withdrawal by Subject|1|||
47079281|NCT01405508|83386151|FG000|Overall Study|AE, non-serious non-fatal|1|||
47079282|NCT01405508|83386152|FG001|Overall Study|AE, non-serious non-fatal|1|||
47079283|NCT01405508|83386153|FG002|Overall Study|AE, non-serious non-fatal|0|||
47079284|NCT01405508|83386154|FG003|Overall Study|AE, non-serious non-fatal|0|||
47079285|NCT01405196|83386290|FG000|Overall Study|Study Terminated by Sponsor|0|||
47079286|NCT01405196|83386291|FG001|Overall Study|Study Terminated by Sponsor|0|||
47079287|NCT01405196|83386292|FG002|Overall Study|Study Terminated by Sponsor|9|||
47079288|NCT01405196|83386293|FG003|Overall Study|Study Terminated by Sponsor|0|||
47079289|NCT01405196|83386290|FG000|Overall Study|Other|2|||
47079290|NCT01405196|83386291|FG001|Overall Study|Other|2|||
47079291|NCT01405196|83386292|FG002|Overall Study|Other|5|||
47079292|NCT01405196|83386293|FG003|Overall Study|Other|0|||
47079293|NCT01405196|83386290|FG000|Overall Study|Withdrawal by Subject|4|||
47079294|NCT01405196|83386291|FG001|Overall Study|Withdrawal by Subject|6|||
47079295|NCT01405196|83386292|FG002|Overall Study|Withdrawal by Subject|3|||
47079296|NCT01405196|83386293|FG003|Overall Study|Withdrawal by Subject|6|||
47079297|NCT01405196|83386290|FG000|Overall Study|Adverse Event|2|||
47079298|NCT01405196|83386291|FG001|Overall Study|Adverse Event|2|||
47079299|NCT01405196|83386292|FG002|Overall Study|Adverse Event|0|||
47079300|NCT01405196|83386293|FG003|Overall Study|Adverse Event|2|||
47079301|NCT01405196|83386290|FG000|Overall Study|Death|1|||
47079302|NCT01405196|83386291|FG001|Overall Study|Death|0|||
47079303|NCT01405196|83386292|FG002|Overall Study|Death|3|||
47079304|NCT01405196|83386293|FG003|Overall Study|Death|0|||
47079305|NCT01405196|83386290|FG000|Overall Study|Lost to Follow-up|2|||
47079306|NCT01405196|83386291|FG001|Overall Study|Lost to Follow-up|2|||
47079307|NCT01405196|83386292|FG002|Overall Study|Lost to Follow-up|3|||
47079308|NCT01405196|83386293|FG003|Overall Study|Lost to Follow-up|1|||
47079309|NCT01402700|83386343|FG000|Overall Study|Death|3|||
47079310|NCT01402700|83386343|FG000|Overall Study|Withdrawal by Subject|3|||
47079311|NCT01402700|83386343|FG000|Overall Study|Missed Visit|1|||
47079312|NCT01424930|83386465|FG000|Overall Study|Adverse Event|0|||
47079313|NCT01424930|83386466|FG001|Overall Study|Adverse Event|1|||
47079314|NCT01424930|83386465|FG000|Overall Study|Death|1|||
47079315|NCT01424930|83386466|FG001|Overall Study|Death|0|||
47079316|NCT01424930|83386465|FG000|Overall Study|Progressive Disease|3|||
47079317|NCT01424930|83386466|FG001|Overall Study|Progressive Disease|6|||
47079318|NCT01424930|83386465|FG000|Overall Study|Screen Failure|0|||
47079319|NCT01424930|83386466|FG001|Overall Study|Screen Failure|1|||
47079320|NCT01424930|83386465|FG000|Overall Study|Reason not specified|0|||
46856149|NCT00356135|83071950|FG002|Overall Study|Lost to Follow-up|1|||
47079321|NCT01424930|83386466|FG001|Overall Study|Reason not specified|6|||
47079322|NCT01424306|83386481|FG000|Overall Study|Protocol Violation|0|||
47079323|NCT01424306|83386482|FG001|Overall Study|Protocol Violation|0|||
47079324|NCT01424306|83386483|FG002|Overall Study|Protocol Violation|0|||
46794401|NCT00491764|83012892|FG005|Overall Study|Non Compliance with the Protocol|0|||
46794402|NCT00491764|83012887|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
46794403|NCT00491764|83012888|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
46794404|NCT00491764|83012889|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
46794405|NCT00491764|83012890|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
46794406|NCT00491764|83012891|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
46794407|NCT00491764|83012892|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
46856150|NCT00356135|83071948|FG000|Overall Study|Physician Decision|1|||
46856151|NCT00356135|83071949|FG001|Overall Study|Physician Decision|1|||
46856152|NCT00356135|83071950|FG002|Overall Study|Physician Decision|1|||
46856153|NCT00356135|83071948|FG000|Overall Study|Subject non-compliance|1|||
46856154|NCT00356135|83071949|FG001|Overall Study|Subject non-compliance|1|||
46856155|NCT00356135|83071950|FG002|Overall Study|Subject non-compliance|3|||
46856156|NCT03383146|83071962|FG000|Overall Study|Screen Failure|1|||
46856157|NCT03383146|83071963|FG001|Overall Study|Screen Failure|0|||
46794408|NCT00491764|83012887|FG000|Overall Study|Administrative|1|||
46794409|NCT00491764|83012888|FG001|Overall Study|Administrative|0|||
46794410|NCT00491764|83012889|FG002|Overall Study|Administrative|2|||
46794411|NCT00491764|83012890|FG003|Overall Study|Administrative|1|||
46856158|NCT03383146|83071962|FG000|Overall Study|Adverse Event|6|||
46856159|NCT03383146|83071963|FG001|Overall Study|Adverse Event|18|||
46856160|NCT03383146|83071962|FG000|Overall Study|Lack of Efficacy|0|||
46856161|NCT03383146|83071963|FG001|Overall Study|Lack of Efficacy|3|||
46856162|NCT03383146|83071962|FG000|Overall Study|Withdrawal by Subject|20|||
46856163|NCT03383146|83071963|FG001|Overall Study|Withdrawal by Subject|36|||
46856164|NCT03383146|83071962|FG000|Overall Study|Lost to Follow-up|5|||
46856165|NCT03383146|83071963|FG001|Overall Study|Lost to Follow-up|15|||
46856166|NCT03383146|83071962|FG000|Overall Study|Death|0|||
46856167|NCT03383146|83071963|FG001|Overall Study|Death|2|||
46856168|NCT03383146|83071962|FG000|Overall Study|Physician Decision|0|||
46856169|NCT03383146|83071963|FG001|Overall Study|Physician Decision|1|||
46856170|NCT03383146|83071962|FG000|Overall Study|Protocol Deviation|1|||
46856171|NCT03383146|83071963|FG001|Overall Study|Protocol Deviation|8|||
46856172|NCT03383146|83071962|FG000|Overall Study|Study Terminated by the Sponsor|48|||
46856173|NCT03383146|83071963|FG001|Overall Study|Study Terminated by the Sponsor|95|||
46856174|NCT03383146|83071962|FG000|Overall Study|Reason not Specified|4|||
46856175|NCT03383146|83071963|FG001|Overall Study|Reason not Specified|6|||
46856176|NCT03616964|83071973|FG000|Overall Study|Adverse Event|15|||
46978638|NCT01659255|83224129|FG007|Overall Study|Death|1|||
46978639|NCT01659255|83224130|FG008|Overall Study|Death|1|||
46978640|NCT01659255|83224131|FG009|Overall Study|Death|0|||
46978641|NCT01659255|83224132|FG010|Overall Study|Death|0|||
46978642|NCT01659255|83224133|FG011|Overall Study|Death|0|||
46978643|NCT01659255|83224134|FG012|Overall Study|Death|1|||
46978644|NCT01659255|83224135|FG013|Overall Study|Death|1|||
46978645|NCT01659255|83224136|FG014|Overall Study|Death|2|||
46978646|NCT01659255|83224137|FG015|Overall Study|Death|1|||
46978647|NCT01659255|83224138|FG016|Overall Study|Death|0|||
46978648|NCT01659255|83224122|FG000|Overall Study|Progressive Disease|2|||
46978649|NCT01659255|83224123|FG001|Overall Study|Progressive Disease|0|||
46978650|NCT01659255|83224124|FG002|Overall Study|Progressive Disease|0|||
46978651|NCT01659255|83224125|FG003|Overall Study|Progressive Disease|0|||
46978652|NCT01659255|83224126|FG004|Overall Study|Progressive Disease|0|||
46978653|NCT01659255|83224127|FG005|Overall Study|Progressive Disease|0|||
47079325|NCT01424306|83386484|FG003|Overall Study|Protocol Violation|0|||
47079326|NCT01424306|83386485|FG004|Overall Study|Protocol Violation|1|||
47079327|NCT01424306|83386486|FG005|Overall Study|Protocol Violation|0|||
47079328|NCT01424228|83386530|FG000|Overall Study|Withdrawal by Subject|27|||
46856177|NCT03616964|83071974|FG001|Overall Study|Adverse Event|10|||
46856178|NCT03616964|83071975|FG002|Overall Study|Adverse Event|16|||
47079329|NCT01424228|83386531|FG001|Overall Study|Withdrawal by Subject|11|||
47079330|NCT01424228|83386530|FG000|Overall Study|Adverse Event|10|||
46794412|NCT00491764|83012891|FG004|Overall Study|Administrative|0|||
46856179|NCT03616964|83071973|FG000|Overall Study|Death|3|||
46856180|NCT03616964|83071974|FG001|Overall Study|Death|0|||
46856181|NCT03616964|83071975|FG002|Overall Study|Death|4|||
46856182|NCT03616964|83071973|FG000|Overall Study|Lack of Efficacy|4|||
46856183|NCT03616964|83071974|FG001|Overall Study|Lack of Efficacy|8|||
46856184|NCT03616964|83071975|FG002|Overall Study|Lack of Efficacy|8|||
46856185|NCT03616964|83071973|FG000|Overall Study|Lost to Follow-up|2|||
46856186|NCT03616964|83071974|FG001|Overall Study|Lost to Follow-up|1|||
46856187|NCT03616964|83071975|FG002|Overall Study|Lost to Follow-up|3|||
46856188|NCT03616964|83071973|FG000|Overall Study|Withdrawal by Subject|18|||
46856189|NCT03616964|83071974|FG001|Overall Study|Withdrawal by Subject|14|||
46978654|NCT01659255|83224128|FG006|Overall Study|Progressive Disease|0|||
46978655|NCT01659255|83224129|FG007|Overall Study|Progressive Disease|1|||
46978656|NCT01659255|83224130|FG008|Overall Study|Progressive Disease|0|||
46978657|NCT01659255|83224131|FG009|Overall Study|Progressive Disease|2|||
46978658|NCT01659255|83224132|FG010|Overall Study|Progressive Disease|2|||
47079331|NCT01424228|83386531|FG001|Overall Study|Adverse Event|14|||
47079332|NCT01424228|83386530|FG000|Overall Study|Sponsor's decision|9|||
47079333|NCT01424228|83386531|FG001|Overall Study|Sponsor's decision|12|||
47079334|NCT01424228|83386530|FG000|Overall Study|Lack of Efficacy|5|||
47079335|NCT01424228|83386531|FG001|Overall Study|Lack of Efficacy|7|||
47079336|NCT01424228|83386530|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
47079337|NCT01424228|83386531|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
47079338|NCT01424228|83386530|FG000|Overall Study|Non-compliance|2|||
47079339|NCT01424228|83386531|FG001|Overall Study|Non-compliance|0|||
47079340|NCT01424228|83386530|FG000|Overall Study|Worsening of symptoms|1|||
47079341|NCT01424228|83386531|FG001|Overall Study|Worsening of symptoms|0|||
47079342|NCT01424228|83386530|FG000|Overall Study|Unplanned journey|0|||
47079343|NCT01424228|83386531|FG001|Overall Study|Unplanned journey|1|||
47079344|NCT01423916|83386540|FG000|Overall Study|Adverse Event|5|||
47079345|NCT01423916|83386541|FG001|Overall Study|Adverse Event|9|||
47079346|NCT01423916|83386542|FG002|Overall Study|Adverse Event|2|||
47079347|NCT01423916|83386540|FG000|Overall Study|Met Withdrawal Criteria|1|||
47079348|NCT01423916|83386541|FG001|Overall Study|Met Withdrawal Criteria|1|||
47079349|NCT01423916|83386542|FG002|Overall Study|Met Withdrawal Criteria|1|||
47079350|NCT01423916|83386540|FG000|Overall Study|Physician Decision|1|||
47079351|NCT01423916|83386541|FG001|Overall Study|Physician Decision|0|||
47079352|NCT01423916|83386542|FG002|Overall Study|Physician Decision|1|||
47079353|NCT01423916|83386540|FG000|Overall Study|Withdrawal by Subject|3|||
46794413|NCT00491764|83012892|FG005|Overall Study|Administrative|0|||
46794414|NCT00491608|83012906|FG000|Overall Study|Death|2|||
46794415|NCT00491608|83012906|FG000|Overall Study|Withdrawal by Subject|1|||
46794416|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
46794417|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
46794418|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
46794419|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
46978659|NCT01659255|83224133|FG011|Overall Study|Progressive Disease|3|||
46978660|NCT01659255|83224134|FG012|Overall Study|Progressive Disease|5|||
46978661|NCT01659255|83224135|FG013|Overall Study|Progressive Disease|13|||
46978662|NCT01659255|83224136|FG014|Overall Study|Progressive Disease|6|||
46978663|NCT01659255|83224137|FG015|Overall Study|Progressive Disease|2|||
46978664|NCT01659255|83224138|FG016|Overall Study|Progressive Disease|3|||
46978665|NCT01659255|83224122|FG000|Overall Study|Withdrew Consent|0|||
46978666|NCT01659255|83224123|FG001|Overall Study|Withdrew Consent|0|||
46978667|NCT01659255|83224124|FG002|Overall Study|Withdrew Consent|0|||
46978668|NCT01659255|83224125|FG003|Overall Study|Withdrew Consent|0|||
46978669|NCT01659255|83224126|FG004|Overall Study|Withdrew Consent|0|||
46978670|NCT01659255|83224127|FG005|Overall Study|Withdrew Consent|0|||
46978671|NCT01659255|83224128|FG006|Overall Study|Withdrew Consent|0|||
46978672|NCT01659255|83224129|FG007|Overall Study|Withdrew Consent|0|||
46978673|NCT01659255|83224130|FG008|Overall Study|Withdrew Consent|0|||
46978674|NCT01659255|83224131|FG009|Overall Study|Withdrew Consent|0|||
46978675|NCT01659255|83224132|FG010|Overall Study|Withdrew Consent|1|||
46978676|NCT01659255|83224133|FG011|Overall Study|Withdrew Consent|0|||
46978677|NCT01659255|83224134|FG012|Overall Study|Withdrew Consent|0|||
46978678|NCT01659255|83224135|FG013|Overall Study|Withdrew Consent|1|||
46978679|NCT01659255|83224136|FG014|Overall Study|Withdrew Consent|0|||
46978680|NCT01659255|83224137|FG015|Overall Study|Withdrew Consent|0|||
46978681|NCT01659255|83224138|FG016|Overall Study|Withdrew Consent|0|||
46978682|NCT01659255|83224122|FG000|Overall Study|Investigator Decision|0|||
46978683|NCT01659255|83224123|FG001|Overall Study|Investigator Decision|0|||
46978684|NCT01659255|83224124|FG002|Overall Study|Investigator Decision|0|||
46978685|NCT01659255|83224125|FG003|Overall Study|Investigator Decision|0|||
46978686|NCT01659255|83224126|FG004|Overall Study|Investigator Decision|0|||
46978687|NCT01659255|83224127|FG005|Overall Study|Investigator Decision|0|||
46978688|NCT01659255|83224128|FG006|Overall Study|Investigator Decision|0|||
46978689|NCT01659255|83224129|FG007|Overall Study|Investigator Decision|0|||
46978690|NCT01659255|83224130|FG008|Overall Study|Investigator Decision|0|||
46978691|NCT01659255|83224131|FG009|Overall Study|Investigator Decision|0|||
46978692|NCT01659255|83224132|FG010|Overall Study|Investigator Decision|0|||
46978693|NCT01659255|83224133|FG011|Overall Study|Investigator Decision|0|||
46978694|NCT01659255|83224134|FG012|Overall Study|Investigator Decision|1|||
46978695|NCT01659255|83224135|FG013|Overall Study|Investigator Decision|1|||
46978696|NCT01659255|83224136|FG014|Overall Study|Investigator Decision|0|||
46978697|NCT01659255|83224137|FG015|Overall Study|Investigator Decision|0|||
46978698|NCT01659255|83224138|FG016|Overall Study|Investigator Decision|0|||
46978699|NCT01659255|83224122|FG000|Overall Study|Sponsor's Decision|0|||
46794420|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
46794421|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
46794422|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
46794423|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
46794424|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
46794425|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
46794426|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
46794427|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
46794428|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
46794429|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
46794430|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
46794431|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
46794432|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
46794433|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
46794434|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
46794435|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
46794436|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
46794437|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
46794438|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
46794439|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
46794440|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
46794441|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
46794442|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
46794443|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
46794444|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
46794445|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
46856190|NCT03616964|83071975|FG002|Overall Study|Withdrawal by Subject|21|||
46856191|NCT03616964|83071973|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
47079354|NCT01423916|83386541|FG001|Overall Study|Withdrawal by Subject|10|||
47079355|NCT01423916|83386542|FG002|Overall Study|Withdrawal by Subject|3|||
47079356|NCT01423916|83386540|FG000|Overall Study|Protocol Deviation|1|||
47079357|NCT01423916|83386541|FG001|Overall Study|Protocol Deviation|0|||
47079358|NCT01423916|83386542|FG002|Overall Study|Protocol Deviation|0|||
47079359|NCT01423604|83386661|FG000|Safety Run-In|Adverse Event|3|||
47079360|NCT01423604|83386662|FG001|Safety Run-In|Adverse Event|0|||
47079361|NCT01423604|83386661|FG000|Safety Run-In|Death|1|||
47079362|NCT01423604|83386662|FG001|Safety Run-In|Death|0|||
47079363|NCT01423604|83386661|FG000|Safety Run-In|Physician Decision|1|||
47079364|NCT01423604|83386662|FG001|Safety Run-In|Physician Decision|0|||
47079365|NCT01423604|83386661|FG000|Safety Run-In|Disease progression|3|||
47079366|NCT01423604|83386662|FG001|Safety Run-In|Disease progression|0|||
47079367|NCT01423604|83386661|FG000|Safety Run-In|Patient decision|1|||
47079368|NCT01423604|83386662|FG001|Safety Run-In|Patient decision|0|||
47079369|NCT01423604|83386661|FG000|Randomized|Adverse Event|4|||
47079370|NCT01423604|83386662|FG001|Randomized|Adverse Event|10|||
47079371|NCT01423604|83386661|FG000|Randomized|Death|1|||
47079372|NCT01423604|83386662|FG001|Randomized|Death|0|||
47079373|NCT01423604|83386661|FG000|Randomized|Physician Decision|16|||
47079374|NCT01423604|83386662|FG001|Randomized|Physician Decision|13|||
47079375|NCT01423604|83386661|FG000|Randomized|Other - unspecified|37|||
47079376|NCT01423604|83386662|FG001|Randomized|Other - unspecified|31|||
47079377|NCT01423604|83386661|FG000|Randomized|Patient decision|5|||
47079378|NCT01423604|83386662|FG001|Randomized|Patient decision|9|||
47079379|NCT01402544|83386678|FG000|Overall Study|Withdrawal by Subject|6|||
47079380|NCT01401842|83386684|FG000|Overall Study|Withdrawal by Subject|3|||
47079381|NCT01401842|83386685|FG001|Overall Study|Withdrawal by Subject|2|||
47079382|NCT01401842|83386684|FG000|Overall Study|academic reason|4|||
47079383|NCT01401842|83386685|FG001|Overall Study|academic reason|1|||
47079384|NCT01401842|83386684|FG000|Overall Study|changed companies|20|||
47079385|NCT01401842|83386685|FG001|Overall Study|changed companies|34|||
47079386|NCT01401842|83386684|FG000|Overall Study|discharged from US Army|3|||
47079387|NCT01401842|83386685|FG001|Overall Study|discharged from US Army|4|||
47079388|NCT01401842|83386684|FG000|Overall Study|invalid follow-up strength data|1|||
47079389|NCT01401842|83386685|FG001|Overall Study|invalid follow-up strength data|4|||
47079390|NCT01401842|83386684|FG000|Overall Study|on profile|9|||
47079391|NCT01401842|83386685|FG001|Overall Study|on profile|5|||
47079392|NCT01401842|83386684|FG000|Overall Study|other/unknown|28|||
47079393|NCT01401842|83386685|FG001|Overall Study|other/unknown|17|||
47079394|NCT01422824|83386691|FG000|Overall Study|Case record form not evaluated|1|||
47079395|NCT01422824|83386691|FG000|Overall Study|Lost to Follow-up|37|||
47079396|NCT01401530|83386754|FG000|Overall Study|Disease Progression|1|||
47079397|NCT01401530|83386755|FG001|Overall Study|Disease Progression|2|||
47079398|NCT01401530|83386756|FG002|Overall Study|Disease Progression|1|||
47079399|NCT01401530|83386754|FG000|Overall Study|Adverse Event|1|||
46794446|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Other|10|||
46794447|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Other|7|||
46794448|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Other|8|||
46794449|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Other|8|||
46794450|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Other|0|||
46794451|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
46794452|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
46794453|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
46794454|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
46794455|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
46794456|NCT00615836|83012914|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
46794457|NCT00615836|83012915|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
46794458|NCT00615836|83012916|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
46794459|NCT00615836|83012917|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
46794460|NCT00615836|83012918|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
46794461|NCT00491530|83012937|FG000|Overall Study|Adverse Event|6|||
46794462|NCT00491530|83012938|FG001|Overall Study|Adverse Event|1|||
46794463|NCT00491530|83012939|FG002|Overall Study|Adverse Event|2|||
46794464|NCT00491530|83012937|FG000|Overall Study|Withdrawal by Subject|3|||
46794465|NCT00491530|83012938|FG001|Overall Study|Withdrawal by Subject|0|||
46794466|NCT00491530|83012939|FG002|Overall Study|Withdrawal by Subject|0|||
46794467|NCT00491530|83012937|FG000|Overall Study|Lost to Follow-up|3|||
46794468|NCT00491530|83012938|FG001|Overall Study|Lost to Follow-up|2|||
46794469|NCT00491530|83012939|FG002|Overall Study|Lost to Follow-up|2|||
46794470|NCT00491530|83012937|FG000|Overall Study|Lack of Efficacy|0|||
46794471|NCT00491530|83012938|FG001|Overall Study|Lack of Efficacy|1|||
46794472|NCT00491530|83012939|FG002|Overall Study|Lack of Efficacy|0|||
46794473|NCT00491530|83012937|FG000|Overall Study|Investigator Discretion|0|||
46794474|NCT00491530|83012938|FG001|Overall Study|Investigator Discretion|1|||
46794475|NCT00491530|83012939|FG002|Overall Study|Investigator Discretion|0|||
46794476|NCT00491530|83012937|FG000|Overall Study|Patient Request|0|||
46794477|NCT00491530|83012938|FG001|Overall Study|Patient Request|1|||
46794478|NCT00491530|83012939|FG002|Overall Study|Patient Request|0|||
46794479|NCT00491530|83012937|FG000|Overall Study|Use of Prohibited Medication|0|||
46794480|NCT00491530|83012938|FG001|Overall Study|Use of Prohibited Medication|0|||
46794481|NCT00491530|83012939|FG002|Overall Study|Use of Prohibited Medication|1|||
46794482|NCT00617240|83012949|FG000|Overall Study|Lack of Efficacy|1|||
46794483|NCT00617240|83012950|FG001|Overall Study|Lack of Efficacy|0|||
46794484|NCT00615290|83012956|FG000|Overall Study|Adverse Event|2|||
46794485|NCT00615290|83012956|FG000|Overall Study|Lost to Follow-up|3|||
46794486|NCT00615290|83012956|FG000|Overall Study|Withdrawal by Subject|1|||
46794487|NCT00615290|83012956|FG000|Overall Study|Other|2|||
46794488|NCT00501046|83012962|FG000|Overall Study|Adverse Event|21|||
46794489|NCT00501046|83012963|FG001|Overall Study|Adverse Event|25|||
46794490|NCT00501046|83012962|FG000|Overall Study|Death|23|||
46794491|NCT00501046|83012963|FG001|Overall Study|Death|30|||
46794492|NCT00501046|83012962|FG000|Overall Study|Lost to Follow-up|14|||
46856192|NCT03616964|83071974|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
46856193|NCT03616964|83071975|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
46856194|NCT03616964|83071973|FG000|Overall Study|Sponsor's Decision|1|||
46856195|NCT03616964|83071974|FG001|Overall Study|Sponsor's Decision|0|||
46856196|NCT03616964|83071975|FG002|Overall Study|Sponsor's Decision|0|||
46856197|NCT03616964|83071973|FG000|Overall Study|Physician Decision|0|||
46856198|NCT03616964|83071974|FG001|Overall Study|Physician Decision|2|||
46856199|NCT03616964|83071975|FG002|Overall Study|Physician Decision|0|||
46856200|NCT03616964|83071973|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
46856201|NCT03616964|83071974|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
46856202|NCT03616964|83071975|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
46856203|NCT03616964|83071973|FG000|Overall Study|Protocol Violation|0|||
46856204|NCT03616964|83071974|FG001|Overall Study|Protocol Violation|1|||
46856205|NCT03616964|83071975|FG002|Overall Study|Protocol Violation|0|||
46856206|NCT03616964|83071973|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
46794493|NCT00501046|83012963|FG001|Overall Study|Lost to Follow-up|13|||
46794494|NCT00501046|83012962|FG000|Overall Study|Physician Decision|7|||
46794495|NCT00501046|83012963|FG001|Overall Study|Physician Decision|2|||
46794496|NCT00501046|83012962|FG000|Overall Study|Pregnancy|0|||
46794497|NCT00501046|83012963|FG001|Overall Study|Pregnancy|3|||
46794498|NCT00501046|83012962|FG000|Overall Study|Protocol Violation|2|||
46794499|NCT00501046|83012963|FG001|Overall Study|Protocol Violation|1|||
46794500|NCT00501046|83012962|FG000|Overall Study|Withdrawal by Subject|84|||
46794501|NCT00501046|83012963|FG001|Overall Study|Withdrawal by Subject|83|||
46856207|NCT03616964|83071974|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
46856208|NCT03616964|83071975|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
46856209|NCT03616964|83071973|FG000|Overall Study|Randomized but Never Treated|1|||
46794502|NCT00501046|83012962|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
46856210|NCT03616964|83071974|FG001|Overall Study|Randomized but Never Treated|1|||
46856211|NCT03616964|83071975|FG002|Overall Study|Randomized but Never Treated|1|||
46856212|NCT00350519|83071987|FG000|Overall Study|Death|0|||
46856213|NCT00350519|83071988|FG001|Overall Study|Death|1|||
46856214|NCT00350519|83071987|FG000|Overall Study|Physician Decision|0|||
46856215|NCT00350519|83071988|FG001|Overall Study|Physician Decision|1|||
46856216|NCT00350519|83071987|FG000|Overall Study|Protocol Violation|1|||
46856217|NCT00350519|83071988|FG001|Overall Study|Protocol Violation|2|||
46856218|NCT00350519|83071987|FG000|Overall Study|Withdrawal by Subject|3|||
46856219|NCT00350519|83071988|FG001|Overall Study|Withdrawal by Subject|2|||
46856220|NCT03382912|83071996|FG000|Overall Study|Physician Decision|0|||
46856221|NCT03382912|83071997|FG001|Overall Study|Physician Decision|1|||
46978700|NCT01659255|83224123|FG001|Overall Study|Sponsor's Decision|0|||
46978701|NCT01659255|83224124|FG002|Overall Study|Sponsor's Decision|0|||
46978702|NCT01659255|83224125|FG003|Overall Study|Sponsor's Decision|0|||
46978703|NCT01659255|83224126|FG004|Overall Study|Sponsor's Decision|0|||
46794503|NCT00501046|83012963|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
46794504|NCT00533949|83012973|FG000|Overall Study|Protocol Violation|12|||
46794505|NCT00533949|83012974|FG001|Overall Study|Protocol Violation|12|||
46794506|NCT00533949|83012975|FG002|Overall Study|Protocol Violation|9|||
46794507|NCT00533949|83012976|FG003|Overall Study|Protocol Violation|9|||
46794508|NCT00533949|83012973|FG000|Overall Study|Withdrawal by Subject|3|||
47079400|NCT01401530|83386755|FG001|Overall Study|Adverse Event|1|||
46794509|NCT00533949|83012974|FG001|Overall Study|Withdrawal by Subject|2|||
46794510|NCT00533949|83012975|FG002|Overall Study|Withdrawal by Subject|1|||
46794511|NCT00533949|83012976|FG003|Overall Study|Withdrawal by Subject|1|||
46794512|NCT00485134|83013002|FG000|Overall Study|Lost to Follow-up|1|||
46794513|NCT00485134|83013003|FG001|Overall Study|Lost to Follow-up|0|||
46794514|NCT00485134|83013004|FG002|Overall Study|Lost to Follow-up|0|||
46794515|NCT00485134|83013005|FG003|Overall Study|Lost to Follow-up|0|||
46794516|NCT00485134|83013006|FG004|Overall Study|Lost to Follow-up|0|||
46794517|NCT00485134|83013007|FG005|Overall Study|Lost to Follow-up|0|||
46794518|NCT00485134|83013008|FG006|Overall Study|Lost to Follow-up|0|||
46794519|NCT00485134|83013009|FG007|Overall Study|Lost to Follow-up|0|||
46794520|NCT00485134|83013002|FG000|Overall Study|Withdrawal by Subject|0|||
46794521|NCT00485134|83013003|FG001|Overall Study|Withdrawal by Subject|1|||
46794522|NCT00485134|83013004|FG002|Overall Study|Withdrawal by Subject|0|||
46794523|NCT00485134|83013005|FG003|Overall Study|Withdrawal by Subject|0|||
46794524|NCT00485134|83013006|FG004|Overall Study|Withdrawal by Subject|0|||
46794525|NCT00485134|83013007|FG005|Overall Study|Withdrawal by Subject|0|||
46794526|NCT00485134|83013008|FG006|Overall Study|Withdrawal by Subject|0|||
46794527|NCT00485134|83013009|FG007|Overall Study|Withdrawal by Subject|0|||
46794528|NCT00485134|83013002|FG000|Overall Study|Change in health status|0|||
46794529|NCT00485134|83013003|FG001|Overall Study|Change in health status|1|||
46794530|NCT00485134|83013004|FG002|Overall Study|Change in health status|2|||
46794531|NCT00485134|83013005|FG003|Overall Study|Change in health status|1|||
46794532|NCT00485134|83013006|FG004|Overall Study|Change in health status|0|||
46794533|NCT00485134|83013007|FG005|Overall Study|Change in health status|1|||
46794534|NCT00485134|83013008|FG006|Overall Study|Change in health status|0|||
46794535|NCT00485134|83013009|FG007|Overall Study|Change in health status|0|||
46794536|NCT00485134|83013002|FG000|Overall Study|Withdrew for adverse event|0|||
46794537|NCT00485134|83013003|FG001|Overall Study|Withdrew for adverse event|0|||
46794538|NCT00485134|83013004|FG002|Overall Study|Withdrew for adverse event|1|||
46794539|NCT00485134|83013005|FG003|Overall Study|Withdrew for adverse event|0|||
46794540|NCT00485134|83013006|FG004|Overall Study|Withdrew for adverse event|0|||
46794541|NCT00485134|83013007|FG005|Overall Study|Withdrew for adverse event|0|||
46794542|NCT00485134|83013008|FG006|Overall Study|Withdrew for adverse event|0|||
46794543|NCT00485134|83013009|FG007|Overall Study|Withdrew for adverse event|0|||
46794544|NCT00485134|83013002|FG000|Overall Study|Positive drug test|0|||
46794545|NCT00485134|83013003|FG001|Overall Study|Positive drug test|0|||
46794546|NCT00485134|83013004|FG002|Overall Study|Positive drug test|0|||
46794547|NCT00485134|83013005|FG003|Overall Study|Positive drug test|0|||
46794548|NCT00485134|83013006|FG004|Overall Study|Positive drug test|2|||
46856222|NCT03382912|83071996|FG000|Overall Study|Sponsor Decision|6|||
46856223|NCT03382912|83071997|FG001|Overall Study|Sponsor Decision|6|||
46856224|NCT03382912|83071996|FG000|Overall Study|Withdrawal by Subject|0|||
46978704|NCT01659255|83224127|FG005|Overall Study|Sponsor's Decision|0|||
46978705|NCT01659255|83224128|FG006|Overall Study|Sponsor's Decision|1|||
47079401|NCT01401530|83386756|FG002|Overall Study|Adverse Event|1|||
47079402|NCT01401530|83386754|FG000|Overall Study|Participant Choice|1|||
46794549|NCT00485134|83013007|FG005|Overall Study|Positive drug test|1|||
46794550|NCT00485134|83013008|FG006|Overall Study|Positive drug test|0|||
46794551|NCT00485134|83013009|FG007|Overall Study|Positive drug test|0|||
46794552|NCT00485134|83013002|FG000|Overall Study|Non-compliance|0|||
46794553|NCT00485134|83013003|FG001|Overall Study|Non-compliance|0|||
46794554|NCT00485134|83013004|FG002|Overall Study|Non-compliance|0|||
46794555|NCT00485134|83013005|FG003|Overall Study|Non-compliance|0|||
46794556|NCT00485134|83013006|FG004|Overall Study|Non-compliance|1|||
46794557|NCT00485134|83013007|FG005|Overall Study|Non-compliance|2|||
46794558|NCT00485134|83013008|FG006|Overall Study|Non-compliance|2|||
46794559|NCT00485134|83013009|FG007|Overall Study|Non-compliance|0|||
46794560|NCT00485134|83013002|FG000|Overall Study|Unable to comply with study schedule|0|||
46794561|NCT00485134|83013003|FG001|Overall Study|Unable to comply with study schedule|0|||
46794562|NCT00485134|83013004|FG002|Overall Study|Unable to comply with study schedule|0|||
46794563|NCT00485134|83013005|FG003|Overall Study|Unable to comply with study schedule|0|||
46794564|NCT00485134|83013006|FG004|Overall Study|Unable to comply with study schedule|0|||
46794565|NCT00485134|83013007|FG005|Overall Study|Unable to comply with study schedule|0|||
46794566|NCT00485134|83013008|FG006|Overall Study|Unable to comply with study schedule|0|||
46794567|NCT00485134|83013009|FG007|Overall Study|Unable to comply with study schedule|1|||
46794568|NCT00485134|83013002|FG000|Overall Study|Pregnancy|0|||
46794569|NCT00485134|83013003|FG001|Overall Study|Pregnancy|0|||
46794570|NCT00485134|83013004|FG002|Overall Study|Pregnancy|0|||
46794571|NCT00485134|83013005|FG003|Overall Study|Pregnancy|0|||
46794572|NCT00485134|83013006|FG004|Overall Study|Pregnancy|0|||
46794573|NCT00485134|83013007|FG005|Overall Study|Pregnancy|0|||
46794574|NCT00485134|83013008|FG006|Overall Study|Pregnancy|1|||
46794575|NCT00485134|83013009|FG007|Overall Study|Pregnancy|0|||
46794576|NCT00583115|83013021|FG000|Overall Study|Death|1|||
46794577|NCT00532779|83013028|FG000|Overall Study|Adverse Event|122|||
46794578|NCT00532779|83013029|FG001|Overall Study|Adverse Event|112|||
46794579|NCT00532779|83013030|FG002|Overall Study|Adverse Event|56|||
46794580|NCT00532779|83013028|FG000|Overall Study|Lost to Follow-up|76|||
46794581|NCT00532779|83013029|FG001|Overall Study|Lost to Follow-up|65|||
46794582|NCT00532779|83013030|FG002|Overall Study|Lost to Follow-up|66|||
46794583|NCT00532779|83013028|FG000|Overall Study|Withdrawal by Subject|63|||
46794584|NCT00532779|83013029|FG001|Overall Study|Withdrawal by Subject|60|||
46794585|NCT00532779|83013030|FG002|Overall Study|Withdrawal by Subject|90|||
46794586|NCT00532779|83013028|FG000|Overall Study|Lack of Efficacy|12|||
46794587|NCT00532779|83013029|FG001|Overall Study|Lack of Efficacy|12|||
46794588|NCT00532779|83013030|FG002|Overall Study|Lack of Efficacy|40|||
46794589|NCT00532779|83013028|FG000|Overall Study|Protocol Violation|5|||
46794590|NCT00532779|83013029|FG001|Overall Study|Protocol Violation|9|||
46794591|NCT00532779|83013030|FG002|Overall Study|Protocol Violation|7|||
46794592|NCT00532779|83013028|FG000|Overall Study|Pregnancy|2|||
46794593|NCT00532779|83013029|FG001|Overall Study|Pregnancy|5|||
46794594|NCT00532779|83013030|FG002|Overall Study|Pregnancy|3|||
46794595|NCT00532779|83013028|FG000|Overall Study|Death|0|||
46794596|NCT00532779|83013029|FG001|Overall Study|Death|1|||
46794597|NCT00532779|83013030|FG002|Overall Study|Death|0|||
46856225|NCT03382912|83071997|FG001|Overall Study|Withdrawal by Subject|5|||
46856226|NCT00350207|83072006|FG000|Overall Study|Adverse Event|5|||
46856227|NCT00350207|83072007|FG001|Overall Study|Adverse Event|2|||
46856228|NCT00350207|83072008|FG002|Overall Study|Adverse Event|2|||
46856229|NCT00350207|83072006|FG000|Overall Study|Lack of Efficacy|1|||
46856230|NCT00350207|83072007|FG001|Overall Study|Lack of Efficacy|0|||
46856231|NCT00350207|83072008|FG002|Overall Study|Lack of Efficacy|2|||
46856232|NCT00350207|83072006|FG000|Overall Study|Lost to Follow-up|1|||
46856233|NCT00350207|83072007|FG001|Overall Study|Lost to Follow-up|0|||
46856234|NCT00350207|83072008|FG002|Overall Study|Lost to Follow-up|1|||
46856235|NCT00350207|83072006|FG000|Overall Study|Withdrawal by Subject|0|||
46856236|NCT00350207|83072007|FG001|Overall Study|Withdrawal by Subject|1|||
46856237|NCT00350207|83072008|FG002|Overall Study|Withdrawal by Subject|1|||
46856238|NCT00350207|83072006|FG000|Overall Study|Other|1|||
46856239|NCT00350207|83072007|FG001|Overall Study|Other|3|||
46856240|NCT00350207|83072008|FG002|Overall Study|Other|1|||
47079403|NCT01401530|83386755|FG001|Overall Study|Participant Choice|2|||
47079404|NCT01401530|83386756|FG002|Overall Study|Participant Choice|1|||
46794598|NCT00532779|83013028|FG000|Overall Study|Drug noncompliance, moved, other|14|||
46794599|NCT00532779|83013029|FG001|Overall Study|Drug noncompliance, moved, other|23|||
46794600|NCT00532779|83013030|FG002|Overall Study|Drug noncompliance, moved, other|29|||
46794601|NCT00500266|83013038|FG000|Overall Study|Death|3|||
46794602|NCT00500266|83013038|FG000|Overall Study|Lost to Follow-up|3|||
46794603|NCT00500266|83013038|FG000|Overall Study|Withdrawal by Subject|3|||
46794604|NCT00500266|83013038|FG000|Overall Study|Assigned, not treated|4|||
46794605|NCT00500110|83013043|FG000|Overall Study|Withdrawal by Subject|3|||
46794606|NCT00534495|83013049|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
46794607|NCT00534495|83013050|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
46794608|NCT00534495|83013051|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
46794609|NCT00534495|83013049|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
46794610|NCT00534495|83013050|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
46794611|NCT00534495|83013051|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
46856241|NCT00349973|83072018|FG000|Overall Study|Adverse Event|3|||
46856242|NCT00349973|83072019|FG001|Overall Study|Adverse Event|3|||
47079405|NCT01401530|83386754|FG000|Overall Study|Physician Decision|0|||
46856243|NCT00349973|83072018|FG000|Overall Study|Withdrawal by Subject|1|||
47079406|NCT01401530|83386755|FG001|Overall Study|Physician Decision|1|||
46856244|NCT00349973|83072019|FG001|Overall Study|Withdrawal by Subject|0|||
46856245|NCT03187262|83072025|FG000|Induction|Lack of Efficacy|2|||
46856246|NCT03187262|83072025|FG000|Induction|Progressive Disease|4|||
47079407|NCT01401530|83386756|FG002|Overall Study|Physician Decision|0|||
46794612|NCT00534495|83013049|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
46794613|NCT00534495|83013050|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
46794614|NCT00534495|83013051|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
46794615|NCT00534495|83013049|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
46794616|NCT00534495|83013050|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
46794617|NCT00534495|83013051|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
46794618|NCT00534495|83013049|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
46794619|NCT00534495|83013050|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
46794620|NCT00534495|83013051|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
46794621|NCT00534495|83013049|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
46794622|NCT00534495|83013050|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
46794623|NCT00534495|83013051|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
46794624|NCT00534495|83013049|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
46794625|NCT00534495|83013050|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
46794626|NCT00534495|83013051|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
46794627|NCT00534495|83013049|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
46794628|NCT00534495|83013050|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
46978706|NCT01659255|83224129|FG007|Overall Study|Sponsor's Decision|0|||
46978707|NCT01659255|83224130|FG008|Overall Study|Sponsor's Decision|0|||
46978708|NCT01659255|83224131|FG009|Overall Study|Sponsor's Decision|0|||
47079408|NCT01387022|83386768|FG000|Overall Study|Death|1|||
46794629|NCT00534495|83013051|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
46794630|NCT00534495|83013049|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
46794631|NCT00534495|83013050|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
46794632|NCT00534495|83013051|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
46794633|NCT00484198|83013075|FG000|Overall Study|Participant Withdrew Consent|12|||
46794634|NCT00484198|83013076|FG001|Overall Study|Participant Withdrew Consent|21|||
46794635|NCT00484198|83013077|FG002|Overall Study|Participant Withdrew Consent|47|||
46794636|NCT00484198|83013078|FG003|Overall Study|Participant Withdrew Consent|59|||
46794637|NCT00484198|83013075|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
46794638|NCT00484198|83013076|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
46794639|NCT00484198|83013077|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
46794640|NCT00484198|83013078|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
46794641|NCT00484198|83013075|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
46794642|NCT00484198|83013076|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
46794643|NCT00484198|83013077|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
46978709|NCT01659255|83224132|FG010|Overall Study|Sponsor's Decision|0|||
47079409|NCT01387022|83386769|FG001|Overall Study|Death|1|||
47079410|NCT01387022|83386768|FG000|Overall Study|Lost to Follow-up|0|||
47079411|NCT01387022|83386769|FG001|Overall Study|Lost to Follow-up|3|||
47079412|NCT01386944|83386795|FG000|Overall Study|Adverse Event|26|||
47079413|NCT01386944|83386795|FG000|Overall Study|Lack of Efficacy|14|||
47079414|NCT01386944|83386795|FG000|Overall Study|Lost to Follow-up|8|||
47079415|NCT01386944|83386795|FG000|Overall Study|Unspecified reason|8|||
47079416|NCT01386788|83386806|FG000|Overall Study|Lost to Follow-up|2|||
47079417|NCT01386554|83386871|FG000|Overall Study|Lost to Follow-up|0|||
46856247|NCT03187262|83072025|FG000|Consolidation|Progressive Disease|5|||
46978710|NCT01659255|83224133|FG011|Overall Study|Sponsor's Decision|0|||
46978711|NCT01659255|83224134|FG012|Overall Study|Sponsor's Decision|0|||
46978712|NCT01659255|83224135|FG013|Overall Study|Sponsor's Decision|0|||
46978713|NCT01659255|83224136|FG014|Overall Study|Sponsor's Decision|0|||
46978714|NCT01659255|83224137|FG015|Overall Study|Sponsor's Decision|0|||
46978715|NCT01659255|83224138|FG016|Overall Study|Sponsor's Decision|0|||
46978716|NCT01659255|83224122|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978717|NCT01659255|83224123|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978718|NCT01659255|83224124|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978719|NCT01659255|83224125|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
47079418|NCT01386554|83386872|FG001|Overall Study|Lost to Follow-up|0|||
47079419|NCT01386554|83386873|FG002|Overall Study|Lost to Follow-up|1|||
47079420|NCT01386554|83386871|FG000|Overall Study|Adverse Event|2|||
47079421|NCT01386554|83386872|FG001|Overall Study|Adverse Event|5|||
47079422|NCT01386554|83386873|FG002|Overall Study|Adverse Event|2|||
47079423|NCT01386554|83386871|FG000|Overall Study|Progressive disease|1|||
47079424|NCT01386554|83386872|FG001|Overall Study|Progressive disease|2|||
47079425|NCT01386554|83386873|FG002|Overall Study|Progressive disease|2|||
47079426|NCT01386554|83386871|FG000|Overall Study|Administration of live vaccines|0|||
47079427|NCT01386554|83386872|FG001|Overall Study|Administration of live vaccines|1|||
47079428|NCT01386554|83386873|FG002|Overall Study|Administration of live vaccines|0|||
47079429|NCT01386554|83386871|FG000|Overall Study|Investigator discretion|0|||
47079430|NCT01386554|83386872|FG001|Overall Study|Investigator discretion|0|||
47079431|NCT01386554|83386873|FG002|Overall Study|Investigator discretion|1|||
47079432|NCT01386554|83386871|FG000|Overall Study|Reason not collected|0|||
47079433|NCT01386554|83386872|FG001|Overall Study|Reason not collected|1|||
47079434|NCT01386554|83386873|FG002|Overall Study|Reason not collected|0|||
46794644|NCT00484198|83013078|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
46794645|NCT00484198|83013075|FG000|Overall Study|Adverse Event|3|||
46794646|NCT00484198|83013076|FG001|Overall Study|Adverse Event|11|||
46794647|NCT00484198|83013077|FG002|Overall Study|Adverse Event|32|||
46794648|NCT00484198|83013078|FG003|Overall Study|Adverse Event|31|||
46794649|NCT00484198|83013075|FG000|Overall Study|Protocol Violation|0|||
46794650|NCT00484198|83013076|FG001|Overall Study|Protocol Violation|5|||
46794651|NCT00484198|83013077|FG002|Overall Study|Protocol Violation|6|||
46794652|NCT00484198|83013078|FG003|Overall Study|Protocol Violation|8|||
46794653|NCT00484198|83013075|FG000|Overall Study|Other|7|||
46794654|NCT00484198|83013076|FG001|Overall Study|Other|10|||
46794655|NCT00484198|83013077|FG002|Overall Study|Other|31|||
47079435|NCT01386008|83386898|FG000|Overall Study|exited w/o incident /study discontinued|17|||
47079436|NCT01386008|83386898|FG000|Overall Study|Adverse Event|3|||
47079437|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
47079438|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
47079439|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
47079440|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
47079441|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
47079442|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
47079443|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
47079444|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
47079445|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
47079446|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
47079447|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
47079448|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
47079449|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
47079450|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
47079451|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
47079452|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
47079453|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
47079454|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
47079455|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
47079456|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
47079457|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
47079458|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
47079459|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
47079460|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
47079461|NCT01421342|83387046|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
47079462|NCT01421342|83387047|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
47079463|NCT01421342|83387048|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
47079464|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
47079465|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
47079466|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
47079467|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
47079468|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
46794656|NCT00484198|83013078|FG003|Overall Study|Other|28|||
46794657|NCT00499486|83013093|FG000|Overall Study|Withdrawal by Subject|16|||
46794658|NCT00499252|83013097|FG000|Overall Study|Adverse Event|3|||
47079469|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
47079470|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
46794659|NCT00499252|83013097|FG000|Overall Study|Refused further treatment|2|||
47079471|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
46856248|NCT03381196|83072031|FG000|Overall Study|Withdrawal by Subject|7|||
46856249|NCT03381196|83072032|FG001|Overall Study|Withdrawal by Subject|7|||
46856250|NCT03381196|83072031|FG000|Overall Study|Other|0|||
46856251|NCT03381196|83072032|FG001|Overall Study|Other|1|||
46856252|NCT03381196|83072031|FG000|Overall Study|Lost to Follow-up|5|||
46856253|NCT03381196|83072032|FG001|Overall Study|Lost to Follow-up|4|||
46794660|NCT00499252|83013097|FG000|Overall Study|Ineligible|4|||
46794661|NCT00499252|83013097|FG000|Overall Study|<no further label>|3|||
46794662|NCT00499174|83013107|FG000|Overall Study|Physician Decision|78|||
46978720|NCT01659255|83224126|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978721|NCT01659255|83224127|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46794663|NCT00499174|83013108|FG001|Overall Study|Physician Decision|9|||
46794664|NCT03775421|83013116|FG000|Overall Study|Lost to Follow-up|2|||
46794665|NCT03775421|83013116|FG000|Overall Study|Withdrawal by Subject|10|||
46794666|NCT03775421|83013116|FG000|Overall Study|Physician Decision|3|||
46794667|NCT03775421|83013116|FG000|Overall Study|Death|1|||
46794668|NCT03775421|83013116|FG000|Overall Study|Study Terminated by Sponsor|94|||
46794669|NCT00532155|83013122|FG000|Overall Study|Adverse Event|66|||
46794670|NCT00532155|83013123|FG001|Overall Study|Adverse Event|123|||
46794671|NCT00532155|83013122|FG000|Overall Study|Lack of Efficacy|332|||
46794672|NCT00532155|83013123|FG001|Overall Study|Lack of Efficacy|255|||
46794673|NCT00532155|83013122|FG000|Overall Study|Protocol Violation|1|||
46794674|NCT00532155|83013123|FG001|Overall Study|Protocol Violation|3|||
46856254|NCT03381196|83072031|FG000|Overall Study|Death|0|||
46856255|NCT03381196|83072032|FG001|Overall Study|Death|1|||
46856256|NCT03381196|83072031|FG000|Overall Study|Adverse Event|1|||
46856257|NCT03381196|83072032|FG001|Overall Study|Adverse Event|0|||
46856258|NCT03381196|83072031|FG000|Overall Study|Randomized, not treated|3|||
46856259|NCT03381196|83072032|FG001|Overall Study|Randomized, not treated|6|||
46856260|NCT02950558|83072040|FG000|Overall Study|Lost to Follow-up|2|||
46856261|NCT02950558|83072041|FG001|Overall Study|Lost to Follow-up|0|||
46978722|NCT01659255|83224128|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978723|NCT01659255|83224129|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978724|NCT01659255|83224130|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978725|NCT01659255|83224131|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978726|NCT01659255|83224132|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978727|NCT01659255|83224133|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978728|NCT01659255|83224134|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978729|NCT01659255|83224135|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978730|NCT01659255|83224136|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978731|NCT01659255|83224137|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
46978732|NCT01659255|83224138|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
46978733|NCT01659255|83224122|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
46794675|NCT00532155|83013122|FG000|Overall Study|Lost to Follow-up|2|||
46794676|NCT00532155|83013123|FG001|Overall Study|Lost to Follow-up|0|||
46794677|NCT00532155|83013122|FG000|Overall Study|Physician Decision|16|||
46794678|NCT00532155|83013123|FG001|Overall Study|Physician Decision|15|||
46794679|NCT00532155|83013122|FG000|Overall Study|Withdrawal by Subject|23|||
46794680|NCT00532155|83013123|FG001|Overall Study|Withdrawal by Subject|44|||
46794681|NCT00532155|83013122|FG000|Overall Study|Consent withdrawn|5|||
46794682|NCT00532155|83013123|FG001|Overall Study|Consent withdrawn|7|||
46794683|NCT00532155|83013122|FG000|Overall Study|Moved|1|||
46794684|NCT00532155|83013123|FG001|Overall Study|Moved|0|||
46978734|NCT01659255|83224123|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
46978735|NCT01659255|83224124|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
46978736|NCT01659255|83224125|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
46978737|NCT01659255|83224126|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
46978738|NCT01659255|83224127|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
46978739|NCT01659255|83224128|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
46978740|NCT01659255|83224129|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
46978741|NCT01659255|83224130|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
46978742|NCT01659255|83224131|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
46978743|NCT01659255|83224132|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
46978744|NCT01659255|83224133|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
46794685|NCT00532155|83013122|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
46794686|NCT00532155|83013123|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
46978745|NCT01659255|83224134|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
46794687|NCT00532155|83013122|FG000|Overall Study|Occurence of a second cancer|0|||
46794688|NCT00532155|83013123|FG001|Overall Study|Occurence of a second cancer|1|||
46856262|NCT03345472|83072048|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
46856263|NCT03345472|83072048|FG000|Implant to 3 Months|Physician Decision|1|||
46856264|NCT03345472|83072048|FG000|Implant to 3 Months|Adverse Event|1|||
46856265|NCT03345472|83072048|FG000|3 Months to 12 Months|Physician Decision|3|||
47079472|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
47079473|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
47079474|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
47079475|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
47079476|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
47079477|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
47079478|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
47079479|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
47079480|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
47079481|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
47079482|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
47079483|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
47079484|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
47079485|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
47079486|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
47079487|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
47079488|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
47079489|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
47079490|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
47079491|NCT01421342|83387046|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
47079492|NCT01421342|83387047|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
47079493|NCT01421342|83387048|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
47079494|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
47079495|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
47079496|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
47079497|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
47079498|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
47079499|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
47079500|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
47079501|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
47079502|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
47079503|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
47079504|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
47079505|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
47079506|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
47079507|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
47079508|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
47079509|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
47079510|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
47079511|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
47079512|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
47079513|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
47079514|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
46674395|NCT01150123|82890039|FG013|Overall Study|Withdrawal by Subject|0|||
46674396|NCT01150123|82890040|FG014|Overall Study|Withdrawal by Subject|0|||
46674397|NCT01150123|82890041|FG015|Overall Study|Withdrawal by Subject|1|||
46674398|NCT01150123|82890042|FG016|Overall Study|Withdrawal by Subject|0|||
46674399|NCT01150123|82890043|FG017|Overall Study|Withdrawal by Subject|1|||
46674400|NCT01150123|82890026|FG000|Overall Study|Lost to Follow-up|2|||
46674401|NCT01150123|82890027|FG001|Overall Study|Lost to Follow-up|1|||
47079515|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
47079516|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
47079517|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
47079518|NCT01421342|83387046|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
47079519|NCT01421342|83387047|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
47079520|NCT01421342|83387048|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
47079521|NCT01384760|83387071|FG000|Overall Study|Lost to Follow-up|0|||
47079522|NCT01384760|83387072|FG001|Overall Study|Lost to Follow-up|6|||
47079523|NCT01384760|83387071|FG000|Overall Study|Protocol Violation|16|||
46674402|NCT01150123|82890028|FG002|Overall Study|Lost to Follow-up|2|||
46674403|NCT01150123|82890029|FG003|Overall Study|Lost to Follow-up|2|||
47079524|NCT01384760|83387072|FG001|Overall Study|Protocol Violation|0|||
47079525|NCT01384292|83387112|FG000|Part B|Severe non-compliance to protocol|1|||
47079526|NCT01384292|83387113|FG001|Part B|Severe non-compliance to protocol|0|||
47079527|NCT01384292|83387114|FG002|Part B|Severe non-compliance to protocol|0|||
47079528|NCT01401452|83387124|FG000|Overall Study|Adverse reaction|9|||
47079529|NCT01401452|83387124|FG000|Overall Study|Lost to Follow-up|12|||
47079530|NCT01401452|83387124|FG000|Overall Study|Lack of Efficacy|30|||
47079531|NCT01401452|83387124|FG000|Overall Study|Participant developed breast cancer|1|||
47079532|NCT01401452|83387124|FG000|Overall Study|Tx stopped due to financial reasons|1|||
47079533|NCT01401452|83387124|FG000|Overall Study|Tx stopped by psychiatrist|1|||
47079534|NCT01401452|83387124|FG000|Overall Study|No more visits within the 36 wk followup|4|||
47079535|NCT01401452|83387124|FG000|Overall Study|Subject did not come to follow up visits|2|||
47079536|NCT01401452|83387124|FG000|Overall Study|Subject didn't return for routine visits|1|||
47079537|NCT01401452|83387124|FG000|Overall Study|Subject moved to another city|1|||
47079538|NCT01401452|83387124|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
47079539|NCT01401452|83387124|FG000|Overall Study|Psoriatic arthritis|1|||
47079540|NCT01401452|83387124|FG000|Overall Study|Participant stopped Tx|2|||
47079541|NCT01401452|83387124|FG000|Overall Study|Discontinuation for personal reasons|1|||
47079542|NCT01401452|83387124|FG000|Overall Study|Treatment failure|1|||
47079543|NCT01401452|83387124|FG000|Overall Study|Unsatisfactory output|1|||
47079544|NCT01401452|83387124|FG000|Overall Study|Subject withdrew because of Tx success|1|||
47079545|NCT01401452|83387124|FG000|Overall Study|Subject chose to discontinue treatment|1|||
47079546|NCT01401452|83387124|FG000|Overall Study|Participant withdrew consent|1|||
47079547|NCT01401062|83387159|FG000|Overall Study|Death|9|||
47079548|NCT01401062|83387160|FG001|Overall Study|Death|7|||
47079549|NCT01401062|83387159|FG000|Overall Study|Physician Decision|1|||
47079550|NCT01401062|83387160|FG001|Overall Study|Physician Decision|0|||
47079551|NCT01401062|83387159|FG000|Overall Study|Withdrawal by Subject|1|||
47079552|NCT01401062|83387160|FG001|Overall Study|Withdrawal by Subject|1|||
47079553|NCT01400516|83387193|FG000|Primary Trial|Withdrawal by Subject|0|||
47079554|NCT01400516|83387194|FG001|Primary Trial|Withdrawal by Subject|2|||
47079555|NCT01383356|83387200|FG000|Period 1|Adverse Event|5|||
47079556|NCT01383356|83387201|FG001|Period 1|Adverse Event|3|||
47079557|NCT01383356|83387200|FG000|Period 1|Non-compliance|3|||
47079558|NCT01383356|83387201|FG001|Period 1|Non-compliance|0|||
47079559|NCT01383356|83387200|FG000|Period 1|Out of Range Mid-study-Test|0|||
47079560|NCT01383356|83387201|FG001|Period 1|Out of Range Mid-study-Test|1|||
47079561|NCT01383356|83387200|FG000|Period 1|Personal|0|||
47079562|NCT01383356|83387201|FG001|Period 1|Personal|2|||
47079563|NCT05740098|83387227|FG000|Overall Study|Lost to Follow-up|26|||
46794689|NCT00532155|83013122|FG000|Overall Study|Occurence of a secondary cancer|0|||
46794690|NCT00532155|83013123|FG001|Overall Study|Occurence of a secondary cancer|1|||
46794691|NCT00532155|83013122|FG000|Overall Study|Promotor ended study|1|||
46794692|NCT00532155|83013123|FG001|Overall Study|Promotor ended study|0|||
46794693|NCT00532155|83013122|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
46794694|NCT00532155|83013123|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
46794695|NCT00532155|83013122|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
47079564|NCT05740098|83387228|FG001|Overall Study|Lost to Follow-up|17|||
47079565|NCT05740098|83387229|FG002|Overall Study|Lost to Follow-up|21|||
47079566|NCT05059080|83387240|FG000|Overall Study|Withdrawal by Subject|3|||
47079567|NCT05059080|83387240|FG000|Overall Study|Study Terminated by Sponsor|64|||
47079568|NCT05012163|83387248|FG000|Overall Study|Protocol Violation|0|||
47079569|NCT05012163|83387249|FG001|Overall Study|Protocol Violation|0|||
47079570|NCT05012163|83387250|FG002|Overall Study|Protocol Violation|1|||
47079571|NCT05012163|83387251|FG003|Overall Study|Protocol Violation|1|||
47079572|NCT05009251|83387266|FG000|Overall Study|Protocol Violation|100|||
47079573|NCT05009251|83387267|FG001|Overall Study|Protocol Violation|105|||
47079574|NCT05009251|83387268|FG002|Overall Study|Protocol Violation|119|||
47079575|NCT05009251|83387269|FG003|Overall Study|Protocol Violation|120|||
47079576|NCT05009251|83387270|FG004|Overall Study|Protocol Violation|119|||
47079577|NCT05009251|83387266|FG000|Overall Study|Death|25|||
47079578|NCT05009251|83387267|FG001|Overall Study|Death|22|||
47079579|NCT05009251|83387268|FG002|Overall Study|Death|24|||
47079580|NCT05009251|83387269|FG003|Overall Study|Death|19|||
47079581|NCT05009251|83387270|FG004|Overall Study|Death|15|||
47079582|NCT04839692|83387284|FG000|Overall Study|Withdrawal by Subject|0|||
46856266|NCT03345472|83072048|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
47079583|NCT04839692|83387285|FG001|Overall Study|Withdrawal by Subject|3|||
47079584|NCT04839692|83387284|FG000|Overall Study|Physician Decision|1|||
47079585|NCT04839692|83387285|FG001|Overall Study|Physician Decision|0|||
47079586|NCT04476017|83387313|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
47079587|NCT04476017|83387314|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
47079588|NCT04422639|83387323|FG000|Overall Study|Death|1|||
47079589|NCT04422639|83387324|FG001|Overall Study|Death|0|||
47079590|NCT04422639|83387323|FG000|Overall Study|study closed prior to completion of FU visits|0|||
47079591|NCT04422639|83387324|FG001|Overall Study|study closed prior to completion of FU visits|2|||
47079592|NCT04384107|83387332|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
47079593|NCT04384107|83387333|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
47079594|NCT04384107|83387332|FG000|Overall Study|Lost to Follow-up|1|||
46978746|NCT01659255|83224135|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
46978747|NCT01659255|83224136|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
46978748|NCT01659255|83224137|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
46978749|NCT01659255|83224138|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
47079595|NCT04384107|83387333|FG001|Overall Study|Lost to Follow-up|0|||
47079596|NCT04275089|83387339|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
46978750|NCT02637037|83224178|FG000|Overall Study|Positive drug screen at admission|1|||
46978751|NCT02637037|83224179|FG001|Overall Study|Positive drug screen at admission|0|||
46978752|NCT02637037|83224178|FG000|Overall Study|Withdrawal by Subject|2|||
46978753|NCT02637037|83224179|FG001|Overall Study|Withdrawal by Subject|1|||
46978754|NCT02637037|83224178|FG000|Overall Study|Adverse Event|1|||
46978755|NCT02637037|83224179|FG001|Overall Study|Adverse Event|0|||
46978756|NCT02637895|83224199|FG000|Overall Study|Lost to Follow-up|4|||
46978757|NCT02637895|83224200|FG001|Overall Study|Lost to Follow-up|0|||
46978758|NCT02637895|83224199|FG000|Overall Study|Protocol Violation|0|||
46978759|NCT02637895|83224200|FG001|Overall Study|Protocol Violation|1|||
46978760|NCT02637895|83224199|FG000|Overall Study|Lack of Efficacy|1|||
46978761|NCT02637895|83224200|FG001|Overall Study|Lack of Efficacy|0|||
46978762|NCT02637895|83224199|FG000|Overall Study|Withdrawal by Subject|1|||
46978763|NCT02637895|83224200|FG001|Overall Study|Withdrawal by Subject|1|||
46978764|NCT02637895|83224199|FG000|Overall Study|Abnormal baseline lab|0|||
46978765|NCT02637895|83224200|FG001|Overall Study|Abnormal baseline lab|1|||
46978766|NCT02522481|83224207|FG000|Overall Study|discontinued|1|||
46978767|NCT02522481|83224207|FG000|Overall Study|Not dosed|2|||
46978768|NCT02522403|83224220|FG000|Overall Study|Lost to Follow-up|2|||
46978769|NCT02522403|83224221|FG001|Overall Study|Lost to Follow-up|2|||
46978770|NCT02522403|83224220|FG000|Overall Study|Withdrawal by Subject|2|||
46978771|NCT02522403|83224221|FG001|Overall Study|Withdrawal by Subject|4|||
46978772|NCT02522325|83224227|FG000|Overall Study|Adverse Event|0|||
46978773|NCT02522325|83224228|FG001|Overall Study|Adverse Event|1|||
46978774|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
46978775|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
46978776|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
46978777|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
46978778|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
46978779|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
47079597|NCT04096326|83387374|FG000|Overall Study|Withdrawal by Subject|0|||
47079598|NCT04096326|83387375|FG001|Overall Study|Withdrawal by Subject|0|||
47079599|NCT04096326|83387376|FG002|Overall Study|Withdrawal by Subject|0|||
47079600|NCT04096326|83387377|FG003|Overall Study|Withdrawal by Subject|0|||
47079601|NCT04096326|83387378|FG004|Overall Study|Withdrawal by Subject|0|||
47079602|NCT04096326|83387379|FG005|Overall Study|Withdrawal by Subject|0|||
47079603|NCT04096326|83387380|FG006|Overall Study|Withdrawal by Subject|1|||
47079604|NCT04096326|83387381|FG007|Overall Study|Withdrawal by Subject|0|||
47079605|NCT04096326|83387382|FG008|Overall Study|Withdrawal by Subject|0|||
47079606|NCT04096326|83387383|FG009|Overall Study|Withdrawal by Subject|0|||
47079607|NCT04096326|83387374|FG000|Overall Study|Lost to Follow-up|0|||
47079608|NCT04096326|83387375|FG001|Overall Study|Lost to Follow-up|1|||
47079609|NCT04096326|83387376|FG002|Overall Study|Lost to Follow-up|0|||
47079610|NCT04096326|83387377|FG003|Overall Study|Lost to Follow-up|0|||
47079611|NCT04096326|83387378|FG004|Overall Study|Lost to Follow-up|0|||
47079612|NCT04096326|83387379|FG005|Overall Study|Lost to Follow-up|0|||
47079613|NCT04096326|83387380|FG006|Overall Study|Lost to Follow-up|0|||
47079614|NCT04096326|83387381|FG007|Overall Study|Lost to Follow-up|0|||
47079615|NCT04096326|83387382|FG008|Overall Study|Lost to Follow-up|0|||
47079616|NCT04096326|83387383|FG009|Overall Study|Lost to Follow-up|0|||
47079617|NCT04096326|83387374|FG000|Overall Study|COVID-19-related reasons|0|||
47079618|NCT04096326|83387375|FG001|Overall Study|COVID-19-related reasons|0|||
47079619|NCT04096326|83387376|FG002|Overall Study|COVID-19-related reasons|0|||
47079620|NCT04096326|83387377|FG003|Overall Study|COVID-19-related reasons|0|||
47079621|NCT04096326|83387378|FG004|Overall Study|COVID-19-related reasons|1|||
47079622|NCT04096326|83387379|FG005|Overall Study|COVID-19-related reasons|5|||
47079623|NCT04096326|83387380|FG006|Overall Study|COVID-19-related reasons|0|||
47079624|NCT04096326|83387381|FG007|Overall Study|COVID-19-related reasons|0|||
47079625|NCT04096326|83387382|FG008|Overall Study|COVID-19-related reasons|0|||
47079626|NCT04096326|83387383|FG009|Overall Study|COVID-19-related reasons|0|||
47079627|NCT04072822|83387407|FG000|Treatment|Adverse Event|9|||
47079628|NCT04072822|83387408|FG001|Treatment|Adverse Event|5|||
47079629|NCT04072822|83387407|FG000|Treatment|Met Stopping Criteria|13|||
47079630|NCT04072822|83387408|FG001|Treatment|Met Stopping Criteria|24|||
47079631|NCT04072822|83387407|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
47079632|NCT04072822|83387408|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
47079633|NCT04072822|83387407|FG000|Treatment|Withdrawal by Subject|0|||
47079634|NCT04072822|83387408|FG001|Treatment|Withdrawal by Subject|2|||
47079635|NCT04072822|83387407|FG000|Treatment|Death|0|||
47079636|NCT04072822|83387408|FG001|Treatment|Death|2|||
47079637|NCT04072822|83387407|FG000|Treatment|Lost to Follow-up|11|||
47079638|NCT04072822|83387408|FG001|Treatment|Lost to Follow-up|3|||
47079639|NCT04072822|83387407|FG000|Treatment|Physician Decision|1|||
47079640|NCT04072822|83387408|FG001|Treatment|Physician Decision|0|||
47079641|NCT04072822|83387407|FG000|Treatment|Other|7|||
47079642|NCT04072822|83387408|FG001|Treatment|Other|9|||
46978780|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
46978781|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
46978782|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
47079643|NCT04072822|83387407|FG000|Follow-up|Withdrawal by Subject|1|||
47079644|NCT04072822|83387408|FG001|Follow-up|Withdrawal by Subject|0|||
47079645|NCT04072822|83387407|FG000|Follow-up|Lost to Follow-up|5|||
47079646|NCT04072822|83387408|FG001|Follow-up|Lost to Follow-up|4|||
47079647|NCT04031846|83387416|FG000|Overall Study|Lost to Follow-up|4|||
47079648|NCT04031846|83387417|FG001|Overall Study|Lost to Follow-up|4|||
47079649|NCT04031846|83387416|FG000|Overall Study|Physician Decision|0|||
47079650|NCT04031846|83387417|FG001|Overall Study|Physician Decision|1|||
47079651|NCT04031846|83387416|FG000|Overall Study|Protocol Violation|1|||
46978783|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
47079652|NCT04031846|83387417|FG001|Overall Study|Protocol Violation|1|||
47079653|NCT04031846|83387416|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
47079654|NCT04031846|83387417|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
47079655|NCT03893448|83387426|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
47079656|NCT03893448|83387427|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
47079657|NCT03893448|83387426|FG000|Overall Study|Physician Decision|8|||
47079658|NCT03893448|83387427|FG001|Overall Study|Physician Decision|14|||
47079659|NCT03893448|83387426|FG000|Overall Study|Lost to Follow-up|34|||
47079660|NCT03893448|83387427|FG001|Overall Study|Lost to Follow-up|27|||
47079661|NCT03893448|83387426|FG000|Overall Study|Death|1|||
47079662|NCT03893448|83387427|FG001|Overall Study|Death|0|||
46674404|NCT01150123|82890030|FG004|Overall Study|Lost to Follow-up|2|||
46674405|NCT01150123|82890031|FG005|Overall Study|Lost to Follow-up|5|||
46674406|NCT01150123|82890032|FG006|Overall Study|Lost to Follow-up|0|||
46674407|NCT01150123|82890033|FG007|Overall Study|Lost to Follow-up|0|||
46674408|NCT01150123|82890034|FG008|Overall Study|Lost to Follow-up|3|||
46674409|NCT01150123|82890035|FG009|Overall Study|Lost to Follow-up|1|||
46674410|NCT01150123|82890036|FG010|Overall Study|Lost to Follow-up|1|||
46674411|NCT01150123|82890037|FG011|Overall Study|Lost to Follow-up|1|||
46674412|NCT01150123|82890038|FG012|Overall Study|Lost to Follow-up|2|||
46674413|NCT01150123|82890039|FG013|Overall Study|Lost to Follow-up|0|||
46674414|NCT01150123|82890040|FG014|Overall Study|Lost to Follow-up|0|||
46674415|NCT01150123|82890041|FG015|Overall Study|Lost to Follow-up|0|||
46674416|NCT01150123|82890042|FG016|Overall Study|Lost to Follow-up|0|||
46674417|NCT01150123|82890043|FG017|Overall Study|Lost to Follow-up|0|||
46674418|NCT01149655|82890102|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
46674419|NCT01149655|82890103|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
46674420|NCT01149655|82890104|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
46978784|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
46978785|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
46674421|NCT01149655|82890105|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
46856267|NCT03345472|83072048|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
46856268|NCT03345472|83072048|FG000|3 Months to 12 Months|Adverse Event|1|||
46856269|NCT03345472|83072048|FG000|3 Months to 12 Months|Death|1|||
46674422|NCT01149655|82890102|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
46674423|NCT01149655|82890103|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
46856270|NCT00349349|83072055|FG000|Overall Study|Adverse Event|5|||
46674424|NCT01149655|82890104|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
46674425|NCT01149655|82890105|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
46674426|NCT01149655|82890102|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
46674427|NCT01149655|82890103|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
46856271|NCT00349349|83072056|FG001|Overall Study|Adverse Event|6|||
47079663|NCT03692871|83387450|FG000|Overall Study|Death|1|||
47079664|NCT03692871|83387451|FG001|Overall Study|Death|1|||
46674428|NCT01149655|82890104|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
46794696|NCT00532155|83013123|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
46794697|NCT00532155|83013122|FG000|Overall Study|Study stopped|1|||
47079665|NCT03692871|83387450|FG000|Overall Study|Lost to Follow-up|24|||
47079666|NCT03692871|83387451|FG001|Overall Study|Lost to Follow-up|9|||
47079667|NCT03692871|83387450|FG000|Overall Study|Physician Decision|22|||
47079668|NCT03692871|83387451|FG001|Overall Study|Physician Decision|7|||
47079669|NCT03692871|83387450|FG000|Overall Study|Protocol Deviation|1|||
47079670|NCT03692871|83387451|FG001|Overall Study|Protocol Deviation|0|||
47079671|NCT03692871|83387450|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
47079672|NCT03692871|83387451|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
47079673|NCT03565900|83387459|FG000|Overall Study|Disposition Unknown|4|||
47079674|NCT03565900|83387460|FG001|Overall Study|Disposition Unknown|1|||
47079675|NCT03565900|83387459|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
47079676|NCT03565900|83387460|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
47079677|NCT03565900|83387459|FG000|Overall Study|Withdrawal by Subject|4|||
47079678|NCT03565900|83387460|FG001|Overall Study|Withdrawal by Subject|5|||
46856272|NCT00349349|83072057|FG002|Overall Study|Adverse Event|2|||
46794698|NCT00532155|83013123|FG001|Overall Study|Study stopped|0|||
46794699|NCT00532155|83013122|FG000|Overall Study|Study terminated by sponsor|1|||
46794700|NCT00532155|83013123|FG001|Overall Study|Study terminated by sponsor|0|||
46794701|NCT00532155|83013122|FG000|Overall Study|Study termination stop further treatment|4|||
46794702|NCT00532155|83013123|FG001|Overall Study|Study termination stop further treatment|0|||
46794703|NCT00532155|83013122|FG000|Overall Study|Did not receive study medication|2|||
46794704|NCT00532155|83013123|FG001|Overall Study|Did not receive study medication|6|||
46794705|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
46794706|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
46794707|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
46794708|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
46856273|NCT00349349|83072055|FG000|Overall Study|Withdrawal by Subject|5|||
46794709|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
46674429|NCT01149655|82890105|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
46674430|NCT01149655|82890102|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
46674431|NCT01149655|82890103|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
46674432|NCT01149655|82890104|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
46674433|NCT01149655|82890105|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
46674434|NCT01149655|82890102|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
46674435|NCT01149655|82890103|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
46674436|NCT01149655|82890104|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
46674437|NCT01149655|82890105|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
46978786|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
47079679|NCT03565900|83387459|FG000|Overall Study|Randomized By Mistake|0|||
47079680|NCT03565900|83387460|FG001|Overall Study|Randomized By Mistake|2|||
47079681|NCT03565900|83387459|FG000|Overall Study|Physician Decision|7|||
47079682|NCT03565900|83387460|FG001|Overall Study|Physician Decision|11|||
47079683|NCT03565900|83387459|FG000|Overall Study|Death|9|||
47079684|NCT03565900|83387460|FG001|Overall Study|Death|7|||
47079685|NCT03443869|83387499|FG000|Overall Study|Death|3|||
47079686|NCT03443869|83387500|FG001|Overall Study|Death|3|||
47079687|NCT03443869|83387499|FG000|Overall Study|Withdrawal by Subject|34|||
47079688|NCT03443869|83387500|FG001|Overall Study|Withdrawal by Subject|22|||
47079689|NCT03443869|83387499|FG000|Overall Study|Lost to Follow-up|1|||
47079690|NCT03443869|83387500|FG001|Overall Study|Lost to Follow-up|2|||
47079691|NCT03443869|83387499|FG000|Overall Study|Physician Decision|3|||
47079692|NCT03443869|83387500|FG001|Overall Study|Physician Decision|3|||
47079693|NCT03443869|83387499|FG000|Overall Study|Other|4|||
47079694|NCT03443869|83387500|FG001|Overall Study|Other|4|||
47079695|NCT03260140|83387508|FG000|Overall Study|Death|4|||
47079696|NCT03260140|83387509|FG001|Overall Study|Death|1|||
47079697|NCT03260140|83387508|FG000|Overall Study|Withdrawal by Subject|1|||
46674438|NCT01149655|82890102|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
46674439|NCT01149655|82890103|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
46674440|NCT01149655|82890104|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
46674441|NCT01149655|82890105|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
46674442|NCT01149655|82890102|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
46674443|NCT01149655|82890103|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
46856274|NCT00349349|83072056|FG001|Overall Study|Withdrawal by Subject|2|||
46856275|NCT00349349|83072057|FG002|Overall Study|Withdrawal by Subject|1|||
46856276|NCT00349349|83072055|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
46856277|NCT00349349|83072056|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
46856278|NCT00349349|83072057|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
46856279|NCT00349349|83072055|FG000|Overall Study|Death|13|||
46856280|NCT00349349|83072056|FG001|Overall Study|Death|10|||
46856281|NCT00349349|83072057|FG002|Overall Study|Death|1|||
46856282|NCT00349349|83072055|FG000|Overall Study|Other Treatment Selected|2|||
46856283|NCT00349349|83072056|FG001|Overall Study|Other Treatment Selected|0|||
46856284|NCT00349349|83072057|FG002|Overall Study|Other Treatment Selected|0|||
46856285|NCT00349349|83072055|FG000|Overall Study|Participant Reduced General Condition|0|||
46856286|NCT00349349|83072056|FG001|Overall Study|Participant Reduced General Condition|1|||
46978787|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
46978788|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
46978789|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
46978790|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
46978791|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
46978792|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
46978793|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
46794710|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
46794711|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Death|9|||
46794712|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Death|7|||
46794713|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Death|14|||
46794714|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Death|7|||
46794715|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Death|0|||
46794716|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Death|0|||
46794717|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
46794718|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
46794719|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
46794720|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
46794721|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
46856287|NCT00349349|83072057|FG002|Overall Study|Participant Reduced General Condition|0|||
46856288|NCT00349349|83072055|FG000|Overall Study|Physician Decision|1|||
46794722|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
46794723|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Other Event|49|||
46856289|NCT00349349|83072056|FG001|Overall Study|Physician Decision|2|||
46856290|NCT00349349|83072057|FG002|Overall Study|Physician Decision|1|||
46856291|NCT00349349|83072055|FG000|Overall Study|No Response|0|||
46856292|NCT00349349|83072056|FG001|Overall Study|No Response|3|||
46794724|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Other Event|52|||
46794725|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Other Event|41|||
46794726|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Other Event|58|||
46794727|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Other Event|0|||
46794728|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Other Event|0|||
46794729|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
46794730|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
46794731|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
46794732|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
46794733|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
46794734|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
46794735|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
46794736|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
46794737|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
46794738|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
46794739|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
46794740|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
46794741|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
46794742|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
46794743|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
46794744|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
46794745|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
46794746|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
46794747|NCT00205777|83013133|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
46794748|NCT00205777|83013134|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
46794749|NCT00205777|83013135|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
46794750|NCT00205777|83013136|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
46794751|NCT00205777|83013137|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
46794752|NCT00205777|83013138|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
46856293|NCT00349349|83072057|FG002|Overall Study|No Response|0|||
46674444|NCT01149655|82890104|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
47079698|NCT03260140|83387509|FG001|Overall Study|Withdrawal by Subject|4|||
47079699|NCT03253796|83387520|FG000|Period 1: Run-In|Adverse Event|4|||
47079700|NCT03253796|83387521|FG001|Period 1: Run-In|Adverse Event|0|||
47079701|NCT03253796|83387522|FG002|Period 1: Run-In|Adverse Event|0|||
47079702|NCT03253796|83387523|FG003|Period 1: Run-In|Adverse Event|0|||
47079703|NCT03253796|83387524|FG004|Period 1: Run-In|Adverse Event|0|||
47079704|NCT03253796|83387520|FG000|Period 1: Run-In|Lack of Efficacy|1|||
47079705|NCT03253796|83387521|FG001|Period 1: Run-In|Lack of Efficacy|0|||
47079706|NCT03253796|83387522|FG002|Period 1: Run-In|Lack of Efficacy|0|||
47079707|NCT03253796|83387523|FG003|Period 1: Run-In|Lack of Efficacy|0|||
47079708|NCT03253796|83387524|FG004|Period 1: Run-In|Lack of Efficacy|0|||
47079709|NCT03253796|83387520|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
47079710|NCT03253796|83387521|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
47079711|NCT03253796|83387522|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
47079712|NCT03253796|83387523|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
47079713|NCT03253796|83387524|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
47079714|NCT03253796|83387520|FG000|Period 1: Run-In|Protocol Violation|5|||
47079715|NCT03253796|83387521|FG001|Period 1: Run-In|Protocol Violation|0|||
47079716|NCT03253796|83387522|FG002|Period 1: Run-In|Protocol Violation|0|||
47079717|NCT03253796|83387523|FG003|Period 1: Run-In|Protocol Violation|0|||
47079718|NCT03253796|83387524|FG004|Period 1: Run-In|Protocol Violation|0|||
47079719|NCT03253796|83387520|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
47079720|NCT03253796|83387521|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
47079721|NCT03253796|83387522|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
47079722|NCT03253796|83387523|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
47079723|NCT03253796|83387524|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
47079724|NCT03253796|83387520|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
47079725|NCT03253796|83387521|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
47079726|NCT03253796|83387522|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
47079727|NCT03253796|83387523|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
47079728|NCT03253796|83387524|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
47079729|NCT03253796|83387520|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
47079730|NCT03253796|83387521|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
47079731|NCT03253796|83387522|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
47079732|NCT03253796|83387523|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
47079733|NCT03253796|83387524|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
47079734|NCT03253796|83387520|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
47079735|NCT03253796|83387521|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
47079736|NCT03253796|83387522|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
47079737|NCT03253796|83387523|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
46674445|NCT01149655|82890105|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
46674446|NCT01149655|82890102|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
46674447|NCT01149655|82890103|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
46978794|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
46978795|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
46978796|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
46978797|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
46978798|NCT01672879|83224237|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
46674448|NCT01149655|82890104|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
46978799|NCT01672879|83224238|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
46856294|NCT00349349|83072055|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
46978800|NCT01672879|83224239|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
46674449|NCT01149655|82890105|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
46794753|NCT00205777|83013133|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
46794754|NCT00205777|83013134|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
46794755|NCT00205777|83013135|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
46856295|NCT00349349|83072056|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
46856296|NCT00349349|83072057|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
46978801|NCT01672879|83224237|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
46978802|NCT01672879|83224238|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
46794756|NCT00205777|83013136|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
46794757|NCT00205777|83013137|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
46794758|NCT00205777|83013138|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
46794759|NCT00205777|83013133|FG000|Completed Core Study, Entered SE I|Other Event|52|||
46794760|NCT00205777|83013134|FG001|Completed Core Study, Entered SE I|Other Event|46|||
46674450|NCT01149655|82890102|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
46674451|NCT01149655|82890103|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
46794761|NCT00205777|83013135|FG002|Completed Core Study, Entered SE I|Other Event|47|||
46794762|NCT00205777|83013136|FG003|Completed Core Study, Entered SE I|Other Event|50|||
46794763|NCT00205777|83013137|FG004|Completed Core Study, Entered SE I|Other Event|0|||
46794764|NCT00205777|83013138|FG005|Completed Core Study, Entered SE I|Other Event|0|||
46794765|NCT00205777|83013133|FG000|Study Extension I|Adverse Event|57|||
46794766|NCT00205777|83013134|FG001|Study Extension I|Adverse Event|0|||
46794767|NCT00205777|83013135|FG002|Study Extension I|Adverse Event|0|||
46794768|NCT00205777|83013136|FG003|Study Extension I|Adverse Event|61|||
46794769|NCT00205777|83013137|FG004|Study Extension I|Adverse Event|58|||
46794770|NCT00205777|83013138|FG005|Study Extension I|Adverse Event|0|||
46794771|NCT00205777|83013133|FG000|Study Extension I|Death|5|||
46794772|NCT00205777|83013134|FG001|Study Extension I|Death|0|||
46794773|NCT00205777|83013135|FG002|Study Extension I|Death|0|||
46856297|NCT02950480|83072069|FG000|Overall Study|Withdrawal by Subject|1|||
46856298|NCT02950480|83072070|FG001|Overall Study|Withdrawal by Subject|0|||
46674452|NCT01149655|82890104|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
46978803|NCT01672879|83224239|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
46978804|NCT01672879|83224237|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
46794774|NCT00205777|83013136|FG003|Study Extension I|Death|1|||
46978805|NCT01672879|83224238|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
46794775|NCT00205777|83013137|FG004|Study Extension I|Death|2|||
46794776|NCT00205777|83013138|FG005|Study Extension I|Death|0|||
46794777|NCT00205777|83013133|FG000|Study Extension I|Withdrawal by Subject|99|||
46856299|NCT00348881|83072078|FG000|Overall Study|Lost to Follow-up|12|||
47079738|NCT03253796|83387524|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
47079739|NCT03253796|83387520|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
47079740|NCT03253796|83387521|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
47079741|NCT03253796|83387522|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
47079742|NCT03253796|83387523|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
47079743|NCT03253796|83387524|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
47079744|NCT03253796|83387520|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
47079745|NCT03253796|83387521|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
47079746|NCT03253796|83387522|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
47079747|NCT03253796|83387523|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
47079748|NCT03253796|83387524|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
47079749|NCT03253796|83387520|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
47079750|NCT03253796|83387521|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
47079751|NCT03253796|83387522|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
47079752|NCT03253796|83387523|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
47079753|NCT03253796|83387524|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
47079754|NCT03073733|83387542|FG000|Overall Study|Lost to Follow-up|1|||
46674453|NCT01149655|82890105|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
46674454|NCT01149655|82890102|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
46674455|NCT01149655|82890103|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
46674456|NCT01149655|82890104|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
46674457|NCT01149655|82890105|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
46674458|NCT01149655|82890102|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
46674459|NCT01149655|82890103|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
46674460|NCT01149655|82890104|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
46674461|NCT01149655|82890105|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
46674462|NCT01149655|82890102|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
46674463|NCT01149655|82890103|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
46674464|NCT01149655|82890104|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
46674465|NCT01149655|82890105|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
46674466|NCT01149655|82890102|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
46674467|NCT01149655|82890103|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
46674468|NCT01149655|82890104|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
46674469|NCT01149655|82890105|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
46674470|NCT01149655|82890102|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
46674471|NCT01149655|82890103|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
46674472|NCT01149655|82890104|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
46674473|NCT01149655|82890105|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
46674474|NCT01149655|82890102|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
46674475|NCT01149655|82890103|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
46674476|NCT01149655|82890104|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
46978806|NCT01672879|83224239|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
46978807|NCT01672879|83224237|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
46978808|NCT01672879|83224238|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
46978809|NCT01672879|83224239|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
46978810|NCT01672879|83224237|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
46856300|NCT00348881|83072079|FG001|Overall Study|Lost to Follow-up|6|||
46856301|NCT00348881|83072078|FG000|Overall Study|Withdrawal by Subject|3|||
46856302|NCT00348881|83072079|FG001|Overall Study|Withdrawal by Subject|4|||
46856303|NCT00348881|83072078|FG000|Overall Study|Adverse Event|2|||
46856304|NCT00348881|83072079|FG001|Overall Study|Adverse Event|0|||
46856305|NCT00348881|83072078|FG000|Overall Study|Serious Adverse Event|0|||
46856306|NCT00348881|83072079|FG001|Overall Study|Serious Adverse Event|2|||
46674477|NCT01149655|82890105|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
46674478|NCT01149655|82890102|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
46674479|NCT01149655|82890103|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
46674480|NCT01149655|82890104|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
46674481|NCT01149655|82890105|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
46856307|NCT03376516|83072089|FG000|Overall Study|Not treated|1|||
46674482|NCT01149538|82890115|FG000|Overall Study|Lost to Follow-up|0|||
46674483|NCT01149538|82890116|FG001|Overall Study|Lost to Follow-up|1|||
46674484|NCT01149538|82890115|FG000|Overall Study|Withdrawal by Subject|5|||
46674485|NCT01149538|82890116|FG001|Overall Study|Withdrawal by Subject|3|||
46674486|NCT01149460|82890124|FG000|Overall Study|Withdrawal by Subject|0|||
46674487|NCT01149460|82890125|FG001|Overall Study|Withdrawal by Subject|2|||
46674488|NCT01149421|82890134|FG000|Overall Study|Adverse Event|22|||
46674489|NCT01149421|82890135|FG001|Overall Study|Adverse Event|6|||
46674490|NCT01149421|82890136|FG002|Overall Study|Adverse Event|11|||
46674491|NCT01149421|82890134|FG000|Overall Study|Withdrawal by Subject|20|||
46674492|NCT01149421|82890135|FG001|Overall Study|Withdrawal by Subject|12|||
46674493|NCT01149421|82890136|FG002|Overall Study|Withdrawal by Subject|13|||
46674494|NCT01149421|82890134|FG000|Overall Study|Sponsor Decision|0|||
46674495|NCT01149421|82890135|FG001|Overall Study|Sponsor Decision|1|||
46674496|NCT01149421|82890136|FG002|Overall Study|Sponsor Decision|1|||
46674497|NCT01149421|82890134|FG000|Overall Study|Lost to Follow-up|2|||
46674498|NCT01149421|82890135|FG001|Overall Study|Lost to Follow-up|4|||
46674499|NCT01149421|82890136|FG002|Overall Study|Lost to Follow-up|5|||
46674500|NCT01149421|82890134|FG000|Overall Study|Physician Decision|5|||
46674501|NCT01149421|82890135|FG001|Overall Study|Physician Decision|3|||
46674502|NCT01149421|82890136|FG002|Overall Study|Physician Decision|6|||
46674503|NCT01149421|82890134|FG000|Overall Study|Entry Criteria Not Met|1|||
46674504|NCT01149421|82890135|FG001|Overall Study|Entry Criteria Not Met|1|||
46674505|NCT01149421|82890136|FG002|Overall Study|Entry Criteria Not Met|2|||
46674506|NCT01149421|82890134|FG000|Overall Study|Protocol Violation|2|||
46674507|NCT01149421|82890135|FG001|Overall Study|Protocol Violation|2|||
46674508|NCT01149421|82890136|FG002|Overall Study|Protocol Violation|6|||
46674509|NCT01149343|82890154|FG000|Overall Study|Withdrawal by Subject|1|||
46674510|NCT01149343|82890155|FG001|Overall Study|Withdrawal by Subject|1|||
46978811|NCT01672879|83224238|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
46978812|NCT01672879|83224239|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
46978813|NCT02601209|83224255|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
46978814|NCT02601209|83224256|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
46978815|NCT02601209|83224257|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
46978816|NCT02601209|83224258|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
46978817|NCT02601209|83224259|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
46978818|NCT02601209|83224260|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
46978819|NCT02601209|83224261|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
46978820|NCT02601209|83224262|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
46978821|NCT02601209|83224263|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
46978822|NCT02601209|83224255|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
46978823|NCT02601209|83224256|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
46978824|NCT02601209|83224257|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
46978825|NCT02601209|83224258|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
46978826|NCT02601209|83224259|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
46978827|NCT02601209|83224260|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
46978828|NCT02601209|83224261|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
47079755|NCT03073733|83387543|FG001|Overall Study|Lost to Follow-up|0|||
47079756|NCT03073733|83387544|FG002|Overall Study|Lost to Follow-up|0|||
47079757|NCT03073733|83387542|FG000|Overall Study|Physician Decision|0|||
46674511|NCT01149343|82890156|FG002|Overall Study|Withdrawal by Subject|1|||
46674512|NCT01149343|82890157|FG003|Overall Study|Withdrawal by Subject|5|||
46674513|NCT01149343|82890154|FG000|Overall Study|Death|10|||
47079758|NCT03073733|83387543|FG001|Overall Study|Physician Decision|1|||
47079759|NCT03073733|83387544|FG002|Overall Study|Physician Decision|0|||
46674514|NCT01149343|82890155|FG001|Overall Study|Death|13|||
46674515|NCT01149343|82890156|FG002|Overall Study|Death|18|||
46674516|NCT01149343|82890157|FG003|Overall Study|Death|18|||
47079760|NCT03073733|83387542|FG000|Overall Study|Withdrawal by Subject|0|||
47079761|NCT03073733|83387543|FG001|Overall Study|Withdrawal by Subject|0|||
47079762|NCT03073733|83387544|FG002|Overall Study|Withdrawal by Subject|1|||
47079763|NCT03029143|83387554|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
47079764|NCT03029143|83387555|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
47079765|NCT03029143|83387556|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
47079766|NCT03029143|83387554|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
47079767|NCT03029143|83387555|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
46794778|NCT00205777|83013134|FG001|Study Extension I|Withdrawal by Subject|0|||
47079768|NCT03029143|83387556|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
47079769|NCT03029143|83387554|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
47079770|NCT03029143|83387555|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
47079771|NCT03029143|83387556|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
47079772|NCT03029143|83387554|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
47079773|NCT03029143|83387555|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
47079774|NCT03029143|83387556|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
47079775|NCT03029143|83387554|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
47079776|NCT03029143|83387555|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
47079777|NCT03029143|83387556|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
47079778|NCT03029143|83387554|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
47079779|NCT03029143|83387555|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
47079780|NCT03029143|83387556|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
47079781|NCT03029143|83387554|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
47079782|NCT03029143|83387555|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
47079783|NCT03029143|83387556|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
47079784|NCT03029143|83387554|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
47079785|NCT03029143|83387555|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
47079786|NCT03029143|83387556|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
47079787|NCT03029143|83387554|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
47079788|NCT03029143|83387555|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
47079789|NCT03029143|83387556|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
47079790|NCT03029143|83387554|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
47079791|NCT03029143|83387555|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
47079792|NCT03029143|83387556|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
47079793|NCT03029143|83387554|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
47079794|NCT03029143|83387555|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
47079795|NCT03029143|83387556|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
47079796|NCT02971137|83387567|FG000|Overall Study|Lost to Follow-up|44|||
47079797|NCT02971137|83387568|FG001|Overall Study|Lost to Follow-up|56|||
47079798|NCT02953262|83387578|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
47079799|NCT02953262|83387579|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
47079800|NCT02953262|83387580|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
47079801|NCT02953262|83387581|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
47079802|NCT02763579|83387597|FG000|Global Period|Death|167|||
47079803|NCT02763579|83387598|FG001|Global Period|Death|151|||
46856308|NCT03376516|83072089|FG000|Overall Study|Consent withdrawn|1|||
46856309|NCT03797144|83072115|FG000|Enrollment|Protocol Violation|4|||
47079804|NCT02763579|83387599|FG002|Global Period|Death|0|||
47079805|NCT02763579|83387600|FG003|Global Period|Death|0|||
47079806|NCT02763579|83387597|FG000|Global Period|Lost to Follow-up|2|||
47079807|NCT02763579|83387598|FG001|Global Period|Lost to Follow-up|4|||
47079808|NCT02763579|83387599|FG002|Global Period|Lost to Follow-up|0|||
47079809|NCT02763579|83387600|FG003|Global Period|Lost to Follow-up|0|||
47079810|NCT02763579|83387597|FG000|Global Period|Physician Decision|0|||
47079811|NCT02763579|83387598|FG001|Global Period|Physician Decision|2|||
47079812|NCT02763579|83387599|FG002|Global Period|Physician Decision|0|||
47079813|NCT02763579|83387600|FG003|Global Period|Physician Decision|0|||
47079814|NCT02763579|83387597|FG000|Global Period|Study Terminated By Sponsor|21|||
47079815|NCT02763579|83387598|FG001|Global Period|Study Terminated By Sponsor|26|||
47079816|NCT02763579|83387599|FG002|Global Period|Study Terminated By Sponsor|0|||
47079817|NCT02763579|83387600|FG003|Global Period|Study Terminated By Sponsor|0|||
47079818|NCT02763579|83387597|FG000|Global Period|Withdrawal by Subject|12|||
47079819|NCT02763579|83387598|FG001|Global Period|Withdrawal by Subject|18|||
47079820|NCT02763579|83387599|FG002|Global Period|Withdrawal by Subject|0|||
47079821|NCT02763579|83387600|FG003|Global Period|Withdrawal by Subject|0|||
47079822|NCT02763579|83387597|FG000|China Period|Death|0|||
47079823|NCT02763579|83387598|FG001|China Period|Death|0|||
47079824|NCT02763579|83387599|FG002|China Period|Death|46|||
47079825|NCT02763579|83387600|FG003|China Period|Death|48|||
47079826|NCT02763579|83387597|FG000|China Period|Lost to Follow-up|0|||
47079827|NCT02763579|83387598|FG001|China Period|Lost to Follow-up|0|||
47079828|NCT02763579|83387599|FG002|China Period|Lost to Follow-up|1|||
47079829|NCT02763579|83387600|FG003|China Period|Lost to Follow-up|1|||
47079830|NCT02763579|83387597|FG000|China Period|Physician Decision|0|||
46978829|NCT02601209|83224262|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
46674517|NCT01149343|82890154|FG000|Overall Study|Lost to Follow-up|1|||
47079831|NCT02763579|83387598|FG001|China Period|Physician Decision|0|||
47079832|NCT02763579|83387599|FG002|China Period|Physician Decision|0|||
47079833|NCT02763579|83387600|FG003|China Period|Physician Decision|1|||
47079834|NCT02763579|83387597|FG000|China Period|Study Terminated By Sponsor|0|||
47079835|NCT02763579|83387598|FG001|China Period|Study Terminated By Sponsor|0|||
47079836|NCT02763579|83387599|FG002|China Period|Study Terminated By Sponsor|3|||
47079837|NCT02763579|83387600|FG003|China Period|Study Terminated By Sponsor|4|||
47079838|NCT02763579|83387597|FG000|China Period|Withdrawal by Subject|0|||
47079839|NCT02763579|83387598|FG001|China Period|Withdrawal by Subject|0|||
47079840|NCT02763579|83387599|FG002|China Period|Withdrawal by Subject|3|||
47079841|NCT02763579|83387600|FG003|China Period|Withdrawal by Subject|3|||
47079842|NCT02623699|83387644|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079843|NCT02623699|83387645|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
47079844|NCT02623699|83387646|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079845|NCT02623699|83387647|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079846|NCT02623699|83387648|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079847|NCT02623699|83387649|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079848|NCT02623699|83387650|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079849|NCT02623699|83387651|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
46794779|NCT00205777|83013135|FG002|Study Extension I|Withdrawal by Subject|0|||
46794780|NCT00205777|83013136|FG003|Study Extension I|Withdrawal by Subject|106|||
46794781|NCT00205777|83013137|FG004|Study Extension I|Withdrawal by Subject|89|||
46794782|NCT00205777|83013138|FG005|Study Extension I|Withdrawal by Subject|0|||
46674518|NCT01149343|82890155|FG001|Overall Study|Lost to Follow-up|0|||
46794783|NCT00205777|83013133|FG000|Study Extension I|Protocol Violation|4|||
47079850|NCT02623699|83387652|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079851|NCT02623699|83387653|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079852|NCT02623699|83387654|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079853|NCT02623699|83387655|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
47079854|NCT02623699|83387644|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079855|NCT02623699|83387645|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079856|NCT02623699|83387646|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079857|NCT02623699|83387647|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079858|NCT02623699|83387648|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079859|NCT02623699|83387649|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079860|NCT02623699|83387650|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
47079861|NCT02623699|83387651|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079862|NCT02623699|83387652|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079863|NCT02623699|83387653|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079864|NCT02623699|83387654|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079865|NCT02623699|83387655|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
47079866|NCT02623699|83387644|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079867|NCT02623699|83387645|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079868|NCT02623699|83387646|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
46674519|NCT01149343|82890156|FG002|Overall Study|Lost to Follow-up|0|||
46674520|NCT01149343|82890157|FG003|Overall Study|Lost to Follow-up|1|||
46674521|NCT01149343|82890154|FG000|Overall Study|Other|8|||
46674522|NCT01149343|82890155|FG001|Overall Study|Other|10|||
46674523|NCT01149343|82890156|FG002|Overall Study|Other|2|||
46674524|NCT01149343|82890157|FG003|Overall Study|Other|14|||
46674525|NCT01149343|82890154|FG000|Overall Study|Sponsor study termination|0|||
46674526|NCT01149343|82890155|FG001|Overall Study|Sponsor study termination|0|||
46794784|NCT00205777|83013134|FG001|Study Extension I|Protocol Violation|0|||
46794785|NCT00205777|83013135|FG002|Study Extension I|Protocol Violation|0|||
46794786|NCT00205777|83013136|FG003|Study Extension I|Protocol Violation|8|||
46794787|NCT00205777|83013137|FG004|Study Extension I|Protocol Violation|8|||
46794788|NCT00205777|83013138|FG005|Study Extension I|Protocol Violation|0|||
46978830|NCT02601209|83224263|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
46794789|NCT00205777|83013133|FG000|Study Extension I|Lack of Efficacy|0|||
46794790|NCT00205777|83013134|FG001|Study Extension I|Lack of Efficacy|0|||
46794791|NCT00205777|83013135|FG002|Study Extension I|Lack of Efficacy|0|||
46794792|NCT00205777|83013136|FG003|Study Extension I|Lack of Efficacy|1|||
46794793|NCT00205777|83013137|FG004|Study Extension I|Lack of Efficacy|2|||
46794794|NCT00205777|83013138|FG005|Study Extension I|Lack of Efficacy|0|||
46794795|NCT00205777|83013133|FG000|Study Extension I|Failed to return|15|||
46794796|NCT00205777|83013134|FG001|Study Extension I|Failed to return|0|||
46794797|NCT00205777|83013135|FG002|Study Extension I|Failed to return|0|||
46794798|NCT00205777|83013136|FG003|Study Extension I|Failed to return|17|||
46794799|NCT00205777|83013137|FG004|Study Extension I|Failed to return|13|||
46794800|NCT00205777|83013138|FG005|Study Extension I|Failed to return|0|||
46794801|NCT00205777|83013133|FG000|Study Extension I|Other Event|34|||
46794802|NCT00205777|83013134|FG001|Study Extension I|Other Event|0|||
46794803|NCT00205777|83013135|FG002|Study Extension I|Other Event|0|||
46794804|NCT00205777|83013136|FG003|Study Extension I|Other Event|34|||
46794805|NCT00205777|83013137|FG004|Study Extension I|Other Event|29|||
46794806|NCT00205777|83013138|FG005|Study Extension I|Other Event|0|||
46794807|NCT00205777|83013133|FG000|Study Extension I|Withdrawn as per protocol|0|||
46794808|NCT00205777|83013134|FG001|Study Extension I|Withdrawn as per protocol|0|||
46794809|NCT00205777|83013135|FG002|Study Extension I|Withdrawn as per protocol|1070|||
46794810|NCT00205777|83013136|FG003|Study Extension I|Withdrawn as per protocol|0|||
46794811|NCT00205777|83013137|FG004|Study Extension I|Withdrawn as per protocol|0|||
46794812|NCT00205777|83013138|FG005|Study Extension I|Withdrawn as per protocol|0|||
46794813|NCT00205777|83013133|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
46794814|NCT00205777|83013134|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
46978831|NCT01659021|83224279|FG000|Main Study|Adverse Event|2|||
46674527|NCT01149343|82890156|FG002|Overall Study|Sponsor study termination|0|||
46674528|NCT01149343|82890157|FG003|Overall Study|Sponsor study termination|2|||
46674529|NCT01149343|82890154|FG000|Overall Study|Recurrence / Progressive disease|0|||
46674530|NCT01149343|82890155|FG001|Overall Study|Recurrence / Progressive disease|0|||
46674531|NCT01149343|82890156|FG002|Overall Study|Recurrence / Progressive disease|1|||
46674532|NCT01149343|82890157|FG003|Overall Study|Recurrence / Progressive disease|0|||
46674533|NCT01149148|82890173|FG000|Overall Study|Lost to Follow-up|1|||
46674534|NCT01149148|82890174|FG001|Overall Study|Lost to Follow-up|2|||
46674535|NCT01149148|82890173|FG000|Overall Study|Death|1|||
46674536|NCT01149148|82890174|FG001|Overall Study|Death|0|||
46674537|NCT01148017|82890185|FG000|Overall Study|Withdrawal by Subject|31|||
46674538|NCT01148017|82890186|FG001|Overall Study|Withdrawal by Subject|14|||
46674539|NCT01148017|82890187|FG002|Overall Study|Withdrawal by Subject|0|||
46674540|NCT01148017|82890188|FG003|Overall Study|Withdrawal by Subject|0|||
46674541|NCT01148017|82890185|FG000|Overall Study|Lost to Follow-up|23|||
46674542|NCT01148017|82890186|FG001|Overall Study|Lost to Follow-up|10|||
46674543|NCT01148017|82890187|FG002|Overall Study|Lost to Follow-up|0|||
46674544|NCT01148017|82890188|FG003|Overall Study|Lost to Follow-up|0|||
46674545|NCT01148017|82890185|FG000|Overall Study|Inappropriate enrollment|1|||
46674546|NCT01148017|82890186|FG001|Overall Study|Inappropriate enrollment|0|||
46794815|NCT00205777|83013135|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
46794816|NCT00205777|83013136|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
46794817|NCT00205777|83013137|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
46856310|NCT03797144|83072116|FG001|Enrollment|Protocol Violation|1|||
46856311|NCT03797144|83072115|FG000|Surgery|Protocol Violation|1|||
46856312|NCT03797144|83072116|FG001|Surgery|Protocol Violation|0|||
46856313|NCT03797144|83072115|FG000|3 Month|Early termination cut-off date|2|||
46856314|NCT03797144|83072116|FG001|3 Month|Early termination cut-off date|0|||
46856315|NCT03797144|83072115|FG000|12 Month|Early termination cut-off date|8|||
46978832|NCT01659021|83224280|FG001|Main Study|Adverse Event|3|||
46794818|NCT00205777|83013138|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
46794819|NCT00205777|83013133|FG000|Study Extension II|Adverse Event|0|||
46794820|NCT00205777|83013134|FG001|Study Extension II|Adverse Event|0|||
46794821|NCT00205777|83013135|FG002|Study Extension II|Adverse Event|0|||
46794822|NCT00205777|83013136|FG003|Study Extension II|Adverse Event|14|||
46794823|NCT00205777|83013137|FG004|Study Extension II|Adverse Event|0|||
46794824|NCT00205777|83013138|FG005|Study Extension II|Adverse Event|30|||
46794825|NCT00205777|83013133|FG000|Study Extension II|Death|0|||
46794826|NCT00205777|83013134|FG001|Study Extension II|Death|0|||
46794827|NCT00205777|83013135|FG002|Study Extension II|Death|0|||
46674547|NCT01148017|82890187|FG002|Overall Study|Inappropriate enrollment|0|||
46674548|NCT01148017|82890188|FG003|Overall Study|Inappropriate enrollment|0|||
46674549|NCT01148017|82890185|FG000|Overall Study|Administrative reason|22|||
46978833|NCT01659021|83224279|FG000|Main Study|Lost to Follow-up|1|||
46674550|NCT01148017|82890186|FG001|Overall Study|Administrative reason|9|||
46674551|NCT01148017|82890187|FG002|Overall Study|Administrative reason|0|||
46674552|NCT01148017|82890188|FG003|Overall Study|Administrative reason|0|||
46674553|NCT01148017|82890185|FG000|Overall Study|Unable to classify|3|||
46674554|NCT01148017|82890186|FG001|Overall Study|Unable to classify|1|||
46794828|NCT00205777|83013136|FG003|Study Extension II|Death|2|||
46674555|NCT01148017|82890187|FG002|Overall Study|Unable to classify|0|||
46674556|NCT01148017|82890188|FG003|Overall Study|Unable to classify|0|||
46674557|NCT01147900|82890202|FG000|At Year 10|Lost to Follow-up|0|||
46674558|NCT01147900|82890203|FG001|At Year 10|Lost to Follow-up|1|||
46674559|NCT01147900|82890204|FG002|At Year 10|Lost to Follow-up|0|||
46674560|NCT01147744|82890219|FG000|Overall Study|Protocol Violation|1|||
46674561|NCT01147744|82890220|FG001|Overall Study|Protocol Violation|0|||
46674562|NCT01147744|82890221|FG002|Overall Study|Protocol Violation|1|||
46674563|NCT01147744|82890222|FG003|Overall Study|Protocol Violation|0|||
46674564|NCT01147744|82890223|FG004|Overall Study|Protocol Violation|1|||
46674565|NCT01147744|82890224|FG005|Overall Study|Protocol Violation|3|||
46794829|NCT00205777|83013137|FG004|Study Extension II|Death|0|||
46794830|NCT00205777|83013138|FG005|Study Extension II|Death|5|||
46794831|NCT00205777|83013133|FG000|Study Extension II|Withdrawal by Subject|0|||
46674566|NCT01147744|82890225|FG006|Overall Study|Protocol Violation|1|||
46794832|NCT00205777|83013134|FG001|Study Extension II|Withdrawal by Subject|0|||
46674567|NCT01147744|82890219|FG000|Overall Study|Physician Decision|0|||
46794833|NCT00205777|83013135|FG002|Study Extension II|Withdrawal by Subject|0|||
46794834|NCT00205777|83013136|FG003|Study Extension II|Withdrawal by Subject|35|||
46794835|NCT00205777|83013137|FG004|Study Extension II|Withdrawal by Subject|0|||
46674568|NCT01147744|82890220|FG001|Overall Study|Physician Decision|1|||
46674569|NCT01147744|82890221|FG002|Overall Study|Physician Decision|1|||
46674570|NCT01147744|82890222|FG003|Overall Study|Physician Decision|0|||
46674571|NCT01147744|82890223|FG004|Overall Study|Physician Decision|0|||
46674572|NCT01147744|82890224|FG005|Overall Study|Physician Decision|0|||
46674573|NCT01147744|82890225|FG006|Overall Study|Physician Decision|1|||
46794836|NCT00205777|83013138|FG005|Study Extension II|Withdrawal by Subject|59|||
46794837|NCT00205777|83013133|FG000|Study Extension II|Protocol Violation|0|||
46794838|NCT00205777|83013134|FG001|Study Extension II|Protocol Violation|0|||
46794839|NCT00205777|83013135|FG002|Study Extension II|Protocol Violation|0|||
46794840|NCT00205777|83013136|FG003|Study Extension II|Protocol Violation|1|||
46794841|NCT00205777|83013137|FG004|Study Extension II|Protocol Violation|0|||
46794842|NCT00205777|83013138|FG005|Study Extension II|Protocol Violation|10|||
46794843|NCT00205777|83013133|FG000|Study Extension II|Lack of Efficacy|0|||
46794844|NCT00205777|83013134|FG001|Study Extension II|Lack of Efficacy|0|||
46794845|NCT00205777|83013135|FG002|Study Extension II|Lack of Efficacy|0|||
46794846|NCT00205777|83013136|FG003|Study Extension II|Lack of Efficacy|0|||
46794847|NCT00205777|83013137|FG004|Study Extension II|Lack of Efficacy|0|||
46794848|NCT00205777|83013138|FG005|Study Extension II|Lack of Efficacy|1|||
46794849|NCT00205777|83013133|FG000|Study Extension II|Failed to return|0|||
46794850|NCT00205777|83013134|FG001|Study Extension II|Failed to return|0|||
46794851|NCT00205777|83013135|FG002|Study Extension II|Failed to return|0|||
46794852|NCT00205777|83013136|FG003|Study Extension II|Failed to return|14|||
46978834|NCT01659021|83224280|FG001|Main Study|Lost to Follow-up|0|||
46794853|NCT00205777|83013137|FG004|Study Extension II|Failed to return|0|||
46794854|NCT00205777|83013138|FG005|Study Extension II|Failed to return|26|||
46794855|NCT00205777|83013133|FG000|Study Extension II|Other Event|0|||
46794856|NCT00205777|83013134|FG001|Study Extension II|Other Event|0|||
46794857|NCT00205777|83013135|FG002|Study Extension II|Other Event|0|||
46794858|NCT00205777|83013136|FG003|Study Extension II|Other Event|12|||
46794859|NCT00205777|83013137|FG004|Study Extension II|Other Event|0|||
46794860|NCT00205777|83013138|FG005|Study Extension II|Other Event|20|||
46794861|NCT00205777|83013133|FG000|Study Extension II|Enrolled but not treated|0|||
46794862|NCT00205777|83013134|FG001|Study Extension II|Enrolled but not treated|0|||
46794863|NCT00205777|83013135|FG002|Study Extension II|Enrolled but not treated|0|||
46674574|NCT01147744|82890219|FG000|Overall Study|Lack of Efficacy|11|||
46674575|NCT01147744|82890220|FG001|Overall Study|Lack of Efficacy|11|||
46674576|NCT01147744|82890221|FG002|Overall Study|Lack of Efficacy|9|||
46674577|NCT01147744|82890222|FG003|Overall Study|Lack of Efficacy|11|||
46674578|NCT01147744|82890223|FG004|Overall Study|Lack of Efficacy|13|||
46674579|NCT01147744|82890224|FG005|Overall Study|Lack of Efficacy|8|||
46674580|NCT01147744|82890225|FG006|Overall Study|Lack of Efficacy|7|||
46794864|NCT00205777|83013136|FG003|Study Extension II|Enrolled but not treated|71|||
46794865|NCT00205777|83013137|FG004|Study Extension II|Enrolled but not treated|0|||
46794866|NCT00205777|83013138|FG005|Study Extension II|Enrolled but not treated|131|||
46794867|NCT00483652|83013155|FG000|Double-blind Treatment Period|Protocol Violation|2|||
46674581|NCT01147744|82890219|FG000|Overall Study|Adverse Event|1|||
46674582|NCT01147744|82890220|FG001|Overall Study|Adverse Event|2|||
46674583|NCT01147744|82890221|FG002|Overall Study|Adverse Event|3|||
46674584|NCT01147744|82890222|FG003|Overall Study|Adverse Event|0|||
46674585|NCT01147744|82890223|FG004|Overall Study|Adverse Event|2|||
46674586|NCT01147744|82890224|FG005|Overall Study|Adverse Event|1|||
46674587|NCT01147744|82890225|FG006|Overall Study|Adverse Event|2|||
46674588|NCT01147744|82890219|FG000|Overall Study|Withdrawal by Subject|8|||
46674589|NCT01147744|82890220|FG001|Overall Study|Withdrawal by Subject|4|||
46674590|NCT01147744|82890221|FG002|Overall Study|Withdrawal by Subject|2|||
46674591|NCT01147744|82890222|FG003|Overall Study|Withdrawal by Subject|2|||
46674592|NCT01147744|82890223|FG004|Overall Study|Withdrawal by Subject|2|||
46674593|NCT01147744|82890224|FG005|Overall Study|Withdrawal by Subject|5|||
46674594|NCT01147744|82890225|FG006|Overall Study|Withdrawal by Subject|2|||
46674595|NCT01147744|82890219|FG000|Overall Study|Lost to Follow-up|0|||
46674596|NCT01147744|82890220|FG001|Overall Study|Lost to Follow-up|1|||
46674597|NCT01147744|82890221|FG002|Overall Study|Lost to Follow-up|0|||
46674598|NCT01147744|82890222|FG003|Overall Study|Lost to Follow-up|0|||
46674599|NCT01147744|82890223|FG004|Overall Study|Lost to Follow-up|0|||
46674600|NCT01147744|82890224|FG005|Overall Study|Lost to Follow-up|0|||
46674601|NCT01147744|82890225|FG006|Overall Study|Lost to Follow-up|0|||
46674602|NCT01147744|82890219|FG000|Overall Study|Sponsor decision to amend protocol|7|||
46674603|NCT01147744|82890220|FG001|Overall Study|Sponsor decision to amend protocol|4|||
46674604|NCT01147744|82890221|FG002|Overall Study|Sponsor decision to amend protocol|2|||
46674605|NCT01147744|82890222|FG003|Overall Study|Sponsor decision to amend protocol|5|||
46674606|NCT01147744|82890223|FG004|Overall Study|Sponsor decision to amend protocol|7|||
46674607|NCT01147744|82890224|FG005|Overall Study|Sponsor decision to amend protocol|2|||
46674608|NCT01147744|82890225|FG006|Overall Study|Sponsor decision to amend protocol|6|||
46674609|NCT01147744|82890219|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
46674610|NCT01147744|82890220|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
46674611|NCT01147744|82890221|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
46674612|NCT01147744|82890222|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
46674613|NCT01147744|82890223|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
46674614|NCT01147744|82890224|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
46794868|NCT00483652|83013156|FG001|Double-blind Treatment Period|Protocol Violation|1|||
46674615|NCT01147744|82890225|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
46856316|NCT03797144|83072116|FG001|12 Month|Early termination cut-off date|9|||
46674616|NCT01147471|82890249|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
46674617|NCT01147471|82890250|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
46674618|NCT01147471|82890249|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
46674619|NCT01147471|82890250|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
46674620|NCT01147471|82890249|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
46794869|NCT00483652|83013155|FG000|Double-blind Treatment Period|Adverse Event|3|||
46794870|NCT00483652|83013156|FG001|Double-blind Treatment Period|Adverse Event|4|||
46674621|NCT01147471|82890250|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
46674622|NCT01147471|82890249|FG000|3 Month Follow Up|Lost to Follow-up|1|||
46978835|NCT01659021|83224279|FG000|Main Study|Unknown Reasons|2|||
46978836|NCT01659021|83224280|FG001|Main Study|Unknown Reasons|1|||
46978837|NCT01659021|83224279|FG000|Main Study|Physician Decision|34|||
46978838|NCT01659021|83224280|FG001|Main Study|Physician Decision|16|||
46978839|NCT01659021|83224279|FG000|Main Study|Withdrawal by Subject|19|||
46978840|NCT01659021|83224280|FG001|Main Study|Withdrawal by Subject|16|||
46978841|NCT01659021|83224279|FG000|Main Study|Study Terminated by Sponsor|16|||
46978842|NCT01659021|83224280|FG001|Main Study|Study Terminated by Sponsor|1|||
46978843|NCT01659021|83224279|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
46978844|NCT01659021|83224280|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
46978845|NCT01659021|83224279|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
46674623|NCT01147471|82890250|FG001|3 Month Follow Up|Lost to Follow-up|1|||
46674624|NCT01147471|82890249|FG000|3 Month Follow Up|Physician Decision|0|||
46674625|NCT01147471|82890250|FG001|3 Month Follow Up|Physician Decision|1|||
46674626|NCT01147471|82890249|FG000|6 Month Follow Up|Lost to Follow-up|4|||
46674627|NCT01147471|82890250|FG001|6 Month Follow Up|Lost to Follow-up|2|||
46674628|NCT01147393|82890256|FG000|Dose Level 1|Dose limiting Toxicity|2|||
46674629|NCT01147393|82890256|FG000|Dose Level -1|Dose Limited Toxicity|1|||
46856317|NCT03797144|83072115|FG000|24 Month|Early termination cut-off date|1|||
46674630|NCT01146652|82890263|FG000|Overall Study|Adverse Event|506|||
46794871|NCT00483652|83013155|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
46794872|NCT00483652|83013156|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
46978846|NCT01659021|83224280|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
46794873|NCT00483652|83013155|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
46794874|NCT00483652|83013156|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
46794875|NCT00483574|83013164|FG000|Overall Study|Adverse Event|6|||
46674631|NCT01146652|82890264|FG001|Overall Study|Adverse Event|15|||
46674632|NCT01146652|82890263|FG000|Overall Study|Lack of Efficacy|91|||
46674633|NCT01146652|82890264|FG001|Overall Study|Lack of Efficacy|7|||
46674634|NCT01146652|82890263|FG000|Overall Study|Poor compliance to protocol|38|||
46674635|NCT01146652|82890264|FG001|Overall Study|Poor compliance to protocol|1|||
46674636|NCT01146652|82890263|FG000|Overall Study|Other unspecified reasons|314|||
46794876|NCT00483574|83013165|FG001|Overall Study|Adverse Event|0|||
46794877|NCT00483574|83013164|FG000|Overall Study|Protocol Violation|28|||
46794878|NCT00483574|83013165|FG001|Overall Study|Protocol Violation|9|||
46794879|NCT00483574|83013164|FG000|Overall Study|Lost to Follow-up|16|||
46794880|NCT00483574|83013165|FG001|Overall Study|Lost to Follow-up|4|||
46794881|NCT00483574|83013164|FG000|Overall Study|Withdrawal by Subject|52|||
46794882|NCT00483574|83013165|FG001|Overall Study|Withdrawal by Subject|0|||
46794883|NCT00483184|83013176|FG000|Overall Study|Withdrawal by Subject|2|||
46794884|NCT00483184|83013177|FG001|Overall Study|Withdrawal by Subject|2|||
46794885|NCT00483184|83013178|FG002|Overall Study|Withdrawal by Subject|0|||
46794886|NCT00483184|83013176|FG000|Overall Study|Lost to Follow-up|1|||
46794887|NCT00483184|83013177|FG001|Overall Study|Lost to Follow-up|0|||
46794888|NCT00483184|83013178|FG002|Overall Study|Lost to Follow-up|0|||
46794889|NCT00483184|83013176|FG000|Overall Study|Adverse Event|1|||
46794890|NCT00483184|83013177|FG001|Overall Study|Adverse Event|2|||
46794891|NCT00483184|83013178|FG002|Overall Study|Adverse Event|2|||
46794892|NCT00483184|83013176|FG000|Overall Study|Protocol Violation|1|||
46794893|NCT00483184|83013177|FG001|Overall Study|Protocol Violation|0|||
46978847|NCT04478266|83224322|FG000|Overall Study|Adverse Event|20|||
46978848|NCT04478266|83224323|FG001|Overall Study|Adverse Event|21|||
46674637|NCT01146652|82890264|FG001|Overall Study|Other unspecified reasons|22|||
46674638|NCT01146652|82890263|FG000|Overall Study|Enrolled but not treated|2|||
46674639|NCT01146652|82890264|FG001|Overall Study|Enrolled but not treated|0|||
46674640|NCT01146613|82890279|FG000|Overall Study|Lost to Follow-up|3|||
46674641|NCT01146613|82890280|FG001|Overall Study|Lost to Follow-up|8|||
46674642|NCT01146613|82890279|FG000|Overall Study|Lack of Efficacy|0|||
46674643|NCT01146613|82890280|FG001|Overall Study|Lack of Efficacy|1|||
46674644|NCT01146613|82890279|FG000|Overall Study|Death|1|||
46674645|NCT01146613|82890280|FG001|Overall Study|Death|0|||
46978849|NCT04478266|83224322|FG000|Overall Study|Progressive disease|146|||
46978850|NCT04478266|83224323|FG001|Overall Study|Progressive disease|168|||
46674646|NCT01146613|82890279|FG000|Overall Study|Physician Decision|1|||
46674647|NCT01146613|82890280|FG001|Overall Study|Physician Decision|0|||
46794894|NCT00483184|83013178|FG002|Overall Study|Protocol Violation|1|||
46674648|NCT01146613|82890279|FG000|Overall Study|Withdrawal by Subject|0|||
46794895|NCT00482170|83013188|FG000|Overall Study|Adverse Event|5|||
46794896|NCT00482170|83013189|FG001|Overall Study|Adverse Event|14|||
46794897|NCT00482170|83013188|FG000|Overall Study|Withdrawal by Subject|6|||
46794898|NCT00482170|83013189|FG001|Overall Study|Withdrawal by Subject|1|||
46794899|NCT00482170|83013188|FG000|Overall Study|Protocol Violation|2|||
46794900|NCT00482170|83013189|FG001|Overall Study|Protocol Violation|3|||
46794901|NCT00482170|83013188|FG000|Overall Study|Lost to Follow-up|2|||
46794902|NCT00482170|83013189|FG001|Overall Study|Lost to Follow-up|0|||
46794903|NCT00482170|83013188|FG000|Overall Study|Unspecified reason|0|||
46794904|NCT00482170|83013189|FG001|Overall Study|Unspecified reason|2|||
46794905|NCT03883113|83013197|FG000|Overall Study|Physician Decision|4|||
46794906|NCT03883113|83013198|FG001|Overall Study|Physician Decision|2|||
46794907|NCT03883113|83013197|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
46794908|NCT03883113|83013198|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
46794909|NCT03883113|83013197|FG000|Overall Study|Pregnancy|1|||
46674649|NCT01146613|82890280|FG001|Overall Study|Withdrawal by Subject|3|||
46794910|NCT03883113|83013198|FG001|Overall Study|Pregnancy|0|||
46674650|NCT01146613|82890279|FG000|Overall Study|schedule conflict|1|||
46794911|NCT03883113|83013197|FG000|Overall Study|Adverse Event|0|||
46794912|NCT03883113|83013198|FG001|Overall Study|Adverse Event|1|||
46674651|NCT01146613|82890280|FG001|Overall Study|schedule conflict|0|||
46674652|NCT01146613|82890279|FG000|Overall Study|Outpatient detox|1|||
46674653|NCT01146613|82890280|FG001|Overall Study|Outpatient detox|0|||
46674654|NCT01145755|82890289|FG000|Overall Study|Adverse Event|2|||
46674655|NCT01145755|82890290|FG001|Overall Study|Adverse Event|4|||
46794913|NCT03883113|83013197|FG000|Overall Study|Withdrawal by Subject|1|||
46794914|NCT03883113|83013198|FG001|Overall Study|Withdrawal by Subject|2|||
46794915|NCT03883113|83013197|FG000|Overall Study|Lost to Follow-up|1|||
46794916|NCT03883113|83013198|FG001|Overall Study|Lost to Follow-up|0|||
46794917|NCT04218695|83013220|FG000|Overall Study|Adverse Event|1|||
46794918|NCT04218695|83013221|FG001|Overall Study|Adverse Event|0|||
46794919|NCT00490282|83013227|FG000|Overall Study|Withdrawal by Subject|3|||
46794920|NCT00615056|83013236|FG000|Overall Study|Death|31|||
46794921|NCT00615056|83013237|FG001|Overall Study|Death|31|||
46794922|NCT00615056|83013238|FG002|Overall Study|Death|21|||
46794923|NCT00615056|83013239|FG003|Overall Study|Death|23|||
46794924|NCT00615056|83013236|FG000|Overall Study|Lost to Follow-up|1|||
46794925|NCT00615056|83013237|FG001|Overall Study|Lost to Follow-up|2|||
46794926|NCT00615056|83013238|FG002|Overall Study|Lost to Follow-up|4|||
46794927|NCT00615056|83013239|FG003|Overall Study|Lost to Follow-up|5|||
46794928|NCT00615056|83013236|FG000|Overall Study|Other|13|||
46794929|NCT00615056|83013237|FG001|Overall Study|Other|15|||
46794930|NCT00615056|83013238|FG002|Overall Study|Other|10|||
46794931|NCT00615056|83013239|FG003|Overall Study|Other|7|||
46794932|NCT00615056|83013236|FG000|Overall Study|Objective progression or relapse|0|||
46794933|NCT00615056|83013237|FG001|Overall Study|Objective progression or relapse|2|||
46794934|NCT00615056|83013238|FG002|Overall Study|Objective progression or relapse|0|||
46794935|NCT00615056|83013239|FG003|Overall Study|Objective progression or relapse|0|||
46794936|NCT00615056|83013236|FG000|Overall Study|Withdrawal by Subject|0|||
46794937|NCT00615056|83013237|FG001|Overall Study|Withdrawal by Subject|1|||
46794938|NCT00615056|83013238|FG002|Overall Study|Withdrawal by Subject|1|||
46794939|NCT00615056|83013239|FG003|Overall Study|Withdrawal by Subject|0|||
46794940|NCT00615056|83013236|FG000|Overall Study|Discontinued by Sponsor|1|||
46794941|NCT00615056|83013237|FG001|Overall Study|Discontinued by Sponsor|0|||
46794942|NCT00615056|83013238|FG002|Overall Study|Discontinued by Sponsor|0|||
46856318|NCT03797144|83072116|FG001|24 Month|Early termination cut-off date|1|||
46978851|NCT04478266|83224322|FG000|Overall Study|Poor compliance to protocol|1|||
46978852|NCT04478266|83224323|FG001|Overall Study|Poor compliance to protocol|0|||
46978853|NCT04478266|83224322|FG000|Overall Study|Withdrawal by Subject|19|||
46978854|NCT04478266|83224323|FG001|Overall Study|Withdrawal by Subject|16|||
46978855|NCT04478266|83224322|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
46978856|NCT04478266|83224323|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
46978857|NCT04478266|83224322|FG000|Overall Study|Study terminated by sponsor|33|||
46978858|NCT04478266|83224323|FG001|Overall Study|Study terminated by sponsor|35|||
46978859|NCT04478266|83224322|FG000|Overall Study|Other: unspecified|5|||
46978860|NCT04478266|83224323|FG001|Overall Study|Other: unspecified|7|||
46978861|NCT04478266|83224322|FG000|Overall Study|Randomized but not treated|1|||
46978862|NCT04478266|83224323|FG001|Overall Study|Randomized but not treated|1|||
46978863|NCT04233216|83224335|FG000|Overall Study|Lost to Follow-up|0|||
46978864|NCT04233216|83224336|FG001|Overall Study|Lost to Follow-up|0|||
46978865|NCT04233216|83224337|FG002|Overall Study|Lost to Follow-up|2|||
46794943|NCT00615056|83013239|FG003|Overall Study|Discontinued by Sponsor|0|||
47079869|NCT02623699|83387647|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079870|NCT02623699|83387648|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079871|NCT02623699|83387649|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
47079872|NCT02623699|83387650|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079873|NCT02623699|83387651|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079874|NCT02623699|83387652|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079875|NCT02623699|83387653|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079876|NCT02623699|83387654|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
46674656|NCT01145755|82890291|FG002|Overall Study|Adverse Event|2|||
46674657|NCT01145755|82890289|FG000|Overall Study|Withdrawal by Subject|2|||
46674658|NCT01145755|82890290|FG001|Overall Study|Withdrawal by Subject|2|||
46674659|NCT01145755|82890291|FG002|Overall Study|Withdrawal by Subject|2|||
46674660|NCT01145755|82890289|FG000|Overall Study|Lost to Follow-up|2|||
46674661|NCT01145755|82890290|FG001|Overall Study|Lost to Follow-up|3|||
46856319|NCT00347009|83072123|FG000|Overall Study|Death|1|||
46856320|NCT00347009|83072123|FG000|Overall Study|Adverse Event|6|||
46856321|NCT00347009|83072123|FG000|Overall Study|Withdrawal by Subject|3|||
46856322|NCT00347009|83072123|FG000|Overall Study|Physician Decision|5|||
46856323|NCT00347009|83072123|FG000|Overall Study|Lost to Follow-up|4|||
46856324|NCT00347009|83072123|FG000|Overall Study|Protocol Violation|2|||
46856325|NCT00347009|83072123|FG000|Overall Study|Adverse Laboratory Experience|1|||
46856326|NCT00347009|83072123|FG000|Overall Study|Insufficient Viral Suppression|3|||
46856327|NCT00347009|83072123|FG000|Overall Study|Increased ALT/HBV DNA|1|||
46856328|NCT00347009|83072123|FG000|Overall Study|Serious Adverse Event|1|||
46856329|NCT00346775|83072131|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
46856330|NCT00346775|83072132|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
46856331|NCT00346775|83072131|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
46856332|NCT00346775|83072132|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
46856333|NCT00346775|83072131|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
46856334|NCT00346775|83072132|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
46856335|NCT00346697|83072144|FG000|Overall Study|Lost to Follow-up|0|||
46856336|NCT00346697|83072145|FG001|Overall Study|Lost to Follow-up|1|||
46856337|NCT03400852|83072155|FG000|Blinded Treatment Period|Physician Decision|0|||
46856338|NCT03400852|83072156|FG001|Blinded Treatment Period|Physician Decision|1|||
46856339|NCT03400852|83072157|FG002|Blinded Treatment Period|Physician Decision|0|||
46856340|NCT03400852|83072155|FG000|Blinded Treatment Period|Adverse Event|1|||
46856341|NCT03400852|83072156|FG001|Blinded Treatment Period|Adverse Event|1|||
46856342|NCT03400852|83072157|FG002|Blinded Treatment Period|Adverse Event|0|||
46856343|NCT03400852|83072155|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
46856344|NCT03400852|83072156|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
46856345|NCT03400852|83072157|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
46856346|NCT03400852|83072155|FG000|Open Label Period|Physician Decision|0|||
46856347|NCT03400852|83072156|FG001|Open Label Period|Physician Decision|0|||
46856348|NCT03400852|83072157|FG002|Open Label Period|Physician Decision|1|||
46856349|NCT03400852|83072155|FG000|Open Label Period|Study terminated by sponsor|0|||
46856350|NCT03400852|83072156|FG001|Open Label Period|Study terminated by sponsor|0|||
46856351|NCT03400852|83072157|FG002|Open Label Period|Study terminated by sponsor|21|||
46856352|NCT03398356|83072168|FG000|Before Treatment|Lost to Follow-up|1|||
46856353|NCT03398356|83072169|FG001|Before Treatment|Lost to Follow-up|2|||
46856354|NCT03398356|83072170|FG002|Before Treatment|Lost to Follow-up|0|||
46856355|NCT03398356|83072168|FG000|Before Treatment|drug intolerance|2|||
46856356|NCT03398356|83072169|FG001|Before Treatment|drug intolerance|1|||
46856357|NCT03398356|83072170|FG002|Before Treatment|drug intolerance|0|||
46856358|NCT03398356|83072168|FG000|Before Treatment|Withdrawal by Subject|0|||
46856359|NCT03398356|83072169|FG001|Before Treatment|Withdrawal by Subject|5|||
46856360|NCT03398356|83072170|FG002|Before Treatment|Withdrawal by Subject|0|||
46856361|NCT03398356|83072168|FG000|Before Treatment|Physician Decision|0|||
46856362|NCT03398356|83072169|FG001|Before Treatment|Physician Decision|0|||
46856363|NCT03398356|83072170|FG002|Before Treatment|Physician Decision|11|||
46856364|NCT03398356|83072168|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
46856365|NCT03398356|83072169|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
46856366|NCT03398356|83072170|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
46856367|NCT00346151|83072178|FG000|Overall Study|Withdrawal by Subject|3|||
46674662|NCT01145755|82890291|FG002|Overall Study|Lost to Follow-up|1|||
46674663|NCT01145755|82890289|FG000|Overall Study|Protocol Violation|0|||
46674664|NCT01145755|82890290|FG001|Overall Study|Protocol Violation|3|||
46674665|NCT01145755|82890291|FG002|Overall Study|Protocol Violation|1|||
46674666|NCT01145755|82890289|FG000|Overall Study|Study Closure|14|||
46674667|NCT01145755|82890290|FG001|Overall Study|Study Closure|14|||
46674668|NCT01145755|82890291|FG002|Overall Study|Study Closure|17|||
46856368|NCT00130286|83072186|FG000|Overall Study|Withdrawal by Subject|0|||
46674669|NCT01145755|82890289|FG000|Overall Study|Lack of Efficacy|0|||
46674670|NCT01145755|82890290|FG001|Overall Study|Lack of Efficacy|1|||
46674671|NCT01145755|82890291|FG002|Overall Study|Lack of Efficacy|0|||
46674672|NCT01145755|82890289|FG000|Overall Study|Patient could not swollow medication|0|||
46674673|NCT01145755|82890290|FG001|Overall Study|Patient could not swollow medication|0|||
46674674|NCT01145755|82890291|FG002|Overall Study|Patient could not swollow medication|1|||
46674675|NCT01145755|82890289|FG000|Overall Study|Withdrawal by Subject|0|||
46674676|NCT01145755|82890290|FG001|Overall Study|Withdrawal by Subject|0|||
46856369|NCT00130286|83072187|FG001|Overall Study|Withdrawal by Subject|1|||
46856370|NCT00130286|83072188|FG002|Overall Study|Withdrawal by Subject|2|||
46674677|NCT01145755|82890291|FG002|Overall Study|Withdrawal by Subject|1|||
46674678|NCT01145755|82890289|FG000|Overall Study|Positive urine ethanol|0|||
46674679|NCT01145755|82890290|FG001|Overall Study|Positive urine ethanol|1|||
46674680|NCT01145755|82890291|FG002|Overall Study|Positive urine ethanol|0|||
46674681|NCT01145560|82890302|FG000|Overall Study|Withdrawal by Subject|2|||
46674682|NCT01145560|82890303|FG001|Overall Study|Withdrawal by Subject|1|||
46674683|NCT01145560|82890304|FG002|Overall Study|Withdrawal by Subject|0|||
46674684|NCT01145560|82890302|FG000|Overall Study|Lost to Follow-up|1|||
46674685|NCT01145560|82890303|FG001|Overall Study|Lost to Follow-up|1|||
46674686|NCT01145560|82890304|FG002|Overall Study|Lost to Follow-up|1|||
46674687|NCT01145560|82890302|FG000|Overall Study|No study drug by 24h after organ failure|1|||
46674688|NCT01145560|82890303|FG001|Overall Study|No study drug by 24h after organ failure|0|||
46674689|NCT01145560|82890304|FG002|Overall Study|No study drug by 24h after organ failure|0|||
46674690|NCT01145560|82890302|FG000|Overall Study|Accidental unblinding of study treatment|0|||
46674691|NCT01145560|82890303|FG001|Overall Study|Accidental unblinding of study treatment|1|||
46794944|NCT00615056|83013236|FG000|Overall Study|Randomized but not treated|3|||
46856371|NCT00130286|83072189|FG003|Overall Study|Withdrawal by Subject|2|||
46674692|NCT01145560|82890304|FG002|Overall Study|Accidental unblinding of study treatment|0|||
46978866|NCT04233216|83224338|FG003|Overall Study|Lost to Follow-up|0|||
46978867|NCT04233216|83224335|FG000|Overall Study|Physician Decision|0|||
46978868|NCT04233216|83224336|FG001|Overall Study|Physician Decision|1|||
46978869|NCT04233216|83224337|FG002|Overall Study|Physician Decision|0|||
46978870|NCT04233216|83224338|FG003|Overall Study|Physician Decision|0|||
46978871|NCT04233216|83224335|FG000|Overall Study|Withdrawal by Subject|0|||
46674693|NCT01145560|82890302|FG000|Overall Study|False insurance information|0|||
46856372|NCT00130286|83072186|FG000|Overall Study|Adverse Event|0|||
46978872|NCT04233216|83224336|FG001|Overall Study|Withdrawal by Subject|1|||
46978873|NCT04233216|83224337|FG002|Overall Study|Withdrawal by Subject|1|||
46978874|NCT04233216|83224338|FG003|Overall Study|Withdrawal by Subject|0|||
46978875|NCT04233216|83224335|FG000|Overall Study|Ongoing participation in study|7|||
46978876|NCT04233216|83224336|FG001|Overall Study|Ongoing participation in study|12|||
46978877|NCT04233216|83224337|FG002|Overall Study|Ongoing participation in study|4|||
46978878|NCT04233216|83224338|FG003|Overall Study|Ongoing participation in study|7|||
46978879|NCT04173507|83224349|FG000|Overall Study|On Treatment|3|||
46978880|NCT04173507|83224349|FG000|Overall Study|Adverse Event|3|||
46674694|NCT01145560|82890303|FG001|Overall Study|False insurance information|1|||
46674695|NCT01145560|82890304|FG002|Overall Study|False insurance information|0|||
46674696|NCT01145560|82890302|FG000|Overall Study|Withdrawal of therapy|0|||
46674697|NCT01145560|82890303|FG001|Overall Study|Withdrawal of therapy|0|||
46674698|NCT01145560|82890304|FG002|Overall Study|Withdrawal of therapy|1|||
46674699|NCT01145482|82890314|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
46674700|NCT01145482|82890315|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
46978881|NCT04173507|83224349|FG000|Overall Study|Progression/Relapse|34|||
46674701|NCT01145053|82890321|FG000|Overall Study|Adverse Event|22|||
46674702|NCT01145053|82890321|FG000|Overall Study|Lost to Follow-up|28|||
46674703|NCT01145053|82890321|FG000|Overall Study|Withdrawal by Subject|25|||
46674704|NCT01145053|82890321|FG000|Overall Study|Other|18|||
46674705|NCT01144663|82890329|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
46674706|NCT01144663|82890330|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
46674707|NCT01144663|82890331|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
46674708|NCT01144663|82890332|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
46674709|NCT01144663|82890329|FG000|Primary Vaccination Phase|Adverse Event|1|||
46674710|NCT01144663|82890330|FG001|Primary Vaccination Phase|Adverse Event|0|||
46856373|NCT00130286|83072187|FG001|Overall Study|Adverse Event|0|||
46674711|NCT01144663|82890331|FG002|Primary Vaccination Phase|Adverse Event|0|||
46856374|NCT00130286|83072188|FG002|Overall Study|Adverse Event|2|||
46856375|NCT00130286|83072189|FG003|Overall Study|Adverse Event|0|||
46674712|NCT01144663|82890332|FG003|Primary Vaccination Phase|Adverse Event|1|||
46674713|NCT01144663|82890329|FG000|Primary Vaccination Phase|Protocol Violation|2|||
46674714|NCT01144663|82890330|FG001|Primary Vaccination Phase|Protocol Violation|0|||
46674715|NCT01144663|82890331|FG002|Primary Vaccination Phase|Protocol Violation|1|||
46674716|NCT01144663|82890332|FG003|Primary Vaccination Phase|Protocol Violation|0|||
46674717|NCT01144663|82890329|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
46674718|NCT01144663|82890330|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
46674719|NCT01144663|82890331|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
46674720|NCT01144663|82890332|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
46674721|NCT01144663|82890329|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
46674722|NCT01144663|82890330|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
46674723|NCT01144663|82890331|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
46674724|NCT01144663|82890332|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
46674725|NCT01144663|82890329|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
46674726|NCT01144663|82890330|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
46674727|NCT01144663|82890331|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
46674728|NCT01144663|82890332|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
46674729|NCT01144663|82890329|FG000|Primary Vaccination Phase|Other|0|||
46674730|NCT01144663|82890330|FG001|Primary Vaccination Phase|Other|1|||
46674731|NCT01144663|82890331|FG002|Primary Vaccination Phase|Other|0|||
46674732|NCT01144663|82890332|FG003|Primary Vaccination Phase|Other|2|||
46674733|NCT01144663|82890329|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
46674734|NCT01144663|82890330|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
46674735|NCT01144663|82890331|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
46674736|NCT01144663|82890332|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
46674737|NCT01144663|82890329|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
46674738|NCT01144663|82890330|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
46674739|NCT01144663|82890331|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
46674740|NCT01144663|82890332|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
46674741|NCT01144663|82890329|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
46674742|NCT01144663|82890330|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
46674743|NCT01144663|82890331|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
46674744|NCT01144663|82890332|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
46674745|NCT01144663|82890329|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
46674746|NCT01144663|82890330|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
46674747|NCT01144663|82890331|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
46674748|NCT01144663|82890332|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
46674749|NCT01144663|82890329|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
46674750|NCT01144663|82890330|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
46674751|NCT01144663|82890331|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
46674752|NCT01144663|82890332|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
46674753|NCT01144663|82890329|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
46674754|NCT01144663|82890330|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
46674755|NCT01144663|82890331|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
46674756|NCT01144663|82890332|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
46674757|NCT01143337|82890344|FG000|Overall Study|Adverse Event|3|||
46674758|NCT01143337|82890345|FG001|Overall Study|Adverse Event|9|||
46674759|NCT01143337|82890346|FG002|Overall Study|Adverse Event|5|||
46674760|NCT01143337|82890344|FG000|Overall Study|Lack of Efficacy|6|||
46674761|NCT01143337|82890345|FG001|Overall Study|Lack of Efficacy|2|||
46674762|NCT01143337|82890346|FG002|Overall Study|Lack of Efficacy|1|||
46674763|NCT01143337|82890344|FG000|Overall Study|Protocol Violation|1|||
46674764|NCT01143337|82890345|FG001|Overall Study|Protocol Violation|0|||
46674765|NCT01143337|82890346|FG002|Overall Study|Protocol Violation|0|||
46674766|NCT01143337|82890344|FG000|Overall Study|Withdrawal by Subject|0|||
46674767|NCT01143337|82890345|FG001|Overall Study|Withdrawal by Subject|0|||
46674768|NCT01143337|82890346|FG002|Overall Study|Withdrawal by Subject|1|||
46674769|NCT01143337|82890344|FG000|Overall Study|Other reason|0|||
46674770|NCT01143337|82890345|FG001|Overall Study|Other reason|0|||
46674771|NCT01143337|82890346|FG002|Overall Study|Other reason|5|||
46674772|NCT01143259|82890363|FG000|Overall Study|Withdrawal by Subject|3|||
46674773|NCT01143259|82890364|FG001|Overall Study|Withdrawal by Subject|2|||
46674774|NCT01143259|82890363|FG000|Overall Study|Protocol Violation|13|||
46674775|NCT01143259|82890364|FG001|Overall Study|Protocol Violation|9|||
46674776|NCT01143259|82890363|FG000|Overall Study|Screen Failure|7|||
46674777|NCT01143259|82890364|FG001|Overall Study|Screen Failure|9|||
46674778|NCT01142791|82890370|FG000|Overall Study|Alternative Treatment|1|||
46674779|NCT01142791|82890371|FG001|Overall Study|Alternative Treatment|0|||
46674780|NCT01142791|82890370|FG000|Overall Study|Lost to Follow-up|1|||
46674781|NCT01142791|82890371|FG001|Overall Study|Lost to Follow-up|0|||
46856376|NCT00130286|83072186|FG000|Overall Study|Missing lab specimens|0|||
46856377|NCT00130286|83072187|FG001|Overall Study|Missing lab specimens|2|||
46856378|NCT00130286|83072188|FG002|Overall Study|Missing lab specimens|0|||
46856379|NCT00130286|83072189|FG003|Overall Study|Missing lab specimens|0|||
46978882|NCT04173507|83224349|FG000|Overall Study|Death|2|||
46856380|NCT00346073|83072201|FG000|Overall Study|Serious Adverse Event|2|||
46978883|NCT03971474|83224355|FG000|Overall Study|Adverse Event|11|||
46674782|NCT01142791|82890370|FG000|Overall Study|Withdrawal by Subject|5|||
46674783|NCT01142791|82890371|FG001|Overall Study|Withdrawal by Subject|0|||
46674784|NCT01142791|82890370|FG000|Overall Study|Received only 1 sonication|0|||
46978884|NCT03971474|83224356|FG001|Overall Study|Adverse Event|7|||
46674785|NCT01142791|82890371|FG001|Overall Study|Received only 1 sonication|6|||
46674786|NCT01142596|82890377|FG000|Overall Study|Withdrawal by Subject|9|||
46978885|NCT03971474|83224355|FG000|Overall Study|Refusal unrelated to adverse event|5|||
46978886|NCT03971474|83224356|FG001|Overall Study|Refusal unrelated to adverse event|1|||
46978887|NCT03971474|83224355|FG000|Overall Study|Progression/relapse|40|||
46978888|NCT03971474|83224356|FG001|Overall Study|Progression/relapse|47|||
46978889|NCT03971474|83224355|FG000|Overall Study|Death|6|||
46978890|NCT03971474|83224356|FG001|Overall Study|Death|3|||
46856381|NCT00346073|83072202|FG001|Overall Study|Serious Adverse Event|0|||
46978891|NCT03971474|83224355|FG000|Overall Study|Other - not protocol specified|5|||
46674787|NCT01142596|82890378|FG001|Overall Study|Withdrawal by Subject|35|||
46674788|NCT01142596|82890377|FG000|Overall Study|Adverse Event|8|||
46674789|NCT01142596|82890378|FG001|Overall Study|Adverse Event|35|||
46674790|NCT01142596|82890377|FG000|Overall Study|Lack of Efficacy|5|||
46674791|NCT01142596|82890378|FG001|Overall Study|Lack of Efficacy|9|||
46856382|NCT00346073|83072201|FG000|Overall Study|Lost to Follow-up|39|||
46674792|NCT01142596|82890377|FG000|Overall Study|Lost to Follow-up|2|||
46674793|NCT01142596|82890378|FG001|Overall Study|Lost to Follow-up|3|||
46674794|NCT01142596|82890377|FG000|Overall Study|Other reason (not specified)|5|||
46674795|NCT01142596|82890378|FG001|Overall Study|Other reason (not specified)|4|||
46674796|NCT01142128|82890388|FG000|Overall Study|Physician Decision|1|||
46674797|NCT01142128|82890388|FG000|Overall Study|Lost to Follow-up|1|||
46674798|NCT01142128|82890388|FG000|Overall Study|Withdrawal by Subject|2|||
46674799|NCT01142089|82890400|FG000|Overall Study|Physician Decision|1|||
46674800|NCT01142089|82890401|FG001|Overall Study|Physician Decision|0|||
46674801|NCT01142089|82890400|FG000|Overall Study|Withdrawal by Subject|1|||
46674802|NCT01142089|82890401|FG001|Overall Study|Withdrawal by Subject|2|||
46674803|NCT01142089|82890400|FG000|Overall Study|Use of prohibited medications|0|||
46674804|NCT01142089|82890401|FG001|Overall Study|Use of prohibited medications|1|||
46674805|NCT01142089|82890400|FG000|Overall Study|Noncompliance with study procedures|2|||
46674806|NCT01142089|82890401|FG001|Overall Study|Noncompliance with study procedures|1|||
46674807|NCT01142089|82890400|FG000|Overall Study|Patient required rescue medication|8|||
46674808|NCT01142089|82890401|FG001|Overall Study|Patient required rescue medication|17|||
46674809|NCT01141660|82890409|FG000|Overall Study|Physician Decision|0|||
46674810|NCT01141660|82890410|FG001|Overall Study|Physician Decision|12|||
46674811|NCT01140880|82890418|FG000|Overall Study|Death|0|||
46674812|NCT01140880|82890419|FG001|Overall Study|Death|1|||
46674813|NCT01140880|82890418|FG000|Overall Study|Withdrawal by Subject|6|||
46674814|NCT01140880|82890419|FG001|Overall Study|Withdrawal by Subject|3|||
46674815|NCT01140880|82890418|FG000|Overall Study|Lost to Follow-up|8|||
46674816|NCT01140880|82890419|FG001|Overall Study|Lost to Follow-up|10|||
46674817|NCT01140880|82890418|FG000|Overall Study|Protocol Violation|0|||
46674818|NCT01140880|82890419|FG001|Overall Study|Protocol Violation|30|||
46674819|NCT01140646|82890425|FG000|Overall Study|Adverse Event|4|||
46674820|NCT01140646|82890425|FG000|Overall Study|Refused Further Treatment|5|||
46674821|NCT01140568|82890429|FG000|Overall Study|disease progression|31|||
46674822|NCT01140568|82890429|FG000|Overall Study|Withdrawal by Subject|1|||
46674823|NCT01140568|82890429|FG000|Overall Study|Screen Fail|4|||
46674824|NCT01140451|82890435|FG000|Overall Study|Withdrawal by Subject|26|||
46674825|NCT01140451|82890436|FG001|Overall Study|Withdrawal by Subject|33|||
46674826|NCT01140451|82890435|FG000|Overall Study|Adverse Event|2|||
46674827|NCT01140451|82890436|FG001|Overall Study|Adverse Event|6|||
46674828|NCT01140451|82890435|FG000|Overall Study|Physician Decision|5|||
46674829|NCT01140451|82890436|FG001|Overall Study|Physician Decision|3|||
46978892|NCT03971474|83224356|FG001|Overall Study|Other - not protocol specified|4|||
46674830|NCT01140451|82890435|FG000|Overall Study|Lost to Follow-up|2|||
46674831|NCT01140451|82890436|FG001|Overall Study|Lost to Follow-up|0|||
46674832|NCT01140451|82890435|FG000|Overall Study|Participants Planning Pregnancy|3|||
46674833|NCT01140451|82890436|FG001|Overall Study|Participants Planning Pregnancy|0|||
46674834|NCT01140061|82890453|FG000|Part I|Adverse Event|1|||
46674835|NCT01140061|82890454|FG001|Part I|Adverse Event|0|||
46674836|NCT01140061|82890455|FG002|Part I|Adverse Event|0|||
46674837|NCT01140061|82890456|FG003|Part I|Adverse Event|0|||
46674838|NCT01140061|82890457|FG004|Part I|Adverse Event|0|||
46674839|NCT01140061|82890458|FG005|Part I|Adverse Event|0|||
46674840|NCT01140061|82890459|FG006|Part I|Adverse Event|0|||
46674841|NCT01140061|82890460|FG007|Part I|Adverse Event|0|||
46674842|NCT01140061|82890461|FG008|Part I|Adverse Event|0|||
46674843|NCT01140061|82890462|FG009|Part I|Adverse Event|0|||
46674844|NCT01140061|82890453|FG000|Extension|Laboratory Adverse Event|0|||
46674845|NCT01140061|82890454|FG001|Extension|Laboratory Adverse Event|0|||
46674846|NCT01140061|82890455|FG002|Extension|Laboratory Adverse Event|0|||
46674847|NCT01140061|82890456|FG003|Extension|Laboratory Adverse Event|0|||
46674848|NCT01140061|82890457|FG004|Extension|Laboratory Adverse Event|0|||
46674849|NCT01140061|82890458|FG005|Extension|Laboratory Adverse Event|0|||
46674850|NCT01140061|82890459|FG006|Extension|Laboratory Adverse Event|0|||
46674851|NCT01140061|82890460|FG007|Extension|Laboratory Adverse Event|0|||
46674852|NCT01140061|82890461|FG008|Extension|Laboratory Adverse Event|0|||
46674853|NCT01140061|82890462|FG009|Extension|Laboratory Adverse Event|1|||
46674854|NCT01139164|82890480|FG000|Overall Study|Withdrawn prior to study start|0|||
46674855|NCT01139164|82890481|FG001|Overall Study|Withdrawn prior to study start|2|||
46674856|NCT01139164|82890482|FG002|Overall Study|Withdrawn prior to study start|0|||
46674857|NCT01139125|82890490|FG000|Overall Study|Withdrawal by Subject|1|||
46674858|NCT01139047|82890494|FG000|Overall Study|Withdrawal by Subject|1|||
46674859|NCT01139008|82890501|FG000|Overall Study|Withdrawal by Subject|5|||
46674860|NCT01139008|82890501|FG000|Overall Study|Non-compliant, lost product|1|||
46674861|NCT01138657|82890510|FG000|Overall Study|Adverse Event|3|||
46674862|NCT01138657|82890511|FG001|Overall Study|Adverse Event|10|||
46674863|NCT01138657|82890510|FG000|Overall Study|Lack of Efficacy|2|||
46674864|NCT01138657|82890511|FG001|Overall Study|Lack of Efficacy|1|||
46674865|NCT01138657|82890510|FG000|Overall Study|Lost to Follow-up|0|||
46674866|NCT01138657|82890511|FG001|Overall Study|Lost to Follow-up|3|||
46674867|NCT01138657|82890510|FG000|Overall Study|Miscellaneous Reasons|3|||
46674868|NCT01138657|82890511|FG001|Overall Study|Miscellaneous Reasons|4|||
46674869|NCT01138501|82890519|FG000|Overall Study|Protocol Violation|2|||
46674870|NCT01138501|82890519|FG000|Overall Study|Withdrawal by Subject|3|||
46674871|NCT01138150|82890525|FG000|Overall Study|blood unable to be processed|0|||
46674872|NCT01138150|82890526|FG001|Overall Study|blood unable to be processed|1|||
46674873|NCT01138150|82890525|FG000|Overall Study|Physician Decision|1|||
46674874|NCT01138150|82890526|FG001|Overall Study|Physician Decision|0|||
46674875|NCT01138111|82890542|FG000|Overall Study|Withdrawal by Subject|5|||
46674876|NCT01138111|82890542|FG000|Overall Study|Adverse Event|1|||
46674877|NCT01138111|82890542|FG000|Overall Study|Death|1|||
46674878|NCT01138111|82890542|FG000|Overall Study|Lost to Follow-up|2|||
46674879|NCT01137955|82890573|FG000|Overall Study|Withdrawal by Subject|5|||
46674880|NCT01137955|82890574|FG001|Overall Study|Withdrawal by Subject|4|||
46674881|NCT01137682|82890584|FG000|Overall Study|Adverse Event-CORE|2|||
46674882|NCT01137682|82890585|FG001|Overall Study|Adverse Event-CORE|4|||
46978893|NCT03971474|83224355|FG000|Overall Study|On treatment|0|||
46978894|NCT03971474|83224356|FG001|Overall Study|On treatment|7|||
46978895|NCT03901079|83224363|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
46978896|NCT03845296|83224369|FG000|Overall Study|On Treatment|2|||
46978897|NCT03845296|83224370|FG001|Overall Study|On Treatment|1|||
46978898|NCT03845296|83224369|FG000|Overall Study|Adverse Event|4|||
46674883|NCT01137682|82890586|FG002|Overall Study|Adverse Event-CORE|0|||
46674884|NCT01137682|82890584|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
46674885|NCT01137682|82890585|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
46674886|NCT01137682|82890586|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
46978899|NCT03845296|83224370|FG001|Overall Study|Adverse Event|11|||
46978900|NCT03845296|83224369|FG000|Overall Study|Refusal unrelated to adverse event|0|||
46978901|NCT03845296|83224370|FG001|Overall Study|Refusal unrelated to adverse event|1|||
46978902|NCT03845296|83224369|FG000|Overall Study|Progression/relapse|14|||
46978903|NCT03845296|83224370|FG001|Overall Study|Progression/relapse|18|||
46978904|NCT03845296|83224369|FG000|Overall Study|Death|4|||
46978905|NCT03845296|83224370|FG001|Overall Study|Death|0|||
46978906|NCT03845296|83224369|FG000|Overall Study|Other - not protocol specified|1|||
46674887|NCT01137682|82890584|FG000|Overall Study|Administrative problems-CORE|2|||
46978907|NCT03845296|83224370|FG001|Overall Study|Other - not protocol specified|3|||
46978908|NCT03841448|83224378|FG000|Double Blind Treatment Period|Death|1|||
46978909|NCT03841448|83224379|FG001|Double Blind Treatment Period|Death|1|||
46978910|NCT03841448|83224380|FG002|Double Blind Treatment Period|Death|0|||
46978911|NCT03841448|83224381|FG003|Double Blind Treatment Period|Death|0|||
46978912|NCT03841448|83224378|FG000|Open-Label Extension Period|Participants Stopped Participation in the Study|0|||
46978913|NCT03841448|83224379|FG001|Open-Label Extension Period|Participants Stopped Participation in the Study|0|||
46856383|NCT00346073|83072202|FG001|Overall Study|Lost to Follow-up|24|||
46856384|NCT03374488|83072210|FG000|Overall Study|Death|13|||
46856385|NCT03374488|83072211|FG001|Overall Study|Death|13|||
46674888|NCT01137682|82890585|FG001|Overall Study|Administrative problems-CORE|1|||
46674889|NCT01137682|82890586|FG002|Overall Study|Administrative problems-CORE|0|||
46674890|NCT01137682|82890584|FG000|Overall Study|Protocol Violation-CORE|0|||
46674891|NCT01137682|82890585|FG001|Overall Study|Protocol Violation-CORE|1|||
46674892|NCT01137682|82890586|FG002|Overall Study|Protocol Violation-CORE|1|||
46674893|NCT01137682|82890584|FG000|Overall Study|Adverse Event-Extension|4|||
46674894|NCT01137682|82890585|FG001|Overall Study|Adverse Event-Extension|8|||
46674895|NCT01137682|82890586|FG002|Overall Study|Adverse Event-Extension|7|||
46674896|NCT01137682|82890584|FG000|Overall Study|Lack of Efficacy-Extension|15|||
46674897|NCT01137682|82890585|FG001|Overall Study|Lack of Efficacy-Extension|9|||
46674898|NCT01137682|82890586|FG002|Overall Study|Lack of Efficacy-Extension|13|||
46674899|NCT01137682|82890584|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
46674900|NCT01137682|82890585|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
46674901|NCT01137682|82890586|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
46674902|NCT01137682|82890584|FG000|Overall Study|Lost to Follow Up-Extension|0|||
46674903|NCT01137682|82890585|FG001|Overall Study|Lost to Follow Up-Extension|1|||
46674904|NCT01137682|82890586|FG002|Overall Study|Lost to Follow Up-Extension|0|||
46674905|NCT01137682|82890584|FG000|Overall Study|Administrative problems-Extension|0|||
46674906|NCT01137682|82890585|FG001|Overall Study|Administrative problems-Extension|2|||
46674907|NCT01137682|82890586|FG002|Overall Study|Administrative problems-Extension|0|||
46674908|NCT01137682|82890584|FG000|Overall Study|Death-Extension|2|||
46674909|NCT01137682|82890585|FG001|Overall Study|Death-Extension|0|||
46674910|NCT01137682|82890586|FG002|Overall Study|Death-Extension|0|||
46674911|NCT01137682|82890584|FG000|Overall Study|Protocol Violation-Extension|2|||
46674912|NCT01137682|82890585|FG001|Overall Study|Protocol Violation-Extension|1|||
46674913|NCT01137682|82890586|FG002|Overall Study|Protocol Violation-Extension|0|||
46674914|NCT01137682|82890584|FG000|Overall Study|Did not enter extension|2|||
46674915|NCT01137682|82890585|FG001|Overall Study|Did not enter extension|3|||
46978914|NCT03841448|83224380|FG002|Open-Label Extension Period|Participants Stopped Participation in the Study|1|||
46978915|NCT03841448|83224381|FG003|Open-Label Extension Period|Participants Stopped Participation in the Study|1|||
46674916|NCT01137682|82890586|FG002|Overall Study|Did not enter extension|2|||
46674917|NCT01137682|82890584|FG000|Overall Study|Did not receive treatment in extension|0|||
46978916|NCT03841448|83224378|FG000|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|0|||
46674918|NCT01137682|82890585|FG001|Overall Study|Did not receive treatment in extension|0|||
46674919|NCT01137682|82890586|FG002|Overall Study|Did not receive treatment in extension|1|||
46674920|NCT03452397|82890602|FG000|Overall Study|Adverse Event|1|||
46674921|NCT03452397|82890603|FG001|Overall Study|Adverse Event|0|||
46674922|NCT03452397|82890604|FG002|Overall Study|Adverse Event|0|||
46674923|NCT03452397|82890605|FG003|Overall Study|Adverse Event|0|||
46674924|NCT03452397|82890602|FG000|Overall Study|Administrative reason|0|||
46674925|NCT03452397|82890603|FG001|Overall Study|Administrative reason|0|||
46674926|NCT03452397|82890604|FG002|Overall Study|Administrative reason|1|||
46674927|NCT03452397|82890605|FG003|Overall Study|Administrative reason|1|||
46674928|NCT03452397|82890602|FG000|Overall Study|Withdrawal by Subject|0|||
46674929|NCT03452397|82890603|FG001|Overall Study|Withdrawal by Subject|0|||
46674930|NCT03452397|82890604|FG002|Overall Study|Withdrawal by Subject|1|||
46674931|NCT03452397|82890605|FG003|Overall Study|Withdrawal by Subject|0|||
46674932|NCT00199875|82890639|FG000|Overall Study|Withdrawal by Subject|0|||
46674933|NCT00199875|82890640|FG001|Overall Study|Withdrawal by Subject|0|||
46674934|NCT00199875|82890641|FG002|Overall Study|Withdrawal by Subject|0|||
46674935|NCT00199875|82890642|FG003|Overall Study|Withdrawal by Subject|0|||
46674936|NCT00199875|82890643|FG004|Overall Study|Withdrawal by Subject|1|||
46674937|NCT00199836|82890655|FG000|Overall Study|Progressive Disease|5|||
46674938|NCT00199836|82890655|FG000|Overall Study|Death|1|||
46674939|NCT00199797|82890660|FG000|Overall Study|Progressive Disease|1|||
46674940|NCT00199797|82890660|FG000|Overall Study|Adverse Event|1|||
46674941|NCT00199797|82890660|FG000|Overall Study|Physician Decision|1|||
46674942|NCT01137604|82890669|FG000|Overall Study|Adverse Event|3|||
46674943|NCT01137604|82890670|FG001|Overall Study|Adverse Event|6|||
46674944|NCT01137604|82890671|FG002|Overall Study|Adverse Event|9|||
46674945|NCT01137604|82890672|FG003|Overall Study|Adverse Event|9|||
46674946|NCT01137604|82890669|FG000|Overall Study|Participant Choice|0|||
46674947|NCT01137604|82890670|FG001|Overall Study|Participant Choice|2|||
46674948|NCT01137604|82890671|FG002|Overall Study|Participant Choice|2|||
46674949|NCT01137604|82890672|FG003|Overall Study|Participant Choice|0|||
46674950|NCT01137604|82890669|FG000|Overall Study|Withdrawal of consent|0|||
46674951|NCT01137604|82890670|FG001|Overall Study|Withdrawal of consent|0|||
46674952|NCT01137604|82890671|FG002|Overall Study|Withdrawal of consent|0|||
46674953|NCT01137604|82890672|FG003|Overall Study|Withdrawal of consent|2|||
46674954|NCT01137604|82890669|FG000|Overall Study|Clinical progression/deterioration|1|||
46674955|NCT01137604|82890670|FG001|Overall Study|Clinical progression/deterioration|2|||
46794945|NCT00615056|83013237|FG001|Overall Study|Randomized but not treated|0|||
46794946|NCT00615056|83013238|FG002|Overall Study|Randomized but not treated|0|||
46794947|NCT00615056|83013239|FG003|Overall Study|Randomized but not treated|0|||
46794948|NCT00482014|83013253|FG000|Overall Study|Withdrawal by Subject|1|||
46794949|NCT00482014|83013254|FG001|Overall Study|Withdrawal by Subject|2|||
46794950|NCT00482014|83013255|FG002|Overall Study|Withdrawal by Subject|3|||
46794951|NCT00482014|83013256|FG003|Overall Study|Withdrawal by Subject|4|||
46978917|NCT03841448|83224379|FG001|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|0|||
46978918|NCT03841448|83224380|FG002|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|7|||
46674956|NCT01137604|82890671|FG002|Overall Study|Clinical progression/deterioration|2|||
46674957|NCT01137604|82890672|FG003|Overall Study|Clinical progression/deterioration|0|||
46674958|NCT00198822|82890685|FG000|Overall Study|Lost to Follow-up|14|||
46674959|NCT00198822|82890686|FG001|Overall Study|Lost to Follow-up|20|||
46674960|NCT00198822|82890687|FG002|Overall Study|Lost to Follow-up|21|||
46794952|NCT00482014|83013253|FG000|Overall Study|Adverse Event|3|||
46794953|NCT00482014|83013254|FG001|Overall Study|Adverse Event|0|||
46674961|NCT01137292|82890695|FG000|Overall Study|Death|30|||
46674962|NCT01137292|82890695|FG000|Overall Study|Adverse Event|3|||
46674963|NCT01137292|82890695|FG000|Overall Study|Lack of Efficacy|13|||
46674964|NCT01137292|82890695|FG000|Overall Study|Lost to Follow-up|1|||
46674965|NCT01137292|82890695|FG000|Overall Study|Other|7|||
46794954|NCT00482014|83013255|FG002|Overall Study|Adverse Event|2|||
46674966|NCT00197496|82890701|FG000|Baseline to Discharge|not interested|1|||
46794955|NCT00482014|83013256|FG003|Overall Study|Adverse Event|8|||
46794956|NCT00482014|83013253|FG000|Overall Study|Death|1|||
46794957|NCT00482014|83013254|FG001|Overall Study|Death|2|||
46794958|NCT00482014|83013255|FG002|Overall Study|Death|1|||
46794959|NCT00482014|83013256|FG003|Overall Study|Death|4|||
46794960|NCT00482014|83013253|FG000|Overall Study|Lack of Efficacy|1|||
46794961|NCT00482014|83013254|FG001|Overall Study|Lack of Efficacy|0|||
46978919|NCT03841448|83224381|FG003|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|19|||
46978920|NCT03382782|83224392|FG000|Cohort 1|Withdrawal by Subject|11|||
46978921|NCT03382782|83224393|FG001|Cohort 1|Withdrawal by Subject|5|||
46978922|NCT03382782|83224394|FG002|Cohort 1|Withdrawal by Subject|0|||
46978923|NCT03382782|83224392|FG000|Cohort 2|Withdrawal by Subject|1|||
46978924|NCT03382782|83224393|FG001|Cohort 2|Withdrawal by Subject|1|||
46674967|NCT00197496|82890702|FG001|Baseline to Discharge|not interested|0|||
46674968|NCT00197496|82890701|FG000|Baseline to Discharge|MRSA|1|||
46674969|NCT00197496|82890702|FG001|Baseline to Discharge|MRSA|0|||
46674970|NCT00197496|82890701|FG000|Baseline to Discharge|Physician Decision|0|||
46794962|NCT00482014|83013255|FG002|Overall Study|Lack of Efficacy|4|||
46794963|NCT00482014|83013256|FG003|Overall Study|Lack of Efficacy|6|||
46794964|NCT00482014|83013253|FG000|Overall Study|Sponsor Decision|1|||
46794965|NCT00482014|83013254|FG001|Overall Study|Sponsor Decision|2|||
46794966|NCT00482014|83013255|FG002|Overall Study|Sponsor Decision|1|||
46794967|NCT00482014|83013256|FG003|Overall Study|Sponsor Decision|1|||
46978925|NCT03382782|83224394|FG002|Cohort 2|Withdrawal by Subject|0|||
46978926|NCT03382782|83224392|FG000|Cohort 3|Withdrawal by Subject|1|||
46978927|NCT03382782|83224393|FG001|Cohort 3|Withdrawal by Subject|2|||
46978928|NCT03382782|83224394|FG002|Cohort 3|Withdrawal by Subject|0|||
46978929|NCT02876328|83224441|FG000|Overall Study|Death|2|||
46978930|NCT02876328|83224442|FG001|Overall Study|Death|1|||
46978931|NCT02876328|83224443|FG002|Overall Study|Death|3|||
46978932|NCT02876328|83224444|FG003|Overall Study|Death|0|||
46978933|NCT02876328|83224445|FG004|Overall Study|Death|0|||
46978934|NCT02876328|83224446|FG005|Overall Study|Death|0|||
46978935|NCT02876328|83224447|FG006|Overall Study|Death|1|||
46978936|NCT02876328|83224448|FG007|Overall Study|Death|3|||
46978937|NCT02876328|83224449|FG008|Overall Study|Death|0|||
46978938|NCT02876328|83224450|FG009|Overall Study|Death|1|||
46978939|NCT02876328|83224451|FG010|Overall Study|Death|1|||
46674971|NCT00197496|82890702|FG001|Baseline to Discharge|Physician Decision|1|||
46674972|NCT00197496|82890701|FG000|Baseline to Discharge|Protocol Violation|0|||
46674973|NCT00197496|82890702|FG001|Baseline to Discharge|Protocol Violation|1|||
46674974|NCT00197496|82890701|FG000|Follow-up|Lost to Follow-up|2|||
46674975|NCT00197496|82890702|FG001|Follow-up|Lost to Follow-up|1|||
46674976|NCT00197145|82890710|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
46674977|NCT00197145|82890711|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
46674978|NCT00197145|82890710|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
46674979|NCT00197145|82890711|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
46674980|NCT00197145|82890710|FG000|Period 1: Randomized Treatment Phase|Other|2|||
46674981|NCT00197145|82890711|FG001|Period 1: Randomized Treatment Phase|Other|2|||
46674982|NCT00197145|82890710|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
46674983|NCT00197145|82890711|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
46674984|NCT00197145|82890710|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
46674985|NCT00197145|82890711|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
46674986|NCT00197145|82890710|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
46978940|NCT02876328|83224452|FG011|Overall Study|Death|0|||
46978941|NCT02876328|83224453|FG012|Overall Study|Death|0|||
46978942|NCT02876328|83224454|FG013|Overall Study|Death|0|||
46978943|NCT02876328|83224455|FG014|Overall Study|Death|0|||
46978944|NCT02876328|83224456|FG015|Overall Study|Death|0|||
46674987|NCT00197145|82890711|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
46674988|NCT00197145|82890710|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
46674989|NCT00197145|82890711|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
46674990|NCT00197145|82890710|FG000|Period 2 : Open Label Phase|Other|1|||
46674991|NCT00197145|82890711|FG001|Period 2 : Open Label Phase|Other|0|||
46674992|NCT01136785|82890720|FG000|Overall Study|Protocol Violation|2|||
46674993|NCT01136785|82890721|FG001|Overall Study|Protocol Violation|1|||
46674994|NCT00197106|82890733|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
46674995|NCT00197106|82890734|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
46674996|NCT00197106|82890735|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
46674997|NCT00197106|82890733|FG000|Overall Treatment Period|Lack of Efficacy|0|||
46674998|NCT00197106|82890734|FG001|Overall Treatment Period|Lack of Efficacy|1|||
46674999|NCT00197106|82890735|FG002|Overall Treatment Period|Lack of Efficacy|0|||
46675000|NCT00197106|82890733|FG000|Overall Treatment Period|Lost to Follow-up|0|||
46675001|NCT00197106|82890734|FG001|Overall Treatment Period|Lost to Follow-up|0|||
46675002|NCT00197106|82890735|FG002|Overall Treatment Period|Lost to Follow-up|2|||
46675003|NCT00197106|82890733|FG000|Overall Treatment Period|Protocol Violation|0|||
46675004|NCT00197106|82890734|FG001|Overall Treatment Period|Protocol Violation|0|||
46675005|NCT00197106|82890735|FG002|Overall Treatment Period|Protocol Violation|2|||
46675006|NCT00197106|82890733|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
46675007|NCT00197106|82890734|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
46675008|NCT00197106|82890735|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
46675009|NCT01136746|82890743|FG000|Overall Study|Lost to Follow-up|0|||
46675010|NCT01136746|82890744|FG001|Overall Study|Lost to Follow-up|2|||
46675011|NCT01136746|82890743|FG000|Overall Study|Protocol Violation|2|||
46675012|NCT01136746|82890744|FG001|Overall Study|Protocol Violation|1|||
46675013|NCT01136746|82890743|FG000|Overall Study|Death|1|||
46675014|NCT01136746|82890744|FG001|Overall Study|Death|0|||
46675015|NCT01136356|82890750|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
46675016|NCT01136356|82890751|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
46675017|NCT01136356|82890750|FG000|First 18-day Withdrawal|Physician Decision|1|||
46675018|NCT01136356|82890751|FG001|First 18-day Withdrawal|Physician Decision|0|||
46675019|NCT01136356|82890750|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
46675020|NCT01136356|82890751|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
46675021|NCT00196326|82890756|FG000|Overall Study|Did not meet protocol requirements|64|||
46675022|NCT00196326|82890756|FG000|Overall Study|Non-compliance with the protocol|81|||
46675023|NCT00196326|82890756|FG000|Overall Study|Physician Decision|3|||
46675024|NCT00196326|82890756|FG000|Overall Study|Withdrawal by Subject|225|||
46675025|NCT00196326|82890756|FG000|Overall Study|Adverse Event|253|||
46675026|NCT00196326|82890756|FG000|Overall Study|Pregnancy|34|||
46675027|NCT00196326|82890756|FG000|Overall Study|Lost to Follow-up|304|||
46675028|NCT00196326|82890756|FG000|Overall Study|Other|22|||
46675029|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
46675030|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
46675031|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
46675032|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Death|0|||
46675033|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Death|2|||
46675034|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Death|0|||
46675035|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
46675036|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
46675037|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
47079877|NCT02623699|83387655|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
47079878|NCT02623699|83387644|FG000|Part B (Up to 289 Days)|Death|0|||
47079879|NCT02623699|83387645|FG001|Part B (Up to 289 Days)|Death|0|||
47079880|NCT02623699|83387646|FG002|Part B (Up to 289 Days)|Death|0|||
47079881|NCT02623699|83387647|FG003|Part B (Up to 289 Days)|Death|0|||
47079882|NCT02623699|83387648|FG004|Part B (Up to 289 Days)|Death|0|||
47079883|NCT02623699|83387649|FG005|Part B (Up to 289 Days)|Death|1|||
47079884|NCT02623699|83387650|FG006|Part B (Up to 289 Days)|Death|1|||
47079885|NCT02623699|83387651|FG007|Part B (Up to 289 Days)|Death|0|||
47079886|NCT02623699|83387652|FG008|Part B (Up to 289 Days)|Death|1|||
47079887|NCT02623699|83387653|FG009|Part B (Up to 289 Days)|Death|0|||
47079888|NCT02623699|83387654|FG010|Part B (Up to 289 Days)|Death|0|||
46675038|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
46675039|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
46675040|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
46675041|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
46675042|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
46675043|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
46675044|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
46675045|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
46675046|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
46675047|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
46675048|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
46856386|NCT03374488|83072210|FG000|Overall Study|Withdrawal by Subject|3|||
46856387|NCT03374488|83072211|FG001|Overall Study|Withdrawal by Subject|1|||
46675049|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
46675050|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Recovery|1|||
46675051|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Recovery|0|||
46675052|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Recovery|1|||
46675053|NCT00195663|82890763|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
46675054|NCT00195663|82890764|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
46675055|NCT00195663|82890765|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
46794968|NCT03595553|83013270|FG000|Overall Study|Withdrawal by Subject|20|||
46794969|NCT03595553|83013271|FG001|Overall Study|Withdrawal by Subject|8|||
46794970|NCT03595553|83013270|FG000|Overall Study|Physician Decision|3|||
46794971|NCT03595553|83013271|FG001|Overall Study|Physician Decision|2|||
46794972|NCT03595553|83013270|FG000|Overall Study|Adverse Event|2|||
46794973|NCT03595553|83013271|FG001|Overall Study|Adverse Event|5|||
46856388|NCT03374488|83072210|FG000|Overall Study|Physician Decision|3|||
46856389|NCT03374488|83072211|FG001|Overall Study|Physician Decision|0|||
46794974|NCT03595553|83013270|FG000|Overall Study|Death|24|||
46794975|NCT03595553|83013271|FG001|Overall Study|Death|22|||
46794976|NCT03595553|83013270|FG000|Overall Study|Lost to Follow-up|6|||
46794977|NCT03595553|83013271|FG001|Overall Study|Lost to Follow-up|7|||
46856390|NCT00345683|83072220|FG000|Overall Study|Lost to Follow-up|19|||
46856391|NCT00345683|83072221|FG001|Overall Study|Lost to Follow-up|7|||
46978945|NCT02876328|83224457|FG016|Overall Study|Death|1|||
46978946|NCT02876328|83224458|FG017|Overall Study|Death|1|||
46978947|NCT02876328|83224459|FG018|Overall Study|Death|0|||
46978948|NCT02876328|83224460|FG019|Overall Study|Death|0|||
46978949|NCT02876328|83224461|FG020|Overall Study|Death|0|||
46978950|NCT02876328|83224462|FG021|Overall Study|Death|1|||
46978951|NCT02876328|83224463|FG022|Overall Study|Death|0|||
46978952|NCT02876328|83224464|FG023|Overall Study|Death|0|||
46978953|NCT02876328|83224441|FG000|Overall Study|Withdrawal by Subject|0|||
46978954|NCT02876328|83224442|FG001|Overall Study|Withdrawal by Subject|2|||
46978955|NCT02876328|83224443|FG002|Overall Study|Withdrawal by Subject|3|||
46978956|NCT02876328|83224444|FG003|Overall Study|Withdrawal by Subject|3|||
46978957|NCT02876328|83224445|FG004|Overall Study|Withdrawal by Subject|0|||
46978958|NCT02876328|83224446|FG005|Overall Study|Withdrawal by Subject|1|||
46978959|NCT02876328|83224447|FG006|Overall Study|Withdrawal by Subject|0|||
46978960|NCT02876328|83224448|FG007|Overall Study|Withdrawal by Subject|1|||
46978961|NCT02876328|83224449|FG008|Overall Study|Withdrawal by Subject|1|||
46978962|NCT02876328|83224450|FG009|Overall Study|Withdrawal by Subject|2|||
46978963|NCT02876328|83224451|FG010|Overall Study|Withdrawal by Subject|0|||
46978964|NCT02876328|83224452|FG011|Overall Study|Withdrawal by Subject|0|||
46794978|NCT03595553|83013270|FG000|Overall Study|Other as indicated in CSR|3|||
46856392|NCT00345683|83072220|FG000|Overall Study|Other|6|||
46856393|NCT00345683|83072221|FG001|Overall Study|Other|2|||
46856394|NCT03828383|83072229|FG000|Overall Study|Lost to Follow-up|3|||
46856395|NCT03828383|83072230|FG001|Overall Study|Lost to Follow-up|2|||
46856396|NCT03828383|83072229|FG000|Overall Study|Withdrawal by Subject|4|||
46978965|NCT02876328|83224453|FG012|Overall Study|Withdrawal by Subject|0|||
46794979|NCT03595553|83013271|FG001|Overall Study|Other as indicated in CSR|3|||
46794980|NCT03595553|83013270|FG000|Overall Study|Sponsor Decision|0|||
46794981|NCT03595553|83013271|FG001|Overall Study|Sponsor Decision|1|||
46978966|NCT02876328|83224454|FG013|Overall Study|Withdrawal by Subject|0|||
46978967|NCT02876328|83224455|FG014|Overall Study|Withdrawal by Subject|0|||
46794982|NCT00614822|83013277|FG000|Overall Study|Adverse Event|3|||
46794983|NCT00529659|83013284|FG000|Overall Study|Adverse Event|8|||
46794984|NCT00529659|83013285|FG001|Overall Study|Adverse Event|7|||
46856397|NCT03828383|83072230|FG001|Overall Study|Withdrawal by Subject|5|||
46856398|NCT00345605|83072236|FG000|Arm 1|Adverse Event|0|||
46978968|NCT02876328|83224456|FG015|Overall Study|Withdrawal by Subject|0|||
46978969|NCT02876328|83224457|FG016|Overall Study|Withdrawal by Subject|1|||
46978970|NCT02876328|83224458|FG017|Overall Study|Withdrawal by Subject|3|||
46978971|NCT02876328|83224459|FG018|Overall Study|Withdrawal by Subject|0|||
46675056|NCT00195663|82890763|FG000|Open-Label Extension Period|Adverse Event|21|||
46675057|NCT00195663|82890764|FG001|Open-Label Extension Period|Adverse Event|32|||
46675058|NCT00195663|82890765|FG002|Open-Label Extension Period|Adverse Event|36|||
46675059|NCT00195663|82890763|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
46675060|NCT00195663|82890764|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
46675061|NCT00195663|82890765|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
46675062|NCT00195663|82890763|FG000|Open-Label Extension Period|Recovery|0|||
46675063|NCT00195663|82890764|FG001|Open-Label Extension Period|Recovery|2|||
46675064|NCT00195663|82890765|FG002|Open-Label Extension Period|Recovery|2|||
46675065|NCT00195663|82890763|FG000|Open-Label Extension Period|Protocol Violation|3|||
46675066|NCT00195663|82890764|FG001|Open-Label Extension Period|Protocol Violation|4|||
46675067|NCT00195663|82890765|FG002|Open-Label Extension Period|Protocol Violation|4|||
46675068|NCT00195663|82890763|FG000|Open-Label Extension Period|Death|2|||
46675069|NCT00195663|82890764|FG001|Open-Label Extension Period|Death|2|||
46675070|NCT00195663|82890765|FG002|Open-Label Extension Period|Death|2|||
46675071|NCT00195663|82890763|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
46675072|NCT00195663|82890764|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
46675073|NCT00195663|82890765|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
46675074|NCT00195663|82890763|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
46675075|NCT00195663|82890764|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
46675076|NCT00195663|82890765|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
46675077|NCT00195663|82890763|FG000|Open-Label Extension Period|Administrative reasons|11|||
46675078|NCT00195663|82890764|FG001|Open-Label Extension Period|Administrative reasons|11|||
46675079|NCT00195663|82890765|FG002|Open-Label Extension Period|Administrative reasons|13|||
46675080|NCT01135498|82890783|FG000|Overall Study|Adverse Event|20|||
46675081|NCT01135498|82890783|FG000|Overall Study|Progressive disease|38|||
46675082|NCT01135498|82890783|FG000|Overall Study|Investigator judgement|25|||
46675083|NCT01135498|82890783|FG000|Overall Study|Withdrawal by Subject|4|||
46675084|NCT01135498|82890783|FG000|Overall Study|Death|1|||
46675085|NCT01135498|82890783|FG000|Overall Study|Ongoing at time of analysis|2|||
46675086|NCT00195507|82890790|FG000|Overall Study|Adverse Event|24|||
46675087|NCT00195507|82890791|FG001|Overall Study|Adverse Event|13|||
46675088|NCT00195507|82890790|FG000|Overall Study|Death|0|||
46675089|NCT00195507|82890791|FG001|Overall Study|Death|1|||
46675090|NCT00195507|82890790|FG000|Overall Study|Failed to Return|4|||
46675091|NCT00195507|82890791|FG001|Overall Study|Failed to Return|3|||
46675092|NCT00195507|82890790|FG000|Overall Study|Physician Decision|1|||
46675093|NCT00195507|82890791|FG001|Overall Study|Physician Decision|2|||
46675094|NCT00195507|82890790|FG000|Overall Study|Lost to Follow-up|3|||
46675095|NCT00195507|82890791|FG001|Overall Study|Lost to Follow-up|2|||
46675096|NCT00195507|82890790|FG000|Overall Study|Protocol Violation|5|||
46675097|NCT00195507|82890791|FG001|Overall Study|Protocol Violation|4|||
46675098|NCT00195507|82890790|FG000|Overall Study|Lack of Efficacy|40|||
46675099|NCT00195507|82890791|FG001|Overall Study|Lack of Efficacy|67|||
46675100|NCT00195507|82890790|FG000|Overall Study|Withdrawal by Subject|16|||
46675101|NCT00195507|82890791|FG001|Overall Study|Withdrawal by Subject|23|||
46675102|NCT00195507|82890790|FG000|Overall Study|Protocol Deviation|6|||
46675103|NCT00195507|82890791|FG001|Overall Study|Protocol Deviation|3|||
46675104|NCT01134562|82890802|FG000|Overall Study|Adverse Event|0|||
46675105|NCT01134562|82890803|FG001|Overall Study|Adverse Event|1|||
46794985|NCT00529659|83013284|FG000|Overall Study|Lost to Follow-up|0|||
46978972|NCT02876328|83224460|FG019|Overall Study|Withdrawal by Subject|0|||
46978973|NCT02876328|83224461|FG020|Overall Study|Withdrawal by Subject|1|||
46978974|NCT02876328|83224462|FG021|Overall Study|Withdrawal by Subject|0|||
46978975|NCT02876328|83224463|FG022|Overall Study|Withdrawal by Subject|0|||
46978976|NCT02876328|83224464|FG023|Overall Study|Withdrawal by Subject|0|||
46978977|NCT02876328|83224441|FG000|Overall Study|Missed 12 Month Visit|15|||
46978978|NCT02876328|83224442|FG001|Overall Study|Missed 12 Month Visit|10|||
46675106|NCT01134562|82890804|FG002|Overall Study|Adverse Event|0|||
46675107|NCT01134562|82890805|FG003|Overall Study|Adverse Event|0|||
46675108|NCT01134562|82890806|FG004|Overall Study|Adverse Event|0|||
46675109|NCT00195351|82890833|FG000|Overall Study|Lost to Follow-up|9|||
46675110|NCT00195351|82890834|FG001|Overall Study|Lost to Follow-up|9|||
46675111|NCT00195351|82890833|FG000|Overall Study|Withdrawal by Subject|6|||
46675112|NCT00195351|82890834|FG001|Overall Study|Withdrawal by Subject|3|||
46675113|NCT00195351|82890833|FG000|Overall Study|Protocol Deviation|3|||
46675114|NCT00195351|82890834|FG001|Overall Study|Protocol Deviation|2|||
46675115|NCT00195351|82890833|FG000|Overall Study|Death|3|||
46978979|NCT02876328|83224443|FG002|Overall Study|Missed 12 Month Visit|11|||
46675116|NCT00195351|82890834|FG001|Overall Study|Death|1|||
46675117|NCT00195351|82890833|FG000|Overall Study|Lack of Efficacy|0|||
46978980|NCT02876328|83224444|FG003|Overall Study|Missed 12 Month Visit|6|||
46978981|NCT02876328|83224445|FG004|Overall Study|Missed 12 Month Visit|10|||
46978982|NCT02876328|83224446|FG005|Overall Study|Missed 12 Month Visit|14|||
46978983|NCT02876328|83224447|FG006|Overall Study|Missed 12 Month Visit|3|||
46978984|NCT02876328|83224448|FG007|Overall Study|Missed 12 Month Visit|8|||
46978985|NCT02876328|83224449|FG008|Overall Study|Missed 12 Month Visit|9|||
46978986|NCT02876328|83224450|FG009|Overall Study|Missed 12 Month Visit|5|||
46978987|NCT02876328|83224451|FG010|Overall Study|Missed 12 Month Visit|4|||
46978988|NCT02876328|83224452|FG011|Overall Study|Missed 12 Month Visit|1|||
46978989|NCT02876328|83224453|FG012|Overall Study|Missed 12 Month Visit|5|||
46675118|NCT00195351|82890834|FG001|Overall Study|Lack of Efficacy|1|||
46675119|NCT00195273|82890842|FG000|Overall Study|Adverse Event|9|||
46675120|NCT00195273|82890843|FG001|Overall Study|Adverse Event|9|||
46675121|NCT00195273|82890842|FG000|Overall Study|Protocol deviation|0|||
46675122|NCT00195273|82890843|FG001|Overall Study|Protocol deviation|1|||
46675123|NCT00195273|82890842|FG000|Overall Study|Lack of Efficacy|3|||
46978990|NCT02876328|83224454|FG013|Overall Study|Missed 12 Month Visit|4|||
46978991|NCT02876328|83224455|FG014|Overall Study|Missed 12 Month Visit|4|||
46675124|NCT00195273|82890843|FG001|Overall Study|Lack of Efficacy|1|||
46675125|NCT00195273|82890842|FG000|Overall Study|Procedural complications|9|||
46794986|NCT00529659|83013285|FG001|Overall Study|Lost to Follow-up|2|||
47079889|NCT02623699|83387655|FG011|Part B (Up to 289 Days)|Death|0|||
46794987|NCT00529659|83013284|FG000|Overall Study|Physician Decision|0|||
47079890|NCT02623699|83387644|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
47079891|NCT02623699|83387645|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
47079892|NCT02623699|83387646|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
47079893|NCT02623699|83387647|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
47079894|NCT02623699|83387648|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
47079895|NCT02623699|83387649|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
47079896|NCT02623699|83387650|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
47079897|NCT02623699|83387651|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
47079898|NCT02623699|83387652|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
47079899|NCT02623699|83387653|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
47079900|NCT02623699|83387654|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
47079901|NCT02623699|83387655|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
47079902|NCT02623699|83387644|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079903|NCT02623699|83387645|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079904|NCT02623699|83387646|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079905|NCT02623699|83387647|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079906|NCT02623699|83387648|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079907|NCT02623699|83387649|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079908|NCT02623699|83387650|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079909|NCT02623699|83387651|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079910|NCT02623699|83387652|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079911|NCT02623699|83387653|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
47079912|NCT02623699|83387654|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
47079913|NCT02623699|83387655|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
47079914|NCT02623699|83387644|FG000|Part C (Up to 236 Days)|Death|0|||
47079915|NCT02623699|83387645|FG001|Part C (Up to 236 Days)|Death|0|||
47079916|NCT02623699|83387646|FG002|Part C (Up to 236 Days)|Death|0|||
47079917|NCT02623699|83387647|FG003|Part C (Up to 236 Days)|Death|0|||
47079918|NCT02623699|83387648|FG004|Part C (Up to 236 Days)|Death|0|||
47079919|NCT02623699|83387649|FG005|Part C (Up to 236 Days)|Death|0|||
47079920|NCT02623699|83387650|FG006|Part C (Up to 236 Days)|Death|0|||
47079921|NCT02623699|83387651|FG007|Part C (Up to 236 Days)|Death|0|||
47079922|NCT02623699|83387652|FG008|Part C (Up to 236 Days)|Death|0|||
47079923|NCT02623699|83387653|FG009|Part C (Up to 236 Days)|Death|0|||
47079924|NCT02623699|83387654|FG010|Part C (Up to 236 Days)|Death|0|||
47079925|NCT02623699|83387655|FG011|Part C (Up to 236 Days)|Death|1|||
47079926|NCT02623699|83387644|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
47079927|NCT02623699|83387645|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
47079928|NCT02623699|83387646|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
47079929|NCT02623699|83387647|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
46794988|NCT00529659|83013285|FG001|Overall Study|Physician Decision|2|||
46794989|NCT00529659|83013284|FG000|Overall Study|Protocol Violation|2|||
46794990|NCT00529659|83013285|FG001|Overall Study|Protocol Violation|6|||
46794991|NCT00529659|83013284|FG000|Overall Study|Withdrawal by Subject|1|||
46856399|NCT00345605|83072237|FG001|Arm 1|Adverse Event|1|||
46856400|NCT00345605|83072236|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
46856401|NCT00345605|83072237|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
46856402|NCT03394924|83072248|FG000|Overall Study|Adverse Event|0|||
46856403|NCT03394924|83072249|FG001|Overall Study|Adverse Event|5|||
46675126|NCT00195273|82890843|FG001|Overall Study|Procedural complications|3|||
46794992|NCT00529659|83013285|FG001|Overall Study|Withdrawal by Subject|6|||
46794993|NCT00143455|83013295|FG000|Cohort 1|Adverse Event|8|||
46794994|NCT00143455|83013296|FG001|Cohort 1|Adverse Event|4|||
46794995|NCT00143455|83013297|FG002|Cohort 1|Adverse Event|0|||
46978992|NCT02876328|83224456|FG015|Overall Study|Missed 12 Month Visit|4|||
46978993|NCT02876328|83224457|FG016|Overall Study|Missed 12 Month Visit|3|||
46675127|NCT00193479|82890849|FG000|Induction Chemotherapy|Adverse Event|2|||
46675128|NCT00193479|82890849|FG000|Induction Chemotherapy|Disease Progression|1|||
46675129|NCT00193479|82890849|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
46675130|NCT00193479|82890849|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
46675131|NCT00193206|82890853|FG000|Preoperative Therapy|Lack of Efficacy|2|||
46675132|NCT00193206|82890853|FG000|Preoperative Therapy|Adverse Event|2|||
46675133|NCT00193206|82890853|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
46675134|NCT00193206|82890853|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
46794996|NCT00143455|83013298|FG003|Cohort 1|Adverse Event|0|||
46978994|NCT02876328|83224458|FG017|Overall Study|Missed 12 Month Visit|6|||
46675135|NCT00193206|82890853|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
46794997|NCT00143455|83013295|FG000|Cohort 1|Death|5|||
46794998|NCT00143455|83013296|FG001|Cohort 1|Death|2|||
46856404|NCT03394924|83072250|FG002|Overall Study|Adverse Event|0|||
46978995|NCT02876328|83224459|FG018|Overall Study|Missed 12 Month Visit|2|||
46794999|NCT00143455|83013297|FG002|Cohort 1|Death|0|||
46795000|NCT00143455|83013298|FG003|Cohort 1|Death|0|||
46795001|NCT00143455|83013295|FG000|Cohort 1|Progressive Disease|0|||
46795002|NCT00143455|83013296|FG001|Cohort 1|Progressive Disease|6|||
46795003|NCT00143455|83013297|FG002|Cohort 1|Progressive Disease|0|||
46795004|NCT00143455|83013298|FG003|Cohort 1|Progressive Disease|0|||
46795005|NCT00143455|83013295|FG000|Cohort 1|Withdrawal by Subject|1|||
46795006|NCT00143455|83013296|FG001|Cohort 1|Withdrawal by Subject|4|||
46795007|NCT00143455|83013297|FG002|Cohort 1|Withdrawal by Subject|0|||
46795008|NCT00143455|83013298|FG003|Cohort 1|Withdrawal by Subject|0|||
46795009|NCT00143455|83013295|FG000|Cohort 1|Randomized But Not Treated|0|||
46795010|NCT00143455|83013296|FG001|Cohort 1|Randomized But Not Treated|1|||
46795011|NCT00143455|83013297|FG002|Cohort 1|Randomized But Not Treated|0|||
46795012|NCT00143455|83013298|FG003|Cohort 1|Randomized But Not Treated|0|||
46795013|NCT00143455|83013295|FG000|Cohort 2|Adverse Event|0|||
46795014|NCT00143455|83013296|FG001|Cohort 2|Adverse Event|0|||
46795015|NCT00143455|83013297|FG002|Cohort 2|Adverse Event|42|||
46795016|NCT00143455|83013298|FG003|Cohort 2|Adverse Event|30|||
46795017|NCT00143455|83013295|FG000|Cohort 2|No Longer Required Study Treatment|0|||
46675136|NCT00193206|82890853|FG000|Postoperative Therapy|Physician Decision|3|||
46675137|NCT00193206|82890853|FG000|Postoperative Therapy|Intercurrent Illness|2|||
46675138|NCT00193206|82890853|FG000|Postoperative Therapy|Lack of Efficacy|1|||
46675139|NCT00193206|82890853|FG000|Postoperative Therapy|Protocol Violation|1|||
46675140|NCT00193050|82890857|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
46675141|NCT00193050|82890857|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
46675142|NCT00193050|82890857|FG000|Neoadjuvant Treatment|Physician Decision|2|||
46675143|NCT00193050|82890857|FG000|Neoadjuvant Treatment|Adverse Event|2|||
46675144|NCT00193050|82890857|FG000|Adjuvant|Physician Decision|5|||
46675145|NCT00193050|82890857|FG000|Adjuvant|Intercurrent Hospitalization|3|||
46675146|NCT00193050|82890857|FG000|Adjuvant|Lack of Efficacy|2|||
46675147|NCT00192504|82890866|FG000|Overall Study|Lost to Follow-up|1|||
46675148|NCT00192504|82890867|FG001|Overall Study|Lost to Follow-up|0|||
46675149|NCT00192504|82890868|FG002|Overall Study|Lost to Follow-up|0|||
46675150|NCT00192504|82890869|FG003|Overall Study|Lost to Follow-up|0|||
46675151|NCT00192504|82890866|FG000|Overall Study|Dosing window missed|0|||
46675152|NCT00192504|82890867|FG001|Overall Study|Dosing window missed|0|||
46675153|NCT00192504|82890868|FG002|Overall Study|Dosing window missed|1|||
46675154|NCT00192504|82890869|FG003|Overall Study|Dosing window missed|0|||
46675155|NCT00192114|82890879|FG000|Overall Study|Objective Tumor Progression|19|||
46675156|NCT00192114|82890879|FG000|Overall Study|Adverse Event|2|||
46795018|NCT00143455|83013296|FG001|Cohort 2|No Longer Required Study Treatment|0|||
46795019|NCT00143455|83013297|FG002|Cohort 2|No Longer Required Study Treatment|1|||
46856405|NCT03394924|83072248|FG000|Overall Study|Withdrawal by Subject|2|||
46795020|NCT00143455|83013298|FG003|Cohort 2|No Longer Required Study Treatment|0|||
46795021|NCT00143455|83013295|FG000|Cohort 2|Protocol Violation|0|||
46795022|NCT00143455|83013296|FG001|Cohort 2|Protocol Violation|0|||
46795023|NCT00143455|83013297|FG002|Cohort 2|Protocol Violation|1|||
46795024|NCT00143455|83013298|FG003|Cohort 2|Protocol Violation|1|||
46675157|NCT00192114|82890879|FG000|Overall Study|Clinical Progression|2|||
46675158|NCT00192114|82890879|FG000|Overall Study|Death|1|||
46675159|NCT00192075|82890885|FG000|Overall Study|Disease Progression|23|||
46675160|NCT00192075|82890886|FG001|Overall Study|Disease Progression|6|||
46675161|NCT00192075|82890885|FG000|Overall Study|Adverse Event|1|||
46795025|NCT00143455|83013295|FG000|Cohort 2|Lost to Follow-up|0|||
46795026|NCT00143455|83013296|FG001|Cohort 2|Lost to Follow-up|0|||
46675162|NCT00192075|82890886|FG001|Overall Study|Adverse Event|3|||
46675163|NCT00192075|82890885|FG000|Overall Study|Death|0|||
46795027|NCT00143455|83013297|FG002|Cohort 2|Lost to Follow-up|1|||
46795028|NCT00143455|83013298|FG003|Cohort 2|Lost to Follow-up|4|||
46795029|NCT00143455|83013295|FG000|Cohort 2|Death|0|||
46795030|NCT00143455|83013296|FG001|Cohort 2|Death|0|||
46978996|NCT02876328|83224460|FG019|Overall Study|Missed 12 Month Visit|2|||
46675164|NCT00192075|82890886|FG001|Overall Study|Death|1|||
46795031|NCT00143455|83013297|FG002|Cohort 2|Death|20|||
46795032|NCT00143455|83013298|FG003|Cohort 2|Death|12|||
46978997|NCT02876328|83224461|FG020|Overall Study|Missed 12 Month Visit|11|||
46978998|NCT02876328|83224462|FG021|Overall Study|Missed 12 Month Visit|7|||
46795033|NCT00143455|83013295|FG000|Cohort 2|Progressive Disease|0|||
46675165|NCT00192075|82890885|FG000|Overall Study|Lack of Efficacy|0|||
46675166|NCT00192075|82890886|FG001|Overall Study|Lack of Efficacy|0|||
46795034|NCT00143455|83013296|FG001|Cohort 2|Progressive Disease|0|||
46978999|NCT02876328|83224463|FG022|Overall Study|Missed 12 Month Visit|1|||
46675167|NCT00192075|82890885|FG000|Overall Study|Physician Decision|3|||
46675168|NCT00192075|82890886|FG001|Overall Study|Physician Decision|0|||
46675169|NCT00192075|82890885|FG000|Overall Study|Withdrawal by Subject|5|||
46856406|NCT03394924|83072249|FG001|Overall Study|Withdrawal by Subject|0|||
46856407|NCT03394924|83072250|FG002|Overall Study|Withdrawal by Subject|0|||
46856408|NCT03394924|83072248|FG000|Overall Study|Lost to Follow-up|0|||
46856409|NCT03394924|83072249|FG001|Overall Study|Lost to Follow-up|1|||
46856410|NCT03394924|83072250|FG002|Overall Study|Lost to Follow-up|0|||
46675170|NCT00192075|82890886|FG001|Overall Study|Withdrawal by Subject|5|||
46675171|NCT00192075|82890885|FG000|Overall Study|Patient Non-Compliance|0|||
46675172|NCT00192075|82890886|FG001|Overall Study|Patient Non-Compliance|1|||
46795035|NCT00143455|83013297|FG002|Cohort 2|Progressive Disease|20|||
46795036|NCT00143455|83013298|FG003|Cohort 2|Progressive Disease|27|||
46795037|NCT00143455|83013295|FG000|Cohort 2|Withdrawal by Subject|0|||
46795038|NCT00143455|83013296|FG001|Cohort 2|Withdrawal by Subject|0|||
46795039|NCT00143455|83013297|FG002|Cohort 2|Withdrawal by Subject|13|||
46795040|NCT00143455|83013298|FG003|Cohort 2|Withdrawal by Subject|12|||
46795041|NCT00143455|83013295|FG000|Cohort 2|Other|0|||
46795042|NCT00143455|83013296|FG001|Cohort 2|Other|0|||
46795043|NCT00143455|83013297|FG002|Cohort 2|Other|7|||
46795044|NCT00143455|83013298|FG003|Cohort 2|Other|6|||
46795045|NCT00143455|83013295|FG000|Cohort 2|Randomized But Not Treated|0|||
46795046|NCT00143455|83013296|FG001|Cohort 2|Randomized But Not Treated|0|||
46856411|NCT03394924|83072248|FG000|Overall Study|Did not meet all inclusion criteria|1|||
46795047|NCT00143455|83013297|FG002|Cohort 2|Randomized But Not Treated|1|||
46795048|NCT00143455|83013298|FG003|Cohort 2|Randomized But Not Treated|1|||
46795049|NCT03529955|83013310|FG000|Overall Study|Adverse Event|1|||
46675173|NCT00192075|82890885|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
46675174|NCT00192075|82890886|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
46675175|NCT00192075|82890885|FG000|Overall Study|Other|5|||
46675176|NCT00192075|82890886|FG001|Overall Study|Other|2|||
46675177|NCT00192036|82890897|FG000|Overall Study|Protocol Violation|3|||
46675178|NCT00192036|82890897|FG000|Overall Study|Adverse Event|6|||
46675179|NCT00192036|82890897|FG000|Overall Study|Patient/Physician Perception|1|||
46675180|NCT00192036|82890897|FG000|Overall Study|Objective Tumor Progression|4|||
46675181|NCT00192036|82890897|FG000|Overall Study|Clinical Disease Progression|1|||
46675182|NCT00192036|82890897|FG000|Overall Study|Death|1|||
46675183|NCT00192036|82890897|FG000|Overall Study|Unknown or Not Specified|5|||
46675184|NCT00191724|82890906|FG000|Overall Study|Adverse Event|0|||
46675185|NCT00191724|82890907|FG001|Overall Study|Adverse Event|0|||
46675186|NCT00191724|82890908|FG002|Overall Study|Adverse Event|1|||
46675187|NCT00191724|82890909|FG003|Overall Study|Adverse Event|0|||
46675188|NCT00191724|82890910|FG004|Overall Study|Adverse Event|0|||
46675189|NCT00191724|82890906|FG000|Overall Study|Lost to Follow-up|1|||
46675190|NCT00191724|82890907|FG001|Overall Study|Lost to Follow-up|1|||
46675191|NCT00191724|82890908|FG002|Overall Study|Lost to Follow-up|0|||
46675192|NCT00191724|82890909|FG003|Overall Study|Lost to Follow-up|2|||
46675193|NCT00191724|82890910|FG004|Overall Study|Lost to Follow-up|3|||
46675194|NCT00191724|82890906|FG000|Overall Study|Withdrawal by Subject|0|||
46675195|NCT00191724|82890907|FG001|Overall Study|Withdrawal by Subject|0|||
46675196|NCT00191724|82890908|FG002|Overall Study|Withdrawal by Subject|0|||
46675197|NCT00191724|82890909|FG003|Overall Study|Withdrawal by Subject|1|||
46675198|NCT00191724|82890910|FG004|Overall Study|Withdrawal by Subject|0|||
46675199|NCT00191646|82890924|FG000|Overall Study|Toxicity|26|||
46675200|NCT00191646|82890925|FG001|Overall Study|Toxicity|37|||
46675201|NCT00191646|82890924|FG000|Overall Study|Disease Progression|5|||
46675202|NCT00191646|82890925|FG001|Overall Study|Disease Progression|6|||
46675203|NCT00191646|82890924|FG000|Overall Study|Physician Decision|20|||
46675204|NCT00191646|82890925|FG001|Overall Study|Physician Decision|11|||
46675205|NCT00191646|82890924|FG000|Overall Study|Withdrawal by Subject|58|||
46675206|NCT00191646|82890925|FG001|Overall Study|Withdrawal by Subject|39|||
46675207|NCT00191646|82890924|FG000|Overall Study|Protocol Violation|5|||
46675208|NCT00191646|82890925|FG001|Overall Study|Protocol Violation|7|||
46675209|NCT00191646|82890924|FG000|Overall Study|Death|6|||
46675210|NCT00191646|82890925|FG001|Overall Study|Death|8|||
46675211|NCT00191646|82890924|FG000|Overall Study|Other|33|||
46675212|NCT00191646|82890925|FG001|Overall Study|Other|34|||
46675213|NCT00191646|82890924|FG000|Overall Study|Missing Data|18|||
46675214|NCT00191646|82890925|FG001|Overall Study|Missing Data|11|||
46675215|NCT00191451|82890942|FG000|Overall Study|Withdrawal by Subject|2|||
46675216|NCT00191451|82890943|FG001|Overall Study|Withdrawal by Subject|3|||
46795050|NCT03529955|83013310|FG000|Overall Study|Lack of Efficacy|1|||
46979000|NCT02876328|83224464|FG023|Overall Study|Missed 12 Month Visit|0|||
46979001|NCT02577354|83224510|FG000|Overall Study|Lack of Efficacy|4|||
46979002|NCT02577354|83224511|FG001|Overall Study|Lack of Efficacy|4|||
46675217|NCT00191451|82890944|FG002|Overall Study|Withdrawal by Subject|5|||
46675218|NCT00191451|82890942|FG000|Overall Study|Physician Decision|2|||
46675219|NCT00191451|82890943|FG001|Overall Study|Physician Decision|9|||
46675220|NCT00191451|82890944|FG002|Overall Study|Physician Decision|6|||
46675221|NCT00191451|82890942|FG000|Overall Study|Sponsor Decision|1|||
46675222|NCT00191451|82890943|FG001|Overall Study|Sponsor Decision|0|||
46856412|NCT03394924|83072249|FG001|Overall Study|Did not meet all inclusion criteria|0|||
46675223|NCT00191451|82890944|FG002|Overall Study|Sponsor Decision|0|||
46675224|NCT00191451|82890942|FG000|Overall Study|Ineligible|0|||
46795051|NCT00142909|83013326|FG000|Randomization|Various Reasons|7|||
46675225|NCT00191451|82890943|FG001|Overall Study|Ineligible|1|||
46675226|NCT00191451|82890944|FG002|Overall Study|Ineligible|0|||
46795052|NCT00142909|83013327|FG001|Randomization|Various Reasons|10|||
46675227|NCT00191451|82890942|FG000|Overall Study|Reason Not Specified|2|||
46856413|NCT03394924|83072250|FG002|Overall Study|Did not meet all inclusion criteria|0|||
46675228|NCT00191451|82890943|FG001|Overall Study|Reason Not Specified|1|||
46675229|NCT00191451|82890944|FG002|Overall Study|Reason Not Specified|3|||
46675230|NCT00191334|82890952|FG000|Overall Study|Adverse Event|4|||
46675231|NCT00191334|82890952|FG000|Overall Study|Disease Progression or Relapse|8|||
46675232|NCT00191334|82890952|FG000|Overall Study|Physician Decision|1|||
46675233|NCT00191334|82890952|FG000|Overall Study|Withdrawal by Subject|4|||
46675234|NCT00191139|82890958|FG000|Overall Study|Adverse Event|2|||
46675235|NCT00191139|82890959|FG001|Overall Study|Adverse Event|6|||
46675236|NCT00191139|82890958|FG000|Overall Study|Death|2|||
46675237|NCT00191139|82890959|FG001|Overall Study|Death|0|||
46675238|NCT00191139|82890958|FG000|Overall Study|Withdrawal by Subject|0|||
46675239|NCT00191139|82890959|FG001|Overall Study|Withdrawal by Subject|3|||
46675240|NCT00191139|82890958|FG000|Overall Study|Disease Progression|0|||
46675241|NCT00191139|82890959|FG001|Overall Study|Disease Progression|1|||
46675242|NCT00191139|82890958|FG000|Overall Study|Other|1|||
46675243|NCT00191139|82890959|FG001|Overall Study|Other|2|||
46675244|NCT00190983|82890965|FG000|Overall Study|Inevaluable (never treated)|2|||
46675245|NCT00190749|82890971|FG000|Overall Study|Lost to Follow-up|8|||
46675246|NCT00190749|82890972|FG001|Overall Study|Lost to Follow-up|11|||
46675247|NCT00190749|82890971|FG000|Overall Study|Withdrawal by Subject|10|||
46675248|NCT00190749|82890972|FG001|Overall Study|Withdrawal by Subject|6|||
46979003|NCT02577354|83224510|FG000|Overall Study|Lost to Follow-up|3|||
46675249|NCT00190749|82890971|FG000|Overall Study|Protocol Violation|5|||
46675250|NCT00190749|82890972|FG001|Overall Study|Protocol Violation|4|||
46675251|NCT00190749|82890971|FG000|Overall Study|Adverse Event|0|||
46675252|NCT00190749|82890972|FG001|Overall Study|Adverse Event|5|||
46675253|NCT00190749|82890971|FG000|Overall Study|Lack of Efficacy|2|||
46675254|NCT00190749|82890972|FG001|Overall Study|Lack of Efficacy|3|||
46675255|NCT00190749|82890971|FG000|Overall Study|Reason Not Specified|0|||
46675256|NCT00190749|82890972|FG001|Overall Study|Reason Not Specified|2|||
46675257|NCT00190749|82890971|FG000|Overall Study|Sponsor Decision|1|||
46675258|NCT00190749|82890972|FG001|Overall Study|Sponsor Decision|0|||
46675259|NCT00190671|82890980|FG000|Overall Study|Satisfactory Response|4|||
46795053|NCT00142909|83013326|FG000|Medications Begin|Protocol Violation|2|||
46795054|NCT00142909|83013327|FG001|Medications Begin|Protocol Violation|0|||
46795055|NCT00142909|83013326|FG000|Medications Begin|Withdrawal by Subject|5|||
46795056|NCT00142909|83013327|FG001|Medications Begin|Withdrawal by Subject|3|||
46795057|NCT00142909|83013326|FG000|Medications Begin|Withdrawal by Subject|2|||
46795058|NCT00142909|83013327|FG001|Medications Begin|Withdrawal by Subject|0|||
46795059|NCT00205699|83013336|FG000|Overall Study|Lost to Follow-up|1|||
46795060|NCT00205699|83013337|FG001|Overall Study|Lost to Follow-up|3|||
46795061|NCT00205699|83013338|FG002|Overall Study|Lost to Follow-up|5|||
46795062|NCT00205699|83013336|FG000|Overall Study|Adverse Event|1|||
46795063|NCT00205699|83013337|FG001|Overall Study|Adverse Event|0|||
46795064|NCT00205699|83013338|FG002|Overall Study|Adverse Event|0|||
46795065|NCT00205699|83013336|FG000|Overall Study|Withdrawal by Subject|1|||
46795066|NCT00205699|83013337|FG001|Overall Study|Withdrawal by Subject|2|||
46795067|NCT00205699|83013338|FG002|Overall Study|Withdrawal by Subject|1|||
46795068|NCT00205699|83013336|FG000|Overall Study|Lack of Efficacy|0|||
46795069|NCT00205699|83013337|FG001|Overall Study|Lack of Efficacy|1|||
46795070|NCT00205699|83013338|FG002|Overall Study|Lack of Efficacy|0|||
46856414|NCT00345293|83072260|FG000|Overall Study|Unable to access line for sample|1|||
46856415|NCT00345293|83072261|FG001|Overall Study|Unable to access line for sample|0|||
46979004|NCT02577354|83224511|FG001|Overall Study|Lost to Follow-up|1|||
46675260|NCT00190671|82890981|FG001|Overall Study|Satisfactory Response|7|||
46675261|NCT00190671|82890980|FG000|Overall Study|Lack of Efficacy|19|||
46675262|NCT00190671|82890981|FG001|Overall Study|Lack of Efficacy|24|||
46675263|NCT00190671|82890980|FG000|Overall Study|Death from Study Disease|1|||
46675264|NCT00190671|82890981|FG001|Overall Study|Death from Study Disease|1|||
46675265|NCT00190671|82890980|FG000|Overall Study|Adverse Event|3|||
46675266|NCT00190671|82890981|FG001|Overall Study|Adverse Event|2|||
46675267|NCT00190671|82890980|FG000|Overall Study|Clinical Relapse|0|||
46675268|NCT00190671|82890981|FG001|Overall Study|Clinical Relapse|1|||
46675269|NCT00190671|82890980|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
46675270|NCT00190671|82890981|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
46675271|NCT00190671|82890980|FG000|Overall Study|Death from Other Causes|0|||
46675272|NCT00190671|82890981|FG001|Overall Study|Death from Other Causes|2|||
46675273|NCT00190671|82890980|FG000|Overall Study|Protocol Violation|0|||
46795071|NCT03882801|83013351|FG000|Period 1|Adverse Event|0|||
46856416|NCT00345293|83072260|FG000|Overall Study|Withdrawal by Subject|1|||
46856417|NCT00345293|83072261|FG001|Overall Study|Withdrawal by Subject|0|||
46856418|NCT00355121|83072270|FG000|Overall Study|Did not receive study vaccine|1|||
46856419|NCT00355121|83072271|FG001|Overall Study|Did not receive study vaccine|0|||
46979005|NCT02577354|83224510|FG000|Overall Study|Missed Visit|4|||
46795072|NCT03882801|83013352|FG001|Period 1|Adverse Event|1|||
46795073|NCT03882801|83013351|FG000|Period 1|Non-compliance with study drug|1|||
46795074|NCT03882801|83013352|FG001|Period 1|Non-compliance with study drug|1|||
46795075|NCT03882801|83013351|FG000|Period 1|Never treated with study drug|1|||
46795076|NCT03882801|83013352|FG001|Period 1|Never treated with study drug|0|||
46795077|NCT03882801|83013351|FG000|Washout Period|Physician Decision|0|||
46795078|NCT03882801|83013352|FG001|Washout Period|Physician Decision|1|||
46795079|NCT03882801|83013351|FG000|Period 2|Non-compliance with study drug|0|||
46795080|NCT03882801|83013352|FG001|Period 2|Non-compliance with study drug|1|||
46795081|NCT03880227|83013362|FG000|First Visit|Withdrawal by Subject|1|||
46795082|NCT03880227|83013363|FG001|First Visit|Withdrawal by Subject|0|||
46795083|NCT03880227|83013364|FG002|First Visit|Withdrawal by Subject|0|||
46795084|NCT03880227|83013365|FG003|First Visit|Withdrawal by Subject|0|||
46795085|NCT03880227|83013362|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
46795086|NCT03880227|83013363|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
46795087|NCT03880227|83013364|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
46795088|NCT03880227|83013365|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
46795089|NCT03880227|83013362|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
46795090|NCT03880227|83013363|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
46795091|NCT03880227|83013364|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
46795092|NCT03880227|83013365|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
46795093|NCT03880227|83013362|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
46795094|NCT03880227|83013363|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
46795095|NCT03880227|83013364|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
46795096|NCT03880227|83013365|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
46795097|NCT00530439|83013389|FG000|Overall Study|GDM|9|||
46795098|NCT00530439|83013390|FG001|Overall Study|GDM|3|||
46795099|NCT00530439|83013389|FG000|Overall Study|Withdraw|18|||
46795100|NCT00530439|83013390|FG001|Overall Study|Withdraw|14|||
46795101|NCT00530439|83013389|FG000|Overall Study|Missed abortion|1|||
46795102|NCT00530439|83013390|FG001|Overall Study|Missed abortion|4|||
46856420|NCT00355121|83072272|FG002|Overall Study|Did not receive study vaccine|1|||
46675274|NCT00190671|82890981|FG001|Overall Study|Protocol Violation|1|||
46675275|NCT00190671|82890980|FG000|Overall Study|Withdrawal by Subject|0|||
46675276|NCT00190671|82890981|FG001|Overall Study|Withdrawal by Subject|2|||
46675277|NCT00477165|82891003|FG000|Overall Study|Adverse Event|7|||
46675278|NCT00477165|82891004|FG001|Overall Study|Adverse Event|2|||
46675279|NCT00476229|82891010|FG000|Overall Study|Progressive shortness of breath|1|||
46675280|NCT00476151|82891016|FG000|Overall Study|Adverse Event|0|||
46675281|NCT00476151|82891017|FG001|Overall Study|Adverse Event|2|||
46675282|NCT00476151|82891016|FG000|Overall Study|Protocol Violation|1|||
46675283|NCT00476151|82891017|FG001|Overall Study|Protocol Violation|3|||
46675284|NCT00476151|82891016|FG000|Overall Study|Withdrawal by Subject|2|||
46675285|NCT00476151|82891017|FG001|Overall Study|Withdrawal by Subject|0|||
46675286|NCT00476151|82891016|FG000|Overall Study|Physician Decision|0|||
46675287|NCT00476151|82891017|FG001|Overall Study|Physician Decision|2|||
46675288|NCT00475644|82891023|FG000|Overall Study|Protocol Violation|13|||
46675289|NCT00474903|82891030|FG000|Overall Study|Protocol Violation|1|||
46675290|NCT00474903|82891031|FG001|Overall Study|Protocol Violation|5|||
46675291|NCT00474903|82891032|FG002|Overall Study|Protocol Violation|2|||
46675292|NCT01134055|82891047|FG000|Overall Study|Adverse Event|5|||
46675293|NCT01134055|82891048|FG001|Overall Study|Adverse Event|2|||
46675294|NCT01134055|82891049|FG002|Overall Study|Adverse Event|2|||
46675295|NCT01134055|82891050|FG003|Overall Study|Adverse Event|2|||
46675296|NCT01134055|82891051|FG004|Overall Study|Adverse Event|5|||
46675297|NCT01134055|82891052|FG005|Overall Study|Adverse Event|7|||
46675298|NCT01134055|82891053|FG006|Overall Study|Adverse Event|2|||
46675299|NCT01134055|82891047|FG000|Overall Study|Lost to Follow-up|0|||
46675300|NCT01134055|82891048|FG001|Overall Study|Lost to Follow-up|1|||
46675301|NCT01134055|82891049|FG002|Overall Study|Lost to Follow-up|0|||
46675302|NCT01134055|82891050|FG003|Overall Study|Lost to Follow-up|1|||
46675303|NCT01134055|82891051|FG004|Overall Study|Lost to Follow-up|0|||
46675304|NCT01134055|82891052|FG005|Overall Study|Lost to Follow-up|0|||
46675305|NCT01134055|82891053|FG006|Overall Study|Lost to Follow-up|0|||
46675306|NCT01134055|82891047|FG000|Overall Study|Withdrawal by Subject|3|||
46675307|NCT01134055|82891048|FG001|Overall Study|Withdrawal by Subject|3|||
46675308|NCT01134055|82891049|FG002|Overall Study|Withdrawal by Subject|1|||
46675309|NCT01134055|82891050|FG003|Overall Study|Withdrawal by Subject|2|||
46675310|NCT01134055|82891051|FG004|Overall Study|Withdrawal by Subject|0|||
46675311|NCT01134055|82891052|FG005|Overall Study|Withdrawal by Subject|0|||
46675312|NCT01134055|82891053|FG006|Overall Study|Withdrawal by Subject|8|||
46675313|NCT01134055|82891047|FG000|Overall Study|Protocol Violation|0|||
46675314|NCT01134055|82891048|FG001|Overall Study|Protocol Violation|0|||
46675315|NCT01134055|82891049|FG002|Overall Study|Protocol Violation|0|||
46675316|NCT01134055|82891050|FG003|Overall Study|Protocol Violation|1|||
46675317|NCT01134055|82891051|FG004|Overall Study|Protocol Violation|1|||
46675318|NCT01134055|82891052|FG005|Overall Study|Protocol Violation|0|||
46675319|NCT01134055|82891053|FG006|Overall Study|Protocol Violation|0|||
46675320|NCT01134055|82891047|FG000|Overall Study|Physician Decision|0|||
46675321|NCT01134055|82891048|FG001|Overall Study|Physician Decision|0|||
46675322|NCT01134055|82891049|FG002|Overall Study|Physician Decision|0|||
46675323|NCT01134055|82891050|FG003|Overall Study|Physician Decision|0|||
46675324|NCT01134055|82891051|FG004|Overall Study|Physician Decision|0|||
46675325|NCT01134055|82891052|FG005|Overall Study|Physician Decision|0|||
46795103|NCT00530439|83013389|FG000|Overall Study|Misclassification|2|||
46795104|NCT00530439|83013390|FG001|Overall Study|Misclassification|0|||
46795105|NCT00530439|83013389|FG000|Overall Study|Twin pregnancy|0|||
46795106|NCT00530439|83013390|FG001|Overall Study|Twin pregnancy|2|||
46795107|NCT00530439|83013389|FG000|Overall Study|Severe malformation/abortion|0|||
46795108|NCT00530439|83013390|FG001|Overall Study|Severe malformation/abortion|3|||
46795109|NCT00497146|83013398|FG000|Treatment Period|Adverse Event|6|||
46795110|NCT00497146|83013399|FG001|Treatment Period|Adverse Event|2|||
46795111|NCT00497146|83013398|FG000|Treatment Period|Withdrawal by Subject|5|||
46675326|NCT01134055|82891053|FG006|Overall Study|Physician Decision|1|||
46675327|NCT00474708|82891077|FG000|Overall Study|Lack of Efficacy|11|||
46675328|NCT00474708|82891078|FG001|Overall Study|Lack of Efficacy|5|||
46675329|NCT00474708|82891077|FG000|Overall Study|Suicide ideation/behavior|0|||
46856421|NCT00355121|83072270|FG000|Overall Study|Adverse Event|0|||
46856422|NCT00355121|83072271|FG001|Overall Study|Adverse Event|1|||
46979006|NCT02577354|83224511|FG001|Overall Study|Missed Visit|3|||
46675330|NCT00474708|82891078|FG001|Overall Study|Suicide ideation/behavior|1|||
46675331|NCT00474708|82891077|FG000|Overall Study|Withdrawal by Subject|7|||
46675332|NCT00474708|82891078|FG001|Overall Study|Withdrawal by Subject|0|||
46675333|NCT00474708|82891077|FG000|Overall Study|Lack of compliance|12|||
46675334|NCT00474708|82891078|FG001|Overall Study|Lack of compliance|4|||
46675335|NCT00474708|82891077|FG000|Overall Study|Lost to Follow-up|18|||
46675336|NCT00474708|82891078|FG001|Overall Study|Lost to Follow-up|9|||
46675337|NCT00474708|82891077|FG000|Overall Study|Physician Decision|9|||
46675338|NCT00474708|82891078|FG001|Overall Study|Physician Decision|6|||
46795112|NCT00497146|83013399|FG001|Treatment Period|Withdrawal by Subject|9|||
46795113|NCT00497146|83013398|FG000|Treatment Period|Lost to Follow-up|1|||
46795114|NCT00497146|83013399|FG001|Treatment Period|Lost to Follow-up|3|||
46795115|NCT00497146|83013398|FG000|Treatment Period|Required dialysis|4|||
46795116|NCT00497146|83013399|FG001|Treatment Period|Required dialysis|1|||
46795117|NCT00497146|83013398|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
46795118|NCT00497146|83013399|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
46795119|NCT00497146|83013398|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
46795120|NCT00497146|83013399|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
46795121|NCT00497146|83013398|FG000|Treatment Period|Other Reason|2|||
46795122|NCT00497146|83013399|FG001|Treatment Period|Other Reason|3|||
46795123|NCT00497146|83013398|FG000|Long-term Follow-up Period|Adverse Event|2|||
46795124|NCT00497146|83013399|FG001|Long-term Follow-up Period|Adverse Event|2|||
46795125|NCT00497146|83013398|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
46795126|NCT00497146|83013399|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
46795127|NCT00497146|83013398|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
46856423|NCT00355121|83072272|FG002|Overall Study|Adverse Event|0|||
46675339|NCT00474240|82891090|FG000|Overall Study|Withdrawal by Subject|1|||
46675340|NCT00474240|82891091|FG001|Overall Study|Withdrawal by Subject|1|||
46675341|NCT00474240|82891092|FG002|Overall Study|Withdrawal by Subject|0|||
46675342|NCT00474240|82891093|FG003|Overall Study|Withdrawal by Subject|2|||
46675343|NCT00474240|82891094|FG004|Overall Study|Withdrawal by Subject|3|||
46675344|NCT00474240|82891095|FG005|Overall Study|Withdrawal by Subject|1|||
46979007|NCT02577354|83224510|FG000|Overall Study|Adverse Event|4|||
46675345|NCT00474240|82891090|FG000|Overall Study|Adverse Event|0|||
46675346|NCT00474240|82891091|FG001|Overall Study|Adverse Event|0|||
46675347|NCT00474240|82891092|FG002|Overall Study|Adverse Event|9|||
46675348|NCT00474240|82891093|FG003|Overall Study|Adverse Event|14|||
46675349|NCT00474240|82891094|FG004|Overall Study|Adverse Event|5|||
46675350|NCT00474240|82891095|FG005|Overall Study|Adverse Event|16|||
46675351|NCT00474240|82891090|FG000|Overall Study|Removed due to lab value|0|||
46675352|NCT00474240|82891091|FG001|Overall Study|Removed due to lab value|0|||
46675353|NCT00474240|82891092|FG002|Overall Study|Removed due to lab value|0|||
46675354|NCT00474240|82891093|FG003|Overall Study|Removed due to lab value|0|||
46675355|NCT00474240|82891094|FG004|Overall Study|Removed due to lab value|0|||
46675356|NCT00474240|82891095|FG005|Overall Study|Removed due to lab value|1|||
46675357|NCT00473889|82891111|FG000|Overall Study|Did not receive study medication|1|||
46675358|NCT00473889|82891112|FG001|Overall Study|Did not receive study medication|4|||
46675359|NCT00473889|82891111|FG000|Overall Study|Adverse Event|30|||
46675360|NCT00473889|82891112|FG001|Overall Study|Adverse Event|17|||
46675361|NCT00473889|82891111|FG000|Overall Study|Protocol Violation|4|||
46675362|NCT00473889|82891112|FG001|Overall Study|Protocol Violation|2|||
46675363|NCT00473889|82891111|FG000|Overall Study|Lack of Efficacy|28|||
46675364|NCT00473889|82891112|FG001|Overall Study|Lack of Efficacy|29|||
46675365|NCT00473889|82891111|FG000|Overall Study|Lost to Follow-up|2|||
46675366|NCT00473889|82891112|FG001|Overall Study|Lost to Follow-up|1|||
46675367|NCT00473889|82891111|FG000|Overall Study|Physician Decision|10|||
46675368|NCT00473889|82891112|FG001|Overall Study|Physician Decision|5|||
46675369|NCT00473889|82891111|FG000|Overall Study|Trial Terminated|3|||
46675370|NCT00473889|82891112|FG001|Overall Study|Trial Terminated|6|||
46675371|NCT00473889|82891111|FG000|Overall Study|Withdrawal by Subject|5|||
46795128|NCT00497146|83013399|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
46795129|NCT00497146|83013398|FG000|Long-term Follow-up Period|Other|0|||
46675372|NCT00473889|82891112|FG001|Overall Study|Withdrawal by Subject|0|||
46675373|NCT00473694|82891122|FG000|Overall Study|Adverse Event|0|||
46675374|NCT00473694|82891123|FG001|Overall Study|Adverse Event|1|||
46675375|NCT00473694|82891124|FG002|Overall Study|Adverse Event|0|||
46675376|NCT00473694|82891125|FG003|Overall Study|Adverse Event|0|||
46675377|NCT00473694|82891122|FG000|Overall Study|Participants did not receive treatment|11|||
46675378|NCT00473694|82891123|FG001|Overall Study|Participants did not receive treatment|3|||
46675379|NCT00473694|82891124|FG002|Overall Study|Participants did not receive treatment|5|||
46675380|NCT00473694|82891125|FG003|Overall Study|Participants did not receive treatment|6|||
46979008|NCT02577354|83224511|FG001|Overall Study|Adverse Event|5|||
46979009|NCT02468232|83224531|FG000|Core Part of Study|Adverse Event|0|||
46979010|NCT02468232|83224532|FG001|Core Part of Study|Adverse Event|1|||
46979011|NCT02468232|83224533|FG002|Core Part of Study|Adverse Event|0|||
46979012|NCT02468232|83224534|FG003|Core Part of Study|Adverse Event|0|||
46856424|NCT00355121|83072270|FG000|Overall Study|Protocol Violation|7|||
46979013|NCT02468232|83224531|FG000|Core Part of Study|Death|20|||
46979014|NCT02468232|83224532|FG001|Core Part of Study|Death|17|||
46979015|NCT02468232|83224533|FG002|Core Part of Study|Death|0|||
46675381|NCT00473694|82891122|FG000|Overall Study|Lost to Follow-up|0|||
46675382|NCT00473694|82891123|FG001|Overall Study|Lost to Follow-up|0|||
46675383|NCT00473694|82891124|FG002|Overall Study|Lost to Follow-up|0|||
46675384|NCT00473694|82891125|FG003|Overall Study|Lost to Follow-up|1|||
46675385|NCT00473655|82891141|FG000|Overall Study|Lost to Follow-up|9|||
46675386|NCT00473655|82891142|FG001|Overall Study|Lost to Follow-up|5|||
46675387|NCT00473655|82891143|FG002|Overall Study|Lost to Follow-up|8|||
46675388|NCT00473382|82891154|FG000|Core Study|Adverse Event|3|||
46675389|NCT00473382|82891155|FG001|Core Study|Adverse Event|1|||
46675390|NCT00473382|82891156|FG002|Core Study|Adverse Event|1|||
46675391|NCT00473382|82891154|FG000|Core Study|Death|3|||
46675392|NCT00473382|82891155|FG001|Core Study|Death|5|||
46675393|NCT00473382|82891156|FG002|Core Study|Death|10|||
46675394|NCT00473382|82891154|FG000|Core Study|Lost to Follow-up|3|||
46675395|NCT00473382|82891155|FG001|Core Study|Lost to Follow-up|3|||
46675396|NCT00473382|82891156|FG002|Core Study|Lost to Follow-up|3|||
46675397|NCT00473382|82891154|FG000|Core Study|Physician Decision|1|||
46675398|NCT00473382|82891155|FG001|Core Study|Physician Decision|2|||
46675399|NCT00473382|82891156|FG002|Core Study|Physician Decision|2|||
46675400|NCT00473382|82891154|FG000|Core Study|Subject non-compliance|5|||
46675401|NCT00473382|82891155|FG001|Core Study|Subject non-compliance|2|||
46675402|NCT00473382|82891156|FG002|Core Study|Subject non-compliance|1|||
46675403|NCT00473382|82891154|FG000|Core Study|Subject needed other treatment|1|||
46675404|NCT00473382|82891155|FG001|Core Study|Subject needed other treatment|3|||
46675405|NCT00473382|82891156|FG002|Core Study|Subject needed other treatment|2|||
46675406|NCT00473382|82891154|FG000|Core Study|Subject's decision|12|||
46675407|NCT00473382|82891155|FG001|Core Study|Subject's decision|11|||
46795130|NCT00497146|83013399|FG001|Long-term Follow-up Period|Other|1|||
46795131|NCT00489970|83013410|FG000|Persistence Year 9|Lost to Follow-up|2|||
46675408|NCT00473382|82891156|FG002|Core Study|Subject's decision|10|||
46675409|NCT00473382|82891154|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
46795132|NCT00489970|83013411|FG001|Persistence Year 9|Lost to Follow-up|2|||
46675410|NCT00473382|82891155|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
46675411|NCT00473382|82891156|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
46675412|NCT00473382|82891154|FG000|Open-label Extension Through Month 48|Death|1|||
46675413|NCT00473382|82891155|FG001|Open-label Extension Through Month 48|Death|3|||
46675414|NCT00473382|82891156|FG002|Open-label Extension Through Month 48|Death|3|||
46675415|NCT00473382|82891154|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
46675416|NCT00473382|82891155|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
46675417|NCT00473382|82891156|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
46675418|NCT00473382|82891154|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
46675419|NCT00473382|82891155|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
46675420|NCT00473382|82891156|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
46675421|NCT00473382|82891154|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
46675422|NCT00473382|82891155|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
46675423|NCT00473382|82891156|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
46675424|NCT00473382|82891154|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
46675425|NCT00473382|82891155|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
46675426|NCT00473382|82891156|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
46675427|NCT00473382|82891154|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
46675428|NCT00473382|82891155|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
46675429|NCT00473382|82891156|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
46675430|NCT00473382|82891154|FG000|Open-label Extension Through Month 60|Death|1|||
46675431|NCT00473382|82891155|FG001|Open-label Extension Through Month 60|Death|7|||
46675432|NCT00473382|82891156|FG002|Open-label Extension Through Month 60|Death|4|||
46675433|NCT00473382|82891154|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
46675434|NCT00473382|82891155|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
46675435|NCT00473382|82891156|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
46979016|NCT02468232|83224534|FG003|Core Part of Study|Death|0|||
46979017|NCT02468232|83224531|FG000|Core Part of Study|Technical Problems|1|||
46979018|NCT02468232|83224532|FG001|Core Part of Study|Technical Problems|1|||
46979019|NCT02468232|83224533|FG002|Core Part of Study|Technical Problems|0|||
46979020|NCT02468232|83224534|FG003|Core Part of Study|Technical Problems|0|||
46979021|NCT02468232|83224531|FG000|OLE Part of Study|Adverse Event|0|||
46979022|NCT02468232|83224532|FG001|OLE Part of Study|Adverse Event|0|||
46979023|NCT02468232|83224533|FG002|OLE Part of Study|Adverse Event|4|||
46979024|NCT02468232|83224534|FG003|OLE Part of Study|Adverse Event|5|||
46979025|NCT02468232|83224531|FG000|OLE Part of Study|Death|0|||
46979026|NCT02468232|83224532|FG001|OLE Part of Study|Death|0|||
46979027|NCT02468232|83224533|FG002|OLE Part of Study|Death|4|||
46979028|NCT02468232|83224534|FG003|OLE Part of Study|Death|2|||
46979029|NCT02468232|83224531|FG000|OLE Part of Study|Physician Decision|0|||
46675436|NCT00473382|82891154|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
46856425|NCT00355121|83072271|FG001|Overall Study|Protocol Violation|9|||
46979030|NCT02468232|83224532|FG001|OLE Part of Study|Physician Decision|0|||
46979031|NCT02468232|83224533|FG002|OLE Part of Study|Physician Decision|4|||
46979032|NCT02468232|83224534|FG003|OLE Part of Study|Physician Decision|0|||
46979033|NCT02468232|83224531|FG000|OLE Part of Study|Subject/Guardian decision|0|||
46675437|NCT00473382|82891155|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
46675438|NCT00473382|82891156|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
46675439|NCT00473382|82891154|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
46675440|NCT00473382|82891155|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
46675441|NCT00473382|82891156|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
46675442|NCT00473382|82891154|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
46675443|NCT00473382|82891155|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
46675444|NCT00473382|82891156|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
46675445|NCT00473265|82891182|FG000|Overall Study|Unrelated adverse event|5|||
46675446|NCT00473265|82891182|FG000|Overall Study|Off treatment early|15|||
46675447|NCT00472641|82891186|FG000|Overall Study|Lack of Efficacy|3|||
46675448|NCT00472641|82891186|FG000|Overall Study|Adverse Event|3|||
46675449|NCT00472641|82891186|FG000|Overall Study|Lost to Follow-up|1|||
46675450|NCT01133977|82891195|FG000|Overall Study|Adverse Event|0|||
46795133|NCT00489970|83013412|FG002|Persistence Year 9|Lost to Follow-up|3|||
46795134|NCT00489970|83013410|FG000|Persistence Year 9|Other|1|||
46795135|NCT00489970|83013411|FG001|Persistence Year 9|Other|0|||
46795136|NCT00489970|83013412|FG002|Persistence Year 9|Other|2|||
46795137|NCT02798471|83013425|FG000|Overall Study|Adverse Event|7|||
46795138|NCT02798471|83013426|FG001|Overall Study|Adverse Event|2|||
46795139|NCT02798471|83013425|FG000|Overall Study|Physician Decision|3|||
46795140|NCT02798471|83013426|FG001|Overall Study|Physician Decision|7|||
46795141|NCT02798471|83013425|FG000|Overall Study|Death|2|||
46795142|NCT02798471|83013426|FG001|Overall Study|Death|3|||
46795143|NCT02798471|83013425|FG000|Overall Study|Lost to Follow-up|0|||
46795144|NCT02798471|83013426|FG001|Overall Study|Lost to Follow-up|1|||
46795145|NCT02798471|83013425|FG000|Overall Study|Other|5|||
46795146|NCT02798471|83013426|FG001|Overall Study|Other|3|||
46795147|NCT02798471|83013425|FG000|Overall Study|Subject withdrew consent|0|||
46795148|NCT02798471|83013426|FG001|Overall Study|Subject withdrew consent|6|||
46795149|NCT02798471|83013425|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
46795150|NCT02798471|83013426|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
46795151|NCT02798471|83013425|FG000|Overall Study|Randomized, but not treated|0|||
46795152|NCT02798471|83013426|FG001|Overall Study|Randomized, but not treated|2|||
46795153|NCT00489736|83013434|FG000|Overall Study|Lack of Efficacy|53|||
46795154|NCT00489736|83013435|FG001|Overall Study|Lack of Efficacy|14|||
46795155|NCT00489736|83013434|FG000|Overall Study|Adverse Event|32|||
46795156|NCT00489736|83013435|FG001|Overall Study|Adverse Event|45|||
46795157|NCT00489736|83013434|FG000|Overall Study|Poor compliance|6|||
46795158|NCT00489736|83013435|FG001|Overall Study|Poor compliance|2|||
46795159|NCT00489736|83013434|FG000|Overall Study|Not coded/ Not pre-specified|5|||
46795160|NCT00489736|83013435|FG001|Overall Study|Not coded/ Not pre-specified|8|||
46795161|NCT00617084|83013443|FG000|Overall Study|Withdrawal by Subject|5|||
46795162|NCT00617084|83013444|FG001|Overall Study|Withdrawal by Subject|7|||
46795163|NCT00617084|83013443|FG000|Overall Study|Missed 12 Months visit|16|||
46795164|NCT00617084|83013444|FG001|Overall Study|Missed 12 Months visit|19|||
46795165|NCT00489424|83013453|FG000|Overall Study|Adverse Event|3|||
46795166|NCT00489424|83013454|FG001|Overall Study|Adverse Event|3|||
46795167|NCT00489424|83013455|FG002|Overall Study|Adverse Event|4|||
46795168|NCT00489424|83013453|FG000|Overall Study|Lack of Efficacy|1|||
46795169|NCT00489424|83013454|FG001|Overall Study|Lack of Efficacy|0|||
46795170|NCT00489424|83013455|FG002|Overall Study|Lack of Efficacy|0|||
46795171|NCT00489424|83013453|FG000|Overall Study|Administrative problems|0|||
46795172|NCT00489424|83013454|FG001|Overall Study|Administrative problems|2|||
46795173|NCT00489424|83013455|FG002|Overall Study|Administrative problems|1|||
46795174|NCT00614744|83013465|FG000|Overall Study|Lost to Follow-up|5|||
46795175|NCT00614744|83013466|FG001|Overall Study|Lost to Follow-up|4|||
46795176|NCT00614744|83013465|FG000|Overall Study|Incomplete for Behavior Issues|0|||
46795177|NCT00614744|83013466|FG001|Overall Study|Incomplete for Behavior Issues|2|||
46795178|NCT00565812|83013475|FG000|Overall Study|Death|2|||
46795179|NCT00565812|83013476|FG001|Overall Study|Death|1|||
46795180|NCT00565812|83013477|FG002|Overall Study|Death|3|||
46856426|NCT00355121|83072272|FG002|Overall Study|Protocol Violation|1|||
46795181|NCT00565812|83013475|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
46795182|NCT00565812|83013476|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
46795183|NCT00565812|83013477|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
47079930|NCT02623699|83387648|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
47079931|NCT02623699|83387649|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
47079932|NCT02623699|83387650|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
47079933|NCT02623699|83387651|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
47079934|NCT02623699|83387652|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
47079935|NCT02623699|83387653|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
47079936|NCT02623699|83387654|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
47079937|NCT02623699|83387655|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
47079938|NCT02501642|83387696|FG000|Overall Study|Lost to Follow-up|7|||
47079939|NCT02501642|83387697|FG001|Overall Study|Lost to Follow-up|11|||
47079940|NCT02475954|83387705|FG000|Overall Study|Withdrawal by Subject|2|||
47079941|NCT02475954|83387706|FG001|Overall Study|Withdrawal by Subject|2|||
47079942|NCT02475954|83387705|FG000|Overall Study|Lost to Follow-up|11|||
47079943|NCT02475954|83387706|FG001|Overall Study|Lost to Follow-up|9|||
47079944|NCT02475954|83387705|FG000|Overall Study|Death|1|||
47079945|NCT02475954|83387706|FG001|Overall Study|Death|1|||
47079946|NCT02459587|83387715|FG000|3-Month Follow-up Assessment|Death|0|||
47079947|NCT02459587|83387716|FG001|3-Month Follow-up Assessment|Death|2|||
47079948|NCT02459587|83387715|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
47079949|NCT02459587|83387716|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
47079950|NCT02459587|83387715|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
47079951|NCT02459587|83387716|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
47079952|NCT02459587|83387715|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
47079953|NCT02459587|83387716|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
47079954|NCT02459587|83387715|FG000|6-month Follow-up Assessment|Death|2|||
47079955|NCT02459587|83387716|FG001|6-month Follow-up Assessment|Death|1|||
47079956|NCT02459587|83387715|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
47079957|NCT02459587|83387716|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
47079958|NCT02459587|83387715|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
47079959|NCT02459587|83387716|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
47079960|NCT02459587|83387715|FG000|12-month Follow-up Assessment|Death|2|||
47079961|NCT02459587|83387716|FG001|12-month Follow-up Assessment|Death|0|||
47079962|NCT02459587|83387715|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
47079963|NCT02459587|83387716|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
47079964|NCT02459587|83387715|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
47079965|NCT02459587|83387716|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
47079966|NCT02459587|83387715|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
47079967|NCT02459587|83387716|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
47079968|NCT01966120|83387734|FG000|Overall Study|Withdrawal by Subject|0|||
47079969|NCT01966120|83387735|FG001|Overall Study|Withdrawal by Subject|5|||
47079970|NCT01966120|83387734|FG000|Overall Study|Lost to Follow-up|1|||
47079971|NCT01966120|83387735|FG001|Overall Study|Lost to Follow-up|1|||
47079972|NCT01399736|83387778|FG000|Overall Study|Withdrawal by Subject|4|||
47079973|NCT01399736|83387779|FG001|Overall Study|Withdrawal by Subject|2|||
47079974|NCT01399736|83387778|FG000|Overall Study|Lost to Follow-up|0|||
47079975|NCT01399736|83387779|FG001|Overall Study|Lost to Follow-up|2|||
47079976|NCT04372927|83387909|FG000|Overall Study|Death|1|||
46795184|NCT00565812|83013475|FG000|Overall Study|Lost to Follow-up|10|||
46979034|NCT02468232|83224532|FG001|OLE Part of Study|Subject/Guardian decision|0|||
47079977|NCT01381874|83387916|FG000|Overall Study|Lost to Follow-up|1|||
47079978|NCT01381874|83387917|FG001|Overall Study|Lost to Follow-up|1|||
47079979|NCT01381874|83387918|FG002|Overall Study|Lost to Follow-up|0|||
46675451|NCT01133977|82891196|FG001|Overall Study|Adverse Event|0|||
46675452|NCT01133977|82891197|FG002|Overall Study|Adverse Event|1|||
46675453|NCT01133977|82891198|FG003|Overall Study|Adverse Event|0|||
46675454|NCT01133977|82891199|FG004|Overall Study|Adverse Event|0|||
46675455|NCT01133977|82891195|FG000|Overall Study|Death|1|||
46675456|NCT01133977|82891196|FG001|Overall Study|Death|1|||
46675457|NCT01133977|82891197|FG002|Overall Study|Death|1|||
46675458|NCT01133977|82891198|FG003|Overall Study|Death|7|||
46675459|NCT01133977|82891199|FG004|Overall Study|Death|3|||
46675460|NCT01133977|82891195|FG000|Overall Study|Started a New Line of Therapy|2|||
46675461|NCT01133977|82891196|FG001|Overall Study|Started a New Line of Therapy|6|||
46675462|NCT01133977|82891197|FG002|Overall Study|Started a New Line of Therapy|4|||
46675463|NCT01133977|82891198|FG003|Overall Study|Started a New Line of Therapy|25|||
46675464|NCT01133977|82891199|FG004|Overall Study|Started a New Line of Therapy|33|||
46675465|NCT01133977|82891195|FG000|Overall Study|Lost to Follow-up|0|||
46675466|NCT01133977|82891196|FG001|Overall Study|Lost to Follow-up|0|||
46675467|NCT01133977|82891197|FG002|Overall Study|Lost to Follow-up|0|||
46675468|NCT01133977|82891198|FG003|Overall Study|Lost to Follow-up|2|||
46675469|NCT01133977|82891199|FG004|Overall Study|Lost to Follow-up|1|||
46795185|NCT00565812|83013476|FG001|Overall Study|Lost to Follow-up|8|||
46795186|NCT00565812|83013477|FG002|Overall Study|Lost to Follow-up|8|||
46795187|NCT00565812|83013475|FG000|Overall Study|Withdrawal by Subject|58|||
47079980|NCT01381874|83387916|FG000|Overall Study|Withdrawal by Subject|9|||
47079981|NCT01381874|83387917|FG001|Overall Study|Withdrawal by Subject|10|||
47079982|NCT01381874|83387918|FG002|Overall Study|Withdrawal by Subject|9|||
47079983|NCT01381874|83387916|FG000|Overall Study|Other|67|||
47079984|NCT01381874|83387917|FG001|Overall Study|Other|52|||
47079985|NCT01381874|83387918|FG002|Overall Study|Other|67|||
47079986|NCT01399190|83387926|FG000|Overall Study|Not Eligible for Final Analysis|5|||
47079987|NCT01399190|83387926|FG000|Overall Study|Adverse Event|8|||
47079988|NCT01399190|83387926|FG000|Overall Study|Participant's Request|5|||
47079989|NCT01399190|83387926|FG000|Overall Study|Physician Decision|2|||
47079990|NCT01381718|83387944|FG000|Overall Study|Withdrawal by Subject|2|||
47079991|NCT01381718|83387945|FG001|Overall Study|Withdrawal by Subject|5|||
47079992|NCT01381718|83387944|FG000|Overall Study|Lost to Follow-up|3|||
47079993|NCT01381718|83387945|FG001|Overall Study|Lost to Follow-up|5|||
47079994|NCT01381718|83387944|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
47079995|NCT01381718|83387945|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
47079996|NCT01398956|83387964|FG000|Overall Study|Withdrawal by Subject|4|||
47079997|NCT01398956|83387964|FG000|Overall Study|AE, non-serious non-fatal|4|||
47079998|NCT01398956|83387964|FG000|Overall Study|Withdrawal Criteria No.3|1|||
47079999|NCT01398956|83387964|FG000|Overall Study|Subject moved a long distance|1|||
47080000|NCT01381562|83387990|FG000|Overall Study|Adverse Event|0|||
47080001|NCT01381562|83387991|FG001|Overall Study|Adverse Event|1|||
47080002|NCT01381562|83387992|FG002|Overall Study|Adverse Event|0|||
47080003|NCT01381016|83388015|FG000|Overall Study|Lost to Follow-up|1|||
47080004|NCT01381016|83388016|FG001|Overall Study|Lost to Follow-up|1|||
47080005|NCT01381016|83388015|FG000|Overall Study|Screen Failure|2|||
47080006|NCT01381016|83388016|FG001|Overall Study|Screen Failure|2|||
47080007|NCT01381016|83388015|FG000|Overall Study|Withdrawal by Subject|0|||
47080008|NCT01381016|83388016|FG001|Overall Study|Withdrawal by Subject|1|||
47080009|NCT01381016|83388015|FG000|Overall Study|Physician Decision|0|||
47080010|NCT01381016|83388016|FG001|Overall Study|Physician Decision|2|||
47080011|NCT01398410|83388043|FG000|Overall Study|Adverse Event|12|||
47080012|NCT01398410|83388044|FG001|Overall Study|Adverse Event|16|||
47080013|NCT01398410|83388043|FG000|Overall Study|Participants Choice|8|||
47080014|NCT01398410|83388044|FG001|Overall Study|Participants Choice|11|||
47080015|NCT01398410|83388043|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
47080016|NCT01398410|83388044|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
47080017|NCT01398410|83388043|FG000|Overall Study|Other|36|||
47080018|NCT01398410|83388044|FG001|Overall Study|Other|29|||
47080019|NCT01380782|83388110|FG000|Overall Study|Adverse Event|0|||
47080020|NCT01380782|83388111|FG001|Overall Study|Adverse Event|1|||
47080021|NCT01380782|83388112|FG002|Overall Study|Adverse Event|0|||
47080022|NCT01380782|83388113|FG003|Overall Study|Adverse Event|0|||
47080023|NCT01380782|83388110|FG000|Overall Study|Death|1|||
47080024|NCT01380782|83388111|FG001|Overall Study|Death|0|||
47080025|NCT01380782|83388112|FG002|Overall Study|Death|0|||
46979035|NCT02468232|83224533|FG002|OLE Part of Study|Subject/Guardian decision|2|||
46675470|NCT01133977|82891195|FG000|Overall Study|Withdrawal by Subject|0|||
46675471|NCT01133977|82891196|FG001|Overall Study|Withdrawal by Subject|0|||
46675472|NCT01133977|82891197|FG002|Overall Study|Withdrawal by Subject|0|||
46675473|NCT01133977|82891198|FG003|Overall Study|Withdrawal by Subject|5|||
46675474|NCT01133977|82891199|FG004|Overall Study|Withdrawal by Subject|1|||
46979036|NCT02468232|83224534|FG003|OLE Part of Study|Subject/Guardian decision|5|||
46979037|NCT01804816|83224544|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
46979038|NCT01804816|83224544|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
46979039|NCT01803555|83224553|FG000|Overall Study|Adverse Event|3|||
46979040|NCT01803555|83224554|FG001|Overall Study|Adverse Event|2|||
46979041|NCT01803555|83224553|FG000|Overall Study|Withdrawal by Subject|3|||
47080026|NCT01380782|83388113|FG003|Overall Study|Death|0|||
47080027|NCT01380782|83388110|FG000|Overall Study|Lack of Efficacy|10|||
47080028|NCT01380782|83388111|FG001|Overall Study|Lack of Efficacy|9|||
47080029|NCT01380782|83388112|FG002|Overall Study|Lack of Efficacy|10|||
47080030|NCT01380782|83388113|FG003|Overall Study|Lack of Efficacy|3|||
47080031|NCT01380782|83388110|FG000|Overall Study|Physician Decision|1|||
47080032|NCT01380782|83388111|FG001|Overall Study|Physician Decision|0|||
47080033|NCT01380782|83388112|FG002|Overall Study|Physician Decision|0|||
47080034|NCT01380782|83388113|FG003|Overall Study|Physician Decision|0|||
47080035|NCT01380782|83388110|FG000|Overall Study|Withdrawal by Subject|0|||
47080036|NCT01380782|83388111|FG001|Overall Study|Withdrawal by Subject|0|||
47080037|NCT01380782|83388112|FG002|Overall Study|Withdrawal by Subject|1|||
47080038|NCT01380782|83388113|FG003|Overall Study|Withdrawal by Subject|1|||
47080039|NCT01398176|83388127|FG000|Overall Study|Lost to Follow-up|1|||
47080040|NCT01398176|83388128|FG001|Overall Study|Lost to Follow-up|3|||
47080041|NCT01398176|83388127|FG000|Overall Study|Physician Decision|2|||
47080042|NCT01398176|83388128|FG001|Overall Study|Physician Decision|3|||
47080043|NCT01397786|83388181|FG000|Phase A|Lost to Follow-up|0|||
47080044|NCT01397786|83388182|FG001|Phase A|Lost to Follow-up|0|||
47080045|NCT01397786|83388183|FG002|Phase A|Lost to Follow-up|6|||
47080046|NCT01397786|83388181|FG000|Phase A|Adverse Event|0|||
47080047|NCT01397786|83388182|FG001|Phase A|Adverse Event|0|||
46675475|NCT01133821|82891216|FG000|Overall Study|Lost to Follow-up|8|||
46675476|NCT01133821|82891217|FG001|Overall Study|Lost to Follow-up|11|||
46675477|NCT01133821|82891216|FG000|Overall Study|Withdrawal by Subject|8|||
46675478|NCT01133821|82891217|FG001|Overall Study|Withdrawal by Subject|3|||
46675479|NCT01133821|82891216|FG000|Overall Study|preferred other treatment|1|||
46675480|NCT01133821|82891217|FG001|Overall Study|preferred other treatment|1|||
47080048|NCT01397786|83388183|FG002|Phase A|Adverse Event|8|||
47080049|NCT01397786|83388181|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
47080050|NCT01397786|83388182|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
47080051|NCT01397786|83388183|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
47080052|NCT01397786|83388181|FG000|Phase A|Physician Decision|0|||
47080053|NCT01397786|83388182|FG001|Phase A|Physician Decision|0|||
47080054|NCT01397786|83388183|FG002|Phase A|Physician Decision|1|||
47080055|NCT01397786|83388181|FG000|Phase A|Withdrawal by Subject|0|||
46795188|NCT00565812|83013476|FG001|Overall Study|Withdrawal by Subject|47|||
46795189|NCT00565812|83013477|FG002|Overall Study|Withdrawal by Subject|48|||
46795190|NCT00565812|83013475|FG000|Overall Study|Work Schedule|5|||
46795191|NCT00565812|83013476|FG001|Overall Study|Work Schedule|3|||
46795192|NCT00565812|83013477|FG002|Overall Study|Work Schedule|1|||
46795193|NCT00565812|83013475|FG000|Overall Study|Protocol Violation|2|||
46795194|NCT00565812|83013476|FG001|Overall Study|Protocol Violation|6|||
46795195|NCT00565812|83013477|FG002|Overall Study|Protocol Violation|4|||
46795196|NCT00565812|83013475|FG000|Overall Study|Adverse Event|41|||
46795197|NCT00565812|83013476|FG001|Overall Study|Adverse Event|54|||
46795198|NCT00565812|83013477|FG002|Overall Study|Adverse Event|40|||
46795199|NCT00565812|83013475|FG000|Overall Study|Jury Duty|1|||
46795200|NCT00565812|83013476|FG001|Overall Study|Jury Duty|0|||
46795201|NCT00565812|83013477|FG002|Overall Study|Jury Duty|0|||
46795202|NCT00565812|83013475|FG000|Overall Study|Relocated Out of Area|5|||
46795203|NCT00565812|83013476|FG001|Overall Study|Relocated Out of Area|8|||
46795204|NCT00565812|83013477|FG002|Overall Study|Relocated Out of Area|9|||
46795205|NCT00565812|83013475|FG000|Overall Study|Sponsor Decision|1|||
46795206|NCT00565812|83013476|FG001|Overall Study|Sponsor Decision|5|||
46795207|NCT00565812|83013477|FG002|Overall Study|Sponsor Decision|1|||
47080056|NCT01397786|83388182|FG001|Phase A|Withdrawal by Subject|0|||
46795208|NCT00565812|83013475|FG000|Overall Study|Domestic Reasons|7|||
46795209|NCT00565812|83013476|FG001|Overall Study|Domestic Reasons|1|||
46795210|NCT00565812|83013477|FG002|Overall Study|Domestic Reasons|3|||
47080057|NCT01397786|83388183|FG002|Phase A|Withdrawal by Subject|5|||
47080058|NCT01397786|83388181|FG000|Phase A|Lack of Efficacy|0|||
47080059|NCT01397786|83388182|FG001|Phase A|Lack of Efficacy|0|||
47080060|NCT01397786|83388183|FG002|Phase A|Lack of Efficacy|1|||
47080061|NCT01397786|83388181|FG000|Phase B|Lost to Follow-up|22|||
47080062|NCT01397786|83388182|FG001|Phase B|Lost to Follow-up|12|||
47080063|NCT01397786|83388183|FG002|Phase B|Lost to Follow-up|22|||
47080064|NCT01397786|83388181|FG000|Phase B|Adverse Event|109|||
46675481|NCT01133821|82891216|FG000|Overall Study|Protocol Violation|0|||
46856427|NCT00355121|83072270|FG000|Overall Study|Lost to Follow-up|4|||
46856428|NCT00355121|83072271|FG001|Overall Study|Lost to Follow-up|7|||
47080065|NCT01397786|83388182|FG001|Phase B|Adverse Event|23|||
47080066|NCT01397786|83388183|FG002|Phase B|Adverse Event|27|||
47080067|NCT01397786|83388181|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
47080068|NCT01397786|83388182|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
47080069|NCT01397786|83388183|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
47080070|NCT01397786|83388181|FG000|Phase B|Physician Decision|9|||
47080071|NCT01397786|83388182|FG001|Phase B|Physician Decision|1|||
47080072|NCT01397786|83388183|FG002|Phase B|Physician Decision|3|||
47080073|NCT01397786|83388181|FG000|Phase B|Withdrawal by Subject|102|||
47080074|NCT01397786|83388182|FG001|Phase B|Withdrawal by Subject|45|||
47080075|NCT01397786|83388183|FG002|Phase B|Withdrawal by Subject|30|||
47080076|NCT01397786|83388181|FG000|Phase B|Protocol Deviation|1|||
47080077|NCT01397786|83388182|FG001|Phase B|Protocol Deviation|2|||
47080078|NCT01397786|83388183|FG002|Phase B|Protocol Deviation|4|||
47080079|NCT01397786|83388181|FG000|Phase B|Lack of Efficacy|22|||
47080080|NCT01397786|83388182|FG001|Phase B|Lack of Efficacy|7|||
47080081|NCT01397786|83388183|FG002|Phase B|Lack of Efficacy|14|||
47080082|NCT01397162|83388245|FG000|Overall Study|Adverse Event|4|||
47080083|NCT01397162|83388246|FG001|Overall Study|Adverse Event|0|||
47080084|NCT01397162|83388247|FG002|Overall Study|Adverse Event|0|||
47080085|NCT01397162|83388248|FG003|Overall Study|Adverse Event|0|||
47080086|NCT01397162|83388249|FG004|Overall Study|Adverse Event|0|||
47080087|NCT01397162|83388245|FG000|Overall Study|Not yet defined|3|||
47080088|NCT01397162|83388246|FG001|Overall Study|Not yet defined|4|||
47080089|NCT01397162|83388247|FG002|Overall Study|Not yet defined|3|||
47080090|NCT01397162|83388248|FG003|Overall Study|Not yet defined|5|||
47080091|NCT01397162|83388249|FG004|Overall Study|Not yet defined|3|||
47080092|NCT01397084|83388282|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
47080093|NCT01397084|83388282|FG000|Overall Study|Protocol Violation|2|||
47080094|NCT01397084|83388282|FG000|Overall Study|Adverse Event|2|||
47080095|NCT01397084|83388282|FG000|Overall Study|Withdrawal by Subject|1|||
47080096|NCT01397084|83388282|FG000|Overall Study|Lost to Follow-up|1|||
47080097|NCT01397084|83388282|FG000|Overall Study|Used other proton pump inhibitor|1|||
47080098|NCT01396148|83388322|FG000|Overall Study|Patient Decision|1|||
47080099|NCT01396070|83388355|FG000|Overall Study|Withdrawal by Subject|2|||
47080100|NCT01396070|83388355|FG000|Overall Study|Death|2|||
47080101|NCT01396070|83388355|FG000|Overall Study|Adverse Event|8|||
47080102|NCT01396070|83388355|FG000|Overall Study|Physician Decision|3|||
47080103|NCT01396070|83388355|FG000|Overall Study|Lack of Efficacy|4|||
47080104|NCT01395914|83388372|FG000|Overall Study|Unrelated to study drug AE|6|||
47080105|NCT01395914|83388373|FG001|Overall Study|Unrelated to study drug AE|1|||
47080106|NCT01395914|83388372|FG000|Overall Study|Death|23|||
47080107|NCT01395914|83388373|FG001|Overall Study|Death|17|||
47080108|NCT01395914|83388372|FG000|Overall Study|Other|9|||
47080109|NCT01395914|83388373|FG001|Overall Study|Other|3|||
47080110|NCT01395914|83388372|FG000|Overall Study|Withdrawal by patient|27|||
47080111|NCT01395914|83388373|FG001|Overall Study|Withdrawal by patient|14|||
47080112|NCT01395914|83388372|FG000|Overall Study|Study drug-related AE|1|||
47080113|NCT01395914|83388373|FG001|Overall Study|Study drug-related AE|0|||
47080114|NCT01395914|83388372|FG000|Overall Study|Lost to Follow-up|6|||
47080115|NCT01395914|83388373|FG001|Overall Study|Lost to Follow-up|2|||
47080116|NCT01395758|83388614|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
47080117|NCT01395758|83388615|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
47080118|NCT01395758|83388616|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
47080119|NCT01395524|83388674|FG000|Overall Study|Non-compliance with study schedule|1|||
47080120|NCT01395524|83388675|FG001|Overall Study|Non-compliance with study schedule|0|||
47080121|NCT01395524|83388676|FG002|Overall Study|Non-compliance with study schedule|1|||
47080122|NCT01395524|83388674|FG000|Overall Study|Lost to Follow-up|3|||
47080123|NCT01395524|83388675|FG001|Overall Study|Lost to Follow-up|1|||
47080124|NCT01395524|83388676|FG002|Overall Study|Lost to Follow-up|1|||
47080125|NCT01395524|83388674|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
47080126|NCT01395524|83388675|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
47080127|NCT01395524|83388676|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
47080128|NCT01395524|83388674|FG000|Overall Study|Severe noncompliance with protocol|1|||
47080129|NCT01395524|83388675|FG001|Overall Study|Severe noncompliance with protocol|0|||
47080130|NCT01395524|83388676|FG002|Overall Study|Severe noncompliance with protocol|0|||
47080131|NCT01395524|83388674|FG000|Overall Study|Adverse Event|4|||
47080132|NCT01395524|83388675|FG001|Overall Study|Adverse Event|4|||
47080133|NCT01395524|83388676|FG002|Overall Study|Adverse Event|3|||
47080134|NCT01395524|83388674|FG000|Overall Study|Death|1|||
47080135|NCT01395524|83388675|FG001|Overall Study|Death|0|||
47080136|NCT01395524|83388676|FG002|Overall Study|Death|0|||
47080137|NCT01395524|83388674|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
47080138|NCT01395524|83388675|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
47080139|NCT01395524|83388676|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
47080140|NCT01395524|83388674|FG000|Overall Study|Withdrawal by Subject|4|||
47080141|NCT01395524|83388675|FG001|Overall Study|Withdrawal by Subject|8|||
47080142|NCT01395524|83388676|FG002|Overall Study|Withdrawal by Subject|8|||
47080143|NCT01395524|83388674|FG000|Overall Study|Did not receive treatment|1|||
47080144|NCT01395524|83388675|FG001|Overall Study|Did not receive treatment|1|||
47080145|NCT01395524|83388676|FG002|Overall Study|Did not receive treatment|3|||
47080146|NCT01395524|83388674|FG000|Overall Study|Subject had spinal surgery|0|||
47080147|NCT01395524|83388675|FG001|Overall Study|Subject had spinal surgery|0|||
47080148|NCT01395524|83388676|FG002|Overall Study|Subject had spinal surgery|1|||
47080149|NCT01395368|83388684|FG000|Overall Study|Physician Decision|14|||
47080150|NCT01395368|83388684|FG000|Overall Study|Withdrawal by Subject|2|||
47080151|NCT01394978|83388691|FG000|Overall Study|Withdrawal by Subject|2|||
47080152|NCT01394978|83388692|FG001|Overall Study|Withdrawal by Subject|4|||
47080153|NCT01394978|83388691|FG000|Overall Study|Lost to Follow-up|13|||
46979042|NCT01803555|83224554|FG001|Overall Study|Withdrawal by Subject|3|||
46675482|NCT01133821|82891217|FG001|Overall Study|Protocol Violation|1|||
46675483|NCT01133821|82891216|FG000|Overall Study|Refused participation|1|||
46675484|NCT01133821|82891217|FG001|Overall Study|Refused participation|3|||
46675485|NCT00472446|82891227|FG000|Overall Study|Protocol Violation|0|||
46795211|NCT00565812|83013475|FG000|Overall Study|Research Site Closure|6|||
46795212|NCT00565812|83013476|FG001|Overall Study|Research Site Closure|1|||
46795213|NCT00565812|83013477|FG002|Overall Study|Research Site Closure|8|||
46795214|NCT00565812|83013475|FG000|Overall Study|Surgical Intervention|0|||
46795215|NCT00565812|83013476|FG001|Overall Study|Surgical Intervention|1|||
46795216|NCT00565812|83013477|FG002|Overall Study|Surgical Intervention|2|||
46675486|NCT00472446|82891228|FG001|Overall Study|Protocol Violation|0|||
46795217|NCT00565812|83013475|FG000|Overall Study|Low Compliance|1|||
46675487|NCT00472446|82891229|FG002|Overall Study|Protocol Violation|0|||
46675488|NCT00472446|82891230|FG003|Overall Study|Protocol Violation|1|||
46675489|NCT00472446|82891227|FG000|Overall Study|Reintervention|0|||
46675490|NCT00472446|82891228|FG001|Overall Study|Reintervention|0|||
46675491|NCT00472446|82891229|FG002|Overall Study|Reintervention|1|||
46675492|NCT00472446|82891230|FG003|Overall Study|Reintervention|1|||
46675493|NCT00472446|82891227|FG000|Overall Study|Questionnaires not returned|5|||
46675494|NCT00472446|82891228|FG001|Overall Study|Questionnaires not returned|6|||
46675495|NCT00472446|82891229|FG002|Overall Study|Questionnaires not returned|6|||
46675496|NCT00472446|82891230|FG003|Overall Study|Questionnaires not returned|4|||
46675497|NCT00472290|82891240|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
46675498|NCT00472290|82891240|FG000|Overall Study|Protocol Specified Criteria|7|||
46675499|NCT00472290|82891240|FG000|Overall Study|Administrative Decision|37|||
46675500|NCT00472290|82891240|FG000|Overall Study|Death|3|||
46675501|NCT00472290|82891240|FG000|Overall Study|Lost to Follow-up|1|||
46675502|NCT00472290|82891240|FG000|Overall Study|Lack of Efficacy|1|||
46675503|NCT00472290|82891240|FG000|Overall Study|Disease Progression|4|||
46675504|NCT00472290|82891240|FG000|Overall Study|Withdrawal by Subject|5|||
46675505|NCT00472290|82891240|FG000|Overall Study|Adverse Event|6|||
46675506|NCT00472290|82891240|FG000|Overall Study|Requirement for alternative therapy|7|||
46675507|NCT01133704|82891246|FG000|Overall Study|Death|44|||
46675508|NCT01133704|82891247|FG001|Overall Study|Death|26|||
46675509|NCT01133704|82891246|FG000|Overall Study|Patient refused to continue|4|||
46675510|NCT01133704|82891247|FG001|Overall Study|Patient refused to continue|0|||
46675511|NCT01133704|82891246|FG000|Overall Study|Study Closure|1|||
46675512|NCT01133704|82891247|FG001|Overall Study|Study Closure|0|||
46675513|NCT01133665|82891253|FG000|Overall Study|Physician Decision|2|||
46675514|NCT01133626|82891260|FG000|Overall Study|Adverse Event|0|||
46675515|NCT01133626|82891261|FG001|Overall Study|Adverse Event|1|||
46675516|NCT01133626|82891262|FG002|Overall Study|Adverse Event|0|||
46979043|NCT01803555|83224553|FG000|Overall Study|Non-compliance|1|||
46979044|NCT01803555|83224554|FG001|Overall Study|Non-compliance|1|||
46979045|NCT01803555|83224553|FG000|Overall Study|Protocol Violation|3|||
46979046|NCT01803555|83224554|FG001|Overall Study|Protocol Violation|5|||
46979047|NCT01803555|83224553|FG000|Overall Study|Lost to Follow-up|0|||
46675517|NCT01133626|82891260|FG000|Overall Study|Withdrawal by Subject|1|||
47080154|NCT01394978|83388692|FG001|Overall Study|Lost to Follow-up|20|||
47080155|NCT01394978|83388691|FG000|Overall Study|Death|6|||
47080156|NCT01394978|83388692|FG001|Overall Study|Death|7|||
47080157|NCT01394276|83388699|FG000|Overall Study|Related Adverse event (AEs)|15|||
47080158|NCT01394276|83388699|FG000|Overall Study|Not related AEs|9|||
47080159|NCT01394276|83388699|FG000|Overall Study|Remission of disease|2|||
47080160|NCT01394276|83388699|FG000|Overall Study|Insufficient therapeutic effect|17|||
47080161|NCT01394276|83388699|FG000|Overall Study|Insufficient compliance|9|||
47080162|NCT01394276|83388699|FG000|Overall Study|Lost to Follow-up|5|||
47080163|NCT01394276|83388699|FG000|Overall Study|Participant moved to another site|1|||
47080164|NCT01394276|83388699|FG000|Overall Study|Pregnancy|1|||
47080165|NCT01394276|83388699|FG000|Overall Study|unavailability of drug at the Hospital|2|||
47080166|NCT01394276|83388699|FG000|Overall Study|Symptoms of concurrent diseases|1|||
47080167|NCT00211172|83388799|FG000|Overall Study|Died or lost health plan eligibility|39|||
47080168|NCT00211172|83388800|FG001|Overall Study|Died or lost health plan eligibility|32|||
47080169|NCT00210626|83388851|FG000|Overall Study|Adverse Event|1|||
47080170|NCT00210626|83388852|FG001|Overall Study|Adverse Event|2|||
47080171|NCT00210626|83388851|FG000|Overall Study|Protocol Violation|1|||
47080172|NCT00210626|83388852|FG001|Overall Study|Protocol Violation|5|||
46675518|NCT01133626|82891261|FG001|Overall Study|Withdrawal by Subject|2|||
47080173|NCT00210626|83388851|FG000|Overall Study|Lost to Follow-up|11|||
47080174|NCT00210626|83388852|FG001|Overall Study|Lost to Follow-up|11|||
46675519|NCT01133626|82891262|FG002|Overall Study|Withdrawal by Subject|2|||
46675520|NCT01133626|82891260|FG000|Overall Study|Other|0|||
46675521|NCT01133626|82891261|FG001|Overall Study|Other|2|||
46675522|NCT01133626|82891262|FG002|Overall Study|Other|0|||
46675523|NCT01133392|82891272|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
46795218|NCT00565812|83013476|FG001|Overall Study|Low Compliance|0|||
47080175|NCT00210626|83388851|FG000|Overall Study|Death|1|||
47080176|NCT00210626|83388852|FG001|Overall Study|Death|0|||
46795219|NCT00565812|83013477|FG002|Overall Study|Low Compliance|1|||
46795220|NCT00565812|83013475|FG000|Overall Study|Follow-up Visit Not Completed|2|||
46795221|NCT00565812|83013476|FG001|Overall Study|Follow-up Visit Not Completed|0|||
46795222|NCT00565812|83013477|FG002|Overall Study|Follow-up Visit Not Completed|1|||
46795223|NCT00565812|83013475|FG000|Overall Study|Physician Decision|2|||
46795224|NCT00565812|83013476|FG001|Overall Study|Physician Decision|0|||
46795225|NCT00565812|83013477|FG002|Overall Study|Physician Decision|0|||
46795226|NCT03974334|83013485|FG000|Overall Study|Lost to Follow-up|1|||
46795227|NCT03970824|83013492|FG000|Overall Study|Withdrawal by Subject|1|||
46795228|NCT03970824|83013493|FG001|Overall Study|Withdrawal by Subject|1|||
46795229|NCT03970824|83013494|FG002|Overall Study|Withdrawal by Subject|3|||
46795230|NCT03970824|83013492|FG000|Overall Study|Lost to Follow-up|0|||
47080177|NCT00210626|83388851|FG000|Overall Study|Withdrawal by Subject|29|||
47080178|NCT00210626|83388852|FG001|Overall Study|Withdrawal by Subject|20|||
47080179|NCT00210626|83388851|FG000|Overall Study|Physician Decision|0|||
47080180|NCT00210626|83388852|FG001|Overall Study|Physician Decision|2|||
47080181|NCT00210626|83388851|FG000|Overall Study|Sponser Request|1|||
47080182|NCT00210626|83388852|FG001|Overall Study|Sponser Request|0|||
47080183|NCT00210626|83388851|FG000|Overall Study|Other|4|||
47080184|NCT00210626|83388852|FG001|Overall Study|Other|5|||
47080185|NCT00217022|83388874|FG000|Overall Study|Withdrawal by Subject|1|||
47080186|NCT00217022|83388875|FG001|Overall Study|Withdrawal by Subject|1|||
47080187|NCT00219284|83389222|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
47080188|NCT00219284|83389223|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
46795231|NCT03970824|83013493|FG001|Overall Study|Lost to Follow-up|2|||
46795232|NCT03970824|83013494|FG002|Overall Study|Lost to Follow-up|1|||
47080189|NCT00219284|83389222|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
46795233|NCT03970824|83013492|FG000|Overall Study|Adverse Event|1|||
47080190|NCT00219284|83389223|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
47080191|NCT00219284|83389222|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
47080192|NCT00219284|83389223|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
47080193|NCT00219284|83389222|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
47080194|NCT00219284|83389223|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
47080195|NCT00219284|83389222|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
47080196|NCT00219284|83389223|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
47080197|NCT00219284|83389222|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
47080198|NCT00219284|83389223|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
47080199|NCT00219284|83389222|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
46979048|NCT01803555|83224554|FG001|Overall Study|Lost to Follow-up|2|||
46979049|NCT01803555|83224553|FG000|Overall Study|Other than specified|3|||
46979050|NCT01803555|83224554|FG001|Overall Study|Other than specified|5|||
46979051|NCT01112306|83224560|FG000|Overall Study|Death|175|||
47080200|NCT00219284|83389223|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
46979052|NCT01112306|83224560|FG000|Overall Study|Lost to Follow-up|9|||
46979053|NCT01112306|83224560|FG000|Overall Study|Withdrawal by Subject|31|||
46979054|NCT01112306|83224560|FG000|Overall Study|Other|70|||
46979055|NCT02524665|83224564|FG000|Overall Study|Lost to Follow-up|1|||
47080201|NCT00219284|83389222|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
47080202|NCT00219284|83389223|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
47080203|NCT00219284|83389222|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
47080204|NCT00219284|83389223|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
47080205|NCT00216476|83389362|FG000|Overall Study|Withdrawal by Subject|59|||
47080206|NCT00216476|83389363|FG001|Overall Study|Withdrawal by Subject|72|||
47080207|NCT00216476|83389364|FG002|Overall Study|Withdrawal by Subject|9|||
47080208|NCT00216476|83389362|FG000|Overall Study|Lost to Follow-up|10|||
47080209|NCT00216476|83389363|FG001|Overall Study|Lost to Follow-up|9|||
46795234|NCT03970824|83013493|FG001|Overall Study|Adverse Event|0|||
46795235|NCT03970824|83013494|FG002|Overall Study|Adverse Event|0|||
46795236|NCT00564486|83013505|FG000|Overall Study|Adverse Event|0|||
46795237|NCT00564486|83013506|FG001|Overall Study|Adverse Event|1|||
46856429|NCT00355121|83072272|FG002|Overall Study|Lost to Follow-up|1|||
46856430|NCT00355121|83072270|FG000|Overall Study|Withdrawal by Subject|9|||
46856431|NCT00355121|83072271|FG001|Overall Study|Withdrawal by Subject|10|||
46856432|NCT00355121|83072272|FG002|Overall Study|Withdrawal by Subject|2|||
46856433|NCT00355121|83072270|FG000|Overall Study|Serious adverse events|0|||
46856434|NCT00355121|83072271|FG001|Overall Study|Serious adverse events|2|||
46856435|NCT00355121|83072272|FG002|Overall Study|Serious adverse events|0|||
46856436|NCT00343889|83072285|FG000|Overall Study|Lost to Follow-up|2|||
46856437|NCT00343889|83072286|FG001|Overall Study|Lost to Follow-up|0|||
46856438|NCT00343889|83072285|FG000|Overall Study|Withdrawal by Subject|0|||
46856439|NCT00343889|83072286|FG001|Overall Study|Withdrawal by Subject|1|||
46856440|NCT00343889|83072285|FG000|Overall Study|Protocol Violation|1|||
46856441|NCT00343889|83072286|FG001|Overall Study|Protocol Violation|0|||
46856442|NCT00354341|83072294|FG000|Overall Study|Adverse Event|1|||
46795238|NCT00564486|83013507|FG002|Overall Study|Adverse Event|0|||
46795239|NCT00564486|83013508|FG003|Overall Study|Adverse Event|0|||
46795240|NCT00564486|83013505|FG000|Overall Study|Withdrawal by Subject|4|||
46795241|NCT00564486|83013506|FG001|Overall Study|Withdrawal by Subject|0|||
46856443|NCT00354341|83072295|FG001|Overall Study|Adverse Event|0|||
47080210|NCT00216476|83389364|FG002|Overall Study|Lost to Follow-up|1|||
47080211|NCT00216476|83389362|FG000|Overall Study|Adverse Event|6|||
47080212|NCT00216476|83389363|FG001|Overall Study|Adverse Event|10|||
47080213|NCT00216476|83389364|FG002|Overall Study|Adverse Event|1|||
47080214|NCT00216476|83389362|FG000|Overall Study|Lack of Efficacy|4|||
47080215|NCT00216476|83389363|FG001|Overall Study|Lack of Efficacy|3|||
47080216|NCT00216476|83389364|FG002|Overall Study|Lack of Efficacy|0|||
47080217|NCT00216476|83389362|FG000|Overall Study|Death|2|||
47080218|NCT00216476|83389363|FG001|Overall Study|Death|0|||
47080219|NCT00216476|83389364|FG002|Overall Study|Death|0|||
47080220|NCT00216476|83389362|FG000|Overall Study|Pregnancy|0|||
47080221|NCT00216476|83389363|FG001|Overall Study|Pregnancy|1|||
47080222|NCT00216476|83389364|FG002|Overall Study|Pregnancy|1|||
47080223|NCT00216476|83389362|FG000|Overall Study|Other|0|||
47080224|NCT00216476|83389363|FG001|Overall Study|Other|0|||
47080225|NCT00216476|83389364|FG002|Overall Study|Other|1|||
47080226|NCT00216476|83389362|FG000|Overall Study|Refuses Injection|11|||
47080227|NCT00216476|83389363|FG001|Overall Study|Refuses Injection|0|||
47080228|NCT00216476|83389364|FG002|Overall Study|Refuses Injection|0|||
47080229|NCT00216476|83389362|FG000|Overall Study|No Further Need for Treatment|3|||
47080230|NCT00216476|83389363|FG001|Overall Study|No Further Need for Treatment|4|||
47080231|NCT00216476|83389364|FG002|Overall Study|No Further Need for Treatment|1|||
47080232|NCT00216476|83389362|FG000|Overall Study|Non-compliance|0|||
47080233|NCT00216476|83389363|FG001|Overall Study|Non-compliance|4|||
47080234|NCT00216476|83389364|FG002|Overall Study|Non-compliance|1|||
47080235|NCT00216476|83389362|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
46979056|NCT02638129|83224571|FG000|Overall Study|Study terminated|28|||
46795242|NCT00564486|83013507|FG002|Overall Study|Withdrawal by Subject|0|||
46795243|NCT00564486|83013508|FG003|Overall Study|Withdrawal by Subject|5|||
46979057|NCT02638129|83224572|FG001|Overall Study|Study terminated|30|||
46675524|NCT01133392|82891273|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
46675525|NCT01133392|82891272|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
46675526|NCT01133392|82891273|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
46675527|NCT00471354|82891279|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
46675528|NCT00471354|82891279|FG000|Overall Study|Adverse Event|13|||
46675529|NCT00471354|82891279|FG000|Overall Study|Protocol Violation|12|||
46675530|NCT00471354|82891279|FG000|Overall Study|Withdrawal by Subject|1|||
46675531|NCT00471354|82891279|FG000|Overall Study|Physician Decision|4|||
46675532|NCT00471354|82891279|FG000|Overall Study|Sponsor Decision|1|||
46675533|NCT00471354|82891279|FG000|Overall Study|Lost to Follow-up|3|||
46675534|NCT00471354|82891279|FG000|Overall Study|Lack of Efficacy|5|||
46675535|NCT00471354|82891279|FG000|Overall Study|Patient/Caregiver Decision|12|||
46675536|NCT00471315|82891283|FG000|Overall Study|Adverse Event|7|||
46675537|NCT00471315|82891283|FG000|Overall Study|Withdrawal by Subject|1|||
46675538|NCT00471237|82891294|FG000|Overall Study|Adverse Event|6|||
46675539|NCT00471237|82891295|FG001|Overall Study|Adverse Event|5|||
46675540|NCT00471237|82891296|FG002|Overall Study|Adverse Event|4|||
46675541|NCT00471237|82891297|FG003|Overall Study|Adverse Event|8|||
46675542|NCT00471237|82891298|FG004|Overall Study|Adverse Event|7|||
46675543|NCT00471237|82891299|FG005|Overall Study|Adverse Event|5|||
46795244|NCT00564486|83013505|FG000|Overall Study|Subject refused to have blood drawn|0|||
46675544|NCT00471237|82891300|FG006|Overall Study|Adverse Event|0|||
46675545|NCT00471237|82891294|FG000|Overall Study|Lost to Follow-up|1|||
46795245|NCT00564486|83013506|FG001|Overall Study|Subject refused to have blood drawn|0|||
46795246|NCT00564486|83013507|FG002|Overall Study|Subject refused to have blood drawn|1|||
46795247|NCT00564486|83013508|FG003|Overall Study|Subject refused to have blood drawn|0|||
46795248|NCT00564486|83013505|FG000|Overall Study|Lost to Follow-up|3|||
46795249|NCT00564486|83013506|FG001|Overall Study|Lost to Follow-up|0|||
46795250|NCT00564486|83013507|FG002|Overall Study|Lost to Follow-up|2|||
46795251|NCT00564486|83013508|FG003|Overall Study|Lost to Follow-up|2|||
46795252|NCT00481078|83013524|FG000|Overall Study|Progression of disease|11|||
46795253|NCT00481078|83013525|FG001|Overall Study|Progression of disease|11|||
46795254|NCT00481078|83013524|FG000|Overall Study|Adverse Event|15|||
46795255|NCT00481078|83013525|FG001|Overall Study|Adverse Event|3|||
46795256|NCT00481078|83013524|FG000|Overall Study|Death|5|||
46795257|NCT00481078|83013525|FG001|Overall Study|Death|3|||
46795258|NCT00481078|83013524|FG000|Overall Study|Intercurrent illness|1|||
46795259|NCT00481078|83013525|FG001|Overall Study|Intercurrent illness|0|||
46856444|NCT00354341|83072294|FG000|Overall Study|Death|0|||
46856445|NCT00354341|83072295|FG001|Overall Study|Death|2|||
46795260|NCT00481078|83013524|FG000|Overall Study|Withdrawal by Subject|7|||
46795261|NCT00481078|83013525|FG001|Overall Study|Withdrawal by Subject|1|||
46795262|NCT00481078|83013524|FG000|Overall Study|Information not available|1|||
46675546|NCT00471237|82891295|FG001|Overall Study|Lost to Follow-up|1|||
46675547|NCT00471237|82891296|FG002|Overall Study|Lost to Follow-up|0|||
46675548|NCT00471237|82891297|FG003|Overall Study|Lost to Follow-up|2|||
46675549|NCT00471237|82891298|FG004|Overall Study|Lost to Follow-up|3|||
46675550|NCT00471237|82891299|FG005|Overall Study|Lost to Follow-up|0|||
46675551|NCT00471237|82891300|FG006|Overall Study|Lost to Follow-up|0|||
46675552|NCT00471237|82891294|FG000|Overall Study|Protocol Violation|3|||
46675553|NCT00471237|82891295|FG001|Overall Study|Protocol Violation|6|||
46675554|NCT00471237|82891296|FG002|Overall Study|Protocol Violation|3|||
47080236|NCT00216476|83389363|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
47080237|NCT00216476|83389364|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
47080238|NCT00216476|83389362|FG000|Overall Study|Administrative Reasons|1|||
47080239|NCT00216476|83389363|FG001|Overall Study|Administrative Reasons|1|||
47080240|NCT00216476|83389364|FG002|Overall Study|Administrative Reasons|0|||
47080241|NCT00216476|83389362|FG000|Overall Study|Protocol Deviation|5|||
47080242|NCT00216476|83389363|FG001|Overall Study|Protocol Deviation|1|||
47080243|NCT00216476|83389364|FG002|Overall Study|Protocol Deviation|0|||
47080244|NCT00216476|83389362|FG000|Overall Study|Patient Moved|2|||
47080245|NCT00216476|83389363|FG001|Overall Study|Patient Moved|2|||
46675555|NCT00471237|82891297|FG003|Overall Study|Protocol Violation|2|||
46795263|NCT00481078|83013525|FG001|Overall Study|Information not available|0|||
46795264|NCT00481078|83013524|FG000|Overall Study|Received other treatment|2|||
46795265|NCT00481078|83013525|FG001|Overall Study|Received other treatment|1|||
46979058|NCT01658943|83224580|FG000|Overall Study|Adverse Event|6|||
46979059|NCT01658943|83224581|FG001|Overall Study|Adverse Event|13|||
47080246|NCT00216476|83389364|FG002|Overall Study|Patient Moved|0|||
47080247|NCT00216086|83389415|FG000|Overall Study|Protocol Violation|1|||
47080248|NCT00216086|83389415|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
47080249|NCT00216086|83389415|FG000|Overall Study|Social Reasons|2|||
47080250|NCT00215150|83389446|FG000|Open Label Phase|Lost to Follow-up|7|||
47080251|NCT00215150|83389446|FG000|Open Label Phase|Withdrawal by Subject|1|||
47080252|NCT00215150|83389446|FG000|Open Label Phase|Did not complete a post base visit|13|||
46795266|NCT00481078|83013524|FG000|Overall Study|Brain metastasis|0|||
46979060|NCT01658943|83224580|FG000|Overall Study|Withdrawal by Subject|9|||
46979061|NCT01658943|83224581|FG001|Overall Study|Withdrawal by Subject|2|||
46979062|NCT01658943|83224580|FG000|Overall Study|Progression/Relapse|39|||
46979063|NCT01658943|83224581|FG001|Overall Study|Progression/Relapse|40|||
46675556|NCT00471237|82891298|FG004|Overall Study|Protocol Violation|2|||
46675557|NCT00471237|82891299|FG005|Overall Study|Protocol Violation|4|||
46675558|NCT00471237|82891300|FG006|Overall Study|Protocol Violation|1|||
46675559|NCT00471237|82891294|FG000|Overall Study|Withdrawal by Subject|8|||
46675560|NCT00471237|82891295|FG001|Overall Study|Withdrawal by Subject|6|||
46675561|NCT00471237|82891296|FG002|Overall Study|Withdrawal by Subject|5|||
46675562|NCT00471237|82891297|FG003|Overall Study|Withdrawal by Subject|8|||
46675563|NCT00471237|82891298|FG004|Overall Study|Withdrawal by Subject|7|||
46675564|NCT00471237|82891299|FG005|Overall Study|Withdrawal by Subject|4|||
46795267|NCT00481078|83013525|FG001|Overall Study|Brain metastasis|1|||
46795268|NCT00480532|83013535|FG000|Overall Study|Withdrawal by Subject|2|||
46979064|NCT01658943|83224580|FG000|Overall Study|Death|4|||
47080253|NCT00215150|83389446|FG000|Open Label Phase|Did not meet randomization criteria|9|||
47080254|NCT00215150|83389446|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
47080255|NCT00215150|83389446|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
47080256|NCT00215150|83389446|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
47080257|NCT00214136|83389454|FG000|Overall Study|Death|5|||
47080258|NCT00213980|83389460|FG000|Overall Study|Withdrawal by Subject|3|||
47080259|NCT00213980|83389461|FG001|Overall Study|Withdrawal by Subject|1|||
47080260|NCT00213980|83389460|FG000|Overall Study|Adverse Event|1|||
47080261|NCT00213980|83389461|FG001|Overall Study|Adverse Event|1|||
47080262|NCT00213980|83389460|FG000|Overall Study|Disease progression|0|||
47080263|NCT00213980|83389461|FG001|Overall Study|Disease progression|2|||
47080264|NCT00213980|83389460|FG000|Overall Study|Developed ovarian cancer|1|||
47080265|NCT00213980|83389461|FG001|Overall Study|Developed ovarian cancer|0|||
47080266|NCT00213980|83389460|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
47080267|NCT00213980|83389461|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
47080268|NCT05086289|83389520|FG000|Overall Study|Adverse Event|4|||
47080269|NCT05086289|83389521|FG001|Overall Study|Adverse Event|2|||
46675565|NCT00471237|82891300|FG006|Overall Study|Withdrawal by Subject|2|||
46675566|NCT00471237|82891294|FG000|Overall Study|Sponsor terminated study|20|||
46795269|NCT00480532|83013536|FG001|Overall Study|Withdrawal by Subject|4|||
46856446|NCT00354341|83072294|FG000|Overall Study|Refused treatment|1|||
46979065|NCT01658943|83224581|FG001|Overall Study|Death|2|||
46856447|NCT00354341|83072295|FG001|Overall Study|Refused treatment|2|||
46856448|NCT00354341|83072294|FG000|Overall Study|Failure to return|0|||
46856449|NCT00354341|83072295|FG001|Overall Study|Failure to return|1|||
46856450|NCT00354341|83072294|FG000|Overall Study|Other|1|||
46856451|NCT00354341|83072295|FG001|Overall Study|Other|2|||
46856452|NCT00354107|83072301|FG000|Overall Study|Adverse Event|2|||
46979066|NCT01658943|83224580|FG000|Overall Study|not protocol specified|4|||
46856453|NCT00354107|83072301|FG000|Overall Study|Physician Decision|2|||
46979067|NCT01658943|83224581|FG001|Overall Study|not protocol specified|1|||
46675567|NCT00471237|82891295|FG001|Overall Study|Sponsor terminated study|23|||
46675568|NCT00471237|82891296|FG002|Overall Study|Sponsor terminated study|19|||
46675569|NCT00471237|82891297|FG003|Overall Study|Sponsor terminated study|22|||
46675570|NCT00471237|82891298|FG004|Overall Study|Sponsor terminated study|18|||
46675571|NCT00471237|82891299|FG005|Overall Study|Sponsor terminated study|24|||
46675572|NCT00471237|82891300|FG006|Overall Study|Sponsor terminated study|0|||
46675573|NCT00471237|82891294|FG000|Overall Study|Non-compliance|0|||
46675574|NCT00471237|82891295|FG001|Overall Study|Non-compliance|1|||
46675575|NCT00471237|82891296|FG002|Overall Study|Non-compliance|0|||
46675576|NCT00471237|82891297|FG003|Overall Study|Non-compliance|1|||
46675577|NCT00471237|82891298|FG004|Overall Study|Non-compliance|0|||
46675578|NCT00471237|82891299|FG005|Overall Study|Non-compliance|0|||
46675579|NCT00471237|82891300|FG006|Overall Study|Non-compliance|0|||
46675580|NCT00471237|82891294|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
46675581|NCT00471237|82891295|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
46675582|NCT00471237|82891296|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
46675583|NCT00471237|82891297|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
46675584|NCT00471237|82891298|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
46675585|NCT00471237|82891299|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
46979068|NCT01658943|83224580|FG000|Overall Study|Not eligible|7|||
46675586|NCT00471237|82891300|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
46675587|NCT00471237|82891294|FG000|Overall Study|Early stopping due to non-efficacy|1|||
46675588|NCT00471237|82891295|FG001|Overall Study|Early stopping due to non-efficacy|0|||
46675589|NCT00471237|82891296|FG002|Overall Study|Early stopping due to non-efficacy|0|||
46675590|NCT00471237|82891297|FG003|Overall Study|Early stopping due to non-efficacy|0|||
46675591|NCT00471237|82891298|FG004|Overall Study|Early stopping due to non-efficacy|1|||
46675592|NCT00471237|82891299|FG005|Overall Study|Early stopping due to non-efficacy|0|||
46675593|NCT00471237|82891300|FG006|Overall Study|Early stopping due to non-efficacy|0|||
46675594|NCT00471237|82891294|FG000|Overall Study|Participant planned to travel to abraod|1|||
46795270|NCT00480532|83013537|FG002|Overall Study|Withdrawal by Subject|3|||
47080270|NCT05086289|83389520|FG000|Overall Study|Lost to Follow-up|2|||
47080271|NCT05086289|83389521|FG001|Overall Study|Lost to Follow-up|0|||
47080272|NCT05086289|83389520|FG000|Overall Study|Non-compliance with study drug|2|||
47080273|NCT05086289|83389521|FG001|Overall Study|Non-compliance with study drug|1|||
47080274|NCT05086289|83389520|FG000|Overall Study|Physician Decision|2|||
47080275|NCT05086289|83389521|FG001|Overall Study|Physician Decision|0|||
47080276|NCT05086289|83389520|FG000|Overall Study|Withdrawal by Subject|5|||
47080277|NCT05086289|83389521|FG001|Overall Study|Withdrawal by Subject|2|||
47080278|NCT05045144|83389534|FG000|Overall Study|Lost to Follow-up|3|||
47080279|NCT05045144|83389535|FG001|Overall Study|Lost to Follow-up|2|||
47080280|NCT05045144|83389536|FG002|Overall Study|Lost to Follow-up|3|||
47080281|NCT05045144|83389537|FG003|Overall Study|Lost to Follow-up|5|||
47080282|NCT05045144|83389538|FG004|Overall Study|Lost to Follow-up|13|||
47080283|NCT05045144|83389534|FG000|Overall Study|Withdrawal by Subject|0|||
47080284|NCT05045144|83389535|FG001|Overall Study|Withdrawal by Subject|1|||
47080285|NCT05045144|83389536|FG002|Overall Study|Withdrawal by Subject|0|||
47080286|NCT05045144|83389537|FG003|Overall Study|Withdrawal by Subject|0|||
47080287|NCT05045144|83389538|FG004|Overall Study|Withdrawal by Subject|0|||
47080288|NCT05045144|83389534|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
47080289|NCT05045144|83389535|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
47080290|NCT05045144|83389536|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
47080291|NCT05045144|83389537|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46675595|NCT00471237|82891295|FG001|Overall Study|Participant planned to travel to abraod|0|||
46979069|NCT01658943|83224581|FG001|Overall Study|Not eligible|9|||
46979070|NCT01658943|83224580|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
46675596|NCT00471237|82891296|FG002|Overall Study|Participant planned to travel to abraod|0|||
46675597|NCT00471237|82891297|FG003|Overall Study|Participant planned to travel to abraod|0|||
46675598|NCT00471237|82891298|FG004|Overall Study|Participant planned to travel to abraod|0|||
46675599|NCT00471237|82891299|FG005|Overall Study|Participant planned to travel to abraod|1|||
46675600|NCT00471237|82891300|FG006|Overall Study|Participant planned to travel to abraod|0|||
46675601|NCT00471237|82891294|FG000|Overall Study|High parathyroid hormone|0|||
46675602|NCT00471237|82891295|FG001|Overall Study|High parathyroid hormone|0|||
46675603|NCT00471237|82891296|FG002|Overall Study|High parathyroid hormone|1|||
46675604|NCT00471237|82891297|FG003|Overall Study|High parathyroid hormone|0|||
46675605|NCT00471237|82891298|FG004|Overall Study|High parathyroid hormone|0|||
46675606|NCT00471237|82891299|FG005|Overall Study|High parathyroid hormone|0|||
46675607|NCT00471237|82891300|FG006|Overall Study|High parathyroid hormone|0|||
46675608|NCT00471237|82891294|FG000|Overall Study|Participant lost medication|0|||
46675609|NCT00471237|82891295|FG001|Overall Study|Participant lost medication|0|||
46675610|NCT00471237|82891296|FG002|Overall Study|Participant lost medication|0|||
46675611|NCT00471237|82891297|FG003|Overall Study|Participant lost medication|0|||
46675612|NCT00471237|82891298|FG004|Overall Study|Participant lost medication|1|||
46675613|NCT00471237|82891299|FG005|Overall Study|Participant lost medication|0|||
46675614|NCT00471237|82891300|FG006|Overall Study|Participant lost medication|0|||
46675615|NCT00471237|82891294|FG000|Overall Study|Administration of prohibited medicine|0|||
46675616|NCT00471237|82891295|FG001|Overall Study|Administration of prohibited medicine|0|||
46675617|NCT00471237|82891296|FG002|Overall Study|Administration of prohibited medicine|0|||
46675618|NCT00471237|82891297|FG003|Overall Study|Administration of prohibited medicine|0|||
46675619|NCT00471237|82891298|FG004|Overall Study|Administration of prohibited medicine|1|||
46675620|NCT00471237|82891299|FG005|Overall Study|Administration of prohibited medicine|0|||
46675621|NCT00471237|82891300|FG006|Overall Study|Administration of prohibited medicine|0|||
46675622|NCT00471237|82891294|FG000|Overall Study|Participant shifted residence|0|||
46675623|NCT00471237|82891295|FG001|Overall Study|Participant shifted residence|0|||
46675624|NCT00471237|82891296|FG002|Overall Study|Participant shifted residence|0|||
46675625|NCT00471237|82891297|FG003|Overall Study|Participant shifted residence|0|||
46675626|NCT00471237|82891298|FG004|Overall Study|Participant shifted residence|1|||
46675627|NCT00471237|82891299|FG005|Overall Study|Participant shifted residence|0|||
46675628|NCT00471237|82891300|FG006|Overall Study|Participant shifted residence|0|||
46675629|NCT00471237|82891294|FG000|Overall Study|Participant's decision|0|||
46675630|NCT00471237|82891295|FG001|Overall Study|Participant's decision|0|||
46675631|NCT00471237|82891296|FG002|Overall Study|Participant's decision|0|||
46675632|NCT00471237|82891297|FG003|Overall Study|Participant's decision|0|||
46675633|NCT00471237|82891298|FG004|Overall Study|Participant's decision|0|||
46675634|NCT00471237|82891299|FG005|Overall Study|Participant's decision|1|||
46675635|NCT00471237|82891300|FG006|Overall Study|Participant's decision|0|||
46675636|NCT00471081|82891322|FG000|Active Phase|Protocol Violation|1|||
46675637|NCT00471081|82891323|FG001|Active Phase|Protocol Violation|1|||
46675638|NCT00471081|82891322|FG000|Active Phase|Withdrawal by Subject|0|||
46675639|NCT00471081|82891323|FG001|Active Phase|Withdrawal by Subject|3|||
46675640|NCT00471081|82891322|FG000|Active Phase|Lost to Follow-up|0|||
46675641|NCT00471081|82891323|FG001|Active Phase|Lost to Follow-up|1|||
46675642|NCT00471081|82891322|FG000|Active Phase|Lost health plan/insurance|1|||
46675643|NCT00471081|82891323|FG001|Active Phase|Lost health plan/insurance|8|||
46675644|NCT00471081|82891322|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
46675645|NCT00471081|82891323|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
46675646|NCT00471081|82891322|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
46675647|NCT00471081|82891323|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
46675648|NCT00471081|82891322|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
46675649|NCT00471081|82891323|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
46675650|NCT00470847|82891330|FG000|Overall Study|Pt still receiving treatment|1|||
46675651|NCT00470535|82891336|FG000|Overall Study|Disease Progression|13|||
46675652|NCT00470535|82891336|FG000|Overall Study|Withdrawal by Subject|1|||
46675653|NCT00470535|82891336|FG000|Overall Study|Adverse Event|1|||
46675654|NCT00470535|82891336|FG000|Overall Study|Death|1|||
46675655|NCT00470535|82891336|FG000|Overall Study|Other|2|||
46675656|NCT00470418|82891342|FG000|Overall Study|Withdrawal by Subject|1|||
46675657|NCT00470418|82891343|FG001|Overall Study|Withdrawal by Subject|0|||
46675658|NCT01133275|82891349|FG000|Overall Study|Withdrawal by Subject|1|||
46795271|NCT00480532|83013538|FG003|Overall Study|Withdrawal by Subject|1|||
46675659|NCT01133275|82891349|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
46675660|NCT00470184|82891353|FG000|Overall Study|Not Treated(became ineligible)|4|||
46675661|NCT00470184|82891353|FG000|Overall Study|Not treated (other)|1|||
46675662|NCT00470184|82891353|FG000|Overall Study|disease Progression|4|||
46675663|NCT00470184|82891353|FG000|Overall Study|Adverse Event|3|||
46979071|NCT01658943|83224581|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
46795272|NCT00480532|83013535|FG000|Overall Study|Protocol Violation|0|||
46795273|NCT00480532|83013536|FG001|Overall Study|Protocol Violation|0|||
46795274|NCT00480532|83013537|FG002|Overall Study|Protocol Violation|1|||
46979072|NCT02600819|83224587|FG000|GEN Phase|Adverse Event|2|||
47080292|NCT05045144|83389538|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
47080293|NCT05016765|83389554|FG000|Overall Study|Lost to Follow-up|4|||
47080294|NCT04982029|83389561|FG000|Overall Study|Lost to Follow-up|2|||
47080295|NCT04982029|83389562|FG001|Overall Study|Lost to Follow-up|3|||
47080296|NCT04897867|83389576|FG000|Overall Study|Withdrawal of Consent|1|||
47080297|NCT04897867|83389576|FG000|Overall Study|Pregnancy|1|||
47080298|NCT04897867|83389576|FG000|Overall Study|Lost to Follow-up|7|||
47080299|NCT04897867|83389576|FG000|Overall Study|Reason not Specified|2|||
47080300|NCT04161157|83389617|FG000|Overall Study|Lost to Follow-up|4|||
47080301|NCT04161157|83389617|FG000|Overall Study|Death|3|||
47080302|NCT04161157|83389617|FG000|Overall Study|Ineligible|2|||
47080303|NCT04161157|83389617|FG000|Overall Study|Withdrawal by Subject|4|||
47080304|NCT04035187|83389625|FG000|Overall Study|Withdrawal by Subject|2|||
47080305|NCT04035187|83389626|FG001|Overall Study|Withdrawal by Subject|1|||
47080306|NCT04035187|83389627|FG002|Overall Study|Withdrawal by Subject|0|||
47080307|NCT04035187|83389628|FG003|Overall Study|Withdrawal by Subject|0|||
47080308|NCT04035187|83389625|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
47080309|NCT04035187|83389626|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
47080310|NCT04035187|83389627|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
46675664|NCT00470184|82891353|FG000|Overall Study|Withdrawal by Subject|4|||
46675665|NCT00470184|82891353|FG000|Overall Study|other|5|||
46675666|NCT00470184|82891353|FG000|Overall Study|recurrence|1|||
46675667|NCT00470067|82891358|FG000|Overall Study|Death|1|||
46675668|NCT00470067|82891358|FG000|Overall Study|Disease Progression|6|||
46675669|NCT00475020|82891362|FG000|Overall Study|Physician Decision|3|||
46675670|NCT00475020|82891362|FG000|Overall Study|Insurance Denial|1|||
46675671|NCT00475020|82891362|FG000|Overall Study|Donor not able to donate the last minute|1|||
46675672|NCT02484456|82891368|FG000|Washout Period|Withdrawal by Subject|0|||
46675673|NCT02484456|82891369|FG001|Washout Period|Withdrawal by Subject|1|||
46675674|NCT02484456|82891368|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
46675675|NCT02484456|82891369|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
46675676|NCT02484456|82891368|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
46675677|NCT02484456|82891369|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
46675678|NCT02484456|82891368|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
46675679|NCT02484456|82891369|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
46675680|NCT01132807|82891376|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
46675681|NCT01132807|82891377|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
46675682|NCT01132807|82891378|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
46675683|NCT01132807|82891376|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
46675684|NCT01132807|82891377|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
46675685|NCT01132807|82891378|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
46675686|NCT01132651|82891388|FG000|Overall Study|Lost to Follow-up|1|||
46675687|NCT01132651|82891389|FG001|Overall Study|Lost to Follow-up|1|||
46675688|NCT01089543|82891399|FG000|Overall Study|Withdrawal by Subject|2|||
46675689|NCT01089543|82891400|FG001|Overall Study|Withdrawal by Subject|3|||
46675690|NCT01089543|82891401|FG002|Overall Study|Withdrawal by Subject|3|||
46675691|NCT01089543|82891402|FG003|Overall Study|Withdrawal by Subject|1|||
46795275|NCT00480532|83013538|FG003|Overall Study|Protocol Violation|0|||
46795276|NCT00496366|83013548|FG000|Overall Study|Death|1|||
46795277|NCT00488644|83013552|FG000|Overall Study|Not Eligible|1|||
46795278|NCT00488644|83013552|FG000|Overall Study|Not Evaluable|1|||
46795279|NCT00564018|83013559|FG000|Overall Study|Withdrawal by Subject|2|||
46795280|NCT00564018|83013560|FG001|Overall Study|Withdrawal by Subject|3|||
46795281|NCT00564018|83013561|FG002|Overall Study|Withdrawal by Subject|1|||
46795282|NCT03381287|83013573|FG000|Overall Study|Withdrawal by Subject|0|||
46795283|NCT03381287|83013574|FG001|Overall Study|Withdrawal by Subject|1|||
46795284|NCT03381287|83013575|FG002|Overall Study|Withdrawal by Subject|0|||
46795285|NCT03381287|83013576|FG003|Overall Study|Withdrawal by Subject|0|||
46795286|NCT03381287|83013573|FG000|Overall Study|Adverse Event|0|||
46795287|NCT03381287|83013574|FG001|Overall Study|Adverse Event|0|||
46795288|NCT03381287|83013575|FG002|Overall Study|Adverse Event|0|||
46795289|NCT03381287|83013576|FG003|Overall Study|Adverse Event|1|||
46675692|NCT01089543|82891399|FG000|Overall Study|Physician Decision|1|||
46675693|NCT01089543|82891400|FG001|Overall Study|Physician Decision|0|||
46675694|NCT01089543|82891401|FG002|Overall Study|Physician Decision|0|||
46675695|NCT01089543|82891402|FG003|Overall Study|Physician Decision|1|||
46675696|NCT01089543|82891399|FG000|Overall Study|Adverse Event|0|||
46675697|NCT01089543|82891400|FG001|Overall Study|Adverse Event|1|||
46675698|NCT01089543|82891401|FG002|Overall Study|Adverse Event|0|||
46675699|NCT01089543|82891402|FG003|Overall Study|Adverse Event|0|||
46675700|NCT01089504|82891414|FG000|Overall Study|Lost to Follow-up|1|||
46675701|NCT01089504|82891415|FG001|Overall Study|Lost to Follow-up|1|||
46675702|NCT01089504|82891414|FG000|Overall Study|Withdrawal by Subject|2|||
46795290|NCT03381287|83013573|FG000|Overall Study|Physician Decision|0|||
46795291|NCT03381287|83013574|FG001|Overall Study|Physician Decision|0|||
46795292|NCT03381287|83013575|FG002|Overall Study|Physician Decision|0|||
46795293|NCT03381287|83013576|FG003|Overall Study|Physician Decision|1|||
46675703|NCT01089504|82891415|FG001|Overall Study|Withdrawal by Subject|0|||
46795294|NCT00616928|83013600|FG000|Overall Study|Adverse Event|6|||
46795295|NCT00616928|83013601|FG001|Overall Study|Adverse Event|3|||
46675704|NCT01088997|82891423|FG000|Overall Study|Physician Decision|1|||
46795296|NCT00616928|83013602|FG002|Overall Study|Adverse Event|2|||
46979073|NCT02600819|83224588|FG001|GEN Phase|Adverse Event|0|||
46979074|NCT02600819|83224587|FG000|GEN Phase|Death|2|||
46979075|NCT02600819|83224588|FG001|GEN Phase|Death|0|||
46979076|NCT02600819|83224587|FG000|GEN Phase|Investigator's Discretion|4|||
46795297|NCT00616928|83013603|FG003|Overall Study|Adverse Event|2|||
46795298|NCT00616928|83013600|FG000|Overall Study|Other|51|||
46979077|NCT02600819|83224588|FG001|GEN Phase|Investigator's Discretion|0|||
46979078|NCT02600819|83224587|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
46795299|NCT00616928|83013601|FG001|Overall Study|Other|8|||
46795300|NCT00616928|83013602|FG002|Overall Study|Other|15|||
46795301|NCT00616928|83013603|FG003|Overall Study|Other|5|||
46979079|NCT02600819|83224588|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
46979080|NCT02600819|83224587|FG000|GEN Phase|Withdrew Consent|5|||
46979081|NCT02600819|83224588|FG001|GEN Phase|Withdrew Consent|0|||
46795302|NCT00616928|83013600|FG000|Overall Study|Lost to Follow-up|5|||
46795303|NCT00616928|83013601|FG001|Overall Study|Lost to Follow-up|7|||
46795304|NCT00616928|83013602|FG002|Overall Study|Lost to Follow-up|0|||
46979082|NCT02600819|83224587|FG000|GEN Phase|Lost to Follow-up|2|||
46979083|NCT02600819|83224588|FG001|GEN Phase|Lost to Follow-up|0|||
46675705|NCT01088997|82891424|FG001|Overall Study|Physician Decision|1|||
47080311|NCT04035187|83389628|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
47080312|NCT03852719|83389641|FG000|Overall Study|Still on study after Week 96|49|||
47080313|NCT03852719|83389642|FG001|Overall Study|Still on study after Week 96|47|||
47080314|NCT03852719|83389643|FG002|Overall Study|Still on study after Week 96|47|||
47080315|NCT03852719|83389641|FG000|Overall Study|Withdrawal of consent|0|||
47080316|NCT03852719|83389642|FG001|Overall Study|Withdrawal of consent|2|||
47080317|NCT03852719|83389643|FG002|Overall Study|Withdrawal of consent|2|||
47080318|NCT03852719|83389641|FG000|Overall Study|Physician Decision|0|||
47080319|NCT03852719|83389642|FG001|Overall Study|Physician Decision|0|||
47080320|NCT03852719|83389643|FG002|Overall Study|Physician Decision|1|||
47080321|NCT03852719|83389641|FG000|Overall Study|Pregnancy|1|||
47080322|NCT03852719|83389642|FG001|Overall Study|Pregnancy|0|||
47080323|NCT03852719|83389643|FG002|Overall Study|Pregnancy|0|||
47080324|NCT03852719|83389641|FG000|Overall Study|Death|1|||
47080325|NCT03852719|83389642|FG001|Overall Study|Death|0|||
47080326|NCT03852719|83389643|FG002|Overall Study|Death|0|||
47080327|NCT03785145|83389660|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
47080328|NCT03785145|83389661|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
47080329|NCT03785145|83389660|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
47080330|NCT03785145|83389661|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
47080331|NCT03785145|83389660|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
47080332|NCT03785145|83389661|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
47080333|NCT03785145|83389660|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
47080334|NCT03785145|83389661|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
47080335|NCT03785145|83389660|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
47080336|NCT03785145|83389661|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
47080337|NCT03785145|83389660|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
47080338|NCT03785145|83389661|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
47080339|NCT03785145|83389660|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
46856454|NCT00354107|83072301|FG000|Overall Study|Withdrawal by Subject|1|||
46856455|NCT00354029|83072307|FG000|Overall Study|Protocol Violation|4|||
46856456|NCT00354029|83072308|FG001|Overall Study|Protocol Violation|2|||
47080340|NCT03785145|83389661|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
47080341|NCT03785145|83389660|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
47080342|NCT03785145|83389661|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
47080343|NCT03785145|83389660|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
47080344|NCT03785145|83389661|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
47080345|NCT03785145|83389660|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
47080346|NCT03785145|83389661|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
47080347|NCT03785145|83389660|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
47080348|NCT03785145|83389661|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
47080349|NCT03320330|83389687|FG000|Overall Study|Lack of Efficacy|5|||
47080350|NCT03320330|83389688|FG001|Overall Study|Lack of Efficacy|5|||
47080351|NCT03320330|83389689|FG002|Overall Study|Lack of Efficacy|14|||
47080352|NCT03320330|83389687|FG000|Overall Study|Physician Decision|1|||
47080353|NCT03320330|83389688|FG001|Overall Study|Physician Decision|0|||
47080354|NCT03320330|83389689|FG002|Overall Study|Physician Decision|0|||
47080355|NCT03284788|83389722|FG000|Overall Study|Withdrawal by Subject|2|||
47080356|NCT03082612|83389728|FG000|Overall Study|Lost to Follow-up|2|||
47080357|NCT03082612|83389729|FG001|Overall Study|Lost to Follow-up|0|||
47080358|NCT02824627|83389768|FG000|Overall Study|Adverse Event|1|||
47080359|NCT02824627|83389769|FG001|Overall Study|Adverse Event|2|||
47080360|NCT02824627|83389768|FG000|Overall Study|Lost to Follow-up|2|||
47080361|NCT02824627|83389769|FG001|Overall Study|Lost to Follow-up|1|||
47080362|NCT02743611|83389775|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
47080363|NCT02743611|83389776|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
47080364|NCT02743611|83389777|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
47080365|NCT02743611|83389778|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
47080366|NCT01873833|83389796|FG000|Overall Study|Withdrawal by Subject|1|||
47080367|NCT04388527|83390233|FG000|Overall Study|Death|14|||
47080368|NCT04388527|83390233|FG000|Overall Study|Withdrawal by Subject|2|||
47080369|NCT04388527|83390233|FG000|Overall Study|Lost to Follow-up|1|||
47080370|NCT03649321|83390260|FG000|Overall Study|Withdrawal by Subject|1|||
47080371|NCT03649321|83390261|FG001|Overall Study|Withdrawal by Subject|0|||
47080372|NCT03649321|83390260|FG000|Overall Study|Death|1|||
47080373|NCT03649321|83390261|FG001|Overall Study|Death|0|||
47080374|NCT04149002|83390494|FG000|Overall Study|Lost to Follow-up|1|||
46675706|NCT01088997|82891423|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
47080375|NCT04149002|83390495|FG001|Overall Study|Lost to Follow-up|0|||
47080376|NCT04149002|83390494|FG000|Overall Study|Withdrawal by Subject|1|||
47080377|NCT04149002|83390495|FG001|Overall Study|Withdrawal by Subject|0|||
47080378|NCT00555321|83390569|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
47080379|NCT00555321|83390570|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
47080380|NCT00555321|83390571|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
47080381|NCT00555321|83390572|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
47080382|NCT00555321|83390573|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
47080383|NCT00555321|83390569|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
47080384|NCT00555321|83390570|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
46675707|NCT01088997|82891424|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
47080385|NCT00555321|83390571|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
47080386|NCT00555321|83390572|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
47080387|NCT00555321|83390573|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
47080388|NCT00555321|83390569|FG000|Treatment Phase up to 12-months|Death|2|||
47080389|NCT00555321|83390570|FG001|Treatment Phase up to 12-months|Death|1|||
47080390|NCT00555321|83390571|FG002|Treatment Phase up to 12-months|Death|4|||
47080391|NCT00555321|83390572|FG003|Treatment Phase up to 12-months|Death|0|||
47080392|NCT00555321|83390573|FG004|Treatment Phase up to 12-months|Death|0|||
47080393|NCT00555321|83390569|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
47080394|NCT00555321|83390570|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
47080395|NCT00555321|83390571|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
47080396|NCT00555321|83390572|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
47080397|NCT00555321|83390573|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
47080398|NCT00555321|83390569|FG000|Treatment Phase up to 12-months|Other Reason|1|||
47080399|NCT00555321|83390570|FG001|Treatment Phase up to 12-months|Other Reason|3|||
47080400|NCT00555321|83390571|FG002|Treatment Phase up to 12-months|Other Reason|2|||
47080401|NCT00555321|83390572|FG003|Treatment Phase up to 12-months|Other Reason|0|||
47080402|NCT00555321|83390573|FG004|Treatment Phase up to 12-months|Other Reason|0|||
47080403|NCT00555321|83390569|FG000|Treatment Phase up to 12-months|Never treated|2|||
47080404|NCT00555321|83390570|FG001|Treatment Phase up to 12-months|Never treated|3|||
47080405|NCT00555321|83390571|FG002|Treatment Phase up to 12-months|Never treated|1|||
47080406|NCT00555321|83390572|FG003|Treatment Phase up to 12-months|Never treated|0|||
47080407|NCT00555321|83390573|FG004|Treatment Phase up to 12-months|Never treated|4|||
47080408|NCT00555321|83390569|FG000|Long-term Extension Phase|Adverse Event|2|||
47080409|NCT00555321|83390570|FG001|Long-term Extension Phase|Adverse Event|5|||
47080410|NCT00555321|83390571|FG002|Long-term Extension Phase|Adverse Event|2|||
47080411|NCT00555321|83390572|FG003|Long-term Extension Phase|Adverse Event|1|||
47080412|NCT00555321|83390573|FG004|Long-term Extension Phase|Adverse Event|0|||
47080413|NCT00555321|83390569|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
47080414|NCT00555321|83390570|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
47080415|NCT00555321|83390571|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
47080416|NCT00555321|83390572|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
47080417|NCT00555321|83390573|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
47080418|NCT00555321|83390569|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
47080419|NCT00555321|83390570|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
47080420|NCT00555321|83390571|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
47080421|NCT00555321|83390572|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
46675708|NCT01088997|82891423|FG000|Overall Study|Excluded prior to receiving drug|1|||
46675709|NCT01088997|82891424|FG001|Overall Study|Excluded prior to receiving drug|1|||
46795305|NCT00616928|83013603|FG003|Overall Study|Lost to Follow-up|0|||
46795306|NCT00563784|83013625|FG000|Overall Study|Withdrawal by Subject|2|||
46795307|NCT00563784|83013625|FG000|Overall Study|Screen Failures|20|||
46795308|NCT00203047|83013640|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
46795309|NCT00203047|83013641|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
46795310|NCT00203047|83013640|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
46795311|NCT00203047|83013641|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
46795312|NCT00203047|83013640|FG000|Overall Study|Withdrawal by Subject|13|||
47080422|NCT00555321|83390573|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
47080423|NCT00555321|83390569|FG000|Long-term Extension Phase|Death|2|||
47080424|NCT00555321|83390570|FG001|Long-term Extension Phase|Death|0|||
46856457|NCT00353873|83072316|FG000|Overall Study|Protocol Violation|1|||
46856458|NCT00353873|83072317|FG001|Overall Study|Protocol Violation|2|||
46979084|NCT02597933|83224596|FG000|Overall Study|Withdrawal by Subject|7|||
46979085|NCT02597933|83224597|FG001|Overall Study|Withdrawal by Subject|5|||
46979086|NCT02597933|83224596|FG000|Overall Study|Protocol Violation|2|||
46856459|NCT00353873|83072316|FG000|Overall Study|Exacerbation|1|||
46856460|NCT00353873|83072317|FG001|Overall Study|Exacerbation|0|||
46856461|NCT00353873|83072316|FG000|Overall Study|Adverse Event|1|||
46979087|NCT02597933|83224597|FG001|Overall Study|Protocol Violation|2|||
47080425|NCT00555321|83390571|FG002|Long-term Extension Phase|Death|0|||
47080426|NCT00555321|83390572|FG003|Long-term Extension Phase|Death|3|||
47080427|NCT00555321|83390573|FG004|Long-term Extension Phase|Death|0|||
47080428|NCT00555321|83390569|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
47080429|NCT00555321|83390570|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
47080430|NCT00555321|83390571|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
47080431|NCT00555321|83390572|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
47080432|NCT00555321|83390573|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
47080433|NCT00555321|83390569|FG000|Long-term Extension Phase|Other Reason|1|||
47080434|NCT00555321|83390570|FG001|Long-term Extension Phase|Other Reason|0|||
47080435|NCT00555321|83390571|FG002|Long-term Extension Phase|Other Reason|2|||
47080436|NCT00555321|83390572|FG003|Long-term Extension Phase|Other Reason|0|||
47080437|NCT00555321|83390573|FG004|Long-term Extension Phase|Other Reason|0|||
47080438|NCT03589976|83391085|FG000|Overall Study|Death|5|||
47080439|NCT03589976|83391086|FG001|Overall Study|Death|1|||
46856462|NCT00353873|83072317|FG001|Overall Study|Adverse Event|0|||
46979088|NCT02597933|83224596|FG000|Overall Study|Adverse Event|20|||
46979089|NCT02597933|83224597|FG001|Overall Study|Adverse Event|28|||
47080440|NCT03589976|83391085|FG000|Overall Study|Adverse Event|5|||
46795313|NCT00203047|83013641|FG001|Overall Study|Withdrawal by Subject|47|||
46795314|NCT00203047|83013640|FG000|Overall Study|Teva requested participant withdrawal|1|||
46795315|NCT00203047|83013641|FG001|Overall Study|Teva requested participant withdrawal|1|||
46795316|NCT00203047|83013640|FG000|Overall Study|Physician Decision|8|||
46795317|NCT00203047|83013641|FG001|Overall Study|Physician Decision|7|||
46795318|NCT00203047|83013640|FG000|Overall Study|Non-compliance|4|||
46795319|NCT00203047|83013641|FG001|Overall Study|Non-compliance|8|||
46795320|NCT00203047|83013640|FG000|Overall Study|Protocol Violation|1|||
46795321|NCT00203047|83013641|FG001|Overall Study|Protocol Violation|0|||
46795322|NCT00203047|83013640|FG000|Overall Study|Lost to Follow-up|11|||
46675710|NCT01088529|82891435|FG000|Overall Study|Did not receive study treatment|0|||
46795323|NCT00203047|83013641|FG001|Overall Study|Lost to Follow-up|5|||
46795324|NCT00203047|83013640|FG000|Overall Study|Adverse Event|8|||
46795325|NCT00203047|83013641|FG001|Overall Study|Adverse Event|18|||
46795326|NCT00203047|83013640|FG000|Overall Study|Death|1|||
46979090|NCT02597933|83224596|FG000|Overall Study|Not treated|2|||
47080441|NCT03589976|83391086|FG001|Overall Study|Adverse Event|1|||
47080442|NCT03589976|83391085|FG000|Overall Study|Withdrawal by Subject|4|||
47080443|NCT03589976|83391086|FG001|Overall Study|Withdrawal by Subject|1|||
47080444|NCT03589976|83391085|FG000|Overall Study|Lost to Follow-up|1|||
47080445|NCT03589976|83391086|FG001|Overall Study|Lost to Follow-up|0|||
47080446|NCT03589976|83391085|FG000|Overall Study|Other|4|||
47080447|NCT03589976|83391086|FG001|Overall Study|Other|3|||
47080448|NCT03029780|83391242|FG000|Overall Study|Disease Progression|20|||
47080449|NCT03029780|83391243|FG001|Overall Study|Disease Progression|22|||
47080450|NCT03029780|83391242|FG000|Overall Study|Study Drug Toxicity|15|||
47080451|NCT03029780|83391243|FG001|Overall Study|Study Drug Toxicity|11|||
47080452|NCT03029780|83391242|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
47080453|NCT03029780|83391243|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
47080454|NCT03029780|83391242|FG000|Overall Study|Participant request to discontinue study treatment|4|||
47080455|NCT03029780|83391243|FG001|Overall Study|Participant request to discontinue study treatment|1|||
47080456|NCT03029780|83391242|FG000|Overall Study|Maximum clinical benefit|1|||
47080457|NCT03029780|83391243|FG001|Overall Study|Maximum clinical benefit|0|||
47080458|NCT03029780|83391242|FG000|Overall Study|Participant no longer meets study criteria|0|||
47080459|NCT03029780|83391243|FG001|Overall Study|Participant no longer meets study criteria|1|||
47080460|NCT03029780|83391242|FG000|Overall Study|Other reasons|6|||
47080461|NCT03029780|83391243|FG001|Overall Study|Other reasons|6|||
47080462|NCT03029780|83391242|FG000|Overall Study|Not reported|1|||
47080463|NCT03029780|83391243|FG001|Overall Study|Not reported|1|||
47080464|NCT03029780|83391242|FG000|Overall Study|Death|2|||
47080465|NCT03029780|83391243|FG001|Overall Study|Death|6|||
46795327|NCT00203047|83013641|FG001|Overall Study|Death|2|||
47080466|NCT03029234|83391303|FG000|Overall Study|Sponsor Decision|1|||
46795328|NCT00203047|83013640|FG000|Overall Study|Pregnancy|3|||
46675711|NCT01088529|82891436|FG001|Overall Study|Did not receive study treatment|1|||
46675712|NCT01087944|82891442|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
46795329|NCT00203047|83013641|FG001|Overall Study|Pregnancy|0|||
46675713|NCT01087944|82891443|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
46795330|NCT00203047|83013640|FG000|Overall Study|Other|5|||
46795331|NCT00203047|83013641|FG001|Overall Study|Other|5|||
46795332|NCT00142519|83013649|FG000|Overall Study|Not Treated|7|||
46795333|NCT00142519|83013650|FG001|Overall Study|Not Treated|9|||
46675714|NCT01087944|82891442|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
46795334|NCT00142519|83013649|FG000|Overall Study|Protocol Violation|1|||
46795335|NCT00142519|83013650|FG001|Overall Study|Protocol Violation|0|||
46795336|NCT00142519|83013649|FG000|Overall Study|Withdrawal by Subject|10|||
46795337|NCT00142519|83013650|FG001|Overall Study|Withdrawal by Subject|7|||
46795338|NCT00141817|83013669|FG000|Overall Study|Protocol Violation|0|||
46795339|NCT00141817|83013670|FG001|Overall Study|Protocol Violation|0|||
46979091|NCT02597933|83224597|FG001|Overall Study|Not treated|2|||
46675715|NCT01087944|82891443|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
46675716|NCT01132612|82891452|FG000|Overall Study|Death|0|||
46675717|NCT01132612|82891453|FG001|Overall Study|Death|0|||
46675718|NCT01132612|82891454|FG002|Overall Study|Death|1|||
46675719|NCT01132612|82891452|FG000|Overall Study|Protocol deviation|0|||
46675720|NCT01132612|82891453|FG001|Overall Study|Protocol deviation|0|||
46675721|NCT01132612|82891454|FG002|Overall Study|Protocol deviation|3|||
46675722|NCT01132612|82891452|FG000|Overall Study|Lost to Follow-up|2|||
46675723|NCT01132612|82891453|FG001|Overall Study|Lost to Follow-up|2|||
46675724|NCT01132612|82891454|FG002|Overall Study|Lost to Follow-up|7|||
46675725|NCT01132612|82891452|FG000|Overall Study|Adverse Event|5|||
46979092|NCT02597933|83224596|FG000|Overall Study|Other than stated above|7|||
46979093|NCT02597933|83224597|FG001|Overall Study|Other than stated above|14|||
46795340|NCT00141817|83013671|FG002|Overall Study|Protocol Violation|1|||
46795341|NCT00141817|83013672|FG003|Overall Study|Protocol Violation|0|||
46795342|NCT00141817|83013669|FG000|Overall Study|Parent request|1|||
46795343|NCT00141817|83013670|FG001|Overall Study|Parent request|0|||
46979094|NCT02597855|83224605|FG000|Overall Study|Lost to Follow-up|2|||
46979095|NCT02597855|83224606|FG001|Overall Study|Lost to Follow-up|1|||
46675726|NCT01132612|82891453|FG001|Overall Study|Adverse Event|2|||
46675727|NCT01132612|82891454|FG002|Overall Study|Adverse Event|15|||
46675728|NCT01132612|82891452|FG000|Overall Study|Withdrawal by Subject|5|||
46675729|NCT01132612|82891453|FG001|Overall Study|Withdrawal by Subject|8|||
46675730|NCT01132612|82891454|FG002|Overall Study|Withdrawal by Subject|19|||
46675731|NCT01132612|82891452|FG000|Overall Study|Administrative problems|5|||
46675732|NCT01132612|82891453|FG001|Overall Study|Administrative problems|1|||
46675733|NCT01132612|82891454|FG002|Overall Study|Administrative problems|52|||
46675734|NCT01132612|82891452|FG000|Overall Study|Lack of Efficacy|23|||
46675735|NCT01132612|82891453|FG001|Overall Study|Lack of Efficacy|22|||
46675736|NCT01132612|82891454|FG002|Overall Study|Lack of Efficacy|73|||
46675737|NCT01132495|82891466|FG000|Overall Study|Various reasons|40|||
46675738|NCT01132495|82891467|FG001|Overall Study|Various reasons|38|||
46675739|NCT01132495|82891468|FG002|Overall Study|Various reasons|20|||
46675740|NCT01132495|82891469|FG003|Overall Study|Various reasons|12|||
46675741|NCT01087905|82891488|FG000|Overall Study|Lost to Follow-up|24|||
46675742|NCT01087905|82891489|FG001|Overall Study|Lost to Follow-up|28|||
46675743|NCT01087905|82891490|FG002|Overall Study|Lost to Follow-up|18|||
46675744|NCT01087905|82891491|FG003|Overall Study|Lost to Follow-up|31|||
46675745|NCT01087905|82891492|FG004|Overall Study|Lost to Follow-up|27|||
46795344|NCT00141817|83013671|FG002|Overall Study|Parent request|0|||
46795345|NCT00141817|83013672|FG003|Overall Study|Parent request|0|||
46795346|NCT00573170|83013682|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
46795347|NCT00573170|83013683|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
46795348|NCT00573170|83013684|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
46795349|NCT00573170|83013685|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
46795350|NCT00573170|83013686|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
46675746|NCT01087905|82891493|FG005|Overall Study|Lost to Follow-up|25|||
46675747|NCT01087905|82891494|FG006|Overall Study|Lost to Follow-up|20|||
46979096|NCT02604407|83224615|FG000|Overall Study|Adverse Event|0|||
46795351|NCT00573170|83013687|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
46856463|NCT00353873|83072316|FG000|Overall Study|Physician Decision|2|||
47080467|NCT03029234|83391303|FG000|Overall Study|Withdrawal by Subject|5|||
47080468|NCT03029234|83391303|FG000|Overall Study|Death|91|||
47080469|NCT03029234|83391303|FG000|Overall Study|Lost to Follow-up|2|||
47080470|NCT03991299|83391974|FG000|Overall Study|Study closed, sponsor decision|3|||
47080471|NCT03991299|83391974|FG000|Overall Study|Withdrawal by Subject|1|||
47080472|NCT03155373|83391992|FG000|Overall Study|No longer required surgery|1|||
47080473|NCT03155373|83391992|FG000|Overall Study|Protocol Violation|1|||
47080474|NCT03155373|83391992|FG000|Overall Study|Death|2|||
47080475|NCT03155373|83391992|FG000|Overall Study|Withdrawal by Subject|3|||
47080476|NCT05310084|83392410|FG000|Overall Study|Withdrawal by Subject|2|||
47080477|NCT05310084|83392411|FG001|Overall Study|Withdrawal by Subject|3|||
47080478|NCT05310084|83392410|FG000|Overall Study|Participant availability|0|||
47080479|NCT05310084|83392411|FG001|Overall Study|Participant availability|4|||
47080480|NCT05310084|83392410|FG000|Overall Study|Lost to Follow-up|1|||
47080481|NCT05310084|83392411|FG001|Overall Study|Lost to Follow-up|1|||
47080482|NCT05310084|83392410|FG000|Overall Study|Adverse Event|1|||
46979097|NCT02604407|83224616|FG001|Overall Study|Adverse Event|7|||
46979098|NCT02604407|83224617|FG002|Overall Study|Adverse Event|5|||
46979099|NCT02604407|83224615|FG000|Overall Study|Protocol Violation|2|||
46675748|NCT01087905|82891495|FG007|Overall Study|Lost to Follow-up|24|||
46675749|NCT01087905|82891488|FG000|Overall Study|Withdrawal by Subject|5|||
46675750|NCT01087905|82891489|FG001|Overall Study|Withdrawal by Subject|4|||
46675751|NCT01087905|82891490|FG002|Overall Study|Withdrawal by Subject|4|||
46675752|NCT01087905|82891491|FG003|Overall Study|Withdrawal by Subject|5|||
46675753|NCT01087905|82891492|FG004|Overall Study|Withdrawal by Subject|4|||
46675754|NCT01087905|82891493|FG005|Overall Study|Withdrawal by Subject|3|||
46675755|NCT01087905|82891494|FG006|Overall Study|Withdrawal by Subject|3|||
46675756|NCT01087905|82891495|FG007|Overall Study|Withdrawal by Subject|5|||
46675757|NCT01087788|82891514|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
46675758|NCT01087788|82891515|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
46675759|NCT01087788|82891516|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
46675760|NCT01087788|82891514|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
46675761|NCT01087788|82891515|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
46675762|NCT01087788|82891516|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
46675763|NCT01087788|82891514|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
46675764|NCT01087788|82891515|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
46675765|NCT01087788|82891516|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
47080483|NCT05310084|83392411|FG001|Overall Study|Adverse Event|1|||
47080484|NCT05310084|83392410|FG000|Overall Study|Randomized but not vaccinated|4|||
47080485|NCT05310084|83392411|FG001|Overall Study|Randomized but not vaccinated|2|||
46675766|NCT01087788|82891514|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
46675767|NCT01087788|82891515|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
46675768|NCT01087788|82891516|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
46675769|NCT01087788|82891514|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
46675770|NCT01087788|82891515|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
46675771|NCT01087788|82891516|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
46675772|NCT01087788|82891514|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
46675773|NCT01087788|82891515|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
46795352|NCT00573170|83013682|FG000|First Washout Period|Adverse Event|1|||
46795353|NCT00573170|83013683|FG001|First Washout Period|Adverse Event|1|||
47080486|NCT04581863|83392446|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
47080487|NCT04581863|83392447|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
47080488|NCT04349891|83392464|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
47080489|NCT04349891|83392465|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
47080490|NCT04349891|83392464|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
47080491|NCT04349891|83392465|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
47080492|NCT04349891|83392464|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
47080493|NCT04349891|83392465|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
47080494|NCT04349891|83392464|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
46795354|NCT00573170|83013684|FG002|First Washout Period|Adverse Event|0|||
46795355|NCT00573170|83013685|FG003|First Washout Period|Adverse Event|0|||
46795356|NCT00573170|83013686|FG004|First Washout Period|Adverse Event|0|||
46795357|NCT00573170|83013687|FG005|First Washout Period|Adverse Event|1|||
46795358|NCT00573170|83013682|FG000|First Washout Period|Lack of Efficacy|0|||
46795359|NCT00573170|83013683|FG001|First Washout Period|Lack of Efficacy|0|||
46795360|NCT00573170|83013684|FG002|First Washout Period|Lack of Efficacy|0|||
47080495|NCT04349891|83392465|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
47080496|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
47080497|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
47080498|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
47080499|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
47080500|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
47080501|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
47080502|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
47080503|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
47080504|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to death|4|||
47080505|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to death|3|||
47080506|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
47080507|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
47080508|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
47080509|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
47080510|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
47080511|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
47080512|NCT02258451|83392473|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
47080513|NCT02258451|83392474|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
47080514|NCT02258451|83392473|FG000|Overall Study|Other reason|1|||
47080515|NCT02258451|83392474|FG001|Overall Study|Other reason|1|||
47080516|NCT02258451|83392473|FG000|Overall Study|Never treated|2|||
47080517|NCT02258451|83392474|FG001|Overall Study|Never treated|3|||
47080518|NCT02168270|83392482|FG000|Overall Study|Lack of Efficacy|4|||
47080519|NCT02775903|83392783|FG000|Overall Study|Death|7|||
47080520|NCT02775903|83392784|FG001|Overall Study|Death|11|||
47080521|NCT02775903|83392785|FG002|Overall Study|Death|12|||
47080522|NCT02775903|83392786|FG003|Overall Study|Death|11|||
47080523|NCT02775903|83392783|FG000|Overall Study|Adverse Event|0|||
47080524|NCT02775903|83392784|FG001|Overall Study|Adverse Event|1|||
47080525|NCT02775903|83392785|FG002|Overall Study|Adverse Event|12|||
47080526|NCT02775903|83392786|FG003|Overall Study|Adverse Event|3|||
47080527|NCT02775903|83392783|FG000|Overall Study|Progressive disease|15|||
47080528|NCT02775903|83392784|FG001|Overall Study|Progressive disease|14|||
47080529|NCT02775903|83392785|FG002|Overall Study|Progressive disease|30|||
47080530|NCT02775903|83392786|FG003|Overall Study|Progressive disease|20|||
47080531|NCT02775903|83392783|FG000|Overall Study|Lack of Efficacy|2|||
47080532|NCT02775903|83392784|FG001|Overall Study|Lack of Efficacy|2|||
47080533|NCT02775903|83392785|FG002|Overall Study|Lack of Efficacy|2|||
47080534|NCT02775903|83392786|FG003|Overall Study|Lack of Efficacy|6|||
47080535|NCT02775903|83392783|FG000|Overall Study|Withdrawal by Subject|7|||
47080536|NCT02775903|83392784|FG001|Overall Study|Withdrawal by Subject|5|||
47080537|NCT02775903|83392785|FG002|Overall Study|Withdrawal by Subject|5|||
47080538|NCT02775903|83392786|FG003|Overall Study|Withdrawal by Subject|8|||
47080539|NCT02775903|83392783|FG000|Overall Study|Other reasons|7|||
47080540|NCT02775903|83392784|FG001|Overall Study|Other reasons|8|||
47080541|NCT02775903|83392785|FG002|Overall Study|Other reasons|2|||
47080542|NCT02775903|83392786|FG003|Overall Study|Other reasons|12|||
47080543|NCT02723019|83392855|FG000|Overall Study|Death|17|||
47080544|NCT02723019|83392856|FG001|Overall Study|Death|13|||
47080545|NCT02723019|83392855|FG000|Overall Study|Withdrawal by Subject|11|||
47080546|NCT02723019|83392856|FG001|Overall Study|Withdrawal by Subject|7|||
47080547|NCT02723019|83392855|FG000|Overall Study|Lost to Follow-up|57|||
47080548|NCT02723019|83392856|FG001|Overall Study|Lost to Follow-up|70|||
47080549|NCT00088166|83393106|FG000|Overall Study|Adverse Event|11|||
47080550|NCT00088166|83393107|FG001|Overall Study|Adverse Event|9|||
47080551|NCT00088166|83393106|FG000|Overall Study|Death|3|||
47080552|NCT00088166|83393107|FG001|Overall Study|Death|1|||
47080553|NCT00088166|83393106|FG000|Overall Study|Lost to Follow-up|0|||
47080554|NCT00088166|83393107|FG001|Overall Study|Lost to Follow-up|1|||
47080555|NCT00088166|83393106|FG000|Overall Study|Physician Decision|4|||
47080556|NCT00088166|83393107|FG001|Overall Study|Physician Decision|1|||
47080557|NCT00088166|83393106|FG000|Overall Study|Protocol Violation|1|||
47080558|NCT00088166|83393107|FG001|Overall Study|Protocol Violation|5|||
47080559|NCT00088166|83393106|FG000|Overall Study|Patient deterioration|29|||
47080560|NCT00088166|83393107|FG001|Overall Study|Patient deterioration|39|||
47080561|NCT00088166|83393106|FG000|Overall Study|Withdrawal by Subject|5|||
47080562|NCT00088166|83393107|FG001|Overall Study|Withdrawal by Subject|5|||
47080563|NCT00087698|83393151|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
47080564|NCT00087698|83393151|FG000|Overall Study|Death from Other Causes|3|||
47080565|NCT00087698|83393151|FG000|Overall Study|Adverse Event|4|||
46675774|NCT01087788|82891516|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
46675775|NCT01087788|82891514|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
46795361|NCT00573170|83013685|FG003|First Washout Period|Lack of Efficacy|0|||
46795362|NCT00573170|83013686|FG004|First Washout Period|Lack of Efficacy|0|||
46795363|NCT00573170|83013687|FG005|First Washout Period|Lack of Efficacy|1|||
46675776|NCT01087788|82891515|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
46675777|NCT01087788|82891516|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
46795364|NCT00573170|83013682|FG000|First Washout Period|Lost to Follow-up|1|||
46675778|NCT01087788|82891514|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
46675779|NCT01087788|82891515|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
46675780|NCT01087788|82891516|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
46795365|NCT00573170|83013683|FG001|First Washout Period|Lost to Follow-up|1|||
46675781|NCT01087788|82891514|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
46675782|NCT01087788|82891515|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
46795366|NCT00573170|83013684|FG002|First Washout Period|Lost to Follow-up|0|||
46795367|NCT00573170|83013685|FG003|First Washout Period|Lost to Follow-up|2|||
46979100|NCT02604407|83224616|FG001|Overall Study|Protocol Violation|0|||
46795368|NCT00573170|83013686|FG004|First Washout Period|Lost to Follow-up|0|||
46795369|NCT00573170|83013687|FG005|First Washout Period|Lost to Follow-up|2|||
46795370|NCT00573170|83013682|FG000|First Washout Period|Withdrawal by Subject|2|||
46795371|NCT00573170|83013683|FG001|First Washout Period|Withdrawal by Subject|0|||
46795372|NCT00573170|83013684|FG002|First Washout Period|Withdrawal by Subject|0|||
46795373|NCT00573170|83013685|FG003|First Washout Period|Withdrawal by Subject|2|||
46795374|NCT00573170|83013686|FG004|First Washout Period|Withdrawal by Subject|3|||
46795375|NCT00573170|83013687|FG005|First Washout Period|Withdrawal by Subject|3|||
46795376|NCT00573170|83013682|FG000|First Washout Period|Other|4|||
46795377|NCT00573170|83013683|FG001|First Washout Period|Other|0|||
46795378|NCT00573170|83013684|FG002|First Washout Period|Other|1|||
46795379|NCT00573170|83013685|FG003|First Washout Period|Other|1|||
46795380|NCT00573170|83013686|FG004|First Washout Period|Other|0|||
46795381|NCT00573170|83013687|FG005|First Washout Period|Other|0|||
46795382|NCT00573170|83013682|FG000|Second Washout Period|Adverse Event|1|||
46795383|NCT00573170|83013683|FG001|Second Washout Period|Adverse Event|0|||
46795384|NCT00573170|83013684|FG002|Second Washout Period|Adverse Event|0|||
46795385|NCT00573170|83013685|FG003|Second Washout Period|Adverse Event|0|||
46795386|NCT00573170|83013686|FG004|Second Washout Period|Adverse Event|1|||
47080566|NCT00087698|83393151|FG000|Overall Study|Withdrawal by Subject|4|||
47080567|NCT00087698|83393151|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
47080568|NCT00087698|83393151|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
47080569|NCT00087698|83393151|FG000|Overall Study|Clinical Relapse|1|||
47080570|NCT00087698|83393151|FG000|Overall Study|Death from Study Disease|2|||
47080571|NCT00087698|83393151|FG000|Overall Study|Death from Study Drug Toxicity|2|||
47080572|NCT00087698|83393151|FG000|Overall Study|Protocol Violation|1|||
47080573|NCT00087152|83393169|FG000|Overall Study|Ineligible|6|||
47080574|NCT00086996|83393221|FG000|Overall Study|Adverse Event|29|||
47080575|NCT00086996|83393221|FG000|Overall Study|Death|4|||
47080576|NCT00086996|83393221|FG000|Overall Study|progression/relapse|7|||
47080577|NCT00086996|83393221|FG000|Overall Study|Withdrawal by Subject|13|||
47080578|NCT00086996|83393221|FG000|Overall Study|Other|6|||
47080579|NCT00086996|83393221|FG000|Overall Study|not eligible|5|||
47080580|NCT00086684|83393523|FG000|Overall Study|Adverse Event|12|||
47080581|NCT00086684|83393524|FG001|Overall Study|Adverse Event|17|||
47080582|NCT00086684|83393525|FG002|Overall Study|Adverse Event|14|||
47080583|NCT00086684|83393523|FG000|Overall Study|Lack of Efficacy|6|||
47080584|NCT00086684|83393524|FG001|Overall Study|Lack of Efficacy|6|||
47080585|NCT00086684|83393525|FG002|Overall Study|Lack of Efficacy|5|||
47080586|NCT00086684|83393523|FG000|Overall Study|Lost to Follow-up|15|||
47080587|NCT00086684|83393524|FG001|Overall Study|Lost to Follow-up|8|||
47080588|NCT00086684|83393525|FG002|Overall Study|Lost to Follow-up|10|||
47080589|NCT00086684|83393523|FG000|Overall Study|Protocol Violation|8|||
47080590|NCT00086684|83393524|FG001|Overall Study|Protocol Violation|3|||
47080591|NCT00086684|83393525|FG002|Overall Study|Protocol Violation|0|||
47080592|NCT00086684|83393523|FG000|Overall Study|Withdrawal by Subject|0|||
47080593|NCT00086684|83393524|FG001|Overall Study|Withdrawal by Subject|4|||
47080594|NCT00086684|83393525|FG002|Overall Study|Withdrawal by Subject|10|||
47080595|NCT00086684|83393523|FG000|Overall Study|NONCOMPLIANCE|5|||
47080596|NCT00086684|83393524|FG001|Overall Study|NONCOMPLIANCE|7|||
47080597|NCT00086684|83393525|FG002|Overall Study|NONCOMPLIANCE|6|||
47080598|NCT00086684|83393523|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
47080599|NCT00086684|83393524|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
47080600|NCT00086684|83393525|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
47080601|NCT00086684|83393523|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
47080602|NCT00086684|83393524|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
47080603|NCT00086684|83393525|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
47080604|NCT00086684|83393523|FG000|Overall Study|Other|4|||
47080605|NCT00086684|83393524|FG001|Overall Study|Other|2|||
47080606|NCT00086684|83393525|FG002|Overall Study|Other|3|||
47080607|NCT00082628|83393589|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
47080608|NCT00082628|83393590|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
47080609|NCT00082628|83393591|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
47080610|NCT00082628|83393592|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
47080611|NCT00082628|83393593|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
47080612|NCT00082628|83393589|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
47080613|NCT00082628|83393590|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
47080614|NCT00082628|83393591|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
47080615|NCT00082628|83393592|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
47080616|NCT00082628|83393593|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
47080617|NCT00082628|83393589|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
47080618|NCT00082628|83393590|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
47080619|NCT00082628|83393591|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
47080620|NCT00082628|83393592|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
47080621|NCT00082628|83393593|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
47080622|NCT00082628|83393589|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
47080623|NCT00082628|83393590|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
47080624|NCT00082628|83393591|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
47080625|NCT00082628|83393592|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
46675783|NCT01087788|82891516|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
46675784|NCT01087788|82891514|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
46675785|NCT01087788|82891515|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
47080626|NCT00082628|83393593|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
47080627|NCT00082628|83393589|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
47080628|NCT00082628|83393590|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
47080629|NCT00082628|83393591|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
47080630|NCT00082628|83393592|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
47080631|NCT00082628|83393593|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
47080632|NCT00082628|83393589|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
47080633|NCT00082628|83393590|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
47080634|NCT00082628|83393591|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
47080635|NCT00082628|83393592|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
47080636|NCT00082628|83393593|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
47080637|NCT00082628|83393589|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
47080638|NCT00082628|83393590|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
47080639|NCT00082628|83393591|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
47080640|NCT00082628|83393592|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
47080641|NCT00082628|83393593|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
47080642|NCT02993263|83393935|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
46675786|NCT01087788|82891516|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
46675787|NCT01087788|82891514|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
46675788|NCT01087788|82891515|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
46675789|NCT01087788|82891516|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
46675790|NCT01087788|82891514|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
46675791|NCT01087788|82891515|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
46675792|NCT01087788|82891516|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
46675793|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
46675794|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
46675795|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
46675796|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
46675797|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
46675798|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
46675799|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
46675800|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
46675801|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
46675802|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
46675803|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
46675804|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
46675805|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
46675806|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
46675807|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
46675808|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
46675809|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
46675810|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
46675811|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
46675812|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
46856464|NCT00353873|83072317|FG001|Overall Study|Physician Decision|0|||
46856465|NCT00353873|83072316|FG000|Overall Study|Withdrawal by Subject|1|||
46856466|NCT00353873|83072317|FG001|Overall Study|Withdrawal by Subject|1|||
46856467|NCT03796676|83072326|FG000|Overall Study|Adverse Event|2|||
46856468|NCT03796676|83072327|FG001|Overall Study|Adverse Event|1|||
46675813|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
46979101|NCT02604407|83224617|FG002|Overall Study|Protocol Violation|0|||
46856469|NCT03796676|83072328|FG002|Overall Study|Adverse Event|2|||
46856470|NCT03796676|83072326|FG000|Overall Study|Lost to Follow-up|2|||
46856471|NCT03796676|83072327|FG001|Overall Study|Lost to Follow-up|1|||
46675814|NCT01087788|82891514|FG000|24-weeks Dose-blind Period|Patient moved|0|||
46675815|NCT01087788|82891515|FG001|24-weeks Dose-blind Period|Patient moved|0|||
46675816|NCT01087788|82891516|FG002|24-weeks Dose-blind Period|Patient moved|1|||
46675817|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
46675818|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
46675819|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
46675820|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
46675821|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
46675822|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
46675823|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
46675824|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
46675825|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
46675826|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
46675827|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
46675828|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
46675829|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
46675830|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
46675831|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
46675832|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
46675833|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
46675834|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
46675835|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
46675836|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
46675837|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
46675838|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
46675839|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
46675840|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
46675841|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
46675842|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
46675843|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
46675844|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
46675845|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
46675846|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
46675847|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
46675848|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
46675849|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
46675850|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
46675851|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
46675852|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
46675853|NCT01087788|82891514|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
46675854|NCT01087788|82891515|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
46675855|NCT01087788|82891516|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
46675856|NCT01086969|82891528|FG000|Overall Study|Withdrawal by Subject|1|||
46675857|NCT01086969|82891529|FG001|Overall Study|Withdrawal by Subject|2|||
46675858|NCT01086969|82891530|FG002|Overall Study|Withdrawal by Subject|0|||
46675859|NCT01086423|82891541|FG000|Overall Study|Protocol Violation|0|||
46675860|NCT01086423|82891542|FG001|Overall Study|Protocol Violation|0|||
46675861|NCT01086423|82891543|FG002|Overall Study|Protocol Violation|1|||
46675862|NCT01086423|82891541|FG000|Overall Study|Migrated/moved from study area|2|||
46675863|NCT01086423|82891542|FG001|Overall Study|Migrated/moved from study area|0|||
46675864|NCT01086423|82891543|FG002|Overall Study|Migrated/moved from study area|4|||
46675865|NCT01086423|82891541|FG000|Overall Study|Adverse event, fatal|1|||
46675866|NCT01086423|82891542|FG001|Overall Study|Adverse event, fatal|1|||
46675867|NCT01086423|82891543|FG002|Overall Study|Adverse event, fatal|0|||
46675868|NCT01086423|82891541|FG000|Overall Study|Adverse event, non-fatal|2|||
46675869|NCT01086423|82891542|FG001|Overall Study|Adverse event, non-fatal|1|||
46675870|NCT01086423|82891543|FG002|Overall Study|Adverse event, non-fatal|0|||
46675871|NCT01086423|82891541|FG000|Overall Study|Withdrawal by Subject|5|||
46675872|NCT01086423|82891542|FG001|Overall Study|Withdrawal by Subject|1|||
46979102|NCT02604407|83224615|FG000|Overall Study|Withdrawal by Subject|3|||
46675873|NCT01086423|82891543|FG002|Overall Study|Withdrawal by Subject|3|||
46675874|NCT01086423|82891541|FG000|Overall Study|Lost to Follow-up|0|||
46675875|NCT01086423|82891542|FG001|Overall Study|Lost to Follow-up|0|||
46675876|NCT01086423|82891543|FG002|Overall Study|Lost to Follow-up|1|||
46675877|NCT01086150|82891554|FG000|Overall Study|Withdrawal by Subject|0|||
46979103|NCT02604407|83224616|FG001|Overall Study|Withdrawal by Subject|3|||
46675878|NCT01086150|82891555|FG001|Overall Study|Withdrawal by Subject|4|||
46675879|NCT01086150|82891556|FG002|Overall Study|Withdrawal by Subject|1|||
46675880|NCT01086150|82891554|FG000|Overall Study|Lost to Follow-up|0|||
46675881|NCT01086150|82891555|FG001|Overall Study|Lost to Follow-up|1|||
46675882|NCT01086150|82891556|FG002|Overall Study|Lost to Follow-up|0|||
46675883|NCT01086150|82891554|FG000|Overall Study|Screen Failure|0|||
46675884|NCT01086150|82891555|FG001|Overall Study|Screen Failure|1|||
46675885|NCT01086150|82891556|FG002|Overall Study|Screen Failure|0|||
46675886|NCT01086033|82891564|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
46675887|NCT01086033|82891564|FG000|Overall Study|Lost to Follow-up|86|||
46675888|NCT01086033|82891564|FG000|Overall Study|Adverse Event|42|||
46675889|NCT01086033|82891564|FG000|Overall Study|Withdrawal by Subject|41|||
46675890|NCT01086033|82891564|FG000|Overall Study|Other|14|||
46675891|NCT01086033|82891564|FG000|Overall Study|Other|13|||
46856472|NCT03796676|83072328|FG002|Overall Study|Lost to Follow-up|0|||
46675892|NCT01086033|82891564|FG000|Overall Study|AE and Withdrew Consent|5|||
46675893|NCT01086033|82891564|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
46675894|NCT01086033|82891564|FG000|Overall Study|Withdrew consent and Other Reason|4|||
46675895|NCT01086033|82891564|FG000|Overall Study|AE and Lack of Efficacy|4|||
46979104|NCT02604407|83224617|FG002|Overall Study|Withdrawal by Subject|5|||
46979105|NCT02604407|83224615|FG000|Overall Study|Lost to Follow-up|2|||
46979106|NCT02604407|83224616|FG001|Overall Study|Lost to Follow-up|1|||
46979107|NCT02604407|83224617|FG002|Overall Study|Lost to Follow-up|2|||
46979108|NCT02604407|83224615|FG000|Overall Study|Lack of Efficacy|1|||
46979109|NCT02604407|83224616|FG001|Overall Study|Lack of Efficacy|0|||
46979110|NCT02604407|83224617|FG002|Overall Study|Lack of Efficacy|0|||
46979111|NCT02604407|83224615|FG000|Overall Study|Other|3|||
46979112|NCT02604407|83224616|FG001|Overall Study|Other|1|||
46979113|NCT02604407|83224617|FG002|Overall Study|Other|4|||
46979114|NCT02593097|83224627|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
46979115|NCT02593097|83224628|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
46979116|NCT02593097|83224627|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
46979117|NCT02593097|83224628|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
46979118|NCT02593097|83224627|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
46979119|NCT02593097|83224628|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
46979120|NCT02593097|83224627|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
46979121|NCT02593097|83224628|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
46795387|NCT00573170|83013687|FG005|Second Washout Period|Adverse Event|0|||
46795388|NCT00573170|83013682|FG000|Second Washout Period|Protocol Violation|2|||
46675896|NCT01086033|82891564|FG000|Overall Study|Death|1|||
46856473|NCT03796676|83072326|FG000|Overall Study|Protocol Violation|0|||
46675897|NCT01086033|82891564|FG000|Overall Study|AE and Lost to Follow-up|1|||
46795389|NCT00573170|83013683|FG001|Second Washout Period|Protocol Violation|1|||
46795390|NCT00573170|83013684|FG002|Second Washout Period|Protocol Violation|1|||
46795391|NCT00573170|83013685|FG003|Second Washout Period|Protocol Violation|0|||
46979122|NCT02593097|83224627|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
46675898|NCT01086033|82891564|FG000|Overall Study|AE and Other Reason|1|||
46856474|NCT03796676|83072327|FG001|Overall Study|Protocol Violation|0|||
46856475|NCT03796676|83072328|FG002|Overall Study|Protocol Violation|1|||
46856476|NCT03796676|83072326|FG000|Overall Study|Withdrawal by Subject|1|||
46856477|NCT03796676|83072327|FG001|Overall Study|Withdrawal by Subject|1|||
46856478|NCT03796676|83072328|FG002|Overall Study|Withdrawal by Subject|0|||
46856479|NCT03796676|83072326|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
46795392|NCT00573170|83013686|FG004|Second Washout Period|Protocol Violation|0|||
46795393|NCT00573170|83013687|FG005|Second Washout Period|Protocol Violation|0|||
46795394|NCT00573170|83013682|FG000|Second Washout Period|Withdrawal by Subject|1|||
46856480|NCT03796676|83072327|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
46856481|NCT03796676|83072328|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
46856482|NCT03342898|83072342|FG000|Overall Study|Adverse Event|3|||
46856483|NCT03342898|83072343|FG001|Overall Study|Adverse Event|1|||
46856484|NCT03342898|83072344|FG002|Overall Study|Adverse Event|0|||
46856485|NCT03342898|83072342|FG000|Overall Study|Lost to Follow-up|44|||
46856486|NCT03342898|83072343|FG001|Overall Study|Lost to Follow-up|40|||
46856487|NCT03342898|83072344|FG002|Overall Study|Lost to Follow-up|42|||
46856488|NCT03342898|83072342|FG000|Overall Study|Withdrawal of Consent|5|||
46856489|NCT03342898|83072343|FG001|Overall Study|Withdrawal of Consent|9|||
47080643|NCT01274533|83393963|FG000|Overall Study|Withdrawal by Subject|1|||
47080644|NCT01274533|83393963|FG000|Overall Study|Non-compliance|1|||
47080645|NCT01274533|83393963|FG000|Overall Study|Disease progression|2|||
47080646|NCT01273597|83393967|FG000|Overall Study|Adverse Event|5|||
47080647|NCT01273597|83393967|FG000|Overall Study|Underwent Kidney Transplantation|2|||
47080648|NCT01273597|83393967|FG000|Overall Study|Reason Not Reported|1|||
47080649|NCT01273519|83393974|FG000|Overall Study|Adverse Event|3|||
47080650|NCT01273519|83393975|FG001|Overall Study|Adverse Event|0|||
47080651|NCT01273519|83393976|FG002|Overall Study|Adverse Event|0|||
46795395|NCT00573170|83013683|FG001|Second Washout Period|Withdrawal by Subject|1|||
46795396|NCT00573170|83013684|FG002|Second Washout Period|Withdrawal by Subject|2|||
46979123|NCT02593097|83224628|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
46979124|NCT01657461|83224636|FG000|Overall Study|Death|9|||
46979125|NCT01657461|83224637|FG001|Overall Study|Death|12|||
46979126|NCT01657461|83224636|FG000|Overall Study|Lost to Follow-up|0|||
46979127|NCT01657461|83224637|FG001|Overall Study|Lost to Follow-up|3|||
46979128|NCT01657461|83224636|FG000|Overall Study|Physician Decision|0|||
46979129|NCT01657461|83224637|FG001|Overall Study|Physician Decision|2|||
46979130|NCT01657461|83224636|FG000|Overall Study|Withdrawal by Subject|1|||
46979131|NCT01657461|83224637|FG001|Overall Study|Withdrawal by Subject|3|||
46979132|NCT02592551|83224646|FG000|Overall Study|Not evaluable|1|||
46979133|NCT02592551|83224647|FG001|Overall Study|Not evaluable|3|||
46979134|NCT02592551|83224648|FG002|Overall Study|Not evaluable|0|||
46979135|NCT02595749|83224659|FG000|Overall Study|Withdrawal by Subject|12|||
46979136|NCT02595749|83224660|FG001|Overall Study|Withdrawal by Subject|7|||
46979137|NCT01657305|83224666|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
46979138|NCT01657305|83224666|FG000|Overall Study|Withdrawal by Subject|4|||
46979139|NCT01657305|83224666|FG000|Overall Study|Adverse Event|1|||
46979140|NCT01657305|83224666|FG000|Overall Study|Lost to Follow-up|1|||
46979141|NCT01657305|83224666|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
46979142|NCT02634307|83224709|FG000|Overall Study|Adverse Event|50|||
46979143|NCT02634307|83224710|FG001|Overall Study|Adverse Event|24|||
46979144|NCT02634307|83224711|FG002|Overall Study|Adverse Event|14|||
46979145|NCT02634307|83224709|FG000|Overall Study|Lost to Follow-up|21|||
46979146|NCT02634307|83224710|FG001|Overall Study|Lost to Follow-up|5|||
46979147|NCT02634307|83224711|FG002|Overall Study|Lost to Follow-up|6|||
46979148|NCT02634307|83224709|FG000|Overall Study|Pregnancy|5|||
46979149|NCT02634307|83224710|FG001|Overall Study|Pregnancy|1|||
46979150|NCT02634307|83224711|FG002|Overall Study|Pregnancy|3|||
46979151|NCT02634307|83224709|FG000|Overall Study|Withdrawal by Subject|38|||
46979152|NCT02634307|83224710|FG001|Overall Study|Withdrawal by Subject|24|||
46979153|NCT02634307|83224711|FG002|Overall Study|Withdrawal by Subject|18|||
46979154|NCT02634307|83224709|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46979155|NCT02634307|83224710|FG001|Overall Study|Non-Compliance with Study Drug|2|||
46979156|NCT02634307|83224711|FG002|Overall Study|Non-Compliance with Study Drug|2|||
46979157|NCT02634307|83224709|FG000|Overall Study|Lack of Efficacy|1|||
46979158|NCT02634307|83224710|FG001|Overall Study|Lack of Efficacy|5|||
46979159|NCT02634307|83224711|FG002|Overall Study|Lack of Efficacy|3|||
46979160|NCT02634307|83224709|FG000|Overall Study|Physician Decision|7|||
46979161|NCT02634307|83224710|FG001|Overall Study|Physician Decision|5|||
46979162|NCT02634307|83224711|FG002|Overall Study|Physician Decision|5|||
46979163|NCT02634307|83224709|FG000|Overall Study|Reason not Specified|3|||
46979164|NCT02634307|83224710|FG001|Overall Study|Reason not Specified|5|||
46979165|NCT02634307|83224711|FG002|Overall Study|Reason not Specified|10|||
46979166|NCT01365273|83224721|FG000|Overall Study|Lost to Follow-up|1|||
46979167|NCT01365273|83224722|FG001|Overall Study|Lost to Follow-up|0|||
46979168|NCT01365273|83224721|FG000|Overall Study|Protocol Violation|0|||
46979169|NCT01365273|83224722|FG001|Overall Study|Protocol Violation|1|||
46979170|NCT01365273|83224721|FG000|Overall Study|Physician Decision|1|||
46979171|NCT01365273|83224722|FG001|Overall Study|Physician Decision|0|||
46979172|NCT02595437|83224728|FG000|Triferic Via IV|Withdrawal by Subject|1|||
46979173|NCT02594735|83224749|FG000|Overall Study|Adverse Event|1|||
46795397|NCT00573170|83013685|FG003|Second Washout Period|Withdrawal by Subject|0|||
46979174|NCT02634151|83224757|FG000|Overall Study|Withdrawal by Subject|1|||
46979175|NCT02634151|83224758|FG001|Overall Study|Withdrawal by Subject|0|||
46979176|NCT02634151|83224757|FG000|Overall Study|Non-Compliance|0|||
46979177|NCT02634151|83224758|FG001|Overall Study|Non-Compliance|1|||
46979178|NCT02634151|83224757|FG000|Overall Study|Other|0|||
46979179|NCT02634151|83224758|FG001|Overall Study|Other|1|||
46979180|NCT01655823|83224769|FG000|Overall Study|Lost to Follow-up|0|||
46979181|NCT01655823|83224770|FG001|Overall Study|Lost to Follow-up|1|||
46979182|NCT01655823|83224771|FG002|Overall Study|Lost to Follow-up|0|||
46979183|NCT01655823|83224772|FG003|Overall Study|Lost to Follow-up|0|||
46979184|NCT01655823|83224773|FG004|Overall Study|Lost to Follow-up|1|||
46979185|NCT01655823|83224769|FG000|Overall Study|Withdrawal by Subject|0|||
46979186|NCT01655823|83224770|FG001|Overall Study|Withdrawal by Subject|1|||
46979187|NCT01655823|83224771|FG002|Overall Study|Withdrawal by Subject|0|||
46795398|NCT00573170|83013686|FG004|Second Washout Period|Withdrawal by Subject|1|||
46979188|NCT01655823|83224772|FG003|Overall Study|Withdrawal by Subject|1|||
46979189|NCT01655823|83224773|FG004|Overall Study|Withdrawal by Subject|0|||
46979190|NCT01360645|83224787|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
46979191|NCT01360645|83224788|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
46979192|NCT01360645|83224789|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
46979193|NCT01360645|83224790|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
46979194|NCT01360645|83224787|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
46979195|NCT01360645|83224788|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
46795399|NCT00573170|83013687|FG005|Second Washout Period|Withdrawal by Subject|0|||
46795400|NCT00573170|83013682|FG000|Second Washout Period|Lost to Follow-up|0|||
46795401|NCT00573170|83013683|FG001|Second Washout Period|Lost to Follow-up|0|||
46795402|NCT00573170|83013684|FG002|Second Washout Period|Lost to Follow-up|0|||
46979196|NCT01360645|83224789|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
46979197|NCT01360645|83224790|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
46795403|NCT00573170|83013685|FG003|Second Washout Period|Lost to Follow-up|1|||
47080652|NCT01273519|83393974|FG000|Overall Study|Lost to Follow-up|2|||
46795404|NCT00573170|83013686|FG004|Second Washout Period|Lost to Follow-up|0|||
46795405|NCT00573170|83013687|FG005|Second Washout Period|Lost to Follow-up|0|||
46795406|NCT00573170|83013682|FG000|Second Washout Period|Other|1|||
46795407|NCT00573170|83013683|FG001|Second Washout Period|Other|2|||
47080653|NCT01273519|83393975|FG001|Overall Study|Lost to Follow-up|1|||
47080654|NCT01273519|83393976|FG002|Overall Study|Lost to Follow-up|3|||
47080655|NCT01273519|83393974|FG000|Overall Study|Lack of Efficacy|8|||
47080656|NCT01273519|83393975|FG001|Overall Study|Lack of Efficacy|3|||
47080657|NCT01273519|83393976|FG002|Overall Study|Lack of Efficacy|4|||
47080658|NCT01273519|83393974|FG000|Overall Study|Other|6|||
47080659|NCT01273519|83393975|FG001|Overall Study|Other|1|||
47080660|NCT01273519|83393976|FG002|Overall Study|Other|1|||
46795408|NCT00573170|83013684|FG002|Second Washout Period|Other|1|||
46795409|NCT00573170|83013685|FG003|Second Washout Period|Other|4|||
46795410|NCT00573170|83013686|FG004|Second Washout Period|Other|6|||
46795411|NCT00573170|83013687|FG005|Second Washout Period|Other|2|||
46795412|NCT00573170|83013682|FG000|Third Treatment Period|Withdrawal by Subject|1|||
46795413|NCT00573170|83013683|FG001|Third Treatment Period|Withdrawal by Subject|0|||
46795414|NCT00573170|83013684|FG002|Third Treatment Period|Withdrawal by Subject|0|||
46795415|NCT00573170|83013685|FG003|Third Treatment Period|Withdrawal by Subject|0|||
46795416|NCT00573170|83013686|FG004|Third Treatment Period|Withdrawal by Subject|0|||
46979198|NCT01360645|83224787|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
46675899|NCT01086033|82891564|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
46675900|NCT01085682|82891573|FG000|Overall Study|Withdrawal by Subject|25|||
46675901|NCT01085682|82891574|FG001|Overall Study|Withdrawal by Subject|25|||
46675902|NCT01085214|82891580|FG000|Overall Study|Alternate treatment required|1|||
46675903|NCT01085136|82891584|FG000|Part A|Other Adverse event|223|||
46675904|NCT01085136|82891585|FG001|Part A|Other Adverse event|0|||
46675905|NCT01085136|82891586|FG002|Part A|Other Adverse event|0|||
46675906|NCT01085136|82891584|FG000|Part A|Protocol Violation|3|||
46675907|NCT01085136|82891585|FG001|Part A|Protocol Violation|0|||
46675908|NCT01085136|82891586|FG002|Part A|Protocol Violation|0|||
46675909|NCT01085136|82891584|FG000|Part A|Lost to Follow-up|3|||
46675910|NCT01085136|82891585|FG001|Part A|Lost to Follow-up|0|||
46675911|NCT01085136|82891586|FG002|Part A|Lost to Follow-up|0|||
46675912|NCT01085136|82891584|FG000|Part A|Refusal to continue trial medication|64|||
46675913|NCT01085136|82891585|FG001|Part A|Refusal to continue trial medication|0|||
46675914|NCT01085136|82891586|FG002|Part A|Refusal to continue trial medication|0|||
46675915|NCT01085136|82891584|FG000|Part A|Other reason not defined above|30|||
46675916|NCT01085136|82891585|FG001|Part A|Other reason not defined above|0|||
46675917|NCT01085136|82891586|FG002|Part A|Other reason not defined above|0|||
46675918|NCT01085136|82891584|FG000|Part B|Other AE|0|||
46675919|NCT01085136|82891585|FG001|Part B|Other AE|29|||
46675920|NCT01085136|82891586|FG002|Part B|Other AE|8|||
46675921|NCT01085136|82891584|FG000|Part B|Refusal to continue trial medication|0|||
46675922|NCT01085136|82891585|FG001|Part B|Refusal to continue trial medication|12|||
46675923|NCT01085136|82891586|FG002|Part B|Refusal to continue trial medication|7|||
46675924|NCT01085136|82891584|FG000|Part B|Not treated|0|||
46675925|NCT01085136|82891585|FG001|Part B|Not treated|4|||
46675926|NCT01085136|82891586|FG002|Part B|Not treated|8|||
46675927|NCT01085136|82891584|FG000|Part B|Other reason not defined above|0|||
46675928|NCT01085136|82891585|FG001|Part B|Other reason not defined above|6|||
46675929|NCT01085136|82891586|FG002|Part B|Other reason not defined above|3|||
46675930|NCT01084707|82891596|FG000|Overall Study|Withdrawal by Subject|6|||
46675931|NCT01084668|82891608|FG000|Overall Study|Lack of Efficacy|5|||
46675932|NCT01084668|82891608|FG000|Overall Study|Withdrawal by Subject|2|||
46675933|NCT01084668|82891608|FG000|Overall Study|Pregnancy|1|||
46675934|NCT01084668|82891608|FG000|Overall Study|Non-compliance|1|||
46675935|NCT01084551|82891617|FG000|Overall Study|Adverse Event|2|||
46675936|NCT01084551|82891618|FG001|Overall Study|Adverse Event|9|||
46675937|NCT01084551|82891619|FG002|Overall Study|Adverse Event|4|||
46675938|NCT01084551|82891617|FG000|Overall Study|Lack of Efficacy|2|||
46675939|NCT01084551|82891618|FG001|Overall Study|Lack of Efficacy|0|||
46675940|NCT01084551|82891619|FG002|Overall Study|Lack of Efficacy|1|||
46675941|NCT01084551|82891617|FG000|Overall Study|Withdrawal by Subject|2|||
46675942|NCT01084551|82891618|FG001|Overall Study|Withdrawal by Subject|1|||
46675943|NCT01084551|82891619|FG002|Overall Study|Withdrawal by Subject|0|||
46675944|NCT01084551|82891617|FG000|Overall Study|Protocol Violation|2|||
46675945|NCT01084551|82891618|FG001|Overall Study|Protocol Violation|4|||
46675946|NCT01084551|82891619|FG002|Overall Study|Protocol Violation|0|||
46675947|NCT01084551|82891617|FG000|Overall Study|Lost to Follow-up|0|||
46795417|NCT00573170|83013687|FG005|Third Treatment Period|Withdrawal by Subject|0|||
46675948|NCT01084551|82891618|FG001|Overall Study|Lost to Follow-up|0|||
46675949|NCT01084551|82891619|FG002|Overall Study|Lost to Follow-up|3|||
46675950|NCT01084551|82891617|FG000|Overall Study|Physician Decision|1|||
46675951|NCT01084551|82891618|FG001|Overall Study|Physician Decision|0|||
46675952|NCT01084551|82891619|FG002|Overall Study|Physician Decision|0|||
46795418|NCT00573170|83013682|FG000|Third Treatment Period|Lost to Follow-up|0|||
46795419|NCT00573170|83013683|FG001|Third Treatment Period|Lost to Follow-up|0|||
46795420|NCT00573170|83013684|FG002|Third Treatment Period|Lost to Follow-up|0|||
46795421|NCT00573170|83013685|FG003|Third Treatment Period|Lost to Follow-up|0|||
46675953|NCT01084005|82891629|FG000|Overall Study|Adverse Event|1|||
46675954|NCT01084005|82891630|FG001|Overall Study|Adverse Event|8|||
46856490|NCT03342898|83072344|FG002|Overall Study|Withdrawal of Consent|11|||
46856491|NCT03342898|83072342|FG000|Overall Study|Death|0|||
46856492|NCT03342898|83072343|FG001|Overall Study|Death|1|||
46856493|NCT03342898|83072344|FG002|Overall Study|Death|1|||
46856494|NCT03342898|83072342|FG000|Overall Study|Reason not Specified|2|||
46856495|NCT03342898|83072343|FG001|Overall Study|Reason not Specified|2|||
46856496|NCT03342898|83072344|FG002|Overall Study|Reason not Specified|0|||
46856497|NCT00339833|83072354|FG000|Overall Study|Withdrawal by Subject|1|||
46856498|NCT00339833|83072355|FG001|Overall Study|Withdrawal by Subject|2|||
46856499|NCT00339833|83072354|FG000|Overall Study|toothache|0|||
46856500|NCT00339833|83072355|FG001|Overall Study|toothache|1|||
46856501|NCT00339833|83072354|FG000|Overall Study|indigestion|0|||
46856502|NCT00339833|83072355|FG001|Overall Study|indigestion|1|||
46856503|NCT00339833|83072354|FG000|Overall Study|Chest pain|0|||
46979199|NCT01360645|83224788|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
46979200|NCT01360645|83224789|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
46979201|NCT01360645|83224790|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
46979202|NCT01360645|83224787|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
46979203|NCT01360645|83224788|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
46856504|NCT00339833|83072355|FG001|Overall Study|Chest pain|1|||
46856505|NCT00339833|83072354|FG000|Overall Study|minor infection|0|||
46856506|NCT00339833|83072355|FG001|Overall Study|minor infection|1|||
46856507|NCT00339833|83072354|FG000|Overall Study|Poor venous access|2|||
46856508|NCT00339833|83072355|FG001|Overall Study|Poor venous access|2|||
46856509|NCT00339833|83072354|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
46675955|NCT01084005|82891629|FG000|Overall Study|Protocol Violation|3|||
46795422|NCT00573170|83013686|FG004|Third Treatment Period|Lost to Follow-up|0|||
46795423|NCT00573170|83013687|FG005|Third Treatment Period|Lost to Follow-up|2|||
46795424|NCT00201643|83013706|FG000|Overall Study|Withdrawal by Subject|5|||
46795425|NCT00201643|83013707|FG001|Overall Study|Withdrawal by Subject|4|||
46795426|NCT00130039|83013715|FG000|Overall Study|Withdrawal by Subject|15|||
46795427|NCT00130039|83013716|FG001|Overall Study|Withdrawal by Subject|11|||
46795428|NCT00130039|83013715|FG000|Overall Study|Lost to Follow-up|3|||
46795429|NCT00130039|83013716|FG001|Overall Study|Lost to Follow-up|1|||
46795430|NCT00130039|83013715|FG000|Overall Study|Adverse Event|4|||
46795431|NCT00130039|83013716|FG001|Overall Study|Adverse Event|2|||
46675956|NCT01084005|82891630|FG001|Overall Study|Protocol Violation|7|||
46856510|NCT00339833|83072355|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
46856511|NCT00339833|83072354|FG000|Overall Study|Error in data records|1|||
46795432|NCT00130039|83013715|FG000|Overall Study|Physician Decision|3|||
46795433|NCT00130039|83013716|FG001|Overall Study|Physician Decision|0|||
46795434|NCT00130039|83013715|FG000|Overall Study|clinical events without follow up MRI|5|||
46795435|NCT00130039|83013716|FG001|Overall Study|clinical events without follow up MRI|4|||
46795436|NCT00475852|83013724|FG000|Overall Study|Death|444|||
46795437|NCT00475852|83013725|FG001|Overall Study|Death|456|||
46795438|NCT00475852|83013724|FG000|Overall Study|Withdrawal by Subject|19|||
46795439|NCT00475852|83013725|FG001|Overall Study|Withdrawal by Subject|24|||
46795440|NCT00475852|83013724|FG000|Overall Study|Lost to Follow-up|54|||
46795441|NCT00475852|83013725|FG001|Overall Study|Lost to Follow-up|68|||
46795442|NCT00141271|83013734|FG000|Overall Study|Adverse Event|31|||
46795443|NCT00141271|83013735|FG001|Overall Study|Adverse Event|19|||
46856512|NCT00339833|83072355|FG001|Overall Study|Error in data records|0|||
46856513|NCT03793556|83072363|FG000|Overall Study|Withdrawal by Subject|12|||
46979204|NCT01360645|83224789|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
46795444|NCT00141271|83013736|FG002|Overall Study|Adverse Event|17|||
46795445|NCT00141271|83013734|FG000|Overall Study|Laboratory Abnormality|2|||
46795446|NCT00141271|83013735|FG001|Overall Study|Laboratory Abnormality|1|||
46795447|NCT00141271|83013736|FG002|Overall Study|Laboratory Abnormality|1|||
46795448|NCT00141271|83013734|FG000|Overall Study|Lack of Efficacy|7|||
46795449|NCT00141271|83013735|FG001|Overall Study|Lack of Efficacy|7|||
46795450|NCT00141271|83013736|FG002|Overall Study|Lack of Efficacy|3|||
46795451|NCT00141271|83013734|FG000|Overall Study|Lost to Follow-up|15|||
47080661|NCT01272661|83394033|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
47080662|NCT01272661|83394034|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
46795452|NCT00141271|83013735|FG001|Overall Study|Lost to Follow-up|15|||
46795453|NCT00141271|83013736|FG002|Overall Study|Lost to Follow-up|21|||
46795454|NCT00141271|83013734|FG000|Overall Study|Withdrawal by Subject|14|||
47080663|NCT01272661|83394035|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
47080664|NCT04276051|83394201|FG000|Overall Study|Lost to Follow-up|0|||
47080665|NCT04276051|83394202|FG001|Overall Study|Lost to Follow-up|1|||
47080666|NCT04276051|83394201|FG000|Overall Study|Physician Decision|0|||
47080667|NCT04276051|83394202|FG001|Overall Study|Physician Decision|1|||
47080668|NCT04276051|83394201|FG000|Overall Study|Withdrawal by Subject|1|||
47080669|NCT04276051|83394202|FG001|Overall Study|Withdrawal by Subject|1|||
47080670|NCT00081770|83394462|FG000|Overall Study|Adverse Event|130|||
47080671|NCT00081770|83394463|FG001|Overall Study|Adverse Event|98|||
47080672|NCT00081770|83394464|FG002|Overall Study|Adverse Event|136|||
47080673|NCT00081770|83394462|FG000|Overall Study|Lack of Efficacy|262|||
47080674|NCT00081770|83394463|FG001|Overall Study|Lack of Efficacy|357|||
47080675|NCT00081770|83394464|FG002|Overall Study|Lack of Efficacy|211|||
47080676|NCT00081770|83394462|FG000|Overall Study|Lost to Follow-up|45|||
47080677|NCT00081770|83394463|FG001|Overall Study|Lost to Follow-up|34|||
47080678|NCT00081770|83394464|FG002|Overall Study|Lost to Follow-up|45|||
47080679|NCT00081770|83394462|FG000|Overall Study|Protocol Violation|15|||
47080680|NCT00081770|83394463|FG001|Overall Study|Protocol Violation|10|||
47080681|NCT00081770|83394464|FG002|Overall Study|Protocol Violation|10|||
47080682|NCT00081770|83394462|FG000|Overall Study|Withdrawal by Subject|45|||
47080683|NCT00081770|83394463|FG001|Overall Study|Withdrawal by Subject|40|||
47080684|NCT00081770|83394464|FG002|Overall Study|Withdrawal by Subject|42|||
47080685|NCT00081770|83394462|FG000|Overall Study|Did not meet protocol eligibility|2|||
47080686|NCT00081770|83394463|FG001|Overall Study|Did not meet protocol eligibility|0|||
47080687|NCT00081770|83394464|FG002|Overall Study|Did not meet protocol eligibility|3|||
47080688|NCT00081770|83394462|FG000|Overall Study|Administrative|1|||
47080689|NCT00081770|83394463|FG001|Overall Study|Administrative|0|||
47080690|NCT00081770|83394464|FG002|Overall Study|Administrative|1|||
47080691|NCT00081770|83394462|FG000|Overall Study|Other|2|||
47080692|NCT00081770|83394463|FG001|Overall Study|Other|7|||
46795455|NCT00141271|83013735|FG001|Overall Study|Withdrawal by Subject|9|||
46795456|NCT00141271|83013736|FG002|Overall Study|Withdrawal by Subject|10|||
47080693|NCT00081770|83394464|FG002|Overall Study|Other|8|||
47080694|NCT00081458|83394564|FG000|Overall Study|Adverse Event|1|||
47080695|NCT00081458|83394565|FG001|Overall Study|Adverse Event|5|||
46675957|NCT01084005|82891629|FG000|Overall Study|Withdrawal by Subject|1|||
46675958|NCT01084005|82891630|FG001|Overall Study|Withdrawal by Subject|1|||
47080696|NCT00081458|83394566|FG002|Overall Study|Adverse Event|2|||
47080697|NCT00081458|83394564|FG000|Overall Study|Withdrawal by Subject|0|||
46675959|NCT01083810|82891639|FG000|Overall Study|Lost to Follow-up|23|||
46795457|NCT00141271|83013734|FG000|Overall Study|Other|11|||
46795458|NCT00141271|83013735|FG001|Overall Study|Other|12|||
46795459|NCT00141271|83013736|FG002|Overall Study|Other|5|||
47080698|NCT00081458|83394565|FG001|Overall Study|Withdrawal by Subject|3|||
47080699|NCT00081458|83394566|FG002|Overall Study|Withdrawal by Subject|1|||
47080700|NCT00081458|83394564|FG000|Overall Study|Randomized but not dosed|0|||
47080701|NCT00081458|83394565|FG001|Overall Study|Randomized but not dosed|0|||
47080702|NCT00081458|83394566|FG002|Overall Study|Randomized but not dosed|1|||
47080703|NCT01271803|83394643|FG000|Overall Study|Progressive disease|0|||
47080704|NCT01271803|83394644|FG001|Overall Study|Progressive disease|0|||
47080705|NCT01271803|83394645|FG002|Overall Study|Progressive disease|2|||
47080706|NCT01271803|83394643|FG000|Overall Study|Death|53|||
46675960|NCT01083810|82891640|FG001|Overall Study|Lost to Follow-up|11|||
46795460|NCT00614120|83013748|FG000|Overall Study|Adverse Event|9|||
47080707|NCT01271803|83394644|FG001|Overall Study|Death|34|||
47080708|NCT01271803|83394645|FG002|Overall Study|Death|0|||
46795461|NCT00614120|83013749|FG001|Overall Study|Adverse Event|22|||
46795462|NCT00614120|83013750|FG002|Overall Study|Adverse Event|30|||
46795463|NCT00614120|83013751|FG003|Overall Study|Adverse Event|3|||
46795464|NCT00614120|83013748|FG000|Overall Study|Lack of Efficacy|3|||
46795465|NCT00614120|83013749|FG001|Overall Study|Lack of Efficacy|3|||
46979205|NCT01360645|83224790|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
46795466|NCT00614120|83013750|FG002|Overall Study|Lack of Efficacy|2|||
46795467|NCT00614120|83013751|FG003|Overall Study|Lack of Efficacy|2|||
46979206|NCT01360645|83224787|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
47080709|NCT01271803|83394643|FG000|Overall Study|Withdrawal by Subject|1|||
47080710|NCT01271803|83394644|FG001|Overall Study|Withdrawal by Subject|5|||
47080711|NCT01271803|83394645|FG002|Overall Study|Withdrawal by Subject|0|||
46795468|NCT00614120|83013748|FG000|Overall Study|Protocol Violation|2|||
46795469|NCT00614120|83013749|FG001|Overall Study|Protocol Violation|5|||
46795470|NCT00614120|83013750|FG002|Overall Study|Protocol Violation|3|||
47080712|NCT01271803|83394643|FG000|Overall Study|Lost to Follow-up|1|||
47080713|NCT01271803|83394644|FG001|Overall Study|Lost to Follow-up|0|||
47080714|NCT01271803|83394645|FG002|Overall Study|Lost to Follow-up|0|||
47080715|NCT00080288|83394696|FG000|Overall Study|Adverse Event|7|||
47080716|NCT00080288|83394697|FG001|Overall Study|Adverse Event|4|||
47080717|NCT00080288|83394696|FG000|Overall Study|Lost to Follow-up|3|||
47080718|NCT00080288|83394697|FG001|Overall Study|Lost to Follow-up|5|||
47080719|NCT00080288|83394696|FG000|Overall Study|Physician Decision|6|||
46795471|NCT00614120|83013751|FG003|Overall Study|Protocol Violation|1|||
46795472|NCT00614120|83013748|FG000|Overall Study|Withdrawal criteria|1|||
47080720|NCT00080288|83394697|FG001|Overall Study|Physician Decision|2|||
46856514|NCT03793556|83072364|FG001|Overall Study|Withdrawal by Subject|1|||
46856515|NCT03793556|83072363|FG000|Overall Study|Lost to Follow-up|1|||
46856516|NCT03793556|83072364|FG001|Overall Study|Lost to Follow-up|1|||
46979207|NCT01360645|83224788|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
46979208|NCT01360645|83224789|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
46979209|NCT01360645|83224790|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
46979210|NCT01360645|83224787|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
46979211|NCT01360645|83224788|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
46979212|NCT01360645|83224789|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
46675961|NCT01083810|82891641|FG002|Overall Study|Lost to Follow-up|4|||
46675962|NCT01083810|82891639|FG000|Overall Study|Adverse Event|15|||
46675963|NCT01083810|82891640|FG001|Overall Study|Adverse Event|11|||
46675964|NCT01083810|82891641|FG002|Overall Study|Adverse Event|4|||
46675965|NCT01083810|82891639|FG000|Overall Study|Withdrawal by Subject|7|||
46795473|NCT00614120|83013749|FG001|Overall Study|Withdrawal criteria|0|||
46795474|NCT00614120|83013750|FG002|Overall Study|Withdrawal criteria|0|||
46795475|NCT00614120|83013751|FG003|Overall Study|Withdrawal criteria|0|||
46795476|NCT00614120|83013748|FG000|Overall Study|Withdrawal by Subject|9|||
46795477|NCT00614120|83013749|FG001|Overall Study|Withdrawal by Subject|10|||
46795478|NCT00614120|83013750|FG002|Overall Study|Withdrawal by Subject|16|||
46795479|NCT00614120|83013751|FG003|Overall Study|Withdrawal by Subject|3|||
46795480|NCT00614120|83013748|FG000|Overall Study|Did not meet trial criteria|0|||
46795481|NCT00614120|83013749|FG001|Overall Study|Did not meet trial criteria|1|||
46675966|NCT01083810|82891640|FG001|Overall Study|Withdrawal by Subject|2|||
46675967|NCT01083810|82891641|FG002|Overall Study|Withdrawal by Subject|4|||
46979213|NCT01360645|83224790|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
47080721|NCT00080288|83394696|FG000|Overall Study|Withdrawal by Subject|3|||
47080722|NCT00080288|83394697|FG001|Overall Study|Withdrawal by Subject|16|||
47080723|NCT00080288|83394696|FG000|Overall Study|Miscellaneous|11|||
47080724|NCT00080288|83394697|FG001|Overall Study|Miscellaneous|11|||
47080725|NCT01271725|83394763|FG000|Part A|Progressive disease according to RECIST|8|||
47080726|NCT01271725|83394764|FG001|Part A|Progressive disease according to RECIST|0|||
47080727|NCT01271725|83394763|FG000|Part A|Clinical signs/symptoms of progression|2|||
47080728|NCT01271725|83394764|FG001|Part A|Clinical signs/symptoms of progression|0|||
47080729|NCT01271725|83394763|FG000|Part A|Other Adverse Event|8|||
47080730|NCT01271725|83394764|FG001|Part A|Other Adverse Event|0|||
47080731|NCT01271725|83394763|FG000|Part A|Lost to Follow-up|1|||
47080732|NCT01271725|83394764|FG001|Part A|Lost to Follow-up|0|||
47080733|NCT01271725|83394763|FG000|Part A|Withdrawal by Subject|12|||
47080734|NCT01271725|83394764|FG001|Part A|Withdrawal by Subject|0|||
47080735|NCT01271725|83394763|FG000|Part A|Other than specified|3|||
47080736|NCT01271725|83394764|FG001|Part A|Other than specified|0|||
47080737|NCT01271725|83394763|FG000|Part A|Protocol Violation|1|||
47080738|NCT01271725|83394764|FG001|Part A|Protocol Violation|0|||
47080739|NCT01271725|83394763|FG000|Part B|Other than specified|0|||
47080740|NCT01271725|83394764|FG001|Part B|Other than specified|2|||
47080741|NCT01271725|83394763|FG000|Part B|Clinical signs/symptoms of progression|0|||
47080742|NCT01271725|83394764|FG001|Part B|Clinical signs/symptoms of progression|2|||
47080743|NCT01271725|83394763|FG000|Part B|Other Adverse Event|0|||
47080744|NCT01271725|83394764|FG001|Part B|Other Adverse Event|1|||
47080745|NCT01271725|83394763|FG000|Part B|Protocol Violation|0|||
47080746|NCT01271725|83394764|FG001|Part B|Protocol Violation|1|||
47080747|NCT01271725|83394763|FG000|Part B|Withdrawal by Subject|0|||
47080748|NCT01271725|83394764|FG001|Part B|Withdrawal by Subject|6|||
47080749|NCT01270321|83394789|FG000|Overall Study|Death|3|||
47080750|NCT01270321|83394790|FG001|Overall Study|Death|1|||
47080751|NCT01270321|83394791|FG002|Overall Study|Death|4|||
47080752|NCT01270321|83394789|FG000|Overall Study|Adverse Event|7|||
47080753|NCT01270321|83394790|FG001|Overall Study|Adverse Event|9|||
46795482|NCT00614120|83013750|FG002|Overall Study|Did not meet trial criteria|1|||
46795483|NCT00614120|83013751|FG003|Overall Study|Did not meet trial criteria|1|||
46795484|NCT00614120|83013748|FG000|Overall Study|hCG positive (not pregnant)|0|||
46795485|NCT00614120|83013749|FG001|Overall Study|hCG positive (not pregnant)|0|||
46795486|NCT00614120|83013750|FG002|Overall Study|hCG positive (not pregnant)|1|||
46795487|NCT00614120|83013751|FG003|Overall Study|hCG positive (not pregnant)|0|||
46795488|NCT00614120|83013748|FG000|Overall Study|Hypoglycaemia|0|||
46795489|NCT00614120|83013749|FG001|Overall Study|Hypoglycaemia|0|||
46795490|NCT00614120|83013750|FG002|Overall Study|Hypoglycaemia|0|||
46795491|NCT00614120|83013751|FG003|Overall Study|Hypoglycaemia|1|||
46979214|NCT01360645|83224787|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
46795492|NCT00614120|83013748|FG000|Overall Study|Lack of trial product|3|||
46675968|NCT01083810|82891639|FG000|Overall Study|Reason not reported|6|||
46675969|NCT01083810|82891640|FG001|Overall Study|Reason not reported|1|||
46675970|NCT01083810|82891641|FG002|Overall Study|Reason not reported|1|||
46675971|NCT01083810|82891639|FG000|Overall Study|Non-compliance|4|||
46675972|NCT01083810|82891640|FG001|Overall Study|Non-compliance|7|||
46675973|NCT01083810|82891641|FG002|Overall Study|Non-compliance|2|||
46675974|NCT01083810|82891639|FG000|Overall Study|Simplification|4|||
46675975|NCT01083810|82891640|FG001|Overall Study|Simplification|1|||
46675976|NCT01083810|82891641|FG002|Overall Study|Simplification|0|||
46675977|NCT01083810|82891639|FG000|Overall Study|Death|2|||
46675978|NCT01083810|82891640|FG001|Overall Study|Death|2|||
46675979|NCT01083810|82891641|FG002|Overall Study|Death|3|||
46675980|NCT01083810|82891639|FG000|Overall Study|Co-morbidities|1|||
46675981|NCT01083810|82891640|FG001|Overall Study|Co-morbidities|0|||
46675982|NCT01083810|82891641|FG002|Overall Study|Co-morbidities|0|||
46675983|NCT01083810|82891639|FG000|Overall Study|Participation in study|1|||
46675984|NCT01083810|82891640|FG001|Overall Study|Participation in study|0|||
46675985|NCT01083810|82891641|FG002|Overall Study|Participation in study|0|||
46675986|NCT01083810|82891639|FG000|Overall Study|Therapy break|1|||
46675987|NCT01083810|82891640|FG001|Overall Study|Therapy break|2|||
46675988|NCT01083810|82891641|FG002|Overall Study|Therapy break|2|||
46675989|NCT01083810|82891639|FG000|Overall Study|Virologic failure|1|||
46675990|NCT01083810|82891640|FG001|Overall Study|Virologic failure|8|||
46675991|NCT01083810|82891641|FG002|Overall Study|Virologic failure|0|||
46675992|NCT01083771|82891647|FG000|Overall Study|non-compliant|2|||
46675993|NCT01083771|82891647|FG000|Overall Study|Withdrawal by Subject|3|||
46675994|NCT01083693|82891654|FG000|Overall Study|Adverse Event|1|||
46675995|NCT01083693|82891655|FG001|Overall Study|Adverse Event|1|||
46675996|NCT01083693|82891656|FG002|Overall Study|Adverse Event|0|||
46675997|NCT01083693|82891654|FG000|Overall Study|Lost to Follow-up|2|||
46856517|NCT03392194|83072375|FG000|Overall Study|Withdrawal by Subject|1|||
47080754|NCT01270321|83394791|FG002|Overall Study|Adverse Event|5|||
47080755|NCT00249769|83394885|FG000|Overall Study|Withdrawal by Subject|1|||
47080756|NCT00249769|83394886|FG001|Overall Study|Withdrawal by Subject|10|||
47080757|NCT00249769|83394887|FG002|Overall Study|Withdrawal by Subject|6|||
47080758|NCT00249769|83394885|FG000|Overall Study|Migration from Study Area|1|||
47080759|NCT00249769|83394886|FG001|Overall Study|Migration from Study Area|3|||
47080760|NCT00249769|83394887|FG002|Overall Study|Migration from Study Area|14|||
47080761|NCT00249769|83394885|FG000|Overall Study|Miscellaneous|0|||
47080762|NCT00249769|83394886|FG001|Overall Study|Miscellaneous|2|||
47080763|NCT00249769|83394887|FG002|Overall Study|Miscellaneous|2|||
47080764|NCT00249769|83394885|FG000|Overall Study|Adverse Event|0|||
47080765|NCT00249769|83394886|FG001|Overall Study|Adverse Event|0|||
47080766|NCT00249769|83394887|FG002|Overall Study|Adverse Event|1|||
47080767|NCT00249769|83394885|FG000|Overall Study|Physician Decision|0|||
47080768|NCT00249769|83394886|FG001|Overall Study|Physician Decision|0|||
47080769|NCT00249769|83394887|FG002|Overall Study|Physician Decision|2|||
47080770|NCT00249769|83394885|FG000|Overall Study|Lost to Follow-up|0|||
47080771|NCT00249769|83394886|FG001|Overall Study|Lost to Follow-up|0|||
47080772|NCT00249769|83394887|FG002|Overall Study|Lost to Follow-up|3|||
47080773|NCT00249613|83394897|FG000|12 Month Follow-up|Death|1|||
46675998|NCT01083693|82891655|FG001|Overall Study|Lost to Follow-up|0|||
46856518|NCT03392194|83072376|FG001|Overall Study|Withdrawal by Subject|2|||
47080774|NCT00249613|83394898|FG001|12 Month Follow-up|Death|1|||
47080775|NCT00249613|83394897|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
47080776|NCT00249613|83394898|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
47080777|NCT00249613|83394897|FG000|12 Month Follow-up|Lost to Follow-up|10|||
46675999|NCT01083693|82891656|FG002|Overall Study|Lost to Follow-up|2|||
46676000|NCT01083693|82891654|FG000|Overall Study|Lack of effectiveness|13|||
46676001|NCT01083693|82891655|FG001|Overall Study|Lack of effectiveness|2|||
46856519|NCT03392194|83072375|FG000|Overall Study|Conflicts with personal schedule|1|||
46676002|NCT01083693|82891656|FG002|Overall Study|Lack of effectiveness|2|||
46676003|NCT01083693|82891654|FG000|Overall Study|Patient Moved|0|||
46676004|NCT01083693|82891655|FG001|Overall Study|Patient Moved|1|||
46676005|NCT01083693|82891656|FG002|Overall Study|Patient Moved|0|||
46676006|NCT01083693|82891654|FG000|Overall Study|Complete remission|0|||
46676007|NCT01083693|82891655|FG001|Overall Study|Complete remission|1|||
46676008|NCT01083693|82891656|FG002|Overall Study|Complete remission|0|||
46676009|NCT01083693|82891654|FG000|Overall Study|Other medical condition/surgery|1|||
46676010|NCT01083693|82891655|FG001|Overall Study|Other medical condition/surgery|1|||
46676011|NCT01083693|82891656|FG002|Overall Study|Other medical condition/surgery|0|||
46676012|NCT01083693|82891654|FG000|Overall Study|Withdrawal by Subject|3|||
46676013|NCT01083693|82891655|FG001|Overall Study|Withdrawal by Subject|0|||
46676014|NCT01083693|82891656|FG002|Overall Study|Withdrawal by Subject|2|||
46676015|NCT01083693|82891654|FG000|Overall Study|Reason unknown|0|||
46676016|NCT01083693|82891655|FG001|Overall Study|Reason unknown|0|||
46676017|NCT01083693|82891656|FG002|Overall Study|Reason unknown|1|||
46676018|NCT01083576|82891670|FG000|Overall Study|Treatment Failure|6|||
46676019|NCT01083576|82891671|FG001|Overall Study|Treatment Failure|1|||
46676020|NCT01083186|82891678|FG000|Overall Study|Lost to Follow-up|48|||
46676021|NCT01083186|82891678|FG000|Overall Study|Consent Withdrawal|7|||
46676022|NCT01083186|82891678|FG000|Overall Study|Death|3|||
46676023|NCT01083186|82891678|FG000|Overall Study|Adverse Event|3|||
46676024|NCT01083186|82891678|FG000|Overall Study|Lack of Efficacy|2|||
46676025|NCT01083186|82891678|FG000|Overall Study|Hemodialysis Initiation|28|||
46676026|NCT01083186|82891678|FG000|Overall Study|Administrative Reasons|2|||
46676027|NCT01083186|82891678|FG000|Overall Study|Non-compliance to Study Treatment|1|||
46676028|NCT01082640|82891705|FG000|Overall Study|Adverse Event|9|||
46676029|NCT01082640|82891706|FG001|Overall Study|Adverse Event|5|||
46676030|NCT01082640|82891707|FG002|Overall Study|Adverse Event|3|||
46676031|NCT01082640|82891705|FG000|Overall Study|Withdrawal by Subject|3|||
46676032|NCT01082640|82891706|FG001|Overall Study|Withdrawal by Subject|3|||
46676033|NCT01082640|82891707|FG002|Overall Study|Withdrawal by Subject|2|||
46676034|NCT01082640|82891705|FG000|Overall Study|Major protocol deviation|3|||
46676035|NCT01082640|82891706|FG001|Overall Study|Major protocol deviation|3|||
46676036|NCT01082640|82891707|FG002|Overall Study|Major protocol deviation|0|||
47080778|NCT00249613|83394898|FG001|12 Month Follow-up|Lost to Follow-up|8|||
46676037|NCT01082640|82891705|FG000|Overall Study|Lost to Follow-up|0|||
46676038|NCT01082640|82891706|FG001|Overall Study|Lost to Follow-up|3|||
46676039|NCT01082640|82891707|FG002|Overall Study|Lost to Follow-up|0|||
46979215|NCT01360645|83224788|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
47080779|NCT00248833|83394934|FG000|Overall Study|Adverse Event|2|||
47080780|NCT00248833|83394935|FG001|Overall Study|Adverse Event|0|||
47080781|NCT00248833|83394936|FG002|Overall Study|Adverse Event|0|||
47080782|NCT00248833|83394934|FG000|Overall Study|Withdrawal by Subject|0|||
47080783|NCT00248833|83394935|FG001|Overall Study|Withdrawal by Subject|1|||
47080784|NCT00248833|83394936|FG002|Overall Study|Withdrawal by Subject|1|||
47080785|NCT00248833|83394934|FG000|Overall Study|Lost to Follow-up|1|||
47080786|NCT00248833|83394935|FG001|Overall Study|Lost to Follow-up|1|||
47080787|NCT00248833|83394936|FG002|Overall Study|Lost to Follow-up|1|||
47080788|NCT00248833|83394934|FG000|Overall Study|Other|0|||
47080789|NCT00248833|83394935|FG001|Overall Study|Other|1|||
47080790|NCT00248833|83394936|FG002|Overall Study|Other|0|||
47080791|NCT00247273|83395098|FG000|Overall Study|Adverse Event|85|||
47080792|NCT00247273|83395099|FG001|Overall Study|Adverse Event|80|||
47080793|NCT00247273|83395098|FG000|Overall Study|Physician Decision|6|||
47080794|NCT00247273|83395099|FG001|Overall Study|Physician Decision|3|||
47080795|NCT00247273|83395098|FG000|Overall Study|Lost to Follow-up|7|||
47080796|NCT00247273|83395099|FG001|Overall Study|Lost to Follow-up|7|||
47080797|NCT00247273|83395098|FG000|Overall Study|Withdrawal by Subject|46|||
47080798|NCT00247273|83395099|FG001|Overall Study|Withdrawal by Subject|47|||
47080799|NCT00247273|83395098|FG000|Overall Study|Did not take any study drug|2|||
46676040|NCT01082640|82891705|FG000|Overall Study|Other|2|||
46979216|NCT01360645|83224789|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
46676041|NCT01082640|82891706|FG001|Overall Study|Other|1|||
46676042|NCT01082640|82891707|FG002|Overall Study|Other|3|||
47080800|NCT00247273|83395099|FG001|Overall Study|Did not take any study drug|0|||
47080801|NCT00246259|83395187|FG000|Overall Study|Other|3|||
46795493|NCT00614120|83013749|FG001|Overall Study|Lack of trial product|3|||
46795494|NCT00614120|83013750|FG002|Overall Study|Lack of trial product|2|||
46795495|NCT00614120|83013751|FG003|Overall Study|Lack of trial product|0|||
46979217|NCT01360645|83224790|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
46795496|NCT00614120|83013748|FG000|Overall Study|Late syphilis, latent|1|||
46795497|NCT00614120|83013749|FG001|Overall Study|Late syphilis, latent|0|||
46795498|NCT00614120|83013750|FG002|Overall Study|Late syphilis, latent|0|||
46795499|NCT00614120|83013751|FG003|Overall Study|Late syphilis, latent|0|||
47080802|NCT00246259|83395188|FG001|Overall Study|Other|3|||
47080803|NCT00246259|83395187|FG000|Overall Study|Not stable by Week 18|2|||
47080804|NCT00246259|83395188|FG001|Overall Study|Not stable by Week 18|1|||
47080805|NCT00246259|83395187|FG000|Overall Study|Participant non-compliant|4|||
47080806|NCT00246259|83395188|FG001|Overall Study|Participant non-compliant|9|||
47080807|NCT00246259|83395187|FG000|Overall Study|Lack of Efficacy|2|||
47080808|NCT00246259|83395188|FG001|Overall Study|Lack of Efficacy|2|||
47080809|NCT00246259|83395187|FG000|Overall Study|Investigator withdrew participant|2|||
47080810|NCT00246259|83395188|FG001|Overall Study|Investigator withdrew participant|0|||
47080811|NCT00246259|83395187|FG000|Overall Study|Adverse Event|5|||
47080812|NCT00246259|83395188|FG001|Overall Study|Adverse Event|0|||
47080813|NCT00246259|83395187|FG000|Overall Study|Lost to Follow-up|3|||
46795500|NCT00614120|83013748|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
46795501|NCT00614120|83013749|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
46795502|NCT00614120|83013750|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
46795503|NCT00614120|83013751|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
46795504|NCT00614120|83013748|FG000|Overall Study|Lost to Follow-up|1|||
46795505|NCT00614120|83013749|FG001|Overall Study|Lost to Follow-up|2|||
46795506|NCT00614120|83013750|FG002|Overall Study|Lost to Follow-up|3|||
46979218|NCT01360645|83224787|FG000|Phase B (6 Weeks)|Adverse Event|0|||
46795507|NCT00614120|83013751|FG003|Overall Study|Lost to Follow-up|4|||
46795508|NCT00496054|83013761|FG000|Overall Study|Adverse Event|1|||
47080814|NCT00246259|83395188|FG001|Overall Study|Lost to Follow-up|4|||
47080815|NCT00246259|83395187|FG000|Overall Study|Withdrawal by Subject|5|||
46676043|NCT01082367|82891720|FG000|Double-blind Period|Administrative problems|0|||
46979219|NCT01360645|83224788|FG001|Phase B (6 Weeks)|Adverse Event|6|||
46979220|NCT01360645|83224789|FG002|Phase B (6 Weeks)|Adverse Event|0|||
46979221|NCT01360645|83224790|FG003|Phase B (6 Weeks)|Adverse Event|0|||
46979222|NCT01360645|83224787|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
46979223|NCT01360645|83224788|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
46979224|NCT01360645|83224789|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
46979225|NCT01360645|83224790|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
46979226|NCT01360645|83224787|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
46979227|NCT01360645|83224788|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
46979228|NCT01360645|83224789|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
46979229|NCT01360645|83224790|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
46979230|NCT01360645|83224787|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
46979231|NCT01360645|83224788|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
46979232|NCT01360645|83224789|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
46979233|NCT01360645|83224790|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
46979234|NCT01360645|83224787|FG000|Phase A+|Lost to Follow-up|0|||
46979235|NCT01360645|83224788|FG001|Phase A+|Lost to Follow-up|0|||
46979236|NCT01360645|83224789|FG002|Phase A+|Lost to Follow-up|0|||
46979237|NCT01360645|83224790|FG003|Phase A+|Lost to Follow-up|7|||
46979238|NCT01360645|83224787|FG000|Phase A+|Adverse Event|0|||
46979239|NCT01360645|83224788|FG001|Phase A+|Adverse Event|0|||
46979240|NCT01360645|83224789|FG002|Phase A+|Adverse Event|0|||
47080816|NCT00246259|83395188|FG001|Overall Study|Withdrawal by Subject|1|||
47080817|NCT00246259|83395187|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
47080818|NCT00246259|83395188|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
47080819|NCT00246025|83395240|FG000|Overall Study|Adverse Event|7|||
47080820|NCT00246025|83395241|FG001|Overall Study|Adverse Event|9|||
47080821|NCT00246025|83395242|FG002|Overall Study|Adverse Event|9|||
47080822|NCT00246025|83395243|FG003|Overall Study|Adverse Event|10|||
47080823|NCT00246025|83395240|FG000|Overall Study|Withdrawal by Subject|3|||
47080824|NCT00246025|83395241|FG001|Overall Study|Withdrawal by Subject|0|||
47080825|NCT00246025|83395242|FG002|Overall Study|Withdrawal by Subject|1|||
47080826|NCT00246025|83395243|FG003|Overall Study|Withdrawal by Subject|2|||
47080827|NCT00246025|83395240|FG000|Overall Study|unsuitable medical history was found|0|||
46979241|NCT01360645|83224790|FG003|Phase A+|Adverse Event|2|||
46979242|NCT01360645|83224787|FG000|Phase A+|Met Withdrawal Criteria|0|||
46979243|NCT01360645|83224788|FG001|Phase A+|Met Withdrawal Criteria|0|||
47080828|NCT00246025|83395241|FG001|Overall Study|unsuitable medical history was found|0|||
46979244|NCT01360645|83224789|FG002|Phase A+|Met Withdrawal Criteria|0|||
46979245|NCT01360645|83224790|FG003|Phase A+|Met Withdrawal Criteria|4|||
46979246|NCT01360645|83224787|FG000|Phase A+|Physician Decision|0|||
46979247|NCT01360645|83224788|FG001|Phase A+|Physician Decision|0|||
46979248|NCT01360645|83224789|FG002|Phase A+|Physician Decision|0|||
46979249|NCT01360645|83224790|FG003|Phase A+|Physician Decision|2|||
46979250|NCT01360645|83224787|FG000|Phase A+|Withdrawal by Subject|0|||
46979251|NCT01360645|83224788|FG001|Phase A+|Withdrawal by Subject|0|||
46979252|NCT01360645|83224789|FG002|Phase A+|Withdrawal by Subject|0|||
46676044|NCT01082367|82891721|FG001|Double-blind Period|Administrative problems|1|||
46676045|NCT01082367|82891720|FG000|Double-blind Period|Lack of Efficacy|5|||
46676046|NCT01082367|82891721|FG001|Double-blind Period|Lack of Efficacy|11|||
46676047|NCT01082367|82891720|FG000|Double-blind Period|Adverse Event|0|||
46795509|NCT00496054|83013761|FG000|Overall Study|Lost to Follow-up|7|||
46795510|NCT00495820|83013767|FG000|Overall Study|Adverse Event|1|||
46795511|NCT00495820|83013768|FG001|Overall Study|Adverse Event|1|||
46979253|NCT01360645|83224790|FG003|Phase A+|Withdrawal by Subject|5|||
46979254|NCT01360645|83224787|FG000|Phase A+|Protocol Deviation|0|||
46979255|NCT01360645|83224788|FG001|Phase A+|Protocol Deviation|0|||
46676048|NCT01082367|82891721|FG001|Double-blind Period|Adverse Event|1|||
46676049|NCT01082367|82891720|FG000|Follow-up (F-U) Period|Administrative problems|1|||
46795512|NCT00495586|83013776|FG000|Overall Study|Withdrawal by Subject|4|||
46795513|NCT00495586|83013777|FG001|Overall Study|Withdrawal by Subject|4|||
46979256|NCT01360645|83224789|FG002|Phase A+|Protocol Deviation|0|||
46795514|NCT00613730|83013785|FG000|Overall Study|Disease progression|2|||
46979257|NCT01360645|83224790|FG003|Phase A+|Protocol Deviation|4|||
46979258|NCT04336163|83224802|FG000|Overall Study|Lost to Follow-up|55|||
46979259|NCT04336163|83224803|FG001|Overall Study|Lost to Follow-up|0|||
46979260|NCT02633527|83224814|FG000|Overall Study|Failed to meet eligibility|0|||
46795515|NCT00613730|83013785|FG000|Overall Study|Administrative decision|1|||
46979261|NCT02633527|83224815|FG001|Overall Study|Failed to meet eligibility|1|||
46979262|NCT02633527|83224816|FG002|Overall Study|Failed to meet eligibility|1|||
46979263|NCT02633527|83224817|FG003|Overall Study|Failed to meet eligibility|0|||
46979264|NCT02633527|83224818|FG004|Overall Study|Failed to meet eligibility|1|||
46856520|NCT03392194|83072376|FG001|Overall Study|Conflicts with personal schedule|0|||
46856521|NCT03828617|83072386|FG000|Overall Study|Lost to Follow-up|22|||
46979265|NCT02633527|83224814|FG000|Overall Study|Adverse Event|0|||
46856522|NCT03828617|83072387|FG001|Overall Study|Lost to Follow-up|12|||
46979266|NCT02633527|83224815|FG001|Overall Study|Adverse Event|4|||
46979267|NCT02633527|83224816|FG002|Overall Study|Adverse Event|3|||
46979268|NCT02633527|83224817|FG003|Overall Study|Adverse Event|1|||
46979269|NCT02633527|83224818|FG004|Overall Study|Adverse Event|5|||
46979270|NCT02633527|83224814|FG000|Overall Study|Lost to Follow-up|1|||
46979271|NCT02633527|83224815|FG001|Overall Study|Lost to Follow-up|2|||
46979272|NCT02633527|83224816|FG002|Overall Study|Lost to Follow-up|5|||
46979273|NCT02633527|83224817|FG003|Overall Study|Lost to Follow-up|5|||
46979274|NCT02633527|83224818|FG004|Overall Study|Lost to Follow-up|4|||
46979275|NCT02633527|83224814|FG000|Overall Study|Withdrawal by Subject|0|||
46979276|NCT02633527|83224815|FG001|Overall Study|Withdrawal by Subject|3|||
46979277|NCT02633527|83224816|FG002|Overall Study|Withdrawal by Subject|5|||
46979278|NCT02633527|83224817|FG003|Overall Study|Withdrawal by Subject|4|||
46979279|NCT02633527|83224818|FG004|Overall Study|Withdrawal by Subject|4|||
46979280|NCT02633527|83224814|FG000|Overall Study|Protocol Violation|0|||
46979281|NCT02633527|83224815|FG001|Overall Study|Protocol Violation|1|||
46979282|NCT02633527|83224816|FG002|Overall Study|Protocol Violation|1|||
46979283|NCT02633527|83224817|FG003|Overall Study|Protocol Violation|1|||
46979284|NCT02633527|83224818|FG004|Overall Study|Protocol Violation|1|||
46979285|NCT02633527|83224814|FG000|Overall Study|Physician Decision|0|||
46979286|NCT02633527|83224815|FG001|Overall Study|Physician Decision|0|||
46979287|NCT02633527|83224816|FG002|Overall Study|Physician Decision|0|||
46979288|NCT02633527|83224817|FG003|Overall Study|Physician Decision|0|||
46676050|NCT01082367|82891721|FG001|Follow-up (F-U) Period|Administrative problems|0|||
46676051|NCT01082367|82891720|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
46676052|NCT01082367|82891721|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
46979289|NCT02633527|83224818|FG004|Overall Study|Physician Decision|1|||
46979290|NCT02633527|83224814|FG000|Overall Study|Administrative reason|1|||
46856523|NCT03828617|83072388|FG002|Overall Study|Lost to Follow-up|23|||
46979291|NCT02633527|83224815|FG001|Overall Study|Administrative reason|0|||
46676053|NCT01082367|82891720|FG000|Follow-up (F-U) Period|Adverse Event|0|||
46676054|NCT01082367|82891721|FG001|Follow-up (F-U) Period|Adverse Event|1|||
46676055|NCT01082211|82891731|FG000|Overall Study|Protocol Violation|4|||
46676056|NCT01082211|82891731|FG000|Overall Study|No protocol treatment received|3|||
46676057|NCT01081665|82891738|FG000|Overall Study|Death|41|||
46676058|NCT01081665|82891738|FG000|Overall Study|Lost to Follow-up|18|||
46676059|NCT01081665|82891738|FG000|Overall Study|Withdrawal by Subject|17|||
46676060|NCT01081665|82891738|FG000|Overall Study|Change of dialysis unit|10|||
46676061|NCT01081665|82891738|FG000|Overall Study|Regulation of iPTH|5|||
46676062|NCT01081665|82891738|FG000|Overall Study|Change in renal replacement therapy|2|||
46676063|NCT01081665|82891738|FG000|Overall Study|Adverse Event|1|||
46676064|NCT01081665|82891738|FG000|Overall Study|Lack of Efficacy|1|||
46676065|NCT01081626|82891744|FG000|Overall Study|Dosing error|1|||
46676066|NCT01081626|82891745|FG001|Overall Study|Dosing error|1|||
46676067|NCT01081626|82891744|FG000|Overall Study|Missing Estradiol|25|||
46676068|NCT01081626|82891745|FG001|Overall Study|Missing Estradiol|28|||
46676069|NCT01081626|82891744|FG000|Overall Study|Low antral follicle count|1|||
46979292|NCT02633527|83224816|FG002|Overall Study|Administrative reason|0|||
46979293|NCT02633527|83224817|FG003|Overall Study|Administrative reason|1|||
46979294|NCT02633527|83224818|FG004|Overall Study|Administrative reason|0|||
46979295|NCT02633527|83224814|FG000|Overall Study|Multiple reasons|1|||
46979296|NCT02633527|83224815|FG001|Overall Study|Multiple reasons|0|||
46676070|NCT01081626|82891745|FG001|Overall Study|Low antral follicle count|0|||
46676071|NCT01081626|82891744|FG000|Overall Study|Overstimulation|0|||
46676072|NCT01081626|82891745|FG001|Overall Study|Overstimulation|1|||
46676073|NCT01081626|82891744|FG000|Overall Study|Lost to Follow-up|0|||
46676074|NCT01081626|82891745|FG001|Overall Study|Lost to Follow-up|1|||
46676075|NCT01081626|82891744|FG000|Overall Study|Other|33|||
46676076|NCT01081626|82891745|FG001|Overall Study|Other|30|||
46676077|NCT01080768|82891753|FG000|Overall Study|Protocol Deviation|2|||
46676078|NCT01080768|82891754|FG001|Overall Study|Protocol Deviation|1|||
46676079|NCT01080300|82891762|FG000|Overall Study|Adverse Event|49|||
46676080|NCT01080300|82891763|FG001|Overall Study|Adverse Event|35|||
46676081|NCT01080300|82891762|FG000|Overall Study|Lack of Efficacy|12|||
46676082|NCT01080300|82891763|FG001|Overall Study|Lack of Efficacy|15|||
46676083|NCT01080300|82891762|FG000|Overall Study|Protocol Violation|7|||
46676084|NCT01080300|82891763|FG001|Overall Study|Protocol Violation|13|||
46676085|NCT01080300|82891762|FG000|Overall Study|Lost to Follow-up|10|||
46676086|NCT01080300|82891763|FG001|Overall Study|Lost to Follow-up|6|||
46676087|NCT01080300|82891762|FG000|Overall Study|Death|0|||
46676088|NCT01080300|82891763|FG001|Overall Study|Death|1|||
46676089|NCT01080300|82891762|FG000|Overall Study|Withdrawal by Subject|12|||
46676090|NCT01080300|82891763|FG001|Overall Study|Withdrawal by Subject|28|||
46676091|NCT01080300|82891762|FG000|Overall Study|Reasons not specified|4|||
46676092|NCT01080300|82891763|FG001|Overall Study|Reasons not specified|6|||
46676093|NCT01085097|82891774|FG000|Overall Study|Adverse Event|0|||
46676094|NCT01085097|82891775|FG001|Overall Study|Adverse Event|0|||
46676095|NCT01085097|82891776|FG002|Overall Study|Adverse Event|2|||
46676096|NCT01085097|82891774|FG000|Overall Study|Treatment failure|2|||
46676097|NCT01085097|82891775|FG001|Overall Study|Treatment failure|0|||
46676098|NCT01085097|82891776|FG002|Overall Study|Treatment failure|0|||
46676099|NCT03450629|82891790|FG000|Overall Study|Adverse Event|15|||
46676100|NCT03450629|82891791|FG001|Overall Study|Adverse Event|14|||
46676101|NCT03450629|82891790|FG000|Overall Study|Physician Decision|2|||
46676102|NCT03450629|82891791|FG001|Overall Study|Physician Decision|2|||
46676103|NCT03450629|82891790|FG000|Overall Study|Lack of Efficacy|2|||
46979297|NCT02633527|83224816|FG002|Overall Study|Multiple reasons|2|||
46979298|NCT02633527|83224817|FG003|Overall Study|Multiple reasons|2|||
46979299|NCT02633527|83224818|FG004|Overall Study|Multiple reasons|1|||
46979300|NCT01667549|83224835|FG000|Overall Study|Withdrawal by Subject|3|||
46979301|NCT01667549|83224836|FG001|Overall Study|Withdrawal by Subject|5|||
46979302|NCT01667549|83224837|FG002|Overall Study|Withdrawal by Subject|7|||
46979303|NCT01667549|83224838|FG003|Overall Study|Withdrawal by Subject|6|||
46676104|NCT03450629|82891791|FG001|Overall Study|Lack of Efficacy|0|||
46676105|NCT03450629|82891790|FG000|Overall Study|Lost to Follow-up|4|||
46979304|NCT01667549|83224839|FG004|Overall Study|Withdrawal by Subject|1|||
46676106|NCT03450629|82891791|FG001|Overall Study|Lost to Follow-up|2|||
46676107|NCT03450629|82891790|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
46676108|NCT03450629|82891791|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
46676109|NCT03450629|82891790|FG000|Overall Study|Non-Compliance With Study Drug|2|||
46676110|NCT03450629|82891791|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46676111|NCT03450629|82891790|FG000|Overall Study|Protocol Violation|11|||
46676112|NCT03450629|82891791|FG001|Overall Study|Protocol Violation|8|||
46676113|NCT03450629|82891790|FG000|Overall Study|Withdrawal by Subject|12|||
46676114|NCT03450629|82891791|FG001|Overall Study|Withdrawal by Subject|6|||
46676115|NCT00198029|82891797|FG000|Overall Study|Withdrawal by Subject|4|||
46676116|NCT00197054|82891804|FG000|Overall Study|Withdrawal by Subject|9|||
46676117|NCT00197054|82891805|FG001|Overall Study|Withdrawal by Subject|3|||
46676118|NCT00197054|82891806|FG002|Overall Study|Withdrawal by Subject|3|||
46676119|NCT00197054|82891804|FG000|Overall Study|Moved from area|7|||
46676120|NCT00197054|82891805|FG001|Overall Study|Moved from area|14|||
46676121|NCT00197054|82891806|FG002|Overall Study|Moved from area|9|||
46676122|NCT00197054|82891804|FG000|Overall Study|Lost to Follow-up|1|||
46676123|NCT00197054|82891805|FG001|Overall Study|Lost to Follow-up|4|||
46676124|NCT00197054|82891806|FG002|Overall Study|Lost to Follow-up|0|||
46676125|NCT00197015|82891827|FG000|Overall Study|Adverse Event|3|||
46676126|NCT00197015|82891828|FG001|Overall Study|Adverse Event|0|||
46676127|NCT00197015|82891829|FG002|Overall Study|Adverse Event|1|||
46676128|NCT00197015|82891827|FG000|Overall Study|Protocol Violation|0|||
46676129|NCT00197015|82891828|FG001|Overall Study|Protocol Violation|3|||
46676130|NCT00197015|82891829|FG002|Overall Study|Protocol Violation|3|||
46676131|NCT00197015|82891827|FG000|Overall Study|Withdrawal by Subject|17|||
46676132|NCT00197015|82891828|FG001|Overall Study|Withdrawal by Subject|37|||
46676133|NCT00197015|82891829|FG002|Overall Study|Withdrawal by Subject|34|||
46676134|NCT00197015|82891827|FG000|Overall Study|Lost to Follow-up|28|||
46676135|NCT00197015|82891828|FG001|Overall Study|Lost to Follow-up|46|||
46676136|NCT00197015|82891829|FG002|Overall Study|Lost to Follow-up|37|||
46676137|NCT00197015|82891827|FG000|Overall Study|Other|2|||
46676138|NCT00197015|82891828|FG001|Overall Study|Other|3|||
46676139|NCT00197015|82891829|FG002|Overall Study|Other|2|||
46676140|NCT00196976|82891851|FG000|Primary Study|Migrated from study area|0|||
46676141|NCT00196976|82891852|FG001|Primary Study|Migrated from study area|0|||
46676142|NCT00196976|82891853|FG002|Primary Study|Migrated from study area|0|||
46676143|NCT00196976|82891854|FG003|Primary Study|Migrated from study area|0|||
46676144|NCT00196976|82891855|FG004|Primary Study|Migrated from study area|0|||
46676145|NCT00196976|82891856|FG005|Primary Study|Migrated from study area|0|||
46676146|NCT00196976|82891857|FG006|Primary Study|Migrated from study area|0|||
46676147|NCT00196976|82891858|FG007|Primary Study|Migrated from study area|1|||
46676148|NCT00196976|82891859|FG008|Primary Study|Migrated from study area|0|||
46676149|NCT00196976|82891860|FG009|Primary Study|Migrated from study area|0|||
46676150|NCT00196976|82891861|FG010|Primary Study|Migrated from study area|0|||
46676151|NCT00196976|82891862|FG011|Primary Study|Migrated from study area|0|||
46676152|NCT00196976|82891863|FG012|Primary Study|Migrated from study area|0|||
46676153|NCT00196976|82891864|FG013|Primary Study|Migrated from study area|0|||
46676154|NCT00196976|82891851|FG000|Primary Study|Protocol Violation|0|||
46676155|NCT00196976|82891852|FG001|Primary Study|Protocol Violation|1|||
46676156|NCT00196976|82891853|FG002|Primary Study|Protocol Violation|1|||
46676157|NCT00196976|82891854|FG003|Primary Study|Protocol Violation|0|||
46676158|NCT00196976|82891855|FG004|Primary Study|Protocol Violation|0|||
46795516|NCT00613574|83013789|FG000|Overall Study|Adverse Event|3|||
46795517|NCT00613574|83013789|FG000|Overall Study|Lost to Follow-up|2|||
46795518|NCT00613574|83013789|FG000|Overall Study|Other|1|||
47080829|NCT00246025|83395242|FG002|Overall Study|unsuitable medical history was found|0|||
47080830|NCT00246025|83395243|FG003|Overall Study|unsuitable medical history was found|1|||
47080831|NCT00245011|83395373|FG000|Overall Study|Lack of Efficacy|1|||
47080832|NCT00244855|83395392|FG000|Overall Study|Withdrawal by Subject|0|||
47080833|NCT00244855|83395393|FG001|Overall Study|Withdrawal by Subject|1|||
47080834|NCT00244621|83395423|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
47080835|NCT00244621|83395424|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
47080836|NCT00244621|83395425|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
47080837|NCT00244621|83395423|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
47080838|NCT00244621|83395424|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
47080839|NCT00244621|83395425|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
47080840|NCT00244621|83395423|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
47080841|NCT00244621|83395424|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
46676159|NCT00196976|82891856|FG005|Primary Study|Protocol Violation|0|||
46676160|NCT00196976|82891857|FG006|Primary Study|Protocol Violation|0|||
46676161|NCT00196976|82891858|FG007|Primary Study|Protocol Violation|0|||
46676162|NCT00196976|82891859|FG008|Primary Study|Protocol Violation|0|||
46676163|NCT00196976|82891860|FG009|Primary Study|Protocol Violation|0|||
46676164|NCT00196976|82891861|FG010|Primary Study|Protocol Violation|0|||
46676165|NCT00196976|82891862|FG011|Primary Study|Protocol Violation|0|||
46676166|NCT00196976|82891863|FG012|Primary Study|Protocol Violation|0|||
46795519|NCT00613106|83013795|FG000|Overall Study|Adverse Event|3|||
46795520|NCT00613106|83013796|FG001|Overall Study|Adverse Event|1|||
46795521|NCT00613106|83013795|FG000|Overall Study|Withdrawal by Subject|6|||
46795522|NCT00613106|83013796|FG001|Overall Study|Withdrawal by Subject|3|||
46795523|NCT00613106|83013795|FG000|Overall Study|Lost to Follow-up|7|||
46795524|NCT00613106|83013796|FG001|Overall Study|Lost to Follow-up|2|||
46795525|NCT00613106|83013795|FG000|Overall Study|misc|4|||
46676167|NCT00196976|82891864|FG013|Primary Study|Protocol Violation|0|||
46676168|NCT00196976|82891851|FG000|Primary Study|Withdrawal by Subject|1|||
46676169|NCT00196976|82891852|FG001|Primary Study|Withdrawal by Subject|0|||
46676170|NCT00196976|82891853|FG002|Primary Study|Withdrawal by Subject|1|||
46676171|NCT00196976|82891854|FG003|Primary Study|Withdrawal by Subject|1|||
46676172|NCT00196976|82891855|FG004|Primary Study|Withdrawal by Subject|2|||
46676173|NCT00196976|82891856|FG005|Primary Study|Withdrawal by Subject|1|||
46676174|NCT00196976|82891857|FG006|Primary Study|Withdrawal by Subject|0|||
46676175|NCT00196976|82891858|FG007|Primary Study|Withdrawal by Subject|0|||
46676176|NCT00196976|82891859|FG008|Primary Study|Withdrawal by Subject|0|||
46676177|NCT00196976|82891860|FG009|Primary Study|Withdrawal by Subject|1|||
46676178|NCT00196976|82891861|FG010|Primary Study|Withdrawal by Subject|0|||
46676179|NCT00196976|82891862|FG011|Primary Study|Withdrawal by Subject|0|||
46676180|NCT00196976|82891863|FG012|Primary Study|Withdrawal by Subject|0|||
46676181|NCT00196976|82891864|FG013|Primary Study|Withdrawal by Subject|0|||
46676182|NCT00196976|82891851|FG000|Primary Study|Lost to Follow-up|0|||
46676183|NCT00196976|82891852|FG001|Primary Study|Lost to Follow-up|0|||
46676184|NCT00196976|82891853|FG002|Primary Study|Lost to Follow-up|0|||
46676185|NCT00196976|82891854|FG003|Primary Study|Lost to Follow-up|0|||
46676186|NCT00196976|82891855|FG004|Primary Study|Lost to Follow-up|1|||
46795526|NCT00613106|83013796|FG001|Overall Study|misc|3|||
46676187|NCT00196976|82891856|FG005|Primary Study|Lost to Follow-up|1|||
46676188|NCT00196976|82891857|FG006|Primary Study|Lost to Follow-up|0|||
46676189|NCT00196976|82891858|FG007|Primary Study|Lost to Follow-up|2|||
46676190|NCT00196976|82891859|FG008|Primary Study|Lost to Follow-up|0|||
46676191|NCT00196976|82891860|FG009|Primary Study|Lost to Follow-up|0|||
46676192|NCT00196976|82891861|FG010|Primary Study|Lost to Follow-up|0|||
46676193|NCT00196976|82891862|FG011|Primary Study|Lost to Follow-up|0|||
46676194|NCT00196976|82891863|FG012|Primary Study|Lost to Follow-up|0|||
46676195|NCT00196976|82891864|FG013|Primary Study|Lost to Follow-up|0|||
46676196|NCT00196976|82891851|FG000|Primary Study|Other|0|||
46676197|NCT00196976|82891852|FG001|Primary Study|Other|0|||
46676198|NCT00196976|82891853|FG002|Primary Study|Other|2|||
46676199|NCT00196976|82891854|FG003|Primary Study|Other|0|||
46676200|NCT00196976|82891855|FG004|Primary Study|Other|0|||
46676201|NCT00196976|82891856|FG005|Primary Study|Other|0|||
46676202|NCT00196976|82891857|FG006|Primary Study|Other|0|||
46676203|NCT00196976|82891858|FG007|Primary Study|Other|0|||
47080842|NCT00244621|83395425|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
47080843|NCT00244621|83395423|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
47080844|NCT00244621|83395424|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
47080845|NCT00244621|83395425|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
47080846|NCT00244621|83395423|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
47080847|NCT00244621|83395424|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
47080848|NCT00244621|83395425|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
47080849|NCT00244621|83395423|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
47080850|NCT00244621|83395424|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
47080851|NCT00244621|83395425|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
47080852|NCT00244621|83395423|FG000|Open-label Treatment Period|Adverse Event|0|||
47080853|NCT00244621|83395424|FG001|Open-label Treatment Period|Adverse Event|0|||
47080854|NCT00244621|83395425|FG002|Open-label Treatment Period|Adverse Event|1|||
47080855|NCT00244621|83395423|FG000|Open-label Treatment Period|Moved abroad|0|||
47080856|NCT00244621|83395424|FG001|Open-label Treatment Period|Moved abroad|0|||
47080857|NCT00244621|83395425|FG002|Open-label Treatment Period|Moved abroad|1|||
47080858|NCT00243841|83395508|FG000|Overall Study|Physician Decision|0|||
47080859|NCT00243841|83395509|FG001|Overall Study|Physician Decision|0|||
47080860|NCT00243841|83395510|FG002|Overall Study|Physician Decision|1|||
47080861|NCT00243841|83395511|FG003|Overall Study|Physician Decision|0|||
47080862|NCT00243841|83395512|FG004|Overall Study|Physician Decision|0|||
47080863|NCT00243841|83395513|FG005|Overall Study|Physician Decision|2|||
47080864|NCT02980731|83395706|FG000|Overall Study|Death|63|||
47080865|NCT02980731|83395706|FG000|Overall Study|Withdrawal by Subject|6|||
47080866|NCT02980731|83395706|FG000|Overall Study|Lost to Follow-up|5|||
47080867|NCT02980731|83395706|FG000|Overall Study|Study terminated by Sponsor|4|||
46979305|NCT01672801|83224878|FG000|Overall Study|Screen Failure|0|||
46979306|NCT01672801|83224879|FG001|Overall Study|Screen Failure|1|||
46979307|NCT01655901|83224885|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
46979308|NCT01655901|83224886|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
46979309|NCT01655901|83224887|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
46979310|NCT01655901|83224888|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
46979311|NCT01655901|83224889|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
46979312|NCT01655901|83224890|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
46979313|NCT01656759|83224911|FG000|Overall Study|Protocol Violation|2|||
46979314|NCT01656759|83224912|FG001|Overall Study|Protocol Violation|3|||
46979315|NCT02631577|83224920|FG000|Overall Study|Death|1|||
46979316|NCT02631577|83224921|FG001|Overall Study|Death|7|||
46979317|NCT02631577|83224920|FG000|Overall Study|Withdrawal by Subject|0|||
46979318|NCT02631577|83224921|FG001|Overall Study|Withdrawal by Subject|3|||
46979319|NCT01667081|83224929|FG000|Overall Study|Death|43|||
46979320|NCT01667081|83224930|FG001|Overall Study|Death|3|||
46979321|NCT01667081|83224929|FG000|Overall Study|Lost to Follow-up|99|||
46979322|NCT01667081|83224930|FG001|Overall Study|Lost to Follow-up|48|||
46979323|NCT01667081|83224929|FG000|Overall Study|Physician Decision|16|||
46979324|NCT01667081|83224930|FG001|Overall Study|Physician Decision|2|||
46979325|NCT01667081|83224929|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
46676204|NCT00196976|82891859|FG008|Primary Study|Other|0|||
46979326|NCT01667081|83224930|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
46676205|NCT00196976|82891860|FG009|Primary Study|Other|0|||
46856524|NCT03828617|83072389|FG003|Overall Study|Lost to Follow-up|7|||
46856525|NCT03828617|83072386|FG000|Overall Study|No longer met eligibility criteria|0|||
46856526|NCT03828617|83072387|FG001|Overall Study|No longer met eligibility criteria|1|||
46856527|NCT03828617|83072388|FG002|Overall Study|No longer met eligibility criteria|1|||
46856528|NCT03828617|83072389|FG003|Overall Study|No longer met eligibility criteria|3|||
46856529|NCT03828617|83072386|FG000|Overall Study|Protocol Violation|0|||
46856530|NCT03828617|83072387|FG001|Overall Study|Protocol Violation|2|||
46856531|NCT03828617|83072388|FG002|Overall Study|Protocol Violation|0|||
46856532|NCT03828617|83072389|FG003|Overall Study|Protocol Violation|0|||
46856533|NCT03828617|83072386|FG000|Overall Study|Withdrawal by Subject|2|||
46856534|NCT03828617|83072387|FG001|Overall Study|Withdrawal by Subject|0|||
46856535|NCT03828617|83072388|FG002|Overall Study|Withdrawal by Subject|2|||
46856536|NCT03828617|83072389|FG003|Overall Study|Withdrawal by Subject|0|||
46856537|NCT03391960|83072398|FG000|Overall Study|Protocol Violation|0|||
46856538|NCT03391960|83072399|FG001|Overall Study|Protocol Violation||||
46856539|NCT03390166|83072425|FG000|Overall Study|Death|0|||
46856540|NCT03390166|83072426|FG001|Overall Study|Death|1|||
46856541|NCT03390166|83072425|FG000|Overall Study|Lost to Follow-up|6|||
46856542|NCT03390166|83072426|FG001|Overall Study|Lost to Follow-up|4|||
46856543|NCT03390166|83072425|FG000|Overall Study|Physician Decision|2|||
46856544|NCT03390166|83072426|FG001|Overall Study|Physician Decision|1|||
46856545|NCT03390166|83072425|FG000|Overall Study|Move from study area|3|||
46856546|NCT03390166|83072426|FG001|Overall Study|Move from study area|2|||
46856547|NCT03390166|83072425|FG000|Overall Study|To militarycamp for conscript|1|||
46856548|NCT03390166|83072426|FG001|Overall Study|To militarycamp for conscript|0|||
46856549|NCT03390166|83072425|FG000|Overall Study|To drug therapy course|0|||
46856550|NCT03390166|83072426|FG001|Overall Study|To drug therapy course|1|||
46856551|NCT03390166|83072425|FG000|Overall Study|Move to work oversea|0|||
46856552|NCT03390166|83072426|FG001|Overall Study|Move to work oversea|1|||
46856553|NCT03828539|83072434|FG000|Overall Study|Adverse Event|3|||
46856554|NCT03828539|83072435|FG001|Overall Study|Adverse Event|12|||
46856555|NCT03828539|83072434|FG000|Overall Study|Patient's/guardian's decision|3|||
46856556|NCT03828539|83072435|FG001|Overall Study|Patient's/guardian's decision|5|||
46856557|NCT03828539|83072434|FG000|Overall Study|Lost to Follow-up|4|||
46856558|NCT03828539|83072435|FG001|Overall Study|Lost to Follow-up|2|||
46856559|NCT03828539|83072434|FG000|Overall Study|Protocol Violation|3|||
46856560|NCT03828539|83072435|FG001|Overall Study|Protocol Violation|2|||
46856561|NCT03828539|83072434|FG000|Overall Study|Withdrawal of informed consent|2|||
46856562|NCT03828539|83072435|FG001|Overall Study|Withdrawal of informed consent|1|||
46856563|NCT03828539|83072434|FG000|Overall Study|New therapy for study indication|1|||
46856564|NCT03828539|83072435|FG001|Overall Study|New therapy for study indication|0|||
46856565|NCT03336502|83072443|FG000|Overall Study|Physician Decision|0|||
46856566|NCT03336502|83072444|FG001|Overall Study|Physician Decision|1|||
46856567|NCT03336502|83072443|FG000|Overall Study|Prohibited Drugs|1|||
46856568|NCT03336502|83072444|FG001|Overall Study|Prohibited Drugs|1|||
46856569|NCT03336502|83072443|FG000|Overall Study|Death|1|||
46856570|NCT03336502|83072444|FG001|Overall Study|Death|2|||
46856571|NCT03336502|83072443|FG000|Overall Study|Adverse Event|2|||
46856572|NCT03336502|83072444|FG001|Overall Study|Adverse Event|5|||
46856573|NCT00338741|83072452|FG000|Overall Study|Lost to Follow-up|2|||
46856574|NCT00338741|83072453|FG001|Overall Study|Lost to Follow-up|0|||
46856575|NCT03370510|83072461|FG000|Overall Study|COVID-19|2|||
46856576|NCT03370510|83072462|FG001|Overall Study|COVID-19|0|||
46856577|NCT00351611|83072470|FG000|Overall Study|Adverse Event|11|||
46856578|NCT00351611|83072471|FG001|Overall Study|Adverse Event|3|||
46856579|NCT00351611|83072470|FG000|Overall Study|Death|1|||
46856580|NCT00351611|83072471|FG001|Overall Study|Death|0|||
46856581|NCT00351611|83072470|FG000|Overall Study|Lost to Follow-up|1|||
46856582|NCT00351611|83072471|FG001|Overall Study|Lost to Follow-up|0|||
46856583|NCT00351611|83072470|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
46856584|NCT00351611|83072471|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
46856585|NCT00351611|83072470|FG000|Overall Study|Other|1|||
46856586|NCT00351611|83072471|FG001|Overall Study|Other|0|||
46856587|NCT00351611|83072470|FG000|Overall Study|Protocol Violation|0|||
46856588|NCT00351611|83072471|FG001|Overall Study|Protocol Violation|2|||
46856589|NCT00351533|83072479|FG000|Overall Study|Extubated before first BAL|1|||
46856590|NCT00351533|83072480|FG001|Overall Study|Extubated before first BAL|0|||
46856591|NCT00351533|83072479|FG000|Overall Study|Lost to Follow-up|1|||
46856592|NCT00351533|83072480|FG001|Overall Study|Lost to Follow-up|3|||
46856593|NCT00351533|83072479|FG000|Overall Study|Physician Decision|0|||
46856594|NCT00351533|83072480|FG001|Overall Study|Physician Decision|1|||
46856595|NCT00351533|83072479|FG000|Overall Study|Withdrawal by Subject|0|||
46795527|NCT00141037|83013804|FG000|Overall Study|Physician Decision|1|||
46795528|NCT00141037|83013805|FG001|Overall Study|Physician Decision|2|||
46795529|NCT00141037|83013804|FG000|Overall Study|Lost to Follow-up|3|||
46795530|NCT00141037|83013805|FG001|Overall Study|Lost to Follow-up|1|||
46979327|NCT01667081|83224929|FG000|Overall Study|Withdrawal by Subject|90|||
46979328|NCT01667081|83224930|FG001|Overall Study|Withdrawal by Subject|35|||
46979329|NCT04545619|83224947|FG000|Overall Study|due to equipment challenges|1|||
46979330|NCT02518971|83224953|FG000|Overall Study|Lost to Follow-up|0|||
46795531|NCT00141037|83013804|FG000|Overall Study|Protocol Violation|0|||
46795532|NCT00141037|83013805|FG001|Overall Study|Protocol Violation|2|||
46795533|NCT00141037|83013804|FG000|Overall Study|Withdrawal by Subject|2|||
46795534|NCT00141037|83013805|FG001|Overall Study|Withdrawal by Subject|1|||
46795535|NCT00141037|83013804|FG000|Overall Study|Other|0|||
46795536|NCT00141037|83013805|FG001|Overall Study|Other|1|||
46795537|NCT00141037|83013804|FG000|Overall Study|Moved from area|1|||
46795538|NCT00141037|83013805|FG001|Overall Study|Moved from area|7|||
46795539|NCT00141037|83013804|FG000|Overall Study|Graft Failure|3|||
46795540|NCT00141037|83013805|FG001|Overall Study|Graft Failure|4|||
46795541|NCT00140413|83013814|FG000|Overall Study|Lost to Follow-up|1|||
46795542|NCT00140413|83013815|FG001|Overall Study|Lost to Follow-up|0|||
46795543|NCT00140413|83013814|FG000|Overall Study|Withdrawal by Subject|2|||
46795544|NCT00140413|83013815|FG001|Overall Study|Withdrawal by Subject|0|||
46795545|NCT00563706|83013831|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
46795546|NCT00563706|83013832|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
46795547|NCT00563706|83013833|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
46795548|NCT00563706|83013834|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
46795549|NCT00563706|83013835|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
46795550|NCT00563706|83013836|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
46795551|NCT00563706|83013837|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
46795552|NCT00563706|83013838|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
46795553|NCT00563706|83013839|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
46795554|NCT00563706|83013831|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
46795555|NCT00563706|83013832|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
46795556|NCT00563706|83013833|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
46795557|NCT00563706|83013834|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
46795558|NCT00563706|83013835|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
46795559|NCT00563706|83013836|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
46795560|NCT00563706|83013837|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
46795561|NCT00563706|83013838|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
46795562|NCT00563706|83013839|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
46795563|NCT00563706|83013831|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
46979331|NCT02518971|83224954|FG001|Overall Study|Lost to Follow-up|1|||
47080868|NCT02980731|83395706|FG000|Overall Study|Completed survival follow-up period|65|||
47080869|NCT02980731|83395706|FG000|Overall Study|COVID-19 infection|1|||
47080870|NCT02980731|83395706|FG000|Overall Study|Other, not specified|66|||
47080871|NCT02641587|83395746|FG000|Confinement Period|Adverse Event|1|||
47080872|NCT02641587|83395747|FG001|Confinement Period|Adverse Event|0|||
47080873|NCT02641587|83395746|FG000|Confinement Period|Withdrawal by Subject|2|||
47080874|NCT02641587|83395747|FG001|Confinement Period|Withdrawal by Subject|1|||
47080875|NCT02641587|83395746|FG000|Ambulatory Period|Withdrawal by Subject|1|||
46856596|NCT00351533|83072480|FG001|Overall Study|Withdrawal by Subject|1|||
47080876|NCT02641587|83395747|FG001|Ambulatory Period|Withdrawal by Subject|0|||
47080877|NCT04672083|83395854|FG000|Overall Study|Lost to Follow-up|1|||
47080878|NCT04672083|83395855|FG001|Overall Study|Lost to Follow-up|0|||
46856597|NCT00351377|83072486|FG000|Overall Study|Adverse Event|5|||
47080879|NCT04672083|83395856|FG002|Overall Study|Lost to Follow-up|0|||
47080880|NCT04672083|83395857|FG003|Overall Study|Lost to Follow-up|0|||
46676206|NCT00196976|82891861|FG010|Primary Study|Other|0|||
47080881|NCT04672083|83395858|FG004|Overall Study|Lost to Follow-up|0|||
47080882|NCT01781637|83395961|FG000|Overall Study|Adverse Event|1|||
46856598|NCT00351377|83072486|FG000|Overall Study|Death|1|||
46856599|NCT00351377|83072486|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46856600|NCT00337727|83072492|FG000|Overall Study|Adverse Event|5|||
46856601|NCT00337727|83072493|FG001|Overall Study|Adverse Event|3|||
46856602|NCT00337727|83072492|FG000|Overall Study|Lost to Follow-up|5|||
46856603|NCT00337727|83072493|FG001|Overall Study|Lost to Follow-up|4|||
46856604|NCT00337727|83072492|FG000|Overall Study|Physician Decision|1|||
46856605|NCT00337727|83072493|FG001|Overall Study|Physician Decision|0|||
46856606|NCT00337727|83072492|FG000|Overall Study|Protocol Violation|4|||
46979332|NCT02518971|83224953|FG000|Overall Study|Physician Decision|6|||
46979333|NCT02518971|83224954|FG001|Overall Study|Physician Decision|6|||
46979334|NCT02518971|83224953|FG000|Overall Study|Protocol Violation|6|||
46979335|NCT02518971|83224954|FG001|Overall Study|Protocol Violation|4|||
46979336|NCT02518971|83224953|FG000|Overall Study|Withdrawal by Subject|4|||
46979337|NCT02518971|83224954|FG001|Overall Study|Withdrawal by Subject|5|||
46979338|NCT02518971|83224953|FG000|Overall Study|Side effects|1|||
46979339|NCT02518971|83224954|FG001|Overall Study|Side effects|0|||
46979340|NCT02518971|83224953|FG000|Overall Study|medication lost in mail|0|||
46979341|NCT02518971|83224954|FG001|Overall Study|medication lost in mail|1|||
46979342|NCT02518971|83224953|FG000|Overall Study|eligibility criteria no longer met|6|||
46979343|NCT02518971|83224954|FG001|Overall Study|eligibility criteria no longer met|3|||
46979344|NCT01365039|83224963|FG000|Overall Study|Study related symptoms and complaints|1|||
46979345|NCT01365039|83224964|FG001|Overall Study|Study related symptoms and complaints|0|||
46979346|NCT01364727|83224971|FG000|Overall Study|Not Eligible|2|||
46979347|NCT02633215|83224979|FG000|Overall Study|Lost to Follow-up|2|||
46979348|NCT02633215|83224980|FG001|Overall Study|Lost to Follow-up|3|||
46979349|NCT01364649|83224988|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
46979350|NCT01364649|83224989|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
46979351|NCT01364649|83224988|FG000|Overall Study|Lack of Efficacy|6|||
46979352|NCT01364649|83224989|FG001|Overall Study|Lack of Efficacy|0|||
46979353|NCT01364649|83224988|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
46979354|NCT01364649|83224989|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
46979355|NCT01364649|83224988|FG000|Overall Study|Protocol Deviations|4|||
46979356|NCT01364649|83224989|FG001|Overall Study|Protocol Deviations|8|||
46979357|NCT01364649|83224988|FG000|Overall Study|Withdrawal of Consent|9|||
46979358|NCT01364649|83224989|FG001|Overall Study|Withdrawal of Consent|7|||
46979359|NCT01364649|83224988|FG000|Overall Study|Lost to Follow-up|12|||
46979360|NCT01364649|83224989|FG001|Overall Study|Lost to Follow-up|13|||
46979361|NCT01364649|83224988|FG000|Overall Study|Other|4|||
46979362|NCT01364649|83224989|FG001|Overall Study|Other|1|||
46979363|NCT02588261|83224997|FG000|Overall Study|Study Terminated by Sponsor|157|||
47080883|NCT01781637|83395962|FG001|Overall Study|Adverse Event|0|||
47080884|NCT01781637|83395961|FG000|Overall Study|Lack of Efficacy|2|||
47080885|NCT01781637|83395962|FG001|Overall Study|Lack of Efficacy|6|||
46979364|NCT02588261|83224998|FG001|Overall Study|Study Terminated by Sponsor|142|||
46979365|NCT02588261|83224997|FG000|Overall Study|Protocol Deviation|1|||
46979366|NCT02588261|83224998|FG001|Overall Study|Protocol Deviation|0|||
46979367|NCT02588261|83224997|FG000|Overall Study|Death|1|||
46979368|NCT02588261|83224998|FG001|Overall Study|Death|2|||
46979369|NCT02588261|83224997|FG000|Overall Study|Withdrawal by Subject|12|||
46979370|NCT02588261|83224998|FG001|Overall Study|Withdrawal by Subject|8|||
46979371|NCT02588261|83224997|FG000|Overall Study|Noncompliance with Study Drug|0|||
46979372|NCT02588261|83224998|FG001|Overall Study|Noncompliance with Study Drug|1|||
46979373|NCT02588261|83224997|FG000|Overall Study|Miscellaneous|5|||
46979374|NCT02588261|83224998|FG001|Overall Study|Miscellaneous|4|||
46979375|NCT02588261|83224997|FG000|Overall Study|Progressive Disease|61|||
46979376|NCT02588261|83224998|FG001|Overall Study|Progressive Disease|82|||
46979377|NCT02588261|83224997|FG000|Overall Study|Adverse Event|29|||
46979378|NCT02588261|83224998|FG001|Overall Study|Adverse Event|24|||
46979379|NCT02588261|83224997|FG000|Overall Study|Lost to Follow-up|1|||
46979380|NCT02588261|83224998|FG001|Overall Study|Lost to Follow-up|0|||
46979381|NCT01359449|83225006|FG000|Overall Study|Lost to Follow-up|1|||
47080886|NCT01781637|83395961|FG000|Overall Study|Withdrawal by Subject|1|||
47080887|NCT01781637|83395962|FG001|Overall Study|Withdrawal by Subject|0|||
47080888|NCT04575584|83396351|FG000|Overall Study|Death|6|||
47080889|NCT04575584|83396352|FG001|Overall Study|Death|4|||
47080890|NCT04575584|83396353|FG002|Overall Study|Death|6|||
47080891|NCT04575584|83396354|FG003|Overall Study|Death|2|||
47080892|NCT04575584|83396355|FG004|Overall Study|Death|0|||
47080893|NCT04575584|83396356|FG005|Overall Study|Death|0|||
47080894|NCT04575584|83396351|FG000|Overall Study|Lost to Follow-up|1|||
47080895|NCT04575584|83396352|FG001|Overall Study|Lost to Follow-up|1|||
47080896|NCT04575584|83396353|FG002|Overall Study|Lost to Follow-up|1|||
47080897|NCT04575584|83396354|FG003|Overall Study|Lost to Follow-up|1|||
47080898|NCT04575584|83396355|FG004|Overall Study|Lost to Follow-up|0|||
47080899|NCT04575584|83396356|FG005|Overall Study|Lost to Follow-up|0|||
47080900|NCT04575584|83396351|FG000|Overall Study|Physician Decision|0|||
47080901|NCT04575584|83396352|FG001|Overall Study|Physician Decision|1|||
47080902|NCT04575584|83396353|FG002|Overall Study|Physician Decision|1|||
47080903|NCT04575584|83396354|FG003|Overall Study|Physician Decision|1|||
47080904|NCT04575584|83396355|FG004|Overall Study|Physician Decision|0|||
47080905|NCT04575584|83396356|FG005|Overall Study|Physician Decision|0|||
47080906|NCT04575584|83396351|FG000|Overall Study|Withdrawal by Subject|7|||
47080907|NCT04575584|83396352|FG001|Overall Study|Withdrawal by Subject|9|||
47080908|NCT04575584|83396353|FG002|Overall Study|Withdrawal by Subject|5|||
46979382|NCT01359449|83225007|FG001|Overall Study|Lost to Follow-up|0|||
46979383|NCT01359449|83225006|FG000|Overall Study|Protocol Violation|0|||
46979384|NCT01359449|83225007|FG001|Overall Study|Protocol Violation|2|||
46979385|NCT01359449|83225006|FG000|Overall Study|Withdrawal by Subject|3|||
46979386|NCT01359449|83225007|FG001|Overall Study|Withdrawal by Subject|2|||
47080909|NCT04575584|83396354|FG003|Overall Study|Withdrawal by Subject|3|||
46979387|NCT01672723|83225013|FG000|First Intervention|Adverse Event|3|||
47080910|NCT04575584|83396355|FG004|Overall Study|Withdrawal by Subject|0|||
47080911|NCT04575584|83396356|FG005|Overall Study|Withdrawal by Subject|0|||
46979388|NCT01672723|83225014|FG001|First Intervention|Adverse Event|0|||
47080912|NCT04575584|83396351|FG000|Overall Study|Not recorded|0|||
46676207|NCT00196976|82891862|FG011|Primary Study|Other|0|||
46676208|NCT00196976|82891863|FG012|Primary Study|Other|0|||
46676209|NCT00196976|82891864|FG013|Primary Study|Other|0|||
46676210|NCT00196976|82891851|FG000|Booster Study|Withdrawal by Subject|0|||
46676211|NCT00196976|82891852|FG001|Booster Study|Withdrawal by Subject|0|||
46676212|NCT00196976|82891853|FG002|Booster Study|Withdrawal by Subject|0|||
46676213|NCT00196976|82891854|FG003|Booster Study|Withdrawal by Subject|0|||
46676214|NCT00196976|82891855|FG004|Booster Study|Withdrawal by Subject|0|||
46676215|NCT00196976|82891856|FG005|Booster Study|Withdrawal by Subject|0|||
46676216|NCT00196976|82891857|FG006|Booster Study|Withdrawal by Subject|0|||
46676217|NCT00196976|82891858|FG007|Booster Study|Withdrawal by Subject|0|||
46676218|NCT00196976|82891859|FG008|Booster Study|Withdrawal by Subject|0|||
46676219|NCT00196976|82891860|FG009|Booster Study|Withdrawal by Subject|0|||
46676220|NCT00196976|82891861|FG010|Booster Study|Withdrawal by Subject|1|||
46676221|NCT00196976|82891862|FG011|Booster Study|Withdrawal by Subject|0|||
46676222|NCT00196976|82891863|FG012|Booster Study|Withdrawal by Subject|0|||
46676223|NCT00196976|82891864|FG013|Booster Study|Withdrawal by Subject|0|||
46676224|NCT00196976|82891851|FG000|Booster Study|Lost to Follow-up|0|||
46676225|NCT00196976|82891852|FG001|Booster Study|Lost to Follow-up|0|||
46676226|NCT00196976|82891853|FG002|Booster Study|Lost to Follow-up|0|||
46676227|NCT00196976|82891854|FG003|Booster Study|Lost to Follow-up|0|||
46676228|NCT00196976|82891855|FG004|Booster Study|Lost to Follow-up|0|||
46676229|NCT00196976|82891856|FG005|Booster Study|Lost to Follow-up|0|||
46676230|NCT00196976|82891857|FG006|Booster Study|Lost to Follow-up|0|||
46676231|NCT00196976|82891858|FG007|Booster Study|Lost to Follow-up|0|||
46676232|NCT00196976|82891859|FG008|Booster Study|Lost to Follow-up|0|||
46676233|NCT00196976|82891860|FG009|Booster Study|Lost to Follow-up|0|||
46676234|NCT00196976|82891861|FG010|Booster Study|Lost to Follow-up|1|||
46676235|NCT00196976|82891862|FG011|Booster Study|Lost to Follow-up|2|||
46676236|NCT00196976|82891863|FG012|Booster Study|Lost to Follow-up|0|||
46676237|NCT00196976|82891864|FG013|Booster Study|Lost to Follow-up|0|||
47080913|NCT04575584|83396352|FG001|Overall Study|Not recorded|0|||
47080914|NCT04575584|83396353|FG002|Overall Study|Not recorded|0|||
47080915|NCT04575584|83396354|FG003|Overall Study|Not recorded|1|||
47080916|NCT04575584|83396355|FG004|Overall Study|Not recorded|0|||
47080917|NCT04575584|83396356|FG005|Overall Study|Not recorded|0|||
47080918|NCT03721965|83396395|FG000|Overall Study|Death|1|||
47080919|NCT03721965|83396395|FG000|Overall Study|Study Terminated by Sponsor|1|||
47080920|NCT03873116|83396451|FG000|Overall Study|Study drug discontinuation due to rash|0|||
46676238|NCT00196313|82891906|FG000|Overall Study|Protocol Violation|2|||
46676239|NCT00196313|82891907|FG001|Overall Study|Protocol Violation|3|||
46676240|NCT00196313|82891906|FG000|Overall Study|Withdrawal by Subject|3|||
46676241|NCT00196313|82891907|FG001|Overall Study|Withdrawal by Subject|1|||
46676242|NCT00196313|82891906|FG000|Overall Study|Adverse Event|3|||
46795564|NCT00563706|83013832|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
46676243|NCT00196313|82891907|FG001|Overall Study|Adverse Event|1|||
46676244|NCT00196313|82891906|FG000|Overall Study|Subject Pregnant|1|||
46676245|NCT00196313|82891907|FG001|Overall Study|Subject Pregnant|1|||
46676246|NCT00196313|82891906|FG000|Overall Study|Lost to Follow-up|2|||
46795565|NCT00563706|83013833|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
46795566|NCT00563706|83013834|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
46795567|NCT00563706|83013835|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
46795568|NCT00563706|83013836|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
46676247|NCT00196313|82891907|FG001|Overall Study|Lost to Follow-up|2|||
46676248|NCT00196196|82891914|FG000|Overall Study|Withdrawal by Subject|2|||
46676249|NCT00196196|82891914|FG000|Overall Study|Did not have required condition (hydroce|5|||
46676250|NCT00195650|82891918|FG000|Overall Study|Adverse Event|194|||
46676251|NCT00195650|82891918|FG000|Overall Study|Lack of Efficacy|99|||
46676252|NCT00195650|82891918|FG000|Overall Study|Withdrawal by Subject|67|||
47080921|NCT03873116|83396452|FG001|Overall Study|Study drug discontinuation due to rash|0|||
46676253|NCT00195650|82891918|FG000|Overall Study|Lost to Follow-up|44|||
46676254|NCT00195650|82891918|FG000|Overall Study|Death|23|||
46676255|NCT00195650|82891918|FG000|Overall Study|Protocol Violation|15|||
46676256|NCT00195650|82891918|FG000|Overall Study|Administrative reasons|83|||
46676257|NCT00195494|82891924|FG000|Year 1|Adverse Event|0|||
46795569|NCT00563706|83013837|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
46676258|NCT00195494|82891925|FG001|Year 1|Adverse Event|0|||
46856607|NCT00337727|83072493|FG001|Overall Study|Protocol Violation|0|||
46856608|NCT00337727|83072492|FG000|Overall Study|Withdrawal by Subject|3|||
46856609|NCT00337727|83072493|FG001|Overall Study|Withdrawal by Subject|5|||
46856610|NCT00324233|83072501|FG000|First Period|unable to insert catheter|1|||
46856611|NCT00324233|83072502|FG001|First Period|unable to insert catheter|0|||
46856612|NCT00324233|83072501|FG000|Second Period|unable to insert catheter|1|||
46856613|NCT00324233|83072502|FG001|Second Period|unable to insert catheter|1|||
46856614|NCT00324233|83072501|FG000|Second Period|Protocol Violation|4|||
46856615|NCT00324233|83072502|FG001|Second Period|Protocol Violation|6|||
46856616|NCT03335566|83072510|FG000|Overall Study|Adverse Event|0|||
46856617|NCT03335566|83072511|FG001|Overall Study|Adverse Event|1|||
46856618|NCT03335566|83072510|FG000|Overall Study|Lost to Follow-up|1|||
46856619|NCT03335566|83072511|FG001|Overall Study|Lost to Follow-up|0|||
46856620|NCT03335566|83072510|FG000|Overall Study|Technical Problems|1|||
46856621|NCT03335566|83072511|FG001|Overall Study|Technical Problems|0|||
46856622|NCT03335566|83072510|FG000|Overall Study|Protocol Violation|1|||
46856623|NCT03335566|83072511|FG001|Overall Study|Protocol Violation|0|||
46856624|NCT03335566|83072510|FG000|Overall Study|Other than specified above|1|||
46856625|NCT03335566|83072511|FG001|Overall Study|Other than specified above|2|||
46856626|NCT03369418|83072519|FG000|Overall Study|Withdrawal by Subject|3|||
46856627|NCT03369418|83072520|FG001|Overall Study|Withdrawal by Subject|3|||
46856628|NCT03334630|83072528|FG000|Overall Study|Withdrawal by Subject|7|||
46856629|NCT03334630|83072529|FG001|Overall Study|Withdrawal by Subject|7|||
46856630|NCT03334630|83072528|FG000|Overall Study|Lost to Follow-up|3|||
46856631|NCT03334630|83072529|FG001|Overall Study|Lost to Follow-up|1|||
46856632|NCT03334630|83072528|FG000|Overall Study|Adverse Event|0|||
46856633|NCT03334630|83072529|FG001|Overall Study|Adverse Event|1|||
46856634|NCT03334630|83072528|FG000|Overall Study|Physician Decision|1|||
46856635|NCT03334630|83072529|FG001|Overall Study|Physician Decision|1|||
46856636|NCT03334630|83072528|FG000|Overall Study|Enrollment closed|2|||
46856637|NCT03334630|83072529|FG001|Overall Study|Enrollment closed|1|||
46856638|NCT03334630|83072528|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
46856639|NCT03334630|83072529|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
46856640|NCT03334630|83072528|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
46856641|NCT03334630|83072529|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
46856642|NCT03368170|83072537|FG000|Overall Study|Adverse Event|2|||
46856643|NCT03368170|83072538|FG001|Overall Study|Adverse Event|1|||
46856644|NCT00324155|83072546|FG000|Enrolled and Randomized|No longer met study criteria|3|||
46856645|NCT00324155|83072547|FG001|Enrolled and Randomized|No longer met study criteria|0|||
46856646|NCT00324155|83072546|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
46856647|NCT00324155|83072547|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
46856648|NCT00324155|83072546|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
46856649|NCT00324155|83072547|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
46856650|NCT00324155|83072546|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
46856651|NCT00324155|83072547|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
46856652|NCT00324155|83072546|FG000|Received Treatment in Induction Phase|Death|8|||
46856653|NCT00324155|83072547|FG001|Received Treatment in Induction Phase|Death|15|||
46979389|NCT02632747|83225022|FG000|Wash-out Period|Adverse Event|1|||
46795570|NCT00563706|83013838|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
46795571|NCT00563706|83013839|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
46795572|NCT00563706|83013831|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
46795573|NCT00563706|83013832|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
46795574|NCT00563706|83013833|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
46795575|NCT00563706|83013834|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
46795576|NCT00563706|83013835|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
46795577|NCT00563706|83013836|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
46795578|NCT00563706|83013837|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
46979390|NCT02632747|83225023|FG001|Wash-out Period|Adverse Event|0|||
46676259|NCT00195494|82891926|FG002|Year 1|Adverse Event|0|||
46856654|NCT00324155|83072546|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
46856655|NCT00324155|83072547|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
46856656|NCT00324155|83072546|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
46856657|NCT00324155|83072547|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
46856658|NCT00324155|83072546|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
46856659|NCT00324155|83072547|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
46856660|NCT00324155|83072546|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
46856661|NCT00324155|83072547|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
46856662|NCT00324155|83072546|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
46856663|NCT00324155|83072547|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
46856664|NCT00324155|83072546|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
46856665|NCT00324155|83072547|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
46856666|NCT00324155|83072546|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
46856667|NCT00324155|83072547|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
46856668|NCT00324155|83072546|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
46856669|NCT00324155|83072547|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
46856670|NCT00324155|83072546|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
46856671|NCT00324155|83072547|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
46856672|NCT00324155|83072546|FG000|Follow-up Phase|On-going participants still on drug|11|||
46856673|NCT00324155|83072547|FG001|Follow-up Phase|On-going participants still on drug|6|||
46856674|NCT03334396|83072574|FG000|Overall Study|Adverse Event|1|||
46856675|NCT03334396|83072575|FG001|Overall Study|Adverse Event|0|||
46856676|NCT03334396|83072576|FG002|Overall Study|Adverse Event|1|||
46856677|NCT03334396|83072577|FG003|Overall Study|Adverse Event|0|||
46856678|NCT03334396|83072578|FG004|Overall Study|Adverse Event|0|||
46856679|NCT03334396|83072579|FG005|Overall Study|Adverse Event|0|||
46856680|NCT03334396|83072580|FG006|Overall Study|Adverse Event|0|||
46856681|NCT03334396|83072581|FG007|Overall Study|Adverse Event|0|||
46856682|NCT03334396|83072574|FG000|Overall Study|Lack of Efficacy|10|||
46856683|NCT03334396|83072575|FG001|Overall Study|Lack of Efficacy|4|||
46856684|NCT03334396|83072576|FG002|Overall Study|Lack of Efficacy|1|||
46856685|NCT03334396|83072577|FG003|Overall Study|Lack of Efficacy|3|||
46856686|NCT03334396|83072578|FG004|Overall Study|Lack of Efficacy|1|||
46856687|NCT03334396|83072579|FG005|Overall Study|Lack of Efficacy|0|||
46795579|NCT00563706|83013838|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
46795580|NCT00563706|83013839|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
46795581|NCT00563706|83013831|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
46795582|NCT00563706|83013832|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
46795583|NCT00563706|83013833|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
46795584|NCT00563706|83013834|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
46795585|NCT00563706|83013835|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
46795586|NCT00563706|83013836|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
46795587|NCT00563706|83013837|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
46795588|NCT00563706|83013838|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
46795589|NCT00563706|83013839|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
46795590|NCT00129961|83013861|FG000|Overall Study|Adverse Event|1|||
46795591|NCT00129961|83013862|FG001|Overall Study|Adverse Event|0|||
46795592|NCT00129961|83013861|FG000|Overall Study|Death|1|||
46856688|NCT03334396|83072580|FG006|Overall Study|Lack of Efficacy|0|||
46856689|NCT03334396|83072581|FG007|Overall Study|Lack of Efficacy|1|||
46856690|NCT03334396|83072574|FG000|Overall Study|Lost to Follow-up|0|||
46856691|NCT03334396|83072575|FG001|Overall Study|Lost to Follow-up|0|||
46979391|NCT01671319|83225040|FG000|Overall Study|Withdrawal by Subject|1|||
46979392|NCT01670539|83225044|FG000|Overall Study|Death|3|||
46979393|NCT01670539|83225045|FG001|Overall Study|Death|5|||
46979394|NCT01670539|83225044|FG000|Overall Study|Withdrawal by Subject|3|||
46979395|NCT01670539|83225045|FG001|Overall Study|Withdrawal by Subject|0|||
46979396|NCT02516163|83225052|FG000|Overall Study|Withdrawal by Subject|1|||
46795593|NCT00129961|83013862|FG001|Overall Study|Death|1|||
46795594|NCT00129961|83013861|FG000|Overall Study|Withdrawal by Sponsor|14|||
46979397|NCT02516163|83225052|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
47080922|NCT03873116|83396453|FG002|Overall Study|Study drug discontinuation due to rash|1|||
47080923|NCT03686384|83396901|FG000|Overall Study|Lack of Efficacy|4|||
47080924|NCT03686384|83396902|FG001|Overall Study|Lack of Efficacy|13|||
47080925|NCT03686384|83396901|FG000|Overall Study|Lost to Follow-up|3|||
47080926|NCT03686384|83396902|FG001|Overall Study|Lost to Follow-up|0|||
47080927|NCT03686384|83396901|FG000|Overall Study|Physician Decision|0|||
47080928|NCT03686384|83396902|FG001|Overall Study|Physician Decision|1|||
47080929|NCT03686384|83396901|FG000|Overall Study|Took prohibited medication|0|||
46795595|NCT00129961|83013862|FG001|Overall Study|Withdrawal by Sponsor|20|||
47080930|NCT03686384|83396902|FG001|Overall Study|Took prohibited medication|1|||
47080931|NCT00240331|83396974|FG000|Overall Study|Withdrawal by Subject|125|||
46856692|NCT03334396|83072576|FG002|Overall Study|Lost to Follow-up|1|||
46856693|NCT03334396|83072577|FG003|Overall Study|Lost to Follow-up|0|||
46856694|NCT03334396|83072578|FG004|Overall Study|Lost to Follow-up|0|||
46979398|NCT02516163|83225052|FG000|Overall Study|Unfit/delay in surgery|3|||
46676260|NCT00195494|82891927|FG003|Year 1|Adverse Event|0|||
46676261|NCT00195494|82891928|FG004|Year 1|Adverse Event|34|||
46676262|NCT00195494|82891929|FG005|Year 1|Adverse Event|27|||
46676263|NCT00195494|82891924|FG000|Year 1|System Toxicity|0|||
46676264|NCT00195494|82891925|FG001|Year 1|System Toxicity|0|||
46676265|NCT00195494|82891926|FG002|Year 1|System Toxicity|0|||
46856695|NCT03334396|83072579|FG005|Overall Study|Lost to Follow-up|0|||
46856696|NCT03334396|83072580|FG006|Overall Study|Lost to Follow-up|1|||
46856697|NCT03334396|83072581|FG007|Overall Study|Lost to Follow-up|0|||
46856698|NCT03334396|83072574|FG000|Overall Study|Physician Decision|1|||
46856699|NCT03334396|83072575|FG001|Overall Study|Physician Decision|0|||
46856700|NCT03334396|83072576|FG002|Overall Study|Physician Decision|0|||
46856701|NCT03334396|83072577|FG003|Overall Study|Physician Decision|0|||
46856702|NCT03334396|83072578|FG004|Overall Study|Physician Decision|0|||
46856703|NCT03334396|83072579|FG005|Overall Study|Physician Decision|0|||
46856704|NCT03334396|83072580|FG006|Overall Study|Physician Decision|0|||
46856705|NCT03334396|83072581|FG007|Overall Study|Physician Decision|0|||
46856706|NCT03334396|83072574|FG000|Overall Study|Withdrawal by Subject|10|||
46856707|NCT03334396|83072575|FG001|Overall Study|Withdrawal by Subject|5|||
46979399|NCT02516163|83225052|FG000|Overall Study|Use of incorrect measurement technique|5|||
46979400|NCT02516163|83225052|FG000|Overall Study|Data not recorded|2|||
46856708|NCT03334396|83072576|FG002|Overall Study|Withdrawal by Subject|7|||
46856709|NCT03334396|83072577|FG003|Overall Study|Withdrawal by Subject|2|||
46856710|NCT03334396|83072578|FG004|Overall Study|Withdrawal by Subject|2|||
46856711|NCT03334396|83072579|FG005|Overall Study|Withdrawal by Subject|1|||
46856712|NCT03334396|83072580|FG006|Overall Study|Withdrawal by Subject|2|||
46856713|NCT03334396|83072581|FG007|Overall Study|Withdrawal by Subject|0|||
46856714|NCT03334396|83072574|FG000|Overall Study|Pregnancy|0|||
46856715|NCT03334396|83072575|FG001|Overall Study|Pregnancy|1|||
46856716|NCT03334396|83072576|FG002|Overall Study|Pregnancy|0|||
46979401|NCT02516163|83225052|FG000|Overall Study|MRI contraindication exclusion|6|||
46979402|NCT02589665|83225060|FG000|Induction Period|Did not receive drug|0|||
46979403|NCT02589665|83225061|FG001|Induction Period|Did not receive drug|0|||
46979404|NCT02589665|83225062|FG002|Induction Period|Did not receive drug|0|||
46979405|NCT02589665|83225063|FG003|Induction Period|Did not receive drug|1|||
46979406|NCT02589665|83225064|FG004|Induction Period|Did not receive drug|0|||
46856717|NCT03334396|83072577|FG003|Overall Study|Pregnancy|0|||
46856718|NCT03334396|83072578|FG004|Overall Study|Pregnancy|0|||
46856719|NCT03334396|83072579|FG005|Overall Study|Pregnancy|0|||
46856720|NCT03334396|83072580|FG006|Overall Study|Pregnancy|0|||
46856721|NCT03334396|83072581|FG007|Overall Study|Pregnancy|0|||
46979407|NCT02589665|83225065|FG005|Induction Period|Did not receive drug|0|||
46979408|NCT02589665|83225066|FG006|Induction Period|Did not receive drug|0|||
46795596|NCT00129961|83013861|FG000|Overall Study|Physician Decision|1|||
46795597|NCT00129961|83013862|FG001|Overall Study|Physician Decision|0|||
46795598|NCT00129961|83013861|FG000|Overall Study|Withdrawal by Subject|2|||
46676266|NCT00195494|82891927|FG003|Year 1|System Toxicity|0|||
46795599|NCT00129961|83013862|FG001|Overall Study|Withdrawal by Subject|1|||
46795600|NCT00129961|83013861|FG000|Overall Study|Missing Record|0|||
46795601|NCT00129961|83013862|FG001|Overall Study|Missing Record|1|||
46795602|NCT00528567|83013870|FG000|Overall Study|Death|4|||
46795603|NCT00528567|83013871|FG001|Overall Study|Death|5|||
46795604|NCT00528567|83013870|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
46795605|NCT00528567|83013871|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
46795606|NCT00528567|83013870|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
46856722|NCT03334396|83072574|FG000|Overall Study|Ineligible|0|||
46856723|NCT03334396|83072575|FG001|Overall Study|Ineligible|1|||
46676267|NCT00195494|82891928|FG004|Year 1|System Toxicity|0|||
46856724|NCT03334396|83072576|FG002|Overall Study|Ineligible|0|||
46795607|NCT00528567|83013871|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
46856725|NCT03334396|83072577|FG003|Overall Study|Ineligible|0|||
46856726|NCT03334396|83072578|FG004|Overall Study|Ineligible|0|||
46676268|NCT00195494|82891929|FG005|Year 1|System Toxicity|1|||
46676269|NCT00195494|82891924|FG000|Year 1|Lack of Efficacy|0|||
46676270|NCT00195494|82891925|FG001|Year 1|Lack of Efficacy|0|||
46676271|NCT00195494|82891926|FG002|Year 1|Lack of Efficacy|0|||
46676272|NCT00195494|82891927|FG003|Year 1|Lack of Efficacy|0|||
46676273|NCT00195494|82891928|FG004|Year 1|Lack of Efficacy|24|||
46676274|NCT00195494|82891929|FG005|Year 1|Lack of Efficacy|9|||
46676275|NCT00195494|82891924|FG000|Year 1|Compliance|0|||
46676276|NCT00195494|82891925|FG001|Year 1|Compliance|0|||
46676277|NCT00195494|82891926|FG002|Year 1|Compliance|0|||
46676278|NCT00195494|82891927|FG003|Year 1|Compliance|0|||
46676279|NCT00195494|82891928|FG004|Year 1|Compliance|5|||
46676280|NCT00195494|82891929|FG005|Year 1|Compliance|1|||
46676281|NCT00195494|82891924|FG000|Year 1|Lost to Follow-up|0|||
46676282|NCT00195494|82891925|FG001|Year 1|Lost to Follow-up|0|||
46676283|NCT00195494|82891926|FG002|Year 1|Lost to Follow-up|0|||
46676284|NCT00195494|82891927|FG003|Year 1|Lost to Follow-up|0|||
46676285|NCT00195494|82891928|FG004|Year 1|Lost to Follow-up|1|||
46676286|NCT00195494|82891929|FG005|Year 1|Lost to Follow-up|0|||
46676287|NCT00195494|82891924|FG000|Year 1|Missed >4 consecutive doses|0|||
46676288|NCT00195494|82891925|FG001|Year 1|Missed >4 consecutive doses|0|||
46676289|NCT00195494|82891926|FG002|Year 1|Missed >4 consecutive doses|0|||
46676290|NCT00195494|82891927|FG003|Year 1|Missed >4 consecutive doses|0|||
46676291|NCT00195494|82891928|FG004|Year 1|Missed >4 consecutive doses|3|||
46676292|NCT00195494|82891929|FG005|Year 1|Missed >4 consecutive doses|2|||
46676293|NCT00195494|82891924|FG000|Year 1|Protocol deviation|0|||
46676294|NCT00195494|82891925|FG001|Year 1|Protocol deviation|0|||
46676295|NCT00195494|82891926|FG002|Year 1|Protocol deviation|0|||
46676296|NCT00195494|82891927|FG003|Year 1|Protocol deviation|0|||
46676297|NCT00195494|82891928|FG004|Year 1|Protocol deviation|2|||
46676298|NCT00195494|82891929|FG005|Year 1|Protocol deviation|3|||
46676299|NCT00195494|82891924|FG000|Year 1|Physician Decision|0|||
46676300|NCT00195494|82891925|FG001|Year 1|Physician Decision|0|||
46676301|NCT00195494|82891926|FG002|Year 1|Physician Decision|0|||
46676302|NCT00195494|82891927|FG003|Year 1|Physician Decision|0|||
46676303|NCT00195494|82891928|FG004|Year 1|Physician Decision|1|||
46676304|NCT00195494|82891929|FG005|Year 1|Physician Decision|0|||
46676305|NCT00195494|82891924|FG000|Year 1|Withdrawal by Subject|0|||
46676306|NCT00195494|82891925|FG001|Year 1|Withdrawal by Subject|0|||
46676307|NCT00195494|82891926|FG002|Year 1|Withdrawal by Subject|0|||
46676308|NCT00195494|82891927|FG003|Year 1|Withdrawal by Subject|0|||
46676309|NCT00195494|82891928|FG004|Year 1|Withdrawal by Subject|8|||
46676310|NCT00195494|82891929|FG005|Year 1|Withdrawal by Subject|9|||
46676311|NCT00195494|82891924|FG000|Year 1|Protocol Violation|0|||
46676312|NCT00195494|82891925|FG001|Year 1|Protocol Violation|0|||
46676313|NCT00195494|82891926|FG002|Year 1|Protocol Violation|0|||
46676314|NCT00195494|82891927|FG003|Year 1|Protocol Violation|0|||
46676315|NCT00195494|82891928|FG004|Year 1|Protocol Violation|1|||
46676316|NCT00195494|82891929|FG005|Year 1|Protocol Violation|1|||
46676317|NCT00195494|82891924|FG000|Year 2|Adverse Event|3|||
46676318|NCT00195494|82891925|FG001|Year 2|Adverse Event|7|||
46676319|NCT00195494|82891926|FG002|Year 2|Adverse Event|5|||
46676320|NCT00195494|82891927|FG003|Year 2|Adverse Event|9|||
46676321|NCT00195494|82891928|FG004|Year 2|Adverse Event|0|||
46676322|NCT00195494|82891929|FG005|Year 2|Adverse Event|0|||
46676323|NCT00195494|82891924|FG000|Year 2|Lack of Efficacy|0|||
46676324|NCT00195494|82891925|FG001|Year 2|Lack of Efficacy|1|||
46676325|NCT00195494|82891926|FG002|Year 2|Lack of Efficacy|7|||
46676326|NCT00195494|82891927|FG003|Year 2|Lack of Efficacy|7|||
46676327|NCT00195494|82891928|FG004|Year 2|Lack of Efficacy|0|||
47080932|NCT00240331|83396975|FG001|Overall Study|Withdrawal by Subject|132|||
47080933|NCT00240331|83396974|FG000|Overall Study|Option selected by investigator|1|||
47080934|NCT00240331|83396975|FG001|Overall Study|Option selected by investigator|2|||
47080935|NCT00240097|83396981|FG000|Part I|Adverse Event|1|||
47080936|NCT00240097|83396981|FG000|Part I|Death|1|||
47080937|NCT00240097|83396981|FG000|Part I|histology|1|||
47080938|NCT00240097|83396981|FG000|Part I|unevaluable|1|||
46676328|NCT00195494|82891929|FG005|Year 2|Lack of Efficacy|0|||
46676329|NCT00195494|82891924|FG000|Year 2|Compliance|1|||
46676330|NCT00195494|82891925|FG001|Year 2|Compliance|0|||
46676331|NCT00195494|82891926|FG002|Year 2|Compliance|0|||
46676332|NCT00195494|82891927|FG003|Year 2|Compliance|2|||
46676333|NCT00195494|82891928|FG004|Year 2|Compliance|0|||
46676334|NCT00195494|82891929|FG005|Year 2|Compliance|0|||
46676335|NCT00195494|82891924|FG000|Year 2|Lost to Follow-up|0|||
47080939|NCT00240097|83396981|FG000|Part II|did not continue from Part I|23|||
47080940|NCT03620162|83397072|FG000|Overall Study|Physician Decision|4|||
47080941|NCT03620162|83397073|FG001|Overall Study|Physician Decision|0|||
46676336|NCT00195494|82891925|FG001|Year 2|Lost to Follow-up|0|||
46676337|NCT00195494|82891926|FG002|Year 2|Lost to Follow-up|1|||
46676338|NCT00195494|82891927|FG003|Year 2|Lost to Follow-up|1|||
46676339|NCT00195494|82891928|FG004|Year 2|Lost to Follow-up|0|||
46676340|NCT00195494|82891929|FG005|Year 2|Lost to Follow-up|0|||
46676341|NCT00195494|82891924|FG000|Year 2|Missed >4 consecutive doses|1|||
46676342|NCT00195494|82891925|FG001|Year 2|Missed >4 consecutive doses|1|||
46676343|NCT00195494|82891926|FG002|Year 2|Missed >4 consecutive doses|1|||
46676344|NCT00195494|82891927|FG003|Year 2|Missed >4 consecutive doses|0|||
46979409|NCT02589665|83225067|FG007|Induction Period|Did not receive drug|0|||
46676345|NCT00195494|82891928|FG004|Year 2|Missed >4 consecutive doses|0|||
46676346|NCT00195494|82891929|FG005|Year 2|Missed >4 consecutive doses|0|||
46676347|NCT00195494|82891924|FG000|Year 2|Protocol deviation|0|||
46676348|NCT00195494|82891925|FG001|Year 2|Protocol deviation|1|||
46676349|NCT00195494|82891926|FG002|Year 2|Protocol deviation|0|||
46795608|NCT00528567|83013870|FG000|Overall Study|Violation Criteria at Entry|3|||
46795609|NCT00528567|83013871|FG001|Overall Study|Violation Criteria at Entry|17|||
46676350|NCT00195494|82891927|FG003|Year 2|Protocol deviation|0|||
46676351|NCT00195494|82891928|FG004|Year 2|Protocol deviation|0|||
46676352|NCT00195494|82891929|FG005|Year 2|Protocol deviation|0|||
46676353|NCT00195494|82891924|FG000|Year 2|Physician Decision|1|||
46676354|NCT00195494|82891925|FG001|Year 2|Physician Decision|1|||
46676355|NCT00195494|82891926|FG002|Year 2|Physician Decision|0|||
46676356|NCT00195494|82891927|FG003|Year 2|Physician Decision|0|||
46676357|NCT00195494|82891928|FG004|Year 2|Physician Decision|0|||
47080942|NCT03620162|83397074|FG002|Overall Study|Physician Decision|1|||
47080943|NCT03620162|83397075|FG003|Overall Study|Physician Decision|0|||
47080944|NCT03620162|83397076|FG004|Overall Study|Physician Decision|2|||
47080945|NCT03620162|83397072|FG000|Overall Study|Lost to Follow-up|2|||
47080946|NCT03620162|83397073|FG001|Overall Study|Lost to Follow-up|6|||
47080947|NCT03620162|83397074|FG002|Overall Study|Lost to Follow-up|7|||
47080948|NCT03620162|83397075|FG003|Overall Study|Lost to Follow-up|3|||
47080949|NCT03620162|83397076|FG004|Overall Study|Lost to Follow-up|2|||
47080950|NCT03620162|83397072|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
47080951|NCT03620162|83397073|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
47080952|NCT03620162|83397074|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
47080953|NCT03620162|83397075|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
47080954|NCT03620162|83397076|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
47080955|NCT03084302|83397217|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
47080956|NCT03084302|83397217|FG000|Overall Study|No valid objective monitor data|6|||
47080957|NCT01279681|83397359|FG000|Overall Study|Disease Progression|9|||
46676358|NCT00195494|82891929|FG005|Year 2|Physician Decision|0|||
46676359|NCT00195494|82891924|FG000|Year 2|Withdrawal by Subject|1|||
46676360|NCT00195494|82891925|FG001|Year 2|Withdrawal by Subject|5|||
46676361|NCT00195494|82891926|FG002|Year 2|Withdrawal by Subject|4|||
46676362|NCT00195494|82891927|FG003|Year 2|Withdrawal by Subject|3|||
46676363|NCT00195494|82891928|FG004|Year 2|Withdrawal by Subject|0|||
46676364|NCT00195494|82891929|FG005|Year 2|Withdrawal by Subject|0|||
46676365|NCT00195494|82891924|FG000|Year 2|System toxicity|0|||
46676366|NCT00195494|82891925|FG001|Year 2|System toxicity|0|||
46676367|NCT00195494|82891926|FG002|Year 2|System toxicity|0|||
46676368|NCT00195494|82891927|FG003|Year 2|System toxicity|1|||
46676369|NCT00195494|82891928|FG004|Year 2|System toxicity|0|||
46676370|NCT00195494|82891929|FG005|Year 2|System toxicity|0|||
46676371|NCT00194987|82891947|FG000|Overall Study|Withdrawal by Subject|0|||
46676372|NCT00194987|82891948|FG001|Overall Study|Withdrawal by Subject|3|||
46676373|NCT00194792|82891956|FG000|Overall Study|Withdrawal by Subject|1|||
46856727|NCT03334396|83072579|FG005|Overall Study|Ineligible|0|||
46856728|NCT03334396|83072580|FG006|Overall Study|Ineligible|0|||
46856729|NCT03334396|83072581|FG007|Overall Study|Ineligible|0|||
46856730|NCT03334396|83072574|FG000|Overall Study|Started New Job|1|||
46856731|NCT03334396|83072575|FG001|Overall Study|Started New Job|0|||
46856732|NCT03334396|83072576|FG002|Overall Study|Started New Job|0|||
46856733|NCT03334396|83072577|FG003|Overall Study|Started New Job|0|||
46856734|NCT03334396|83072578|FG004|Overall Study|Started New Job|0|||
46856735|NCT03334396|83072579|FG005|Overall Study|Started New Job|0|||
46856736|NCT03334396|83072580|FG006|Overall Study|Started New Job|0|||
46856737|NCT03334396|83072581|FG007|Overall Study|Started New Job|0|||
46856738|NCT03338998|83072600|FG000|Treatment Period|Withdrawal by Subject|1|||
46856739|NCT03338998|83072601|FG001|Treatment Period|Withdrawal by Subject|1|||
46979410|NCT02589665|83225068|FG008|Induction Period|Did not receive drug|0|||
46676374|NCT00194675|82891971|FG000|Overall Study|Lost to Follow-up|1|||
46676375|NCT00194675|82891972|FG001|Overall Study|Lost to Follow-up|1|||
46676376|NCT00194675|82891971|FG000|Overall Study|lack of interest|1|||
46856740|NCT03338998|83072600|FG000|Treatment Period|Adverse Event|0|||
46676377|NCT00194675|82891972|FG001|Overall Study|lack of interest|1|||
46856741|NCT03338998|83072601|FG001|Treatment Period|Adverse Event|2|||
46856742|NCT03338998|83072600|FG000|Treatment Period|Protocol deviation|1|||
46676378|NCT00194675|82891971|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
46979411|NCT02589665|83225069|FG009|Induction Period|Did not receive drug|0|||
46979412|NCT02589665|83225060|FG000|Induction Period|Adverse Event|3|||
46856743|NCT03338998|83072601|FG001|Treatment Period|Protocol deviation|0|||
46856744|NCT03338998|83072600|FG000|Treatment Period|Physician Decision|2|||
46856745|NCT03338998|83072601|FG001|Treatment Period|Physician Decision|0|||
46856746|NCT03338998|83072600|FG000|Treatment Period|Subject failed swallow test|4|||
46979413|NCT02589665|83225061|FG001|Induction Period|Adverse Event|0|||
46676379|NCT00194675|82891972|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
46979414|NCT02589665|83225062|FG002|Induction Period|Adverse Event|2|||
46795610|NCT00528567|83013870|FG000|Overall Study|Withdrew Consent|59|||
46979415|NCT02589665|83225063|FG003|Induction Period|Adverse Event|2|||
46979416|NCT02589665|83225064|FG004|Induction Period|Adverse Event|0|||
46979417|NCT02589665|83225065|FG005|Induction Period|Adverse Event|0|||
46795611|NCT00528567|83013871|FG001|Overall Study|Withdrew Consent|55|||
46795612|NCT00528567|83013870|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
46979418|NCT02589665|83225066|FG006|Induction Period|Adverse Event|0|||
46979419|NCT02589665|83225067|FG007|Induction Period|Adverse Event|0|||
46979420|NCT02589665|83225068|FG008|Induction Period|Adverse Event|0|||
46676380|NCT00194675|82891971|FG000|Overall Study|Protocol Violation|1|||
46979421|NCT02589665|83225069|FG009|Induction Period|Adverse Event|0|||
46676381|NCT00194675|82891972|FG001|Overall Study|Protocol Violation|0|||
46676382|NCT00194675|82891971|FG000|Overall Study|Death|1|||
46979422|NCT02589665|83225060|FG000|Induction Period|Withdrawal by Subject|0|||
46979423|NCT02589665|83225061|FG001|Induction Period|Withdrawal by Subject|1|||
46979424|NCT02589665|83225062|FG002|Induction Period|Withdrawal by Subject|0|||
46795613|NCT00528567|83013871|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
46795614|NCT00528567|83013870|FG000|Overall Study|Failure to Return|1|||
46795615|NCT00528567|83013871|FG001|Overall Study|Failure to Return|4|||
46795616|NCT00528567|83013870|FG000|Overall Study|Other Protocol Violation|5|||
46676383|NCT00194675|82891972|FG001|Overall Study|Death|0|||
46676384|NCT00194012|82891982|FG000|Randomized Phase|Lack of Efficacy|8|||
46676385|NCT00194012|82891983|FG001|Randomized Phase|Lack of Efficacy|18|||
46676386|NCT00194012|82891982|FG000|Randomized Phase|Study nonadherence|2|||
46676387|NCT00194012|82891983|FG001|Randomized Phase|Study nonadherence|1|||
46676388|NCT00194012|82891982|FG000|Randomized Phase|Withdrawal by Subject|3|||
46676389|NCT00194012|82891983|FG001|Randomized Phase|Withdrawal by Subject|3|||
46676390|NCT00194012|82891982|FG000|Randomized Phase|Adverse Event|2|||
46676391|NCT00194012|82891983|FG001|Randomized Phase|Adverse Event|1|||
46676392|NCT00194012|82891982|FG000|Randomized Phase|Participant reported having a rash|1|||
46676393|NCT00194012|82891983|FG001|Randomized Phase|Participant reported having a rash|0|||
46676394|NCT00194012|82891982|FG000|Randomized Phase|Emesis and enuresis|0|||
46676395|NCT00194012|82891983|FG001|Randomized Phase|Emesis and enuresis|1|||
46676396|NCT00194012|82891982|FG000|Randomized Phase|Oral/nasal twitching|0|||
46676397|NCT00194012|82891983|FG001|Randomized Phase|Oral/nasal twitching|1|||
46676398|NCT00194012|82891982|FG000|Open Label Extension (OLE)|Weight Gain|1|||
46676399|NCT00194012|82891983|FG001|Open Label Extension (OLE)|Weight Gain|0|||
46676400|NCT00194012|82891982|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
46676401|NCT00194012|82891983|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
46676402|NCT00194012|82891982|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
46676403|NCT00194012|82891983|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
46676404|NCT00194012|82891982|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
46676405|NCT00194012|82891983|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
46676406|NCT00192647|82891997|FG000|Overall Study|Death|1|||
46676407|NCT00192647|82891998|FG001|Overall Study|Death|1|||
46676408|NCT00192647|82891997|FG000|Overall Study|Adverse Event|35|||
46676409|NCT00192647|82891998|FG001|Overall Study|Adverse Event|29|||
46676410|NCT00192647|82891997|FG000|Overall Study|Laboratory Test Abnormality|4|||
46676411|NCT00192647|82891998|FG001|Overall Study|Laboratory Test Abnormality|2|||
46676412|NCT00192647|82891997|FG000|Overall Study|Insufficient Therapeutic Response|53|||
46676413|NCT00192647|82891998|FG001|Overall Study|Insufficient Therapeutic Response|83|||
46676414|NCT00192647|82891997|FG000|Overall Study|Entry Criteria Violation|6|||
46676415|NCT00192647|82891998|FG001|Overall Study|Entry Criteria Violation|6|||
46676416|NCT00192647|82891997|FG000|Overall Study|Protocol Violation|3|||
46676417|NCT00192647|82891998|FG001|Overall Study|Protocol Violation|1|||
46676418|NCT00192647|82891997|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
46676419|NCT00192647|82891998|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
46676420|NCT00192647|82891997|FG000|Overall Study|Failure to Return|11|||
46676421|NCT00192647|82891998|FG001|Overall Study|Failure to Return|13|||
46676422|NCT00192647|82891997|FG000|Overall Study|Other/Administrative|5|||
46676423|NCT00192647|82891998|FG001|Overall Study|Other/Administrative|3|||
46676424|NCT00192296|82892008|FG000|Overall Study|Withdrawal by Subject|0|||
46676425|NCT00192296|82892009|FG001|Overall Study|Withdrawal by Subject|1|||
46676426|NCT00192296|82892010|FG002|Overall Study|Withdrawal by Subject|0|||
46676427|NCT00192296|82892011|FG003|Overall Study|Withdrawal by Subject|0|||
46676428|NCT00192023|82892023|FG000|Period III - Double-Blind|Adverse Event|3|||
46676429|NCT00192023|82892024|FG001|Period III - Double-Blind|Adverse Event|0|||
46676430|NCT00192023|82892023|FG000|Period III - Double-Blind|Physician Decision|2|||
46676431|NCT00192023|82892024|FG001|Period III - Double-Blind|Physician Decision|0|||
46676432|NCT00192023|82892023|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
46676433|NCT00192023|82892024|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
46676434|NCT00192023|82892023|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
46676435|NCT00192023|82892024|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
46676436|NCT00192023|82892023|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
46676437|NCT00192023|82892024|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
46676438|NCT00192023|82892023|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
46676439|NCT00192023|82892024|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
46676440|NCT00192023|82892023|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
46676441|NCT00192023|82892024|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
46676442|NCT00192023|82892023|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
46676443|NCT00192023|82892024|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
46676444|NCT00192023|82892023|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
46676445|NCT00192023|82892024|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
46676446|NCT00192023|82892023|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
46676447|NCT00192023|82892024|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
46795617|NCT00528567|83013871|FG001|Overall Study|Other Protocol Violation|21|||
46795618|NCT00528567|83013870|FG000|Overall Study|Administrative/Other|22|||
46979425|NCT02589665|83225063|FG003|Induction Period|Withdrawal by Subject|1|||
46795619|NCT00528567|83013871|FG001|Overall Study|Administrative/Other|75|||
46795620|NCT00138151|83013884|FG000|Overall Study|Withdrawal by Subject|3|||
46979426|NCT02589665|83225064|FG004|Induction Period|Withdrawal by Subject|0|||
46979427|NCT02589665|83225065|FG005|Induction Period|Withdrawal by Subject|0|||
46676448|NCT00191984|82892030|FG000|Overall Study|Disease Progression|21|||
47080958|NCT01279681|83397360|FG001|Overall Study|Disease Progression|6|||
47080959|NCT01279681|83397359|FG000|Overall Study|Withdrawal by Subject|3|||
47080960|NCT01279681|83397360|FG001|Overall Study|Withdrawal by Subject|4|||
47080961|NCT01279681|83397359|FG000|Overall Study|Adverse Event|2|||
47080962|NCT01279681|83397360|FG001|Overall Study|Adverse Event|3|||
47080963|NCT01279681|83397359|FG000|Overall Study|Death|0|||
47080964|NCT01279681|83397360|FG001|Overall Study|Death|1|||
47080965|NCT01279681|83397359|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
47080966|NCT01279681|83397360|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
47080967|NCT01279681|83397359|FG000|Overall Study|Physician Decision|1|||
47080968|NCT01279681|83397360|FG001|Overall Study|Physician Decision|0|||
47080969|NCT01279681|83397359|FG000|Overall Study|Other Reason|0|||
47080970|NCT01279681|83397360|FG001|Overall Study|Other Reason|2|||
47080971|NCT01279057|83397378|FG000|Overall Study|Adverse Event|1|||
47080972|NCT01279057|83397379|FG001|Overall Study|Adverse Event|0|||
47080973|NCT01279057|83397380|FG002|Overall Study|Adverse Event|1|||
47080974|NCT01279057|83397378|FG000|Overall Study|Insufficient therapeutic response|0|||
47080975|NCT01279057|83397379|FG001|Overall Study|Insufficient therapeutic response|0|||
47080976|NCT01279057|83397380|FG002|Overall Study|Insufficient therapeutic response|1|||
46856747|NCT03338998|83072601|FG001|Treatment Period|Subject failed swallow test|0|||
46856748|NCT03338998|83072600|FG000|Safety Follow-Up Period|Adverse Event|0|||
46856749|NCT03338998|83072601|FG001|Safety Follow-Up Period|Adverse Event|1|||
46856750|NCT03338998|83072600|FG000|Safety Follow-Up Period|Protocol deviation|1|||
46856751|NCT03338998|83072601|FG001|Safety Follow-Up Period|Protocol deviation|0|||
46856752|NCT03338998|83072600|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
46856753|NCT03338998|83072601|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
46979428|NCT02589665|83225066|FG006|Induction Period|Withdrawal by Subject|0|||
46979429|NCT02589665|83225067|FG007|Induction Period|Withdrawal by Subject|0|||
46979430|NCT02589665|83225068|FG008|Induction Period|Withdrawal by Subject|0|||
46979431|NCT02589665|83225069|FG009|Induction Period|Withdrawal by Subject|0|||
46979432|NCT02589665|83225060|FG000|Induction Period|Protocol Violation|0|||
46979433|NCT02589665|83225061|FG001|Induction Period|Protocol Violation|1|||
46979434|NCT02589665|83225062|FG002|Induction Period|Protocol Violation|0|||
46979435|NCT02589665|83225063|FG003|Induction Period|Protocol Violation|0|||
46979436|NCT02589665|83225064|FG004|Induction Period|Protocol Violation|0|||
46979437|NCT02589665|83225065|FG005|Induction Period|Protocol Violation|0|||
46979438|NCT02589665|83225066|FG006|Induction Period|Protocol Violation|0|||
46979439|NCT02589665|83225067|FG007|Induction Period|Protocol Violation|0|||
46979440|NCT02589665|83225068|FG008|Induction Period|Protocol Violation|0|||
46979441|NCT02589665|83225069|FG009|Induction Period|Protocol Violation|0|||
46979442|NCT02589665|83225060|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979443|NCT02589665|83225061|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979444|NCT02589665|83225062|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979445|NCT02589665|83225063|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979446|NCT02589665|83225064|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
46979447|NCT02589665|83225065|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
46979448|NCT02589665|83225066|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
46979449|NCT02589665|83225067|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979450|NCT02589665|83225068|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979451|NCT02589665|83225069|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979452|NCT02589665|83225060|FG000|Maintenance Period|Withdrawal by Subject|0|||
46979453|NCT02589665|83225061|FG001|Maintenance Period|Withdrawal by Subject|0|||
46979454|NCT02589665|83225062|FG002|Maintenance Period|Withdrawal by Subject|0|||
46979455|NCT02589665|83225063|FG003|Maintenance Period|Withdrawal by Subject|0|||
46979456|NCT02589665|83225064|FG004|Maintenance Period|Withdrawal by Subject|4|||
46979457|NCT02589665|83225065|FG005|Maintenance Period|Withdrawal by Subject|2|||
46979458|NCT02589665|83225066|FG006|Maintenance Period|Withdrawal by Subject|4|||
46979459|NCT02589665|83225067|FG007|Maintenance Period|Withdrawal by Subject|0|||
46979460|NCT02589665|83225068|FG008|Maintenance Period|Withdrawal by Subject|0|||
46979461|NCT02589665|83225069|FG009|Maintenance Period|Withdrawal by Subject|0|||
46979462|NCT02589665|83225060|FG000|Maintenance Period|Lack of Efficacy|0|||
46979463|NCT02589665|83225061|FG001|Maintenance Period|Lack of Efficacy|0|||
46979464|NCT02589665|83225062|FG002|Maintenance Period|Lack of Efficacy|0|||
46979465|NCT02589665|83225063|FG003|Maintenance Period|Lack of Efficacy|0|||
46979466|NCT02589665|83225064|FG004|Maintenance Period|Lack of Efficacy|2|||
46979467|NCT02589665|83225065|FG005|Maintenance Period|Lack of Efficacy|1|||
46979468|NCT02589665|83225066|FG006|Maintenance Period|Lack of Efficacy|0|||
46979469|NCT02589665|83225067|FG007|Maintenance Period|Lack of Efficacy|0|||
46979470|NCT02589665|83225068|FG008|Maintenance Period|Lack of Efficacy|0|||
46979471|NCT02589665|83225069|FG009|Maintenance Period|Lack of Efficacy|0|||
46979472|NCT02589665|83225060|FG000|Maintenance Period|Adverse Event|0|||
46979473|NCT02589665|83225061|FG001|Maintenance Period|Adverse Event|0|||
46979474|NCT02589665|83225062|FG002|Maintenance Period|Adverse Event|0|||
47080977|NCT01279057|83397378|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
47080978|NCT01279057|83397379|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
47080979|NCT01279057|83397380|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
47080980|NCT01279057|83397378|FG000|Overall Study|Withdrew consent|2|||
47080981|NCT01279057|83397379|FG001|Overall Study|Withdrew consent|0|||
47080982|NCT01279057|83397380|FG002|Overall Study|Withdrew consent|1|||
47080983|NCT01279057|83397378|FG000|Overall Study|Pregnancy|0|||
47080984|NCT01279057|83397379|FG001|Overall Study|Pregnancy|1|||
47080985|NCT01279057|83397380|FG002|Overall Study|Pregnancy|0|||
47080986|NCT01279057|83397378|FG000|Overall Study|Other|3|||
47080987|NCT01279057|83397379|FG001|Overall Study|Other|3|||
47080988|NCT01279057|83397380|FG002|Overall Study|Other|0|||
47080989|NCT02999633|83397388|FG000|Overall Study|Adverse Event|2|||
46856754|NCT03338296|83072610|FG000|Overall Study|Adverse Event|0|||
46979475|NCT02589665|83225063|FG003|Maintenance Period|Adverse Event|0|||
46979476|NCT02589665|83225064|FG004|Maintenance Period|Adverse Event|0|||
47080990|NCT02999633|83397388|FG000|Overall Study|Progressive disease|12|||
47080991|NCT01278745|83397490|FG000|Overall Study|Death|2|||
46856755|NCT03338296|83072611|FG001|Overall Study|Adverse Event|1|||
47080992|NCT01278745|83397491|FG001|Overall Study|Death|5|||
46979477|NCT02589665|83225065|FG005|Maintenance Period|Adverse Event|0|||
46979478|NCT02589665|83225066|FG006|Maintenance Period|Adverse Event|2|||
46979479|NCT02589665|83225067|FG007|Maintenance Period|Adverse Event|0|||
46979480|NCT02589665|83225068|FG008|Maintenance Period|Adverse Event|0|||
46979481|NCT02589665|83225069|FG009|Maintenance Period|Adverse Event|0|||
46979482|NCT02589665|83225060|FG000|Maintenance Period|Lost to Follow-up|0|||
46979483|NCT02589665|83225061|FG001|Maintenance Period|Lost to Follow-up|0|||
46979484|NCT02589665|83225062|FG002|Maintenance Period|Lost to Follow-up|0|||
46979485|NCT02589665|83225063|FG003|Maintenance Period|Lost to Follow-up|0|||
46979486|NCT02589665|83225064|FG004|Maintenance Period|Lost to Follow-up|0|||
46979487|NCT02589665|83225065|FG005|Maintenance Period|Lost to Follow-up|1|||
46979488|NCT02589665|83225066|FG006|Maintenance Period|Lost to Follow-up|0|||
46979489|NCT02589665|83225067|FG007|Maintenance Period|Lost to Follow-up|0|||
46979490|NCT02589665|83225068|FG008|Maintenance Period|Lost to Follow-up|0|||
46979491|NCT02589665|83225069|FG009|Maintenance Period|Lost to Follow-up|0|||
46979492|NCT02589665|83225060|FG000|Maintenance Period|Physician Decision|0|||
46979493|NCT02589665|83225061|FG001|Maintenance Period|Physician Decision|0|||
46979494|NCT02589665|83225062|FG002|Maintenance Period|Physician Decision|0|||
46979495|NCT02589665|83225063|FG003|Maintenance Period|Physician Decision|0|||
46979496|NCT02589665|83225064|FG004|Maintenance Period|Physician Decision|0|||
46979497|NCT02589665|83225065|FG005|Maintenance Period|Physician Decision|1|||
46979498|NCT02589665|83225066|FG006|Maintenance Period|Physician Decision|0|||
46979499|NCT02589665|83225067|FG007|Maintenance Period|Physician Decision|0|||
46979500|NCT02589665|83225068|FG008|Maintenance Period|Physician Decision|0|||
46979501|NCT02589665|83225069|FG009|Maintenance Period|Physician Decision|0|||
46979502|NCT02589665|83225060|FG000|Maintenance Period|Reason Not Collected|0|||
46979503|NCT02589665|83225061|FG001|Maintenance Period|Reason Not Collected|0|||
46979504|NCT02589665|83225062|FG002|Maintenance Period|Reason Not Collected|0|||
46979505|NCT02589665|83225063|FG003|Maintenance Period|Reason Not Collected|0|||
46979506|NCT02589665|83225064|FG004|Maintenance Period|Reason Not Collected|0|||
46979507|NCT02589665|83225065|FG005|Maintenance Period|Reason Not Collected|1|||
46979508|NCT02589665|83225066|FG006|Maintenance Period|Reason Not Collected|1|||
46979509|NCT02589665|83225067|FG007|Maintenance Period|Reason Not Collected|0|||
46979510|NCT02589665|83225068|FG008|Maintenance Period|Reason Not Collected|0|||
46979511|NCT02589665|83225069|FG009|Maintenance Period|Reason Not Collected|0|||
46979512|NCT02589665|83225060|FG000|Induction Extension Period|Adverse Event|0|||
46979513|NCT02589665|83225061|FG001|Induction Extension Period|Adverse Event|0|||
46979514|NCT02589665|83225062|FG002|Induction Extension Period|Adverse Event|0|||
46979515|NCT02589665|83225063|FG003|Induction Extension Period|Adverse Event|0|||
46979516|NCT02589665|83225064|FG004|Induction Extension Period|Adverse Event|0|||
46979517|NCT02589665|83225065|FG005|Induction Extension Period|Adverse Event|0|||
46979518|NCT02589665|83225066|FG006|Induction Extension Period|Adverse Event|0|||
46979519|NCT02589665|83225067|FG007|Induction Extension Period|Adverse Event|0|||
46979520|NCT02589665|83225068|FG008|Induction Extension Period|Adverse Event|4|||
46979521|NCT02589665|83225069|FG009|Induction Extension Period|Adverse Event|0|||
46979522|NCT02589665|83225060|FG000|Induction Extension Period|Lack of Efficacy|0|||
46979523|NCT02589665|83225061|FG001|Induction Extension Period|Lack of Efficacy|0|||
46979524|NCT02589665|83225062|FG002|Induction Extension Period|Lack of Efficacy|0|||
46979525|NCT02589665|83225063|FG003|Induction Extension Period|Lack of Efficacy|0|||
46795621|NCT00138151|83013884|FG000|Overall Study|Physician Decision|1|||
46795622|NCT00138073|83013888|FG000|Overall Study|lack of resources|55|||
46795623|NCT02581631|83013897|FG000|Overall Study|Disease progression|29|||
46979526|NCT02589665|83225064|FG004|Induction Extension Period|Lack of Efficacy|0|||
46979527|NCT02589665|83225065|FG005|Induction Extension Period|Lack of Efficacy|0|||
46979528|NCT02589665|83225066|FG006|Induction Extension Period|Lack of Efficacy|0|||
46979529|NCT02589665|83225067|FG007|Induction Extension Period|Lack of Efficacy|0|||
46979530|NCT02589665|83225068|FG008|Induction Extension Period|Lack of Efficacy|3|||
46676449|NCT00191984|82892030|FG000|Overall Study|Adverse Event|4|||
46676450|NCT00191984|82892030|FG000|Overall Study|Death|2|||
46676451|NCT00191984|82892030|FG000|Overall Study|Entry Criteria Exclusion|1|||
46795624|NCT02581631|83013898|FG001|Overall Study|Disease progression|19|||
46795625|NCT02581631|83013899|FG002|Overall Study|Disease progression|13|||
46795626|NCT02581631|83013900|FG003|Overall Study|Disease progression|5|||
46979531|NCT02589665|83225069|FG009|Induction Extension Period|Lack of Efficacy|0|||
46979532|NCT02589665|83225060|FG000|Induction Extension Period|Withdrawal by Subject|0|||
46979533|NCT02589665|83225061|FG001|Induction Extension Period|Withdrawal by Subject|0|||
46795627|NCT02581631|83013901|FG004|Overall Study|Disease progression|8|||
46979534|NCT02589665|83225062|FG002|Induction Extension Period|Withdrawal by Subject|0|||
46979535|NCT02589665|83225063|FG003|Induction Extension Period|Withdrawal by Subject|0|||
46979536|NCT02589665|83225064|FG004|Induction Extension Period|Withdrawal by Subject|0|||
46795628|NCT02581631|83013897|FG000|Overall Study|Study drug toxicity|4|||
46979537|NCT02589665|83225065|FG005|Induction Extension Period|Withdrawal by Subject|0|||
46979538|NCT02589665|83225066|FG006|Induction Extension Period|Withdrawal by Subject|0|||
46979539|NCT02589665|83225067|FG007|Induction Extension Period|Withdrawal by Subject|2|||
46979540|NCT02589665|83225068|FG008|Induction Extension Period|Withdrawal by Subject|3|||
46979541|NCT02589665|83225069|FG009|Induction Extension Period|Withdrawal by Subject|0|||
46979542|NCT02589665|83225060|FG000|Induction Extension Period|Physician Decision|0|||
46979543|NCT02589665|83225061|FG001|Induction Extension Period|Physician Decision|0|||
46979544|NCT02589665|83225062|FG002|Induction Extension Period|Physician Decision|0|||
46979545|NCT02589665|83225063|FG003|Induction Extension Period|Physician Decision|0|||
46979546|NCT02589665|83225064|FG004|Induction Extension Period|Physician Decision|0|||
46979547|NCT02589665|83225065|FG005|Induction Extension Period|Physician Decision|0|||
46979548|NCT02589665|83225066|FG006|Induction Extension Period|Physician Decision|0|||
46979549|NCT02589665|83225067|FG007|Induction Extension Period|Physician Decision|0|||
46979550|NCT02589665|83225068|FG008|Induction Extension Period|Physician Decision|1|||
46979551|NCT02589665|83225069|FG009|Induction Extension Period|Physician Decision|0|||
46979552|NCT02589665|83225060|FG000|Induction Extension Period|Reason Not Collected|0|||
46979553|NCT02589665|83225061|FG001|Induction Extension Period|Reason Not Collected|0|||
46979554|NCT02589665|83225062|FG002|Induction Extension Period|Reason Not Collected|0|||
46979555|NCT02589665|83225063|FG003|Induction Extension Period|Reason Not Collected|0|||
46979556|NCT02589665|83225064|FG004|Induction Extension Period|Reason Not Collected|0|||
46979557|NCT02589665|83225065|FG005|Induction Extension Period|Reason Not Collected|0|||
46979558|NCT02589665|83225066|FG006|Induction Extension Period|Reason Not Collected|0|||
46979559|NCT02589665|83225067|FG007|Induction Extension Period|Reason Not Collected|0|||
47080993|NCT01278745|83397492|FG002|Overall Study|Death|7|||
47080994|NCT01278745|83397493|FG003|Overall Study|Death|0|||
47080995|NCT01278745|83397490|FG000|Overall Study|Physician Decision|1|||
47080996|NCT01278745|83397491|FG001|Overall Study|Physician Decision|0|||
47080997|NCT01278745|83397492|FG002|Overall Study|Physician Decision|0|||
47080998|NCT01278745|83397493|FG003|Overall Study|Physician Decision|9|||
47080999|NCT01278745|83397490|FG000|Overall Study|Withdrawal by Subject|1|||
47081000|NCT01278745|83397491|FG001|Overall Study|Withdrawal by Subject|1|||
47081001|NCT01278745|83397492|FG002|Overall Study|Withdrawal by Subject|5|||
47081002|NCT01278745|83397493|FG003|Overall Study|Withdrawal by Subject|1|||
47081003|NCT01278745|83397490|FG000|Overall Study|Sponsor Decision|1|||
47081004|NCT01278745|83397491|FG001|Overall Study|Sponsor Decision|0|||
47081005|NCT01278745|83397492|FG002|Overall Study|Sponsor Decision|62|||
47081006|NCT01278745|83397493|FG003|Overall Study|Sponsor Decision|6|||
47081007|NCT01278745|83397490|FG000|Overall Study|Ineligible|0|||
47081008|NCT01278745|83397491|FG001|Overall Study|Ineligible|0|||
47081009|NCT01278745|83397492|FG002|Overall Study|Ineligible|42|||
47081010|NCT01278745|83397493|FG003|Overall Study|Ineligible|61|||
47081011|NCT01278745|83397490|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
47081012|NCT01278745|83397491|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
47081013|NCT01278745|83397492|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
47081014|NCT01278745|83397493|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
47081015|NCT01277887|83397555|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
46856756|NCT03338296|83072610|FG000|Overall Study|Withdrawal by Subject|14|||
46856757|NCT03338296|83072611|FG001|Overall Study|Withdrawal by Subject|13|||
46856758|NCT03338296|83072610|FG000|Overall Study|Lost to Follow-up|10|||
46856759|NCT03338296|83072611|FG001|Overall Study|Lost to Follow-up|10|||
46856760|NCT03338296|83072610|FG000|Overall Study|Study Terminated by Sponsor|77|||
46856761|NCT03338296|83072611|FG001|Overall Study|Study Terminated by Sponsor|76|||
46856762|NCT03338296|83072610|FG000|Overall Study|Other|2|||
46856763|NCT03338296|83072611|FG001|Overall Study|Other|7|||
46856764|NCT03338296|83072610|FG000|Overall Study|Missing|0|||
46856765|NCT03338296|83072611|FG001|Overall Study|Missing|1|||
46856766|NCT03338062|83072619|FG000|Overall Study|Alternative Therapy|1|||
46856767|NCT03338062|83072620|FG001|Overall Study|Alternative Therapy|0|||
46856768|NCT03364192|83072627|FG000|Overall Study|Ineligible|10|||
46856769|NCT03364192|83072627|FG000|Overall Study|Withdrawal by Subject|5|||
46676452|NCT00191984|82892030|FG000|Overall Study|Withdrawal by Subject|7|||
46676453|NCT00191984|82892030|FG000|Overall Study|Physician Decision|4|||
46856770|NCT03364192|83072627|FG000|Overall Study|Lost to Follow-up|1|||
46676454|NCT00191906|82892038|FG000|Study Period II|Adverse Event|0|||
46856771|NCT03783962|83072634|FG000|Overall Study|Lost to Follow-up|3|||
46856772|NCT03783962|83072635|FG001|Overall Study|Lost to Follow-up|6|||
46856773|NCT03783962|83072634|FG000|Overall Study|Protocol Violation|0|||
46856774|NCT03783962|83072635|FG001|Overall Study|Protocol Violation|1|||
46856775|NCT03361228|83072643|FG000|Overall Study|Other|1|||
46856776|NCT03361228|83072644|FG001|Overall Study|Other|1|||
46856777|NCT03361228|83072643|FG000|Overall Study|Death|3|||
46856778|NCT03361228|83072644|FG001|Overall Study|Death|0|||
46856779|NCT03359590|83072650|FG000|First Intervention|Withdrawal by Subject|1|||
46856780|NCT03359590|83072651|FG001|First Intervention|Withdrawal by Subject|1|||
46856781|NCT03359590|83072650|FG000|First Intervention|Protocol Violation|0|||
46856782|NCT03359590|83072651|FG001|First Intervention|Protocol Violation|1|||
46856783|NCT05085964|83072659|FG000|Overall Study|Premature termination of study|21|||
46856784|NCT05085964|83072660|FG001|Overall Study|Premature termination of study|0|||
46856785|NCT02891200|83072669|FG000|Overall Study|Lost to Follow-up|31|||
46856786|NCT02891200|83072670|FG001|Overall Study|Lost to Follow-up|36|||
46856787|NCT02891200|83072669|FG000|Overall Study|Death|10|||
46856788|NCT02891200|83072670|FG001|Overall Study|Death|9|||
46856789|NCT02891200|83072669|FG000|Overall Study|Withdrawal by Subject|1|||
46856790|NCT02891200|83072670|FG001|Overall Study|Withdrawal by Subject|4|||
46856791|NCT02946580|83072678|FG000|Overall Study|Withdrawal by Subject|1|||
46795629|NCT02581631|83013898|FG001|Overall Study|Study drug toxicity|6|||
46795630|NCT02581631|83013899|FG002|Overall Study|Study drug toxicity|7|||
46795631|NCT02581631|83013900|FG003|Overall Study|Study drug toxicity|0|||
46795632|NCT02581631|83013901|FG004|Overall Study|Study drug toxicity|3|||
46795633|NCT02581631|83013897|FG000|Overall Study|AE unrelated to study drug|3|||
46795634|NCT02581631|83013898|FG001|Overall Study|AE unrelated to study drug|1|||
47081016|NCT01277887|83397556|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
47081017|NCT01277887|83397555|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
47081018|NCT01277887|83397556|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
47081019|NCT01277887|83397555|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
47081020|NCT01277887|83397556|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
47081021|NCT01276327|83397570|FG000|Overall Study|Adverse Event|1|||
47081022|NCT01276327|83397571|FG001|Overall Study|Adverse Event|3|||
47081023|NCT01276327|83397570|FG000|Overall Study|Withdrawal by Subject|1|||
47081024|NCT01276327|83397571|FG001|Overall Study|Withdrawal by Subject|0|||
47081025|NCT00639002|83397684|FG000|Overall Study|Death|1|||
47081026|NCT00639002|83397684|FG000|Overall Study|Adverse Event|1|||
47081027|NCT00639002|83397684|FG000|Overall Study|Protocol Violation|1|||
47081028|NCT00639002|83397684|FG000|Overall Study|Disease progression|3|||
47081029|NCT00639002|83397684|FG000|Overall Study|Physician Decision|6|||
47081030|NCT00639002|83397684|FG000|Overall Study|Lack of Efficacy|1|||
47081031|NCT00638846|83397720|FG000|Overall Study|Adverse Event|0|||
47081032|NCT00638846|83397721|FG001|Overall Study|Adverse Event|1|||
47081033|NCT00638846|83397720|FG000|Overall Study|Lost to Follow-up|3|||
47081034|NCT00638846|83397721|FG001|Overall Study|Lost to Follow-up|2|||
47081035|NCT00638846|83397720|FG000|Overall Study|lens issue|1|||
47081036|NCT00638846|83397721|FG001|Overall Study|lens issue|3|||
47081037|NCT00638456|83397729|FG000|Overall Study|Withdrawal by Subject|6|||
47081038|NCT00638456|83397730|FG001|Overall Study|Withdrawal by Subject|2|||
47081039|NCT00638378|83397759|FG000|Overall Study|Death|2|||
47081040|NCT00638378|83397759|FG000|Overall Study|Adverse Event|1|||
47081041|NCT00638378|83397759|FG000|Overall Study|Disease progression|15|||
47081042|NCT00638378|83397759|FG000|Overall Study|Physician Decision|4|||
46856792|NCT02946580|83072679|FG001|Overall Study|Withdrawal by Subject|2|||
46795635|NCT02581631|83013899|FG002|Overall Study|AE unrelated to study drug|1|||
46795636|NCT02581631|83013900|FG003|Overall Study|AE unrelated to study drug|0|||
46676455|NCT00191906|82892039|FG001|Study Period II|Adverse Event|1|||
46795637|NCT02581631|83013901|FG004|Overall Study|AE unrelated to study drug|2|||
46795638|NCT02581631|83013897|FG000|Overall Study|Request to discontinue|1|||
46795639|NCT02581631|83013898|FG001|Overall Study|Request to discontinue|0|||
46795640|NCT02581631|83013899|FG002|Overall Study|Request to discontinue|3|||
46795641|NCT02581631|83013900|FG003|Overall Study|Request to discontinue|0|||
46795642|NCT02581631|83013901|FG004|Overall Study|Request to discontinue|1|||
46795643|NCT02581631|83013897|FG000|Overall Study|participant withdrew consent|3|||
46795644|NCT02581631|83013898|FG001|Overall Study|participant withdrew consent|0|||
46795645|NCT02581631|83013899|FG002|Overall Study|participant withdrew consent|1|||
46856793|NCT02946580|83072678|FG000|Overall Study|Adverse Event|0|||
46676456|NCT00191906|82892040|FG002|Study Period II|Adverse Event|0|||
46856794|NCT02946580|83072679|FG001|Overall Study|Adverse Event|2|||
46676457|NCT00191906|82892041|FG003|Study Period II|Adverse Event|0|||
46676458|NCT00191906|82892038|FG000|Study Period II|Withdrawal by Subject|0|||
46676459|NCT00191906|82892039|FG001|Study Period II|Withdrawal by Subject|3|||
46676460|NCT00191906|82892040|FG002|Study Period II|Withdrawal by Subject|0|||
46676461|NCT00191906|82892041|FG003|Study Period II|Withdrawal by Subject|0|||
46676462|NCT00191906|82892038|FG000|Study Period II|Parent/Caregiver Decision|0|||
46676463|NCT00191906|82892039|FG001|Study Period II|Parent/Caregiver Decision|1|||
46676464|NCT00191906|82892040|FG002|Study Period II|Parent/Caregiver Decision|0|||
46676465|NCT00191906|82892041|FG003|Study Period II|Parent/Caregiver Decision|0|||
46676466|NCT00191906|82892038|FG000|Study Period II|Entry Criteria Exclusion|0|||
46676467|NCT00191906|82892039|FG001|Study Period II|Entry Criteria Exclusion|0|||
46676468|NCT00191906|82892040|FG002|Study Period II|Entry Criteria Exclusion|1|||
46676469|NCT00191906|82892041|FG003|Study Period II|Entry Criteria Exclusion|0|||
46676470|NCT00191906|82892038|FG000|Study Period III|Adverse Event|1|||
46676471|NCT00191906|82892039|FG001|Study Period III|Adverse Event|0|||
46676472|NCT00191906|82892040|FG002|Study Period III|Adverse Event|0|||
46676473|NCT00191906|82892041|FG003|Study Period III|Adverse Event|0|||
46676474|NCT00191906|82892038|FG000|Study Period III|Lost to Follow-up|0|||
46676475|NCT00191906|82892039|FG001|Study Period III|Lost to Follow-up|1|||
46676476|NCT00191906|82892040|FG002|Study Period III|Lost to Follow-up|0|||
46676477|NCT00191906|82892041|FG003|Study Period III|Lost to Follow-up|0|||
46676478|NCT00191906|82892038|FG000|Study Period III|Parent/Caregiver Decision|1|||
46676479|NCT00191906|82892039|FG001|Study Period III|Parent/Caregiver Decision|0|||
46676480|NCT00191906|82892040|FG002|Study Period III|Parent/Caregiver Decision|0|||
46676481|NCT00191906|82892041|FG003|Study Period III|Parent/Caregiver Decision|0|||
46676482|NCT00191906|82892038|FG000|Study Period III|Lack of Efficacy|3|||
46676483|NCT00191906|82892039|FG001|Study Period III|Lack of Efficacy|3|||
46676484|NCT00191906|82892040|FG002|Study Period III|Lack of Efficacy|0|||
46676485|NCT00191906|82892041|FG003|Study Period III|Lack of Efficacy|0|||
46676486|NCT00191789|82892057|FG000|Overall Study|Adverse Event|5|||
46676487|NCT00191789|82892057|FG000|Overall Study|Patient: Satisfactory Response|5|||
46676488|NCT00191789|82892057|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
46676489|NCT00191789|82892057|FG000|Overall Study|Withdrawal by Subject|4|||
46676490|NCT00191789|82892057|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
46676491|NCT00191789|82892057|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
46676492|NCT00191789|82892057|FG000|Overall Study|Death - Not Study-Drug Related|1|||
46676493|NCT00191282|82892063|FG000|Overall Study|Adverse Event|5|||
46676494|NCT00191282|82892064|FG001|Overall Study|Adverse Event|6|||
46676495|NCT00191282|82892063|FG000|Overall Study|Death|51|||
46676496|NCT00191282|82892064|FG001|Overall Study|Death|51|||
46676497|NCT00191282|82892063|FG000|Overall Study|Lack of Efficacy|11|||
46676498|NCT00191282|82892064|FG001|Overall Study|Lack of Efficacy|6|||
46676499|NCT00191282|82892063|FG000|Overall Study|Noncompliance|14|||
46676500|NCT00191282|82892064|FG001|Overall Study|Noncompliance|17|||
46676501|NCT00191282|82892063|FG000|Overall Study|Patient moved|11|||
46676502|NCT00191282|82892064|FG001|Overall Study|Patient moved|14|||
46676503|NCT00191282|82892063|FG000|Overall Study|Withdrawal by Subject|59|||
46676504|NCT00191282|82892064|FG001|Overall Study|Withdrawal by Subject|44|||
46676505|NCT00191282|82892063|FG000|Overall Study|Physician Decision|18|||
46676506|NCT00191282|82892064|FG001|Overall Study|Physician Decision|15|||
46676507|NCT00191282|82892063|FG000|Overall Study|Protocol entry criteria not met|14|||
46676508|NCT00191282|82892064|FG001|Overall Study|Protocol entry criteria not met|9|||
46676509|NCT00191282|82892063|FG000|Overall Study|Protocol Violation|9|||
46676510|NCT00191282|82892064|FG001|Overall Study|Protocol Violation|12|||
46676511|NCT00191282|82892063|FG000|Overall Study|Severity of outcome|2|||
46979560|NCT02589665|83225068|FG008|Induction Extension Period|Reason Not Collected|1|||
46676512|NCT00191282|82892064|FG001|Overall Study|Severity of outcome|5|||
46676513|NCT00191282|82892063|FG000|Overall Study|Sponsor's decision|2|||
46676514|NCT00191282|82892064|FG001|Overall Study|Sponsor's decision|2|||
46676515|NCT00191282|82892063|FG000|Overall Study|Lost to Follow-up|24|||
46676516|NCT00191282|82892064|FG001|Overall Study|Lost to Follow-up|31|||
46856795|NCT02946580|83072678|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
47081043|NCT03807349|83397936|FG000|Overall Study|Early Study Termination|9|||
47081044|NCT03802825|83397946|FG000|Overall Study|Lost to follow-up for intervention|12|||
47081045|NCT03802825|83397947|FG001|Overall Study|Lost to follow-up for intervention|3|||
47081046|NCT03802825|83397946|FG000|Overall Study|Received only 1 component of intervention|0|||
46676517|NCT00191165|82892072|FG000|Overall Study|Adverse Event|2|||
46676518|NCT00191165|82892073|FG001|Overall Study|Adverse Event|0|||
46676519|NCT00191165|82892072|FG000|Overall Study|Protocol Violation|0|||
46676520|NCT00191165|82892073|FG001|Overall Study|Protocol Violation|1|||
46676521|NCT00191165|82892072|FG000|Overall Study|Participant Moved Away|0|||
46856796|NCT02946580|83072679|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
46856797|NCT00323609|83072687|FG000|Overall Study|Death|16|||
46856798|NCT00323609|83072688|FG001|Overall Study|Death|21|||
46856799|NCT00323609|83072689|FG002|Overall Study|Death|0|||
47081047|NCT03802825|83397947|FG001|Overall Study|Received only 1 component of intervention|13|||
47081048|NCT03808909|83397966|FG000|Overall Study|Lost to Follow-up|3|||
47081049|NCT03808909|83397967|FG001|Overall Study|Lost to Follow-up|0|||
47081050|NCT03802513|83397988|FG000|Overall Study|Lost to Follow-up|1|||
47081051|NCT01276223|83398179|FG000|Overall Study|Adverse Event|7|||
46856800|NCT00323609|83072690|FG003|Overall Study|Death|0|||
46856801|NCT00323609|83072687|FG000|Overall Study|Lost to Follow-up|9|||
46856802|NCT00323609|83072688|FG001|Overall Study|Lost to Follow-up|10|||
46856803|NCT00323609|83072689|FG002|Overall Study|Lost to Follow-up|0|||
46856804|NCT00323609|83072690|FG003|Overall Study|Lost to Follow-up|0|||
46856805|NCT00323609|83072687|FG000|Overall Study|Physician Decision|2|||
46676522|NCT00191165|82892073|FG001|Overall Study|Participant Moved Away|1|||
46676523|NCT00190775|82892081|FG000|Overall Study|Adverse Event|57|||
46676524|NCT00190775|82892082|FG001|Overall Study|Adverse Event|22|||
46676525|NCT00190775|82892081|FG000|Overall Study|Satisfactory Response|1|||
46676526|NCT00190775|82892082|FG001|Overall Study|Satisfactory Response|0|||
46676527|NCT00190775|82892081|FG000|Overall Study|Lack of Efficacy|28|||
46676528|NCT00190775|82892082|FG001|Overall Study|Lack of Efficacy|32|||
46676529|NCT00190775|82892081|FG000|Overall Study|Lost to Follow-up|31|||
46676530|NCT00190775|82892082|FG001|Overall Study|Lost to Follow-up|23|||
46676531|NCT00190775|82892081|FG000|Overall Study|Participant Moved|0|||
46676532|NCT00190775|82892082|FG001|Overall Study|Participant Moved|1|||
46676533|NCT00190775|82892081|FG000|Overall Study|Withdrawal by Subject|24|||
46676534|NCT00190775|82892082|FG001|Overall Study|Withdrawal by Subject|13|||
46676535|NCT00190775|82892081|FG000|Overall Study|Sponsor Decision|1|||
46676536|NCT00190775|82892082|FG001|Overall Study|Sponsor Decision|0|||
46676537|NCT00190775|82892081|FG000|Overall Study|Physician Decision|3|||
46676538|NCT00190775|82892082|FG001|Overall Study|Physician Decision|0|||
46676539|NCT00190775|82892081|FG000|Overall Study|Noncompliance|3|||
46676540|NCT00190775|82892082|FG001|Overall Study|Noncompliance|5|||
46676541|NCT00190775|82892081|FG000|Overall Study|Protocol Violation|0|||
46676542|NCT00190775|82892082|FG001|Overall Study|Protocol Violation|1|||
46676543|NCT00190775|82892081|FG000|Overall Study|Exclusion Criteria Met|1|||
46676544|NCT00190775|82892082|FG001|Overall Study|Exclusion Criteria Met|3|||
46676545|NCT00199901|82892097|FG000|Overall Study|Protocol Violation|2|||
46676546|NCT00199901|82892098|FG001|Overall Study|Protocol Violation|0|||
46676547|NCT00199901|82892097|FG000|Overall Study|Withdrawal by Subject|1|||
46676548|NCT00199901|82892098|FG001|Overall Study|Withdrawal by Subject|0|||
46676549|NCT00199901|82892097|FG000|Overall Study|Progressive Disease|24|||
46676550|NCT00199901|82892098|FG001|Overall Study|Progressive Disease|24|||
46676551|NCT00198107|82892108|FG000|Double-Blind Period|Adverse Event|1|||
46676552|NCT00198107|82892109|FG001|Double-Blind Period|Adverse Event|1|||
46676553|NCT00198107|82892110|FG002|Double-Blind Period|Adverse Event|0|||
46676554|NCT00198107|82892108|FG000|Double-Blind Period|Lack of Efficacy|2|||
46676555|NCT00198107|82892109|FG001|Double-Blind Period|Lack of Efficacy|0|||
46795646|NCT02581631|83013900|FG003|Overall Study|participant withdrew consent|0|||
46795647|NCT02581631|83013901|FG004|Overall Study|participant withdrew consent|0|||
46795648|NCT02581631|83013897|FG000|Overall Study|Maximum clinical benefit|1|||
46795649|NCT02581631|83013898|FG001|Overall Study|Maximum clinical benefit|7|||
46795650|NCT02581631|83013899|FG002|Overall Study|Maximum clinical benefit|1|||
46795651|NCT02581631|83013900|FG003|Overall Study|Maximum clinical benefit|3|||
46795652|NCT02581631|83013901|FG004|Overall Study|Maximum clinical benefit|13|||
46795653|NCT02581631|83013897|FG000|Overall Study|Other Reasons|1|||
46795654|NCT02581631|83013898|FG001|Overall Study|Other Reasons|0|||
46795655|NCT02581631|83013899|FG002|Overall Study|Other Reasons|2|||
46795656|NCT02581631|83013900|FG003|Overall Study|Other Reasons|2|||
46795657|NCT02581631|83013901|FG004|Overall Study|Other Reasons|3|||
46856806|NCT00323609|83072688|FG001|Overall Study|Physician Decision|0|||
46856807|NCT00323609|83072689|FG002|Overall Study|Physician Decision|0|||
46856808|NCT00323609|83072690|FG003|Overall Study|Physician Decision|1|||
46856809|NCT00323609|83072687|FG000|Overall Study|Withdrawal by Subject|11|||
46676556|NCT00198107|82892110|FG002|Double-Blind Period|Lack of Efficacy|0|||
46676557|NCT00198107|82892108|FG000|Double-Blind Period|Lost to Follow-up|2|||
46676558|NCT00198107|82892109|FG001|Double-Blind Period|Lost to Follow-up|1|||
46676559|NCT00198107|82892110|FG002|Double-Blind Period|Lost to Follow-up|0|||
46676560|NCT00198107|82892108|FG000|Double-Blind Period|Physician Decision|1|||
46676561|NCT00198107|82892109|FG001|Double-Blind Period|Physician Decision|0|||
46676562|NCT00198107|82892110|FG002|Double-Blind Period|Physician Decision|0|||
46676563|NCT00198107|82892108|FG000|Double-Blind Period|Withdrawal by Subject|0|||
46676564|NCT00198107|82892109|FG001|Double-Blind Period|Withdrawal by Subject|1|||
46676565|NCT00198107|82892110|FG002|Double-Blind Period|Withdrawal by Subject|0|||
46676566|NCT00198107|82892108|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
46676567|NCT00198107|82892109|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
46676568|NCT00198107|82892110|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
46676569|NCT00179660|82892118|FG000|Overall Study|Adverse Event|7|||
46676570|NCT00179660|82892118|FG000|Overall Study|Lack of therapeutic effect|28|||
46676571|NCT00179660|82892118|FG000|Overall Study|Withdrawal by Subject|2|||
46676572|NCT00179660|82892118|FG000|Overall Study|Lost to Follow-up|1|||
46676573|NCT00179660|82892118|FG000|Overall Study|Death|3|||
46676574|NCT00179660|82892118|FG000|Overall Study|Other - Unspecified|9|||
46676575|NCT00178256|82892122|FG000|Overall Study|Adverse Event|2|||
46676576|NCT00178256|82892123|FG001|Overall Study|Adverse Event|0|||
46676577|NCT00178256|82892124|FG002|Overall Study|Adverse Event|0|||
46676578|NCT00178256|82892125|FG003|Overall Study|Adverse Event|0|||
46676579|NCT00178256|82892122|FG000|Overall Study|Death|0|||
46676580|NCT00178256|82892123|FG001|Overall Study|Death|1|||
46676581|NCT00178256|82892124|FG002|Overall Study|Death|0|||
46676582|NCT00178256|82892125|FG003|Overall Study|Death|1|||
46676583|NCT00178256|82892122|FG000|Overall Study|Cancer progression|2|||
46676584|NCT00178256|82892123|FG001|Overall Study|Cancer progression|0|||
46676585|NCT00178256|82892124|FG002|Overall Study|Cancer progression|0|||
46676586|NCT00178256|82892125|FG003|Overall Study|Cancer progression|1|||
46676587|NCT00177164|82892134|FG000|Overall Study|Protocol Violation|0|||
46676588|NCT00177164|82892135|FG001|Overall Study|Protocol Violation|7|||
46676589|NCT00177164|82892134|FG000|Overall Study|Lost to Follow-up|4|||
46676590|NCT00177164|82892135|FG001|Overall Study|Lost to Follow-up|5|||
46676591|NCT00177164|82892134|FG000|Overall Study|increase in alcohol and drug use|1|||
46676592|NCT00177164|82892135|FG001|Overall Study|increase in alcohol and drug use|2|||
46676593|NCT00177164|82892134|FG000|Overall Study|Adverse Event|1|||
46676594|NCT00177164|82892135|FG001|Overall Study|Adverse Event|0|||
46676595|NCT00177164|82892134|FG000|Overall Study|discharge from hospital|1|||
46676596|NCT00177164|82892135|FG001|Overall Study|discharge from hospital|0|||
46676597|NCT00177164|82892134|FG000|Overall Study|Lack of Efficacy|2|||
46676598|NCT00177164|82892135|FG001|Overall Study|Lack of Efficacy|1|||
46676599|NCT00177164|82892134|FG000|Overall Study|Pregnancy|0|||
46676600|NCT00177164|82892135|FG001|Overall Study|Pregnancy|1|||
46676601|NCT02489942|82892158|FG000|Overall Study|Request by patient|602|||
46676602|NCT02489942|82892158|FG000|Overall Study|Improvement/remission|157|||
46676603|NCT02489942|82892158|FG000|Overall Study|No change/Progressive disease|263|||
46676604|NCT02489942|82892158|FG000|Overall Study|Adverse Event|522|||
46676605|NCT02489942|82892158|FG000|Overall Study|Other personal reasons|1218|||
46676606|NCT02489942|82892158|FG000|Overall Study|Lost to Follow-up|456|||
46676607|NCT02489942|82892158|FG000|Overall Study|Not continuously investigated|7|||
46676608|NCT02489942|82892158|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
46676609|NCT02489942|82892158|FG000|Overall Study|Multiple registration|1|||
46676610|NCT02489942|82892158|FG000|Overall Study|No patient visit after entry|100|||
46676611|NCT02489942|82892158|FG000|Overall Study|No treatment with Jardiance|2|||
46676612|NCT02489942|82892158|FG000|Overall Study|Patient received Jardiance before registration|1|||
46676613|NCT02489942|82892158|FG000|Overall Study|No CRF collected|86|||
46676614|NCT00176462|82892164|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
46795658|NCT02581631|83013897|FG000|Overall Study|Poor/Non-Compliance|0|||
46795659|NCT02581631|83013898|FG001|Overall Study|Poor/Non-Compliance|0|||
46795660|NCT02581631|83013899|FG002|Overall Study|Poor/Non-Compliance|1|||
46676615|NCT00176462|82892165|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
46676616|NCT00176462|82892164|FG000|Induction (4 Weeks)|Death|1|||
46676617|NCT00176462|82892165|FG001|Induction (4 Weeks)|Death|2|||
46676618|NCT00176462|82892164|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
46676619|NCT00176462|82892165|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
46676620|NCT00176462|82892164|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
46795661|NCT02581631|83013900|FG003|Overall Study|Poor/Non-Compliance|0|||
46795662|NCT02581631|83013901|FG004|Overall Study|Poor/Non-Compliance|0|||
46795663|NCT00529035|83013913|FG000|Overall Study|Withdrawal by Subject|1|||
46795664|NCT04074317|83013930|FG000|Third Period|Withdrawal by Subject|0|||
46795665|NCT04074317|83013931|FG001|Third Period|Withdrawal by Subject|0|||
46676621|NCT00176462|82892165|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
46676622|NCT00176462|82892164|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
46676623|NCT00176462|82892165|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
46676624|NCT00176462|82892164|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
46676625|NCT00176462|82892165|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
46676626|NCT00176462|82892164|FG000|Consolidation (12 Weeks)|Not documented|0|||
46676627|NCT00176462|82892165|FG001|Consolidation (12 Weeks)|Not documented|1|||
46676628|NCT00176462|82892164|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
46676629|NCT00176462|82892165|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
46979561|NCT02589665|83225069|FG009|Induction Extension Period|Reason Not Collected|0|||
46979562|NCT02589665|83225060|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46676630|NCT00176462|82892164|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
46676631|NCT00176462|82892165|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
46676632|NCT00175019|82892175|FG000|Overall Study|Adverse Event|54|||
46676633|NCT00175019|82892176|FG001|Overall Study|Adverse Event|22|||
46676634|NCT00175019|82892177|FG002|Overall Study|Adverse Event|2|||
46676635|NCT00175019|82892175|FG000|Overall Study|Protocol Violation|6|||
46676636|NCT00175019|82892176|FG001|Overall Study|Protocol Violation|3|||
46676637|NCT00175019|82892177|FG002|Overall Study|Protocol Violation|3|||
46676638|NCT00175019|82892175|FG000|Overall Study|Lost to Follow-up|42|||
46676639|NCT00175019|82892176|FG001|Overall Study|Lost to Follow-up|39|||
46676640|NCT00175019|82892177|FG002|Overall Study|Lost to Follow-up|9|||
46676641|NCT00175019|82892175|FG000|Overall Study|Did not continue under Amendment 4|1|||
46676642|NCT00175019|82892176|FG001|Overall Study|Did not continue under Amendment 4|1|||
46676643|NCT00175019|82892177|FG002|Overall Study|Did not continue under Amendment 4|2|||
46676644|NCT00175019|82892175|FG000|Overall Study|Personal Reason(s)|39|||
46676645|NCT00175019|82892176|FG001|Overall Study|Personal Reason(s)|31|||
47081052|NCT01276223|83398180|FG001|Overall Study|Adverse Event|4|||
46676646|NCT00175019|82892177|FG002|Overall Study|Personal Reason(s)|8|||
46676647|NCT00175019|82892175|FG000|Overall Study|Therapeutic Failure|10|||
46676648|NCT00175019|82892176|FG001|Overall Study|Therapeutic Failure|38|||
46856810|NCT00323609|83072688|FG001|Overall Study|Withdrawal by Subject|23|||
47081053|NCT01276223|83398181|FG002|Overall Study|Adverse Event|1|||
47081054|NCT01276223|83398179|FG000|Overall Study|Lost to Follow-up|0|||
47081055|NCT01276223|83398180|FG001|Overall Study|Lost to Follow-up|0|||
47081056|NCT01276223|83398181|FG002|Overall Study|Lost to Follow-up|1|||
47081057|NCT01276223|83398179|FG000|Overall Study|Other|0|||
47081058|NCT01276223|83398180|FG001|Overall Study|Other|0|||
47081059|NCT01276223|83398181|FG002|Overall Study|Other|1|||
47081060|NCT01276223|83398179|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
47081061|NCT01276223|83398180|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
46979563|NCT02589665|83225061|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979564|NCT02589665|83225062|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979565|NCT02589665|83225063|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979566|NCT02589665|83225064|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979567|NCT02589665|83225065|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979568|NCT02589665|83225066|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979569|NCT02589665|83225067|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979570|NCT02589665|83225068|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
46979571|NCT02589665|83225069|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
46979572|NCT02589665|83225060|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
46979573|NCT02589665|83225061|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
46979574|NCT02589665|83225062|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
46979575|NCT02589665|83225063|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
46979576|NCT02589665|83225064|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
46979577|NCT02589665|83225065|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
46979578|NCT02589665|83225066|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
46979579|NCT02589665|83225067|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
46979580|NCT02589665|83225068|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
46979581|NCT02589665|83225069|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
46979582|NCT02589665|83225060|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
46979583|NCT02589665|83225061|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
46979584|NCT02589665|83225062|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
46795666|NCT04074317|83013932|FG002|Third Period|Withdrawal by Subject|0|||
46795667|NCT04074317|83013933|FG003|Third Period|Withdrawal by Subject|1|||
46979585|NCT02589665|83225063|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
47081062|NCT01276223|83398181|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
47081063|NCT01276223|83398179|FG000|Overall Study|Protocol Violation|1|||
47081064|NCT01276223|83398180|FG001|Overall Study|Protocol Violation|0|||
47081065|NCT01276223|83398181|FG002|Overall Study|Protocol Violation|0|||
47081066|NCT01275833|83398190|FG000|Overall Study|Study terminated|1|||
47081067|NCT01275833|83398191|FG001|Overall Study|Study terminated|1|||
47081068|NCT01275755|83398199|FG000|Double-blind Treatment Period|Adverse Event|0|||
47081069|NCT01275755|83398200|FG001|Double-blind Treatment Period|Adverse Event|2|||
47081070|NCT01275755|83398199|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
47081071|NCT01275755|83398200|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
47081072|NCT01275755|83398199|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
47081073|NCT01275755|83398200|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
46856811|NCT00323609|83072689|FG002|Overall Study|Withdrawal by Subject|4|||
46979586|NCT02589665|83225064|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
46979587|NCT02589665|83225065|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
46979588|NCT02589665|83225066|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
46676649|NCT00175019|82892177|FG002|Overall Study|Therapeutic Failure|22|||
46856812|NCT00323609|83072690|FG003|Overall Study|Withdrawal by Subject|4|||
46856813|NCT00323609|83072687|FG000|Overall Study|Other non-VCF-related medical condition|3|||
46676650|NCT00175019|82892175|FG000|Overall Study|Gout Flare|2|||
46676651|NCT00175019|82892176|FG001|Overall Study|Gout Flare|3|||
46676652|NCT00175019|82892177|FG002|Overall Study|Gout Flare|0|||
46676653|NCT00175019|82892175|FG000|Overall Study|Reason Not Specified|40|||
46676654|NCT00175019|82892176|FG001|Overall Study|Reason Not Specified|34|||
46676655|NCT00175019|82892177|FG002|Overall Study|Reason Not Specified|11|||
46676656|NCT00174941|82892188|FG000|Overall Study|Adverse Event|1|||
46676657|NCT00174941|82892189|FG001|Overall Study|Adverse Event|10|||
46676658|NCT00174941|82892190|FG002|Overall Study|Adverse Event|2|||
46676659|NCT00174941|82892191|FG003|Overall Study|Adverse Event|13|||
46676660|NCT00174941|82892188|FG000|Overall Study|Protocol Violation|0|||
46676661|NCT00174941|82892189|FG001|Overall Study|Protocol Violation|1|||
46676662|NCT00174941|82892190|FG002|Overall Study|Protocol Violation|0|||
46676663|NCT00174941|82892191|FG003|Overall Study|Protocol Violation|1|||
46676664|NCT00174941|82892188|FG000|Overall Study|Lost to Follow-up|0|||
46676665|NCT00174941|82892189|FG001|Overall Study|Lost to Follow-up|3|||
46676666|NCT00174941|82892190|FG002|Overall Study|Lost to Follow-up|2|||
46676667|NCT00174941|82892191|FG003|Overall Study|Lost to Follow-up|5|||
46676668|NCT00174941|82892188|FG000|Overall Study|Personal Reason(s)|0|||
46676669|NCT00174941|82892189|FG001|Overall Study|Personal Reason(s)|14|||
46676670|NCT00174941|82892190|FG002|Overall Study|Personal Reason(s)|8|||
46676671|NCT00174941|82892191|FG003|Overall Study|Personal Reason(s)|22|||
46676672|NCT00174941|82892188|FG000|Overall Study|Gout Flare|0|||
46676673|NCT00174941|82892189|FG001|Overall Study|Gout Flare|4|||
46676674|NCT00174941|82892190|FG002|Overall Study|Gout Flare|4|||
46676675|NCT00174941|82892191|FG003|Overall Study|Gout Flare|8|||
46676676|NCT00174941|82892188|FG000|Overall Study|Reason Not Specified|1|||
46676677|NCT00174941|82892189|FG001|Overall Study|Reason Not Specified|6|||
46676678|NCT00174941|82892190|FG002|Overall Study|Reason Not Specified|2|||
46676679|NCT00174941|82892191|FG003|Overall Study|Reason Not Specified|9|||
46676680|NCT00171704|82892203|FG000|Overall Study|Adverse Event|24|||
46676681|NCT00171704|82892204|FG001|Overall Study|Adverse Event|33|||
46795668|NCT04074317|83013934|FG004|Third Period|Withdrawal by Subject|0|||
46795669|NCT04074317|83013935|FG005|Third Period|Withdrawal by Subject|0|||
46676682|NCT00171704|82892203|FG000|Overall Study|Disease Progression|14|||
46676683|NCT00171704|82892204|FG001|Overall Study|Disease Progression|9|||
46676684|NCT00171704|82892203|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
46676685|NCT00171704|82892204|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
46676686|NCT00171704|82892203|FG000|Overall Study|Administrative Problems|2|||
46676687|NCT00171704|82892204|FG001|Overall Study|Administrative Problems|1|||
46676688|NCT00171704|82892203|FG000|Overall Study|Death|2|||
46676689|NCT00171704|82892204|FG001|Overall Study|Death|2|||
46676690|NCT00171704|82892203|FG000|Overall Study|Withdrawal by Subject|1|||
46676691|NCT00171704|82892204|FG001|Overall Study|Withdrawal by Subject|3|||
46676692|NCT00171704|82892203|FG000|Overall Study|Protocol Violation|0|||
46676693|NCT00171704|82892204|FG001|Overall Study|Protocol Violation|1|||
46676694|NCT00171314|82892212|FG000|Overall Study|Adverse Event|44|||
46676695|NCT00171314|82892213|FG001|Overall Study|Adverse Event|41|||
46676696|NCT00171314|82892212|FG000|Overall Study|Lack of Efficacy|19|||
46676697|NCT00171314|82892213|FG001|Overall Study|Lack of Efficacy|14|||
46676698|NCT00171314|82892212|FG000|Overall Study|Withdrawal by Subject|9|||
46676699|NCT00171314|82892213|FG001|Overall Study|Withdrawal by Subject|6|||
46676700|NCT00171314|82892212|FG000|Overall Study|Abnormal Test Procedure Results|9|||
46676701|NCT00171314|82892213|FG001|Overall Study|Abnormal Test Procedure Results|3|||
46676702|NCT00171314|82892212|FG000|Overall Study|Protocol Violation|3|||
46676703|NCT00171314|82892213|FG001|Overall Study|Protocol Violation|7|||
46676704|NCT00171314|82892212|FG000|Overall Study|Administrative Problems|4|||
46676705|NCT00171314|82892213|FG001|Overall Study|Administrative Problems|3|||
46676706|NCT00171314|82892212|FG000|Overall Study|Lost to Follow-up|1|||
46676707|NCT00171314|82892213|FG001|Overall Study|Lost to Follow-up|3|||
46676708|NCT00171314|82892212|FG000|Overall Study|Death|2|||
46676709|NCT00171314|82892213|FG001|Overall Study|Death|1|||
46676710|NCT00171158|82892219|FG000|Core Study|Death|27|||
46676711|NCT00171158|82892219|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
46676712|NCT00171158|82892219|FG000|Core Study|Protocol Violation|4|||
46676713|NCT00171158|82892219|FG000|Core Study|Administrative problems|1|||
46676714|NCT00171158|82892219|FG000|Core Study|Adverse event, non-fatal|21|||
46676715|NCT00171158|82892219|FG000|Core Study|Consent withdrawn by subject|6|||
46676716|NCT00171158|82892219|FG000|Core Study|No longer required drug (BMT)|14|||
46676717|NCT00171158|82892219|FG000|Core Study|Abnormal Laboratory Values|2|||
46676718|NCT00171158|82892219|FG000|Core Study|Lost to Follow-up|1|||
46676719|NCT00171158|82892219|FG000|E2 Extension|Other|7|||
46676720|NCT00170846|82892226|FG000|Overall Study|Subject withdrew Informed Consent|5|||
46676721|NCT00170846|82892227|FG001|Overall Study|Subject withdrew Informed Consent|12|||
46676722|NCT00170846|82892228|FG002|Overall Study|Subject withdrew Informed Consent|8|||
46676723|NCT00170846|82892226|FG000|Overall Study|Lost to Follow-up|6|||
46676724|NCT00170846|82892227|FG001|Overall Study|Lost to Follow-up|3|||
46676725|NCT00170846|82892228|FG002|Overall Study|Lost to Follow-up|2|||
46676726|NCT00170846|82892226|FG000|Overall Study|Death|0|||
46676727|NCT00170846|82892227|FG001|Overall Study|Death|3|||
46676728|NCT00170846|82892228|FG002|Overall Study|Death|3|||
46676729|NCT00170846|82892226|FG000|Overall Study|Reason Missing|0|||
46676730|NCT00170846|82892227|FG001|Overall Study|Reason Missing|1|||
46795670|NCT00609674|83013945|FG000|Overall Study|Adverse Event|1|||
46979589|NCT02589665|83225067|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
46676731|NCT00170846|82892228|FG002|Overall Study|Reason Missing|0|||
46676732|NCT00479882|82892240|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
46676733|NCT00479882|82892241|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
46676734|NCT00479882|82892242|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
46676735|NCT00479882|82892243|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
46676736|NCT00479882|82892240|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
46676737|NCT00479882|82892241|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
46676738|NCT00479882|82892242|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
46795671|NCT00609674|83013946|FG001|Overall Study|Adverse Event|1|||
46856814|NCT00323609|83072688|FG001|Overall Study|Other non-VCF-related medical condition|2|||
46856815|NCT00323609|83072689|FG002|Overall Study|Other non-VCF-related medical condition|0|||
46856816|NCT00323609|83072690|FG003|Overall Study|Other non-VCF-related medical condition|0|||
46856817|NCT00323609|83072687|FG000|Overall Study|Sponsor discontinued trial|29|||
46856818|NCT00323609|83072688|FG001|Overall Study|Sponsor discontinued trial|29|||
46856819|NCT00323609|83072689|FG002|Overall Study|Sponsor discontinued trial|0|||
46856820|NCT00323609|83072690|FG003|Overall Study|Sponsor discontinued trial|0|||
46856821|NCT00323609|83072687|FG000|Overall Study|Unrelenting or severe back pain|1|||
46795672|NCT00609674|83013945|FG000|Overall Study|Protocol Violation|3|||
46795673|NCT00609674|83013946|FG001|Overall Study|Protocol Violation|5|||
46795674|NCT00609674|83013945|FG000|Overall Study|Lost to Follow-up|1|||
46795675|NCT00609674|83013946|FG001|Overall Study|Lost to Follow-up|0|||
46795676|NCT00609674|83013945|FG000|Overall Study|Withdrew consent|2|||
46795677|NCT00609674|83013946|FG001|Overall Study|Withdrew consent|1|||
46979590|NCT02589665|83225068|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
46979591|NCT02589665|83225069|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
46979592|NCT02589665|83225060|FG000|Maintenance Extension Period|Adverse Event|0|||
46979593|NCT02589665|83225061|FG001|Maintenance Extension Period|Adverse Event|0|||
46979594|NCT02589665|83225062|FG002|Maintenance Extension Period|Adverse Event|0|||
46979595|NCT02589665|83225063|FG003|Maintenance Extension Period|Adverse Event|0|||
46795678|NCT00137839|83013952|FG000|Overall Study|Adverse Event|7|||
47081074|NCT01275755|83398199|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
47081075|NCT01275755|83398200|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
47081076|NCT01275131|83398231|FG000|Period 1|Withdrawal by Subject|1|||
47081077|NCT01275131|83398232|FG001|Period 1|Withdrawal by Subject|0|||
47081078|NCT01275131|83398233|FG002|Period 1|Withdrawal by Subject|3|||
47081079|NCT01275131|83398234|FG003|Period 1|Withdrawal by Subject|2|||
47081080|NCT01275131|83398231|FG000|Period 1|Physician Decision|1|||
47081081|NCT01275131|83398232|FG001|Period 1|Physician Decision|0|||
47081082|NCT01275131|83398233|FG002|Period 1|Physician Decision|0|||
47081083|NCT01275131|83398234|FG003|Period 1|Physician Decision|0|||
47081084|NCT01275131|83398231|FG000|Period 2 (Crossover)|Adverse Event|0|||
47081085|NCT01275131|83398232|FG001|Period 2 (Crossover)|Adverse Event|1|||
47081086|NCT01275131|83398233|FG002|Period 2 (Crossover)|Adverse Event|0|||
47081087|NCT01275131|83398234|FG003|Period 2 (Crossover)|Adverse Event|0|||
47081088|NCT01275131|83398231|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
47081089|NCT01275131|83398232|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
47081090|NCT01275131|83398233|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
47081091|NCT01275131|83398234|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
47081092|NCT01274429|83398263|FG000|Overall Study|Study closed do to lack of funding|5|||
46676739|NCT00479882|82892243|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
46676740|NCT00479882|82892240|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
46676741|NCT00479882|82892241|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
46676742|NCT00479882|82892242|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
46676743|NCT00479882|82892243|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
46676744|NCT00479882|82892240|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
46676745|NCT00479882|82892241|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
46676746|NCT00479882|82892242|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
46676747|NCT00479882|82892243|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
46676748|NCT00479882|82892240|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
46676749|NCT00479882|82892241|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
46676750|NCT00479882|82892242|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
46676751|NCT00479882|82892243|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
46676752|NCT00479882|82892240|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
46676753|NCT00479882|82892241|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
46676754|NCT00479882|82892242|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
46676755|NCT00479882|82892243|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
46676756|NCT00479882|82892240|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
46676757|NCT00479882|82892241|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
46676758|NCT00479882|82892242|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
46676759|NCT00479882|82892243|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
46676760|NCT00479882|82892240|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
46676761|NCT00479882|82892241|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
46676762|NCT00479882|82892242|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
46676763|NCT00479882|82892243|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
46676764|NCT00479882|82892240|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
46676765|NCT00479882|82892241|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
46676766|NCT00479882|82892242|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
46676767|NCT00479882|82892243|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
46676768|NCT00479882|82892240|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
46676769|NCT00479882|82892241|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
46676770|NCT00479882|82892242|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
46676771|NCT00479882|82892243|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
46676772|NCT00479882|82892240|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
46676773|NCT00479882|82892241|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
46676774|NCT00479882|82892242|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
46676775|NCT00479882|82892243|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
46795679|NCT00137839|83013952|FG000|Overall Study|Physician Decision|7|||
46795680|NCT00137839|83013952|FG000|Overall Study|Death|8|||
46979596|NCT02589665|83225064|FG004|Maintenance Extension Period|Adverse Event|0|||
47081093|NCT01273883|83398267|FG000|First Intervention|Adverse Event|2|||
47081094|NCT01273883|83398268|FG001|First Intervention|Adverse Event|1|||
47081095|NCT01273883|83398267|FG000|Second Intervention|Lost to Follow-up|1|||
47081096|NCT01273883|83398268|FG001|Second Intervention|Lost to Follow-up|1|||
47081097|NCT01273883|83398267|FG000|Second Intervention|Lack of Efficacy|1|||
47081098|NCT01273883|83398268|FG001|Second Intervention|Lack of Efficacy|0|||
46676776|NCT00479882|82892240|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
46676777|NCT00479882|82892241|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
46676778|NCT00479882|82892242|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
46676779|NCT00479882|82892243|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
46795681|NCT00137839|83013952|FG000|Overall Study|Disease Progression|60|||
46979597|NCT02589665|83225065|FG005|Maintenance Extension Period|Adverse Event|0|||
47081099|NCT01273805|83398276|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
47081100|NCT01273805|83398277|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
47081101|NCT01273181|83398287|FG000|Phase I, Dose 1|Study termination|1|||
47081102|NCT01273181|83398288|FG001|Phase I, Dose 1|Study termination|0|||
47081103|NCT01273181|83398289|FG002|Phase I, Dose 1|Study termination|0|||
46795682|NCT00137839|83013952|FG000|Overall Study|Not Start Treatment|1|||
46795683|NCT00137839|83013952|FG000|Overall Study|Prolonged Treatment Delay|1|||
46979598|NCT02589665|83225066|FG006|Maintenance Extension Period|Adverse Event|0|||
46979599|NCT02589665|83225067|FG007|Maintenance Extension Period|Adverse Event|0|||
46979600|NCT02589665|83225068|FG008|Maintenance Extension Period|Adverse Event|0|||
46979601|NCT02589665|83225069|FG009|Maintenance Extension Period|Adverse Event|2|||
46979602|NCT02589665|83225060|FG000|Maintenance Extension Period|Non-responder|0|||
46979603|NCT02589665|83225061|FG001|Maintenance Extension Period|Non-responder|0|||
46795684|NCT00563316|83013959|FG000|Overall Study|Adverse Event|2|||
46795685|NCT00563316|83013959|FG000|Overall Study|Physician Decision|1|||
46795686|NCT00563316|83013959|FG000|Overall Study|Lost to Follow-up|2|||
46979604|NCT02589665|83225062|FG002|Maintenance Extension Period|Non-responder|0|||
46979605|NCT02589665|83225063|FG003|Maintenance Extension Period|Non-responder|0|||
46979606|NCT02589665|83225064|FG004|Maintenance Extension Period|Non-responder|0|||
46979607|NCT02589665|83225065|FG005|Maintenance Extension Period|Non-responder|0|||
46979608|NCT02589665|83225066|FG006|Maintenance Extension Period|Non-responder|0|||
46979609|NCT02589665|83225067|FG007|Maintenance Extension Period|Non-responder|0|||
46979610|NCT02589665|83225068|FG008|Maintenance Extension Period|Non-responder|0|||
46979611|NCT02589665|83225069|FG009|Maintenance Extension Period|Non-responder|1|||
46979612|NCT01905397|83225095|FG000|Overall Study|Death|0|||
46979613|NCT01905397|83225096|FG001|Overall Study|Death|1|||
46979614|NCT01905397|83225095|FG000|Overall Study|Withdrawal by Subject|2|||
46676780|NCT00479882|82892240|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
46795687|NCT00563316|83013959|FG000|Overall Study|Death|1|||
46795688|NCT00563316|83013959|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
46795689|NCT00563316|83013959|FG000|Overall Study|Other|1|||
46795690|NCT03178487|83013969|FG000|Period 1|Adverse Event|1|||
46979615|NCT01905397|83225096|FG001|Overall Study|Withdrawal by Subject|0|||
46676781|NCT00479882|82892241|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
46676782|NCT00479882|82892242|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
46676783|NCT00479882|82892243|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
46676784|NCT00479882|82892240|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
46676785|NCT00479882|82892241|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
46676786|NCT00479882|82892242|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
46676787|NCT00479882|82892243|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
46676788|NCT00479765|82892269|FG000|Overall Study|study terminated|4|||
46676789|NCT00479687|82892275|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
46676790|NCT00479687|82892276|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
46676791|NCT00479687|82892277|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
46676792|NCT00479687|82892275|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
46795691|NCT03178487|83013970|FG001|Period 1|Adverse Event|2|||
46795692|NCT03178487|83013969|FG000|Period 1|Withdrawal by Subject|2|||
46795693|NCT03178487|83013970|FG001|Period 1|Withdrawal by Subject|1|||
46795694|NCT03178487|83013969|FG000|Period 1|Lost to Follow-up|1|||
46795695|NCT03178487|83013970|FG001|Period 1|Lost to Follow-up|0|||
46676793|NCT00479687|82892276|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
46676794|NCT00479687|82892277|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
46795696|NCT03178487|83013969|FG000|Period 1|Other|0|||
46676795|NCT00479687|82892275|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
46795697|NCT03178487|83013970|FG001|Period 1|Other|1|||
46795698|NCT03178487|83013969|FG000|Period 2|Adverse Event|4|||
46795699|NCT03178487|83013970|FG001|Period 2|Adverse Event|4|||
46795700|NCT03178487|83013969|FG000|Period 2|Withdrawal by Subject|6|||
46795701|NCT03178487|83013970|FG001|Period 2|Withdrawal by Subject|6|||
46795702|NCT03178487|83013969|FG000|Period 2|Lost to Follow-up|2|||
46795703|NCT03178487|83013970|FG001|Period 2|Lost to Follow-up|2|||
46795704|NCT03178487|83013969|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
46795705|NCT03178487|83013970|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
46795706|NCT03178487|83013969|FG000|Period 2|Other|8|||
46795707|NCT03178487|83013970|FG001|Period 2|Other|7|||
46795708|NCT00528957|83013979|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
46795709|NCT00528957|83013980|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
46795710|NCT00528957|83013979|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
46795711|NCT00528957|83013980|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
46795712|NCT00528957|83013979|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
46795713|NCT00528957|83013980|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
46795714|NCT00528957|83013979|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
46795715|NCT00528957|83013980|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
46795716|NCT00528957|83013979|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
46795717|NCT00528957|83013980|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
46795718|NCT00528957|83013979|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
46795719|NCT00528957|83013980|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
46795720|NCT00528957|83013979|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
46795721|NCT00528957|83013980|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
46795722|NCT00528957|83013979|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
46795723|NCT00528957|83013980|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
46979616|NCT01905397|83225095|FG000|Overall Study|Surgery canceled/aborted|9|||
46676796|NCT00479687|82892276|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
46676797|NCT00479687|82892277|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
46676798|NCT00479687|82892275|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
46676799|NCT00479687|82892276|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
46676800|NCT00479687|82892277|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
46795724|NCT00528957|83013979|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
46795725|NCT00528957|83013980|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
46795726|NCT00528957|83013979|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
46795727|NCT00528957|83013980|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
46795728|NCT00528957|83013979|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
46856822|NCT00323609|83072688|FG001|Overall Study|Unrelenting or severe back pain|1|||
46856823|NCT00323609|83072689|FG002|Overall Study|Unrelenting or severe back pain|0|||
46856824|NCT00323609|83072690|FG003|Overall Study|Unrelenting or severe back pain|0|||
46856825|NCT00323609|83072687|FG000|Overall Study|Logistical withdrawal|9|||
46856826|NCT00323609|83072688|FG001|Overall Study|Logistical withdrawal|5|||
46856827|NCT00323609|83072689|FG002|Overall Study|Logistical withdrawal|0|||
46856828|NCT00323609|83072690|FG003|Overall Study|Logistical withdrawal|1|||
46856829|NCT00323609|83072687|FG000|Overall Study|Other reason|11|||
46856830|NCT00323609|83072688|FG001|Overall Study|Other reason|8|||
46856831|NCT00323609|83072689|FG002|Overall Study|Other reason|4|||
46979617|NCT01905397|83225096|FG001|Overall Study|Surgery canceled/aborted|5|||
46795729|NCT00528957|83013980|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
46795730|NCT00528957|83013979|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
46795731|NCT00528957|83013980|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
46795732|NCT00528957|83013979|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
46795733|NCT00528957|83013980|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
46856832|NCT00323609|83072690|FG003|Overall Study|Other reason|9|||
46856833|NCT04598152|83072696|FG000|Overall Study|Lost to Follow-up|0|||
46856834|NCT04598152|83072697|FG001|Overall Study|Lost to Follow-up|1|||
46856835|NCT00323297|83072705|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
46856836|NCT00323297|83072706|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
46979618|NCT01905397|83225095|FG000|Overall Study|Incision < 7 cm|2|||
46979619|NCT01905397|83225096|FG001|Overall Study|Incision < 7 cm|0|||
46979620|NCT01905397|83225095|FG000|Overall Study|Wrong treatment|1|||
47081104|NCT01273181|83398290|FG003|Phase I, Dose 1|Study termination|0|||
47081105|NCT01273181|83398287|FG000|Phase I, Dose 2|Death during treatment|0|||
47081106|NCT01273181|83398288|FG001|Phase I, Dose 2|Death during treatment|1|||
47081107|NCT01273181|83398289|FG002|Phase I, Dose 2|Death during treatment|0|||
47081108|NCT01273181|83398290|FG003|Phase I, Dose 2|Death during treatment|0|||
47081109|NCT01273181|83398287|FG000|Phase 2, Dose 1|Study termination|0|||
47081110|NCT01273181|83398288|FG001|Phase 2, Dose 1|Study termination|0|||
47081111|NCT01273181|83398289|FG002|Phase 2, Dose 1|Study termination|1|||
46856837|NCT00323297|83072705|FG000|Part A (Double Blind Randomized)|Death|0|||
46856838|NCT00323297|83072706|FG001|Part A (Double Blind Randomized)|Death|1|||
46676801|NCT00479687|82892275|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
46676802|NCT00479687|82892276|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
46676803|NCT00479687|82892277|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
46795734|NCT00528957|83013979|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
46795735|NCT00528957|83013980|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
46795736|NCT00528957|83013979|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
46795737|NCT00528957|83013980|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
46795738|NCT00528957|83013979|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
46795739|NCT00528957|83013980|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
46795740|NCT00560508|83013998|FG000|12 Week Double-blind Period|Adverse Event|3|||
46795741|NCT00560508|83013999|FG001|12 Week Double-blind Period|Adverse Event|2|||
46795742|NCT00560508|83013998|FG000|12 Week Double-blind Period|Protocol Violation|1|||
46795743|NCT00560508|83013999|FG001|12 Week Double-blind Period|Protocol Violation|0|||
46795744|NCT00560508|83013998|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
46795745|NCT00560508|83013999|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
46795746|NCT00560508|83013998|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
46795747|NCT00560508|83013999|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
46795748|NCT00560508|83013998|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
46795749|NCT00560508|83013999|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
46795750|NCT00560508|83013998|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
46795751|NCT00560508|83013999|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
46795752|NCT00560508|83013998|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
46795753|NCT00560508|83013999|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
46795754|NCT03962790|83014010|FG000|Period 1|Adverse Event|0|||
46795755|NCT03962790|83014011|FG001|Period 1|Adverse Event|1|||
46795756|NCT03962790|83014010|FG000|Period 1|Failed to meet all eligibility criteria|1|||
46795757|NCT03962790|83014011|FG001|Period 1|Failed to meet all eligibility criteria|1|||
46795758|NCT03962790|83014010|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
46795759|NCT03962790|83014011|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
46795760|NCT03962790|83014010|FG000|Period 1|Withdrawal by Subject|1|||
46795761|NCT03962790|83014011|FG001|Period 1|Withdrawal by Subject|0|||
46795762|NCT00609518|83014019|FG000|Overall Study|Death from Study Disease|32|||
46795763|NCT00609518|83014020|FG001|Overall Study|Death from Study Disease|32|||
46795764|NCT00609518|83014019|FG000|Overall Study|Withdrawal by Subject|5|||
46795765|NCT00609518|83014020|FG001|Overall Study|Withdrawal by Subject|3|||
46795766|NCT00609518|83014019|FG000|Overall Study|Lost to Follow-up|3|||
46795767|NCT00609518|83014020|FG001|Overall Study|Lost to Follow-up|0|||
46795768|NCT00609518|83014019|FG000|Overall Study|Physician Decision|1|||
46856839|NCT00323297|83072705|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
46856840|NCT00323297|83072706|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
46856841|NCT00323297|83072705|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
46856842|NCT00323297|83072706|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
46856843|NCT00323297|83072705|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
46856844|NCT00323297|83072706|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
46856845|NCT00323297|83072705|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
46856846|NCT00323297|83072706|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
46856847|NCT00323297|83072705|FG000|Part B (Open-label)|Death|0|||
46856848|NCT00323297|83072706|FG001|Part B (Open-label)|Death|1|||
46856849|NCT00323297|83072705|FG000|Part B (Open-label)|Reason unspecified|0|||
46795769|NCT00609518|83014020|FG001|Overall Study|Physician Decision|3|||
46795770|NCT00609518|83014019|FG000|Overall Study|Death from Adverse Event|2|||
46795771|NCT00609518|83014020|FG001|Overall Study|Death from Adverse Event|2|||
46795772|NCT00609362|83014028|FG000|Overall Study|Withdrawal by Subject|2|||
46979621|NCT01905397|83225096|FG001|Overall Study|Wrong treatment|1|||
46979622|NCT01905397|83225095|FG000|Overall Study|Device not applied|3|||
46979623|NCT01905397|83225096|FG001|Overall Study|Device not applied|0|||
46676804|NCT00479687|82892275|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
46676805|NCT00479687|82892276|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
46676806|NCT00479687|82892277|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
46979624|NCT01905397|83225095|FG000|Overall Study|Dressing not applied in operating room|1|||
46676807|NCT00479687|82892275|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
46676808|NCT00479687|82892276|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
46676809|NCT00479687|82892277|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
46676810|NCT00479687|82892275|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
46676811|NCT00479687|82892276|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
46676812|NCT00479687|82892277|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
46676813|NCT00479687|82892275|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
46676814|NCT00479687|82892276|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
46676815|NCT00479687|82892277|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
46676816|NCT00479336|82892288|FG000|Overall Study|Adverse Event|1|||
46676817|NCT00479336|82892289|FG001|Overall Study|Adverse Event|1|||
46676818|NCT00479336|82892290|FG002|Overall Study|Adverse Event|1|||
46676819|NCT00479336|82892291|FG003|Overall Study|Adverse Event|3|||
46676820|NCT00479336|82892288|FG000|Overall Study|Lack of Efficacy|1|||
46676821|NCT00479336|82892289|FG001|Overall Study|Lack of Efficacy|0|||
46676822|NCT00479336|82892290|FG002|Overall Study|Lack of Efficacy|0|||
46676823|NCT00479336|82892291|FG003|Overall Study|Lack of Efficacy|0|||
46676824|NCT00479336|82892288|FG000|Overall Study|Protocol Violation|0|||
46676825|NCT00479336|82892289|FG001|Overall Study|Protocol Violation|1|||
46676826|NCT00479336|82892290|FG002|Overall Study|Protocol Violation|0|||
46676827|NCT00479336|82892291|FG003|Overall Study|Protocol Violation|0|||
46676828|NCT00479336|82892288|FG000|Overall Study|Withdrawal by Subject|1|||
46676829|NCT00479336|82892289|FG001|Overall Study|Withdrawal by Subject|2|||
46676830|NCT00479336|82892290|FG002|Overall Study|Withdrawal by Subject|0|||
46676831|NCT00479336|82892291|FG003|Overall Study|Withdrawal by Subject|0|||
46676832|NCT00479336|82892288|FG000|Overall Study|Physician Decision|0|||
46676833|NCT00479336|82892289|FG001|Overall Study|Physician Decision|1|||
46676834|NCT00479336|82892290|FG002|Overall Study|Physician Decision|0|||
46676835|NCT00479336|82892291|FG003|Overall Study|Physician Decision|2|||
46676836|NCT00479336|82892288|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
46676837|NCT00479336|82892289|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
46676838|NCT00479336|82892290|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
46676839|NCT00479336|82892291|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
46676840|NCT00478244|82892301|FG000|Overall Study|Did not receive transplant|1|||
46676841|NCT00478205|82892307|FG000|Overall Study|Adverse Event|182|||
46676842|NCT00478205|82892308|FG001|Overall Study|Adverse Event|39|||
46676843|NCT00478205|82892307|FG000|Overall Study|Medication Non-compliance|9|||
46676844|NCT00478205|82892308|FG001|Overall Study|Medication Non-compliance|4|||
46676845|NCT00478205|82892307|FG000|Overall Study|Protocol Violation|15|||
46676846|NCT00478205|82892308|FG001|Overall Study|Protocol Violation|5|||
46676847|NCT00478205|82892307|FG000|Overall Study|Request of Investigator or Sponsor|4|||
46676848|NCT00478205|82892308|FG001|Overall Study|Request of Investigator or Sponsor|5|||
46676849|NCT00478205|82892307|FG000|Overall Study|Withdrawal by Subject|61|||
46676850|NCT00478205|82892308|FG001|Overall Study|Withdrawal by Subject|22|||
46676851|NCT00478205|82892307|FG000|Overall Study|Lack of Efficacy|1|||
46676852|NCT00478205|82892308|FG001|Overall Study|Lack of Efficacy|0|||
46676853|NCT00478205|82892307|FG000|Overall Study|Other|24|||
46676854|NCT00478205|82892308|FG001|Overall Study|Other|12|||
46676855|NCT00477971|82892316|FG000|Overall Study|Disease progression|6|||
46676856|NCT00477971|82892317|FG001|Overall Study|Disease progression|0|||
46676857|NCT00477971|82892316|FG000|Overall Study|Withdrawal by Subject|3|||
46676858|NCT00477971|82892317|FG001|Overall Study|Withdrawal by Subject|1|||
46676859|NCT00477971|82892316|FG000|Overall Study|Adverse Event|3|||
46676860|NCT00477971|82892317|FG001|Overall Study|Adverse Event|0|||
46676861|NCT00477971|82892316|FG000|Overall Study|Death|2|||
46676862|NCT00477971|82892317|FG001|Overall Study|Death|4|||
46676863|NCT00477971|82892316|FG000|Overall Study|Alternative treatment|3|||
46676864|NCT00477971|82892317|FG001|Overall Study|Alternative treatment|1|||
46676865|NCT00477464|82892323|FG000|Overall Study|Lost to Follow-up|1|||
46676866|NCT00477464|82892323|FG000|Overall Study|Death|36|||
47081112|NCT01273181|83398290|FG003|Phase 2, Dose 1|Study termination|0|||
46676867|NCT00477464|82892323|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
46676868|NCT00477386|82892331|FG000|Overall Study|Adverse Event|4|||
46676869|NCT00477386|82892332|FG001|Overall Study|Adverse Event|8|||
46676870|NCT00477386|82892331|FG000|Overall Study|Disease progression, relapse|3|||
46676871|NCT00477386|82892332|FG001|Overall Study|Disease progression, relapse|4|||
46676872|NCT00477386|82892331|FG000|Overall Study|Disease progression, refractory|1|||
46676873|NCT00477386|82892332|FG001|Overall Study|Disease progression, refractory|3|||
46676874|NCT00477386|82892331|FG000|Overall Study|Other|1|||
46676875|NCT00477386|82892332|FG001|Overall Study|Other|2|||
46676876|NCT00477386|82892331|FG000|Overall Study|Physician Decision|1|||
46676877|NCT00477386|82892332|FG001|Overall Study|Physician Decision|0|||
46676878|NCT00477386|82892331|FG000|Overall Study|Withdrawal by Subject|1|||
46676879|NCT00477386|82892332|FG001|Overall Study|Withdrawal by Subject|0|||
46676880|NCT00477269|82892340|FG000|Core Study|Adverse Event|6|||
46676881|NCT00477269|82892341|FG001|Core Study|Adverse Event|4|||
46676882|NCT00477269|82892342|FG002|Core Study|Adverse Event|0|||
46676883|NCT00477269|82892340|FG000|Core Study|Death|3|||
46676884|NCT00477269|82892341|FG001|Core Study|Death|3|||
46676885|NCT00477269|82892342|FG002|Core Study|Death|0|||
46676886|NCT00477269|82892340|FG000|Core Study|Withdrawn Consent|0|||
46676887|NCT00477269|82892341|FG001|Core Study|Withdrawn Consent|1|||
46676888|NCT00477269|82892342|FG002|Core Study|Withdrawn Consent|0|||
46676889|NCT00477269|82892340|FG000|Open Label Extension|Adverse Event|0|||
46676890|NCT00477269|82892341|FG001|Open Label Extension|Adverse Event|0|||
46676891|NCT00477269|82892342|FG002|Open Label Extension|Adverse Event|4|||
46676892|NCT00477269|82892340|FG000|Open Label Extension|Abnormal laboratory values|0|||
46676893|NCT00477269|82892341|FG001|Open Label Extension|Abnormal laboratory values|0|||
46676894|NCT00477269|82892342|FG002|Open Label Extension|Abnormal laboratory values|1|||
46676895|NCT00477269|82892340|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
46676896|NCT00477269|82892341|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
46676897|NCT00477269|82892342|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
46676898|NCT00477269|82892340|FG000|Open Label Extension|Adminiatrative problems|0|||
46676899|NCT00477269|82892341|FG001|Open Label Extension|Adminiatrative problems|0|||
46676900|NCT00477269|82892342|FG002|Open Label Extension|Adminiatrative problems|2|||
46676901|NCT00477269|82892340|FG000|Open Label Extension|Death|0|||
46676902|NCT00477269|82892341|FG001|Open Label Extension|Death|0|||
46676903|NCT00477269|82892342|FG002|Open Label Extension|Death|4|||
46676904|NCT00477152|82892350|FG000|Overall Study|Parent withdrew consent|2|||
46676905|NCT00477152|82892350|FG000|Overall Study|Adverse Event|1|||
46676906|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
46676907|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
46676908|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
46676909|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
46676910|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
46676911|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
46676912|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
46676913|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
46676914|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
46676915|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
46676916|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
46676917|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
46979625|NCT01905397|83225096|FG001|Overall Study|Dressing not applied in operating room|0|||
46979626|NCT01905397|83225095|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
46676918|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
46676919|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
46676920|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
46676921|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
46676922|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
46676923|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
46676924|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
46676925|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
46676926|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
46979627|NCT01905397|83225096|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
47081113|NCT01273181|83398287|FG000|Phase 2, Dose 2|Death during treatment|0|||
47081114|NCT01273181|83398288|FG001|Phase 2, Dose 2|Death during treatment|0|||
47081115|NCT01273181|83398289|FG002|Phase 2, Dose 2|Death during treatment|0|||
47081116|NCT01273181|83398290|FG003|Phase 2, Dose 2|Death during treatment|1|||
47081117|NCT01272947|83398306|FG000|Overall Study|Abnormal Laboratory Value|2|||
47081118|NCT01272947|83398307|FG001|Overall Study|Abnormal Laboratory Value|2|||
47081119|NCT01279343|83398315|FG000|Overall Study|Did not receive treatment|2|||
47081120|NCT01279343|83398316|FG001|Overall Study|Did not receive treatment|6|||
47081121|NCT01278797|83398322|FG000|Period 1|Adverse Event|0|||
47081122|NCT01278797|83398323|FG001|Period 1|Adverse Event|1|||
46676927|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
46795773|NCT00609362|83014029|FG001|Overall Study|Withdrawal by Subject|1|||
46795774|NCT00609362|83014028|FG000|Overall Study|Adverse Event|1|||
46795775|NCT00609362|83014029|FG001|Overall Study|Adverse Event|0|||
46795776|NCT00611858|83014035|FG000|Overall Study|Adverse Event|2|||
46795777|NCT00611858|83014035|FG000|Overall Study|Withdrawal by Subject|2|||
46795778|NCT00137449|83014043|FG000|Overall Study|Disease Progression|8|||
46795779|NCT00137449|83014044|FG001|Overall Study|Disease Progression|13|||
46795780|NCT00137449|83014043|FG000|Overall Study|Death|4|||
46676928|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
46676929|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
46676930|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
46795781|NCT00137449|83014044|FG001|Overall Study|Death|3|||
46795782|NCT00137449|83014043|FG000|Overall Study|Adverse Event|3|||
46795783|NCT00137449|83014044|FG001|Overall Study|Adverse Event|1|||
46795784|NCT00137449|83014043|FG000|Overall Study|Withdrawal by Subject|1|||
46795785|NCT00137449|83014044|FG001|Overall Study|Withdrawal by Subject|1|||
46856850|NCT00323297|83072706|FG001|Part B (Open-label)|Reason unspecified|1|||
46856851|NCT00323297|83072705|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
46856852|NCT00323297|83072706|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
46795786|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
46795787|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
46856853|NCT00323297|83072705|FG000|Part B (Open-label)|Lack of Efficacy|3|||
46795788|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
46795789|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
47081123|NCT01278797|83398322|FG000|Period 1|Protocol Violation|1|||
47081124|NCT01278797|83398323|FG001|Period 1|Protocol Violation|0|||
47081125|NCT01272869|83398331|FG000|Period 2 (14 Days)|Adverse Event|1|||
47081126|NCT01272869|83398332|FG001|Period 2 (14 Days)|Adverse Event|0|||
47081127|NCT01272635|83398340|FG000|Overall Study|Lost to Follow-up|31|||
47081128|NCT01272635|83398341|FG001|Overall Study|Lost to Follow-up|20|||
47081129|NCT01272635|83398342|FG002|Overall Study|Lost to Follow-up|31|||
47081130|NCT01272635|83398343|FG003|Overall Study|Lost to Follow-up|23|||
47081131|NCT01272011|83398354|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
47081132|NCT01272011|83398355|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
47081133|NCT01272011|83398356|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
47081134|NCT01270841|83398377|FG000|Overall Study|Adverse Event|0|||
47081135|NCT01270841|83398378|FG001|Overall Study|Adverse Event|1|||
47081136|NCT01270841|83398379|FG002|Overall Study|Adverse Event|0|||
47081137|NCT01270841|83398380|FG003|Overall Study|Adverse Event|3|||
47081138|NCT01270841|83398377|FG000|Overall Study|Withdrawal by Subject|3|||
47081139|NCT01270841|83398378|FG001|Overall Study|Withdrawal by Subject|2|||
46856854|NCT00323297|83072706|FG001|Part B (Open-label)|Lack of Efficacy|1|||
46856855|NCT00323297|83072705|FG000|Part B (Open-label)|Adverse Event|5|||
46856856|NCT00323297|83072706|FG001|Part B (Open-label)|Adverse Event|5|||
46856857|NCT00323297|83072705|FG000|Part B (Open-label)|Protocol Violation|0|||
46856858|NCT00323297|83072706|FG001|Part B (Open-label)|Protocol Violation|1|||
46979628|NCT01362595|83225102|FG000|Overall Study|Screen failure|10|||
46979629|NCT01362595|83225102|FG000|Overall Study|Withdrawal by Subject|2|||
46979630|NCT02519595|83225109|FG000|Overall Study|Protocol Violation|8|||
46979631|NCT02519595|83225110|FG001|Overall Study|Protocol Violation|22|||
46979632|NCT02519595|83225111|FG002|Overall Study|Protocol Violation|16|||
46795790|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
46795791|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
46795792|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
46795793|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
46795794|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
46795795|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
46795796|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
46795797|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
46795798|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
46795799|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
46795800|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
46795801|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
46979633|NCT00660673|83225123|FG000|Overall Study|Adverse Event|84|||
46979634|NCT00660673|83225123|FG000|Overall Study|Lack of Efficacy|7|||
46979635|NCT00660673|83225123|FG000|Overall Study|Withdrawal by Subject|22|||
46979636|NCT00660673|83225123|FG000|Overall Study|Administrative|2|||
46676931|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
46676932|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
46676933|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
46676934|NCT00476996|82892357|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
46676935|NCT00476996|82892358|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
46676936|NCT00476996|82892359|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
46676937|NCT00476996|82892360|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
46676938|NCT00476996|82892357|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
46676939|NCT00476996|82892358|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
46676940|NCT00476996|82892359|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
46676941|NCT00476996|82892360|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
46676942|NCT00476996|82892357|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
46676943|NCT00476996|82892358|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
46676944|NCT00476996|82892359|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
46676945|NCT00476996|82892360|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
46676946|NCT00476996|82892357|FG000|OLE Phase (From Week 48)|Death|0|||
46676947|NCT00476996|82892358|FG001|OLE Phase (From Week 48)|Death|0|||
46676948|NCT00476996|82892359|FG002|OLE Phase (From Week 48)|Death|0|||
46676949|NCT00476996|82892360|FG003|OLE Phase (From Week 48)|Death|7|||
46676950|NCT00476996|82892357|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
46676951|NCT00476996|82892358|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
46676952|NCT00476996|82892359|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
46676953|NCT00476996|82892360|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
46676954|NCT00476996|82892357|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
46676955|NCT00476996|82892358|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
46676956|NCT00476996|82892359|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
46676957|NCT00476996|82892360|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
46676958|NCT00476996|82892357|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
46676959|NCT00476996|82892358|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
46676960|NCT00476996|82892359|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
46676961|NCT00476996|82892360|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
46676962|NCT00476996|82892357|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
46676963|NCT00476996|82892358|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
46676964|NCT00476996|82892359|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
46795802|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
46795803|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
46795804|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
46795805|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
46795806|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
46795807|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
46795808|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
46795809|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
46795810|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
46795811|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
46795812|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
46795813|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
46795814|NCT00528879|83014055|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
46795815|NCT00528879|83014056|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
46795816|NCT00528879|83014057|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
46795817|NCT00528879|83014058|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
46795818|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
46795819|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
46795820|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
46795821|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
46795822|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
46795823|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
46795824|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
46795825|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
46795826|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
46795827|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
46795828|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
46795829|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
46795830|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
46795831|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
46795832|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
46795833|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
46795834|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
46795835|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
46795836|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
46795837|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
46795838|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
46795839|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
46795840|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
46795841|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
46795842|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
46795843|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
46795844|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
46795845|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
46856859|NCT00323063|83072714|FG000|Overall Study|Adverse Event|1|||
46979637|NCT00660673|83225123|FG000|Overall Study|Protocol Violation|2|||
46676965|NCT00476996|82892360|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
46676966|NCT00476957|82892371|FG000|Overall Study|Lost to Follow-up|176|||
46676967|NCT00476957|82892372|FG001|Overall Study|Lost to Follow-up|193|||
46676968|NCT00475865|82892381|FG000|Overall Study|Adverse Event|0|||
46676969|NCT00475865|82892382|FG001|Overall Study|Adverse Event|3|||
46676970|NCT00475865|82892383|FG002|Overall Study|Adverse Event|4|||
46676971|NCT00475865|82892381|FG000|Overall Study|Lack of Efficacy|1|||
46676972|NCT00475865|82892382|FG001|Overall Study|Lack of Efficacy|0|||
46676973|NCT00475865|82892383|FG002|Overall Study|Lack of Efficacy|0|||
46676974|NCT00475865|82892381|FG000|Overall Study|Progressive disease|0|||
46676975|NCT00475865|82892382|FG001|Overall Study|Progressive disease|1|||
46676976|NCT00475865|82892383|FG002|Overall Study|Progressive disease|2|||
46676977|NCT00475865|82892381|FG000|Overall Study|Participant did not wish to continue|1|||
46676978|NCT00475865|82892382|FG001|Overall Study|Participant did not wish to continue|0|||
46676979|NCT00475865|82892383|FG002|Overall Study|Participant did not wish to continue|0|||
46676980|NCT00475865|82892381|FG000|Overall Study|Other than above|0|||
46676981|NCT00475865|82892382|FG001|Overall Study|Other than above|1|||
46676982|NCT00475865|82892383|FG002|Overall Study|Other than above|0|||
46676983|NCT00475709|82892393|FG000|Overall Study|Did not meet eligibility criteria|8|||
46795846|NCT00528879|83014055|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
46795847|NCT00528879|83014056|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
46795848|NCT00528879|83014057|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
46795849|NCT00528879|83014058|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
46676984|NCT00475709|82892393|FG000|Overall Study|Death|41|||
46676985|NCT00475709|82892393|FG000|Overall Study|Device Explant|6|||
46676986|NCT00475709|82892393|FG000|Overall Study|Lost to Follow-up|21|||
46795850|NCT00608894|83014070|FG000|Overall Study|Withdrawal by Subject|0|||
46676987|NCT00475670|82892399|FG000|Overall Study|Death|0|||
46856860|NCT00323063|83072715|FG001|Overall Study|Adverse Event|0|||
46676988|NCT00475670|82892400|FG001|Overall Study|Death|1|||
46676989|NCT00475670|82892399|FG000|Overall Study|Lack of Efficacy|3|||
46676990|NCT00475670|82892400|FG001|Overall Study|Lack of Efficacy|34|||
46856861|NCT00323063|83072714|FG000|Overall Study|brain mets discovered prior to treatment|1|||
46856862|NCT00323063|83072715|FG001|Overall Study|brain mets discovered prior to treatment|0|||
46856863|NCT00322049|83072725|FG000|Overall Study|Moved out of area|0|||
46856864|NCT00322049|83072726|FG001|Overall Study|Moved out of area|0|||
46856865|NCT00322049|83072727|FG002|Overall Study|Moved out of area|0|||
46856866|NCT00322049|83072728|FG003|Overall Study|Moved out of area|1|||
46856867|NCT00322049|83072725|FG000|Overall Study|Infected with Dengue during study|0|||
46856868|NCT00322049|83072726|FG001|Overall Study|Infected with Dengue during study|1|||
46856869|NCT00322049|83072727|FG002|Overall Study|Infected with Dengue during study|0|||
46856870|NCT00322049|83072728|FG003|Overall Study|Infected with Dengue during study|0|||
46856871|NCT00321893|83072749|FG000|Overall Study|Non-Compliance/Refusal|16|||
46856872|NCT00321893|83072750|FG001|Overall Study|Non-Compliance/Refusal|10|||
46856873|NCT00321893|83072749|FG000|Overall Study|Lost to Follow-up|2|||
46856874|NCT00321893|83072750|FG001|Overall Study|Lost to Follow-up|1|||
46856875|NCT00321893|83072749|FG000|Overall Study|Adverse Event|6|||
46856876|NCT00321893|83072750|FG001|Overall Study|Adverse Event|3|||
46856877|NCT00371345|83072758|FG000|Overall Study|Disease Progression|21|||
46856878|NCT00371345|83072759|FG001|Overall Study|Disease Progression|35|||
46856879|NCT00371345|83072758|FG000|Overall Study|Study Drug Toxicity|1|||
46856880|NCT00371345|83072759|FG001|Overall Study|Study Drug Toxicity|7|||
46856881|NCT00371345|83072758|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
46856882|NCT00371345|83072759|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
46856883|NCT00371345|83072758|FG000|Overall Study|Participant Request|1|||
46856884|NCT00371345|83072759|FG001|Overall Study|Participant Request|1|||
46856885|NCT00371345|83072758|FG000|Overall Study|Participant Withdrew Consent|0|||
46856886|NCT00371345|83072759|FG001|Overall Study|Participant Withdrew Consent|1|||
46856887|NCT00321737|83072782|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
46856888|NCT00321737|83072783|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
46856889|NCT00321737|83072784|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
46856890|NCT00321737|83072782|FG000|Overall Study|Adverse Event|11|||
46856891|NCT00321737|83072783|FG001|Overall Study|Adverse Event|3|||
46856892|NCT00321737|83072784|FG002|Overall Study|Adverse Event|6|||
46856893|NCT00321737|83072782|FG000|Overall Study|Lost to Follow-up|5|||
46856894|NCT00321737|83072783|FG001|Overall Study|Lost to Follow-up|5|||
46856895|NCT00321737|83072784|FG002|Overall Study|Lost to Follow-up|6|||
46856896|NCT00321737|83072782|FG000|Overall Study|Withdrawal by Subject|19|||
46856897|NCT00321737|83072783|FG001|Overall Study|Withdrawal by Subject|12|||
46856898|NCT00321737|83072784|FG002|Overall Study|Withdrawal by Subject|17|||
46856899|NCT00321737|83072782|FG000|Overall Study|Protocol Violation|0|||
46856900|NCT00321737|83072783|FG001|Overall Study|Protocol Violation|0|||
46856901|NCT00321737|83072784|FG002|Overall Study|Protocol Violation|1|||
46856902|NCT00321737|83072782|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
46856903|NCT00321737|83072783|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
46856904|NCT00321737|83072784|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
46856905|NCT00321737|83072782|FG000|Overall Study|Possible Barrett's Esophagus|2|||
46856906|NCT00321737|83072783|FG001|Overall Study|Possible Barrett's Esophagus|1|||
46856907|NCT00321737|83072784|FG002|Overall Study|Possible Barrett's Esophagus|1|||
46856908|NCT00321737|83072782|FG000|Overall Study|Therapeutic Failure|6|||
46856909|NCT00321737|83072783|FG001|Overall Study|Therapeutic Failure|0|||
46856910|NCT00321737|83072784|FG002|Overall Study|Therapeutic Failure|2|||
46676991|NCT00475670|82892399|FG000|Overall Study|Refused treatment|0|||
46676992|NCT00475670|82892400|FG001|Overall Study|Refused treatment|2|||
46676993|NCT00475670|82892399|FG000|Overall Study|Failure to Return|0|||
46676994|NCT00475670|82892400|FG001|Overall Study|Failure to Return|1|||
46795851|NCT00608894|83014071|FG001|Overall Study|Withdrawal by Subject|2|||
46795852|NCT00557856|83014079|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
46795853|NCT00557856|83014080|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
46795854|NCT00557856|83014081|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
46795855|NCT00557856|83014082|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
46795856|NCT00557856|83014083|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
46795857|NCT00557856|83014084|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
46795858|NCT00557856|83014085|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
46856911|NCT00321737|83072782|FG000|Overall Study|Pregnancy|0|||
46856912|NCT00321737|83072783|FG001|Overall Study|Pregnancy|2|||
46856913|NCT00321737|83072784|FG002|Overall Study|Pregnancy|0|||
46856914|NCT00321737|83072782|FG000|Overall Study|Noncompliance|2|||
46676995|NCT00475670|82892399|FG000|Overall Study|Other|0|||
46856915|NCT00321737|83072783|FG001|Overall Study|Noncompliance|0|||
46856916|NCT00321737|83072784|FG002|Overall Study|Noncompliance|0|||
46856917|NCT00321737|83072782|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
46856918|NCT00321737|83072783|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
46856919|NCT00321737|83072784|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
46856920|NCT00320801|83072794|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
46856921|NCT00320801|83072795|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
46856922|NCT00320801|83072796|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
46856923|NCT00320801|83072797|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
46856924|NCT00320801|83072794|FG000|Open-label Run-in Period|Adverse Event|33|||
46856925|NCT00320801|83072795|FG001|Open-label Run-in Period|Adverse Event|0|||
46856926|NCT00320801|83072796|FG002|Open-label Run-in Period|Adverse Event|0|||
46856927|NCT00320801|83072797|FG003|Open-label Run-in Period|Adverse Event|0|||
46856928|NCT00320801|83072794|FG000|Open-label Run-in Period|Administrative|10|||
46856929|NCT00320801|83072795|FG001|Open-label Run-in Period|Administrative|0|||
46856930|NCT00320801|83072796|FG002|Open-label Run-in Period|Administrative|0|||
46856931|NCT00320801|83072797|FG003|Open-label Run-in Period|Administrative|0|||
46856932|NCT00320801|83072794|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
46856933|NCT00320801|83072795|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
46856934|NCT00320801|83072796|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
46856935|NCT00320801|83072797|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
46856936|NCT00320801|83072794|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
46856937|NCT00320801|83072795|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
46856938|NCT00320801|83072796|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
46856939|NCT00320801|83072797|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
46856940|NCT00320801|83072794|FG000|Open-label Run-in Period|Did not qualify|1|||
46856941|NCT00320801|83072795|FG001|Open-label Run-in Period|Did not qualify|0|||
46856942|NCT00320801|83072796|FG002|Open-label Run-in Period|Did not qualify|0|||
46856943|NCT00320801|83072797|FG003|Open-label Run-in Period|Did not qualify|0|||
46856944|NCT00320801|83072794|FG000|Double-blind Phase|Withdrawal by Subject|0|||
46856945|NCT00320801|83072795|FG001|Double-blind Phase|Withdrawal by Subject|0|||
46856946|NCT00320801|83072796|FG002|Double-blind Phase|Withdrawal by Subject|1|||
46856947|NCT00320801|83072797|FG003|Double-blind Phase|Withdrawal by Subject|0|||
46676996|NCT00475670|82892400|FG001|Overall Study|Other|3|||
46676997|NCT00474968|82892408|FG000|Overall Study|Withdrawal by Subject|8|||
46676998|NCT00474968|82892409|FG001|Overall Study|Withdrawal by Subject|7|||
46676999|NCT00474968|82892408|FG000|Overall Study|Protocol Violation|9|||
46677000|NCT00474968|82892409|FG001|Overall Study|Protocol Violation|8|||
46677001|NCT00474968|82892408|FG000|Overall Study|Sample not collected|1|||
46677002|NCT00474968|82892409|FG001|Overall Study|Sample not collected|1|||
46677003|NCT00474929|82892420|FG000|Overall Study|Withdrawal by Subject|0|||
46677004|NCT00474929|82892421|FG001|Overall Study|Withdrawal by Subject|1|||
46677005|NCT00474929|82892422|FG002|Overall Study|Withdrawal by Subject|0|||
46795859|NCT00557856|83014086|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
46795860|NCT00557856|83014087|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
46795861|NCT00557856|83014079|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
46795862|NCT00557856|83014080|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
46795863|NCT00557856|83014081|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
46795864|NCT00557856|83014082|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
46795865|NCT00557856|83014083|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
46795866|NCT00557856|83014084|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
46795867|NCT00557856|83014085|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
46795868|NCT00557856|83014086|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
46795869|NCT00557856|83014087|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
46795870|NCT00557856|83014079|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
46795871|NCT00557856|83014080|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
46795872|NCT00557856|83014081|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
46795873|NCT00557856|83014082|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
46795874|NCT00557856|83014083|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
46795875|NCT00557856|83014084|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
46795876|NCT00557856|83014085|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
46795877|NCT00557856|83014086|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
46795878|NCT00557856|83014087|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
46795879|NCT00557856|83014079|FG000|Part 1: Dose Escalation Phase|Other|0|||
46795880|NCT00557856|83014080|FG001|Part 1: Dose Escalation Phase|Other|0|||
46795881|NCT00557856|83014081|FG002|Part 1: Dose Escalation Phase|Other|1|||
46795882|NCT00557856|83014082|FG003|Part 1: Dose Escalation Phase|Other|1|||
46795883|NCT00557856|83014083|FG004|Part 1: Dose Escalation Phase|Other|0|||
46795884|NCT00557856|83014084|FG005|Part 1: Dose Escalation Phase|Other|0|||
46795885|NCT00557856|83014085|FG006|Part 1: Dose Escalation Phase|Other|0|||
46795886|NCT00557856|83014086|FG007|Part 1: Dose Escalation Phase|Other|1|||
46795887|NCT00557856|83014087|FG008|Part 1: Dose Escalation Phase|Other|0|||
46795888|NCT00557856|83014079|FG000|Part 1: Dose Escalation Phase|Death|0|||
46795889|NCT00557856|83014080|FG001|Part 1: Dose Escalation Phase|Death|0|||
46795890|NCT00557856|83014081|FG002|Part 1: Dose Escalation Phase|Death|0|||
46856948|NCT00320801|83072794|FG000|Double-blind Phase|Adverse Event|0|||
46856949|NCT00320801|83072795|FG001|Double-blind Phase|Adverse Event|2|||
46856950|NCT00320801|83072796|FG002|Double-blind Phase|Adverse Event|8|||
46856951|NCT00320801|83072797|FG003|Double-blind Phase|Adverse Event|0|||
46677006|NCT00474929|82892423|FG003|Overall Study|Withdrawal by Subject|0|||
46795891|NCT00557856|83014082|FG003|Part 1: Dose Escalation Phase|Death|0|||
46795892|NCT00557856|83014083|FG004|Part 1: Dose Escalation Phase|Death|0|||
46795893|NCT00557856|83014084|FG005|Part 1: Dose Escalation Phase|Death|1|||
46795894|NCT00557856|83014085|FG006|Part 1: Dose Escalation Phase|Death|0|||
46795895|NCT00557856|83014086|FG007|Part 1: Dose Escalation Phase|Death|0|||
46856952|NCT00320801|83072794|FG000|Double-blind Phase|Administrative|0|||
46795896|NCT00557856|83014087|FG008|Part 1: Dose Escalation Phase|Death|0|||
46795897|NCT00557856|83014079|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
46795898|NCT00557856|83014080|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
46795899|NCT00557856|83014081|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
46795900|NCT00557856|83014082|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
46795901|NCT00557856|83014083|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
46979638|NCT02630563|83225138|FG000|Overall Study|Administrative|1|||
46979639|NCT02588339|83225152|FG000|Overall Study|Withdrawal by Subject|1|||
46979640|NCT02588339|83225152|FG000|Overall Study|GVHD Progression prior to treatment|2|||
46979641|NCT02629159|83225159|FG000|Overall Study|Adverse Event|17|||
46979642|NCT02629159|83225160|FG001|Overall Study|Adverse Event|20|||
46677007|NCT00474929|82892424|FG004|Overall Study|Withdrawal by Subject|0|||
46677008|NCT00474929|82892420|FG000|Overall Study|Unrelated medical condition|0|||
46677009|NCT00474929|82892421|FG001|Overall Study|Unrelated medical condition|0|||
46677010|NCT00474929|82892422|FG002|Overall Study|Unrelated medical condition|1|||
46677011|NCT00474929|82892423|FG003|Overall Study|Unrelated medical condition|0|||
46677012|NCT00474929|82892424|FG004|Overall Study|Unrelated medical condition|0|||
46677013|NCT00474929|82892420|FG000|Overall Study|Physician Decision|0|||
46677014|NCT00474929|82892421|FG001|Overall Study|Physician Decision|0|||
46677015|NCT00474929|82892422|FG002|Overall Study|Physician Decision|1|||
46677016|NCT00474929|82892423|FG003|Overall Study|Physician Decision|2|||
46677017|NCT00474929|82892424|FG004|Overall Study|Physician Decision|0|||
46677018|NCT00474812|82892437|FG000|Overall Study|Withdrawal by Subject|5|||
46677019|NCT00474812|82892437|FG000|Overall Study|No Initiation of treatment|2|||
46677020|NCT00474383|82892441|FG000|Main Study|Adverse Event|11|||
46677021|NCT00474383|82892442|FG001|Main Study|Adverse Event|0|||
46677022|NCT00474383|82892441|FG000|Main Study|Symptomatic Deterioration|1|||
46677023|NCT00474383|82892442|FG001|Main Study|Symptomatic Deterioration|0|||
46677024|NCT00474383|82892441|FG000|Main Study|Progressive Disease|23|||
46677025|NCT00474383|82892442|FG001|Main Study|Progressive Disease|0|||
46677026|NCT00474383|82892441|FG000|Main Study|Other|1|||
46677027|NCT00474383|82892442|FG001|Main Study|Other|0|||
46677028|NCT00474383|82892441|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
46677029|NCT00474383|82892442|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
46677030|NCT00474383|82892441|FG000|Extension|Progressive Disease|0|||
46677031|NCT00474383|82892442|FG001|Extension|Progressive Disease|5|||
46677032|NCT00474266|82892450|FG000|Overall Study|Withdrawal by Subject|7|||
46677033|NCT00474266|82892451|FG001|Overall Study|Withdrawal by Subject|20|||
46677034|NCT00474266|82892452|FG002|Overall Study|Withdrawal by Subject|4|||
46677035|NCT00474266|82892453|FG003|Overall Study|Withdrawal by Subject|7|||
46677036|NCT00473564|82892466|FG000|Overall Study|robot surgery aborted in OR|23|||
46677037|NCT00472199|82892472|FG000|Overall Study|Adverse Event|19|||
46677038|NCT00472199|82892473|FG001|Overall Study|Adverse Event|23|||
46677039|NCT00472199|82892472|FG000|Overall Study|Lack of Efficacy|4|||
46677040|NCT00472199|82892473|FG001|Overall Study|Lack of Efficacy|25|||
46677041|NCT00472199|82892472|FG000|Overall Study|Lost to Follow-up|2|||
46677042|NCT00472199|82892473|FG001|Overall Study|Lost to Follow-up|4|||
46677043|NCT00472199|82892472|FG000|Overall Study|Protocol Violation|3|||
46677044|NCT00472199|82892473|FG001|Overall Study|Protocol Violation|2|||
46677045|NCT00472199|82892472|FG000|Overall Study|Withdrawal by Subject|6|||
46795902|NCT00557856|83014084|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
46856953|NCT00320801|83072795|FG001|Double-blind Phase|Administrative|0|||
46979643|NCT02629159|83225161|FG002|Overall Study|Adverse Event|22|||
46795903|NCT00557856|83014085|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
46795904|NCT00557856|83014086|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
46795905|NCT00557856|83014087|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
46795906|NCT00557856|83014079|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
46677046|NCT00472199|82892473|FG001|Overall Study|Withdrawal by Subject|5|||
46677047|NCT00472199|82892472|FG000|Overall Study|personal reason|0|||
46677048|NCT00472199|82892473|FG001|Overall Study|personal reason|1|||
46677049|NCT00472199|82892472|FG000|Overall Study|patient was asymptomatic|1|||
46677050|NCT00472199|82892473|FG001|Overall Study|patient was asymptomatic|0|||
46677051|NCT00472082|82892479|FG000|Overall Study|Study prematurely terminated|5|||
46979644|NCT02629159|83225159|FG000|Overall Study|Withdrawal by Subject|22|||
46979645|NCT02629159|83225160|FG001|Overall Study|Withdrawal by Subject|11|||
46979646|NCT02629159|83225161|FG002|Overall Study|Withdrawal by Subject|15|||
46979647|NCT02629159|83225159|FG000|Overall Study|Lost to Follow-up|7|||
46979648|NCT02629159|83225160|FG001|Overall Study|Lost to Follow-up|4|||
46979649|NCT02629159|83225161|FG002|Overall Study|Lost to Follow-up|5|||
46979650|NCT02629159|83225159|FG000|Overall Study|Lack of Efficacy|4|||
46979651|NCT02629159|83225160|FG001|Overall Study|Lack of Efficacy|0|||
46979652|NCT02629159|83225161|FG002|Overall Study|Lack of Efficacy|1|||
46979653|NCT02629159|83225159|FG000|Overall Study|Other|6|||
47081140|NCT01270841|83398379|FG002|Overall Study|Withdrawal by Subject|3|||
47081141|NCT01270841|83398380|FG003|Overall Study|Withdrawal by Subject|3|||
47081142|NCT01270841|83398377|FG000|Overall Study|Lost to Follow-up|3|||
47081143|NCT01270841|83398378|FG001|Overall Study|Lost to Follow-up|1|||
47081144|NCT01270841|83398379|FG002|Overall Study|Lost to Follow-up|4|||
47081145|NCT01270841|83398380|FG003|Overall Study|Lost to Follow-up|2|||
47081146|NCT01270841|83398377|FG000|Overall Study|Physician Decision|0|||
47081147|NCT01270841|83398378|FG001|Overall Study|Physician Decision|1|||
47081148|NCT01270841|83398379|FG002|Overall Study|Physician Decision|0|||
47081149|NCT01270841|83398380|FG003|Overall Study|Physician Decision|0|||
47081150|NCT01270841|83398377|FG000|Overall Study|Did not qualify|6|||
47081151|NCT01270841|83398378|FG001|Overall Study|Did not qualify|3|||
47081152|NCT01270841|83398379|FG002|Overall Study|Did not qualify|4|||
47081153|NCT01270841|83398380|FG003|Overall Study|Did not qualify|5|||
47081154|NCT01270841|83398377|FG000|Overall Study|Protocol Violation|1|||
47081155|NCT01270841|83398378|FG001|Overall Study|Protocol Violation|5|||
47081156|NCT01270841|83398379|FG002|Overall Study|Protocol Violation|0|||
47081157|NCT01270841|83398380|FG003|Overall Study|Protocol Violation|0|||
47081158|NCT01270841|83398377|FG000|Overall Study|Enrolled in error|0|||
47081159|NCT01270841|83398378|FG001|Overall Study|Enrolled in error|1|||
47081160|NCT01270841|83398379|FG002|Overall Study|Enrolled in error|0|||
47081161|NCT01270841|83398380|FG003|Overall Study|Enrolled in error|0|||
47081162|NCT01270139|83398393|FG000|Overall Study|Adverse Event|8|||
47081163|NCT01270139|83398394|FG001|Overall Study|Adverse Event|17|||
47081164|NCT01270139|83398395|FG002|Overall Study|Adverse Event|18|||
47081165|NCT01270139|83398393|FG000|Overall Study|Lost to Follow-up|10|||
47081166|NCT01270139|83398394|FG001|Overall Study|Lost to Follow-up|9|||
47081167|NCT01270139|83398395|FG002|Overall Study|Lost to Follow-up|2|||
47081168|NCT01278407|83398413|FG000|Confirmatory Phase|Adverse Event|5|||
47081169|NCT01278407|83398414|FG001|Confirmatory Phase|Adverse Event|10|||
47081170|NCT01278407|83398415|FG002|Confirmatory Phase|Adverse Event|1|||
47081171|NCT01278407|83398416|FG003|Confirmatory Phase|Adverse Event|0|||
47081172|NCT01278407|83398417|FG004|Confirmatory Phase|Adverse Event|0|||
46677052|NCT00471887|82892483|FG000|Overall Study|Adverse Event|9|||
46677053|NCT00471536|82892487|FG000|Overall Study|Withdrawal by Subject|1|||
46979654|NCT02629159|83225160|FG001|Overall Study|Other|4|||
46979655|NCT02629159|83225161|FG002|Overall Study|Other|8|||
46979656|NCT02628769|83225172|FG000|First Intervention|Adverse Event|1|||
46979657|NCT02628769|83225173|FG001|First Intervention|Adverse Event|0|||
46979658|NCT02628769|83225172|FG000|First Intervention|Withdrawal by Subject|0|||
46979659|NCT02628769|83225173|FG001|First Intervention|Withdrawal by Subject|1|||
46979660|NCT02628769|83225172|FG000|Second Intervention|Adverse Event|2|||
46979661|NCT02628769|83225173|FG001|Second Intervention|Adverse Event|0|||
46979662|NCT02628769|83225172|FG000|Second Intervention|Physician Decision|0|||
46979663|NCT02628769|83225173|FG001|Second Intervention|Physician Decision|1|||
46979664|NCT02626819|83225181|FG000|Overall Study|Lost to Follow-up|3|||
46979665|NCT02626819|83225182|FG001|Overall Study|Lost to Follow-up|2|||
46979666|NCT02626819|83225181|FG000|Overall Study|Withdrawal by Subject|1|||
46979667|NCT02626819|83225182|FG001|Overall Study|Withdrawal by Subject|0|||
46979668|NCT02626819|83225181|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
46979669|NCT02626819|83225182|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
46979670|NCT02630251|83225192|FG000|Overall Study|Physician Decision|0|||
46979671|NCT02630251|83225193|FG001|Overall Study|Physician Decision|0|||
46979672|NCT02630251|83225194|FG002|Overall Study|Physician Decision|1|||
46979673|NCT02630251|83225195|FG003|Overall Study|Physician Decision|0|||
46979674|NCT02518113|83225209|FG000|Overall Study|Adverse Event|1|||
46979675|NCT02518113|83225210|FG001|Overall Study|Adverse Event|0|||
46979676|NCT02518113|83225211|FG002|Overall Study|Adverse Event|1|||
46979677|NCT02518113|83225212|FG003|Overall Study|Adverse Event|0|||
46979678|NCT02518113|83225209|FG000|Overall Study|Death|1|||
46979679|NCT02518113|83225210|FG001|Overall Study|Death|2|||
46979680|NCT02518113|83225211|FG002|Overall Study|Death|0|||
46979681|NCT02518113|83225212|FG003|Overall Study|Death|0|||
47081173|NCT01278407|83398413|FG000|Confirmatory Phase|Participant's Choice|3|||
47081174|NCT01278407|83398414|FG001|Confirmatory Phase|Participant's Choice|5|||
47081175|NCT01278407|83398415|FG002|Confirmatory Phase|Participant's Choice|3|||
46979682|NCT02518113|83225209|FG000|Overall Study|Physician Decision|0|||
46979683|NCT02518113|83225210|FG001|Overall Study|Physician Decision|1|||
46677054|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
46677055|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
46677056|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Adverse Event|7|||
46677057|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Adverse Event|6|||
46677058|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
46677059|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
46677060|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Physician Decision|4|||
46677061|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Physician Decision|4|||
46677062|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
46677063|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
46677064|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
46677065|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
46677066|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
46677067|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
46677068|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Non-compliance|1|||
46677069|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Non-compliance|0|||
46677070|NCT00470834|82892493|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
46677071|NCT00470834|82892494|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
46677072|NCT00470834|82892493|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
46677073|NCT00470834|82892494|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
46677074|NCT00470834|82892493|FG000|Extension Period (24 Months)|Adverse Event|3|||
46677075|NCT00470834|82892494|FG001|Extension Period (24 Months)|Adverse Event|4|||
46677076|NCT00470834|82892493|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
46677077|NCT00470834|82892494|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
46677078|NCT00470834|82892493|FG000|Extension Period (24 Months)|Physician Decision|4|||
46677079|NCT00470834|82892494|FG001|Extension Period (24 Months)|Physician Decision|3|||
46677080|NCT00470834|82892493|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
46677081|NCT00470834|82892494|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
46677082|NCT00470834|82892493|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
46677083|NCT00470834|82892494|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
46677084|NCT00470834|82892493|FG000|Extension Period (24 Months)|Non-compliance|0|||
46677085|NCT00470834|82892494|FG001|Extension Period (24 Months)|Non-compliance|1|||
46677086|NCT00470834|82892493|FG000|Extension Period (24 Months)|Disease Progression|0|||
46677087|NCT00470834|82892494|FG001|Extension Period (24 Months)|Disease Progression|1|||
46677088|NCT00470366|82892500|FG000|Overall Study|Adverse Event|3|||
46677089|NCT00470366|82892500|FG000|Overall Study|Poor compliance|1|||
46677090|NCT00470093|82892504|FG000|Overall Study|Adverse Event|2|||
46677091|NCT00470054|82892508|FG000|Overall Study|Ineligible|1|||
46677092|NCT00474188|82892512|FG000|Overall Study|Withdrawal by Subject|1|||
46677093|NCT00474188|82892512|FG000|Overall Study|Study discontinued by sponsor|5|||
46677094|NCT00475982|82892517|FG000|Overall Study|surgery rescheduled|7|||
46677095|NCT00475982|82892518|FG001|Overall Study|surgery rescheduled|3|||
46677096|NCT01089647|82892526|FG000|Overall Study|Lost to Follow-up|2|||
46677097|NCT01089647|82892527|FG001|Overall Study|Lost to Follow-up|2|||
46677098|NCT01089647|82892526|FG000|Overall Study|Withdrawal by Subject|2|||
46677099|NCT01089647|82892527|FG001|Overall Study|Withdrawal by Subject|1|||
46677100|NCT01089647|82892526|FG000|Overall Study|Adverse Event|0|||
46677101|NCT01089647|82892527|FG001|Overall Study|Adverse Event|1|||
46677102|NCT01089608|82892535|FG000|Overall Study|Adverse Event|0|||
46677103|NCT01089608|82892536|FG001|Overall Study|Adverse Event|4|||
46677104|NCT01089608|82892535|FG000|Overall Study|Lost to Follow-up|0|||
46677105|NCT01089608|82892536|FG001|Overall Study|Lost to Follow-up|2|||
46677106|NCT01089413|82892545|FG000|Overall Study|Lost to Follow-up|1|||
46677107|NCT01089413|82892545|FG000|Overall Study|Progressive Disease|93|||
46795907|NCT00557856|83014080|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46795908|NCT00557856|83014081|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46795909|NCT00557856|83014082|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46795910|NCT00557856|83014083|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46795911|NCT00557856|83014084|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46979684|NCT02518113|83225211|FG002|Overall Study|Physician Decision|0|||
46979685|NCT02518113|83225212|FG003|Overall Study|Physician Decision|0|||
46979686|NCT02518113|83225209|FG000|Overall Study|Progressive Disease|1|||
46979687|NCT02518113|83225210|FG001|Overall Study|Progressive Disease|2|||
46677108|NCT01089413|82892545|FG000|Overall Study|Participant Withdrew Consent|1|||
46795912|NCT00557856|83014085|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46795913|NCT00557856|83014086|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46795914|NCT00557856|83014087|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
46795915|NCT00557856|83014079|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
46795916|NCT00557856|83014080|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
46979688|NCT02518113|83225211|FG002|Overall Study|Progressive Disease|3|||
46979689|NCT02518113|83225212|FG003|Overall Study|Progressive Disease|0|||
46979690|NCT02629861|83225228|FG000|Overall Study|Adverse Event|7|||
46979691|NCT02629861|83225229|FG001|Overall Study|Adverse Event|5|||
46979692|NCT02629861|83225230|FG002|Overall Study|Adverse Event|4|||
46979693|NCT02629861|83225228|FG000|Overall Study|Withdrawal by Subject|5|||
46979694|NCT02629861|83225229|FG001|Overall Study|Withdrawal by Subject|8|||
46979695|NCT02629861|83225230|FG002|Overall Study|Withdrawal by Subject|13|||
46979696|NCT02629861|83225228|FG000|Overall Study|Protocol Violation|2|||
46979697|NCT02629861|83225229|FG001|Overall Study|Protocol Violation|3|||
46979698|NCT02629861|83225230|FG002|Overall Study|Protocol Violation|7|||
46979699|NCT02629861|83225228|FG000|Overall Study|Lost to Follow-up|12|||
46979700|NCT02629861|83225229|FG001|Overall Study|Lost to Follow-up|9|||
46979701|NCT02629861|83225230|FG002|Overall Study|Lost to Follow-up|4|||
46979702|NCT02629861|83225228|FG000|Overall Study|Other|1|||
46979703|NCT02629861|83225229|FG001|Overall Study|Other|1|||
46795917|NCT00557856|83014081|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
46795918|NCT00557856|83014082|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
46795919|NCT00557856|83014083|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
46795920|NCT00557856|83014084|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
46677109|NCT01089413|82892545|FG000|Overall Study|Unacceptable Toxicity|12|||
46677110|NCT01089413|82892545|FG000|Overall Study|Death|10|||
46677111|NCT01089413|82892545|FG000|Overall Study|Metastasectomy|13|||
46677112|NCT01089413|82892545|FG000|Overall Study|Other|71|||
46677113|NCT01089023|82892555|FG000|Overall Study|Lost to Follow-up|3|||
46677114|NCT01089023|82892555|FG000|Overall Study|Adverse Event|1|||
46677115|NCT01089023|82892555|FG000|Overall Study|Withdrawal by Subject|1|||
46677116|NCT01089023|82892555|FG000|Overall Study|Protocol Violation|1|||
46677117|NCT01089023|82892555|FG000|Overall Study|Lack of Efficacy|1|||
46677118|NCT01088984|82892561|FG000|Phase 1|Death|2|||
46677119|NCT01088984|82892562|FG001|Phase 1|Death|1|||
46677120|NCT01088984|82892561|FG000|Phase 1|Disease Progression|2|||
46677121|NCT01088984|82892562|FG001|Phase 1|Disease Progression|4|||
46677122|NCT01088984|82892561|FG000|Phase 1|Other|1|||
46677123|NCT01088984|82892562|FG001|Phase 1|Other|1|||
46677124|NCT01088984|82892561|FG000|Phase 2|Death|0|||
46677125|NCT01088984|82892562|FG001|Phase 2|Death|5|||
46677126|NCT01088984|82892561|FG000|Phase 2|Withdrawal by Subject|0|||
46677127|NCT01088984|82892562|FG001|Phase 2|Withdrawal by Subject|1|||
46677128|NCT01088984|82892561|FG000|Phase 2|DIsease Progression|0|||
46677129|NCT01088984|82892562|FG001|Phase 2|DIsease Progression|25|||
46677130|NCT01088984|82892561|FG000|Phase 2|Other|0|||
46677131|NCT01088984|82892562|FG001|Phase 2|Other|1|||
46979704|NCT02629861|83225230|FG002|Overall Study|Other|0|||
46979705|NCT02629861|83225228|FG000|Overall Study|Pregnancy|2|||
46677132|NCT01088438|82892573|FG000|Overall Study|Withdrawal by Subject|11|||
46677133|NCT01088438|82892574|FG001|Overall Study|Withdrawal by Subject|6|||
46677134|NCT01088438|82892573|FG000|Overall Study|Lost to Follow-up|18|||
46979706|NCT02629861|83225229|FG001|Overall Study|Pregnancy|1|||
46979707|NCT02629861|83225230|FG002|Overall Study|Pregnancy|0|||
46979708|NCT02482935|83225238|FG000|Period 1|Withdrawal by Subject|1|||
46979709|NCT02482935|83225239|FG001|Period 1|Withdrawal by Subject|0|||
46979710|NCT02513823|83225245|FG000|Overall Study|Lost to Follow-up|4|||
46979711|NCT02513823|83225245|FG000|Overall Study|Physician Decision|1|||
46979712|NCT02513745|83225251|FG000|Overall Study|Criteria at time of surgery not met.|3|||
46979713|NCT02513745|83225252|FG001|Overall Study|Criteria at time of surgery not met.|3|||
46979714|NCT02477553|83225260|FG000|Overall Study|Screening up-to-date|12|||
46979715|NCT02477553|83225261|FG001|Overall Study|Screening up-to-date|13|||
46979716|NCT02477553|83225260|FG000|Overall Study|No MD visit|1|||
46979717|NCT02477553|83225261|FG001|Overall Study|No MD visit|1|||
46979718|NCT02477553|83225260|FG000|Overall Study|Workup consistent w/CRC|1|||
46979719|NCT02477553|83225261|FG001|Overall Study|Workup consistent w/CRC|1|||
46979720|NCT02477553|83225260|FG000|Overall Study|Technical issues with intervention|2|||
46979721|NCT02477553|83225261|FG001|Overall Study|Technical issues with intervention|0|||
47081176|NCT01278407|83398416|FG003|Confirmatory Phase|Participant's Choice|0|||
47081177|NCT01278407|83398417|FG004|Confirmatory Phase|Participant's Choice|0|||
47081178|NCT01278407|83398413|FG000|Confirmatory Phase|Other|1|||
47081179|NCT01278407|83398414|FG001|Confirmatory Phase|Other|1|||
47081180|NCT01278407|83398415|FG002|Confirmatory Phase|Other|2|||
47081181|NCT01278407|83398416|FG003|Confirmatory Phase|Other|0|||
47081182|NCT01278407|83398417|FG004|Confirmatory Phase|Other|0|||
47081183|NCT01278407|83398413|FG000|Extension Phase|Adverse Event|0|||
47081184|NCT01278407|83398414|FG001|Extension Phase|Adverse Event|0|||
47081185|NCT01278407|83398415|FG002|Extension Phase|Adverse Event|0|||
47081186|NCT01278407|83398416|FG003|Extension Phase|Adverse Event|7|||
47081187|NCT01278407|83398417|FG004|Extension Phase|Adverse Event|16|||
47081188|NCT01278407|83398413|FG000|Extension Phase|Participant's Choice|0|||
46979722|NCT02477553|83225260|FG000|Overall Study|Elevated risk for CRC|2|||
47081189|NCT01278407|83398414|FG001|Extension Phase|Participant's Choice|0|||
46795921|NCT00557856|83014085|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
46795922|NCT00557856|83014086|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
46795923|NCT00557856|83014087|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
46677135|NCT01088438|82892574|FG001|Overall Study|Lost to Follow-up|30|||
46677136|NCT01088243|82892582|FG000|Overall Study|Adverse Event|1|||
46677137|NCT01088243|82892583|FG001|Overall Study|Adverse Event|0|||
46677138|NCT01088048|82892599|FG000|Overall Study|Adverse Event|7|||
46677139|NCT01088048|82892600|FG001|Overall Study|Adverse Event|9|||
46677140|NCT01088048|82892601|FG002|Overall Study|Adverse Event|7|||
46677141|NCT01088048|82892602|FG003|Overall Study|Adverse Event|5|||
46677142|NCT01088048|82892603|FG004|Overall Study|Adverse Event|6|||
46677143|NCT01088048|82892604|FG005|Overall Study|Adverse Event|3|||
46677144|NCT01088048|82892605|FG006|Overall Study|Adverse Event|3|||
46677145|NCT01088048|82892606|FG007|Overall Study|Adverse Event|0|||
46677146|NCT01088048|82892607|FG008|Overall Study|Adverse Event|2|||
46677147|NCT01088048|82892608|FG009|Overall Study|Adverse Event|2|||
46677148|NCT01088048|82892599|FG000|Overall Study|Withdrew Consent|1|||
46677149|NCT01088048|82892600|FG001|Overall Study|Withdrew Consent|1|||
46677150|NCT01088048|82892601|FG002|Overall Study|Withdrew Consent|1|||
46677151|NCT01088048|82892602|FG003|Overall Study|Withdrew Consent|1|||
46677152|NCT01088048|82892603|FG004|Overall Study|Withdrew Consent|2|||
46677153|NCT01088048|82892604|FG005|Overall Study|Withdrew Consent|1|||
46677154|NCT01088048|82892605|FG006|Overall Study|Withdrew Consent|0|||
46677155|NCT01088048|82892606|FG007|Overall Study|Withdrew Consent|2|||
46677156|NCT01088048|82892607|FG008|Overall Study|Withdrew Consent|2|||
46677157|NCT01088048|82892608|FG009|Overall Study|Withdrew Consent|1|||
46677158|NCT01088048|82892599|FG000|Overall Study|Concomitant Medication Prohibited|1|||
46677159|NCT01088048|82892600|FG001|Overall Study|Concomitant Medication Prohibited|0|||
46979723|NCT02477553|83225261|FG001|Overall Study|Elevated risk for CRC|2|||
46677160|NCT01088048|82892601|FG002|Overall Study|Concomitant Medication Prohibited|0|||
46677161|NCT01088048|82892602|FG003|Overall Study|Concomitant Medication Prohibited|0|||
46677162|NCT01088048|82892603|FG004|Overall Study|Concomitant Medication Prohibited|0|||
46677163|NCT01088048|82892604|FG005|Overall Study|Concomitant Medication Prohibited|0|||
46677164|NCT01088048|82892605|FG006|Overall Study|Concomitant Medication Prohibited|0|||
46677165|NCT01088048|82892606|FG007|Overall Study|Concomitant Medication Prohibited|0|||
46677166|NCT01088048|82892607|FG008|Overall Study|Concomitant Medication Prohibited|0|||
46677167|NCT01088048|82892608|FG009|Overall Study|Concomitant Medication Prohibited|0|||
46677168|NCT01088048|82892599|FG000|Overall Study|Investigator Request|2|||
46677169|NCT01088048|82892600|FG001|Overall Study|Investigator Request|2|||
46677170|NCT01088048|82892601|FG002|Overall Study|Investigator Request|0|||
46677171|NCT01088048|82892602|FG003|Overall Study|Investigator Request|0|||
46677172|NCT01088048|82892603|FG004|Overall Study|Investigator Request|3|||
46677173|NCT01088048|82892604|FG005|Overall Study|Investigator Request|1|||
46677174|NCT01088048|82892605|FG006|Overall Study|Investigator Request|1|||
46677175|NCT01088048|82892606|FG007|Overall Study|Investigator Request|0|||
46677176|NCT01088048|82892607|FG008|Overall Study|Investigator Request|0|||
47081190|NCT01278407|83398415|FG002|Extension Phase|Participant's Choice|0|||
47081191|NCT01278407|83398416|FG003|Extension Phase|Participant's Choice|4|||
47081192|NCT01278407|83398417|FG004|Extension Phase|Participant's Choice|11|||
47081193|NCT01278407|83398413|FG000|Extension Phase|Other|0|||
47081194|NCT01278407|83398414|FG001|Extension Phase|Other|0|||
47081195|NCT01278407|83398415|FG002|Extension Phase|Other|0|||
47081196|NCT01278407|83398416|FG003|Extension Phase|Other|1|||
47081197|NCT01278407|83398417|FG004|Extension Phase|Other|3|||
47081198|NCT01278173|83398427|FG000|Overall Study|Lack of Efficacy|13|||
47081199|NCT01278173|83398427|FG000|Overall Study|Adverse Event|8|||
47081200|NCT01278173|83398427|FG000|Overall Study|Administrative or other reason|4|||
47081201|NCT01278173|83398427|FG000|Overall Study|Protocol Violation|1|||
47081202|NCT01278173|83398427|FG000|Overall Study|Withdrawal by Subject|1|||
47081203|NCT01277861|83398460|FG000|Overall Study|Physician Decision|2|||
47081204|NCT01277861|83398461|FG001|Overall Study|Physician Decision|2|||
47081205|NCT01277549|83398488|FG000|Overall Study|Failed to meet eligibility criteria|13|||
47081206|NCT01277549|83398489|FG001|Overall Study|Failed to meet eligibility criteria|9|||
47081207|NCT01277549|83398488|FG000|Overall Study|Withdrawal by Subject|1|||
47081208|NCT01277549|83398489|FG001|Overall Study|Withdrawal by Subject|3|||
47081209|NCT01277549|83398488|FG000|Overall Study|Protocol Violation|10|||
47081210|NCT01277549|83398489|FG001|Overall Study|Protocol Violation|1|||
47081211|NCT01277549|83398488|FG000|Overall Study|Physician Decision|2|||
47081212|NCT01277549|83398489|FG001|Overall Study|Physician Decision|1|||
47081213|NCT01276847|83398501|FG000|Overall Study|Withdrawal by Subject|1|||
47081214|NCT01276847|83398502|FG001|Overall Study|Withdrawal by Subject|0|||
47081215|NCT01276847|83398503|FG002|Overall Study|Withdrawal by Subject|0|||
47081216|NCT01276457|83398535|FG000|Core Study|Adverse Event|6|||
46677177|NCT01088048|82892608|FG009|Overall Study|Investigator Request|0|||
46677178|NCT01088048|82892599|FG000|Overall Study|Patient Non-compliance|0|||
46677179|NCT01088048|82892600|FG001|Overall Study|Patient Non-compliance|1|||
46677180|NCT01088048|82892601|FG002|Overall Study|Patient Non-compliance|0|||
46677181|NCT01088048|82892602|FG003|Overall Study|Patient Non-compliance|0|||
46677182|NCT01088048|82892603|FG004|Overall Study|Patient Non-compliance|0|||
46677183|NCT01088048|82892604|FG005|Overall Study|Patient Non-compliance|0|||
46795924|NCT00557856|83014079|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46677184|NCT01088048|82892605|FG006|Overall Study|Patient Non-compliance|0|||
46677185|NCT01088048|82892606|FG007|Overall Study|Patient Non-compliance|0|||
46677186|NCT01088048|82892607|FG008|Overall Study|Patient Non-compliance|0|||
46677187|NCT01088048|82892608|FG009|Overall Study|Patient Non-compliance|0|||
46677188|NCT01088048|82892599|FG000|Overall Study|Disease Progression|7|||
46677189|NCT01088048|82892600|FG001|Overall Study|Disease Progression|4|||
46677190|NCT01088048|82892601|FG002|Overall Study|Disease Progression|3|||
46677191|NCT01088048|82892602|FG003|Overall Study|Disease Progression|5|||
46677192|NCT01088048|82892603|FG004|Overall Study|Disease Progression|3|||
46677193|NCT01088048|82892604|FG005|Overall Study|Disease Progression|3|||
46677194|NCT01088048|82892605|FG006|Overall Study|Disease Progression|2|||
46677195|NCT01088048|82892606|FG007|Overall Study|Disease Progression|1|||
46677196|NCT01088048|82892607|FG008|Overall Study|Disease Progression|0|||
46677197|NCT01088048|82892608|FG009|Overall Study|Disease Progression|0|||
46677198|NCT01088048|82892599|FG000|Overall Study|Death|1|||
46677199|NCT01088048|82892600|FG001|Overall Study|Death|5|||
46677200|NCT01088048|82892601|FG002|Overall Study|Death|3|||
46677201|NCT01088048|82892602|FG003|Overall Study|Death|3|||
46677202|NCT01088048|82892603|FG004|Overall Study|Death|1|||
46677203|NCT01088048|82892604|FG005|Overall Study|Death|3|||
46677204|NCT01088048|82892605|FG006|Overall Study|Death|0|||
46677205|NCT01088048|82892606|FG007|Overall Study|Death|0|||
46677206|NCT01088048|82892607|FG008|Overall Study|Death|3|||
46677207|NCT01088048|82892608|FG009|Overall Study|Death|1|||
46677208|NCT01088048|82892599|FG000|Overall Study|Other|3|||
46677209|NCT01088048|82892600|FG001|Overall Study|Other|5|||
46677210|NCT01088048|82892601|FG002|Overall Study|Other|0|||
46677211|NCT01088048|82892602|FG003|Overall Study|Other|0|||
46677212|NCT01088048|82892603|FG004|Overall Study|Other|2|||
46677213|NCT01088048|82892604|FG005|Overall Study|Other|0|||
46677214|NCT01088048|82892605|FG006|Overall Study|Other|0|||
46677215|NCT01088048|82892606|FG007|Overall Study|Other|2|||
46677216|NCT01088048|82892607|FG008|Overall Study|Other|0|||
46677217|NCT01088048|82892608|FG009|Overall Study|Other|0|||
46677218|NCT01087970|82892641|FG000|Overall Study|Protocol Violation|2|||
46677219|NCT01087814|82892648|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
46677220|NCT01087814|82892649|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
46677221|NCT01087814|82892648|FG000|Second Intervention (5 Days)|Physician Decision|1|||
46677222|NCT01087814|82892649|FG001|Second Intervention (5 Days)|Physician Decision|0|||
46677223|NCT01087775|82892655|FG000|Overall Study|failed inclusion criteria|2|||
46677224|NCT01087502|82892662|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
46677225|NCT01087502|82892663|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
46677226|NCT01087502|82892662|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
46677227|NCT01087502|82892663|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
46677228|NCT01087502|82892662|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
46677229|NCT01087502|82892663|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
46677230|NCT01087502|82892662|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
46677231|NCT01087502|82892663|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
46677232|NCT01087502|82892662|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
46677233|NCT01087502|82892663|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
46677234|NCT01087502|82892662|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
46677235|NCT01087502|82892663|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
46677236|NCT01087502|82892662|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
46677237|NCT01087502|82892663|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
46795925|NCT00557856|83014080|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46795926|NCT00557856|83014081|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46677238|NCT01087502|82892662|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
46677239|NCT01087502|82892663|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
46677240|NCT01087502|82892662|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
46856954|NCT00320801|83072796|FG002|Double-blind Phase|Administrative|4|||
46856955|NCT00320801|83072797|FG003|Double-blind Phase|Administrative|0|||
46856956|NCT00320801|83072794|FG000|Double-blind Phase|Lack of Efficacy|0|||
46856957|NCT00320801|83072795|FG001|Double-blind Phase|Lack of Efficacy|9|||
46856958|NCT00320801|83072796|FG002|Double-blind Phase|Lack of Efficacy|1|||
46856959|NCT00320801|83072797|FG003|Double-blind Phase|Lack of Efficacy|0|||
46856960|NCT00320801|83072794|FG000|Extension Phase|Withdrawal by Subject|0|||
46856961|NCT00320801|83072795|FG001|Extension Phase|Withdrawal by Subject|0|||
46856962|NCT00320801|83072796|FG002|Extension Phase|Withdrawal by Subject|0|||
46856963|NCT00320801|83072797|FG003|Extension Phase|Withdrawal by Subject|6|||
46856964|NCT00320801|83072794|FG000|Extension Phase|Adverse Event|0|||
46856965|NCT00320801|83072795|FG001|Extension Phase|Adverse Event|0|||
46856966|NCT00320801|83072796|FG002|Extension Phase|Adverse Event|0|||
46856967|NCT00320801|83072797|FG003|Extension Phase|Adverse Event|8|||
46856968|NCT00320801|83072794|FG000|Extension Phase|Administrative|0|||
46856969|NCT00320801|83072795|FG001|Extension Phase|Administrative|0|||
46856970|NCT00320801|83072796|FG002|Extension Phase|Administrative|0|||
46856971|NCT00320801|83072797|FG003|Extension Phase|Administrative|29|||
46856972|NCT00320801|83072794|FG000|Extension Phase|Lack of Efficacy|0|||
46856973|NCT00320801|83072795|FG001|Extension Phase|Lack of Efficacy|0|||
46856974|NCT00320801|83072796|FG002|Extension Phase|Lack of Efficacy|0|||
46856975|NCT00320801|83072797|FG003|Extension Phase|Lack of Efficacy|2|||
46856976|NCT00320801|83072794|FG000|Extension Phase|Lost to Follow-up|0|||
46856977|NCT00320801|83072795|FG001|Extension Phase|Lost to Follow-up|0|||
46856978|NCT00320801|83072796|FG002|Extension Phase|Lost to Follow-up|0|||
46856979|NCT00320801|83072797|FG003|Extension Phase|Lost to Follow-up|3|||
46856980|NCT00320489|83072809|FG000|Overall Study|Adverse Event|26|||
46856981|NCT00320489|83072810|FG001|Overall Study|Adverse Event|25|||
46856982|NCT00320489|83072809|FG000|Overall Study|Clinical Relapse|26|||
46856983|NCT00320489|83072810|FG001|Overall Study|Clinical Relapse|20|||
46856984|NCT00320489|83072809|FG000|Overall Study|Death|0|||
46856985|NCT00320489|83072810|FG001|Overall Study|Death|2|||
46856986|NCT00320489|83072809|FG000|Overall Study|Entry Criteria Exclusion|2|||
46677241|NCT01087502|82892663|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
46677242|NCT01087502|82892662|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
46677243|NCT01087502|82892663|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
46856987|NCT00320489|83072810|FG001|Overall Study|Entry Criteria Exclusion|4|||
46856988|NCT00320489|83072809|FG000|Overall Study|Lack of Efficacy|16|||
46856989|NCT00320489|83072810|FG001|Overall Study|Lack of Efficacy|7|||
46856990|NCT00320489|83072809|FG000|Overall Study|Lost to Follow-up|21|||
46856991|NCT00320489|83072810|FG001|Overall Study|Lost to Follow-up|22|||
46856992|NCT00320489|83072809|FG000|Overall Study|Physician Decision|8|||
46856993|NCT00320489|83072810|FG001|Overall Study|Physician Decision|8|||
46856994|NCT00320489|83072809|FG000|Overall Study|Protocol Violation|4|||
46979724|NCT02477553|83225260|FG000|Overall Study|MD advised against screening|1|||
46979725|NCT02477553|83225261|FG001|Overall Study|MD advised against screening|3|||
46979726|NCT02477553|83225260|FG000|Overall Study|patient deceased|1|||
46795927|NCT00557856|83014082|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46795928|NCT00557856|83014083|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46795929|NCT00557856|83014084|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46795930|NCT00557856|83014085|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46795931|NCT00557856|83014086|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
46979727|NCT02477553|83225261|FG001|Overall Study|patient deceased|0|||
46979728|NCT01665911|83225267|FG000|Overall Study|Protocol Violation|4|||
47081217|NCT01276457|83398536|FG001|Core Study|Adverse Event|3|||
47081218|NCT01276457|83398535|FG000|Core Study|Lost to Follow-up|1|||
47081219|NCT01276457|83398536|FG001|Core Study|Lost to Follow-up|2|||
46795932|NCT00557856|83014087|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
46795933|NCT00557856|83014079|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
47081220|NCT01276457|83398535|FG000|Core Study|Administrative problems|1|||
47081221|NCT01276457|83398536|FG001|Core Study|Administrative problems|1|||
47081222|NCT01276457|83398535|FG000|Core Study|Death|2|||
47081223|NCT01276457|83398536|FG001|Core Study|Death|2|||
47081224|NCT01276457|83398535|FG000|Core Study|Lack of Efficacy|3|||
47081225|NCT01276457|83398536|FG001|Core Study|Lack of Efficacy|12|||
47081226|NCT01276457|83398535|FG000|Extension Study|Lost to Follow-up|3|||
47081227|NCT01276457|83398536|FG001|Extension Study|Lost to Follow-up|0|||
47081228|NCT01276457|83398535|FG000|Extension Study|Death|0|||
46979729|NCT01665911|83225267|FG000|Overall Study|Withdrawal by Subject|1|||
47081229|NCT01276457|83398536|FG001|Extension Study|Death|1|||
46795934|NCT00557856|83014080|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
46795935|NCT00557856|83014081|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
46795936|NCT00557856|83014082|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
46856995|NCT00320489|83072810|FG001|Overall Study|Protocol Violation|4|||
47081230|NCT01276457|83398535|FG000|Extension Study|Lack of Efficacy|3|||
47081231|NCT01276457|83398536|FG001|Extension Study|Lack of Efficacy|1|||
47081232|NCT01276379|83398626|FG000|Overall Study|Screening failure|40|||
47081233|NCT03809663|83398922|FG000|Overall Study|Decision by sponsor|24|||
47081234|NCT03809663|83398923|FG001|Overall Study|Decision by sponsor|18|||
47081235|NCT03809663|83398924|FG002|Overall Study|Decision by sponsor|20|||
47081236|NCT03809663|83398925|FG003|Overall Study|Decision by sponsor|20|||
47081237|NCT03809663|83398926|FG004|Overall Study|Decision by sponsor|0|||
47081238|NCT03809663|83398927|FG005|Overall Study|Decision by sponsor|0|||
47081239|NCT03809663|83398922|FG000|Overall Study|Withdrawal by Subject|26|||
47081240|NCT03809663|83398923|FG001|Overall Study|Withdrawal by Subject|22|||
47081241|NCT03809663|83398924|FG002|Overall Study|Withdrawal by Subject|27|||
47081242|NCT03809663|83398925|FG003|Overall Study|Withdrawal by Subject|26|||
47081243|NCT03809663|83398926|FG004|Overall Study|Withdrawal by Subject|0|||
47081244|NCT03809663|83398927|FG005|Overall Study|Withdrawal by Subject|0|||
47081245|NCT03809663|83398922|FG000|Overall Study|Lost to Follow-up|1|||
47081246|NCT03809663|83398923|FG001|Overall Study|Lost to Follow-up|4|||
46795937|NCT00557856|83014083|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
46795938|NCT00557856|83014084|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
46795939|NCT00557856|83014085|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
46795940|NCT00557856|83014086|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
46795941|NCT00557856|83014087|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
46795942|NCT00557856|83014079|FG000|Part 2: Exploratory Phase|Other|0|||
46795943|NCT00557856|83014080|FG001|Part 2: Exploratory Phase|Other|0|||
46795944|NCT00557856|83014081|FG002|Part 2: Exploratory Phase|Other|0|||
46795945|NCT00557856|83014082|FG003|Part 2: Exploratory Phase|Other|0|||
46795946|NCT00557856|83014083|FG004|Part 2: Exploratory Phase|Other|0|||
46795947|NCT00557856|83014084|FG005|Part 2: Exploratory Phase|Other|0|||
46795948|NCT00557856|83014085|FG006|Part 2: Exploratory Phase|Other|0|||
46795949|NCT00557856|83014086|FG007|Part 2: Exploratory Phase|Other|0|||
46795950|NCT00557856|83014087|FG008|Part 2: Exploratory Phase|Other|1|||
46795951|NCT00557856|83014079|FG000|Part 2: Exploratory Phase|Death|0|||
47081247|NCT03809663|83398924|FG002|Overall Study|Lost to Follow-up|1|||
47081248|NCT03809663|83398925|FG003|Overall Study|Lost to Follow-up|1|||
47081249|NCT03809663|83398926|FG004|Overall Study|Lost to Follow-up|0|||
47081250|NCT03809663|83398927|FG005|Overall Study|Lost to Follow-up|0|||
47081251|NCT00249821|83398989|FG000|Overall Study|Technical problem|0|||
47081252|NCT00249821|83398990|FG001|Overall Study|Technical problem|1|||
47081253|NCT00248651|83399065|FG000|Overall Study|Withdrawal by Subject|28|||
47081254|NCT00248651|83399066|FG001|Overall Study|Withdrawal by Subject|40|||
47081255|NCT00248651|83399067|FG002|Overall Study|Withdrawal by Subject|32|||
47081256|NCT00248495|83399104|FG000|Overall Study|Withdrawal by Subject|1|||
47081257|NCT03802565|83399201|FG000|Overall Study|Adverse Event|0|||
47081258|NCT03802565|83399202|FG001|Overall Study|Adverse Event|1|||
47081259|NCT03802565|83399203|FG002|Overall Study|Adverse Event|2|||
47081260|NCT03802565|83399204|FG003|Overall Study|Adverse Event|1|||
47081261|NCT03802565|83399205|FG004|Overall Study|Adverse Event|1|||
47081262|NCT03802565|83399201|FG000|Overall Study|Withdrawal by Subject|2|||
47081263|NCT03802565|83399202|FG001|Overall Study|Withdrawal by Subject|2|||
47081264|NCT03802565|83399203|FG002|Overall Study|Withdrawal by Subject|2|||
47081265|NCT03802565|83399204|FG003|Overall Study|Withdrawal by Subject|0|||
47081266|NCT03802565|83399205|FG004|Overall Study|Withdrawal by Subject|1|||
47081267|NCT03802565|83399201|FG000|Overall Study|Protocol Violation|2|||
47081268|NCT03802565|83399202|FG001|Overall Study|Protocol Violation|1|||
47081269|NCT03802565|83399203|FG002|Overall Study|Protocol Violation|4|||
47081270|NCT03802565|83399204|FG003|Overall Study|Protocol Violation|5|||
47081271|NCT03802565|83399205|FG004|Overall Study|Protocol Violation|1|||
46795952|NCT00557856|83014080|FG001|Part 2: Exploratory Phase|Death|0|||
46795953|NCT00557856|83014081|FG002|Part 2: Exploratory Phase|Death|0|||
46795954|NCT00557856|83014082|FG003|Part 2: Exploratory Phase|Death|0|||
47081272|NCT03802565|83399201|FG000|Overall Study|Lost to Follow-up|0|||
46795955|NCT00557856|83014083|FG004|Part 2: Exploratory Phase|Death|0|||
47081273|NCT03802565|83399202|FG001|Overall Study|Lost to Follow-up|0|||
47081274|NCT03802565|83399203|FG002|Overall Study|Lost to Follow-up|1|||
47081275|NCT03802565|83399204|FG003|Overall Study|Lost to Follow-up|0|||
46677244|NCT01087502|82892662|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
46677245|NCT01087502|82892663|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
46856996|NCT00320489|83072809|FG000|Overall Study|Sponsor Decision|3|||
46677246|NCT01087502|82892662|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
46677247|NCT01087502|82892663|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
46677248|NCT01086410|82892675|FG000|Overall Study|Adverse Event|1|||
46677249|NCT01086410|82892676|FG001|Overall Study|Adverse Event|0|||
46677250|NCT01086410|82892677|FG002|Overall Study|Adverse Event|0|||
46677251|NCT01086410|82892678|FG003|Overall Study|Adverse Event|2|||
46677252|NCT01086410|82892675|FG000|Overall Study|Lack of Efficacy|1|||
46677253|NCT01086410|82892676|FG001|Overall Study|Lack of Efficacy|1|||
46677254|NCT01086410|82892677|FG002|Overall Study|Lack of Efficacy|0|||
46677255|NCT01086410|82892678|FG003|Overall Study|Lack of Efficacy|0|||
46677256|NCT01086410|82892675|FG000|Overall Study|Protocol Violation|1|||
46677257|NCT01086410|82892676|FG001|Overall Study|Protocol Violation|1|||
46677258|NCT01086410|82892677|FG002|Overall Study|Protocol Violation|0|||
46677259|NCT01086410|82892678|FG003|Overall Study|Protocol Violation|0|||
46677260|NCT01086410|82892675|FG000|Overall Study|Lost to Follow-up|0|||
46677261|NCT01086410|82892676|FG001|Overall Study|Lost to Follow-up|0|||
46677262|NCT01086410|82892677|FG002|Overall Study|Lost to Follow-up|1|||
46677263|NCT01086410|82892678|FG003|Overall Study|Lost to Follow-up|0|||
47081276|NCT03802565|83399205|FG004|Overall Study|Lost to Follow-up|0|||
47081277|NCT03802565|83399201|FG000|Overall Study|Subjects Related to Each Other|1|||
47081278|NCT03802565|83399202|FG001|Overall Study|Subjects Related to Each Other|0|||
47081279|NCT03802565|83399203|FG002|Overall Study|Subjects Related to Each Other|0|||
47081280|NCT03802565|83399204|FG003|Overall Study|Subjects Related to Each Other|2|||
47081281|NCT03802565|83399205|FG004|Overall Study|Subjects Related to Each Other|1|||
47081282|NCT03802565|83399201|FG000|Overall Study|Elevated Enzymes|0|||
47081283|NCT03802565|83399202|FG001|Overall Study|Elevated Enzymes|0|||
47081284|NCT03802565|83399203|FG002|Overall Study|Elevated Enzymes|0|||
47081285|NCT03802565|83399204|FG003|Overall Study|Elevated Enzymes|0|||
47081286|NCT03802565|83399205|FG004|Overall Study|Elevated Enzymes|2|||
47081287|NCT00245765|83399249|FG000|Overall Study|Adverse Event|1|||
46677264|NCT04553679|82892690|FG000|Overall Study|Withdrawal by Subject|2|||
46677265|NCT04553679|82892691|FG001|Overall Study|Withdrawal by Subject|0|||
46677266|NCT04553679|82892690|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
46677267|NCT04553679|82892691|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
46677268|NCT01086215|82892705|FG000|Overall Study|Death|14|||
46677269|NCT01086215|82892706|FG001|Overall Study|Death|8|||
46677270|NCT01086215|82892707|FG002|Overall Study|Death|8|||
46677271|NCT01086215|82892708|FG003|Overall Study|Death|1|||
46677272|NCT01086215|82892705|FG000|Overall Study|Lost to Follow-up|22|||
46795956|NCT00557856|83014084|FG005|Part 2: Exploratory Phase|Death|0|||
46677273|NCT01086215|82892706|FG001|Overall Study|Lost to Follow-up|39|||
46677274|NCT01086215|82892707|FG002|Overall Study|Lost to Follow-up|18|||
46677275|NCT01086215|82892708|FG003|Overall Study|Lost to Follow-up|2|||
46677276|NCT01085591|82892721|FG000|Overall Study|Adverse Event|0|||
46677277|NCT01085591|82892722|FG001|Overall Study|Adverse Event|1|||
46856997|NCT00320489|83072810|FG001|Overall Study|Sponsor Decision|3|||
46856998|NCT00320489|83072809|FG000|Overall Study|Withdrawal by Subject|39|||
46677278|NCT01085591|82892723|FG002|Overall Study|Adverse Event|3|||
46677279|NCT01085591|82892721|FG000|Overall Study|Physician Decision|1|||
47081288|NCT00245765|83399250|FG001|Overall Study|Adverse Event|1|||
47081289|NCT00245765|83399251|FG002|Overall Study|Adverse Event|0|||
47081290|NCT00245765|83399249|FG000|Overall Study|Lack of Efficacy|14|||
47081291|NCT00245765|83399250|FG001|Overall Study|Lack of Efficacy|7|||
47081292|NCT00245765|83399251|FG002|Overall Study|Lack of Efficacy|0|||
47081293|NCT00245765|83399249|FG000|Overall Study|Lost to Follow-up|1|||
47081294|NCT00245765|83399250|FG001|Overall Study|Lost to Follow-up|2|||
47081295|NCT00245765|83399251|FG002|Overall Study|Lost to Follow-up|0|||
47081296|NCT00245765|83399249|FG000|Overall Study|Withdrawal by Subject|1|||
47081297|NCT00245765|83399250|FG001|Overall Study|Withdrawal by Subject|0|||
47081298|NCT00245765|83399251|FG002|Overall Study|Withdrawal by Subject|3|||
47081299|NCT00245765|83399249|FG000|Overall Study|Other reason|2|||
46979730|NCT01665911|83225267|FG000|Overall Study|Adverse Event|1|||
46979731|NCT02452359|83225272|FG000|Overall Study|Adverse Event|1|||
46677280|NCT01085591|82892722|FG001|Overall Study|Physician Decision|0|||
46856999|NCT00320489|83072810|FG001|Overall Study|Withdrawal by Subject|41|||
46857000|NCT03928028|83072819|FG000|Overall Study|Physician Decision|9|||
46857001|NCT03928028|83072820|FG001|Overall Study|Physician Decision|6|||
46857002|NCT03928028|83072821|FG002|Overall Study|Physician Decision|3|||
46857003|NCT03928028|83072819|FG000|Overall Study|Withdrawal by Subject|12|||
46857004|NCT03928028|83072820|FG001|Overall Study|Withdrawal by Subject|3|||
46857005|NCT03928028|83072821|FG002|Overall Study|Withdrawal by Subject|3|||
46857006|NCT00320411|83072829|FG000|Overall Study|No investigational product admin.|4|||
46857007|NCT00320255|83072839|FG000|Overall Study|Lack of Efficacy|1|||
46857008|NCT00320255|83072840|FG001|Overall Study|Lack of Efficacy|0|||
46857009|NCT00320255|83072841|FG002|Overall Study|Lack of Efficacy|0|||
46795957|NCT00557856|83014085|FG006|Part 2: Exploratory Phase|Death|0|||
46795958|NCT00557856|83014086|FG007|Part 2: Exploratory Phase|Death|0|||
46795959|NCT00557856|83014087|FG008|Part 2: Exploratory Phase|Death|2|||
46857010|NCT00320255|83072842|FG003|Overall Study|Lack of Efficacy|0|||
46857011|NCT00320255|83072843|FG004|Overall Study|Lack of Efficacy|0|||
46857012|NCT00320255|83072844|FG005|Overall Study|Lack of Efficacy|0|||
46857013|NCT00320255|83072839|FG000|Overall Study|Adverse Event|5|||
46857014|NCT00320255|83072840|FG001|Overall Study|Adverse Event|2|||
46857015|NCT00320255|83072841|FG002|Overall Study|Adverse Event|3|||
46857016|NCT00320255|83072842|FG003|Overall Study|Adverse Event|2|||
46677281|NCT01085591|82892723|FG002|Overall Study|Physician Decision|1|||
46677282|NCT01085591|82892721|FG000|Overall Study|Withdrawal by Subject|0|||
46677283|NCT01085591|82892722|FG001|Overall Study|Withdrawal by Subject|2|||
46677284|NCT01085591|82892723|FG002|Overall Study|Withdrawal by Subject|1|||
46677285|NCT01085591|82892721|FG000|Overall Study|Lost to Follow-up|0|||
46677286|NCT01085591|82892722|FG001|Overall Study|Lost to Follow-up|1|||
46677287|NCT01085591|82892723|FG002|Overall Study|Lost to Follow-up|1|||
46677288|NCT01085591|82892721|FG000|Overall Study|Protocol Violation|1|||
46677289|NCT01085591|82892722|FG001|Overall Study|Protocol Violation|1|||
46677290|NCT01085591|82892723|FG002|Overall Study|Protocol Violation|1|||
46677291|NCT01085591|82892721|FG000|Overall Study|Other|0|||
46677292|NCT01085591|82892722|FG001|Overall Study|Other|1|||
46677293|NCT01085591|82892723|FG002|Overall Study|Other|0|||
46677294|NCT01085591|82892721|FG000|Overall Study|Not Properly Consented|1|||
46677295|NCT01085591|82892722|FG001|Overall Study|Not Properly Consented|0|||
46677296|NCT01085591|82892723|FG002|Overall Study|Not Properly Consented|0|||
46677297|NCT01085357|82892734|FG000|Overall Study|Adverse Event|1|||
46677298|NCT01085357|82892735|FG001|Overall Study|Adverse Event|1|||
46677299|NCT01085357|82892734|FG000|Overall Study|Subject Decision|4|||
46795960|NCT00557856|83014079|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
46795961|NCT00557856|83014080|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
46795962|NCT00557856|83014081|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
46795963|NCT00557856|83014082|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
46857017|NCT00320255|83072843|FG004|Overall Study|Adverse Event|0|||
46857018|NCT00320255|83072844|FG005|Overall Study|Adverse Event|0|||
46857019|NCT00320255|83072839|FG000|Overall Study|Withdrawal by Subject|1|||
46677300|NCT01085357|82892735|FG001|Overall Study|Subject Decision|3|||
46677301|NCT01085357|82892734|FG000|Overall Study|Investigator Decision|1|||
46677302|NCT01085357|82892735|FG001|Overall Study|Investigator Decision|1|||
46677303|NCT01085357|82892734|FG000|Overall Study|Death|11|||
46677304|NCT01085357|82892735|FG001|Overall Study|Death|1|||
46677305|NCT01085357|82892734|FG000|Overall Study|Lost to Follow-up|2|||
46677306|NCT01085357|82892735|FG001|Overall Study|Lost to Follow-up|0|||
46677307|NCT01085201|82892746|FG000|Overall Study|Scheduling conflict|1|||
46677308|NCT01085201|82892747|FG001|Overall Study|Scheduling conflict|0|||
46677309|NCT01085201|82892748|FG002|Overall Study|Scheduling conflict|1|||
46677310|NCT01085201|82892749|FG003|Overall Study|Scheduling conflict|0|||
46677311|NCT01085201|82892750|FG004|Overall Study|Scheduling conflict|0|||
46677312|NCT01085201|82892746|FG000|Overall Study|Unknown- no study drug|2|||
46857020|NCT00320255|83072840|FG001|Overall Study|Withdrawal by Subject|2|||
46677313|NCT01085201|82892747|FG001|Overall Study|Unknown- no study drug|0|||
46677314|NCT01085201|82892748|FG002|Overall Study|Unknown- no study drug|0|||
46979732|NCT02452359|83225272|FG000|Overall Study|Lost to Follow-up|15|||
47081300|NCT00245765|83399250|FG001|Overall Study|Other reason|0|||
46677315|NCT01085201|82892749|FG003|Overall Study|Unknown- no study drug|0|||
46677316|NCT01085201|82892750|FG004|Overall Study|Unknown- no study drug|0|||
46677317|NCT01085201|82892746|FG000|Overall Study|Fond ineligible after consent|0|||
46677318|NCT01085201|82892747|FG001|Overall Study|Fond ineligible after consent|1|||
46677319|NCT01085201|82892748|FG002|Overall Study|Fond ineligible after consent|1|||
46677320|NCT01085201|82892749|FG003|Overall Study|Fond ineligible after consent|0|||
46677321|NCT01085201|82892750|FG004|Overall Study|Fond ineligible after consent|0|||
46677322|NCT01085084|82892770|FG000|Overall Study|Withdrawal by Subject|1|||
46677323|NCT01085084|82892771|FG001|Overall Study|Withdrawal by Subject|0|||
46677324|NCT01085084|82892772|FG002|Overall Study|Withdrawal by Subject|0|||
46677325|NCT01085084|82892770|FG000|Overall Study|Lost to Follow-up|2|||
46677326|NCT01085084|82892771|FG001|Overall Study|Lost to Follow-up|1|||
46677327|NCT01085084|82892772|FG002|Overall Study|Lost to Follow-up|1|||
46677328|NCT01085084|82892770|FG000|Overall Study|Adverse Event|4|||
46677329|NCT01085084|82892771|FG001|Overall Study|Adverse Event|3|||
46677330|NCT01085084|82892772|FG002|Overall Study|Adverse Event|6|||
46677331|NCT01085084|82892770|FG000|Overall Study|Treatment Failure|0|||
46677332|NCT01085084|82892771|FG001|Overall Study|Treatment Failure|1|||
46677333|NCT01085084|82892772|FG002|Overall Study|Treatment Failure|2|||
46677334|NCT01085045|82892780|FG000|Part A|Withdrawal by Subject|4|||
46677335|NCT01085045|82892780|FG000|Part A|Adverse Event|6|||
46677336|NCT01085045|82892780|FG000|Part A|Protocol Violation|1|||
46677337|NCT01085045|82892780|FG000|Part A|Protocol Specified Criteria|7|||
46677338|NCT01085045|82892780|FG000|Part B|Withdrawal by Subject|2|||
46677339|NCT01085045|82892780|FG000|Part B|Protocol Specified Criteria|6|||
46677340|NCT01085045|82892780|FG000|Part B|Lost to Follow-up|1|||
46677341|NCT01085045|82892780|FG000|Part B|Adverse Event|6|||
46677342|NCT01084772|82892802|FG000|Baseline|Withdrawal by Subject|7|||
46677343|NCT01084772|82892803|FG001|Baseline|Withdrawal by Subject|6|||
46677344|NCT01084772|82892802|FG000|3 Months|Death|1|||
46677345|NCT01084772|82892803|FG001|3 Months|Death|0|||
46677346|NCT01084772|82892802|FG000|3 Months|Study Termination|2|||
46677347|NCT01084772|82892803|FG001|3 Months|Study Termination|2|||
46677348|NCT01084772|82892802|FG000|1 Year|Withdrawal by Subject|0|||
46677349|NCT01084772|82892803|FG001|1 Year|Withdrawal by Subject|1|||
46677350|NCT01084772|82892802|FG000|1 Year|Lost to Follow-up|3|||
46677351|NCT01084772|82892803|FG001|1 Year|Lost to Follow-up|0|||
46677352|NCT01084772|82892802|FG000|1 Year|Study Termination|0|||
46677353|NCT01084772|82892803|FG001|1 Year|Study Termination|7|||
46677354|NCT01084772|82892802|FG000|2 Years|Withdrawal by Subject|1|||
47081301|NCT00245765|83399251|FG002|Overall Study|Other reason|1|||
47081302|NCT00245765|83399249|FG000|Overall Study|Other|13|||
47081303|NCT00245765|83399250|FG001|Overall Study|Other|4|||
47081304|NCT00245765|83399251|FG002|Overall Study|Other|4|||
47081305|NCT00245063|83399323|FG000|Overall Study|Adverse Event|6|||
47081306|NCT00245063|83399324|FG001|Overall Study|Adverse Event|5|||
47081307|NCT00245063|83399323|FG000|Overall Study|Death|1|||
47081308|NCT00245063|83399324|FG001|Overall Study|Death|0|||
47081309|NCT04329091|83399389|FG000|Overall Study|Physician Decision|5|||
47081310|NCT00244751|83399396|FG000|Overall Study|Adverse Event|7|||
47081311|NCT00244751|83399397|FG001|Overall Study|Adverse Event|7|||
47081312|NCT00244751|83399398|FG002|Overall Study|Adverse Event|5|||
47081313|NCT00244751|83399396|FG000|Overall Study|Lost to Follow-up|0|||
47081314|NCT00244751|83399397|FG001|Overall Study|Lost to Follow-up|1|||
46677355|NCT01084772|82892803|FG001|2 Years|Withdrawal by Subject|0|||
46677356|NCT01084772|82892802|FG000|2 Years|Lost to Follow-up|5|||
46677357|NCT01084772|82892803|FG001|2 Years|Lost to Follow-up|2|||
46677358|NCT01084772|82892802|FG000|2 Years|Study Termination|3|||
46677359|NCT01084772|82892803|FG001|2 Years|Study Termination|2|||
46677360|NCT00179673|82892809|FG000|Overall Study|Adverse Event|7|||
46677361|NCT00179673|82892809|FG000|Overall Study|Lack of Efficacy|15|||
46677362|NCT00179673|82892809|FG000|Overall Study|Withdrawal by Subject|3|||
46677363|NCT00179673|82892809|FG000|Overall Study|Death|4|||
46677364|NCT00179673|82892809|FG000|Overall Study|Other Observations and options|14|||
46677365|NCT01084655|82892816|FG000|Overall Study|Radiographic disease progression|3|||
47081315|NCT00244751|83399398|FG002|Overall Study|Lost to Follow-up|0|||
46677366|NCT01084655|82892817|FG001|Overall Study|Radiographic disease progression|2|||
46677367|NCT01084655|82892818|FG002|Overall Study|Radiographic disease progression|8|||
46677368|NCT01084655|82892816|FG000|Overall Study|Withdrawal by Subject|1|||
47081316|NCT00244751|83399396|FG000|Overall Study|Protocol Violation|1|||
46677369|NCT01084655|82892817|FG001|Overall Study|Withdrawal by Subject|0|||
46677370|NCT01084655|82892818|FG002|Overall Study|Withdrawal by Subject|4|||
46677371|NCT01084655|82892816|FG000|Overall Study|Adverse Event|2|||
46677372|NCT01084655|82892817|FG001|Overall Study|Adverse Event|1|||
46677373|NCT01084655|82892818|FG002|Overall Study|Adverse Event|2|||
46677374|NCT01084655|82892816|FG000|Overall Study|Other|0|||
46677375|NCT01084655|82892817|FG001|Overall Study|Other|3|||
46677376|NCT01084655|82892818|FG002|Overall Study|Other|2|||
46677377|NCT01084655|82892816|FG000|Overall Study|Symptomatic deterioration|0|||
46677378|NCT01084655|82892817|FG001|Overall Study|Symptomatic deterioration|0|||
46677379|NCT01084655|82892818|FG002|Overall Study|Symptomatic deterioration|2|||
46677380|NCT01084655|82892816|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
46677381|NCT01084655|82892817|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
46677382|NCT01084655|82892818|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
46677383|NCT01084538|82892830|FG000|Overall Study|Drug not available|30|||
46677384|NCT01084538|82892830|FG000|Overall Study|Adverse Event|9|||
46677385|NCT01084538|82892830|FG000|Overall Study|Kidney transplant|6|||
46677386|NCT01084538|82892830|FG000|Overall Study|Serious Adverse Event|3|||
46677387|NCT01084538|82892830|FG000|Overall Study|Lack of effectiveness|2|||
46677388|NCT01084538|82892830|FG000|Overall Study|Patient noncompliance|2|||
46677389|NCT01084538|82892830|FG000|Overall Study|Hyperphosphatemia|2|||
46677390|NCT01084538|82892830|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
46677391|NCT01084538|82892830|FG000|Overall Study|Change of residence|2|||
46677392|NCT01084538|82892830|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
46677393|NCT01084538|82892830|FG000|Overall Study|Reason unknown|8|||
46677394|NCT01083680|82892834|FG000|Overall Study|Lost to Follow-up|2758|||
46677395|NCT01083680|82892834|FG000|Overall Study|Withdrawal by Subject|1086|||
46677396|NCT00179517|82892840|FG000|Overall Study|Withdrawal by Subject|2|||
46677397|NCT00179517|82892841|FG001|Overall Study|Withdrawal by Subject|1|||
46677398|NCT01083641|82892847|FG000|Overall Study|Withdrawal by Subject|2|||
46677399|NCT00179010|82892853|FG000|Overall Study|Muscle probe defective|1|||
46677400|NCT00179010|82892854|FG001|Overall Study|Muscle probe defective|1|||
46677401|NCT00179010|82892853|FG000|Overall Study|Failure to place arterial line|0|||
46677402|NCT00179010|82892854|FG001|Overall Study|Failure to place arterial line|1|||
46677403|NCT01083602|82892861|FG000|Overall Study|Adverse Event|11|||
46677404|NCT01083602|82892861|FG000|Overall Study|New Cancer Therapy|2|||
46677405|NCT01083602|82892861|FG000|Overall Study|Death|1|||
46677406|NCT01083602|82892861|FG000|Overall Study|Withdrawal by Subject|5|||
46677407|NCT01083602|82892861|FG000|Overall Study|Lack of Efficacy|36|||
46677408|NCT00178464|82892865|FG000|Overall Study|Withdrawal by Subject|1|||
46677409|NCT00178464|82892865|FG000|Overall Study|Physician Decision|1|||
46677410|NCT01083485|82892871|FG000|Overall Study|Adverse Event|0|||
46677411|NCT01083485|82892872|FG001|Overall Study|Adverse Event|1|||
46677412|NCT01083485|82892871|FG000|Overall Study|Protocol Violation|1|||
46677413|NCT01083485|82892872|FG001|Overall Study|Protocol Violation|0|||
46677414|NCT01083485|82892871|FG000|Overall Study|Withdrawal by Subject|5|||
46677415|NCT01083485|82892872|FG001|Overall Study|Withdrawal by Subject|2|||
46677416|NCT01083485|82892871|FG000|Overall Study|Other|1|||
46677417|NCT01083485|82892872|FG001|Overall Study|Other|0|||
46677418|NCT01083173|82892880|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
46677419|NCT01083173|82892881|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
46677420|NCT01083173|82892880|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
46677421|NCT01083173|82892881|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
46677422|NCT01083173|82892880|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
46677423|NCT01083173|82892881|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
46677424|NCT01083173|82892880|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
46677425|NCT01083173|82892881|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
46677426|NCT01083173|82892880|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
46677427|NCT01083173|82892881|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
46677428|NCT01083173|82892880|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
46677429|NCT01083173|82892881|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
46979733|NCT02452359|83225272|FG000|Overall Study|Pregnancy|1|||
46795964|NCT00557856|83014083|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
46795965|NCT00557856|83014084|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
46795966|NCT00557856|83014085|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
46677430|NCT01083173|82892880|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
46677431|NCT01083173|82892881|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
46677432|NCT01083173|82892880|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
46677433|NCT01083173|82892881|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
46677434|NCT01083173|82892880|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
46677435|NCT01083173|82892881|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
46677436|NCT01083173|82892880|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
46677437|NCT01083173|82892881|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
46677438|NCT01083173|82892880|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
46677439|NCT01083173|82892881|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
46677440|NCT00177294|82892892|FG000|Overall Study|Withdrawal by Subject|7|||
46677441|NCT00177294|82892893|FG001|Overall Study|Withdrawal by Subject|5|||
46677442|NCT01082081|82892902|FG000|Overall Study|Lost to Follow-up|0|||
46677443|NCT01082081|82892903|FG001|Overall Study|Lost to Follow-up|0|||
46677444|NCT01082081|82892904|FG002|Overall Study|Lost to Follow-up|1|||
46677445|NCT01082081|82892902|FG000|Overall Study|Withdrawal by Subject|0|||
46677446|NCT01082081|82892903|FG001|Overall Study|Withdrawal by Subject|0|||
46795967|NCT00557856|83014086|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
46795968|NCT00557856|83014087|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
46795969|NCT00191113|83014104|FG000|Core Study|Withdrawal by Subject|25|||
46795970|NCT00191113|83014105|FG001|Core Study|Withdrawal by Subject|9|||
46795971|NCT00191113|83014104|FG000|Core Study|Protocol Violation|6|||
46795972|NCT00191113|83014105|FG001|Core Study|Protocol Violation|2|||
46795973|NCT00191113|83014104|FG000|Core Study|Lost to Follow-up|3|||
46795974|NCT00191113|83014105|FG001|Core Study|Lost to Follow-up|0|||
46795975|NCT00191113|83014104|FG000|Core Study|Adverse Event|0|||
46795976|NCT00191113|83014105|FG001|Core Study|Adverse Event|2|||
46795977|NCT00191113|83014104|FG000|Core Study|Lack of Efficacy|0|||
46795978|NCT00191113|83014105|FG001|Core Study|Lack of Efficacy|2|||
46795979|NCT00191113|83014104|FG000|Core Study|Death|1|||
46795980|NCT00191113|83014105|FG001|Core Study|Death|0|||
46795981|NCT00608582|83014119|FG000|Overall Study|Lost to Follow-up|2|||
46795982|NCT00608582|83014120|FG001|Overall Study|Lost to Follow-up|0|||
47081317|NCT00244751|83399397|FG001|Overall Study|Protocol Violation|0|||
47081318|NCT00244751|83399398|FG002|Overall Study|Protocol Violation|1|||
47081319|NCT00244751|83399396|FG000|Overall Study|Withdrawal by Subject|7|||
47081320|NCT00244751|83399397|FG001|Overall Study|Withdrawal by Subject|5|||
47081321|NCT00244751|83399398|FG002|Overall Study|Withdrawal by Subject|3|||
47081322|NCT00244751|83399396|FG000|Overall Study|Elevated liver enzymes|1|||
46795983|NCT00608582|83014119|FG000|Overall Study|No Best Response in Phase 1 located|1|||
46795984|NCT00608582|83014120|FG001|Overall Study|No Best Response in Phase 1 located|1|||
46795985|NCT00608582|83014119|FG000|Overall Study|Illicit Drug Use|1|||
46795986|NCT00608582|83014120|FG001|Overall Study|Illicit Drug Use|0|||
46795987|NCT00608582|83014119|FG000|Overall Study|Early stage Design Change|0|||
46795988|NCT00608582|83014120|FG001|Overall Study|Early stage Design Change|3|||
46795989|NCT03965052|83014130|FG000|Overall Study|Protocol Violation|1|||
47081323|NCT00244751|83399397|FG001|Overall Study|Elevated liver enzymes|0|||
47081324|NCT00244751|83399398|FG002|Overall Study|Elevated liver enzymes|0|||
47081325|NCT00244751|83399396|FG000|Overall Study|Lack of compliance with protocol|0|||
47081326|NCT00244751|83399397|FG001|Overall Study|Lack of compliance with protocol|1|||
47081327|NCT00244751|83399398|FG002|Overall Study|Lack of compliance with protocol|0|||
46795990|NCT03965052|83014131|FG001|Overall Study|Protocol Violation|0|||
46795991|NCT03964974|83014139|FG000|Overall Study|Lost to Follow-up|3|||
46795992|NCT03964974|83014140|FG001|Overall Study|Lost to Follow-up|2|||
46795993|NCT03964974|83014139|FG000|Overall Study|Withdrawal by Subject|0|||
46795994|NCT03964974|83014140|FG001|Overall Study|Withdrawal by Subject|3|||
46857021|NCT00320255|83072841|FG002|Overall Study|Withdrawal by Subject|2|||
46857022|NCT00320255|83072842|FG003|Overall Study|Withdrawal by Subject|4|||
46857023|NCT00320255|83072843|FG004|Overall Study|Withdrawal by Subject|0|||
46857024|NCT00320255|83072844|FG005|Overall Study|Withdrawal by Subject|0|||
46857025|NCT00320255|83072839|FG000|Overall Study|Poor compliance/noncompliance|1|||
46857026|NCT00320255|83072840|FG001|Overall Study|Poor compliance/noncompliance|1|||
46857027|NCT00320255|83072841|FG002|Overall Study|Poor compliance/noncompliance|0|||
46857028|NCT00320255|83072842|FG003|Overall Study|Poor compliance/noncompliance|1|||
46857029|NCT00320255|83072843|FG004|Overall Study|Poor compliance/noncompliance|0|||
46857030|NCT00320255|83072844|FG005|Overall Study|Poor compliance/noncompliance|0|||
46857031|NCT00320255|83072839|FG000|Overall Study|No longer meets study criteria|0|||
46857032|NCT00320255|83072840|FG001|Overall Study|No longer meets study criteria|0|||
46677447|NCT01082081|82892904|FG002|Overall Study|Withdrawal by Subject|1|||
46677448|NCT01082081|82892902|FG000|Overall Study|Other Reason|0|||
46677449|NCT01082081|82892903|FG001|Overall Study|Other Reason|1|||
46677450|NCT01082081|82892904|FG002|Overall Study|Other Reason|0|||
46677451|NCT00177216|82892915|FG000|Overall Study|Withdrawal by Subject|6|||
46677452|NCT00177216|82892916|FG001|Overall Study|Withdrawal by Subject|3|||
46677453|NCT00177216|82892917|FG002|Overall Study|Withdrawal by Subject|1|||
46677454|NCT01081886|82892931|FG000|Overall Study|Study termination|11|||
46677455|NCT01081886|82892932|FG001|Overall Study|Study termination|13|||
46677456|NCT01081769|82892940|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
46677457|NCT01081769|82892941|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
46677458|NCT01081769|82892940|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
46677459|NCT01081769|82892941|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
46677460|NCT01081769|82892940|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
46857033|NCT00320255|83072841|FG002|Overall Study|No longer meets study criteria|0|||
46857034|NCT00320255|83072842|FG003|Overall Study|No longer meets study criteria|1|||
46979734|NCT02452359|83225272|FG000|Overall Study|Withdrawal by Subject|4|||
46979735|NCT02476617|83225276|FG000|Overall Study|Adverse Event|1|||
46979736|NCT02476617|83225276|FG000|Overall Study|Lost to Follow-up|1|||
46677461|NCT01081769|82892941|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
46979737|NCT01665599|83225293|FG000|Overall Study|Adverse Event|1|||
46979738|NCT01665599|83225293|FG000|Overall Study|Consent Withdrawn|1|||
46677462|NCT01081769|82892940|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
46677463|NCT01081769|82892941|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
46677464|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Adverse Event|14|||
46677465|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Adverse Event|11|||
46677466|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Death|1|||
46677467|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Death|1|||
46677468|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
46857035|NCT00320255|83072843|FG004|Overall Study|No longer meets study criteria|0|||
46677469|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
46677470|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
46979739|NCT01665599|83225293|FG000|Overall Study|Investigator/Sponsor decision|1|||
46677471|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
46677472|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Pregnancy|1|||
46795995|NCT00606320|83014146|FG000|Overall Study|Adverse Event|3|||
46795996|NCT00606320|83014146|FG000|Overall Study|Lack of Efficacy|5|||
46795997|NCT00606320|83014146|FG000|Overall Study|Physician Decision|7|||
46795998|NCT00606320|83014146|FG000|Overall Study|Protocol Violation|8|||
46795999|NCT00606320|83014146|FG000|Overall Study|Withdrawal by Subject|10|||
46796000|NCT00606320|83014146|FG000|Overall Study|Progression to depressive phase|4|||
46796001|NCT00528411|83014153|FG000|Overall Study|Adverse Event|4|||
46796002|NCT00528411|83014154|FG001|Overall Study|Adverse Event|0|||
46796003|NCT00528411|83014155|FG002|Overall Study|Adverse Event|1|||
46796004|NCT00528411|83014153|FG000|Overall Study|Incorrect Enrolment|1|||
46796005|NCT00528411|83014154|FG001|Overall Study|Incorrect Enrolment|1|||
46796006|NCT00528411|83014155|FG002|Overall Study|Incorrect Enrolment|0|||
46796007|NCT00528411|83014153|FG000|Overall Study|Severe non-compliance to protocol|0|||
46796008|NCT00528411|83014154|FG001|Overall Study|Severe non-compliance to protocol|1|||
46857036|NCT00320255|83072844|FG005|Overall Study|No longer meets study criteria|0|||
47081328|NCT00244751|83399396|FG000|Overall Study|Safety reasons|0|||
47081329|NCT00244751|83399397|FG001|Overall Study|Safety reasons|1|||
47081330|NCT00244751|83399398|FG002|Overall Study|Safety reasons|0|||
47081331|NCT00244751|83399396|FG000|Overall Study|Participant randomized by mistake|0|||
47081332|NCT00244751|83399397|FG001|Overall Study|Participant randomized by mistake|0|||
47081333|NCT00244751|83399398|FG002|Overall Study|Participant randomized by mistake|1|||
47081334|NCT00243659|83399440|FG000|Overall Study|Withdrawal by Subject|1|||
47081335|NCT00243659|83399441|FG001|Overall Study|Withdrawal by Subject|1|||
47081336|NCT00243659|83399440|FG000|Overall Study|Protocol Violation|1|||
47081337|NCT00243659|83399441|FG001|Overall Study|Protocol Violation|2|||
47081338|NCT00243347|83399456|FG000|Overall Study|Lack of Efficacy|4|||
47081339|NCT00243347|83399456|FG000|Overall Study|Adverse Event|2|||
47081340|NCT00243347|83399456|FG000|Overall Study|Death|1|||
47081341|NCT00243347|83399456|FG000|Overall Study|Withdrawal by Subject|5|||
47081342|NCT00243347|83399456|FG000|Overall Study|Condition worsened|7|||
47081343|NCT00243269|83399464|FG000|Overall Study|Protocol Violation|2|||
47081344|NCT00243269|83399465|FG001|Overall Study|Protocol Violation|1|||
47081345|NCT00243269|83399466|FG002|Overall Study|Protocol Violation|0|||
46677473|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Pregnancy|0|||
46677474|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
46677475|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
46677476|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
46677477|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
46677478|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Other|0|||
46677479|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Other|1|||
46677480|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Ineligibility|3|||
46677481|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Ineligibility|4|||
46677482|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
46677483|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
46677484|NCT01081769|82892940|FG000|CORE Intent-To-Treat|Patient Moved|2|||
46677485|NCT01081769|82892941|FG001|CORE Intent-To-Treat|Patient Moved|2|||
46677486|NCT01081301|82892947|FG000|Overall Study|Bereaved|3|||
46677487|NCT01081301|82892947|FG000|Overall Study|Too busy|5|||
46677488|NCT01081301|82892947|FG000|Overall Study|Patient too ill|2|||
46677489|NCT01081301|82892947|FG000|Overall Study|Lost to Follow-up|4|||
46677490|NCT00174954|82892968|FG000|Overall Study|Adverse Event|2|||
46677491|NCT00174954|82892968|FG000|Overall Study|No tophi found in MRI|1|||
46677492|NCT00174954|82892968|FG000|Overall Study|Physician Decision|1|||
46677493|NCT01081145|82892972|FG000|Open-Label Phase|Lack of Efficacy|56|||
46677494|NCT01081145|82892973|FG001|Open-Label Phase|Lack of Efficacy|0|||
46677495|NCT01081145|82892972|FG000|Open-Label Phase|Response criteria not met|46|||
46677496|NCT01081145|82892973|FG001|Open-Label Phase|Response criteria not met|0|||
46677497|NCT01081145|82892972|FG000|Open-Label Phase|Adverse Event|42|||
46677498|NCT01081145|82892973|FG001|Open-Label Phase|Adverse Event|0|||
46677499|NCT01081145|82892972|FG000|Open-Label Phase|Withdrawal by Subject|41|||
46677500|NCT01081145|82892973|FG001|Open-Label Phase|Withdrawal by Subject|0|||
46796009|NCT00528411|83014155|FG002|Overall Study|Severe non-compliance to protocol|0|||
46796010|NCT00528411|83014153|FG000|Overall Study|Prior commitment medication|0|||
46796011|NCT00528411|83014154|FG001|Overall Study|Prior commitment medication|1|||
46796012|NCT00528411|83014155|FG002|Overall Study|Prior commitment medication|0|||
46796013|NCT00136357|83014165|FG000|Overall Study|Withdrawal by Subject|3|||
46796014|NCT00136357|83014166|FG001|Overall Study|Withdrawal by Subject|2|||
46677501|NCT01081145|82892972|FG000|Open-Label Phase|Other|12|||
46677502|NCT01081145|82892973|FG001|Open-Label Phase|Other|0|||
46677503|NCT01081145|82892972|FG000|Open-Label Phase|Lost to Follow-up|11|||
46677504|NCT01081145|82892973|FG001|Open-Label Phase|Lost to Follow-up|0|||
46677505|NCT01081145|82892972|FG000|Open-Label Phase|Protocol Violation|4|||
46677506|NCT01081145|82892973|FG001|Open-Label Phase|Protocol Violation|0|||
46796015|NCT00129649|83014174|FG000|Overall Study|Withdrawal by Subject|76|||
46796016|NCT00129649|83014175|FG001|Overall Study|Withdrawal by Subject|65|||
46677507|NCT01081145|82892972|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
46677508|NCT01081145|82892973|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
46796017|NCT00187135|83014187|FG000|Visit One|Withdrawal by Subject|1|||
46677509|NCT01081145|82892972|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
46677510|NCT01081145|82892973|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
46796018|NCT00187135|83014188|FG001|Visit One|Withdrawal by Subject|0|||
46796019|NCT00187135|83014189|FG002|Visit One|Withdrawal by Subject|0|||
47081346|NCT00243269|83399467|FG003|Overall Study|Protocol Violation|1|||
47081347|NCT00243269|83399464|FG000|Overall Study|Lost to Follow-up|1|||
47081348|NCT00243269|83399465|FG001|Overall Study|Lost to Follow-up|0|||
47081349|NCT00243269|83399466|FG002|Overall Study|Lost to Follow-up|1|||
47081350|NCT00243269|83399467|FG003|Overall Study|Lost to Follow-up|3|||
47081351|NCT00242567|83400682|FG000|Overall Study|Adverse Event|70|||
47081352|NCT00242567|83400683|FG001|Overall Study|Adverse Event|43|||
47081353|NCT00242567|83400682|FG000|Overall Study|Disease Progression|17|||
47081354|NCT00242567|83400683|FG001|Overall Study|Disease Progression|22|||
47081355|NCT00242567|83400682|FG000|Overall Study|Symptomatic deterioration|9|||
47081356|NCT00242567|83400683|FG001|Overall Study|Symptomatic deterioration|3|||
47081357|NCT00242567|83400682|FG000|Overall Study|Lack of Efficacy|2|||
46796020|NCT00187135|83014190|FG003|Visit One|Withdrawal by Subject|0|||
46796021|NCT00187135|83014191|FG004|Visit One|Withdrawal by Subject|0|||
46796022|NCT00187135|83014192|FG005|Visit One|Withdrawal by Subject|1|||
46796023|NCT00187135|83014187|FG000|Visit One|Physician Decision|3|||
46796024|NCT00187135|83014188|FG001|Visit One|Physician Decision|1|||
46796025|NCT00187135|83014189|FG002|Visit One|Physician Decision|0|||
46796026|NCT00187135|83014190|FG003|Visit One|Physician Decision|0|||
46796027|NCT00187135|83014191|FG004|Visit One|Physician Decision|0|||
46796028|NCT00187135|83014192|FG005|Visit One|Physician Decision|1|||
46677511|NCT01081145|82892972|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
46796029|NCT00187135|83014187|FG000|Visit Two|Death|0|||
46857037|NCT00320255|83072839|FG000|Overall Study|Other|3|||
46979740|NCT01665599|83225293|FG000|Overall Study|Death|1|||
46979741|NCT01665599|83225293|FG000|Overall Study|Lost to Follow-up|2|||
47081358|NCT00242567|83400683|FG001|Overall Study|Lack of Efficacy|2|||
47081359|NCT00242567|83400682|FG000|Overall Study|Lost to Follow-up|9|||
47081360|NCT00242567|83400683|FG001|Overall Study|Lost to Follow-up|19|||
47081361|NCT00242567|83400682|FG000|Overall Study|Withdrawal by Subject|33|||
46979742|NCT01665599|83225293|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
46979743|NCT01665599|83225293|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
46979744|NCT01671085|83225299|FG000|Overall Study|Withdrawal by Subject|1|||
46979745|NCT01671085|83225300|FG001|Overall Study|Withdrawal by Subject|0|||
46979746|NCT02510001|83225315|FG000|Overall Study|Early disease progression|0|||
46979747|NCT02510001|83225316|FG001|Overall Study|Early disease progression|0|||
46979748|NCT02510001|83225317|FG002|Overall Study|Early disease progression|0|||
46796030|NCT00187135|83014188|FG001|Visit Two|Death|0|||
47081362|NCT00242567|83400683|FG001|Overall Study|Withdrawal by Subject|28|||
47081363|NCT00242567|83400682|FG000|Overall Study|Protocol Violation|12|||
47081364|NCT00242567|83400683|FG001|Overall Study|Protocol Violation|12|||
47081365|NCT00242567|83400682|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
47081366|NCT00242567|83400683|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
47081367|NCT00242567|83400682|FG000|Overall Study|Other|14|||
47081368|NCT00242567|83400683|FG001|Overall Study|Other|9|||
47081369|NCT00241631|83400693|FG000|Run in (2 Weeks)|Physician Decision|3|||
47081370|NCT00241631|83400694|FG001|Run in (2 Weeks)|Physician Decision|3|||
47081371|NCT00241631|83400693|FG000|Phase 1 (4 Weeks)|sore throat|1|||
47081372|NCT00241631|83400694|FG001|Phase 1 (4 Weeks)|sore throat|0|||
47081373|NCT00241631|83400693|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
47081374|NCT00241631|83400694|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
47081375|NCT00241631|83400693|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
47081376|NCT00241631|83400694|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
47081377|NCT00241631|83400693|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
47081378|NCT00241631|83400694|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
47081379|NCT00240071|83400709|FG000|Overall Study|Withdrawal by Subject|3|||
47081380|NCT03761277|83401683|FG000|Enrollment to Implant|Screen Failure|17|||
47081381|NCT03761277|83401683|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
47081382|NCT03761277|83401683|FG000|Enrollment to Implant|Physician Decision|2|||
47081383|NCT03761277|83401683|FG000|Enrollment to Implant|Site Closure|3|||
47081384|NCT03761277|83401683|FG000|Enrollment to Implant|Sponsor Request|2|||
47081385|NCT03761277|83401683|FG000|Post-Implant to 6 Months|Adverse Event|2|||
47081386|NCT03761277|83401683|FG000|Post-Implant to 6 Months|Death|1|||
47081387|NCT03761277|83401683|FG000|Post-Implant to 6 Months|Site Closure|2|||
47081388|NCT03761277|83401683|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
47081389|NCT03761277|83401683|FG000|6 Months to 12 Months|Physician Decision|2|||
47081390|NCT03761277|83401683|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
47081391|NCT04099641|83401734|FG000|Overall Study|Death|46|||
47081392|NCT04099641|83401735|FG001|Overall Study|Death|12|||
47081393|NCT04099641|83401734|FG000|Overall Study|Lost to Follow-up|1|||
47081394|NCT04099641|83401735|FG001|Overall Study|Lost to Follow-up|0|||
47081395|NCT04099641|83401734|FG000|Overall Study|Withdrawal by Subject|2|||
46677512|NCT01081145|82892973|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
46796031|NCT00187135|83014189|FG002|Visit Two|Death|0|||
46857038|NCT00320255|83072840|FG001|Overall Study|Other|2|||
46979749|NCT02510001|83225318|FG003|Overall Study|Early disease progression|1|||
47081396|NCT04099641|83401735|FG001|Overall Study|Withdrawal by Subject|0|||
47081397|NCT03123393|83401861|FG000|Overall Study|Study Terminated by Sponsor|6|||
47081398|NCT03123393|83401862|FG001|Overall Study|Study Terminated by Sponsor|9|||
47081399|NCT03123393|83401861|FG000|Overall Study|Withdrawal by Subject|2|||
47081400|NCT03123393|83401862|FG001|Overall Study|Withdrawal by Subject|1|||
47081401|NCT03123393|83401861|FG000|Overall Study|Reason not Specified|13|||
47081402|NCT03123393|83401862|FG001|Overall Study|Reason not Specified|13|||
47081403|NCT02834247|83402484|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
47081404|NCT02834247|83402485|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
47081405|NCT02834247|83402486|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
47081406|NCT02834247|83402487|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
47081407|NCT02834247|83402484|FG000|Dose Escalation Phase|Death|5|||
46796032|NCT00187135|83014190|FG003|Visit Two|Death|1|||
46796033|NCT00187135|83014191|FG004|Visit Two|Death|0|||
46796034|NCT00187135|83014192|FG005|Visit Two|Death|1|||
46796035|NCT00187135|83014187|FG000|Visit Two|Physician Decision|1|||
46796036|NCT00187135|83014188|FG001|Visit Two|Physician Decision|0|||
46796037|NCT00187135|83014189|FG002|Visit Two|Physician Decision|0|||
46796038|NCT00187135|83014190|FG003|Visit Two|Physician Decision|0|||
47081408|NCT02834247|83402485|FG001|Dose Escalation Phase|Death|6|||
47081409|NCT02834247|83402486|FG002|Dose Escalation Phase|Death|5|||
47081410|NCT02834247|83402487|FG003|Dose Escalation Phase|Death|0|||
47081411|NCT02834247|83402484|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
47081412|NCT02834247|83402485|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
47081413|NCT02834247|83402486|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
47081414|NCT02834247|83402487|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
47081415|NCT02834247|83402484|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
47081416|NCT02834247|83402485|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
47081417|NCT02834247|83402486|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
47081418|NCT02834247|83402487|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
46796039|NCT00187135|83014191|FG004|Visit Two|Physician Decision|0|||
47081419|NCT02834247|83402484|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
47081420|NCT02834247|83402485|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
47081421|NCT02834247|83402486|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
47081422|NCT02834247|83402487|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
46857039|NCT00320255|83072841|FG002|Overall Study|Other|1|||
46979750|NCT02510001|83225319|FG004|Overall Study|Early disease progression|1|||
46979751|NCT02510001|83225320|FG005|Overall Study|Early disease progression|1|||
46979752|NCT02510001|83225321|FG006|Overall Study|Early disease progression|0|||
46979753|NCT02510001|83225322|FG007|Overall Study|Early disease progression|0|||
47081423|NCT02834247|83402484|FG000|Dose Expansion Phase|Death|0|||
47081424|NCT02834247|83402485|FG001|Dose Expansion Phase|Death|0|||
47081425|NCT02834247|83402486|FG002|Dose Expansion Phase|Death|0|||
47081426|NCT02834247|83402487|FG003|Dose Expansion Phase|Death|8|||
47081427|NCT02834247|83402484|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
47081428|NCT02834247|83402485|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
47081429|NCT02834247|83402486|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
47081430|NCT02834247|83402487|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
47081431|NCT02834247|83402484|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
46979754|NCT02510001|83225315|FG000|Overall Study|Adverse Event|0|||
47081432|NCT02834247|83402485|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
46979755|NCT02510001|83225316|FG001|Overall Study|Adverse Event|0|||
46979756|NCT02510001|83225317|FG002|Overall Study|Adverse Event|0|||
46979757|NCT02510001|83225318|FG003|Overall Study|Adverse Event|1|||
46979758|NCT02510001|83225319|FG004|Overall Study|Adverse Event|2|||
46979759|NCT02510001|83225320|FG005|Overall Study|Adverse Event|1|||
46979760|NCT02510001|83225321|FG006|Overall Study|Adverse Event|2|||
46979761|NCT02510001|83225322|FG007|Overall Study|Adverse Event|5|||
46979762|NCT02510001|83225315|FG000|Overall Study|Physician Decision|0|||
46979763|NCT02510001|83225316|FG001|Overall Study|Physician Decision|0|||
46979764|NCT02510001|83225317|FG002|Overall Study|Physician Decision|0|||
46979765|NCT02510001|83225318|FG003|Overall Study|Physician Decision|0|||
46979766|NCT02510001|83225319|FG004|Overall Study|Physician Decision|1|||
46979767|NCT02510001|83225320|FG005|Overall Study|Physician Decision|0|||
46979768|NCT02510001|83225321|FG006|Overall Study|Physician Decision|0|||
46979769|NCT02510001|83225322|FG007|Overall Study|Physician Decision|0|||
46979770|NCT02510001|83225315|FG000|Overall Study|Withdrawal by Subject|0|||
46979771|NCT02510001|83225316|FG001|Overall Study|Withdrawal by Subject|0|||
46979772|NCT02510001|83225317|FG002|Overall Study|Withdrawal by Subject|0|||
46979773|NCT02510001|83225318|FG003|Overall Study|Withdrawal by Subject|0|||
46979774|NCT02510001|83225319|FG004|Overall Study|Withdrawal by Subject|0|||
46979775|NCT02510001|83225320|FG005|Overall Study|Withdrawal by Subject|0|||
46796040|NCT00187135|83014192|FG005|Visit Two|Physician Decision|0|||
46796041|NCT00187135|83014187|FG000|Visit Two|Withdrawal by Subject|1|||
46979776|NCT02510001|83225321|FG006|Overall Study|Withdrawal by Subject|0|||
46979777|NCT02510001|83225322|FG007|Overall Study|Withdrawal by Subject|2|||
46979778|NCT02452047|83225361|FG000|Overall Study|Adverse Event|0|||
46979779|NCT02452047|83225362|FG001|Overall Study|Adverse Event|1|||
46979780|NCT02452047|83225363|FG002|Overall Study|Adverse Event|1|||
46677513|NCT01081145|82892972|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
46796042|NCT00187135|83014188|FG001|Visit Two|Withdrawal by Subject|1|||
46796043|NCT00187135|83014189|FG002|Visit Two|Withdrawal by Subject|1|||
46796044|NCT00187135|83014190|FG003|Visit Two|Withdrawal by Subject|0|||
46796045|NCT00187135|83014191|FG004|Visit Two|Withdrawal by Subject|1|||
47081433|NCT02834247|83402486|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
47081434|NCT02834247|83402487|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
47081435|NCT01839331|83403752|FG000|Overall Study|Early Termination|3|||
47081436|NCT01839331|83403753|FG001|Overall Study|Early Termination|0|||
47081437|NCT01839331|83403754|FG002|Overall Study|Early Termination|1|||
47081438|NCT01839331|83403755|FG003|Overall Study|Early Termination|2|||
47081439|NCT01839331|83403752|FG000|Overall Study|Protocol Violation|1|||
47081440|NCT01839331|83403753|FG001|Overall Study|Protocol Violation|6|||
47081441|NCT01839331|83403754|FG002|Overall Study|Protocol Violation|4|||
46677514|NCT01081145|82892973|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
47081442|NCT01839331|83403755|FG003|Overall Study|Protocol Violation|3|||
46979781|NCT02452047|83225361|FG000|Overall Study|Death|1|||
46979782|NCT02452047|83225362|FG001|Overall Study|Death|3|||
46796046|NCT00187135|83014192|FG005|Visit Two|Withdrawal by Subject|1|||
46796047|NCT00187135|83014187|FG000|Visit Two|Study Discontinued|3|||
46796048|NCT00187135|83014188|FG001|Visit Two|Study Discontinued|2|||
46796049|NCT00187135|83014189|FG002|Visit Two|Study Discontinued|1|||
46796050|NCT00187135|83014190|FG003|Visit Two|Study Discontinued|7|||
46796051|NCT00187135|83014191|FG004|Visit Two|Study Discontinued|5|||
46796052|NCT00187135|83014192|FG005|Visit Two|Study Discontinued|6|||
46979783|NCT02452047|83225363|FG002|Overall Study|Death|1|||
46796053|NCT00187135|83014187|FG000|Visit Three|Death|0|||
46979784|NCT02452047|83225361|FG000|Overall Study|Physician Decision|1|||
46796054|NCT00187135|83014188|FG001|Visit Three|Death|0|||
46796055|NCT00187135|83014189|FG002|Visit Three|Death|1|||
46796056|NCT00187135|83014190|FG003|Visit Three|Death|0|||
46796057|NCT00187135|83014191|FG004|Visit Three|Death|1|||
46796058|NCT00187135|83014192|FG005|Visit Three|Death|0|||
46796059|NCT00187135|83014187|FG000|Visit Three|Withdrawal by Subject|0|||
46796060|NCT00187135|83014188|FG001|Visit Three|Withdrawal by Subject|1|||
46796061|NCT00187135|83014189|FG002|Visit Three|Withdrawal by Subject|1|||
46979785|NCT02452047|83225362|FG001|Overall Study|Physician Decision|0|||
46979786|NCT02452047|83225363|FG002|Overall Study|Physician Decision|0|||
46979787|NCT02452047|83225361|FG000|Overall Study|Lost to Follow-up|1|||
46979788|NCT02452047|83225362|FG001|Overall Study|Lost to Follow-up|1|||
46979789|NCT02452047|83225363|FG002|Overall Study|Lost to Follow-up|0|||
46796062|NCT00187135|83014190|FG003|Visit Three|Withdrawal by Subject|2|||
46979790|NCT02452047|83225361|FG000|Overall Study|Withdrawal by Subject|1|||
46979791|NCT02452047|83225362|FG001|Overall Study|Withdrawal by Subject|0|||
46979792|NCT02452047|83225363|FG002|Overall Study|Withdrawal by Subject|0|||
46979793|NCT02475369|83225371|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
47081443|NCT01606176|83404093|FG000|Overall Study|Adverse Event|2|||
47081444|NCT01606176|83404094|FG001|Overall Study|Adverse Event|3|||
47081445|NCT01606176|83404093|FG000|Overall Study|Disease progression|1|||
47081446|NCT01606176|83404094|FG001|Overall Study|Disease progression|0|||
47081447|NCT01606176|83404093|FG000|Overall Study|Withdrawal by Subject|1|||
47081448|NCT01606176|83404094|FG001|Overall Study|Withdrawal by Subject|0|||
47081449|NCT01663896|83404160|FG000|Overall Study|Various reasons|43|||
47081450|NCT02576652|83404213|FG000|Overall Study|Withdrawal by Subject|2|||
47081451|NCT02575950|83404297|FG000|Overall Study|Withdrawal by Subject|0|||
47081452|NCT02575950|83404298|FG001|Overall Study|Withdrawal by Subject|0|||
47081453|NCT02575950|83404299|FG002|Overall Study|Withdrawal by Subject|0|||
47081454|NCT02575950|83404300|FG003|Overall Study|Withdrawal by Subject|2|||
47081455|NCT02575950|83404297|FG000|Overall Study|Lost to Follow-up|0|||
47081456|NCT02575950|83404298|FG001|Overall Study|Lost to Follow-up|1|||
47081457|NCT02575950|83404299|FG002|Overall Study|Lost to Follow-up|0|||
47081458|NCT02575950|83404300|FG003|Overall Study|Lost to Follow-up|3|||
47081459|NCT01049581|83404382|FG000|Overall Study|Lost to Follow-up|2|||
47081460|NCT01049581|83404383|FG001|Overall Study|Lost to Follow-up|1|||
47081461|NCT02571972|83404401|FG000|Overall Study|Protocol Violation|2|||
47081462|NCT02571972|83404401|FG000|Overall Study|Withdrawal by Subject|2|||
47081463|NCT02166905|83404499|FG000|Overall Study|Withdrawal by Subject|1|||
47081464|NCT02166905|83404500|FG001|Overall Study|Withdrawal by Subject|0|||
47081465|NCT02166905|83404501|FG002|Overall Study|Withdrawal by Subject|0|||
47081466|NCT02166905|83404502|FG003|Overall Study|Withdrawal by Subject|0|||
47081467|NCT01501955|83404549|FG000|Overall Study|Withdrawal by Subject|1|||
47081468|NCT01501955|83404550|FG001|Overall Study|Withdrawal by Subject|0|||
46796063|NCT00187135|83014191|FG004|Visit Three|Withdrawal by Subject|0|||
46796064|NCT00187135|83014192|FG005|Visit Three|Withdrawal by Subject|0|||
46796065|NCT00187135|83014187|FG000|Visit Three|Study Discontinued|7|||
46979794|NCT02475369|83225372|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
46979795|NCT02474589|83225385|FG000|Overall Study|Adverse Event|6|||
47081469|NCT01501955|83404549|FG000|Overall Study|Adverse Event|1|||
46796066|NCT00187135|83014188|FG001|Visit Three|Study Discontinued|6|||
46796067|NCT00187135|83014189|FG002|Visit Three|Study Discontinued|7|||
46796068|NCT00187135|83014190|FG003|Visit Three|Study Discontinued|7|||
46796069|NCT00187135|83014191|FG004|Visit Three|Study Discontinued|7|||
46796070|NCT00187135|83014192|FG005|Visit Three|Study Discontinued|6|||
46796071|NCT00528021|83014208|FG000|Overall Study|Lack of Efficacy|17|||
46796072|NCT00528021|83014209|FG001|Overall Study|Lack of Efficacy|13|||
46857040|NCT00320255|83072842|FG003|Overall Study|Other|0|||
46857041|NCT00320255|83072843|FG004|Overall Study|Other|0|||
46796073|NCT00528021|83014210|FG002|Overall Study|Lack of Efficacy|7|||
46796074|NCT00528021|83014211|FG003|Overall Study|Lack of Efficacy|9|||
46796075|NCT00560352|83014224|FG000|Overall Study|Adverse event unrelated to study drug|2|||
46796076|NCT00560352|83014225|FG001|Overall Study|Adverse event unrelated to study drug|1|||
46796077|NCT00560352|83014226|FG002|Overall Study|Adverse event unrelated to study drug|1|||
46796078|NCT00560352|83014224|FG000|Overall Study|Study drug toxicity|3|||
46796079|NCT00560352|83014225|FG001|Overall Study|Study drug toxicity|0|||
46796080|NCT00560352|83014226|FG002|Overall Study|Study drug toxicity|1|||
46857042|NCT00320255|83072844|FG005|Overall Study|Other|0|||
46857043|NCT00370331|83072861|FG000|Overall Study|Adverse Event|4|||
46857044|NCT00370331|83072862|FG001|Overall Study|Adverse Event|13|||
46796081|NCT00560352|83014224|FG000|Overall Study|Disease progression|0|||
46796082|NCT00560352|83014225|FG001|Overall Study|Disease progression|1|||
46796083|NCT00560352|83014226|FG002|Overall Study|Disease progression|1|||
46796084|NCT00560352|83014224|FG000|Overall Study|Withdrawal by Subject|1|||
46796085|NCT00560352|83014225|FG001|Overall Study|Withdrawal by Subject|1|||
46796086|NCT00560352|83014226|FG002|Overall Study|Withdrawal by Subject|1|||
46796087|NCT00560352|83014224|FG000|Overall Study|Maximum clinical benefit|1|||
46796088|NCT00560352|83014225|FG001|Overall Study|Maximum clinical benefit|0|||
46796089|NCT00560352|83014226|FG002|Overall Study|Maximum clinical benefit|0|||
46796090|NCT00527787|83014240|FG000|Overall Study|Adverse Event|14|||
46796091|NCT00527787|83014241|FG001|Overall Study|Adverse Event|24|||
46796092|NCT00527787|83014240|FG000|Overall Study|Withdrawal by Subject|13|||
46796093|NCT00527787|83014241|FG001|Overall Study|Withdrawal by Subject|25|||
46796094|NCT00527787|83014240|FG000|Overall Study|Lost to Follow-up|5|||
46796095|NCT00527787|83014241|FG001|Overall Study|Lost to Follow-up|2|||
46796096|NCT00527787|83014240|FG000|Overall Study|Duodenal Ulcer|1|||
46796097|NCT00527787|83014241|FG001|Overall Study|Duodenal Ulcer|10|||
46796098|NCT00527787|83014240|FG000|Overall Study|misc|5|||
46857045|NCT00370331|83072861|FG000|Overall Study|Withdrawal by Subject|2|||
46857046|NCT00370331|83072862|FG001|Overall Study|Withdrawal by Subject|4|||
46857047|NCT00370331|83072861|FG000|Overall Study|Lost to Follow-up|0|||
46677515|NCT01081145|82892972|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
46677516|NCT01081145|82892973|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
46677517|NCT01081145|82892972|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
46677518|NCT01081145|82892973|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
46677519|NCT01081145|82892972|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
46677520|NCT01081145|82892973|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
46677521|NCT00174915|82892986|FG000|Overall Study|Lost to Follow-up|19|||
46677522|NCT00174915|82892987|FG001|Overall Study|Lost to Follow-up|17|||
46677523|NCT00174915|82892988|FG002|Overall Study|Lost to Follow-up|9|||
46677524|NCT00174915|82892989|FG003|Overall Study|Lost to Follow-up|17|||
46677525|NCT00174915|82892990|FG004|Overall Study|Lost to Follow-up|10|||
46677526|NCT00174915|82892986|FG000|Overall Study|Adverse Event|18|||
46677527|NCT00174915|82892987|FG001|Overall Study|Adverse Event|16|||
46677528|NCT00174915|82892988|FG002|Overall Study|Adverse Event|11|||
46677529|NCT00174915|82892989|FG003|Overall Study|Adverse Event|18|||
46677530|NCT00174915|82892990|FG004|Overall Study|Adverse Event|5|||
46677531|NCT00174915|82892986|FG000|Overall Study|Personal Reason(s)|16|||
46677532|NCT00174915|82892987|FG001|Overall Study|Personal Reason(s)|16|||
46677533|NCT00174915|82892988|FG002|Overall Study|Personal Reason(s)|9|||
46677534|NCT00174915|82892989|FG003|Overall Study|Personal Reason(s)|9|||
46677535|NCT00174915|82892990|FG004|Overall Study|Personal Reason(s)|9|||
46677536|NCT00174915|82892986|FG000|Overall Study|Other|15|||
46677537|NCT00174915|82892987|FG001|Overall Study|Other|8|||
46677538|NCT00174915|82892988|FG002|Overall Study|Other|6|||
46677539|NCT00174915|82892989|FG003|Overall Study|Other|5|||
46677540|NCT00174915|82892990|FG004|Overall Study|Other|3|||
46677541|NCT00174915|82892986|FG000|Overall Study|Gout Flare|13|||
46677542|NCT00174915|82892987|FG001|Overall Study|Gout Flare|6|||
46677543|NCT00174915|82892988|FG002|Overall Study|Gout Flare|8|||
46677544|NCT00174915|82892989|FG003|Overall Study|Gout Flare|1|||
46677545|NCT00174915|82892990|FG004|Overall Study|Gout Flare|0|||
46677546|NCT00174915|82892986|FG000|Overall Study|Protocol Violation|6|||
46677547|NCT00174915|82892987|FG001|Overall Study|Protocol Violation|3|||
46677548|NCT00174915|82892988|FG002|Overall Study|Protocol Violation|3|||
46677549|NCT00174915|82892989|FG003|Overall Study|Protocol Violation|6|||
46677550|NCT00174915|82892990|FG004|Overall Study|Protocol Violation|3|||
46677551|NCT00174915|82892986|FG000|Overall Study|Therapeutic Failure|6|||
46677552|NCT00174915|82892987|FG001|Overall Study|Therapeutic Failure|3|||
46677553|NCT00174915|82892988|FG002|Overall Study|Therapeutic Failure|2|||
46677554|NCT00174915|82892989|FG003|Overall Study|Therapeutic Failure|1|||
46677555|NCT00174915|82892990|FG004|Overall Study|Therapeutic Failure|3|||
46677556|NCT01080716|82893006|FG000|Part 1|Physician Decision|1|||
46677557|NCT01080716|82893007|FG001|Part 1|Physician Decision|0|||
46979796|NCT02474589|83225386|FG001|Overall Study|Adverse Event|2|||
46677558|NCT01080716|82893008|FG002|Part 1|Physician Decision|0|||
46677559|NCT01080716|82893009|FG003|Part 1|Physician Decision|0|||
46796099|NCT00527787|83014241|FG001|Overall Study|misc|2|||
46796100|NCT00608426|83014249|FG000|Overall Study|Death|32|||
46796101|NCT00608426|83014250|FG001|Overall Study|Death|36|||
46796102|NCT00608426|83014249|FG000|Overall Study|Lost to Follow-up|485|||
46677560|NCT00172185|82893027|FG000|Overall Study|Adverse Event|0|||
46677561|NCT00172185|82893028|FG001|Overall Study|Adverse Event|1|||
46677562|NCT00172185|82893029|FG002|Overall Study|Adverse Event|3|||
46677563|NCT00172185|82893030|FG003|Overall Study|Adverse Event|4|||
46677564|NCT00172185|82893027|FG000|Overall Study|Physician Decision|0|||
46677565|NCT00172185|82893028|FG001|Overall Study|Physician Decision|0|||
46796103|NCT00608426|83014250|FG001|Overall Study|Lost to Follow-up|521|||
46796104|NCT00608426|83014249|FG000|Overall Study|refused, health issues, wrong address|319|||
46796105|NCT00608426|83014250|FG001|Overall Study|refused, health issues, wrong address|348|||
46796106|NCT00557076|83014258|FG000|Overall Study|Unblinding|0|||
46796107|NCT00557076|83014259|FG001|Overall Study|Unblinding|1|||
46796108|NCT00129259|83014267|FG000|Overall Study|Lost to Follow-up|1|||
46796109|NCT00129259|83014268|FG001|Overall Study|Lost to Follow-up|1|||
46796110|NCT00129259|83014267|FG000|Overall Study|Withdrawal by Subject|2|||
46796111|NCT00129259|83014268|FG001|Overall Study|Withdrawal by Subject|1|||
46796112|NCT00129259|83014267|FG000|Overall Study|Only available minimal phone assessments|0|||
46796113|NCT00129259|83014268|FG001|Overall Study|Only available minimal phone assessments|1|||
46796114|NCT00186901|83014277|FG000|Overall Study|Pregnancy|6|||
46979797|NCT02474589|83225385|FG000|Overall Study|Lost to Follow-up|6|||
46796115|NCT00186901|83014278|FG001|Overall Study|Pregnancy|3|||
46796116|NCT00186901|83014279|FG002|Overall Study|Pregnancy|0|||
46796117|NCT00186901|83014277|FG000|Overall Study|Lost to Follow-up|6|||
46796118|NCT00186901|83014278|FG001|Overall Study|Lost to Follow-up|3|||
46979798|NCT02474589|83225386|FG001|Overall Study|Lost to Follow-up|1|||
46979799|NCT02474589|83225385|FG000|Overall Study|Protocol Violation|4|||
47081470|NCT01501955|83404550|FG001|Overall Study|Adverse Event|3|||
47081471|NCT02574312|83404678|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
47081472|NCT02574312|83404679|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
47081473|NCT01049035|83404701|FG000|Overall Study|Serious adverse event|0|||
47081474|NCT01049035|83404702|FG001|Overall Study|Serious adverse event|1|||
47081475|NCT01049035|83404703|FG002|Overall Study|Serious adverse event|1|||
47081476|NCT01049035|83404704|FG003|Overall Study|Serious adverse event|2|||
47081477|NCT01049035|83404705|FG004|Overall Study|Serious adverse event|0|||
47081478|NCT01049035|83404706|FG005|Overall Study|Serious adverse event|0|||
47081479|NCT01049035|83404707|FG006|Overall Study|Serious adverse event|0|||
47081480|NCT01049035|83404701|FG000|Overall Study|Other adverse event (AE)|0|||
46979800|NCT02474589|83225386|FG001|Overall Study|Protocol Violation|1|||
47081481|NCT01049035|83404702|FG001|Overall Study|Other adverse event (AE)|0|||
47081482|NCT01049035|83404703|FG002|Overall Study|Other adverse event (AE)|0|||
46796119|NCT00186901|83014279|FG002|Overall Study|Lost to Follow-up|0|||
46677566|NCT00172185|82893029|FG002|Overall Study|Physician Decision|1|||
46677567|NCT00172185|82893030|FG003|Overall Study|Physician Decision|0|||
46979801|NCT02474589|83225385|FG000|Overall Study|Withdrawal by Subject|4|||
46979802|NCT02474589|83225386|FG001|Overall Study|Withdrawal by Subject|0|||
46857048|NCT00370331|83072862|FG001|Overall Study|Lost to Follow-up|3|||
46857049|NCT00370331|83072861|FG000|Overall Study|Lack of Efficacy|0|||
46857050|NCT00370331|83072862|FG001|Overall Study|Lack of Efficacy|1|||
46857051|NCT00370331|83072861|FG000|Overall Study|Non-compliance|0|||
46857052|NCT00370331|83072862|FG001|Overall Study|Non-compliance|1|||
46857053|NCT00370331|83072861|FG000|Overall Study|Protocol Violation|1|||
46857054|NCT00370331|83072862|FG001|Overall Study|Protocol Violation|1|||
46857055|NCT02962960|83072871|FG000|Overall Study|Withdrawal by Subject|1|||
46857056|NCT02962960|83072872|FG001|Overall Study|Withdrawal by Subject|1|||
46857057|NCT02962960|83072873|FG002|Overall Study|Withdrawal by Subject|0|||
46857058|NCT02962960|83072871|FG000|Overall Study|Adverse Event|1|||
46857059|NCT02962960|83072872|FG001|Overall Study|Adverse Event|1|||
46857060|NCT02962960|83072873|FG002|Overall Study|Adverse Event|0|||
46857061|NCT02962960|83072871|FG000|Overall Study|Protocol Violation|1|||
46857062|NCT02962960|83072872|FG001|Overall Study|Protocol Violation|0|||
46857063|NCT02962960|83072873|FG002|Overall Study|Protocol Violation|0|||
46857064|NCT00369941|83072885|FG000|Overall Study|Never Treated|1|||
46857065|NCT00369941|83072886|FG001|Overall Study|Never Treated|2|||
46857066|NCT00369941|83072885|FG000|Overall Study|Adverse Event|14|||
46677568|NCT00172185|82893027|FG000|Overall Study|SPONSOR Decision|0|||
46677569|NCT00172185|82893028|FG001|Overall Study|SPONSOR Decision|1|||
46677570|NCT00172185|82893029|FG002|Overall Study|SPONSOR Decision|0|||
46677571|NCT00172185|82893030|FG003|Overall Study|SPONSOR Decision|0|||
46677572|NCT00172185|82893027|FG000|Overall Study|Withdrawal by Subject|0|||
46677573|NCT00172185|82893028|FG001|Overall Study|Withdrawal by Subject|0|||
46677574|NCT00172185|82893029|FG002|Overall Study|Withdrawal by Subject|1|||
46677575|NCT00172185|82893030|FG003|Overall Study|Withdrawal by Subject|0|||
46677576|NCT01080326|82893044|FG000|Overall Study|Patient deterioration prior to procedure|3|||
46796120|NCT00186901|83014277|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
46796121|NCT00186901|83014278|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
46796122|NCT00186901|83014279|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
46796123|NCT00186901|83014277|FG000|Overall Study|ALL relapse or second malignancy|1|||
46796124|NCT00186901|83014278|FG001|Overall Study|ALL relapse or second malignancy|2|||
46796125|NCT00186901|83014279|FG002|Overall Study|ALL relapse or second malignancy|0|||
46796126|NCT00186901|83014277|FG000|Overall Study|Withdrawal by Subject|4|||
46796127|NCT00186901|83014278|FG001|Overall Study|Withdrawal by Subject|5|||
46796128|NCT00186901|83014279|FG002|Overall Study|Withdrawal by Subject|0|||
46796129|NCT00186901|83014277|FG000|Overall Study|Open label|3|||
46796130|NCT00186901|83014278|FG001|Overall Study|Open label|2|||
46796131|NCT00186901|83014279|FG002|Overall Study|Open label|0|||
46796132|NCT00186901|83014277|FG000|Overall Study|Limited adherence to study requirements|20|||
46796133|NCT00186901|83014278|FG001|Overall Study|Limited adherence to study requirements|23|||
46796134|NCT00186901|83014279|FG002|Overall Study|Limited adherence to study requirements|0|||
46796135|NCT00186901|83014277|FG000|Overall Study|Bone Mineral Density > 0|0|||
46796136|NCT00186901|83014278|FG001|Overall Study|Bone Mineral Density > 0|0|||
46796137|NCT00186901|83014279|FG002|Overall Study|Bone Mineral Density > 0|149|||
46796138|NCT00186121|83014316|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
46796139|NCT00186121|83014316|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
46796140|NCT00186121|83014316|FG000|Overall Study|Not eligible (no treatment)|1|||
46796141|NCT00186043|83014322|FG000|Overall Study|Lack of Efficacy|1|||
46796142|NCT00186043|83014323|FG001|Overall Study|Lack of Efficacy|3|||
46796143|NCT00186043|83014322|FG000|Overall Study|Lost to Follow-up|4|||
46796144|NCT00186043|83014323|FG001|Overall Study|Lost to Follow-up|6|||
46796145|NCT00186043|83014322|FG000|Overall Study|Withdrawal by Subject|1|||
46796146|NCT00186043|83014323|FG001|Overall Study|Withdrawal by Subject|0|||
46796147|NCT00186043|83014322|FG000|Overall Study|Adverse Event|7|||
46796148|NCT00186043|83014323|FG001|Overall Study|Adverse Event|3|||
46796149|NCT00186043|83014322|FG000|Overall Study|Protocol Violation|2|||
46796150|NCT00186043|83014323|FG001|Overall Study|Protocol Violation|1|||
46796151|NCT00185965|83014331|FG000|Overall Study|Adverse Event|0|||
46796152|NCT00185965|83014332|FG001|Overall Study|Adverse Event|1|||
46796153|NCT00607880|83014340|FG000|Overall Study|Unable to place port due to occlusion|1|||
46796154|NCT00607880|83014341|FG001|Overall Study|Unable to place port due to occlusion|0|||
46796155|NCT00127933|83014349|FG000|Overall Study|Randomized but not dosed|1|||
46796156|NCT00127933|83014350|FG001|Overall Study|Randomized but not dosed|0|||
46796157|NCT03875313|83014361|FG000|Overall Study|Withdrawal by Subject|1|||
46796158|NCT03875313|83014362|FG001|Overall Study|Withdrawal by Subject|3|||
46796159|NCT03875313|83014363|FG002|Overall Study|Withdrawal by Subject|0|||
46796160|NCT03875313|83014364|FG003|Overall Study|Withdrawal by Subject|0|||
46796161|NCT03875313|83014365|FG004|Overall Study|Withdrawal by Subject|0|||
46796162|NCT03875313|83014361|FG000|Overall Study|Death|0|||
47081483|NCT01049035|83404704|FG003|Overall Study|Other adverse event (AE)|1|||
46677577|NCT01080326|82893044|FG000|Overall Study|Surgeon decision|1|||
46677578|NCT00171951|82893048|FG000|Overall Study|Adverse Event|1|||
46677579|NCT00171951|82893048|FG000|Overall Study|Abnormal Laboratory Values|2|||
46796163|NCT03875313|83014362|FG001|Overall Study|Death|0|||
46796164|NCT03875313|83014363|FG002|Overall Study|Death|0|||
46796165|NCT03875313|83014364|FG003|Overall Study|Death|0|||
47081484|NCT01049035|83404705|FG004|Overall Study|Other adverse event (AE)|0|||
47081485|NCT01049035|83404706|FG005|Overall Study|Other adverse event (AE)|0|||
47081486|NCT01049035|83404707|FG006|Overall Study|Other adverse event (AE)|0|||
47081487|NCT01049035|83404701|FG000|Overall Study|Non-compliance with the protocol|12|||
47081488|NCT01049035|83404702|FG001|Overall Study|Non-compliance with the protocol|6|||
47081489|NCT01049035|83404703|FG002|Overall Study|Non-compliance with the protocol|14|||
46677580|NCT00171951|82893048|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
46677581|NCT00171951|82893048|FG000|Overall Study|Participants Withdrew Consent|3|||
46677582|NCT00171951|82893048|FG000|Overall Study|New Cancer Therapy|5|||
46677583|NCT00171951|82893048|FG000|Overall Study|Reason not Specified|2|||
46677584|NCT01080131|82893057|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
46677585|NCT01080131|82893058|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
46677586|NCT01080131|82893057|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
46677587|NCT01080131|82893058|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
46677588|NCT01080131|82893057|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
46677589|NCT01080131|82893058|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
46677590|NCT01080131|82893057|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
46677591|NCT01080131|82893058|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
46677592|NCT01080131|82893057|FG000|Core Study (0- 12 Weeks)|Death|1|||
46677593|NCT01080131|82893058|FG001|Core Study (0- 12 Weeks)|Death|0|||
46677594|NCT01080131|82893057|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
46677595|NCT01080131|82893058|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
46677596|NCT01080131|82893057|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
46677597|NCT01080131|82893058|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
46677598|NCT01080131|82893057|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
46677599|NCT01080131|82893058|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
46677600|NCT01080131|82893057|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
46677601|NCT01080131|82893058|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
46677602|NCT01080131|82893057|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
46677603|NCT01080131|82893058|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
46677604|NCT01080131|82893057|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
46677605|NCT01080131|82893058|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
46677606|NCT01080131|82893057|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
46677607|NCT01080131|82893058|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
46677608|NCT01080131|82893057|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
46677609|NCT01080131|82893058|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
46677610|NCT00171873|82893084|FG000|Overall Study|Withdrawal by Subject|4|||
46677611|NCT00171873|82893085|FG001|Overall Study|Withdrawal by Subject|2|||
46677612|NCT00171873|82893084|FG000|Overall Study|Adverse Event|5|||
46677613|NCT00171873|82893085|FG001|Overall Study|Adverse Event|0|||
46677614|NCT00171873|82893084|FG000|Overall Study|Switched to Octreotide|0|||
46979803|NCT02474589|83225385|FG000|Overall Study|Inability to complete study procedures|5|||
46979804|NCT02474589|83225386|FG001|Overall Study|Inability to complete study procedures|1|||
46979805|NCT02586233|83225399|FG000|Overall Study|Randomized but did not receive treatment|0|||
46979806|NCT02586233|83225400|FG001|Overall Study|Randomized but did not receive treatment|1|||
46979807|NCT02586233|83225401|FG002|Overall Study|Randomized but did not receive treatment|0|||
46979808|NCT02586233|83225402|FG003|Overall Study|Randomized but did not receive treatment|0|||
46979809|NCT02586233|83225403|FG004|Overall Study|Randomized but did not receive treatment|0|||
46979810|NCT02586233|83225404|FG005|Overall Study|Randomized but did not receive treatment|2|||
46979811|NCT02586233|83225405|FG006|Overall Study|Randomized but did not receive treatment|2|||
46979812|NCT02586233|83225399|FG000|Overall Study|Death|0|||
46979813|NCT02586233|83225400|FG001|Overall Study|Death|1|||
46677615|NCT00171873|82893085|FG001|Overall Study|Switched to Octreotide|1|||
46677616|NCT00171834|82893098|FG000|Overall Study|Adverse Event|2|||
46677617|NCT00171834|82893099|FG001|Overall Study|Adverse Event|1|||
46796166|NCT03875313|83014365|FG004|Overall Study|Death|1|||
46796167|NCT03875313|83014361|FG000|Overall Study|Lost to Follow-up|0|||
46796168|NCT03875313|83014362|FG001|Overall Study|Lost to Follow-up|0|||
46796169|NCT03875313|83014363|FG002|Overall Study|Lost to Follow-up|0|||
46796170|NCT03875313|83014364|FG003|Overall Study|Lost to Follow-up|0|||
46677618|NCT00171834|82893100|FG002|Overall Study|Adverse Event|3|||
46677619|NCT00171834|82893101|FG003|Overall Study|Adverse Event|2|||
46677620|NCT00171834|82893102|FG004|Overall Study|Adverse Event|2|||
46677621|NCT00171834|82893103|FG005|Overall Study|Adverse Event|15|||
46677622|NCT00171834|82893104|FG006|Overall Study|Adverse Event|1|||
46677623|NCT00171834|82893098|FG000|Overall Study|Withdrawal by Subject|0|||
46677624|NCT00171834|82893099|FG001|Overall Study|Withdrawal by Subject|2|||
46677625|NCT00171834|82893100|FG002|Overall Study|Withdrawal by Subject|0|||
46796171|NCT03875313|83014365|FG004|Overall Study|Lost to Follow-up|1|||
46796172|NCT03875313|83014361|FG000|Overall Study|Study Termination by Sponsor|0|||
46796173|NCT03875313|83014362|FG001|Overall Study|Study Termination by Sponsor|1|||
46857067|NCT00369941|83072886|FG001|Overall Study|Adverse Event|28|||
46677626|NCT00171834|82893101|FG003|Overall Study|Withdrawal by Subject|1|||
46677627|NCT00171834|82893102|FG004|Overall Study|Withdrawal by Subject|1|||
46677628|NCT00171834|82893103|FG005|Overall Study|Withdrawal by Subject|1|||
46677629|NCT00171834|82893104|FG006|Overall Study|Withdrawal by Subject|0|||
46677630|NCT00171834|82893098|FG000|Overall Study|Death from study indication|0|||
46677631|NCT00171834|82893099|FG001|Overall Study|Death from study indication|1|||
46677632|NCT00171834|82893100|FG002|Overall Study|Death from study indication|0|||
46677633|NCT00171834|82893101|FG003|Overall Study|Death from study indication|0|||
46677634|NCT00171834|82893102|FG004|Overall Study|Death from study indication|1|||
46677635|NCT00171834|82893103|FG005|Overall Study|Death from study indication|0|||
46677636|NCT00171834|82893104|FG006|Overall Study|Death from study indication|0|||
46677637|NCT00171834|82893098|FG000|Overall Study|Disease Progression|4|||
46677638|NCT00171834|82893099|FG001|Overall Study|Disease Progression|8|||
46677639|NCT00171834|82893100|FG002|Overall Study|Disease Progression|8|||
46677640|NCT00171834|82893101|FG003|Overall Study|Disease Progression|9|||
46677641|NCT00171834|82893102|FG004|Overall Study|Disease Progression|2|||
46677642|NCT00171834|82893103|FG005|Overall Study|Disease Progression|18|||
46677643|NCT00171834|82893104|FG006|Overall Study|Disease Progression|3|||
46677644|NCT00171834|82893098|FG000|Overall Study|Treatment Duration Completed|0|||
46677645|NCT00171834|82893099|FG001|Overall Study|Treatment Duration Completed|0|||
46677646|NCT00171834|82893100|FG002|Overall Study|Treatment Duration Completed|1|||
46677647|NCT00171834|82893101|FG003|Overall Study|Treatment Duration Completed|0|||
46677648|NCT00171834|82893102|FG004|Overall Study|Treatment Duration Completed|2|||
46677649|NCT00171834|82893103|FG005|Overall Study|Treatment Duration Completed|1|||
46677650|NCT00171834|82893104|FG006|Overall Study|Treatment Duration Completed|0|||
46677651|NCT00171249|82893134|FG000|Overall Study|Withdrawal by Subject|2|||
46677652|NCT00171249|82893135|FG001|Overall Study|Withdrawal by Subject|0|||
46796174|NCT03875313|83014363|FG002|Overall Study|Study Termination by Sponsor|1|||
46796175|NCT03875313|83014364|FG003|Overall Study|Study Termination by Sponsor|0|||
46857068|NCT00369941|83072885|FG000|Overall Study|Lack of Efficacy|6|||
46979814|NCT02586233|83225401|FG002|Overall Study|Death|0|||
46677653|NCT00171249|82893136|FG002|Overall Study|Withdrawal by Subject|0|||
46677654|NCT00171249|82893137|FG003|Overall Study|Withdrawal by Subject|6|||
46677655|NCT00171249|82893138|FG004|Overall Study|Withdrawal by Subject|0|||
46979815|NCT02586233|83225402|FG003|Overall Study|Death|0|||
46979816|NCT02586233|83225403|FG004|Overall Study|Death|2|||
46979817|NCT02586233|83225404|FG005|Overall Study|Death|0|||
46979818|NCT02586233|83225405|FG006|Overall Study|Death|0|||
46979819|NCT02474355|83225425|FG000|Overall Study|Other|43|||
46677656|NCT00171249|82893139|FG005|Overall Study|Withdrawal by Subject|0|||
46677657|NCT00171249|82893140|FG006|Overall Study|Withdrawal by Subject|0|||
46796176|NCT03875313|83014365|FG004|Overall Study|Study Termination by Sponsor|1|||
46796177|NCT03875313|83014361|FG000|Overall Study|New Anticancer Treatment|0|||
46796178|NCT03875313|83014362|FG001|Overall Study|New Anticancer Treatment|1|||
46796179|NCT03875313|83014363|FG002|Overall Study|New Anticancer Treatment|2|||
46796180|NCT03875313|83014364|FG003|Overall Study|New Anticancer Treatment|1|||
46796181|NCT03875313|83014365|FG004|Overall Study|New Anticancer Treatment|0|||
46796182|NCT03875313|83014361|FG000|Overall Study|Other, Not Specified|2|||
46796183|NCT03875313|83014362|FG001|Overall Study|Other, Not Specified|11|||
46796184|NCT03875313|83014363|FG002|Overall Study|Other, Not Specified|3|||
46796185|NCT03875313|83014364|FG003|Overall Study|Other, Not Specified|3|||
46979820|NCT02474355|83225425|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
46979821|NCT02474355|83225425|FG000|Overall Study|Lost to Follow-up|98|||
46979822|NCT02474355|83225425|FG000|Overall Study|Withdrawal by Subject|124|||
46857069|NCT00369941|83072886|FG001|Overall Study|Lack of Efficacy|10|||
46857070|NCT00369941|83072885|FG000|Overall Study|Lost to Follow-up|12|||
46857071|NCT00369941|83072886|FG001|Overall Study|Lost to Follow-up|22|||
46857072|NCT00369941|83072885|FG000|Overall Study|Protocol Violation|5|||
46857073|NCT00369941|83072886|FG001|Overall Study|Protocol Violation|3|||
46857074|NCT00369941|83072885|FG000|Overall Study|Withdrawal by Subject|5|||
46857075|NCT00369941|83072886|FG001|Overall Study|Withdrawal by Subject|18|||
46677658|NCT00171249|82893134|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
46677659|NCT00171249|82893135|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
46677660|NCT00171249|82893136|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
46677661|NCT00171249|82893137|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
46677662|NCT00171249|82893138|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
46677663|NCT00171249|82893139|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
46677664|NCT00171249|82893140|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
46677665|NCT00171249|82893134|FG000|Overall Study|Death|7|||
46677666|NCT00171249|82893135|FG001|Overall Study|Death|1|||
46677667|NCT00171249|82893136|FG002|Overall Study|Death|0|||
46677668|NCT00171249|82893137|FG003|Overall Study|Death|4|||
46677669|NCT00171249|82893138|FG004|Overall Study|Death|0|||
46677670|NCT00171249|82893139|FG005|Overall Study|Death|3|||
46677671|NCT00171249|82893140|FG006|Overall Study|Death|1|||
46677672|NCT00171249|82893134|FG000|Overall Study|Other|10|||
46677673|NCT00171249|82893135|FG001|Overall Study|Other|0|||
46677674|NCT00171249|82893136|FG002|Overall Study|Other|0|||
46677675|NCT00171249|82893137|FG003|Overall Study|Other|43|||
46677676|NCT00171249|82893138|FG004|Overall Study|Other|0|||
46677677|NCT00171249|82893139|FG005|Overall Study|Other|2|||
46677678|NCT00171249|82893140|FG006|Overall Study|Other|0|||
46677679|NCT00171249|82893134|FG000|Overall Study|No Longer Requires Study Drug|4|||
46857076|NCT00369941|83072885|FG000|Overall Study|Pregnancy|4|||
46857077|NCT00369941|83072886|FG001|Overall Study|Pregnancy|2|||
46857078|NCT00369941|83072885|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
46857079|NCT00369941|83072886|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
46857080|NCT00369941|83072885|FG000|Overall Study|Moved|11|||
46796186|NCT03875313|83014365|FG004|Overall Study|Other, Not Specified|1|||
46796187|NCT04796415|83014408|FG000|Overall Study|not interested|12|||
46796188|NCT04796415|83014408|FG000|Overall Study|health issue|8|||
46796189|NCT04796415|83014408|FG000|Overall Study|Other|4|||
46796190|NCT04796415|83014408|FG000|Overall Study|discharged from home health service|3|||
46796191|NCT04796415|83014408|FG000|Overall Study|re-hospitalization|2|||
46796192|NCT04796415|83014408|FG000|Overall Study|moving to nursing home|1|||
46796193|NCT04796415|83014408|FG000|Overall Study|lost contact|1|||
46796194|NCT04678557|83014415|FG000|Overall Study|Withdrawal by Subject|1|||
46796195|NCT04678557|83014416|FG001|Overall Study|Withdrawal by Subject|0|||
46796196|NCT04678557|83014415|FG000|Overall Study|Lack of Efficacy|0|||
46796197|NCT04678557|83014416|FG001|Overall Study|Lack of Efficacy|13|||
46796198|NCT04678557|83014415|FG000|Overall Study|Safety Evaluation|0|||
46796199|NCT04678557|83014416|FG001|Overall Study|Safety Evaluation|1|||
46796200|NCT04230980|83014437|FG000|Overall Study|Lost to Follow-up|1|||
46796201|NCT04230980|83014438|FG001|Overall Study|Lost to Follow-up|2|||
46796202|NCT04230980|83014437|FG000|Overall Study|Adverse Event|0|||
46796203|NCT04230980|83014438|FG001|Overall Study|Adverse Event|1|||
46796204|NCT03697720|83014475|FG000|Overall Study|Lost to Follow-up|7|||
46796205|NCT03635983|83014481|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
46796206|NCT03635983|83014482|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
46796207|NCT03635983|83014481|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
46796208|NCT03635983|83014482|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
46796209|NCT03635983|83014481|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
46796210|NCT03635983|83014482|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
46796211|NCT03635983|83014481|FG000|Pre-Treatment Period|Other reasons|1|||
46796212|NCT03635983|83014482|FG001|Pre-Treatment Period|Other reasons|2|||
46796213|NCT03635983|83014481|FG000|Pre-Treatment Period|Disease Progression|0|||
46796214|NCT03635983|83014482|FG001|Pre-Treatment Period|Disease Progression|1|||
46796215|NCT03635983|83014481|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
46796216|NCT03635983|83014482|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
46796217|NCT03635983|83014481|FG000|Treatment Period|Completed treatment period|13|||
46796218|NCT03635983|83014482|FG001|Treatment Period|Completed treatment period|20|||
46857081|NCT00369941|83072886|FG001|Overall Study|Moved|5|||
46857082|NCT00369941|83072885|FG000|Overall Study|Treatment with Prohibited Medication|3|||
46857083|NCT00369941|83072886|FG001|Overall Study|Treatment with Prohibited Medication|1|||
46857084|NCT00369941|83072885|FG000|Overall Study|Employment Interfered with Study Visits|1|||
46677680|NCT00171249|82893135|FG001|Overall Study|No Longer Requires Study Drug|0|||
46796219|NCT03635983|83014481|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
46796220|NCT03635983|83014482|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
46796221|NCT03635983|83014481|FG000|Treatment Period|Withdrawal by Subject|2|||
46857085|NCT00369941|83072886|FG001|Overall Study|Employment Interfered with Study Visits|0|||
46677681|NCT00171249|82893136|FG002|Overall Study|No Longer Requires Study Drug|0|||
46677682|NCT00171249|82893137|FG003|Overall Study|No Longer Requires Study Drug|3|||
46677683|NCT00171249|82893138|FG004|Overall Study|No Longer Requires Study Drug|0|||
46979823|NCT02474355|83225425|FG000|Overall Study|Death|1361|||
46796222|NCT03635983|83014482|FG001|Treatment Period|Withdrawal by Subject|4|||
46796223|NCT03635983|83014481|FG000|Treatment Period|Death|3|||
46796224|NCT03635983|83014482|FG001|Treatment Period|Death|4|||
46796225|NCT03635983|83014481|FG000|Treatment Period|Poor/Non-compliance|1|||
46796226|NCT03635983|83014482|FG001|Treatment Period|Poor/Non-compliance|0|||
46796227|NCT03635983|83014481|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
46796228|NCT03635983|83014482|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
46796229|NCT03635983|83014481|FG000|Treatment Period|Other reasons|5|||
46796230|NCT03635983|83014482|FG001|Treatment Period|Other reasons|2|||
46796231|NCT03635983|83014481|FG000|Treatment Period|Disease progression|184|||
46796232|NCT03635983|83014482|FG001|Treatment Period|Disease progression|168|||
47081490|NCT01049035|83404704|FG003|Overall Study|Non-compliance with the protocol|5|||
47081491|NCT01049035|83404705|FG004|Overall Study|Non-compliance with the protocol|3|||
47081492|NCT01049035|83404706|FG005|Overall Study|Non-compliance with the protocol|4|||
47081493|NCT01049035|83404707|FG006|Overall Study|Non-compliance with the protocol|10|||
47081494|NCT01049035|83404701|FG000|Overall Study|Lost to Follow-up|5|||
47081495|NCT01049035|83404702|FG001|Overall Study|Lost to Follow-up|4|||
47081496|NCT01049035|83404703|FG002|Overall Study|Lost to Follow-up|4|||
47081497|NCT01049035|83404704|FG003|Overall Study|Lost to Follow-up|1|||
47081498|NCT01049035|83404705|FG004|Overall Study|Lost to Follow-up|0|||
47081499|NCT01049035|83404706|FG005|Overall Study|Lost to Follow-up|3|||
47081500|NCT01049035|83404707|FG006|Overall Study|Lost to Follow-up|3|||
47081501|NCT01049035|83404701|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
47081502|NCT01049035|83404702|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
47081503|NCT01049035|83404703|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
47081504|NCT01049035|83404704|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
47081505|NCT01049035|83404705|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
47081506|NCT01049035|83404706|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
47081507|NCT01049035|83404707|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
47081508|NCT01048333|83404733|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
47081509|NCT01048333|83404734|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
47081510|NCT01048333|83404735|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
47081511|NCT01048333|83404736|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
47081512|NCT01048333|83404737|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
47081513|NCT01048333|83404738|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
47081514|NCT02323113|83404753|FG000|Overall Study|Adverse Event|3|||
47081515|NCT02323113|83404754|FG001|Overall Study|Adverse Event|3|||
47081516|NCT02323113|83404755|FG002|Overall Study|Adverse Event|2|||
47081517|NCT02323113|83404756|FG003|Overall Study|Adverse Event|5|||
47081518|NCT02323113|83404757|FG004|Overall Study|Adverse Event|8|||
47081519|NCT02323113|83404758|FG005|Overall Study|Adverse Event|3|||
47081520|NCT02323113|83404759|FG006|Overall Study|Adverse Event|6|||
47081521|NCT02323113|83404760|FG007|Overall Study|Adverse Event|0|||
47081522|NCT02323113|83404753|FG000|Overall Study|Progressive Disease|0|||
47081523|NCT02323113|83404754|FG001|Overall Study|Progressive Disease|1|||
47081524|NCT02323113|83404755|FG002|Overall Study|Progressive Disease|1|||
47081525|NCT02323113|83404756|FG003|Overall Study|Progressive Disease|0|||
47081526|NCT02323113|83404757|FG004|Overall Study|Progressive Disease|0|||
47081527|NCT02323113|83404758|FG005|Overall Study|Progressive Disease|3|||
47081528|NCT02323113|83404759|FG006|Overall Study|Progressive Disease|0|||
47081529|NCT02323113|83404760|FG007|Overall Study|Progressive Disease|0|||
47081530|NCT02323113|83404753|FG000|Overall Study|Symptomatic Deterioration|0|||
47081531|NCT02323113|83404754|FG001|Overall Study|Symptomatic Deterioration|0|||
47081532|NCT02323113|83404755|FG002|Overall Study|Symptomatic Deterioration|1|||
47081533|NCT02323113|83404756|FG003|Overall Study|Symptomatic Deterioration|0|||
47081534|NCT02323113|83404757|FG004|Overall Study|Symptomatic Deterioration|1|||
47081535|NCT02323113|83404758|FG005|Overall Study|Symptomatic Deterioration|0|||
47081536|NCT02323113|83404759|FG006|Overall Study|Symptomatic Deterioration|0|||
47081537|NCT02323113|83404760|FG007|Overall Study|Symptomatic Deterioration|0|||
47081538|NCT02323113|83404753|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
47081539|NCT02323113|83404754|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
47081540|NCT02323113|83404755|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
47081541|NCT02323113|83404756|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
47081542|NCT02323113|83404757|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
47081543|NCT02323113|83404758|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
47081544|NCT02323113|83404759|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
46857086|NCT00369941|83072885|FG000|Overall Study|Study Site Terminated|2|||
46857087|NCT00369941|83072886|FG001|Overall Study|Study Site Terminated|0|||
46857088|NCT00369941|83072885|FG000|Overall Study|Miscellaneous|3|||
46857089|NCT00369941|83072886|FG001|Overall Study|Miscellaneous|3|||
46857090|NCT00319553|83072895|FG000|Overall Study|Protocol Violation|1|||
47081545|NCT02323113|83404760|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
47081546|NCT02323113|83404753|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
47081547|NCT02323113|83404754|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
47081548|NCT02323113|83404755|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
47081549|NCT02323113|83404756|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
47081550|NCT02323113|83404757|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
47081551|NCT02323113|83404758|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
46857091|NCT00319553|83072896|FG001|Overall Study|Protocol Violation|2|||
46857092|NCT00319553|83072895|FG000|Overall Study|Lost to Follow-up|2|||
46857093|NCT00319553|83072896|FG001|Overall Study|Lost to Follow-up|1|||
46857094|NCT00319553|83072895|FG000|Overall Study|Withdrawal by Subject|1|||
46857095|NCT00319553|83072896|FG001|Overall Study|Withdrawal by Subject|1|||
46857096|NCT00369785|83072904|FG000|Overall Study|Physician Decision|3|||
46857097|NCT00369785|83072905|FG001|Overall Study|Physician Decision|2|||
46677684|NCT00171249|82893139|FG005|Overall Study|No Longer Requires Study Drug|5|||
46677685|NCT00171249|82893140|FG006|Overall Study|No Longer Requires Study Drug|0|||
46677686|NCT00171249|82893134|FG000|Overall Study|Administrative Problems|1|||
46677687|NCT00171249|82893135|FG001|Overall Study|Administrative Problems|0|||
46677688|NCT00171249|82893136|FG002|Overall Study|Administrative Problems|0|||
46677689|NCT00171249|82893137|FG003|Overall Study|Administrative Problems|2|||
46677690|NCT00171249|82893138|FG004|Overall Study|Administrative Problems|0|||
46677691|NCT00171249|82893139|FG005|Overall Study|Administrative Problems|0|||
46677692|NCT00171249|82893140|FG006|Overall Study|Administrative Problems|0|||
46677693|NCT00171249|82893134|FG000|Overall Study|Adverse Event|3|||
46677694|NCT00171249|82893135|FG001|Overall Study|Adverse Event|1|||
46677695|NCT00171249|82893136|FG002|Overall Study|Adverse Event|0|||
46796233|NCT03635983|83014481|FG000|Treatment Period|Study drug toxicity|26|||
46796234|NCT03635983|83014482|FG001|Treatment Period|Study drug toxicity|29|||
46796235|NCT03635983|83014481|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
46796236|NCT03635983|83014482|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
46796237|NCT03635983|83014481|FG000|Treatment Period|Maximum clinical benefit|3|||
46796238|NCT03635983|83014482|FG001|Treatment Period|Maximum clinical benefit|2|||
46796239|NCT03517449|83014490|FG000|Overall Study|Death|184|||
46796240|NCT03517449|83014491|FG001|Overall Study|Death|236|||
46796241|NCT03517449|83014490|FG000|Overall Study|Lost to Follow-up|0|||
46796242|NCT03517449|83014491|FG001|Overall Study|Lost to Follow-up|2|||
46796243|NCT03517449|83014490|FG000|Overall Study|Withdrawal by Subject|7|||
46796244|NCT03517449|83014491|FG001|Overall Study|Withdrawal by Subject|26|||
46796245|NCT03517449|83014490|FG000|Overall Study|Participants Ongoing|220|||
46796246|NCT03517449|83014491|FG001|Overall Study|Participants Ongoing|152|||
46796247|NCT03257631|83014509|FG000|Overall Study|Death|8|||
46796248|NCT03257631|83014510|FG001|Overall Study|Death|5|||
46796249|NCT03257631|83014511|FG002|Overall Study|Death|13|||
46796250|NCT03257631|83014512|FG003|Overall Study|Death|5|||
46796251|NCT03257631|83014509|FG000|Overall Study|Progressive Disease|0|||
46796252|NCT03257631|83014510|FG001|Overall Study|Progressive Disease|0|||
46796253|NCT03257631|83014511|FG002|Overall Study|Progressive Disease|1|||
46796254|NCT03257631|83014512|FG003|Overall Study|Progressive Disease|0|||
46796255|NCT03257631|83014509|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
46796256|NCT03257631|83014510|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
46796257|NCT03257631|83014511|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
46796258|NCT03257631|83014512|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
46796259|NCT03257631|83014509|FG000|Overall Study|Lost to Follow-up|0|||
46796260|NCT03257631|83014510|FG001|Overall Study|Lost to Follow-up|0|||
46796261|NCT03257631|83014511|FG002|Overall Study|Lost to Follow-up|1|||
46796262|NCT03257631|83014512|FG003|Overall Study|Lost to Follow-up|0|||
46796263|NCT03257631|83014509|FG000|Overall Study|Still on Study|3|||
46796264|NCT03257631|83014510|FG001|Overall Study|Still on Study|2|||
46796265|NCT03257631|83014511|FG002|Overall Study|Still on Study|4|||
46796266|NCT03257631|83014512|FG003|Overall Study|Still on Study|4|||
46796267|NCT03055767|83014524|FG000|Open-Label Period|Lost to Follow-up|0|||
46796268|NCT03055767|83014525|FG001|Open-Label Period|Lost to Follow-up|0|||
46796269|NCT03055767|83014526|FG002|Open-Label Period|Lost to Follow-up|2|||
46796270|NCT03055767|83014527|FG003|Open-Label Period|Lost to Follow-up|0|||
46796271|NCT03055767|83014524|FG000|Open-Label Period|Withdrawal by Subject|0|||
46796272|NCT03055767|83014525|FG001|Open-Label Period|Withdrawal by Subject|0|||
46796273|NCT03055767|83014526|FG002|Open-Label Period|Withdrawal by Subject|0|||
46857098|NCT00369785|83072904|FG000|Overall Study|Death|1|||
46857099|NCT00369785|83072905|FG001|Overall Study|Death|2|||
46857100|NCT00369785|83072904|FG000|Overall Study|Withdrawal by Subject|7|||
46857101|NCT00369785|83072905|FG001|Overall Study|Withdrawal by Subject|6|||
46857102|NCT00369785|83072904|FG000|Overall Study|Toxicity|6|||
46857103|NCT00369785|83072905|FG001|Overall Study|Toxicity|4|||
46796274|NCT03055767|83014527|FG003|Open-Label Period|Withdrawal by Subject|1|||
46796275|NCT02702414|83014544|FG000|Overall Study|Death|77|||
46796276|NCT02702414|83014545|FG001|Overall Study|Death|34|||
46796277|NCT02702414|83014544|FG000|Overall Study|Lost to Follow-up|0|||
46796278|NCT02702414|83014545|FG001|Overall Study|Lost to Follow-up|1|||
46796279|NCT02702414|83014544|FG000|Overall Study|Withdrawal by Subject|0|||
46796280|NCT02702414|83014545|FG001|Overall Study|Withdrawal by Subject|1|||
46796281|NCT02702414|83014544|FG000|Overall Study|Participants Ongoing in Study|27|||
46796282|NCT02702414|83014545|FG001|Overall Study|Participants Ongoing in Study|15|||
46796283|NCT02702414|83014544|FG000|Overall Study|Not Treated|1|||
46796284|NCT02702414|83014545|FG001|Overall Study|Not Treated|0|||
46796285|NCT01064479|83014575|FG000|Overall Study|Death|10|||
46796286|NCT01064479|83014576|FG001|Overall Study|Death|11|||
46796287|NCT01064479|83014575|FG000|Overall Study|Withdrawal by Subject|2|||
46796288|NCT01064479|83014576|FG001|Overall Study|Withdrawal by Subject|2|||
46796289|NCT01064479|83014575|FG000|Overall Study|Disease progression|1|||
46796290|NCT01064479|83014576|FG001|Overall Study|Disease progression|1|||
46796291|NCT01064479|83014575|FG000|Overall Study|Toxicity|1|||
46796292|NCT01064479|83014576|FG001|Overall Study|Toxicity|1|||
46796293|NCT01064479|83014575|FG000|Overall Study|Other|1|||
46796294|NCT01064479|83014576|FG001|Overall Study|Other|2|||
46796295|NCT00556998|83014590|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
46796296|NCT00556998|83014590|FG000|Voriconazole Intravenous (IV)|Other|4|||
46796297|NCT00556998|83014590|FG000|Voriconazole Oral|Adverse Event|1|||
46796298|NCT00556998|83014590|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
46796299|NCT00528801|83014600|FG000|Overall Study|Withdrawal by Subject|1|||
46796300|NCT00528801|83014601|FG001|Overall Study|Withdrawal by Subject|1|||
46796301|NCT00528801|83014600|FG000|Overall Study|Protocol Violation|11|||
46796302|NCT00528801|83014601|FG001|Overall Study|Protocol Violation|5|||
46796303|NCT00528801|83014600|FG000|Overall Study|Lost to Follow-up|15|||
46796304|NCT00528801|83014601|FG001|Overall Study|Lost to Follow-up|4|||
46796305|NCT00528801|83014600|FG000|Overall Study|Administrative Reasons|0|||
46796306|NCT00528801|83014601|FG001|Overall Study|Administrative Reasons|1|||
46796307|NCT00527397|83014607|FG000|Overall Study|Adverse Event|3|||
46796308|NCT00527397|83014607|FG000|Overall Study|Lack of Efficacy|1|||
46796309|NCT00527397|83014607|FG000|Overall Study|Protocol Violation|1|||
46796310|NCT00527397|83014607|FG000|Overall Study|Withdrawal by Subject|6|||
46796311|NCT00527397|83014607|FG000|Overall Study|Study terminated by sponsor|13|||
46677696|NCT00171249|82893137|FG003|Overall Study|Adverse Event|15|||
46796312|NCT00527319|83014617|FG000|Overall Study|Withdrawal by Subject|5|||
46796313|NCT00527319|83014618|FG001|Overall Study|Withdrawal by Subject|0|||
46796314|NCT00527319|83014619|FG002|Overall Study|Withdrawal by Subject|1|||
46796315|NCT00527319|83014617|FG000|Overall Study|Lost to Follow-up|1|||
46796316|NCT00527319|83014618|FG001|Overall Study|Lost to Follow-up|0|||
46796317|NCT00527319|83014619|FG002|Overall Study|Lost to Follow-up|0|||
46796318|NCT00527319|83014617|FG000|Overall Study|Death|0|||
46796319|NCT00527319|83014618|FG001|Overall Study|Death|3|||
46796320|NCT00527319|83014619|FG002|Overall Study|Death|1|||
46796321|NCT00527319|83014617|FG000|Overall Study|Intercurrent Medical Illness|0|||
46796322|NCT00527319|83014618|FG001|Overall Study|Intercurrent Medical Illness|1|||
46796323|NCT00527319|83014619|FG002|Overall Study|Intercurrent Medical Illness|3|||
46796324|NCT00527319|83014617|FG000|Overall Study|Adverse Event|0|||
46796325|NCT00527319|83014618|FG001|Overall Study|Adverse Event|0|||
46796326|NCT00527319|83014619|FG002|Overall Study|Adverse Event|1|||
46796327|NCT00562302|83014629|FG000|Overall Study|Lost to Follow-up|3|||
46796328|NCT00562302|83014630|FG001|Overall Study|Lost to Follow-up|3|||
46796329|NCT00562302|83014629|FG000|Overall Study|Adverse Event|0|||
46857104|NCT00369785|83072904|FG000|Overall Study|Never started|0|||
46857105|NCT00369785|83072905|FG001|Overall Study|Never started|2|||
46857106|NCT00369785|83072904|FG000|Overall Study|Progression|4|||
46857107|NCT00369785|83072905|FG001|Overall Study|Progression|4|||
46979824|NCT02474199|83225431|FG000|Overall Study|Lost to Follow-up|1|||
46796330|NCT00562302|83014630|FG001|Overall Study|Adverse Event|6|||
46796331|NCT00562302|83014629|FG000|Overall Study|Non-compliance|1|||
46796332|NCT00562302|83014630|FG001|Overall Study|Non-compliance|2|||
46796333|NCT00562302|83014629|FG000|Overall Study|Withdrawal by Subject|7|||
46677697|NCT00171249|82893138|FG004|Overall Study|Adverse Event|0|||
46796334|NCT00562302|83014630|FG001|Overall Study|Withdrawal by Subject|8|||
46796335|NCT00562302|83014629|FG000|Overall Study|Death|1|||
46796336|NCT00562302|83014630|FG001|Overall Study|Death|2|||
46796337|NCT00562302|83014629|FG000|Overall Study|Lung resection prior to study completion|7|||
46796338|NCT00562302|83014630|FG001|Overall Study|Lung resection prior to study completion|7|||
46796339|NCT00562302|83014629|FG000|Overall Study|Not stated|1|||
46796340|NCT00562302|83014630|FG001|Overall Study|Not stated|4|||
46796341|NCT00134719|83014639|FG000|Primary Vaccination Phase|Adverse Event|4|||
46796342|NCT00134719|83014640|FG001|Primary Vaccination Phase|Adverse Event|0|||
46796343|NCT00134719|83014641|FG002|Primary Vaccination Phase|Adverse Event|0|||
46796344|NCT00134719|83014639|FG000|Primary Vaccination Phase|Protocol Violation|1|||
46796345|NCT00134719|83014640|FG001|Primary Vaccination Phase|Protocol Violation|0|||
46796346|NCT00134719|83014641|FG002|Primary Vaccination Phase|Protocol Violation|0|||
46796347|NCT00134719|83014639|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
46796348|NCT00134719|83014640|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
46796349|NCT00134719|83014641|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
46796350|NCT00134719|83014639|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
46796351|NCT00134719|83014640|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
46796352|NCT00134719|83014641|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
46796353|NCT00134719|83014639|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
46796354|NCT00134719|83014640|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
46796355|NCT00134719|83014641|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
46796356|NCT00134719|83014639|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
46796357|NCT00134719|83014640|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
46796358|NCT00134719|83014641|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
46796359|NCT00526071|83014649|FG000|Overall Study|Adverse Event|1|||
46796360|NCT00526071|83014649|FG000|Overall Study|Withdrawal by Subject|1|||
46796361|NCT00526071|83014649|FG000|Overall Study|Lack of Response to Study Drug|4|||
46796362|NCT00525915|83014659|FG000|Overall Study|Non-Compliance|0|||
46796363|NCT00525915|83014660|FG001|Overall Study|Non-Compliance|1|||
46796364|NCT00525915|83014659|FG000|Overall Study|Disease Progression|5|||
46796365|NCT00525915|83014660|FG001|Overall Study|Disease Progression|6|||
46796366|NCT00525915|83014659|FG000|Overall Study|Withdrawal by Subject|1|||
46796367|NCT00525915|83014660|FG001|Overall Study|Withdrawal by Subject|0|||
46796368|NCT00525915|83014659|FG000|Overall Study|Refused Surgery|1|||
46796369|NCT00525915|83014660|FG001|Overall Study|Refused Surgery|2|||
46796370|NCT00525915|83014659|FG000|Overall Study|Unrelated illness|1|||
46857108|NCT00369785|83072904|FG000|Overall Study|Multiple reasons|6|||
46796371|NCT00525915|83014660|FG001|Overall Study|Unrelated illness|0|||
46796372|NCT00521079|83014668|FG000|Overall Study|Adverse Event|7|||
46796373|NCT00521079|83014669|FG001|Overall Study|Adverse Event|1|||
46796374|NCT00521079|83014668|FG000|Overall Study|Lost to Follow-up|2|||
46796375|NCT00521079|83014669|FG001|Overall Study|Lost to Follow-up|1|||
46796376|NCT00521079|83014668|FG000|Overall Study|Withdrawal by Subject|5|||
46796377|NCT00521079|83014669|FG001|Overall Study|Withdrawal by Subject|3|||
46796378|NCT00521001|83014675|FG000|Overall Study|Ineligible|1|||
46796379|NCT00134563|83014682|FG000|Overall Study|Not treated due to protocol violation|0|||
46857109|NCT00369785|83072905|FG001|Overall Study|Multiple reasons|5|||
46857110|NCT00369707|83072911|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
46796380|NCT00134563|83014683|FG001|Overall Study|Not treated due to protocol violation|1|||
46796381|NCT00134563|83014684|FG002|Overall Study|Not treated due to protocol violation|1|||
46796382|NCT00134563|83014682|FG000|Overall Study|Adverse Event|29|||
46979825|NCT02474199|83225432|FG001|Overall Study|Lost to Follow-up|0|||
46796383|NCT00134563|83014683|FG001|Overall Study|Adverse Event|37|||
46796384|NCT00134563|83014684|FG002|Overall Study|Adverse Event|38|||
46796385|NCT00134563|83014682|FG000|Overall Study|Lack of Efficacy|24|||
46796386|NCT00134563|83014683|FG001|Overall Study|Lack of Efficacy|14|||
46796387|NCT00134563|83014684|FG002|Overall Study|Lack of Efficacy|17|||
46796388|NCT00134563|83014682|FG000|Overall Study|Protocol Violation|3|||
46796389|NCT00134563|83014683|FG001|Overall Study|Protocol Violation|2|||
46796390|NCT00134563|83014684|FG002|Overall Study|Protocol Violation|5|||
46796391|NCT00134563|83014682|FG000|Overall Study|Lost to Follow-up|4|||
46796392|NCT00134563|83014683|FG001|Overall Study|Lost to Follow-up|0|||
46796393|NCT00134563|83014684|FG002|Overall Study|Lost to Follow-up|2|||
46796394|NCT00134563|83014682|FG000|Overall Study|progressive disease|11|||
46796395|NCT00134563|83014683|FG001|Overall Study|progressive disease|4|||
46796396|NCT00134563|83014684|FG002|Overall Study|progressive disease|2|||
46796397|NCT00134563|83014682|FG000|Overall Study|did not wish to continue|33|||
46796398|NCT00134563|83014683|FG001|Overall Study|did not wish to continue|32|||
46796399|NCT00134563|83014684|FG002|Overall Study|did not wish to continue|26|||
46796400|NCT00134563|83014682|FG000|Overall Study|Reason other than above|0|||
46796401|NCT00134563|83014683|FG001|Overall Study|Reason other than above|2|||
46796402|NCT00134563|83014684|FG002|Overall Study|Reason other than above|5|||
46796403|NCT00520845|83014692|FG000|Overall Study|Death|3|||
46796404|NCT00520845|83014692|FG000|Overall Study|Adverse Event|4|||
46796405|NCT00520845|83014692|FG000|Overall Study|Disease Progression, relapse|13|||
46796406|NCT00520845|83014692|FG000|Overall Study|Withdrawal by Subject|1|||
46796407|NCT00520845|83014692|FG000|Overall Study|Alternative Therapy|1|||
46796408|NCT00185731|83014696|FG000|Overall Study|Withdrawal by Subject|1|||
46796409|NCT00185731|83014696|FG000|Overall Study|Not Eligible|1|||
46796410|NCT00582491|83014704|FG000|Overall Study|Withdrawal by Subject|1|||
46796411|NCT00582491|83014705|FG001|Overall Study|Withdrawal by Subject|0|||
46796412|NCT00520767|83014711|FG000|Overall Study|Death|2|||
46796413|NCT04679051|83014717|FG000|Overall Study|felt tired after restricted time in bed|3|||
46796414|NCT04679051|83014718|FG001|Overall Study|felt tired after restricted time in bed|0|||
46796415|NCT04679051|83014717|FG000|Overall Study|discomfort with blood pressure cuff|2|||
46796416|NCT04679051|83014718|FG001|Overall Study|discomfort with blood pressure cuff|0|||
46796417|NCT04679051|83014717|FG000|Overall Study|scheduling conflict|1|||
46796418|NCT04679051|83014718|FG001|Overall Study|scheduling conflict|1|||
46796419|NCT04679051|83014717|FG000|Overall Study|Protocol Violation|0|||
46796420|NCT04679051|83014718|FG001|Overall Study|Protocol Violation|4|||
46796421|NCT03873987|83014729|FG000|Overall Study|Adverse Event|1|||
46796422|NCT03873987|83014730|FG001|Overall Study|Adverse Event|0|||
46796423|NCT03873987|83014729|FG000|Overall Study|staff was unable to start a new IV line|1|||
46796424|NCT03873987|83014730|FG001|Overall Study|staff was unable to start a new IV line|0|||
46796425|NCT03873987|83014729|FG000|Overall Study|Lost to Follow-up|0|||
46796426|NCT03873987|83014730|FG001|Overall Study|Lost to Follow-up|1|||
46796427|NCT00474760|83014748|FG000|Overall Study|Death|0|||
46796428|NCT00474760|83014749|FG001|Overall Study|Death|0|||
46796429|NCT00474760|83014750|FG002|Overall Study|Death|0|||
46796430|NCT00474760|83014751|FG003|Overall Study|Death|0|||
46796431|NCT00474760|83014752|FG004|Overall Study|Death|2|||
46796432|NCT00474760|83014753|FG005|Overall Study|Death|0|||
46796433|NCT00474760|83014754|FG006|Overall Study|Death|0|||
46796434|NCT00474760|83014748|FG000|Overall Study|Adverse Event|0|||
46796435|NCT00474760|83014749|FG001|Overall Study|Adverse Event|0|||
46796436|NCT00474760|83014750|FG002|Overall Study|Adverse Event|0|||
46796437|NCT00474760|83014751|FG003|Overall Study|Adverse Event|0|||
46796438|NCT00474760|83014752|FG004|Overall Study|Adverse Event|1|||
46796439|NCT00474760|83014753|FG005|Overall Study|Adverse Event|7|||
46796440|NCT00474760|83014754|FG006|Overall Study|Adverse Event|0|||
46796441|NCT00474760|83014748|FG000|Overall Study|Laboratory abnormality|0|||
46796442|NCT00474760|83014749|FG001|Overall Study|Laboratory abnormality|0|||
46796443|NCT00474760|83014750|FG002|Overall Study|Laboratory abnormality|0|||
46796444|NCT00474760|83014751|FG003|Overall Study|Laboratory abnormality|0|||
46796445|NCT00474760|83014752|FG004|Overall Study|Laboratory abnormality|0|||
46796446|NCT00474760|83014753|FG005|Overall Study|Laboratory abnormality|1|||
46796447|NCT00474760|83014754|FG006|Overall Study|Laboratory abnormality|0|||
46796448|NCT00474760|83014748|FG000|Overall Study|Withdrawal by Subject|0|||
46796449|NCT00474760|83014749|FG001|Overall Study|Withdrawal by Subject|0|||
46796450|NCT00474760|83014750|FG002|Overall Study|Withdrawal by Subject|0|||
46796451|NCT00474760|83014751|FG003|Overall Study|Withdrawal by Subject|1|||
46796452|NCT00474760|83014752|FG004|Overall Study|Withdrawal by Subject|0|||
46796453|NCT00474760|83014753|FG005|Overall Study|Withdrawal by Subject|1|||
46796454|NCT00474760|83014754|FG006|Overall Study|Withdrawal by Subject|1|||
46796455|NCT00474760|83014748|FG000|Overall Study|Other|0|||
46796456|NCT00474760|83014749|FG001|Overall Study|Other|1|||
46796457|NCT00474760|83014750|FG002|Overall Study|Other|0|||
46796458|NCT00474760|83014751|FG003|Overall Study|Other|0|||
46796459|NCT00474760|83014752|FG004|Overall Study|Other|1|||
46796460|NCT00474760|83014753|FG005|Overall Study|Other|0|||
46796461|NCT00474760|83014754|FG006|Overall Study|Other|0|||
46796462|NCT00474760|83014748|FG000|Overall Study|Progressive disease|3|||
46796463|NCT00474760|83014749|FG001|Overall Study|Progressive disease|2|||
46796464|NCT00474760|83014750|FG002|Overall Study|Progressive disease|3|||
46796465|NCT00474760|83014751|FG003|Overall Study|Progressive disease|2|||
46796466|NCT00474760|83014752|FG004|Overall Study|Progressive disease|8|||
46796467|NCT00474760|83014753|FG005|Overall Study|Progressive disease|20|||
46796468|NCT00474760|83014754|FG006|Overall Study|Progressive disease|7|||
46796469|NCT00474760|83014748|FG000|Overall Study|Terminated by sponsor|0|||
46796470|NCT00474760|83014749|FG001|Overall Study|Terminated by sponsor|0|||
46796471|NCT00474760|83014750|FG002|Overall Study|Terminated by sponsor|0|||
46796472|NCT00474760|83014751|FG003|Overall Study|Terminated by sponsor|0|||
46796473|NCT00474760|83014752|FG004|Overall Study|Terminated by sponsor|0|||
46796474|NCT00474760|83014753|FG005|Overall Study|Terminated by sponsor|0|||
46796475|NCT00474760|83014754|FG006|Overall Study|Terminated by sponsor|2|||
46796476|NCT00528645|83014777|FG000|Overall Study|Adverse Event|3|||
46796477|NCT00524745|83014786|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
46796478|NCT00524745|83014787|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
46796479|NCT00524745|83014788|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
46857111|NCT00369707|83072911|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
46857112|NCT00369707|83072911|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
46857113|NCT00369707|83072911|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
46857114|NCT00369707|83072911|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
46677698|NCT00171249|82893139|FG005|Overall Study|Adverse Event|2|||
46677699|NCT00171249|82893140|FG006|Overall Study|Adverse Event|0|||
46677700|NCT00171249|82893134|FG000|Overall Study|Lost to Follow-up|5|||
46677701|NCT00171249|82893135|FG001|Overall Study|Lost to Follow-up|0|||
46677702|NCT00171249|82893136|FG002|Overall Study|Lost to Follow-up|0|||
46677703|NCT00171249|82893137|FG003|Overall Study|Lost to Follow-up|9|||
46677704|NCT00171249|82893138|FG004|Overall Study|Lost to Follow-up|0|||
46677705|NCT00171249|82893139|FG005|Overall Study|Lost to Follow-up|0|||
46677706|NCT00171249|82893140|FG006|Overall Study|Lost to Follow-up|0|||
46677707|NCT01085630|82893151|FG000|Overall Study|Insufficient data|1|||
46677708|NCT01085630|82893152|FG001|Overall Study|Insufficient data|0|||
46677709|NCT01085630|82893151|FG000|Overall Study|Ineligible|3|||
46677710|NCT01085630|82893152|FG001|Overall Study|Ineligible|0|||
46677711|NCT00171210|82893160|FG000|Overall Study|Adverse Event|16|||
46677712|NCT00171210|82893161|FG001|Overall Study|Adverse Event|27|||
46677713|NCT00171210|82893160|FG000|Overall Study|Abnormal laboratory value(s)|6|||
46677714|NCT00171210|82893161|FG001|Overall Study|Abnormal laboratory value(s)|3|||
46677715|NCT00171210|82893160|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46677716|NCT00171210|82893161|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46677717|NCT00171210|82893160|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
46677718|NCT00171210|82893161|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
46677719|NCT00171210|82893160|FG000|Overall Study|Protocol Violation|0|||
46677720|NCT00171210|82893161|FG001|Overall Study|Protocol Violation|2|||
46677721|NCT00171210|82893160|FG000|Overall Study|Withdrawal by Subject|32|||
46677722|NCT00171210|82893161|FG001|Overall Study|Withdrawal by Subject|30|||
46677723|NCT00171210|82893160|FG000|Overall Study|Lost to Follow-up|1|||
46677724|NCT00171210|82893161|FG001|Overall Study|Lost to Follow-up|0|||
46677725|NCT00171210|82893160|FG000|Overall Study|Administrative problems|1|||
46677726|NCT00171210|82893161|FG001|Overall Study|Administrative problems|1|||
46677727|NCT00171210|82893160|FG000|Overall Study|Death|2|||
46677728|NCT00171210|82893161|FG001|Overall Study|Death|3|||
46677729|NCT00171210|82893160|FG000|Overall Study|Stopped at end of core|0|||
46677730|NCT00171210|82893161|FG001|Overall Study|Stopped at end of core|32|||
46677731|NCT00171210|82893160|FG000|Overall Study|Stopped at end of extension 1|0|||
46677732|NCT00171210|82893161|FG001|Overall Study|Stopped at end of extension 1|1|||
46677733|NCT00171054|82893169|FG000|Overall Study|Protocol Violation|1|||
46677734|NCT00171054|82893170|FG001|Overall Study|Protocol Violation|2|||
46677735|NCT00171054|82893169|FG000|Overall Study|Patient withdrew consent|1|||
46677736|NCT00171054|82893170|FG001|Overall Study|Patient withdrew consent|0|||
46677737|NCT00171054|82893169|FG000|Overall Study|Lost to Follow-up|0|||
46677738|NCT00171054|82893170|FG001|Overall Study|Lost to Follow-up|1|||
46677739|NCT00171054|82893169|FG000|Overall Study|Adverse Event|8|||
46677740|NCT00171054|82893170|FG001|Overall Study|Adverse Event|8|||
46677741|NCT00171054|82893169|FG000|Overall Study|Condition no longer required study drug|0|||
46796480|NCT00524745|83014789|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
46796481|NCT00495040|83014799|FG000|Overall Study|Withdrawal by Subject|3|||
46796482|NCT00494026|83014807|FG000|Overall Study|Sponsor Decision|4|||
46857115|NCT00369707|83072911|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
46677742|NCT00171054|82893170|FG001|Overall Study|Condition no longer required study drug|1|||
46677743|NCT01084694|82893178|FG000|Overall Study|Withdrawal by Subject|2|||
46677744|NCT01084694|82893179|FG001|Overall Study|Withdrawal by Subject|1|||
46796483|NCT00524589|83014811|FG000|Overall Study|Withdrawal by Subject|2|||
46796484|NCT00524589|83014811|FG000|Overall Study|Disease Progression|16|||
46796485|NCT00472030|83014817|FG000|Overall Study|Physician Decision|1|||
46796486|NCT00472030|83014818|FG001|Overall Study|Physician Decision|0|||
46796487|NCT00127855|83014833|FG000|Primary Vaccination Course|Adverse Event|0|||
46796488|NCT00127855|83014834|FG001|Primary Vaccination Course|Adverse Event|0|||
46796489|NCT00127855|83014835|FG002|Primary Vaccination Course|Adverse Event|1|||
46796490|NCT00127855|83014836|FG003|Primary Vaccination Course|Adverse Event|0|||
46796491|NCT00127855|83014837|FG004|Primary Vaccination Course|Adverse Event|0|||
46796492|NCT00127855|83014833|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
46796493|NCT00127855|83014834|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
46796494|NCT00127855|83014835|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
46796495|NCT00127855|83014836|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
46796496|NCT00127855|83014837|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
46796497|NCT00127855|83014833|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
46796498|NCT00127855|83014834|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
46796499|NCT00127855|83014835|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
46796500|NCT00127855|83014836|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
46796501|NCT00127855|83014837|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
46796502|NCT00127855|83014833|FG000|Primary Vaccination Course|Other|0|||
46796503|NCT00127855|83014834|FG001|Primary Vaccination Course|Other|0|||
46796504|NCT00127855|83014835|FG002|Primary Vaccination Course|Other|0|||
46796505|NCT00127855|83014836|FG003|Primary Vaccination Course|Other|0|||
46796506|NCT00127855|83014837|FG004|Primary Vaccination Course|Other|1|||
46796507|NCT00493636|83014851|FG000|Overall Study|Withdrawal by Subject|1|||
46796508|NCT00493636|83014852|FG001|Overall Study|Withdrawal by Subject|0|||
46796509|NCT00493636|83014851|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
46796510|NCT00493636|83014852|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
46796511|NCT00493636|83014851|FG000|Overall Study|Mis-randomization|1|||
46796512|NCT00493636|83014852|FG001|Overall Study|Mis-randomization|1|||
46796513|NCT00524121|83014858|FG000|Overall Study|Disease progression|6|||
46796514|NCT00524121|83014858|FG000|Overall Study|Adverse Event|4|||
46796515|NCT00524121|83014858|FG000|Overall Study|Patient refused|2|||
46796516|NCT00524121|83014858|FG000|Overall Study|Other|1|||
46796517|NCT00524121|83014858|FG000|Overall Study|Death|1|||
46796518|NCT00524121|83014858|FG000|Overall Study|Not treated (became ineligible)|4|||
46796519|NCT00524121|83014858|FG000|Overall Study|Not treated (changed mind)|1|||
46796520|NCT00470626|83014873|FG000|Overall Study|Lost to Follow-up|10|||
46796521|NCT00470626|83014873|FG000|Overall Study|Withdrawal by Subject|7|||
46796522|NCT00132769|83014879|FG000|Overall Study|Withdrawal by Subject|1|||
46796523|NCT00132769|83014880|FG001|Overall Study|Withdrawal by Subject|3|||
46677745|NCT01084694|82893178|FG000|Overall Study|Death|2|||
46677746|NCT01084694|82893179|FG001|Overall Study|Death|12|||
46677747|NCT01084694|82893178|FG000|Overall Study|eligibility not maintained|2|||
46677748|NCT01084694|82893179|FG001|Overall Study|eligibility not maintained|7|||
46677749|NCT00479856|82893193|FG000|Overall Study|Adverse Event|1|||
46677750|NCT00479856|82893193|FG000|Overall Study|Withdrawal by Subject|1|||
46677751|NCT00479856|82893193|FG000|Overall Study|Physician Decision|1|||
46677752|NCT00479466|82893203|FG000|Overall Study|Adverse Event|5|||
46677753|NCT00479466|82893204|FG001|Overall Study|Adverse Event|1|||
46677754|NCT00479466|82893205|FG002|Overall Study|Adverse Event|0|||
46677755|NCT00479466|82893206|FG003|Overall Study|Adverse Event|1|||
46677756|NCT00479466|82893207|FG004|Overall Study|Adverse Event|2|||
46796524|NCT00132769|83014879|FG000|Overall Study|Lack of Efficacy|7|||
46796525|NCT00132769|83014880|FG001|Overall Study|Lack of Efficacy|6|||
46796526|NCT00132769|83014879|FG000|Overall Study|Adverse Event|2|||
46796527|NCT00132769|83014880|FG001|Overall Study|Adverse Event|1|||
46796528|NCT00132769|83014879|FG000|Overall Study|Protocol Violation|1|||
46796529|NCT00132769|83014880|FG001|Overall Study|Protocol Violation|1|||
46796530|NCT00520299|83014889|FG000|Overall Study|Withdrawal by Subject|0|||
46796531|NCT00520299|83014890|FG001|Overall Study|Withdrawal by Subject|0|||
46677757|NCT00479466|82893208|FG005|Overall Study|Adverse Event|0|||
46796532|NCT00520299|83014891|FG002|Overall Study|Withdrawal by Subject|2|||
46796533|NCT00520299|83014889|FG000|Overall Study|Progressive disease|0|||
46796534|NCT00520299|83014890|FG001|Overall Study|Progressive disease|3|||
46796535|NCT00520299|83014891|FG002|Overall Study|Progressive disease|4|||
46796536|NCT02478255|83014901|FG000|Overall Study|Physician Decision|6|||
46796537|NCT02478255|83014902|FG001|Overall Study|Physician Decision|0|||
46796538|NCT02478255|83014901|FG000|Overall Study|Withdrawal by Subject|2|||
46677758|NCT00479466|82893203|FG000|Overall Study|Hyperglycemia|0|||
46857116|NCT00369707|83072911|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
46796539|NCT02478255|83014902|FG001|Overall Study|Withdrawal by Subject|0|||
46796540|NCT00132691|83014910|FG000|Overall Study|Lost to Follow-up|5|||
46796541|NCT00132691|83014911|FG001|Overall Study|Lost to Follow-up|8|||
46796542|NCT00132691|83014910|FG000|Overall Study|Missed 2-year visit|4|||
46796543|NCT00132691|83014911|FG001|Overall Study|Missed 2-year visit|4|||
46796544|NCT00132691|83014910|FG000|Overall Study|Death|2|||
46796545|NCT00132691|83014911|FG001|Overall Study|Death|0|||
46796546|NCT00125359|83014922|FG000|Overall Study|Death|4|||
46796547|NCT00125359|83014922|FG000|Overall Study|Adverse Event|5|||
46796548|NCT00125359|83014922|FG000|Overall Study|Physician Decision|14|||
46796549|NCT00524043|83014929|FG000|Overall Study|Lack of Efficacy|15|||
46796550|NCT00524043|83014930|FG001|Overall Study|Lack of Efficacy|13|||
46796551|NCT00524043|83014931|FG002|Overall Study|Lack of Efficacy|14|||
46796552|NCT00524043|83014929|FG000|Overall Study|Withdrawal by Subject|5|||
46796553|NCT00524043|83014930|FG001|Overall Study|Withdrawal by Subject|7|||
46796554|NCT00524043|83014931|FG002|Overall Study|Withdrawal by Subject|7|||
46796555|NCT00524043|83014929|FG000|Overall Study|Adverse Event|5|||
46796556|NCT00524043|83014930|FG001|Overall Study|Adverse Event|2|||
47081552|NCT02323113|83404759|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
47081553|NCT02323113|83404760|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
47081554|NCT02281383|83404807|FG000|Overall Study|Progressive Disease|1|||
47081555|NCT02281383|83404807|FG000|Overall Study|Withdrawal by Subject|6|||
47081556|NCT02281383|83404807|FG000|Overall Study|Protocol Violation|2|||
47081557|NCT02281383|83404807|FG000|Overall Study|Death|1|||
47081558|NCT02281383|83404807|FG000|Overall Study|Adverse Event|2|||
47081559|NCT01047553|83404813|FG000|Overall Study|Adverse Event|10|||
46677759|NCT00479466|82893204|FG001|Overall Study|Hyperglycemia|0|||
46677760|NCT00479466|82893205|FG002|Overall Study|Hyperglycemia|0|||
46677761|NCT00479466|82893206|FG003|Overall Study|Hyperglycemia|0|||
46796557|NCT00524043|83014931|FG002|Overall Study|Adverse Event|7|||
46796558|NCT00524043|83014929|FG000|Overall Study|Lost to Follow-up|3|||
47081560|NCT01047553|83404814|FG001|Overall Study|Adverse Event|5|||
47081561|NCT01047553|83404813|FG000|Overall Study|Withdrawal by Subject|4|||
47081562|NCT01047553|83404814|FG001|Overall Study|Withdrawal by Subject|2|||
47081563|NCT01047553|83404813|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
47081564|NCT01047553|83404814|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
47081565|NCT01047553|83404813|FG000|Overall Study|Lost to Follow-up|1|||
47081566|NCT01047553|83404814|FG001|Overall Study|Lost to Follow-up|0|||
47081567|NCT01047553|83404813|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
47081568|NCT01047553|83404814|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
47081569|NCT01047553|83404813|FG000|Overall Study|PI's decision|0|||
47081570|NCT01047553|83404814|FG001|Overall Study|PI's decision|1|||
46796559|NCT00524043|83014930|FG001|Overall Study|Lost to Follow-up|5|||
46796560|NCT00524043|83014931|FG002|Overall Study|Lost to Follow-up|3|||
46796561|NCT00524043|83014929|FG000|Overall Study|Various (eg, incarceration)|2|||
46796562|NCT00524043|83014930|FG001|Overall Study|Various (eg, incarceration)|1|||
46796563|NCT00524043|83014931|FG002|Overall Study|Various (eg, incarceration)|0|||
46796564|NCT00523419|83014939|FG000|Overall Study|Adverse Event|1|||
46796565|NCT00523419|83014939|FG000|Overall Study|Withdrawal by Subject|1|||
46796566|NCT00523419|83014939|FG000|Overall Study|Physician Decision|2|||
46796567|NCT00523419|83014939|FG000|Overall Study|Progressive Disease|22|||
46796568|NCT00523419|83014939|FG000|Overall Study|Death due to Study Disease|4|||
46796569|NCT00523419|83014939|FG000|Overall Study|Death due to Adverse Event|2|||
46796570|NCT03868059|83014943|FG000|Overall Study|Adverse Event|3|||
46796571|NCT03868059|83014943|FG000|Overall Study|Lost to Follow-up|3|||
46796572|NCT03868059|83014943|FG000|Overall Study|Withdrawal by Subject|6|||
46796573|NCT00522951|83014947|FG000|Period 1|body motion|0|||
46796574|NCT00522951|83014948|FG001|Period 1|body motion|1|||
46796575|NCT00522951|83014947|FG000|Washout Period|Adverse Event|0|||
46796576|NCT00522951|83014948|FG001|Washout Period|Adverse Event|1|||
46796577|NCT00522951|83014947|FG000|Washout Period|Death|0|||
46796578|NCT00522951|83014948|FG001|Washout Period|Death|1|||
46796579|NCT00522951|83014947|FG000|Period 2|Withdrawal by Subject|1|||
46796580|NCT00522951|83014948|FG001|Period 2|Withdrawal by Subject|0|||
46796581|NCT00522951|83014947|FG000|Period 2|residual contrast medium|1|||
46796582|NCT00522951|83014948|FG001|Period 2|residual contrast medium|1|||
46796583|NCT03865953|83014960|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
46796584|NCT03865953|83014961|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
46796585|NCT03865953|83014960|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
46796586|NCT03865953|83014961|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
46796587|NCT03865953|83014960|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
46796588|NCT03865953|83014961|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
46796589|NCT05439941|83014979|FG000|Overall Study|Lack of Efficacy|8|||
46796590|NCT05439941|83014980|FG001|Overall Study|Lack of Efficacy|5|||
46796591|NCT05439941|83014981|FG002|Overall Study|Lack of Efficacy|3|||
46796592|NCT05439941|83014979|FG000|Overall Study|Treatment Failure|0|||
46796593|NCT05439941|83014980|FG001|Overall Study|Treatment Failure|1|||
46796594|NCT05439941|83014981|FG002|Overall Study|Treatment Failure|0|||
46796595|NCT05439941|83014979|FG000|Overall Study|Adverse Event|1|||
46796596|NCT05439941|83014980|FG001|Overall Study|Adverse Event|3|||
46796597|NCT05439941|83014981|FG002|Overall Study|Adverse Event|0|||
46796598|NCT05439941|83014979|FG000|Overall Study|Adverse Event - Parent Study|1|||
46796599|NCT05439941|83014980|FG001|Overall Study|Adverse Event - Parent Study|0|||
46979826|NCT02474199|83225433|FG002|Overall Study|Lost to Follow-up|0|||
46677762|NCT00479466|82893207|FG004|Overall Study|Hyperglycemia|0|||
46677763|NCT00479466|82893208|FG005|Overall Study|Hyperglycemia|1|||
46677764|NCT00479466|82893203|FG000|Overall Study|Lack of Efficacy|2|||
46677765|NCT00479466|82893204|FG001|Overall Study|Lack of Efficacy|0|||
46677766|NCT00479466|82893205|FG002|Overall Study|Lack of Efficacy|1|||
46677767|NCT00479466|82893206|FG003|Overall Study|Lack of Efficacy|0|||
46677768|NCT00479466|82893207|FG004|Overall Study|Lack of Efficacy|0|||
46677769|NCT00479466|82893208|FG005|Overall Study|Lack of Efficacy|0|||
46677770|NCT00479466|82893203|FG000|Overall Study|Lost to Follow-up|0|||
46677771|NCT00479466|82893204|FG001|Overall Study|Lost to Follow-up|1|||
46677772|NCT00479466|82893205|FG002|Overall Study|Lost to Follow-up|1|||
46677773|NCT00479466|82893206|FG003|Overall Study|Lost to Follow-up|0|||
46677774|NCT00479466|82893207|FG004|Overall Study|Lost to Follow-up|2|||
46677775|NCT00479466|82893208|FG005|Overall Study|Lost to Follow-up|2|||
46677776|NCT00479466|82893203|FG000|Overall Study|Physician Decision|2|||
46677777|NCT00479466|82893204|FG001|Overall Study|Physician Decision|1|||
46677778|NCT00479466|82893205|FG002|Overall Study|Physician Decision|1|||
46677779|NCT00479466|82893206|FG003|Overall Study|Physician Decision|0|||
46677780|NCT00479466|82893207|FG004|Overall Study|Physician Decision|0|||
46677781|NCT00479466|82893208|FG005|Overall Study|Physician Decision|0|||
46677782|NCT00479466|82893203|FG000|Overall Study|Pregnancy|0|||
46677783|NCT00479466|82893204|FG001|Overall Study|Pregnancy|0|||
46677784|NCT00479466|82893205|FG002|Overall Study|Pregnancy|0|||
46677785|NCT00479466|82893206|FG003|Overall Study|Pregnancy|0|||
46677786|NCT00479466|82893207|FG004|Overall Study|Pregnancy|1|||
46677787|NCT00479466|82893208|FG005|Overall Study|Pregnancy|0|||
46677788|NCT00479466|82893203|FG000|Overall Study|Protocol Violation|1|||
46677789|NCT00479466|82893204|FG001|Overall Study|Protocol Violation|0|||
46677790|NCT00479466|82893205|FG002|Overall Study|Protocol Violation|0|||
46677791|NCT00479466|82893206|FG003|Overall Study|Protocol Violation|0|||
46677792|NCT00479466|82893207|FG004|Overall Study|Protocol Violation|0|||
46677793|NCT00479466|82893208|FG005|Overall Study|Protocol Violation|0|||
46677794|NCT00479466|82893203|FG000|Overall Study|Withdrawal by Subject|3|||
46677795|NCT00479466|82893204|FG001|Overall Study|Withdrawal by Subject|5|||
46677796|NCT00479466|82893205|FG002|Overall Study|Withdrawal by Subject|0|||
46677797|NCT00479466|82893206|FG003|Overall Study|Withdrawal by Subject|2|||
46677798|NCT00479466|82893207|FG004|Overall Study|Withdrawal by Subject|3|||
46677799|NCT00479466|82893208|FG005|Overall Study|Withdrawal by Subject|1|||
46677800|NCT00479388|82893224|FG000|Overall Study|Adverse Event|90|||
46677801|NCT00479388|82893225|FG001|Overall Study|Adverse Event|45|||
46677802|NCT00479388|82893224|FG000|Overall Study|Lost to Follow-up|0|||
46677803|NCT00479388|82893225|FG001|Overall Study|Lost to Follow-up|2|||
46677804|NCT00479388|82893224|FG000|Overall Study|Protocol Violation|10|||
46677805|NCT00479388|82893225|FG001|Overall Study|Protocol Violation|9|||
46677806|NCT00479388|82893224|FG000|Overall Study|Withdrawal by Subject|32|||
46677807|NCT00479388|82893225|FG001|Overall Study|Withdrawal by Subject|17|||
46677808|NCT00479232|82893233|FG000|Overall Study|Adverse Event|0|||
46677809|NCT00479232|82893234|FG001|Overall Study|Adverse Event|0|||
46677810|NCT00479232|82893235|FG002|Overall Study|Adverse Event|5|||
46677811|NCT00479232|82893236|FG003|Overall Study|Adverse Event|0|||
46677812|NCT00479232|82893237|FG004|Overall Study|Adverse Event|0|||
46677813|NCT00479232|82893238|FG005|Overall Study|Adverse Event|10|||
46677814|NCT00479232|82893233|FG000|Overall Study|Deviation from Protocol|0|||
46677815|NCT00479232|82893234|FG001|Overall Study|Deviation from Protocol|0|||
46677816|NCT00479232|82893235|FG002|Overall Study|Deviation from Protocol|1|||
46677817|NCT00479232|82893236|FG003|Overall Study|Deviation from Protocol|0|||
46677818|NCT00479232|82893237|FG004|Overall Study|Deviation from Protocol|0|||
46677819|NCT00479232|82893238|FG005|Overall Study|Deviation from Protocol|0|||
46677820|NCT00479232|82893233|FG000|Overall Study|Lack of Efficacy|0|||
46677821|NCT00479232|82893234|FG001|Overall Study|Lack of Efficacy|0|||
46677822|NCT00479232|82893235|FG002|Overall Study|Lack of Efficacy|2|||
46677823|NCT00479232|82893236|FG003|Overall Study|Lack of Efficacy|0|||
46677824|NCT00479232|82893237|FG004|Overall Study|Lack of Efficacy|0|||
46677825|NCT00479232|82893238|FG005|Overall Study|Lack of Efficacy|4|||
46677826|NCT00479232|82893233|FG000|Overall Study|Physician Decision|0|||
46677827|NCT00479232|82893234|FG001|Overall Study|Physician Decision|0|||
46677828|NCT00479232|82893235|FG002|Overall Study|Physician Decision|2|||
46677829|NCT00479232|82893236|FG003|Overall Study|Physician Decision|0|||
46677830|NCT00479232|82893237|FG004|Overall Study|Physician Decision|0|||
46677831|NCT00479232|82893238|FG005|Overall Study|Physician Decision|1|||
46677832|NCT00479232|82893233|FG000|Overall Study|Progressive Disease|3|||
46677833|NCT00479232|82893234|FG001|Overall Study|Progressive Disease|1|||
46677834|NCT00479232|82893235|FG002|Overall Study|Progressive Disease|12|||
46677835|NCT00479232|82893236|FG003|Overall Study|Progressive Disease|3|||
46677836|NCT00479232|82893237|FG004|Overall Study|Progressive Disease|3|||
46677837|NCT00479232|82893238|FG005|Overall Study|Progressive Disease|12|||
46677838|NCT00479232|82893233|FG000|Overall Study|Withdrew Consent|0|||
46677839|NCT00479232|82893234|FG001|Overall Study|Withdrew Consent|2|||
46677840|NCT00479232|82893235|FG002|Overall Study|Withdrew Consent|6|||
46677841|NCT00479232|82893236|FG003|Overall Study|Withdrew Consent|0|||
46677842|NCT00479232|82893237|FG004|Overall Study|Withdrew Consent|1|||
46677843|NCT00479232|82893238|FG005|Overall Study|Withdrew Consent|3|||
46677844|NCT00478881|82893258|FG000|Overall Study|Adverse Event|31|||
46677845|NCT00478881|82893259|FG001|Overall Study|Adverse Event|12|||
46677846|NCT00478881|82893258|FG000|Overall Study|Lack of Efficacy|0|||
46677847|NCT00478881|82893259|FG001|Overall Study|Lack of Efficacy|3|||
46677848|NCT00478881|82893258|FG000|Overall Study|Lost to Follow-up|0|||
46677849|NCT00478881|82893259|FG001|Overall Study|Lost to Follow-up|1|||
46677850|NCT00478881|82893258|FG000|Overall Study|Protocol Violation|2|||
46677851|NCT00478881|82893259|FG001|Overall Study|Protocol Violation|2|||
46677852|NCT00478881|82893258|FG000|Overall Study|Withdrawal by Subject|6|||
46796600|NCT05439941|83014981|FG002|Overall Study|Adverse Event - Parent Study|0|||
46796601|NCT05439941|83014979|FG000|Overall Study|Pregnancy|1|||
46796602|NCT05439941|83014980|FG001|Overall Study|Pregnancy|0|||
46677853|NCT00478881|82893259|FG001|Overall Study|Withdrawal by Subject|2|||
46677854|NCT00478881|82893258|FG000|Overall Study|Non-Compliance with Study Medication|0|||
46677855|NCT00478881|82893259|FG001|Overall Study|Non-Compliance with Study Medication|2|||
46796603|NCT05439941|83014981|FG002|Overall Study|Pregnancy|0|||
46677856|NCT00478647|82893265|FG000|Overall Study|Adverse Event|1|||
46677857|NCT00478647|82893265|FG000|Overall Study|Withdrawal by Subject|1|||
46677858|NCT00478608|82893269|FG000|Overall Study|Adverse Event|1|||
46677859|NCT00478608|82893269|FG000|Overall Study|Serious Adverse Event|14|||
46677860|NCT00478608|82893269|FG000|Overall Study|Withdrawal by Subject|2|||
46677861|NCT00478608|82893269|FG000|Overall Study|Protocol Violation|3|||
46677862|NCT00478257|82893275|FG000|Overall Study|Withdrawal by Subject|8|||
46677863|NCT00478257|82893276|FG001|Overall Study|Withdrawal by Subject|3|||
46677864|NCT00478140|82893282|FG000|Overall Study|Clinical Disease Progression|1|||
46677865|NCT00478023|82893291|FG000|Overall Study|Adverse Event|11|||
46677866|NCT00478023|82893292|FG001|Overall Study|Adverse Event|7|||
46677867|NCT00478023|82893293|FG002|Overall Study|Adverse Event|8|||
46677868|NCT00478023|82893294|FG003|Overall Study|Adverse Event|14|||
46677869|NCT00478023|82893295|FG004|Overall Study|Adverse Event|6|||
46677870|NCT00478023|82893291|FG000|Overall Study|Death|1|||
46677871|NCT00478023|82893292|FG001|Overall Study|Death|0|||
46677872|NCT00478023|82893293|FG002|Overall Study|Death|0|||
46677873|NCT00478023|82893294|FG003|Overall Study|Death|0|||
46677874|NCT00478023|82893295|FG004|Overall Study|Death|0|||
46677875|NCT00478023|82893291|FG000|Overall Study|Lack of Efficacy|11|||
46677876|NCT00478023|82893292|FG001|Overall Study|Lack of Efficacy|10|||
46677877|NCT00478023|82893293|FG002|Overall Study|Lack of Efficacy|4|||
46677878|NCT00478023|82893294|FG003|Overall Study|Lack of Efficacy|5|||
46677879|NCT00478023|82893295|FG004|Overall Study|Lack of Efficacy|41|||
46677880|NCT00478023|82893291|FG000|Overall Study|Lost to Follow-up|3|||
46677881|NCT00478023|82893292|FG001|Overall Study|Lost to Follow-up|1|||
46677882|NCT00478023|82893293|FG002|Overall Study|Lost to Follow-up|1|||
46677883|NCT00478023|82893294|FG003|Overall Study|Lost to Follow-up|1|||
46677884|NCT00478023|82893295|FG004|Overall Study|Lost to Follow-up|0|||
46677885|NCT00478023|82893291|FG000|Overall Study|Withdrawal by Subject|2|||
46677886|NCT00478023|82893292|FG001|Overall Study|Withdrawal by Subject|3|||
46677887|NCT00478023|82893293|FG002|Overall Study|Withdrawal by Subject|2|||
46677888|NCT00478023|82893294|FG003|Overall Study|Withdrawal by Subject|4|||
46677889|NCT00478023|82893295|FG004|Overall Study|Withdrawal by Subject|5|||
46677890|NCT00478023|82893291|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
46677891|NCT00478023|82893292|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
46677892|NCT00478023|82893293|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
46677893|NCT00478023|82893294|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
46677894|NCT00478023|82893295|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
46677895|NCT00477750|82893307|FG000|Overall Study|Currently Receiving Treatment|11|||
46677896|NCT00477672|82893316|FG000|Overall Study|Adverse Event|3|||
46677897|NCT00477672|82893317|FG001|Overall Study|Adverse Event|5|||
46677898|NCT00477672|82893318|FG002|Overall Study|Adverse Event|6|||
46677899|NCT00477672|82893316|FG000|Overall Study|Death|0|||
46677900|NCT00477672|82893317|FG001|Overall Study|Death|1|||
46677901|NCT00477672|82893318|FG002|Overall Study|Death|0|||
46677902|NCT00477672|82893316|FG000|Overall Study|Disease progression|0|||
46677903|NCT00477672|82893317|FG001|Overall Study|Disease progression|1|||
46677904|NCT00477672|82893318|FG002|Overall Study|Disease progression|0|||
46677905|NCT00477672|82893316|FG000|Overall Study|Physician Decision|1|||
46677906|NCT00477672|82893317|FG001|Overall Study|Physician Decision|0|||
46677907|NCT00477672|82893318|FG002|Overall Study|Physician Decision|0|||
46677908|NCT00477672|82893316|FG000|Overall Study|Protocol noncompliance|0|||
46677909|NCT00477672|82893317|FG001|Overall Study|Protocol noncompliance|2|||
46677910|NCT00477672|82893318|FG002|Overall Study|Protocol noncompliance|0|||
46677911|NCT00477672|82893316|FG000|Overall Study|Consent withdrawn|2|||
46677912|NCT00477672|82893317|FG001|Overall Study|Consent withdrawn|5|||
46677913|NCT00477672|82893318|FG002|Overall Study|Consent withdrawn|10|||
46677914|NCT00477672|82893316|FG000|Overall Study|Discretion of Sponsor|1|||
46677915|NCT00477672|82893317|FG001|Overall Study|Discretion of Sponsor|2|||
46677916|NCT00477672|82893318|FG002|Overall Study|Discretion of Sponsor|0|||
46677917|NCT00477633|82893326|FG000|Overall Study|Did not receive treatment|23|||
46677918|NCT00477633|82893326|FG000|Overall Study|Adverse Event|143|||
46796604|NCT05439941|83014979|FG000|Overall Study|Withdrawal by Subject|9|||
46796605|NCT05439941|83014980|FG001|Overall Study|Withdrawal by Subject|6|||
46796606|NCT05439941|83014981|FG002|Overall Study|Withdrawal by Subject|10|||
46796607|NCT05439941|83014979|FG000|Overall Study|Non-Compliance|1|||
46796608|NCT05439941|83014980|FG001|Overall Study|Non-Compliance|1|||
46677919|NCT00477633|82893326|FG000|Overall Study|Pregnancy|23|||
46677920|NCT00477633|82893326|FG000|Overall Study|Lost to Follow-up|271|||
46677921|NCT00477633|82893326|FG000|Overall Study|Withdrawal by Subject|149|||
46677922|NCT00477633|82893326|FG000|Overall Study|Protocol Violation|25|||
46677923|NCT00477633|82893326|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
46677924|NCT01131676|82893342|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
46677925|NCT01131676|82893343|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
46677926|NCT01131676|82893344|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
46677927|NCT01131676|82893342|FG000|Discontinuation From Treatment|Not treated|4|||
46677928|NCT01131676|82893343|FG001|Discontinuation From Treatment|Not treated|2|||
46677929|NCT01131676|82893344|FG002|Discontinuation From Treatment|Not treated|2|||
46677930|NCT01131676|82893342|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
46677931|NCT01131676|82893343|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
46677932|NCT01131676|82893344|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
46677933|NCT01131676|82893342|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
46677934|NCT01131676|82893343|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
46677935|NCT01131676|82893344|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
46677936|NCT01131676|82893342|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
46677937|NCT01131676|82893343|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
46677938|NCT01131676|82893344|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
46677939|NCT01131676|82893342|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
46677940|NCT01131676|82893343|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
46677941|NCT01131676|82893344|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
46677942|NCT01131676|82893342|FG000|Discontinuation From Treatment|Other than those specified|162|||
46677943|NCT01131676|82893343|FG001|Discontinuation From Treatment|Other than those specified|142|||
46677944|NCT01131676|82893344|FG002|Discontinuation From Treatment|Other than those specified|125|||
46677945|NCT01131676|82893342|FG000|Discontinuation From Treatment|Adverse Event|303|||
46677946|NCT01131676|82893343|FG001|Discontinuation From Treatment|Adverse Event|267|||
46677947|NCT01131676|82893344|FG002|Discontinuation From Treatment|Adverse Event|273|||
46677948|NCT01131676|82893342|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
46677949|NCT01131676|82893343|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
46677950|NCT01131676|82893344|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
46677951|NCT01131676|82893342|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
46796609|NCT05439941|83014981|FG002|Overall Study|Non-Compliance|1|||
46796610|NCT05439941|83014979|FG000|Overall Study|Lost to Follow-up|2|||
46796611|NCT05439941|83014980|FG001|Overall Study|Lost to Follow-up|2|||
46796612|NCT05439941|83014981|FG002|Overall Study|Lost to Follow-up|0|||
46796613|NCT05439941|83014979|FG000|Overall Study|Physician Decision|1|||
46796614|NCT05439941|83014980|FG001|Overall Study|Physician Decision|0|||
46796615|NCT05439941|83014981|FG002|Overall Study|Physician Decision|0|||
47081571|NCT01046695|83404846|FG000|Overall Study|Subject had a pacemaker|0|||
46677952|NCT01131676|82893343|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
47081572|NCT01046695|83404847|FG001|Overall Study|Subject had a pacemaker|1|||
46677953|NCT01131676|82893344|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
46796616|NCT05439941|83014979|FG000|Overall Study|Trial Termination by Sponsor|78|||
46796617|NCT05439941|83014980|FG001|Overall Study|Trial Termination by Sponsor|83|||
47081573|NCT01046695|83404846|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
46796618|NCT05439941|83014981|FG002|Overall Study|Trial Termination by Sponsor|65|||
46796619|NCT05439941|83014979|FG000|Overall Study|Other than Reasons Listed|2|||
46677954|NCT01131676|82893342|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
46677955|NCT01131676|82893343|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
46677956|NCT01131676|82893344|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
46677957|NCT01131676|82893342|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
46677958|NCT01131676|82893343|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
46677959|NCT01131676|82893344|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
46677960|NCT01131676|82893342|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
46677961|NCT01131676|82893343|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
46677962|NCT01131676|82893344|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
46677963|NCT01131676|82893342|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
46677964|NCT01131676|82893343|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
46677965|NCT01131676|82893344|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
46677966|NCT01131520|82893366|FG000|Overall Study|Computer problem|1|||
46677967|NCT01131520|82893367|FG001|Overall Study|Computer problem|0|||
46796620|NCT05439941|83014980|FG001|Overall Study|Other than Reasons Listed|1|||
46796621|NCT05439941|83014981|FG002|Overall Study|Other than Reasons Listed|0|||
46796622|NCT05091918|83014989|FG000|Overall Study|Adverse Event|1|||
46796623|NCT05091918|83014989|FG000|Overall Study|Withdrawal by Subject|81|||
46796624|NCT04912895|83014996|FG000|Overall Study|Unable to provide specimen|2|||
46796625|NCT04912895|83014997|FG001|Overall Study|Unable to provide specimen|0|||
46796626|NCT04912895|83014998|FG002|Overall Study|Unable to provide specimen|0|||
46796627|NCT04776720|83015006|FG000|Overall Study|COVID Related|4|||
46796628|NCT04776720|83015007|FG001|Overall Study|COVID Related|2|||
46796629|NCT04776720|83015006|FG000|Overall Study|Adverse Event|2|||
46796630|NCT04776720|83015007|FG001|Overall Study|Adverse Event|0|||
46796631|NCT04776720|83015006|FG000|Overall Study|Serious Adverse Event|0|||
46796632|NCT04776720|83015007|FG001|Overall Study|Serious Adverse Event|1|||
46796633|NCT04776720|83015006|FG000|Overall Study|Too Busy|3|||
46796634|NCT04776720|83015007|FG001|Overall Study|Too Busy|1|||
46857117|NCT00369707|83072911|FG000|Follow up for 2 Years After Treatment|Death|1|||
46857118|NCT00369707|83072911|FG000|Follow up for 2 Years After Treatment|Other|2|||
46857119|NCT02943460|83072918|FG000|Blinded Study Phase|Adverse Event|3|||
46857120|NCT02943460|83072919|FG001|Blinded Study Phase|Adverse Event|0|||
46857121|NCT02943460|83072920|FG002|Blinded Study Phase|Adverse Event|0|||
46857122|NCT02943460|83072918|FG000|Blinded Study Phase|Withdrew Consent|0|||
46857123|NCT02943460|83072919|FG001|Blinded Study Phase|Withdrew Consent|1|||
46857124|NCT02943460|83072920|FG002|Blinded Study Phase|Withdrew Consent|0|||
46857125|NCT02943460|83072918|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
46796635|NCT04776720|83015006|FG000|Overall Study|Lost to Follow-up|1|||
46857126|NCT02943460|83072919|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
46857127|NCT02943460|83072920|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
46857128|NCT02943460|83072918|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
46857129|NCT02943460|83072919|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
46796636|NCT04776720|83015007|FG001|Overall Study|Lost to Follow-up|2|||
46677968|NCT01131520|82893366|FG000|Overall Study|Counselor not available|0|||
46677969|NCT01131520|82893367|FG001|Overall Study|Counselor not available|3|||
46677970|NCT01131520|82893366|FG000|Overall Study|Subject changed history after enrollment|0|||
46677971|NCT01131520|82893367|FG001|Overall Study|Subject changed history after enrollment|1|||
46677972|NCT01131325|82893373|FG000|Overall Study|Adverse Event|1|||
46677973|NCT01131325|82893373|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
46677974|NCT01131130|82893377|FG000|Period 1 - Baseline|Pregnancy|1|||
46677975|NCT01131130|82893377|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
46677976|NCT01130974|82893387|FG000|Overall Study|Protocol Violation|10|||
46677977|NCT01130974|82893388|FG001|Overall Study|Protocol Violation|10|||
46677978|NCT01130974|82893387|FG000|Overall Study|Withdrawal by Subject|0|||
46677979|NCT01130974|82893388|FG001|Overall Study|Withdrawal by Subject|1|||
46677980|NCT01130974|82893387|FG000|Overall Study|Ineligibility criteria|5|||
46677981|NCT01130974|82893388|FG001|Overall Study|Ineligibility criteria|2|||
46677982|NCT01130272|82893400|FG000|Overall Study|Adverse Event|2|||
46677983|NCT01130272|82893401|FG001|Overall Study|Adverse Event|5|||
46677984|NCT01130272|82893402|FG002|Overall Study|Adverse Event|6|||
46677985|NCT01130272|82893403|FG003|Overall Study|Adverse Event|22|||
46677986|NCT01130272|82893404|FG004|Overall Study|Adverse Event|7|||
46677987|NCT01130272|82893400|FG000|Overall Study|IVRS-confirmed constipation|0|||
46796637|NCT04776720|83015006|FG000|Overall Study|Family|2|||
46796638|NCT04776720|83015007|FG001|Overall Study|Family|2|||
46796639|NCT04776720|83015006|FG000|Overall Study|No remote technology access|0|||
46979827|NCT02474199|83225434|FG003|Overall Study|Lost to Follow-up|0|||
46979828|NCT02474199|83225431|FG000|Overall Study|Withdrawal by Subject|1|||
46979829|NCT02474199|83225432|FG001|Overall Study|Withdrawal by Subject|2|||
46979830|NCT02474199|83225433|FG002|Overall Study|Withdrawal by Subject|0|||
46796640|NCT04776720|83015007|FG001|Overall Study|No remote technology access|1|||
46979831|NCT02474199|83225434|FG003|Overall Study|Withdrawal by Subject|1|||
46979832|NCT02474199|83225431|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
46979833|NCT02474199|83225432|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
46979834|NCT02474199|83225433|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
46979835|NCT02474199|83225434|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
46979836|NCT02474199|83225431|FG000|Overall Study|Did not meet eligibility criteria|0|||
46979837|NCT02474199|83225432|FG001|Overall Study|Did not meet eligibility criteria|0|||
46979838|NCT02474199|83225433|FG002|Overall Study|Did not meet eligibility criteria|2|||
46979839|NCT02474199|83225434|FG003|Overall Study|Did not meet eligibility criteria|2|||
46979840|NCT02450487|83225441|FG000|Overall Study|Lost to Follow-up|3|||
46979841|NCT02473965|83225448|FG000|Overall Study|Adverse Event|6|||
46979842|NCT02473965|83225449|FG001|Overall Study|Adverse Event|4|||
46979843|NCT02473965|83225448|FG000|Overall Study|MG worsening|4|||
46979844|NCT02473965|83225449|FG001|Overall Study|MG worsening|1|||
46979845|NCT02473965|83225448|FG000|Overall Study|Withdrawal by Subject|2|||
46979846|NCT02473965|83225449|FG001|Overall Study|Withdrawal by Subject|3|||
46979847|NCT02473965|83225448|FG000|Overall Study|Physician Decision|0|||
46979848|NCT02473965|83225449|FG001|Overall Study|Physician Decision|2|||
46979849|NCT02472795|83225460|FG000|Overall Study|Adverse Event|0|||
46979850|NCT02472795|83225461|FG001|Overall Study|Adverse Event|1|||
46979851|NCT02472795|83225462|FG002|Overall Study|Adverse Event|0|||
46979852|NCT02472795|83225463|FG003|Overall Study|Adverse Event|0|||
46979853|NCT02472795|83225464|FG004|Overall Study|Adverse Event|2|||
46979854|NCT02472795|83225460|FG000|Overall Study|Withdrawal by Subject|0|||
46979855|NCT02472795|83225461|FG001|Overall Study|Withdrawal by Subject|0|||
46979856|NCT02472795|83225462|FG002|Overall Study|Withdrawal by Subject|0|||
46979857|NCT02472795|83225463|FG003|Overall Study|Withdrawal by Subject|0|||
46979858|NCT02472795|83225464|FG004|Overall Study|Withdrawal by Subject|1|||
46979859|NCT02507349|83225478|FG000|Overall Study|Death|12|||
46979860|NCT02507349|83225479|FG001|Overall Study|Death|16|||
46979861|NCT02507349|83225478|FG000|Overall Study|Withdrawal by Subject|1|||
46979862|NCT02507349|83225479|FG001|Overall Study|Withdrawal by Subject|1|||
46979863|NCT02507349|83225478|FG000|Overall Study|Lost to Follow-up|174|||
46979864|NCT02507349|83225479|FG001|Overall Study|Lost to Follow-up|144|||
46677988|NCT01130272|82893401|FG001|Overall Study|IVRS-confirmed constipation|1|||
46796641|NCT04776720|83015006|FG000|Overall Study|Withdrawal by Subject|1|||
46796642|NCT04776720|83015007|FG001|Overall Study|Withdrawal by Subject|0|||
46677989|NCT01130272|82893402|FG002|Overall Study|IVRS-confirmed constipation|1|||
46796643|NCT04776720|83015006|FG000|Overall Study|Cannot tolerate intervention|1|||
46796644|NCT04776720|83015007|FG001|Overall Study|Cannot tolerate intervention|0|||
46796645|NCT04776720|83015006|FG000|Overall Study|Incomplete outcome data|6|||
46796646|NCT04776720|83015007|FG001|Overall Study|Incomplete outcome data|1|||
46979865|NCT02506881|83225489|FG000|First Intervention (Day 1)|Protocol Violation|0|||
46677990|NCT01130272|82893403|FG003|Overall Study|IVRS-confirmed constipation|2|||
46796647|NCT04675151|83015026|FG000|Overall Study|Protocol Violation|1|||
46796648|NCT04675151|83015027|FG001|Overall Study|Protocol Violation|0|||
46796649|NCT04675151|83015028|FG002|Overall Study|Protocol Violation|0|||
46857130|NCT02943460|83072920|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
46857131|NCT02943460|83072918|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
46857132|NCT02943460|83072919|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
46857133|NCT02943460|83072920|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
46796650|NCT04675151|83015029|FG003|Overall Study|Protocol Violation|1|||
46796651|NCT04599907|83015042|FG000|Overall Study|Withdrawal by Subject|1|||
46796652|NCT04599907|83015043|FG001|Overall Study|Withdrawal by Subject|7|||
46796653|NCT04599907|83015044|FG002|Overall Study|Withdrawal by Subject|6|||
46796654|NCT04599907|83015042|FG000|Overall Study|Lost to Follow-up|0|||
46979866|NCT02506881|83225490|FG001|First Intervention (Day 1)|Protocol Violation|0|||
46979867|NCT02506881|83225491|FG002|First Intervention (Day 1)|Protocol Violation|1|||
46979868|NCT02506881|83225492|FG003|First Intervention (Day 1)|Protocol Violation|0|||
46979869|NCT02506881|83225489|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
46979870|NCT02506881|83225490|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
46979871|NCT02506881|83225491|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
46979872|NCT02506881|83225492|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
46979873|NCT02506881|83225489|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
46979874|NCT02506881|83225490|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
46979875|NCT02506881|83225491|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
46979876|NCT02506881|83225492|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
46979877|NCT02506257|83225516|FG000|Overall Study|Adverse Event|0|||
46979878|NCT02506257|83225517|FG001|Overall Study|Adverse Event|2|||
46979879|NCT02506257|83225518|FG002|Overall Study|Adverse Event|3|||
46979880|NCT02506257|83225519|FG003|Overall Study|Adverse Event|0|||
46979881|NCT02506257|83225516|FG000|Overall Study|Protocol Violation|0|||
46979882|NCT02506257|83225517|FG001|Overall Study|Protocol Violation|0|||
46979883|NCT02506257|83225518|FG002|Overall Study|Protocol Violation|1|||
46979884|NCT02506257|83225519|FG003|Overall Study|Protocol Violation|0|||
46979885|NCT02506101|83225531|FG000|Overall Study|Transportation issues|1|||
46979886|NCT02506101|83225532|FG001|Overall Study|Transportation issues|0|||
46979887|NCT02506101|83225531|FG000|Overall Study|No enrollment and staff unavailability|1|||
46979888|NCT02506101|83225532|FG001|Overall Study|No enrollment and staff unavailability|0|||
46979889|NCT01671007|83225547|FG000|Overall Study|Other reasons than listed|166|||
46979890|NCT01671007|83225548|FG001|Overall Study|Other reasons than listed|373|||
46857134|NCT03768206|83072931|FG000|Overall Study|Lost to Follow-up|2|||
46857135|NCT03768206|83072932|FG001|Overall Study|Lost to Follow-up|1|||
46857136|NCT03768206|83072931|FG000|Overall Study|Withdrawal by Subject|0|||
46857137|NCT03768206|83072932|FG001|Overall Study|Withdrawal by Subject|1|||
46857138|NCT03767894|83072939|FG000|Overall Study|Withdrawal by Subject|1|||
46979891|NCT01671007|83225549|FG002|Overall Study|Other reasons than listed|197|||
46979892|NCT01671007|83225550|FG003|Overall Study|Other reasons than listed|228|||
46979893|NCT01671007|83225551|FG004|Overall Study|Other reasons than listed|14|||
46979894|NCT01671007|83225552|FG005|Overall Study|Other reasons than listed|71|||
46979895|NCT01671007|83225553|FG006|Overall Study|Other reasons than listed|17|||
46979896|NCT01671007|83225554|FG007|Overall Study|Other reasons than listed|66|||
46979897|NCT01671007|83225555|FG008|Overall Study|Other reasons than listed|0|||
46796655|NCT04599907|83015043|FG001|Overall Study|Lost to Follow-up|1|||
46796656|NCT04599907|83015044|FG002|Overall Study|Lost to Follow-up|0|||
46979898|NCT01671007|83225547|FG000|Overall Study|Withdrawal by Subject|36|||
46796657|NCT04503096|83015067|FG000|Overall Study|Withdrawal by Subject|3|||
46796658|NCT04270760|83015076|FG000|Overall Study|Withdrawal by Subject|0|||
46796659|NCT04270760|83015077|FG001|Overall Study|Withdrawal by Subject|1|||
46857139|NCT03766646|83072945|FG000|Overall Study|Withdrawal by Subject|1|||
46857140|NCT03766646|83072946|FG001|Overall Study|Withdrawal by Subject|0|||
46857141|NCT03766646|83072945|FG000|Overall Study|Protocol Violation|0|||
46857142|NCT03766646|83072946|FG001|Overall Study|Protocol Violation|3|||
46857143|NCT03765164|83072954|FG000|Pre-intervention|Withdrawal by Subject|5|||
46857144|NCT03765164|83072955|FG001|Pre-intervention|Withdrawal by Subject|6|||
46796660|NCT04270760|83015078|FG002|Overall Study|Withdrawal by Subject|3|||
46796661|NCT04270760|83015079|FG003|Overall Study|Withdrawal by Subject|0|||
46796662|NCT04270760|83015080|FG004|Overall Study|Withdrawal by Subject|0|||
46796663|NCT04270760|83015076|FG000|Overall Study|Lost to Follow-up|1|||
46796664|NCT04270760|83015077|FG001|Overall Study|Lost to Follow-up|2|||
46796665|NCT04270760|83015078|FG002|Overall Study|Lost to Follow-up|1|||
46857145|NCT00369629|83072961|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
46857146|NCT00369629|83072962|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
46857147|NCT00369629|83072963|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
46857148|NCT00369629|83072964|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
46857149|NCT00369629|83072961|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
46857150|NCT00369629|83072962|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
46857151|NCT00369629|83072963|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
46857152|NCT00369629|83072964|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
46857153|NCT00369629|83072961|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
46979899|NCT01671007|83225548|FG001|Overall Study|Withdrawal by Subject|59|||
46979900|NCT01671007|83225549|FG002|Overall Study|Withdrawal by Subject|53|||
46677991|NCT01130272|82893404|FG004|Overall Study|IVRS-confirmed constipation|0|||
46677992|NCT01130272|82893400|FG000|Overall Study|Rescue medications due to diarrhea|3|||
46677993|NCT01130272|82893401|FG001|Overall Study|Rescue medications due to diarrhea|5|||
46677994|NCT01130272|82893402|FG002|Overall Study|Rescue medications due to diarrhea|8|||
46677995|NCT01130272|82893403|FG003|Overall Study|Rescue medications due to diarrhea|8|||
46677996|NCT01130272|82893404|FG004|Overall Study|Rescue medications due to diarrhea|6|||
46677997|NCT01130272|82893400|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
46677998|NCT01130272|82893401|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
46677999|NCT01130272|82893402|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
46678000|NCT01130272|82893403|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
46678001|NCT01130272|82893404|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
46678002|NCT01130272|82893400|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
46678003|NCT01130272|82893401|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
46678004|NCT01130272|82893402|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
46678005|NCT01130272|82893403|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
46678006|NCT01130272|82893404|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
46678007|NCT01130272|82893400|FG000|Overall Study|Protocol Violation|0|||
46678008|NCT01130272|82893401|FG001|Overall Study|Protocol Violation|0|||
46678009|NCT01130272|82893402|FG002|Overall Study|Protocol Violation|3|||
46678010|NCT01130272|82893403|FG003|Overall Study|Protocol Violation|5|||
46678011|NCT01130272|82893404|FG004|Overall Study|Protocol Violation|5|||
46678012|NCT01130272|82893400|FG000|Overall Study|Lost to Follow-up|4|||
46678013|NCT01130272|82893401|FG001|Overall Study|Lost to Follow-up|3|||
46678014|NCT01130272|82893402|FG002|Overall Study|Lost to Follow-up|4|||
46678015|NCT01130272|82893403|FG003|Overall Study|Lost to Follow-up|7|||
46796666|NCT04270760|83015079|FG003|Overall Study|Lost to Follow-up|0|||
46678016|NCT01130272|82893404|FG004|Overall Study|Lost to Follow-up|6|||
46678017|NCT01130272|82893400|FG000|Overall Study|Withdrawal by Subject|4|||
46678018|NCT01130272|82893401|FG001|Overall Study|Withdrawal by Subject|11|||
46678019|NCT01130272|82893402|FG002|Overall Study|Withdrawal by Subject|10|||
46678020|NCT01130272|82893403|FG003|Overall Study|Withdrawal by Subject|9|||
46678021|NCT01130272|82893404|FG004|Overall Study|Withdrawal by Subject|8|||
46678022|NCT01130272|82893400|FG000|Overall Study|Physician Decision|1|||
46678023|NCT01130272|82893401|FG001|Overall Study|Physician Decision|1|||
46678024|NCT01130272|82893402|FG002|Overall Study|Physician Decision|0|||
46678025|NCT01130272|82893403|FG003|Overall Study|Physician Decision|1|||
46678026|NCT01130272|82893404|FG004|Overall Study|Physician Decision|2|||
46678027|NCT01130272|82893400|FG000|Overall Study|Sponsor decision|6|||
46678028|NCT01130272|82893401|FG001|Overall Study|Sponsor decision|15|||
46678029|NCT01130272|82893402|FG002|Overall Study|Sponsor decision|16|||
46678030|NCT01130272|82893403|FG003|Overall Study|Sponsor decision|13|||
46678031|NCT01130272|82893404|FG004|Overall Study|Sponsor decision|16|||
46678032|NCT01130272|82893400|FG000|Overall Study|Study arm discontinued|38|||
46678033|NCT01130272|82893401|FG001|Overall Study|Study arm discontinued|0|||
46678034|NCT01130272|82893402|FG002|Overall Study|Study arm discontinued|0|||
46796667|NCT04270760|83015080|FG004|Overall Study|Lost to Follow-up|0|||
46796668|NCT04270760|83015076|FG000|Overall Study|Death|0|||
46796669|NCT04270760|83015077|FG001|Overall Study|Death|0|||
46796670|NCT04270760|83015078|FG002|Overall Study|Death|0|||
46796671|NCT04270760|83015079|FG003|Overall Study|Death|0|||
46796672|NCT04270760|83015080|FG004|Overall Study|Death|1|||
46796673|NCT04198363|83015099|FG000|Overall Study|Adverse Event|1|||
46796674|NCT04198363|83015100|FG001|Overall Study|Adverse Event|1|||
46796675|NCT04198363|83015099|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
46796676|NCT04198363|83015100|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
46678035|NCT01130272|82893403|FG003|Overall Study|Study arm discontinued|0|||
46678036|NCT01130272|82893404|FG004|Overall Study|Study arm discontinued|0|||
46796677|NCT04198363|83015099|FG000|Overall Study|Reason not Specified|1|||
46796678|NCT04198363|83015100|FG001|Overall Study|Reason not Specified|0|||
46678037|NCT01129960|82893420|FG000|Overall Study|Withdrawal by Subject|3|||
46678038|NCT01129960|82893421|FG001|Overall Study|Withdrawal by Subject|0|||
46678039|NCT01129960|82893422|FG002|Overall Study|Withdrawal by Subject|3|||
46678040|NCT01129960|82893423|FG003|Overall Study|Withdrawal by Subject|2|||
46678041|NCT01129960|82893420|FG000|Overall Study|Lack of Efficacy|1|||
46678042|NCT01129960|82893421|FG001|Overall Study|Lack of Efficacy|1|||
46678043|NCT01129960|82893422|FG002|Overall Study|Lack of Efficacy|1|||
46678044|NCT01129960|82893423|FG003|Overall Study|Lack of Efficacy|1|||
46678045|NCT01129960|82893420|FG000|Overall Study|Adverse Event|23|||
46678046|NCT01129960|82893421|FG001|Overall Study|Adverse Event|16|||
46678047|NCT01129960|82893422|FG002|Overall Study|Adverse Event|16|||
46678048|NCT01129960|82893423|FG003|Overall Study|Adverse Event|7|||
46678049|NCT01129960|82893420|FG000|Overall Study|Protocol Violation|1|||
46678050|NCT01129960|82893421|FG001|Overall Study|Protocol Violation|2|||
46678051|NCT01129960|82893422|FG002|Overall Study|Protocol Violation|3|||
46678052|NCT01129960|82893423|FG003|Overall Study|Protocol Violation|0|||
46678053|NCT01129960|82893420|FG000|Overall Study|Lost to Follow-up|0|||
46678054|NCT01129960|82893421|FG001|Overall Study|Lost to Follow-up|2|||
46678055|NCT01129960|82893422|FG002|Overall Study|Lost to Follow-up|3|||
46678056|NCT01129960|82893423|FG003|Overall Study|Lost to Follow-up|3|||
46678057|NCT01129960|82893420|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
46678058|NCT01129960|82893421|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
46678059|NCT01129960|82893422|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
46678060|NCT01129960|82893423|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
46678061|NCT01129960|82893420|FG000|Overall Study|Physician Decision|1|||
46678062|NCT01129960|82893421|FG001|Overall Study|Physician Decision|0|||
46678063|NCT01129960|82893422|FG002|Overall Study|Physician Decision|0|||
46678064|NCT01129960|82893423|FG003|Overall Study|Physician Decision|0|||
46678065|NCT01129960|82893420|FG000|Overall Study|Pregnancy|1|||
46678066|NCT01129960|82893421|FG001|Overall Study|Pregnancy|0|||
46678067|NCT01129960|82893422|FG002|Overall Study|Pregnancy|0|||
46678068|NCT01129960|82893423|FG003|Overall Study|Pregnancy|0|||
46678069|NCT01129921|82893435|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
46678070|NCT01129921|82893436|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
46678071|NCT01129921|82893435|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
46678072|NCT01129921|82893436|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
46678073|NCT01129921|82893435|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
46678074|NCT01129921|82893436|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
46678075|NCT01129921|82893435|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
46678076|NCT01129921|82893436|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
46678077|NCT01129882|82893455|FG000|Overall Study|Adverse Event|39|||
46678078|NCT01129882|82893455|FG000|Overall Study|Death|6|||
46678079|NCT01129882|82893455|FG000|Overall Study|Lack of Efficacy|5|||
46678080|NCT01129882|82893455|FG000|Overall Study|Lost to Follow-up|13|||
46678081|NCT01129882|82893455|FG000|Overall Study|Physician Decision|27|||
46678082|NCT01129882|82893455|FG000|Overall Study|Protocol Deviation|3|||
46678083|NCT01129882|82893455|FG000|Overall Study|Withdrawal Criteria Met|19|||
46678084|NCT01129882|82893455|FG000|Overall Study|Trial Termination by Sponsor|6|||
46678085|NCT01129882|82893455|FG000|Overall Study|Withdrawal by Subject|160|||
46678086|NCT01129102|82893462|FG000|Overall Study|No study drug treatment|2|||
46678087|NCT01129102|82893463|FG001|Overall Study|No study drug treatment|3|||
46678088|NCT01129102|82893464|FG002|Overall Study|No study drug treatment|1|||
46678089|NCT01129102|82893462|FG000|Overall Study|Withdrawal by Subject|2|||
46678090|NCT01129102|82893463|FG001|Overall Study|Withdrawal by Subject|0|||
46678091|NCT01129102|82893464|FG002|Overall Study|Withdrawal by Subject|3|||
46678092|NCT01129102|82893462|FG000|Overall Study|Protocol Violation|0|||
46678093|NCT01129102|82893463|FG001|Overall Study|Protocol Violation|1|||
46678094|NCT01129102|82893464|FG002|Overall Study|Protocol Violation|1|||
46678095|NCT01129102|82893462|FG000|Overall Study|Pregnancy|0|||
46678096|NCT01129102|82893463|FG001|Overall Study|Pregnancy|0|||
46678097|NCT01129102|82893464|FG002|Overall Study|Pregnancy|1|||
46678098|NCT01129102|82893462|FG000|Overall Study|Adverse Event|2|||
46678099|NCT01129102|82893463|FG001|Overall Study|Adverse Event|2|||
46678100|NCT01129102|82893464|FG002|Overall Study|Adverse Event|1|||
46678101|NCT01129102|82893462|FG000|Overall Study|Lost to Follow-up|2|||
46678102|NCT01129102|82893463|FG001|Overall Study|Lost to Follow-up|0|||
46678103|NCT01129102|82893464|FG002|Overall Study|Lost to Follow-up|0|||
46678104|NCT01129024|82893471|FG000|Overall Study|Physician Decision|5|||
46678105|NCT01129024|82893471|FG000|Overall Study|Study Terminated by Sponsor|8|||
46678106|NCT01129024|82893471|FG000|Overall Study|Withdrawal by Subject|2|||
46678107|NCT01129024|82893471|FG000|Overall Study|Lack of Efficacy|3|||
46678108|NCT01129024|82893471|FG000|Overall Study|Needed a Platelet Transfusion|1|||
46678109|NCT01128946|82893475|FG000|Period I|Protocol Violation|0|||
46678110|NCT01128946|82893476|FG001|Period I|Protocol Violation|1|||
46678111|NCT01128946|82893477|FG002|Period I|Protocol Violation|0|||
46678112|NCT01128946|82893478|FG003|Period I|Protocol Violation|0|||
46678113|NCT01128946|82893475|FG000|Period I|Withdrawal by Subject|0|||
46678114|NCT01128946|82893476|FG001|Period I|Withdrawal by Subject|0|||
46678115|NCT01128946|82893477|FG002|Period I|Withdrawal by Subject|1|||
46678116|NCT01128946|82893478|FG003|Period I|Withdrawal by Subject|1|||
46678117|NCT01128946|82893475|FG000|Period II|Protocol Violation|0|||
46678118|NCT01128946|82893476|FG001|Period II|Protocol Violation|1|||
46678119|NCT01128946|82893477|FG002|Period II|Protocol Violation|0|||
46678120|NCT01128946|82893478|FG003|Period II|Protocol Violation|0|||
46678121|NCT01128946|82893475|FG000|Period II|Withdrawal by Subject|0|||
46678122|NCT01128946|82893476|FG001|Period II|Withdrawal by Subject|0|||
46678123|NCT01128946|82893477|FG002|Period II|Withdrawal by Subject|0|||
46678124|NCT01128946|82893478|FG003|Period II|Withdrawal by Subject|1|||
46678125|NCT01128946|82893475|FG000|Period III|Protocol Violation|1|||
46678126|NCT01128946|82893476|FG001|Period III|Protocol Violation|0|||
46678127|NCT01128946|82893477|FG002|Period III|Protocol Violation|0|||
46678128|NCT01128946|82893478|FG003|Period III|Protocol Violation|0|||
46678129|NCT01128595|82893489|FG000|Treatment Period 3|Withdrawal by Subject|0|||
46678130|NCT01128595|82893490|FG001|Treatment Period 3|Withdrawal by Subject|1|||
46678131|NCT01128595|82893491|FG002|Treatment Period 3|Withdrawal by Subject|0|||
46678132|NCT01128595|82893492|FG003|Treatment Period 3|Withdrawal by Subject|0|||
46678133|NCT01129336|82893505|FG000|Overall Study|Protocol Violation|1|||
46678134|NCT01129336|82893506|FG001|Overall Study|Protocol Violation|0|||
46678135|NCT01129336|82893505|FG000|Overall Study|Disease Progression|1|||
46678136|NCT01129336|82893506|FG001|Overall Study|Disease Progression|4|||
46678137|NCT01129336|82893505|FG000|Overall Study|Lost to Follow-up|1|||
46678138|NCT01129336|82893506|FG001|Overall Study|Lost to Follow-up|0|||
46678139|NCT01129336|82893505|FG000|Overall Study|Withdrawal by Subject|7|||
46678140|NCT01129336|82893506|FG001|Overall Study|Withdrawal by Subject|4|||
46678141|NCT01129336|82893505|FG000|Overall Study|Adverse Event|0|||
46678142|NCT01129336|82893506|FG001|Overall Study|Adverse Event|1|||
46678143|NCT01129336|82893505|FG000|Overall Study|Missing Study Completion Status|2|||
46678144|NCT01129336|82893506|FG001|Overall Study|Missing Study Completion Status|3|||
46678145|NCT01129336|82893505|FG000|Overall Study|Death|0|||
46678146|NCT01129336|82893506|FG001|Overall Study|Death|4|||
46678147|NCT01128400|82893515|FG000|Overall Study|Lost to Follow-up|1|||
46678148|NCT01128400|82893516|FG001|Overall Study|Lost to Follow-up|0|||
46678149|NCT01128400|82893517|FG002|Overall Study|Lost to Follow-up|1|||
46678150|NCT01128400|82893515|FG000|Overall Study|Screening failure|1|||
46678151|NCT01128400|82893516|FG001|Overall Study|Screening failure|0|||
46678152|NCT01128400|82893517|FG002|Overall Study|Screening failure|0|||
46678153|NCT01128400|82893515|FG000|Overall Study|were not invited to participate on taste|0|||
46678154|NCT01128400|82893516|FG001|Overall Study|were not invited to participate on taste|0|||
46678155|NCT01128400|82893517|FG002|Overall Study|were not invited to participate on taste|15|||
46678156|NCT01128400|82893515|FG000|Overall Study|Excluded due to sinus problems|0|||
46678157|NCT01128400|82893516|FG001|Overall Study|Excluded due to sinus problems|1|||
46678158|NCT01128400|82893517|FG002|Overall Study|Excluded due to sinus problems|0|||
46678159|NCT01128361|82893527|FG000|Overall Study|Lost to Follow-up|0|||
46678160|NCT01128361|82893528|FG001|Overall Study|Lost to Follow-up|1|||
46678161|NCT01128361|82893527|FG000|Overall Study|Withdrawal by Subject|5|||
46678162|NCT01128361|82893528|FG001|Overall Study|Withdrawal by Subject|2|||
46678163|NCT01128244|82893534|FG000|Overall Study|Adverse Event|1|||
46678164|NCT01128244|82893534|FG000|Overall Study|Scheduling conflict|2|||
46678165|NCT01127893|82893542|FG000|Overall Study|Study Termination by the Sponsor|1|||
46678166|NCT01126879|82893548|FG000|Overall Study|Progressive Disease|3|||
46678167|NCT01126879|82893549|FG001|Overall Study|Progressive Disease|1|||
46678168|NCT01126879|82893548|FG000|Overall Study|Withdrawal by Subject|1|||
46678169|NCT01126879|82893549|FG001|Overall Study|Withdrawal by Subject|0|||
46678170|NCT01126879|82893548|FG000|Overall Study|Adverse Event|0|||
46678171|NCT01126879|82893549|FG001|Overall Study|Adverse Event|1|||
46678172|NCT01126879|82893548|FG000|Overall Study|Physician Decision|1|||
46678173|NCT01126879|82893549|FG001|Overall Study|Physician Decision|0|||
46678174|NCT01126060|82893557|FG000|Overall Study|Protocol Violation|0|||
46678175|NCT01126060|82893558|FG001|Overall Study|Protocol Violation|2|||
46678176|NCT01125748|82893566|FG000|Overall Study|Adverse Event|0|||
46678177|NCT01125748|82893567|FG001|Overall Study|Adverse Event|2|||
46678178|NCT01125748|82893566|FG000|Overall Study|Lost to Follow-up|0|||
46678179|NCT01125748|82893567|FG001|Overall Study|Lost to Follow-up|1|||
46678180|NCT01125748|82893566|FG000|Overall Study|Physician Decision|8|||
46678181|NCT01125748|82893567|FG001|Overall Study|Physician Decision|7|||
46678182|NCT01125748|82893566|FG000|Overall Study|Patient Decision to Withdraw|2|||
46678183|NCT01125748|82893567|FG001|Overall Study|Patient Decision to Withdraw|4|||
46678184|NCT01125514|82893573|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
46678185|NCT01125514|82893573|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
46678186|NCT01125514|82893573|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
46678187|NCT01125514|82893573|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
46678188|NCT01125514|82893573|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
46678189|NCT01125514|82893573|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
46678190|NCT01125358|82893591|FG000|Overall Study|Adverse Event|3|||
46678191|NCT01125358|82893592|FG001|Overall Study|Adverse Event|0|||
46678192|NCT01125358|82893593|FG002|Overall Study|Adverse Event|0|||
46678193|NCT01125358|82893594|FG003|Overall Study|Adverse Event|2|||
46678194|NCT01125358|82893591|FG000|Overall Study|Perceived Lack of Efficacy|6|||
46678195|NCT01125358|82893592|FG001|Overall Study|Perceived Lack of Efficacy|3|||
46678196|NCT01125358|82893593|FG002|Overall Study|Perceived Lack of Efficacy|7|||
46678197|NCT01125358|82893594|FG003|Overall Study|Perceived Lack of Efficacy|4|||
46678198|NCT01125358|82893591|FG000|Overall Study|Protocol Violation|1|||
46678199|NCT01125358|82893592|FG001|Overall Study|Protocol Violation|0|||
46678200|NCT01125358|82893593|FG002|Overall Study|Protocol Violation|0|||
46678201|NCT01125358|82893594|FG003|Overall Study|Protocol Violation|0|||
46678202|NCT01125358|82893591|FG000|Overall Study|Sponsor Decision|0|||
46678203|NCT01125358|82893592|FG001|Overall Study|Sponsor Decision|0|||
46678204|NCT01125358|82893593|FG002|Overall Study|Sponsor Decision|1|||
46678205|NCT01125358|82893594|FG003|Overall Study|Sponsor Decision|1|||
46678206|NCT01125358|82893591|FG000|Overall Study|Withdrawal by Subject|2|||
46678207|NCT01125358|82893592|FG001|Overall Study|Withdrawal by Subject|1|||
46678208|NCT01125358|82893593|FG002|Overall Study|Withdrawal by Subject|1|||
46678209|NCT01125358|82893594|FG003|Overall Study|Withdrawal by Subject|1|||
46678210|NCT01125046|82893604|FG000|First 6 Months of Treatment|Death|1|||
46678211|NCT01125046|82893604|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
46678212|NCT01125046|82893604|FG000|First 6 Months of Treatment|Non-compliance|1|||
46678213|NCT01125046|82893604|FG000|First 6 Months of Treatment|Surgery|1|||
46678214|NCT01125046|82893604|FG000|First 6 Months of Treatment|Progressive Disease|7|||
46678215|NCT01125046|82893604|FG000|First 6 Months of Treatment|Adverse Event|2|||
46678216|NCT01125046|82893604|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
46678217|NCT01125046|82893604|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
46678218|NCT01125046|82893604|FG000|Follow-up/Data Cut Off Point|Death|29|||
46678219|NCT01125046|82893604|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
46678220|NCT01124734|82893608|FG000|Overall Study|Disease progression|13|||
46678221|NCT01124734|82893608|FG000|Overall Study|Adverse Event|1|||
46678222|NCT01124734|82893608|FG000|Overall Study|Withdrawal by Subject|1|||
46678223|NCT01124734|82893608|FG000|Overall Study|Elected for alternative treatment|2|||
46678224|NCT01124617|82893619|FG000|Overall Study|Adverse Event|5|||
46678225|NCT01124617|82893620|FG001|Overall Study|Adverse Event|2|||
46678226|NCT01124617|82893619|FG000|Overall Study|Lack of Efficacy|2|||
46678227|NCT01124617|82893620|FG001|Overall Study|Lack of Efficacy|1|||
46678228|NCT01124617|82893619|FG000|Overall Study|Protocol Violation|1|||
46678229|NCT01124617|82893620|FG001|Overall Study|Protocol Violation|1|||
46678230|NCT01124617|82893619|FG000|Overall Study|Withdrawal by Subject|9|||
46678231|NCT01124617|82893620|FG001|Overall Study|Withdrawal by Subject|1|||
46678232|NCT01124617|82893619|FG000|Overall Study|Other|2|||
46678233|NCT01124617|82893620|FG001|Overall Study|Other|1|||
46678234|NCT01124422|82893628|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
46678235|NCT01124422|82893629|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
46796679|NCT04173247|83015108|FG000|Overall Study|Withdrawal by Subject|0|||
46796680|NCT04173247|83015109|FG001|Overall Study|Withdrawal by Subject|2|||
46796681|NCT04173247|83015108|FG000|Overall Study|Death|1|||
47081574|NCT01046695|83404847|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
47081575|NCT03304379|83404862|FG000|Overall Study|Protocol Violation|8|||
47081576|NCT03304379|83404863|FG001|Overall Study|Protocol Violation|10|||
47081577|NCT03304379|83404864|FG002|Overall Study|Protocol Violation|5|||
47081578|NCT03304379|83404865|FG003|Overall Study|Protocol Violation|0|||
47081579|NCT03304379|83404866|FG004|Overall Study|Protocol Violation|2|||
47081580|NCT03304379|83404862|FG000|Overall Study|Adverse Event|4|||
47081581|NCT03304379|83404863|FG001|Overall Study|Adverse Event|20|||
47081582|NCT03304379|83404864|FG002|Overall Study|Adverse Event|17|||
47081583|NCT03304379|83404865|FG003|Overall Study|Adverse Event|1|||
47081584|NCT03304379|83404866|FG004|Overall Study|Adverse Event|0|||
47081585|NCT03304379|83404862|FG000|Overall Study|Lack of Efficacy|17|||
47081586|NCT03304379|83404863|FG001|Overall Study|Lack of Efficacy|16|||
47081587|NCT03304379|83404864|FG002|Overall Study|Lack of Efficacy|20|||
47081588|NCT03304379|83404865|FG003|Overall Study|Lack of Efficacy|0|||
47081589|NCT03304379|83404866|FG004|Overall Study|Lack of Efficacy|0|||
47081590|NCT03304379|83404862|FG000|Overall Study|Physician Decision|6|||
46678236|NCT01124422|82893630|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
46678237|NCT01124422|82893628|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
46678238|NCT01124422|82893629|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
46678239|NCT01124422|82893630|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
46678240|NCT01124422|82893628|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
46678241|NCT01124422|82893629|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
46678242|NCT01124422|82893630|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
46678243|NCT01124422|82893628|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
46678244|NCT01124422|82893629|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
46678245|NCT01124422|82893630|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
47081591|NCT03304379|83404863|FG001|Overall Study|Physician Decision|10|||
47081592|NCT03304379|83404864|FG002|Overall Study|Physician Decision|6|||
46796682|NCT04173247|83015109|FG001|Overall Study|Death|0|||
46796683|NCT04173247|83015108|FG000|Overall Study|Physician Decision|1|||
46796684|NCT04173247|83015109|FG001|Overall Study|Physician Decision|0|||
46796685|NCT03943446|83015122|FG000|Overall Study|Lost to Follow-up|0|||
46796686|NCT03943446|83015123|FG001|Overall Study|Lost to Follow-up|0|||
46796687|NCT03943446|83015124|FG002|Overall Study|Lost to Follow-up|1|||
46796688|NCT03943446|83015122|FG000|Overall Study|Withdrawal by Subject|1|||
47081593|NCT03304379|83404865|FG003|Overall Study|Physician Decision|9|||
47081594|NCT03304379|83404866|FG004|Overall Study|Physician Decision|10|||
47081595|NCT03304379|83404862|FG000|Overall Study|Withdrawal by Subject|26|||
47081596|NCT03304379|83404863|FG001|Overall Study|Withdrawal by Subject|58|||
47081597|NCT03304379|83404864|FG002|Overall Study|Withdrawal by Subject|66|||
47081598|NCT03304379|83404865|FG003|Overall Study|Withdrawal by Subject|3|||
47081599|NCT03304379|83404866|FG004|Overall Study|Withdrawal by Subject|5|||
47081600|NCT03304379|83404862|FG000|Overall Study|Lost to Follow-up|8|||
47081601|NCT03304379|83404863|FG001|Overall Study|Lost to Follow-up|24|||
47081602|NCT03304379|83404864|FG002|Overall Study|Lost to Follow-up|35|||
47081603|NCT03304379|83404865|FG003|Overall Study|Lost to Follow-up|4|||
47081604|NCT03304379|83404866|FG004|Overall Study|Lost to Follow-up|0|||
46796689|NCT03943446|83015123|FG001|Overall Study|Withdrawal by Subject|1|||
47081605|NCT03304379|83404862|FG000|Overall Study|Death|1|||
47081606|NCT03304379|83404863|FG001|Overall Study|Death|2|||
47081607|NCT03304379|83404864|FG002|Overall Study|Death|0|||
46979901|NCT01671007|83225550|FG003|Overall Study|Withdrawal by Subject|58|||
46979902|NCT01671007|83225551|FG004|Overall Study|Withdrawal by Subject|4|||
46979903|NCT01671007|83225552|FG005|Overall Study|Withdrawal by Subject|15|||
46979904|NCT01671007|83225553|FG006|Overall Study|Withdrawal by Subject|1|||
46678246|NCT01124422|82893628|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
46979905|NCT01671007|83225554|FG007|Overall Study|Withdrawal by Subject|19|||
46979906|NCT01671007|83225555|FG008|Overall Study|Withdrawal by Subject|0|||
46678247|NCT01124422|82893629|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
46678248|NCT01124422|82893630|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
46857154|NCT00369629|83072962|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
46857155|NCT00369629|83072963|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
47081608|NCT03304379|83404865|FG003|Overall Study|Death|0|||
47081609|NCT03304379|83404866|FG004|Overall Study|Death|0|||
47081610|NCT03304379|83404862|FG000|Overall Study|Other|0|||
47081611|NCT03304379|83404863|FG001|Overall Study|Other|1|||
47081612|NCT03304379|83404864|FG002|Overall Study|Other|0|||
47081613|NCT03304379|83404865|FG003|Overall Study|Other|0|||
47081614|NCT03304379|83404866|FG004|Overall Study|Other|0|||
47081615|NCT01044433|83404939|FG000|Overall Study|Lost to Follow-up|3|||
47081616|NCT01044433|83404939|FG000|Overall Study|Withdrawal by Subject|3|||
47081617|NCT01043185|83404948|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
47081618|NCT01043185|83404949|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
47081619|NCT01043185|83404950|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
47081620|NCT01043185|83404951|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
47081621|NCT01043185|83404952|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
47081622|NCT01043185|83404953|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
47081623|NCT01043185|83404954|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
47081624|NCT01043185|83404955|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
47081625|NCT01043185|83404956|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
47081626|NCT01043185|83404957|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
47081627|NCT01042093|83404982|FG000|Overall Study|Protocol Violation|2|||
47081628|NCT01042093|83404983|FG001|Overall Study|Protocol Violation|2|||
47081629|NCT01042093|83404984|FG002|Overall Study|Protocol Violation|2|||
47081630|NCT01042093|83404985|FG003|Overall Study|Protocol Violation|3|||
47081631|NCT01042093|83404982|FG000|Overall Study|Withdrawal by Subject|0|||
47081632|NCT01042093|83404983|FG001|Overall Study|Withdrawal by Subject|0|||
47081633|NCT01042093|83404984|FG002|Overall Study|Withdrawal by Subject|0|||
47081634|NCT01042093|83404985|FG003|Overall Study|Withdrawal by Subject|1|||
47081635|NCT01041859|83405015|FG000|Open-Label Titration|Adverse Event|69|||
46796690|NCT03943446|83015124|FG002|Overall Study|Withdrawal by Subject|2|||
46796691|NCT03943446|83015122|FG000|Overall Study|Study Terminated by Sponsor|1|||
46796692|NCT03943446|83015123|FG001|Overall Study|Study Terminated by Sponsor|2|||
46796693|NCT03943446|83015124|FG002|Overall Study|Study Terminated by Sponsor|1|||
46796694|NCT03943446|83015122|FG000|Overall Study|Reason not Specified|5|||
46796695|NCT03943446|83015123|FG001|Overall Study|Reason not Specified|1|||
46796696|NCT03943446|83015124|FG002|Overall Study|Reason not Specified|3|||
46796697|NCT03632993|83015201|FG000|Overall Study|Withdrawal by Subject|1|||
46796698|NCT03632993|83015202|FG001|Overall Study|Withdrawal by Subject|0|||
46796699|NCT03632993|83015203|FG002|Overall Study|Withdrawal by Subject|0|||
46796700|NCT03632993|83015204|FG003|Overall Study|Withdrawal by Subject|0|||
46796701|NCT03632993|83015205|FG004|Overall Study|Withdrawal by Subject|0|||
46796702|NCT03632993|83015206|FG005|Overall Study|Withdrawal by Subject|0|||
46796703|NCT03632993|83015207|FG006|Overall Study|Withdrawal by Subject|0|||
46796704|NCT03632993|83015208|FG007|Overall Study|Withdrawal by Subject|0|||
46796705|NCT03632993|83015209|FG008|Overall Study|Withdrawal by Subject|0|||
46796706|NCT03632993|83015210|FG009|Overall Study|Withdrawal by Subject|1|||
46796707|NCT03632993|83015201|FG000|Overall Study|Protocol Non-compliance|0|||
46796708|NCT03632993|83015202|FG001|Overall Study|Protocol Non-compliance|1|||
46796709|NCT03632993|83015203|FG002|Overall Study|Protocol Non-compliance|0|||
46796710|NCT03632993|83015204|FG003|Overall Study|Protocol Non-compliance|0|||
46796711|NCT03632993|83015205|FG004|Overall Study|Protocol Non-compliance|0|||
46857156|NCT00369629|83072964|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
46857157|NCT00369629|83072961|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
46857158|NCT00369629|83072962|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
46857159|NCT00369629|83072963|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
46857160|NCT00369629|83072964|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
46857161|NCT00369629|83072961|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
46857162|NCT00369629|83072962|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
46857163|NCT00369629|83072963|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
46857164|NCT00369629|83072964|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
46857165|NCT00369629|83072961|FG000|Completed 4 More Cycles|Progressive disease|2|||
46857166|NCT00369629|83072962|FG001|Completed 4 More Cycles|Progressive disease|1|||
46857167|NCT00369629|83072963|FG002|Completed 4 More Cycles|Progressive disease|2|||
46857168|NCT00369629|83072964|FG003|Completed 4 More Cycles|Progressive disease|0|||
46857169|NCT00369629|83072961|FG000|Follow up for 1 Year|Death|2|||
46857170|NCT00369629|83072962|FG001|Follow up for 1 Year|Death|1|||
46857171|NCT00369629|83072963|FG002|Follow up for 1 Year|Death|1|||
46857172|NCT00369629|83072964|FG003|Follow up for 1 Year|Death|0|||
46857173|NCT00369629|83072961|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
46857174|NCT00369629|83072962|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
46857175|NCT00369629|83072963|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
46857176|NCT00369629|83072964|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
46857177|NCT00369629|83072961|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
46857178|NCT00369629|83072962|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
46857179|NCT00369629|83072963|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
46857180|NCT00369629|83072964|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
46857181|NCT02469064|83072976|FG000|Overall Study|Request not to receive intervention.|1|||
46857182|NCT02469064|83072977|FG001|Overall Study|Request not to receive intervention.|3|||
46857183|NCT02446912|83072986|FG000|Overall Study|Adverse Event|3|||
46857184|NCT02446912|83072987|FG001|Overall Study|Adverse Event|13|||
46857185|NCT02446912|83072988|FG002|Overall Study|Adverse Event|5|||
46857186|NCT02446912|83072986|FG000|Overall Study|Condition under investigation worsened|0|||
46857187|NCT02446912|83072987|FG001|Overall Study|Condition under investigation worsened|1|||
46857188|NCT02446912|83072988|FG002|Overall Study|Condition under investigation worsened|1|||
46857189|NCT02446912|83072986|FG000|Overall Study|Study-specific withdrawal criteria|1|||
46857190|NCT02446912|83072987|FG001|Overall Study|Study-specific withdrawal criteria|0|||
46857191|NCT02446912|83072988|FG002|Overall Study|Study-specific withdrawal criteria|0|||
46857192|NCT02446912|83072986|FG000|Overall Study|Lack of Efficacy|1|||
46857193|NCT02446912|83072987|FG001|Overall Study|Lack of Efficacy|4|||
46857194|NCT02446912|83072988|FG002|Overall Study|Lack of Efficacy|7|||
46857195|NCT02446912|83072986|FG000|Overall Study|Lost to Follow-up|0|||
46857196|NCT02446912|83072987|FG001|Overall Study|Lost to Follow-up|0|||
46857197|NCT02446912|83072988|FG002|Overall Study|Lost to Follow-up|2|||
46857198|NCT02446912|83072986|FG000|Overall Study|Severe non-compliance to protocol|1|||
46857199|NCT02446912|83072987|FG001|Overall Study|Severe non-compliance to protocol|0|||
46979907|NCT01671007|83225547|FG000|Overall Study|Lost to Follow-up|93|||
46857200|NCT02446912|83072988|FG002|Overall Study|Severe non-compliance to protocol|1|||
46979908|NCT01671007|83225548|FG001|Overall Study|Lost to Follow-up|142|||
46796712|NCT03632993|83015206|FG005|Overall Study|Protocol Non-compliance|0|||
46796713|NCT03632993|83015207|FG006|Overall Study|Protocol Non-compliance|0|||
46857201|NCT02446912|83072986|FG000|Overall Study|Withdrawal by Subject|10|||
46857202|NCT02446912|83072987|FG001|Overall Study|Withdrawal by Subject|15|||
46979909|NCT01671007|83225549|FG002|Overall Study|Lost to Follow-up|91|||
46979910|NCT01671007|83225550|FG003|Overall Study|Lost to Follow-up|63|||
46979911|NCT01671007|83225551|FG004|Overall Study|Lost to Follow-up|7|||
46979912|NCT01671007|83225552|FG005|Overall Study|Lost to Follow-up|20|||
46979913|NCT01671007|83225553|FG006|Overall Study|Lost to Follow-up|2|||
46979914|NCT01671007|83225554|FG007|Overall Study|Lost to Follow-up|28|||
46979915|NCT01671007|83225555|FG008|Overall Study|Lost to Follow-up|0|||
46979916|NCT01671007|83225547|FG000|Overall Study|No end of study case report form|3|||
46979917|NCT01671007|83225548|FG001|Overall Study|No end of study case report form|1|||
46979918|NCT01671007|83225549|FG002|Overall Study|No end of study case report form|0|||
46979919|NCT01671007|83225550|FG003|Overall Study|No end of study case report form|2|||
46979920|NCT01671007|83225551|FG004|Overall Study|No end of study case report form|0|||
46979921|NCT01671007|83225552|FG005|Overall Study|No end of study case report form|0|||
46979922|NCT01671007|83225553|FG006|Overall Study|No end of study case report form|0|||
46979923|NCT01671007|83225554|FG007|Overall Study|No end of study case report form|0|||
46979924|NCT01671007|83225555|FG008|Overall Study|No end of study case report form|0|||
46979925|NCT01671007|83225547|FG000|Overall Study|Not eligible|23|||
46979926|NCT01671007|83225548|FG001|Overall Study|Not eligible|76|||
46979927|NCT01671007|83225549|FG002|Overall Study|Not eligible|25|||
46979928|NCT01671007|83225550|FG003|Overall Study|Not eligible|17|||
46979929|NCT01671007|83225551|FG004|Overall Study|Not eligible|0|||
46979930|NCT01671007|83225552|FG005|Overall Study|Not eligible|6|||
46979931|NCT01671007|83225553|FG006|Overall Study|Not eligible|1|||
46979932|NCT01671007|83225554|FG007|Overall Study|Not eligible|19|||
46979933|NCT01671007|83225555|FG008|Overall Study|Not eligible|0|||
46979934|NCT02505945|83225568|FG000|Overall Study|Withdrawal by Subject|13|||
46979935|NCT02505945|83225569|FG001|Overall Study|Withdrawal by Subject|2|||
46979936|NCT02505945|83225568|FG000|Overall Study|Adverse Event|1|||
46979937|NCT02505945|83225569|FG001|Overall Study|Adverse Event|0|||
46979938|NCT02505945|83225568|FG000|Overall Study|Physician Decision|2|||
46979939|NCT02505945|83225569|FG001|Overall Study|Physician Decision|1|||
46979940|NCT02505945|83225568|FG000|Overall Study|Lost to Follow-up|6|||
46979941|NCT02505945|83225569|FG001|Overall Study|Lost to Follow-up|1|||
46979942|NCT02505867|83225577|FG000|Overall Study|Lack of Efficacy|6|||
46979943|NCT02505867|83225578|FG001|Overall Study|Lack of Efficacy|6|||
46979944|NCT02472639|83225586|FG000|Overall Study|Physician Decision|4|||
46979945|NCT02472639|83225587|FG001|Overall Study|Physician Decision|3|||
46979946|NCT02472405|83225593|FG000|Overall Study|Lost to Follow-up|9|||
46979947|NCT02472405|83225593|FG000|Overall Study|Adverse Event|1|||
46979948|NCT02448771|83225599|FG000|Overall Study|Disease Progression|30|||
46979949|NCT02448771|83225599|FG000|Overall Study|Unacceptable Toxicity|1|||
46979950|NCT02448771|83225599|FG000|Overall Study|Physician Decision|3|||
46979951|NCT02448771|83225599|FG000|Overall Study|Started new therapy|2|||
46979952|NCT02504541|83225604|FG000|Overall Study|Adverse Event|4|||
46979953|NCT02504541|83225604|FG000|Overall Study|Withdrawal by Subject|4|||
46979954|NCT02504541|83225604|FG000|Overall Study|Lost to Follow-up|1|||
46979955|NCT02504541|83225604|FG000|Overall Study|Met Stopping Criteria|1|||
46979956|NCT02504541|83225604|FG000|Overall Study|Protocol Violation|2|||
46979957|NCT02504541|83225604|FG000|Overall Study|Termination by Sponsor|1|||
47081636|NCT01041859|83405016|FG001|Open-Label Titration|Adverse Event|0|||
47081637|NCT01041859|83405017|FG002|Open-Label Titration|Adverse Event|0|||
47081638|NCT01041859|83405015|FG000|Open-Label Titration|Lack of Efficacy|3|||
46857203|NCT02446912|83072988|FG002|Overall Study|Withdrawal by Subject|15|||
46857204|NCT02446912|83072986|FG000|Overall Study|Miscellaneous|2|||
46857205|NCT02446912|83072987|FG001|Overall Study|Miscellaneous|2|||
46857206|NCT02446912|83072988|FG002|Overall Study|Miscellaneous|4|||
46857207|NCT00736840|83072996|FG000|Overall Study|Lost to Follow-up|13|||
46857208|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Adverse Event|11|||
46857209|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Adverse Event|23|||
46857210|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Adverse Event|29|||
46857211|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Adverse Event|2|||
46857212|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Adverse Event|8|||
46857213|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
46979958|NCT02504541|83225604|FG000|Overall Study|Other|2|||
46979959|NCT02504541|83225604|FG000|Overall Study|Multiple|5|||
47081639|NCT01041859|83405016|FG001|Open-Label Titration|Lack of Efficacy|0|||
47081640|NCT01041859|83405017|FG002|Open-Label Titration|Lack of Efficacy|0|||
47081641|NCT01041859|83405015|FG000|Open-Label Titration|Lost to Follow-up|1|||
46979960|NCT02448537|83225611|FG000|Overall Study|Withdrawal by Subject|1|||
46979961|NCT02448537|83225612|FG001|Overall Study|Withdrawal by Subject|1|||
47081642|NCT01041859|83405016|FG001|Open-Label Titration|Lost to Follow-up|0|||
46857214|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
46857215|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
46857216|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
46857217|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
46979962|NCT02448537|83225613|FG002|Overall Study|Withdrawal by Subject|1|||
46979963|NCT02504151|83225623|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
47081643|NCT01041859|83405017|FG002|Open-Label Titration|Lost to Follow-up|0|||
47081644|NCT01041859|83405015|FG000|Open-Label Titration|Physician Decision|1|||
47081645|NCT01041859|83405016|FG001|Open-Label Titration|Physician Decision|0|||
47081646|NCT01041859|83405017|FG002|Open-Label Titration|Physician Decision|0|||
47081647|NCT01041859|83405015|FG000|Open-Label Titration|Protocol Violation|1|||
47081648|NCT01041859|83405016|FG001|Open-Label Titration|Protocol Violation|0|||
47081649|NCT01041859|83405017|FG002|Open-Label Titration|Protocol Violation|0|||
47081650|NCT01041859|83405015|FG000|Open-Label Titration|Other|7|||
47081651|NCT01041859|83405016|FG001|Open-Label Titration|Other|0|||
47081652|NCT01041859|83405017|FG002|Open-Label Titration|Other|0|||
47081653|NCT01041859|83405015|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
47081654|NCT01041859|83405016|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
47081655|NCT01041859|83405017|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
47081656|NCT01041859|83405015|FG000|Open-Label Titration|Withdrawal by Subject|11|||
47081657|NCT01041859|83405016|FG001|Open-Label Titration|Withdrawal by Subject|0|||
47081658|NCT01041859|83405017|FG002|Open-Label Titration|Withdrawal by Subject|0|||
47081659|NCT01041859|83405015|FG000|Double-Blind Maintenance|Adverse Event|0|||
47081660|NCT01041859|83405016|FG001|Double-Blind Maintenance|Adverse Event|23|||
47081661|NCT01041859|83405017|FG002|Double-Blind Maintenance|Adverse Event|13|||
47081662|NCT01041859|83405015|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
47081663|NCT01041859|83405016|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
47081664|NCT01041859|83405017|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
47081665|NCT01041859|83405015|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
46678249|NCT01124422|82893628|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
46678250|NCT01124422|82893629|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
46678251|NCT01124422|82893630|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
46678252|NCT01124422|82893628|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
46678253|NCT01124422|82893629|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
46857218|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
46857219|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
46857220|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
46857221|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
46857222|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
46857223|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
46857224|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
46857225|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
46857226|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
46857227|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
46857228|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
46857229|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
47081666|NCT01041859|83405016|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
46678254|NCT01124422|82893630|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
46678255|NCT01124422|82893628|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
46678256|NCT01124422|82893629|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
46678257|NCT01124422|82893630|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
47081667|NCT01041859|83405017|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
47081668|NCT01041859|83405015|FG000|Double-Blind Maintenance|Physician Decision|0|||
47081669|NCT01041859|83405016|FG001|Double-Blind Maintenance|Physician Decision|2|||
46678258|NCT01124422|82893628|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
46678259|NCT01124422|82893629|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
46678260|NCT01124422|82893630|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
46678261|NCT01124422|82893628|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
46678262|NCT01124422|82893629|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
46678263|NCT01124422|82893630|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
46678264|NCT01124149|82893637|FG000|Acute Phase|Withdrawal by Subject|22|||
46678265|NCT01124149|82893637|FG000|Acute Phase|Adverse Event|21|||
46678266|NCT01124149|82893637|FG000|Acute Phase|Lack of Efficacy|17|||
46678267|NCT01124149|82893637|FG000|Acute Phase|Protocol Violation|14|||
46678268|NCT01124149|82893637|FG000|Acute Phase|Lost to Follow-up|2|||
46678269|NCT01124149|82893637|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
46678270|NCT01124149|82893637|FG000|Acute Phase|Sponsor request|1|||
46678271|NCT01124149|82893637|FG000|Acute Phase|UC symptoms not ameliorated|1|||
46678272|NCT01124149|82893637|FG000|Acute Phase|Non-compliance|1|||
46678273|NCT01124149|82893637|FG000|Acute Phase|Low hemoglobin|1|||
46678274|NCT01124149|82893637|FG000|Acute Phase|Travelling to another country|1|||
46678275|NCT01124149|82893637|FG000|Acute Phase|Sponsor decision|1|||
46678276|NCT01124149|82893637|FG000|Maintenance Phase|Lack of Efficacy|40|||
46678277|NCT01124149|82893637|FG000|Maintenance Phase|Adverse Event|24|||
46678278|NCT01124149|82893637|FG000|Maintenance Phase|Lost to Follow-up|15|||
46678279|NCT01124149|82893637|FG000|Maintenance Phase|Withdrawal by Subject|10|||
46678280|NCT01124149|82893637|FG000|Maintenance Phase|Protocol Violation|5|||
46678281|NCT01124149|82893637|FG000|Maintenance Phase|Coordinator error|1|||
46678282|NCT01124149|82893637|FG000|Maintenance Phase|Non-compliance|1|||
46678283|NCT01123642|82893644|FG000|Overall Study|Lost to Follow-up|23|||
46678284|NCT01123642|82893644|FG000|Overall Study|Withdrawal by Subject|9|||
47081670|NCT01041859|83405017|FG002|Double-Blind Maintenance|Physician Decision|1|||
47081671|NCT01041859|83405015|FG000|Double-Blind Maintenance|Protocol Violation|0|||
47081672|NCT01041859|83405016|FG001|Double-Blind Maintenance|Protocol Violation|1|||
47081673|NCT01041859|83405017|FG002|Double-Blind Maintenance|Protocol Violation|3|||
47081674|NCT01041859|83405015|FG000|Double-Blind Maintenance|Other|0|||
47081675|NCT01041859|83405016|FG001|Double-Blind Maintenance|Other|6|||
47081676|NCT01041859|83405017|FG002|Double-Blind Maintenance|Other|2|||
47081677|NCT01041859|83405015|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
47081678|NCT01041859|83405016|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
46796714|NCT03632993|83015208|FG007|Overall Study|Protocol Non-compliance|0|||
46796715|NCT03632993|83015209|FG008|Overall Study|Protocol Non-compliance|0|||
46796716|NCT03632993|83015210|FG009|Overall Study|Protocol Non-compliance|0|||
46678285|NCT01123642|82893644|FG000|Overall Study|ineligible at baseline assessment|36|||
46678286|NCT01122862|82893649|FG000|Period 1|Protocol Violation|0|||
46678287|NCT01122862|82893650|FG001|Period 1|Protocol Violation|1|||
46796717|NCT03632993|83015201|FG000|Overall Study|Lost to Follow-up|0|||
47081679|NCT01041859|83405017|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
47081680|NCT01041859|83405015|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
47081681|NCT01041859|83405016|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
47081682|NCT01041859|83405017|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
47081683|NCT01040845|83405026|FG000|Overall Study|Withdrawal by Subject|1|||
47081684|NCT01040845|83405027|FG001|Overall Study|Withdrawal by Subject|1|||
47081685|NCT01040845|83405026|FG000|Overall Study|Physician Decision|1|||
47081686|NCT01040845|83405027|FG001|Overall Study|Physician Decision|0|||
47081687|NCT01040689|83405035|FG000|Overall Study|Adverse Event|0|||
47081688|NCT01040689|83405036|FG001|Overall Study|Adverse Event|0|||
47081689|NCT01040689|83405037|FG002|Overall Study|Adverse Event|2|||
47081690|NCT01040689|83405038|FG003|Overall Study|Adverse Event|4|||
47081691|NCT01040689|83405035|FG000|Overall Study|Lack of Efficacy|0|||
47081692|NCT01040689|83405036|FG001|Overall Study|Lack of Efficacy|0|||
47081693|NCT01040689|83405037|FG002|Overall Study|Lack of Efficacy|1|||
47081694|NCT01040689|83405038|FG003|Overall Study|Lack of Efficacy|0|||
47081695|NCT01040689|83405035|FG000|Overall Study|Lost to Follow-up|1|||
47081696|NCT01040689|83405036|FG001|Overall Study|Lost to Follow-up|0|||
47081697|NCT01040689|83405037|FG002|Overall Study|Lost to Follow-up|0|||
47081698|NCT01040689|83405038|FG003|Overall Study|Lost to Follow-up|0|||
47081699|NCT01040689|83405035|FG000|Overall Study|Withdrawal by Subject|2|||
47081700|NCT01040689|83405036|FG001|Overall Study|Withdrawal by Subject|1|||
47081701|NCT01040689|83405037|FG002|Overall Study|Withdrawal by Subject|1|||
47081702|NCT01040689|83405038|FG003|Overall Study|Withdrawal by Subject|0|||
47081703|NCT01040689|83405035|FG000|Overall Study|Other reasons not listed above|0|||
46796718|NCT03632993|83015202|FG001|Overall Study|Lost to Follow-up|0|||
46678288|NCT01122862|82893651|FG002|Period 1|Protocol Violation|0|||
47081704|NCT01040689|83405036|FG001|Overall Study|Other reasons not listed above|1|||
47081705|NCT01040689|83405037|FG002|Overall Study|Other reasons not listed above|0|||
46979964|NCT02504151|83225624|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
46979965|NCT02504151|83225623|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
46979966|NCT02504151|83225624|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
46979967|NCT02504151|83225623|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
46979968|NCT02504151|83225624|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
46979969|NCT02504151|83225623|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
46979970|NCT02504151|83225624|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
46979971|NCT02448381|83225632|FG000|Overall Study|Adverse Event|2|||
46979972|NCT02448381|83225633|FG001|Overall Study|Adverse Event|0|||
46979973|NCT02448381|83225632|FG000|Overall Study|Lost to Follow-up|16|||
46979974|NCT02448381|83225633|FG001|Overall Study|Lost to Follow-up|9|||
46979975|NCT02448381|83225632|FG000|Overall Study|Physician Decision|1|||
46979976|NCT02448381|83225633|FG001|Overall Study|Physician Decision|1|||
46979977|NCT02448381|83225632|FG000|Overall Study|Pregnancy|1|||
46979978|NCT02448381|83225633|FG001|Overall Study|Pregnancy|0|||
46979979|NCT02448381|83225632|FG000|Overall Study|Withdrawal by Subject|13|||
46979980|NCT02448381|83225633|FG001|Overall Study|Withdrawal by Subject|9|||
46979981|NCT02448381|83225632|FG000|Overall Study|Noncompliance with Study Procedures|2|||
46979982|NCT02448381|83225633|FG001|Overall Study|Noncompliance with Study Procedures|0|||
46979983|NCT02448225|83225645|FG000|Overall Study|Withdrawal by Subject|1|||
46979984|NCT02448225|83225645|FG000|Overall Study|Did not get FSPG scan|18|||
46979985|NCT02448225|83225645|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
46979986|NCT02503215|83225652|FG000|Overall Study|Unable to wear compression stockings|1|||
46979987|NCT02503215|83225652|FG000|Overall Study|Unable to use positive airway pressure|2|||
46979988|NCT02447991|83225658|FG000|Overall Study|Withdrawn by subject - no data|0|||
46979989|NCT02447991|83225659|FG001|Overall Study|Withdrawn by subject - no data|2|||
46979990|NCT02447991|83225658|FG000|Overall Study|Withdrawn by Subject - with data|4|||
46979991|NCT02447991|83225659|FG001|Overall Study|Withdrawn by Subject - with data|4|||
46979992|NCT02447991|83225658|FG000|Overall Study|Lost to Follow-up - no data|3|||
46979993|NCT02447991|83225659|FG001|Overall Study|Lost to Follow-up - no data|6|||
46979994|NCT02447991|83225658|FG000|Overall Study|Lost to follow-up - with data|0|||
46979995|NCT02447991|83225659|FG001|Overall Study|Lost to follow-up - with data|3|||
46979996|NCT02447991|83225658|FG000|Overall Study|End of study - no treatment results|3|||
46979997|NCT02447991|83225659|FG001|Overall Study|End of study - no treatment results|6|||
46678289|NCT01122862|82893649|FG000|Period 2|Adverse Event|0|||
46678290|NCT01122862|82893650|FG001|Period 2|Adverse Event|0|||
46678291|NCT01122862|82893651|FG002|Period 2|Adverse Event|1|||
46678292|NCT01122394|82893662|FG000|Overall Study|Withdrawal by Subject|1|||
46678293|NCT01122394|82893663|FG001|Overall Study|Withdrawal by Subject|1|||
46678294|NCT01122394|82893662|FG000|Overall Study|Lost to Follow-up|2|||
46678295|NCT01122394|82893663|FG001|Overall Study|Lost to Follow-up|2|||
46678296|NCT01122394|82893662|FG000|Overall Study|Adverse Event|0|||
46678297|NCT01122394|82893663|FG001|Overall Study|Adverse Event|1|||
46678298|NCT01121926|82893671|FG000|First Intervention Period|Adverse Event|1|||
46678299|NCT01121926|82893672|FG001|First Intervention Period|Adverse Event|0|||
46678300|NCT01121926|82893671|FG000|Washout Period|Adverse Event|0|||
46678301|NCT01121926|82893672|FG001|Washout Period|Adverse Event|1|||
46678302|NCT01121926|82893671|FG000|Washout Period|Positive pregnancy test|0|||
46678303|NCT01121926|82893672|FG001|Washout Period|Positive pregnancy test|1|||
46678304|NCT01121575|82893693|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
46796719|NCT03632993|83015203|FG002|Overall Study|Lost to Follow-up|0|||
46796720|NCT03632993|83015204|FG003|Overall Study|Lost to Follow-up|0|||
46678305|NCT01121575|82893694|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
46678306|NCT01121575|82893695|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
46678307|NCT01121575|82893696|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
46796721|NCT03632993|83015205|FG004|Overall Study|Lost to Follow-up|0|||
47081706|NCT01040689|83405038|FG003|Overall Study|Other reasons not listed above|0|||
47081707|NCT01047319|83405087|FG000|Overall Study|Teva requested participant withdrawal|3|||
47081708|NCT01047319|83405088|FG001|Overall Study|Teva requested participant withdrawal|0|||
47081709|NCT01047319|83405089|FG002|Overall Study|Teva requested participant withdrawal|1|||
47081710|NCT01047319|83405087|FG000|Overall Study|Protocol Violation|3|||
47081711|NCT01047319|83405088|FG001|Overall Study|Protocol Violation|2|||
47081712|NCT01047319|83405089|FG002|Overall Study|Protocol Violation|4|||
47081713|NCT01047319|83405087|FG000|Overall Study|Lack of Efficacy|4|||
47081714|NCT01047319|83405088|FG001|Overall Study|Lack of Efficacy|3|||
47081715|NCT01047319|83405089|FG002|Overall Study|Lack of Efficacy|3|||
47081716|NCT01047319|83405087|FG000|Overall Study|Death|5|||
47081717|NCT01047319|83405088|FG001|Overall Study|Death|1|||
47081718|NCT01047319|83405089|FG002|Overall Study|Death|5|||
47081719|NCT01047319|83405087|FG000|Overall Study|Pregnancy|13|||
47081720|NCT01047319|83405088|FG001|Overall Study|Pregnancy|8|||
47081721|NCT01047319|83405089|FG002|Overall Study|Pregnancy|8|||
47081722|NCT01047319|83405087|FG000|Overall Study|Physician Decision|12|||
47081723|NCT01047319|83405088|FG001|Overall Study|Physician Decision|9|||
47081724|NCT01047319|83405089|FG002|Overall Study|Physician Decision|10|||
47081725|NCT01047319|83405087|FG000|Overall Study|Lost to Follow-up|14|||
47081726|NCT01047319|83405088|FG001|Overall Study|Lost to Follow-up|10|||
47081727|NCT01047319|83405089|FG002|Overall Study|Lost to Follow-up|10|||
47081728|NCT01047319|83405087|FG000|Overall Study|Adverse Event|16|||
47081729|NCT01047319|83405088|FG001|Overall Study|Adverse Event|27|||
47081730|NCT01047319|83405089|FG002|Overall Study|Adverse Event|21|||
47081731|NCT01047319|83405087|FG000|Overall Study|Withdrawal by Subject|77|||
47081732|NCT01047319|83405088|FG001|Overall Study|Withdrawal by Subject|75|||
46678308|NCT01121575|82893697|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
46678309|NCT01121575|82893698|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
46678310|NCT01121575|82893693|FG000|Overall Study|Unspecified Reasons|8|||
46678311|NCT01121575|82893694|FG001|Overall Study|Unspecified Reasons|6|||
47081733|NCT01047319|83405089|FG002|Overall Study|Withdrawal by Subject|87|||
47081734|NCT01047319|83405087|FG000|Overall Study|Study terminated by Sponsor|198|||
47081735|NCT01047319|83405088|FG001|Overall Study|Study terminated by Sponsor|215|||
47081736|NCT01047319|83405089|FG002|Overall Study|Study terminated by Sponsor|203|||
47081737|NCT00014911|83405406|FG000|Overall Study|Adverse Event|1|||
46678312|NCT01121575|82893695|FG002|Overall Study|Unspecified Reasons|7|||
46678313|NCT01121575|82893696|FG003|Overall Study|Unspecified Reasons|5|||
46678314|NCT01121575|82893697|FG004|Overall Study|Unspecified Reasons|13|||
46678315|NCT01121575|82893698|FG005|Overall Study|Unspecified Reasons|10|||
46678316|NCT01121575|82893693|FG000|Overall Study|Death|6|||
46678317|NCT01121575|82893694|FG001|Overall Study|Death|0|||
46678318|NCT01121575|82893695|FG002|Overall Study|Death|0|||
46678319|NCT01121575|82893696|FG003|Overall Study|Death|1|||
46678320|NCT01121575|82893697|FG004|Overall Study|Death|7|||
46678321|NCT01121575|82893698|FG005|Overall Study|Death|1|||
46857230|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
47081738|NCT00014911|83405406|FG000|Overall Study|Lost to Follow-up|1|||
47081739|NCT00014911|83405406|FG000|Overall Study|Withdrawal by Subject|6|||
47081740|NCT00014911|83405406|FG000|Overall Study|Unknown Reasons|2|||
47081741|NCT00014911|83405406|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
47081742|NCT01049009|83405953|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
47081743|NCT01049009|83405954|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
47081744|NCT01049009|83405953|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
47081745|NCT01049009|83405954|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
47081746|NCT01049009|83405953|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
47081747|NCT01049009|83405954|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
47081748|NCT01049009|83405953|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
47081749|NCT01049009|83405954|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
47081750|NCT01047683|83405976|FG000|Overall Study|Adverse Event|3|||
47081751|NCT01047683|83405977|FG001|Overall Study|Adverse Event|1|||
46678322|NCT01121536|82893721|FG000|Overall Study|Adverse Event|63|||
46678323|NCT01121536|82893721|FG000|Overall Study|Lack of Efficacy|35|||
46678324|NCT01121536|82893721|FG000|Overall Study|Withdrawal by Subject|65|||
46678325|NCT01121536|82893721|FG000|Overall Study|Protocol Violation|20|||
46678326|NCT01121536|82893721|FG000|Overall Study|Noncompliance with study medication|12|||
46678327|NCT01121536|82893721|FG000|Overall Study|Noncompliance with study procedures|9|||
47081752|NCT01047683|83405978|FG002|Overall Study|Adverse Event|0|||
47081753|NCT01047683|83405976|FG000|Overall Study|Withdrew Consent|1|||
47081754|NCT01047683|83405977|FG001|Overall Study|Withdrew Consent|4|||
47081755|NCT01047683|83405978|FG002|Overall Study|Withdrew Consent|2|||
47081756|NCT01047683|83405976|FG000|Overall Study|Lost to Follow-up|0|||
47081757|NCT01047683|83405977|FG001|Overall Study|Lost to Follow-up|1|||
47081758|NCT01047683|83405978|FG002|Overall Study|Lost to Follow-up|0|||
47081759|NCT01047683|83405976|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
47081760|NCT01047683|83405977|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
47081761|NCT01047683|83405978|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
47081762|NCT01047293|83406066|FG000|Overall Study|DLT criteria not fulfilled|1|||
47081763|NCT01047293|83406067|FG001|Overall Study|DLT criteria not fulfilled|1|||
47081764|NCT01047293|83406068|FG002|Overall Study|DLT criteria not fulfilled|0|||
47081765|NCT01047293|83406069|FG003|Overall Study|DLT criteria not fulfilled|0|||
46678328|NCT01121536|82893721|FG000|Overall Study|Lost to Follow-up|39|||
46678329|NCT01121536|82893721|FG000|Overall Study|Other|118|||
46678330|NCT01121263|82893727|FG000|Overall Study|Death|3|||
46678331|NCT01121263|82893728|FG001|Overall Study|Death|2|||
46678332|NCT01121263|82893727|FG000|Overall Study|Lost to Follow-up|22|||
46678333|NCT01121263|82893728|FG001|Overall Study|Lost to Follow-up|12|||
46678334|NCT01121263|82893727|FG000|Overall Study|Withdrawal by Subject|0|||
46678335|NCT01121263|82893728|FG001|Overall Study|Withdrawal by Subject|1|||
47081766|NCT01045967|83406078|FG000|Second Intervention|Protocol Violation|0|||
47081767|NCT01045967|83406079|FG001|Second Intervention|Protocol Violation|1|||
47081768|NCT01045421|83406665|FG000|Phase 1|Progressive Disease|0|||
47081769|NCT01045421|83406666|FG001|Phase 1|Progressive Disease|0|||
46678336|NCT01121185|82893738|FG000|Overall Study|Not infused|0|||
46678337|NCT01121185|82893739|FG001|Overall Study|Not infused|1|||
46678338|NCT01121185|82893738|FG000|Overall Study|Not transplanted|1|||
46678339|NCT01121185|82893739|FG001|Overall Study|Not transplanted|0|||
46678340|NCT01121146|82893747|FG000|Overall Study|Death|17|||
46678341|NCT01121146|82893748|FG001|Overall Study|Death|15|||
46678342|NCT01121146|82893747|FG000|Overall Study|Adverse Event|2|||
46678343|NCT01121146|82893748|FG001|Overall Study|Adverse Event|11|||
46678344|NCT01121146|82893747|FG000|Overall Study|Lost to Follow-up|7|||
46678345|NCT01121146|82893748|FG001|Overall Study|Lost to Follow-up|16|||
46678346|NCT01120756|82893757|FG000|Overall Study|Withdrawal by Subject|1|||
46678347|NCT01120756|82893758|FG001|Overall Study|Withdrawal by Subject|1|||
46678348|NCT01120717|82893766|FG000|Overall Study|Withdrawal by Subject|11|||
46678349|NCT01120717|82893767|FG001|Overall Study|Withdrawal by Subject|6|||
46678350|NCT01120717|82893766|FG000|Overall Study|Adverse Event|10|||
46678351|NCT01120717|82893767|FG001|Overall Study|Adverse Event|6|||
46678352|NCT01120717|82893766|FG000|Overall Study|Protocol Deviation|2|||
47081770|NCT01045421|83406667|FG002|Phase 1|Progressive Disease|0|||
47081771|NCT01045421|83406668|FG003|Phase 1|Progressive Disease|0|||
47081772|NCT01045421|83406669|FG004|Phase 1|Progressive Disease|1|||
47081773|NCT01045421|83406670|FG005|Phase 1|Progressive Disease|0|||
47081774|NCT01045421|83406671|FG006|Phase 1|Progressive Disease|0|||
47081775|NCT01045421|83406672|FG007|Phase 1|Progressive Disease|0|||
47081776|NCT01045421|83406673|FG008|Phase 1|Progressive Disease|0|||
46678353|NCT01120717|82893767|FG001|Overall Study|Protocol Deviation|5|||
46678354|NCT01120717|82893766|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
46678355|NCT01120717|82893767|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
46678356|NCT01120717|82893766|FG000|Overall Study|Lost to Follow-up|2|||
46678357|NCT01120717|82893767|FG001|Overall Study|Lost to Follow-up|3|||
46678358|NCT01120717|82893766|FG000|Overall Study|Death|3|||
46678359|NCT01120717|82893767|FG001|Overall Study|Death|1|||
46678360|NCT01120717|82893766|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
46678361|NCT01120717|82893767|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
47081777|NCT01045421|83406674|FG009|Phase 1|Progressive Disease|0|||
47081778|NCT01045421|83406675|FG010|Phase 1|Progressive Disease|0|||
47081779|NCT01045421|83406665|FG000|Phase 1|Withdrawal by Subject|0|||
46979998|NCT02447991|83225658|FG000|Overall Study|End of study - partial treatment results|0|||
46979999|NCT02447991|83225659|FG001|Overall Study|End of study - partial treatment results|9|||
47081780|NCT01045421|83406666|FG001|Phase 1|Withdrawal by Subject|0|||
47081781|NCT01045421|83406667|FG002|Phase 1|Withdrawal by Subject|0|||
47081782|NCT01045421|83406668|FG003|Phase 1|Withdrawal by Subject|1|||
47081783|NCT01045421|83406669|FG004|Phase 1|Withdrawal by Subject|0|||
47081784|NCT01045421|83406670|FG005|Phase 1|Withdrawal by Subject|0|||
47081785|NCT01045421|83406671|FG006|Phase 1|Withdrawal by Subject|0|||
47081786|NCT01045421|83406672|FG007|Phase 1|Withdrawal by Subject|0|||
47081787|NCT01045421|83406673|FG008|Phase 1|Withdrawal by Subject|0|||
47081788|NCT01045421|83406674|FG009|Phase 1|Withdrawal by Subject|0|||
47081789|NCT01045421|83406675|FG010|Phase 1|Withdrawal by Subject|0|||
47081790|NCT01045421|83406665|FG000|Phase 2|Progressive Disease|0|||
47081791|NCT01045421|83406666|FG001|Phase 2|Progressive Disease|0|||
47081792|NCT01045421|83406667|FG002|Phase 2|Progressive Disease|0|||
47081793|NCT01045421|83406668|FG003|Phase 2|Progressive Disease|0|||
47081794|NCT01045421|83406669|FG004|Phase 2|Progressive Disease|0|||
47081795|NCT01045421|83406670|FG005|Phase 2|Progressive Disease|0|||
47081796|NCT01045421|83406671|FG006|Phase 2|Progressive Disease|0|||
47081797|NCT01045421|83406672|FG007|Phase 2|Progressive Disease|1|||
47081798|NCT01045421|83406673|FG008|Phase 2|Progressive Disease|1|||
47081799|NCT01045421|83406674|FG009|Phase 2|Progressive Disease|1|||
47081800|NCT01045421|83406675|FG010|Phase 2|Progressive Disease|1|||
47081801|NCT01045421|83406665|FG000|Phase 2|Death|0|||
47081802|NCT01045421|83406666|FG001|Phase 2|Death|0|||
47081803|NCT01045421|83406667|FG002|Phase 2|Death|0|||
47081804|NCT01045421|83406668|FG003|Phase 2|Death|0|||
47081805|NCT01045421|83406669|FG004|Phase 2|Death|0|||
47081806|NCT01045421|83406670|FG005|Phase 2|Death|0|||
47081807|NCT01045421|83406671|FG006|Phase 2|Death|0|||
47081808|NCT01045421|83406672|FG007|Phase 2|Death|1|||
46678362|NCT01120600|82893775|FG000|Overall Study|Adverse Event|7|||
47081809|NCT01045421|83406673|FG008|Phase 2|Death|1|||
47081810|NCT01045421|83406674|FG009|Phase 2|Death|2|||
47081811|NCT01045421|83406675|FG010|Phase 2|Death|0|||
47081812|NCT01045421|83406665|FG000|Phase 2|Other|0|||
47081813|NCT01045421|83406666|FG001|Phase 2|Other|0|||
47081814|NCT01045421|83406667|FG002|Phase 2|Other|0|||
47081815|NCT01045421|83406668|FG003|Phase 2|Other|0|||
47081816|NCT01045421|83406669|FG004|Phase 2|Other|0|||
46796722|NCT03632993|83015206|FG005|Overall Study|Lost to Follow-up|1|||
46796723|NCT03632993|83015207|FG006|Overall Study|Lost to Follow-up|0|||
46796724|NCT03632993|83015208|FG007|Overall Study|Lost to Follow-up|1|||
46678363|NCT01120600|82893776|FG001|Overall Study|Adverse Event|7|||
46796725|NCT03632993|83015209|FG008|Overall Study|Lost to Follow-up|0|||
46796726|NCT03632993|83015210|FG009|Overall Study|Lost to Follow-up|0|||
46796727|NCT03632993|83015201|FG000|Overall Study|Adverse Event|0|||
46796728|NCT03632993|83015202|FG001|Overall Study|Adverse Event|0|||
46678364|NCT01120600|82893775|FG000|Overall Study|Excessive Bone Loss|0|||
46678365|NCT01120600|82893776|FG001|Overall Study|Excessive Bone Loss|4|||
46678366|NCT01120600|82893775|FG000|Overall Study|Lost to Follow-up|1|||
46678367|NCT01120600|82893776|FG001|Overall Study|Lost to Follow-up|3|||
46678368|NCT01120600|82893775|FG000|Overall Study|Physician Decision|1|||
46678369|NCT01120600|82893776|FG001|Overall Study|Physician Decision|3|||
46678370|NCT01120600|82893775|FG000|Overall Study|Protocol Violation|0|||
46678371|NCT01120600|82893776|FG001|Overall Study|Protocol Violation|4|||
46678372|NCT01120600|82893775|FG000|Overall Study|Withdrawal by Subject|10|||
46678373|NCT01120600|82893776|FG001|Overall Study|Withdrawal by Subject|11|||
46796729|NCT03632993|83015203|FG002|Overall Study|Adverse Event|0|||
46796730|NCT03632993|83015204|FG003|Overall Study|Adverse Event|0|||
46796731|NCT03632993|83015205|FG004|Overall Study|Adverse Event|0|||
46796732|NCT03632993|83015206|FG005|Overall Study|Adverse Event|1|||
46796733|NCT03632993|83015207|FG006|Overall Study|Adverse Event|0|||
46796734|NCT03632993|83015208|FG007|Overall Study|Adverse Event|1|||
46796735|NCT03632993|83015209|FG008|Overall Study|Adverse Event|0|||
46980000|NCT02586155|83225671|FG000|Overall Study|Adverse Event|2|||
47081817|NCT01045421|83406670|FG005|Phase 2|Other|0|||
47081818|NCT01045421|83406671|FG006|Phase 2|Other|0|||
47081819|NCT01045421|83406672|FG007|Phase 2|Other|3|||
47081820|NCT01045421|83406673|FG008|Phase 2|Other|0|||
47081821|NCT01045421|83406674|FG009|Phase 2|Other|0|||
47081822|NCT01045421|83406675|FG010|Phase 2|Other|1|||
47081823|NCT01042535|83406723|FG000|Overall Study|disease progression prior to treatment|3|||
47081824|NCT01042535|83406723|FG000|Overall Study|disease progression during treatment|3|||
47081825|NCT01042535|83406723|FG000|Overall Study|complications from other disease|2|||
46678374|NCT01120210|82893784|FG000|MAIN INFUSION|Adverse Event|1|||
46678375|NCT01120210|82893785|FG001|MAIN INFUSION|Adverse Event|0|||
46678376|NCT01120210|82893784|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
47081826|NCT01041287|83406729|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
47081827|NCT01041287|83406730|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
47081828|NCT01041287|83406729|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
46678377|NCT01120210|82893785|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
46678378|NCT01120093|82893791|FG000|Treatment Period 1|Adverse Event|0|||
46678379|NCT01120093|82893792|FG001|Treatment Period 1|Adverse Event|0|||
46678380|NCT01120093|82893793|FG002|Treatment Period 1|Adverse Event|1|||
46678381|NCT01120093|82893794|FG003|Treatment Period 1|Adverse Event|0|||
46678382|NCT01120093|82893795|FG004|Treatment Period 1|Adverse Event|1|||
46678383|NCT01120093|82893791|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46678384|NCT01120093|82893792|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46678385|NCT01120093|82893793|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46678386|NCT01120093|82893794|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46678387|NCT01120093|82893795|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46678388|NCT01120093|82893791|FG000|Treatment Period 2|Adverse Event|0|||
46678389|NCT01120093|82893792|FG001|Treatment Period 2|Adverse Event|0|||
46678390|NCT01120093|82893793|FG002|Treatment Period 2|Adverse Event|0|||
46678391|NCT01120093|82893794|FG003|Treatment Period 2|Adverse Event|1|||
46678392|NCT01120093|82893795|FG004|Treatment Period 2|Adverse Event|0|||
46678393|NCT01120093|82893791|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46678394|NCT01120093|82893792|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46678395|NCT01120093|82893793|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46678396|NCT01120093|82893794|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46678397|NCT01120093|82893795|FG004|Treatment Period 2|Withdrawal by Subject|1|||
46678398|NCT01120093|82893791|FG000|Treatment Period 3|Lack of Efficacy|0|||
46678399|NCT01120093|82893792|FG001|Treatment Period 3|Lack of Efficacy|0|||
46678400|NCT01120093|82893793|FG002|Treatment Period 3|Lack of Efficacy|0|||
47081829|NCT01041287|83406730|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
47081830|NCT01040351|83406751|FG000|Overall Study|poor ovarian response|1|||
47081831|NCT01040351|83406752|FG001|Overall Study|poor ovarian response|2|||
47081832|NCT02049957|83406772|FG000|Overall Study|Progressive Disease|5|||
47081833|NCT02049957|83406773|FG001|Overall Study|Progressive Disease|4|||
47081834|NCT02049957|83406774|FG002|Overall Study|Progressive Disease|2|||
47081835|NCT02049957|83406775|FG003|Overall Study|Progressive Disease|2|||
47081836|NCT02049957|83406776|FG004|Overall Study|Progressive Disease|6|||
46678401|NCT01120093|82893794|FG003|Treatment Period 3|Lack of Efficacy|1|||
46678402|NCT01120093|82893795|FG004|Treatment Period 3|Lack of Efficacy|0|||
46678403|NCT01120093|82893791|FG000|Treatment Period 3|Adverse Event|0|||
46678404|NCT01120093|82893792|FG001|Treatment Period 3|Adverse Event|0|||
46678405|NCT01120093|82893793|FG002|Treatment Period 3|Adverse Event|0|||
46678406|NCT01120093|82893794|FG003|Treatment Period 3|Adverse Event|0|||
46980001|NCT02586155|83225672|FG001|Overall Study|Adverse Event|3|||
46980002|NCT02586155|83225671|FG000|Overall Study|Withdrawal by Subject|31|||
46980003|NCT02586155|83225672|FG001|Overall Study|Withdrawal by Subject|24|||
46980004|NCT02586155|83225671|FG000|Overall Study|Lost to Follow-up|7|||
46980005|NCT02586155|83225672|FG001|Overall Study|Lost to Follow-up|13|||
46980006|NCT02586155|83225671|FG000|Overall Study|Death|61|||
46980007|NCT02586155|83225672|FG001|Overall Study|Death|72|||
46980008|NCT02586155|83225671|FG000|Overall Study|Other reasons|26|||
46980009|NCT02586155|83225672|FG001|Overall Study|Other reasons|15|||
46980010|NCT02446743|83225680|FG000|Overall Study|Withdrawal by Subject|1|||
46980011|NCT02446743|83225681|FG001|Overall Study|Withdrawal by Subject|1|||
46980012|NCT02446743|83225680|FG000|Overall Study|Lost to Follow-up|1|||
46980013|NCT02446743|83225681|FG001|Overall Study|Lost to Follow-up|0|||
46980014|NCT02446743|83225680|FG000|Overall Study|Adverse Event|1|||
46980015|NCT02446743|83225681|FG001|Overall Study|Adverse Event|1|||
46980016|NCT02446743|83225680|FG000|Overall Study|Other|2|||
46980017|NCT02446743|83225681|FG001|Overall Study|Other|3|||
46980018|NCT02586077|83225696|FG000|Overall Study|Withdrawal by Subject|1|||
46980019|NCT02586077|83225696|FG000|Overall Study|Physician Decision|4|||
46980020|NCT02586077|83225696|FG000|Overall Study|Lost to Follow-up|3|||
46678407|NCT01120093|82893795|FG004|Treatment Period 3|Adverse Event|1|||
46678408|NCT01120093|82893791|FG000|Treatment Period 3|Withdrawal by Subject|0|||
46678409|NCT01120093|82893792|FG001|Treatment Period 3|Withdrawal by Subject|0|||
46678410|NCT01120093|82893793|FG002|Treatment Period 3|Withdrawal by Subject|1|||
46678411|NCT01120093|82893794|FG003|Treatment Period 3|Withdrawal by Subject|0|||
46678412|NCT01120093|82893795|FG004|Treatment Period 3|Withdrawal by Subject|0|||
46980021|NCT02583425|83225701|FG000|Screening|Did not meet entry criteria|12|||
46980022|NCT02583425|83225701|FG000|Baseline|Did not meet continued criteria|5|||
47081837|NCT02049957|83406777|FG005|Overall Study|Progressive Disease|35|||
47081838|NCT02049957|83406778|FG006|Overall Study|Progressive Disease|7|||
46980023|NCT02583425|83225701|FG000|Treatment Period|Adverse Event|1|||
46980024|NCT02581163|83225706|FG000|Overall Study|Failure to return|15|||
46980025|NCT02581163|83225706|FG000|Overall Study|Insufficient virological response|3|||
46980026|NCT02581163|83225706|FG000|Overall Study|Withdrew consent|1|||
46980027|NCT02581163|83225706|FG000|Overall Study|Death|1|||
46980028|NCT02581163|83225706|FG000|Overall Study|Other, not specified|9|||
46980029|NCT02627677|83225716|FG000|Overall Study|Adverse event (not progressive disease)|1|||
46980030|NCT02627677|83225717|FG001|Overall Study|Adverse event (not progressive disease)|4|||
46980031|NCT02627677|83225718|FG002|Overall Study|Adverse event (not progressive disease)|1|||
46980032|NCT02627677|83225716|FG000|Overall Study|Progressive disease|1|||
46980033|NCT02627677|83225717|FG001|Overall Study|Progressive disease|3|||
46980034|NCT02627677|83225718|FG002|Overall Study|Progressive disease|0|||
46678413|NCT01120093|82893791|FG000|Treatment Period 4|Adverse Event|1|||
46980035|NCT02627677|83225716|FG000|Overall Study|Lack of Efficacy|1|||
46678414|NCT01120093|82893792|FG001|Treatment Period 4|Adverse Event|0|||
46678415|NCT01120093|82893793|FG002|Treatment Period 4|Adverse Event|0|||
46678416|NCT01120093|82893794|FG003|Treatment Period 4|Adverse Event|0|||
46678417|NCT01120093|82893795|FG004|Treatment Period 4|Adverse Event|0|||
46678418|NCT01120093|82893791|FG000|Treatment Period 5|Adverse Event|0|||
46796736|NCT03632993|83015210|FG009|Overall Study|Adverse Event|0|||
46796737|NCT03493282|83015235|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
46796738|NCT03493282|83015236|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
46796739|NCT03493282|83015237|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
46678419|NCT01120093|82893792|FG001|Treatment Period 5|Adverse Event|1|||
46678420|NCT01120093|82893793|FG002|Treatment Period 5|Adverse Event|0|||
46678421|NCT01120093|82893794|FG003|Treatment Period 5|Adverse Event|1|||
46678422|NCT01120093|82893795|FG004|Treatment Period 5|Adverse Event|0|||
46678423|NCT01119937|82893809|FG000|Overall Study|Adverse Event|11|||
46678424|NCT01119937|82893810|FG001|Overall Study|Adverse Event|5|||
46678425|NCT01119937|82893809|FG000|Overall Study|Protocol deviation|3|||
46678426|NCT01119937|82893810|FG001|Overall Study|Protocol deviation|1|||
46678427|NCT01119937|82893809|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
46678428|NCT01119937|82893810|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46796740|NCT03493282|83015235|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
46796741|NCT03493282|83015236|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
46796742|NCT03493282|83015237|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
46796743|NCT02998203|83015290|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
46796744|NCT02998203|83015291|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
46796745|NCT02998203|83015290|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
46678429|NCT01119937|82893809|FG000|Overall Study|Withdrawal by Subject|2|||
46678430|NCT01119937|82893810|FG001|Overall Study|Withdrawal by Subject|1|||
46678431|NCT01119898|82893818|FG000|Overall Study|Adverse Event|4|||
46857231|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
46857232|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
46857233|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
46857234|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
46857235|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
46857236|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
46857237|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
46980036|NCT02627677|83225717|FG001|Overall Study|Lack of Efficacy|2|||
46980037|NCT02627677|83225718|FG002|Overall Study|Lack of Efficacy|0|||
46980038|NCT02627677|83225716|FG000|Overall Study|Lost to Follow-up|0|||
46980039|NCT02627677|83225717|FG001|Overall Study|Lost to Follow-up|0|||
46980040|NCT02627677|83225718|FG002|Overall Study|Lost to Follow-up|1|||
46980041|NCT02627677|83225716|FG000|Overall Study|Pregnancy|0|||
46980042|NCT02627677|83225717|FG001|Overall Study|Pregnancy|1|||
46980043|NCT02627677|83225718|FG002|Overall Study|Pregnancy|0|||
46980044|NCT02627677|83225716|FG000|Overall Study|Study Terminated by Sponsor|5|||
46980045|NCT02627677|83225717|FG001|Overall Study|Study Terminated by Sponsor|10|||
46980046|NCT02627677|83225718|FG002|Overall Study|Study Terminated by Sponsor|6|||
46980047|NCT02627677|83225716|FG000|Overall Study|Physician Decision|0|||
46980048|NCT02627677|83225717|FG001|Overall Study|Physician Decision|0|||
46980049|NCT02627677|83225718|FG002|Overall Study|Physician Decision|2|||
46980050|NCT02627677|83225716|FG000|Overall Study|Withdrawal by Subject|2|||
46980051|NCT02627677|83225717|FG001|Overall Study|Withdrawal by Subject|1|||
47081839|NCT02049957|83406779|FG007|Overall Study|Progressive Disease|26|||
47081840|NCT02049957|83406780|FG008|Overall Study|Progressive Disease|6|||
47081841|NCT02049957|83406772|FG000|Overall Study|Adverse Event|1|||
47081842|NCT02049957|83406773|FG001|Overall Study|Adverse Event|1|||
47081843|NCT02049957|83406774|FG002|Overall Study|Adverse Event|1|||
47081844|NCT02049957|83406775|FG003|Overall Study|Adverse Event|0|||
47081845|NCT02049957|83406776|FG004|Overall Study|Adverse Event|0|||
47081846|NCT02049957|83406777|FG005|Overall Study|Adverse Event|5|||
47081847|NCT02049957|83406778|FG006|Overall Study|Adverse Event|0|||
47081848|NCT02049957|83406779|FG007|Overall Study|Adverse Event|6|||
47081849|NCT02049957|83406780|FG008|Overall Study|Adverse Event|1|||
47081850|NCT02049957|83406772|FG000|Overall Study|Study Terminated by Sponsor|0|||
47081851|NCT02049957|83406773|FG001|Overall Study|Study Terminated by Sponsor|1|||
47081852|NCT02049957|83406774|FG002|Overall Study|Study Terminated by Sponsor|0|||
47081853|NCT02049957|83406775|FG003|Overall Study|Study Terminated by Sponsor|0|||
47081854|NCT02049957|83406776|FG004|Overall Study|Study Terminated by Sponsor|0|||
47081855|NCT02049957|83406777|FG005|Overall Study|Study Terminated by Sponsor|0|||
47081856|NCT02049957|83406778|FG006|Overall Study|Study Terminated by Sponsor|1|||
47081857|NCT02049957|83406779|FG007|Overall Study|Study Terminated by Sponsor|0|||
47081858|NCT02049957|83406780|FG008|Overall Study|Study Terminated by Sponsor|0|||
47081859|NCT02049957|83406772|FG000|Overall Study|Withdrawal by Subject|0|||
47081860|NCT02049957|83406773|FG001|Overall Study|Withdrawal by Subject|0|||
47081861|NCT02049957|83406774|FG002|Overall Study|Withdrawal by Subject|0|||
47081862|NCT02049957|83406775|FG003|Overall Study|Withdrawal by Subject|1|||
47081863|NCT02049957|83406776|FG004|Overall Study|Withdrawal by Subject|0|||
47081864|NCT02049957|83406777|FG005|Overall Study|Withdrawal by Subject|2|||
47081865|NCT02049957|83406778|FG006|Overall Study|Withdrawal by Subject|0|||
47081866|NCT02049957|83406779|FG007|Overall Study|Withdrawal by Subject|3|||
47081867|NCT02049957|83406780|FG008|Overall Study|Withdrawal by Subject|1|||
47081868|NCT02049957|83406772|FG000|Overall Study|Physician Decision|0|||
47081869|NCT02049957|83406773|FG001|Overall Study|Physician Decision|0|||
47081870|NCT02049957|83406774|FG002|Overall Study|Physician Decision|0|||
47081871|NCT02049957|83406775|FG003|Overall Study|Physician Decision|0|||
47081872|NCT02049957|83406776|FG004|Overall Study|Physician Decision|0|||
47081873|NCT02049957|83406777|FG005|Overall Study|Physician Decision|1|||
47081874|NCT02049957|83406778|FG006|Overall Study|Physician Decision|0|||
47081875|NCT02049957|83406779|FG007|Overall Study|Physician Decision|0|||
47081876|NCT02049957|83406780|FG008|Overall Study|Physician Decision|0|||
47081877|NCT00014495|83407043|FG000|Overall Study|Death|0|||
47081878|NCT00014495|83407044|FG001|Overall Study|Death|0|||
47081879|NCT00014495|83407045|FG002|Overall Study|Death|1|||
47081880|NCT00014495|83407046|FG003|Overall Study|Death|0|||
47081881|NCT00014495|83407043|FG000|Overall Study|Clinical deterioration|0|||
47081882|NCT00014495|83407044|FG001|Overall Study|Clinical deterioration|0|||
47081883|NCT00014495|83407045|FG002|Overall Study|Clinical deterioration|0|||
47081884|NCT00014495|83407046|FG003|Overall Study|Clinical deterioration|1|||
47081885|NCT01351623|83409069|FG000|Overall Study|Protocol Violation|2|||
46980052|NCT02627677|83225718|FG002|Overall Study|Withdrawal by Subject|1|||
47081886|NCT01351623|83409069|FG000|Overall Study|Adverse Event|4|||
47081887|NCT01351623|83409069|FG000|Overall Study|Withdrawal by Subject|1|||
47081888|NCT01351623|83409069|FG000|Overall Study|Death|2|||
47081889|NCT03670953|83409210|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
47081890|NCT03670953|83409211|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
47081891|NCT03670953|83409212|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
46980053|NCT02627677|83225716|FG000|Overall Study|Reason not Specified|0|||
46980054|NCT02627677|83225717|FG001|Overall Study|Reason not Specified|0|||
46980055|NCT02627677|83225718|FG002|Overall Study|Reason not Specified|1|||
46980056|NCT02627677|83225716|FG000|Overall Study|Randomized but not Treated|1|||
46980057|NCT02627677|83225717|FG001|Overall Study|Randomized but not Treated|0|||
46980058|NCT02627677|83225718|FG002|Overall Study|Randomized but not Treated|0|||
46980059|NCT02501811|83225731|FG000|Overall Study|Death|1|||
46980060|NCT02501811|83225732|FG001|Overall Study|Death|3|||
46980061|NCT02501811|83225733|FG002|Overall Study|Death|2|||
46980062|NCT02501811|83225734|FG003|Overall Study|Death|3|||
46980063|NCT02501811|83225731|FG000|Overall Study|Withdrawal by Subject|3|||
46980064|NCT02501811|83225732|FG001|Overall Study|Withdrawal by Subject|3|||
46980065|NCT02501811|83225733|FG002|Overall Study|Withdrawal by Subject|2|||
46796746|NCT02998203|83015291|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
46796747|NCT02873338|83015317|FG000|Overall Study|Adverse Event|0|||
46796748|NCT02873338|83015318|FG001|Overall Study|Adverse Event|2|||
46796749|NCT02873338|83015319|FG002|Overall Study|Adverse Event|1|||
46796750|NCT02873338|83015317|FG000|Overall Study|Death|2|||
46796751|NCT02873338|83015318|FG001|Overall Study|Death|1|||
46796752|NCT02873338|83015319|FG002|Overall Study|Death|1|||
46796753|NCT02873338|83015317|FG000|Overall Study|Withdrawal by Subject|2|||
46796754|NCT02873338|83015318|FG001|Overall Study|Withdrawal by Subject|1|||
46980066|NCT02501811|83225734|FG003|Overall Study|Withdrawal by Subject|3|||
46678432|NCT01119898|82893819|FG001|Overall Study|Adverse Event|5|||
46678433|NCT01119898|82893818|FG000|Overall Study|Withdrawal by Subject|1|||
46678434|NCT01119898|82893819|FG001|Overall Study|Withdrawal by Subject|4|||
46678435|NCT01119898|82893818|FG000|Overall Study|Lack of Efficacy|0|||
46678436|NCT01119898|82893819|FG001|Overall Study|Lack of Efficacy|2|||
46857238|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
46857239|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
46857240|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
47081892|NCT03670953|83409213|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
47081893|NCT03670953|83409210|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
47081894|NCT03670953|83409211|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
47081895|NCT03670953|83409212|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
47081896|NCT03670953|83409213|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
47081897|NCT03670953|83409210|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
47081898|NCT03670953|83409211|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
47081899|NCT03670953|83409212|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
47081900|NCT03670953|83409213|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
47081901|NCT03670953|83409210|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
47081902|NCT03670953|83409211|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
47081903|NCT03670953|83409212|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
47081904|NCT03670953|83409213|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
47081905|NCT03670953|83409210|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
47081906|NCT03670953|83409211|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
47081907|NCT03670953|83409212|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
47081908|NCT03670953|83409213|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
47081909|NCT03670953|83409210|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
47081910|NCT03670953|83409211|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
47081911|NCT03670953|83409212|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
47081912|NCT03670953|83409213|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
47081913|NCT03670953|83409210|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
47081914|NCT03670953|83409211|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
47081915|NCT03670953|83409212|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
47081916|NCT03670953|83409213|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
47081917|NCT03670953|83409210|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
47081918|NCT03670953|83409211|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
47081919|NCT03670953|83409212|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
46857241|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
46857242|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
46857243|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Move|0|||
47081920|NCT03670953|83409213|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
46857244|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Move|1|||
47081921|NCT03670953|83409210|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
47081922|NCT03670953|83409211|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
47081923|NCT03670953|83409212|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
47081924|NCT03670953|83409213|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
47081925|NCT03670953|83409210|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
47081926|NCT03670953|83409211|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
47081927|NCT03670953|83409212|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
47081928|NCT03670953|83409213|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
47081929|NCT03670953|83409210|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
47081930|NCT03670953|83409211|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
47081931|NCT03670953|83409212|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
47081932|NCT03670953|83409213|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
47081933|NCT03670953|83409210|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
47081934|NCT03670953|83409211|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
47081935|NCT03670953|83409212|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
47081936|NCT03670953|83409213|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
47081937|NCT03670953|83409210|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
47081938|NCT03670953|83409211|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
47081939|NCT03670953|83409212|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
47081940|NCT03670953|83409213|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
47081941|NCT03670953|83409210|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
47081942|NCT03670953|83409211|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
47081943|NCT03670953|83409212|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
47081944|NCT03670953|83409213|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
47081945|NCT03670953|83409210|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
47081946|NCT03670953|83409211|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
47081947|NCT03670953|83409212|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
47081948|NCT03670953|83409213|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
47081949|NCT03670953|83409210|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
47081950|NCT03670953|83409211|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
47081951|NCT03670953|83409212|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
47081952|NCT03670953|83409213|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
47081953|NCT03670953|83409210|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
47081954|NCT03670953|83409211|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
47081955|NCT03670953|83409212|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
47081956|NCT03670953|83409213|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
47081957|NCT03670953|83409210|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
46857245|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Move|0|||
46857246|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Move|0|||
46857247|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Move|0|||
46857248|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
46980067|NCT02501811|83225731|FG000|Overall Study|Lost to Follow-up|0|||
46857249|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
46857250|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
46857251|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
46857252|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
46857253|NCT00318461|83073005|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
46857254|NCT00318461|83073006|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
46857255|NCT00318461|83073007|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
46857256|NCT00318461|83073008|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
46857257|NCT00318461|83073009|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
46857258|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Work commitment|0|||
46857259|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Work commitment|0|||
46857260|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Work commitment|0|||
46857261|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Work commitment|0|||
46980068|NCT02501811|83225732|FG001|Overall Study|Lost to Follow-up|0|||
46980069|NCT02501811|83225733|FG002|Overall Study|Lost to Follow-up|2|||
46980070|NCT02501811|83225734|FG003|Overall Study|Lost to Follow-up|1|||
46980071|NCT02585999|83225744|FG000|Overall Study|Lost to Follow-up|1|||
46980072|NCT02585999|83225744|FG000|Overall Study|Protocol Violation|1|||
46980073|NCT02582255|83225751|FG000|Overall Study|Protocol Violation|0|||
46980074|NCT02582255|83225752|FG001|Overall Study|Protocol Violation|3|||
46796755|NCT02873338|83015319|FG002|Overall Study|Withdrawal by Subject|3|||
46796756|NCT02873338|83015317|FG000|Overall Study|Lack of Efficacy|0|||
46796757|NCT02873338|83015318|FG001|Overall Study|Lack of Efficacy|2|||
46796758|NCT02873338|83015319|FG002|Overall Study|Lack of Efficacy|0|||
46796759|NCT02873338|83015317|FG000|Overall Study|Other or Missing|14|||
46796760|NCT02873338|83015318|FG001|Overall Study|Other or Missing|15|||
46796761|NCT02873338|83015319|FG002|Overall Study|Other or Missing|13|||
46796762|NCT02725567|83015334|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
46980075|NCT02500719|83225761|FG000|Overall Study|Lost to Follow-up|2|||
46980076|NCT02500719|83225762|FG001|Overall Study|Lost to Follow-up|3|||
46980077|NCT02500719|83225761|FG000|Overall Study|Trauma history|1|||
46678437|NCT01119898|82893818|FG000|Overall Study|Protocol Violation|1|||
46678438|NCT01119898|82893819|FG001|Overall Study|Protocol Violation|1|||
46678439|NCT01119898|82893818|FG000|Overall Study|Medical procedure|1|||
46678440|NCT01119898|82893819|FG001|Overall Study|Medical procedure|0|||
46678441|NCT01119898|82893818|FG000|Overall Study|Randomized in error did not participate|1|||
46980078|NCT02500719|83225762|FG001|Overall Study|Trauma history|0|||
46678442|NCT01119898|82893819|FG001|Overall Study|Randomized in error did not participate|0|||
46796763|NCT02725567|83015335|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
46796764|NCT02725567|83015334|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
46678443|NCT01119859|82893827|FG000|Overall Study|Adverse Event|9|||
46678444|NCT01119859|82893828|FG001|Overall Study|Adverse Event|10|||
46678445|NCT01119859|82893827|FG000|Overall Study|Death|2|||
46678446|NCT01119859|82893828|FG001|Overall Study|Death|0|||
46678447|NCT01119859|82893827|FG000|Overall Study|Insufficient therapeutic response|7|||
46678448|NCT01119859|82893828|FG001|Overall Study|Insufficient therapeutic response|14|||
46678449|NCT01119859|82893827|FG000|Overall Study|Refused treatment|3|||
46678450|NCT01119859|82893828|FG001|Overall Study|Refused treatment|6|||
46678451|NCT01119859|82893827|FG000|Overall Study|Failure to return|3|||
46678452|NCT01119859|82893828|FG001|Overall Study|Failure to return|0|||
46678453|NCT01119703|82893836|FG000|Overall Study|Adverse Event|0|||
46678454|NCT01119703|82893837|FG001|Overall Study|Adverse Event|1|||
46678455|NCT01119625|82893844|FG000|Overall Study|Lost to Follow-up|1|||
46678456|NCT01119625|82893845|FG001|Overall Study|Lost to Follow-up|2|||
46678457|NCT01119625|82893844|FG000|Overall Study|Withdrawal by Subject|2|||
46678458|NCT01119625|82893845|FG001|Overall Study|Withdrawal by Subject|1|||
46678459|NCT01119625|82893844|FG000|Overall Study|Other|0|||
46678460|NCT01119625|82893845|FG001|Overall Study|Other|1|||
46678461|NCT01119118|82893851|FG000|Overall Study|Adverse Event|1|||
46678462|NCT01119001|82893855|FG000|Overall Study|Withdrawal by Subject|2|||
46678463|NCT01118962|82893861|FG000|Overall Study|Adverse Event|2|||
46678464|NCT01118962|82893861|FG000|Overall Study|Lack of Efficacy|1|||
46678465|NCT01118962|82893861|FG000|Overall Study|Protocol Violation|1|||
46678466|NCT01118962|82893861|FG000|Overall Study|Withdrawal by Subject|4|||
46678467|NCT01118962|82893861|FG000|Overall Study|Pregnancy|1|||
46678468|NCT01118962|82893861|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
46678469|NCT01118728|82893865|FG000|Overall Study|Adverse Event|17|||
46678470|NCT01118728|82893865|FG000|Overall Study|Lack of Efficacy|27|||
46678471|NCT01118728|82893865|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
46678472|NCT01118728|82893865|FG000|Overall Study|Withdrawal by Subject|3|||
46678473|NCT01118728|82893865|FG000|Overall Study|Lost to Follow-up|4|||
46678474|NCT01118455|82893871|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
46678475|NCT01118455|82893872|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
46678476|NCT01118377|82893886|FG000|Overall Study|Did Not Receive Study Medication|1|||
46678477|NCT01118377|82893886|FG000|Overall Study|Death|38|||
46678478|NCT01118377|82893886|FG000|Overall Study|Failure to Return|3|||
46678479|NCT01118299|82893892|FG000|Overall Study|Death|7|||
46678480|NCT01118299|82893893|FG001|Overall Study|Death|5|||
46678481|NCT01118299|82893892|FG000|Overall Study|Withdrawal by Subject|8|||
46678482|NCT01118299|82893893|FG001|Overall Study|Withdrawal by Subject|8|||
46678483|NCT01118299|82893892|FG000|Overall Study|Lost to Follow-up|2|||
46678484|NCT01118299|82893893|FG001|Overall Study|Lost to Follow-up|1|||
46678485|NCT01118299|82893892|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
46678486|NCT01118299|82893893|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
46678487|NCT01118143|82893900|FG000|Overall Study|Withdrawal by Subject|2|||
46678488|NCT01118143|82893901|FG001|Overall Study|Withdrawal by Subject|5|||
46678489|NCT01117987|82893911|FG000|Overall Study|Protocol deviation|0|||
46678490|NCT01117987|82893912|FG001|Overall Study|Protocol deviation|1|||
46678491|NCT01117987|82893911|FG000|Overall Study|Subject no longer requires study drug|1|||
46980079|NCT02500719|83225761|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
46678492|NCT01117987|82893912|FG001|Overall Study|Subject no longer requires study drug|0|||
46678493|NCT01117987|82893911|FG000|Overall Study|Lost to Follow-up|1|||
46678494|NCT01117987|82893912|FG001|Overall Study|Lost to Follow-up|1|||
46678495|NCT01117987|82893911|FG000|Overall Study|Abnormal test procedure result|2|||
46678496|NCT01117987|82893912|FG001|Overall Study|Abnormal test procedure result|0|||
46678497|NCT01117987|82893911|FG000|Overall Study|Lack of Efficacy|3|||
46796765|NCT02725567|83015335|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
47081958|NCT03670953|83409211|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
46678498|NCT01117987|82893912|FG001|Overall Study|Lack of Efficacy|4|||
46678499|NCT01117987|82893911|FG000|Overall Study|Death|5|||
46678500|NCT01117987|82893912|FG001|Overall Study|Death|10|||
46678501|NCT01117987|82893911|FG000|Overall Study|Withdrawal by Subject|5|||
46678502|NCT01117987|82893912|FG001|Overall Study|Withdrawal by Subject|10|||
46678503|NCT01117987|82893911|FG000|Overall Study|Adverse Event|19|||
46678504|NCT01117987|82893912|FG001|Overall Study|Adverse Event|26|||
46678505|NCT01117987|82893911|FG000|Overall Study|Administrative problems|25|||
46678506|NCT01117987|82893912|FG001|Overall Study|Administrative problems|22|||
46678507|NCT01117870|82893920|FG000|Overall Study|Inability to place needle|1|||
46678508|NCT01117870|82893921|FG001|Overall Study|Inability to place needle|0|||
46678509|NCT01117792|82893931|FG000|Overall Study|Death|1|||
46678510|NCT01117792|82893931|FG000|Overall Study|Adverse Event|3|||
46678511|NCT02219490|82893935|FG000|Overall Study|Adverse Event|24|||
46678512|NCT02219490|82893935|FG000|Overall Study|Withdrew consent|96|||
46678513|NCT02219490|82893935|FG000|Overall Study|Lost to Follow-up|126|||
46678514|NCT02219490|82893935|FG000|Overall Study|COVID-19 infection|2|||
46678515|NCT02219490|82893935|FG000|Overall Study|COVID-19 logistical restrictions|33|||
46678516|NCT02219490|82893935|FG000|Overall Study|Other, not specified|57|||
46678517|NCT01117480|82893943|FG000|Overall Study|Protocol Violation|8|||
46678518|NCT01117480|82893943|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
46678519|NCT01117051|82893949|FG000|Overall Study|Withdrawal by Subject|5|||
46678520|NCT01117051|82893950|FG001|Overall Study|Withdrawal by Subject|3|||
46678521|NCT01117051|82893949|FG000|Overall Study|Adverse Event|4|||
46678522|NCT01117051|82893950|FG001|Overall Study|Adverse Event|3|||
46678523|NCT01117051|82893949|FG000|Overall Study|Lost to Follow-up|0|||
46678524|NCT01117051|82893950|FG001|Overall Study|Lost to Follow-up|1|||
46678525|NCT01117051|82893949|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
46678526|NCT01117051|82893950|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
46678527|NCT01117051|82893949|FG000|Overall Study|Sponsor's decision|3|||
46678528|NCT01117051|82893950|FG001|Overall Study|Sponsor's decision|1|||
46678529|NCT01117051|82893949|FG000|Overall Study|Surgical procedure|0|||
46678530|NCT01117051|82893950|FG001|Overall Study|Surgical procedure|1|||
46678531|NCT01117051|82893949|FG000|Overall Study|Randomized by mistake|0|||
46678532|NCT01117051|82893950|FG001|Overall Study|Randomized by mistake|1|||
46678533|NCT01117051|82893949|FG000|Overall Study|Convenience issue|1|||
46678534|NCT01117051|82893950|FG001|Overall Study|Convenience issue|0|||
46678535|NCT02211417|82893959|FG000|Overall Study|Withdrawal by Subject|11|||
46678536|NCT02211417|82893960|FG001|Overall Study|Withdrawal by Subject|8|||
46678537|NCT02211417|82893959|FG000|Overall Study|Protocol Violation|1|||
46678538|NCT02211417|82893960|FG001|Overall Study|Protocol Violation|0|||
46678539|NCT02211417|82893959|FG000|Overall Study|Pregnancy|0|||
46678540|NCT02211417|82893960|FG001|Overall Study|Pregnancy|1|||
46678541|NCT02211417|82893959|FG000|Overall Study|Lost to Follow-up|2|||
46678542|NCT02211417|82893960|FG001|Overall Study|Lost to Follow-up|3|||
46796766|NCT02725567|83015334|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
46796767|NCT02725567|83015335|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
46980080|NCT02500719|83225762|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
47081959|NCT03670953|83409212|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
47081960|NCT03670953|83409213|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
47081961|NCT00636818|83409239|FG000|Overall Study|Adverse Event|1|||
47081962|NCT00636818|83409239|FG000|Overall Study|Lost to Follow-up|2|||
47081963|NCT00636818|83409239|FG000|Overall Study|Entry Criteria Exclusion|3|||
47081964|NCT00636818|83409239|FG000|Overall Study|Protocol Violation|1|||
47081965|NCT00636818|83409239|FG000|Overall Study|Withdrawal by Subject|4|||
47081966|NCT03127137|83409245|FG000|Overall Study|Requested sedation after consent|1|||
46678543|NCT02211417|82893959|FG000|Overall Study|Adverse Event|1|||
46678544|NCT02211417|82893960|FG001|Overall Study|Adverse Event|4|||
46678545|NCT01117012|82893973|FG000|Overall Study|Adverse Event|0|||
46678546|NCT01117012|82893974|FG001|Overall Study|Adverse Event|1|||
47081967|NCT03127137|83409246|FG001|Overall Study|Requested sedation after consent|0|||
46678547|NCT01117012|82893973|FG000|Overall Study|Death|1|||
46678548|NCT01117012|82893974|FG001|Overall Study|Death|1|||
46678549|NCT01117012|82893973|FG000|Overall Study|Withdrawal by Subject|3|||
46796768|NCT02108964|83015367|FG000|Overall Study|Progressive disease|12|||
46796769|NCT02108964|83015368|FG001|Overall Study|Progressive disease|25|||
46796770|NCT02108964|83015369|FG002|Overall Study|Progressive disease|50|||
46857262|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Work commitment|1|||
46857263|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Investigator decision|0|||
46857264|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Investigator decision|0|||
46857265|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Investigator decision|0|||
46857266|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Investigator decision|0|||
46857267|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Investigator decision|1|||
46857268|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Lack of time|1|||
46796771|NCT02108964|83015370|FG003|Overall Study|Progressive disease|6|||
46796772|NCT02108964|83015371|FG004|Overall Study|Progressive disease|18|||
46796773|NCT02108964|83015372|FG005|Overall Study|Progressive disease|5|||
46796774|NCT02108964|83015373|FG006|Overall Study|Progressive disease|7|||
46796775|NCT02108964|83015374|FG007|Overall Study|Progressive disease|9|||
46796776|NCT02108964|83015367|FG000|Overall Study|Physician Decision|1|||
46796777|NCT02108964|83015368|FG001|Overall Study|Physician Decision|5|||
46796778|NCT02108964|83015369|FG002|Overall Study|Physician Decision|6|||
46796779|NCT02108964|83015370|FG003|Overall Study|Physician Decision|0|||
46796780|NCT02108964|83015371|FG004|Overall Study|Physician Decision|1|||
46796781|NCT02108964|83015372|FG005|Overall Study|Physician Decision|0|||
46796782|NCT02108964|83015373|FG006|Overall Study|Physician Decision|0|||
46796783|NCT02108964|83015374|FG007|Overall Study|Physician Decision|0|||
46857269|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Lack of time|0|||
46857270|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Lack of time|0|||
46796784|NCT02108964|83015367|FG000|Overall Study|Adverse Event|0|||
46796785|NCT02108964|83015368|FG001|Overall Study|Adverse Event|0|||
46796786|NCT02108964|83015369|FG002|Overall Study|Adverse Event|4|||
46796787|NCT02108964|83015370|FG003|Overall Study|Adverse Event|0|||
46796788|NCT02108964|83015371|FG004|Overall Study|Adverse Event|1|||
46796789|NCT02108964|83015372|FG005|Overall Study|Adverse Event|0|||
46796790|NCT02108964|83015373|FG006|Overall Study|Adverse Event|3|||
46796791|NCT02108964|83015374|FG007|Overall Study|Adverse Event|1|||
46796792|NCT02108964|83015367|FG000|Overall Study|Death|1|||
46796793|NCT02108964|83015368|FG001|Overall Study|Death|1|||
46796794|NCT02108964|83015369|FG002|Overall Study|Death|2|||
46796795|NCT02108964|83015370|FG003|Overall Study|Death|0|||
46796796|NCT02108964|83015371|FG004|Overall Study|Death|3|||
46796797|NCT02108964|83015372|FG005|Overall Study|Death|0|||
46796798|NCT02108964|83015373|FG006|Overall Study|Death|0|||
46796799|NCT02108964|83015374|FG007|Overall Study|Death|1|||
46796800|NCT02108964|83015367|FG000|Overall Study|Subject/Guardian decision|0|||
46796801|NCT02108964|83015368|FG001|Overall Study|Subject/Guardian decision|1|||
46678550|NCT01117012|82893974|FG001|Overall Study|Withdrawal by Subject|0|||
46678551|NCT01117012|82893973|FG000|Overall Study|Undefined|4|||
46678552|NCT01117012|82893974|FG001|Overall Study|Undefined|3|||
46678553|NCT01116739|82893982|FG000|Overall Study|Child had 2 years of HS|110|||
46796802|NCT02108964|83015369|FG002|Overall Study|Subject/Guardian decision|3|||
46796803|NCT02108964|83015370|FG003|Overall Study|Subject/Guardian decision|0|||
46980081|NCT02500719|83225761|FG000|Overall Study|Did not meet criteria for PTSD|0|||
46980082|NCT02500719|83225762|FG001|Overall Study|Did not meet criteria for PTSD|1|||
46980083|NCT02500719|83225761|FG000|Overall Study|Claustrophobia|0|||
46796804|NCT02108964|83015371|FG004|Overall Study|Subject/Guardian decision|2|||
46796805|NCT02108964|83015372|FG005|Overall Study|Subject/Guardian decision|0|||
46796806|NCT02108964|83015373|FG006|Overall Study|Subject/Guardian decision|1|||
46796807|NCT02108964|83015374|FG007|Overall Study|Subject/Guardian decision|1|||
46796808|NCT01882803|83015393|FG000|Overall Study|Disease Progression|1|||
46980084|NCT02500719|83225762|FG001|Overall Study|Claustrophobia|1|||
46796809|NCT01882803|83015393|FG000|Overall Study|Withdrawal by Subject|9|||
46980085|NCT02500719|83225761|FG000|Overall Study|History of head trauma|0|||
46796810|NCT01882803|83015393|FG000|Overall Study|Death|68|||
46796811|NCT01882803|83015393|FG000|Overall Study|Physician Decision|3|||
46796812|NCT01882803|83015393|FG000|Overall Study|Lost to Follow-up|3|||
46796813|NCT01882803|83015393|FG000|Overall Study|Follow-up Completed|39|||
46980086|NCT02500719|83225762|FG001|Overall Study|History of head trauma|1|||
46678554|NCT01116739|82893983|FG001|Overall Study|Child had 2 years of HS|128|||
46678555|NCT01116739|82893982|FG000|Overall Study|Withdrawal by Subject|6|||
46796814|NCT01882803|83015393|FG000|Overall Study|Study Terminated by the Sponsor|6|||
46796815|NCT01196390|83015404|FG000|Overall Study|Protocol Violation|4|||
46980087|NCT02500641|83225770|FG000|Overall Study|Adverse Event|0|||
46980088|NCT02500641|83225771|FG001|Overall Study|Adverse Event|2|||
46796816|NCT01196390|83015405|FG001|Overall Study|Protocol Violation|5|||
46796817|NCT00659126|83015428|FG000|Overall Study|Adverse Event|2|||
46980089|NCT02500641|83225770|FG000|Overall Study|Withdrawal by Subject|4|||
46796818|NCT00659126|83015429|FG001|Overall Study|Adverse Event|2|||
46796819|NCT00659126|83015428|FG000|Overall Study|Screen failure|1|||
46796820|NCT00659126|83015429|FG001|Overall Study|Screen failure|1|||
46796821|NCT00659126|83015428|FG000|Overall Study|Technical problems with MRI|0|||
46796822|NCT00659126|83015429|FG001|Overall Study|Technical problems with MRI|1|||
46796823|NCT00152503|83015460|FG000|Overall Study|Adverse Event|4|||
46678556|NCT01116739|82893983|FG001|Overall Study|Withdrawal by Subject|0|||
46678557|NCT01116739|82893982|FG000|Overall Study|child too young|2|||
46678558|NCT01116739|82893983|FG001|Overall Study|child too young|6|||
46678559|NCT01116739|82893982|FG000|Overall Study|child not enrolled in head start|10|||
46678560|NCT01116739|82893983|FG001|Overall Study|child not enrolled in head start|2|||
46678561|NCT01116739|82893982|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
46678562|NCT01116739|82893983|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
46678563|NCT01116544|82893991|FG000|Overall Study|Protocol Violation|1|||
46678564|NCT01116544|82893992|FG001|Overall Study|Protocol Violation|0|||
46678565|NCT01116544|82893991|FG000|Overall Study|Withdrawal by Subject|1|||
46678566|NCT01116544|82893992|FG001|Overall Study|Withdrawal by Subject|1|||
46678567|NCT01116427|82894000|FG000|Core Phase|Adverse Event|0|||
46678568|NCT01116427|82894001|FG001|Core Phase|Adverse Event|1|||
46678569|NCT01116427|82894000|FG000|Core Phase|Lost to Follow-up|1|||
46678570|NCT01116427|82894001|FG001|Core Phase|Lost to Follow-up|0|||
46678571|NCT01116427|82894000|FG000|Core Phase|Withdrawal by Subject|3|||
46678572|NCT01116427|82894001|FG001|Core Phase|Withdrawal by Subject|0|||
46678573|NCT01116427|82894000|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
46678574|NCT01116427|82894001|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
46678575|NCT01116427|82894000|FG000|Extension Phase|Adverse Event|1|||
46678576|NCT01116427|82894001|FG001|Extension Phase|Adverse Event|1|||
46678577|NCT01116427|82894000|FG000|Extension Phase|Lost to Follow-up|2|||
46796824|NCT03865407|83015466|FG000|Overall Study|Adverse Event|1|||
46796825|NCT03865407|83015467|FG001|Overall Study|Adverse Event|0|||
46980090|NCT02500641|83225771|FG001|Overall Study|Withdrawal by Subject|5|||
46980091|NCT02500641|83225770|FG000|Overall Study|Unable to follow study procedures|3|||
46980092|NCT02500641|83225771|FG001|Overall Study|Unable to follow study procedures|2|||
46980093|NCT02500641|83225770|FG000|Overall Study|Protocol Violation|1|||
46980094|NCT02500641|83225771|FG001|Overall Study|Protocol Violation|2|||
46980095|NCT02500641|83225770|FG000|Overall Study|Lost to Follow-up|1|||
46678578|NCT01116427|82894001|FG001|Extension Phase|Lost to Follow-up|0|||
46678579|NCT01116427|82894000|FG000|Extension Phase|Withdrawal by Subject|5|||
46678580|NCT01116427|82894001|FG001|Extension Phase|Withdrawal by Subject|1|||
46678581|NCT01116427|82894000|FG000|Extension Phase|Not using appropriate birth control|1|||
46678582|NCT01116427|82894001|FG001|Extension Phase|Not using appropriate birth control|0|||
46678583|NCT01116232|82894011|FG000|Overall Study|Progressive diease|4|||
46678584|NCT01115998|82894020|FG000|Overall Study|Lost to Follow-up|6|||
46678585|NCT01115998|82894021|FG001|Overall Study|Lost to Follow-up|6|||
46678586|NCT01205230|82894029|FG000|Overall Study|Adverse Event|4|||
46678587|NCT01205230|82894030|FG001|Overall Study|Adverse Event|0|||
46678588|NCT01205230|82894029|FG000|Overall Study|Physician Decision|1|||
46678589|NCT01205230|82894030|FG001|Overall Study|Physician Decision|0|||
46678590|NCT01205152|82894041|FG000|Overall Study|Death|1|||
46678591|NCT01205035|82894049|FG000|Overall Study|Withdrawal by Subject|1|||
46678592|NCT01205035|82894050|FG001|Overall Study|Withdrawal by Subject|0|||
46678593|NCT01205035|82894049|FG000|Overall Study|Physician Decision|1|||
46678594|NCT01205035|82894050|FG001|Overall Study|Physician Decision|0|||
46678595|NCT01204918|82894059|FG000|Overall Study|Withdrawal by Subject|4|||
46678596|NCT01204918|82894060|FG001|Overall Study|Withdrawal by Subject|10|||
46678597|NCT01204918|82894061|FG002|Overall Study|Withdrawal by Subject|5|||
46678598|NCT01204294|82894076|FG000|Overall Study|Adverse Event|2|||
46678599|NCT01204294|82894077|FG001|Overall Study|Adverse Event|6|||
46678600|NCT01204294|82894078|FG002|Overall Study|Adverse Event|0|||
46678601|NCT01204294|82894079|FG003|Overall Study|Adverse Event|7|||
46678602|NCT01204294|82894080|FG004|Overall Study|Adverse Event|1|||
46678603|NCT01204294|82894081|FG005|Overall Study|Adverse Event|4|||
46678604|NCT01204294|82894082|FG006|Overall Study|Adverse Event|0|||
46678605|NCT01204294|82894076|FG000|Overall Study|Protocol Violation|1|||
46678606|NCT01204294|82894077|FG001|Overall Study|Protocol Violation|0|||
46678607|NCT01204294|82894078|FG002|Overall Study|Protocol Violation|2|||
46678608|NCT01204294|82894079|FG003|Overall Study|Protocol Violation|1|||
46678609|NCT01204294|82894080|FG004|Overall Study|Protocol Violation|0|||
46678610|NCT01204294|82894081|FG005|Overall Study|Protocol Violation|0|||
46678611|NCT01204294|82894082|FG006|Overall Study|Protocol Violation|0|||
46678612|NCT01204294|82894076|FG000|Overall Study|Withdrawal by Subject|0|||
46678613|NCT01204294|82894077|FG001|Overall Study|Withdrawal by Subject|2|||
46796826|NCT03865407|83015466|FG000|Overall Study|Withdrawal by Subject|1|||
47081968|NCT03127137|83409245|FG000|Overall Study|Malfunction in electronic data collection|1|||
47081969|NCT03127137|83409246|FG001|Overall Study|Malfunction in electronic data collection|0|||
47081970|NCT03127137|83409245|FG000|Overall Study|Post procedure testing could not be obtained|0|||
47081971|NCT03127137|83409246|FG001|Overall Study|Post procedure testing could not be obtained|1|||
47081972|NCT00636506|83409254|FG000|Overall Study|Lost to Follow-up|8|||
47081973|NCT00636506|83409254|FG000|Overall Study|Explanted|1|||
47081974|NCT00636506|83409254|FG000|Overall Study|Withdrawal by Subject|6|||
47081975|NCT00636506|83409254|FG000|Overall Study|Procedure aborted|1|||
47081976|NCT00636194|83409278|FG000|Overall Study|Study related symptoms and complaints|1|||
47081977|NCT00636194|83409279|FG001|Overall Study|Study related symptoms and complaints|0|||
47081978|NCT00636194|83409278|FG000|Overall Study|Protocol Violation|2|||
47081979|NCT00636194|83409279|FG001|Overall Study|Protocol Violation|0|||
47081980|NCT00635804|83409341|FG000|Overall Study|Adverse Event|0|||
47081981|NCT00635804|83409342|FG001|Overall Study|Adverse Event|0|||
47081982|NCT00635804|83409343|FG002|Overall Study|Adverse Event|0|||
47081983|NCT00635804|83409344|FG003|Overall Study|Adverse Event|0|||
47081984|NCT00635804|83409345|FG004|Overall Study|Adverse Event|0|||
47081985|NCT00635804|83409346|FG005|Overall Study|Adverse Event|1|||
47081986|NCT00635804|83409347|FG006|Overall Study|Adverse Event|0|||
47081987|NCT00635804|83409348|FG007|Overall Study|Adverse Event|0|||
47081988|NCT00635804|83409341|FG000|Overall Study|Withdrawal by Subject|1|||
47081989|NCT00635804|83409342|FG001|Overall Study|Withdrawal by Subject|0|||
47081990|NCT00635804|83409343|FG002|Overall Study|Withdrawal by Subject|0|||
47081991|NCT00635804|83409344|FG003|Overall Study|Withdrawal by Subject|0|||
47081992|NCT00635804|83409345|FG004|Overall Study|Withdrawal by Subject|0|||
47081993|NCT00635804|83409346|FG005|Overall Study|Withdrawal by Subject|0|||
47081994|NCT00635804|83409347|FG006|Overall Study|Withdrawal by Subject|0|||
46678614|NCT01204294|82894078|FG002|Overall Study|Withdrawal by Subject|2|||
46796827|NCT03865407|83015467|FG001|Overall Study|Withdrawal by Subject|0|||
46796828|NCT03865407|83015466|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
47081995|NCT00635804|83409348|FG007|Overall Study|Withdrawal by Subject|0|||
47081996|NCT00635648|83409378|FG000|Overall Study|Adverse Event|12|||
47081997|NCT00635648|83409378|FG000|Overall Study|Withdrawal by Subject|9|||
47081998|NCT00635648|83409378|FG000|Overall Study|Physician Decision|4|||
47081999|NCT00635648|83409378|FG000|Overall Study|Rapid progression of baseline disease|4|||
47082000|NCT00635648|83409378|FG000|Overall Study|Use of other antifungal agent needed|1|||
47082001|NCT00635648|83409378|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
46678615|NCT01204294|82894079|FG003|Overall Study|Withdrawal by Subject|1|||
46678616|NCT01204294|82894080|FG004|Overall Study|Withdrawal by Subject|1|||
46678617|NCT01204294|82894081|FG005|Overall Study|Withdrawal by Subject|1|||
46678618|NCT01204294|82894082|FG006|Overall Study|Withdrawal by Subject|2|||
46678619|NCT01204294|82894076|FG000|Overall Study|Lack of Efficacy|0|||
46678620|NCT01204294|82894077|FG001|Overall Study|Lack of Efficacy|0|||
46678621|NCT01204294|82894078|FG002|Overall Study|Lack of Efficacy|0|||
46678622|NCT01204294|82894079|FG003|Overall Study|Lack of Efficacy|2|||
46678623|NCT01204294|82894080|FG004|Overall Study|Lack of Efficacy|0|||
46678624|NCT01204294|82894081|FG005|Overall Study|Lack of Efficacy|0|||
46678625|NCT01204294|82894082|FG006|Overall Study|Lack of Efficacy|0|||
46678626|NCT01204294|82894076|FG000|Overall Study|Other (house moving)|0|||
46678627|NCT01204294|82894077|FG001|Overall Study|Other (house moving)|0|||
46678628|NCT01204294|82894078|FG002|Overall Study|Other (house moving)|1|||
46678629|NCT01204294|82894079|FG003|Overall Study|Other (house moving)|0|||
46678630|NCT01204294|82894080|FG004|Overall Study|Other (house moving)|0|||
46678631|NCT01204294|82894081|FG005|Overall Study|Other (house moving)|0|||
46678632|NCT01204294|82894082|FG006|Overall Study|Other (house moving)|0|||
46678633|NCT01182181|82894100|FG000|First Intervention|Adverse Event|1|||
46678634|NCT01182181|82894101|FG001|First Intervention|Adverse Event|0|||
46678635|NCT01182181|82894100|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
46678636|NCT01182181|82894101|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
46796829|NCT03865407|83015467|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
46796830|NCT00487942|83015477|FG000|Overall Study|Adverse Event|1|||
46796831|NCT00487942|83015478|FG001|Overall Study|Adverse Event|1|||
46796832|NCT00487942|83015479|FG002|Overall Study|Adverse Event|1|||
46796833|NCT00487942|83015480|FG003|Overall Study|Adverse Event|1|||
46796834|NCT00487942|83015477|FG000|Overall Study|Lost to Follow-up|1|||
46796835|NCT00487942|83015478|FG001|Overall Study|Lost to Follow-up|0|||
46796836|NCT00487942|83015479|FG002|Overall Study|Lost to Follow-up|0|||
46796837|NCT00487942|83015480|FG003|Overall Study|Lost to Follow-up|1|||
46857271|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Lack of time|0|||
46857272|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Lack of time|0|||
46857273|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
46857274|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
46857275|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
46857276|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
46857277|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
46857278|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
46857279|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
46857280|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
46857281|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
47082002|NCT00635648|83409378|FG000|Overall Study|Noncompliance with protocol|1|||
47082003|NCT00635648|83409378|FG000|Overall Study|Other reason|2|||
47082004|NCT00635102|83409403|FG000|Overall Study|Withdrawal by Subject|7|||
47082005|NCT00635102|83409404|FG001|Overall Study|Withdrawal by Subject|8|||
47082006|NCT00635024|83409419|FG000|Overall Study|Adverse Event|1|||
47082007|NCT00634244|83409477|FG000|Overall Study|Never started treatment|0|||
47082008|NCT00634244|83409478|FG001|Overall Study|Never started treatment|1|||
47082009|NCT00634244|83409479|FG002|Overall Study|Never started treatment|0|||
47082010|NCT00634244|83409477|FG000|Overall Study|Death|1|||
46678637|NCT01181986|82894109|FG000|Phase 1|Lost to Follow-up|0|||
46678638|NCT01181986|82894110|FG001|Phase 1|Lost to Follow-up|1|||
46678639|NCT01181986|82894111|FG002|Phase 1|Lost to Follow-up|1|||
47082011|NCT00634244|83409478|FG001|Overall Study|Death|6|||
47082012|NCT00634244|83409479|FG002|Overall Study|Death|0|||
46678640|NCT01181986|82894109|FG000|Phase 1|Adverse Event|0|||
46678641|NCT01181986|82894110|FG001|Phase 1|Adverse Event|0|||
46678642|NCT01181986|82894111|FG002|Phase 1|Adverse Event|1|||
46678643|NCT01181986|82894109|FG000|Phase 1|Protocol Violation|1|||
46796838|NCT00487942|83015477|FG000|Overall Study|Protocol Violation|1|||
46796839|NCT00487942|83015478|FG001|Overall Study|Protocol Violation|1|||
46796840|NCT00487942|83015479|FG002|Overall Study|Protocol Violation|0|||
46796841|NCT00487942|83015480|FG003|Overall Study|Protocol Violation|0|||
46796842|NCT00487942|83015477|FG000|Overall Study|Withdrawal by Subject|0|||
46796843|NCT00487942|83015478|FG001|Overall Study|Withdrawal by Subject|1|||
46796844|NCT00487942|83015479|FG002|Overall Study|Withdrawal by Subject|2|||
46796845|NCT00487942|83015480|FG003|Overall Study|Withdrawal by Subject|0|||
46796846|NCT00132301|83015492|FG000|Overall Study|Death|7|||
46796847|NCT00132301|83015493|FG001|Overall Study|Death|6|||
46796848|NCT00132301|83015492|FG000|Overall Study|Withdrawal by Subject|5|||
46796849|NCT00132301|83015493|FG001|Overall Study|Withdrawal by Subject|2|||
46796850|NCT00132301|83015492|FG000|Overall Study|Physician Decision|1|||
46796851|NCT00132301|83015493|FG001|Overall Study|Physician Decision|1|||
46796852|NCT00132301|83015492|FG000|Overall Study|Lost to Follow-up|5|||
46796853|NCT00132301|83015493|FG001|Overall Study|Lost to Follow-up|3|||
46796854|NCT00132301|83015492|FG000|Overall Study|Other|1|||
46796855|NCT00132301|83015493|FG001|Overall Study|Other|1|||
46796856|NCT00132301|83015492|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
46796857|NCT00132301|83015493|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
46796858|NCT00522873|83015501|FG000|Overall Study|Adverse Event|41|||
46796859|NCT00522873|83015502|FG001|Overall Study|Adverse Event|26|||
46796860|NCT00522873|83015501|FG000|Overall Study|Withdrawal by Subject|20|||
46796861|NCT00522873|83015502|FG001|Overall Study|Withdrawal by Subject|9|||
46796862|NCT00522873|83015501|FG000|Overall Study|Protocol Violation|14|||
46796863|NCT00522873|83015502|FG001|Overall Study|Protocol Violation|4|||
46796864|NCT00522873|83015501|FG000|Overall Study|Lost to Follow-up|11|||
46796865|NCT00522873|83015502|FG001|Overall Study|Lost to Follow-up|3|||
46796866|NCT00522873|83015501|FG000|Overall Study|Personal Reasons|8|||
46796867|NCT00522873|83015502|FG001|Overall Study|Personal Reasons|1|||
46796868|NCT00522873|83015501|FG000|Overall Study|Medication Errors|1|||
46857282|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
46857283|NCT00318461|83073005|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
46857284|NCT00318461|83073006|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
46857285|NCT00318461|83073007|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
47082013|NCT00634244|83409477|FG000|Overall Study|Adverse Event|0|||
47082014|NCT00634244|83409478|FG001|Overall Study|Adverse Event|2|||
47082015|NCT00634244|83409479|FG002|Overall Study|Adverse Event|0|||
47082016|NCT00634244|83409477|FG000|Overall Study|Withdrawal by Subject|0|||
47082017|NCT00634244|83409478|FG001|Overall Study|Withdrawal by Subject|1|||
47082018|NCT00634244|83409479|FG002|Overall Study|Withdrawal by Subject|0|||
47082019|NCT00634244|83409477|FG000|Overall Study|Physician Decision|0|||
47082020|NCT00634244|83409478|FG001|Overall Study|Physician Decision|1|||
47082021|NCT00634244|83409479|FG002|Overall Study|Physician Decision|0|||
47082022|NCT00634244|83409477|FG000|Overall Study|Disease progression/relapse|0|||
47082023|NCT00634244|83409478|FG001|Overall Study|Disease progression/relapse|1|||
47082024|NCT00634244|83409479|FG002|Overall Study|Disease progression/relapse|0|||
47082025|NCT00634244|83409477|FG000|Overall Study|Other complicating disease|0|||
47082026|NCT00634244|83409478|FG001|Overall Study|Other complicating disease|1|||
47082027|NCT00634244|83409479|FG002|Overall Study|Other complicating disease|0|||
47082028|NCT00634088|83409663|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
47082029|NCT00634088|83409664|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
47082030|NCT00634088|83409665|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
47082031|NCT00634088|83409666|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
47082032|NCT00634088|83409663|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
47082033|NCT00634088|83409664|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
47082034|NCT00634088|83409665|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
47082035|NCT00634088|83409666|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
46796869|NCT00522873|83015502|FG001|Overall Study|Medication Errors|1|||
46678644|NCT01181986|82894110|FG001|Phase 1|Protocol Violation|0|||
46796870|NCT00522873|83015501|FG000|Overall Study|Never Received Medication|1|||
46678645|NCT01181986|82894111|FG002|Phase 1|Protocol Violation|0|||
46796871|NCT00522873|83015502|FG001|Overall Study|Never Received Medication|0|||
46796872|NCT03684057|83015510|FG000|Overall Study|Withdrawal by Subject|4|||
46796873|NCT03684057|83015511|FG001|Overall Study|Withdrawal by Subject|5|||
46796874|NCT03864627|83015520|FG000|Overall Study|Adverse Event|0|||
46796875|NCT03864627|83015521|FG001|Overall Study|Adverse Event|1|||
46796876|NCT03864627|83015520|FG000|Overall Study|Lack of Efficacy|0|||
46796877|NCT03864627|83015521|FG001|Overall Study|Lack of Efficacy|1|||
46796878|NCT03864627|83015520|FG000|Overall Study|Lost to Follow-up|0|||
46796879|NCT03864627|83015521|FG001|Overall Study|Lost to Follow-up|1|||
46796880|NCT03864627|83015520|FG000|Overall Study|Withdrawal by Subject|4|||
46796881|NCT03864627|83015521|FG001|Overall Study|Withdrawal by Subject|8|||
46796882|NCT03864627|83015520|FG000|Overall Study|Study terminated by sponsor|0|||
46796883|NCT03864627|83015521|FG001|Overall Study|Study terminated by sponsor|1|||
46796884|NCT00519831|83015528|FG000|Overall Study|Adverse Event|3|||
46796885|NCT00131911|83015538|FG000|Overall Study|Withdrawal by Subject|1|||
46796886|NCT00131911|83015539|FG001|Overall Study|Withdrawal by Subject|0|||
46796887|NCT00184093|83015544|FG000|Overall Study|Adverse Event|3|||
46796888|NCT00184093|83015544|FG000|Overall Study|Lost to Follow-up|3|||
46796889|NCT00184093|83015544|FG000|Overall Study|Physician Decision|1|||
46796890|NCT00184093|83015544|FG000|Overall Study|Withdrawal by Subject|2|||
46796891|NCT00183625|83015550|FG000|Overall Study|Withdrawal by Subject|18|||
46796892|NCT00183625|83015551|FG001|Overall Study|Withdrawal by Subject|18|||
46796893|NCT00183625|83015552|FG002|Overall Study|Withdrawal by Subject|19|||
46678646|NCT01181986|82894109|FG000|Phase 2|Adverse Event|0|||
46678647|NCT01181986|82894110|FG001|Phase 2|Adverse Event|3|||
46678648|NCT01181986|82894111|FG002|Phase 2|Adverse Event|0|||
46678649|NCT01181986|82894109|FG000|Phase 2|Medical condition|0|||
46678650|NCT01181986|82894110|FG001|Phase 2|Medical condition|1|||
46678651|NCT01181986|82894111|FG002|Phase 2|Medical condition|0|||
46678652|NCT01181167|82894127|FG000|Overall Study|Adverse Event|11|||
46678653|NCT01181167|82894128|FG001|Overall Study|Adverse Event|21|||
46678654|NCT01181167|82894127|FG000|Overall Study|Lost to Follow-up|1|||
46678655|NCT01181167|82894128|FG001|Overall Study|Lost to Follow-up|0|||
46678656|NCT01181167|82894127|FG000|Overall Study|Physician Decision|2|||
46678657|NCT01181167|82894128|FG001|Overall Study|Physician Decision|3|||
46678658|NCT01181167|82894127|FG000|Overall Study|Protocol Violation|3|||
46678659|NCT01181167|82894128|FG001|Overall Study|Protocol Violation|0|||
46678660|NCT01181167|82894127|FG000|Overall Study|Withdrawal by Subject|6|||
46678661|NCT01181167|82894128|FG001|Overall Study|Withdrawal by Subject|8|||
46678662|NCT01181128|82894137|FG000|Overall Study|Withdrawal by Subject|2|||
46678663|NCT01181128|82894138|FG001|Overall Study|Withdrawal by Subject|2|||
46678664|NCT01181128|82894139|FG002|Overall Study|Withdrawal by Subject|0|||
46678665|NCT01181128|82894137|FG000|Overall Study|Death|1|||
46678666|NCT01181128|82894138|FG001|Overall Study|Death|0|||
46678667|NCT01181128|82894139|FG002|Overall Study|Death|0|||
46678668|NCT01181128|82894137|FG000|Overall Study|Physician Decision|2|||
46678669|NCT01181128|82894138|FG001|Overall Study|Physician Decision|0|||
46678670|NCT01181128|82894139|FG002|Overall Study|Physician Decision|0|||
46678671|NCT01181128|82894137|FG000|Overall Study|Adverse Event|0|||
46678672|NCT01181128|82894138|FG001|Overall Study|Adverse Event|2|||
46678673|NCT01181128|82894139|FG002|Overall Study|Adverse Event|0|||
46678674|NCT01181128|82894137|FG000|Overall Study|Other|1|||
46678675|NCT01181128|82894138|FG001|Overall Study|Other|1|||
46678676|NCT01181128|82894139|FG002|Overall Study|Other|1|||
46678677|NCT01203787|82894161|FG000|Overall Study|Death|12|||
46678678|NCT01203787|82894162|FG001|Overall Study|Death|10|||
46678679|NCT01203787|82894161|FG000|Overall Study|Withdrawal by Subject|6|||
46796894|NCT00183625|83015553|FG003|Overall Study|Withdrawal by Subject|14|||
46796895|NCT00511875|83015563|FG000|Overall Study|Lost to Follow-up|4|||
46796896|NCT00511875|83015564|FG001|Overall Study|Lost to Follow-up|0|||
46796897|NCT00511875|83015563|FG000|Overall Study|Missing variables|1|||
46857286|NCT00318461|83073008|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
46678680|NCT01203787|82894162|FG001|Overall Study|Withdrawal by Subject|2|||
46678681|NCT01203787|82894161|FG000|Overall Study|Lost to Follow-up|2|||
46678682|NCT01203787|82894162|FG001|Overall Study|Lost to Follow-up|0|||
46678683|NCT01203787|82894161|FG000|Overall Study|Adverse Event|11|||
46678684|NCT01203787|82894162|FG001|Overall Study|Adverse Event|15|||
46678685|NCT01181011|82894170|FG000|Overall Study|Adverse Event|2|||
46678686|NCT01181011|82894170|FG000|Overall Study|Lost to Follow-up|1|||
46678687|NCT01180777|82894179|FG000|Overall Study|Protocol Violation|6|||
46796898|NCT00511875|83015564|FG001|Overall Study|Missing variables|0|||
46796899|NCT00183391|83015572|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
46796900|NCT00183391|83015573|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
46796901|NCT00183391|83015572|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
46796902|NCT00183391|83015573|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
46796903|NCT00493246|83015589|FG000|Overall Study|Withdrawal by Subject|0|||
46796904|NCT00493246|83015590|FG001|Overall Study|Withdrawal by Subject|0|||
46796905|NCT00493246|83015591|FG002|Overall Study|Withdrawal by Subject|0|||
46796906|NCT00493246|83015592|FG003|Overall Study|Withdrawal by Subject|0|||
46796907|NCT00493246|83015593|FG004|Overall Study|Withdrawal by Subject|1|||
46796908|NCT00493246|83015594|FG005|Overall Study|Withdrawal by Subject|0|||
46796909|NCT00493246|83015595|FG006|Overall Study|Withdrawal by Subject|0|||
46796910|NCT00493246|83015596|FG007|Overall Study|Withdrawal by Subject|0|||
46796911|NCT00493246|83015589|FG000|Overall Study|No access to draw blood|0|||
46796912|NCT00493246|83015590|FG001|Overall Study|No access to draw blood|0|||
46796913|NCT00493246|83015591|FG002|Overall Study|No access to draw blood|0|||
46796914|NCT00493246|83015592|FG003|Overall Study|No access to draw blood|0|||
46796915|NCT00493246|83015593|FG004|Overall Study|No access to draw blood|0|||
46796916|NCT00493246|83015594|FG005|Overall Study|No access to draw blood|1|||
46796917|NCT00493246|83015595|FG006|Overall Study|No access to draw blood|0|||
46796918|NCT00493246|83015596|FG007|Overall Study|No access to draw blood|0|||
46796919|NCT00493246|83015589|FG000|Overall Study|Lost to Follow-up|0|||
46796920|NCT00493246|83015590|FG001|Overall Study|Lost to Follow-up|0|||
46796921|NCT00493246|83015591|FG002|Overall Study|Lost to Follow-up|0|||
46796922|NCT00493246|83015592|FG003|Overall Study|Lost to Follow-up|0|||
46796923|NCT00493246|83015593|FG004|Overall Study|Lost to Follow-up|0|||
46796924|NCT00493246|83015594|FG005|Overall Study|Lost to Follow-up|0|||
46796925|NCT00493246|83015595|FG006|Overall Study|Lost to Follow-up|1|||
46796926|NCT00493246|83015596|FG007|Overall Study|Lost to Follow-up|0|||
46857287|NCT00318461|83073009|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
46857288|NCT00318461|83073005|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
46857289|NCT00318461|83073006|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
46857290|NCT00318461|83073007|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
46857291|NCT00318461|83073008|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
46796927|NCT00511797|83015618|FG000|Overall Study|Adverse Event|1|||
46796928|NCT00511797|83015619|FG001|Overall Study|Adverse Event|2|||
46796929|NCT00511797|83015620|FG002|Overall Study|Adverse Event|2|||
46796930|NCT00511797|83015621|FG003|Overall Study|Adverse Event|2|||
46796931|NCT00511797|83015618|FG000|Overall Study|Lost to Follow-up|1|||
46796932|NCT00511797|83015619|FG001|Overall Study|Lost to Follow-up|0|||
46796933|NCT00511797|83015620|FG002|Overall Study|Lost to Follow-up|0|||
46796934|NCT00511797|83015621|FG003|Overall Study|Lost to Follow-up|1|||
46796935|NCT00511797|83015618|FG000|Overall Study|Pregnancy|0|||
46980096|NCT02500641|83225771|FG001|Overall Study|Lost to Follow-up|0|||
46796936|NCT00511797|83015619|FG001|Overall Study|Pregnancy|0|||
46796937|NCT00511797|83015620|FG002|Overall Study|Pregnancy|0|||
46796938|NCT00511797|83015621|FG003|Overall Study|Pregnancy|1|||
46796939|NCT00511797|83015618|FG000|Overall Study|Protocol Violation|0|||
46796940|NCT00511797|83015619|FG001|Overall Study|Protocol Violation|2|||
46796941|NCT00511797|83015620|FG002|Overall Study|Protocol Violation|2|||
46796942|NCT00511797|83015621|FG003|Overall Study|Protocol Violation|3|||
46796943|NCT00511797|83015618|FG000|Overall Study|Withdrawal by Subject|3|||
46796944|NCT00511797|83015619|FG001|Overall Study|Withdrawal by Subject|3|||
46796945|NCT00511797|83015620|FG002|Overall Study|Withdrawal by Subject|4|||
46796946|NCT00511797|83015621|FG003|Overall Study|Withdrawal by Subject|2|||
46796947|NCT00511797|83015618|FG000|Overall Study|Never dispensed|1|||
46796948|NCT00511797|83015619|FG001|Overall Study|Never dispensed|0|||
46796949|NCT00511797|83015620|FG002|Overall Study|Never dispensed|1|||
46796950|NCT00511797|83015621|FG003|Overall Study|Never dispensed|3|||
46796951|NCT00511797|83015618|FG000|Overall Study|Study drug not taken|0|||
46796952|NCT00511797|83015619|FG001|Overall Study|Study drug not taken|1|||
46796953|NCT00511797|83015620|FG002|Overall Study|Study drug not taken|0|||
46796954|NCT00511797|83015621|FG003|Overall Study|Study drug not taken|1|||
46796955|NCT00511797|83015618|FG000|Overall Study|Partially missing diary|0|||
46796956|NCT00511797|83015619|FG001|Overall Study|Partially missing diary|0|||
46796957|NCT00511797|83015620|FG002|Overall Study|Partially missing diary|1|||
46796958|NCT00511797|83015621|FG003|Overall Study|Partially missing diary|0|||
46796959|NCT00511797|83015618|FG000|Overall Study|Other (moving etc)|1|||
46796960|NCT00511797|83015619|FG001|Overall Study|Other (moving etc)|0|||
46796961|NCT00511797|83015620|FG002|Overall Study|Other (moving etc)|1|||
46796962|NCT00511797|83015621|FG003|Overall Study|Other (moving etc)|2|||
46796963|NCT00487552|83015631|FG000|Overall Study|Unsuccessful magnet placements|3|||
46796964|NCT00487552|83015631|FG000|Overall Study|Death due to progressive malignancy|2|||
46796965|NCT00487552|83015631|FG000|Overall Study|Stent not placed|1|||
46796966|NCT00182689|83015638|FG000|Overall Study|Adverse Event|8|||
46796967|NCT00182689|83015639|FG001|Overall Study|Adverse Event|11|||
46796968|NCT00182689|83015638|FG000|Overall Study|Withdrawal by Subject|2|||
46796969|NCT00182689|83015639|FG001|Overall Study|Withdrawal by Subject|2|||
46796970|NCT00182689|83015638|FG000|Overall Study|Progression|27|||
46796971|NCT00182689|83015639|FG001|Overall Study|Progression|29|||
46796972|NCT00182689|83015638|FG000|Overall Study|Death|1|||
46796973|NCT00182689|83015639|FG001|Overall Study|Death|0|||
46796974|NCT00182689|83015638|FG000|Overall Study|not protocol specified|0|||
46796975|NCT00182689|83015639|FG001|Overall Study|not protocol specified|3|||
46796976|NCT00182689|83015638|FG000|Overall Study|Ineligible|1|||
46796977|NCT00182689|83015639|FG001|Overall Study|Ineligible|4|||
46796978|NCT00182689|83015638|FG000|Overall Study|Never received treatment|1|||
46796979|NCT00182689|83015639|FG001|Overall Study|Never received treatment|0|||
46796980|NCT03860259|83015651|FG000|Overall Study|Lost to Follow-up|5|||
46796981|NCT03860259|83015652|FG001|Overall Study|Lost to Follow-up|5|||
46796982|NCT03860259|83015651|FG000|Overall Study|Protocol Violation|1|||
46796983|NCT03860259|83015652|FG001|Overall Study|Protocol Violation|0|||
46796984|NCT00131365|83015658|FG000|Overall Study|Withdrawal by Subject|1|||
46796985|NCT00131365|83015658|FG000|Overall Study|Alternative treatment|3|||
46796986|NCT00487240|83015665|FG000|Overall Study|Withdrawal by Subject|12|||
46796987|NCT00487240|83015666|FG001|Overall Study|Withdrawal by Subject|6|||
46796988|NCT00487240|83015665|FG000|Overall Study|Lost to Follow-up|7|||
46796989|NCT00487240|83015666|FG001|Overall Study|Lost to Follow-up|6|||
46796990|NCT00487240|83015665|FG000|Overall Study|Adverse Event|0|||
46796991|NCT00487240|83015666|FG001|Overall Study|Adverse Event|4|||
46796992|NCT00487240|83015665|FG000|Overall Study|Protocol Violation|5|||
46796993|NCT00487240|83015666|FG001|Overall Study|Protocol Violation|5|||
46796994|NCT00487240|83015665|FG000|Overall Study|Entry Criteria Not Met|3|||
46796995|NCT00487240|83015666|FG001|Overall Study|Entry Criteria Not Met|4|||
46796996|NCT00487240|83015665|FG000|Overall Study|Sponsor Decision|2|||
46796997|NCT00487240|83015666|FG001|Overall Study|Sponsor Decision|1|||
46796998|NCT00487240|83015665|FG000|Overall Study|Physician Decision|2|||
46796999|NCT00487240|83015666|FG001|Overall Study|Physician Decision|0|||
46797000|NCT02224391|83015674|FG000|Overall Study|Lost to Follow-up|26|||
46797001|NCT02224391|83015675|FG001|Overall Study|Lost to Follow-up|19|||
46797002|NCT02224391|83015674|FG000|Overall Study|Withdrawal by Subject|6|||
46797003|NCT02224391|83015675|FG001|Overall Study|Withdrawal by Subject|5|||
46797004|NCT00487162|83015683|FG000|Overall Study|Adverse Event|0|||
46797005|NCT00487162|83015684|FG001|Overall Study|Adverse Event|1|||
46797006|NCT00487162|83015683|FG000|Overall Study|Physician Decision|0|||
46797007|NCT00487162|83015684|FG001|Overall Study|Physician Decision|1|||
46797008|NCT00487162|83015683|FG000|Overall Study|Withdrawal by Subject|2|||
46797009|NCT00487162|83015684|FG001|Overall Study|Withdrawal by Subject|3|||
46797010|NCT00487084|83015693|FG000|Overall Study|Did not receive intervention|4|||
46797011|NCT00487084|83015694|FG001|Overall Study|Did not receive intervention|3|||
46797012|NCT00487084|83015695|FG002|Overall Study|Did not receive intervention|5|||
46797013|NCT00466726|83015703|FG000|Overall Study|Not evaluable for response|14|||
46797014|NCT01721291|83015709|FG000|Overall Study|Withdrawal by Subject|1|||
46797015|NCT01721291|83015710|FG001|Overall Study|Withdrawal by Subject|0|||
46797016|NCT01721291|83015709|FG000|Overall Study|did not like the treatment|1|||
46797017|NCT01721291|83015710|FG001|Overall Study|did not like the treatment|0|||
46797018|NCT00486226|83015736|FG000|Overall Study|Death|3|||
46797019|NCT00486226|83015736|FG000|Overall Study|Adverse Event|1|||
46797020|NCT00486226|83015736|FG000|Overall Study|Withdrawal by Subject|1|||
46797021|NCT00486226|83015736|FG000|Overall Study|Lost to Follow-up|8|||
46797022|NCT00485758|83015745|FG000|Overall Study|Adverse Event|102|||
46797023|NCT00485758|83015746|FG001|Overall Study|Adverse Event|31|||
46797024|NCT00485758|83015745|FG000|Overall Study|Death|0|||
46797025|NCT00485758|83015746|FG001|Overall Study|Death|1|||
46797026|NCT00485758|83015745|FG000|Overall Study|Lost to Follow-up|5|||
46797027|NCT00485758|83015746|FG001|Overall Study|Lost to Follow-up|1|||
46797028|NCT00485758|83015745|FG000|Overall Study|Physician Decision|3|||
46797029|NCT00485758|83015746|FG001|Overall Study|Physician Decision|3|||
46797030|NCT00485758|83015745|FG000|Overall Study|Protocol Violation|11|||
46797031|NCT00485758|83015746|FG001|Overall Study|Protocol Violation|2|||
46797032|NCT00485758|83015745|FG000|Overall Study|Withdrawal by Subject|32|||
46797033|NCT00485758|83015746|FG001|Overall Study|Withdrawal by Subject|27|||
46797034|NCT00485758|83015745|FG000|Overall Study|Study Terminated by Sponsor|3|||
46797035|NCT00485758|83015746|FG001|Overall Study|Study Terminated by Sponsor|0|||
46797036|NCT00469612|83015754|FG000|Overall Study|Study terminated before data collected|2|||
46797037|NCT00469612|83015755|FG001|Overall Study|Study terminated before data collected|0|||
46797038|NCT00469456|83015763|FG000|Overall Study|Adverse Event|4|||
46797039|NCT00469456|83015764|FG001|Overall Study|Adverse Event|3|||
46797040|NCT00469456|83015763|FG000|Overall Study|Protocol Violation|1|||
46797041|NCT00469456|83015764|FG001|Overall Study|Protocol Violation|0|||
46797042|NCT00469456|83015763|FG000|Overall Study|Withdrawal by Subject|4|||
46797043|NCT00469456|83015764|FG001|Overall Study|Withdrawal by Subject|1|||
46797044|NCT00581555|83015772|FG000|Overall Study|Adverse Event|4|||
46797045|NCT00581555|83015773|FG001|Overall Study|Adverse Event|3|||
46797046|NCT00581555|83015772|FG000|Overall Study|Physician Decision|3|||
46797047|NCT00581555|83015773|FG001|Overall Study|Physician Decision|2|||
46797048|NCT00581555|83015772|FG000|Overall Study|Withdrawal by Subject|18|||
46797049|NCT00581555|83015773|FG001|Overall Study|Withdrawal by Subject|9|||
46797050|NCT00581555|83015772|FG000|Overall Study|Lost to Follow-up|2|||
46797051|NCT00581555|83015773|FG001|Overall Study|Lost to Follow-up|2|||
46797052|NCT00581555|83015772|FG000|Overall Study|Other reasons|16|||
46797053|NCT00581555|83015773|FG001|Overall Study|Other reasons|4|||
46797054|NCT00469144|83015781|FG000|Overall Study|Death|0|||
46797055|NCT00469144|83015782|FG001|Overall Study|Death|1|||
46797056|NCT00469144|83015781|FG000|Overall Study|No Response|5|||
46797057|NCT00469144|83015782|FG001|Overall Study|No Response|5|||
46797058|NCT00469144|83015781|FG000|Overall Study|Progressive Disease|1|||
46797059|NCT00469144|83015782|FG001|Overall Study|Progressive Disease|0|||
46797060|NCT00468910|83015794|FG000|Overall Study|Lost to Follow-up|2|||
46797061|NCT00468910|83015795|FG001|Overall Study|Lost to Follow-up|1|||
46797062|NCT00468910|83015794|FG000|Overall Study|Withdrawal by Subject|2|||
46797063|NCT00468910|83015795|FG001|Overall Study|Withdrawal by Subject|1|||
46797064|NCT00468910|83015794|FG000|Overall Study|Medical Contraindication|0|||
46797065|NCT00468910|83015795|FG001|Overall Study|Medical Contraindication|1|||
46797066|NCT00519285|83015804|FG000|Overall Study|Adverse Event|127|||
46797067|NCT00519285|83015805|FG001|Overall Study|Adverse Event|266|||
46797068|NCT00519285|83015804|FG000|Overall Study|Disease progression|334|||
46797069|NCT00519285|83015805|FG001|Overall Study|Disease progression|186|||
46797070|NCT00519285|83015804|FG000|Overall Study|Physician Decision|75|||
46797071|NCT00519285|83015805|FG001|Overall Study|Physician Decision|47|||
46797072|NCT00519285|83015804|FG000|Overall Study|Participant's request|53|||
46797073|NCT00519285|83015805|FG001|Overall Study|Participant's request|84|||
46797074|NCT00519285|83015804|FG000|Overall Study|Consent withdrawn|4|||
46797075|NCT00519285|83015805|FG001|Overall Study|Consent withdrawn|5|||
46857292|NCT00318461|83073009|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
46797076|NCT00519285|83015804|FG000|Overall Study|Poor compliance to protocol|5|||
46797077|NCT00519285|83015805|FG001|Overall Study|Poor compliance to protocol|7|||
46797078|NCT00519285|83015804|FG000|Overall Study|Reason unspecified|5|||
46797079|NCT00519285|83015805|FG001|Overall Study|Reason unspecified|8|||
46797080|NCT00519285|83015804|FG000|Overall Study|Not treated|8|||
46797081|NCT00519285|83015805|FG001|Overall Study|Not treated|7|||
46797082|NCT00519285|83015804|FG000|Overall Study|Treatment ongoing|1|||
46797083|NCT00519285|83015805|FG001|Overall Study|Treatment ongoing|2|||
46797084|NCT00464620|83015811|FG000|Overall Study|Physician Decision|1|||
46797085|NCT00464620|83015812|FG001|Overall Study|Physician Decision|0|||
46797086|NCT00464620|83015813|FG002|Overall Study|Physician Decision|0|||
46797087|NCT00464620|83015811|FG000|Overall Study|Withdrawal by Subject|1|||
46797088|NCT00464620|83015812|FG001|Overall Study|Withdrawal by Subject|0|||
46797089|NCT00464620|83015813|FG002|Overall Study|Withdrawal by Subject|3|||
46797090|NCT00464620|83015811|FG000|Overall Study|Ineligible sarcoma subtype|0|||
46797091|NCT00464620|83015812|FG001|Overall Study|Ineligible sarcoma subtype|2|||
46797092|NCT00464620|83015813|FG002|Overall Study|Ineligible sarcoma subtype|2|||
46797093|NCT00464620|83015811|FG000|Overall Study|Use of prohibited concomitant medication|0|||
46797094|NCT00464620|83015812|FG001|Overall Study|Use of prohibited concomitant medication|0|||
46797095|NCT00464620|83015813|FG002|Overall Study|Use of prohibited concomitant medication|2|||
46797096|NCT00464542|83015826|FG000|Pre-treatment|Withdrawal by Subject|2|||
46797097|NCT00468676|83015832|FG000|Overall Study|Lost to Follow-up|14|||
46797098|NCT00468676|83015833|FG001|Overall Study|Lost to Follow-up|11|||
46797099|NCT00468676|83015832|FG000|Overall Study|Death|2|||
46797100|NCT00468676|83015833|FG001|Overall Study|Death|1|||
46797101|NCT00464308|83015844|FG000|Overall Study|Adverse Event|22|||
46797102|NCT00464308|83015845|FG001|Overall Study|Adverse Event|27|||
46797103|NCT00464308|83015846|FG002|Overall Study|Adverse Event|16|||
46797104|NCT00464308|83015844|FG000|Overall Study|Lost to Follow-up|29|||
46797105|NCT00464308|83015845|FG001|Overall Study|Lost to Follow-up|19|||
46797106|NCT00464308|83015846|FG002|Overall Study|Lost to Follow-up|20|||
46797107|NCT00464308|83015844|FG000|Overall Study|Patient discontinued and other reasons|17|||
46797108|NCT00464308|83015845|FG001|Overall Study|Patient discontinued and other reasons|17|||
46797109|NCT00464308|83015846|FG002|Overall Study|Patient discontinued and other reasons|23|||
46797110|NCT00464308|83015844|FG000|Overall Study|Physician Decision|1|||
46678688|NCT01180777|82894179|FG000|Overall Study|Poor lens fit|4|||
46678689|NCT01180777|82894179|FG000|Overall Study|Lost to Follow-up|1|||
46678690|NCT01180777|82894179|FG000|Overall Study|Adverse Event|1|||
46678691|NCT01648023|82894187|FG000|Overall Study|Screen Fail Post Randomization|1|||
46678692|NCT01648023|82894188|FG001|Overall Study|Screen Fail Post Randomization|2|||
46678693|NCT02756208|82894202|FG000|Overall Study|Withdrawal by Subject|1|||
46678694|NCT02756208|82894203|FG001|Overall Study|Withdrawal by Subject|0|||
46678695|NCT02756208|82894204|FG002|Overall Study|Withdrawal by Subject|1|||
46678696|NCT02756208|82894205|FG003|Overall Study|Withdrawal by Subject|3|||
46678697|NCT02756208|82894202|FG000|Overall Study|Lost to Follow-up|3|||
46678698|NCT02756208|82894203|FG001|Overall Study|Lost to Follow-up|1|||
46678699|NCT02756208|82894204|FG002|Overall Study|Lost to Follow-up|1|||
46678700|NCT02756208|82894205|FG003|Overall Study|Lost to Follow-up|1|||
46678701|NCT02756208|82894202|FG000|Overall Study|Physician Decision|1|||
46678702|NCT02756208|82894203|FG001|Overall Study|Physician Decision|0|||
46678703|NCT02756208|82894204|FG002|Overall Study|Physician Decision|0|||
46678704|NCT02756208|82894205|FG003|Overall Study|Physician Decision|0|||
46678705|NCT02756208|82894202|FG000|Overall Study|Protocol Violation|0|||
46678706|NCT02756208|82894203|FG001|Overall Study|Protocol Violation|1|||
46678707|NCT02756208|82894204|FG002|Overall Study|Protocol Violation|0|||
46678708|NCT02756208|82894205|FG003|Overall Study|Protocol Violation|0|||
46678709|NCT02756013|82894215|FG000|Overall Study|Adverse Event|1|||
46678710|NCT02756013|82894215|FG000|Overall Study|Hypersensitivity|1|||
46678711|NCT01202773|82894222|FG000|Overall Study|Adverse Event|4|||
46678712|NCT01202773|82894223|FG001|Overall Study|Adverse Event|5|||
46678713|NCT01202773|82894224|FG002|Overall Study|Adverse Event|5|||
46678714|NCT01202773|82894222|FG000|Overall Study|Lack of Efficacy|5|||
46797111|NCT00464308|83015845|FG001|Overall Study|Physician Decision|0|||
46797112|NCT00464308|83015846|FG002|Overall Study|Physician Decision|0|||
46797113|NCT00468286|83015856|FG000|Overall Study|Adverse Event|1|||
46797114|NCT00468286|83015857|FG001|Overall Study|Adverse Event|6|||
46797115|NCT00468286|83015856|FG000|Overall Study|Protocol Violation|2|||
46797116|NCT00468286|83015857|FG001|Overall Study|Protocol Violation|2|||
46678715|NCT01202773|82894223|FG001|Overall Study|Lack of Efficacy|4|||
46797117|NCT00468286|83015856|FG000|Overall Study|Withdrawal by Subject|4|||
46797118|NCT00468286|83015857|FG001|Overall Study|Withdrawal by Subject|3|||
46797119|NCT00468286|83015856|FG000|Overall Study|Physician Decision|0|||
46797120|NCT00468286|83015857|FG001|Overall Study|Physician Decision|1|||
46797121|NCT00463840|83015863|FG000|Overall Study|Disease progression|7|||
46797122|NCT00463840|83015863|FG000|Overall Study|Withdrawal by Subject|2|||
46678716|NCT01202773|82894224|FG002|Overall Study|Lack of Efficacy|9|||
46678717|NCT01202773|82894222|FG000|Overall Study|Entry Criteria Not Met|2|||
46678718|NCT01202773|82894223|FG001|Overall Study|Entry Criteria Not Met|0|||
46678719|NCT01202773|82894224|FG002|Overall Study|Entry Criteria Not Met|1|||
46678720|NCT01202773|82894222|FG000|Overall Study|Lost to Follow-up|1|||
46678721|NCT01202773|82894223|FG001|Overall Study|Lost to Follow-up|2|||
46797123|NCT00463840|83015863|FG000|Overall Study|Adverse Event|3|||
46797124|NCT00129389|83015869|FG000|Overall Study|Adverse Event|19|||
46797125|NCT00129389|83015870|FG001|Overall Study|Adverse Event|87|||
46797126|NCT00129389|83015869|FG000|Overall Study|Death|0|||
46678722|NCT01202773|82894224|FG002|Overall Study|Lost to Follow-up|2|||
46678723|NCT01202773|82894222|FG000|Overall Study|Withdrawal by Subject|13|||
46678724|NCT01202773|82894223|FG001|Overall Study|Withdrawal by Subject|6|||
46678725|NCT01202773|82894224|FG002|Overall Study|Withdrawal by Subject|5|||
46678726|NCT01202773|82894222|FG000|Overall Study|Physician Decision|2|||
46678727|NCT01202773|82894223|FG001|Overall Study|Physician Decision|0|||
46797127|NCT00129389|83015870|FG001|Overall Study|Death|1|||
46797128|NCT00129389|83015869|FG000|Overall Study|Lost to Follow-up|2|||
46797129|NCT00129389|83015870|FG001|Overall Study|Lost to Follow-up|1|||
46678728|NCT01202773|82894224|FG002|Overall Study|Physician Decision|0|||
46678729|NCT01202773|82894222|FG000|Overall Study|Protocol Violation|11|||
46678730|NCT01202773|82894223|FG001|Overall Study|Protocol Violation|6|||
46678731|NCT01202773|82894224|FG002|Overall Study|Protocol Violation|10|||
46678732|NCT01202773|82894222|FG000|Overall Study|Sponsor Decision|19|||
46797130|NCT00129389|83015869|FG000|Overall Study|Physician Decision|0|||
46857293|NCT00318461|83073005|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
46857294|NCT00318461|83073006|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
46857295|NCT00318461|83073007|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
46857296|NCT00318461|83073008|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
46980097|NCT02500641|83225770|FG000|Overall Study|Sponsor decision|1|||
46980098|NCT02500641|83225771|FG001|Overall Study|Sponsor decision|0|||
46797131|NCT00129389|83015870|FG001|Overall Study|Physician Decision|4|||
46797132|NCT00129389|83015869|FG000|Overall Study|Protocol Violation|0|||
46797133|NCT00129389|83015870|FG001|Overall Study|Protocol Violation|6|||
46797134|NCT00129389|83015869|FG000|Overall Study|Withdrawal by Subject|9|||
46797135|NCT00129389|83015870|FG001|Overall Study|Withdrawal by Subject|23|||
46980099|NCT02500641|83225770|FG000|Overall Study|Non compliance to study drug|0|||
46980100|NCT02500641|83225771|FG001|Overall Study|Non compliance to study drug|1|||
46980101|NCT02499783|83225779|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
47082036|NCT00634088|83409663|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
47082037|NCT00634088|83409664|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
47082038|NCT00634088|83409665|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
47082039|NCT00634088|83409666|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
47082040|NCT00634088|83409663|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
47082041|NCT00634088|83409664|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
47082042|NCT00634088|83409665|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
47082043|NCT00634088|83409666|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
47082044|NCT00634088|83409663|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
47082045|NCT00634088|83409664|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
47082046|NCT00634088|83409665|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
47082047|NCT00634088|83409666|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
47082048|NCT00634088|83409663|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
47082049|NCT00634088|83409664|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
47082050|NCT00634088|83409665|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
47082051|NCT00634088|83409666|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
47082052|NCT00634010|83409766|FG000|Overall Study|Adverse Event|2|||
47082053|NCT00634010|83409767|FG001|Overall Study|Adverse Event|5|||
47082054|NCT00634010|83409766|FG000|Overall Study|Withdrawal by Subject|5|||
47082055|NCT00634010|83409767|FG001|Overall Study|Withdrawal by Subject|6|||
47082056|NCT00634010|83409766|FG000|Overall Study|Physician Decision|1|||
47082057|NCT00634010|83409767|FG001|Overall Study|Physician Decision|1|||
47082058|NCT00634010|83409766|FG000|Overall Study|Disease Progression|1|||
47082059|NCT00634010|83409767|FG001|Overall Study|Disease Progression|1|||
47082060|NCT00634010|83409766|FG000|Overall Study|Non-Compliant|1|||
47082061|NCT00634010|83409767|FG001|Overall Study|Non-Compliant|1|||
47082062|NCT00633932|83409780|FG000|Overall Study|Adverse Event|1|||
47082063|NCT00633932|83409781|FG001|Overall Study|Adverse Event|3|||
47082064|NCT00633932|83409782|FG002|Overall Study|Adverse Event|4|||
47082065|NCT00633932|83409780|FG000|Overall Study|Withdrawal by Subject|3|||
47082066|NCT00633932|83409781|FG001|Overall Study|Withdrawal by Subject|9|||
47082067|NCT00633932|83409782|FG002|Overall Study|Withdrawal by Subject|1|||
47082068|NCT00633932|83409780|FG000|Overall Study|Lost to Follow-up|1|||
47082069|NCT00633932|83409781|FG001|Overall Study|Lost to Follow-up|0|||
47082070|NCT00633932|83409782|FG002|Overall Study|Lost to Follow-up|2|||
47082071|NCT00633932|83409780|FG000|Overall Study|Protocol Violation|5|||
47082072|NCT00633932|83409781|FG001|Overall Study|Protocol Violation|2|||
47082073|NCT00633932|83409782|FG002|Overall Study|Protocol Violation|3|||
47082074|NCT00633932|83409780|FG000|Overall Study|Physician Decision|0|||
47082075|NCT00633932|83409781|FG001|Overall Study|Physician Decision|0|||
47082076|NCT00633932|83409782|FG002|Overall Study|Physician Decision|1|||
46797136|NCT00129389|83015869|FG000|Overall Study|Relapse|1|||
47082077|NCT00633932|83409780|FG000|Overall Study|Doctor's judgement|1|||
47082078|NCT00633932|83409781|FG001|Overall Study|Doctor's judgement|0|||
46678733|NCT01202773|82894223|FG001|Overall Study|Sponsor Decision|20|||
46678734|NCT01202773|82894224|FG002|Overall Study|Sponsor Decision|23|||
46797137|NCT00129389|83015870|FG001|Overall Study|Relapse|0|||
46797138|NCT00129389|83015869|FG000|Overall Study|Not eligible|1|||
46797139|NCT00129389|83015870|FG001|Overall Study|Not eligible|2|||
46797140|NCT00129389|83015869|FG000|Overall Study|Crossed to the other arm|1|||
46797141|NCT00129389|83015870|FG001|Overall Study|Crossed to the other arm|16|||
46797142|NCT00468052|83015878|FG000|Overall Study|Protocol Violation|7|||
46797143|NCT00468052|83015879|FG001|Overall Study|Protocol Violation|8|||
46797144|NCT00453310|83015887|FG000|Overall Study|Progression of Disease|10|||
46797145|NCT00124657|83015894|FG000|Overall Study|Toxicity|0|||
46797146|NCT00124657|83015895|FG001|Overall Study|Toxicity|0|||
46797147|NCT00124657|83015896|FG002|Overall Study|Toxicity|1|||
46797148|NCT00124657|83015894|FG000|Overall Study|Non-compliance|1|||
46797149|NCT00124657|83015895|FG001|Overall Study|Non-compliance|0|||
46797150|NCT00124657|83015896|FG002|Overall Study|Non-compliance|4|||
46797151|NCT00124657|83015894|FG000|Overall Study|Progressive disease|14|||
46797152|NCT00124657|83015895|FG001|Overall Study|Progressive disease|5|||
46797153|NCT00124657|83015896|FG002|Overall Study|Progressive disease|27|||
46797154|NCT00124657|83015894|FG000|Overall Study|Intercurrent illness|1|||
46797155|NCT00124657|83015895|FG001|Overall Study|Intercurrent illness|0|||
46797156|NCT00124657|83015896|FG002|Overall Study|Intercurrent illness|0|||
46797157|NCT00581945|83015919|FG000|Overall Study|Adverse Event|4|||
46797158|NCT00581945|83015920|FG001|Overall Study|Adverse Event|4|||
46797159|NCT00581945|83015919|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46797160|NCT00581945|83015920|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46797161|NCT00581945|83015919|FG000|Overall Study|Withdrawal by Subject|2|||
46797162|NCT00581945|83015920|FG001|Overall Study|Withdrawal by Subject|6|||
46797163|NCT00581945|83015919|FG000|Overall Study|Death|1|||
46797164|NCT00581945|83015920|FG001|Overall Study|Death|0|||
46797165|NCT00555906|83015929|FG000|Phase 1|Objective Progression or Relapse|3|||
46797166|NCT00555906|83015930|FG001|Phase 1|Objective Progression or Relapse|5|||
46797167|NCT00555906|83015931|FG002|Phase 1|Objective Progression or Relapse|3|||
46797168|NCT00555906|83015932|FG003|Phase 1|Objective Progression or Relapse|1|||
46797169|NCT00555906|83015933|FG004|Phase 1|Objective Progression or Relapse|0|||
46797170|NCT00555906|83015929|FG000|Phase 1|Global Deterioration of Health Status|0|||
46797171|NCT00555906|83015930|FG001|Phase 1|Global Deterioration of Health Status|1|||
46797172|NCT00555906|83015931|FG002|Phase 1|Global Deterioration of Health Status|1|||
46797173|NCT00555906|83015932|FG003|Phase 1|Global Deterioration of Health Status|1|||
46797174|NCT00555906|83015933|FG004|Phase 1|Global Deterioration of Health Status|0|||
46797175|NCT00555906|83015929|FG000|Phase 1|Adverse Event|0|||
46797176|NCT00555906|83015930|FG001|Phase 1|Adverse Event|0|||
46797177|NCT00555906|83015931|FG002|Phase 1|Adverse Event|3|||
46797178|NCT00555906|83015932|FG003|Phase 1|Adverse Event|2|||
46797179|NCT00555906|83015933|FG004|Phase 1|Adverse Event|0|||
46797180|NCT00555906|83015929|FG000|Phase 1|Withdrawal by Subject|0|||
46797181|NCT00555906|83015930|FG001|Phase 1|Withdrawal by Subject|0|||
46797182|NCT00555906|83015931|FG002|Phase 1|Withdrawal by Subject|0|||
46797183|NCT00555906|83015932|FG003|Phase 1|Withdrawal by Subject|1|||
46797184|NCT00555906|83015933|FG004|Phase 1|Withdrawal by Subject|0|||
46797185|NCT00555906|83015929|FG000|Phase 2|Adverse Event|0|||
46797186|NCT00555906|83015930|FG001|Phase 2|Adverse Event|0|||
46797187|NCT00555906|83015931|FG002|Phase 2|Adverse Event|0|||
46797188|NCT00555906|83015932|FG003|Phase 2|Adverse Event|0|||
46797189|NCT00555906|83015933|FG004|Phase 2|Adverse Event|4|||
46797190|NCT00555906|83015929|FG000|Phase 2|Global Deterioration of Health Status|0|||
46797191|NCT00555906|83015930|FG001|Phase 2|Global Deterioration of Health Status|0|||
46797192|NCT00555906|83015931|FG002|Phase 2|Global Deterioration of Health Status|0|||
46797193|NCT00555906|83015932|FG003|Phase 2|Global Deterioration of Health Status|0|||
46797194|NCT00555906|83015933|FG004|Phase 2|Global Deterioration of Health Status|2|||
46797195|NCT00555906|83015929|FG000|Phase 2|Objective Progression or Relapse|0|||
46797196|NCT00555906|83015930|FG001|Phase 2|Objective Progression or Relapse|0|||
46797197|NCT00555906|83015931|FG002|Phase 2|Objective Progression or Relapse|0|||
46797198|NCT00555906|83015932|FG003|Phase 2|Objective Progression or Relapse|0|||
46797199|NCT00555906|83015933|FG004|Phase 2|Objective Progression or Relapse|16|||
46797200|NCT00555906|83015929|FG000|Phase 2|Withdrawal by Subject|0|||
46797201|NCT00555906|83015930|FG001|Phase 2|Withdrawal by Subject|0|||
46797202|NCT00555906|83015931|FG002|Phase 2|Withdrawal by Subject|0|||
46797203|NCT00555906|83015932|FG003|Phase 2|Withdrawal by Subject|0|||
46797204|NCT00555906|83015933|FG004|Phase 2|Withdrawal by Subject|2|||
46797205|NCT00555906|83015929|FG000|Phase 2|Other|0|||
46797206|NCT00555906|83015930|FG001|Phase 2|Other|0|||
46797207|NCT00555906|83015931|FG002|Phase 2|Other|0|||
46797208|NCT00555906|83015932|FG003|Phase 2|Other|0|||
46797209|NCT00555906|83015933|FG004|Phase 2|Other|6|||
46797210|NCT00555906|83015929|FG000|Phase 2|Randomized but not Treated|0|||
46797211|NCT00555906|83015930|FG001|Phase 2|Randomized but not Treated|0|||
46797212|NCT00555906|83015931|FG002|Phase 2|Randomized but not Treated|0|||
46797213|NCT00555906|83015932|FG003|Phase 2|Randomized but not Treated|0|||
46797214|NCT00555906|83015933|FG004|Phase 2|Randomized but not Treated|2|||
46857297|NCT00318461|83073009|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
46797215|NCT03817879|83015950|FG000|Overall Study|Drop out|5|||
46797216|NCT03817879|83015951|FG001|Overall Study|Drop out|12|||
46797217|NCT03817879|83015950|FG000|Overall Study|Withdrawal by Subject|0|||
46797218|NCT03817879|83015951|FG001|Overall Study|Withdrawal by Subject|1|||
46797219|NCT00555672|83015959|FG000|Overall Study|Death|0|||
46797220|NCT00555672|83015960|FG001|Overall Study|Death|2|||
46797221|NCT00555672|83015959|FG000|Overall Study|Adverse Event|8|||
46797222|NCT00555672|83015960|FG001|Overall Study|Adverse Event|2|||
46797223|NCT00555672|83015959|FG000|Overall Study|Objective progression or relapse|11|||
46797224|NCT00555672|83015960|FG001|Overall Study|Objective progression or relapse|5|||
46797225|NCT00555672|83015959|FG000|Overall Study|Other|3|||
46797226|NCT00555672|83015960|FG001|Overall Study|Other|1|||
46797227|NCT00555672|83015959|FG000|Overall Study|Participant refused|2|||
46797228|NCT00555672|83015960|FG001|Overall Study|Participant refused|0|||
46797229|NCT03958656|83015970|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
46797230|NCT03958656|83015971|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
46797231|NCT03958656|83015972|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
46797232|NCT03958656|83015973|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
46797233|NCT03958656|83015970|FG000|Overall Study|No longer meets eligibility criteria|0|||
46797234|NCT03958656|83015971|FG001|Overall Study|No longer meets eligibility criteria|0|||
46797235|NCT03958656|83015972|FG002|Overall Study|No longer meets eligibility criteria|1|||
46797236|NCT03958656|83015973|FG003|Overall Study|No longer meets eligibility criteria|0|||
46797237|NCT03958656|83015970|FG000|Overall Study|Started anti-cancer treatment|0|||
46797238|NCT03958656|83015971|FG001|Overall Study|Started anti-cancer treatment|0|||
46797239|NCT03958656|83015972|FG002|Overall Study|Started anti-cancer treatment|1|||
46797240|NCT03958656|83015973|FG003|Overall Study|Started anti-cancer treatment|0|||
46797241|NCT00561912|83015983|FG000|Overall Study|ineligible|1|||
46797242|NCT00561678|83015989|FG000|Overall Study|Withdrawal by Subject|4|||
46797243|NCT00561678|83015990|FG001|Overall Study|Withdrawal by Subject|3|||
46797244|NCT00561678|83015989|FG000|Overall Study|surgery cancelled|1|||
46797245|NCT00561678|83015990|FG001|Overall Study|surgery cancelled|1|||
46797246|NCT00561678|83015989|FG000|Overall Study|surgery rescheduled to different site|2|||
46797247|NCT00561678|83015990|FG001|Overall Study|surgery rescheduled to different site|2|||
46797248|NCT00561678|83015989|FG000|Overall Study|anesthesia provider refusal|1|||
46797249|NCT00561678|83015990|FG001|Overall Study|anesthesia provider refusal|0|||
46797250|NCT00463684|83015996|FG000|Overall Study|Withdrawal by Subject|1|||
46797251|NCT00463684|83015996|FG000|Overall Study|Lost to Follow-up|3|||
46797252|NCT00463606|83016003|FG000|Overall Study|Adverse Event|21|||
46797253|NCT00463606|83016004|FG001|Overall Study|Adverse Event|18|||
46797254|NCT00463606|83016005|FG002|Overall Study|Adverse Event|11|||
46797255|NCT00463606|83016003|FG000|Overall Study|Withdrawal by Subject|11|||
46797256|NCT00463606|83016004|FG001|Overall Study|Withdrawal by Subject|11|||
46797257|NCT00463606|83016005|FG002|Overall Study|Withdrawal by Subject|5|||
46797258|NCT00463606|83016003|FG000|Overall Study|Lost to Follow-up|2|||
46797259|NCT00463606|83016004|FG001|Overall Study|Lost to Follow-up|2|||
46797260|NCT00463606|83016005|FG002|Overall Study|Lost to Follow-up|3|||
46797261|NCT00463606|83016003|FG000|Overall Study|Subject noncompliance|1|||
46797262|NCT00463606|83016004|FG001|Overall Study|Subject noncompliance|1|||
46797263|NCT00463606|83016005|FG002|Overall Study|Subject noncompliance|0|||
46797264|NCT00463606|83016003|FG000|Overall Study|Subject moved out of town|1|||
46797265|NCT00463606|83016004|FG001|Overall Study|Subject moved out of town|0|||
46797266|NCT00463606|83016005|FG002|Overall Study|Subject moved out of town|0|||
46797267|NCT00463606|83016003|FG000|Overall Study|Physician Decision|0|||
46797268|NCT00463606|83016004|FG001|Overall Study|Physician Decision|1|||
46797269|NCT00463606|83016005|FG002|Overall Study|Physician Decision|0|||
46797270|NCT00463606|83016003|FG000|Overall Study|Sponsor request|0|||
46797271|NCT00463606|83016004|FG001|Overall Study|Sponsor request|1|||
46797272|NCT00463606|83016005|FG002|Overall Study|Sponsor request|0|||
46797273|NCT00463606|83016003|FG000|Overall Study|Exclusion criteria violation|2|||
46797274|NCT00463606|83016004|FG001|Overall Study|Exclusion criteria violation|0|||
47082079|NCT00633932|83409782|FG002|Overall Study|Doctor's judgement|0|||
46797275|NCT00463606|83016005|FG002|Overall Study|Exclusion criteria violation|0|||
46797276|NCT00463606|83016003|FG000|Overall Study|Coordinator error|1|||
46797277|NCT00463606|83016004|FG001|Overall Study|Coordinator error|0|||
46797278|NCT00463606|83016005|FG002|Overall Study|Coordinator error|0|||
46797279|NCT00463606|83016003|FG000|Overall Study|Patient randomized in error|1|||
46797280|NCT00463606|83016004|FG001|Overall Study|Patient randomized in error|0|||
46797281|NCT00463606|83016005|FG002|Overall Study|Patient randomized in error|0|||
46797282|NCT00463606|83016003|FG000|Overall Study|Participation in another ABT-335 trial|1|||
46797283|NCT00463606|83016004|FG001|Overall Study|Participation in another ABT-335 trial|0|||
46797284|NCT00463606|83016005|FG002|Overall Study|Participation in another ABT-335 trial|0|||
46797285|NCT00463606|83016003|FG000|Overall Study|Protocol Violation|0|||
46797286|NCT00463606|83016004|FG001|Overall Study|Protocol Violation|0|||
46797287|NCT00463606|83016005|FG002|Overall Study|Protocol Violation|1|||
46797288|NCT03961308|83016015|FG000|Overall Study|Withdrawal by Subject|1|||
46797289|NCT03961308|83016016|FG001|Overall Study|Withdrawal by Subject|0|||
46797290|NCT03961308|83016015|FG000|Overall Study|Other|1|||
46797291|NCT03961308|83016016|FG001|Overall Study|Other|0|||
46797292|NCT03961308|83016015|FG000|Overall Study|Lost to Follow-up|0|||
46797293|NCT03961308|83016016|FG001|Overall Study|Lost to Follow-up|1|||
46797294|NCT03961308|83016015|FG000|Overall Study|Adverse Event|0|||
46797295|NCT03961308|83016016|FG001|Overall Study|Adverse Event|1|||
46797296|NCT00174187|83016024|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
46797297|NCT00174187|83016025|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
46797298|NCT00174187|83016026|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
46797299|NCT00174187|83016024|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
46797300|NCT00174187|83016025|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
46797301|NCT00174187|83016026|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
46797302|NCT00174187|83016024|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
46797303|NCT00174187|83016025|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
46797304|NCT00174187|83016026|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
46797305|NCT00174187|83016024|FG000|Period 1 (up to 3 Years)|Other|0|||
46797306|NCT00174187|83016025|FG001|Period 1 (up to 3 Years)|Other|1|||
46797307|NCT00174187|83016026|FG002|Period 1 (up to 3 Years)|Other|0|||
46797308|NCT00174187|83016024|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
46797309|NCT00174187|83016025|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
46797310|NCT00174187|83016026|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
46797311|NCT00174187|83016024|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
46797312|NCT00174187|83016025|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
46797313|NCT00174187|83016026|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
46797314|NCT00174187|83016024|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
46797315|NCT00174187|83016025|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
46797316|NCT00174187|83016026|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
46797317|NCT00174187|83016024|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
46797318|NCT00174187|83016025|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
46797319|NCT00174187|83016026|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
46797320|NCT00174187|83016024|FG000|Period 2 (After 3 Years)|Other|0|||
46797321|NCT00174187|83016025|FG001|Period 2 (After 3 Years)|Other|0|||
46797322|NCT00174187|83016026|FG002|Period 2 (After 3 Years)|Other|5|||
46797323|NCT01011335|83016038|FG000|Overall Study|Lost to Follow-up|0|||
46797324|NCT01011335|83016039|FG001|Overall Study|Lost to Follow-up|0|||
46797325|NCT01011335|83016040|FG002|Overall Study|Lost to Follow-up|1|||
46797326|NCT01011335|83016041|FG003|Overall Study|Lost to Follow-up|1|||
46797327|NCT01011335|83016042|FG004|Overall Study|Lost to Follow-up|1|||
46797328|NCT01011335|83016043|FG005|Overall Study|Lost to Follow-up|1|||
46797329|NCT01011335|83016044|FG006|Overall Study|Lost to Follow-up|2|||
46797330|NCT01011335|83016045|FG007|Overall Study|Lost to Follow-up|2|||
46797331|NCT01011335|83016046|FG008|Overall Study|Lost to Follow-up|1|||
46797332|NCT01011335|83016047|FG009|Overall Study|Lost to Follow-up|0|||
46797333|NCT01011335|83016048|FG010|Overall Study|Lost to Follow-up|0|||
46797334|NCT01011335|83016049|FG011|Overall Study|Lost to Follow-up|1|||
46797335|NCT01011335|83016050|FG012|Overall Study|Lost to Follow-up|2|||
46797336|NCT01011335|83016038|FG000|Overall Study|Protocol Violation|0|||
46797337|NCT01011335|83016039|FG001|Overall Study|Protocol Violation|1|||
46797338|NCT01011335|83016040|FG002|Overall Study|Protocol Violation|0|||
46797339|NCT01011335|83016041|FG003|Overall Study|Protocol Violation|0|||
46797340|NCT01011335|83016042|FG004|Overall Study|Protocol Violation|0|||
46797341|NCT01011335|83016043|FG005|Overall Study|Protocol Violation|0|||
46797342|NCT01011335|83016044|FG006|Overall Study|Protocol Violation|0|||
46857298|NCT00318461|83073005|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
46857299|NCT00318461|83073006|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
46857300|NCT00318461|83073007|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
47082080|NCT00633932|83409780|FG000|Overall Study|Moved Away|1|||
46797343|NCT01011335|83016045|FG007|Overall Study|Protocol Violation|0|||
46797344|NCT01011335|83016046|FG008|Overall Study|Protocol Violation|0|||
46797345|NCT01011335|83016047|FG009|Overall Study|Protocol Violation|0|||
46797346|NCT01011335|83016048|FG010|Overall Study|Protocol Violation|0|||
46797347|NCT01011335|83016049|FG011|Overall Study|Protocol Violation|0|||
46797348|NCT01011335|83016050|FG012|Overall Study|Protocol Violation|0|||
46797349|NCT01011335|83016038|FG000|Overall Study|Moved/deployed or no booster|1|||
46797350|NCT01011335|83016039|FG001|Overall Study|Moved/deployed or no booster|0|||
46797351|NCT01011335|83016040|FG002|Overall Study|Moved/deployed or no booster|0|||
46797352|NCT01011335|83016041|FG003|Overall Study|Moved/deployed or no booster|1|||
46797353|NCT01011335|83016042|FG004|Overall Study|Moved/deployed or no booster|0|||
46857301|NCT00318461|83073008|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
46797354|NCT01011335|83016043|FG005|Overall Study|Moved/deployed or no booster|0|||
46797355|NCT01011335|83016044|FG006|Overall Study|Moved/deployed or no booster|1|||
46797356|NCT01011335|83016045|FG007|Overall Study|Moved/deployed or no booster|0|||
46797357|NCT01011335|83016046|FG008|Overall Study|Moved/deployed or no booster|1|||
46797358|NCT01011335|83016047|FG009|Overall Study|Moved/deployed or no booster|0|||
46797359|NCT01011335|83016048|FG010|Overall Study|Moved/deployed or no booster|2|||
46797360|NCT01011335|83016049|FG011|Overall Study|Moved/deployed or no booster|0|||
46797361|NCT01011335|83016050|FG012|Overall Study|Moved/deployed or no booster|0|||
46797362|NCT01011335|83016038|FG000|Overall Study|Adverse Event|0|||
46797363|NCT01011335|83016039|FG001|Overall Study|Adverse Event|0|||
46797364|NCT01011335|83016040|FG002|Overall Study|Adverse Event|0|||
46797365|NCT01011335|83016041|FG003|Overall Study|Adverse Event|0|||
46797366|NCT01011335|83016042|FG004|Overall Study|Adverse Event|0|||
46797367|NCT01011335|83016043|FG005|Overall Study|Adverse Event|0|||
46797368|NCT01011335|83016044|FG006|Overall Study|Adverse Event|0|||
46797369|NCT01011335|83016045|FG007|Overall Study|Adverse Event|0|||
46797370|NCT01011335|83016046|FG008|Overall Study|Adverse Event|0|||
46797371|NCT01011335|83016047|FG009|Overall Study|Adverse Event|0|||
46797372|NCT01011335|83016048|FG010|Overall Study|Adverse Event|4|||
46797373|NCT01011335|83016049|FG011|Overall Study|Adverse Event|0|||
46797374|NCT01011335|83016050|FG012|Overall Study|Adverse Event|1|||
46797375|NCT00467896|83016087|FG000|Overall Study|Consent Withdrawal|18|||
46797376|NCT00467896|83016087|FG000|Overall Study|Adverse Event|7|||
46797377|NCT00467896|83016087|FG000|Overall Study|Serious Adverse Event|13|||
46797378|NCT00467896|83016087|FG000|Overall Study|Non-compliance|3|||
46797379|NCT00467896|83016087|FG000|Overall Study|Changed therapy|2|||
46797380|NCT00467896|83016087|FG000|Overall Study|Patient received transplant|2|||
46797381|NCT00467896|83016087|FG000|Overall Study|Patient had atrial septostomy|1|||
46797382|NCT00467896|83016087|FG000|Overall Study|Patient weaned off iloprost|1|||
46797383|NCT00467896|83016087|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
46797384|NCT00467896|83016087|FG000|Overall Study|Started intravenous prostacyclin|1|||
46797385|NCT00467896|83016087|FG000|Overall Study|Started inhaled Remodulin|1|||
46797386|NCT00467896|83016087|FG000|Overall Study|Patient had no improvement|1|||
46797387|NCT00579059|83016095|FG000|Overall Study|Study Canceled at 1 Year|21|||
46797388|NCT00579059|83016096|FG001|Overall Study|Study Canceled at 1 Year|10|||
46797389|NCT00467818|83016104|FG000|Overall Study|Adverse Event|1|||
46797390|NCT00467818|83016105|FG001|Overall Study|Adverse Event|0|||
46797391|NCT00467818|83016104|FG000|Overall Study|Lost to Follow-up|2|||
46797392|NCT00467818|83016105|FG001|Overall Study|Lost to Follow-up|2|||
46797393|NCT00467740|83016118|FG000|Overall Study|Adverse Event|0|||
46797394|NCT00467740|83016119|FG001|Overall Study|Adverse Event|0|||
46797395|NCT00467740|83016120|FG002|Overall Study|Adverse Event|1|||
46797396|NCT00467740|83016121|FG003|Overall Study|Adverse Event|0|||
46797397|NCT00467740|83016122|FG004|Overall Study|Adverse Event|0|||
46797398|NCT00467740|83016118|FG000|Overall Study|Protocol Violation|0|||
46797399|NCT00467740|83016119|FG001|Overall Study|Protocol Violation|0|||
46797400|NCT00467740|83016120|FG002|Overall Study|Protocol Violation|1|||
46797401|NCT00467740|83016121|FG003|Overall Study|Protocol Violation|0|||
46797402|NCT00467740|83016122|FG004|Overall Study|Protocol Violation|0|||
46797403|NCT00467740|83016118|FG000|Overall Study|Lost to Follow-up|0|||
46797404|NCT00467740|83016119|FG001|Overall Study|Lost to Follow-up|1|||
46797405|NCT00467740|83016120|FG002|Overall Study|Lost to Follow-up|0|||
46797406|NCT00467740|83016121|FG003|Overall Study|Lost to Follow-up|0|||
46797407|NCT00467740|83016122|FG004|Overall Study|Lost to Follow-up|0|||
46797408|NCT00467740|83016118|FG000|Overall Study|Withdrawal by Subject|1|||
46797409|NCT00467740|83016119|FG001|Overall Study|Withdrawal by Subject|1|||
46797410|NCT00467740|83016120|FG002|Overall Study|Withdrawal by Subject|0|||
46797411|NCT00467740|83016121|FG003|Overall Study|Withdrawal by Subject|1|||
47082081|NCT00633932|83409781|FG001|Overall Study|Moved Away|0|||
46797412|NCT00467740|83016122|FG004|Overall Study|Withdrawal by Subject|0|||
46797413|NCT00467740|83016118|FG000|Overall Study|Lack of Efficacy|0|||
46797414|NCT00467740|83016119|FG001|Overall Study|Lack of Efficacy|1|||
47082082|NCT00633932|83409782|FG002|Overall Study|Moved Away|0|||
47082083|NCT00633464|83409908|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
47082084|NCT00633464|83409909|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
47082085|NCT00633464|83409908|FG000|Overall Study|Never Treated (Randomized in error)|0|||
47082086|NCT00633464|83409909|FG001|Overall Study|Never Treated (Randomized in error)|1|||
47082087|NCT00633152|83409950|FG000|Overall Study|Adverse Event|1|||
47082088|NCT00633152|83409951|FG001|Overall Study|Adverse Event|0|||
47082089|NCT00633152|83409950|FG000|Overall Study|Randomized, did not receive study drug|5|||
47082090|NCT00633152|83409951|FG001|Overall Study|Randomized, did not receive study drug|2|||
47082091|NCT00633152|83409950|FG000|Overall Study|Withdrawal by Subject|1|||
47082092|NCT00633152|83409951|FG001|Overall Study|Withdrawal by Subject|1|||
47082093|NCT00633152|83409950|FG000|Overall Study|Lost to Follow-up|4|||
47082094|NCT00633152|83409951|FG001|Overall Study|Lost to Follow-up|1|||
47082095|NCT00633152|83409950|FG000|Overall Study|Miscellaneous Other|3|||
47082096|NCT00633152|83409951|FG001|Overall Study|Miscellaneous Other|2|||
47082097|NCT00633074|83409970|FG000|Overall Study|Adverse Event|1|||
47082098|NCT00633074|83409971|FG001|Overall Study|Adverse Event|0|||
47082099|NCT00630344|83410141|FG000|Overall Study|Adverse Event|5|||
47082100|NCT00630344|83410141|FG000|Overall Study|Progressive Disease|19|||
47082101|NCT00630344|83410141|FG000|Overall Study|Physician Decision|9|||
47082102|NCT00630344|83410141|FG000|Overall Study|Withdrawal by Subject|1|||
47082103|NCT00630344|83410141|FG000|Overall Study|Intercurrent Illness|1|||
47082104|NCT00630344|83410141|FG000|Overall Study|Other|1|||
47082105|NCT02913261|83410167|FG000|Overall Study|Technical problems|0|||
47082106|NCT02913261|83410168|FG001|Overall Study|Technical problems|1|||
47082107|NCT02913261|83410167|FG000|Overall Study|Lack of Efficacy|32|||
47082108|NCT02913261|83410168|FG001|Overall Study|Lack of Efficacy|69|||
47082109|NCT02913261|83410167|FG000|Overall Study|Adverse Event|27|||
47082110|NCT02913261|83410168|FG001|Overall Study|Adverse Event|5|||
47082111|NCT02913261|83410167|FG000|Overall Study|Death|25|||
47082112|NCT02913261|83410168|FG001|Overall Study|Death|22|||
47082113|NCT02913261|83410167|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
47082114|NCT02913261|83410168|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
47082115|NCT02913261|83410167|FG000|Overall Study|Disease relapse|8|||
47082116|NCT02913261|83410168|FG001|Overall Study|Disease relapse|13|||
47082117|NCT02913261|83410167|FG000|Overall Study|Physician Decision|8|||
47082118|NCT02913261|83410168|FG001|Overall Study|Physician Decision|9|||
47082119|NCT02913261|83410167|FG000|Overall Study|Subject/guardian decision|4|||
47082120|NCT02913261|83410168|FG001|Overall Study|Subject/guardian decision|6|||
47082121|NCT02913261|83410167|FG000|Overall Study|Graft loss|2|||
47082122|NCT02913261|83410168|FG001|Overall Study|Graft loss|0|||
47082123|NCT00635882|83410232|FG000|Overall Study|Protocol Violation|1|||
47082124|NCT00635882|83410233|FG001|Overall Study|Protocol Violation|0|||
47082125|NCT00635882|83410234|FG002|Overall Study|Protocol Violation|0|||
47082126|NCT00635882|83410235|FG003|Overall Study|Protocol Violation|0|||
47082127|NCT00635882|83410236|FG004|Overall Study|Protocol Violation|0|||
47082128|NCT00635882|83410237|FG005|Overall Study|Protocol Violation|0|||
47082129|NCT00986570|83410488|FG000|Overall Study|Lost to Follow-up|6|||
47082130|NCT00986570|83410488|FG000|Overall Study|Potential bias for objective assessment|1|||
46797415|NCT00467740|83016120|FG002|Overall Study|Lack of Efficacy|0|||
46797416|NCT00467740|83016121|FG003|Overall Study|Lack of Efficacy|0|||
46797417|NCT00467740|83016122|FG004|Overall Study|Lack of Efficacy|0|||
46678735|NCT01180660|82894244|FG000|Overall Study|Changed to open surgery|1|||
46797418|NCT00553254|83016136|FG000|Overall Study|Death|3|||
46797419|NCT00553254|83016137|FG001|Overall Study|Death|6|||
46678736|NCT01180660|82894245|FG001|Overall Study|Changed to open surgery|0|||
46678737|NCT01202227|82894251|FG000|Overall Study|Adverse Event|16|||
46678738|NCT01202227|82894251|FG000|Overall Study|Withdrawal by Subject|2|||
46678739|NCT01202227|82894251|FG000|Overall Study|Lack of Efficacy|1|||
46678740|NCT01202188|82894260|FG000|Overall Study|Protocol deviation|14|||
46678741|NCT01202188|82894261|FG001|Overall Study|Protocol deviation|8|||
46857302|NCT00318461|83073009|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
46857303|NCT00318461|83073005|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
46857304|NCT00318461|83073006|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
46857305|NCT00318461|83073007|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
46857306|NCT00318461|83073008|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
46857307|NCT00318461|83073009|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
46678742|NCT01202188|82894262|FG002|Overall Study|Protocol deviation|12|||
46678743|NCT01202188|82894263|FG003|Overall Study|Protocol deviation|10|||
46678744|NCT01202188|82894264|FG004|Overall Study|Protocol deviation|11|||
46678745|NCT01202188|82894260|FG000|Overall Study|Subject withdrew consent|12|||
46678746|NCT01202188|82894261|FG001|Overall Study|Subject withdrew consent|13|||
46678747|NCT01202188|82894262|FG002|Overall Study|Subject withdrew consent|22|||
46678748|NCT01202188|82894263|FG003|Overall Study|Subject withdrew consent|11|||
46678749|NCT01202188|82894264|FG004|Overall Study|Subject withdrew consent|13|||
46678750|NCT01202188|82894260|FG000|Overall Study|Adverse Event|5|||
46678751|NCT01202188|82894261|FG001|Overall Study|Adverse Event|23|||
46678752|NCT01202188|82894262|FG002|Overall Study|Adverse Event|13|||
46678753|NCT01202188|82894263|FG003|Overall Study|Adverse Event|10|||
46678754|NCT01202188|82894264|FG004|Overall Study|Adverse Event|10|||
46678755|NCT01202188|82894260|FG000|Overall Study|Administrative problems|3|||
46678756|NCT01202188|82894261|FG001|Overall Study|Administrative problems|2|||
46678757|NCT01202188|82894262|FG002|Overall Study|Administrative problems|1|||
46678758|NCT01202188|82894263|FG003|Overall Study|Administrative problems|1|||
46678759|NCT01202188|82894264|FG004|Overall Study|Administrative problems|2|||
46678760|NCT01202188|82894260|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
46678761|NCT01202188|82894261|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
46678762|NCT01202188|82894262|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
46678763|NCT01202188|82894263|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
46678764|NCT01202188|82894264|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
46678765|NCT01202188|82894260|FG000|Overall Study|Lost to Follow-up|1|||
46678766|NCT01202188|82894261|FG001|Overall Study|Lost to Follow-up|1|||
46678767|NCT01202188|82894262|FG002|Overall Study|Lost to Follow-up|0|||
46678768|NCT01202188|82894263|FG003|Overall Study|Lost to Follow-up|4|||
46678769|NCT01202188|82894264|FG004|Overall Study|Lost to Follow-up|1|||
46678770|NCT01202188|82894260|FG000|Overall Study|Death|1|||
46678771|NCT01202188|82894261|FG001|Overall Study|Death|1|||
46678772|NCT01202188|82894262|FG002|Overall Study|Death|1|||
46678773|NCT01202188|82894263|FG003|Overall Study|Death|1|||
46678774|NCT01202188|82894264|FG004|Overall Study|Death|0|||
46678775|NCT01202188|82894260|FG000|Overall Study|Abnormal test procedure result (s)|0|||
46678776|NCT01202188|82894261|FG001|Overall Study|Abnormal test procedure result (s)|0|||
46678777|NCT01202188|82894262|FG002|Overall Study|Abnormal test procedure result (s)|2|||
46678778|NCT01202188|82894263|FG003|Overall Study|Abnormal test procedure result (s)|0|||
46678779|NCT01202188|82894264|FG004|Overall Study|Abnormal test procedure result (s)|0|||
46678780|NCT01201915|82894285|FG000|Overall Study|Adverse Event|2|||
46678781|NCT01201915|82894286|FG001|Overall Study|Adverse Event|1|||
46678782|NCT01201915|82894287|FG002|Overall Study|Adverse Event|1|||
46678783|NCT01201915|82894285|FG000|Overall Study|Lost to Follow-up|0|||
46678784|NCT01201915|82894286|FG001|Overall Study|Lost to Follow-up|4|||
46678785|NCT01201915|82894287|FG002|Overall Study|Lost to Follow-up|0|||
46678786|NCT01201915|82894285|FG000|Overall Study|Physician Decision|3|||
46678787|NCT01201915|82894286|FG001|Overall Study|Physician Decision|0|||
46678788|NCT01201915|82894287|FG002|Overall Study|Physician Decision|0|||
46678789|NCT01201915|82894285|FG000|Overall Study|Subject Decision|3|||
46678790|NCT01201915|82894286|FG001|Overall Study|Subject Decision|3|||
46678791|NCT01201915|82894287|FG002|Overall Study|Subject Decision|5|||
46678792|NCT01201915|82894285|FG000|Overall Study|Target Lesion Progression|0|||
46678793|NCT01201915|82894286|FG001|Overall Study|Target Lesion Progression|3|||
46678794|NCT01201915|82894287|FG002|Overall Study|Target Lesion Progression|0|||
46797420|NCT00553254|83016138|FG002|Overall Study|Death|25|||
46797421|NCT00553254|83016136|FG000|Overall Study|Lost to Follow-up|0|||
46678795|NCT01179919|82894295|FG000|Overall Study|Protocol Violation|1|||
46678796|NCT01179919|82894295|FG000|Overall Study|Adverse Event|1|||
46678797|NCT01201798|82894301|FG000|Overall Study|Adverse Event|2|||
46678798|NCT01201798|82894302|FG001|Overall Study|Adverse Event|0|||
46678799|NCT01201798|82894301|FG000|Overall Study|Lost to Follow-up|3|||
46678800|NCT01201798|82894302|FG001|Overall Study|Lost to Follow-up|5|||
46678801|NCT01201798|82894301|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
46678802|NCT01201798|82894302|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
46678803|NCT01201798|82894301|FG000|Overall Study|Noncompliance|1|||
46678804|NCT01201798|82894302|FG001|Overall Study|Noncompliance|0|||
46678805|NCT01201798|82894301|FG000|Overall Study|Protocol Violation|1|||
46678806|NCT01201798|82894302|FG001|Overall Study|Protocol Violation|1|||
46678807|NCT01201798|82894301|FG000|Overall Study|Treatment Failure|1|||
46678808|NCT01201798|82894302|FG001|Overall Study|Treatment Failure|8|||
46678809|NCT01201759|82894310|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
46678810|NCT01201759|82894311|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
46678811|NCT01201759|82894310|FG000|Visit 3 - Washout|Adverse Event|0|||
46678812|NCT01201759|82894311|FG001|Visit 3 - Washout|Adverse Event|3|||
46678813|NCT01201759|82894310|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
46678814|NCT01201759|82894311|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
46678815|NCT01201759|82894310|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
46678816|NCT01201759|82894311|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
46678817|NCT01200589|82894321|FG000|Overall Study|Withdrawal by Subject|13|||
46678818|NCT01200589|82894322|FG001|Overall Study|Withdrawal by Subject|11|||
46678819|NCT01200589|82894321|FG000|Overall Study|Physician Decision|2|||
46678820|NCT01200589|82894322|FG001|Overall Study|Physician Decision|2|||
46678821|NCT01200589|82894321|FG000|Overall Study|Lost to Follow-up|5|||
46678822|NCT01200589|82894322|FG001|Overall Study|Lost to Follow-up|4|||
46678823|NCT01200589|82894321|FG000|Overall Study|Study terminated|170|||
46678824|NCT01200589|82894322|FG001|Overall Study|Study terminated|172|||
46678825|NCT01200511|82894328|FG000|Overall Study|Lost to Follow-up|3|||
46678826|NCT01200511|82894328|FG000|Overall Study|Withdrawal by Subject|1|||
46678827|NCT01200511|82894328|FG000|Overall Study|Adverse Event|1|||
46678828|NCT01179334|82894336|FG000|Treatment Period|Adverse Event|1|||
46678829|NCT01179334|82894337|FG001|Treatment Period|Adverse Event|0|||
46678830|NCT01179334|82894336|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
46678831|NCT01179334|82894337|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
46678832|NCT01179334|82894336|FG000|Long-term Extension (LTE) Period|Death|3|||
46678833|NCT01179334|82894337|FG001|Long-term Extension (LTE) Period|Death|0|||
46678834|NCT01179334|82894336|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
46678835|NCT01179334|82894337|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
46678836|NCT01178671|82894345|FG000|Overall Study|Adverse Event|4|||
46678837|NCT01178671|82894346|FG001|Overall Study|Adverse Event|6|||
46678838|NCT01178671|82894345|FG000|Overall Study|Protocol Violation|1|||
46678839|NCT01178671|82894346|FG001|Overall Study|Protocol Violation|1|||
46678840|NCT01178671|82894345|FG000|Overall Study|Lack of Efficacy|0|||
46678841|NCT01178671|82894346|FG001|Overall Study|Lack of Efficacy|1|||
46678842|NCT01178671|82894345|FG000|Overall Study|Lost to Follow-up|3|||
46678843|NCT01178671|82894346|FG001|Overall Study|Lost to Follow-up|1|||
47082131|NCT00986258|83410492|FG000|Observation Period|Not eligible to be dosed|11|||
47082132|NCT00986258|83410492|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
47082133|NCT00986258|83410492|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
47082134|NCT00986258|83410492|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
47082135|NCT00986258|83410492|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
47082136|NCT00986258|83410492|FG000|Titration and Optimal Dose Period|Other|1|||
47082137|NCT00986258|83410492|FG000|Maintenance Period|Adverse Event|5|||
47082138|NCT00986258|83410492|FG000|Maintenance Period|Lack of Efficacy|2|||
47082139|NCT00986258|83410492|FG000|Maintenance Period|Withdrawal by Subject|2|||
47082140|NCT00986180|83410508|FG000|Overall Study|Adverse Event|21|||
47082141|NCT00986180|83410509|FG001|Overall Study|Adverse Event|23|||
47082142|NCT00986180|83410508|FG000|Overall Study|Lack of Efficacy|4|||
47082143|NCT00986180|83410509|FG001|Overall Study|Lack of Efficacy|3|||
46678844|NCT01178671|82894345|FG000|Overall Study|Physician Decision|4|||
46678845|NCT01178671|82894346|FG001|Overall Study|Physician Decision|6|||
46678846|NCT01178125|82894352|FG000|Overall Study|Lost to Follow-up|397|||
47082144|NCT00986180|83410508|FG000|Overall Study|Lost to Follow-up|5|||
46678847|NCT01178125|82894352|FG000|Overall Study|Adverse Event|244|||
46678848|NCT01178125|82894352|FG000|Overall Study|Withdrawal by Subject|209|||
46678849|NCT01178125|82894352|FG000|Overall Study|Noncompliance|184|||
46678850|NCT01178125|82894352|FG000|Overall Study|Pregnancy|55|||
46678851|NCT01178125|82894352|FG000|Overall Study|Other Reason|39|||
46678852|NCT01178125|82894352|FG000|Overall Study|Sponsor Decision|28|||
46678853|NCT01178125|82894352|FG000|Overall Study|Protocol Violation|17|||
46678854|NCT01178125|82894352|FG000|Overall Study|Investigator Decision|5|||
46678855|NCT01178086|82894374|FG000|Overall Study|Participant refusal|7|||
46678856|NCT01178086|82894374|FG000|Overall Study|Physician Decision|44|||
46678857|NCT01178086|82894374|FG000|Overall Study|Switch to other CLL therapy|113|||
46678858|NCT01178086|82894374|FG000|Overall Study|Death|59|||
46678859|NCT01178086|82894374|FG000|Overall Study|Other unspecified|89|||
46678860|NCT01178086|82894374|FG000|Overall Study|Excluded from EAS|20|||
46678861|NCT01177969|82894382|FG000|Overall Study|Protocol Violation|2|||
46678862|NCT01177969|82894383|FG001|Overall Study|Protocol Violation|1|||
46678863|NCT01177969|82894382|FG000|Overall Study|Withdrawal by Subject|1|||
46678864|NCT01177969|82894383|FG001|Overall Study|Withdrawal by Subject|2|||
46678865|NCT01177813|82894394|FG000|Overall Study|Adverse Event|8|||
46678866|NCT01177813|82894395|FG001|Overall Study|Adverse Event|2|||
46678867|NCT01177813|82894396|FG002|Overall Study|Adverse Event|4|||
46678868|NCT01177813|82894397|FG003|Overall Study|Adverse Event|6|||
46678869|NCT01177813|82894398|FG004|Overall Study|Adverse Event|3|||
46678870|NCT01177813|82894394|FG000|Overall Study|Lack of Efficacy|1|||
46678871|NCT01177813|82894395|FG001|Overall Study|Lack of Efficacy|0|||
46678872|NCT01177813|82894396|FG002|Overall Study|Lack of Efficacy|0|||
46678873|NCT01177813|82894397|FG003|Overall Study|Lack of Efficacy|0|||
46678874|NCT01177813|82894398|FG004|Overall Study|Lack of Efficacy|0|||
46678875|NCT01177813|82894394|FG000|Overall Study|Protocol Violation|3|||
46678876|NCT01177813|82894395|FG001|Overall Study|Protocol Violation|2|||
46678877|NCT01177813|82894396|FG002|Overall Study|Protocol Violation|2|||
46678878|NCT01177813|82894397|FG003|Overall Study|Protocol Violation|0|||
46678879|NCT01177813|82894398|FG004|Overall Study|Protocol Violation|1|||
46678880|NCT01177813|82894394|FG000|Overall Study|Lost to Follow-up|12|||
47082145|NCT00986180|83410509|FG001|Overall Study|Lost to Follow-up|7|||
47082146|NCT00986180|83410508|FG000|Overall Study|Physician Decision|1|||
47082147|NCT00986180|83410509|FG001|Overall Study|Physician Decision|3|||
47082148|NCT00986180|83410508|FG000|Overall Study|Protocol Violation|2|||
47082149|NCT00986180|83410509|FG001|Overall Study|Protocol Violation|0|||
47082150|NCT00986180|83410508|FG000|Overall Study|Withdrawal by Subject|1|||
47082151|NCT00986180|83410509|FG001|Overall Study|Withdrawal by Subject|9|||
47082152|NCT00986180|83410508|FG000|Overall Study|Miscellanies|10|||
47082153|NCT00986180|83410509|FG001|Overall Study|Miscellanies|11|||
47082154|NCT00986102|83410691|FG000|Overall Study|Lost to Follow-up|0|||
46678881|NCT01177813|82894395|FG001|Overall Study|Lost to Follow-up|5|||
46678882|NCT01177813|82894396|FG002|Overall Study|Lost to Follow-up|6|||
46678883|NCT01177813|82894397|FG003|Overall Study|Lost to Follow-up|3|||
46678884|NCT01177813|82894398|FG004|Overall Study|Lost to Follow-up|0|||
46678885|NCT01177813|82894394|FG000|Overall Study|Withdrawal by Subject|12|||
47082155|NCT00986102|83410692|FG001|Overall Study|Lost to Follow-up|1|||
47082156|NCT00986102|83410693|FG002|Overall Study|Lost to Follow-up|0|||
46857308|NCT00318461|83073005|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
46857309|NCT00318461|83073006|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
46857310|NCT00318461|83073007|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
46857311|NCT00318461|83073008|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
46980102|NCT02499783|83225780|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
46980103|NCT02499783|83225781|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
46980104|NCT02499783|83225779|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
46980105|NCT02499783|83225780|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
46980106|NCT02499783|83225781|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
46980107|NCT02499783|83225779|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
46980108|NCT02499783|83225780|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
46980109|NCT02499783|83225781|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
46980110|NCT02499783|83225779|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
46980111|NCT02499783|83225780|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
46980112|NCT02499783|83225781|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
46980113|NCT02499783|83225779|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
46857312|NCT00318461|83073009|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
46857313|NCT03764072|83073036|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
46857314|NCT03764072|83073037|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
46857315|NCT03764072|83073038|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
46857316|NCT03764072|83073039|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
46857317|NCT03764072|83073040|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
46857318|NCT03764072|83073041|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
46980114|NCT02499783|83225780|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
46980115|NCT02499783|83225781|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
46980116|NCT02499783|83225779|FG000|DB Period: Weeks 0-8|Other|1|||
46980117|NCT02499783|83225780|FG001|DB Period: Weeks 0-8|Other|1|||
46980118|NCT02499783|83225781|FG002|DB Period: Weeks 0-8|Other|0|||
46980119|NCT02499783|83225779|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
46980120|NCT02499783|83225780|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
46980121|NCT02499783|83225781|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
46980122|NCT02499783|83225779|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
46980123|NCT02499783|83225780|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
46980124|NCT02499783|83225781|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
46980125|NCT02499783|83225779|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
46980126|NCT02499783|83225780|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
46980127|NCT02499783|83225781|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
46980128|NCT02499783|83225779|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
46678886|NCT01177813|82894395|FG001|Overall Study|Withdrawal by Subject|7|||
46678887|NCT01177813|82894396|FG002|Overall Study|Withdrawal by Subject|6|||
46678888|NCT01177813|82894397|FG003|Overall Study|Withdrawal by Subject|5|||
46678889|NCT01177813|82894398|FG004|Overall Study|Withdrawal by Subject|3|||
46678890|NCT01177813|82894394|FG000|Overall Study|Other reason not defined above|5|||
46678891|NCT01177813|82894395|FG001|Overall Study|Other reason not defined above|2|||
46678892|NCT01177813|82894396|FG002|Overall Study|Other reason not defined above|2|||
46678893|NCT01177813|82894397|FG003|Overall Study|Other reason not defined above|3|||
46678894|NCT01177813|82894398|FG004|Overall Study|Other reason not defined above|2|||
46678895|NCT01200394|82894412|FG000|Overall Study|Adverse Event|0|||
46678896|NCT01200394|82894413|FG001|Overall Study|Adverse Event|14|||
46797422|NCT00553254|83016137|FG001|Overall Study|Lost to Follow-up|0|||
46797423|NCT00553254|83016138|FG002|Overall Study|Lost to Follow-up|2|||
46797424|NCT00553254|83016136|FG000|Overall Study|Withdrawal by Subject|2|||
46797425|NCT00553254|83016137|FG001|Overall Study|Withdrawal by Subject|0|||
46797426|NCT00553254|83016138|FG002|Overall Study|Withdrawal by Subject|2|||
46797427|NCT00553254|83016136|FG000|Overall Study|Study terminated by Sponsor|0|||
46797428|NCT00553254|83016137|FG001|Overall Study|Study terminated by Sponsor|0|||
46797429|NCT00553254|83016138|FG002|Overall Study|Study terminated by Sponsor|1|||
46857319|NCT03764072|83073036|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
46678897|NCT01200394|82894412|FG000|Overall Study|Death|1|||
46678898|NCT01200394|82894413|FG001|Overall Study|Death|0|||
46857320|NCT03764072|83073037|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
46797430|NCT00553254|83016136|FG000|Overall Study|Other|1|||
46678899|NCT01200394|82894412|FG000|Overall Study|Lost to Follow-up|0|||
46678900|NCT01200394|82894413|FG001|Overall Study|Lost to Follow-up|1|||
46678901|NCT01200394|82894412|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
46678902|NCT01200394|82894413|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
46678903|NCT01200394|82894412|FG000|Overall Study|Protocol Violation|0|||
46678904|NCT01200394|82894413|FG001|Overall Study|Protocol Violation|3|||
46678905|NCT01200394|82894412|FG000|Overall Study|Withdrawal by Subject|0|||
46678906|NCT01200394|82894413|FG001|Overall Study|Withdrawal by Subject|5|||
46678907|NCT01200394|82894412|FG000|Overall Study|Other|0|||
46678908|NCT01200394|82894413|FG001|Overall Study|Other|1|||
46678909|NCT01200355|82894422|FG000|Overall Study|Death|7|||
46678910|NCT01200355|82894423|FG001|Overall Study|Death|2|||
46678911|NCT01200238|82894431|FG000|Overall Study|Adverse Event|2|||
46678912|NCT01200238|82894432|FG001|Overall Study|Adverse Event|1|||
46678913|NCT01200238|82894431|FG000|Overall Study|Progressive Disease|5|||
46678914|NCT01200238|82894432|FG001|Overall Study|Progressive Disease|8|||
46678915|NCT01200238|82894431|FG000|Overall Study|Withdrawal by Subject|0|||
46678916|NCT01200238|82894432|FG001|Overall Study|Withdrawal by Subject|1|||
46678917|NCT01199731|82894441|FG000|Overall Study|Adverse Event|0|||
46678918|NCT01199731|82894442|FG001|Overall Study|Adverse Event|1|||
46678919|NCT01199731|82894443|FG002|Overall Study|Adverse Event|0|||
46678920|NCT01199731|82894441|FG000|Overall Study|Study closed/terminated|7|||
46678921|NCT01199731|82894442|FG001|Overall Study|Study closed/terminated|9|||
46678922|NCT01199731|82894443|FG002|Overall Study|Study closed/terminated|7|||
46678923|NCT01199731|82894441|FG000|Overall Study|Lost to Follow-up|0|||
46678924|NCT01199731|82894442|FG001|Overall Study|Lost to Follow-up|0|||
46678925|NCT01199731|82894443|FG002|Overall Study|Lost to Follow-up|2|||
46678926|NCT01199731|82894441|FG000|Overall Study|Physician Decision|0|||
46678927|NCT01199731|82894442|FG001|Overall Study|Physician Decision|1|||
46678928|NCT01199731|82894443|FG002|Overall Study|Physician Decision|1|||
46678929|NCT01199731|82894441|FG000|Overall Study|Withdrawal by Subject|2|||
46678930|NCT01199731|82894442|FG001|Overall Study|Withdrawal by Subject|0|||
46678931|NCT01199731|82894443|FG002|Overall Study|Withdrawal by Subject|0|||
46678932|NCT01199263|82894453|FG000|Overall Study|Ineligible|0|||
46678933|NCT01199263|82894454|FG001|Overall Study|Ineligible|2|||
46678934|NCT01199263|82894453|FG000|Overall Study|Never Treated|6|||
46678935|NCT01199263|82894454|FG001|Overall Study|Never Treated|0|||
46678936|NCT01199068|82894465|FG000|Overall Study|Unacceptable toxicity|0|||
46678937|NCT01199068|82894466|FG001|Overall Study|Unacceptable toxicity|0|||
46678938|NCT01199068|82894467|FG002|Overall Study|Unacceptable toxicity|2|||
46678939|NCT01199068|82894465|FG000|Overall Study|Progressive disease|3|||
46678940|NCT01199068|82894466|FG001|Overall Study|Progressive disease|3|||
46678941|NCT01199068|82894467|FG002|Overall Study|Progressive disease|6|||
46678942|NCT01199068|82894465|FG000|Overall Study|Withdrawal by Subject|0|||
46678943|NCT01199068|82894466|FG001|Overall Study|Withdrawal by Subject|0|||
46678944|NCT01199068|82894467|FG002|Overall Study|Withdrawal by Subject|1|||
46678945|NCT01198873|82894484|FG000|Overall Study|Adverse Event|4|||
46678946|NCT01198873|82894485|FG001|Overall Study|Adverse Event|7|||
46678947|NCT01198873|82894484|FG000|Overall Study|Study closure|29|||
46678948|NCT01198873|82894485|FG001|Overall Study|Study closure|23|||
46678949|NCT01198873|82894484|FG000|Overall Study|Other than above|4|||
46678950|NCT01198873|82894485|FG001|Overall Study|Other than above|2|||
46797431|NCT00553254|83016137|FG001|Overall Study|Other|0|||
46797432|NCT00553254|83016138|FG002|Overall Study|Other|13|||
46797433|NCT00168805|83016153|FG000|Overall Study|Adverse Event|7|||
46797434|NCT00168805|83016154|FG001|Overall Study|Adverse Event|11|||
46797435|NCT00168805|83016155|FG002|Overall Study|Adverse Event|16|||
46797436|NCT00168805|83016153|FG000|Overall Study|Protocol Violation|12|||
46797437|NCT00168805|83016154|FG001|Overall Study|Protocol Violation|11|||
46678951|NCT01198795|82894491|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
46678952|NCT01198795|82894491|FG000|Overall Study|Withdrawal by Subject|17|||
46678953|NCT01198795|82894491|FG000|Overall Study|Lost to Follow-up|15|||
46678954|NCT01198795|82894491|FG000|Overall Study|Adverse Event|9|||
46678955|NCT01198795|82894491|FG000|Overall Study|Lack of Efficacy|5|||
46678956|NCT01198795|82894491|FG000|Overall Study|Protocol Violation|2|||
46678957|NCT01198795|82894491|FG000|Overall Study|Other Reason|4|||
46678958|NCT01198756|82894499|FG000|Overall Study|Adverse Event|0|||
46678959|NCT01198756|82894500|FG001|Overall Study|Adverse Event|0|||
46678960|NCT01198756|82894501|FG002|Overall Study|Adverse Event|0|||
46678961|NCT01198756|82894502|FG003|Overall Study|Adverse Event|1|||
46678962|NCT01198756|82894499|FG000|Overall Study|Protocol Violation|0|||
46678963|NCT01198756|82894500|FG001|Overall Study|Protocol Violation|0|||
46678964|NCT01198756|82894501|FG002|Overall Study|Protocol Violation|0|||
46678965|NCT01198756|82894502|FG003|Overall Study|Protocol Violation|2|||
46678966|NCT01198756|82894499|FG000|Overall Study|Withdrawal by Subject|9|||
46678967|NCT01198756|82894500|FG001|Overall Study|Withdrawal by Subject|4|||
46678968|NCT01198756|82894501|FG002|Overall Study|Withdrawal by Subject|7|||
46678969|NCT01198756|82894502|FG003|Overall Study|Withdrawal by Subject|5|||
46797438|NCT00168805|83016155|FG002|Overall Study|Protocol Violation|8|||
46797439|NCT00168805|83016153|FG000|Overall Study|Lost to Follow-up|12|||
46678970|NCT01198756|82894499|FG000|Overall Study|Lost to Follow-up|29|||
46678971|NCT01198756|82894500|FG001|Overall Study|Lost to Follow-up|36|||
46678972|NCT01198756|82894501|FG002|Overall Study|Lost to Follow-up|23|||
46678973|NCT01198756|82894502|FG003|Overall Study|Lost to Follow-up|18|||
46678974|NCT01198600|82894519|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
46678975|NCT01198600|82894520|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
46678976|NCT01198600|82894521|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
46678977|NCT01198600|82894522|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
46678978|NCT01198600|82894519|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
46678979|NCT01198600|82894520|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
46678980|NCT01198600|82894521|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
46678981|NCT01198600|82894522|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
46678982|NCT01198600|82894519|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
46678983|NCT01198600|82894520|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
46797440|NCT00168805|83016154|FG001|Overall Study|Lost to Follow-up|17|||
46797441|NCT00168805|83016155|FG002|Overall Study|Lost to Follow-up|11|||
46797442|NCT00168805|83016153|FG000|Overall Study|Withdrawal by Subject|16|||
46797443|NCT00168805|83016154|FG001|Overall Study|Withdrawal by Subject|18|||
46797444|NCT00168805|83016155|FG002|Overall Study|Withdrawal by Subject|21|||
46797445|NCT00168805|83016153|FG000|Overall Study|Other|24|||
46797446|NCT00168805|83016154|FG001|Overall Study|Other|21|||
46857321|NCT03764072|83073038|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
46797447|NCT00168805|83016155|FG002|Overall Study|Other|22|||
46678984|NCT01198600|82894521|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
46678985|NCT01198600|82894522|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
46678986|NCT01198600|82894519|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
46678987|NCT01198600|82894520|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
46678988|NCT01198600|82894521|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
46678989|NCT01198600|82894522|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
46678990|NCT01198600|82894519|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
46678991|NCT01198600|82894520|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
46678992|NCT01198600|82894521|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
46678993|NCT01198600|82894522|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
46678994|NCT01198600|82894519|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
46678995|NCT01198600|82894520|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
46678996|NCT01198600|82894521|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
46678997|NCT01198600|82894522|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
46678998|NCT01198600|82894519|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
46678999|NCT01198600|82894520|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
46679000|NCT01198600|82894521|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
46679001|NCT01198600|82894522|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
46679002|NCT01198132|82894532|FG000|Overall Study|Withdrawal by Subject|4|||
46679003|NCT01198132|82894533|FG001|Overall Study|Withdrawal by Subject|5|||
46679004|NCT01198132|82894532|FG000|Overall Study|Physician Decision|5|||
46679005|NCT01198132|82894533|FG001|Overall Study|Physician Decision|4|||
46679006|NCT01198132|82894532|FG000|Overall Study|Other Unspecified|3|||
46679007|NCT01198132|82894533|FG001|Overall Study|Other Unspecified|6|||
46679008|NCT01198132|82894532|FG000|Overall Study|Lack of Efficacy|2|||
46679009|NCT01198132|82894533|FG001|Overall Study|Lack of Efficacy|3|||
46679010|NCT01198132|82894532|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
46679011|NCT01198132|82894533|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
46679012|NCT01198132|82894532|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
46679013|NCT01198132|82894533|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
46679014|NCT01198132|82894532|FG000|Overall Study|Adverse Event|0|||
46679015|NCT01198132|82894533|FG001|Overall Study|Adverse Event|1|||
46679016|NCT01198132|82894532|FG000|Overall Study|Protocol Violation|1|||
46679017|NCT01198132|82894533|FG001|Overall Study|Protocol Violation|0|||
46679018|NCT01197508|82894545|FG000|Overall Study|Withdrawal by Subject|8|||
46797448|NCT00168805|83016153|FG000|Treatment|Adverse Event|25|||
46797449|NCT00168805|83016154|FG001|Treatment|Adverse Event|26|||
46797450|NCT00168805|83016155|FG002|Treatment|Adverse Event|32|||
46797451|NCT00168805|83016153|FG000|Treatment|Protocol Violation|3|||
46797452|NCT00168805|83016154|FG001|Treatment|Protocol Violation|5|||
46980129|NCT02499783|83225780|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
46679019|NCT01197508|82894546|FG001|Overall Study|Withdrawal by Subject|7|||
47082157|NCT00986102|83410694|FG003|Overall Study|Lost to Follow-up|1|||
46679020|NCT01197508|82894547|FG002|Overall Study|Withdrawal by Subject|15|||
46679021|NCT01197508|82894548|FG003|Overall Study|Withdrawal by Subject|4|||
46679022|NCT01197508|82894545|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
46679023|NCT01197508|82894546|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
46797453|NCT00168805|83016155|FG002|Treatment|Protocol Violation|5|||
46797454|NCT00168805|83016153|FG000|Treatment|Withdrawal by Subject|3|||
47082158|NCT00986102|83410691|FG000|Overall Study|Withdrawal by Subject|1|||
47082159|NCT00986102|83410692|FG001|Overall Study|Withdrawal by Subject|1|||
47082160|NCT00986102|83410693|FG002|Overall Study|Withdrawal by Subject|0|||
47082161|NCT00986102|83410694|FG003|Overall Study|Withdrawal by Subject|0|||
47082162|NCT00985946|83410717|FG000|Overall Study|Lost to Follow-up|6|||
47082163|NCT00985946|83410717|FG000|Overall Study|Withdrawal by Subject|1|||
47082164|NCT00985790|83410732|FG000|Overall Study|Withdrawal by Subject|1|||
46857322|NCT03764072|83073039|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
46980130|NCT02499783|83225781|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
46980131|NCT02468193|83225791|FG000|Overall Study|Adverse Event|4|||
46679024|NCT01197508|82894547|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
46679025|NCT01197508|82894548|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
46679026|NCT01197508|82894545|FG000|Overall Study|Adverse Event|10|||
46679027|NCT01197508|82894546|FG001|Overall Study|Adverse Event|13|||
46679028|NCT01197508|82894547|FG002|Overall Study|Adverse Event|23|||
46679029|NCT01197508|82894548|FG003|Overall Study|Adverse Event|3|||
46679030|NCT01197508|82894545|FG000|Overall Study|Severe non-compliance to protocol|0|||
46797455|NCT00168805|83016154|FG001|Treatment|Withdrawal by Subject|7|||
46797456|NCT00168805|83016155|FG002|Treatment|Withdrawal by Subject|8|||
46797457|NCT00168805|83016153|FG000|Treatment|Other|18|||
46797458|NCT00168805|83016154|FG001|Treatment|Other|18|||
46797459|NCT00168805|83016155|FG002|Treatment|Other|17|||
46797460|NCT00467584|83016166|FG000|Overall Study|Withdrawal by Subject|4|||
46797461|NCT00467584|83016167|FG001|Overall Study|Withdrawal by Subject|5|||
46797462|NCT00467584|83016168|FG002|Overall Study|Withdrawal by Subject|1|||
46797463|NCT03839212|83016176|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
46679031|NCT01197508|82894546|FG001|Overall Study|Severe non-compliance to protocol|3|||
46679032|NCT01197508|82894547|FG002|Overall Study|Severe non-compliance to protocol|1|||
46679033|NCT01197508|82894548|FG003|Overall Study|Severe non-compliance to protocol|3|||
46679034|NCT01197508|82894545|FG000|Overall Study|Condition under investigation worsened|1|||
46679035|NCT01197508|82894546|FG001|Overall Study|Condition under investigation worsened|1|||
46679036|NCT01197508|82894547|FG002|Overall Study|Condition under investigation worsened|1|||
46857323|NCT03764072|83073040|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
46857324|NCT03764072|83073041|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
46857325|NCT03764072|83073036|FG000|Overall Study|Lost to Follow-up|0|||
46857326|NCT03764072|83073037|FG001|Overall Study|Lost to Follow-up|0|||
46857327|NCT03764072|83073038|FG002|Overall Study|Lost to Follow-up|0|||
46857328|NCT03764072|83073039|FG003|Overall Study|Lost to Follow-up|0|||
46857329|NCT03764072|83073040|FG004|Overall Study|Lost to Follow-up|1|||
46857330|NCT03764072|83073041|FG005|Overall Study|Lost to Follow-up|0|||
46679037|NCT01197508|82894548|FG003|Overall Study|Condition under investigation worsened|1|||
46679038|NCT01197508|82894545|FG000|Overall Study|Lack of Efficacy|1|||
46679039|NCT01197508|82894546|FG001|Overall Study|Lack of Efficacy|2|||
46797464|NCT00168103|83016183|FG000|Overall Study|Withdrawal by Subject|1|||
46857331|NCT03333928|83073063|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
46679040|NCT01197508|82894547|FG002|Overall Study|Lack of Efficacy|2|||
46679041|NCT01197508|82894548|FG003|Overall Study|Lack of Efficacy|1|||
46679042|NCT01197508|82894545|FG000|Overall Study|Study-specific withdrawal criteria|0|||
46679043|NCT01197508|82894546|FG001|Overall Study|Study-specific withdrawal criteria|0|||
46797465|NCT00168103|83016184|FG001|Overall Study|Withdrawal by Subject|2|||
46797466|NCT00168103|83016185|FG002|Overall Study|Withdrawal by Subject|1|||
46857332|NCT03333928|83073064|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
46679044|NCT01197508|82894547|FG002|Overall Study|Study-specific withdrawal criteria|1|||
46679045|NCT01197508|82894548|FG003|Overall Study|Study-specific withdrawal criteria|2|||
46679046|NCT01197508|82894545|FG000|Overall Study|Lost to Follow-up|1|||
46679047|NCT01197508|82894546|FG001|Overall Study|Lost to Follow-up|1|||
46679048|NCT01197508|82894547|FG002|Overall Study|Lost to Follow-up|2|||
46679049|NCT01197508|82894548|FG003|Overall Study|Lost to Follow-up|0|||
46679050|NCT01197508|82894545|FG000|Overall Study|Other|2|||
46679051|NCT01197508|82894546|FG001|Overall Study|Other|3|||
46679052|NCT01197508|82894547|FG002|Overall Study|Other|2|||
46679053|NCT01197508|82894548|FG003|Overall Study|Other|2|||
46679054|NCT01196416|82894565|FG000|Overall Study|Withdrawal by Subject|2|||
46679055|NCT01196104|82894571|FG000|Overall Study|Lost to Follow-up|1|||
46679056|NCT01196104|82894572|FG001|Overall Study|Lost to Follow-up|0|||
46679057|NCT01196104|82894571|FG000|Overall Study|Physician Decision|0|||
46679058|NCT01196104|82894572|FG001|Overall Study|Physician Decision|1|||
46679059|NCT01196104|82894571|FG000|Overall Study|Withdrawal by Subject|3|||
46679060|NCT01196104|82894572|FG001|Overall Study|Withdrawal by Subject|3|||
46679061|NCT01196104|82894571|FG000|Overall Study|Various|0|||
46679062|NCT01196104|82894572|FG001|Overall Study|Various|1|||
46679063|NCT01196026|82894590|FG000|Overall Study|Withdrawal by Subject|1|||
46679064|NCT01196026|82894591|FG001|Overall Study|Withdrawal by Subject|4|||
46679065|NCT01196026|82894592|FG002|Overall Study|Withdrawal by Subject|0|||
46679066|NCT01196026|82894593|FG003|Overall Study|Withdrawal by Subject|0|||
46679067|NCT01196026|82894594|FG004|Overall Study|Withdrawal by Subject|0|||
46679068|NCT01196026|82894595|FG005|Overall Study|Withdrawal by Subject|0|||
46679069|NCT01196026|82894590|FG000|Overall Study|Lost to Follow-up|0|||
46679070|NCT01196026|82894591|FG001|Overall Study|Lost to Follow-up|3|||
46679071|NCT01196026|82894592|FG002|Overall Study|Lost to Follow-up|0|||
46679072|NCT01196026|82894593|FG003|Overall Study|Lost to Follow-up|0|||
46679073|NCT01196026|82894594|FG004|Overall Study|Lost to Follow-up|1|||
46679074|NCT01196026|82894595|FG005|Overall Study|Lost to Follow-up|0|||
46679075|NCT01196026|82894590|FG000|Overall Study|Other|0|||
46679076|NCT01196026|82894591|FG001|Overall Study|Other|1|||
46679077|NCT01196026|82894592|FG002|Overall Study|Other|0|||
46679078|NCT01196026|82894593|FG003|Overall Study|Other|0|||
46679079|NCT01196026|82894594|FG004|Overall Study|Other|0|||
46679080|NCT01196026|82894595|FG005|Overall Study|Other|0|||
46679081|NCT01195948|82894614|FG000|Overall Study|Lost to Follow-up|0|||
46679082|NCT01195948|82894615|FG001|Overall Study|Lost to Follow-up|1|||
46679083|NCT01195948|82894616|FG002|Overall Study|Lost to Follow-up|2|||
46679084|NCT01195831|82894629|FG000|Overall Study|Lost to Follow-up|2|||
46679085|NCT01195831|82894630|FG001|Overall Study|Lost to Follow-up|4|||
46679086|NCT01195831|82894629|FG000|Overall Study|Withdrawal by Subject|2|||
46679087|NCT01195831|82894630|FG001|Overall Study|Withdrawal by Subject|2|||
46679088|NCT01195831|82894629|FG000|Overall Study|Adverse Event|4|||
46679089|NCT01195831|82894630|FG001|Overall Study|Adverse Event|2|||
46679090|NCT01195831|82894629|FG000|Overall Study|Protocol Violation|0|||
46980132|NCT02468193|83225791|FG000|Overall Study|Subject/ Guardian decision|2|||
46679091|NCT01195831|82894630|FG001|Overall Study|Protocol Violation|2|||
46679092|NCT01195675|82894636|FG000|Overall Study|Adverse Event|1|||
46679093|NCT01195675|82894636|FG000|Overall Study|Withdrawal by Subject|2|||
46679094|NCT01195636|82894653|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
46679095|NCT01195636|82894654|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
46679096|NCT01195636|82894653|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
46857333|NCT03333928|83073065|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
46679097|NCT01195636|82894654|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
46679098|NCT01195636|82894653|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46679099|NCT01195636|82894654|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
46679100|NCT01195636|82894653|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
46679101|NCT01195636|82894654|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
46679102|NCT01195636|82894653|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
46679103|NCT01195636|82894654|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
46679104|NCT01195636|82894653|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
46679105|NCT01195636|82894654|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
46679106|NCT01195636|82894653|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
46679107|NCT01195636|82894654|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
46679108|NCT01195636|82894653|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
46679109|NCT01195636|82894654|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
46679110|NCT01195363|82894662|FG000|Overall Study|Lost to Follow-up|7|||
46679111|NCT01195363|82894663|FG001|Overall Study|Lost to Follow-up|4|||
46679112|NCT01195363|82894662|FG000|Overall Study|Adverse Event|3|||
46679113|NCT01195363|82894663|FG001|Overall Study|Adverse Event|1|||
46679114|NCT01195363|82894662|FG000|Overall Study|Lack of Efficacy|0|||
46679115|NCT01195363|82894663|FG001|Overall Study|Lack of Efficacy|4|||
46679116|NCT01195363|82894662|FG000|Overall Study|incarceration|1|||
46679117|NCT01195363|82894663|FG001|Overall Study|incarceration|0|||
46679118|NCT01195090|82894671|FG000|Overall Study|Adverse Event|1|||
46679119|NCT01195090|82894672|FG001|Overall Study|Adverse Event|2|||
46679120|NCT01195090|82894671|FG000|Overall Study|Lost to Follow-up|2|||
46679121|NCT01195090|82894672|FG001|Overall Study|Lost to Follow-up|2|||
46679122|NCT01195090|82894671|FG000|Overall Study|Protocol Violation|3|||
46679123|NCT01195090|82894672|FG001|Overall Study|Protocol Violation|4|||
46679124|NCT01194973|82894678|FG000|Screening Period|Screen Failure|3|||
46679125|NCT01194973|82894678|FG000|26 Week Treatment Period|Adverse Event|1|||
46679126|NCT01194973|82894678|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
46679127|NCT01194973|82894678|FG000|26 Week Treatment Period|Pregnancy|1|||
46679128|NCT02218697|82894684|FG000|Overall Study|Adverse Event|0|||
46679129|NCT02218697|82894685|FG001|Overall Study|Adverse Event|2|||
46679130|NCT02218697|82894684|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
46679131|NCT02218697|82894685|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
46679132|NCT02218697|82894684|FG000|Overall Study|Withdrawal by Subject|2|||
46679133|NCT02218697|82894685|FG001|Overall Study|Withdrawal by Subject|3|||
46679134|NCT01177540|82894693|FG000|Overall Study|Adverse Event|1|||
46679135|NCT01177540|82894694|FG001|Overall Study|Adverse Event|0|||
46679136|NCT01177384|82894702|FG000|Overall Study|Adverse Event|6|||
46679137|NCT01177384|82894703|FG001|Overall Study|Adverse Event|4|||
46679138|NCT01177384|82894702|FG000|Overall Study|Lack of Efficacy|0|||
46679139|NCT01177384|82894703|FG001|Overall Study|Lack of Efficacy|1|||
46679140|NCT01177384|82894702|FG000|Overall Study|Lost to Follow-up|3|||
46679141|NCT01177384|82894703|FG001|Overall Study|Lost to Follow-up|4|||
46679142|NCT01177384|82894702|FG000|Overall Study|Physician Decision|0|||
46679143|NCT01177384|82894703|FG001|Overall Study|Physician Decision|3|||
46679144|NCT01177384|82894702|FG000|Overall Study|Protocol Violation|0|||
46679145|NCT01177384|82894703|FG001|Overall Study|Protocol Violation|2|||
46679146|NCT01177384|82894702|FG000|Overall Study|Withdrawal by Subject|5|||
46679147|NCT01177384|82894703|FG001|Overall Study|Withdrawal by Subject|12|||
46679148|NCT01194154|82894711|FG000|Overall Study|Adverse Event|12|||
46679149|NCT01194154|82894712|FG001|Overall Study|Adverse Event|7|||
46679150|NCT01194154|82894711|FG000|Overall Study|Lost to Follow-up|2|||
46679151|NCT01194154|82894712|FG001|Overall Study|Lost to Follow-up|3|||
46679152|NCT01194154|82894711|FG000|Overall Study|Protocol Violation|0|||
46679153|NCT01194154|82894712|FG001|Overall Study|Protocol Violation|1|||
46679154|NCT01194154|82894711|FG000|Overall Study|Withdrawal by Subject|5|||
46679155|NCT01194154|82894712|FG001|Overall Study|Withdrawal by Subject|6|||
46679156|NCT01194154|82894711|FG000|Overall Study|Blood pressure increase|5|||
46679157|NCT01194154|82894712|FG001|Overall Study|Blood pressure increase|3|||
46679158|NCT01194154|82894711|FG000|Overall Study|Hemoglobin decrease|0|||
46679159|NCT01194154|82894712|FG001|Overall Study|Hemoglobin decrease|1|||
46679160|NCT01194154|82894711|FG000|Overall Study|Hemoglobin increase|12|||
46679161|NCT01194154|82894712|FG001|Overall Study|Hemoglobin increase|3|||
46679162|NCT01194154|82894711|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
46679163|NCT01194154|82894712|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
46679164|NCT01194154|82894711|FG000|Overall Study|Treatment with prohibited medication|4|||
46679165|NCT01194154|82894712|FG001|Overall Study|Treatment with prohibited medication|5|||
46679166|NCT01194154|82894711|FG000|Overall Study|Other|4|||
46797467|NCT00168103|83016186|FG003|Overall Study|Withdrawal by Subject|0|||
47082165|NCT00985790|83410733|FG001|Overall Study|Withdrawal by Subject|1|||
47082166|NCT00985790|83410732|FG000|Overall Study|Lost to Follow-up|6|||
47082167|NCT00985790|83410733|FG001|Overall Study|Lost to Follow-up|7|||
47082168|NCT00985712|83410760|FG000|Overall Study|Adverse Event|0|||
47082169|NCT00985712|83410761|FG001|Overall Study|Adverse Event|1|||
47082170|NCT00985712|83410760|FG000|Overall Study|Lost to Follow-up|2|||
47082171|NCT00985712|83410761|FG001|Overall Study|Lost to Follow-up|2|||
47082172|NCT00985712|83410760|FG000|Overall Study|Protocol Violation|0|||
47082173|NCT00985712|83410761|FG001|Overall Study|Protocol Violation|1|||
47082174|NCT00985712|83410760|FG000|Overall Study|Withdrawal by Subject|4|||
47082175|NCT00985712|83410761|FG001|Overall Study|Withdrawal by Subject|1|||
47082176|NCT00985712|83410760|FG000|Overall Study|Sponsor decision|0|||
47082177|NCT00985712|83410761|FG001|Overall Study|Sponsor decision|2|||
47082178|NCT00985166|83410868|FG000|Overall Study|Lost to Follow-up|3|||
47082179|NCT00985166|83410869|FG001|Overall Study|Lost to Follow-up|2|||
47082180|NCT00985166|83410870|FG002|Overall Study|Lost to Follow-up|2|||
47082181|NCT00985166|83410868|FG000|Overall Study|Withdrawal by Subject|3|||
47082182|NCT00985166|83410869|FG001|Overall Study|Withdrawal by Subject|2|||
46679167|NCT01194154|82894712|FG001|Overall Study|Other|0|||
46679168|NCT01194154|82894711|FG000|Overall Study|Did not receive study medication|2|||
46679169|NCT01194154|82894712|FG001|Overall Study|Did not receive study medication|4|||
46679170|NCT05034731|82894734|FG000|Overall Study|Screen fail|1|||
46679171|NCT05034731|82894735|FG001|Overall Study|Screen fail|1|||
46679172|NCT04984993|82894745|FG000|Overall Study|Withdrawal by Subject|8|||
46679173|NCT04984993|82894746|FG001|Overall Study|Withdrawal by Subject|2|||
46679174|NCT04984993|82894745|FG000|Overall Study|Lost to Follow-up|2|||
46679175|NCT04984993|82894746|FG001|Overall Study|Lost to Follow-up|2|||
46797468|NCT00168103|83016183|FG000|Overall Study|Lost to Follow-up|1|||
47082183|NCT00985166|83410870|FG002|Overall Study|Withdrawal by Subject|0|||
47082184|NCT00985166|83410868|FG000|Overall Study|Test not done|2|||
47082185|NCT00985166|83410869|FG001|Overall Study|Test not done|0|||
47082186|NCT00985166|83410870|FG002|Overall Study|Test not done|4|||
47082187|NCT00985166|83410868|FG000|Overall Study|Other|1|||
47082188|NCT00985166|83410869|FG001|Overall Study|Other|0|||
47082189|NCT00985166|83410870|FG002|Overall Study|Other|1|||
47082190|NCT01341405|83411116|FG000|Overall Study|Adverse Event|0|||
47082191|NCT01341405|83411117|FG001|Overall Study|Adverse Event|1|||
47082192|NCT01341405|83411118|FG002|Overall Study|Adverse Event|1|||
47082193|NCT01341405|83411116|FG000|Overall Study|Withdrawal by Subject|3|||
47082194|NCT01341405|83411117|FG001|Overall Study|Withdrawal by Subject|2|||
47082195|NCT01341405|83411118|FG002|Overall Study|Withdrawal by Subject|1|||
47082196|NCT00633945|83412343|FG000|Overall Study|Physician Decision|2|||
47082197|NCT02574078|83412620|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082198|NCT02574078|83412621|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082199|NCT02574078|83412622|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082200|NCT02574078|83412623|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082201|NCT02574078|83412624|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082202|NCT02574078|83412625|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
47082203|NCT02574078|83412626|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
47082204|NCT02574078|83412627|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082205|NCT02574078|83412628|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
47082206|NCT02574078|83412629|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082207|NCT02574078|83412630|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082208|NCT02574078|83412631|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082209|NCT02574078|83412632|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
47082210|NCT02574078|83412620|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
47082211|NCT02574078|83412621|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
47082212|NCT02574078|83412622|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
47082213|NCT02574078|83412623|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
47082214|NCT02574078|83412624|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
47082215|NCT02574078|83412625|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
47082216|NCT02574078|83412626|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
47082217|NCT02574078|83412627|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
47082218|NCT02574078|83412628|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
47082219|NCT02574078|83412629|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
47082220|NCT02574078|83412630|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
47082221|NCT02574078|83412631|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
47082222|NCT02574078|83412632|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
47082223|NCT02574078|83412620|FG000|Pre-Treatment Period|Other reasons|0|||
46679176|NCT04984993|82894745|FG000|Overall Study|Both patients moved to another country|4|||
46679177|NCT04984993|82894746|FG001|Overall Study|Both patients moved to another country|0|||
46679178|NCT04880161|82894753|FG000|Overall Study|Withdrawal by Subject|1|||
46679179|NCT04880161|82894754|FG001|Overall Study|Withdrawal by Subject|0|||
46857334|NCT03333928|83073063|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
46857335|NCT03333928|83073064|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
46679180|NCT04880161|82894753|FG000|Overall Study|Lack of Compliance|1|||
46797469|NCT00168103|83016184|FG001|Overall Study|Lost to Follow-up|3|||
46797470|NCT00168103|83016185|FG002|Overall Study|Lost to Follow-up|0|||
46797471|NCT00168103|83016186|FG003|Overall Study|Lost to Follow-up|0|||
46797472|NCT00463060|83016196|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
46797473|NCT00463060|83016196|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
46797474|NCT00462982|83016205|FG000|Overall Study|Adverse Event|1|||
46797475|NCT00462982|83016205|FG000|Overall Study|Patient Not Treated|2|||
46679181|NCT04880161|82894754|FG001|Overall Study|Lack of Compliance|1|||
46857336|NCT03333928|83073065|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
46857337|NCT03333928|83073063|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
46857338|NCT03333928|83073064|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
46857339|NCT03333928|83073065|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
46857340|NCT03333928|83073063|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
46857341|NCT03333928|83073064|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
46857342|NCT03333928|83073065|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
46857343|NCT03333928|83073063|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
46857344|NCT03333928|83073064|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
46980133|NCT02466555|83225811|FG000|Overall Study|Lost to Follow-up|2|||
46980134|NCT02466399|83225818|FG000|Overall Study|Adverse Event|1|||
46980135|NCT02466399|83225819|FG001|Overall Study|Adverse Event|0|||
46679182|NCT04880161|82894753|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
46679183|NCT04880161|82894754|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
46679184|NCT04880161|82894753|FG000|Overall Study|Screen Failure|0|||
46679185|NCT04880161|82894754|FG001|Overall Study|Screen Failure|1|||
46679186|NCT04809220|82894762|FG000|Overall Study|Adverse Event|4|||
46679187|NCT04809220|82894763|FG001|Overall Study|Adverse Event|0|||
46679188|NCT04809220|82894762|FG000|Overall Study|Death|1|||
46679189|NCT04809220|82894763|FG001|Overall Study|Death|0|||
46857345|NCT03333928|83073065|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
46857346|NCT03333928|83073063|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
46980136|NCT02466399|83225818|FG000|Overall Study|Early exit due to family emergency|1|||
46980137|NCT02466399|83225819|FG001|Overall Study|Early exit due to family emergency|0|||
46679190|NCT04809220|82894762|FG000|Overall Study|Lost to Follow-up|3|||
46679191|NCT04809220|82894763|FG001|Overall Study|Lost to Follow-up|0|||
46679192|NCT04809220|82894762|FG000|Overall Study|Physician Decision|0|||
46679193|NCT04809220|82894763|FG001|Overall Study|Physician Decision|1|||
46679194|NCT04809220|82894762|FG000|Overall Study|Withdrawal by Subject|9|||
46679195|NCT04809220|82894763|FG001|Overall Study|Withdrawal by Subject|5|||
46679196|NCT04809220|82894762|FG000|Overall Study|Due to long-term overseas business trips|1|||
46679197|NCT04809220|82894763|FG001|Overall Study|Due to long-term overseas business trips|0|||
46679198|NCT04740827|82894772|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
46679199|NCT04740827|82894773|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
46679200|NCT04740827|82894772|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
46679201|NCT04740827|82894773|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
46679202|NCT04740827|82894772|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
46679203|NCT04740827|82894773|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
46679204|NCT04740827|82894772|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
46679205|NCT04740827|82894773|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
46679206|NCT04740827|82894772|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
46679207|NCT04740827|82894773|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
46679208|NCT04740827|82894772|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
46679209|NCT04740827|82894773|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
46679210|NCT04725240|82894779|FG000|Overall Study|Adverse Event|2|||
46679211|NCT04620746|82894794|FG000|Overall Study|Adverse Event|2|||
46679212|NCT04620746|82894795|FG001|Overall Study|Adverse Event|0|||
46679213|NCT04620746|82894794|FG000|Overall Study|Uniterpretable skin test|1|||
46679214|NCT04620746|82894795|FG001|Overall Study|Uniterpretable skin test|0|||
46679215|NCT04620746|82894794|FG000|Overall Study|Withdrawal by Subject|0|||
46679216|NCT04620746|82894795|FG001|Overall Study|Withdrawal by Subject|1|||
46679217|NCT04524858|82894826|FG000|Overall Study|Adverse Event|1|||
46679218|NCT04464265|82894830|FG000|Overall Study|Physician Decision|2|||
46679219|NCT04326231|82894843|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
46679220|NCT04275336|82894850|FG000|Overall Study|First venipuncture failed|4|||
46679221|NCT04275336|82894851|FG001|Overall Study|First venipuncture failed|6|||
46679222|NCT04275336|82894852|FG002|Overall Study|First venipuncture failed|5|||
46679223|NCT04275336|82894850|FG000|Overall Study|Unscheduled venipuncture|9|||
46679224|NCT04275336|82894851|FG001|Overall Study|Unscheduled venipuncture|13|||
46679225|NCT04275336|82894852|FG002|Overall Study|Unscheduled venipuncture|7|||
46679226|NCT04275336|82894850|FG000|Overall Study|Failed specimen of saliva|4|||
46679227|NCT04275336|82894851|FG001|Overall Study|Failed specimen of saliva|3|||
46679228|NCT04275336|82894852|FG002|Overall Study|Failed specimen of saliva|4|||
46679229|NCT04251910|82894878|FG000|Overall Study|Covid 19 lockdown|0|||
46797476|NCT00462904|83016226|FG000|Overall Study|Lost to Follow-up|1|||
46797477|NCT00467272|83016230|FG000|Overall Study|Pneumonia|2|||
46797478|NCT00467272|83016230|FG000|Overall Study|Thrombophlebitis|1|||
46797479|NCT00462826|83016234|FG000|Overall Study|Ineligible - second primary|1|||
46797480|NCT00462826|83016234|FG000|Overall Study|Ineligible - wrong cell type|1|||
46797481|NCT00462826|83016234|FG000|Overall Study|Ineligible - wrong primary|2|||
46797482|NCT00462826|83016234|FG000|Overall Study|Never treated|1|||
46679230|NCT04251910|82894879|FG001|Overall Study|Covid 19 lockdown|5|||
46679231|NCT04251910|82894880|FG002|Overall Study|Covid 19 lockdown|0|||
46679232|NCT04251910|82894881|FG003|Overall Study|Covid 19 lockdown|4|||
46679233|NCT04251910|82894882|FG004|Overall Study|Covid 19 lockdown|0|||
46797483|NCT00551616|83016246|FG000|Overall Study|Lost to Follow-up|48|||
46797484|NCT00551616|83016247|FG001|Overall Study|Lost to Follow-up|40|||
46679234|NCT04251910|82894883|FG005|Overall Study|Covid 19 lockdown|0|||
46679235|NCT04251910|82894878|FG000|Overall Study|Assisted living facility was closed|0|||
46679236|NCT04251910|82894879|FG001|Overall Study|Assisted living facility was closed|0|||
46797485|NCT00452530|83016255|FG000|Overall Study|Death|1|||
46797486|NCT00452530|83016256|FG001|Overall Study|Death|0|||
46797487|NCT00452530|83016255|FG000|Overall Study|Adverse Event|40|||
46679237|NCT04251910|82894880|FG002|Overall Study|Assisted living facility was closed|0|||
46679238|NCT04251910|82894881|FG003|Overall Study|Assisted living facility was closed|0|||
46679239|NCT04251910|82894882|FG004|Overall Study|Assisted living facility was closed|1|||
46679240|NCT04251910|82894883|FG005|Overall Study|Assisted living facility was closed|0|||
46679241|NCT04248491|82894902|FG000|Overall Study|Lost to Follow-up|1|||
46679242|NCT04248491|82894903|FG001|Overall Study|Lost to Follow-up|0|||
46679243|NCT04101318|82894917|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
46679244|NCT04101318|82894918|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
46679245|NCT04101318|82894917|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
46679246|NCT04101318|82894918|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
46679247|NCT04101318|82894917|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
46679248|NCT04101318|82894918|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
46679249|NCT04091672|82894926|FG000|Overall Study|Death|6|||
46679250|NCT04091672|82894927|FG001|Overall Study|Death|6|||
46679251|NCT04091672|82894926|FG000|Overall Study|Lost to Follow-up|7|||
46679252|NCT04091672|82894927|FG001|Overall Study|Lost to Follow-up|7|||
46679253|NCT04091672|82894926|FG000|Overall Study|Withdrawal by Subject|3|||
46679254|NCT04091672|82894927|FG001|Overall Study|Withdrawal by Subject|3|||
46679255|NCT04091672|82894926|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
46679256|NCT04091672|82894927|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
46679257|NCT04003389|82894943|FG000|Overall Study|Adverse Event|27|||
46679258|NCT04003389|82894944|FG001|Overall Study|Adverse Event|34|||
46679259|NCT04003389|82894945|FG002|Overall Study|Adverse Event|28|||
46679260|NCT04003389|82894943|FG000|Overall Study|Lost to Follow-up|39|||
46679261|NCT04003389|82894944|FG001|Overall Study|Lost to Follow-up|30|||
46679262|NCT04003389|82894945|FG002|Overall Study|Lost to Follow-up|33|||
46679263|NCT04003389|82894943|FG000|Overall Study|Protocol Violation|1|||
46679264|NCT04003389|82894944|FG001|Overall Study|Protocol Violation|6|||
46679265|NCT04003389|82894945|FG002|Overall Study|Protocol Violation|5|||
46679266|NCT04003389|82894943|FG000|Overall Study|Withdrawal by Subject|119|||
46679267|NCT04003389|82894944|FG001|Overall Study|Withdrawal by Subject|79|||
46679268|NCT04003389|82894945|FG002|Overall Study|Withdrawal by Subject|85|||
46679269|NCT04003389|82894943|FG000|Overall Study|Miscellaneous|14|||
46679270|NCT04003389|82894944|FG001|Overall Study|Miscellaneous|11|||
46679271|NCT04003389|82894945|FG002|Overall Study|Miscellaneous|14|||
46679272|NCT04003389|82894943|FG000|Overall Study|Participant did not receive study drug|1|||
46679273|NCT04003389|82894944|FG001|Overall Study|Participant did not receive study drug|0|||
46679274|NCT04003389|82894945|FG002|Overall Study|Participant did not receive study drug|0|||
46679275|NCT03960437|82894953|FG000|Overall Study|Removed by PI|4|||
46679276|NCT03960437|82894953|FG000|Overall Study|Lost to Follow-up|2|||
46679277|NCT03960437|82894953|FG000|Overall Study|Withdrawal by Subject|1|||
46857347|NCT03333928|83073064|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
46679278|NCT03960437|82894953|FG000|Overall Study|Death|2|||
46679279|NCT03959488|82894962|FG000|Season 1|Other|6|||
46679280|NCT03959488|82894963|FG001|Season 1|Other|7|||
46679281|NCT03959488|82894964|FG002|Season 1|Other|0|||
46857348|NCT03333928|83073065|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
46679282|NCT03959488|82894965|FG003|Season 1|Other|0|||
46679283|NCT03959488|82894966|FG004|Season 1|Other|0|||
46679284|NCT03959488|82894962|FG000|Season 1|Withdrawal by parent/guardian|43|||
46679285|NCT03959488|82894963|FG001|Season 1|Withdrawal by parent/guardian|28|||
46679286|NCT03959488|82894964|FG002|Season 1|Withdrawal by parent/guardian|0|||
46679287|NCT03959488|82894965|FG003|Season 1|Withdrawal by parent/guardian|0|||
46679288|NCT03959488|82894966|FG004|Season 1|Withdrawal by parent/guardian|0|||
46679289|NCT03959488|82894962|FG000|Season 1|Due to COVID-19 pandemic|2|||
46679290|NCT03959488|82894963|FG001|Season 1|Due to COVID-19 pandemic|3|||
46679291|NCT03959488|82894964|FG002|Season 1|Due to COVID-19 pandemic|0|||
46679292|NCT03959488|82894965|FG003|Season 1|Due to COVID-19 pandemic|0|||
46679293|NCT03959488|82894966|FG004|Season 1|Due to COVID-19 pandemic|0|||
46679294|NCT03959488|82894962|FG000|Season 1|Lost to Follow-up|17|||
46679295|NCT03959488|82894963|FG001|Season 1|Lost to Follow-up|7|||
46679296|NCT03959488|82894964|FG002|Season 1|Lost to Follow-up|0|||
46679297|NCT03959488|82894965|FG003|Season 1|Lost to Follow-up|0|||
46679298|NCT03959488|82894966|FG004|Season 1|Lost to Follow-up|0|||
46679299|NCT03959488|82894962|FG000|Season 1|Death|5|||
46679300|NCT03959488|82894963|FG001|Season 1|Death|1|||
46679301|NCT03959488|82894964|FG002|Season 1|Death|0|||
46679302|NCT03959488|82894965|FG003|Season 1|Death|0|||
46679303|NCT03959488|82894966|FG004|Season 1|Death|0|||
46679304|NCT03959488|82894962|FG000|Season 2|Other|0|||
46679305|NCT03959488|82894963|FG001|Season 2|Other|0|||
46679306|NCT03959488|82894964|FG002|Season 2|Other|2|||
46679307|NCT03959488|82894965|FG003|Season 2|Other|0|||
46679308|NCT03959488|82894966|FG004|Season 2|Other|0|||
46679309|NCT03959488|82894962|FG000|Season 2|Withdrawal by parent/guardian|0|||
46679310|NCT03959488|82894963|FG001|Season 2|Withdrawal by parent/guardian|0|||
46679311|NCT03959488|82894964|FG002|Season 2|Withdrawal by parent/guardian|3|||
46679312|NCT03959488|82894965|FG003|Season 2|Withdrawal by parent/guardian|1|||
46679313|NCT03959488|82894966|FG004|Season 2|Withdrawal by parent/guardian|1|||
46679314|NCT03959488|82894962|FG000|Season 2|Lost to Follow-up|0|||
46679315|NCT03959488|82894963|FG001|Season 2|Lost to Follow-up|0|||
46679316|NCT03959488|82894964|FG002|Season 2|Lost to Follow-up|1|||
46679317|NCT03959488|82894965|FG003|Season 2|Lost to Follow-up|0|||
46679318|NCT03959488|82894966|FG004|Season 2|Lost to Follow-up|1|||
46679319|NCT03847194|82894987|FG000|Overall Study|Lost to Follow-up|2|||
46679320|NCT03847194|82894988|FG001|Overall Study|Lost to Follow-up|5|||
46679321|NCT03847194|82894987|FG000|Overall Study|Withdrawal by Subject|1|||
46679322|NCT03847194|82894988|FG001|Overall Study|Withdrawal by Subject|2|||
46679323|NCT03847194|82894987|FG000|Overall Study|Death|0|||
46679324|NCT03847194|82894988|FG001|Overall Study|Death|1|||
46679325|NCT03828747|82894996|FG000|Double-Blind Treatment Period|Adverse Event|6|||
46679326|NCT03828747|82894997|FG001|Double-Blind Treatment Period|Adverse Event|6|||
46679327|NCT03828747|82894996|FG000|Double-Blind Treatment Period|Death|1|||
46679328|NCT03828747|82894997|FG001|Double-Blind Treatment Period|Death|2|||
46679329|NCT03828747|82894996|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46679330|NCT03828747|82894997|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
46679331|NCT03828747|82894996|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
46679332|NCT03828747|82894997|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
46679333|NCT03828747|82894996|FG000|Double-Blind Treatment Period|Physician Decision|0|||
46679334|NCT03828747|82894997|FG001|Double-Blind Treatment Period|Physician Decision|3|||
46679335|NCT03828747|82894996|FG000|Double-Blind Treatment Period|Various reasons|5|||
46679336|NCT03828747|82894997|FG001|Double-Blind Treatment Period|Various reasons|3|||
46679337|NCT03828747|82894996|FG000|Open-Label Extension|Continuing on Study|77|||
46679338|NCT03828747|82894997|FG001|Open-Label Extension|Continuing on Study|72|||
46679339|NCT03828747|82894996|FG000|Open-Label Extension|Adverse Event|3|||
46679340|NCT03828747|82894997|FG001|Open-Label Extension|Adverse Event|4|||
46679341|NCT03828747|82894996|FG000|Open-Label Extension|Death|0|||
46679342|NCT03828747|82894997|FG001|Open-Label Extension|Death|2|||
46679343|NCT03828747|82894996|FG000|Open-Label Extension|Lost to Follow-up|4|||
46679344|NCT03828747|82894997|FG001|Open-Label Extension|Lost to Follow-up|0|||
46679345|NCT03828747|82894996|FG000|Open-Label Extension|Withdrawal by Subject|19|||
46679346|NCT03828747|82894997|FG001|Open-Label Extension|Withdrawal by Subject|16|||
46679347|NCT03828747|82894996|FG000|Open-Label Extension|Various reasons|1|||
46679348|NCT03828747|82894997|FG001|Open-Label Extension|Various reasons|1|||
46679349|NCT03712098|82895043|FG000|Overall Study|Lost to Follow-up|3|||
46679350|NCT03712098|82895044|FG001|Overall Study|Lost to Follow-up|7|||
46679351|NCT03712098|82895043|FG000|Overall Study|Withdrawal by Subject|9|||
46679352|NCT03712098|82895044|FG001|Overall Study|Withdrawal by Subject|4|||
46679353|NCT03712098|82895043|FG000|Overall Study|Protocol Violation|2|||
46679354|NCT03712098|82895044|FG001|Overall Study|Protocol Violation|1|||
46679355|NCT03704688|82895056|FG000|Overall Study|Adverse Event|0|||
46679356|NCT03704688|82895057|FG001|Overall Study|Adverse Event|0|||
46679357|NCT03704688|82895058|FG002|Overall Study|Adverse Event|0|||
46679358|NCT03704688|82895059|FG003|Overall Study|Adverse Event|4|||
46679359|NCT03704688|82895060|FG004|Overall Study|Adverse Event|1|||
46679360|NCT03704688|82895061|FG005|Overall Study|Adverse Event|0|||
46679361|NCT03704688|82895056|FG000|Overall Study|Disease Progression|0|||
46679362|NCT03704688|82895057|FG001|Overall Study|Disease Progression|0|||
46679363|NCT03704688|82895058|FG002|Overall Study|Disease Progression|0|||
46679364|NCT03704688|82895059|FG003|Overall Study|Disease Progression|3|||
46679365|NCT03704688|82895060|FG004|Overall Study|Disease Progression|1|||
46679366|NCT03704688|82895061|FG005|Overall Study|Disease Progression|0|||
46679367|NCT03704688|82895056|FG000|Overall Study|Death|0|||
46679368|NCT03704688|82895057|FG001|Overall Study|Death|0|||
46679369|NCT03704688|82895058|FG002|Overall Study|Death|0|||
46679370|NCT03704688|82895059|FG003|Overall Study|Death|0|||
46679371|NCT03704688|82895060|FG004|Overall Study|Death|3|||
46679372|NCT03704688|82895061|FG005|Overall Study|Death|0|||
46679373|NCT03683394|82895078|FG000|Overall Study|Withdrawal by Subject|4|||
46679374|NCT03683394|82895079|FG001|Overall Study|Withdrawal by Subject|8|||
46679375|NCT03683394|82895078|FG000|Overall Study|Lost to Follow-up|7|||
46679376|NCT03683394|82895079|FG001|Overall Study|Lost to Follow-up|0|||
46679377|NCT03683394|82895078|FG000|Overall Study|Death|3|||
46679378|NCT03683394|82895079|FG001|Overall Study|Death|1|||
46679379|NCT03656510|82895091|FG000|Overall Study|Lost to Follow-up|1|||
46679380|NCT03656510|82895092|FG001|Overall Study|Lost to Follow-up|0|||
46679381|NCT03656510|82895093|FG002|Overall Study|Lost to Follow-up|0|||
46679382|NCT03656510|82895094|FG003|Overall Study|Lost to Follow-up|0|||
46679383|NCT03656510|82895095|FG004|Overall Study|Lost to Follow-up|0|||
46679384|NCT03656510|82895096|FG005|Overall Study|Lost to Follow-up|0|||
46679385|NCT03656510|82895091|FG000|Overall Study|Withdrawal by Subject|1|||
46679386|NCT03656510|82895092|FG001|Overall Study|Withdrawal by Subject|1|||
46679387|NCT03656510|82895093|FG002|Overall Study|Withdrawal by Subject|0|||
46679388|NCT03656510|82895094|FG003|Overall Study|Withdrawal by Subject|1|||
46797488|NCT00452530|83016256|FG001|Overall Study|Adverse Event|44|||
46797489|NCT00452530|83016255|FG000|Overall Study|Withdrawal by Subject|68|||
46797490|NCT00452530|83016256|FG001|Overall Study|Withdrawal by Subject|57|||
46797491|NCT00452530|83016255|FG000|Overall Study|Lost to Follow-up|1|||
46797492|NCT00452530|83016256|FG001|Overall Study|Lost to Follow-up|0|||
46797493|NCT00452530|83016255|FG000|Overall Study|Poor compliance/noncompliance|1|||
46797494|NCT00452530|83016256|FG001|Overall Study|Poor compliance/noncompliance|2|||
46797495|NCT00452530|83016255|FG000|Overall Study|No longer met study criteria|18|||
46679389|NCT03656510|82895095|FG004|Overall Study|Withdrawal by Subject|0|||
46679390|NCT03656510|82895096|FG005|Overall Study|Withdrawal by Subject|0|||
46679391|NCT03539081|82895125|FG000|Overall Study|Withdrawal by Subject|2|||
46679392|NCT03539081|82895126|FG001|Overall Study|Withdrawal by Subject|3|||
46679393|NCT03539081|82895127|FG002|Overall Study|Withdrawal by Subject|0|||
46679394|NCT03539081|82895125|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
46679395|NCT03539081|82895126|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
46679396|NCT03539081|82895127|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
46679397|NCT03518203|82895138|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
46679398|NCT03518203|82895138|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
46679399|NCT03500172|82895152|FG000|Period 1: Baseline Randomization|Death|0|||
46679400|NCT03500172|82895153|FG001|Period 1: Baseline Randomization|Death|0|||
46679401|NCT03500172|82895154|FG002|Period 1: Baseline Randomization|Death|0|||
46679402|NCT03500172|82895155|FG003|Period 1: Baseline Randomization|Death|0|||
46679403|NCT03500172|82895156|FG004|Period 1: Baseline Randomization|Death|0|||
46679404|NCT03500172|82895157|FG005|Period 1: Baseline Randomization|Death|0|||
46797496|NCT00452530|83016256|FG001|Overall Study|No longer met study criteria|22|||
46797497|NCT00452530|83016255|FG000|Overall Study|Other|7|||
46797498|NCT00452530|83016256|FG001|Overall Study|Other|11|||
46797499|NCT00549198|83016268|FG000|Overall Study|Adverse Event|28|||
46797500|NCT00549198|83016269|FG001|Overall Study|Adverse Event|26|||
46797501|NCT00549198|83016268|FG000|Overall Study|Insufficient Viral Load Response|4|||
46679405|NCT03500172|82895158|FG006|Period 1: Baseline Randomization|Death|0|||
46679406|NCT03500172|82895159|FG007|Period 1: Baseline Randomization|Death|0|||
46797502|NCT00549198|83016269|FG001|Overall Study|Insufficient Viral Load Response|2|||
46797503|NCT00549198|83016268|FG000|Overall Study|Protocol-defined Virological Failure|7|||
46797504|NCT00549198|83016269|FG001|Overall Study|Protocol-defined Virological Failure|0|||
46797505|NCT00549198|83016268|FG000|Overall Study|Non-compliance|2|||
46797506|NCT00549198|83016269|FG001|Overall Study|Non-compliance|4|||
46797507|NCT00549198|83016268|FG000|Overall Study|Lost to Follow-up|7|||
46797508|NCT00549198|83016269|FG001|Overall Study|Lost to Follow-up|8|||
47082224|NCT02574078|83412621|FG001|Pre-Treatment Period|Other reasons|0|||
47082225|NCT02574078|83412622|FG002|Pre-Treatment Period|Other reasons|0|||
47082226|NCT02574078|83412623|FG003|Pre-Treatment Period|Other reasons|0|||
47082227|NCT02574078|83412624|FG004|Pre-Treatment Period|Other reasons|0|||
47082228|NCT02574078|83412625|FG005|Pre-Treatment Period|Other reasons|0|||
47082229|NCT02574078|83412626|FG006|Pre-Treatment Period|Other reasons|2|||
47082230|NCT02574078|83412627|FG007|Pre-Treatment Period|Other reasons|0|||
47082231|NCT02574078|83412628|FG008|Pre-Treatment Period|Other reasons|0|||
47082232|NCT02574078|83412629|FG009|Pre-Treatment Period|Other reasons|0|||
47082233|NCT02574078|83412630|FG010|Pre-Treatment Period|Other reasons|2|||
47082234|NCT02574078|83412631|FG011|Pre-Treatment Period|Other reasons|0|||
47082235|NCT02574078|83412632|FG012|Pre-Treatment Period|Other reasons|0|||
47082236|NCT02574078|83412620|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
47082237|NCT02574078|83412621|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
47082238|NCT02574078|83412622|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
47082239|NCT02574078|83412623|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
47082240|NCT02574078|83412624|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
46679407|NCT03500172|82895160|FG008|Period 1: Baseline Randomization|Death|0|||
46679408|NCT03500172|82895161|FG009|Period 1: Baseline Randomization|Death|2|||
47082241|NCT02574078|83412625|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
47082242|NCT02574078|83412626|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
47082243|NCT02574078|83412627|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
47082244|NCT02574078|83412628|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
47082245|NCT02574078|83412629|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
47082246|NCT02574078|83412630|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
47082247|NCT02574078|83412631|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
47082248|NCT02574078|83412632|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
47082249|NCT02574078|83412620|FG000|Treatment Period|Disease progression|6|||
47082250|NCT02574078|83412621|FG001|Treatment Period|Disease progression|4|||
47082251|NCT02574078|83412622|FG002|Treatment Period|Disease progression|7|||
47082252|NCT02574078|83412623|FG003|Treatment Period|Disease progression|18|||
47082253|NCT02574078|83412624|FG004|Treatment Period|Disease progression|16|||
47082254|NCT02574078|83412625|FG005|Treatment Period|Disease progression|26|||
47082255|NCT02574078|83412626|FG006|Treatment Period|Disease progression|5|||
47082256|NCT02574078|83412627|FG007|Treatment Period|Disease progression|9|||
47082257|NCT02574078|83412628|FG008|Treatment Period|Disease progression|8|||
47082258|NCT02574078|83412629|FG009|Treatment Period|Disease progression|5|||
47082259|NCT02574078|83412630|FG010|Treatment Period|Disease progression|20|||
47082260|NCT02574078|83412631|FG011|Treatment Period|Disease progression|29|||
47082261|NCT02574078|83412632|FG012|Treatment Period|Disease progression|2|||
47082262|NCT02574078|83412620|FG000|Treatment Period|Study drug toxicity|1|||
47082263|NCT02574078|83412621|FG001|Treatment Period|Study drug toxicity|1|||
47082264|NCT02574078|83412622|FG002|Treatment Period|Study drug toxicity|0|||
47082265|NCT02574078|83412623|FG003|Treatment Period|Study drug toxicity|5|||
47082266|NCT02574078|83412624|FG004|Treatment Period|Study drug toxicity|3|||
47082267|NCT02574078|83412625|FG005|Treatment Period|Study drug toxicity|1|||
47082268|NCT02574078|83412626|FG006|Treatment Period|Study drug toxicity|2|||
47082269|NCT02574078|83412627|FG007|Treatment Period|Study drug toxicity|0|||
47082270|NCT02574078|83412628|FG008|Treatment Period|Study drug toxicity|2|||
47082271|NCT02574078|83412629|FG009|Treatment Period|Study drug toxicity|1|||
47082272|NCT02574078|83412630|FG010|Treatment Period|Study drug toxicity|16|||
47082273|NCT02574078|83412631|FG011|Treatment Period|Study drug toxicity|2|||
46980138|NCT02465931|83225827|FG000|Overall Study|Lost to Follow-up|9|||
47082274|NCT02574078|83412632|FG012|Treatment Period|Study drug toxicity|4|||
47082275|NCT02574078|83412620|FG000|Treatment Period|Death|2|||
47082276|NCT02574078|83412621|FG001|Treatment Period|Death|0|||
47082277|NCT02574078|83412622|FG002|Treatment Period|Death|0|||
47082278|NCT02574078|83412623|FG003|Treatment Period|Death|0|||
47082279|NCT02574078|83412624|FG004|Treatment Period|Death|1|||
47082280|NCT02574078|83412625|FG005|Treatment Period|Death|1|||
47082281|NCT02574078|83412626|FG006|Treatment Period|Death|1|||
47082282|NCT02574078|83412627|FG007|Treatment Period|Death|1|||
47082283|NCT02574078|83412628|FG008|Treatment Period|Death|7|||
47082284|NCT02574078|83412629|FG009|Treatment Period|Death|1|||
47082285|NCT02574078|83412630|FG010|Treatment Period|Death|0|||
47082286|NCT02574078|83412631|FG011|Treatment Period|Death|2|||
47082287|NCT02574078|83412632|FG012|Treatment Period|Death|1|||
47082288|NCT02574078|83412620|FG000|Treatment Period|Adverse event unrelated to drug|0|||
47082289|NCT02574078|83412621|FG001|Treatment Period|Adverse event unrelated to drug|0|||
46797509|NCT00549198|83016268|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
47082290|NCT02574078|83412622|FG002|Treatment Period|Adverse event unrelated to drug|1|||
47082291|NCT02574078|83412623|FG003|Treatment Period|Adverse event unrelated to drug|0|||
46679409|NCT03500172|82895162|FG010|Period 1: Baseline Randomization|Death|0|||
46679410|NCT03500172|82895152|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
46679411|NCT03500172|82895153|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
46679412|NCT03500172|82895154|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
46797510|NCT00549198|83016269|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797511|NCT00549198|83016268|FG000|Overall Study|Protocol Violation|7|||
46797512|NCT00549198|83016269|FG001|Overall Study|Protocol Violation|2|||
46797513|NCT00549198|83016268|FG000|Overall Study|Investigator Decision|4|||
47082292|NCT02574078|83412624|FG004|Treatment Period|Adverse event unrelated to drug|2|||
47082293|NCT02574078|83412625|FG005|Treatment Period|Adverse event unrelated to drug|3|||
47082294|NCT02574078|83412626|FG006|Treatment Period|Adverse event unrelated to drug|0|||
47082295|NCT02574078|83412627|FG007|Treatment Period|Adverse event unrelated to drug|0|||
47082296|NCT02574078|83412628|FG008|Treatment Period|Adverse event unrelated to drug|1|||
47082297|NCT02574078|83412629|FG009|Treatment Period|Adverse event unrelated to drug|2|||
47082298|NCT02574078|83412630|FG010|Treatment Period|Adverse event unrelated to drug|4|||
47082299|NCT02574078|83412631|FG011|Treatment Period|Adverse event unrelated to drug|1|||
47082300|NCT02574078|83412632|FG012|Treatment Period|Adverse event unrelated to drug|0|||
47082301|NCT02574078|83412620|FG000|Treatment Period|Administrative reason by Sponsor|0|||
47082302|NCT02574078|83412621|FG001|Treatment Period|Administrative reason by Sponsor|1|||
47082303|NCT02574078|83412622|FG002|Treatment Period|Administrative reason by Sponsor|0|||
46679413|NCT03500172|82895155|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
46679414|NCT03500172|82895156|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
46679415|NCT03500172|82895157|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
46679416|NCT03500172|82895158|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
46679417|NCT03500172|82895159|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
46679418|NCT03500172|82895160|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
46679419|NCT03500172|82895161|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
46679420|NCT03500172|82895162|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
46679421|NCT03500172|82895152|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
46679422|NCT03500172|82895153|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
46679423|NCT03500172|82895154|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
46679424|NCT03500172|82895155|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
46679425|NCT03500172|82895156|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
46679426|NCT03500172|82895157|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
46679427|NCT03500172|82895158|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
46679428|NCT03500172|82895159|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
46679429|NCT03500172|82895160|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
46679430|NCT03500172|82895161|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
46679431|NCT03500172|82895162|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
46679432|NCT03500172|82895152|FG000|Period 2: Re-Randomization|Death|0|||
46679433|NCT03500172|82895153|FG001|Period 2: Re-Randomization|Death|0|||
46679434|NCT03500172|82895154|FG002|Period 2: Re-Randomization|Death|0|||
46679435|NCT03500172|82895155|FG003|Period 2: Re-Randomization|Death|4|||
46679436|NCT03500172|82895156|FG004|Period 2: Re-Randomization|Death|2|||
46679437|NCT03500172|82895157|FG005|Period 2: Re-Randomization|Death|0|||
46679438|NCT03500172|82895158|FG006|Period 2: Re-Randomization|Death|5|||
46679439|NCT03500172|82895159|FG007|Period 2: Re-Randomization|Death|2|||
46679440|NCT03500172|82895160|FG008|Period 2: Re-Randomization|Death|0|||
46679441|NCT03500172|82895161|FG009|Period 2: Re-Randomization|Death|0|||
46679442|NCT03500172|82895162|FG010|Period 2: Re-Randomization|Death|0|||
46679443|NCT03470922|82895180|FG000|Overall Study|Death|107|||
46679444|NCT03470922|82895181|FG001|Overall Study|Death|118|||
46679445|NCT03470922|82895180|FG000|Overall Study|Lost to Follow-up|5|||
46679446|NCT03470922|82895181|FG001|Overall Study|Lost to Follow-up|5|||
46679447|NCT03470922|82895180|FG000|Overall Study|Participant Withdrew Consent|4|||
46679448|NCT03470922|82895181|FG001|Overall Study|Participant Withdrew Consent|9|||
46679449|NCT03470922|82895180|FG000|Overall Study|Other reasons|1|||
46679450|NCT03470922|82895181|FG001|Overall Study|Other reasons|0|||
46679451|NCT03470922|82895180|FG000|Overall Study|Not reported|1|||
46797514|NCT00549198|83016269|FG001|Overall Study|Investigator Decision|3|||
47082304|NCT02574078|83412623|FG003|Treatment Period|Administrative reason by Sponsor|0|||
47082305|NCT02574078|83412624|FG004|Treatment Period|Administrative reason by Sponsor|0|||
47082306|NCT02574078|83412625|FG005|Treatment Period|Administrative reason by Sponsor|0|||
47082307|NCT02574078|83412626|FG006|Treatment Period|Administrative reason by Sponsor|1|||
47082308|NCT02574078|83412627|FG007|Treatment Period|Administrative reason by Sponsor|0|||
47082309|NCT02574078|83412628|FG008|Treatment Period|Administrative reason by Sponsor|0|||
47082310|NCT02574078|83412629|FG009|Treatment Period|Administrative reason by Sponsor|0|||
47082311|NCT02574078|83412630|FG010|Treatment Period|Administrative reason by Sponsor|0|||
47082312|NCT02574078|83412631|FG011|Treatment Period|Administrative reason by Sponsor|0|||
47082313|NCT02574078|83412632|FG012|Treatment Period|Administrative reason by Sponsor|3|||
47082314|NCT02574078|83412620|FG000|Treatment Period|Other reasons|1|||
47082315|NCT02574078|83412621|FG001|Treatment Period|Other reasons|0|||
47082316|NCT02574078|83412622|FG002|Treatment Period|Other reasons|1|||
47082317|NCT02574078|83412623|FG003|Treatment Period|Other reasons|3|||
46679452|NCT03470922|82895181|FG001|Overall Study|Not reported|0|||
46797515|NCT00549198|83016268|FG000|Overall Study|Withdrawal by Subject|7|||
46980139|NCT02465931|83225828|FG001|Overall Study|Lost to Follow-up|11|||
46980140|NCT02465931|83225827|FG000|Overall Study|Protocol Violation|1|||
46980141|NCT02465931|83225828|FG001|Overall Study|Protocol Violation|0|||
46980142|NCT02465931|83225827|FG000|Overall Study|Withdrawal by Subject|1|||
47082318|NCT02574078|83412624|FG004|Treatment Period|Other reasons|3|||
47082319|NCT02574078|83412625|FG005|Treatment Period|Other reasons|1|||
47082320|NCT02574078|83412626|FG006|Treatment Period|Other reasons|2|||
47082321|NCT02574078|83412627|FG007|Treatment Period|Other reasons|1|||
47082322|NCT02574078|83412628|FG008|Treatment Period|Other reasons|3|||
47082323|NCT02574078|83412629|FG009|Treatment Period|Other reasons|1|||
47082324|NCT02574078|83412630|FG010|Treatment Period|Other reasons|1|||
47082325|NCT02574078|83412631|FG011|Treatment Period|Other reasons|3|||
47082326|NCT02574078|83412632|FG012|Treatment Period|Other reasons|1|||
46980143|NCT02465931|83225828|FG001|Overall Study|Withdrawal by Subject|0|||
47082327|NCT02574078|83412620|FG000|Treatment Period|Participant request to stop drug|0|||
47082328|NCT02574078|83412621|FG001|Treatment Period|Participant request to stop drug|0|||
46679453|NCT03440814|82895189|FG000|Overall Study|Adverse Event|2|||
46679454|NCT03440814|82895190|FG001|Overall Study|Adverse Event|1|||
46679455|NCT03440814|82895189|FG000|Overall Study|Lost to Follow-up|2|||
46679456|NCT03440814|82895190|FG001|Overall Study|Lost to Follow-up|0|||
46679457|NCT03440814|82895189|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
46797516|NCT00549198|83016269|FG001|Overall Study|Withdrawal by Subject|7|||
46797517|NCT00549198|83016268|FG000|Overall Study|Disease Progression|1|||
46797518|NCT00549198|83016269|FG001|Overall Study|Disease Progression|0|||
46797519|NCT00549198|83016268|FG000|Overall Study|Participant Moved|2|||
46797520|NCT00549198|83016269|FG001|Overall Study|Participant Moved|0|||
46679458|NCT03440814|82895190|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
46679459|NCT03427814|82895198|FG000|Overall Study|Withdrawal by Subject|4|||
46980144|NCT02465463|83225836|FG000|Overall Study|Lost to Follow-up|2|||
46797521|NCT00549198|83016268|FG000|Overall Study|Participant not able to perform Week 96|1|||
46797522|NCT00549198|83016269|FG001|Overall Study|Participant not able to perform Week 96|0|||
46980145|NCT02465463|83225837|FG001|Overall Study|Lost to Follow-up|1|||
46980146|NCT02465463|83225836|FG000|Overall Study|Death|1|||
46980147|NCT02465463|83225837|FG001|Overall Study|Death|0|||
46980148|NCT02465463|83225836|FG000|Overall Study|Protocol Violation|1|||
46980149|NCT02465463|83225837|FG001|Overall Study|Protocol Violation|0|||
46980150|NCT02464059|83225844|FG000|Overall Study|Lost to Follow-up|6|||
46980151|NCT02463357|83225853|FG000|Overall Study|Withdrawal by Subject|1|||
46980152|NCT02463357|83225854|FG001|Overall Study|Withdrawal by Subject|0|||
47082329|NCT02574078|83412622|FG002|Treatment Period|Participant request to stop drug|0|||
47082330|NCT02574078|83412623|FG003|Treatment Period|Participant request to stop drug|2|||
47082331|NCT02574078|83412624|FG004|Treatment Period|Participant request to stop drug|4|||
46797523|NCT00549198|83016268|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
46797524|NCT00549198|83016269|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
47082332|NCT02574078|83412625|FG005|Treatment Period|Participant request to stop drug|0|||
47082333|NCT02574078|83412626|FG006|Treatment Period|Participant request to stop drug|1|||
47082334|NCT02574078|83412627|FG007|Treatment Period|Participant request to stop drug|0|||
47082335|NCT02574078|83412628|FG008|Treatment Period|Participant request to stop drug|3|||
47082336|NCT02574078|83412629|FG009|Treatment Period|Participant request to stop drug|2|||
47082337|NCT02574078|83412630|FG010|Treatment Period|Participant request to stop drug|2|||
47082338|NCT02574078|83412631|FG011|Treatment Period|Participant request to stop drug|4|||
47082339|NCT02574078|83412632|FG012|Treatment Period|Participant request to stop drug|1|||
47082340|NCT02574078|83412620|FG000|Treatment Period|Participant withdrew consent|0|||
47082341|NCT02574078|83412621|FG001|Treatment Period|Participant withdrew consent|0|||
47082342|NCT02574078|83412622|FG002|Treatment Period|Participant withdrew consent|0|||
47082343|NCT02574078|83412623|FG003|Treatment Period|Participant withdrew consent|0|||
47082344|NCT02574078|83412624|FG004|Treatment Period|Participant withdrew consent|1|||
47082345|NCT02574078|83412625|FG005|Treatment Period|Participant withdrew consent|1|||
47082346|NCT02574078|83412626|FG006|Treatment Period|Participant withdrew consent|0|||
47082347|NCT02574078|83412627|FG007|Treatment Period|Participant withdrew consent|1|||
47082348|NCT02574078|83412628|FG008|Treatment Period|Participant withdrew consent|0|||
46980153|NCT02463357|83225855|FG002|Overall Study|Withdrawal by Subject|0|||
46980154|NCT02463357|83225856|FG003|Overall Study|Withdrawal by Subject|0|||
46797525|NCT00549198|83016268|FG000|Overall Study|Prohibited Medication|1|||
46797526|NCT00549198|83016269|FG001|Overall Study|Prohibited Medication|2|||
46980155|NCT02463357|83225857|FG004|Overall Study|Withdrawal by Subject|0|||
46980156|NCT02463357|83225853|FG000|Overall Study|Withdrawal by Subject|0|||
46980157|NCT02463357|83225854|FG001|Overall Study|Withdrawal by Subject|0|||
46980158|NCT02463357|83225855|FG002|Overall Study|Withdrawal by Subject|0|||
46980159|NCT02463357|83225856|FG003|Overall Study|Withdrawal by Subject|0|||
46980160|NCT02463357|83225857|FG004|Overall Study|Withdrawal by Subject|1|||
47082349|NCT02574078|83412629|FG009|Treatment Period|Participant withdrew consent|2|||
47082350|NCT02574078|83412630|FG010|Treatment Period|Participant withdrew consent|1|||
47082351|NCT02574078|83412631|FG011|Treatment Period|Participant withdrew consent|4|||
47082352|NCT02574078|83412632|FG012|Treatment Period|Participant withdrew consent|1|||
47082353|NCT02574078|83412620|FG000|Treatment Period|Participant no longer meets criteria|0|||
47082354|NCT02574078|83412621|FG001|Treatment Period|Participant no longer meets criteria|0|||
47082355|NCT02574078|83412622|FG002|Treatment Period|Participant no longer meets criteria|0|||
47082356|NCT02574078|83412623|FG003|Treatment Period|Participant no longer meets criteria|0|||
47082357|NCT02574078|83412624|FG004|Treatment Period|Participant no longer meets criteria|1|||
47082358|NCT02574078|83412625|FG005|Treatment Period|Participant no longer meets criteria|0|||
47082359|NCT02574078|83412626|FG006|Treatment Period|Participant no longer meets criteria|0|||
47082360|NCT02574078|83412627|FG007|Treatment Period|Participant no longer meets criteria|0|||
47082361|NCT02574078|83412628|FG008|Treatment Period|Participant no longer meets criteria|0|||
47082362|NCT02574078|83412629|FG009|Treatment Period|Participant no longer meets criteria|1|||
47082363|NCT02574078|83412630|FG010|Treatment Period|Participant no longer meets criteria|1|||
47082364|NCT02574078|83412631|FG011|Treatment Period|Participant no longer meets criteria|1|||
46797527|NCT00549198|83016268|FG000|Overall Study|Participant planning pregnancy|1|||
46797528|NCT00549198|83016269|FG001|Overall Study|Participant planning pregnancy|0|||
46797529|NCT00549198|83016268|FG000|Overall Study|Participant overweight, no scan possible|1|||
46797530|NCT00549198|83016269|FG001|Overall Study|Participant overweight, no scan possible|0|||
46797531|NCT00549198|83016268|FG000|Overall Study|No scan facilities|0|||
46797532|NCT00549198|83016269|FG001|Overall Study|No scan facilities|2|||
46980161|NCT02579759|83225872|FG000|Overall Study|Protocol Violation|2|||
46797533|NCT00549198|83016268|FG000|Overall Study|Pregnancy|0|||
46797534|NCT00549198|83016269|FG001|Overall Study|Pregnancy|3|||
46980162|NCT02579759|83225873|FG001|Overall Study|Protocol Violation|0|||
46980163|NCT02579759|83225874|FG002|Overall Study|Protocol Violation|0|||
46980164|NCT02579759|83225872|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
46980165|NCT02579759|83225873|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
46980166|NCT02579759|83225874|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
46980167|NCT02579759|83225872|FG000|Overall Study|BfArM hold|13|||
46980168|NCT02579759|83225873|FG001|Overall Study|BfArM hold|12|||
46679460|NCT03427814|82895199|FG001|Overall Study|Withdrawal by Subject|4|||
46679461|NCT03427814|82895198|FG000|Overall Study|Lost to Follow-up|0|||
46980169|NCT02579759|83225874|FG002|Overall Study|BfArM hold|12|||
46980170|NCT02579759|83225872|FG000|Overall Study|Sponsor stopped Dose 2|0|||
46857349|NCT03333928|83073063|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
46679462|NCT03427814|82895199|FG001|Overall Study|Lost to Follow-up|2|||
46980171|NCT02579759|83225873|FG001|Overall Study|Sponsor stopped Dose 2|41|||
46980172|NCT02579759|83225874|FG002|Overall Study|Sponsor stopped Dose 2|0|||
46857350|NCT03333928|83073064|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
46857351|NCT03333928|83073065|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
47082365|NCT02574078|83412632|FG012|Treatment Period|Participant no longer meets criteria|0|||
47082366|NCT02574078|83412620|FG000|Treatment Period|Lost to Follow-up|0|||
47082367|NCT02574078|83412621|FG001|Treatment Period|Lost to Follow-up|0|||
47082368|NCT02574078|83412622|FG002|Treatment Period|Lost to Follow-up|0|||
47082369|NCT02574078|83412623|FG003|Treatment Period|Lost to Follow-up|0|||
47082370|NCT02574078|83412624|FG004|Treatment Period|Lost to Follow-up|0|||
47082371|NCT02574078|83412625|FG005|Treatment Period|Lost to Follow-up|0|||
47082372|NCT02574078|83412626|FG006|Treatment Period|Lost to Follow-up|0|||
47082373|NCT02574078|83412627|FG007|Treatment Period|Lost to Follow-up|0|||
47082374|NCT02574078|83412628|FG008|Treatment Period|Lost to Follow-up|0|||
47082375|NCT02574078|83412629|FG009|Treatment Period|Lost to Follow-up|1|||
47082376|NCT02574078|83412630|FG010|Treatment Period|Lost to Follow-up|0|||
47082377|NCT02574078|83412631|FG011|Treatment Period|Lost to Follow-up|1|||
47082378|NCT02574078|83412632|FG012|Treatment Period|Lost to Follow-up|0|||
47082379|NCT02574078|83412620|FG000|Treatment Period|Maximum clinical benefit|0|||
47082380|NCT02574078|83412621|FG001|Treatment Period|Maximum clinical benefit|0|||
47082381|NCT02574078|83412622|FG002|Treatment Period|Maximum clinical benefit|0|||
47082382|NCT02574078|83412623|FG003|Treatment Period|Maximum clinical benefit|0|||
47082383|NCT02574078|83412624|FG004|Treatment Period|Maximum clinical benefit|0|||
47082384|NCT02574078|83412625|FG005|Treatment Period|Maximum clinical benefit|0|||
47082385|NCT02574078|83412626|FG006|Treatment Period|Maximum clinical benefit|0|||
47082386|NCT02574078|83412627|FG007|Treatment Period|Maximum clinical benefit|0|||
47082387|NCT02574078|83412628|FG008|Treatment Period|Maximum clinical benefit|0|||
47082388|NCT02574078|83412629|FG009|Treatment Period|Maximum clinical benefit|1|||
47082389|NCT02574078|83412630|FG010|Treatment Period|Maximum clinical benefit|0|||
47082390|NCT02574078|83412631|FG011|Treatment Period|Maximum clinical benefit|0|||
47082391|NCT02574078|83412632|FG012|Treatment Period|Maximum clinical benefit|0|||
47082392|NCT02565810|83412750|FG000|Overall Study|Withdrawal by Subject|1|||
47082393|NCT02561832|83412915|FG000|Overall Study|Withdrawal by Subject|1|||
47082394|NCT02561832|83412916|FG001|Overall Study|Withdrawal by Subject|1|||
47082395|NCT02561832|83412915|FG000|Overall Study|Adverse Event|3|||
47082396|NCT02561832|83412916|FG001|Overall Study|Adverse Event|0|||
47082397|NCT02561832|83412915|FG000|Overall Study|Disease progression|3|||
47082398|NCT02561832|83412916|FG001|Overall Study|Disease progression|3|||
46980173|NCT02579759|83225872|FG000|Overall Study|Non compliance|0|||
46679463|NCT03427814|82895198|FG000|Overall Study|Death|42|||
46857352|NCT03333928|83073063|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
46679464|NCT03427814|82895199|FG001|Overall Study|Death|31|||
46679465|NCT03427814|82895198|FG000|Overall Study|Sponsor's Decision|1|||
46797535|NCT00549198|83016268|FG000|Overall Study|Not Exposed to Study Drug|3|||
46797536|NCT00549198|83016269|FG001|Overall Study|Not Exposed to Study Drug|4|||
46797537|NCT00607724|83016282|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
46797538|NCT00607724|83016283|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
46797539|NCT00607724|83016284|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
46797540|NCT00607724|83016285|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
46797541|NCT00607724|83016286|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
46797542|NCT00607724|83016287|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
46679466|NCT03427814|82895199|FG001|Overall Study|Sponsor's Decision|0|||
46797543|NCT00607724|83016288|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
46797544|NCT00607724|83016282|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
46797545|NCT00607724|83016283|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
46797546|NCT00607724|83016284|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
46797547|NCT00607724|83016285|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
46797548|NCT00607724|83016286|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
46679467|NCT03427814|82895198|FG000|Overall Study|Investigator's Decision|1|||
46797549|NCT00607724|83016287|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
46797550|NCT00607724|83016288|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
46797551|NCT00607724|83016282|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
46797552|NCT00607724|83016283|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
46797553|NCT00607724|83016284|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
46679468|NCT03427814|82895199|FG001|Overall Study|Investigator's Decision|2|||
46679469|NCT03427814|82895198|FG000|Overall Study|Disease progression|1|||
46679470|NCT03427814|82895199|FG001|Overall Study|Disease progression|0|||
46679471|NCT03427814|82895198|FG000|Overall Study|Treatment Completed|0|||
46679472|NCT03427814|82895199|FG001|Overall Study|Treatment Completed|1|||
46679473|NCT03427814|82895198|FG000|Overall Study|Sponsor's Decision to End study|21|||
46679474|NCT03427814|82895199|FG001|Overall Study|Sponsor's Decision to End study|25|||
46679475|NCT03427814|82895198|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
46797554|NCT00607724|83016285|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
46797555|NCT00607724|83016286|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
46797556|NCT00607724|83016287|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
46797557|NCT00607724|83016288|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
46797558|NCT00607724|83016282|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
46797559|NCT00607724|83016283|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
46797560|NCT00607724|83016284|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
46797561|NCT00607724|83016285|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
46679476|NCT03427814|82895199|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
46679477|NCT03418493|82895216|FG000|Overall Study|Adverse Event|1|||
46679478|NCT03418493|82895217|FG001|Overall Study|Adverse Event|0|||
46679479|NCT03418493|82895218|FG002|Overall Study|Adverse Event|0|||
46679480|NCT03418493|82895219|FG003|Overall Study|Adverse Event|0|||
46679481|NCT03418493|82895220|FG004|Overall Study|Adverse Event|0|||
46679482|NCT03418493|82895221|FG005|Overall Study|Adverse Event|0|||
46679483|NCT03418493|82895222|FG006|Overall Study|Adverse Event|0|||
46797562|NCT00607724|83016286|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
46797563|NCT00607724|83016287|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
46797564|NCT00607724|83016288|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
46679484|NCT03418493|82895223|FG007|Overall Study|Adverse Event|0|||
46679485|NCT03418493|82895224|FG008|Overall Study|Adverse Event|0|||
46679486|NCT03418493|82895225|FG009|Overall Study|Adverse Event|0|||
46797565|NCT00607724|83016282|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
46797566|NCT00607724|83016283|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
46797567|NCT00607724|83016284|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
46980174|NCT02579759|83225873|FG001|Overall Study|Non compliance|1|||
46980175|NCT02579759|83225874|FG002|Overall Study|Non compliance|0|||
46980176|NCT02579759|83225872|FG000|Overall Study|Pregnancy|0|||
46980177|NCT02579759|83225873|FG001|Overall Study|Pregnancy|1|||
46980178|NCT02579759|83225874|FG002|Overall Study|Pregnancy|0|||
46679487|NCT03418493|82895226|FG010|Overall Study|Adverse Event|0|||
46679488|NCT03418493|82895216|FG000|Overall Study|Protocol Violation|0|||
46679489|NCT03418493|82895217|FG001|Overall Study|Protocol Violation|0|||
46679490|NCT03418493|82895218|FG002|Overall Study|Protocol Violation|0|||
46679491|NCT03418493|82895219|FG003|Overall Study|Protocol Violation|0|||
46679492|NCT03418493|82895220|FG004|Overall Study|Protocol Violation|0|||
46679493|NCT03418493|82895221|FG005|Overall Study|Protocol Violation|0|||
46679494|NCT03418493|82895222|FG006|Overall Study|Protocol Violation|0|||
46857353|NCT03333928|83073064|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
46857354|NCT03333928|83073065|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
46857355|NCT02945410|83073087|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
46857356|NCT02945410|83073088|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
46857357|NCT02945410|83073089|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
46857358|NCT02945410|83073090|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
46857359|NCT02945410|83073091|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
46857360|NCT02945410|83073092|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
46857361|NCT02945410|83073087|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
46857362|NCT02945410|83073088|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
46857363|NCT02945410|83073089|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
46857364|NCT02945410|83073090|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
46857365|NCT02945410|83073091|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
46857366|NCT02945410|83073092|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
46679495|NCT03418493|82895223|FG007|Overall Study|Protocol Violation|0|||
46679496|NCT03418493|82895224|FG008|Overall Study|Protocol Violation|0|||
46679497|NCT03418493|82895225|FG009|Overall Study|Protocol Violation|1|||
46679498|NCT03418493|82895226|FG010|Overall Study|Protocol Violation|0|||
46679499|NCT03368664|82895259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
46679500|NCT03368664|82895259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
46857367|NCT02945410|83073087|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
46679501|NCT03368664|82895259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
46980179|NCT02579759|83225872|FG000|Overall Study|Inclusion/exclusion criteria|0|||
46980180|NCT02579759|83225873|FG001|Overall Study|Inclusion/exclusion criteria|0|||
46980181|NCT02579759|83225874|FG002|Overall Study|Inclusion/exclusion criteria|1|||
46980182|NCT02579759|83225872|FG000|Overall Study|Adverse Event|4|||
46980183|NCT02579759|83225873|FG001|Overall Study|Adverse Event|3|||
46980184|NCT02579759|83225874|FG002|Overall Study|Adverse Event|1|||
46980185|NCT02579759|83225872|FG000|Overall Study|Withdrawal by Subject|3|||
46980186|NCT02579759|83225873|FG001|Overall Study|Withdrawal by Subject|3|||
46857368|NCT02945410|83073088|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
46980187|NCT02579759|83225874|FG002|Overall Study|Withdrawal by Subject|5|||
46980188|NCT02579759|83225872|FG000|Overall Study|Lost to Follow-up|2|||
46980189|NCT02579759|83225873|FG001|Overall Study|Lost to Follow-up|2|||
46980190|NCT02579759|83225874|FG002|Overall Study|Lost to Follow-up|2|||
46980191|NCT02445963|83225888|FG000|Overall Study|Lost to Follow-up|1|||
46980192|NCT02445963|83225889|FG001|Overall Study|Lost to Follow-up|0|||
46980193|NCT02445963|83225890|FG002|Overall Study|Lost to Follow-up|0|||
46980194|NCT02445963|83225891|FG003|Overall Study|Lost to Follow-up|0|||
46980195|NCT02445963|83225888|FG000|Overall Study|Change in employment|1|||
46980196|NCT02445963|83225889|FG001|Overall Study|Change in employment|0|||
46980197|NCT02445963|83225890|FG002|Overall Study|Change in employment|0|||
46980198|NCT02445963|83225891|FG003|Overall Study|Change in employment|0|||
46980199|NCT02445963|83225888|FG000|Overall Study|Symptoms post-vaccination|0|||
46980200|NCT02445963|83225889|FG001|Overall Study|Symptoms post-vaccination|0|||
46980201|NCT02445963|83225890|FG002|Overall Study|Symptoms post-vaccination|1|||
46980202|NCT02445963|83225891|FG003|Overall Study|Symptoms post-vaccination|0|||
46980203|NCT02499159|83225905|FG000|Randomization|Protocol Violation|1|||
46980204|NCT02499159|83225906|FG001|Randomization|Protocol Violation|1|||
46679502|NCT03368664|82895259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
46679503|NCT03343054|82895270|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
46679504|NCT03343054|82895271|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
46679505|NCT03343054|82895272|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
46679506|NCT03343054|82895270|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
46679507|NCT03343054|82895271|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
46679508|NCT03343054|82895272|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
46679509|NCT03343054|82895270|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
46679510|NCT03343054|82895271|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
46679511|NCT03343054|82895272|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
46679512|NCT03343054|82895270|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
46679513|NCT03343054|82895271|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
46679514|NCT03343054|82895272|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
46679515|NCT03309878|82895310|FG000|Overall Study|Adverse Event|1|||
46679516|NCT03309878|82895311|FG001|Overall Study|Adverse Event|0|||
46679517|NCT03309878|82895312|FG002|Overall Study|Adverse Event|0|||
46679518|NCT03309878|82895313|FG003|Overall Study|Adverse Event|0|||
46679519|NCT03309878|82895310|FG000|Overall Study|Did not maintain eligibility|2|||
46679520|NCT03309878|82895311|FG001|Overall Study|Did not maintain eligibility|1|||
46679521|NCT03309878|82895312|FG002|Overall Study|Did not maintain eligibility|0|||
46679522|NCT03309878|82895313|FG003|Overall Study|Did not maintain eligibility|0|||
46679523|NCT03309878|82895310|FG000|Overall Study|Withdrawal by Subject|0|||
46679524|NCT03309878|82895311|FG001|Overall Study|Withdrawal by Subject|1|||
46679525|NCT03309878|82895312|FG002|Overall Study|Withdrawal by Subject|0|||
46679526|NCT03309878|82895313|FG003|Overall Study|Withdrawal by Subject|0|||
46679527|NCT03200704|82895331|FG000|Overall Study|Withdrawal by Subject|1|||
46679528|NCT03176472|82895337|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
46679529|NCT03176472|82895338|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
46679530|NCT03176472|82895337|FG000|Double Blind Treatment Period|Adverse Event|0|||
46679531|NCT03176472|82895338|FG001|Double Blind Treatment Period|Adverse Event|5|||
46679532|NCT03176472|82895337|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
46679533|NCT03176472|82895338|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
46679534|NCT03176472|82895337|FG000|Double Blind Treatment Period|Physician Decision|0|||
46679535|NCT03176472|82895338|FG001|Double Blind Treatment Period|Physician Decision|1|||
46679536|NCT03176472|82895337|FG000|Double Blind Treatment Period|Protocol Violation|1|||
46679537|NCT03176472|82895338|FG001|Double Blind Treatment Period|Protocol Violation|0|||
46679538|NCT03176472|82895337|FG000|Double Blind Treatment Period|Not Provided|1|||
46679539|NCT03176472|82895338|FG001|Double Blind Treatment Period|Not Provided|0|||
46679540|NCT03176472|82895337|FG000|Open Label Extension|Withdrawal by Subject|3|||
46679541|NCT03176472|82895338|FG001|Open Label Extension|Withdrawal by Subject|4|||
46679542|NCT03176472|82895337|FG000|Open Label Extension|Adverse Event|2|||
46679543|NCT03176472|82895338|FG001|Open Label Extension|Adverse Event|4|||
46679544|NCT03176472|82895337|FG000|Open Label Extension|Lost to Follow-up|1|||
46679545|NCT03176472|82895338|FG001|Open Label Extension|Lost to Follow-up|2|||
46679546|NCT03176472|82895337|FG000|Open Label Extension|Protocol Violation|0|||
46679547|NCT03176472|82895338|FG001|Open Label Extension|Protocol Violation|1|||
46679548|NCT03176472|82895337|FG000|Open Label Extension|Not Provided|2|||
46679549|NCT03176472|82895338|FG001|Open Label Extension|Not Provided|1|||
46679550|NCT04876599|82895373|FG000|Overall Study|Missed|2|||
46679551|NCT04876599|82895374|FG001|Overall Study|Missed|0|||
46679552|NCT04876599|82895373|FG000|Overall Study|Declined|2|||
46797568|NCT00607724|83016285|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
46679553|NCT04876599|82895374|FG001|Overall Study|Declined|3|||
46679554|NCT04730947|82895383|FG000|Overall Study|Withdrawal by Subject|0|||
46679555|NCT04730947|82895384|FG001|Overall Study|Withdrawal by Subject|1|||
46679556|NCT04660799|82895392|FG000|Overall Study|Progressive Disease|1|||
46679557|NCT04660799|82895393|FG001|Overall Study|Progressive Disease|1|||
46679558|NCT04660799|82895392|FG000|Overall Study|Death|2|||
46679559|NCT04660799|82895393|FG001|Overall Study|Death|1|||
46679560|NCT04660799|82895392|FG000|Overall Study|Adverse Event|2|||
46679561|NCT04660799|82895393|FG001|Overall Study|Adverse Event|1|||
46679562|NCT04660799|82895392|FG000|Overall Study|Withdrawal by Subject|2|||
46980205|NCT02499159|83225905|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
46679563|NCT04660799|82895393|FG001|Overall Study|Withdrawal by Subject|5|||
46679564|NCT04553471|82895408|FG000|Overall Study|Did not start treatment on protocol|3|||
46980206|NCT02499159|83225906|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
46980207|NCT02499159|83225905|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
46980208|NCT02499159|83225906|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
46980209|NCT02499159|83225905|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
46980210|NCT02499159|83225906|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
46980211|NCT02499159|83225905|FG000|30-Day Follow-Up Phone Call|Other|1|||
46980212|NCT02499159|83225906|FG001|30-Day Follow-Up Phone Call|Other|0|||
46980213|NCT01664039|83225914|FG000|Overall Study|Adverse Event|3|||
46980214|NCT01664039|83225915|FG001|Overall Study|Adverse Event|4|||
46980215|NCT01664039|83225914|FG000|Overall Study|Lost to Follow-up|1|||
46980216|NCT01664039|83225915|FG001|Overall Study|Lost to Follow-up|1|||
46980217|NCT01664039|83225914|FG000|Overall Study|Withdrawal by Subject|1|||
46980218|NCT01664039|83225915|FG001|Overall Study|Withdrawal by Subject|3|||
46980219|NCT01664039|83225914|FG000|Overall Study|Noncompliance|1|||
46797569|NCT00607724|83016286|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
46797570|NCT00607724|83016287|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
46797571|NCT00607724|83016288|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
46797572|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
46797573|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
46797574|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
46857369|NCT02945410|83073089|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
46857370|NCT02945410|83073090|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
46797575|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
46797576|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
46857371|NCT02945410|83073091|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
46857372|NCT02945410|83073092|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
46857373|NCT02945254|83073102|FG000|Overall Study|Lost to Follow-up|1|||
46857374|NCT02945254|83073103|FG001|Overall Study|Lost to Follow-up|0|||
46857375|NCT02945254|83073102|FG000|Overall Study|Withdrawal by Subject|1|||
46857376|NCT02945254|83073103|FG001|Overall Study|Withdrawal by Subject|0|||
46980220|NCT01664039|83225915|FG001|Overall Study|Noncompliance|1|||
46980221|NCT02445573|83225923|FG000|Overall Study|Withdrawal by Subject|1|||
46980222|NCT02445573|83225924|FG001|Overall Study|Withdrawal by Subject|1|||
46980223|NCT02445573|83225923|FG000|Overall Study|Lost to Follow-up|0|||
46980224|NCT02445573|83225924|FG001|Overall Study|Lost to Follow-up|1|||
46980225|NCT02445339|83225932|FG000|Overall Study|Physician Decision|1|||
46980226|NCT02445339|83225933|FG001|Overall Study|Physician Decision|0|||
46980227|NCT02445339|83225932|FG000|Overall Study|Lost to Follow-up|11|||
46980228|NCT02445339|83225933|FG001|Overall Study|Lost to Follow-up|15|||
46980229|NCT02579603|83225941|FG000|Overall Study|Not treated|1|||
46980230|NCT02579603|83225942|FG001|Overall Study|Not treated|0|||
46980231|NCT02579603|83225941|FG000|Overall Study|Adverse Event|2|||
46980232|NCT02579603|83225942|FG001|Overall Study|Adverse Event|2|||
46980233|NCT02579603|83225941|FG000|Overall Study|Other than stated|1|||
46980234|NCT02579603|83225942|FG001|Overall Study|Other than stated|0|||
46980235|NCT02625259|83225954|FG000|First Intervention (Day 1)|Other|0|||
46980236|NCT02625259|83225955|FG001|First Intervention (Day 1)|Other|0|||
46980237|NCT02625259|83225956|FG002|First Intervention (Day 1)|Other|1|||
46980238|NCT02625259|83225957|FG003|First Intervention (Day 1)|Other|0|||
46980239|NCT02625259|83225958|FG004|First Intervention (Day 1)|Other|0|||
46980240|NCT02625259|83225954|FG000|First Intervention (Day 1)|Adverse Event|2|||
46980241|NCT02625259|83225955|FG001|First Intervention (Day 1)|Adverse Event|1|||
46980242|NCT02625259|83225956|FG002|First Intervention (Day 1)|Adverse Event|0|||
46980243|NCT02625259|83225957|FG003|First Intervention (Day 1)|Adverse Event|0|||
46980244|NCT02625259|83225958|FG004|First Intervention (Day 1)|Adverse Event|0|||
46980245|NCT02625259|83225954|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
46980246|NCT02625259|83225955|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
46980247|NCT02625259|83225956|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
46980248|NCT02625259|83225957|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
46980249|NCT02625259|83225958|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
46980250|NCT02577107|83225975|FG000|Overall Study|Protocol deviation|0|||
46980251|NCT02577107|83225976|FG001|Overall Study|Protocol deviation|1|||
46980252|NCT02444793|83225986|FG000|Overall Study|Lost to Follow-up|2|||
46980253|NCT02444793|83225987|FG001|Overall Study|Lost to Follow-up|2|||
46980254|NCT02444793|83225988|FG002|Overall Study|Lost to Follow-up|0|||
46980255|NCT02444793|83225989|FG003|Overall Study|Lost to Follow-up|0|||
46980256|NCT02444793|83225986|FG000|Overall Study|Death|0|||
46980257|NCT02444793|83225987|FG001|Overall Study|Death|3|||
46980258|NCT02444793|83225988|FG002|Overall Study|Death|0|||
46980259|NCT02444793|83225989|FG003|Overall Study|Death|0|||
46980260|NCT02444793|83225986|FG000|Overall Study|Other|0|||
46980261|NCT02444793|83225987|FG001|Overall Study|Other|0|||
46980262|NCT02444793|83225988|FG002|Overall Study|Other|2|||
46980263|NCT02444793|83225989|FG003|Overall Study|Other|0|||
46980264|NCT02444793|83225986|FG000|Overall Study|Objective progression or relapse|9|||
46980265|NCT02444793|83225987|FG001|Overall Study|Objective progression or relapse|1|||
46797577|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
46980266|NCT02444793|83225988|FG002|Overall Study|Objective progression or relapse|2|||
46980267|NCT02444793|83225989|FG003|Overall Study|Objective progression or relapse|3|||
46980268|NCT02624713|83226002|FG000|Overall Study|Lost to Follow-up|14|||
46980269|NCT02624713|83226003|FG001|Overall Study|Lost to Follow-up|0|||
46980270|NCT02624791|83226010|FG000|Overall Study|Withdrawal by Subject|2|||
46980271|NCT02624791|83226011|FG001|Overall Study|Withdrawal by Subject|0|||
46980272|NCT02624791|83226012|FG002|Overall Study|Withdrawal by Subject|0|||
46679565|NCT04553471|82895408|FG000|Overall Study|Death|1|||
46679566|NCT04484831|82895414|FG000|Overall Study|Withdrawal by Subject|1|||
46679567|NCT04484831|82895415|FG001|Overall Study|Withdrawal by Subject|0|||
46679568|NCT04063787|82895453|FG000|Overall Study|Inadequate Doppler data|4|||
46679569|NCT04063787|82895453|FG000|Overall Study|Lost to Follow-up|2|||
46679570|NCT04063787|82895453|FG000|Overall Study|Death|3|||
46679571|NCT03995316|82895467|FG000|Overall Study|Lost to Follow-up|10|||
46679572|NCT03995316|82895468|FG001|Overall Study|Lost to Follow-up|3|||
46679573|NCT03927690|82895477|FG000|Overall Study|Withdrawal by Subject|3|||
46679574|NCT03927690|82895478|FG001|Overall Study|Withdrawal by Subject|1|||
46679575|NCT03927690|82895479|FG002|Overall Study|Withdrawal by Subject|1|||
46679576|NCT03927690|82895477|FG000|Overall Study|Adverse Event|1|||
46679577|NCT03927690|82895478|FG001|Overall Study|Adverse Event|0|||
46679578|NCT03927690|82895479|FG002|Overall Study|Adverse Event|0|||
46679579|NCT03927690|82895477|FG000|Overall Study|Death|1|||
46679580|NCT03927690|82895478|FG001|Overall Study|Death|0|||
46679581|NCT03927690|82895479|FG002|Overall Study|Death|0|||
46679582|NCT03927690|82895477|FG000|Overall Study|Lost to Follow-up|2|||
46679583|NCT03927690|82895478|FG001|Overall Study|Lost to Follow-up|2|||
46679584|NCT03927690|82895479|FG002|Overall Study|Lost to Follow-up|1|||
46679585|NCT03793842|82895491|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
46679586|NCT03793842|82895492|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
46679587|NCT03793842|82895491|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
46679588|NCT03793842|82895492|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
46679589|NCT03555695|82895502|FG000|Overall Study|Withdrawal by Subject|1|||
46679590|NCT03555695|82895502|FG000|Overall Study|Lost to Follow-up|1|||
46679591|NCT03555695|82895502|FG000|Overall Study|appendicitis (unrelated)|1|||
46679592|NCT03555695|82895502|FG000|Overall Study|pre-existing sciatica|1|||
46679593|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
46679594|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
46679595|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
46679596|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
46679597|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
46679598|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
46679599|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
46679600|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
46679601|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
46679602|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
46679603|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
46679604|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
46679605|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
46679606|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
46679607|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
46679608|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
46679609|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
46679610|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
46679611|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
46679612|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
46679613|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
46679614|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
46679615|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
46679616|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
46679617|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
46679618|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
46679619|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
46679620|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
46679621|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
46679622|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
46679623|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
46679624|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
46679625|NCT03538691|82895506|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
46857377|NCT02943070|83073121|FG000|Overall Study|Physician Decision|1|||
46980273|NCT02624791|83226013|FG003|Overall Study|Withdrawal by Subject|0|||
46857378|NCT02943070|83073121|FG000|Overall Study|Adverse Event|2|||
46857379|NCT02943070|83073121|FG000|Overall Study|Death|2|||
46980274|NCT02624791|83226014|FG004|Overall Study|Withdrawal by Subject|0|||
46980275|NCT02624791|83226015|FG005|Overall Study|Withdrawal by Subject|0|||
46980276|NCT02577029|83226027|FG000|Overall Study|Adverse Event|1|||
46980277|NCT02577029|83226028|FG001|Overall Study|Adverse Event|0|||
46679626|NCT03538691|82895507|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
46980278|NCT02577029|83226029|FG002|Overall Study|Adverse Event|2|||
46980279|NCT02577029|83226030|FG003|Overall Study|Adverse Event|0|||
46980280|NCT02577029|83226031|FG004|Overall Study|Adverse Event|1|||
46980281|NCT02577029|83226032|FG005|Overall Study|Adverse Event|0|||
46980282|NCT02577029|83226033|FG006|Overall Study|Adverse Event|0|||
46980283|NCT02577029|83226034|FG007|Overall Study|Adverse Event|0|||
46980284|NCT02577029|83226027|FG000|Overall Study|Withdrawal by Subject|0|||
46980285|NCT02577029|83226028|FG001|Overall Study|Withdrawal by Subject|0|||
46980286|NCT02577029|83226029|FG002|Overall Study|Withdrawal by Subject|0|||
46980287|NCT02577029|83226030|FG003|Overall Study|Withdrawal by Subject|0|||
46980288|NCT02577029|83226031|FG004|Overall Study|Withdrawal by Subject|0|||
46980289|NCT02577029|83226032|FG005|Overall Study|Withdrawal by Subject|1|||
46980290|NCT02577029|83226033|FG006|Overall Study|Withdrawal by Subject|0|||
46797578|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
46679627|NCT03538691|82895508|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
46679628|NCT03538691|82895509|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
46679629|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
46679630|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
46679631|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
46679632|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
46679633|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
46679634|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
46679635|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
46797579|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
46797580|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
46797581|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
46797582|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
46797583|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
46797584|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
46797585|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
46797586|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
46797587|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
46797588|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
46980291|NCT02577029|83226034|FG007|Overall Study|Withdrawal by Subject|0|||
46679636|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
46679637|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
46797589|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
46797590|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
46797591|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
46679638|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
46679639|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
46797592|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
46797593|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
46797594|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
46797595|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
46797596|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
46797597|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
46797598|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
46797599|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
46797600|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
46797601|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
46797602|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
46797603|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
46797604|NCT00506415|83016312|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
46857380|NCT02943070|83073121|FG000|Overall Study|Withdrawal by Subject|3|||
46797605|NCT00506415|83016313|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
46797606|NCT00506415|83016314|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
46797607|NCT00506415|83016315|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
46797608|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
46797609|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
46857381|NCT02943070|83073121|FG000|Overall Study|Lost to Follow-up|4|||
46797610|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
46797611|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
46797612|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
46980292|NCT02577029|83226027|FG000|Overall Study|Sponsor Termination of the Study|9|||
46980293|NCT02577029|83226028|FG001|Overall Study|Sponsor Termination of the Study|2|||
46980294|NCT02577029|83226029|FG002|Overall Study|Sponsor Termination of the Study|5|||
46980295|NCT02577029|83226030|FG003|Overall Study|Sponsor Termination of the Study|12|||
46980296|NCT02577029|83226031|FG004|Overall Study|Sponsor Termination of the Study|10|||
46980297|NCT02577029|83226032|FG005|Overall Study|Sponsor Termination of the Study|12|||
46980298|NCT02577029|83226033|FG006|Overall Study|Sponsor Termination of the Study|12|||
46980299|NCT02577029|83226034|FG007|Overall Study|Sponsor Termination of the Study|12|||
46980300|NCT02577887|83226052|FG000|Overall Study|Death|93|||
46980301|NCT02577887|83226052|FG000|Overall Study|Protocol Violation|125|||
46980302|NCT02577887|83226052|FG000|Overall Study|Withdrawal by Subject|80|||
46980303|NCT03597347|83226059|FG000|Overall Study|Withdrawal by Subject|1|||
46980304|NCT03597347|83226060|FG001|Overall Study|Withdrawal by Subject|1|||
46980305|NCT03597347|83226061|FG002|Overall Study|Withdrawal by Subject|0|||
46980306|NCT03597347|83226059|FG000|Overall Study|Withdrawal due to Covid-19|3|||
46797613|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
46797614|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
46797615|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
46797616|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
46797617|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
46797618|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
46797619|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
46857382|NCT02943070|83073121|FG000|Overall Study|Retreatment or TURP|13|||
46857383|NCT02943070|83073121|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
46857384|NCT03332212|83073145|FG000|Overall Study|Not treated|0|||
46857385|NCT03332212|83073146|FG001|Overall Study|Not treated|1|||
46857386|NCT03332212|83073147|FG002|Overall Study|Not treated|0|||
46857387|NCT03332212|83073148|FG003|Overall Study|Not treated|0|||
46857388|NCT03332212|83073145|FG000|Overall Study|Adverse Event|0|||
46857389|NCT03332212|83073146|FG001|Overall Study|Adverse Event|0|||
46857390|NCT03332212|83073147|FG002|Overall Study|Adverse Event|0|||
46857391|NCT03332212|83073148|FG003|Overall Study|Adverse Event|1|||
46857392|NCT03332212|83073145|FG000|Overall Study|worsening of disease under study|1|||
46857393|NCT03332212|83073146|FG001|Overall Study|worsening of disease under study|1|||
46857394|NCT03332212|83073147|FG002|Overall Study|worsening of disease under study|0|||
46857395|NCT03332212|83073148|FG003|Overall Study|worsening of disease under study|0|||
46857396|NCT03331666|83073158|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
46857397|NCT03331666|83073159|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
46857398|NCT03331042|83073169|FG000|Overall Study|Protocol Violation|1|||
46857399|NCT03331042|83073170|FG001|Overall Study|Protocol Violation|0|||
46857400|NCT03331042|83073171|FG002|Overall Study|Protocol Violation|0|||
46857401|NCT03331042|83073172|FG003|Overall Study|Protocol Violation|0|||
46857402|NCT03331042|83073169|FG000|Overall Study|Physician Decision|0|||
46857403|NCT03331042|83073170|FG001|Overall Study|Physician Decision|0|||
46857404|NCT03331042|83073171|FG002|Overall Study|Physician Decision|1|||
46857405|NCT03331042|83073172|FG003|Overall Study|Physician Decision|0|||
46857406|NCT03331042|83073169|FG000|Overall Study|Lost to Follow-up|0|||
46980307|NCT03597347|83226060|FG001|Overall Study|Withdrawal due to Covid-19|0|||
46857407|NCT03331042|83073170|FG001|Overall Study|Lost to Follow-up|0|||
46980308|NCT03597347|83226061|FG002|Overall Study|Withdrawal due to Covid-19|0|||
46980309|NCT03597347|83226059|FG000|Overall Study|Sponsor decision to terminate study|3|||
46980310|NCT03597347|83226060|FG001|Overall Study|Sponsor decision to terminate study|2|||
46980311|NCT03597347|83226061|FG002|Overall Study|Sponsor decision to terminate study|4|||
46980312|NCT02576951|83226073|FG000|Overall Study|Lost to Follow-up|0|||
46980313|NCT02576951|83226074|FG001|Overall Study|Lost to Follow-up|0|||
46980314|NCT02576951|83226075|FG002|Overall Study|Lost to Follow-up|2|||
46980315|NCT02576951|83226076|FG003|Overall Study|Lost to Follow-up|2|||
46980316|NCT02576951|83226073|FG000|Overall Study|Withdrawal by Subject|1|||
46980317|NCT02576951|83226074|FG001|Overall Study|Withdrawal by Subject|0|||
46980318|NCT02576951|83226075|FG002|Overall Study|Withdrawal by Subject|0|||
46980319|NCT02576951|83226076|FG003|Overall Study|Withdrawal by Subject|2|||
46679640|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
46679641|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
46679642|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
46679643|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
46679644|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
46679645|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
46679646|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
46797620|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
46797621|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
46679647|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
46679648|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
46797622|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
46857408|NCT03331042|83073171|FG002|Overall Study|Lost to Follow-up|0|||
46797623|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
46797624|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
46797625|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
46797626|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
46679649|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
46679650|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
46679651|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
46980320|NCT02576951|83226073|FG000|Overall Study|Protocol Violation|0|||
46980321|NCT02576951|83226074|FG001|Overall Study|Protocol Violation|0|||
46679652|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
46797627|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
46679653|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
46679654|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
46679655|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
46679656|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
46679657|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
46679658|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
46679659|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
46679660|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
46679661|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
46679662|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
46679663|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
46679664|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
46679665|NCT03538691|82895506|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
46679666|NCT03538691|82895507|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
46679667|NCT03538691|82895508|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
46679668|NCT03538691|82895509|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
46679669|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
46679670|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
46797628|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
46797629|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
46797630|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
46797631|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
46797632|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
46679671|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
46797633|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
46797634|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
46797635|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
46797636|NCT00506415|83016312|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
46797637|NCT00506415|83016313|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
46797638|NCT00506415|83016314|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
46797639|NCT00506415|83016315|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
46797640|NCT00506415|83016312|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
46797641|NCT00506415|83016313|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
46797642|NCT00506415|83016314|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
46797643|NCT00506415|83016315|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
46797644|NCT00506415|83016312|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
46797645|NCT00506415|83016313|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
46679672|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
46797646|NCT00506415|83016314|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
46797647|NCT00506415|83016315|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
46797648|NCT00506415|83016312|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
46797649|NCT00506415|83016313|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
46797650|NCT00506415|83016314|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
46980322|NCT02576951|83226075|FG002|Overall Study|Protocol Violation|0|||
46679673|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
46679674|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
46679675|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
46679676|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
46679677|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
46679678|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
46679679|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
46679680|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
46679681|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
46679682|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
46679683|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
46679684|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
46679685|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
46679686|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
46679687|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
46679688|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
46679689|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
46679690|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
46679691|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
46679692|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
46679693|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
46679694|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
46797651|NCT00506415|83016315|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
46797652|NCT00506415|83016312|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
46797653|NCT00506415|83016313|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
46980323|NCT02576951|83226076|FG003|Overall Study|Protocol Violation|1|||
46857409|NCT03331042|83073172|FG003|Overall Study|Lost to Follow-up|1|||
46857410|NCT03762668|83073190|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
46857411|NCT03762668|83073191|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
46857412|NCT03762200|83073197|FG000|Overall Study|Death|2|||
46857413|NCT03711370|83073203|FG000|Overall Study|Lost to Follow-up|16|||
46857414|NCT03711370|83073204|FG001|Overall Study|Lost to Follow-up|10|||
46857415|NCT03711370|83073203|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
46857416|NCT03711370|83073204|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
46857417|NCT03478930|83073220|FG000|Overall Study|Adverse Event|0|||
46857418|NCT03478930|83073221|FG001|Overall Study|Adverse Event|1|||
46857419|NCT03478930|83073220|FG000|Overall Study|Lack of Efficacy|3|||
46857420|NCT03478930|83073221|FG001|Overall Study|Lack of Efficacy|3|||
46980324|NCT04929613|83226088|FG000|Overall Study|Withdrawal by Subject|12|||
46980325|NCT02621047|83226095|FG000|Overall Study|Adverse Event|0|||
46679695|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
46679696|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
46679697|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
46797654|NCT00506415|83016314|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
46797655|NCT00506415|83016315|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
46797656|NCT00506415|83016312|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
46679698|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
46679699|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
46797657|NCT00506415|83016313|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
46797658|NCT00506415|83016314|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
46797659|NCT00506415|83016315|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
46797660|NCT00506415|83016312|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
46797661|NCT00506415|83016313|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
46797662|NCT00506415|83016314|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
46797663|NCT00506415|83016315|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
46980326|NCT02621047|83226096|FG001|Overall Study|Adverse Event|0|||
46857421|NCT03478930|83073220|FG000|Overall Study|Withdrawal by Subject|6|||
46797664|NCT00506415|83016312|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
46797665|NCT00506415|83016313|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
46679700|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
46679701|NCT03538691|82895506|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
46679702|NCT03538691|82895507|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
46679703|NCT03538691|82895508|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
46679704|NCT03538691|82895509|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
46679705|NCT03120949|82895528|FG000|Overall Study|randomized in error|1|||
46679706|NCT03120949|82895529|FG001|Overall Study|randomized in error|0|||
46679707|NCT03120949|82895528|FG000|Overall Study|Death|13|||
46679708|NCT03120949|82895529|FG001|Overall Study|Death|13|||
46679709|NCT03120949|82895528|FG000|Overall Study|Lost to Follow-up|23|||
46679710|NCT03120949|82895529|FG001|Overall Study|Lost to Follow-up|13|||
46679711|NCT03120949|82895528|FG000|Overall Study|Withdrawal by Subject|139|||
46797666|NCT00506415|83016314|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
46797667|NCT00506415|83016315|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
46797668|NCT00452452|83016331|FG000|Overall Study|Protocol Violation|0|||
46797669|NCT00452452|83016332|FG001|Overall Study|Protocol Violation|0|||
46797670|NCT00452452|83016333|FG002|Overall Study|Protocol Violation|1|||
46679712|NCT03120949|82895529|FG001|Overall Study|Withdrawal by Subject|124|||
46679713|NCT03120949|82895528|FG000|Overall Study|Covid-19|43|||
46797671|NCT00452452|83016331|FG000|Overall Study|Withdrawal by Subject|1|||
46679714|NCT03120949|82895529|FG001|Overall Study|Covid-19|34|||
46679715|NCT03120949|82895528|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
46857422|NCT03478930|83073221|FG001|Overall Study|Withdrawal by Subject|5|||
46857423|NCT03038438|83073227|FG000|Overall Study|Death|3|||
46857424|NCT03038438|83073227|FG000|Overall Study|Lost to Follow-up|8|||
46857425|NCT03038438|83073227|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
46857426|NCT03038438|83073227|FG000|Overall Study|Withdrawal by Subject|5|||
46857427|NCT03038438|83073227|FG000|Overall Study|No 36-Month Follow-Up|18|||
46857428|NCT03523000|83073231|FG000|Overall Study|Withdrawal by Subject|3|||
46857429|NCT03523000|83073232|FG001|Overall Study|Withdrawal by Subject|0|||
46857430|NCT03523000|83073231|FG000|Overall Study|Unsuccessful trial|2|||
46857431|NCT03523000|83073232|FG001|Overall Study|Unsuccessful trial|0|||
46857432|NCT03327220|83073243|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
46679716|NCT03120949|82895529|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
46707569|NCT01176240|82923136|FG001|Study 306B|withdrew prior to dosing|1|||
46857433|NCT03327220|83073244|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
46857434|NCT03327220|83073243|FG000|Overall Study|Investigator Decision|2|||
46679717|NCT03120949|82895528|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
46679718|NCT03120949|82895529|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
46679719|NCT03120949|82895528|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
46679720|NCT03120949|82895529|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
46679721|NCT03120949|82895528|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
46679722|NCT03120949|82895529|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
46679723|NCT03120949|82895528|FG000|Overall Study|Site was closed|2|||
46679724|NCT03120949|82895529|FG001|Overall Study|Site was closed|3|||
46679725|NCT03120949|82895528|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
46679726|NCT03120949|82895529|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
46679727|NCT03120949|82895528|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
46679728|NCT03120949|82895529|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
46679729|NCT03120949|82895528|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
46679730|NCT03120949|82895529|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
46679731|NCT03120949|82895528|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
46679732|NCT03120949|82895529|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
46679733|NCT03120949|82895528|FG000|Overall Study|Other: Adverse Event|0|||
46679734|NCT03120949|82895529|FG001|Overall Study|Other: Adverse Event|1|||
46679735|NCT03120949|82895528|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
46679736|NCT03120949|82895529|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
46679737|NCT03120949|82895528|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
46679738|NCT03120949|82895529|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
46679739|NCT03120949|82895528|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
46679740|NCT03120949|82895529|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
46679741|NCT03120949|82895528|FG000|Overall Study|Personal Reasons|0|||
46679742|NCT03120949|82895529|FG001|Overall Study|Personal Reasons|1|||
46679743|NCT03120949|82895528|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
46679744|NCT03120949|82895529|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
46679745|NCT03120949|82895528|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
46679746|NCT03120949|82895529|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
46679747|NCT03120949|82895528|FG000|Overall Study|Compliance With Medication|0|||
46679748|NCT03120949|82895529|FG001|Overall Study|Compliance With Medication|1|||
46679749|NCT03120949|82895528|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
46679750|NCT03120949|82895529|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
46679751|NCT03120949|82895528|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
46679752|NCT03120949|82895529|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
46679753|NCT03120949|82895528|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
46679754|NCT03120949|82895529|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
46679755|NCT02921256|82895552|FG000|Arm 1a v. Arm II|Adverse Event|6|||
46679756|NCT02921256|82895553|FG001|Arm 1a v. Arm II|Adverse Event|15|||
46679757|NCT02921256|82895554|FG002|Arm 1a v. Arm II|Adverse Event|0|||
46679758|NCT02921256|82895552|FG000|Arm 1a v. Arm II|Death|0|||
46679759|NCT02921256|82895553|FG001|Arm 1a v. Arm II|Death|2|||
46679760|NCT02921256|82895554|FG002|Arm 1a v. Arm II|Death|0|||
46679761|NCT02921256|82895552|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
46679762|NCT02921256|82895553|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
46797672|NCT00452452|83016332|FG001|Overall Study|Withdrawal by Subject|0|||
46797673|NCT00452452|83016333|FG002|Overall Study|Withdrawal by Subject|0|||
46797674|NCT00452452|83016331|FG000|Overall Study|Lost to Follow-up|1|||
46797675|NCT00452452|83016332|FG001|Overall Study|Lost to Follow-up|0|||
46797676|NCT00452452|83016333|FG002|Overall Study|Lost to Follow-up|0|||
46797677|NCT00510783|83016349|FG000|Overall Study|Lost to Follow-up|29|||
46797678|NCT00510783|83016350|FG001|Overall Study|Lost to Follow-up|25|||
46679763|NCT02921256|82895554|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
46679764|NCT02921256|82895552|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
46679765|NCT02921256|82895553|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
46679766|NCT02921256|82895554|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
46679767|NCT02921256|82895552|FG000|Arm 1a v. Arm II|Physician Decision|1|||
46679768|NCT02921256|82895553|FG001|Arm 1a v. Arm II|Physician Decision|1|||
46679769|NCT02921256|82895554|FG002|Arm 1a v. Arm II|Physician Decision|0|||
46679770|NCT02921256|82895552|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
46679771|NCT02921256|82895553|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
46679772|NCT02921256|82895554|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
46679773|NCT02921256|82895552|FG000|Arm Ib v Arm III|Adverse Event|9|||
46679774|NCT02921256|82895553|FG001|Arm Ib v Arm III|Adverse Event|0|||
46679775|NCT02921256|82895554|FG002|Arm Ib v Arm III|Adverse Event|4|||
46679776|NCT02921256|82895552|FG000|Arm Ib v Arm III|Death|1|||
46679777|NCT02921256|82895553|FG001|Arm Ib v Arm III|Death|0|||
46679778|NCT02921256|82895554|FG002|Arm Ib v Arm III|Death|1|||
46679779|NCT02921256|82895552|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
46679780|NCT02921256|82895553|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
46679781|NCT02921256|82895554|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
46679782|NCT02921256|82895552|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
46679783|NCT02921256|82895553|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
46679784|NCT02921256|82895554|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
46679785|NCT02921256|82895552|FG000|Arm Ib v Arm III|Physician Decision|4|||
46679786|NCT02921256|82895553|FG001|Arm Ib v Arm III|Physician Decision|0|||
46679787|NCT02921256|82895554|FG002|Arm Ib v Arm III|Physician Decision|1|||
46679788|NCT02921256|82895552|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
46679789|NCT02921256|82895553|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
46679790|NCT02921256|82895554|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
46679791|NCT02757885|82895568|FG000|Overall Study|Screen Failures|4|||
46797679|NCT00510783|83016349|FG000|Overall Study|Withdrawal by Subject|2|||
46679792|NCT02635867|82895586|FG000|Overall Study|Lost to Follow-up|4|||
46980327|NCT02621047|83226097|FG002|Overall Study|Adverse Event|1|||
46679793|NCT02635867|82895587|FG001|Overall Study|Lost to Follow-up|3|||
46857435|NCT03327220|83073244|FG001|Overall Study|Investigator Decision|0|||
46679794|NCT02635867|82895588|FG002|Overall Study|Lost to Follow-up|3|||
46679795|NCT02635867|82895589|FG003|Overall Study|Lost to Follow-up|4|||
46679796|NCT02635867|82895590|FG004|Overall Study|Lost to Follow-up|1|||
46679797|NCT02426658|82895607|FG000|Overall Study|Withdrawal by Subject|1|||
46679798|NCT02426658|82895607|FG000|Overall Study|Patient expired before treatment|2|||
46679799|NCT02158091|82895614|FG000|Overall Study|DLT|2|||
46679800|NCT02158091|82895615|FG001|Overall Study|DLT|1|||
46679801|NCT02158091|82895616|FG002|Overall Study|DLT|0|||
46679802|NCT02903420|82895646|FG000|Overall Study|Death|3|||
46679803|NCT02831933|82895650|FG000|Overall Study|Physician Decision|11|||
46679804|NCT02813668|82895654|FG000|Overall Study|Death|4|||
46679805|NCT02813668|82895654|FG000|Overall Study|Lost to Follow-up|509|||
46679806|NCT02813668|82895654|FG000|Overall Study|Withdrawal by Subject|148|||
46679807|NCT02813668|82895654|FG000|Overall Study|No longer at worksite|85|||
46679808|NCT02813668|82895654|FG000|Overall Study|Medical reasons not related to the study|4|||
46679809|NCT02760433|82895663|FG000|Overall Study|Lost to Follow-up|1|||
46679810|NCT02760433|82895664|FG001|Overall Study|Lost to Follow-up|0|||
46679811|NCT02760433|82895665|FG002|Overall Study|Lost to Follow-up|1|||
46679812|NCT02760433|82895666|FG003|Overall Study|Lost to Follow-up|0|||
46679813|NCT02760433|82895667|FG004|Overall Study|Lost to Follow-up|0|||
46679814|NCT02760433|82895663|FG000|Overall Study|Withdrawal by Subject|23|||
46679815|NCT02760433|82895664|FG001|Overall Study|Withdrawal by Subject|9|||
46679816|NCT02760433|82895665|FG002|Overall Study|Withdrawal by Subject|0|||
46679817|NCT02760433|82895666|FG003|Overall Study|Withdrawal by Subject|2|||
46679818|NCT02760433|82895667|FG004|Overall Study|Withdrawal by Subject|9|||
46679819|NCT02760433|82895663|FG000|Overall Study|Lack of Response At Week 14|0|||
46679820|NCT02760433|82895664|FG001|Overall Study|Lack of Response At Week 14|0|||
46679821|NCT02760433|82895665|FG002|Overall Study|Lack of Response At Week 14|0|||
46679822|NCT02760433|82895666|FG003|Overall Study|Lack of Response At Week 14|0|||
46679823|NCT02760433|82895667|FG004|Overall Study|Lack of Response At Week 14|1|||
46679824|NCT02760433|82895663|FG000|Overall Study|Subject refused to continue the study|1|||
46679825|NCT02760433|82895664|FG001|Overall Study|Subject refused to continue the study|0|||
46679826|NCT02760433|82895665|FG002|Overall Study|Subject refused to continue the study|0|||
46679827|NCT02760433|82895666|FG003|Overall Study|Subject refused to continue the study|0|||
46679828|NCT02760433|82895667|FG004|Overall Study|Subject refused to continue the study|0|||
46679829|NCT02760433|82895663|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
46679830|NCT02760433|82895664|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
46679831|NCT02760433|82895665|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
46679832|NCT02760433|82895666|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
46857436|NCT03327220|83073243|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
46857437|NCT03327220|83073244|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
46857438|NCT03327220|83073243|FG000|Overall Study|Fungal infection|1|||
46797680|NCT00510783|83016350|FG001|Overall Study|Withdrawal by Subject|3|||
46797681|NCT00510783|83016349|FG000|Overall Study|Protocol Violation|0|||
46797682|NCT00510783|83016350|FG001|Overall Study|Protocol Violation|1|||
46797683|NCT00518973|83016358|FG000|Overall Study|Withdrawal by Subject|3|||
46797684|NCT00518973|83016359|FG001|Overall Study|Withdrawal by Subject|2|||
46797685|NCT00462670|83016367|FG000|Overall Study|Adverse Event|3|||
46797686|NCT00462670|83016368|FG001|Overall Study|Adverse Event|5|||
46797687|NCT00462670|83016367|FG000|Overall Study|Lack of Efficacy|1|||
46679833|NCT02760433|82895667|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
46797688|NCT00462670|83016368|FG001|Overall Study|Lack of Efficacy|0|||
46679834|NCT02760433|82895663|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
46679835|NCT02760433|82895664|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
46679836|NCT02760433|82895665|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
46679837|NCT02760433|82895666|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
46679838|NCT02760433|82895667|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
46679839|NCT02760407|82895687|FG000|Overall Study|Death|2|||
46679840|NCT02760407|82895688|FG001|Overall Study|Death|3|||
46679841|NCT02760407|82895689|FG002|Overall Study|Death|1|||
46679842|NCT02760407|82895690|FG003|Overall Study|Death|1|||
46679843|NCT02760407|82895687|FG000|Overall Study|Lost to Follow-up|1|||
46679844|NCT02760407|82895688|FG001|Overall Study|Lost to Follow-up|7|||
46679845|NCT02760407|82895689|FG002|Overall Study|Lost to Follow-up|4|||
46679846|NCT02760407|82895690|FG003|Overall Study|Lost to Follow-up|6|||
46679847|NCT02760407|82895687|FG000|Overall Study|Withdrawal by Subject|25|||
46679848|NCT02760407|82895688|FG001|Overall Study|Withdrawal by Subject|31|||
46679849|NCT02760407|82895689|FG002|Overall Study|Withdrawal by Subject|37|||
46679850|NCT02760407|82895690|FG003|Overall Study|Withdrawal by Subject|25|||
46679851|NCT02760407|82895687|FG000|Overall Study|Violation of Eligibility criteria|0|||
46679852|NCT02760407|82895688|FG001|Overall Study|Violation of Eligibility criteria|0|||
46679853|NCT02760407|82895689|FG002|Overall Study|Violation of Eligibility criteria|1|||
46679854|NCT02760407|82895690|FG003|Overall Study|Violation of Eligibility criteria|1|||
46679855|NCT02760407|82895687|FG000|Overall Study|Personal reasons|0|||
46679856|NCT02760407|82895688|FG001|Overall Study|Personal reasons|0|||
46679857|NCT02760407|82895689|FG002|Overall Study|Personal reasons|0|||
46679858|NCT02760407|82895690|FG003|Overall Study|Personal reasons|1|||
46679859|NCT02760407|82895687|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
46679860|NCT02760407|82895688|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
46679861|NCT02760407|82895689|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
46679862|NCT02760407|82895690|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
46679863|NCT02760407|82895687|FG000|Overall Study|Use of prohibited Medication|0|||
46679864|NCT02760407|82895688|FG001|Overall Study|Use of prohibited Medication|0|||
46679865|NCT02760407|82895689|FG002|Overall Study|Use of prohibited Medication|1|||
46679866|NCT02760407|82895690|FG003|Overall Study|Use of prohibited Medication|0|||
46679867|NCT02760407|82895687|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
46679868|NCT02760407|82895688|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
46679869|NCT02760407|82895689|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
46679870|NCT02760407|82895690|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
46679871|NCT02760407|82895687|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
46679872|NCT02760407|82895688|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
46679873|NCT02760407|82895689|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
46679874|NCT02760407|82895690|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
46679875|NCT02760407|82895687|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
46679876|NCT02760407|82895688|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
46679877|NCT02760407|82895689|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
46679878|NCT02760407|82895690|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
46679879|NCT02760407|82895687|FG000|Overall Study|Inadequately Enrolled|0|||
46679880|NCT02760407|82895688|FG001|Overall Study|Inadequately Enrolled|0|||
46679881|NCT02760407|82895689|FG002|Overall Study|Inadequately Enrolled|0|||
46797689|NCT00462670|83016367|FG000|Overall Study|Protocol Violation|1|||
46797690|NCT00462670|83016368|FG001|Overall Study|Protocol Violation|0|||
46797691|NCT00462670|83016367|FG000|Overall Study|Resolution of signs and symptoms|0|||
46797692|NCT00462670|83016368|FG001|Overall Study|Resolution of signs and symptoms|2|||
46797693|NCT00606086|83016376|FG000|Overall Study|Adverse Event|1|||
46797694|NCT00606086|83016377|FG001|Overall Study|Adverse Event|1|||
46797695|NCT00606086|83016376|FG000|Overall Study|Lost to Follow-up|4|||
46797696|NCT00606086|83016377|FG001|Overall Study|Lost to Follow-up|8|||
46797697|NCT00606086|83016376|FG000|Overall Study|Protocol Violation|1|||
46797698|NCT00606086|83016377|FG001|Overall Study|Protocol Violation|0|||
46797699|NCT00606086|83016376|FG000|Overall Study|Withdrawal by Subject|5|||
46679882|NCT02760407|82895690|FG003|Overall Study|Inadequately Enrolled|1|||
46797700|NCT00606086|83016377|FG001|Overall Study|Withdrawal by Subject|3|||
46980328|NCT02443155|83226110|FG000|Overall Study|Adverse Event|3|||
46980329|NCT02443155|83226111|FG001|Overall Study|Adverse Event|4|||
46980330|NCT02443155|83226112|FG002|Overall Study|Adverse Event|1|||
46980331|NCT02443155|83226113|FG003|Overall Study|Adverse Event|2|||
46980332|NCT02443155|83226110|FG000|Overall Study|Unclassified|0|||
46980333|NCT02443155|83226111|FG001|Overall Study|Unclassified|0|||
46980334|NCT02443155|83226112|FG002|Overall Study|Unclassified|2|||
46679883|NCT02760407|82895687|FG000|Overall Study|Withdrawal By PI's Decision|0|||
46679884|NCT02760407|82895688|FG001|Overall Study|Withdrawal By PI's Decision|1|||
46679885|NCT02760407|82895689|FG002|Overall Study|Withdrawal By PI's Decision|0|||
46679886|NCT02760407|82895690|FG003|Overall Study|Withdrawal By PI's Decision|0|||
46679887|NCT02760407|82895687|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
46679888|NCT02760407|82895688|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
46679889|NCT02760407|82895689|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
46679890|NCT02760407|82895690|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
46679891|NCT02760407|82895687|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
46679892|NCT02760407|82895688|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
46679893|NCT02760407|82895689|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
46679894|NCT02760407|82895690|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
46679895|NCT02760407|82895687|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
46679896|NCT02760407|82895688|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
46679897|NCT02760407|82895689|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
46679898|NCT02760407|82895690|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
46679899|NCT02760407|82895687|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
46679900|NCT02760407|82895688|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
46679901|NCT02760407|82895689|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
46679902|NCT02760407|82895690|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
46679903|NCT02760407|82895687|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
46679904|NCT02760407|82895688|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
46679905|NCT02760407|82895689|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
46679906|NCT02760407|82895690|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
46679907|NCT02760407|82895687|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
46679908|NCT02760407|82895688|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
46679909|NCT02760407|82895689|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
46679910|NCT02760407|82895690|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
46857439|NCT03327220|83073244|FG001|Overall Study|Fungal infection|0|||
46679911|NCT02760407|82895687|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
46857440|NCT03327220|83073243|FG000|Overall Study|Discharged to Rehabilitation|0|||
46679912|NCT02760407|82895688|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
46707570|NCT00988221|82923145|FG000|Part I|Adverse Event|0|||
46980335|NCT02443155|83226113|FG003|Overall Study|Unclassified|1|||
46980336|NCT02443155|83226110|FG000|Overall Study|Withdrawal by Subject|4|||
46980337|NCT02443155|83226111|FG001|Overall Study|Withdrawal by Subject|7|||
46679913|NCT02760407|82895689|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
46679914|NCT02760407|82895690|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
46707571|NCT00988221|82923146|FG001|Part I|Adverse Event|1|||
46679915|NCT02760407|82895687|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
46679916|NCT02760407|82895688|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
46679917|NCT02760407|82895689|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
46679918|NCT02760407|82895690|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
46679919|NCT02760407|82895687|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
46679920|NCT02760407|82895688|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
46679921|NCT02760407|82895689|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
46679922|NCT02760407|82895690|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
46679923|NCT02760368|82895706|FG000|Overall Study|Withdrawal by Subject|8|||
46679924|NCT02760368|82895707|FG001|Overall Study|Withdrawal by Subject|12|||
46679925|NCT02760368|82895708|FG002|Overall Study|Withdrawal by Subject|9|||
46679926|NCT02760368|82895706|FG000|Overall Study|Screen Failure|0|||
46679927|NCT02760368|82895707|FG001|Overall Study|Screen Failure|0|||
46679928|NCT02760368|82895708|FG002|Overall Study|Screen Failure|1|||
46679929|NCT02760368|82895706|FG000|Overall Study|Death|0|||
46679930|NCT02760368|82895707|FG001|Overall Study|Death|1|||
46679931|NCT02760368|82895708|FG002|Overall Study|Death|0|||
46679932|NCT02760368|82895706|FG000|Overall Study|Withdrawal by Sponsor|0|||
46679933|NCT02760368|82895707|FG001|Overall Study|Withdrawal by Sponsor|0|||
46679934|NCT02760368|82895708|FG002|Overall Study|Withdrawal by Sponsor|1|||
46679935|NCT02741570|82895721|FG000|Pre-Treatment Period|Other reasons|0|||
46679936|NCT02741570|82895722|FG001|Pre-Treatment Period|Other reasons|3|||
46679937|NCT02741570|82895721|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
46679938|NCT02741570|82895722|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
46679939|NCT02741570|82895721|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
46679940|NCT02741570|82895722|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
46679941|NCT02741570|82895721|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
46679942|NCT02741570|82895722|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
46679943|NCT02741570|82895721|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
46679944|NCT02741570|82895722|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
46679945|NCT02741570|82895721|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
46679946|NCT02741570|82895722|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
46857441|NCT03327220|83073244|FG001|Overall Study|Discharged to Rehabilitation|1|||
46857442|NCT03327220|83073243|FG000|Overall Study|Missing|1|||
46857443|NCT03327220|83073244|FG001|Overall Study|Missing|0|||
46857444|NCT00318149|83073256|FG000|Overall Study|Adverse Event|0|||
46857445|NCT00318149|83073257|FG001|Overall Study|Adverse Event|0|||
46797701|NCT00606086|83016376|FG000|Overall Study|Non-compliance|0|||
46797702|NCT00606086|83016377|FG001|Overall Study|Non-compliance|1|||
46797703|NCT00606086|83016376|FG000|Overall Study|Randomized, not treated|1|||
46797704|NCT00606086|83016377|FG001|Overall Study|Randomized, not treated|2|||
46797705|NCT00609986|83016385|FG000|Overall Study|Did not receive transplant or treatment|8|||
46797706|NCT00609986|83016386|FG001|Overall Study|Did not receive transplant or treatment|3|||
46797707|NCT00451906|83016392|FG000|Overall Study|Adverse Event|515|||
46797708|NCT00451906|83016392|FG000|Overall Study|Lost to Follow-up|31|||
46797709|NCT00451906|83016392|FG000|Overall Study|Withdrawal by Subject|111|||
46797710|NCT00451906|83016392|FG000|Overall Study|Protocol Violation|21|||
46797711|NCT00451906|83016392|FG000|Overall Study|Progressive disease|1328|||
46797712|NCT00451906|83016392|FG000|Overall Study|Termination of the study|108|||
46797713|NCT00451906|83016392|FG000|Overall Study|Other Reasons|121|||
46797714|NCT00451906|83016392|FG000|Overall Study|Did not complete final visit|4|||
46797715|NCT00451282|83016398|FG000|Overall Study|Lost to Follow-up|6|||
46797716|NCT00451282|83016399|FG001|Overall Study|Lost to Follow-up|5|||
46857446|NCT00318149|83073258|FG002|Overall Study|Adverse Event|0|||
46707572|NCT00988221|82923147|FG002|Part I|Adverse Event|2|||
46679947|NCT02741570|82895721|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
46679948|NCT02741570|82895722|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
46679949|NCT02741570|82895721|FG000|Pre-Treatment Period|Death|0|||
46679950|NCT02741570|82895722|FG001|Pre-Treatment Period|Death|1|||
46679951|NCT02741570|82895721|FG000|Pre-Treatment Period|Disease progression|0|||
46679952|NCT02741570|82895722|FG001|Pre-Treatment Period|Disease progression|1|||
46679953|NCT02741570|82895721|FG000|Treatment Period|Other reasons|47|||
46679954|NCT02741570|82895722|FG001|Treatment Period|Other reasons|12|||
46679955|NCT02741570|82895721|FG000|Treatment Period|Poor/non-compliance|0|||
46679956|NCT02741570|82895722|FG001|Treatment Period|Poor/non-compliance|2|||
46679957|NCT02741570|82895721|FG000|Treatment Period|Maximum clinical benefit|4|||
46679958|NCT02741570|82895722|FG001|Treatment Period|Maximum clinical benefit|6|||
46679959|NCT02741570|82895721|FG000|Treatment Period|Lost to Follow-up|1|||
46679960|NCT02741570|82895722|FG001|Treatment Period|Lost to Follow-up|3|||
46679961|NCT02741570|82895721|FG000|Treatment Period|Participant withdrew consent|9|||
46679962|NCT02741570|82895722|FG001|Treatment Period|Participant withdrew consent|13|||
46679963|NCT02741570|82895721|FG000|Treatment Period|Participant request to discontinue treatment|8|||
46797717|NCT03838198|83016407|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
46797718|NCT03838198|83016408|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
46679964|NCT02741570|82895722|FG001|Treatment Period|Participant request to discontinue treatment|23|||
46707573|NCT00988221|82923148|FG003|Part I|Adverse Event|0|||
46797719|NCT03838198|83016409|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
46797720|NCT03838198|83016410|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
46857447|NCT00318149|83073259|FG003|Overall Study|Adverse Event|0|||
46797721|NCT03838198|83016407|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
46797722|NCT03838198|83016408|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
46797723|NCT03838198|83016409|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
46797724|NCT03838198|83016410|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
46797725|NCT00115765|83016425|FG000|Overall Study|Withdrawal by Subject|22|||
46797726|NCT00115765|83016426|FG001|Overall Study|Withdrawal by Subject|53|||
46797727|NCT00115765|83016427|FG002|Overall Study|Withdrawal by Subject|76|||
46797728|NCT00115765|83016428|FG003|Overall Study|Withdrawal by Subject|15|||
46797729|NCT00115765|83016425|FG000|Overall Study|Physician Decision|4|||
46797730|NCT00115765|83016426|FG001|Overall Study|Physician Decision|15|||
46797731|NCT00115765|83016427|FG002|Overall Study|Physician Decision|18|||
46797732|NCT00115765|83016428|FG003|Overall Study|Physician Decision|13|||
46797733|NCT00115765|83016425|FG000|Overall Study|Lost to Follow-up|3|||
46797734|NCT00115765|83016426|FG001|Overall Study|Lost to Follow-up|20|||
46797735|NCT00115765|83016427|FG002|Overall Study|Lost to Follow-up|18|||
46797736|NCT00115765|83016428|FG003|Overall Study|Lost to Follow-up|1|||
46797737|NCT00115765|83016425|FG000|Overall Study|Other|6|||
46797738|NCT00115765|83016426|FG001|Overall Study|Other|12|||
46797739|NCT00115765|83016427|FG002|Overall Study|Other|9|||
46797740|NCT00115765|83016428|FG003|Overall Study|Other|2|||
46797741|NCT00606008|83016436|FG000|Overall Study|Adverse Event|1|||
46797742|NCT00606008|83016436|FG000|Overall Study|Withdrawal by Subject|4|||
46679965|NCT02741570|82895721|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
46679966|NCT02741570|82895722|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
46797743|NCT00461812|83016448|FG000|Overall Study|study terminated|10|||
46797744|NCT00123955|83016455|FG000|Overall Study|Adverse Event|1|||
46797745|NCT00123955|83016456|FG001|Overall Study|Adverse Event|0|||
46797746|NCT00123955|83016455|FG000|Overall Study|Withdrawal by Subject|4|||
46797747|NCT00123955|83016456|FG001|Overall Study|Withdrawal by Subject|3|||
46797748|NCT00123955|83016455|FG000|Overall Study|Death|0|||
46797749|NCT00123955|83016456|FG001|Overall Study|Death|1|||
46980338|NCT02443155|83226112|FG002|Overall Study|Withdrawal by Subject|3|||
46980339|NCT02443155|83226113|FG003|Overall Study|Withdrawal by Subject|9|||
46797750|NCT03837028|83016466|FG000|Overall Study|Lost to Follow-up|4|||
46857448|NCT00318149|83073260|FG004|Overall Study|Adverse Event|0|||
46857449|NCT00318149|83073261|FG005|Overall Study|Adverse Event|2|||
46679967|NCT02741570|82895721|FG000|Treatment Period|Death|9|||
46679968|NCT02741570|82895722|FG001|Treatment Period|Death|7|||
46679969|NCT02741570|82895721|FG000|Treatment Period|Study drug toxicity|55|||
46679970|NCT02741570|82895722|FG001|Treatment Period|Study drug toxicity|47|||
46679971|NCT02741570|82895721|FG000|Treatment Period|Disease progression|294|||
46679972|NCT02741570|82895722|FG001|Treatment Period|Disease progression|301|||
46679973|NCT02741570|82895721|FG000|Treatment Period|Administrative reason by sponsor|0|||
46679974|NCT02741570|82895722|FG001|Treatment Period|Administrative reason by sponsor|1|||
46679975|NCT02603887|82895750|FG000|Stage 1|Adverse Event|4|||
46679976|NCT02603887|82895750|FG000|Stage 1|Disease progression|1|||
46857450|NCT00317603|83073277|FG000|Overall Study|Progressive Disease|3|||
46857451|NCT03326518|83073284|FG000|Overall Study|Protocol Violation|1|||
46857452|NCT03326518|83073285|FG001|Overall Study|Protocol Violation|0|||
46857453|NCT03326518|83073286|FG002|Overall Study|Protocol Violation|0|||
46857454|NCT03326518|83073284|FG000|Overall Study|Withdrawal by Subject|1|||
46857455|NCT03326518|83073285|FG001|Overall Study|Withdrawal by Subject|0|||
46857456|NCT03326518|83073286|FG002|Overall Study|Withdrawal by Subject|0|||
46857457|NCT03326518|83073284|FG000|Overall Study|Lost to Follow-up|1|||
46857458|NCT03326518|83073285|FG001|Overall Study|Lost to Follow-up|0|||
46857459|NCT03326518|83073286|FG002|Overall Study|Lost to Follow-up|1|||
46857460|NCT00317369|83073297|FG000|Overall Study|Adverse Event|2|||
46857461|NCT00317369|83073298|FG001|Overall Study|Adverse Event|1|||
46857462|NCT00317369|83073299|FG002|Overall Study|Adverse Event|0|||
46857463|NCT00317369|83073297|FG000|Overall Study|Lack of Efficacy|0|||
46857464|NCT00317369|83073298|FG001|Overall Study|Lack of Efficacy|1|||
46857465|NCT00317369|83073299|FG002|Overall Study|Lack of Efficacy|1|||
46857466|NCT00317369|83073297|FG000|Overall Study|Withdrawal by Subject|0|||
46857467|NCT00317369|83073298|FG001|Overall Study|Withdrawal by Subject|0|||
46857468|NCT00317369|83073299|FG002|Overall Study|Withdrawal by Subject|1|||
46857469|NCT03325894|83073309|FG000|Overall Study|Adverse Event|2|||
46857470|NCT03325894|83073310|FG001|Overall Study|Adverse Event|3|||
46857471|NCT03325894|83073309|FG000|Overall Study|Protocol Violation|1|||
46857472|NCT03325894|83073310|FG001|Overall Study|Protocol Violation|2|||
46980340|NCT02443155|83226110|FG000|Overall Study|Pregnancy|3|||
46980341|NCT02443155|83226111|FG001|Overall Study|Pregnancy|1|||
46980342|NCT02443155|83226112|FG002|Overall Study|Pregnancy|1|||
46980343|NCT02443155|83226113|FG003|Overall Study|Pregnancy|2|||
46980344|NCT02443155|83226110|FG000|Overall Study|Lost to Follow-up|1|||
46980345|NCT02443155|83226111|FG001|Overall Study|Lost to Follow-up|2|||
46797751|NCT03837028|83016467|FG001|Overall Study|Lost to Follow-up|0|||
46797752|NCT03837028|83016468|FG002|Overall Study|Lost to Follow-up|2|||
46797753|NCT03837028|83016469|FG003|Overall Study|Lost to Follow-up|0|||
46797754|NCT03837028|83016466|FG000|Overall Study|Withdrawal by Subject|12|||
46980346|NCT02443155|83226112|FG002|Overall Study|Lost to Follow-up|0|||
46980347|NCT02443155|83226113|FG003|Overall Study|Lost to Follow-up|1|||
46679977|NCT02603887|82895750|FG000|Stage 2|FDA guidance|1|||
46679978|NCT02554279|82895756|FG000|Overall Study|Adverse Event|2|||
46980348|NCT02443155|83226110|FG000|Overall Study|Protocol Violation|1|||
46980349|NCT02443155|83226111|FG001|Overall Study|Protocol Violation|0|||
46980350|NCT02443155|83226112|FG002|Overall Study|Protocol Violation|1|||
46980351|NCT02443155|83226113|FG003|Overall Study|Protocol Violation|1|||
46980352|NCT02443155|83226110|FG000|Overall Study|Death|0|||
46980353|NCT02443155|83226111|FG001|Overall Study|Death|0|||
46980354|NCT02443155|83226112|FG002|Overall Study|Death|1|||
46980355|NCT02443155|83226113|FG003|Overall Study|Death|0|||
46980356|NCT02460159|83226126|FG000|Overall Study|Adverse Event|4|||
46980357|NCT02460159|83226127|FG001|Overall Study|Adverse Event|1|||
46980358|NCT02460159|83226126|FG000|Overall Study|Withdrawal by Subject|2|||
46980359|NCT02460159|83226127|FG001|Overall Study|Withdrawal by Subject|0|||
46679979|NCT02554279|82895757|FG001|Overall Study|Adverse Event|5|||
46797755|NCT03837028|83016467|FG001|Overall Study|Withdrawal by Subject|11|||
46797756|NCT03837028|83016468|FG002|Overall Study|Withdrawal by Subject|11|||
46980360|NCT02498067|83226133|FG000|Overall Study|Lost to Follow-up|22|||
46980361|NCT02498067|83226133|FG000|Overall Study|Did not meet inclusion criteria|11|||
46980362|NCT02497755|83226141|FG000|Overall Study|Protocol Violation|1|||
46980363|NCT02497755|83226142|FG001|Overall Study|Protocol Violation|0|||
46980364|NCT02619175|83226151|FG000|Overall Study|Withdrawal by Subject|1|||
46980365|NCT02619175|83226152|FG001|Overall Study|Withdrawal by Subject|0|||
46797757|NCT03837028|83016469|FG003|Overall Study|Withdrawal by Subject|7|||
46679980|NCT02554279|82895756|FG000|Overall Study|Lost to Follow-up|3|||
46679981|NCT02554279|82895757|FG001|Overall Study|Lost to Follow-up|2|||
46797758|NCT00115063|83016481|FG000|Overall Study|Lost to Follow-up|98|||
46679982|NCT02554279|82895756|FG000|Overall Study|Withdrawal by Subject|6|||
46679983|NCT02554279|82895757|FG001|Overall Study|Withdrawal by Subject|4|||
46797759|NCT00115063|83016482|FG001|Overall Study|Lost to Follow-up|104|||
46679984|NCT02554279|82895756|FG000|Overall Study|Protocol Violation|2|||
46980366|NCT02619175|83226151|FG000|Overall Study|foot pain|1|||
46980367|NCT02619175|83226152|FG001|Overall Study|foot pain|0|||
46980368|NCT01360021|83226169|FG000|Overall Study|Eligibility criteria + other|2|||
46980369|NCT01360021|83226170|FG001|Overall Study|Eligibility criteria + other|1|||
46980370|NCT01360021|83226171|FG002|Overall Study|Eligibility criteria + other|1|||
46980371|NCT01360021|83226169|FG000|Overall Study|Protocol Violation|0|||
46980372|NCT01360021|83226170|FG001|Overall Study|Protocol Violation|0|||
46980373|NCT01360021|83226171|FG002|Overall Study|Protocol Violation|1|||
46679985|NCT02554279|82895757|FG001|Overall Study|Protocol Violation|1|||
46679986|NCT02554279|82895756|FG000|Overall Study|Other reason|19|||
46679987|NCT02554279|82895757|FG001|Overall Study|Other reason|6|||
46679988|NCT02439450|82895785|FG000|Overall Study|Adverse Event|4|||
46679989|NCT02439450|82895786|FG001|Overall Study|Adverse Event|1|||
46679990|NCT02439450|82895787|FG002|Overall Study|Adverse Event|0|||
46679991|NCT02439450|82895788|FG003|Overall Study|Adverse Event|0|||
46679992|NCT02439450|82895785|FG000|Overall Study|Withdrawal by Subject|1|||
46679993|NCT02439450|82895786|FG001|Overall Study|Withdrawal by Subject|2|||
46679994|NCT02439450|82895787|FG002|Overall Study|Withdrawal by Subject|0|||
46679995|NCT02439450|82895788|FG003|Overall Study|Withdrawal by Subject|0|||
46679996|NCT02439450|82895785|FG000|Overall Study|Death|3|||
46679997|NCT02439450|82895786|FG001|Overall Study|Death|0|||
46679998|NCT02439450|82895787|FG002|Overall Study|Death|0|||
46679999|NCT02439450|82895788|FG003|Overall Study|Death|1|||
46680000|NCT02439450|82895785|FG000|Overall Study|Progressive Disease|18|||
46680001|NCT02439450|82895786|FG001|Overall Study|Progressive Disease|41|||
46680002|NCT02439450|82895787|FG002|Overall Study|Progressive Disease|2|||
46680003|NCT02439450|82895788|FG003|Overall Study|Progressive Disease|3|||
46680004|NCT02312258|82895809|FG000|Overall Study|Lost to Follow-up|8|||
46680005|NCT02312258|82895810|FG001|Overall Study|Lost to Follow-up|8|||
46680006|NCT02312258|82895809|FG000|Overall Study|Withdrawal by Patient|49|||
46680007|NCT02312258|82895810|FG001|Overall Study|Withdrawal by Patient|76|||
46797760|NCT00115063|83016481|FG000|Overall Study|Death|1|||
46797761|NCT00115063|83016482|FG001|Overall Study|Death|0|||
46797762|NCT00461500|83016490|FG000|Overall Study|Adverse Event|1|||
46797763|NCT00461500|83016491|FG001|Overall Study|Adverse Event|0|||
46797764|NCT00461500|83016490|FG000|Overall Study|Lack of Efficacy|0|||
46680008|NCT02312258|82895809|FG000|Overall Study|Reason not Specified|107|||
46680009|NCT02312258|82895810|FG001|Overall Study|Reason not Specified|159|||
46857473|NCT03325894|83073309|FG000|Overall Study|Withdrawal by Subject|10|||
46680010|NCT02312258|82895809|FG000|Overall Study|Missing|2|||
46680011|NCT02312258|82895810|FG001|Overall Study|Missing|1|||
46797765|NCT00461500|83016491|FG001|Overall Study|Lack of Efficacy|1|||
46797766|NCT00461500|83016490|FG000|Overall Study|Expired Drug Treatment|1|||
46797767|NCT00461500|83016491|FG001|Overall Study|Expired Drug Treatment|1|||
46797768|NCT00461500|83016490|FG000|Overall Study|Study Stopped|1|||
46797769|NCT00461500|83016491|FG001|Overall Study|Study Stopped|2|||
46797770|NCT00461500|83016490|FG000|Overall Study|Drug Treatment Misuse|1|||
46680012|NCT02312258|82895809|FG000|Overall Study|Death|115|||
46680013|NCT02312258|82895810|FG001|Overall Study|Death|181|||
46680014|NCT02049515|82895847|FG000|Overall Study|Adverse Event|46|||
46680015|NCT02049515|82895848|FG001|Overall Study|Adverse Event|2|||
46680016|NCT02049515|82895847|FG000|Overall Study|Protocol-specified Disease Progression|23|||
46680017|NCT02049515|82895848|FG001|Overall Study|Protocol-specified Disease Progression|2|||
46797771|NCT00461500|83016491|FG001|Overall Study|Drug Treatment Misuse|0|||
46797772|NCT00461500|83016490|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
46680018|NCT02049515|82895847|FG000|Overall Study|Death|6|||
46797773|NCT00461500|83016491|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
46980374|NCT01360021|83226169|FG000|Overall Study|Withdrawal by Subject|4|||
46980375|NCT01360021|83226170|FG001|Overall Study|Withdrawal by Subject|0|||
46980376|NCT01360021|83226171|FG002|Overall Study|Withdrawal by Subject|2|||
46980377|NCT01360021|83226169|FG000|Overall Study|Adverse Event|2|||
46980378|NCT01360021|83226170|FG001|Overall Study|Adverse Event|3|||
46980379|NCT01360021|83226171|FG002|Overall Study|Adverse Event|3|||
46980380|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
46980381|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
46980382|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
46680019|NCT02049515|82895848|FG001|Overall Study|Death|0|||
46980383|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
46680020|NCT02049515|82895847|FG000|Overall Study|Physician Decision|5|||
46980384|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Other|13|||
46980385|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
46980386|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
46980387|NCT02497287|83226188|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
46980388|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
46980389|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
46980390|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
46980391|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
46980392|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
46980393|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
46680021|NCT02049515|82895848|FG001|Overall Study|Physician Decision|1|||
46680022|NCT02049515|82895847|FG000|Overall Study|Withdrawal by Subject|3|||
46680023|NCT02049515|82895848|FG001|Overall Study|Withdrawal by Subject|0|||
46680024|NCT02049515|82895847|FG000|Overall Study|Termination of the Study by Sponsor|2|||
46680025|NCT02049515|82895848|FG001|Overall Study|Termination of the Study by Sponsor|0|||
46680026|NCT02049515|82895847|FG000|Overall Study|Protocol Violation|1|||
46680027|NCT02049515|82895848|FG001|Overall Study|Protocol Violation|1|||
46680028|NCT02049515|82895847|FG000|Overall Study|Clinical Deterioration|1|||
46680029|NCT02049515|82895848|FG001|Overall Study|Clinical Deterioration|0|||
46680030|NCT02049515|82895847|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
46680031|NCT02049515|82895848|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
46680032|NCT02049515|82895847|FG000|Overall Study|Treatment Interruption >42 Days|1|||
46680033|NCT02049515|82895848|FG001|Overall Study|Treatment Interruption >42 Days|0|||
46680034|NCT02049515|82895847|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
46680035|NCT02049515|82895848|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
46680036|NCT02039401|82895856|FG000|Overall Study|Adverse Event|0|||
46680037|NCT02039401|82895857|FG001|Overall Study|Adverse Event|1|||
46680038|NCT02004522|82895866|FG000|Overall Study|Adverse Event|55|||
46680039|NCT02004522|82895867|FG001|Overall Study|Adverse Event|6|||
46680040|NCT02004522|82895866|FG000|Overall Study|Withdrawal by Subject|13|||
46680041|NCT02004522|82895867|FG001|Overall Study|Withdrawal by Subject|7|||
46680042|NCT02004522|82895866|FG000|Overall Study|Death|12|||
46680043|NCT02004522|82895867|FG001|Overall Study|Death|3|||
46680044|NCT02004522|82895866|FG000|Overall Study|Physician Decision|3|||
46680045|NCT02004522|82895867|FG001|Overall Study|Physician Decision|4|||
46680046|NCT02004522|82895866|FG000|Overall Study|Protocol Violation|1|||
46680047|NCT02004522|82895867|FG001|Overall Study|Protocol Violation|0|||
46680048|NCT02004522|82895866|FG000|Overall Study|Other is reason listed by PI|4|||
46680049|NCT02004522|82895867|FG001|Overall Study|Other is reason listed by PI|1|||
46680050|NCT02004522|82895866|FG000|Overall Study|Never Dosed|2|||
46680051|NCT02004522|82895867|FG001|Overall Study|Never Dosed|4|||
46680052|NCT02004522|82895866|FG000|Overall Study|Disease Progression|35|||
46680053|NCT02004522|82895867|FG001|Overall Study|Disease Progression|31|||
46680054|NCT02004522|82895866|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
46680055|NCT02004522|82895867|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
46680056|NCT01932697|82895875|FG000|Overall Study|Received a different amount of tx|1|||
46707718|NCT01192295|82923242|FG000|Overall Study|Adverse Event|3|||
46797774|NCT00461500|83016490|FG000|Overall Study|Lost to Follow-up|2|||
46797775|NCT00461500|83016491|FG001|Overall Study|Lost to Follow-up|2|||
46797776|NCT00167245|83016499|FG000|Overall Study|Lost to Follow-up|20|||
46797777|NCT00167245|83016500|FG001|Overall Study|Lost to Follow-up|31|||
46797778|NCT00167245|83016499|FG000|Overall Study|Withdrawal by Subject|5|||
46797779|NCT00167245|83016500|FG001|Overall Study|Withdrawal by Subject|8|||
46980394|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
46980395|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
46980396|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
46980397|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
46980398|NCT02497287|83226188|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
46797780|NCT00167245|83016499|FG000|Overall Study|Incarcerated|3|||
46797781|NCT00167245|83016500|FG001|Overall Study|Incarcerated|2|||
46797782|NCT00167245|83016499|FG000|Overall Study|Drowsy|1|||
46797783|NCT00167245|83016500|FG001|Overall Study|Drowsy|0|||
46680057|NCT01932697|82895876|FG001|Overall Study|Received a different amount of tx|0|||
46680058|NCT01932697|82895875|FG000|Overall Study|Ineligible|1|||
46980399|NCT02497287|83226188|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
46980400|NCT02497287|83226188|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
46980401|NCT02497287|83226188|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
46980402|NCT02497287|83226188|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
46980403|NCT02497287|83226188|FG000|Follow-up Phase (4 Week)|Other|1|||
46980404|NCT02458287|83226198|FG000|Overall Study|Adverse Event|0|||
46980405|NCT02458287|83226199|FG001|Overall Study|Adverse Event|0|||
46980406|NCT02458287|83226200|FG002|Overall Study|Adverse Event|0|||
46980407|NCT02458287|83226201|FG003|Overall Study|Adverse Event|1|||
46980408|NCT02458287|83226198|FG000|Overall Study|Lost to Follow-up|0|||
46797784|NCT00443560|83016511|FG000|Overall Study|No intrathecal dose|58|||
46797785|NCT00443560|83016512|FG001|Overall Study|No intrathecal dose|26|||
46797786|NCT00443560|83016511|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
46797787|NCT00443560|83016512|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
46797788|NCT00451204|83016520|FG000|Overall Study|Adverse Event|4|||
46797789|NCT00451204|83016521|FG001|Overall Study|Adverse Event|6|||
46797790|NCT00451204|83016520|FG000|Overall Study|Lack of Efficacy|4|||
46797791|NCT00451204|83016521|FG001|Overall Study|Lack of Efficacy|4|||
46680059|NCT01932697|82895876|FG001|Overall Study|Ineligible|0|||
46680060|NCT01739309|82895922|FG000|Overall Study|Adverse Event|1|||
46797792|NCT00451204|83016520|FG000|Overall Study|Lost to Follow-up|4|||
46797793|NCT00451204|83016521|FG001|Overall Study|Lost to Follow-up|4|||
46680061|NCT01739309|82895922|FG000|Overall Study|Withdrawal by Subject|1|||
46797794|NCT00451204|83016520|FG000|Overall Study|Protocol Violation|1|||
46797795|NCT00451204|83016521|FG001|Overall Study|Protocol Violation|0|||
46797796|NCT00451204|83016520|FG000|Overall Study|Patient refusal|8|||
46797797|NCT00451204|83016521|FG001|Overall Study|Patient refusal|4|||
46797798|NCT00451204|83016520|FG000|Overall Study|Other|1|||
46797799|NCT00451204|83016521|FG001|Overall Study|Other|2|||
46797800|NCT00605540|83016530|FG000|Overall Study|Death|15|||
46797801|NCT00605540|83016530|FG000|Overall Study|Lost to Follow-up|23|||
46797802|NCT00605306|83016536|FG000|Overall Study|Adverse Event|0|||
46797803|NCT00605306|83016537|FG001|Overall Study|Adverse Event|1|||
46797804|NCT00607022|83016546|FG000|Overall Study|Withdrawal by Subject|1|||
46797805|NCT00607022|83016547|FG001|Overall Study|Withdrawal by Subject|0|||
46797806|NCT00607022|83016548|FG002|Overall Study|Withdrawal by Subject|0|||
46797807|NCT00606632|83016556|FG000|Overall Study|Withdrawal by Subject|13|||
46797808|NCT00606632|83016556|FG000|Overall Study|Miscellaneous reasons|9|||
46797809|NCT00450814|83016575|FG000|Overall Study|Failed to complete the initial therapy|0|||
46980409|NCT02458287|83226199|FG001|Overall Study|Lost to Follow-up|1|||
46797810|NCT00450814|83016576|FG001|Overall Study|Failed to complete the initial therapy|0|||
46980410|NCT02458287|83226200|FG002|Overall Study|Lost to Follow-up|1|||
46980411|NCT02458287|83226201|FG003|Overall Study|Lost to Follow-up|0|||
46797811|NCT00450814|83016577|FG002|Overall Study|Failed to complete the initial therapy|0|||
46797812|NCT00450814|83016578|FG003|Overall Study|Failed to complete the initial therapy|1|||
46797813|NCT00450814|83016579|FG004|Overall Study|Failed to complete the initial therapy|1|||
46797814|NCT00450814|83016580|FG005|Overall Study|Failed to complete the initial therapy|1|||
46797815|NCT00450814|83016581|FG006|Overall Study|Failed to complete the initial therapy|0|||
46797816|NCT00450814|83016582|FG007|Overall Study|Failed to complete the initial therapy|0|||
46797817|NCT00450814|83016583|FG008|Overall Study|Failed to complete the initial therapy|0|||
46797818|NCT00450814|83016584|FG009|Overall Study|Failed to complete the initial therapy|0|||
46797819|NCT00450814|83016585|FG010|Overall Study|Failed to complete the initial therapy|0|||
46797820|NCT00450814|83016575|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
46797821|NCT00450814|83016576|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
46797822|NCT00450814|83016577|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
46797823|NCT00450814|83016578|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
46797824|NCT00450814|83016579|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
46797825|NCT00450814|83016580|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
46797826|NCT00450814|83016581|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
46797827|NCT00450814|83016582|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
46797828|NCT00450814|83016583|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
46797829|NCT00450814|83016584|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
46797830|NCT00450814|83016585|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
46797831|NCT00518115|83016620|FG000|Overall Study|Adverse Event|6|||
46797832|NCT00518115|83016621|FG001|Overall Study|Adverse Event|1|||
46797833|NCT00518115|83016622|FG002|Overall Study|Adverse Event|5|||
46797834|NCT00518115|83016623|FG003|Overall Study|Adverse Event|6|||
46797835|NCT00518115|83016624|FG004|Overall Study|Adverse Event|5|||
46797836|NCT00518115|83016625|FG005|Overall Study|Adverse Event|5|||
46797837|NCT00518115|83016626|FG006|Overall Study|Adverse Event|5|||
46797838|NCT00518115|83016627|FG007|Overall Study|Adverse Event|10|||
46797839|NCT00518115|83016628|FG008|Overall Study|Adverse Event|2|||
46797840|NCT00518115|83016629|FG009|Overall Study|Adverse Event|9|||
46797841|NCT00518115|83016620|FG000|Overall Study|Lost to Follow-up|0|||
46797842|NCT00518115|83016621|FG001|Overall Study|Lost to Follow-up|0|||
46797843|NCT00518115|83016622|FG002|Overall Study|Lost to Follow-up|2|||
46680062|NCT01659658|82895933|FG000|Overall Study|Withdrawal by Patient|18|||
46797844|NCT00518115|83016623|FG003|Overall Study|Lost to Follow-up|3|||
46797845|NCT00518115|83016624|FG004|Overall Study|Lost to Follow-up|1|||
46797846|NCT00518115|83016625|FG005|Overall Study|Lost to Follow-up|3|||
46797847|NCT00518115|83016626|FG006|Overall Study|Lost to Follow-up|0|||
46797848|NCT00518115|83016627|FG007|Overall Study|Lost to Follow-up|1|||
46797849|NCT00518115|83016628|FG008|Overall Study|Lost to Follow-up|1|||
46797850|NCT00518115|83016629|FG009|Overall Study|Lost to Follow-up|1|||
46797851|NCT00518115|83016620|FG000|Overall Study|Protocol Violation|1|||
46797852|NCT00518115|83016621|FG001|Overall Study|Protocol Violation|3|||
46797853|NCT00518115|83016622|FG002|Overall Study|Protocol Violation|1|||
46797854|NCT00518115|83016623|FG003|Overall Study|Protocol Violation|0|||
46797855|NCT00518115|83016624|FG004|Overall Study|Protocol Violation|0|||
46797856|NCT00518115|83016625|FG005|Overall Study|Protocol Violation|0|||
46797857|NCT00518115|83016626|FG006|Overall Study|Protocol Violation|0|||
46797858|NCT00518115|83016627|FG007|Overall Study|Protocol Violation|0|||
46797859|NCT00518115|83016628|FG008|Overall Study|Protocol Violation|0|||
46797860|NCT00518115|83016629|FG009|Overall Study|Protocol Violation|0|||
46797861|NCT00518115|83016620|FG000|Overall Study|Withdrawal by Subject|1|||
46797862|NCT00518115|83016621|FG001|Overall Study|Withdrawal by Subject|1|||
46797863|NCT00518115|83016622|FG002|Overall Study|Withdrawal by Subject|5|||
46797864|NCT00518115|83016623|FG003|Overall Study|Withdrawal by Subject|0|||
46797865|NCT00518115|83016624|FG004|Overall Study|Withdrawal by Subject|2|||
46797866|NCT00518115|83016625|FG005|Overall Study|Withdrawal by Subject|1|||
46797867|NCT00518115|83016626|FG006|Overall Study|Withdrawal by Subject|0|||
46980412|NCT02458287|83226198|FG000|Overall Study|Protocol Violation|0|||
46980413|NCT02458287|83226199|FG001|Overall Study|Protocol Violation|1|||
46980414|NCT02458287|83226200|FG002|Overall Study|Protocol Violation|0|||
46980415|NCT02458287|83226201|FG003|Overall Study|Protocol Violation|0|||
46980416|NCT02458287|83226198|FG000|Overall Study|Withdrawal by Subject|0|||
46980417|NCT02458287|83226199|FG001|Overall Study|Withdrawal by Subject|2|||
46980418|NCT02458287|83226200|FG002|Overall Study|Withdrawal by Subject|2|||
46980419|NCT02458287|83226201|FG003|Overall Study|Withdrawal by Subject|1|||
46980420|NCT02458287|83226198|FG000|Overall Study|Relocated Out of State|0|||
46980421|NCT02458287|83226199|FG001|Overall Study|Relocated Out of State|0|||
46980422|NCT02458287|83226200|FG002|Overall Study|Relocated Out of State|0|||
46980423|NCT02458287|83226201|FG003|Overall Study|Relocated Out of State|1|||
46980424|NCT02441517|83226217|FG000|Overall Study|Lost to Follow-up|1|||
46980425|NCT02441517|83226217|FG000|Overall Study|Withdrawal by Subject|2|||
46980426|NCT02441517|83226217|FG000|Overall Study|Study Terminated by Sponsor|1|||
46980427|NCT02457819|83226221|FG000|Overall Study|reason not given|8|||
46980428|NCT02457819|83226221|FG000|Overall Study|Withdrawal by Subject|24|||
46980429|NCT02457819|83226221|FG000|Overall Study|Protocol Violation|1|||
46980430|NCT02457819|83226221|FG000|Overall Study|non compliance with study drug|4|||
46980431|NCT02457819|83226221|FG000|Overall Study|Lost to Follow-up|10|||
46980432|NCT02457819|83226221|FG000|Overall Study|Lack of Efficacy|19|||
46980433|NCT02457819|83226221|FG000|Overall Study|Adverse Event|33|||
46980434|NCT02496039|83226225|FG000|Overall Study|Adverse Event|3|||
46980435|NCT02496039|83226225|FG000|Overall Study|Protocol Violation|1|||
46980436|NCT02441283|83226229|FG000|Overall Study|Withdrew consent|15|||
46797868|NCT00518115|83016627|FG007|Overall Study|Withdrawal by Subject|2|||
46797869|NCT00518115|83016628|FG008|Overall Study|Withdrawal by Subject|1|||
46797870|NCT00518115|83016629|FG009|Overall Study|Withdrawal by Subject|3|||
46797871|NCT00518115|83016620|FG000|Overall Study|Lack of Efficacy|1|||
46797872|NCT00518115|83016621|FG001|Overall Study|Lack of Efficacy|0|||
46980437|NCT02441283|83226229|FG000|Overall Study|Lost to Follow-up|42|||
46980438|NCT02441283|83226229|FG000|Overall Study|Death|1|||
46980439|NCT02441283|83226229|FG000|Overall Study|Other, not specified|32|||
46980440|NCT02495883|83226235|FG000|Overall Study|Excessive head motion|1|||
46797873|NCT00518115|83016622|FG002|Overall Study|Lack of Efficacy|1|||
46797874|NCT00518115|83016623|FG003|Overall Study|Lack of Efficacy|1|||
46797875|NCT00518115|83016624|FG004|Overall Study|Lack of Efficacy|0|||
46797876|NCT00518115|83016625|FG005|Overall Study|Lack of Efficacy|0|||
46797877|NCT00518115|83016626|FG006|Overall Study|Lack of Efficacy|0|||
46797878|NCT00518115|83016627|FG007|Overall Study|Lack of Efficacy|1|||
46797879|NCT00518115|83016628|FG008|Overall Study|Lack of Efficacy|0|||
46797880|NCT00518115|83016629|FG009|Overall Study|Lack of Efficacy|0|||
46797881|NCT00518115|83016620|FG000|Overall Study|Non-Compliance|1|||
46797882|NCT00518115|83016621|FG001|Overall Study|Non-Compliance|0|||
46797883|NCT00518115|83016622|FG002|Overall Study|Non-Compliance|1|||
46797884|NCT00518115|83016623|FG003|Overall Study|Non-Compliance|0|||
46797885|NCT00518115|83016624|FG004|Overall Study|Non-Compliance|1|||
46797886|NCT00518115|83016625|FG005|Overall Study|Non-Compliance|1|||
46797887|NCT00518115|83016626|FG006|Overall Study|Non-Compliance|1|||
46797888|NCT00518115|83016627|FG007|Overall Study|Non-Compliance|1|||
46797889|NCT00518115|83016628|FG008|Overall Study|Non-Compliance|0|||
46797890|NCT00518115|83016629|FG009|Overall Study|Non-Compliance|1|||
46797891|NCT00518115|83016620|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
46797892|NCT00518115|83016621|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
46797893|NCT00518115|83016622|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797894|NCT00518115|83016623|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797895|NCT00518115|83016624|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797896|NCT00518115|83016625|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
46797897|NCT00518115|83016626|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797898|NCT00518115|83016627|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797899|NCT00518115|83016628|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797900|NCT00518115|83016629|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
46797901|NCT00518115|83016620|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
46797902|NCT00518115|83016621|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797903|NCT00518115|83016622|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797904|NCT00518115|83016623|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797905|NCT00518115|83016624|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797906|NCT00518115|83016625|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797907|NCT00518115|83016626|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797908|NCT00518115|83016627|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797909|NCT00518115|83016628|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797910|NCT00518115|83016629|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
46797911|NCT00518115|83016620|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797912|NCT00518115|83016621|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797913|NCT00518115|83016622|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
46797914|NCT00518115|83016623|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797915|NCT00518115|83016624|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797916|NCT00518115|83016625|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797917|NCT00518115|83016626|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797918|NCT00518115|83016627|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797919|NCT00518115|83016628|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
46797920|NCT00518115|83016629|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
46797921|NCT00518115|83016620|FG000|Overall Study|Wrong Monotherapy Administered|0|||
46797922|NCT00518115|83016621|FG001|Overall Study|Wrong Monotherapy Administered|0|||
46797923|NCT00518115|83016622|FG002|Overall Study|Wrong Monotherapy Administered|1|||
46797924|NCT00518115|83016623|FG003|Overall Study|Wrong Monotherapy Administered|0|||
46797925|NCT00518115|83016624|FG004|Overall Study|Wrong Monotherapy Administered|0|||
46797926|NCT00518115|83016625|FG005|Overall Study|Wrong Monotherapy Administered|0|||
46797927|NCT00518115|83016626|FG006|Overall Study|Wrong Monotherapy Administered|1|||
46797928|NCT00518115|83016627|FG007|Overall Study|Wrong Monotherapy Administered|0|||
46797929|NCT00518115|83016628|FG008|Overall Study|Wrong Monotherapy Administered|0|||
46797930|NCT00518115|83016629|FG009|Overall Study|Wrong Monotherapy Administered|0|||
46797931|NCT00518115|83016620|FG000|Overall Study|Violation of Exclusion Criteria|0|||
46797932|NCT00518115|83016621|FG001|Overall Study|Violation of Exclusion Criteria|0|||
46857474|NCT03325894|83073310|FG001|Overall Study|Withdrawal by Subject|6|||
46857475|NCT03325894|83073309|FG000|Overall Study|Lost to Follow-up|4|||
46857476|NCT03325894|83073310|FG001|Overall Study|Lost to Follow-up|9|||
46857477|NCT03325894|83073309|FG000|Overall Study|Lack of Efficacy|8|||
46857478|NCT03325894|83073310|FG001|Overall Study|Lack of Efficacy|14|||
46857479|NCT03325894|83073309|FG000|Overall Study|Study Terminated by Sponsor|38|||
46857480|NCT03325894|83073310|FG001|Overall Study|Study Terminated by Sponsor|43|||
46857481|NCT03325894|83073309|FG000|Overall Study|Other (Not received Treatment)|1|||
46857482|NCT03325894|83073310|FG001|Overall Study|Other (Not received Treatment)|0|||
46857483|NCT01239368|83073329|FG000|Overall Study|Principal investigator discretion|1|||
46857484|NCT01239368|83073330|FG001|Overall Study|Principal investigator discretion|0|||
46857485|NCT01239368|83073331|FG002|Overall Study|Principal investigator discretion|0|||
46857486|NCT01239368|83073332|FG003|Overall Study|Principal investigator discretion|0|||
46857487|NCT01239368|83073333|FG004|Overall Study|Principal investigator discretion|1|||
46857488|NCT01239368|83073334|FG005|Overall Study|Principal investigator discretion|2|||
46857489|NCT01239368|83073335|FG006|Overall Study|Principal investigator discretion|0|||
46857490|NCT01239368|83073336|FG007|Overall Study|Principal investigator discretion|0|||
46980441|NCT02495883|83226236|FG001|Overall Study|Excessive head motion|0|||
46857491|NCT01239368|83073337|FG008|Overall Study|Principal investigator discretion|0|||
46857492|NCT01239368|83073338|FG009|Overall Study|Principal investigator discretion|1|||
46857493|NCT01239368|83073329|FG000|Overall Study|Disease progression on study|1|||
46857494|NCT01239368|83073330|FG001|Overall Study|Disease progression on study|1|||
46857495|NCT01239368|83073331|FG002|Overall Study|Disease progression on study|1|||
46857496|NCT01239368|83073332|FG003|Overall Study|Disease progression on study|1|||
46857497|NCT01239368|83073333|FG004|Overall Study|Disease progression on study|4|||
46857498|NCT01239368|83073334|FG005|Overall Study|Disease progression on study|2|||
46857499|NCT01239368|83073335|FG006|Overall Study|Disease progression on study|5|||
46857500|NCT01239368|83073336|FG007|Overall Study|Disease progression on study|0|||
46857501|NCT01239368|83073337|FG008|Overall Study|Disease progression on study|0|||
46857502|NCT01239368|83073338|FG009|Overall Study|Disease progression on study|2|||
46857503|NCT01239368|83073329|FG000|Overall Study|Refused further treatment|0|||
46857504|NCT01239368|83073330|FG001|Overall Study|Refused further treatment|0|||
46857505|NCT01239368|83073331|FG002|Overall Study|Refused further treatment|0|||
46857506|NCT01239368|83073332|FG003|Overall Study|Refused further treatment|0|||
46980442|NCT02495025|83226243|FG000|Overall Study|Lost to Follow-up|21|||
46857507|NCT01239368|83073333|FG004|Overall Study|Refused further treatment|0|||
46857508|NCT01239368|83073334|FG005|Overall Study|Refused further treatment|0|||
46857509|NCT01239368|83073335|FG006|Overall Study|Refused further treatment|0|||
46857510|NCT01239368|83073336|FG007|Overall Study|Refused further treatment|0|||
46857511|NCT01239368|83073337|FG008|Overall Study|Refused further treatment|0|||
46857512|NCT01239368|83073338|FG009|Overall Study|Refused further treatment|1|||
46857513|NCT01239368|83073329|FG000|Overall Study|Death|0|||
46857514|NCT01239368|83073330|FG001|Overall Study|Death|0|||
46857515|NCT01239368|83073331|FG002|Overall Study|Death|0|||
46857516|NCT01239368|83073332|FG003|Overall Study|Death|0|||
46857517|NCT01239368|83073333|FG004|Overall Study|Death|0|||
46857518|NCT01239368|83073334|FG005|Overall Study|Death|0|||
46797933|NCT00518115|83016622|FG002|Overall Study|Violation of Exclusion Criteria|0|||
46797934|NCT00518115|83016623|FG003|Overall Study|Violation of Exclusion Criteria|1|||
46797935|NCT00518115|83016624|FG004|Overall Study|Violation of Exclusion Criteria|0|||
46797936|NCT00518115|83016625|FG005|Overall Study|Violation of Exclusion Criteria|0|||
46857519|NCT01239368|83073335|FG006|Overall Study|Death|1|||
46857520|NCT01239368|83073336|FG007|Overall Study|Death|0|||
46857521|NCT01239368|83073337|FG008|Overall Study|Death|0|||
46857522|NCT01239368|83073338|FG009|Overall Study|Death|0|||
46980443|NCT02495025|83226244|FG001|Overall Study|Lost to Follow-up|14|||
46980444|NCT02495025|83226243|FG000|Overall Study|Withdrawal by Subject|5|||
46980445|NCT02495025|83226244|FG001|Overall Study|Withdrawal by Subject|0|||
46980446|NCT02439957|83226252|FG000|Overall Study|Study Terminated|3|||
46980447|NCT02439957|83226253|FG001|Overall Study|Study Terminated|3|||
46980448|NCT02494401|83226261|FG000|Overall Study|Lost to Follow-up|22|||
46980449|NCT02494401|83226262|FG001|Overall Study|Lost to Follow-up|25|||
46980450|NCT02494401|83226261|FG000|Overall Study|Withdrawal by Subject|3|||
46797937|NCT00518115|83016626|FG006|Overall Study|Violation of Exclusion Criteria|1|||
46797938|NCT00518115|83016627|FG007|Overall Study|Violation of Exclusion Criteria|0|||
46980451|NCT02494401|83226262|FG001|Overall Study|Withdrawal by Subject|2|||
46980452|NCT02457195|83226268|FG000|Overall Study|Adverse Event|3|||
46980453|NCT02457195|83226268|FG000|Overall Study|Protocol Violation|2|||
46980454|NCT02457195|83226268|FG000|Overall Study|Withdrawal by Subject|4|||
46680063|NCT01659658|82895934|FG001|Overall Study|Withdrawal by Patient|4|||
46680064|NCT01659658|82895935|FG002|Overall Study|Withdrawal by Patient|2|||
46680065|NCT01659658|82895936|FG003|Overall Study|Withdrawal by Patient|0|||
46680066|NCT01659658|82895937|FG004|Overall Study|Withdrawal by Patient|11|||
46680067|NCT01659658|82895933|FG000|Overall Study|Study Terminated by Sponsor|9|||
46680068|NCT01659658|82895934|FG001|Overall Study|Study Terminated by Sponsor|7|||
46680069|NCT01659658|82895935|FG002|Overall Study|Study Terminated by Sponsor|0|||
46680070|NCT01659658|82895936|FG003|Overall Study|Study Terminated by Sponsor|1|||
46680071|NCT01659658|82895937|FG004|Overall Study|Study Terminated by Sponsor|4|||
46797939|NCT00518115|83016628|FG008|Overall Study|Violation of Exclusion Criteria|0|||
46797940|NCT00518115|83016629|FG009|Overall Study|Violation of Exclusion Criteria|0|||
46797941|NCT00518115|83016620|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
46980455|NCT02456727|83226274|FG000|Overall Study|Lost to Follow-up|63|||
46680072|NCT01659658|82895933|FG000|Overall Study|Reason not Specified|61|||
46680073|NCT01659658|82895934|FG001|Overall Study|Reason not Specified|15|||
46980456|NCT02456727|83226275|FG001|Overall Study|Lost to Follow-up|65|||
46857523|NCT00369161|83073386|FG000|Overall Study|Adverse Event|15|||
46857524|NCT00369161|83073387|FG001|Overall Study|Adverse Event|13|||
46857525|NCT00369161|83073386|FG000|Overall Study|Abnormal laboratory value|0|||
46680074|NCT01659658|82895935|FG002|Overall Study|Reason not Specified|8|||
46857526|NCT00369161|83073387|FG001|Overall Study|Abnormal laboratory value|1|||
46980457|NCT02456727|83226274|FG000|Overall Study|Death|2|||
46980458|NCT02456727|83226275|FG001|Overall Study|Death|1|||
46680075|NCT01659658|82895936|FG003|Overall Study|Reason not Specified|1|||
46857527|NCT00369161|83073386|FG000|Overall Study|Lack of Efficacy|3|||
46857528|NCT00369161|83073387|FG001|Overall Study|Lack of Efficacy|1|||
46857529|NCT00369161|83073386|FG000|Overall Study|Protocol Violation|0|||
46857530|NCT00369161|83073387|FG001|Overall Study|Protocol Violation|2|||
46857531|NCT00369161|83073386|FG000|Overall Study|Withdrawal by Subject|2|||
46857532|NCT00369161|83073387|FG001|Overall Study|Withdrawal by Subject|3|||
46680076|NCT01659658|82895937|FG004|Overall Study|Reason not Specified|34|||
46680077|NCT01659658|82895933|FG000|Overall Study|Lost to Follow-up|2|||
46680078|NCT01659658|82895934|FG001|Overall Study|Lost to Follow-up|0|||
46680079|NCT01659658|82895935|FG002|Overall Study|Lost to Follow-up|0|||
46797942|NCT00518115|83016621|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
46797943|NCT00518115|83016622|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
46797944|NCT00518115|83016623|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
46797945|NCT00518115|83016624|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
46797946|NCT00518115|83016625|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
46797947|NCT00518115|83016626|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
46797948|NCT00518115|83016627|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
46797949|NCT00518115|83016628|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
46797950|NCT00518115|83016629|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
46797951|NCT00518115|83016620|FG000|Overall Study|Withdrew Consent|0|||
46797952|NCT00518115|83016621|FG001|Overall Study|Withdrew Consent|0|||
46797953|NCT00518115|83016622|FG002|Overall Study|Withdrew Consent|0|||
46797954|NCT00518115|83016623|FG003|Overall Study|Withdrew Consent|0|||
46797955|NCT00518115|83016624|FG004|Overall Study|Withdrew Consent|0|||
46797956|NCT00518115|83016625|FG005|Overall Study|Withdrew Consent|1|||
46797957|NCT00518115|83016626|FG006|Overall Study|Withdrew Consent|0|||
46797958|NCT00518115|83016627|FG007|Overall Study|Withdrew Consent|0|||
46797959|NCT00518115|83016628|FG008|Overall Study|Withdrew Consent|0|||
46797960|NCT00518115|83016629|FG009|Overall Study|Withdrew Consent|0|||
46797961|NCT00518115|83016620|FG000|Overall Study|Moved Out of State|0|||
46797962|NCT00518115|83016621|FG001|Overall Study|Moved Out of State|0|||
46797963|NCT00518115|83016622|FG002|Overall Study|Moved Out of State|0|||
46797964|NCT00518115|83016623|FG003|Overall Study|Moved Out of State|0|||
46857533|NCT00369161|83073386|FG000|Overall Study|Death|1|||
46797965|NCT00518115|83016624|FG004|Overall Study|Moved Out of State|0|||
46797966|NCT00518115|83016625|FG005|Overall Study|Moved Out of State|0|||
46797967|NCT00518115|83016626|FG006|Overall Study|Moved Out of State|0|||
46797968|NCT00518115|83016627|FG007|Overall Study|Moved Out of State|0|||
46797969|NCT00518115|83016628|FG008|Overall Study|Moved Out of State|0|||
46797970|NCT00518115|83016629|FG009|Overall Study|Moved Out of State|1|||
46797971|NCT00450658|83016654|FG000|Overall Study|Adverse Event|24|||
46797972|NCT00450658|83016655|FG001|Overall Study|Adverse Event|15|||
46797973|NCT00450658|83016654|FG000|Overall Study|Withdrawal by Subject|43|||
46797974|NCT00450658|83016655|FG001|Overall Study|Withdrawal by Subject|26|||
46797975|NCT00450658|83016654|FG000|Overall Study|Lost to Follow-up|22|||
46797976|NCT00450658|83016655|FG001|Overall Study|Lost to Follow-up|5|||
46797977|NCT00450658|83016654|FG000|Overall Study|UGI ulcer|33|||
46797978|NCT00450658|83016655|FG001|Overall Study|UGI ulcer|34|||
46797979|NCT00450658|83016654|FG000|Overall Study|misc|21|||
46797980|NCT00450658|83016655|FG001|Overall Study|misc|10|||
46797981|NCT00517881|83016661|FG000|Overall Study|Protocol Violation|2|||
46797982|NCT00517881|83016661|FG000|Overall Study|Adverse Event|1|||
46797983|NCT00517881|83016661|FG000|Overall Study|Renal transplantation|2|||
46797984|NCT00517413|83016682|FG000|Overall Study|Adverse Event|7|||
46797985|NCT00517413|83016682|FG000|Overall Study|Death|13|||
46797986|NCT00517413|83016682|FG000|Overall Study|Protocol Violation|15|||
46797987|NCT00517413|83016682|FG000|Overall Study|Withdrawal by Subject|2|||
46797988|NCT00517413|83016682|FG000|Overall Study|Failure to return|1|||
46797989|NCT00517413|83016682|FG000|Overall Study|Other-Reasons|23|||
46797990|NCT00604214|83016696|FG000|Baseline to Day 28|Death|223|||
46797991|NCT00604214|83016697|FG001|Baseline to Day 28|Death|202|||
46980459|NCT02456727|83226274|FG000|Overall Study|Withdrawal by Subject|1|||
46980460|NCT02456727|83226275|FG001|Overall Study|Withdrawal by Subject|10|||
46797992|NCT00604214|83016696|FG000|Baseline to Day 28|Lost to Follow-up|2|||
46797993|NCT00604214|83016697|FG001|Baseline to Day 28|Lost to Follow-up|4|||
46797994|NCT00604214|83016696|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
46797995|NCT00604214|83016697|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
46797996|NCT00604214|83016696|FG000|Day 29 to Day 90|Death|64|||
46797997|NCT00604214|83016697|FG001|Day 29 to Day 90|Death|67|||
46797998|NCT00604214|83016696|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
46797999|NCT00604214|83016697|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
46798000|NCT00604214|83016696|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
46798001|NCT00604214|83016697|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
46798002|NCT00604214|83016696|FG000|Day 91 to Day 180|Death|19|||
46798003|NCT00604214|83016697|FG001|Day 91 to Day 180|Death|23|||
46798004|NCT00604214|83016696|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
46798005|NCT00604214|83016697|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
46798006|NCT00604214|83016696|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
46798007|NCT00604214|83016697|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
46857534|NCT00369161|83073387|FG001|Overall Study|Death|2|||
46857535|NCT00369161|83073386|FG000|Overall Study|Graft loss|4|||
46857536|NCT00369161|83073387|FG001|Overall Study|Graft loss|0|||
46857537|NCT00369161|83073386|FG000|Overall Study|Administrative Problem|2|||
46857538|NCT00369161|83073387|FG001|Overall Study|Administrative Problem|2|||
46857539|NCT00337571|83073397|FG000|Overall Study|Lack of Efficacy|3|||
46857540|NCT00337571|83073398|FG001|Overall Study|Lack of Efficacy|0|||
46857541|NCT00337571|83073399|FG002|Overall Study|Lack of Efficacy|0|||
46857542|NCT00337571|83073400|FG003|Overall Study|Lack of Efficacy|0|||
46857543|NCT00337571|83073397|FG000|Overall Study|Adverse Event|4|||
46857544|NCT00337571|83073398|FG001|Overall Study|Adverse Event|5|||
46857545|NCT00337571|83073399|FG002|Overall Study|Adverse Event|8|||
46857546|NCT00337571|83073400|FG003|Overall Study|Adverse Event|4|||
46857547|NCT00337571|83073397|FG000|Overall Study|Withdrawal by Subject|2|||
46857548|NCT00337571|83073398|FG001|Overall Study|Withdrawal by Subject|2|||
46857549|NCT00337571|83073399|FG002|Overall Study|Withdrawal by Subject|1|||
46857550|NCT00337571|83073400|FG003|Overall Study|Withdrawal by Subject|0|||
46857551|NCT00337571|83073397|FG000|Overall Study|Lost to Follow-up|3|||
46857552|NCT00337571|83073398|FG001|Overall Study|Lost to Follow-up|1|||
46857553|NCT00337571|83073399|FG002|Overall Study|Lost to Follow-up|0|||
46857554|NCT00337571|83073400|FG003|Overall Study|Lost to Follow-up|1|||
46857555|NCT00337571|83073397|FG000|Overall Study|Poor/noncompliance|1|||
46680080|NCT01659658|82895936|FG003|Overall Study|Lost to Follow-up|0|||
46680081|NCT01659658|82895937|FG004|Overall Study|Lost to Follow-up|0|||
46798008|NCT00450580|83016705|FG000|Overall Study|Adverse Event|5|||
46798009|NCT00450580|83016706|FG001|Overall Study|Adverse Event|7|||
46798010|NCT00450580|83016705|FG000|Overall Study|Lost to Follow-up|4|||
46798011|NCT00450580|83016706|FG001|Overall Study|Lost to Follow-up|5|||
46798012|NCT00450580|83016705|FG000|Overall Study|Withdrawal by Subject|2|||
46798013|NCT00450580|83016706|FG001|Overall Study|Withdrawal by Subject|2|||
46857556|NCT00337571|83073398|FG001|Overall Study|Poor/noncompliance|1|||
46857557|NCT00337571|83073399|FG002|Overall Study|Poor/noncompliance|1|||
46857558|NCT00337571|83073400|FG003|Overall Study|Poor/noncompliance|1|||
46857559|NCT00337571|83073397|FG000|Overall Study|No longer met study criteria|1|||
46798014|NCT00450580|83016705|FG000|Overall Study|Protocol Violation|1|||
46798015|NCT00450580|83016706|FG001|Overall Study|Protocol Violation|1|||
46798016|NCT00450580|83016705|FG000|Overall Study|Protocol-defined virologic failure|1|||
46798017|NCT00450580|83016706|FG001|Overall Study|Protocol-defined virologic failure|0|||
46798018|NCT00450580|83016705|FG000|Overall Study|Could not comply with scheduled visits|1|||
46798019|NCT00450580|83016706|FG001|Overall Study|Could not comply with scheduled visits|0|||
46798020|NCT00450580|83016705|FG000|Overall Study|Patient went to Brazil|1|||
46857560|NCT00337571|83073398|FG001|Overall Study|No longer met study criteria|0|||
46857561|NCT00337571|83073399|FG002|Overall Study|No longer met study criteria|0|||
46857562|NCT00337571|83073400|FG003|Overall Study|No longer met study criteria|0|||
46857563|NCT00337571|83073397|FG000|Overall Study|High Potassium level|0|||
46857564|NCT00337571|83073398|FG001|Overall Study|High Potassium level|0|||
46857565|NCT00337571|83073399|FG002|Overall Study|High Potassium level|0|||
46857566|NCT00337571|83073400|FG003|Overall Study|High Potassium level|1|||
46857567|NCT00368927|83073412|FG000|Overall Study|Lost to Follow-up|2|||
46857568|NCT00368927|83073413|FG001|Overall Study|Lost to Follow-up|0|||
46857569|NCT00368927|83073412|FG000|Overall Study|Adverse Event|1|||
46857570|NCT00368927|83073413|FG001|Overall Study|Adverse Event|1|||
46857571|NCT00368927|83073412|FG000|Overall Study|Withdrawal by Subject|1|||
46857572|NCT00368927|83073413|FG001|Overall Study|Withdrawal by Subject|2|||
46857573|NCT00368927|83073412|FG000|Overall Study|Physician Decision|1|||
46857574|NCT00368927|83073413|FG001|Overall Study|Physician Decision|0|||
46857575|NCT00316589|83073436|FG000|Overall Study|Withdrawal by Subject|0|||
46857576|NCT00316589|83073437|FG001|Overall Study|Withdrawal by Subject|5|||
46857577|NCT00316589|83073438|FG002|Overall Study|Withdrawal by Subject|0|||
46857578|NCT00316589|83073439|FG003|Overall Study|Withdrawal by Subject|1|||
46857579|NCT00316589|83073436|FG000|Overall Study|Subject unwilling/unable to comply|0|||
46857580|NCT00316589|83073437|FG001|Overall Study|Subject unwilling/unable to comply|6|||
46857581|NCT00316589|83073438|FG002|Overall Study|Subject unwilling/unable to comply|0|||
46857582|NCT00316589|83073439|FG003|Overall Study|Subject unwilling/unable to comply|2|||
46857583|NCT00316589|83073436|FG000|Overall Study|Adverse Event|1|||
46857584|NCT00316589|83073437|FG001|Overall Study|Adverse Event|0|||
46857585|NCT00316589|83073438|FG002|Overall Study|Adverse Event|0|||
46857586|NCT00316589|83073439|FG003|Overall Study|Adverse Event|1|||
46857587|NCT00316589|83073436|FG000|Overall Study|Physician Decision|0|||
46857588|NCT00316589|83073437|FG001|Overall Study|Physician Decision|1|||
46857589|NCT00316589|83073438|FG002|Overall Study|Physician Decision|0|||
46857590|NCT00316589|83073439|FG003|Overall Study|Physician Decision|0|||
46857591|NCT00316589|83073436|FG000|Overall Study|Other reason|0|||
46857592|NCT00316589|83073437|FG001|Overall Study|Other reason|12|||
46857593|NCT00316589|83073438|FG002|Overall Study|Other reason|1|||
46857594|NCT00316589|83073439|FG003|Overall Study|Other reason|1|||
46857595|NCT00316277|83073453|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
46857596|NCT00316277|83073454|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
46857597|NCT00316277|83073453|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
46857598|NCT00316277|83073454|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
46857599|NCT00316277|83073453|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
46857600|NCT00316277|83073454|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
46857601|NCT00316277|83073453|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
46857602|NCT00316277|83073454|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
46857603|NCT00316277|83073453|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
46680082|NCT01357161|82895957|FG000|Part 1 (Open Label Run-in)|Death|5|||
46680083|NCT01357161|82895958|FG001|Part 1 (Open Label Run-in)|Death|0|||
46798021|NCT00450580|83016706|FG001|Overall Study|Patient went to Brazil|0|||
46857604|NCT00316277|83073454|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
46857605|NCT00368849|83073468|FG000|Overall Study|Withdrawal by Subject|0|||
46857606|NCT00368849|83073469|FG001|Overall Study|Withdrawal by Subject|1|||
46857607|NCT00368849|83073468|FG000|Overall Study|Physician Decision|0|||
46857608|NCT00368849|83073469|FG001|Overall Study|Physician Decision|1|||
46680084|NCT01357161|82895959|FG002|Part 1 (Open Label Run-in)|Death|0|||
46857609|NCT00316199|83073476|FG000|Overall Study|Adverse Event|2|||
46798022|NCT00450580|83016705|FG000|Overall Study|Patient could not swallow Norvir|1|||
46798023|NCT00450580|83016706|FG001|Overall Study|Patient could not swallow Norvir|0|||
46798024|NCT00450580|83016705|FG000|Overall Study|Withdrawal due to pregnancy|0|||
46798025|NCT00450580|83016706|FG001|Overall Study|Withdrawal due to pregnancy|1|||
46798026|NCT00123487|83016714|FG000|Randomized|Death prior to starting treatment|0|||
46798027|NCT00123487|83016715|FG001|Randomized|Death prior to starting treatment|1|||
46798028|NCT00123487|83016714|FG000|Randomized|SAE prior to starting treatment|1|||
46798029|NCT00123487|83016715|FG001|Randomized|SAE prior to starting treatment|0|||
46798030|NCT00123487|83016714|FG000|Treated With Study Drug|Adverse Event|23|||
46798031|NCT00123487|83016715|FG001|Treated With Study Drug|Adverse Event|22|||
46798032|NCT00123487|83016714|FG000|Treated With Study Drug|Disease Progression|141|||
46798033|NCT00123487|83016715|FG001|Treated With Study Drug|Disease Progression|122|||
46798034|NCT00123487|83016714|FG000|Treated With Study Drug|Physician Decision|8|||
46798035|NCT00123487|83016715|FG001|Treated With Study Drug|Physician Decision|9|||
46798036|NCT00123487|83016714|FG000|Treated With Study Drug|Other|59|||
46798037|NCT00123487|83016715|FG001|Treated With Study Drug|Other|58|||
46798038|NCT00123487|83016714|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
46798039|NCT00123487|83016715|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
46798040|NCT00123487|83016714|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
46798041|NCT00123487|83016715|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
46798042|NCT00123487|83016714|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
46798043|NCT00123487|83016715|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
46798044|NCT00509925|83016722|FG000|Overall Study|Personal reasons|0|||
46798045|NCT00509925|83016723|FG001|Overall Study|Personal reasons|1|||
46798046|NCT00504777|83016731|FG000|Overall Study|Adverse Event|1|||
46798047|NCT00509769|83016735|FG000|Overall Study|Progressive disease|77|||
46798048|NCT00509769|83016735|FG000|Overall Study|Adverse Event|4|||
46798049|NCT00509769|83016735|FG000|Overall Study|Patient's decision|1|||
46798050|NCT00509769|83016735|FG000|Overall Study|Physician Decision|8|||
46798051|NCT00509769|83016735|FG000|Overall Study|Use of prohibited therapies during study|1|||
46798052|NCT00114127|83016741|FG000|Overall Study|Adverse Event|2|||
46798053|NCT00114127|83016742|FG001|Overall Study|Adverse Event|1|||
46798054|NCT00114127|83016741|FG000|Overall Study|Lost to Follow-up|1|||
46798055|NCT00114127|83016742|FG001|Overall Study|Lost to Follow-up|0|||
46798056|NCT00114127|83016741|FG000|Overall Study|Withdrawal by Subject|1|||
46798057|NCT00114127|83016742|FG001|Overall Study|Withdrawal by Subject|3|||
46798058|NCT00572624|83016754|FG000|Overall Study|Lost to Follow-up|10|||
46798059|NCT00572624|83016755|FG001|Overall Study|Lost to Follow-up|4|||
46798060|NCT00572624|83016754|FG000|Overall Study|Wanted to do a different diet program|1|||
46798061|NCT00572624|83016755|FG001|Overall Study|Wanted to do a different diet program|0|||
46798062|NCT00572624|83016754|FG000|Overall Study|Medication change|1|||
46798063|NCT00572624|83016755|FG001|Overall Study|Medication change|0|||
46798064|NCT00572624|83016754|FG000|Overall Study|Started a new job-- no time for study|1|||
46798065|NCT00572624|83016755|FG001|Overall Study|Started a new job-- no time for study|0|||
46798066|NCT00572624|83016754|FG000|Overall Study|Admitted to being a smoker|1|||
46798067|NCT00572624|83016755|FG001|Overall Study|Admitted to being a smoker|0|||
46798068|NCT00572624|83016754|FG000|Overall Study|Refused to do the stress test|1|||
46798069|NCT00572624|83016755|FG001|Overall Study|Refused to do the stress test|0|||
46798070|NCT00572624|83016754|FG000|Overall Study|Problem with vascular access|1|||
46798071|NCT00572624|83016755|FG001|Overall Study|Problem with vascular access|0|||
46798072|NCT00572624|83016754|FG000|Overall Study|Health issues unrelated to the study|1|||
46798073|NCT00572624|83016755|FG001|Overall Study|Health issues unrelated to the study|0|||
46798074|NCT00122317|83016761|FG000|Overall Study|Death|3|||
46798075|NCT00122317|83016761|FG000|Overall Study|Adverse Event|4|||
46798076|NCT00122317|83016761|FG000|Overall Study|Physician Decision|2|||
46798077|NCT00122317|83016761|FG000|Overall Study|patient non-compliance|1|||
46798078|NCT00122317|83016761|FG000|Overall Study|Withdrawal by Subject|1|||
46798079|NCT03870555|83016768|FG000|Period 3 (2 Days)|Adverse Event|1|||
46798080|NCT03870555|83016769|FG001|Period 3 (2 Days)|Adverse Event|0|||
46798081|NCT03870555|83016770|FG002|Period 3 (2 Days)|Adverse Event|0|||
46798082|NCT03870477|83016781|FG000|Overall Study|Early Study Termination|1|||
46798083|NCT00165841|83016787|FG000|Overall Study|Adverse Event|2|||
46798084|NCT00165841|83016788|FG001|Overall Study|Adverse Event|3|||
46798085|NCT00165841|83016787|FG000|Overall Study|Lack of Efficacy|6|||
46798086|NCT00165841|83016788|FG001|Overall Study|Lack of Efficacy|33|||
46680085|NCT01357161|82895957|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
46680086|NCT01357161|82895958|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
46680087|NCT01357161|82895959|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
46680088|NCT01357161|82895957|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
46680089|NCT01357161|82895958|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
46798087|NCT00165841|83016787|FG000|Overall Study|Lost to Follow-up|4|||
46798088|NCT00165841|83016788|FG001|Overall Study|Lost to Follow-up|4|||
46798089|NCT00165841|83016787|FG000|Overall Study|Withdrawal by Subject|7|||
46798090|NCT00165841|83016788|FG001|Overall Study|Withdrawal by Subject|8|||
46798091|NCT00165841|83016787|FG000|Overall Study|Physician Decision|1|||
46798092|NCT00165841|83016788|FG001|Overall Study|Physician Decision|0|||
46798093|NCT00165841|83016787|FG000|Overall Study|Protocol Violation|6|||
46798094|NCT00165841|83016788|FG001|Overall Study|Protocol Violation|8|||
46798095|NCT00165841|83016787|FG000|Overall Study|Other|3|||
46798096|NCT00165841|83016788|FG001|Overall Study|Other|5|||
46798097|NCT00165841|83016787|FG000|Overall Study|Medication Noncompliance|1|||
46798098|NCT00165841|83016788|FG001|Overall Study|Medication Noncompliance|1|||
46798099|NCT00509223|83016796|FG000|Overall Study|Lost to Follow-up|1|||
46798100|NCT00509223|83016797|FG001|Overall Study|Lost to Follow-up|1|||
46798101|NCT00509223|83016796|FG000|Overall Study|Adverse Event|1|||
46798102|NCT00509223|83016797|FG001|Overall Study|Adverse Event|1|||
46798103|NCT00509223|83016796|FG000|Overall Study|Withdrawal by Subject|25|||
46798104|NCT00509223|83016797|FG001|Overall Study|Withdrawal by Subject|6|||
46798105|NCT00509223|83016796|FG000|Overall Study|Including: subject change of address|5|||
46798106|NCT00509223|83016797|FG001|Overall Study|Including: subject change of address|2|||
46798107|NCT00509223|83016796|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
46798108|NCT00509223|83016797|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
46798109|NCT00460798|83016803|FG000|Overall Study|Death|59|||
46798110|NCT00460798|83016803|FG000|Overall Study|Adverse Event|27|||
46798111|NCT00460798|83016803|FG000|Overall Study|Lost to Follow-up|19|||
46798112|NCT00460798|83016803|FG000|Overall Study|Progressive Disease|99|||
46798113|NCT00460798|83016803|FG000|Overall Study|Other|27|||
46798114|NCT00460798|83016803|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
46798115|NCT00460798|83016803|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
46798116|NCT00603980|83016807|FG000|Study Qualification|Protocol Violation|3|||
46798117|NCT00603980|83016807|FG000|Study Qualification|Inconsistent data reporting|13|||
46798118|NCT00603980|83016807|FG000|Main Study|14th subject completed trial|1|||
46798119|NCT00450190|83016827|FG000|Overall Study|Withdrawal by Subject|2|||
46798120|NCT00450112|83016833|FG000|Overall Study|Other Treatment Required|5|||
46798121|NCT00450112|83016834|FG001|Overall Study|Other Treatment Required|1|||
46798122|NCT00450112|83016833|FG000|Overall Study|Withdrawal by Subject|4|||
46980461|NCT02456727|83226274|FG000|Overall Study|Never Initiated Treatment|43|||
46980462|NCT02456727|83226275|FG001|Overall Study|Never Initiated Treatment|30|||
46980463|NCT02456103|83226297|FG000|Overall Study|Study Closure|207|||
46980464|NCT02456103|83226297|FG000|Overall Study|Physician Decision|1|||
46680090|NCT01357161|82895959|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
46707719|NCT01192295|82923243|FG001|Overall Study|Adverse Event|7|||
46707720|NCT01192295|82923242|FG000|Overall Study|Withdrawal by Subject|3|||
46707721|NCT01192295|82923243|FG001|Overall Study|Withdrawal by Subject|4|||
46707722|NCT01192295|82923242|FG000|Overall Study|Lost to Follow-up|0|||
46707723|NCT01192295|82923243|FG001|Overall Study|Lost to Follow-up|1|||
46707724|NCT01192295|82923242|FG000|Overall Study|Lack of Efficacy|0|||
46707725|NCT01192295|82923243|FG001|Overall Study|Lack of Efficacy|5|||
46707726|NCT01192295|82923242|FG000|Overall Study|Administrative|4|||
46707727|NCT01192295|82923243|FG001|Overall Study|Administrative|6|||
46707728|NCT01154166|82923253|FG000|Overall Study|Adverse Event|14|||
46707729|NCT01154166|82923254|FG001|Overall Study|Adverse Event|9|||
46707730|NCT01154166|82923253|FG000|Overall Study|Lost to Follow-up|1|||
46707731|NCT01154166|82923254|FG001|Overall Study|Lost to Follow-up|1|||
46707732|NCT01154166|82923253|FG000|Overall Study|Protocol Violation|4|||
46707733|NCT01154166|82923254|FG001|Overall Study|Protocol Violation|1|||
46707734|NCT01154166|82923253|FG000|Overall Study|Withdrawal by Subject|10|||
46707735|NCT01154166|82923254|FG001|Overall Study|Withdrawal by Subject|1|||
46707736|NCT01154166|82923253|FG000|Overall Study|Lack of Efficacy|3|||
46707737|NCT01154166|82923254|FG001|Overall Study|Lack of Efficacy|0|||
46707738|NCT01154166|82923253|FG000|Overall Study|Disease Progression|1|||
46707739|NCT01154166|82923254|FG001|Overall Study|Disease Progression|0|||
46707740|NCT01154166|82923253|FG000|Overall Study|Poor Compliance|1|||
46707741|NCT01154166|82923254|FG001|Overall Study|Poor Compliance|0|||
46707742|NCT00975585|82923262|FG000|Overall Study|Adverse Event|0|||
46707743|NCT00975585|82923263|FG001|Overall Study|Adverse Event|4|||
46707744|NCT00975585|82923262|FG000|Overall Study|Lost to Follow-up|3|||
46707745|NCT00975585|82923263|FG001|Overall Study|Lost to Follow-up|5|||
46707746|NCT00975585|82923262|FG000|Overall Study|Withdrawal by Subject|2|||
46707747|NCT00975585|82923263|FG001|Overall Study|Withdrawal by Subject|1|||
46707748|NCT00975585|82923262|FG000|Overall Study|Lens issue|2|||
46707749|NCT00975585|82923263|FG001|Overall Study|Lens issue|2|||
46707750|NCT01181921|82923271|FG000|Overall Study|Lost to Follow-up|1|||
46707751|NCT01174446|82923275|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
46707752|NCT01174446|82923276|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
46707753|NCT01174446|82923277|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
46707754|NCT01174446|82923278|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
46707755|NCT01174446|82923275|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
46707756|NCT01174446|82923276|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
46980465|NCT02456103|83226297|FG000|Overall Study|Required prohibited medications|5|||
46980466|NCT02456103|83226297|FG000|Overall Study|Protocol Violation|1|||
46980467|NCT02456103|83226297|FG000|Overall Study|Adverse Event|5|||
46980468|NCT02456103|83226297|FG000|Overall Study|Abnormal Laboratory Value|2|||
46980469|NCT02456103|83226297|FG000|Overall Study|Lost to Follow-up|1|||
46980470|NCT02456103|83226297|FG000|Overall Study|Withdrawal by Subject|24|||
46980471|NCT01653327|83226301|FG000|Overall Study|Withdrawal by Subject|1|||
46980472|NCT02493855|83226310|FG000|Overall Study|Non-compliance|1|||
46980473|NCT02493855|83226311|FG001|Overall Study|Non-compliance|0|||
46980474|NCT02493855|83226312|FG002|Overall Study|Non-compliance|0|||
46980475|NCT02493855|83226310|FG000|Overall Study|Adverse Event|0|||
46980476|NCT02493855|83226311|FG001|Overall Study|Adverse Event|1|||
46980477|NCT02493855|83226312|FG002|Overall Study|Adverse Event|0|||
46980478|NCT02493855|83226310|FG000|Overall Study|Withdrawal by Subject|1|||
46980479|NCT02493855|83226311|FG001|Overall Study|Withdrawal by Subject|0|||
46980480|NCT02493855|83226312|FG002|Overall Study|Withdrawal by Subject|0|||
46980481|NCT02438787|83226323|FG000|Overall Study|Adverse Event|1|||
46798123|NCT00450112|83016834|FG001|Overall Study|Withdrawal by Subject|1|||
46798124|NCT00450112|83016833|FG000|Overall Study|Lost to Follow-up|2|||
46798125|NCT00450112|83016834|FG001|Overall Study|Lost to Follow-up|1|||
46798126|NCT00450112|83016833|FG000|Overall Study|Others|2|||
46680091|NCT01357161|82895957|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
46680092|NCT01357161|82895958|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
46680093|NCT01357161|82895959|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
46680094|NCT01357161|82895957|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
46680095|NCT01357161|82895958|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
46680096|NCT01357161|82895959|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
46680097|NCT01357161|82895957|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
46680098|NCT01357161|82895958|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
46798127|NCT00450112|83016834|FG001|Overall Study|Others|3|||
46798128|NCT00449956|83016843|FG000|Overall Study|Adverse Event|7|||
46680099|NCT01357161|82895959|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
46798129|NCT00449956|83016844|FG001|Overall Study|Adverse Event|1|||
46798130|NCT00449956|83016845|FG002|Overall Study|Adverse Event|6|||
46798131|NCT00449956|83016843|FG000|Overall Study|Lack of Efficacy|0|||
46798132|NCT00449956|83016844|FG001|Overall Study|Lack of Efficacy|0|||
46857610|NCT00316199|83073476|FG000|Overall Study|Death|8|||
46857611|NCT00316199|83073476|FG000|Overall Study|Lost to Follow-up|2|||
46857612|NCT00316121|83073482|FG000|Overall Study|Death|1|||
46857613|NCT00316121|83073483|FG001|Overall Study|Death|0|||
46857614|NCT00316121|83073482|FG000|Overall Study|Lost to Follow-up|14|||
46857615|NCT00316121|83073483|FG001|Overall Study|Lost to Follow-up|8|||
46857616|NCT00316121|83073482|FG000|Overall Study|Withdrawal by Subject|2|||
46857617|NCT00316121|83073483|FG001|Overall Study|Withdrawal by Subject|0|||
46857618|NCT00316121|83073482|FG000|Overall Study|Reason is missing|1|||
46798133|NCT00449956|83016845|FG002|Overall Study|Lack of Efficacy|1|||
46798134|NCT00449956|83016843|FG000|Overall Study|Protocol Violation|1|||
46798135|NCT00449956|83016844|FG001|Overall Study|Protocol Violation|1|||
46798136|NCT00449956|83016845|FG002|Overall Study|Protocol Violation|1|||
46798137|NCT00449956|83016843|FG000|Overall Study|Withdrawal by Subject|0|||
46857619|NCT00316121|83073483|FG001|Overall Study|Reason is missing|0|||
46857620|NCT00316121|83073482|FG000|Overall Study|Subject relocated|1|||
46857621|NCT00316121|83073483|FG001|Overall Study|Subject relocated|1|||
46857622|NCT00316121|83073482|FG000|Overall Study|Subject refused to return|1|||
46857623|NCT00316121|83073483|FG001|Overall Study|Subject refused to return|0|||
46857624|NCT00316121|83073482|FG000|Overall Study|Subject no show for visit x 3|1|||
46857625|NCT00316121|83073483|FG001|Overall Study|Subject no show for visit x 3|0|||
46857626|NCT00316121|83073482|FG000|Overall Study|Subject did not have 24 month visit|1|||
46857627|NCT00316121|83073483|FG001|Overall Study|Subject did not have 24 month visit|0|||
46980482|NCT02438787|83226324|FG001|Overall Study|Adverse Event|0|||
46980483|NCT02438787|83226325|FG002|Overall Study|Adverse Event|2|||
46980484|NCT02438787|83226323|FG000|Overall Study|Lack of Efficacy|1|||
46980485|NCT02438787|83226324|FG001|Overall Study|Lack of Efficacy|2|||
46980486|NCT02438787|83226325|FG002|Overall Study|Lack of Efficacy|0|||
46980487|NCT02438787|83226323|FG000|Overall Study|Lost to Follow-up|0|||
46980488|NCT02438787|83226324|FG001|Overall Study|Lost to Follow-up|1|||
46980489|NCT02438787|83226325|FG002|Overall Study|Lost to Follow-up|0|||
46798138|NCT00449956|83016844|FG001|Overall Study|Withdrawal by Subject|1|||
46798139|NCT00449956|83016845|FG002|Overall Study|Withdrawal by Subject|0|||
46798140|NCT00449956|83016843|FG000|Overall Study|Physician Decision|2|||
46980490|NCT02438787|83226323|FG000|Overall Study|Protocol Violation|0|||
46980491|NCT02438787|83226324|FG001|Overall Study|Protocol Violation|0|||
46857628|NCT00337103|83073502|FG000|Overall Study|Progressive Disease|414|||
46857629|NCT00337103|83073503|FG001|Overall Study|Progressive Disease|410|||
46857630|NCT00337103|83073502|FG000|Overall Study|Adverse Event|45|||
46857631|NCT00337103|83073503|FG001|Overall Study|Adverse Event|59|||
46798141|NCT00449956|83016844|FG001|Overall Study|Physician Decision|1|||
46798142|NCT00449956|83016845|FG002|Overall Study|Physician Decision|1|||
46798143|NCT00509145|83016855|FG000|Overall Study|Death|0|||
46798144|NCT00509145|83016856|FG001|Overall Study|Death|2|||
46798145|NCT00509145|83016855|FG000|Overall Study|Adverse Event|42|||
46798146|NCT00509145|83016856|FG001|Overall Study|Adverse Event|28|||
46798147|NCT00509145|83016855|FG000|Overall Study|Withdrawal by Subject|32|||
46798148|NCT00509145|83016856|FG001|Overall Study|Withdrawal by Subject|38|||
46798149|NCT00509145|83016855|FG000|Overall Study|Physician Decision|11|||
46680100|NCT01357161|82895957|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
46707901|NCT01147848|82923422|FG002|Run-in Period|Screen Failure|0|||
46707902|NCT01147848|82923420|FG000|Run-in Period|Run-in Failure|135|||
46707903|NCT01147848|82923421|FG001|Run-in Period|Run-in Failure|0|||
46707904|NCT01147848|82923422|FG002|Run-in Period|Run-in Failure|0|||
46707905|NCT01147848|82923420|FG000|Randomized Phase|Adverse Event|0|||
46707906|NCT01147848|82923421|FG001|Randomized Phase|Adverse Event|6|||
46707907|NCT01147848|82923422|FG002|Randomized Phase|Adverse Event|8|||
46707908|NCT01147848|82923420|FG000|Randomized Phase|Lack of Efficacy|0|||
46707909|NCT01147848|82923421|FG001|Randomized Phase|Lack of Efficacy|20|||
46707910|NCT01147848|82923422|FG002|Randomized Phase|Lack of Efficacy|11|||
46680101|NCT01357161|82895958|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
46680102|NCT01357161|82895959|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
46680103|NCT01357161|82895957|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
46680104|NCT01357161|82895958|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
46680105|NCT01357161|82895959|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
46680106|NCT01357161|82895957|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
46680107|NCT01357161|82895958|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
46798150|NCT00509145|83016856|FG001|Overall Study|Physician Decision|14|||
46798151|NCT00509145|83016855|FG000|Overall Study|Protocol Violation|1|||
46798152|NCT00509145|83016856|FG001|Overall Study|Protocol Violation|6|||
46798153|NCT00509145|83016855|FG000|Overall Study|Pregnancy|3|||
46798154|NCT00509145|83016856|FG001|Overall Study|Pregnancy|8|||
46798155|NCT00509145|83016855|FG000|Overall Study|Lost to Follow-up|6|||
46798156|NCT00509145|83016856|FG001|Overall Study|Lost to Follow-up|5|||
46798157|NCT00509145|83016855|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
46980492|NCT02438787|83226325|FG002|Overall Study|Protocol Violation|1|||
46980493|NCT02438787|83226323|FG000|Overall Study|Withdrawal by Subject|15|||
46980494|NCT02438787|83226324|FG001|Overall Study|Withdrawal by Subject|7|||
46980495|NCT02438787|83226325|FG002|Overall Study|Withdrawal by Subject|10|||
46980496|NCT02438787|83226323|FG000|Overall Study|Study discontinued by sponsor|64|||
46980497|NCT02438787|83226324|FG001|Overall Study|Study discontinued by sponsor|72|||
46680108|NCT01357161|82895959|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
46680109|NCT01357161|82895957|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
46680110|NCT01357161|82895958|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
46680111|NCT01357161|82895959|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
46680112|NCT01357161|82895957|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
46680113|NCT01357161|82895958|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
46680114|NCT01357161|82895959|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
46680115|NCT01321073|82895967|FG000|Overall Study|Did not attempt implant|4|||
46680116|NCT01321073|82895967|FG000|Overall Study|Death|3|||
46680117|NCT01276704|82895973|FG000|Overall Study|Lost to Follow-up|2|||
46680118|NCT01276704|82895974|FG001|Overall Study|Lost to Follow-up|3|||
46680119|NCT01276704|82895973|FG000|Overall Study|Non-compliant|2|||
46680120|NCT01276704|82895974|FG001|Overall Study|Non-compliant|2|||
46680121|NCT01276704|82895973|FG000|Overall Study|Withdrawal by Subject|7|||
46680122|NCT01276704|82895974|FG001|Overall Study|Withdrawal by Subject|1|||
46680123|NCT01276704|82895973|FG000|Overall Study|Physician Decision|3|||
46680124|NCT01276704|82895974|FG001|Overall Study|Physician Decision|5|||
46680125|NCT01190930|82895982|FG000|Induction|Adverse Event|17|||
46680126|NCT01190930|82895983|FG001|Induction|Adverse Event|0|||
46680127|NCT01190930|82895984|FG002|Induction|Adverse Event|0|||
46680128|NCT01190930|82895985|FG003|Induction|Adverse Event|0|||
46680129|NCT01190930|82895986|FG004|Induction|Adverse Event|0|||
46680130|NCT01190930|82895987|FG005|Induction|Adverse Event|0|||
46680131|NCT01190930|82895988|FG006|Induction|Adverse Event|0|||
46680132|NCT01190930|82895989|FG007|Induction|Adverse Event|0|||
46680133|NCT01190930|82895990|FG008|Induction|Adverse Event|0|||
46680134|NCT01190930|82895991|FG009|Induction|Adverse Event|0|||
46680135|NCT01190930|82895982|FG000|Induction|Death|34|||
46680136|NCT01190930|82895983|FG001|Induction|Death|0|||
46680137|NCT01190930|82895984|FG002|Induction|Death|0|||
46680138|NCT01190930|82895985|FG003|Induction|Death|0|||
46680139|NCT01190930|82895986|FG004|Induction|Death|0|||
46680140|NCT01190930|82895987|FG005|Induction|Death|0|||
46680141|NCT01190930|82895988|FG006|Induction|Death|0|||
46680142|NCT01190930|82895989|FG007|Induction|Death|0|||
46798158|NCT00509145|83016856|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
46798159|NCT00509145|83016855|FG000|Overall Study|Other|6|||
46798160|NCT00509145|83016856|FG001|Overall Study|Other|6|||
46980498|NCT02438787|83226325|FG002|Overall Study|Study discontinued by sponsor|69|||
46980499|NCT02438787|83226323|FG000|Overall Study|Other|0|||
46680143|NCT01190930|82895990|FG008|Induction|Death|0|||
46680144|NCT01190930|82895991|FG009|Induction|Death|0|||
46680145|NCT01190930|82895982|FG000|Induction|Lost to Follow-up|1|||
46680146|NCT01190930|82895983|FG001|Induction|Lost to Follow-up|0|||
46680147|NCT01190930|82895984|FG002|Induction|Lost to Follow-up|0|||
46680148|NCT01190930|82895985|FG003|Induction|Lost to Follow-up|0|||
46680149|NCT01190930|82895986|FG004|Induction|Lost to Follow-up|0|||
46680150|NCT01190930|82895987|FG005|Induction|Lost to Follow-up|0|||
46680151|NCT01190930|82895988|FG006|Induction|Lost to Follow-up|0|||
46680152|NCT01190930|82895989|FG007|Induction|Lost to Follow-up|0|||
46680153|NCT01190930|82895990|FG008|Induction|Lost to Follow-up|0|||
46680154|NCT01190930|82895991|FG009|Induction|Lost to Follow-up|0|||
46680155|NCT01190930|82895982|FG000|Induction|Physician Decision|125|||
46680156|NCT01190930|82895983|FG001|Induction|Physician Decision|3|||
46680157|NCT01190930|82895984|FG002|Induction|Physician Decision|0|||
46680158|NCT01190930|82895985|FG003|Induction|Physician Decision|0|||
46680159|NCT01190930|82895986|FG004|Induction|Physician Decision|0|||
46680160|NCT01190930|82895987|FG005|Induction|Physician Decision|0|||
46680161|NCT01190930|82895988|FG006|Induction|Physician Decision|0|||
46680162|NCT01190930|82895989|FG007|Induction|Physician Decision|0|||
46680163|NCT01190930|82895990|FG008|Induction|Physician Decision|0|||
46680164|NCT01190930|82895991|FG009|Induction|Physician Decision|0|||
46680165|NCT01190930|82895982|FG000|Induction|Withdrawal by Subject|9|||
46680166|NCT01190930|82895983|FG001|Induction|Withdrawal by Subject|0|||
46680167|NCT01190930|82895984|FG002|Induction|Withdrawal by Subject|0|||
46680168|NCT01190930|82895985|FG003|Induction|Withdrawal by Subject|0|||
46680169|NCT01190930|82895986|FG004|Induction|Withdrawal by Subject|0|||
46680170|NCT01190930|82895987|FG005|Induction|Withdrawal by Subject|0|||
46680171|NCT01190930|82895988|FG006|Induction|Withdrawal by Subject|0|||
46680172|NCT01190930|82895989|FG007|Induction|Withdrawal by Subject|0|||
46680173|NCT01190930|82895990|FG008|Induction|Withdrawal by Subject|0|||
46680174|NCT01190930|82895991|FG009|Induction|Withdrawal by Subject|0|||
46680175|NCT01190930|82895982|FG000|Induction|Refusal|235|||
46680176|NCT01190930|82895983|FG001|Induction|Refusal|0|||
46680177|NCT01190930|82895984|FG002|Induction|Refusal|0|||
46680178|NCT01190930|82895985|FG003|Induction|Refusal|0|||
46680179|NCT01190930|82895986|FG004|Induction|Refusal|0|||
46680180|NCT01190930|82895987|FG005|Induction|Refusal|0|||
46680181|NCT01190930|82895988|FG006|Induction|Refusal|0|||
46680182|NCT01190930|82895989|FG007|Induction|Refusal|0|||
46680183|NCT01190930|82895990|FG008|Induction|Refusal|0|||
46680184|NCT01190930|82895991|FG009|Induction|Refusal|0|||
46680185|NCT01190930|82895982|FG000|Induction|Inevaluable|23|||
46680186|NCT01190930|82895983|FG001|Induction|Inevaluable|1|||
46680187|NCT01190930|82895984|FG002|Induction|Inevaluable|0|||
46680188|NCT01190930|82895985|FG003|Induction|Inevaluable|0|||
46680189|NCT01190930|82895986|FG004|Induction|Inevaluable|0|||
46680190|NCT01190930|82895987|FG005|Induction|Inevaluable|0|||
46680191|NCT01190930|82895988|FG006|Induction|Inevaluable|0|||
46680192|NCT01190930|82895989|FG007|Induction|Inevaluable|0|||
46680193|NCT01190930|82895990|FG008|Induction|Inevaluable|0|||
46680194|NCT01190930|82895991|FG009|Induction|Inevaluable|0|||
46680195|NCT01190930|82895982|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
46680196|NCT01190930|82895983|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46680197|NCT01190930|82895984|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46680198|NCT01190930|82895985|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46857632|NCT00337103|83073502|FG000|Overall Study|Subject Choice|34|||
46857633|NCT00337103|83073503|FG001|Overall Study|Subject Choice|27|||
46857634|NCT00337103|83073502|FG000|Overall Study|Clinical Progression|27|||
46980500|NCT02438787|83226324|FG001|Overall Study|Other|1|||
46680199|NCT01190930|82895986|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46980501|NCT02438787|83226325|FG002|Overall Study|Other|0|||
46680200|NCT01190930|82895987|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46680201|NCT01190930|82895988|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46680202|NCT01190930|82895989|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46680203|NCT01190930|82895990|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46680204|NCT01190930|82895991|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
46680205|NCT01190930|82895982|FG000|Induction|High Risk Downs|80|||
46680206|NCT01190930|82895983|FG001|Induction|High Risk Downs|0|||
46680207|NCT01190930|82895984|FG002|Induction|High Risk Downs|0|||
46680208|NCT01190930|82895985|FG003|Induction|High Risk Downs|0|||
46680209|NCT01190930|82895986|FG004|Induction|High Risk Downs|0|||
46680210|NCT01190930|82895987|FG005|Induction|High Risk Downs|0|||
46680211|NCT01190930|82895988|FG006|Induction|High Risk Downs|0|||
46680212|NCT01190930|82895989|FG007|Induction|High Risk Downs|0|||
46680213|NCT01190930|82895990|FG008|Induction|High Risk Downs|0|||
46680214|NCT01190930|82895991|FG009|Induction|High Risk Downs|0|||
46680215|NCT01190930|82895982|FG000|Induction|Enrollment onto another COG Protocol|1|||
46680216|NCT01190930|82895983|FG001|Induction|Enrollment onto another COG Protocol|0|||
46680217|NCT01190930|82895984|FG002|Induction|Enrollment onto another COG Protocol|0|||
46680218|NCT01190930|82895985|FG003|Induction|Enrollment onto another COG Protocol|0|||
46680219|NCT01190930|82895986|FG004|Induction|Enrollment onto another COG Protocol|0|||
46680220|NCT01190930|82895987|FG005|Induction|Enrollment onto another COG Protocol|0|||
46680221|NCT01190930|82895988|FG006|Induction|Enrollment onto another COG Protocol|0|||
46680222|NCT01190930|82895989|FG007|Induction|Enrollment onto another COG Protocol|0|||
46798161|NCT00509067|83016864|FG000|Overall Study|Lost to Follow-up|1|||
46798162|NCT00509067|83016865|FG001|Overall Study|Lost to Follow-up|1|||
46798163|NCT00509067|83016864|FG000|Overall Study|Adverse Event|3|||
46798164|NCT00509067|83016865|FG001|Overall Study|Adverse Event|1|||
46798165|NCT00509067|83016864|FG000|Overall Study|Protocol Violation|0|||
46798166|NCT00509067|83016865|FG001|Overall Study|Protocol Violation|3|||
46798167|NCT00504309|83016881|FG000|Overall Study|Death|0|||
46798168|NCT00504309|83016882|FG001|Overall Study|Death|0|||
46798169|NCT00504309|83016883|FG002|Overall Study|Death|0|||
46798170|NCT00504309|83016884|FG003|Overall Study|Death|0|||
46680223|NCT01190930|82895990|FG008|Induction|Enrollment onto another COG Protocol|0|||
46680224|NCT01190930|82895991|FG009|Induction|Enrollment onto another COG Protocol|0|||
46680225|NCT01190930|82895982|FG000|Induction|Average Risk|1847|||
46680226|NCT01190930|82895983|FG001|Induction|Average Risk|0|||
46680227|NCT01190930|82895984|FG002|Induction|Average Risk|0|||
46680228|NCT01190930|82895985|FG003|Induction|Average Risk|0|||
46680229|NCT01190930|82895986|FG004|Induction|Average Risk|0|||
46680230|NCT01190930|82895987|FG005|Induction|Average Risk|0|||
46680231|NCT01190930|82895988|FG006|Induction|Average Risk|0|||
46680232|NCT01190930|82895989|FG007|Induction|Average Risk|0|||
46680233|NCT01190930|82895990|FG008|Induction|Average Risk|0|||
46680234|NCT01190930|82895991|FG009|Induction|Average Risk|0|||
46680235|NCT01190930|82895982|FG000|Induction|High Risk|1227|||
46680236|NCT01190930|82895983|FG001|Induction|High Risk|0|||
46680237|NCT01190930|82895984|FG002|Induction|High Risk|0|||
46680238|NCT01190930|82895985|FG003|Induction|High Risk|0|||
46680239|NCT01190930|82895986|FG004|Induction|High Risk|0|||
46798171|NCT00504309|83016885|FG004|Overall Study|Death|1|||
46680240|NCT01190930|82895987|FG005|Induction|High Risk|0|||
46680241|NCT01190930|82895988|FG006|Induction|High Risk|0|||
46798172|NCT00504309|83016886|FG005|Overall Study|Death|0|||
46798173|NCT00504309|83016881|FG000|Overall Study|Withdrawal by Subject|0|||
46680242|NCT01190930|82895989|FG007|Induction|High Risk|0|||
46680243|NCT01190930|82895990|FG008|Induction|High Risk|0|||
46680244|NCT01190930|82895991|FG009|Induction|High Risk|0|||
46680245|NCT01190930|82895982|FG000|Induction|Low Risk|443|||
46680246|NCT01190930|82895983|FG001|Induction|Low Risk|0|||
46680247|NCT01190930|82895984|FG002|Induction|Low Risk|0|||
46680248|NCT01190930|82895985|FG003|Induction|Low Risk|0|||
46680249|NCT01190930|82895986|FG004|Induction|Low Risk|0|||
46680250|NCT01190930|82895987|FG005|Induction|Low Risk|0|||
46680251|NCT01190930|82895988|FG006|Induction|Low Risk|0|||
46680252|NCT01190930|82895989|FG007|Induction|Low Risk|0|||
46857635|NCT00337103|83073503|FG001|Overall Study|Clinical Progression|24|||
46857636|NCT00337103|83073502|FG000|Overall Study|Physician Decision|15|||
46857637|NCT00337103|83073503|FG001|Overall Study|Physician Decision|14|||
46857638|NCT00337103|83073502|FG000|Overall Study|Withdrawal by Subject|8|||
46857639|NCT00337103|83073503|FG001|Overall Study|Withdrawal by Subject|5|||
46857640|NCT00337103|83073502|FG000|Overall Study|Other|5|||
46980502|NCT02438787|83226323|FG000|Overall Study|Site terminated by sponsor|0|||
46857641|NCT00337103|83073503|FG001|Overall Study|Other|6|||
46857642|NCT00337103|83073502|FG000|Overall Study|Entry Criteria Not Met|4|||
46857643|NCT00337103|83073503|FG001|Overall Study|Entry Criteria Not Met|1|||
46857644|NCT00337103|83073502|FG000|Overall Study|Lost to Follow-up|1|||
46857645|NCT00337103|83073503|FG001|Overall Study|Lost to Follow-up|2|||
46857646|NCT00337103|83073502|FG000|Overall Study|Death|1|||
46857647|NCT00337103|83073503|FG001|Overall Study|Death|0|||
46857648|NCT00415532|83073512|FG000|Treatment Period|Adverse Event|2|||
46857649|NCT00415532|83073513|FG001|Treatment Period|Adverse Event|3|||
46857650|NCT00415532|83073512|FG000|Treatment Period|Death|2|||
46980503|NCT02438787|83226324|FG001|Overall Study|Site terminated by sponsor|0|||
46980504|NCT02438787|83226325|FG002|Overall Study|Site terminated by sponsor|1|||
46980505|NCT02493777|83226340|FG000|Overall Study|Lost to Follow-up|0|||
46980506|NCT02493777|83226341|FG001|Overall Study|Lost to Follow-up|1|||
46980507|NCT02616601|83226350|FG000|Overall Study|Withdrawal by Subject|4|||
46980508|NCT02616601|83226351|FG001|Overall Study|Withdrawal by Subject|4|||
46980509|NCT02616601|83226352|FG002|Overall Study|Withdrawal by Subject|3|||
46980510|NCT02616601|83226350|FG000|Overall Study|Adverse Event|2|||
46980511|NCT02616601|83226351|FG001|Overall Study|Adverse Event|0|||
46980512|NCT02616601|83226352|FG002|Overall Study|Adverse Event|2|||
46980513|NCT02616601|83226350|FG000|Overall Study|Death|1|||
46980514|NCT02616601|83226351|FG001|Overall Study|Death|0|||
46980515|NCT02616601|83226352|FG002|Overall Study|Death|0|||
46980516|NCT02616601|83226350|FG000|Overall Study|Lost to Follow-up|1|||
46980517|NCT02616601|83226351|FG001|Overall Study|Lost to Follow-up|0|||
46980518|NCT02616601|83226352|FG002|Overall Study|Lost to Follow-up|1|||
46857651|NCT00415532|83073513|FG001|Treatment Period|Death|1|||
46857652|NCT00415532|83073512|FG000|Treatment Period|Lost to Follow-up|1|||
46980519|NCT02616601|83226350|FG000|Overall Study|Non-Compliance with Test Article|1|||
46980520|NCT02616601|83226351|FG001|Overall Study|Non-Compliance with Test Article|0|||
46680253|NCT01190930|82895990|FG008|Induction|Low Risk|0|||
46680254|NCT01190930|82895991|FG009|Induction|Low Risk|0|||
46680255|NCT01190930|82895982|FG000|Induction|Very High Risk|1012|||
46680256|NCT01190930|82895983|FG001|Induction|Very High Risk|0|||
46680257|NCT01190930|82895984|FG002|Induction|Very High Risk|0|||
46680258|NCT01190930|82895985|FG003|Induction|Very High Risk|0|||
46680259|NCT01190930|82895986|FG004|Induction|Very High Risk|0|||
46680260|NCT01190930|82895987|FG005|Induction|Very High Risk|0|||
46680261|NCT01190930|82895988|FG006|Induction|Very High Risk|0|||
46680262|NCT01190930|82895989|FG007|Induction|Very High Risk|0|||
46680263|NCT01190930|82895990|FG008|Induction|Very High Risk|0|||
46680264|NCT01190930|82895991|FG009|Induction|Very High Risk|0|||
46680265|NCT01190930|82895982|FG000|Induction|Philadelphia chromosome-positive|99|||
46680266|NCT01190930|82895983|FG001|Induction|Philadelphia chromosome-positive|0|||
46680267|NCT01190930|82895984|FG002|Induction|Philadelphia chromosome-positive|0|||
46680268|NCT01190930|82895985|FG003|Induction|Philadelphia chromosome-positive|0|||
46680269|NCT01190930|82895986|FG004|Induction|Philadelphia chromosome-positive|0|||
46680270|NCT01190930|82895987|FG005|Induction|Philadelphia chromosome-positive|0|||
46680271|NCT01190930|82895988|FG006|Induction|Philadelphia chromosome-positive|0|||
46680272|NCT01190930|82895989|FG007|Induction|Philadelphia chromosome-positive|0|||
46680273|NCT01190930|82895990|FG008|Induction|Philadelphia chromosome-positive|0|||
46680274|NCT01190930|82895991|FG009|Induction|Philadelphia chromosome-positive|0|||
46680275|NCT01190930|82895982|FG000|Induction|Incomplete Induction data|63|||
46680276|NCT01190930|82895983|FG001|Induction|Incomplete Induction data|0|||
46680277|NCT01190930|82895984|FG002|Induction|Incomplete Induction data|0|||
46680278|NCT01190930|82895985|FG003|Induction|Incomplete Induction data|0|||
46680279|NCT01190930|82895986|FG004|Induction|Incomplete Induction data|0|||
46680280|NCT01190930|82895987|FG005|Induction|Incomplete Induction data|0|||
46680281|NCT01190930|82895988|FG006|Induction|Incomplete Induction data|0|||
46680282|NCT01190930|82895989|FG007|Induction|Incomplete Induction data|0|||
46680283|NCT01190930|82895990|FG008|Induction|Incomplete Induction data|0|||
46680284|NCT01190930|82895991|FG009|Induction|Incomplete Induction data|0|||
46680285|NCT01190930|82895982|FG000|Induction|Progressive disease|0|||
46680286|NCT01190930|82895983|FG001|Induction|Progressive disease|1|||
46680287|NCT01190930|82895984|FG002|Induction|Progressive disease|0|||
46680288|NCT01190930|82895985|FG003|Induction|Progressive disease|0|||
46680289|NCT01190930|82895986|FG004|Induction|Progressive disease|0|||
46680290|NCT01190930|82895987|FG005|Induction|Progressive disease|0|||
46680291|NCT01190930|82895988|FG006|Induction|Progressive disease|0|||
46680292|NCT01190930|82895989|FG007|Induction|Progressive disease|0|||
46680293|NCT01190930|82895990|FG008|Induction|Progressive disease|0|||
46680294|NCT01190930|82895991|FG009|Induction|Progressive disease|0|||
46680295|NCT01190930|82895982|FG000|Induction|No treatment|3|||
46680296|NCT01190930|82895983|FG001|Induction|No treatment|0|||
46680297|NCT01190930|82895984|FG002|Induction|No treatment|0|||
46680298|NCT01190930|82895985|FG003|Induction|No treatment|0|||
46680299|NCT01190930|82895986|FG004|Induction|No treatment|0|||
46680300|NCT01190930|82895987|FG005|Induction|No treatment|0|||
46680301|NCT01190930|82895988|FG006|Induction|No treatment|0|||
46680302|NCT01190930|82895989|FG007|Induction|No treatment|0|||
46680303|NCT01190930|82895990|FG008|Induction|No treatment|0|||
46680304|NCT01190930|82895991|FG009|Induction|No treatment|0|||
46680305|NCT01190930|82895982|FG000|Induction|Ineligible|69|||
46680306|NCT01190930|82895983|FG001|Induction|Ineligible|4|||
46680307|NCT01190930|82895984|FG002|Induction|Ineligible|0|||
46680308|NCT01190930|82895985|FG003|Induction|Ineligible|0|||
46857653|NCT00415532|83073513|FG001|Treatment Period|Lost to Follow-up|1|||
46680309|NCT01190930|82895986|FG004|Induction|Ineligible|0|||
46680310|NCT01190930|82895987|FG005|Induction|Ineligible|0|||
46680311|NCT01190930|82895988|FG006|Induction|Ineligible|0|||
46680312|NCT01190930|82895989|FG007|Induction|Ineligible|0|||
46857654|NCT00415532|83073512|FG000|Treatment Period|Protocol Violation|1|||
46857655|NCT00415532|83073513|FG001|Treatment Period|Protocol Violation|0|||
46857656|NCT00415532|83073512|FG000|Treatment Period|Withdrawal by Subject|6|||
46857657|NCT00415532|83073513|FG001|Treatment Period|Withdrawal by Subject|6|||
46680313|NCT01190930|82895990|FG008|Induction|Ineligible|0|||
46680314|NCT01190930|82895991|FG009|Induction|Ineligible|0|||
46680315|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
46680316|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
46680317|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
46680318|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
46680319|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
46680320|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
46680321|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
46680322|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
46680323|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
46680324|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
46680325|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Death|0|||
46680326|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Death|0|||
46680327|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Death|8|||
46680328|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Death|4|||
46680329|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Death|0|||
46680330|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Death|0|||
46680331|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Death|0|||
46680332|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Death|0|||
46680333|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Death|0|||
46680334|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Death|0|||
46680335|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
46680336|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
46680337|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
46680338|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
46680339|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
46857658|NCT00415532|83073512|FG000|Treatment Period|Other|2|||
46857659|NCT00415532|83073513|FG001|Treatment Period|Other|2|||
46857660|NCT00415532|83073512|FG000|Treatment Period|Ineligibility determined|1|||
46857661|NCT00415532|83073513|FG001|Treatment Period|Ineligibility determined|1|||
46857662|NCT00415532|83073512|FG000|Treatment Period|Noncompliance|1|||
46857663|NCT00415532|83073513|FG001|Treatment Period|Noncompliance|1|||
46857664|NCT00415532|83073512|FG000|Treatment Period|Requirement for alternative therapy|1|||
46857665|NCT00415532|83073513|FG001|Treatment Period|Requirement for alternative therapy|0|||
46857666|NCT00415532|83073512|FG000|Safety Follow Up Period|Adverse Event|1|||
46857667|NCT00415532|83073513|FG001|Safety Follow Up Period|Adverse Event|3|||
46980521|NCT02616601|83226352|FG002|Overall Study|Non-Compliance with Test Article|1|||
46980522|NCT02492997|83226362|FG000|Overall Study|Withdrawal by Subject|1|||
46980523|NCT02492997|83226363|FG001|Overall Study|Withdrawal by Subject|0|||
46980524|NCT02492997|83226362|FG000|Overall Study|Gained Weight|1|||
46980525|NCT02492997|83226363|FG001|Overall Study|Gained Weight|0|||
46980526|NCT02492997|83226362|FG000|Overall Study|Lost to Follow-up|0|||
46980527|NCT02492997|83226363|FG001|Overall Study|Lost to Follow-up|1|||
46980528|NCT02437305|83226371|FG000|Overall Study|Lost to Follow-up|18|||
46857668|NCT00415532|83073512|FG000|Safety Follow Up Period|Death|3|||
46857669|NCT00415532|83073513|FG001|Safety Follow Up Period|Death|0|||
46980529|NCT02437305|83226372|FG001|Overall Study|Lost to Follow-up|12|||
46980530|NCT02492841|83226381|FG000|Overall Study|Lost to Follow-up|34|||
46980531|NCT02492841|83226382|FG001|Overall Study|Lost to Follow-up|31|||
46980532|NCT02492841|83226383|FG002|Overall Study|Lost to Follow-up|35|||
46980533|NCT02436915|83226396|FG000|Overall Study|Withdrawal by Subject|0|||
46680340|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
46980534|NCT02436915|83226397|FG001|Overall Study|Withdrawal by Subject|1|||
46680341|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
46680342|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
46680343|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
46680344|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
46680345|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
46680346|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
46680347|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
46680348|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
46680349|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
46680350|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
46680351|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
46680352|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
46680353|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
46680354|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
46680355|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Refusal|0|||
46680356|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Refusal|2|||
46680357|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Refusal|694|||
46680358|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Refusal|4|||
46680359|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Refusal|0|||
46680360|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Refusal|3|||
46680361|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Refusal|0|||
46680362|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Refusal|0|||
46680363|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Refusal|0|||
46680364|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Refusal|0|||
46680365|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
46680366|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
46680367|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
46680368|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
46680369|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
46680370|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
46680371|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
46680372|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
46680373|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
46680374|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
46680375|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680376|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
46680377|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680378|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680379|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680380|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680381|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680382|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680383|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680384|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
46680385|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
46680386|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
46980535|NCT02492763|83226409|FG000|Overall Study|Withdrawal by Subject|0|||
46980536|NCT02492763|83226410|FG001|Overall Study|Withdrawal by Subject|2|||
46980537|NCT02492763|83226411|FG002|Overall Study|Withdrawal by Subject|1|||
46980538|NCT02492763|83226412|FG003|Overall Study|Withdrawal by Subject|0|||
46980539|NCT02492763|83226409|FG000|Overall Study|Adverse Event|3|||
46980540|NCT02492763|83226410|FG001|Overall Study|Adverse Event|1|||
46980541|NCT02492763|83226411|FG002|Overall Study|Adverse Event|1|||
46980542|NCT02492763|83226412|FG003|Overall Study|Adverse Event|2|||
46980543|NCT02492763|83226409|FG000|Overall Study|Death|0|||
46980544|NCT02492763|83226410|FG001|Overall Study|Death|0|||
46980545|NCT02492763|83226411|FG002|Overall Study|Death|1|||
46980546|NCT02492763|83226412|FG003|Overall Study|Death|0|||
46680387|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
46680388|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
46680389|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
46680390|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
46680391|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
46680392|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
46680393|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
46680394|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
46680395|NCT01190930|82895982|FG000|Post Induction Pre-Maintenance|Relapse|0|||
46680396|NCT01190930|82895983|FG001|Post Induction Pre-Maintenance|Relapse|0|||
46680397|NCT01190930|82895984|FG002|Post Induction Pre-Maintenance|Relapse|1|||
46680398|NCT01190930|82895985|FG003|Post Induction Pre-Maintenance|Relapse|0|||
46680399|NCT01190930|82895986|FG004|Post Induction Pre-Maintenance|Relapse|0|||
46680400|NCT01190930|82895987|FG005|Post Induction Pre-Maintenance|Relapse|0|||
46680401|NCT01190930|82895988|FG006|Post Induction Pre-Maintenance|Relapse|0|||
46680402|NCT01190930|82895989|FG007|Post Induction Pre-Maintenance|Relapse|0|||
46680403|NCT01190930|82895990|FG008|Post Induction Pre-Maintenance|Relapse|0|||
46680404|NCT01190930|82895991|FG009|Post Induction Pre-Maintenance|Relapse|0|||
46680405|NCT01190930|82895982|FG000|Maintenance|Adverse Event|0|||
46680406|NCT01190930|82895983|FG001|Maintenance|Adverse Event|0|||
46680407|NCT01190930|82895984|FG002|Maintenance|Adverse Event|0|||
46680408|NCT01190930|82895985|FG003|Maintenance|Adverse Event|0|||
46680409|NCT01190930|82895986|FG004|Maintenance|Adverse Event|0|||
46680410|NCT01190930|82895987|FG005|Maintenance|Adverse Event|1|||
46680411|NCT01190930|82895988|FG006|Maintenance|Adverse Event|1|||
46680412|NCT01190930|82895989|FG007|Maintenance|Adverse Event|3|||
46680413|NCT01190930|82895990|FG008|Maintenance|Adverse Event|3|||
46680414|NCT01190930|82895991|FG009|Maintenance|Adverse Event|0|||
46680415|NCT01190930|82895982|FG000|Maintenance|Death|0|||
46680416|NCT01190930|82895983|FG001|Maintenance|Death|0|||
46680417|NCT01190930|82895984|FG002|Maintenance|Death|0|||
46680418|NCT01190930|82895985|FG003|Maintenance|Death|1|||
46680419|NCT01190930|82895986|FG004|Maintenance|Death|0|||
46680420|NCT01190930|82895987|FG005|Maintenance|Death|0|||
46680421|NCT01190930|82895988|FG006|Maintenance|Death|2|||
46680422|NCT01190930|82895989|FG007|Maintenance|Death|2|||
46680423|NCT01190930|82895990|FG008|Maintenance|Death|2|||
46680424|NCT01190930|82895991|FG009|Maintenance|Death|2|||
46680425|NCT01190930|82895982|FG000|Maintenance|Lost to Follow-up|0|||
46680426|NCT01190930|82895983|FG001|Maintenance|Lost to Follow-up|0|||
46680427|NCT01190930|82895984|FG002|Maintenance|Lost to Follow-up|0|||
46680428|NCT01190930|82895985|FG003|Maintenance|Lost to Follow-up|0|||
46680429|NCT01190930|82895986|FG004|Maintenance|Lost to Follow-up|0|||
46680430|NCT01190930|82895987|FG005|Maintenance|Lost to Follow-up|0|||
46680431|NCT01190930|82895988|FG006|Maintenance|Lost to Follow-up|1|||
46680432|NCT01190930|82895989|FG007|Maintenance|Lost to Follow-up|1|||
46980547|NCT02492763|83226409|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
46680433|NCT01190930|82895990|FG008|Maintenance|Lost to Follow-up|1|||
46680434|NCT01190930|82895991|FG009|Maintenance|Lost to Follow-up|0|||
46680435|NCT01190930|82895982|FG000|Maintenance|Physician Decision|0|||
46680436|NCT01190930|82895983|FG001|Maintenance|Physician Decision|1|||
46680437|NCT01190930|82895984|FG002|Maintenance|Physician Decision|0|||
46680438|NCT01190930|82895985|FG003|Maintenance|Physician Decision|5|||
46680439|NCT01190930|82895986|FG004|Maintenance|Physician Decision|9|||
46680440|NCT01190930|82895987|FG005|Maintenance|Physician Decision|4|||
46680441|NCT01190930|82895988|FG006|Maintenance|Physician Decision|8|||
46798174|NCT00504309|83016882|FG001|Overall Study|Withdrawal by Subject|0|||
46798175|NCT00504309|83016883|FG002|Overall Study|Withdrawal by Subject|1|||
46798176|NCT00504309|83016884|FG003|Overall Study|Withdrawal by Subject|0|||
46798177|NCT00504309|83016885|FG004|Overall Study|Withdrawal by Subject|0|||
46798178|NCT00504309|83016886|FG005|Overall Study|Withdrawal by Subject|0|||
46798179|NCT00508755|83016898|FG000|Overall Study|Withdrawal by Subject|1|||
46798180|NCT00504231|83016908|FG000|Overall Study|Discrepant chart documentation re route|0|||
46798181|NCT00504231|83016909|FG001|Overall Study|Discrepant chart documentation re route|0|||
46798182|NCT00504231|83016910|FG002|Overall Study|Discrepant chart documentation re route|1|||
46798183|NCT00504231|83016911|FG003|Overall Study|Discrepant chart documentation re route|0|||
46798184|NCT03095417|83016938|FG000|Overall Study|missed|1|||
46680442|NCT01190930|82895989|FG007|Maintenance|Physician Decision|8|||
46798185|NCT03095417|83016939|FG001|Overall Study|missed|2|||
46798186|NCT03095417|83016940|FG002|Overall Study|missed|0|||
46798187|NCT03095417|83016941|FG003|Overall Study|missed|1|||
46798188|NCT03095417|83016938|FG000|Overall Study|Lost to Follow-up|2|||
46798189|NCT03095417|83016939|FG001|Overall Study|Lost to Follow-up|2|||
46980548|NCT02492763|83226410|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
46980549|NCT02492763|83226411|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
46980550|NCT02492763|83226412|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
46980551|NCT02492763|83226409|FG000|Overall Study|Lost to Follow-up|0|||
46980552|NCT02492763|83226410|FG001|Overall Study|Lost to Follow-up|0|||
46980553|NCT02492763|83226411|FG002|Overall Study|Lost to Follow-up|1|||
46980554|NCT02492763|83226412|FG003|Overall Study|Lost to Follow-up|0|||
46980555|NCT02492763|83226409|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46980556|NCT02492763|83226410|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46798190|NCT03095417|83016940|FG002|Overall Study|Lost to Follow-up|1|||
46798191|NCT03095417|83016941|FG003|Overall Study|Lost to Follow-up|0|||
46980557|NCT02492763|83226411|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46798192|NCT03095417|83016938|FG000|Overall Study|refusal|0|||
46680443|NCT01190930|82895990|FG008|Maintenance|Physician Decision|10|||
46798193|NCT03095417|83016939|FG001|Overall Study|refusal|1|||
46798194|NCT03095417|83016940|FG002|Overall Study|refusal|0|||
46980558|NCT02492763|83226412|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46980559|NCT02492763|83226409|FG000|Overall Study|Screen Failure|0|||
46980560|NCT02492763|83226410|FG001|Overall Study|Screen Failure|0|||
46980561|NCT02492763|83226411|FG002|Overall Study|Screen Failure|0|||
46980562|NCT02492763|83226412|FG003|Overall Study|Screen Failure|1|||
46980563|NCT02492763|83226409|FG000|Overall Study|Study Terminated by Sponsor|13|||
46980564|NCT02492763|83226410|FG001|Overall Study|Study Terminated by Sponsor|10|||
46980565|NCT02492763|83226411|FG002|Overall Study|Study Terminated by Sponsor|6|||
46980566|NCT02492763|83226412|FG003|Overall Study|Study Terminated by Sponsor|10|||
46680444|NCT01190930|82895991|FG009|Maintenance|Physician Decision|17|||
46680445|NCT01190930|82895982|FG000|Maintenance|Withdrawal by Subject|0|||
46680446|NCT01190930|82895983|FG001|Maintenance|Withdrawal by Subject|0|||
46798195|NCT03095417|83016941|FG003|Overall Study|refusal|1|||
46798196|NCT03095417|83016938|FG000|Overall Study|Withdrawal by Subject|8|||
46798197|NCT03095417|83016939|FG001|Overall Study|Withdrawal by Subject|2|||
46798198|NCT03095417|83016940|FG002|Overall Study|Withdrawal by Subject|5|||
46798199|NCT03095417|83016941|FG003|Overall Study|Withdrawal by Subject|4|||
46980567|NCT02491671|83226424|FG000|Overall Study|Adverse Event|6|||
46680447|NCT01190930|82895984|FG002|Maintenance|Withdrawal by Subject|0|||
46680448|NCT01190930|82895985|FG003|Maintenance|Withdrawal by Subject|0|||
46680449|NCT01190930|82895986|FG004|Maintenance|Withdrawal by Subject|0|||
46680450|NCT01190930|82895987|FG005|Maintenance|Withdrawal by Subject|0|||
46680451|NCT01190930|82895988|FG006|Maintenance|Withdrawal by Subject|2|||
46680452|NCT01190930|82895989|FG007|Maintenance|Withdrawal by Subject|1|||
46680453|NCT01190930|82895990|FG008|Maintenance|Withdrawal by Subject|4|||
46798200|NCT03095417|83016938|FG000|Overall Study|Physician Decision|1|||
46798201|NCT03095417|83016939|FG001|Overall Study|Physician Decision|2|||
46680454|NCT01190930|82895991|FG009|Maintenance|Withdrawal by Subject|1|||
46680455|NCT01190930|82895982|FG000|Maintenance|Refusal|0|||
46798202|NCT03095417|83016940|FG002|Overall Study|Physician Decision|2|||
46680456|NCT01190930|82895983|FG001|Maintenance|Refusal|1|||
46680457|NCT01190930|82895984|FG002|Maintenance|Refusal|0|||
46680458|NCT01190930|82895985|FG003|Maintenance|Refusal|2|||
46680459|NCT01190930|82895986|FG004|Maintenance|Refusal|0|||
46680460|NCT01190930|82895987|FG005|Maintenance|Refusal|4|||
46680461|NCT01190930|82895988|FG006|Maintenance|Refusal|5|||
46680462|NCT01190930|82895989|FG007|Maintenance|Refusal|17|||
46680463|NCT01190930|82895990|FG008|Maintenance|Refusal|13|||
46680464|NCT01190930|82895991|FG009|Maintenance|Refusal|6|||
46680465|NCT01190930|82895982|FG000|Maintenance|second malignant neoplasm|0|||
46680466|NCT01190930|82895983|FG001|Maintenance|second malignant neoplasm|0|||
46680467|NCT01190930|82895984|FG002|Maintenance|second malignant neoplasm|0|||
46680468|NCT01190930|82895985|FG003|Maintenance|second malignant neoplasm|1|||
46680469|NCT01190930|82895986|FG004|Maintenance|second malignant neoplasm|0|||
46680470|NCT01190930|82895987|FG005|Maintenance|second malignant neoplasm|1|||
46680471|NCT01190930|82895988|FG006|Maintenance|second malignant neoplasm|0|||
46680472|NCT01190930|82895989|FG007|Maintenance|second malignant neoplasm|0|||
46680473|NCT01190930|82895990|FG008|Maintenance|second malignant neoplasm|1|||
46680474|NCT01190930|82895991|FG009|Maintenance|second malignant neoplasm|0|||
46798203|NCT03095417|83016941|FG003|Overall Study|Physician Decision|2|||
46798204|NCT03095417|83016938|FG000|Overall Study|Death|1|||
46798205|NCT03095417|83016939|FG001|Overall Study|Death|2|||
46798206|NCT03095417|83016940|FG002|Overall Study|Death|1|||
46798207|NCT03095417|83016941|FG003|Overall Study|Death|3|||
46798208|NCT00568178|83016972|FG000|Double Blind Base Study|Adverse Event|0|||
46980568|NCT02491671|83226425|FG001|Overall Study|Adverse Event|8|||
46980569|NCT02491671|83226424|FG000|Overall Study|Death|0|||
46680475|NCT01190930|82895982|FG000|Maintenance|Inevaluable|0|||
46680476|NCT01190930|82895983|FG001|Maintenance|Inevaluable|0|||
46680477|NCT01190930|82895984|FG002|Maintenance|Inevaluable|0|||
46680478|NCT01190930|82895985|FG003|Maintenance|Inevaluable|0|||
46680479|NCT01190930|82895986|FG004|Maintenance|Inevaluable|0|||
46680480|NCT01190930|82895987|FG005|Maintenance|Inevaluable|1|||
46680481|NCT01190930|82895988|FG006|Maintenance|Inevaluable|1|||
46798209|NCT00568178|83016973|FG001|Double Blind Base Study|Adverse Event|2|||
46680482|NCT01190930|82895989|FG007|Maintenance|Inevaluable|1|||
46680483|NCT01190930|82895990|FG008|Maintenance|Inevaluable|0|||
46680484|NCT01190930|82895991|FG009|Maintenance|Inevaluable|0|||
46680485|NCT01190930|82895982|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
46680486|NCT01190930|82895983|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
46798210|NCT00568178|83016974|FG002|Double Blind Base Study|Adverse Event|1|||
46798211|NCT00568178|83016975|FG003|Double Blind Base Study|Adverse Event|2|||
46798212|NCT00568178|83016976|FG004|Double Blind Base Study|Adverse Event|0|||
46798213|NCT00568178|83016977|FG005|Double Blind Base Study|Adverse Event|0|||
46798214|NCT00568178|83016972|FG000|Double Blind Base Study|Lost to Follow-up|1|||
46798215|NCT00568178|83016973|FG001|Double Blind Base Study|Lost to Follow-up|0|||
46798216|NCT00568178|83016974|FG002|Double Blind Base Study|Lost to Follow-up|0|||
46798217|NCT00568178|83016975|FG003|Double Blind Base Study|Lost to Follow-up|1|||
46798218|NCT00568178|83016976|FG004|Double Blind Base Study|Lost to Follow-up|0|||
46798219|NCT00568178|83016977|FG005|Double Blind Base Study|Lost to Follow-up|0|||
46980570|NCT02491671|83226425|FG001|Overall Study|Death|2|||
46980571|NCT02491671|83226424|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
46680487|NCT01190930|82895984|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
46680488|NCT01190930|82895985|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
46680489|NCT01190930|82895986|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
46798220|NCT00568178|83016972|FG000|Double Blind Base Study|Physician Decision|1|||
46680490|NCT01190930|82895987|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
46680491|NCT01190930|82895988|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
46680492|NCT01190930|82895989|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
46680493|NCT01190930|82895990|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
46680494|NCT01190930|82895991|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
46680495|NCT01190930|82895982|FG000|Maintenance|Relapse|0|||
46680496|NCT01190930|82895983|FG001|Maintenance|Relapse|0|||
46680497|NCT01190930|82895984|FG002|Maintenance|Relapse|0|||
46680498|NCT01190930|82895985|FG003|Maintenance|Relapse|2|||
46680499|NCT01190930|82895986|FG004|Maintenance|Relapse|0|||
46680500|NCT01190930|82895987|FG005|Maintenance|Relapse|1|||
46680501|NCT01190930|82895988|FG006|Maintenance|Relapse|6|||
46680502|NCT01190930|82895989|FG007|Maintenance|Relapse|13|||
46680503|NCT01190930|82895990|FG008|Maintenance|Relapse|11|||
46680504|NCT01190930|82895991|FG009|Maintenance|Relapse|11|||
46680505|NCT01190930|82895982|FG000|Maintenance|Still on therapy|0|||
46680506|NCT01190930|82895983|FG001|Maintenance|Still on therapy|8|||
46680507|NCT01190930|82895984|FG002|Maintenance|Still on therapy|0|||
46680508|NCT01190930|82895985|FG003|Maintenance|Still on therapy|29|||
46680509|NCT01190930|82895986|FG004|Maintenance|Still on therapy|0|||
46680510|NCT01190930|82895987|FG005|Maintenance|Still on therapy|0|||
46680511|NCT01190930|82895988|FG006|Maintenance|Still on therapy|0|||
46680512|NCT01190930|82895989|FG007|Maintenance|Still on therapy|0|||
46680513|NCT01190930|82895990|FG008|Maintenance|Still on therapy|0|||
46680514|NCT01190930|82895991|FG009|Maintenance|Still on therapy|0|||
46680515|NCT01163682|82896017|FG000|Overall Study|Lost to Follow-up|6|||
46798221|NCT00568178|83016973|FG001|Double Blind Base Study|Physician Decision|1|||
46680516|NCT01163682|82896018|FG001|Overall Study|Lost to Follow-up|9|||
46680517|NCT01047007|82896028|FG000|Overall Study|Adverse Event|0|||
46680518|NCT01047007|82896029|FG001|Overall Study|Adverse Event|2|||
46680519|NCT01047007|82896030|FG002|Overall Study|Adverse Event|1|||
46680520|NCT01047007|82896031|FG003|Overall Study|Adverse Event|0|||
46680521|NCT01047007|82896028|FG000|Overall Study|Progressive Disease|2|||
46680522|NCT01047007|82896029|FG001|Overall Study|Progressive Disease|4|||
46680523|NCT01047007|82896030|FG002|Overall Study|Progressive Disease|1|||
46680524|NCT01047007|82896031|FG003|Overall Study|Progressive Disease|0|||
46680525|NCT00546351|82896171|FG000|Overall Study|Adverse Event|76|||
46680526|NCT00546351|82896171|FG000|Overall Study|Lack of Efficacy|15|||
46680527|NCT00546351|82896171|FG000|Overall Study|Withdrawal by Subject|109|||
46680528|NCT00546351|82896171|FG000|Overall Study|Lost to Follow-up|9|||
46680529|NCT00546351|82896171|FG000|Overall Study|Protocol Deviation|1|||
46680530|NCT00546351|82896171|FG000|Overall Study|Unsatisfactory compliance|9|||
46680531|NCT00546351|82896171|FG000|Overall Study|Other reasons for premature termination|17|||
46680532|NCT00003838|82896187|FG000|Overall Study|Death|0|||
46680533|NCT00003838|82896188|FG001|Overall Study|Death|12|||
46680534|NCT00003838|82896189|FG002|Overall Study|Death|7|||
46680535|NCT00003838|82896187|FG000|Overall Study|Lost to Follow-up|0|||
46680536|NCT00003838|82896188|FG001|Overall Study|Lost to Follow-up|1|||
46680537|NCT00003838|82896189|FG002|Overall Study|Lost to Follow-up|1|||
46680538|NCT00003838|82896187|FG000|Overall Study|Disease Progression|0|||
46680539|NCT00003838|82896188|FG001|Overall Study|Disease Progression|12|||
46680540|NCT00003838|82896189|FG002|Overall Study|Disease Progression|0|||
46680541|NCT04276883|82896221|FG000|Overall Study|Withdrawal by Subject|2|||
46680542|NCT04276883|82896222|FG001|Overall Study|Withdrawal by Subject|3|||
46680543|NCT04276883|82896223|FG002|Overall Study|Withdrawal by Subject|6|||
46680544|NCT04276883|82896221|FG000|Overall Study|Lost to Follow-up|1|||
46680545|NCT04276883|82896222|FG001|Overall Study|Lost to Follow-up|3|||
46680546|NCT04276883|82896223|FG002|Overall Study|Lost to Follow-up|0|||
46680547|NCT04276883|82896221|FG000|Overall Study|Adverse Event|0|||
46680548|NCT04276883|82896222|FG001|Overall Study|Adverse Event|1|||
46680549|NCT04276883|82896223|FG002|Overall Study|Adverse Event|0|||
46680550|NCT04276883|82896221|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
46680551|NCT04276883|82896222|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
46680552|NCT04276883|82896223|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
46680553|NCT04099888|82896233|FG000|Overall Study|Study terminated by sponsor|9|||
46680554|NCT04099888|82896234|FG001|Overall Study|Study terminated by sponsor|11|||
46680555|NCT04099888|82896233|FG000|Overall Study|Lost to Follow-up|1|||
46680556|NCT04099888|82896234|FG001|Overall Study|Lost to Follow-up|1|||
46680557|NCT04099888|82896233|FG000|Overall Study|Withdrawal by Subject|5|||
46680558|NCT04099888|82896234|FG001|Overall Study|Withdrawal by Subject|6|||
46680559|NCT04099888|82896233|FG000|Overall Study|Death|5|||
46680560|NCT04099888|82896234|FG001|Overall Study|Death|2|||
46680561|NCT04099888|82896233|FG000|Overall Study|Other|1|||
46680562|NCT04099888|82896234|FG001|Overall Study|Other|0|||
46680563|NCT04081389|82896244|FG000|Overall Study|Withdrawal by Subject|0|||
46680564|NCT04081389|82896245|FG001|Overall Study|Withdrawal by Subject|0|||
46680565|NCT04081389|82896246|FG002|Overall Study|Withdrawal by Subject|1|||
46680566|NCT04081389|82896247|FG003|Overall Study|Withdrawal by Subject|0|||
46680567|NCT04032080|82896257|FG000|Overall Study|Death|6|||
46680568|NCT03781323|82896271|FG000|Overall Study|Withdrawal by Subject|1|||
46680569|NCT03729362|82896277|FG000|Overall Study|Withdrawal by Subject|2|||
46680570|NCT03729362|82896278|FG001|Overall Study|Withdrawal by Subject|0|||
46680571|NCT03729362|82896277|FG000|Overall Study|Physician Decision|1|||
46680572|NCT03729362|82896278|FG001|Overall Study|Physician Decision|0|||
46680573|NCT03729362|82896277|FG000|Overall Study|COVID-19 Pandemic|1|||
46680574|NCT03729362|82896278|FG001|Overall Study|COVID-19 Pandemic|0|||
46680575|NCT03729362|82896277|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
46680576|NCT03729362|82896278|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
46980572|NCT02491671|83226425|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
46980573|NCT02453841|83226431|FG000|Overall Study|Protocol Violation|1|||
46980574|NCT02453841|83226431|FG000|Overall Study|Unable to obtain blood samples|2|||
46680577|NCT03729362|82896277|FG000|Overall Study|Adverse Event|0|||
46680578|NCT03729362|82896278|FG001|Overall Study|Adverse Event|1|||
46680579|NCT03729362|82896277|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
46680580|NCT03729362|82896278|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
46680581|NCT03340766|82896305|FG000|Overall Study|Death|6|||
46680582|NCT03340766|82896306|FG001|Overall Study|Death|6|||
46680583|NCT03340766|82896307|FG002|Overall Study|Death|2|||
46680584|NCT03340766|82896305|FG000|Overall Study|Withdrawal by Subject|2|||
46680585|NCT03340766|82896306|FG001|Overall Study|Withdrawal by Subject|1|||
46680586|NCT03340766|82896307|FG002|Overall Study|Withdrawal by Subject|2|||
46680587|NCT03340766|82896305|FG000|Overall Study|Continuing Study|3|||
46680588|NCT03340766|82896306|FG001|Overall Study|Continuing Study|3|||
46857670|NCT00415532|83073512|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
46857671|NCT00415532|83073513|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
46857672|NCT00415532|83073512|FG000|Safety Follow Up Period|Other|1|||
46857673|NCT00415532|83073513|FG001|Safety Follow Up Period|Other|4|||
46980575|NCT02453685|83226437|FG000|Overall Study|Adverse Event|0|||
46980576|NCT02453685|83226438|FG001|Overall Study|Adverse Event|1|||
46980577|NCT02453685|83226437|FG000|Overall Study|Protocol Violation|7|||
46980578|NCT02453685|83226438|FG001|Overall Study|Protocol Violation|4|||
46980579|NCT02453685|83226437|FG000|Overall Study|Lost to Follow-up|0|||
46980580|NCT02453685|83226438|FG001|Overall Study|Lost to Follow-up|1|||
46680589|NCT03340766|82896307|FG002|Overall Study|Continuing Study|5|||
46680590|NCT02711852|82896343|FG000|Overall Study|Death|5|||
46680591|NCT02711852|82896343|FG000|Overall Study|Lost to Follow-up|1|||
46680592|NCT02711852|82896343|FG000|Overall Study|Completed follow-up|3|||
46680593|NCT02711852|82896343|FG000|Overall Study|Withdrawal by Subject|1|||
46680594|NCT01977417|82896372|FG000|Overall Study|Adverse Event|1|||
46680595|NCT01977417|82896373|FG001|Overall Study|Adverse Event|0|||
46680596|NCT01977417|82896372|FG000|Overall Study|Withdrawal by Subject|2|||
46680597|NCT01977417|82896373|FG001|Overall Study|Withdrawal by Subject|4|||
46680598|NCT01977417|82896372|FG000|Overall Study|Female enrollment goal met|0|||
46680599|NCT01977417|82896373|FG001|Overall Study|Female enrollment goal met|2|||
46680600|NCT01951885|82896381|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
46680601|NCT01951885|82896382|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
46680602|NCT01951885|82896381|FG000|Overall Study|Adverse Event|1|||
46680603|NCT01951885|82896382|FG001|Overall Study|Adverse Event|0|||
46680604|NCT01951885|82896381|FG000|Overall Study|Withdrawal by Subject|0|||
46680605|NCT01951885|82896382|FG001|Overall Study|Withdrawal by Subject|1|||
46680606|NCT01951885|82896381|FG000|Overall Study|ineligible due to a change in donor|0|||
46680607|NCT01951885|82896382|FG001|Overall Study|ineligible due to a change in donor|1|||
46680608|NCT01951885|82896381|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
46680609|NCT01951885|82896382|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
46680610|NCT00626990|82896392|FG000|Overall Study|Lack of Efficacy|6|||
46680611|NCT00626990|82896393|FG001|Overall Study|Lack of Efficacy|7|||
46680612|NCT00626990|82896394|FG002|Overall Study|Lack of Efficacy|49|||
46680613|NCT00626990|82896395|FG003|Overall Study|Lack of Efficacy|40|||
46680614|NCT00626990|82896392|FG000|Overall Study|Adverse Event|1|||
46680615|NCT00626990|82896393|FG001|Overall Study|Adverse Event|7|||
46680616|NCT00626990|82896394|FG002|Overall Study|Adverse Event|14|||
46680617|NCT00626990|82896395|FG003|Overall Study|Adverse Event|28|||
46680618|NCT00626990|82896392|FG000|Overall Study|Death|0|||
46680619|NCT00626990|82896393|FG001|Overall Study|Death|1|||
46680620|NCT00626990|82896394|FG002|Overall Study|Death|0|||
46680621|NCT00626990|82896395|FG003|Overall Study|Death|0|||
46680622|NCT00626990|82896392|FG000|Overall Study|Withdrawal by Subject|3|||
46680623|NCT00626990|82896393|FG001|Overall Study|Withdrawal by Subject|1|||
46680624|NCT00626990|82896394|FG002|Overall Study|Withdrawal by Subject|5|||
46798222|NCT00568178|83016974|FG002|Double Blind Base Study|Physician Decision|0|||
46798223|NCT00568178|83016975|FG003|Double Blind Base Study|Physician Decision|1|||
46798224|NCT00568178|83016976|FG004|Double Blind Base Study|Physician Decision|0|||
46798225|NCT00568178|83016977|FG005|Double Blind Base Study|Physician Decision|0|||
46798226|NCT00568178|83016972|FG000|Double Blind Base Study|Protocol Violation|3|||
46798227|NCT00568178|83016973|FG001|Double Blind Base Study|Protocol Violation|2|||
46798228|NCT00568178|83016974|FG002|Double Blind Base Study|Protocol Violation|0|||
46798229|NCT00568178|83016975|FG003|Double Blind Base Study|Protocol Violation|0|||
46798230|NCT00568178|83016976|FG004|Double Blind Base Study|Protocol Violation|0|||
46798231|NCT00568178|83016977|FG005|Double Blind Base Study|Protocol Violation|0|||
46798232|NCT00568178|83016972|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
46798233|NCT00568178|83016973|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
46798234|NCT00568178|83016974|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
46798235|NCT00568178|83016975|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
46798236|NCT00568178|83016976|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
46798237|NCT00568178|83016977|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
46798238|NCT00568178|83016972|FG000|Double Blind Base Study|Progressive Disease|0|||
46798239|NCT00568178|83016973|FG001|Double Blind Base Study|Progressive Disease|0|||
46798240|NCT00568178|83016974|FG002|Double Blind Base Study|Progressive Disease|0|||
46798241|NCT00568178|83016975|FG003|Double Blind Base Study|Progressive Disease|1|||
46798242|NCT00568178|83016976|FG004|Double Blind Base Study|Progressive Disease|0|||
46798243|NCT00568178|83016977|FG005|Double Blind Base Study|Progressive Disease|0|||
46798244|NCT00568178|83016972|FG000|Open Label Extension|Adverse Event|0|||
46798245|NCT00568178|83016973|FG001|Open Label Extension|Adverse Event|0|||
46798246|NCT00568178|83016974|FG002|Open Label Extension|Adverse Event|0|||
46798247|NCT00568178|83016975|FG003|Open Label Extension|Adverse Event|0|||
46680625|NCT00626990|82896395|FG003|Overall Study|Withdrawal by Subject|11|||
46680626|NCT00626990|82896392|FG000|Overall Study|Protocol Violation|0|||
46680627|NCT00626990|82896393|FG001|Overall Study|Protocol Violation|1|||
46680628|NCT00626990|82896394|FG002|Overall Study|Protocol Violation|1|||
46680629|NCT00626990|82896395|FG003|Overall Study|Protocol Violation|0|||
46680630|NCT00626990|82896392|FG000|Overall Study|Various different reasons/missing|4|||
46680631|NCT00626990|82896393|FG001|Overall Study|Various different reasons/missing|8|||
46680632|NCT00626990|82896394|FG002|Overall Study|Various different reasons/missing|8|||
46680633|NCT00626990|82896395|FG003|Overall Study|Various different reasons/missing|16|||
46680634|NCT00107198|82896409|FG000|Overall Study|Lack of Efficacy|28|||
46680635|NCT00107198|82896409|FG000|Overall Study|Lost to Follow-up|12|||
46680636|NCT00107198|82896409|FG000|Overall Study|Protocol Violation|1|||
46680637|NCT00107198|82896409|FG000|Overall Study|Withdrawal by Subject|6|||
46680638|NCT00107198|82896409|FG000|Overall Study|Ineligible|5|||
46680639|NCT01193920|82896432|FG000|Overall Study|Withdrawal by Subject|1|||
46680640|NCT01193920|82896433|FG001|Overall Study|Withdrawal by Subject|0|||
46680641|NCT01193920|82896434|FG002|Overall Study|Withdrawal by Subject|5|||
46680642|NCT01193920|82896435|FG003|Overall Study|Withdrawal by Subject|1|||
46680643|NCT01193920|82896436|FG004|Overall Study|Withdrawal by Subject|3|||
46680644|NCT01193920|82896437|FG005|Overall Study|Withdrawal by Subject|1|||
46680645|NCT01193920|82896438|FG006|Overall Study|Withdrawal by Subject|3|||
46980581|NCT02453685|83226437|FG000|Overall Study|Withdrawal by Subject|8|||
46680646|NCT01193920|82896439|FG007|Overall Study|Withdrawal by Subject|0|||
46798248|NCT00568178|83016976|FG004|Open Label Extension|Adverse Event|11|||
46798249|NCT00568178|83016977|FG005|Open Label Extension|Adverse Event|8|||
46798250|NCT00568178|83016972|FG000|Open Label Extension|Protocol Violation|0|||
46798251|NCT00568178|83016973|FG001|Open Label Extension|Protocol Violation|0|||
46798252|NCT00568178|83016974|FG002|Open Label Extension|Protocol Violation|0|||
46798253|NCT00568178|83016975|FG003|Open Label Extension|Protocol Violation|0|||
46798254|NCT00568178|83016976|FG004|Open Label Extension|Protocol Violation|1|||
46798255|NCT00568178|83016977|FG005|Open Label Extension|Protocol Violation|0|||
46798256|NCT00568178|83016972|FG000|Open Label Extension|Lost to Follow-up|0|||
46798257|NCT00568178|83016973|FG001|Open Label Extension|Lost to Follow-up|0|||
46798258|NCT00568178|83016974|FG002|Open Label Extension|Lost to Follow-up|0|||
46798259|NCT00568178|83016975|FG003|Open Label Extension|Lost to Follow-up|0|||
46798260|NCT00568178|83016976|FG004|Open Label Extension|Lost to Follow-up|6|||
46798261|NCT00568178|83016977|FG005|Open Label Extension|Lost to Follow-up|11|||
46680647|NCT01193920|82896440|FG008|Overall Study|Withdrawal by Subject|1|||
46680648|NCT01193920|82896441|FG009|Overall Study|Withdrawal by Subject|0|||
46680649|NCT01193920|82896432|FG000|Overall Study|Lost to Follow-up|1|||
46680650|NCT01193920|82896433|FG001|Overall Study|Lost to Follow-up|0|||
46680651|NCT01193920|82896434|FG002|Overall Study|Lost to Follow-up|1|||
46680652|NCT01193920|82896435|FG003|Overall Study|Lost to Follow-up|1|||
46680653|NCT01193920|82896436|FG004|Overall Study|Lost to Follow-up|3|||
46680654|NCT01193920|82896437|FG005|Overall Study|Lost to Follow-up|3|||
46680655|NCT01193920|82896438|FG006|Overall Study|Lost to Follow-up|1|||
46680656|NCT01193920|82896439|FG007|Overall Study|Lost to Follow-up|0|||
46680657|NCT01193920|82896440|FG008|Overall Study|Lost to Follow-up|2|||
46680658|NCT01193920|82896441|FG009|Overall Study|Lost to Follow-up|3|||
46680659|NCT01193920|82896432|FG000|Overall Study|Protocol Violation|1|||
46680660|NCT01193920|82896433|FG001|Overall Study|Protocol Violation|0|||
46680661|NCT01193920|82896434|FG002|Overall Study|Protocol Violation|0|||
46680662|NCT01193920|82896435|FG003|Overall Study|Protocol Violation|0|||
46680663|NCT01193920|82896436|FG004|Overall Study|Protocol Violation|0|||
46680664|NCT01193920|82896437|FG005|Overall Study|Protocol Violation|0|||
46680665|NCT01193920|82896438|FG006|Overall Study|Protocol Violation|0|||
46680666|NCT01193920|82896439|FG007|Overall Study|Protocol Violation|0|||
46680667|NCT01193920|82896440|FG008|Overall Study|Protocol Violation|0|||
46680668|NCT01193920|82896441|FG009|Overall Study|Protocol Violation|0|||
46680669|NCT01193920|82896432|FG000|Overall Study|Death|0|||
46680670|NCT01193920|82896433|FG001|Overall Study|Death|0|||
46680671|NCT01193920|82896434|FG002|Overall Study|Death|0|||
46680672|NCT01193920|82896435|FG003|Overall Study|Death|1|||
46680673|NCT01193920|82896436|FG004|Overall Study|Death|0|||
46680674|NCT01193920|82896437|FG005|Overall Study|Death|0|||
46680675|NCT01193920|82896438|FG006|Overall Study|Death|2|||
46680676|NCT01193920|82896439|FG007|Overall Study|Death|3|||
46798262|NCT00568178|83016972|FG000|Open Label Extension|Physician Decision|0|||
46798263|NCT00568178|83016973|FG001|Open Label Extension|Physician Decision|0|||
46798264|NCT00568178|83016974|FG002|Open Label Extension|Physician Decision|0|||
46798265|NCT00568178|83016975|FG003|Open Label Extension|Physician Decision|0|||
46680677|NCT01193920|82896440|FG008|Overall Study|Death|2|||
46680678|NCT01193920|82896441|FG009|Overall Study|Death|4|||
46680679|NCT01193920|82896432|FG000|Overall Study|Unable to classify|0|||
46680680|NCT01193920|82896433|FG001|Overall Study|Unable to classify|0|||
46680681|NCT01193920|82896434|FG002|Overall Study|Unable to classify|0|||
46680682|NCT01193920|82896435|FG003|Overall Study|Unable to classify|1|||
46680683|NCT01193920|82896436|FG004|Overall Study|Unable to classify|0|||
46680684|NCT01193920|82896437|FG005|Overall Study|Unable to classify|0|||
46680685|NCT01193920|82896438|FG006|Overall Study|Unable to classify|0|||
46680686|NCT01193920|82896439|FG007|Overall Study|Unable to classify|1|||
46680687|NCT01193920|82896440|FG008|Overall Study|Unable to classify|0|||
46680688|NCT01193920|82896441|FG009|Overall Study|Unable to classify|0|||
46680689|NCT01193686|82896466|FG000|Overall Study|Withdrawal by Subject|4|||
46680690|NCT01193686|82896467|FG001|Overall Study|Withdrawal by Subject|1|||
46857674|NCT00415532|83073512|FG000|Safety Follow Up Period|Ineligibility determined|1|||
46857675|NCT00415532|83073513|FG001|Safety Follow Up Period|Ineligibility determined|1|||
46857676|NCT00415532|83073512|FG000|Safety Follow Up Period|Noncompliance|1|||
46857677|NCT00415532|83073513|FG001|Safety Follow Up Period|Noncompliance|0|||
46857678|NCT00415532|83073512|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
46857679|NCT00415532|83073513|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
46857680|NCT00315731|83073519|FG000|Overall Study|Lost to Follow-up|1|||
46857681|NCT00315731|83073519|FG000|Overall Study|Death|5|||
46857682|NCT00062868|83073546|FG000|Dose Level 1|Death|2|||
46857683|NCT00062868|83073547|FG001|Dose Level 1|Death|0|||
46857684|NCT00062868|83073548|FG002|Dose Level 1|Death|0|||
46857685|NCT00062868|83073549|FG003|Dose Level 1|Death|2|||
46857686|NCT00062868|83073550|FG004|Dose Level 1|Death|0|||
46857687|NCT00062868|83073551|FG005|Dose Level 1|Death|0|||
46857688|NCT00062868|83073552|FG006|Dose Level 1|Death|3|||
46857689|NCT00062868|83073553|FG007|Dose Level 1|Death|0|||
46680691|NCT01193686|82896466|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
46680692|NCT01193686|82896467|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
46680693|NCT01193608|82896480|FG000|Overall Study|Other|0|||
46680694|NCT01193608|82896481|FG001|Overall Study|Other|1|||
46680695|NCT01193608|82896482|FG002|Overall Study|Other|0|||
46680696|NCT01193608|82896483|FG003|Overall Study|Other|0|||
46680697|NCT01193608|82896484|FG004|Overall Study|Other|0|||
46680698|NCT01193608|82896485|FG005|Overall Study|Other|0|||
46680699|NCT01193608|82896480|FG000|Overall Study|Withdrawal by Subject|0|||
46857690|NCT00062868|83073554|FG008|Dose Level 1|Death|0|||
46857691|NCT00062868|83073555|FG009|Dose Level 1|Death|0|||
46680700|NCT01193608|82896481|FG001|Overall Study|Withdrawal by Subject|1|||
46680701|NCT01193608|82896482|FG002|Overall Study|Withdrawal by Subject|2|||
46680702|NCT01193608|82896483|FG003|Overall Study|Withdrawal by Subject|3|||
46857692|NCT00062868|83073556|FG010|Dose Level 1|Death|0|||
46857693|NCT00062868|83073557|FG011|Dose Level 1|Death|0|||
46857694|NCT00062868|83073558|FG012|Dose Level 1|Death|0|||
46857695|NCT00062868|83073559|FG013|Dose Level 1|Death|0|||
46857696|NCT00062868|83073560|FG014|Dose Level 1|Death|0|||
46857697|NCT00062868|83073561|FG015|Dose Level 1|Death|0|||
46857698|NCT00062868|83073562|FG016|Dose Level 1|Death|0|||
46857699|NCT00062868|83073563|FG017|Dose Level 1|Death|0|||
46857700|NCT00062868|83073564|FG018|Dose Level 1|Death|7|||
46857701|NCT00062868|83073565|FG019|Dose Level 1|Death|0|||
46857702|NCT00062868|83073566|FG020|Dose Level 1|Death|1|||
46857703|NCT00062868|83073546|FG000|Dose Level 1|Lost to Follow-up|0|||
46857704|NCT00062868|83073547|FG001|Dose Level 1|Lost to Follow-up|0|||
46857705|NCT00062868|83073548|FG002|Dose Level 1|Lost to Follow-up|0|||
46857706|NCT00062868|83073549|FG003|Dose Level 1|Lost to Follow-up|0|||
46857707|NCT00062868|83073550|FG004|Dose Level 1|Lost to Follow-up|0|||
46857708|NCT00062868|83073551|FG005|Dose Level 1|Lost to Follow-up|0|||
46857709|NCT00062868|83073552|FG006|Dose Level 1|Lost to Follow-up|0|||
46857710|NCT00062868|83073553|FG007|Dose Level 1|Lost to Follow-up|0|||
46857711|NCT00062868|83073554|FG008|Dose Level 1|Lost to Follow-up|0|||
46857712|NCT00062868|83073555|FG009|Dose Level 1|Lost to Follow-up|0|||
46680703|NCT01193608|82896484|FG004|Overall Study|Withdrawal by Subject|3|||
46857713|NCT00062868|83073556|FG010|Dose Level 1|Lost to Follow-up|0|||
46857714|NCT00062868|83073557|FG011|Dose Level 1|Lost to Follow-up|0|||
46857715|NCT00062868|83073558|FG012|Dose Level 1|Lost to Follow-up|1|||
46857716|NCT00062868|83073559|FG013|Dose Level 1|Lost to Follow-up|0|||
46857717|NCT00062868|83073560|FG014|Dose Level 1|Lost to Follow-up|0|||
46857718|NCT00062868|83073561|FG015|Dose Level 1|Lost to Follow-up|0|||
46857719|NCT00062868|83073562|FG016|Dose Level 1|Lost to Follow-up|0|||
46680704|NCT01193608|82896485|FG005|Overall Study|Withdrawal by Subject|0|||
46680705|NCT01193608|82896480|FG000|Overall Study|Lost to Follow-up|0|||
46680706|NCT01193608|82896481|FG001|Overall Study|Lost to Follow-up|0|||
46680707|NCT01193608|82896482|FG002|Overall Study|Lost to Follow-up|0|||
46680708|NCT01193608|82896483|FG003|Overall Study|Lost to Follow-up|0|||
46680709|NCT01193608|82896484|FG004|Overall Study|Lost to Follow-up|1|||
46798266|NCT00568178|83016976|FG004|Open Label Extension|Physician Decision|9|||
46857720|NCT00062868|83073563|FG017|Dose Level 1|Lost to Follow-up|0|||
46857721|NCT00062868|83073564|FG018|Dose Level 1|Lost to Follow-up|2|||
46857722|NCT00062868|83073565|FG019|Dose Level 1|Lost to Follow-up|0|||
46857723|NCT00062868|83073566|FG020|Dose Level 1|Lost to Follow-up|1|||
46857724|NCT00062868|83073546|FG000|Dose Level 2|Death|0|||
46857725|NCT00062868|83073547|FG001|Dose Level 2|Death|3|||
46857726|NCT00062868|83073548|FG002|Dose Level 2|Death|0|||
46857727|NCT00062868|83073549|FG003|Dose Level 2|Death|0|||
46857728|NCT00062868|83073550|FG004|Dose Level 2|Death|2|||
46857729|NCT00062868|83073551|FG005|Dose Level 2|Death|0|||
46857730|NCT00062868|83073552|FG006|Dose Level 2|Death|0|||
46857731|NCT00062868|83073553|FG007|Dose Level 2|Death|0|||
46857732|NCT00062868|83073554|FG008|Dose Level 2|Death|0|||
46857733|NCT00062868|83073555|FG009|Dose Level 2|Death|0|||
46857734|NCT00062868|83073556|FG010|Dose Level 2|Death|1|||
46980582|NCT02453685|83226438|FG001|Overall Study|Withdrawal by Subject|4|||
46980583|NCT02453685|83226437|FG000|Overall Study|Unclassified|4|||
46980584|NCT02453685|83226438|FG001|Overall Study|Unclassified|2|||
46798267|NCT00568178|83016977|FG005|Open Label Extension|Physician Decision|8|||
46798268|NCT00568178|83016972|FG000|Open Label Extension|Pregnancy|0|||
46798269|NCT00568178|83016973|FG001|Open Label Extension|Pregnancy|0|||
46798270|NCT00568178|83016974|FG002|Open Label Extension|Pregnancy|0|||
46798271|NCT00568178|83016975|FG003|Open Label Extension|Pregnancy|0|||
46798272|NCT00568178|83016976|FG004|Open Label Extension|Pregnancy|0|||
46798273|NCT00568178|83016977|FG005|Open Label Extension|Pregnancy|1|||
46798274|NCT00568178|83016972|FG000|Open Label Extension|Progressive Disease|0|||
46798275|NCT00568178|83016973|FG001|Open Label Extension|Progressive Disease|0|||
46980585|NCT02436759|83226446|FG000|Overall Study|Adverse Event|3|||
46980586|NCT02436759|83226447|FG001|Overall Study|Adverse Event|0|||
46798276|NCT00568178|83016974|FG002|Open Label Extension|Progressive Disease|0|||
46798277|NCT00568178|83016975|FG003|Open Label Extension|Progressive Disease|0|||
46857735|NCT00062868|83073557|FG011|Dose Level 2|Death|0|||
46857736|NCT00062868|83073558|FG012|Dose Level 2|Death|0|||
46857737|NCT00062868|83073559|FG013|Dose Level 2|Death|0|||
46980587|NCT02436759|83226446|FG000|Overall Study|Protocol Violation|1|||
46857738|NCT00062868|83073560|FG014|Dose Level 2|Death|0|||
46798278|NCT00568178|83016976|FG004|Open Label Extension|Progressive Disease|3|||
46798279|NCT00568178|83016977|FG005|Open Label Extension|Progressive Disease|1|||
46798280|NCT00568178|83016972|FG000|Open Label Extension|Termination of Trial|0|||
46798281|NCT00568178|83016973|FG001|Open Label Extension|Termination of Trial|0|||
46798282|NCT00568178|83016974|FG002|Open Label Extension|Termination of Trial|0|||
46857739|NCT00062868|83073561|FG015|Dose Level 2|Death|0|||
46857740|NCT00062868|83073562|FG016|Dose Level 2|Death|2|||
46680710|NCT01193608|82896485|FG005|Overall Study|Lost to Follow-up|2|||
46680711|NCT01193608|82896480|FG000|Overall Study|Adverse Event|0|||
46680712|NCT01193608|82896481|FG001|Overall Study|Adverse Event|0|||
46680713|NCT01193608|82896482|FG002|Overall Study|Adverse Event|0|||
46680714|NCT01193608|82896483|FG003|Overall Study|Adverse Event|0|||
46680715|NCT01193608|82896484|FG004|Overall Study|Adverse Event|1|||
46680716|NCT01193608|82896485|FG005|Overall Study|Adverse Event|0|||
46680717|NCT01177228|82896508|FG000|Overall Study|Positive tuberculosis test|0|||
46680718|NCT01177228|82896509|FG001|Overall Study|Positive tuberculosis test|1|||
46680719|NCT01177228|82896510|FG002|Overall Study|Positive tuberculosis test|0|||
46680720|NCT01177228|82896511|FG003|Overall Study|Positive tuberculosis test|0|||
46680721|NCT01177228|82896508|FG000|Overall Study|Worsening disease activity|1|||
46680722|NCT01177228|82896509|FG001|Overall Study|Worsening disease activity|0|||
46680723|NCT01177228|82896510|FG002|Overall Study|Worsening disease activity|0|||
46680724|NCT01177228|82896511|FG003|Overall Study|Worsening disease activity|0|||
46680725|NCT01177228|82896508|FG000|Overall Study|Withdrawal by Subject|0|||
46680726|NCT01177228|82896509|FG001|Overall Study|Withdrawal by Subject|1|||
46680727|NCT01177228|82896510|FG002|Overall Study|Withdrawal by Subject|0|||
46680728|NCT01177228|82896511|FG003|Overall Study|Withdrawal by Subject|0|||
46680729|NCT01193530|82896528|FG000|Overall Study|Withdrawal by Subject|2|||
46680730|NCT01193530|82896529|FG001|Overall Study|Withdrawal by Subject|2|||
46680731|NCT01193530|82896528|FG000|Overall Study|Began Contraindicated Therapy|1|||
46680732|NCT01193530|82896529|FG001|Overall Study|Began Contraindicated Therapy|0|||
46680733|NCT01193530|82896528|FG000|Overall Study|Lost Light Box|0|||
46680734|NCT01193530|82896529|FG001|Overall Study|Lost Light Box|1|||
46680735|NCT01193530|82896528|FG000|Overall Study|Returned home - out of state|0|||
46680736|NCT01193530|82896529|FG001|Overall Study|Returned home - out of state|1|||
46680737|NCT01193530|82896528|FG000|Overall Study|Non-Compliance|0|||
46980588|NCT02436759|83226447|FG001|Overall Study|Protocol Violation|0|||
46680738|NCT01193530|82896529|FG001|Overall Study|Non-Compliance|1|||
46680739|NCT00107172|82896537|FG000|Overall Study|Withdrawal by Subject|1|||
46680740|NCT00107172|82896538|FG001|Overall Study|Withdrawal by Subject|0|||
46680741|NCT00107172|82896537|FG000|Overall Study|Death|0|||
46798283|NCT00568178|83016975|FG003|Open Label Extension|Termination of Trial|0|||
46798284|NCT00568178|83016976|FG004|Open Label Extension|Termination of Trial|45|||
46798285|NCT00568178|83016977|FG005|Open Label Extension|Termination of Trial|47|||
46798286|NCT00568178|83016972|FG000|Open Label Extension|Withdrawal by Subject|0|||
46798287|NCT00568178|83016973|FG001|Open Label Extension|Withdrawal by Subject|0|||
46980589|NCT02436759|83226446|FG000|Overall Study|Withdrawal by Subject|0|||
46980590|NCT02436759|83226447|FG001|Overall Study|Withdrawal by Subject|1|||
46980591|NCT02436681|83226453|FG000|Overall Study|Lost to Follow-up|10|||
46680742|NCT00107172|82896538|FG001|Overall Study|Death|2|||
46980592|NCT02436681|83226453|FG000|Overall Study|Withdrawal by Subject|2|||
46980593|NCT02436681|83226453|FG000|Overall Study|Death|2|||
46680743|NCT00107172|82896537|FG000|Overall Study|Other Reason|4|||
46680744|NCT00107172|82896538|FG001|Overall Study|Other Reason|3|||
46680745|NCT01680965|82896552|FG000|Overall Study|Death|0|||
46680746|NCT01680965|82896553|FG001|Overall Study|Death|0|||
46680747|NCT01680965|82896554|FG002|Overall Study|Death|0|||
46680748|NCT01680965|82896555|FG003|Overall Study|Death|6|||
46680749|NCT01339923|82896570|FG000|Overall Study|Adverse Event|1|||
46680750|NCT01339923|82896571|FG001|Overall Study|Adverse Event|1|||
46680751|NCT01339923|82896572|FG002|Overall Study|Adverse Event|1|||
46680752|NCT01339923|82896573|FG003|Overall Study|Adverse Event|0|||
46680753|NCT01339923|82896574|FG004|Overall Study|Adverse Event|0|||
46680754|NCT01339923|82896575|FG005|Overall Study|Adverse Event|0|||
46680755|NCT01339923|82896576|FG006|Overall Study|Adverse Event|1|||
46680756|NCT01339923|82896570|FG000|Overall Study|Inappropriate Enrollment|1|||
46680757|NCT01339923|82896571|FG001|Overall Study|Inappropriate Enrollment|0|||
46798288|NCT00568178|83016974|FG002|Open Label Extension|Withdrawal by Subject|0|||
46798289|NCT00568178|83016975|FG003|Open Label Extension|Withdrawal by Subject|0|||
46798290|NCT00568178|83016976|FG004|Open Label Extension|Withdrawal by Subject|4|||
46798291|NCT00568178|83016977|FG005|Open Label Extension|Withdrawal by Subject|4|||
46798292|NCT00577889|83016994|FG000|Overall Study|Withdrawal by Subject|1|||
46798293|NCT00577889|83016995|FG001|Overall Study|Withdrawal by Subject|0|||
46798294|NCT00577889|83016996|FG002|Overall Study|Withdrawal by Subject|0|||
46798295|NCT00460564|83017008|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
46680758|NCT01339923|82896572|FG002|Overall Study|Inappropriate Enrollment|0|||
46680759|NCT01339923|82896573|FG003|Overall Study|Inappropriate Enrollment|0|||
46680760|NCT01339923|82896574|FG004|Overall Study|Inappropriate Enrollment|0|||
46680761|NCT01339923|82896575|FG005|Overall Study|Inappropriate Enrollment|1|||
46680762|NCT01339923|82896576|FG006|Overall Study|Inappropriate Enrollment|0|||
46680763|NCT01339923|82896570|FG000|Overall Study|Lost to Follow-up|4|||
46680764|NCT01339923|82896571|FG001|Overall Study|Lost to Follow-up|4|||
46857741|NCT00062868|83073563|FG017|Dose Level 2|Death|0|||
46857742|NCT00062868|83073564|FG018|Dose Level 2|Death|0|||
46857743|NCT00062868|83073565|FG019|Dose Level 2|Death|0|||
46857744|NCT00062868|83073566|FG020|Dose Level 2|Death|0|||
46857745|NCT00062868|83073546|FG000|Dose Level 2|Lost to Follow-up|0|||
46857746|NCT00062868|83073547|FG001|Dose Level 2|Lost to Follow-up|0|||
46857747|NCT00062868|83073548|FG002|Dose Level 2|Lost to Follow-up|0|||
46857748|NCT00062868|83073549|FG003|Dose Level 2|Lost to Follow-up|0|||
46857749|NCT00062868|83073550|FG004|Dose Level 2|Lost to Follow-up|0|||
46857750|NCT00062868|83073551|FG005|Dose Level 2|Lost to Follow-up|0|||
46857751|NCT00062868|83073552|FG006|Dose Level 2|Lost to Follow-up|0|||
46857752|NCT00062868|83073553|FG007|Dose Level 2|Lost to Follow-up|0|||
46857753|NCT00062868|83073554|FG008|Dose Level 2|Lost to Follow-up|0|||
46857754|NCT00062868|83073555|FG009|Dose Level 2|Lost to Follow-up|0|||
46798296|NCT00460564|83017009|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
46798297|NCT00460564|83017010|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46798298|NCT00460564|83017011|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46798299|NCT00460564|83017012|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46798300|NCT00460564|83017013|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46798301|NCT00460564|83017014|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46798302|NCT00460564|83017015|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
46798303|NCT00460564|83017008|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
46798304|NCT00460564|83017009|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46857755|NCT00062868|83073556|FG010|Dose Level 2|Lost to Follow-up|0|||
46857756|NCT00062868|83073557|FG011|Dose Level 2|Lost to Follow-up|0|||
46857757|NCT00062868|83073558|FG012|Dose Level 2|Lost to Follow-up|0|||
46857758|NCT00062868|83073559|FG013|Dose Level 2|Lost to Follow-up|1|||
46680765|NCT01339923|82896572|FG002|Overall Study|Lost to Follow-up|0|||
46798305|NCT00460564|83017010|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46798306|NCT00460564|83017011|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46857759|NCT00062868|83073560|FG014|Dose Level 2|Lost to Follow-up|0|||
46857760|NCT00062868|83073561|FG015|Dose Level 2|Lost to Follow-up|0|||
46798307|NCT00460564|83017012|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46798308|NCT00460564|83017013|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46798309|NCT00460564|83017014|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46798310|NCT00460564|83017015|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
46798311|NCT00460564|83017008|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
46798312|NCT00460564|83017009|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
46857761|NCT00062868|83073562|FG016|Dose Level 2|Lost to Follow-up|1|||
46857762|NCT00062868|83073563|FG017|Dose Level 2|Lost to Follow-up|0|||
46980594|NCT02436135|83226459|FG000|Overall Study|Progressive Disease|3|||
46980595|NCT02436135|83226460|FG001|Overall Study|Progressive Disease|1|||
46980596|NCT02436135|83226459|FG000|Overall Study|Investigator Discretion|1|||
46857763|NCT00062868|83073564|FG018|Dose Level 2|Lost to Follow-up|0|||
46857764|NCT00062868|83073565|FG019|Dose Level 2|Lost to Follow-up|0|||
46857765|NCT00062868|83073566|FG020|Dose Level 2|Lost to Follow-up|0|||
46857766|NCT00062868|83073546|FG000|Dose Level 3|Death|0|||
46857767|NCT00062868|83073547|FG001|Dose Level 3|Death|0|||
46857768|NCT00062868|83073548|FG002|Dose Level 3|Death|0|||
46857769|NCT00062868|83073549|FG003|Dose Level 3|Death|0|||
46857770|NCT00062868|83073550|FG004|Dose Level 3|Death|0|||
46857771|NCT00062868|83073551|FG005|Dose Level 3|Death|0|||
46857772|NCT00062868|83073552|FG006|Dose Level 3|Death|0|||
46857773|NCT00062868|83073553|FG007|Dose Level 3|Death|0|||
46857774|NCT00062868|83073554|FG008|Dose Level 3|Death|0|||
46857775|NCT00062868|83073555|FG009|Dose Level 3|Death|0|||
46980597|NCT02436135|83226460|FG001|Overall Study|Investigator Discretion|2|||
46680766|NCT01339923|82896573|FG003|Overall Study|Lost to Follow-up|3|||
46857776|NCT00062868|83073556|FG010|Dose Level 3|Death|0|||
46857777|NCT00062868|83073557|FG011|Dose Level 3|Death|1|||
46857778|NCT00062868|83073558|FG012|Dose Level 3|Death|0|||
46857779|NCT00062868|83073559|FG013|Dose Level 3|Death|0|||
46980598|NCT02436135|83226459|FG000|Overall Study|Adverse Event|1|||
46857780|NCT00062868|83073560|FG014|Dose Level 3|Death|0|||
46857781|NCT00062868|83073561|FG015|Dose Level 3|Death|0|||
46857782|NCT00062868|83073562|FG016|Dose Level 3|Death|0|||
46857783|NCT00062868|83073563|FG017|Dose Level 3|Death|1|||
46857784|NCT00062868|83073564|FG018|Dose Level 3|Death|0|||
46980599|NCT02436135|83226460|FG001|Overall Study|Adverse Event|0|||
46857785|NCT00062868|83073565|FG019|Dose Level 3|Death|0|||
46857786|NCT00062868|83073566|FG020|Dose Level 3|Death|0|||
46857787|NCT00062868|83073546|FG000|Dose Level 3|Lost to Follow-up|0|||
46857788|NCT00062868|83073547|FG001|Dose Level 3|Lost to Follow-up|0|||
46857789|NCT00062868|83073548|FG002|Dose Level 3|Lost to Follow-up|0|||
46857790|NCT00062868|83073549|FG003|Dose Level 3|Lost to Follow-up|0|||
46857791|NCT00062868|83073550|FG004|Dose Level 3|Lost to Follow-up|0|||
46857792|NCT00062868|83073551|FG005|Dose Level 3|Lost to Follow-up|0|||
46857793|NCT00062868|83073552|FG006|Dose Level 3|Lost to Follow-up|0|||
46857794|NCT00062868|83073553|FG007|Dose Level 3|Lost to Follow-up|0|||
46857795|NCT00062868|83073554|FG008|Dose Level 3|Lost to Follow-up|0|||
46857796|NCT00062868|83073555|FG009|Dose Level 3|Lost to Follow-up|0|||
46857797|NCT00062868|83073556|FG010|Dose Level 3|Lost to Follow-up|0|||
46857798|NCT00062868|83073557|FG011|Dose Level 3|Lost to Follow-up|0|||
46857799|NCT00062868|83073558|FG012|Dose Level 3|Lost to Follow-up|0|||
46857800|NCT00062868|83073559|FG013|Dose Level 3|Lost to Follow-up|0|||
46857801|NCT00062868|83073560|FG014|Dose Level 3|Lost to Follow-up|1|||
46857802|NCT00062868|83073561|FG015|Dose Level 3|Lost to Follow-up|0|||
46857803|NCT00062868|83073562|FG016|Dose Level 3|Lost to Follow-up|0|||
46857804|NCT00062868|83073563|FG017|Dose Level 3|Lost to Follow-up|0|||
46857805|NCT00062868|83073564|FG018|Dose Level 3|Lost to Follow-up|0|||
46857806|NCT00062868|83073565|FG019|Dose Level 3|Lost to Follow-up|0|||
46857807|NCT00062868|83073566|FG020|Dose Level 3|Lost to Follow-up|0|||
46857808|NCT00062868|83073546|FG000|Dose Level 3|Withdrew|0|||
46857809|NCT00062868|83073547|FG001|Dose Level 3|Withdrew|0|||
46857810|NCT00062868|83073548|FG002|Dose Level 3|Withdrew|2|||
46857811|NCT00062868|83073549|FG003|Dose Level 3|Withdrew|0|||
46857812|NCT00062868|83073550|FG004|Dose Level 3|Withdrew|0|||
46857813|NCT00062868|83073551|FG005|Dose Level 3|Withdrew|0|||
46857814|NCT00062868|83073552|FG006|Dose Level 3|Withdrew|0|||
46857815|NCT00062868|83073553|FG007|Dose Level 3|Withdrew|0|||
46857816|NCT00062868|83073554|FG008|Dose Level 3|Withdrew|0|||
46857817|NCT00062868|83073555|FG009|Dose Level 3|Withdrew|0|||
46857818|NCT00062868|83073556|FG010|Dose Level 3|Withdrew|0|||
46857819|NCT00062868|83073557|FG011|Dose Level 3|Withdrew|0|||
46857820|NCT00062868|83073558|FG012|Dose Level 3|Withdrew|0|||
46857821|NCT00062868|83073559|FG013|Dose Level 3|Withdrew|0|||
46857822|NCT00062868|83073560|FG014|Dose Level 3|Withdrew|0|||
46857823|NCT00062868|83073561|FG015|Dose Level 3|Withdrew|0|||
46857824|NCT00062868|83073562|FG016|Dose Level 3|Withdrew|0|||
46857825|NCT00062868|83073563|FG017|Dose Level 3|Withdrew|0|||
46857826|NCT00062868|83073564|FG018|Dose Level 3|Withdrew|0|||
46857827|NCT00062868|83073565|FG019|Dose Level 3|Withdrew|0|||
46857828|NCT00062868|83073566|FG020|Dose Level 3|Withdrew|0|||
46857829|NCT00075504|83073612|FG000|Overall Study|Withdrawal by Subject|9|||
46857830|NCT00075504|83073613|FG001|Overall Study|Withdrawal by Subject|7|||
46680767|NCT01339923|82896574|FG004|Overall Study|Lost to Follow-up|1|||
46857831|NCT00062166|83073619|FG000|Overall Study|Withdrawal by Subject|6|||
46857832|NCT00087438|83073624|FG000|Overall Study|Ineligible / No protocol treatment|4|||
46680768|NCT01339923|82896575|FG005|Overall Study|Lost to Follow-up|1|||
46680769|NCT01339923|82896576|FG006|Overall Study|Lost to Follow-up|5|||
46680770|NCT01339923|82896570|FG000|Overall Study|Protocol Violation|0|||
46680771|NCT01339923|82896571|FG001|Overall Study|Protocol Violation|0|||
46680772|NCT01339923|82896572|FG002|Overall Study|Protocol Violation|0|||
46680773|NCT01339923|82896573|FG003|Overall Study|Protocol Violation|0|||
46680774|NCT01339923|82896574|FG004|Overall Study|Protocol Violation|0|||
46680775|NCT01339923|82896575|FG005|Overall Study|Protocol Violation|3|||
46680776|NCT01339923|82896576|FG006|Overall Study|Protocol Violation|1|||
46680777|NCT01339923|82896570|FG000|Overall Study|Unable to Classify|1|||
46680778|NCT01339923|82896571|FG001|Overall Study|Unable to Classify|0|||
46680779|NCT01339923|82896572|FG002|Overall Study|Unable to Classify|1|||
46680780|NCT01339923|82896573|FG003|Overall Study|Unable to Classify|0|||
46680781|NCT01339923|82896574|FG004|Overall Study|Unable to Classify|0|||
46680782|NCT01339923|82896575|FG005|Overall Study|Unable to Classify|1|||
46680783|NCT01339923|82896576|FG006|Overall Study|Unable to Classify|5|||
46680784|NCT01339923|82896570|FG000|Overall Study|Withdrawal by Subject|7|||
46680785|NCT01339923|82896571|FG001|Overall Study|Withdrawal by Subject|11|||
46680786|NCT01339923|82896572|FG002|Overall Study|Withdrawal by Subject|6|||
46980600|NCT02436135|83226459|FG000|Overall Study|Withdrawal by Participant|1|||
46980601|NCT02436135|83226460|FG001|Overall Study|Withdrawal by Participant|0|||
46980602|NCT02436135|83226459|FG000|Overall Study|Study Terminated By Sponsor|0|||
46980603|NCT02436135|83226460|FG001|Overall Study|Study Terminated By Sponsor|1|||
46980604|NCT02489799|83226468|FG000|Overall Study|Lost to Follow-up|4|||
46980605|NCT02489799|83226469|FG001|Overall Study|Lost to Follow-up|1|||
46680787|NCT01339923|82896573|FG003|Overall Study|Withdrawal by Subject|1|||
46680788|NCT01339923|82896574|FG004|Overall Study|Withdrawal by Subject|4|||
46680789|NCT01339923|82896575|FG005|Overall Study|Withdrawal by Subject|3|||
46680790|NCT01339923|82896576|FG006|Overall Study|Withdrawal by Subject|2|||
46680791|NCT01380093|82896609|FG000|Naloxone Challenge Phase|Screen failures|21|||
46680792|NCT01380093|82896610|FG001|Naloxone Challenge Phase|Screen failures|0|||
46680793|NCT01380093|82896611|FG002|Naloxone Challenge Phase|Screen failures|0|||
46680794|NCT01380093|82896612|FG003|Naloxone Challenge Phase|Screen failures|0|||
46680795|NCT01380093|82896613|FG004|Naloxone Challenge Phase|Screen failures|0|||
46798313|NCT00460564|83017010|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
46980606|NCT02489799|83226468|FG000|Overall Study|Failure to Maintain Eligibility|4|||
46680796|NCT01380093|82896614|FG005|Naloxone Challenge Phase|Screen failures|0|||
46680797|NCT01380093|82896615|FG006|Naloxone Challenge Phase|Screen failures|0|||
46680798|NCT01380093|82896616|FG007|Naloxone Challenge Phase|Screen failures|0|||
46680799|NCT01380093|82896617|FG008|Naloxone Challenge Phase|Screen failures|0|||
46798314|NCT00460564|83017011|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
46798315|NCT00460564|83017012|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
46680800|NCT01380093|82896609|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680801|NCT01380093|82896610|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
46680802|NCT01380093|82896611|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680803|NCT01380093|82896612|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680804|NCT01380093|82896613|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680805|NCT01380093|82896614|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680806|NCT01380093|82896615|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680807|NCT01380093|82896616|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680808|NCT01380093|82896617|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
46680809|NCT01380093|82896609|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
46680810|NCT01380093|82896610|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
46680811|NCT01380093|82896611|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
46680812|NCT01380093|82896612|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
46680813|NCT01380093|82896613|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
46680814|NCT01380093|82896614|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
46680815|NCT01380093|82896615|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
46680816|NCT01380093|82896616|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
46680817|NCT01380093|82896617|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
46680818|NCT01380093|82896609|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46680819|NCT01380093|82896610|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
46680820|NCT01380093|82896611|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46680821|NCT01380093|82896612|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46680822|NCT01380093|82896613|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46680823|NCT01380093|82896614|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46680824|NCT01380093|82896615|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46680825|NCT01380093|82896616|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46980607|NCT02489799|83226469|FG001|Overall Study|Failure to Maintain Eligibility|6|||
46980608|NCT02489799|83226468|FG000|Overall Study|Withdrawal by Subject|1|||
46980609|NCT02489799|83226469|FG001|Overall Study|Withdrawal by Subject|1|||
46980610|NCT02489799|83226468|FG000|Overall Study|Death|0|||
46980611|NCT02489799|83226469|FG001|Overall Study|Death|1|||
46857833|NCT00321464|83073632|FG000|Overall Study|Death|169|||
46980612|NCT02435277|83226479|FG000|Overall Study|Adverse Event|1|||
46980613|NCT02435277|83226480|FG001|Overall Study|Adverse Event|1|||
46980614|NCT02435277|83226481|FG002|Overall Study|Adverse Event|0|||
46980615|NCT02435277|83226482|FG003|Overall Study|Adverse Event|0|||
46980616|NCT02435277|83226479|FG000|Overall Study|Withdrawal by Subject|1|||
46980617|NCT02435277|83226480|FG001|Overall Study|Withdrawal by Subject|0|||
46980618|NCT02435277|83226481|FG002|Overall Study|Withdrawal by Subject|0|||
46980619|NCT02435277|83226482|FG003|Overall Study|Withdrawal by Subject|0|||
46980620|NCT02420223|83226494|FG000|Overall Study|Adverse Event|1|||
46980621|NCT02420223|83226495|FG001|Overall Study|Adverse Event|0|||
46980622|NCT02420223|83226494|FG000|Overall Study|Physician Decision|0|||
46980623|NCT02420223|83226495|FG001|Overall Study|Physician Decision|2|||
46980624|NCT02433483|83226501|FG000|Overall Study|Unacceptable toxicity|1|||
46980625|NCT02433483|83226501|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
46980626|NCT02419755|83226507|FG000|Overall Study|Death|1|||
46980627|NCT02419755|83226508|FG001|Overall Study|Death|3|||
46980628|NCT02419755|83226507|FG000|Overall Study|Relapse|0|||
46680826|NCT01380093|82896617|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
46680827|NCT01380093|82896609|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
46680828|NCT01380093|82896610|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
46680829|NCT01380093|82896611|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
46680830|NCT01380093|82896612|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
46680831|NCT01380093|82896613|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
46680832|NCT01380093|82896614|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
46680833|NCT01380093|82896615|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
46680834|NCT01380093|82896616|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
46680835|NCT01380093|82896617|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
46680836|NCT01380093|82896609|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
46680837|NCT01380093|82896610|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
46680838|NCT01380093|82896611|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
46680839|NCT01380093|82896612|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
46680840|NCT01380093|82896613|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
46680841|NCT01380093|82896614|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
46680842|NCT01380093|82896615|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
46798316|NCT00460564|83017013|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
46798317|NCT00460564|83017014|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
46798318|NCT00460564|83017015|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
46798319|NCT00460564|83017008|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46798320|NCT00460564|83017009|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46798321|NCT00460564|83017010|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46798322|NCT00460564|83017011|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46798323|NCT00460564|83017012|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
46798324|NCT00460564|83017013|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
46798325|NCT00460564|83017014|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46798326|NCT00460564|83017015|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
46798327|NCT00460564|83017008|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
46798328|NCT00460564|83017009|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
46798329|NCT00460564|83017010|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
46798330|NCT00460564|83017011|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
46798331|NCT00460564|83017012|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
46798332|NCT00460564|83017013|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
46798333|NCT00460564|83017014|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
46798334|NCT00460564|83017015|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
46798335|NCT00567476|83017037|FG000|Overall Study|Adverse Event|2|||
46798336|NCT00567476|83017038|FG001|Overall Study|Adverse Event|0|||
46798337|NCT00567476|83017037|FG000|Overall Study|Pregnancy|1|||
46798338|NCT00567476|83017038|FG001|Overall Study|Pregnancy|0|||
46798339|NCT00567476|83017037|FG000|Overall Study|Protocol Violation|4|||
46798340|NCT00567476|83017038|FG001|Overall Study|Protocol Violation|1|||
46798341|NCT00567476|83017037|FG000|Overall Study|Lost to Follow-up|0|||
46798342|NCT00567476|83017038|FG001|Overall Study|Lost to Follow-up|1|||
46798343|NCT00567476|83017037|FG000|Overall Study|Administrative issues|1|||
46798344|NCT00567476|83017038|FG001|Overall Study|Administrative issues|0|||
46798345|NCT00567476|83017037|FG000|Overall Study|Medical Decision|0|||
46980629|NCT02419755|83226508|FG001|Overall Study|Relapse|1|||
46980630|NCT02419755|83226507|FG000|Overall Study|Ineligible|1|||
46980631|NCT02419755|83226508|FG001|Overall Study|Ineligible|0|||
46680843|NCT01380093|82896616|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
46680844|NCT01380093|82896617|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
46680845|NCT01380093|82896609|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
46980632|NCT02419755|83226507|FG000|Overall Study|Withdrawal by Subject|1|||
46980633|NCT02419755|83226508|FG001|Overall Study|Withdrawal by Subject|0|||
46980634|NCT02488551|83226518|FG000|Overall Study|Lost to Follow-up|4|||
46980635|NCT02488551|83226519|FG001|Overall Study|Lost to Follow-up|7|||
46980636|NCT02488551|83226520|FG002|Overall Study|Lost to Follow-up|0|||
46980637|NCT02488551|83226521|FG003|Overall Study|Lost to Follow-up|0|||
46980638|NCT02488551|83226518|FG000|Overall Study|Military Deployment|1|||
46980639|NCT02488551|83226519|FG001|Overall Study|Military Deployment|1|||
46980640|NCT02488551|83226520|FG002|Overall Study|Military Deployment|0|||
46980641|NCT02488551|83226521|FG003|Overall Study|Military Deployment|0|||
46980642|NCT02488239|83226531|FG000|Overall Study|Death|3|||
46980643|NCT02488239|83226531|FG000|Overall Study|Withdrawal by Subject|3|||
46980644|NCT02488239|83226531|FG000|Overall Study|Physician Decision|2|||
46980645|NCT02488239|83226531|FG000|Overall Study|Consent ineligible|1|||
46980646|NCT02488239|83226531|FG000|Overall Study|Did not undergo implant procedure|1|||
46680846|NCT01380093|82896610|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
46680847|NCT01380093|82896611|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
46680848|NCT01380093|82896612|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
46680849|NCT01380093|82896613|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
46680850|NCT01380093|82896614|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
46680851|NCT01380093|82896615|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
46680852|NCT01380093|82896616|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
46680853|NCT01380093|82896617|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
46680854|NCT01380093|82896609|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46680855|NCT01380093|82896610|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46680856|NCT01380093|82896611|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
46680857|NCT01380093|82896612|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46680858|NCT01380093|82896613|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46680859|NCT01380093|82896614|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46680860|NCT01380093|82896615|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46980647|NCT02488005|83226536|FG000|Overall Study|Lost to Follow-up|2|||
46980648|NCT02487771|83226542|FG000|Overall Study|Lost to Follow-up|2|||
46980649|NCT02487771|83226543|FG001|Overall Study|Lost to Follow-up|3|||
46980650|NCT02487771|83226542|FG000|Overall Study|Moved out of area|5|||
46980651|NCT02487771|83226543|FG001|Overall Study|Moved out of area|6|||
46980652|NCT02487771|83226542|FG000|Overall Study|Withdrawal by Subject|3|||
46980653|NCT02487771|83226543|FG001|Overall Study|Withdrawal by Subject|5|||
46980654|NCT01359943|83226552|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
46680861|NCT01380093|82896616|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46680862|NCT01380093|82896617|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
46680863|NCT01380093|82896609|FG000|Treatment Phase: Second Intervention|Other|0|||
46680864|NCT01380093|82896610|FG001|Treatment Phase: Second Intervention|Other|0|||
46798346|NCT00567476|83017038|FG001|Overall Study|Medical Decision|1|||
46798347|NCT00567476|83017037|FG000|Overall Study|Non-adherence to protocol|0|||
46980655|NCT01359943|83226553|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
46980656|NCT01359943|83226554|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
46980657|NCT01359943|83226552|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
46980658|NCT01359943|83226553|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
46980659|NCT01359943|83226554|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
46980660|NCT01359943|83226552|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
46980661|NCT01359943|83226553|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
46980662|NCT01359943|83226554|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
46980663|NCT01359943|83226552|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
46980664|NCT01359943|83226553|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
46680865|NCT01380093|82896611|FG002|Treatment Phase: Second Intervention|Other|0|||
46980665|NCT01359943|83226554|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
46980666|NCT01359943|83226552|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
46680866|NCT01380093|82896612|FG003|Treatment Phase: Second Intervention|Other|1|||
46680867|NCT01380093|82896613|FG004|Treatment Phase: Second Intervention|Other|0|||
46680868|NCT01380093|82896614|FG005|Treatment Phase: Second Intervention|Other|0|||
46680869|NCT01380093|82896615|FG006|Treatment Phase: Second Intervention|Other|0|||
46680870|NCT01380093|82896616|FG007|Treatment Phase: Second Intervention|Other|0|||
46680871|NCT01380093|82896617|FG008|Treatment Phase: Second Intervention|Other|0|||
46680872|NCT01380093|82896609|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
46980667|NCT01359943|83226553|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
46980668|NCT01359943|83226554|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
46980669|NCT01359943|83226552|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
46980670|NCT01359943|83226553|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
46980671|NCT01359943|83226554|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
46980672|NCT01359943|83226552|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
46980673|NCT01359943|83226553|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
46980674|NCT01359943|83226554|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
46980675|NCT01359943|83226552|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
46980676|NCT01359943|83226553|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
46980677|NCT01359943|83226554|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
46980678|NCT01359943|83226552|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
46980679|NCT01359943|83226553|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
46980680|NCT01359943|83226554|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
46980681|NCT01359943|83226552|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
46980682|NCT01359943|83226553|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
46980683|NCT01359943|83226554|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
46980684|NCT01359943|83226552|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
46980685|NCT01359943|83226553|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
46980686|NCT01359943|83226554|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
46980687|NCT01359943|83226552|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
46680873|NCT01380093|82896610|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
46680874|NCT01380093|82896611|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
46680875|NCT01380093|82896612|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
46680876|NCT01380093|82896613|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
46980688|NCT01359943|83226553|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
46980689|NCT01359943|83226554|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
46980690|NCT01359943|83226552|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
46980691|NCT01359943|83226553|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
46980692|NCT01359943|83226554|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
46980693|NCT01359943|83226552|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
46980694|NCT01359943|83226553|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
46980695|NCT01359943|83226554|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
46980696|NCT01359943|83226552|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
46980697|NCT01359943|83226553|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
46980698|NCT01359943|83226554|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
46980699|NCT02432703|83226566|FG000|Overall Study|Adverse Event|1|||
46980700|NCT02432703|83226567|FG001|Overall Study|Adverse Event|4|||
46680877|NCT01380093|82896614|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
46680878|NCT01380093|82896615|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
46680879|NCT01380093|82896616|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
46798348|NCT00567476|83017038|FG001|Overall Study|Non-adherence to protocol|1|||
46980701|NCT02432703|83226566|FG000|Overall Study|Lack of Efficacy|1|||
46857834|NCT00321464|83073633|FG001|Overall Study|Death|174|||
46980702|NCT02432703|83226567|FG001|Overall Study|Lack of Efficacy|0|||
46980703|NCT02432703|83226566|FG000|Overall Study|Lost to Follow-up|5|||
46980704|NCT02432703|83226567|FG001|Overall Study|Lost to Follow-up|3|||
46980705|NCT02432703|83226566|FG000|Overall Study|Withdrawal by Subject|9|||
46680880|NCT01380093|82896617|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
46680881|NCT01380093|82896609|FG000|Treatment Phase: Third Intervention|Other|0|||
46680882|NCT01380093|82896610|FG001|Treatment Phase: Third Intervention|Other|0|||
46680883|NCT01380093|82896611|FG002|Treatment Phase: Third Intervention|Other|0|||
46680884|NCT01380093|82896612|FG003|Treatment Phase: Third Intervention|Other|0|||
46680885|NCT01380093|82896613|FG004|Treatment Phase: Third Intervention|Other|0|||
46680886|NCT01380093|82896614|FG005|Treatment Phase: Third Intervention|Other|0|||
46680887|NCT01380093|82896615|FG006|Treatment Phase: Third Intervention|Other|0|||
46680888|NCT01380093|82896616|FG007|Treatment Phase: Third Intervention|Other|0|||
46680889|NCT01380093|82896617|FG008|Treatment Phase: Third Intervention|Other|1|||
46680890|NCT01379937|82896635|FG000|Overall Study|Protocol Violation|0|||
46680891|NCT01379937|82896636|FG001|Overall Study|Protocol Violation|0|||
46680892|NCT01379937|82896637|FG002|Overall Study|Protocol Violation|0|||
46680893|NCT01379937|82896638|FG003|Overall Study|Protocol Violation|1|||
46680894|NCT01379937|82896635|FG000|Overall Study|Consent withdrawal|0|||
46680895|NCT01379937|82896636|FG001|Overall Study|Consent withdrawal|1|||
46680896|NCT01379937|82896637|FG002|Overall Study|Consent withdrawal|0|||
46680897|NCT01379937|82896638|FG003|Overall Study|Consent withdrawal|0|||
46680898|NCT01379937|82896635|FG000|Overall Study|Lost to Follow-up|1|||
46680899|NCT01379937|82896636|FG001|Overall Study|Lost to Follow-up|2|||
46680900|NCT01379937|82896637|FG002|Overall Study|Lost to Follow-up|2|||
46680901|NCT01379937|82896638|FG003|Overall Study|Lost to Follow-up|0|||
46680902|NCT01379781|82896664|FG000|Overall Study|Lost to Follow-up|11|||
46680903|NCT01379781|82896665|FG001|Overall Study|Lost to Follow-up|8|||
46680904|NCT01379703|82896671|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
46680905|NCT01379703|82896672|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
46680906|NCT01379703|82896673|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
46680907|NCT01379703|82896671|FG000|Study Start Through 9 Months|Adverse Event|0|||
46680908|NCT01379703|82896672|FG001|Study Start Through 9 Months|Adverse Event|14|||
46798349|NCT00516321|83017046|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
46680909|NCT01379703|82896673|FG002|Study Start Through 9 Months|Adverse Event|10|||
46680910|NCT01379703|82896671|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
46680911|NCT01379703|82896672|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
46680912|NCT01379703|82896673|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
46680913|NCT01379703|82896671|FG000|Study Start Through 9 Months|Treatment Failure|0|||
46680914|NCT01379703|82896672|FG001|Study Start Through 9 Months|Treatment Failure|2|||
46708068|NCT01147458|82923545|FG001|Second Intervention|Adverse Event|0|||
46680915|NCT01379703|82896673|FG002|Study Start Through 9 Months|Treatment Failure|2|||
46680916|NCT01379703|82896671|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
46680917|NCT01379703|82896672|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
46680918|NCT01379703|82896673|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
46680919|NCT01379703|82896671|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
46680920|NCT01379703|82896672|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
46680921|NCT01379703|82896673|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
46680922|NCT01379703|82896671|FG000|Study Start Through 9 Months|Medication not available|0|||
46680923|NCT01379703|82896672|FG001|Study Start Through 9 Months|Medication not available|2|||
46680924|NCT01379703|82896673|FG002|Study Start Through 9 Months|Medication not available|1|||
46680925|NCT01379703|82896671|FG000|Study Start Through 9 Months|Poor general condition|0|||
46680926|NCT01379703|82896672|FG001|Study Start Through 9 Months|Poor general condition|1|||
46680927|NCT01379703|82896673|FG002|Study Start Through 9 Months|Poor general condition|0|||
46680928|NCT01379703|82896671|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
46680929|NCT01379703|82896672|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
46680930|NCT01379703|82896673|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
46680931|NCT01379703|82896671|FG000|Study Start Through 9 Months|Reason unknown|2|||
46680932|NCT01379703|82896672|FG001|Study Start Through 9 Months|Reason unknown|31|||
46680933|NCT01379703|82896673|FG002|Study Start Through 9 Months|Reason unknown|24|||
46680934|NCT01379703|82896671|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
46680935|NCT01379703|82896672|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
46680936|NCT01379703|82896673|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
46680937|NCT01379703|82896671|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
46680938|NCT01379703|82896672|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
46680939|NCT01379703|82896673|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
46680940|NCT01379703|82896671|FG000|9 Months Through 18 Months|Adverse Event|0|||
46680941|NCT01379703|82896672|FG001|9 Months Through 18 Months|Adverse Event|6|||
46680942|NCT01379703|82896673|FG002|9 Months Through 18 Months|Adverse Event|0|||
46680943|NCT01379703|82896671|FG000|9 Months Through 18 Months|Treatment failure|0|||
46680944|NCT01379703|82896672|FG001|9 Months Through 18 Months|Treatment failure|5|||
46708069|NCT01147458|82923546|FG002|Second Intervention|Adverse Event|1|||
46857835|NCT00321464|83073632|FG000|Overall Study|Disease progression|124|||
46857836|NCT00321464|83073633|FG001|Overall Study|Disease progression|124|||
46857837|NCT00321464|83073632|FG000|Overall Study|Withdrawal by Subject|117|||
46857838|NCT00321464|83073633|FG001|Overall Study|Withdrawal by Subject|118|||
46857839|NCT00321464|83073632|FG000|Overall Study|Participant request|57|||
46857840|NCT00321464|83073633|FG001|Overall Study|Participant request|61|||
46857841|NCT00321464|83073632|FG000|Overall Study|Adverse Event|43|||
46857842|NCT00321464|83073633|FG001|Overall Study|Adverse Event|28|||
46857843|NCT00321464|83073632|FG000|Overall Study|Physician Decision|15|||
46857844|NCT00321464|83073633|FG001|Overall Study|Physician Decision|14|||
46857845|NCT00321464|83073632|FG000|Overall Study|Noncompliance|4|||
46857846|NCT00321464|83073633|FG001|Overall Study|Noncompliance|10|||
46857847|NCT00321464|83073632|FG000|Overall Study|Lost to Follow-up|7|||
46857848|NCT00321464|83073633|FG001|Overall Study|Lost to Follow-up|8|||
46857849|NCT00321464|83073632|FG000|Overall Study|Protocol deviation|0|||
46857850|NCT00321464|83073633|FG001|Overall Study|Protocol deviation|2|||
46857851|NCT00321464|83073632|FG000|Overall Study|Ineligibility determined|2|||
46857852|NCT00321464|83073633|FG001|Overall Study|Ineligibility determined|1|||
46857853|NCT00321464|83073632|FG000|Overall Study|Other|21|||
46857854|NCT00321464|83073633|FG001|Overall Study|Other|18|||
46857855|NCT02889796|83073643|FG000|Overall Study|Withdrew Consent|18|||
46857856|NCT02889796|83073644|FG001|Overall Study|Withdrew Consent|29|||
46857857|NCT02889796|83073645|FG002|Overall Study|Withdrew Consent|20|||
46857858|NCT02889796|83073646|FG003|Overall Study|Withdrew Consent|1|||
46857859|NCT02889796|83073647|FG004|Overall Study|Withdrew Consent|2|||
46857860|NCT02889796|83073648|FG005|Overall Study|Withdrew Consent|35|||
46857861|NCT02889796|83073643|FG000|Overall Study|Investigator's Discretion|10|||
46857862|NCT02889796|83073644|FG001|Overall Study|Investigator's Discretion|9|||
46857863|NCT02889796|83073645|FG002|Overall Study|Investigator's Discretion|10|||
46857864|NCT02889796|83073646|FG003|Overall Study|Investigator's Discretion|3|||
46857865|NCT02889796|83073647|FG004|Overall Study|Investigator's Discretion|0|||
46857866|NCT02889796|83073648|FG005|Overall Study|Investigator's Discretion|15|||
46857867|NCT02889796|83073643|FG000|Overall Study|Adverse Event|17|||
46857868|NCT02889796|83073644|FG001|Overall Study|Adverse Event|8|||
46857869|NCT02889796|83073645|FG002|Overall Study|Adverse Event|8|||
46857870|NCT02889796|83073646|FG003|Overall Study|Adverse Event|4|||
46857871|NCT02889796|83073647|FG004|Overall Study|Adverse Event|1|||
46857872|NCT02889796|83073648|FG005|Overall Study|Adverse Event|7|||
46857873|NCT02889796|83073643|FG000|Overall Study|Lost to Follow-up|5|||
46857874|NCT02889796|83073644|FG001|Overall Study|Lost to Follow-up|7|||
46857875|NCT02889796|83073645|FG002|Overall Study|Lost to Follow-up|2|||
46857876|NCT02889796|83073646|FG003|Overall Study|Lost to Follow-up|0|||
46857877|NCT02889796|83073647|FG004|Overall Study|Lost to Follow-up|2|||
46857878|NCT02889796|83073648|FG005|Overall Study|Lost to Follow-up|6|||
46857879|NCT02889796|83073643|FG000|Overall Study|Protocol Violation|0|||
46857880|NCT02889796|83073644|FG001|Overall Study|Protocol Violation|1|||
46857881|NCT02889796|83073645|FG002|Overall Study|Protocol Violation|3|||
46857882|NCT02889796|83073646|FG003|Overall Study|Protocol Violation|0|||
46857883|NCT02889796|83073647|FG004|Overall Study|Protocol Violation|0|||
46857884|NCT02889796|83073648|FG005|Overall Study|Protocol Violation|4|||
46857885|NCT02889796|83073643|FG000|Overall Study|Non-compliance With Study Drug|0|||
46857886|NCT02889796|83073644|FG001|Overall Study|Non-compliance With Study Drug|2|||
46857887|NCT02889796|83073645|FG002|Overall Study|Non-compliance With Study Drug|0|||
46857888|NCT02889796|83073646|FG003|Overall Study|Non-compliance With Study Drug|0|||
46857889|NCT02889796|83073647|FG004|Overall Study|Non-compliance With Study Drug|1|||
46857890|NCT02889796|83073648|FG005|Overall Study|Non-compliance With Study Drug|2|||
46857891|NCT02889796|83073643|FG000|Overall Study|Death|1|||
46857892|NCT02889796|83073644|FG001|Overall Study|Death|1|||
46857893|NCT02889796|83073645|FG002|Overall Study|Death|0|||
46857894|NCT02889796|83073646|FG003|Overall Study|Death|1|||
46857895|NCT02889796|83073647|FG004|Overall Study|Death|0|||
46857896|NCT02889796|83073648|FG005|Overall Study|Death|1|||
46857897|NCT02889796|83073643|FG000|Overall Study|Pregnancy|0|||
46857898|NCT02889796|83073644|FG001|Overall Study|Pregnancy|1|||
46857899|NCT02889796|83073645|FG002|Overall Study|Pregnancy|1|||
46680945|NCT01379703|82896673|FG002|9 Months Through 18 Months|Treatment failure|0|||
46857900|NCT02889796|83073646|FG003|Overall Study|Pregnancy|0|||
46857901|NCT02889796|83073647|FG004|Overall Study|Pregnancy|0|||
46857902|NCT02889796|83073648|FG005|Overall Study|Pregnancy|0|||
46857903|NCT02889796|83073643|FG000|Overall Study|Randomized but not Dosed|2|||
46857904|NCT02889796|83073644|FG001|Overall Study|Randomized but not Dosed|0|||
46857905|NCT02889796|83073645|FG002|Overall Study|Randomized but not Dosed|0|||
46857906|NCT02889796|83073646|FG003|Overall Study|Randomized but not Dosed|0|||
46857907|NCT02889796|83073647|FG004|Overall Study|Randomized but not Dosed|0|||
46857908|NCT02889796|83073648|FG005|Overall Study|Randomized but not Dosed|2|||
46857909|NCT02889562|83073673|FG000|Overall Study|Physician Decision|0|||
46857910|NCT02889562|83073674|FG001|Overall Study|Physician Decision|1|||
46857911|NCT02889562|83073673|FG000|Overall Study|Withdrawal by Subject|0|||
46857912|NCT02889562|83073674|FG001|Overall Study|Withdrawal by Subject|1|||
46857913|NCT03323164|83073682|FG000|Overall Study|Poor quality imaging/scans|2|||
46857914|NCT03323164|83073683|FG001|Overall Study|Poor quality imaging/scans|2|||
46857915|NCT03323086|83073695|FG000|Overall Study|Lost to Follow-up|3|||
46857916|NCT03323086|83073696|FG001|Overall Study|Lost to Follow-up|2|||
46857917|NCT02888080|83073704|FG000|Overall Study|Subject / Guardian decision|1|||
46857918|NCT02888080|83073705|FG001|Overall Study|Subject / Guardian decision|3|||
46857919|NCT02888080|83073704|FG000|Overall Study|New Therapy for study indication|1|||
46857920|NCT02888080|83073705|FG001|Overall Study|New Therapy for study indication|0|||
46857921|NCT02888080|83073704|FG000|Overall Study|Lack of Efficacy|0|||
46857922|NCT02888080|83073705|FG001|Overall Study|Lack of Efficacy|1|||
46857923|NCT02888080|83073704|FG000|Overall Study|Adverse Event|0|||
46857924|NCT02888080|83073705|FG001|Overall Study|Adverse Event|1|||
46857925|NCT03322462|83073711|FG000|Overall Study|Technical difficulties|2|||
46857926|NCT03322462|83073711|FG000|Overall Study|Other|1|||
46857927|NCT00086580|83073719|FG000|Treatment Period|Disease progression|9|||
46857928|NCT00086580|83073720|FG001|Treatment Period|Disease progression|8|||
46980706|NCT02432703|83226567|FG001|Overall Study|Withdrawal by Subject|6|||
46980707|NCT02432703|83226566|FG000|Overall Study|Other|6|||
46980708|NCT02432703|83226567|FG001|Overall Study|Other|5|||
46857929|NCT00086580|83073719|FG000|Treatment Period|Unable to comply with protocol|3|||
46857930|NCT00086580|83073720|FG001|Treatment Period|Unable to comply with protocol|1|||
46857931|NCT00086580|83073719|FG000|Treatment Period|Withdrawal by Subject|7|||
46857932|NCT00086580|83073720|FG001|Treatment Period|Withdrawal by Subject|8|||
46857933|NCT00086580|83073719|FG000|Treatment Period|Physician Decision|13|||
46857934|NCT00086580|83073720|FG001|Treatment Period|Physician Decision|7|||
46857935|NCT00086580|83073719|FG000|Treatment Period|AE - not treatment related|7|||
46857936|NCT00086580|83073720|FG001|Treatment Period|AE - not treatment related|7|||
46857937|NCT00086580|83073719|FG000|Treatment Period|Toxicity - treatment related|15|||
46857938|NCT00086580|83073720|FG001|Treatment Period|Toxicity - treatment related|15|||
46857939|NCT00086580|83073719|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
46980709|NCT02486757|83226573|FG000|Overall Study|Lost to Follow-up|1|||
46980710|NCT02418819|83226581|FG000|Overall Study|Adverse Event|0|||
46857940|NCT00086580|83073720|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
46980711|NCT02418819|83226582|FG001|Overall Study|Adverse Event|0|||
46857941|NCT00086580|83073719|FG000|Treatment Period|Death|5|||
46857942|NCT00086580|83073720|FG001|Treatment Period|Death|7|||
46857943|NCT00086580|83073719|FG000|Treatment Period|Other|5|||
46857944|NCT00086580|83073720|FG001|Treatment Period|Other|3|||
46857945|NCT00086580|83073719|FG000|Follow-up Period|Disease progression|72|||
46857946|NCT00086580|83073720|FG001|Follow-up Period|Disease progression|99|||
46857947|NCT00086580|83073719|FG000|Follow-up Period|Unable to comply with protocol|5|||
46857948|NCT00086580|83073720|FG001|Follow-up Period|Unable to comply with protocol|0|||
46857949|NCT00086580|83073719|FG000|Follow-up Period|Withdrawal by Subject|6|||
46857950|NCT00086580|83073720|FG001|Follow-up Period|Withdrawal by Subject|6|||
46857951|NCT00086580|83073719|FG000|Follow-up Period|Physician Decision|0|||
46857952|NCT00086580|83073720|FG001|Follow-up Period|Physician Decision|1|||
46857953|NCT00086580|83073719|FG000|Follow-up Period|AE - not related|1|||
46857954|NCT00086580|83073720|FG001|Follow-up Period|AE - not related|0|||
46857955|NCT00086580|83073719|FG000|Follow-up Period|Death|13|||
46857956|NCT00086580|83073720|FG001|Follow-up Period|Death|7|||
46857957|NCT00086580|83073719|FG000|Follow-up Period|Other|7|||
46857958|NCT00086580|83073720|FG001|Follow-up Period|Other|6|||
46857959|NCT00086580|83073719|FG000|Observation Period|Unable to comply with protocol|1|||
46857960|NCT00086580|83073720|FG001|Observation Period|Unable to comply with protocol|1|||
46857961|NCT00086580|83073719|FG000|Observation Period|Withdrawal by Subject|4|||
46857962|NCT00086580|83073720|FG001|Observation Period|Withdrawal by Subject|2|||
46857963|NCT00086580|83073719|FG000|Observation Period|Death|33|||
46857964|NCT00086580|83073720|FG001|Observation Period|Death|55|||
46857965|NCT00086580|83073719|FG000|Observation Period|Other|8|||
46857966|NCT00086580|83073720|FG001|Observation Period|Other|7|||
46857967|NCT00086502|83073728|FG000|Overall Study|Adverse Event|11|||
46857968|NCT00086502|83073729|FG001|Overall Study|Adverse Event|2|||
46857969|NCT00086502|83073728|FG000|Overall Study|Lack of Efficacy|0|||
46857970|NCT00086502|83073729|FG001|Overall Study|Lack of Efficacy|2|||
46857971|NCT00086502|83073728|FG000|Overall Study|Lost to Follow-up|3|||
46857972|NCT00086502|83073729|FG001|Overall Study|Lost to Follow-up|1|||
46798350|NCT00516321|83017047|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
46798351|NCT00516321|83017048|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
46798352|NCT00516321|83017046|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
46798353|NCT00516321|83017047|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
46798354|NCT00516321|83017048|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
46980712|NCT02418819|83226583|FG002|Overall Study|Adverse Event|1|||
46857973|NCT00086502|83073728|FG000|Overall Study|Physician Decision|1|||
46857974|NCT00086502|83073729|FG001|Overall Study|Physician Decision|1|||
46857975|NCT00086502|83073728|FG000|Overall Study|Pregnancy|0|||
46857976|NCT00086502|83073729|FG001|Overall Study|Pregnancy|1|||
46857977|NCT00086502|83073728|FG000|Overall Study|Protocol Violation|3|||
46857978|NCT00086502|83073729|FG001|Overall Study|Protocol Violation|3|||
46857979|NCT00086502|83073728|FG000|Overall Study|Withdrawal by Subject|5|||
46798355|NCT00516321|83017046|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
46798356|NCT00516321|83017047|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
46798357|NCT00516321|83017048|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
46798358|NCT00516321|83017046|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
46798359|NCT00516321|83017047|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
46857980|NCT00086502|83073729|FG001|Overall Study|Withdrawal by Subject|6|||
46857981|NCT00086502|83073728|FG000|Overall Study|Patient Moved|1|||
46857982|NCT00086502|83073729|FG001|Overall Study|Patient Moved|1|||
46857983|NCT00086502|83073728|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
46857984|NCT00086502|83073729|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
46857985|NCT00086502|83073728|FG000|Overall Study|Patient Accidentally Unblinded|1|||
46857986|NCT00086502|83073729|FG001|Overall Study|Patient Accidentally Unblinded|0|||
46857987|NCT03826667|83073735|FG000|Overall Study|Protocol deviation|21|||
46857988|NCT03636542|83073747|FG000|Overall Study|Lost to Follow-up|1|||
46980713|NCT02418819|83226584|FG003|Overall Study|Adverse Event|0|||
46980714|NCT02418819|83226581|FG000|Overall Study|Lost to Follow-up|1|||
46980715|NCT02418819|83226582|FG001|Overall Study|Lost to Follow-up|0|||
46857989|NCT03636542|83073748|FG001|Overall Study|Lost to Follow-up|1|||
46857990|NCT03636542|83073747|FG000|Overall Study|Physician Decision|0|||
46857991|NCT03636542|83073748|FG001|Overall Study|Physician Decision|1|||
46857992|NCT03636542|83073747|FG000|Overall Study|Withdrawal by Subject|1|||
46857993|NCT03636542|83073748|FG001|Overall Study|Withdrawal by Subject|0|||
46857994|NCT03305770|83073756|FG000|Overall Study|Physician Decision - prior to dispense|0|||
46857995|NCT03305770|83073757|FG001|Overall Study|Physician Decision - prior to dispense|1|||
46857996|NCT03305770|83073756|FG000|Overall Study|Subject moved|1|||
46857997|NCT03305770|83073757|FG001|Overall Study|Subject moved|0|||
46857998|NCT00086190|83073768|FG000|Overall Study|Adverse Event|6|||
46798360|NCT00516321|83017048|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
46798361|NCT00516321|83017046|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
46798362|NCT00516321|83017047|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
46798363|NCT00516321|83017048|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
46798364|NCT00516321|83017046|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
46798365|NCT00516321|83017047|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
46798366|NCT00516321|83017048|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
46798367|NCT00516321|83017046|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
46798368|NCT00516321|83017047|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
46798369|NCT00516321|83017048|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
46798370|NCT00516321|83017046|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
46798371|NCT00516321|83017047|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
46857999|NCT00086190|83073769|FG001|Overall Study|Adverse Event|2|||
46980716|NCT02418819|83226583|FG002|Overall Study|Lost to Follow-up|0|||
46980717|NCT02418819|83226584|FG003|Overall Study|Lost to Follow-up|0|||
46980718|NCT02418819|83226581|FG000|Overall Study|No longer meets eligibility criteria|0|||
46858000|NCT00086190|83073770|FG002|Overall Study|Adverse Event|2|||
46858001|NCT00086190|83073768|FG000|Overall Study|Withdrawal by Subject|0|||
46858002|NCT00086190|83073769|FG001|Overall Study|Withdrawal by Subject|2|||
46980719|NCT02418819|83226582|FG001|Overall Study|No longer meets eligibility criteria|0|||
46980720|NCT02418819|83226583|FG002|Overall Study|No longer meets eligibility criteria|1|||
46980721|NCT02418819|83226584|FG003|Overall Study|No longer meets eligibility criteria|0|||
46980722|NCT02418819|83226581|FG000|Overall Study|No longer willing to participate|0|||
46980723|NCT02418819|83226582|FG001|Overall Study|No longer willing to participate|0|||
46980724|NCT02418819|83226583|FG002|Overall Study|No longer willing to participate|2|||
46980725|NCT02418819|83226584|FG003|Overall Study|No longer willing to participate|1|||
46980726|NCT02576639|83226599|FG000|Overall Study|Withdrawal by Subject|1|||
46980727|NCT02576639|83226600|FG001|Overall Study|Withdrawal by Subject|2|||
46980728|NCT02576639|83226601|FG002|Overall Study|Withdrawal by Subject|1|||
46980729|NCT02576639|83226602|FG003|Overall Study|Withdrawal by Subject|0|||
46980730|NCT02576639|83226603|FG004|Overall Study|Withdrawal by Subject|1|||
46980731|NCT02576639|83226599|FG000|Overall Study|Adverse Event|1|||
46980732|NCT02576639|83226600|FG001|Overall Study|Adverse Event|0|||
46980733|NCT02576639|83226601|FG002|Overall Study|Adverse Event|1|||
46980734|NCT02576639|83226602|FG003|Overall Study|Adverse Event|1|||
46980735|NCT02576639|83226603|FG004|Overall Study|Adverse Event|2|||
46980736|NCT02576639|83226599|FG000|Overall Study|Physician Decision|0|||
46980737|NCT02576639|83226600|FG001|Overall Study|Physician Decision|0|||
46980738|NCT02576639|83226601|FG002|Overall Study|Physician Decision|0|||
46980739|NCT02576639|83226602|FG003|Overall Study|Physician Decision|0|||
46980740|NCT02576639|83226603|FG004|Overall Study|Physician Decision|1|||
46858003|NCT00086190|83073770|FG002|Overall Study|Withdrawal by Subject|2|||
46858004|NCT00086190|83073768|FG000|Overall Study|Protocol Violation|1|||
46858005|NCT00086190|83073769|FG001|Overall Study|Protocol Violation|0|||
46858006|NCT00086190|83073770|FG002|Overall Study|Protocol Violation|0|||
46858007|NCT00086190|83073768|FG000|Overall Study|Moved|1|||
46858008|NCT00086190|83073769|FG001|Overall Study|Moved|0|||
46980741|NCT02418585|83226621|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
46980742|NCT02418585|83226622|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
46798372|NCT00516321|83017048|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
46798373|NCT00516321|83017046|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
46980743|NCT02418585|83226621|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
46980744|NCT02418585|83226622|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
46980745|NCT02418585|83226621|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
46980746|NCT02418585|83226622|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
46980747|NCT02418585|83226621|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
46980748|NCT02418585|83226622|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
46980749|NCT02418585|83226621|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
46798374|NCT00516321|83017047|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
46980750|NCT02418585|83226622|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
46980751|NCT02418585|83226621|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
46980752|NCT02418585|83226622|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
46980753|NCT02418585|83226621|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
46980754|NCT02418585|83226622|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
46798375|NCT00516321|83017048|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
46798376|NCT00516321|83017046|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
46798377|NCT00516321|83017047|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
46798378|NCT00516321|83017048|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
46798379|NCT00516321|83017046|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
46798380|NCT00516321|83017047|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
46798381|NCT00516321|83017048|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
46798382|NCT00460408|83017060|FG000|Overall Study|Adverse Event|1|||
46798383|NCT00460408|83017061|FG001|Overall Study|Adverse Event|0|||
46858009|NCT00086190|83073770|FG002|Overall Study|Moved|0|||
46858010|NCT00086190|83073768|FG000|Overall Study|Worsening depression|0|||
46858011|NCT00086190|83073769|FG001|Overall Study|Worsening depression|0|||
46980755|NCT02418585|83226621|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
46980756|NCT02418585|83226622|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
46980757|NCT02418585|83226621|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
46980758|NCT02418585|83226622|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
46980759|NCT02418585|83226621|FG000|Follow-up Phase (24 Weeks)|Other|3|||
46980760|NCT02418585|83226622|FG001|Follow-up Phase (24 Weeks)|Other|2|||
46980761|NCT02417961|83226630|FG000|Overall Study|Adverse Event|1|||
46980762|NCT02417961|83226630|FG000|Overall Study|Lost to Follow-up|1|||
46980763|NCT02417961|83226630|FG000|Overall Study|Withdrawal by Subject|2|||
46980764|NCT01596127|83226634|FG000|Overall Study|Patient Ineligible|1|||
46980765|NCT01595581|83226640|FG000|Overall Study|Withdrawal by Subject|1|||
46980766|NCT01595581|83226641|FG001|Overall Study|Withdrawal by Subject|0|||
46980767|NCT01610687|83226649|FG000|Overall Study|Lack of Efficacy|26|||
46980768|NCT01610687|83226649|FG000|Overall Study|Adverse Event|18|||
46980769|NCT01610687|83226649|FG000|Overall Study|Moved out of area|6|||
46980770|NCT01610687|83226649|FG000|Overall Study|Withdrawal by Subject|7|||
46980771|NCT01610687|83226649|FG000|Overall Study|Lost to Follow-up|4|||
46980772|NCT01610687|83226649|FG000|Overall Study|Symptom control without study medication|2|||
46980773|NCT01610687|83226649|FG000|Overall Study|Unable to make journey|1|||
46798384|NCT00460408|83017062|FG002|Overall Study|Adverse Event|0|||
46980774|NCT01610687|83226649|FG000|Overall Study|Death|1|||
46980775|NCT01610687|83226649|FG000|Overall Study|Cannabis affecting job|1|||
46980776|NCT01610687|83226649|FG000|Overall Study|Felt more alter without study medication|1|||
46980777|NCT02615509|83226653|FG000|Overall Study|Lost to Follow-up|134|||
46980778|NCT02615509|83226653|FG000|Overall Study|Death|4|||
46980779|NCT02615509|83226653|FG000|Overall Study|Withdrawal by Subject|8|||
46980780|NCT02575079|83226659|FG000|Overall Study|Death|3|||
46980781|NCT02575079|83226660|FG001|Overall Study|Death|0|||
46980782|NCT02575079|83226659|FG000|Overall Study|Withdrawal by Subject|3|||
46980783|NCT02575079|83226660|FG001|Overall Study|Withdrawal by Subject|0|||
46980784|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Adverse Event|10|||
46980785|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Adverse Event|9|||
46980786|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Adverse Event|7|||
46980787|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
46980788|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
46798385|NCT00460408|83017063|FG003|Overall Study|Adverse Event|0|||
46980789|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
46980790|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
46980791|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
46980792|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
46980793|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Physician Decision|7|||
46980794|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Physician Decision|3|||
46980795|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Physician Decision|2|||
46980796|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Pregnancy|2|||
46980797|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Pregnancy|1|||
46980798|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Pregnancy|3|||
46980799|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
46980800|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
46980801|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
46980802|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
46980803|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
46980804|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
46980805|NCT02614183|83226668|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
46980806|NCT02614183|83226669|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
46980807|NCT02614183|83226670|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
46980808|NCT02614183|83226668|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
46980809|NCT02614183|83226669|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
46980810|NCT02614183|83226670|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
46980811|NCT02614183|83226668|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
46980812|NCT02614183|83226669|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
46980813|NCT02614183|83226670|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
46980814|NCT02614183|83226668|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
46980815|NCT02614183|83226669|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
46980816|NCT02614183|83226670|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
46980817|NCT02614183|83226668|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
46980818|NCT02614183|83226669|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
46980819|NCT02614183|83226670|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
46980820|NCT02612155|83226695|FG000|Overall Study|Death|1|||
46980821|NCT02612155|83226696|FG001|Overall Study|Death|1|||
46980822|NCT02612155|83226695|FG000|Overall Study|Lost to Follow-up|2|||
46980823|NCT02612155|83226696|FG001|Overall Study|Lost to Follow-up|2|||
46798386|NCT00460408|83017060|FG000|Overall Study|Death|7|||
46798387|NCT00460408|83017061|FG001|Overall Study|Death|0|||
46798388|NCT00460408|83017062|FG002|Overall Study|Death|0|||
46798389|NCT00460408|83017063|FG003|Overall Study|Death|0|||
46798390|NCT00460408|83017060|FG000|Overall Study|Lost to Follow-up|11|||
46798391|NCT00460408|83017061|FG001|Overall Study|Lost to Follow-up|0|||
46980824|NCT02614729|83226704|FG000|Overall Study|Withdrawal by Subject|1|||
46980825|NCT02614729|83226705|FG001|Overall Study|Withdrawal by Subject|0|||
46980826|NCT02613871|83226713|FG000|Overall Study|Death|2|||
46980827|NCT02613871|83226713|FG000|Overall Study|Withdrew Consent|1|||
46980828|NCT05021081|83226719|FG000|Phase 2|Subject enrolled in error|1|||
46980829|NCT05021081|83226720|FG001|Phase 2|Subject enrolled in error|1|||
46980830|NCT05021081|83226721|FG002|Phase 2|Subject enrolled in error|0|||
46980831|NCT02612077|83226737|FG000|Overall Study|Adverse Event|3|||
46798392|NCT00460408|83017062|FG002|Overall Study|Lost to Follow-up|1|||
46980832|NCT02612077|83226737|FG000|Overall Study|Withdrawal by Subject|9|||
46980833|NCT02612077|83226737|FG000|Overall Study|Protocol Violation|28|||
46980834|NCT02612077|83226737|FG000|Overall Study|Lost to Follow-up|20|||
46980835|NCT02612077|83226737|FG000|Overall Study|Death|377|||
46980836|NCT02612077|83226737|FG000|Overall Study|Moved or Changed Medical Team|23|||
46980837|NCT02612077|83226737|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
46980838|NCT02612077|83226737|FG000|Overall Study|Disease Progression|3|||
46980839|NCT02612077|83226737|FG000|Overall Study|Unknown reason|2|||
46980840|NCT02613481|83226744|FG000|Overall Study|Lost to Follow-up|7|||
46980841|NCT02613481|83226744|FG000|Overall Study|Withdrawal by Subject|2|||
46980842|NCT02613403|83226752|FG000|Overall Study|Lost to Follow-up|0|||
46980843|NCT02613403|83226753|FG001|Overall Study|Lost to Follow-up|1|||
46980844|NCT02613403|83226754|FG002|Overall Study|Lost to Follow-up|0|||
46980845|NCT02613403|83226755|FG003|Overall Study|Lost to Follow-up|0|||
46980846|NCT02613403|83226756|FG004|Overall Study|Lost to Follow-up|0|||
46980847|NCT02613403|83226752|FG000|Overall Study|Withdrawal by Subject|2|||
46980848|NCT02613403|83226753|FG001|Overall Study|Withdrawal by Subject|0|||
46980849|NCT02613403|83226754|FG002|Overall Study|Withdrawal by Subject|0|||
46980850|NCT02613403|83226755|FG003|Overall Study|Withdrawal by Subject|0|||
46980851|NCT02613403|83226756|FG004|Overall Study|Withdrawal by Subject|0|||
46980852|NCT02572817|83226768|FG000|Overall Study|Death|6|||
46980853|NCT02572817|83226769|FG001|Overall Study|Death|3|||
46980854|NCT02572817|83226768|FG000|Overall Study|Lost to Follow-up|3|||
46980855|NCT02572817|83226769|FG001|Overall Study|Lost to Follow-up|3|||
46980856|NCT02566109|83226775|FG000|Overall Study|Withdrawal by Subject|1|||
46980857|NCT02566031|83226781|FG000|Overall Study|Patient/guardian decision|14|||
46980858|NCT02566031|83226782|FG001|Overall Study|Patient/guardian decision|7|||
46980859|NCT02566031|83226781|FG000|Overall Study|Protocol deviation|2|||
46980860|NCT02566031|83226782|FG001|Overall Study|Protocol deviation|3|||
46708070|NCT01147458|82923547|FG003|Second Intervention|Adverse Event|1|||
46680946|NCT01379703|82896671|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
46680947|NCT01379703|82896672|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
46680948|NCT01379703|82896673|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
46680949|NCT01379703|82896671|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
46680950|NCT01379703|82896672|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
46798393|NCT00460408|83017063|FG003|Overall Study|Lost to Follow-up|0|||
46798394|NCT00460408|83017060|FG000|Overall Study|Withdrawal by Subject|31|||
46798395|NCT00460408|83017061|FG001|Overall Study|Withdrawal by Subject|0|||
46798396|NCT00460408|83017062|FG002|Overall Study|Withdrawal by Subject|0|||
46980861|NCT02566031|83226781|FG000|Overall Study|Adverse Event|3|||
46980862|NCT02566031|83226782|FG001|Overall Study|Adverse Event|1|||
46980863|NCT02566031|83226781|FG000|Overall Study|Lost to Follow-up|1|||
46980864|NCT02566031|83226782|FG001|Overall Study|Lost to Follow-up|1|||
46980865|NCT02569853|83226791|FG000|Overall Study|Adverse Event|2|||
46980866|NCT02569853|83226792|FG001|Overall Study|Adverse Event|0|||
46980867|NCT02569853|83226791|FG000|Overall Study|Withdrawal by Subject|3|||
46980868|NCT02569853|83226792|FG001|Overall Study|Withdrawal by Subject|2|||
46980869|NCT02569853|83226791|FG000|Overall Study|Lost to Follow-up|3|||
46980870|NCT02569853|83226792|FG001|Overall Study|Lost to Follow-up|3|||
46980871|NCT02569853|83226791|FG000|Overall Study|Protocol Violation|1|||
46980872|NCT02569853|83226792|FG001|Overall Study|Protocol Violation|1|||
46980873|NCT02569853|83226791|FG000|Overall Study|Did not experience migraine attack|10|||
46980874|NCT02569853|83226792|FG001|Overall Study|Did not experience migraine attack|7|||
46980875|NCT02569853|83226791|FG000|Overall Study|Physician Decision|1|||
46980876|NCT02569853|83226792|FG001|Overall Study|Physician Decision|1|||
46980877|NCT02570711|83226802|FG000|Overall Study|Death|1|||
46980878|NCT02570711|83226803|FG001|Overall Study|Death|0|||
46980879|NCT02570711|83226802|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
46980880|NCT02570711|83226803|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
46980881|NCT02570165|83226816|FG000|Overall Study|Adverse Event|1|||
46980882|NCT02570165|83226817|FG001|Overall Study|Adverse Event|0|||
46980883|NCT02570165|83226818|FG002|Overall Study|Adverse Event|2|||
46980884|NCT02570165|83226819|FG003|Overall Study|Adverse Event|0|||
46980885|NCT02570165|83226820|FG004|Overall Study|Adverse Event|0|||
46980886|NCT02570165|83226821|FG005|Overall Study|Adverse Event|0|||
46980887|NCT02570165|83226822|FG006|Overall Study|Adverse Event|0|||
46980888|NCT02570165|83226816|FG000|Overall Study|Lack of Efficacy|0|||
46980889|NCT02570165|83226817|FG001|Overall Study|Lack of Efficacy|1|||
46798397|NCT00460408|83017063|FG003|Overall Study|Withdrawal by Subject|0|||
46980890|NCT02570165|83226818|FG002|Overall Study|Lack of Efficacy|0|||
46980891|NCT02570165|83226819|FG003|Overall Study|Lack of Efficacy|0|||
46980892|NCT02570165|83226820|FG004|Overall Study|Lack of Efficacy|4|||
46980893|NCT02570165|83226821|FG005|Overall Study|Lack of Efficacy|0|||
46980894|NCT02570165|83226822|FG006|Overall Study|Lack of Efficacy|0|||
46980895|NCT02570165|83226816|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
46980896|NCT02570165|83226817|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
46980897|NCT02570165|83226818|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
46980898|NCT02570165|83226819|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
46980899|NCT02570165|83226820|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
46980900|NCT02570165|83226821|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
46980901|NCT02570165|83226822|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
46980902|NCT02570165|83226816|FG000|Overall Study|Lost to Follow-up|0|||
46980903|NCT02570165|83226817|FG001|Overall Study|Lost to Follow-up|0|||
46798398|NCT00460408|83017060|FG000|Overall Study|Insufficient clinical response|5|||
46980904|NCT02570165|83226818|FG002|Overall Study|Lost to Follow-up|1|||
46980905|NCT02570165|83226819|FG003|Overall Study|Lost to Follow-up|1|||
46980906|NCT02570165|83226820|FG004|Overall Study|Lost to Follow-up|0|||
46980907|NCT02570165|83226821|FG005|Overall Study|Lost to Follow-up|0|||
46980908|NCT02570165|83226822|FG006|Overall Study|Lost to Follow-up|0|||
46980909|NCT02570165|83226816|FG000|Overall Study|Physician Decision|0|||
46980910|NCT02570165|83226817|FG001|Overall Study|Physician Decision|1|||
46980911|NCT02570165|83226818|FG002|Overall Study|Physician Decision|0|||
46980912|NCT02570165|83226819|FG003|Overall Study|Physician Decision|0|||
46980913|NCT02570165|83226820|FG004|Overall Study|Physician Decision|0|||
46980914|NCT02570165|83226821|FG005|Overall Study|Physician Decision|0|||
46980915|NCT02570165|83226822|FG006|Overall Study|Physician Decision|0|||
46980916|NCT02570165|83226816|FG000|Overall Study|Withdrawal by Subject|0|||
46980917|NCT02570165|83226817|FG001|Overall Study|Withdrawal by Subject|0|||
46980918|NCT02570165|83226818|FG002|Overall Study|Withdrawal by Subject|0|||
46980919|NCT02570165|83226819|FG003|Overall Study|Withdrawal by Subject|2|||
46980920|NCT02570165|83226820|FG004|Overall Study|Withdrawal by Subject|1|||
46980921|NCT02570165|83226821|FG005|Overall Study|Withdrawal by Subject|0|||
46980922|NCT02570165|83226822|FG006|Overall Study|Withdrawal by Subject|0|||
46980923|NCT02570165|83226816|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
46980924|NCT02570165|83226817|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
46980925|NCT02570165|83226818|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
46980926|NCT02570165|83226819|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
46980927|NCT02570165|83226820|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
46980928|NCT02570165|83226821|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
46980929|NCT02570165|83226822|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
46980930|NCT02570165|83226816|FG000|Overall Study|Withdrawal Request by GSK|0|||
46980931|NCT02570165|83226817|FG001|Overall Study|Withdrawal Request by GSK|0|||
46980932|NCT02570165|83226818|FG002|Overall Study|Withdrawal Request by GSK|2|||
46980933|NCT02570165|83226819|FG003|Overall Study|Withdrawal Request by GSK|0|||
46980934|NCT02570165|83226820|FG004|Overall Study|Withdrawal Request by GSK|0|||
46980935|NCT02570165|83226821|FG005|Overall Study|Withdrawal Request by GSK|0|||
46980936|NCT02570165|83226822|FG006|Overall Study|Withdrawal Request by GSK|0|||
46980937|NCT02564471|83226842|FG000|Overall Study|Adverse Event|1|||
46980938|NCT02564471|83226843|FG001|Overall Study|Adverse Event|0|||
46980939|NCT02564471|83226844|FG002|Overall Study|Adverse Event|0|||
46980940|NCT02564471|83226845|FG003|Overall Study|Adverse Event|0|||
46980941|NCT02564471|83226842|FG000|Overall Study|Withdrawal by Subject|2|||
46980942|NCT02564471|83226843|FG001|Overall Study|Withdrawal by Subject|1|||
46980943|NCT02564471|83226844|FG002|Overall Study|Withdrawal by Subject|3|||
46980944|NCT02564471|83226845|FG003|Overall Study|Withdrawal by Subject|0|||
46980945|NCT02564471|83226842|FG000|Overall Study|Lost to Follow-up|0|||
46980946|NCT02564471|83226843|FG001|Overall Study|Lost to Follow-up|2|||
46980947|NCT02564471|83226844|FG002|Overall Study|Lost to Follow-up|0|||
46980948|NCT02564471|83226845|FG003|Overall Study|Lost to Follow-up|0|||
46980949|NCT02563067|83226858|FG000|Overall Study|Subject/guardian decision|14|||
46980950|NCT02563067|83226859|FG001|Overall Study|Subject/guardian decision|20|||
46980951|NCT02563067|83226860|FG002|Overall Study|Subject/guardian decision|16|||
46980952|NCT02563067|83226858|FG000|Overall Study|Physician Decision|0|||
46980953|NCT02563067|83226859|FG001|Overall Study|Physician Decision|1|||
46980954|NCT02563067|83226860|FG002|Overall Study|Physician Decision|3|||
46980955|NCT02563067|83226858|FG000|Overall Study|Lost to Follow-up|1|||
46980956|NCT02563067|83226859|FG001|Overall Study|Lost to Follow-up|2|||
46980957|NCT02563067|83226860|FG002|Overall Study|Lost to Follow-up|0|||
46980958|NCT02563067|83226858|FG000|Overall Study|Technical problems|0|||
46980959|NCT02563067|83226859|FG001|Overall Study|Technical problems|1|||
46980960|NCT02563067|83226860|FG002|Overall Study|Technical problems|0|||
46980961|NCT02563067|83226858|FG000|Overall Study|Lack of Efficacy|1|||
46980962|NCT02563067|83226859|FG001|Overall Study|Lack of Efficacy|0|||
46980963|NCT02563067|83226860|FG002|Overall Study|Lack of Efficacy|0|||
46980964|NCT02563067|83226858|FG000|Overall Study|Death|0|||
46980965|NCT02563067|83226859|FG001|Overall Study|Death|1|||
46980966|NCT02563067|83226860|FG002|Overall Study|Death|1|||
46980967|NCT02563067|83226858|FG000|Overall Study|Adverse Event|2|||
46980968|NCT02563067|83226859|FG001|Overall Study|Adverse Event|1|||
46980969|NCT02563067|83226860|FG002|Overall Study|Adverse Event|0|||
46980970|NCT02563067|83226858|FG000|Overall Study|Death post Treatment/safety period|1|||
46980971|NCT02563067|83226859|FG001|Overall Study|Death post Treatment/safety period|0|||
46980972|NCT02563067|83226860|FG002|Overall Study|Death post Treatment/safety period|0|||
46980973|NCT02568683|83226870|FG000|Overall Study|Death|0|||
46680951|NCT01379703|82896673|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
46980974|NCT02568683|83226871|FG001|Overall Study|Death|2|||
46980975|NCT02568683|83226870|FG000|Overall Study|Withdrew Consent|1|||
46980976|NCT02568683|83226871|FG001|Overall Study|Withdrew Consent|0|||
46980977|NCT02568683|83226870|FG000|Overall Study|Study Terminated By Sponsor|5|||
46680952|NCT01379703|82896671|FG000|9 Months Through 18 Months|Fatigue|0|||
46680953|NCT01379703|82896672|FG001|9 Months Through 18 Months|Fatigue|1|||
46680954|NCT01379703|82896673|FG002|9 Months Through 18 Months|Fatigue|0|||
46980978|NCT02568683|83226871|FG001|Overall Study|Study Terminated By Sponsor|2|||
46980979|NCT02563925|83226877|FG000|Overall Study|Withdrawal by Subject|2|||
46980980|NCT01663727|83226884|FG000|Overall Study|Death|161|||
46980981|NCT01663727|83226885|FG001|Overall Study|Death|155|||
46980982|NCT01663727|83226884|FG000|Overall Study|Lost to Follow-up|10|||
46980983|NCT01663727|83226885|FG001|Overall Study|Lost to Follow-up|8|||
46980984|NCT01663727|83226884|FG000|Overall Study|Withdrawal by Subject|18|||
46980985|NCT01663727|83226885|FG001|Overall Study|Withdrawal by Subject|25|||
46980986|NCT01663727|83226884|FG000|Overall Study|Study Terminated|51|||
46980987|NCT01663727|83226885|FG001|Overall Study|Study Terminated|50|||
46980988|NCT01663727|83226884|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
46708071|NCT01147458|82923544|FG000|Second Intervention|Other|0|||
46980989|NCT01663727|83226885|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
46980990|NCT01663727|83226884|FG000|Overall Study|Withdrawal prior to dosing.|1|||
46980991|NCT01663727|83226885|FG001|Overall Study|Withdrawal prior to dosing.|0|||
46980992|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
46980993|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
46980994|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
46980995|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
46980996|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
46980997|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
46980998|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
46980999|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
46981000|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
46981001|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
46981002|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
46981003|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46680955|NCT01379703|82896671|FG000|9 Months Through 18 Months|Reason Unknown|0|||
46680956|NCT01379703|82896672|FG001|9 Months Through 18 Months|Reason Unknown|23|||
46680957|NCT01379703|82896673|FG002|9 Months Through 18 Months|Reason Unknown|0|||
46680958|NCT01335477|82896684|FG000|Overall Study|Adverse Event|30|||
46680959|NCT01335477|82896685|FG001|Overall Study|Adverse Event|42|||
46680960|NCT01335477|82896684|FG000|Overall Study|Non compliant with protocol|0|||
46680961|NCT01335477|82896685|FG001|Overall Study|Non compliant with protocol|2|||
46680962|NCT01335477|82896684|FG000|Overall Study|Lost to Follow-up|1|||
46680963|NCT01335477|82896685|FG001|Overall Study|Lost to Follow-up|2|||
46680964|NCT01335477|82896684|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
46680965|NCT01335477|82896685|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
46680966|NCT01335477|82896684|FG000|Overall Study|Not treated|1|||
46680967|NCT01335477|82896685|FG001|Overall Study|Not treated|2|||
46680968|NCT01335477|82896684|FG000|Overall Study|Reason other than those stated above|2|||
46680969|NCT01335477|82896685|FG001|Overall Study|Reason other than those stated above|2|||
46680970|NCT01371825|82896691|FG000|Overall Study|Death|4|||
46680971|NCT01371747|82896701|FG000|Overall Study|Adverse Event|4|||
46680972|NCT01371747|82896702|FG001|Overall Study|Adverse Event|2|||
46680973|NCT01371747|82896703|FG002|Overall Study|Adverse Event|7|||
46680974|NCT01371747|82896704|FG003|Overall Study|Adverse Event|2|||
46680975|NCT01371747|82896705|FG004|Overall Study|Adverse Event|2|||
46680976|NCT01371747|82896706|FG005|Overall Study|Adverse Event|2|||
46680977|NCT01371747|82896701|FG000|Overall Study|Death|1|||
46680978|NCT01371747|82896702|FG001|Overall Study|Death|0|||
46680979|NCT01371747|82896703|FG002|Overall Study|Death|4|||
46680980|NCT01371747|82896704|FG003|Overall Study|Death|1|||
46680981|NCT01371747|82896705|FG004|Overall Study|Death|2|||
46680982|NCT01371747|82896706|FG005|Overall Study|Death|0|||
46680983|NCT01371747|82896701|FG000|Overall Study|Abnormal Renal Function|0|||
46680984|NCT01371747|82896702|FG001|Overall Study|Abnormal Renal Function|2|||
46680985|NCT01371747|82896703|FG002|Overall Study|Abnormal Renal Function|0|||
46680986|NCT01371747|82896704|FG003|Overall Study|Abnormal Renal Function|1|||
46798399|NCT00460408|83017061|FG001|Overall Study|Insufficient clinical response|1|||
46798400|NCT00460408|83017062|FG002|Overall Study|Insufficient clinical response|5|||
46798401|NCT00460408|83017063|FG003|Overall Study|Insufficient clinical response|0|||
46798402|NCT00460408|83017060|FG000|Overall Study|Other|12|||
46798403|NCT00460408|83017061|FG001|Overall Study|Other|2|||
46798404|NCT00460408|83017062|FG002|Overall Study|Other|0|||
46981004|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
46680987|NCT01371747|82896705|FG004|Overall Study|Abnormal Renal Function|0|||
46680988|NCT01371747|82896706|FG005|Overall Study|Abnormal Renal Function|1|||
46680989|NCT01371747|82896701|FG000|Overall Study|High Serum Potassium Results|1|||
46680990|NCT01371747|82896702|FG001|Overall Study|High Serum Potassium Results|1|||
46680991|NCT01371747|82896703|FG002|Overall Study|High Serum Potassium Results|1|||
46680992|NCT01371747|82896704|FG003|Overall Study|High Serum Potassium Results|2|||
46680993|NCT01371747|82896705|FG004|Overall Study|High Serum Potassium Results|0|||
46680994|NCT01371747|82896706|FG005|Overall Study|High Serum Potassium Results|2|||
46680995|NCT01371747|82896701|FG000|Overall Study|Low Serum Potassium Results|1|||
46680996|NCT01371747|82896702|FG001|Overall Study|Low Serum Potassium Results|1|||
46680997|NCT01371747|82896703|FG002|Overall Study|Low Serum Potassium Results|1|||
46680998|NCT01371747|82896704|FG003|Overall Study|Low Serum Potassium Results|1|||
46680999|NCT01371747|82896705|FG004|Overall Study|Low Serum Potassium Results|0|||
46681000|NCT01371747|82896706|FG005|Overall Study|Low Serum Potassium Results|3|||
46681001|NCT01371747|82896701|FG000|Overall Study|Protocol Violation|0|||
46681002|NCT01371747|82896702|FG001|Overall Study|Protocol Violation|0|||
46681003|NCT01371747|82896703|FG002|Overall Study|Protocol Violation|1|||
46681004|NCT01371747|82896704|FG003|Overall Study|Protocol Violation|0|||
46681005|NCT01371747|82896705|FG004|Overall Study|Protocol Violation|0|||
46681006|NCT01371747|82896706|FG005|Overall Study|Protocol Violation|0|||
46681007|NCT01371747|82896701|FG000|Overall Study|Non-Compliance|3|||
46681008|NCT01371747|82896702|FG001|Overall Study|Non-Compliance|4|||
46681009|NCT01371747|82896703|FG002|Overall Study|Non-Compliance|3|||
46858012|NCT00086190|83073770|FG002|Overall Study|Worsening depression|2|||
46858013|NCT03320824|83073780|FG000|Overall Study|Withdrawal by Subject|8|||
46858014|NCT03320824|83073781|FG001|Overall Study|Withdrawal by Subject|1|||
46858015|NCT03320824|83073780|FG000|Overall Study|Lost to Follow-up|10|||
46858016|NCT03320824|83073781|FG001|Overall Study|Lost to Follow-up|1|||
46858017|NCT03320824|83073780|FG000|Overall Study|moved out of state|0|||
46681010|NCT01371747|82896704|FG003|Overall Study|Non-Compliance|0|||
46681011|NCT01371747|82896705|FG004|Overall Study|Non-Compliance|0|||
46681012|NCT01371747|82896706|FG005|Overall Study|Non-Compliance|1|||
46681013|NCT01371747|82896701|FG000|Overall Study|Physician Decision|0|||
46858018|NCT03320824|83073781|FG001|Overall Study|moved out of state|1|||
46858019|NCT03320824|83073780|FG000|Overall Study|could not complete final visit|0|||
46858020|NCT03320824|83073781|FG001|Overall Study|could not complete final visit|1|||
46858021|NCT03275350|83073793|FG000|Overall Study|Lost to Follow-up|4|||
46858022|NCT03275350|83073794|FG001|Overall Study|Lost to Follow-up|6|||
46681014|NCT01371747|82896702|FG001|Overall Study|Physician Decision|0|||
46681015|NCT01371747|82896703|FG002|Overall Study|Physician Decision|0|||
46681016|NCT01371747|82896704|FG003|Overall Study|Physician Decision|0|||
46681017|NCT01371747|82896705|FG004|Overall Study|Physician Decision|1|||
46681018|NCT01371747|82896706|FG005|Overall Study|Physician Decision|0|||
46681019|NCT01371747|82896701|FG000|Overall Study|Withdrawal by Subject|6|||
46681020|NCT01371747|82896702|FG001|Overall Study|Withdrawal by Subject|12|||
46681021|NCT01371747|82896703|FG002|Overall Study|Withdrawal by Subject|5|||
46681022|NCT01371747|82896704|FG003|Overall Study|Withdrawal by Subject|2|||
46681023|NCT01371747|82896705|FG004|Overall Study|Withdrawal by Subject|2|||
46681024|NCT01371747|82896706|FG005|Overall Study|Withdrawal by Subject|4|||
46681025|NCT01371747|82896701|FG000|Overall Study|Other Reasons|2|||
46681026|NCT01371747|82896702|FG001|Overall Study|Other Reasons|1|||
46681027|NCT01371747|82896703|FG002|Overall Study|Other Reasons|2|||
46681028|NCT01371747|82896704|FG003|Overall Study|Other Reasons|0|||
46681029|NCT01371747|82896705|FG004|Overall Study|Other Reasons|0|||
46681030|NCT01371747|82896706|FG005|Overall Study|Other Reasons|1|||
46681031|NCT01371708|82896741|FG000|Overall Study|Insufficient clinical response|3|||
46681032|NCT01371708|82896742|FG001|Overall Study|Insufficient clinical response|2|||
46681033|NCT01371708|82896743|FG002|Overall Study|Insufficient clinical response|0|||
46681034|NCT01371708|82896741|FG000|Overall Study|Lost to Follow-up|5|||
46681035|NCT01371708|82896742|FG001|Overall Study|Lost to Follow-up|9|||
46681036|NCT01371708|82896743|FG002|Overall Study|Lost to Follow-up|7|||
46681037|NCT01371708|82896741|FG000|Overall Study|Protocol Violation|2|||
46681038|NCT01371708|82896742|FG001|Overall Study|Protocol Violation|1|||
46681039|NCT01371708|82896743|FG002|Overall Study|Protocol Violation|2|||
46681040|NCT01371708|82896741|FG000|Overall Study|No longer willing to participate|7|||
46681041|NCT01371708|82896742|FG001|Overall Study|No longer willing to participate|7|||
46681042|NCT01371708|82896743|FG002|Overall Study|No longer willing to participate|13|||
46681043|NCT01371708|82896741|FG000|Overall Study|Medication error/not related to AE|0|||
46681044|NCT01371708|82896742|FG001|Overall Study|Medication error/not related to AE|1|||
46681045|NCT01371708|82896743|FG002|Overall Study|Medication error/not related to AE|0|||
46681046|NCT01371708|82896741|FG000|Overall Study|Other|3|||
46681047|NCT01371708|82896742|FG001|Overall Study|Other|2|||
46681048|NCT01371708|82896743|FG002|Overall Study|Other|4|||
46681049|NCT01371708|82896741|FG000|Overall Study|Adverse Event|5|||
46681050|NCT01371708|82896742|FG001|Overall Study|Adverse Event|8|||
46681051|NCT01371708|82896743|FG002|Overall Study|Adverse Event|12|||
46681052|NCT01371708|82896741|FG000|Overall Study|Started but did not receive treatment|1|||
46681053|NCT01371708|82896742|FG001|Overall Study|Started but did not receive treatment|0|||
46681054|NCT01371708|82896743|FG002|Overall Study|Started but did not receive treatment|1|||
46681055|NCT01335399|82896755|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
46681056|NCT01335399|82896756|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
46681057|NCT01335399|82896755|FG000|Pre-treatment Period|Participant request to discontinue|0|||
46681058|NCT01335399|82896756|FG001|Pre-treatment Period|Participant request to discontinue|1|||
46681059|NCT01335399|82896755|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
46681060|NCT01335399|82896756|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
46681061|NCT01335399|82896755|FG000|Pre-treatment Period|Consent withdrawal|3|||
46858023|NCT03275350|83073793|FG000|Overall Study|Death|2|||
46858024|NCT03275350|83073794|FG001|Overall Study|Death|1|||
46681062|NCT01335399|82896756|FG001|Pre-treatment Period|Consent withdrawal|0|||
46681063|NCT01335399|82896755|FG000|Treatment Period|Disease progression|117|||
46681064|NCT01335399|82896756|FG001|Treatment Period|Disease progression|145|||
46681065|NCT01335399|82896755|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
46681066|NCT01335399|82896756|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
46681067|NCT01335399|82896755|FG000|Treatment Period|Study drug toxicity|52|||
46681068|NCT01335399|82896756|FG001|Treatment Period|Study drug toxicity|64|||
46681069|NCT01335399|82896755|FG000|Treatment Period|Participant request to discontinue|30|||
46681070|NCT01335399|82896756|FG001|Treatment Period|Participant request to discontinue|22|||
46681071|NCT01335399|82896755|FG000|Treatment Period|Other reasons|30|||
46681072|NCT01335399|82896756|FG001|Treatment Period|Other reasons|30|||
46681073|NCT01335399|82896755|FG000|Treatment Period|Consent withdrawal|10|||
46681074|NCT01335399|82896756|FG001|Treatment Period|Consent withdrawal|7|||
46681075|NCT01335399|82896755|FG000|Treatment Period|Death|7|||
46681076|NCT01335399|82896756|FG001|Treatment Period|Death|6|||
46681077|NCT01335399|82896755|FG000|Treatment Period|Poor/Non-compliance|3|||
46681078|NCT01335399|82896756|FG001|Treatment Period|Poor/Non-compliance|4|||
46681079|NCT01335399|82896755|FG000|Treatment Period|Lost to Follow-up|2|||
46681080|NCT01335399|82896756|FG001|Treatment Period|Lost to Follow-up|2|||
46798405|NCT00460408|83017063|FG003|Overall Study|Other|0|||
46681081|NCT01335399|82896755|FG000|Treatment Period|Maximum clinical benefit|1|||
46681082|NCT01335399|82896756|FG001|Treatment Period|Maximum clinical benefit|1|||
46708072|NCT01147458|82923545|FG001|Second Intervention|Other|0|||
46708073|NCT01147458|82923546|FG002|Second Intervention|Other|1|||
46681083|NCT01335399|82896755|FG000|Treatment Period|No longer meet study criteria|1|||
46681084|NCT01335399|82896756|FG001|Treatment Period|No longer meet study criteria|1|||
46681085|NCT01335399|82896755|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
46681086|NCT01335399|82896756|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
46681087|NCT01366521|82896766|FG000|Overall Study|Adverse Event|1|||
46681088|NCT01366521|82896767|FG001|Overall Study|Adverse Event|0|||
46681089|NCT01366521|82896768|FG002|Overall Study|Adverse Event|0|||
46681090|NCT01366521|82896769|FG003|Overall Study|Adverse Event|0|||
46681091|NCT01366521|82896766|FG000|Overall Study|Protocol Violation|0|||
46681092|NCT01366521|82896767|FG001|Overall Study|Protocol Violation|0|||
46681093|NCT01366521|82896768|FG002|Overall Study|Protocol Violation|1|||
46681094|NCT01366521|82896769|FG003|Overall Study|Protocol Violation|0|||
46681095|NCT01366521|82896766|FG000|Overall Study|Physician Decision|0|||
46681096|NCT01366521|82896767|FG001|Overall Study|Physician Decision|0|||
46681097|NCT01366521|82896768|FG002|Overall Study|Physician Decision|1|||
46681098|NCT01366521|82896769|FG003|Overall Study|Physician Decision|0|||
46681099|NCT01366521|82896766|FG000|Overall Study|Withdrawal by Subject|0|||
46681100|NCT01366521|82896767|FG001|Overall Study|Withdrawal by Subject|1|||
46681101|NCT01366521|82896768|FG002|Overall Study|Withdrawal by Subject|0|||
46681102|NCT01366521|82896769|FG003|Overall Study|Withdrawal by Subject|0|||
46681103|NCT01335009|82896783|FG000|Overall Study|Too ill to travel to study sites|1|||
46681104|NCT01335009|82896784|FG001|Overall Study|Too ill to travel to study sites|0|||
46681105|NCT01335009|82896783|FG000|Overall Study|Death|28|||
46681106|NCT01335009|82896784|FG001|Overall Study|Death|32|||
46681107|NCT01335009|82896783|FG000|Overall Study|Withdrawal by Subject|1|||
46681108|NCT01335009|82896784|FG001|Overall Study|Withdrawal by Subject|1|||
46681109|NCT01335009|82896783|FG000|Overall Study|Lost to Follow-up|1|||
46681110|NCT01335009|82896784|FG001|Overall Study|Lost to Follow-up|0|||
46681111|NCT01366443|82896799|FG000|Overall Study|Lost to Follow-up|2|||
46681112|NCT01366443|82896799|FG000|Overall Study|Under 18 yo|1|||
46681113|NCT01332630|82896804|FG000|Overall Study|Withdrawal by Subject|3|||
46681114|NCT01366209|82896810|FG000|Overall Study|Adverse Event|6|||
46681115|NCT01366209|82896811|FG001|Overall Study|Adverse Event|7|||
46681116|NCT01366209|82896810|FG000|Overall Study|Withdrawal by Subject|4|||
46681117|NCT01366209|82896811|FG001|Overall Study|Withdrawal by Subject|4|||
46681118|NCT01366209|82896810|FG000|Overall Study|Death|12|||
46681119|NCT01366209|82896811|FG001|Overall Study|Death|19|||
46681120|NCT01366209|82896810|FG000|Overall Study|Lung transplantation|6|||
46681121|NCT01366209|82896811|FG001|Overall Study|Lung transplantation|1|||
46681122|NCT01366209|82896810|FG000|Overall Study|Lost to Follow-up|2|||
46681123|NCT01366209|82896811|FG001|Overall Study|Lost to Follow-up|1|||
46681124|NCT01366209|82896810|FG000|Overall Study|Physician Decision|1|||
46681125|NCT01366209|82896811|FG001|Overall Study|Physician Decision|0|||
46681126|NCT01366209|82896810|FG000|Overall Study|Sponsors decision|0|||
46681127|NCT01366209|82896811|FG001|Overall Study|Sponsors decision|1|||
46681128|NCT01366209|82896810|FG000|Overall Study|Withdrew consent|4|||
46681129|NCT01366209|82896811|FG001|Overall Study|Withdrew consent|3|||
46681130|NCT01365546|82896817|FG000|Overall Study|Withdrawal by Subject|1|||
46681131|NCT01365546|82896817|FG000|Overall Study|Screen failure|9|||
46681132|NCT01365546|82896817|FG000|Overall Study|Study termination|1|||
46681133|NCT01365507|82896827|FG000|Overall Study|Withdrawal Criteria|8|||
46681134|NCT01365507|82896828|FG001|Overall Study|Withdrawal Criteria|5|||
46681135|NCT01365507|82896827|FG000|Overall Study|Unclassified|1|||
46681136|NCT01365507|82896828|FG001|Overall Study|Unclassified|4|||
46681137|NCT01365468|82896852|FG000|Overall Study|Physician Decision|1|||
46681138|NCT01365468|82896853|FG001|Overall Study|Physician Decision|0|||
46681139|NCT01365468|82896852|FG000|Overall Study|Disease progression|1|||
46681140|NCT01365468|82896853|FG001|Overall Study|Disease progression|0|||
46681141|NCT01365468|82896852|FG000|Overall Study|Lost to Follow-up|2|||
46681142|NCT01365468|82896853|FG001|Overall Study|Lost to Follow-up|0|||
46681143|NCT01357980|82896864|FG000|Overall Study|Lack of Efficacy|0|||
46681144|NCT01357980|82896865|FG001|Overall Study|Lack of Efficacy|1|||
46681145|NCT01357980|82896866|FG002|Overall Study|Lack of Efficacy|0|||
46681146|NCT01357980|82896867|FG003|Overall Study|Lack of Efficacy|0|||
46681147|NCT01357980|82896864|FG000|Overall Study|Consent withdrawn|0|||
46681148|NCT01357980|82896865|FG001|Overall Study|Consent withdrawn|0|||
46681149|NCT01357980|82896866|FG002|Overall Study|Consent withdrawn|1|||
46681150|NCT01357980|82896867|FG003|Overall Study|Consent withdrawn|0|||
46681151|NCT01332318|82896881|FG000|Overall Study|Adverse Event|0|||
46681152|NCT01332318|82896882|FG001|Overall Study|Adverse Event|3|||
46681153|NCT01332318|82896883|FG002|Overall Study|Adverse Event|0|||
46681154|NCT01332318|82896884|FG003|Overall Study|Adverse Event|0|||
46681155|NCT01332318|82896881|FG000|Overall Study|Withdrawal by Subject|1|||
46681156|NCT01332318|82896882|FG001|Overall Study|Withdrawal by Subject|1|||
46681157|NCT01332318|82896883|FG002|Overall Study|Withdrawal by Subject|0|||
46681158|NCT01332318|82896884|FG003|Overall Study|Withdrawal by Subject|1|||
46681159|NCT01332318|82896881|FG000|Overall Study|Protocol Violation|1|||
46681160|NCT01332318|82896882|FG001|Overall Study|Protocol Violation|0|||
46681161|NCT01332318|82896883|FG002|Overall Study|Protocol Violation|1|||
46681162|NCT01332318|82896884|FG003|Overall Study|Protocol Violation|1|||
46681163|NCT01331109|82896899|FG000|Overall Study|Adverse Event|6|||
46681164|NCT01331109|82896899|FG000|Overall Study|Lack of Efficacy|2|||
46981005|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
46981006|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
46981007|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
46981008|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
46981009|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
46981010|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
46981011|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
46681165|NCT01331109|82896899|FG000|Overall Study|Protocol Violation|3|||
46681166|NCT01331109|82896899|FG000|Overall Study|Withdrawal by Subject|7|||
46681167|NCT01331109|82896899|FG000|Overall Study|Lost to Follow-up|1|||
46858025|NCT03275350|83073793|FG000|Overall Study|Physician Decision|1|||
46858026|NCT03275350|83073794|FG001|Overall Study|Physician Decision|0|||
46981012|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
46981013|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
46681168|NCT01331109|82896899|FG000|Overall Study|Study Terminated by Sponsor|38|||
46681169|NCT01357551|82896905|FG000|Overall Study|Withdrawal by Subject|6|||
46858027|NCT03275350|83073793|FG000|Overall Study|Incarcerated|1|||
46681170|NCT01357551|82896906|FG001|Overall Study|Withdrawal by Subject|4|||
46681171|NCT01357551|82896905|FG000|Overall Study|Death|0|||
46681172|NCT01357551|82896906|FG001|Overall Study|Death|1|||
46681173|NCT01357551|82896905|FG000|Overall Study|Lost to Follow-up|16|||
46681174|NCT01357551|82896906|FG001|Overall Study|Lost to Follow-up|6|||
46681175|NCT01357239|82896919|FG000|Stratum: All Patients|Adverse Event|0|||
46681176|NCT01357239|82896920|FG001|Stratum: All Patients|Adverse Event|0|||
46681177|NCT01357239|82896921|FG002|Stratum: All Patients|Adverse Event|1|||
46681178|NCT01357239|82896922|FG003|Stratum: All Patients|Adverse Event|1|||
46858028|NCT03275350|83073794|FG001|Overall Study|Incarcerated|1|||
46981014|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
46798406|NCT00507819|83017073|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
46798407|NCT00507819|83017074|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
46681179|NCT01357239|82896919|FG000|Stratum: All Patients|Subject withdrew consent|0|||
46681180|NCT01357239|82896920|FG001|Stratum: All Patients|Subject withdrew consent|0|||
46681181|NCT01357239|82896921|FG002|Stratum: All Patients|Subject withdrew consent|1|||
46681182|NCT01357239|82896922|FG003|Stratum: All Patients|Subject withdrew consent|1|||
46681183|NCT01357239|82896919|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
46681184|NCT01357239|82896920|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
46681185|NCT01357239|82896921|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
46681186|NCT01357239|82896922|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
46681187|NCT01357239|82896919|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
46681188|NCT01357239|82896920|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
46681189|NCT01357239|82896921|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
46681190|NCT01357239|82896922|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
46708074|NCT01147458|82923547|FG003|Second Intervention|Other|0|||
46858029|NCT03319732|83073801|FG000|Overall Study|Adverse Event|40|||
46981015|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
46981016|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Screen failure|0|||
46981017|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Screen failure|1|||
46981018|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Screen failure|2|||
46981019|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Screen failure|0|||
46981020|NCT02614261|83226894|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
46981021|NCT02614261|83226895|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
46981022|NCT02614261|83226896|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
46681191|NCT01357239|82896919|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
46681192|NCT01357239|82896920|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
46681193|NCT01357239|82896921|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
46681194|NCT01357239|82896922|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
46681195|NCT01351350|82896940|FG000|Overall Study|Disease Progression|5|||
46681196|NCT01351350|82896941|FG001|Overall Study|Disease Progression|13|||
46681197|NCT01351350|82896942|FG002|Overall Study|Disease Progression|6|||
46681198|NCT01351350|82896943|FG003|Overall Study|Disease Progression|8|||
46681199|NCT01351350|82896944|FG004|Overall Study|Disease Progression|5|||
46681200|NCT01351350|82896940|FG000|Overall Study|Adverse Event|1|||
46681201|NCT01351350|82896941|FG001|Overall Study|Adverse Event|10|||
46681202|NCT01351350|82896942|FG002|Overall Study|Adverse Event|1|||
46681203|NCT01351350|82896943|FG003|Overall Study|Adverse Event|2|||
46681204|NCT01351350|82896944|FG004|Overall Study|Adverse Event|0|||
46681205|NCT01351350|82896940|FG000|Overall Study|Participant Decision|2|||
46681206|NCT01351350|82896941|FG001|Overall Study|Participant Decision|6|||
46681207|NCT01351350|82896942|FG002|Overall Study|Participant Decision|3|||
46681208|NCT01351350|82896943|FG003|Overall Study|Participant Decision|3|||
46681209|NCT01351350|82896944|FG004|Overall Study|Participant Decision|2|||
46681210|NCT01351350|82896940|FG000|Overall Study|Enrolled but not Treated|0|||
46681211|NCT01351350|82896941|FG001|Overall Study|Enrolled but not Treated|0|||
46681212|NCT01351350|82896942|FG002|Overall Study|Enrolled but not Treated|1|||
46681213|NCT01351350|82896943|FG003|Overall Study|Enrolled but not Treated|0|||
46681214|NCT01351350|82896944|FG004|Overall Study|Enrolled but not Treated|0|||
46681215|NCT01350999|82896972|FG000|Overall Study|Adverse Event|4|||
46681216|NCT01350999|82896973|FG001|Overall Study|Adverse Event|9|||
46681217|NCT01350999|82896974|FG002|Overall Study|Adverse Event|10|||
46681218|NCT01350999|82896972|FG000|Overall Study|Voluntary withdrawal|3|||
46681219|NCT01350999|82896973|FG001|Overall Study|Voluntary withdrawal|4|||
46681220|NCT01350999|82896974|FG002|Overall Study|Voluntary withdrawal|6|||
46681221|NCT01350999|82896972|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
46681222|NCT01350999|82896973|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
46681223|NCT01350999|82896974|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
46681224|NCT01330914|82896993|FG000|Overall Study|Withdrawal by Subject|4|||
46681225|NCT01330914|82896993|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
46681226|NCT01350804|82897001|FG000|Core Study|Withdrawal by Subject|11|||
46681227|NCT01350804|82897002|FG001|Core Study|Withdrawal by Subject|17|||
46981023|NCT02614261|83226897|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
46681228|NCT01350804|82897003|FG002|Core Study|Withdrawal by Subject|16|||
46798408|NCT00442936|83017104|FG000|Overall Study|Protocol Violation|1|||
46798409|NCT00442936|83017105|FG001|Overall Study|Protocol Violation|0|||
46798410|NCT00442936|83017106|FG002|Overall Study|Protocol Violation|1|||
46798411|NCT00442936|83017107|FG003|Overall Study|Protocol Violation|1|||
46798412|NCT00577655|83017119|FG000|Overall Study|Patient Request|0|||
46681229|NCT01350804|82897004|FG003|Core Study|Withdrawal by Subject|7|||
46681230|NCT01350804|82897001|FG000|Core Study|Study terminated by Sponsor|0|||
46681231|NCT01350804|82897002|FG001|Core Study|Study terminated by Sponsor|0|||
46681232|NCT01350804|82897003|FG002|Core Study|Study terminated by Sponsor|0|||
46858030|NCT03319732|83073801|FG000|Overall Study|Withdrawal by Subject|50|||
46858031|NCT03319732|83073801|FG000|Overall Study|MS relapse|10|||
46681233|NCT01350804|82897004|FG003|Core Study|Study terminated by Sponsor|2|||
46681234|NCT01350804|82897001|FG000|Core Study|Protocol deviation|1|||
46798413|NCT00577655|83017120|FG001|Overall Study|Patient Request|2|||
46798414|NCT00577655|83017119|FG000|Overall Study|Protocol Violation|0|||
46798415|NCT00577655|83017120|FG001|Overall Study|Protocol Violation|1|||
46798416|NCT00577655|83017119|FG000|Overall Study|Lost to Follow-up|1|||
46798417|NCT00577655|83017120|FG001|Overall Study|Lost to Follow-up|1|||
46798418|NCT00113269|83017131|FG000|Overall Study|Not transplanted, donor issues|4|||
46798419|NCT00113269|83017132|FG001|Overall Study|Not transplanted, donor issues|0|||
46798420|NCT00113269|83017133|FG002|Overall Study|Not transplanted, donor issues|2|||
46798421|NCT00113269|83017134|FG003|Overall Study|Not transplanted, donor issues|2|||
46981024|NCT02614261|83226894|FG000|Open-Label Extension Phase|Adverse Event|23|||
46981025|NCT02614261|83226895|FG001|Open-Label Extension Phase|Adverse Event|12|||
46981026|NCT02614261|83226896|FG002|Open-Label Extension Phase|Adverse Event|11|||
46981027|NCT02614261|83226897|FG003|Open-Label Extension Phase|Adverse Event|0|||
46981028|NCT02614261|83226894|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
46981029|NCT02614261|83226895|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
46981030|NCT02614261|83226896|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
46981031|NCT02614261|83226897|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
46981032|NCT02614261|83226894|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
46981033|NCT02614261|83226895|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
46981034|NCT02614261|83226896|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
46981035|NCT02614261|83226897|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
46981036|NCT02614261|83226894|FG000|Open-Label Extension Phase|Physician Decision|2|||
46981037|NCT02614261|83226895|FG001|Open-Label Extension Phase|Physician Decision|0|||
46981038|NCT02614261|83226896|FG002|Open-Label Extension Phase|Physician Decision|0|||
46981039|NCT02614261|83226897|FG003|Open-Label Extension Phase|Physician Decision|0|||
46981040|NCT02614261|83226894|FG000|Open-Label Extension Phase|Pregnancy|1|||
46981041|NCT02614261|83226895|FG001|Open-Label Extension Phase|Pregnancy|2|||
46981042|NCT02614261|83226896|FG002|Open-Label Extension Phase|Pregnancy|1|||
46981043|NCT02614261|83226897|FG003|Open-Label Extension Phase|Pregnancy|0|||
46981044|NCT02614261|83226894|FG000|Open-Label Extension Phase|Protocol Violation|3|||
46981045|NCT02614261|83226895|FG001|Open-Label Extension Phase|Protocol Violation|4|||
46981046|NCT02614261|83226896|FG002|Open-Label Extension Phase|Protocol Violation|1|||
46981047|NCT02614261|83226897|FG003|Open-Label Extension Phase|Protocol Violation|0|||
46981048|NCT02614261|83226894|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
46981049|NCT02614261|83226895|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
46981050|NCT02614261|83226896|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
46981051|NCT02614261|83226897|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
46981052|NCT02614261|83226894|FG000|Follow-up Phase|Adverse Event|2|||
46981053|NCT02614261|83226895|FG001|Follow-up Phase|Adverse Event|0|||
46981054|NCT02614261|83226896|FG002|Follow-up Phase|Adverse Event|1|||
46981055|NCT02614261|83226897|FG003|Follow-up Phase|Adverse Event|0|||
46981056|NCT02614261|83226894|FG000|Follow-up Phase|Lost to Follow-up|12|||
46981057|NCT02614261|83226895|FG001|Follow-up Phase|Lost to Follow-up|5|||
46681235|NCT01350804|82897002|FG001|Core Study|Protocol deviation|0|||
46681236|NCT01350804|82897003|FG002|Core Study|Protocol deviation|1|||
46681237|NCT01350804|82897004|FG003|Core Study|Protocol deviation|0|||
46681238|NCT01350804|82897001|FG000|Core Study|Physician Decision|1|||
46681239|NCT01350804|82897002|FG001|Core Study|Physician Decision|0|||
46681240|NCT01350804|82897003|FG002|Core Study|Physician Decision|1|||
46681241|NCT01350804|82897004|FG003|Core Study|Physician Decision|3|||
46981058|NCT02614261|83226896|FG002|Follow-up Phase|Lost to Follow-up|2|||
46981059|NCT02614261|83226897|FG003|Follow-up Phase|Lost to Follow-up|0|||
46981060|NCT02614261|83226894|FG000|Follow-up Phase|Physician Decision|5|||
46981061|NCT02614261|83226895|FG001|Follow-up Phase|Physician Decision|1|||
46681242|NCT01350804|82897001|FG000|Core Study|Lost to Follow-up|3|||
46681243|NCT01350804|82897002|FG001|Core Study|Lost to Follow-up|0|||
46981062|NCT02614261|83226896|FG002|Follow-up Phase|Physician Decision|0|||
46981063|NCT02614261|83226897|FG003|Follow-up Phase|Physician Decision|0|||
46981064|NCT02614261|83226894|FG000|Follow-up Phase|Pregnancy|0|||
46981065|NCT02614261|83226895|FG001|Follow-up Phase|Pregnancy|1|||
46981066|NCT02614261|83226896|FG002|Follow-up Phase|Pregnancy|0|||
46981067|NCT02614261|83226897|FG003|Follow-up Phase|Pregnancy|0|||
46981068|NCT02614261|83226894|FG000|Follow-up Phase|Protocol Violation|1|||
46981069|NCT02614261|83226895|FG001|Follow-up Phase|Protocol Violation|0|||
46981070|NCT02614261|83226896|FG002|Follow-up Phase|Protocol Violation|0|||
46981071|NCT02614261|83226897|FG003|Follow-up Phase|Protocol Violation|0|||
46681244|NCT01350804|82897003|FG002|Core Study|Lost to Follow-up|2|||
46681245|NCT01350804|82897004|FG003|Core Study|Lost to Follow-up|1|||
46681246|NCT01350804|82897001|FG000|Core Study|Lack of Efficacy|16|||
46681247|NCT01350804|82897002|FG001|Core Study|Lack of Efficacy|19|||
46681248|NCT01350804|82897003|FG002|Core Study|Lack of Efficacy|18|||
46681249|NCT01350804|82897004|FG003|Core Study|Lack of Efficacy|5|||
46681250|NCT01350804|82897001|FG000|Core Study|Death|1|||
46681251|NCT01350804|82897002|FG001|Core Study|Death|1|||
46681252|NCT01350804|82897003|FG002|Core Study|Death|1|||
46681253|NCT01350804|82897004|FG003|Core Study|Death|0|||
46681254|NCT01350804|82897001|FG000|Core Study|Adverse Event|8|||
46681255|NCT01350804|82897002|FG001|Core Study|Adverse Event|10|||
46681256|NCT01350804|82897003|FG002|Core Study|Adverse Event|8|||
46681257|NCT01350804|82897004|FG003|Core Study|Adverse Event|8|||
46681258|NCT01350804|82897001|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
46681259|NCT01350804|82897002|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
46681260|NCT01350804|82897003|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
46681261|NCT01350804|82897004|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
46681262|NCT01350804|82897001|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
46681263|NCT01350804|82897002|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
46681264|NCT01350804|82897003|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
46681265|NCT01350804|82897004|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
46681266|NCT01350804|82897001|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
46681267|NCT01350804|82897002|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
46681268|NCT01350804|82897003|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
46681269|NCT01350804|82897004|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
46798422|NCT00113269|83017131|FG000|Overall Study|Not transplanted, recipient issues|2|||
46798423|NCT00113269|83017132|FG001|Overall Study|Not transplanted, recipient issues|1|||
46798424|NCT00113269|83017133|FG002|Overall Study|Not transplanted, recipient issues|7|||
46798425|NCT00113269|83017134|FG003|Overall Study|Not transplanted, recipient issues|4|||
46798426|NCT00113269|83017131|FG000|Overall Study|Early graft loss, technical|0|||
46798427|NCT00113269|83017132|FG001|Overall Study|Early graft loss, technical|0|||
46798428|NCT00113269|83017133|FG002|Overall Study|Early graft loss, technical|2|||
46798429|NCT00113269|83017134|FG003|Overall Study|Early graft loss, technical|0|||
46798430|NCT00113269|83017131|FG000|Overall Study|Death in operating room|0|||
46798431|NCT00113269|83017132|FG001|Overall Study|Death in operating room|0|||
46858032|NCT03319732|83073801|FG000|Overall Study|reason not specified|5|||
46858033|NCT03304522|83073808|FG000|Overall Study|Adverse Event|0|||
46681270|NCT01350804|82897001|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
46681271|NCT01350804|82897002|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
46681272|NCT01350804|82897003|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
46681273|NCT01350804|82897004|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
46681274|NCT01350804|82897001|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
46981072|NCT02614261|83226894|FG000|Follow-up Phase|Withdrawal by Subject|12|||
46981073|NCT02614261|83226895|FG001|Follow-up Phase|Withdrawal by Subject|4|||
46981074|NCT02614261|83226896|FG002|Follow-up Phase|Withdrawal by Subject|11|||
46981075|NCT02614261|83226897|FG003|Follow-up Phase|Withdrawal by Subject|0|||
46981076|NCT02614261|83226894|FG000|Israel Addendum|Withdrawal by Subject|0|||
46981077|NCT02614261|83226895|FG001|Israel Addendum|Withdrawal by Subject|0|||
46981078|NCT02614261|83226896|FG002|Israel Addendum|Withdrawal by Subject|0|||
46981079|NCT02614261|83226897|FG003|Israel Addendum|Withdrawal by Subject|4|||
46981080|NCT01594411|83226923|FG000|Overall Study|Lost to Follow-up|2|||
46981081|NCT01594333|83226932|FG000|Overall Study|Death|96|||
46981082|NCT01594333|83226933|FG001|Overall Study|Death|83|||
46981083|NCT01594333|83226932|FG000|Overall Study|Lost to Follow-up|5|||
46981084|NCT01594333|83226933|FG001|Overall Study|Lost to Follow-up|5|||
46981085|NCT01594333|83226932|FG000|Overall Study|Withdrawal by Subject|60|||
46981086|NCT01594333|83226933|FG001|Overall Study|Withdrawal by Subject|63|||
46981087|NCT02609659|83226939|FG000|Overall Study|Adverse Event|1|||
46981088|NCT02609659|83226939|FG000|Overall Study|Lost to Follow-up|6|||
46981089|NCT02609659|83226939|FG000|Overall Study|Other|1|||
46981090|NCT02612779|83226945|FG000|Overall Study|Administrative reason by sponsor|4|||
46981091|NCT02612779|83226946|FG001|Overall Study|Administrative reason by sponsor|1|||
46981092|NCT02612779|83226945|FG000|Overall Study|No longer meet study criteria|0|||
46858034|NCT03304522|83073809|FG001|Overall Study|Adverse Event|4|||
46981093|NCT02612779|83226946|FG001|Overall Study|No longer meet study criteria|1|||
46981094|NCT02612779|83226945|FG000|Overall Study|Disease progression|29|||
46981095|NCT02612779|83226946|FG001|Overall Study|Disease progression|2|||
46981096|NCT02612779|83226945|FG000|Overall Study|Study drug toxicity|10|||
46981097|NCT02612779|83226946|FG001|Overall Study|Study drug toxicity|1|||
46981098|NCT02612779|83226945|FG000|Overall Study|Death|1|||
46981099|NCT02612779|83226946|FG001|Overall Study|Death|0|||
46681275|NCT01350804|82897002|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
46681276|NCT01350804|82897003|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
46681277|NCT01350804|82897004|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
46681278|NCT01350804|82897001|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
46681279|NCT01350804|82897002|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
46681280|NCT01350804|82897003|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
46681281|NCT01350804|82897004|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
46681282|NCT01350492|82897026|FG000|Intervention|Lost to Follow-up|2|||
46681283|NCT01350492|82897027|FG001|Intervention|Lost to Follow-up|5|||
46681284|NCT01350492|82897026|FG000|Intervention|Withdrawal by Subject|3|||
46681285|NCT01350492|82897027|FG001|Intervention|Withdrawal by Subject|1|||
46681286|NCT01350492|82897026|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
46681287|NCT01350492|82897027|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
46681288|NCT01350492|82897026|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
46858035|NCT03304522|83073808|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
46858036|NCT03304522|83073809|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
46981100|NCT02612779|83226945|FG000|Overall Study|Adverse event unrelated to study drug|5|||
46681289|NCT01350492|82897027|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
46681290|NCT02270957|82897035|FG000|Overall Study|Lack of Efficacy|2|||
46981101|NCT02612779|83226946|FG001|Overall Study|Adverse event unrelated to study drug|0|||
46981102|NCT02612779|83226945|FG000|Overall Study|Participant withdrew consent|4|||
46981103|NCT02612779|83226946|FG001|Overall Study|Participant withdrew consent|0|||
46981104|NCT02612779|83226945|FG000|Overall Study|Lost to Follow-up|1|||
46981105|NCT02612779|83226946|FG001|Overall Study|Lost to Follow-up|0|||
46981106|NCT02612779|83226945|FG000|Overall Study|Maximum clinical benefit|10|||
46981107|NCT02612779|83226946|FG001|Overall Study|Maximum clinical benefit|1|||
46981108|NCT02612779|83226945|FG000|Overall Study|Other reasons|4|||
46981109|NCT02612779|83226946|FG001|Overall Study|Other reasons|0|||
46981110|NCT02612623|83226957|FG000|Overall Study|Withdrawal by Subject|0|||
46981111|NCT02612623|83226958|FG001|Overall Study|Withdrawal by Subject|1|||
46981112|NCT02612623|83226959|FG002|Overall Study|Withdrawal by Subject|0|||
46981113|NCT02612623|83226960|FG003|Overall Study|Withdrawal by Subject|0|||
46681291|NCT02270957|82897036|FG001|Overall Study|Lack of Efficacy|4|||
46681292|NCT02270957|82897035|FG000|Overall Study|Adverse Event|2|||
46981114|NCT02612623|83226957|FG000|Overall Study|Adverse Event|1|||
46981115|NCT02612623|83226958|FG001|Overall Study|Adverse Event|0|||
46681293|NCT02270957|82897036|FG001|Overall Study|Adverse Event|0|||
46681294|NCT01350414|82897043|FG000|Overall Study|Lost to Follow-up|13|||
46681295|NCT01350414|82897043|FG000|Overall Study|Withdrawal by Subject|4|||
46681296|NCT01350414|82897043|FG000|Overall Study|Physician Decision|2|||
46681297|NCT01350336|82897053|FG000|Overall Study|Lost to Follow-up|31|||
46681298|NCT01350336|82897053|FG000|Overall Study|Withdrawal by Subject|14|||
46681299|NCT01350336|82897053|FG000|Overall Study|Physician Decision|8|||
46681300|NCT01350336|82897053|FG000|Overall Study|Death|4|||
46681301|NCT01349049|82897111|FG000|Overall Study|Disease progression|3|||
46681302|NCT01349049|82897112|FG001|Overall Study|Disease progression|5|||
46681303|NCT01349049|82897113|FG002|Overall Study|Disease progression|3|||
46681304|NCT01349049|82897114|FG003|Overall Study|Disease progression|2|||
46858037|NCT03304522|83073808|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
46681305|NCT01349049|82897115|FG004|Overall Study|Disease progression|2|||
46681306|NCT01349049|82897116|FG005|Overall Study|Disease progression|2|||
46681307|NCT01349049|82897117|FG006|Overall Study|Disease progression|3|||
46681308|NCT01349049|82897118|FG007|Overall Study|Disease progression|2|||
46681309|NCT01349049|82897119|FG008|Overall Study|Disease progression|33|||
46681310|NCT01349049|82897111|FG000|Overall Study|Adverse Event|0|||
46681311|NCT01349049|82897112|FG001|Overall Study|Adverse Event|1|||
46798432|NCT00113269|83017133|FG002|Overall Study|Death in operating room|0|||
46681312|NCT01349049|82897113|FG002|Overall Study|Adverse Event|0|||
46798433|NCT00113269|83017134|FG003|Overall Study|Death in operating room|1|||
46798434|NCT00113269|83017131|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
46798435|NCT00113269|83017132|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
46981116|NCT02612623|83226959|FG002|Overall Study|Adverse Event|1|||
46681313|NCT01349049|82897114|FG003|Overall Study|Adverse Event|0|||
46681314|NCT01349049|82897115|FG004|Overall Study|Adverse Event|0|||
46681315|NCT01349049|82897116|FG005|Overall Study|Adverse Event|3|||
46681316|NCT01349049|82897117|FG006|Overall Study|Adverse Event|1|||
46681317|NCT01349049|82897118|FG007|Overall Study|Adverse Event|0|||
46681318|NCT01349049|82897119|FG008|Overall Study|Adverse Event|4|||
46681319|NCT01349049|82897111|FG000|Overall Study|Physician Decision|0|||
46681320|NCT01349049|82897112|FG001|Overall Study|Physician Decision|1|||
46681321|NCT01349049|82897113|FG002|Overall Study|Physician Decision|0|||
46681322|NCT01349049|82897114|FG003|Overall Study|Physician Decision|0|||
46681323|NCT01349049|82897115|FG004|Overall Study|Physician Decision|0|||
46681324|NCT01349049|82897116|FG005|Overall Study|Physician Decision|0|||
46858038|NCT03304522|83073809|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
46981117|NCT02612623|83226960|FG003|Overall Study|Adverse Event|0|||
46858039|NCT03304522|83073808|FG000|Overall Study|Other|0|||
46681325|NCT01349049|82897117|FG006|Overall Study|Physician Decision|0|||
46681326|NCT01349049|82897118|FG007|Overall Study|Physician Decision|0|||
46858040|NCT03304522|83073809|FG001|Overall Study|Other|1|||
46681327|NCT01349049|82897119|FG008|Overall Study|Physician Decision|2|||
46681328|NCT01349049|82897111|FG000|Overall Study|Protocol Violation|0|||
46681329|NCT01349049|82897112|FG001|Overall Study|Protocol Violation|0|||
46681330|NCT01349049|82897113|FG002|Overall Study|Protocol Violation|0|||
46681331|NCT01349049|82897114|FG003|Overall Study|Protocol Violation|0|||
46681332|NCT01349049|82897115|FG004|Overall Study|Protocol Violation|0|||
46681333|NCT01349049|82897116|FG005|Overall Study|Protocol Violation|0|||
46681334|NCT01349049|82897117|FG006|Overall Study|Protocol Violation|0|||
46681335|NCT01349049|82897118|FG007|Overall Study|Protocol Violation|0|||
46681336|NCT01349049|82897119|FG008|Overall Study|Protocol Violation|1|||
46681337|NCT01349049|82897111|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
46681338|NCT01349049|82897112|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
46681339|NCT01349049|82897113|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
46681340|NCT01349049|82897114|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
46681341|NCT01349049|82897115|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
46681342|NCT01349049|82897116|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
46681343|NCT01349049|82897117|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
46681344|NCT01349049|82897118|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
46681345|NCT01349049|82897119|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
46681346|NCT01349049|82897111|FG000|Overall Study|Other|0|||
46981118|NCT02607865|83226974|FG000|Overall Study|Lost to Follow-up|9|||
46681347|NCT01349049|82897112|FG001|Overall Study|Other|0|||
46681348|NCT01349049|82897113|FG002|Overall Study|Other|0|||
46681349|NCT01349049|82897114|FG003|Overall Study|Other|0|||
46681350|NCT01349049|82897115|FG004|Overall Study|Other|0|||
46681351|NCT01349049|82897116|FG005|Overall Study|Other|1|||
46981119|NCT02607865|83226975|FG001|Overall Study|Lost to Follow-up|7|||
46798436|NCT00113269|83017133|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
46798437|NCT00113269|83017134|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
46798438|NCT00113269|83017131|FG000|Overall Study|Adverse Event|2|||
46798439|NCT00113269|83017132|FG001|Overall Study|Adverse Event|7|||
46981120|NCT02607865|83226976|FG002|Overall Study|Lost to Follow-up|7|||
46981121|NCT02607865|83226977|FG003|Overall Study|Lost to Follow-up|5|||
46981122|NCT02607865|83226974|FG000|Overall Study|Withdrawal by Subject|18|||
46681352|NCT01349049|82897117|FG006|Overall Study|Other|0|||
46681353|NCT01349049|82897118|FG007|Overall Study|Other|0|||
46681354|NCT01349049|82897119|FG008|Overall Study|Other|4|||
46981123|NCT02607865|83226975|FG001|Overall Study|Withdrawal by Subject|18|||
46681355|NCT01349049|82897111|FG000|Overall Study|Death|0|||
46681356|NCT01349049|82897112|FG001|Overall Study|Death|0|||
46681357|NCT01349049|82897113|FG002|Overall Study|Death|0|||
46681358|NCT01349049|82897114|FG003|Overall Study|Death|0|||
46681359|NCT01349049|82897115|FG004|Overall Study|Death|0|||
46681360|NCT01349049|82897116|FG005|Overall Study|Death|0|||
46681361|NCT01349049|82897117|FG006|Overall Study|Death|0|||
46681362|NCT01349049|82897118|FG007|Overall Study|Death|1|||
46681363|NCT01349049|82897119|FG008|Overall Study|Death|5|||
46981124|NCT02607865|83226976|FG002|Overall Study|Withdrawal by Subject|17|||
46981125|NCT02607865|83226977|FG003|Overall Study|Withdrawal by Subject|8|||
46981126|NCT02607865|83226974|FG000|Overall Study|Death|5|||
46981127|NCT02607865|83226975|FG001|Overall Study|Death|4|||
46981128|NCT02607865|83226976|FG002|Overall Study|Death|1|||
46981129|NCT02607865|83226977|FG003|Overall Study|Death|3|||
46981130|NCT02607865|83226974|FG000|Overall Study|Unclassified|1|||
46681364|NCT01349049|82897111|FG000|Overall Study|Non-compliance|0|||
46681365|NCT01349049|82897112|FG001|Overall Study|Non-compliance|0|||
46798440|NCT00113269|83017133|FG002|Overall Study|Adverse Event|11|||
46798441|NCT00113269|83017134|FG003|Overall Study|Adverse Event|7|||
46981131|NCT02607865|83226975|FG001|Overall Study|Unclassified|1|||
46981132|NCT02607865|83226976|FG002|Overall Study|Unclassified|2|||
46981133|NCT02607865|83226977|FG003|Overall Study|Unclassified|0|||
46981134|NCT01668667|83226991|FG000|Overall Study|Adverse Event|3|||
46981135|NCT01668667|83226992|FG001|Overall Study|Adverse Event|6|||
46981136|NCT01668667|83226993|FG002|Overall Study|Adverse Event|4|||
46981137|NCT01668667|83226994|FG003|Overall Study|Adverse Event|4|||
46981138|NCT01668667|83226991|FG000|Overall Study|Lack of Efficacy|3|||
46981139|NCT01668667|83226992|FG001|Overall Study|Lack of Efficacy|2|||
46981140|NCT01668667|83226993|FG002|Overall Study|Lack of Efficacy|2|||
46981141|NCT01668667|83226994|FG003|Overall Study|Lack of Efficacy|3|||
46981142|NCT01668667|83226991|FG000|Overall Study|Protocol Violation|6|||
46681366|NCT01349049|82897113|FG002|Overall Study|Non-compliance|0|||
46681367|NCT01349049|82897114|FG003|Overall Study|Non-compliance|1|||
46681368|NCT01349049|82897115|FG004|Overall Study|Non-compliance|0|||
46681369|NCT01349049|82897116|FG005|Overall Study|Non-compliance|0|||
46981143|NCT01668667|83226992|FG001|Overall Study|Protocol Violation|10|||
46981144|NCT01668667|83226993|FG002|Overall Study|Protocol Violation|12|||
46681370|NCT01349049|82897117|FG006|Overall Study|Non-compliance|0|||
46681371|NCT01349049|82897118|FG007|Overall Study|Non-compliance|0|||
46681372|NCT01349049|82897119|FG008|Overall Study|Non-compliance|0|||
46681373|NCT01349049|82897111|FG000|Overall Study|Withdrawal by Subject|0|||
46681374|NCT01349049|82897112|FG001|Overall Study|Withdrawal by Subject|0|||
46681375|NCT01349049|82897113|FG002|Overall Study|Withdrawal by Subject|0|||
46681376|NCT01349049|82897114|FG003|Overall Study|Withdrawal by Subject|0|||
46681377|NCT01349049|82897115|FG004|Overall Study|Withdrawal by Subject|0|||
46681378|NCT01349049|82897116|FG005|Overall Study|Withdrawal by Subject|0|||
46681379|NCT01349049|82897117|FG006|Overall Study|Withdrawal by Subject|0|||
46681380|NCT01349049|82897118|FG007|Overall Study|Withdrawal by Subject|0|||
46681381|NCT01349049|82897119|FG008|Overall Study|Withdrawal by Subject|6|||
46681382|NCT01348854|82897153|FG000|Overall Study|Lost to Follow-up|2|||
46681383|NCT01348854|82897154|FG001|Overall Study|Lost to Follow-up|1|||
46681384|NCT01348854|82897153|FG000|Overall Study|Withdrawal by Subject|1|||
46681385|NCT01348854|82897154|FG001|Overall Study|Withdrawal by Subject|0|||
46681386|NCT01348776|82897160|FG000|Overall Study|Lost to Follow-up|3|||
46681387|NCT01348698|82897173|FG000|Overall Study|Does not meet lesion size criteria|1|||
46681388|NCT01348698|82897173|FG000|Overall Study|Death|3|||
46681389|NCT01348698|82897173|FG000|Overall Study|PI decision to close study|68|||
46681390|NCT01348542|82897179|FG000|Overall Study|Withdrawal by Subject|3|||
46681391|NCT01348542|82897180|FG001|Overall Study|Withdrawal by Subject|0|||
46681392|NCT01346709|82897186|FG000|Overall Study|Protocol Violation|35|||
46681393|NCT01346709|82897186|FG000|Overall Study|Lost to Follow-up|31|||
46681394|NCT01346709|82897186|FG000|Overall Study|Missing data in candidate risk factor|285|||
46681395|NCT01346592|82897193|FG000|Overall Study|Lost to Follow-up|62|||
46681396|NCT01346592|82897194|FG001|Overall Study|Lost to Follow-up|29|||
46681397|NCT01346592|82897195|FG002|Overall Study|Lost to Follow-up|29|||
46681398|NCT01346592|82897193|FG000|Overall Study|Protocol Violation|2|||
46681399|NCT01346592|82897194|FG001|Overall Study|Protocol Violation|1|||
46681400|NCT01346592|82897195|FG002|Overall Study|Protocol Violation|0|||
46681401|NCT01346592|82897193|FG000|Overall Study|Death|1|||
46681402|NCT01346592|82897194|FG001|Overall Study|Death|3|||
46681403|NCT01346592|82897195|FG002|Overall Study|Death|4|||
46681404|NCT01346592|82897193|FG000|Overall Study|Adverse Event|0|||
46681405|NCT01346592|82897194|FG001|Overall Study|Adverse Event|1|||
46681406|NCT01346592|82897195|FG002|Overall Study|Adverse Event|0|||
46681407|NCT01346592|82897193|FG000|Overall Study|Withdrawal by Subject|77|||
46681408|NCT01346592|82897194|FG001|Overall Study|Withdrawal by Subject|51|||
46681409|NCT01346592|82897195|FG002|Overall Study|Withdrawal by Subject|38|||
46681410|NCT01346592|82897193|FG000|Overall Study|Inappropriate enrollment|3|||
46681411|NCT01346592|82897194|FG001|Overall Study|Inappropriate enrollment|1|||
46681412|NCT01346592|82897195|FG002|Overall Study|Inappropriate enrollment|1|||
46681413|NCT01346592|82897193|FG000|Overall Study|Administrative reason|1|||
46681414|NCT01346592|82897194|FG001|Overall Study|Administrative reason|0|||
46681415|NCT01346592|82897195|FG002|Overall Study|Administrative reason|0|||
46681416|NCT01346592|82897193|FG000|Overall Study|Unable to Classify|7|||
46681417|NCT01346592|82897194|FG001|Overall Study|Unable to Classify|3|||
46981145|NCT01668667|83226994|FG003|Overall Study|Protocol Violation|5|||
46981146|NCT01668667|83226991|FG000|Overall Study|Lost to Follow-up|9|||
46681418|NCT01346592|82897195|FG002|Overall Study|Unable to Classify|6|||
46681419|NCT01346514|82897222|FG000|Overall Study|Lost to Follow-up|19|||
46681420|NCT01346514|82897223|FG001|Overall Study|Lost to Follow-up|30|||
46681421|NCT01346514|82897222|FG000|Overall Study|Withdrawal by Subject|7|||
46681422|NCT01346514|82897223|FG001|Overall Study|Withdrawal by Subject|3|||
46681423|NCT01346514|82897222|FG000|Overall Study|Death|3|||
46681424|NCT01346514|82897223|FG001|Overall Study|Death|4|||
46681425|NCT01193335|82897233|FG000|After Infant Series|Lost to Follow-up|1|||
46681426|NCT01193335|82897234|FG001|After Infant Series|Lost to Follow-up|2|||
46681427|NCT01193335|82897233|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
46681428|NCT01193335|82897234|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
46681429|NCT01193335|82897233|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
46681430|NCT01193335|82897234|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
46681431|NCT01193335|82897233|FG000|1-Year Follow-up|Lost to Follow-up|4|||
46681432|NCT01193335|82897234|FG001|1-Year Follow-up|Lost to Follow-up|0|||
46681433|NCT01193335|82897233|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
46681434|NCT01193335|82897234|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
46681435|NCT01193335|82897233|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
46681436|NCT01193335|82897234|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
46681437|NCT01342887|82897256|FG000|Overall Study|Death|2|||
46858041|NCT03315286|83073817|FG000|Overall Study|Lost to Follow-up|0|||
46681438|NCT01342341|82897262|FG000|Overall Study|Lost to Follow-up|4|||
46681439|NCT01342341|82897263|FG001|Overall Study|Lost to Follow-up|4|||
46681440|NCT01340664|82897272|FG000|Overall Study|Adverse Event|0|||
46681441|NCT01340664|82897273|FG001|Overall Study|Adverse Event|1|||
46681442|NCT01340664|82897274|FG002|Overall Study|Adverse Event|7|||
46681443|NCT01340664|82897272|FG000|Overall Study|Lost to Follow-up|2|||
46681444|NCT01340664|82897273|FG001|Overall Study|Lost to Follow-up|0|||
46681445|NCT01340664|82897274|FG002|Overall Study|Lost to Follow-up|2|||
46681446|NCT01340664|82897272|FG000|Overall Study|Withdrawal by Subject|2|||
46681447|NCT01340664|82897273|FG001|Overall Study|Withdrawal by Subject|4|||
46681448|NCT01340664|82897274|FG002|Overall Study|Withdrawal by Subject|0|||
46681449|NCT01340664|82897272|FG000|Overall Study|Glycemic withdrawal criteria|2|||
46981147|NCT01668667|83226992|FG001|Overall Study|Lost to Follow-up|4|||
46981148|NCT01668667|83226993|FG002|Overall Study|Lost to Follow-up|7|||
46681450|NCT01340664|82897273|FG001|Overall Study|Glycemic withdrawal criteria|0|||
46681451|NCT01340664|82897274|FG002|Overall Study|Glycemic withdrawal criteria|0|||
46681452|NCT01340664|82897272|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
46981149|NCT01668667|83226994|FG003|Overall Study|Lost to Follow-up|6|||
46981150|NCT01668667|83226991|FG000|Overall Study|Physician Decision|3|||
46981151|NCT01668667|83226992|FG001|Overall Study|Physician Decision|0|||
46981152|NCT01668667|83226993|FG002|Overall Study|Physician Decision|1|||
46981153|NCT01668667|83226994|FG003|Overall Study|Physician Decision|0|||
46981154|NCT01668667|83226991|FG000|Overall Study|Withdrawal by Subject|7|||
46798442|NCT00113269|83017131|FG000|Overall Study|Withdrawal by Subject|4|||
46981155|NCT01668667|83226992|FG001|Overall Study|Withdrawal by Subject|4|||
46681453|NCT01340664|82897273|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
46681454|NCT01340664|82897274|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
46681455|NCT01340664|82897272|FG000|Overall Study|Other|1|||
46681456|NCT01340664|82897273|FG001|Overall Study|Other|2|||
46681457|NCT01340664|82897274|FG002|Overall Study|Other|2|||
46681458|NCT01340625|82897284|FG000|First Intervention|Adverse Event|1|||
46681459|NCT01340625|82897285|FG001|First Intervention|Adverse Event|0|||
46681460|NCT01340625|82897284|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
46681461|NCT01340625|82897285|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
46681462|NCT01340196|82897291|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
46681463|NCT01327599|82897300|FG000|Overall Study|Adverse Event|1|||
46681464|NCT01327599|82897300|FG000|Overall Study|Could Not Attend Visit|1|||
46681465|NCT01327599|82897300|FG000|Overall Study|Withdrawal of Consent|1|||
46681466|NCT01193257|82897306|FG000|Overall Study|Death|202|||
46681467|NCT01193257|82897307|FG001|Overall Study|Death|391|||
46681468|NCT01193257|82897306|FG000|Overall Study|Study termination by sponsor|0|||
46681469|NCT01193257|82897307|FG001|Overall Study|Study termination by sponsor|3|||
46681470|NCT01193257|82897306|FG000|Overall Study|Withdrawal by Subject|26|||
46681471|NCT01193257|82897307|FG001|Overall Study|Withdrawal by Subject|86|||
46798443|NCT00113269|83017132|FG001|Overall Study|Withdrawal by Subject|3|||
46798444|NCT00113269|83017133|FG002|Overall Study|Withdrawal by Subject|4|||
46681472|NCT01193257|82897306|FG000|Overall Study|Lost to Follow-up|2|||
46681473|NCT01193257|82897307|FG001|Overall Study|Lost to Follow-up|3|||
46681474|NCT01193257|82897306|FG000|Overall Study|Unblinded due to futility|135|||
46681475|NCT01193257|82897307|FG001|Overall Study|Unblinded due to futility|251|||
46681476|NCT01193218|82897318|FG000|0-12 Weeks|Adverse Event|6|||
46798445|NCT00113269|83017134|FG003|Overall Study|Withdrawal by Subject|2|||
46981156|NCT01668667|83226993|FG002|Overall Study|Withdrawal by Subject|5|||
46858042|NCT03315286|83073818|FG001|Overall Study|Lost to Follow-up|3|||
46858043|NCT03315286|83073817|FG000|Overall Study|Withdrawal by Subject|1|||
46858044|NCT03315286|83073818|FG001|Overall Study|Withdrawal by Subject|0|||
46858045|NCT03315286|83073817|FG000|Overall Study|Protocol Violation|0|||
46858046|NCT03315286|83073818|FG001|Overall Study|Protocol Violation|1|||
46858047|NCT03273946|83073824|FG000|Overall Study|Withdrawal by Subject|5|||
46858048|NCT03273946|83073824|FG000|Overall Study|Unwillingness of the guardian|1|||
46858049|NCT03273946|83073824|FG000|Overall Study|Participant refused to use the drug|2|||
46858050|NCT03273946|83073824|FG000|Overall Study|Participant relative refused to use drug|1|||
46858051|NCT00314951|83073830|FG000|Treatment|Didn't meet criteria for mITT population|16|||
46858052|NCT00314951|83073831|FG001|Treatment|Didn't meet criteria for mITT population|11|||
46858053|NCT00314951|83073830|FG000|Follow-up|mITT failure|44|||
46858054|NCT00314951|83073831|FG001|Follow-up|mITT failure|34|||
46858055|NCT00085644|83073839|FG000|Double-Blind Period|Adverse Event|5|||
46858056|NCT00085644|83073840|FG001|Double-Blind Period|Adverse Event|2|||
46858057|NCT00085644|83073841|FG002|Double-Blind Period|Adverse Event|0|||
46858058|NCT00085644|83073839|FG000|Double-Blind Period|Withdrawal by Subject|3|||
46858059|NCT00085644|83073840|FG001|Double-Blind Period|Withdrawal by Subject|0|||
46858060|NCT00085644|83073841|FG002|Double-Blind Period|Withdrawal by Subject|0|||
46858061|NCT00085644|83073839|FG000|Double-Blind Period|Lost to Follow-up|2|||
46858062|NCT00085644|83073840|FG001|Double-Blind Period|Lost to Follow-up|1|||
46858063|NCT00085644|83073841|FG002|Double-Blind Period|Lost to Follow-up|0|||
46858064|NCT00085644|83073839|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
46858065|NCT00085644|83073840|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
46858066|NCT00085644|83073841|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
46858067|NCT00085644|83073839|FG000|Double-Blind Period|Contemplating pregnancy|1|||
46858068|NCT00085644|83073840|FG001|Double-Blind Period|Contemplating pregnancy|0|||
46858069|NCT00085644|83073841|FG002|Double-Blind Period|Contemplating pregnancy|0|||
46858070|NCT00085644|83073839|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
46858071|NCT00085644|83073840|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
46858072|NCT00085644|83073841|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
46981157|NCT01668667|83226994|FG003|Overall Study|Withdrawal by Subject|5|||
46981158|NCT02608879|83227007|FG000|Overall Study|Lost to Follow-up|1|||
46798446|NCT00113269|83017131|FG000|Overall Study|Graft loss|6|||
46981159|NCT02608879|83227008|FG001|Overall Study|Lost to Follow-up|0|||
46981160|NCT02608879|83227009|FG002|Overall Study|Lost to Follow-up|0|||
46981161|NCT02608879|83227007|FG000|Overall Study|Did not meet continuation criteria|0|||
46981162|NCT02608879|83227008|FG001|Overall Study|Did not meet continuation criteria|0|||
46981163|NCT02608879|83227009|FG002|Overall Study|Did not meet continuation criteria|3|||
46981164|NCT02608099|83227019|FG000|Overall Study|Ablation procedure not initiated|3|||
46981165|NCT02608099|83227020|FG001|Overall Study|Ablation procedure not initiated|2|||
46981166|NCT01668589|83227030|FG000|Overall Study|Lost to Follow-up|29|||
46981167|NCT01668589|83227031|FG001|Overall Study|Lost to Follow-up|37|||
46981168|NCT01668589|83227032|FG002|Overall Study|Lost to Follow-up|15|||
46981169|NCT01668589|83227033|FG003|Overall Study|Lost to Follow-up|5|||
46798447|NCT00113269|83017132|FG001|Overall Study|Graft loss|6|||
46798448|NCT00113269|83017133|FG002|Overall Study|Graft loss|4|||
46798449|NCT00113269|83017134|FG003|Overall Study|Graft loss|9|||
46798450|NCT00113269|83017131|FG000|Overall Study|Protocol Violation|1|||
46798451|NCT00113269|83017132|FG001|Overall Study|Protocol Violation|0|||
46798452|NCT00113269|83017133|FG002|Overall Study|Protocol Violation|4|||
46798453|NCT00113269|83017134|FG003|Overall Study|Protocol Violation|2|||
46798454|NCT00113269|83017131|FG000|Overall Study|Lost to Follow-up|2|||
46798455|NCT00113269|83017132|FG001|Overall Study|Lost to Follow-up|3|||
46798456|NCT00113269|83017133|FG002|Overall Study|Lost to Follow-up|6|||
46798457|NCT00113269|83017134|FG003|Overall Study|Lost to Follow-up|3|||
46798458|NCT00113269|83017131|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
46798459|NCT00113269|83017132|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
46798460|NCT00113269|83017133|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
46858073|NCT00085644|83073839|FG000|Open-Label Period|Adverse Event|0|||
46858074|NCT00085644|83073840|FG001|Open-Label Period|Adverse Event|0|||
46858075|NCT00085644|83073841|FG002|Open-Label Period|Adverse Event|38|||
46858076|NCT00085644|83073839|FG000|Open-Label Period|Withdrawal by Subject|0|||
46981170|NCT01668589|83227030|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
46981171|NCT01668589|83227031|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
46981172|NCT01668589|83227032|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
46981173|NCT01668589|83227033|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
46981174|NCT01668589|83227030|FG000|Overall Study|Death|12|||
46981175|NCT01668589|83227031|FG001|Overall Study|Death|3|||
46981176|NCT01668589|83227032|FG002|Overall Study|Death|2|||
46981177|NCT01668589|83227033|FG003|Overall Study|Death|11|||
46981178|NCT01668589|83227030|FG000|Overall Study|Other|44|||
46981179|NCT01668589|83227031|FG001|Overall Study|Other|10|||
46981180|NCT01668589|83227032|FG002|Overall Study|Other|7|||
46981181|NCT01668589|83227033|FG003|Overall Study|Other|15|||
46981182|NCT02432235|83227055|FG000|Overall Study|Death|1|||
46981183|NCT02432235|83227056|FG001|Overall Study|Death|1|||
46981184|NCT02432235|83227057|FG002|Overall Study|Death|2|||
46681477|NCT01193218|82897319|FG001|0-12 Weeks|Adverse Event|0|||
46681478|NCT01193218|82897320|FG002|0-12 Weeks|Adverse Event|1|||
46681479|NCT01193218|82897321|FG003|0-12 Weeks|Adverse Event|0|||
46681480|NCT01193218|82897322|FG004|0-12 Weeks|Adverse Event|0|||
46681481|NCT01193218|82897323|FG005|0-12 Weeks|Adverse Event|2|||
46681482|NCT01193218|82897324|FG006|0-12 Weeks|Adverse Event|2|||
46681483|NCT01193218|82897325|FG007|0-12 Weeks|Adverse Event|0|||
46681484|NCT01193218|82897318|FG000|0-12 Weeks|Protocol Violation|0|||
46981185|NCT02432235|83227058|FG003|Overall Study|Death|2|||
46981186|NCT02432235|83227059|FG004|Overall Study|Death|1|||
46981187|NCT02432235|83227060|FG005|Overall Study|Death|3|||
46981188|NCT02432235|83227061|FG006|Overall Study|Death|11|||
46681485|NCT01193218|82897319|FG001|0-12 Weeks|Protocol Violation|0|||
46798461|NCT00113269|83017134|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
46798462|NCT00113269|83017131|FG000|Overall Study|Discontinued due to rejection|0|||
46798463|NCT00113269|83017132|FG001|Overall Study|Discontinued due to rejection|0|||
46798464|NCT00113269|83017133|FG002|Overall Study|Discontinued due to rejection|1|||
46798465|NCT00113269|83017134|FG003|Overall Study|Discontinued due to rejection|0|||
46798466|NCT00113269|83017131|FG000|Overall Study|Moved|0|||
46798467|NCT00113269|83017132|FG001|Overall Study|Moved|1|||
46798468|NCT00113269|83017133|FG002|Overall Study|Moved|0|||
46798469|NCT00113269|83017134|FG003|Overall Study|Moved|3|||
46798470|NCT00113269|83017131|FG000|Overall Study|Received pancreas transplant|0|||
46681486|NCT01193218|82897320|FG002|0-12 Weeks|Protocol Violation|0|||
46681487|NCT01193218|82897321|FG003|0-12 Weeks|Protocol Violation|0|||
46681488|NCT01193218|82897322|FG004|0-12 Weeks|Protocol Violation|1|||
46798471|NCT00113269|83017132|FG001|Overall Study|Received pancreas transplant|0|||
46798472|NCT00113269|83017133|FG002|Overall Study|Received pancreas transplant|0|||
46798473|NCT00113269|83017134|FG003|Overall Study|Received pancreas transplant|2|||
46981189|NCT02432235|83227062|FG007|Overall Study|Death|15|||
46981190|NCT02432235|83227063|FG008|Overall Study|Death|15|||
46981191|NCT02432235|83227064|FG009|Overall Study|Death|3|||
46981192|NCT02432235|83227065|FG010|Overall Study|Death|1|||
46681489|NCT01193218|82897323|FG005|0-12 Weeks|Protocol Violation|1|||
46981193|NCT02432235|83227066|FG011|Overall Study|Death|0|||
46681490|NCT01193218|82897324|FG006|0-12 Weeks|Protocol Violation|0|||
46681491|NCT01193218|82897325|FG007|0-12 Weeks|Protocol Violation|0|||
46681492|NCT01193218|82897318|FG000|0-12 Weeks|Withdrawal by Subject|3|||
46681493|NCT01193218|82897319|FG001|0-12 Weeks|Withdrawal by Subject|0|||
46798474|NCT00113269|83017131|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
46681494|NCT01193218|82897320|FG002|0-12 Weeks|Withdrawal by Subject|2|||
46681495|NCT01193218|82897321|FG003|0-12 Weeks|Withdrawal by Subject|0|||
46681496|NCT01193218|82897322|FG004|0-12 Weeks|Withdrawal by Subject|0|||
46681497|NCT01193218|82897323|FG005|0-12 Weeks|Withdrawal by Subject|0|||
46681498|NCT01193218|82897324|FG006|0-12 Weeks|Withdrawal by Subject|1|||
46681499|NCT01193218|82897325|FG007|0-12 Weeks|Withdrawal by Subject|0|||
46681500|NCT01193218|82897318|FG000|12-52 Weeks|Adverse Event|1|||
46681501|NCT01193218|82897319|FG001|12-52 Weeks|Adverse Event|0|||
46681502|NCT01193218|82897320|FG002|12-52 Weeks|Adverse Event|1|||
46681503|NCT01193218|82897321|FG003|12-52 Weeks|Adverse Event|2|||
46681504|NCT01193218|82897322|FG004|12-52 Weeks|Adverse Event|3|||
46681505|NCT01193218|82897323|FG005|12-52 Weeks|Adverse Event|3|||
46681506|NCT01193218|82897324|FG006|12-52 Weeks|Adverse Event|1|||
46798475|NCT00113269|83017132|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
46681507|NCT01193218|82897325|FG007|12-52 Weeks|Adverse Event|2|||
46681508|NCT01193218|82897318|FG000|12-52 Weeks|Lack of Efficacy|0|||
46681509|NCT01193218|82897319|FG001|12-52 Weeks|Lack of Efficacy|0|||
46681510|NCT01193218|82897320|FG002|12-52 Weeks|Lack of Efficacy|0|||
46681511|NCT01193218|82897321|FG003|12-52 Weeks|Lack of Efficacy|0|||
46681512|NCT01193218|82897322|FG004|12-52 Weeks|Lack of Efficacy|0|||
46681513|NCT01193218|82897323|FG005|12-52 Weeks|Lack of Efficacy|0|||
46681514|NCT01193218|82897324|FG006|12-52 Weeks|Lack of Efficacy|1|||
46681515|NCT01193218|82897325|FG007|12-52 Weeks|Lack of Efficacy|0|||
46681516|NCT01193218|82897318|FG000|12-52 Weeks|Withdrawal by Subject|3|||
46681517|NCT01193218|82897319|FG001|12-52 Weeks|Withdrawal by Subject|0|||
46681518|NCT01193218|82897320|FG002|12-52 Weeks|Withdrawal by Subject|3|||
46681519|NCT01193218|82897321|FG003|12-52 Weeks|Withdrawal by Subject|0|||
46681520|NCT01193218|82897322|FG004|12-52 Weeks|Withdrawal by Subject|0|||
46681521|NCT01193218|82897323|FG005|12-52 Weeks|Withdrawal by Subject|2|||
46681522|NCT01193218|82897324|FG006|12-52 Weeks|Withdrawal by Subject|1|||
46681523|NCT01193218|82897325|FG007|12-52 Weeks|Withdrawal by Subject|2|||
46681524|NCT01193218|82897318|FG000|12-52 Weeks|Other reason than above|1|||
46681525|NCT01193218|82897319|FG001|12-52 Weeks|Other reason than above|0|||
46681526|NCT01193218|82897320|FG002|12-52 Weeks|Other reason than above|0|||
46681527|NCT01193218|82897321|FG003|12-52 Weeks|Other reason than above|1|||
46681528|NCT01193218|82897322|FG004|12-52 Weeks|Other reason than above|1|||
46681529|NCT01193218|82897323|FG005|12-52 Weeks|Other reason than above|0|||
46681530|NCT01193218|82897324|FG006|12-52 Weeks|Other reason than above|0|||
46681531|NCT01193218|82897325|FG007|12-52 Weeks|Other reason than above|0|||
46681532|NCT01193101|82897345|FG000|Overall Study|Adverse Event|0|||
46681533|NCT01193101|82897346|FG001|Overall Study|Adverse Event|1|||
46681534|NCT01193101|82897347|FG002|Overall Study|Adverse Event|1|||
46681535|NCT01193101|82897348|FG003|Overall Study|Adverse Event|3|||
46681536|NCT01193101|82897345|FG000|Overall Study|Lack of Efficacy|3|||
46681537|NCT01193101|82897346|FG001|Overall Study|Lack of Efficacy|1|||
46681538|NCT01193101|82897347|FG002|Overall Study|Lack of Efficacy|0|||
46681539|NCT01193101|82897348|FG003|Overall Study|Lack of Efficacy|8|||
46681540|NCT01193101|82897345|FG000|Overall Study|Withdrawal by Subject|2|||
46681541|NCT01193101|82897346|FG001|Overall Study|Withdrawal by Subject|4|||
46681542|NCT01193101|82897347|FG002|Overall Study|Withdrawal by Subject|1|||
46681543|NCT01193101|82897348|FG003|Overall Study|Withdrawal by Subject|1|||
46798476|NCT00113269|83017133|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
46681544|NCT01193101|82897345|FG000|Overall Study|Administrative problems|0|||
46681545|NCT01193101|82897346|FG001|Overall Study|Administrative problems|0|||
46681546|NCT01193101|82897347|FG002|Overall Study|Administrative problems|1|||
46681547|NCT01193101|82897348|FG003|Overall Study|Administrative problems|0|||
46681548|NCT01193101|82897345|FG000|Overall Study|Abnormal test procedure results|0|||
46681549|NCT01193101|82897346|FG001|Overall Study|Abnormal test procedure results|1|||
46708075|NCT01172808|82923563|FG000|Overall Study|Adverse Event|8|||
46681550|NCT01193101|82897347|FG002|Overall Study|Abnormal test procedure results|0|||
46681551|NCT01193101|82897348|FG003|Overall Study|Abnormal test procedure results|0|||
46681552|NCT01192516|82897361|FG000|Overall Study|Lost to Follow-up|7|||
46681553|NCT01192516|82897362|FG001|Overall Study|Lost to Follow-up|10|||
46681554|NCT01192516|82897363|FG002|Overall Study|Lost to Follow-up|7|||
46681555|NCT01192516|82897361|FG000|Overall Study|Withdrawal by Subject|4|||
46681556|NCT01192516|82897362|FG001|Overall Study|Withdrawal by Subject|4|||
46681557|NCT01192516|82897363|FG002|Overall Study|Withdrawal by Subject|1|||
46681558|NCT01192516|82897361|FG000|Overall Study|started new treatment|5|||
46681559|NCT01192516|82897362|FG001|Overall Study|started new treatment|1|||
46681560|NCT01192516|82897363|FG002|Overall Study|started new treatment|0|||
46681561|NCT01192516|82897361|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
46681562|NCT01192516|82897362|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
46681563|NCT01192516|82897363|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
46681564|NCT01192399|82897375|FG000|Overall Study|Lack of Efficacy|2|||
46681565|NCT01176916|82897379|FG000|Overall Study|Adverse Event|61|||
46681566|NCT01176916|82897379|FG000|Overall Study|Death|1|||
46681567|NCT01176916|82897379|FG000|Overall Study|Lost to Follow-up|15|||
46681568|NCT01176916|82897379|FG000|Overall Study|Objective progression or relapse|17|||
46858077|NCT00085644|83073840|FG001|Open-Label Period|Withdrawal by Subject|0|||
46858078|NCT00085644|83073841|FG002|Open-Label Period|Withdrawal by Subject|29|||
46858079|NCT00085644|83073839|FG000|Open-Label Period|Lost to Follow-up|0|||
46858080|NCT00085644|83073840|FG001|Open-Label Period|Lost to Follow-up|0|||
46858081|NCT00085644|83073841|FG002|Open-Label Period|Lost to Follow-up|13|||
46858082|NCT00085644|83073839|FG000|Open-Label Period|Lack of Efficacy|0|||
46858083|NCT00085644|83073840|FG001|Open-Label Period|Lack of Efficacy|0|||
46858084|NCT00085644|83073841|FG002|Open-Label Period|Lack of Efficacy|15|||
46858085|NCT00085644|83073839|FG000|Open-Label Period|Pregnancy|0|||
46858086|NCT00085644|83073840|FG001|Open-Label Period|Pregnancy|0|||
46981194|NCT02432235|83227055|FG000|Overall Study|Withdrawal by Subject|0|||
46981195|NCT02432235|83227056|FG001|Overall Study|Withdrawal by Subject|1|||
46981196|NCT02432235|83227057|FG002|Overall Study|Withdrawal by Subject|0|||
46981197|NCT02432235|83227058|FG003|Overall Study|Withdrawal by Subject|0|||
46981198|NCT02432235|83227059|FG004|Overall Study|Withdrawal by Subject|0|||
46981199|NCT02432235|83227060|FG005|Overall Study|Withdrawal by Subject|2|||
46981200|NCT02432235|83227061|FG006|Overall Study|Withdrawal by Subject|5|||
46981201|NCT02432235|83227062|FG007|Overall Study|Withdrawal by Subject|3|||
46981202|NCT02432235|83227063|FG008|Overall Study|Withdrawal by Subject|1|||
46681569|NCT01176916|82897379|FG000|Overall Study|Protocol Violation|24|||
46681570|NCT01176916|82897379|FG000|Overall Study|Withdrawal by Subject|37|||
46681571|NCT01176916|82897379|FG000|Overall Study|Other|6|||
46681572|NCT01176916|82897379|FG000|Overall Study|Withdrawal prior to Treatment|6|||
46858087|NCT00085644|83073841|FG002|Open-Label Period|Pregnancy|3|||
46681573|NCT01192204|82897385|FG000|Overall Study|could not keep recall appointments|1|||
46681574|NCT01192204|82897386|FG001|Overall Study|could not keep recall appointments|0|||
46681575|NCT01192126|82897393|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
46681576|NCT01192126|82897394|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
46681577|NCT01192126|82897393|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
46681578|NCT01192126|82897394|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
46681579|NCT01327482|82897400|FG000|Overall Study|Adverse Event|1|||
46681580|NCT01176565|82897406|FG000|Overall Study|Lost to Follow-up|12|||
46681581|NCT01176565|82897407|FG001|Overall Study|Lost to Follow-up|16|||
46681582|NCT01176565|82897406|FG000|Overall Study|Withdrawal by Subject|7|||
46681583|NCT01176565|82897407|FG001|Overall Study|Withdrawal by Subject|1|||
46681584|NCT01176565|82897406|FG000|Overall Study|Not Analyzed (any other reason)|1|||
46681585|NCT01176565|82897407|FG001|Overall Study|Not Analyzed (any other reason)|2|||
46681586|NCT01176292|82897415|FG000|Overall Study|Lost to Follow-up|2|||
46981203|NCT02432235|83227064|FG009|Overall Study|Withdrawal by Subject|0|||
46981204|NCT02432235|83227065|FG010|Overall Study|Withdrawal by Subject|0|||
46981205|NCT02432235|83227066|FG011|Overall Study|Withdrawal by Subject|0|||
46981206|NCT02432235|83227055|FG000|Overall Study|Lost to Follow-up|0|||
46981207|NCT02432235|83227056|FG001|Overall Study|Lost to Follow-up|0|||
46681587|NCT01176292|82897416|FG001|Overall Study|Lost to Follow-up|4|||
46681588|NCT01176292|82897415|FG000|Overall Study|Adverse Event|1|||
46681589|NCT01176292|82897416|FG001|Overall Study|Adverse Event|1|||
46681590|NCT01176292|82897415|FG000|Overall Study|Physician Decision|0|||
46681591|NCT01176292|82897416|FG001|Overall Study|Physician Decision|2|||
46681592|NCT01176292|82897415|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
46681593|NCT01176292|82897416|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
46681594|NCT01113541|82897422|FG000|Overall Study|Withdrawal by Subject|1|||
46681595|NCT01113541|82897422|FG000|Overall Study|Protocol Violation|1|||
46681596|NCT01113541|82897422|FG000|Overall Study|Study Terminated by Sponsor|7|||
46681597|NCT01113541|82897422|FG000|Overall Study|Adverse Event|4|||
46681598|NCT01113502|82897435|FG000|Overall Study|Withdrawal by Subject|1|||
46681599|NCT01113502|82897436|FG001|Overall Study|Withdrawal by Subject|0|||
46681600|NCT01113502|82897437|FG002|Overall Study|Withdrawal by Subject|1|||
46681601|NCT01113502|82897438|FG003|Overall Study|Withdrawal by Subject|1|||
46681602|NCT01113502|82897439|FG004|Overall Study|Withdrawal by Subject|0|||
46681603|NCT01113502|82897435|FG000|Overall Study|Adverse Event|0|||
46681604|NCT01113502|82897436|FG001|Overall Study|Adverse Event|0|||
46681605|NCT01113502|82897437|FG002|Overall Study|Adverse Event|3|||
46681606|NCT01113502|82897438|FG003|Overall Study|Adverse Event|2|||
46681607|NCT01113502|82897439|FG004|Overall Study|Adverse Event|0|||
46681608|NCT01113463|82897452|FG000|Overall Study|Physician Decision|5|||
46681609|NCT01112917|82897456|FG000|Overall Study|Death|2|||
46681610|NCT01112917|82897457|FG001|Overall Study|Death|11|||
46681611|NCT01112917|82897456|FG000|Overall Study|Lost to Follow-up|1|||
46681612|NCT01112917|82897457|FG001|Overall Study|Lost to Follow-up|1|||
46681613|NCT01112917|82897456|FG000|Overall Study|Withdrawal by Subject|1|||
46681614|NCT01112917|82897457|FG001|Overall Study|Withdrawal by Subject|3|||
46681615|NCT01112917|82897456|FG000|Overall Study|Unable to Convert Filter|3|||
46681616|NCT01112917|82897457|FG001|Overall Study|Unable to Convert Filter|0|||
46681617|NCT01176058|82897463|FG000|Overall Study|Adverse Event|1|||
46981208|NCT02432235|83227057|FG002|Overall Study|Lost to Follow-up|0|||
46981209|NCT02432235|83227058|FG003|Overall Study|Lost to Follow-up|0|||
46681618|NCT01176058|82897464|FG001|Overall Study|Adverse Event|0|||
46681619|NCT01176058|82897463|FG000|Overall Study|Insufficient clinical response|2|||
46681620|NCT01176058|82897464|FG001|Overall Study|Insufficient clinical response|2|||
46681621|NCT01176058|82897463|FG000|Overall Study|Insufficient mycological response|0|||
46681622|NCT01176058|82897464|FG001|Overall Study|Insufficient mycological response|1|||
46681623|NCT01176058|82897463|FG000|Overall Study|Withdrawal by Subject|1|||
46681624|NCT01176058|82897464|FG001|Overall Study|Withdrawal by Subject|0|||
46798477|NCT00113269|83017134|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
46981210|NCT02432235|83227059|FG004|Overall Study|Lost to Follow-up|0|||
46981211|NCT02432235|83227060|FG005|Overall Study|Lost to Follow-up|1|||
46981212|NCT02432235|83227061|FG006|Overall Study|Lost to Follow-up|0|||
46981213|NCT02432235|83227062|FG007|Overall Study|Lost to Follow-up|0|||
46981214|NCT02432235|83227063|FG008|Overall Study|Lost to Follow-up|1|||
46981215|NCT02432235|83227064|FG009|Overall Study|Lost to Follow-up|0|||
46981216|NCT02432235|83227065|FG010|Overall Study|Lost to Follow-up|0|||
46981217|NCT02432235|83227066|FG011|Overall Study|Lost to Follow-up|0|||
46681625|NCT01175824|82897472|FG000|Overall Study|Adverse Event|2|||
46681626|NCT01175824|82897473|FG001|Overall Study|Adverse Event|1|||
46681627|NCT01175824|82897472|FG000|Overall Study|Lack of Efficacy|2|||
46681628|NCT01175824|82897473|FG001|Overall Study|Lack of Efficacy|0|||
46681629|NCT01175824|82897472|FG000|Overall Study|Lost to Follow-up|0|||
46681630|NCT01175824|82897473|FG001|Overall Study|Lost to Follow-up|1|||
46681631|NCT01175824|82897472|FG000|Overall Study|Physician Decision|0|||
46681632|NCT01175824|82897473|FG001|Overall Study|Physician Decision|4|||
46681633|NCT01175824|82897472|FG000|Overall Study|Protocol Violation|2|||
46681634|NCT01175824|82897473|FG001|Overall Study|Protocol Violation|5|||
46681635|NCT01175824|82897472|FG000|Overall Study|Withdrawal by Subject|3|||
46681636|NCT01175824|82897473|FG001|Overall Study|Withdrawal by Subject|7|||
46681637|NCT01175824|82897472|FG000|Overall Study|Sponsor Decision|1|||
46681638|NCT01175824|82897473|FG001|Overall Study|Sponsor Decision|0|||
46681639|NCT01175824|82897472|FG000|Overall Study|Entry Criteria Not Met|6|||
46681640|NCT01175824|82897473|FG001|Overall Study|Entry Criteria Not Met|4|||
46681641|NCT01175707|82897481|FG000|Overall Study|Adverse Event|4|||
46681642|NCT01175707|82897482|FG001|Overall Study|Adverse Event|6|||
46681643|NCT01112059|82897491|FG000|Overall Study|Withdrawal by Subject|1|||
46681644|NCT01112059|82897492|FG001|Overall Study|Withdrawal by Subject|0|||
46681645|NCT01175668|82897503|FG000|Overall Study|Withdrawal by Subject|2|||
46681646|NCT01175668|82897504|FG001|Overall Study|Withdrawal by Subject|0|||
46681647|NCT01111825|82897514|FG000|Overall Study|Withdrawal by Subject|0|||
46681648|NCT01111825|82897515|FG001|Overall Study|Withdrawal by Subject|0|||
46681649|NCT01111825|82897516|FG002|Overall Study|Withdrawal by Subject|1|||
46681650|NCT01111825|82897517|FG003|Overall Study|Withdrawal by Subject|0|||
46681651|NCT01111825|82897514|FG000|Overall Study|Lost to Follow-up|0|||
46858088|NCT00085644|83073839|FG000|Open-Label Period|Contemplating pregnancy|0|||
46858089|NCT00085644|83073840|FG001|Open-Label Period|Contemplating pregnancy|0|||
46981218|NCT02432235|83227055|FG000|Overall Study|Miscellaneous|0|||
46981219|NCT02432235|83227056|FG001|Overall Study|Miscellaneous|0|||
46981220|NCT02432235|83227057|FG002|Overall Study|Miscellaneous|0|||
46681652|NCT01111825|82897515|FG001|Overall Study|Lost to Follow-up|0|||
46981221|NCT02432235|83227058|FG003|Overall Study|Miscellaneous|0|||
46981222|NCT02432235|83227059|FG004|Overall Study|Miscellaneous|1|||
46681653|NCT01111825|82897516|FG002|Overall Study|Lost to Follow-up|3|||
46858090|NCT00085644|83073841|FG002|Open-Label Period|Contemplating pregnancy|3|||
46681654|NCT01111825|82897517|FG003|Overall Study|Lost to Follow-up|1|||
46681655|NCT01111825|82897514|FG000|Overall Study|Adverse Event|2|||
46681656|NCT01111825|82897515|FG001|Overall Study|Adverse Event|1|||
46681657|NCT01111825|82897516|FG002|Overall Study|Adverse Event|4|||
46681658|NCT01111825|82897517|FG003|Overall Study|Adverse Event|0|||
46681659|NCT01111825|82897514|FG000|Overall Study|Disease Progression|1|||
46858091|NCT00085644|83073839|FG000|Open-Label Period|Protocol Violation|0|||
46858092|NCT00085644|83073840|FG001|Open-Label Period|Protocol Violation|0|||
46858093|NCT00085644|83073841|FG002|Open-Label Period|Protocol Violation|4|||
46681660|NCT01111825|82897515|FG001|Overall Study|Disease Progression|0|||
46681661|NCT01111825|82897516|FG002|Overall Study|Disease Progression|0|||
46858094|NCT00085644|83073839|FG000|Open-Label Period|Personal reason|0|||
46681662|NCT01111825|82897517|FG003|Overall Study|Disease Progression|0|||
46681663|NCT01111825|82897514|FG000|Overall Study|Discontinuation by Sponsor|0|||
46681664|NCT01111825|82897515|FG001|Overall Study|Discontinuation by Sponsor|0|||
46681665|NCT01111825|82897516|FG002|Overall Study|Discontinuation by Sponsor|0|||
46681666|NCT01111825|82897517|FG003|Overall Study|Discontinuation by Sponsor|20|||
46681667|NCT01175590|82897529|FG000|Overall Study|Lost to Follow-up|1|||
46681668|NCT01175590|82897530|FG001|Overall Study|Lost to Follow-up|0|||
46681669|NCT01175590|82897529|FG000|Overall Study|Withdrawal by Subject|0|||
46681670|NCT01175590|82897530|FG001|Overall Study|Withdrawal by Subject|2|||
46681671|NCT01175590|82897529|FG000|Overall Study|Adverse Event|4|||
46681672|NCT01175590|82897530|FG001|Overall Study|Adverse Event|0|||
46681673|NCT01175590|82897529|FG000|Overall Study|Physician Decision|1|||
46681674|NCT01175590|82897530|FG001|Overall Study|Physician Decision|4|||
46681675|NCT01175590|82897529|FG000|Overall Study|Lack of Efficacy|1|||
46681676|NCT01175590|82897530|FG001|Overall Study|Lack of Efficacy|1|||
46681677|NCT01175590|82897529|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
46681678|NCT01175590|82897530|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
46681679|NCT01175590|82897529|FG000|Overall Study|Treated not as randomized|3|||
46681680|NCT01175590|82897530|FG001|Overall Study|Treated not as randomized|2|||
46681681|NCT01175590|82897529|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
46681682|NCT01175590|82897530|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
46681683|NCT01175590|82897529|FG000|Overall Study|Protocol Violation|0|||
46981223|NCT02432235|83227060|FG005|Overall Study|Miscellaneous|6|||
46981224|NCT02432235|83227061|FG006|Overall Study|Miscellaneous|2|||
46858095|NCT00085644|83073840|FG001|Open-Label Period|Personal reason|0|||
46858096|NCT00085644|83073841|FG002|Open-Label Period|Personal reason|4|||
46858097|NCT03315208|83073850|FG000|Overall Study|Lost to Follow-up|11|||
46858098|NCT03315208|83073851|FG001|Overall Study|Lost to Follow-up|6|||
46858099|NCT03315208|83073850|FG000|Overall Study|Withdrawal by Subject|2|||
46858100|NCT03315208|83073851|FG001|Overall Study|Withdrawal by Subject|0|||
46858101|NCT00314795|83073858|FG000|Overall Study|Adverse Event|8|||
46858102|NCT00314795|83073858|FG000|Overall Study|Death|4|||
46681684|NCT01175590|82897530|FG001|Overall Study|Protocol Violation|1|||
46858103|NCT00314795|83073858|FG000|Overall Study|Reason not Specified|3|||
46858104|NCT00314795|83073858|FG000|Overall Study|Renal Transplant|3|||
46858105|NCT00314795|83073858|FG000|Overall Study|Participants Withdrew Consent|2|||
46981225|NCT02432235|83227062|FG007|Overall Study|Miscellaneous|2|||
46981226|NCT02432235|83227063|FG008|Overall Study|Miscellaneous|4|||
46981227|NCT02432235|83227064|FG009|Overall Study|Miscellaneous|0|||
46981228|NCT02432235|83227065|FG010|Overall Study|Miscellaneous|0|||
46981229|NCT02432235|83227066|FG011|Overall Study|Miscellaneous|1|||
46981230|NCT02431533|83227096|FG000|Overall Study|Withdrawal by Subject|1|||
46981231|NCT02431533|83227097|FG001|Overall Study|Withdrawal by Subject|3|||
46981232|NCT02431533|83227096|FG000|Overall Study|Developed Exclusionary criteria|1|||
46981233|NCT02431533|83227097|FG001|Overall Study|Developed Exclusionary criteria|0|||
46981234|NCT02416791|83227106|FG000|6 Months|Lost to Follow-up|0|||
46981235|NCT02416791|83227107|FG001|6 Months|Lost to Follow-up|0|||
46981236|NCT02416791|83227108|FG002|6 Months|Lost to Follow-up|1|||
46858106|NCT00314327|83073862|FG000|Overall Study|Withdrawal by Subject|1|||
46858107|NCT00336479|83073870|FG000|Overall Study|Adverse Event|8|||
46858108|NCT00336479|83073871|FG001|Overall Study|Adverse Event|11|||
46981237|NCT02414841|83227118|FG000|Overall Study|Withdrawal by Subject|7|||
46681685|NCT01175473|82897539|FG000|Overall Study|Adverse Event|2|||
46681686|NCT01175473|82897540|FG001|Overall Study|Adverse Event|2|||
46681687|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
46681688|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46681689|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46681690|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46681691|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46681692|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
46681693|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46681694|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46681695|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46681696|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46681697|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
46681698|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46681699|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46681700|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46681701|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46681702|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
46681703|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
46681704|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
46681705|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
46681706|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
46681707|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
46681708|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
46681709|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
46681710|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
46681711|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
46681712|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
46681713|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
46681714|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
46681715|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
46681716|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
46681717|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
46681718|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46681719|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46681720|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46708076|NCT01172808|82923564|FG001|Overall Study|Adverse Event|4|||
46858109|NCT00336479|83073872|FG002|Overall Study|Adverse Event|18|||
46681721|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46681722|NCT01111552|82897546|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
46681723|NCT01111552|82897547|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
46681724|NCT01111552|82897548|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
46681725|NCT01111552|82897549|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
46981238|NCT02414841|83227119|FG001|Overall Study|Withdrawal by Subject|5|||
46981239|NCT02414841|83227118|FG000|Overall Study|Lost to Follow-up|13|||
46981240|NCT02414841|83227119|FG001|Overall Study|Lost to Follow-up|6|||
46981241|NCT02414841|83227118|FG000|Overall Study|Death|17|||
46981242|NCT02414841|83227119|FG001|Overall Study|Death|14|||
46981243|NCT02414841|83227118|FG000|Overall Study|Received a Kidney Transplant|13|||
46981244|NCT02414841|83227119|FG001|Overall Study|Received a Kidney Transplant|4|||
46681726|NCT01111552|82897550|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
46681727|NCT01111552|82897546|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46681728|NCT01111552|82897547|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46681729|NCT01111552|82897548|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46681730|NCT01111552|82897549|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
46681731|NCT01111552|82897550|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46681732|NCT01111552|82897546|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
46681733|NCT01111552|82897547|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
46681734|NCT01111552|82897548|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
46681735|NCT01111552|82897549|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
46681736|NCT01111552|82897550|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
46681737|NCT01111552|82897546|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
46681738|NCT01111552|82897547|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
46681739|NCT01111552|82897548|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
46681740|NCT01111552|82897549|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
46681741|NCT01111552|82897550|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
46681742|NCT01111552|82897546|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
46681743|NCT01111552|82897547|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
46681744|NCT01111552|82897548|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
46681745|NCT01111552|82897549|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
46681746|NCT01111552|82897550|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
46681747|NCT01111552|82897546|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
46981245|NCT02414841|83227118|FG000|Overall Study|Randomized But Not Treated|6|||
46681748|NCT01111552|82897547|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
46681749|NCT01111552|82897548|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
46681750|NCT01111552|82897549|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
46681751|NCT01111552|82897550|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
46681752|NCT01111552|82897546|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46681753|NCT01111552|82897547|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46681754|NCT01111552|82897548|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
46681755|NCT01111552|82897549|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46681756|NCT01111552|82897550|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46681757|NCT01175083|82897566|FG000|Primary Epoch|Withdrawal by Subject|0|||
46681758|NCT01175083|82897567|FG001|Primary Epoch|Withdrawal by Subject|0|||
46681759|NCT01175083|82897568|FG002|Primary Epoch|Withdrawal by Subject|0|||
46681760|NCT01175083|82897569|FG003|Primary Epoch|Withdrawal by Subject|0|||
46681761|NCT01175083|82897570|FG004|Primary Epoch|Withdrawal by Subject|0|||
46681762|NCT01175083|82897571|FG005|Primary Epoch|Withdrawal by Subject|2|||
46681763|NCT01175083|82897566|FG000|Primary Epoch|Lost to Follow-up|0|||
46681764|NCT01175083|82897567|FG001|Primary Epoch|Lost to Follow-up|0|||
46858110|NCT00336479|83073873|FG003|Overall Study|Adverse Event|4|||
46858111|NCT00336479|83073870|FG000|Overall Study|Noncompliant|1|||
46858112|NCT00336479|83073871|FG001|Overall Study|Noncompliant|7|||
46681765|NCT01175083|82897568|FG002|Primary Epoch|Lost to Follow-up|0|||
46858113|NCT00336479|83073872|FG002|Overall Study|Noncompliant|3|||
46858114|NCT00336479|83073873|FG003|Overall Study|Noncompliant|0|||
46858115|NCT00336479|83073870|FG000|Overall Study|Physician Decision|2|||
46858116|NCT00336479|83073871|FG001|Overall Study|Physician Decision|3|||
46858117|NCT00336479|83073872|FG002|Overall Study|Physician Decision|1|||
46858118|NCT00336479|83073873|FG003|Overall Study|Physician Decision|0|||
46858119|NCT00336479|83073870|FG000|Overall Study|Lost to Follow-up|3|||
46858120|NCT00336479|83073871|FG001|Overall Study|Lost to Follow-up|2|||
46858121|NCT00336479|83073872|FG002|Overall Study|Lost to Follow-up|0|||
46858122|NCT00336479|83073873|FG003|Overall Study|Lost to Follow-up|0|||
46858123|NCT00336479|83073870|FG000|Overall Study|Withdrawal by Subject|3|||
46858124|NCT00336479|83073871|FG001|Overall Study|Withdrawal by Subject|2|||
46681766|NCT01175083|82897569|FG003|Primary Epoch|Lost to Follow-up|0|||
46681767|NCT01175083|82897570|FG004|Primary Epoch|Lost to Follow-up|0|||
46681768|NCT01175083|82897571|FG005|Primary Epoch|Lost to Follow-up|1|||
46681769|NCT01175083|82897566|FG000|Booster Epoch|Death|0|||
46681770|NCT01175083|82897567|FG001|Booster Epoch|Death|0|||
46681771|NCT01175083|82897568|FG002|Booster Epoch|Death|1|||
46681772|NCT01175083|82897569|FG003|Booster Epoch|Death|0|||
46681773|NCT01175083|82897570|FG004|Booster Epoch|Death|0|||
46681774|NCT01175083|82897571|FG005|Booster Epoch|Death|0|||
46681775|NCT01175083|82897566|FG000|Booster Epoch|Withdrawal by Subject|0|||
46681776|NCT01175083|82897567|FG001|Booster Epoch|Withdrawal by Subject|0|||
46681777|NCT01175083|82897568|FG002|Booster Epoch|Withdrawal by Subject|0|||
46681778|NCT01175083|82897569|FG003|Booster Epoch|Withdrawal by Subject|1|||
46681779|NCT01175083|82897570|FG004|Booster Epoch|Withdrawal by Subject|0|||
46681780|NCT01175083|82897571|FG005|Booster Epoch|Withdrawal by Subject|0|||
46681781|NCT01174459|82897589|FG000|Overall Study|case report form (CRF) not collected|5|||
46681782|NCT01174342|82897593|FG000|Overall Study|Conversion to cesarean section|4|||
46858125|NCT00336479|83073872|FG002|Overall Study|Withdrawal by Subject|3|||
46858126|NCT00336479|83073873|FG003|Overall Study|Withdrawal by Subject|0|||
46858127|NCT00336479|83073870|FG000|Overall Study|Other|0|||
46858128|NCT00336479|83073871|FG001|Overall Study|Other|0|||
46858129|NCT00336479|83073872|FG002|Overall Study|Other|1|||
46858130|NCT00336479|83073873|FG003|Overall Study|Other|0|||
46858131|NCT00336479|83073870|FG000|Overall Study|Virologic Stopping Rule|20|||
46858132|NCT00336479|83073871|FG001|Overall Study|Virologic Stopping Rule|0|||
46858133|NCT00336479|83073872|FG002|Overall Study|Virologic Stopping Rule|0|||
46858134|NCT00336479|83073873|FG003|Overall Study|Virologic Stopping Rule|0|||
46858135|NCT00314249|83073886|FG000|Overall Study|Adverse Event|73|||
46858136|NCT00314249|83073887|FG001|Overall Study|Adverse Event|94|||
46681783|NCT01111474|82897597|FG000|Overall Study|Lost to Follow-up|12|||
46681784|NCT01174264|82897606|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
46681785|NCT01174264|82897607|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
46681786|NCT01174264|82897608|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
46681787|NCT01174264|82897606|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
46681788|NCT01174264|82897607|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
46681789|NCT01174264|82897608|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
46681790|NCT01174264|82897606|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
46681791|NCT01174264|82897607|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
46681792|NCT01174264|82897608|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
46681793|NCT01174186|82897618|FG000|Overall Study|Lost to Follow-up|0|||
46681794|NCT01174186|82897619|FG001|Overall Study|Lost to Follow-up|1|||
46681795|NCT01174186|82897618|FG000|Overall Study|Withdrawal by Subject|0|||
46681796|NCT01174186|82897619|FG001|Overall Study|Withdrawal by Subject|2|||
46681797|NCT01173718|82897625|FG000|Overall Study|Death|17|||
46681798|NCT01173718|82897625|FG000|Overall Study|Abandonment of study graft|27|||
46681799|NCT01111240|82897629|FG000|Overall Study|Adverse Event|190|||
46681800|NCT01111240|82897629|FG000|Overall Study|Lack of Efficacy|545|||
46681801|NCT01111240|82897629|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
46681802|NCT01111240|82897629|FG000|Overall Study|Other|312|||
46681803|NCT01111123|82897635|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
46681804|NCT01111123|82897636|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
46858137|NCT00314249|83073886|FG000|Overall Study|Lack of Efficacy|33|||
46858138|NCT00314249|83073887|FG001|Overall Study|Lack of Efficacy|24|||
46858139|NCT00314249|83073886|FG000|Overall Study|Withdrawal by Subject|21|||
46858140|NCT00314249|83073887|FG001|Overall Study|Withdrawal by Subject|28|||
46858141|NCT00314249|83073886|FG000|Overall Study|Lost to Follow-up|15|||
46681805|NCT01111123|82897635|FG000|Maintenance Phase|Lost to Follow-up|0|||
46858142|NCT00314249|83073887|FG001|Overall Study|Lost to Follow-up|9|||
46858143|NCT00314249|83073886|FG000|Overall Study|Physician Decision|1|||
46681806|NCT01111123|82897636|FG001|Maintenance Phase|Lost to Follow-up|2|||
46858144|NCT00314249|83073887|FG001|Overall Study|Physician Decision|1|||
46681807|NCT01173679|82897644|FG000|Overall Study|Death|1|||
46858145|NCT00314249|83073886|FG000|Overall Study|Withdrawn for other reasons|4|||
46858146|NCT00314249|83073887|FG001|Overall Study|Withdrawn for other reasons|1|||
46858147|NCT00314249|83073886|FG000|Overall Study|Non-Compliant|5|||
46708077|NCT01172808|82923565|FG002|Overall Study|Adverse Event|8|||
46858148|NCT00314249|83073887|FG001|Overall Study|Non-Compliant|6|||
46858149|NCT03315130|83073896|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
46858150|NCT03315130|83073897|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
46858151|NCT03315130|83073898|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
46858152|NCT03315130|83073899|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
46858153|NCT03315130|83073896|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
46681808|NCT01110382|82897651|FG000|Overall Study|Withdrawal by Subject|0|||
46681809|NCT01110382|82897652|FG001|Overall Study|Withdrawal by Subject|1|||
46681810|NCT01110382|82897651|FG000|Overall Study|Protocol Violation|0|||
46681811|NCT01110382|82897652|FG001|Overall Study|Protocol Violation|1|||
46681812|NCT01173601|82897662|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
46681813|NCT01173601|82897663|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46681814|NCT01173601|82897664|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46681815|NCT01173601|82897665|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46681816|NCT01173601|82897666|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
46681817|NCT01173601|82897662|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
46681818|NCT01173601|82897663|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46681819|NCT01173601|82897664|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46981246|NCT02414841|83227119|FG001|Overall Study|Randomized But Not Treated|4|||
46981247|NCT02413593|83227127|FG000|Overall Study|Lost to Follow-up|3|||
46981248|NCT02413593|83227127|FG000|Overall Study|Adverse Event|1|||
46858154|NCT03315130|83073897|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
46981249|NCT01652703|83227137|FG000|Overall Study|Withdrawal by Subject|0|||
46681820|NCT01173601|82897665|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46858155|NCT03315130|83073898|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
46858156|NCT03315130|83073899|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
46681821|NCT01173601|82897666|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
46681822|NCT01173601|82897662|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
46681823|NCT01173601|82897663|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46681824|NCT01173601|82897664|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46681825|NCT01173601|82897665|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46681826|NCT01173601|82897666|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
46681827|NCT01173601|82897662|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
46681828|NCT01173601|82897663|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46681829|NCT01173601|82897664|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46681830|NCT01173601|82897665|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46681831|NCT01173601|82897666|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
46681832|NCT01173601|82897662|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
46681833|NCT01173601|82897663|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46681834|NCT01173601|82897664|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46681835|NCT01173601|82897665|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46681836|NCT01173601|82897666|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
46681837|NCT01173601|82897662|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
46681838|NCT01173601|82897663|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46681839|NCT01173601|82897664|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46681840|NCT01173601|82897665|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46681841|NCT01173601|82897666|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
46681842|NCT01173601|82897662|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
46681843|NCT01173601|82897663|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46681844|NCT01173601|82897664|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46681845|NCT01173601|82897665|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46681846|NCT01173601|82897666|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
46681847|NCT01173601|82897662|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
46681848|NCT01173601|82897663|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
46681849|NCT01173601|82897664|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
46681850|NCT01173601|82897665|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
46681851|NCT01173601|82897666|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
46681852|NCT01173601|82897662|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
46981250|NCT01652703|83227138|FG001|Overall Study|Withdrawal by Subject|1|||
46681853|NCT01173601|82897663|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
46681854|NCT01173601|82897664|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
46681855|NCT01173601|82897665|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
46681856|NCT01173601|82897666|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
46681857|NCT01173601|82897662|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
46681858|NCT01173601|82897663|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
46681859|NCT01173601|82897664|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
46681860|NCT01173601|82897665|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
46681861|NCT01173601|82897666|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
46681862|NCT01173601|82897662|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
46681863|NCT01173601|82897663|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
46681864|NCT01173601|82897664|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
46681865|NCT01173601|82897665|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
46681866|NCT01173601|82897666|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
46681867|NCT01173601|82897662|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
46681868|NCT01173601|82897663|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
46681869|NCT01173601|82897664|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
46681870|NCT01173601|82897665|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
46681871|NCT01173601|82897666|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
46681872|NCT01173601|82897662|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
46681873|NCT01173601|82897663|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
46681874|NCT01173601|82897664|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
46681875|NCT01173601|82897665|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
46681876|NCT01173601|82897666|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
46681877|NCT01173601|82897662|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
46681878|NCT01173601|82897663|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
46681879|NCT01173601|82897664|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
46681880|NCT01173601|82897665|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
46681881|NCT01173601|82897666|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
46681882|NCT01173523|82897686|FG000|Overall Study|Clinical Progression|1|||
46681883|NCT01173523|82897687|FG001|Overall Study|Clinical Progression|1|||
46681884|NCT01173523|82897686|FG000|Overall Study|Progressive Disease|10|||
46681885|NCT01173523|82897687|FG001|Overall Study|Progressive Disease|8|||
46681886|NCT01173523|82897686|FG000|Overall Study|Other|2|||
46681887|NCT01173523|82897687|FG001|Overall Study|Other|3|||
46681888|NCT01173055|82897695|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
46681889|NCT01173055|82897696|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
46681890|NCT01173055|82897695|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
46681891|NCT01173055|82897696|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
46681892|NCT01172938|82897705|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
46681893|NCT01172938|82897706|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
46681894|NCT01172938|82897707|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
46681895|NCT01172938|82897708|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
46681896|NCT01172938|82897709|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
46681897|NCT01172938|82897710|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
46681898|NCT01172938|82897711|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
46681899|NCT01172938|82897712|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
46681900|NCT01172938|82897713|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
46681901|NCT01172938|82897705|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
46681902|NCT01172938|82897706|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
46681903|NCT01172938|82897707|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
46681904|NCT01172938|82897708|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
46681905|NCT01172938|82897709|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
46681906|NCT01172938|82897710|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
46681907|NCT01172938|82897711|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
46681908|NCT01172938|82897712|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
46681909|NCT01172938|82897713|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
46681910|NCT01172938|82897705|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
46681911|NCT01172938|82897706|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
46681912|NCT01172938|82897707|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
46681913|NCT01172938|82897708|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
46681914|NCT01172938|82897709|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
46681915|NCT01172938|82897710|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
46681916|NCT01172938|82897711|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
46681917|NCT01172938|82897712|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
46681918|NCT01172938|82897713|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
46681919|NCT01172938|82897705|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
46681920|NCT01172938|82897706|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
46681921|NCT01172938|82897707|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
46681922|NCT01172938|82897708|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
46681923|NCT01172938|82897709|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
46681924|NCT01172938|82897710|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
46681925|NCT01172938|82897711|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
46681926|NCT01172938|82897712|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
46681927|NCT01172938|82897713|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
46681928|NCT01172938|82897705|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
46681929|NCT01172938|82897706|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
46681930|NCT01172938|82897707|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
46681931|NCT01172938|82897708|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
46981251|NCT01652703|83227139|FG002|Overall Study|Withdrawal by Subject|3|||
46981252|NCT01652703|83227140|FG003|Overall Study|Withdrawal by Subject|1|||
46981253|NCT01652703|83227141|FG004|Overall Study|Withdrawal by Subject|0|||
46981254|NCT01652703|83227142|FG005|Overall Study|Withdrawal by Subject|1|||
46981255|NCT01652703|83227137|FG000|Overall Study|Other|0|||
46981256|NCT01652703|83227138|FG001|Overall Study|Other|0|||
46681932|NCT01172938|82897709|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
46681933|NCT01172938|82897710|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
46681934|NCT01172938|82897711|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
46981257|NCT01652703|83227139|FG002|Overall Study|Other|0|||
46981258|NCT01652703|83227140|FG003|Overall Study|Other|1|||
46981259|NCT01652703|83227141|FG004|Overall Study|Other|1|||
46981260|NCT01652703|83227142|FG005|Overall Study|Other|1|||
46681935|NCT01172938|82897712|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
46681936|NCT01172938|82897713|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
46681937|NCT01172938|82897705|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
46681938|NCT01172938|82897706|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681939|NCT01172938|82897707|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681940|NCT01172938|82897708|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681941|NCT01172938|82897709|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681942|NCT01172938|82897710|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681943|NCT01172938|82897711|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681944|NCT01172938|82897712|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681945|NCT01172938|82897713|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
46681946|NCT01172938|82897705|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
46681947|NCT01172938|82897706|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
46681948|NCT01172938|82897707|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
46681949|NCT01172938|82897708|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
46681950|NCT01172938|82897709|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
46681951|NCT01172938|82897710|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
46681952|NCT01172938|82897711|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
46681953|NCT01172938|82897712|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
46681954|NCT01172938|82897713|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
46681955|NCT01172938|82897705|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
46681956|NCT01172938|82897706|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
46681957|NCT01172938|82897707|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
46681958|NCT01172938|82897708|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
46681959|NCT01172938|82897709|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
46681960|NCT01172938|82897710|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
46681961|NCT01172938|82897711|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
46681962|NCT01172938|82897712|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
46681963|NCT01172938|82897713|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
46681964|NCT01172938|82897705|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
46681965|NCT01172938|82897706|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
46681966|NCT01172938|82897707|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
46681967|NCT01172938|82897708|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
46681968|NCT01172938|82897709|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
46681969|NCT01172938|82897710|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
46681970|NCT01172938|82897711|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
46681971|NCT01172938|82897712|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
46681972|NCT01172938|82897713|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
46681973|NCT01172938|82897705|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46681974|NCT01172938|82897706|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46681975|NCT01172938|82897707|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
46681976|NCT01172938|82897708|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46708078|NCT01172808|82923566|FG003|Overall Study|Adverse Event|3|||
46981261|NCT01652469|83227158|FG000|Overall Study|Withdrawal by Subject|1|||
46981262|NCT01652469|83227159|FG001|Overall Study|Withdrawal by Subject|4|||
46981263|NCT01652469|83227158|FG000|Overall Study|Lost to Follow-up|0|||
46981264|NCT01652469|83227159|FG001|Overall Study|Lost to Follow-up|2|||
46981265|NCT02429427|83227167|FG000|Overall Study|Adverse Event|220|||
46981266|NCT02429427|83227168|FG001|Overall Study|Adverse Event|92|||
46981267|NCT02429427|83227167|FG000|Overall Study|Protocol Violation|10|||
46981268|NCT02429427|83227168|FG001|Overall Study|Protocol Violation|6|||
46981269|NCT02429427|83227167|FG000|Overall Study|Lost to Follow-up|15|||
46681977|NCT01172938|82897709|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46681978|NCT01172938|82897710|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46681979|NCT01172938|82897711|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46681980|NCT01172938|82897712|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46681981|NCT01172938|82897713|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
46681982|NCT01172938|82897705|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
46681983|NCT01172938|82897706|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
46681984|NCT01172938|82897707|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
46681985|NCT01172938|82897708|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
46681986|NCT01172938|82897709|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
46681987|NCT01172938|82897710|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
46681988|NCT01172938|82897711|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
46681989|NCT01172938|82897712|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
46681990|NCT01172938|82897713|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
46681991|NCT01172938|82897705|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
46681992|NCT01172938|82897706|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
46681993|NCT01172938|82897707|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
46681994|NCT01172938|82897708|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
46681995|NCT01172938|82897709|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
46681996|NCT01172938|82897710|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
46681997|NCT01172938|82897711|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
46681998|NCT01172938|82897712|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
46681999|NCT01172938|82897713|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
46682000|NCT01172938|82897705|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
46682001|NCT01172938|82897706|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
46682002|NCT01172938|82897707|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
46682003|NCT01172938|82897708|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
46682004|NCT01172938|82897709|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
46682005|NCT01172938|82897710|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
46682006|NCT01172938|82897711|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
46682007|NCT01172938|82897712|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
46682008|NCT01172938|82897713|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
46682009|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
46682010|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
46682011|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
46682012|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
46682013|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
46682014|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
46682015|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
46682016|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
46682017|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
46682018|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
46682019|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
46682020|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
46682021|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
46682022|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
46682023|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
46682024|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
46682025|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
46682026|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
46682027|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682028|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682029|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
46682030|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682031|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682032|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682033|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682034|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682035|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
46682036|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
46682037|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
46682038|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
46682039|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
46682040|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
46682041|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
46682042|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
46682043|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
46682044|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
46682045|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46682046|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46981270|NCT02429427|83227168|FG001|Overall Study|Lost to Follow-up|6|||
46682047|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
46682048|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46682049|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46682050|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46682051|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46682052|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46682053|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
46682054|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
46682055|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
46682056|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
46682057|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
46682058|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
46682059|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
46682060|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
46682061|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
46682062|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
46682063|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
46682064|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
46682065|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
46682066|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
46682067|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
46682068|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
46682069|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
46682070|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
46682071|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
46682072|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46682073|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
46682074|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46682075|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46682076|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46682077|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46682078|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46858157|NCT03315130|83073896|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
46682079|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46682080|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
46682081|NCT01172938|82897705|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682082|NCT01172938|82897706|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682083|NCT01172938|82897707|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682084|NCT01172938|82897708|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682085|NCT01172938|82897709|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682086|NCT01172938|82897710|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682087|NCT01172938|82897711|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682088|NCT01172938|82897712|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
46682089|NCT01172938|82897713|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
46682090|NCT01172938|82897705|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
46682091|NCT01172938|82897706|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
46682092|NCT01172938|82897707|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
46682093|NCT01172938|82897708|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
46682094|NCT01172938|82897709|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
46682095|NCT01172938|82897710|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
46682096|NCT01172938|82897711|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
46682097|NCT01172938|82897712|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
46682098|NCT01172938|82897713|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
46682099|NCT01172938|82897705|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
46682100|NCT01172938|82897706|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
46682101|NCT01172938|82897707|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
46682102|NCT01172938|82897708|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
46682103|NCT01172938|82897709|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
46682104|NCT01172938|82897710|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
46682105|NCT01172938|82897711|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
46682106|NCT01172938|82897712|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
46682107|NCT01172938|82897713|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
46682108|NCT01172938|82897705|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682109|NCT01172938|82897706|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682110|NCT01172938|82897707|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682111|NCT01172938|82897708|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682112|NCT01172938|82897709|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682113|NCT01172938|82897710|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682114|NCT01172938|82897711|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682115|NCT01172938|82897712|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
46682116|NCT01172938|82897713|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
46682117|NCT01172938|82897705|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682118|NCT01172938|82897706|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
46682119|NCT01172938|82897707|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682120|NCT01172938|82897708|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682121|NCT01172938|82897709|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682122|NCT01172938|82897710|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682123|NCT01172938|82897711|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682124|NCT01172938|82897712|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682125|NCT01172938|82897713|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
46682126|NCT01172938|82897705|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682127|NCT01172938|82897706|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682128|NCT01172938|82897707|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
46682129|NCT01172938|82897708|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682130|NCT01172938|82897709|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682131|NCT01172938|82897710|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682132|NCT01172938|82897711|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682133|NCT01172938|82897712|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682134|NCT01172938|82897713|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
46682135|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
46682136|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
46682137|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
46682138|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
46682139|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
46682140|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
46682141|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
46682142|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
46682143|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
46682144|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
46682145|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
46682146|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
46682147|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
46682148|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
46682149|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
46682150|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
46682151|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
46682152|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
46682153|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
46682154|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
46682155|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
46682156|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
46682157|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
46682158|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
46682159|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
46682160|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
46858158|NCT03315130|83073897|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
46981271|NCT02429427|83227167|FG000|Overall Study|Withdrawal by Subject|64|||
46981272|NCT02429427|83227168|FG001|Overall Study|Withdrawal by Subject|34|||
46981273|NCT02429427|83227167|FG000|Overall Study|Other|62|||
46981274|NCT02429427|83227168|FG001|Overall Study|Other|41|||
46981275|NCT02412735|83227177|FG000|Overall Study|Adverse Event|0|||
46981276|NCT02412735|83227178|FG001|Overall Study|Adverse Event|1|||
46981277|NCT02412735|83227179|FG002|Overall Study|Adverse Event|2|||
46981278|NCT02412735|83227177|FG000|Overall Study|Withdrawal by Subject|23|||
46682161|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
46682162|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
46682163|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
46682164|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
46682165|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
46981279|NCT02412735|83227178|FG001|Overall Study|Withdrawal by Subject|27|||
46981280|NCT02412735|83227179|FG002|Overall Study|Withdrawal by Subject|22|||
46682166|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
46682167|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
46682168|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
46682169|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
46682170|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
46682171|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682172|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682173|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682174|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682175|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682176|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682177|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682178|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
46682179|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
46682180|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
46682181|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
46682182|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
46682183|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
46682184|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
46682185|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
46682186|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
46682187|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
46682188|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
46682189|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46682190|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46682191|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
46682192|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46682193|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46682194|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46682195|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46682196|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46798478|NCT00113269|83017131|FG000|Overall Study|Did not meet eligibility criteria|1|||
46682197|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
46682198|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
46682199|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
46682200|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
46682201|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
46682202|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
46682203|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
46682204|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
46682205|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
46682206|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
46682207|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
46682208|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
46682209|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
46682210|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
46682211|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
46682212|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
46682213|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
46682214|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
46682215|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
46682216|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682217|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682218|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
46682219|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682220|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682221|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682222|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682223|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682224|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
46682225|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46682226|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46682227|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
46682228|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46682229|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46682230|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46682231|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46682232|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46682233|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
46798479|NCT00113269|83017132|FG001|Overall Study|Did not meet eligibility criteria|0|||
46798480|NCT00113269|83017133|FG002|Overall Study|Did not meet eligibility criteria|0|||
46798481|NCT00113269|83017134|FG003|Overall Study|Did not meet eligibility criteria|1|||
46798482|NCT00113269|83017131|FG000|Overall Study|Unable to return for follow up|2|||
46708079|NCT01172808|82923563|FG000|Overall Study|Lack of Efficacy|1|||
46798483|NCT00113269|83017132|FG001|Overall Study|Unable to return for follow up|1|||
46798484|NCT00113269|83017133|FG002|Overall Study|Unable to return for follow up|0|||
46798485|NCT00113269|83017134|FG003|Overall Study|Unable to return for follow up|0|||
46798486|NCT00515619|83017144|FG000|Overall Study|Adverse Event|34|||
46682234|NCT01172938|82897705|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46682235|NCT01172938|82897706|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46682236|NCT01172938|82897707|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46981281|NCT02412735|83227177|FG000|Overall Study|Investigator Decision|3|||
46981282|NCT02412735|83227178|FG001|Overall Study|Investigator Decision|3|||
46981283|NCT02412735|83227179|FG002|Overall Study|Investigator Decision|2|||
46682237|NCT01172938|82897708|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46682238|NCT01172938|82897709|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46682239|NCT01172938|82897710|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46682240|NCT01172938|82897711|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46682241|NCT01172938|82897712|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
46682242|NCT01172938|82897713|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
46682243|NCT01109992|82897733|FG000|Overall Study|Withdrawal by Subject|0|||
46682244|NCT01109992|82897734|FG001|Overall Study|Withdrawal by Subject|1|||
46682245|NCT01109992|82897733|FG000|Overall Study|Movement during rest scan.|0|||
46682246|NCT01109992|82897734|FG001|Overall Study|Movement during rest scan.|1|||
46682247|NCT01109524|82897743|FG000|Overall Study|Disease Progression|29|||
46682248|NCT01109524|82897743|FG000|Overall Study|Study Drug toxicity|6|||
46682249|NCT01109524|82897743|FG000|Overall Study|Adverse Event|4|||
46682250|NCT01109524|82897743|FG000|Overall Study|Withdrawal by Subject|2|||
46682251|NCT01109524|82897743|FG000|Overall Study|Maximum clinical benefit|3|||
46682252|NCT01109524|82897743|FG000|Overall Study|Death|2|||
46682253|NCT01109524|82897743|FG000|Overall Study|No longer meets criteria|2|||
46682254|NCT01109524|82897743|FG000|Overall Study|Participant requested to end treatment|4|||
46682255|NCT01109524|82897743|FG000|Overall Study|Other|5|||
46682256|NCT01109173|82897758|FG000|Overall Study|Adverse Event|15|||
46682257|NCT01109173|82897759|FG001|Overall Study|Adverse Event|17|||
46682258|NCT01109173|82897760|FG002|Overall Study|Adverse Event|9|||
46682259|NCT01109173|82897761|FG003|Overall Study|Adverse Event|6|||
46682260|NCT01109173|82897758|FG000|Overall Study|Lost to Follow-up|0|||
46682261|NCT01109173|82897759|FG001|Overall Study|Lost to Follow-up|1|||
46682262|NCT01109173|82897760|FG002|Overall Study|Lost to Follow-up|0|||
46682263|NCT01109173|82897761|FG003|Overall Study|Lost to Follow-up|0|||
46682264|NCT01109173|82897758|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
46682265|NCT01109173|82897759|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
46682266|NCT01109173|82897760|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
46682267|NCT01109173|82897761|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
46682268|NCT01109173|82897758|FG000|Overall Study|Noncompliance|0|||
46682269|NCT01109173|82897759|FG001|Overall Study|Noncompliance|1|||
46682270|NCT01109173|82897760|FG002|Overall Study|Noncompliance|0|||
46682271|NCT01109173|82897761|FG003|Overall Study|Noncompliance|0|||
46682272|NCT01109173|82897758|FG000|Overall Study|Treatment Failure|25|||
46682273|NCT01109173|82897759|FG001|Overall Study|Treatment Failure|32|||
46682274|NCT01109173|82897760|FG002|Overall Study|Treatment Failure|69|||
46682275|NCT01109173|82897761|FG003|Overall Study|Treatment Failure|64|||
46682276|NCT01109173|82897758|FG000|Overall Study|Protocol Violation|4|||
46682277|NCT01109173|82897759|FG001|Overall Study|Protocol Violation|5|||
46682278|NCT01109173|82897760|FG002|Overall Study|Protocol Violation|1|||
46682279|NCT01109173|82897761|FG003|Overall Study|Protocol Violation|2|||
46682280|NCT01109173|82897758|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
46682281|NCT01109173|82897759|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
46682282|NCT01109173|82897760|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
46682283|NCT01109173|82897761|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
46682284|NCT01109173|82897758|FG000|Overall Study|Not Specifiied|5|||
46682285|NCT01109173|82897759|FG001|Overall Study|Not Specifiied|4|||
46858159|NCT03315130|83073898|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
46981284|NCT02412735|83227177|FG000|Overall Study|Lost to Follow-up|17|||
46682286|NCT01109173|82897760|FG002|Overall Study|Not Specifiied|9|||
46682287|NCT01109173|82897761|FG003|Overall Study|Not Specifiied|14|||
46981285|NCT02412735|83227178|FG001|Overall Study|Lost to Follow-up|11|||
46682288|NCT01172821|82897775|FG000|Overall Study|Adverse Event|5|||
46682289|NCT01172821|82897776|FG001|Overall Study|Adverse Event|2|||
46682290|NCT01172821|82897777|FG002|Overall Study|Adverse Event|2|||
46981286|NCT02412735|83227179|FG002|Overall Study|Lost to Follow-up|18|||
46682291|NCT01172821|82897778|FG003|Overall Study|Adverse Event|7|||
46682292|NCT01172821|82897775|FG000|Overall Study|Protocol Violation|0|||
46682293|NCT01172821|82897776|FG001|Overall Study|Protocol Violation|2|||
46682294|NCT01172821|82897777|FG002|Overall Study|Protocol Violation|1|||
46682295|NCT01172821|82897778|FG003|Overall Study|Protocol Violation|2|||
46682296|NCT01172821|82897775|FG000|Overall Study|Lost to Follow-up|4|||
46682297|NCT01172821|82897776|FG001|Overall Study|Lost to Follow-up|1|||
46682298|NCT01172821|82897777|FG002|Overall Study|Lost to Follow-up|2|||
46682299|NCT01172821|82897778|FG003|Overall Study|Lost to Follow-up|2|||
46682300|NCT01172821|82897775|FG000|Overall Study|Withdrawal by Subject|2|||
46682301|NCT01172821|82897776|FG001|Overall Study|Withdrawal by Subject|3|||
46682302|NCT01172821|82897777|FG002|Overall Study|Withdrawal by Subject|3|||
46682303|NCT01172821|82897778|FG003|Overall Study|Withdrawal by Subject|3|||
46682304|NCT01172821|82897775|FG000|Overall Study|Other|3|||
46682305|NCT01172821|82897776|FG001|Overall Study|Other|4|||
46682306|NCT01172821|82897777|FG002|Overall Study|Other|5|||
46682307|NCT01172821|82897778|FG003|Overall Study|Other|3|||
46682308|NCT01172275|82897790|FG000|Overall Study|Lost to Follow-up|1|||
46682309|NCT01172275|82897791|FG001|Overall Study|Lost to Follow-up|0|||
46981287|NCT02412735|83227177|FG000|Overall Study|Reason not Specified|3|||
46981288|NCT02412735|83227178|FG001|Overall Study|Reason not Specified|2|||
46981289|NCT02412735|83227179|FG002|Overall Study|Reason not Specified|2|||
46981290|NCT02412657|83227190|FG000|Overall Study|Lost to Follow-up|1|||
46981291|NCT02412657|83227191|FG001|Overall Study|Lost to Follow-up|0|||
46981292|NCT02412657|83227192|FG002|Overall Study|Lost to Follow-up|0|||
46981293|NCT02412657|83227190|FG000|Overall Study|Protocol Violation|0|||
46981294|NCT02412657|83227191|FG001|Overall Study|Protocol Violation|2|||
46981295|NCT02412657|83227192|FG002|Overall Study|Protocol Violation|3|||
46981296|NCT02428413|83227202|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
46981297|NCT02428413|83227203|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
46981298|NCT02428413|83227202|FG000|Overall Study|Protocol Violation|1|||
46981299|NCT02428413|83227203|FG001|Overall Study|Protocol Violation|2|||
46981300|NCT02428413|83227202|FG000|Overall Study|Case Cancelled|2|||
46981301|NCT02428413|83227203|FG001|Overall Study|Case Cancelled|0|||
46981302|NCT02428413|83227202|FG000|Overall Study|Missed Cases|1|||
46981303|NCT02428413|83227203|FG001|Overall Study|Missed Cases|2|||
46981304|NCT02428413|83227202|FG000|Overall Study|Nurse Refusal|1|||
46981305|NCT02428413|83227203|FG001|Overall Study|Nurse Refusal|0|||
46981306|NCT02412111|83227211|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
46981307|NCT02412111|83227212|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
46981308|NCT02412111|83227213|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
46981309|NCT02412111|83227211|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
46981310|NCT02412111|83227212|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
46682310|NCT01172275|82897790|FG000|Overall Study|Protocol Violation|1|||
46682311|NCT01172275|82897791|FG001|Overall Study|Protocol Violation|0|||
46682312|NCT01108510|82897799|FG000|Overall Study|Randomized but Not Treated|5|||
46682313|NCT01108510|82897800|FG001|Overall Study|Randomized but Not Treated|1|||
46682314|NCT01108510|82897799|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
46682315|NCT01108510|82897800|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
46798487|NCT00515619|83017144|FG000|Overall Study|Lack of Efficacy|92|||
46682316|NCT01108510|82897799|FG000|Overall Study|Adverse Event|26|||
46682317|NCT01108510|82897800|FG001|Overall Study|Adverse Event|19|||
46981311|NCT02412111|83227213|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
46981312|NCT02412111|83227211|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
46981313|NCT02412111|83227212|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
46981314|NCT02412111|83227213|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
46981315|NCT02412111|83227211|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
46682318|NCT01108510|82897799|FG000|Overall Study|Lost to Follow-up|20|||
46682319|NCT01108510|82897800|FG001|Overall Study|Lost to Follow-up|17|||
46682320|NCT01108510|82897799|FG000|Overall Study|Withdrew Consent|21|||
46682321|NCT01108510|82897800|FG001|Overall Study|Withdrew Consent|15|||
46682322|NCT01108510|82897799|FG000|Overall Study|Investigator's Discretion|12|||
46682323|NCT01108510|82897800|FG001|Overall Study|Investigator's Discretion|10|||
46682324|NCT01108510|82897799|FG000|Overall Study|Participant Noncompliance|5|||
46682325|NCT01108510|82897800|FG001|Overall Study|Participant Noncompliance|7|||
46682326|NCT01108510|82897799|FG000|Overall Study|Lack of Efficacy|3|||
46682327|NCT01108510|82897800|FG001|Overall Study|Lack of Efficacy|0|||
46682328|NCT01108510|82897799|FG000|Overall Study|Pregnancy|0|||
46682329|NCT01108510|82897800|FG001|Overall Study|Pregnancy|3|||
46682330|NCT01108510|82897799|FG000|Overall Study|Death|1|||
46682331|NCT01108510|82897800|FG001|Overall Study|Death|1|||
46682332|NCT01340027|82897818|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
46682333|NCT01340027|82897819|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
46682334|NCT01340027|82897820|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
46682335|NCT01340027|82897821|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
46682336|NCT01340027|82897822|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
46682337|NCT01340027|82897823|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
46682338|NCT01340027|82897824|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
46682339|NCT01340027|82897825|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
46682340|NCT01340027|82897826|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
46682341|NCT01340027|82897827|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
46682342|NCT01340027|82897828|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
46682343|NCT01340027|82897829|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
46682344|NCT01340027|82897818|FG000|Overall Study|Adverse Event|0|||
46682345|NCT01340027|82897819|FG001|Overall Study|Adverse Event|1|||
46682346|NCT01340027|82897820|FG002|Overall Study|Adverse Event|2|||
46682347|NCT01340027|82897821|FG003|Overall Study|Adverse Event|0|||
46682348|NCT01340027|82897822|FG004|Overall Study|Adverse Event|1|||
46682349|NCT01340027|82897823|FG005|Overall Study|Adverse Event|2|||
46682350|NCT01340027|82897824|FG006|Overall Study|Adverse Event|2|||
46981316|NCT02412111|83227212|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
46981317|NCT02412111|83227213|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
46682351|NCT01340027|82897825|FG007|Overall Study|Adverse Event|1|||
46682352|NCT01340027|82897826|FG008|Overall Study|Adverse Event|4|||
46682353|NCT01340027|82897827|FG009|Overall Study|Adverse Event|1|||
46682354|NCT01340027|82897828|FG010|Overall Study|Adverse Event|1|||
46682355|NCT01340027|82897829|FG011|Overall Study|Adverse Event|3|||
46682356|NCT01340027|82897818|FG000|Overall Study|Lack of Efficacy|0|||
46682357|NCT01340027|82897819|FG001|Overall Study|Lack of Efficacy|0|||
46682358|NCT01340027|82897820|FG002|Overall Study|Lack of Efficacy|0|||
46682359|NCT01340027|82897821|FG003|Overall Study|Lack of Efficacy|0|||
46682360|NCT01340027|82897822|FG004|Overall Study|Lack of Efficacy|0|||
46682361|NCT01340027|82897823|FG005|Overall Study|Lack of Efficacy|0|||
46682362|NCT01340027|82897824|FG006|Overall Study|Lack of Efficacy|1|||
46682363|NCT01340027|82897825|FG007|Overall Study|Lack of Efficacy|1|||
46682364|NCT01340027|82897826|FG008|Overall Study|Lack of Efficacy|1|||
46682365|NCT01340027|82897827|FG009|Overall Study|Lack of Efficacy|0|||
46682366|NCT01340027|82897828|FG010|Overall Study|Lack of Efficacy|0|||
46682367|NCT01340027|82897829|FG011|Overall Study|Lack of Efficacy|0|||
46682368|NCT01340027|82897818|FG000|Overall Study|Lost to Follow-up|0|||
46682369|NCT01340027|82897819|FG001|Overall Study|Lost to Follow-up|1|||
46682370|NCT01340027|82897820|FG002|Overall Study|Lost to Follow-up|0|||
46682371|NCT01340027|82897821|FG003|Overall Study|Lost to Follow-up|0|||
46682372|NCT01340027|82897822|FG004|Overall Study|Lost to Follow-up|0|||
46682373|NCT01340027|82897823|FG005|Overall Study|Lost to Follow-up|0|||
46682374|NCT01340027|82897824|FG006|Overall Study|Lost to Follow-up|1|||
46682375|NCT01340027|82897825|FG007|Overall Study|Lost to Follow-up|0|||
46682376|NCT01340027|82897826|FG008|Overall Study|Lost to Follow-up|0|||
46682377|NCT01340027|82897827|FG009|Overall Study|Lost to Follow-up|1|||
46682378|NCT01340027|82897828|FG010|Overall Study|Lost to Follow-up|0|||
46682379|NCT01340027|82897829|FG011|Overall Study|Lost to Follow-up|0|||
46682380|NCT01340027|82897818|FG000|Overall Study|Protocol Violation|1|||
46682381|NCT01340027|82897819|FG001|Overall Study|Protocol Violation|2|||
46682382|NCT01340027|82897820|FG002|Overall Study|Protocol Violation|0|||
46682383|NCT01340027|82897821|FG003|Overall Study|Protocol Violation|0|||
46682384|NCT01340027|82897822|FG004|Overall Study|Protocol Violation|6|||
46682385|NCT01340027|82897823|FG005|Overall Study|Protocol Violation|0|||
46682386|NCT01340027|82897824|FG006|Overall Study|Protocol Violation|0|||
46682387|NCT01340027|82897825|FG007|Overall Study|Protocol Violation|1|||
46682388|NCT01340027|82897826|FG008|Overall Study|Protocol Violation|2|||
46858160|NCT03315130|83073899|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
46981318|NCT02412111|83227211|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
46682389|NCT01340027|82897827|FG009|Overall Study|Protocol Violation|2|||
46682390|NCT01340027|82897828|FG010|Overall Study|Protocol Violation|0|||
46682391|NCT01340027|82897829|FG011|Overall Study|Protocol Violation|0|||
46682392|NCT01340027|82897818|FG000|Overall Study|Withdrawal by Subject|4|||
46682393|NCT01340027|82897819|FG001|Overall Study|Withdrawal by Subject|3|||
46682394|NCT01340027|82897820|FG002|Overall Study|Withdrawal by Subject|1|||
46682395|NCT01340027|82897821|FG003|Overall Study|Withdrawal by Subject|3|||
46682396|NCT01340027|82897822|FG004|Overall Study|Withdrawal by Subject|3|||
46682397|NCT01340027|82897823|FG005|Overall Study|Withdrawal by Subject|2|||
46682398|NCT01340027|82897824|FG006|Overall Study|Withdrawal by Subject|3|||
46682399|NCT01340027|82897825|FG007|Overall Study|Withdrawal by Subject|4|||
46682400|NCT01340027|82897826|FG008|Overall Study|Withdrawal by Subject|1|||
46682401|NCT01340027|82897827|FG009|Overall Study|Withdrawal by Subject|2|||
46682402|NCT01340027|82897828|FG010|Overall Study|Withdrawal by Subject|0|||
46682403|NCT01340027|82897829|FG011|Overall Study|Withdrawal by Subject|1|||
46682404|NCT01340027|82897818|FG000|Overall Study|Miscellaneous|0|||
46682405|NCT01340027|82897819|FG001|Overall Study|Miscellaneous|0|||
46682406|NCT01340027|82897820|FG002|Overall Study|Miscellaneous|0|||
46682407|NCT01340027|82897821|FG003|Overall Study|Miscellaneous|1|||
46682408|NCT01340027|82897822|FG004|Overall Study|Miscellaneous|0|||
46682409|NCT01340027|82897823|FG005|Overall Study|Miscellaneous|0|||
46682410|NCT01340027|82897824|FG006|Overall Study|Miscellaneous|0|||
46682411|NCT01340027|82897825|FG007|Overall Study|Miscellaneous|0|||
46682412|NCT01340027|82897826|FG008|Overall Study|Miscellaneous|0|||
46682413|NCT01340027|82897827|FG009|Overall Study|Miscellaneous|0|||
46682414|NCT01340027|82897828|FG010|Overall Study|Miscellaneous|1|||
46682415|NCT01340027|82897829|FG011|Overall Study|Miscellaneous|0|||
46682416|NCT01327053|82897857|FG000|Overall Study|Adverse Event|23|||
46682417|NCT01327053|82897858|FG001|Overall Study|Adverse Event|57|||
46682418|NCT01327053|82897857|FG000|Overall Study|Patient/guardian decision|11|||
46682419|NCT01327053|82897858|FG001|Overall Study|Patient/guardian decision|35|||
46682420|NCT01327053|82897857|FG000|Overall Study|Physician Decision|10|||
46682421|NCT01327053|82897858|FG001|Overall Study|Physician Decision|14|||
46682422|NCT01327053|82897857|FG000|Overall Study|Death|1|||
46682423|NCT01327053|82897858|FG001|Overall Study|Death|5|||
46682424|NCT01327053|82897857|FG000|Overall Study|Lost to Follow-up|2|||
46798488|NCT00515619|83017144|FG000|Overall Study|Withdrawal by Subject|66|||
46682425|NCT01327053|82897858|FG001|Overall Study|Lost to Follow-up|4|||
46682426|NCT01327053|82897857|FG000|Overall Study|Non-compliance with study treatment|0|||
46682427|NCT01327053|82897858|FG001|Overall Study|Non-compliance with study treatment|5|||
46682428|NCT01327053|82897857|FG000|Overall Study|Study terminated by Sponsor|1|||
46682429|NCT01327053|82897858|FG001|Overall Study|Study terminated by Sponsor|3|||
46682430|NCT01327053|82897857|FG000|Overall Study|Progressive disease|31|||
46682431|NCT01327053|82897858|FG001|Overall Study|Progressive disease|26|||
46682432|NCT01327053|82897857|FG000|Overall Study|Protocol Violation|0|||
46682433|NCT01327053|82897858|FG001|Overall Study|Protocol Violation|1|||
46682434|NCT01327053|82897857|FG000|Overall Study|Untreated|0|||
46682435|NCT01327053|82897858|FG001|Overall Study|Untreated|1|||
46682436|NCT01107925|82897872|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
46682437|NCT01107925|82897873|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
46682438|NCT01107925|82897874|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
46682439|NCT01107925|82897875|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
46682440|NCT01107925|82897876|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
46682441|NCT01107925|82897877|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
46682442|NCT01107925|82897872|FG000|Period 2|Withdrawal by Subject|0|||
46682443|NCT01107925|82897873|FG001|Period 2|Withdrawal by Subject|1|||
46682444|NCT01107925|82897874|FG002|Period 2|Withdrawal by Subject|0|||
46682445|NCT01107925|82897875|FG003|Period 2|Withdrawal by Subject|0|||
46682446|NCT01107925|82897876|FG004|Period 2|Withdrawal by Subject|0|||
46682447|NCT01107925|82897877|FG005|Period 2|Withdrawal by Subject|1|||
46682448|NCT01339832|82897905|FG000|Overall Study|Lost to Follow-up|3|||
46682449|NCT01339832|82897905|FG000|Overall Study|Death|11|||
46682450|NCT01339559|82897909|FG000|Overall Study|Adverse Event|92|||
46682451|NCT01339559|82897909|FG000|Overall Study|Death|5|||
46682452|NCT01339559|82897909|FG000|Overall Study|Lack of Efficacy|164|||
46682453|NCT01339559|82897909|FG000|Overall Study|Lost to Follow-up|22|||
46682454|NCT01339559|82897909|FG000|Overall Study|Subject choice|89|||
46682455|NCT01339559|82897909|FG000|Overall Study|Protocol Violation|15|||
46682456|NCT01339559|82897909|FG000|Overall Study|Study closure at site|1|||
46682457|NCT01339559|82897909|FG000|Overall Study|Incarcerated|2|||
46682458|NCT01339559|82897909|FG000|Overall Study|Epilepsy surgery|1|||
46682459|NCT01339559|82897909|FG000|Overall Study|Pregnancy planned|2|||
46682460|NCT01339559|82897909|FG000|Overall Study|Left the country|1|||
46682461|NCT01339559|82897909|FG000|Overall Study|Investigator decision|2|||
46682462|NCT01339559|82897909|FG000|Overall Study|Patient didn't wish to continue|1|||
46682463|NCT01339559|82897909|FG000|Overall Study|PI decision|1|||
46682464|NCT00107900|82897920|FG000|Overall Study|Adverse Event|3|||
46682465|NCT00107900|82897921|FG001|Overall Study|Adverse Event|2|||
46682466|NCT00107900|82897922|FG002|Overall Study|Adverse Event|10|||
46682467|NCT00107900|82897923|FG003|Overall Study|Adverse Event|3|||
46682468|NCT00107900|82897924|FG004|Overall Study|Adverse Event|5|||
46682469|NCT00107900|82897925|FG005|Overall Study|Adverse Event|3|||
46682470|NCT00107900|82897920|FG000|Overall Study|Death|0|||
46682471|NCT00107900|82897921|FG001|Overall Study|Death|0|||
46682472|NCT00107900|82897922|FG002|Overall Study|Death|0|||
46682473|NCT00107900|82897923|FG003|Overall Study|Death|0|||
46682474|NCT00107900|82897924|FG004|Overall Study|Death|1|||
46682475|NCT00107900|82897925|FG005|Overall Study|Death|0|||
46682476|NCT00107900|82897920|FG000|Overall Study|Lost to Follow-up|4|||
46682477|NCT00107900|82897921|FG001|Overall Study|Lost to Follow-up|1|||
46682478|NCT00107900|82897922|FG002|Overall Study|Lost to Follow-up|3|||
46682479|NCT00107900|82897923|FG003|Overall Study|Lost to Follow-up|2|||
46682480|NCT00107900|82897924|FG004|Overall Study|Lost to Follow-up|5|||
46682481|NCT00107900|82897925|FG005|Overall Study|Lost to Follow-up|5|||
46682482|NCT00107900|82897920|FG000|Overall Study|Protocol Violation|1|||
46682483|NCT00107900|82897921|FG001|Overall Study|Protocol Violation|0|||
46682484|NCT00107900|82897922|FG002|Overall Study|Protocol Violation|5|||
46682485|NCT00107900|82897923|FG003|Overall Study|Protocol Violation|5|||
46682486|NCT00107900|82897924|FG004|Overall Study|Protocol Violation|7|||
46682487|NCT00107900|82897925|FG005|Overall Study|Protocol Violation|0|||
46682488|NCT00107900|82897920|FG000|Overall Study|Withdrawal by Subject|1|||
46682489|NCT00107900|82897921|FG001|Overall Study|Withdrawal by Subject|0|||
46682490|NCT00107900|82897922|FG002|Overall Study|Withdrawal by Subject|5|||
46682491|NCT00107900|82897923|FG003|Overall Study|Withdrawal by Subject|0|||
46682492|NCT00107900|82897924|FG004|Overall Study|Withdrawal by Subject|1|||
46682493|NCT00107900|82897925|FG005|Overall Study|Withdrawal by Subject|1|||
46682494|NCT00107900|82897920|FG000|Overall Study|Administrative Reasons|1|||
46682495|NCT00107900|82897921|FG001|Overall Study|Administrative Reasons|0|||
46682496|NCT00107900|82897922|FG002|Overall Study|Administrative Reasons|2|||
46682497|NCT00107900|82897923|FG003|Overall Study|Administrative Reasons|2|||
46682498|NCT00107900|82897924|FG004|Overall Study|Administrative Reasons|2|||
46682499|NCT00107900|82897925|FG005|Overall Study|Administrative Reasons|0|||
46682500|NCT01339052|82897941|FG000|Overall Study|Disease progression|13|||
46682501|NCT01339052|82897942|FG001|Overall Study|Disease progression|46|||
46981319|NCT02412111|83227212|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
46682502|NCT01339052|82897941|FG000|Overall Study|Adverse Event|1|||
46682503|NCT01339052|82897942|FG001|Overall Study|Adverse Event|1|||
46682504|NCT01339052|82897941|FG000|Overall Study|Withdrawal by Subject|0|||
46682505|NCT01339052|82897942|FG001|Overall Study|Withdrawal by Subject|3|||
46798489|NCT00515619|83017144|FG000|Overall Study|Protocol Violation|3|||
46981320|NCT02412111|83227213|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
46981321|NCT02412111|83227211|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
46981322|NCT02412111|83227212|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
46981323|NCT02412111|83227213|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
46981324|NCT02412111|83227211|FG000|Active Comparator Period (8 Weeks)|Other|0|||
46981325|NCT02412111|83227212|FG001|Active Comparator Period (8 Weeks)|Other|0|||
46981326|NCT02412111|83227213|FG002|Active Comparator Period (8 Weeks)|Other|2|||
46981327|NCT02427477|83227225|FG000|Period 1|Adverse Event|1|||
46981328|NCT02427477|83227226|FG001|Period 1|Adverse Event|0|||
46981329|NCT02427399|83227237|FG000|Overall Study|Protocol Violation|14|||
46981330|NCT02427399|83227238|FG001|Overall Study|Protocol Violation|16|||
46981331|NCT02427399|83227239|FG002|Overall Study|Protocol Violation|12|||
46981332|NCT02427399|83227240|FG003|Overall Study|Protocol Violation|18|||
46981333|NCT02427399|83227241|FG004|Overall Study|Protocol Violation|15|||
46981334|NCT02426541|83227255|FG000|Overall Study|Protocol Violation|1|||
46981335|NCT02426541|83227256|FG001|Overall Study|Protocol Violation|0|||
46981336|NCT02484651|83227264|FG000|Overall Study|Patients' data files were corrupted.|1|||
46981337|NCT02484651|83227265|FG001|Overall Study|Patients' data files were corrupted.|1|||
46981338|NCT02484651|83227264|FG000|Overall Study|BIS monitoring failed.|1|||
46981339|NCT02484651|83227265|FG001|Overall Study|BIS monitoring failed.|1|||
46798490|NCT00515619|83017144|FG000|Overall Study|Lost to Follow-up|4|||
46798491|NCT00515619|83017144|FG000|Overall Study|Unsatisfactory compliance|6|||
46798492|NCT00515619|83017144|FG000|Overall Study|Other: Site discontinuing trials|2|||
46798493|NCT00515619|83017144|FG000|Overall Study|Other: Subject cannot attend visits|2|||
46798494|NCT00515619|83017144|FG000|Overall Study|Other: Subject required surgery|1|||
46798495|NCT00515619|83017144|FG000|Overall Study|Other: Subject moved to another country|1|||
46981340|NCT02484651|83227264|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
46981341|NCT02484651|83227265|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
46981342|NCT02410551|83227272|FG000|Overall Study|Adverse Event|1|||
46981343|NCT02410551|83227272|FG000|Overall Study|Withdrawal by Subject|1|||
46981344|NCT02410551|83227272|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
46981345|NCT02424591|83227279|FG000|Overall Study|Protocol Violation|2|||
46981346|NCT02424591|83227280|FG001|Overall Study|Protocol Violation|3|||
46981347|NCT02408523|83227288|FG000|Overall Study|Adverse Event|4|||
46981348|NCT02408523|83227289|FG001|Overall Study|Adverse Event|10|||
46981349|NCT02408523|83227288|FG000|Overall Study|Lack of Efficacy|0|||
46981350|NCT02408523|83227289|FG001|Overall Study|Lack of Efficacy|1|||
46981351|NCT02408523|83227288|FG000|Overall Study|Protocol Violation|1|||
46981352|NCT02408523|83227289|FG001|Overall Study|Protocol Violation|2|||
46682506|NCT01339052|82897941|FG000|Overall Study|Physician Decision|1|||
46798496|NCT00515619|83017144|FG000|Overall Study|Other: Investigator decision|1|||
46858161|NCT03315130|83073896|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
46981353|NCT02408523|83227288|FG000|Overall Study|Lost to Follow-up|2|||
46981354|NCT02408523|83227289|FG001|Overall Study|Lost to Follow-up|3|||
46981355|NCT02408523|83227288|FG000|Overall Study|Withdrawal by Subject|3|||
46981356|NCT02408523|83227289|FG001|Overall Study|Withdrawal by Subject|1|||
46981357|NCT02408523|83227288|FG000|Overall Study|Sponsor request|1|||
46981358|NCT02408523|83227289|FG001|Overall Study|Sponsor request|0|||
46682507|NCT01339052|82897942|FG001|Overall Study|Physician Decision|0|||
46682508|NCT00107315|82897951|FG000|Overall Study|Disease Progression|9|||
46682509|NCT00107315|82897951|FG000|Overall Study|Adverse Event|4|||
46682510|NCT00107315|82897951|FG000|Overall Study|Withdrawal by Subject|2|||
46682511|NCT01335971|82897958|FG000|Overall Study|Withdrawal by Subject|1|||
46682512|NCT01335971|82897959|FG001|Overall Study|Withdrawal by Subject|0|||
46682513|NCT01335971|82897960|FG002|Overall Study|Withdrawal by Subject|0|||
46682514|NCT01335971|82897958|FG000|Overall Study|Did not complete bronchoscopy|1|||
46682515|NCT01335971|82897959|FG001|Overall Study|Did not complete bronchoscopy|1|||
46682516|NCT01335971|82897960|FG002|Overall Study|Did not complete bronchoscopy|1|||
46682517|NCT00107276|82897968|FG000|Overall Study|Progression|46|||
46682518|NCT00107276|82897968|FG000|Overall Study|Adverse Event|6|||
46682519|NCT00107276|82897968|FG000|Overall Study|M.D. decision|2|||
46682520|NCT00107276|82897968|FG000|Overall Study|Patient refusal|1|||
46682521|NCT00107276|82897968|FG000|Overall Study|Death|1|||
46682522|NCT00107276|82897968|FG000|Overall Study|Ineligible|16|||
46682523|NCT01335698|82897978|FG000|Treatment Stage 1|Lack of Efficacy|3|||
46682524|NCT01335698|82897979|FG001|Treatment Stage 1|Lack of Efficacy|1|||
46682525|NCT01335698|82897980|FG002|Treatment Stage 1|Lack of Efficacy|3|||
46682526|NCT01335698|82897981|FG003|Treatment Stage 1|Lack of Efficacy|3|||
46682527|NCT01335698|82897982|FG004|Treatment Stage 1|Lack of Efficacy|1|||
46682528|NCT01335698|82897978|FG000|Treatment Stage 1|Adverse Event|1|||
46682529|NCT01335698|82897979|FG001|Treatment Stage 1|Adverse Event|2|||
46682530|NCT01335698|82897980|FG002|Treatment Stage 1|Adverse Event|2|||
46682531|NCT01335698|82897981|FG003|Treatment Stage 1|Adverse Event|1|||
46682532|NCT01335698|82897982|FG004|Treatment Stage 1|Adverse Event|1|||
46682533|NCT01335698|82897978|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
46682534|NCT01335698|82897979|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
46682535|NCT01335698|82897980|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
46682536|NCT01335698|82897981|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
46682537|NCT01335698|82897982|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
46682538|NCT01335698|82897978|FG000|Treatment Stage 1|Lost to Follow-up|1|||
46682539|NCT01335698|82897979|FG001|Treatment Stage 1|Lost to Follow-up|1|||
46682540|NCT01335698|82897980|FG002|Treatment Stage 1|Lost to Follow-up|0|||
46682541|NCT01335698|82897981|FG003|Treatment Stage 1|Lost to Follow-up|0|||
46682542|NCT01335698|82897982|FG004|Treatment Stage 1|Lost to Follow-up|0|||
46682543|NCT01335698|82897978|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
46682544|NCT01335698|82897979|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
46682545|NCT01335698|82897980|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
46682546|NCT01335698|82897981|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
46682547|NCT01335698|82897982|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
46682548|NCT01335698|82897978|FG000|Treatment Stage 1|No longer meets study criteria|1|||
46682549|NCT01335698|82897979|FG001|Treatment Stage 1|No longer meets study criteria|1|||
46682550|NCT01335698|82897980|FG002|Treatment Stage 1|No longer meets study criteria|0|||
46682551|NCT01335698|82897981|FG003|Treatment Stage 1|No longer meets study criteria|1|||
46682552|NCT01335698|82897982|FG004|Treatment Stage 1|No longer meets study criteria|0|||
46682553|NCT01335698|82897978|FG000|Treatment Stage 1|Other|1|||
46682554|NCT01335698|82897979|FG001|Treatment Stage 1|Other|0|||
46682555|NCT01335698|82897980|FG002|Treatment Stage 1|Other|0|||
46682556|NCT01335698|82897981|FG003|Treatment Stage 1|Other|1|||
46682557|NCT01335698|82897982|FG004|Treatment Stage 1|Other|0|||
46981359|NCT02408523|83227288|FG000|Overall Study|Did not satisfy extension conditions|0|||
46682558|NCT01335698|82897978|FG000|Treatment Stage 2|Lack of Efficacy|2|||
46682559|NCT01335698|82897979|FG001|Treatment Stage 2|Lack of Efficacy|1|||
46682560|NCT01335698|82897980|FG002|Treatment Stage 2|Lack of Efficacy|3|||
46682561|NCT01335698|82897981|FG003|Treatment Stage 2|Lack of Efficacy|1|||
46981360|NCT02408523|83227289|FG001|Overall Study|Did not satisfy extension conditions|1|||
46682562|NCT01335698|82897982|FG004|Treatment Stage 2|Lack of Efficacy|0|||
46682563|NCT01335698|82897978|FG000|Treatment Stage 2|Adverse Event|2|||
46682564|NCT01335698|82897979|FG001|Treatment Stage 2|Adverse Event|0|||
46682565|NCT01335698|82897980|FG002|Treatment Stage 2|Adverse Event|0|||
46682566|NCT01335698|82897981|FG003|Treatment Stage 2|Adverse Event|3|||
46682567|NCT01335698|82897982|FG004|Treatment Stage 2|Adverse Event|0|||
46682568|NCT01335698|82897978|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
46682569|NCT01335698|82897979|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
46682570|NCT01335698|82897980|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
46682571|NCT01335698|82897981|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
46682572|NCT01335698|82897982|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
46682573|NCT01335698|82897978|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
46682574|NCT01335698|82897979|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
46682575|NCT01335698|82897980|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
46682576|NCT01335698|82897981|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
46682577|NCT01335698|82897982|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
46682578|NCT01335698|82897978|FG000|Treatment Stage 2|Lost to Follow-up|1|||
46682579|NCT01335698|82897979|FG001|Treatment Stage 2|Lost to Follow-up|0|||
46682580|NCT01335698|82897980|FG002|Treatment Stage 2|Lost to Follow-up|0|||
46682581|NCT01335698|82897981|FG003|Treatment Stage 2|Lost to Follow-up|0|||
46682582|NCT01335698|82897982|FG004|Treatment Stage 2|Lost to Follow-up|0|||
46682583|NCT01335698|82897978|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
46682584|NCT01335698|82897979|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
46682585|NCT01335698|82897980|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
46682586|NCT01335698|82897981|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
46682587|NCT01335698|82897982|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
46682588|NCT01335698|82897978|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
46682589|NCT01335698|82897979|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
46682590|NCT01335698|82897980|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
46682591|NCT01335698|82897981|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
46682592|NCT01335698|82897982|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
46682593|NCT01335698|82897978|FG000|Treatment Stage 2|Switched to another formulation|1|||
46682594|NCT01335698|82897979|FG001|Treatment Stage 2|Switched to another formulation|1|||
46682595|NCT01335698|82897980|FG002|Treatment Stage 2|Switched to another formulation|0|||
46682596|NCT01335698|82897981|FG003|Treatment Stage 2|Switched to another formulation|0|||
46682597|NCT01335698|82897982|FG004|Treatment Stage 2|Switched to another formulation|0|||
46682598|NCT00107120|82897998|FG000|Overall Study|Adverse Event|4|||
46682599|NCT00107120|82897999|FG001|Overall Study|Adverse Event|1|||
46682600|NCT00107120|82897998|FG000|Overall Study|Lack of Efficacy|5|||
46682601|NCT00107120|82897999|FG001|Overall Study|Lack of Efficacy|5|||
46682602|NCT00107120|82897998|FG000|Overall Study|Protocol Violation|3|||
46682603|NCT00107120|82897999|FG001|Overall Study|Protocol Violation|0|||
46682604|NCT00107120|82897998|FG000|Overall Study|Withdrawal by Subject|8|||
46682605|NCT00107120|82897999|FG001|Overall Study|Withdrawal by Subject|9|||
46682606|NCT00107120|82897998|FG000|Overall Study|Lost to Follow-up|8|||
46682607|NCT00107120|82897999|FG001|Overall Study|Lost to Follow-up|6|||
46682608|NCT00107120|82897998|FG000|Overall Study|Pregnancy|0|||
46858162|NCT03315130|83073897|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
46858163|NCT03315130|83073898|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
46682609|NCT00107120|82897999|FG001|Overall Study|Pregnancy|1|||
46682610|NCT00107120|82897998|FG000|Overall Study|moving away from site|1|||
46682611|NCT00107120|82897999|FG001|Overall Study|moving away from site|1|||
46682612|NCT00107120|82897998|FG000|Overall Study|death of parent|0|||
46682613|NCT00107120|82897999|FG001|Overall Study|death of parent|1|||
46858164|NCT03315130|83073899|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
46682614|NCT01335464|82898007|FG000|Overall Study|Adverse Event|15|||
46682615|NCT01335464|82898008|FG001|Overall Study|Adverse Event|25|||
46682616|NCT01335464|82898007|FG000|Overall Study|Non compliant with protocol|2|||
46682617|NCT01335464|82898008|FG001|Overall Study|Non compliant with protocol|0|||
46682618|NCT01335464|82898007|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
46682619|NCT01335464|82898008|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
46682620|NCT01335464|82898007|FG000|Overall Study|Not treated|2|||
46682621|NCT01335464|82898008|FG001|Overall Study|Not treated|0|||
46682622|NCT01335464|82898007|FG000|Overall Study|Reason other than those stated above|1|||
46682623|NCT01335464|82898008|FG001|Overall Study|Reason other than those stated above|1|||
46682624|NCT00107042|82898016|FG000|Overall Study|Lost to Follow-up|9|||
46682625|NCT00107042|82898017|FG001|Overall Study|Lost to Follow-up|7|||
46682626|NCT00107042|82898016|FG000|Overall Study|Withdrawal by Subject|6|||
46682627|NCT00107042|82898017|FG001|Overall Study|Withdrawal by Subject|1|||
46682628|NCT00107042|82898016|FG000|Overall Study|Moved out of area|5|||
46682629|NCT00107042|82898017|FG001|Overall Study|Moved out of area|3|||
46682630|NCT00107042|82898016|FG000|Overall Study|Pregnancy|1|||
46682631|NCT00107042|82898017|FG001|Overall Study|Pregnancy|1|||
46682632|NCT00107042|82898016|FG000|Overall Study|Inadvertent enrollment|0|||
46682633|NCT00107042|82898017|FG001|Overall Study|Inadvertent enrollment|1|||
46682634|NCT00107042|82898016|FG000|Overall Study|vaccinated outside window|1|||
46682635|NCT00107042|82898017|FG001|Overall Study|vaccinated outside window|1|||
46682636|NCT00107042|82898016|FG000|Overall Study|Disallowed medications|0|||
46682637|NCT00107042|82898017|FG001|Overall Study|Disallowed medications|2|||
46682638|NCT00106964|82898068|FG000|Overall Study|Lost to Follow-up|8|||
46682639|NCT00106964|82898069|FG001|Overall Study|Lost to Follow-up|6|||
46682640|NCT00106964|82898070|FG002|Overall Study|Lost to Follow-up|2|||
46682641|NCT00106964|82898068|FG000|Overall Study|Pregnancy|2|||
46682642|NCT00106964|82898069|FG001|Overall Study|Pregnancy|3|||
46682643|NCT00106964|82898070|FG002|Overall Study|Pregnancy|2|||
46682644|NCT00106964|82898068|FG000|Overall Study|Death|1|||
46682645|NCT00106964|82898069|FG001|Overall Study|Death|1|||
46682646|NCT00106964|82898070|FG002|Overall Study|Death|0|||
46682647|NCT00106964|82898068|FG000|Overall Study|Incarceration|0|||
46682648|NCT00106964|82898069|FG001|Overall Study|Incarceration|1|||
46682649|NCT00106964|82898070|FG002|Overall Study|Incarceration|0|||
46682650|NCT00106964|82898068|FG000|Overall Study|Site Funding Terminated|0|||
46798497|NCT00515619|83017144|FG000|Overall Study|Other: Subject became pregnant|1|||
46798498|NCT00515619|83017144|FG000|Overall Study|Other: Request from sponsor|1|||
46798499|NCT00515619|83017144|FG000|Overall Study|Other: Drug available on license|1|||
46798500|NCT00515619|83017144|FG000|Overall Study|Other: Subject interested in other AED|1|||
46682651|NCT00106964|82898069|FG001|Overall Study|Site Funding Terminated|1|||
46682652|NCT00106964|82898070|FG002|Overall Study|Site Funding Terminated|1|||
46798501|NCT00449644|83017152|FG000|Overall Study|Adverse Event|0|||
46682653|NCT00106964|82898068|FG000|Overall Study|Failure to adhere|2|||
46682654|NCT00106964|82898069|FG001|Overall Study|Failure to adhere|0|||
46682655|NCT00106964|82898070|FG002|Overall Study|Failure to adhere|0|||
46682656|NCT00106964|82898068|FG000|Overall Study|Did not meet eligibility criteria|0|||
46682657|NCT00106964|82898069|FG001|Overall Study|Did not meet eligibility criteria|2|||
46682658|NCT00106964|82898070|FG002|Overall Study|Did not meet eligibility criteria|2|||
46682659|NCT00106964|82898068|FG000|Overall Study|Required disallowed medication|0|||
46682660|NCT00106964|82898069|FG001|Overall Study|Required disallowed medication|1|||
46682661|NCT00106964|82898070|FG002|Overall Study|Required disallowed medication|0|||
46682662|NCT00106184|82898089|FG000|Overall Study|Withdrawal by Subject|3|||
46682663|NCT00106184|82898090|FG001|Overall Study|Withdrawal by Subject|2|||
46682664|NCT01334918|82898100|FG000|Overall Study|Did not receive study drug|6|||
46682665|NCT01334918|82898101|FG001|Overall Study|Did not receive study drug|0|||
46682666|NCT01334918|82898100|FG000|Overall Study|Adverse Event|2|||
46682667|NCT01334918|82898101|FG001|Overall Study|Adverse Event|0|||
46682668|NCT01334918|82898100|FG000|Overall Study|Withdrawal by Subject|0|||
46682669|NCT01334918|82898101|FG001|Overall Study|Withdrawal by Subject|1|||
46682670|NCT01332968|82898120|FG000|Induction Period|Adverse Event|23|||
46682671|NCT01332968|82898121|FG001|Induction Period|Adverse Event|26|||
46682672|NCT01332968|82898122|FG002|Induction Period|Adverse Event|0|||
46682673|NCT01332968|82898123|FG003|Induction Period|Adverse Event|0|||
46682674|NCT01332968|82898124|FG004|Induction Period|Adverse Event|0|||
46682675|NCT01332968|82898125|FG005|Induction Period|Adverse Event|0|||
46682676|NCT01332968|82898126|FG006|Induction Period|Adverse Event|0|||
46682677|NCT01332968|82898127|FG007|Induction Period|Adverse Event|0|||
46682678|NCT01332968|82898120|FG000|Induction Period|Death|1|||
46682679|NCT01332968|82898121|FG001|Induction Period|Death|4|||
46682680|NCT01332968|82898122|FG002|Induction Period|Death|0|||
46682681|NCT01332968|82898123|FG003|Induction Period|Death|0|||
46682682|NCT01332968|82898124|FG004|Induction Period|Death|0|||
46682683|NCT01332968|82898125|FG005|Induction Period|Death|0|||
46682684|NCT01332968|82898126|FG006|Induction Period|Death|0|||
46682685|NCT01332968|82898127|FG007|Induction Period|Death|0|||
46682686|NCT01332968|82898120|FG000|Induction Period|Non-compliance|1|||
46682687|NCT01332968|82898121|FG001|Induction Period|Non-compliance|0|||
46682688|NCT01332968|82898122|FG002|Induction Period|Non-compliance|0|||
46682689|NCT01332968|82898123|FG003|Induction Period|Non-compliance|0|||
46682690|NCT01332968|82898124|FG004|Induction Period|Non-compliance|0|||
46682691|NCT01332968|82898125|FG005|Induction Period|Non-compliance|0|||
46682692|NCT01332968|82898126|FG006|Induction Period|Non-compliance|0|||
46682693|NCT01332968|82898127|FG007|Induction Period|Non-compliance|0|||
46682694|NCT01332968|82898120|FG000|Induction Period|Other|2|||
46682695|NCT01332968|82898121|FG001|Induction Period|Other|2|||
46682696|NCT01332968|82898122|FG002|Induction Period|Other|0|||
46682697|NCT01332968|82898123|FG003|Induction Period|Other|0|||
46682698|NCT01332968|82898124|FG004|Induction Period|Other|0|||
46682699|NCT01332968|82898125|FG005|Induction Period|Other|0|||
46682700|NCT01332968|82898126|FG006|Induction Period|Other|0|||
46682701|NCT01332968|82898127|FG007|Induction Period|Other|0|||
46682702|NCT01332968|82898120|FG000|Induction Period|Physician Decision|6|||
46682703|NCT01332968|82898121|FG001|Induction Period|Physician Decision|1|||
46682704|NCT01332968|82898122|FG002|Induction Period|Physician Decision|0|||
46682705|NCT01332968|82898123|FG003|Induction Period|Physician Decision|0|||
46682706|NCT01332968|82898124|FG004|Induction Period|Physician Decision|0|||
46682707|NCT01332968|82898125|FG005|Induction Period|Physician Decision|0|||
46682708|NCT01332968|82898126|FG006|Induction Period|Physician Decision|0|||
46682709|NCT01332968|82898127|FG007|Induction Period|Physician Decision|0|||
46682710|NCT01332968|82898120|FG000|Induction Period|Progressive Disease|15|||
46682711|NCT01332968|82898121|FG001|Induction Period|Progressive Disease|7|||
46682712|NCT01332968|82898122|FG002|Induction Period|Progressive Disease|0|||
46682713|NCT01332968|82898123|FG003|Induction Period|Progressive Disease|0|||
46682714|NCT01332968|82898124|FG004|Induction Period|Progressive Disease|0|||
46682715|NCT01332968|82898125|FG005|Induction Period|Progressive Disease|0|||
46682716|NCT01332968|82898126|FG006|Induction Period|Progressive Disease|0|||
46682717|NCT01332968|82898127|FG007|Induction Period|Progressive Disease|0|||
46682718|NCT01332968|82898120|FG000|Induction Period|Protocol Violation|3|||
46682719|NCT01332968|82898121|FG001|Induction Period|Protocol Violation|4|||
46682720|NCT01332968|82898122|FG002|Induction Period|Protocol Violation|0|||
46798502|NCT00449644|83017153|FG001|Overall Study|Adverse Event|0|||
46798503|NCT00449644|83017154|FG002|Overall Study|Adverse Event|3|||
46798504|NCT00449644|83017155|FG003|Overall Study|Adverse Event|5|||
46798505|NCT00449644|83017152|FG000|Overall Study|Death|1|||
46798506|NCT00449644|83017153|FG001|Overall Study|Death|0|||
46682721|NCT01332968|82898123|FG003|Induction Period|Protocol Violation|0|||
46798507|NCT00449644|83017154|FG002|Overall Study|Death|6|||
46981361|NCT02603419|83227309|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
46682722|NCT01332968|82898124|FG004|Induction Period|Protocol Violation|0|||
46798508|NCT00449644|83017155|FG003|Overall Study|Death|1|||
46858165|NCT03315130|83073896|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
46682723|NCT01332968|82898125|FG005|Induction Period|Protocol Violation|0|||
46682724|NCT01332968|82898126|FG006|Induction Period|Protocol Violation|0|||
46682725|NCT01332968|82898127|FG007|Induction Period|Protocol Violation|0|||
46682726|NCT01332968|82898120|FG000|Induction Period|Withdrawal by Subject|3|||
46798509|NCT00449644|83017152|FG000|Overall Study|Lost to Follow-up|1|||
46682727|NCT01332968|82898121|FG001|Induction Period|Withdrawal by Subject|5|||
46682728|NCT01332968|82898122|FG002|Induction Period|Withdrawal by Subject|0|||
46682729|NCT01332968|82898123|FG003|Induction Period|Withdrawal by Subject|0|||
46682730|NCT01332968|82898124|FG004|Induction Period|Withdrawal by Subject|0|||
46682731|NCT01332968|82898125|FG005|Induction Period|Withdrawal by Subject|0|||
46682732|NCT01332968|82898126|FG006|Induction Period|Withdrawal by Subject|0|||
46682733|NCT01332968|82898127|FG007|Induction Period|Withdrawal by Subject|0|||
46682734|NCT01332968|82898120|FG000|Induction Period|Randomised but not treated|4|||
46682735|NCT01332968|82898121|FG001|Induction Period|Randomised but not treated|7|||
46682736|NCT01332968|82898122|FG002|Induction Period|Randomised but not treated|0|||
46682737|NCT01332968|82898123|FG003|Induction Period|Randomised but not treated|0|||
46682738|NCT01332968|82898124|FG004|Induction Period|Randomised but not treated|0|||
46682739|NCT01332968|82898125|FG005|Induction Period|Randomised but not treated|0|||
46682740|NCT01332968|82898126|FG006|Induction Period|Randomised but not treated|0|||
46682741|NCT01332968|82898127|FG007|Induction Period|Randomised but not treated|0|||
46682742|NCT01332968|82898120|FG000|Maintenance/Observation Period|Adverse Event|0|||
46682743|NCT01332968|82898121|FG001|Maintenance/Observation Period|Adverse Event|0|||
46682744|NCT01332968|82898122|FG002|Maintenance/Observation Period|Adverse Event|53|||
46682745|NCT01332968|82898123|FG003|Maintenance/Observation Period|Adverse Event|66|||
46682746|NCT01332968|82898124|FG004|Maintenance/Observation Period|Adverse Event|0|||
46682747|NCT01332968|82898125|FG005|Maintenance/Observation Period|Adverse Event|0|||
46682748|NCT01332968|82898126|FG006|Maintenance/Observation Period|Adverse Event|0|||
46682749|NCT01332968|82898127|FG007|Maintenance/Observation Period|Adverse Event|0|||
46682750|NCT01332968|82898120|FG000|Maintenance/Observation Period|Death|0|||
46682751|NCT01332968|82898121|FG001|Maintenance/Observation Period|Death|0|||
46682752|NCT01332968|82898122|FG002|Maintenance/Observation Period|Death|5|||
46682753|NCT01332968|82898123|FG003|Maintenance/Observation Period|Death|6|||
46682754|NCT01332968|82898124|FG004|Maintenance/Observation Period|Death|0|||
46682755|NCT01332968|82898125|FG005|Maintenance/Observation Period|Death|0|||
46682756|NCT01332968|82898126|FG006|Maintenance/Observation Period|Death|0|||
46682757|NCT01332968|82898127|FG007|Maintenance/Observation Period|Death|0|||
46682758|NCT01332968|82898120|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
46682759|NCT01332968|82898121|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
46682760|NCT01332968|82898122|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
46682761|NCT01332968|82898123|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
46682762|NCT01332968|82898124|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
46682763|NCT01332968|82898125|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
46682764|NCT01332968|82898126|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
46682765|NCT01332968|82898127|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
46682766|NCT01332968|82898120|FG000|Maintenance/Observation Period|Non-compliance|0|||
46682767|NCT01332968|82898121|FG001|Maintenance/Observation Period|Non-compliance|0|||
46682768|NCT01332968|82898122|FG002|Maintenance/Observation Period|Non-compliance|4|||
46682769|NCT01332968|82898123|FG003|Maintenance/Observation Period|Non-compliance|3|||
46682770|NCT01332968|82898124|FG004|Maintenance/Observation Period|Non-compliance|0|||
46682771|NCT01332968|82898125|FG005|Maintenance/Observation Period|Non-compliance|0|||
46682772|NCT01332968|82898126|FG006|Maintenance/Observation Period|Non-compliance|0|||
46682773|NCT01332968|82898127|FG007|Maintenance/Observation Period|Non-compliance|0|||
46682774|NCT01332968|82898120|FG000|Maintenance/Observation Period|Other|0|||
46682775|NCT01332968|82898121|FG001|Maintenance/Observation Period|Other|0|||
46682776|NCT01332968|82898122|FG002|Maintenance/Observation Period|Other|4|||
46682777|NCT01332968|82898123|FG003|Maintenance/Observation Period|Other|7|||
46682778|NCT01332968|82898124|FG004|Maintenance/Observation Period|Other|0|||
46682779|NCT01332968|82898125|FG005|Maintenance/Observation Period|Other|0|||
46682780|NCT01332968|82898126|FG006|Maintenance/Observation Period|Other|0|||
46682781|NCT01332968|82898127|FG007|Maintenance/Observation Period|Other|0|||
46682782|NCT01332968|82898120|FG000|Maintenance/Observation Period|Physician Decision|0|||
46682783|NCT01332968|82898121|FG001|Maintenance/Observation Period|Physician Decision|0|||
46682784|NCT01332968|82898122|FG002|Maintenance/Observation Period|Physician Decision|14|||
46682785|NCT01332968|82898123|FG003|Maintenance/Observation Period|Physician Decision|19|||
46682786|NCT01332968|82898124|FG004|Maintenance/Observation Period|Physician Decision|0|||
46682787|NCT01332968|82898125|FG005|Maintenance/Observation Period|Physician Decision|1|||
46682788|NCT01332968|82898126|FG006|Maintenance/Observation Period|Physician Decision|0|||
46682789|NCT01332968|82898127|FG007|Maintenance/Observation Period|Physician Decision|0|||
46682790|NCT01332968|82898120|FG000|Maintenance/Observation Period|Progressive Disease|0|||
46682791|NCT01332968|82898121|FG001|Maintenance/Observation Period|Progressive Disease|0|||
46682792|NCT01332968|82898122|FG002|Maintenance/Observation Period|Progressive Disease|72|||
46682793|NCT01332968|82898123|FG003|Maintenance/Observation Period|Progressive Disease|40|||
46682794|NCT01332968|82898124|FG004|Maintenance/Observation Period|Progressive Disease|0|||
46708080|NCT01172808|82923564|FG001|Overall Study|Lack of Efficacy|0|||
46682795|NCT01332968|82898125|FG005|Maintenance/Observation Period|Progressive Disease|0|||
46858166|NCT03315130|83073897|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
46858167|NCT03315130|83073898|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
46858168|NCT03315130|83073899|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
46682796|NCT01332968|82898126|FG006|Maintenance/Observation Period|Progressive Disease|0|||
46682797|NCT01332968|82898127|FG007|Maintenance/Observation Period|Progressive Disease|0|||
46682798|NCT01332968|82898120|FG000|Maintenance/Observation Period|Protocol Violation|0|||
46682799|NCT01332968|82898121|FG001|Maintenance/Observation Period|Protocol Violation|0|||
46682800|NCT01332968|82898122|FG002|Maintenance/Observation Period|Protocol Violation|1|||
46682801|NCT01332968|82898123|FG003|Maintenance/Observation Period|Protocol Violation|1|||
46682802|NCT01332968|82898124|FG004|Maintenance/Observation Period|Protocol Violation|0|||
46682803|NCT01332968|82898125|FG005|Maintenance/Observation Period|Protocol Violation|0|||
46682804|NCT01332968|82898126|FG006|Maintenance/Observation Period|Protocol Violation|0|||
46682805|NCT01332968|82898127|FG007|Maintenance/Observation Period|Protocol Violation|0|||
46682806|NCT01332968|82898120|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
46682807|NCT01332968|82898121|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
46682808|NCT01332968|82898122|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
46682809|NCT01332968|82898123|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
46682810|NCT01332968|82898124|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
46682811|NCT01332968|82898125|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
46682812|NCT01332968|82898126|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
46682813|NCT01332968|82898127|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
46682814|NCT01332968|82898120|FG000|Follow-Up Period|Adverse Event|0|||
46682815|NCT01332968|82898121|FG001|Follow-Up Period|Adverse Event|0|||
46682816|NCT01332968|82898122|FG002|Follow-Up Period|Adverse Event|0|||
46682817|NCT01332968|82898123|FG003|Follow-Up Period|Adverse Event|0|||
46682818|NCT01332968|82898124|FG004|Follow-Up Period|Adverse Event|0|||
46682819|NCT01332968|82898125|FG005|Follow-Up Period|Adverse Event|0|||
46682820|NCT01332968|82898126|FG006|Follow-Up Period|Adverse Event|0|||
46682821|NCT01332968|82898127|FG007|Follow-Up Period|Adverse Event|4|||
46682822|NCT01332968|82898120|FG000|Follow-Up Period|Death|0|||
46682823|NCT01332968|82898121|FG001|Follow-Up Period|Death|0|||
46682824|NCT01332968|82898122|FG002|Follow-Up Period|Death|0|||
46682825|NCT01332968|82898123|FG003|Follow-Up Period|Death|0|||
46682826|NCT01332968|82898124|FG004|Follow-Up Period|Death|0|||
46682827|NCT01332968|82898125|FG005|Follow-Up Period|Death|0|||
46682828|NCT01332968|82898126|FG006|Follow-Up Period|Death|27|||
46682829|NCT01332968|82898127|FG007|Follow-Up Period|Death|30|||
46682830|NCT01332968|82898120|FG000|Follow-Up Period|Lost to Follow-up|0|||
46682831|NCT01332968|82898121|FG001|Follow-Up Period|Lost to Follow-up|0|||
46682832|NCT01332968|82898122|FG002|Follow-Up Period|Lost to Follow-up|0|||
46682833|NCT01332968|82898123|FG003|Follow-Up Period|Lost to Follow-up|0|||
46682834|NCT01332968|82898124|FG004|Follow-Up Period|Lost to Follow-up|0|||
46682835|NCT01332968|82898125|FG005|Follow-Up Period|Lost to Follow-up|0|||
46682836|NCT01332968|82898126|FG006|Follow-Up Period|Lost to Follow-up|11|||
46682837|NCT01332968|82898127|FG007|Follow-Up Period|Lost to Follow-up|15|||
46682838|NCT01332968|82898120|FG000|Follow-Up Period|Non-compliance|0|||
46682839|NCT01332968|82898121|FG001|Follow-Up Period|Non-compliance|0|||
46682840|NCT01332968|82898122|FG002|Follow-Up Period|Non-compliance|0|||
46682841|NCT01332968|82898123|FG003|Follow-Up Period|Non-compliance|0|||
46682842|NCT01332968|82898124|FG004|Follow-Up Period|Non-compliance|0|||
46682843|NCT01332968|82898125|FG005|Follow-Up Period|Non-compliance|0|||
46682844|NCT01332968|82898126|FG006|Follow-Up Period|Non-compliance|4|||
46682845|NCT01332968|82898127|FG007|Follow-Up Period|Non-compliance|9|||
46682846|NCT01332968|82898120|FG000|Follow-Up Period|Other|0|||
46682847|NCT01332968|82898121|FG001|Follow-Up Period|Other|0|||
46682848|NCT01332968|82898122|FG002|Follow-Up Period|Other|0|||
46682849|NCT01332968|82898123|FG003|Follow-Up Period|Other|0|||
46682850|NCT01332968|82898124|FG004|Follow-Up Period|Other|0|||
46682851|NCT01332968|82898125|FG005|Follow-Up Period|Other|0|||
46682852|NCT01332968|82898126|FG006|Follow-Up Period|Other|18|||
46682853|NCT01332968|82898127|FG007|Follow-Up Period|Other|21|||
46682854|NCT01332968|82898120|FG000|Follow-Up Period|Physician Decision|0|||
46682855|NCT01332968|82898121|FG001|Follow-Up Period|Physician Decision|0|||
46682856|NCT01332968|82898122|FG002|Follow-Up Period|Physician Decision|0|||
46682857|NCT01332968|82898123|FG003|Follow-Up Period|Physician Decision|0|||
46682858|NCT01332968|82898124|FG004|Follow-Up Period|Physician Decision|0|||
46682859|NCT01332968|82898125|FG005|Follow-Up Period|Physician Decision|0|||
46682860|NCT01332968|82898126|FG006|Follow-Up Period|Physician Decision|12|||
46682861|NCT01332968|82898127|FG007|Follow-Up Period|Physician Decision|15|||
46682862|NCT01332968|82898120|FG000|Follow-Up Period|Progressive Disease|0|||
46682863|NCT01332968|82898121|FG001|Follow-Up Period|Progressive Disease|0|||
46682864|NCT01332968|82898122|FG002|Follow-Up Period|Progressive Disease|0|||
46682865|NCT01332968|82898123|FG003|Follow-Up Period|Progressive Disease|0|||
46682866|NCT01332968|82898124|FG004|Follow-Up Period|Progressive Disease|0|||
46682867|NCT01332968|82898125|FG005|Follow-Up Period|Progressive Disease|0|||
46682868|NCT01332968|82898126|FG006|Follow-Up Period|Progressive Disease|126|||
46682869|NCT01332968|82898127|FG007|Follow-Up Period|Progressive Disease|106|||
46682870|NCT01332968|82898120|FG000|Follow-Up Period|Protocol Violation|0|||
46682871|NCT01332968|82898121|FG001|Follow-Up Period|Protocol Violation|0|||
46682872|NCT01332968|82898122|FG002|Follow-Up Period|Protocol Violation|0|||
46682873|NCT01332968|82898123|FG003|Follow-Up Period|Protocol Violation|0|||
46682874|NCT01332968|82898124|FG004|Follow-Up Period|Protocol Violation|0|||
46798510|NCT00449644|83017153|FG001|Overall Study|Lost to Follow-up|1|||
46981362|NCT02603419|83227310|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
46981363|NCT02603419|83227311|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
46682875|NCT01332968|82898125|FG005|Follow-Up Period|Protocol Violation|0|||
46682876|NCT01332968|82898126|FG006|Follow-Up Period|Protocol Violation|1|||
46682877|NCT01332968|82898127|FG007|Follow-Up Period|Protocol Violation|0|||
46682878|NCT01332968|82898120|FG000|Follow-Up Period|Withdrawal by Subject|0|||
46682879|NCT01332968|82898121|FG001|Follow-Up Period|Withdrawal by Subject|0|||
46682880|NCT01332968|82898122|FG002|Follow-Up Period|Withdrawal by Subject|0|||
46682881|NCT01332968|82898123|FG003|Follow-Up Period|Withdrawal by Subject|0|||
46682882|NCT01332968|82898124|FG004|Follow-Up Period|Withdrawal by Subject|0|||
46682883|NCT01332968|82898125|FG005|Follow-Up Period|Withdrawal by Subject|0|||
46682884|NCT01332968|82898126|FG006|Follow-Up Period|Withdrawal by Subject|29|||
46682885|NCT01332968|82898127|FG007|Follow-Up Period|Withdrawal by Subject|32|||
46682886|NCT01332968|82898120|FG000|Follow-Up Period|No reason provided|0|||
46682887|NCT01332968|82898121|FG001|Follow-Up Period|No reason provided|0|||
46682888|NCT01332968|82898122|FG002|Follow-Up Period|No reason provided|0|||
46682889|NCT01332968|82898123|FG003|Follow-Up Period|No reason provided|0|||
46682890|NCT01332968|82898124|FG004|Follow-Up Period|No reason provided|0|||
46682891|NCT01332968|82898125|FG005|Follow-Up Period|No reason provided|0|||
46981364|NCT02603419|83227312|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
46981365|NCT02603419|83227313|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
46682892|NCT01332968|82898126|FG006|Follow-Up Period|No reason provided|2|||
46682893|NCT01332968|82898127|FG007|Follow-Up Period|No reason provided|3|||
46682894|NCT01332851|82898137|FG000|Overall Study|Withdrawal by Subject|4|||
46798511|NCT00449644|83017154|FG002|Overall Study|Lost to Follow-up|5|||
46798512|NCT00449644|83017155|FG003|Overall Study|Lost to Follow-up|3|||
46798513|NCT00449644|83017152|FG000|Overall Study|Pregnancy|0|||
46682895|NCT01332851|82898138|FG001|Overall Study|Withdrawal by Subject|2|||
46682896|NCT01332851|82898137|FG000|Overall Study|Lost to Follow-up|7|||
46682897|NCT01332851|82898138|FG001|Overall Study|Lost to Follow-up|11|||
46682898|NCT01332305|82898153|FG000|Overall Study|Adverse Event|1|||
46682899|NCT01332305|82898154|FG001|Overall Study|Adverse Event|4|||
46682900|NCT01332305|82898155|FG002|Overall Study|Adverse Event|6|||
46682901|NCT01332305|82898156|FG003|Overall Study|Adverse Event|3|||
46682902|NCT01332305|82898157|FG004|Overall Study|Adverse Event|5|||
46798514|NCT00449644|83017153|FG001|Overall Study|Pregnancy|0|||
46798515|NCT00449644|83017154|FG002|Overall Study|Pregnancy|3|||
46682903|NCT01332305|82898153|FG000|Overall Study|Withdrawal by Subject|6|||
46682904|NCT01332305|82898154|FG001|Overall Study|Withdrawal by Subject|5|||
46798516|NCT00449644|83017155|FG003|Overall Study|Pregnancy|2|||
46798517|NCT00449644|83017152|FG000|Overall Study|Protocol Violation|4|||
46682905|NCT01332305|82898155|FG002|Overall Study|Withdrawal by Subject|4|||
46682906|NCT01332305|82898156|FG003|Overall Study|Withdrawal by Subject|1|||
46682907|NCT01332305|82898157|FG004|Overall Study|Withdrawal by Subject|0|||
46682908|NCT01332305|82898153|FG000|Overall Study|Lost to Follow-up|0|||
46682909|NCT01332305|82898154|FG001|Overall Study|Lost to Follow-up|2|||
46682910|NCT01332305|82898155|FG002|Overall Study|Lost to Follow-up|3|||
46682911|NCT01332305|82898156|FG003|Overall Study|Lost to Follow-up|2|||
46682912|NCT01332305|82898157|FG004|Overall Study|Lost to Follow-up|3|||
46682913|NCT01332305|82898153|FG000|Overall Study|Protocol Violation|1|||
46682914|NCT01332305|82898154|FG001|Overall Study|Protocol Violation|2|||
46682915|NCT01332305|82898155|FG002|Overall Study|Protocol Violation|1|||
46682916|NCT01332305|82898156|FG003|Overall Study|Protocol Violation|0|||
46682917|NCT01332305|82898157|FG004|Overall Study|Protocol Violation|3|||
46682918|NCT01332305|82898153|FG000|Overall Study|Withdrawal by Sponsor|1|||
46682919|NCT01332305|82898154|FG001|Overall Study|Withdrawal by Sponsor|0|||
46682920|NCT01332305|82898155|FG002|Overall Study|Withdrawal by Sponsor|0|||
46682921|NCT01332305|82898156|FG003|Overall Study|Withdrawal by Sponsor|1|||
46682922|NCT01332305|82898157|FG004|Overall Study|Withdrawal by Sponsor|1|||
46682923|NCT01332305|82898153|FG000|Overall Study|Treatment Failure|1|||
46682924|NCT01332305|82898154|FG001|Overall Study|Treatment Failure|1|||
46682925|NCT01332305|82898155|FG002|Overall Study|Treatment Failure|0|||
46682926|NCT01332305|82898156|FG003|Overall Study|Treatment Failure|0|||
46682927|NCT01332305|82898157|FG004|Overall Study|Treatment Failure|0|||
46682928|NCT01332305|82898153|FG000|Overall Study|Physician Decision|0|||
46682929|NCT01332305|82898154|FG001|Overall Study|Physician Decision|0|||
46682930|NCT01332305|82898155|FG002|Overall Study|Physician Decision|0|||
46682931|NCT01332305|82898156|FG003|Overall Study|Physician Decision|1|||
46682932|NCT01332305|82898157|FG004|Overall Study|Physician Decision|0|||
46682933|NCT01332227|82898171|FG000|Overall Study|Adverse Event|4|||
46682934|NCT01332227|82898172|FG001|Overall Study|Adverse Event|1|||
46682935|NCT01332227|82898171|FG000|Overall Study|Withdrawal by Subject|5|||
46858169|NCT03315130|83073896|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
46858170|NCT03315130|83073897|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
46858171|NCT03315130|83073898|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
46858172|NCT03315130|83073899|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
46682936|NCT01332227|82898172|FG001|Overall Study|Withdrawal by Subject|1|||
46682937|NCT01332227|82898171|FG000|Overall Study|Lost to Follow-up|2|||
46682938|NCT01332227|82898172|FG001|Overall Study|Lost to Follow-up|0|||
46858173|NCT03273166|83073919|FG000|Overall Study|Withdrawn prior to Completion|31|||
46858174|NCT03314662|83073927|FG000|Overall Study|Withdrawal by Subject|1|||
46682939|NCT01332227|82898171|FG000|Overall Study|Lack of Efficacy|3|||
46682940|NCT01332227|82898172|FG001|Overall Study|Lack of Efficacy|1|||
46682941|NCT01332227|82898171|FG000|Overall Study|Poor compliance/noncompliance|1|||
46682942|NCT01332227|82898172|FG001|Overall Study|Poor compliance/noncompliance|1|||
46858175|NCT03314662|83073928|FG001|Overall Study|Withdrawal by Subject|1|||
46858176|NCT03314662|83073929|FG002|Overall Study|Withdrawal by Subject|1|||
46858177|NCT03314662|83073927|FG000|Overall Study|Lost to Follow-up|5|||
46858178|NCT03314662|83073928|FG001|Overall Study|Lost to Follow-up|4|||
46858179|NCT03314662|83073929|FG002|Overall Study|Lost to Follow-up|4|||
46858180|NCT03314662|83073927|FG000|Overall Study|Death|2|||
46858181|NCT03314662|83073928|FG001|Overall Study|Death|0|||
46858182|NCT03314662|83073929|FG002|Overall Study|Death|0|||
46858183|NCT03271528|83073947|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
46858184|NCT03271528|83073948|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
46858185|NCT03271528|83073947|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
46858186|NCT03271528|83073948|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
46858187|NCT03271528|83073947|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
46858188|NCT03271528|83073948|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
46858189|NCT03271528|83073947|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
46858190|NCT03271528|83073948|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
46798518|NCT00449644|83017153|FG001|Overall Study|Protocol Violation|4|||
46798519|NCT00449644|83017154|FG002|Overall Study|Protocol Violation|3|||
46798520|NCT00449644|83017155|FG003|Overall Study|Protocol Violation|7|||
46798521|NCT00449644|83017152|FG000|Overall Study|Withdrawal by Subject|3|||
46858191|NCT03271528|83073947|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
46858192|NCT03271528|83073948|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
46858193|NCT03271528|83073947|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
46858194|NCT03271528|83073948|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
46798522|NCT00449644|83017153|FG001|Overall Study|Withdrawal by Subject|4|||
46798523|NCT00449644|83017154|FG002|Overall Study|Withdrawal by Subject|6|||
46798524|NCT00449644|83017155|FG003|Overall Study|Withdrawal by Subject|7|||
46858195|NCT03271528|83073947|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
46858196|NCT03271528|83073948|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
46858197|NCT03301714|83073957|FG000|Overall Study|Lost to Follow-up|10|||
46858198|NCT03301714|83073958|FG001|Overall Study|Lost to Follow-up|4|||
46858199|NCT03301714|83073959|FG002|Overall Study|Lost to Follow-up|4|||
46858200|NCT03301714|83073957|FG000|Overall Study|Did not receive allocated intervention|0|||
46798525|NCT00449644|83017152|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
46798526|NCT00449644|83017153|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
46798527|NCT00449644|83017154|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
46798528|NCT00449644|83017155|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
46798529|NCT00449644|83017152|FG000|Overall Study|Other|1|||
46798530|NCT00449644|83017153|FG001|Overall Study|Other|4|||
46798531|NCT00449644|83017154|FG002|Overall Study|Other|1|||
46798532|NCT00449644|83017155|FG003|Overall Study|Other|0|||
46798533|NCT00449644|83017152|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
46798534|NCT00449644|83017153|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
46798535|NCT00449644|83017154|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
46798536|NCT00449644|83017155|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
46981366|NCT02603419|83227314|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
46981367|NCT02603419|83227309|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
46981368|NCT02603419|83227310|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
46981369|NCT02603419|83227311|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
46981370|NCT02603419|83227312|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
46981371|NCT02603419|83227313|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
46981372|NCT02603419|83227314|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
46981373|NCT02603419|83227309|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
46981374|NCT02603419|83227310|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
46981375|NCT02603419|83227311|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
46981376|NCT02603419|83227312|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
46981377|NCT02603419|83227313|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
46981378|NCT02603419|83227314|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
46981379|NCT02603419|83227309|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
46981380|NCT02603419|83227310|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
46981381|NCT02603419|83227311|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
46981382|NCT02603419|83227312|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
46981383|NCT02603419|83227313|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
46981384|NCT02603419|83227314|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
46798537|NCT00515541|83017172|FG000|Overall Study|Physician Decision|0|||
46798538|NCT00515541|83017173|FG001|Overall Study|Physician Decision|2|||
46798539|NCT00515541|83017174|FG002|Overall Study|Physician Decision|0|||
46798540|NCT00515541|83017175|FG003|Overall Study|Physician Decision|1|||
46798541|NCT00515541|83017172|FG000|Overall Study|No show for appointments|0|||
46798542|NCT00515541|83017173|FG001|Overall Study|No show for appointments|1|||
46798543|NCT00515541|83017174|FG002|Overall Study|No show for appointments|0|||
46798544|NCT00515541|83017175|FG003|Overall Study|No show for appointments|2|||
46798545|NCT00515541|83017172|FG000|Overall Study|Withdrawal by Subject|0|||
46798546|NCT00515541|83017173|FG001|Overall Study|Withdrawal by Subject|2|||
46798547|NCT00515541|83017174|FG002|Overall Study|Withdrawal by Subject|0|||
46798548|NCT00515541|83017175|FG003|Overall Study|Withdrawal by Subject|2|||
46798549|NCT00112489|83017185|FG000|Overall Study|Refused further treatment|8|||
46798550|NCT00112489|83017185|FG000|Overall Study|Adverse Event|12|||
46798551|NCT00112489|83017185|FG000|Overall Study|Death|2|||
46798552|NCT00112489|83017185|FG000|Overall Study|Other, Not Specified|9|||
46798553|NCT00112489|83017185|FG000|Overall Study|Patient never treated|2|||
46798554|NCT00112489|83017185|FG000|Overall Study|Ineligible|7|||
46798555|NCT00711971|83017198|FG000|Overall Study|Lost to Follow-up|3|||
46798556|NCT00711971|83017199|FG001|Overall Study|Lost to Follow-up|4|||
46798557|NCT00711971|83017200|FG002|Overall Study|Lost to Follow-up|1|||
46798558|NCT00515463|83017214|FG000|Overall Study|Physician Decision|4|||
46798559|NCT00515463|83017215|FG001|Overall Study|Physician Decision|2|||
46798560|NCT00515463|83017214|FG000|Overall Study|Adverse Event|1|||
46798561|NCT00515463|83017215|FG001|Overall Study|Adverse Event|2|||
46798562|NCT00515463|83017214|FG000|Overall Study|Withdrawal by Subject|3|||
46798563|NCT00515463|83017215|FG001|Overall Study|Withdrawal by Subject|4|||
46798564|NCT00515463|83017214|FG000|Overall Study|Lost to Follow-up|6|||
46798565|NCT00515463|83017215|FG001|Overall Study|Lost to Follow-up|5|||
46798566|NCT00515463|83017214|FG000|Overall Study|Other|0|||
46798567|NCT00515463|83017215|FG001|Overall Study|Other|1|||
46798568|NCT00507507|83017224|FG000|Treatment Period|Lost to Follow-up|0|||
46798569|NCT00507507|83017225|FG001|Treatment Period|Lost to Follow-up|2|||
46798570|NCT00507507|83017224|FG000|Treatment Period|Physician Decision|4|||
46798571|NCT00507507|83017225|FG001|Treatment Period|Physician Decision|1|||
46798572|NCT00507507|83017224|FG000|Treatment Period|Protocol Violation|1|||
46798573|NCT00507507|83017225|FG001|Treatment Period|Protocol Violation|2|||
46798574|NCT00507507|83017224|FG000|Treatment Period|Adverse Event|1|||
46798575|NCT00507507|83017225|FG001|Treatment Period|Adverse Event|1|||
46798576|NCT00507507|83017224|FG000|Treatment Period|Withdrawal by Subject|46|||
46798577|NCT00507507|83017225|FG001|Treatment Period|Withdrawal by Subject|47|||
46798578|NCT00507507|83017224|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
46981385|NCT02603419|83227309|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
46981386|NCT02603419|83227310|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
46981387|NCT02603419|83227311|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
46981388|NCT02603419|83227312|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
46981389|NCT02603419|83227313|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
46981390|NCT02603419|83227314|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
46981391|NCT02603419|83227309|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
46981392|NCT02603419|83227310|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
46798579|NCT00507507|83017225|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
46798580|NCT00507507|83017224|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
46798581|NCT00507507|83017225|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
46798582|NCT00507507|83017224|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
46798583|NCT00507507|83017225|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
46858201|NCT03301714|83073958|FG001|Overall Study|Did not receive allocated intervention|2|||
46858202|NCT03301714|83073959|FG002|Overall Study|Did not receive allocated intervention|3|||
46858203|NCT03299686|83073972|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
46858204|NCT03299686|83073973|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
46858205|NCT03299686|83073972|FG000|Treatment Epoch|Physician Decision|1|||
46858206|NCT03299686|83073973|FG001|Treatment Epoch|Physician Decision|0|||
46858207|NCT03299686|83073972|FG000|Treatment Epoch|Adverse Event|8|||
46858208|NCT03299686|83073973|FG001|Treatment Epoch|Adverse Event|4|||
46858209|NCT03299686|83073972|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
46858210|NCT03299686|83073973|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
46858211|NCT03462758|83073981|FG000|Overall Study|Chose no or other method of contraception|20|||
46858212|NCT03462758|83073982|FG001|Overall Study|Chose no or other method of contraception|23|||
46858213|NCT03462758|83073981|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
46858214|NCT03462758|83073982|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
46858215|NCT03462758|83073981|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
46858216|NCT03462758|83073982|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
46858217|NCT03462758|83073981|FG000|Overall Study|Medical contraindication|2|||
46858218|NCT03462758|83073982|FG001|Overall Study|Medical contraindication|2|||
46858219|NCT03462758|83073981|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
46858220|NCT03462758|83073982|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
46858221|NCT00075270|83073990|FG000|Overall Study|Withdrawal by Subject|28|||
46858222|NCT00075270|83073991|FG001|Overall Study|Withdrawal by Subject|21|||
46858223|NCT00075270|83073990|FG000|Overall Study|Lost to Follow-up|25|||
46858224|NCT00075270|83073991|FG001|Overall Study|Lost to Follow-up|28|||
46858225|NCT00075270|83073990|FG000|Overall Study|Protocol Violation|0|||
46858226|NCT00075270|83073991|FG001|Overall Study|Protocol Violation|2|||
46682943|NCT01332227|82898171|FG000|Overall Study|Patient moved from area|1|||
46682944|NCT01332227|82898172|FG001|Overall Study|Patient moved from area|0|||
46682945|NCT01332227|82898171|FG000|Overall Study|Patient began prohibited medication|0|||
46682946|NCT01332227|82898172|FG001|Overall Study|Patient began prohibited medication|1|||
46682947|NCT01332149|82898180|FG000|Overall Study|Adverse Event|11|||
46682948|NCT01332149|82898181|FG001|Overall Study|Adverse Event|9|||
46682949|NCT01332149|82898180|FG000|Overall Study|Other unspecified|5|||
46682950|NCT01332149|82898181|FG001|Overall Study|Other unspecified|7|||
46682951|NCT01332149|82898180|FG000|Overall Study|Protocol Violation|1|||
46682952|NCT01332149|82898181|FG001|Overall Study|Protocol Violation|3|||
46682953|NCT01332149|82898180|FG000|Overall Study|Withdrawal by Subject|4|||
46682954|NCT01332149|82898181|FG001|Overall Study|Withdrawal by Subject|5|||
46682955|NCT01332149|82898180|FG000|Overall Study|Lost to Follow-up|1|||
46682956|NCT01332149|82898181|FG001|Overall Study|Lost to Follow-up|1|||
46682957|NCT01332149|82898180|FG000|Overall Study|Insufficient clinical response|4|||
46682958|NCT01332149|82898181|FG001|Overall Study|Insufficient clinical response|7|||
46682959|NCT01332149|82898180|FG000|Overall Study|Did not meet entrance criteria|3|||
46682960|NCT01332149|82898181|FG001|Overall Study|Did not meet entrance criteria|4|||
46682961|NCT01332149|82898180|FG000|Overall Study|Randomized but not treated|1|||
46682962|NCT01332149|82898181|FG001|Overall Study|Randomized but not treated|2|||
46707540|NCT01155024|82923123|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
46707541|NCT01155024|82923124|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
46707542|NCT01155024|82923123|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
46707543|NCT01155024|82923124|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
46707544|NCT01155024|82923123|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
46858227|NCT00075270|83073990|FG000|Overall Study|Death|198|||
46858228|NCT00075270|83073991|FG001|Overall Study|Death|215|||
46858229|NCT00075270|83073990|FG000|Overall Study|Other/Unknown|9|||
46858230|NCT00075270|83073991|FG001|Overall Study|Other/Unknown|5|||
46858231|NCT00075270|83073990|FG000|Overall Study|Missing|26|||
46858232|NCT00075270|83073991|FG001|Overall Study|Missing|13|||
46858233|NCT00074958|83073998|FG000|Overall Study|Adverse Event|1|||
46682963|NCT01330628|82898189|FG000|Overall Study|Death|2|||
46682964|NCT01330628|82898190|FG001|Overall Study|Death|3|||
46682965|NCT01330628|82898189|FG000|Overall Study|Lost to Follow-up|5|||
46682966|NCT01330628|82898190|FG001|Overall Study|Lost to Follow-up|6|||
46682967|NCT01330628|82898189|FG000|Overall Study|Adverse Event|44|||
46682968|NCT01330628|82898190|FG001|Overall Study|Adverse Event|25|||
46682969|NCT01330628|82898189|FG000|Overall Study|Withdrawn|18|||
46682970|NCT01330628|82898190|FG001|Overall Study|Withdrawn|6|||
46682971|NCT01330628|82898189|FG000|Overall Study|Didn't receive study treatment|1|||
46682972|NCT01330628|82898190|FG001|Overall Study|Didn't receive study treatment|0|||
46682973|NCT01330433|82898198|FG000|Overall Study|Death|1|||
46682974|NCT01330433|82898199|FG001|Overall Study|Death|3|||
46682975|NCT01330433|82898198|FG000|Overall Study|Lost to Follow-up|1|||
46682976|NCT01330433|82898199|FG001|Overall Study|Lost to Follow-up|0|||
46682977|NCT01330316|82898207|FG000|Overall Study|Adverse Event|2|||
46682978|NCT01330316|82898208|FG001|Overall Study|Adverse Event|2|||
46682979|NCT01330316|82898207|FG000|Overall Study|Lack of Efficacy|0|||
46682980|NCT01330316|82898208|FG001|Overall Study|Lack of Efficacy|10|||
46682981|NCT01330316|82898207|FG000|Overall Study|Lost to Follow-up|0|||
46682982|NCT01330316|82898208|FG001|Overall Study|Lost to Follow-up|1|||
46682983|NCT01330316|82898207|FG000|Overall Study|Withdrawal by Subject|0|||
46682984|NCT01330316|82898208|FG001|Overall Study|Withdrawal by Subject|1|||
46682985|NCT01330316|82898207|FG000|Overall Study|other than above|0|||
46682986|NCT01330316|82898208|FG001|Overall Study|other than above|1|||
46682987|NCT01326702|82898221|FG000|Overall Study|Other|1|||
46682988|NCT01326702|82898222|FG001|Overall Study|Other|0|||
46682989|NCT01326702|82898223|FG002|Overall Study|Other|0|||
46682990|NCT01326702|82898224|FG003|Overall Study|Other|0|||
46682991|NCT01326702|82898225|FG004|Overall Study|Other|0|||
46682992|NCT01326702|82898226|FG005|Overall Study|Other|1|||
46682993|NCT01326702|82898227|FG006|Overall Study|Other|0|||
46682994|NCT01326702|82898221|FG000|Overall Study|progressive disease|1|||
46682995|NCT01326702|82898222|FG001|Overall Study|progressive disease|1|||
46682996|NCT01326702|82898223|FG002|Overall Study|progressive disease|3|||
46682997|NCT01326702|82898224|FG003|Overall Study|progressive disease|1|||
46682998|NCT01326702|82898225|FG004|Overall Study|progressive disease|3|||
46682999|NCT01326702|82898226|FG005|Overall Study|progressive disease|2|||
46858234|NCT02940574|83074004|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
46858235|NCT02940574|83074005|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
46858236|NCT02940574|83074004|FG000|1-year Follow-up|Lost to Follow-up|3|||
46858237|NCT02940574|83074005|FG001|1-year Follow-up|Lost to Follow-up|4|||
46858238|NCT03760250|83074024|FG000|Overall Study|Withdrawal by Subject|1|||
46858239|NCT03760250|83074024|FG000|Overall Study|Physician Decision|1|||
46683000|NCT01326702|82898227|FG006|Overall Study|progressive disease|3|||
46683001|NCT01326702|82898221|FG000|Overall Study|Death|0|||
46683002|NCT01326702|82898222|FG001|Overall Study|Death|1|||
46683003|NCT01326702|82898223|FG002|Overall Study|Death|0|||
46683004|NCT01326702|82898224|FG003|Overall Study|Death|0|||
46798584|NCT00459706|83017235|FG000|Overall Study|Adverse Event|19|||
46798585|NCT00459706|83017236|FG001|Overall Study|Adverse Event|13|||
46798586|NCT00459706|83017235|FG000|Overall Study|Withdrawal by Subject|1|||
46798587|NCT00459706|83017236|FG001|Overall Study|Withdrawal by Subject|6|||
46798588|NCT00459706|83017235|FG000|Overall Study|Physician Decision|2|||
46798589|NCT00459706|83017236|FG001|Overall Study|Physician Decision|0|||
46798590|NCT00459706|83017235|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
46798591|NCT00459706|83017236|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
46798592|NCT00459706|83017235|FG000|Overall Study|Protocol Violation|2|||
46798593|NCT00459706|83017236|FG001|Overall Study|Protocol Violation|1|||
46798594|NCT00459706|83017235|FG000|Overall Study|Failed to Return|1|||
46798595|NCT00459706|83017236|FG001|Overall Study|Failed to Return|0|||
46798596|NCT00459706|83017235|FG000|Overall Study|Other|0|||
46798597|NCT00459706|83017236|FG001|Overall Study|Other|1|||
46798598|NCT00507429|83017244|FG000|Treatment Phase|Disease Progression|12|||
46798599|NCT00507429|83017245|FG001|Treatment Phase|Disease Progression|5|||
46798600|NCT00507429|83017244|FG000|Treatment Phase|Adverse Event|12|||
46798601|NCT00507429|83017245|FG001|Treatment Phase|Adverse Event|5|||
46798602|NCT00507429|83017244|FG000|Treatment Phase|Withdrawal by Subject|3|||
46798603|NCT00507429|83017245|FG001|Treatment Phase|Withdrawal by Subject|3|||
46798604|NCT00507429|83017244|FG000|Treatment Phase|Physician Decision|4|||
46798605|NCT00507429|83017245|FG001|Treatment Phase|Physician Decision|2|||
46798606|NCT00507429|83017244|FG000|Treatment Phase|Other|6|||
46798607|NCT00507429|83017245|FG001|Treatment Phase|Other|3|||
46798608|NCT00507429|83017244|FG000|Maintenance Phase|Progressive Disease|14|||
46798609|NCT00507429|83017245|FG001|Maintenance Phase|Progressive Disease|0|||
46798610|NCT00449176|83017256|FG000|Overall Study|Withdrawal by Subject|39|||
46798611|NCT00449176|83017257|FG001|Overall Study|Withdrawal by Subject|43|||
46798612|NCT00449176|83017258|FG002|Overall Study|Withdrawal by Subject|59|||
46798613|NCT00449176|83017256|FG000|Overall Study|Lost to Follow-up|13|||
46798614|NCT00449176|83017257|FG001|Overall Study|Lost to Follow-up|8|||
46798615|NCT00449176|83017258|FG002|Overall Study|Lost to Follow-up|12|||
46798616|NCT00449176|83017256|FG000|Overall Study|Adverse Event|51|||
46798617|NCT00449176|83017257|FG001|Overall Study|Adverse Event|107|||
46798618|NCT00449176|83017258|FG002|Overall Study|Adverse Event|15|||
46798619|NCT00449176|83017256|FG000|Overall Study|Lack of Efficacy|13|||
46798620|NCT00449176|83017257|FG001|Overall Study|Lack of Efficacy|7|||
46798621|NCT00449176|83017258|FG002|Overall Study|Lack of Efficacy|50|||
46798622|NCT00449176|83017256|FG000|Overall Study|Study drug non-compliant|14|||
46798623|NCT00449176|83017257|FG001|Overall Study|Study drug non-compliant|11|||
46798624|NCT00449176|83017258|FG002|Overall Study|Study drug non-compliant|11|||
46798625|NCT00449176|83017256|FG000|Overall Study|all other|22|||
46798626|NCT00449176|83017257|FG001|Overall Study|all other|19|||
46798627|NCT00449176|83017258|FG002|Overall Study|all other|20|||
46798628|NCT00515073|83017266|FG000|Overall Study|Withdrawal by Subject|1|||
46798629|NCT00515073|83017266|FG000|Overall Study|Physician Decision|1|||
46798630|NCT00710021|83017273|FG000|Overall Study|Lost to Follow-up|1|||
46858240|NCT03757988|83074028|FG000|Overall Study|Withdrawal by Subject|1|||
46858241|NCT00313781|83074035|FG000|Before Crossover|Death|22|||
46858242|NCT00313781|83074036|FG001|Before Crossover|Death|8|||
46981393|NCT02603419|83227311|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
46683005|NCT01326702|82898225|FG004|Overall Study|Death|0|||
46683006|NCT01326702|82898226|FG005|Overall Study|Death|0|||
46798631|NCT00710021|83017274|FG001|Overall Study|Lost to Follow-up|0|||
46798632|NCT00710021|83017275|FG002|Overall Study|Lost to Follow-up|0|||
46798633|NCT00710021|83017273|FG000|Overall Study|Subject's Decision|0|||
46798634|NCT00710021|83017274|FG001|Overall Study|Subject's Decision|1|||
46798635|NCT00710021|83017275|FG002|Overall Study|Subject's Decision|0|||
46798636|NCT00710021|83017273|FG000|Overall Study|Subject misrandomized|0|||
46798637|NCT00710021|83017274|FG001|Overall Study|Subject misrandomized|1|||
46798638|NCT00710021|83017275|FG002|Overall Study|Subject misrandomized|1|||
46798639|NCT00710021|83017273|FG000|Overall Study|Physician Decision|0|||
46798640|NCT00710021|83017274|FG001|Overall Study|Physician Decision|1|||
46798641|NCT00710021|83017275|FG002|Overall Study|Physician Decision|0|||
46798642|NCT00504153|83017284|FG000|Overall Study|Withdrawal by Subject|1|||
46683007|NCT01326702|82898227|FG006|Overall Study|Death|0|||
46798643|NCT00504153|83017284|FG000|Overall Study|Adverse Event|4|||
46683008|NCT01326702|82898221|FG000|Overall Study|Adverse Event|0|||
46683009|NCT01326702|82898222|FG001|Overall Study|Adverse Event|0|||
46683010|NCT01326702|82898223|FG002|Overall Study|Adverse Event|1|||
46683011|NCT01326702|82898224|FG003|Overall Study|Adverse Event|1|||
46683012|NCT01326702|82898225|FG004|Overall Study|Adverse Event|0|||
46683013|NCT01326702|82898226|FG005|Overall Study|Adverse Event|3|||
46858243|NCT00313781|83074037|FG002|Before Crossover|Death|0|||
46858244|NCT00313781|83074035|FG000|Before Crossover|Lost to Follow-up|0|||
46858245|NCT00313781|83074036|FG001|Before Crossover|Lost to Follow-up|3|||
46981394|NCT02603419|83227312|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
46981395|NCT02603419|83227313|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
46798644|NCT00504153|83017284|FG000|Overall Study|Death|1|||
46798645|NCT00442702|83017290|FG000|Titration Period|Adverse Event|2|||
46798646|NCT00442702|83017291|FG001|Titration Period|Adverse Event|0|||
46798647|NCT00442702|83017290|FG000|Titration Period|Death|3|||
46683014|NCT01326702|82898227|FG006|Overall Study|Adverse Event|1|||
46683015|NCT01326702|82898221|FG000|Overall Study|Withdrawal by Subject|0|||
46683016|NCT01326702|82898222|FG001|Overall Study|Withdrawal by Subject|0|||
46683017|NCT01326702|82898223|FG002|Overall Study|Withdrawal by Subject|1|||
46683018|NCT01326702|82898224|FG003|Overall Study|Withdrawal by Subject|0|||
46683019|NCT01326702|82898225|FG004|Overall Study|Withdrawal by Subject|1|||
46683020|NCT01326702|82898226|FG005|Overall Study|Withdrawal by Subject|1|||
46683021|NCT01326702|82898227|FG006|Overall Study|Withdrawal by Subject|3|||
46683022|NCT01326702|82898221|FG000|Overall Study|Not Treated|0|||
46683023|NCT01326702|82898222|FG001|Overall Study|Not Treated|0|||
46683024|NCT01326702|82898223|FG002|Overall Study|Not Treated|0|||
46683025|NCT01326702|82898224|FG003|Overall Study|Not Treated|1|||
46683026|NCT01326702|82898225|FG004|Overall Study|Not Treated|0|||
46683027|NCT01326702|82898226|FG005|Overall Study|Not Treated|1|||
46683028|NCT01326702|82898227|FG006|Overall Study|Not Treated|0|||
46683029|NCT01327703|82898246|FG000|Second Treatment Period|Adverse Event|1|||
46683030|NCT01327703|82898247|FG001|Second Treatment Period|Adverse Event|1|||
46683031|NCT01327703|82898246|FG000|Second Treatment Period|Protocol Violation|0|||
46683032|NCT01327703|82898247|FG001|Second Treatment Period|Protocol Violation|1|||
46683033|NCT01380080|82898258|FG000|Overall Study|Death|36|||
46683034|NCT01380080|82898259|FG001|Overall Study|Death|44|||
46683035|NCT01380080|82898258|FG000|Overall Study|Site is closing|28|||
46683036|NCT01380080|82898259|FG001|Overall Study|Site is closing|31|||
46683037|NCT01380080|82898258|FG000|Overall Study|Not able to get to clinic|7|||
46683038|NCT01380080|82898259|FG001|Overall Study|Not able to get to clinic|1|||
46683039|NCT01380080|82898258|FG000|Overall Study|Not willing to adhere to requirements|6|||
46683040|NCT01380080|82898259|FG001|Overall Study|Not willing to adhere to requirements|2|||
46683041|NCT01380080|82898258|FG000|Overall Study|Withdrawal by Subject|5|||
46683042|NCT01380080|82898259|FG001|Overall Study|Withdrawal by Subject|2|||
46683043|NCT01380080|82898258|FG000|Overall Study|Lost to Follow-up|3|||
46683044|NCT01380080|82898259|FG001|Overall Study|Lost to Follow-up|3|||
46683045|NCT01379768|82898268|FG000|Overall Study|Adverse Event|1|||
46798648|NCT00442702|83017291|FG001|Titration Period|Death|2|||
46798649|NCT00442702|83017290|FG000|Titration Period|Insufficient Therapeutic Response|1|||
46798650|NCT00442702|83017291|FG001|Titration Period|Insufficient Therapeutic Response|0|||
46798651|NCT00442702|83017290|FG000|Titration Period|Refused Treatment|4|||
46798652|NCT00442702|83017291|FG001|Titration Period|Refused Treatment|1|||
46798653|NCT00442702|83017290|FG000|Titration Period|Failure to return|1|||
46683046|NCT01379768|82898269|FG001|Overall Study|Adverse Event|1|||
46683047|NCT01379768|82898270|FG002|Overall Study|Adverse Event|0|||
46683048|NCT01379768|82898268|FG000|Overall Study|Lost to Follow-up|2|||
46683049|NCT01379768|82898269|FG001|Overall Study|Lost to Follow-up|0|||
46683050|NCT01379768|82898270|FG002|Overall Study|Lost to Follow-up|0|||
46683051|NCT01379573|82898278|FG000|Overall Study|Lost to Follow-up|1|||
46683052|NCT01379573|82898278|FG000|Overall Study|Screen Failure|10|||
46683053|NCT01379534|82898284|FG000|Treatment Phase|Withdrawal by Subject|2|||
46683054|NCT01379534|82898285|FG001|Treatment Phase|Withdrawal by Subject|2|||
46683055|NCT01379534|82898284|FG000|Treatment Phase|Progressive disease|13|||
46683056|NCT01379534|82898285|FG001|Treatment Phase|Progressive disease|22|||
46683057|NCT01379534|82898284|FG000|Treatment Phase|Adverse Event|7|||
46683058|NCT01379534|82898285|FG001|Treatment Phase|Adverse Event|7|||
46683059|NCT01379534|82898284|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
46683060|NCT01379534|82898285|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
46683061|NCT01379534|82898284|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
46683062|NCT01379534|82898285|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
46683063|NCT01379534|82898284|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
46683064|NCT01379534|82898285|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
46683065|NCT01379534|82898284|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
46683066|NCT01379534|82898285|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
46683067|NCT01371851|82898293|FG000|Overall Study|Lost to Follow-up|5|||
46683068|NCT01371851|82898294|FG001|Overall Study|Lost to Follow-up|8|||
46683069|NCT01371851|82898293|FG000|Overall Study|was arrested and put in jail|0|||
46683070|NCT01371851|82898294|FG001|Overall Study|was arrested and put in jail|1|||
46683071|NCT01371851|82898293|FG000|Overall Study|non study related adverse event|1|||
46683072|NCT01371851|82898294|FG001|Overall Study|non study related adverse event|0|||
46683073|NCT01371851|82898293|FG000|Overall Study|Blood Pressure outside study parameters|2|||
46683074|NCT01371851|82898294|FG001|Overall Study|Blood Pressure outside study parameters|0|||
46683075|NCT01371734|82898303|FG000|Overall Study|Other|2|||
46683076|NCT01371734|82898304|FG001|Overall Study|Other|1|||
46683077|NCT01371734|82898305|FG002|Overall Study|Other|2|||
46683078|NCT01371734|82898303|FG000|Overall Study|Withdrawal by Subject|3|||
46683079|NCT01371734|82898304|FG001|Overall Study|Withdrawal by Subject|4|||
46683080|NCT01371734|82898305|FG002|Overall Study|Withdrawal by Subject|9|||
46683081|NCT01371734|82898303|FG000|Overall Study|Lost to Follow-up|5|||
46683082|NCT01371734|82898304|FG001|Overall Study|Lost to Follow-up|3|||
46683083|NCT01371734|82898305|FG002|Overall Study|Lost to Follow-up|1|||
46683084|NCT01371734|82898303|FG000|Overall Study|Protocol Violation|3|||
46683085|NCT01371734|82898304|FG001|Overall Study|Protocol Violation|1|||
46683086|NCT01371734|82898305|FG002|Overall Study|Protocol Violation|2|||
46683087|NCT01371734|82898303|FG000|Overall Study|Adverse Event|8|||
46683088|NCT01371734|82898304|FG001|Overall Study|Adverse Event|8|||
46683089|NCT01371734|82898305|FG002|Overall Study|Adverse Event|3|||
46683090|NCT01371734|82898303|FG000|Overall Study|Lack of Efficacy|2|||
46683091|NCT01371734|82898304|FG001|Overall Study|Lack of Efficacy|2|||
46683092|NCT01371734|82898305|FG002|Overall Study|Lack of Efficacy|0|||
46683093|NCT01365494|82898315|FG000|Overall Study|Adverse Event|1|||
46683094|NCT01365494|82898316|FG001|Overall Study|Adverse Event|0|||
46683095|NCT01365494|82898315|FG000|Overall Study|Withdrawal by Subject|0|||
46683096|NCT01365494|82898316|FG001|Overall Study|Withdrawal by Subject|1|||
46683097|NCT01365494|82898315|FG000|Overall Study|Lost to Follow-up|1|||
46683098|NCT01365494|82898316|FG001|Overall Study|Lost to Follow-up|2|||
46683099|NCT01357889|82898325|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
46683100|NCT01357889|82898326|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
46683101|NCT01357889|82898325|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
46683102|NCT01357889|82898326|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
46683103|NCT01357889|82898325|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
46683104|NCT01357889|82898326|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
46683105|NCT01357889|82898325|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
46683106|NCT01357889|82898326|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
46683107|NCT01357889|82898325|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
46683108|NCT01357889|82898326|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
46683109|NCT01357889|82898325|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
46683110|NCT01357889|82898326|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
46683111|NCT01357889|82898325|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
46683112|NCT01357889|82898326|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
46683113|NCT01357889|82898325|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
46683114|NCT01357889|82898326|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
46683115|NCT01357889|82898325|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
46683116|NCT01357889|82898326|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
46683117|NCT01357889|82898325|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
46683118|NCT01357889|82898326|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
46683119|NCT01357889|82898325|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
46683120|NCT01357889|82898326|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
46798654|NCT00442702|83017291|FG001|Titration Period|Failure to return|0|||
46683121|NCT01357889|82898325|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
46798655|NCT00442702|83017290|FG000|Titration Period|Hospitalized in another hospital|1|||
46798656|NCT00442702|83017291|FG001|Titration Period|Hospitalized in another hospital|0|||
46683122|NCT01357889|82898326|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
46683123|NCT01357889|82898325|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
46683124|NCT01357889|82898326|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
46798657|NCT00442702|83017290|FG000|Evaluation Period|Adverse Event|1|||
46798658|NCT00442702|83017291|FG001|Evaluation Period|Adverse Event|0|||
46798659|NCT00442702|83017290|FG000|Evaluation Period|Death|1|||
46798660|NCT00442702|83017291|FG001|Evaluation Period|Death|1|||
46798661|NCT00442702|83017290|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
46798662|NCT00442702|83017291|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
46798663|NCT00442702|83017290|FG000|Evaluation Period|Refused treatment|1|||
46798664|NCT00442702|83017291|FG001|Evaluation Period|Refused treatment|1|||
46798665|NCT00442702|83017290|FG000|Evaluation Period|Renal transplant|0|||
46798666|NCT00442702|83017291|FG001|Evaluation Period|Renal transplant|1|||
46798667|NCT00442702|83017290|FG000|Evaluation Period|Failure to return|1|||
46798668|NCT00442702|83017291|FG001|Evaluation Period|Failure to return|0|||
46683125|NCT01357850|82898338|FG000|Overall Study|Lost to Follow-up|1|||
46683126|NCT01357850|82898339|FG001|Overall Study|Lost to Follow-up|0|||
46683127|NCT01357850|82898340|FG002|Overall Study|Lost to Follow-up|0|||
46683128|NCT01357850|82898341|FG003|Overall Study|Lost to Follow-up|0|||
46683129|NCT01357655|82898354|FG000|Overall Study|Administrative Reason by Sponsor|45|||
46683130|NCT01357655|82898355|FG001|Overall Study|Administrative Reason by Sponsor|0|||
46683131|NCT01357655|82898354|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
46683132|NCT01357655|82898355|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
46683133|NCT01357655|82898354|FG000|Overall Study|Disease Progression|1|||
46683134|NCT01357655|82898355|FG001|Overall Study|Disease Progression|0|||
46683135|NCT01357655|82898354|FG000|Overall Study|Lost to Follow-up|2|||
46683136|NCT01357655|82898355|FG001|Overall Study|Lost to Follow-up|0|||
46798669|NCT00442702|83017290|FG000|Evaluation Period|Site closure|0|||
46798670|NCT00442702|83017291|FG001|Evaluation Period|Site closure|1|||
46683137|NCT01357655|82898354|FG000|Overall Study|Maximum Clinical Benefit|2|||
46683138|NCT01357655|82898355|FG001|Overall Study|Maximum Clinical Benefit|0|||
46798671|NCT00514917|83017299|FG000|Overall Study|Death|4|||
46798672|NCT00514917|83017300|FG001|Overall Study|Death|10|||
46798673|NCT00514917|83017299|FG000|Overall Study|Protocol Violation|1|||
46798674|NCT00514917|83017300|FG001|Overall Study|Protocol Violation|0|||
46683139|NCT01357655|82898354|FG000|Overall Study|Reason Unspecified|1|||
46683140|NCT01357655|82898355|FG001|Overall Study|Reason Unspecified|0|||
46683141|NCT01357655|82898354|FG000|Overall Study|Study Drug Toxicity|11|||
46683142|NCT01357655|82898355|FG001|Overall Study|Study Drug Toxicity|0|||
46683143|NCT01357655|82898354|FG000|Overall Study|Subject Withdrew Consent|1|||
46683144|NCT01357655|82898355|FG001|Overall Study|Subject Withdrew Consent|0|||
46683145|NCT01357616|82898362|FG000|Overall Study|Adverse Event|1|||
46683146|NCT01357616|82898363|FG001|Overall Study|Adverse Event|1|||
46683147|NCT01357616|82898362|FG000|Overall Study|Lost to Follow-up|4|||
46683148|NCT01357616|82898363|FG001|Overall Study|Lost to Follow-up|3|||
46683149|NCT01357616|82898362|FG000|Overall Study|Protocol Violation|0|||
46683150|NCT01357616|82898363|FG001|Overall Study|Protocol Violation|2|||
46683151|NCT01357616|82898362|FG000|Overall Study|Inadequate Control of IOP|1|||
46683152|NCT01357616|82898363|FG001|Overall Study|Inadequate Control of IOP|2|||
46683153|NCT01357616|82898362|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
46683154|NCT01357616|82898363|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
46683155|NCT01357616|82898362|FG000|Overall Study|Withdrawal by Subject|1|||
46683156|NCT01357616|82898363|FG001|Overall Study|Withdrawal by Subject|0|||
46683157|NCT01357577|82898371|FG000|Overall Study|Lost to Follow-up|20|||
46683158|NCT01357577|82898372|FG001|Overall Study|Lost to Follow-up|16|||
46683159|NCT01357577|82898371|FG000|Overall Study|Withdrawal by Subject|16|||
46683160|NCT01357577|82898372|FG001|Overall Study|Withdrawal by Subject|8|||
46683161|NCT01357577|82898371|FG000|Overall Study|look at data in database?|1|||
46683162|NCT01357577|82898372|FG001|Overall Study|look at data in database?|2|||
46683163|NCT01351025|82898381|FG000|Week 0 - 20|Lost to Follow-up|2|||
46683164|NCT01351025|82898382|FG001|Week 0 - 20|Lost to Follow-up|1|||
46858246|NCT00313781|83074037|FG002|Before Crossover|Lost to Follow-up|0|||
46858247|NCT00313781|83074035|FG000|Before Crossover|Withdrawal by Subject|3|||
46683165|NCT01351025|82898381|FG000|Week 0 - 20|Withdrawal by Subject|1|||
46683166|NCT01351025|82898382|FG001|Week 0 - 20|Withdrawal by Subject|0|||
46683167|NCT01351025|82898381|FG000|Week 24 - 44|Lost to Follow-up|0|||
46683168|NCT01351025|82898382|FG001|Week 24 - 44|Lost to Follow-up|2|||
46858248|NCT00313781|83074036|FG001|Before Crossover|Withdrawal by Subject|1|||
46858249|NCT00313781|83074037|FG002|Before Crossover|Withdrawal by Subject|0|||
46858250|NCT00313781|83074035|FG000|Before Crossover|Other|45|||
46858251|NCT00313781|83074036|FG001|Before Crossover|Other|30|||
46683169|NCT01351025|82898381|FG000|Week 24 - 44|Site closed|0|||
46683170|NCT01351025|82898382|FG001|Week 24 - 44|Site closed|1|||
46858252|NCT00313781|83074037|FG002|Before Crossover|Other|0|||
46683171|NCT01351025|82898381|FG000|Week 24 - 44|unable to get to clinic|1|||
46683172|NCT01351025|82898382|FG001|Week 24 - 44|unable to get to clinic|1|||
46683173|NCT01349036|82898396|FG000|Overall Study|Disease progression|13|||
46683174|NCT01349036|82898397|FG001|Overall Study|Disease progression|22|||
46683175|NCT01349036|82898396|FG000|Overall Study|Other|1|||
46683176|NCT01349036|82898397|FG001|Overall Study|Other|0|||
46683177|NCT01349036|82898396|FG000|Overall Study|Withdrawal by Subject|0|||
46683178|NCT01349036|82898397|FG001|Overall Study|Withdrawal by Subject|2|||
46683179|NCT01348763|82898407|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
46683180|NCT01348763|82898407|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
46683181|NCT01346969|82898415|FG000|Overall Study|Withdrawal by Subject|0|||
46683182|NCT01346969|82898416|FG001|Overall Study|Withdrawal by Subject|0|||
46683183|NCT01346969|82898417|FG002|Overall Study|Withdrawal by Subject|1|||
46683184|NCT01346969|82898418|FG003|Overall Study|Withdrawal by Subject|0|||
46683185|NCT01346969|82898415|FG000|Overall Study|Lost to Follow-up|1|||
46683186|NCT01346969|82898416|FG001|Overall Study|Lost to Follow-up|0|||
46683187|NCT01346969|82898417|FG002|Overall Study|Lost to Follow-up|2|||
46683188|NCT01346969|82898418|FG003|Overall Study|Lost to Follow-up|0|||
46683189|NCT01346969|82898415|FG000|Overall Study|Physician Decision|0|||
46683190|NCT01346969|82898416|FG001|Overall Study|Physician Decision|0|||
46683191|NCT01346969|82898417|FG002|Overall Study|Physician Decision|0|||
46683192|NCT01346969|82898418|FG003|Overall Study|Physician Decision|1|||
46683193|NCT01346969|82898415|FG000|Overall Study|Randomized but not treated|1|||
46683194|NCT01346969|82898416|FG001|Overall Study|Randomized but not treated|0|||
46683195|NCT01346969|82898417|FG002|Overall Study|Randomized but not treated|0|||
46683196|NCT01346969|82898418|FG003|Overall Study|Randomized but not treated|0|||
46683197|NCT01346774|82898430|FG000|Overall Study|Did not take a single dose|6|||
46683198|NCT01346774|82898431|FG001|Overall Study|Did not take a single dose|4|||
46683199|NCT01346774|82898430|FG000|Overall Study|Lost to Follow-up|3|||
46683200|NCT01346774|82898431|FG001|Overall Study|Lost to Follow-up|4|||
46798675|NCT00514917|83017299|FG000|Overall Study|Lost to Follow-up|4|||
46798676|NCT00514917|83017300|FG001|Overall Study|Lost to Follow-up|3|||
46683201|NCT01346774|82898430|FG000|Overall Study|Withdrawal by Subject|1|||
46683202|NCT01346774|82898431|FG001|Overall Study|Withdrawal by Subject|4|||
46683203|NCT01346774|82898430|FG000|Overall Study|Protocol Violation|2|||
46683204|NCT01346774|82898431|FG001|Overall Study|Protocol Violation|3|||
46683205|NCT01346774|82898430|FG000|Overall Study|Adverse Event|1|||
46683206|NCT01346774|82898431|FG001|Overall Study|Adverse Event|2|||
46683207|NCT01346696|82898437|FG000|Overall Study|Death|1|||
46683208|NCT01346540|82898443|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
46708081|NCT01172808|82923565|FG002|Overall Study|Lack of Efficacy|0|||
46683209|NCT01346540|82898444|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
46683210|NCT01346540|82898443|FG000|Overall Study|Adverse Event|0|||
46683211|NCT01346540|82898444|FG001|Overall Study|Adverse Event|4|||
46683212|NCT01342913|82898453|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
46683213|NCT01342913|82898454|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46798677|NCT00514917|83017299|FG000|Overall Study|Withdrawal by Subject|18|||
46683214|NCT01342913|82898455|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
46798678|NCT00514917|83017300|FG001|Overall Study|Withdrawal by Subject|16|||
46683215|NCT01342913|82898453|FG000|2-week Run-in Period|Physician Decision|6|||
46683216|NCT01342913|82898454|FG001|2-week Run-in Period|Physician Decision|0|||
46683217|NCT01342913|82898455|FG002|2-week Run-in Period|Physician Decision|0|||
46798679|NCT00514917|83017299|FG000|Overall Study|Discontinued due to study closure|88|||
46798680|NCT00514917|83017300|FG001|Overall Study|Discontinued due to study closure|81|||
46798681|NCT00514917|83017299|FG000|Overall Study|Undefined|11|||
46798682|NCT00514917|83017300|FG001|Overall Study|Undefined|5|||
46683218|NCT01342913|82898453|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
46683219|NCT01342913|82898454|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
46683220|NCT01342913|82898455|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
46683221|NCT01342913|82898453|FG000|2-week Run-in Period|Adverse Event|2|||
46683222|NCT01342913|82898454|FG001|2-week Run-in Period|Adverse Event|0|||
46683223|NCT01342913|82898455|FG002|2-week Run-in Period|Adverse Event|0|||
46683224|NCT01342913|82898453|FG000|2-week Run-in Period|Protocol Violation|5|||
46683225|NCT01342913|82898454|FG001|2-week Run-in Period|Protocol Violation|0|||
46683226|NCT01342913|82898455|FG002|2-week Run-in Period|Protocol Violation|0|||
46683227|NCT01342913|82898453|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
46683228|NCT01342913|82898454|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
46683229|NCT01342913|82898455|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
46683230|NCT01342913|82898453|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46683231|NCT01342913|82898454|FG001|Double-Blind Treatment Period|Adverse Event|3|||
46683232|NCT01342913|82898455|FG002|Double-Blind Treatment Period|Adverse Event|6|||
46683233|NCT01342913|82898453|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
46683234|NCT01342913|82898454|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
46683235|NCT01342913|82898455|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
46683236|NCT01342913|82898453|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
46683237|NCT01342913|82898454|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
46683238|NCT01342913|82898455|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
46683239|NCT01342913|82898453|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46683240|NCT01342913|82898454|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
46683241|NCT01342913|82898455|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
46683242|NCT01342913|82898453|FG000|Double-Blind Treatment Period|Physician Decision|0|||
46683243|NCT01342913|82898454|FG001|Double-Blind Treatment Period|Physician Decision|2|||
46683244|NCT01342913|82898455|FG002|Double-Blind Treatment Period|Physician Decision|0|||
46683245|NCT01342913|82898453|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46683246|NCT01342913|82898454|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
46683247|NCT01342913|82898455|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
46683248|NCT01342796|82898463|FG000|Overall Study|Withdrawal by Subject|2|||
46683249|NCT01342796|82898464|FG001|Overall Study|Withdrawal by Subject|0|||
46683250|NCT01342796|82898463|FG000|Overall Study|Lost to Follow-up|0|||
46683251|NCT01342796|82898464|FG001|Overall Study|Lost to Follow-up|3|||
46683252|NCT01342796|82898463|FG000|Overall Study|Inappropriate enrollment|1|||
46683253|NCT01342796|82898464|FG001|Overall Study|Inappropriate enrollment|0|||
46683254|NCT01342640|82898470|FG000|Overall Study|Adverse Event|3|||
46683255|NCT01342640|82898470|FG000|Overall Study|Protocol Violation|16|||
46683256|NCT01342640|82898470|FG000|Overall Study|Lost to Follow-up|21|||
46683257|NCT01342640|82898470|FG000|Overall Study|Other|1|||
46683258|NCT01342484|82898477|FG000|Overall Study|Other Reasons|1|||
46683259|NCT01342484|82898478|FG001|Overall Study|Other Reasons|0|||
46683260|NCT01342484|82898479|FG002|Overall Study|Other Reasons|0|||
46683261|NCT01342484|82898477|FG000|Overall Study|Protocol Violation|0|||
46683262|NCT01342484|82898478|FG001|Overall Study|Protocol Violation|0|||
46683263|NCT01342484|82898479|FG002|Overall Study|Protocol Violation|1|||
46683264|NCT01342484|82898477|FG000|Overall Study|Withdrawal by Subject|1|||
46683265|NCT01342484|82898478|FG001|Overall Study|Withdrawal by Subject|0|||
46683266|NCT01342484|82898479|FG002|Overall Study|Withdrawal by Subject|0|||
46683267|NCT01342445|82898489|FG000|Overall Study|Experienced side effects|0|||
46683268|NCT01342445|82898490|FG001|Overall Study|Experienced side effects|2|||
46683269|NCT01342211|82898505|FG000|Overall Study|Lost to Follow-up|0|||
46683270|NCT01342211|82898506|FG001|Overall Study|Lost to Follow-up|0|||
46683271|NCT01342211|82898507|FG002|Overall Study|Lost to Follow-up|0|||
46798683|NCT00711425|83017308|FG000|Overall Study|Protocol Violation|1|||
46798684|NCT00711425|83017308|FG000|Overall Study|Death|2|||
46798685|NCT00711425|83017308|FG000|Overall Study|Lost to Follow-up|1|||
46798686|NCT00504075|83017312|FG000|Overall Study|Adverse Event|1|||
46798687|NCT00504075|83017312|FG000|Overall Study|Lost to Follow-up|5|||
46798688|NCT00504075|83017312|FG000|Overall Study|Withdrawal by Subject|1|||
46798689|NCT00504075|83017312|FG000|Overall Study|Required other therapeutic intervention|1|||
46798690|NCT00503997|83017317|FG000|Overall Study|disease progression|1|||
46798691|NCT00503997|83017317|FG000|Overall Study|Adverse Event|5|||
46798692|NCT00503997|83017317|FG000|Overall Study|Death|1|||
46683272|NCT01342211|82898508|FG003|Overall Study|Lost to Follow-up|1|||
46683273|NCT01342211|82898509|FG004|Overall Study|Lost to Follow-up|0|||
46683274|NCT01342211|82898505|FG000|Overall Study|Adverse Event|0|||
46683275|NCT01342211|82898506|FG001|Overall Study|Adverse Event|0|||
46683276|NCT01342211|82898507|FG002|Overall Study|Adverse Event|0|||
46683277|NCT01342211|82898508|FG003|Overall Study|Adverse Event|0|||
46683278|NCT01342211|82898509|FG004|Overall Study|Adverse Event|1|||
46683279|NCT01342211|82898505|FG000|Overall Study|Withdrawal by Subject|0|||
46683280|NCT01342211|82898506|FG001|Overall Study|Withdrawal by Subject|0|||
46798693|NCT00503997|83017317|FG000|Overall Study|Withdrawal by Subject|1|||
46798694|NCT00096265|83017324|FG000|Overall Study|Ineligible|1|||
46683281|NCT01342211|82898507|FG002|Overall Study|Withdrawal by Subject|0|||
46683282|NCT01342211|82898508|FG003|Overall Study|Withdrawal by Subject|1|||
46858253|NCT00313781|83074035|FG000|Before Crossover|Crossover|0|||
46858254|NCT00313781|83074036|FG001|Before Crossover|Crossover|37|||
46858255|NCT00313781|83074037|FG002|Before Crossover|Crossover|0|||
46858256|NCT00313781|83074035|FG000|Before Crossover|Randomized, not treated|5|||
46858257|NCT00313781|83074036|FG001|Before Crossover|Randomized, not treated|0|||
46683283|NCT01342211|82898509|FG004|Overall Study|Withdrawal by Subject|0|||
46683284|NCT01342211|82898505|FG000|Overall Study|Randomized, but not Treated|0|||
46683285|NCT01342211|82898506|FG001|Overall Study|Randomized, but not Treated|2|||
46683286|NCT01342211|82898507|FG002|Overall Study|Randomized, but not Treated|0|||
46683287|NCT01342211|82898508|FG003|Overall Study|Randomized, but not Treated|0|||
46683288|NCT01342211|82898509|FG004|Overall Study|Randomized, but not Treated|1|||
46683289|NCT01342094|82898527|FG000|Overall Study|Adverse Event|5|||
46683290|NCT01342094|82898528|FG001|Overall Study|Adverse Event|0|||
46683291|NCT01342094|82898527|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
46683292|NCT01342094|82898528|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
46683293|NCT01342094|82898527|FG000|Overall Study|Withdrawal by Subject|0|||
46683294|NCT01342094|82898528|FG001|Overall Study|Withdrawal by Subject|2|||
46683295|NCT01340768|82898536|FG000|Overall Study|Lost to Follow-up|10|||
46683296|NCT01340768|82898537|FG001|Overall Study|Lost to Follow-up|4|||
46798695|NCT00096265|83017325|FG001|Overall Study|Ineligible|0|||
46858258|NCT00313781|83074037|FG002|Before Crossover|Randomized, not treated|0|||
46858259|NCT00313781|83074035|FG000|After Crossover|Death|0|||
46858260|NCT00313781|83074036|FG001|After Crossover|Death|0|||
46858261|NCT00313781|83074037|FG002|After Crossover|Death|6|||
46858262|NCT00313781|83074035|FG000|After Crossover|Withdrawal by Subject|0|||
46858263|NCT00313781|83074036|FG001|After Crossover|Withdrawal by Subject|0|||
46858264|NCT00313781|83074037|FG002|After Crossover|Withdrawal by Subject|3|||
46858265|NCT00313781|83074035|FG000|After Crossover|Other|0|||
46858266|NCT00313781|83074036|FG001|After Crossover|Other|0|||
46858267|NCT00313781|83074037|FG002|After Crossover|Other|18|||
46858268|NCT00368537|83074048|FG000|Randomization|No study drug dosed|13|||
46683297|NCT01340768|82898536|FG000|Overall Study|Withdrawal by Subject|5|||
46683298|NCT01340768|82898537|FG001|Overall Study|Withdrawal by Subject|1|||
46798696|NCT00096265|83017326|FG002|Overall Study|Ineligible|0|||
46798697|NCT00711191|83017338|FG000|Overall Study|Adverse Event|1|||
46798698|NCT00711191|83017339|FG001|Overall Study|Adverse Event|1|||
46798699|NCT00711191|83017340|FG002|Overall Study|Adverse Event|2|||
46798700|NCT00711191|83017338|FG000|Overall Study|Objective progression or relapse|2|||
46798701|NCT00711191|83017339|FG001|Overall Study|Objective progression or relapse|3|||
46798702|NCT00711191|83017340|FG002|Overall Study|Objective progression or relapse|7|||
46798703|NCT00711191|83017338|FG000|Overall Study|Withdrawal by Subject|0|||
46798704|NCT00711191|83017339|FG001|Overall Study|Withdrawal by Subject|1|||
46798705|NCT00711191|83017340|FG002|Overall Study|Withdrawal by Subject|3|||
46858269|NCT00368537|83074049|FG001|Randomization|No study drug dosed|6|||
46858270|NCT00368537|83074048|FG000|Baseline Participants|Lost to Follow-up|16|||
46683299|NCT01340768|82898536|FG000|Overall Study|Other|2|||
46858271|NCT00368537|83074049|FG001|Baseline Participants|Lost to Follow-up|17|||
46683300|NCT01340768|82898537|FG001|Overall Study|Other|0|||
46683301|NCT01340651|82898543|FG000|Overall Study|Adverse Event|3|||
46683302|NCT01340651|82898543|FG000|Overall Study|Consent Withdrawn|2|||
46683303|NCT01340651|82898543|FG000|Overall Study|Commercial Supply per Sponsor|12|||
46683304|NCT01340495|82898549|FG000|Overall Study|Withdrawal by Subject|1|||
46683305|NCT01340300|82898557|FG000|Overall Study|Lost to Follow-up|3|||
46683306|NCT01340300|82898558|FG001|Overall Study|Lost to Follow-up|0|||
46683307|NCT01340300|82898559|FG002|Overall Study|Lost to Follow-up|5|||
46683308|NCT01340300|82898560|FG003|Overall Study|Lost to Follow-up|10|||
46683309|NCT01340300|82898557|FG000|Overall Study|Withdrawal by Subject|5|||
46683310|NCT01340300|82898558|FG001|Overall Study|Withdrawal by Subject|6|||
46683311|NCT01340300|82898559|FG002|Overall Study|Withdrawal by Subject|6|||
46683312|NCT01340300|82898560|FG003|Overall Study|Withdrawal by Subject|3|||
46683313|NCT01340300|82898557|FG000|Overall Study|Adverse Event|1|||
46683314|NCT01340300|82898558|FG001|Overall Study|Adverse Event|0|||
46683315|NCT01340300|82898559|FG002|Overall Study|Adverse Event|4|||
46683316|NCT01340300|82898560|FG003|Overall Study|Adverse Event|0|||
46683317|NCT01340300|82898557|FG000|Overall Study|Physician Decision|0|||
46683318|NCT01340300|82898558|FG001|Overall Study|Physician Decision|1|||
46683319|NCT01340300|82898559|FG002|Overall Study|Physician Decision|0|||
46683320|NCT01340300|82898560|FG003|Overall Study|Physician Decision|0|||
46683321|NCT01340300|82898557|FG000|Overall Study|Unrelated sickness|0|||
46683322|NCT01340300|82898558|FG001|Overall Study|Unrelated sickness|2|||
46683323|NCT01340300|82898559|FG002|Overall Study|Unrelated sickness|0|||
46683324|NCT01340300|82898560|FG003|Overall Study|Unrelated sickness|1|||
46683325|NCT01340066|82898572|FG000|Placebo Run in Period|Screen Failures|27|||
46683326|NCT01340066|82898573|FG001|Placebo Run in Period|Screen Failures|0|||
46683327|NCT01340066|82898574|FG002|Placebo Run in Period|Screen Failures|0|||
46683328|NCT01340066|82898572|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
46683329|NCT01340066|82898573|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
46683330|NCT01340066|82898574|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
46683331|NCT01340066|82898572|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
46683332|NCT01340066|82898573|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
46683333|NCT01340066|82898574|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
46683334|NCT01340066|82898572|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
46683335|NCT01340066|82898573|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
46683336|NCT01340066|82898574|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
46798706|NCT00706511|83017355|FG000|Overall Study|Withdrawal by Subject|1|||
46798707|NCT00706511|83017356|FG001|Overall Study|Withdrawal by Subject|0|||
46683337|NCT01107535|82898581|FG000|Overall Study|Death|5|||
46798708|NCT00706511|83017357|FG002|Overall Study|Withdrawal by Subject|0|||
46798709|NCT00706511|83017358|FG003|Overall Study|Withdrawal by Subject|0|||
46798710|NCT00448864|83017369|FG000|Overall Study|Death|1|||
46798711|NCT00448864|83017370|FG001|Overall Study|Death|0|||
46683338|NCT01326546|82898587|FG000|Overall Study|Lost to Follow-up|8|||
46683339|NCT01326546|82898588|FG001|Overall Study|Lost to Follow-up|7|||
46683340|NCT01326546|82898587|FG000|Overall Study|Protocol Violation|3|||
46683341|NCT01326546|82898588|FG001|Overall Study|Protocol Violation|4|||
46683342|NCT01326546|82898587|FG000|Overall Study|Pregnancy|0|||
46683343|NCT01326546|82898588|FG001|Overall Study|Pregnancy|1|||
46683344|NCT01326546|82898587|FG000|Overall Study|Adverse Event|1|||
46683345|NCT01326546|82898588|FG001|Overall Study|Adverse Event|0|||
46683346|NCT01326546|82898587|FG000|Overall Study|Withdrawal by Subject|5|||
46683347|NCT01326546|82898588|FG001|Overall Study|Withdrawal by Subject|1|||
46798712|NCT00448864|83017371|FG002|Overall Study|Death|0|||
46683348|NCT01325532|82898596|FG000|Overall Study|Withdrawal by Subject|2|||
46683349|NCT01325532|82898597|FG001|Overall Study|Withdrawal by Subject|0|||
46683350|NCT01171963|82898605|FG000|Overall Study|Adverse Event|10|||
46683351|NCT01171963|82898606|FG001|Overall Study|Adverse Event|15|||
46683352|NCT01171963|82898605|FG000|Overall Study|Lost to Follow-up|23|||
46683353|NCT01171963|82898606|FG001|Overall Study|Lost to Follow-up|24|||
46683354|NCT01171963|82898605|FG000|Overall Study|Other - diarrhoea|1|||
46683355|NCT01171963|82898606|FG001|Overall Study|Other - diarrhoea|0|||
46683356|NCT01171963|82898605|FG000|Overall Study|Withdrawal by Subject|114|||
46683357|NCT01171963|82898606|FG001|Overall Study|Withdrawal by Subject|129|||
46683358|NCT01171183|82898617|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
46683359|NCT01171183|82898618|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
46683360|NCT01171183|82898617|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
46683361|NCT01171183|82898618|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
46683362|NCT01171183|82898617|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
46683363|NCT01171183|82898618|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
46683364|NCT01171183|82898617|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
46798713|NCT00448864|83017369|FG000|Overall Study|Lost to Follow-up|3|||
46683365|NCT01171183|82898618|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
46683366|NCT01171183|82898617|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
46683367|NCT01171183|82898618|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
46683368|NCT01171183|82898617|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
46683369|NCT01171183|82898618|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
46683370|NCT01170091|82898624|FG000|Overall Study|Missing efficacy evaluation|3|||
46683371|NCT01170091|82898624|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
46798714|NCT00448864|83017370|FG001|Overall Study|Lost to Follow-up|1|||
46798715|NCT00448864|83017371|FG002|Overall Study|Lost to Follow-up|0|||
46798716|NCT00448864|83017369|FG000|Overall Study|Physician Decision|1|||
46683372|NCT01169779|82898630|FG000|Overall Study|Adverse Event|3|||
46683373|NCT01169779|82898631|FG001|Overall Study|Adverse Event|11|||
46683374|NCT01169779|82898630|FG000|Overall Study|Lack of Efficacy|1|||
46683375|NCT01169779|82898631|FG001|Overall Study|Lack of Efficacy|0|||
46683376|NCT01169779|82898630|FG000|Overall Study|Protocol Violation|1|||
46981396|NCT02603419|83227314|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
46981397|NCT02603419|83227309|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
46683377|NCT01169779|82898631|FG001|Overall Study|Protocol Violation|1|||
46683378|NCT01169779|82898630|FG000|Overall Study|Withdrawal by Subject|3|||
46683379|NCT01169779|82898631|FG001|Overall Study|Withdrawal by Subject|2|||
46683380|NCT01169779|82898630|FG000|Overall Study|Familial and personal reasons|3|||
46683381|NCT01169779|82898631|FG001|Overall Study|Familial and personal reasons|3|||
46683382|NCT01169701|82898639|FG000|Overall Study|Lost to Follow-up|1|||
46683383|NCT01169701|82898640|FG001|Overall Study|Lost to Follow-up|1|||
46683384|NCT01169701|82898639|FG000|Overall Study|Withdrawal by Subject|1|||
46683385|NCT01169701|82898640|FG001|Overall Study|Withdrawal by Subject|3|||
46683386|NCT01169701|82898639|FG000|Overall Study|Adverse Event|1|||
46683387|NCT01169701|82898640|FG001|Overall Study|Adverse Event|2|||
46683388|NCT01169701|82898639|FG000|Overall Study|Exclusion criteria|2|||
46683389|NCT01169701|82898640|FG001|Overall Study|Exclusion criteria|0|||
46683390|NCT01169701|82898639|FG000|Overall Study|Death|0|||
46683391|NCT01169701|82898640|FG001|Overall Study|Death|1|||
46683392|NCT01169701|82898639|FG000|Overall Study|Administrative problems|0|||
46798717|NCT00448864|83017370|FG001|Overall Study|Physician Decision|0|||
46981398|NCT02603419|83227310|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
46683393|NCT01169701|82898640|FG001|Overall Study|Administrative problems|1|||
46683394|NCT01169701|82898639|FG000|Overall Study|Serious adverse event|0|||
46683395|NCT01169701|82898640|FG001|Overall Study|Serious adverse event|1|||
46683396|NCT01169701|82898639|FG000|Overall Study|Sponsor decision|0|||
46683397|NCT01169701|82898640|FG001|Overall Study|Sponsor decision|1|||
46683398|NCT01168999|82898650|FG000|Overall Study|Lost to Follow-up|2|||
46683399|NCT01168999|82898651|FG001|Overall Study|Lost to Follow-up|1|||
46683400|NCT01168999|82898652|FG002|Overall Study|Lost to Follow-up|0|||
46683401|NCT01168999|82898653|FG003|Overall Study|Lost to Follow-up|0|||
46683402|NCT01167907|82898665|FG000|Overall Study|Protocol Violation|1|||
46683403|NCT01167907|82898666|FG001|Overall Study|Protocol Violation|0|||
46683404|NCT01167907|82898665|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
46798718|NCT00448864|83017371|FG002|Overall Study|Physician Decision|1|||
46798719|NCT00448864|83017369|FG000|Overall Study|Withdrawal by Subject|0|||
46798720|NCT00448864|83017370|FG001|Overall Study|Withdrawal by Subject|2|||
46683405|NCT01167907|82898666|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
46683406|NCT01166659|82898672|FG000|Overall Study|Subject Decision|8|||
46683407|NCT01166659|82898672|FG000|Overall Study|Investigator Decision|2|||
46683408|NCT01166659|82898672|FG000|Overall Study|Death|1|||
46683409|NCT01166659|82898672|FG000|Overall Study|Lost to Follow-up|1|||
46683410|NCT01166659|82898672|FG000|Overall Study|Study Closed at Site|1|||
46683411|NCT01115491|82898677|FG000|Overall Study|Death|22|||
46683412|NCT01115491|82898677|FG000|Overall Study|Adverse Event|3|||
46683413|NCT01115491|82898677|FG000|Overall Study|Lost to Follow-up|3|||
46683414|NCT01115491|82898677|FG000|Overall Study|Withdrawal by Subject|1|||
46683415|NCT01115491|82898677|FG000|Overall Study|Physician Decision|1|||
46683416|NCT01113931|82898683|FG000|Overall Study|Adverse Event|2|||
46683417|NCT01113931|82898684|FG001|Overall Study|Adverse Event|2|||
46683418|NCT01113931|82898683|FG000|Overall Study|Physician Decision|0|||
46683419|NCT01113931|82898684|FG001|Overall Study|Physician Decision|2|||
46683420|NCT01113931|82898683|FG000|Overall Study|Lost to Follow-up|12|||
46683421|NCT01113931|82898684|FG001|Overall Study|Lost to Follow-up|9|||
46683422|NCT01113931|82898683|FG000|Overall Study|Various|2|||
46683423|NCT01113931|82898684|FG001|Overall Study|Various|4|||
46683424|NCT01113931|82898683|FG000|Overall Study|Withdrawal by Subject|3|||
46683425|NCT01113931|82898684|FG001|Overall Study|Withdrawal by Subject|0|||
46683426|NCT01107379|82898690|FG000|Overall Study|Withdrawal by Subject|18|||
46683427|NCT01107379|82898690|FG000|Overall Study|Lost to Follow-up|3|||
46683428|NCT01106911|82898694|FG000|Overall Study|Physician Decision|2|||
46683429|NCT01106911|82898694|FG000|Overall Study|deemed ineligible after screening|3|||
46683430|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
46683431|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
46683432|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
46683433|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
46683434|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Death|0|||
46683435|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Death|0|||
46683436|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Death|1|||
46683437|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Death|0|||
46683438|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
46683439|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
46683440|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
46683441|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
46683442|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
46683443|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
46683444|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
46683445|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
46858272|NCT00368537|83074048|FG000|Baseline Participants|Withdrawal by Subject|6|||
46683446|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
46683447|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
46683448|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
46683449|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
46683450|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
46683451|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
46683452|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
46683453|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
46683454|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
46683455|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
46683456|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
46683457|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
46683458|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
46683459|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
46683460|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
46683461|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
46683462|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
46683463|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
46683464|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46683465|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46683466|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
46683467|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
46683468|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
46683469|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
46683470|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
46683471|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
46683472|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
46683473|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
46683474|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Other|8|||
46683475|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Other|14|||
46683476|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Other|8|||
46683477|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Other|23|||
46683478|NCT01106677|82898702|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
46683479|NCT01106677|82898703|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
46683480|NCT01106677|82898704|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
46683481|NCT01106677|82898705|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
46683482|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
46683483|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
46683484|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
46683485|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
46683486|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Death|0|||
46683487|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Death|0|||
46981399|NCT02603419|83227311|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
46981400|NCT02603419|83227312|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
46981401|NCT02603419|83227313|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
46981402|NCT02603419|83227314|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
46981403|NCT02603419|83227309|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
46981404|NCT02603419|83227310|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
46981405|NCT02603419|83227311|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
46981406|NCT02603419|83227312|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
46981407|NCT02603419|83227313|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
46981408|NCT02603419|83227314|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
46981409|NCT02603419|83227309|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
46981410|NCT02603419|83227310|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
46981411|NCT02603419|83227311|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
46981412|NCT02603419|83227312|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
46981413|NCT02603419|83227313|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
46981414|NCT02603419|83227314|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
46981415|NCT02603419|83227309|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
46981416|NCT02603419|83227310|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
46981417|NCT02603419|83227311|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
46981418|NCT02603419|83227312|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
46981419|NCT02603419|83227313|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
46981420|NCT02603419|83227314|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
46981421|NCT01668355|83227331|FG000|Overall Study|Death|3|||
46981422|NCT01668355|83227332|FG001|Overall Study|Death|1|||
46981423|NCT01668355|83227331|FG000|Overall Study|Withdrawal by Subject|6|||
46981424|NCT01668355|83227332|FG001|Overall Study|Withdrawal by Subject|1|||
46981425|NCT01667731|83227344|FG000|Overall Study|Enrolled but not treated|0|||
46981426|NCT01667731|83227345|FG001|Overall Study|Enrolled but not treated|0|||
46981427|NCT01667731|83227346|FG002|Overall Study|Enrolled but not treated|0|||
46981428|NCT01667731|83227347|FG003|Overall Study|Enrolled but not treated|0|||
46981429|NCT01667731|83227348|FG004|Overall Study|Enrolled but not treated|1|||
46981430|NCT01667731|83227344|FG000|Overall Study|Efficacy Failure|1|||
46981431|NCT01667731|83227345|FG001|Overall Study|Efficacy Failure|12|||
46683488|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Death|0|||
46683489|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Death|1|||
46683490|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
46683491|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
46683492|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
46683493|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
46683494|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46683495|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
46683496|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
46683497|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
46683498|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
46683499|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
46683500|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
46683501|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
46683502|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
46683503|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46683504|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46683505|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46683506|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46683507|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
46683508|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
46683509|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46683510|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
46683511|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
46683512|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
46683513|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
46683514|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
46683515|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
46683516|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
46683517|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
46683518|NCT01106677|82898702|FG000|Extension Period: Week 26 to Week 52|Other|6|||
46683519|NCT01106677|82898703|FG001|Extension Period: Week 26 to Week 52|Other|5|||
46683520|NCT01106677|82898704|FG002|Extension Period: Week 26 to Week 52|Other|8|||
46683521|NCT01106677|82898705|FG003|Extension Period: Week 26 to Week 52|Other|5|||
46683522|NCT01106287|82898726|FG000|Overall Study|Adverse Event|1|||
46683523|NCT01106287|82898727|FG001|Overall Study|Adverse Event|0|||
46683524|NCT01106287|82898728|FG002|Overall Study|Adverse Event|0|||
46683525|NCT01106287|82898729|FG003|Overall Study|Adverse Event|0|||
46683526|NCT01104493|82898745|FG000|Overall Study|Lost to Follow-up|0|||
46683527|NCT01104493|82898746|FG001|Overall Study|Lost to Follow-up|2|||
46683528|NCT01104415|82898752|FG000|Core Phase|Consent withdrawn by subjects|1|||
46683529|NCT01104415|82898753|FG001|Core Phase|Consent withdrawn by subjects|0|||
46683530|NCT01104415|82898752|FG000|Extension Period|Progressive disease|0|||
46683531|NCT01104415|82898753|FG001|Extension Period|Progressive disease|4|||
46683532|NCT01104415|82898752|FG000|Extension Period|Death|0|||
46683533|NCT01104415|82898753|FG001|Extension Period|Death|1|||
46683534|NCT01104415|82898752|FG000|Extension Period|Physician Decision|0|||
46683535|NCT01104415|82898753|FG001|Extension Period|Physician Decision|1|||
46683536|NCT01104415|82898752|FG000|Extension Period|Transition to Study LX1606.302|0|||
46683537|NCT01104415|82898753|FG001|Extension Period|Transition to Study LX1606.302|4|||
46683538|NCT01104415|82898752|FG000|Extension Period|Heart surgery/feeling miserable|0|||
46683539|NCT01104415|82898753|FG001|Extension Period|Heart surgery/feeling miserable|1|||
46683540|NCT01099579|82898763|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
46683541|NCT01099579|82898764|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
46683542|NCT01099579|82898765|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
46683543|NCT01099579|82898763|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
46683544|NCT01099579|82898764|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
46683545|NCT01099579|82898765|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
46683546|NCT01099579|82898763|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
46683547|NCT01099579|82898764|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
46683548|NCT01099579|82898765|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
46798721|NCT00448864|83017371|FG002|Overall Study|Withdrawal by Subject|0|||
46798722|NCT00448864|83017369|FG000|Overall Study|Protocol Violation|0|||
46798723|NCT00448864|83017370|FG001|Overall Study|Protocol Violation|2|||
46798724|NCT00448864|83017371|FG002|Overall Study|Protocol Violation|0|||
46798725|NCT00567398|83017383|FG000|Overall Study|Adverse Event|6|||
46683549|NCT01099579|82898763|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
46683550|NCT01099579|82898764|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
46683551|NCT01099579|82898765|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
46683552|NCT01099579|82898763|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
46683553|NCT01099579|82898764|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
46683554|NCT01099579|82898765|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
46683555|NCT01099579|82898763|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
46683556|NCT01099579|82898764|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
46683557|NCT01099579|82898765|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
46683558|NCT01099579|82898763|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
46683559|NCT01099579|82898764|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
46683560|NCT01099579|82898765|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
46683561|NCT01099579|82898763|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
46683562|NCT01099579|82898764|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
46683563|NCT01099579|82898765|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
46683564|NCT01099579|82898763|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
46683565|NCT01099579|82898764|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
46683566|NCT01099579|82898765|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
46683567|NCT01099579|82898763|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
46683568|NCT01099579|82898764|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
46683569|NCT01099579|82898765|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
46683570|NCT01103713|82898775|FG000|Overall Study|Lost to Follow-up|2|||
46683571|NCT01103713|82898775|FG000|Overall Study|Withdrawal by Subject|8|||
46683572|NCT01103713|82898775|FG000|Overall Study|Study terminated by sponsor|2|||
46683573|NCT01103713|82898775|FG000|Overall Study|Other|1|||
46683574|NCT01103479|82898785|FG000|Overall Study|Up to date with CRC screening|1|||
46683575|NCT01103479|82898786|FG001|Overall Study|Up to date with CRC screening|9|||
46683576|NCT01103479|82898787|FG002|Overall Study|Up to date with CRC screening|12|||
46683577|NCT01103479|82898785|FG000|Overall Study|Family history of CRC|1|||
46683578|NCT01103479|82898786|FG001|Overall Study|Family history of CRC|0|||
46683579|NCT01103479|82898787|FG002|Overall Study|Family history of CRC|2|||
46683580|NCT01103479|82898785|FG000|Overall Study|Active cancer|1|||
46683581|NCT01103479|82898786|FG001|Overall Study|Active cancer|0|||
46683582|NCT01103479|82898787|FG002|Overall Study|Active cancer|0|||
46683583|NCT01103479|82898785|FG000|Overall Study|Saw non-study physician|2|||
46683584|NCT01103479|82898786|FG001|Overall Study|Saw non-study physician|0|||
46683585|NCT01103479|82898787|FG002|Overall Study|Saw non-study physician|0|||
46683586|NCT01103323|82898798|FG000|Without/Before Drug Switch|Adverse Event|50|||
46683587|NCT01103323|82898799|FG001|Without/Before Drug Switch|Adverse Event|7|||
46683588|NCT01103323|82898798|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
46683589|NCT01103323|82898799|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
46683590|NCT01103323|82898798|FG000|Without/Before Drug Switch|Protocol Violation|2|||
46683591|NCT01103323|82898799|FG001|Without/Before Drug Switch|Protocol Violation|0|||
46683592|NCT01103323|82898798|FG000|Without/Before Drug Switch|Physician Decision|2|||
46683593|NCT01103323|82898799|FG001|Without/Before Drug Switch|Physician Decision|0|||
46981432|NCT01667731|83227346|FG002|Overall Study|Efficacy Failure|0|||
46981433|NCT01667731|83227347|FG003|Overall Study|Efficacy Failure|1|||
46683594|NCT01103323|82898798|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
46683595|NCT01103323|82898799|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
46683596|NCT01103323|82898798|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
46683597|NCT01103323|82898799|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
46683598|NCT01103323|82898798|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
46683599|NCT01103323|82898799|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
46683600|NCT01103245|82898810|FG000|Overall Study|Withdrawal by Subject|1|||
46683601|NCT01103245|82898811|FG001|Overall Study|Withdrawal by Subject|0|||
46981434|NCT01667731|83227348|FG004|Overall Study|Efficacy Failure|24|||
46683602|NCT01103245|82898812|FG002|Overall Study|Withdrawal by Subject|3|||
46683603|NCT01103245|82898813|FG003|Overall Study|Withdrawal by Subject|0|||
46683604|NCT01103245|82898810|FG000|Overall Study|Inadequate IV access|1|||
46683605|NCT01103245|82898811|FG001|Overall Study|Inadequate IV access|0|||
46683606|NCT01103245|82898812|FG002|Overall Study|Inadequate IV access|0|||
46683607|NCT01103245|82898813|FG003|Overall Study|Inadequate IV access|0|||
46683608|NCT01103245|82898810|FG000|Overall Study|Adverse Event|0|||
46683609|NCT01103245|82898811|FG001|Overall Study|Adverse Event|2|||
46683610|NCT01103245|82898812|FG002|Overall Study|Adverse Event|1|||
46683611|NCT01103245|82898813|FG003|Overall Study|Adverse Event|0|||
46683612|NCT01103245|82898810|FG000|Overall Study|Physician Decision|1|||
46798726|NCT00567398|83017384|FG001|Overall Study|Adverse Event|14|||
46683613|NCT01103245|82898811|FG001|Overall Study|Physician Decision|0|||
46683614|NCT01103245|82898812|FG002|Overall Study|Physician Decision|0|||
46683615|NCT01103245|82898813|FG003|Overall Study|Physician Decision|0|||
46683616|NCT01099267|82898823|FG000|MDS-003 Study|Adverse Event|37|||
46683617|NCT01099267|82898823|FG000|MDS-003 Study|Lack of Efficacy|52|||
46683618|NCT01099267|82898823|FG000|MDS-003 Study|Withdrawal by Subject|8|||
46683619|NCT01099267|82898823|FG000|MDS-003 Study|Lost to Follow-up|1|||
46683620|NCT01099267|82898823|FG000|MDS-003 Study|Death|11|||
46683621|NCT01099267|82898823|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
46683622|NCT01099267|82898823|FG000|MDS-003 Study|Disease Progression|7|||
46683623|NCT01099267|82898823|FG000|MDS-003 Study|Investigator Decision|2|||
46683624|NCT01099267|82898823|FG000|MDS-003 Study|Non-Compliance|2|||
46683625|NCT01099267|82898823|FG000|MDS-003 Study|Loss of Response|1|||
46683626|NCT01099267|82898823|FG000|MDS-003 Study|Secondary Malign Disease|1|||
46683627|NCT01098487|82898827|FG000|Overall Study|Adverse Event|22|||
46683628|NCT01098487|82898827|FG000|Overall Study|Lack of Efficacy|11|||
46683629|NCT01098487|82898827|FG000|Overall Study|Withdrawal by Subject|7|||
46683630|NCT01098487|82898827|FG000|Overall Study|Lost to Follow-up|3|||
46683631|NCT01098487|82898827|FG000|Overall Study|Physician Decision|1|||
46683632|NCT01098097|82898831|FG000|Overall Study|Adverse Event|17|||
46683633|NCT01098097|82898831|FG000|Overall Study|Lost to Follow-up|18|||
46683634|NCT01098097|82898831|FG000|Overall Study|Status unknown|16|||
46683635|NCT01098097|82898831|FG000|Overall Study|No reason reported|31|||
46683636|NCT01097863|82898838|FG000|Overall Study|Discomfort|1|||
46683637|NCT01097863|82898839|FG001|Overall Study|Discomfort|0|||
46683638|NCT01097863|82898840|FG002|Overall Study|Discomfort|1|||
46683639|NCT01097863|82898838|FG000|Overall Study|Did not return for final visit|0|||
46683640|NCT01097863|82898839|FG001|Overall Study|Did not return for final visit|0|||
46683641|NCT01097863|82898840|FG002|Overall Study|Did not return for final visit|1|||
46683642|NCT01326962|82898848|FG000|Overall Study|Adverse Event|1|||
46683643|NCT01326962|82898848|FG000|Overall Study|Withdrawal by Subject|1|||
46683644|NCT01326962|82898848|FG000|Overall Study|Lost to Follow-up|3|||
46683645|NCT01326962|82898848|FG000|Overall Study|Other|2|||
46683646|NCT01326728|82898854|FG000|Overall Study|Death|13|||
46683647|NCT01326728|82898855|FG001|Overall Study|Death|0|||
46683648|NCT01326728|82898854|FG000|Overall Study|Early closure of study|34|||
46683649|NCT01326728|82898855|FG001|Overall Study|Early closure of study|9|||
46683650|NCT01097707|82898865|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
46683651|NCT01097707|82898866|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
46683652|NCT01097707|82898867|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
46683653|NCT01097707|82898868|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
46683654|NCT01097707|82898869|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
46683655|NCT01097707|82898865|FG000|Overall Study|Adverse Event|4|||
46683656|NCT01097707|82898866|FG001|Overall Study|Adverse Event|2|||
46683657|NCT01097707|82898867|FG002|Overall Study|Adverse Event|3|||
46683658|NCT01097707|82898868|FG003|Overall Study|Adverse Event|1|||
46683659|NCT01097707|82898869|FG004|Overall Study|Adverse Event|3|||
46683660|NCT01097707|82898865|FG000|Overall Study|Entry Criteria Not Met|2|||
46683661|NCT01097707|82898866|FG001|Overall Study|Entry Criteria Not Met|1|||
46683662|NCT01097707|82898867|FG002|Overall Study|Entry Criteria Not Met|1|||
46683663|NCT01097707|82898868|FG003|Overall Study|Entry Criteria Not Met|0|||
46683664|NCT01097707|82898869|FG004|Overall Study|Entry Criteria Not Met|1|||
46683665|NCT01097707|82898865|FG000|Overall Study|Lack of Efficacy|1|||
46683666|NCT01097707|82898866|FG001|Overall Study|Lack of Efficacy|0|||
46683667|NCT01097707|82898867|FG002|Overall Study|Lack of Efficacy|0|||
46683668|NCT01097707|82898868|FG003|Overall Study|Lack of Efficacy|1|||
46683669|NCT01097707|82898869|FG004|Overall Study|Lack of Efficacy|0|||
46858273|NCT00368537|83074049|FG001|Baseline Participants|Withdrawal by Subject|4|||
46858274|NCT00368537|83074048|FG000|Baseline Participants|Death|1|||
46858275|NCT00368537|83074049|FG001|Baseline Participants|Death|2|||
46683670|NCT01097707|82898865|FG000|Overall Study|Lost to Follow-up|1|||
46683671|NCT01097707|82898866|FG001|Overall Study|Lost to Follow-up|1|||
46683672|NCT01097707|82898867|FG002|Overall Study|Lost to Follow-up|2|||
46683673|NCT01097707|82898868|FG003|Overall Study|Lost to Follow-up|0|||
46683674|NCT01097707|82898869|FG004|Overall Study|Lost to Follow-up|3|||
46683675|NCT01097707|82898865|FG000|Overall Study|Protocol Violation|2|||
46683676|NCT01097707|82898866|FG001|Overall Study|Protocol Violation|2|||
46683677|NCT01097707|82898867|FG002|Overall Study|Protocol Violation|3|||
46683678|NCT01097707|82898868|FG003|Overall Study|Protocol Violation|2|||
46683679|NCT01097707|82898869|FG004|Overall Study|Protocol Violation|2|||
46683680|NCT01097707|82898865|FG000|Overall Study|Sponsor Decision|31|||
46683681|NCT01097707|82898866|FG001|Overall Study|Sponsor Decision|31|||
46683682|NCT01097707|82898867|FG002|Overall Study|Sponsor Decision|34|||
46683683|NCT01097707|82898868|FG003|Overall Study|Sponsor Decision|35|||
46683684|NCT01097707|82898869|FG004|Overall Study|Sponsor Decision|36|||
46683685|NCT01097707|82898865|FG000|Overall Study|Withdrawal by Subject|3|||
46683686|NCT01097707|82898866|FG001|Overall Study|Withdrawal by Subject|6|||
46683687|NCT01097707|82898867|FG002|Overall Study|Withdrawal by Subject|1|||
46683688|NCT01097707|82898868|FG003|Overall Study|Withdrawal by Subject|4|||
46683689|NCT01097707|82898869|FG004|Overall Study|Withdrawal by Subject|3|||
46683690|NCT01097707|82898865|FG000|Overall Study|Reason unknown|0|||
46683691|NCT01097707|82898866|FG001|Overall Study|Reason unknown|0|||
46683692|NCT01097707|82898867|FG002|Overall Study|Reason unknown|0|||
46683693|NCT01097707|82898868|FG003|Overall Study|Reason unknown|0|||
46683694|NCT01097707|82898869|FG004|Overall Study|Reason unknown|1|||
46683695|NCT01326026|82898883|FG000|Overall Study|Adverse Event|4|||
46683696|NCT01326026|82898884|FG001|Overall Study|Adverse Event|3|||
46683697|NCT01326026|82898883|FG000|Overall Study|Withdrawal Criteria|5|||
46683698|NCT01326026|82898884|FG001|Overall Study|Withdrawal Criteria|7|||
46683699|NCT01326026|82898883|FG000|Overall Study|Other|3|||
46683700|NCT01326026|82898884|FG001|Overall Study|Other|3|||
46683701|NCT01097629|82898893|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
46683702|NCT01097629|82898894|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
46858276|NCT00368537|83074048|FG000|Baseline Participants|No susceptibility|1|||
46858277|NCT00368537|83074049|FG001|Baseline Participants|No susceptibility|0|||
46858278|NCT00368537|83074048|FG000|Baseline Participants|Patient uncompliant|0|||
46858279|NCT00368537|83074049|FG001|Baseline Participants|Patient uncompliant|1|||
46858280|NCT00313703|83074059|FG000|Overall Study|Lost to Follow-up|11|||
46858281|NCT00313703|83074060|FG001|Overall Study|Lost to Follow-up|2|||
46858282|NCT00313703|83074061|FG002|Overall Study|Lost to Follow-up|5|||
46858283|NCT00313703|83074062|FG003|Overall Study|Lost to Follow-up|12|||
46858284|NCT00313313|83074075|FG000|Overall Study|Lack of Efficacy|14|||
46858285|NCT00313313|83074076|FG001|Overall Study|Lack of Efficacy|9|||
46858286|NCT00313313|83074077|FG002|Overall Study|Lack of Efficacy|20|||
46858287|NCT00313313|83074075|FG000|Overall Study|Withdrawal of consent by subject|18|||
46683703|NCT01097629|82898895|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
46683704|NCT01097629|82898896|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46683705|NCT01097629|82898897|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46683706|NCT01097629|82898898|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46683707|NCT01097629|82898899|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46683708|NCT01097629|82898900|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
46683709|NCT01097629|82898893|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
46683710|NCT01097629|82898894|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
46858288|NCT00313313|83074076|FG001|Overall Study|Withdrawal of consent by subject|17|||
46683711|NCT01097629|82898895|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
46683712|NCT01097629|82898896|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46683713|NCT01097629|82898897|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46683714|NCT01097629|82898898|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46683715|NCT01097629|82898899|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46683716|NCT01097629|82898900|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
46683717|NCT01097629|82898893|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
46683718|NCT01097629|82898894|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
46683719|NCT01097629|82898895|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
46683720|NCT01097629|82898896|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46683721|NCT01097629|82898897|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46683722|NCT01097629|82898898|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46981435|NCT01667731|83227344|FG000|Overall Study|Lost to Follow-up|2|||
46981436|NCT01667731|83227345|FG001|Overall Study|Lost to Follow-up|3|||
46981437|NCT01667731|83227346|FG002|Overall Study|Lost to Follow-up|1|||
46981438|NCT01667731|83227347|FG003|Overall Study|Lost to Follow-up|1|||
46981439|NCT01667731|83227348|FG004|Overall Study|Lost to Follow-up|2|||
46981440|NCT01667731|83227344|FG000|Overall Study|Subject Withdrew Consent|2|||
46981441|NCT01667731|83227345|FG001|Overall Study|Subject Withdrew Consent|0|||
46981442|NCT01667731|83227346|FG002|Overall Study|Subject Withdrew Consent|1|||
46981443|NCT01667731|83227347|FG003|Overall Study|Subject Withdrew Consent|0|||
46981444|NCT01667731|83227348|FG004|Overall Study|Subject Withdrew Consent|1|||
46981445|NCT01667731|83227344|FG000|Overall Study|Death|0|||
46981446|NCT01667731|83227345|FG001|Overall Study|Death|1|||
46981447|NCT01667731|83227346|FG002|Overall Study|Death|0|||
46981448|NCT01667731|83227347|FG003|Overall Study|Death|0|||
46683723|NCT01097629|82898899|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46683724|NCT01097629|82898900|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
46683725|NCT01097629|82898893|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
46683726|NCT01097629|82898894|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
46683727|NCT01097629|82898895|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
46683728|NCT01097629|82898896|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46683729|NCT01097629|82898897|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46708082|NCT01172808|82923566|FG003|Overall Study|Lack of Efficacy|0|||
46981449|NCT01667731|83227348|FG004|Overall Study|Death|0|||
46981450|NCT02605837|83227363|FG000|Overall Study|Adverse Event|3|||
46981451|NCT02605837|83227364|FG001|Overall Study|Adverse Event|1|||
46981452|NCT02605837|83227363|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46683730|NCT01097629|82898898|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46683731|NCT01097629|82898899|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46683732|NCT01097629|82898900|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
46683733|NCT01097629|82898893|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
46683734|NCT01097629|82898894|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
46683735|NCT01097629|82898895|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
46683736|NCT01097629|82898896|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46683737|NCT01097629|82898897|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46683738|NCT01097629|82898898|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46683739|NCT01097629|82898899|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46683740|NCT01097629|82898900|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
46683741|NCT01097629|82898893|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
46683742|NCT01097629|82898894|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
46683743|NCT01097629|82898895|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46981453|NCT02605837|83227364|FG001|Overall Study|Non-Compliance with Study Drug|1|||
46981454|NCT02605837|83227363|FG000|Overall Study|Withdrawal by Subject|8|||
46981455|NCT02605837|83227364|FG001|Overall Study|Withdrawal by Subject|8|||
46981456|NCT02605837|83227363|FG000|Overall Study|Physician Decision|0|||
46981457|NCT02605837|83227364|FG001|Overall Study|Physician Decision|1|||
46708083|NCT01172808|82923563|FG000|Overall Study|Protocol Violation|2|||
46981458|NCT02423343|83227377|FG000|Overall Study|Withdrawal by Subject|0|||
46683744|NCT01097629|82898896|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46683745|NCT01097629|82898897|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46683746|NCT01097629|82898898|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46683747|NCT01097629|82898899|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46683748|NCT01097629|82898900|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
46683749|NCT01097629|82898893|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
46683750|NCT01097629|82898894|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
46683751|NCT01097629|82898895|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
46683752|NCT01097629|82898896|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46683753|NCT01097629|82898897|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46683754|NCT01097629|82898898|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46683755|NCT01097629|82898899|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46683756|NCT01097629|82898900|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
46683757|NCT01097629|82898893|FG000|DB RO Phase|Withdrawal by Subject|0|||
46683758|NCT01097629|82898894|FG001|DB RO Phase|Withdrawal by Subject|0|||
46683759|NCT01097629|82898895|FG002|DB RO Phase|Withdrawal by Subject|0|||
46683760|NCT01097629|82898896|FG003|DB RO Phase|Withdrawal by Subject|0|||
46683761|NCT01097629|82898897|FG004|DB RO Phase|Withdrawal by Subject|0|||
46683762|NCT01097629|82898898|FG005|DB RO Phase|Withdrawal by Subject|0|||
46683763|NCT01097629|82898899|FG006|DB RO Phase|Withdrawal by Subject|0|||
46683764|NCT01097629|82898900|FG007|DB RO Phase|Withdrawal by Subject|1|||
46683765|NCT01097629|82898893|FG000|DB RO Phase|Protocol Violation|0|||
46683766|NCT01097629|82898894|FG001|DB RO Phase|Protocol Violation|0|||
46683767|NCT01097629|82898895|FG002|DB RO Phase|Protocol Violation|0|||
46683768|NCT01097629|82898896|FG003|DB RO Phase|Protocol Violation|1|||
46683769|NCT01097629|82898897|FG004|DB RO Phase|Protocol Violation|0|||
46683770|NCT01097629|82898898|FG005|DB RO Phase|Protocol Violation|1|||
46683771|NCT01097629|82898899|FG006|DB RO Phase|Protocol Violation|1|||
46683772|NCT01097629|82898900|FG007|DB RO Phase|Protocol Violation|0|||
46683773|NCT01097629|82898893|FG000|DB RO Phase|Lost to Follow-up|0|||
46683774|NCT01097629|82898894|FG001|DB RO Phase|Lost to Follow-up|0|||
46683775|NCT01097629|82898895|FG002|DB RO Phase|Lost to Follow-up|0|||
46683776|NCT01097629|82898896|FG003|DB RO Phase|Lost to Follow-up|0|||
46683777|NCT01097629|82898897|FG004|DB RO Phase|Lost to Follow-up|0|||
46683778|NCT01097629|82898898|FG005|DB RO Phase|Lost to Follow-up|0|||
46683779|NCT01097629|82898899|FG006|DB RO Phase|Lost to Follow-up|2|||
46683780|NCT01097629|82898900|FG007|DB RO Phase|Lost to Follow-up|0|||
46683781|NCT01324622|82898925|FG000|Overall Study|Lost to Follow-up|7|||
46683782|NCT01324622|82898926|FG001|Overall Study|Lost to Follow-up|7|||
46683783|NCT01324622|82898925|FG000|Overall Study|Death|1|||
46683784|NCT01324622|82898926|FG001|Overall Study|Death|0|||
46683785|NCT01324622|82898925|FG000|Overall Study|Lack of Efficacy|1|||
46683786|NCT01324622|82898926|FG001|Overall Study|Lack of Efficacy|0|||
46683787|NCT01097005|82898933|FG000|Overall Study|Case Report Form not collected|18|||
46683788|NCT01097005|82898933|FG000|Overall Study|Subjects cannot visit the hospital|1|||
46683789|NCT01097005|82898933|FG000|Overall Study|Poor medication compliance|1|||
46683790|NCT01097005|82898933|FG000|Overall Study|No examination data available|244|||
46683791|NCT01097005|82898933|FG000|Overall Study|Deviation from exclusion criteria|37|||
46683792|NCT01097005|82898933|FG000|Overall Study|Adverse Event|14|||
46683793|NCT01097005|82898933|FG000|Overall Study|Discontinuance by complication|50|||
46683794|NCT01096849|82898942|FG000|Overall Study|Consent Withdrawn|1|||
46683795|NCT01096849|82898943|FG001|Overall Study|Consent Withdrawn|4|||
46798727|NCT00567398|83017383|FG000|Overall Study|Physician Decision|0|||
46683796|NCT01096849|82898944|FG002|Overall Study|Consent Withdrawn|2|||
46683797|NCT01096849|82898942|FG000|Overall Study|Lack of Efficacy|0|||
46683798|NCT01096849|82898943|FG001|Overall Study|Lack of Efficacy|2|||
46683799|NCT01096849|82898944|FG002|Overall Study|Lack of Efficacy|0|||
46683800|NCT01096849|82898942|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
46683801|NCT01096849|82898943|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
46683802|NCT01096849|82898944|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
46683803|NCT01096849|82898942|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
46683804|NCT01096849|82898943|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
46683805|NCT01096849|82898944|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
46683806|NCT01096849|82898942|FG000|Overall Study|Administrative Reasons|0|||
46683807|NCT01096849|82898943|FG001|Overall Study|Administrative Reasons|1|||
46683808|NCT01096849|82898944|FG002|Overall Study|Administrative Reasons|2|||
46683809|NCT01096849|82898942|FG000|Overall Study|Lost to Follow-up|1|||
46683810|NCT01096849|82898943|FG001|Overall Study|Lost to Follow-up|3|||
46683811|NCT01096849|82898944|FG002|Overall Study|Lost to Follow-up|1|||
46683812|NCT01324388|82898955|FG000|Part 1 of Study|Adverse Event|2|||
46683813|NCT01324388|82898956|FG001|Part 1 of Study|Adverse Event|0|||
46683814|NCT01324388|82898957|FG002|Part 1 of Study|Adverse Event|0|||
46683815|NCT01324388|82898958|FG003|Part 1 of Study|Adverse Event|0|||
46683816|NCT01324388|82898955|FG000|Part 1 of Study|Protocol Violation|1|||
46683817|NCT01324388|82898956|FG001|Part 1 of Study|Protocol Violation|2|||
46683818|NCT01324388|82898957|FG002|Part 1 of Study|Protocol Violation|0|||
46683819|NCT01324388|82898958|FG003|Part 1 of Study|Protocol Violation|0|||
46798728|NCT00567398|83017384|FG001|Overall Study|Physician Decision|4|||
46798729|NCT00567398|83017383|FG000|Overall Study|Withdrawal by Subject|0|||
46683820|NCT01324388|82898955|FG000|Part 1 of Study|Physician Decision|1|||
46683821|NCT01324388|82898956|FG001|Part 1 of Study|Physician Decision|0|||
46683822|NCT01324388|82898957|FG002|Part 1 of Study|Physician Decision|0|||
46798730|NCT00567398|83017384|FG001|Overall Study|Withdrawal by Subject|2|||
46683823|NCT01324388|82898958|FG003|Part 1 of Study|Physician Decision|0|||
46683824|NCT01324388|82898955|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
46683825|NCT01324388|82898956|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
46683826|NCT01324388|82898957|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
46683827|NCT01324388|82898958|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
46683828|NCT01324388|82898955|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
46683829|NCT01324388|82898956|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
46683830|NCT01324388|82898957|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
46683831|NCT01324388|82898958|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
46683832|NCT01102777|82898972|FG000|Overall Study|Death|2|||
46683833|NCT01102777|82898973|FG001|Overall Study|Death|6|||
46683834|NCT01102777|82898972|FG000|Overall Study|Lost to Follow-up|7|||
46683835|NCT01102777|82898973|FG001|Overall Study|Lost to Follow-up|10|||
46683836|NCT01324310|82898980|FG000|Overall Study|Adverse Event|1|||
46683837|NCT01324310|82898980|FG000|Overall Study|Disease Progression|1|||
46683838|NCT01102231|82898986|FG000|Overall Study|Protocol Violation|3|||
46683839|NCT01102231|82898986|FG000|Overall Study|Lack of Efficacy|2|||
46683840|NCT01102231|82898986|FG000|Overall Study|Death|2|||
46683841|NCT01102231|82898986|FG000|Overall Study|Adverse Event|3|||
46683842|NCT01102231|82898986|FG000|Overall Study|Withdrawal by Subject|1|||
46683843|NCT01102231|82898986|FG000|Overall Study|Did not received the treatment|4|||
46683844|NCT01094743|82898991|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
46683845|NCT01095835|82898999|FG000|Overall Study|Adverse Event|8|||
46683846|NCT01095835|82899000|FG001|Overall Study|Adverse Event|6|||
46683847|NCT01095835|82899001|FG002|Overall Study|Adverse Event|6|||
46683848|NCT01095835|82898999|FG000|Overall Study|Lack of Efficacy|0|||
46683849|NCT01095835|82899000|FG001|Overall Study|Lack of Efficacy|1|||
46683850|NCT01095835|82899001|FG002|Overall Study|Lack of Efficacy|0|||
46683851|NCT01095835|82898999|FG000|Overall Study|Physician Decision|0|||
46683852|NCT01095835|82899000|FG001|Overall Study|Physician Decision|0|||
46683853|NCT01095835|82899001|FG002|Overall Study|Physician Decision|1|||
46683854|NCT01095835|82898999|FG000|Overall Study|Withdrawal by Subject|1|||
46683855|NCT01095835|82899000|FG001|Overall Study|Withdrawal by Subject|3|||
46683856|NCT01095835|82899001|FG002|Overall Study|Withdrawal by Subject|0|||
46683857|NCT01095835|82898999|FG000|Overall Study|Non study compliance|0|||
46683858|NCT01095835|82899000|FG001|Overall Study|Non study compliance|0|||
46683859|NCT01095835|82899001|FG002|Overall Study|Non study compliance|1|||
46683860|NCT01095835|82898999|FG000|Overall Study|Protocol Violation|1|||
46981459|NCT02423343|83227378|FG001|Overall Study|Withdrawal by Subject|1|||
46683861|NCT01095835|82899000|FG001|Overall Study|Protocol Violation|2|||
46683862|NCT01095835|82899001|FG002|Overall Study|Protocol Violation|0|||
46683863|NCT01324232|82899014|FG000|Overall Study|Protocol Violation|0|||
46683864|NCT01324232|82899015|FG001|Overall Study|Protocol Violation|0|||
46683865|NCT01324232|82899016|FG002|Overall Study|Protocol Violation|0|||
46683866|NCT01324232|82899017|FG003|Overall Study|Protocol Violation|2|||
46683867|NCT01324232|82899014|FG000|Overall Study|Missing|0|||
46683868|NCT01324232|82899015|FG001|Overall Study|Missing|0|||
46683869|NCT01324232|82899016|FG002|Overall Study|Missing|1|||
46683870|NCT01324232|82899017|FG003|Overall Study|Missing|0|||
46683871|NCT01324232|82899014|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
46981460|NCT02423343|83227379|FG002|Overall Study|Withdrawal by Subject|0|||
46981461|NCT02423343|83227380|FG003|Overall Study|Withdrawal by Subject|0|||
46981462|NCT02423343|83227381|FG004|Overall Study|Withdrawal by Subject|0|||
46683872|NCT01324232|82899015|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
46981463|NCT02423343|83227382|FG005|Overall Study|Withdrawal by Subject|0|||
46981464|NCT02423343|83227377|FG000|Overall Study|Progressive Disease|0|||
46981465|NCT02423343|83227378|FG001|Overall Study|Progressive Disease|0|||
46981466|NCT02423343|83227379|FG002|Overall Study|Progressive Disease|0|||
46981467|NCT02423343|83227380|FG003|Overall Study|Progressive Disease|0|||
46981468|NCT02423343|83227381|FG004|Overall Study|Progressive Disease|2|||
46981469|NCT02423343|83227382|FG005|Overall Study|Progressive Disease|0|||
46981470|NCT02423343|83227377|FG000|Overall Study|Adverse Event|0|||
46981471|NCT02423343|83227378|FG001|Overall Study|Adverse Event|0|||
46981472|NCT02423343|83227379|FG002|Overall Study|Adverse Event|0|||
46981473|NCT02423343|83227380|FG003|Overall Study|Adverse Event|0|||
46981474|NCT02423343|83227381|FG004|Overall Study|Adverse Event|2|||
46981475|NCT02423343|83227382|FG005|Overall Study|Adverse Event|0|||
46981476|NCT02423343|83227377|FG000|Overall Study|Death|0|||
46981477|NCT02423343|83227378|FG001|Overall Study|Death|0|||
46981478|NCT02423343|83227379|FG002|Overall Study|Death|0|||
46981479|NCT02423343|83227380|FG003|Overall Study|Death|0|||
46981480|NCT02423343|83227381|FG004|Overall Study|Death|1|||
46981481|NCT02423343|83227382|FG005|Overall Study|Death|0|||
46981482|NCT02605447|83227410|FG000|Overall Study|Death|66|||
46981483|NCT02605447|83227410|FG000|Overall Study|Physician Decision|1|||
46981484|NCT02605447|83227410|FG000|Overall Study|Lost to Follow-up|24|||
46981485|NCT02605447|83227410|FG000|Overall Study|Withdrawal by Subject|10|||
46981486|NCT02605447|83227410|FG000|Overall Study|Not disclosed|1|||
46981487|NCT02485899|83227417|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
46981488|NCT02485899|83227418|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
46981489|NCT02485899|83227417|FG000|Overall Study|Withdrawal by Subject|1|||
46981490|NCT02485899|83227418|FG001|Overall Study|Withdrawal by Subject|0|||
46683873|NCT01324232|82899016|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
46981491|NCT02485899|83227417|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
46981492|NCT02485899|83227418|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
46981493|NCT02423109|83227424|FG000|Lens 1|Adverse Event|1|||
46981494|NCT02423109|83227425|FG001|Lens 1|Adverse Event|0|||
46981495|NCT02420691|83227433|FG000|Overall Study|Adverse Event|3|||
46981496|NCT02420691|83227433|FG000|Overall Study|Withdrawal by Subject|3|||
46981497|NCT02406651|83227437|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
46981498|NCT02406261|83227444|FG000|Period 1|Lost to Follow-up|2|||
46981499|NCT02406261|83227445|FG001|Period 1|Lost to Follow-up|0|||
46981500|NCT02406261|83227444|FG000|Period 1|Adverse Event|1|||
46981501|NCT02406261|83227445|FG001|Period 1|Adverse Event|0|||
46683874|NCT01324232|82899017|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
46683875|NCT01324232|82899014|FG000|Overall Study|Lack of Efficacy|2|||
46683876|NCT01324232|82899015|FG001|Overall Study|Lack of Efficacy|1|||
46683877|NCT01324232|82899016|FG002|Overall Study|Lack of Efficacy|2|||
46683878|NCT01324232|82899017|FG003|Overall Study|Lack of Efficacy|2|||
46683879|NCT01324232|82899014|FG000|Overall Study|Participant Refused Medication|0|||
46798731|NCT00567398|83017383|FG000|Overall Study|Renal Transplantation|0|||
46798732|NCT00567398|83017384|FG001|Overall Study|Renal Transplantation|3|||
46798733|NCT00567398|83017383|FG000|Overall Study|Other|1|||
46798734|NCT00567398|83017384|FG001|Overall Study|Other|0|||
46798735|NCT00448708|83017392|FG000|Overall Study|Death|21|||
46798736|NCT00448708|83017393|FG001|Overall Study|Death|17|||
46798737|NCT00448708|83017392|FG000|Overall Study|Withdrawal by Subject|8|||
46798738|NCT00448708|83017393|FG001|Overall Study|Withdrawal by Subject|4|||
46858289|NCT00313313|83074077|FG002|Overall Study|Withdrawal of consent by subject|31|||
46858290|NCT00313313|83074075|FG000|Overall Study|Lost to Follow-up|10|||
46858291|NCT00313313|83074076|FG001|Overall Study|Lost to Follow-up|7|||
46858292|NCT00313313|83074077|FG002|Overall Study|Lost to Follow-up|9|||
46858293|NCT00313313|83074075|FG000|Overall Study|Adverse Event|15|||
46858294|NCT00313313|83074076|FG001|Overall Study|Adverse Event|16|||
46858295|NCT00313313|83074077|FG002|Overall Study|Adverse Event|12|||
46858296|NCT00313313|83074075|FG000|Overall Study|Physician Decision|2|||
46858297|NCT00313313|83074076|FG001|Overall Study|Physician Decision|6|||
46858298|NCT00313313|83074077|FG002|Overall Study|Physician Decision|4|||
46858299|NCT00313313|83074075|FG000|Overall Study|Poor/Noncompliance|3|||
46858300|NCT00313313|83074076|FG001|Overall Study|Poor/Noncompliance|6|||
46981502|NCT02406261|83227444|FG000|Period 2|Physician Decision|0|||
46683880|NCT01324232|82899015|FG001|Overall Study|Participant Refused Medication|1|||
46708084|NCT01172808|82923564|FG001|Overall Study|Protocol Violation|2|||
46798739|NCT00448708|83017392|FG000|Overall Study|Lost to Follow-up|6|||
46798740|NCT00448708|83017393|FG001|Overall Study|Lost to Follow-up|8|||
46708085|NCT01172808|82923565|FG002|Overall Study|Protocol Violation|2|||
46708086|NCT01172808|82923566|FG003|Overall Study|Protocol Violation|0|||
46708087|NCT01172808|82923563|FG000|Overall Study|Lost to Follow-up|0|||
46708088|NCT01172808|82923564|FG001|Overall Study|Lost to Follow-up|1|||
46798741|NCT00448708|83017392|FG000|Overall Study|not listed|0|||
46798742|NCT00448708|83017393|FG001|Overall Study|not listed|2|||
46798743|NCT00706355|83017403|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
46798744|NCT00706355|83017404|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
46858301|NCT00313313|83074077|FG002|Overall Study|Poor/Noncompliance|2|||
46858302|NCT00313313|83074075|FG000|Overall Study|Pregnancy|1|||
46858303|NCT00313313|83074076|FG001|Overall Study|Pregnancy|2|||
46683881|NCT01324232|82899016|FG002|Overall Study|Participant Refused Medication|0|||
46683882|NCT01324232|82899017|FG003|Overall Study|Participant Refused Medication|0|||
46683883|NCT01324232|82899014|FG000|Overall Study|Intercurrent illness|0|||
46683884|NCT01324232|82899015|FG001|Overall Study|Intercurrent illness|0|||
46683885|NCT01324232|82899016|FG002|Overall Study|Intercurrent illness|0|||
46683886|NCT01324232|82899017|FG003|Overall Study|Intercurrent illness|1|||
46683887|NCT01324232|82899014|FG000|Overall Study|Adverse Event|2|||
46683888|NCT01324232|82899015|FG001|Overall Study|Adverse Event|5|||
46683889|NCT01324232|82899016|FG002|Overall Study|Adverse Event|6|||
46683890|NCT01324232|82899017|FG003|Overall Study|Adverse Event|6|||
46858304|NCT00313313|83074077|FG002|Overall Study|Pregnancy|0|||
46683891|NCT01324232|82899014|FG000|Overall Study|Withdrawal by Subject|0|||
46683892|NCT01324232|82899015|FG001|Overall Study|Withdrawal by Subject|3|||
46683893|NCT01324232|82899016|FG002|Overall Study|Withdrawal by Subject|4|||
46683894|NCT01324232|82899017|FG003|Overall Study|Withdrawal by Subject|0|||
46683895|NCT01324232|82899014|FG000|Overall Study|Lost to Follow-up|1|||
46683896|NCT01324232|82899015|FG001|Overall Study|Lost to Follow-up|0|||
46683897|NCT01324232|82899016|FG002|Overall Study|Lost to Follow-up|0|||
46798745|NCT00706355|83017405|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
46798746|NCT00706355|83017406|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
46798747|NCT00706355|83017403|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
46798748|NCT00706355|83017404|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
46798749|NCT00706355|83017405|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
46798750|NCT00706355|83017406|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
46798751|NCT00706355|83017403|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
46798752|NCT00706355|83017404|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
46798753|NCT00706355|83017405|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
46798754|NCT00706355|83017406|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
46798755|NCT00706355|83017403|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
46798756|NCT00706355|83017404|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
46798757|NCT00706355|83017405|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
46798758|NCT00706355|83017406|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
46798759|NCT00706355|83017403|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
46798760|NCT00706355|83017404|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
46798761|NCT00706355|83017405|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
46798762|NCT00706355|83017406|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
46798763|NCT00706355|83017403|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
46798764|NCT00706355|83017404|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
46798765|NCT00706355|83017405|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
46798766|NCT00706355|83017406|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
46798767|NCT00706355|83017403|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
46981503|NCT02406261|83227445|FG001|Period 2|Physician Decision|1|||
46981504|NCT02406261|83227444|FG000|Period 2|Protocol Violation|0|||
46798768|NCT00706355|83017404|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
46981505|NCT02406261|83227445|FG001|Period 2|Protocol Violation|1|||
46981506|NCT02406261|83227444|FG000|Period 2|Withdrawal by Subject|0|||
46981507|NCT02406261|83227445|FG001|Period 2|Withdrawal by Subject|1|||
46683898|NCT01324232|82899017|FG003|Overall Study|Lost to Follow-up|0|||
46981508|NCT02405091|83227455|FG000|Overall Study|Adverse Event|16|||
46981509|NCT02405091|83227456|FG001|Overall Study|Adverse Event|10|||
46683899|NCT01094119|82899034|FG000|Overall Study|Lack of Efficacy|2|||
46683900|NCT01094119|82899035|FG001|Overall Study|Lack of Efficacy|4|||
46683901|NCT01323920|82899041|FG000|Overall Study|Death|5|||
46683902|NCT01323920|82899041|FG000|Overall Study|Withdrawal by Subject|1|||
46683903|NCT01093885|82899045|FG000|Overall Study|Adverse Event|4|||
46683904|NCT01093885|82899045|FG000|Overall Study|Lost to Follow-up|1|||
46683905|NCT01101997|82899050|FG000|Overall Study|Withdrawal by Subject|2|||
46683906|NCT01324830|82899080|FG000|Overall Study|Progressive Disease|3|||
46683907|NCT01324830|82899081|FG001|Overall Study|Progressive Disease|2|||
46683908|NCT01324830|82899082|FG002|Overall Study|Progressive Disease|3|||
46683909|NCT01324830|82899083|FG003|Overall Study|Progressive Disease|3|||
46683910|NCT01324830|82899084|FG004|Overall Study|Progressive Disease|6|||
46683911|NCT01324830|82899085|FG005|Overall Study|Progressive Disease|6|||
46683912|NCT01324830|82899086|FG006|Overall Study|Progressive Disease|3|||
46683913|NCT01324830|82899087|FG007|Overall Study|Progressive Disease|3|||
46683914|NCT01324830|82899088|FG008|Overall Study|Progressive Disease|3|||
46683915|NCT01324830|82899089|FG009|Overall Study|Progressive Disease|6|||
46683916|NCT01324830|82899090|FG010|Overall Study|Progressive Disease|2|||
46683917|NCT01324830|82899091|FG011|Overall Study|Progressive Disease|1|||
46683918|NCT01324830|82899092|FG012|Overall Study|Progressive Disease|1|||
46683919|NCT01324830|82899093|FG013|Overall Study|Progressive Disease|1|||
46683920|NCT01324830|82899094|FG014|Overall Study|Progressive Disease|1|||
46683921|NCT01324830|82899095|FG015|Overall Study|Progressive Disease|3|||
46683922|NCT01324830|82899096|FG016|Overall Study|Progressive Disease|2|||
46683923|NCT01324830|82899097|FG017|Overall Study|Progressive Disease|3|||
46683924|NCT01324830|82899098|FG018|Overall Study|Progressive Disease|4|||
46683925|NCT01324830|82899080|FG000|Overall Study|Dose limiting toxicity|0|||
46683926|NCT01324830|82899081|FG001|Overall Study|Dose limiting toxicity|0|||
46683927|NCT01324830|82899082|FG002|Overall Study|Dose limiting toxicity|0|||
46683928|NCT01324830|82899083|FG003|Overall Study|Dose limiting toxicity|0|||
46683929|NCT01324830|82899084|FG004|Overall Study|Dose limiting toxicity|1|||
46683930|NCT01324830|82899085|FG005|Overall Study|Dose limiting toxicity|0|||
46683931|NCT01324830|82899086|FG006|Overall Study|Dose limiting toxicity|0|||
46683932|NCT01324830|82899087|FG007|Overall Study|Dose limiting toxicity|0|||
46683933|NCT01324830|82899088|FG008|Overall Study|Dose limiting toxicity|0|||
46683934|NCT01324830|82899089|FG009|Overall Study|Dose limiting toxicity|0|||
46683935|NCT01324830|82899090|FG010|Overall Study|Dose limiting toxicity|0|||
46683936|NCT01324830|82899091|FG011|Overall Study|Dose limiting toxicity|0|||
46683937|NCT01324830|82899092|FG012|Overall Study|Dose limiting toxicity|0|||
46683938|NCT01324830|82899093|FG013|Overall Study|Dose limiting toxicity|0|||
46683939|NCT01324830|82899094|FG014|Overall Study|Dose limiting toxicity|0|||
46683940|NCT01324830|82899095|FG015|Overall Study|Dose limiting toxicity|0|||
46683941|NCT01324830|82899096|FG016|Overall Study|Dose limiting toxicity|1|||
46683942|NCT01324830|82899097|FG017|Overall Study|Dose limiting toxicity|1|||
46683943|NCT01324830|82899098|FG018|Overall Study|Dose limiting toxicity|1|||
46683944|NCT01324830|82899080|FG000|Overall Study|Reason not mentioned above|0|||
46683945|NCT01324830|82899081|FG001|Overall Study|Reason not mentioned above|0|||
46683946|NCT01324830|82899082|FG002|Overall Study|Reason not mentioned above|0|||
46683947|NCT01324830|82899083|FG003|Overall Study|Reason not mentioned above|0|||
46683948|NCT01324830|82899084|FG004|Overall Study|Reason not mentioned above|0|||
46683949|NCT01324830|82899085|FG005|Overall Study|Reason not mentioned above|0|||
46683950|NCT01324830|82899086|FG006|Overall Study|Reason not mentioned above|0|||
46981510|NCT02405091|83227457|FG002|Overall Study|Adverse Event|0|||
46981511|NCT02405091|83227455|FG000|Overall Study|Protocol Violation|1|||
46981512|NCT02405091|83227456|FG001|Overall Study|Protocol Violation|0|||
46981513|NCT02405091|83227457|FG002|Overall Study|Protocol Violation|0|||
46981514|NCT02405091|83227455|FG000|Overall Study|Noncompliance|1|||
46981515|NCT02405091|83227456|FG001|Overall Study|Noncompliance|6|||
46981516|NCT02405091|83227457|FG002|Overall Study|Noncompliance|2|||
46981517|NCT02405091|83227455|FG000|Overall Study|Withdrawal by Subject|4|||
46981518|NCT02405091|83227456|FG001|Overall Study|Withdrawal by Subject|8|||
46981519|NCT02405091|83227457|FG002|Overall Study|Withdrawal by Subject|0|||
46981520|NCT02405091|83227455|FG000|Overall Study|Death|0|||
46981521|NCT02405091|83227456|FG001|Overall Study|Death|1|||
46981522|NCT02405091|83227457|FG002|Overall Study|Death|0|||
46981523|NCT02405091|83227455|FG000|Overall Study|Lost to Follow-up|5|||
46981524|NCT02405091|83227456|FG001|Overall Study|Lost to Follow-up|6|||
46981525|NCT02405091|83227457|FG002|Overall Study|Lost to Follow-up|0|||
46981526|NCT02405091|83227455|FG000|Overall Study|Physician Decision|2|||
46981527|NCT02405091|83227456|FG001|Overall Study|Physician Decision|2|||
46683951|NCT01324830|82899087|FG007|Overall Study|Reason not mentioned above|0|||
46683952|NCT01324830|82899088|FG008|Overall Study|Reason not mentioned above|0|||
46683953|NCT01324830|82899089|FG009|Overall Study|Reason not mentioned above|0|||
46683954|NCT01324830|82899090|FG010|Overall Study|Reason not mentioned above|0|||
46683955|NCT01324830|82899091|FG011|Overall Study|Reason not mentioned above|0|||
46683956|NCT01324830|82899092|FG012|Overall Study|Reason not mentioned above|0|||
46683957|NCT01324830|82899093|FG013|Overall Study|Reason not mentioned above|0|||
46683958|NCT01324830|82899094|FG014|Overall Study|Reason not mentioned above|0|||
46683959|NCT01324830|82899095|FG015|Overall Study|Reason not mentioned above|0|||
46683960|NCT01324830|82899096|FG016|Overall Study|Reason not mentioned above|0|||
46981528|NCT02405091|83227457|FG002|Overall Study|Physician Decision|0|||
46981529|NCT02485353|83227468|FG000|Overall Study|Death|1|||
46981530|NCT02485353|83227468|FG000|Overall Study|Disease Progression|1|||
46981531|NCT02603107|83227474|FG000|Randomized Phase|Withdrew consent|8|||
46981532|NCT02603107|83227475|FG001|Randomized Phase|Withdrew consent|15|||
46981533|NCT02603107|83227474|FG000|Randomized Phase|Lost to Follow-up|1|||
46981534|NCT02603107|83227475|FG001|Randomized Phase|Lost to Follow-up|3|||
46981535|NCT02603107|83227474|FG000|Randomized Phase|Adverse Event|2|||
46981536|NCT02603107|83227475|FG001|Randomized Phase|Adverse Event|0|||
46981537|NCT02603107|83227474|FG000|Randomized Phase|Death|1|||
46981538|NCT02603107|83227475|FG001|Randomized Phase|Death|1|||
46981539|NCT02603107|83227474|FG000|Randomized Phase|Non-compliance with study drug|1|||
46981540|NCT02603107|83227475|FG001|Randomized Phase|Non-compliance with study drug|1|||
46981541|NCT02603107|83227474|FG000|Randomized Phase|Investigator's discretion|0|||
46981542|NCT02603107|83227475|FG001|Randomized Phase|Investigator's discretion|1|||
46981543|NCT02603107|83227474|FG000|Randomized Phase|Lack of Efficacy|1|||
46981544|NCT02603107|83227475|FG001|Randomized Phase|Lack of Efficacy|0|||
46981545|NCT02603107|83227474|FG000|Randomized Phase|Protocol Violation|1|||
46981546|NCT02603107|83227475|FG001|Randomized Phase|Protocol Violation|0|||
46981547|NCT02603107|83227474|FG000|Optional Extension Phase|Lost to Follow-up|3|||
46981548|NCT02603107|83227475|FG001|Optional Extension Phase|Lost to Follow-up|3|||
46683961|NCT01324830|82899097|FG017|Overall Study|Reason not mentioned above|1|||
46683962|NCT01324830|82899098|FG018|Overall Study|Reason not mentioned above|0|||
46981549|NCT02603107|83227474|FG000|Optional Extension Phase|Withdrew consent|3|||
46981550|NCT02603107|83227475|FG001|Optional Extension Phase|Withdrew consent|2|||
46981551|NCT02603107|83227474|FG000|Optional Extension Phase|Investigator's discretion|2|||
46981552|NCT02603107|83227475|FG001|Optional Extension Phase|Investigator's discretion|2|||
46981553|NCT02603107|83227474|FG000|Optional Extension Phase|Pregnancy|0|||
46981554|NCT02603107|83227475|FG001|Optional Extension Phase|Pregnancy|3|||
46981555|NCT02603107|83227474|FG000|Optional Extension Phase|Adverse Event|0|||
46981556|NCT02603107|83227475|FG001|Optional Extension Phase|Adverse Event|2|||
46981557|NCT02603107|83227474|FG000|Optional Extension Phase|Not treated in extension phase|0|||
46683963|NCT01324830|82899080|FG000|Overall Study|Adverse Event, serious fatal|0|||
46683964|NCT01324830|82899081|FG001|Overall Study|Adverse Event, serious fatal|1|||
46683965|NCT01324830|82899082|FG002|Overall Study|Adverse Event, serious fatal|0|||
46981558|NCT02603107|83227475|FG001|Optional Extension Phase|Not treated in extension phase|1|||
46981559|NCT02603107|83227474|FG000|Optional Extension Phase|Protocol Violation|1|||
46981560|NCT02603107|83227475|FG001|Optional Extension Phase|Protocol Violation|0|||
46981561|NCT02484729|83227493|FG000|Overall Study|Failure of IntelliCap Error|0|||
46981562|NCT02484729|83227494|FG001|Overall Study|Failure of IntelliCap Error|0|||
46683966|NCT01324830|82899083|FG003|Overall Study|Adverse Event, serious fatal|0|||
46981563|NCT02484729|83227495|FG002|Overall Study|Failure of IntelliCap Error|0|||
46683967|NCT01324830|82899084|FG004|Overall Study|Adverse Event, serious fatal|0|||
46683968|NCT01324830|82899085|FG005|Overall Study|Adverse Event, serious fatal|0|||
46683969|NCT01324830|82899086|FG006|Overall Study|Adverse Event, serious fatal|0|||
46683970|NCT01324830|82899087|FG007|Overall Study|Adverse Event, serious fatal|0|||
46683971|NCT01324830|82899088|FG008|Overall Study|Adverse Event, serious fatal|0|||
46683972|NCT01324830|82899089|FG009|Overall Study|Adverse Event, serious fatal|0|||
46683973|NCT01324830|82899090|FG010|Overall Study|Adverse Event, serious fatal|0|||
46683974|NCT01324830|82899091|FG011|Overall Study|Adverse Event, serious fatal|0|||
46683975|NCT01324830|82899092|FG012|Overall Study|Adverse Event, serious fatal|0|||
46683976|NCT01324830|82899093|FG013|Overall Study|Adverse Event, serious fatal|0|||
46683977|NCT01324830|82899094|FG014|Overall Study|Adverse Event, serious fatal|0|||
46683978|NCT01324830|82899095|FG015|Overall Study|Adverse Event, serious fatal|0|||
46683979|NCT01324830|82899096|FG016|Overall Study|Adverse Event, serious fatal|0|||
46683980|NCT01324830|82899097|FG017|Overall Study|Adverse Event, serious fatal|0|||
46683981|NCT01324830|82899098|FG018|Overall Study|Adverse Event, serious fatal|0|||
46683982|NCT01324830|82899080|FG000|Overall Study|Adverse Event, non-fatal|0|||
46683983|NCT01324830|82899081|FG001|Overall Study|Adverse Event, non-fatal|0|||
46683984|NCT01324830|82899082|FG002|Overall Study|Adverse Event, non-fatal|0|||
46683985|NCT01324830|82899083|FG003|Overall Study|Adverse Event, non-fatal|0|||
46683986|NCT01324830|82899084|FG004|Overall Study|Adverse Event, non-fatal|0|||
46683987|NCT01324830|82899085|FG005|Overall Study|Adverse Event, non-fatal|0|||
46683988|NCT01324830|82899086|FG006|Overall Study|Adverse Event, non-fatal|0|||
46683989|NCT01324830|82899087|FG007|Overall Study|Adverse Event, non-fatal|0|||
46683990|NCT01324830|82899088|FG008|Overall Study|Adverse Event, non-fatal|2|||
46683991|NCT01324830|82899089|FG009|Overall Study|Adverse Event, non-fatal|0|||
46683992|NCT01324830|82899090|FG010|Overall Study|Adverse Event, non-fatal|1|||
46683993|NCT01324830|82899091|FG011|Overall Study|Adverse Event, non-fatal|0|||
46683994|NCT01324830|82899092|FG012|Overall Study|Adverse Event, non-fatal|0|||
46683995|NCT01324830|82899093|FG013|Overall Study|Adverse Event, non-fatal|0|||
46683996|NCT01324830|82899094|FG014|Overall Study|Adverse Event, non-fatal|0|||
46683997|NCT01324830|82899095|FG015|Overall Study|Adverse Event, non-fatal|0|||
46683998|NCT01324830|82899096|FG016|Overall Study|Adverse Event, non-fatal|0|||
46683999|NCT01324830|82899097|FG017|Overall Study|Adverse Event, non-fatal|1|||
46684000|NCT01324830|82899098|FG018|Overall Study|Adverse Event, non-fatal|0|||
46684001|NCT01324830|82899080|FG000|Overall Study|Withdrawal by Subject|0|||
46684002|NCT01324830|82899081|FG001|Overall Study|Withdrawal by Subject|0|||
46684003|NCT01324830|82899082|FG002|Overall Study|Withdrawal by Subject|0|||
46684004|NCT01324830|82899083|FG003|Overall Study|Withdrawal by Subject|0|||
46684005|NCT01324830|82899084|FG004|Overall Study|Withdrawal by Subject|0|||
46684006|NCT01324830|82899085|FG005|Overall Study|Withdrawal by Subject|1|||
46684007|NCT01324830|82899086|FG006|Overall Study|Withdrawal by Subject|0|||
46684008|NCT01324830|82899087|FG007|Overall Study|Withdrawal by Subject|0|||
46684009|NCT01324830|82899088|FG008|Overall Study|Withdrawal by Subject|0|||
46684010|NCT01324830|82899089|FG009|Overall Study|Withdrawal by Subject|0|||
46684011|NCT01324830|82899090|FG010|Overall Study|Withdrawal by Subject|1|||
46684012|NCT01324830|82899091|FG011|Overall Study|Withdrawal by Subject|0|||
46684013|NCT01324830|82899092|FG012|Overall Study|Withdrawal by Subject|0|||
46684014|NCT01324830|82899093|FG013|Overall Study|Withdrawal by Subject|0|||
46684015|NCT01324830|82899094|FG014|Overall Study|Withdrawal by Subject|0|||
46684016|NCT01324830|82899095|FG015|Overall Study|Withdrawal by Subject|0|||
46684017|NCT01324830|82899096|FG016|Overall Study|Withdrawal by Subject|0|||
46684018|NCT01324830|82899097|FG017|Overall Study|Withdrawal by Subject|0|||
46684019|NCT01324830|82899098|FG018|Overall Study|Withdrawal by Subject|1|||
46684020|NCT01324440|82899146|FG000|Overall Study|Subject moved|0|||
46684021|NCT01324440|82899147|FG001|Overall Study|Subject moved|1|||
46684022|NCT01325493|82899155|FG000|Overall Study|Protocol Violation|0|||
46684023|NCT01325493|82899156|FG001|Overall Study|Protocol Violation|1|||
46684024|NCT01325493|82899155|FG000|Overall Study|loss of neuromonitoring signals|0|||
46684025|NCT01325493|82899156|FG001|Overall Study|loss of neuromonitoring signals|2|||
46981564|NCT02484729|83227496|FG003|Overall Study|Failure of IntelliCap Error|0|||
46684026|NCT01325493|82899155|FG000|Overall Study|Allergy|1|||
46684027|NCT01325493|82899156|FG001|Overall Study|Allergy|0|||
46684028|NCT01323972|82899166|FG000|Overall Study|Withdrawal by Subject|1|||
46684029|NCT01323972|82899167|FG001|Overall Study|Withdrawal by Subject|0|||
46684030|NCT01323972|82899168|FG002|Overall Study|Withdrawal by Subject|1|||
46684031|NCT01323972|82899169|FG003|Overall Study|Withdrawal by Subject|0|||
46684032|NCT01323972|82899166|FG000|Overall Study|Migrated/moved from study area|1|||
46981565|NCT02484729|83227497|FG004|Overall Study|Failure of IntelliCap Error|0|||
46981566|NCT02484729|83227498|FG005|Overall Study|Failure of IntelliCap Error|0|||
46981567|NCT02484729|83227499|FG006|Overall Study|Failure of IntelliCap Error|0|||
46981568|NCT02484729|83227500|FG007|Overall Study|Failure of IntelliCap Error|0|||
46981569|NCT02484729|83227501|FG008|Overall Study|Failure of IntelliCap Error|0|||
46981570|NCT02484729|83227502|FG009|Overall Study|Failure of IntelliCap Error|1|||
46981571|NCT02601625|83227540|FG000|Overall Study|Lost to Follow-up|0|||
46981572|NCT02601625|83227541|FG001|Overall Study|Lost to Follow-up|0|||
46981573|NCT02601625|83227542|FG002|Overall Study|Lost to Follow-up|1|||
46981574|NCT02601625|83227543|FG003|Overall Study|Lost to Follow-up|1|||
46981575|NCT02601469|83227569|FG000|Overall Study|Enrolled in Error|1|||
46981576|NCT02601469|83227570|FG001|Overall Study|Enrolled in Error|0|||
46981577|NCT02604589|83227579|FG000|Overall Study|catheter dislodgement|0|||
46981578|NCT02604589|83227580|FG001|Overall Study|catheter dislodgement|0|||
46684033|NCT01323972|82899167|FG001|Overall Study|Migrated/moved from study area|2|||
46684034|NCT01323972|82899168|FG002|Overall Study|Migrated/moved from study area|0|||
46684035|NCT01323972|82899169|FG003|Overall Study|Migrated/moved from study area|0|||
46684036|NCT01323972|82899166|FG000|Overall Study|Lost to Follow-up|0|||
46684037|NCT01323972|82899167|FG001|Overall Study|Lost to Follow-up|1|||
46684038|NCT01323972|82899168|FG002|Overall Study|Lost to Follow-up|1|||
46684039|NCT01323972|82899169|FG003|Overall Study|Lost to Follow-up|1|||
46684040|NCT01325337|82899186|FG000|Overall Study|Adverse Event|0|||
46684041|NCT01325337|82899187|FG001|Overall Study|Adverse Event|2|||
46684042|NCT01325337|82899188|FG002|Overall Study|Adverse Event|2|||
46684043|NCT01325337|82899189|FG003|Overall Study|Adverse Event|1|||
46684044|NCT01325337|82899190|FG004|Overall Study|Adverse Event|2|||
46684045|NCT01325337|82899186|FG000|Overall Study|Lost to Follow-up|2|||
46684046|NCT01325337|82899187|FG001|Overall Study|Lost to Follow-up|2|||
46684047|NCT01325337|82899188|FG002|Overall Study|Lost to Follow-up|2|||
46684048|NCT01325337|82899189|FG003|Overall Study|Lost to Follow-up|1|||
46684049|NCT01325337|82899190|FG004|Overall Study|Lost to Follow-up|2|||
46684050|NCT01325337|82899186|FG000|Overall Study|Personal Reasons|2|||
46684051|NCT01325337|82899187|FG001|Overall Study|Personal Reasons|5|||
46684052|NCT01325337|82899188|FG002|Overall Study|Personal Reasons|4|||
46684053|NCT01325337|82899189|FG003|Overall Study|Personal Reasons|8|||
46684054|NCT01325337|82899190|FG004|Overall Study|Personal Reasons|3|||
46684055|NCT01325337|82899186|FG000|Overall Study|Withdrawal by Subject|1|||
46684056|NCT01325337|82899187|FG001|Overall Study|Withdrawal by Subject|0|||
46684057|NCT01325337|82899188|FG002|Overall Study|Withdrawal by Subject|1|||
46684058|NCT01325337|82899189|FG003|Overall Study|Withdrawal by Subject|0|||
46684059|NCT01325337|82899190|FG004|Overall Study|Withdrawal by Subject|1|||
46684060|NCT01324947|82899202|FG000|Overall Study|Adverse Event|7|||
46684061|NCT01324947|82899202|FG000|Overall Study|Death|10|||
46684062|NCT01324947|82899202|FG000|Overall Study|Other|3|||
46684063|NCT01324947|82899202|FG000|Overall Study|Progressive Disease|50|||
46684064|NCT01324947|82899202|FG000|Overall Study|Withdrawal by Subject|3|||
46684065|NCT01324947|82899202|FG000|Overall Study|1 discontinued before starting drug|1|||
46684066|NCT01101841|82899210|FG000|Overall Study|Adverse Event|15|||
46684067|NCT01101841|82899211|FG001|Overall Study|Adverse Event|15|||
46684068|NCT01101841|82899210|FG000|Overall Study|Lost to Follow-up|9|||
46684069|NCT01101841|82899211|FG001|Overall Study|Lost to Follow-up|3|||
46684070|NCT01101841|82899210|FG000|Overall Study|Withdrawal by Subject|21|||
46684071|NCT01101841|82899211|FG001|Overall Study|Withdrawal by Subject|40|||
46684072|NCT01101841|82899210|FG000|Overall Study|Protocol Violation|1|||
46684073|NCT01101841|82899211|FG001|Overall Study|Protocol Violation|1|||
46684074|NCT01101841|82899210|FG000|Overall Study|Physician Decision|0|||
46684075|NCT01101841|82899211|FG001|Overall Study|Physician Decision|2|||
46684076|NCT01101841|82899210|FG000|Overall Study|Lack of Efficacy|0|||
46981579|NCT02604589|83227581|FG002|Overall Study|catheter dislodgement|1|||
46981580|NCT02601001|83227592|FG000|Dosing Period 2|Adverse Event|0|||
46684077|NCT01101841|82899211|FG001|Overall Study|Lack of Efficacy|2|||
46684078|NCT01101841|82899210|FG000|Overall Study|Other|0|||
46684079|NCT01101841|82899211|FG001|Overall Study|Other|1|||
46684080|NCT01101841|82899210|FG000|Overall Study|Suicidality Tracking Scale|3|||
46684081|NCT01101841|82899211|FG001|Overall Study|Suicidality Tracking Scale|1|||
46684082|NCT01101841|82899210|FG000|Overall Study|Eligibility Criteria|1|||
46684083|NCT01101841|82899211|FG001|Overall Study|Eligibility Criteria|2|||
46684084|NCT01324401|82899220|FG000|Overall Study|Withdrawn before any treatment|0|||
46684085|NCT01324401|82899221|FG001|Overall Study|Withdrawn before any treatment|3|||
46684086|NCT01324401|82899220|FG000|Overall Study|Adverse Event|1|||
46684087|NCT01324401|82899221|FG001|Overall Study|Adverse Event|3|||
46684088|NCT01323660|82899227|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
46684089|NCT01323660|82899228|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
46684090|NCT01323660|82899229|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
46684091|NCT01323660|82899230|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
46684092|NCT01323660|82899231|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
46684093|NCT01323660|82899232|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
46684094|NCT01323660|82899227|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
46684095|NCT01323660|82899228|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
46684096|NCT01323660|82899229|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
46684097|NCT01323660|82899230|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
46684098|NCT01323660|82899231|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
46684099|NCT01323660|82899232|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
46684100|NCT01323660|82899227|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
46684101|NCT01323660|82899228|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
46684102|NCT01323660|82899229|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
46684103|NCT01323660|82899230|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
46684104|NCT01323660|82899231|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
46684105|NCT01323660|82899232|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
46684106|NCT01323660|82899227|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
46684107|NCT01323660|82899228|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
46684108|NCT01323660|82899229|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
46684109|NCT01323660|82899230|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
46684110|NCT01323660|82899231|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
46684111|NCT01323660|82899232|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
46684112|NCT01323660|82899227|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46684113|NCT01323660|82899228|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46684114|NCT01323660|82899229|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46684115|NCT01323660|82899230|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46684116|NCT01323660|82899231|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
46684117|NCT01323660|82899232|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46684118|NCT01323660|82899227|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
46684119|NCT01323660|82899228|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
46684120|NCT01323660|82899229|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
46684121|NCT01323660|82899230|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
46684122|NCT01323660|82899231|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
46684123|NCT01323660|82899232|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
46684124|NCT01323660|82899227|FG000|Washout Period (14 Days)|Adverse Event|0|||
46684125|NCT01323660|82899228|FG001|Washout Period (14 Days)|Adverse Event|0|||
46684126|NCT01323660|82899229|FG002|Washout Period (14 Days)|Adverse Event|0|||
46684127|NCT01323660|82899230|FG003|Washout Period (14 Days)|Adverse Event|0|||
46684128|NCT01323660|82899231|FG004|Washout Period (14 Days)|Adverse Event|1|||
46684129|NCT01323660|82899232|FG005|Washout Period (14 Days)|Adverse Event|0|||
46684130|NCT01323660|82899227|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
46684131|NCT01323660|82899228|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
46684132|NCT01323660|82899229|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
46684133|NCT01323660|82899230|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
46684134|NCT01323660|82899231|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
46684135|NCT01323660|82899232|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
46684136|NCT01323660|82899227|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
46684137|NCT01323660|82899228|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
46684138|NCT01323660|82899229|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
46684139|NCT01323660|82899230|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
46684140|NCT01323660|82899231|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
46684141|NCT01323660|82899232|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
46684142|NCT01323660|82899227|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
46684143|NCT01323660|82899228|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
46684144|NCT01323660|82899229|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
46684145|NCT01323660|82899230|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
46684146|NCT01323660|82899231|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
46684147|NCT01323660|82899232|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
46684148|NCT01323660|82899227|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
46684149|NCT01323660|82899228|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
46684150|NCT01323660|82899229|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
46684151|NCT01323660|82899230|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
46684152|NCT01323660|82899231|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
46684153|NCT01323660|82899232|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
46684154|NCT01323660|82899227|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
46684155|NCT01323660|82899228|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
46684156|NCT01323660|82899229|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
46684157|NCT01323660|82899230|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
46684158|NCT01323660|82899231|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
46684159|NCT01323660|82899232|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
46684160|NCT01323660|82899227|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46684161|NCT01323660|82899228|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46684162|NCT01323660|82899229|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46684163|NCT01323660|82899230|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46858305|NCT00313313|83074075|FG000|Overall Study|Death|0|||
46684164|NCT01323660|82899231|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
46684165|NCT01323660|82899232|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46858306|NCT00313313|83074076|FG001|Overall Study|Death|0|||
46684166|NCT01092637|82899248|FG000|Overall Study|Death|47|||
46684167|NCT01092637|82899249|FG001|Overall Study|Death|49|||
46684168|NCT01324323|82899256|FG000|Overall Study|Withdrawal by Subject|1|||
46858307|NCT00313313|83074077|FG002|Overall Study|Death|2|||
46858308|NCT00313313|83074075|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
46858309|NCT00313313|83074076|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
46858310|NCT00313313|83074077|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
46858311|NCT00312845|83074087|FG000|Overall Study|Adverse Event|19|||
46858312|NCT00312845|83074088|FG001|Overall Study|Adverse Event|5|||
46684169|NCT01323582|82899270|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
46684170|NCT01323582|82899271|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
46684171|NCT01323582|82899270|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
46684172|NCT01323582|82899271|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
46858313|NCT00312845|83074087|FG000|Overall Study|Death|2|||
46858314|NCT00312845|83074088|FG001|Overall Study|Death|2|||
46981581|NCT02601001|83227593|FG001|Dosing Period 2|Adverse Event|0|||
46981582|NCT02601001|83227594|FG002|Dosing Period 2|Adverse Event|0|||
46981583|NCT02601001|83227595|FG003|Dosing Period 2|Adverse Event|0|||
46981584|NCT02601001|83227596|FG004|Dosing Period 2|Adverse Event|0|||
46858315|NCT00312845|83074087|FG000|Overall Study|Withdrawal by Subject|14|||
46981585|NCT02601001|83227597|FG005|Dosing Period 2|Adverse Event|0|||
46684173|NCT01323582|82899270|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
46684174|NCT01323582|82899271|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
46684175|NCT01323621|82899281|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
46684176|NCT01323621|82899282|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
46708089|NCT01172808|82923565|FG002|Overall Study|Lost to Follow-up|1|||
46981586|NCT02601001|83227598|FG006|Dosing Period 2|Adverse Event|1|||
46981587|NCT02604199|83227623|FG000|Overall Study|Pregnancy|0|||
46981588|NCT02604199|83227624|FG001|Overall Study|Pregnancy|0|||
46981589|NCT02604199|83227625|FG002|Overall Study|Pregnancy|0|||
46684177|NCT01323621|82899283|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
46684178|NCT01323621|82899281|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
46684179|NCT01323621|82899282|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
46684180|NCT01323621|82899283|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
46684181|NCT01323621|82899281|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
46684182|NCT01323621|82899282|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
46684183|NCT01323621|82899283|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
46684184|NCT01323621|82899281|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
46684185|NCT01323621|82899282|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
46684186|NCT01323621|82899283|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
46684187|NCT01323621|82899281|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
46684188|NCT01323621|82899282|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
46684189|NCT01323621|82899283|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
46684190|NCT01323621|82899281|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
46684191|NCT01323621|82899282|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
46684192|NCT01323621|82899283|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
46684193|NCT01323621|82899281|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
46684194|NCT01323621|82899282|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
46684195|NCT01323621|82899283|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
46684196|NCT01323621|82899281|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
46684197|NCT01323621|82899282|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
46684198|NCT01323621|82899283|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
46684199|NCT01323621|82899281|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
46684200|NCT01323621|82899282|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
46684201|NCT01323621|82899283|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
46684202|NCT01323621|82899281|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46684203|NCT01323621|82899282|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
46684204|NCT01323621|82899283|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46684205|NCT01323621|82899281|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
46981590|NCT02604199|83227626|FG003|Overall Study|Pregnancy|1|||
46981591|NCT02604199|83227623|FG000|Overall Study|Study terminated by sponsor|0|||
46981592|NCT02604199|83227624|FG001|Overall Study|Study terminated by sponsor|2|||
46684206|NCT01323621|82899282|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
46684207|NCT01323621|82899283|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
46684208|NCT01323621|82899281|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
46684209|NCT01323621|82899282|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
46708090|NCT01172808|82923566|FG003|Overall Study|Lost to Follow-up|3|||
46981593|NCT02604199|83227625|FG002|Overall Study|Study terminated by sponsor|0|||
46684210|NCT01323621|82899283|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
46684211|NCT01323192|82899291|FG000|Overall Study|Adverse Event|6|||
46684212|NCT01323192|82899292|FG001|Overall Study|Adverse Event|1|||
46684213|NCT01323192|82899291|FG000|Overall Study|Withdrawal by Subject|3|||
46684214|NCT01323192|82899292|FG001|Overall Study|Withdrawal by Subject|1|||
46684215|NCT01323192|82899291|FG000|Overall Study|Noncompliance with study medication|0|||
46684216|NCT01323192|82899292|FG001|Overall Study|Noncompliance with study medication|3|||
46684217|NCT01323192|82899291|FG000|Overall Study|Nonmedical reasons|0|||
46684218|NCT01323192|82899292|FG001|Overall Study|Nonmedical reasons|1|||
46684219|NCT01323387|82899298|FG000|Overall Study|Withdrawal by Subject|41|||
46684220|NCT01323387|82899298|FG000|Overall Study|Radiographic Data Unavailable|1|||
46684221|NCT01323387|82899298|FG000|Overall Study|Revision|14|||
46684222|NCT01323387|82899298|FG000|Overall Study|Protocol Violation|12|||
46684223|NCT01323387|82899298|FG000|Overall Study|Randomized but Never Treated|16|||
46684224|NCT01321749|82899306|FG000|Overall Study|Lost to Follow-up|4|||
46684225|NCT01321749|82899307|FG001|Overall Study|Lost to Follow-up|11|||
46684226|NCT01321749|82899306|FG000|Overall Study|Protocol Violation|4|||
46981594|NCT02604199|83227626|FG003|Overall Study|Study terminated by sponsor|2|||
46981595|NCT02604199|83227623|FG000|Overall Study|Withdrawal by Subject|0|||
46684227|NCT01321749|82899307|FG001|Overall Study|Protocol Violation|7|||
46684228|NCT01321749|82899306|FG000|Overall Study|Withdrawal by Subject|5|||
46684229|NCT01321749|82899307|FG001|Overall Study|Withdrawal by Subject|4|||
46981596|NCT02604199|83227624|FG001|Overall Study|Withdrawal by Subject|1|||
46684230|NCT01320735|82899313|FG000|Overall Study|Adverse Event|3|||
46684231|NCT01320735|82899313|FG000|Overall Study|Withdrawal by Subject|3|||
46684232|NCT01320735|82899313|FG000|Overall Study|Lost to Follow-up|13|||
46684233|NCT01320735|82899313|FG000|Overall Study|Administrative Reason|6|||
46684234|NCT01320735|82899313|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
46684235|NCT01320735|82899313|FG000|Overall Study|Protocol Violation|1|||
46684236|NCT01320735|82899313|FG000|Overall Study|Other|1|||
46684237|NCT01320735|82899313|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
46684238|NCT01320735|82899313|FG000|Overall Study|Investigator Unable to be Contacted|17|||
46684239|NCT01320033|82899320|FG000|Overall Study|Lack of Efficacy|0|||
46684240|NCT01320033|82899321|FG001|Overall Study|Lack of Efficacy|0|||
46684241|NCT01320033|82899322|FG002|Overall Study|Lack of Efficacy|1|||
46684242|NCT01320033|82899320|FG000|Overall Study|Adverse Event|9|||
46684243|NCT01320033|82899321|FG001|Overall Study|Adverse Event|7|||
46684244|NCT01320033|82899322|FG002|Overall Study|Adverse Event|8|||
46684245|NCT01320033|82899320|FG000|Overall Study|Withdrawal by Subject|22|||
46684246|NCT01320033|82899321|FG001|Overall Study|Withdrawal by Subject|23|||
46684247|NCT01320033|82899322|FG002|Overall Study|Withdrawal by Subject|23|||
46684248|NCT01320033|82899320|FG000|Overall Study|Protocol Violation|3|||
46684249|NCT01320033|82899321|FG001|Overall Study|Protocol Violation|5|||
46684250|NCT01320033|82899322|FG002|Overall Study|Protocol Violation|3|||
46684251|NCT01320033|82899320|FG000|Overall Study|Lost to Follow-up|22|||
46684252|NCT01320033|82899321|FG001|Overall Study|Lost to Follow-up|26|||
46684253|NCT01320033|82899322|FG002|Overall Study|Lost to Follow-up|17|||
46684254|NCT01320033|82899320|FG000|Overall Study|Other|2|||
46684255|NCT01320033|82899321|FG001|Overall Study|Other|3|||
46684256|NCT01320033|82899322|FG002|Overall Study|Other|1|||
46684257|NCT01101061|82899336|FG000|Overall Study|Adverse Event|0|||
46684258|NCT01101061|82899337|FG001|Overall Study|Adverse Event|0|||
46684259|NCT01101061|82899338|FG002|Overall Study|Adverse Event|1|||
46684260|NCT01101061|82899339|FG003|Overall Study|Adverse Event|0|||
46684261|NCT01101061|82899340|FG004|Overall Study|Adverse Event|0|||
46981597|NCT02604199|83227625|FG002|Overall Study|Withdrawal by Subject|0|||
46981598|NCT02604199|83227626|FG003|Overall Study|Withdrawal by Subject|0|||
46684262|NCT01101061|82899341|FG005|Overall Study|Adverse Event|0|||
46684263|NCT01317615|82899359|FG000|Overall Study|Disease progression|25|||
46981599|NCT02600845|83227639|FG000|Overall Study|Reason Not Specified|3|||
46684264|NCT01317615|82899359|FG000|Overall Study|New cancer therapy|5|||
46684265|NCT01317615|82899359|FG000|Overall Study|Death|6|||
46684266|NCT01317615|82899359|FG000|Overall Study|Withdrawal by Subject|5|||
46684267|NCT01317615|82899359|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46684268|NCT01317615|82899359|FG000|Overall Study|Adverse Event|7|||
46684269|NCT01078675|82899365|FG000|Overall Study|Withdrawal by Subject|7|||
46684270|NCT01078675|82899366|FG001|Overall Study|Withdrawal by Subject|3|||
46684271|NCT01078675|82899365|FG000|Overall Study|Protocol Violation|56|||
46684272|NCT01078675|82899366|FG001|Overall Study|Protocol Violation|0|||
46684273|NCT01078675|82899365|FG000|Overall Study|Provided in CRF for specific reasons|2|||
46684274|NCT01078675|82899366|FG001|Overall Study|Provided in CRF for specific reasons|3|||
46684275|NCT01078675|82899365|FG000|Overall Study|Adverse Event|3|||
46684276|NCT01078675|82899366|FG001|Overall Study|Adverse Event|0|||
46684277|NCT01100437|82899372|FG000|Titration/Stabilization|Adverse Event|0|||
46684278|NCT01100437|82899373|FG001|Titration/Stabilization|Adverse Event|0|||
46684279|NCT01100437|82899374|FG002|Titration/Stabilization|Adverse Event|4|||
46684280|NCT01100437|82899372|FG000|Titration/Stabilization|Non-compliance|0|||
46684281|NCT01100437|82899373|FG001|Titration/Stabilization|Non-compliance|0|||
46684282|NCT01100437|82899374|FG002|Titration/Stabilization|Non-compliance|1|||
46684283|NCT01100437|82899372|FG000|Titration/Stabilization|Sponsor canceled study|0|||
46684284|NCT01100437|82899373|FG001|Titration/Stabilization|Sponsor canceled study|0|||
46684285|NCT01100437|82899374|FG002|Titration/Stabilization|Sponsor canceled study|1|||
46684286|NCT01100437|82899372|FG000|Maintenance|Withdrawal by Subject|0|||
46684287|NCT01100437|82899373|FG001|Maintenance|Withdrawal by Subject|0|||
46684288|NCT01100437|82899374|FG002|Maintenance|Withdrawal by Subject|1|||
46684289|NCT01100437|82899372|FG000|Maintenance|Sponsor termination of study|0|||
46684290|NCT01100437|82899373|FG001|Maintenance|Sponsor termination of study|0|||
46684291|NCT01100437|82899374|FG002|Maintenance|Sponsor termination of study|1|||
46684292|NCT01322490|82899386|FG000|Treatment Period|Adverse Event|12|||
46684293|NCT01322490|82899387|FG001|Treatment Period|Adverse Event|18|||
46684294|NCT01322490|82899388|FG002|Treatment Period|Adverse Event|15|||
46684295|NCT01322490|82899386|FG000|Treatment Period|Death|5|||
46684296|NCT01322490|82899387|FG001|Treatment Period|Death|7|||
46684297|NCT01322490|82899388|FG002|Treatment Period|Death|3|||
46684298|NCT01322490|82899386|FG000|Treatment Period|Lack of Efficacy|89|||
46684299|NCT01322490|82899387|FG001|Treatment Period|Lack of Efficacy|100|||
46684300|NCT01322490|82899388|FG002|Treatment Period|Lack of Efficacy|112|||
46684301|NCT01322490|82899386|FG000|Treatment Period|Physician Decision|0|||
46684302|NCT01322490|82899387|FG001|Treatment Period|Physician Decision|2|||
46981600|NCT02600845|83227639|FG000|Overall Study|Non-compliance with Study Procedures|10|||
46981601|NCT02600845|83227639|FG000|Overall Study|Consent Withdrawal|5|||
46684303|NCT01322490|82899388|FG002|Treatment Period|Physician Decision|1|||
46684304|NCT01322490|82899386|FG000|Treatment Period|Protocol Violation|7|||
46684305|NCT01322490|82899387|FG001|Treatment Period|Protocol Violation|5|||
46684306|NCT01322490|82899388|FG002|Treatment Period|Protocol Violation|4|||
46684307|NCT01322490|82899386|FG000|Treatment Period|Withdrawal by Subject|14|||
46684308|NCT01322490|82899387|FG001|Treatment Period|Withdrawal by Subject|16|||
46981602|NCT02599129|83227645|FG000|Overall Study|Lack of Efficacy|2|||
46981603|NCT02599129|83227646|FG001|Overall Study|Lack of Efficacy|2|||
46981604|NCT02599129|83227645|FG000|Overall Study|Lost to Follow-up|1|||
46981605|NCT02599129|83227646|FG001|Overall Study|Lost to Follow-up|0|||
46981606|NCT02599129|83227645|FG000|Overall Study|Withdrawal by Subject|2|||
46981607|NCT02599129|83227646|FG001|Overall Study|Withdrawal by Subject|1|||
46684309|NCT01322490|82899388|FG002|Treatment Period|Withdrawal by Subject|11|||
46684310|NCT01322490|82899386|FG000|Treatment Period|Non-compliance with study drug|0|||
46981608|NCT02596711|83227655|FG000|Overall Study|Lost to Follow-up|1|||
46981609|NCT02596711|83227656|FG001|Overall Study|Lost to Follow-up|2|||
46684311|NCT01322490|82899387|FG001|Treatment Period|Non-compliance with study drug|0|||
46684312|NCT01322490|82899388|FG002|Treatment Period|Non-compliance with study drug|1|||
46684313|NCT01322490|82899386|FG000|Treatment Period|Other per report|2|||
46684314|NCT01322490|82899387|FG001|Treatment Period|Other per report|2|||
46684315|NCT01322490|82899388|FG002|Treatment Period|Other per report|1|||
46684316|NCT01322490|82899386|FG000|Treatment Period|Randomized but Not Treated|3|||
46684317|NCT01322490|82899387|FG001|Treatment Period|Randomized but Not Treated|3|||
46684318|NCT01322490|82899388|FG002|Treatment Period|Randomized but Not Treated|5|||
46684319|NCT01322490|82899386|FG000|Long Term Follow-up Period|Death|235|||
46684320|NCT01322490|82899387|FG001|Long Term Follow-up Period|Death|239|||
46684321|NCT01322490|82899388|FG002|Long Term Follow-up Period|Death|236|||
46684322|NCT01322490|82899386|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
46684323|NCT01322490|82899387|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
46684324|NCT01322490|82899388|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
46684325|NCT01322490|82899386|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
46684326|NCT01322490|82899387|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
46684327|NCT01322490|82899388|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
46684328|NCT01322490|82899386|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
46684329|NCT01322490|82899387|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
46684330|NCT01322490|82899388|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
46684331|NCT01322490|82899386|FG000|Long Term Follow-up Period|Other per report|3|||
46684332|NCT01322490|82899387|FG001|Long Term Follow-up Period|Other per report|2|||
46684333|NCT01322490|82899388|FG002|Long Term Follow-up Period|Other per report|2|||
46684334|NCT01322490|82899386|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
46684335|NCT01322490|82899387|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
46981610|NCT02596711|83227657|FG002|Overall Study|Lost to Follow-up|3|||
46981611|NCT02596009|83227665|FG000|Overall Study|Administrative problems|0|||
46684336|NCT01322490|82899388|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
46684337|NCT01314261|82899400|FG000|Overall Study|Adverse Event|1|||
46684338|NCT01314261|82899401|FG001|Overall Study|Adverse Event|0|||
46684339|NCT01314261|82899402|FG002|Overall Study|Adverse Event|0|||
46684340|NCT01314261|82899403|FG003|Overall Study|Adverse Event|0|||
46684341|NCT01314261|82899400|FG000|Overall Study|Withdrawal by Subject|0|||
46684342|NCT01314261|82899401|FG001|Overall Study|Withdrawal by Subject|3|||
46798769|NCT00706355|83017405|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
46684343|NCT01314261|82899402|FG002|Overall Study|Withdrawal by Subject|1|||
46684344|NCT01314261|82899403|FG003|Overall Study|Withdrawal by Subject|0|||
46684345|NCT01314261|82899400|FG000|Overall Study|Lost to Follow-up|1|||
46798770|NCT00706355|83017406|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
46798771|NCT00706355|83017403|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
46798772|NCT00706355|83017404|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
46684346|NCT01314261|82899401|FG001|Overall Study|Lost to Follow-up|0|||
46684347|NCT01314261|82899402|FG002|Overall Study|Lost to Follow-up|2|||
46684348|NCT01314261|82899403|FG003|Overall Study|Lost to Follow-up|2|||
46684349|NCT01314261|82899400|FG000|Overall Study|Virologic Failure|0|||
46798773|NCT00706355|83017405|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
46981612|NCT02596009|83227666|FG001|Overall Study|Administrative problems|1|||
46684350|NCT01314261|82899401|FG001|Overall Study|Virologic Failure|1|||
46684351|NCT01314261|82899402|FG002|Overall Study|Virologic Failure|0|||
46684352|NCT01314261|82899403|FG003|Overall Study|Virologic Failure|1|||
46684353|NCT01321710|82899416|FG000|Overall Study|Lost to Follow-up|4|||
46684354|NCT01321710|82899417|FG001|Overall Study|Lost to Follow-up|5|||
46981613|NCT02596009|83227667|FG002|Overall Study|Administrative problems|0|||
46981614|NCT02596009|83227668|FG003|Overall Study|Administrative problems|0|||
46981615|NCT02596009|83227669|FG004|Overall Study|Administrative problems|0|||
46981616|NCT02596009|83227670|FG005|Overall Study|Administrative problems|0|||
46684355|NCT01321710|82899418|FG002|Overall Study|Lost to Follow-up|0|||
46684356|NCT01321008|82899428|FG000|Overall Study|Early Study Termination|1|||
46684357|NCT01320150|82899434|FG000|Overall Study|Protocol Violation|15|||
46684358|NCT01320150|82899434|FG000|Overall Study|Withdrawal by Subject|5|||
46798774|NCT00706355|83017406|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
46981617|NCT02590939|83227678|FG000|Overall Study|Withdrawal by Subject|3|||
46981618|NCT02590939|83227679|FG001|Overall Study|Withdrawal by Subject|1|||
46981619|NCT02590939|83227678|FG000|Overall Study|Failed the nociceptive test|2|||
46981620|NCT02590939|83227679|FG001|Overall Study|Failed the nociceptive test|1|||
46981621|NCT04351087|83227687|FG000|Overall Study|Lost to Follow-up|7|||
46981622|NCT04351087|83227688|FG001|Overall Study|Lost to Follow-up|3|||
46981623|NCT04351087|83227687|FG000|Overall Study|Withdrawal by Subject|3|||
46981624|NCT04351087|83227688|FG001|Overall Study|Withdrawal by Subject|4|||
46981625|NCT04351087|83227687|FG000|Overall Study|Lack of Efficacy|3|||
46981626|NCT04351087|83227688|FG001|Overall Study|Lack of Efficacy|2|||
46981627|NCT02598193|83227694|FG000|Overall Study|Adverse Event|13|||
46981628|NCT02598193|83227694|FG000|Overall Study|Withdrawal by Subject|1|||
46981629|NCT02598193|83227694|FG000|Overall Study|Listed in active lung transplant list|1|||
46981630|NCT02598193|83227694|FG000|Overall Study|Does not want to take Nintedanib|1|||
46981631|NCT02595073|83227700|FG000|Overall Study|Progressive Disease|0|||
46981632|NCT02595073|83227701|FG001|Overall Study|Progressive Disease|1|||
46981633|NCT02595073|83227700|FG000|Overall Study|Protocol Violation|2|||
46981634|NCT02595073|83227701|FG001|Overall Study|Protocol Violation|0|||
46798775|NCT00706355|83017403|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
46798776|NCT00706355|83017404|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
46798777|NCT00706355|83017405|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
46798778|NCT00706355|83017406|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
46798779|NCT00711113|83017418|FG000|Overall Study|Lost to Follow-up|9|||
46798780|NCT00711113|83017418|FG000|Overall Study|Implant lost|2|||
46798781|NCT00710879|83017428|FG000|Overall Study|Lost to Follow-up|2|||
46798782|NCT00710879|83017429|FG001|Overall Study|Lost to Follow-up|1|||
46798783|NCT00710879|83017428|FG000|Overall Study|Protocol Violation|0|||
46798784|NCT00710879|83017429|FG001|Overall Study|Protocol Violation|3|||
46798785|NCT03979274|83017435|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46798786|NCT03979274|83017436|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46858316|NCT00312845|83074088|FG001|Overall Study|Withdrawal by Subject|6|||
46858317|NCT00312845|83074087|FG000|Overall Study|Disease Progression|56|||
46981635|NCT02388165|83227709|FG000|Overall Study|Study terminated by sponsor|5|||
46981636|NCT02388165|83227710|FG001|Overall Study|Study terminated by sponsor|5|||
46981637|NCT02388165|83227709|FG000|Overall Study|Other|11|||
46981638|NCT02388165|83227710|FG001|Overall Study|Other|13|||
46981639|NCT02388165|83227709|FG000|Overall Study|No longer meet eligibility criteria|40|||
46981640|NCT02388165|83227710|FG001|Overall Study|No longer meet eligibility criteria|43|||
46684359|NCT01320150|82899434|FG000|Overall Study|Death|2|||
46798787|NCT00459316|83017446|FG000|Steps 1 & 2|Other eligibility failure|1|||
46798788|NCT00459316|83017447|FG001|Steps 1 & 2|Other eligibility failure|1|||
46684360|NCT01320150|82899434|FG000|Overall Study|Lost to Follow-up|44|||
46684361|NCT01323530|82899445|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
46684362|NCT01323530|82899446|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
46684363|NCT01323530|82899447|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
46684364|NCT01323530|82899448|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
46684365|NCT01323530|82899449|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
46684366|NCT01323530|82899450|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
46684367|NCT01323530|82899451|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
46684368|NCT01323530|82899445|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
46684369|NCT01323530|82899446|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
46684370|NCT01323530|82899447|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
46684371|NCT01323530|82899448|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
46684372|NCT01323530|82899449|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
46684373|NCT01323530|82899450|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
46684374|NCT01323530|82899451|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
46684375|NCT01323530|82899445|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
46684376|NCT01323530|82899446|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
46684377|NCT01323530|82899447|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
46684378|NCT01323530|82899448|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
46684379|NCT01323530|82899449|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
46684380|NCT01323530|82899450|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
46684381|NCT01323530|82899451|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
46684382|NCT01323530|82899445|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
46684383|NCT01323530|82899446|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
46684384|NCT01323530|82899447|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
46684385|NCT01323530|82899448|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
46684386|NCT01323530|82899449|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
46684387|NCT01323530|82899450|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
46684388|NCT01323530|82899451|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
46684389|NCT01323530|82899445|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
46684390|NCT01323530|82899446|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
46684391|NCT01323530|82899447|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
46684392|NCT01323530|82899448|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
46684393|NCT01323530|82899449|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
46684394|NCT01323530|82899450|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
46684395|NCT01323530|82899451|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
46684396|NCT01323530|82899445|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
46684397|NCT01323530|82899446|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
46684398|NCT01323530|82899447|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
46684399|NCT01323530|82899448|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
46798789|NCT00459316|83017448|FG002|Steps 1 & 2|Other eligibility failure|0|||
46798790|NCT00459316|83017446|FG000|Steps 1 & 2|Death|1|||
46798791|NCT00459316|83017447|FG001|Steps 1 & 2|Death|1|||
46684400|NCT01323530|82899449|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
46684401|NCT01323530|82899450|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
46684402|NCT01323530|82899451|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
46684403|NCT01323530|82899445|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
46684404|NCT01323530|82899446|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
46684405|NCT01323530|82899447|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
46684406|NCT01323530|82899448|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
46684407|NCT01323530|82899449|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
46684408|NCT01323530|82899450|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
46798792|NCT00459316|83017448|FG002|Steps 1 & 2|Death|0|||
46684409|NCT01323530|82899451|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
46684410|NCT01323530|82899445|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
46684411|NCT01323530|82899446|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
46684412|NCT01323530|82899447|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
46684413|NCT01323530|82899448|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
46684414|NCT01323530|82899449|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
46798793|NCT00459316|83017446|FG000|Steps 1 & 2|Not able to get to clinic|7|||
46798794|NCT00459316|83017447|FG001|Steps 1 & 2|Not able to get to clinic|4|||
46798795|NCT00459316|83017448|FG002|Steps 1 & 2|Not able to get to clinic|0|||
46798796|NCT00459316|83017446|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
46798797|NCT00459316|83017447|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
46798798|NCT00459316|83017448|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
46798799|NCT00459316|83017446|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
46798800|NCT00459316|83017447|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
46798801|NCT00459316|83017448|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
46798802|NCT00459316|83017446|FG000|Steps 1 & 2|Lost to Follow-up|5|||
46798803|NCT00459316|83017447|FG001|Steps 1 & 2|Lost to Follow-up|0|||
46858318|NCT00312845|83074088|FG001|Overall Study|Disease Progression|77|||
46858319|NCT00312845|83074087|FG000|Overall Study|Lost to Follow-up|2|||
46858320|NCT00312845|83074088|FG001|Overall Study|Lost to Follow-up|0|||
46858321|NCT00312845|83074087|FG000|Overall Study|Other|6|||
46858322|NCT00312845|83074088|FG001|Overall Study|Other|5|||
46858323|NCT00368069|83074096|FG000|Overall Study|Adverse Event|5|||
46858324|NCT00368069|83074097|FG001|Overall Study|Adverse Event|2|||
46858325|NCT00368069|83074096|FG000|Overall Study|Lack of Efficacy|0|||
46858326|NCT00368069|83074097|FG001|Overall Study|Lack of Efficacy|1|||
46858327|NCT00368069|83074096|FG000|Overall Study|Lost to Follow-up|1|||
46858328|NCT00368069|83074097|FG001|Overall Study|Lost to Follow-up|0|||
46858329|NCT00368069|83074096|FG000|Overall Study|Protocol Violation|0|||
46858330|NCT00368069|83074097|FG001|Overall Study|Protocol Violation|2|||
46798804|NCT00459316|83017448|FG002|Steps 1 & 2|Lost to Follow-up|2|||
46798805|NCT00459316|83017446|FG000|Step 3|Withdrawal by Subject|3|||
46798806|NCT00459316|83017447|FG001|Step 3|Withdrawal by Subject|0|||
46798807|NCT00459316|83017448|FG002|Step 3|Withdrawal by Subject|1|||
46798808|NCT05445557|83017471|FG000|Double Blind Part|Lost to Follow-up|1|||
46798809|NCT05074498|83017505|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
46858331|NCT00368069|83074096|FG000|Overall Study|Withdrawal of Consent|2|||
46858332|NCT00368069|83074097|FG001|Overall Study|Withdrawal of Consent|1|||
46858333|NCT00368069|83074096|FG000|Overall Study|no blood sampling possible|0|||
46858334|NCT00368069|83074097|FG001|Overall Study|no blood sampling possible|1|||
46858335|NCT00367991|83074105|FG000|Overall Study|Withdrawal by Subject|1|||
46858336|NCT00367991|83074106|FG001|Overall Study|Withdrawal by Subject|1|||
46858337|NCT00367991|83074105|FG000|Overall Study|Adverse Event|1|||
46858338|NCT00367991|83074106|FG001|Overall Study|Adverse Event|1|||
46858339|NCT00367835|83074114|FG000|Overall Study|Adverse Event|14|||
46858340|NCT00367835|83074115|FG001|Overall Study|Adverse Event|1|||
46858341|NCT00367835|83074114|FG000|Overall Study|Protocol Violation|1|||
46858342|NCT00367835|83074115|FG001|Overall Study|Protocol Violation|7|||
46858343|NCT00367835|83074114|FG000|Overall Study|Withdrawal by Subject|7|||
46684415|NCT01323530|82899450|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
46684416|NCT01323530|82899451|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
46684417|NCT01313637|82899472|FG000|Overall Study|Adverse Event|17|||
46684418|NCT01313637|82899473|FG001|Overall Study|Adverse Event|24|||
46684419|NCT01313637|82899474|FG002|Overall Study|Adverse Event|25|||
46684420|NCT01313637|82899475|FG003|Overall Study|Adverse Event|18|||
46684421|NCT01313637|82899472|FG000|Overall Study|Lack of Efficacy|44|||
46684422|NCT01313637|82899473|FG001|Overall Study|Lack of Efficacy|38|||
46684423|NCT01313637|82899474|FG002|Overall Study|Lack of Efficacy|37|||
46684424|NCT01313637|82899475|FG003|Overall Study|Lack of Efficacy|24|||
46858344|NCT00367835|83074115|FG001|Overall Study|Withdrawal by Subject|6|||
46798810|NCT05074498|83017506|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
46798811|NCT05074498|83017507|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
46798812|NCT05074498|83017508|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
46858345|NCT00367835|83074114|FG000|Overall Study|Lost to Follow-up|1|||
46858346|NCT00367835|83074115|FG001|Overall Study|Lost to Follow-up|4|||
46858347|NCT00367835|83074114|FG000|Overall Study|Lack of Efficacy|3|||
46858348|NCT00367835|83074115|FG001|Overall Study|Lack of Efficacy|12|||
46684425|NCT01313637|82899472|FG000|Overall Study|Protocol Violation|4|||
46858349|NCT00367835|83074114|FG000|Overall Study|Subject in juvenile detention center|1|||
46858350|NCT00367835|83074115|FG001|Overall Study|Subject in juvenile detention center|0|||
46684426|NCT01313637|82899473|FG001|Overall Study|Protocol Violation|3|||
46684427|NCT01313637|82899474|FG002|Overall Study|Protocol Violation|11|||
46684428|NCT01313637|82899475|FG003|Overall Study|Protocol Violation|5|||
46684429|NCT01313637|82899472|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
46684430|NCT01313637|82899473|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
46684431|NCT01313637|82899474|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
46684432|NCT01313637|82899475|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
46684433|NCT01313637|82899472|FG000|Overall Study|Lost to Follow-up|0|||
46684434|NCT01313637|82899473|FG001|Overall Study|Lost to Follow-up|2|||
46684435|NCT01313637|82899474|FG002|Overall Study|Lost to Follow-up|1|||
46684436|NCT01313637|82899475|FG003|Overall Study|Lost to Follow-up|3|||
46684437|NCT01313637|82899472|FG000|Overall Study|Withdrawal by Subject|11|||
46684438|NCT01313637|82899473|FG001|Overall Study|Withdrawal by Subject|13|||
46684439|NCT01313637|82899474|FG002|Overall Study|Withdrawal by Subject|18|||
46684440|NCT01313637|82899475|FG003|Overall Study|Withdrawal by Subject|15|||
46684441|NCT01320722|82899490|FG000|Overall Study|Did not Receive Intervention|3|||
46684442|NCT01320722|82899491|FG001|Overall Study|Did not Receive Intervention|2|||
46684443|NCT01320722|82899492|FG002|Overall Study|Did not Receive Intervention|1|||
46684444|NCT01320722|82899493|FG003|Overall Study|Did not Receive Intervention|1|||
46684445|NCT01320722|82899494|FG004|Overall Study|Did not Receive Intervention|2|||
46684446|NCT01320722|82899490|FG000|Overall Study|Lost to Follow-up|0|||
46684447|NCT01320722|82899491|FG001|Overall Study|Lost to Follow-up|1|||
46798813|NCT05074498|83017509|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
46798814|NCT05074498|83017510|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
46798815|NCT05074498|83017505|FG000|Part 1 (Upto Day 104)|Other|1|||
46798816|NCT05074498|83017506|FG001|Part 1 (Upto Day 104)|Other|0|||
46798817|NCT05074498|83017507|FG002|Part 1 (Upto Day 104)|Other|0|||
46798818|NCT05074498|83017508|FG003|Part 1 (Upto Day 104)|Other|0|||
46798819|NCT05074498|83017509|FG004|Part 1 (Upto Day 104)|Other|0|||
46798820|NCT05074498|83017510|FG005|Part 1 (Upto Day 104)|Other|0|||
46798821|NCT05074498|83017505|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
46798822|NCT05074498|83017506|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
46798823|NCT05074498|83017507|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
46798824|NCT05074498|83017508|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
46684448|NCT01320722|82899492|FG002|Overall Study|Lost to Follow-up|0|||
46684449|NCT01320722|82899493|FG003|Overall Study|Lost to Follow-up|1|||
46684450|NCT01320722|82899494|FG004|Overall Study|Lost to Follow-up|3|||
46684451|NCT01320722|82899490|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
46684452|NCT01320722|82899491|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
46684453|NCT01320722|82899492|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
46684454|NCT01320722|82899493|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
46684455|NCT01320722|82899494|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
46684456|NCT01320722|82899490|FG000|Overall Study|Participant Developed a Rash|0|||
46684457|NCT01320722|82899491|FG001|Overall Study|Participant Developed a Rash|0|||
46684458|NCT01320722|82899492|FG002|Overall Study|Participant Developed a Rash|2|||
46684459|NCT01320722|82899493|FG003|Overall Study|Participant Developed a Rash|1|||
46684460|NCT01320722|82899494|FG004|Overall Study|Participant Developed a Rash|1|||
46684461|NCT01320722|82899490|FG000|Overall Study|Non-compliant with Medication|0|||
46798825|NCT05074498|83017509|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
46798826|NCT05074498|83017510|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
46798827|NCT05074498|83017505|FG000|Part 2 (Upto Day 104)|Death|0|||
46798828|NCT05074498|83017506|FG001|Part 2 (Upto Day 104)|Death|0|||
46798829|NCT05074498|83017507|FG002|Part 2 (Upto Day 104)|Death|0|||
46798830|NCT05074498|83017508|FG003|Part 2 (Upto Day 104)|Death|0|||
46798831|NCT05074498|83017509|FG004|Part 2 (Upto Day 104)|Death|1|||
46798832|NCT05074498|83017510|FG005|Part 2 (Upto Day 104)|Death|0|||
46798833|NCT05074498|83017505|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
46798834|NCT05074498|83017506|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
46798835|NCT05074498|83017507|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
46798836|NCT05074498|83017508|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
46798837|NCT05074498|83017509|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
46798838|NCT05074498|83017510|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
46798839|NCT05074498|83017505|FG000|Part 2 (Upto Day 104)|Other|0|||
46684462|NCT01320722|82899491|FG001|Overall Study|Non-compliant with Medication|0|||
46798840|NCT05074498|83017506|FG001|Part 2 (Upto Day 104)|Other|0|||
46798841|NCT05074498|83017507|FG002|Part 2 (Upto Day 104)|Other|0|||
46798842|NCT05074498|83017508|FG003|Part 2 (Upto Day 104)|Other|0|||
46798843|NCT05074498|83017509|FG004|Part 2 (Upto Day 104)|Other|1|||
46684463|NCT01320722|82899492|FG002|Overall Study|Non-compliant with Medication|1|||
46684464|NCT01320722|82899493|FG003|Overall Study|Non-compliant with Medication|0|||
46684465|NCT01320722|82899494|FG004|Overall Study|Non-compliant with Medication|0|||
46684466|NCT01320722|82899490|FG000|Overall Study|Adverse Event|0|||
46684467|NCT01320722|82899491|FG001|Overall Study|Adverse Event|0|||
46684468|NCT01320722|82899492|FG002|Overall Study|Adverse Event|3|||
46684469|NCT01320722|82899493|FG003|Overall Study|Adverse Event|6|||
46684470|NCT01320722|82899494|FG004|Overall Study|Adverse Event|0|||
46684471|NCT01320722|82899490|FG000|Overall Study|Not Compliant with Study Procedures|0|||
46684472|NCT01320722|82899491|FG001|Overall Study|Not Compliant with Study Procedures|0|||
46858351|NCT00367835|83074114|FG000|Overall Study|refused blood collection|1|||
46858352|NCT00367835|83074115|FG001|Overall Study|refused blood collection|0|||
46684473|NCT01320722|82899492|FG002|Overall Study|Not Compliant with Study Procedures|0|||
46684474|NCT01320722|82899493|FG003|Overall Study|Not Compliant with Study Procedures|4|||
46684475|NCT01320722|82899494|FG004|Overall Study|Not Compliant with Study Procedures|0|||
46684476|NCT01320722|82899490|FG000|Overall Study|Pregnancy|0|||
46684477|NCT01320722|82899491|FG001|Overall Study|Pregnancy|0|||
46684478|NCT01320722|82899492|FG002|Overall Study|Pregnancy|0|||
46858353|NCT00367835|83074114|FG000|Overall Study|Did not respond to calls|1|||
46684479|NCT01320722|82899493|FG003|Overall Study|Pregnancy|1|||
46684480|NCT01320722|82899494|FG004|Overall Study|Pregnancy|0|||
46684481|NCT01320722|82899490|FG000|Overall Study|Started an Exclusionary Medication|0|||
46684482|NCT01320722|82899491|FG001|Overall Study|Started an Exclusionary Medication|0|||
46684483|NCT01320722|82899492|FG002|Overall Study|Started an Exclusionary Medication|0|||
46684484|NCT01320722|82899493|FG003|Overall Study|Started an Exclusionary Medication|0|||
46684485|NCT01320722|82899494|FG004|Overall Study|Started an Exclusionary Medication|1|||
46858354|NCT00367835|83074115|FG001|Overall Study|Did not respond to calls|0|||
46858355|NCT00367835|83074114|FG000|Overall Study|History of lead poisoning|0|||
46684486|NCT01320722|82899490|FG000|Overall Study|Withdrew due to Health Condition|0|||
46684487|NCT01320722|82899491|FG001|Overall Study|Withdrew due to Health Condition|0|||
46684488|NCT01320722|82899492|FG002|Overall Study|Withdrew due to Health Condition|0|||
46981641|NCT02388165|83227709|FG000|Overall Study|Withdrawal of consent|31|||
46684489|NCT01320722|82899493|FG003|Overall Study|Withdrew due to Health Condition|0|||
46684490|NCT01320722|82899494|FG004|Overall Study|Withdrew due to Health Condition|1|||
46684491|NCT01313559|82899511|FG000|Overall Study|Withdrawal by Subject|1|||
46684492|NCT01313559|82899512|FG001|Overall Study|Withdrawal by Subject|2|||
46684493|NCT01313559|82899511|FG000|Overall Study|Disease progression|1|||
46684494|NCT01313559|82899512|FG001|Overall Study|Disease progression|0|||
46684495|NCT01313559|82899511|FG000|Overall Study|Rising PSA|2|||
46981642|NCT02388165|83227710|FG001|Overall Study|Withdrawal of consent|32|||
46684496|NCT01313559|82899512|FG001|Overall Study|Rising PSA|0|||
46981643|NCT02388165|83227709|FG000|Overall Study|Lost to Follow-up|19|||
46684497|NCT01312779|82899518|FG000|Overall Study|Withdrawal by Subject|2|||
46684498|NCT01312779|82899518|FG000|Overall Study|Death|3|||
46684499|NCT01312779|82899518|FG000|Overall Study|Not Implanted with Device|27|||
46981644|NCT02388165|83227710|FG001|Overall Study|Lost to Follow-up|20|||
46981645|NCT02388165|83227709|FG000|Overall Study|Death|13|||
46684500|NCT01312467|82899531|FG000|Overall Study|Adverse Event|4|||
46684501|NCT01312467|82899531|FG000|Overall Study|Lost to Follow-up|1|||
46684502|NCT01312467|82899531|FG000|Overall Study|Withdrawal by Subject|2|||
46684503|NCT01312467|82899531|FG000|Overall Study|Deported to country of origin|1|||
46684504|NCT01312467|82899531|FG000|Overall Study|Another medical condition|1|||
46684505|NCT01312467|82899531|FG000|Overall Study|Ineligible|4|||
46684506|NCT01310127|82899538|FG000|Overall Study|Protocol Violation|1|||
46684507|NCT01310127|82899539|FG001|Overall Study|Protocol Violation|1|||
46684508|NCT01310127|82899538|FG000|Overall Study|advanced psc cataract outlier|1|||
46684509|NCT01310127|82899539|FG001|Overall Study|advanced psc cataract outlier|0|||
46684510|NCT01309893|82899545|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
46684511|NCT01309893|82899546|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
46684512|NCT01309893|82899545|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
46684513|NCT01309893|82899546|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
46684514|NCT01318902|82899556|FG000|Overall Study|Symptomatic Deterioration|0|||
46684515|NCT01318902|82899557|FG001|Overall Study|Symptomatic Deterioration|1|||
46684516|NCT01318902|82899558|FG002|Overall Study|Symptomatic Deterioration|1|||
46684517|NCT01318902|82899559|FG003|Overall Study|Symptomatic Deterioration|2|||
46684518|NCT01318902|82899556|FG000|Overall Study|Withdrawal by Patient|0|||
46684519|NCT01318902|82899557|FG001|Overall Study|Withdrawal by Patient|1|||
46684520|NCT01318902|82899558|FG002|Overall Study|Withdrawal by Patient|0|||
46684521|NCT01318902|82899559|FG003|Overall Study|Withdrawal by Patient|3|||
46684522|NCT01318902|82899556|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
46684523|NCT01318902|82899557|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
46684524|NCT01318902|82899558|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
46684525|NCT01318902|82899559|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
46684526|NCT01318902|82899556|FG000|Overall Study|Adverse Event|0|||
46684527|NCT01318902|82899557|FG001|Overall Study|Adverse Event|1|||
46684528|NCT01318902|82899558|FG002|Overall Study|Adverse Event|0|||
46684529|NCT01318902|82899559|FG003|Overall Study|Adverse Event|0|||
46684530|NCT01318902|82899556|FG000|Overall Study|Terminated by Sponsor|0|||
46684531|NCT01318902|82899557|FG001|Overall Study|Terminated by Sponsor|0|||
46684532|NCT01318902|82899558|FG002|Overall Study|Terminated by Sponsor|1|||
46684533|NCT01318902|82899559|FG003|Overall Study|Terminated by Sponsor|0|||
46684534|NCT01313858|82899574|FG000|Overall Study|Premature Treatment Termination|251|||
46684535|NCT01313858|82899575|FG001|Overall Study|Premature Treatment Termination|219|||
46798844|NCT05074498|83017510|FG005|Part 2 (Upto Day 104)|Other|0|||
46798845|NCT04871113|83017547|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
46684536|NCT01313858|82899576|FG002|Overall Study|Premature Treatment Termination|191|||
46684537|NCT01313858|82899574|FG000|Overall Study|Lost to Follow-up|35|||
46684538|NCT01313858|82899575|FG001|Overall Study|Lost to Follow-up|51|||
46684539|NCT01313858|82899576|FG002|Overall Study|Lost to Follow-up|47|||
46798846|NCT04871113|83017548|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
46858356|NCT00367835|83074115|FG001|Overall Study|History of lead poisoning|1|||
46858357|NCT03267940|83074127|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
46858358|NCT03267940|83074128|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
46858359|NCT03267940|83074129|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
46858360|NCT03267940|83074130|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
46858361|NCT03267940|83074131|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
46858362|NCT03267940|83074132|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
46858363|NCT03267940|83074127|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
46858364|NCT03267940|83074128|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
46858365|NCT03267940|83074129|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
46858366|NCT03267940|83074130|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
46858367|NCT03267940|83074131|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
46858368|NCT03267940|83074132|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
46858369|NCT03267940|83074127|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
46858370|NCT03267940|83074128|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
46858371|NCT03267940|83074129|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
46858372|NCT03267940|83074130|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
46798847|NCT04871113|83017549|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
46798848|NCT04871113|83017550|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
46798849|NCT04871113|83017551|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
46798850|NCT04871113|83017552|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|7|||
46798851|NCT04871113|83017553|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|5|||
46798852|NCT04871113|83017554|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
46798853|NCT04871113|83017555|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
46798854|NCT04871113|83017556|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
46798855|NCT04871113|83017547|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798856|NCT04871113|83017548|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798857|NCT04871113|83017549|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798858|NCT04871113|83017550|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798859|NCT04871113|83017551|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798860|NCT04871113|83017552|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798861|NCT04871113|83017553|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|1|||
46798862|NCT04871113|83017554|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798863|NCT04871113|83017555|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798864|NCT04871113|83017556|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
46798865|NCT04715230|83017580|FG000|Overall Study|Withdrawal by Subject|1|||
46798866|NCT04715230|83017581|FG001|Overall Study|Withdrawal by Subject|0|||
46798867|NCT04715230|83017582|FG002|Overall Study|Withdrawal by Subject|0|||
46798868|NCT04715230|83017580|FG000|Overall Study|Lost to Follow-up|0|||
46798869|NCT04715230|83017581|FG001|Overall Study|Lost to Follow-up|5|||
46798870|NCT04715230|83017582|FG002|Overall Study|Lost to Follow-up|1|||
46798871|NCT04710368|83017590|FG000|Overall Study|Withdrawal by Subject|9|||
46798872|NCT04710368|83017590|FG000|Overall Study|Lost to Follow-up|4|||
46798873|NCT04710368|83017590|FG000|Overall Study|Death|2|||
46798874|NCT04710368|83017590|FG000|Overall Study|Patient preference|11|||
46684540|NCT01090765|82899588|FG000|Overall Study|Patient withdrew consent|0|||
46798875|NCT04710368|83017590|FG000|Overall Study|Treatment discontinuation|1|||
46798876|NCT04590963|83017622|FG000|Overall Study|Death|118|||
46798877|NCT04590963|83017623|FG001|Overall Study|Death|59|||
46798878|NCT04590963|83017622|FG000|Overall Study|Lost to Follow-up|1|||
46684541|NCT01090765|82899589|FG001|Overall Study|Patient withdrew consent|0|||
46684542|NCT01090765|82899590|FG002|Overall Study|Patient withdrew consent|0|||
46798879|NCT04590963|83017623|FG001|Overall Study|Lost to Follow-up|1|||
46798880|NCT04590963|83017622|FG000|Overall Study|Progressive disease|0|||
46798881|NCT04590963|83017623|FG001|Overall Study|Progressive disease|1|||
46684543|NCT01090765|82899591|FG003|Overall Study|Patient withdrew consent|0|||
46684544|NCT01090765|82899592|FG004|Overall Study|Patient withdrew consent|1|||
46684545|NCT01090765|82899593|FG005|Overall Study|Patient withdrew consent|1|||
46684546|NCT01090765|82899588|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
46684547|NCT01090765|82899589|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
46684548|NCT01090765|82899590|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
46684549|NCT01090765|82899591|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
46684550|NCT01090765|82899592|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
46684551|NCT01090765|82899593|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
46684552|NCT01090765|82899588|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
46684553|NCT01090765|82899589|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
46684554|NCT01090765|82899590|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
46684555|NCT01090765|82899591|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
46684556|NCT01090765|82899592|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
46684557|NCT01090765|82899593|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
46684558|NCT01313780|82899610|FG000|Overall Study|Lack of Efficacy|4|||
46684559|NCT01313780|82899611|FG001|Overall Study|Lack of Efficacy|2|||
46684560|NCT01313780|82899610|FG000|Overall Study|Adverse Event|6|||
46684561|NCT01313780|82899611|FG001|Overall Study|Adverse Event|11|||
46684562|NCT01313780|82899610|FG000|Overall Study|Withdrawal by Subject|2|||
46684563|NCT01313780|82899611|FG001|Overall Study|Withdrawal by Subject|8|||
46684564|NCT01313780|82899610|FG000|Overall Study|Protocol Violation|10|||
46684565|NCT01313780|82899611|FG001|Overall Study|Protocol Violation|4|||
46684566|NCT01313780|82899610|FG000|Overall Study|missing data|3|||
46684567|NCT01313780|82899611|FG001|Overall Study|missing data|3|||
46684568|NCT01090453|82899619|FG000|Overall Study|Withdrawal by Subject|1|||
46684569|NCT01090453|82899620|FG001|Overall Study|Withdrawal by Subject|2|||
46684570|NCT01090453|82899619|FG000|Overall Study|Lost to Follow-up|7|||
46684571|NCT01090453|82899620|FG001|Overall Study|Lost to Follow-up|7|||
46684572|NCT01090453|82899619|FG000|Overall Study|Non serious AEs|1|||
46684573|NCT01090453|82899620|FG001|Overall Study|Non serious AEs|0|||
46684574|NCT01090453|82899619|FG000|Overall Study|Protocol Violation|2|||
46684575|NCT01090453|82899620|FG001|Overall Study|Protocol Violation|0|||
46798882|NCT04590963|83017622|FG000|Overall Study|Study terminated by sponsor|103|||
46798883|NCT04590963|83017623|FG001|Overall Study|Study terminated by sponsor|50|||
46798884|NCT04590963|83017622|FG000|Overall Study|Withdrawal by Subject|15|||
46798885|NCT04590963|83017623|FG001|Overall Study|Withdrawal by Subject|8|||
46798886|NCT04590963|83017622|FG000|Overall Study|Ongoing at data cut-off|9|||
46798887|NCT04590963|83017623|FG001|Overall Study|Ongoing at data cut-off|4|||
46798888|NCT04590963|83017622|FG000|Overall Study|Screen failure|1|||
46798889|NCT04590963|83017623|FG001|Overall Study|Screen failure|0|||
46798890|NCT04493216|83017633|FG000|Overall Study|Adverse Event|1|||
46684576|NCT01090453|82899619|FG000|Overall Study|Other|2|||
46684577|NCT01090453|82899620|FG001|Overall Study|Other|4|||
46684578|NCT01090453|82899619|FG000|Overall Study|Eligibility Criteria|0|||
46684579|NCT01090453|82899620|FG001|Overall Study|Eligibility Criteria|1|||
46684580|NCT01171612|82899626|FG000|Overall Study|Lost to Follow-up|51|||
46684581|NCT01171534|82899635|FG000|Overall Study|Lost to Follow-up|0|||
46684582|NCT01171534|82899636|FG001|Overall Study|Lost to Follow-up|2|||
46684583|NCT01171534|82899635|FG000|Overall Study|screen failure|0|||
46684584|NCT01171534|82899636|FG001|Overall Study|screen failure|1|||
46684585|NCT01170598|82899642|FG000|Overall Study|Withdrawal by Subject|1|||
46684586|NCT01170598|82899642|FG000|Overall Study|Death|3|||
46684587|NCT01170598|82899642|FG000|Overall Study|Lost to Follow-up|1|||
46684588|NCT01170598|82899642|FG000|Overall Study|Refused|1|||
46684589|NCT01170364|82899648|FG000|Overall Study|Protocol Violation|4|||
46684590|NCT01170364|82899649|FG001|Overall Study|Protocol Violation|1|||
46684591|NCT01076179|82899655|FG000|Overall Study|Withdrawal by Subject|1|||
46684592|NCT01170208|82899663|FG000|Overall Study|Withdrawal by Subject|5|||
46684593|NCT01170208|82899664|FG001|Overall Study|Withdrawal by Subject|0|||
46684594|NCT01170208|82899665|FG002|Overall Study|Withdrawal by Subject|1|||
46684595|NCT01170208|82899663|FG000|Overall Study|Protocol Violation|1|||
46684596|NCT01170208|82899664|FG001|Overall Study|Protocol Violation|0|||
46684597|NCT01170208|82899665|FG002|Overall Study|Protocol Violation|1|||
46684598|NCT01313624|82899678|FG000|Double-Blind Phase|Adverse Event|27|||
46684599|NCT01313624|82899679|FG001|Double-Blind Phase|Adverse Event|4|||
46684600|NCT01313624|82899678|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
46684601|NCT01313624|82899679|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
46684602|NCT01313624|82899678|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46684603|NCT01313624|82899679|FG001|Double-Blind Phase|Lost to Follow-up|2|||
46684604|NCT01313624|82899678|FG000|Double-Blind Phase|Physician Decision|1|||
46684605|NCT01313624|82899679|FG001|Double-Blind Phase|Physician Decision|0|||
46684606|NCT01313624|82899678|FG000|Double-Blind Phase|Lack of Efficacy|1|||
46684607|NCT01313624|82899679|FG001|Double-Blind Phase|Lack of Efficacy|0|||
46684608|NCT01313624|82899678|FG000|Open-Label Phase|Adverse Event|1|||
46684609|NCT01313624|82899679|FG001|Open-Label Phase|Adverse Event|10|||
46684610|NCT01313624|82899678|FG000|Open-Label Phase|Withdrawal by Subject|2|||
46684611|NCT01313624|82899679|FG001|Open-Label Phase|Withdrawal by Subject|2|||
46684612|NCT01313624|82899678|FG000|Open-Label Phase|Lost to Follow-up|1|||
46684613|NCT01313624|82899679|FG001|Open-Label Phase|Lost to Follow-up|1|||
46684614|NCT01169350|82899687|FG000|Overall Study|Physician Decision|3|||
46684615|NCT01169350|82899687|FG000|Overall Study|Lost to Follow-up|2|||
46684616|NCT01169038|82899691|FG000|Overall Study|Death|1|||
46684617|NCT01169038|82899691|FG000|Overall Study|Adverse Event|5|||
46684618|NCT01169038|82899691|FG000|Overall Study|Required antibiotic administration|1|||
46684619|NCT01167634|82899699|FG000|Overall Study|Lost to Follow-up|1|||
46684620|NCT01167634|82899700|FG001|Overall Study|Lost to Follow-up|3|||
46684621|NCT01167634|82899701|FG002|Overall Study|Lost to Follow-up|3|||
46684622|NCT01167634|82899702|FG003|Overall Study|Lost to Follow-up|4|||
46684623|NCT01167634|82899699|FG000|Overall Study|Withdrawal by Subject|1|||
46684624|NCT01167634|82899700|FG001|Overall Study|Withdrawal by Subject|1|||
46684625|NCT01167634|82899701|FG002|Overall Study|Withdrawal by Subject|0|||
46684626|NCT01167634|82899702|FG003|Overall Study|Withdrawal by Subject|0|||
46684627|NCT01166386|82899714|FG000|Overall Study|Withdrawal by Subject|3|||
46684628|NCT01166386|82899715|FG001|Overall Study|Withdrawal by Subject|5|||
46684629|NCT01114828|82899723|FG000|Overall Study|Adverse Event|1|||
46684630|NCT01114828|82899724|FG001|Overall Study|Adverse Event|1|||
46981646|NCT02388165|83227710|FG001|Overall Study|Death|10|||
46981647|NCT02388165|83227709|FG000|Overall Study|Adverse Event|3|||
46981648|NCT02388165|83227710|FG001|Overall Study|Adverse Event|5|||
46981649|NCT02388165|83227709|FG000|Overall Study|Did not meet entrance criteria|5|||
46981650|NCT02388165|83227710|FG001|Overall Study|Did not meet entrance criteria|2|||
46684631|NCT01114828|82899723|FG000|Overall Study|Lack of Efficacy|0|||
46684632|NCT01114828|82899724|FG001|Overall Study|Lack of Efficacy|2|||
46684633|NCT01114828|82899723|FG000|Overall Study|Protocol Violation|2|||
46684634|NCT01114828|82899724|FG001|Overall Study|Protocol Violation|0|||
46684635|NCT01114828|82899723|FG000|Overall Study|Withdrawal by Subject|0|||
46684636|NCT01114828|82899724|FG001|Overall Study|Withdrawal by Subject|1|||
46684637|NCT01313312|82899730|FG000|Overall Study|Adverse Event|5|||
46684638|NCT01313312|82899730|FG000|Overall Study|Withdrawal by Subject|18|||
46684639|NCT01313312|82899730|FG000|Overall Study|Lack of Efficacy|3|||
46684640|NCT01313312|82899730|FG000|Overall Study|Investigator Decision|1|||
46684641|NCT01313312|82899730|FG000|Overall Study|Observational Phase|1|||
46684642|NCT01313312|82899730|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
46684643|NCT01313312|82899730|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
46684644|NCT01114672|82899736|FG000|Overall Study|Death|0|||
46684645|NCT01114672|82899737|FG001|Overall Study|Death|1|||
46684646|NCT01114672|82899736|FG000|Overall Study|Withdrawal by Subject|2|||
46684647|NCT01114672|82899737|FG001|Overall Study|Withdrawal by Subject|1|||
46684648|NCT01114672|82899736|FG000|Overall Study|Lost to Follow-up|1|||
46684649|NCT01114672|82899737|FG001|Overall Study|Lost to Follow-up|0|||
46684650|NCT01114672|82899736|FG000|Overall Study|transplanted|1|||
46684651|NCT01114672|82899737|FG001|Overall Study|transplanted|0|||
46684652|NCT01114516|82899745|FG000|Overall Study|Lost to Follow-up|2|||
46684653|NCT01114516|82899746|FG001|Overall Study|Lost to Follow-up|1|||
46684654|NCT01114438|82899752|FG000|Overall Study|Adverse Event|10|||
46684655|NCT01114438|82899752|FG000|Overall Study|concomitant medication|1|||
46684656|NCT01114438|82899752|FG000|Overall Study|Physician Decision|1|||
46684657|NCT01114438|82899752|FG000|Overall Study|Withdrawal by Subject|2|||
46684658|NCT01313078|82899761|FG000|Overall Study|Death|1|||
46981651|NCT02404545|83227718|FG000|Overall Study|Sponsor Termination|6|||
46981652|NCT02404545|83227719|FG001|Overall Study|Sponsor Termination|6|||
46684659|NCT01313078|82899761|FG000|Overall Study|Discontinued study drug|1|||
46684660|NCT01313078|82899761|FG000|Overall Study|Withdrawal by Subject|1|||
46684661|NCT01114360|82899765|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
46684662|NCT01114360|82899766|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
46798891|NCT04493216|83017634|FG001|Overall Study|Adverse Event|4|||
46684663|NCT01310036|82899786|FG000|Overall Study|Administrative/other|10|||
46684664|NCT01310036|82899786|FG000|Overall Study|Withdrew Consent|11|||
46684665|NCT01310036|82899786|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
46684666|NCT01310036|82899786|FG000|Overall Study|Progression of Disease|164|||
46684667|NCT01310036|82899786|FG000|Overall Study|Death|1|||
46684668|NCT01310036|82899786|FG000|Overall Study|Adverse event or intercurrent illness|12|||
46684669|NCT01309100|82899790|FG000|Overall Study|Protocol Violation|1|||
46684670|NCT01309100|82899790|FG000|Overall Study|Positive Slit lamp finding|1|||
46684671|NCT01308788|82899799|FG000|2-year Treatment|medication change by treating physician|4|||
46684672|NCT01308788|82899800|FG001|2-year Treatment|medication change by treating physician|11|||
46684673|NCT01075321|82899806|FG000|Overall Study|Withdrawal by Subject|0|||
46684674|NCT01075321|82899807|FG001|Overall Study|Withdrawal by Subject|0|||
46684675|NCT01075321|82899808|FG002|Overall Study|Withdrawal by Subject|1|||
46684676|NCT01075321|82899809|FG003|Overall Study|Withdrawal by Subject|1|||
46684677|NCT01075321|82899806|FG000|Overall Study|Protocol Violation|0|||
46684678|NCT01075321|82899807|FG001|Overall Study|Protocol Violation|0|||
46684679|NCT01075321|82899808|FG002|Overall Study|Protocol Violation|1|||
46684680|NCT01075321|82899809|FG003|Overall Study|Protocol Violation|0|||
46684681|NCT01075321|82899806|FG000|Overall Study|Treatment Incomplete due to progression|1|||
46684682|NCT01075321|82899807|FG001|Overall Study|Treatment Incomplete due to progression|0|||
46684683|NCT01075321|82899808|FG002|Overall Study|Treatment Incomplete due to progression|0|||
46684684|NCT01075321|82899809|FG003|Overall Study|Treatment Incomplete due to progression|0|||
46684685|NCT01075321|82899806|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
46684686|NCT01075321|82899807|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
46684687|NCT01075321|82899808|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
46684688|NCT01075321|82899809|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
46684689|NCT01114204|82899823|FG000|Overall Study|Adverse Event|3|||
46684690|NCT01114204|82899824|FG001|Overall Study|Adverse Event|2|||
46684691|NCT01114204|82899823|FG000|Overall Study|Lost to Follow-up|1|||
46684692|NCT01114204|82899824|FG001|Overall Study|Lost to Follow-up|0|||
46684693|NCT01114204|82899823|FG000|Overall Study|Withdrawal by Subject|10|||
46684694|NCT01114204|82899824|FG001|Overall Study|Withdrawal by Subject|6|||
46684695|NCT01114204|82899823|FG000|Overall Study|Death|1|||
46684696|NCT01114204|82899824|FG001|Overall Study|Death|0|||
46684697|NCT01114204|82899823|FG000|Overall Study|Other-Personal reasons|2|||
46684698|NCT01114204|82899824|FG001|Overall Study|Other-Personal reasons|0|||
46684699|NCT01114204|82899823|FG000|Overall Study|Other-Medical monitor request|1|||
46684700|NCT01114204|82899824|FG001|Overall Study|Other-Medical monitor request|0|||
46684701|NCT01114204|82899823|FG000|Overall Study|Other-Participant request|2|||
46684702|NCT01114204|82899824|FG001|Overall Study|Other-Participant request|0|||
46684703|NCT01114204|82899823|FG000|Overall Study|Other-Protocol Violation|1|||
46684704|NCT01114204|82899824|FG001|Overall Study|Other-Protocol Violation|0|||
46684705|NCT01075243|82899833|FG000|Overall Study|Lost to Follow-up|5|||
46684706|NCT01075243|82899834|FG001|Overall Study|Lost to Follow-up|2|||
46684707|NCT01075243|82899835|FG002|Overall Study|Lost to Follow-up|0|||
46684708|NCT01075243|82899833|FG000|Overall Study|Withdrawal by Subject|1|||
46684709|NCT01075243|82899834|FG001|Overall Study|Withdrawal by Subject|1|||
46684710|NCT01075243|82899835|FG002|Overall Study|Withdrawal by Subject|0|||
46684711|NCT01308476|82899847|FG000|Overall Study|Lost to Follow-up|2|||
46684712|NCT01308476|82899848|FG001|Overall Study|Lost to Follow-up|2|||
46684713|NCT01308476|82899847|FG000|Overall Study|Other|1|||
46684714|NCT01308476|82899848|FG001|Overall Study|Other|0|||
46684715|NCT01078441|82899854|FG000|Overall Study|Withdrawal by Subject|1|||
46684716|NCT01308008|82899860|FG000|4 Weeks|Illness, disinterest, time|9|||
46684717|NCT01308008|82899861|FG001|4 Weeks|Illness, disinterest, time|2|||
46684718|NCT01113892|82899869|FG000|Overall Study|Lost to Follow-up|2|||
46684719|NCT01113892|82899870|FG001|Overall Study|Lost to Follow-up|2|||
46684720|NCT01113892|82899869|FG000|Overall Study|Withdrawal by Subject|1|||
46684721|NCT01113892|82899870|FG001|Overall Study|Withdrawal by Subject|1|||
46684722|NCT01113892|82899869|FG000|Overall Study|Death|2|||
46684723|NCT01113892|82899870|FG001|Overall Study|Death|4|||
46684724|NCT01113892|82899869|FG000|Overall Study|Graft no longer evaluable|9|||
46684725|NCT01113892|82899870|FG001|Overall Study|Graft no longer evaluable|9|||
46684726|NCT01090063|82899876|FG000|Screen|Screen Failed|4|||
46684727|NCT01090063|82899876|FG000|Treatment|Withdrawal by Subject|4|||
46684728|NCT01113580|82899892|FG000|Overall Study|Protocol Violation|1|||
46684729|NCT01113580|82899893|FG001|Overall Study|Protocol Violation|0|||
46684730|NCT01306214|82899902|FG000|Overall Study|Death|0|||
46684731|NCT01306214|82899903|FG001|Overall Study|Death|0|||
46684732|NCT01306214|82899904|FG002|Overall Study|Death|1|||
46684733|NCT01306214|82899902|FG000|Overall Study|Lost to Follow-up|3|||
46684734|NCT01306214|82899903|FG001|Overall Study|Lost to Follow-up|5|||
46684735|NCT01306214|82899904|FG002|Overall Study|Lost to Follow-up|4|||
46684736|NCT01306214|82899902|FG000|Overall Study|Withdrawal by Subject|24|||
46684737|NCT01306214|82899903|FG001|Overall Study|Withdrawal by Subject|22|||
46684738|NCT01306214|82899904|FG002|Overall Study|Withdrawal by Subject|16|||
46684739|NCT01306214|82899902|FG000|Overall Study|Not treated|1|||
46684740|NCT01306214|82899903|FG001|Overall Study|Not treated|1|||
46684741|NCT01306214|82899904|FG002|Overall Study|Not treated|1|||
46684742|NCT01077739|82899914|FG000|Overall Study|Premature withdrawal|1|||
46684743|NCT01077739|82899915|FG001|Overall Study|Premature withdrawal|3|||
46684744|NCT01077739|82899914|FG000|Overall Study|Withdrawal by Subject|1|||
46684745|NCT01077739|82899915|FG001|Overall Study|Withdrawal by Subject|0|||
46684746|NCT01077739|82899914|FG000|Overall Study|Death|0|||
46684747|NCT01077739|82899915|FG001|Overall Study|Death|3|||
46684748|NCT01077739|82899914|FG000|Overall Study|Unacceptable toxicity|1|||
46684749|NCT01077739|82899915|FG001|Overall Study|Unacceptable toxicity|2|||
46798892|NCT04493216|83017635|FG002|Overall Study|Adverse Event|5|||
46798893|NCT04493216|83017636|FG003|Overall Study|Adverse Event|2|||
46798894|NCT04493216|83017633|FG000|Overall Study|Lost to Follow-up|1|||
46798895|NCT04493216|83017634|FG001|Overall Study|Lost to Follow-up|1|||
46798896|NCT04493216|83017635|FG002|Overall Study|Lost to Follow-up|0|||
46798897|NCT04493216|83017636|FG003|Overall Study|Lost to Follow-up|1|||
46798898|NCT04493216|83017633|FG000|Overall Study|Physician Decision|0|||
46798899|NCT04493216|83017634|FG001|Overall Study|Physician Decision|0|||
46684750|NCT01077739|82899914|FG000|Overall Study|Other|2|||
46684751|NCT01077739|82899915|FG001|Overall Study|Other|2|||
46684752|NCT01306058|82899921|FG000|Overall Study|Death|1|||
46684753|NCT01306058|82899921|FG000|Overall Study|Enrolled but did not get treatment|1|||
46684754|NCT01305200|82899928|FG000|Overall Study|Physician Decision|4|||
46684755|NCT01305200|82899929|FG001|Overall Study|Physician Decision|6|||
46684756|NCT01305200|82899930|FG002|Overall Study|Physician Decision|1|||
46684757|NCT01305200|82899928|FG000|Overall Study|Withdrawal by Subject|24|||
46798900|NCT04493216|83017635|FG002|Overall Study|Physician Decision|1|||
46684758|NCT01305200|82899929|FG001|Overall Study|Withdrawal by Subject|21|||
46798901|NCT04493216|83017636|FG003|Overall Study|Physician Decision|0|||
46798902|NCT04493216|83017633|FG000|Overall Study|Withdrawal by Subject|1|||
46798903|NCT04493216|83017634|FG001|Overall Study|Withdrawal by Subject|1|||
46798904|NCT04493216|83017635|FG002|Overall Study|Withdrawal by Subject|1|||
46798905|NCT04493216|83017636|FG003|Overall Study|Withdrawal by Subject|2|||
46798906|NCT04493216|83017633|FG000|Overall Study|Ongoing|18|||
46798907|NCT04493216|83017634|FG001|Overall Study|Ongoing|18|||
46858373|NCT03267940|83074131|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
46858374|NCT03267940|83074132|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
46858375|NCT03267940|83074127|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
46858376|NCT03267940|83074128|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
46858377|NCT03267940|83074129|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
46858378|NCT03267940|83074130|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
46858379|NCT03267940|83074131|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
46858380|NCT03267940|83074132|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
46858381|NCT03267940|83074127|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
46858382|NCT03267940|83074128|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
46798908|NCT04493216|83017635|FG002|Overall Study|Ongoing|16|||
46798909|NCT04493216|83017636|FG003|Overall Study|Ongoing|16|||
46798910|NCT04493216|83017633|FG000|Overall Study|Site closed|14|||
46798911|NCT04493216|83017634|FG001|Overall Study|Site closed|15|||
46798912|NCT04493216|83017635|FG002|Overall Study|Site closed|11|||
46798913|NCT04493216|83017636|FG003|Overall Study|Site closed|11|||
46858383|NCT03267940|83074129|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
46684759|NCT01305200|82899930|FG002|Overall Study|Withdrawal by Subject|1|||
46798914|NCT04493216|83017633|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|4|||
46798915|NCT04493216|83017634|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
46684760|NCT01305200|82899928|FG000|Overall Study|Ineligible|1|||
46684761|NCT01305200|82899929|FG001|Overall Study|Ineligible|2|||
46684762|NCT01305200|82899930|FG002|Overall Study|Ineligible|1|||
46684763|NCT01305200|82899928|FG000|Overall Study|Death|0|||
46684764|NCT01305200|82899929|FG001|Overall Study|Death|2|||
46684765|NCT01305200|82899930|FG002|Overall Study|Death|0|||
46684766|NCT01077271|82899940|FG000|Overall Study|Parental desire|8|||
46858384|NCT03267940|83074130|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
46684767|NCT01077271|82899940|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
46684768|NCT01077271|82899940|FG000|Overall Study|Noncompliance|2|||
46684769|NCT01077271|82899940|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
46684770|NCT01077271|82899940|FG000|Overall Study|Changed doctors|2|||
46684771|NCT01077271|82899940|FG000|Overall Study|Parents thought too many injections|2|||
46684772|NCT01077271|82899940|FG000|Overall Study|End of RSV season nearly reached|1|||
46684773|NCT01077271|82899940|FG000|Overall Study|Mother unconvinced of the necessity|1|||
46684774|NCT01305044|82899954|FG000|Overall Study|Withdrawal by Subject|3|||
46684775|NCT01305044|82899955|FG001|Overall Study|Withdrawal by Subject|6|||
46684776|NCT01304498|82899963|FG000|Overall Study|Adverse Event|1|||
46684777|NCT01304498|82899964|FG001|Overall Study|Adverse Event|1|||
46684778|NCT01304498|82899963|FG000|Overall Study|Withdrawal by Subject|2|||
46684779|NCT01304498|82899964|FG001|Overall Study|Withdrawal by Subject|3|||
46684780|NCT01304498|82899963|FG000|Overall Study|Protocol Violation|1|||
46684781|NCT01304498|82899964|FG001|Overall Study|Protocol Violation|0|||
46684782|NCT01304498|82899963|FG000|Overall Study|Lost to Follow-up|2|||
46684783|NCT01304498|82899964|FG001|Overall Study|Lost to Follow-up|1|||
46684784|NCT01077193|82899970|FG000|Overall Study|Lost to Follow-up|1|||
46684785|NCT01077193|82899970|FG000|Overall Study|Withdrawal by Subject|2|||
46684786|NCT01077193|82899970|FG000|Overall Study|Lack of Efficacy|1|||
46684787|NCT01077193|82899970|FG000|Overall Study|Study Terminated by Sponsor|40|||
46684788|NCT01074931|82899974|FG000|Overall Study|Economic reasons|1|||
46684789|NCT01074931|82899974|FG000|Overall Study|Death|5|||
46684790|NCT01303172|82899984|FG000|Overall Study|Physician Decision|9|||
46684791|NCT01303172|82899985|FG001|Overall Study|Physician Decision|6|||
46684792|NCT01303172|82899984|FG000|Overall Study|Adverse Event|5|||
46684793|NCT01303172|82899985|FG001|Overall Study|Adverse Event|2|||
46798916|NCT04493216|83017635|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|8|||
46798917|NCT04493216|83017636|FG003|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
46798918|NCT04493216|83017633|FG000|Overall Study|Protocol Deviation|1|||
46798919|NCT04493216|83017634|FG001|Overall Study|Protocol Deviation|2|||
46798920|NCT04493216|83017635|FG002|Overall Study|Protocol Deviation|0|||
46798921|NCT04493216|83017636|FG003|Overall Study|Protocol Deviation|2|||
46798922|NCT04329949|83017667|FG000|Overall Study|Death|36|||
46798923|NCT04329949|83017667|FG000|Overall Study|Withdrawal by Subject|4|||
46798924|NCT04329949|83017667|FG000|Overall Study|Termination of study by sponsor|3|||
46798925|NCT04290624|83017673|FG000|Overall Study|Adverse Event|1|||
46798926|NCT04290624|83017674|FG001|Overall Study|Adverse Event|0|||
46858385|NCT03267940|83074131|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
46684794|NCT01303172|82899984|FG000|Overall Study|Withdrawal by Subject|4|||
46684795|NCT01303172|82899985|FG001|Overall Study|Withdrawal by Subject|2|||
46684796|NCT01303172|82899984|FG000|Overall Study|Death|20|||
46798927|NCT04288115|83017682|FG000|Overall Study|Withdrawal by Subject|0|||
46798928|NCT04288115|83017683|FG001|Overall Study|Withdrawal by Subject|1|||
46798929|NCT04288115|83017682|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
46684797|NCT01303172|82899985|FG001|Overall Study|Death|7|||
46684798|NCT01303172|82899984|FG000|Overall Study|Lack of Efficacy|25|||
46684799|NCT01303172|82899985|FG001|Overall Study|Lack of Efficacy|17|||
46858386|NCT03267940|83074132|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
46858387|NCT03267940|83074127|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
46858388|NCT03267940|83074128|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
46858389|NCT03267940|83074129|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
46858390|NCT03267940|83074130|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
46858391|NCT03267940|83074131|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
46858392|NCT03267940|83074132|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
46858393|NCT03267940|83074127|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
46858394|NCT03267940|83074128|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
46858395|NCT03267940|83074129|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
46858396|NCT03267940|83074130|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
46858397|NCT03267940|83074131|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
46858398|NCT03267940|83074132|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
46858399|NCT03267940|83074127|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
46858400|NCT03267940|83074128|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
46858401|NCT03267940|83074129|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
46858402|NCT03267940|83074130|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
46858403|NCT03267940|83074131|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
46858404|NCT03267940|83074132|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
46858405|NCT03267940|83074127|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
46858406|NCT03267940|83074128|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
46858407|NCT03267940|83074129|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
46858408|NCT03267940|83074130|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
46858409|NCT03267940|83074131|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
46981653|NCT02420379|83227728|FG000|Overall Study|Withdrawal by Subject|0|||
46981654|NCT02420379|83227729|FG001|Overall Study|Withdrawal by Subject|3|||
46981655|NCT02420379|83227728|FG000|Overall Study|Unable to complete due to schooling|0|||
46981656|NCT02420379|83227729|FG001|Overall Study|Unable to complete due to schooling|1|||
46684800|NCT01302938|82899994|FG000|Overall Study|Withdrawal by Subject|1|||
46684801|NCT01302938|82899995|FG001|Overall Study|Withdrawal by Subject|0|||
46684802|NCT01302938|82899994|FG000|Overall Study|Adverse Event|1|||
46684803|NCT01302938|82899995|FG001|Overall Study|Adverse Event|0|||
46684804|NCT01302548|82900004|FG000|Overall Study|Lost to Follow-up|2|||
46684805|NCT01302548|82900005|FG001|Overall Study|Lost to Follow-up|1|||
46684806|NCT01076959|82900011|FG000|Overall Study|Adverse Event|767|||
46684807|NCT01076959|82900011|FG000|Overall Study|Lack of Efficacy|849|||
46684808|NCT01076959|82900011|FG000|Overall Study|Non-compliance|274|||
46684809|NCT01076959|82900011|FG000|Overall Study|Lost to Follow-up|241|||
46684810|NCT01076959|82900011|FG000|Overall Study|Other|119|||
46684811|NCT01302392|82900030|FG000|Overall Study|Lost to Follow-up|1|||
46684812|NCT01302392|82900031|FG001|Overall Study|Lost to Follow-up|0|||
46684813|NCT01302392|82900030|FG000|Overall Study|Withdrawal by Subject|6|||
46684814|NCT01302392|82900031|FG001|Overall Study|Withdrawal by Subject|1|||
46684815|NCT01076647|82900039|FG000|Overall Study|Adverse Event|4|||
46684816|NCT01076647|82900040|FG001|Overall Study|Adverse Event|1|||
46684817|NCT01076647|82900039|FG000|Overall Study|Lack of Efficacy|0|||
46684818|NCT01076647|82900040|FG001|Overall Study|Lack of Efficacy|1|||
46684819|NCT01076647|82900039|FG000|Overall Study|Protocol Violation|7|||
46684820|NCT01076647|82900040|FG001|Overall Study|Protocol Violation|9|||
46684821|NCT01076647|82900039|FG000|Overall Study|Withdrawal criteria|2|||
46798930|NCT04288115|83017683|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
46798931|NCT04287868|83017694|FG000|Overall Study|Screening fail|1|||
46798932|NCT04287868|83017695|FG001|Overall Study|Screening fail|0|||
46798933|NCT04276935|83017706|FG000|Overall Study|Lost to Follow-up|3|||
46798934|NCT04191096|83017712|FG000|Overall Study|Death|102|||
46798935|NCT04191096|83017713|FG001|Overall Study|Death|89|||
46798936|NCT04191096|83017712|FG000|Overall Study|Lost to Follow-up|1|||
46798937|NCT04191096|83017713|FG001|Overall Study|Lost to Follow-up|1|||
46798938|NCT04191096|83017712|FG000|Overall Study|Withdrawal by Subject|5|||
46798939|NCT04191096|83017713|FG001|Overall Study|Withdrawal by Subject|5|||
46798940|NCT04191096|83017712|FG000|Overall Study|Participants Ongoing|518|||
46798941|NCT04191096|83017713|FG001|Overall Study|Participants Ongoing|530|||
46684822|NCT01076647|82900040|FG001|Overall Study|Withdrawal criteria|2|||
46684823|NCT01076647|82900039|FG000|Overall Study|Unclassified|12|||
46684824|NCT01076647|82900040|FG001|Overall Study|Unclassified|12|||
46684825|NCT01074307|82900048|FG000|Overall Study|No primary endpoint evaluation|14|||
46684826|NCT01074307|82900049|FG001|Overall Study|No primary endpoint evaluation|6|||
46684827|NCT01074307|82900048|FG000|Overall Study|Exclusion criterion|0|||
46798942|NCT04145531|83017723|FG000|Part A|Adverse Event|2|||
46684828|NCT01074307|82900049|FG001|Overall Study|Exclusion criterion|1|||
46684829|NCT01074307|82900048|FG000|Overall Study|Protocol Violation|8|||
46798943|NCT04145531|83017724|FG001|Part A|Adverse Event|12|||
46858410|NCT03267940|83074132|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
46858411|NCT03296566|83074152|FG000|Overall Study|Lost to Follow-up|19|||
46798944|NCT04145531|83017725|FG002|Part A|Adverse Event|6|||
46684830|NCT01074307|82900049|FG001|Overall Study|Protocol Violation|5|||
46684831|NCT01076335|82900055|FG000|Overall Study|Withdrawal by Subject|3|||
46684832|NCT01076335|82900055|FG000|Overall Study|Withdrawal without treatment|1|||
46684833|NCT01309737|82900062|FG000|Week 0 to 16|Death|1|||
46798945|NCT04145531|83017726|FG003|Part A|Adverse Event|0|||
46798946|NCT04145531|83017723|FG000|Part A|Death|1|||
46798947|NCT04145531|83017724|FG001|Part A|Death|2|||
46798948|NCT04145531|83017725|FG002|Part A|Death|0|||
46798949|NCT04145531|83017726|FG003|Part A|Death|0|||
46798950|NCT04145531|83017723|FG000|Part A|Physician Decision|2|||
46798951|NCT04145531|83017724|FG001|Part A|Physician Decision|5|||
46798952|NCT04145531|83017725|FG002|Part A|Physician Decision|2|||
46858412|NCT03296566|83074153|FG001|Overall Study|Lost to Follow-up|46|||
46858413|NCT03296566|83074152|FG000|Overall Study|Withdrawal by Subject|0|||
46858414|NCT03296566|83074153|FG001|Overall Study|Withdrawal by Subject|3|||
46858415|NCT03755882|83074163|FG000|Period 1|Protocol Violation|1|||
46858416|NCT03755882|83074164|FG001|Period 1|Protocol Violation|0|||
46858417|NCT03755882|83074163|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
46684834|NCT01309737|82900063|FG001|Week 0 to 16|Death|0|||
46684835|NCT01309737|82900064|FG002|Week 0 to 16|Death|1|||
46684836|NCT01309737|82900065|FG003|Week 0 to 16|Death|0|||
46684837|NCT01309737|82900066|FG004|Week 0 to 16|Death|0|||
46684838|NCT01309737|82900062|FG000|Week 0 to 16|Adverse Event|11|||
46684839|NCT01309737|82900063|FG001|Week 0 to 16|Adverse Event|10|||
46684840|NCT01309737|82900064|FG002|Week 0 to 16|Adverse Event|5|||
46684841|NCT01309737|82900065|FG003|Week 0 to 16|Adverse Event|0|||
46684842|NCT01309737|82900066|FG004|Week 0 to 16|Adverse Event|0|||
46858418|NCT03755882|83074164|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
46858419|NCT00312377|83074172|FG000|Overall Study|Death|403|||
46858420|NCT00312377|83074173|FG001|Overall Study|Death|418|||
46684843|NCT01309737|82900062|FG000|Week 0 to 16|Lack of Efficacy|15|||
46684844|NCT01309737|82900063|FG001|Week 0 to 16|Lack of Efficacy|2|||
46684845|NCT01309737|82900064|FG002|Week 0 to 16|Lack of Efficacy|24|||
46684846|NCT01309737|82900065|FG003|Week 0 to 16|Lack of Efficacy|0|||
46684847|NCT01309737|82900066|FG004|Week 0 to 16|Lack of Efficacy|0|||
46684848|NCT01309737|82900062|FG000|Week 0 to 16|Lost to Follow-up|7|||
46684849|NCT01309737|82900063|FG001|Week 0 to 16|Lost to Follow-up|8|||
46684850|NCT01309737|82900064|FG002|Week 0 to 16|Lost to Follow-up|3|||
46684851|NCT01309737|82900065|FG003|Week 0 to 16|Lost to Follow-up|0|||
46684852|NCT01309737|82900066|FG004|Week 0 to 16|Lost to Follow-up|0|||
46684853|NCT01309737|82900062|FG000|Week 0 to 16|Withdrawal by Subject|7|||
46684854|NCT01309737|82900063|FG001|Week 0 to 16|Withdrawal by Subject|6|||
46798953|NCT04145531|83017726|FG003|Part A|Physician Decision|0|||
46798954|NCT04145531|83017723|FG000|Part A|Progressive disease|0|||
46798955|NCT04145531|83017724|FG001|Part A|Progressive disease|2|||
46798956|NCT04145531|83017725|FG002|Part A|Progressive disease|1|||
46798957|NCT04145531|83017726|FG003|Part A|Progressive disease|0|||
46798958|NCT04145531|83017723|FG000|Part A|Protocol deviation|0|||
46858421|NCT00312377|83074172|FG000|Overall Study|Withdrawal by Subject|23|||
46858422|NCT00312377|83074173|FG001|Overall Study|Withdrawal by Subject|30|||
46858423|NCT00312377|83074172|FG000|Overall Study|Lost to Follow-up|9|||
46858424|NCT00312377|83074173|FG001|Overall Study|Lost to Follow-up|12|||
46684855|NCT01309737|82900064|FG002|Week 0 to 16|Withdrawal by Subject|7|||
46798959|NCT04145531|83017724|FG001|Part A|Protocol deviation|0|||
46684856|NCT01309737|82900065|FG003|Week 0 to 16|Withdrawal by Subject|0|||
46798960|NCT04145531|83017725|FG002|Part A|Protocol deviation|1|||
46684857|NCT01309737|82900066|FG004|Week 0 to 16|Withdrawal by Subject|0|||
46684858|NCT01309737|82900062|FG000|Week 0 to 16|Other|10|||
46684859|NCT01309737|82900063|FG001|Week 0 to 16|Other|14|||
46858425|NCT00312377|83074172|FG000|Overall Study|Non-compliance|0|||
46684860|NCT01309737|82900064|FG002|Week 0 to 16|Other|4|||
46798961|NCT04145531|83017726|FG003|Part A|Protocol deviation|0|||
46798962|NCT04145531|83017723|FG000|Part A|Withdrawal by parent or guardian|1|||
46858426|NCT00312377|83074173|FG001|Overall Study|Non-compliance|2|||
46858427|NCT00312377|83074172|FG000|Overall Study|Randomised but never received treatment|6|||
46858428|NCT00312377|83074173|FG001|Overall Study|Randomised but never received treatment|6|||
46858429|NCT00312377|83074172|FG000|Overall Study|Discontinue treatment survival follow up|202|||
46858430|NCT00312377|83074173|FG001|Overall Study|Discontinue treatment survival follow up|200|||
46858431|NCT00312377|83074172|FG000|Overall Study|Site ended participation in study|1|||
46858432|NCT00312377|83074173|FG001|Overall Study|Site ended participation in study|0|||
46858433|NCT03295318|83074182|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
46858434|NCT03295318|83074183|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
46858435|NCT03295318|83074184|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
46858436|NCT03295318|83074182|FG000|Overall Study|Death|1|||
46858437|NCT03295318|83074183|FG001|Overall Study|Death|1|||
46858438|NCT03295318|83074184|FG002|Overall Study|Death|1|||
46858439|NCT03295318|83074182|FG000|Overall Study|Protocol Violation|4|||
46858440|NCT03295318|83074183|FG001|Overall Study|Protocol Violation|3|||
46858441|NCT03295318|83074184|FG002|Overall Study|Protocol Violation|3|||
46858442|NCT03295318|83074182|FG000|Overall Study|Withdrawal by Subject|0|||
46858443|NCT03295318|83074183|FG001|Overall Study|Withdrawal by Subject|0|||
46858444|NCT03295318|83074184|FG002|Overall Study|Withdrawal by Subject|1|||
46981657|NCT02420379|83227728|FG000|Overall Study|Transitioned to commercial drug|1|||
46684861|NCT01309737|82900065|FG003|Week 0 to 16|Other|0|||
46684862|NCT01309737|82900066|FG004|Week 0 to 16|Other|0|||
46684863|NCT01309737|82900062|FG000|Week 0 to 16|Randomized, but not treated|1|||
46684864|NCT01309737|82900063|FG001|Week 0 to 16|Randomized, but not treated|0|||
46684865|NCT01309737|82900064|FG002|Week 0 to 16|Randomized, but not treated|0|||
46684866|NCT01309737|82900065|FG003|Week 0 to 16|Randomized, but not treated|0|||
46684867|NCT01309737|82900066|FG004|Week 0 to 16|Randomized, but not treated|0|||
46684868|NCT01309737|82900062|FG000|Week 16 to 52|Death|0|||
46684869|NCT01309737|82900063|FG001|Week 16 to 52|Death|0|||
46684870|NCT01309737|82900064|FG002|Week 16 to 52|Death|0|||
46684871|NCT01309737|82900065|FG003|Week 16 to 52|Death|0|||
46684872|NCT01309737|82900066|FG004|Week 16 to 52|Death|1|||
46684873|NCT01309737|82900062|FG000|Week 16 to 52|Adverse Event|7|||
46684874|NCT01309737|82900063|FG001|Week 16 to 52|Adverse Event|7|||
46684875|NCT01309737|82900064|FG002|Week 16 to 52|Adverse Event|0|||
46684876|NCT01309737|82900065|FG003|Week 16 to 52|Adverse Event|6|||
46684877|NCT01309737|82900066|FG004|Week 16 to 52|Adverse Event|5|||
46684878|NCT01309737|82900062|FG000|Week 16 to 52|Lack of Efficacy|107|||
46684879|NCT01309737|82900063|FG001|Week 16 to 52|Lack of Efficacy|76|||
46684880|NCT01309737|82900064|FG002|Week 16 to 52|Lack of Efficacy|0|||
46684881|NCT01309737|82900065|FG003|Week 16 to 52|Lack of Efficacy|25|||
46684882|NCT01309737|82900066|FG004|Week 16 to 52|Lack of Efficacy|21|||
46684883|NCT01309737|82900062|FG000|Week 16 to 52|Lost to Follow-up|4|||
46684884|NCT01309737|82900063|FG001|Week 16 to 52|Lost to Follow-up|2|||
46684885|NCT01309737|82900064|FG002|Week 16 to 52|Lost to Follow-up|0|||
46684886|NCT01309737|82900065|FG003|Week 16 to 52|Lost to Follow-up|1|||
46684887|NCT01309737|82900066|FG004|Week 16 to 52|Lost to Follow-up|4|||
46684888|NCT01309737|82900062|FG000|Week 16 to 52|Withdrawal by Subject|5|||
46684889|NCT01309737|82900063|FG001|Week 16 to 52|Withdrawal by Subject|6|||
46684890|NCT01309737|82900064|FG002|Week 16 to 52|Withdrawal by Subject|0|||
46684891|NCT01309737|82900065|FG003|Week 16 to 52|Withdrawal by Subject|0|||
46684892|NCT01309737|82900066|FG004|Week 16 to 52|Withdrawal by Subject|2|||
46684893|NCT01309737|82900062|FG000|Week 16 to 52|Other|10|||
46684894|NCT01309737|82900063|FG001|Week 16 to 52|Other|12|||
46684895|NCT01309737|82900064|FG002|Week 16 to 52|Other|0|||
46684896|NCT01309737|82900065|FG003|Week 16 to 52|Other|2|||
46684897|NCT01309737|82900066|FG004|Week 16 to 52|Other|0|||
46684898|NCT01074229|82900092|FG000|Overall Study|Lost to Follow-up|1|||
46684899|NCT01074229|82900093|FG001|Overall Study|Lost to Follow-up|0|||
46684900|NCT01074229|82900094|FG002|Overall Study|Lost to Follow-up|0|||
46684901|NCT01074229|82900092|FG000|Overall Study|Change to open surgical procedure|1|||
46684902|NCT01074229|82900093|FG001|Overall Study|Change to open surgical procedure|3|||
46684903|NCT01074229|82900094|FG002|Overall Study|Change to open surgical procedure|4|||
46684904|NCT01106014|82900106|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
46684905|NCT01106014|82900107|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
46684906|NCT01106014|82900106|FG000|Overall Study|Adverse Event|78|||
46858445|NCT03295318|83074182|FG000|Overall Study|Subject discontinued due to travel|0|||
46858446|NCT03295318|83074183|FG001|Overall Study|Subject discontinued due to travel|1|||
46981658|NCT02420379|83227729|FG001|Overall Study|Transitioned to commercial drug|0|||
46684907|NCT01106014|82900107|FG001|Overall Study|Adverse Event|42|||
46684908|NCT01106014|82900106|FG000|Overall Study|Withdrawal by Subject|43|||
46684909|NCT01106014|82900107|FG001|Overall Study|Withdrawal by Subject|37|||
46684910|NCT01106014|82900106|FG000|Overall Study|Administrative reason|7|||
46684911|NCT01106014|82900107|FG001|Overall Study|Administrative reason|6|||
46684912|NCT01106014|82900106|FG000|Overall Study|Lost to Follow-up|2|||
46684913|NCT01106014|82900107|FG001|Overall Study|Lost to Follow-up|3|||
46684914|NCT01073605|82900116|FG000|Overall Study|Ongoing at Cutoff Date|1|||
46684915|NCT01073605|82900117|FG001|Overall Study|Ongoing at Cutoff Date|1|||
46684916|NCT01073605|82900118|FG002|Overall Study|Ongoing at Cutoff Date|0|||
46684917|NCT01073605|82900116|FG000|Overall Study|Adverse Event|2|||
46684918|NCT01073605|82900117|FG001|Overall Study|Adverse Event|1|||
46684919|NCT01073605|82900118|FG002|Overall Study|Adverse Event|0|||
46684920|NCT01073605|82900116|FG000|Overall Study|Lost to Follow-up|3|||
46684921|NCT01073605|82900117|FG001|Overall Study|Lost to Follow-up|4|||
46684922|NCT01073605|82900118|FG002|Overall Study|Lost to Follow-up|9|||
46684923|NCT01073605|82900116|FG000|Overall Study|Other|25|||
46684924|NCT01073605|82900117|FG001|Overall Study|Other|21|||
46684925|NCT01073605|82900118|FG002|Overall Study|Other|29|||
46684926|NCT01073605|82900116|FG000|Overall Study|Withdrawal by Subject|31|||
46684927|NCT01073605|82900117|FG001|Overall Study|Withdrawal by Subject|39|||
46684928|NCT01073605|82900118|FG002|Overall Study|Withdrawal by Subject|22|||
46684929|NCT01073605|82900116|FG000|Overall Study|Randomized But Not Treated|0|||
46684930|NCT01073605|82900117|FG001|Overall Study|Randomized But Not Treated|1|||
46684931|NCT01073605|82900118|FG002|Overall Study|Randomized But Not Treated|1|||
46684932|NCT01073293|82900128|FG000|Overall Study|Lost to Follow-up|0|||
46684933|NCT01073293|82900129|FG001|Overall Study|Lost to Follow-up|1|||
46684934|NCT01073293|82900128|FG000|Overall Study|Withdrawal by Subject|5|||
46684935|NCT01073293|82900129|FG001|Overall Study|Withdrawal by Subject|10|||
46684936|NCT01105936|82900135|FG000|Period 1|Adverse Event|0|||
46798963|NCT04145531|83017724|FG001|Part A|Withdrawal by parent or guardian|0|||
46798964|NCT04145531|83017725|FG002|Part A|Withdrawal by parent or guardian|0|||
46798965|NCT04145531|83017726|FG003|Part A|Withdrawal by parent or guardian|0|||
46798966|NCT04145531|83017723|FG000|Part A|Withdrawal by participant|0|||
46798967|NCT04145531|83017724|FG001|Part A|Withdrawal by participant|0|||
46798968|NCT04145531|83017725|FG002|Part A|Withdrawal by participant|1|||
46798969|NCT04145531|83017726|FG003|Part A|Withdrawal by participant|0|||
46798970|NCT04145531|83017723|FG000|Part A|Other|0|||
46798971|NCT04145531|83017724|FG001|Part A|Other|0|||
46798972|NCT04145531|83017725|FG002|Part A|Other|1|||
46798973|NCT04145531|83017726|FG003|Part A|Other|0|||
46798974|NCT04145531|83017723|FG000|Part B|Adverse Event|0|||
46684937|NCT01105936|82900136|FG001|Period 1|Adverse Event|0|||
46684938|NCT01105936|82900137|FG002|Period 1|Adverse Event|0|||
46684939|NCT01105936|82900138|FG003|Period 1|Adverse Event|1|||
46684940|NCT01105936|82900135|FG000|Period 2|Adverse Event|1|||
46684941|NCT01105936|82900136|FG001|Period 2|Adverse Event|0|||
46684942|NCT01105936|82900137|FG002|Period 2|Adverse Event|0|||
46798975|NCT04145531|83017724|FG001|Part B|Adverse Event|0|||
46798976|NCT04145531|83017725|FG002|Part B|Adverse Event|0|||
46798977|NCT04145531|83017726|FG003|Part B|Adverse Event|21|||
46798978|NCT04145531|83017723|FG000|Part B|Physician Decision|0|||
46684943|NCT01105936|82900138|FG003|Period 2|Adverse Event|0|||
46684944|NCT01105936|82900135|FG000|Period 3|Protocol Violation|0|||
46798979|NCT04145531|83017724|FG001|Part B|Physician Decision|0|||
46684945|NCT01105936|82900136|FG001|Period 3|Protocol Violation|2|||
46684946|NCT01105936|82900137|FG002|Period 3|Protocol Violation|0|||
46684947|NCT01105936|82900138|FG003|Period 3|Protocol Violation|0|||
46684948|NCT01309659|82900149|FG000|Overall Study|Protocol Violation|0|||
46858447|NCT03295318|83074184|FG002|Overall Study|Subject discontinued due to travel|0|||
46858448|NCT03311230|83074214|FG000|Overall Study|Withdrawal by Subject|1|||
46858449|NCT03311230|83074215|FG001|Overall Study|Withdrawal by Subject|4|||
46858450|NCT03311230|83074216|FG002|Overall Study|Withdrawal by Subject|2|||
46858451|NCT03311230|83074217|FG003|Overall Study|Withdrawal by Subject|7|||
46858452|NCT03311230|83074214|FG000|Overall Study|Unrelated injury|0|||
46858453|NCT03311230|83074215|FG001|Overall Study|Unrelated injury|1|||
46858454|NCT03311230|83074216|FG002|Overall Study|Unrelated injury|0|||
46684949|NCT01309659|82900150|FG001|Overall Study|Protocol Violation|1|||
46684950|NCT01104766|82900160|FG000|Overall Study|Did not meet inc/exc criteria|1|||
46684951|NCT01104766|82900161|FG001|Overall Study|Did not meet inc/exc criteria|0|||
46684952|NCT01104766|82900162|FG002|Overall Study|Did not meet inc/exc criteria|0|||
46684953|NCT01104766|82900163|FG003|Overall Study|Did not meet inc/exc criteria|0|||
46684954|NCT01104766|82900160|FG000|Overall Study|Adverse Event|17|||
46684955|NCT01104766|82900161|FG001|Overall Study|Adverse Event|15|||
46684956|NCT01104766|82900162|FG002|Overall Study|Adverse Event|20|||
46684957|NCT01104766|82900163|FG003|Overall Study|Adverse Event|14|||
46684958|NCT01104766|82900160|FG000|Overall Study|Lack of Efficacy|20|||
46684959|NCT01104766|82900161|FG001|Overall Study|Lack of Efficacy|15|||
46684960|NCT01104766|82900162|FG002|Overall Study|Lack of Efficacy|14|||
46684961|NCT01104766|82900163|FG003|Overall Study|Lack of Efficacy|8|||
46684962|NCT01104766|82900160|FG000|Overall Study|Protocol Violation|2|||
46684963|NCT01104766|82900161|FG001|Overall Study|Protocol Violation|0|||
46684964|NCT01104766|82900162|FG002|Overall Study|Protocol Violation|0|||
46684965|NCT01104766|82900163|FG003|Overall Study|Protocol Violation|0|||
46684966|NCT01104766|82900160|FG000|Overall Study|Withdrawal by Subject|17|||
46684967|NCT01104766|82900161|FG001|Overall Study|Withdrawal by Subject|19|||
46684968|NCT01104766|82900162|FG002|Overall Study|Withdrawal by Subject|25|||
46684969|NCT01104766|82900163|FG003|Overall Study|Withdrawal by Subject|15|||
46684970|NCT01104766|82900160|FG000|Overall Study|Lost to Follow-up|1|||
46684971|NCT01104766|82900161|FG001|Overall Study|Lost to Follow-up|2|||
46684972|NCT01104766|82900162|FG002|Overall Study|Lost to Follow-up|1|||
46684973|NCT01104766|82900163|FG003|Overall Study|Lost to Follow-up|1|||
46798980|NCT04145531|83017725|FG002|Part B|Physician Decision|0|||
46798981|NCT04145531|83017726|FG003|Part B|Physician Decision|7|||
46798982|NCT04145531|83017723|FG000|Part B|Progressive disease|0|||
46798983|NCT04145531|83017724|FG001|Part B|Progressive disease|0|||
46798984|NCT04145531|83017725|FG002|Part B|Progressive disease|0|||
46798985|NCT04145531|83017726|FG003|Part B|Progressive disease|1|||
46798986|NCT04145531|83017723|FG000|Part B|Recurrent disease|0|||
46858455|NCT03311230|83074217|FG003|Overall Study|Unrelated injury|0|||
46858456|NCT00312221|83074230|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
46858457|NCT00312221|83074231|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
46858458|NCT00312221|83074232|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
46981659|NCT02347761|83227738|FG000|All Collected|Death|1|||
46981660|NCT02347761|83227739|FG001|All Collected|Death|0|||
46684974|NCT01104376|82900173|FG000|Overall Study|Withdrawal by Subject|15|||
46684975|NCT01104376|82900173|FG000|Overall Study|Consented but excluded after labs|13|||
46684976|NCT01072357|82900179|FG000|Overall Study|Lost to Follow-up|0|||
46684977|NCT01072357|82900180|FG001|Overall Study|Lost to Follow-up|1|||
46798987|NCT04145531|83017724|FG001|Part B|Recurrent disease|0|||
46684978|NCT01072201|82900188|FG000|Overall Study|Lost to Follow-up|0|||
46798988|NCT04145531|83017725|FG002|Part B|Recurrent disease|0|||
46684979|NCT01072201|82900189|FG001|Overall Study|Lost to Follow-up|1|||
46798989|NCT04145531|83017726|FG003|Part B|Recurrent disease|1|||
46798990|NCT04145531|83017723|FG000|Part B|Withdrawal by parent or guardian|0|||
46798991|NCT04145531|83017724|FG001|Part B|Withdrawal by parent or guardian|0|||
46798992|NCT04145531|83017725|FG002|Part B|Withdrawal by parent or guardian|0|||
46798993|NCT04145531|83017726|FG003|Part B|Withdrawal by parent or guardian|3|||
46798994|NCT04145531|83017723|FG000|Part B|Withdrawal by participant|0|||
46798995|NCT04145531|83017724|FG001|Part B|Withdrawal by participant|0|||
46798996|NCT04145531|83017725|FG002|Part B|Withdrawal by participant|0|||
46798997|NCT04145531|83017726|FG003|Part B|Withdrawal by participant|1|||
46798998|NCT04145531|83017723|FG000|Part B|Other|0|||
46798999|NCT04145531|83017724|FG001|Part B|Other|0|||
46684980|NCT01103362|82900195|FG000|Overall Study|study terminated|596|||
46684981|NCT01103284|82900201|FG000|Overall Study|Death|2|||
46684982|NCT01103284|82900202|FG001|Overall Study|Death|0|||
46684983|NCT01103284|82900201|FG000|Overall Study|Lost to Follow-up|9|||
46684984|NCT01103284|82900202|FG001|Overall Study|Lost to Follow-up|10|||
46684985|NCT01103284|82900201|FG000|Overall Study|Pregnancy|3|||
46684986|NCT01103284|82900202|FG001|Overall Study|Pregnancy|1|||
46858459|NCT00312221|83074233|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
46858460|NCT00312221|83074230|FG000|Open-label Run-in Period|Adverse Event|74|||
46858461|NCT00312221|83074231|FG001|Open-label Run-in Period|Adverse Event|0|||
46858462|NCT00312221|83074232|FG002|Open-label Run-in Period|Adverse Event|0|||
46684987|NCT01103284|82900201|FG000|Overall Study|Protocol Violation|12|||
46684988|NCT01103284|82900202|FG001|Overall Study|Protocol Violation|5|||
46799000|NCT04145531|83017725|FG002|Part B|Other|0|||
46799001|NCT04145531|83017726|FG003|Part B|Other|1|||
46799002|NCT04124692|83017738|FG000|Overall Study|Medical reason|0|||
46858463|NCT00312221|83074233|FG003|Open-label Run-in Period|Adverse Event|0|||
46799003|NCT04124692|83017739|FG001|Overall Study|Medical reason|1|||
46684989|NCT01103284|82900201|FG000|Overall Study|Adverse Event|0|||
46684990|NCT01103284|82900202|FG001|Overall Study|Adverse Event|5|||
46684991|NCT01103284|82900201|FG000|Overall Study|Withdrawal by Subject|14|||
46684992|NCT01103284|82900202|FG001|Overall Study|Withdrawal by Subject|18|||
46684993|NCT01103284|82900201|FG000|Overall Study|Dermal Hypersensitivity|0|||
46684994|NCT01103284|82900202|FG001|Overall Study|Dermal Hypersensitivity|1|||
46684995|NCT01103284|82900201|FG000|Overall Study|Termination by the Sponsor|0|||
46684996|NCT01103284|82900202|FG001|Overall Study|Termination by the Sponsor|1|||
46684997|NCT01103284|82900201|FG000|Overall Study|Not described|2|||
46684998|NCT01103284|82900202|FG001|Overall Study|Not described|1|||
46684999|NCT01103284|82900201|FG000|Overall Study|Missing CRF entries for study completion|0|||
46685000|NCT01103284|82900202|FG001|Overall Study|Missing CRF entries for study completion|2|||
46685001|NCT01070953|82900208|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
46685002|NCT01070953|82900208|FG000|Participants for Safety Evaluation|Off-label use|283|||
46685003|NCT01070953|82900208|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
46685004|NCT01070953|82900208|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
46685005|NCT01070953|82900208|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
46685006|NCT01070953|82900208|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
46685007|NCT01070953|82900208|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
46685008|NCT01070953|82900208|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
46685009|NCT01070953|82900208|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
46685010|NCT01070953|82900208|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
46685011|NCT01089361|82900220|FG000|Overall Study|Death|1|||
46685012|NCT01089361|82900221|FG001|Overall Study|Death|0|||
46685013|NCT01102972|82900231|FG000|Overall Study|Adverse Event|8|||
46685014|NCT01102972|82900232|FG001|Overall Study|Adverse Event|2|||
46685015|NCT01102972|82900231|FG000|Overall Study|Lack of Efficacy|2|||
46685016|NCT01102972|82900232|FG001|Overall Study|Lack of Efficacy|1|||
46685017|NCT01102972|82900231|FG000|Overall Study|Protocol Violation|1|||
46685018|NCT01102972|82900232|FG001|Overall Study|Protocol Violation|0|||
46685019|NCT01102972|82900231|FG000|Overall Study|Lost to Follow-up|10|||
46685020|NCT01102972|82900232|FG001|Overall Study|Lost to Follow-up|5|||
46685021|NCT01102972|82900231|FG000|Overall Study|Investigator Discretion|2|||
46685022|NCT01102972|82900232|FG001|Overall Study|Investigator Discretion|0|||
46685023|NCT01102972|82900231|FG000|Overall Study|Withdrawal by Subject|6|||
46685024|NCT01102972|82900232|FG001|Overall Study|Withdrawal by Subject|6|||
46685025|NCT01309269|82900238|FG000|Overall Study|Adverse Event|56|||
46685026|NCT01309269|82900238|FG000|Overall Study|Withdrawal by Subject|25|||
46685027|NCT01309269|82900238|FG000|Overall Study|Lack of Acceptance|15|||
46685028|NCT01309269|82900238|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
46685029|NCT01309269|82900238|FG000|Overall Study|Kidney Transplant|25|||
46685030|NCT01309269|82900238|FG000|Overall Study|Administrative Problems|141|||
46685031|NCT01309269|82900238|FG000|Overall Study|Other|256|||
46858464|NCT00312221|83074230|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
46981661|NCT02347761|83227740|FG002|All Collected|Death|0|||
46685032|NCT01309269|82900238|FG000|Overall Study|Other|1|||
46685033|NCT01309269|82900238|FG000|Overall Study|Study Completion Data Not Recorded|95|||
46981662|NCT02347761|83227738|FG000|All Collected|Lost to Follow-up|3|||
46685034|NCT01309269|82900238|FG000|Overall Study|Enrolled but not Treated|107|||
46685035|NCT01088503|82900245|FG000|Overall Study|Withdrawal by Subject|118|||
46981663|NCT02347761|83227739|FG001|All Collected|Lost to Follow-up|2|||
46685036|NCT01088503|82900246|FG001|Overall Study|Withdrawal by Subject|327|||
46685037|NCT01088503|82900247|FG002|Overall Study|Withdrawal by Subject|10|||
46685038|NCT01088503|82900245|FG000|Overall Study|Death|64|||
46685039|NCT01088503|82900246|FG001|Overall Study|Death|358|||
46685040|NCT01088503|82900247|FG002|Overall Study|Death|7|||
46685041|NCT01087489|82900253|FG000|Overall Study|enrolled in another VA study|0|||
46685042|NCT01087489|82900254|FG001|Overall Study|enrolled in another VA study|1|||
46685043|NCT01087489|82900253|FG000|Overall Study|Death|0|||
46685044|NCT01087489|82900254|FG001|Overall Study|Death|1|||
46685045|NCT01087489|82900253|FG000|Overall Study|unable to survey by telephone|0|||
46685046|NCT01087489|82900254|FG001|Overall Study|unable to survey by telephone|1|||
46685047|NCT01082965|82900262|FG000|Overall Study|Protocol Violation|0|||
46685048|NCT01082965|82900263|FG001|Overall Study|Protocol Violation|1|||
46685049|NCT01082965|82900262|FG000|Overall Study|Other|1|||
46799004|NCT04124692|83017738|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
46799005|NCT04124692|83017739|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
46799006|NCT04124692|83017738|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
46981664|NCT02347761|83227740|FG002|All Collected|Lost to Follow-up|3|||
46685050|NCT01082965|82900263|FG001|Overall Study|Other|1|||
46685051|NCT01102426|82900271|FG000|Overall Study|Randomized but not treated|4|||
46685052|NCT01102426|82900272|FG001|Overall Study|Randomized but not treated|1|||
46685053|NCT01102426|82900271|FG000|Overall Study|Adverse Events (treatment-related)|15|||
46685054|NCT01102426|82900272|FG001|Overall Study|Adverse Events (treatment-related)|8|||
46685055|NCT01102426|82900271|FG000|Overall Study|Physician Decision|9|||
46685056|NCT01102426|82900272|FG001|Overall Study|Physician Decision|6|||
46685057|NCT01102426|82900271|FG000|Overall Study|Progressive Disease|85|||
46685058|NCT01102426|82900272|FG001|Overall Study|Progressive Disease|44|||
46685059|NCT01102426|82900271|FG000|Overall Study|Adverse Events (unrelated to|9|||
46685060|NCT01102426|82900272|FG001|Overall Study|Adverse Events (unrelated to|1|||
46685061|NCT01102426|82900271|FG000|Overall Study|Patient Refusal|24|||
46685062|NCT01102426|82900272|FG001|Overall Study|Patient Refusal|12|||
46685063|NCT01102426|82900271|FG000|Overall Study|Death (due to adverse events|0|||
46685064|NCT01102426|82900272|FG001|Overall Study|Death (due to adverse events|1|||
46685065|NCT01102426|82900271|FG000|Overall Study|Death (non-related to the study|19|||
46685066|NCT01102426|82900272|FG001|Overall Study|Death (non-related to the study|8|||
46685067|NCT01101334|82900280|FG000|Overall Study|Adverse Event|9|||
46685068|NCT01101334|82900281|FG001|Overall Study|Adverse Event|4|||
46685069|NCT01101334|82900280|FG000|Overall Study|Death|7|||
46685070|NCT01101334|82900281|FG001|Overall Study|Death|1|||
46685071|NCT01101334|82900280|FG000|Overall Study|Withdrawal by Subject|4|||
46685072|NCT01101334|82900281|FG001|Overall Study|Withdrawal by Subject|3|||
46685073|NCT01101334|82900280|FG000|Overall Study|Withdrawal by Sponsor|1|||
46685074|NCT01101334|82900281|FG001|Overall Study|Withdrawal by Sponsor|1|||
46685075|NCT01101334|82900280|FG000|Overall Study|Progressive Disease|22|||
46981665|NCT02347761|83227738|FG000|All Collected|Withdrawal by Subject|11|||
46685076|NCT01101334|82900281|FG001|Overall Study|Progressive Disease|35|||
46685077|NCT01101334|82900280|FG000|Overall Study|Other|2|||
46685078|NCT01101334|82900281|FG001|Overall Study|Other|1|||
46685079|NCT01327547|82900289|FG000|Overall Study|Adverse Event|4|||
46685080|NCT01327547|82900290|FG001|Overall Study|Adverse Event|1|||
46685081|NCT01327547|82900289|FG000|Overall Study|Death|1|||
46685082|NCT01327547|82900290|FG001|Overall Study|Death|2|||
46685083|NCT01327547|82900289|FG000|Overall Study|Lost to Follow-up|6|||
46685084|NCT01327547|82900290|FG001|Overall Study|Lost to Follow-up|6|||
46685085|NCT01327547|82900289|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
46685086|NCT01327547|82900290|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
46685087|NCT01327547|82900289|FG000|Overall Study|Withdrawal by Subject|3|||
46685088|NCT01327547|82900290|FG001|Overall Study|Withdrawal by Subject|7|||
46685089|NCT01327547|82900289|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
46685090|NCT01327547|82900290|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
46685091|NCT01327547|82900289|FG000|Overall Study|Protocol Violation|1|||
46685092|NCT01327547|82900290|FG001|Overall Study|Protocol Violation|0|||
46685093|NCT01327547|82900289|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
46685094|NCT01327547|82900290|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
46685095|NCT01327547|82900289|FG000|Overall Study|Required prohibited medication|2|||
46685096|NCT01327547|82900290|FG001|Overall Study|Required prohibited medication|0|||
46685097|NCT01327547|82900289|FG000|Overall Study|Non-compliance with study procedures|1|||
46685098|NCT01327547|82900290|FG001|Overall Study|Non-compliance with study procedures|0|||
46685099|NCT01327547|82900289|FG000|Overall Study|By investigator in subject's interest|0|||
46685100|NCT01327547|82900290|FG001|Overall Study|By investigator in subject's interest|1|||
46685101|NCT01308567|82900312|FG000|Overall Study|Lost to Follow-up|2|||
46685102|NCT01308567|82900313|FG001|Overall Study|Lost to Follow-up|4|||
46685103|NCT01308567|82900314|FG002|Overall Study|Lost to Follow-up|4|||
46685104|NCT01307319|82900325|FG000|Overall Study|Adverse Event|2|||
46685105|NCT01307319|82900326|FG001|Overall Study|Adverse Event|2|||
46685106|NCT01307319|82900327|FG002|Overall Study|Adverse Event|1|||
46685107|NCT01307319|82900325|FG000|Overall Study|Lost to Follow-up|1|||
46685108|NCT01307319|82900326|FG001|Overall Study|Lost to Follow-up|0|||
46685109|NCT01307319|82900327|FG002|Overall Study|Lost to Follow-up|1|||
46685110|NCT01307319|82900325|FG000|Overall Study|Protocol Violation|1|||
46685111|NCT01307319|82900326|FG001|Overall Study|Protocol Violation|1|||
46685112|NCT01307319|82900327|FG002|Overall Study|Protocol Violation|0|||
46685113|NCT01307319|82900325|FG000|Overall Study|Withdrawal by Subject|0|||
46685114|NCT01307319|82900326|FG001|Overall Study|Withdrawal by Subject|1|||
46685115|NCT01307319|82900327|FG002|Overall Study|Withdrawal by Subject|2|||
46685116|NCT01307319|82900325|FG000|Overall Study|Other|0|||
46685117|NCT01307319|82900326|FG001|Overall Study|Other|4|||
46685118|NCT01307319|82900327|FG002|Overall Study|Other|3|||
46685119|NCT01080391|82900337|FG000|Overall Study|Randomized but not treated|7|||
46685120|NCT01080391|82900338|FG001|Overall Study|Randomized but not treated|4|||
46685121|NCT01070329|82900346|FG000|Overall Study|Adverse Event|13|||
46799007|NCT04124692|83017739|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
46799008|NCT04124692|83017738|FG000|Overall Study|Lost to Follow-up|2|||
46799009|NCT04124692|83017739|FG001|Overall Study|Lost to Follow-up|4|||
46799010|NCT04124692|83017738|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
46685122|NCT01070329|82900347|FG001|Overall Study|Adverse Event|10|||
46685123|NCT01070329|82900346|FG000|Overall Study|Lost to Follow-up|22|||
46685124|NCT01070329|82900347|FG001|Overall Study|Lost to Follow-up|12|||
46799011|NCT04124692|83017739|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
46858465|NCT00312221|83074231|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
46685125|NCT01070329|82900346|FG000|Overall Study|Withdrawal by Subject|9|||
46685126|NCT01070329|82900347|FG001|Overall Study|Withdrawal by Subject|11|||
46685127|NCT01070329|82900346|FG000|Overall Study|Protocol Violation|3|||
46685128|NCT01070329|82900347|FG001|Overall Study|Protocol Violation|8|||
46685129|NCT01070329|82900346|FG000|Overall Study|Lack of Efficacy|2|||
46685130|NCT01070329|82900347|FG001|Overall Study|Lack of Efficacy|6|||
46685131|NCT01070329|82900346|FG000|Overall Study|Physician Decision|2|||
46685132|NCT01070329|82900347|FG001|Overall Study|Physician Decision|1|||
46685133|NCT01070329|82900346|FG000|Overall Study|Entry Criteria Not Met|1|||
46685134|NCT01070329|82900347|FG001|Overall Study|Entry Criteria Not Met|0|||
46685135|NCT01070329|82900346|FG000|Overall Study|Sponsor Decision|0|||
46685136|NCT01070329|82900347|FG001|Overall Study|Sponsor Decision|1|||
46685137|NCT01069861|82900353|FG000|Overall Study|Death|1|||
46685138|NCT01069861|82900353|FG000|Overall Study|Adverse Event|1|||
46685139|NCT01069861|82900353|FG000|Overall Study|Did not meet entrance criteria|1|||
46685140|NCT01306929|82900357|FG000|Overall Study|Withdrawal by Subject|23|||
46685141|NCT01306929|82900357|FG000|Overall Study|Adverse Event|21|||
46685142|NCT01306929|82900357|FG000|Overall Study|Physician Decision|13|||
46685143|NCT01306929|82900357|FG000|Overall Study|Death|8|||
46685144|NCT01306929|82900357|FG000|Overall Study|Withdrawal by parent/guardian|5|||
46685145|NCT01306929|82900357|FG000|Overall Study|Protocol Violation|3|||
46685146|NCT01306929|82900357|FG000|Overall Study|Non-compliance with study drug|2|||
46685147|NCT01306929|82900357|FG000|Overall Study|Lost to Follow-up|2|||
46685148|NCT01306929|82900357|FG000|Overall Study|Various|17|||
46685149|NCT01064401|82900363|FG000|Overall Study|Adverse Event|47|||
46685150|NCT01064401|82900364|FG001|Overall Study|Adverse Event|56|||
46685151|NCT01064401|82900363|FG000|Overall Study|Lack of Efficacy|46|||
46685152|NCT01064401|82900364|FG001|Overall Study|Lack of Efficacy|23|||
46685153|NCT01064401|82900363|FG000|Overall Study|Lost to Follow-up|12|||
46685154|NCT01064401|82900364|FG001|Overall Study|Lost to Follow-up|9|||
46685155|NCT01064401|82900363|FG000|Overall Study|Consent Withdrawn|98|||
46685156|NCT01064401|82900364|FG001|Overall Study|Consent Withdrawn|80|||
46685157|NCT01064401|82900363|FG000|Overall Study|Investigator Decision|4|||
46685158|NCT01064401|82900364|FG001|Overall Study|Investigator Decision|6|||
46685159|NCT01064401|82900363|FG000|Overall Study|Death|4|||
46685160|NCT01064401|82900364|FG001|Overall Study|Death|0|||
46685161|NCT01064401|82900363|FG000|Overall Study|Pregnancy|4|||
46685162|NCT01064401|82900364|FG001|Overall Study|Pregnancy|7|||
46685163|NCT01064401|82900363|FG000|Overall Study|Noncompliance|7|||
46685164|NCT01064401|82900364|FG001|Overall Study|Noncompliance|8|||
46685165|NCT01064401|82900363|FG000|Overall Study|Site Closure|4|||
46685166|NCT01064401|82900364|FG001|Overall Study|Site Closure|5|||
46685167|NCT01064401|82900363|FG000|Overall Study|Other|2|||
46685168|NCT01064401|82900364|FG001|Overall Study|Other|1|||
46685169|NCT01306617|82900374|FG000|Overall Study|Adverse Event|1|||
46685170|NCT01306617|82900375|FG001|Overall Study|Adverse Event|0|||
46685171|NCT01306617|82900376|FG002|Overall Study|Adverse Event|0|||
46685172|NCT01306617|82900374|FG000|Overall Study|Virologic Failure|0|||
46685173|NCT01306617|82900375|FG001|Overall Study|Virologic Failure|0|||
46685174|NCT01306617|82900376|FG002|Overall Study|Virologic Failure|5|||
46685175|NCT01306617|82900374|FG000|Overall Study|Non-compliance|0|||
46685176|NCT01306617|82900375|FG001|Overall Study|Non-compliance|1|||
46685177|NCT01306617|82900376|FG002|Overall Study|Non-compliance|0|||
46685178|NCT01306305|82900386|FG000|Overall Study|Lost to Follow-up|1|||
46685179|NCT01306305|82900387|FG001|Overall Study|Lost to Follow-up|0|||
46685180|NCT01306305|82900386|FG000|Overall Study|Withdrew consent|1|||
46685181|NCT01306305|82900387|FG001|Overall Study|Withdrew consent|0|||
46685182|NCT01038427|82900396|FG000|Overall Study|Lost to follow up|1|||
46685183|NCT01038427|82900397|FG001|Overall Study|Lost to follow up|1|||
46685184|NCT01038427|82900398|FG002|Overall Study|Lost to follow up|0|||
46685185|NCT01038427|82900396|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
46685186|NCT01038427|82900397|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
46685187|NCT01038427|82900398|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
46685188|NCT01038427|82900396|FG000|Overall Study|Withdrew consent|0|||
46685189|NCT01038427|82900397|FG001|Overall Study|Withdrew consent|0|||
46685190|NCT01038427|82900398|FG002|Overall Study|Withdrew consent|1|||
46685191|NCT01038427|82900396|FG000|Overall Study|Adverse Event|2|||
46685192|NCT01038427|82900397|FG001|Overall Study|Adverse Event|2|||
46858466|NCT00312221|83074232|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
46685193|NCT01038427|82900398|FG002|Overall Study|Adverse Event|1|||
46685194|NCT01038427|82900396|FG000|Overall Study|Enrolled in error|0|||
46685195|NCT01038427|82900397|FG001|Overall Study|Enrolled in error|1|||
46685196|NCT01038427|82900398|FG002|Overall Study|Enrolled in error|1|||
46685197|NCT01038427|82900396|FG000|Overall Study|Other|0|||
46685198|NCT01038427|82900397|FG001|Overall Study|Other|2|||
46685199|NCT01038427|82900398|FG002|Overall Study|Other|0|||
46685200|NCT01037413|82900406|FG000|Part A: Skin Testing|Adverse Event|1|||
46685201|NCT01037413|82900407|FG001|Part A: Skin Testing|Adverse Event|0|||
46685202|NCT01037413|82900406|FG000|Part A: Skin Testing|Protocol Violation|1|||
46685203|NCT01037413|82900407|FG001|Part A: Skin Testing|Protocol Violation|0|||
46685204|NCT01037413|82900406|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
46685205|NCT01037413|82900407|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
46685206|NCT01037413|82900406|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
46685207|NCT01037413|82900407|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
46685208|NCT01326845|82900422|FG000|Overall Study|Administrative Problems|5|||
46685209|NCT01326845|82900423|FG001|Overall Study|Administrative Problems|2|||
46685210|NCT01326845|82900422|FG000|Overall Study|Adverse Event|1|||
46685211|NCT01326845|82900423|FG001|Overall Study|Adverse Event|0|||
46685212|NCT01326845|82900422|FG000|Overall Study|Misisng|1|||
46685213|NCT01326845|82900423|FG001|Overall Study|Misisng|3|||
46685214|NCT01062763|82900431|FG000|Overall Study|Adverse Event|3|||
46685215|NCT01062763|82900432|FG001|Overall Study|Adverse Event|4|||
46685216|NCT01048099|82900438|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
46685217|NCT01048099|82900438|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
46685218|NCT01303965|82900446|FG000|Overall Study|Adverse Event|1|||
46685219|NCT01303965|82900447|FG001|Overall Study|Adverse Event|1|||
46685220|NCT01303965|82900446|FG000|Overall Study|Death|0|||
46685221|NCT01303965|82900447|FG001|Overall Study|Death|3|||
46685222|NCT01303965|82900446|FG000|Overall Study|Withdrawal by Subject|1|||
46685223|NCT01303965|82900447|FG001|Overall Study|Withdrawal by Subject|0|||
46685224|NCT01303965|82900446|FG000|Overall Study|Disease Progression|1|||
46685225|NCT01303965|82900447|FG001|Overall Study|Disease Progression|6|||
46685226|NCT01045993|82900457|FG000|Overall Study|Treated-later found eligibility not met|0|||
46685227|NCT01045993|82900458|FG001|Overall Study|Treated-later found eligibility not met|1|||
46685228|NCT01045993|82900459|FG002|Overall Study|Treated-later found eligibility not met|0|||
46981666|NCT02347761|83227739|FG001|All Collected|Withdrawal by Subject|11|||
46981667|NCT02347761|83227740|FG002|All Collected|Withdrawal by Subject|22|||
46981668|NCT02347761|83227738|FG000|All Collected|invetigator disretion|2|||
46981669|NCT02347761|83227739|FG001|All Collected|invetigator disretion|0|||
46981670|NCT02347761|83227740|FG002|All Collected|invetigator disretion|0|||
46685229|NCT01045993|82900460|FG003|Overall Study|Treated-later found eligibility not met|0|||
46685230|NCT01303419|82900470|FG000|Overall Study|Discontinuation of study|60|||
46685231|NCT01303419|82900470|FG000|Overall Study|Did not complete both imaging methods|5|||
46685232|NCT01303419|82900470|FG000|Overall Study|Did not meet all I/E after screening|31|||
46685233|NCT01326533|82900476|FG000|Overall Study|Lost to Follow-up|2|||
46685234|NCT01326533|82900477|FG001|Overall Study|Lost to Follow-up|0|||
46685235|NCT01326533|82900476|FG000|Overall Study|Withdrawal by Subject|1|||
46685236|NCT01326533|82900477|FG001|Overall Study|Withdrawal by Subject|0|||
46685237|NCT01326533|82900476|FG000|Overall Study|Adverse Event|1|||
46685238|NCT01326533|82900477|FG001|Overall Study|Adverse Event|0|||
46685239|NCT01045447|82900485|FG000|Overall Study|Adverse Event|0|||
46685240|NCT01045447|82900486|FG001|Overall Study|Adverse Event|1|||
46685241|NCT01045447|82900485|FG000|Overall Study|Lack of Efficacy|3|||
46685242|NCT01045447|82900486|FG001|Overall Study|Lack of Efficacy|1|||
46685243|NCT01045447|82900485|FG000|Overall Study|Protocol Violation|6|||
46685244|NCT01045447|82900486|FG001|Overall Study|Protocol Violation|3|||
46685245|NCT01045447|82900485|FG000|Overall Study|Withdrawal Criteria|10|||
46685246|NCT01045447|82900486|FG001|Overall Study|Withdrawal Criteria|10|||
46685247|NCT01045447|82900485|FG000|Overall Study|Unclassified|17|||
46685248|NCT01045447|82900486|FG001|Overall Study|Unclassified|13|||
46685249|NCT01301625|82900492|FG000|Overall Study|Death|5|||
46685250|NCT01301625|82900492|FG000|Overall Study|Not Due|21|||
46685251|NCT01301625|82900492|FG000|Overall Study|Expected|8|||
46685252|NCT01301625|82900492|FG000|Overall Study|Lost to Follow-up|1|||
46685253|NCT01301391|82900496|FG000|Overall Study|Death|13|||
46685254|NCT01301391|82900496|FG000|Overall Study|Lost to Follow-up|3|||
46685255|NCT01301391|82900496|FG000|Overall Study|Physician Decision|2|||
46685256|NCT01301391|82900496|FG000|Overall Study|Sponsor's decision|8|||
46685257|NCT01036321|82900502|FG000|Overall Study|Ineligible after randomization|0|||
46685258|NCT01036321|82900503|FG001|Overall Study|Ineligible after randomization|1|||
46685259|NCT01036321|82900502|FG000|Overall Study|Withdrawal by Subject|3|||
46685260|NCT01036321|82900503|FG001|Overall Study|Withdrawal by Subject|2|||
46685261|NCT01036321|82900502|FG000|Overall Study|Adverse Event|2|||
46799012|NCT04018066|83017761|FG000|Overall Study|participants started taking medications during the study period|3|||
46799013|NCT04018066|83017761|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
46799014|NCT03811249|83017766|FG000|Overall Study|Withdrawal by Subject|44|||
46799015|NCT03811249|83017766|FG000|Overall Study|Missed Visit|24|||
46799016|NCT03678688|83017780|FG000|Overall Study|Reason not Specified|0|||
46799017|NCT03678688|83017781|FG001|Overall Study|Reason not Specified|0|||
46799018|NCT03678688|83017782|FG002|Overall Study|Reason not Specified|3|||
46799019|NCT03678688|83017783|FG003|Overall Study|Reason not Specified|0|||
46799020|NCT03678688|83017784|FG004|Overall Study|Reason not Specified|1|||
46799021|NCT03678688|83017785|FG005|Overall Study|Reason not Specified|0|||
46799022|NCT03678688|83017786|FG006|Overall Study|Reason not Specified|0|||
46799023|NCT03678688|83017787|FG007|Overall Study|Reason not Specified|0|||
46799024|NCT03678688|83017788|FG008|Overall Study|Reason not Specified|0|||
46858467|NCT00312221|83074233|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
46685262|NCT01036321|82900503|FG001|Overall Study|Adverse Event|1|||
46685263|NCT01061359|82900509|FG000|Overall Study|Death|32|||
46685264|NCT01061359|82900509|FG000|Overall Study|Lost to Follow-up|1072|||
46685265|NCT01061359|82900509|FG000|Overall Study|Relapse|187|||
46685266|NCT01061359|82900509|FG000|Overall Study|Secondary neoplasm|11|||
46685267|NCT01301079|82900515|FG000|Overall Study|Lost to Follow-up|2|||
46799025|NCT03678688|83017780|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
46858468|NCT00312221|83074230|FG000|Open-label Run-in Period|Administrative|42|||
46685268|NCT01301079|82900516|FG001|Overall Study|Lost to Follow-up|2|||
46685269|NCT01036165|82900526|FG000|Overall Study|Adverse Event|6|||
46685270|NCT01036165|82900526|FG000|Overall Study|Lost to Follow-up|2|||
46799026|NCT03678688|83017781|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
46799027|NCT03678688|83017782|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
46685271|NCT01036165|82900526|FG000|Overall Study|Withdrawal by Subject|3|||
46685272|NCT01036165|82900526|FG000|Overall Study|Device Related Issues|3|||
46685273|NCT01036165|82900526|FG000|Overall Study|Problems finding proper area to inject|1|||
46685274|NCT01301001|82900530|FG000|First Intervention|Lost to Follow-up|4|||
46685275|NCT01301001|82900531|FG001|First Intervention|Lost to Follow-up|4|||
46685276|NCT01301001|82900530|FG000|First Intervention|Withdrawal by Subject|1|||
46685277|NCT01301001|82900531|FG001|First Intervention|Withdrawal by Subject|4|||
46685278|NCT01301001|82900530|FG000|First Intervention|Adverse Event|5|||
46685279|NCT01301001|82900531|FG001|First Intervention|Adverse Event|0|||
46685280|NCT01301001|82900530|FG000|First Intervention|Protocol Violation|0|||
46685281|NCT01301001|82900531|FG001|First Intervention|Protocol Violation|1|||
46685282|NCT01301001|82900530|FG000|Second Intervention|Adverse Event|2|||
46685283|NCT01301001|82900531|FG001|Second Intervention|Adverse Event|0|||
46685284|NCT01301001|82900530|FG000|Second Intervention|Withdrawal by Subject|2|||
46685285|NCT01301001|82900531|FG001|Second Intervention|Withdrawal by Subject|0|||
46685286|NCT01300923|82900538|FG000|Overall Study|Physician Decision|0|||
46685287|NCT01300923|82900539|FG001|Overall Study|Physician Decision|2|||
46685288|NCT01300767|82900544|FG000|Overall Study|Discomfort|2|||
46685289|NCT01300767|82900544|FG000|Overall Study|Biomicroscopy|1|||
46685290|NCT01300767|82900544|FG000|Overall Study|Unacceptable fit|1|||
46685291|NCT01300455|82900552|FG000|Washout|Withdrawal by Subject|1|||
46685292|NCT01300455|82900553|FG001|Washout|Withdrawal by Subject|0|||
46685293|NCT01107418|82900563|FG000|Overall Study|Disease Progression|45|||
46685294|NCT01107418|82900563|FG000|Overall Study|Adverse Event|3|||
46685295|NCT01107418|82900563|FG000|Overall Study|Withdrawal by Subject|1|||
46685296|NCT01107418|82900563|FG000|Overall Study|Study Closing|1|||
46685297|NCT01107418|82900563|FG000|Overall Study|Started Other Therapy|1|||
46685298|NCT01107418|82900563|FG000|Overall Study|Entered Extension Study|1|||
46685299|NCT01101178|82900578|FG000|Period 1|Withdrawal by Subject|1|||
46685300|NCT01101178|82900579|FG001|Period 1|Withdrawal by Subject|2|||
46685301|NCT01101178|82900578|FG000|Period 1|Positive drug screen|1|||
46685302|NCT01101178|82900579|FG001|Period 1|Positive drug screen|1|||
46685303|NCT01101178|82900578|FG000|Period 1|Adverse Event|2|||
46685304|NCT01101178|82900579|FG001|Period 1|Adverse Event|1|||
46685305|NCT01101178|82900578|FG000|Period 2|Withdrawal by Subject|0|||
46685306|NCT01101178|82900579|FG001|Period 2|Withdrawal by Subject|1|||
46685307|NCT01101022|82900588|FG000|Overall Study|Adverse Event|6|||
46685308|NCT01101022|82900589|FG001|Overall Study|Adverse Event|2|||
46685309|NCT01101022|82900588|FG000|Overall Study|Protocol Violation|4|||
46685310|NCT01101022|82900589|FG001|Overall Study|Protocol Violation|3|||
46685311|NCT01101022|82900588|FG000|Overall Study|Withdrawal by Subject|3|||
46685312|NCT01101022|82900589|FG001|Overall Study|Withdrawal by Subject|8|||
46685313|NCT01101022|82900588|FG000|Overall Study|Lost to Follow-up|1|||
46685314|NCT01101022|82900589|FG001|Overall Study|Lost to Follow-up|4|||
46685315|NCT01101022|82900588|FG000|Overall Study|Lack of Efficacy|0|||
46685316|NCT01101022|82900589|FG001|Overall Study|Lack of Efficacy|7|||
46685317|NCT01101022|82900588|FG000|Overall Study|Sponsor decision|1|||
46685318|NCT01101022|82900589|FG001|Overall Study|Sponsor decision|1|||
46685319|NCT01101022|82900588|FG000|Overall Study|Non-compliance|1|||
46685320|NCT01101022|82900589|FG001|Overall Study|Non-compliance|0|||
46685321|NCT01101022|82900588|FG000|Overall Study|Work schedule|1|||
46799028|NCT03678688|83017783|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
46799029|NCT03678688|83017784|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
46799030|NCT03678688|83017785|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
46799031|NCT03678688|83017786|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
46685322|NCT01101022|82900589|FG001|Overall Study|Work schedule|1|||
46685323|NCT01101022|82900588|FG000|Overall Study|Vacation|0|||
46685324|NCT01101022|82900589|FG001|Overall Study|Vacation|1|||
46685325|NCT01299909|82900598|FG000|Overall Study|Lost to Follow-up|22|||
46685326|NCT01299909|82900599|FG001|Overall Study|Lost to Follow-up|18|||
46799032|NCT03678688|83017787|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
46799033|NCT03678688|83017788|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
46685327|NCT01299909|82900600|FG002|Overall Study|Lost to Follow-up|17|||
46685328|NCT01298661|82900610|FG000|Overall Study|Withdrawal by Subject|2|||
46685329|NCT01298661|82900611|FG001|Overall Study|Withdrawal by Subject|0|||
46685330|NCT01298661|82900612|FG002|Overall Study|Withdrawal by Subject|2|||
46685331|NCT01100944|82900621|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
46685332|NCT01100944|82900622|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
46685333|NCT01100944|82900623|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
46685334|NCT01100944|82900621|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
46685335|NCT01100944|82900622|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
46685336|NCT01100944|82900623|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
46685337|NCT01100944|82900621|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
46685338|NCT01100944|82900622|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
46685339|NCT01100944|82900623|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
46685340|NCT01100944|82900621|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
46685341|NCT01100944|82900622|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
46685342|NCT01100944|82900623|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
46685343|NCT01100320|82900644|FG000|Period 1|Withdrawal by Subject|2|||
46685344|NCT01100320|82900645|FG001|Period 1|Withdrawal by Subject|4|||
46685345|NCT01100320|82900644|FG000|Period 1|Positive Drug Screen|1|||
46685346|NCT01100320|82900645|FG001|Period 1|Positive Drug Screen|1|||
46685347|NCT01100320|82900644|FG000|Period 1|Adverse Event|2|||
46685348|NCT01100320|82900645|FG001|Period 1|Adverse Event|2|||
46685349|NCT01100320|82900644|FG000|Period 2|Withdrawal by Subject|1|||
46685350|NCT01100320|82900645|FG001|Period 2|Withdrawal by Subject|1|||
46685351|NCT01100086|82900651|FG000|Period 1|Withdrawal by Subject|1|||
46685352|NCT01100086|82900652|FG001|Period 1|Withdrawal by Subject|0|||
46685353|NCT01297959|82900660|FG000|Overall Study|Adverse Event|0|||
46685354|NCT01297959|82900661|FG001|Overall Study|Adverse Event|1|||
46685355|NCT01297959|82900660|FG000|Overall Study|Protocol Violation|2|||
46685356|NCT01297959|82900661|FG001|Overall Study|Protocol Violation|1|||
46685357|NCT01297959|82900660|FG000|Overall Study|Withdrawal by Subject|5|||
46685358|NCT01297959|82900661|FG001|Overall Study|Withdrawal by Subject|4|||
46685359|NCT01297959|82900660|FG000|Overall Study|Physician Decision|0|||
46685360|NCT01297959|82900661|FG001|Overall Study|Physician Decision|1|||
46685361|NCT01297959|82900660|FG000|Overall Study|Unrelated medical illness / complication|0|||
46685362|NCT01297959|82900661|FG001|Overall Study|Unrelated medical illness / complication|2|||
46685363|NCT01297959|82900660|FG000|Overall Study|Other|13|||
46685364|NCT01297959|82900661|FG001|Overall Study|Other|7|||
46685365|NCT01035229|82900669|FG000|Overall Study|Adverse Event|61|||
46685366|NCT01035229|82900670|FG001|Overall Study|Adverse Event|14|||
46685367|NCT01035229|82900669|FG000|Overall Study|Withdrawal by Subject|20|||
46685368|NCT01035229|82900670|FG001|Overall Study|Withdrawal by Subject|7|||
46685369|NCT01035229|82900669|FG000|Overall Study|Lost to Follow-up|1|||
46685370|NCT01035229|82900670|FG001|Overall Study|Lost to Follow-up|0|||
46685371|NCT01035229|82900669|FG000|Overall Study|Administrative problems|1|||
46685372|NCT01035229|82900670|FG001|Overall Study|Administrative problems|1|||
46685373|NCT01035229|82900669|FG000|Overall Study|Death|13|||
46685374|NCT01035229|82900670|FG001|Overall Study|Death|5|||
46685375|NCT01035229|82900669|FG000|Overall Study|New cancer therapy|2|||
46685376|NCT01035229|82900670|FG001|Overall Study|New cancer therapy|0|||
46685377|NCT01035229|82900669|FG000|Overall Study|Protocol Violation|0|||
46685378|NCT01035229|82900670|FG001|Overall Study|Protocol Violation|2|||
46685379|NCT01035229|82900669|FG000|Overall Study|Sponsor's decision to end study|3|||
46685380|NCT01035229|82900670|FG001|Overall Study|Sponsor's decision to end study|3|||
46685381|NCT01035229|82900669|FG000|Overall Study|Disease Progression|261|||
46685382|NCT01035229|82900670|FG001|Overall Study|Disease Progression|152|||
46685383|NCT01106404|82900680|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
46685384|NCT01106404|82900681|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
46685385|NCT01106404|82900680|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
46685386|NCT01106404|82900681|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
46685387|NCT01106404|82900680|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
46685388|NCT01106404|82900681|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
46685389|NCT01106404|82900680|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
46685390|NCT01106404|82900681|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
46799034|NCT03678688|83017780|FG000|Overall Study|Covid Related Adverse Event|0|||
46685391|NCT01059799|82900695|FG000|Overall Study|Adverse Event|2|||
46685392|NCT01059799|82900696|FG001|Overall Study|Adverse Event|3|||
46685393|NCT01059799|82900695|FG000|Overall Study|Lack of Efficacy|1|||
46685394|NCT01059799|82900696|FG001|Overall Study|Lack of Efficacy|0|||
46685395|NCT01059799|82900695|FG000|Overall Study|Protocol Violation|3|||
46685396|NCT01059799|82900696|FG001|Overall Study|Protocol Violation|2|||
46685397|NCT01059799|82900695|FG000|Overall Study|Withdrawal criteria|13|||
46685398|NCT01059799|82900696|FG001|Overall Study|Withdrawal criteria|2|||
46685399|NCT01059799|82900695|FG000|Overall Study|Other|12|||
46685400|NCT01059799|82900696|FG001|Overall Study|Other|3|||
46685401|NCT01106248|82900702|FG000|Overall Study|Adverse Event|1|||
46685402|NCT01106248|82900702|FG000|Overall Study|Administrative|2|||
46685403|NCT01059175|82900708|FG000|Overall Study|Death|17|||
46685404|NCT01059175|82900709|FG001|Overall Study|Death|17|||
46685405|NCT01059175|82900708|FG000|Overall Study|Adverse Event|4|||
46685406|NCT01059175|82900709|FG001|Overall Study|Adverse Event|2|||
46685407|NCT01059175|82900708|FG000|Overall Study|Lost to Follow-up|0|||
46685408|NCT01059175|82900709|FG001|Overall Study|Lost to Follow-up|1|||
46685409|NCT01297491|82900717|FG000|Overall Study|Adverse Event|11|||
46685410|NCT01297491|82900718|FG001|Overall Study|Adverse Event|6|||
46685411|NCT01297491|82900717|FG000|Overall Study|Physician Decision|3|||
46685412|NCT01297491|82900718|FG001|Overall Study|Physician Decision|2|||
46685413|NCT01297491|82900717|FG000|Overall Study|Progressive disease|11|||
46685414|NCT01297491|82900718|FG001|Overall Study|Progressive disease|20|||
46685415|NCT01297491|82900717|FG000|Overall Study|Patient/Guardian decision|3|||
46799035|NCT03678688|83017781|FG001|Overall Study|Covid Related Adverse Event|0|||
46799036|NCT03678688|83017782|FG002|Overall Study|Covid Related Adverse Event|0|||
46799037|NCT03678688|83017783|FG003|Overall Study|Covid Related Adverse Event|0|||
46799038|NCT03678688|83017784|FG004|Overall Study|Covid Related Adverse Event|0|||
46799039|NCT03678688|83017785|FG005|Overall Study|Covid Related Adverse Event|3|||
46799040|NCT03678688|83017786|FG006|Overall Study|Covid Related Adverse Event|1|||
46799041|NCT03678688|83017787|FG007|Overall Study|Covid Related Adverse Event|1|||
46799042|NCT03678688|83017788|FG008|Overall Study|Covid Related Adverse Event|0|||
46799043|NCT03678688|83017780|FG000|Overall Study|Physician Decision|0|||
46799044|NCT03678688|83017781|FG001|Overall Study|Physician Decision|0|||
46799045|NCT03678688|83017782|FG002|Overall Study|Physician Decision|0|||
46799046|NCT03678688|83017783|FG003|Overall Study|Physician Decision|0|||
46799047|NCT03678688|83017784|FG004|Overall Study|Physician Decision|0|||
46685416|NCT01297491|82900718|FG001|Overall Study|Patient/Guardian decision|4|||
46685417|NCT01297491|82900717|FG000|Overall Study|Death|2|||
46685418|NCT01297491|82900718|FG001|Overall Study|Death|1|||
46685419|NCT01106092|82900728|FG000|Overall Study|Withdrawal by Subject|0|||
46685420|NCT01106092|82900729|FG001|Overall Study|Withdrawal by Subject|0|||
46685421|NCT01106092|82900730|FG002|Overall Study|Withdrawal by Subject|0|||
46799048|NCT03678688|83017785|FG005|Overall Study|Physician Decision|1|||
46685422|NCT01106092|82900731|FG003|Overall Study|Withdrawal by Subject|1|||
46685423|NCT01097668|82900743|FG000|Overall Study|Withdrawal by Subject|1|||
46685424|NCT01097668|82900744|FG001|Overall Study|Withdrawal by Subject|2|||
46685425|NCT01097668|82900743|FG000|Overall Study|Lost to Follow-up|1|||
46685426|NCT01097668|82900744|FG001|Overall Study|Lost to Follow-up|0|||
46685427|NCT01325207|82900760|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
46685428|NCT01325207|82900761|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
46685429|NCT01325207|82900762|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
46685430|NCT01325207|82900763|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
46685431|NCT01325207|82900764|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
46685432|NCT01325207|82900765|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
46685433|NCT01325207|82900760|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
46685434|NCT01325207|82900761|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
46685435|NCT01325207|82900762|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
46685436|NCT01325207|82900763|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
46685437|NCT01325207|82900764|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
46685438|NCT01325207|82900765|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
46685439|NCT01325207|82900760|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
46685440|NCT01325207|82900761|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
46685441|NCT01325207|82900762|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
46685442|NCT01325207|82900763|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
46685443|NCT01325207|82900764|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
46685444|NCT01325207|82900765|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
46685445|NCT01325207|82900760|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
46685446|NCT01325207|82900761|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
46685447|NCT01325207|82900762|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
46685448|NCT01325207|82900763|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
46685449|NCT01325207|82900764|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
46685450|NCT01325207|82900765|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
46685451|NCT01325207|82900760|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
46685452|NCT01325207|82900761|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
46685453|NCT01325207|82900762|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
46685454|NCT01325207|82900763|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
46685455|NCT01325207|82900764|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
46685456|NCT01325207|82900765|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
46685457|NCT01325207|82900760|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
46685458|NCT01325207|82900761|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
46685459|NCT01325207|82900762|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
46685460|NCT01325207|82900763|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
46685461|NCT01325207|82900764|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
46685462|NCT01325207|82900765|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
46685463|NCT01325207|82900760|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
46685464|NCT01325207|82900761|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
46685465|NCT01325207|82900762|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
46685466|NCT01325207|82900763|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
46685467|NCT01325207|82900764|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
46685468|NCT01325207|82900765|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
46685469|NCT01324349|82900782|FG000|Overall Study|Death|1|||
46685470|NCT01324349|82900783|FG001|Overall Study|Death|1|||
46685471|NCT01324349|82900782|FG000|Overall Study|Withdrawal by Subject|0|||
46685472|NCT01324349|82900783|FG001|Overall Study|Withdrawal by Subject|1|||
46685473|NCT01095250|82900793|FG000|Overall Study|administrative reasons|8|||
46685474|NCT01095250|82900794|FG001|Overall Study|administrative reasons|10|||
46685475|NCT01095250|82900795|FG002|Overall Study|administrative reasons|7|||
46685476|NCT01095250|82900796|FG003|Overall Study|administrative reasons|5|||
46685477|NCT01095250|82900793|FG000|Overall Study|Withdrawal by Subject|0|||
46685478|NCT01095250|82900794|FG001|Overall Study|Withdrawal by Subject|0|||
46685479|NCT01095250|82900795|FG002|Overall Study|Withdrawal by Subject|1|||
46685480|NCT01095250|82900796|FG003|Overall Study|Withdrawal by Subject|0|||
46685481|NCT01324271|82900806|FG000|Overall Study|Lost to Follow-up|3|||
46685482|NCT01324271|82900807|FG001|Overall Study|Lost to Follow-up|0|||
46685483|NCT01324271|82900806|FG000|Overall Study|Physician Decision|1|||
46685484|NCT01324271|82900807|FG001|Overall Study|Physician Decision|0|||
46685485|NCT01095094|82900813|FG000|Overall Study|Withdrawal by Subject|1|||
46685486|NCT01095094|82900813|FG000|Overall Study|Death|1|||
46858469|NCT00312221|83074231|FG001|Open-label Run-in Period|Administrative|0|||
46685487|NCT01095094|82900813|FG000|Overall Study|Physician Decision|1|||
46685488|NCT01323647|82900819|FG000|Overall Study|Migrated/moved from study area|2|||
46685489|NCT01323647|82900820|FG001|Overall Study|Migrated/moved from study area|0|||
46685490|NCT01323647|82900819|FG000|Overall Study|Withdrawal by Subject|5|||
46685491|NCT01323647|82900820|FG001|Overall Study|Withdrawal by Subject|0|||
46685492|NCT01323647|82900819|FG000|Overall Study|Lost to Follow-up|2|||
46685493|NCT01323647|82900820|FG001|Overall Study|Lost to Follow-up|0|||
46685494|NCT01094782|82900832|FG000|Overall Study|Withdrawal by Subject|5|||
46685495|NCT01094782|82900833|FG001|Overall Study|Withdrawal by Subject|5|||
46685496|NCT01094782|82900834|FG002|Overall Study|Withdrawal by Subject|1|||
46685497|NCT01094782|82900835|FG003|Overall Study|Withdrawal by Subject|5|||
46685498|NCT01094782|82900836|FG004|Overall Study|Withdrawal by Subject|5|||
46685499|NCT01094782|82900837|FG005|Overall Study|Withdrawal by Subject|0|||
46685500|NCT01094782|82900832|FG000|Overall Study|Lost to Follow-up|1|||
46685501|NCT01094782|82900833|FG001|Overall Study|Lost to Follow-up|0|||
46685502|NCT01094782|82900834|FG002|Overall Study|Lost to Follow-up|0|||
46685503|NCT01094782|82900835|FG003|Overall Study|Lost to Follow-up|2|||
46858470|NCT00312221|83074232|FG002|Open-label Run-in Period|Administrative|0|||
46685504|NCT01094782|82900836|FG004|Overall Study|Lost to Follow-up|1|||
46685505|NCT01094782|82900837|FG005|Overall Study|Lost to Follow-up|4|||
46685506|NCT01094782|82900832|FG000|Overall Study|Positive Drug Screen|2|||
46685507|NCT01094782|82900833|FG001|Overall Study|Positive Drug Screen|2|||
46685508|NCT01094782|82900834|FG002|Overall Study|Positive Drug Screen|1|||
46685509|NCT01094782|82900835|FG003|Overall Study|Positive Drug Screen|1|||
46685510|NCT01094782|82900836|FG004|Overall Study|Positive Drug Screen|3|||
46685511|NCT01094782|82900837|FG005|Overall Study|Positive Drug Screen|2|||
46685512|NCT01094782|82900832|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
46685513|NCT01094782|82900833|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
46685514|NCT01094782|82900834|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
46685515|NCT01094782|82900835|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
46685516|NCT01094782|82900836|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
46685517|NCT01094782|82900837|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
46685518|NCT01094782|82900832|FG000|Overall Study|Unable to Complete Questionnaires|0|||
46685519|NCT01094782|82900833|FG001|Overall Study|Unable to Complete Questionnaires|1|||
46685520|NCT01094782|82900834|FG002|Overall Study|Unable to Complete Questionnaires|0|||
46685521|NCT01094782|82900835|FG003|Overall Study|Unable to Complete Questionnaires|0|||
46685522|NCT01094782|82900836|FG004|Overall Study|Unable to Complete Questionnaires|0|||
46685523|NCT01094782|82900837|FG005|Overall Study|Unable to Complete Questionnaires|0|||
46685524|NCT01094782|82900832|FG000|Overall Study|Healthy Subject Had Pain|0|||
46685525|NCT01094782|82900833|FG001|Overall Study|Healthy Subject Had Pain|1|||
46685526|NCT01094782|82900834|FG002|Overall Study|Healthy Subject Had Pain|0|||
46685527|NCT01094782|82900835|FG003|Overall Study|Healthy Subject Had Pain|0|||
46685528|NCT01094782|82900836|FG004|Overall Study|Healthy Subject Had Pain|0|||
46685529|NCT01094782|82900837|FG005|Overall Study|Healthy Subject Had Pain|0|||
46685530|NCT01094782|82900832|FG000|Overall Study|Hypertension|0|||
46685531|NCT01094782|82900833|FG001|Overall Study|Hypertension|0|||
46685532|NCT01094782|82900834|FG002|Overall Study|Hypertension|1|||
46685533|NCT01094782|82900835|FG003|Overall Study|Hypertension|0|||
46685534|NCT01094782|82900836|FG004|Overall Study|Hypertension|0|||
46685535|NCT01094782|82900837|FG005|Overall Study|Hypertension|0|||
46685536|NCT01094782|82900832|FG000|Overall Study|Wrong Pain Condition|0|||
46685537|NCT01094782|82900833|FG001|Overall Study|Wrong Pain Condition|0|||
46685538|NCT01094782|82900834|FG002|Overall Study|Wrong Pain Condition|0|||
46685539|NCT01094782|82900835|FG003|Overall Study|Wrong Pain Condition|2|||
46685540|NCT01094782|82900836|FG004|Overall Study|Wrong Pain Condition|1|||
46685541|NCT01094782|82900837|FG005|Overall Study|Wrong Pain Condition|1|||
46685542|NCT01094782|82900832|FG000|Overall Study|Recent Interventional Injection|0|||
46685543|NCT01094782|82900833|FG001|Overall Study|Recent Interventional Injection|0|||
46685544|NCT01094782|82900834|FG002|Overall Study|Recent Interventional Injection|0|||
46685545|NCT01094782|82900835|FG003|Overall Study|Recent Interventional Injection|0|||
46685546|NCT01094782|82900836|FG004|Overall Study|Recent Interventional Injection|0|||
46685547|NCT01094782|82900837|FG005|Overall Study|Recent Interventional Injection|1|||
46685548|NCT01094782|82900832|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
46685549|NCT01094782|82900833|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
46685550|NCT01094782|82900834|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
46685551|NCT01094782|82900835|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
46685552|NCT01094782|82900836|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
46685553|NCT01094782|82900837|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
46685554|NCT01094782|82900832|FG000|Overall Study|Noncompliance With Study Schedule|0|||
46685555|NCT01094782|82900833|FG001|Overall Study|Noncompliance With Study Schedule|0|||
46685556|NCT01094782|82900834|FG002|Overall Study|Noncompliance With Study Schedule|0|||
46685557|NCT01094782|82900835|FG003|Overall Study|Noncompliance With Study Schedule|1|||
46685558|NCT01094782|82900836|FG004|Overall Study|Noncompliance With Study Schedule|0|||
46685559|NCT01094782|82900837|FG005|Overall Study|Noncompliance With Study Schedule|0|||
46685560|NCT01097044|82900853|FG000|Overall Study|Withdrawal by Subject|4|||
46685561|NCT01097044|82900854|FG001|Overall Study|Withdrawal by Subject|4|||
46685562|NCT01097044|82900853|FG000|Overall Study|Lost to Follow-up|1|||
46685563|NCT01097044|82900854|FG001|Overall Study|Lost to Follow-up|0|||
46685564|NCT01097044|82900853|FG000|Overall Study|Withdrawal by Sponsor|0|||
46685565|NCT01097044|82900854|FG001|Overall Study|Withdrawal by Sponsor|1|||
46685566|NCT01322009|82900864|FG000|Overall Study|Death|0|||
46685567|NCT01322009|82900865|FG001|Overall Study|Death|1|||
46685568|NCT01322009|82900864|FG000|Overall Study|Adverse Event|0|||
46685569|NCT01322009|82900865|FG001|Overall Study|Adverse Event|1|||
46685570|NCT01322009|82900864|FG000|Overall Study|ng tube discontinued|0|||
46685571|NCT01322009|82900865|FG001|Overall Study|ng tube discontinued|1|||
46685572|NCT01321697|82900871|FG000|Overall Study|Study Terminated|7|||
46685573|NCT01320683|82900875|FG000|Overall Study|Positive antibody response|1|||
46685574|NCT01320293|82900879|FG000|Overall Study|Lack of Efficacy|1|||
46685575|NCT01320293|82900879|FG000|Overall Study|Adverse Event|1|||
46685576|NCT01318811|82900885|FG000|Overall Study|Physician Decision|1|||
46685577|NCT01318811|82900886|FG001|Overall Study|Physician Decision|1|||
46685578|NCT01318811|82900885|FG000|Overall Study|CRRT stopped for head CT|0|||
46685579|NCT01318811|82900886|FG001|Overall Study|CRRT stopped for head CT|1|||
46685580|NCT01318811|82900885|FG000|Overall Study|Death|0|||
46685581|NCT01318811|82900886|FG001|Overall Study|Death|1|||
46685582|NCT01318811|82900885|FG000|Overall Study|CRRT stopped for head MRI|0|||
46685583|NCT01318811|82900886|FG001|Overall Study|CRRT stopped for head MRI|1|||
46685584|NCT01093846|82900895|FG000|Overall Study|Adverse Event|0|||
46685585|NCT01093846|82900896|FG001|Overall Study|Adverse Event|0|||
46685586|NCT01093846|82900897|FG002|Overall Study|Adverse Event|1|||
46685587|NCT01093846|82900895|FG000|Overall Study|Lack of Efficacy|0|||
46685588|NCT01093846|82900896|FG001|Overall Study|Lack of Efficacy|0|||
46685589|NCT01093846|82900897|FG002|Overall Study|Lack of Efficacy|4|||
46858471|NCT00312221|83074233|FG003|Open-label Run-in Period|Administrative|0|||
46685590|NCT01093846|82900895|FG000|Overall Study|Condition no longer required study drug|1|||
46685591|NCT01093846|82900896|FG001|Overall Study|Condition no longer required study drug|1|||
46685592|NCT01093846|82900897|FG002|Overall Study|Condition no longer required study drug|1|||
46685593|NCT01093846|82900895|FG000|Overall Study|Administrative Problems|18|||
46685594|NCT01093846|82900896|FG001|Overall Study|Administrative Problems|17|||
46685595|NCT01093846|82900897|FG002|Overall Study|Administrative Problems|15|||
46685596|NCT01315847|82900905|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
46685597|NCT01315847|82900906|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
46685598|NCT01315847|82900905|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
46685599|NCT01315847|82900906|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
46685600|NCT01093534|82900915|FG000|Overall Study|Adverse Event|2|||
46685601|NCT01093534|82900916|FG001|Overall Study|Adverse Event|5|||
46685602|NCT01093534|82900917|FG002|Overall Study|Adverse Event|2|||
46685603|NCT01093534|82900915|FG000|Overall Study|Lack of Efficacy|2|||
46685604|NCT01093534|82900916|FG001|Overall Study|Lack of Efficacy|1|||
46685605|NCT01093534|82900917|FG002|Overall Study|Lack of Efficacy|1|||
46685606|NCT01093534|82900915|FG000|Overall Study|Withdrawal by Subject|5|||
46685607|NCT01093534|82900916|FG001|Overall Study|Withdrawal by Subject|7|||
46685608|NCT01093534|82900917|FG002|Overall Study|Withdrawal by Subject|2|||
46685609|NCT01093534|82900915|FG000|Overall Study|Other|1|||
46685610|NCT01093534|82900916|FG001|Overall Study|Other|3|||
46685611|NCT01093534|82900917|FG002|Overall Study|Other|4|||
46685612|NCT01314911|82900928|FG000|Overall Study|Lost to Follow-up|3|||
46685613|NCT01314911|82900929|FG001|Overall Study|Lost to Follow-up|2|||
46685614|NCT01314911|82900928|FG000|Overall Study|Withdrawal by Subject|1|||
46685615|NCT01314911|82900929|FG001|Overall Study|Withdrawal by Subject|3|||
46685616|NCT01314911|82900928|FG000|Overall Study|Received Non-randomized Study Drug|0|||
46685617|NCT01314911|82900929|FG001|Overall Study|Received Non-randomized Study Drug|1|||
46685618|NCT01314911|82900928|FG000|Overall Study|Never Started Treatment|1|||
46685619|NCT01314911|82900929|FG001|Overall Study|Never Started Treatment|0|||
46685620|NCT01093222|82900935|FG000|Overall Study|Ineligible|6|||
46685621|NCT01093222|82900935|FG000|Overall Study|Adverse Event|7|||
46685622|NCT01093222|82900935|FG000|Overall Study|Progression/relapse|24|||
46685623|NCT01093222|82900935|FG000|Overall Study|Death|2|||
46685624|NCT01093222|82900935|FG000|Overall Study|Not protocol specified|1|||
46685625|NCT01313663|82900941|FG000|Overall Study|Study Closed/Terminated|2|||
46708235|NCT01134042|82923688|FG000|Overall Study|Adverse Event|3|||
46685626|NCT01313663|82900942|FG001|Overall Study|Study Closed/Terminated|4|||
46685627|NCT01313663|82900941|FG000|Overall Study|Lost to Follow-up|0|||
46685628|NCT01313663|82900942|FG001|Overall Study|Lost to Follow-up|1|||
46685629|NCT01313663|82900941|FG000|Overall Study|Physician Decision|0|||
46685630|NCT01313663|82900942|FG001|Overall Study|Physician Decision|2|||
46685631|NCT01313663|82900941|FG000|Overall Study|Withdrawal by Subject|2|||
46685632|NCT01313663|82900942|FG001|Overall Study|Withdrawal by Subject|1|||
46685633|NCT01092832|82900950|FG000|Overall Study|Other|1|||
46685634|NCT01092832|82900951|FG001|Overall Study|Other|0|||
46685635|NCT01313273|82900959|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
46685636|NCT01313273|82900960|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
46685637|NCT01313273|82900959|FG000|Overall Study|Withdrawal by Subject|1|||
46685638|NCT01313273|82900960|FG001|Overall Study|Withdrawal by Subject|0|||
46685639|NCT01313273|82900959|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
46799049|NCT03678688|83017786|FG006|Overall Study|Physician Decision|0|||
46799050|NCT03678688|83017787|FG007|Overall Study|Physician Decision|0|||
46799051|NCT03678688|83017788|FG008|Overall Study|Physician Decision|0|||
46799052|NCT03678688|83017780|FG000|Overall Study|Withdrawal by Subject|0|||
46981671|NCT02347761|83227738|FG000|All Collected|instillation site pain|0|||
46981672|NCT02347761|83227739|FG001|All Collected|instillation site pain|0|||
46685640|NCT01313273|82900960|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
46685641|NCT01091974|82900970|FG000|Overall Study|Did not start intervention|3|||
46685642|NCT01091974|82900971|FG001|Overall Study|Did not start intervention|1|||
46685643|NCT01091974|82900972|FG002|Overall Study|Did not start intervention|3|||
46685644|NCT01091974|82900973|FG003|Overall Study|Did not start intervention|1|||
46685645|NCT01091974|82900970|FG000|Overall Study|resumed sleep medication|0|||
46685646|NCT01091974|82900971|FG001|Overall Study|resumed sleep medication|0|||
46685647|NCT01091974|82900972|FG002|Overall Study|resumed sleep medication|1|||
46685648|NCT01091974|82900973|FG003|Overall Study|resumed sleep medication|2|||
46685649|NCT01091974|82900970|FG000|Overall Study|Withdrawal by Subject|1|||
46685650|NCT01091974|82900971|FG001|Overall Study|Withdrawal by Subject|3|||
46685651|NCT01091974|82900972|FG002|Overall Study|Withdrawal by Subject|2|||
46685652|NCT01091974|82900973|FG003|Overall Study|Withdrawal by Subject|2|||
46685653|NCT01091974|82900970|FG000|Overall Study|side-effects|1|||
46685654|NCT01091974|82900971|FG001|Overall Study|side-effects|1|||
46685655|NCT01091974|82900972|FG002|Overall Study|side-effects|0|||
46685656|NCT01091974|82900973|FG003|Overall Study|side-effects|2|||
46685657|NCT01313117|82900983|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
46685658|NCT01313117|82900983|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
46685659|NCT01313039|82900988|FG000|Overall Study|Physician Decision|1|||
46685660|NCT01313039|82900988|FG000|Overall Study|Adverse Event|1|||
46685661|NCT01091662|82900994|FG000|Overall Study|Adverse Event|1|||
46685662|NCT01091662|82900995|FG001|Overall Study|Adverse Event|9|||
46685663|NCT01091662|82900994|FG000|Overall Study|Physician Decision|1|||
46685664|NCT01091662|82900995|FG001|Overall Study|Physician Decision|1|||
46685665|NCT01091662|82900994|FG000|Overall Study|Withdrawal by Subject|7|||
46685666|NCT01091662|82900995|FG001|Overall Study|Withdrawal by Subject|6|||
46685667|NCT01091662|82900994|FG000|Overall Study|met exit criteria|7|||
46685668|NCT01091662|82900995|FG001|Overall Study|met exit criteria|13|||
46685669|NCT01091662|82900994|FG000|Overall Study|met exclusion criteria|1|||
46685670|NCT01091662|82900995|FG001|Overall Study|met exclusion criteria|0|||
46685671|NCT01091662|82900994|FG000|Overall Study|Lost to Follow-up|0|||
46685672|NCT01091662|82900995|FG001|Overall Study|Lost to Follow-up|1|||
46685673|NCT01091662|82900994|FG000|Overall Study|Pregnancy|0|||
46685674|NCT01091662|82900995|FG001|Overall Study|Pregnancy|1|||
46685675|NCT01091662|82900994|FG000|Overall Study|Protocol Violation|0|||
46799053|NCT03678688|83017781|FG001|Overall Study|Withdrawal by Subject|0|||
46799054|NCT03678688|83017782|FG002|Overall Study|Withdrawal by Subject|0|||
46799055|NCT03678688|83017783|FG003|Overall Study|Withdrawal by Subject|0|||
46799056|NCT03678688|83017784|FG004|Overall Study|Withdrawal by Subject|0|||
46799057|NCT03678688|83017785|FG005|Overall Study|Withdrawal by Subject|0|||
46685676|NCT01091662|82900995|FG001|Overall Study|Protocol Violation|2|||
46685677|NCT01091662|82900994|FG000|Overall Study|unable to swallow capsule|0|||
46685678|NCT01091662|82900995|FG001|Overall Study|unable to swallow capsule|1|||
46685679|NCT01312961|82901008|FG000|Overall Study|Adverse Event|3|||
46799058|NCT03678688|83017786|FG006|Overall Study|Withdrawal by Subject|2|||
46685680|NCT01312961|82901009|FG001|Overall Study|Adverse Event|3|||
46685681|NCT01312961|82901008|FG000|Overall Study|Lack of Efficacy|11|||
46685682|NCT01312961|82901009|FG001|Overall Study|Lack of Efficacy|1|||
46685683|NCT01312961|82901008|FG000|Overall Study|Poor compliance to protocol|1|||
46685684|NCT01312961|82901009|FG001|Overall Study|Poor compliance to protocol|0|||
46685685|NCT01312961|82901008|FG000|Overall Study|Other than specified above|2|||
46685686|NCT01312961|82901009|FG001|Overall Study|Other than specified above|3|||
46685687|NCT01311557|82901018|FG000|Overall Study|Serious adverse event|0|||
46685688|NCT01311557|82901019|FG001|Overall Study|Serious adverse event|1|||
46685689|NCT01311557|82901018|FG000|Overall Study|Protocol Violation|4|||
46685690|NCT01311557|82901019|FG001|Overall Study|Protocol Violation|2|||
46685691|NCT01311557|82901018|FG000|Overall Study|Lost to Follow-up|0|||
46685692|NCT01311557|82901019|FG001|Overall Study|Lost to Follow-up|1|||
46685693|NCT01311557|82901018|FG000|Overall Study|Withdrawal by Subject|1|||
46685694|NCT01311557|82901019|FG001|Overall Study|Withdrawal by Subject|2|||
46685695|NCT01310777|82901028|FG000|Overall Study|Adverse Event|23|||
46685696|NCT01310777|82901029|FG001|Overall Study|Adverse Event|1|||
46685697|NCT01310777|82901030|FG002|Overall Study|Adverse Event|15|||
46685698|NCT01310777|82901028|FG000|Overall Study|Lost to Follow-up|0|||
46685699|NCT01310777|82901029|FG001|Overall Study|Lost to Follow-up|4|||
46685700|NCT01310777|82901030|FG002|Overall Study|Lost to Follow-up|1|||
46685701|NCT01310777|82901028|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
46685702|NCT01310777|82901029|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
46685703|NCT01310777|82901030|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
46685704|NCT01310777|82901028|FG000|Overall Study|Inadequate Control of IOP|5|||
46685705|NCT01310777|82901029|FG001|Overall Study|Inadequate Control of IOP|7|||
46685706|NCT01310777|82901030|FG002|Overall Study|Inadequate Control of IOP|10|||
46685707|NCT01310777|82901028|FG000|Overall Study|Other|4|||
46685708|NCT01310777|82901029|FG001|Overall Study|Other|1|||
46685709|NCT01310777|82901030|FG002|Overall Study|Other|2|||
46685710|NCT01310699|82901040|FG000|Overall Study|Patients did not complete tandem.|4|||
46685711|NCT01310699|82901041|FG001|Overall Study|Patients did not complete tandem.|6|||
46685712|NCT01310075|82901051|FG000|Overall Study|Lost to Follow-up|1|||
46685713|NCT01310075|82901052|FG001|Overall Study|Lost to Follow-up|0|||
46685714|NCT01310075|82901051|FG000|Overall Study|Physician Decision|10|||
46685715|NCT01310075|82901052|FG001|Overall Study|Physician Decision|7|||
46685716|NCT01310075|82901051|FG000|Overall Study|Protocol Violation|2|||
46685717|NCT01310075|82901052|FG001|Overall Study|Protocol Violation|2|||
46685718|NCT01310075|82901051|FG000|Overall Study|Withdrawal by Subject|1|||
46685719|NCT01310075|82901052|FG001|Overall Study|Withdrawal by Subject|1|||
46685720|NCT01309997|82901060|FG000|Overall Study|Adverse Event|1|||
46685721|NCT01309997|82901061|FG001|Overall Study|Adverse Event|0|||
46685722|NCT01309997|82901060|FG000|Overall Study|Death|1|||
46685723|NCT01309997|82901061|FG001|Overall Study|Death|3|||
46685724|NCT01309997|82901060|FG000|Overall Study|Lack of Efficacy|2|||
46685725|NCT01309997|82901061|FG001|Overall Study|Lack of Efficacy|2|||
46685726|NCT01309997|82901060|FG000|Overall Study|Withdrawal by Subject|1|||
46685727|NCT01309997|82901061|FG001|Overall Study|Withdrawal by Subject|1|||
46799059|NCT03678688|83017787|FG007|Overall Study|Withdrawal by Subject|1|||
46799060|NCT03678688|83017788|FG008|Overall Study|Withdrawal by Subject|0|||
46799061|NCT03624036|83017835|FG000|Overall Study|Death|2|||
46799062|NCT03624036|83017836|FG001|Overall Study|Death|3|||
46799063|NCT03624036|83017837|FG002|Overall Study|Death|0|||
46685728|NCT01309919|82901080|FG000|Overall Study|Did not receive a postpartum IUD|17|||
46685729|NCT01309919|82901081|FG001|Overall Study|Did not receive a postpartum IUD|48|||
46685730|NCT01309841|82901090|FG000|Overall Study|Other|0|||
46685731|NCT01309841|82901091|FG001|Overall Study|Other|1|||
46799064|NCT03624036|83017838|FG003|Overall Study|Death|1|||
46685732|NCT01309841|82901092|FG002|Overall Study|Other|1|||
46685733|NCT01309841|82901090|FG000|Overall Study|Lost to Follow-up|7|||
46685734|NCT01309841|82901091|FG001|Overall Study|Lost to Follow-up|6|||
46685735|NCT01309841|82901092|FG002|Overall Study|Lost to Follow-up|4|||
46685736|NCT01309841|82901090|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
46799065|NCT03624036|83017835|FG000|Overall Study|Withdrawal by Subject|1|||
46685737|NCT01309841|82901091|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
46685738|NCT01309841|82901092|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
46685739|NCT01309841|82901090|FG000|Overall Study|Lack of Efficacy|0|||
46685740|NCT01309841|82901091|FG001|Overall Study|Lack of Efficacy|0|||
46685741|NCT01309841|82901092|FG002|Overall Study|Lack of Efficacy|2|||
46685742|NCT01309841|82901090|FG000|Overall Study|Adverse Event|9|||
46685743|NCT01309841|82901091|FG001|Overall Study|Adverse Event|22|||
46685744|NCT01309841|82901092|FG002|Overall Study|Adverse Event|11|||
46685745|NCT01309841|82901090|FG000|Overall Study|Death|1|||
46685746|NCT01309841|82901091|FG001|Overall Study|Death|0|||
46685747|NCT01309841|82901092|FG002|Overall Study|Death|0|||
46685748|NCT01309841|82901090|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
46685749|NCT01309841|82901091|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
46685750|NCT01309841|82901092|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
46685751|NCT01309841|82901090|FG000|Overall Study|Withdrawal by Subject|17|||
46685752|NCT01309841|82901091|FG001|Overall Study|Withdrawal by Subject|6|||
46685753|NCT01309841|82901092|FG002|Overall Study|Withdrawal by Subject|13|||
46685754|NCT01309841|82901090|FG000|Overall Study|Did Not Receive Treatment|2|||
46685755|NCT01309841|82901091|FG001|Overall Study|Did Not Receive Treatment|0|||
46685756|NCT01309841|82901092|FG002|Overall Study|Did Not Receive Treatment|1|||
46685757|NCT01309841|82901090|FG000|Overall Study|Severe non-compliance with protocol|0|||
46685758|NCT01309841|82901091|FG001|Overall Study|Severe non-compliance with protocol|5|||
46685759|NCT01309841|82901092|FG002|Overall Study|Severe non-compliance with protocol|2|||
46685760|NCT01308749|82901102|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
46685761|NCT01308749|82901103|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
46685762|NCT01308749|82901102|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
46685763|NCT01308749|82901103|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
46685764|NCT01308749|82901102|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
46685765|NCT01308749|82901103|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
46685766|NCT01307891|82901125|FG000|Overall Study|Progressive Disease|3|||
46685767|NCT01307891|82901126|FG001|Overall Study|Progressive Disease|1|||
46685768|NCT01307579|82901134|FG000|Overall Study|Death|3|||
46685769|NCT01307579|82901135|FG001|Overall Study|Death|6|||
46685770|NCT01307579|82901134|FG000|Overall Study|Physician Decision|26|||
46685771|NCT01307579|82901135|FG001|Overall Study|Physician Decision|29|||
46685772|NCT01307579|82901134|FG000|Overall Study|Withdrawal by Subject|7|||
46685773|NCT01307579|82901135|FG001|Overall Study|Withdrawal by Subject|3|||
46685774|NCT01307579|82901134|FG000|Overall Study|Institutional diagnosis of IFD|21|||
46685775|NCT01307579|82901135|FG001|Overall Study|Institutional diagnosis of IFD|36|||
46685776|NCT01307579|82901134|FG000|Overall Study|Begin conditioning for HSCT|42|||
46799066|NCT03624036|83017836|FG001|Overall Study|Withdrawal by Subject|0|||
46799067|NCT03624036|83017837|FG002|Overall Study|Withdrawal by Subject|1|||
46799068|NCT03624036|83017838|FG003|Overall Study|Withdrawal by Subject|0|||
46799069|NCT03624036|83017835|FG000|Overall Study|Enrolled but Never Treated|1|||
46799070|NCT03624036|83017836|FG001|Overall Study|Enrolled but Never Treated|0|||
46799071|NCT03624036|83017837|FG002|Overall Study|Enrolled but Never Treated|0|||
46981673|NCT02347761|83227740|FG002|All Collected|instillation site pain|1|||
46685777|NCT01307579|82901135|FG001|Overall Study|Begin conditioning for HSCT|44|||
46685778|NCT01307579|82901134|FG000|Overall Study|Refractory or relapsed AML|38|||
46685779|NCT01307579|82901135|FG001|Overall Study|Refractory or relapsed AML|23|||
46685780|NCT01307579|82901134|FG000|Overall Study|Ineligible|3|||
46685781|NCT01307579|82901135|FG001|Overall Study|Ineligible|4|||
46685782|NCT01057693|82901141|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
46685783|NCT01057693|82901142|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
46685784|NCT01057693|82901143|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
46685785|NCT01057693|82901141|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
46685786|NCT01057693|82901142|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
46685787|NCT01057693|82901143|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
46685788|NCT01057693|82901141|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
46685789|NCT01057693|82901142|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
46685790|NCT01057693|82901143|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
46685791|NCT01057693|82901141|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
46685792|NCT01057693|82901142|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
46685793|NCT01057693|82901143|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
46685794|NCT01057693|82901141|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
46685795|NCT01057693|82901142|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
46685796|NCT01057693|82901143|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
46685797|NCT01057693|82901141|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
46685798|NCT01057693|82901142|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
46685799|NCT01057693|82901143|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
46685800|NCT01057693|82901141|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
46685801|NCT01057693|82901142|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
46685802|NCT01057693|82901143|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
46685803|NCT01057693|82901141|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
46685804|NCT01057693|82901142|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
46685805|NCT01057693|82901143|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
46685806|NCT01057693|82901141|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
46685807|NCT01057693|82901142|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
46685808|NCT01057693|82901143|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
46685809|NCT01057693|82901141|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
46685810|NCT01057693|82901142|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
46685811|NCT01057693|82901143|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
46685812|NCT01057693|82901141|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
46685813|NCT01057693|82901142|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
46685814|NCT01057693|82901143|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
46685815|NCT01057693|82901141|FG000|Between Single-Blind and Double-Blind|Other|6|||
46685816|NCT01057693|82901142|FG001|Between Single-Blind and Double-Blind|Other|0|||
46685817|NCT01057693|82901143|FG002|Between Single-Blind and Double-Blind|Other|0|||
46685818|NCT01057693|82901141|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
46685819|NCT01057693|82901142|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
46685820|NCT01057693|82901143|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
46685821|NCT01057693|82901141|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
46685822|NCT01057693|82901142|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
46685823|NCT01057693|82901143|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
46685824|NCT01057693|82901141|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
46685825|NCT01057693|82901142|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
46685826|NCT01057693|82901143|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
46685827|NCT01057693|82901141|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
46685828|NCT01057693|82901142|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
46685829|NCT01057693|82901143|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
46799072|NCT03624036|83017838|FG003|Overall Study|Enrolled but Never Treated|0|||
46799073|NCT03624036|83017835|FG000|Overall Study|Reason not Specified|3|||
46981674|NCT02347761|83227738|FG000|All Collected|exacerbation of COPD|0|||
46685830|NCT01057693|82901141|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
46685831|NCT01057693|82901142|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
46685832|NCT01057693|82901143|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
46685833|NCT01057693|82901141|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
46685834|NCT01057693|82901142|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
46685835|NCT01057693|82901143|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
46685836|NCT01057693|82901141|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
46685837|NCT01057693|82901142|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
46685838|NCT01057693|82901143|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
46685839|NCT01307501|82901151|FG000|Overall Study|Treatment Failure|1|||
46685840|NCT01307501|82901151|FG000|Overall Study|Death|20|||
46685841|NCT01307501|82901151|FG000|Overall Study|Lost to Follow-up|1|||
46685842|NCT01307501|82901151|FG000|Overall Study|Starting Hospice|1|||
46685843|NCT01034137|82901158|FG000|Overall Study|Adverse Event|9|||
46685844|NCT01034137|82901159|FG001|Overall Study|Adverse Event|10|||
46685845|NCT01034137|82901160|FG002|Overall Study|Adverse Event|8|||
46685846|NCT01034137|82901158|FG000|Overall Study|Withdrawal by Subject|4|||
46685847|NCT01034137|82901159|FG001|Overall Study|Withdrawal by Subject|3|||
46685848|NCT01034137|82901160|FG002|Overall Study|Withdrawal by Subject|3|||
46685849|NCT01034137|82901158|FG000|Overall Study|Lack of Efficacy|9|||
46685850|NCT01034137|82901159|FG001|Overall Study|Lack of Efficacy|4|||
46685851|NCT01034137|82901160|FG002|Overall Study|Lack of Efficacy|13|||
46685852|NCT01034137|82901158|FG000|Overall Study|Protocol Violation|2|||
46685853|NCT01034137|82901159|FG001|Overall Study|Protocol Violation|2|||
46799074|NCT03624036|83017836|FG001|Overall Study|Reason not Specified|0|||
46799075|NCT03624036|83017837|FG002|Overall Study|Reason not Specified|2|||
46799076|NCT03624036|83017838|FG003|Overall Study|Reason not Specified|2|||
46799077|NCT03442569|83017887|FG000|Overall Study|Subject was ineligible after enrollment|1|||
46799078|NCT03235544|83017895|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
46799079|NCT03235544|83017896|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
46799080|NCT03235544|83017897|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
46799081|NCT03235544|83017898|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
46799082|NCT03235544|83017895|FG000|Overall Study|Death|11|||
46799083|NCT03235544|83017896|FG001|Overall Study|Death|23|||
46685854|NCT01034137|82901160|FG002|Overall Study|Protocol Violation|1|||
46685855|NCT01034137|82901158|FG000|Overall Study|Refused treatment or did not cooperate|2|||
46685856|NCT01034137|82901159|FG001|Overall Study|Refused treatment or did not cooperate|0|||
46685857|NCT01034137|82901160|FG002|Overall Study|Refused treatment or did not cooperate|1|||
46685858|NCT01034137|82901158|FG000|Overall Study|Administrative or other|2|||
46685859|NCT01034137|82901159|FG001|Overall Study|Administrative or other|3|||
46685860|NCT01034137|82901160|FG002|Overall Study|Administrative or other|4|||
46685861|NCT01056289|82901169|FG000|Open-label Phase|Adverse Event|29|||
46685862|NCT01056289|82901170|FG001|Open-label Phase|Adverse Event|0|||
46799084|NCT03235544|83017897|FG002|Overall Study|Death|11|||
46799085|NCT03235544|83017898|FG003|Overall Study|Death|20|||
46799086|NCT03235544|83017895|FG000|Overall Study|Lost to Follow-up|0|||
46799087|NCT03235544|83017896|FG001|Overall Study|Lost to Follow-up|1|||
46685863|NCT01056289|82901171|FG002|Open-label Phase|Adverse Event|0|||
46685864|NCT01056289|82901172|FG003|Open-label Phase|Adverse Event|0|||
46685865|NCT01056289|82901169|FG000|Open-label Phase|Lost to Follow-up|30|||
46685866|NCT01056289|82901170|FG001|Open-label Phase|Lost to Follow-up|0|||
46685867|NCT01056289|82901171|FG002|Open-label Phase|Lost to Follow-up|0|||
46685868|NCT01056289|82901172|FG003|Open-label Phase|Lost to Follow-up|0|||
46685869|NCT01056289|82901169|FG000|Open-label Phase|Other|9|||
46685870|NCT01056289|82901170|FG001|Open-label Phase|Other|0|||
46685871|NCT01056289|82901171|FG002|Open-label Phase|Other|0|||
46685872|NCT01056289|82901172|FG003|Open-label Phase|Other|0|||
46685873|NCT01056289|82901169|FG000|Open-label Phase|Protocol Violation|6|||
46685874|NCT01056289|82901170|FG001|Open-label Phase|Protocol Violation|0|||
46685875|NCT01056289|82901171|FG002|Open-label Phase|Protocol Violation|0|||
46685876|NCT01056289|82901172|FG003|Open-label Phase|Protocol Violation|0|||
46685877|NCT01056289|82901169|FG000|Open-label Phase|Withdrawal by Subject|26|||
46685878|NCT01056289|82901170|FG001|Open-label Phase|Withdrawal by Subject|0|||
46685879|NCT01056289|82901171|FG002|Open-label Phase|Withdrawal by Subject|0|||
46685880|NCT01056289|82901172|FG003|Open-label Phase|Withdrawal by Subject|0|||
46685881|NCT01056289|82901169|FG000|Open-label Phase|Lack of Efficacy|18|||
46685882|NCT01056289|82901170|FG001|Open-label Phase|Lack of Efficacy|0|||
46685883|NCT01056289|82901171|FG002|Open-label Phase|Lack of Efficacy|0|||
46981675|NCT02347761|83227739|FG001|All Collected|exacerbation of COPD|0|||
46981676|NCT02347761|83227740|FG002|All Collected|exacerbation of COPD|1|||
46981677|NCT02347761|83227738|FG000|All Collected|moved/travel|0|||
46981678|NCT02347761|83227739|FG001|All Collected|moved/travel|1|||
46981679|NCT02347761|83227740|FG002|All Collected|moved/travel|0|||
46981680|NCT02347761|83227738|FG000|On Study Treatment|Lack of Efficacy|2|||
46685884|NCT01056289|82901172|FG003|Open-label Phase|Lack of Efficacy|0|||
46685885|NCT01056289|82901169|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
46685886|NCT01056289|82901170|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
46981681|NCT02347761|83227739|FG001|On Study Treatment|Lack of Efficacy|3|||
46685887|NCT01056289|82901171|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
46685888|NCT01056289|82901172|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
46685889|NCT01056289|82901169|FG000|Double-blind Phase|Adverse Event|0|||
46685890|NCT01056289|82901170|FG001|Double-blind Phase|Adverse Event|1|||
46685891|NCT01056289|82901171|FG002|Double-blind Phase|Adverse Event|2|||
46685892|NCT01056289|82901172|FG003|Double-blind Phase|Adverse Event|1|||
46685893|NCT01056289|82901169|FG000|Double-blind Phase|Lost to Follow-up|0|||
46685894|NCT01056289|82901170|FG001|Double-blind Phase|Lost to Follow-up|2|||
46685895|NCT01056289|82901171|FG002|Double-blind Phase|Lost to Follow-up|2|||
46685896|NCT01056289|82901172|FG003|Double-blind Phase|Lost to Follow-up|2|||
46685897|NCT01056289|82901169|FG000|Double-blind Phase|Other|0|||
46685898|NCT01056289|82901170|FG001|Double-blind Phase|Other|0|||
46685899|NCT01056289|82901171|FG002|Double-blind Phase|Other|1|||
46685900|NCT01056289|82901172|FG003|Double-blind Phase|Other|2|||
46685901|NCT01056289|82901169|FG000|Double-blind Phase|Protocol Violation|0|||
46685902|NCT01056289|82901170|FG001|Double-blind Phase|Protocol Violation|0|||
46685903|NCT01056289|82901171|FG002|Double-blind Phase|Protocol Violation|1|||
46685904|NCT01056289|82901172|FG003|Double-blind Phase|Protocol Violation|1|||
46685905|NCT01056289|82901169|FG000|Double-blind Phase|Withdrawal by Subject|0|||
46685906|NCT01056289|82901170|FG001|Double-blind Phase|Withdrawal by Subject|0|||
46685907|NCT01056289|82901171|FG002|Double-blind Phase|Withdrawal by Subject|4|||
46685908|NCT01056289|82901172|FG003|Double-blind Phase|Withdrawal by Subject|2|||
46685909|NCT01056289|82901169|FG000|Double-blind Phase|Discontinuation symptom|0|||
46685910|NCT01056289|82901170|FG001|Double-blind Phase|Discontinuation symptom|1|||
46685911|NCT01056289|82901171|FG002|Double-blind Phase|Discontinuation symptom|2|||
46685912|NCT01056289|82901172|FG003|Double-blind Phase|Discontinuation symptom|2|||
46685913|NCT01056289|82901169|FG000|Double-blind Phase|Physician Decision|0|||
46685914|NCT01056289|82901170|FG001|Double-blind Phase|Physician Decision|0|||
46685915|NCT01056289|82901171|FG002|Double-blind Phase|Physician Decision|1|||
46685916|NCT01056289|82901172|FG003|Double-blind Phase|Physician Decision|0|||
46685917|NCT01039675|82901184|FG000|Overall Study|Adverse Event|0|||
46685918|NCT01039675|82901185|FG001|Overall Study|Adverse Event|2|||
46685919|NCT01039675|82901184|FG000|Overall Study|Lack of Efficacy|0|||
46685920|NCT01039675|82901185|FG001|Overall Study|Lack of Efficacy|2|||
46685921|NCT01039675|82901184|FG000|Overall Study|Withdrawal by Subject|0|||
46685922|NCT01039675|82901185|FG001|Overall Study|Withdrawal by Subject|1|||
46685923|NCT01039675|82901184|FG000|Overall Study|Lost to Follow-up|0|||
46685924|NCT01039675|82901185|FG001|Overall Study|Lost to Follow-up|1|||
46685925|NCT01039675|82901184|FG000|Overall Study|Physician Decision|0|||
46685926|NCT01039675|82901185|FG001|Overall Study|Physician Decision|1|||
46685927|NCT01033825|82901198|FG000|Overall Study|Withdrawal by Subject|2|||
46685928|NCT01033825|82901199|FG001|Overall Study|Withdrawal by Subject|3|||
46685929|NCT01033825|82901200|FG002|Overall Study|Withdrawal by Subject|2|||
46685930|NCT01033825|82901201|FG003|Overall Study|Withdrawal by Subject|1|||
46685931|NCT01033825|82901202|FG004|Overall Study|Withdrawal by Subject|1|||
46685932|NCT01033825|82901203|FG005|Overall Study|Withdrawal by Subject|0|||
46685933|NCT01033825|82901204|FG006|Overall Study|Withdrawal by Subject|0|||
46685934|NCT01033825|82901198|FG000|Overall Study|Adverse Event|0|||
46685935|NCT01033825|82901199|FG001|Overall Study|Adverse Event|0|||
46685936|NCT01033825|82901200|FG002|Overall Study|Adverse Event|0|||
46685937|NCT01033825|82901201|FG003|Overall Study|Adverse Event|1|||
46685938|NCT01033825|82901202|FG004|Overall Study|Adverse Event|0|||
46685939|NCT01033825|82901203|FG005|Overall Study|Adverse Event|0|||
46685940|NCT01033825|82901204|FG006|Overall Study|Adverse Event|0|||
46685941|NCT01033825|82901198|FG000|Overall Study|Protocol Violation|1|||
46685942|NCT01033825|82901199|FG001|Overall Study|Protocol Violation|0|||
46685943|NCT01033825|82901200|FG002|Overall Study|Protocol Violation|0|||
46799088|NCT03235544|83017897|FG002|Overall Study|Lost to Follow-up|0|||
46685944|NCT01033825|82901201|FG003|Overall Study|Protocol Violation|0|||
46685945|NCT01033825|82901202|FG004|Overall Study|Protocol Violation|0|||
46685946|NCT01033825|82901203|FG005|Overall Study|Protocol Violation|0|||
46685947|NCT01033825|82901204|FG006|Overall Study|Protocol Violation|0|||
46685948|NCT01033825|82901198|FG000|Overall Study|Other|0|||
46685949|NCT01033825|82901199|FG001|Overall Study|Other|0|||
46685950|NCT01033825|82901200|FG002|Overall Study|Other|0|||
46799089|NCT03235544|83017898|FG003|Overall Study|Lost to Follow-up|1|||
46799090|NCT03235544|83017895|FG000|Overall Study|Withdrawal by Participant|0|||
46799091|NCT03235544|83017896|FG001|Overall Study|Withdrawal by Participant|0|||
46685951|NCT01033825|82901201|FG003|Overall Study|Other|0|||
46685952|NCT01033825|82901202|FG004|Overall Study|Other|1|||
46685953|NCT01033825|82901203|FG005|Overall Study|Other|0|||
46685954|NCT01033825|82901204|FG006|Overall Study|Other|0|||
46685955|NCT01033747|82901224|FG000|Overall Study|Adverse Event|9|||
46799092|NCT03235544|83017897|FG002|Overall Study|Withdrawal by Participant|1|||
46685956|NCT01033747|82901225|FG001|Overall Study|Adverse Event|4|||
46799093|NCT03235544|83017898|FG003|Overall Study|Withdrawal by Participant|0|||
46685957|NCT01033747|82901224|FG000|Overall Study|Abnormal Laboratory Value|1|||
46685958|NCT01033747|82901225|FG001|Overall Study|Abnormal Laboratory Value|0|||
46685959|NCT01033747|82901224|FG000|Overall Study|Abnormal test procedure|0|||
46685960|NCT01033747|82901225|FG001|Overall Study|Abnormal test procedure|1|||
46685961|NCT01033747|82901224|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
46799094|NCT03235544|83017895|FG000|Overall Study|Reason not Specified|0|||
46799095|NCT03235544|83017896|FG001|Overall Study|Reason not Specified|4|||
46799096|NCT03235544|83017897|FG002|Overall Study|Reason not Specified|0|||
46799097|NCT03235544|83017898|FG003|Overall Study|Reason not Specified|1|||
46685962|NCT01033747|82901225|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
46799098|NCT03187353|83017911|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
46685963|NCT01033747|82901224|FG000|Overall Study|Protocol Violation|1|||
46685964|NCT01033747|82901225|FG001|Overall Study|Protocol Violation|0|||
46685965|NCT01033747|82901224|FG000|Overall Study|Withdrawal by Subject|9|||
46685966|NCT01033747|82901225|FG001|Overall Study|Withdrawal by Subject|6|||
46685967|NCT01033747|82901224|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
46685968|NCT01033747|82901225|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
46685969|NCT01033747|82901224|FG000|Overall Study|Stopped at end of Extension 1|2|||
46685970|NCT01033747|82901225|FG001|Overall Study|Stopped at end of Extension 1|0|||
46685971|NCT01091428|82901235|FG000|Phase 1|Progressive Disease|24|||
46685972|NCT01091428|82901236|FG001|Phase 1|Progressive Disease|8|||
46685973|NCT01091428|82901237|FG002|Phase 1|Progressive Disease|0|||
46685974|NCT01091428|82901238|FG003|Phase 1|Progressive Disease|0|||
46685975|NCT01091428|82901235|FG000|Phase 1|Symptomatic Deterioration|3|||
46799099|NCT03187353|83017912|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
46799100|NCT03187353|83017911|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
46799101|NCT03187353|83017912|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
46799102|NCT03187353|83017911|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
46799103|NCT03187353|83017912|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
46799104|NCT03187353|83017911|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
46799105|NCT03187353|83017912|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
46799106|NCT03187353|83017911|FG000|Washout (2 Weeks)|Adverse Event|2|||
46799107|NCT03187353|83017912|FG001|Washout (2 Weeks)|Adverse Event|0|||
46799108|NCT03187353|83017911|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
46799109|NCT03187353|83017912|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
46799110|NCT03056001|83017948|FG000|Overall Study|Death|24|||
46799111|NCT02998918|83017954|FG000|Overall Study|Withdrawal by Subject|1|||
46799112|NCT02998918|83017955|FG001|Overall Study|Withdrawal by Subject|0|||
46799113|NCT02990338|83017963|FG000|Overall Study|Ongoing|30|||
46799114|NCT02990338|83017964|FG001|Overall Study|Ongoing|36|||
46685976|NCT01091428|82901236|FG001|Phase 1|Symptomatic Deterioration|2|||
46685977|NCT01091428|82901237|FG002|Phase 1|Symptomatic Deterioration|0|||
46799115|NCT02742246|83017985|FG000|Overall Study|Never initiated treatment|5|||
46799116|NCT02742246|83017986|FG001|Overall Study|Never initiated treatment|3|||
46799117|NCT02742246|83017987|FG002|Overall Study|Never initiated treatment|1|||
46685978|NCT01091428|82901238|FG003|Phase 1|Symptomatic Deterioration|0|||
46685979|NCT01091428|82901235|FG000|Phase 1|Adverse Event|2|||
46685980|NCT01091428|82901236|FG001|Phase 1|Adverse Event|0|||
46685981|NCT01091428|82901237|FG002|Phase 1|Adverse Event|0|||
46685982|NCT01091428|82901238|FG003|Phase 1|Adverse Event|0|||
46685983|NCT01091428|82901235|FG000|Phase 1|Withdrawal by Subject|7|||
46685984|NCT01091428|82901236|FG001|Phase 1|Withdrawal by Subject|0|||
46685985|NCT01091428|82901237|FG002|Phase 1|Withdrawal by Subject|0|||
46685986|NCT01091428|82901238|FG003|Phase 1|Withdrawal by Subject|0|||
46685987|NCT01091428|82901235|FG000|Phase 1|Reason not specified|0|||
46685988|NCT01091428|82901236|FG001|Phase 1|Reason not specified|1|||
46685989|NCT01091428|82901237|FG002|Phase 1|Reason not specified|0|||
46685990|NCT01091428|82901238|FG003|Phase 1|Reason not specified|0|||
46685991|NCT01091428|82901235|FG000|Phase 1|Single-Patient IND|2|||
46685992|NCT01091428|82901236|FG001|Phase 1|Single-Patient IND|0|||
46799118|NCT02742246|83017985|FG000|Overall Study|dropped out during treatment|7|||
46799119|NCT02742246|83017986|FG001|Overall Study|dropped out during treatment|13|||
46799120|NCT02742246|83017987|FG002|Overall Study|dropped out during treatment|10|||
46799121|NCT02742246|83017985|FG000|Overall Study|Death|1|||
46799122|NCT02742246|83017986|FG001|Overall Study|Death|0|||
46799123|NCT02742246|83017987|FG002|Overall Study|Death|0|||
46799124|NCT02733042|83018014|FG000|Overall Study|Adverse Event|1|||
46799125|NCT02733042|83018015|FG001|Overall Study|Adverse Event|0|||
46799126|NCT02733042|83018016|FG002|Overall Study|Adverse Event|1|||
46799127|NCT02733042|83018017|FG003|Overall Study|Adverse Event|1|||
46685993|NCT01091428|82901237|FG002|Phase 1|Single-Patient IND|0|||
46685994|NCT01091428|82901238|FG003|Phase 1|Single-Patient IND|0|||
46685995|NCT01091428|82901235|FG000|Phase 2|Progressive Disease|0|||
46799128|NCT02733042|83018018|FG004|Overall Study|Adverse Event|0|||
46799129|NCT02733042|83018019|FG005|Overall Study|Adverse Event|0|||
46799130|NCT02733042|83018020|FG006|Overall Study|Adverse Event|0|||
46799131|NCT02733042|83018021|FG007|Overall Study|Adverse Event|0|||
46858472|NCT00312221|83074230|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
46858473|NCT00312221|83074231|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
46685996|NCT01091428|82901236|FG001|Phase 2|Progressive Disease|0|||
46685997|NCT01091428|82901237|FG002|Phase 2|Progressive Disease|44|||
46685998|NCT01091428|82901238|FG003|Phase 2|Progressive Disease|46|||
46685999|NCT01091428|82901235|FG000|Phase 2|Symptomatic Deterioration|0|||
46686000|NCT01091428|82901236|FG001|Phase 2|Symptomatic Deterioration|0|||
46686001|NCT01091428|82901237|FG002|Phase 2|Symptomatic Deterioration|1|||
46686002|NCT01091428|82901238|FG003|Phase 2|Symptomatic Deterioration|6|||
46686003|NCT01091428|82901235|FG000|Phase 2|Adverse Event|0|||
46686004|NCT01091428|82901236|FG001|Phase 2|Adverse Event|0|||
46686005|NCT01091428|82901237|FG002|Phase 2|Adverse Event|12|||
46686006|NCT01091428|82901238|FG003|Phase 2|Adverse Event|5|||
46686007|NCT01091428|82901235|FG000|Phase 2|Withdrawal by Subject|0|||
46799132|NCT02733042|83018022|FG008|Overall Study|Adverse Event|0|||
46799133|NCT02733042|83018023|FG009|Overall Study|Adverse Event|0|||
46799134|NCT02733042|83018024|FG010|Overall Study|Adverse Event|2|||
46799135|NCT02733042|83018025|FG011|Overall Study|Adverse Event|2|||
46799136|NCT02733042|83018026|FG012|Overall Study|Adverse Event|0|||
46799137|NCT02733042|83018027|FG013|Overall Study|Adverse Event|2|||
46799138|NCT02733042|83018028|FG014|Overall Study|Adverse Event|0|||
46799139|NCT02733042|83018029|FG015|Overall Study|Adverse Event|0|||
46799140|NCT02733042|83018030|FG016|Overall Study|Adverse Event|0|||
46799141|NCT02733042|83018031|FG017|Overall Study|Adverse Event|1|||
46799142|NCT02733042|83018032|FG018|Overall Study|Adverse Event|0|||
46799143|NCT02733042|83018014|FG000|Overall Study|Progressive Disease|2|||
46799144|NCT02733042|83018015|FG001|Overall Study|Progressive Disease|1|||
46799145|NCT02733042|83018016|FG002|Overall Study|Progressive Disease|3|||
46799146|NCT02733042|83018017|FG003|Overall Study|Progressive Disease|1|||
46799147|NCT02733042|83018018|FG004|Overall Study|Progressive Disease|2|||
46799148|NCT02733042|83018019|FG005|Overall Study|Progressive Disease|3|||
46799149|NCT02733042|83018020|FG006|Overall Study|Progressive Disease|0|||
46799150|NCT02733042|83018021|FG007|Overall Study|Progressive Disease|3|||
46799151|NCT02733042|83018022|FG008|Overall Study|Progressive Disease|3|||
46799152|NCT02733042|83018023|FG009|Overall Study|Progressive Disease|2|||
46858474|NCT00312221|83074232|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
46858475|NCT00312221|83074233|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
46858476|NCT00312221|83074230|FG000|Open-label Run-in Period|Did not qualify|5|||
46858477|NCT00312221|83074231|FG001|Open-label Run-in Period|Did not qualify|0|||
46858478|NCT00312221|83074232|FG002|Open-label Run-in Period|Did not qualify|0|||
46858479|NCT00312221|83074233|FG003|Open-label Run-in Period|Did not qualify|0|||
46799153|NCT02733042|83018024|FG010|Overall Study|Progressive Disease|2|||
46799154|NCT02733042|83018025|FG011|Overall Study|Progressive Disease|2|||
46799155|NCT02733042|83018026|FG012|Overall Study|Progressive Disease|8|||
46981682|NCT02347761|83227740|FG002|On Study Treatment|Lack of Efficacy|4|||
46686008|NCT01091428|82901236|FG001|Phase 2|Withdrawal by Subject|0|||
46686009|NCT01091428|82901237|FG002|Phase 2|Withdrawal by Subject|9|||
46799156|NCT02733042|83018027|FG013|Overall Study|Progressive Disease|1|||
46799157|NCT02733042|83018028|FG014|Overall Study|Progressive Disease|4|||
46799158|NCT02733042|83018029|FG015|Overall Study|Progressive Disease|7|||
46799159|NCT02733042|83018030|FG016|Overall Study|Progressive Disease|2|||
46799160|NCT02733042|83018031|FG017|Overall Study|Progressive Disease|3|||
46799161|NCT02733042|83018032|FG018|Overall Study|Progressive Disease|4|||
46799162|NCT02733042|83018014|FG000|Overall Study|Withdrawal by Subject|0|||
46686010|NCT01091428|82901238|FG003|Phase 2|Withdrawal by Subject|8|||
46686011|NCT01091428|82901235|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
46686012|NCT01091428|82901236|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
46686013|NCT01091428|82901237|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
46686014|NCT01091428|82901238|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
46686015|NCT01091428|82901235|FG000|Phase 2|Reason not specified|0|||
46686016|NCT01091428|82901236|FG001|Phase 2|Reason not specified|0|||
46686017|NCT01091428|82901237|FG002|Phase 2|Reason not specified|4|||
46686018|NCT01091428|82901238|FG003|Phase 2|Reason not specified|3|||
46686019|NCT01091428|82901235|FG000|Phase 2|Physician Decision|0|||
46686020|NCT01091428|82901236|FG001|Phase 2|Physician Decision|0|||
46686021|NCT01091428|82901237|FG002|Phase 2|Physician Decision|2|||
46686022|NCT01091428|82901238|FG003|Phase 2|Physician Decision|0|||
46686023|NCT01096342|82901257|FG000|Overall Study|Protocol Violation|1|||
46686024|NCT01039519|82901261|FG000|Treatment|Progressive disease|20|||
46686025|NCT01039519|82901261|FG000|Treatment|Treatment failure|2|||
46686026|NCT01039519|82901261|FG000|Treatment|Adverse Event|3|||
46686027|NCT01039519|82901261|FG000|Treatment|Physician Decision|2|||
46686028|NCT01039519|82901261|FG000|Survival Follow-up|Death|23|||
46799163|NCT02733042|83018015|FG001|Overall Study|Withdrawal by Subject|1|||
46799164|NCT02733042|83018016|FG002|Overall Study|Withdrawal by Subject|2|||
46799165|NCT02733042|83018017|FG003|Overall Study|Withdrawal by Subject|1|||
46799166|NCT02733042|83018018|FG004|Overall Study|Withdrawal by Subject|1|||
46799167|NCT02733042|83018019|FG005|Overall Study|Withdrawal by Subject|0|||
46799168|NCT02733042|83018020|FG006|Overall Study|Withdrawal by Subject|0|||
46799169|NCT02733042|83018021|FG007|Overall Study|Withdrawal by Subject|0|||
46799170|NCT02733042|83018022|FG008|Overall Study|Withdrawal by Subject|1|||
46799171|NCT02733042|83018023|FG009|Overall Study|Withdrawal by Subject|1|||
46799172|NCT02733042|83018024|FG010|Overall Study|Withdrawal by Subject|0|||
46799173|NCT02733042|83018025|FG011|Overall Study|Withdrawal by Subject|2|||
46799174|NCT02733042|83018026|FG012|Overall Study|Withdrawal by Subject|1|||
46799175|NCT02733042|83018027|FG013|Overall Study|Withdrawal by Subject|1|||
46799176|NCT02733042|83018028|FG014|Overall Study|Withdrawal by Subject|0|||
46799177|NCT02733042|83018029|FG015|Overall Study|Withdrawal by Subject|0|||
46799178|NCT02733042|83018030|FG016|Overall Study|Withdrawal by Subject|0|||
46799179|NCT02733042|83018031|FG017|Overall Study|Withdrawal by Subject|0|||
46799180|NCT02733042|83018032|FG018|Overall Study|Withdrawal by Subject|0|||
46799181|NCT02733042|83018014|FG000|Overall Study|Other Reasons|0|||
46799182|NCT02733042|83018015|FG001|Overall Study|Other Reasons|0|||
46799183|NCT02733042|83018016|FG002|Overall Study|Other Reasons|1|||
46799184|NCT02733042|83018017|FG003|Overall Study|Other Reasons|0|||
46799185|NCT02733042|83018018|FG004|Overall Study|Other Reasons|0|||
46799186|NCT02733042|83018019|FG005|Overall Study|Other Reasons|0|||
46799187|NCT02733042|83018020|FG006|Overall Study|Other Reasons|0|||
46799188|NCT02733042|83018021|FG007|Overall Study|Other Reasons|0|||
46799189|NCT02733042|83018022|FG008|Overall Study|Other Reasons|0|||
46799190|NCT02733042|83018023|FG009|Overall Study|Other Reasons|1|||
46799191|NCT02733042|83018024|FG010|Overall Study|Other Reasons|1|||
46799192|NCT02733042|83018025|FG011|Overall Study|Other Reasons|0|||
46799193|NCT02733042|83018026|FG012|Overall Study|Other Reasons|0|||
46799194|NCT02733042|83018027|FG013|Overall Study|Other Reasons|0|||
46799195|NCT02733042|83018028|FG014|Overall Study|Other Reasons|0|||
46799196|NCT02733042|83018029|FG015|Overall Study|Other Reasons|1|||
46799197|NCT02733042|83018030|FG016|Overall Study|Other Reasons|0|||
46799198|NCT02733042|83018031|FG017|Overall Study|Other Reasons|1|||
46799199|NCT02733042|83018032|FG018|Overall Study|Other Reasons|0|||
46686029|NCT01039519|82901261|FG000|Survival Follow-up|Sponsor decision|4|||
46799200|NCT02733042|83018014|FG000|Overall Study|Death|0|||
46686030|NCT01096186|82901265|FG000|Overall Study|Adverse Event|16|||
46799201|NCT02733042|83018015|FG001|Overall Study|Death|0|||
46799202|NCT02733042|83018016|FG002|Overall Study|Death|0|||
46799203|NCT02733042|83018017|FG003|Overall Study|Death|0|||
46799204|NCT02733042|83018018|FG004|Overall Study|Death|0|||
46799205|NCT02733042|83018019|FG005|Overall Study|Death|0|||
46686031|NCT01096186|82901265|FG000|Overall Study|Death|4|||
46686032|NCT01096186|82901265|FG000|Overall Study|Lack of Efficacy|4|||
46686033|NCT01096186|82901265|FG000|Overall Study|Lost to Follow-up|2|||
46686034|NCT01096186|82901265|FG000|Overall Study|Withdrawal by Subject|22|||
46686035|NCT01096186|82901265|FG000|Overall Study|Physician Decision|1|||
46686036|NCT01096186|82901265|FG000|Overall Study|Noncompliance with study drug|1|||
46686037|NCT01032889|82901272|FG000|Overall Study|Adverse Event|2|||
46686038|NCT01032889|82901273|FG001|Overall Study|Adverse Event|2|||
46686039|NCT01032889|82901274|FG002|Overall Study|Adverse Event|0|||
46686040|NCT01032889|82901272|FG000|Overall Study|Withdrawal of Consent|1|||
46686041|NCT01032889|82901273|FG001|Overall Study|Withdrawal of Consent|2|||
46686042|NCT01032889|82901274|FG002|Overall Study|Withdrawal of Consent|1|||
46686043|NCT01032889|82901272|FG000|Overall Study|Patient Request|0|||
46686044|NCT01032889|82901273|FG001|Overall Study|Patient Request|1|||
46686045|NCT01032889|82901274|FG002|Overall Study|Patient Request|0|||
46686046|NCT01032889|82901272|FG000|Overall Study|Lost to Follow-up|1|||
46686047|NCT01032889|82901273|FG001|Overall Study|Lost to Follow-up|1|||
46686048|NCT01032889|82901274|FG002|Overall Study|Lost to Follow-up|0|||
46686049|NCT01032889|82901272|FG000|Overall Study|Lack of Submental Fat|2|||
46686050|NCT01032889|82901273|FG001|Overall Study|Lack of Submental Fat|8|||
46686051|NCT01032889|82901274|FG002|Overall Study|Lack of Submental Fat|1|||
46686052|NCT01032889|82901272|FG000|Overall Study|Miscellaneous Reasons|2|||
46686053|NCT01032889|82901273|FG001|Overall Study|Miscellaneous Reasons|1|||
46686054|NCT01032889|82901274|FG002|Overall Study|Miscellaneous Reasons|1|||
46686055|NCT01049503|82901288|FG000|Overall Study|Lost to Follow-up|11|||
46686056|NCT01049503|82901289|FG001|Overall Study|Lost to Follow-up|12|||
46686057|NCT01049503|82901290|FG002|Overall Study|Lost to Follow-up|24|||
46686058|NCT01049503|82901291|FG003|Overall Study|Lost to Follow-up|26|||
46686059|NCT01049503|82901292|FG004|Overall Study|Lost to Follow-up|27|||
46686060|NCT01049503|82901293|FG005|Overall Study|Lost to Follow-up|8|||
46686061|NCT01029925|82901316|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
46686062|NCT01029925|82901316|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
46686063|NCT01029925|82901316|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
46686064|NCT01029691|82901323|FG000|Continued APAP to Delivery|Death|0|||
46686065|NCT01029691|82901324|FG001|Continued APAP to Delivery|Death|0|||
46686066|NCT01029691|82901325|FG002|Continued APAP to Delivery|Death|1|||
46686067|NCT01029535|82901334|FG000|Overall Study|Lost to Follow-up|24|||
46686068|NCT01029535|82901334|FG000|Overall Study|Protocol Violation|2|||
46686069|NCT01029535|82901334|FG000|Overall Study|Participant Withdrew Consent|2|||
46686070|NCT01029535|82901334|FG000|Overall Study|Adverse Event|1|||
46686071|NCT01029535|82901334|FG000|Overall Study|Use of Another Treatment|1|||
46686072|NCT01029535|82901334|FG000|Overall Study|Death|1|||
46686073|NCT01028053|82901339|FG000|Overall Study|Screen Failure|113|||
46686074|NCT01028053|82901339|FG000|Overall Study|Patient Request|11|||
46686075|NCT01028053|82901339|FG000|Overall Study|Protocol Violation|1|||
46686076|NCT01028053|82901339|FG000|Overall Study|Physician Decision|2|||
46686077|NCT01028053|82901339|FG000|Overall Study|Technical Problem|1|||
46686078|NCT01028053|82901339|FG000|Overall Study|Terminated by Sponsor|1|||
46686079|NCT01028053|82901339|FG000|Overall Study|Various reasons|4|||
46686080|NCT01023217|82901347|FG000|Overall Study|Withdrawal by Subject|1|||
46686081|NCT01023217|82901348|FG001|Overall Study|Withdrawal by Subject|0|||
46686082|NCT01095796|82901356|FG000|Overall Study|Randomized but Not Treated|5|||
46686083|NCT01095796|82901357|FG001|Overall Study|Randomized but Not Treated|2|||
46686084|NCT01095796|82901356|FG000|Overall Study|Adverse Event|9|||
46686085|NCT01095796|82901357|FG001|Overall Study|Adverse Event|19|||
46686086|NCT01095796|82901356|FG000|Overall Study|Death|3|||
46686087|NCT01095796|82901357|FG001|Overall Study|Death|2|||
46686088|NCT01095796|82901356|FG000|Overall Study|Pregnancy|2|||
46686089|NCT01095796|82901357|FG001|Overall Study|Pregnancy|0|||
46686090|NCT01095796|82901356|FG000|Overall Study|Lack of Efficacy|5|||
46686091|NCT01095796|82901357|FG001|Overall Study|Lack of Efficacy|3|||
46686092|NCT01095796|82901356|FG000|Overall Study|Investigator's Discretion|7|||
46686093|NCT01095796|82901357|FG001|Overall Study|Investigator's Discretion|2|||
46686094|NCT01095796|82901356|FG000|Overall Study|Withdrew Consent|16|||
46686095|NCT01095796|82901357|FG001|Overall Study|Withdrew Consent|22|||
46686096|NCT01095796|82901356|FG000|Overall Study|Lost to Follow-up|27|||
46686097|NCT01095796|82901357|FG001|Overall Study|Lost to Follow-up|29|||
46686098|NCT01095796|82901356|FG000|Overall Study|Participant Noncompliance|5|||
46686099|NCT01095796|82901357|FG001|Overall Study|Participant Noncompliance|10|||
46686100|NCT01095796|82901356|FG000|Overall Study|Protocol Violation|1|||
46686101|NCT01095796|82901357|FG001|Overall Study|Protocol Violation|0|||
46686102|NCT01095796|82901356|FG000|Overall Study|Participant Transferred to Another Study|215|||
46686103|NCT01095796|82901357|FG001|Overall Study|Participant Transferred to Another Study|200|||
46686104|NCT01023061|82901363|FG000|Overall Study|Withdrawal prior to treatment|2|||
46686105|NCT01027897|82901367|FG000|Overall Study|Protocol Violation|1|||
46686106|NCT01027897|82901367|FG000|Overall Study|Withdrawal by Subject|1|||
46686107|NCT01027351|82901377|FG000|Overall Study|Withdrawal by Subject|1|||
46686108|NCT01027351|82901378|FG001|Overall Study|Withdrawal by Subject|0|||
46686109|NCT01027351|82901379|FG002|Overall Study|Withdrawal by Subject|1|||
46686110|NCT01027351|82901380|FG003|Overall Study|Withdrawal by Subject|0|||
46799206|NCT02733042|83018020|FG006|Overall Study|Death|1|||
46799207|NCT02733042|83018021|FG007|Overall Study|Death|0|||
46686111|NCT01027351|82901381|FG004|Overall Study|Withdrawal by Subject|3|||
46686112|NCT01027351|82901382|FG005|Overall Study|Withdrawal by Subject|5|||
46686113|NCT01027351|82901377|FG000|Overall Study|Lost to Follow-up|1|||
46686114|NCT01027351|82901378|FG001|Overall Study|Lost to Follow-up|1|||
46686115|NCT01027351|82901379|FG002|Overall Study|Lost to Follow-up|0|||
46686116|NCT01027351|82901380|FG003|Overall Study|Lost to Follow-up|1|||
46686117|NCT01027351|82901381|FG004|Overall Study|Lost to Follow-up|6|||
46686118|NCT01027351|82901382|FG005|Overall Study|Lost to Follow-up|0|||
46686119|NCT01027351|82901377|FG000|Overall Study|Inappropriate enrollment|0|||
46686120|NCT01027351|82901378|FG001|Overall Study|Inappropriate enrollment|0|||
46686121|NCT01027351|82901379|FG002|Overall Study|Inappropriate enrollment|0|||
46686122|NCT01027351|82901380|FG003|Overall Study|Inappropriate enrollment|0|||
46686123|NCT01027351|82901381|FG004|Overall Study|Inappropriate enrollment|1|||
46686124|NCT01027351|82901382|FG005|Overall Study|Inappropriate enrollment|0|||
46686125|NCT01027351|82901377|FG000|Overall Study|Protocol Violation|1|||
46686126|NCT01027351|82901378|FG001|Overall Study|Protocol Violation|0|||
46686127|NCT01027351|82901379|FG002|Overall Study|Protocol Violation|0|||
46686128|NCT01027351|82901380|FG003|Overall Study|Protocol Violation|1|||
46686129|NCT01027351|82901381|FG004|Overall Study|Protocol Violation|1|||
46686130|NCT01027351|82901382|FG005|Overall Study|Protocol Violation|0|||
46686131|NCT01027273|82901405|FG000|Overall Study|Lost to Follow-up|57|||
46686132|NCT01027273|82901406|FG001|Overall Study|Lost to Follow-up|31|||
46686133|NCT01027273|82901405|FG000|Overall Study|Death|2|||
46686134|NCT01027273|82901406|FG001|Overall Study|Death|2|||
46799208|NCT02733042|83018022|FG008|Overall Study|Death|1|||
46799209|NCT02733042|83018023|FG009|Overall Study|Death|0|||
46686135|NCT01022203|82901414|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
46686136|NCT01022203|82901415|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
46686137|NCT01022203|82901414|FG000|Post Treatment Assessment|Physician Decision|2|||
46686138|NCT01022203|82901415|FG001|Post Treatment Assessment|Physician Decision|0|||
46686139|NCT01022203|82901414|FG000|Post Treatment Assessment|Adverse Event|0|||
46686140|NCT01022203|82901415|FG001|Post Treatment Assessment|Adverse Event|2|||
46686141|NCT01022203|82901414|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
46686142|NCT01022203|82901415|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
46686143|NCT01296711|82901432|FG000|Overall Study|Adverse Event|3|||
46686144|NCT01296711|82901433|FG001|Overall Study|Adverse Event|1|||
46799210|NCT02733042|83018024|FG010|Overall Study|Death|1|||
46799211|NCT02733042|83018025|FG011|Overall Study|Death|0|||
46799212|NCT02733042|83018026|FG012|Overall Study|Death|0|||
46686145|NCT01296711|82901434|FG002|Overall Study|Adverse Event|4|||
46686146|NCT01296711|82901435|FG003|Overall Study|Adverse Event|3|||
46686147|NCT01296711|82901436|FG004|Overall Study|Adverse Event|1|||
46686148|NCT01296711|82901437|FG005|Overall Study|Adverse Event|6|||
46686149|NCT01296711|82901438|FG006|Overall Study|Adverse Event|11|||
46686150|NCT01296711|82901439|FG007|Overall Study|Adverse Event|3|||
46686151|NCT01296711|82901432|FG000|Overall Study|Lack of Efficacy|1|||
46686152|NCT01296711|82901433|FG001|Overall Study|Lack of Efficacy|4|||
46686153|NCT01296711|82901434|FG002|Overall Study|Lack of Efficacy|1|||
46686154|NCT01296711|82901435|FG003|Overall Study|Lack of Efficacy|1|||
46686155|NCT01296711|82901436|FG004|Overall Study|Lack of Efficacy|1|||
46686156|NCT01296711|82901437|FG005|Overall Study|Lack of Efficacy|0|||
46686157|NCT01296711|82901438|FG006|Overall Study|Lack of Efficacy|2|||
46686158|NCT01296711|82901439|FG007|Overall Study|Lack of Efficacy|3|||
46686159|NCT01296711|82901432|FG000|Overall Study|Lost to Follow-up|0|||
46686160|NCT01296711|82901433|FG001|Overall Study|Lost to Follow-up|0|||
46686161|NCT01296711|82901434|FG002|Overall Study|Lost to Follow-up|1|||
46686162|NCT01296711|82901435|FG003|Overall Study|Lost to Follow-up|1|||
46686163|NCT01296711|82901436|FG004|Overall Study|Lost to Follow-up|2|||
46686164|NCT01296711|82901437|FG005|Overall Study|Lost to Follow-up|0|||
46686165|NCT01296711|82901438|FG006|Overall Study|Lost to Follow-up|4|||
46686166|NCT01296711|82901439|FG007|Overall Study|Lost to Follow-up|2|||
46686167|NCT01296711|82901432|FG000|Overall Study|Protocol Violation|0|||
46686168|NCT01296711|82901433|FG001|Overall Study|Protocol Violation|0|||
46686169|NCT01296711|82901434|FG002|Overall Study|Protocol Violation|0|||
46686170|NCT01296711|82901435|FG003|Overall Study|Protocol Violation|1|||
46686171|NCT01296711|82901436|FG004|Overall Study|Protocol Violation|1|||
46686172|NCT01296711|82901437|FG005|Overall Study|Protocol Violation|0|||
46686173|NCT01296711|82901438|FG006|Overall Study|Protocol Violation|0|||
46686174|NCT01296711|82901439|FG007|Overall Study|Protocol Violation|0|||
46686175|NCT01296711|82901432|FG000|Overall Study|Withdrawal by Subject|4|||
46858480|NCT00312221|83074230|FG000|Double-blind Phase|Withdrawal by Subject|0|||
46858481|NCT00312221|83074231|FG001|Double-blind Phase|Withdrawal by Subject|6|||
46981683|NCT02347761|83227738|FG000|On Study Treatment|non-compliance with study medication|0|||
46686176|NCT01296711|82901433|FG001|Overall Study|Withdrawal by Subject|2|||
46686177|NCT01296711|82901434|FG002|Overall Study|Withdrawal by Subject|2|||
46686178|NCT01296711|82901435|FG003|Overall Study|Withdrawal by Subject|1|||
46686179|NCT01296711|82901436|FG004|Overall Study|Withdrawal by Subject|1|||
46686180|NCT01296711|82901437|FG005|Overall Study|Withdrawal by Subject|1|||
46686181|NCT01296711|82901438|FG006|Overall Study|Withdrawal by Subject|2|||
46686182|NCT01296711|82901439|FG007|Overall Study|Withdrawal by Subject|1|||
46686183|NCT01296711|82901432|FG000|Overall Study|Study termination|8|||
46686184|NCT01296711|82901433|FG001|Overall Study|Study termination|1|||
46686185|NCT01296711|82901434|FG002|Overall Study|Study termination|5|||
46686186|NCT01296711|82901435|FG003|Overall Study|Study termination|4|||
46686187|NCT01296711|82901436|FG004|Overall Study|Study termination|4|||
46686188|NCT01296711|82901437|FG005|Overall Study|Study termination|4|||
46686189|NCT01296711|82901438|FG006|Overall Study|Study termination|8|||
46686190|NCT01296711|82901439|FG007|Overall Study|Study termination|10|||
46981684|NCT02347761|83227739|FG001|On Study Treatment|non-compliance with study medication|0|||
46981685|NCT02347761|83227740|FG002|On Study Treatment|non-compliance with study medication|2|||
46981686|NCT02347761|83227738|FG000|On Study Treatment|Withdrawal by Subject|7|||
46981687|NCT02347761|83227739|FG001|On Study Treatment|Withdrawal by Subject|3|||
46981688|NCT02347761|83227740|FG002|On Study Treatment|Withdrawal by Subject|5|||
46981689|NCT02347761|83227738|FG000|On Study Treatment|move/travel|2|||
46981690|NCT02347761|83227739|FG001|On Study Treatment|move/travel|6|||
46686191|NCT01296711|82901432|FG000|Overall Study|Continued elevated liver enzymes|0|||
46686192|NCT01296711|82901433|FG001|Overall Study|Continued elevated liver enzymes|0|||
46686193|NCT01296711|82901434|FG002|Overall Study|Continued elevated liver enzymes|0|||
46686194|NCT01296711|82901435|FG003|Overall Study|Continued elevated liver enzymes|1|||
46686195|NCT01296711|82901436|FG004|Overall Study|Continued elevated liver enzymes|0|||
46686196|NCT01296711|82901437|FG005|Overall Study|Continued elevated liver enzymes|0|||
46686197|NCT01296711|82901438|FG006|Overall Study|Continued elevated liver enzymes|0|||
46686198|NCT01296711|82901439|FG007|Overall Study|Continued elevated liver enzymes|0|||
46686199|NCT01296711|82901432|FG000|Overall Study|Methotrexate discontinued|0|||
46686200|NCT01296711|82901433|FG001|Overall Study|Methotrexate discontinued|0|||
46686201|NCT01296711|82901434|FG002|Overall Study|Methotrexate discontinued|0|||
46686202|NCT01296711|82901435|FG003|Overall Study|Methotrexate discontinued|1|||
46686203|NCT01296711|82901436|FG004|Overall Study|Methotrexate discontinued|0|||
46686204|NCT01296711|82901437|FG005|Overall Study|Methotrexate discontinued|0|||
46686205|NCT01296711|82901438|FG006|Overall Study|Methotrexate discontinued|0|||
46686206|NCT01296711|82901439|FG007|Overall Study|Methotrexate discontinued|0|||
46686207|NCT01296711|82901432|FG000|Overall Study|Investigator discretion|0|||
46686208|NCT01296711|82901433|FG001|Overall Study|Investigator discretion|0|||
46686209|NCT01296711|82901434|FG002|Overall Study|Investigator discretion|0|||
46686210|NCT01296711|82901435|FG003|Overall Study|Investigator discretion|0|||
46686211|NCT01296711|82901436|FG004|Overall Study|Investigator discretion|0|||
46686212|NCT01296711|82901437|FG005|Overall Study|Investigator discretion|0|||
46686213|NCT01296711|82901438|FG006|Overall Study|Investigator discretion|1|||
46686214|NCT01296711|82901439|FG007|Overall Study|Investigator discretion|0|||
46686215|NCT01296711|82901432|FG000|Overall Study|Other|0|||
46686216|NCT01296711|82901433|FG001|Overall Study|Other|0|||
46686217|NCT01296711|82901434|FG002|Overall Study|Other|0|||
46686218|NCT01296711|82901435|FG003|Overall Study|Other|0|||
46686219|NCT01296711|82901436|FG004|Overall Study|Other|0|||
46686220|NCT01296711|82901437|FG005|Overall Study|Other|0|||
46686221|NCT01296711|82901438|FG006|Overall Study|Other|1|||
46686222|NCT01296711|82901439|FG007|Overall Study|Other|0|||
46686223|NCT01296711|82901432|FG000|Overall Study|Required restricted steroid injections|0|||
46686224|NCT01296711|82901433|FG001|Overall Study|Required restricted steroid injections|0|||
46686225|NCT01296711|82901434|FG002|Overall Study|Required restricted steroid injections|0|||
46686226|NCT01296711|82901435|FG003|Overall Study|Required restricted steroid injections|0|||
46686227|NCT01296711|82901436|FG004|Overall Study|Required restricted steroid injections|0|||
46686228|NCT01296711|82901437|FG005|Overall Study|Required restricted steroid injections|0|||
46686229|NCT01296711|82901438|FG006|Overall Study|Required restricted steroid injections|1|||
46686230|NCT01296711|82901439|FG007|Overall Study|Required restricted steroid injections|0|||
46686231|NCT01296711|82901432|FG000|Overall Study|Ongoing missed appointments|0|||
46686232|NCT01296711|82901433|FG001|Overall Study|Ongoing missed appointments|0|||
46686233|NCT01296711|82901434|FG002|Overall Study|Ongoing missed appointments|0|||
46686234|NCT01296711|82901435|FG003|Overall Study|Ongoing missed appointments|0|||
46686235|NCT01296711|82901436|FG004|Overall Study|Ongoing missed appointments|0|||
46686236|NCT01296711|82901437|FG005|Overall Study|Ongoing missed appointments|0|||
46686237|NCT01296711|82901438|FG006|Overall Study|Ongoing missed appointments|1|||
46686238|NCT01296711|82901439|FG007|Overall Study|Ongoing missed appointments|0|||
46686239|NCT01296711|82901432|FG000|Overall Study|Failure to comply with visits|0|||
46686240|NCT01296711|82901433|FG001|Overall Study|Failure to comply with visits|0|||
46686241|NCT01296711|82901434|FG002|Overall Study|Failure to comply with visits|0|||
46686242|NCT01296711|82901435|FG003|Overall Study|Failure to comply with visits|0|||
46686243|NCT01296711|82901436|FG004|Overall Study|Failure to comply with visits|0|||
46686244|NCT01296711|82901437|FG005|Overall Study|Failure to comply with visits|0|||
46686245|NCT01296711|82901438|FG006|Overall Study|Failure to comply with visits|0|||
46686246|NCT01296711|82901439|FG007|Overall Study|Failure to comply with visits|1|||
46686247|NCT01296711|82901432|FG000|Overall Study|Patient decision due to transport|0|||
46686248|NCT01296711|82901433|FG001|Overall Study|Patient decision due to transport|0|||
46686249|NCT01296711|82901434|FG002|Overall Study|Patient decision due to transport|0|||
46686250|NCT01296711|82901435|FG003|Overall Study|Patient decision due to transport|0|||
46686251|NCT01296711|82901436|FG004|Overall Study|Patient decision due to transport|0|||
46686252|NCT01296711|82901437|FG005|Overall Study|Patient decision due to transport|0|||
46686253|NCT01296711|82901438|FG006|Overall Study|Patient decision due to transport|0|||
46686254|NCT01296711|82901439|FG007|Overall Study|Patient decision due to transport|1|||
46686255|NCT01294917|82901457|FG000|Overall Study|Relocation|5|||
46686256|NCT01294917|82901457|FG000|Overall Study|Inconvenience|1|||
46686257|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
46686258|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
46686259|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
46686260|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
46686261|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
46686262|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
46686263|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
46686264|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
46686265|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
46686266|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
46686267|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
46686268|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
46686269|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
46686270|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
46686271|NCT01294683|82901465|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
46686272|NCT01294683|82901466|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
46686273|NCT01294683|82901465|FG000|Post Crossover (Period III)|Adverse Event|6|||
46686274|NCT01294683|82901466|FG001|Post Crossover (Period III)|Adverse Event|6|||
46686275|NCT01294683|82901465|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
46686276|NCT01294683|82901466|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
46686277|NCT01294683|82901465|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
46686278|NCT01294683|82901466|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
46686279|NCT01294683|82901465|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
46686280|NCT01294683|82901466|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
46686281|NCT01294449|82901480|FG000|Overall Study|Death|11|||
46686282|NCT01294449|82901481|FG001|Overall Study|Death|12|||
46686283|NCT01294449|82901480|FG000|Overall Study|Withdrawal by Subject|1|||
46686284|NCT01294449|82901481|FG001|Overall Study|Withdrawal by Subject|3|||
46686285|NCT01294371|82901487|FG000|Overall Study|Adverse Event|1|||
46686286|NCT01294371|82901487|FG000|Overall Study|Withdrawal by Subject|12|||
46686287|NCT01294371|82901487|FG000|Overall Study|Lost to Follow-up|6|||
46686288|NCT01294371|82901487|FG000|Overall Study|Administrative Reason|1|||
46686289|NCT01294371|82901487|FG000|Overall Study|Other|14|||
46686290|NCT01293123|82901496|FG000|Overall Study|Lost to Follow-up|0|||
46686291|NCT01293123|82901497|FG001|Overall Study|Lost to Follow-up|1|||
46686292|NCT01292187|82901505|FG000|Overall Study|Adverse Event|10|||
46686293|NCT01292187|82901506|FG001|Overall Study|Adverse Event|5|||
46799213|NCT02733042|83018027|FG013|Overall Study|Death|0|||
46799214|NCT02733042|83018028|FG014|Overall Study|Death|1|||
46799215|NCT02733042|83018029|FG015|Overall Study|Death|2|||
46799216|NCT02733042|83018030|FG016|Overall Study|Death|0|||
46799217|NCT02733042|83018031|FG017|Overall Study|Death|0|||
46799218|NCT02733042|83018032|FG018|Overall Study|Death|0|||
46799219|NCT02614066|83018085|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
46799220|NCT02614066|83018086|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
46858482|NCT00312221|83074232|FG002|Double-blind Phase|Withdrawal by Subject|8|||
46981691|NCT02347761|83227740|FG002|On Study Treatment|move/travel|5|||
46858483|NCT00312221|83074233|FG003|Double-blind Phase|Withdrawal by Subject|7|||
46858484|NCT00312221|83074230|FG000|Double-blind Phase|Adverse Event|0|||
46858485|NCT00312221|83074231|FG001|Double-blind Phase|Adverse Event|10|||
46858486|NCT00312221|83074232|FG002|Double-blind Phase|Adverse Event|19|||
46858487|NCT00312221|83074233|FG003|Double-blind Phase|Adverse Event|18|||
46858488|NCT00312221|83074230|FG000|Double-blind Phase|Lost to Follow-up|0|||
46858489|NCT00312221|83074231|FG001|Double-blind Phase|Lost to Follow-up|0|||
46858490|NCT00312221|83074232|FG002|Double-blind Phase|Lost to Follow-up|2|||
46858491|NCT00312221|83074233|FG003|Double-blind Phase|Lost to Follow-up|2|||
46858492|NCT00312221|83074230|FG000|Double-blind Phase|Administrative|0|||
46858493|NCT00312221|83074231|FG001|Double-blind Phase|Administrative|26|||
46858494|NCT00312221|83074232|FG002|Double-blind Phase|Administrative|37|||
46858495|NCT00312221|83074233|FG003|Double-blind Phase|Administrative|33|||
46858496|NCT00312221|83074230|FG000|Double-blind Phase|Lack of Efficacy|0|||
46858497|NCT00312221|83074231|FG001|Double-blind Phase|Lack of Efficacy|17|||
46858498|NCT00312221|83074232|FG002|Double-blind Phase|Lack of Efficacy|6|||
46858499|NCT00312221|83074233|FG003|Double-blind Phase|Lack of Efficacy|10|||
46858500|NCT03294538|83074257|FG000|Overall Study|Adverse Event|0|||
46858501|NCT03294538|83074258|FG001|Overall Study|Adverse Event|1|||
46858502|NCT03294538|83074259|FG002|Overall Study|Adverse Event|1|||
46858503|NCT03294538|83074257|FG000|Overall Study|Lost to Follow-up|1|||
46858504|NCT03294538|83074258|FG001|Overall Study|Lost to Follow-up|0|||
46686294|NCT01292187|82901505|FG000|Overall Study|Withdrawal by Subject|6|||
46686295|NCT01292187|82901506|FG001|Overall Study|Withdrawal by Subject|5|||
46686296|NCT01292187|82901505|FG000|Overall Study|All other reasons|1|||
46686297|NCT01292187|82901506|FG001|Overall Study|All other reasons|3|||
46799221|NCT02614066|83018087|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
46799222|NCT02614066|83018088|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
46858505|NCT03294538|83074259|FG002|Overall Study|Lost to Follow-up|0|||
46686298|NCT01026493|82901521|FG000|Overall Study|Protocol Violation|0|||
46858506|NCT03294538|83074257|FG000|Overall Study|Outside of Visit Window|4|||
46686299|NCT01026493|82901522|FG001|Overall Study|Protocol Violation|1|||
46686300|NCT01026493|82901523|FG002|Overall Study|Protocol Violation|0|||
46686301|NCT01026493|82901524|FG003|Overall Study|Protocol Violation|0|||
46686302|NCT01026493|82901525|FG004|Overall Study|Protocol Violation|2|||
46686303|NCT01026493|82901526|FG005|Overall Study|Protocol Violation|3|||
46686304|NCT01026493|82901527|FG006|Overall Study|Protocol Violation|4|||
46686305|NCT01026493|82901528|FG007|Overall Study|Protocol Violation|1|||
46686306|NCT01026103|82901546|FG000|Overall Study|Physician Decision|1|||
46686307|NCT01026103|82901546|FG000|Overall Study|did not receive study device bc of error|1|||
46686308|NCT01291173|82901554|FG000|Overall Study|Adverse Event|0|||
46686309|NCT01291173|82901555|FG001|Overall Study|Adverse Event|3|||
46686310|NCT01291173|82901556|FG002|Overall Study|Adverse Event|1|||
46686311|NCT01291173|82901557|FG003|Overall Study|Adverse Event|3|||
46686312|NCT01291173|82901554|FG000|Overall Study|Protocol Violation|7|||
46686313|NCT01291173|82901555|FG001|Overall Study|Protocol Violation|2|||
46686314|NCT01291173|82901556|FG002|Overall Study|Protocol Violation|2|||
46686315|NCT01291173|82901557|FG003|Overall Study|Protocol Violation|5|||
46686316|NCT01291173|82901554|FG000|Overall Study|Withdrawal by Subject|6|||
46686317|NCT01291173|82901555|FG001|Overall Study|Withdrawal by Subject|4|||
46686318|NCT01291173|82901556|FG002|Overall Study|Withdrawal by Subject|4|||
46686319|NCT01291173|82901557|FG003|Overall Study|Withdrawal by Subject|2|||
46686320|NCT01291173|82901554|FG000|Overall Study|Lost to Follow-up|4|||
46686321|NCT01291173|82901555|FG001|Overall Study|Lost to Follow-up|6|||
46686322|NCT01291173|82901556|FG002|Overall Study|Lost to Follow-up|3|||
46686323|NCT01291173|82901557|FG003|Overall Study|Lost to Follow-up|2|||
46686324|NCT01291173|82901554|FG000|Overall Study|Unable to meet visit schedule|0|||
46686325|NCT01291173|82901555|FG001|Overall Study|Unable to meet visit schedule|0|||
46686326|NCT01291173|82901556|FG002|Overall Study|Unable to meet visit schedule|1|||
46686327|NCT01291173|82901557|FG003|Overall Study|Unable to meet visit schedule|0|||
46686328|NCT01291173|82901554|FG000|Overall Study|Lack of compliance|0|||
46686329|NCT01291173|82901555|FG001|Overall Study|Lack of compliance|0|||
46686330|NCT01291173|82901556|FG002|Overall Study|Lack of compliance|0|||
46686331|NCT01291173|82901557|FG003|Overall Study|Lack of compliance|1|||
46686332|NCT01291173|82901554|FG000|Overall Study|Subject was unblinded|0|||
46686333|NCT01291173|82901555|FG001|Overall Study|Subject was unblinded|0|||
46686334|NCT01291173|82901556|FG002|Overall Study|Subject was unblinded|1|||
46686335|NCT01291173|82901557|FG003|Overall Study|Subject was unblinded|0|||
46686336|NCT01291173|82901554|FG000|Overall Study|Excluded therapy|0|||
46686337|NCT01291173|82901555|FG001|Overall Study|Excluded therapy|0|||
46799223|NCT02614066|83018085|FG000|Overall Study|Full Consent Withdrawn|0|||
46799224|NCT02614066|83018086|FG001|Overall Study|Full Consent Withdrawn|1|||
46799225|NCT02614066|83018087|FG002|Overall Study|Full Consent Withdrawn|0|||
46799226|NCT02614066|83018088|FG003|Overall Study|Full Consent Withdrawn|3|||
46799227|NCT02614066|83018085|FG000|Overall Study|Lost to Follow-up|0|||
46799228|NCT02614066|83018086|FG001|Overall Study|Lost to Follow-up|1|||
46799229|NCT02614066|83018087|FG002|Overall Study|Lost to Follow-up|0|||
46799230|NCT02614066|83018088|FG003|Overall Study|Lost to Follow-up|0|||
46799231|NCT02614066|83018085|FG000|Overall Study|Still on-study|1|||
46799232|NCT02614066|83018086|FG001|Overall Study|Still on-study|9|||
46799233|NCT02614066|83018087|FG002|Overall Study|Still on-study|5|||
46799234|NCT02614066|83018088|FG003|Overall Study|Still on-study|32|||
46799235|NCT02614066|83018085|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
46799236|NCT02614066|83018086|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
46799237|NCT02614066|83018087|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
46799238|NCT02614066|83018088|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
46799239|NCT02504866|83018152|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
46799240|NCT02504866|83018153|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
46799241|NCT02504866|83018154|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
46799242|NCT02459769|83018166|FG000|Overall Study|Withdrawal by Subject|7|||
46799243|NCT02459769|83018167|FG001|Overall Study|Withdrawal by Subject|4|||
46799244|NCT02459769|83018168|FG002|Overall Study|Withdrawal by Subject|8|||
46799245|NCT02459769|83018169|FG003|Overall Study|Withdrawal by Subject|5|||
46799246|NCT02459769|83018166|FG000|Overall Study|Lost to Follow-up|1|||
46799247|NCT02459769|83018167|FG001|Overall Study|Lost to Follow-up|0|||
46799248|NCT02459769|83018168|FG002|Overall Study|Lost to Follow-up|1|||
46799249|NCT02459769|83018169|FG003|Overall Study|Lost to Follow-up|0|||
46799250|NCT02369016|83018181|FG000|Overall Study|AE associated with clinical disease progression|2|||
46799251|NCT02369016|83018182|FG001|Overall Study|AE associated with clinical disease progression|1|||
46858507|NCT03294538|83074258|FG001|Overall Study|Outside of Visit Window|4|||
46981692|NCT02347761|83227738|FG000|On Study Treatment|dissastisfaction with device|2|||
46686338|NCT01291173|82901556|FG002|Overall Study|Excluded therapy|1|||
46686339|NCT01291173|82901557|FG003|Overall Study|Excluded therapy|0|||
46686340|NCT01291017|82901567|FG000|Overall Study|Lost to Follow-up|2|||
46686341|NCT01291017|82901567|FG000|Overall Study|Withdrawal by Subject|3|||
46686342|NCT01290315|82901575|FG000|Overall Study|Adverse Event|0|||
46686343|NCT01290315|82901576|FG001|Overall Study|Adverse Event|0|||
46799252|NCT02369016|83018181|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
46686344|NCT01290315|82901577|FG002|Overall Study|Adverse Event|0|||
46686345|NCT01290315|82901578|FG003|Overall Study|Adverse Event|3|||
46686346|NCT01290315|82901575|FG000|Overall Study|Selection criteria/compliance|2|||
46686347|NCT01290315|82901576|FG001|Overall Study|Selection criteria/compliance|1|||
46686348|NCT01290315|82901577|FG002|Overall Study|Selection criteria/compliance|0|||
46686349|NCT01290315|82901578|FG003|Overall Study|Selection criteria/compliance|2|||
46686350|NCT01290315|82901575|FG000|Overall Study|Lost to Follow-up|0|||
46686351|NCT01290315|82901576|FG001|Overall Study|Lost to Follow-up|1|||
46686352|NCT01290315|82901577|FG002|Overall Study|Lost to Follow-up|0|||
46686353|NCT01290315|82901578|FG003|Overall Study|Lost to Follow-up|0|||
46686354|NCT01290315|82901575|FG000|Overall Study|Withdrawal by Subject|1|||
46686355|NCT01290315|82901576|FG001|Overall Study|Withdrawal by Subject|1|||
46686356|NCT01290315|82901577|FG002|Overall Study|Withdrawal by Subject|0|||
46686357|NCT01290315|82901578|FG003|Overall Study|Withdrawal by Subject|0|||
46686358|NCT01289847|82901587|FG000|Overall Study|Patient could not comply with visits|1|||
46686359|NCT01079182|82901591|FG000|Overall Study|Lost to Follow-up|1634|||
46686360|NCT01079182|82901591|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
46686361|NCT01079182|82901591|FG000|Overall Study|Lack of Efficacy|514|||
46686362|NCT01079182|82901591|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
46686363|NCT01079182|82901591|FG000|Overall Study|Reasons not Evaluated|271|||
46686364|NCT01021813|82901597|FG000|DB Treatment Phase|Adverse Event|60|||
46686365|NCT01021813|82901598|FG001|DB Treatment Phase|Adverse Event|22|||
46686366|NCT01021813|82901599|FG002|DB Treatment Phase|Adverse Event|0|||
46686367|NCT01021813|82901600|FG003|DB Treatment Phase|Adverse Event|0|||
46686368|NCT01021813|82901601|FG004|DB Treatment Phase|Adverse Event|0|||
46686369|NCT01021813|82901597|FG000|DB Treatment Phase|Lack of Efficacy|44|||
46686370|NCT01021813|82901598|FG001|DB Treatment Phase|Lack of Efficacy|28|||
46799253|NCT02369016|83018182|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
46799254|NCT02369016|83018181|FG000|Overall Study|Progressive disease - clinical progression|1|||
46799255|NCT02369016|83018182|FG001|Overall Study|Progressive disease - clinical progression|4|||
46799256|NCT02369016|83018181|FG000|Overall Study|withdrawal by patient|4|||
46799257|NCT02369016|83018182|FG001|Overall Study|withdrawal by patient|0|||
46799258|NCT02369016|83018181|FG000|Overall Study|Progressive disease - radiological progression|6|||
46799259|NCT02369016|83018182|FG001|Overall Study|Progressive disease - radiological progression|2|||
46799260|NCT02363959|83018195|FG000|Overall Study|Medical instability|1|||
46799261|NCT02363959|83018196|FG001|Overall Study|Medical instability|0|||
46799262|NCT01756040|83018210|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
46799263|NCT01756040|83018210|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
46799264|NCT01756040|83018210|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
46799265|NCT00567164|83018229|FG000|Overall Study|Withdrawal by Subject|171|||
46799266|NCT00567164|83018230|FG001|Overall Study|Withdrawal by Subject|21|||
46799267|NCT00567164|83018231|FG002|Overall Study|Withdrawal by Subject|17|||
46799268|NCT00567164|83018229|FG000|Overall Study|Protocol Violation|23|||
46799269|NCT00567164|83018230|FG001|Overall Study|Protocol Violation|4|||
46799270|NCT00567164|83018231|FG002|Overall Study|Protocol Violation|2|||
46799271|NCT00567164|83018229|FG000|Overall Study|Adverse Event|92|||
46799272|NCT00567164|83018230|FG001|Overall Study|Adverse Event|13|||
46799273|NCT00567164|83018231|FG002|Overall Study|Adverse Event|9|||
46799274|NCT00567164|83018229|FG000|Overall Study|Death|0|||
46799275|NCT00567164|83018230|FG001|Overall Study|Death|0|||
46799276|NCT00567164|83018231|FG002|Overall Study|Death|1|||
46799277|NCT00567164|83018229|FG000|Overall Study|Lost to Follow-up|202|||
46799278|NCT00567164|83018230|FG001|Overall Study|Lost to Follow-up|23|||
46799279|NCT00567164|83018231|FG002|Overall Study|Lost to Follow-up|21|||
46799280|NCT00567164|83018229|FG000|Overall Study|Pregnancy|20|||
46799281|NCT00567164|83018230|FG001|Overall Study|Pregnancy|4|||
46799282|NCT00567164|83018231|FG002|Overall Study|Pregnancy|6|||
46799283|NCT00567164|83018229|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
46799284|NCT00567164|83018230|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
46799285|NCT00567164|83018231|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
46799286|NCT00567164|83018229|FG000|Overall Study|Missing|1|||
46799287|NCT00567164|83018230|FG001|Overall Study|Missing|0|||
46799288|NCT00567164|83018231|FG002|Overall Study|Missing|0|||
46799289|NCT00713219|83018243|FG000|Overall Study|Death|1|||
46799290|NCT00713219|83018243|FG000|Overall Study|Protocol Violation|1|||
46799291|NCT00712985|83018247|FG000|Overall Study|1 withdrew prior to start of drug|1|||
46799292|NCT00712985|83018247|FG000|Overall Study|1 patient moved out of state|1|||
46799293|NCT00712985|83018247|FG000|Overall Study|Lack of Efficacy|3|||
46686371|NCT01021813|82901599|FG002|DB Treatment Phase|Lack of Efficacy|0|||
46686372|NCT01021813|82901600|FG003|DB Treatment Phase|Lack of Efficacy|0|||
46686373|NCT01021813|82901601|FG004|DB Treatment Phase|Lack of Efficacy|0|||
46686374|NCT01021813|82901597|FG000|DB Treatment Phase|Lost to Follow-up|14|||
46686375|NCT01021813|82901598|FG001|DB Treatment Phase|Lost to Follow-up|12|||
46799294|NCT00700115|83018253|FG000|Overall Study|Withdrawal by Subject|1|||
46799295|NCT00700115|83018254|FG001|Overall Study|Withdrawal by Subject|0|||
46799296|NCT00700115|83018253|FG000|Overall Study|Lost to Follow-up|0|||
46799297|NCT00700115|83018254|FG001|Overall Study|Lost to Follow-up|1|||
46799298|NCT00566852|83018262|FG000|Overall Study|Protocol Violation|22|||
46799299|NCT00566852|83018263|FG001|Overall Study|Protocol Violation|24|||
46799300|NCT00566852|83018262|FG000|Overall Study|Death|95|||
46799301|NCT00566852|83018263|FG001|Overall Study|Death|78|||
46799302|NCT00566852|83018262|FG000|Overall Study|Withdrawal by Subject|30|||
46799303|NCT00566852|83018263|FG001|Overall Study|Withdrawal by Subject|25|||
46799304|NCT00566852|83018262|FG000|Overall Study|Patient refusal|37|||
46799305|NCT00566852|83018263|FG001|Overall Study|Patient refusal|37|||
46858508|NCT03294538|83074259|FG002|Overall Study|Outside of Visit Window|1|||
46858509|NCT03265600|83074269|FG000|Overall Study|Lost to Follow-up|17|||
46858510|NCT03265600|83074270|FG001|Overall Study|Lost to Follow-up|5|||
46858511|NCT03265600|83074269|FG000|Overall Study|Withdrawal by Subject|4|||
46858512|NCT03265600|83074270|FG001|Overall Study|Withdrawal by Subject|2|||
46858513|NCT03265600|83074269|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
46858514|NCT03265600|83074270|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
46858515|NCT00335153|83074276|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
46686376|NCT01021813|82901599|FG002|DB Treatment Phase|Lost to Follow-up|0|||
46686377|NCT01021813|82901600|FG003|DB Treatment Phase|Lost to Follow-up|0|||
46686378|NCT01021813|82901601|FG004|DB Treatment Phase|Lost to Follow-up|0|||
46686379|NCT01021813|82901597|FG000|DB Treatment Phase|Physician Decision|17|||
46686380|NCT01021813|82901598|FG001|DB Treatment Phase|Physician Decision|8|||
46686381|NCT01021813|82901599|FG002|DB Treatment Phase|Physician Decision|0|||
46686382|NCT01021813|82901600|FG003|DB Treatment Phase|Physician Decision|0|||
46686383|NCT01021813|82901601|FG004|DB Treatment Phase|Physician Decision|0|||
46686384|NCT01021813|82901597|FG000|DB Treatment Phase|Pregnancy|1|||
46686385|NCT01021813|82901598|FG001|DB Treatment Phase|Pregnancy|0|||
46686386|NCT01021813|82901599|FG002|DB Treatment Phase|Pregnancy|0|||
46686387|NCT01021813|82901600|FG003|DB Treatment Phase|Pregnancy|0|||
46686388|NCT01021813|82901601|FG004|DB Treatment Phase|Pregnancy|0|||
46686389|NCT01021813|82901597|FG000|DB Treatment Phase|Protocol Violation|4|||
46686390|NCT01021813|82901598|FG001|DB Treatment Phase|Protocol Violation|3|||
46686391|NCT01021813|82901599|FG002|DB Treatment Phase|Protocol Violation|0|||
46686392|NCT01021813|82901600|FG003|DB Treatment Phase|Protocol Violation|0|||
46686393|NCT01021813|82901601|FG004|DB Treatment Phase|Protocol Violation|0|||
46686394|NCT01021813|82901597|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
46686395|NCT01021813|82901598|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
46686396|NCT01021813|82901599|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
46686397|NCT01021813|82901600|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
46686398|NCT01021813|82901601|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
46686399|NCT01021813|82901597|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
46686400|NCT01021813|82901598|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
46686401|NCT01021813|82901599|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
46686402|NCT01021813|82901600|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
46686403|NCT01021813|82901601|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
46686404|NCT01021813|82901597|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
46686405|NCT01021813|82901598|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
46686406|NCT01021813|82901599|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
46686407|NCT01021813|82901600|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
46686408|NCT01021813|82901601|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
46686409|NCT01021813|82901597|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
46686410|NCT01021813|82901598|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
46686411|NCT01021813|82901599|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
46686412|NCT01021813|82901600|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
46686413|NCT01021813|82901601|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
46686414|NCT01021813|82901597|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
46686415|NCT01021813|82901598|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
46799306|NCT00566852|83018262|FG000|Overall Study|Not tested due to disability|6|||
46799307|NCT00566852|83018263|FG001|Overall Study|Not tested due to disability|12|||
46799308|NCT00566852|83018262|FG000|Overall Study|Missing reason not specified|1|||
46686416|NCT01021813|82901599|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
46686417|NCT01021813|82901600|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
46686418|NCT01021813|82901601|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
46686419|NCT01021813|82901597|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
46708236|NCT01134042|82923689|FG001|Overall Study|Adverse Event|7|||
46708237|NCT01134042|82923690|FG002|Overall Study|Adverse Event|2|||
46708238|NCT01134042|82923688|FG000|Overall Study|Lack of Efficacy|21|||
46708239|NCT01134042|82923689|FG001|Overall Study|Lack of Efficacy|6|||
46708240|NCT01134042|82923690|FG002|Overall Study|Lack of Efficacy|18|||
46708241|NCT01134042|82923688|FG000|Overall Study|Protocol Violation|5|||
46708242|NCT01134042|82923689|FG001|Overall Study|Protocol Violation|3|||
46708243|NCT01134042|82923690|FG002|Overall Study|Protocol Violation|5|||
46708244|NCT01134042|82923688|FG000|Overall Study|Lost to Follow-up|2|||
46708245|NCT01134042|82923689|FG001|Overall Study|Lost to Follow-up|0|||
46686420|NCT01021813|82901598|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
46686421|NCT01021813|82901599|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
46686422|NCT01021813|82901600|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
46686423|NCT01021813|82901601|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
46686424|NCT01025635|82901620|FG000|Overall Study|Withdrawal by Subject|6|||
46686425|NCT01025635|82901621|FG001|Overall Study|Withdrawal by Subject|7|||
46686426|NCT01025635|82901620|FG000|Overall Study|Protocol Violation|4|||
46686427|NCT01025635|82901621|FG001|Overall Study|Protocol Violation|2|||
46686428|NCT01025635|82901620|FG000|Overall Study|Lack of Efficacy|0|||
46686429|NCT01025635|82901621|FG001|Overall Study|Lack of Efficacy|1|||
46686430|NCT01025635|82901620|FG000|Overall Study|Lost to Follow-up|9|||
46686431|NCT01025635|82901621|FG001|Overall Study|Lost to Follow-up|13|||
46686432|NCT01025635|82901620|FG000|Overall Study|Reason not known|4|||
46686433|NCT01025635|82901621|FG001|Overall Study|Reason not known|2|||
46686434|NCT01021423|82901629|FG000|Overall Study|Study terminated|4|||
46686435|NCT01021423|82901630|FG001|Overall Study|Study terminated|5|||
46686436|NCT01020877|82901638|FG000|Second Intervention|Withdrawal by Subject|1|||
46686437|NCT01020877|82901639|FG001|Second Intervention|Withdrawal by Subject|0|||
46686438|NCT01020799|82901648|FG000|Overall Study|Adverse Event|4|||
46686439|NCT01020799|82901649|FG001|Overall Study|Adverse Event|3|||
46686440|NCT01020799|82901650|FG002|Overall Study|Adverse Event|2|||
46686441|NCT01020799|82901648|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
46686442|NCT01020799|82901649|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
46686443|NCT01020799|82901650|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
46686444|NCT01020799|82901648|FG000|Overall Study|Protocol Violation|3|||
46686445|NCT01020799|82901649|FG001|Overall Study|Protocol Violation|2|||
46686446|NCT01020799|82901650|FG002|Overall Study|Protocol Violation|0|||
46686447|NCT01020799|82901648|FG000|Overall Study|Withdrawal by Subject|2|||
46686448|NCT01020799|82901649|FG001|Overall Study|Withdrawal by Subject|2|||
46686449|NCT01020799|82901650|FG002|Overall Study|Withdrawal by Subject|3|||
46686450|NCT01020799|82901648|FG000|Overall Study|Lost to Follow-up|6|||
46799309|NCT00566852|83018263|FG001|Overall Study|Missing reason not specified|2|||
46799310|NCT00566852|83018262|FG000|Overall Study|Missing reason not reported|16|||
46799311|NCT00566852|83018263|FG001|Overall Study|Missing reason not reported|20|||
46799312|NCT00442546|83018272|FG000|Overall Study|Adverse Event|11|||
46799313|NCT00442546|83018273|FG001|Overall Study|Adverse Event|17|||
46799314|NCT00442546|83018274|FG002|Overall Study|Adverse Event|13|||
46799315|NCT00442546|83018272|FG000|Overall Study|Lost to Follow-up|1|||
46799316|NCT00442546|83018273|FG001|Overall Study|Lost to Follow-up|2|||
46799317|NCT00442546|83018274|FG002|Overall Study|Lost to Follow-up|1|||
46799318|NCT00442546|83018272|FG000|Overall Study|Other|4|||
46799319|NCT00442546|83018273|FG001|Overall Study|Other|9|||
46799320|NCT00442546|83018274|FG002|Overall Study|Other|6|||
46799321|NCT00442546|83018272|FG000|Overall Study|Withdrawal by Subject|5|||
46799322|NCT00442546|83018273|FG001|Overall Study|Withdrawal by Subject|5|||
46799323|NCT00442546|83018274|FG002|Overall Study|Withdrawal by Subject|7|||
46799324|NCT00442546|83018272|FG000|Overall Study|Randomized But Not Treated|5|||
46799325|NCT00442546|83018273|FG001|Overall Study|Randomized But Not Treated|4|||
46799326|NCT00442546|83018274|FG002|Overall Study|Randomized But Not Treated|6|||
46799327|NCT00514683|83018289|FG000|Overall Study|Not treated|2|||
46799328|NCT00514683|83018290|FG001|Overall Study|Not treated|1|||
46799329|NCT00514683|83018291|FG002|Overall Study|Not treated|0|||
46799330|NCT00514683|83018292|FG003|Overall Study|Not treated|0|||
46799331|NCT00514683|83018293|FG004|Overall Study|Not treated|1|||
46799332|NCT00514683|83018289|FG000|Overall Study|Adverse Event|21|||
46799333|NCT00514683|83018290|FG001|Overall Study|Adverse Event|20|||
46799334|NCT00514683|83018291|FG002|Overall Study|Adverse Event|15|||
46799335|NCT00514683|83018292|FG003|Overall Study|Adverse Event|13|||
46799336|NCT00514683|83018293|FG004|Overall Study|Adverse Event|27|||
46799337|NCT00514683|83018289|FG000|Overall Study|Protocol Violation|1|||
46799338|NCT00514683|83018290|FG001|Overall Study|Protocol Violation|1|||
46799339|NCT00514683|83018291|FG002|Overall Study|Protocol Violation|0|||
46799340|NCT00514683|83018292|FG003|Overall Study|Protocol Violation|1|||
46799341|NCT00514683|83018293|FG004|Overall Study|Protocol Violation|0|||
46799342|NCT00514683|83018289|FG000|Overall Study|Withdrawal by Subject|2|||
46858516|NCT00335153|83074276|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
46858517|NCT00335153|83074276|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
46686451|NCT01020799|82901649|FG001|Overall Study|Lost to Follow-up|4|||
46799343|NCT00514683|83018290|FG001|Overall Study|Withdrawal by Subject|2|||
46799344|NCT00514683|83018291|FG002|Overall Study|Withdrawal by Subject|1|||
46799345|NCT00514683|83018292|FG003|Overall Study|Withdrawal by Subject|0|||
46686452|NCT01020799|82901650|FG002|Overall Study|Lost to Follow-up|2|||
46686453|NCT01288989|82901663|FG000|Overall Study|Death|0|||
46686454|NCT01288989|82901664|FG001|Overall Study|Death|0|||
46799346|NCT00514683|83018293|FG004|Overall Study|Withdrawal by Subject|4|||
46799347|NCT00514683|83018289|FG000|Overall Study|Reason other than listed above|0|||
46799348|NCT00514683|83018290|FG001|Overall Study|Reason other than listed above|1|||
46981693|NCT02347761|83227739|FG001|On Study Treatment|dissastisfaction with device|1|||
46858518|NCT00335153|83074276|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
46858519|NCT00335153|83074276|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
46858520|NCT00335153|83074276|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
46858521|NCT00335153|83074276|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
46858522|NCT00335153|83074276|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
46858523|NCT00335153|83074276|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
46858524|NCT00335153|83074276|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
46858525|NCT03265132|83074282|FG000|Overall Study|Adverse Event|0|||
46858526|NCT03265132|83074283|FG001|Overall Study|Adverse Event|1|||
46858527|NCT03265132|83074282|FG000|Overall Study|Lack of Efficacy|0|||
46858528|NCT03265132|83074283|FG001|Overall Study|Lack of Efficacy|2|||
46858529|NCT03265132|83074282|FG000|Overall Study|Progressive disease|0|||
46686455|NCT01288989|82901665|FG002|Overall Study|Death|0|||
46686456|NCT01288989|82901666|FG003|Overall Study|Death|1|||
46686457|NCT01288989|82901667|FG004|Overall Study|Death|0|||
46686458|NCT01288989|82901663|FG000|Overall Study|Dose limiting toxicity|1|||
46686459|NCT01288989|82901664|FG001|Overall Study|Dose limiting toxicity|0|||
46686460|NCT01288989|82901665|FG002|Overall Study|Dose limiting toxicity|0|||
46686461|NCT01288989|82901666|FG003|Overall Study|Dose limiting toxicity|0|||
46686462|NCT01288989|82901667|FG004|Overall Study|Dose limiting toxicity|0|||
46686463|NCT01288989|82901663|FG000|Overall Study|Adverse Event|0|||
46686464|NCT01288989|82901664|FG001|Overall Study|Adverse Event|0|||
46686465|NCT01288989|82901665|FG002|Overall Study|Adverse Event|0|||
46686466|NCT01288989|82901666|FG003|Overall Study|Adverse Event|0|||
46686467|NCT01288989|82901667|FG004|Overall Study|Adverse Event|2|||
46686468|NCT01288989|82901663|FG000|Overall Study|Physician Decision|0|||
46686469|NCT01288989|82901664|FG001|Overall Study|Physician Decision|0|||
46686470|NCT01288989|82901665|FG002|Overall Study|Physician Decision|0|||
46686471|NCT01288989|82901666|FG003|Overall Study|Physician Decision|0|||
46686472|NCT01288989|82901667|FG004|Overall Study|Physician Decision|1|||
46686473|NCT01288989|82901663|FG000|Overall Study|Withdrawal by Subject|0|||
46686474|NCT01288989|82901664|FG001|Overall Study|Withdrawal by Subject|0|||
46686475|NCT01288989|82901665|FG002|Overall Study|Withdrawal by Subject|0|||
46686476|NCT01288989|82901666|FG003|Overall Study|Withdrawal by Subject|0|||
46686477|NCT01288989|82901667|FG004|Overall Study|Withdrawal by Subject|3|||
46686478|NCT01020487|82901688|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
46686479|NCT01020487|82901689|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
46686480|NCT01020487|82901690|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
46686481|NCT01020487|82901688|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
46686482|NCT01020487|82901689|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
46686483|NCT01020487|82901690|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
46686484|NCT01020487|82901688|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
46686485|NCT01020487|82901689|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
46686486|NCT01020487|82901690|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
46686487|NCT01020487|82901688|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
46686488|NCT01020487|82901689|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
46686489|NCT01020487|82901690|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
46686490|NCT01020487|82901688|FG000|Part 2 Open-label Period|Adverse Event|0|||
46686491|NCT01020487|82901689|FG001|Part 2 Open-label Period|Adverse Event|4|||
46686492|NCT01020487|82901690|FG002|Part 2 Open-label Period|Adverse Event|1|||
46686493|NCT01024855|82901700|FG000|Overall Study|Inclusion/exclusion criteria|1|||
46686494|NCT01014013|82901707|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
46686495|NCT01014013|82901708|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
46686496|NCT01014013|82901707|FG000|Overall Study|Clinical adverse experience|4|||
46686497|NCT01014013|82901708|FG001|Overall Study|Clinical adverse experience|2|||
46686498|NCT01014013|82901707|FG000|Overall Study|Laboratory adverse experience|1|||
46686499|NCT01014013|82901708|FG001|Overall Study|Laboratory adverse experience|1|||
46686500|NCT01014013|82901707|FG000|Overall Study|Protocol Violation|1|||
46799349|NCT00514683|83018291|FG002|Overall Study|Reason other than listed above|2|||
46799350|NCT00514683|83018292|FG003|Overall Study|Reason other than listed above|0|||
46799351|NCT00514683|83018293|FG004|Overall Study|Reason other than listed above|1|||
46799352|NCT00566696|83018309|FG000|Overall Study|Met Exclusion Criteria|2|||
46799353|NCT00566696|83018309|FG000|Overall Study|Muromonab not available|1|||
46799354|NCT00566696|83018309|FG000|Overall Study|Health Status Change|1|||
46799355|NCT00566696|83018309|FG000|Overall Study|Physician Decision|1|||
46981694|NCT02347761|83227740|FG002|On Study Treatment|dissastisfaction with device|4|||
46686501|NCT01014013|82901708|FG001|Overall Study|Protocol Violation|3|||
46686502|NCT01014013|82901707|FG000|Overall Study|Withdrawal by Subject|7|||
46686503|NCT01014013|82901708|FG001|Overall Study|Withdrawal by Subject|4|||
46686504|NCT01014013|82901707|FG000|Overall Study|Clinical/microbiologic failure|1|||
46799356|NCT00566696|83018309|FG000|Overall Study|Non-Patient Donors|37|||
46799357|NCT00503841|83018313|FG000|Overall Study|All screen failures|44|||
46858530|NCT03265132|83074283|FG001|Overall Study|Progressive disease|2|||
46686505|NCT01014013|82901708|FG001|Overall Study|Clinical/microbiologic failure|2|||
46686506|NCT01014013|82901707|FG000|Overall Study|Pathogen culture = no growth|26|||
46858531|NCT03265132|83074282|FG000|Overall Study|Withdrawal by Subject|0|||
46858532|NCT03265132|83074283|FG001|Overall Study|Withdrawal by Subject|1|||
46858533|NCT02939950|83074293|FG000|Overall Study|Lost to Follow-up|13|||
46858534|NCT02939950|83074294|FG001|Overall Study|Lost to Follow-up|16|||
46858535|NCT02939950|83074293|FG000|Overall Study|Positive slit lamp findings|0|||
46858536|NCT02939950|83074294|FG001|Overall Study|Positive slit lamp findings|1|||
46858537|NCT02939950|83074293|FG000|Overall Study|Chalazion upper lid|0|||
46858538|NCT02939950|83074294|FG001|Overall Study|Chalazion upper lid|1|||
46858539|NCT02939950|83074293|FG000|Overall Study|Lack of motivation|0|||
46858540|NCT02939950|83074294|FG001|Overall Study|Lack of motivation|2|||
46858541|NCT02939950|83074293|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
46858542|NCT02939950|83074294|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
46858543|NCT02939950|83074293|FG000|Overall Study|Military orders|1|||
46858544|NCT02939950|83074294|FG001|Overall Study|Military orders|0|||
46799358|NCT00442468|83018319|FG000|Overall Study|Adverse Event|4|||
46799359|NCT00442468|83018319|FG000|Overall Study|Withdrawal by Subject|91|||
46799360|NCT00442468|83018319|FG000|Overall Study|Did not complete all study procedures|88|||
46799361|NCT00506883|83018326|FG000|Overall Study|Lost to Follow-up|1|||
46799362|NCT00506883|83018327|FG001|Overall Study|Lost to Follow-up|1|||
46799363|NCT00506883|83018328|FG002|Overall Study|Lost to Follow-up|1|||
46799364|NCT00506883|83018326|FG000|Overall Study|Withdrawal by Subject|1|||
46799365|NCT00506883|83018327|FG001|Overall Study|Withdrawal by Subject|0|||
46799366|NCT00506883|83018328|FG002|Overall Study|Withdrawal by Subject|1|||
46686507|NCT01014013|82901708|FG001|Overall Study|Pathogen culture = no growth|34|||
46686508|NCT01014013|82901707|FG000|Overall Study|Negative urine culture|2|||
46686509|NCT01014013|82901708|FG001|Overall Study|Negative urine culture|0|||
46686510|NCT01014013|82901707|FG000|Overall Study|Pathogen resistant|7|||
46686511|NCT01014013|82901708|FG001|Overall Study|Pathogen resistant|4|||
46686512|NCT01014013|82901707|FG000|Overall Study|Physician Decision|0|||
46686513|NCT01014013|82901708|FG001|Overall Study|Physician Decision|1|||
46981695|NCT02347761|83227738|FG000|On Study Treatment|Lost to Follow-up|2|||
46981696|NCT02347761|83227739|FG001|On Study Treatment|Lost to Follow-up|1|||
46981697|NCT02347761|83227740|FG002|On Study Treatment|Lost to Follow-up|1|||
46981698|NCT02347761|83227738|FG000|On Study Treatment|investigator discretion|2|||
46799367|NCT00506883|83018326|FG000|Overall Study|Lack of Efficacy|0|||
46799368|NCT00506883|83018327|FG001|Overall Study|Lack of Efficacy|1|||
46799369|NCT00506883|83018328|FG002|Overall Study|Lack of Efficacy|1|||
46799370|NCT00506883|83018326|FG000|Overall Study|Other|5|||
46799371|NCT00506883|83018327|FG001|Overall Study|Other|1|||
46799372|NCT00506883|83018328|FG002|Overall Study|Other|1|||
46799373|NCT00503685|83018339|FG000|Overall Study|Adverse Event|0|||
46799374|NCT00503685|83018340|FG001|Overall Study|Adverse Event|0|||
46799375|NCT00503685|83018341|FG002|Overall Study|Adverse Event|2|||
46799376|NCT00503685|83018339|FG000|Overall Study|Withdrawal by Subject|0|||
46799377|NCT00503685|83018340|FG001|Overall Study|Withdrawal by Subject|1|||
46799378|NCT00503685|83018341|FG002|Overall Study|Withdrawal by Subject|0|||
46799379|NCT00503685|83018339|FG000|Overall Study|Protocol Violation|0|||
46799380|NCT00503685|83018340|FG001|Overall Study|Protocol Violation|1|||
46799381|NCT00503685|83018341|FG002|Overall Study|Protocol Violation|0|||
46799382|NCT00503685|83018339|FG000|Overall Study|Eligibility Criteria Not Met|0|||
46799383|NCT00503685|83018340|FG001|Overall Study|Eligibility Criteria Not Met|1|||
46799384|NCT00503685|83018341|FG002|Overall Study|Eligibility Criteria Not Met|0|||
46799385|NCT00712673|83018353|FG000|Overall Study|Adverse Event|3|||
46858545|NCT02939950|83074293|FG000|Overall Study|Participant Relocated|5|||
46858546|NCT02939950|83074294|FG001|Overall Study|Participant Relocated|3|||
46858547|NCT02939950|83074293|FG000|Overall Study|Study related symptoms|8|||
46981699|NCT02347761|83227739|FG001|On Study Treatment|investigator discretion|0|||
46981700|NCT02347761|83227740|FG002|On Study Treatment|investigator discretion|0|||
46981701|NCT02347761|83227738|FG000|On Study Treatment|durg not working|0|||
46686514|NCT01014013|82901707|FG000|Overall Study|Another antibiotic therapy required|0|||
46686515|NCT01014013|82901708|FG001|Overall Study|Another antibiotic therapy required|1|||
46686516|NCT01014013|82901707|FG000|Overall Study|Appendectomy|1|||
46686517|NCT01014013|82901708|FG001|Overall Study|Appendectomy|0|||
46981702|NCT02347761|83227739|FG001|On Study Treatment|durg not working|1|||
46708246|NCT01134042|82923690|FG002|Overall Study|Lost to Follow-up|1|||
46708247|NCT01134042|82923688|FG000|Overall Study|Physician Decision|4|||
46708248|NCT01134042|82923689|FG001|Overall Study|Physician Decision|8|||
46708249|NCT01134042|82923690|FG002|Overall Study|Physician Decision|1|||
46708250|NCT01134042|82923688|FG000|Overall Study|Withdrawal by Subject|13|||
46708251|NCT01134042|82923689|FG001|Overall Study|Withdrawal by Subject|4|||
46708252|NCT01134042|82923690|FG002|Overall Study|Withdrawal by Subject|7|||
46708253|NCT01179347|82923701|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
46708254|NCT01179347|82923702|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
46708255|NCT01179347|82923701|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
46858548|NCT02939950|83074294|FG001|Overall Study|Study related symptoms|8|||
46858549|NCT02939950|83074293|FG000|Overall Study|Unacceptable lens movement|2|||
46858550|NCT02939950|83074294|FG001|Overall Study|Unacceptable lens movement|0|||
46858551|NCT02939950|83074293|FG000|Overall Study|Protocol Violation|6|||
46858552|NCT02939950|83074294|FG001|Overall Study|Protocol Violation|3|||
46858553|NCT02939950|83074293|FG000|Overall Study|Physician Decision|2|||
46858554|NCT02939950|83074294|FG001|Overall Study|Physician Decision|0|||
46858555|NCT02939950|83074293|FG000|Overall Study|Pregnancy|6|||
46858556|NCT02939950|83074294|FG001|Overall Study|Pregnancy|7|||
46858557|NCT02939950|83074293|FG000|Overall Study|Withdrawal by Subject|12|||
46858558|NCT02939950|83074294|FG001|Overall Study|Withdrawal by Subject|28|||
46858559|NCT02939950|83074293|FG000|Overall Study|Adverse Event|7|||
46858560|NCT02939950|83074294|FG001|Overall Study|Adverse Event|3|||
46686518|NCT01014013|82901707|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
46686519|NCT01014013|82901708|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
46686520|NCT01013701|82901716|FG000|Overall Study|study prematurely terminated|7|||
46686521|NCT01020019|82901723|FG000|Overall Study|Lost to Follow-up|21|||
46686522|NCT01020019|82901724|FG001|Overall Study|Lost to Follow-up|18|||
46686523|NCT01020019|82901723|FG000|Overall Study|Adverse Event|1|||
46686524|NCT01020019|82901724|FG001|Overall Study|Adverse Event|5|||
46686525|NCT01020019|82901723|FG000|Overall Study|not interested in treatment|4|||
46686526|NCT01020019|82901724|FG001|Overall Study|not interested in treatment|4|||
46686527|NCT01020019|82901723|FG000|Overall Study|moving|0|||
46686528|NCT01020019|82901724|FG001|Overall Study|moving|2|||
46686529|NCT01024465|82901730|FG000|Overall Study|Adverse Event|2|||
46686530|NCT01024465|82901730|FG000|Overall Study|Physician Decision|1|||
46686531|NCT01024387|82901734|FG000|Overall Study|Radiographic Progression|29|||
46686532|NCT01024387|82901734|FG000|Overall Study|Symptomatic Progression|10|||
46686533|NCT01024387|82901734|FG000|Overall Study|Physician Decision|5|||
46686534|NCT01024387|82901734|FG000|Overall Study|Withdrawal by Subject|5|||
46686535|NCT01024387|82901734|FG000|Overall Study|Death|2|||
46686536|NCT01024387|82901734|FG000|Overall Study|Prolonged Treatment Delay|1|||
46686537|NCT01024387|82901734|FG000|Overall Study|Adverse Event|3|||
46799386|NCT00712673|83018354|FG001|Overall Study|Adverse Event|3|||
46799387|NCT00712673|83018355|FG002|Overall Study|Adverse Event|21|||
46799388|NCT00712673|83018356|FG003|Overall Study|Adverse Event|26|||
46799389|NCT00712673|83018353|FG000|Overall Study|Lack of Efficacy|2|||
46799390|NCT00712673|83018354|FG001|Overall Study|Lack of Efficacy|8|||
46799391|NCT00712673|83018355|FG002|Overall Study|Lack of Efficacy|8|||
46799392|NCT00712673|83018356|FG003|Overall Study|Lack of Efficacy|6|||
46799393|NCT00712673|83018353|FG000|Overall Study|Poor Compliance to Protocol|3|||
46799394|NCT00712673|83018354|FG001|Overall Study|Poor Compliance to Protocol|3|||
46799395|NCT00712673|83018355|FG002|Overall Study|Poor Compliance to Protocol|4|||
46799396|NCT00712673|83018356|FG003|Overall Study|Poor Compliance to Protocol|16|||
46858561|NCT02939950|83074293|FG000|Overall Study|Randomized, not dispensed|1|||
46858562|NCT02939950|83074294|FG001|Overall Study|Randomized, not dispensed|0|||
46858563|NCT02939950|83074293|FG000|Overall Study|Ineligible at Baseline|2|||
46981703|NCT02347761|83227740|FG002|On Study Treatment|durg not working|1|||
46981704|NCT02347761|83227738|FG000|On Study Treatment|Adverse Event|10|||
46981705|NCT02347761|83227739|FG001|On Study Treatment|Adverse Event|8|||
46981706|NCT02347761|83227740|FG002|On Study Treatment|Adverse Event|20|||
46981707|NCT02596945|83227748|FG000|Overall Study|No documentation of study drug dosing|3|||
46981708|NCT02596945|83227748|FG000|Overall Study|Other|32|||
46981709|NCT02596945|83227748|FG000|Overall Study|Change to hemodialysis|15|||
46799397|NCT00712673|83018353|FG000|Overall Study|Lost to Follow-up|1|||
46799398|NCT00712673|83018354|FG001|Overall Study|Lost to Follow-up|0|||
46799399|NCT00712673|83018355|FG002|Overall Study|Lost to Follow-up|2|||
46799400|NCT00712673|83018356|FG003|Overall Study|Lost to Follow-up|0|||
46799401|NCT00712673|83018353|FG000|Overall Study|Withdrawal by Subject|6|||
46799402|NCT00712673|83018354|FG001|Overall Study|Withdrawal by Subject|7|||
46799403|NCT00712673|83018355|FG002|Overall Study|Withdrawal by Subject|15|||
46799404|NCT00712673|83018356|FG003|Overall Study|Withdrawal by Subject|20|||
46799405|NCT00712673|83018353|FG000|Overall Study|Familial and Personal Reasons|5|||
46799406|NCT00712673|83018354|FG001|Overall Study|Familial and Personal Reasons|0|||
46799407|NCT00712673|83018355|FG002|Overall Study|Familial and Personal Reasons|5|||
46799408|NCT00712673|83018356|FG003|Overall Study|Familial and Personal Reasons|2|||
46799409|NCT00712673|83018353|FG000|Overall Study|Investigator's Decision|1|||
46799410|NCT00712673|83018354|FG001|Overall Study|Investigator's Decision|0|||
46799411|NCT00712673|83018355|FG002|Overall Study|Investigator's Decision|0|||
46799412|NCT00712673|83018356|FG003|Overall Study|Investigator's Decision|0|||
46799413|NCT00712673|83018353|FG000|Overall Study|Protocol Violation|0|||
46799414|NCT00712673|83018354|FG001|Overall Study|Protocol Violation|0|||
46799415|NCT00712673|83018355|FG002|Overall Study|Protocol Violation|2|||
46799416|NCT00712673|83018356|FG003|Overall Study|Protocol Violation|0|||
46799417|NCT03976466|83018377|FG000|Overall Study|Lost to Follow-up|1|||
46799418|NCT03976466|83018378|FG001|Overall Study|Lost to Follow-up|3|||
46799419|NCT02536755|83018386|FG000|Overall Study|Adverse Event|4|||
46799420|NCT03303105|83018395|FG000|Overall Study|Adverse Event|0|||
46799421|NCT03303105|83018396|FG001|Overall Study|Adverse Event|2|||
46799422|NCT03303105|83018395|FG000|Overall Study|Lack of Efficacy|1|||
46799423|NCT03303105|83018396|FG001|Overall Study|Lack of Efficacy|0|||
46799424|NCT03303105|83018395|FG000|Overall Study|Protocol Violation|1|||
46799425|NCT03303105|83018396|FG001|Overall Study|Protocol Violation|0|||
46799426|NCT03303105|83018395|FG000|Overall Study|Withdrawal by Subject|0|||
46799427|NCT03303105|83018396|FG001|Overall Study|Withdrawal by Subject|2|||
46799428|NCT00447694|83018402|FG000|Overall Study|Adverse Event|2|||
46799429|NCT00447694|83018402|FG000|Overall Study|Abnormal laboratory value|1|||
46799430|NCT00447694|83018402|FG000|Overall Study|Abnormal test procedure result|1|||
46799431|NCT00447694|83018402|FG000|Overall Study|Withdrawal by Subject|2|||
46686538|NCT01024387|82901734|FG000|Overall Study|Other|5|||
46686539|NCT01019317|82901738|FG000|Overall Study|Not Eligible|4|||
46799432|NCT00564278|83018408|FG000|Overall Study|Lost to Follow-up|35|||
46799433|NCT00564278|83018409|FG001|Overall Study|Lost to Follow-up|33|||
46981710|NCT02596945|83227748|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
46799434|NCT00564278|83018408|FG000|Overall Study|Physician Decision|1|||
46799435|NCT00564278|83018409|FG001|Overall Study|Physician Decision|2|||
46981711|NCT02596945|83227748|FG000|Overall Study|Withdrawal by Subject|1|||
46981712|NCT02596945|83227748|FG000|Overall Study|Missing|1|||
46799436|NCT00564278|83018408|FG000|Overall Study|Withdrawal by Subject|11|||
46686540|NCT01024309|82901744|FG000|Overall Study|Physician Decision|4|||
46686541|NCT01024309|82901745|FG001|Overall Study|Physician Decision|0|||
46686542|NCT01024309|82901744|FG000|Overall Study|Withdrawal by Subject|4|||
46686543|NCT01024309|82901745|FG001|Overall Study|Withdrawal by Subject|4|||
46686544|NCT01090492|82901759|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
46686545|NCT01090492|82901760|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
46686546|NCT01090492|82901761|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
46686547|NCT01090492|82901762|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
46686548|NCT01090492|82901763|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
46686549|NCT01090492|82901764|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
46686550|NCT01090492|82901765|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
46686551|NCT01090492|82901766|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
46686552|NCT01090492|82901759|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
46686553|NCT01090492|82901760|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
46686554|NCT01090492|82901761|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
46686555|NCT01090492|82901762|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
46686556|NCT01090492|82901763|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
46686557|NCT01090492|82901764|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
46686558|NCT01090492|82901765|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
46686559|NCT01090492|82901766|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
46686560|NCT01090492|82901759|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686561|NCT01090492|82901760|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686562|NCT01090492|82901761|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
46686563|NCT01090492|82901762|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686564|NCT01090492|82901763|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686565|NCT01090492|82901764|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686566|NCT01090492|82901765|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686567|NCT01090492|82901766|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686568|NCT01090492|82901759|FG000|First Intervention Period (4 Weeks)|Other|0|||
46686569|NCT01090492|82901760|FG001|First Intervention Period (4 Weeks)|Other|0|||
46686570|NCT01090492|82901761|FG002|First Intervention Period (4 Weeks)|Other|1|||
46686571|NCT01090492|82901762|FG003|First Intervention Period (4 Weeks)|Other|1|||
46686572|NCT01090492|82901763|FG004|First Intervention Period (4 Weeks)|Other|2|||
46686573|NCT01090492|82901764|FG005|First Intervention Period (4 Weeks)|Other|0|||
46686574|NCT01090492|82901765|FG006|First Intervention Period (4 Weeks)|Other|0|||
46686575|NCT01090492|82901766|FG007|First Intervention Period (4 Weeks)|Other|0|||
46686576|NCT01090492|82901759|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
46686577|NCT01090492|82901760|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
46686578|NCT01090492|82901761|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
46686579|NCT01090492|82901762|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
46686580|NCT01090492|82901763|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
46686581|NCT01090492|82901764|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
46686582|NCT01090492|82901765|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
46686583|NCT01090492|82901766|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
46686584|NCT01090492|82901759|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
46686585|NCT01090492|82901760|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
46686586|NCT01090492|82901761|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
46799437|NCT00564278|83018409|FG001|Overall Study|Withdrawal by Subject|7|||
46686587|NCT01090492|82901762|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
46686588|NCT01090492|82901763|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
46686589|NCT01090492|82901764|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
46799438|NCT00565604|83018415|FG000|Overall Study|Failure to treat|2|||
46799439|NCT00565604|83018415|FG000|Overall Study|Lost to Follow-up|2|||
46686590|NCT01090492|82901765|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
46686591|NCT01090492|82901766|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
46686592|NCT01090492|82901759|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
46686593|NCT01090492|82901760|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
46686594|NCT01090492|82901761|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
46686595|NCT01090492|82901762|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
46686596|NCT01090492|82901763|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
46686597|NCT01090492|82901764|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
46686598|NCT01090492|82901765|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
46686599|NCT01090492|82901766|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
46686600|NCT01090492|82901759|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
46686601|NCT01090492|82901760|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
46686602|NCT01090492|82901761|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
46686603|NCT01090492|82901762|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
46686604|NCT01090492|82901763|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
46686605|NCT01090492|82901764|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
46686606|NCT01090492|82901765|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
46686607|NCT01090492|82901766|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
46686608|NCT01090492|82901759|FG000|Second Intervention Period (4 Weeks)|Other|0|||
46686609|NCT01090492|82901760|FG001|Second Intervention Period (4 Weeks)|Other|1|||
46686610|NCT01090492|82901761|FG002|Second Intervention Period (4 Weeks)|Other|1|||
46686611|NCT01090492|82901762|FG003|Second Intervention Period (4 Weeks)|Other|0|||
46686612|NCT01090492|82901763|FG004|Second Intervention Period (4 Weeks)|Other|0|||
46686613|NCT01090492|82901764|FG005|Second Intervention Period (4 Weeks)|Other|0|||
46686614|NCT01090492|82901765|FG006|Second Intervention Period (4 Weeks)|Other|0|||
46686615|NCT01090492|82901766|FG007|Second Intervention Period (4 Weeks)|Other|0|||
46686616|NCT01090492|82901759|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
46686617|NCT01090492|82901760|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
46686618|NCT01090492|82901761|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
46799440|NCT00447226|83018419|FG000|12-Week Open-label Phase|Adverse Event|0|||
46799441|NCT00447226|83018420|FG001|12-Week Open-label Phase|Adverse Event|3|||
46799442|NCT00447226|83018419|FG000|12-Week Open-label Phase|Protocol Violation|0|||
46799443|NCT00447226|83018420|FG001|12-Week Open-label Phase|Protocol Violation|1|||
46799444|NCT00447226|83018419|FG000|12-Week Open-label Phase|Disease Progression|0|||
46799445|NCT00447226|83018420|FG001|12-Week Open-label Phase|Disease Progression|20|||
46799446|NCT00447226|83018419|FG000|12-Week Open-label Phase|Physician Decision|0|||
46686619|NCT01090492|82901762|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
46686620|NCT01090492|82901763|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
46686621|NCT01090492|82901764|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
46799447|NCT00447226|83018420|FG001|12-Week Open-label Phase|Physician Decision|1|||
46686622|NCT01090492|82901765|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
46686623|NCT01090492|82901766|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
46686624|NCT01090492|82901759|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686625|NCT01090492|82901760|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686626|NCT01090492|82901761|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686627|NCT01090492|82901762|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686628|NCT01090492|82901763|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686629|NCT01090492|82901764|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686630|NCT01090492|82901765|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
46686631|NCT01090492|82901766|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
46686632|NCT01288911|82901787|FG000|Double-blind Period|Death|11|||
46686633|NCT01288911|82901788|FG001|Double-blind Period|Death|7|||
46686634|NCT01288911|82901787|FG000|Double-blind Period|Lost to Follow-up|0|||
46686635|NCT01288911|82901788|FG001|Double-blind Period|Lost to Follow-up|2|||
46686636|NCT01288911|82901787|FG000|Double-blind Period|Progressive Disease|75|||
46686637|NCT01288911|82901788|FG001|Double-blind Period|Progressive Disease|103|||
46981713|NCT02404389|83227766|FG000|Overall Study|Adverse Event|1|||
46686638|NCT01288911|82901787|FG000|Double-blind Period|Protocol Violation|1|||
46686639|NCT01288911|82901788|FG001|Double-blind Period|Protocol Violation|0|||
46686640|NCT01288911|82901787|FG000|Double-blind Period|Withdrawal by Subject|25|||
46686641|NCT01288911|82901788|FG001|Double-blind Period|Withdrawal by Subject|26|||
46686642|NCT01288911|82901787|FG000|Double-blind Period|Miscellaneous Reason|29|||
46686643|NCT01288911|82901788|FG001|Double-blind Period|Miscellaneous Reason|42|||
46686644|NCT01288911|82901787|FG000|Double-blind Period|Randomized but never received study drug|1|||
46686645|NCT01288911|82901788|FG001|Double-blind Period|Randomized but never received study drug|2|||
46686646|NCT01288911|82901787|FG000|Open-label Period (All Enzalutamide)|Death|0|||
46686647|NCT01288911|82901788|FG001|Open-label Period (All Enzalutamide)|Death|1|||
46686648|NCT01288911|82901787|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
46686649|NCT01288911|82901788|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
46686650|NCT01288911|82901787|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
46686651|NCT01288911|82901788|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
46686652|NCT01288911|82901787|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
46686653|NCT01288911|82901788|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
46686654|NCT01288911|82901787|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
46686655|NCT01288911|82901788|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
46686656|NCT01288911|82901787|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
46686657|NCT01288911|82901788|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
46686658|NCT01288443|82901803|FG000|Overall Study|Adverse Event|0|||
46686659|NCT01288443|82901804|FG001|Overall Study|Adverse Event|0|||
46686660|NCT01288443|82901805|FG002|Overall Study|Adverse Event|1|||
46686661|NCT01288443|82901806|FG003|Overall Study|Adverse Event|1|||
46686662|NCT01288443|82901807|FG004|Overall Study|Adverse Event|3|||
46686663|NCT01288443|82901808|FG005|Overall Study|Adverse Event|1|||
46686664|NCT01288443|82901803|FG000|Overall Study|Poor compliance to protocol|0|||
46686665|NCT01288443|82901804|FG001|Overall Study|Poor compliance to protocol|0|||
46686666|NCT01288443|82901805|FG002|Overall Study|Poor compliance to protocol|0|||
46686667|NCT01288443|82901806|FG003|Overall Study|Poor compliance to protocol|0|||
46686668|NCT01288443|82901807|FG004|Overall Study|Poor compliance to protocol|0|||
46686669|NCT01288443|82901808|FG005|Overall Study|Poor compliance to protocol|1|||
46686670|NCT01288443|82901803|FG000|Overall Study|Participant Moved|0|||
46686671|NCT01288443|82901804|FG001|Overall Study|Participant Moved|0|||
46686672|NCT01288443|82901805|FG002|Overall Study|Participant Moved|0|||
46686673|NCT01288443|82901806|FG003|Overall Study|Participant Moved|1|||
46686674|NCT01288443|82901807|FG004|Overall Study|Participant Moved|2|||
46686675|NCT01288443|82901808|FG005|Overall Study|Participant Moved|1|||
46686676|NCT01288443|82901803|FG000|Overall Study|Consent withdrawn by Participant|0|||
46686677|NCT01288443|82901804|FG001|Overall Study|Consent withdrawn by Participant|0|||
46686678|NCT01288443|82901805|FG002|Overall Study|Consent withdrawn by Participant|0|||
46686679|NCT01288443|82901806|FG003|Overall Study|Consent withdrawn by Participant|0|||
46686680|NCT01288443|82901807|FG004|Overall Study|Consent withdrawn by Participant|0|||
46686681|NCT01288443|82901808|FG005|Overall Study|Consent withdrawn by Participant|1|||
46686682|NCT01288443|82901803|FG000|Overall Study|Lost to Follow-up|0|||
46686683|NCT01288443|82901804|FG001|Overall Study|Lost to Follow-up|1|||
46686684|NCT01288443|82901805|FG002|Overall Study|Lost to Follow-up|0|||
46686685|NCT01288443|82901806|FG003|Overall Study|Lost to Follow-up|0|||
46686686|NCT01288443|82901807|FG004|Overall Study|Lost to Follow-up|0|||
46686687|NCT01288443|82901808|FG005|Overall Study|Lost to Follow-up|0|||
46686688|NCT01288443|82901803|FG000|Overall Study|Study drug auto-injector administration|0|||
46686689|NCT01288443|82901804|FG001|Overall Study|Study drug auto-injector administration|0|||
46686690|NCT01288443|82901805|FG002|Overall Study|Study drug auto-injector administration|0|||
46686691|NCT01288443|82901806|FG003|Overall Study|Study drug auto-injector administration|0|||
46686692|NCT01288443|82901807|FG004|Overall Study|Study drug auto-injector administration|1|||
46686693|NCT01288443|82901808|FG005|Overall Study|Study drug auto-injector administration|1|||
46686694|NCT01288443|82901803|FG000|Overall Study|Other than above|0|||
46686695|NCT01288443|82901804|FG001|Overall Study|Other than above|0|||
46686696|NCT01288443|82901805|FG002|Overall Study|Other than above|0|||
46686697|NCT01288443|82901806|FG003|Overall Study|Other than above|2|||
46686698|NCT01288443|82901807|FG004|Overall Study|Other than above|1|||
46686699|NCT01288443|82901808|FG005|Overall Study|Other than above|0|||
46686700|NCT01288287|82901822|FG000|Overall Study|Lost to Follow-up|8|||
46686701|NCT01288287|82901822|FG000|Overall Study|Withdrawal by Subject|4|||
46686702|NCT01288287|82901822|FG000|Overall Study|Lack of Efficacy|13|||
46686703|NCT01288287|82901822|FG000|Overall Study|Other Reason|13|||
46686704|NCT01288287|82901822|FG000|Overall Study|Unknown Reason|1|||
46686705|NCT01288287|82901822|FG000|Overall Study|Unknown Status|7|||
46686706|NCT01288209|82901829|FG000|Overall Study|Withdrawal by Subject|1|||
46686707|NCT01288209|82901830|FG001|Overall Study|Withdrawal by Subject|3|||
46686708|NCT01288209|82901829|FG000|Overall Study|Other|1|||
46686709|NCT01288209|82901830|FG001|Overall Study|Other|0|||
46686710|NCT01288053|82901836|FG000|Overall Study|Death|1|||
46686711|NCT01287195|82901840|FG000|Overall Study|Withdrawal by Subject|2|||
46686712|NCT01287117|82901848|FG000|Overall Study|Adverse Event|2|||
46686713|NCT01287117|82901849|FG001|Overall Study|Adverse Event|1|||
46686714|NCT01287117|82901850|FG002|Overall Study|Adverse Event|1|||
46686715|NCT01287117|82901851|FG003|Overall Study|Adverse Event|1|||
46686716|NCT01287117|82901848|FG000|Overall Study|Lost to Follow-up|1|||
46799448|NCT00447226|83018419|FG000|Double-blind Phase|Disease Progression|4|||
46799449|NCT00447226|83018420|FG001|Double-blind Phase|Disease Progression|3|||
46686717|NCT01287117|82901849|FG001|Overall Study|Lost to Follow-up|1|||
46686718|NCT01287117|82901850|FG002|Overall Study|Lost to Follow-up|0|||
46686719|NCT01287117|82901851|FG003|Overall Study|Lost to Follow-up|0|||
46686720|NCT01287117|82901848|FG000|Overall Study|Physician Decision|0|||
46686721|NCT01287117|82901849|FG001|Overall Study|Physician Decision|1|||
46686722|NCT01287117|82901850|FG002|Overall Study|Physician Decision|1|||
46686723|NCT01287117|82901851|FG003|Overall Study|Physician Decision|1|||
46686724|NCT01287117|82901848|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
46686725|NCT01287117|82901849|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
46686726|NCT01287117|82901850|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
46686727|NCT01287117|82901851|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
46686728|NCT01287117|82901848|FG000|Overall Study|Disease Progression|10|||
46686729|NCT01287117|82901849|FG001|Overall Study|Disease Progression|5|||
46686730|NCT01287117|82901850|FG002|Overall Study|Disease Progression|6|||
46686731|NCT01287117|82901851|FG003|Overall Study|Disease Progression|5|||
46686732|NCT01287039|82901863|FG000|Overall Study|Noncompliance with study procedures|0|||
46686733|NCT01287039|82901864|FG001|Overall Study|Noncompliance with study procedures|1|||
46686734|NCT01287039|82901863|FG000|Overall Study|Change of location/residence|0|||
46686735|NCT01287039|82901864|FG001|Overall Study|Change of location/residence|3|||
46686736|NCT01287039|82901863|FG000|Overall Study|Elective surgery|0|||
46686737|NCT01287039|82901864|FG001|Overall Study|Elective surgery|1|||
46686738|NCT01287039|82901863|FG000|Overall Study|Protocol Violation|2|||
46686739|NCT01287039|82901864|FG001|Overall Study|Protocol Violation|3|||
46686740|NCT01287039|82901863|FG000|Overall Study|Excluded medication taken|1|||
46686741|NCT01287039|82901864|FG001|Overall Study|Excluded medication taken|0|||
46686742|NCT01287039|82901863|FG000|Overall Study|Noncompliance with study medication|0|||
46686743|NCT01287039|82901864|FG001|Overall Study|Noncompliance with study medication|1|||
46799450|NCT00446992|83018435|FG000|Overall Study|Adverse Event|11|||
46799451|NCT00446992|83018435|FG000|Overall Study|Lost to Follow-up|5|||
46799452|NCT00503139|83018439|FG000|Overall Study|Case Report Forms were not collected|4|||
46799453|NCT00503139|83018439|FG000|Overall Study|Protocol Violation|4|||
46799454|NCT00577031|83018443|FG000|Overall Study|Adverse Event|52|||
46799455|NCT00577031|83018443|FG000|Overall Study|Progression of disease|93|||
46799456|NCT00577031|83018443|FG000|Overall Study|Protocol Violation|5|||
46799457|NCT00577031|83018443|FG000|Overall Study|Participant withdrew consent|13|||
46858564|NCT02939950|83074294|FG001|Overall Study|Ineligible at Baseline|8|||
46686744|NCT01287039|82901863|FG000|Overall Study|Problem with travel|0|||
46686745|NCT01287039|82901864|FG001|Overall Study|Problem with travel|1|||
46686746|NCT01287039|82901863|FG000|Overall Study|Death|1|||
46686747|NCT01287039|82901864|FG001|Overall Study|Death|0|||
46686748|NCT01287039|82901863|FG000|Overall Study|Change of residence|1|||
46686749|NCT01287039|82901864|FG001|Overall Study|Change of residence|0|||
46686750|NCT01287039|82901863|FG000|Overall Study|Adverse Event|7|||
46686751|NCT01287039|82901864|FG001|Overall Study|Adverse Event|4|||
46799458|NCT00577031|83018443|FG000|Overall Study|Participant non-compliance|5|||
46858565|NCT03753542|83074302|FG000|Overall Study|Lost to Follow-up|9|||
46858566|NCT03753542|83074303|FG001|Overall Study|Lost to Follow-up|14|||
46686752|NCT01287039|82901863|FG000|Overall Study|Withdrawal by Subject|14|||
46686753|NCT01287039|82901864|FG001|Overall Study|Withdrawal by Subject|11|||
46686754|NCT01287039|82901863|FG000|Overall Study|Lost to Follow-up|3|||
46686755|NCT01287039|82901864|FG001|Overall Study|Lost to Follow-up|2|||
46686756|NCT01285401|82901872|FG000|Overall Study|Prematurely withdrawn from the study|17|||
46686757|NCT01285401|82901873|FG001|Overall Study|Prematurely withdrawn from the study|29|||
46686758|NCT01285323|82901881|FG000|Overall Study|Adverse Event|9|||
46686759|NCT01285323|82901882|FG001|Overall Study|Adverse Event|8|||
46686760|NCT01285323|82901881|FG000|Overall Study|Lack of Efficacy|4|||
46686761|NCT01285323|82901882|FG001|Overall Study|Lack of Efficacy|2|||
46686762|NCT01285323|82901881|FG000|Overall Study|Withdrawal by Subject|15|||
46686763|NCT01285323|82901882|FG001|Overall Study|Withdrawal by Subject|11|||
46686764|NCT01285323|82901881|FG000|Overall Study|Protocol Violation|1|||
46686765|NCT01285323|82901882|FG001|Overall Study|Protocol Violation|2|||
46686766|NCT01285323|82901881|FG000|Overall Study|Non-compliance with study procedures|2|||
46686767|NCT01285323|82901882|FG001|Overall Study|Non-compliance with study procedures|3|||
46686768|NCT01285323|82901881|FG000|Overall Study|Lost to Follow-up|1|||
46686769|NCT01285323|82901882|FG001|Overall Study|Lost to Follow-up|1|||
46686770|NCT01285323|82901881|FG000|Overall Study|Other|1|||
46686771|NCT01285323|82901882|FG001|Overall Study|Other|3|||
46686772|NCT01284621|82901888|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
46686773|NCT01284621|82901889|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
46686774|NCT01284621|82901890|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
46981714|NCT02404389|83227767|FG001|Overall Study|Adverse Event|0|||
46981715|NCT02404389|83227768|FG002|Overall Study|Adverse Event|1|||
46981716|NCT02404389|83227769|FG003|Overall Study|Adverse Event|0|||
46981717|NCT02404389|83227770|FG004|Overall Study|Adverse Event|2|||
46981718|NCT02404389|83227766|FG000|Overall Study|Subject/guardian decision|1|||
46981719|NCT02404389|83227767|FG001|Overall Study|Subject/guardian decision|0|||
46686775|NCT01284621|82901891|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
46686776|NCT01284621|82901892|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
46686777|NCT01284621|82901893|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
46686778|NCT01283139|82901907|FG000|Overall Study|Lost to Follow-up|5|||
46686779|NCT01283139|82901908|FG001|Overall Study|Lost to Follow-up|2|||
46686780|NCT01283139|82901909|FG002|Overall Study|Lost to Follow-up|3|||
46686781|NCT01283139|82901910|FG003|Overall Study|Lost to Follow-up|1|||
46686782|NCT01283139|82901907|FG000|Overall Study|Withdrawal by Subject|8|||
46686783|NCT01283139|82901908|FG001|Overall Study|Withdrawal by Subject|8|||
46686784|NCT01283139|82901909|FG002|Overall Study|Withdrawal by Subject|6|||
46686785|NCT01283139|82901910|FG003|Overall Study|Withdrawal by Subject|8|||
46686786|NCT01283139|82901907|FG000|Overall Study|Death|2|||
46686787|NCT01283139|82901908|FG001|Overall Study|Death|0|||
46686788|NCT01283139|82901909|FG002|Overall Study|Death|2|||
46686789|NCT01283139|82901910|FG003|Overall Study|Death|2|||
46686790|NCT01283139|82901907|FG000|Overall Study|Lack of Efficacy|1|||
46686791|NCT01283139|82901908|FG001|Overall Study|Lack of Efficacy|2|||
46686792|NCT01283139|82901909|FG002|Overall Study|Lack of Efficacy|2|||
46686793|NCT01283139|82901910|FG003|Overall Study|Lack of Efficacy|1|||
46686794|NCT01283139|82901907|FG000|Overall Study|Early termination due to AE/SAE|1|||
46686795|NCT01283139|82901908|FG001|Overall Study|Early termination due to AE/SAE|1|||
46858567|NCT03292588|83074311|FG000|Overall Study|Death|1|||
46858568|NCT03292588|83074312|FG001|Overall Study|Death|0|||
46686796|NCT01283139|82901909|FG002|Overall Study|Early termination due to AE/SAE|0|||
46686797|NCT01283139|82901910|FG003|Overall Study|Early termination due to AE/SAE|0|||
46686798|NCT01283139|82901907|FG000|Overall Study|Participant's refusal to continue|0|||
46686799|NCT01283139|82901908|FG001|Overall Study|Participant's refusal to continue|3|||
46686800|NCT01283139|82901909|FG002|Overall Study|Participant's refusal to continue|1|||
46686801|NCT01283139|82901910|FG003|Overall Study|Participant's refusal to continue|1|||
46686802|NCT01283139|82901907|FG000|Overall Study|Pregnancy|0|||
46858569|NCT03292588|83074311|FG000|Overall Study|Lost to Follow-up|12|||
46858570|NCT03292588|83074312|FG001|Overall Study|Lost to Follow-up|16|||
46981720|NCT02404389|83227768|FG002|Overall Study|Subject/guardian decision|0|||
46981721|NCT02404389|83227769|FG003|Overall Study|Subject/guardian decision|1|||
46686803|NCT01283139|82901908|FG001|Overall Study|Pregnancy|1|||
46686804|NCT01283139|82901909|FG002|Overall Study|Pregnancy|1|||
46686805|NCT01283139|82901910|FG003|Overall Study|Pregnancy|0|||
46686806|NCT01283139|82901907|FG000|Overall Study|Missed follow-up visit|0|||
46686807|NCT01283139|82901908|FG001|Overall Study|Missed follow-up visit|1|||
46686808|NCT01283139|82901909|FG002|Overall Study|Missed follow-up visit|2|||
46686809|NCT01283139|82901910|FG003|Overall Study|Missed follow-up visit|2|||
46686810|NCT01283139|82901907|FG000|Overall Study|Participant randomized in error|0|||
46686811|NCT01283139|82901908|FG001|Overall Study|Participant randomized in error|0|||
46686812|NCT01283139|82901909|FG002|Overall Study|Participant randomized in error|1|||
46686813|NCT01283139|82901910|FG003|Overall Study|Participant randomized in error|0|||
46686814|NCT01282203|82901920|FG000|Overall Study|Adverse Event|1|||
46686815|NCT01281969|82901929|FG000|Overall Study|not randomized didn't meet criteria|0|||
46686816|NCT01281969|82901930|FG001|Overall Study|not randomized didn't meet criteria|0|||
46686817|NCT01281969|82901931|FG002|Overall Study|not randomized didn't meet criteria|7|||
46686818|NCT01281969|82901929|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
46686819|NCT01281969|82901930|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
46686820|NCT01281969|82901931|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
46686821|NCT01281969|82901929|FG000|Overall Study|not randomized, child consent not given|0|||
46686822|NCT01281969|82901930|FG001|Overall Study|not randomized, child consent not given|0|||
46686823|NCT01281969|82901931|FG002|Overall Study|not randomized, child consent not given|2|||
46686824|NCT01281813|82901942|FG000|Overall Study|Adverse Event|0|||
46686825|NCT01281813|82901943|FG001|Overall Study|Adverse Event|0|||
46686826|NCT01281813|82901944|FG002|Overall Study|Adverse Event|10|||
46686827|NCT01281813|82901942|FG000|Overall Study|Lost to Follow-up|0|||
46686828|NCT01281813|82901943|FG001|Overall Study|Lost to Follow-up|0|||
46686829|NCT01281813|82901944|FG002|Overall Study|Lost to Follow-up|31|||
46686830|NCT01281813|82901942|FG000|Overall Study|Withdrawal by Subject|0|||
46686831|NCT01281813|82901943|FG001|Overall Study|Withdrawal by Subject|0|||
46686832|NCT01281813|82901944|FG002|Overall Study|Withdrawal by Subject|13|||
46686833|NCT01281813|82901942|FG000|Overall Study|Subject Non-Compliant|0|||
46686834|NCT01281813|82901943|FG001|Overall Study|Subject Non-Compliant|0|||
46686835|NCT01281813|82901944|FG002|Overall Study|Subject Non-Compliant|6|||
46686836|NCT01281813|82901942|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
46686837|NCT01281813|82901943|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
46686838|NCT01281813|82901944|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
46686839|NCT01281813|82901942|FG000|Overall Study|Sponsor's Decision|4|||
46686840|NCT01281813|82901943|FG001|Overall Study|Sponsor's Decision|3|||
46686841|NCT01281813|82901944|FG002|Overall Study|Sponsor's Decision|7|||
46858571|NCT03292588|83074311|FG000|Overall Study|Physician Decision|0|||
46686842|NCT01281813|82901942|FG000|Overall Study|Switched to Commercially Available Medication|0|||
46686843|NCT01281813|82901943|FG001|Overall Study|Switched to Commercially Available Medication|0|||
46686844|NCT01281813|82901944|FG002|Overall Study|Switched to Commercially Available Medication|26|||
46686845|NCT01281813|82901942|FG000|Overall Study|Other|0|||
46686846|NCT01281813|82901943|FG001|Overall Study|Other|1|||
46686847|NCT01281813|82901944|FG002|Overall Study|Other|39|||
46686848|NCT01090414|82901956|FG000|Study 101-99|Progressive Disease|28|||
46686849|NCT01090414|82901957|FG001|Study 101-99|Progressive Disease|48|||
46686850|NCT01090414|82901958|FG002|Study 101-99|Progressive Disease|10|||
46686851|NCT01090414|82901959|FG003|Study 101-99|Progressive Disease|4|||
46686852|NCT01090414|82901956|FG000|Study 101-99|Adverse Event|10|||
46686853|NCT01090414|82901957|FG001|Study 101-99|Adverse Event|28|||
46686854|NCT01090414|82901958|FG002|Study 101-99|Adverse Event|18|||
46686855|NCT01090414|82901959|FG003|Study 101-99|Adverse Event|0|||
46686856|NCT01090414|82901956|FG000|Study 101-99|Investigator Request|1|||
46686857|NCT01090414|82901957|FG001|Study 101-99|Investigator Request|11|||
46686858|NCT01090414|82901958|FG002|Study 101-99|Investigator Request|4|||
46686859|NCT01090414|82901959|FG003|Study 101-99|Investigator Request|0|||
46799459|NCT00577031|83018443|FG000|Overall Study|Need for surgery|17|||
46686860|NCT01090414|82901956|FG000|Study 101-99|Death|3|||
46686861|NCT01090414|82901957|FG001|Study 101-99|Death|8|||
46686862|NCT01090414|82901958|FG002|Study 101-99|Death|1|||
46686863|NCT01090414|82901959|FG003|Study 101-99|Death|0|||
46686864|NCT01090414|82901956|FG000|Study 101-99|Sponsor Discontinued Study|0|||
46686865|NCT01090414|82901957|FG001|Study 101-99|Sponsor Discontinued Study|7|||
46686866|NCT01090414|82901958|FG002|Study 101-99|Sponsor Discontinued Study|5|||
46686867|NCT01090414|82901959|FG003|Study 101-99|Sponsor Discontinued Study|0|||
46686868|NCT01090414|82901956|FG000|Study 101-99|Other (Unknown Reasons)|3|||
46686869|NCT01090414|82901957|FG001|Study 101-99|Other (Unknown Reasons)|3|||
46686870|NCT01090414|82901958|FG002|Study 101-99|Other (Unknown Reasons)|0|||
46686871|NCT01090414|82901959|FG003|Study 101-99|Other (Unknown Reasons)|0|||
46686872|NCT01090414|82901956|FG000|Study 101-99|Withdrew Consent|0|||
46686873|NCT01090414|82901957|FG001|Study 101-99|Withdrew Consent|2|||
46686874|NCT01090414|82901958|FG002|Study 101-99|Withdrew Consent|3|||
46686875|NCT01090414|82901959|FG003|Study 101-99|Withdrew Consent|1|||
46686876|NCT01090414|82901956|FG000|Study 101-99|Participant Request|3|||
46686877|NCT01090414|82901957|FG001|Study 101-99|Participant Request|1|||
46686878|NCT01090414|82901958|FG002|Study 101-99|Participant Request|0|||
46686879|NCT01090414|82901959|FG003|Study 101-99|Participant Request|0|||
46686880|NCT01090102|82901983|FG000|First 12 Weeks|Withdrawal by Subject|1|||
46686881|NCT01090102|82901984|FG001|First 12 Weeks|Withdrawal by Subject|1|||
46686882|NCT01090102|82901983|FG000|First 12 Weeks|Adverse Event|2|||
46686883|NCT01090102|82901984|FG001|First 12 Weeks|Adverse Event|0|||
46686884|NCT01090102|82901983|FG000|First 12 Weeks|Death|1|||
46686885|NCT01090102|82901984|FG001|First 12 Weeks|Death|1|||
46686886|NCT01090102|82901983|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
46686887|NCT01090102|82901984|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
46686888|NCT01287897|82901994|FG000|Overall Study|Adverse Event|5|||
46686889|NCT01287897|82901995|FG001|Overall Study|Adverse Event|3|||
46686890|NCT01287897|82901996|FG002|Overall Study|Adverse Event|6|||
46686891|NCT01287897|82901997|FG003|Overall Study|Adverse Event|4|||
46686892|NCT01287897|82901994|FG000|Overall Study|Lack of Efficacy|2|||
46686893|NCT01287897|82901995|FG001|Overall Study|Lack of Efficacy|0|||
46686894|NCT01287897|82901996|FG002|Overall Study|Lack of Efficacy|0|||
46686895|NCT01287897|82901997|FG003|Overall Study|Lack of Efficacy|0|||
46686896|NCT01287897|82901994|FG000|Overall Study|Protocol Violation|1|||
46686897|NCT01287897|82901995|FG001|Overall Study|Protocol Violation|1|||
46686898|NCT01287897|82901996|FG002|Overall Study|Protocol Violation|0|||
46686899|NCT01287897|82901997|FG003|Overall Study|Protocol Violation|1|||
46686900|NCT01287897|82901994|FG000|Overall Study|Lost to Follow-up|0|||
46686901|NCT01287897|82901995|FG001|Overall Study|Lost to Follow-up|0|||
46686902|NCT01287897|82901996|FG002|Overall Study|Lost to Follow-up|2|||
46686903|NCT01287897|82901997|FG003|Overall Study|Lost to Follow-up|0|||
46686904|NCT01287897|82901994|FG000|Overall Study|Withdrawal by Subject|1|||
46686905|NCT01287897|82901995|FG001|Overall Study|Withdrawal by Subject|5|||
46686906|NCT01287897|82901996|FG002|Overall Study|Withdrawal by Subject|3|||
46686907|NCT01287897|82901997|FG003|Overall Study|Withdrawal by Subject|2|||
46686908|NCT01287897|82901994|FG000|Overall Study|Not consented properly|0|||
46686909|NCT01287897|82901995|FG001|Overall Study|Not consented properly|1|||
46686910|NCT01287897|82901996|FG002|Overall Study|Not consented properly|0|||
46686911|NCT01287897|82901997|FG003|Overall Study|Not consented properly|0|||
46686912|NCT01287897|82901994|FG000|Overall Study|Not meeting entrance criteria|1|||
46686913|NCT01287897|82901995|FG001|Overall Study|Not meeting entrance criteria|1|||
46686914|NCT01287897|82901996|FG002|Overall Study|Not meeting entrance criteria|0|||
46686915|NCT01287897|82901997|FG003|Overall Study|Not meeting entrance criteria|0|||
46686916|NCT01287897|82901994|FG000|Overall Study|Other|1|||
46686917|NCT01287897|82901995|FG001|Overall Study|Other|0|||
46686918|NCT01287897|82901996|FG002|Overall Study|Other|1|||
46686919|NCT01287897|82901997|FG003|Overall Study|Other|0|||
46686920|NCT01090024|82902011|FG000|Period 1|Met exclusion criteria|0|||
46686921|NCT01090024|82902012|FG001|Period 1|Met exclusion criteria|0|||
46686922|NCT01090024|82902013|FG002|Period 1|Met exclusion criteria|0|||
46686923|NCT01090024|82902014|FG003|Period 1|Met exclusion criteria|0|||
46686924|NCT01090024|82902015|FG004|Period 1|Met exclusion criteria|0|||
46686925|NCT01090024|82902016|FG005|Period 1|Met exclusion criteria|0|||
46686926|NCT01090024|82902017|FG006|Period 1|Met exclusion criteria|0|||
46686927|NCT01090024|82902018|FG007|Period 1|Met exclusion criteria|0|||
46686928|NCT01090024|82902019|FG008|Period 1|Met exclusion criteria|0|||
46686929|NCT01090024|82902020|FG009|Period 1|Met exclusion criteria|0|||
46686930|NCT01090024|82902021|FG010|Period 1|Met exclusion criteria|0|||
46686931|NCT01090024|82902022|FG011|Period 1|Met exclusion criteria|0|||
46686932|NCT01090024|82902023|FG012|Period 1|Met exclusion criteria|0|||
46686933|NCT01090024|82902024|FG013|Period 1|Met exclusion criteria|0|||
46686934|NCT01090024|82902025|FG014|Period 1|Met exclusion criteria|1|||
46686935|NCT01090024|82902026|FG015|Period 1|Met exclusion criteria|0|||
46686936|NCT01090024|82902027|FG016|Period 1|Met exclusion criteria|0|||
46686937|NCT01090024|82902028|FG017|Period 1|Met exclusion criteria|0|||
46686938|NCT01090024|82902011|FG000|Period 1|Adverse Event|0|||
46686939|NCT01090024|82902012|FG001|Period 1|Adverse Event|0|||
46686940|NCT01090024|82902013|FG002|Period 1|Adverse Event|0|||
46686941|NCT01090024|82902014|FG003|Period 1|Adverse Event|0|||
46686942|NCT01090024|82902015|FG004|Period 1|Adverse Event|0|||
46686943|NCT01090024|82902016|FG005|Period 1|Adverse Event|0|||
46686944|NCT01090024|82902017|FG006|Period 1|Adverse Event|0|||
46686945|NCT01090024|82902018|FG007|Period 1|Adverse Event|0|||
46686946|NCT01090024|82902019|FG008|Period 1|Adverse Event|0|||
46686947|NCT01090024|82902020|FG009|Period 1|Adverse Event|1|||
46686948|NCT01090024|82902021|FG010|Period 1|Adverse Event|0|||
46686949|NCT01090024|82902022|FG011|Period 1|Adverse Event|1|||
46686950|NCT01090024|82902023|FG012|Period 1|Adverse Event|0|||
46686951|NCT01090024|82902024|FG013|Period 1|Adverse Event|0|||
46686952|NCT01090024|82902025|FG014|Period 1|Adverse Event|0|||
46686953|NCT01090024|82902026|FG015|Period 1|Adverse Event|0|||
46686954|NCT01090024|82902027|FG016|Period 1|Adverse Event|0|||
46686955|NCT01090024|82902028|FG017|Period 1|Adverse Event|1|||
46686956|NCT01090024|82902011|FG000|Period 1|Withdrawal by Subject|0|||
46686957|NCT01090024|82902012|FG001|Period 1|Withdrawal by Subject|0|||
46686958|NCT01090024|82902013|FG002|Period 1|Withdrawal by Subject|0|||
46799460|NCT00577031|83018443|FG000|Overall Study|Medical decision|14|||
46799461|NCT00577031|83018443|FG000|Overall Study|Death|6|||
46686959|NCT01090024|82902014|FG003|Period 1|Withdrawal by Subject|1|||
46686960|NCT01090024|82902015|FG004|Period 1|Withdrawal by Subject|0|||
46686961|NCT01090024|82902016|FG005|Period 1|Withdrawal by Subject|0|||
46686962|NCT01090024|82902017|FG006|Period 1|Withdrawal by Subject|0|||
46686963|NCT01090024|82902018|FG007|Period 1|Withdrawal by Subject|0|||
46686964|NCT01090024|82902019|FG008|Period 1|Withdrawal by Subject|0|||
46799462|NCT00565448|83018452|FG000|Overall Study|Adverse Event|1|||
46799463|NCT00565448|83018453|FG001|Overall Study|Adverse Event|2|||
46799464|NCT00565448|83018452|FG000|Overall Study|Disease progression|1|||
46686965|NCT01090024|82902020|FG009|Period 1|Withdrawal by Subject|0|||
46686966|NCT01090024|82902021|FG010|Period 1|Withdrawal by Subject|0|||
46686967|NCT01090024|82902022|FG011|Period 1|Withdrawal by Subject|0|||
46686968|NCT01090024|82902023|FG012|Period 1|Withdrawal by Subject|0|||
46686969|NCT01090024|82902024|FG013|Period 1|Withdrawal by Subject|0|||
46686970|NCT01090024|82902025|FG014|Period 1|Withdrawal by Subject|0|||
46686971|NCT01090024|82902026|FG015|Period 1|Withdrawal by Subject|0|||
46686972|NCT01090024|82902027|FG016|Period 1|Withdrawal by Subject|0|||
46686973|NCT01090024|82902028|FG017|Period 1|Withdrawal by Subject|0|||
46686974|NCT01090024|82902011|FG000|Period 1|Lost to Follow-up|0|||
46686975|NCT01090024|82902012|FG001|Period 1|Lost to Follow-up|1|||
46686976|NCT01090024|82902013|FG002|Period 1|Lost to Follow-up|0|||
46686977|NCT01090024|82902014|FG003|Period 1|Lost to Follow-up|0|||
46686978|NCT01090024|82902015|FG004|Period 1|Lost to Follow-up|0|||
46686979|NCT01090024|82902016|FG005|Period 1|Lost to Follow-up|0|||
46686980|NCT01090024|82902017|FG006|Period 1|Lost to Follow-up|0|||
46686981|NCT01090024|82902018|FG007|Period 1|Lost to Follow-up|0|||
46686982|NCT01090024|82902019|FG008|Period 1|Lost to Follow-up|0|||
46686983|NCT01090024|82902020|FG009|Period 1|Lost to Follow-up|0|||
46686984|NCT01090024|82902021|FG010|Period 1|Lost to Follow-up|0|||
46686985|NCT01090024|82902022|FG011|Period 1|Lost to Follow-up|0|||
46686986|NCT01090024|82902023|FG012|Period 1|Lost to Follow-up|0|||
46686987|NCT01090024|82902024|FG013|Period 1|Lost to Follow-up|0|||
46799465|NCT00565448|83018453|FG001|Overall Study|Disease progression|0|||
46799466|NCT00565448|83018452|FG000|Overall Study|Withdrawal by Subject|1|||
46799467|NCT00565448|83018453|FG001|Overall Study|Withdrawal by Subject|0|||
46686988|NCT01090024|82902025|FG014|Period 1|Lost to Follow-up|0|||
46686989|NCT01090024|82902026|FG015|Period 1|Lost to Follow-up|0|||
46686990|NCT01090024|82902027|FG016|Period 1|Lost to Follow-up|0|||
46686991|NCT01090024|82902028|FG017|Period 1|Lost to Follow-up|0|||
46686992|NCT01090024|82902011|FG000|Period 2|Lost to Follow-up|0|||
46686993|NCT01090024|82902012|FG001|Period 2|Lost to Follow-up|0|||
46686994|NCT01090024|82902013|FG002|Period 2|Lost to Follow-up|0|||
46686995|NCT01090024|82902014|FG003|Period 2|Lost to Follow-up|1|||
46686996|NCT01090024|82902015|FG004|Period 2|Lost to Follow-up|0|||
46686997|NCT01090024|82902016|FG005|Period 2|Lost to Follow-up|0|||
46686998|NCT01090024|82902017|FG006|Period 2|Lost to Follow-up|0|||
46686999|NCT01090024|82902018|FG007|Period 2|Lost to Follow-up|0|||
46687000|NCT01090024|82902019|FG008|Period 2|Lost to Follow-up|0|||
46687001|NCT01090024|82902020|FG009|Period 2|Lost to Follow-up|0|||
46687002|NCT01090024|82902021|FG010|Period 2|Lost to Follow-up|0|||
46687003|NCT01090024|82902022|FG011|Period 2|Lost to Follow-up|0|||
46687004|NCT01090024|82902023|FG012|Period 2|Lost to Follow-up|0|||
46687005|NCT01090024|82902024|FG013|Period 2|Lost to Follow-up|0|||
46687006|NCT01090024|82902025|FG014|Period 2|Lost to Follow-up|0|||
46687007|NCT01090024|82902026|FG015|Period 2|Lost to Follow-up|0|||
46687008|NCT01090024|82902027|FG016|Period 2|Lost to Follow-up|0|||
46687009|NCT01090024|82902028|FG017|Period 2|Lost to Follow-up|0|||
46799468|NCT00446446|83018462|FG000|Overall Study|Death|10|||
46799469|NCT00446446|83018462|FG000|Overall Study|Withdrawal by Subject|6|||
46799470|NCT00446446|83018462|FG000|Overall Study|Other|4|||
46799471|NCT00446446|83018462|FG000|Overall Study|Disease Progession|2|||
46687010|NCT01090024|82902011|FG000|Period 2|Adverse Event|1|||
46687011|NCT01090024|82902012|FG001|Period 2|Adverse Event|0|||
46687012|NCT01090024|82902013|FG002|Period 2|Adverse Event|0|||
46687013|NCT01090024|82902014|FG003|Period 2|Adverse Event|0|||
46687014|NCT01090024|82902015|FG004|Period 2|Adverse Event|0|||
46687015|NCT01090024|82902016|FG005|Period 2|Adverse Event|0|||
46687016|NCT01090024|82902017|FG006|Period 2|Adverse Event|0|||
46687017|NCT01090024|82902018|FG007|Period 2|Adverse Event|0|||
46687018|NCT01090024|82902019|FG008|Period 2|Adverse Event|0|||
46799472|NCT00446446|83018462|FG000|Overall Study|Adverse Event|1|||
46687019|NCT01090024|82902020|FG009|Period 2|Adverse Event|0|||
46687020|NCT01090024|82902021|FG010|Period 2|Adverse Event|0|||
46687021|NCT01090024|82902022|FG011|Period 2|Adverse Event|0|||
46687022|NCT01090024|82902023|FG012|Period 2|Adverse Event|0|||
46687023|NCT01090024|82902024|FG013|Period 2|Adverse Event|0|||
46687024|NCT01090024|82902025|FG014|Period 2|Adverse Event|0|||
46687025|NCT01090024|82902026|FG015|Period 2|Adverse Event|0|||
46687026|NCT01090024|82902027|FG016|Period 2|Adverse Event|0|||
46687027|NCT01090024|82902028|FG017|Period 2|Adverse Event|0|||
46687028|NCT01090024|82902011|FG000|Period 3|Withdrawal by Subject|0|||
46687029|NCT01090024|82902012|FG001|Period 3|Withdrawal by Subject|0|||
46687030|NCT01090024|82902013|FG002|Period 3|Withdrawal by Subject|0|||
46687031|NCT01090024|82902014|FG003|Period 3|Withdrawal by Subject|0|||
46687032|NCT01090024|82902015|FG004|Period 3|Withdrawal by Subject|0|||
46687033|NCT01090024|82902016|FG005|Period 3|Withdrawal by Subject|0|||
46687034|NCT01090024|82902017|FG006|Period 3|Withdrawal by Subject|0|||
46687035|NCT01090024|82902018|FG007|Period 3|Withdrawal by Subject|0|||
46687036|NCT01090024|82902019|FG008|Period 3|Withdrawal by Subject|0|||
46687037|NCT01090024|82902020|FG009|Period 3|Withdrawal by Subject|0|||
46687038|NCT01090024|82902021|FG010|Period 3|Withdrawal by Subject|0|||
46687039|NCT01090024|82902022|FG011|Period 3|Withdrawal by Subject|0|||
46687040|NCT01090024|82902023|FG012|Period 3|Withdrawal by Subject|0|||
46687041|NCT01090024|82902024|FG013|Period 3|Withdrawal by Subject|0|||
46687042|NCT01090024|82902025|FG014|Period 3|Withdrawal by Subject|0|||
46687043|NCT01090024|82902026|FG015|Period 3|Withdrawal by Subject|1|||
46687044|NCT01090024|82902027|FG016|Period 3|Withdrawal by Subject|0|||
46687045|NCT01090024|82902028|FG017|Period 3|Withdrawal by Subject|0|||
46687046|NCT01090024|82902011|FG000|Period 3|Protocol Violation|0|||
46799473|NCT00446446|83018462|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
46799474|NCT00514449|83018468|FG000|Overall Study|Withdrawal by Subject|1|||
46799475|NCT00514449|83018469|FG001|Overall Study|Withdrawal by Subject|2|||
46799476|NCT00514449|83018468|FG000|Overall Study|Protocol Violation|1|||
46799477|NCT00514449|83018469|FG001|Overall Study|Protocol Violation|2|||
46799478|NCT00514449|83018468|FG000|Overall Study|Lost to Follow-up|1|||
46799479|NCT00514449|83018469|FG001|Overall Study|Lost to Follow-up|0|||
46687047|NCT01090024|82902012|FG001|Period 3|Protocol Violation|0|||
46687048|NCT01090024|82902013|FG002|Period 3|Protocol Violation|0|||
46687049|NCT01090024|82902014|FG003|Period 3|Protocol Violation|0|||
46687050|NCT01090024|82902015|FG004|Period 3|Protocol Violation|0|||
46687051|NCT01090024|82902016|FG005|Period 3|Protocol Violation|0|||
46687052|NCT01090024|82902017|FG006|Period 3|Protocol Violation|0|||
46687053|NCT01090024|82902018|FG007|Period 3|Protocol Violation|0|||
46687054|NCT01090024|82902019|FG008|Period 3|Protocol Violation|1|||
46687055|NCT01090024|82902020|FG009|Period 3|Protocol Violation|0|||
46687056|NCT01090024|82902021|FG010|Period 3|Protocol Violation|0|||
46687057|NCT01090024|82902022|FG011|Period 3|Protocol Violation|0|||
46687058|NCT01090024|82902023|FG012|Period 3|Protocol Violation|0|||
46687059|NCT01090024|82902024|FG013|Period 3|Protocol Violation|0|||
46687060|NCT01090024|82902025|FG014|Period 3|Protocol Violation|0|||
46687061|NCT01090024|82902026|FG015|Period 3|Protocol Violation|0|||
46687062|NCT01090024|82902027|FG016|Period 3|Protocol Violation|0|||
46687063|NCT01090024|82902028|FG017|Period 3|Protocol Violation|0|||
46687064|NCT01090024|82902011|FG000|Period 3|Adverse Event|0|||
46687065|NCT01090024|82902012|FG001|Period 3|Adverse Event|0|||
46687066|NCT01090024|82902013|FG002|Period 3|Adverse Event|0|||
46687067|NCT01090024|82902014|FG003|Period 3|Adverse Event|0|||
46687068|NCT01090024|82902015|FG004|Period 3|Adverse Event|0|||
46687069|NCT01090024|82902016|FG005|Period 3|Adverse Event|1|||
46687070|NCT01090024|82902017|FG006|Period 3|Adverse Event|0|||
46687071|NCT01090024|82902018|FG007|Period 3|Adverse Event|0|||
46687072|NCT01090024|82902019|FG008|Period 3|Adverse Event|0|||
46687073|NCT01090024|82902020|FG009|Period 3|Adverse Event|0|||
46687074|NCT01090024|82902021|FG010|Period 3|Adverse Event|0|||
46687075|NCT01090024|82902022|FG011|Period 3|Adverse Event|0|||
46687076|NCT01090024|82902023|FG012|Period 3|Adverse Event|0|||
46687077|NCT01090024|82902024|FG013|Period 3|Adverse Event|0|||
46687078|NCT01090024|82902025|FG014|Period 3|Adverse Event|0|||
46687079|NCT01090024|82902026|FG015|Period 3|Adverse Event|0|||
46687080|NCT01090024|82902027|FG016|Period 3|Adverse Event|0|||
46687081|NCT01090024|82902028|FG017|Period 3|Adverse Event|0|||
46687082|NCT04868890|82902040|FG000|Overall Study|Death|2|||
46687083|NCT04868890|82902041|FG001|Overall Study|Death|1|||
46687084|NCT04868890|82902040|FG000|Overall Study|Withdrawal by Subject|1|||
46687085|NCT04868890|82902041|FG001|Overall Study|Withdrawal by Subject|5|||
46687086|NCT01281189|82902049|FG000|Overall Study|Adverse Event|7|||
46687087|NCT01281189|82902050|FG001|Overall Study|Adverse Event|9|||
46687088|NCT01281189|82902049|FG000|Overall Study|Lost to Follow-up|6|||
46687089|NCT01281189|82902050|FG001|Overall Study|Lost to Follow-up|4|||
46687090|NCT01281189|82902049|FG000|Overall Study|Withdrawal by Subject|21|||
46687091|NCT01281189|82902050|FG001|Overall Study|Withdrawal by Subject|24|||
46687092|NCT01281189|82902049|FG000|Overall Study|Physician Decision|2|||
46687093|NCT01281189|82902050|FG001|Overall Study|Physician Decision|3|||
46687094|NCT01281189|82902049|FG000|Overall Study|Death|103|||
46687095|NCT01281189|82902050|FG001|Overall Study|Death|91|||
46687096|NCT01281189|82902049|FG000|Overall Study|Other|8|||
46687097|NCT01281189|82902050|FG001|Overall Study|Other|12|||
46687098|NCT01280955|82902056|FG000|Overall Study|Death|2|||
46687099|NCT01280955|82902056|FG000|Overall Study|Withdrawal by Subject|1|||
46687100|NCT01280721|82902062|FG000|Overall Study|Adverse Event|4|||
46687101|NCT01280721|82902062|FG000|Overall Study|Physician Decision|3|||
46687102|NCT01280721|82902062|FG000|Overall Study|Withdrawal by Subject|6|||
46687103|NCT01280721|82902062|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
46687104|NCT01280721|82902062|FG000|Overall Study|No tolerability for the lowest dose|2|||
46687105|NCT01087762|82902080|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
46687106|NCT01087762|82902081|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
46687107|NCT01087762|82902082|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
46687108|NCT01087762|82902083|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
46687109|NCT01087762|82902084|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
46687110|NCT01087762|82902080|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
46687111|NCT01087762|82902081|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
46687112|NCT01087762|82902082|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
46687113|NCT01087762|82902083|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
46687114|NCT01087762|82902084|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
46687115|NCT01087762|82902080|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
46687116|NCT01087762|82902081|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
46687117|NCT01087762|82902082|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
46687118|NCT01087762|82902083|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
46687119|NCT01087762|82902084|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
46687120|NCT01087762|82902080|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
46687121|NCT01087762|82902081|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
46687122|NCT01087762|82902082|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
46687123|NCT01087762|82902083|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
46687124|NCT01087762|82902084|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
46687125|NCT01087762|82902080|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
46687126|NCT01087762|82902081|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
46687127|NCT01087762|82902082|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
46687128|NCT01087762|82902083|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
46687129|NCT01087762|82902084|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
46687130|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
46687131|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
46687132|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
46687133|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
46687134|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
46687135|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
46687136|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
46687137|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
46687138|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
46687139|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
46687140|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
46687141|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
46687142|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
46687143|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
46687144|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
46687145|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
46687146|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
46687147|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
46687148|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
46687149|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
46687150|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
46687151|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
46687152|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
46687153|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
46687154|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
46687155|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
46687156|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
46687157|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
46687158|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
46687159|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
46687160|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
46687161|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
46687162|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
46687163|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
46687164|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
46687165|NCT01087762|82902080|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
46687166|NCT01087762|82902081|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
46687167|NCT01087762|82902082|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
46687168|NCT01087762|82902083|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
46687169|NCT01087762|82902084|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
46687170|NCT01078168|82902096|FG000|Overall Study|Physician Decision|0|||
46687171|NCT01078168|82902097|FG001|Overall Study|Physician Decision|1|||
46687172|NCT01086358|82902103|FG000|First Intervention|Lost to Follow-up|9|||
46687173|NCT01086358|82902104|FG001|First Intervention|Lost to Follow-up|4|||
46799480|NCT00565136|83018478|FG000|Overall Study|Lost to Follow-up|1|||
46687174|NCT01086358|82902103|FG000|First Intervention|Withdrawal by Subject|0|||
46687175|NCT01086358|82902104|FG001|First Intervention|Withdrawal by Subject|1|||
46687176|NCT01086358|82902103|FG000|Second Intervention|Lost to Follow-up|4|||
46687177|NCT01086358|82902104|FG001|Second Intervention|Lost to Follow-up|4|||
46687178|NCT01277601|82902114|FG000|Overall Study|Adverse Event|5|||
46687179|NCT01277601|82902115|FG001|Overall Study|Adverse Event|3|||
46687180|NCT01277601|82902116|FG002|Overall Study|Adverse Event|0|||
46687181|NCT01277601|82902117|FG003|Overall Study|Adverse Event|7|||
46687182|NCT01277601|82902114|FG000|Overall Study|Withdrawal by Subject|18|||
46687183|NCT01277601|82902115|FG001|Overall Study|Withdrawal by Subject|21|||
46687184|NCT01277601|82902116|FG002|Overall Study|Withdrawal by Subject|8|||
46687185|NCT01277601|82902117|FG003|Overall Study|Withdrawal by Subject|17|||
46687186|NCT01277601|82902114|FG000|Overall Study|Lost to Follow-up|7|||
46687187|NCT01277601|82902115|FG001|Overall Study|Lost to Follow-up|9|||
46687188|NCT01277601|82902116|FG002|Overall Study|Lost to Follow-up|4|||
46687189|NCT01277601|82902117|FG003|Overall Study|Lost to Follow-up|2|||
46687190|NCT01277601|82902114|FG000|Overall Study|Physician Decision|3|||
46799481|NCT00565136|83018478|FG000|Overall Study|Withdrawal by Subject|1|||
46799482|NCT00565136|83018478|FG000|Overall Study|Protocol Violation|1|||
46799483|NCT00492921|83018482|FG000|Overall Study|Death|1|||
46799484|NCT00492921|83018483|FG001|Overall Study|Death|0|||
46799485|NCT00492921|83018484|FG002|Overall Study|Death|1|||
46799486|NCT00502671|83018492|FG000|Overall Study|Disease Progression|13|||
46799487|NCT00502671|83018492|FG000|Overall Study|Personal Reasons|22|||
46799488|NCT00502671|83018492|FG000|Overall Study|Lost to Follow-up|7|||
46799489|NCT00502671|83018492|FG000|Overall Study|Protocol Violation|16|||
46799490|NCT00502671|83018492|FG000|Overall Study|Adverse Event|19|||
46799491|NCT00697463|83018496|FG000|Overall Study|Withdrawal by Subject|1|||
46799492|NCT00492531|83018502|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
46687191|NCT01277601|82902115|FG001|Overall Study|Physician Decision|5|||
46687192|NCT01277601|82902116|FG002|Overall Study|Physician Decision|1|||
46687193|NCT01277601|82902117|FG003|Overall Study|Physician Decision|6|||
46687194|NCT01277601|82902114|FG000|Overall Study|Pregnancy|2|||
46687195|NCT01277601|82902115|FG001|Overall Study|Pregnancy|2|||
46687196|NCT01277601|82902116|FG002|Overall Study|Pregnancy|4|||
46687197|NCT01277601|82902117|FG003|Overall Study|Pregnancy|1|||
46687198|NCT01277601|82902114|FG000|Overall Study|Noncompliance with Study Drug|1|||
46687199|NCT01277601|82902115|FG001|Overall Study|Noncompliance with Study Drug|3|||
46687200|NCT01277601|82902116|FG002|Overall Study|Noncompliance with Study Drug|2|||
46687201|NCT01277601|82902117|FG003|Overall Study|Noncompliance with Study Drug|0|||
46687202|NCT01277601|82902114|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
46687203|NCT01277601|82902115|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
46687204|NCT01277601|82902116|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
46687205|NCT01277601|82902117|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
46687206|NCT01277601|82902114|FG000|Overall Study|Protocol Violation|0|||
46687207|NCT01277601|82902115|FG001|Overall Study|Protocol Violation|2|||
46687208|NCT01277601|82902116|FG002|Overall Study|Protocol Violation|5|||
46687209|NCT01277601|82902117|FG003|Overall Study|Protocol Violation|0|||
46687210|NCT01277601|82902114|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
46687211|NCT01277601|82902115|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
46687212|NCT01277601|82902116|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
46687213|NCT01277601|82902117|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
46799493|NCT00492531|83018503|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
46799494|NCT00111475|83018519|FG000|Overall Study|Lost to Follow-up|0|||
46799495|NCT00111475|83018520|FG001|Overall Study|Lost to Follow-up|0|||
46687214|NCT01277523|82902147|FG000|Overall Study|Adverse Event|1|||
46687215|NCT01277523|82902148|FG001|Overall Study|Adverse Event|0|||
46687216|NCT01277523|82902149|FG002|Overall Study|Adverse Event|0|||
46687217|NCT01277523|82902147|FG000|Overall Study|Protocol Violation|2|||
46687218|NCT01277523|82902148|FG001|Overall Study|Protocol Violation|0|||
46687219|NCT01277523|82902149|FG002|Overall Study|Protocol Violation|0|||
46687220|NCT01277523|82902147|FG000|Overall Study|Other Reason not Defined|0|||
46687221|NCT01277523|82902148|FG001|Overall Study|Other Reason not Defined|1|||
46687222|NCT01277523|82902149|FG002|Overall Study|Other Reason not Defined|0|||
46687223|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
46687224|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
46687225|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
46799496|NCT00111475|83018521|FG002|Overall Study|Lost to Follow-up|0|||
46687226|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
46687227|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
46687228|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
46687229|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
46687230|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
46687231|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
46687232|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
46687233|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Death|1|||
46687234|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Death|0|||
46687235|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Death|0|||
46687236|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Death|0|||
46687237|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Death|0|||
46687238|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
46687239|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
46687240|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
46687241|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
46687242|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
46687243|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
46687244|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
46687245|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
46687246|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
46687247|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
46687248|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
46687249|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
46687250|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
46687251|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
46687252|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
46687253|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
46687254|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
46687255|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
46687256|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
46687257|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46687258|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
46687259|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
46687260|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
46687261|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
46687262|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
46687263|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Other|4|||
46687264|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Other|4|||
46687265|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Other|3|||
46687266|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Other|1|||
46687267|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Other|0|||
46687268|NCT01081834|82902162|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
46687269|NCT01081834|82902163|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
46687270|NCT01081834|82902164|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
46687271|NCT01081834|82902165|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
46687272|NCT01081834|82902166|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
46687273|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
46687274|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
46687275|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
46687276|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
46687277|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
46687278|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Death|1|||
46687279|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Death|0|||
46687280|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Death|0|||
46687281|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Death|0|||
46687282|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Death|0|||
46687283|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
46687284|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
46687285|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46687286|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46687287|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
46687288|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46687289|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
46687290|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46687291|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46981722|NCT02404389|83227770|FG004|Overall Study|Subject/guardian decision|1|||
46687292|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46687293|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46687294|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
46687295|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
46687296|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
46687297|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
46687298|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
46687299|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
46687300|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
46687301|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
46687302|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
46687303|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
46687304|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
46687305|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
46687306|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
46687307|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
46687308|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Other|4|||
46687309|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Other|5|||
46687310|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Other|4|||
46687311|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Other|0|||
46981723|NCT01667419|83227788|FG000|Overall Study|Reason Not Specified|1|||
46687312|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Other|0|||
46687313|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
46687314|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
46687315|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
46687316|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
46687317|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
46687318|NCT01081834|82902162|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46687319|NCT01081834|82902163|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
46687320|NCT01081834|82902164|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46981724|NCT01667419|83227789|FG001|Overall Study|Reason Not Specified|0|||
46981725|NCT01667419|83227790|FG002|Overall Study|Reason Not Specified|0|||
46981726|NCT01667419|83227791|FG003|Overall Study|Reason Not Specified|0|||
46981727|NCT01667419|83227788|FG000|Overall Study|Withdrawal by Subject|16|||
46687321|NCT01081834|82902165|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46687322|NCT01081834|82902166|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46687323|NCT01276509|82902189|FG000|Overall Study|Adverse Event|9|||
46687324|NCT01276509|82902190|FG001|Overall Study|Adverse Event|8|||
46981728|NCT01667419|83227789|FG001|Overall Study|Withdrawal by Subject|8|||
46981729|NCT01667419|83227790|FG002|Overall Study|Withdrawal by Subject|9|||
46981730|NCT01667419|83227791|FG003|Overall Study|Withdrawal by Subject|8|||
46981731|NCT01667419|83227788|FG000|Overall Study|Non-compliance|0|||
46981732|NCT01667419|83227789|FG001|Overall Study|Non-compliance|0|||
46981733|NCT01667419|83227790|FG002|Overall Study|Non-compliance|0|||
46687325|NCT01276509|82902191|FG002|Overall Study|Adverse Event|4|||
46687326|NCT01276509|82902192|FG003|Overall Study|Adverse Event|3|||
46687327|NCT01276509|82902189|FG000|Overall Study|Lack of Efficacy|2|||
46687328|NCT01276509|82902190|FG001|Overall Study|Lack of Efficacy|1|||
46687329|NCT01276509|82902191|FG002|Overall Study|Lack of Efficacy|1|||
46687330|NCT01276509|82902192|FG003|Overall Study|Lack of Efficacy|2|||
46687331|NCT01276509|82902189|FG000|Overall Study|Pregnancy|1|||
46687332|NCT01276509|82902190|FG001|Overall Study|Pregnancy|0|||
46687333|NCT01276509|82902191|FG002|Overall Study|Pregnancy|0|||
46687334|NCT01276509|82902192|FG003|Overall Study|Pregnancy|0|||
46687335|NCT01276509|82902189|FG000|Overall Study|Withdrawal by Subject|1|||
46687336|NCT01276509|82902190|FG001|Overall Study|Withdrawal by Subject|2|||
46687337|NCT01276509|82902191|FG002|Overall Study|Withdrawal by Subject|0|||
46687338|NCT01276509|82902192|FG003|Overall Study|Withdrawal by Subject|0|||
46687339|NCT01276509|82902189|FG000|Overall Study|Other|0|||
46687340|NCT01276509|82902190|FG001|Overall Study|Other|1|||
46687341|NCT01276509|82902191|FG002|Overall Study|Other|0|||
46687342|NCT01276509|82902192|FG003|Overall Study|Other|0|||
46687343|NCT01079962|82902204|FG000|Overall Study|Adverse Event|2|||
46687344|NCT01079962|82902205|FG001|Overall Study|Adverse Event|2|||
46687345|NCT01079962|82902204|FG000|Overall Study|Withdrawal by Subject|5|||
46687346|NCT01079962|82902205|FG001|Overall Study|Withdrawal by Subject|7|||
46687347|NCT01079962|82902204|FG000|Overall Study|Protocol Violation|2|||
46687348|NCT01079962|82902205|FG001|Overall Study|Protocol Violation|2|||
46687349|NCT01079962|82902204|FG000|Overall Study|No blood pressure (BP) control|3|||
46687350|NCT01079962|82902205|FG001|Overall Study|No blood pressure (BP) control|0|||
46687351|NCT01079962|82902204|FG000|Overall Study|Inclusion/exclusion criteria|1|||
46687352|NCT01079962|82902205|FG001|Overall Study|Inclusion/exclusion criteria|3|||
46687353|NCT01079962|82902204|FG000|Overall Study|Participant not returning for next visit|1|||
46687354|NCT01079962|82902205|FG001|Overall Study|Participant not returning for next visit|0|||
46687355|NCT01079962|82902204|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
46687356|NCT01079962|82902205|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
46687357|NCT01274637|82902213|FG000|Overall Study|Withdrawal by Subject|0|||
46687358|NCT01274637|82902214|FG001|Overall Study|Withdrawal by Subject|1|||
46687359|NCT01274637|82902213|FG000|Overall Study|Lost to Follow-up|0|||
46687360|NCT01274637|82902214|FG001|Overall Study|Lost to Follow-up|1|||
46687361|NCT01079806|82902222|FG000|Day 1 to Week 96|Adverse Event|0|||
46687362|NCT01079806|82902223|FG001|Day 1 to Week 96|Adverse Event|3|||
46687363|NCT01079806|82902222|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
46687364|NCT01079806|82902223|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
46981734|NCT01667419|83227791|FG003|Overall Study|Non-compliance|1|||
46981735|NCT01667419|83227788|FG000|Overall Study|Protocol Violation|1|||
46981736|NCT01667419|83227789|FG001|Overall Study|Protocol Violation|0|||
46981737|NCT01667419|83227790|FG002|Overall Study|Protocol Violation|0|||
46981738|NCT01667419|83227791|FG003|Overall Study|Protocol Violation|0|||
46687365|NCT01079806|82902222|FG000|Day 1 to Week 96|Pregnancy|0|||
46687366|NCT01079806|82902223|FG001|Day 1 to Week 96|Pregnancy|1|||
46687367|NCT01079806|82902222|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
46687368|NCT01079806|82902223|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
46981739|NCT01667419|83227788|FG000|Overall Study|Lost to Follow-up|7|||
46981740|NCT01667419|83227789|FG001|Overall Study|Lost to Follow-up|6|||
46981741|NCT01667419|83227790|FG002|Overall Study|Lost to Follow-up|2|||
46687369|NCT01079806|82902222|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
46687370|NCT01079806|82902223|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
46981742|NCT01667419|83227791|FG003|Overall Study|Lost to Follow-up|4|||
46687371|NCT01079806|82902222|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
46687372|NCT01079806|82902223|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
46687373|NCT01079806|82902222|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
46687374|NCT01079806|82902223|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
46687375|NCT01079806|82902222|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
46687376|NCT01079806|82902223|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
46687377|NCT01079806|82902222|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
46687378|NCT01079806|82902223|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
46687379|NCT01079806|82902222|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
46687380|NCT01079806|82902223|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
46687381|NCT01078090|82902231|FG000|Overall Study|Lost to Follow-up|2363|||
46687382|NCT01078090|82902231|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
46687383|NCT01078090|82902231|FG000|Overall Study|Lack of Efficacy|1193|||
46687384|NCT01078090|82902231|FG000|Overall Study|ADR and lack of efficacy|61|||
46687385|NCT01078090|82902231|FG000|Overall Study|Other|523|||
46687386|NCT01077622|82902249|FG000|Overall Study|Physician Decision|2|||
46687387|NCT01077622|82902249|FG000|Overall Study|Withdrawal by Subject|1|||
46687388|NCT01313676|82902257|FG000|Overall Study|Adverse Event|395|||
46687389|NCT01313676|82902258|FG001|Overall Study|Adverse Event|365|||
46687390|NCT01313676|82902259|FG002|Overall Study|Adverse Event|372|||
46687391|NCT01313676|82902260|FG003|Overall Study|Adverse Event|333|||
46687392|NCT01313676|82902257|FG000|Overall Study|Lack of Efficacy|98|||
46687393|NCT01313676|82902258|FG001|Overall Study|Lack of Efficacy|90|||
46687394|NCT01313676|82902259|FG002|Overall Study|Lack of Efficacy|65|||
46687395|NCT01313676|82902260|FG003|Overall Study|Lack of Efficacy|46|||
46687396|NCT01313676|82902257|FG000|Overall Study|Protocol Violation|37|||
46687397|NCT01313676|82902258|FG001|Overall Study|Protocol Violation|44|||
46687398|NCT01313676|82902259|FG002|Overall Study|Protocol Violation|46|||
46687399|NCT01313676|82902260|FG003|Overall Study|Protocol Violation|44|||
46687400|NCT01313676|82902257|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
46687401|NCT01313676|82902258|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
46687402|NCT01313676|82902259|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
46687403|NCT01313676|82902260|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
46687404|NCT01313676|82902257|FG000|Overall Study|Study Closed/terminated|7|||
46687405|NCT01313676|82902258|FG001|Overall Study|Study Closed/terminated|6|||
46687406|NCT01313676|82902259|FG002|Overall Study|Study Closed/terminated|9|||
46687407|NCT01313676|82902260|FG003|Overall Study|Study Closed/terminated|9|||
46687408|NCT01313676|82902257|FG000|Overall Study|Lost to Follow-up|0|||
46687409|NCT01313676|82902258|FG001|Overall Study|Lost to Follow-up|0|||
46687410|NCT01313676|82902259|FG002|Overall Study|Lost to Follow-up|1|||
46687411|NCT01313676|82902260|FG003|Overall Study|Lost to Follow-up|0|||
46981743|NCT01667419|83227788|FG000|Overall Study|Death|18|||
46981744|NCT01667419|83227789|FG001|Overall Study|Death|33|||
46981745|NCT01667419|83227790|FG002|Overall Study|Death|25|||
46981746|NCT01667419|83227791|FG003|Overall Study|Death|26|||
46981747|NCT02588833|83227808|FG000|Part 1|Withdrawal by Subject|1|||
46981748|NCT02588833|83227809|FG001|Part 1|Withdrawal by Subject|0|||
46981749|NCT02588833|83227808|FG000|Part 2A|Physician Decision|0|||
46981750|NCT02588833|83227809|FG001|Part 2A|Physician Decision|1|||
46981751|NCT02588833|83227808|FG000|Part 2A|Withdrawal by Subject|0|||
46687412|NCT01313676|82902257|FG000|Overall Study|Physician Decision|53|||
46687413|NCT01313676|82902258|FG001|Overall Study|Physician Decision|64|||
46687414|NCT01313676|82902259|FG002|Overall Study|Physician Decision|62|||
46687415|NCT01313676|82902260|FG003|Overall Study|Physician Decision|48|||
46687416|NCT01313676|82902257|FG000|Overall Study|Decision by Participant or Proxy|643|||
46687417|NCT01313676|82902258|FG001|Overall Study|Decision by Participant or Proxy|527|||
46687418|NCT01313676|82902259|FG002|Overall Study|Decision by Participant or Proxy|515|||
46687419|NCT01313676|82902260|FG003|Overall Study|Decision by Participant or Proxy|492|||
46687420|NCT01313676|82902257|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
46799497|NCT00111475|83018522|FG003|Overall Study|Lost to Follow-up|0|||
46799498|NCT00111475|83018523|FG004|Overall Study|Lost to Follow-up|0|||
46799499|NCT00111475|83018524|FG005|Overall Study|Lost to Follow-up|1|||
46799500|NCT00111475|83018525|FG006|Overall Study|Lost to Follow-up|0|||
46799501|NCT00111475|83018526|FG007|Overall Study|Lost to Follow-up|0|||
46799502|NCT00111475|83018527|FG008|Overall Study|Lost to Follow-up|0|||
46799503|NCT00111475|83018528|FG009|Overall Study|Lost to Follow-up|0|||
46799504|NCT00111241|83018557|FG000|Overall Study|Lost to Follow-up|1|||
46799505|NCT00111241|83018558|FG001|Overall Study|Lost to Follow-up|0|||
46799506|NCT00111241|83018557|FG000|Overall Study|Withdrawal by Subject|4|||
46799507|NCT00111241|83018558|FG001|Overall Study|Withdrawal by Subject|0|||
46799508|NCT00111241|83018557|FG000|Overall Study|Protocol Violation|9|||
46799509|NCT00111241|83018558|FG001|Overall Study|Protocol Violation|8|||
46799510|NCT00111241|83018557|FG000|Overall Study|Adverse Event|1|||
46799511|NCT00111241|83018558|FG001|Overall Study|Adverse Event|0|||
46799512|NCT00492297|83018566|FG000|Treatment|Death|2|||
46799513|NCT00492297|83018566|FG000|Treatment|Study terminated by sponsor|3|||
46799514|NCT00492297|83018566|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
46799515|NCT00492297|83018566|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
46981752|NCT02588833|83227809|FG001|Part 2A|Withdrawal by Subject|1|||
46981753|NCT02588833|83227808|FG000|Part 2B|Adverse Event|0|||
46687421|NCT01313676|82902258|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
46799516|NCT00492297|83018566|FG000|Survival Only Follow-up|Death|46|||
46799517|NCT00492297|83018566|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
46799518|NCT00492297|83018566|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
46799519|NCT00565058|83018572|FG000|Overall Study|Adverse Event|1|||
46799520|NCT00565058|83018573|FG001|Overall Study|Adverse Event|0|||
46981754|NCT02588833|83227809|FG001|Part 2B|Adverse Event|1|||
46981755|NCT02588833|83227808|FG000|Part 2C|Adverse Event|0|||
46981756|NCT02588833|83227809|FG001|Part 2C|Adverse Event|1|||
46981757|NCT02588833|83227808|FG000|Part 2C|Withdrawal by Subject|0|||
46981758|NCT02588833|83227809|FG001|Part 2C|Withdrawal by Subject|1|||
46981759|NCT02588833|83227808|FG000|Part 3 (Safety Follow-up)|Other|0|||
46981760|NCT02588833|83227809|FG001|Part 3 (Safety Follow-up)|Other|2|||
46981761|NCT01667107|83227818|FG000|Overall Study|Adverse Event|4|||
46981762|NCT01667107|83227819|FG001|Overall Study|Adverse Event|3|||
46981763|NCT01667107|83227818|FG000|Overall Study|Tolerability issues|0|||
46981764|NCT01667107|83227819|FG001|Overall Study|Tolerability issues|2|||
46981765|NCT01667107|83227818|FG000|Overall Study|Protocol Violation|0|||
46799521|NCT00564902|83018582|FG000|Overall Study|Withdrawal by Subject|0|||
46799522|NCT00564902|83018583|FG001|Overall Study|Withdrawal by Subject|3|||
46799523|NCT00564902|83018584|FG002|Overall Study|Withdrawal by Subject|4|||
46799524|NCT00564902|83018582|FG000|Overall Study|Death|1|||
46799525|NCT00564902|83018583|FG001|Overall Study|Death|1|||
46799526|NCT00564902|83018584|FG002|Overall Study|Death|0|||
46687422|NCT01313676|82902259|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
46687423|NCT01313676|82902260|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
46687424|NCT01313676|82902257|FG000|Overall Study|Investigator Site Closed|12|||
46687425|NCT01313676|82902258|FG001|Overall Study|Investigator Site Closed|11|||
46687426|NCT01313676|82902259|FG002|Overall Study|Investigator Site Closed|15|||
46687427|NCT01313676|82902260|FG003|Overall Study|Investigator Site Closed|10|||
46687428|NCT01313676|82902257|FG000|Overall Study|Missing|1|||
46799527|NCT00446134|83018596|FG000|Overall Study|Adverse Event|7|||
46799528|NCT00446134|83018597|FG001|Overall Study|Adverse Event|17|||
46799529|NCT00446134|83018598|FG002|Overall Study|Adverse Event|13|||
46799530|NCT00446134|83018599|FG003|Overall Study|Adverse Event|18|||
46799531|NCT00446134|83018596|FG000|Overall Study|Lack of Efficacy|19|||
46799532|NCT00446134|83018597|FG001|Overall Study|Lack of Efficacy|19|||
46799533|NCT00446134|83018598|FG002|Overall Study|Lack of Efficacy|24|||
46799534|NCT00446134|83018599|FG003|Overall Study|Lack of Efficacy|19|||
46799535|NCT00446134|83018596|FG000|Overall Study|Protocol Violation|0|||
46799536|NCT00446134|83018597|FG001|Overall Study|Protocol Violation|2|||
46799537|NCT00446134|83018598|FG002|Overall Study|Protocol Violation|1|||
46799538|NCT00446134|83018599|FG003|Overall Study|Protocol Violation|0|||
46799539|NCT00446134|83018596|FG000|Overall Study|Lost to Follow-up|1|||
46799540|NCT00446134|83018597|FG001|Overall Study|Lost to Follow-up|3|||
46799541|NCT00446134|83018598|FG002|Overall Study|Lost to Follow-up|1|||
46799542|NCT00446134|83018599|FG003|Overall Study|Lost to Follow-up|1|||
46799543|NCT00446134|83018596|FG000|Overall Study|Withdrawal by Subject|3|||
46799544|NCT00446134|83018597|FG001|Overall Study|Withdrawal by Subject|3|||
46799545|NCT00446134|83018598|FG002|Overall Study|Withdrawal by Subject|1|||
46799546|NCT00446134|83018599|FG003|Overall Study|Withdrawal by Subject|3|||
46799547|NCT00446134|83018596|FG000|Overall Study|Physician Decision|0|||
46799548|NCT00446134|83018597|FG001|Overall Study|Physician Decision|0|||
46799549|NCT00446134|83018598|FG002|Overall Study|Physician Decision|0|||
46799550|NCT00446134|83018599|FG003|Overall Study|Physician Decision|2|||
46799551|NCT00446134|83018596|FG000|Overall Study|Adverse Event-Diarrhea|1|||
46799552|NCT00446134|83018597|FG001|Overall Study|Adverse Event-Diarrhea|1|||
46799553|NCT00446134|83018598|FG002|Overall Study|Adverse Event-Diarrhea|2|||
46799554|NCT00446134|83018599|FG003|Overall Study|Adverse Event-Diarrhea|0|||
46799555|NCT00446134|83018596|FG000|Overall Study|Reason Not Completed|3|||
46799556|NCT00446134|83018597|FG001|Overall Study|Reason Not Completed|0|||
46799557|NCT00446134|83018598|FG002|Overall Study|Reason Not Completed|1|||
46799558|NCT00446134|83018599|FG003|Overall Study|Reason Not Completed|2|||
46799559|NCT00563186|83018611|FG000|Overall Study|LOS<48 hours|97|||
46799560|NCT00563186|83018612|FG001|Overall Study|LOS<48 hours|74|||
46799561|NCT00563186|83018611|FG000|Overall Study|Incomplete data|1|||
46799562|NCT00563186|83018612|FG001|Overall Study|Incomplete data|1|||
46799563|NCT00699413|83018623|FG000|Overall Study|Withdrawal by Subject|0|||
46799564|NCT00699413|83018624|FG001|Overall Study|Withdrawal by Subject|2|||
46799565|NCT00699413|83018623|FG000|Overall Study|Study terminated by sponsor|4|||
46799566|NCT00699413|83018624|FG001|Overall Study|Study terminated by sponsor|2|||
46799567|NCT04808609|83018632|FG000|Overall Study|Lost to Follow-up|0|||
46858572|NCT03292588|83074312|FG001|Overall Study|Physician Decision|1|||
46687429|NCT01313676|82902258|FG001|Overall Study|Missing|1|||
46687430|NCT01313676|82902259|FG002|Overall Study|Missing|1|||
46799568|NCT04808609|83018633|FG001|Overall Study|Lost to Follow-up|2|||
46799569|NCT04808609|83018632|FG000|Overall Study|Administrative Withdrawal|0|||
46799570|NCT04808609|83018633|FG001|Overall Study|Administrative Withdrawal|1|||
46799571|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
46799572|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
46799573|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Death|5|||
46799574|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Death|2|||
46799575|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
46799576|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
46687431|NCT01313676|82902260|FG003|Overall Study|Missing|0|||
46687432|NCT01313286|82902271|FG000|Period 1|Withdrawal by Subject|2|||
46687433|NCT01313286|82902272|FG001|Period 1|Withdrawal by Subject|0|||
46687434|NCT01313208|82902280|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
46687435|NCT01313208|82902281|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
46687436|NCT01313208|82902280|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
46687437|NCT01313208|82902281|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
46687438|NCT01313208|82902280|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
46687439|NCT01313208|82902281|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
46687440|NCT01313208|82902280|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
46687441|NCT01313208|82902281|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
46687442|NCT01313208|82902280|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
46687443|NCT01313208|82902281|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
46687444|NCT01313208|82902280|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
46687445|NCT01313208|82902281|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
46687446|NCT01313208|82902280|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
46687447|NCT01313208|82902281|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
46799577|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
46799578|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
46799579|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
46799580|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
46799581|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Relapse|1|||
46799582|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Relapse|0|||
46799583|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
46858573|NCT03292588|83074311|FG000|Overall Study|Withdrawal by Subject|4|||
46799584|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
46858574|NCT03292588|83074312|FG001|Overall Study|Withdrawal by Subject|4|||
46981766|NCT01667107|83227819|FG001|Overall Study|Protocol Violation|1|||
46799585|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
46799586|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
46799587|NCT00111007|83018641|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
46799588|NCT00111007|83018642|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
46799589|NCT00111007|83018641|FG000|Active Follow-up|Adverse Event|1|||
46799590|NCT00111007|83018642|FG001|Active Follow-up|Adverse Event|0|||
46799591|NCT00111007|83018641|FG000|Active Follow-up|Death|2|||
46799592|NCT00111007|83018642|FG001|Active Follow-up|Death|0|||
46799593|NCT00111007|83018641|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
46799594|NCT00111007|83018642|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
46799595|NCT00111007|83018641|FG000|Long Term Follow-up|Death|34|||
46799596|NCT00111007|83018642|FG001|Long Term Follow-up|Death|39|||
46799597|NCT00111007|83018641|FG000|Long Term Follow-up|Lost to Follow-up|1|||
46799598|NCT00111007|83018642|FG001|Long Term Follow-up|Lost to Follow-up|1|||
46799599|NCT00111007|83018641|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
46858575|NCT03292588|83074311|FG000|Overall Study|Move out of town|1|||
46858576|NCT03292588|83074312|FG001|Overall Study|Move out of town|0|||
46858577|NCT03292588|83074311|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
46799600|NCT00111007|83018642|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
46858578|NCT03292588|83074312|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
46858579|NCT03752528|83074320|FG000|Part A|Lost to Follow-up|1|||
46858580|NCT03752528|83074320|FG000|Part A|Protocol Violation|1|||
46858581|NCT03752528|83074320|FG000|Part B|Protocol Violation|1|||
46858582|NCT03752528|83074320|FG000|Part B|Study terminated by sponsor|3|||
46858583|NCT00334295|83074327|FG000|Overall Study|Patients received fewer than 3 injection|5|||
46858584|NCT03292432|83074333|FG000|Overall Study|Lost to Follow-up|11|||
46858585|NCT03292432|83074334|FG001|Overall Study|Lost to Follow-up|8|||
46858586|NCT03292432|83074333|FG000|Overall Study|Death|2|||
46858587|NCT03292432|83074334|FG001|Overall Study|Death|1|||
46858588|NCT03292432|83074333|FG000|Overall Study|Withdrawal by Subject|1|||
46858589|NCT03292432|83074334|FG001|Overall Study|Withdrawal by Subject|2|||
46858590|NCT03292432|83074333|FG000|Overall Study|Site closed before any data collected|1|||
46858591|NCT03292432|83074334|FG001|Overall Study|Site closed before any data collected|0|||
46858592|NCT03291808|83074340|FG000|Overall Study|Lost to Follow-up|6|||
46858593|NCT03291808|83074340|FG000|Overall Study|Research burden|4|||
46858594|NCT03263806|83074346|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
46858595|NCT03263806|83074347|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
46858596|NCT03263806|83074346|FG000|Overall Study|Withdrawal by Subject|0|||
46858597|NCT03263806|83074347|FG001|Overall Study|Withdrawal by Subject|1|||
46858598|NCT03263806|83074346|FG000|Overall Study|Study Termination|5|||
46858599|NCT03263806|83074347|FG001|Overall Study|Study Termination|6|||
46687448|NCT01313208|82902280|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
46687449|NCT01313208|82902281|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
46687450|NCT01313208|82902280|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
46687451|NCT01313208|82902281|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
46687452|NCT01312428|82902291|FG000|Overall Study|Study Termination|3|||
46687453|NCT01312428|82902292|FG001|Overall Study|Study Termination|4|||
46687454|NCT01075984|82902305|FG000|Treatment Phase|Adverse Event|0|||
46687455|NCT01075984|82902306|FG001|Treatment Phase|Adverse Event|1|||
46687456|NCT01075984|82902307|FG002|Treatment Phase|Adverse Event|3|||
46687457|NCT01075984|82902308|FG003|Treatment Phase|Adverse Event|7|||
46687458|NCT01075984|82902309|FG004|Treatment Phase|Adverse Event|35|||
46687459|NCT01075984|82902305|FG000|Treatment Phase|Protocol Violation|0|||
46687460|NCT01075984|82902306|FG001|Treatment Phase|Protocol Violation|0|||
46687461|NCT01075984|82902307|FG002|Treatment Phase|Protocol Violation|1|||
46687462|NCT01075984|82902308|FG003|Treatment Phase|Protocol Violation|0|||
46687463|NCT01075984|82902309|FG004|Treatment Phase|Protocol Violation|3|||
46687464|NCT01075984|82902305|FG000|Treatment Phase|Withdrawal by Subject|0|||
46687465|NCT01075984|82902306|FG001|Treatment Phase|Withdrawal by Subject|0|||
46687466|NCT01075984|82902307|FG002|Treatment Phase|Withdrawal by Subject|2|||
46687467|NCT01075984|82902308|FG003|Treatment Phase|Withdrawal by Subject|0|||
46687468|NCT01075984|82902309|FG004|Treatment Phase|Withdrawal by Subject|15|||
46687469|NCT01075984|82902305|FG000|Treatment Phase|Treatment Failure|0|||
46687470|NCT01075984|82902306|FG001|Treatment Phase|Treatment Failure|0|||
46687471|NCT01075984|82902307|FG002|Treatment Phase|Treatment Failure|1|||
46687472|NCT01075984|82902308|FG003|Treatment Phase|Treatment Failure|0|||
46687473|NCT01075984|82902309|FG004|Treatment Phase|Treatment Failure|5|||
46687474|NCT01075984|82902305|FG000|Treatment Phase|Progression of disease|0|||
46687475|NCT01075984|82902306|FG001|Treatment Phase|Progression of disease|0|||
46687476|NCT01075984|82902307|FG002|Treatment Phase|Progression of disease|0|||
46687477|NCT01075984|82902308|FG003|Treatment Phase|Progression of disease|0|||
46858600|NCT03751280|83074355|FG000|Overall Study|Adverse Event|0|||
46858601|NCT03751280|83074356|FG001|Overall Study|Adverse Event|1|||
46687478|NCT01075984|82902309|FG004|Treatment Phase|Progression of disease|2|||
46687479|NCT01075984|82902305|FG000|Follow-up Phase|Protocol Violation|0|||
46687480|NCT01075984|82902306|FG001|Follow-up Phase|Protocol Violation|0|||
46687481|NCT01075984|82902307|FG002|Follow-up Phase|Protocol Violation|1|||
46687482|NCT01075984|82902308|FG003|Follow-up Phase|Protocol Violation|0|||
46687483|NCT01075984|82902309|FG004|Follow-up Phase|Protocol Violation|3|||
46687484|NCT01075984|82902305|FG000|Follow-up Phase|Adverse Event|0|||
46687485|NCT01075984|82902306|FG001|Follow-up Phase|Adverse Event|0|||
46687486|NCT01075984|82902307|FG002|Follow-up Phase|Adverse Event|0|||
46687487|NCT01075984|82902308|FG003|Follow-up Phase|Adverse Event|2|||
46687488|NCT01075984|82902309|FG004|Follow-up Phase|Adverse Event|27|||
46687489|NCT01075984|82902305|FG000|Follow-up Phase|Administrative|0|||
46687490|NCT01075984|82902306|FG001|Follow-up Phase|Administrative|0|||
46687491|NCT01075984|82902307|FG002|Follow-up Phase|Administrative|0|||
46687492|NCT01075984|82902308|FG003|Follow-up Phase|Administrative|0|||
46687493|NCT01075984|82902309|FG004|Follow-up Phase|Administrative|1|||
46687494|NCT01075984|82902305|FG000|Follow-up Phase|Withdrawal by Subject|0|||
46687495|NCT01075984|82902306|FG001|Follow-up Phase|Withdrawal by Subject|0|||
46687496|NCT01075984|82902307|FG002|Follow-up Phase|Withdrawal by Subject|0|||
46687497|NCT01075984|82902308|FG003|Follow-up Phase|Withdrawal by Subject|0|||
46687498|NCT01075984|82902309|FG004|Follow-up Phase|Withdrawal by Subject|10|||
46687499|NCT01075984|82902305|FG000|Follow-up Phase|Progression of disease|0|||
46687500|NCT01075984|82902306|FG001|Follow-up Phase|Progression of disease|0|||
46687501|NCT01075984|82902307|FG002|Follow-up Phase|Progression of disease|0|||
46687502|NCT01075984|82902308|FG003|Follow-up Phase|Progression of disease|0|||
46687503|NCT01075984|82902309|FG004|Follow-up Phase|Progression of disease|2|||
46687504|NCT01075984|82902305|FG000|Follow-up Phase|Treatment failure|0|||
46687505|NCT01075984|82902306|FG001|Follow-up Phase|Treatment failure|0|||
46687506|NCT01075984|82902307|FG002|Follow-up Phase|Treatment failure|0|||
46687507|NCT01075984|82902308|FG003|Follow-up Phase|Treatment failure|0|||
46687508|NCT01075984|82902309|FG004|Follow-up Phase|Treatment failure|4|||
46687509|NCT01024231|82902328|FG000|Overall Study|Other Reasons|1|||
46687510|NCT01024231|82902329|FG001|Overall Study|Other Reasons|2|||
46687511|NCT01024231|82902330|FG002|Overall Study|Other Reasons|0|||
46687512|NCT01024231|82902331|FG003|Overall Study|Other Reasons|0|||
46687513|NCT01024231|82902332|FG004|Overall Study|Other Reasons|2|||
46687514|NCT01024231|82902333|FG005|Overall Study|Other Reasons|0|||
46687515|NCT01024231|82902334|FG006|Overall Study|Other Reasons|1|||
46687516|NCT01024231|82902328|FG000|Overall Study|Maximum Clinical Benefit|1|||
46687517|NCT01024231|82902329|FG001|Overall Study|Maximum Clinical Benefit|2|||
46687518|NCT01024231|82902330|FG002|Overall Study|Maximum Clinical Benefit|0|||
46687519|NCT01024231|82902331|FG003|Overall Study|Maximum Clinical Benefit|1|||
46687520|NCT01024231|82902332|FG004|Overall Study|Maximum Clinical Benefit|1|||
46687521|NCT01024231|82902333|FG005|Overall Study|Maximum Clinical Benefit|0|||
46687522|NCT01024231|82902334|FG006|Overall Study|Maximum Clinical Benefit|0|||
46687523|NCT01024231|82902328|FG000|Overall Study|Disease Progression|3|||
46687524|NCT01024231|82902329|FG001|Overall Study|Disease Progression|1|||
46687525|NCT01024231|82902330|FG002|Overall Study|Disease Progression|3|||
46687526|NCT01024231|82902331|FG003|Overall Study|Disease Progression|0|||
46687527|NCT01024231|82902332|FG004|Overall Study|Disease Progression|4|||
46687528|NCT01024231|82902333|FG005|Overall Study|Disease Progression|11|||
46687529|NCT01024231|82902334|FG006|Overall Study|Disease Progression|6|||
46687530|NCT01024231|82902328|FG000|Overall Study|AE unrelated to Study Drug|0|||
46687531|NCT01024231|82902329|FG001|Overall Study|AE unrelated to Study Drug|1|||
46687532|NCT01024231|82902330|FG002|Overall Study|AE unrelated to Study Drug|0|||
46687533|NCT01024231|82902331|FG003|Overall Study|AE unrelated to Study Drug|0|||
46687534|NCT01024231|82902332|FG004|Overall Study|AE unrelated to Study Drug|0|||
46687535|NCT01024231|82902333|FG005|Overall Study|AE unrelated to Study Drug|0|||
46687536|NCT01024231|82902334|FG006|Overall Study|AE unrelated to Study Drug|0|||
46687537|NCT01024231|82902328|FG000|Overall Study|No longer meets criteria|0|||
46687538|NCT01024231|82902329|FG001|Overall Study|No longer meets criteria|0|||
46687539|NCT01024231|82902330|FG002|Overall Study|No longer meets criteria|0|||
46687540|NCT01024231|82902331|FG003|Overall Study|No longer meets criteria|0|||
46687541|NCT01024231|82902332|FG004|Overall Study|No longer meets criteria|1|||
46687542|NCT01024231|82902333|FG005|Overall Study|No longer meets criteria|0|||
46687543|NCT01024231|82902334|FG006|Overall Study|No longer meets criteria|1|||
46687544|NCT01024231|82902328|FG000|Overall Study|Study Drug Toxicity|1|||
46687545|NCT01024231|82902329|FG001|Overall Study|Study Drug Toxicity|6|||
46687546|NCT01024231|82902330|FG002|Overall Study|Study Drug Toxicity|6|||
46687547|NCT01024231|82902331|FG003|Overall Study|Study Drug Toxicity|4|||
46687548|NCT01024231|82902332|FG004|Overall Study|Study Drug Toxicity|2|||
46687549|NCT01024231|82902333|FG005|Overall Study|Study Drug Toxicity|0|||
46687550|NCT01024231|82902334|FG006|Overall Study|Study Drug Toxicity|7|||
46687551|NCT01024231|82902328|FG000|Overall Study|Death|6|||
46687552|NCT01024231|82902329|FG001|Overall Study|Death|2|||
46687553|NCT01024231|82902330|FG002|Overall Study|Death|1|||
46687554|NCT01024231|82902331|FG003|Overall Study|Death|0|||
46687555|NCT01024231|82902332|FG004|Overall Study|Death|4|||
46687556|NCT01024231|82902333|FG005|Overall Study|Death|3|||
46687557|NCT01024231|82902334|FG006|Overall Study|Death|5|||
46687558|NCT01024231|82902328|FG000|Overall Study|Lost to Follow-up|0|||
46687559|NCT01024231|82902329|FG001|Overall Study|Lost to Follow-up|0|||
46687560|NCT01024231|82902330|FG002|Overall Study|Lost to Follow-up|0|||
46687561|NCT01024231|82902331|FG003|Overall Study|Lost to Follow-up|0|||
46687562|NCT01024231|82902332|FG004|Overall Study|Lost to Follow-up|0|||
46687563|NCT01024231|82902333|FG005|Overall Study|Lost to Follow-up|0|||
46687564|NCT01024231|82902334|FG006|Overall Study|Lost to Follow-up|1|||
46687565|NCT01024231|82902328|FG000|Overall Study|Withdrew Consent|0|||
46687566|NCT01024231|82902329|FG001|Overall Study|Withdrew Consent|1|||
46687567|NCT01024231|82902330|FG002|Overall Study|Withdrew Consent|0|||
46687568|NCT01024231|82902331|FG003|Overall Study|Withdrew Consent|0|||
46687569|NCT01024231|82902332|FG004|Overall Study|Withdrew Consent|0|||
46687570|NCT01024231|82902333|FG005|Overall Study|Withdrew Consent|0|||
46687571|NCT01024231|82902334|FG006|Overall Study|Withdrew Consent|0|||
46687572|NCT01024231|82902328|FG000|Overall Study|Continuing on Treatment|0|||
46687573|NCT01024231|82902329|FG001|Overall Study|Continuing on Treatment|0|||
46687574|NCT01024231|82902330|FG002|Overall Study|Continuing on Treatment|0|||
46687575|NCT01024231|82902331|FG003|Overall Study|Continuing on Treatment|0|||
46687576|NCT01024231|82902332|FG004|Overall Study|Continuing on Treatment|3|||
46687577|NCT01024231|82902333|FG005|Overall Study|Continuing on Treatment|2|||
46687578|NCT01024231|82902334|FG006|Overall Study|Continuing on Treatment|0|||
46687579|NCT01077544|82902357|FG000|Overall Study|New Cancer Therapy|3|||
46687580|NCT01077544|82902358|FG001|Overall Study|New Cancer Therapy|3|||
46687581|NCT01077544|82902357|FG000|Overall Study|Adverse Event|0|||
46687582|NCT01077544|82902358|FG001|Overall Study|Adverse Event|1|||
46687583|NCT01077544|82902357|FG000|Overall Study|Disease Progression|0|||
46687584|NCT01077544|82902358|FG001|Overall Study|Disease Progression|1|||
46687585|NCT01075516|82902366|FG000|Overall Study|Death|5|||
46687586|NCT01075516|82902367|FG001|Overall Study|Death|9|||
46687587|NCT01075516|82902366|FG000|Overall Study|Lost to Follow-up|10|||
46687588|NCT01075516|82902367|FG001|Overall Study|Lost to Follow-up|2|||
46687589|NCT01075516|82902366|FG000|Overall Study|Withdrawal by Subject|3|||
46687590|NCT01075516|82902367|FG001|Overall Study|Withdrawal by Subject|5|||
46687591|NCT01012999|82902373|FG000|Overall Study|Protocol Violation|1|||
46687592|NCT01017601|82902379|FG000|Overall Study|Disease Progression|12|||
46687593|NCT01017601|82902380|FG001|Overall Study|Disease Progression|12|||
46687594|NCT01017601|82902379|FG000|Overall Study|Withdrawal by Subject|0|||
46687595|NCT01017601|82902380|FG001|Overall Study|Withdrawal by Subject|1|||
46687596|NCT01016977|82902388|FG000|Overall Study|Lost to Follow-up|1|||
46687597|NCT01016977|82902389|FG001|Overall Study|Lost to Follow-up|0|||
46687598|NCT01016977|82902388|FG000|Overall Study|Withdrawal by Subject|2|||
46687599|NCT01016977|82902389|FG001|Overall Study|Withdrawal by Subject|2|||
46687600|NCT01012765|82902398|FG000|Treatment Period 1|Adverse Event|1|||
46687601|NCT01012765|82902399|FG001|Treatment Period 1|Adverse Event|0|||
46687602|NCT01012765|82902400|FG002|Treatment Period 1|Adverse Event|1|||
46687603|NCT01012765|82902401|FG003|Treatment Period 1|Adverse Event|0|||
46687604|NCT01012765|82902402|FG004|Treatment Period 1|Adverse Event|0|||
46687605|NCT01012765|82902403|FG005|Treatment Period 1|Adverse Event|0|||
46687606|NCT01012765|82902398|FG000|Treatment Period 1|Withdrawal by Subject|2|||
46687607|NCT01012765|82902399|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46687608|NCT01012765|82902400|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46981767|NCT01667107|83227818|FG000|Overall Study|Lack of Efficacy|0|||
46981768|NCT01667107|83227819|FG001|Overall Study|Lack of Efficacy|1|||
46981769|NCT02590003|83227843|FG000|Overall Study|Death|1|||
46981770|NCT02590003|83227844|FG001|Overall Study|Death|2|||
46981771|NCT02404311|83227864|FG000|Part A: Month 0-18|Death|2|||
46981772|NCT02404311|83227865|FG001|Part A: Month 0-18|Death|0|||
46687609|NCT01012765|82902401|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46687610|NCT01012765|82902402|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46687611|NCT01012765|82902403|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46687612|NCT01012765|82902398|FG000|Treatment Period 1|Administrative problems|0|||
46687613|NCT01012765|82902399|FG001|Treatment Period 1|Administrative problems|0|||
46687614|NCT01012765|82902400|FG002|Treatment Period 1|Administrative problems|1|||
46981773|NCT02404311|83227866|FG002|Part A: Month 0-18|Death|0|||
46981774|NCT02404311|83227867|FG003|Part A: Month 0-18|Death|0|||
46981775|NCT02404311|83227868|FG004|Part A: Month 0-18|Death|0|||
46687615|NCT01012765|82902401|FG003|Treatment Period 1|Administrative problems|1|||
46687616|NCT01012765|82902402|FG004|Treatment Period 1|Administrative problems|1|||
46687617|NCT01012765|82902403|FG005|Treatment Period 1|Administrative problems|0|||
46687618|NCT01012765|82902398|FG000|Treatment Period 1|Protocol Violation|0|||
46687619|NCT01012765|82902399|FG001|Treatment Period 1|Protocol Violation|0|||
46687620|NCT01012765|82902400|FG002|Treatment Period 1|Protocol Violation|0|||
46687621|NCT01012765|82902401|FG003|Treatment Period 1|Protocol Violation|2|||
46687622|NCT01012765|82902402|FG004|Treatment Period 1|Protocol Violation|1|||
46687623|NCT01012765|82902403|FG005|Treatment Period 1|Protocol Violation|0|||
46687624|NCT01012765|82902398|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
46687625|NCT01012765|82902399|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
46687626|NCT01012765|82902400|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
46687627|NCT01012765|82902401|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
46687628|NCT01012765|82902402|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
46799601|NCT00111007|83018641|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
46799602|NCT00111007|83018642|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
46799603|NCT00111007|83018641|FG000|Long Term Follow-up|Missing|10|||
46799604|NCT00111007|83018642|FG001|Long Term Follow-up|Missing|3|||
46799605|NCT03975920|83018650|FG000|Overall Study|Lost to Follow-up|1|||
46799606|NCT03975920|83018651|FG001|Overall Study|Lost to Follow-up|2|||
46981776|NCT02404311|83227864|FG000|Part A: Month 0-18|Physician Decision|1|||
46981777|NCT02404311|83227865|FG001|Part A: Month 0-18|Physician Decision|0|||
46981778|NCT02404311|83227866|FG002|Part A: Month 0-18|Physician Decision|0|||
46981779|NCT02404311|83227867|FG003|Part A: Month 0-18|Physician Decision|0|||
46981780|NCT02404311|83227868|FG004|Part A: Month 0-18|Physician Decision|0|||
46981781|NCT02404311|83227864|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
46981782|NCT02404311|83227865|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
46981783|NCT02404311|83227866|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
46981784|NCT02404311|83227867|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
46981785|NCT02404311|83227868|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
46981786|NCT02404311|83227864|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
46981787|NCT02404311|83227865|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
46981788|NCT02404311|83227866|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
46981789|NCT02404311|83227867|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
46981790|NCT02404311|83227868|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
46981791|NCT02404311|83227864|FG000|Part A: Month 0-18|HIV Infection|6|||
46981792|NCT02404311|83227865|FG001|Part A: Month 0-18|HIV Infection|2|||
46981793|NCT02404311|83227866|FG002|Part A: Month 0-18|HIV Infection|0|||
46981794|NCT02404311|83227867|FG003|Part A: Month 0-18|HIV Infection|0|||
46981795|NCT02404311|83227868|FG004|Part A: Month 0-18|HIV Infection|0|||
46799607|NCT03975920|83018650|FG000|Overall Study|Protocol Violation|1|||
46799608|NCT03975920|83018651|FG001|Overall Study|Protocol Violation|1|||
46799609|NCT03975920|83018650|FG000|Overall Study|Did not complete survey|2|||
46799610|NCT03975920|83018651|FG001|Overall Study|Did not complete survey|1|||
46799611|NCT00699335|83018657|FG000|Overall Study|Combination of multiple reasons|176|||
46799612|NCT00699335|83018657|FG000|Overall Study|Missing data|52|||
46799613|NCT00445978|83018664|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
46858602|NCT03751280|83074355|FG000|Overall Study|Lost to Follow-up|3|||
46687629|NCT01012765|82902403|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
46687630|NCT01012765|82902398|FG000|Treatment Period 2|Withdrawal by Subject|1|||
46687631|NCT01012765|82902399|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46858603|NCT03751280|83074356|FG001|Overall Study|Lost to Follow-up|5|||
46981796|NCT02404311|83227864|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
46981797|NCT02404311|83227865|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
46981798|NCT02404311|83227866|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
46981799|NCT02404311|83227867|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
46981800|NCT02404311|83227868|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
46687632|NCT01012765|82902400|FG002|Treatment Period 2|Withdrawal by Subject|1|||
46687633|NCT01012765|82902401|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46799614|NCT00445978|83018664|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
46981801|NCT01650519|83227882|FG000|Overall Study|Withdrawal by Subject|1|||
46687634|NCT01012765|82902402|FG004|Treatment Period 2|Withdrawal by Subject|1|||
46687635|NCT01012765|82902403|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46687636|NCT01012765|82902398|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
46687637|NCT01012765|82902399|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
46687638|NCT01012765|82902400|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
46687639|NCT01012765|82902401|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
46687640|NCT01012765|82902402|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
46687641|NCT01012765|82902403|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
46687642|NCT01012765|82902398|FG000|Treatment Period 2|Adverse Event|0|||
46687643|NCT01012765|82902399|FG001|Treatment Period 2|Adverse Event|1|||
46858604|NCT03751280|83074355|FG000|Overall Study|Physician Decision|0|||
46799615|NCT00445978|83018664|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
46687644|NCT01012765|82902400|FG002|Treatment Period 2|Adverse Event|1|||
46687645|NCT01012765|82902401|FG003|Treatment Period 2|Adverse Event|0|||
46687646|NCT01012765|82902402|FG004|Treatment Period 2|Adverse Event|0|||
46687647|NCT01012765|82902403|FG005|Treatment Period 2|Adverse Event|0|||
46687648|NCT01012765|82902398|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
46687649|NCT01012765|82902399|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
46687650|NCT01012765|82902400|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
46687651|NCT01012765|82902401|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
46687652|NCT01012765|82902402|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
46687653|NCT01012765|82902403|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
46687654|NCT01010503|82902411|FG000|Overall Study|Adverse Event|1|||
46687655|NCT01010503|82902411|FG000|Overall Study|Death|1|||
46687656|NCT01006291|82902418|FG000|Overall Study|Adverse Event|2|||
46687657|NCT01006291|82902419|FG001|Overall Study|Adverse Event|1|||
46687658|NCT01006291|82902420|FG002|Overall Study|Adverse Event|2|||
46687659|NCT01006291|82902418|FG000|Overall Study|Lack of Efficacy|2|||
46687660|NCT01006291|82902419|FG001|Overall Study|Lack of Efficacy|2|||
46687661|NCT01006291|82902420|FG002|Overall Study|Lack of Efficacy|1|||
46687662|NCT01006291|82902418|FG000|Overall Study|Protocol Violation|3|||
46687663|NCT01006291|82902419|FG001|Overall Study|Protocol Violation|3|||
46687664|NCT01006291|82902420|FG002|Overall Study|Protocol Violation|3|||
46687665|NCT01006291|82902418|FG000|Overall Study|Withdrawal criteria|5|||
46687666|NCT01006291|82902419|FG001|Overall Study|Withdrawal criteria|4|||
46799616|NCT00445978|83018664|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
46799617|NCT00445978|83018664|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
46799618|NCT00445978|83018664|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
46799619|NCT00445978|83018664|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
46799620|NCT00445978|83018664|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
46799621|NCT00445978|83018664|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
46799622|NCT00566228|83018677|FG000|Overall Study|Withdrawal by Subject|1|||
46799623|NCT00566228|83018678|FG001|Overall Study|Withdrawal by Subject|0|||
46799624|NCT00566228|83018677|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
46799625|NCT00566228|83018678|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
46799626|NCT00566228|83018677|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
46799627|NCT00566228|83018678|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
46799628|NCT00566228|83018677|FG000|Overall Study|progressed before infusion could occur|0|||
46799629|NCT00566228|83018678|FG001|Overall Study|progressed before infusion could occur|1|||
46799630|NCT00698009|83018684|FG000|Overall Study|Withdrawal by Subject|1|||
46799631|NCT03968978|83018690|FG000|Overall Study|Adverse Event|1|||
46799632|NCT03968978|83018691|FG001|Overall Study|Adverse Event|0|||
46799633|NCT00562718|83018697|FG000|Overall Study|Death|1|||
46799634|NCT00562718|83018697|FG000|Overall Study|Withdrawal by Subject|3|||
46799635|NCT00562718|83018697|FG000|Overall Study|Adverse Event|4|||
46799636|NCT00562718|83018697|FG000|Overall Study|Lack of Efficacy|2|||
46799637|NCT00562718|83018697|FG000|Overall Study|not stated|1|||
46799638|NCT00697619|83018703|FG000|Overall Study|Lack of Efficacy|2|||
46799639|NCT00697619|83018704|FG001|Overall Study|Lack of Efficacy|2|||
46799640|NCT00697619|83018703|FG000|Overall Study|Adverse Event|4|||
46687667|NCT01006291|82902420|FG002|Overall Study|Withdrawal criteria|4|||
46687668|NCT01006291|82902418|FG000|Overall Study|Other|14|||
46687669|NCT01006291|82902419|FG001|Overall Study|Other|14|||
46799641|NCT00697619|83018704|FG001|Overall Study|Adverse Event|6|||
46799642|NCT00445432|83018713|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
46799643|NCT00445432|83018714|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
46687670|NCT01006291|82902420|FG002|Overall Study|Other|17|||
46687671|NCT01006135|82902428|FG000|Overall Study|Adverse Event|22|||
46687672|NCT01006135|82902428|FG000|Overall Study|Protocol Violation|14|||
46687673|NCT01006135|82902428|FG000|Overall Study|Lost to Follow-up|32|||
46687674|NCT01006135|82902428|FG000|Overall Study|Other|72|||
46687675|NCT01012609|82902434|FG000|Overall Study|Withdrawal by Subject|1|||
46687676|NCT01012609|82902435|FG001|Overall Study|Withdrawal by Subject|1|||
46687677|NCT01012219|82902442|FG000|Period 1|Withdrawal by Subject|1|||
46687678|NCT01012219|82902442|FG000|Period 2|Withdrawal by Subject|1|||
46687679|NCT01011907|82902451|FG000|Overall Study|Withdrawal by Subject|13|||
46687680|NCT01011907|82902452|FG001|Overall Study|Withdrawal by Subject|11|||
46687681|NCT01011907|82902451|FG000|Overall Study|Adverse Event|1|||
46687682|NCT01011907|82902452|FG001|Overall Study|Adverse Event|4|||
46687683|NCT01011673|82902460|FG000|Randomized|Secondary headache|2|||
46687684|NCT01011673|82902461|FG001|Randomized|Secondary headache|1|||
46687685|NCT01011673|82902460|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
46687686|NCT01011673|82902461|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
46687687|NCT01011439|82902467|FG000|Overall Study|Death|37|||
46687688|NCT01011439|82902467|FG000|Overall Study|Lost to Follow-up|4|||
46687689|NCT01011439|82902467|FG000|Overall Study|Withdrawal by Subject|1|||
46687690|NCT01011439|82902467|FG000|Overall Study|Sponsor's decision|15|||
46687691|NCT01311024|82902474|FG000|Overall Study|Protocol Violation|35|||
46687692|NCT01311024|82902475|FG001|Overall Study|Protocol Violation|22|||
46687693|NCT01310868|82902481|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
46687694|NCT01273155|82902489|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
46687695|NCT01273155|82902490|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
46687696|NCT01273155|82902491|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
46687697|NCT01273155|82902492|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
46687698|NCT01273155|82902493|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
46687699|NCT01273155|82902494|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
46687700|NCT01273155|82902495|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
46687701|NCT01273155|82902489|FG000|Overall Study|Change in liver function/no longer eval.|0|||
46799644|NCT00445432|83018715|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
46799645|NCT00445432|83018716|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
46799646|NCT00445432|83018713|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
46799647|NCT00445432|83018714|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
46799648|NCT00445432|83018715|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
46799649|NCT00445432|83018716|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
46799650|NCT00445432|83018713|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
46799651|NCT00445432|83018714|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
46799652|NCT00445432|83018715|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
46799653|NCT00445432|83018716|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
46799654|NCT00445432|83018713|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
46858605|NCT03751280|83074356|FG001|Overall Study|Physician Decision|2|||
46858606|NCT03751280|83074355|FG000|Overall Study|Protocol Violation|0|||
46858607|NCT03751280|83074356|FG001|Overall Study|Protocol Violation|2|||
46981802|NCT01650519|83227883|FG001|Overall Study|Withdrawal by Subject|0|||
46858608|NCT03751280|83074355|FG000|Overall Study|Withdrawal by Subject|5|||
46858609|NCT03751280|83074356|FG001|Overall Study|Withdrawal by Subject|2|||
46858610|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
46858611|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
46858612|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
46858613|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
46858614|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
46858615|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
46687702|NCT01273155|82902490|FG001|Overall Study|Change in liver function/no longer eval.|1|||
46687703|NCT01273155|82902491|FG002|Overall Study|Change in liver function/no longer eval.|0|||
46687704|NCT01273155|82902492|FG003|Overall Study|Change in liver function/no longer eval.|0|||
46687705|NCT01273155|82902493|FG004|Overall Study|Change in liver function/no longer eval.|1|||
46687706|NCT01273155|82902494|FG005|Overall Study|Change in liver function/no longer eval.|0|||
46687707|NCT01273155|82902495|FG006|Overall Study|Change in liver function/no longer eval.|0|||
46687708|NCT01273155|82902489|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
46687709|NCT01273155|82902490|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
46687710|NCT01273155|82902491|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
46687711|NCT01273155|82902492|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
46687712|NCT01273155|82902493|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
46687713|NCT01273155|82902494|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
46687714|NCT01273155|82902495|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
46687715|NCT01273155|82902489|FG000|Overall Study|Died during Cycle 1|0|||
46687716|NCT01273155|82902490|FG001|Overall Study|Died during Cycle 1|0|||
46687717|NCT01273155|82902491|FG002|Overall Study|Died during Cycle 1|1|||
46687718|NCT01273155|82902492|FG003|Overall Study|Died during Cycle 1|1|||
46687719|NCT01273155|82902493|FG004|Overall Study|Died during Cycle 1|0|||
46687720|NCT01273155|82902494|FG005|Overall Study|Died during Cycle 1|2|||
46687721|NCT01273155|82902495|FG006|Overall Study|Died during Cycle 1|2|||
46687722|NCT01273155|82902489|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
46687723|NCT01273155|82902490|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
46687724|NCT01273155|82902491|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
46687725|NCT01273155|82902492|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
46687726|NCT01273155|82902493|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
46687727|NCT01273155|82902494|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
46687728|NCT01273155|82902495|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
46687729|NCT01005901|82902520|FG000|Overall Study|Withdrawal by Subject|38|||
46687730|NCT01005901|82902521|FG001|Overall Study|Withdrawal by Subject|14|||
46687731|NCT01005901|82902520|FG000|Overall Study|Adverse Event|30|||
46687732|NCT01005901|82902521|FG001|Overall Study|Adverse Event|16|||
46687733|NCT01005901|82902520|FG000|Overall Study|Administrative problems|21|||
46687734|NCT01005901|82902521|FG001|Overall Study|Administrative problems|13|||
46687735|NCT01005901|82902520|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
46799655|NCT00445432|83018714|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
46799656|NCT00445432|83018715|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
46799657|NCT00445432|83018716|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
46799658|NCT00445432|83018713|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
46799659|NCT00445432|83018714|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
46687736|NCT01005901|82902521|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
46687737|NCT01005901|82902520|FG000|Overall Study|Protocol Violation|4|||
46799660|NCT00445432|83018715|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
46799661|NCT00445432|83018716|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
46981803|NCT01650285|83227889|FG000|Overall Study|Adverse Event|1|||
46687738|NCT01005901|82902521|FG001|Overall Study|Protocol Violation|3|||
46687739|NCT01005901|82902520|FG000|Overall Study|Death|2|||
46687740|NCT01005901|82902521|FG001|Overall Study|Death|3|||
46687741|NCT01005901|82902520|FG000|Overall Study|Lost to Follow-up|1|||
46687742|NCT01005901|82902521|FG001|Overall Study|Lost to Follow-up|2|||
46687743|NCT01005901|82902520|FG000|Overall Study|Patient's inability to use the device|1|||
46687744|NCT01005901|82902521|FG001|Overall Study|Patient's inability to use the device|1|||
46687745|NCT01005901|82902520|FG000|Overall Study|No longer requires study drug|0|||
46687746|NCT01005901|82902521|FG001|Overall Study|No longer requires study drug|1|||
46687747|NCT04968925|82902529|FG000|Phase I- Period 1|COVID-19 related|0|||
46687748|NCT04968925|82902530|FG001|Phase I- Period 1|COVID-19 related|1|||
46687749|NCT04968925|82902531|FG002|Phase I- Period 1|COVID-19 related|0|||
46687750|NCT04968925|82902532|FG003|Phase I- Period 1|COVID-19 related|0|||
46687751|NCT04968925|82902529|FG000|Phase I- Period 1|Subject enrolled in error|1|||
46687752|NCT04968925|82902530|FG001|Phase I- Period 1|Subject enrolled in error|1|||
46687753|NCT04968925|82902531|FG002|Phase I- Period 1|Subject enrolled in error|0|||
46687754|NCT04968925|82902532|FG003|Phase I- Period 1|Subject enrolled in error|0|||
46687755|NCT04968925|82902529|FG000|Phase II- Period 1|COVID-19 Related|0|||
46687756|NCT04968925|82902530|FG001|Phase II- Period 1|COVID-19 Related|0|||
46687757|NCT04968925|82902531|FG002|Phase II- Period 1|COVID-19 Related|6|||
46981804|NCT02347527|83227897|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
46981805|NCT02347527|83227898|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
46981806|NCT02347527|83227899|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
46981807|NCT02347527|83227900|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
46981808|NCT02347527|83227897|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
46687758|NCT04968925|82902532|FG003|Phase II- Period 1|COVID-19 Related|6|||
46687759|NCT04968925|82902529|FG000|Phase II- Period 1|Subject enrolled in error|0|||
46687760|NCT04968925|82902530|FG001|Phase II- Period 1|Subject enrolled in error|0|||
46687761|NCT04968925|82902531|FG002|Phase II- Period 1|Subject enrolled in error|1|||
46687762|NCT04968925|82902532|FG003|Phase II- Period 1|Subject enrolled in error|0|||
46687763|NCT04968925|82902529|FG000|Phase II -Period 2|COVID-19 related|0|||
46799662|NCT00445432|83018713|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
46799663|NCT00445432|83018714|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
46799664|NCT00445432|83018715|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
46799665|NCT00445432|83018716|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
46799666|NCT00445432|83018713|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
46858616|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
46981809|NCT02347527|83227898|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
46981810|NCT02347527|83227899|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
46981811|NCT02347527|83227900|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
46981812|NCT02347527|83227897|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
46981813|NCT02347527|83227898|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
46687764|NCT04968925|82902530|FG001|Phase II -Period 2|COVID-19 related|0|||
46687765|NCT04968925|82902531|FG002|Phase II -Period 2|COVID-19 related|4|||
46687766|NCT04968925|82902532|FG003|Phase II -Period 2|COVID-19 related|3|||
46687767|NCT04968925|82902529|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
46687768|NCT04968925|82902530|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
46687769|NCT04968925|82902531|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
46687770|NCT04968925|82902532|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
46687771|NCT01266993|82902544|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
46687772|NCT01266993|82902545|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
46687773|NCT01266993|82902544|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
46687774|NCT01266993|82902545|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
46687775|NCT01309386|82902553|FG000|Overall Study|Other|2|||
46687776|NCT01309386|82902554|FG001|Overall Study|Other|0|||
46687777|NCT01309386|82902553|FG000|Overall Study|Withdrawal by Subject|2|||
46687778|NCT01309386|82902554|FG001|Overall Study|Withdrawal by Subject|0|||
46687779|NCT01309386|82902553|FG000|Overall Study|Progressive disease|9|||
46687780|NCT01309386|82902554|FG001|Overall Study|Progressive disease|11|||
46687781|NCT01309386|82902553|FG000|Overall Study|Physician Decision|1|||
46687782|NCT01309386|82902554|FG001|Overall Study|Physician Decision|1|||
46687783|NCT01309386|82902553|FG000|Overall Study|Lack of Efficacy|3|||
46687784|NCT01309386|82902554|FG001|Overall Study|Lack of Efficacy|1|||
46858617|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
46687785|NCT01309386|82902553|FG000|Overall Study|Adverse Event|5|||
46687786|NCT01309386|82902554|FG001|Overall Study|Adverse Event|8|||
46858618|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
46858619|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
46981814|NCT02347527|83227899|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
46981815|NCT02347527|83227900|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
46687787|NCT01266603|82902560|FG000|Overall Study|Adverse Event|1|||
46687788|NCT01266603|82902560|FG000|Overall Study|Lack of Efficacy|14|||
46687789|NCT01266603|82902560|FG000|Overall Study|Withdrawal by Subject|1|||
46687790|NCT01266603|82902560|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
46687791|NCT01309308|82902566|FG000|Overall Study|Lost to Follow-up|6|||
46687792|NCT01309308|82902567|FG001|Overall Study|Lost to Follow-up|4|||
46687793|NCT01266291|82902573|FG000|Overall Study|Adverse Event|1|||
46687794|NCT01004263|82902577|FG000|Overall Study|Adverse Event|15|||
46687795|NCT01004263|82902577|FG000|Overall Study|Withdrawal by Subject|58|||
46687796|NCT01004263|82902577|FG000|Overall Study|Protocol Violation|10|||
46687797|NCT01004263|82902577|FG000|Overall Study|Lost to Follow-up|64|||
46687798|NCT01004263|82902577|FG000|Overall Study|Lack of Efficacy|13|||
46687799|NCT01004263|82902577|FG000|Overall Study|Pregnancy|2|||
46687800|NCT01004263|82902577|FG000|Overall Study|Physician Decision|15|||
46687801|NCT01004263|82902577|FG000|Overall Study|Lack of Qualifying Event|2|||
46687802|NCT01308762|82902584|FG000|Overall Study|Protocol Violation|0|||
46687803|NCT01308762|82902585|FG001|Overall Study|Protocol Violation|1|||
46687804|NCT01308762|82902586|FG002|Overall Study|Protocol Violation|0|||
46687805|NCT01265823|82902597|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
46687806|NCT01265823|82902597|FG000|Overall Study|Failure to Return|4|||
46687807|NCT01265823|82902597|FG000|Overall Study|Protocol Violation|1|||
46687808|NCT01265823|82902597|FG000|Overall Study|Participant Request|1|||
46687809|NCT01004185|82902607|FG000|Overall Study|Adverse Event|1|||
46687810|NCT01004185|82902608|FG001|Overall Study|Adverse Event|1|||
46687811|NCT01004185|82902607|FG000|Overall Study|Lost to Follow-up|0|||
46687812|NCT01004185|82902608|FG001|Overall Study|Lost to Follow-up|1|||
46687813|NCT01004185|82902607|FG000|Overall Study|Lack of Efficacy|2|||
46687814|NCT01004185|82902608|FG001|Overall Study|Lack of Efficacy|1|||
46687815|NCT01004185|82902607|FG000|Overall Study|Sponsor Terminated Study|4|||
46687816|NCT01004185|82902608|FG001|Overall Study|Sponsor Terminated Study|5|||
46799667|NCT00445432|83018714|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
46799668|NCT00445432|83018715|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
46799669|NCT00445432|83018716|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
46799670|NCT00696137|83018727|FG000|Overall Study|Withdrawal by Subject|2|||
46799671|NCT00441142|83018735|FG000|Overall Study|Adverse Event|2|||
46799672|NCT00441142|83018736|FG001|Overall Study|Adverse Event|3|||
46799673|NCT00441142|83018737|FG002|Overall Study|Adverse Event|3|||
46799674|NCT00441142|83018738|FG003|Overall Study|Adverse Event|22|||
46799675|NCT00441142|83018735|FG000|Overall Study|Lack of Efficacy|3|||
46799676|NCT00441142|83018736|FG001|Overall Study|Lack of Efficacy|3|||
46799677|NCT00441142|83018737|FG002|Overall Study|Lack of Efficacy|17|||
46799678|NCT00441142|83018738|FG003|Overall Study|Lack of Efficacy|32|||
46799679|NCT00441142|83018735|FG000|Overall Study|Withdrawal by Subject|0|||
46687817|NCT01004185|82902607|FG000|Overall Study|Withdrawal by Subject|2|||
46687818|NCT01004185|82902608|FG001|Overall Study|Withdrawal by Subject|1|||
46687819|NCT01265511|82902616|FG000|Overall Study|Lack of Efficacy|2|||
46687820|NCT01265511|82902617|FG001|Overall Study|Lack of Efficacy|1|||
46687821|NCT01265511|82902616|FG000|Overall Study|Met stopping rules|0|||
46687822|NCT01265511|82902617|FG001|Overall Study|Met stopping rules|2|||
46687823|NCT01264965|82902623|FG000|Overall Study|Withdrawal by Subject|10|||
46687824|NCT01264887|82902627|FG000|Overall Study|Adverse Event|5|||
46799680|NCT00441142|83018736|FG001|Overall Study|Withdrawal by Subject|0|||
46799681|NCT00441142|83018737|FG002|Overall Study|Withdrawal by Subject|2|||
46799682|NCT00441142|83018738|FG003|Overall Study|Withdrawal by Subject|10|||
46799683|NCT00441142|83018735|FG000|Overall Study|Patient still receiving active study tx|1|||
46687825|NCT01264887|82902627|FG000|Overall Study|Death|7|||
46687826|NCT01264887|82902627|FG000|Overall Study|Lack of Efficacy|5|||
46687827|NCT01264887|82902627|FG000|Overall Study|Physician Decision|4|||
46687828|NCT01264887|82902627|FG000|Overall Study|Withdrawal by Subject|6|||
46687829|NCT01264887|82902627|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
46799684|NCT00441142|83018736|FG001|Overall Study|Patient still receiving active study tx|0|||
46799685|NCT00441142|83018737|FG002|Overall Study|Patient still receiving active study tx|0|||
46799686|NCT00441142|83018738|FG003|Overall Study|Patient still receiving active study tx|2|||
46799687|NCT00441142|83018735|FG000|Overall Study|Physician Decision|0|||
46799688|NCT00441142|83018736|FG001|Overall Study|Physician Decision|1|||
46799689|NCT00441142|83018737|FG002|Overall Study|Physician Decision|0|||
46799690|NCT00441142|83018738|FG003|Overall Study|Physician Decision|1|||
46799691|NCT00441142|83018735|FG000|Overall Study|Death|0|||
46799692|NCT00441142|83018736|FG001|Overall Study|Death|0|||
46799693|NCT00441142|83018737|FG002|Overall Study|Death|0|||
46799694|NCT00441142|83018738|FG003|Overall Study|Death|1|||
46799695|NCT04025021|83018752|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
46799696|NCT04025021|83018753|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
46799697|NCT03848416|83018763|FG000|Overall Study|Withdrawal by Subject|1|||
46799698|NCT03848416|83018764|FG001|Overall Study|Withdrawal by Subject|0|||
46799699|NCT03848416|83018765|FG002|Overall Study|Withdrawal by Subject|0|||
46799700|NCT03848416|83018763|FG000|Overall Study|Death|0|||
46687830|NCT01264887|82902627|FG000|Overall Study|Other|2|||
46799701|NCT03848416|83018764|FG001|Overall Study|Death|0|||
46799702|NCT03848416|83018765|FG002|Overall Study|Death|1|||
46799703|NCT00458302|83018775|FG000|Overall Study|Adverse Event|4|||
46858620|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
46858621|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
46687831|NCT01306968|82902637|FG000|Overall Study|Lost to Follow-up|1|||
46799704|NCT00458302|83018776|FG001|Overall Study|Adverse Event|14|||
46799705|NCT00458302|83018775|FG000|Overall Study|Pregnancy|2|||
46799706|NCT00458302|83018776|FG001|Overall Study|Pregnancy|1|||
46799707|NCT00458302|83018775|FG000|Overall Study|Protocol Violation|0|||
46799708|NCT00458302|83018776|FG001|Overall Study|Protocol Violation|2|||
46799709|NCT00458302|83018775|FG000|Overall Study|Withdrawal by Subject|6|||
46687832|NCT01306968|82902638|FG001|Overall Study|Lost to Follow-up|1|||
46687833|NCT01306968|82902639|FG002|Overall Study|Lost to Follow-up|0|||
46687834|NCT01306968|82902640|FG003|Overall Study|Lost to Follow-up|0|||
46687835|NCT01306968|82902637|FG000|Overall Study|Physician Decision|0|||
46687836|NCT01306968|82902638|FG001|Overall Study|Physician Decision|1|||
46687837|NCT01306968|82902639|FG002|Overall Study|Physician Decision|0|||
46687838|NCT01306968|82902640|FG003|Overall Study|Physician Decision|0|||
46799710|NCT00458302|83018776|FG001|Overall Study|Withdrawal by Subject|4|||
46799711|NCT00458302|83018775|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
46799712|NCT00458302|83018776|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
46799713|NCT00458302|83018775|FG000|Overall Study|Study Termination By Sponsor|1|||
46687839|NCT01306968|82902637|FG000|Overall Study|Relocated and left active duty|0|||
46799714|NCT00458302|83018776|FG001|Overall Study|Study Termination By Sponsor|0|||
46799715|NCT00458302|83018775|FG000|Overall Study|Lost to Follow-up|2|||
46687840|NCT01306968|82902638|FG001|Overall Study|Relocated and left active duty|1|||
46687841|NCT01306968|82902639|FG002|Overall Study|Relocated and left active duty|1|||
46687842|NCT01306968|82902640|FG003|Overall Study|Relocated and left active duty|1|||
46687843|NCT01306968|82902637|FG000|Overall Study|Withdrew - time commitment|0|||
46687844|NCT01306968|82902638|FG001|Overall Study|Withdrew - time commitment|0|||
46687845|NCT01306968|82902639|FG002|Overall Study|Withdrew - time commitment|0|||
46687846|NCT01306968|82902640|FG003|Overall Study|Withdrew - time commitment|2|||
46687847|NCT01306968|82902637|FG000|Overall Study|Withdrew over privacy concerns|0|||
46687848|NCT01306968|82902638|FG001|Overall Study|Withdrew over privacy concerns|0|||
46799716|NCT00458302|83018776|FG001|Overall Study|Lost to Follow-up|0|||
46799717|NCT00458302|83018775|FG000|Overall Study|Other|4|||
46799718|NCT00458302|83018776|FG001|Overall Study|Other|2|||
46799719|NCT00444106|83018786|FG000|Overall Study|Lost to Follow-up|2|||
46799720|NCT00444106|83018787|FG001|Overall Study|Lost to Follow-up|1|||
46687849|NCT01306968|82902639|FG002|Overall Study|Withdrew over privacy concerns|0|||
46687850|NCT01306968|82902640|FG003|Overall Study|Withdrew over privacy concerns|1|||
46687851|NCT01264419|82902652|FG000|Overall Study|Lost to Follow-up|3|||
46799721|NCT00444106|83018788|FG002|Overall Study|Lost to Follow-up|0|||
46799722|NCT00444106|83018786|FG000|Overall Study|Abnormal Test Procedure Results|0|||
46799723|NCT00444106|83018787|FG001|Overall Study|Abnormal Test Procedure Results|0|||
46799724|NCT00444106|83018788|FG002|Overall Study|Abnormal Test Procedure Results|1|||
46799725|NCT00561470|83018801|FG000|Overall Study|Adverse Event|74|||
46799726|NCT00561470|83018802|FG001|Overall Study|Adverse Event|163|||
46799727|NCT00561470|83018801|FG000|Overall Study|Disease progression|437|||
46799728|NCT00561470|83018802|FG001|Overall Study|Disease progression|305|||
46799729|NCT00561470|83018801|FG000|Overall Study|poor compliance to protocol|4|||
46799730|NCT00561470|83018802|FG001|Overall Study|poor compliance to protocol|4|||
46799731|NCT00561470|83018801|FG000|Overall Study|Lost to Follow-up|2|||
46799732|NCT00561470|83018802|FG001|Overall Study|Lost to Follow-up|0|||
46799733|NCT00561470|83018801|FG000|Overall Study|Physician Decision|21|||
46799734|NCT00561470|83018802|FG001|Overall Study|Physician Decision|20|||
46799735|NCT00561470|83018801|FG000|Overall Study|Consent Withdrawn|2|||
46799736|NCT00561470|83018802|FG001|Overall Study|Consent Withdrawn|6|||
46799737|NCT00561470|83018801|FG000|Overall Study|Subject request|43|||
46799738|NCT00561470|83018802|FG001|Overall Study|Subject request|77|||
46799739|NCT00561470|83018801|FG000|Overall Study|Metastatic surgery|10|||
46687852|NCT01263873|82902658|FG000|Overall Study|One provider unable to complete numbers|1|||
46687853|NCT01263873|82902659|FG001|Overall Study|One provider unable to complete numbers|1|||
46687854|NCT01263639|82902667|FG000|Overall Study|Lost to Follow-up|66|||
46687855|NCT01263639|82902668|FG001|Overall Study|Lost to Follow-up|70|||
46687856|NCT01263639|82902667|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
46687857|NCT01263639|82902668|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
46687858|NCT01011283|82902676|FG000|Overall Study|Adverse Event|4|||
46687859|NCT01011283|82902677|FG001|Overall Study|Adverse Event|2|||
46687860|NCT01011283|82902676|FG000|Overall Study|Progressive Disease|0|||
46687861|NCT01011283|82902677|FG001|Overall Study|Progressive Disease|2|||
46687862|NCT01011283|82902676|FG000|Overall Study|Terminated by Sponsor|5|||
46687863|NCT01011283|82902677|FG001|Overall Study|Terminated by Sponsor|5|||
46687864|NCT01011283|82902676|FG000|Overall Study|Other|2|||
46687865|NCT01011283|82902677|FG001|Overall Study|Other|2|||
46687866|NCT01263561|82902685|FG000|Overall Study|Death|1|||
46687867|NCT01263561|82902686|FG001|Overall Study|Death|2|||
46687868|NCT01009099|82902694|FG000|Overall Study|Lost to Follow-up|1|||
46687869|NCT01009099|82902695|FG001|Overall Study|Lost to Follow-up|0|||
46687870|NCT01009099|82902694|FG000|Overall Study|Physician Decision|3|||
46687871|NCT01009099|82902695|FG001|Overall Study|Physician Decision|2|||
46687872|NCT01009099|82902694|FG000|Overall Study|Withdrawal by Subject|1|||
46687873|NCT01009099|82902695|FG001|Overall Study|Withdrawal by Subject|1|||
46687874|NCT01009099|82902694|FG000|Overall Study|Death|0|||
46687875|NCT01009099|82902695|FG001|Overall Study|Death|1|||
46687876|NCT01263483|82902704|FG000|Overall Study|Adverse Event|4|||
46687877|NCT01263483|82902705|FG001|Overall Study|Adverse Event|0|||
46687878|NCT01263483|82902706|FG002|Overall Study|Adverse Event|3|||
46687879|NCT01263483|82902704|FG000|Overall Study|Withdrawal by Subject|1|||
46687880|NCT01263483|82902705|FG001|Overall Study|Withdrawal by Subject|0|||
46687881|NCT01263483|82902706|FG002|Overall Study|Withdrawal by Subject|0|||
46687882|NCT01263483|82902704|FG000|Overall Study|Lack of Efficacy|2|||
46687883|NCT01263483|82902705|FG001|Overall Study|Lack of Efficacy|0|||
46687884|NCT01263483|82902706|FG002|Overall Study|Lack of Efficacy|0|||
46687885|NCT01263483|82902704|FG000|Overall Study|Protocol Violation|0|||
46687886|NCT01263483|82902705|FG001|Overall Study|Protocol Violation|1|||
46687887|NCT01263483|82902706|FG002|Overall Study|Protocol Violation|1|||
46687888|NCT01263483|82902704|FG000|Overall Study|Participant Unavailability|0|||
46687889|NCT01263483|82902705|FG001|Overall Study|Participant Unavailability|1|||
46799740|NCT00561470|83018802|FG001|Overall Study|Metastatic surgery|12|||
46799741|NCT00561470|83018801|FG000|Overall Study|Unauthorized procedure|3|||
46799742|NCT00561470|83018802|FG001|Overall Study|Unauthorized procedure|1|||
46799743|NCT00561470|83018801|FG000|Overall Study|Randomized but not treated|5|||
46799744|NCT00561470|83018802|FG001|Overall Study|Randomized but not treated|5|||
46799745|NCT00561470|83018801|FG000|Overall Study|Missed visit window|1|||
46799746|NCT00561470|83018802|FG001|Overall Study|Missed visit window|4|||
46799747|NCT00561470|83018801|FG000|Overall Study|Planning surgery|1|||
46799748|NCT00561470|83018802|FG001|Overall Study|Planning surgery|1|||
46799749|NCT00561470|83018801|FG000|Overall Study|Ongoing Treatment|11|||
46799750|NCT00561470|83018802|FG001|Overall Study|Ongoing Treatment|14|||
46799751|NCT00443872|83018810|FG000|Overall Study|Protocol Violation|7|||
46799752|NCT00443872|83018810|FG000|Overall Study|Lost to Follow-up|2|||
46799753|NCT00443872|83018810|FG000|Overall Study|Adverse Event|8|||
46799754|NCT04839562|83018825|FG000|Overall Study|Withdrawal by Subject|0|||
46687890|NCT01263483|82902706|FG002|Overall Study|Participant Unavailability|1|||
46687891|NCT01306890|82902714|FG000|Overall Study|Adverse Event|2|||
46687892|NCT01306890|82902714|FG000|Overall Study|Death|1223|||
46687893|NCT01306890|82902714|FG000|Overall Study|Lost to Follow-up|58|||
46687894|NCT01306890|82902714|FG000|Overall Study|Withdrawal by Subject|88|||
46687895|NCT01306890|82902714|FG000|Overall Study|Unspecified reasons|104|||
46687896|NCT01306890|82902714|FG000|Overall Study|Study Termination|3|||
46687897|NCT01306890|82902714|FG000|Overall Study|No discontinuation documentation|41|||
46687898|NCT01011049|82902722|FG000|Overall Study|Protocol Violation|0|||
46687899|NCT01011049|82902723|FG001|Overall Study|Protocol Violation|0|||
46687900|NCT01011049|82902724|FG002|Overall Study|Protocol Violation|2|||
46687901|NCT01011049|82902725|FG003|Overall Study|Protocol Violation|0|||
46687902|NCT01011049|82902722|FG000|Overall Study|Lost to Follow-up|1|||
46687903|NCT01011049|82902723|FG001|Overall Study|Lost to Follow-up|2|||
46687904|NCT01011049|82902724|FG002|Overall Study|Lost to Follow-up|1|||
46687905|NCT01011049|82902725|FG003|Overall Study|Lost to Follow-up|0|||
46687906|NCT01011049|82902722|FG000|Overall Study|Withdrawal by Subject|0|||
46687907|NCT01011049|82902723|FG001|Overall Study|Withdrawal by Subject|0|||
46687908|NCT01011049|82902724|FG002|Overall Study|Withdrawal by Subject|1|||
46687909|NCT01011049|82902725|FG003|Overall Study|Withdrawal by Subject|0|||
46687910|NCT01263093|82902737|FG000|Washout|Physician Decision|1|||
46687911|NCT01263093|82902738|FG001|Washout|Physician Decision|0|||
46687912|NCT01263093|82902737|FG000|Period 2|Adverse Event|1|||
46687913|NCT01263093|82902738|FG001|Period 2|Adverse Event|0|||
46687914|NCT01010971|82902748|FG000|Overall Study|Adverse Event|2|||
46687915|NCT01010971|82902749|FG001|Overall Study|Adverse Event|4|||
46687916|NCT01010971|82902750|FG002|Overall Study|Adverse Event|3|||
46799755|NCT04839562|83018826|FG001|Overall Study|Withdrawal by Subject|1|||
46799756|NCT04839562|83018825|FG000|Overall Study|Physician Decision|0|||
46799757|NCT04839562|83018826|FG001|Overall Study|Physician Decision|1|||
46799758|NCT00441064|83018834|FG000|Overall Study|Adverse Event|1|||
46799759|NCT00441064|83018835|FG001|Overall Study|Adverse Event|0|||
46799760|NCT00441064|83018834|FG000|Overall Study|Abnormal laboratory values|0|||
46799761|NCT00441064|83018835|FG001|Overall Study|Abnormal laboratory values|2|||
46799762|NCT00441064|83018834|FG000|Overall Study|Abnormal test procedure results|0|||
46799763|NCT00441064|83018835|FG001|Overall Study|Abnormal test procedure results|1|||
46799764|NCT00441064|83018834|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46799765|NCT00441064|83018835|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
46799766|NCT00441064|83018834|FG000|Overall Study|Protocol Deviation|3|||
46799767|NCT00441064|83018835|FG001|Overall Study|Protocol Deviation|2|||
46799768|NCT00441064|83018834|FG000|Overall Study|Patient withdrew consent|5|||
46799769|NCT00441064|83018835|FG001|Overall Study|Patient withdrew consent|2|||
46799770|NCT03962738|83018845|FG000|Overall Study|Protocol Deviation|3|||
46687917|NCT01010971|82902748|FG000|Overall Study|Withdrawal by Subject|0|||
46687918|NCT01010971|82902749|FG001|Overall Study|Withdrawal by Subject|2|||
46687919|NCT01010971|82902750|FG002|Overall Study|Withdrawal by Subject|5|||
46799771|NCT03962738|83018846|FG001|Overall Study|Protocol Deviation|0|||
46799772|NCT03962738|83018847|FG002|Overall Study|Protocol Deviation|1|||
46799773|NCT03962738|83018848|FG003|Overall Study|Protocol Deviation|1|||
46687920|NCT01010971|82902748|FG000|Overall Study|Lost to Follow-up|0|||
46687921|NCT01010971|82902749|FG001|Overall Study|Lost to Follow-up|2|||
46687922|NCT01010971|82902750|FG002|Overall Study|Lost to Follow-up|3|||
46687923|NCT01010971|82902748|FG000|Overall Study|Other|1|||
46687924|NCT01010971|82902749|FG001|Overall Study|Other|0|||
46687925|NCT01010971|82902750|FG002|Overall Study|Other|2|||
46799774|NCT03962738|83018845|FG000|Overall Study|Withdrawal by Subject|4|||
46799775|NCT03962738|83018846|FG001|Overall Study|Withdrawal by Subject|0|||
46799776|NCT03962738|83018847|FG002|Overall Study|Withdrawal by Subject|0|||
46799777|NCT03962738|83018848|FG003|Overall Study|Withdrawal by Subject|0|||
46799778|NCT03962738|83018845|FG000|Overall Study|Lost to Follow-up|0|||
46799779|NCT03962738|83018846|FG001|Overall Study|Lost to Follow-up|0|||
46799780|NCT03962738|83018847|FG002|Overall Study|Lost to Follow-up|1|||
46858622|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
46858623|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
46858624|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
46858625|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
46858626|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
46858627|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
46858628|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
46858629|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
46799781|NCT03962738|83018848|FG003|Overall Study|Lost to Follow-up|0|||
46799782|NCT00561392|83018866|FG000|Overall Study|Adverse Event|38|||
46799783|NCT00561392|83018866|FG000|Overall Study|Lack of Efficacy|2|||
46687926|NCT01306656|82902760|FG000|Overall Study|Lost to Follow-up|1|||
46799784|NCT00561392|83018866|FG000|Overall Study|Protocol Violation|1|||
46799785|NCT00561392|83018866|FG000|Overall Study|Withdrawal by Subject|8|||
46799786|NCT00561392|83018866|FG000|Overall Study|Administrative problems|4|||
46799787|NCT00694109|83018870|FG000|Overall Study|Physician Decision|3|||
46799788|NCT00694109|83018870|FG000|Overall Study|Adverse Event|74|||
46687927|NCT01306656|82902761|FG001|Overall Study|Lost to Follow-up|0|||
46687928|NCT01008943|82902769|FG000|Overall Study|Withdrawal by Subject|1|||
46687929|NCT01003639|82902775|FG000|Overall Study|Lost to Follow-up|6|||
46687930|NCT01003639|82902776|FG001|Overall Study|Lost to Follow-up|9|||
46687931|NCT01003639|82902775|FG000|Overall Study|Withdrawal by Subject|9|||
46687932|NCT01003639|82902776|FG001|Overall Study|Withdrawal by Subject|5|||
46687933|NCT01003639|82902775|FG000|Overall Study|Lack of Efficacy|1|||
46687934|NCT01003639|82902776|FG001|Overall Study|Lack of Efficacy|6|||
46687935|NCT01003639|82902775|FG000|Overall Study|Adverse Event|0|||
46687936|NCT01003639|82902776|FG001|Overall Study|Adverse Event|1|||
46687937|NCT01003639|82902775|FG000|Overall Study|Protocol Violation|0|||
46687938|NCT01003639|82902776|FG001|Overall Study|Protocol Violation|1|||
46687939|NCT01003639|82902775|FG000|Overall Study|Physician Decision|1|||
46687940|NCT01003639|82902776|FG001|Overall Study|Physician Decision|0|||
46687941|NCT01003249|82902782|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
46687942|NCT01003249|82902783|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
46687943|NCT01003249|82902782|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
46687944|NCT01003249|82902783|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
46687945|NCT01003249|82902782|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
46687946|NCT01003249|82902783|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
46687947|NCT01003249|82902782|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
46687948|NCT01003249|82902783|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
46687949|NCT01001767|82902795|FG000|Overall Study|no baseline study performed|1|||
46687950|NCT01001767|82902796|FG001|Overall Study|no baseline study performed|0|||
46687951|NCT01001767|82902795|FG000|Overall Study|Protocol Violation|1|||
46687952|NCT01001767|82902796|FG001|Overall Study|Protocol Violation|0|||
46687953|NCT01001767|82902795|FG000|Overall Study|Lost to Follow-up|1|||
46687954|NCT01001767|82902796|FG001|Overall Study|Lost to Follow-up|0|||
46687955|NCT01001767|82902795|FG000|Overall Study|Physician Decision|1|||
46687956|NCT01001767|82902796|FG001|Overall Study|Physician Decision|0|||
46687957|NCT01306032|82902808|FG000|First Intervention|Adverse Event|1|||
46687958|NCT01306032|82902809|FG001|First Intervention|Adverse Event|0|||
46687959|NCT01306032|82902810|FG002|First Intervention|Adverse Event|1|||
46687960|NCT01306032|82902811|FG003|First Intervention|Adverse Event|0|||
46687961|NCT01306032|82902812|FG004|First Intervention|Adverse Event|0|||
46687962|NCT01306032|82902813|FG005|First Intervention|Adverse Event|1|||
46687963|NCT01306032|82902808|FG000|First Intervention|Withdrawal by Subject|0|||
46687964|NCT01306032|82902809|FG001|First Intervention|Withdrawal by Subject|2|||
46687965|NCT01306032|82902810|FG002|First Intervention|Withdrawal by Subject|0|||
46687966|NCT01306032|82902811|FG003|First Intervention|Withdrawal by Subject|1|||
46799789|NCT00694109|83018870|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
46799790|NCT00694109|83018870|FG000|Overall Study|Lack of Efficacy|2|||
46799791|NCT00694109|83018870|FG000|Overall Study|Withdrawal by Subject|13|||
46799792|NCT00694109|83018870|FG000|Overall Study|Pregnancy|1|||
46799793|NCT00694109|83018870|FG000|Overall Study|Enrolled but not treated|1|||
46687967|NCT01306032|82902812|FG004|First Intervention|Withdrawal by Subject|0|||
46687968|NCT01306032|82902813|FG005|First Intervention|Withdrawal by Subject|0|||
46799794|NCT00694109|83018870|FG000|Overall Study|Other|2|||
46799795|NCT00694109|83018870|FG000|Overall Study|Consented but no additional treatment|3|||
46687969|NCT01306032|82902808|FG000|First Intervention|Death|0|||
46687970|NCT01306032|82902809|FG001|First Intervention|Death|0|||
46687971|NCT01306032|82902810|FG002|First Intervention|Death|1|||
46799796|NCT00562484|83018881|FG000|Overall Study|Adverse Event|6|||
46799797|NCT00562484|83018882|FG001|Overall Study|Adverse Event|1|||
46799798|NCT00562484|83018881|FG000|Overall Study|Protocol Violation|11|||
46687972|NCT01306032|82902811|FG003|First Intervention|Death|0|||
46687973|NCT01306032|82902812|FG004|First Intervention|Death|0|||
46687974|NCT01306032|82902813|FG005|First Intervention|Death|0|||
46687975|NCT01306032|82902808|FG000|First Intervention|Ineligible|0|||
46687976|NCT01306032|82902809|FG001|First Intervention|Ineligible|0|||
46799799|NCT00562484|83018882|FG001|Overall Study|Protocol Violation|2|||
46799800|NCT00562484|83018881|FG000|Overall Study|Withdrawal by Subject|12|||
46687977|NCT01306032|82902810|FG002|First Intervention|Ineligible|0|||
46687978|NCT01306032|82902811|FG003|First Intervention|Ineligible|0|||
46687979|NCT01306032|82902812|FG004|First Intervention|Ineligible|0|||
46687980|NCT01306032|82902813|FG005|First Intervention|Ineligible|1|||
46687981|NCT01306032|82902808|FG000|First Intervention|Progressive disease|0|||
46687982|NCT01306032|82902809|FG001|First Intervention|Progressive disease|0|||
46687983|NCT01306032|82902810|FG002|First Intervention|Progressive disease|0|||
46687984|NCT01306032|82902811|FG003|First Intervention|Progressive disease|0|||
46687985|NCT01306032|82902812|FG004|First Intervention|Progressive disease|2|||
46687986|NCT01306032|82902813|FG005|First Intervention|Progressive disease|0|||
46687987|NCT01306032|82902808|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
46687988|NCT01306032|82902809|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
46687989|NCT01306032|82902810|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
46687990|NCT01306032|82902811|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
46687991|NCT01306032|82902812|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
46687992|NCT01306032|82902813|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
46687993|NCT01306032|82902808|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
46687994|NCT01306032|82902809|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
46687995|NCT01306032|82902810|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
46687996|NCT01306032|82902811|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
46687997|NCT01306032|82902812|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
46687998|NCT01306032|82902813|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
46687999|NCT01263015|82902841|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
46688000|NCT01263015|82902842|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
46688001|NCT01263015|82902841|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
46688002|NCT01263015|82902842|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
46688003|NCT01263015|82902841|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
46688004|NCT01263015|82902842|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
46688005|NCT01263015|82902841|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
46688006|NCT01263015|82902842|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
46688007|NCT01263015|82902841|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
46688008|NCT01263015|82902842|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
46688009|NCT01263015|82902841|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
46688010|NCT01263015|82902842|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
46688011|NCT01263015|82902841|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
46688012|NCT01263015|82902842|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
46688013|NCT01263015|82902841|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
46688014|NCT01263015|82902842|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
46688015|NCT01263015|82902841|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
46688016|NCT01263015|82902842|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
46688017|NCT01263015|82902841|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
46688018|NCT01263015|82902842|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
46688019|NCT01263015|82902841|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
46688020|NCT01263015|82902842|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
46688021|NCT01263015|82902841|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
46688022|NCT01263015|82902842|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
46799801|NCT00562484|83018882|FG001|Overall Study|Withdrawal by Subject|9|||
46799802|NCT00562484|83018881|FG000|Overall Study|Moved away from the study area|20|||
46799803|NCT00562484|83018882|FG001|Overall Study|Moved away from the study area|9|||
46799804|NCT00562484|83018881|FG000|Overall Study|Lost to Follow-up|132|||
46799805|NCT00562484|83018882|FG001|Overall Study|Lost to Follow-up|71|||
46799806|NCT00562484|83018881|FG000|Overall Study|Reason not provided or not specified|25|||
46799807|NCT00562484|83018882|FG001|Overall Study|Reason not provided or not specified|12|||
46799808|NCT00561080|83018891|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
46799809|NCT00561080|83018892|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
46799810|NCT00561080|83018893|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
46799811|NCT00561080|83018891|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
46799812|NCT00561080|83018892|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
46799813|NCT00561080|83018893|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
46858630|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
46858631|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
46799814|NCT00561080|83018891|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
46799815|NCT00561080|83018892|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
46799816|NCT00561080|83018893|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
46799817|NCT00561080|83018891|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
46799818|NCT00561080|83018892|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
46799819|NCT00561080|83018893|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
46799820|NCT00561080|83018891|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
46799821|NCT00561080|83018892|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
46799822|NCT00561080|83018893|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
46799823|NCT00561080|83018891|FG000|Vaccination Period (up to Month 4)|Other|0|||
46688023|NCT01305564|82902848|FG000|Overall Study|Death|21|||
46688024|NCT01305564|82902848|FG000|Overall Study|Lost to Follow-up|12|||
46688025|NCT01305564|82902848|FG000|Overall Study|Withdrawal by Subject|1|||
46688026|NCT01305564|82902848|FG000|Overall Study|Physician Decision|3|||
46688027|NCT01305408|82902865|FG000|Overall Study|Adverse Event|10|||
46688028|NCT01305408|82902866|FG001|Overall Study|Adverse Event|7|||
46688029|NCT01305408|82902865|FG000|Overall Study|Lack of Efficacy|3|||
46688030|NCT01305408|82902866|FG001|Overall Study|Lack of Efficacy|4|||
46799824|NCT00561080|83018892|FG001|Vaccination Period (up to Month 4)|Other|2|||
46799825|NCT00561080|83018893|FG002|Vaccination Period (up to Month 4)|Other|1|||
46688031|NCT01305408|82902865|FG000|Overall Study|Withdrawal by Subject|9|||
46688032|NCT01305408|82902866|FG001|Overall Study|Withdrawal by Subject|9|||
46688033|NCT01305408|82902865|FG000|Overall Study|Protocol Violation|4|||
46688034|NCT01305408|82902866|FG001|Overall Study|Protocol Violation|6|||
46688035|NCT01305408|82902865|FG000|Overall Study|Lost to Follow-up|5|||
46688036|NCT01305408|82902866|FG001|Overall Study|Lost to Follow-up|3|||
46688037|NCT01305408|82902865|FG000|Overall Study|Noncompliance with study medication|0|||
46688038|NCT01305408|82902866|FG001|Overall Study|Noncompliance with study medication|1|||
46688039|NCT01305408|82902865|FG000|Overall Study|Noncompliance with study procedures|0|||
46688040|NCT01305408|82902866|FG001|Overall Study|Noncompliance with study procedures|1|||
46688041|NCT01305408|82902865|FG000|Overall Study|Other|1|||
46688042|NCT01305408|82902866|FG001|Overall Study|Other|0|||
46799826|NCT00561080|83018891|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
46799827|NCT00561080|83018892|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
46799828|NCT00561080|83018893|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
46799829|NCT00561080|83018891|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
46981816|NCT02347527|83227897|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
46981817|NCT02347527|83227898|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
46688043|NCT01304940|82902874|FG000|Overall Study|not meet symptom severity requirement|3|||
46688044|NCT01304940|82902875|FG001|Overall Study|not meet symptom severity requirement|0|||
46688045|NCT01261611|82902884|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
46688046|NCT01261611|82902885|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
46688047|NCT01261611|82902886|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
46688048|NCT01261611|82902884|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
46799830|NCT00561080|83018892|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
46799831|NCT00561080|83018893|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
46799832|NCT00561080|83018891|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
46688049|NCT01261611|82902885|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
46688050|NCT01261611|82902886|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
46688051|NCT01261611|82902884|FG000|Treatment Cycle 1|Adverse Event|0|||
46688052|NCT01261611|82902885|FG001|Treatment Cycle 1|Adverse Event|1|||
46688053|NCT01261611|82902886|FG002|Treatment Cycle 1|Adverse Event|0|||
46688054|NCT01261611|82902884|FG000|Treatment Cycle 1|Protocol Violation|0|||
46688055|NCT01261611|82902885|FG001|Treatment Cycle 1|Protocol Violation|0|||
46688056|NCT01261611|82902886|FG002|Treatment Cycle 1|Protocol Violation|2|||
46688057|NCT01261611|82902884|FG000|Treatment Cycle 2|Completed study|4|||
46688058|NCT01261611|82902885|FG001|Treatment Cycle 2|Completed study|0|||
46688059|NCT01261611|82902886|FG002|Treatment Cycle 2|Completed study|0|||
46688060|NCT01261611|82902884|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
46688061|NCT01261611|82902885|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
46688062|NCT01261611|82902886|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
46688063|NCT01261611|82902884|FG000|Treatment Cycle 2|Adverse Event|1|||
46688064|NCT01261611|82902885|FG001|Treatment Cycle 2|Adverse Event|0|||
46688065|NCT01261611|82902886|FG002|Treatment Cycle 2|Adverse Event|0|||
46688066|NCT01261611|82902884|FG000|Treatment Cycle 2|Protocol Violation|2|||
46688067|NCT01261611|82902885|FG001|Treatment Cycle 2|Protocol Violation|0|||
46688068|NCT01261611|82902886|FG002|Treatment Cycle 2|Protocol Violation|0|||
46688069|NCT01261611|82902884|FG000|Treatment Cycle 2|Not otherwise specified|2|||
46688070|NCT01261611|82902885|FG001|Treatment Cycle 2|Not otherwise specified|0|||
46688071|NCT01261611|82902886|FG002|Treatment Cycle 2|Not otherwise specified|0|||
46688072|NCT01261611|82902884|FG000|Treatment Cycle 3|Completed study|24|||
46688073|NCT01261611|82902885|FG001|Treatment Cycle 3|Completed study|0|||
46688074|NCT01261611|82902886|FG002|Treatment Cycle 3|Completed study|0|||
46688075|NCT01261611|82902884|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
46688076|NCT01261611|82902885|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
46688077|NCT01261611|82902886|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
46688078|NCT01261611|82902884|FG000|Treatment Cycle 3|Adverse Event|1|||
46688079|NCT01261611|82902885|FG001|Treatment Cycle 3|Adverse Event|0|||
46799833|NCT00561080|83018892|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
46799834|NCT00561080|83018893|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
46799835|NCT00561080|83018891|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
46799836|NCT00561080|83018892|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
46981818|NCT02347527|83227899|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
46688080|NCT01261611|82902886|FG002|Treatment Cycle 3|Adverse Event|0|||
46688081|NCT01261611|82902884|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
46688082|NCT01261611|82902885|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
46688083|NCT01261611|82902886|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
46688084|NCT01261611|82902884|FG000|Treatment Cycle 4|Completed study|87|||
46688085|NCT01261611|82902885|FG001|Treatment Cycle 4|Completed study|0|||
46688086|NCT01261611|82902886|FG002|Treatment Cycle 4|Completed study|0|||
46688087|NCT01261611|82902884|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
46688088|NCT01261611|82902885|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
46688089|NCT01261611|82902886|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
46688090|NCT01261611|82902884|FG000|Treatment Cycle 4|Adverse Event|1|||
46688091|NCT01261611|82902885|FG001|Treatment Cycle 4|Adverse Event|0|||
46688092|NCT01261611|82902886|FG002|Treatment Cycle 4|Adverse Event|0|||
46688093|NCT01261611|82902884|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
46688094|NCT01261611|82902885|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
46688095|NCT01261611|82902886|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
46688096|NCT01261611|82902884|FG000|Treatment Cycle 4|Not otherwise specified|3|||
46688097|NCT01261611|82902885|FG001|Treatment Cycle 4|Not otherwise specified|0|||
46688098|NCT01261611|82902886|FG002|Treatment Cycle 4|Not otherwise specified|0|||
46688099|NCT01261611|82902884|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
46799837|NCT00561080|83018893|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
46799838|NCT00562094|83018903|FG000|Overall Study|Lost to Follow-up|62|||
46799839|NCT03817853|83018911|FG000|Induction Phase|Adverse Event|5|||
46799840|NCT03817853|83018912|FG001|Induction Phase|Adverse Event|0|||
46799841|NCT03817853|83018913|FG002|Induction Phase|Adverse Event|0|||
46688100|NCT01261611|82902885|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
46688101|NCT01261611|82902886|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
46688102|NCT01261611|82902884|FG000|Treatment Cycle 5|Adverse Event|1|||
46688103|NCT01261611|82902885|FG001|Treatment Cycle 5|Adverse Event|0|||
46688104|NCT01261611|82902886|FG002|Treatment Cycle 5|Adverse Event|0|||
46858632|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
46688105|NCT01261611|82902884|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
46688106|NCT01261611|82902885|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
46688107|NCT01261611|82902886|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
46688108|NCT01304706|82902898|FG000|Overall Study|Adverse Event|2|||
46688109|NCT01304706|82902898|FG000|Overall Study|Lack of Efficacy|1|||
46688110|NCT01304706|82902898|FG000|Overall Study|Death|3|||
46688111|NCT01304706|82902898|FG000|Overall Study|Withdrawal by Subject|3|||
46688112|NCT01304706|82902898|FG000|Overall Study|Lost to Follow-up|7|||
46688113|NCT01304706|82902898|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
46688114|NCT01303380|82902902|FG000|Overall Study|Lack of compliance to study procedures|1|||
46688115|NCT01008553|82902906|FG000|Period 1 (Titration Period)|Physician Decision|2|||
46688116|NCT01008553|82902907|FG001|Period 1 (Titration Period)|Physician Decision|0|||
46688117|NCT01008553|82902908|FG002|Period 1 (Titration Period)|Physician Decision|0|||
46688118|NCT01008553|82902906|FG000|Period 1 (Titration Period)|Adverse Event|33|||
46688119|NCT01008553|82902907|FG001|Period 1 (Titration Period)|Adverse Event|0|||
46688120|NCT01008553|82902908|FG002|Period 1 (Titration Period)|Adverse Event|0|||
46688121|NCT01008553|82902906|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
46688122|NCT01008553|82902907|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
46688123|NCT01008553|82902908|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
46799842|NCT03817853|83018911|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
46799843|NCT03817853|83018912|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
46688124|NCT01008553|82902906|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
46688125|NCT01008553|82902907|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
46688126|NCT01008553|82902908|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
46688127|NCT01008553|82902906|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
46688128|NCT01008553|82902907|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
46688129|NCT01008553|82902908|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
46688130|NCT01008553|82902906|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
46688131|NCT01008553|82902907|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
46688132|NCT01008553|82902908|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
46688133|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
46688134|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
46688135|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
46688136|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
46688137|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
46688138|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
46688139|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
46688140|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
46688141|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
46688142|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
46688143|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
46688144|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
46688145|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
46688146|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
46688147|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
46688148|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
46688149|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
46688150|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
46688151|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
46688152|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
46688153|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
46688154|NCT01008553|82902906|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
46688155|NCT01008553|82902907|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
46688156|NCT01008553|82902908|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
46688157|NCT01259115|82902917|FG000|Period 1|Adverse Event|1|||
46688158|NCT01259115|82902918|FG001|Period 1|Adverse Event|0|||
46688159|NCT01259115|82902917|FG000|Period 1|Protocol Violation|2|||
46688160|NCT01259115|82902918|FG001|Period 1|Protocol Violation|0|||
46688161|NCT01259115|82902917|FG000|Period 1|Lost to Follow-up|0|||
46688162|NCT01259115|82902918|FG001|Period 1|Lost to Follow-up|1|||
46688163|NCT01259115|82902917|FG000|Period 2|Adverse Event|1|||
46858633|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
46858634|NCT00311363|83074366|FG000|24-Week Single-Blind Treatment Period|Death|1|||
46858635|NCT00311363|83074367|FG001|24-Week Single-Blind Treatment Period|Death|0|||
46858636|NCT00311363|83074368|FG002|24-Week Single-Blind Treatment Period|Death|0|||
46858637|NCT00311363|83074366|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
46858638|NCT00311363|83074367|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
46858639|NCT00311363|83074368|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
46858640|NCT00311363|83074366|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
46858641|NCT00311363|83074367|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
46858642|NCT00311363|83074368|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
46858643|NCT00311363|83074366|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
46858644|NCT00311363|83074367|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
46858645|NCT00311363|83074368|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
46858646|NCT00311363|83074366|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
46858647|NCT00311363|83074367|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
46858648|NCT00311363|83074368|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
46858649|NCT00311363|83074366|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
46858650|NCT00311363|83074367|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
46858651|NCT00311363|83074368|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
46688164|NCT01259115|82902918|FG001|Period 2|Adverse Event|0|||
46688165|NCT01302366|82902929|FG000|Overall Study|patient choice or noncompliance|5|||
46688166|NCT01302054|82902933|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
46688167|NCT01302054|82902934|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
46688168|NCT01302054|82902935|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
46688169|NCT01302054|82902933|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
46688170|NCT01302054|82902934|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
46688171|NCT01302054|82902935|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
46688172|NCT01302054|82902933|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
46688173|NCT01302054|82902934|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
46688174|NCT01302054|82902935|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
46688175|NCT01302054|82902933|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
46688176|NCT01302054|82902934|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
46688177|NCT01302054|82902935|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
46688178|NCT01302054|82902933|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
46688179|NCT01302054|82902934|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
46688180|NCT01302054|82902935|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
46688181|NCT01302054|82902933|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
46688182|NCT01302054|82902934|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
46688183|NCT01302054|82902935|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
46688184|NCT01302054|82902933|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
46688185|NCT01302054|82902934|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
46688186|NCT01302054|82902935|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
46688187|NCT01302054|82902933|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
46688188|NCT01302054|82902934|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
46688189|NCT01302054|82902935|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
46688190|NCT01302054|82902933|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
46688191|NCT01302054|82902934|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
46688192|NCT01302054|82902935|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
46688193|NCT01302054|82902933|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46688194|NCT01302054|82902934|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
46688195|NCT01302054|82902935|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
46688196|NCT01302054|82902933|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
46688197|NCT01302054|82902934|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
46688198|NCT01302054|82902935|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
46688199|NCT01302054|82902933|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
46688200|NCT01302054|82902934|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
46688201|NCT01302054|82902935|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
46688202|NCT01302054|82902933|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
46688203|NCT01302054|82902934|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
46688204|NCT01302054|82902935|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
46688205|NCT01302054|82902933|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
46688206|NCT01302054|82902934|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
46688207|NCT01302054|82902935|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
46688208|NCT01302054|82902933|FG000|Double-Blind Treatment Phase|Other|0|||
46688209|NCT01302054|82902934|FG001|Double-Blind Treatment Phase|Other|4|||
46688210|NCT01302054|82902935|FG002|Double-Blind Treatment Phase|Other|9|||
46688211|NCT01301508|82902946|FG000|Overall Study|Withdrawal by Subject|1|||
46688212|NCT01301508|82902947|FG001|Overall Study|Withdrawal by Subject|2|||
46688213|NCT01301508|82902946|FG000|Overall Study|Lost to Follow-up|0|||
46688214|NCT01301508|82902947|FG001|Overall Study|Lost to Follow-up|1|||
46688215|NCT01301274|82902955|FG000|Overall Study|Physician Decision|2|||
46688216|NCT01301274|82902956|FG001|Overall Study|Physician Decision|1|||
46688217|NCT01300650|82902967|FG000|Overall Study|Adverse Event|1|||
46688218|NCT01300572|82902972|FG000|Overall Study|HAMA + post dosimetry|1|||
46688219|NCT01077154|82902979|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
46688220|NCT01077154|82902980|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
46688221|NCT01077154|82902979|FG000|Overall Study|Withdrawal by Subject|369|||
46688222|NCT01077154|82902980|FG001|Overall Study|Withdrawal by Subject|385|||
46688223|NCT01077154|82902979|FG000|Overall Study|Death|215|||
46799844|NCT03817853|83018913|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
46799845|NCT03817853|83018911|FG000|Induction Phase|Physician Decision|2|||
46688224|NCT01077154|82902980|FG001|Overall Study|Death|214|||
46799846|NCT03817853|83018912|FG001|Induction Phase|Physician Decision|0|||
46799847|NCT03817853|83018913|FG002|Induction Phase|Physician Decision|0|||
46799848|NCT03817853|83018911|FG000|Induction Phase|Progressive Disease|4|||
46799849|NCT03817853|83018912|FG001|Induction Phase|Progressive Disease|0|||
46981819|NCT02347527|83227900|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
46688225|NCT01077154|82902979|FG000|Overall Study|Lost to Follow-up|43|||
46688226|NCT01077154|82902980|FG001|Overall Study|Lost to Follow-up|35|||
46688227|NCT01077154|82902979|FG000|Overall Study|Noncompliance|22|||
46688228|NCT01077154|82902980|FG001|Overall Study|Noncompliance|20|||
46688229|NCT01077154|82902979|FG000|Overall Study|Disease Progression|18|||
46688230|NCT01077154|82902980|FG001|Overall Study|Disease Progression|20|||
46688231|NCT01077154|82902979|FG000|Overall Study|Ineligibility Determined|10|||
46981820|NCT02347527|83227897|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
46981821|NCT02347527|83227898|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
46981822|NCT02347527|83227899|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
46981823|NCT02347527|83227900|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
46981824|NCT02386839|83227914|FG000|Overall Study|Death|1|||
46688232|NCT01077154|82902980|FG001|Overall Study|Ineligibility Determined|14|||
46688233|NCT01077154|82902979|FG000|Overall Study|Other|14|||
46688234|NCT01077154|82902980|FG001|Overall Study|Other|11|||
46688235|NCT01077154|82902979|FG000|Overall Study|Adverse Event|9|||
46688236|NCT01077154|82902980|FG001|Overall Study|Adverse Event|9|||
46688237|NCT01077154|82902979|FG000|Overall Study|Administrative Decision|1|||
46981825|NCT02386839|83227915|FG001|Overall Study|Death|0|||
46981826|NCT02386839|83227914|FG000|Overall Study|Withdrawal by Subject|9|||
46981827|NCT02386839|83227915|FG001|Overall Study|Withdrawal by Subject|10|||
46981828|NCT02386839|83227914|FG000|Overall Study|Lost to Follow-up|4|||
46981829|NCT02386839|83227915|FG001|Overall Study|Lost to Follow-up|4|||
46981830|NCT02386839|83227914|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
46981831|NCT02386839|83227915|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
46981832|NCT02386839|83227914|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
46688238|NCT01077154|82902980|FG001|Overall Study|Administrative Decision|6|||
46688239|NCT01077154|82902979|FG000|Overall Study|Protocol Deviation|1|||
46688240|NCT01077154|82902980|FG001|Overall Study|Protocol Deviation|0|||
46688241|NCT01258101|82902990|FG000|Overall Study|Adverse Event|5|||
46688242|NCT01258101|82902991|FG001|Overall Study|Adverse Event|6|||
46688243|NCT01258101|82902992|FG002|Overall Study|Adverse Event|0|||
46688244|NCT01258101|82902993|FG003|Overall Study|Adverse Event|0|||
46688245|NCT01258101|82902990|FG000|Overall Study|Extra exclusion criterion amended|2|||
46688246|NCT01258101|82902991|FG001|Overall Study|Extra exclusion criterion amended|1|||
46688247|NCT01258101|82902992|FG002|Overall Study|Extra exclusion criterion amended|1|||
46688248|NCT01258101|82902993|FG003|Overall Study|Extra exclusion criterion amended|1|||
46688249|NCT01258101|82902990|FG000|Overall Study|Informed consent has been withdrawn|2|||
46688250|NCT01258101|82902991|FG001|Overall Study|Informed consent has been withdrawn|2|||
46688251|NCT01258101|82902992|FG002|Overall Study|Informed consent has been withdrawn|1|||
46688252|NCT01258101|82902993|FG003|Overall Study|Informed consent has been withdrawn|1|||
46688253|NCT01258101|82902990|FG000|Overall Study|Patient is not able to attend visits|8|||
46688254|NCT01258101|82902991|FG001|Overall Study|Patient is not able to attend visits|9|||
46688255|NCT01258101|82902992|FG002|Overall Study|Patient is not able to attend visits|7|||
46688256|NCT01258101|82902993|FG003|Overall Study|Patient is not able to attend visits|6|||
46688257|NCT01258101|82902990|FG000|Overall Study|Patient´s compliance|4|||
46688258|NCT01258101|82902991|FG001|Overall Study|Patient´s compliance|3|||
46688259|NCT01258101|82902992|FG002|Overall Study|Patient´s compliance|1|||
46688260|NCT01258101|82902993|FG003|Overall Study|Patient´s compliance|2|||
46688261|NCT01258101|82902990|FG000|Overall Study|Lost to Follow-up|5|||
46688262|NCT01258101|82902991|FG001|Overall Study|Lost to Follow-up|5|||
46688263|NCT01258101|82902992|FG002|Overall Study|Lost to Follow-up|0|||
46688264|NCT01258101|82902993|FG003|Overall Study|Lost to Follow-up|6|||
46688265|NCT01258101|82902990|FG000|Overall Study|PCR positive at week 24|0|||
46799850|NCT03817853|83018913|FG002|Induction Phase|Progressive Disease|0|||
46799851|NCT03817853|83018911|FG000|Induction Phase|Withdrawal by Subject|3|||
46981833|NCT02386839|83227915|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
46981834|NCT02386839|83227914|FG000|Overall Study|Other (unspecified)|1|||
46799852|NCT03817853|83018912|FG001|Induction Phase|Withdrawal by Subject|0|||
46799853|NCT03817853|83018913|FG002|Induction Phase|Withdrawal by Subject|0|||
46799854|NCT03817853|83018911|FG000|Induction Phase|Continuing on Study|34|||
46981835|NCT02386839|83227915|FG001|Overall Study|Other (unspecified)|0|||
46981836|NCT01649271|83227927|FG000|Overall Study|Progressive disease|4|||
46981837|NCT01649271|83227928|FG001|Overall Study|Progressive disease|5|||
46981838|NCT01649271|83227927|FG000|Overall Study|Other Adverse Event|0|||
46981839|NCT01649271|83227928|FG001|Overall Study|Other Adverse Event|2|||
46688266|NCT01258101|82902991|FG001|Overall Study|PCR positive at week 24|0|||
46688267|NCT01258101|82902992|FG002|Overall Study|PCR positive at week 24|0|||
46688268|NCT01258101|82902993|FG003|Overall Study|PCR positive at week 24|1|||
46688269|NCT01258101|82902990|FG000|Overall Study|Other reason|7|||
46688270|NCT01258101|82902991|FG001|Overall Study|Other reason|8|||
46688271|NCT01258101|82902992|FG002|Overall Study|Other reason|1|||
46799855|NCT03817853|83018912|FG001|Induction Phase|Continuing on Study|0|||
46688272|NCT01258101|82902993|FG003|Overall Study|Other reason|8|||
46688273|NCT01300338|82903005|FG000|Overall Study|Lost to Follow-up|5|||
46799856|NCT03817853|83018913|FG002|Induction Phase|Continuing on Study|0|||
46981840|NCT01649271|83227927|FG000|Overall Study|Withdrawal by Subject|1|||
46981841|NCT01649271|83227928|FG001|Overall Study|Withdrawal by Subject|0|||
46688274|NCT01300338|82903006|FG001|Overall Study|Lost to Follow-up|0|||
46688275|NCT01300260|82903014|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
46688276|NCT01300260|82903015|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
46688277|NCT01300260|82903014|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
46688278|NCT01300260|82903015|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
46688279|NCT01300260|82903014|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
46799857|NCT03817853|83018911|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
46799858|NCT03817853|83018912|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
46688280|NCT01300260|82903015|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
46688281|NCT01256385|82903034|FG000|Overall Study|Physician Decision|1|||
46688282|NCT01256385|82903035|FG001|Overall Study|Physician Decision|1|||
46688283|NCT01256385|82903034|FG000|Overall Study|Withdrawal by Subject|2|||
46688284|NCT01256385|82903035|FG001|Overall Study|Withdrawal by Subject|2|||
46688285|NCT01298778|82903043|FG000|Overall Study|Lost to Follow-up|2|||
46688286|NCT01298778|82903044|FG001|Overall Study|Lost to Follow-up|3|||
46688287|NCT01298778|82903043|FG000|Overall Study|Incorrect use of VAS|1|||
46688288|NCT01298778|82903044|FG001|Overall Study|Incorrect use of VAS|0|||
46688289|NCT01298778|82903043|FG000|Overall Study|Withdrawal by Subject|0|||
46688290|NCT01298778|82903044|FG001|Overall Study|Withdrawal by Subject|1|||
46688291|NCT01298778|82903043|FG000|Overall Study|Protocol Violation|0|||
46688292|NCT01298778|82903044|FG001|Overall Study|Protocol Violation|1|||
46688293|NCT01298778|82903043|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
46799859|NCT03817853|83018913|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
46799860|NCT03817853|83018911|FG000|Maintenance/ Follow-up Phase|Death|0|||
46799861|NCT03817853|83018912|FG001|Maintenance/ Follow-up Phase|Death|1|||
46799862|NCT03817853|83018913|FG002|Maintenance/ Follow-up Phase|Death|1|||
46799863|NCT03817853|83018911|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
46799864|NCT03817853|83018912|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
46799865|NCT03817853|83018913|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
46799866|NCT03817853|83018911|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
46799867|NCT03817853|83018912|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
46799868|NCT03817853|83018913|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
46799869|NCT03817853|83018911|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
46799870|NCT03817853|83018912|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
46799871|NCT03817853|83018913|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
46799872|NCT00439270|83018926|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
46981842|NCT01649271|83227927|FG000|Overall Study|Other than stated above|1|||
46981843|NCT01649271|83227928|FG001|Overall Study|Other than stated above|0|||
46688294|NCT01298778|82903044|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
46688295|NCT01298700|82903054|FG000|Overall Study|Adverse Event|50|||
46688296|NCT01298700|82903055|FG001|Overall Study|Adverse Event|51|||
46799873|NCT00439270|83018927|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
46799874|NCT00439270|83018928|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
46688297|NCT01298700|82903054|FG000|Overall Study|Lack of Efficacy|9|||
46688298|NCT01298700|82903055|FG001|Overall Study|Lack of Efficacy|14|||
46688299|NCT01298700|82903054|FG000|Overall Study|Lost to Follow-up|5|||
46688300|NCT01298700|82903055|FG001|Overall Study|Lost to Follow-up|2|||
46688301|NCT01298700|82903054|FG000|Overall Study|Withdrawal by Subject|12|||
46688302|NCT01298700|82903055|FG001|Overall Study|Withdrawal by Subject|9|||
46688303|NCT01298700|82903054|FG000|Overall Study|Protocol Violation|6|||
46688304|NCT01298700|82903055|FG001|Overall Study|Protocol Violation|4|||
46688305|NCT01298700|82903054|FG000|Overall Study|Other Miscellaneous Reasons|16|||
46688306|NCT01298700|82903055|FG001|Overall Study|Other Miscellaneous Reasons|15|||
46688307|NCT01298700|82903054|FG000|Overall Study|Did not Receive Study Drug|3|||
46688308|NCT01298700|82903055|FG001|Overall Study|Did not Receive Study Drug|5|||
46688309|NCT01297920|82903064|FG000|Overall Study|Adverse Event|42|||
46688310|NCT01297920|82903065|FG001|Overall Study|Adverse Event|10|||
46688311|NCT01297920|82903066|FG002|Overall Study|Adverse Event|38|||
46688312|NCT01297920|82903064|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
46688313|NCT01297920|82903065|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
46688314|NCT01297920|82903066|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
46688315|NCT01297920|82903064|FG000|Overall Study|Noncompliance|1|||
46688316|NCT01297920|82903065|FG001|Overall Study|Noncompliance|0|||
46688317|NCT01297920|82903066|FG002|Overall Study|Noncompliance|0|||
46688318|NCT01297920|82903064|FG000|Overall Study|Protocol Violation|1|||
46688319|NCT01297920|82903065|FG001|Overall Study|Protocol Violation|3|||
46688320|NCT01297920|82903066|FG002|Overall Study|Protocol Violation|0|||
46688321|NCT01297920|82903064|FG000|Overall Study|Inadequate Control of IOP|7|||
46688322|NCT01297920|82903065|FG001|Overall Study|Inadequate Control of IOP|9|||
46688323|NCT01297920|82903066|FG002|Overall Study|Inadequate Control of IOP|17|||
46688324|NCT01297920|82903064|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
46688325|NCT01297920|82903065|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
46688326|NCT01297920|82903066|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
46688327|NCT01255761|82903076|FG000|Overall Study|Adverse Event|29|||
46688328|NCT01255761|82903077|FG001|Overall Study|Adverse Event|43|||
46688329|NCT01255761|82903076|FG000|Overall Study|Lack of Efficacy|86|||
46688330|NCT01255761|82903077|FG001|Overall Study|Lack of Efficacy|74|||
46688331|NCT01255761|82903076|FG000|Overall Study|Protocol Violation|9|||
46688332|NCT01255761|82903077|FG001|Overall Study|Protocol Violation|5|||
46688333|NCT01255761|82903076|FG000|Overall Study|Lost to Follow-up|10|||
46688334|NCT01255761|82903077|FG001|Overall Study|Lost to Follow-up|8|||
46688335|NCT01255761|82903076|FG000|Overall Study|Withdrawal by Subject|11|||
46688336|NCT01255761|82903077|FG001|Overall Study|Withdrawal by Subject|27|||
46688337|NCT01255761|82903076|FG000|Overall Study|Other Reasons|37|||
46688338|NCT01255761|82903077|FG001|Overall Study|Other Reasons|18|||
46688339|NCT01297062|82903089|FG000|Overall Study|Adverse Event|2|||
46688340|NCT01297062|82903090|FG001|Overall Study|Adverse Event|0|||
46688341|NCT01297062|82903091|FG002|Overall Study|Adverse Event|1|||
46688342|NCT01297062|82903092|FG003|Overall Study|Adverse Event|0|||
46688343|NCT01297062|82903093|FG004|Overall Study|Adverse Event|0|||
46688344|NCT01297062|82903094|FG005|Overall Study|Adverse Event|0|||
46688345|NCT01297062|82903095|FG006|Overall Study|Adverse Event|0|||
46688346|NCT01297062|82903089|FG000|Overall Study|Physician Decision|1|||
46688347|NCT01297062|82903090|FG001|Overall Study|Physician Decision|0|||
46688348|NCT01297062|82903091|FG002|Overall Study|Physician Decision|1|||
46688349|NCT01297062|82903092|FG003|Overall Study|Physician Decision|0|||
46688350|NCT01297062|82903093|FG004|Overall Study|Physician Decision|0|||
46688351|NCT01297062|82903094|FG005|Overall Study|Physician Decision|0|||
46688352|NCT01297062|82903095|FG006|Overall Study|Physician Decision|6|||
46688353|NCT01297062|82903089|FG000|Overall Study|Protocol Violation|0|||
46688354|NCT01297062|82903090|FG001|Overall Study|Protocol Violation|0|||
46688355|NCT01297062|82903091|FG002|Overall Study|Protocol Violation|0|||
46688356|NCT01297062|82903092|FG003|Overall Study|Protocol Violation|0|||
46688357|NCT01297062|82903093|FG004|Overall Study|Protocol Violation|1|||
46688358|NCT01297062|82903094|FG005|Overall Study|Protocol Violation|0|||
46688359|NCT01297062|82903095|FG006|Overall Study|Protocol Violation|0|||
46688360|NCT01297062|82903089|FG000|Overall Study|Subject Decision|1|||
46688361|NCT01297062|82903090|FG001|Overall Study|Subject Decision|1|||
46688362|NCT01297062|82903091|FG002|Overall Study|Subject Decision|0|||
46688363|NCT01297062|82903092|FG003|Overall Study|Subject Decision|1|||
46688364|NCT01297062|82903093|FG004|Overall Study|Subject Decision|1|||
46688365|NCT01297062|82903094|FG005|Overall Study|Subject Decision|1|||
46688366|NCT01297062|82903095|FG006|Overall Study|Subject Decision|2|||
46688367|NCT01254747|82903107|FG000|Overall Study|Unacceptable subjective vision|0|||
46688368|NCT01254747|82903108|FG001|Overall Study|Unacceptable subjective vision|0|||
46688369|NCT01254747|82903109|FG002|Overall Study|Unacceptable subjective vision|0|||
46688370|NCT01254747|82903110|FG003|Overall Study|Unacceptable subjective vision|2|||
46688371|NCT01254747|82903107|FG000|Overall Study|Difficult removal handling|0|||
46688372|NCT01254747|82903108|FG001|Overall Study|Difficult removal handling|0|||
46688373|NCT01254747|82903109|FG002|Overall Study|Difficult removal handling|1|||
46688374|NCT01254747|82903110|FG003|Overall Study|Difficult removal handling|0|||
46688375|NCT01254747|82903107|FG000|Overall Study|Symptoms and problems|0|||
46688376|NCT01254747|82903108|FG001|Overall Study|Symptoms and problems|2|||
46688377|NCT01254747|82903109|FG002|Overall Study|Symptoms and problems|1|||
46688378|NCT01254747|82903110|FG003|Overall Study|Symptoms and problems|0|||
46688379|NCT01254747|82903107|FG000|Overall Study|Lost to Follow-up|0|||
46688380|NCT01254747|82903108|FG001|Overall Study|Lost to Follow-up|0|||
46688381|NCT01254747|82903109|FG002|Overall Study|Lost to Follow-up|1|||
46688382|NCT01254747|82903110|FG003|Overall Study|Lost to Follow-up|0|||
46688383|NCT01254747|82903107|FG000|Overall Study|Biomicroscopy|0|||
46688384|NCT01254747|82903108|FG001|Overall Study|Biomicroscopy|0|||
46688385|NCT01254747|82903109|FG002|Overall Study|Biomicroscopy|1|||
46688386|NCT01254747|82903110|FG003|Overall Study|Biomicroscopy|0|||
46688387|NCT01254747|82903107|FG000|Overall Study|Discomfort|0|||
46688388|NCT01254747|82903108|FG001|Overall Study|Discomfort|4|||
46688389|NCT01254747|82903109|FG002|Overall Study|Discomfort|0|||
46688390|NCT01254747|82903110|FG003|Overall Study|Discomfort|0|||
46688391|NCT01296672|82903122|FG000|Overall Study|Lost to Follow-up|73|||
46688392|NCT01296672|82903123|FG001|Overall Study|Lost to Follow-up|18|||
46688393|NCT01254669|82903133|FG000|Overall Study|Withdrawal by Subject|0|||
46688394|NCT01254669|82903134|FG001|Overall Study|Withdrawal by Subject|1|||
46688395|NCT01254669|82903133|FG000|Overall Study|time constraint|2|||
46688396|NCT01254669|82903134|FG001|Overall Study|time constraint|2|||
46688397|NCT01254669|82903133|FG000|Overall Study|called to clinic during intervention|1|||
46688398|NCT01254669|82903134|FG001|Overall Study|called to clinic during intervention|1|||
46688399|NCT01295814|82903144|FG000|Overall Study|Lack of Efficacy|0|||
46688400|NCT01295814|82903145|FG001|Overall Study|Lack of Efficacy|2|||
46688401|NCT01295814|82903144|FG000|Overall Study|Withdrawal by Subject|2|||
46688402|NCT01295814|82903145|FG001|Overall Study|Withdrawal by Subject|0|||
46688403|NCT01254045|82903151|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
46688404|NCT01254045|82903152|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
46688405|NCT01254045|82903153|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
46688406|NCT01254045|82903154|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
46688407|NCT01254045|82903155|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
46688408|NCT01254045|82903156|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
46688409|NCT01075282|82903169|FG000|Overall Study|Withdrawal by Subject|11|||
46688410|NCT01075282|82903170|FG001|Overall Study|Withdrawal by Subject|7|||
46688411|NCT01075282|82903171|FG002|Overall Study|Withdrawal by Subject|11|||
46688412|NCT01075282|82903169|FG000|Overall Study|Adverse Event|9|||
46688413|NCT01075282|82903170|FG001|Overall Study|Adverse Event|8|||
46688414|NCT01075282|82903171|FG002|Overall Study|Adverse Event|5|||
46688415|NCT01075282|82903169|FG000|Overall Study|Entry Criteria Not Met|3|||
46688416|NCT01075282|82903170|FG001|Overall Study|Entry Criteria Not Met|2|||
46688417|NCT01075282|82903171|FG002|Overall Study|Entry Criteria Not Met|0|||
46688418|NCT01075282|82903169|FG000|Overall Study|Lost to Follow-up|3|||
46688419|NCT01075282|82903170|FG001|Overall Study|Lost to Follow-up|3|||
46688420|NCT01075282|82903171|FG002|Overall Study|Lost to Follow-up|3|||
46799875|NCT00439270|83018929|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
46799876|NCT00439270|83018930|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
46688421|NCT01075282|82903169|FG000|Overall Study|Physician Decision|3|||
46688422|NCT01075282|82903170|FG001|Overall Study|Physician Decision|3|||
46688423|NCT01075282|82903171|FG002|Overall Study|Physician Decision|3|||
46688424|NCT01075282|82903169|FG000|Overall Study|Lack of Efficacy|1|||
46688425|NCT01075282|82903170|FG001|Overall Study|Lack of Efficacy|1|||
46688426|NCT01075282|82903171|FG002|Overall Study|Lack of Efficacy|0|||
46688427|NCT01075282|82903169|FG000|Overall Study|Treatment Non-compliance|1|||
46799877|NCT00439270|83018926|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
46799878|NCT00439270|83018927|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
46799879|NCT00439270|83018928|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
46688428|NCT01075282|82903170|FG001|Overall Study|Treatment Non-compliance|2|||
46688429|NCT01075282|82903171|FG002|Overall Study|Treatment Non-compliance|2|||
46799880|NCT00439270|83018929|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
46688430|NCT01075282|82903169|FG000|Overall Study|Protocol Violation|0|||
46688431|NCT01075282|82903170|FG001|Overall Study|Protocol Violation|2|||
46688432|NCT01075282|82903171|FG002|Overall Study|Protocol Violation|1|||
46799881|NCT00439270|83018930|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
46688433|NCT01075282|82903169|FG000|Overall Study|Death|0|||
46688434|NCT01075282|82903170|FG001|Overall Study|Death|1|||
46688435|NCT01075282|82903171|FG002|Overall Study|Death|2|||
46688436|NCT01253811|82903180|FG000|Overall Study|Withdrawal criteria|1|||
46688437|NCT01295580|82903186|FG000|Overall Study|Protocol Violation|4|||
46688438|NCT01295580|82903187|FG001|Overall Study|Protocol Violation|2|||
46688439|NCT01295580|82903186|FG000|Overall Study|Withdrawal by Subject|1|||
46688440|NCT01295580|82903187|FG001|Overall Study|Withdrawal by Subject|4|||
46688441|NCT01295580|82903186|FG000|Overall Study|Adverse Event|2|||
46688442|NCT01295580|82903187|FG001|Overall Study|Adverse Event|1|||
46688443|NCT01295580|82903186|FG000|Overall Study|Lost to Follow-up|1|||
46688444|NCT01295580|82903187|FG001|Overall Study|Lost to Follow-up|0|||
46688445|NCT01295580|82903186|FG000|Overall Study|Lack of Efficacy|1|||
46688446|NCT01295580|82903187|FG001|Overall Study|Lack of Efficacy|0|||
46688447|NCT01295580|82903186|FG000|Overall Study|Other: inconvenience|1|||
46688448|NCT01295580|82903187|FG001|Overall Study|Other: inconvenience|0|||
46688449|NCT01295580|82903186|FG000|Overall Study|Other: family objection|0|||
46688450|NCT01295580|82903187|FG001|Overall Study|Other: family objection|1|||
46688451|NCT01253577|82903193|FG000|Overall Study|Lost to Follow-up|3|||
46799882|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
46799883|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
46799884|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
46799885|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
46799886|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
46799887|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
46688452|NCT01295034|82903201|FG000|Overall Study|Lost to Follow-up|5|||
46688453|NCT01295034|82903202|FG001|Overall Study|Lost to Follow-up|5|||
46688454|NCT01253421|82903213|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
46688455|NCT01253421|82903214|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
46688456|NCT01253421|82903215|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
46688457|NCT01253421|82903216|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
46688458|NCT01253421|82903217|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
46688459|NCT01253421|82903213|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
46688460|NCT01253421|82903214|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
46688461|NCT01253421|82903215|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
46688462|NCT01253421|82903216|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
46688463|NCT01253421|82903217|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
46688464|NCT01253421|82903213|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
46688465|NCT01253421|82903214|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
46688466|NCT01253421|82903215|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
46799888|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
46799889|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
46799890|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
46799891|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
46799892|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
46799893|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
46799894|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
46799895|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
46799896|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
46799897|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
46799898|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
46799899|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
46799900|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
46799901|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
46688467|NCT01253421|82903216|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
46688468|NCT01253421|82903217|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
46688469|NCT01253421|82903213|FG000|Assessment and Scheduling|Physician Decision|1|||
46688470|NCT01253421|82903214|FG001|Assessment and Scheduling|Physician Decision|0|||
46688471|NCT01253421|82903215|FG002|Assessment and Scheduling|Physician Decision|0|||
46688472|NCT01253421|82903216|FG003|Assessment and Scheduling|Physician Decision|0|||
46688473|NCT01253421|82903217|FG004|Assessment and Scheduling|Physician Decision|0|||
46799902|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
46688474|NCT01253421|82903213|FG000|Drug+Scanning Visit|Physician Decision|0|||
46688475|NCT01253421|82903214|FG001|Drug+Scanning Visit|Physician Decision|0|||
46688476|NCT01253421|82903215|FG002|Drug+Scanning Visit|Physician Decision|0|||
46688477|NCT01253421|82903216|FG003|Drug+Scanning Visit|Physician Decision|0|||
46688478|NCT01253421|82903217|FG004|Drug+Scanning Visit|Physician Decision|1|||
46688479|NCT01077076|82903227|FG000|First Intervention|Withdrawal by Subject|1|||
46688480|NCT01077076|82903228|FG001|First Intervention|Withdrawal by Subject|0|||
46688481|NCT01077076|82903229|FG002|First Intervention|Withdrawal by Subject|0|||
46688482|NCT01077076|82903230|FG003|First Intervention|Withdrawal by Subject|0|||
46688483|NCT01077076|82903231|FG004|First Intervention|Withdrawal by Subject|0|||
46688484|NCT01077076|82903232|FG005|First Intervention|Withdrawal by Subject|0|||
46688485|NCT01077076|82903227|FG000|Third Intervention|Death in the participant's family|0|||
46688486|NCT01077076|82903228|FG001|Third Intervention|Death in the participant's family|0|||
46688487|NCT01077076|82903229|FG002|Third Intervention|Death in the participant's family|0|||
46688488|NCT01077076|82903230|FG003|Third Intervention|Death in the participant's family|0|||
46688489|NCT01077076|82903231|FG004|Third Intervention|Death in the participant's family|0|||
46688490|NCT01077076|82903232|FG005|Third Intervention|Death in the participant's family|1|||
46688491|NCT01294800|82903244|FG000|Overall Study|Adverse Event|7|||
46688492|NCT01294800|82903245|FG001|Overall Study|Adverse Event|6|||
46688493|NCT01294800|82903246|FG002|Overall Study|Adverse Event|12|||
46688494|NCT01294800|82903247|FG003|Overall Study|Adverse Event|5|||
46688495|NCT01294800|82903244|FG000|Overall Study|Subject Withdrew Consent|2|||
46688496|NCT01294800|82903245|FG001|Overall Study|Subject Withdrew Consent|2|||
46688497|NCT01294800|82903246|FG002|Overall Study|Subject Withdrew Consent|2|||
46688498|NCT01294800|82903247|FG003|Overall Study|Subject Withdrew Consent|11|||
46688499|NCT01294800|82903244|FG000|Overall Study|Lost to Follow-up|0|||
46688500|NCT01294800|82903245|FG001|Overall Study|Lost to Follow-up|0|||
46688501|NCT01294800|82903246|FG002|Overall Study|Lost to Follow-up|1|||
46688502|NCT01294800|82903247|FG003|Overall Study|Lost to Follow-up|0|||
46688503|NCT01294800|82903244|FG000|Overall Study|Non-compliance With Protocol|0|||
46688504|NCT01294800|82903245|FG001|Overall Study|Non-compliance With Protocol|1|||
46688505|NCT01294800|82903246|FG002|Overall Study|Non-compliance With Protocol|1|||
46688506|NCT01294800|82903247|FG003|Overall Study|Non-compliance With Protocol|0|||
46688507|NCT01294800|82903244|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
46688508|NCT01294800|82903245|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
46688509|NCT01294800|82903246|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
46688510|NCT01294800|82903247|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
46688511|NCT01294644|82903260|FG000|Overall Study|Adverse Event|2|||
46688512|NCT01294644|82903261|FG001|Overall Study|Adverse Event|0|||
46688513|NCT01294644|82903262|FG002|Overall Study|Adverse Event|1|||
46688514|NCT01294644|82903260|FG000|Overall Study|Withdrawal by Subject|3|||
46688515|NCT01294644|82903261|FG001|Overall Study|Withdrawal by Subject|7|||
46688516|NCT01294644|82903262|FG002|Overall Study|Withdrawal by Subject|4|||
46688517|NCT01294644|82903260|FG000|Overall Study|Lost to Follow-up|3|||
46688518|NCT01294644|82903261|FG001|Overall Study|Lost to Follow-up|2|||
46688519|NCT01294644|82903262|FG002|Overall Study|Lost to Follow-up|5|||
46688520|NCT01294644|82903260|FG000|Overall Study|Miscellaneous Reason|2|||
46688521|NCT01294644|82903261|FG001|Overall Study|Miscellaneous Reason|1|||
46688522|NCT01294644|82903262|FG002|Overall Study|Miscellaneous Reason|4|||
46688523|NCT01293240|82903270|FG000|Overall Study|Noncompliance|2|||
46688524|NCT01253265|82903279|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
46688525|NCT01253265|82903280|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
46688526|NCT01253265|82903281|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
46688527|NCT01253265|82903282|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
46688528|NCT01253265|82903283|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
46688529|NCT01253265|82903279|FG000|Overall Study|Withdrawal by Subject|0|||
46688530|NCT01253265|82903280|FG001|Overall Study|Withdrawal by Subject|0|||
46688531|NCT01253265|82903281|FG002|Overall Study|Withdrawal by Subject|0|||
46688532|NCT01253265|82903282|FG003|Overall Study|Withdrawal by Subject|0|||
46688533|NCT01253265|82903283|FG004|Overall Study|Withdrawal by Subject|1|||
46688534|NCT01293084|82903295|FG000|Overall Study|Physician Decision|3|||
46688535|NCT01293084|82903295|FG000|Overall Study|Withdrawal by Subject|2|||
46688536|NCT01293006|82903305|FG000|Period 2|Lost to Follow-up|1|||
46688537|NCT01293006|82903306|FG001|Period 2|Lost to Follow-up|0|||
46688538|NCT01293006|82903307|FG002|Period 2|Lost to Follow-up|0|||
46688539|NCT01293006|82903308|FG003|Period 2|Lost to Follow-up|0|||
46688540|NCT01253187|82903327|FG000|Period 2|Withdrawal by Subject|0|||
46688541|NCT01253187|82903328|FG001|Period 2|Withdrawal by Subject|0|||
46688542|NCT01253187|82903329|FG002|Period 2|Withdrawal by Subject|0|||
46688543|NCT01253187|82903330|FG003|Period 2|Withdrawal by Subject|0|||
46799903|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
46799904|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
46799905|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
46799906|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
46688544|NCT01253187|82903331|FG004|Period 2|Withdrawal by Subject|1|||
46688545|NCT01253187|82903332|FG005|Period 2|Withdrawal by Subject|0|||
46688546|NCT01253187|82903327|FG000|Period 3|Pregnancy|1|||
46688547|NCT01253187|82903328|FG001|Period 3|Pregnancy|0|||
46799907|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
46799908|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
46799909|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
46688548|NCT01253187|82903329|FG002|Period 3|Pregnancy|0|||
46688549|NCT01253187|82903330|FG003|Period 3|Pregnancy|0|||
46688550|NCT01253187|82903331|FG004|Period 3|Pregnancy|0|||
46688551|NCT01253187|82903332|FG005|Period 3|Pregnancy|0|||
46688552|NCT01253187|82903327|FG000|Period 3|difficulty with blood sampling|0|||
46688553|NCT01253187|82903328|FG001|Period 3|difficulty with blood sampling|1|||
46688554|NCT01253187|82903329|FG002|Period 3|difficulty with blood sampling|0|||
46688555|NCT01253187|82903330|FG003|Period 3|difficulty with blood sampling|0|||
46688556|NCT01253187|82903331|FG004|Period 3|difficulty with blood sampling|0|||
46688557|NCT01253187|82903332|FG005|Period 3|difficulty with blood sampling|0|||
46688558|NCT01253187|82903327|FG000|Period 3|non-compliance|0|||
46688559|NCT01253187|82903328|FG001|Period 3|non-compliance|0|||
46688560|NCT01253187|82903329|FG002|Period 3|non-compliance|0|||
46688561|NCT01253187|82903330|FG003|Period 3|non-compliance|0|||
46688562|NCT01253187|82903331|FG004|Period 3|non-compliance|1|||
46688563|NCT01253187|82903332|FG005|Period 3|non-compliance|0|||
46688564|NCT01252563|82903343|FG000|Overall Study|Contract Deviation|41|||
46688565|NCT01252563|82903343|FG000|Overall Study|Centralized Registration Deviation|30|||
46688566|NCT01252563|82903343|FG000|Overall Study|Lost to Follow-up|161|||
46688567|NCT01252563|82903343|FG000|Overall Study|No visit after first day of treatment|194|||
46688568|NCT01252563|82903343|FG000|Overall Study|No drug administration|6|||
46688569|NCT01292226|82903378|FG000|Overall Study|Adverse Event|5|||
46688570|NCT01292226|82903378|FG000|Overall Study|Death|1|||
46688571|NCT01292226|82903378|FG000|Overall Study|Graft loss|1|||
46688572|NCT01292226|82903378|FG000|Overall Study|Protocol Violation|3|||
46688573|NCT01292226|82903378|FG000|Overall Study|Withdrawal by Subject|1|||
46688574|NCT01292226|82903378|FG000|Overall Study|Other|2|||
46688575|NCT01290822|82903382|FG000|Overall Study|Withdrawal by Subject|1|||
46688576|NCT01290822|82903382|FG000|Overall Study|Physician Decision|10|||
46981844|NCT02385669|83227935|FG000|Overall Study|Adverse Event|2|||
46688577|NCT01075048|82903389|FG000|Overall Study|Death|4|||
46688578|NCT01075048|82903390|FG001|Overall Study|Death|17|||
46688579|NCT01075048|82903391|FG002|Overall Study|Death|12|||
46688580|NCT01075048|82903389|FG000|Overall Study|Start of other or new therapy|4|||
46981845|NCT02402907|83227941|FG000|Overall Study|Delivered vaginally|9|||
46688581|NCT01075048|82903390|FG001|Overall Study|Start of other or new therapy|36|||
46688582|NCT01075048|82903391|FG002|Overall Study|Start of other or new therapy|46|||
46688583|NCT01075048|82903389|FG000|Overall Study|Withdrawal by Subject|1|||
46688584|NCT01075048|82903390|FG001|Overall Study|Withdrawal by Subject|6|||
46688585|NCT01075048|82903391|FG002|Overall Study|Withdrawal by Subject|3|||
46688586|NCT01075048|82903389|FG000|Overall Study|Lost to Follow-up|0|||
46688587|NCT01075048|82903390|FG001|Overall Study|Lost to Follow-up|1|||
46688588|NCT01075048|82903391|FG002|Overall Study|Lost to Follow-up|1|||
46688589|NCT01290666|82903402|FG000|Overall Study|Lost to Follow-up|11|||
46688590|NCT01290666|82903402|FG000|Overall Study|Withdrawal by Subject|23|||
46688591|NCT01290666|82903402|FG000|Overall Study|Early Termination of Study|4|||
46688592|NCT01252251|82903406|FG000|Overall Study|Withdrawal by Subject|1|||
46688593|NCT01289574|82903413|FG000|Overall Study|Lack of Efficacy|4|||
46688594|NCT01289574|82903414|FG001|Overall Study|Lack of Efficacy|0|||
46688595|NCT01289574|82903415|FG002|Overall Study|Lack of Efficacy|1|||
46688596|NCT01289574|82903413|FG000|Overall Study|Lost to Follow-up|2|||
46688597|NCT01289574|82903414|FG001|Overall Study|Lost to Follow-up|0|||
46688598|NCT01289574|82903415|FG002|Overall Study|Lost to Follow-up|1|||
46688599|NCT01289574|82903413|FG000|Overall Study|Withdrawal by Subject|1|||
46688600|NCT01289574|82903414|FG001|Overall Study|Withdrawal by Subject|1|||
46688601|NCT01289574|82903415|FG002|Overall Study|Withdrawal by Subject|1|||
46688602|NCT01289574|82903413|FG000|Overall Study|Adverse Event|0|||
46688603|NCT01289574|82903414|FG001|Overall Study|Adverse Event|1|||
46688604|NCT01289574|82903415|FG002|Overall Study|Adverse Event|0|||
46688605|NCT01289574|82903413|FG000|Overall Study|Subject wanted alternate treatment|0|||
46799910|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
46799911|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
46799912|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
46799913|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
46799914|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
46858652|NCT00311363|83074366|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
46799915|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
46799916|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
46799917|NCT00439270|83018926|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
46799918|NCT00439270|83018927|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
46799919|NCT00439270|83018928|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
46799920|NCT00439270|83018929|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
46799921|NCT00439270|83018930|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
46858653|NCT00311363|83074367|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
46688606|NCT01289574|82903414|FG001|Overall Study|Subject wanted alternate treatment|1|||
46688607|NCT01289574|82903415|FG002|Overall Study|Subject wanted alternate treatment|0|||
46688608|NCT01252095|82903426|FG000|Overall Study|Disease progression|1|||
46688609|NCT01252095|82903427|FG001|Overall Study|Disease progression|0|||
46688610|NCT01289418|82903436|FG000|Day 8 Survey|email address invalid|283|||
46688611|NCT01289418|82903436|FG000|Day 8 Survey|participants did not complete the survey|1935|||
46688612|NCT01289418|82903436|FG000|Day 29 Survey|email address invalid|283|||
46688613|NCT01289418|82903436|FG000|Day 29 Survey|participants did not complete the survey|2185|||
46688614|NCT01074658|82903442|FG000|Overall Study|No implant attempted|19|||
46688615|NCT01074502|82903446|FG000|Overall Study|Withdrawal by Subject|1|||
46688616|NCT01289028|82903450|FG000|Overall Study|Progressive Disease|49|||
46688617|NCT01289028|82903450|FG000|Overall Study|Adverse Event|14|||
46688618|NCT01289028|82903450|FG000|Overall Study|Withdrawal by Subject|6|||
46688619|NCT01289028|82903450|FG000|Overall Study|Death|4|||
46688620|NCT01289028|82903450|FG000|Overall Study|Lack of Efficacy|2|||
46688621|NCT01289028|82903450|FG000|Overall Study|No longer required|2|||
46688622|NCT01289028|82903450|FG000|Overall Study|Lost to Follow-up|2|||
46688623|NCT01289028|82903450|FG000|Overall Study|New Cancer Therapy|2|||
46688624|NCT01289028|82903450|FG000|Overall Study|Abnormal Lab Value|1|||
46688625|NCT01289028|82903450|FG000|Overall Study|Missing reason for discon|1|||
46688626|NCT01250925|82903459|FG000|Overall Study|Lost to Follow-up|1|||
46688627|NCT01250925|82903460|FG001|Overall Study|Lost to Follow-up|1|||
46688628|NCT01250925|82903461|FG002|Overall Study|Lost to Follow-up|0|||
46688629|NCT01250925|82903459|FG000|Overall Study|Withdrawal by Subject|2|||
46688630|NCT01250925|82903460|FG001|Overall Study|Withdrawal by Subject|0|||
46688631|NCT01250925|82903461|FG002|Overall Study|Withdrawal by Subject|0|||
46688632|NCT01250925|82903459|FG000|Overall Study|Protocol Violation|2|||
46688633|NCT01250925|82903460|FG001|Overall Study|Protocol Violation|0|||
46688634|NCT01250925|82903461|FG002|Overall Study|Protocol Violation|0|||
46688635|NCT01250925|82903459|FG000|Overall Study|Physician Decision|0|||
46688636|NCT01250925|82903460|FG001|Overall Study|Physician Decision|2|||
46688637|NCT01250925|82903461|FG002|Overall Study|Physician Decision|1|||
46688638|NCT01250925|82903459|FG000|Overall Study|Adverse Event|0|||
46688639|NCT01250925|82903460|FG001|Overall Study|Adverse Event|0|||
46688640|NCT01250925|82903461|FG002|Overall Study|Adverse Event|1|||
46688641|NCT01285908|82903469|FG000|Baseline Measurement|unable to insert catheter|1|||
46688642|NCT01285908|82903470|FG001|Baseline Measurement|unable to insert catheter|0|||
46688643|NCT01285908|82903471|FG002|Baseline Measurement|unable to insert catheter|0|||
46688644|NCT01285908|82903469|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
46688645|NCT01285908|82903470|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
46688646|NCT01285908|82903471|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
46688647|NCT01285908|82903469|FG000|Baseline Measurement|unable to tolerate procedure|1|||
46688648|NCT01285908|82903470|FG001|Baseline Measurement|unable to tolerate procedure|0|||
46688649|NCT01285908|82903471|FG002|Baseline Measurement|unable to tolerate procedure|0|||
46688650|NCT01250769|82903505|FG000|Overall Study|Withdrawal by Subject|0|||
46688651|NCT01250769|82903506|FG001|Overall Study|Withdrawal by Subject|1|||
46688652|NCT01250769|82903507|FG002|Overall Study|Withdrawal by Subject|1|||
46688653|NCT01250769|82903508|FG003|Overall Study|Withdrawal by Subject|0|||
46688654|NCT01250769|82903505|FG000|Overall Study|Adverse Event|0|||
46688655|NCT01250769|82903506|FG001|Overall Study|Adverse Event|0|||
46688656|NCT01250769|82903507|FG002|Overall Study|Adverse Event|1|||
46688657|NCT01250769|82903508|FG003|Overall Study|Adverse Event|0|||
46688658|NCT01074268|82903520|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
46799922|NCT00553280|83018949|FG000|Overall Study|Adverse Event|19|||
46799923|NCT00553280|83018949|FG000|Overall Study|Lack of Efficacy|3|||
46799924|NCT00553280|83018949|FG000|Overall Study|Withdrawal by Subject|3|||
46799925|NCT00553280|83018949|FG000|Overall Study|Physician Decision|1|||
46688659|NCT01074268|82903521|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
46688660|NCT01074268|82903520|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
46688661|NCT01074268|82903521|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
46688662|NCT01074268|82903520|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
46688663|NCT01074268|82903521|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
46688664|NCT01074268|82903520|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
46688665|NCT01074268|82903521|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
46688666|NCT01074268|82903520|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
46688667|NCT01074268|82903521|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
46688668|NCT01074268|82903520|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
46688669|NCT01074268|82903521|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
46688670|NCT01074268|82903520|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
46688671|NCT01074268|82903521|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
46688672|NCT01074268|82903520|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
46688673|NCT01074268|82903521|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
46688674|NCT01074268|82903520|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
46688675|NCT01074268|82903521|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
46688676|NCT01074190|82903530|FG000|Overall Study|Emergency Cesarean Delivery|1|||
46688677|NCT01074190|82903531|FG001|Overall Study|Emergency Cesarean Delivery|2|||
46688678|NCT01074190|82903532|FG002|Overall Study|Emergency Cesarean Delivery|1|||
46688679|NCT01074190|82903530|FG000|Overall Study|Protocol Violation|2|||
46688680|NCT01074190|82903531|FG001|Overall Study|Protocol Violation|1|||
46688681|NCT01074190|82903532|FG002|Overall Study|Protocol Violation|0|||
46688682|NCT01074190|82903530|FG000|Overall Study|Delivered in under 90 minutes|0|||
46688683|NCT01074190|82903531|FG001|Overall Study|Delivered in under 90 minutes|2|||
46688684|NCT01074190|82903532|FG002|Overall Study|Delivered in under 90 minutes|1|||
46688685|NCT01074190|82903530|FG000|Overall Study|Subject withdrew consent|1|||
46688686|NCT01074190|82903531|FG001|Overall Study|Subject withdrew consent|1|||
46688687|NCT01074190|82903532|FG002|Overall Study|Subject withdrew consent|1|||
46688688|NCT01073566|82903545|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
46799926|NCT00440518|83018956|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
46799927|NCT00440518|83018957|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
46799928|NCT00440518|83018958|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
46799929|NCT00440518|83018956|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
46799930|NCT00440518|83018957|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
46799931|NCT00440518|83018958|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
46799932|NCT00440518|83018956|FG000|Randomized /Titration Period|Protocol Deviation|1|||
46799933|NCT00440518|83018957|FG001|Randomized /Titration Period|Protocol Deviation|0|||
46799934|NCT00440518|83018958|FG002|Randomized /Titration Period|Protocol Deviation|0|||
46799935|NCT00440518|83018956|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
46799936|NCT00440518|83018957|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
46799937|NCT00440518|83018958|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
46688689|NCT01073566|82903546|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
46688690|NCT01072396|82903554|FG000|Period One|Adverse Event|1|||
46688691|NCT01072396|82903555|FG001|Period One|Adverse Event|1|||
46799938|NCT00440518|83018956|FG000|Randomized /Titration Period|Other|1|||
46799939|NCT00440518|83018957|FG001|Randomized /Titration Period|Other|0|||
46981846|NCT02402907|83227942|FG001|Overall Study|Delivered vaginally|3|||
46981847|NCT02402907|83227941|FG000|Overall Study|Delivered outside of Sinai|1|||
46688692|NCT01072396|82903554|FG000|Period One|Protocol Violation|2|||
46688693|NCT01072396|82903555|FG001|Period One|Protocol Violation|1|||
46688694|NCT01072396|82903554|FG000|Period One|Withdrawal by Subject|2|||
46688695|NCT01072396|82903555|FG001|Period One|Withdrawal by Subject|0|||
46688696|NCT01072396|82903554|FG000|Washout Period|Missing termination information|0|||
46688697|NCT01072396|82903555|FG001|Washout Period|Missing termination information|1|||
46688698|NCT01072396|82903554|FG000|Period Two|Adverse Event|0|||
46688699|NCT01072396|82903555|FG001|Period Two|Adverse Event|3|||
46688700|NCT01072396|82903554|FG000|Period Two|Lost to Follow-up|1|||
46688701|NCT01072396|82903555|FG001|Period Two|Lost to Follow-up|0|||
46688702|NCT01045096|82903564|FG000|Overall Study|Withdrawal by Subject|2|||
46688703|NCT01045096|82903565|FG001|Overall Study|Withdrawal by Subject|0|||
46688704|NCT01045096|82903566|FG002|Overall Study|Withdrawal by Subject|0|||
46688705|NCT01045096|82903564|FG000|Overall Study|Other|1|||
46688706|NCT01045096|82903565|FG001|Overall Study|Other|0|||
46688707|NCT01045096|82903566|FG002|Overall Study|Other|0|||
46688708|NCT01285518|82903582|FG000|Overall Study|Lost to Follow-up|0|||
46688709|NCT01285518|82903583|FG001|Overall Study|Lost to Follow-up|0|||
46688710|NCT01285518|82903584|FG002|Overall Study|Lost to Follow-up|0|||
46688711|NCT01285518|82903585|FG003|Overall Study|Lost to Follow-up|0|||
46688712|NCT01285518|82903586|FG004|Overall Study|Lost to Follow-up|0|||
46688713|NCT01285518|82903587|FG005|Overall Study|Lost to Follow-up|1|||
46688714|NCT01285518|82903588|FG006|Overall Study|Lost to Follow-up|0|||
46688715|NCT01285518|82903589|FG007|Overall Study|Lost to Follow-up|0|||
46688716|NCT01073020|82903612|FG000|Overall Study|Withdrawal by Subject|6|||
46688717|NCT01073020|82903613|FG001|Overall Study|Withdrawal by Subject|4|||
46688718|NCT01073020|82903614|FG002|Overall Study|Withdrawal by Subject|1|||
46688719|NCT01073020|82903615|FG003|Overall Study|Withdrawal by Subject|2|||
46688720|NCT01073020|82903612|FG000|Overall Study|Physician Decision|1|||
46688721|NCT01073020|82903613|FG001|Overall Study|Physician Decision|0|||
46688722|NCT01073020|82903614|FG002|Overall Study|Physician Decision|2|||
46688723|NCT01073020|82903615|FG003|Overall Study|Physician Decision|0|||
46688724|NCT01073020|82903612|FG000|Overall Study|Death|0|||
46688725|NCT01073020|82903613|FG001|Overall Study|Death|1|||
46688726|NCT01073020|82903614|FG002|Overall Study|Death|0|||
46688727|NCT01073020|82903615|FG003|Overall Study|Death|0|||
46688728|NCT01284114|82903625|FG000|Overall Study|viral infection|1|||
46688729|NCT01284114|82903625|FG000|Overall Study|From the results of ALLTITUDE study|1|||
46799940|NCT00440518|83018958|FG002|Randomized /Titration Period|Other|0|||
46799941|NCT00440518|83018956|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
46981848|NCT02402907|83227942|FG001|Overall Study|Delivered outside of Sinai|1|||
46981849|NCT02402907|83227941|FG000|Overall Study|Lost to follow up after C-Section|10|||
46981850|NCT02402907|83227942|FG001|Overall Study|Lost to follow up after C-Section|23|||
46981851|NCT02345889|83227952|FG000|Overall Study|Inadequate Bowel Prep|17|||
46981852|NCT02345889|83227953|FG001|Overall Study|Inadequate Bowel Prep|16|||
46981853|NCT02345889|83227954|FG002|Overall Study|Inadequate Bowel Prep|18|||
46981854|NCT02345889|83227955|FG003|Overall Study|Inadequate Bowel Prep|14|||
46981855|NCT02345889|83227952|FG000|Overall Study|Polyposis identified during procedure|1|||
46981856|NCT02345889|83227953|FG001|Overall Study|Polyposis identified during procedure|1|||
46981857|NCT02345889|83227954|FG002|Overall Study|Polyposis identified during procedure|0|||
46981858|NCT02345889|83227955|FG003|Overall Study|Polyposis identified during procedure|1|||
46981859|NCT02345889|83227952|FG000|Overall Study|Recognized ineligible post-randomization|1|||
46981860|NCT02345889|83227953|FG001|Overall Study|Recognized ineligible post-randomization|0|||
46981861|NCT02345889|83227954|FG002|Overall Study|Recognized ineligible post-randomization|2|||
46981862|NCT02345889|83227955|FG003|Overall Study|Recognized ineligible post-randomization|1|||
46981863|NCT02345889|83227952|FG000|Overall Study|Ulcerative Colitis identified|1|||
46981864|NCT02345889|83227953|FG001|Overall Study|Ulcerative Colitis identified|0|||
46981865|NCT02345889|83227954|FG002|Overall Study|Ulcerative Colitis identified|0|||
46981866|NCT02345889|83227955|FG003|Overall Study|Ulcerative Colitis identified|0|||
46981867|NCT02345889|83227952|FG000|Overall Study|Cecum not intubated|1|||
46981868|NCT02345889|83227953|FG001|Overall Study|Cecum not intubated|0|||
46981869|NCT02345889|83227954|FG002|Overall Study|Cecum not intubated|0|||
46981870|NCT02345889|83227955|FG003|Overall Study|Cecum not intubated|0|||
46981871|NCT02345811|83227965|FG000|First Intervention|Withdrawal by Subject|1|||
46981872|NCT02345811|83227966|FG001|First Intervention|Withdrawal by Subject|1|||
46981873|NCT02344173|83227974|FG000|Procedure|Ablation Procedure Not Performed|7|||
46981874|NCT02344173|83227974|FG000|12-month Visit|Death|8|||
46981875|NCT02344173|83227974|FG000|12-month Visit|Withdrawal by Subject|30|||
46981876|NCT02344173|83227974|FG000|12-month Visit|Lost to Follow-up|58|||
46981877|NCT02586493|83227980|FG000|Overall Study|Adverse Event|4|||
46688730|NCT01284114|82903625|FG000|Overall Study|Symptomatic hypotension|1|||
46688731|NCT01284114|82903625|FG000|Overall Study|dizziness|1|||
46688732|NCT01283334|82903630|FG000|Overall Study|Withdrawal by Subject|1|||
46981878|NCT02586493|83227980|FG000|Overall Study|Protocol Violation|6|||
46981879|NCT02586493|83227980|FG000|Overall Study|Lost to Follow-up|1|||
46688733|NCT01283334|82903630|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
46688734|NCT01283334|82903630|FG000|Overall Study|Adverse Event|4|||
46688735|NCT01283334|82903630|FG000|Overall Study|Physician Decision|1|||
46688736|NCT01282866|82903636|FG000|Overall Study|Adverse Event|1|||
46688737|NCT01071070|82903642|FG000|Overall Study|Adverse Event|0|||
46688738|NCT01071070|82903643|FG001|Overall Study|Adverse Event|3|||
46688739|NCT01071070|82903642|FG000|Overall Study|Withdrawal by Subject|1|||
46688740|NCT01071070|82903643|FG001|Overall Study|Withdrawal by Subject|0|||
46688741|NCT01071070|82903642|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
46688742|NCT01071070|82903643|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
46688743|NCT01071070|82903642|FG000|Overall Study|Hypercalcemia|1|||
46688744|NCT01071070|82903643|FG001|Overall Study|Hypercalcemia|0|||
46688745|NCT01282476|82903649|FG000|Overall Study|Death|11|||
46688746|NCT01282164|82903655|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
46688747|NCT01282164|82903656|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
46688748|NCT01250379|82903672|FG000|Overall Study|Death|141|||
46688749|NCT01250379|82903673|FG001|Overall Study|Death|148|||
46688750|NCT01250379|82903672|FG000|Overall Study|Withdrawal by Subject|32|||
46688751|NCT01250379|82903673|FG001|Overall Study|Withdrawal by Subject|20|||
46688752|NCT01250379|82903672|FG000|Overall Study|Physician Decision|11|||
46688753|NCT01250379|82903673|FG001|Overall Study|Physician Decision|3|||
46688754|NCT01250379|82903672|FG000|Overall Study|Protocol Violation|2|||
46688755|NCT01250379|82903673|FG001|Overall Study|Protocol Violation|8|||
46688756|NCT01250379|82903672|FG000|Overall Study|Lost to Follow-up|9|||
46688757|NCT01250379|82903673|FG001|Overall Study|Lost to Follow-up|6|||
46688758|NCT01250379|82903672|FG000|Overall Study|Adverse Event|5|||
46858654|NCT00311363|83074368|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
46688759|NCT01250379|82903673|FG001|Overall Study|Adverse Event|4|||
46688760|NCT01250379|82903672|FG000|Overall Study|Other|0|||
46688761|NCT01250379|82903673|FG001|Overall Study|Other|4|||
46858655|NCT00333983|83074381|FG000|Overall Study|Lost to Follow-up|2|||
46858656|NCT00333983|83074382|FG001|Overall Study|Lost to Follow-up|1|||
46981880|NCT02586493|83227980|FG000|Overall Study|Withdrawal by Subject|1|||
46981881|NCT02400333|83227988|FG000|Overall Study|Withdrawal by Subject|0|||
46981882|NCT02400333|83227989|FG001|Overall Study|Withdrawal by Subject|1|||
46981883|NCT02400333|83227990|FG002|Overall Study|Withdrawal by Subject|0|||
46981884|NCT02400333|83227991|FG003|Overall Study|Withdrawal by Subject|1|||
46688762|NCT01250379|82903672|FG000|Overall Study|Participant noncompliance|2|||
46688763|NCT01250379|82903673|FG001|Overall Study|Participant noncompliance|0|||
46688764|NCT01072630|82903682|FG000|Overall Study|Adverse Event|11|||
46688765|NCT01072630|82903683|FG001|Overall Study|Adverse Event|19|||
46688766|NCT01072630|82903684|FG002|Overall Study|Adverse Event|2|||
46688767|NCT01072630|82903682|FG000|Overall Study|Lack of Efficacy|10|||
46688768|NCT01072630|82903683|FG001|Overall Study|Lack of Efficacy|10|||
46688769|NCT01072630|82903684|FG002|Overall Study|Lack of Efficacy|1|||
46688770|NCT01072630|82903682|FG000|Overall Study|Withdrawal by Subject|8|||
46688771|NCT01072630|82903683|FG001|Overall Study|Withdrawal by Subject|7|||
46688772|NCT01072630|82903684|FG002|Overall Study|Withdrawal by Subject|2|||
46688773|NCT01072630|82903682|FG000|Overall Study|Protocol Violation|10|||
46688774|NCT01072630|82903683|FG001|Overall Study|Protocol Violation|8|||
46688775|NCT01072630|82903684|FG002|Overall Study|Protocol Violation|4|||
46688776|NCT01072630|82903682|FG000|Overall Study|Lost to Follow-up|11|||
46688777|NCT01072630|82903683|FG001|Overall Study|Lost to Follow-up|11|||
46688778|NCT01072630|82903684|FG002|Overall Study|Lost to Follow-up|1|||
46688779|NCT01072630|82903682|FG000|Overall Study|Noncompliance with study medication|1|||
46688780|NCT01072630|82903683|FG001|Overall Study|Noncompliance with study medication|1|||
46799942|NCT00440518|83018957|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
46799943|NCT00440518|83018958|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
46799944|NCT00440518|83018956|FG000|Randomized /Titration Period|Adverse Event|2|||
46799945|NCT00440518|83018957|FG001|Randomized /Titration Period|Adverse Event|3|||
46799946|NCT00440518|83018958|FG002|Randomized /Titration Period|Adverse Event|0|||
46799947|NCT00440518|83018956|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
46799948|NCT00440518|83018957|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
46799949|NCT00440518|83018958|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
46799950|NCT00440518|83018956|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
46799951|NCT00440518|83018957|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
46799952|NCT00440518|83018958|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
46799953|NCT00440518|83018956|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
46799954|NCT00440518|83018957|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
46799955|NCT00440518|83018958|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
46799956|NCT00440518|83018956|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
46799957|NCT00440518|83018957|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
46858657|NCT00333983|83074383|FG002|Overall Study|Lost to Follow-up|0|||
46858658|NCT00333983|83074381|FG000|Overall Study|Adverse Event|1|||
46858659|NCT00333983|83074382|FG001|Overall Study|Adverse Event|1|||
46858660|NCT00333983|83074383|FG002|Overall Study|Adverse Event|1|||
46858661|NCT00333983|83074381|FG000|Overall Study|Withdrawal by Subject|0|||
46858662|NCT00333983|83074382|FG001|Overall Study|Withdrawal by Subject|3|||
46858663|NCT00333983|83074383|FG002|Overall Study|Withdrawal by Subject|1|||
46858664|NCT03262012|83074395|FG000|Overall Study|Withdrawal by Subject|15|||
46858665|NCT03262012|83074396|FG001|Overall Study|Withdrawal by Subject|13|||
46858666|NCT03262012|83074397|FG002|Overall Study|Withdrawal by Subject|8|||
46858667|NCT03262012|83074398|FG003|Overall Study|Withdrawal by Subject|7|||
46858668|NCT03262012|83074395|FG000|Overall Study|Adverse Event|10|||
46858669|NCT03262012|83074396|FG001|Overall Study|Adverse Event|12|||
46858670|NCT03262012|83074397|FG002|Overall Study|Adverse Event|4|||
46858671|NCT03262012|83074398|FG003|Overall Study|Adverse Event|6|||
46858672|NCT03262012|83074395|FG000|Overall Study|Physician Decision|2|||
46858673|NCT03262012|83074396|FG001|Overall Study|Physician Decision|5|||
46858674|NCT03262012|83074397|FG002|Overall Study|Physician Decision|1|||
46858675|NCT03262012|83074398|FG003|Overall Study|Physician Decision|0|||
46858676|NCT03262012|83074395|FG000|Overall Study|Lack of Efficacy|0|||
46858677|NCT03262012|83074396|FG001|Overall Study|Lack of Efficacy|5|||
46688781|NCT01072630|82903684|FG002|Overall Study|Noncompliance with study medication|1|||
46688782|NCT01072630|82903682|FG000|Overall Study|Noncompliance with study procedures|1|||
46688783|NCT01072630|82903683|FG001|Overall Study|Noncompliance with study procedures|2|||
46688784|NCT01072630|82903684|FG002|Overall Study|Noncompliance with study procedures|1|||
46688785|NCT01072630|82903682|FG000|Overall Study|Other|3|||
46981885|NCT02400333|83227988|FG000|Overall Study|Protocol Violation|1|||
46981886|NCT02400333|83227989|FG001|Overall Study|Protocol Violation|0|||
46981887|NCT02400333|83227990|FG002|Overall Study|Protocol Violation|2|||
46981888|NCT02400333|83227991|FG003|Overall Study|Protocol Violation|1|||
46688786|NCT01072630|82903683|FG001|Overall Study|Other|2|||
46688787|NCT01072630|82903684|FG002|Overall Study|Other|1|||
46688788|NCT01281306|82903700|FG000|Overall Study|Lack of Efficacy|0|||
46688789|NCT01281306|82903701|FG001|Overall Study|Lack of Efficacy|1|||
46688790|NCT01281306|82903702|FG002|Overall Study|Lack of Efficacy|3|||
46688791|NCT01281306|82903703|FG003|Overall Study|Lack of Efficacy|0|||
46688792|NCT01281306|82903704|FG004|Overall Study|Lack of Efficacy|2|||
46688793|NCT01281306|82903705|FG005|Overall Study|Lack of Efficacy|0|||
46688794|NCT01281306|82903706|FG006|Overall Study|Lack of Efficacy|1|||
46688795|NCT01281306|82903700|FG000|Overall Study|Withdrawal by Subject|1|||
46688796|NCT01281306|82903701|FG001|Overall Study|Withdrawal by Subject|0|||
46688797|NCT01281306|82903702|FG002|Overall Study|Withdrawal by Subject|2|||
46688798|NCT01281306|82903703|FG003|Overall Study|Withdrawal by Subject|4|||
46688799|NCT01281306|82903704|FG004|Overall Study|Withdrawal by Subject|1|||
46688800|NCT01281306|82903705|FG005|Overall Study|Withdrawal by Subject|3|||
46688801|NCT01281306|82903706|FG006|Overall Study|Withdrawal by Subject|1|||
46688802|NCT01281306|82903700|FG000|Overall Study|Protocol deviation|0|||
46688803|NCT01281306|82903701|FG001|Overall Study|Protocol deviation|1|||
46688804|NCT01281306|82903702|FG002|Overall Study|Protocol deviation|1|||
46688805|NCT01281306|82903703|FG003|Overall Study|Protocol deviation|1|||
46688806|NCT01281306|82903704|FG004|Overall Study|Protocol deviation|1|||
46688807|NCT01281306|82903705|FG005|Overall Study|Protocol deviation|0|||
46688808|NCT01281306|82903706|FG006|Overall Study|Protocol deviation|0|||
46688809|NCT01281306|82903700|FG000|Overall Study|Condition no longer requires study drug|1|||
46688810|NCT01281306|82903701|FG001|Overall Study|Condition no longer requires study drug|0|||
46688811|NCT01281306|82903702|FG002|Overall Study|Condition no longer requires study drug|0|||
46688812|NCT01281306|82903703|FG003|Overall Study|Condition no longer requires study drug|0|||
46688813|NCT01281306|82903704|FG004|Overall Study|Condition no longer requires study drug|0|||
46688814|NCT01281306|82903705|FG005|Overall Study|Condition no longer requires study drug|1|||
46688815|NCT01281306|82903706|FG006|Overall Study|Condition no longer requires study drug|1|||
46981889|NCT02399475|83228004|FG000|Overall Study|Physician Decision|1|||
46981890|NCT02399475|83228005|FG001|Overall Study|Physician Decision|0|||
46688816|NCT01281306|82903700|FG000|Overall Study|Lost to Follow-up|1|||
46688817|NCT01281306|82903701|FG001|Overall Study|Lost to Follow-up|0|||
46688818|NCT01281306|82903702|FG002|Overall Study|Lost to Follow-up|0|||
46688819|NCT01281306|82903703|FG003|Overall Study|Lost to Follow-up|2|||
46688820|NCT01281306|82903704|FG004|Overall Study|Lost to Follow-up|0|||
46688821|NCT01281306|82903705|FG005|Overall Study|Lost to Follow-up|0|||
46688822|NCT01281306|82903706|FG006|Overall Study|Lost to Follow-up|1|||
46688823|NCT01281306|82903700|FG000|Overall Study|Death|1|||
46858678|NCT03262012|83074397|FG002|Overall Study|Lack of Efficacy|1|||
46688824|NCT01281306|82903701|FG001|Overall Study|Death|0|||
46981891|NCT02399163|83228011|FG000|Overall Study|Adverse Event|2|||
46688825|NCT01281306|82903702|FG002|Overall Study|Death|0|||
46688826|NCT01281306|82903703|FG003|Overall Study|Death|0|||
46688827|NCT01281306|82903704|FG004|Overall Study|Death|0|||
46688828|NCT01281306|82903705|FG005|Overall Study|Death|0|||
46688829|NCT01281306|82903706|FG006|Overall Study|Death|0|||
46688830|NCT01281306|82903700|FG000|Overall Study|Adverse Event|3|||
46688831|NCT01281306|82903701|FG001|Overall Study|Adverse Event|2|||
46688832|NCT01281306|82903702|FG002|Overall Study|Adverse Event|2|||
46688833|NCT01281306|82903703|FG003|Overall Study|Adverse Event|3|||
46688834|NCT01281306|82903704|FG004|Overall Study|Adverse Event|5|||
46688835|NCT01281306|82903705|FG005|Overall Study|Adverse Event|3|||
46688836|NCT01281306|82903706|FG006|Overall Study|Adverse Event|3|||
46688837|NCT01281306|82903700|FG000|Overall Study|Randomized in error|1|||
46688838|NCT01281306|82903701|FG001|Overall Study|Randomized in error|0|||
46688839|NCT01281306|82903702|FG002|Overall Study|Randomized in error|0|||
46688840|NCT01281306|82903703|FG003|Overall Study|Randomized in error|1|||
46688841|NCT01281306|82903704|FG004|Overall Study|Randomized in error|0|||
46688842|NCT01281306|82903705|FG005|Overall Study|Randomized in error|0|||
46688843|NCT01281306|82903706|FG006|Overall Study|Randomized in error|0|||
46688844|NCT01250145|82903724|FG000|Overall Study|Adverse Event|2|||
46688845|NCT01250145|82903725|FG001|Overall Study|Adverse Event|1|||
46688846|NCT01250145|82903724|FG000|Overall Study|Withdrawal by Subject|0|||
46688847|NCT01250145|82903725|FG001|Overall Study|Withdrawal by Subject|4|||
46688848|NCT01067326|82903747|FG000|Overall Study|Adverse Event|0|||
46688849|NCT01067326|82903748|FG001|Overall Study|Adverse Event|2|||
46688850|NCT01067326|82903747|FG000|Overall Study|Withdrawal by Subject|1|||
46688851|NCT01067326|82903748|FG001|Overall Study|Withdrawal by Subject|0|||
46688852|NCT01067326|82903747|FG000|Overall Study|Early Study Termination|1|||
46688853|NCT01067326|82903748|FG001|Overall Study|Early Study Termination|1|||
46799958|NCT00440518|83018958|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
46981892|NCT02399163|83228011|FG000|Overall Study|Protocol Deviation|2|||
46688854|NCT01279200|82903756|FG000|Overall Study|Withdrawal by Subject|1|||
46688855|NCT01279200|82903757|FG001|Overall Study|Withdrawal by Subject|3|||
46688856|NCT01279200|82903756|FG000|Overall Study|Patient withdrawal due to high cost|0|||
46688857|NCT01279200|82903757|FG001|Overall Study|Patient withdrawal due to high cost|1|||
46688858|NCT01279200|82903756|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
46688859|NCT01279200|82903757|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
46688860|NCT01279200|82903756|FG000|Overall Study|ultrasound screening failure|0|||
46688861|NCT01279200|82903757|FG001|Overall Study|ultrasound screening failure|1|||
46688862|NCT01279200|82903756|FG000|Overall Study|Lost to Follow-up|0|||
46688863|NCT01279200|82903757|FG001|Overall Study|Lost to Follow-up|1|||
46688864|NCT01279200|82903756|FG000|Overall Study|Adverse Event|1|||
46688865|NCT01279200|82903757|FG001|Overall Study|Adverse Event|0|||
46688866|NCT01273818|82903766|FG000|Overall Study|Physician Decision|13|||
46688867|NCT01273818|82903767|FG001|Overall Study|Physician Decision|2|||
46688868|NCT01273818|82903768|FG002|Overall Study|Physician Decision|9|||
46688869|NCT01245387|82903776|FG000|Overall Study|Lost to Follow-up|106|||
46799959|NCT00440518|83018956|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
46799960|NCT00440518|83018957|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
46799961|NCT00440518|83018958|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
46799962|NCT00440518|83018956|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
46799963|NCT00440518|83018957|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
46799964|NCT00440518|83018958|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
46688870|NCT01245387|82903776|FG000|Overall Study|Lack of Efficacy|195|||
46688871|NCT01245387|82903776|FG000|Overall Study|Adverse Event|9|||
46688872|NCT01245387|82903776|FG000|Overall Study|Death|3|||
46688873|NCT01245387|82903776|FG000|Overall Study|Other|131|||
46688874|NCT01245387|82903776|FG000|Overall Study|Missing discontinuation status|369|||
46688875|NCT01037218|82903784|FG000|Overall Study|Adverse Event|4|||
46688876|NCT01037218|82903785|FG001|Overall Study|Adverse Event|2|||
46688877|NCT01037218|82903786|FG002|Overall Study|Adverse Event|2|||
46688878|NCT01037218|82903787|FG003|Overall Study|Adverse Event|1|||
46688879|NCT01037218|82903784|FG000|Overall Study|Lack of Efficacy|0|||
46688880|NCT01037218|82903785|FG001|Overall Study|Lack of Efficacy|2|||
46799965|NCT00438256|83018966|FG000|Overall Study|Ineligible for Resection|2|||
46799966|NCT00438256|83018967|FG001|Overall Study|Ineligible for Resection|1|||
46799967|NCT00438256|83018968|FG002|Overall Study|Ineligible for Resection|1|||
46799968|NCT00438256|83018969|FG003|Overall Study|Ineligible for Resection|7|||
46799969|NCT00438256|83018966|FG000|Overall Study|Excluded final Diagnosis|0|||
46799970|NCT00438256|83018967|FG001|Overall Study|Excluded final Diagnosis|0|||
46799971|NCT00438256|83018968|FG002|Overall Study|Excluded final Diagnosis|0|||
46799972|NCT00438256|83018969|FG003|Overall Study|Excluded final Diagnosis|2|||
46799973|NCT00436852|83018988|FG000|Overall Study|Death|23|||
46799974|NCT00436852|83018989|FG001|Overall Study|Death|34|||
46799975|NCT00436852|83018988|FG000|Overall Study|Lack of Efficacy|9|||
46688881|NCT01037218|82903786|FG002|Overall Study|Lack of Efficacy|1|||
46688882|NCT01037218|82903787|FG003|Overall Study|Lack of Efficacy|5|||
46688883|NCT01037218|82903784|FG000|Overall Study|Lost to Follow-up|3|||
46688884|NCT01037218|82903785|FG001|Overall Study|Lost to Follow-up|5|||
46688885|NCT01037218|82903786|FG002|Overall Study|Lost to Follow-up|4|||
46688886|NCT01037218|82903787|FG003|Overall Study|Lost to Follow-up|2|||
46688887|NCT01037218|82903784|FG000|Overall Study|Withdrawal by Subject|6|||
46688888|NCT01037218|82903785|FG001|Overall Study|Withdrawal by Subject|7|||
46688889|NCT01037218|82903786|FG002|Overall Study|Withdrawal by Subject|7|||
46688890|NCT01037218|82903787|FG003|Overall Study|Withdrawal by Subject|4|||
46688891|NCT01037218|82903784|FG000|Overall Study|Partner Withdrew Consent|0|||
46688892|NCT01037218|82903785|FG001|Overall Study|Partner Withdrew Consent|3|||
46688893|NCT01037218|82903786|FG002|Overall Study|Partner Withdrew Consent|2|||
46688894|NCT01037218|82903787|FG003|Overall Study|Partner Withdrew Consent|1|||
46688895|NCT01037218|82903784|FG000|Overall Study|Protocol Violation|0|||
46688896|NCT01037218|82903785|FG001|Overall Study|Protocol Violation|0|||
46688897|NCT01037218|82903786|FG002|Overall Study|Protocol Violation|2|||
46688898|NCT01037218|82903787|FG003|Overall Study|Protocol Violation|2|||
46688899|NCT01037218|82903784|FG000|Overall Study|Various|3|||
46688900|NCT01037218|82903785|FG001|Overall Study|Various|2|||
46688901|NCT01037218|82903786|FG002|Overall Study|Various|3|||
46688902|NCT01037218|82903787|FG003|Overall Study|Various|1|||
46688903|NCT01038856|82903797|FG000|Overall Study|Adverse Event|2|||
46688904|NCT01066546|82903803|FG000|Overall Study|Study terminated by sponsor|5|||
46688905|NCT01272804|82903813|FG000|Overall Study|Adverse Event|1|||
46688906|NCT01272804|82903814|FG001|Overall Study|Adverse Event|0|||
46688907|NCT01272804|82903815|FG002|Overall Study|Adverse Event|0|||
46688908|NCT01272804|82903816|FG003|Overall Study|Adverse Event|0|||
46688909|NCT01272804|82903817|FG004|Overall Study|Adverse Event|2|||
46688910|NCT01272804|82903818|FG005|Overall Study|Adverse Event|1|||
46688911|NCT01269918|82903834|FG000|Overall Study|Did not receive study drug|0|||
46688912|NCT01269918|82903835|FG001|Overall Study|Did not receive study drug|3|||
46688913|NCT01036594|82903841|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
46688914|NCT01036594|82903842|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
46799976|NCT00436852|83018989|FG001|Overall Study|Lack of Efficacy|7|||
46799977|NCT00436852|83018988|FG000|Overall Study|Withdrawal by Subject|2|||
46799978|NCT00436852|83018989|FG001|Overall Study|Withdrawal by Subject|4|||
46799979|NCT00436852|83018988|FG000|Overall Study|Ineligible|1|||
46799980|NCT00436852|83018989|FG001|Overall Study|Ineligible|0|||
46688915|NCT01036594|82903841|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
46688916|NCT01036594|82903842|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
46688917|NCT01036594|82903841|FG000|Week 12 Evaluation|Adverse Event|5|||
46688918|NCT01036594|82903842|FG001|Week 12 Evaluation|Adverse Event|0|||
46688919|NCT01036594|82903841|FG000|Week 12 Evaluation|Physician Decision|1|||
46688920|NCT01036594|82903842|FG001|Week 12 Evaluation|Physician Decision|0|||
46688921|NCT01036594|82903841|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
46688922|NCT01036594|82903842|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
46688923|NCT01036594|82903841|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
46688924|NCT01036594|82903842|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
46799981|NCT00120289|83019000|FG000|Overall Study|Death|96|||
46799982|NCT00120289|83019001|FG001|Overall Study|Death|82|||
46688925|NCT01036594|82903841|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
46688926|NCT01036594|82903842|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
46688927|NCT01036594|82903841|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
46688928|NCT01036594|82903842|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
46688929|NCT01036594|82903841|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
46688930|NCT01036594|82903842|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
46688931|NCT01036438|82903850|FG000|Overall Study|Adverse Event|7|||
46688932|NCT01036438|82903851|FG001|Overall Study|Adverse Event|8|||
46688933|NCT01036438|82903850|FG000|Overall Study|Death|0|||
46799983|NCT00120289|83019000|FG000|Overall Study|Lost to Follow-up|11|||
46799984|NCT00120289|83019001|FG001|Overall Study|Lost to Follow-up|14|||
46799985|NCT00120289|83019000|FG000|Overall Study|Withdrawal by Subject|14|||
46799986|NCT00120289|83019001|FG001|Overall Study|Withdrawal by Subject|13|||
46799987|NCT00550446|83019014|FG000|Up To Week 12|Adverse Event|2|||
46799988|NCT00550446|83019015|FG001|Up To Week 12|Adverse Event|2|||
46799989|NCT00550446|83019016|FG002|Up To Week 12|Adverse Event|0|||
46799990|NCT00550446|83019017|FG003|Up To Week 12|Adverse Event|0|||
46799991|NCT00550446|83019018|FG004|Up To Week 12|Adverse Event|2|||
46799992|NCT00550446|83019019|FG005|Up To Week 12|Adverse Event|2|||
46799993|NCT00550446|83019020|FG006|Up To Week 12|Adverse Event|1|||
46799994|NCT00550446|83019021|FG007|Up To Week 12|Adverse Event|0|||
46799995|NCT00550446|83019022|FG008|Up To Week 12|Adverse Event|0|||
46799996|NCT00550446|83019023|FG009|Up To Week 12|Adverse Event|0|||
46799997|NCT00550446|83019024|FG010|Up To Week 12|Adverse Event|0|||
46799998|NCT00550446|83019014|FG000|Up To Week 12|Lack of Efficacy|3|||
46799999|NCT00550446|83019015|FG001|Up To Week 12|Lack of Efficacy|1|||
46800000|NCT00550446|83019016|FG002|Up To Week 12|Lack of Efficacy|0|||
46800001|NCT00550446|83019017|FG003|Up To Week 12|Lack of Efficacy|1|||
46800002|NCT00550446|83019018|FG004|Up To Week 12|Lack of Efficacy|0|||
46800003|NCT00550446|83019019|FG005|Up To Week 12|Lack of Efficacy|3|||
46800004|NCT00550446|83019020|FG006|Up To Week 12|Lack of Efficacy|3|||
46800005|NCT00550446|83019021|FG007|Up To Week 12|Lack of Efficacy|0|||
46800006|NCT00550446|83019022|FG008|Up To Week 12|Lack of Efficacy|0|||
46800007|NCT00550446|83019023|FG009|Up To Week 12|Lack of Efficacy|0|||
46800008|NCT00550446|83019024|FG010|Up To Week 12|Lack of Efficacy|0|||
46800009|NCT00550446|83019014|FG000|Up To Week 12|Lost to Follow-up|0|||
46800010|NCT00550446|83019015|FG001|Up To Week 12|Lost to Follow-up|1|||
46800011|NCT00550446|83019016|FG002|Up To Week 12|Lost to Follow-up|0|||
46800012|NCT00550446|83019017|FG003|Up To Week 12|Lost to Follow-up|0|||
46800013|NCT00550446|83019018|FG004|Up To Week 12|Lost to Follow-up|1|||
46800014|NCT00550446|83019019|FG005|Up To Week 12|Lost to Follow-up|1|||
46800015|NCT00550446|83019020|FG006|Up To Week 12|Lost to Follow-up|2|||
46800016|NCT00550446|83019021|FG007|Up To Week 12|Lost to Follow-up|0|||
46800017|NCT00550446|83019022|FG008|Up To Week 12|Lost to Follow-up|0|||
46800018|NCT00550446|83019023|FG009|Up To Week 12|Lost to Follow-up|0|||
46800019|NCT00550446|83019024|FG010|Up To Week 12|Lost to Follow-up|0|||
46800020|NCT00550446|83019014|FG000|Up To Week 12|Withdrawal by Subject|2|||
46800021|NCT00550446|83019015|FG001|Up To Week 12|Withdrawal by Subject|0|||
46800022|NCT00550446|83019016|FG002|Up To Week 12|Withdrawal by Subject|3|||
46800023|NCT00550446|83019017|FG003|Up To Week 12|Withdrawal by Subject|2|||
46800024|NCT00550446|83019018|FG004|Up To Week 12|Withdrawal by Subject|0|||
46858679|NCT03262012|83074398|FG003|Overall Study|Lack of Efficacy|2|||
46858680|NCT03262012|83074395|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
46858681|NCT03262012|83074396|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
46800025|NCT00550446|83019019|FG005|Up To Week 12|Withdrawal by Subject|1|||
46800026|NCT00550446|83019020|FG006|Up To Week 12|Withdrawal by Subject|3|||
46800027|NCT00550446|83019021|FG007|Up To Week 12|Withdrawal by Subject|0|||
46800028|NCT00550446|83019022|FG008|Up To Week 12|Withdrawal by Subject|0|||
46800029|NCT00550446|83019023|FG009|Up To Week 12|Withdrawal by Subject|0|||
46688934|NCT01036438|82903851|FG001|Overall Study|Death|1|||
46688935|NCT01036438|82903850|FG000|Overall Study|No effect of study treatment|3|||
46800030|NCT00550446|83019024|FG010|Up To Week 12|Withdrawal by Subject|0|||
46800031|NCT00550446|83019014|FG000|Up To Week 12|Other|3|||
46800032|NCT00550446|83019015|FG001|Up To Week 12|Other|0|||
46800033|NCT00550446|83019016|FG002|Up To Week 12|Other|0|||
46800034|NCT00550446|83019017|FG003|Up To Week 12|Other|0|||
46800035|NCT00550446|83019018|FG004|Up To Week 12|Other|0|||
46688936|NCT01036438|82903851|FG001|Overall Study|No effect of study treatment|1|||
46688937|NCT01268046|82903861|FG000|Overall Study|Withdrawal by Subject|1|||
46688938|NCT01268046|82903862|FG001|Overall Study|Withdrawal by Subject|0|||
46688939|NCT01268046|82903863|FG002|Overall Study|Withdrawal by Subject|0|||
46858682|NCT03262012|83074397|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
46858683|NCT03262012|83074398|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
46858684|NCT03288142|83074410|FG000|Overall Study|Lost to Follow-up|22|||
46858685|NCT03288142|83074411|FG001|Overall Study|Lost to Follow-up|15|||
46858686|NCT00310817|83074423|FG000|Overall Study|AE or Death|3|||
46858687|NCT00310817|83074424|FG001|Overall Study|AE or Death|1|||
46858688|NCT00310817|83074425|FG002|Overall Study|AE or Death|0|||
46858689|NCT00310817|83074426|FG003|Overall Study|AE or Death|0|||
46858690|NCT00310817|83074423|FG000|Overall Study|Withdrawal by Subject|1|||
46858691|NCT00310817|83074424|FG001|Overall Study|Withdrawal by Subject|4|||
46858692|NCT00310817|83074425|FG002|Overall Study|Withdrawal by Subject|6|||
46858693|NCT00310817|83074426|FG003|Overall Study|Withdrawal by Subject|7|||
46858694|NCT00310817|83074423|FG000|Overall Study|Lost to Follow-up|2|||
46858695|NCT00310817|83074424|FG001|Overall Study|Lost to Follow-up|1|||
46800036|NCT00550446|83019019|FG005|Up To Week 12|Other|1|||
46800037|NCT00550446|83019020|FG006|Up To Week 12|Other|4|||
46800038|NCT00550446|83019021|FG007|Up To Week 12|Other|0|||
46800039|NCT00550446|83019022|FG008|Up To Week 12|Other|0|||
46800040|NCT00550446|83019023|FG009|Up To Week 12|Other|0|||
46800041|NCT00550446|83019024|FG010|Up To Week 12|Other|0|||
46800042|NCT00550446|83019014|FG000|Up To Week 12|Randomized not treated|0|||
46800043|NCT00550446|83019015|FG001|Up To Week 12|Randomized not treated|1|||
46800044|NCT00550446|83019016|FG002|Up To Week 12|Randomized not treated|1|||
46800045|NCT00550446|83019017|FG003|Up To Week 12|Randomized not treated|0|||
46800046|NCT00550446|83019018|FG004|Up To Week 12|Randomized not treated|0|||
46800047|NCT00550446|83019019|FG005|Up To Week 12|Randomized not treated|0|||
46858696|NCT00310817|83074425|FG002|Overall Study|Lost to Follow-up|0|||
46858697|NCT00310817|83074426|FG003|Overall Study|Lost to Follow-up|0|||
46858698|NCT00310817|83074423|FG000|Overall Study|Inappropriate Enrollment|1|||
46858699|NCT00310817|83074424|FG001|Overall Study|Inappropriate Enrollment|0|||
46858700|NCT00310817|83074425|FG002|Overall Study|Inappropriate Enrollment|1|||
46688940|NCT01268046|82903864|FG003|Overall Study|Withdrawal by Subject|1|||
46688941|NCT01268046|82903861|FG000|Overall Study|Lost to Follow-up|0|||
46688942|NCT01268046|82903862|FG001|Overall Study|Lost to Follow-up|0|||
46688943|NCT01268046|82903863|FG002|Overall Study|Lost to Follow-up|1|||
46688944|NCT01268046|82903864|FG003|Overall Study|Lost to Follow-up|0|||
46688945|NCT01267266|82903874|FG000|Enrollment Phase|Withdrawal by Subject|2|||
46688946|NCT01267266|82903875|FG001|Enrollment Phase|Withdrawal by Subject|0|||
46688947|NCT01267266|82903874|FG000|Lead-in Phase|Lack of Efficacy|20|||
46688948|NCT01267266|82903875|FG001|Lead-in Phase|Lack of Efficacy|0|||
46688949|NCT01267266|82903874|FG000|Lead-in Phase|Adverse Event|2|||
46688950|NCT01267266|82903875|FG001|Lead-in Phase|Adverse Event|0|||
46688951|NCT01267266|82903874|FG000|Lead-in Phase|Withdrawal by Subject|1|||
46688952|NCT01267266|82903875|FG001|Lead-in Phase|Withdrawal by Subject|0|||
46800048|NCT00550446|83019020|FG006|Up To Week 12|Randomized not treated|0|||
46800049|NCT00550446|83019021|FG007|Up To Week 12|Randomized not treated|0|||
46800050|NCT00550446|83019022|FG008|Up To Week 12|Randomized not treated|0|||
46858701|NCT00310817|83074426|FG003|Overall Study|Inappropriate Enrollment|0|||
46858702|NCT00310817|83074423|FG000|Overall Study|Protocol Violation|1|||
46858703|NCT00310817|83074424|FG001|Overall Study|Protocol Violation|1|||
46858704|NCT00310817|83074425|FG002|Overall Study|Protocol Violation|1|||
46858705|NCT00310817|83074426|FG003|Overall Study|Protocol Violation|1|||
46858706|NCT00310817|83074423|FG000|Overall Study|Unable to classify|3|||
46858707|NCT00310817|83074424|FG001|Overall Study|Unable to classify|1|||
46688953|NCT01034176|82903886|FG000|Overall Study|Physician Decision|2|||
46688954|NCT01034176|82903887|FG001|Overall Study|Physician Decision|0|||
46688955|NCT01034176|82903886|FG000|Overall Study|Withdrawal by Subject|0|||
46688956|NCT01034176|82903887|FG001|Overall Study|Withdrawal by Subject|1|||
46688957|NCT01034176|82903886|FG000|Overall Study|Lost to Follow-up|0|||
46688958|NCT01034176|82903887|FG001|Overall Study|Lost to Follow-up|1|||
46800051|NCT00550446|83019023|FG009|Up To Week 12|Randomized not treated|0|||
46800052|NCT00550446|83019024|FG010|Up To Week 12|Randomized not treated|0|||
46858708|NCT00310817|83074425|FG002|Overall Study|Unable to classify|0|||
46858709|NCT00310817|83074426|FG003|Overall Study|Unable to classify|0|||
46858710|NCT02940886|83074471|FG000|Overall Study|Adverse Event|7|||
46688959|NCT01033942|82903896|FG000|Overall Study|Withdrawal by Subject|1|||
46688960|NCT01033942|82903897|FG001|Overall Study|Withdrawal by Subject|1|||
46688961|NCT01033942|82903898|FG002|Overall Study|Withdrawal by Subject|1|||
46688962|NCT01033942|82903896|FG000|Overall Study|Lost to Follow-up|1|||
46688963|NCT01033942|82903897|FG001|Overall Study|Lost to Follow-up|0|||
46688964|NCT01033942|82903898|FG002|Overall Study|Lost to Follow-up|0|||
46800053|NCT00550446|83019014|FG000|Post Week 12|Adverse Event|2|||
46800054|NCT00550446|83019015|FG001|Post Week 12|Adverse Event|1|||
46800055|NCT00550446|83019016|FG002|Post Week 12|Adverse Event|1|||
46800056|NCT00550446|83019017|FG003|Post Week 12|Adverse Event|1|||
46800057|NCT00550446|83019018|FG004|Post Week 12|Adverse Event|1|||
46800058|NCT00550446|83019019|FG005|Post Week 12|Adverse Event|1|||
46800059|NCT00550446|83019020|FG006|Post Week 12|Adverse Event|0|||
46800060|NCT00550446|83019021|FG007|Post Week 12|Adverse Event|0|||
46800061|NCT00550446|83019022|FG008|Post Week 12|Adverse Event|0|||
46800062|NCT00550446|83019023|FG009|Post Week 12|Adverse Event|4|||
46800063|NCT00550446|83019024|FG010|Post Week 12|Adverse Event|0|||
46800064|NCT00550446|83019014|FG000|Post Week 12|Lack of Efficacy|0|||
46800065|NCT00550446|83019015|FG001|Post Week 12|Lack of Efficacy|0|||
46800066|NCT00550446|83019016|FG002|Post Week 12|Lack of Efficacy|1|||
46800067|NCT00550446|83019017|FG003|Post Week 12|Lack of Efficacy|0|||
46800068|NCT00550446|83019018|FG004|Post Week 12|Lack of Efficacy|0|||
46800069|NCT00550446|83019019|FG005|Post Week 12|Lack of Efficacy|0|||
46800070|NCT00550446|83019020|FG006|Post Week 12|Lack of Efficacy|0|||
46858711|NCT02940886|83074472|FG001|Overall Study|Adverse Event|3|||
46858712|NCT02940886|83074471|FG000|Overall Study|Protocol Violation|0|||
46858713|NCT02940886|83074472|FG001|Overall Study|Protocol Violation|2|||
46858714|NCT02940886|83074471|FG000|Overall Study|Withdrawal by Subject|28|||
46858715|NCT02940886|83074472|FG001|Overall Study|Withdrawal by Subject|20|||
46858716|NCT02940886|83074471|FG000|Overall Study|Death|1|||
46858717|NCT02940886|83074472|FG001|Overall Study|Death|0|||
46858718|NCT02940886|83074471|FG000|Overall Study|Lack of Efficacy|1|||
46858719|NCT02940886|83074472|FG001|Overall Study|Lack of Efficacy|0|||
46858720|NCT02940886|83074471|FG000|Overall Study|Lost to Follow-up|49|||
46688965|NCT01033942|82903896|FG000|Overall Study|Enrolled in Extension Study|0|||
46688966|NCT01033942|82903897|FG001|Overall Study|Enrolled in Extension Study|3|||
46688967|NCT01033942|82903898|FG002|Overall Study|Enrolled in Extension Study|0|||
46688968|NCT01062256|82903911|FG000|Overall Study|Adverse Event|1|||
46688969|NCT01062256|82903912|FG001|Overall Study|Adverse Event|0|||
46688970|NCT01062256|82903913|FG002|Overall Study|Adverse Event|0|||
46688971|NCT01062256|82903911|FG000|Overall Study|Withdrawal by Subject|1|||
46688972|NCT01062256|82903912|FG001|Overall Study|Withdrawal by Subject|1|||
46688973|NCT01062256|82903913|FG002|Overall Study|Withdrawal by Subject|1|||
46688974|NCT01062256|82903911|FG000|Overall Study|Ineligible|1|||
46688975|NCT01062256|82903912|FG001|Overall Study|Ineligible|4|||
46688976|NCT01062256|82903913|FG002|Overall Study|Ineligible|3|||
46688977|NCT01062256|82903911|FG000|Overall Study|Administrative|0|||
46688978|NCT01062256|82903912|FG001|Overall Study|Administrative|2|||
46688979|NCT01062256|82903913|FG002|Overall Study|Administrative|0|||
46688980|NCT01029886|82903923|FG000|Overall Study|Adverse Event|12|||
46688981|NCT01029886|82903924|FG001|Overall Study|Adverse Event|25|||
46800071|NCT00550446|83019021|FG007|Post Week 12|Lack of Efficacy|1|||
46800072|NCT00550446|83019022|FG008|Post Week 12|Lack of Efficacy|1|||
46800073|NCT00550446|83019023|FG009|Post Week 12|Lack of Efficacy|2|||
46800074|NCT00550446|83019024|FG010|Post Week 12|Lack of Efficacy|1|||
46981893|NCT02399163|83228011|FG000|Overall Study|Withdrawal by Participant|5|||
46981894|NCT02398227|83228025|FG000|Overall Study|Lost to Follow-up|21|||
46688982|NCT01029886|82903923|FG000|Overall Study|Lost to Follow-up|1|||
46688983|NCT01029886|82903924|FG001|Overall Study|Lost to Follow-up|0|||
46800075|NCT00550446|83019014|FG000|Post Week 12|Lost to Follow-up|0|||
46800076|NCT00550446|83019015|FG001|Post Week 12|Lost to Follow-up|0|||
46858721|NCT02940886|83074472|FG001|Overall Study|Lost to Follow-up|21|||
46688984|NCT01029886|82903923|FG000|Overall Study|Physician Decision|2|||
46800077|NCT00550446|83019016|FG002|Post Week 12|Lost to Follow-up|1|||
46800078|NCT00550446|83019017|FG003|Post Week 12|Lost to Follow-up|1|||
46858722|NCT02940886|83074471|FG000|Overall Study|Physician Decision|9|||
46858723|NCT02940886|83074472|FG001|Overall Study|Physician Decision|4|||
46688985|NCT01029886|82903924|FG001|Overall Study|Physician Decision|6|||
46688986|NCT01029886|82903923|FG000|Overall Study|Protocol Violation|17|||
46688987|NCT01029886|82903924|FG001|Overall Study|Protocol Violation|5|||
46688988|NCT01029886|82903923|FG000|Overall Study|Withdrawal by Subject|8|||
46688989|NCT01029886|82903924|FG001|Overall Study|Withdrawal by Subject|18|||
46688990|NCT01029886|82903923|FG000|Overall Study|Entry Criteria Not Met|13|||
46688991|NCT01029886|82903924|FG001|Overall Study|Entry Criteria Not Met|5|||
46688992|NCT01029886|82903923|FG000|Overall Study|Sponsor Decision|1|||
46688993|NCT01029886|82903924|FG001|Overall Study|Sponsor Decision|0|||
46688994|NCT01029886|82903923|FG000|Overall Study|Loss Glucose Control|7|||
46688995|NCT01029886|82903924|FG001|Overall Study|Loss Glucose Control|1|||
46688996|NCT01244763|82903940|FG000|Overall Study|Adverse Event|1|||
46688997|NCT01244763|82903941|FG001|Overall Study|Adverse Event|0|||
46688998|NCT01244763|82903942|FG002|Overall Study|Adverse Event|0|||
46688999|NCT01244763|82903943|FG003|Overall Study|Adverse Event|0|||
46689000|NCT01244763|82903944|FG004|Overall Study|Adverse Event|0|||
46689001|NCT01244763|82903945|FG005|Overall Study|Adverse Event|1|||
46689002|NCT01244763|82903940|FG000|Overall Study|Death|1|||
46689003|NCT01244763|82903941|FG001|Overall Study|Death|0|||
46689004|NCT01244763|82903942|FG002|Overall Study|Death|1|||
46689005|NCT01244763|82903943|FG003|Overall Study|Death|0|||
46689006|NCT01244763|82903944|FG004|Overall Study|Death|2|||
46689007|NCT01244763|82903945|FG005|Overall Study|Death|0|||
46689008|NCT01244763|82903940|FG000|Overall Study|Physician Decision|0|||
46689009|NCT01244763|82903941|FG001|Overall Study|Physician Decision|0|||
46689010|NCT01244763|82903942|FG002|Overall Study|Physician Decision|1|||
46689011|NCT01244763|82903943|FG003|Overall Study|Physician Decision|0|||
46689012|NCT01244763|82903944|FG004|Overall Study|Physician Decision|0|||
46689013|NCT01244763|82903945|FG005|Overall Study|Physician Decision|0|||
46689014|NCT01244763|82903940|FG000|Overall Study|Withdrawal by Subject|1|||
46689015|NCT01244763|82903941|FG001|Overall Study|Withdrawal by Subject|2|||
46689016|NCT01244763|82903942|FG002|Overall Study|Withdrawal by Subject|0|||
46689017|NCT01244763|82903943|FG003|Overall Study|Withdrawal by Subject|1|||
46689018|NCT01244763|82903944|FG004|Overall Study|Withdrawal by Subject|1|||
46689019|NCT01244763|82903945|FG005|Overall Study|Withdrawal by Subject|2|||
46689020|NCT01244763|82903940|FG000|Overall Study|Lost to Follow-up|0|||
46689021|NCT01244763|82903941|FG001|Overall Study|Lost to Follow-up|1|||
46689022|NCT01244763|82903942|FG002|Overall Study|Lost to Follow-up|0|||
46689023|NCT01244763|82903943|FG003|Overall Study|Lost to Follow-up|0|||
46689024|NCT01244763|82903944|FG004|Overall Study|Lost to Follow-up|0|||
46689025|NCT01244763|82903945|FG005|Overall Study|Lost to Follow-up|0|||
46689026|NCT01244763|82903940|FG000|Overall Study|Enrolled into the Extension Study|0|||
46689027|NCT01244763|82903941|FG001|Overall Study|Enrolled into the Extension Study|0|||
46689028|NCT01244763|82903942|FG002|Overall Study|Enrolled into the Extension Study|0|||
46689029|NCT01244763|82903943|FG003|Overall Study|Enrolled into the Extension Study|0|||
46689030|NCT01244763|82903944|FG004|Overall Study|Enrolled into the Extension Study|0|||
46858724|NCT02940886|83074471|FG000|Overall Study|Sponsor decision|0|||
46858725|NCT02940886|83074472|FG001|Overall Study|Sponsor decision|1|||
46689031|NCT01244763|82903945|FG005|Overall Study|Enrolled into the Extension Study|1|||
46689032|NCT01244061|82903961|FG000|Overall Study|Death|1|||
46689033|NCT01244061|82903962|FG001|Overall Study|Death|0|||
46689034|NCT01244061|82903961|FG000|Overall Study|Did not meet entrance criteria|1|||
46689035|NCT01244061|82903962|FG001|Overall Study|Did not meet entrance criteria|0|||
46858726|NCT02940886|83074471|FG000|Overall Study|No treatment|7|||
46689036|NCT01244061|82903961|FG000|Overall Study|Lack of Efficacy|1|||
46689037|NCT01244061|82903962|FG001|Overall Study|Lack of Efficacy|3|||
46689038|NCT01244061|82903961|FG000|Overall Study|Lost to Follow-up|34|||
46689039|NCT01244061|82903962|FG001|Overall Study|Lost to Follow-up|30|||
46689040|NCT01244061|82903961|FG000|Overall Study|Withdrawal by Subject|29|||
46689041|NCT01244061|82903962|FG001|Overall Study|Withdrawal by Subject|46|||
46689042|NCT01244061|82903961|FG000|Overall Study|Other|8|||
46689043|NCT01244061|82903962|FG001|Overall Study|Other|19|||
46689044|NCT01244061|82903961|FG000|Overall Study|Protocol Violation|1|||
46689045|NCT01244061|82903962|FG001|Overall Study|Protocol Violation|1|||
46689046|NCT01244061|82903961|FG000|Overall Study|Adverse Event|5|||
46689047|NCT01244061|82903962|FG001|Overall Study|Adverse Event|2|||
46689048|NCT01244061|82903961|FG000|Overall Study|Randomized but not treated|2|||
46689049|NCT01244061|82903962|FG001|Overall Study|Randomized but not treated|2|||
46689050|NCT01243671|82903968|FG000|Overall Study|Adverse Event|3|||
46689051|NCT01243671|82903968|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
46689052|NCT01243671|82903968|FG000|Overall Study|Other|1|||
46689053|NCT01240785|82903974|FG000|Overall Study|Lost to Follow-up|1|||
46800079|NCT00550446|83019018|FG004|Post Week 12|Lost to Follow-up|0|||
46800080|NCT00550446|83019019|FG005|Post Week 12|Lost to Follow-up|0|||
46800081|NCT00550446|83019020|FG006|Post Week 12|Lost to Follow-up|1|||
46800082|NCT00550446|83019021|FG007|Post Week 12|Lost to Follow-up|0|||
46800083|NCT00550446|83019022|FG008|Post Week 12|Lost to Follow-up|0|||
46981895|NCT02398227|83228026|FG001|Overall Study|Lost to Follow-up|12|||
46981896|NCT02398227|83228025|FG000|Overall Study|Withdrawal by Subject|5|||
46981897|NCT02398227|83228026|FG001|Overall Study|Withdrawal by Subject|6|||
46981898|NCT02398227|83228025|FG000|Overall Study|Removed from treatment and dropped out|1|||
46981899|NCT02398227|83228026|FG001|Overall Study|Removed from treatment and dropped out|0|||
46981900|NCT02397915|83228032|FG000|Period 1|Protocol Violation|0|||
46689054|NCT01240785|82903975|FG001|Overall Study|Lost to Follow-up|0|||
46689055|NCT01240785|82903974|FG000|Overall Study|Protocol Violation|0|||
46800084|NCT00550446|83019023|FG009|Post Week 12|Lost to Follow-up|0|||
46800085|NCT00550446|83019024|FG010|Post Week 12|Lost to Follow-up|0|||
46689056|NCT01240785|82903975|FG001|Overall Study|Protocol Violation|3|||
46689057|NCT01240551|82903983|FG000|Overall Study|Refused further treatment|3|||
46689058|NCT01240551|82903984|FG001|Overall Study|Refused further treatment|2|||
46689059|NCT01240551|82903983|FG000|Overall Study|Lost to Follow-up|1|||
46689060|NCT01240551|82903984|FG001|Overall Study|Lost to Follow-up|1|||
46689061|NCT01239381|82903990|FG000|Overall Study|Protocol Violation|1|||
46689062|NCT01239381|82903990|FG000|Overall Study|Withdrawal by Subject|1|||
46689063|NCT01266876|82904000|FG000|Overall Study|Adverse Event|0|||
46689064|NCT01266876|82904001|FG001|Overall Study|Adverse Event|0|||
46689065|NCT01266876|82904002|FG002|Overall Study|Adverse Event|0|||
46689066|NCT01266876|82904003|FG003|Overall Study|Adverse Event|1|||
46689067|NCT01266876|82904004|FG004|Overall Study|Adverse Event|0|||
46689068|NCT01033240|82904019|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
46689069|NCT01033240|82904020|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
46689070|NCT01033240|82904021|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
46689071|NCT01033240|82904019|FG000|Overall Study|Death|2|||
46689072|NCT01033240|82904020|FG001|Overall Study|Death|0|||
46689073|NCT01033240|82904021|FG002|Overall Study|Death|0|||
46689074|NCT01033240|82904019|FG000|Overall Study|Withdrew Consent|2|||
46689075|NCT01033240|82904020|FG001|Overall Study|Withdrew Consent|9|||
46689076|NCT01033240|82904021|FG002|Overall Study|Withdrew Consent|2|||
46689077|NCT01033240|82904019|FG000|Overall Study|Disease Progression|35|||
46800086|NCT00550446|83019014|FG000|Post Week 12|Withdrawal by Subject|0|||
46800087|NCT00550446|83019015|FG001|Post Week 12|Withdrawal by Subject|0|||
46800088|NCT00550446|83019016|FG002|Post Week 12|Withdrawal by Subject|0|||
46800089|NCT00550446|83019017|FG003|Post Week 12|Withdrawal by Subject|0|||
46800090|NCT00550446|83019018|FG004|Post Week 12|Withdrawal by Subject|1|||
46800091|NCT00550446|83019019|FG005|Post Week 12|Withdrawal by Subject|0|||
46800092|NCT00550446|83019020|FG006|Post Week 12|Withdrawal by Subject|0|||
46800093|NCT00550446|83019021|FG007|Post Week 12|Withdrawal by Subject|0|||
46800094|NCT00550446|83019022|FG008|Post Week 12|Withdrawal by Subject|0|||
46800095|NCT00550446|83019023|FG009|Post Week 12|Withdrawal by Subject|0|||
46800096|NCT00550446|83019024|FG010|Post Week 12|Withdrawal by Subject|0|||
46800097|NCT00550446|83019014|FG000|Post Week 12|Other|1|||
46800098|NCT00550446|83019015|FG001|Post Week 12|Other|1|||
46800099|NCT00550446|83019016|FG002|Post Week 12|Other|0|||
46800100|NCT00550446|83019017|FG003|Post Week 12|Other|1|||
46800101|NCT00550446|83019018|FG004|Post Week 12|Other|0|||
46800102|NCT00550446|83019019|FG005|Post Week 12|Other|0|||
46800103|NCT00550446|83019020|FG006|Post Week 12|Other|1|||
46800104|NCT00550446|83019021|FG007|Post Week 12|Other|0|||
46800105|NCT00550446|83019022|FG008|Post Week 12|Other|1|||
46800106|NCT00550446|83019023|FG009|Post Week 12|Other|1|||
46800107|NCT00550446|83019024|FG010|Post Week 12|Other|0|||
46800108|NCT00436618|83019065|FG000|Overall Study|Withdrawal by Subject|5|||
46800109|NCT00436618|83019066|FG001|Overall Study|Withdrawal by Subject|8|||
46800110|NCT00436618|83019067|FG002|Overall Study|Withdrawal by Subject|11|||
46800111|NCT00436618|83019065|FG000|Overall Study|Adverse Event|8|||
46800112|NCT00436618|83019066|FG001|Overall Study|Adverse Event|8|||
46800113|NCT00436618|83019067|FG002|Overall Study|Adverse Event|9|||
46800114|NCT00436618|83019065|FG000|Overall Study|Alternate Treatment|3|||
46689078|NCT01033240|82904020|FG001|Overall Study|Disease Progression|32|||
46689079|NCT01033240|82904021|FG002|Overall Study|Disease Progression|41|||
46800115|NCT00436618|83019066|FG001|Overall Study|Alternate Treatment|4|||
46800116|NCT00436618|83019067|FG002|Overall Study|Alternate Treatment|12|||
46800117|NCT00436618|83019065|FG000|Overall Study|Other Medical Problems|3|||
46800118|NCT00436618|83019066|FG001|Overall Study|Other Medical Problems|1|||
46689080|NCT01033240|82904019|FG000|Overall Study|Investigator Discretion|0|||
46689081|NCT01033240|82904020|FG001|Overall Study|Investigator Discretion|0|||
46800119|NCT00436618|83019067|FG002|Overall Study|Other Medical Problems|7|||
46800120|NCT00436618|83019065|FG000|Overall Study|Death|4|||
46689082|NCT01033240|82904021|FG002|Overall Study|Investigator Discretion|2|||
46689083|NCT01033240|82904019|FG000|Overall Study|Other|0|||
46689084|NCT01033240|82904020|FG001|Overall Study|Other|1|||
46689085|NCT01033240|82904021|FG002|Overall Study|Other|2|||
46689086|NCT01266018|82904029|FG000|Overall Study|Physician Decision|1|||
46800121|NCT00436618|83019066|FG001|Overall Study|Death|2|||
46800122|NCT00436618|83019067|FG002|Overall Study|Death|3|||
46800123|NCT00436618|83019065|FG000|Overall Study|New Primary or Other Reasons|6|||
46689087|NCT01266018|82904030|FG001|Overall Study|Physician Decision|0|||
46689088|NCT01266018|82904029|FG000|Overall Study|Progressive disease|0|||
46689089|NCT01266018|82904030|FG001|Overall Study|Progressive disease|1|||
46689090|NCT01032382|82904038|FG000|Overall Study|Disease dissemination|1|||
46689091|NCT01032382|82904039|FG001|Overall Study|Disease dissemination|1|||
46689092|NCT01032382|82904038|FG000|Overall Study|Treatment failure|3|||
46689093|NCT01032382|82904039|FG001|Overall Study|Treatment failure|1|||
46689094|NCT01032382|82904038|FG000|Overall Study|Index lesion relapse|1|||
46689095|NCT01032382|82904039|FG001|Overall Study|Index lesion relapse|3|||
46689096|NCT01029652|82904047|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
46689097|NCT01029652|82904048|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
46689098|NCT01029652|82904047|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
46689099|NCT01029652|82904048|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
46689100|NCT01029652|82904047|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
46689101|NCT01029652|82904048|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
46689102|NCT01029652|82904047|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
46689103|NCT01029652|82904048|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
46689104|NCT01029652|82904047|FG000|Core Study (0-12 Weeks)|Death|0|||
46689105|NCT01029652|82904048|FG001|Core Study (0-12 Weeks)|Death|1|||
46689106|NCT01029652|82904047|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
46689107|NCT01029652|82904048|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
46689108|NCT01029652|82904047|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
46689109|NCT01029652|82904048|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
46689110|NCT01029652|82904047|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
46689111|NCT01029652|82904048|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
46689112|NCT01029652|82904047|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
46689113|NCT01029652|82904048|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
46689114|NCT01029652|82904047|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
46689115|NCT01029652|82904048|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
46689116|NCT01029652|82904047|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
46689117|NCT01029652|82904048|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
46689118|NCT01029652|82904047|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
46689119|NCT01029652|82904048|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
46689120|NCT01029340|82904077|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
46689121|NCT01029340|82904078|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
46689122|NCT01029340|82904079|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
46689123|NCT01029340|82904080|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
46689124|NCT01029340|82904081|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
46689125|NCT01029340|82904082|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
46689126|NCT01029340|82904077|FG000|Part B Treatment Period|Protocol Violation|0|||
46689127|NCT01029340|82904078|FG001|Part B Treatment Period|Protocol Violation|0|||
46689128|NCT01029340|82904079|FG002|Part B Treatment Period|Protocol Violation|1|||
46689129|NCT01029340|82904080|FG003|Part B Treatment Period|Protocol Violation|0|||
46689130|NCT01029340|82904081|FG004|Part B Treatment Period|Protocol Violation|0|||
46689131|NCT01029340|82904082|FG005|Part B Treatment Period|Protocol Violation|0|||
46800124|NCT00436618|83019066|FG001|Overall Study|New Primary or Other Reasons|2|||
46800125|NCT00436618|83019067|FG002|Overall Study|New Primary or Other Reasons|12|||
46981901|NCT02397915|83228033|FG001|Period 1|Protocol Violation|1|||
46981902|NCT02397915|83228034|FG002|Period 1|Protocol Violation|0|||
46689132|NCT01029340|82904077|FG000|Extension Period|Adverse Event|0|||
46800126|NCT00436618|83019065|FG000|Overall Study|Still on treatment|1|||
46689133|NCT01029340|82904078|FG001|Extension Period|Adverse Event|0|||
46689134|NCT01029340|82904079|FG002|Extension Period|Adverse Event|0|||
46689135|NCT01029340|82904080|FG003|Extension Period|Adverse Event|0|||
46689136|NCT01029340|82904081|FG004|Extension Period|Adverse Event|0|||
46981903|NCT02397915|83228035|FG003|Period 1|Protocol Violation|0|||
46689137|NCT01029340|82904082|FG005|Extension Period|Adverse Event|1|||
46689138|NCT01029340|82904077|FG000|Extension Period|starting another study|0|||
46689139|NCT01029340|82904078|FG001|Extension Period|starting another study|0|||
46689140|NCT01029340|82904079|FG002|Extension Period|starting another study|0|||
46689141|NCT01029340|82904080|FG003|Extension Period|starting another study|0|||
46689142|NCT01029340|82904081|FG004|Extension Period|starting another study|0|||
46689143|NCT01029340|82904082|FG005|Extension Period|starting another study|8|||
46689144|NCT01029340|82904077|FG000|Extension Period|non-compliance|0|||
46689145|NCT01029340|82904078|FG001|Extension Period|non-compliance|0|||
46689146|NCT01029340|82904079|FG002|Extension Period|non-compliance|0|||
46689147|NCT01029340|82904080|FG003|Extension Period|non-compliance|0|||
46689148|NCT01029340|82904081|FG004|Extension Period|non-compliance|0|||
46689149|NCT01029340|82904082|FG005|Extension Period|non-compliance|1|||
46689150|NCT01029340|82904077|FG000|Extension Period|Withdrawal by Subject|0|||
46689151|NCT01029340|82904078|FG001|Extension Period|Withdrawal by Subject|0|||
46689152|NCT01029340|82904079|FG002|Extension Period|Withdrawal by Subject|0|||
46689153|NCT01029340|82904080|FG003|Extension Period|Withdrawal by Subject|0|||
46689154|NCT01029340|82904081|FG004|Extension Period|Withdrawal by Subject|0|||
46689155|NCT01029340|82904082|FG005|Extension Period|Withdrawal by Subject|1|||
46689156|NCT01029340|82904077|FG000|Extension Period|Physician Decision|0|||
46689157|NCT01029340|82904078|FG001|Extension Period|Physician Decision|0|||
46689158|NCT01029340|82904079|FG002|Extension Period|Physician Decision|0|||
46689159|NCT01029340|82904080|FG003|Extension Period|Physician Decision|0|||
46689160|NCT01029340|82904081|FG004|Extension Period|Physician Decision|0|||
46689161|NCT01029340|82904082|FG005|Extension Period|Physician Decision|1|||
46689162|NCT01265550|82904099|FG000|Pre Randomization|Withdrawal by Subject|0|||
46858727|NCT02940886|83074472|FG001|Overall Study|No treatment|2|||
46858728|NCT02940886|83074471|FG000|Overall Study|Enrolment error|0|||
46858729|NCT02940886|83074472|FG001|Overall Study|Enrolment error|1|||
46858730|NCT03285958|83074482|FG000|Overall Study|Lost to Follow-up|1|||
46858731|NCT03285958|83074483|FG001|Overall Study|Lost to Follow-up|1|||
46858732|NCT03285958|83074482|FG000|Overall Study|Withdrawal by Subject|1|||
46858733|NCT03285958|83074483|FG001|Overall Study|Withdrawal by Subject|0|||
46858734|NCT03285958|83074482|FG000|Overall Study|Not able to attend required orientation|3|||
46858735|NCT03285958|83074483|FG001|Overall Study|Not able to attend required orientation|0|||
46858736|NCT03285646|83074492|FG000|Overall Study|Adverse Event|1|||
46858737|NCT03285646|83074493|FG001|Overall Study|Adverse Event|0|||
46689163|NCT01265550|82904100|FG001|Pre Randomization|Withdrawal by Subject|0|||
46689164|NCT01265550|82904101|FG002|Pre Randomization|Withdrawal by Subject|0|||
46689165|NCT01265550|82904102|FG003|Pre Randomization|Withdrawal by Subject|70|||
46858738|NCT03285646|83074492|FG000|Overall Study|Withdrawal by Subject|10|||
46858739|NCT03285646|83074493|FG001|Overall Study|Withdrawal by Subject|2|||
46689166|NCT01265550|82904099|FG000|Pre Randomization|Technical Exclusions|0|||
46689167|NCT01265550|82904100|FG001|Pre Randomization|Technical Exclusions|0|||
46689168|NCT01265550|82904101|FG002|Pre Randomization|Technical Exclusions|0|||
46689169|NCT01265550|82904102|FG003|Pre Randomization|Technical Exclusions|54|||
46858740|NCT03285646|83074492|FG000|Overall Study|Lost to Follow-up|2|||
46689170|NCT01265550|82904099|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
46689171|NCT01265550|82904100|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
46689172|NCT01265550|82904101|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
46689173|NCT01265550|82904102|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
46689174|NCT01265550|82904099|FG000|Pre Randomization|Non-GERD organic disorders|0|||
46689175|NCT01265550|82904100|FG001|Pre Randomization|Non-GERD organic disorders|0|||
46689176|NCT01265550|82904101|FG002|Pre Randomization|Non-GERD organic disorders|0|||
46689177|NCT01265550|82904102|FG003|Pre Randomization|Non-GERD organic disorders|23|||
46689178|NCT01265550|82904099|FG000|Pre Randomization|Functional heartburn|0|||
46689179|NCT01265550|82904100|FG001|Pre Randomization|Functional heartburn|0|||
46689180|NCT01265550|82904101|FG002|Pre Randomization|Functional heartburn|0|||
46689181|NCT01265550|82904102|FG003|Pre Randomization|Functional heartburn|99|||
46689182|NCT01265394|82904116|FG000|Overall Study|Subjects withdrawn|37|||
46689183|NCT01029262|82904123|FG000|Overall Study|Adverse Event|9|||
46689184|NCT01029262|82904124|FG001|Overall Study|Adverse Event|52|||
46689185|NCT01029262|82904123|FG000|Overall Study|Lack of therapeutic effect|57|||
46689186|NCT01029262|82904124|FG001|Overall Study|Lack of therapeutic effect|76|||
46689187|NCT01029262|82904123|FG000|Overall Study|Withdrawal by Subject|10|||
46689188|NCT01029262|82904124|FG001|Overall Study|Withdrawal by Subject|17|||
46689189|NCT01029262|82904123|FG000|Overall Study|Protocol Violation|2|||
46689190|NCT01029262|82904124|FG001|Overall Study|Protocol Violation|3|||
46689191|NCT01029262|82904123|FG000|Overall Study|Miscellaneous|1|||
46689192|NCT01029262|82904124|FG001|Overall Study|Miscellaneous|9|||
46689193|NCT01029262|82904123|FG000|Overall Study|Death|0|||
46689194|NCT01029262|82904124|FG001|Overall Study|Death|3|||
46689195|NCT01028560|82904137|FG000|Overall Study|Lack of Efficacy|3|||
46689196|NCT01028560|82904138|FG001|Overall Study|Lack of Efficacy|6|||
46689197|NCT01028560|82904137|FG000|Overall Study|Withdrawal by Subject|7|||
46689198|NCT01028560|82904138|FG001|Overall Study|Withdrawal by Subject|12|||
46689199|NCT01061710|82904145|FG000|Overall Study|Protocol Violation|14|||
46689200|NCT01028014|82904155|FG000|Overall Study|Lost to Follow-up|1|||
46689201|NCT01028014|82904156|FG001|Overall Study|Lost to Follow-up|2|||
46689202|NCT01028014|82904157|FG002|Overall Study|Lost to Follow-up|0|||
46689203|NCT01028014|82904158|FG003|Overall Study|Lost to Follow-up|1|||
46689204|NCT01028014|82904159|FG004|Overall Study|Lost to Follow-up|1|||
46689205|NCT01028014|82904160|FG005|Overall Study|Lost to Follow-up|2|||
46689206|NCT01264770|82904180|FG000|Overall Study|Not reported|0|||
46689207|NCT01264770|82904181|FG001|Overall Study|Not reported|0|||
46689208|NCT01264770|82904182|FG002|Overall Study|Not reported|1|||
46800127|NCT00436618|83019066|FG001|Overall Study|Still on treatment|2|||
46800128|NCT00436618|83019067|FG002|Overall Study|Still on treatment|7|||
46800129|NCT00548808|83019104|FG000|Overall Study|Lost to Follow-up|9|||
46858741|NCT03285646|83074493|FG001|Overall Study|Lost to Follow-up|1|||
46858742|NCT03285646|83074492|FG000|Overall Study|Investigator/Sponsor Decision|0|||
46800130|NCT00548808|83019105|FG001|Overall Study|Lost to Follow-up|3|||
46800131|NCT00548808|83019104|FG000|Overall Study|Protocol Violation|8|||
46800132|NCT00548808|83019105|FG001|Overall Study|Protocol Violation|8|||
46800133|NCT00548808|83019104|FG000|Overall Study|Withdrawal by Subject|8|||
46800134|NCT00548808|83019105|FG001|Overall Study|Withdrawal by Subject|4|||
46800135|NCT00548808|83019104|FG000|Overall Study|Physician Decision|6|||
46800136|NCT00548808|83019105|FG001|Overall Study|Physician Decision|3|||
46800137|NCT00548808|83019104|FG000|Overall Study|Adverse Event|4|||
46800138|NCT00548808|83019105|FG001|Overall Study|Adverse Event|5|||
46800139|NCT00548808|83019104|FG000|Overall Study|Death|2|||
46800140|NCT00548808|83019105|FG001|Overall Study|Death|0|||
46858743|NCT03285646|83074493|FG001|Overall Study|Investigator/Sponsor Decision|1|||
46800141|NCT00548808|83019104|FG000|Overall Study|Entry Criteria Not Met|2|||
46800142|NCT00548808|83019105|FG001|Overall Study|Entry Criteria Not Met|2|||
46689209|NCT01264770|82904183|FG003|Overall Study|Not reported|0|||
46689210|NCT01264770|82904184|FG004|Overall Study|Not reported|0|||
46689211|NCT01264770|82904185|FG005|Overall Study|Not reported|0|||
46689212|NCT01264770|82904180|FG000|Overall Study|e.g., change in circumstances|8|||
46689213|NCT01264770|82904181|FG001|Overall Study|e.g., change in circumstances|3|||
46689214|NCT01264770|82904182|FG002|Overall Study|e.g., change in circumstances|3|||
46800143|NCT00548808|83019104|FG000|Overall Study|Lack of Efficacy|2|||
46800144|NCT00548808|83019105|FG001|Overall Study|Lack of Efficacy|0|||
46800145|NCT00548808|83019104|FG000|Overall Study|Sponsor Decision|1|||
46689215|NCT01264770|82904183|FG003|Overall Study|e.g., change in circumstances|3|||
46858744|NCT03309202|83074504|FG000|Overall Study|Lost to Follow-up|1|||
46858745|NCT03309202|83074505|FG001|Overall Study|Lost to Follow-up|0|||
46858746|NCT03309202|83074506|FG002|Overall Study|Lost to Follow-up|0|||
46858747|NCT03309202|83074507|FG003|Overall Study|Lost to Follow-up|0|||
46858748|NCT00074490|83074522|FG000|Overall Study|Progressive malignancy|0|||
46858749|NCT00074490|83074523|FG001|Overall Study|Progressive malignancy|7|||
46858750|NCT00074490|83074524|FG002|Overall Study|Progressive malignancy|0|||
46858751|NCT00074490|83074525|FG003|Overall Study|Progressive malignancy|0|||
46858752|NCT00074490|83074526|FG004|Overall Study|Progressive malignancy|3|||
46858753|NCT00074490|83074527|FG005|Overall Study|Progressive malignancy|0|||
46858754|NCT03285490|83074542|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
46800146|NCT00548808|83019105|FG001|Overall Study|Sponsor Decision|1|||
46800147|NCT00110617|83019113|FG000|Overall Study|Adverse Event|2|||
46800148|NCT00110617|83019114|FG001|Overall Study|Adverse Event|4|||
46800149|NCT00110617|83019113|FG000|Overall Study|Abnormal Laboratory Value|4|||
46800150|NCT00110617|83019114|FG001|Overall Study|Abnormal Laboratory Value|2|||
46800151|NCT00110617|83019113|FG000|Overall Study|Lack of Efficacy|1|||
46800152|NCT00110617|83019114|FG001|Overall Study|Lack of Efficacy|0|||
46800153|NCT00110617|83019113|FG000|Overall Study|Patient no longer requires study drug|1|||
46800154|NCT00110617|83019114|FG001|Overall Study|Patient no longer requires study drug|0|||
46800155|NCT00110617|83019113|FG000|Overall Study|Protocol Violation|5|||
46800156|NCT00110617|83019114|FG001|Overall Study|Protocol Violation|0|||
46800157|NCT00110617|83019113|FG000|Overall Study|Withdrawal by Subject|10|||
46800158|NCT00110617|83019114|FG001|Overall Study|Withdrawal by Subject|4|||
46800159|NCT00110617|83019113|FG000|Overall Study|Lost to Follow-up|9|||
46800160|NCT00110617|83019114|FG001|Overall Study|Lost to Follow-up|1|||
46800161|NCT00110617|83019113|FG000|Overall Study|Administrative problems|6|||
46800162|NCT00110617|83019114|FG001|Overall Study|Administrative problems|5|||
46800163|NCT00110617|83019113|FG000|Overall Study|Death|1|||
46800164|NCT00110617|83019114|FG001|Overall Study|Death|1|||
46800165|NCT00110617|83019113|FG000|Overall Study|Did not receive study drug|0|||
46858755|NCT03285490|83074543|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
46800166|NCT00110617|83019114|FG001|Overall Study|Did not receive study drug|12|||
46800167|NCT03956862|83019124|FG000|Overall Study|Lost to Follow-up|1|||
46800168|NCT03956862|83019125|FG001|Overall Study|Lost to Follow-up|1|||
46800169|NCT03956862|83019124|FG000|Overall Study|Withdrawal by Subject|1|||
46800170|NCT03956862|83019125|FG001|Overall Study|Withdrawal by Subject|1|||
46981904|NCT02397915|83228032|FG000|Period 1|Physician Decision|1|||
46800171|NCT00550238|83019131|FG000|Overall Study|Adverse Event|88|||
46858756|NCT03285490|83074542|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
46858757|NCT03285490|83074543|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
46800172|NCT00550238|83019131|FG000|Overall Study|Death|34|||
46800173|NCT00550238|83019131|FG000|Overall Study|Disease progression|46|||
46689216|NCT01264770|82904184|FG004|Overall Study|e.g., change in circumstances|4|||
46800174|NCT00550238|83019131|FG000|Overall Study|Withdrawal by Subject|167|||
46689217|NCT01264770|82904185|FG005|Overall Study|e.g., change in circumstances|4|||
46800175|NCT00550238|83019131|FG000|Overall Study|Physician Decision|31|||
46858758|NCT02939716|83074550|FG000|Overall Study|scanner failure|0|||
46689218|NCT01264770|82904180|FG000|Overall Study|Severe non-compliance to protocol|0|||
46689219|NCT01264770|82904181|FG001|Overall Study|Severe non-compliance to protocol|0|||
46689220|NCT01264770|82904182|FG002|Overall Study|Severe non-compliance to protocol|1|||
46689221|NCT01264770|82904183|FG003|Overall Study|Severe non-compliance to protocol|1|||
46689222|NCT01264770|82904184|FG004|Overall Study|Severe non-compliance to protocol|0|||
46689223|NCT01264770|82904185|FG005|Overall Study|Severe non-compliance to protocol|0|||
46689224|NCT01264770|82904180|FG000|Overall Study|Lack of therapeutic response|1|||
46800176|NCT00550238|83019131|FG000|Overall Study|Patient noncompliance|25|||
46800177|NCT00550238|83019131|FG000|Overall Study|Lost to Follow-up|13|||
46800178|NCT00550238|83019131|FG000|Overall Study|Sponsor decision|55|||
46800179|NCT03956550|83019138|FG000|Overall Study|Sponsor decision|65|||
46800180|NCT03956550|83019139|FG001|Overall Study|Sponsor decision|66|||
46800181|NCT03956550|83019140|FG002|Overall Study|Sponsor decision|64|||
46689225|NCT01264770|82904181|FG001|Overall Study|Lack of therapeutic response|0|||
46689226|NCT01264770|82904182|FG002|Overall Study|Lack of therapeutic response|2|||
46689227|NCT01264770|82904183|FG003|Overall Study|Lack of therapeutic response|1|||
46689228|NCT01264770|82904184|FG004|Overall Study|Lack of therapeutic response|1|||
46689229|NCT01264770|82904185|FG005|Overall Study|Lack of therapeutic response|0|||
46689230|NCT01264770|82904180|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
46689231|NCT01264770|82904181|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
46689232|NCT01264770|82904182|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
46689233|NCT01264770|82904183|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
46689234|NCT01264770|82904184|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
46689235|NCT01264770|82904185|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
46689236|NCT01264770|82904180|FG000|Overall Study|Lost to Follow-up|0|||
46689237|NCT01264770|82904181|FG001|Overall Study|Lost to Follow-up|0|||
46689238|NCT01264770|82904182|FG002|Overall Study|Lost to Follow-up|1|||
46689239|NCT01264770|82904183|FG003|Overall Study|Lost to Follow-up|1|||
46689240|NCT01264770|82904184|FG004|Overall Study|Lost to Follow-up|0|||
46800182|NCT03956550|83019138|FG000|Overall Study|Adverse Event|0|||
46800183|NCT03956550|83019139|FG001|Overall Study|Adverse Event|1|||
46689241|NCT01264770|82904185|FG005|Overall Study|Lost to Follow-up|0|||
46689242|NCT01264770|82904180|FG000|Overall Study|Adverse Event|7|||
46689243|NCT01264770|82904181|FG001|Overall Study|Adverse Event|7|||
46800184|NCT03956550|83019140|FG002|Overall Study|Adverse Event|0|||
46800185|NCT03956550|83019138|FG000|Overall Study|Withdrawal by Subject|5|||
46800186|NCT03956550|83019139|FG001|Overall Study|Withdrawal by Subject|5|||
46689244|NCT01264770|82904182|FG002|Overall Study|Adverse Event|8|||
46689245|NCT01264770|82904183|FG003|Overall Study|Adverse Event|0|||
46689246|NCT01264770|82904184|FG004|Overall Study|Adverse Event|2|||
46689247|NCT01264770|82904185|FG005|Overall Study|Adverse Event|1|||
46689248|NCT01027702|82904205|FG000|Overall Study|Received subsequent therapy|1|||
46689249|NCT01027702|82904206|FG001|Overall Study|Received subsequent therapy|2|||
46689250|NCT01027702|82904207|FG002|Overall Study|Received subsequent therapy|0|||
46689251|NCT01027702|82904208|FG003|Overall Study|Received subsequent therapy|4|||
46689252|NCT01027702|82904209|FG004|Overall Study|Received subsequent therapy|1|||
46689253|NCT01027702|82904210|FG005|Overall Study|Received subsequent therapy|0|||
46689254|NCT01027702|82904211|FG006|Overall Study|Received subsequent therapy|1|||
46689255|NCT01027702|82904205|FG000|Overall Study|Death|0|||
46689256|NCT01027702|82904206|FG001|Overall Study|Death|0|||
46689257|NCT01027702|82904207|FG002|Overall Study|Death|1|||
46689258|NCT01027702|82904208|FG003|Overall Study|Death|0|||
46689259|NCT01027702|82904209|FG004|Overall Study|Death|0|||
46689260|NCT01027702|82904210|FG005|Overall Study|Death|0|||
46689261|NCT01027702|82904211|FG006|Overall Study|Death|0|||
46689262|NCT01302080|82904225|FG000|Overall Study|Withdrew Consent|92|||
46689263|NCT01302080|82904226|FG001|Overall Study|Withdrew Consent|39|||
46689264|NCT01302080|82904225|FG000|Overall Study|Patient/Family Moved|28|||
46800187|NCT03956550|83019140|FG002|Overall Study|Withdrawal by Subject|6|||
46800188|NCT00110305|83019152|FG000|Overall Study|Adverse Event|46|||
46689265|NCT01302080|82904226|FG001|Overall Study|Patient/Family Moved|3|||
46689266|NCT01302080|82904225|FG000|Overall Study|Lost to Follow-up|192|||
46689267|NCT01302080|82904226|FG001|Overall Study|Lost to Follow-up|93|||
46689268|NCT01302080|82904225|FG000|Overall Study|Death|1|||
46689269|NCT01302080|82904226|FG001|Overall Study|Death|0|||
46689270|NCT01302080|82904225|FG000|Overall Study|Other|52|||
46800189|NCT00110305|83019153|FG001|Overall Study|Adverse Event|13|||
46800190|NCT00110305|83019152|FG000|Overall Study|Sponsors Decision|1|||
46689271|NCT01302080|82904226|FG001|Overall Study|Other|8|||
46689272|NCT01302080|82904225|FG000|Overall Study|Reason Missing For Discontinuation|1|||
46689273|NCT01302080|82904226|FG001|Overall Study|Reason Missing For Discontinuation|0|||
46689274|NCT01238991|82904266|FG000|Overall Study|Adverse Event|1|||
46689275|NCT01238991|82904267|FG001|Overall Study|Adverse Event|0|||
46689276|NCT01238991|82904268|FG002|Overall Study|Adverse Event|3|||
46689277|NCT01238991|82904269|FG003|Overall Study|Adverse Event|1|||
46689278|NCT01238991|82904270|FG004|Overall Study|Adverse Event|1|||
46689279|NCT01238991|82904271|FG005|Overall Study|Adverse Event|0|||
46689280|NCT01238991|82904272|FG006|Overall Study|Adverse Event|1|||
46689281|NCT01238991|82904273|FG007|Overall Study|Adverse Event|1|||
46689282|NCT01238991|82904274|FG008|Overall Study|Adverse Event|0|||
46689283|NCT01238991|82904275|FG009|Overall Study|Adverse Event|0|||
46689284|NCT01238991|82904266|FG000|Overall Study|Death|0|||
46689285|NCT01238991|82904267|FG001|Overall Study|Death|0|||
46689286|NCT01238991|82904268|FG002|Overall Study|Death|0|||
46689287|NCT01238991|82904269|FG003|Overall Study|Death|1|||
46689288|NCT01238991|82904270|FG004|Overall Study|Death|0|||
46689289|NCT01238991|82904271|FG005|Overall Study|Death|0|||
46689290|NCT01238991|82904272|FG006|Overall Study|Death|0|||
46689291|NCT01238991|82904273|FG007|Overall Study|Death|0|||
46689292|NCT01238991|82904274|FG008|Overall Study|Death|0|||
46689293|NCT01238991|82904275|FG009|Overall Study|Death|0|||
46689294|NCT01238991|82904266|FG000|Overall Study|Lack of Efficacy|0|||
46689295|NCT01238991|82904267|FG001|Overall Study|Lack of Efficacy|0|||
46689296|NCT01238991|82904268|FG002|Overall Study|Lack of Efficacy|1|||
46689297|NCT01238991|82904269|FG003|Overall Study|Lack of Efficacy|0|||
46689298|NCT01238991|82904270|FG004|Overall Study|Lack of Efficacy|0|||
46689299|NCT01238991|82904271|FG005|Overall Study|Lack of Efficacy|0|||
46689300|NCT01238991|82904272|FG006|Overall Study|Lack of Efficacy|0|||
46689301|NCT01238991|82904273|FG007|Overall Study|Lack of Efficacy|0|||
46689302|NCT01238991|82904274|FG008|Overall Study|Lack of Efficacy|1|||
46689303|NCT01238991|82904275|FG009|Overall Study|Lack of Efficacy|0|||
46689304|NCT01238991|82904266|FG000|Overall Study|Withdrawal by Subject|0|||
46689305|NCT01238991|82904267|FG001|Overall Study|Withdrawal by Subject|0|||
46689306|NCT01238991|82904268|FG002|Overall Study|Withdrawal by Subject|1|||
46689307|NCT01238991|82904269|FG003|Overall Study|Withdrawal by Subject|0|||
46689308|NCT01238991|82904270|FG004|Overall Study|Withdrawal by Subject|0|||
46689309|NCT01238991|82904271|FG005|Overall Study|Withdrawal by Subject|0|||
46689310|NCT01238991|82904272|FG006|Overall Study|Withdrawal by Subject|0|||
46689311|NCT01238991|82904273|FG007|Overall Study|Withdrawal by Subject|0|||
46689312|NCT01238991|82904274|FG008|Overall Study|Withdrawal by Subject|0|||
46689313|NCT01238991|82904275|FG009|Overall Study|Withdrawal by Subject|0|||
46689314|NCT01238991|82904266|FG000|Overall Study|Study Terminated by Sponsor|0|||
46689315|NCT01238991|82904267|FG001|Overall Study|Study Terminated by Sponsor|0|||
46689316|NCT01238991|82904268|FG002|Overall Study|Study Terminated by Sponsor|0|||
46689317|NCT01238991|82904269|FG003|Overall Study|Study Terminated by Sponsor|0|||
46689318|NCT01238991|82904270|FG004|Overall Study|Study Terminated by Sponsor|1|||
46981905|NCT02397915|83228033|FG001|Period 1|Physician Decision|0|||
46689319|NCT01238991|82904271|FG005|Overall Study|Study Terminated by Sponsor|0|||
46689320|NCT01238991|82904272|FG006|Overall Study|Study Terminated by Sponsor|7|||
46689321|NCT01238991|82904273|FG007|Overall Study|Study Terminated by Sponsor|4|||
46689322|NCT01238991|82904274|FG008|Overall Study|Study Terminated by Sponsor|2|||
46689323|NCT01238991|82904275|FG009|Overall Study|Study Terminated by Sponsor|2|||
46689324|NCT01238991|82904266|FG000|Overall Study|Caregiver's request|0|||
46689325|NCT01238991|82904267|FG001|Overall Study|Caregiver's request|0|||
46689326|NCT01238991|82904268|FG002|Overall Study|Caregiver's request|0|||
46689327|NCT01238991|82904269|FG003|Overall Study|Caregiver's request|0|||
46689328|NCT01238991|82904270|FG004|Overall Study|Caregiver's request|0|||
46689329|NCT01238991|82904271|FG005|Overall Study|Caregiver's request|0|||
46689330|NCT01238991|82904272|FG006|Overall Study|Caregiver's request|0|||
46689331|NCT01238991|82904273|FG007|Overall Study|Caregiver's request|0|||
46689332|NCT01238991|82904274|FG008|Overall Study|Caregiver's request|1|||
46689333|NCT01238991|82904275|FG009|Overall Study|Caregiver's request|0|||
46689334|NCT01238991|82904266|FG000|Overall Study|Admission to a nursing home|1|||
46689335|NCT01238991|82904267|FG001|Overall Study|Admission to a nursing home|0|||
46689336|NCT01238991|82904268|FG002|Overall Study|Admission to a nursing home|1|||
46689337|NCT01238991|82904269|FG003|Overall Study|Admission to a nursing home|0|||
46689338|NCT01238991|82904270|FG004|Overall Study|Admission to a nursing home|0|||
46689339|NCT01238991|82904271|FG005|Overall Study|Admission to a nursing home|0|||
46689340|NCT01238991|82904272|FG006|Overall Study|Admission to a nursing home|0|||
46689341|NCT01238991|82904273|FG007|Overall Study|Admission to a nursing home|0|||
46689342|NCT01238991|82904274|FG008|Overall Study|Admission to a nursing home|0|||
46689343|NCT01238991|82904275|FG009|Overall Study|Admission to a nursing home|0|||
46689344|NCT01238835|82904300|FG000|Overall Study|Death|124|||
46689345|NCT01238835|82904300|FG000|Overall Study|Withdrawal by Subject|9|||
46689346|NCT01238835|82904300|FG000|Overall Study|Lost to Follow-up|1|||
46689347|NCT01238835|82904300|FG000|Overall Study|Site early discontinuation|2|||
46689348|NCT01032070|82904306|FG000|Overall Study|Disease progression|13|||
46689349|NCT01032070|82904307|FG001|Overall Study|Disease progression|8|||
46689350|NCT01032070|82904306|FG000|Overall Study|Medical or ethical reasons|0|||
46689351|NCT01032070|82904307|FG001|Overall Study|Medical or ethical reasons|2|||
46689352|NCT01032070|82904306|FG000|Overall Study|Withdrawal by Subject|0|||
46689353|NCT01032070|82904307|FG001|Overall Study|Withdrawal by Subject|2|||
46689354|NCT01237899|82904324|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
46689355|NCT01237899|82904325|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
46689356|NCT01237899|82904326|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
46689357|NCT01237899|82904327|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
46689358|NCT01237899|82904328|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
46689359|NCT01237899|82904329|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
46689360|NCT01237899|82904330|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
46689361|NCT01237899|82904331|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
46689362|NCT01237899|82904332|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
46689363|NCT01237899|82904333|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
46689364|NCT01237899|82904334|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
46689365|NCT01264380|82904352|FG000|Period C|Disease Progression|0|||
46689366|NCT01264380|82904353|FG001|Period C|Disease Progression|0|||
46689367|NCT01264380|82904354|FG002|Period C|Disease Progression|4|||
46689368|NCT01264380|82904352|FG000|Period C|Death|0|||
46689369|NCT01264380|82904353|FG001|Period C|Death|0|||
46689370|NCT01264380|82904354|FG002|Period C|Death|2|||
46689371|NCT01264380|82904352|FG000|Period C|Follow-up for survival status|0|||
46689372|NCT01264380|82904353|FG001|Period C|Follow-up for survival status|0|||
46689373|NCT01264380|82904354|FG002|Period C|Follow-up for survival status|6|||
46689374|NCT01264380|82904352|FG000|Period C|Withdrawal by Subject|0|||
46689375|NCT01264380|82904353|FG001|Period C|Withdrawal by Subject|0|||
46689376|NCT01264380|82904354|FG002|Period C|Withdrawal by Subject|1|||
46689377|NCT01264380|82904352|FG000|Period C|Adverse Event|0|||
46689378|NCT01264380|82904353|FG001|Period C|Adverse Event|0|||
46689379|NCT01264380|82904354|FG002|Period C|Adverse Event|1|||
46689380|NCT01263444|82904362|FG000|Overall Study|Adverse Event|8|||
46689381|NCT01263444|82904362|FG000|Overall Study|Withdrawal by Subject|1|||
46689382|NCT01263444|82904362|FG000|Overall Study|Protocol Violation|1|||
46689383|NCT01263054|82904368|FG000|Overall Study|Death|1|||
46689384|NCT01263054|82904369|FG001|Overall Study|Death|0|||
46689385|NCT01263054|82904368|FG000|Overall Study|Lost to Follow-up|2|||
46689386|NCT01263054|82904369|FG001|Overall Study|Lost to Follow-up|2|||
46689387|NCT01263054|82904368|FG000|Overall Study|Withdrawal by Subject|1|||
46689388|NCT01263054|82904369|FG001|Overall Study|Withdrawal by Subject|3|||
46689389|NCT01263054|82904368|FG000|Overall Study|Qualification Violation|1|||
46689390|NCT01263054|82904369|FG001|Overall Study|Qualification Violation|0|||
46689391|NCT01263054|82904368|FG000|Overall Study|Other|0|||
46689392|NCT01263054|82904369|FG001|Overall Study|Other|1|||
46689393|NCT01031836|82904381|FG000|Stage I|Adverse Event|1|||
46689394|NCT01031836|82904382|FG001|Stage I|Adverse Event|1|||
46689395|NCT01031836|82904383|FG002|Stage I|Adverse Event|0|||
46689396|NCT01031836|82904384|FG003|Stage I|Adverse Event|0|||
46689397|NCT01031836|82904385|FG004|Stage I|Adverse Event|0|||
46689398|NCT01031836|82904386|FG005|Stage I|Adverse Event|0|||
46689399|NCT01031836|82904381|FG000|Stage I|Other|0|||
46689400|NCT01031836|82904382|FG001|Stage I|Other|1|||
46689401|NCT01031836|82904383|FG002|Stage I|Other|0|||
46689402|NCT01031836|82904384|FG003|Stage I|Other|0|||
46689403|NCT01031836|82904385|FG004|Stage I|Other|0|||
46689404|NCT01031836|82904386|FG005|Stage I|Other|1|||
46981906|NCT02397915|83228034|FG002|Period 1|Physician Decision|0|||
46689405|NCT01031836|82904381|FG000|Stage II|Adverse Event|0|||
46689406|NCT01031836|82904382|FG001|Stage II|Adverse Event|0|||
46689407|NCT01031836|82904383|FG002|Stage II|Adverse Event|2|||
46689408|NCT01031836|82904384|FG003|Stage II|Adverse Event|2|||
46689409|NCT01031836|82904385|FG004|Stage II|Adverse Event|1|||
46689410|NCT01031836|82904386|FG005|Stage II|Adverse Event|1|||
46689411|NCT01031836|82904381|FG000|Stage II|Other|2|||
46689412|NCT01031836|82904382|FG001|Stage II|Other|0|||
46689413|NCT01031836|82904383|FG002|Stage II|Other|0|||
46689414|NCT01031836|82904384|FG003|Stage II|Other|1|||
46689415|NCT01031836|82904385|FG004|Stage II|Other|1|||
46689416|NCT01031836|82904386|FG005|Stage II|Other|0|||
46689417|NCT01237587|82904402|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
46689418|NCT01237587|82904403|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
46689419|NCT01237587|82904402|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
46689420|NCT01237587|82904403|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
46689421|NCT01237587|82904402|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
46689422|NCT01237587|82904403|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
46689423|NCT01237587|82904402|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
46689424|NCT01237587|82904403|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
46689425|NCT01237587|82904402|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
46689426|NCT01237587|82904403|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
46689427|NCT01237587|82904402|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
46689428|NCT01237587|82904403|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
46689429|NCT01237587|82904402|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
46689430|NCT01237587|82904403|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
46689431|NCT01237587|82904402|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
46689432|NCT01237587|82904403|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
46689433|NCT01237587|82904402|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
46689434|NCT01237587|82904403|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
46689435|NCT01237587|82904402|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
46800191|NCT00110305|83019153|FG001|Overall Study|Sponsors Decision|0|||
46800192|NCT00110305|83019152|FG000|Overall Study|Subject Non-Compliant|9|||
46800193|NCT00110305|83019153|FG001|Overall Study|Subject Non-Compliant|2|||
46800194|NCT00110305|83019152|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
46800195|NCT00110305|83019153|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
46800196|NCT00110305|83019152|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
46800197|NCT00110305|83019153|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
46800198|NCT00110305|83019152|FG000|Overall Study|Protocol Violation|0|||
46800199|NCT00110305|83019153|FG001|Overall Study|Protocol Violation|1|||
46800200|NCT00110305|83019152|FG000|Overall Study|Withdrawal by Subject|7|||
46800201|NCT00110305|83019153|FG001|Overall Study|Withdrawal by Subject|7|||
46800202|NCT00110305|83019152|FG000|Overall Study|Lost to Follow-up|20|||
46800203|NCT00110305|83019153|FG001|Overall Study|Lost to Follow-up|3|||
46800204|NCT00110305|83019152|FG000|Overall Study|Other|8|||
46800205|NCT00110305|83019153|FG001|Overall Study|Other|2|||
46800206|NCT00428116|83019172|FG000|Overall Study|Death|1|||
46800207|NCT00428116|83019173|FG001|Overall Study|Death|0|||
46800208|NCT00428116|83019172|FG000|Overall Study|Withdrawal by Subject|1|||
46800209|NCT00428116|83019173|FG001|Overall Study|Withdrawal by Subject|0|||
46800210|NCT00428116|83019172|FG000|Overall Study|Lost to Follow-up|1|||
46800211|NCT00428116|83019173|FG001|Overall Study|Lost to Follow-up|0|||
46800212|NCT00560066|83019182|FG000|Overall Study|Death|2|||
46800213|NCT00560066|83019183|FG001|Overall Study|Death|1|||
46800214|NCT00560066|83019182|FG000|Overall Study|Withdrawal by Subject|0|||
46800215|NCT00560066|83019183|FG001|Overall Study|Withdrawal by Subject|3|||
46800216|NCT00560066|83019182|FG000|Overall Study|Lost to Follow-up|4|||
46800217|NCT00560066|83019183|FG001|Overall Study|Lost to Follow-up|10|||
46800218|NCT00560066|83019182|FG000|Overall Study|Protocol Violation|0|||
46689436|NCT01237587|82904403|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
46800219|NCT00560066|83019183|FG001|Overall Study|Protocol Violation|1|||
46800220|NCT00560066|83019182|FG000|Overall Study|Administrative reason|0|||
46800221|NCT00560066|83019183|FG001|Overall Study|Administrative reason|5|||
46800222|NCT00560066|83019182|FG000|Overall Study|Missing primary reason|0|||
46689437|NCT01237587|82904402|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
46689438|NCT01237587|82904403|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
46689439|NCT01237587|82904402|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
46800223|NCT00560066|83019183|FG001|Overall Study|Missing primary reason|2|||
46800224|NCT00549900|83019194|FG000|Overall Study|Adverse Event|1|||
46800225|NCT00435994|83019201|FG000|Overall Study|Lost to Follow-up|7|||
46800226|NCT00435994|83019202|FG001|Overall Study|Lost to Follow-up|0|||
46800227|NCT00435994|83019203|FG002|Overall Study|Lost to Follow-up|0|||
46800228|NCT00435370|83019214|FG000|Overall Study|Adverse Event|8|||
46689440|NCT01237587|82904403|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
46689441|NCT01237587|82904402|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
46689442|NCT01237587|82904403|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
46689443|NCT01237587|82904402|FG000|Taper Phase|Adverse Event|0|||
46689444|NCT01237587|82904403|FG001|Taper Phase|Adverse Event|2|||
46689445|NCT01237587|82904402|FG000|Taper Phase|Protocol Violation|2|||
46689446|NCT01237587|82904403|FG001|Taper Phase|Protocol Violation|0|||
46689447|NCT01237587|82904402|FG000|Taper Phase|Lack of Efficacy|2|||
46689448|NCT01237587|82904403|FG001|Taper Phase|Lack of Efficacy|5|||
46689449|NCT01237587|82904402|FG000|Taper Phase|Parent/Guardian Decision|0|||
46689450|NCT01237587|82904403|FG001|Taper Phase|Parent/Guardian Decision|2|||
46689451|NCT01237587|82904402|FG000|Taper Phase|Sponsor Decision|1|||
46689452|NCT01237587|82904403|FG001|Taper Phase|Sponsor Decision|0|||
46689453|NCT01237587|82904402|FG000|Taper Phase|Withdrawal by Subject|0|||
46689454|NCT01237587|82904403|FG001|Taper Phase|Withdrawal by Subject|1|||
46689455|NCT01031680|82904418|FG000|Overall Study|Adverse Event|8|||
46689456|NCT01031680|82904419|FG001|Overall Study|Adverse Event|3|||
46689457|NCT01031680|82904418|FG000|Overall Study|Lost to Follow-up|2|||
46689458|NCT01031680|82904419|FG001|Overall Study|Lost to Follow-up|10|||
46689459|NCT01031680|82904418|FG000|Overall Study|Withdrawal by Subject|12|||
46689460|NCT01031680|82904419|FG001|Overall Study|Withdrawal by Subject|16|||
46689461|NCT01031680|82904418|FG000|Overall Study|Death|2|||
46689462|NCT01031680|82904419|FG001|Overall Study|Death|1|||
46689463|NCT01031680|82904418|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
46689464|NCT01031680|82904419|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
46689465|NCT01031680|82904418|FG000|Overall Study|Poor/Non-compliance|5|||
46689466|NCT01031680|82904419|FG001|Overall Study|Poor/Non-compliance|6|||
46689467|NCT01031680|82904418|FG000|Overall Study|Safety|1|||
46689468|NCT01031680|82904419|FG001|Overall Study|Safety|0|||
46689469|NCT01031680|82904418|FG000|Overall Study|Incorrect Enrolment|1|||
46689470|NCT01031680|82904419|FG001|Overall Study|Incorrect Enrolment|2|||
46689471|NCT01031680|82904418|FG000|Overall Study|Administrative Reason by Sponsor|0|||
46689472|NCT01031680|82904419|FG001|Overall Study|Administrative Reason by Sponsor|1|||
46689473|NCT01031680|82904418|FG000|Overall Study|Various|0|||
46689474|NCT01031680|82904419|FG001|Overall Study|Various|2|||
46689475|NCT01031446|82904425|FG000|Overall Study|Disease Progression|38|||
46689476|NCT01031446|82904425|FG000|Overall Study|Adverse Event|9|||
46689477|NCT01031446|82904425|FG000|Overall Study|Physician Decision|4|||
46800229|NCT00435370|83019215|FG001|Overall Study|Adverse Event|8|||
46800230|NCT00435370|83019214|FG000|Overall Study|Withdrawal by Subject|10|||
46800231|NCT00435370|83019215|FG001|Overall Study|Withdrawal by Subject|10|||
46689478|NCT01031446|82904425|FG000|Overall Study|Withdrawal by Subject|3|||
46689479|NCT01031446|82904425|FG000|Overall Study|Still on treatment|1|||
46689480|NCT01030900|82904431|FG000|Overall Study|Not treated due to congestive heart failure|1|||
46689481|NCT01030900|82904431|FG000|Overall Study|Not treated due to rapid disease|1|||
46689482|NCT01030822|82904438|FG000|Overall Study|Moved/migrated from study area|6|||
46689483|NCT01030822|82904439|FG001|Overall Study|Moved/migrated from study area|7|||
46689484|NCT01030822|82904440|FG002|Overall Study|Moved/migrated from study area|3|||
46689485|NCT01030822|82904438|FG000|Overall Study|Withdrawal by Subject|16|||
46689486|NCT01030822|82904439|FG001|Overall Study|Withdrawal by Subject|13|||
46689487|NCT01030822|82904440|FG002|Overall Study|Withdrawal by Subject|16|||
46689488|NCT01030822|82904438|FG000|Overall Study|Lost to Follow-up|9|||
46689489|NCT01030822|82904439|FG001|Overall Study|Lost to Follow-up|4|||
46689490|NCT01030822|82904440|FG002|Overall Study|Lost to Follow-up|7|||
46689491|NCT01026454|82904451|FG000|Second Intervention|Pregnancy|1|||
46689492|NCT01026454|82904452|FG001|Second Intervention|Pregnancy|1|||
46689493|NCT01026220|82904458|FG000|Induction|Death|1|||
46689494|NCT01026220|82904459|FG001|Induction|Death|0|||
46689495|NCT01026220|82904460|FG002|Induction|Death|0|||
46689496|NCT01026220|82904458|FG000|Induction|Lack of Efficacy|2|||
46689497|NCT01026220|82904459|FG001|Induction|Lack of Efficacy|0|||
46689498|NCT01026220|82904460|FG002|Induction|Lack of Efficacy|0|||
46689499|NCT01026220|82904458|FG000|Induction|Physician Decision|12|||
46689500|NCT01026220|82904459|FG001|Induction|Physician Decision|0|||
46689501|NCT01026220|82904460|FG002|Induction|Physician Decision|0|||
46689502|NCT01026220|82904458|FG000|Induction|Withdrawal by Subject|9|||
46689503|NCT01026220|82904459|FG001|Induction|Withdrawal by Subject|0|||
46689504|NCT01026220|82904460|FG002|Induction|Withdrawal by Subject|0|||
46689505|NCT01026220|82904458|FG000|Induction|Ineligible|1|||
46689506|NCT01026220|82904459|FG001|Induction|Ineligible|0|||
46689507|NCT01026220|82904460|FG002|Induction|Ineligible|0|||
46689508|NCT01026220|82904458|FG000|Consolidation Maintenance|Death|0|||
46689509|NCT01026220|82904459|FG001|Consolidation Maintenance|Death|1|||
46689510|NCT01026220|82904460|FG002|Consolidation Maintenance|Death|0|||
46689511|NCT01026220|82904458|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
46689512|NCT01026220|82904459|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
46689513|NCT01026220|82904460|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
46689514|NCT01026220|82904458|FG000|Consolidation Maintenance|Physician Decision|0|||
46689515|NCT01026220|82904459|FG001|Consolidation Maintenance|Physician Decision|2|||
46689516|NCT01026220|82904460|FG002|Consolidation Maintenance|Physician Decision|7|||
46689517|NCT01026220|82904458|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
46689518|NCT01026220|82904459|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
46689519|NCT01026220|82904460|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
46689520|NCT01026142|82904477|FG000|Overall Study|Death|136|||
46689521|NCT01026142|82904478|FG001|Overall Study|Death|134|||
46689522|NCT01026142|82904477|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
46689523|NCT01026142|82904478|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
46689524|NCT04615403|82904493|FG000|Overall Study|Death|1|||
46689525|NCT04368429|82904503|FG000|Overall Study|Adverse Event|1|||
46858759|NCT02939716|83074551|FG001|Overall Study|scanner failure|0|||
46689526|NCT04368429|82904504|FG001|Overall Study|Adverse Event|0|||
46689527|NCT04091438|82904521|FG000|Treatment Period 1 (1 Day)|Other|1|||
46689528|NCT04091438|82904522|FG001|Treatment Period 1 (1 Day)|Other|0|||
46689529|NCT04091438|82904521|FG000|Washout Period (1 Day)|Protocol deviation|0|||
46689530|NCT04091438|82904522|FG001|Washout Period (1 Day)|Protocol deviation|1|||
46689531|NCT04091438|82904521|FG000|Washout Period (1 Day)|Other|0|||
46689532|NCT04091438|82904522|FG001|Washout Period (1 Day)|Other|1|||
46689533|NCT04084769|82904534|FG000|Overall Study|Protocol Violation|1|||
46689534|NCT04084769|82904535|FG001|Overall Study|Protocol Violation|3|||
46689535|NCT04084769|82904536|FG002|Overall Study|Protocol Violation|0|||
46689536|NCT04084769|82904537|FG003|Overall Study|Protocol Violation|1|||
46689537|NCT04084769|82904534|FG000|Overall Study|Withdrawal by Subject|0|||
46689538|NCT04084769|82904535|FG001|Overall Study|Withdrawal by Subject|1|||
46689539|NCT04084769|82904536|FG002|Overall Study|Withdrawal by Subject|0|||
46689540|NCT04084769|82904537|FG003|Overall Study|Withdrawal by Subject|0|||
46689541|NCT04084769|82904534|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46689542|NCT04084769|82904535|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46689543|NCT04084769|82904536|FG002|Overall Study|Withdrawal by parent/guardian|0|||
46689544|NCT04084769|82904537|FG003|Overall Study|Withdrawal by parent/guardian|1|||
46689545|NCT04084769|82904534|FG000|Overall Study|Lost to Follow-up|2|||
46689546|NCT04084769|82904535|FG001|Overall Study|Lost to Follow-up|0|||
46981907|NCT02397915|83228035|FG003|Period 1|Physician Decision|0|||
46689547|NCT04084769|82904536|FG002|Overall Study|Lost to Follow-up|0|||
46981908|NCT02397837|83228045|FG000|Overall Study|Withdrawal by Subject|6|||
46981909|NCT02397837|83228046|FG001|Overall Study|Withdrawal by Subject|5|||
46981910|NCT02397837|83228045|FG000|Overall Study|Physician Decision|1|||
46981911|NCT02397837|83228046|FG001|Overall Study|Physician Decision|1|||
46981912|NCT02586415|83228054|FG000|Overall Study|Death|13|||
46981913|NCT02586415|83228055|FG001|Overall Study|Death|23|||
46981914|NCT02586415|83228054|FG000|Overall Study|Lost to Follow-up|1|||
46981915|NCT02586415|83228055|FG001|Overall Study|Lost to Follow-up|2|||
46981916|NCT02383017|83228064|FG000|Overall Study|Injury Sustained Outside Study|1|||
46981917|NCT02383017|83228065|FG001|Overall Study|Injury Sustained Outside Study|0|||
46981918|NCT02383017|83228064|FG000|Overall Study|Compliance|3|||
46981919|NCT02383017|83228065|FG001|Overall Study|Compliance|2|||
46689548|NCT04084769|82904537|FG003|Overall Study|Lost to Follow-up|0|||
46689549|NCT03890367|82904555|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46689550|NCT03890367|82904556|FG001|Overall Study|Withdrawal by parent/guardian|3|||
46689551|NCT03890367|82904557|FG002|Overall Study|Withdrawal by parent/guardian|0|||
46689552|NCT03890367|82904555|FG000|Overall Study|Protocol deviation|2|||
46689553|NCT03890367|82904556|FG001|Overall Study|Protocol deviation|2|||
46689554|NCT03890367|82904557|FG002|Overall Study|Protocol deviation|1|||
46689555|NCT03890367|82904555|FG000|Overall Study|Lost to Follow-up|1|||
46689556|NCT03890367|82904556|FG001|Overall Study|Lost to Follow-up|1|||
46689557|NCT03890367|82904557|FG002|Overall Study|Lost to Follow-up|0|||
46689558|NCT03868124|82904568|FG000|Overall Study|Withdrawal by Subject|4|||
46689559|NCT03868124|82904569|FG001|Overall Study|Withdrawal by Subject|0|||
46689560|NCT03868124|82904570|FG002|Overall Study|Withdrawal by Subject|1|||
46689561|NCT03868124|82904568|FG000|Overall Study|Physician Decision|1|||
46689562|NCT03868124|82904569|FG001|Overall Study|Physician Decision|0|||
46689563|NCT03868124|82904570|FG002|Overall Study|Physician Decision|1|||
46689564|NCT03868124|82904568|FG000|Overall Study|Lost to Follow-up|1|||
46689565|NCT03868124|82904569|FG001|Overall Study|Lost to Follow-up|1|||
46689566|NCT03868124|82904570|FG002|Overall Study|Lost to Follow-up|2|||
46689567|NCT03868124|82904568|FG000|Overall Study|Death|1|||
46689568|NCT03868124|82904569|FG001|Overall Study|Death|1|||
46689569|NCT03868124|82904570|FG002|Overall Study|Death|2|||
46689570|NCT03868124|82904568|FG000|Overall Study|Adverse Event|0|||
46689571|NCT03868124|82904569|FG001|Overall Study|Adverse Event|0|||
46689572|NCT03868124|82904570|FG002|Overall Study|Adverse Event|3|||
46689573|NCT03868124|82904568|FG000|Overall Study|Explanted|2|||
46689574|NCT03868124|82904569|FG001|Overall Study|Explanted|1|||
46800232|NCT00435370|83019214|FG000|Overall Study|Antipsychotic medication changed|4|||
46800233|NCT00435370|83019215|FG001|Overall Study|Antipsychotic medication changed|2|||
46800234|NCT00096031|83019221|FG000|Overall Study|Adverse Event|3|||
46689575|NCT03868124|82904570|FG002|Overall Study|Explanted|0|||
46689576|NCT03868124|82904568|FG000|Overall Study|Ongoing in study|176|||
46689577|NCT03868124|82904569|FG001|Overall Study|Ongoing in study|180|||
46689578|NCT03868124|82904570|FG002|Overall Study|Ongoing in study|183|||
46689579|NCT03733249|82904578|FG000|Overall Study|Death|7|||
46800235|NCT00096031|83019221|FG000|Overall Study|Lack of Efficacy|42|||
46689580|NCT03733249|82904578|FG000|Overall Study|Disease relapse|16|||
46689581|NCT03733249|82904578|FG000|Overall Study|Lost to Follow-up|4|||
46689582|NCT03733249|82904578|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
46689583|NCT03733249|82904578|FG000|Overall Study|Withdrawal by Subject|1|||
46689584|NCT03469271|82904590|FG000|Overall Study|Withdrawal by Subject|2|||
46689585|NCT03469271|82904591|FG001|Overall Study|Withdrawal by Subject|0|||
46689586|NCT03469271|82904592|FG002|Overall Study|Withdrawal by Subject|0|||
46689587|NCT03469271|82904593|FG003|Overall Study|Withdrawal by Subject|1|||
46689588|NCT03302234|82904609|FG000|Overall Study|Death|191|||
46689589|NCT03302234|82904610|FG001|Overall Study|Death|192|||
46689590|NCT03302234|82904609|FG000|Overall Study|Withdrawal by Subject|2|||
46689591|NCT03302234|82904610|FG001|Overall Study|Withdrawal by Subject|2|||
46689592|NCT03302234|82904609|FG000|Overall Study|Sponsor Decision|90|||
46689593|NCT03302234|82904610|FG001|Overall Study|Sponsor Decision|89|||
46689594|NCT03302234|82904609|FG000|Overall Study|Laryngeal carcinoma|0|||
46689595|NCT03302234|82904610|FG001|Overall Study|Laryngeal carcinoma|1|||
46689596|NCT03302234|82904609|FG000|Overall Study|Not Reported|1|||
46689597|NCT03302234|82904610|FG001|Overall Study|Not Reported|0|||
46689598|NCT02754596|82904620|FG000|Overall Study|Withdrawal by Subject|3|||
46689599|NCT02754596|82904621|FG001|Overall Study|Withdrawal by Subject|4|||
46689600|NCT02754596|82904622|FG002|Overall Study|Withdrawal by Subject|0|||
46689601|NCT02754596|82904620|FG000|Overall Study|Physician Decision|1|||
46689602|NCT02754596|82904621|FG001|Overall Study|Physician Decision|1|||
46689603|NCT02754596|82904622|FG002|Overall Study|Physician Decision|1|||
46689604|NCT02754596|82904620|FG000|Overall Study|Lost to Follow-up|1|||
46689605|NCT02754596|82904621|FG001|Overall Study|Lost to Follow-up|1|||
46689606|NCT02754596|82904622|FG002|Overall Study|Lost to Follow-up|2|||
46689607|NCT02754596|82904620|FG000|Overall Study|Death|0|||
46689608|NCT02754596|82904621|FG001|Overall Study|Death|2|||
46689609|NCT02754596|82904622|FG002|Overall Study|Death|0|||
46689610|NCT02754596|82904620|FG000|Overall Study|Adverse Event|1|||
46689611|NCT02754596|82904621|FG001|Overall Study|Adverse Event|0|||
46689612|NCT02754596|82904622|FG002|Overall Study|Adverse Event|1|||
46689613|NCT02754596|82904620|FG000|Overall Study|Other|1|||
46689614|NCT02754596|82904621|FG001|Overall Study|Other|0|||
46689615|NCT02754596|82904622|FG002|Overall Study|Other|0|||
46689616|NCT02744898|82904630|FG000|Overall Study|Progressive Disease|2|||
46689617|NCT02744898|82904630|FG000|Overall Study|Physician Decision|1|||
46689618|NCT02744898|82904630|FG000|Overall Study|Toxicity|1|||
46689619|NCT02095132|82904643|FG000|Overall Study|Adverse Event|0|||
46689620|NCT02095132|82904644|FG001|Overall Study|Adverse Event|0|||
46689621|NCT02095132|82904645|FG002|Overall Study|Adverse Event|0|||
46689622|NCT02095132|82904646|FG003|Overall Study|Adverse Event|0|||
46689623|NCT02095132|82904647|FG004|Overall Study|Adverse Event|1|||
46689624|NCT02095132|82904648|FG005|Overall Study|Adverse Event|0|||
46689625|NCT02095132|82904649|FG006|Overall Study|Adverse Event|1|||
46689626|NCT02095132|82904650|FG007|Overall Study|Adverse Event|0|||
46689627|NCT02095132|82904651|FG008|Overall Study|Adverse Event|0|||
46689628|NCT02095132|82904643|FG000|Overall Study|Death|0|||
46689629|NCT02095132|82904644|FG001|Overall Study|Death|0|||
46689630|NCT02095132|82904645|FG002|Overall Study|Death|0|||
46689631|NCT02095132|82904646|FG003|Overall Study|Death|0|||
46689632|NCT02095132|82904647|FG004|Overall Study|Death|0|||
46689633|NCT02095132|82904648|FG005|Overall Study|Death|0|||
46689634|NCT02095132|82904649|FG006|Overall Study|Death|1|||
46689635|NCT02095132|82904650|FG007|Overall Study|Death|0|||
46689636|NCT02095132|82904651|FG008|Overall Study|Death|0|||
46689637|NCT02095132|82904643|FG000|Overall Study|Lack of Efficacy|3|||
46689638|NCT02095132|82904644|FG001|Overall Study|Lack of Efficacy|5|||
46689639|NCT02095132|82904645|FG002|Overall Study|Lack of Efficacy|2|||
46689640|NCT02095132|82904646|FG003|Overall Study|Lack of Efficacy|8|||
46689641|NCT02095132|82904647|FG004|Overall Study|Lack of Efficacy|3|||
46689642|NCT02095132|82904648|FG005|Overall Study|Lack of Efficacy|6|||
46689643|NCT02095132|82904649|FG006|Overall Study|Lack of Efficacy|10|||
46689644|NCT02095132|82904650|FG007|Overall Study|Lack of Efficacy|9|||
46689645|NCT02095132|82904651|FG008|Overall Study|Lack of Efficacy|8|||
46689646|NCT02095132|82904643|FG000|Overall Study|Physician Decision|1|||
46689647|NCT02095132|82904644|FG001|Overall Study|Physician Decision|0|||
46689648|NCT02095132|82904645|FG002|Overall Study|Physician Decision|0|||
46689649|NCT02095132|82904646|FG003|Overall Study|Physician Decision|0|||
46689650|NCT02095132|82904647|FG004|Overall Study|Physician Decision|0|||
46689651|NCT02095132|82904648|FG005|Overall Study|Physician Decision|0|||
46689652|NCT02095132|82904649|FG006|Overall Study|Physician Decision|1|||
46689653|NCT02095132|82904650|FG007|Overall Study|Physician Decision|0|||
46689654|NCT02095132|82904651|FG008|Overall Study|Physician Decision|2|||
46689655|NCT02095132|82904643|FG000|Overall Study|Withdrawal by Subject|0|||
46689656|NCT02095132|82904644|FG001|Overall Study|Withdrawal by Subject|0|||
46689657|NCT02095132|82904645|FG002|Overall Study|Withdrawal by Subject|2|||
46689658|NCT02095132|82904646|FG003|Overall Study|Withdrawal by Subject|2|||
46689659|NCT02095132|82904647|FG004|Overall Study|Withdrawal by Subject|3|||
46689660|NCT02095132|82904648|FG005|Overall Study|Withdrawal by Subject|0|||
46689661|NCT02095132|82904649|FG006|Overall Study|Withdrawal by Subject|5|||
46689662|NCT02095132|82904650|FG007|Overall Study|Withdrawal by Subject|0|||
46689663|NCT02095132|82904651|FG008|Overall Study|Withdrawal by Subject|0|||
46689664|NCT01867333|82904676|FG000|Overall Study|Withdrawal by Subject|1|||
46689665|NCT01867333|82904677|FG001|Overall Study|Withdrawal by Subject|0|||
46689666|NCT01867333|82904676|FG000|Overall Study|Adverse Event|1|||
46689667|NCT01867333|82904677|FG001|Overall Study|Adverse Event|0|||
46689668|NCT01867333|82904676|FG000|Overall Study|Participant choice|1|||
46689669|NCT01867333|82904677|FG001|Overall Study|Participant choice|2|||
46689670|NCT01867333|82904676|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
46689671|NCT01867333|82904677|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
46689672|NCT01867333|82904676|FG000|Overall Study|Death|0|||
46689673|NCT01867333|82904677|FG001|Overall Study|Death|1|||
46689674|NCT01867333|82904676|FG000|Overall Study|Physician Decision|3|||
46689675|NCT01867333|82904677|FG001|Overall Study|Physician Decision|2|||
46689676|NCT01867333|82904676|FG000|Overall Study|Switched to alternative treatment|1|||
46689677|NCT01867333|82904677|FG001|Overall Study|Switched to alternative treatment|0|||
46800236|NCT00096031|83019221|FG000|Overall Study|Death|4|||
46689678|NCT01534494|82904683|FG000|Overall Study|Withdrawal by Subject|1|||
46689684|NCT00602797|82904700|FG000|Overall Study|Adverse Event|1|||
46689685|NCT00550615|82904707|FG000|Overall Study|Withdrawal by Subject|0|||
46689686|NCT00550615|82904708|FG001|Overall Study|Withdrawal by Subject|0|||
46689687|NCT00550615|82904709|FG002|Overall Study|Withdrawal by Subject|2|||
46689688|NCT00550615|82904710|FG003|Overall Study|Withdrawal by Subject|3|||
46689689|NCT00550615|82904707|FG000|Overall Study|Not evaluable|0|||
46689690|NCT00550615|82904708|FG001|Overall Study|Not evaluable|0|||
46689691|NCT00550615|82904709|FG002|Overall Study|Not evaluable|2|||
46689692|NCT00550615|82904710|FG003|Overall Study|Not evaluable|7|||
46689693|NCT00006721|82904723|FG000|Overall Study|Adverse Event|0|||
46689694|NCT00006721|82904724|FG001|Overall Study|Adverse Event|4|||
46689695|NCT00006721|82904725|FG002|Overall Study|Adverse Event|4|||
46689696|NCT00006721|82904723|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
46689697|NCT00006721|82904724|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
46689698|NCT00006721|82904725|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
46689699|NCT00006721|82904723|FG000|Overall Study|Progression/Relapse|0|||
46689700|NCT00006721|82904724|FG001|Overall Study|Progression/Relapse|1|||
46689701|NCT00006721|82904725|FG002|Overall Study|Progression/Relapse|2|||
46689702|NCT00006721|82904723|FG000|Overall Study|Death|0|||
46689703|NCT00006721|82904724|FG001|Overall Study|Death|1|||
46689704|NCT00006721|82904725|FG002|Overall Study|Death|2|||
46689705|NCT00006721|82904723|FG000|Overall Study|Other - Not Protocol Specified|0|||
46689706|NCT00006721|82904724|FG001|Overall Study|Other - Not Protocol Specified|7|||
46689707|NCT00006721|82904725|FG002|Overall Study|Other - Not Protocol Specified|7|||
46689708|NCT00006721|82904723|FG000|Overall Study|Ineligible|2|||
46689709|NCT00006721|82904724|FG001|Overall Study|Ineligible|12|||
46689710|NCT00006721|82904725|FG002|Overall Study|Ineligible|10|||
46689711|NCT00006721|82904723|FG000|Overall Study|Eligible but no Treatment Received|1|||
46689712|NCT00006721|82904724|FG001|Overall Study|Eligible but no Treatment Received|0|||
46689713|NCT00006721|82904725|FG002|Overall Study|Eligible but no Treatment Received|0|||
46689714|NCT01030666|82904737|FG000|Overall Study|Lost to Follow-up|3|||
46689715|NCT01030666|82904738|FG001|Overall Study|Lost to Follow-up|2|||
46689716|NCT01025752|82904747|FG000|Overall Study|Lost to Follow-up|7|||
46800237|NCT00096031|83019221|FG000|Overall Study|Withdrawal by Subject|1|||
46800238|NCT00096031|83019221|FG000|Overall Study|Ineligible|8|||
46800239|NCT00096031|83019221|FG000|Overall Study|Not protocol specified|5|||
46800240|NCT00118417|83019225|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
46800241|NCT00118417|83019226|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
46800242|NCT00118417|83019225|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
46800243|NCT00118417|83019226|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
46800244|NCT00118417|83019225|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
46800245|NCT00118417|83019226|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
46800246|NCT00118417|83019225|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
46800247|NCT00118417|83019226|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
46800248|NCT00118417|83019225|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
46800249|NCT00118417|83019226|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
46800250|NCT00549848|83019239|FG000|Overall Study|Death|1|||
46800251|NCT00549848|83019240|FG001|Overall Study|Death|4|||
46800252|NCT00549848|83019241|FG002|Overall Study|Death|13|||
46800253|NCT00549848|83019239|FG000|Overall Study|Physician Decision|0|||
46800254|NCT00549848|83019240|FG001|Overall Study|Physician Decision|0|||
46800255|NCT00549848|83019241|FG002|Overall Study|Physician Decision|4|||
46800256|NCT00549848|83019239|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
46800257|NCT00549848|83019240|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
46800258|NCT00549848|83019241|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
46800259|NCT00549848|83019239|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
46800260|NCT00549848|83019240|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
46800261|NCT00549848|83019241|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
46800262|NCT00549848|83019239|FG000|Overall Study|Participant/Family Withdraw|2|||
46800263|NCT00549848|83019240|FG001|Overall Study|Participant/Family Withdraw|3|||
46800264|NCT00549848|83019241|FG002|Overall Study|Participant/Family Withdraw|5|||
46800265|NCT00549848|83019239|FG000|Overall Study|Second Malignancy|1|||
46800266|NCT00549848|83019240|FG001|Overall Study|Second Malignancy|0|||
46689717|NCT01025752|82904748|FG001|Overall Study|Lost to Follow-up|10|||
46800267|NCT00549848|83019241|FG002|Overall Study|Second Malignancy|0|||
46800268|NCT00549848|83019239|FG000|Overall Study|Transplant|3|||
46689718|NCT01025752|82904747|FG000|Overall Study|Physician Decision|1|||
46689719|NCT01025752|82904748|FG001|Overall Study|Physician Decision|3|||
46689720|NCT01030198|82904756|FG000|Overall Study|Could not measure efficacy accurately|0|||
46689721|NCT01030198|82904757|FG001|Overall Study|Could not measure efficacy accurately|7|||
46689722|NCT01301456|82904775|FG000|Stage 1|Withdrawal by Subject|0|||
46689723|NCT01301456|82904776|FG001|Stage 1|Withdrawal by Subject|0|||
46689724|NCT01301456|82904777|FG002|Stage 1|Withdrawal by Subject|1|||
46689725|NCT01301456|82904778|FG003|Stage 1|Withdrawal by Subject|0|||
46689726|NCT01301456|82904779|FG004|Stage 1|Withdrawal by Subject|1|||
46689727|NCT01301456|82904780|FG005|Stage 1|Withdrawal by Subject|0|||
46689728|NCT01301456|82904781|FG006|Stage 1|Withdrawal by Subject|0|||
46689729|NCT01301456|82904782|FG007|Stage 1|Withdrawal by Subject|0|||
46689730|NCT01301456|82904783|FG008|Stage 1|Withdrawal by Subject|0|||
46689731|NCT01301456|82904784|FG009|Stage 1|Withdrawal by Subject|0|||
46689732|NCT01301456|82904785|FG010|Stage 1|Withdrawal by Subject|0|||
46689733|NCT01301456|82904786|FG011|Stage 1|Withdrawal by Subject|0|||
46689734|NCT01301456|82904775|FG000|Stage 1|Randomized but not treated|0|||
46689735|NCT01301456|82904776|FG001|Stage 1|Randomized but not treated|0|||
46689736|NCT01301456|82904777|FG002|Stage 1|Randomized but not treated|0|||
46689737|NCT01301456|82904778|FG003|Stage 1|Randomized but not treated|0|||
46689738|NCT01301456|82904779|FG004|Stage 1|Randomized but not treated|0|||
46689739|NCT01301456|82904780|FG005|Stage 1|Randomized but not treated|0|||
46689740|NCT01301456|82904781|FG006|Stage 1|Randomized but not treated|1|||
46689741|NCT01301456|82904782|FG007|Stage 1|Randomized but not treated|0|||
46689742|NCT01301456|82904783|FG008|Stage 1|Randomized but not treated|0|||
46689743|NCT01301456|82904784|FG009|Stage 1|Randomized but not treated|0|||
46689744|NCT01301456|82904785|FG010|Stage 1|Randomized but not treated|0|||
46689745|NCT01301456|82904786|FG011|Stage 1|Randomized but not treated|0|||
46689746|NCT01301456|82904775|FG000|Stage 2|Adverse Event|0|||
46689747|NCT01301456|82904776|FG001|Stage 2|Adverse Event|0|||
46689748|NCT01301456|82904777|FG002|Stage 2|Adverse Event|0|||
46689749|NCT01301456|82904778|FG003|Stage 2|Adverse Event|0|||
46689750|NCT01301456|82904779|FG004|Stage 2|Adverse Event|0|||
46689751|NCT01301456|82904780|FG005|Stage 2|Adverse Event|0|||
46689752|NCT01301456|82904781|FG006|Stage 2|Adverse Event|0|||
46689753|NCT01301456|82904782|FG007|Stage 2|Adverse Event|0|||
46689754|NCT01301456|82904783|FG008|Stage 2|Adverse Event|0|||
46689755|NCT01301456|82904784|FG009|Stage 2|Adverse Event|0|||
46689756|NCT01301456|82904785|FG010|Stage 2|Adverse Event|1|||
46689757|NCT01301456|82904786|FG011|Stage 2|Adverse Event|0|||
46689758|NCT01023256|82904834|FG000|Overall Study|Protocol Violation|2|||
46689759|NCT01023256|82904835|FG001|Overall Study|Protocol Violation|3|||
46689760|NCT01023256|82904836|FG002|Overall Study|Protocol Violation|0|||
46689761|NCT01023256|82904837|FG003|Overall Study|Protocol Violation|0|||
46689762|NCT01023256|82904834|FG000|Overall Study|Randomized but not treated|1|||
46689763|NCT01023256|82904835|FG001|Overall Study|Randomized but not treated|0|||
46689764|NCT01023256|82904836|FG002|Overall Study|Randomized but not treated|1|||
46689765|NCT01023256|82904837|FG003|Overall Study|Randomized but not treated|0|||
46689766|NCT01023256|82904834|FG000|Overall Study|Other|1|||
46689767|NCT01023256|82904835|FG001|Overall Study|Other|0|||
46689768|NCT01023256|82904836|FG002|Overall Study|Other|0|||
46689769|NCT01023256|82904837|FG003|Overall Study|Other|2|||
46689770|NCT01023256|82904834|FG000|Overall Study|Adverse Event|0|||
46689771|NCT01023256|82904835|FG001|Overall Study|Adverse Event|0|||
46689772|NCT01023256|82904836|FG002|Overall Study|Adverse Event|0|||
46689773|NCT01023256|82904837|FG003|Overall Study|Adverse Event|1|||
46689774|NCT01023256|82904834|FG000|Overall Study|Withdrawal by Subject|0|||
46689775|NCT01023256|82904835|FG001|Overall Study|Withdrawal by Subject|0|||
46689776|NCT01023256|82904836|FG002|Overall Study|Withdrawal by Subject|0|||
46689777|NCT01023256|82904837|FG003|Overall Study|Withdrawal by Subject|2|||
46689778|NCT01023022|82904850|FG000|Overall Study|Death|5|||
46689779|NCT01023022|82904850|FG000|Overall Study|Lost to Follow-up|7|||
46689780|NCT01023022|82904850|FG000|Overall Study|due to technical issues|2|||
46689781|NCT01058668|82904857|FG000|Double-blind Treatment Phase|Adverse Event|8|||
46689782|NCT01058668|82904858|FG001|Double-blind Treatment Phase|Adverse Event|15|||
46689783|NCT01058668|82904859|FG002|Double-blind Treatment Phase|Adverse Event|25|||
46689784|NCT01058668|82904857|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
46689785|NCT01058668|82904858|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
46689786|NCT01058668|82904859|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
46689787|NCT01058668|82904857|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
46689788|NCT01058668|82904858|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
46689789|NCT01058668|82904859|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
46689790|NCT01058668|82904857|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
46689791|NCT01058668|82904858|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
46689792|NCT01058668|82904859|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
46689793|NCT01058668|82904857|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
46689794|NCT01058668|82904858|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
46689795|NCT01058668|82904859|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
46689796|NCT01058668|82904857|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
46689797|NCT01058668|82904858|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
46689798|NCT01058668|82904859|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
46689799|NCT01301066|82904869|FG000|Overall Study|Lost to Follow-up|5|||
46689800|NCT01301066|82904870|FG001|Overall Study|Lost to Follow-up|11|||
46689801|NCT01301066|82904869|FG000|Overall Study|Protocol Violation|8|||
46689802|NCT01301066|82904870|FG001|Overall Study|Protocol Violation|7|||
46689803|NCT01301066|82904869|FG000|Overall Study|Withdrawal by Subject|4|||
46689804|NCT01301066|82904870|FG001|Overall Study|Withdrawal by Subject|9|||
46689805|NCT01301066|82904869|FG000|Overall Study|Adverse Event|6|||
46689806|NCT01301066|82904870|FG001|Overall Study|Adverse Event|6|||
46689807|NCT01301066|82904869|FG000|Overall Study|Sponsor Decision|2|||
46689808|NCT01301066|82904870|FG001|Overall Study|Sponsor Decision|1|||
46689809|NCT01301066|82904869|FG000|Overall Study|Physician Decision|0|||
46689810|NCT01301066|82904870|FG001|Overall Study|Physician Decision|1|||
46689811|NCT01301066|82904869|FG000|Overall Study|Other|2|||
46689812|NCT01301066|82904870|FG001|Overall Study|Other|0|||
46689813|NCT01022398|82904878|FG000|Overall Study|Study terminated|2|||
46689814|NCT01022398|82904879|FG001|Overall Study|Study terminated|2|||
46689815|NCT01262976|82904890|FG000|Up to Month 2|Serious Adverse Event|0|||
46689816|NCT01262976|82904891|FG001|Up to Month 2|Serious Adverse Event|0|||
46689817|NCT01262976|82904892|FG002|Up to Month 2|Serious Adverse Event|1|||
46689818|NCT01262976|82904893|FG003|Up to Month 2|Serious Adverse Event|0|||
46689819|NCT01262976|82904894|FG004|Up to Month 2|Serious Adverse Event|0|||
46689820|NCT01262976|82904895|FG005|Up to Month 2|Serious Adverse Event|0|||
46689821|NCT01262976|82904890|FG000|Up to Month 2|Withdrawal by Subject|1|||
46689822|NCT01262976|82904891|FG001|Up to Month 2|Withdrawal by Subject|0|||
46689823|NCT01262976|82904892|FG002|Up to Month 2|Withdrawal by Subject|0|||
46689824|NCT01262976|82904893|FG003|Up to Month 2|Withdrawal by Subject|0|||
46689825|NCT01262976|82904894|FG004|Up to Month 2|Withdrawal by Subject|0|||
46689826|NCT01262976|82904895|FG005|Up to Month 2|Withdrawal by Subject|0|||
46689827|NCT01262976|82904890|FG000|Up to Month 2|Migrated/moved from study area|0|||
46689828|NCT01262976|82904891|FG001|Up to Month 2|Migrated/moved from study area|1|||
46689829|NCT01262976|82904892|FG002|Up to Month 2|Migrated/moved from study area|0|||
46689830|NCT01262976|82904893|FG003|Up to Month 2|Migrated/moved from study area|0|||
46689831|NCT01262976|82904894|FG004|Up to Month 2|Migrated/moved from study area|1|||
46689832|NCT01262976|82904895|FG005|Up to Month 2|Migrated/moved from study area|1|||
46689833|NCT01262976|82904890|FG000|Up to Month 2|Lost to Follow-up|1|||
46689834|NCT01262976|82904891|FG001|Up to Month 2|Lost to Follow-up|0|||
46689835|NCT01262976|82904892|FG002|Up to Month 2|Lost to Follow-up|0|||
46689836|NCT01262976|82904893|FG003|Up to Month 2|Lost to Follow-up|1|||
46689837|NCT01262976|82904894|FG004|Up to Month 2|Lost to Follow-up|1|||
46689838|NCT01262976|82904895|FG005|Up to Month 2|Lost to Follow-up|1|||
46689839|NCT01262976|82904890|FG000|Up to Month 2|Other|1|||
46689840|NCT01262976|82904891|FG001|Up to Month 2|Other|0|||
46689841|NCT01262976|82904892|FG002|Up to Month 2|Other|0|||
46689842|NCT01262976|82904893|FG003|Up to Month 2|Other|1|||
46689843|NCT01262976|82904894|FG004|Up to Month 2|Other|0|||
46689844|NCT01262976|82904895|FG005|Up to Month 2|Other|2|||
46689845|NCT01262976|82904890|FG000|Up to Month 7|Serious Adverse Event|0|||
46689846|NCT01262976|82904891|FG001|Up to Month 7|Serious Adverse Event|0|||
46689847|NCT01262976|82904892|FG002|Up to Month 7|Serious Adverse Event|2|||
46689848|NCT01262976|82904893|FG003|Up to Month 7|Serious Adverse Event|0|||
46689849|NCT01262976|82904894|FG004|Up to Month 7|Serious Adverse Event|0|||
46689850|NCT01262976|82904895|FG005|Up to Month 7|Serious Adverse Event|0|||
46689851|NCT01262976|82904890|FG000|Up to Month 7|Withdrawal by Subject|1|||
46800269|NCT00549848|83019240|FG001|Overall Study|Transplant|3|||
46800270|NCT00549848|83019241|FG002|Overall Study|Transplant|18|||
46800271|NCT00549848|83019239|FG000|Overall Study|Unacceptable Toxicity|1|||
46800272|NCT00549848|83019240|FG001|Overall Study|Unacceptable Toxicity|6|||
46800273|NCT00549848|83019241|FG002|Overall Study|Unacceptable Toxicity|6|||
46689852|NCT01262976|82904891|FG001|Up to Month 7|Withdrawal by Subject|0|||
46689853|NCT01262976|82904892|FG002|Up to Month 7|Withdrawal by Subject|0|||
46689854|NCT01262976|82904893|FG003|Up to Month 7|Withdrawal by Subject|0|||
46689855|NCT01262976|82904894|FG004|Up to Month 7|Withdrawal by Subject|0|||
46800274|NCT00549770|83019265|FG000|Overall Study|Protocol deviation|1|||
46689856|NCT01262976|82904895|FG005|Up to Month 7|Withdrawal by Subject|0|||
46689857|NCT01262976|82904890|FG000|Up to Month 7|Migrated/moved from study area|0|||
46689858|NCT01262976|82904891|FG001|Up to Month 7|Migrated/moved from study area|0|||
46689859|NCT01262976|82904892|FG002|Up to Month 7|Migrated/moved from study area|1|||
46689860|NCT01262976|82904893|FG003|Up to Month 7|Migrated/moved from study area|3|||
46689861|NCT01262976|82904894|FG004|Up to Month 7|Migrated/moved from study area|1|||
46689862|NCT01262976|82904895|FG005|Up to Month 7|Migrated/moved from study area|1|||
46689863|NCT01262976|82904890|FG000|Up to Month 7|Lost to Follow-up|1|||
46689864|NCT01262976|82904891|FG001|Up to Month 7|Lost to Follow-up|0|||
46689865|NCT01262976|82904892|FG002|Up to Month 7|Lost to Follow-up|1|||
46689866|NCT01262976|82904893|FG003|Up to Month 7|Lost to Follow-up|3|||
46689867|NCT01262976|82904894|FG004|Up to Month 7|Lost to Follow-up|1|||
46689868|NCT01262976|82904895|FG005|Up to Month 7|Lost to Follow-up|3|||
46689869|NCT01262976|82904890|FG000|Up to Month 7|Other|3|||
46689870|NCT01262976|82904891|FG001|Up to Month 7|Other|0|||
46689871|NCT01262976|82904892|FG002|Up to Month 7|Other|2|||
46689872|NCT01262976|82904893|FG003|Up to Month 7|Other|0|||
46689873|NCT01262976|82904894|FG004|Up to Month 7|Other|0|||
46689874|NCT01262976|82904895|FG005|Up to Month 7|Other|0|||
46689875|NCT01262976|82904890|FG000|Up to Year 1|Serious Adverse Event|0|||
46689876|NCT01262976|82904891|FG001|Up to Year 1|Serious Adverse Event|0|||
46689877|NCT01262976|82904892|FG002|Up to Year 1|Serious Adverse Event|2|||
46689878|NCT01262976|82904893|FG003|Up to Year 1|Serious Adverse Event|0|||
46689879|NCT01262976|82904894|FG004|Up to Year 1|Serious Adverse Event|0|||
46689880|NCT01262976|82904895|FG005|Up to Year 1|Serious Adverse Event|0|||
46689881|NCT01262976|82904890|FG000|Up to Year 1|Withdrawal by Subject|1|||
46689882|NCT01262976|82904891|FG001|Up to Year 1|Withdrawal by Subject|0|||
46689883|NCT01262976|82904892|FG002|Up to Year 1|Withdrawal by Subject|0|||
46689884|NCT01262976|82904893|FG003|Up to Year 1|Withdrawal by Subject|0|||
46689885|NCT01262976|82904894|FG004|Up to Year 1|Withdrawal by Subject|0|||
46689886|NCT01262976|82904895|FG005|Up to Year 1|Withdrawal by Subject|0|||
46689887|NCT01262976|82904890|FG000|Up to Year 1|Migrated/moved from study area|1|||
46689888|NCT01262976|82904891|FG001|Up to Year 1|Migrated/moved from study area|0|||
46689889|NCT01262976|82904892|FG002|Up to Year 1|Migrated/moved from study area|0|||
46689890|NCT01262976|82904893|FG003|Up to Year 1|Migrated/moved from study area|3|||
46689891|NCT01262976|82904894|FG004|Up to Year 1|Migrated/moved from study area|3|||
46689892|NCT01262976|82904895|FG005|Up to Year 1|Migrated/moved from study area|2|||
46689893|NCT01262976|82904890|FG000|Up to Year 1|Lost to Follow-up|4|||
46689894|NCT01262976|82904891|FG001|Up to Year 1|Lost to Follow-up|0|||
46689895|NCT01262976|82904892|FG002|Up to Year 1|Lost to Follow-up|0|||
46689896|NCT01262976|82904893|FG003|Up to Year 1|Lost to Follow-up|1|||
46689897|NCT01262976|82904894|FG004|Up to Year 1|Lost to Follow-up|6|||
46689898|NCT01262976|82904895|FG005|Up to Year 1|Lost to Follow-up|5|||
46689899|NCT01262976|82904890|FG000|Up to Year 1|Other|3|||
46689900|NCT01262976|82904891|FG001|Up to Year 1|Other|1|||
46689901|NCT01262976|82904892|FG002|Up to Year 1|Other|0|||
46689902|NCT01262976|82904893|FG003|Up to Year 1|Other|0|||
46689903|NCT01262976|82904894|FG004|Up to Year 1|Other|2|||
46689904|NCT01262976|82904895|FG005|Up to Year 1|Other|1|||
46689905|NCT01262976|82904890|FG000|Up to Year 1|Subjects with unknown completion status|0|||
46689906|NCT01262976|82904891|FG001|Up to Year 1|Subjects with unknown completion status|0|||
46689907|NCT01262976|82904892|FG002|Up to Year 1|Subjects with unknown completion status|1|||
46689908|NCT01262976|82904893|FG003|Up to Year 1|Subjects with unknown completion status|0|||
46689909|NCT01262976|82904894|FG004|Up to Year 1|Subjects with unknown completion status|0|||
46689910|NCT01262976|82904895|FG005|Up to Year 1|Subjects with unknown completion status|1|||
46689911|NCT01262976|82904890|FG000|Up to Year 2|Serious Adverse Event|0|||
46689912|NCT01262976|82904891|FG001|Up to Year 2|Serious Adverse Event|0|||
46689913|NCT01262976|82904892|FG002|Up to Year 2|Serious Adverse Event|2|||
46689914|NCT01262976|82904893|FG003|Up to Year 2|Serious Adverse Event|0|||
46689915|NCT01262976|82904894|FG004|Up to Year 2|Serious Adverse Event|0|||
46689916|NCT01262976|82904895|FG005|Up to Year 2|Serious Adverse Event|0|||
46689917|NCT01262976|82904890|FG000|Up to Year 2|Withdrawal by Subject|1|||
46689918|NCT01262976|82904891|FG001|Up to Year 2|Withdrawal by Subject|0|||
46689919|NCT01262976|82904892|FG002|Up to Year 2|Withdrawal by Subject|0|||
46689920|NCT01262976|82904893|FG003|Up to Year 2|Withdrawal by Subject|0|||
46689921|NCT01262976|82904894|FG004|Up to Year 2|Withdrawal by Subject|0|||
46689922|NCT01262976|82904895|FG005|Up to Year 2|Withdrawal by Subject|0|||
46689923|NCT01262976|82904890|FG000|Up to Year 2|Migrated/moved from study area|0|||
46689924|NCT01262976|82904891|FG001|Up to Year 2|Migrated/moved from study area|0|||
46689925|NCT01262976|82904892|FG002|Up to Year 2|Migrated/moved from study area|0|||
46689926|NCT01262976|82904893|FG003|Up to Year 2|Migrated/moved from study area|2|||
46689927|NCT01262976|82904894|FG004|Up to Year 2|Migrated/moved from study area|1|||
46689928|NCT01262976|82904895|FG005|Up to Year 2|Migrated/moved from study area|2|||
46689929|NCT01262976|82904890|FG000|Up to Year 2|Lost to Follow-up|1|||
46689930|NCT01262976|82904891|FG001|Up to Year 2|Lost to Follow-up|1|||
46800275|NCT00549770|83019266|FG001|Overall Study|Protocol deviation|1|||
46800276|NCT00549770|83019267|FG002|Overall Study|Protocol deviation|1|||
46800277|NCT00549770|83019268|FG003|Overall Study|Protocol deviation|2|||
46689931|NCT01262976|82904892|FG002|Up to Year 2|Lost to Follow-up|2|||
46689932|NCT01262976|82904893|FG003|Up to Year 2|Lost to Follow-up|2|||
46800278|NCT00549770|83019269|FG004|Overall Study|Protocol deviation|2|||
46689933|NCT01262976|82904894|FG004|Up to Year 2|Lost to Follow-up|3|||
46689934|NCT01262976|82904895|FG005|Up to Year 2|Lost to Follow-up|3|||
46689935|NCT01262976|82904890|FG000|Up to Year 2|Subjects with unknown completion status|0|||
46689936|NCT01262976|82904891|FG001|Up to Year 2|Subjects with unknown completion status|0|||
46689937|NCT01262976|82904892|FG002|Up to Year 2|Subjects with unknown completion status|1|||
46689938|NCT01262976|82904893|FG003|Up to Year 2|Subjects with unknown completion status|0|||
46689939|NCT01262976|82904894|FG004|Up to Year 2|Subjects with unknown completion status|0|||
46689940|NCT01262976|82904895|FG005|Up to Year 2|Subjects with unknown completion status|0|||
46689941|NCT01262976|82904890|FG000|Up to Year 2|Other|3|||
46689942|NCT01262976|82904891|FG001|Up to Year 2|Other|0|||
46689943|NCT01262976|82904892|FG002|Up to Year 2|Other|0|||
46689944|NCT01262976|82904893|FG003|Up to Year 2|Other|0|||
46689945|NCT01262976|82904894|FG004|Up to Year 2|Other|0|||
46689946|NCT01262976|82904895|FG005|Up to Year 2|Other|0|||
46689947|NCT01262976|82904890|FG000|Up to Year 3|Serious Adverse Event|0|||
46689948|NCT01262976|82904891|FG001|Up to Year 3|Serious Adverse Event|0|||
46689949|NCT01262976|82904892|FG002|Up to Year 3|Serious Adverse Event|2|||
46689950|NCT01262976|82904893|FG003|Up to Year 3|Serious Adverse Event|0|||
46689951|NCT01262976|82904894|FG004|Up to Year 3|Serious Adverse Event|0|||
46689952|NCT01262976|82904895|FG005|Up to Year 3|Serious Adverse Event|0|||
46689953|NCT01262976|82904890|FG000|Up to Year 3|Withdrawal by Subject|1|||
46689954|NCT01262976|82904891|FG001|Up to Year 3|Withdrawal by Subject|0|||
46689955|NCT01262976|82904892|FG002|Up to Year 3|Withdrawal by Subject|0|||
46689956|NCT01262976|82904893|FG003|Up to Year 3|Withdrawal by Subject|0|||
46689957|NCT01262976|82904894|FG004|Up to Year 3|Withdrawal by Subject|0|||
46689958|NCT01262976|82904895|FG005|Up to Year 3|Withdrawal by Subject|0|||
46689959|NCT01262976|82904890|FG000|Up to Year 3|Migrated/moved from study area|0|||
46689960|NCT01262976|82904891|FG001|Up to Year 3|Migrated/moved from study area|0|||
46689961|NCT01262976|82904892|FG002|Up to Year 3|Migrated/moved from study area|0|||
46689962|NCT01262976|82904893|FG003|Up to Year 3|Migrated/moved from study area|2|||
46689963|NCT01262976|82904894|FG004|Up to Year 3|Migrated/moved from study area|1|||
46689964|NCT01262976|82904895|FG005|Up to Year 3|Migrated/moved from study area|1|||
46689965|NCT01262976|82904890|FG000|Up to Year 3|Lost to Follow-up|2|||
46689966|NCT01262976|82904891|FG001|Up to Year 3|Lost to Follow-up|2|||
46689967|NCT01262976|82904892|FG002|Up to Year 3|Lost to Follow-up|4|||
46689968|NCT01262976|82904893|FG003|Up to Year 3|Lost to Follow-up|3|||
46689969|NCT01262976|82904894|FG004|Up to Year 3|Lost to Follow-up|1|||
46689970|NCT01262976|82904895|FG005|Up to Year 3|Lost to Follow-up|3|||
46689971|NCT01262976|82904890|FG000|Up to Year 3|Subjects with unknown completion status|0|||
46689972|NCT01262976|82904891|FG001|Up to Year 3|Subjects with unknown completion status|0|||
46689973|NCT01262976|82904892|FG002|Up to Year 3|Subjects with unknown completion status|1|||
46689974|NCT01262976|82904893|FG003|Up to Year 3|Subjects with unknown completion status|0|||
46689975|NCT01262976|82904894|FG004|Up to Year 3|Subjects with unknown completion status|0|||
46689976|NCT01262976|82904895|FG005|Up to Year 3|Subjects with unknown completion status|0|||
46689977|NCT01262976|82904890|FG000|Up to Year 3|Other|3|||
46689978|NCT01262976|82904891|FG001|Up to Year 3|Other|0|||
46689979|NCT01262976|82904892|FG002|Up to Year 3|Other|0|||
46689980|NCT01262976|82904893|FG003|Up to Year 3|Other|0|||
46689981|NCT01262976|82904894|FG004|Up to Year 3|Other|0|||
46689982|NCT01262976|82904895|FG005|Up to Year 3|Other|0|||
46689983|NCT01300286|82904910|FG000|Overall Study|did not get dosed|1|||
46689984|NCT01300052|82904917|FG000|Overall Study|Adverse Event|3|||
46689985|NCT01300052|82904918|FG001|Overall Study|Adverse Event|0|||
46689986|NCT01300052|82904917|FG000|Overall Study|Withdrawal by Subject|2|||
46689987|NCT01300052|82904918|FG001|Overall Study|Withdrawal by Subject|2|||
46689988|NCT01300052|82904917|FG000|Overall Study|Protocol Violation|1|||
46689989|NCT01300052|82904918|FG001|Overall Study|Protocol Violation|1|||
46689990|NCT01299896|82904926|FG000|Overall Study|Withdrawal by Subject|1|||
46689991|NCT01299896|82904927|FG001|Overall Study|Withdrawal by Subject|7|||
46689992|NCT01299896|82904926|FG000|Overall Study|Lost to Follow-up|0|||
46689993|NCT01299896|82904927|FG001|Overall Study|Lost to Follow-up|11|||
46689994|NCT01299584|82904933|FG000|Overall Study|Protocol Violation|9|||
46689995|NCT01236573|82904948|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46689996|NCT01236573|82904949|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46689997|NCT01236573|82904950|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46689998|NCT01236573|82904951|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46689999|NCT01236573|82904952|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46690000|NCT01236573|82904953|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46690001|NCT01236573|82904954|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
46690002|NCT01236573|82904955|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46690003|NCT01236573|82904956|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
46690004|NCT01236573|82904957|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
46690005|NCT01236573|82904958|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
46690006|NCT01236573|82904948|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690007|NCT01236573|82904949|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690008|NCT01236573|82904950|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690009|NCT01236573|82904951|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690010|NCT01236573|82904952|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690011|NCT01236573|82904953|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690012|NCT01236573|82904954|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690013|NCT01236573|82904955|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690014|NCT01236573|82904956|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
46690015|NCT01236573|82904957|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690016|NCT01236573|82904958|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
46690017|NCT01236573|82904948|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690018|NCT01236573|82904949|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690019|NCT01236573|82904950|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690020|NCT01236573|82904951|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690021|NCT01236573|82904952|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690022|NCT01236573|82904953|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690023|NCT01236573|82904954|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690024|NCT01236573|82904955|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690025|NCT01236573|82904956|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690026|NCT01236573|82904957|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
46690027|NCT01236573|82904958|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
46690028|NCT01236339|82904985|FG000|Overall Study|Termination of study by sponsor|11|||
46690029|NCT01236339|82904986|FG001|Overall Study|Termination of study by sponsor|13|||
46690030|NCT01262898|82904997|FG000|Overall Study|Protocol Violation|1|||
46690031|NCT01262898|82904998|FG001|Overall Study|Protocol Violation|1|||
46690032|NCT01262898|82904999|FG002|Overall Study|Protocol Violation|0|||
46690033|NCT01262898|82905000|FG003|Overall Study|Protocol Violation|0|||
46690034|NCT01262898|82904997|FG000|Overall Study|Lost to Follow-up|1|||
46690035|NCT01262898|82904998|FG001|Overall Study|Lost to Follow-up|0|||
46690036|NCT01262898|82904999|FG002|Overall Study|Lost to Follow-up|0|||
46690037|NCT01262898|82905000|FG003|Overall Study|Lost to Follow-up|0|||
46690038|NCT01262898|82904997|FG000|Overall Study|Withdrawal by Subject|1|||
46690039|NCT01262898|82904998|FG001|Overall Study|Withdrawal by Subject|1|||
46690040|NCT01262898|82904999|FG002|Overall Study|Withdrawal by Subject|0|||
46690041|NCT01262898|82905000|FG003|Overall Study|Withdrawal by Subject|0|||
46690042|NCT01262820|82905013|FG000|Overall Study|Adverse Event|5|||
46690043|NCT01262820|82905013|FG000|Overall Study|Lack of Efficacy|9|||
46690044|NCT01262820|82905013|FG000|Overall Study|Drug held for 21+ days|1|||
46690045|NCT01057810|82905019|FG000|Overall Study|Disease progression|156|||
46800279|NCT00549770|83019270|FG005|Overall Study|Protocol deviation|2|||
46800280|NCT00549770|83019271|FG006|Overall Study|Protocol deviation|1|||
46800281|NCT00549770|83019272|FG007|Overall Study|Protocol deviation|2|||
46800282|NCT00549770|83019265|FG000|Overall Study|Administrative problems|0|||
46800283|NCT00549770|83019266|FG001|Overall Study|Administrative problems|1|||
46690046|NCT01057810|82905020|FG001|Overall Study|Disease progression|197|||
46690047|NCT01057810|82905019|FG000|Overall Study|Study drug toxicity|5|||
46690048|NCT01057810|82905020|FG001|Overall Study|Study drug toxicity|114|||
46690049|NCT01057810|82905019|FG000|Overall Study|Adverse event unrelated to study drug|13|||
46800284|NCT00549770|83019267|FG002|Overall Study|Administrative problems|0|||
46800285|NCT00549770|83019268|FG003|Overall Study|Administrative problems|0|||
46690050|NCT01057810|82905020|FG001|Overall Study|Adverse event unrelated to study drug|29|||
46690051|NCT01057810|82905019|FG000|Overall Study|Withdrawal by Subject|10|||
46690052|NCT01057810|82905020|FG001|Overall Study|Withdrawal by Subject|25|||
46690053|NCT01057810|82905019|FG000|Overall Study|Death|2|||
46690054|NCT01057810|82905020|FG001|Overall Study|Death|12|||
46690055|NCT01057810|82905019|FG000|Overall Study|Maximum clinical benefit|5|||
46690056|NCT01057810|82905020|FG001|Overall Study|Maximum clinical benefit|5|||
46690057|NCT01057810|82905019|FG000|Overall Study|Poor/non-compliance|0|||
46690058|NCT01057810|82905020|FG001|Overall Study|Poor/non-compliance|1|||
46690059|NCT01057810|82905019|FG000|Overall Study|No longer met study criteria|0|||
46690060|NCT01057810|82905020|FG001|Overall Study|No longer met study criteria|1|||
46690061|NCT01057810|82905019|FG000|Overall Study|Other|7|||
46690062|NCT01057810|82905020|FG001|Overall Study|Other|14|||
46690063|NCT01262352|82905028|FG000|Period 1|Illness after randomization|1|||
46690064|NCT01262352|82905029|FG001|Period 1|Illness after randomization|0|||
46800286|NCT00549770|83019269|FG004|Overall Study|Administrative problems|0|||
46800287|NCT00549770|83019270|FG005|Overall Study|Administrative problems|0|||
46800288|NCT00549770|83019271|FG006|Overall Study|Administrative problems|0|||
46800289|NCT00549770|83019272|FG007|Overall Study|Administrative problems|1|||
46800290|NCT00549770|83019265|FG000|Overall Study|Lost to Follow-up|0|||
46800291|NCT00549770|83019266|FG001|Overall Study|Lost to Follow-up|0|||
46800292|NCT00549770|83019267|FG002|Overall Study|Lost to Follow-up|2|||
46690065|NCT01262352|82905028|FG000|Washout|Adverse Event|1|||
46800293|NCT00549770|83019268|FG003|Overall Study|Lost to Follow-up|2|||
46690066|NCT01262352|82905029|FG001|Washout|Adverse Event|1|||
46690067|NCT01262352|82905028|FG000|Washout|Extended Washout|0|||
46690068|NCT01262352|82905029|FG001|Washout|Extended Washout|1|||
46690069|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
46690070|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
46690071|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
46690072|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
46858760|NCT02939716|83074552|FG002|Overall Study|scanner failure|0|||
46858761|NCT02939716|83074553|FG003|Overall Study|scanner failure|1|||
46690073|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
46690074|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
46690075|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
46690076|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
46690077|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
46690078|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
46690079|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
46800294|NCT00549770|83019269|FG004|Overall Study|Lost to Follow-up|3|||
46800295|NCT00549770|83019270|FG005|Overall Study|Lost to Follow-up|2|||
46800296|NCT00549770|83019271|FG006|Overall Study|Lost to Follow-up|0|||
46800297|NCT00549770|83019272|FG007|Overall Study|Lost to Follow-up|0|||
46800298|NCT00549770|83019265|FG000|Overall Study|Withdrawal by Subject|4|||
46800299|NCT00549770|83019266|FG001|Overall Study|Withdrawal by Subject|6|||
46800300|NCT00549770|83019267|FG002|Overall Study|Withdrawal by Subject|4|||
46800301|NCT00549770|83019268|FG003|Overall Study|Withdrawal by Subject|5|||
46800302|NCT00549770|83019269|FG004|Overall Study|Withdrawal by Subject|6|||
46800303|NCT00549770|83019270|FG005|Overall Study|Withdrawal by Subject|6|||
46800304|NCT00549770|83019271|FG006|Overall Study|Withdrawal by Subject|4|||
46800305|NCT00549770|83019272|FG007|Overall Study|Withdrawal by Subject|9|||
46800306|NCT00549770|83019265|FG000|Overall Study|Lack of Efficacy|1|||
46800307|NCT00549770|83019266|FG001|Overall Study|Lack of Efficacy|0|||
46800308|NCT00549770|83019267|FG002|Overall Study|Lack of Efficacy|2|||
46800309|NCT00549770|83019268|FG003|Overall Study|Lack of Efficacy|3|||
46800310|NCT00549770|83019269|FG004|Overall Study|Lack of Efficacy|5|||
46800311|NCT00549770|83019270|FG005|Overall Study|Lack of Efficacy|1|||
46800312|NCT00549770|83019271|FG006|Overall Study|Lack of Efficacy|3|||
46800313|NCT00549770|83019272|FG007|Overall Study|Lack of Efficacy|8|||
46800314|NCT00549770|83019265|FG000|Overall Study|Abnormal test procedure results|0|||
46800315|NCT00549770|83019266|FG001|Overall Study|Abnormal test procedure results|0|||
46800316|NCT00549770|83019267|FG002|Overall Study|Abnormal test procedure results|0|||
46800317|NCT00549770|83019268|FG003|Overall Study|Abnormal test procedure results|2|||
46800318|NCT00549770|83019269|FG004|Overall Study|Abnormal test procedure results|0|||
46800319|NCT00549770|83019270|FG005|Overall Study|Abnormal test procedure results|1|||
46690080|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
46690081|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
46690082|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
46690083|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
46800320|NCT00549770|83019271|FG006|Overall Study|Abnormal test procedure results|1|||
46800321|NCT00549770|83019272|FG007|Overall Study|Abnormal test procedure results|1|||
46800322|NCT00549770|83019265|FG000|Overall Study|Abnormal laboratory values|0|||
46800323|NCT00549770|83019266|FG001|Overall Study|Abnormal laboratory values|0|||
46800324|NCT00549770|83019267|FG002|Overall Study|Abnormal laboratory values|0|||
46858762|NCT02939716|83074554|FG004|Overall Study|scanner failure|1|||
46690084|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
46690085|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
46690086|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
46690087|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
46690088|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
46690089|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
46690090|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
46690091|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
46690092|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
46690093|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
46690094|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
46690095|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
46690096|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
46690097|NCT01299272|82905035|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
46690098|NCT01299272|82905036|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
46690099|NCT01299272|82905037|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
46690100|NCT01299272|82905038|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
46690101|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
46690102|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
46690103|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
46690104|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
46690105|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
46690106|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
46690107|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
46690108|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
46690109|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
46690110|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
46690111|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
46690112|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
46690113|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
46690114|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
46690115|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
46690116|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
46690117|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
46690118|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
46690119|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
46690120|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
46800325|NCT00549770|83019268|FG003|Overall Study|Abnormal laboratory values|0|||
46800326|NCT00549770|83019269|FG004|Overall Study|Abnormal laboratory values|0|||
46800327|NCT00549770|83019270|FG005|Overall Study|Abnormal laboratory values|1|||
46800328|NCT00549770|83019271|FG006|Overall Study|Abnormal laboratory values|0|||
46800329|NCT00549770|83019272|FG007|Overall Study|Abnormal laboratory values|0|||
46800330|NCT00549770|83019265|FG000|Overall Study|Adverse Event|1|||
46800331|NCT00549770|83019266|FG001|Overall Study|Adverse Event|3|||
46800332|NCT00549770|83019267|FG002|Overall Study|Adverse Event|1|||
46800333|NCT00549770|83019268|FG003|Overall Study|Adverse Event|2|||
46800334|NCT00549770|83019269|FG004|Overall Study|Adverse Event|1|||
46800335|NCT00549770|83019270|FG005|Overall Study|Adverse Event|0|||
46800336|NCT00549770|83019271|FG006|Overall Study|Adverse Event|5|||
46800337|NCT00549770|83019272|FG007|Overall Study|Adverse Event|4|||
46800338|NCT00548184|83019290|FG000|Overall Study|Adverse Event|3|||
46800339|NCT00548184|83019290|FG000|Overall Study|took other drug|1|||
46800340|NCT00548184|83019290|FG000|Overall Study|Found Her2 negative|1|||
46800341|NCT00454636|83019298|FG000|Overall Study|Adverse Event|10|||
46800342|NCT00454636|83019299|FG001|Overall Study|Adverse Event|6|||
46690121|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
46690122|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
46690123|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
46690124|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
46690125|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
46690126|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
46690127|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
46690128|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
46690129|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
46690130|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
46690131|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
46690132|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
46690133|NCT01299272|82905035|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
46690134|NCT01299272|82905036|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
46690135|NCT01299272|82905037|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
46690136|NCT01299272|82905038|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
46690137|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
46690138|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
46690139|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
46690140|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
46690141|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
46690142|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
46690143|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
46690144|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
46690145|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
46690146|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
46690147|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
46690148|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
46690149|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
46690150|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
46690151|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
46690152|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
46690153|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
46690154|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
46690155|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
46690156|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
46690157|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
46690158|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
46690159|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
46690160|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
46690161|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
46800343|NCT00454636|83019300|FG002|Overall Study|Adverse Event|9|||
46800344|NCT00454636|83019301|FG003|Overall Study|Adverse Event|15|||
46690162|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
46690163|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
46690164|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
46690165|NCT01299272|82905035|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
46690166|NCT01299272|82905036|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
46690167|NCT01299272|82905037|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
46800345|NCT00454636|83019298|FG000|Overall Study|Disease Progression|11|||
46800346|NCT00454636|83019299|FG001|Overall Study|Disease Progression|12|||
46800347|NCT00454636|83019300|FG002|Overall Study|Disease Progression|4|||
46800348|NCT00454636|83019301|FG003|Overall Study|Disease Progression|11|||
46858763|NCT02939716|83074555|FG005|Overall Study|scanner failure|1|||
46858764|NCT00367133|83074584|FG000|2 Years|Death|20|||
46800349|NCT00454636|83019298|FG000|Overall Study|Protocol Violation|3|||
46800350|NCT00454636|83019299|FG001|Overall Study|Protocol Violation|2|||
46800351|NCT00454636|83019300|FG002|Overall Study|Protocol Violation|3|||
46800352|NCT00454636|83019301|FG003|Overall Study|Protocol Violation|3|||
46800353|NCT00454636|83019298|FG000|Overall Study|Death|6|||
46800354|NCT00454636|83019299|FG001|Overall Study|Death|1|||
46800355|NCT00454636|83019300|FG002|Overall Study|Death|1|||
46800356|NCT00454636|83019301|FG003|Overall Study|Death|1|||
46800357|NCT00454636|83019298|FG000|Overall Study|Patient refusal|1|||
46800358|NCT00454636|83019299|FG001|Overall Study|Patient refusal|1|||
46858765|NCT00367133|83074585|FG001|2 Years|Death|12|||
46800359|NCT00454636|83019300|FG002|Overall Study|Patient refusal|3|||
46800360|NCT00454636|83019301|FG003|Overall Study|Patient refusal|2|||
46800361|NCT00454636|83019298|FG000|Overall Study|Lost to Follow-up|0|||
46800362|NCT00454636|83019299|FG001|Overall Study|Lost to Follow-up|1|||
46858766|NCT00367133|83074586|FG002|2 Years|Death|12|||
46690168|NCT01299272|82905038|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
46690169|NCT01299116|82905055|FG000|Overall Study|Lost to Follow-up|65|||
46690170|NCT01299116|82905056|FG001|Overall Study|Lost to Follow-up|9|||
46690171|NCT01299116|82905057|FG002|Overall Study|Lost to Follow-up|11|||
46690172|NCT01299038|82905070|FG000|Overall Study|Withdrawal by Subject|1|||
46690173|NCT01299038|82905071|FG001|Overall Study|Withdrawal by Subject|0|||
46690174|NCT01298648|82905077|FG000|Overall Study|Withdrawal by Subject|2|||
46690175|NCT01298648|82905077|FG000|Overall Study|Lost to Follow-up|21|||
46690176|NCT01261338|82905083|FG000|Overall Study|Withdrawal by Subject|3|||
46690177|NCT01261338|82905084|FG001|Overall Study|Withdrawal by Subject|2|||
46690178|NCT01260948|82905092|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
46690179|NCT01260948|82905093|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
46690180|NCT01260948|82905092|FG000|Second Intervention|Emesis|0|||
46690181|NCT01260948|82905093|FG001|Second Intervention|Emesis|1|||
46690182|NCT01025284|82905102|FG000|Overall Study|Investigator Decision|0|||
46690183|NCT01025284|82905103|FG001|Overall Study|Investigator Decision|1|||
46690184|NCT01025284|82905104|FG002|Overall Study|Investigator Decision|0|||
46690185|NCT01025284|82905102|FG000|Overall Study|Withdrawal by Subject|0|||
46690186|NCT01025284|82905103|FG001|Overall Study|Withdrawal by Subject|1|||
46690187|NCT01025284|82905104|FG002|Overall Study|Withdrawal by Subject|0|||
46690188|NCT01021852|82905122|FG000|Treatment Period 1|Adverse Event|3|||
46690189|NCT01021852|82905123|FG001|Treatment Period 1|Adverse Event|1|||
46690190|NCT01021852|82905124|FG002|Treatment Period 1|Adverse Event|1|||
46690191|NCT01021852|82905125|FG003|Treatment Period 1|Adverse Event|0|||
46690192|NCT01021852|82905126|FG004|Treatment Period 1|Adverse Event|2|||
46690193|NCT01021852|82905127|FG005|Treatment Period 1|Adverse Event|2|||
46690194|NCT01021852|82905128|FG006|Treatment Period 1|Adverse Event|0|||
46690195|NCT01021852|82905129|FG007|Treatment Period 1|Adverse Event|0|||
46690196|NCT01021852|82905122|FG000|Treatment Period 1|Pregnancy|0|||
46690197|NCT01021852|82905123|FG001|Treatment Period 1|Pregnancy|0|||
46690198|NCT01021852|82905124|FG002|Treatment Period 1|Pregnancy|1|||
46690199|NCT01021852|82905125|FG003|Treatment Period 1|Pregnancy|0|||
46690200|NCT01021852|82905126|FG004|Treatment Period 1|Pregnancy|0|||
46690201|NCT01021852|82905127|FG005|Treatment Period 1|Pregnancy|0|||
46690202|NCT01021852|82905128|FG006|Treatment Period 1|Pregnancy|0|||
46690203|NCT01021852|82905129|FG007|Treatment Period 1|Pregnancy|0|||
46690204|NCT01021852|82905122|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46690205|NCT01021852|82905123|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46690206|NCT01021852|82905124|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46690207|NCT01021852|82905125|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46690208|NCT01021852|82905126|FG004|Treatment Period 1|Withdrawal by Subject|1|||
46690209|NCT01021852|82905127|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46690210|NCT01021852|82905128|FG006|Treatment Period 1|Withdrawal by Subject|0|||
46690211|NCT01021852|82905129|FG007|Treatment Period 1|Withdrawal by Subject|1|||
46690212|NCT01021852|82905122|FG000|Treatment Period 1|Not Treated|0|||
46690213|NCT01021852|82905123|FG001|Treatment Period 1|Not Treated|0|||
46690214|NCT01021852|82905124|FG002|Treatment Period 1|Not Treated|0|||
46690215|NCT01021852|82905125|FG003|Treatment Period 1|Not Treated|2|||
46690216|NCT01021852|82905126|FG004|Treatment Period 1|Not Treated|0|||
46800363|NCT00454636|83019300|FG002|Overall Study|Lost to Follow-up|0|||
46800364|NCT00454636|83019301|FG003|Overall Study|Lost to Follow-up|0|||
46690217|NCT01021852|82905127|FG005|Treatment Period 1|Not Treated|0|||
46690218|NCT01021852|82905128|FG006|Treatment Period 1|Not Treated|0|||
46690219|NCT01021852|82905129|FG007|Treatment Period 1|Not Treated|0|||
46690220|NCT01021852|82905122|FG000|Washout Period-Placebo|Adverse Event|0|||
46690221|NCT01021852|82905123|FG001|Washout Period-Placebo|Adverse Event|0|||
46690222|NCT01021852|82905124|FG002|Washout Period-Placebo|Adverse Event|0|||
46800365|NCT00427960|83019313|FG000|Overall Study|Adverse Event|2|||
46690223|NCT01021852|82905125|FG003|Washout Period-Placebo|Adverse Event|1|||
46690224|NCT01021852|82905126|FG004|Washout Period-Placebo|Adverse Event|0|||
46690225|NCT01021852|82905127|FG005|Washout Period-Placebo|Adverse Event|1|||
46690226|NCT01021852|82905128|FG006|Washout Period-Placebo|Adverse Event|0|||
46690227|NCT01021852|82905129|FG007|Washout Period-Placebo|Adverse Event|0|||
46690228|NCT01021852|82905122|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
46690229|NCT01021852|82905123|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
46690230|NCT01021852|82905124|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
46690231|NCT01021852|82905125|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
46690232|NCT01021852|82905126|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
46690233|NCT01021852|82905127|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
46690234|NCT01021852|82905128|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
46690235|NCT01021852|82905129|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
46690236|NCT01021852|82905122|FG000|Washout Period-Placebo|Protocol Violation|0|||
46690237|NCT01021852|82905123|FG001|Washout Period-Placebo|Protocol Violation|0|||
46690238|NCT01021852|82905124|FG002|Washout Period-Placebo|Protocol Violation|0|||
46690239|NCT01021852|82905125|FG003|Washout Period-Placebo|Protocol Violation|0|||
46690240|NCT01021852|82905126|FG004|Washout Period-Placebo|Protocol Violation|0|||
46690241|NCT01021852|82905127|FG005|Washout Period-Placebo|Protocol Violation|0|||
46690242|NCT01021852|82905128|FG006|Washout Period-Placebo|Protocol Violation|1|||
46690243|NCT01021852|82905129|FG007|Washout Period-Placebo|Protocol Violation|0|||
46690244|NCT01021852|82905122|FG000|Washout Period-No Drug|Adverse Event|1|||
46690245|NCT01021852|82905123|FG001|Washout Period-No Drug|Adverse Event|0|||
46690246|NCT01021852|82905124|FG002|Washout Period-No Drug|Adverse Event|0|||
46690247|NCT01021852|82905125|FG003|Washout Period-No Drug|Adverse Event|0|||
46690248|NCT01021852|82905126|FG004|Washout Period-No Drug|Adverse Event|0|||
46690249|NCT01021852|82905127|FG005|Washout Period-No Drug|Adverse Event|1|||
46690250|NCT01021852|82905128|FG006|Washout Period-No Drug|Adverse Event|0|||
46690251|NCT01021852|82905129|FG007|Washout Period-No Drug|Adverse Event|0|||
46690252|NCT01021852|82905122|FG000|Treatment Period 2|Adverse Event|0|||
46690253|NCT01021852|82905123|FG001|Treatment Period 2|Adverse Event|1|||
46690254|NCT01021852|82905124|FG002|Treatment Period 2|Adverse Event|0|||
46690255|NCT01021852|82905125|FG003|Treatment Period 2|Adverse Event|0|||
46690256|NCT01021852|82905126|FG004|Treatment Period 2|Adverse Event|1|||
46690257|NCT01021852|82905127|FG005|Treatment Period 2|Adverse Event|0|||
46690258|NCT01021852|82905128|FG006|Treatment Period 2|Adverse Event|1|||
46690259|NCT01021852|82905129|FG007|Treatment Period 2|Adverse Event|0|||
46690260|NCT01021852|82905122|FG000|Treatment Period 2|Lack of Efficacy|0|||
46690261|NCT01021852|82905123|FG001|Treatment Period 2|Lack of Efficacy|0|||
46690262|NCT01021852|82905124|FG002|Treatment Period 2|Lack of Efficacy|0|||
46690263|NCT01021852|82905125|FG003|Treatment Period 2|Lack of Efficacy|0|||
46690264|NCT01021852|82905126|FG004|Treatment Period 2|Lack of Efficacy|0|||
46690265|NCT01021852|82905127|FG005|Treatment Period 2|Lack of Efficacy|1|||
46690266|NCT01021852|82905128|FG006|Treatment Period 2|Lack of Efficacy|0|||
46690267|NCT01021852|82905129|FG007|Treatment Period 2|Lack of Efficacy|0|||
46690268|NCT01021852|82905122|FG000|Treatment Period 2|Physician Decision|0|||
46690269|NCT01021852|82905123|FG001|Treatment Period 2|Physician Decision|0|||
46690270|NCT01021852|82905124|FG002|Treatment Period 2|Physician Decision|1|||
46690271|NCT01021852|82905125|FG003|Treatment Period 2|Physician Decision|0|||
46690272|NCT01021852|82905126|FG004|Treatment Period 2|Physician Decision|0|||
46690273|NCT01021852|82905127|FG005|Treatment Period 2|Physician Decision|0|||
46690274|NCT01021852|82905128|FG006|Treatment Period 2|Physician Decision|0|||
46690275|NCT01021852|82905129|FG007|Treatment Period 2|Physician Decision|0|||
46690276|NCT01021852|82905122|FG000|Treatment Period 2|Protocol Violation|0|||
46690277|NCT01021852|82905123|FG001|Treatment Period 2|Protocol Violation|0|||
46690278|NCT01021852|82905124|FG002|Treatment Period 2|Protocol Violation|0|||
46690279|NCT01021852|82905125|FG003|Treatment Period 2|Protocol Violation|0|||
46690280|NCT01021852|82905126|FG004|Treatment Period 2|Protocol Violation|1|||
46690281|NCT01021852|82905127|FG005|Treatment Period 2|Protocol Violation|0|||
46690282|NCT01021852|82905128|FG006|Treatment Period 2|Protocol Violation|1|||
46690283|NCT01021852|82905129|FG007|Treatment Period 2|Protocol Violation|0|||
46690284|NCT01021852|82905122|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46690285|NCT01021852|82905123|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46690286|NCT01021852|82905124|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46690287|NCT01021852|82905125|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46690288|NCT01021852|82905126|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46690289|NCT01021852|82905127|FG005|Treatment Period 2|Withdrawal by Subject|0|||
46690290|NCT01021852|82905128|FG006|Treatment Period 2|Withdrawal by Subject|1|||
46690291|NCT01021852|82905129|FG007|Treatment Period 2|Withdrawal by Subject|2|||
46690292|NCT01056718|82905143|FG000|Overall Study|Withdrawal by Subject|2|||
46690293|NCT01056718|82905143|FG000|Overall Study|Ischemia on baseline stress test|1|||
46690294|NCT01298570|82905150|FG000|Overall Study|Disease progression, relapse during acti|64|||
46690295|NCT01298570|82905151|FG001|Overall Study|Disease progression, relapse during acti|40|||
46690296|NCT01298570|82905150|FG000|Overall Study|Adverse Event|20|||
46800366|NCT00427960|83019314|FG001|Overall Study|Adverse Event|0|||
46800367|NCT00427960|83019313|FG000|Overall Study|Withdrawal by Subject|0|||
46800368|NCT00427960|83019314|FG001|Overall Study|Withdrawal by Subject|3|||
46800369|NCT00427960|83019313|FG000|Overall Study|Other|0|||
46800370|NCT00427960|83019314|FG001|Overall Study|Other|1|||
46800371|NCT00548340|83019323|FG000|Overall Study|Protocol Violation|2|||
46800372|NCT00548340|83019324|FG001|Overall Study|Protocol Violation|3|||
46800373|NCT00548340|83019325|FG002|Overall Study|Protocol Violation|3|||
46800374|NCT00548340|83019323|FG000|Overall Study|Adverse Event|2|||
46800375|NCT00548340|83019324|FG001|Overall Study|Adverse Event|2|||
46800376|NCT00548340|83019325|FG002|Overall Study|Adverse Event|2|||
46800377|NCT00548340|83019323|FG000|Overall Study|Lost to Follow-up|1|||
46800378|NCT00548340|83019324|FG001|Overall Study|Lost to Follow-up|1|||
46800379|NCT00548340|83019325|FG002|Overall Study|Lost to Follow-up|0|||
46800380|NCT00548340|83019323|FG000|Overall Study|Withdrawal by Subject|2|||
46800381|NCT00548340|83019324|FG001|Overall Study|Withdrawal by Subject|4|||
46800382|NCT00548340|83019325|FG002|Overall Study|Withdrawal by Subject|3|||
46800383|NCT00548340|83019323|FG000|Overall Study|Other|1|||
46800384|NCT00548340|83019324|FG001|Overall Study|Other|1|||
46800385|NCT00548340|83019325|FG002|Overall Study|Other|1|||
46800386|NCT00454246|83019336|FG000|Overall Study|Adverse Event|2|||
46800387|NCT00454246|83019337|FG001|Overall Study|Adverse Event|2|||
46800388|NCT00454246|83019338|FG002|Overall Study|Adverse Event|0|||
46800389|NCT00454246|83019336|FG000|Overall Study|Violation of selection criteria at entry|6|||
46800390|NCT00454246|83019337|FG001|Overall Study|Violation of selection criteria at entry|0|||
46800391|NCT00454246|83019338|FG002|Overall Study|Violation of selection criteria at entry|0|||
46800392|NCT00454246|83019336|FG000|Overall Study|Protocol Violation|1|||
46800393|NCT00454246|83019337|FG001|Overall Study|Protocol Violation|0|||
46800394|NCT00454246|83019338|FG002|Overall Study|Protocol Violation|0|||
46800395|NCT00454246|83019336|FG000|Overall Study|Refused Treatment|1|||
46800396|NCT00454246|83019337|FG001|Overall Study|Refused Treatment|1|||
46800397|NCT00454246|83019338|FG002|Overall Study|Refused Treatment|0|||
46800398|NCT00454246|83019336|FG000|Overall Study|Failure to return|1|||
46690297|NCT01298570|82905151|FG001|Overall Study|Adverse Event|2|||
46690298|NCT01298570|82905150|FG000|Overall Study|Withdrawal by Subject|21|||
46690299|NCT01298570|82905151|FG001|Overall Study|Withdrawal by Subject|6|||
46690300|NCT01298570|82905150|FG000|Overall Study|Treatment delay > 4 weeks|4|||
46690301|NCT01298570|82905151|FG001|Overall Study|Treatment delay > 4 weeks|5|||
46690302|NCT01298570|82905150|FG000|Overall Study|Physician Decision|4|||
46690303|NCT01298570|82905151|FG001|Overall Study|Physician Decision|2|||
46690304|NCT01298570|82905150|FG000|Overall Study|Other complicating disease|2|||
46690305|NCT01298570|82905151|FG001|Overall Study|Other complicating disease|1|||
46690306|NCT01298570|82905150|FG000|Overall Study|Surgery|2|||
46690307|NCT01298570|82905151|FG001|Overall Study|Surgery|1|||
46690308|NCT01298570|82905150|FG000|Overall Study|Symptomatic progression/deterioration|3|||
46690309|NCT01298570|82905151|FG001|Overall Study|Symptomatic progression/deterioration|2|||
46690310|NCT01298570|82905150|FG000|Overall Study|Death|0|||
46690311|NCT01298570|82905151|FG001|Overall Study|Death|1|||
46690312|NCT01298570|82905150|FG000|Overall Study|Ineligibility|0|||
46690313|NCT01298570|82905151|FG001|Overall Study|Ineligibility|1|||
46690314|NCT01259856|82905159|FG000|Overall Study|Adverse Event|12|||
46690315|NCT01259856|82905160|FG001|Overall Study|Adverse Event|9|||
46690316|NCT01259856|82905159|FG000|Overall Study|Death|0|||
46690317|NCT01259856|82905160|FG001|Overall Study|Death|1|||
46690318|NCT01259856|82905159|FG000|Overall Study|Lack of Efficacy|3|||
46690319|NCT01259856|82905160|FG001|Overall Study|Lack of Efficacy|1|||
46690320|NCT01259856|82905159|FG000|Overall Study|Lost to Follow-up|1|||
46690321|NCT01259856|82905160|FG001|Overall Study|Lost to Follow-up|1|||
46690322|NCT01259856|82905159|FG000|Overall Study|Physician Decision|2|||
46690323|NCT01259856|82905160|FG001|Overall Study|Physician Decision|1|||
46690324|NCT01259856|82905159|FG000|Overall Study|Withdrawal by Subject|9|||
46690325|NCT01259856|82905160|FG001|Overall Study|Withdrawal by Subject|10|||
46690326|NCT01259856|82905159|FG000|Overall Study|Treatment never started|0|||
46690327|NCT01259856|82905160|FG001|Overall Study|Treatment never started|6|||
46690328|NCT01259856|82905159|FG000|Overall Study|Study closure by sponsor|40|||
46690329|NCT01259856|82905160|FG001|Overall Study|Study closure by sponsor|41|||
46690330|NCT01259856|82905159|FG000|Overall Study|Patient developed other disease|0|||
46690331|NCT01259856|82905160|FG001|Overall Study|Patient developed other disease|1|||
46690332|NCT01259856|82905159|FG000|Overall Study|Transfer to another study|0|||
46690333|NCT01259856|82905160|FG001|Overall Study|Transfer to another study|1|||
46690334|NCT01259856|82905159|FG000|Overall Study|Unknown/missing|2|||
46690335|NCT01259856|82905160|FG001|Overall Study|Unknown/missing|2|||
46690336|NCT01020838|82905166|FG000|Overall Study|Death|90|||
46690337|NCT01020838|82905166|FG000|Overall Study|Adverse Event|1|||
46690338|NCT01020838|82905166|FG000|Overall Study|Withdrawal by Subject|9|||
46690339|NCT01020838|82905166|FG000|Overall Study|Lost to Follow-up|6|||
46690340|NCT01020838|82905166|FG000|Overall Study|Most common: Study ended by sponsor|77|||
46690341|NCT01259466|82905181|FG000|Overall Study|Withdrawal by Subject|1|||
46690342|NCT01259466|82905182|FG001|Overall Study|Withdrawal by Subject|9|||
46690343|NCT01259388|82905190|FG000|Overall Study|Adverse Event|3|||
46690344|NCT01259388|82905191|FG001|Overall Study|Adverse Event|0|||
46690345|NCT01259388|82905190|FG000|Overall Study|Withdrawal by Subject|1|||
46690346|NCT01259388|82905191|FG001|Overall Study|Withdrawal by Subject|1|||
46690347|NCT01259388|82905190|FG000|Overall Study|Physician Decision|1|||
46690348|NCT01259388|82905191|FG001|Overall Study|Physician Decision|0|||
46690349|NCT01298492|82905197|FG000|Overall Study|Death|2|||
46690350|NCT01298492|82905197|FG000|Overall Study|Insufficient Clinical Response|22|||
46690351|NCT01298492|82905197|FG000|Overall Study|Lost to Follow-up|12|||
46690352|NCT01298492|82905197|FG000|Overall Study|Withdrawal by Subject|47|||
46690353|NCT01298492|82905197|FG000|Overall Study|Other (Unspecified)|7|||
46690354|NCT01298492|82905197|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
46690355|NCT01298492|82905197|FG000|Overall Study|Protocol Violation|2|||
46690356|NCT01298492|82905197|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
46690357|NCT01298492|82905197|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
46690358|NCT01297322|82905203|FG000|Overall Study|Lost to Follow-up|1|||
46690359|NCT01297322|82905204|FG001|Overall Study|Lost to Follow-up|0|||
46690360|NCT01297322|82905203|FG000|Overall Study|Withdrawal by Subject|0|||
46690361|NCT01297322|82905204|FG001|Overall Study|Withdrawal by Subject|1|||
46690362|NCT01297322|82905203|FG000|Overall Study|Protocol Violation|0|||
46690363|NCT01297322|82905204|FG001|Overall Study|Protocol Violation|3|||
46690364|NCT01297244|82905213|FG000|Overall Study|Progressive disease|22|||
46690365|NCT01297244|82905214|FG001|Overall Study|Progressive disease|3|||
46690366|NCT01297244|82905213|FG000|Overall Study|Adverse Event|9|||
46690367|NCT01297244|82905214|FG001|Overall Study|Adverse Event|1|||
46690368|NCT01297244|82905213|FG000|Overall Study|Death|1|||
46690369|NCT01297244|82905214|FG001|Overall Study|Death|1|||
46690370|NCT01297244|82905213|FG000|Overall Study|Clinical progression|1|||
46690371|NCT01297244|82905214|FG001|Overall Study|Clinical progression|1|||
46690372|NCT01297244|82905213|FG000|Overall Study|Withdrawal by Subject|2|||
46690373|NCT01297244|82905214|FG001|Overall Study|Withdrawal by Subject|0|||
46690374|NCT03456726|82905227|FG000|Overall Study|Disease Progression|6|||
46690375|NCT03456726|82905228|FG001|Overall Study|Disease Progression|1|||
46690376|NCT03456726|82905227|FG000|Overall Study|Adverse Event|4|||
46690377|NCT03456726|82905228|FG001|Overall Study|Adverse Event|2|||
46690378|NCT03456726|82905227|FG000|Overall Study|Withdrawal by Subject|1|||
46690379|NCT03456726|82905228|FG001|Overall Study|Withdrawal by Subject|0|||
46690380|NCT03456726|82905227|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
46690381|NCT03456726|82905228|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
46800399|NCT00454246|83019337|FG001|Overall Study|Failure to return|0|||
46690382|NCT03181932|82905236|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
46690383|NCT03181932|82905237|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
46690384|NCT03181932|82905236|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
46690385|NCT03181932|82905237|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
46690386|NCT03181932|82905236|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
46690387|NCT03181932|82905237|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
46690388|NCT03181932|82905236|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
46690389|NCT03181932|82905237|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
46690390|NCT03181932|82905236|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
46690391|NCT03181932|82905237|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
46690392|NCT03181932|82905236|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
46690393|NCT03181932|82905237|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
46690394|NCT03181932|82905236|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
46690395|NCT03181932|82905237|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
46690396|NCT03181932|82905236|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
46690397|NCT03181932|82905237|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
46690398|NCT03181932|82905236|FG000|Period 2 (Open-label Period)|Reason missing|2|||
46690399|NCT03181932|82905237|FG001|Period 2 (Open-label Period)|Reason missing|0|||
46690400|NCT02864862|82905247|FG000|Overall Study|Lost to Follow-up|1|||
46690401|NCT02864862|82905248|FG001|Overall Study|Lost to Follow-up|0|||
46690402|NCT02864862|82905249|FG002|Overall Study|Lost to Follow-up|1|||
46690403|NCT02864862|82905247|FG000|Overall Study|Protocol Violation|0|||
46690404|NCT02864862|82905248|FG001|Overall Study|Protocol Violation|0|||
46690405|NCT02864862|82905249|FG002|Overall Study|Protocol Violation|1|||
46690406|NCT01598298|82905261|FG000|Overall Study|Not eligible|5|||
46690407|NCT01598298|82905262|FG001|Overall Study|Not eligible|5|||
46690408|NCT01598298|82905261|FG000|Overall Study|Adverse Event|21|||
46690409|NCT01598298|82905262|FG001|Overall Study|Adverse Event|19|||
46690410|NCT01598298|82905261|FG000|Overall Study|Progression/relapse|0|||
46690411|NCT01598298|82905262|FG001|Overall Study|Progression/relapse|2|||
46690412|NCT01598298|82905261|FG000|Overall Study|Withdrawal by Subject|10|||
46690413|NCT01598298|82905262|FG001|Overall Study|Withdrawal by Subject|15|||
46690414|NCT01598298|82905261|FG000|Overall Study|Other reason (not protocol specified)|4|||
46800400|NCT00454246|83019338|FG002|Overall Study|Failure to return|0|||
46800401|NCT00454246|83019336|FG000|Overall Study|Early termination of study|62|||
46800402|NCT00454246|83019337|FG001|Overall Study|Early termination of study|26|||
46800403|NCT00454246|83019338|FG002|Overall Study|Early termination of study|9|||
46800404|NCT00434590|83019348|FG000|Overall Study|Administrative problems|5|||
46800405|NCT00434590|83019349|FG001|Overall Study|Administrative problems|5|||
46800406|NCT02891837|83019357|FG000|Overall Study|Lost to Follow-up|2|||
46800407|NCT02891837|83019358|FG001|Overall Study|Lost to Follow-up|0|||
46800408|NCT02891837|83019357|FG000|Overall Study|Withdrawal by Subject|1|||
46800409|NCT02891837|83019358|FG001|Overall Study|Withdrawal by Subject|0|||
46800410|NCT00695903|83019382|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
46800411|NCT00695903|83019383|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
46800412|NCT00695903|83019382|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
46800413|NCT00695903|83019383|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
46800414|NCT00695903|83019382|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
46690415|NCT01598298|82905262|FG001|Overall Study|Other reason (not protocol specified)|0|||
46690416|NCT01235949|82905286|FG000|Primary Phase|Migrated/moved from study area|1|||
46690417|NCT01235949|82905287|FG001|Primary Phase|Migrated/moved from study area|1|||
46690418|NCT01235949|82905288|FG002|Primary Phase|Migrated/moved from study area|0|||
46690419|NCT01235949|82905289|FG003|Primary Phase|Migrated/moved from study area|0|||
46690420|NCT01235949|82905290|FG004|Primary Phase|Migrated/moved from study area|1|||
46800415|NCT00695903|83019383|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
46690421|NCT01235949|82905291|FG005|Primary Phase|Migrated/moved from study area|2|||
46690422|NCT01235949|82905292|FG006|Primary Phase|Migrated/moved from study area|0|||
46690423|NCT01235949|82905293|FG007|Primary Phase|Migrated/moved from study area|0|||
46690424|NCT01235949|82905294|FG008|Primary Phase|Migrated/moved from study area|0|||
46690425|NCT01235949|82905295|FG009|Primary Phase|Migrated/moved from study area|0|||
46690426|NCT01235949|82905296|FG010|Primary Phase|Migrated/moved from study area|0|||
46690427|NCT01235949|82905297|FG011|Primary Phase|Migrated/moved from study area|0|||
46690428|NCT01235949|82905298|FG012|Primary Phase|Migrated/moved from study area|0|||
46690429|NCT01235949|82905299|FG013|Primary Phase|Migrated/moved from study area|0|||
46690430|NCT01235949|82905300|FG014|Primary Phase|Migrated/moved from study area|0|||
46690431|NCT01235949|82905301|FG015|Primary Phase|Migrated/moved from study area|0|||
46690432|NCT01235949|82905302|FG016|Primary Phase|Migrated/moved from study area|0|||
46690433|NCT01235949|82905303|FG017|Primary Phase|Migrated/moved from study area|0|||
46690434|NCT01235949|82905286|FG000|Primary Phase|Adverse Event|0|||
46690435|NCT01235949|82905287|FG001|Primary Phase|Adverse Event|0|||
46800416|NCT00695903|83019382|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
46800417|NCT00695903|83019383|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
46800418|NCT00695903|83019382|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
46800419|NCT00695903|83019383|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
46800420|NCT00695903|83019382|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
46690436|NCT01235949|82905288|FG002|Primary Phase|Adverse Event|0|||
46690437|NCT01235949|82905289|FG003|Primary Phase|Adverse Event|1|||
46690438|NCT01235949|82905290|FG004|Primary Phase|Adverse Event|0|||
46690439|NCT01235949|82905291|FG005|Primary Phase|Adverse Event|0|||
46690440|NCT01235949|82905292|FG006|Primary Phase|Adverse Event|0|||
46690441|NCT01235949|82905293|FG007|Primary Phase|Adverse Event|0|||
46690442|NCT01235949|82905294|FG008|Primary Phase|Adverse Event|0|||
46690443|NCT01235949|82905295|FG009|Primary Phase|Adverse Event|0|||
46690444|NCT01235949|82905296|FG010|Primary Phase|Adverse Event|0|||
46690445|NCT01235949|82905297|FG011|Primary Phase|Adverse Event|0|||
46690446|NCT01235949|82905298|FG012|Primary Phase|Adverse Event|0|||
46690447|NCT01235949|82905299|FG013|Primary Phase|Adverse Event|0|||
46690448|NCT01235949|82905300|FG014|Primary Phase|Adverse Event|0|||
46690449|NCT01235949|82905301|FG015|Primary Phase|Adverse Event|0|||
46690450|NCT01235949|82905302|FG016|Primary Phase|Adverse Event|0|||
46690451|NCT01235949|82905303|FG017|Primary Phase|Adverse Event|0|||
46690452|NCT01235949|82905286|FG000|Primary Phase|Withdrawal by Subject|3|||
46690453|NCT01235949|82905287|FG001|Primary Phase|Withdrawal by Subject|2|||
46690454|NCT01235949|82905288|FG002|Primary Phase|Withdrawal by Subject|2|||
46690455|NCT01235949|82905289|FG003|Primary Phase|Withdrawal by Subject|0|||
46690456|NCT01235949|82905290|FG004|Primary Phase|Withdrawal by Subject|0|||
46690457|NCT01235949|82905291|FG005|Primary Phase|Withdrawal by Subject|3|||
46690458|NCT01235949|82905292|FG006|Primary Phase|Withdrawal by Subject|0|||
46690459|NCT01235949|82905293|FG007|Primary Phase|Withdrawal by Subject|0|||
46690460|NCT01235949|82905294|FG008|Primary Phase|Withdrawal by Subject|0|||
46690461|NCT01235949|82905295|FG009|Primary Phase|Withdrawal by Subject|0|||
46690462|NCT01235949|82905296|FG010|Primary Phase|Withdrawal by Subject|0|||
46690463|NCT01235949|82905297|FG011|Primary Phase|Withdrawal by Subject|0|||
46690464|NCT01235949|82905298|FG012|Primary Phase|Withdrawal by Subject|0|||
46800421|NCT00695903|83019383|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
46800422|NCT00695903|83019382|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
46800423|NCT00695903|83019383|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
46800424|NCT00695903|83019382|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
46800425|NCT00695903|83019383|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
46800426|NCT00695903|83019382|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
46800427|NCT00695903|83019383|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
46800428|NCT00548262|83019389|FG000|Overall Study|Death|21|||
46800429|NCT00548262|83019389|FG000|Overall Study|Adverse Event|2|||
46800430|NCT00548262|83019389|FG000|Overall Study|Lack of Efficacy|4|||
46800431|NCT00548262|83019389|FG000|Overall Study|Lost to Follow-up|1|||
46800432|NCT00548262|83019389|FG000|Overall Study|Other|3|||
46800433|NCT00548262|83019389|FG000|Overall Study|Withdrawal by Subject|1|||
46800434|NCT00095173|83019393|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
46690465|NCT01235949|82905299|FG013|Primary Phase|Withdrawal by Subject|0|||
46690466|NCT01235949|82905300|FG014|Primary Phase|Withdrawal by Subject|0|||
46690467|NCT01235949|82905301|FG015|Primary Phase|Withdrawal by Subject|0|||
46690468|NCT01235949|82905302|FG016|Primary Phase|Withdrawal by Subject|0|||
46690469|NCT01235949|82905303|FG017|Primary Phase|Withdrawal by Subject|0|||
46800435|NCT00095173|83019394|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
46800436|NCT00095173|83019395|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
46800437|NCT00095173|83019396|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
46800438|NCT00095173|83019397|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
46800439|NCT00095173|83019398|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
46800440|NCT00095173|83019393|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
46800441|NCT00095173|83019394|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
46800442|NCT00095173|83019395|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
46800443|NCT00095173|83019396|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
46800444|NCT00095173|83019397|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
46800445|NCT00095173|83019398|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
46800446|NCT00095173|83019393|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
46800447|NCT00095173|83019394|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
46800448|NCT00095173|83019395|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
46800449|NCT00095173|83019396|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
46800450|NCT00095173|83019397|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
46800451|NCT00095173|83019398|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
46800452|NCT00095173|83019393|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
46800453|NCT00095173|83019394|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
46800454|NCT00095173|83019395|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
46800455|NCT00095173|83019396|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
46800456|NCT00095173|83019397|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
46800457|NCT00095173|83019398|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
46800458|NCT00095173|83019393|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
46800459|NCT00095173|83019394|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
46800460|NCT00095173|83019395|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
46800461|NCT00095173|83019396|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
46800462|NCT00095173|83019397|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
46800463|NCT00095173|83019398|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
46800464|NCT00095173|83019393|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
46800465|NCT00095173|83019394|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
46800466|NCT00095173|83019395|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
46800467|NCT00095173|83019396|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
46800468|NCT00095173|83019397|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
46800469|NCT00095173|83019398|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
46800470|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Death|0|||
46800471|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Death|0|||
46800472|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Death|0|||
46690470|NCT01235949|82905286|FG000|Primary Phase|Lost to Follow-up|0|||
46690471|NCT01235949|82905287|FG001|Primary Phase|Lost to Follow-up|0|||
46690472|NCT01235949|82905288|FG002|Primary Phase|Lost to Follow-up|1|||
46690473|NCT01235949|82905289|FG003|Primary Phase|Lost to Follow-up|1|||
46690474|NCT01235949|82905290|FG004|Primary Phase|Lost to Follow-up|0|||
46690475|NCT01235949|82905291|FG005|Primary Phase|Lost to Follow-up|2|||
46800473|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Death|0|||
46690476|NCT01235949|82905292|FG006|Primary Phase|Lost to Follow-up|0|||
46690477|NCT01235949|82905293|FG007|Primary Phase|Lost to Follow-up|0|||
46800474|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Death|0|||
46690478|NCT01235949|82905294|FG008|Primary Phase|Lost to Follow-up|0|||
46690479|NCT01235949|82905295|FG009|Primary Phase|Lost to Follow-up|0|||
46800475|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Death|1|||
46800476|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
46690480|NCT01235949|82905296|FG010|Primary Phase|Lost to Follow-up|0|||
46690481|NCT01235949|82905297|FG011|Primary Phase|Lost to Follow-up|0|||
46690482|NCT01235949|82905298|FG012|Primary Phase|Lost to Follow-up|0|||
46690483|NCT01235949|82905299|FG013|Primary Phase|Lost to Follow-up|0|||
46690484|NCT01235949|82905300|FG014|Primary Phase|Lost to Follow-up|0|||
46690485|NCT01235949|82905301|FG015|Primary Phase|Lost to Follow-up|0|||
46690486|NCT01235949|82905302|FG016|Primary Phase|Lost to Follow-up|0|||
46690487|NCT01235949|82905303|FG017|Primary Phase|Lost to Follow-up|0|||
46690488|NCT01235949|82905286|FG000|Booster Phase|Migrated/moved from study area|0|||
46690489|NCT01235949|82905287|FG001|Booster Phase|Migrated/moved from study area|0|||
46690490|NCT01235949|82905288|FG002|Booster Phase|Migrated/moved from study area|0|||
46690491|NCT01235949|82905289|FG003|Booster Phase|Migrated/moved from study area|0|||
46690492|NCT01235949|82905290|FG004|Booster Phase|Migrated/moved from study area|0|||
46690493|NCT01235949|82905291|FG005|Booster Phase|Migrated/moved from study area|0|||
46690494|NCT01235949|82905292|FG006|Booster Phase|Migrated/moved from study area|0|||
46690495|NCT01235949|82905293|FG007|Booster Phase|Migrated/moved from study area|0|||
46690496|NCT01235949|82905294|FG008|Booster Phase|Migrated/moved from study area|0|||
46690497|NCT01235949|82905295|FG009|Booster Phase|Migrated/moved from study area|0|||
46690498|NCT01235949|82905296|FG010|Booster Phase|Migrated/moved from study area|0|||
46690499|NCT01235949|82905297|FG011|Booster Phase|Migrated/moved from study area|1|||
46690500|NCT01235949|82905298|FG012|Booster Phase|Migrated/moved from study area|1|||
46690501|NCT01235949|82905299|FG013|Booster Phase|Migrated/moved from study area|0|||
46690502|NCT01235949|82905300|FG014|Booster Phase|Migrated/moved from study area|0|||
46690503|NCT01235949|82905301|FG015|Booster Phase|Migrated/moved from study area|0|||
46690504|NCT01235949|82905302|FG016|Booster Phase|Migrated/moved from study area|0|||
46690505|NCT01235949|82905303|FG017|Booster Phase|Migrated/moved from study area|1|||
46690506|NCT01235949|82905286|FG000|Booster Phase|Adverse Event|0|||
46690507|NCT01235949|82905287|FG001|Booster Phase|Adverse Event|0|||
46690508|NCT01235949|82905288|FG002|Booster Phase|Adverse Event|0|||
46690509|NCT01235949|82905289|FG003|Booster Phase|Adverse Event|0|||
46690510|NCT01235949|82905290|FG004|Booster Phase|Adverse Event|0|||
46690511|NCT01235949|82905291|FG005|Booster Phase|Adverse Event|0|||
46690512|NCT01235949|82905292|FG006|Booster Phase|Adverse Event|0|||
46690513|NCT01235949|82905293|FG007|Booster Phase|Adverse Event|0|||
46690514|NCT01235949|82905294|FG008|Booster Phase|Adverse Event|0|||
46690515|NCT01235949|82905295|FG009|Booster Phase|Adverse Event|0|||
46690516|NCT01235949|82905296|FG010|Booster Phase|Adverse Event|0|||
46690517|NCT01235949|82905297|FG011|Booster Phase|Adverse Event|0|||
46690518|NCT01235949|82905298|FG012|Booster Phase|Adverse Event|0|||
46690519|NCT01235949|82905299|FG013|Booster Phase|Adverse Event|0|||
46690520|NCT01235949|82905300|FG014|Booster Phase|Adverse Event|0|||
46690521|NCT01235949|82905301|FG015|Booster Phase|Adverse Event|1|||
46690522|NCT01235949|82905302|FG016|Booster Phase|Adverse Event|0|||
46690523|NCT01235949|82905303|FG017|Booster Phase|Adverse Event|0|||
46981920|NCT02383017|83228064|FG000|Overall Study|Found to be Hypogonadal|1|||
46690524|NCT01235949|82905286|FG000|Booster Phase|Withdrawal by Subject|0|||
46690525|NCT01235949|82905287|FG001|Booster Phase|Withdrawal by Subject|0|||
46690526|NCT01235949|82905288|FG002|Booster Phase|Withdrawal by Subject|0|||
46690527|NCT01235949|82905289|FG003|Booster Phase|Withdrawal by Subject|0|||
46690528|NCT01235949|82905290|FG004|Booster Phase|Withdrawal by Subject|0|||
46690529|NCT01235949|82905291|FG005|Booster Phase|Withdrawal by Subject|0|||
46690530|NCT01235949|82905292|FG006|Booster Phase|Withdrawal by Subject|0|||
46690531|NCT01235949|82905293|FG007|Booster Phase|Withdrawal by Subject|1|||
46690532|NCT01235949|82905294|FG008|Booster Phase|Withdrawal by Subject|1|||
46690533|NCT01235949|82905295|FG009|Booster Phase|Withdrawal by Subject|0|||
46690534|NCT01235949|82905296|FG010|Booster Phase|Withdrawal by Subject|1|||
46690535|NCT01235949|82905297|FG011|Booster Phase|Withdrawal by Subject|1|||
46690536|NCT01235949|82905298|FG012|Booster Phase|Withdrawal by Subject|2|||
46690537|NCT01235949|82905299|FG013|Booster Phase|Withdrawal by Subject|0|||
46690538|NCT01235949|82905300|FG014|Booster Phase|Withdrawal by Subject|2|||
46690539|NCT01235949|82905301|FG015|Booster Phase|Withdrawal by Subject|0|||
46690540|NCT01235949|82905302|FG016|Booster Phase|Withdrawal by Subject|0|||
46690541|NCT01235949|82905303|FG017|Booster Phase|Withdrawal by Subject|0|||
46690542|NCT01235949|82905286|FG000|Booster Phase|Lost to Follow-up|0|||
46690543|NCT01235949|82905287|FG001|Booster Phase|Lost to Follow-up|0|||
46690544|NCT01235949|82905288|FG002|Booster Phase|Lost to Follow-up|0|||
46690545|NCT01235949|82905289|FG003|Booster Phase|Lost to Follow-up|0|||
46690546|NCT01235949|82905290|FG004|Booster Phase|Lost to Follow-up|0|||
46690547|NCT01235949|82905291|FG005|Booster Phase|Lost to Follow-up|0|||
46690548|NCT01235949|82905292|FG006|Booster Phase|Lost to Follow-up|0|||
46690549|NCT01235949|82905293|FG007|Booster Phase|Lost to Follow-up|0|||
46690550|NCT01235949|82905294|FG008|Booster Phase|Lost to Follow-up|1|||
46690551|NCT01235949|82905295|FG009|Booster Phase|Lost to Follow-up|1|||
46690552|NCT01235949|82905296|FG010|Booster Phase|Lost to Follow-up|1|||
46690553|NCT01235949|82905297|FG011|Booster Phase|Lost to Follow-up|1|||
46690554|NCT01235949|82905298|FG012|Booster Phase|Lost to Follow-up|0|||
46690555|NCT01235949|82905299|FG013|Booster Phase|Lost to Follow-up|0|||
46690556|NCT01235949|82905300|FG014|Booster Phase|Lost to Follow-up|0|||
46690557|NCT01235949|82905301|FG015|Booster Phase|Lost to Follow-up|0|||
46690558|NCT01235949|82905302|FG016|Booster Phase|Lost to Follow-up|0|||
46690559|NCT01235949|82905303|FG017|Booster Phase|Lost to Follow-up|1|||
46690560|NCT01235793|82905341|FG000|Overall Study|Death|6|||
46690561|NCT01258998|82905346|FG000|Overall Study|Ineligible|1|||
46690562|NCT01235715|82905352|FG000|Overall Study|Physician Decision|0|||
46690563|NCT01235715|82905353|FG001|Overall Study|Physician Decision|2|||
46690564|NCT01235403|82905360|FG000|Overall Study|Adverse Event|14|||
46690565|NCT01235403|82905360|FG000|Overall Study|Lost to Follow-up|2|||
46690566|NCT01235403|82905360|FG000|Overall Study|Withdrawal by Subject|4|||
46690567|NCT01235403|82905360|FG000|Overall Study|Lack of Efficacy|2|||
46690568|NCT01235403|82905360|FG000|Overall Study|Other reasons for premature termination|4|||
46690569|NCT01024036|82905366|FG000|Blinded Treatment|Adverse Event|1|||
46690570|NCT01024036|82905367|FG001|Blinded Treatment|Adverse Event|1|||
46690571|NCT01024036|82905366|FG000|Blinded Treatment|Lack of Efficacy|16|||
46690572|NCT01024036|82905367|FG001|Blinded Treatment|Lack of Efficacy|14|||
46690573|NCT01024036|82905366|FG000|Blinded Treatment|Physician Decision|1|||
46800477|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
46800478|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
46690574|NCT01024036|82905367|FG001|Blinded Treatment|Physician Decision|0|||
46690575|NCT01024036|82905366|FG000|Blinded Treatment|Death|0|||
46690576|NCT01024036|82905367|FG001|Blinded Treatment|Death|2|||
46690577|NCT01024036|82905366|FG000|Blinded Treatment|Withdrawal by Subject|4|||
46690578|NCT01024036|82905367|FG001|Blinded Treatment|Withdrawal by Subject|3|||
46690579|NCT01024036|82905366|FG000|Unblinded Treatment|Adverse Event|0|||
46690580|NCT01024036|82905367|FG001|Unblinded Treatment|Adverse Event|1|||
46690581|NCT01024036|82905366|FG000|Unblinded Treatment|Lack of Efficacy|0|||
46800479|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
46800480|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
46800481|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
46800482|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
46800483|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
46800484|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
46800485|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
46800486|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
46800487|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
46800488|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
46800489|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
46800490|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
46800491|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
46800492|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
46800493|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
46800494|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
46800495|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
46800496|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
46800497|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
46800498|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
46800499|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
46800500|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
46800501|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
46800502|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
46800503|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
46800504|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
46800505|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
46800506|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
46800507|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
46800508|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
46800509|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
46800510|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
46800511|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
46800512|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
46800513|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
46800514|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
46800515|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
46800516|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
46800517|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
46800518|NCT00095173|83019393|FG000|Open-Label Extension Phase (Period C)|Other|0|||
46800519|NCT00095173|83019394|FG001|Open-Label Extension Phase (Period C)|Other|0|||
46800520|NCT00095173|83019395|FG002|Open-Label Extension Phase (Period C)|Other|0|||
46800521|NCT00095173|83019396|FG003|Open-Label Extension Phase (Period C)|Other|4|||
46800522|NCT00095173|83019397|FG004|Open-Label Extension Phase (Period C)|Other|6|||
46800523|NCT00095173|83019398|FG005|Open-Label Extension Phase (Period C)|Other|8|||
46800524|NCT00690443|83019414|FG000|Overall Study|Adverse Event|1|||
46800525|NCT00690443|83019415|FG001|Overall Study|Adverse Event|2|||
46800526|NCT03954834|83019425|FG000|Overall Study|Adverse Event|1|||
46800527|NCT03954834|83019426|FG001|Overall Study|Adverse Event|3|||
46800528|NCT03954834|83019427|FG002|Overall Study|Adverse Event|1|||
46800529|NCT03954834|83019428|FG003|Overall Study|Adverse Event|1|||
46800530|NCT03954834|83019425|FG000|Overall Study|Death|0|||
46800531|NCT03954834|83019426|FG001|Overall Study|Death|0|||
46800532|NCT03954834|83019427|FG002|Overall Study|Death|0|||
46800533|NCT03954834|83019428|FG003|Overall Study|Death|1|||
46800534|NCT03954834|83019425|FG000|Overall Study|Physician Decision|0|||
46800535|NCT03954834|83019426|FG001|Overall Study|Physician Decision|1|||
46800536|NCT03954834|83019427|FG002|Overall Study|Physician Decision|0|||
46800537|NCT03954834|83019428|FG003|Overall Study|Physician Decision|2|||
46800538|NCT03954834|83019425|FG000|Overall Study|Protocol Violation|1|||
46800539|NCT03954834|83019426|FG001|Overall Study|Protocol Violation|0|||
46800540|NCT03954834|83019427|FG002|Overall Study|Protocol Violation|0|||
46800541|NCT03954834|83019428|FG003|Overall Study|Protocol Violation|1|||
46858767|NCT00367133|83074584|FG000|2 Years|Dropped|34|||
46858768|NCT00367133|83074585|FG001|2 Years|Dropped|19|||
46858769|NCT00367133|83074586|FG002|2 Years|Dropped|33|||
46858770|NCT00367133|83074584|FG000|2 Years|Missed visit|4|||
46858771|NCT00367133|83074585|FG001|2 Years|Missed visit|5|||
46858772|NCT00367133|83074586|FG002|2 Years|Missed visit|4|||
46858773|NCT00367055|83074596|FG000|Overall Study|Adverse Event|6|||
46858774|NCT00367055|83074597|FG001|Overall Study|Adverse Event|3|||
46858775|NCT00367055|83074596|FG000|Overall Study|Patient's Willing|3|||
46858776|NCT00367055|83074597|FG001|Overall Study|Patient's Willing|2|||
46858777|NCT00367055|83074596|FG000|Overall Study|Lack of Efficacy|1|||
46858778|NCT00367055|83074597|FG001|Overall Study|Lack of Efficacy|2|||
46858779|NCT00367055|83074596|FG000|Overall Study|Lost to Follow-up|1|||
46858780|NCT00367055|83074597|FG001|Overall Study|Lost to Follow-up|1|||
46858781|NCT00367055|83074596|FG000|Overall Study|Protocol Violation|0|||
46858782|NCT00367055|83074597|FG001|Overall Study|Protocol Violation|1|||
46858783|NCT00367055|83074596|FG000|Overall Study|Stopping Criterion Met|0|||
46858784|NCT00367055|83074597|FG001|Overall Study|Stopping Criterion Met|1|||
46858785|NCT00367055|83074596|FG000|Overall Study|Participant Living too Far from Hospital|0|||
46858786|NCT00367055|83074597|FG001|Overall Study|Participant Living too Far from Hospital|1|||
46858787|NCT00057330|83074605|FG000|Overall Study|Adverse Event|9|||
46858788|NCT00057330|83074606|FG001|Overall Study|Adverse Event|12|||
46858789|NCT00057330|83074605|FG000|Overall Study|Death|1|||
46858790|NCT00057330|83074606|FG001|Overall Study|Death|0|||
46858791|NCT00057330|83074605|FG000|Overall Study|Protocol Violation|1|||
46858792|NCT00057330|83074606|FG001|Overall Study|Protocol Violation|1|||
46858793|NCT00057330|83074605|FG000|Overall Study|Withdrawal by Subject|115|||
46858794|NCT00057330|83074606|FG001|Overall Study|Withdrawal by Subject|84|||
46858795|NCT00057330|83074605|FG000|Overall Study|Lost to Follow-up|745|||
46858796|NCT00057330|83074606|FG001|Overall Study|Lost to Follow-up|617|||
46858797|NCT00057330|83074605|FG000|Overall Study|Physician Decision|1|||
46858798|NCT00057330|83074606|FG001|Overall Study|Physician Decision|0|||
46858799|NCT00057330|83074605|FG000|Overall Study|Other|260|||
46858800|NCT00057330|83074606|FG001|Overall Study|Other|206|||
46858801|NCT03283696|83074614|FG000|Overall Study|Physician Decision|5|||
46858802|NCT03283696|83074615|FG001|Overall Study|Physician Decision|6|||
46858803|NCT03283696|83074614|FG000|Overall Study|Withdrawal by Subject|2|||
46858804|NCT03283696|83074615|FG001|Overall Study|Withdrawal by Subject|0|||
46800542|NCT03954834|83019425|FG000|Overall Study|Withdrawal by Subject|2|||
46800543|NCT03954834|83019426|FG001|Overall Study|Withdrawal by Subject|3|||
46858805|NCT02939560|83074621|FG000|Overall Study|Withdrawal by Subject|2|||
46858806|NCT02939560|83074621|FG000|Overall Study|Protocol Violation|1|||
46858807|NCT03748706|83074625|FG000|Overall Study|Lost to Follow-up|1|||
46858808|NCT03747302|83074631|FG000|Overall Study|Withdrawal by Subject|1|||
46858809|NCT03747302|83074632|FG001|Overall Study|Withdrawal by Subject|2|||
46858810|NCT00056862|83074642|FG000|Overall Study|Protocol Violation|1|||
46800544|NCT03954834|83019427|FG002|Overall Study|Withdrawal by Subject|13|||
46858811|NCT00056862|83074643|FG001|Overall Study|Protocol Violation|0|||
46858812|NCT00056316|83074651|FG000|Overall Study|Withdrawal by Subject|2|||
46858813|NCT00056316|83074652|FG001|Overall Study|Withdrawal by Subject|2|||
46858814|NCT00056316|83074651|FG000|Overall Study|Death/NH placement of pt|1|||
46858815|NCT00056316|83074652|FG001|Overall Study|Death/NH placement of pt|1|||
46858816|NCT03308968|83074661|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
46690582|NCT01024036|82905367|FG001|Unblinded Treatment|Lack of Efficacy|2|||
46690583|NCT01024036|82905366|FG000|Follow-Up Period|Lost to Follow-up|1|||
46690584|NCT01024036|82905367|FG001|Follow-Up Period|Lost to Follow-up|1|||
46690585|NCT01024036|82905366|FG000|Follow-Up Period|Withdrawal by Subject|0|||
46690586|NCT01024036|82905367|FG001|Follow-Up Period|Withdrawal by Subject|1|||
46690587|NCT01024036|82905366|FG000|Follow-Up Period|Adverse Event|4|||
46690588|NCT01024036|82905367|FG001|Follow-Up Period|Adverse Event|1|||
46690589|NCT01234467|82905376|FG000|Overall Study|Adverse Event|3|||
46690590|NCT01234467|82905376|FG000|Overall Study|Death|2|||
46690591|NCT01234467|82905376|FG000|Overall Study|Withdrawal by Subject|2|||
46690592|NCT01234467|82905376|FG000|Overall Study|Disease Progression|2|||
46690593|NCT01234467|82905376|FG000|Overall Study|Clinical deterioration|1|||
46690594|NCT01234467|82905376|FG000|Overall Study|Physician Decision|1|||
46690595|NCT01234467|82905376|FG000|Overall Study|Other complicating disease (stroke)|1|||
46690596|NCT01233999|82905380|FG000|Overall Study|Withdrawal by Subject|1|||
46690597|NCT01233999|82905380|FG000|Overall Study|Lost to Follow-up|1|||
46690598|NCT01233687|82905384|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
46690599|NCT01233687|82905384|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
46690600|NCT01233687|82905384|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
46690601|NCT01023958|82905388|FG000|Overall Study|Progressive disease|48|||
46690602|NCT01023958|82905388|FG000|Overall Study|Other adverse event|1|||
46690603|NCT01023958|82905388|FG000|Overall Study|Refused to continue medication|1|||
46690604|NCT01233609|82905394|FG000|Overall Study|Death|1|||
46690605|NCT01233609|82905395|FG001|Overall Study|Death|0|||
46690606|NCT01233609|82905394|FG000|Overall Study|Lost to Follow-up|3|||
46690607|NCT01233609|82905395|FG001|Overall Study|Lost to Follow-up|1|||
46690608|NCT01233609|82905394|FG000|Overall Study|Adverse Event|2|||
46690609|NCT01233609|82905395|FG001|Overall Study|Adverse Event|1|||
46690610|NCT01233609|82905394|FG000|Overall Study|Withdrawal by Subject|3|||
46690611|NCT01233609|82905395|FG001|Overall Study|Withdrawal by Subject|0|||
46690612|NCT01232283|82905411|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
46690613|NCT01232283|82905412|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
46690614|NCT01232283|82905413|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46690615|NCT01232283|82905414|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46690616|NCT01232283|82905415|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46690617|NCT01232283|82905416|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46800545|NCT03954834|83019428|FG003|Overall Study|Withdrawal by Subject|6|||
46800546|NCT03954834|83019425|FG000|Overall Study|Participant left the country|0|||
46800547|NCT03954834|83019426|FG001|Overall Study|Participant left the country|0|||
46858817|NCT03308968|83074662|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
46690618|NCT01232283|82905417|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46690619|NCT01232283|82905418|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46690620|NCT01232283|82905419|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46690621|NCT01232283|82905420|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
46690622|NCT01232283|82905411|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
46690623|NCT01232283|82905412|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
46690624|NCT01232283|82905413|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690625|NCT01232283|82905414|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690626|NCT01232283|82905415|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690627|NCT01232283|82905416|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690628|NCT01232283|82905417|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690629|NCT01232283|82905418|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690630|NCT01232283|82905419|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690631|NCT01232283|82905420|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
46690632|NCT01232283|82905411|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
46690633|NCT01232283|82905412|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690634|NCT01232283|82905413|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690635|NCT01232283|82905414|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690636|NCT01232283|82905415|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690637|NCT01232283|82905416|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690638|NCT01232283|82905417|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690639|NCT01232283|82905418|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46800548|NCT03954834|83019427|FG002|Overall Study|Participant left the country|1|||
46800549|NCT03954834|83019428|FG003|Overall Study|Participant left the country|0|||
46800550|NCT03954834|83019425|FG000|Overall Study|Lost to Follow-up|3|||
46800551|NCT03954834|83019426|FG001|Overall Study|Lost to Follow-up|2|||
46800552|NCT03954834|83019427|FG002|Overall Study|Lost to Follow-up|3|||
46800553|NCT03954834|83019428|FG003|Overall Study|Lost to Follow-up|5|||
46800554|NCT00693017|83019440|FG000|Overall Study|Sponsor Decision|2|||
46800555|NCT00693017|83019441|FG001|Overall Study|Sponsor Decision|1|||
46800556|NCT00693017|83019440|FG000|Overall Study|Death|0|||
46800557|NCT00693017|83019441|FG001|Overall Study|Death|1|||
46800558|NCT00692237|83019449|FG000|Overall Study|Withdrawal by Subject|1|||
46800559|NCT00692237|83019450|FG001|Overall Study|Withdrawal by Subject|3|||
46800560|NCT00692237|83019449|FG000|Overall Study|Adverse Event|0|||
46800561|NCT00692237|83019450|FG001|Overall Study|Adverse Event|1|||
46800562|NCT00110149|83019456|FG000|Overall Study|Physician Decision|3|||
46800563|NCT03954444|83019464|FG000|Overall Study|Withdrawal by Subject|5|||
46800564|NCT03954444|83019465|FG001|Overall Study|Withdrawal by Subject|5|||
46800565|NCT03954444|83019466|FG002|Overall Study|Withdrawal by Subject|5|||
46800566|NCT03954444|83019464|FG000|Overall Study|Adverse Event|1|||
46800567|NCT03954444|83019465|FG001|Overall Study|Adverse Event|3|||
46800568|NCT03954444|83019466|FG002|Overall Study|Adverse Event|2|||
46800569|NCT03954444|83019464|FG000|Overall Study|Protocol Violation|0|||
46800570|NCT03954444|83019465|FG001|Overall Study|Protocol Violation|3|||
46800571|NCT03954444|83019466|FG002|Overall Study|Protocol Violation|5|||
46800572|NCT03954444|83019464|FG000|Overall Study|Use of prohibited therapy|1|||
46800573|NCT03954444|83019465|FG001|Overall Study|Use of prohibited therapy|1|||
46800574|NCT03954444|83019466|FG002|Overall Study|Use of prohibited therapy|2|||
46800575|NCT03954444|83019464|FG000|Overall Study|Lost to Follow-up|1|||
46800576|NCT03954444|83019465|FG001|Overall Study|Lost to Follow-up|0|||
46800577|NCT03954444|83019466|FG002|Overall Study|Lost to Follow-up|1|||
46800578|NCT03954444|83019464|FG000|Overall Study|Non-compliant with study drug application|2|||
46800579|NCT03954444|83019465|FG001|Overall Study|Non-compliant with study drug application|2|||
46800580|NCT03954444|83019466|FG002|Overall Study|Non-compliant with study drug application|0|||
46800581|NCT03954444|83019464|FG000|Overall Study|Administrative reasons|0|||
46800582|NCT03954444|83019465|FG001|Overall Study|Administrative reasons|0|||
46800583|NCT03954444|83019466|FG002|Overall Study|Administrative reasons|1|||
46800584|NCT03954444|83019464|FG000|Overall Study|Miscellaneous|3|||
46800585|NCT03954444|83019465|FG001|Overall Study|Miscellaneous|2|||
46800586|NCT03954444|83019466|FG002|Overall Study|Miscellaneous|1|||
46800587|NCT03953820|83019474|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
46800588|NCT03953820|83019475|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
46800589|NCT03953820|83019476|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
46858818|NCT03308968|83074663|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
46858819|NCT03308968|83074661|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
46800590|NCT03953820|83019474|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
46800591|NCT03953820|83019475|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
46800592|NCT03953820|83019476|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
46800593|NCT00117949|83019493|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
46800594|NCT00117949|83019494|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
46690640|NCT01232283|82905419|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690641|NCT01232283|82905420|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
46690642|NCT01232283|82905411|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
46690643|NCT01232283|82905412|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
46690644|NCT01232283|82905413|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690645|NCT01232283|82905414|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690646|NCT01232283|82905415|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690647|NCT01232283|82905416|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690648|NCT01232283|82905417|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690649|NCT01232283|82905418|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690650|NCT01232283|82905419|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690651|NCT01232283|82905420|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
46690652|NCT01232283|82905411|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
46690653|NCT01232283|82905412|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
46690654|NCT01232283|82905413|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46690655|NCT01232283|82905414|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46690656|NCT01232283|82905415|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46690657|NCT01232283|82905416|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46800595|NCT00117949|83019495|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
46800596|NCT00117949|83019496|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
46800597|NCT00117949|83019493|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
46800598|NCT00117949|83019494|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
46800599|NCT00117949|83019495|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
46800600|NCT00117949|83019496|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
46800601|NCT00117949|83019493|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
46800602|NCT00117949|83019494|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
46800603|NCT00117949|83019495|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
46800604|NCT00117949|83019496|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
46800605|NCT00117949|83019493|FG000|Overall Study|PSA increase >=10ng/mL|0|||
46800606|NCT00117949|83019494|FG001|Overall Study|PSA increase >=10ng/mL|1|||
46800607|NCT00117949|83019495|FG002|Overall Study|PSA increase >=10ng/mL|1|||
46800608|NCT00117949|83019496|FG003|Overall Study|PSA increase >=10ng/mL|0|||
46800609|NCT00117949|83019493|FG000|Overall Study|PSA reduction <=50%|0|||
46800610|NCT00117949|83019494|FG001|Overall Study|PSA reduction <=50%|2|||
46800611|NCT00117949|83019495|FG002|Overall Study|PSA reduction <=50%|2|||
46800612|NCT00117949|83019496|FG003|Overall Study|PSA reduction <=50%|4|||
46800613|NCT00117949|83019493|FG000|Overall Study|Hepatic abnormalities|0|||
46800614|NCT00117949|83019494|FG001|Overall Study|Hepatic abnormalities|1|||
46800615|NCT00117949|83019495|FG002|Overall Study|Hepatic abnormalities|0|||
46800616|NCT00117949|83019496|FG003|Overall Study|Hepatic abnormalities|1|||
46800617|NCT00117793|83019506|FG000|Overall Study|Withdrawal by Subject|12|||
46800618|NCT00695669|83019515|FG000|Overall Study|Adverse Event|0|||
46800619|NCT00695669|83019516|FG001|Overall Study|Adverse Event|0|||
46800620|NCT00695669|83019517|FG002|Overall Study|Adverse Event|2|||
46800621|NCT00695669|83019518|FG003|Overall Study|Adverse Event|0|||
46800622|NCT00695669|83019515|FG000|Overall Study|Lost to Follow-up|4|||
46800623|NCT00695669|83019516|FG001|Overall Study|Lost to Follow-up|4|||
46800624|NCT00695669|83019517|FG002|Overall Study|Lost to Follow-up|1|||
46800625|NCT00695669|83019518|FG003|Overall Study|Lost to Follow-up|4|||
46800626|NCT03671369|83019531|FG000|Overall Study|Other|1|||
46800627|NCT03671369|83019531|FG000|Overall Study|Withdrawal by Subject|289|||
46800628|NCT03671369|83019531|FG000|Overall Study|Not willing to be vaccinated|1|||
46800629|NCT00692003|83019537|FG000|Overall Study|Sponsor Decision|5|||
46800630|NCT00692003|83019538|FG001|Overall Study|Sponsor Decision|1|||
46800631|NCT00434512|83019550|FG000|Overall Study|Migrated/moved from study area|0|||
46800632|NCT00434512|83019551|FG001|Overall Study|Migrated/moved from study area|0|||
46800633|NCT00434512|83019552|FG002|Overall Study|Migrated/moved from study area|0|||
46800634|NCT00434512|83019553|FG003|Overall Study|Migrated/moved from study area|1|||
46800635|NCT00434512|83019554|FG004|Overall Study|Migrated/moved from study area|1|||
46800636|NCT00434512|83019555|FG005|Overall Study|Migrated/moved from study area|1|||
46800637|NCT00434512|83019550|FG000|Overall Study|Other|0|||
46800638|NCT00434512|83019551|FG001|Overall Study|Other|1|||
46800639|NCT00434512|83019552|FG002|Overall Study|Other|0|||
46800640|NCT00434512|83019553|FG003|Overall Study|Other|0|||
46800641|NCT00434512|83019554|FG004|Overall Study|Other|0|||
46800642|NCT00434512|83019555|FG005|Overall Study|Other|0|||
46800643|NCT00427648|83019575|FG000|Overall Study|Protocol Violation|1|||
46800644|NCT00427648|83019576|FG001|Overall Study|Protocol Violation|2|||
46800645|NCT00427648|83019575|FG000|Overall Study|Adverse Event|0|||
46800646|NCT00427648|83019576|FG001|Overall Study|Adverse Event|1|||
46800647|NCT00416884|83019584|FG000|Overall Study|Study terminated due to low accrual|1|||
46800648|NCT00434122|83019590|FG000|Overall Study|Non-compliance with protocol|0|||
46800649|NCT00434122|83019591|FG001|Overall Study|Non-compliance with protocol|1|||
46800650|NCT00434122|83019590|FG000|Overall Study|loss of subject contact|1|||
46800651|NCT00434122|83019591|FG001|Overall Study|loss of subject contact|1|||
46800652|NCT00434122|83019590|FG000|Overall Study|Personal reasons|1|||
46800653|NCT00434122|83019591|FG001|Overall Study|Personal reasons|1|||
46800654|NCT00434122|83019590|FG000|Overall Study|Large follicle size|2|||
46800655|NCT00434122|83019591|FG001|Overall Study|Large follicle size|2|||
46800656|NCT00434122|83019590|FG000|Overall Study|Low follicular response.|1|||
46690658|NCT01232283|82905417|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46690659|NCT01232283|82905418|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46690660|NCT01232283|82905419|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46690661|NCT01232283|82905420|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
46690662|NCT01232283|82905411|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
46690663|NCT01232283|82905412|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
46690664|NCT01232283|82905413|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690665|NCT01232283|82905414|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690666|NCT01232283|82905415|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690667|NCT01232283|82905416|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690668|NCT01232283|82905417|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690669|NCT01232283|82905418|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690670|NCT01232283|82905419|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690671|NCT01232283|82905420|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
46690672|NCT01232283|82905411|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
46690673|NCT01232283|82905412|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
46690674|NCT01232283|82905413|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690675|NCT01232283|82905414|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690676|NCT01232283|82905415|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690677|NCT01232283|82905416|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690678|NCT01232283|82905417|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690679|NCT01232283|82905418|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690680|NCT01232283|82905419|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690681|NCT01232283|82905420|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
46690682|NCT01232283|82905411|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690683|NCT01232283|82905412|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690684|NCT01232283|82905413|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
46690685|NCT01232283|82905414|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
46690686|NCT01232283|82905415|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690687|NCT01232283|82905416|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690688|NCT01232283|82905417|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690689|NCT01232283|82905418|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690690|NCT01232283|82905419|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690691|NCT01232283|82905420|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
46690692|NCT01232283|82905411|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690693|NCT01232283|82905412|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690694|NCT01232283|82905413|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
46690695|NCT01232283|82905414|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
46690696|NCT01232283|82905415|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690697|NCT01232283|82905416|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690698|NCT01232283|82905417|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690699|NCT01232283|82905418|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690700|NCT01232283|82905419|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690701|NCT01232283|82905420|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
46690702|NCT01232283|82905411|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46690703|NCT01232283|82905412|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46690704|NCT01232283|82905413|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
46690705|NCT01232283|82905414|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46690706|NCT01232283|82905415|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46800657|NCT00434122|83019591|FG001|Overall Study|Low follicular response.|2|||
46690707|NCT01232283|82905416|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46690708|NCT01232283|82905417|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46690709|NCT01232283|82905418|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46690710|NCT01232283|82905419|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46800658|NCT00434122|83019590|FG000|Overall Study|Travelling of subject.|1|||
46800659|NCT00434122|83019591|FG001|Overall Study|Travelling of subject.|0|||
46800660|NCT00555620|83019605|FG000|Overall Study|Death|0|||
46800661|NCT00555620|83019606|FG001|Overall Study|Death|1|||
46800662|NCT00555620|83019607|FG002|Overall Study|Death|0|||
46800663|NCT00555620|83019608|FG003|Overall Study|Death|0|||
46690711|NCT01232283|82905420|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
46690712|NCT01232283|82905411|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690713|NCT01232283|82905412|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690714|NCT01232283|82905413|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
46690715|NCT01232283|82905414|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
46690716|NCT01232283|82905415|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690717|NCT01232283|82905416|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690718|NCT01232283|82905417|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690719|NCT01232283|82905418|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690720|NCT01232283|82905419|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690721|NCT01232283|82905420|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
46690722|NCT01232283|82905411|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46690723|NCT01232283|82905412|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46800664|NCT00555620|83019609|FG004|Overall Study|Death|0|||
46800665|NCT00555620|83019610|FG005|Overall Study|Death|1|||
46800666|NCT00555620|83019605|FG000|Overall Study|Study terminated by sponsor|0|||
46800667|NCT00555620|83019606|FG001|Overall Study|Study terminated by sponsor|0|||
46800668|NCT00555620|83019607|FG002|Overall Study|Study terminated by sponsor|1|||
46800669|NCT00555620|83019608|FG003|Overall Study|Study terminated by sponsor|0|||
46800670|NCT00555620|83019609|FG004|Overall Study|Study terminated by sponsor|0|||
46800671|NCT00555620|83019610|FG005|Overall Study|Study terminated by sponsor|0|||
46800672|NCT00555620|83019605|FG000|Overall Study|Adverse Event|0|||
46690724|NCT01232283|82905413|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
46690725|NCT01232283|82905414|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
46690726|NCT01232283|82905415|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46690727|NCT01232283|82905416|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46690728|NCT01232283|82905417|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46690729|NCT01232283|82905418|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46690730|NCT01232283|82905419|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46690731|NCT01232283|82905420|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
46690732|NCT01232283|82905411|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
46690733|NCT01232283|82905412|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
46690734|NCT01232283|82905413|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
46690735|NCT01232283|82905414|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
46690736|NCT01232283|82905415|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
46690737|NCT01232283|82905416|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
46690738|NCT01232283|82905417|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
46690739|NCT01232283|82905418|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
46690740|NCT01232283|82905419|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
46690741|NCT01232283|82905420|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
46690742|NCT01232283|82905411|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
46690743|NCT01232283|82905412|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
46690744|NCT01232283|82905413|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
46690745|NCT01232283|82905414|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
46690746|NCT01232283|82905415|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
46690747|NCT01232283|82905416|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
46690748|NCT01232283|82905417|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
46690749|NCT01232283|82905418|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
46690750|NCT01232283|82905419|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
46690751|NCT01232283|82905420|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
46690752|NCT01232283|82905411|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
46690753|NCT01232283|82905412|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
46690754|NCT01232283|82905413|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
46690755|NCT01232283|82905414|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
46800673|NCT00555620|83019606|FG001|Overall Study|Adverse Event|0|||
46690756|NCT01232283|82905415|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
46690757|NCT01232283|82905416|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
46690758|NCT01232283|82905417|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
46690759|NCT01232283|82905418|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
46690760|NCT01232283|82905419|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
46690761|NCT01232283|82905420|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
46690762|NCT01232283|82905411|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
46690763|NCT01232283|82905412|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
46690764|NCT01232283|82905413|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
46690765|NCT01232283|82905414|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
46690766|NCT01232283|82905415|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
46690767|NCT01232283|82905416|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
46690768|NCT01232283|82905417|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
46981921|NCT02383017|83228065|FG001|Overall Study|Found to be Hypogonadal|0|||
46981922|NCT02382939|83228073|FG000|Overall Study|Adverse Event|1|||
46981923|NCT02382939|83228074|FG001|Overall Study|Adverse Event|1|||
46981924|NCT02382939|83228073|FG000|Overall Study|Withdrawal by Subject|2|||
46981925|NCT02382939|83228074|FG001|Overall Study|Withdrawal by Subject|2|||
46690769|NCT01232283|82905418|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
46690770|NCT01232283|82905419|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
46690771|NCT01232283|82905420|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
46690772|NCT01232283|82905411|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690773|NCT01232283|82905412|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690774|NCT01232283|82905413|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690775|NCT01232283|82905414|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690776|NCT01232283|82905415|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
46690777|NCT01232283|82905416|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690778|NCT01232283|82905417|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690779|NCT01232283|82905418|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46981926|NCT02587819|83228081|FG000|Overall Study|Adverse Event|1|||
46981927|NCT02587819|83228081|FG000|Overall Study|Lost to Follow-up|1|||
46690780|NCT01232283|82905419|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690781|NCT01232283|82905420|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
46690782|NCT01232283|82905411|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
46690783|NCT01232283|82905412|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
46690784|NCT01232283|82905413|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
46690785|NCT01232283|82905414|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
46690786|NCT01232283|82905415|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
46690787|NCT01232283|82905416|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
46690788|NCT01232283|82905417|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
46690789|NCT01232283|82905418|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
46690790|NCT01232283|82905419|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
46690791|NCT01232283|82905420|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
46690792|NCT01232283|82905411|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690793|NCT01232283|82905412|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690794|NCT01232283|82905413|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690795|NCT01232283|82905414|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690796|NCT01232283|82905415|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690797|NCT01232283|82905416|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690798|NCT01232283|82905417|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690799|NCT01232283|82905418|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
46690800|NCT01232283|82905419|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690801|NCT01232283|82905420|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
46690802|NCT01232283|82905411|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690803|NCT01232283|82905412|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690804|NCT01232283|82905413|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690805|NCT01232283|82905414|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690806|NCT01232283|82905415|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690807|NCT01232283|82905416|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
46690808|NCT01232283|82905417|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690809|NCT01232283|82905418|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690810|NCT01232283|82905419|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46690811|NCT01232283|82905420|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
46800674|NCT00555620|83019607|FG002|Overall Study|Adverse Event|1|||
46800675|NCT00555620|83019608|FG003|Overall Study|Adverse Event|5|||
46800676|NCT00555620|83019609|FG004|Overall Study|Adverse Event|0|||
46800677|NCT00555620|83019610|FG005|Overall Study|Adverse Event|1|||
46800678|NCT00555620|83019605|FG000|Overall Study|Objective progression or relapse|6|||
46800679|NCT00555620|83019606|FG001|Overall Study|Objective progression or relapse|5|||
46800680|NCT00555620|83019607|FG002|Overall Study|Objective progression or relapse|12|||
46800681|NCT00555620|83019608|FG003|Overall Study|Objective progression or relapse|17|||
46800682|NCT00555620|83019609|FG004|Overall Study|Objective progression or relapse|3|||
46981928|NCT01666951|83228088|FG000|Overall Study|Not dosed|1|||
46981929|NCT01666951|83228089|FG001|Overall Study|Not dosed|1|||
46981930|NCT02586805|83228099|FG000|Overall Study|Withdrawal by Subject|3|||
46981931|NCT02586805|83228100|FG001|Overall Study|Withdrawal by Subject|1|||
46981932|NCT02586805|83228101|FG002|Overall Study|Withdrawal by Subject|1|||
46690812|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690813|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690814|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690815|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690816|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690817|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690818|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690819|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
46690820|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
46800683|NCT00555620|83019610|FG005|Overall Study|Objective progression or relapse|16|||
46800684|NCT00555620|83019605|FG000|Overall Study|Participant refused treatment|0|||
46690821|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
46690822|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46800685|NCT00555620|83019606|FG001|Overall Study|Participant refused treatment|1|||
46981933|NCT02586805|83228102|FG003|Overall Study|Withdrawal by Subject|2|||
46981934|NCT02586805|83228099|FG000|Overall Study|Adverse Event|2|||
46690823|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46800686|NCT00555620|83019607|FG002|Overall Study|Participant refused treatment|1|||
46690824|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46690825|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46690826|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46690827|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46690828|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46690829|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
46690830|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
46690831|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
46690832|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690833|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690834|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690835|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690836|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690837|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690838|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690839|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
46690840|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
46690841|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
46690842|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690843|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690844|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690845|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690846|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690847|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690848|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690849|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
46690850|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
46690851|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
46690852|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690853|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690854|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690855|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690856|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690857|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690858|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690859|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
46690860|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
46690861|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
46690862|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46690863|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46690864|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46800687|NCT00555620|83019608|FG003|Overall Study|Participant refused treatment|0|||
46800688|NCT00555620|83019609|FG004|Overall Study|Participant refused treatment|0|||
46800689|NCT00555620|83019610|FG005|Overall Study|Participant refused treatment|1|||
46690865|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46800690|NCT00555620|83019605|FG000|Overall Study|Other|0|||
46800691|NCT00555620|83019606|FG001|Overall Study|Other|0|||
46690866|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46690867|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46690868|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46690869|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46690870|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
46800692|NCT00555620|83019607|FG002|Overall Study|Other|0|||
46800693|NCT00555620|83019608|FG003|Overall Study|Other|1|||
46800694|NCT00555620|83019609|FG004|Overall Study|Other|0|||
46800695|NCT00555620|83019610|FG005|Overall Study|Other|3|||
46800696|NCT00433966|83019630|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
46800697|NCT00433966|83019631|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
46800698|NCT00433966|83019632|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
46800699|NCT00433966|83019633|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
46800700|NCT00433966|83019630|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
46800701|NCT00433966|83019631|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
46800702|NCT00433966|83019632|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
46800703|NCT00433966|83019633|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
46800704|NCT00433966|83019630|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
46800705|NCT00433966|83019631|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
46800706|NCT00433966|83019632|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
46800707|NCT00433966|83019633|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
46800708|NCT00433966|83019630|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
46800709|NCT00433966|83019631|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
46800710|NCT00433966|83019632|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
46800711|NCT00433966|83019633|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
46800712|NCT00433966|83019630|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
46800713|NCT00433966|83019631|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
46800714|NCT00433966|83019632|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
46800715|NCT00433966|83019633|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
46800716|NCT03952650|83019650|FG000|Overall Study|TRAVEL|0|||
46800717|NCT03952650|83019651|FG001|Overall Study|TRAVEL|4|||
46800718|NCT03952650|83019652|FG002|Overall Study|TRAVEL|0|||
46800719|NCT03952650|83019653|FG003|Overall Study|TRAVEL|4|||
46800720|NCT03952650|83019654|FG004|Overall Study|TRAVEL|0|||
46800721|NCT03952650|83019655|FG005|Overall Study|TRAVEL|3|||
46800722|NCT03952650|83019656|FG006|Overall Study|TRAVEL|2|||
46800723|NCT03952650|83019650|FG000|Overall Study|Withdrawal by Subject|0|||
46800724|NCT03952650|83019651|FG001|Overall Study|Withdrawal by Subject|2|||
46800725|NCT03952650|83019652|FG002|Overall Study|Withdrawal by Subject|0|||
46800726|NCT03952650|83019653|FG003|Overall Study|Withdrawal by Subject|3|||
46800727|NCT03952650|83019654|FG004|Overall Study|Withdrawal by Subject|0|||
46800728|NCT03952650|83019655|FG005|Overall Study|Withdrawal by Subject|1|||
46800729|NCT03952650|83019656|FG006|Overall Study|Withdrawal by Subject|1|||
46690871|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
46690872|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690873|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690874|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690875|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690876|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690877|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690878|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690879|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690880|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
46690881|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
46690882|NCT01232283|82905411|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46690883|NCT01232283|82905412|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46858820|NCT03308968|83074662|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
46858821|NCT03308968|83074663|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
46858822|NCT03308968|83074661|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
46858823|NCT03308968|83074662|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
46858824|NCT03308968|83074663|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
46858825|NCT03308968|83074661|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
46858826|NCT03308968|83074662|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
46858827|NCT03308968|83074663|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
46858828|NCT03308968|83074661|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
46858829|NCT03308968|83074662|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
46858830|NCT03308968|83074663|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
46858831|NCT03308968|83074661|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
46858832|NCT03308968|83074662|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
46858833|NCT03308968|83074663|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
46858834|NCT03308968|83074661|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
46858835|NCT03308968|83074662|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
46858836|NCT03308968|83074663|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
46858837|NCT03308968|83074661|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
46858838|NCT03308968|83074662|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
46858839|NCT03308968|83074663|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
46858840|NCT03308968|83074661|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
46858841|NCT03308968|83074662|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
46858842|NCT03308968|83074663|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
46858843|NCT03308968|83074661|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
46858844|NCT03308968|83074662|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
46858845|NCT03308968|83074663|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
46858846|NCT03308968|83074661|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
46690884|NCT01232283|82905413|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46690885|NCT01232283|82905414|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46690886|NCT01232283|82905415|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46690887|NCT01232283|82905416|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46690888|NCT01232283|82905417|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46690889|NCT01232283|82905418|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
46690890|NCT01232283|82905419|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
46690891|NCT01232283|82905420|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
46690892|NCT01232127|82905442|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
46690893|NCT01232127|82905443|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
46690894|NCT01232127|82905444|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
46690895|NCT01258608|82905458|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
46690896|NCT01258608|82905459|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
46690897|NCT01258608|82905458|FG000|Overall Study|Clinical progression|1|||
46690898|NCT01258608|82905459|FG001|Overall Study|Clinical progression|0|||
46690899|NCT01258608|82905458|FG000|Overall Study|Sponsor decision|0|||
46690900|NCT01258608|82905459|FG001|Overall Study|Sponsor decision|1|||
46690901|NCT01258608|82905458|FG000|Overall Study|Physician Decision|6|||
46690902|NCT01258608|82905459|FG001|Overall Study|Physician Decision|1|||
46690903|NCT01258608|82905458|FG000|Overall Study|Lost to Follow-up|0|||
46690904|NCT01258608|82905459|FG001|Overall Study|Lost to Follow-up|1|||
46690905|NCT01258608|82905458|FG000|Overall Study|Lack of compliance|1|||
46690906|NCT01258608|82905459|FG001|Overall Study|Lack of compliance|0|||
46690907|NCT01258608|82905458|FG000|Overall Study|Lack of Efficacy|0|||
46690908|NCT01258608|82905459|FG001|Overall Study|Lack of Efficacy|1|||
46690909|NCT01258608|82905458|FG000|Overall Study|Adverse Event|6|||
46690910|NCT01258608|82905459|FG001|Overall Study|Adverse Event|10|||
46690911|NCT01258608|82905458|FG000|Overall Study|Withdrawal by Subject|6|||
46690912|NCT01258608|82905459|FG001|Overall Study|Withdrawal by Subject|5|||
46690913|NCT01015612|82905466|FG000|Overall Study|Death|113|||
46690914|NCT01015612|82905466|FG000|Overall Study|Withdrawal by Subject|40|||
46690915|NCT01231659|82905470|FG000|Overall Study|Adverse Event|9|||
46690916|NCT01231659|82905470|FG000|Overall Study|Disease Progression|48|||
46690917|NCT01231659|82905470|FG000|Overall Study|Death|2|||
46690918|NCT01231659|82905470|FG000|Overall Study|Patient refused to complete study visit|1|||
46690919|NCT01231659|82905470|FG000|Overall Study|Other protocol defined criteria|12|||
46690920|NCT01054222|82905474|FG000|Overall Study|Lack of Efficacy|1|||
46690921|NCT01054222|82905474|FG000|Overall Study|Lost to Follow-up|4|||
46690922|NCT01054222|82905474|FG000|Overall Study|Withdrawal by Subject|6|||
46690923|NCT01052428|82905480|FG000|Overall Study|Death|1|||
46690924|NCT01052428|82905481|FG001|Overall Study|Death|0|||
46690925|NCT01052428|82905480|FG000|Overall Study|Withdrawal by Subject|0|||
46690926|NCT01052428|82905481|FG001|Overall Study|Withdrawal by Subject|1|||
46690927|NCT01052272|82905491|FG000|Overall Study|Death|0|||
46690928|NCT01052272|82905492|FG001|Overall Study|Death|0|||
46690929|NCT01052272|82905493|FG002|Overall Study|Death|1|||
46690930|NCT01052272|82905494|FG003|Overall Study|Death|1|||
46690931|NCT01052272|82905491|FG000|Overall Study|Physician Decision|0|||
46690932|NCT01052272|82905492|FG001|Overall Study|Physician Decision|1|||
46690933|NCT01052272|82905493|FG002|Overall Study|Physician Decision|0|||
46690934|NCT01052272|82905494|FG003|Overall Study|Physician Decision|0|||
46690935|NCT01052272|82905491|FG000|Overall Study|patient refuses follow-up|5|||
46690936|NCT01052272|82905492|FG001|Overall Study|patient refuses follow-up|4|||
46800730|NCT03952650|83019650|FG000|Overall Study|Lost to Follow-up|0|||
46800731|NCT03952650|83019651|FG001|Overall Study|Lost to Follow-up|1|||
46800732|NCT03952650|83019652|FG002|Overall Study|Lost to Follow-up|0|||
46690937|NCT01052272|82905493|FG002|Overall Study|patient refuses follow-up|2|||
46690938|NCT01052272|82905494|FG003|Overall Study|patient refuses follow-up|4|||
46690939|NCT01052272|82905491|FG000|Overall Study|Withdrawal by Subject|0|||
46690940|NCT01052272|82905492|FG001|Overall Study|Withdrawal by Subject|2|||
46690941|NCT01052272|82905493|FG002|Overall Study|Withdrawal by Subject|3|||
46690942|NCT01052272|82905494|FG003|Overall Study|Withdrawal by Subject|2|||
46690943|NCT01052272|82905491|FG000|Overall Study|placed in long-term care|0|||
46690944|NCT01052272|82905492|FG001|Overall Study|placed in long-term care|0|||
46690945|NCT01052272|82905493|FG002|Overall Study|placed in long-term care|1|||
46690946|NCT01052272|82905494|FG003|Overall Study|placed in long-term care|0|||
46690947|NCT01052272|82905491|FG000|Overall Study|decline in health|0|||
46800733|NCT03952650|83019653|FG003|Overall Study|Lost to Follow-up|0|||
46690948|NCT01052272|82905492|FG001|Overall Study|decline in health|0|||
46690949|NCT01052272|82905493|FG002|Overall Study|decline in health|1|||
46690950|NCT01052272|82905494|FG003|Overall Study|decline in health|0|||
46690951|NCT01257204|82905507|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
46690952|NCT01257204|82905508|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
46690953|NCT01257204|82905509|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
46690954|NCT01257204|82905507|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
46690955|NCT01257204|82905508|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
46690956|NCT01257204|82905509|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
46690957|NCT01257204|82905507|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
46690958|NCT01257204|82905508|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
46690959|NCT01257204|82905509|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
46690960|NCT01257204|82905507|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
46690961|NCT01257204|82905508|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
46690962|NCT01257204|82905509|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
46690963|NCT01257204|82905507|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
46690964|NCT01257204|82905508|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
46690965|NCT01257204|82905509|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
46690966|NCT01257204|82905507|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
46690967|NCT01257204|82905508|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
46690968|NCT01257204|82905509|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
46690969|NCT01257204|82905507|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
46690970|NCT01257204|82905508|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
46690971|NCT01257204|82905509|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
46690972|NCT01257204|82905507|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
46690973|NCT01257204|82905508|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
46690974|NCT01257204|82905509|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
46690975|NCT01257204|82905507|FG000|Follow-up Period (up to Week 48)|Other|0|||
46690976|NCT01257204|82905508|FG001|Follow-up Period (up to Week 48)|Other|0|||
46690977|NCT01257204|82905509|FG002|Follow-up Period (up to Week 48)|Other|5|||
46690978|NCT01231581|82905531|FG000|Overall Study|Lost to Follow-up|2|||
46690979|NCT01231581|82905532|FG001|Overall Study|Lost to Follow-up|2|||
46690980|NCT01231581|82905531|FG000|Overall Study|Withdrawal by Subject|6|||
46690981|NCT01231581|82905532|FG001|Overall Study|Withdrawal by Subject|9|||
46690982|NCT01231581|82905531|FG000|Overall Study|Study Closed/Terminated|6|||
46690983|NCT01231581|82905532|FG001|Overall Study|Study Closed/Terminated|5|||
46690984|NCT01231581|82905531|FG000|Overall Study|Death|65|||
46690985|NCT01231581|82905532|FG001|Overall Study|Death|64|||
46690986|NCT01231581|82905531|FG000|Overall Study|Ongoing|1|||
46690987|NCT01231581|82905532|FG001|Overall Study|Ongoing|0|||
46690988|NCT01050634|82905538|FG000|Overall Study|Enrolled, but Not Treated|56|||
46690989|NCT01050634|82905538|FG000|Overall Study|Death|2|||
46800734|NCT03952650|83019654|FG004|Overall Study|Lost to Follow-up|0|||
46800735|NCT03952650|83019655|FG005|Overall Study|Lost to Follow-up|1|||
46690990|NCT01050634|82905538|FG000|Overall Study|Adverse Event|42|||
46690991|NCT01050634|82905538|FG000|Overall Study|Lost to Follow-up|2|||
46690992|NCT01050634|82905538|FG000|Overall Study|Other|21|||
46690993|NCT01050634|82905538|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
46690994|NCT01020526|82905542|FG000|Overall Study|Withdrawal by Subject|5|||
46690995|NCT01020526|82905542|FG000|Overall Study|Other reasons|3|||
46690996|NCT01020526|82905542|FG000|Overall Study|Insufficient clinical response|3|||
46690997|NCT01020526|82905542|FG000|Overall Study|Lost to Follow-up|1|||
46690998|NCT01020526|82905542|FG000|Overall Study|Adverse Event|2|||
46690999|NCT01020448|82905546|FG000|Pre-assignment|Adverse Event|6|||
46691000|NCT01020448|82905546|FG000|Pre-assignment|Withdrawal by Subject|5|||
46691001|NCT01020448|82905546|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
46691002|NCT01020448|82905546|FG000|Treatment|Adverse Event|11|||
46691003|NCT01020448|82905546|FG000|Treatment|Consent Withdrawn|3|||
46691004|NCT01020448|82905546|FG000|Treatment|Disease Progression|2|||
46691005|NCT01020448|82905546|FG000|Treatment|Lack of Efficacy|8|||
46691006|NCT01020448|82905546|FG000|Treatment|Lost to Follow-up|2|||
46800736|NCT03952650|83019656|FG006|Overall Study|Lost to Follow-up|1|||
46800737|NCT03952650|83019650|FG000|Overall Study|Received wrong vaccine and travelled|0|||
46800738|NCT03952650|83019651|FG001|Overall Study|Received wrong vaccine and travelled|0|||
46800739|NCT03952650|83019652|FG002|Overall Study|Received wrong vaccine and travelled|0|||
46800740|NCT03952650|83019653|FG003|Overall Study|Received wrong vaccine and travelled|0|||
46691007|NCT01256658|82905553|FG000|Period 1|Lost to Follow-up|837|||
46800741|NCT03952650|83019654|FG004|Overall Study|Received wrong vaccine and travelled|0|||
46981935|NCT02586805|83228100|FG001|Overall Study|Adverse Event|0|||
46691008|NCT01256658|82905554|FG001|Period 1|Lost to Follow-up|661|||
46691009|NCT01256658|82905553|FG000|Period 1|Withdrawal by Subject|35|||
46691010|NCT01256658|82905554|FG001|Period 1|Withdrawal by Subject|43|||
46691011|NCT01256658|82905553|FG000|Period 1|Death|48|||
46691012|NCT01256658|82905554|FG001|Period 1|Death|44|||
46691013|NCT01256502|82905563|FG000|Overall Study|Had scaffold removed|4|||
46691014|NCT01256502|82905563|FG000|Overall Study|Personal reasons|5|||
46691015|NCT01256502|82905563|FG000|Overall Study|Protocol deviation|1|||
46691016|NCT01256190|82905574|FG000|Overall Study|Lost to Follow-up|2|||
46691017|NCT01256190|82905575|FG001|Overall Study|Lost to Follow-up|0|||
46691018|NCT01255722|82905584|FG000|Overall Study|Adverse Event|0|||
46691019|NCT01255722|82905585|FG001|Overall Study|Adverse Event|1|||
46691020|NCT01255722|82905586|FG002|Overall Study|Adverse Event|1|||
46691021|NCT01255722|82905584|FG000|Overall Study|asymptomatic patient|1|||
46691022|NCT01255722|82905585|FG001|Overall Study|asymptomatic patient|0|||
46691023|NCT01255722|82905586|FG002|Overall Study|asymptomatic patient|0|||
46691024|NCT01255722|82905584|FG000|Overall Study|beta-blocker contraindicated|2|||
46691025|NCT01255722|82905585|FG001|Overall Study|beta-blocker contraindicated|0|||
46691026|NCT01255722|82905586|FG002|Overall Study|beta-blocker contraindicated|0|||
46691027|NCT01231503|82905603|FG000|Overall Study|Adverse Event|0|||
46691028|NCT01231503|82905604|FG001|Overall Study|Adverse Event|0|||
46691029|NCT01231503|82905605|FG002|Overall Study|Adverse Event|0|||
46691030|NCT01231503|82905606|FG003|Overall Study|Adverse Event|0|||
46691031|NCT01231503|82905607|FG004|Overall Study|Adverse Event|0|||
46691032|NCT01231503|82905608|FG005|Overall Study|Adverse Event|1|||
46691033|NCT01231503|82905609|FG006|Overall Study|Adverse Event|0|||
46691034|NCT01231503|82905610|FG007|Overall Study|Adverse Event|0|||
46691035|NCT01231503|82905603|FG000|Overall Study|Adverse event, serious fatal|0|||
46691036|NCT01231503|82905604|FG001|Overall Study|Adverse event, serious fatal|0|||
46691037|NCT01231503|82905605|FG002|Overall Study|Adverse event, serious fatal|1|||
46691038|NCT01231503|82905606|FG003|Overall Study|Adverse event, serious fatal|1|||
46691039|NCT01231503|82905607|FG004|Overall Study|Adverse event, serious fatal|0|||
46691040|NCT01231503|82905608|FG005|Overall Study|Adverse event, serious fatal|1|||
46691041|NCT01231503|82905609|FG006|Overall Study|Adverse event, serious fatal|0|||
46691042|NCT01231503|82905610|FG007|Overall Study|Adverse event, serious fatal|0|||
46691043|NCT01231503|82905603|FG000|Overall Study|Withdrawal by Subject|6|||
46691044|NCT01231503|82905604|FG001|Overall Study|Withdrawal by Subject|3|||
46691045|NCT01231503|82905605|FG002|Overall Study|Withdrawal by Subject|3|||
46691046|NCT01231503|82905606|FG003|Overall Study|Withdrawal by Subject|1|||
46691047|NCT01231503|82905607|FG004|Overall Study|Withdrawal by Subject|3|||
46691048|NCT01231503|82905608|FG005|Overall Study|Withdrawal by Subject|5|||
46691049|NCT01231503|82905609|FG006|Overall Study|Withdrawal by Subject|1|||
46691050|NCT01231503|82905610|FG007|Overall Study|Withdrawal by Subject|2|||
46691051|NCT01231503|82905603|FG000|Overall Study|Lost to Follow-up|8|||
46691052|NCT01231503|82905604|FG001|Overall Study|Lost to Follow-up|10|||
46691053|NCT01231503|82905605|FG002|Overall Study|Lost to Follow-up|8|||
46691054|NCT01231503|82905606|FG003|Overall Study|Lost to Follow-up|5|||
46691055|NCT01231503|82905607|FG004|Overall Study|Lost to Follow-up|7|||
46691056|NCT01231503|82905608|FG005|Overall Study|Lost to Follow-up|9|||
46691057|NCT01231503|82905609|FG006|Overall Study|Lost to Follow-up|6|||
46691058|NCT01231503|82905610|FG007|Overall Study|Lost to Follow-up|6|||
46691059|NCT01231503|82905603|FG000|Overall Study|Protocol Violation|0|||
46691060|NCT01231503|82905604|FG001|Overall Study|Protocol Violation|0|||
46691061|NCT01231503|82905605|FG002|Overall Study|Protocol Violation|0|||
46691062|NCT01231503|82905606|FG003|Overall Study|Protocol Violation|1|||
46691063|NCT01231503|82905607|FG004|Overall Study|Protocol Violation|0|||
46691064|NCT01231503|82905608|FG005|Overall Study|Protocol Violation|0|||
46691065|NCT01231503|82905609|FG006|Overall Study|Protocol Violation|0|||
46691066|NCT01231503|82905610|FG007|Overall Study|Protocol Violation|0|||
46691067|NCT01230489|82905638|FG000|Overall Study|Death|2|||
46691068|NCT01230489|82905638|FG000|Overall Study|Adverse Event|2|||
46691069|NCT01230489|82905638|FG000|Overall Study|Treatment modality changed|1|||
46691070|NCT01229397|82905644|FG000|Overall Study|Withdrawal by Subject|3|||
46691071|NCT01229397|82905645|FG001|Overall Study|Withdrawal by Subject|3|||
46691072|NCT01229397|82905644|FG000|Overall Study|Lost to Follow-up|7|||
46691073|NCT01229397|82905645|FG001|Overall Study|Lost to Follow-up|6|||
46691074|NCT01229397|82905644|FG000|Overall Study|Migrated/moved from study area|1|||
46691075|NCT01229397|82905645|FG001|Overall Study|Migrated/moved from study area|0|||
46691076|NCT01228071|82905655|FG000|Overall Study|Protocol Violation|1|||
46691077|NCT01228071|82905655|FG000|Overall Study|Withdrawal by Subject|1|||
46691078|NCT01008475|82905666|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
46691079|NCT01008475|82905667|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
46691080|NCT01008475|82905668|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
46691081|NCT01008475|82905669|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
46691082|NCT01008475|82905670|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
46691083|NCT01008475|82905671|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
46691084|NCT01008475|82905672|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
46691085|NCT01226745|82905694|FG000|Overall Study|Did not complete schedule of assessments|8|||
46691086|NCT01226745|82905695|FG001|Overall Study|Did not complete schedule of assessments|3|||
46691087|NCT01226745|82905696|FG002|Overall Study|Did not complete schedule of assessments|6|||
46691088|NCT01226745|82905697|FG003|Overall Study|Did not complete schedule of assessments|0|||
46691089|NCT01226745|82905698|FG004|Overall Study|Did not complete schedule of assessments|0|||
46691090|NCT01226745|82905699|FG005|Overall Study|Did not complete schedule of assessments|1|||
46691091|NCT01226745|82905694|FG000|Overall Study|Lost to Follow-up|2|||
46691092|NCT01226745|82905695|FG001|Overall Study|Lost to Follow-up|6|||
46691093|NCT01226745|82905696|FG002|Overall Study|Lost to Follow-up|6|||
46691094|NCT01226745|82905697|FG003|Overall Study|Lost to Follow-up|1|||
46691095|NCT01226745|82905698|FG004|Overall Study|Lost to Follow-up|1|||
46691096|NCT01226745|82905699|FG005|Overall Study|Lost to Follow-up|2|||
46691097|NCT01226745|82905694|FG000|Overall Study|Death|1|||
46691098|NCT01226745|82905695|FG001|Overall Study|Death|0|||
46691099|NCT01226745|82905696|FG002|Overall Study|Death|0|||
46691100|NCT01226745|82905697|FG003|Overall Study|Death|0|||
46691101|NCT01226745|82905698|FG004|Overall Study|Death|0|||
46691102|NCT01226745|82905699|FG005|Overall Study|Death|1|||
46691103|NCT01226745|82905694|FG000|Overall Study|Other|6|||
46691104|NCT01226745|82905695|FG001|Overall Study|Other|7|||
46691105|NCT01226745|82905696|FG002|Overall Study|Other|8|||
46691106|NCT01226745|82905697|FG003|Overall Study|Other|4|||
46691107|NCT01226745|82905698|FG004|Overall Study|Other|3|||
46691108|NCT01226745|82905699|FG005|Overall Study|Other|1|||
46691109|NCT01226511|82905716|FG000|Acute Treatment Period|Adverse Event|7|||
46691110|NCT01226511|82905717|FG001|Acute Treatment Period|Adverse Event|6|||
46691111|NCT01226511|82905716|FG000|Acute Treatment Period|Lack of Efficacy|2|||
46691112|NCT01226511|82905717|FG001|Acute Treatment Period|Lack of Efficacy|1|||
46691113|NCT01226511|82905716|FG000|Acute Treatment Period|Lost to Follow-up|3|||
46691114|NCT01226511|82905717|FG001|Acute Treatment Period|Lost to Follow-up|6|||
46691115|NCT01226511|82905716|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
46691116|NCT01226511|82905717|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
46691117|NCT01226511|82905716|FG000|Acute Treatment Period|Protocol Violation|5|||
46691118|NCT01226511|82905717|FG001|Acute Treatment Period|Protocol Violation|5|||
46691119|NCT01226511|82905716|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
46691120|NCT01226511|82905717|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
46800742|NCT03952650|83019655|FG005|Overall Study|Received wrong vaccine and travelled|1|||
46800743|NCT03952650|83019656|FG006|Overall Study|Received wrong vaccine and travelled|0|||
46800744|NCT03952650|83019650|FG000|Overall Study|Unable to make study visit|0|||
46800745|NCT03952650|83019651|FG001|Overall Study|Unable to make study visit|0|||
46800746|NCT03952650|83019652|FG002|Overall Study|Unable to make study visit|0|||
46691121|NCT01226511|82905716|FG000|Extension Treatment Period|Adverse Event|8|||
46691122|NCT01226511|82905717|FG001|Extension Treatment Period|Adverse Event|8|||
46691123|NCT01226511|82905716|FG000|Extension Treatment Period|Lack of Efficacy|3|||
46691124|NCT01226511|82905717|FG001|Extension Treatment Period|Lack of Efficacy|2|||
46691125|NCT01226511|82905716|FG000|Extension Treatment Period|Lost to Follow-up|4|||
46800747|NCT03952650|83019653|FG003|Overall Study|Unable to make study visit|0|||
46800748|NCT03952650|83019654|FG004|Overall Study|Unable to make study visit|0|||
46800749|NCT03952650|83019655|FG005|Overall Study|Unable to make study visit|1|||
46981936|NCT02586805|83228101|FG002|Overall Study|Adverse Event|1|||
46691126|NCT01226511|82905717|FG001|Extension Treatment Period|Lost to Follow-up|3|||
46691127|NCT01226511|82905716|FG000|Extension Treatment Period|Protocol Violation|2|||
46691128|NCT01226511|82905717|FG001|Extension Treatment Period|Protocol Violation|2|||
46691129|NCT01226511|82905716|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
46691130|NCT01226511|82905717|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
46691131|NCT01226511|82905716|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
46691132|NCT01226511|82905717|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
46691133|NCT01226511|82905716|FG000|Extension Treatment Period|Sponsor Decision|1|||
46691134|NCT01226511|82905717|FG001|Extension Treatment Period|Sponsor Decision|1|||
46691135|NCT01226511|82905716|FG000|Taper Period|Adverse Event|1|||
46691136|NCT01226511|82905717|FG001|Taper Period|Adverse Event|0|||
46691137|NCT01226511|82905716|FG000|Taper Period|Lost to Follow-up|2|||
46691138|NCT01226511|82905717|FG001|Taper Period|Lost to Follow-up|2|||
46691139|NCT01226511|82905716|FG000|Taper Period|Protocol Violation|1|||
46691140|NCT01226511|82905717|FG001|Taper Period|Protocol Violation|0|||
46691141|NCT01226511|82905716|FG000|Taper Period|Parent/Caregiver Decision|1|||
46691142|NCT01226511|82905717|FG001|Taper Period|Parent/Caregiver Decision|1|||
46691143|NCT01226121|82905732|FG000|Overall Study|Lost to Follow-up|2|||
46691144|NCT01226121|82905733|FG001|Overall Study|Lost to Follow-up|0|||
46691145|NCT01226121|82905734|FG002|Overall Study|Lost to Follow-up|1|||
46691146|NCT01226043|82905744|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
46691147|NCT01226043|82905745|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
46691148|NCT01226043|82905746|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
46691149|NCT01226043|82905747|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
46691150|NCT01226043|82905744|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
46691151|NCT01226043|82905745|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
46691152|NCT01226043|82905746|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
46691153|NCT01226043|82905747|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
46691154|NCT01226043|82905744|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
46691155|NCT01226043|82905745|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
46691156|NCT01226043|82905746|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
46691157|NCT01226043|82905747|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
46691158|NCT01226043|82905744|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
46691159|NCT01226043|82905745|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
46691160|NCT01226043|82905746|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
46691161|NCT01226043|82905747|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
46691162|NCT01226043|82905744|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
46691163|NCT01226043|82905745|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
46691164|NCT01226043|82905746|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
46691165|NCT01226043|82905747|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
46691166|NCT01226043|82905744|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
46981937|NCT02586805|83228102|FG003|Overall Study|Adverse Event|0|||
46691167|NCT01226043|82905745|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
46691168|NCT01226043|82905746|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
46691169|NCT01226043|82905747|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
46691170|NCT01226043|82905744|FG000|6-week Re-randomization Phase|Adverse Event|0|||
46691171|NCT01226043|82905745|FG001|6-week Re-randomization Phase|Adverse Event|0|||
46691172|NCT01226043|82905746|FG002|6-week Re-randomization Phase|Adverse Event|1|||
46691173|NCT01226043|82905747|FG003|6-week Re-randomization Phase|Adverse Event|1|||
46691174|NCT01226043|82905744|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
46691175|NCT01226043|82905745|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
46691176|NCT01226043|82905746|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
46691177|NCT01226043|82905747|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
46691178|NCT01226043|82905744|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
46691179|NCT01226043|82905745|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
46691180|NCT01226043|82905746|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
46691181|NCT01226043|82905747|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
46691182|NCT01226043|82905744|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
46691183|NCT01226043|82905745|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
46800750|NCT03952650|83019656|FG006|Overall Study|Unable to make study visit|0|||
46691184|NCT01226043|82905746|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
46800751|NCT00691301|83019672|FG000|Overall Study|Adverse Event|10|||
46800752|NCT00691301|83019672|FG000|Overall Study|Death|2|||
46800753|NCT00691301|83019672|FG000|Overall Study|Lack of Efficacy|32|||
46800754|NCT00691301|83019672|FG000|Overall Study|Withdrawal by Subject|4|||
46800755|NCT00691301|83019672|FG000|Overall Study|Concurrent illness|2|||
46800756|NCT00691301|83019672|FG000|Overall Study|other reason|3|||
46691185|NCT01226043|82905747|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
46800757|NCT00691301|83019672|FG000|Overall Study|Did not initiate study treatment|1|||
46800758|NCT00927563|83019682|FG000|Overall Study|Lost to Follow-up|1|||
46691186|NCT01226043|82905744|FG000|6-week Re-randomization Phase|Physician Decision|0|||
46691187|NCT01226043|82905745|FG001|6-week Re-randomization Phase|Physician Decision|0|||
46800759|NCT00927563|83019682|FG000|Overall Study|Withdrawal by Subject|1|||
46800760|NCT00653159|83019697|FG000|Overall Study|Adverse Event|4|||
46800761|NCT00653159|83019698|FG001|Overall Study|Adverse Event|1|||
46800762|NCT00653159|83019697|FG000|Overall Study|Lost to Follow-up|1|||
46800763|NCT00653159|83019698|FG001|Overall Study|Lost to Follow-up|2|||
46800764|NCT00117637|83019706|FG000|First Intervention (Period 1)|Adverse Event|11|||
46800765|NCT00117637|83019707|FG001|First Intervention (Period 1)|Adverse Event|16|||
46800766|NCT00117637|83019706|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
46800767|NCT00117637|83019707|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
46800768|NCT00117637|83019706|FG000|First Intervention (Period 1)|Protocol Violation|1|||
46800769|NCT00117637|83019707|FG001|First Intervention (Period 1)|Protocol Violation|0|||
46800770|NCT00117637|83019706|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
46800771|NCT00117637|83019707|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
46800772|NCT00117637|83019706|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
46800773|NCT00117637|83019707|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
46800774|NCT00117637|83019706|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
46800775|NCT00117637|83019707|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
46800776|NCT00117637|83019706|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
46800777|NCT00117637|83019707|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
46800778|NCT00117637|83019706|FG000|First Intervention (Period 1)|reason not reported|0|||
46800779|NCT00117637|83019707|FG001|First Intervention (Period 1)|reason not reported|1|||
46800780|NCT00117637|83019706|FG000|Second Intervention (Period 2)|Adverse Event|0|||
46800781|NCT00117637|83019707|FG001|Second Intervention (Period 2)|Adverse Event|9|||
46800782|NCT00117637|83019706|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
46800783|NCT00117637|83019707|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
46800784|NCT00117637|83019706|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
46800785|NCT00117637|83019707|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
46800786|NCT00117637|83019706|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
46800787|NCT00117637|83019707|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
46800788|NCT00117637|83019706|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
46800789|NCT00117637|83019707|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
46800790|NCT00117637|83019706|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
46800791|NCT00117637|83019707|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
46800792|NCT00117637|83019706|FG000|Second Intervention (Period 2)|reason not reported|1|||
46800793|NCT00117637|83019707|FG001|Second Intervention (Period 2)|reason not reported|0|||
46800794|NCT00690755|83019727|FG000|Overall Study|Physician Decision|2|||
46800795|NCT00690755|83019728|FG001|Overall Study|Physician Decision|0|||
46800796|NCT00690755|83019729|FG002|Overall Study|Physician Decision|46|||
46800797|NCT00690755|83019730|FG003|Overall Study|Physician Decision|5|||
46800798|NCT00690755|83019731|FG004|Overall Study|Physician Decision|0|||
46800799|NCT00690755|83019732|FG005|Overall Study|Physician Decision|4|||
46800800|NCT00690755|83019733|FG006|Overall Study|Physician Decision|0|||
46800801|NCT00549302|83019751|FG000|Double-Blind|Death|2|||
46800802|NCT00549302|83019752|FG001|Double-Blind|Death|9|||
46800803|NCT00549302|83019753|FG002|Double-Blind|Death|0|||
46800804|NCT00549302|83019751|FG000|Double-Blind|Adverse Event|3|||
46800805|NCT00549302|83019752|FG001|Double-Blind|Adverse Event|16|||
46800806|NCT00549302|83019753|FG002|Double-Blind|Adverse Event|0|||
46858847|NCT03308968|83074662|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
46858848|NCT03308968|83074663|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
46800807|NCT00549302|83019751|FG000|Double-Blind|Withdrawal by Subject|3|||
46981938|NCT02586805|83228099|FG000|Overall Study|Lost to Follow-up|0|||
46691188|NCT01226043|82905746|FG002|6-week Re-randomization Phase|Physician Decision|3|||
46691189|NCT01226043|82905747|FG003|6-week Re-randomization Phase|Physician Decision|2|||
46691190|NCT01226043|82905744|FG000|6-week Re-randomization Phase|completed in error|0|||
46691191|NCT01226043|82905745|FG001|6-week Re-randomization Phase|completed in error|0|||
46691192|NCT01226043|82905746|FG002|6-week Re-randomization Phase|completed in error|0|||
46691193|NCT01226043|82905747|FG003|6-week Re-randomization Phase|completed in error|1|||
46691194|NCT01226043|82905744|FG000|30-week Observational Phase|Adverse Event|0|||
46691195|NCT01226043|82905745|FG001|30-week Observational Phase|Adverse Event|0|||
46691196|NCT01226043|82905746|FG002|30-week Observational Phase|Adverse Event|1|||
46691197|NCT01226043|82905747|FG003|30-week Observational Phase|Adverse Event|1|||
46691198|NCT01226043|82905744|FG000|30-week Observational Phase|Protocol Violation|0|||
46691199|NCT01226043|82905745|FG001|30-week Observational Phase|Protocol Violation|0|||
46691200|NCT01226043|82905746|FG002|30-week Observational Phase|Protocol Violation|0|||
46691201|NCT01226043|82905747|FG003|30-week Observational Phase|Protocol Violation|1|||
46691202|NCT01226043|82905744|FG000|30-week Observational Phase|Lost to Follow-up|0|||
46691203|NCT01226043|82905745|FG001|30-week Observational Phase|Lost to Follow-up|0|||
46691204|NCT01226043|82905746|FG002|30-week Observational Phase|Lost to Follow-up|2|||
46691205|NCT01226043|82905747|FG003|30-week Observational Phase|Lost to Follow-up|2|||
46691206|NCT01226043|82905744|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
46691207|NCT01226043|82905745|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
46691208|NCT01226043|82905746|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
46691209|NCT01226043|82905747|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
46691210|NCT01226043|82905744|FG000|30-week Observational Phase|Physician Decision|0|||
46691211|NCT01226043|82905745|FG001|30-week Observational Phase|Physician Decision|0|||
46800808|NCT00549302|83019752|FG001|Double-Blind|Withdrawal by Subject|8|||
46800809|NCT00549302|83019753|FG002|Double-Blind|Withdrawal by Subject|0|||
46800810|NCT00549302|83019751|FG000|Double-Blind|Investigator Decision|1|||
46800811|NCT00549302|83019752|FG001|Double-Blind|Investigator Decision|5|||
46800812|NCT00549302|83019753|FG002|Double-Blind|Investigator Decision|0|||
46800813|NCT00549302|83019751|FG000|Double-Blind|Sponsor Decision|0|||
46800814|NCT00549302|83019752|FG001|Double-Blind|Sponsor Decision|1|||
46800815|NCT00549302|83019753|FG002|Double-Blind|Sponsor Decision|0|||
46800816|NCT00549302|83019751|FG000|Double-Blind|Lost to Follow-up|1|||
46800817|NCT00549302|83019752|FG001|Double-Blind|Lost to Follow-up|2|||
46800818|NCT00549302|83019753|FG002|Double-Blind|Lost to Follow-up|0|||
46800819|NCT00549302|83019751|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
46800820|NCT00549302|83019752|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
46800821|NCT00549302|83019753|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
46800822|NCT00549302|83019751|FG000|Double-Blind|New condition or starts new therapy|0|||
46691212|NCT01226043|82905746|FG002|30-week Observational Phase|Physician Decision|2|||
46800823|NCT00549302|83019752|FG001|Double-Blind|New condition or starts new therapy|2|||
46981939|NCT02586805|83228100|FG001|Overall Study|Lost to Follow-up|0|||
46800824|NCT00549302|83019753|FG002|Double-Blind|New condition or starts new therapy|0|||
46800825|NCT00549302|83019751|FG000|Open-Label|Adverse Event|0|||
46858849|NCT03308968|83074661|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
46691213|NCT01226043|82905747|FG003|30-week Observational Phase|Physician Decision|2|||
46691214|NCT01001377|82905779|FG000|Overall Study|Ineligibility determined|2|||
46691215|NCT01001377|82905780|FG001|Overall Study|Ineligibility determined|0|||
46691216|NCT01001377|82905779|FG000|Overall Study|Withdrawal by Subject|19|||
46691217|NCT01001377|82905780|FG001|Overall Study|Withdrawal by Subject|20|||
46691218|NCT01001377|82905779|FG000|Overall Study|Lost to Follow-up|14|||
46691219|NCT01001377|82905780|FG001|Overall Study|Lost to Follow-up|17|||
46691220|NCT01001377|82905779|FG000|Overall Study|Death|391|||
46691221|NCT01001377|82905780|FG001|Overall Study|Death|384|||
46691222|NCT01225887|82905786|FG000|Overall Study|Ineligible:required test not done|2|||
46691223|NCT01225887|82905786|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
46691224|NCT01225887|82905786|FG000|Overall Study|Ineligible:inadequate pathology|2|||
46691225|NCT01001299|82905790|FG000|Overall Study|Insufficient Therapeutic Response|20|||
46691226|NCT01001299|82905790|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
46691227|NCT01001299|82905790|FG000|Overall Study|Death|1|||
46691228|NCT01001299|82905790|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
46691229|NCT01001299|82905790|FG000|Overall Study|Withdrew Consent|1|||
46691230|NCT01296932|82905803|FG000|Overall Study|Dose limiting toxicity|0|||
46691231|NCT01296932|82905804|FG001|Overall Study|Dose limiting toxicity|0|||
46691232|NCT01296932|82905805|FG002|Overall Study|Dose limiting toxicity|0|||
46691233|NCT01296932|82905806|FG003|Overall Study|Dose limiting toxicity|0|||
46691234|NCT01296932|82905807|FG004|Overall Study|Dose limiting toxicity|0|||
46691235|NCT01296932|82905808|FG005|Overall Study|Dose limiting toxicity|0|||
46691236|NCT01296932|82905809|FG006|Overall Study|Dose limiting toxicity|1|||
46691237|NCT01296932|82905810|FG007|Overall Study|Dose limiting toxicity|0|||
46691238|NCT01296932|82905811|FG008|Overall Study|Dose limiting toxicity|1|||
46691239|NCT01296932|82905803|FG000|Overall Study|Progressive disease|2|||
46691240|NCT01296932|82905804|FG001|Overall Study|Progressive disease|0|||
46691241|NCT01296932|82905805|FG002|Overall Study|Progressive disease|1|||
46691242|NCT01296932|82905806|FG003|Overall Study|Progressive disease|1|||
46691243|NCT01296932|82905807|FG004|Overall Study|Progressive disease|2|||
46691244|NCT01296932|82905808|FG005|Overall Study|Progressive disease|3|||
46691245|NCT01296932|82905809|FG006|Overall Study|Progressive disease|1|||
46691246|NCT01296932|82905810|FG007|Overall Study|Progressive disease|0|||
46691247|NCT01296932|82905811|FG008|Overall Study|Progressive disease|0|||
46691248|NCT01296932|82905803|FG000|Overall Study|Withdrawal by Subject|0|||
46691249|NCT01296932|82905804|FG001|Overall Study|Withdrawal by Subject|0|||
46691250|NCT01296932|82905805|FG002|Overall Study|Withdrawal by Subject|1|||
46691251|NCT01296932|82905806|FG003|Overall Study|Withdrawal by Subject|1|||
46691252|NCT01296932|82905807|FG004|Overall Study|Withdrawal by Subject|0|||
46691253|NCT01296932|82905808|FG005|Overall Study|Withdrawal by Subject|0|||
46691254|NCT01296932|82905809|FG006|Overall Study|Withdrawal by Subject|3|||
46691255|NCT01296932|82905810|FG007|Overall Study|Withdrawal by Subject|0|||
46691256|NCT01296932|82905811|FG008|Overall Study|Withdrawal by Subject|0|||
46691257|NCT01296932|82905803|FG000|Overall Study|Adverse Event|1|||
46691258|NCT01296932|82905804|FG001|Overall Study|Adverse Event|1|||
46691259|NCT01296932|82905805|FG002|Overall Study|Adverse Event|1|||
46691260|NCT01296932|82905806|FG003|Overall Study|Adverse Event|2|||
46691261|NCT01296932|82905807|FG004|Overall Study|Adverse Event|1|||
46691262|NCT01296932|82905808|FG005|Overall Study|Adverse Event|0|||
46691263|NCT01296932|82905809|FG006|Overall Study|Adverse Event|0|||
46691264|NCT01296932|82905810|FG007|Overall Study|Adverse Event|0|||
46691265|NCT01296932|82905811|FG008|Overall Study|Adverse Event|1|||
46691266|NCT01296932|82905803|FG000|Overall Study|Investigator decision|0|||
46691267|NCT01296932|82905804|FG001|Overall Study|Investigator decision|1|||
46691268|NCT01296932|82905805|FG002|Overall Study|Investigator decision|0|||
46691269|NCT01296932|82905806|FG003|Overall Study|Investigator decision|1|||
46691270|NCT01296932|82905807|FG004|Overall Study|Investigator decision|0|||
46691271|NCT01296932|82905808|FG005|Overall Study|Investigator decision|0|||
46691272|NCT01296932|82905809|FG006|Overall Study|Investigator decision|1|||
46691273|NCT01296932|82905810|FG007|Overall Study|Investigator decision|0|||
46691274|NCT01296932|82905811|FG008|Overall Study|Investigator decision|1|||
46691275|NCT01296932|82905803|FG000|Overall Study|No clinical benefit anymore|0|||
46691276|NCT01296932|82905804|FG001|Overall Study|No clinical benefit anymore|1|||
46691277|NCT01296932|82905805|FG002|Overall Study|No clinical benefit anymore|0|||
46691278|NCT01296932|82905806|FG003|Overall Study|No clinical benefit anymore|0|||
46691279|NCT01296932|82905807|FG004|Overall Study|No clinical benefit anymore|0|||
46691280|NCT01296932|82905808|FG005|Overall Study|No clinical benefit anymore|0|||
46691281|NCT01296932|82905809|FG006|Overall Study|No clinical benefit anymore|0|||
46691282|NCT01296932|82905810|FG007|Overall Study|No clinical benefit anymore|0|||
46691283|NCT01296932|82905811|FG008|Overall Study|No clinical benefit anymore|0|||
46691284|NCT01296932|82905803|FG000|Overall Study|Physician Decision|0|||
46691285|NCT01296932|82905804|FG001|Overall Study|Physician Decision|0|||
46691286|NCT01296932|82905805|FG002|Overall Study|Physician Decision|1|||
46691287|NCT01296932|82905806|FG003|Overall Study|Physician Decision|0|||
46691288|NCT01296932|82905807|FG004|Overall Study|Physician Decision|0|||
46691289|NCT01296932|82905808|FG005|Overall Study|Physician Decision|0|||
46691290|NCT01296932|82905809|FG006|Overall Study|Physician Decision|0|||
46691291|NCT01296932|82905810|FG007|Overall Study|Physician Decision|0|||
46691292|NCT01296932|82905811|FG008|Overall Study|Physician Decision|0|||
46691293|NCT01296932|82905803|FG000|Overall Study|IV problems, administration not possible|0|||
46691294|NCT01296932|82905804|FG001|Overall Study|IV problems, administration not possible|0|||
46691295|NCT01296932|82905805|FG002|Overall Study|IV problems, administration not possible|1|||
46691296|NCT01296932|82905806|FG003|Overall Study|IV problems, administration not possible|0|||
46691297|NCT01296932|82905807|FG004|Overall Study|IV problems, administration not possible|0|||
46691298|NCT01296932|82905808|FG005|Overall Study|IV problems, administration not possible|0|||
46691299|NCT01296932|82905809|FG006|Overall Study|IV problems, administration not possible|0|||
46691300|NCT01296932|82905810|FG007|Overall Study|IV problems, administration not possible|0|||
46691301|NCT01296932|82905811|FG008|Overall Study|IV problems, administration not possible|0|||
46691302|NCT01296932|82905803|FG000|Overall Study|per protocol|0|||
46691303|NCT01296932|82905804|FG001|Overall Study|per protocol|0|||
46691304|NCT01296932|82905805|FG002|Overall Study|per protocol|1|||
46691305|NCT01296932|82905806|FG003|Overall Study|per protocol|1|||
46691306|NCT01296932|82905807|FG004|Overall Study|per protocol|0|||
46691307|NCT01296932|82905808|FG005|Overall Study|per protocol|0|||
46691308|NCT01296932|82905809|FG006|Overall Study|per protocol|0|||
46691309|NCT01296932|82905810|FG007|Overall Study|per protocol|0|||
46691310|NCT01296932|82905811|FG008|Overall Study|per protocol|0|||
46691311|NCT01296932|82905803|FG000|Overall Study|Low benefit and too many side effects|0|||
46691312|NCT01296932|82905804|FG001|Overall Study|Low benefit and too many side effects|0|||
46800826|NCT00549302|83019752|FG001|Open-Label|Adverse Event|0|||
46981940|NCT02586805|83228101|FG002|Overall Study|Lost to Follow-up|1|||
46691313|NCT01296932|82905805|FG002|Overall Study|Low benefit and too many side effects|0|||
46691314|NCT01296932|82905806|FG003|Overall Study|Low benefit and too many side effects|0|||
46691315|NCT01296932|82905807|FG004|Overall Study|Low benefit and too many side effects|0|||
46691316|NCT01296932|82905808|FG005|Overall Study|Low benefit and too many side effects|0|||
46691317|NCT01296932|82905809|FG006|Overall Study|Low benefit and too many side effects|0|||
46691318|NCT01296932|82905810|FG007|Overall Study|Low benefit and too many side effects|1|||
46691319|NCT01296932|82905811|FG008|Overall Study|Low benefit and too many side effects|0|||
46691320|NCT01296932|82905803|FG000|Overall Study|No adequate treatment response|0|||
46691321|NCT01296932|82905804|FG001|Overall Study|No adequate treatment response|0|||
46691322|NCT01296932|82905805|FG002|Overall Study|No adequate treatment response|0|||
46691323|NCT01296932|82905806|FG003|Overall Study|No adequate treatment response|0|||
46691324|NCT01296932|82905807|FG004|Overall Study|No adequate treatment response|0|||
46691325|NCT01296932|82905808|FG005|Overall Study|No adequate treatment response|0|||
46981941|NCT02586805|83228102|FG003|Overall Study|Lost to Follow-up|0|||
46691326|NCT01296932|82905809|FG006|Overall Study|No adequate treatment response|0|||
46800827|NCT00549302|83019753|FG002|Open-Label|Adverse Event|11|||
46691327|NCT01296932|82905810|FG007|Overall Study|No adequate treatment response|1|||
46691328|NCT01296932|82905811|FG008|Overall Study|No adequate treatment response|0|||
46691329|NCT01296932|82905803|FG000|Overall Study|Dosage already reduced, AE still present|0|||
46691330|NCT01296932|82905804|FG001|Overall Study|Dosage already reduced, AE still present|0|||
46691331|NCT01296932|82905805|FG002|Overall Study|Dosage already reduced, AE still present|0|||
46691332|NCT01296932|82905806|FG003|Overall Study|Dosage already reduced, AE still present|0|||
46691333|NCT01296932|82905807|FG004|Overall Study|Dosage already reduced, AE still present|0|||
46691334|NCT01296932|82905808|FG005|Overall Study|Dosage already reduced, AE still present|0|||
46691335|NCT01296932|82905809|FG006|Overall Study|Dosage already reduced, AE still present|0|||
46691336|NCT01296932|82905810|FG007|Overall Study|Dosage already reduced, AE still present|0|||
46691337|NCT01296932|82905811|FG008|Overall Study|Dosage already reduced, AE still present|1|||
46691338|NCT01296698|82905834|FG000|Overall Study|Adverse Event|1|||
46691339|NCT01296698|82905835|FG001|Overall Study|Adverse Event|0|||
46691340|NCT01296698|82905834|FG000|Overall Study|Death|1|||
46691341|NCT01296698|82905835|FG001|Overall Study|Death|0|||
46691342|NCT01296698|82905834|FG000|Overall Study|Lost to Follow-up|19|||
46691343|NCT01296698|82905835|FG001|Overall Study|Lost to Follow-up|1|||
46691344|NCT01296698|82905834|FG000|Overall Study|Withdrawal by Subject|12|||
46691345|NCT01296698|82905835|FG001|Overall Study|Withdrawal by Subject|0|||
46691346|NCT01296698|82905834|FG000|Overall Study|Difficulty Contacting Subject|2|||
46691347|NCT01296698|82905835|FG001|Overall Study|Difficulty Contacting Subject|0|||
46691348|NCT01296698|82905834|FG000|Overall Study|Study Terminated by Sponsor|209|||
46691349|NCT01296698|82905835|FG001|Overall Study|Study Terminated by Sponsor|12|||
46691350|NCT01001221|82905845|FG000|Overall Study|Adverse Event|1|||
46691351|NCT01001221|82905846|FG001|Overall Study|Adverse Event|2|||
46691352|NCT01001221|82905847|FG002|Overall Study|Adverse Event|0|||
46691353|NCT01001221|82905848|FG003|Overall Study|Adverse Event|2|||
46691354|NCT01001221|82905849|FG004|Overall Study|Adverse Event|0|||
46691355|NCT01001221|82905845|FG000|Overall Study|Disease progression|3|||
46691356|NCT01001221|82905846|FG001|Overall Study|Disease progression|2|||
46981942|NCT02586805|83228099|FG000|Overall Study|Physician Decision|1|||
46981943|NCT02586805|83228100|FG001|Overall Study|Physician Decision|0|||
46981944|NCT02586805|83228101|FG002|Overall Study|Physician Decision|0|||
46981945|NCT02586805|83228102|FG003|Overall Study|Physician Decision|0|||
46981946|NCT02580877|83228114|FG000|Overall Study|Withdrawal by Subject|1|||
46981947|NCT02580877|83228115|FG001|Overall Study|Withdrawal by Subject|3|||
46981948|NCT02580877|83228114|FG000|Overall Study|Adverse Event|0|||
46981949|NCT02580877|83228115|FG001|Overall Study|Adverse Event|1|||
46981950|NCT02582983|83228131|FG000|Overall Study|Death|3|||
46981951|NCT02582983|83228131|FG000|Overall Study|Withdrawal by Subject|2|||
46981952|NCT02582983|83228131|FG000|Overall Study|Adverse Event|1|||
46691357|NCT01001221|82905847|FG002|Overall Study|Disease progression|2|||
46691358|NCT01001221|82905848|FG003|Overall Study|Disease progression|4|||
46691359|NCT01001221|82905849|FG004|Overall Study|Disease progression|0|||
46691360|NCT01001221|82905845|FG000|Overall Study|Other|1|||
46691361|NCT01001221|82905846|FG001|Overall Study|Other|1|||
46691362|NCT01001221|82905847|FG002|Overall Study|Other|0|||
46691363|NCT01001221|82905848|FG003|Overall Study|Other|0|||
46691364|NCT01001221|82905849|FG004|Overall Study|Other|0|||
46691365|NCT01001221|82905845|FG000|Overall Study|Not treated; protocol exclusion|0|||
46691366|NCT01001221|82905846|FG001|Overall Study|Not treated; protocol exclusion|0|||
46691367|NCT01001221|82905847|FG002|Overall Study|Not treated; protocol exclusion|1|||
46981953|NCT02582749|83228137|FG000|Overall Study|Study terminated by funder|5|||
46981954|NCT02582749|83228138|FG001|Overall Study|Study terminated by funder|10|||
46981955|NCT02582749|83228137|FG000|Overall Study|Withdrawal by Subject|0|||
46691368|NCT01001221|82905848|FG003|Overall Study|Not treated; protocol exclusion|0|||
46691369|NCT01001221|82905849|FG004|Overall Study|Not treated; protocol exclusion|0|||
46800828|NCT00549302|83019751|FG000|Open-Label|Death|0|||
46981956|NCT02582749|83228138|FG001|Overall Study|Withdrawal by Subject|1|||
46981957|NCT02582671|83228144|FG000|Overall Study|Failure to return|1|||
46981958|NCT02582671|83228144|FG000|Overall Study|Other, not specified|1|||
46981959|NCT02585713|83228151|FG000|Overall Study|Withdrew prior to treatment|2|||
46981960|NCT02585713|83228152|FG001|Overall Study|Withdrew prior to treatment|7|||
46981961|NCT02585713|83228151|FG000|Overall Study|Other|3|||
46981962|NCT02585713|83228152|FG001|Overall Study|Other|1|||
46981963|NCT02579863|83228160|FG000|Overall Study|Final Disposition Unknown|2|||
46981964|NCT02579863|83228161|FG001|Overall Study|Final Disposition Unknown|1|||
46981965|NCT02579863|83228160|FG000|Overall Study|Adverse Event|18|||
46981966|NCT02579863|83228161|FG001|Overall Study|Adverse Event|11|||
46800829|NCT00549302|83019752|FG001|Open-Label|Death|0|||
46800830|NCT00549302|83019753|FG002|Open-Label|Death|40|||
46691370|NCT01296152|82905860|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
46800831|NCT00549302|83019751|FG000|Open-Label|Investigator Decision|0|||
46800832|NCT00549302|83019752|FG001|Open-Label|Investigator Decision|0|||
46981967|NCT02579863|83228160|FG000|Overall Study|Death|31|||
46981968|NCT02579863|83228161|FG001|Overall Study|Death|29|||
46800833|NCT00549302|83019753|FG002|Open-Label|Investigator Decision|5|||
46981969|NCT02579863|83228160|FG000|Overall Study|Lost to Follow-up|2|||
46981970|NCT02579863|83228161|FG001|Overall Study|Lost to Follow-up|1|||
46691371|NCT01002547|82905867|FG000|Overall Study|Withdrawal by Subject|4|||
46691372|NCT01002547|82905868|FG001|Overall Study|Withdrawal by Subject|0|||
46691373|NCT01002547|82905869|FG002|Overall Study|Withdrawal by Subject|5|||
46691374|NCT01002547|82905867|FG000|Overall Study|Lost to Follow-up|2|||
46691375|NCT01002547|82905868|FG001|Overall Study|Lost to Follow-up|1|||
46691376|NCT01002547|82905869|FG002|Overall Study|Lost to Follow-up|1|||
46691377|NCT01002547|82905867|FG000|Overall Study|Physician Decision|1|||
46691378|NCT01002547|82905868|FG001|Overall Study|Physician Decision|0|||
46691379|NCT01002547|82905869|FG002|Overall Study|Physician Decision|0|||
46691380|NCT01002547|82905867|FG000|Overall Study|Death|0|||
46691381|NCT01002547|82905868|FG001|Overall Study|Death|2|||
46691382|NCT01002547|82905869|FG002|Overall Study|Death|2|||
46691383|NCT01002547|82905867|FG000|Overall Study|Adverse Event|1|||
46691384|NCT01002547|82905868|FG001|Overall Study|Adverse Event|0|||
46691385|NCT01002547|82905869|FG002|Overall Study|Adverse Event|0|||
46691386|NCT01225731|82905882|FG000|Part 1|Did not meet eligibility criteria|1|||
46691387|NCT01225731|82905883|FG001|Part 1|Did not meet eligibility criteria|0|||
46691388|NCT01225731|82905884|FG002|Part 1|Did not meet eligibility criteria|0|||
46691389|NCT01225731|82905885|FG003|Part 1|Did not meet eligibility criteria|0|||
46691390|NCT01225731|82905886|FG004|Part 1|Did not meet eligibility criteria|1|||
46691391|NCT01225731|82905887|FG005|Part 1|Did not meet eligibility criteria|0|||
46691392|NCT01225731|82905888|FG006|Part 1|Did not meet eligibility criteria|0|||
46691393|NCT01225731|82905889|FG007|Part 1|Did not meet eligibility criteria|0|||
46691394|NCT01225731|82905890|FG008|Part 1|Did not meet eligibility criteria|0|||
46691395|NCT01225731|82905891|FG009|Part 1|Did not meet eligibility criteria|0|||
46691396|NCT01225731|82905892|FG010|Part 1|Did not meet eligibility criteria|0|||
46691397|NCT01225731|82905893|FG011|Part 1|Did not meet eligibility criteria|0|||
46691398|NCT01225731|82905894|FG012|Part 1|Did not meet eligibility criteria|0|||
46800834|NCT00549302|83019751|FG000|Open-Label|Lost to Follow-up|0|||
46800835|NCT00549302|83019752|FG001|Open-Label|Lost to Follow-up|0|||
46800836|NCT00549302|83019753|FG002|Open-Label|Lost to Follow-up|2|||
46800837|NCT00549302|83019751|FG000|Open-Label|Other|0|||
46800838|NCT00549302|83019752|FG001|Open-Label|Other|0|||
46800839|NCT00549302|83019753|FG002|Open-Label|Other|3|||
46800840|NCT00549302|83019751|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
46800841|NCT00549302|83019752|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
46800842|NCT00549302|83019753|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
46800843|NCT00549302|83019751|FG000|Open-Label|Withdrawal by Subject|0|||
46800844|NCT00549302|83019752|FG001|Open-Label|Withdrawal by Subject|0|||
46800845|NCT00549302|83019753|FG002|Open-Label|Withdrawal by Subject|6|||
46800846|NCT00117325|83019763|FG000|Overall Study|Adverse Event|3|||
46800847|NCT00117325|83019764|FG001|Overall Study|Adverse Event|3|||
46800848|NCT00117325|83019763|FG000|Overall Study|Lost to Follow-up|1|||
46691399|NCT01225731|82905882|FG000|Part 1|Adverse Event|1|||
46691400|NCT01225731|82905883|FG001|Part 1|Adverse Event|2|||
46691401|NCT01225731|82905884|FG002|Part 1|Adverse Event|1|||
46691402|NCT01225731|82905885|FG003|Part 1|Adverse Event|1|||
46691403|NCT01225731|82905886|FG004|Part 1|Adverse Event|1|||
46691404|NCT01225731|82905887|FG005|Part 1|Adverse Event|0|||
46691405|NCT01225731|82905888|FG006|Part 1|Adverse Event|0|||
46691406|NCT01225731|82905889|FG007|Part 1|Adverse Event|0|||
46691407|NCT01225731|82905890|FG008|Part 1|Adverse Event|0|||
46691408|NCT01225731|82905891|FG009|Part 1|Adverse Event|0|||
46691409|NCT01225731|82905892|FG010|Part 1|Adverse Event|0|||
46691410|NCT01225731|82905893|FG011|Part 1|Adverse Event|0|||
46800849|NCT00117325|83019764|FG001|Overall Study|Lost to Follow-up|1|||
46800850|NCT00117325|83019763|FG000|Overall Study|Protocol Violation|2|||
46800851|NCT00117325|83019764|FG001|Overall Study|Protocol Violation|3|||
46800852|NCT00117325|83019763|FG000|Overall Study|Withdrawal by Subject|3|||
46691411|NCT01225731|82905894|FG012|Part 1|Adverse Event|0|||
46691412|NCT01225731|82905882|FG000|Part 1|Withdrawal by Subject|0|||
46691413|NCT01225731|82905883|FG001|Part 1|Withdrawal by Subject|3|||
46691414|NCT01225731|82905884|FG002|Part 1|Withdrawal by Subject|0|||
46800853|NCT00117325|83019764|FG001|Overall Study|Withdrawal by Subject|2|||
46691415|NCT01225731|82905885|FG003|Part 1|Withdrawal by Subject|0|||
46691416|NCT01225731|82905886|FG004|Part 1|Withdrawal by Subject|4|||
46691417|NCT01225731|82905887|FG005|Part 1|Withdrawal by Subject|0|||
46691418|NCT01225731|82905888|FG006|Part 1|Withdrawal by Subject|0|||
46691419|NCT01225731|82905889|FG007|Part 1|Withdrawal by Subject|0|||
46691420|NCT01225731|82905890|FG008|Part 1|Withdrawal by Subject|0|||
46691421|NCT01225731|82905891|FG009|Part 1|Withdrawal by Subject|0|||
46691422|NCT01225731|82905892|FG010|Part 1|Withdrawal by Subject|0|||
46691423|NCT01225731|82905893|FG011|Part 1|Withdrawal by Subject|0|||
46691424|NCT01225731|82905894|FG012|Part 1|Withdrawal by Subject|0|||
46691425|NCT01225731|82905882|FG000|Part 1|Protocol Violation|0|||
46691426|NCT01225731|82905883|FG001|Part 1|Protocol Violation|0|||
46691427|NCT01225731|82905884|FG002|Part 1|Protocol Violation|0|||
46691428|NCT01225731|82905885|FG003|Part 1|Protocol Violation|1|||
46691429|NCT01225731|82905886|FG004|Part 1|Protocol Violation|0|||
46691430|NCT01225731|82905887|FG005|Part 1|Protocol Violation|0|||
46691431|NCT01225731|82905888|FG006|Part 1|Protocol Violation|0|||
46691432|NCT01225731|82905889|FG007|Part 1|Protocol Violation|0|||
46691433|NCT01225731|82905890|FG008|Part 1|Protocol Violation|0|||
46691434|NCT01225731|82905891|FG009|Part 1|Protocol Violation|0|||
46858850|NCT03308968|83074662|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
46858851|NCT03308968|83074663|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
46858852|NCT03308968|83074661|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
46858853|NCT03308968|83074662|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
46691435|NCT01225731|82905892|FG010|Part 1|Protocol Violation|0|||
46691436|NCT01225731|82905893|FG011|Part 1|Protocol Violation|0|||
46691437|NCT01225731|82905894|FG012|Part 1|Protocol Violation|0|||
46691438|NCT01225731|82905882|FG000|Part 2|Protocol Violation|0|||
46691439|NCT01225731|82905883|FG001|Part 2|Protocol Violation|0|||
46691440|NCT01225731|82905884|FG002|Part 2|Protocol Violation|0|||
46691441|NCT01225731|82905885|FG003|Part 2|Protocol Violation|0|||
46691442|NCT01225731|82905886|FG004|Part 2|Protocol Violation|0|||
46691443|NCT01225731|82905887|FG005|Part 2|Protocol Violation|1|||
46691444|NCT01225731|82905888|FG006|Part 2|Protocol Violation|0|||
46691445|NCT01225731|82905889|FG007|Part 2|Protocol Violation|0|||
46691446|NCT01225731|82905890|FG008|Part 2|Protocol Violation|1|||
46691447|NCT01225731|82905891|FG009|Part 2|Protocol Violation|0|||
46691448|NCT01225731|82905892|FG010|Part 2|Protocol Violation|0|||
46691449|NCT01225731|82905893|FG011|Part 2|Protocol Violation|0|||
46691450|NCT01225731|82905894|FG012|Part 2|Protocol Violation|0|||
46691451|NCT01225731|82905882|FG000|Part 2|Adverse Event|0|||
46691452|NCT01225731|82905883|FG001|Part 2|Adverse Event|0|||
46691453|NCT01225731|82905884|FG002|Part 2|Adverse Event|0|||
46691454|NCT01225731|82905885|FG003|Part 2|Adverse Event|0|||
46691455|NCT01225731|82905886|FG004|Part 2|Adverse Event|0|||
46691456|NCT01225731|82905887|FG005|Part 2|Adverse Event|0|||
46691457|NCT01225731|82905888|FG006|Part 2|Adverse Event|4|||
46691458|NCT01225731|82905889|FG007|Part 2|Adverse Event|4|||
46691459|NCT01225731|82905890|FG008|Part 2|Adverse Event|2|||
46858854|NCT03308968|83074663|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
46858855|NCT03308968|83074661|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
46981971|NCT02579863|83228160|FG000|Overall Study|Physician Decision|1|||
46691460|NCT01225731|82905891|FG009|Part 2|Adverse Event|0|||
46691461|NCT01225731|82905892|FG010|Part 2|Adverse Event|0|||
46691462|NCT01225731|82905893|FG011|Part 2|Adverse Event|0|||
46691463|NCT01225731|82905894|FG012|Part 2|Adverse Event|0|||
46691464|NCT01225731|82905882|FG000|Part 2|Lack of Efficacy|0|||
46691465|NCT01225731|82905883|FG001|Part 2|Lack of Efficacy|0|||
46858856|NCT03308968|83074662|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
46981972|NCT02579863|83228161|FG001|Overall Study|Physician Decision|2|||
46691466|NCT01225731|82905884|FG002|Part 2|Lack of Efficacy|0|||
46691467|NCT01225731|82905885|FG003|Part 2|Lack of Efficacy|0|||
46691468|NCT01225731|82905886|FG004|Part 2|Lack of Efficacy|0|||
46691469|NCT01225731|82905887|FG005|Part 2|Lack of Efficacy|1|||
46691470|NCT01225731|82905888|FG006|Part 2|Lack of Efficacy|0|||
46691471|NCT01225731|82905889|FG007|Part 2|Lack of Efficacy|12|||
46691472|NCT01225731|82905890|FG008|Part 2|Lack of Efficacy|3|||
46691473|NCT01225731|82905891|FG009|Part 2|Lack of Efficacy|0|||
46691474|NCT01225731|82905892|FG010|Part 2|Lack of Efficacy|0|||
46691475|NCT01225731|82905893|FG011|Part 2|Lack of Efficacy|0|||
46691476|NCT01225731|82905894|FG012|Part 2|Lack of Efficacy|0|||
46691477|NCT01225731|82905882|FG000|Part 2|Pregnancy|0|||
46691478|NCT01225731|82905883|FG001|Part 2|Pregnancy|0|||
46691479|NCT01225731|82905884|FG002|Part 2|Pregnancy|0|||
46691480|NCT01225731|82905885|FG003|Part 2|Pregnancy|0|||
46691481|NCT01225731|82905886|FG004|Part 2|Pregnancy|0|||
46691482|NCT01225731|82905887|FG005|Part 2|Pregnancy|0|||
46691483|NCT01225731|82905888|FG006|Part 2|Pregnancy|1|||
46691484|NCT01225731|82905889|FG007|Part 2|Pregnancy|0|||
46691485|NCT01225731|82905890|FG008|Part 2|Pregnancy|1|||
46691486|NCT01225731|82905891|FG009|Part 2|Pregnancy|0|||
46691487|NCT01225731|82905892|FG010|Part 2|Pregnancy|0|||
46691488|NCT01225731|82905893|FG011|Part 2|Pregnancy|0|||
46691489|NCT01225731|82905894|FG012|Part 2|Pregnancy|0|||
46691490|NCT01225731|82905882|FG000|Part 2|Lost to Follow-up|0|||
46691491|NCT01225731|82905883|FG001|Part 2|Lost to Follow-up|0|||
46691492|NCT01225731|82905884|FG002|Part 2|Lost to Follow-up|0|||
46691493|NCT01225731|82905885|FG003|Part 2|Lost to Follow-up|0|||
46691494|NCT01225731|82905886|FG004|Part 2|Lost to Follow-up|0|||
46691495|NCT01225731|82905887|FG005|Part 2|Lost to Follow-up|0|||
46691496|NCT01225731|82905888|FG006|Part 2|Lost to Follow-up|0|||
46691497|NCT01225731|82905889|FG007|Part 2|Lost to Follow-up|3|||
46691498|NCT01225731|82905890|FG008|Part 2|Lost to Follow-up|1|||
46691499|NCT01225731|82905891|FG009|Part 2|Lost to Follow-up|0|||
46691500|NCT01225731|82905892|FG010|Part 2|Lost to Follow-up|0|||
46691501|NCT01225731|82905893|FG011|Part 2|Lost to Follow-up|0|||
46691502|NCT01225731|82905894|FG012|Part 2|Lost to Follow-up|0|||
46691503|NCT01225731|82905882|FG000|Part 2|Physician Decision|0|||
46691504|NCT01225731|82905883|FG001|Part 2|Physician Decision|0|||
46691505|NCT01225731|82905884|FG002|Part 2|Physician Decision|0|||
46691506|NCT01225731|82905885|FG003|Part 2|Physician Decision|0|||
46691507|NCT01225731|82905886|FG004|Part 2|Physician Decision|0|||
46691508|NCT01225731|82905887|FG005|Part 2|Physician Decision|0|||
46800854|NCT00117325|83019763|FG000|Overall Study|Lack of Efficacy|1|||
46800855|NCT00117325|83019764|FG001|Overall Study|Lack of Efficacy|0|||
46691509|NCT01225731|82905888|FG006|Part 2|Physician Decision|0|||
46691510|NCT01225731|82905889|FG007|Part 2|Physician Decision|2|||
46800856|NCT00117325|83019763|FG000|Overall Study|Use of prohibited medicine|1|||
46691511|NCT01225731|82905890|FG008|Part 2|Physician Decision|2|||
46691512|NCT01225731|82905891|FG009|Part 2|Physician Decision|0|||
46691513|NCT01225731|82905892|FG010|Part 2|Physician Decision|0|||
46691514|NCT01225731|82905893|FG011|Part 2|Physician Decision|0|||
46800857|NCT00117325|83019764|FG001|Overall Study|Use of prohibited medicine|2|||
46800858|NCT00117325|83019763|FG000|Overall Study|Early termination|1|||
46800859|NCT00117325|83019764|FG001|Overall Study|Early termination|1|||
46691515|NCT01225731|82905894|FG012|Part 2|Physician Decision|0|||
46691516|NCT01225731|82905882|FG000|Part 2|Withdrawal by Subject|0|||
46691517|NCT01225731|82905883|FG001|Part 2|Withdrawal by Subject|0|||
46691518|NCT01225731|82905884|FG002|Part 2|Withdrawal by Subject|0|||
46691519|NCT01225731|82905885|FG003|Part 2|Withdrawal by Subject|0|||
46691520|NCT01225731|82905886|FG004|Part 2|Withdrawal by Subject|0|||
46800860|NCT00117325|83019763|FG000|Overall Study|Admisnitrative|1|||
46691521|NCT01225731|82905887|FG005|Part 2|Withdrawal by Subject|1|||
46691522|NCT01225731|82905888|FG006|Part 2|Withdrawal by Subject|3|||
46691523|NCT01225731|82905889|FG007|Part 2|Withdrawal by Subject|4|||
46691524|NCT01225731|82905890|FG008|Part 2|Withdrawal by Subject|1|||
46691525|NCT01225731|82905891|FG009|Part 2|Withdrawal by Subject|0|||
46691526|NCT01225731|82905892|FG010|Part 2|Withdrawal by Subject|0|||
46691527|NCT01225731|82905893|FG011|Part 2|Withdrawal by Subject|0|||
46691528|NCT01225731|82905894|FG012|Part 2|Withdrawal by Subject|0|||
46691529|NCT01225731|82905882|FG000|Part 3|Adverse Event|0|||
46691530|NCT01225731|82905883|FG001|Part 3|Adverse Event|0|||
46691531|NCT01225731|82905884|FG002|Part 3|Adverse Event|0|||
46691532|NCT01225731|82905885|FG003|Part 3|Adverse Event|0|||
46691533|NCT01225731|82905886|FG004|Part 3|Adverse Event|0|||
46691534|NCT01225731|82905887|FG005|Part 3|Adverse Event|0|||
46691535|NCT01225731|82905888|FG006|Part 3|Adverse Event|0|||
46691536|NCT01225731|82905889|FG007|Part 3|Adverse Event|0|||
46691537|NCT01225731|82905890|FG008|Part 3|Adverse Event|0|||
46691538|NCT01225731|82905891|FG009|Part 3|Adverse Event|0|||
46691539|NCT01225731|82905892|FG010|Part 3|Adverse Event|1|||
46691540|NCT01225731|82905893|FG011|Part 3|Adverse Event|1|||
46691541|NCT01225731|82905894|FG012|Part 3|Adverse Event|0|||
46691542|NCT01225731|82905882|FG000|Part 3|Lost to Follow-up|0|||
46691543|NCT01225731|82905883|FG001|Part 3|Lost to Follow-up|0|||
46691544|NCT01225731|82905884|FG002|Part 3|Lost to Follow-up|0|||
46691545|NCT01225731|82905885|FG003|Part 3|Lost to Follow-up|0|||
46691546|NCT01225731|82905886|FG004|Part 3|Lost to Follow-up|0|||
46691547|NCT01225731|82905887|FG005|Part 3|Lost to Follow-up|0|||
46691548|NCT01225731|82905888|FG006|Part 3|Lost to Follow-up|0|||
46691549|NCT01225731|82905889|FG007|Part 3|Lost to Follow-up|0|||
46691550|NCT01225731|82905890|FG008|Part 3|Lost to Follow-up|0|||
46691551|NCT01225731|82905891|FG009|Part 3|Lost to Follow-up|0|||
46691552|NCT01225731|82905892|FG010|Part 3|Lost to Follow-up|1|||
46858857|NCT03308968|83074663|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
46858858|NCT02940730|83074676|FG000|Intervention 2|Physician Decision|7|||
46858859|NCT02940730|83074677|FG001|Intervention 2|Physician Decision|0|||
46858860|NCT03741062|83074685|FG000|Overall Study|Protocol Violation|1|||
46858861|NCT03741062|83074686|FG001|Overall Study|Protocol Violation|0|||
46858862|NCT03281668|83074692|FG000|Overall Study|Physician Decision|1|||
46858863|NCT03281668|83074692|FG000|Overall Study|scheduling conflict, family circumstance|2|||
46858864|NCT03281668|83074692|FG000|Overall Study|Withdrawal by Subject|4|||
46858865|NCT03281668|83074692|FG000|Overall Study|Lost to Follow-up|1|||
46858866|NCT03307174|83074698|FG000|Overall Study|Unplanned ICU Administrion|5|||
46858867|NCT03307174|83074699|FG001|Overall Study|Unplanned ICU Administrion|3|||
46858868|NCT03307174|83074698|FG000|Overall Study|Aborted Surgery|1|||
46858869|NCT03307174|83074699|FG001|Overall Study|Aborted Surgery|2|||
46858870|NCT03307174|83074698|FG000|Overall Study|Hypotension|6|||
46858871|NCT03307174|83074699|FG001|Overall Study|Hypotension|0|||
46858872|NCT03307174|83074698|FG000|Overall Study|Nonfunctional epidural|1|||
46691553|NCT01225731|82905893|FG011|Part 3|Lost to Follow-up|2|||
46691554|NCT01225731|82905894|FG012|Part 3|Lost to Follow-up|1|||
46691555|NCT01225731|82905882|FG000|Part 3|Physician Decision|0|||
46691556|NCT01225731|82905883|FG001|Part 3|Physician Decision|0|||
46691557|NCT01225731|82905884|FG002|Part 3|Physician Decision|0|||
46691558|NCT01225731|82905885|FG003|Part 3|Physician Decision|0|||
46691559|NCT01225731|82905886|FG004|Part 3|Physician Decision|0|||
46691560|NCT01225731|82905887|FG005|Part 3|Physician Decision|0|||
46691561|NCT01225731|82905888|FG006|Part 3|Physician Decision|0|||
46691562|NCT01225731|82905889|FG007|Part 3|Physician Decision|0|||
46691563|NCT01225731|82905890|FG008|Part 3|Physician Decision|0|||
46691564|NCT01225731|82905891|FG009|Part 3|Physician Decision|0|||
46691565|NCT01225731|82905892|FG010|Part 3|Physician Decision|0|||
46691566|NCT01225731|82905893|FG011|Part 3|Physician Decision|1|||
46691567|NCT01225731|82905894|FG012|Part 3|Physician Decision|2|||
46858873|NCT03307174|83074699|FG001|Overall Study|Nonfunctional epidural|1|||
46691568|NCT01225731|82905882|FG000|Part 3|Withdrawal by Subject|0|||
46691569|NCT01225731|82905883|FG001|Part 3|Withdrawal by Subject|0|||
46691570|NCT01225731|82905884|FG002|Part 3|Withdrawal by Subject|0|||
46691571|NCT01225731|82905885|FG003|Part 3|Withdrawal by Subject|0|||
46691572|NCT01225731|82905886|FG004|Part 3|Withdrawal by Subject|0|||
46691573|NCT01225731|82905887|FG005|Part 3|Withdrawal by Subject|0|||
46858874|NCT03307174|83074698|FG000|Overall Study|Planned epidural removal|1|||
46858875|NCT03307174|83074699|FG001|Overall Study|Planned epidural removal|0|||
46858876|NCT03307174|83074698|FG000|Overall Study|Intrathecal catheter placement|0|||
46858877|NCT03307174|83074699|FG001|Overall Study|Intrathecal catheter placement|1|||
46800861|NCT00117325|83019764|FG001|Overall Study|Admisnitrative|0|||
46800862|NCT00108433|83019773|FG000|Overall Study|Lack of Efficacy|1|||
46800863|NCT00108433|83019774|FG001|Overall Study|Lack of Efficacy|2|||
46691574|NCT01225731|82905888|FG006|Part 3|Withdrawal by Subject|0|||
46691575|NCT01225731|82905889|FG007|Part 3|Withdrawal by Subject|0|||
46691576|NCT01225731|82905890|FG008|Part 3|Withdrawal by Subject|0|||
46691577|NCT01225731|82905891|FG009|Part 3|Withdrawal by Subject|0|||
46691578|NCT01225731|82905892|FG010|Part 3|Withdrawal by Subject|4|||
46691579|NCT01225731|82905893|FG011|Part 3|Withdrawal by Subject|6|||
46691580|NCT01225731|82905894|FG012|Part 3|Withdrawal by Subject|4|||
46800864|NCT00108433|83019773|FG000|Overall Study|Death|3|||
46800865|NCT00108433|83019774|FG001|Overall Study|Death|0|||
46800866|NCT00108433|83019773|FG000|Overall Study|Adverse Event|3|||
46800867|NCT00108433|83019774|FG001|Overall Study|Adverse Event|1|||
46800868|NCT00108433|83019773|FG000|Overall Study|Other|14|||
46800869|NCT00108433|83019774|FG001|Overall Study|Other|14|||
46800870|NCT00116779|83019782|FG000|Overall Study|Adverse Event|4|||
46800871|NCT00116779|83019783|FG001|Overall Study|Adverse Event|2|||
46800872|NCT00116779|83019782|FG000|Overall Study|Protocol Violation|1|||
46800873|NCT00116779|83019783|FG001|Overall Study|Protocol Violation|4|||
46800874|NCT00116779|83019782|FG000|Overall Study|Withdrawal by Subject|4|||
46800875|NCT00116779|83019783|FG001|Overall Study|Withdrawal by Subject|1|||
46800876|NCT00116779|83019782|FG000|Overall Study|Inadequate testosterone suppression|7|||
46800877|NCT00116779|83019783|FG001|Overall Study|Inadequate testosterone suppression|9|||
46800878|NCT00116779|83019782|FG000|Overall Study|Physician Decision|3|||
46800879|NCT00116779|83019783|FG001|Overall Study|Physician Decision|1|||
46800880|NCT00116779|83019782|FG000|Overall Study|Elevated PSA levels|2|||
46800881|NCT00116779|83019783|FG001|Overall Study|Elevated PSA levels|2|||
46800882|NCT03943290|83019798|FG000|Overall Study|Sponsor Terminated Study|6|||
46800883|NCT03943290|83019799|FG001|Overall Study|Sponsor Terminated Study|1|||
46800884|NCT03943290|83019800|FG002|Overall Study|Sponsor Terminated Study|11|||
46800885|NCT03943290|83019801|FG003|Overall Study|Sponsor Terminated Study|6|||
46800886|NCT03943290|83019802|FG004|Overall Study|Sponsor Terminated Study|7|||
46800887|NCT03943290|83019803|FG005|Overall Study|Sponsor Terminated Study|6|||
46800888|NCT03943290|83019804|FG006|Overall Study|Sponsor Terminated Study|6|||
46800889|NCT03943290|83019805|FG007|Overall Study|Sponsor Terminated Study|7|||
46800890|NCT03943290|83019806|FG008|Overall Study|Sponsor Terminated Study|8|||
46800891|NCT03943290|83019798|FG000|Overall Study|Lost to Follow-up|1|||
46800892|NCT03943290|83019799|FG001|Overall Study|Lost to Follow-up|0|||
46800893|NCT03943290|83019800|FG002|Overall Study|Lost to Follow-up|1|||
46800894|NCT03943290|83019801|FG003|Overall Study|Lost to Follow-up|0|||
46800895|NCT03943290|83019802|FG004|Overall Study|Lost to Follow-up|0|||
46858878|NCT03258814|83074707|FG000|Overall Study|Early Termination|4|||
46858879|NCT03258814|83074708|FG001|Overall Study|Early Termination|3|||
46858880|NCT03258814|83074709|FG002|Overall Study|Early Termination|10|||
46858881|NCT03257410|83074718|FG000|Overall Study|Adverse Event|2|||
46858882|NCT03257410|83074719|FG001|Overall Study|Adverse Event|3|||
46981973|NCT02579863|83228160|FG000|Overall Study|Screen Failure|0|||
46691581|NCT01007149|82905925|FG000|Overall Study|Administrative problems|0|||
46691582|NCT01007149|82905926|FG001|Overall Study|Administrative problems|1|||
46800896|NCT03943290|83019803|FG005|Overall Study|Lost to Follow-up|0|||
46800897|NCT03943290|83019804|FG006|Overall Study|Lost to Follow-up|0|||
46800898|NCT03943290|83019805|FG007|Overall Study|Lost to Follow-up|1|||
46800899|NCT03943290|83019806|FG008|Overall Study|Lost to Follow-up|0|||
46800900|NCT03943290|83019798|FG000|Overall Study|Withdrawal by Subject|0|||
46800901|NCT03943290|83019799|FG001|Overall Study|Withdrawal by Subject|0|||
46800902|NCT03943290|83019800|FG002|Overall Study|Withdrawal by Subject|1|||
46800903|NCT03943290|83019801|FG003|Overall Study|Withdrawal by Subject|0|||
46800904|NCT03943290|83019802|FG004|Overall Study|Withdrawal by Subject|0|||
46800905|NCT03943290|83019803|FG005|Overall Study|Withdrawal by Subject|0|||
46691583|NCT00998335|82905934|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
46691584|NCT00998335|82905935|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
46691585|NCT01294670|82905952|FG000|Overall Study|Not treated|1|||
46691586|NCT01294670|82905953|FG001|Overall Study|Not treated|0|||
46691587|NCT01294670|82905954|FG002|Overall Study|Not treated|0|||
46691588|NCT01294670|82905955|FG003|Overall Study|Not treated|0|||
46691589|NCT01294670|82905956|FG004|Overall Study|Not treated|0|||
46691590|NCT01006603|82905970|FG000|Overall Study|Withdrawal by Subject|17|||
46691591|NCT01006603|82905971|FG001|Overall Study|Withdrawal by Subject|19|||
46691592|NCT01006603|82905970|FG000|Overall Study|Lost to Follow-up|0|||
46691593|NCT01006603|82905971|FG001|Overall Study|Lost to Follow-up|1|||
46691594|NCT01006603|82905970|FG000|Overall Study|Safety reason|1|||
46691595|NCT01006603|82905971|FG001|Overall Study|Safety reason|1|||
46691596|NCT01006603|82905970|FG000|Overall Study|Protocol Violation|1|||
46691597|NCT01006603|82905971|FG001|Overall Study|Protocol Violation|3|||
46691598|NCT01006603|82905970|FG000|Overall Study|Incorrect enrolment|0|||
46691599|NCT01006603|82905971|FG001|Overall Study|Incorrect enrolment|2|||
46691600|NCT01006603|82905970|FG000|Overall Study|Adverse Event|15|||
46691601|NCT01006603|82905971|FG001|Overall Study|Adverse Event|7|||
46691602|NCT01006603|82905970|FG000|Overall Study|Death|1|||
46691603|NCT01006603|82905971|FG001|Overall Study|Death|1|||
46691604|NCT01006603|82905970|FG000|Overall Study|Study specific discontinuation criteria|33|||
46691605|NCT01006603|82905971|FG001|Overall Study|Study specific discontinuation criteria|34|||
46691606|NCT01006603|82905970|FG000|Overall Study|Other|3|||
46691607|NCT01006603|82905971|FG001|Overall Study|Other|7|||
46691608|NCT00997321|82905979|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
46691609|NCT00997321|82905980|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
46691610|NCT01294592|82905994|FG000|Overall Study|Adverse Event|28|||
46691611|NCT01294592|82905995|FG001|Overall Study|Adverse Event|13|||
46691612|NCT01294592|82905994|FG000|Overall Study|Lack of Efficacy|7|||
46691613|NCT01294592|82905995|FG001|Overall Study|Lack of Efficacy|5|||
46691614|NCT01294592|82905994|FG000|Overall Study|Protocol Violation|1|||
46691615|NCT01294592|82905995|FG001|Overall Study|Protocol Violation|7|||
46691616|NCT01294592|82905994|FG000|Overall Study|Lost to Follow-up|7|||
46691617|NCT01294592|82905995|FG001|Overall Study|Lost to Follow-up|9|||
46691618|NCT01294592|82905994|FG000|Overall Study|Physician Decision|6|||
46691619|NCT01294592|82905995|FG001|Overall Study|Physician Decision|11|||
46691620|NCT01294592|82905994|FG000|Overall Study|Withdrawal by Subject|28|||
46691621|NCT01294592|82905995|FG001|Overall Study|Withdrawal by Subject|28|||
46691622|NCT00997243|82906004|FG000|Overall Study|Early termination of study by sponsor|7|||
46691623|NCT01294514|82906008|FG000|Overall Study|Excluded due to Arrhythmia|1|||
46691624|NCT00999661|82906016|FG000|Overall Study|Lost to Follow-up|59|||
46691625|NCT00999661|82906016|FG000|Overall Study|Adverse Event|1|||
46691626|NCT00999661|82906016|FG000|Overall Study|Withdrawal by Subject|1|||
46691627|NCT00999661|82906016|FG000|Overall Study|Not meeting eligibility criteria|9|||
46691628|NCT01294436|82906022|FG000|Overall Study|Adverse Event|10|||
46981974|NCT02579863|83228161|FG001|Overall Study|Screen Failure|2|||
46691629|NCT01294436|82906023|FG001|Overall Study|Adverse Event|17|||
46981975|NCT02579863|83228160|FG000|Overall Study|Study Terminated at Selected Sites|82|||
46800906|NCT03943290|83019804|FG006|Overall Study|Withdrawal by Subject|0|||
46800907|NCT03943290|83019805|FG007|Overall Study|Withdrawal by Subject|0|||
46800908|NCT03943290|83019806|FG008|Overall Study|Withdrawal by Subject|0|||
46691630|NCT01294436|82906022|FG000|Overall Study|Withdrawal by Subject|11|||
46691631|NCT01294436|82906023|FG001|Overall Study|Withdrawal by Subject|28|||
46691632|NCT01294436|82906022|FG000|Overall Study|subject no longer meets study criteria|5|||
46691633|NCT01294436|82906023|FG001|Overall Study|subject no longer meets study criteria|20|||
46691634|NCT01294436|82906022|FG000|Overall Study|poor/non-compliance|2|||
46691635|NCT01294436|82906023|FG001|Overall Study|poor/non-compliance|5|||
46691636|NCT00995371|82906031|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
46800909|NCT00108355|83019841|FG000|Overall Study|Peritonitis at index paracentesis|1|||
46800910|NCT00108355|83019842|FG001|Overall Study|Peritonitis at index paracentesis|1|||
46800911|NCT00108355|83019841|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
46800912|NCT00108355|83019842|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
46800913|NCT00094861|83019863|FG000|Overall Study|Adverse Event|5|||
46800914|NCT00094861|83019864|FG001|Overall Study|Adverse Event|2|||
46800915|NCT00094861|83019863|FG000|Overall Study|Withdrawal by Subject|5|||
46800916|NCT00094861|83019864|FG001|Overall Study|Withdrawal by Subject|3|||
46800917|NCT00094861|83019863|FG000|Overall Study|Physician Decision|1|||
46800918|NCT00094861|83019864|FG001|Overall Study|Physician Decision|1|||
46800919|NCT00094861|83019863|FG000|Overall Study|Lost to Follow-up|0|||
46800920|NCT00094861|83019864|FG001|Overall Study|Lost to Follow-up|1|||
46691637|NCT00995371|82906032|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
46691638|NCT01294358|82906040|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
46691639|NCT01294358|82906041|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
46800921|NCT00094861|83019863|FG000|Overall Study|Death|4|||
46800922|NCT00094861|83019864|FG001|Overall Study|Death|2|||
46800923|NCT00094861|83019863|FG000|Overall Study|Other|3|||
46800924|NCT00094861|83019864|FG001|Overall Study|Other|0|||
46800925|NCT00426556|83019874|FG000|Phase I - Core Phase|Disease Progression|0|||
46691640|NCT01294358|82906042|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
46691641|NCT01294358|82906043|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
46691642|NCT01294358|82906044|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
46691643|NCT01294358|82906040|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
46691644|NCT01294358|82906041|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
46691645|NCT01294358|82906042|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
46691646|NCT01294358|82906043|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
46691647|NCT01294358|82906044|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
46691648|NCT01294358|82906040|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
46691649|NCT01294358|82906041|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
46691650|NCT01294358|82906042|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
46691651|NCT01294358|82906043|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
46691652|NCT01294358|82906044|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
46691653|NCT01294358|82906040|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
46691654|NCT01294358|82906041|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
46691655|NCT01294358|82906042|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
46691656|NCT01294358|82906043|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
46691657|NCT01294358|82906044|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
46691658|NCT00994279|82906063|FG000|Overall Study|Withdrawal by Subject|2|||
46691659|NCT00994279|82906064|FG001|Overall Study|Withdrawal by Subject|2|||
46691660|NCT00994279|82906063|FG000|Overall Study|Toxicity|1|||
46691661|NCT00994279|82906064|FG001|Overall Study|Toxicity|0|||
46691662|NCT00994279|82906063|FG000|Overall Study|Multiple reasons|1|||
46691663|NCT00994279|82906064|FG001|Overall Study|Multiple reasons|3|||
46691664|NCT01294046|82906070|FG000|Overall Study|Infection and surgical explant|1|||
46691665|NCT01294046|82906070|FG000|Overall Study|Eligibility criteria expanded|1|||
46691666|NCT01294046|82906070|FG000|Overall Study|Stimulation response inadqequate|1|||
46691667|NCT01224639|82906085|FG000|Overall Study|Withdrawal by Subject|0|||
46691668|NCT01224639|82906086|FG001|Overall Study|Withdrawal by Subject|0|||
46691669|NCT01224639|82906087|FG002|Overall Study|Withdrawal by Subject|0|||
46691670|NCT01224639|82906088|FG003|Overall Study|Withdrawal by Subject|0|||
46691671|NCT01224639|82906089|FG004|Overall Study|Withdrawal by Subject|2|||
46691672|NCT01224639|82906090|FG005|Overall Study|Withdrawal by Subject|0|||
46691673|NCT01224639|82906091|FG006|Overall Study|Withdrawal by Subject|1|||
46691674|NCT01224639|82906092|FG007|Overall Study|Withdrawal by Subject|1|||
46691675|NCT01224639|82906085|FG000|Overall Study|Adverse Event|0|||
46691676|NCT01224639|82906086|FG001|Overall Study|Adverse Event|0|||
46691677|NCT01224639|82906087|FG002|Overall Study|Adverse Event|0|||
46691678|NCT01224639|82906088|FG003|Overall Study|Adverse Event|0|||
46691679|NCT01224639|82906089|FG004|Overall Study|Adverse Event|0|||
46691680|NCT01224639|82906090|FG005|Overall Study|Adverse Event|0|||
46691681|NCT01224639|82906091|FG006|Overall Study|Adverse Event|0|||
46691682|NCT01224639|82906092|FG007|Overall Study|Adverse Event|1|||
46691683|NCT01293968|82906112|FG000|Overall Study|non-cooperation|3|||
46691684|NCT01293968|82906113|FG001|Overall Study|non-cooperation|3|||
46691685|NCT01293032|82906123|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
46691686|NCT01293032|82906124|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
46691687|NCT01293032|82906125|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
46691688|NCT01293032|82906126|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
46981976|NCT02579863|83228161|FG001|Overall Study|Study Terminated at Selected Sites|88|||
46981977|NCT02579863|83228160|FG000|Overall Study|Withdrawal by Subject|20|||
46981978|NCT02579863|83228161|FG001|Overall Study|Withdrawal by Subject|20|||
46981979|NCT02582515|83228169|FG000|Overall Study|Withdrawal by Subject|0|||
46981980|NCT02582515|83228170|FG001|Overall Study|Withdrawal by Subject|1|||
46981981|NCT02579629|83228179|FG000|Overall Study|Withdrawal by Subject|0|||
46981982|NCT02579629|83228180|FG001|Overall Study|Withdrawal by Subject|1|||
46981983|NCT02579629|83228181|FG002|Overall Study|Withdrawal by Subject|0|||
46981984|NCT02579629|83228179|FG000|Overall Study|Screen Failure|2|||
46981985|NCT02579629|83228180|FG001|Overall Study|Screen Failure|0|||
46981986|NCT02579629|83228181|FG002|Overall Study|Screen Failure|2|||
46981987|NCT02343939|83228198|FG000|Overall Study|Death|0|||
46981988|NCT02343939|83228199|FG001|Overall Study|Death|15|||
46981989|NCT02343939|83228200|FG002|Overall Study|Death|4|||
46691689|NCT01293032|82906123|FG000|Treatment|Adverse Event|0|||
46691690|NCT01293032|82906124|FG001|Treatment|Adverse Event|0|||
46691691|NCT01293032|82906125|FG002|Treatment|Adverse Event|1|||
46691692|NCT01293032|82906126|FG003|Treatment|Adverse Event|1|||
46691693|NCT01293032|82906123|FG000|Treatment|Withdrawal by Subject|2|||
46691694|NCT01293032|82906124|FG001|Treatment|Withdrawal by Subject|4|||
46691695|NCT01293032|82906125|FG002|Treatment|Withdrawal by Subject|0|||
46691696|NCT01293032|82906126|FG003|Treatment|Withdrawal by Subject|0|||
46691697|NCT01293032|82906123|FG000|Treatment|Disease Progression, relapse|0|||
46691698|NCT01293032|82906124|FG001|Treatment|Disease Progression, relapse|1|||
46691699|NCT01293032|82906125|FG002|Treatment|Disease Progression, relapse|0|||
46691700|NCT01293032|82906126|FG003|Treatment|Disease Progression, relapse|0|||
46691701|NCT01292876|82906133|FG000|Overall Study|Physician Decision|4|||
46691702|NCT01224171|82906141|FG000|Overall Study|Adverse Event|8|||
46691703|NCT01224171|82906142|FG001|Overall Study|Adverse Event|4|||
46691704|NCT01224171|82906141|FG000|Overall Study|Protocol Violation|0|||
46691705|NCT01224171|82906142|FG001|Overall Study|Protocol Violation|1|||
46691706|NCT01224171|82906141|FG000|Overall Study|Lack of Efficacy|5|||
46691707|NCT01224171|82906142|FG001|Overall Study|Lack of Efficacy|1|||
46691708|NCT01224171|82906141|FG000|Overall Study|Withdrawal of Consent|2|||
46691709|NCT01224171|82906142|FG001|Overall Study|Withdrawal of Consent|4|||
46800926|NCT00426556|83019875|FG001|Phase I - Core Phase|Disease Progression|6|||
46691710|NCT01224171|82906141|FG000|Overall Study|Lost to Follow-up|0|||
46691711|NCT01224171|82906142|FG001|Overall Study|Lost to Follow-up|3|||
46691712|NCT01292486|82906148|FG000|Overall Study|Protocol Violation|2|||
46691713|NCT01292486|82906148|FG000|Overall Study|Did not meet screening criteria|2|||
46691714|NCT01292486|82906148|FG000|Overall Study|Adverse Event|1|||
46800927|NCT00426556|83019876|FG002|Phase I - Core Phase|Disease Progression|2|||
46981990|NCT02343939|83228201|FG003|Overall Study|Death|2|||
46981991|NCT02343939|83228202|FG004|Overall Study|Death|5|||
46691715|NCT01292486|82906148|FG000|Overall Study|Physician Decision|1|||
46691716|NCT01223937|82906155|FG000|Overall Study|Withdrawal by Subject|3|||
46691717|NCT01223937|82906156|FG001|Overall Study|Withdrawal by Subject|2|||
46691718|NCT01223937|82906155|FG000|Overall Study|Lost to Follow-up|1|||
46981992|NCT02343939|83228203|FG005|Overall Study|Death|11|||
46981993|NCT02343939|83228204|FG006|Overall Study|Death|8|||
46981994|NCT02343939|83228205|FG007|Overall Study|Death|22|||
46691719|NCT01223937|82906156|FG001|Overall Study|Lost to Follow-up|4|||
46691720|NCT01223937|82906155|FG000|Overall Study|Adverse Event|1|||
46691721|NCT01223937|82906156|FG001|Overall Study|Adverse Event|4|||
46691722|NCT01223937|82906155|FG000|Overall Study|Protocol Violation|8|||
46691723|NCT01223937|82906156|FG001|Overall Study|Protocol Violation|7|||
46800928|NCT00426556|83019877|FG003|Phase I - Core Phase|Disease Progression|0|||
46800929|NCT00426556|83019874|FG000|Phase I - Core Phase|Adverse Event|1|||
46691724|NCT01223937|82906155|FG000|Overall Study|Other|4|||
46691725|NCT01223937|82906156|FG001|Overall Study|Other|1|||
46691726|NCT01290224|82906162|FG000|Overall Study|Adverse Event|1|||
46691727|NCT01290224|82906162|FG000|Overall Study|Refused Further Treatment|4|||
46691728|NCT01223235|82906168|FG000|Overall Study|Withdrawal by Subject|1|||
46691729|NCT01290068|82906174|FG000|Overall Study|Adverse Event|1|||
46691730|NCT01290068|82906175|FG001|Overall Study|Adverse Event|3|||
46691731|NCT01290068|82906174|FG000|Overall Study|Lost to Follow-up|3|||
46691732|NCT01290068|82906175|FG001|Overall Study|Lost to Follow-up|0|||
46691733|NCT01290068|82906174|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
46691734|NCT01290068|82906175|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
46691735|NCT01290068|82906174|FG000|Overall Study|Other|3|||
46691736|NCT01290068|82906175|FG001|Overall Study|Other|1|||
46691737|NCT00998881|82906183|FG000|Overall Study|Adverse Event|2|||
46691738|NCT00998881|82906184|FG001|Overall Study|Adverse Event|2|||
46691739|NCT00998881|82906183|FG000|Overall Study|Lack of Efficacy|1|||
46691740|NCT00998881|82906184|FG001|Overall Study|Lack of Efficacy|0|||
46691741|NCT00998881|82906183|FG000|Overall Study|Physician Decision|3|||
46691742|NCT00998881|82906184|FG001|Overall Study|Physician Decision|0|||
46800930|NCT00426556|83019875|FG001|Phase I - Core Phase|Adverse Event|3|||
46800931|NCT00426556|83019876|FG002|Phase I - Core Phase|Adverse Event|1|||
46800932|NCT00426556|83019877|FG003|Phase I - Core Phase|Adverse Event|0|||
46800933|NCT00426556|83019874|FG000|Phase I - Core Phase|Death|0|||
46800934|NCT00426556|83019875|FG001|Phase I - Core Phase|Death|1|||
46800935|NCT00426556|83019876|FG002|Phase I - Core Phase|Death|0|||
46691743|NCT00998881|82906183|FG000|Overall Study|Withdrawal by Subject|1|||
46691744|NCT00998881|82906184|FG001|Overall Study|Withdrawal by Subject|0|||
46691745|NCT00998881|82906183|FG000|Overall Study|Personal matter|1|||
46800936|NCT00426556|83019877|FG003|Phase I - Core Phase|Death|0|||
46800937|NCT00426556|83019874|FG000|Phase I - Extension Phase|Adverse Event|0|||
46691746|NCT00998881|82906184|FG001|Overall Study|Personal matter|0|||
46691747|NCT01222767|82906190|FG000|Overall Study|Progressive disease|13|||
46691748|NCT01222767|82906190|FG000|Overall Study|Adverse Event|2|||
46691749|NCT01222767|82906190|FG000|Overall Study|Surgical resection|1|||
46691750|NCT01222767|82906190|FG000|Overall Study|Never treated|1|||
46691751|NCT00993967|82906194|FG000|Overall Study|Adverse Event|8|||
46691752|NCT00993967|82906194|FG000|Overall Study|Death|1|||
46691753|NCT00993967|82906194|FG000|Overall Study|Lost to Follow-up|14|||
46691754|NCT00993967|82906194|FG000|Overall Study|Withdrawal by Subject|36|||
46691755|NCT00993967|82906194|FG000|Overall Study|Protocol Violation|2|||
46691756|NCT01222533|82906198|FG000|Overall Study|Adverse Event|5|||
46691757|NCT01222533|82906198|FG000|Overall Study|Withdrawal by Subject|5|||
46691758|NCT01222533|82906198|FG000|Overall Study|Other|4|||
46691759|NCT01221753|82906210|FG000|Overall Study|Adverse Event|1|||
46691760|NCT01221597|82906216|FG000|Overall Study|Adverse Event|4|||
46691761|NCT01221597|82906217|FG001|Overall Study|Adverse Event|1|||
46691762|NCT01221597|82906216|FG000|Overall Study|Withdrawal by Subject|20|||
46691763|NCT01221597|82906217|FG001|Overall Study|Withdrawal by Subject|6|||
46691764|NCT01221597|82906216|FG000|Overall Study|Lost to Follow-up|6|||
46691765|NCT01221597|82906217|FG001|Overall Study|Lost to Follow-up|5|||
46691766|NCT01221597|82906216|FG000|Overall Study|Protocol Violation|1|||
46691767|NCT01221597|82906217|FG001|Overall Study|Protocol Violation|0|||
46691768|NCT01221597|82906216|FG000|Overall Study|Other|3|||
46691769|NCT01221597|82906217|FG001|Overall Study|Other|4|||
46691770|NCT01221597|82906216|FG000|Overall Study|Death|2|||
46691771|NCT01221597|82906217|FG001|Overall Study|Death|0|||
46691772|NCT01221363|82906226|FG000|Overall Study|Pregnancy|1|||
46691773|NCT01221363|82906227|FG001|Overall Study|Pregnancy|0|||
46691774|NCT01221363|82906226|FG000|Overall Study|Withdrawal by Subject|11|||
46691775|NCT01221363|82906227|FG001|Overall Study|Withdrawal by Subject|5|||
46691776|NCT01221285|82906233|FG000|Overall Study|Withdrawal by Subject|1|||
46691777|NCT01014988|82906243|FG000|Overall Study|Adverse Event|20|||
46691778|NCT01014988|82906244|FG001|Overall Study|Adverse Event|0|||
46691779|NCT01014988|82906245|FG002|Overall Study|Adverse Event|1|||
46691780|NCT01014988|82906246|FG003|Overall Study|Adverse Event|0|||
46691781|NCT01014988|82906247|FG004|Overall Study|Adverse Event|1|||
46691782|NCT01014988|82906248|FG005|Overall Study|Adverse Event|3|||
46691783|NCT01014988|82906243|FG000|Overall Study|Lost to Follow-up|1|||
46691784|NCT01014988|82906244|FG001|Overall Study|Lost to Follow-up|0|||
46691785|NCT01014988|82906245|FG002|Overall Study|Lost to Follow-up|1|||
46691786|NCT01014988|82906246|FG003|Overall Study|Lost to Follow-up|0|||
46691787|NCT01014988|82906247|FG004|Overall Study|Lost to Follow-up|0|||
46691788|NCT01014988|82906248|FG005|Overall Study|Lost to Follow-up|0|||
46691789|NCT01014988|82906243|FG000|Overall Study|Physician Decision|1|||
46691790|NCT01014988|82906244|FG001|Overall Study|Physician Decision|0|||
46691791|NCT01014988|82906245|FG002|Overall Study|Physician Decision|0|||
46691792|NCT01014988|82906246|FG003|Overall Study|Physician Decision|0|||
46691793|NCT01014988|82906247|FG004|Overall Study|Physician Decision|0|||
46691794|NCT01014988|82906248|FG005|Overall Study|Physician Decision|0|||
46691795|NCT01014988|82906243|FG000|Overall Study|Withdrawal by Subject|1|||
46691796|NCT01014988|82906244|FG001|Overall Study|Withdrawal by Subject|0|||
46691797|NCT01014988|82906245|FG002|Overall Study|Withdrawal by Subject|0|||
46691798|NCT01014988|82906246|FG003|Overall Study|Withdrawal by Subject|0|||
46691799|NCT01014988|82906247|FG004|Overall Study|Withdrawal by Subject|0|||
46691800|NCT01014988|82906248|FG005|Overall Study|Withdrawal by Subject|0|||
46691801|NCT01014910|82906272|FG000|Overall Study|Withdrawal by Subject|0|||
46691802|NCT01014910|82906273|FG001|Overall Study|Withdrawal by Subject|2|||
46691803|NCT01019980|82906281|FG000|Overall Study|Drug not available.|2|||
46691804|NCT01019980|82906282|FG001|Overall Study|Drug not available.|0|||
46691805|NCT00993499|82906294|FG000|Run-in Period (8 Days)|Adverse Event|0|||
46691806|NCT00993499|82906295|FG001|Run-in Period (8 Days)|Adverse Event|1|||
46691807|NCT00993499|82906296|FG002|Run-in Period (8 Days)|Adverse Event|0|||
46691808|NCT00993499|82906297|FG003|Run-in Period (8 Days)|Adverse Event|0|||
46691809|NCT00993499|82906298|FG004|Run-in Period (8 Days)|Adverse Event|0|||
46691810|NCT00993499|82906299|FG005|Run-in Period (8 Days)|Adverse Event|0|||
46691811|NCT00993499|82906294|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
46691812|NCT00993499|82906295|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
46691813|NCT00993499|82906296|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
46691814|NCT00993499|82906297|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
46691815|NCT00993499|82906298|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
46691816|NCT00993499|82906299|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
46691817|NCT00993499|82906294|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
46691818|NCT00993499|82906295|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
46691819|NCT00993499|82906296|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
46691820|NCT00993499|82906297|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
46691821|NCT00993499|82906298|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
46691822|NCT00993499|82906299|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
46691823|NCT00993499|82906294|FG000|Run-in Period (8 Days)|Progressive disease|0|||
46691824|NCT00993499|82906295|FG001|Run-in Period (8 Days)|Progressive disease|1|||
46691825|NCT00993499|82906296|FG002|Run-in Period (8 Days)|Progressive disease|1|||
46691826|NCT00993499|82906297|FG003|Run-in Period (8 Days)|Progressive disease|0|||
46691827|NCT00993499|82906298|FG004|Run-in Period (8 Days)|Progressive disease|0|||
46691828|NCT00993499|82906299|FG005|Run-in Period (8 Days)|Progressive disease|0|||
46691829|NCT00993499|82906294|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
46691830|NCT00993499|82906295|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
46691831|NCT00993499|82906296|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
46691832|NCT00993499|82906297|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
46691833|NCT00993499|82906298|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
46691834|NCT00993499|82906299|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
46691835|NCT00993499|82906294|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
46691836|NCT00993499|82906295|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
46691837|NCT00993499|82906296|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
46691838|NCT00993499|82906297|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
46691839|NCT00993499|82906298|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
46691840|NCT00993499|82906299|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
46691841|NCT00993499|82906294|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
46691842|NCT00993499|82906295|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
46691843|NCT00993499|82906296|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
46858883|NCT03257410|83074718|FG000|Overall Study|Protocol Violation|1|||
46858884|NCT03257410|83074719|FG001|Overall Study|Protocol Violation|2|||
46691844|NCT00993499|82906297|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
46691845|NCT00993499|82906298|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
46691846|NCT00993499|82906299|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
46691847|NCT00993499|82906294|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
46691848|NCT00993499|82906295|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
46691849|NCT00993499|82906296|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
46691850|NCT00993499|82906297|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
46691851|NCT00993499|82906298|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
46691852|NCT00993499|82906299|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
46691853|NCT00993499|82906294|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
46691854|NCT00993499|82906295|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
46691855|NCT00993499|82906296|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
46691856|NCT00993499|82906297|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
46691857|NCT00993499|82906298|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
46691858|NCT00993499|82906299|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
46691859|NCT00993499|82906294|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
46691860|NCT00993499|82906295|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
46691861|NCT00993499|82906296|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
46691862|NCT00993499|82906297|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
46691863|NCT00993499|82906298|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
46691864|NCT00993499|82906299|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
46691865|NCT00993499|82906294|FG000|Discontinued After Starting Course 3|DLT|1|||
46691866|NCT00993499|82906295|FG001|Discontinued After Starting Course 3|DLT|0|||
46691867|NCT00993499|82906296|FG002|Discontinued After Starting Course 3|DLT|2|||
46800938|NCT00426556|83019875|FG001|Phase I - Extension Phase|Adverse Event|1|||
46800939|NCT00426556|83019876|FG002|Phase I - Extension Phase|Adverse Event|1|||
46800940|NCT00426556|83019877|FG003|Phase I - Extension Phase|Adverse Event|0|||
46800941|NCT00426556|83019874|FG000|Phase I - Extension Phase|Disease Progression|5|||
46800942|NCT00426556|83019875|FG001|Phase I - Extension Phase|Disease Progression|5|||
46691868|NCT00993499|82906297|FG003|Discontinued After Starting Course 3|DLT|1|||
46691869|NCT00993499|82906298|FG004|Discontinued After Starting Course 3|DLT|0|||
46691870|NCT00993499|82906299|FG005|Discontinued After Starting Course 3|DLT|0|||
46691871|NCT00993499|82906294|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
46691872|NCT00993499|82906295|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
46691873|NCT00993499|82906296|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
46691874|NCT00993499|82906297|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
46691875|NCT00993499|82906298|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
46691876|NCT00993499|82906299|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
46691877|NCT01014442|82906315|FG000|Overall Study|Adverse Event|0|||
46691878|NCT01014442|82906316|FG001|Overall Study|Adverse Event|8|||
46691879|NCT01014442|82906315|FG000|Overall Study|Withdrawal by Subject|4|||
46691880|NCT01014442|82906316|FG001|Overall Study|Withdrawal by Subject|4|||
46691881|NCT01014442|82906315|FG000|Overall Study|Protocol Violation|2|||
46691882|NCT01014442|82906316|FG001|Overall Study|Protocol Violation|5|||
46691883|NCT01014442|82906315|FG000|Overall Study|Lack of Compliance|0|||
46800943|NCT00426556|83019876|FG002|Phase I - Extension Phase|Disease Progression|6|||
46800944|NCT00426556|83019877|FG003|Phase I - Extension Phase|Disease Progression|0|||
46800945|NCT00426556|83019874|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
46800946|NCT00426556|83019875|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
46800947|NCT00426556|83019876|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
46800948|NCT00426556|83019877|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
46800949|NCT00426556|83019874|FG000|Phase II - Core Phase|Disease Progression|0|||
46800950|NCT00426556|83019875|FG001|Phase II - Core Phase|Disease Progression|0|||
46800951|NCT00426556|83019876|FG002|Phase II - Core Phase|Disease Progression|0|||
46800952|NCT00426556|83019877|FG003|Phase II - Core Phase|Disease Progression|16|||
46800953|NCT00426556|83019874|FG000|Phase II - Core Phase|Adverse Event|0|||
46800954|NCT00426556|83019875|FG001|Phase II - Core Phase|Adverse Event|0|||
46800955|NCT00426556|83019876|FG002|Phase II - Core Phase|Adverse Event|0|||
46800956|NCT00426556|83019877|FG003|Phase II - Core Phase|Adverse Event|8|||
46800957|NCT00426556|83019874|FG000|Phase II - Extension Phase|Disease Progression|0|||
46800958|NCT00426556|83019875|FG001|Phase II - Extension Phase|Disease Progression|0|||
46800959|NCT00426556|83019876|FG002|Phase II - Extension Phase|Disease Progression|0|||
46800960|NCT00426556|83019877|FG003|Phase II - Extension Phase|Disease Progression|21|||
46800961|NCT00426556|83019874|FG000|Phase II - Extension Phase|Adverse Event|0|||
46800962|NCT00426556|83019875|FG001|Phase II - Extension Phase|Adverse Event|0|||
46800963|NCT00426556|83019876|FG002|Phase II - Extension Phase|Adverse Event|0|||
46800964|NCT00426556|83019877|FG003|Phase II - Extension Phase|Adverse Event|2|||
46800965|NCT00107653|83019889|FG000|Overall Study|Adverse Event|24|||
46800966|NCT00107653|83019890|FG001|Overall Study|Adverse Event|43|||
46800967|NCT00107653|83019889|FG000|Overall Study|Insufficient Therapeutic Response|25|||
46800968|NCT00107653|83019890|FG001|Overall Study|Insufficient Therapeutic Response|11|||
46800969|NCT00107653|83019889|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
46800970|NCT00107653|83019890|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
46800971|NCT00107653|83019889|FG000|Overall Study|Protocol Violation|1|||
46800972|NCT00107653|83019890|FG001|Overall Study|Protocol Violation|0|||
46800973|NCT00107653|83019889|FG000|Overall Study|Withdrawal by Subject|12|||
46800974|NCT00107653|83019890|FG001|Overall Study|Withdrawal by Subject|13|||
46858885|NCT03257410|83074718|FG000|Overall Study|Lost to Follow-up|1|||
46691884|NCT01014442|82906316|FG001|Overall Study|Lack of Compliance|1|||
46691885|NCT01014442|82906315|FG000|Overall Study|Unspecified Reason|1|||
46800975|NCT00107653|83019889|FG000|Overall Study|Lost to Follow-up|13|||
46800976|NCT00107653|83019890|FG001|Overall Study|Lost to Follow-up|5|||
46800977|NCT00107653|83019889|FG000|Overall Study|Administrative Reasons|3|||
46800978|NCT00107653|83019890|FG001|Overall Study|Administrative Reasons|3|||
46800979|NCT03950856|83019900|FG000|Overall Study|Death|1|||
46800980|NCT03950856|83019901|FG001|Overall Study|Death|2|||
46800981|NCT03950856|83019902|FG002|Overall Study|Death|0|||
46800982|NCT03950856|83019903|FG003|Overall Study|Death|0|||
46691886|NCT01014442|82906316|FG001|Overall Study|Unspecified Reason|1|||
46691887|NCT00996307|82906330|FG000|Overall Study|Adverse Event|0|||
46691888|NCT00996307|82906331|FG001|Overall Study|Adverse Event|1|||
46691889|NCT00996307|82906332|FG002|Overall Study|Adverse Event|0|||
46691890|NCT00996307|82906333|FG003|Overall Study|Adverse Event|0|||
46691891|NCT00996307|82906330|FG000|Overall Study|Withdrawal by Subject|3|||
46691892|NCT00996307|82906331|FG001|Overall Study|Withdrawal by Subject|2|||
46691893|NCT00996307|82906332|FG002|Overall Study|Withdrawal by Subject|5|||
46691894|NCT00996307|82906333|FG003|Overall Study|Withdrawal by Subject|5|||
46691895|NCT00996307|82906330|FG000|Overall Study|Lost to Follow-up|13|||
46691896|NCT00996307|82906331|FG001|Overall Study|Lost to Follow-up|13|||
46691897|NCT00996307|82906332|FG002|Overall Study|Lost to Follow-up|7|||
46800983|NCT03950856|83019900|FG000|Overall Study|Lost to Follow-up|5|||
46800984|NCT03950856|83019901|FG001|Overall Study|Lost to Follow-up|6|||
46800985|NCT03950856|83019902|FG002|Overall Study|Lost to Follow-up|8|||
46800986|NCT03950856|83019903|FG003|Overall Study|Lost to Follow-up|2|||
46800987|NCT03950856|83019900|FG000|Overall Study|Protocol Violation|2|||
46800988|NCT03950856|83019901|FG001|Overall Study|Protocol Violation|0|||
46800989|NCT03950856|83019902|FG002|Overall Study|Protocol Violation|0|||
46800990|NCT03950856|83019903|FG003|Overall Study|Protocol Violation|1|||
46800991|NCT03950856|83019900|FG000|Overall Study|Withdrawal by Subject|4|||
46800992|NCT03950856|83019901|FG001|Overall Study|Withdrawal by Subject|1|||
46800993|NCT03950856|83019902|FG002|Overall Study|Withdrawal by Subject|3|||
46800994|NCT03950856|83019903|FG003|Overall Study|Withdrawal by Subject|1|||
46800995|NCT03950856|83019900|FG000|Overall Study|Unable to phone|7|||
46800996|NCT03950856|83019901|FG001|Overall Study|Unable to phone|6|||
46800997|NCT03950856|83019902|FG002|Overall Study|Unable to phone|7|||
46800998|NCT03950856|83019903|FG003|Overall Study|Unable to phone|2|||
46800999|NCT00433654|83019917|FG000|Overall Study|Death|4|||
46801000|NCT00433654|83019918|FG001|Overall Study|Death|0|||
46801001|NCT00433654|83019917|FG000|Overall Study|Missed visit|6|||
46801002|NCT00433654|83019918|FG001|Overall Study|Missed visit|3|||
46801003|NCT00433654|83019917|FG000|Overall Study|Subject not yet due for visit|4|||
46801004|NCT00433654|83019918|FG001|Overall Study|Subject not yet due for visit|0|||
46801005|NCT00433654|83019917|FG000|Overall Study|Withdrawal by Subject|1|||
46801006|NCT00433654|83019918|FG001|Overall Study|Withdrawal by Subject|2|||
46801007|NCT00689351|83019932|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
46801008|NCT00689351|83019933|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
46801009|NCT00689351|83019932|FG000|Infant Series of Dosing|Adverse Event|1|||
46801010|NCT00689351|83019933|FG001|Infant Series of Dosing|Adverse Event|0|||
46801011|NCT00689351|83019932|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
46801012|NCT00689351|83019933|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
46801013|NCT00689351|83019932|FG000|After Infant Series|Parent/legal guardian request|1|||
46801014|NCT00689351|83019933|FG001|After Infant Series|Parent/legal guardian request|0|||
46801015|NCT03950622|83019945|FG000|Overall Study|Withdrawal by Subject|1|||
46801016|NCT03950622|83019946|FG001|Overall Study|Withdrawal by Subject|0|||
46801017|NCT03950622|83019945|FG000|Overall Study|Protocol Deviation|0|||
46801018|NCT03950622|83019946|FG001|Overall Study|Protocol Deviation|1|||
46801019|NCT03950622|83019945|FG000|Overall Study|Physician Decision|1|||
46691898|NCT00996307|82906333|FG003|Overall Study|Lost to Follow-up|15|||
46691899|NCT00996307|82906330|FG000|Overall Study|Administrative reason|0|||
46801020|NCT03950622|83019946|FG001|Overall Study|Physician Decision|0|||
46801021|NCT03950622|83019945|FG000|Overall Study|Lost to Follow-up|5|||
46801022|NCT03950622|83019946|FG001|Overall Study|Lost to Follow-up|5|||
46858886|NCT03257410|83074719|FG001|Overall Study|Lost to Follow-up|0|||
46858887|NCT03257410|83074718|FG000|Overall Study|Withdrawal by Subject|1|||
46858888|NCT03257410|83074719|FG001|Overall Study|Withdrawal by Subject|2|||
46691900|NCT00996307|82906331|FG001|Overall Study|Administrative reason|1|||
46691901|NCT00996307|82906332|FG002|Overall Study|Administrative reason|0|||
46691902|NCT00996307|82906333|FG003|Overall Study|Administrative reason|0|||
46691903|NCT00996307|82906330|FG000|Overall Study|Unable to classify|4|||
46691904|NCT00996307|82906331|FG001|Overall Study|Unable to classify|0|||
46801023|NCT03950622|83019945|FG000|Overall Study|Death|1|||
46801024|NCT03950622|83019946|FG001|Overall Study|Death|1|||
46691905|NCT00996307|82906332|FG002|Overall Study|Unable to classify|2|||
46801025|NCT03937908|83019952|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
46801026|NCT03937908|83019953|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
46801027|NCT00689273|83019961|FG000|Overall Study|Adverse Event|3|||
46801028|NCT00689273|83019962|FG001|Overall Study|Adverse Event|1|||
46858889|NCT03257410|83074718|FG000|Overall Study|Physician Decision|1|||
46801029|NCT00689273|83019961|FG000|Overall Study|Lack of Efficacy|3|||
46801030|NCT00689273|83019962|FG001|Overall Study|Lack of Efficacy|0|||
46801031|NCT00689273|83019961|FG000|Overall Study|Lost to Follow-up|0|||
46691906|NCT00996307|82906333|FG003|Overall Study|Unable to classify|1|||
46691907|NCT01219959|82906363|FG000|Overall Study|Adverse Event|6|||
46691908|NCT01219959|82906364|FG001|Overall Study|Adverse Event|14|||
46691909|NCT01219959|82906363|FG000|Overall Study|Physician Decision|0|||
46691910|NCT01219959|82906364|FG001|Overall Study|Physician Decision|4|||
46691911|NCT01219959|82906363|FG000|Overall Study|Withdrawal by Subject|0|||
46691912|NCT01219959|82906364|FG001|Overall Study|Withdrawal by Subject|2|||
46691913|NCT01219959|82906363|FG000|Overall Study|Renal Transplantation|0|||
46691914|NCT01219959|82906364|FG001|Overall Study|Renal Transplantation|3|||
46691915|NCT01219959|82906363|FG000|Overall Study|Other|1|||
46691916|NCT01219959|82906364|FG001|Overall Study|Other|0|||
46691917|NCT00993421|82906377|FG000|Overall Study|Adverse Event|2|||
46691918|NCT00993421|82906378|FG001|Overall Study|Adverse Event|7|||
46691919|NCT00993421|82906379|FG002|Overall Study|Adverse Event|6|||
46691920|NCT00993421|82906380|FG003|Overall Study|Adverse Event|9|||
46691921|NCT00993421|82906381|FG004|Overall Study|Adverse Event|5|||
46691922|NCT00993421|82906382|FG005|Overall Study|Adverse Event|7|||
46691923|NCT00993421|82906383|FG006|Overall Study|Adverse Event|1|||
46691924|NCT00993421|82906377|FG000|Overall Study|Sponsor Decision|36|||
46691925|NCT00993421|82906378|FG001|Overall Study|Sponsor Decision|31|||
46691926|NCT00993421|82906379|FG002|Overall Study|Sponsor Decision|28|||
46691927|NCT00993421|82906380|FG003|Overall Study|Sponsor Decision|30|||
46691928|NCT00993421|82906381|FG004|Overall Study|Sponsor Decision|38|||
46691929|NCT00993421|82906382|FG005|Overall Study|Sponsor Decision|30|||
46691930|NCT00993421|82906383|FG006|Overall Study|Sponsor Decision|29|||
46691931|NCT00993421|82906377|FG000|Overall Study|Lost to Follow-up|3|||
46691932|NCT00993421|82906378|FG001|Overall Study|Lost to Follow-up|5|||
46691933|NCT00993421|82906379|FG002|Overall Study|Lost to Follow-up|5|||
46691934|NCT00993421|82906380|FG003|Overall Study|Lost to Follow-up|0|||
46691935|NCT00993421|82906381|FG004|Overall Study|Lost to Follow-up|0|||
46691936|NCT00993421|82906382|FG005|Overall Study|Lost to Follow-up|0|||
46691937|NCT00993421|82906383|FG006|Overall Study|Lost to Follow-up|6|||
46691938|NCT00993421|82906377|FG000|Overall Study|Withdrawal by Subject|3|||
46691939|NCT00993421|82906378|FG001|Overall Study|Withdrawal by Subject|2|||
46691940|NCT00993421|82906379|FG002|Overall Study|Withdrawal by Subject|3|||
46691941|NCT00993421|82906380|FG003|Overall Study|Withdrawal by Subject|3|||
46691942|NCT00993421|82906381|FG004|Overall Study|Withdrawal by Subject|3|||
46691943|NCT00993421|82906382|FG005|Overall Study|Withdrawal by Subject|5|||
46691944|NCT00993421|82906383|FG006|Overall Study|Withdrawal by Subject|3|||
46691945|NCT00993421|82906377|FG000|Overall Study|Death|0|||
46691946|NCT00993421|82906378|FG001|Overall Study|Death|0|||
46691947|NCT00993421|82906379|FG002|Overall Study|Death|0|||
46691948|NCT00993421|82906380|FG003|Overall Study|Death|0|||
46691949|NCT00993421|82906381|FG004|Overall Study|Death|0|||
46691950|NCT00993421|82906382|FG005|Overall Study|Death|0|||
46691951|NCT00993421|82906383|FG006|Overall Study|Death|1|||
46691952|NCT00993421|82906377|FG000|Overall Study|Entry Criteria Exclusion|0|||
46691953|NCT00993421|82906378|FG001|Overall Study|Entry Criteria Exclusion|0|||
46691954|NCT00993421|82906379|FG002|Overall Study|Entry Criteria Exclusion|1|||
46691955|NCT00993421|82906380|FG003|Overall Study|Entry Criteria Exclusion|3|||
46691956|NCT00993421|82906381|FG004|Overall Study|Entry Criteria Exclusion|0|||
46691957|NCT00993421|82906382|FG005|Overall Study|Entry Criteria Exclusion|1|||
46691958|NCT00993421|82906383|FG006|Overall Study|Entry Criteria Exclusion|0|||
46691959|NCT00993421|82906377|FG000|Overall Study|Physician Decision|0|||
46691960|NCT00993421|82906378|FG001|Overall Study|Physician Decision|0|||
46691961|NCT00993421|82906379|FG002|Overall Study|Physician Decision|0|||
46691962|NCT00993421|82906380|FG003|Overall Study|Physician Decision|0|||
46691963|NCT00993421|82906381|FG004|Overall Study|Physician Decision|0|||
46691964|NCT00993421|82906382|FG005|Overall Study|Physician Decision|1|||
46691965|NCT00993421|82906383|FG006|Overall Study|Physician Decision|1|||
46691966|NCT00993421|82906377|FG000|Overall Study|Protocol Violation|0|||
46691967|NCT00993421|82906378|FG001|Overall Study|Protocol Violation|0|||
46691968|NCT00993421|82906379|FG002|Overall Study|Protocol Violation|0|||
46691969|NCT00993421|82906380|FG003|Overall Study|Protocol Violation|0|||
46691970|NCT00993421|82906381|FG004|Overall Study|Protocol Violation|0|||
46691971|NCT00993421|82906382|FG005|Overall Study|Protocol Violation|2|||
46691972|NCT00993421|82906383|FG006|Overall Study|Protocol Violation|1|||
46691973|NCT01014208|82906401|FG000|Overall Study|Lost to Follow-up|2|||
46691974|NCT01014208|82906402|FG001|Overall Study|Lost to Follow-up|5|||
46691975|NCT01014208|82906401|FG000|Overall Study|Participant Withdrew Consent|12|||
46691976|NCT01014208|82906402|FG001|Overall Study|Participant Withdrew Consent|12|||
46691977|NCT01014208|82906401|FG000|Overall Study|Did Not Receive Study Drug|2|||
46691978|NCT01014208|82906402|FG001|Overall Study|Did Not Receive Study Drug|0|||
46691979|NCT01014208|82906401|FG000|Overall Study|Study Closed/terminated|78|||
46691980|NCT01014208|82906402|FG001|Overall Study|Study Closed/terminated|83|||
46691981|NCT00991939|82906410|FG000|Overall Study|Lost to Follow-up|0|||
46691982|NCT00991939|82906411|FG001|Overall Study|Lost to Follow-up|1|||
46691983|NCT00991939|82906410|FG000|Overall Study|Withdrawal by Subject|1|||
46691984|NCT00991939|82906411|FG001|Overall Study|Withdrawal by Subject|0|||
46691985|NCT00991939|82906410|FG000|Overall Study|Entire study terminated|4|||
46691986|NCT00991939|82906411|FG001|Overall Study|Entire study terminated|1|||
46691987|NCT00993265|82906421|FG000|Overall Study|Adverse Event|1|||
46691988|NCT00993265|82906422|FG001|Overall Study|Adverse Event|0|||
46691989|NCT00993265|82906421|FG000|Overall Study|Changed dose of concomitant drug|2|||
46691990|NCT00993265|82906422|FG001|Overall Study|Changed dose of concomitant drug|0|||
46691991|NCT00993265|82906421|FG000|Overall Study|Non-compliant with study medication|1|||
46691992|NCT00993265|82906422|FG001|Overall Study|Non-compliant with study medication|0|||
46691993|NCT04211389|82906430|FG000|Overall Study|Adverse Event|1|||
46801032|NCT00689273|83019962|FG001|Overall Study|Lost to Follow-up|2|||
46801033|NCT00689273|83019961|FG000|Overall Study|Other|6|||
46801034|NCT00689273|83019962|FG001|Overall Study|Other|2|||
46801035|NCT00689273|83019961|FG000|Overall Study|Randomized but not Treated|1|||
46691994|NCT04211389|82906431|FG001|Overall Study|Adverse Event|2|||
46691995|NCT04211389|82906430|FG000|Overall Study|Lost to Follow-up|15|||
46691996|NCT04211389|82906431|FG001|Overall Study|Lost to Follow-up|7|||
46801036|NCT00689273|83019962|FG001|Overall Study|Randomized but not Treated|0|||
46691997|NCT04211389|82906430|FG000|Overall Study|Protocol Violation|0|||
46691998|NCT04211389|82906431|FG001|Overall Study|Protocol Violation|1|||
46691999|NCT04211389|82906430|FG000|Overall Study|Withdrawal by Subject|10|||
46692000|NCT04211389|82906431|FG001|Overall Study|Withdrawal by Subject|11|||
46692001|NCT00993031|82906439|FG000|Overall Study|Death|0|||
46692002|NCT00993031|82906440|FG001|Overall Study|Death|1|||
46692003|NCT00993031|82906439|FG000|Overall Study|Physician Decision|0|||
46692004|NCT00993031|82906440|FG001|Overall Study|Physician Decision|2|||
46692005|NCT00993031|82906439|FG000|Overall Study|Withdrawal by Subject|3|||
46692006|NCT00993031|82906440|FG001|Overall Study|Withdrawal by Subject|3|||
46692007|NCT00993031|82906439|FG000|Overall Study|Lost to Follow-up|19|||
46692008|NCT00993031|82906440|FG001|Overall Study|Lost to Follow-up|13|||
46692009|NCT01010776|82906450|FG000|Main Phase|Withdrawal by Subject|14|||
46692010|NCT01010776|82906450|FG000|Main Phase|Lack of Efficacy|8|||
46692011|NCT01010776|82906450|FG000|Main Phase|Adverse Event|7|||
46692012|NCT01010776|82906450|FG000|Main Phase|Lost to Follow-up|6|||
46692013|NCT01010776|82906450|FG000|Main Phase|Non-compliance to study medication|5|||
46692014|NCT01010776|82906450|FG000|Main Phase|Selection failure|2|||
46692015|NCT01010776|82906450|FG000|Main Phase|Inform consent withdrawal|1|||
46692016|NCT01010776|82906450|FG000|Main Phase|Other|1|||
46692017|NCT01010776|82906450|FG000|Main Phase|Did not received study medication|5|||
46692018|NCT01010776|82906450|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
46692019|NCT01010776|82906450|FG000|Extension Phase|Other|3|||
46692020|NCT01018810|82906470|FG000|Overall Study|Withdrawal by Subject|0|||
46692021|NCT01018810|82906471|FG001|Overall Study|Withdrawal by Subject|1|||
46692022|NCT01018810|82906472|FG002|Overall Study|Withdrawal by Subject|0|||
46692023|NCT01018810|82906473|FG003|Overall Study|Withdrawal by Subject|0|||
46692024|NCT01018810|82906474|FG004|Overall Study|Withdrawal by Subject|0|||
46692025|NCT01018810|82906470|FG000|Overall Study|Sponsor Decision|2|||
46692026|NCT01018810|82906471|FG001|Overall Study|Sponsor Decision|0|||
46692027|NCT01018810|82906472|FG002|Overall Study|Sponsor Decision|1|||
46692028|NCT01018810|82906473|FG003|Overall Study|Sponsor Decision|1|||
46692029|NCT01018810|82906474|FG004|Overall Study|Sponsor Decision|1|||
46692030|NCT01018732|82906489|FG000|Overall Study|Lost to Follow-up|0|||
46692031|NCT01018732|82906490|FG001|Overall Study|Lost to Follow-up|0|||
46692032|NCT01018732|82906491|FG002|Overall Study|Lost to Follow-up|3|||
46692033|NCT01018732|82906489|FG000|Overall Study|Protocol Violation|1|||
46692034|NCT01018732|82906490|FG001|Overall Study|Protocol Violation|1|||
46692035|NCT01018732|82906491|FG002|Overall Study|Protocol Violation|0|||
46692036|NCT01018732|82906489|FG000|Overall Study|Inappropriate Enrollment|0|||
46692037|NCT01018732|82906490|FG001|Overall Study|Inappropriate Enrollment|1|||
46692038|NCT01018732|82906491|FG002|Overall Study|Inappropriate Enrollment|0|||
46692039|NCT01018732|82906489|FG000|Overall Study|Unable to Classify|0|||
46692040|NCT01018732|82906490|FG001|Overall Study|Unable to Classify|0|||
46692041|NCT01018732|82906491|FG002|Overall Study|Unable to Classify|1|||
46692042|NCT01218867|82906510|FG000|Overall Study|Death during treatment|0|||
46692043|NCT01218867|82906511|FG001|Overall Study|Death during treatment|0|||
46692044|NCT01218867|82906512|FG002|Overall Study|Death during treatment|0|||
46692045|NCT01218867|82906513|FG003|Overall Study|Death during treatment|0|||
46692046|NCT01218867|82906514|FG004|Overall Study|Death during treatment|0|||
46692047|NCT01218867|82906515|FG005|Overall Study|Death during treatment|0|||
46692048|NCT01218867|82906516|FG006|Overall Study|Death during treatment|1|||
46692049|NCT01218867|82906517|FG007|Overall Study|Death during treatment|0|||
46692050|NCT01218867|82906518|FG008|Overall Study|Death during treatment|0|||
46692051|NCT01218867|82906519|FG009|Overall Study|Death during treatment|0|||
46692052|NCT01218867|82906520|FG010|Overall Study|Death during treatment|0|||
46692053|NCT01018264|82906557|FG000|Overall Study|Withdrawal by Subject|1|||
46692054|NCT01018264|82906558|FG001|Overall Study|Withdrawal by Subject|0|||
46801037|NCT00553358|83019971|FG000|Overall Study|Randomized but did not receive treatment|3|||
46801038|NCT00553358|83019972|FG001|Overall Study|Randomized but did not receive treatment|3|||
46801039|NCT00553358|83019973|FG002|Overall Study|Randomized but did not receive treatment|1|||
46801040|NCT00553358|83019971|FG000|Overall Study|Lost to Follow-up|22|||
46801041|NCT00553358|83019972|FG001|Overall Study|Lost to Follow-up|26|||
46801042|NCT00553358|83019973|FG002|Overall Study|Lost to Follow-up|18|||
46801043|NCT00553358|83019971|FG000|Overall Study|Withdrew completely|23|||
46801044|NCT00553358|83019972|FG001|Overall Study|Withdrew completely|33|||
46692055|NCT01018264|82906557|FG000|Overall Study|Lost to Follow-up|0|||
46801045|NCT00553358|83019973|FG002|Overall Study|Withdrew completely|34|||
46801046|NCT00553358|83019971|FG000|Overall Study|Died during clinical follow-up|25|||
46801047|NCT00553358|83019972|FG001|Overall Study|Died during clinical follow-up|29|||
46692056|NCT01018264|82906558|FG001|Overall Study|Lost to Follow-up|1|||
46692057|NCT01018186|82906567|FG000|2-week Run-in Period|Protocol Violation|1|||
46692058|NCT01018186|82906568|FG001|2-week Run-in Period|Protocol Violation|0|||
46692059|NCT01018186|82906569|FG002|2-week Run-in Period|Protocol Violation|0|||
46692060|NCT01018186|82906570|FG003|2-week Run-in Period|Protocol Violation|0|||
46692061|NCT01018186|82906567|FG000|2-week Run-in Period|Lost to Follow-up|2|||
46692062|NCT01018186|82906568|FG001|2-week Run-in Period|Lost to Follow-up|0|||
46692063|NCT01018186|82906569|FG002|2-week Run-in Period|Lost to Follow-up|0|||
46692064|NCT01018186|82906570|FG003|2-week Run-in Period|Lost to Follow-up|0|||
46692065|NCT01018186|82906567|FG000|2-week Run-in Period|Physician Decision|3|||
46692066|NCT01018186|82906568|FG001|2-week Run-in Period|Physician Decision|0|||
46692067|NCT01018186|82906569|FG002|2-week Run-in Period|Physician Decision|0|||
46692068|NCT01018186|82906570|FG003|2-week Run-in Period|Physician Decision|0|||
46692069|NCT01018186|82906567|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
46692070|NCT01018186|82906568|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
46692071|NCT01018186|82906569|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
46692072|NCT01018186|82906570|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
46692073|NCT01018186|82906567|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
46692074|NCT01018186|82906568|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
46692075|NCT01018186|82906569|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
46692076|NCT01018186|82906570|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
46692077|NCT01018186|82906567|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
46692078|NCT01018186|82906568|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
46692079|NCT01018186|82906569|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
46692080|NCT01018186|82906570|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
46692081|NCT01018186|82906567|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
46692082|NCT01018186|82906568|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
46692083|NCT01018186|82906569|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
46692084|NCT01018186|82906570|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
46692085|NCT01018186|82906567|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
46692086|NCT01018186|82906568|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
46692087|NCT01018186|82906569|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
46692088|NCT01018186|82906570|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
46692089|NCT01018186|82906567|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
46692090|NCT01018186|82906568|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
46692091|NCT01018186|82906569|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
46692092|NCT01018186|82906570|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
46692093|NCT01018186|82906567|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
46692094|NCT01018186|82906568|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
46692095|NCT01018186|82906569|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
46692096|NCT01018186|82906570|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
46692097|NCT01018186|82906567|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
46692098|NCT01018186|82906568|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
46692099|NCT01018186|82906569|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
46692100|NCT01018186|82906570|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
46692101|NCT01018186|82906567|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
46692102|NCT01018186|82906568|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
46692103|NCT01018186|82906569|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
46692104|NCT01018186|82906570|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
46692105|NCT00987337|82906585|FG000|Overall Study|Adverse Event|10|||
46801048|NCT00553358|83019973|FG002|Overall Study|Died during clinical follow-up|32|||
46801049|NCT00553358|83019971|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
46858890|NCT03257410|83074719|FG001|Overall Study|Physician Decision|1|||
46692106|NCT00987337|82906586|FG001|Overall Study|Adverse Event|9|||
46692107|NCT00987337|82906587|FG002|Overall Study|Adverse Event|8|||
46692108|NCT00987337|82906585|FG000|Overall Study|Insufficient Virologic Response|10|||
46692109|NCT00987337|82906586|FG001|Overall Study|Insufficient Virologic Response|7|||
46692110|NCT00987337|82906587|FG002|Overall Study|Insufficient Virologic Response|12|||
46692111|NCT00987337|82906585|FG000|Overall Study|Virologic Breakthrough|2|||
46692112|NCT00987337|82906586|FG001|Overall Study|Virologic Breakthrough|2|||
46692113|NCT00987337|82906587|FG002|Overall Study|Virologic Breakthrough|8|||
46692114|NCT00987337|82906585|FG000|Overall Study|Lost to Follow-up|10|||
46692115|NCT00987337|82906586|FG001|Overall Study|Lost to Follow-up|6|||
46692116|NCT00987337|82906587|FG002|Overall Study|Lost to Follow-up|2|||
46692117|NCT00987337|82906585|FG000|Overall Study|Withdrawal by Subject|6|||
46692118|NCT00987337|82906586|FG001|Overall Study|Withdrawal by Subject|9|||
46692119|NCT00987337|82906587|FG002|Overall Study|Withdrawal by Subject|9|||
46692120|NCT00987337|82906585|FG000|Overall Study|Other|0|||
46801050|NCT00553358|83019972|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
46801051|NCT00553358|83019973|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
46801052|NCT00553358|83019971|FG000|Overall Study|Died after clinical follow-up ended|1|||
46801053|NCT00553358|83019972|FG001|Overall Study|Died after clinical follow-up ended|2|||
46801054|NCT00553358|83019973|FG002|Overall Study|Died after clinical follow-up ended|0|||
46801055|NCT00553358|83019971|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
46801056|NCT00553358|83019972|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
46801057|NCT00553358|83019973|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
46801058|NCT00688259|83019989|FG000|Overall Study|Lost to Follow-up|2|||
46801059|NCT00688259|83019990|FG001|Overall Study|Lost to Follow-up|4|||
46801060|NCT00688259|83019989|FG000|Overall Study|Physician Decision|1|||
46801061|NCT00688259|83019990|FG001|Overall Study|Physician Decision|0|||
46801062|NCT00688259|83019989|FG000|Overall Study|Withdrawal by Subject|2|||
46801063|NCT00688259|83019990|FG001|Overall Study|Withdrawal by Subject|0|||
46801064|NCT00688259|83019989|FG000|Overall Study|Declined Interview|2|||
46801065|NCT00688259|83019990|FG001|Overall Study|Declined Interview|3|||
46801066|NCT00688259|83019989|FG000|Overall Study|Hospitalized at Follow-up|0|||
46801067|NCT00688259|83019990|FG001|Overall Study|Hospitalized at Follow-up|1|||
46801068|NCT00688181|83019996|FG000|Overall Study|Lost to Follow-up|17|||
46801069|NCT00688181|83019996|FG000|Overall Study|Unknown Reason|4|||
46801070|NCT00688181|83019996|FG000|Overall Study|Non-clinical Reason|2|||
46801071|NCT00689117|83020015|FG000|Overall Study|Adverse Event|6|||
46801072|NCT00689117|83020016|FG001|Overall Study|Adverse Event|0|||
46801073|NCT00689117|83020017|FG002|Overall Study|Adverse Event|5|||
46801074|NCT00689117|83020018|FG003|Overall Study|Adverse Event|0|||
46801075|NCT00689117|83020015|FG000|Overall Study|Lost to Follow-up|26|||
46801076|NCT00689117|83020016|FG001|Overall Study|Lost to Follow-up|19|||
46801077|NCT00689117|83020017|FG002|Overall Study|Lost to Follow-up|17|||
46801078|NCT00689117|83020018|FG003|Overall Study|Lost to Follow-up|11|||
46801079|NCT00689117|83020015|FG000|Overall Study|Lack of Efficacy|1|||
46801080|NCT00689117|83020016|FG001|Overall Study|Lack of Efficacy|2|||
46801081|NCT00689117|83020017|FG002|Overall Study|Lack of Efficacy|2|||
46801082|NCT00689117|83020018|FG003|Overall Study|Lack of Efficacy|2|||
46692121|NCT00987337|82906586|FG001|Overall Study|Other|2|||
46692122|NCT00987337|82906587|FG002|Overall Study|Other|5|||
46801083|NCT00689117|83020015|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
46801084|NCT00689117|83020016|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
46801085|NCT00689117|83020017|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
46801086|NCT00689117|83020018|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
46692123|NCT00987337|82906585|FG000|Overall Study|Protocol Violation|1|||
46692124|NCT00987337|82906586|FG001|Overall Study|Protocol Violation|0|||
46692125|NCT00987337|82906587|FG002|Overall Study|Protocol Violation|2|||
46692126|NCT00987337|82906585|FG000|Overall Study|Participant Relapsed|18|||
46692127|NCT00987337|82906586|FG001|Overall Study|Participant Relapsed|20|||
46692128|NCT00987337|82906587|FG002|Overall Study|Participant Relapsed|5|||
46692129|NCT00992407|82906599|FG000|Overall Study|Protocol Violation|2|||
46692130|NCT00992407|82906600|FG001|Overall Study|Protocol Violation|1|||
46692131|NCT00992407|82906599|FG000|Overall Study|Lost to Follow-up|3|||
46692132|NCT00992407|82906600|FG001|Overall Study|Lost to Follow-up|3|||
46692133|NCT00992407|82906599|FG000|Overall Study|Adverse Event|3|||
46692134|NCT00992407|82906600|FG001|Overall Study|Adverse Event|2|||
46692135|NCT00992407|82906599|FG000|Overall Study|protocol Violation & Adverse events|2|||
46692136|NCT00992407|82906600|FG001|Overall Study|protocol Violation & Adverse events|4|||
46801087|NCT00689117|83020015|FG000|Overall Study|Withdrawal by Subject|19|||
46801088|NCT00689117|83020016|FG001|Overall Study|Withdrawal by Subject|18|||
46801089|NCT00689117|83020017|FG002|Overall Study|Withdrawal by Subject|26|||
46801090|NCT00689117|83020018|FG003|Overall Study|Withdrawal by Subject|13|||
46801091|NCT00689117|83020015|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
46801092|NCT00689117|83020016|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
46801093|NCT00689117|83020017|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
46801094|NCT00689117|83020018|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
46801095|NCT00689117|83020015|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
46801096|NCT00689117|83020016|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
46801097|NCT00689117|83020017|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46801098|NCT00689117|83020018|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
46801099|NCT00689117|83020015|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
46801100|NCT00689117|83020016|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
46801101|NCT00689117|83020017|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
46801102|NCT00689117|83020018|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
46801103|NCT00689117|83020015|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
46801104|NCT00689117|83020016|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
46801105|NCT00689117|83020017|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
46801106|NCT00689117|83020018|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
46801107|NCT00689117|83020015|FG000|Overall Study|Use of Prohibitive Medication|2|||
46801108|NCT00689117|83020016|FG001|Overall Study|Use of Prohibitive Medication|1|||
46801109|NCT00689117|83020017|FG002|Overall Study|Use of Prohibitive Medication|3|||
46801110|NCT00689117|83020018|FG003|Overall Study|Use of Prohibitive Medication|0|||
46801111|NCT00689117|83020015|FG000|Overall Study|Pregnancy|0|||
46801112|NCT00689117|83020016|FG001|Overall Study|Pregnancy|2|||
46801113|NCT00689117|83020017|FG002|Overall Study|Pregnancy|0|||
46801114|NCT00689117|83020018|FG003|Overall Study|Pregnancy|2|||
46801115|NCT00689117|83020015|FG000|Overall Study|Incarceration|2|||
46858891|NCT03257410|83074718|FG000|Overall Study|Renal transplantation|2|||
46692137|NCT00992407|82906599|FG000|Overall Study|Other|2|||
46692138|NCT00992407|82906600|FG001|Overall Study|Other|0|||
46692139|NCT00992407|82906599|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
46692140|NCT00992407|82906600|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
46858892|NCT03257410|83074719|FG001|Overall Study|Renal transplantation|0|||
46692141|NCT00992407|82906599|FG000|Overall Study|Study medication not administered|17|||
46692142|NCT00992407|82906600|FG001|Overall Study|Study medication not administered|13|||
46858893|NCT03257410|83074718|FG000|Overall Study|Switch to peritoneal dialysis|1|||
46692143|NCT00986479|82906611|FG000|Period 1|Improved mood|1|||
46858894|NCT03257410|83074719|FG001|Overall Study|Switch to peritoneal dialysis|0|||
46692144|NCT00986479|82906612|FG001|Period 1|Improved mood|0|||
46692145|NCT00986479|82906611|FG000|Period 1|Administrative reasons|1|||
46801116|NCT00689117|83020016|FG001|Overall Study|Incarceration|0|||
46801117|NCT00689117|83020017|FG002|Overall Study|Incarceration|0|||
46801118|NCT00689117|83020018|FG003|Overall Study|Incarceration|0|||
46692146|NCT00986479|82906612|FG001|Period 1|Administrative reasons|0|||
46692147|NCT00986245|82906618|FG000|First Intervention|Poor compliance|8|||
46692148|NCT00986245|82906619|FG001|First Intervention|Poor compliance|4|||
46692149|NCT00986245|82906618|FG000|First Intervention|Lack of Efficacy|1|||
46692150|NCT00986245|82906619|FG001|First Intervention|Lack of Efficacy|2|||
46692151|NCT00986245|82906618|FG000|First Intervention|Withdrawal by Subject|0|||
46692152|NCT00986245|82906619|FG001|First Intervention|Withdrawal by Subject|1|||
46692153|NCT00986245|82906618|FG000|First Intervention|Protocol Violation|0|||
46692154|NCT00986245|82906619|FG001|First Intervention|Protocol Violation|1|||
46692155|NCT00986245|82906618|FG000|First Intervention|Out of indication|1|||
46692156|NCT00986245|82906619|FG001|First Intervention|Out of indication|0|||
46692157|NCT00986245|82906618|FG000|Second Intervention|Poor compliance|1|||
46692158|NCT00986245|82906619|FG001|Second Intervention|Poor compliance|0|||
46692159|NCT00986245|82906618|FG000|Second Intervention|Lost to Follow-up|1|||
46692160|NCT00986245|82906619|FG001|Second Intervention|Lost to Follow-up|0|||
46692161|NCT00986245|82906618|FG000|Second Intervention|Protocol Violation|0|||
46692162|NCT00986245|82906619|FG001|Second Intervention|Protocol Violation|1|||
46692163|NCT00989833|82906633|FG000|Overall Study|Lost to Follow-up|0|||
46692164|NCT00989833|82906634|FG001|Overall Study|Lost to Follow-up|1|||
46692165|NCT00989833|82906635|FG002|Overall Study|Lost to Follow-up|0|||
46692166|NCT00989833|82906633|FG000|Overall Study|Protocol Violation|1|||
46692167|NCT00989833|82906634|FG001|Overall Study|Protocol Violation|2|||
46692168|NCT00989833|82906635|FG002|Overall Study|Protocol Violation|1|||
46692169|NCT00989833|82906633|FG000|Overall Study|Withdrawal by Subject|0|||
46692170|NCT00989833|82906634|FG001|Overall Study|Withdrawal by Subject|0|||
46692171|NCT00989833|82906635|FG002|Overall Study|Withdrawal by Subject|1|||
46692172|NCT00989833|82906633|FG000|Overall Study|Incorrectly randomized|1|||
46692173|NCT00989833|82906634|FG001|Overall Study|Incorrectly randomized|0|||
46692174|NCT00989833|82906635|FG002|Overall Study|Incorrectly randomized|0|||
46801119|NCT00689117|83020015|FG000|Overall Study|Fear of Birth Defects|0|||
46692175|NCT01218477|82906647|FG000|Overall Study|Disease progression|2|||
46801120|NCT00689117|83020016|FG001|Overall Study|Fear of Birth Defects|0|||
46801121|NCT00689117|83020017|FG002|Overall Study|Fear of Birth Defects|1|||
46692176|NCT01218477|82906648|FG001|Overall Study|Disease progression|3|||
46692177|NCT01218477|82906649|FG002|Overall Study|Disease progression|6|||
46801122|NCT00689117|83020018|FG003|Overall Study|Fear of Birth Defects|0|||
46692178|NCT01218477|82906650|FG003|Overall Study|Disease progression|2|||
46692179|NCT01218477|82906647|FG000|Overall Study|Study drug toxicity|0|||
46692180|NCT01218477|82906648|FG001|Overall Study|Study drug toxicity|2|||
46692181|NCT01218477|82906649|FG002|Overall Study|Study drug toxicity|5|||
46692182|NCT01218477|82906650|FG003|Overall Study|Study drug toxicity|0|||
46692183|NCT01218477|82906647|FG000|Overall Study|No longer meets study criteria|1|||
46692184|NCT01218477|82906648|FG001|Overall Study|No longer meets study criteria|0|||
46692185|NCT01218477|82906649|FG002|Overall Study|No longer meets study criteria|0|||
46692186|NCT01218477|82906650|FG003|Overall Study|No longer meets study criteria|0|||
46692187|NCT01218477|82906647|FG000|Overall Study|Withdrawal by Subject|0|||
46692188|NCT01218477|82906648|FG001|Overall Study|Withdrawal by Subject|0|||
46692189|NCT01218477|82906649|FG002|Overall Study|Withdrawal by Subject|1|||
46692190|NCT01218477|82906650|FG003|Overall Study|Withdrawal by Subject|0|||
46692191|NCT01218477|82906647|FG000|Overall Study|Prepared for cell transplantation|0|||
46692192|NCT01218477|82906648|FG001|Overall Study|Prepared for cell transplantation|1|||
46692193|NCT01218477|82906649|FG002|Overall Study|Prepared for cell transplantation|1|||
46692194|NCT01218477|82906650|FG003|Overall Study|Prepared for cell transplantation|0|||
46692195|NCT01218477|82906647|FG000|Overall Study|Administrative reason by sponsor|0|||
46692196|NCT01218477|82906648|FG001|Overall Study|Administrative reason by sponsor|0|||
46692197|NCT01218477|82906649|FG002|Overall Study|Administrative reason by sponsor|1|||
46692198|NCT01218477|82906650|FG003|Overall Study|Administrative reason by sponsor|0|||
46692199|NCT01218477|82906647|FG000|Overall Study|Maximum clinical benefit|0|||
46692200|NCT01218477|82906648|FG001|Overall Study|Maximum clinical benefit|2|||
46858895|NCT03257410|83074718|FG000|Overall Study|Death|3|||
46692201|NCT01218477|82906649|FG002|Overall Study|Maximum clinical benefit|0|||
46692202|NCT01218477|82906650|FG003|Overall Study|Maximum clinical benefit|0|||
46692203|NCT01218243|82906666|FG000|Overall Study|Lack of Efficacy|1|||
46692204|NCT01218243|82906667|FG001|Overall Study|Lack of Efficacy|1|||
46692205|NCT01218243|82906666|FG000|Overall Study|Lost to Follow-up|3|||
46692206|NCT01218243|82906667|FG001|Overall Study|Lost to Follow-up|3|||
46692207|NCT01218243|82906666|FG000|Overall Study|Protocol Violation|5|||
46692208|NCT01218243|82906667|FG001|Overall Study|Protocol Violation|10|||
46692209|NCT00989287|82906675|FG000|Overall Study|Adverse Event|1|||
46692210|NCT00989287|82906676|FG001|Overall Study|Adverse Event|0|||
46692211|NCT00989287|82906675|FG000|Overall Study|Lost to Follow-up|0|||
46692212|NCT00989287|82906676|FG001|Overall Study|Lost to Follow-up|1|||
46692213|NCT01218087|82906697|FG000|Overall Study|Death|2|||
46692214|NCT01218087|82906698|FG001|Overall Study|Death|1|||
46692215|NCT01218087|82906697|FG000|Overall Study|Withdrawal by Subject|5|||
46692216|NCT01218087|82906698|FG001|Overall Study|Withdrawal by Subject|0|||
46692217|NCT01218087|82906697|FG000|Overall Study|Transferred|8|||
46692218|NCT01218087|82906698|FG001|Overall Study|Transferred|5|||
46692219|NCT01218009|82906706|FG000|Overall Study|Protocol Violation|2|||
46692220|NCT01218009|82906707|FG001|Overall Study|Protocol Violation|1|||
46692221|NCT01218009|82906706|FG000|Overall Study|Withdrawal by Subject|3|||
46692222|NCT01218009|82906707|FG001|Overall Study|Withdrawal by Subject|1|||
46692223|NCT01218009|82906706|FG000|Overall Study|Sponsor terminated study|161|||
46801123|NCT00689117|83020015|FG000|Overall Study|Transportation|1|||
46801124|NCT00689117|83020016|FG001|Overall Study|Transportation|0|||
46801125|NCT00689117|83020017|FG002|Overall Study|Transportation|0|||
46801126|NCT00689117|83020018|FG003|Overall Study|Transportation|0|||
46801127|NCT00689117|83020015|FG000|Overall Study|Patient Withdrew from Study|0|||
46801128|NCT00689117|83020016|FG001|Overall Study|Patient Withdrew from Study|0|||
46801129|NCT00689117|83020017|FG002|Overall Study|Patient Withdrew from Study|0|||
46801130|NCT00689117|83020018|FG003|Overall Study|Patient Withdrew from Study|1|||
46801131|NCT00689117|83020015|FG000|Overall Study|Personal Reason|0|||
46801132|NCT00689117|83020016|FG001|Overall Study|Personal Reason|1|||
46801133|NCT00689117|83020017|FG002|Overall Study|Personal Reason|0|||
46801134|NCT00689117|83020018|FG003|Overall Study|Personal Reason|0|||
46801135|NCT00689117|83020015|FG000|Overall Study|Dispensing Error|0|||
46801136|NCT00689117|83020016|FG001|Overall Study|Dispensing Error|1|||
46801137|NCT00689117|83020017|FG002|Overall Study|Dispensing Error|0|||
46801138|NCT00689117|83020018|FG003|Overall Study|Dispensing Error|0|||
46801139|NCT00547248|83020032|FG000|Overall Study|Protocol Violation|0|||
46801140|NCT00547248|83020033|FG001|Overall Study|Protocol Violation|0|||
46801141|NCT00547248|83020034|FG002|Overall Study|Protocol Violation|1|||
46801142|NCT00547248|83020035|FG003|Overall Study|Protocol Violation|1|||
46801143|NCT00547248|83020032|FG000|Overall Study|Migrated/moved from study area|0|||
46801144|NCT00547248|83020033|FG001|Overall Study|Migrated/moved from study area|0|||
46801145|NCT00547248|83020034|FG002|Overall Study|Migrated/moved from study area|2|||
46801146|NCT00547248|83020035|FG003|Overall Study|Migrated/moved from study area|0|||
46801147|NCT00547248|83020032|FG000|Overall Study|Withdrawal by Subject|0|||
46801148|NCT00547248|83020033|FG001|Overall Study|Withdrawal by Subject|0|||
46801149|NCT00547248|83020034|FG002|Overall Study|Withdrawal by Subject|7|||
46801150|NCT00547248|83020035|FG003|Overall Study|Withdrawal by Subject|1|||
46801151|NCT00688103|83020050|FG000|Overall Study|Adverse Event|4|||
46692224|NCT01218009|82906707|FG001|Overall Study|Sponsor terminated study|163|||
46692225|NCT00992017|82906713|FG000|Overall Study|Lost to Follow-up|2|||
46692226|NCT00992017|82906713|FG000|Overall Study|Withdrawal by Subject|2|||
46692227|NCT00992017|82906713|FG000|Overall Study|Unable to get to clinic|5|||
46692228|NCT00992017|82906713|FG000|Overall Study|Not adhere to study requirements|1|||
46692229|NCT01217463|82906724|FG000|Overall Study|Adverse Event|8|||
46692230|NCT01217463|82906725|FG001|Overall Study|Adverse Event|5|||
46692231|NCT01217463|82906724|FG000|Overall Study|Physician Decision|0|||
46801152|NCT00688103|83020051|FG001|Overall Study|Adverse Event|1|||
46801153|NCT00688103|83020050|FG000|Overall Study|Lack of Efficacy|11|||
46801154|NCT00688103|83020051|FG001|Overall Study|Lack of Efficacy|1|||
46801155|NCT00688103|83020050|FG000|Overall Study|Withdrawal by Subject|4|||
46801156|NCT00688103|83020051|FG001|Overall Study|Withdrawal by Subject|2|||
46692232|NCT01217463|82906725|FG001|Overall Study|Physician Decision|1|||
46692233|NCT01217463|82906724|FG000|Overall Study|Withdrawal by Subject|3|||
46692234|NCT01217463|82906725|FG001|Overall Study|Withdrawal by Subject|0|||
46692235|NCT01217463|82906724|FG000|Overall Study|Surgery on the Target Limb|0|||
46692236|NCT01217463|82906725|FG001|Overall Study|Surgery on the Target Limb|1|||
46692237|NCT01217463|82906724|FG000|Overall Study|Patient Non-compliant|1|||
46692238|NCT01217463|82906725|FG001|Overall Study|Patient Non-compliant|0|||
46692239|NCT01217463|82906724|FG000|Overall Study|Other|1|||
46692240|NCT01217463|82906725|FG001|Overall Study|Other|1|||
46692241|NCT01217307|82906735|FG000|Overall Study|Withdrawal by Subject|0|||
46692242|NCT01217307|82906736|FG001|Overall Study|Withdrawal by Subject|1|||
46692243|NCT01217229|82906742|FG000|Overall Study|Adverse Event|1|||
46692244|NCT01217229|82906742|FG000|Overall Study|Disease progression, deterioration|2|||
46692245|NCT01217229|82906742|FG000|Overall Study|Disease progression, Cheson criteria|14|||
46692246|NCT01217229|82906742|FG000|Overall Study|Protocol Violation|1|||
46692247|NCT01217229|82906742|FG000|Overall Study|Disease progression not confirmed|2|||
46692248|NCT01013740|82906748|FG000|Overall Study|Lost to Follow-up|3|||
46692249|NCT01013740|82906749|FG001|Overall Study|Lost to Follow-up|5|||
46692250|NCT01013740|82906748|FG000|Overall Study|Physician Decision|2|||
46801157|NCT00688103|83020050|FG000|Overall Study|complex reasons|11|||
46801158|NCT00688103|83020051|FG001|Overall Study|complex reasons|9|||
46801159|NCT00686855|83020061|FG000|Overall Study|Lost to Follow-up|1|||
46801160|NCT00686855|83020062|FG001|Overall Study|Lost to Follow-up|0|||
46692251|NCT01013740|82906749|FG001|Overall Study|Physician Decision|0|||
46692252|NCT01013740|82906748|FG000|Overall Study|Withdrawal by Subject|2|||
46692253|NCT01013740|82906749|FG001|Overall Study|Withdrawal by Subject|10|||
46801161|NCT00686855|83020061|FG000|Overall Study|Progressive GVHD|0|||
46801162|NCT00686855|83020062|FG001|Overall Study|Progressive GVHD|1|||
46801163|NCT00686777|83020068|FG000|Overall Study|Adverse Event|2|||
46692254|NCT01013740|82906748|FG000|Overall Study|study close / terminated : done in error|2|||
46692255|NCT01013740|82906749|FG001|Overall Study|study close / terminated : done in error|1|||
46692256|NCT01013740|82906748|FG000|Overall Study|Missing|2|||
46692257|NCT01013740|82906749|FG001|Overall Study|Missing|1|||
46692258|NCT01013740|82906748|FG000|Overall Study|Ongoing: Study records not completed|0|||
46801164|NCT00686777|83020068|FG000|Overall Study|Pregnancy|1|||
46801165|NCT00686777|83020068|FG000|Overall Study|Withdrawal by Subject|2|||
46801166|NCT00686777|83020068|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
46801167|NCT00686777|83020068|FG000|Overall Study|No Visit|1|||
46801168|NCT00686699|83020074|FG000|Treatment Period 1|Adverse Event|0|||
46801169|NCT00686699|83020075|FG001|Treatment Period 1|Adverse Event|2|||
46801170|NCT00106639|83020084|FG000|Overall Study|Adverse Event|3|||
46801171|NCT00106639|83020085|FG001|Overall Study|Adverse Event|4|||
46801172|NCT00106639|83020086|FG002|Overall Study|Adverse Event|1|||
46801173|NCT00106639|83020084|FG000|Overall Study|Protocol Violation|0|||
46801174|NCT00106639|83020085|FG001|Overall Study|Protocol Violation|1|||
46801175|NCT00106639|83020086|FG002|Overall Study|Protocol Violation|0|||
46801176|NCT00106639|83020084|FG000|Overall Study|Withdrawal by Subject|0|||
46801177|NCT00106639|83020085|FG001|Overall Study|Withdrawal by Subject|1|||
46801178|NCT00106639|83020086|FG002|Overall Study|Withdrawal by Subject|0|||
46801179|NCT00106639|83020084|FG000|Overall Study|Participant defaulted|0|||
46801180|NCT00106639|83020085|FG001|Overall Study|Participant defaulted|1|||
46801181|NCT00106639|83020086|FG002|Overall Study|Participant defaulted|1|||
46801182|NCT00106249|83020097|FG000|Overall Study|Lost to Follow-up|3|||
46801183|NCT00106249|83020098|FG001|Overall Study|Lost to Follow-up|2|||
46801184|NCT00105469|83020106|FG000|Overall Study|Adverse Event|9|||
46801185|NCT00105469|83020107|FG001|Overall Study|Adverse Event|8|||
46801186|NCT00105469|83020106|FG000|Overall Study|Protocol Violation|4|||
46801187|NCT00105469|83020107|FG001|Overall Study|Protocol Violation|0|||
46801188|NCT00105469|83020106|FG000|Overall Study|Withdrawal by Subject|2|||
46801189|NCT00105469|83020107|FG001|Overall Study|Withdrawal by Subject|3|||
46801190|NCT00105469|83020106|FG000|Overall Study|Lost to Follow-up|1|||
46801191|NCT00105469|83020107|FG001|Overall Study|Lost to Follow-up|0|||
46801192|NCT00105469|83020106|FG000|Overall Study|Lack of Efficacy|2|||
46801193|NCT00105469|83020107|FG001|Overall Study|Lack of Efficacy|0|||
46801194|NCT00105469|83020106|FG000|Overall Study|Other Reason|4|||
46801195|NCT00105469|83020107|FG001|Overall Study|Other Reason|0|||
46801196|NCT00105235|83020113|FG000|Overall Study|Death|4|||
46692259|NCT01013740|82906749|FG001|Overall Study|Ongoing: Study records not completed|2|||
46692260|NCT01013350|82906759|FG000|Overall Study|Lost to Follow-up|15|||
46692261|NCT01013350|82906760|FG001|Overall Study|Lost to Follow-up|95|||
46692262|NCT01013350|82906759|FG000|Overall Study|Adverse Event|0|||
46692263|NCT01013350|82906760|FG001|Overall Study|Adverse Event|1|||
46801197|NCT00105235|83020113|FG000|Overall Study|Physician Decision|1|||
46801198|NCT00105235|83020113|FG000|Overall Study|Withdrawal by Subject|2|||
46981995|NCT02343939|83228206|FG008|Overall Study|Death|1|||
46981996|NCT02343939|83228198|FG000|Overall Study|Study terminated by sponsor|0|||
46981997|NCT02343939|83228199|FG001|Overall Study|Study terminated by sponsor|27|||
46981998|NCT02343939|83228200|FG002|Overall Study|Study terminated by sponsor|0|||
46981999|NCT02343939|83228201|FG003|Overall Study|Study terminated by sponsor|1|||
46982000|NCT02343939|83228202|FG004|Overall Study|Study terminated by sponsor|1|||
46982001|NCT02343939|83228203|FG005|Overall Study|Study terminated by sponsor|5|||
46982002|NCT02343939|83228204|FG006|Overall Study|Study terminated by sponsor|3|||
46692264|NCT01013350|82906759|FG000|Overall Study|Physician Decision|4|||
46692265|NCT01013350|82906760|FG001|Overall Study|Physician Decision|20|||
46692266|NCT01013350|82906759|FG000|Overall Study|Withdrawal by Subject|15|||
46801199|NCT00547118|83020123|FG000|Overall Study|Did not qualify prior to starting drug|1|||
46801200|NCT00547118|83020124|FG001|Overall Study|Did not qualify prior to starting drug|1|||
46801201|NCT00547118|83020123|FG000|Overall Study|Study suspended|7|||
46801202|NCT00547118|83020124|FG001|Overall Study|Study suspended|8|||
46801203|NCT00502593|83020144|FG000|Overall Study|Withdrawn unspecified reason|1|||
46801204|NCT00502593|83020145|FG001|Overall Study|Withdrawn unspecified reason|1|||
46801205|NCT00502593|83020146|FG002|Overall Study|Withdrawn unspecified reason|3|||
46801206|NCT00502593|83020147|FG003|Overall Study|Withdrawn unspecified reason|1|||
46982003|NCT02343939|83228205|FG007|Overall Study|Study terminated by sponsor|4|||
46801207|NCT00502593|83020148|FG004|Overall Study|Withdrawn unspecified reason|2|||
46801208|NCT00502593|83020149|FG005|Overall Study|Withdrawn unspecified reason|0|||
46692267|NCT01013350|82906760|FG001|Overall Study|Withdrawal by Subject|38|||
46692268|NCT01013350|82906759|FG000|Overall Study|Death|3|||
46692269|NCT01013350|82906760|FG001|Overall Study|Death|5|||
46692270|NCT01013350|82906759|FG000|Overall Study|Participant entered interventional study|0|||
46692271|NCT01013350|82906760|FG001|Overall Study|Participant entered interventional study|8|||
46692272|NCT01013350|82906759|FG000|Overall Study|Other|1|||
46692273|NCT01013350|82906760|FG001|Overall Study|Other|25|||
46692274|NCT01018030|82906770|FG000|Overall Study|Adverse Event|10|||
46692275|NCT01018030|82906771|FG001|Overall Study|Adverse Event|5|||
46692276|NCT01018030|82906772|FG002|Overall Study|Adverse Event|5|||
46692277|NCT01018030|82906770|FG000|Overall Study|Withdrawal by Subject|2|||
46692278|NCT01018030|82906771|FG001|Overall Study|Withdrawal by Subject|2|||
46692279|NCT01018030|82906772|FG002|Overall Study|Withdrawal by Subject|4|||
46692280|NCT01018030|82906770|FG000|Overall Study|Lost to Follow-up|2|||
46692281|NCT01018030|82906771|FG001|Overall Study|Lost to Follow-up|0|||
46692282|NCT01018030|82906772|FG002|Overall Study|Lost to Follow-up|3|||
46692283|NCT01018030|82906770|FG000|Overall Study|Protocol Violation|2|||
46692284|NCT01018030|82906771|FG001|Overall Study|Protocol Violation|1|||
46692285|NCT01018030|82906772|FG002|Overall Study|Protocol Violation|0|||
46692286|NCT01018030|82906770|FG000|Overall Study|Physician Decision|1|||
46692287|NCT01018030|82906771|FG001|Overall Study|Physician Decision|0|||
46692288|NCT01018030|82906772|FG002|Overall Study|Physician Decision|1|||
46692289|NCT01018030|82906770|FG000|Overall Study|Lack of Efficacy|1|||
46692290|NCT01018030|82906771|FG001|Overall Study|Lack of Efficacy|0|||
46692291|NCT01018030|82906772|FG002|Overall Study|Lack of Efficacy|0|||
46692292|NCT01018030|82906770|FG000|Overall Study|Did Not Receive Study Drug|1|||
46692293|NCT01018030|82906771|FG001|Overall Study|Did Not Receive Study Drug|3|||
46692294|NCT01018030|82906772|FG002|Overall Study|Did Not Receive Study Drug|0|||
46692295|NCT01217073|82906788|FG000|Base Period|Adverse Event|1|||
46692296|NCT01217073|82906789|FG001|Base Period|Adverse Event|0|||
46692297|NCT01217073|82906790|FG002|Base Period|Adverse Event|1|||
46692298|NCT01217073|82906791|FG003|Base Period|Adverse Event|0|||
46692299|NCT01217073|82906792|FG004|Base Period|Adverse Event|4|||
46692300|NCT01217073|82906793|FG005|Base Period|Adverse Event|1|||
46692301|NCT01217073|82906794|FG006|Base Period|Adverse Event|0|||
46692302|NCT01217073|82906795|FG007|Base Period|Adverse Event|0|||
46692303|NCT01217073|82906788|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
46858896|NCT03257410|83074719|FG001|Overall Study|Death|2|||
46858897|NCT03257410|83074718|FG000|Overall Study|Change to another dialysis center|2|||
46692304|NCT01217073|82906789|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
46692305|NCT01217073|82906790|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
46692306|NCT01217073|82906791|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
46692307|NCT01217073|82906792|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
46692308|NCT01217073|82906793|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
46692309|NCT01217073|82906794|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
46692310|NCT01217073|82906795|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
46692311|NCT01217073|82906788|FG000|Base Period|Excluded medication|0|||
46692312|NCT01217073|82906789|FG001|Base Period|Excluded medication|0|||
46692313|NCT01217073|82906790|FG002|Base Period|Excluded medication|0|||
46692314|NCT01217073|82906791|FG003|Base Period|Excluded medication|0|||
46692315|NCT01217073|82906792|FG004|Base Period|Excluded medication|1|||
46692316|NCT01217073|82906793|FG005|Base Period|Excluded medication|0|||
46692317|NCT01217073|82906794|FG006|Base Period|Excluded medication|0|||
46692318|NCT01217073|82906795|FG007|Base Period|Excluded medication|0|||
46692319|NCT01217073|82906788|FG000|Base Period|Lack of Efficacy|0|||
46692320|NCT01217073|82906789|FG001|Base Period|Lack of Efficacy|0|||
46692321|NCT01217073|82906790|FG002|Base Period|Lack of Efficacy|0|||
46692322|NCT01217073|82906791|FG003|Base Period|Lack of Efficacy|0|||
46692323|NCT01217073|82906792|FG004|Base Period|Lack of Efficacy|0|||
46692324|NCT01217073|82906793|FG005|Base Period|Lack of Efficacy|1|||
46692325|NCT01217073|82906794|FG006|Base Period|Lack of Efficacy|0|||
46692326|NCT01217073|82906795|FG007|Base Period|Lack of Efficacy|0|||
46692327|NCT01217073|82906788|FG000|Base Period|Lost to Follow-up|0|||
46692328|NCT01217073|82906789|FG001|Base Period|Lost to Follow-up|0|||
46692329|NCT01217073|82906790|FG002|Base Period|Lost to Follow-up|1|||
46692330|NCT01217073|82906791|FG003|Base Period|Lost to Follow-up|1|||
46692331|NCT01217073|82906792|FG004|Base Period|Lost to Follow-up|3|||
46692332|NCT01217073|82906793|FG005|Base Period|Lost to Follow-up|0|||
46692333|NCT01217073|82906794|FG006|Base Period|Lost to Follow-up|0|||
46692334|NCT01217073|82906795|FG007|Base Period|Lost to Follow-up|0|||
46692335|NCT01217073|82906788|FG000|Base Period|Physician Decision|0|||
46692336|NCT01217073|82906789|FG001|Base Period|Physician Decision|0|||
46692337|NCT01217073|82906790|FG002|Base Period|Physician Decision|0|||
46692338|NCT01217073|82906791|FG003|Base Period|Physician Decision|0|||
46692339|NCT01217073|82906792|FG004|Base Period|Physician Decision|1|||
46692340|NCT01217073|82906793|FG005|Base Period|Physician Decision|0|||
46692341|NCT01217073|82906794|FG006|Base Period|Physician Decision|0|||
46692342|NCT01217073|82906795|FG007|Base Period|Physician Decision|0|||
46692343|NCT01217073|82906788|FG000|Base Period|Protocol Violation|1|||
46692344|NCT01217073|82906789|FG001|Base Period|Protocol Violation|0|||
46692345|NCT01217073|82906790|FG002|Base Period|Protocol Violation|0|||
46692346|NCT01217073|82906791|FG003|Base Period|Protocol Violation|0|||
46692347|NCT01217073|82906792|FG004|Base Period|Protocol Violation|1|||
46692348|NCT01217073|82906793|FG005|Base Period|Protocol Violation|2|||
46692349|NCT01217073|82906794|FG006|Base Period|Protocol Violation|0|||
46692350|NCT01217073|82906795|FG007|Base Period|Protocol Violation|0|||
46692351|NCT01217073|82906788|FG000|Base Period|Withdrawal by Subject|4|||
46692352|NCT01217073|82906789|FG001|Base Period|Withdrawal by Subject|5|||
46692353|NCT01217073|82906790|FG002|Base Period|Withdrawal by Subject|5|||
46692354|NCT01217073|82906791|FG003|Base Period|Withdrawal by Subject|1|||
46692355|NCT01217073|82906792|FG004|Base Period|Withdrawal by Subject|5|||
46692356|NCT01217073|82906793|FG005|Base Period|Withdrawal by Subject|5|||
46692357|NCT01217073|82906794|FG006|Base Period|Withdrawal by Subject|0|||
46692358|NCT01217073|82906795|FG007|Base Period|Withdrawal by Subject|0|||
46692359|NCT01217073|82906788|FG000|Extension Period|Adverse Event|0|||
46692360|NCT01217073|82906789|FG001|Extension Period|Adverse Event|0|||
46692361|NCT01217073|82906790|FG002|Extension Period|Adverse Event|0|||
46692362|NCT01217073|82906791|FG003|Extension Period|Adverse Event|0|||
46692363|NCT01217073|82906792|FG004|Extension Period|Adverse Event|0|||
46692364|NCT01217073|82906793|FG005|Extension Period|Adverse Event|0|||
46692365|NCT01217073|82906794|FG006|Extension Period|Adverse Event|19|||
46692366|NCT01217073|82906795|FG007|Extension Period|Adverse Event|5|||
46692367|NCT01217073|82906788|FG000|Extension Period|ALT/AST|0|||
46692368|NCT01217073|82906789|FG001|Extension Period|ALT/AST|0|||
46692369|NCT01217073|82906790|FG002|Extension Period|ALT/AST|0|||
46692370|NCT01217073|82906791|FG003|Extension Period|ALT/AST|0|||
46692371|NCT01217073|82906792|FG004|Extension Period|ALT/AST|0|||
46692372|NCT01217073|82906793|FG005|Extension Period|ALT/AST|0|||
46692373|NCT01217073|82906794|FG006|Extension Period|ALT/AST|2|||
46692374|NCT01217073|82906795|FG007|Extension Period|ALT/AST|0|||
46692375|NCT01217073|82906788|FG000|Extension Period|Contraindication to study medication|0|||
46692376|NCT01217073|82906789|FG001|Extension Period|Contraindication to study medication|0|||
46692377|NCT01217073|82906790|FG002|Extension Period|Contraindication to study medication|0|||
46692378|NCT01217073|82906791|FG003|Extension Period|Contraindication to study medication|0|||
46692379|NCT01217073|82906792|FG004|Extension Period|Contraindication to study medication|0|||
46692380|NCT01217073|82906793|FG005|Extension Period|Contraindication to study medication|0|||
46692381|NCT01217073|82906794|FG006|Extension Period|Contraindication to study medication|1|||
46692382|NCT01217073|82906795|FG007|Extension Period|Contraindication to study medication|0|||
46692383|NCT01217073|82906788|FG000|Extension Period|Creatinine/eGFR|0|||
46692384|NCT01217073|82906789|FG001|Extension Period|Creatinine/eGFR|0|||
46692385|NCT01217073|82906790|FG002|Extension Period|Creatinine/eGFR|0|||
46692386|NCT01217073|82906791|FG003|Extension Period|Creatinine/eGFR|0|||
46692387|NCT01217073|82906792|FG004|Extension Period|Creatinine/eGFR|0|||
46692388|NCT01217073|82906793|FG005|Extension Period|Creatinine/eGFR|0|||
46692389|NCT01217073|82906794|FG006|Extension Period|Creatinine/eGFR|11|||
46692390|NCT01217073|82906795|FG007|Extension Period|Creatinine/eGFR|1|||
46692391|NCT01217073|82906788|FG000|Extension Period|Death|0|||
46692392|NCT01217073|82906789|FG001|Extension Period|Death|0|||
46692393|NCT01217073|82906790|FG002|Extension Period|Death|0|||
46692394|NCT01217073|82906791|FG003|Extension Period|Death|0|||
46692395|NCT01217073|82906792|FG004|Extension Period|Death|0|||
46692396|NCT01217073|82906793|FG005|Extension Period|Death|0|||
46692397|NCT01217073|82906794|FG006|Extension Period|Death|1|||
46692398|NCT01217073|82906795|FG007|Extension Period|Death|0|||
46692399|NCT01217073|82906788|FG000|Extension Period|Excluded medication|0|||
46692400|NCT01217073|82906789|FG001|Extension Period|Excluded medication|0|||
46692401|NCT01217073|82906790|FG002|Extension Period|Excluded medication|0|||
46692402|NCT01217073|82906791|FG003|Extension Period|Excluded medication|0|||
46801209|NCT00502593|83020150|FG006|Overall Study|Withdrawn unspecified reason|2|||
46801210|NCT00502593|83020151|FG007|Overall Study|Withdrawn unspecified reason|0|||
46801211|NCT00502593|83020152|FG008|Overall Study|Withdrawn unspecified reason|0|||
46801212|NCT00502593|83020153|FG009|Overall Study|Withdrawn unspecified reason|0|||
46801213|NCT00502593|83020154|FG010|Overall Study|Withdrawn unspecified reason|0|||
46801214|NCT00502593|83020155|FG011|Overall Study|Withdrawn unspecified reason|0|||
46801215|NCT00502593|83020144|FG000|Overall Study|Withdrawal by Subject|0|||
46801216|NCT00502593|83020145|FG001|Overall Study|Withdrawal by Subject|0|||
46801217|NCT00502593|83020146|FG002|Overall Study|Withdrawal by Subject|6|||
46801218|NCT00502593|83020147|FG003|Overall Study|Withdrawal by Subject|2|||
46801219|NCT00502593|83020148|FG004|Overall Study|Withdrawal by Subject|2|||
46801220|NCT00502593|83020149|FG005|Overall Study|Withdrawal by Subject|0|||
46801221|NCT00502593|83020150|FG006|Overall Study|Withdrawal by Subject|3|||
46801222|NCT00502593|83020151|FG007|Overall Study|Withdrawal by Subject|0|||
46801223|NCT00502593|83020152|FG008|Overall Study|Withdrawal by Subject|3|||
46801224|NCT00502593|83020153|FG009|Overall Study|Withdrawal by Subject|0|||
46801225|NCT00502593|83020154|FG010|Overall Study|Withdrawal by Subject|1|||
46801226|NCT00502593|83020155|FG011|Overall Study|Withdrawal by Subject|0|||
46801227|NCT00502593|83020144|FG000|Overall Study|Lost to Follow-up|2|||
46801228|NCT00502593|83020145|FG001|Overall Study|Lost to Follow-up|1|||
46801229|NCT00502593|83020146|FG002|Overall Study|Lost to Follow-up|1|||
46801230|NCT00502593|83020147|FG003|Overall Study|Lost to Follow-up|1|||
46801231|NCT00502593|83020148|FG004|Overall Study|Lost to Follow-up|0|||
46801232|NCT00502593|83020149|FG005|Overall Study|Lost to Follow-up|0|||
46692403|NCT01217073|82906792|FG004|Extension Period|Excluded medication|0|||
46692404|NCT01217073|82906793|FG005|Extension Period|Excluded medication|0|||
46692405|NCT01217073|82906794|FG006|Extension Period|Excluded medication|2|||
46801233|NCT00502593|83020150|FG006|Overall Study|Lost to Follow-up|0|||
46692406|NCT01217073|82906795|FG007|Extension Period|Excluded medication|0|||
46692407|NCT01217073|82906788|FG000|Extension Period|Lack of Efficacy|0|||
46692408|NCT01217073|82906789|FG001|Extension Period|Lack of Efficacy|0|||
46692409|NCT01217073|82906790|FG002|Extension Period|Lack of Efficacy|0|||
46692410|NCT01217073|82906791|FG003|Extension Period|Lack of Efficacy|0|||
46692411|NCT01217073|82906792|FG004|Extension Period|Lack of Efficacy|0|||
46692412|NCT01217073|82906793|FG005|Extension Period|Lack of Efficacy|0|||
46692413|NCT01217073|82906794|FG006|Extension Period|Lack of Efficacy|3|||
46801234|NCT00502593|83020151|FG007|Overall Study|Lost to Follow-up|0|||
46801235|NCT00502593|83020152|FG008|Overall Study|Lost to Follow-up|3|||
46801236|NCT00502593|83020153|FG009|Overall Study|Lost to Follow-up|0|||
46801237|NCT00502593|83020154|FG010|Overall Study|Lost to Follow-up|1|||
46801238|NCT00502593|83020155|FG011|Overall Study|Lost to Follow-up|0|||
46692414|NCT01217073|82906795|FG007|Extension Period|Lack of Efficacy|0|||
46692415|NCT01217073|82906788|FG000|Extension Period|Lost to Follow-up|0|||
46692416|NCT01217073|82906789|FG001|Extension Period|Lost to Follow-up|0|||
46692417|NCT01217073|82906790|FG002|Extension Period|Lost to Follow-up|0|||
46692418|NCT01217073|82906791|FG003|Extension Period|Lost to Follow-up|0|||
46692419|NCT01217073|82906792|FG004|Extension Period|Lost to Follow-up|0|||
46692420|NCT01217073|82906793|FG005|Extension Period|Lost to Follow-up|0|||
46692421|NCT01217073|82906794|FG006|Extension Period|Lost to Follow-up|9|||
46692422|NCT01217073|82906795|FG007|Extension Period|Lost to Follow-up|1|||
46692423|NCT01217073|82906788|FG000|Extension Period|Non-compliance with study drug|0|||
46692424|NCT01217073|82906789|FG001|Extension Period|Non-compliance with study drug|0|||
46692425|NCT01217073|82906790|FG002|Extension Period|Non-compliance with study drug|0|||
46692426|NCT01217073|82906791|FG003|Extension Period|Non-compliance with study drug|0|||
46692427|NCT01217073|82906792|FG004|Extension Period|Non-compliance with study drug|0|||
46801239|NCT00686543|83020208|FG000|Overall Study|Adverse Event|9|||
46801240|NCT00686543|83020209|FG001|Overall Study|Adverse Event|1|||
46801241|NCT00686543|83020210|FG002|Overall Study|Adverse Event|3|||
46801242|NCT00686543|83020211|FG003|Overall Study|Adverse Event|2|||
46801243|NCT00686543|83020208|FG000|Overall Study|Withdrawal by Subject|2|||
46801244|NCT00686543|83020209|FG001|Overall Study|Withdrawal by Subject|0|||
46801245|NCT00686543|83020210|FG002|Overall Study|Withdrawal by Subject|0|||
46801246|NCT00686543|83020211|FG003|Overall Study|Withdrawal by Subject|0|||
46801247|NCT00686543|83020208|FG000|Overall Study|Protocol Violation|3|||
46801248|NCT00686543|83020209|FG001|Overall Study|Protocol Violation|0|||
46801249|NCT00686543|83020210|FG002|Overall Study|Protocol Violation|2|||
46801250|NCT00686543|83020211|FG003|Overall Study|Protocol Violation|1|||
46801251|NCT00545688|83020225|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
46801252|NCT00545688|83020226|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
46801253|NCT00545688|83020227|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
46801254|NCT00545688|83020228|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
46801255|NCT00545688|83020225|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
46801256|NCT00545688|83020226|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
46801257|NCT00545688|83020227|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
46801258|NCT00545688|83020228|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
46801259|NCT00545688|83020225|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
46801260|NCT00545688|83020226|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
46801261|NCT00545688|83020227|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
46801262|NCT00545688|83020228|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
46801263|NCT00545688|83020225|FG000|Neo-Adjuvant Treatment Period|Death|0|||
46801264|NCT00545688|83020226|FG001|Neo-Adjuvant Treatment Period|Death|1|||
46801265|NCT00545688|83020227|FG002|Neo-Adjuvant Treatment Period|Death|0|||
46858898|NCT03257410|83074719|FG001|Overall Study|Change to another dialysis center|2|||
46858899|NCT03257410|83074718|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
46858900|NCT03257410|83074719|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
46858901|NCT03257410|83074718|FG000|Overall Study|Miscellaneous|2|||
46858902|NCT03257410|83074719|FG001|Overall Study|Miscellaneous|2|||
46858903|NCT03257410|83074718|FG000|Overall Study|Other|0|||
46858904|NCT03257410|83074719|FG001|Overall Study|Other|1|||
46858905|NCT00056160|83074727|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
46858906|NCT00056160|83074728|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
46858907|NCT00056160|83074727|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
46858908|NCT00056160|83074728|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
46858909|NCT00056160|83074727|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
46858910|NCT00056160|83074728|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
46692428|NCT01217073|82906793|FG005|Extension Period|Non-compliance with study drug|0|||
46692429|NCT01217073|82906794|FG006|Extension Period|Non-compliance with study drug|0|||
46692430|NCT01217073|82906795|FG007|Extension Period|Non-compliance with study drug|1|||
46692431|NCT01217073|82906788|FG000|Extension Period|Physician Decision|0|||
46692432|NCT01217073|82906789|FG001|Extension Period|Physician Decision|0|||
46858911|NCT00056160|83074727|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
46858912|NCT00056160|83074728|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
46692433|NCT01217073|82906790|FG002|Extension Period|Physician Decision|0|||
46692434|NCT01217073|82906791|FG003|Extension Period|Physician Decision|0|||
46801266|NCT00545688|83020228|FG003|Neo-Adjuvant Treatment Period|Death|0|||
46801267|NCT00545688|83020225|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
46801268|NCT00545688|83020226|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
46801269|NCT00545688|83020227|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
46801270|NCT00545688|83020228|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
46801271|NCT00545688|83020225|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
46801272|NCT00545688|83020226|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
46801273|NCT00545688|83020227|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
46801274|NCT00545688|83020228|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
46801275|NCT00545688|83020225|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
46801276|NCT00545688|83020226|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
46801277|NCT00545688|83020227|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
46801278|NCT00545688|83020228|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
46801279|NCT00545688|83020225|FG000|Adjuvant Treatment Period|Disease Progression|3|||
46801280|NCT00545688|83020226|FG001|Adjuvant Treatment Period|Disease Progression|3|||
46801281|NCT00545688|83020227|FG002|Adjuvant Treatment Period|Disease Progression|0|||
46801282|NCT00545688|83020228|FG003|Adjuvant Treatment Period|Disease Progression|7|||
46692435|NCT01217073|82906792|FG004|Extension Period|Physician Decision|0|||
46692436|NCT01217073|82906793|FG005|Extension Period|Physician Decision|0|||
46692437|NCT01217073|82906794|FG006|Extension Period|Physician Decision|4|||
46692438|NCT01217073|82906795|FG007|Extension Period|Physician Decision|1|||
46692439|NCT01217073|82906788|FG000|Extension Period|Protocol Violation|0|||
46692440|NCT01217073|82906789|FG001|Extension Period|Protocol Violation|0|||
46692441|NCT01217073|82906790|FG002|Extension Period|Protocol Violation|0|||
46692442|NCT01217073|82906791|FG003|Extension Period|Protocol Violation|0|||
46692443|NCT01217073|82906792|FG004|Extension Period|Protocol Violation|0|||
46692444|NCT01217073|82906793|FG005|Extension Period|Protocol Violation|0|||
46692445|NCT01217073|82906794|FG006|Extension Period|Protocol Violation|2|||
46692446|NCT01217073|82906795|FG007|Extension Period|Protocol Violation|1|||
46692447|NCT01217073|82906788|FG000|Extension Period|Site discontinued study participation|0|||
46692448|NCT01217073|82906789|FG001|Extension Period|Site discontinued study participation|0|||
46692449|NCT01217073|82906790|FG002|Extension Period|Site discontinued study participation|0|||
46692450|NCT01217073|82906791|FG003|Extension Period|Site discontinued study participation|0|||
46692451|NCT01217073|82906792|FG004|Extension Period|Site discontinued study participation|0|||
46692452|NCT01217073|82906793|FG005|Extension Period|Site discontinued study participation|0|||
46692453|NCT01217073|82906794|FG006|Extension Period|Site discontinued study participation|7|||
46692454|NCT01217073|82906795|FG007|Extension Period|Site discontinued study participation|2|||
46692455|NCT01217073|82906788|FG000|Extension Period|Withdrawal by Subject|0|||
46801283|NCT00545688|83020225|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
46801284|NCT00545688|83020226|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
46801285|NCT00545688|83020227|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
46801286|NCT00545688|83020228|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
46801287|NCT00545688|83020225|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
46801288|NCT00545688|83020226|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
46801289|NCT00545688|83020227|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
46801290|NCT00545688|83020228|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
46801291|NCT00545688|83020225|FG000|Adjuvant Treatment Period|Adverse Event|0|||
46801292|NCT00545688|83020226|FG001|Adjuvant Treatment Period|Adverse Event|3|||
46692456|NCT01217073|82906789|FG001|Extension Period|Withdrawal by Subject|0|||
46692457|NCT01217073|82906790|FG002|Extension Period|Withdrawal by Subject|0|||
46692458|NCT01217073|82906791|FG003|Extension Period|Withdrawal by Subject|0|||
46692459|NCT01217073|82906792|FG004|Extension Period|Withdrawal by Subject|0|||
46801293|NCT00545688|83020227|FG002|Adjuvant Treatment Period|Adverse Event|2|||
46801294|NCT00545688|83020228|FG003|Adjuvant Treatment Period|Adverse Event|2|||
46692460|NCT01217073|82906793|FG005|Extension Period|Withdrawal by Subject|0|||
46692461|NCT01217073|82906794|FG006|Extension Period|Withdrawal by Subject|30|||
46692462|NCT01217073|82906795|FG007|Extension Period|Withdrawal by Subject|8|||
46692463|NCT00985621|82906823|FG000|Overall Study|Adverse Event|2|||
46692464|NCT00985621|82906824|FG001|Overall Study|Adverse Event|3|||
46692465|NCT00985621|82906825|FG002|Overall Study|Adverse Event|4|||
46692466|NCT00985621|82906826|FG003|Overall Study|Adverse Event|16|||
46692467|NCT00985621|82906823|FG000|Overall Study|Lack of Efficacy|10|||
46692468|NCT00985621|82906824|FG001|Overall Study|Lack of Efficacy|6|||
46692469|NCT00985621|82906825|FG002|Overall Study|Lack of Efficacy|5|||
46692470|NCT00985621|82906826|FG003|Overall Study|Lack of Efficacy|12|||
46692471|NCT00985621|82906823|FG000|Overall Study|Lost to Follow-up|2|||
46692472|NCT00985621|82906824|FG001|Overall Study|Lost to Follow-up|3|||
46692473|NCT00985621|82906825|FG002|Overall Study|Lost to Follow-up|4|||
46692474|NCT00985621|82906826|FG003|Overall Study|Lost to Follow-up|4|||
46692475|NCT00985621|82906823|FG000|Overall Study|Study Terminated by Sponsor|89|||
46692476|NCT00985621|82906824|FG001|Overall Study|Study Terminated by Sponsor|108|||
46692477|NCT00985621|82906825|FG002|Overall Study|Study Terminated by Sponsor|99|||
46692478|NCT00985621|82906826|FG003|Overall Study|Study Terminated by Sponsor|92|||
46692479|NCT00985621|82906823|FG000|Overall Study|Protocol Violation|1|||
46692480|NCT00985621|82906824|FG001|Overall Study|Protocol Violation|1|||
46692481|NCT00985621|82906825|FG002|Overall Study|Protocol Violation|1|||
46692482|NCT00985621|82906826|FG003|Overall Study|Protocol Violation|0|||
46692483|NCT00985621|82906823|FG000|Overall Study|Withdrawal by Subject|8|||
46692484|NCT00985621|82906824|FG001|Overall Study|Withdrawal by Subject|10|||
46982004|NCT02343939|83228206|FG008|Overall Study|Study terminated by sponsor|0|||
46982005|NCT02343939|83228198|FG000|Overall Study|Withdrew consent|3|||
46982006|NCT02343939|83228199|FG001|Overall Study|Withdrew consent|6|||
46982007|NCT02343939|83228200|FG002|Overall Study|Withdrew consent|1|||
46982008|NCT02343939|83228201|FG003|Overall Study|Withdrew consent|2|||
46692485|NCT00985621|82906825|FG002|Overall Study|Withdrawal by Subject|8|||
46692486|NCT00985621|82906826|FG003|Overall Study|Withdrawal by Subject|12|||
46692487|NCT00985621|82906823|FG000|Overall Study|Other|1|||
46692488|NCT00985621|82906824|FG001|Overall Study|Other|0|||
46692489|NCT00985621|82906825|FG002|Overall Study|Other|0|||
46692490|NCT00985621|82906826|FG003|Overall Study|Other|0|||
46692491|NCT00985621|82906823|FG000|Overall Study|Randomized but not Treated|1|||
46692492|NCT00985621|82906824|FG001|Overall Study|Randomized but not Treated|0|||
46982009|NCT02343939|83228202|FG004|Overall Study|Withdrew consent|2|||
46982010|NCT02343939|83228203|FG005|Overall Study|Withdrew consent|0|||
46692493|NCT00985621|82906825|FG002|Overall Study|Randomized but not Treated|2|||
46692494|NCT00985621|82906826|FG003|Overall Study|Randomized but not Treated|1|||
46692495|NCT01215981|82906840|FG000|Overall Study|Physician Decision|0|||
46692496|NCT01215981|82906841|FG001|Overall Study|Physician Decision|1|||
46692497|NCT01215981|82906840|FG000|Overall Study|Protocol Violation|1|||
46692498|NCT01215981|82906841|FG001|Overall Study|Protocol Violation|0|||
46692499|NCT01215981|82906840|FG000|Overall Study|Withdrawal by Subject|1|||
46692500|NCT01215981|82906841|FG001|Overall Study|Withdrawal by Subject|0|||
46692501|NCT01215513|82906847|FG000|Overall Study|Not completed CS42|9|||
46692502|NCT01215513|82906847|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
46692503|NCT01215513|82906847|FG000|Overall Study|Adverse event (CS42A)|2|||
46692504|NCT01215513|82906847|FG000|Overall Study|Physician decision (CS42A)|6|||
46692505|NCT01215513|82906847|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
46692506|NCT01215513|82906847|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
46692507|NCT01215435|82906854|FG000|Overall Study|Adverse Event|1|||
46692508|NCT01215435|82906855|FG001|Overall Study|Adverse Event|0|||
46692509|NCT01215435|82906854|FG000|Overall Study|Protocol Violation|2|||
46692510|NCT01215435|82906855|FG001|Overall Study|Protocol Violation|0|||
46692511|NCT01215435|82906854|FG000|Overall Study|Withdrawal Criteria|8|||
46692512|NCT01215435|82906855|FG001|Overall Study|Withdrawal Criteria|11|||
46692513|NCT01215435|82906854|FG000|Overall Study|Lost to Follow-up|3|||
46692514|NCT01215435|82906855|FG001|Overall Study|Lost to Follow-up|0|||
46692515|NCT01215435|82906854|FG000|Overall Study|Unclassified|5|||
46692516|NCT01215435|82906855|FG001|Overall Study|Unclassified|5|||
46692517|NCT01215357|82906861|FG000|Overall Study|Withdrawal by Subject|3|||
46692518|NCT01215357|82906861|FG000|Overall Study|Protocol Violation|9|||
46692519|NCT00984295|82906868|FG000|Overall Study|Lost to Follow-up|31|||
46692520|NCT00984295|82906869|FG001|Overall Study|Lost to Follow-up|12|||
46692521|NCT00984295|82906870|FG002|Overall Study|Lost to Follow-up|13|||
46692522|NCT00984295|82906868|FG000|Overall Study|Protocol Violation|2|||
46692523|NCT00984295|82906869|FG001|Overall Study|Protocol Violation|1|||
46692524|NCT00984295|82906870|FG002|Overall Study|Protocol Violation|4|||
46692525|NCT00984295|82906868|FG000|Overall Study|Withdrawal by Subject|18|||
46692526|NCT00984295|82906869|FG001|Overall Study|Withdrawal by Subject|9|||
46692527|NCT00984295|82906870|FG002|Overall Study|Withdrawal by Subject|12|||
46692528|NCT00984295|82906868|FG000|Overall Study|CAE - discontinued test vaccine|0|||
46692529|NCT00984295|82906869|FG001|Overall Study|CAE - discontinued test vaccine|1|||
46692530|NCT00984295|82906870|FG002|Overall Study|CAE - discontinued test vaccine|3|||
46692531|NCT00984295|82906868|FG000|Overall Study|Missed one or more blood samplings|3|||
46692532|NCT00984295|82906869|FG001|Overall Study|Missed one or more blood samplings|7|||
46692533|NCT00984295|82906870|FG002|Overall Study|Missed one or more blood samplings|2|||
46858913|NCT00056160|83074727|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
46692534|NCT00984295|82906868|FG000|Overall Study|Incomplete safety follow-up|11|||
46692535|NCT00984295|82906869|FG001|Overall Study|Incomplete safety follow-up|2|||
46692536|NCT00984295|82906870|FG002|Overall Study|Incomplete safety follow-up|3|||
46692537|NCT01017952|82906882|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
46692538|NCT01017952|82906883|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46692539|NCT01017952|82906884|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46692540|NCT01017952|82906885|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46858914|NCT00056160|83074728|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
46692541|NCT01017952|82906886|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
46692542|NCT01017952|82906882|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
46692543|NCT01017952|82906883|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
46692544|NCT01017952|82906884|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
46692545|NCT01017952|82906885|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
46692546|NCT01017952|82906886|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
46692547|NCT01017952|82906882|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
46692548|NCT01017952|82906883|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
46692549|NCT01017952|82906884|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
46692550|NCT01017952|82906885|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
46692551|NCT01017952|82906886|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
46692552|NCT01017952|82906882|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
46692553|NCT01017952|82906883|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46692554|NCT01017952|82906884|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46692555|NCT01017952|82906885|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46692556|NCT01017952|82906886|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
46692557|NCT01017952|82906882|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
46692558|NCT01017952|82906883|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
46692559|NCT01017952|82906884|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
46692560|NCT01017952|82906885|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
46692561|NCT01017952|82906886|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
46692562|NCT01017952|82906882|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
46692563|NCT01017952|82906883|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46692564|NCT01017952|82906884|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46692565|NCT01017952|82906885|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46692566|NCT01017952|82906886|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
46692567|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
46692568|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
46692569|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
46692570|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
46692571|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
46692572|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
46692573|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
46692574|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
46692575|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
46692576|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
46692577|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
46692578|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
46692579|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
46692580|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
46692581|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
46692582|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
46692583|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
46692584|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
46692585|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
46692586|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
46801295|NCT00545688|83020225|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
46692587|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
46692588|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
46692589|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
46692590|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
46692591|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
46692592|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
46692593|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
46692594|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
46692595|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
46692596|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
46692597|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
46692598|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
46692599|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
46692600|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
46692601|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
46692602|NCT01017952|82906882|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
46692603|NCT01017952|82906883|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
46692604|NCT01017952|82906884|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
46692605|NCT01017952|82906885|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
46692606|NCT01017952|82906886|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
46692607|NCT01214655|82906899|FG000|Part A|Progressive Disease|7|||
46692608|NCT01214655|82906900|FG001|Part A|Progressive Disease|0|||
46692609|NCT01214655|82906901|FG002|Part A|Progressive Disease|0|||
46692610|NCT01214655|82906899|FG000|Part A|Physician Decision|1|||
46692611|NCT01214655|82906900|FG001|Part A|Physician Decision|0|||
46692612|NCT01214655|82906901|FG002|Part A|Physician Decision|0|||
46692613|NCT01214655|82906899|FG000|Part B|Progressive disease|0|||
46692614|NCT01214655|82906900|FG001|Part B|Progressive disease|10|||
46692615|NCT01214655|82906901|FG002|Part B|Progressive disease|0|||
46692616|NCT01214655|82906899|FG000|Part B|Death|0|||
46692617|NCT01214655|82906900|FG001|Part B|Death|1|||
46692618|NCT01214655|82906901|FG002|Part B|Death|0|||
46692619|NCT01214655|82906899|FG000|Part B|Withdrawal by Subject|0|||
46692620|NCT01214655|82906900|FG001|Part B|Withdrawal by Subject|2|||
46692621|NCT01214655|82906901|FG002|Part B|Withdrawal by Subject|0|||
46692622|NCT01214655|82906899|FG000|Part C|Progressive Disease|0|||
46692623|NCT01214655|82906900|FG001|Part C|Progressive Disease|0|||
46692624|NCT01214655|82906901|FG002|Part C|Progressive Disease|5|||
46692625|NCT01214655|82906899|FG000|Part C|Death|0|||
46692626|NCT01214655|82906900|FG001|Part C|Death|0|||
46692627|NCT01214655|82906901|FG002|Part C|Death|1|||
46692628|NCT01214655|82906899|FG000|Part C|Physician Decision|0|||
46692629|NCT01214655|82906900|FG001|Part C|Physician Decision|0|||
46801296|NCT00545688|83020226|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
46801297|NCT00545688|83020227|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
46801298|NCT00545688|83020228|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
46801299|NCT00545688|83020225|FG000|Follow-Up Period|Death|4|||
46801300|NCT00545688|83020226|FG001|Follow-Up Period|Death|2|||
46801301|NCT00545688|83020227|FG002|Follow-Up Period|Death|2|||
46692630|NCT01214655|82906901|FG002|Part C|Physician Decision|1|||
46692631|NCT01017874|82906949|FG000|Overall Study|Withdrawal by Subject|23|||
46692632|NCT01017874|82906950|FG001|Overall Study|Withdrawal by Subject|20|||
46801302|NCT00545688|83020228|FG003|Follow-Up Period|Death|6|||
46801303|NCT00545688|83020225|FG000|Follow-Up Period|Disease Progression|6|||
46801304|NCT00545688|83020226|FG001|Follow-Up Period|Disease Progression|5|||
46692633|NCT01017874|82906949|FG000|Overall Study|Sponsor decision|3|||
46801305|NCT00545688|83020227|FG002|Follow-Up Period|Disease Progression|9|||
46692634|NCT01017874|82906950|FG001|Overall Study|Sponsor decision|1|||
46692635|NCT01017874|82906949|FG000|Overall Study|Lost to Follow-up|3|||
46692636|NCT01017874|82906950|FG001|Overall Study|Lost to Follow-up|2|||
46692637|NCT01017874|82906949|FG000|Overall Study|Physician Decision|1|||
46692638|NCT01017874|82906950|FG001|Overall Study|Physician Decision|3|||
46692639|NCT01015768|82906956|FG000|Overall Study|Some subject data unuseable|4|||
46692640|NCT01015768|82906957|FG001|Overall Study|Some subject data unuseable|4|||
46692641|NCT04426630|82906965|FG000|Overall Study|Death|4|||
46692642|NCT04426630|82906965|FG000|Overall Study|Lost to Follow-up|2|||
46692643|NCT01010230|82906971|FG000|Overall Study|Withdrawal by Subject|6|||
46692644|NCT01010230|82906972|FG001|Overall Study|Withdrawal by Subject|5|||
46692645|NCT01010230|82906971|FG000|Overall Study|Lost to Follow-up|4|||
46692646|NCT01010230|82906972|FG001|Overall Study|Lost to Follow-up|2|||
46692647|NCT01009840|82906978|FG000|Overall Study|Lost to Follow-up|1|||
46692648|NCT01009840|82906978|FG000|Overall Study|Adverse Event|4|||
46692649|NCT01009840|82906978|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
46692650|NCT01009840|82906978|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
46692651|NCT01009840|82906978|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
46692652|NCT00982657|82906986|FG000|Overall Study|Death|1|||
46692653|NCT00982657|82906987|FG001|Overall Study|Death|0|||
46692654|NCT00982657|82906988|FG002|Overall Study|Death|1|||
46692655|NCT00982657|82906989|FG003|Overall Study|Death|1|||
46692656|NCT00982657|82906986|FG000|Overall Study|Withdrawal by Subject|0|||
46692657|NCT00982657|82906987|FG001|Overall Study|Withdrawal by Subject|0|||
46692658|NCT00982657|82906988|FG002|Overall Study|Withdrawal by Subject|1|||
46692659|NCT00982657|82906989|FG003|Overall Study|Withdrawal by Subject|3|||
46692660|NCT00982657|82906986|FG000|Overall Study|Other|0|||
46692661|NCT00982657|82906987|FG001|Overall Study|Other|0|||
46692662|NCT00982657|82906988|FG002|Overall Study|Other|0|||
46692663|NCT00982657|82906989|FG003|Overall Study|Other|4|||
46692664|NCT00982657|82906986|FG000|Overall Study|On going at date of cut-off|0|||
46692665|NCT00982657|82906987|FG001|Overall Study|On going at date of cut-off|0|||
46692666|NCT00982657|82906988|FG002|Overall Study|On going at date of cut-off|0|||
46692667|NCT00982657|82906989|FG003|Overall Study|On going at date of cut-off|1|||
46692668|NCT01005316|82907012|FG000|Overall Study|Adverse Event|0|||
46692669|NCT01005316|82907013|FG001|Overall Study|Adverse Event|0|||
46692670|NCT01005316|82907014|FG002|Overall Study|Adverse Event|0|||
46692671|NCT01005316|82907015|FG003|Overall Study|Adverse Event|1|||
46692672|NCT01005316|82907012|FG000|Overall Study|Death|20|||
46692673|NCT01005316|82907013|FG001|Overall Study|Death|5|||
46692674|NCT01005316|82907014|FG002|Overall Study|Death|1|||
46692675|NCT01005316|82907015|FG003|Overall Study|Death|15|||
46692676|NCT01005316|82907012|FG000|Overall Study|Study Termination|5|||
46692677|NCT01005316|82907013|FG001|Overall Study|Study Termination|63|||
46692678|NCT01005316|82907014|FG002|Overall Study|Study Termination|9|||
46692679|NCT01005316|82907015|FG003|Overall Study|Study Termination|85|||
46692680|NCT01005316|82907012|FG000|Overall Study|Lost to Follow-up|1|||
46692681|NCT01005316|82907013|FG001|Overall Study|Lost to Follow-up|3|||
46692682|NCT01005316|82907014|FG002|Overall Study|Lost to Follow-up|0|||
46692683|NCT01005316|82907015|FG003|Overall Study|Lost to Follow-up|2|||
46692684|NCT01005316|82907012|FG000|Overall Study|Physician Decision|6|||
46692685|NCT01005316|82907013|FG001|Overall Study|Physician Decision|0|||
46692686|NCT01005316|82907014|FG002|Overall Study|Physician Decision|0|||
46692687|NCT01005316|82907015|FG003|Overall Study|Physician Decision|0|||
46692688|NCT01005316|82907012|FG000|Overall Study|Sponsor Decision|6|||
46692689|NCT01005316|82907013|FG001|Overall Study|Sponsor Decision|3|||
46692690|NCT01005316|82907014|FG002|Overall Study|Sponsor Decision|0|||
46692691|NCT01005316|82907015|FG003|Overall Study|Sponsor Decision|0|||
46692692|NCT01005316|82907012|FG000|Overall Study|Withdrawal by Subject|1|||
46692693|NCT01005316|82907013|FG001|Overall Study|Withdrawal by Subject|1|||
46692694|NCT01005316|82907014|FG002|Overall Study|Withdrawal by Subject|0|||
46692695|NCT01005316|82907015|FG003|Overall Study|Withdrawal by Subject|2|||
46692696|NCT01005316|82907012|FG000|Overall Study|Consented to Another Study|2|||
46692697|NCT01005316|82907013|FG001|Overall Study|Consented to Another Study|0|||
46692698|NCT01005316|82907014|FG002|Overall Study|Consented to Another Study|0|||
46801306|NCT00545688|83020228|FG003|Follow-Up Period|Disease Progression|9|||
46801307|NCT00545688|83020225|FG000|Follow-Up Period|Refused Treatment|6|||
46801308|NCT00545688|83020226|FG001|Follow-Up Period|Refused Treatment|2|||
46801309|NCT00545688|83020227|FG002|Follow-Up Period|Refused Treatment|0|||
46801310|NCT00545688|83020228|FG003|Follow-Up Period|Refused Treatment|2|||
46801311|NCT00545688|83020225|FG000|Follow-Up Period|Lost to Follow-up|3|||
46801312|NCT00545688|83020226|FG001|Follow-Up Period|Lost to Follow-up|3|||
46801313|NCT00545688|83020227|FG002|Follow-Up Period|Lost to Follow-up|3|||
46801314|NCT00545688|83020228|FG003|Follow-Up Period|Lost to Follow-up|1|||
46801315|NCT00545688|83020225|FG000|Follow-Up Period|Unspecified Reason|2|||
46801316|NCT00545688|83020226|FG001|Follow-Up Period|Unspecified Reason|5|||
46801317|NCT00545688|83020227|FG002|Follow-Up Period|Unspecified Reason|6|||
46801318|NCT00545688|83020228|FG003|Follow-Up Period|Unspecified Reason|8|||
46801319|NCT00545688|83020225|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
46801320|NCT00545688|83020226|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
46801321|NCT00545688|83020227|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
46801322|NCT00545688|83020228|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
46801323|NCT00502203|83020241|FG000|Overall Study|Inevaluable|1|||
46801324|NCT00546078|83020247|FG000|Overall Study|Lost to Follow-up|1|||
46801325|NCT00546078|83020248|FG001|Overall Study|Lost to Follow-up|3|||
46801326|NCT00546078|83020247|FG000|Overall Study|Withdrawal by Subject|2|||
46801327|NCT00546078|83020248|FG001|Overall Study|Withdrawal by Subject|3|||
46801328|NCT00546078|83020247|FG000|Overall Study|Other reason|1|||
46801329|NCT00546078|83020248|FG001|Overall Study|Other reason|1|||
46801330|NCT00546000|83020254|FG000|Overall Study|Adverse Event|1|||
46801331|NCT00546000|83020254|FG000|Overall Study|Lost to Follow-up|1|||
46801332|NCT00546000|83020254|FG000|Overall Study|Baseline HPA Axis Supression|2|||
46801333|NCT00501969|83020258|FG000|Overall Study|Major Protocol Violation|4|||
46801334|NCT00501969|83020258|FG000|Overall Study|Lack of Efficacy|29|||
46801335|NCT00501969|83020258|FG000|Overall Study|Adverse Event|76|||
46801336|NCT00501969|83020258|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
46858915|NCT00056160|83074727|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
46858916|NCT00056160|83074728|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
46982011|NCT02343939|83228204|FG006|Overall Study|Withdrew consent|0|||
46692699|NCT01005316|82907015|FG003|Overall Study|Consented to Another Study|0|||
46692700|NCT01005316|82907012|FG000|Overall Study|Delisted|8|||
46692701|NCT01005316|82907013|FG001|Overall Study|Delisted|0|||
46692702|NCT01005316|82907014|FG002|Overall Study|Delisted|0|||
46801337|NCT00501969|83020258|FG000|Overall Study|Subject withdrew consent|51|||
46801338|NCT00501969|83020258|FG000|Overall Study|Lost to Follow-up|4|||
46801339|NCT00501969|83020258|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
46801340|NCT00501969|83020258|FG000|Overall Study|Other: Sponsors Request|10|||
46801341|NCT00501969|83020258|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
46801342|NCT00501969|83020258|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
46801343|NCT00501969|83020258|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
46692703|NCT01005316|82907015|FG003|Overall Study|Delisted|0|||
46692704|NCT01005316|82907012|FG000|Overall Study|Transferred Care|1|||
46692705|NCT01005316|82907013|FG001|Overall Study|Transferred Care|0|||
46692706|NCT01005316|82907014|FG002|Overall Study|Transferred Care|1|||
46692707|NCT01005316|82907015|FG003|Overall Study|Transferred Care|3|||
46692708|NCT01005316|82907012|FG000|Overall Study|Retransplanted|0|||
46692709|NCT01005316|82907013|FG001|Overall Study|Retransplanted|1|||
46692710|NCT01005316|82907014|FG002|Overall Study|Retransplanted|0|||
46692711|NCT01005316|82907015|FG003|Overall Study|Retransplanted|0|||
46692712|NCT01004848|82907028|FG000|Overall Study|Lost to Follow-up|55|||
46692713|NCT01004848|82907029|FG001|Overall Study|Lost to Follow-up|45|||
46692714|NCT01009294|82907037|FG000|Overall Study|Study discontinued by Sponsor|6|||
46692715|NCT01009060|82907043|FG000|Overall Study|Adverse Event|1|||
46692716|NCT01009060|82907044|FG001|Overall Study|Adverse Event|2|||
46692717|NCT01009060|82907043|FG000|Overall Study|Protocol Violation|0|||
46692718|NCT01009060|82907044|FG001|Overall Study|Protocol Violation|1|||
46692719|NCT01009060|82907043|FG000|Overall Study|Lost to Follow-up|1|||
46692720|NCT01009060|82907044|FG001|Overall Study|Lost to Follow-up|0|||
46692721|NCT01009060|82907043|FG000|Overall Study|Physician Decision|1|||
46692722|NCT01009060|82907044|FG001|Overall Study|Physician Decision|1|||
46692723|NCT01009060|82907043|FG000|Overall Study|Withdrawal by Subject|1|||
46692724|NCT01009060|82907044|FG001|Overall Study|Withdrawal by Subject|1|||
46692725|NCT00988429|82907057|FG000|Overall Study|Adverse Event|9|||
46692726|NCT00988429|82907058|FG001|Overall Study|Adverse Event|21|||
46692727|NCT00988429|82907059|FG002|Overall Study|Adverse Event|45|||
46692728|NCT00988429|82907057|FG000|Overall Study|Lack of Efficacy|0|||
46692729|NCT00988429|82907058|FG001|Overall Study|Lack of Efficacy|0|||
46692730|NCT00988429|82907059|FG002|Overall Study|Lack of Efficacy|1|||
46692731|NCT00988429|82907057|FG000|Overall Study|Non-Compliance with Study Drug|5|||
46692732|NCT00988429|82907058|FG001|Overall Study|Non-Compliance with Study Drug|1|||
46692733|NCT00988429|82907059|FG002|Overall Study|Non-Compliance with Study Drug|3|||
46692734|NCT00988429|82907057|FG000|Overall Study|Physician Decision|1|||
46692735|NCT00988429|82907058|FG001|Overall Study|Physician Decision|0|||
46692736|NCT00988429|82907059|FG002|Overall Study|Physician Decision|3|||
46692737|NCT00988429|82907057|FG000|Overall Study|Pregnancy|2|||
46692738|NCT00988429|82907058|FG001|Overall Study|Pregnancy|1|||
46692739|NCT00988429|82907059|FG002|Overall Study|Pregnancy|0|||
46692740|NCT00988429|82907057|FG000|Overall Study|Protocol Violation|4|||
46692741|NCT00988429|82907058|FG001|Overall Study|Protocol Violation|3|||
46692742|NCT00988429|82907059|FG002|Overall Study|Protocol Violation|3|||
46692743|NCT00988429|82907057|FG000|Overall Study|Withdrawal by Subject|7|||
46692744|NCT00988429|82907058|FG001|Overall Study|Withdrawal by Subject|7|||
46692745|NCT00988429|82907059|FG002|Overall Study|Withdrawal by Subject|12|||
46692746|NCT00988429|82907057|FG000|Overall Study|Administrative Reasons|1|||
46692747|NCT00988429|82907058|FG001|Overall Study|Administrative Reasons|2|||
46692748|NCT00988429|82907059|FG002|Overall Study|Administrative Reasons|1|||
46692749|NCT00988429|82907057|FG000|Overall Study|other reasons|8|||
46692750|NCT00988429|82907058|FG001|Overall Study|other reasons|8|||
46692751|NCT00988429|82907059|FG002|Overall Study|other reasons|1|||
46692752|NCT01008904|82907068|FG000|Overall Study|Lost to Follow-up|1|||
46692753|NCT01008904|82907068|FG000|Overall Study|Adverse Event|2|||
46692754|NCT01008904|82907068|FG000|Overall Study|unexpected unrelated surgery|1|||
46692755|NCT01004614|82907076|FG000|Washout|Withdrawal by Subject|0|||
46982012|NCT02343939|83228205|FG007|Overall Study|Withdrew consent|8|||
46692756|NCT01004614|82907077|FG001|Washout|Withdrawal by Subject|1|||
46692757|NCT01004614|82907078|FG002|Washout|Withdrawal by Subject|0|||
46692758|NCT01004614|82907079|FG003|Washout|Withdrawal by Subject|0|||
46692759|NCT00981409|82907091|FG000|Overall Study|Adverse Event|4|||
46692760|NCT00981409|82907092|FG001|Overall Study|Adverse Event|0|||
46692761|NCT00981409|82907091|FG000|Overall Study|Protocol Violation|0|||
46692762|NCT00981409|82907092|FG001|Overall Study|Protocol Violation|1|||
46692763|NCT00981409|82907091|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
46692764|NCT00981409|82907092|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
46692765|NCT01008748|82907098|FG000|Overall Study|Lost to Follow-up|80|||
46692766|NCT01008748|82907098|FG000|Overall Study|Other|1|||
46692767|NCT01004146|82907104|FG000|Overall Study|Withdrawal by Subject|4|||
46692768|NCT01004146|82907105|FG001|Overall Study|Withdrawal by Subject|5|||
46692769|NCT01012414|82907111|FG000|Overall Study|Withdrawal by Subject|2|||
46692770|NCT01012414|82907111|FG000|Overall Study|Lost to Follow-up|1|||
46692771|NCT01012414|82907111|FG000|Overall Study|Trial was stopped before completed|7|||
46692772|NCT00975715|82907119|FG000|Titration Period|Adverse Event|6|||
46692773|NCT00975715|82907120|FG001|Titration Period|Adverse Event|0|||
46692774|NCT00975715|82907119|FG000|Titration Period|Protocol Violation|1|||
46692775|NCT00975715|82907120|FG001|Titration Period|Protocol Violation|0|||
46692776|NCT00975715|82907119|FG000|Maintenance Period|Adverse Event|2|||
46692777|NCT00975715|82907120|FG001|Maintenance Period|Adverse Event|1|||
46692778|NCT03962491|82907128|FG000|Overall Study|Lost to Follow-up|4|||
46692779|NCT03962491|82907129|FG001|Overall Study|Lost to Follow-up|5|||
46692780|NCT00978757|82907137|FG000|Overall Study|Physician Decision|1|||
46692781|NCT00978757|82907138|FG001|Overall Study|Physician Decision|3|||
46692782|NCT01214421|82907148|FG000|Overall Study|Lost to Follow-up|7|||
46692783|NCT01214421|82907149|FG001|Overall Study|Lost to Follow-up|3|||
46692784|NCT01214421|82907150|FG002|Overall Study|Lost to Follow-up|7|||
46692785|NCT01214421|82907151|FG003|Overall Study|Lost to Follow-up|3|||
46692786|NCT01214421|82907148|FG000|Overall Study|Adverse Event|16|||
46692787|NCT01214421|82907149|FG001|Overall Study|Adverse Event|35|||
46692788|NCT01214421|82907150|FG002|Overall Study|Adverse Event|14|||
46692789|NCT01214421|82907151|FG003|Overall Study|Adverse Event|3|||
46692790|NCT01214421|82907148|FG000|Overall Study|Sponsor Discontinued Site|1|||
46692791|NCT01214421|82907149|FG001|Overall Study|Sponsor Discontinued Site|2|||
46692792|NCT01214421|82907150|FG002|Overall Study|Sponsor Discontinued Site|0|||
46692793|NCT01214421|82907151|FG003|Overall Study|Sponsor Discontinued Site|0|||
46692794|NCT01214421|82907148|FG000|Overall Study|Withdrawal Criteria Met|3|||
46692795|NCT01214421|82907149|FG001|Overall Study|Withdrawal Criteria Met|0|||
46692796|NCT01214421|82907150|FG002|Overall Study|Withdrawal Criteria Met|2|||
46692797|NCT01214421|82907151|FG003|Overall Study|Withdrawal Criteria Met|1|||
46692798|NCT01214421|82907148|FG000|Overall Study|Physician Decision|2|||
46692799|NCT01214421|82907149|FG001|Overall Study|Physician Decision|0|||
46692800|NCT01214421|82907150|FG002|Overall Study|Physician Decision|4|||
46692801|NCT01214421|82907151|FG003|Overall Study|Physician Decision|0|||
46692802|NCT01214421|82907148|FG000|Overall Study|Withdrawal by Subject|21|||
46692803|NCT01214421|82907149|FG001|Overall Study|Withdrawal by Subject|18|||
46692804|NCT01214421|82907150|FG002|Overall Study|Withdrawal by Subject|11|||
46692805|NCT01214421|82907151|FG003|Overall Study|Withdrawal by Subject|2|||
46692806|NCT04102111|82907163|FG000|Overall Study|Withdrawal by Subject|2|||
46692807|NCT04102111|82907164|FG001|Overall Study|Withdrawal by Subject|3|||
46801344|NCT00501969|83020258|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
46801345|NCT00501969|83020258|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
46801346|NCT00501969|83020258|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
46692808|NCT04102111|82907163|FG000|Overall Study|Adverse Event|1|||
46692809|NCT04102111|82907164|FG001|Overall Study|Adverse Event|1|||
46801347|NCT00501969|83020258|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
46801348|NCT00501969|83020258|FG000|Overall Study|Other: As Required by Local EC|2|||
46692810|NCT04102111|82907163|FG000|Overall Study|Study terminated by sponsor|1|||
46692811|NCT04102111|82907164|FG001|Overall Study|Study terminated by sponsor|3|||
46692812|NCT01214187|82907172|FG000|Overall Study|Adverse Event|6|||
46692813|NCT01214187|82907173|FG001|Overall Study|Adverse Event|2|||
46692814|NCT01214187|82907172|FG000|Overall Study|Death|1|||
46692815|NCT01214187|82907173|FG001|Overall Study|Death|1|||
46692816|NCT01214187|82907172|FG000|Overall Study|Withdrawal by Subject|0|||
46692817|NCT01214187|82907173|FG001|Overall Study|Withdrawal by Subject|3|||
46692818|NCT01003990|82907182|FG000|Overall Study|Adverse Event|8|||
46692819|NCT01003990|82907183|FG001|Overall Study|Adverse Event|5|||
46692820|NCT01003990|82907184|FG002|Overall Study|Adverse Event|11|||
46692821|NCT01003990|82907182|FG000|Overall Study|Death|0|||
46692822|NCT01003990|82907183|FG001|Overall Study|Death|8|||
46692823|NCT01003990|82907184|FG002|Overall Study|Death|1|||
46692824|NCT01003990|82907182|FG000|Overall Study|Lack of Efficacy|10|||
46692825|NCT01003990|82907183|FG001|Overall Study|Lack of Efficacy|2|||
46692826|NCT01003990|82907184|FG002|Overall Study|Lack of Efficacy|3|||
46692827|NCT01003990|82907182|FG000|Overall Study|Lost to Follow-up|30|||
46692828|NCT01003990|82907183|FG001|Overall Study|Lost to Follow-up|12|||
46692829|NCT01003990|82907184|FG002|Overall Study|Lost to Follow-up|7|||
46692830|NCT01003990|82907182|FG000|Overall Study|Reasons Not Identified|14|||
46692831|NCT01003990|82907183|FG001|Overall Study|Reasons Not Identified|13|||
46692832|NCT01003990|82907184|FG002|Overall Study|Reasons Not Identified|8|||
46692833|NCT01003990|82907182|FG000|Overall Study|Poor/Non-compliance|4|||
46692834|NCT01003990|82907183|FG001|Overall Study|Poor/Non-compliance|3|||
46692835|NCT01003990|82907184|FG002|Overall Study|Poor/Non-compliance|2|||
46692836|NCT01003990|82907182|FG000|Overall Study|Pregnancy|10|||
46692837|NCT01003990|82907183|FG001|Overall Study|Pregnancy|2|||
46692838|NCT01003990|82907184|FG002|Overall Study|Pregnancy|4|||
46692839|NCT01003990|82907182|FG000|Overall Study|No Longer Met Study Criteria|4|||
46692840|NCT01003990|82907183|FG001|Overall Study|No Longer Met Study Criteria|1|||
46692841|NCT01003990|82907184|FG002|Overall Study|No Longer Met Study Criteria|0|||
46692842|NCT01003990|82907182|FG000|Overall Study|Subject Withdrew Consent|12|||
46692843|NCT01003990|82907183|FG001|Overall Study|Subject Withdrew Consent|5|||
46982013|NCT02343939|83228206|FG008|Overall Study|Withdrew consent|6|||
46692844|NCT01003990|82907184|FG002|Overall Study|Subject Withdrew Consent|7|||
46692845|NCT01003210|82907194|FG000|Overall Study|Lost to Follow-up|1|||
46692846|NCT01003210|82907195|FG001|Overall Study|Lost to Follow-up|3|||
46692847|NCT01002820|82907201|FG000|Overall Study|Adverse Event|1|||
46692848|NCT01002820|82907201|FG000|Overall Study|Withdrawal by Subject|2|||
46692849|NCT01002820|82907201|FG000|Overall Study|Lack of Efficacy|1|||
46982014|NCT02343939|83228198|FG000|Overall Study|Treatment failure|0|||
46982015|NCT02343939|83228199|FG001|Overall Study|Treatment failure|0|||
46692850|NCT01012258|82907205|FG000|Overall Study|Death|14|||
46692851|NCT01012258|82907205|FG000|Overall Study|Lost to Follow-up|1|||
46692852|NCT01012258|82907205|FG000|Overall Study|Adverse Event|1|||
46692853|NCT01012258|82907205|FG000|Overall Study|Progressive Disease (PD)|18|||
46692854|NCT01012258|82907205|FG000|Overall Study|Symptomatic Deterioration|1|||
46692855|NCT01012258|82907205|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
46692856|NCT01012258|82907205|FG000|Overall Study|Another Tumor Discovered|1|||
46692857|NCT01012258|82907205|FG000|Overall Study|Ongoing|29|||
46692858|NCT01011946|82907210|FG000|Overall Study|Transferred to another hospital|2|||
46692859|NCT01011946|82907210|FG000|Overall Study|No pathological lab value|1|||
46692860|NCT00975481|82907214|FG000|Second Intervention Period|Adverse Event|2|||
46692861|NCT00975481|82907215|FG001|Second Intervention Period|Adverse Event|1|||
46692862|NCT00975481|82907216|FG002|Second Intervention Period|Adverse Event|0|||
46692863|NCT00975481|82907217|FG003|Second Intervention Period|Adverse Event|0|||
46692864|NCT00975481|82907218|FG004|Second Intervention Period|Adverse Event|0|||
46692865|NCT00975481|82907219|FG005|Second Intervention Period|Adverse Event|0|||
46692866|NCT00975481|82907214|FG000|Second Intervention Period|Withdrawal by Subject|0|||
46692867|NCT00975481|82907215|FG001|Second Intervention Period|Withdrawal by Subject|0|||
46692868|NCT00975481|82907216|FG002|Second Intervention Period|Withdrawal by Subject|1|||
46692869|NCT00975481|82907217|FG003|Second Intervention Period|Withdrawal by Subject|0|||
46692870|NCT00975481|82907218|FG004|Second Intervention Period|Withdrawal by Subject|0|||
46692871|NCT00975481|82907219|FG005|Second Intervention Period|Withdrawal by Subject|0|||
46692872|NCT00975481|82907214|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
46692873|NCT00975481|82907215|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
46801349|NCT00501969|83020258|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
46801350|NCT00501969|83020258|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
46801351|NCT03942042|83020264|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
46801352|NCT03942042|83020265|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
46801353|NCT03942042|83020264|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
46801354|NCT03942042|83020265|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
46801355|NCT00104299|83020277|FG000|Overall Study|Adverse Event|3|||
46801356|NCT00104299|83020278|FG001|Overall Study|Adverse Event|1|||
46801357|NCT00104299|83020277|FG000|Overall Study|Death|2|||
46801358|NCT00104299|83020278|FG001|Overall Study|Death|2|||
46801359|NCT00104299|83020277|FG000|Overall Study|Withdrawal by Subject|2|||
46801360|NCT00104299|83020278|FG001|Overall Study|Withdrawal by Subject|6|||
46801361|NCT00104299|83020277|FG000|Overall Study|Physician Decision|1|||
46801362|NCT00104299|83020278|FG001|Overall Study|Physician Decision|1|||
46801363|NCT00104299|83020277|FG000|Overall Study|To have renal transplant|1|||
46801364|NCT00104299|83020278|FG001|Overall Study|To have renal transplant|0|||
46801365|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
46801366|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
46801367|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
46801368|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
46801369|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
46801370|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
46801371|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
46801372|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
46801373|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
46801374|NCT03939312|83020284|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
46801375|NCT03939312|83020284|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
46692874|NCT00975481|82907216|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
46692875|NCT00975481|82907217|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
46692876|NCT00975481|82907218|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
46692877|NCT00975481|82907219|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
46801376|NCT03939312|83020284|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
46801377|NCT00082381|83020292|FG000|Overall Study|Adverse Event|27|||
46801378|NCT00082381|83020293|FG001|Overall Study|Adverse Event|2|||
46801379|NCT00082381|83020292|FG000|Overall Study|Lost to Follow-up|5|||
46801380|NCT00082381|83020293|FG001|Overall Study|Lost to Follow-up|7|||
46801381|NCT00082381|83020292|FG000|Overall Study|Patient Decision|8|||
46801382|NCT00082381|83020293|FG001|Overall Study|Patient Decision|4|||
46692878|NCT00975481|82907214|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
46692879|NCT00975481|82907215|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
46692880|NCT00975481|82907216|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
46692881|NCT00975481|82907217|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
46692882|NCT00975481|82907218|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
46692883|NCT00975481|82907219|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
46692884|NCT01011868|82907240|FG000|After Week 18 Follow-up|Adverse Event|8|||
46692885|NCT01011868|82907241|FG001|After Week 18 Follow-up|Adverse Event|6|||
46692886|NCT01011868|82907242|FG002|After Week 18 Follow-up|Adverse Event|13|||
46692887|NCT01011868|82907240|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
46692888|NCT01011868|82907241|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
46692889|NCT01011868|82907242|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
46692890|NCT01011868|82907240|FG000|After Week 18 Follow-up|Protocol Violation|1|||
46692891|NCT01011868|82907241|FG001|After Week 18 Follow-up|Protocol Violation|1|||
46692892|NCT01011868|82907242|FG002|After Week 18 Follow-up|Protocol Violation|1|||
46692893|NCT01011868|82907240|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
46692894|NCT01011868|82907241|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
46692895|NCT01011868|82907242|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
46692896|NCT01011868|82907240|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
46692897|NCT01011868|82907241|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
46692898|NCT01011868|82907242|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
46692899|NCT01011868|82907240|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
46692900|NCT01011868|82907241|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
46692901|NCT01011868|82907242|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
46692902|NCT01011868|82907240|FG000|After Week 78 Follow-up|Adverse Event|14|||
46692903|NCT01011868|82907241|FG001|After Week 78 Follow-up|Adverse Event|18|||
46692904|NCT01011868|82907242|FG002|After Week 78 Follow-up|Adverse Event|21|||
46692905|NCT01011868|82907240|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
46801383|NCT00082381|83020292|FG000|Overall Study|Physician Decision|1|||
46801384|NCT00082381|83020293|FG001|Overall Study|Physician Decision|2|||
46801385|NCT00082381|83020292|FG000|Overall Study|Protocol Violation|10|||
46801386|NCT00082381|83020293|FG001|Overall Study|Protocol Violation|11|||
46801387|NCT00082381|83020292|FG000|Overall Study|Loss of Glucose Control|4|||
46801388|NCT00082381|83020293|FG001|Overall Study|Loss of Glucose Control|0|||
46858917|NCT00056160|83074727|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
46858918|NCT00056160|83074728|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
46858919|NCT00056160|83074727|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
46858920|NCT00056160|83074728|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
46858921|NCT00056160|83074727|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
46858922|NCT00056160|83074728|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
46858923|NCT00056160|83074727|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
46858924|NCT00056160|83074728|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
46858925|NCT00056160|83074727|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
46858926|NCT00056160|83074728|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
46858927|NCT00056160|83074727|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
46858928|NCT00056160|83074728|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
46858929|NCT00056160|83074727|FG000|Final Follow-up|Transferred into expanded access study.|3|||
46858930|NCT00056160|83074728|FG001|Final Follow-up|Transferred into expanded access study.|0|||
46858931|NCT00056160|83074727|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
46858932|NCT00056160|83074728|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
46858933|NCT00056160|83074727|FG000|Final Follow-up|Adverse Event|1|||
46858934|NCT00056160|83074728|FG001|Final Follow-up|Adverse Event|0|||
46858935|NCT00061932|83074736|FG000|Overall Study|Withdrawal by Subject|13|||
46858936|NCT00061932|83074737|FG001|Overall Study|Withdrawal by Subject|4|||
46858937|NCT04984889|83074779|FG000|Extension Part|Ongoing|5|||
46858938|NCT04769739|83074805|FG000|Overall Study|Colorectal cancer obstruction|2|||
46858939|NCT04769739|83074806|FG001|Overall Study|Colorectal cancer obstruction|0|||
46858940|NCT04769739|83074807|FG002|Overall Study|Colorectal cancer obstruction|0|||
46858941|NCT04769739|83074808|FG003|Overall Study|Colorectal cancer obstruction|0|||
46692906|NCT01011868|82907241|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
46692907|NCT01011868|82907242|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
46692908|NCT01011868|82907240|FG000|After Week 78 Follow-up|Protocol Violation|9|||
46692909|NCT01011868|82907241|FG001|After Week 78 Follow-up|Protocol Violation|1|||
46858942|NCT04769739|83074805|FG000|Overall Study|Failed cecal intubation|1|||
46858943|NCT04769739|83074806|FG001|Overall Study|Failed cecal intubation|0|||
46858944|NCT04769739|83074807|FG002|Overall Study|Failed cecal intubation|0|||
46858945|NCT04769739|83074808|FG003|Overall Study|Failed cecal intubation|1|||
46858946|NCT04769739|83074805|FG000|Overall Study|Poor bowel preparation|0|||
46858947|NCT04769739|83074806|FG001|Overall Study|Poor bowel preparation|0|||
46858948|NCT04769739|83074807|FG002|Overall Study|Poor bowel preparation|0|||
46692910|NCT01011868|82907242|FG002|After Week 78 Follow-up|Protocol Violation|2|||
46692911|NCT01011868|82907240|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
46692912|NCT01011868|82907241|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
46692913|NCT01011868|82907242|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
46692914|NCT01011868|82907240|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
46692915|NCT01011868|82907241|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
46692916|NCT01011868|82907242|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
46692917|NCT01011868|82907240|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
46692918|NCT01011868|82907241|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
46692919|NCT01011868|82907242|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
46692920|NCT01213251|82907253|FG000|Overall Study|Death|2|||
46692921|NCT01213251|82907254|FG001|Overall Study|Death|1|||
46692922|NCT01213251|82907255|FG002|Overall Study|Death|2|||
46692923|NCT01213251|82907253|FG000|Overall Study|Exit|3|||
46692924|NCT01213251|82907254|FG001|Overall Study|Exit|2|||
46692925|NCT01213251|82907255|FG002|Overall Study|Exit|8|||
46692926|NCT01213251|82907253|FG000|Overall Study|Protocol Violation|1|||
46692927|NCT01213251|82907254|FG001|Overall Study|Protocol Violation|1|||
46692928|NCT01213251|82907255|FG002|Overall Study|Protocol Violation|0|||
46692929|NCT01213251|82907253|FG000|Overall Study|Missed 18-Month Follow-up|0|||
46692930|NCT01213251|82907254|FG001|Overall Study|Missed 18-Month Follow-up|0|||
46692931|NCT01213251|82907255|FG002|Overall Study|Missed 18-Month Follow-up|1|||
46692932|NCT01213173|82907270|FG000|Overall Study|Protocol Violation|2|||
46692933|NCT01213173|82907271|FG001|Overall Study|Protocol Violation|0|||
46692934|NCT01213173|82907270|FG000|Overall Study|Adverse Event|4|||
46692935|NCT01213173|82907271|FG001|Overall Study|Adverse Event|8|||
46801389|NCT00545844|83020299|FG000|Overall Study|Lost to Follow-up|9|||
46801390|NCT00545844|83020299|FG000|Overall Study|Protocol Violation|1|||
46801391|NCT00545844|83020299|FG000|Overall Study|Withdrawal by Subject|2|||
46801392|NCT00492063|83020309|FG000|Overall Study|Death|0|||
46801393|NCT00492063|83020310|FG001|Overall Study|Death|0|||
46801394|NCT00492063|83020311|FG002|Overall Study|Death|1|||
46801395|NCT00492063|83020312|FG003|Overall Study|Death|2|||
46801396|NCT00492063|83020309|FG000|Overall Study|Withdrawal by Subject|4|||
46801397|NCT00492063|83020310|FG001|Overall Study|Withdrawal by Subject|3|||
46801398|NCT00492063|83020311|FG002|Overall Study|Withdrawal by Subject|5|||
46692936|NCT01213173|82907270|FG000|Overall Study|Withdrawal by Subject|5|||
46982016|NCT02343939|83228200|FG002|Overall Study|Treatment failure|0|||
46692937|NCT01213173|82907271|FG001|Overall Study|Withdrawal by Subject|5|||
46801399|NCT00492063|83020312|FG003|Overall Study|Withdrawal by Subject|4|||
46801400|NCT00492063|83020309|FG000|Overall Study|Lost to Follow-up|6|||
46801401|NCT00492063|83020310|FG001|Overall Study|Lost to Follow-up|11|||
46801402|NCT00492063|83020311|FG002|Overall Study|Lost to Follow-up|5|||
46801403|NCT00492063|83020312|FG003|Overall Study|Lost to Follow-up|3|||
46801404|NCT00492063|83020309|FG000|Overall Study|Protocol Violation|0|||
46801405|NCT00492063|83020310|FG001|Overall Study|Protocol Violation|0|||
46801406|NCT00492063|83020311|FG002|Overall Study|Protocol Violation|0|||
46801407|NCT00492063|83020312|FG003|Overall Study|Protocol Violation|1|||
46801408|NCT00093145|83020322|FG000|Overall Study|Unacceptable Toxicity Only|2|||
46801409|NCT00093145|83020322|FG000|Overall Study|Physician Decision|5|||
46801410|NCT00093145|83020322|FG000|Overall Study|Withdrawal by Subject|9|||
46801411|NCT00093145|83020322|FG000|Overall Study|Other|1|||
46801412|NCT00513357|83020328|FG000|Overall Study|did not receive allocated placebo|2|||
46801413|NCT00513357|83020329|FG001|Overall Study|did not receive allocated placebo|3|||
46801414|NCT00513357|83020328|FG000|Overall Study|Adverse Event|4|||
46692938|NCT01213173|82907270|FG000|Overall Study|Incorrect Enrollment|1|||
46692939|NCT01213173|82907271|FG001|Overall Study|Incorrect Enrollment|3|||
46692940|NCT01212159|82907279|FG000|Overall Study|Withdrawal by Subject|12|||
46692941|NCT01212159|82907280|FG001|Overall Study|Withdrawal by Subject|12|||
46692942|NCT00973765|82907288|FG000|Overall Study|Lost to Follow-up|8|||
46692943|NCT00973765|82907289|FG001|Overall Study|Lost to Follow-up|14|||
46692944|NCT01211769|82907299|FG000|Overall Study|Lost to Follow-up|7|||
46692945|NCT01211769|82907300|FG001|Overall Study|Lost to Follow-up|9|||
46692946|NCT01211769|82907301|FG002|Overall Study|Lost to Follow-up|5|||
46692947|NCT01211769|82907302|FG003|Overall Study|Lost to Follow-up|9|||
46692948|NCT01211769|82907299|FG000|Overall Study|Physician Decision|2|||
46692949|NCT01211769|82907300|FG001|Overall Study|Physician Decision|0|||
46692950|NCT01211769|82907301|FG002|Overall Study|Physician Decision|2|||
46692951|NCT01211769|82907302|FG003|Overall Study|Physician Decision|1|||
46692952|NCT01211769|82907299|FG000|Overall Study|Adverse Event|0|||
46692953|NCT01211769|82907300|FG001|Overall Study|Adverse Event|1|||
46692954|NCT01211769|82907301|FG002|Overall Study|Adverse Event|1|||
46692955|NCT01211769|82907302|FG003|Overall Study|Adverse Event|1|||
46692956|NCT01211613|82907315|FG000|Overall Study|Lost to Follow-up|2|||
46692957|NCT01211613|82907316|FG001|Overall Study|Lost to Follow-up|2|||
46692958|NCT01211613|82907317|FG002|Overall Study|Lost to Follow-up|2|||
46692959|NCT01211613|82907315|FG000|Overall Study|Withdrawal by Subject|1|||
46692960|NCT01211613|82907316|FG001|Overall Study|Withdrawal by Subject|0|||
46692961|NCT01211613|82907317|FG002|Overall Study|Withdrawal by Subject|0|||
46692962|NCT01211535|82907327|FG000|Overall Study|Adverse Event|0|||
46692963|NCT01211535|82907328|FG001|Overall Study|Adverse Event|1|||
46692964|NCT01011556|82907338|FG000|Overall Study|Adverse Event|1|||
46692965|NCT01011556|82907339|FG001|Overall Study|Adverse Event|3|||
46692966|NCT01011556|82907340|FG002|Overall Study|Adverse Event|2|||
46692967|NCT01011556|82907341|FG003|Overall Study|Adverse Event|1|||
46801415|NCT00513357|83020329|FG001|Overall Study|Adverse Event|2|||
46801416|NCT00513357|83020328|FG000|Overall Study|Death|2|||
46801417|NCT00513357|83020329|FG001|Overall Study|Death|0|||
46801418|NCT00513357|83020328|FG000|Overall Study|Withdrawal by Subject|5|||
46692968|NCT01011556|82907338|FG000|Overall Study|Lost to Follow-up|1|||
46692969|NCT01011556|82907339|FG001|Overall Study|Lost to Follow-up|0|||
46692970|NCT01011556|82907340|FG002|Overall Study|Lost to Follow-up|0|||
46692971|NCT01011556|82907341|FG003|Overall Study|Lost to Follow-up|0|||
46692972|NCT01011556|82907338|FG000|Overall Study|Physician Decision|1|||
46801419|NCT00513357|83020329|FG001|Overall Study|Withdrawal by Subject|4|||
46801420|NCT00513357|83020328|FG000|Overall Study|Disease Progression|2|||
46801421|NCT00513357|83020329|FG001|Overall Study|Disease Progression|1|||
46692973|NCT01011556|82907339|FG001|Overall Study|Physician Decision|0|||
46692974|NCT01011556|82907340|FG002|Overall Study|Physician Decision|0|||
46801422|NCT03933462|83020335|FG000|Overall Study|Adverse Event|2|||
46801423|NCT03933462|83020336|FG001|Overall Study|Adverse Event|0|||
46692975|NCT01011556|82907341|FG003|Overall Study|Physician Decision|1|||
46692976|NCT01011556|82907338|FG000|Overall Study|Protocol Violation|0|||
46692977|NCT01011556|82907339|FG001|Overall Study|Protocol Violation|1|||
46692978|NCT01011556|82907340|FG002|Overall Study|Protocol Violation|0|||
46692979|NCT01011556|82907341|FG003|Overall Study|Protocol Violation|0|||
46692980|NCT01011556|82907338|FG000|Overall Study|Withdrawal by Subject|1|||
46692981|NCT01011556|82907339|FG001|Overall Study|Withdrawal by Subject|2|||
46692982|NCT01011556|82907340|FG002|Overall Study|Withdrawal by Subject|4|||
46692983|NCT01011556|82907341|FG003|Overall Study|Withdrawal by Subject|4|||
46692984|NCT01011556|82907338|FG000|Overall Study|Sponsor decision|0|||
46692985|NCT01011556|82907339|FG001|Overall Study|Sponsor decision|1|||
46692986|NCT01011556|82907340|FG002|Overall Study|Sponsor decision|1|||
46692987|NCT01011556|82907341|FG003|Overall Study|Sponsor decision|2|||
46692988|NCT01011556|82907338|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
46692989|NCT01011556|82907339|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
46692990|NCT01011556|82907340|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
46692991|NCT01011556|82907341|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
46692992|NCT01211145|82907358|FG000|Overall Study|Reason not specified|3|||
46692993|NCT01211145|82907359|FG001|Overall Study|Reason not specified|2|||
46692994|NCT01211145|82907360|FG002|Overall Study|Reason not specified|2|||
46692995|NCT01211145|82907361|FG003|Overall Study|Reason not specified|1|||
46692996|NCT01211145|82907358|FG000|Overall Study|Lost to Follow-up|3|||
46692997|NCT01211145|82907359|FG001|Overall Study|Lost to Follow-up|2|||
46692998|NCT01211145|82907360|FG002|Overall Study|Lost to Follow-up|1|||
46692999|NCT01211145|82907361|FG003|Overall Study|Lost to Follow-up|2|||
46693000|NCT01211145|82907358|FG000|Overall Study|Study-specific withdrawal criteria|1|||
46693001|NCT01211145|82907359|FG001|Overall Study|Study-specific withdrawal criteria|0|||
46693002|NCT01211145|82907360|FG002|Overall Study|Study-specific withdrawal criteria|0|||
46693003|NCT01211145|82907361|FG003|Overall Study|Study-specific withdrawal criteria|0|||
46693004|NCT01211145|82907358|FG000|Overall Study|Severe noncompliance to protocol|1|||
46693005|NCT01211145|82907359|FG001|Overall Study|Severe noncompliance to protocol|0|||
46693006|NCT01211145|82907360|FG002|Overall Study|Severe noncompliance to protocol|0|||
46693007|NCT01211145|82907361|FG003|Overall Study|Severe noncompliance to protocol|0|||
46693008|NCT01211145|82907358|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
46693009|NCT01211145|82907359|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
46693010|NCT01211145|82907360|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
46693011|NCT01211145|82907361|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
46693012|NCT01211145|82907358|FG000|Overall Study|Patient decision|2|||
46693013|NCT01211145|82907359|FG001|Overall Study|Patient decision|1|||
46693014|NCT01211145|82907360|FG002|Overall Study|Patient decision|0|||
46693015|NCT01211145|82907361|FG003|Overall Study|Patient decision|2|||
46693016|NCT00977665|82907373|FG000|Overall Study|Withdrawal by Subject|1|||
46693017|NCT00977665|82907374|FG001|Overall Study|Withdrawal by Subject|3|||
46693018|NCT00977665|82907373|FG000|Overall Study|Physician Decision|2|||
46693019|NCT00977665|82907374|FG001|Overall Study|Physician Decision|1|||
46693020|NCT00977665|82907373|FG000|Overall Study|Sponsor requested withdrawal|0|||
46693021|NCT00977665|82907374|FG001|Overall Study|Sponsor requested withdrawal|1|||
46693022|NCT00977665|82907373|FG000|Overall Study|Lost to Follow-up|1|||
46693023|NCT00977665|82907374|FG001|Overall Study|Lost to Follow-up|0|||
46801424|NCT03929562|83020344|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
46801425|NCT03929562|83020345|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
46801426|NCT03929562|83020344|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
46801427|NCT03929562|83020345|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
46801428|NCT03929562|83020344|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
46693024|NCT00977665|82907373|FG000|Overall Study|Death|3|||
46693025|NCT00977665|82907374|FG001|Overall Study|Death|2|||
46693026|NCT00977665|82907373|FG000|Overall Study|Adverse Event|14|||
46693027|NCT00977665|82907374|FG001|Overall Study|Adverse Event|7|||
46693028|NCT00977665|82907373|FG000|Overall Study|Treatment failure|0|||
46693029|NCT00977665|82907374|FG001|Overall Study|Treatment failure|1|||
46693030|NCT01210443|82907380|FG000|Overall Study|Study terminated by sponsor|2|||
46693031|NCT01007812|82907384|FG000|Period 1, One Week|Lost to Follow-up|0|||
46693032|NCT01007812|82907385|FG001|Period 1, One Week|Lost to Follow-up|1|||
46693033|NCT01007812|82907384|FG000|Period 1, One Week|Discomfort|1|||
46693034|NCT01007812|82907385|FG001|Period 1, One Week|Discomfort|0|||
46693035|NCT01208961|82907391|FG000|High-Fat Period III|Protocol Violation|1|||
46693036|NCT01208961|82907392|FG001|High-Fat Period III|Protocol Violation|0|||
46693037|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
46693038|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
46693039|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
46693040|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
46693041|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
46693042|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
46693043|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
46693044|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
46693045|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
46693046|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
46693047|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
46693048|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
46693049|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
46693050|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
46693051|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
46693052|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
46693053|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
46693054|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
46693055|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
46693056|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
46693057|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
46693058|NCT01001572|82907399|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
46693059|NCT01001572|82907400|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
46693060|NCT01001572|82907401|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
46693061|NCT01001572|82907399|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
46693062|NCT01001572|82907400|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
46693063|NCT01001572|82907401|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
46693064|NCT01001572|82907399|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
46693065|NCT01001572|82907400|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
46693066|NCT01001572|82907401|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
46693067|NCT01001572|82907399|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
46693068|NCT01001572|82907400|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
46693069|NCT01001572|82907401|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
46693070|NCT01001572|82907399|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
46693071|NCT01001572|82907400|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
46693072|NCT01001572|82907401|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
46693073|NCT01001572|82907399|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
46693074|NCT01001572|82907400|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
46693075|NCT01001572|82907401|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
46693076|NCT01001572|82907399|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46693077|NCT01001572|82907400|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46693078|NCT01001572|82907401|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
46693079|NCT01208415|82907407|FG000|Overall Study|Death|1|||
46982017|NCT02343939|83228201|FG003|Overall Study|Treatment failure|0|||
46693080|NCT01208415|82907407|FG000|Overall Study|Lost to Follow-up|2|||
46693081|NCT01208415|82907407|FG000|Overall Study|Withdrawal by Subject|3|||
46693082|NCT01208415|82907407|FG000|Overall Study|Device not placed|1|||
46693083|NCT01208415|82907407|FG000|Overall Study|Still be eligible for follow-up|33|||
46693084|NCT01208337|82907411|FG000|Overall Study|Death|3|||
46693085|NCT01208181|82907427|FG000|Part 1|Withdrawal by Subject|11|||
46693086|NCT01208181|82907428|FG001|Part 1|Withdrawal by Subject|10|||
46693087|NCT01208181|82907429|FG002|Part 1|Withdrawal by Subject|0|||
46693088|NCT01208181|82907430|FG003|Part 1|Withdrawal by Subject|0|||
46693089|NCT01208181|82907431|FG004|Part 1|Withdrawal by Subject|0|||
46693090|NCT01208181|82907427|FG000|Part 1|Technical problem|5|||
46693091|NCT01208181|82907428|FG001|Part 1|Technical problem|0|||
46693092|NCT01208181|82907429|FG002|Part 1|Technical problem|0|||
46693093|NCT01208181|82907430|FG003|Part 1|Technical problem|0|||
46693094|NCT01208181|82907431|FG004|Part 1|Technical problem|0|||
46693095|NCT01208181|82907427|FG000|Part 1|Protocol Violation|10|||
46693096|NCT01208181|82907428|FG001|Part 1|Protocol Violation|5|||
46693097|NCT01208181|82907429|FG002|Part 1|Protocol Violation|0|||
46693098|NCT01208181|82907430|FG003|Part 1|Protocol Violation|0|||
46693099|NCT01208181|82907431|FG004|Part 1|Protocol Violation|0|||
46693100|NCT01208181|82907427|FG000|Part 1|Physician Decision|4|||
46693101|NCT01208181|82907428|FG001|Part 1|Physician Decision|0|||
46693102|NCT01208181|82907429|FG002|Part 1|Physician Decision|0|||
46693103|NCT01208181|82907430|FG003|Part 1|Physician Decision|0|||
46693104|NCT01208181|82907431|FG004|Part 1|Physician Decision|0|||
46693105|NCT01208181|82907427|FG000|Part 1|Non-compliance with study drug|1|||
46693106|NCT01208181|82907428|FG001|Part 1|Non-compliance with study drug|1|||
46693107|NCT01208181|82907429|FG002|Part 1|Non-compliance with study drug|0|||
46693108|NCT01208181|82907430|FG003|Part 1|Non-compliance with study drug|0|||
46693109|NCT01208181|82907431|FG004|Part 1|Non-compliance with study drug|0|||
46693110|NCT01208181|82907427|FG000|Part 1|Lost to Follow-up|5|||
46693111|NCT01208181|82907428|FG001|Part 1|Lost to Follow-up|3|||
46693112|NCT01208181|82907429|FG002|Part 1|Lost to Follow-up|0|||
46693113|NCT01208181|82907430|FG003|Part 1|Lost to Follow-up|0|||
46693114|NCT01208181|82907431|FG004|Part 1|Lost to Follow-up|1|||
46693115|NCT01208181|82907427|FG000|Part 1|Lack of Efficacy|37|||
46693116|NCT01208181|82907428|FG001|Part 1|Lack of Efficacy|12|||
46693117|NCT01208181|82907429|FG002|Part 1|Lack of Efficacy|0|||
46693118|NCT01208181|82907430|FG003|Part 1|Lack of Efficacy|0|||
46693119|NCT01208181|82907431|FG004|Part 1|Lack of Efficacy|17|||
46693120|NCT01208181|82907427|FG000|Part 1|Adverse Event|26|||
46693121|NCT01208181|82907428|FG001|Part 1|Adverse Event|24|||
46693122|NCT01208181|82907429|FG002|Part 1|Adverse Event|0|||
46801429|NCT03929562|83020345|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
46801430|NCT00415636|83020359|FG000|Overall Study|Symptomatic deterioration|1|||
46801431|NCT00415636|83020360|FG001|Overall Study|Symptomatic deterioration|0|||
46801432|NCT00415636|83020361|FG002|Overall Study|Symptomatic deterioration|1|||
46801433|NCT00415636|83020362|FG003|Overall Study|Symptomatic deterioration|2|||
46801434|NCT00415636|83020363|FG004|Overall Study|Symptomatic deterioration|0|||
46801435|NCT00415636|83020364|FG005|Overall Study|Symptomatic deterioration|1|||
46858949|NCT04769739|83074808|FG003|Overall Study|Poor bowel preparation|1|||
46858950|NCT04750278|83074821|FG000|Overall Study|Death|9|||
46858951|NCT04750278|83074822|FG001|Overall Study|Death|10|||
46858952|NCT04750278|83074823|FG002|Overall Study|Death|10|||
46858953|NCT04750278|83074821|FG000|Overall Study|Withdrawal by Subject|4|||
46858954|NCT04750278|83074822|FG001|Overall Study|Withdrawal by Subject|1|||
46858955|NCT04750278|83074823|FG002|Overall Study|Withdrawal by Subject|2|||
46858956|NCT04750278|83074821|FG000|Overall Study|Lost to Follow-up|1|||
46858957|NCT04750278|83074822|FG001|Overall Study|Lost to Follow-up|1|||
46858958|NCT04750278|83074823|FG002|Overall Study|Lost to Follow-up|1|||
46858959|NCT04750278|83074821|FG000|Overall Study|Pregnancy|1|||
46858960|NCT04750278|83074822|FG001|Overall Study|Pregnancy|0|||
46858961|NCT04750278|83074823|FG002|Overall Study|Pregnancy|0|||
46858962|NCT04750278|83074821|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
46858963|NCT04750278|83074822|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
46858964|NCT04750278|83074823|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
46858965|NCT04750278|83074821|FG000|Overall Study|Non-compliance|0|||
46858966|NCT04750278|83074822|FG001|Overall Study|Non-compliance|0|||
46858967|NCT04750278|83074823|FG002|Overall Study|Non-compliance|1|||
46858968|NCT04750278|83074821|FG000|Overall Study|Transfer to Outside Facility|0|||
46858969|NCT04750278|83074822|FG001|Overall Study|Transfer to Outside Facility|2|||
46858970|NCT04750278|83074823|FG002|Overall Study|Transfer to Outside Facility|1|||
46982018|NCT02343939|83228202|FG004|Overall Study|Treatment failure|0|||
46693123|NCT01208181|82907430|FG003|Part 1|Adverse Event|0|||
46693124|NCT01208181|82907431|FG004|Part 1|Adverse Event|4|||
46693125|NCT01208181|82907427|FG000|Part 2|Adverse Event|0|||
46801436|NCT00415636|83020359|FG000|Overall Study|Adverse Event|0|||
46801437|NCT00415636|83020360|FG001|Overall Study|Adverse Event|0|||
46801438|NCT00415636|83020361|FG002|Overall Study|Adverse Event|0|||
46801439|NCT00415636|83020362|FG003|Overall Study|Adverse Event|1|||
46801440|NCT00415636|83020363|FG004|Overall Study|Adverse Event|1|||
46801441|NCT00415636|83020364|FG005|Overall Study|Adverse Event|0|||
46801442|NCT00415636|83020359|FG000|Overall Study|Withdrawal by Subject|0|||
46801443|NCT00415636|83020360|FG001|Overall Study|Withdrawal by Subject|0|||
46801444|NCT00415636|83020361|FG002|Overall Study|Withdrawal by Subject|0|||
46801445|NCT00415636|83020362|FG003|Overall Study|Withdrawal by Subject|0|||
46801446|NCT00415636|83020363|FG004|Overall Study|Withdrawal by Subject|1|||
46801447|NCT00415636|83020364|FG005|Overall Study|Withdrawal by Subject|0|||
46801448|NCT00415636|83020359|FG000|Overall Study|Disease progression|0|||
46801449|NCT00415636|83020360|FG001|Overall Study|Disease progression|0|||
46801450|NCT00415636|83020361|FG002|Overall Study|Disease progression|0|||
46801451|NCT00415636|83020362|FG003|Overall Study|Disease progression|3|||
46801452|NCT00415636|83020363|FG004|Overall Study|Disease progression|0|||
46801453|NCT00415636|83020364|FG005|Overall Study|Disease progression|1|||
46801454|NCT00425854|83020388|FG000|Overall Study|Progressive Disease|19|||
46801455|NCT00425854|83020389|FG001|Overall Study|Progressive Disease|12|||
46801456|NCT00425854|83020388|FG000|Overall Study|Dose reduction toxicity AE|8|||
46801457|NCT00425854|83020389|FG001|Overall Study|Dose reduction toxicity AE|7|||
46801458|NCT00425854|83020388|FG000|Overall Study|Other Adverse Event|2|||
46801459|NCT00425854|83020389|FG001|Overall Study|Other Adverse Event|2|||
46801460|NCT00425698|83020398|FG000|Overall Study|Adverse Event|3|||
46801461|NCT00425698|83020399|FG001|Overall Study|Adverse Event|1|||
46693126|NCT01208181|82907428|FG001|Part 2|Adverse Event|0|||
46693127|NCT01208181|82907429|FG002|Part 2|Adverse Event|6|||
46693128|NCT01208181|82907430|FG003|Part 2|Adverse Event|7|||
46693129|NCT01208181|82907431|FG004|Part 2|Adverse Event|0|||
46693130|NCT01208181|82907427|FG000|Part 2|Withdrawal by Subject|0|||
46693131|NCT01208181|82907428|FG001|Part 2|Withdrawal by Subject|0|||
46693132|NCT01208181|82907429|FG002|Part 2|Withdrawal by Subject|1|||
46693133|NCT01208181|82907430|FG003|Part 2|Withdrawal by Subject|1|||
46693134|NCT01208181|82907431|FG004|Part 2|Withdrawal by Subject|0|||
46693135|NCT01208181|82907427|FG000|Part 2|Protocol Violation|0|||
46693136|NCT01208181|82907428|FG001|Part 2|Protocol Violation|0|||
46693137|NCT01208181|82907429|FG002|Part 2|Protocol Violation|1|||
46693138|NCT01208181|82907430|FG003|Part 2|Protocol Violation|0|||
46693139|NCT01208181|82907431|FG004|Part 2|Protocol Violation|0|||
46693140|NCT01208181|82907427|FG000|Part 2|Physician Decision|0|||
46693141|NCT01208181|82907428|FG001|Part 2|Physician Decision|0|||
46693142|NCT01208181|82907429|FG002|Part 2|Physician Decision|1|||
46693143|NCT01208181|82907430|FG003|Part 2|Physician Decision|2|||
46693144|NCT01208181|82907431|FG004|Part 2|Physician Decision|0|||
46693145|NCT01208181|82907427|FG000|Part 2|Non-compliance with study drug|0|||
46693146|NCT01208181|82907428|FG001|Part 2|Non-compliance with study drug|0|||
46693147|NCT01208181|82907429|FG002|Part 2|Non-compliance with study drug|1|||
46693148|NCT01208181|82907430|FG003|Part 2|Non-compliance with study drug|1|||
46693149|NCT01208181|82907431|FG004|Part 2|Non-compliance with study drug|0|||
46693150|NCT01208181|82907427|FG000|Part 2|Lost to Follow-up|0|||
46693151|NCT01208181|82907428|FG001|Part 2|Lost to Follow-up|0|||
46693152|NCT01208181|82907429|FG002|Part 2|Lost to Follow-up|1|||
46693153|NCT01208181|82907430|FG003|Part 2|Lost to Follow-up|2|||
46693154|NCT01208181|82907431|FG004|Part 2|Lost to Follow-up|0|||
46693155|NCT01208181|82907427|FG000|Part 2|Lack of Efficacy|0|||
46693156|NCT01208181|82907428|FG001|Part 2|Lack of Efficacy|0|||
46693157|NCT01208181|82907429|FG002|Part 2|Lack of Efficacy|5|||
46693158|NCT01208181|82907430|FG003|Part 2|Lack of Efficacy|7|||
46693159|NCT01208181|82907431|FG004|Part 2|Lack of Efficacy|0|||
46693160|NCT01208103|82907448|FG000|Overall Study|Adverse Event|1|||
46693161|NCT01208103|82907448|FG000|Overall Study|Withdrawal by Subject|1|||
46693162|NCT01206777|82907453|FG000|Overall Study|Death|1|||
46693163|NCT01206777|82907453|FG000|Overall Study|Adverse Event|1|||
46693164|NCT01001494|82907460|FG000|Overall Study|Adverse Event|8|||
46693165|NCT01001494|82907461|FG001|Overall Study|Adverse Event|4|||
46801462|NCT00425698|83020398|FG000|Overall Study|Withdrawal by Subject|0|||
46801463|NCT00425698|83020399|FG001|Overall Study|Withdrawal by Subject|1|||
46801464|NCT00425308|83020407|FG000|Overall Study|Adverse Event|2|||
46801465|NCT00425308|83020408|FG001|Overall Study|Adverse Event|1|||
46801466|NCT00425308|83020407|FG000|Overall Study|Withdrawal by Subject|1|||
46801467|NCT00425308|83020408|FG001|Overall Study|Withdrawal by Subject|0|||
46801468|NCT00425308|83020407|FG000|Overall Study|Death|1|||
46801469|NCT00425308|83020408|FG001|Overall Study|Death|0|||
46801470|NCT00545064|83020414|FG000|Overall Study|Lost to Follow-up|3|||
46801471|NCT00545064|83020414|FG000|Overall Study|Withdrawal by Subject|2|||
46801472|NCT00545064|83020414|FG000|Overall Study|did not complete course of treatment|1|||
46801473|NCT00545064|83020414|FG000|Overall Study|cancel all appointments, no rebooking|1|||
46801474|NCT00545064|83020414|FG000|Overall Study|inclement weather|1|||
46801475|NCT00432562|83020422|FG000|Overall Study|Death|3|||
46801476|NCT00432562|83020423|FG001|Overall Study|Death|0|||
46858971|NCT04750278|83074821|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
46858972|NCT04750278|83074822|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
46693166|NCT01001494|82907462|FG002|Overall Study|Adverse Event|6|||
46858973|NCT04750278|83074823|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
46693167|NCT01001494|82907460|FG000|Overall Study|Protocol Violation|0|||
46693168|NCT01001494|82907461|FG001|Overall Study|Protocol Violation|1|||
46801477|NCT00432172|83020433|FG000|Overall Study|Physician Decision|0|||
46801478|NCT00432172|83020434|FG001|Overall Study|Physician Decision|0|||
46801479|NCT00432172|83020435|FG002|Overall Study|Physician Decision|2|||
46897052|NCT00706654|83122632|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
46693169|NCT01001494|82907462|FG002|Overall Study|Protocol Violation|1|||
46693170|NCT01001494|82907460|FG000|Overall Study|Lost to Follow-up|2|||
46693171|NCT01001494|82907461|FG001|Overall Study|Lost to Follow-up|0|||
46693172|NCT01001494|82907462|FG002|Overall Study|Lost to Follow-up|1|||
46693173|NCT01001494|82907460|FG000|Overall Study|Withdrawal by Subject|9|||
46693174|NCT01001494|82907461|FG001|Overall Study|Withdrawal by Subject|7|||
46982019|NCT02343939|83228203|FG005|Overall Study|Treatment failure|0|||
46982020|NCT02343939|83228204|FG006|Overall Study|Treatment failure|2|||
46982021|NCT02343939|83228205|FG007|Overall Study|Treatment failure|1|||
46693175|NCT01001494|82907462|FG002|Overall Study|Withdrawal by Subject|17|||
46693176|NCT01001494|82907460|FG000|Overall Study|COPD exacerbation|3|||
46693177|NCT01001494|82907461|FG001|Overall Study|COPD exacerbation|4|||
46693178|NCT01001494|82907462|FG002|Overall Study|COPD exacerbation|5|||
46693179|NCT01001494|82907460|FG000|Overall Study|Lack of Efficacy|2|||
46693180|NCT01001494|82907461|FG001|Overall Study|Lack of Efficacy|0|||
46693181|NCT01001494|82907462|FG002|Overall Study|Lack of Efficacy|8|||
46693182|NCT01001494|82907460|FG000|Overall Study|Other|0|||
46693183|NCT01001494|82907461|FG001|Overall Study|Other|1|||
46693184|NCT01001494|82907462|FG002|Overall Study|Other|3|||
46693185|NCT01205685|82907470|FG000|Overall Study|Disease Progression|10|||
46693186|NCT01205685|82907470|FG000|Overall Study|Withdrawal by Subject|1|||
46693187|NCT01205529|82907474|FG000|Overall Study|Procedure Cancelled|4|||
46693188|NCT01205529|82907474|FG000|Overall Study|Withdrawal by Subject|2|||
46693189|NCT01205529|82907474|FG000|Overall Study|Physician Decision|4|||
46693190|NCT01205529|82907474|FG000|Overall Study|Unstable post op|15|||
46693191|NCT01205529|82907474|FG000|Overall Study|No longer met criteria|30|||
46693192|NCT01205451|82907480|FG000|Overall Study|Lost to Follow-up|1|||
46693193|NCT01205451|82907481|FG001|Overall Study|Lost to Follow-up|1|||
46693194|NCT01205451|82907480|FG000|Overall Study|Withdrawal by Subject|5|||
46693195|NCT01205451|82907481|FG001|Overall Study|Withdrawal by Subject|9|||
46693196|NCT01001104|82907491|FG000|Overall Study|Adverse Event|2|||
46693197|NCT01001104|82907492|FG001|Overall Study|Adverse Event|1|||
46693198|NCT01001104|82907493|FG002|Overall Study|Adverse Event|0|||
46693199|NCT01001104|82907494|FG003|Overall Study|Adverse Event|0|||
46693200|NCT01001104|82907491|FG000|Overall Study|Lost to Follow-up|0|||
46693201|NCT01001104|82907492|FG001|Overall Study|Lost to Follow-up|0|||
46693202|NCT01001104|82907493|FG002|Overall Study|Lost to Follow-up|1|||
46693203|NCT01001104|82907494|FG003|Overall Study|Lost to Follow-up|0|||
46693204|NCT01001104|82907491|FG000|Overall Study|Entry Criteria Not Met|0|||
46693205|NCT01001104|82907492|FG001|Overall Study|Entry Criteria Not Met|0|||
46693206|NCT01001104|82907493|FG002|Overall Study|Entry Criteria Not Met|0|||
46693207|NCT01001104|82907494|FG003|Overall Study|Entry Criteria Not Met|1|||
46693208|NCT01001104|82907491|FG000|Overall Study|Withdrawal by Subject|0|||
46693209|NCT01001104|82907492|FG001|Overall Study|Withdrawal by Subject|0|||
46693210|NCT01001104|82907493|FG002|Overall Study|Withdrawal by Subject|0|||
46693211|NCT01001104|82907494|FG003|Overall Study|Withdrawal by Subject|2|||
46693212|NCT00998764|82907509|FG000|Overall Study|Lack of Efficacy|3|||
46693213|NCT00998764|82907510|FG001|Overall Study|Lack of Efficacy|6|||
46693214|NCT00998764|82907509|FG000|Overall Study|Adverse Event|17|||
46982022|NCT02343939|83228206|FG008|Overall Study|Treatment failure|0|||
46982023|NCT02343939|83228198|FG000|Overall Study|Investigator's discretion|0|||
46982024|NCT02343939|83228199|FG001|Overall Study|Investigator's discretion|0|||
46693215|NCT00998764|82907510|FG001|Overall Study|Adverse Event|12|||
46693216|NCT00998764|82907509|FG000|Overall Study|Withdrawal by Subject|19|||
46693217|NCT00998764|82907510|FG001|Overall Study|Withdrawal by Subject|25|||
46693218|NCT00998764|82907509|FG000|Overall Study|Physician Decision|3|||
46693219|NCT00998764|82907510|FG001|Overall Study|Physician Decision|3|||
46693220|NCT00998764|82907509|FG000|Overall Study|Death|3|||
46693221|NCT00998764|82907510|FG001|Overall Study|Death|1|||
46693222|NCT00998764|82907509|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
46982025|NCT02343939|83228200|FG002|Overall Study|Investigator's discretion|0|||
46693223|NCT00998764|82907510|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
46693224|NCT00998764|82907509|FG000|Overall Study|Protocol Violation|0|||
46693225|NCT00998764|82907510|FG001|Overall Study|Protocol Violation|1|||
46693226|NCT00998764|82907509|FG000|Overall Study|Failed to Return|1|||
46693227|NCT00998764|82907510|FG001|Overall Study|Failed to Return|1|||
46693228|NCT00998764|82907509|FG000|Overall Study|Lost to Follow-up|1|||
46693229|NCT00998764|82907510|FG001|Overall Study|Lost to Follow-up|1|||
46693230|NCT00998764|82907509|FG000|Overall Study|Loss of Caregiver|0|||
46693231|NCT00998764|82907510|FG001|Overall Study|Loss of Caregiver|3|||
46693232|NCT00998764|82907509|FG000|Overall Study|Other|4|||
46693233|NCT00998764|82907510|FG001|Overall Study|Other|4|||
46693234|NCT00998764|82907509|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
46693235|NCT00998764|82907510|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
46693236|NCT01204671|82907523|FG000|Overall Study|Adverse Event|4|||
46693237|NCT01204671|82907524|FG001|Overall Study|Adverse Event|3|||
46693238|NCT01204671|82907525|FG002|Overall Study|Adverse Event|3|||
46693239|NCT01204671|82907526|FG003|Overall Study|Adverse Event|3|||
46693240|NCT01204671|82907527|FG004|Overall Study|Adverse Event|1|||
46693241|NCT01204671|82907523|FG000|Overall Study|Withdrawal by Subject|2|||
46693242|NCT01204671|82907524|FG001|Overall Study|Withdrawal by Subject|3|||
46693243|NCT01204671|82907525|FG002|Overall Study|Withdrawal by Subject|4|||
46693244|NCT01204671|82907526|FG003|Overall Study|Withdrawal by Subject|5|||
46693245|NCT01204671|82907527|FG004|Overall Study|Withdrawal by Subject|3|||
46693246|NCT01204671|82907523|FG000|Overall Study|Lost to Follow-up|7|||
46693247|NCT01204671|82907524|FG001|Overall Study|Lost to Follow-up|8|||
46693248|NCT01204671|82907525|FG002|Overall Study|Lost to Follow-up|6|||
46693249|NCT01204671|82907526|FG003|Overall Study|Lost to Follow-up|4|||
46693250|NCT01204671|82907527|FG004|Overall Study|Lost to Follow-up|0|||
46693251|NCT01204671|82907523|FG000|Overall Study|Unknown Completion Status|1|||
46693252|NCT01204671|82907524|FG001|Overall Study|Unknown Completion Status|1|||
46693253|NCT01204671|82907525|FG002|Overall Study|Unknown Completion Status|0|||
46693254|NCT01204671|82907526|FG003|Overall Study|Unknown Completion Status|0|||
46693255|NCT01204671|82907527|FG004|Overall Study|Unknown Completion Status|0|||
46693256|NCT01204671|82907523|FG000|Overall Study|Physician Decision|0|||
46693257|NCT01204671|82907524|FG001|Overall Study|Physician Decision|0|||
46693258|NCT01204671|82907525|FG002|Overall Study|Physician Decision|0|||
46801480|NCT00432172|83020436|FG003|Overall Study|Physician Decision|0|||
46693259|NCT01204671|82907526|FG003|Overall Study|Physician Decision|1|||
46693260|NCT01204671|82907527|FG004|Overall Study|Physician Decision|0|||
46801481|NCT00432172|83020433|FG000|Overall Study|Adverse Event|4|||
46801482|NCT00432172|83020434|FG001|Overall Study|Adverse Event|2|||
46693261|NCT01202955|82907545|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
46693262|NCT01202955|82907546|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
46801483|NCT00432172|83020435|FG002|Overall Study|Adverse Event|4|||
46982026|NCT02343939|83228201|FG003|Overall Study|Investigator's discretion|1|||
46693263|NCT01202877|82907555|FG000|Overall Study|Disease Progression|0|||
46693264|NCT01202877|82907556|FG001|Overall Study|Disease Progression|1|||
46693265|NCT01202877|82907557|FG002|Overall Study|Disease Progression|2|||
46693266|NCT01202877|82907555|FG000|Overall Study|Adverse Event|0|||
46693267|NCT01202877|82907556|FG001|Overall Study|Adverse Event|0|||
46693268|NCT01202877|82907557|FG002|Overall Study|Adverse Event|2|||
46693269|NCT01202877|82907555|FG000|Overall Study|Withdrawal by Subject|0|||
46693270|NCT01202877|82907556|FG001|Overall Study|Withdrawal by Subject|0|||
46693271|NCT01202877|82907557|FG002|Overall Study|Withdrawal by Subject|1|||
46693272|NCT01202877|82907555|FG000|Overall Study|Death|0|||
46693273|NCT01202877|82907556|FG001|Overall Study|Death|0|||
46693274|NCT01202877|82907557|FG002|Overall Study|Death|1|||
46693275|NCT01202409|82907565|FG000|Overall Study|Adverse Event|1|||
46693276|NCT01202409|82907565|FG000|Overall Study|Ineligible - KRAS mutants|7|||
46693277|NCT01202175|82907571|FG000|Overall Study|Lost to Follow-up|2|||
46693278|NCT01202175|82907571|FG000|Overall Study|Withdrawal by Subject|1|||
46693279|NCT01202175|82907571|FG000|Overall Study|Adverse Event|2|||
46693280|NCT01201785|82907576|FG000|Overall Study|Lost to Follow-up|16|||
46982027|NCT02343939|83228202|FG004|Overall Study|Investigator's discretion|0|||
46982028|NCT02343939|83228203|FG005|Overall Study|Investigator's discretion|0|||
46982029|NCT02343939|83228204|FG006|Overall Study|Investigator's discretion|1|||
46982030|NCT02343939|83228205|FG007|Overall Study|Investigator's discretion|0|||
46982031|NCT02343939|83228206|FG008|Overall Study|Investigator's discretion|0|||
46693281|NCT01201317|82907583|FG000|Overall Study|Withdrawal by Subject|5|||
46693282|NCT01201317|82907584|FG001|Overall Study|Withdrawal by Subject|0|||
46693283|NCT01201317|82907585|FG002|Overall Study|Withdrawal by Subject|3|||
46693284|NCT01201317|82907583|FG000|Overall Study|Adverse Event|2|||
46982032|NCT02343939|83228198|FG000|Overall Study|Adverse Event|0|||
46982033|NCT02343939|83228199|FG001|Overall Study|Adverse Event|0|||
46693285|NCT01201317|82907584|FG001|Overall Study|Adverse Event|2|||
46693286|NCT01201317|82907585|FG002|Overall Study|Adverse Event|2|||
46693287|NCT01201317|82907583|FG000|Overall Study|Screen failure|1|||
46693288|NCT01201317|82907584|FG001|Overall Study|Screen failure|1|||
46693289|NCT01201317|82907585|FG002|Overall Study|Screen failure|0|||
46693290|NCT01201317|82907583|FG000|Overall Study|Protocol Violation|0|||
46693291|NCT01201317|82907584|FG001|Overall Study|Protocol Violation|1|||
46693292|NCT01201317|82907585|FG002|Overall Study|Protocol Violation|1|||
46693293|NCT01201317|82907583|FG000|Overall Study|Death|0|||
46693294|NCT01201317|82907584|FG001|Overall Study|Death|1|||
46693295|NCT01201317|82907585|FG002|Overall Study|Death|0|||
46693296|NCT01201317|82907583|FG000|Overall Study|Study-specific withdrawal criteria|0|||
46693297|NCT01201317|82907584|FG001|Overall Study|Study-specific withdrawal criteria|0|||
46693298|NCT01201317|82907585|FG002|Overall Study|Study-specific withdrawal criteria|1|||
46693299|NCT01201317|82907583|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
46693300|NCT01201317|82907584|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
46693301|NCT01201317|82907585|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
46693302|NCT01201317|82907583|FG000|Overall Study|Decrease in renal function|0|||
46693303|NCT01201317|82907584|FG001|Overall Study|Decrease in renal function|1|||
46693304|NCT01201317|82907585|FG002|Overall Study|Decrease in renal function|0|||
46693305|NCT01201317|82907583|FG000|Overall Study|Lack of Efficacy|1|||
46693306|NCT01201317|82907584|FG001|Overall Study|Lack of Efficacy|0|||
46982034|NCT02343939|83228200|FG002|Overall Study|Adverse Event|0|||
46982035|NCT02343939|83228201|FG003|Overall Study|Adverse Event|0|||
46693307|NCT01201317|82907585|FG002|Overall Study|Lack of Efficacy|0|||
46693308|NCT01201317|82907583|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
46693309|NCT01201317|82907584|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
46693310|NCT01201317|82907585|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
46693311|NCT01200069|82907595|FG000|Overall Study|Withdrawal by Subject|0|||
46693312|NCT01200069|82907596|FG001|Overall Study|Withdrawal by Subject|1|||
46693313|NCT01199601|82907647|FG000|Overall Study|Lost to Follow-up|47|||
46693314|NCT01199601|82907648|FG001|Overall Study|Lost to Follow-up|66|||
46693315|NCT01199601|82907647|FG000|Overall Study|Withdrawal by Subject|15|||
46982036|NCT02343939|83228202|FG004|Overall Study|Adverse Event|0|||
46693316|NCT01199601|82907648|FG001|Overall Study|Withdrawal by Subject|3|||
46693317|NCT01199601|82907647|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
46693318|NCT01199601|82907648|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
46693319|NCT01199289|82907658|FG000|Overall Study|Ineligibility determined|2|||
46693320|NCT01199289|82907659|FG001|Overall Study|Ineligibility determined|1|||
46693321|NCT01199289|82907660|FG002|Overall Study|Ineligibility determined|0|||
46693322|NCT01199289|82907661|FG003|Overall Study|Ineligibility determined|0|||
46693323|NCT01199289|82907658|FG000|Overall Study|Protocol Violation|1|||
46693324|NCT01199289|82907659|FG001|Overall Study|Protocol Violation|0|||
46693325|NCT01199289|82907660|FG002|Overall Study|Protocol Violation|0|||
46693326|NCT01199289|82907661|FG003|Overall Study|Protocol Violation|1|||
46693327|NCT01199289|82907658|FG000|Overall Study|Noncompliance|1|||
46693328|NCT01199289|82907659|FG001|Overall Study|Noncompliance|0|||
46693329|NCT01199289|82907660|FG002|Overall Study|Noncompliance|2|||
46693330|NCT01199289|82907661|FG003|Overall Study|Noncompliance|0|||
46693331|NCT01199289|82907658|FG000|Overall Study|Adverse Event|0|||
46693332|NCT01199289|82907659|FG001|Overall Study|Adverse Event|3|||
46693333|NCT01199289|82907660|FG002|Overall Study|Adverse Event|1|||
46693334|NCT01199289|82907661|FG003|Overall Study|Adverse Event|4|||
46693335|NCT01199289|82907658|FG000|Overall Study|Full consent withdrawn|2|||
46693336|NCT01199289|82907659|FG001|Overall Study|Full consent withdrawn|2|||
46693337|NCT01199289|82907660|FG002|Overall Study|Full consent withdrawn|2|||
46693338|NCT01199289|82907661|FG003|Overall Study|Full consent withdrawn|3|||
46693339|NCT01199289|82907658|FG000|Overall Study|Administrative decision|0|||
46693340|NCT01199289|82907659|FG001|Overall Study|Administrative decision|0|||
46693341|NCT01199289|82907660|FG002|Overall Study|Administrative decision|0|||
46693342|NCT01199289|82907661|FG003|Overall Study|Administrative decision|1|||
46693343|NCT01199289|82907658|FG000|Overall Study|Lost to Follow-up|0|||
46693344|NCT01199289|82907659|FG001|Overall Study|Lost to Follow-up|0|||
46693345|NCT01199289|82907660|FG002|Overall Study|Lost to Follow-up|0|||
46693346|NCT01199289|82907661|FG003|Overall Study|Lost to Follow-up|1|||
46693347|NCT01199289|82907658|FG000|Overall Study|Protocol-specified criteria|3|||
46693348|NCT01199289|82907659|FG001|Overall Study|Protocol-specified criteria|0|||
46693349|NCT01199289|82907660|FG002|Overall Study|Protocol-specified criteria|0|||
46693350|NCT01199289|82907661|FG003|Overall Study|Protocol-specified criteria|1|||
46693351|NCT01199289|82907658|FG000|Overall Study|Pregnancy|0|||
46693352|NCT01199289|82907659|FG001|Overall Study|Pregnancy|1|||
46693353|NCT01199289|82907660|FG002|Overall Study|Pregnancy|0|||
46693354|NCT01199289|82907661|FG003|Overall Study|Pregnancy|1|||
46693355|NCT01199055|82907677|FG000|Overall Study|Death|0|||
46693356|NCT01199055|82907678|FG001|Overall Study|Death|1|||
46693357|NCT01199055|82907679|FG002|Overall Study|Death|0|||
46693358|NCT01199055|82907677|FG000|Overall Study|Physician Decision|0|||
46693359|NCT01199055|82907678|FG001|Overall Study|Physician Decision|1|||
46693360|NCT01199055|82907679|FG002|Overall Study|Physician Decision|1|||
46693361|NCT01199055|82907677|FG000|Overall Study|Progressive disease|2|||
46693362|NCT01199055|82907678|FG001|Overall Study|Progressive disease|1|||
46693363|NCT01199055|82907679|FG002|Overall Study|Progressive disease|2|||
46693364|NCT01199055|82907677|FG000|Overall Study|Withdrawal by Subject|0|||
46693365|NCT01199055|82907678|FG001|Overall Study|Withdrawal by Subject|0|||
46693366|NCT01199055|82907679|FG002|Overall Study|Withdrawal by Subject|1|||
46982037|NCT02343939|83228203|FG005|Overall Study|Adverse Event|1|||
46982038|NCT02343939|83228204|FG006|Overall Study|Adverse Event|0|||
46693367|NCT01198977|82907691|FG000|Overall Study|Lost to Follow-up|1|||
46693368|NCT01198977|82907692|FG001|Overall Study|Lost to Follow-up|0|||
46693369|NCT01198587|82907704|FG000|Overall Study|Lost to Follow-up|8|||
46693370|NCT01198587|82907705|FG001|Overall Study|Lost to Follow-up|0|||
46693371|NCT01198587|82907706|FG002|Overall Study|Lost to Follow-up|9|||
46693372|NCT01198587|82907707|FG003|Overall Study|Lost to Follow-up|0|||
46693373|NCT01198509|82907728|FG000|Overall Study|Withdrawal by Subject|1|||
46693374|NCT01198509|82907729|FG001|Overall Study|Withdrawal by Subject|0|||
46693375|NCT01198509|82907730|FG002|Overall Study|Withdrawal by Subject|0|||
46693376|NCT01198509|82907731|FG003|Overall Study|Withdrawal by Subject|0|||
46693377|NCT01198509|82907732|FG004|Overall Study|Withdrawal by Subject|0|||
46693378|NCT01198509|82907733|FG005|Overall Study|Withdrawal by Subject|0|||
46693379|NCT01198275|82907747|FG000|Overall Study|Adverse Event|2|||
46693380|NCT01198275|82907748|FG001|Overall Study|Adverse Event|3|||
46693381|NCT01198275|82907747|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
46693382|NCT01198275|82907748|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
46693383|NCT01197417|82907756|FG000|Overall Study|Physician Decision|3|||
46693384|NCT01197417|82907757|FG001|Overall Study|Physician Decision|2|||
46693385|NCT01197417|82907756|FG000|Overall Study|Withdrawal by Subject|2|||
46693386|NCT01197417|82907757|FG001|Overall Study|Withdrawal by Subject|4|||
46693387|NCT01197417|82907756|FG000|Overall Study|Site miscommunication|0|||
46693388|NCT01197417|82907757|FG001|Overall Study|Site miscommunication|1|||
46693389|NCT01197417|82907756|FG000|Overall Study|Subject transferred to intensive care|0|||
46693390|NCT01197417|82907757|FG001|Overall Study|Subject transferred to intensive care|1|||
46693391|NCT01197417|82907756|FG000|Overall Study|Not consented in time to receive drug|0|||
46693392|NCT01197417|82907757|FG001|Overall Study|Not consented in time to receive drug|1|||
46693393|NCT01197417|82907756|FG000|Overall Study|Hypotension|1|||
46693394|NCT01197417|82907757|FG001|Overall Study|Hypotension|2|||
46693395|NCT01197417|82907756|FG000|Overall Study|Found to be ineligible|2|||
46693396|NCT01197417|82907757|FG001|Overall Study|Found to be ineligible|5|||
46693397|NCT01197417|82907756|FG000|Overall Study|No 25-hour magnesium level|0|||
46693398|NCT01197417|82907757|FG001|Overall Study|No 25-hour magnesium level|2|||
46693399|NCT00977431|82907768|FG000|Overall Study|Other than listed|1|||
46801484|NCT00432172|83020436|FG003|Overall Study|Adverse Event|3|||
46693400|NCT00977431|82907769|FG001|Overall Study|Other than listed|0|||
46693401|NCT00977431|82907770|FG002|Overall Study|Other than listed|0|||
46693402|NCT00977431|82907771|FG003|Overall Study|Other than listed|0|||
46693403|NCT00977431|82907772|FG004|Overall Study|Other than listed|2|||
46693404|NCT00977431|82907768|FG000|Overall Study|Protocol Violation|0|||
46693405|NCT00977431|82907769|FG001|Overall Study|Protocol Violation|0|||
46693406|NCT00977431|82907770|FG002|Overall Study|Protocol Violation|1|||
46693407|NCT00977431|82907771|FG003|Overall Study|Protocol Violation|0|||
46693408|NCT00977431|82907772|FG004|Overall Study|Protocol Violation|0|||
46693409|NCT00977431|82907768|FG000|Overall Study|Adverse Event|3|||
46693410|NCT00977431|82907769|FG001|Overall Study|Adverse Event|0|||
46693411|NCT00977431|82907770|FG002|Overall Study|Adverse Event|4|||
46693412|NCT00977431|82907771|FG003|Overall Study|Adverse Event|0|||
46693413|NCT00977431|82907772|FG004|Overall Study|Adverse Event|6|||
46693414|NCT00977431|82907768|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
46693415|NCT00977431|82907769|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
46693416|NCT00977431|82907770|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
46693417|NCT00977431|82907771|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
46693418|NCT00977431|82907772|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
46693419|NCT00977431|82907768|FG000|Overall Study|Progressive disease|2|||
46693420|NCT00977431|82907769|FG001|Overall Study|Progressive disease|6|||
46693421|NCT00977431|82907770|FG002|Overall Study|Progressive disease|1|||
46693422|NCT00977431|82907771|FG003|Overall Study|Progressive disease|3|||
46693423|NCT00977431|82907772|FG004|Overall Study|Progressive disease|5|||
46693424|NCT00977197|82907790|FG000|Overall Study|Withdrawal by Subject|3|||
46693425|NCT00977197|82907791|FG001|Overall Study|Withdrawal by Subject|4|||
46693426|NCT00977197|82907790|FG000|Overall Study|Adverse Event|3|||
46982039|NCT02343939|83228205|FG007|Overall Study|Adverse Event|0|||
46982040|NCT02343939|83228206|FG008|Overall Study|Adverse Event|0|||
46982041|NCT02343939|83228198|FG000|Overall Study|Never Treated With ENTO|0|||
46982042|NCT02343939|83228199|FG001|Overall Study|Never Treated With ENTO|0|||
46982043|NCT02343939|83228200|FG002|Overall Study|Never Treated With ENTO|0|||
46982044|NCT02343939|83228201|FG003|Overall Study|Never Treated With ENTO|0|||
46982045|NCT02343939|83228202|FG004|Overall Study|Never Treated With ENTO|0|||
46982046|NCT02343939|83228203|FG005|Overall Study|Never Treated With ENTO|0|||
46982047|NCT02343939|83228204|FG006|Overall Study|Never Treated With ENTO|1|||
46982048|NCT02343939|83228205|FG007|Overall Study|Never Treated With ENTO|2|||
46982049|NCT02343939|83228206|FG008|Overall Study|Never Treated With ENTO|0|||
46982050|NCT02397447|83228242|FG000|Overall Study|Lost to Follow-up|2|||
46982051|NCT02397447|83228243|FG001|Overall Study|Lost to Follow-up|2|||
46982052|NCT02397057|83228251|FG000|Overall Study|Withdrawal by Subject|6|||
46982053|NCT02397057|83228252|FG001|Overall Study|Withdrawal by Subject|7|||
46982054|NCT02397057|83228251|FG000|Overall Study|Lost to Follow-up|4|||
46982055|NCT02397057|83228252|FG001|Overall Study|Lost to Follow-up|3|||
46982056|NCT02397057|83228251|FG000|Overall Study|Death|1|||
46982057|NCT02397057|83228252|FG001|Overall Study|Death|0|||
46982058|NCT02397057|83228251|FG000|Overall Study|Adverse Event|0|||
46982059|NCT02397057|83228252|FG001|Overall Study|Adverse Event|1|||
46982060|NCT02397057|83228251|FG000|Overall Study|Physician Decision|0|||
46693427|NCT00977197|82907791|FG001|Overall Study|Adverse Event|1|||
46693428|NCT00977197|82907790|FG000|Overall Study|Lack of Efficacy|1|||
46693429|NCT00977197|82907791|FG001|Overall Study|Lack of Efficacy|0|||
46693430|NCT00977197|82907790|FG000|Overall Study|Lost to Follow-up|1|||
46693431|NCT00977197|82907791|FG001|Overall Study|Lost to Follow-up|3|||
46693432|NCT00977197|82907790|FG000|Overall Study|Nonadherence|1|||
46693433|NCT00977197|82907791|FG001|Overall Study|Nonadherence|1|||
46693434|NCT00974311|82907799|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
46693435|NCT00974311|82907800|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
46693436|NCT00974311|82907799|FG000|DB Phase (up to 24 Months)|Death|561|||
46693437|NCT00974311|82907800|FG001|DB Phase (up to 24 Months)|Death|298|||
46693438|NCT00974311|82907799|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
46693439|NCT00974311|82907800|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
46982061|NCT02397057|83228252|FG001|Overall Study|Physician Decision|1|||
46693440|NCT00974311|82907799|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
46693441|NCT00974311|82907800|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
46693442|NCT00974311|82907799|FG000|DB Phase (up to 24 Months)|Other|1|||
46693443|NCT00974311|82907800|FG001|DB Phase (up to 24 Months)|Other|0|||
46693444|NCT00974311|82907799|FG000|OLE Phase (up to 77 Months)|Death|14|||
46693445|NCT00974311|82907800|FG001|OLE Phase (up to 77 Months)|Death|21|||
46693446|NCT00974311|82907799|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
46693447|NCT00974311|82907800|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
46693448|NCT00974311|82907799|FG000|OLE Phase (up to 77 Months)|Other|15|||
46693449|NCT00974311|82907800|FG001|OLE Phase (up to 77 Months)|Other|2|||
46693450|NCT00974311|82907799|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
46693451|NCT00974311|82907800|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
46693452|NCT00974233|82907809|FG000|Induction Chemoimmunotherapy|Death|2|||
46693453|NCT00974233|82907809|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
46693454|NCT00974233|82907809|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
46801485|NCT00432172|83020433|FG000|Overall Study|Disease progression|0|||
46801486|NCT00432172|83020434|FG001|Overall Study|Disease progression|2|||
46801487|NCT00432172|83020435|FG002|Overall Study|Disease progression|5|||
46801488|NCT00432172|83020436|FG003|Overall Study|Disease progression|1|||
46801489|NCT00432172|83020433|FG000|Overall Study|Withdrawal by Subject|0|||
46801490|NCT00432172|83020434|FG001|Overall Study|Withdrawal by Subject|1|||
46801491|NCT00432172|83020435|FG002|Overall Study|Withdrawal by Subject|0|||
46801492|NCT00432172|83020436|FG003|Overall Study|Withdrawal by Subject|2|||
46801493|NCT00432172|83020433|FG000|Overall Study|No treatment received|2|||
46801494|NCT00432172|83020434|FG001|Overall Study|No treatment received|2|||
46801495|NCT00432172|83020435|FG002|Overall Study|No treatment received|0|||
46801496|NCT00432172|83020436|FG003|Overall Study|No treatment received|1|||
46801497|NCT00415168|83020448|FG000|Overall Study|Death|26|||
46801498|NCT00415168|83020448|FG000|Overall Study|Lost to Follow-up|3|||
46801499|NCT00415168|83020448|FG000|Overall Study|Physician Decision|13|||
46801500|NCT00415168|83020448|FG000|Overall Study|Sponsor Decision|4|||
46801501|NCT00415168|83020448|FG000|Overall Study|Withdrawal by Subject|6|||
46801502|NCT00424762|83020454|FG000|Overall Study|Withdrawal by Subject|18|||
46801503|NCT00424762|83020455|FG001|Overall Study|Withdrawal by Subject|19|||
46801504|NCT00424762|83020454|FG000|Overall Study|Lost to Follow-up|2|||
46801505|NCT00424762|83020455|FG001|Overall Study|Lost to Follow-up|3|||
46801506|NCT00414544|83020461|FG000|Overall Study|Lost to Follow-up|14|||
46801507|NCT00414466|83020471|FG000|Overall Study|Adverse Event|0|||
46801508|NCT00414466|83020472|FG001|Overall Study|Adverse Event|0|||
46801509|NCT00414466|83020473|FG002|Overall Study|Adverse Event|1|||
46801510|NCT00414466|83020474|FG003|Overall Study|Adverse Event|1|||
46801511|NCT00414466|83020471|FG000|Overall Study|Lack of Efficacy|1|||
46801512|NCT00414466|83020472|FG001|Overall Study|Lack of Efficacy|0|||
46801513|NCT00414466|83020473|FG002|Overall Study|Lack of Efficacy|0|||
46693455|NCT00974233|82907809|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
46693456|NCT00974233|82907809|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
46801514|NCT00414466|83020474|FG003|Overall Study|Lack of Efficacy|0|||
46801515|NCT00414466|83020471|FG000|Overall Study|Withdrawn by Sponsor|1|||
46801516|NCT00414466|83020472|FG001|Overall Study|Withdrawn by Sponsor|0|||
46801517|NCT00414466|83020473|FG002|Overall Study|Withdrawn by Sponsor|0|||
46801518|NCT00414466|83020474|FG003|Overall Study|Withdrawn by Sponsor|0|||
46693457|NCT00974233|82907809|FG000|Maintenance Lenalidomide|Adverse Event|8|||
46693458|NCT00973921|82907821|FG000|Overall Study|IVUS results were not available|9|||
46801519|NCT00424528|83020490|FG000|Overall Study|Adverse Event|2|||
46801520|NCT00424528|83020491|FG001|Overall Study|Adverse Event|1|||
46693459|NCT00972595|82907825|FG000|Period 1|Adverse Event|1|||
46693460|NCT00972595|82907826|FG001|Period 1|Adverse Event|0|||
46693461|NCT01196091|82907835|FG000|Overall Study|Adverse Event|22|||
46693462|NCT01196091|82907836|FG001|Overall Study|Adverse Event|27|||
46693463|NCT01196091|82907837|FG002|Overall Study|Adverse Event|26|||
46693464|NCT01196091|82907835|FG000|Overall Study|Death|3|||
46693465|NCT01196091|82907836|FG001|Overall Study|Death|2|||
46693466|NCT01196091|82907837|FG002|Overall Study|Death|2|||
46693467|NCT01196091|82907835|FG000|Overall Study|Entry Criteria Not Met|11|||
46693468|NCT01196091|82907836|FG001|Overall Study|Entry Criteria Not Met|11|||
46693469|NCT01196091|82907837|FG002|Overall Study|Entry Criteria Not Met|10|||
46801521|NCT00424528|83020492|FG002|Overall Study|Adverse Event|2|||
46801522|NCT00424528|83020490|FG000|Overall Study|Protocol Violation|1|||
46801523|NCT00424528|83020491|FG001|Overall Study|Protocol Violation|1|||
46801524|NCT00424528|83020492|FG002|Overall Study|Protocol Violation|0|||
46982062|NCT02397057|83228251|FG000|Overall Study|Subject did not receive study drug|0|||
46982063|NCT02397057|83228252|FG001|Overall Study|Subject did not receive study drug|1|||
46982064|NCT02343549|83228258|FG000|Overall Study|Death|11|||
46982065|NCT02343549|83228258|FG000|Overall Study|Withdrawal by Subject|2|||
46982066|NCT02343159|83228265|FG000|Overall Study|Early Study Termination|16|||
46982067|NCT02343159|83228266|FG001|Overall Study|Early Study Termination|19|||
46982068|NCT02343159|83228267|FG002|Overall Study|Early Study Termination|23|||
46982069|NCT02343159|83228265|FG000|Overall Study|Physician Decision|2|||
46982070|NCT02343159|83228266|FG001|Overall Study|Physician Decision|0|||
46982071|NCT02343159|83228267|FG002|Overall Study|Physician Decision|1|||
46982072|NCT02343159|83228265|FG000|Overall Study|Withdrawal by Subject|3|||
46982073|NCT02343159|83228266|FG001|Overall Study|Withdrawal by Subject|0|||
46982074|NCT02343159|83228267|FG002|Overall Study|Withdrawal by Subject|2|||
46982075|NCT02343159|83228265|FG000|Overall Study|Lost to Follow-up|0|||
46982076|NCT02343159|83228266|FG001|Overall Study|Lost to Follow-up|2|||
46801525|NCT00424528|83020490|FG000|Overall Study|Lost to Follow-up|0|||
46801526|NCT00424528|83020491|FG001|Overall Study|Lost to Follow-up|1|||
46801527|NCT00424528|83020492|FG002|Overall Study|Lost to Follow-up|0|||
46801528|NCT00424528|83020490|FG000|Overall Study|noncompliance with study requirements|2|||
46801529|NCT00424528|83020491|FG001|Overall Study|noncompliance with study requirements|1|||
46801530|NCT00424528|83020492|FG002|Overall Study|noncompliance with study requirements|2|||
46801531|NCT00545532|83020502|FG000|Overall Study|Withdrawal by Subject|1|||
46982077|NCT02343159|83228267|FG002|Overall Study|Lost to Follow-up|2|||
46982078|NCT02343159|83228265|FG000|Overall Study|Adverse Event|4|||
46982079|NCT02343159|83228266|FG001|Overall Study|Adverse Event|4|||
46982080|NCT02343159|83228267|FG002|Overall Study|Adverse Event|2|||
46982081|NCT02343159|83228265|FG000|Overall Study|Sponsor Decision|0|||
46982082|NCT02343159|83228266|FG001|Overall Study|Sponsor Decision|1|||
46801532|NCT00545532|83020503|FG001|Overall Study|Withdrawal by Subject|3|||
46801533|NCT00545532|83020502|FG000|Overall Study|Lost to Follow-up|5|||
46693470|NCT01196091|82907835|FG000|Overall Study|Lack of Efficacy|15|||
46693471|NCT01196091|82907836|FG001|Overall Study|Lack of Efficacy|12|||
46693472|NCT01196091|82907837|FG002|Overall Study|Lack of Efficacy|17|||
46693473|NCT01196091|82907835|FG000|Overall Study|Lost to Follow-up|5|||
46982083|NCT02343159|83228267|FG002|Overall Study|Sponsor Decision|0|||
46982084|NCT02343159|83228265|FG000|Overall Study|Enrollment Error|1|||
46982085|NCT02343159|83228266|FG001|Overall Study|Enrollment Error|0|||
46693474|NCT01196091|82907836|FG001|Overall Study|Lost to Follow-up|5|||
46693475|NCT01196091|82907837|FG002|Overall Study|Lost to Follow-up|6|||
46693476|NCT01196091|82907835|FG000|Overall Study|Parent/Caregiver Decision|0|||
46693477|NCT01196091|82907836|FG001|Overall Study|Parent/Caregiver Decision|0|||
46693478|NCT01196091|82907837|FG002|Overall Study|Parent/Caregiver Decision|1|||
46693479|NCT01196091|82907835|FG000|Overall Study|Withdrawal by Subject|16|||
46693480|NCT01196091|82907836|FG001|Overall Study|Withdrawal by Subject|19|||
46693481|NCT01196091|82907837|FG002|Overall Study|Withdrawal by Subject|22|||
46693482|NCT01196091|82907835|FG000|Overall Study|Physician Decision|3|||
46693483|NCT01196091|82907836|FG001|Overall Study|Physician Decision|3|||
46693484|NCT01196091|82907837|FG002|Overall Study|Physician Decision|4|||
46693485|NCT01196091|82907835|FG000|Overall Study|Protocol Violation|1|||
46693486|NCT01196091|82907836|FG001|Overall Study|Protocol Violation|3|||
46693487|NCT01196091|82907837|FG002|Overall Study|Protocol Violation|3|||
46693488|NCT01196091|82907835|FG000|Overall Study|Sponsor Decision|6|||
46693489|NCT01196091|82907836|FG001|Overall Study|Sponsor Decision|5|||
46693490|NCT01196091|82907837|FG002|Overall Study|Sponsor Decision|4|||
46693491|NCT01196091|82907835|FG000|Overall Study|Excluded Site|5|||
46693492|NCT01196091|82907836|FG001|Overall Study|Excluded Site|11|||
46693493|NCT01196091|82907837|FG002|Overall Study|Excluded Site|8|||
46693494|NCT01196091|82907835|FG000|Overall Study|Randomized, No Study Drug Received|1|||
46693495|NCT01196091|82907836|FG001|Overall Study|Randomized, No Study Drug Received|0|||
46693496|NCT01196091|82907837|FG002|Overall Study|Randomized, No Study Drug Received|1|||
46693497|NCT01195623|82907852|FG000|Overall Study|Lost to Follow-up|35|||
46693498|NCT01195623|82907853|FG001|Overall Study|Lost to Follow-up|37|||
46693499|NCT01195545|82907859|FG000|Overall Study|Protocol Violation|4|||
46693500|NCT01194999|82907863|FG000|Overall Study|Lost to Follow-up|17|||
46693501|NCT01194531|82907869|FG000|Overall Study|Withdrawal by Subject|1|||
46693502|NCT01194531|82907870|FG001|Overall Study|Withdrawal by Subject|0|||
46693503|NCT01194531|82907869|FG000|Overall Study|Protocol Violation|4|||
46693504|NCT01194531|82907870|FG001|Overall Study|Protocol Violation|1|||
46693505|NCT01194531|82907869|FG000|Overall Study|Physician Decision|0|||
46693506|NCT01194531|82907870|FG001|Overall Study|Physician Decision|2|||
46693507|NCT00972517|82907876|FG000|Overall Study|Adverse Event|0|||
46693508|NCT00972517|82907877|FG001|Overall Study|Adverse Event|0|||
46693509|NCT00972517|82907878|FG002|Overall Study|Adverse Event|0|||
46693510|NCT00972517|82907879|FG003|Overall Study|Adverse Event|1|||
46801534|NCT00545532|83020503|FG001|Overall Study|Lost to Follow-up|6|||
46801535|NCT00545532|83020502|FG000|Overall Study|Death|0|||
46801536|NCT00545532|83020503|FG001|Overall Study|Death|1|||
46801537|NCT00544440|83020511|FG000|Overall Study|Other|1|||
46801538|NCT00544440|83020511|FG000|Overall Study|Adverse Event|1|||
46801539|NCT00544440|83020511|FG000|Overall Study|Withdrawal by Subject|2|||
46801540|NCT00544440|83020511|FG000|Overall Study|Subject Non-compliance|1|||
46801541|NCT00544440|83020511|FG000|Overall Study|Progressive Disease|47|||
46801542|NCT00544440|83020511|FG000|Overall Study|Other|5|||
46801543|NCT03920670|83020517|FG000|Overall Study|Protocol Violation|2|||
46801544|NCT03920670|83020518|FG001|Overall Study|Protocol Violation|2|||
46693511|NCT00972517|82907880|FG004|Overall Study|Adverse Event|0|||
46801545|NCT03920670|83020517|FG000|Overall Study|Adverse Event|1|||
46693512|NCT00972517|82907881|FG005|Overall Study|Adverse Event|0|||
46693513|NCT00972517|82907876|FG000|Overall Study|Withdrawal by Subject|0|||
46693514|NCT00972517|82907877|FG001|Overall Study|Withdrawal by Subject|1|||
46801546|NCT03920670|83020518|FG001|Overall Study|Adverse Event|0|||
46693515|NCT00972517|82907878|FG002|Overall Study|Withdrawal by Subject|0|||
46693516|NCT00972517|82907879|FG003|Overall Study|Withdrawal by Subject|2|||
46693517|NCT00972517|82907880|FG004|Overall Study|Withdrawal by Subject|1|||
46693518|NCT00972517|82907881|FG005|Overall Study|Withdrawal by Subject|0|||
46693519|NCT00972283|82907903|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
46693520|NCT00972283|82907904|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
46693521|NCT00972283|82907903|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
46693522|NCT00972283|82907904|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
46693523|NCT00972283|82907903|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
46693524|NCT00972283|82907904|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
46693525|NCT00972283|82907903|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
46693526|NCT00972283|82907904|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
46693527|NCT00972283|82907903|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
46693528|NCT00972283|82907904|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
46693529|NCT00972283|82907903|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
46693530|NCT00972283|82907904|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
46693531|NCT00972283|82907903|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
46693532|NCT00972283|82907904|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
46693533|NCT00972283|82907903|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
46693534|NCT00972283|82907904|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
46693535|NCT00972283|82907903|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
46693536|NCT00972283|82907904|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
46693537|NCT00972283|82907903|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
46693538|NCT00972283|82907904|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
46693539|NCT00969709|82907914|FG000|Overall Study|Adverse Event|3|||
46693540|NCT00969709|82907915|FG001|Overall Study|Adverse Event|13|||
46693541|NCT00969709|82907916|FG002|Overall Study|Adverse Event|26|||
46801547|NCT00430300|83020528|FG000|Overall Study|Adverse Event|0|||
46801548|NCT00430300|83020529|FG001|Overall Study|Adverse Event|2|||
46801549|NCT00430300|83020530|FG002|Overall Study|Adverse Event|1|||
46801550|NCT00430300|83020531|FG003|Overall Study|Adverse Event|1|||
46801551|NCT00430300|83020528|FG000|Overall Study|Withdrawal by Subject|1|||
46801552|NCT00430300|83020529|FG001|Overall Study|Withdrawal by Subject|0|||
46801553|NCT00430300|83020530|FG002|Overall Study|Withdrawal by Subject|5|||
46801554|NCT00430300|83020531|FG003|Overall Study|Withdrawal by Subject|0|||
46801555|NCT00430300|83020528|FG000|Overall Study|Laboratory abnormality|1|||
46801556|NCT00430300|83020529|FG001|Overall Study|Laboratory abnormality|0|||
46801557|NCT00430300|83020530|FG002|Overall Study|Laboratory abnormality|0|||
46801558|NCT00430300|83020531|FG003|Overall Study|Laboratory abnormality|0|||
46801559|NCT00430300|83020528|FG000|Overall Study|Other|0|||
46801560|NCT00430300|83020529|FG001|Overall Study|Other|0|||
46801561|NCT00430300|83020530|FG002|Overall Study|Other|0|||
46801562|NCT00430300|83020531|FG003|Overall Study|Other|1|||
46801563|NCT03927846|83020543|FG000|Overall Study|Lost to Follow-up|10|||
46801564|NCT03927846|83020544|FG001|Overall Study|Lost to Follow-up|11|||
46801565|NCT00545298|83020553|FG000|Overall Study|Issues with Standard of Care|2|||
46801566|NCT00545298|83020554|FG001|Overall Study|Issues with Standard of Care|0|||
46801567|NCT00545298|83020555|FG002|Overall Study|Issues with Standard of Care|1|||
46801568|NCT00429364|83020568|FG000|Overall Study|Withdrawal by Subject|11|||
46801569|NCT00429364|83020569|FG001|Overall Study|Withdrawal by Subject|5|||
46801570|NCT00429364|83020568|FG000|Overall Study|Physician Decision|4|||
46801571|NCT00429364|83020569|FG001|Overall Study|Physician Decision|2|||
46801572|NCT00429364|83020568|FG000|Overall Study|Lost to Follow-up|7|||
46801573|NCT00429364|83020569|FG001|Overall Study|Lost to Follow-up|6|||
46801574|NCT00429364|83020568|FG000|Overall Study|Death|0|||
46801575|NCT00429364|83020569|FG001|Overall Study|Death|1|||
46801576|NCT00429364|83020568|FG000|Overall Study|Underwent aortic root surgery|10|||
46801577|NCT00429364|83020569|FG001|Overall Study|Underwent aortic root surgery|18|||
46801578|NCT00429364|83020568|FG000|Overall Study|Pregnancy|0|||
46801579|NCT00429364|83020569|FG001|Overall Study|Pregnancy|1|||
46801580|NCT00414388|83020575|FG000|Overall Study|Adverse Event|1|||
46801581|NCT03920280|83020582|FG000|Overall Study|Adverse Event|2|||
46801582|NCT03920280|83020583|FG001|Overall Study|Adverse Event|3|||
46693542|NCT00969709|82907917|FG003|Overall Study|Adverse Event|12|||
46693543|NCT00969709|82907914|FG000|Overall Study|Lack of Efficacy|7|||
46693544|NCT00969709|82907915|FG001|Overall Study|Lack of Efficacy|4|||
46693545|NCT00969709|82907916|FG002|Overall Study|Lack of Efficacy|1|||
46801583|NCT03920280|83020582|FG000|Overall Study|Lost to Follow-up|0|||
46801584|NCT03920280|83020583|FG001|Overall Study|Lost to Follow-up|1|||
46801585|NCT03920280|83020582|FG000|Overall Study|Withdrawal by Subject|1|||
46801586|NCT03920280|83020583|FG001|Overall Study|Withdrawal by Subject|1|||
46801587|NCT03920280|83020582|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
46801588|NCT03920280|83020583|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
46801589|NCT00424372|83020592|FG000|Overall Study|Death|1|||
46801590|NCT00424372|83020592|FG000|Overall Study|Adverse Event|18|||
46693546|NCT00969709|82907917|FG003|Overall Study|Lack of Efficacy|3|||
46693547|NCT00969709|82907914|FG000|Overall Study|Protocol Violation|9|||
46693548|NCT00969709|82907915|FG001|Overall Study|Protocol Violation|5|||
46693549|NCT00969709|82907916|FG002|Overall Study|Protocol Violation|9|||
46693550|NCT00969709|82907917|FG003|Overall Study|Protocol Violation|10|||
46693551|NCT00969709|82907914|FG000|Overall Study|Withdrawal by Subject|9|||
46693552|NCT00969709|82907915|FG001|Overall Study|Withdrawal by Subject|12|||
46693553|NCT00969709|82907916|FG002|Overall Study|Withdrawal by Subject|11|||
46693554|NCT00969709|82907917|FG003|Overall Study|Withdrawal by Subject|23|||
46693555|NCT00969709|82907914|FG000|Overall Study|Lost to Follow-up|10|||
46693556|NCT00969709|82907915|FG001|Overall Study|Lost to Follow-up|14|||
46801591|NCT00424372|83020592|FG000|Overall Study|Lack of Efficacy|6|||
46801592|NCT00424372|83020592|FG000|Overall Study|Withdrawal by Subject|4|||
46801593|NCT00424372|83020592|FG000|Overall Study|Protocol Violation|1|||
46801594|NCT00424372|83020592|FG000|Overall Study|Health deterioration|1|||
46801595|NCT00414310|83020598|FG000|Overall Study|Not treated|1|||
46801596|NCT00414310|83020599|FG001|Overall Study|Not treated|0|||
46801597|NCT00542880|83020609|FG000|Period 1|Eligibility criteria not fulfilled|2|||
46801598|NCT00542880|83020610|FG001|Period 1|Eligibility criteria not fulfilled|6|||
46801599|NCT00542880|83020609|FG000|Period 1|Adverse Event|2|||
46801600|NCT00542880|83020610|FG001|Period 1|Adverse Event|2|||
46801601|NCT00542880|83020609|FG000|Period 1|Development of study-specific criteria|1|||
46801602|NCT00542880|83020610|FG001|Period 1|Development of study-specific criteria|2|||
46801603|NCT00542880|83020609|FG000|Period 1|Withdrawal by Subject|1|||
46801604|NCT00542880|83020610|FG001|Period 1|Withdrawal by Subject|1|||
46801605|NCT00542880|83020609|FG000|Period 1|Protocol Violation|0|||
46801606|NCT00542880|83020610|FG001|Period 1|Protocol Violation|1|||
46801607|NCT00542880|83020609|FG000|Period 2|Adverse Event|5|||
46801608|NCT00542880|83020610|FG001|Period 2|Adverse Event|7|||
46801609|NCT00542880|83020609|FG000|Period 2|Eligibility not fulfilled|0|||
46801610|NCT00542880|83020610|FG001|Period 2|Eligibility not fulfilled|1|||
46801611|NCT00542880|83020609|FG000|Period 2|Discontinuation criteria|2|||
46801612|NCT00542880|83020610|FG001|Period 2|Discontinuation criteria|0|||
46801613|NCT00542880|83020609|FG000|Period 2|Severe non-compliance|0|||
46801614|NCT00542880|83020610|FG001|Period 2|Severe non-compliance|1|||
46801615|NCT00542880|83020609|FG000|Period 2|Other|0|||
46801616|NCT00542880|83020610|FG001|Period 2|Other|1|||
46801617|NCT00542880|83020609|FG000|Period 3|Adverse Event|0|||
46801618|NCT00542880|83020610|FG001|Period 3|Adverse Event|2|||
46801619|NCT00414076|83020619|FG000|Overall Study|Progression|1|||
46801620|NCT00414076|83020620|FG001|Overall Study|Progression|2|||
46801621|NCT00414076|83020619|FG000|Overall Study|Withdrawal by Subject|1|||
46801622|NCT00414076|83020620|FG001|Overall Study|Withdrawal by Subject|3|||
46801623|NCT00414076|83020619|FG000|Overall Study|Adverse Event|1|||
46801624|NCT00414076|83020620|FG001|Overall Study|Adverse Event|0|||
46801625|NCT00092677|83020628|FG000|Overall Study|Lost to Follow-up|0|||
46801626|NCT00092677|83020629|FG001|Overall Study|Lost to Follow-up|2|||
46801627|NCT00092677|83020628|FG000|Overall Study|Adminstrative|5|||
46801628|NCT00092677|83020629|FG001|Overall Study|Adminstrative|9|||
46801629|NCT00542178|83020641|FG000|Overall Study|did not complete year 4 follow-up|75|||
46801630|NCT00542178|83020642|FG001|Overall Study|did not complete year 4 follow-up|80|||
46801631|NCT00542178|83020643|FG002|Overall Study|did not complete year 4 follow-up|74|||
46693557|NCT00969709|82907916|FG002|Overall Study|Lost to Follow-up|8|||
46693558|NCT00969709|82907917|FG003|Overall Study|Lost to Follow-up|15|||
46693559|NCT00969709|82907914|FG000|Overall Study|Other reasons|0|||
46693560|NCT00969709|82907915|FG001|Overall Study|Other reasons|0|||
46693561|NCT00969709|82907916|FG002|Overall Study|Other reasons|3|||
46693562|NCT00969709|82907917|FG003|Overall Study|Other reasons|0|||
46693563|NCT01193517|82907934|FG000|Overall Study|Early Progression|1|||
46801632|NCT00542178|83020644|FG003|Overall Study|did not complete year 4 follow-up|62|||
46801633|NCT00542178|83020645|FG004|Overall Study|did not complete year 4 follow-up|64|||
46982086|NCT02343159|83228267|FG002|Overall Study|Enrollment Error|0|||
46693564|NCT01193517|82907935|FG001|Overall Study|Early Progression|0|||
46801634|NCT00542178|83020646|FG005|Overall Study|did not complete year 4 follow-up|89|||
46801635|NCT00542178|83020647|FG006|Overall Study|did not complete year 4 follow-up|87|||
46801636|NCT00542178|83020648|FG007|Overall Study|did not complete year 4 follow-up|85|||
46982087|NCT02395653|83228276|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
46693565|NCT01193517|82907936|FG002|Overall Study|Early Progression|0|||
46801637|NCT00424294|83020664|FG000|Overall Study|Adverse Event|4|||
46801638|NCT00424294|83020665|FG001|Overall Study|Adverse Event|10|||
46693566|NCT01193283|82907945|FG000|Overall Study|Death|1|||
46801639|NCT00424294|83020664|FG000|Overall Study|Lack of Efficacy|2|||
46801640|NCT00424294|83020665|FG001|Overall Study|Lack of Efficacy|1|||
46801641|NCT00424294|83020664|FG000|Overall Study|Withdrawal by Subject|1|||
46693567|NCT00971425|82907951|FG000|Overall Study|Adverse Event|1|||
46801642|NCT00424294|83020665|FG001|Overall Study|Withdrawal by Subject|2|||
46801643|NCT00424294|83020664|FG000|Overall Study|Other|0|||
46801644|NCT00424294|83020665|FG001|Overall Study|Other|2|||
46801645|NCT00424294|83020664|FG000|Overall Study|Randomized but not Treated|1|||
46693568|NCT00971425|82907952|FG001|Overall Study|Adverse Event|1|||
46693569|NCT00971425|82907951|FG000|Overall Study|Withdrawal by Subject|0|||
46693570|NCT00971425|82907952|FG001|Overall Study|Withdrawal by Subject|1|||
46693571|NCT01193127|82907962|FG000|Randomized|Surgery Cancelled|0|||
46693572|NCT01193127|82907963|FG001|Randomized|Surgery Cancelled|0|||
46693573|NCT01193127|82907964|FG002|Randomized|Surgery Cancelled|0|||
46693574|NCT01193127|82907965|FG003|Randomized|Surgery Cancelled|1|||
46693575|NCT01193127|82907962|FG000|Treated|Withdrawal by Subject|0|||
46693576|NCT01193127|82907963|FG001|Treated|Withdrawal by Subject|0|||
46693577|NCT01193127|82907964|FG002|Treated|Withdrawal by Subject|0|||
46693578|NCT01193127|82907965|FG003|Treated|Withdrawal by Subject|1|||
46693579|NCT01192815|82907977|FG000|Overall Study|Withdrawal by Subject|1|||
46693580|NCT01192815|82907977|FG000|Overall Study|Lack of Efficacy|1|||
46693581|NCT01192347|82907981|FG000|Overall Study|Death|3|||
46693582|NCT01192347|82907981|FG000|Overall Study|Lost to Follow-up|3|||
46693583|NCT01192347|82907981|FG000|Overall Study|Withdrawal by Subject|1|||
46693584|NCT01192347|82907981|FG000|Overall Study|Adverse Event|1|||
46693585|NCT01192347|82907981|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
46693586|NCT01192347|82907981|FG000|Overall Study|Patient seen in different hospital|1|||
46693587|NCT01192347|82907981|FG000|Overall Study|Patient not visiting hospital regularly|1|||
46693588|NCT01192347|82907981|FG000|Overall Study|Patient did not show up for visits|1|||
46693589|NCT01192191|82907987|FG000|Overall Study|Adverse Event|7|||
46693590|NCT01192191|82907988|FG001|Overall Study|Adverse Event|12|||
46693591|NCT01192191|82907987|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
46693592|NCT01192191|82907988|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
46693593|NCT01192191|82907987|FG000|Overall Study|Lost to Follow-up|0|||
46693594|NCT01192191|82907988|FG001|Overall Study|Lost to Follow-up|1|||
46693595|NCT01192191|82907987|FG000|Overall Study|Withdrawal by Subject|1|||
46693596|NCT01192191|82907988|FG001|Overall Study|Withdrawal by Subject|6|||
46693597|NCT01307267|82908017|FG000|Overall Study|Death|4|||
46693598|NCT01307267|82908018|FG001|Overall Study|Death|3|||
46693599|NCT01307267|82908019|FG002|Overall Study|Death|5|||
46693600|NCT01307267|82908020|FG003|Overall Study|Death|3|||
46693601|NCT01307267|82908021|FG004|Overall Study|Death|1|||
46693602|NCT01307267|82908022|FG005|Overall Study|Death|26|||
46693603|NCT01307267|82908023|FG006|Overall Study|Death|2|||
46693604|NCT01307267|82908024|FG007|Overall Study|Death|2|||
46693605|NCT01307267|82908025|FG008|Overall Study|Death|21|||
46693606|NCT01307267|82908026|FG009|Overall Study|Death|2|||
46693607|NCT01307267|82908027|FG010|Overall Study|Death|3|||
46693608|NCT01307267|82908028|FG011|Overall Study|Death|9|||
46693609|NCT01307267|82908029|FG012|Overall Study|Death|0|||
46693610|NCT01307267|82908030|FG013|Overall Study|Death|0|||
46693611|NCT01307267|82908031|FG014|Overall Study|Death|0|||
46693612|NCT01307267|82908032|FG015|Overall Study|Death|0|||
46693613|NCT01307267|82908033|FG016|Overall Study|Death|1|||
46693614|NCT01307267|82908034|FG017|Overall Study|Death|1|||
46693615|NCT01307267|82908035|FG018|Overall Study|Death|2|||
46693616|NCT01307267|82908036|FG019|Overall Study|Death|8|||
46693617|NCT01307267|82908037|FG020|Overall Study|Death|1|||
46693618|NCT01307267|82908038|FG021|Overall Study|Death|2|||
46693619|NCT01307267|82908039|FG022|Overall Study|Death|2|||
46693620|NCT01307267|82908017|FG000|Overall Study|Lost to Follow-up|0|||
46693621|NCT01307267|82908018|FG001|Overall Study|Lost to Follow-up|0|||
46693622|NCT01307267|82908019|FG002|Overall Study|Lost to Follow-up|0|||
46693623|NCT01307267|82908020|FG003|Overall Study|Lost to Follow-up|0|||
46693624|NCT01307267|82908021|FG004|Overall Study|Lost to Follow-up|0|||
46693625|NCT01307267|82908022|FG005|Overall Study|Lost to Follow-up|7|||
46693626|NCT01307267|82908023|FG006|Overall Study|Lost to Follow-up|0|||
46693627|NCT01307267|82908024|FG007|Overall Study|Lost to Follow-up|0|||
46693628|NCT01307267|82908025|FG008|Overall Study|Lost to Follow-up|1|||
46693629|NCT01307267|82908026|FG009|Overall Study|Lost to Follow-up|2|||
46693630|NCT01307267|82908027|FG010|Overall Study|Lost to Follow-up|1|||
46693631|NCT01307267|82908028|FG011|Overall Study|Lost to Follow-up|0|||
46693632|NCT01307267|82908029|FG012|Overall Study|Lost to Follow-up|0|||
46693633|NCT01307267|82908030|FG013|Overall Study|Lost to Follow-up|0|||
46693634|NCT01307267|82908031|FG014|Overall Study|Lost to Follow-up|0|||
46693635|NCT01307267|82908032|FG015|Overall Study|Lost to Follow-up|0|||
46693636|NCT01307267|82908033|FG016|Overall Study|Lost to Follow-up|0|||
46693637|NCT01307267|82908034|FG017|Overall Study|Lost to Follow-up|0|||
46693638|NCT01307267|82908035|FG018|Overall Study|Lost to Follow-up|0|||
46693639|NCT01307267|82908036|FG019|Overall Study|Lost to Follow-up|2|||
46693640|NCT01307267|82908037|FG020|Overall Study|Lost to Follow-up|0|||
46693641|NCT01307267|82908038|FG021|Overall Study|Lost to Follow-up|0|||
46693642|NCT01307267|82908039|FG022|Overall Study|Lost to Follow-up|0|||
46693643|NCT01307267|82908017|FG000|Overall Study|Withdrawal by Subject|0|||
46693644|NCT01307267|82908018|FG001|Overall Study|Withdrawal by Subject|0|||
46693645|NCT01307267|82908019|FG002|Overall Study|Withdrawal by Subject|0|||
46693646|NCT01307267|82908020|FG003|Overall Study|Withdrawal by Subject|0|||
46693647|NCT01307267|82908021|FG004|Overall Study|Withdrawal by Subject|0|||
46693648|NCT01307267|82908022|FG005|Overall Study|Withdrawal by Subject|1|||
46693649|NCT01307267|82908023|FG006|Overall Study|Withdrawal by Subject|0|||
46693650|NCT01307267|82908024|FG007|Overall Study|Withdrawal by Subject|1|||
46693651|NCT01307267|82908025|FG008|Overall Study|Withdrawal by Subject|5|||
46693652|NCT01307267|82908026|FG009|Overall Study|Withdrawal by Subject|1|||
46693653|NCT01307267|82908027|FG010|Overall Study|Withdrawal by Subject|1|||
46693654|NCT01307267|82908028|FG011|Overall Study|Withdrawal by Subject|1|||
46693655|NCT01307267|82908029|FG012|Overall Study|Withdrawal by Subject|0|||
46693656|NCT01307267|82908030|FG013|Overall Study|Withdrawal by Subject|0|||
46693657|NCT01307267|82908031|FG014|Overall Study|Withdrawal by Subject|0|||
46693658|NCT01307267|82908032|FG015|Overall Study|Withdrawal by Subject|0|||
46693659|NCT01307267|82908033|FG016|Overall Study|Withdrawal by Subject|0|||
46693660|NCT01307267|82908034|FG017|Overall Study|Withdrawal by Subject|0|||
46693661|NCT01307267|82908035|FG018|Overall Study|Withdrawal by Subject|0|||
46693662|NCT01307267|82908036|FG019|Overall Study|Withdrawal by Subject|3|||
46693663|NCT01307267|82908037|FG020|Overall Study|Withdrawal by Subject|0|||
46693664|NCT01307267|82908038|FG021|Overall Study|Withdrawal by Subject|0|||
46693665|NCT01307267|82908039|FG022|Overall Study|Withdrawal by Subject|0|||
46693666|NCT01307267|82908017|FG000|Overall Study|Other|0|||
46693667|NCT01307267|82908018|FG001|Overall Study|Other|0|||
46693668|NCT01307267|82908019|FG002|Overall Study|Other|0|||
46693669|NCT01307267|82908020|FG003|Overall Study|Other|0|||
46693670|NCT01307267|82908021|FG004|Overall Study|Other|0|||
46693671|NCT01307267|82908022|FG005|Overall Study|Other|7|||
46693672|NCT01307267|82908023|FG006|Overall Study|Other|0|||
46693673|NCT01307267|82908024|FG007|Overall Study|Other|1|||
46693674|NCT01307267|82908025|FG008|Overall Study|Other|3|||
46693675|NCT01307267|82908026|FG009|Overall Study|Other|0|||
46693676|NCT01307267|82908027|FG010|Overall Study|Other|1|||
46693677|NCT01307267|82908028|FG011|Overall Study|Other|1|||
46693678|NCT01307267|82908029|FG012|Overall Study|Other|1|||
46693679|NCT01307267|82908030|FG013|Overall Study|Other|0|||
46693680|NCT01307267|82908031|FG014|Overall Study|Other|2|||
46693681|NCT01307267|82908032|FG015|Overall Study|Other|1|||
46693682|NCT01307267|82908033|FG016|Overall Study|Other|0|||
46693683|NCT01307267|82908034|FG017|Overall Study|Other|0|||
46693684|NCT01307267|82908035|FG018|Overall Study|Other|0|||
46693685|NCT01307267|82908036|FG019|Overall Study|Other|19|||
46693686|NCT01307267|82908037|FG020|Overall Study|Other|2|||
46693687|NCT01307267|82908038|FG021|Overall Study|Other|3|||
46693688|NCT01307267|82908039|FG022|Overall Study|Other|2|||
46693689|NCT01307111|82908101|FG000|IUD Insertion|Lost to Follow-up|2|||
46693690|NCT01307111|82908102|FG001|IUD Insertion|Lost to Follow-up|0|||
46693691|NCT01307111|82908101|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
46858974|NCT04750278|83074821|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
46693692|NCT01307111|82908102|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
46693693|NCT01306877|82908110|FG000|Overall Study|Lost to Follow-up|3|||
46693694|NCT01306877|82908111|FG001|Overall Study|Lost to Follow-up|3|||
46693695|NCT01306877|82908110|FG000|Overall Study|Physician Decision|0|||
46693696|NCT01306877|82908111|FG001|Overall Study|Physician Decision|1|||
46693697|NCT01191801|82908119|FG000|Overall Study|Death|36|||
46693698|NCT01191801|82908120|FG001|Overall Study|Death|12|||
46693699|NCT01191801|82908119|FG000|Overall Study|Lack of Efficacy|176|||
46693700|NCT01191801|82908120|FG001|Overall Study|Lack of Efficacy|258|||
46693701|NCT01191801|82908119|FG000|Overall Study|Adverse Event|9|||
46693702|NCT01191801|82908120|FG001|Overall Study|Adverse Event|8|||
46693703|NCT01191801|82908119|FG000|Overall Study|Protocol Violation|2|||
46693704|NCT01191801|82908120|FG001|Overall Study|Protocol Violation|4|||
46693705|NCT01191801|82908119|FG000|Overall Study|Physician Decision|47|||
46693706|NCT01191801|82908120|FG001|Overall Study|Physician Decision|24|||
46693707|NCT01191801|82908119|FG000|Overall Study|Withdrawal by Subject|1|||
46693708|NCT01191801|82908120|FG001|Overall Study|Withdrawal by Subject|4|||
46693709|NCT01191801|82908119|FG000|Overall Study|Not Provided|45|||
46693710|NCT01191801|82908120|FG001|Overall Study|Not Provided|27|||
46693711|NCT01306643|82908126|FG000|Overall Study|Adverse Event|5|||
46693712|NCT01306643|82908126|FG000|Overall Study|Disease Progression|7|||
46693713|NCT01306643|82908126|FG000|Overall Study|Other: Change in Eligibility Status|1|||
46693714|NCT01306331|82908132|FG000|Overall Study|Adverse Event|28|||
46693715|NCT01306331|82908133|FG001|Overall Study|Adverse Event|25|||
46693716|NCT01306331|82908132|FG000|Overall Study|Lost to Follow-up|321|||
46693717|NCT01306331|82908133|FG001|Overall Study|Lost to Follow-up|323|||
46693718|NCT01306331|82908132|FG000|Overall Study|Physician Decision|26|||
46693719|NCT01306331|82908133|FG001|Overall Study|Physician Decision|22|||
46693720|NCT01306331|82908132|FG000|Overall Study|Pregnancy|136|||
46693721|NCT01306331|82908133|FG001|Overall Study|Pregnancy|151|||
46693722|NCT01306331|82908132|FG000|Overall Study|Protocol Violation|154|||
46693723|NCT01306331|82908133|FG001|Overall Study|Protocol Violation|124|||
46693724|NCT01306331|82908132|FG000|Overall Study|Withdrawal by Subject|163|||
46693725|NCT01306331|82908133|FG001|Overall Study|Withdrawal by Subject|152|||
46693726|NCT01306331|82908132|FG000|Overall Study|Not sexually active|29|||
46693727|NCT01306331|82908133|FG001|Overall Study|Not sexually active|28|||
46693728|NCT01306331|82908132|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
46693729|NCT01306331|82908133|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
46693730|NCT01306331|82908132|FG000|Overall Study|Other|34|||
46693731|NCT01306331|82908133|FG001|Overall Study|Other|32|||
46693732|NCT01306253|82908141|FG000|Overall Study|Lost to Follow-up|1|||
46693733|NCT01306253|82908142|FG001|Overall Study|Lost to Follow-up|1|||
46693734|NCT01305941|82908148|FG000|Overall Study|Adverse Event|6|||
46693735|NCT01305941|82908148|FG000|Overall Study|Clinical decline|2|||
46693736|NCT01305941|82908148|FG000|Overall Study|Withdrawal by Subject|1|||
46693737|NCT01305941|82908148|FG000|Overall Study|Death|1|||
46693738|NCT01305239|82908152|FG000|Overall Study|Adverse Event|22|||
46693739|NCT01305239|82908152|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
46693740|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
46693741|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
46693742|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693743|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693744|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693745|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693746|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693747|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693748|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693749|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
46693750|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
46693751|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
46693752|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693753|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693754|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693755|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693756|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693757|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693758|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693759|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
46693760|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
46693761|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693762|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693763|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693764|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693765|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693766|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693767|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693768|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693769|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
46693770|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
46693771|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
46693772|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693773|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693774|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693775|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693776|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693777|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693778|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693779|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
46693780|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693781|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
46693782|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693783|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693784|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693785|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693786|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693787|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693788|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693789|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
46693790|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
46693791|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
46693792|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46693793|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46693794|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46693795|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46693796|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46693797|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46801646|NCT00424294|83020665|FG001|Overall Study|Randomized but not Treated|0|||
46801647|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
46801648|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
46693798|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46693799|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
46693800|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
46693801|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
46693802|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693803|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693804|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693805|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693806|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693807|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693808|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693809|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
46693810|NCT01194219|82908158|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
46693811|NCT01194219|82908159|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
46693812|NCT01194219|82908160|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693813|NCT01194219|82908161|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693814|NCT01194219|82908162|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693815|NCT01194219|82908163|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693816|NCT01194219|82908164|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693817|NCT01194219|82908165|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693818|NCT01194219|82908166|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693819|NCT01194219|82908167|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
46693820|NCT01194219|82908158|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693821|NCT01194219|82908159|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693822|NCT01194219|82908160|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
46693823|NCT01194219|82908161|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
46693824|NCT01194219|82908162|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693825|NCT01194219|82908163|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693826|NCT01194219|82908164|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693827|NCT01194219|82908165|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693828|NCT01194219|82908166|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693829|NCT01194219|82908167|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
46693830|NCT01194219|82908158|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46693831|NCT01194219|82908159|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46693832|NCT01194219|82908160|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
46693833|NCT01194219|82908161|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
46693834|NCT01194219|82908162|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46693835|NCT01194219|82908163|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46693836|NCT01194219|82908164|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46801649|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
46801650|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
46801651|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
46801652|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
46801653|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
46801654|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
46693837|NCT01194219|82908165|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46693838|NCT01194219|82908166|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46693839|NCT01194219|82908167|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
46693840|NCT01194219|82908158|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693841|NCT01194219|82908159|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693842|NCT01194219|82908160|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
46693843|NCT01194219|82908161|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
46693844|NCT01194219|82908162|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693845|NCT01194219|82908163|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693846|NCT01194219|82908164|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693847|NCT01194219|82908165|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693848|NCT01194219|82908166|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693849|NCT01194219|82908167|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
46693850|NCT01194219|82908158|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693851|NCT01194219|82908159|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693852|NCT01194219|82908160|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
46693853|NCT01194219|82908161|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
46693854|NCT01194219|82908162|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693855|NCT01194219|82908163|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693856|NCT01194219|82908164|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693857|NCT01194219|82908165|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693858|NCT01194219|82908166|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693859|NCT01194219|82908167|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
46693860|NCT01194219|82908158|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693861|NCT01194219|82908159|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693862|NCT01194219|82908160|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
46693863|NCT01194219|82908161|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693864|NCT01194219|82908162|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693865|NCT01194219|82908163|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693866|NCT01194219|82908164|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693867|NCT01194219|82908165|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693868|NCT01194219|82908166|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693869|NCT01194219|82908167|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
46693870|NCT01194219|82908158|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693871|NCT01194219|82908159|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693872|NCT01194219|82908160|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693873|NCT01194219|82908161|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
46693874|NCT01194219|82908162|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693875|NCT01194219|82908163|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693876|NCT01194219|82908164|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693877|NCT01194219|82908165|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693878|NCT01194219|82908166|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693879|NCT01194219|82908167|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
46693880|NCT01194219|82908158|FG000|Maintenance Phase Weeks16-32|Other|0|||
46693881|NCT01194219|82908159|FG001|Maintenance Phase Weeks16-32|Other|0|||
46693882|NCT01194219|82908160|FG002|Maintenance Phase Weeks16-32|Other|2|||
46693883|NCT01194219|82908161|FG003|Maintenance Phase Weeks16-32|Other|1|||
46693884|NCT01194219|82908162|FG004|Maintenance Phase Weeks16-32|Other|0|||
46693885|NCT01194219|82908163|FG005|Maintenance Phase Weeks16-32|Other|0|||
46801655|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
46801656|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
46801657|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
46801658|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
46801659|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
46693886|NCT01194219|82908164|FG006|Maintenance Phase Weeks16-32|Other|0|||
46693887|NCT01194219|82908165|FG007|Maintenance Phase Weeks16-32|Other|0|||
46693888|NCT01194219|82908166|FG008|Maintenance Phase Weeks16-32|Other|0|||
46693889|NCT01194219|82908167|FG009|Maintenance Phase Weeks16-32|Other|0|||
46693890|NCT01194219|82908158|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
46801660|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
46693891|NCT01194219|82908159|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
46801661|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
46801662|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
46801663|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
46801664|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
46801665|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
46801666|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
46801667|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
46801668|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
46801669|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
46801670|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
46801671|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
46801672|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
46801673|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
46801674|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
46801675|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
46801676|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
46801677|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
46801678|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
46801679|NCT00092521|83020674|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
46801680|NCT00092521|83020675|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
46801681|NCT00092521|83020676|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
46801682|NCT00092521|83020677|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
46801683|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
46801684|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
46801685|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
46801686|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
46801687|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
46801688|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
46801689|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
46801690|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
46801691|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
46801692|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
46801693|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
46801694|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
46801695|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Death|2|||
46801696|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Death|0|||
46801697|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Death|1|||
46801698|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Death|0|||
46801699|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
46801700|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
46801701|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
46801702|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
46801703|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
46801704|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
46801705|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
46801706|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
46801707|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
46801708|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
46801709|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
46801710|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
46801711|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Moved|32|||
46801712|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Moved|2|||
46801713|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Moved|28|||
46801714|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Moved|0|||
46801715|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
46801716|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
46982088|NCT02395653|83228276|FG000|Overall Study|Consent Withdrawn at Screening|1|||
46801717|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
46801718|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
46858975|NCT04750278|83074822|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
46858976|NCT04750278|83074823|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
46858977|NCT04317274|83074880|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
46858978|NCT04317274|83074881|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
46858979|NCT04317274|83074882|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
46858980|NCT04317274|83074883|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
46858981|NCT03875911|83074896|FG000|Overall Study|Lost to Follow-up|3|||
46858982|NCT03875911|83074897|FG001|Overall Study|Lost to Follow-up|6|||
46858983|NCT03875911|83074898|FG002|Overall Study|Lost to Follow-up|2|||
46858984|NCT03875911|83074896|FG000|Overall Study|Surgery cancelled|1|||
46858985|NCT03875911|83074897|FG001|Overall Study|Surgery cancelled|0|||
46858986|NCT03875911|83074898|FG002|Overall Study|Surgery cancelled|1|||
46858987|NCT03875911|83074896|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
46858988|NCT03875911|83074897|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
46858989|NCT03875911|83074898|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
46858990|NCT03836053|83074920|FG000|Overall Study|Protocol-specified criteria|0|||
46858991|NCT03836053|83074921|FG001|Overall Study|Protocol-specified criteria|2|||
46858992|NCT03836053|83074922|FG002|Overall Study|Protocol-specified criteria|1|||
46858993|NCT03836053|83074920|FG000|Overall Study|Death|1|||
46858994|NCT03836053|83074921|FG001|Overall Study|Death|6|||
46858995|NCT03836053|83074922|FG002|Overall Study|Death|4|||
46858996|NCT03836053|83074920|FG000|Overall Study|Withdrawal of consent from study|0|||
46858997|NCT03836053|83074921|FG001|Overall Study|Withdrawal of consent from study|0|||
46858998|NCT03836053|83074922|FG002|Overall Study|Withdrawal of consent from study|1|||
46801719|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Travel|2|||
46801720|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Travel|0|||
46801721|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Travel|0|||
46801722|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Travel|0|||
46693892|NCT01194219|82908160|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
46693893|NCT01194219|82908161|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
46693894|NCT01194219|82908162|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
46693895|NCT01194219|82908163|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
46693896|NCT01194219|82908164|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
46693897|NCT01194219|82908165|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
46693898|NCT01194219|82908166|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
46693899|NCT01194219|82908167|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
46693900|NCT01194219|82908158|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
46801723|NCT00092521|83020674|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
46801724|NCT00092521|83020675|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
46801725|NCT00092521|83020676|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
46801726|NCT00092521|83020677|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
46801727|NCT00092521|83020674|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
46801728|NCT00092521|83020675|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
46801729|NCT00092521|83020676|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
46858999|NCT03836053|83074920|FG000|Overall Study|Decision by sponsor|0|||
46859000|NCT03836053|83074921|FG001|Overall Study|Decision by sponsor|2|||
46693901|NCT01194219|82908159|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
46693902|NCT01194219|82908160|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
46693903|NCT01194219|82908161|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
46693904|NCT01194219|82908162|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
46693905|NCT01194219|82908163|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
46693906|NCT01194219|82908164|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
46693907|NCT01194219|82908165|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
46693908|NCT01194219|82908166|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
46693909|NCT01194219|82908167|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
46693910|NCT01194219|82908158|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693911|NCT01194219|82908159|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693912|NCT01194219|82908160|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693913|NCT01194219|82908161|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693914|NCT01194219|82908162|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
46693915|NCT01194219|82908163|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693916|NCT01194219|82908164|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
46693917|NCT01194219|82908165|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693918|NCT01194219|82908166|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693919|NCT01194219|82908167|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
46693920|NCT01194219|82908158|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
46693921|NCT01194219|82908159|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
46693922|NCT01194219|82908160|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
46693923|NCT01194219|82908161|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
46693924|NCT01194219|82908162|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
46693925|NCT01194219|82908163|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
46693926|NCT01194219|82908164|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
46693927|NCT01194219|82908165|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
46693928|NCT01194219|82908166|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
46693929|NCT01194219|82908167|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
46693930|NCT01194219|82908158|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
46693931|NCT01194219|82908159|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
46693932|NCT01194219|82908160|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
46693933|NCT01194219|82908161|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
46693934|NCT01194219|82908162|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
46801730|NCT00092521|83020677|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
46801731|NCT00092521|83020674|FG000|Extension Study (Group 4)|Adverse Event|0|||
46801732|NCT00092521|83020675|FG001|Extension Study (Group 4)|Adverse Event|0|||
46801733|NCT00092521|83020676|FG002|Extension Study (Group 4)|Adverse Event|0|||
46801734|NCT00092521|83020677|FG003|Extension Study (Group 4)|Adverse Event|2|||
46801735|NCT00092521|83020674|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
46693935|NCT01194219|82908163|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
46693936|NCT01194219|82908164|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
46693937|NCT01194219|82908165|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
46693938|NCT01194219|82908166|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
46693939|NCT01194219|82908167|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
46693940|NCT01194219|82908158|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693941|NCT01194219|82908159|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693942|NCT01194219|82908160|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693943|NCT01194219|82908161|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693944|NCT01194219|82908162|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693945|NCT01194219|82908163|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693946|NCT01194219|82908164|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693947|NCT01194219|82908165|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
46693948|NCT01194219|82908166|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693949|NCT01194219|82908167|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
46693950|NCT01194219|82908158|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693951|NCT01194219|82908159|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693952|NCT01194219|82908160|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693953|NCT01194219|82908161|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693954|NCT01194219|82908162|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693955|NCT01194219|82908163|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693956|NCT01194219|82908164|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
46693957|NCT01194219|82908165|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693958|NCT01194219|82908166|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693959|NCT01194219|82908167|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
46693960|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693961|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693962|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693963|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693964|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693965|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693966|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693967|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
46693968|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
46693969|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
46693970|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693971|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693972|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693973|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693974|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693975|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693976|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693977|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
46693978|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
46693979|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
46693980|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693981|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693982|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693983|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693984|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693985|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693986|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693987|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
46693988|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
46693989|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
46693990|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46693991|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46693992|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46693993|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46693994|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46801736|NCT00092521|83020675|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
46801737|NCT00092521|83020676|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
46801738|NCT00092521|83020677|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
46801739|NCT00092521|83020674|FG000|Extension Study (Group 4)|Pregnancy|0|||
46801740|NCT00092521|83020675|FG001|Extension Study (Group 4)|Pregnancy|0|||
46801741|NCT00092521|83020676|FG002|Extension Study (Group 4)|Pregnancy|0|||
46693995|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46693996|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46693997|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
46693998|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
46693999|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
46694000|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
46694001|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
46694002|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
46694003|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
46694004|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
46694005|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
46694006|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
46694007|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
46694008|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
46694009|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
46694010|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694011|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694012|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694013|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694014|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694015|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694016|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694017|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
46694018|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
46694019|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
46694020|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694021|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694022|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694023|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694024|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694025|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694026|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694027|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694028|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
46694029|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
46694030|NCT01194219|82908158|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694031|NCT01194219|82908159|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694032|NCT01194219|82908160|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694033|NCT01194219|82908161|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694034|NCT01194219|82908162|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694035|NCT01194219|82908163|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694036|NCT01194219|82908164|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694037|NCT01194219|82908165|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
46694038|NCT01194219|82908166|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
46694039|NCT01194219|82908167|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
46694040|NCT01304693|82908195|FG000|Overall Study|Adverse Event|0|||
46694041|NCT01304693|82908196|FG001|Overall Study|Adverse Event|0|||
46694042|NCT01304693|82908197|FG002|Overall Study|Adverse Event|0|||
46694043|NCT01304693|82908198|FG003|Overall Study|Adverse Event|0|||
46694044|NCT01304693|82908199|FG004|Overall Study|Adverse Event|1|||
46801742|NCT00092521|83020677|FG003|Extension Study (Group 4)|Pregnancy|4|||
46801743|NCT00092521|83020674|FG000|Extension Study (Group 4)|Protocol Violation|0|||
46694045|NCT01304693|82908195|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
46801744|NCT00092521|83020675|FG001|Extension Study (Group 4)|Protocol Violation|0|||
46801745|NCT00092521|83020676|FG002|Extension Study (Group 4)|Protocol Violation|0|||
46801746|NCT00092521|83020677|FG003|Extension Study (Group 4)|Protocol Violation|2|||
46801747|NCT00092521|83020674|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
46694046|NCT01304693|82908196|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
46694047|NCT01304693|82908197|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
46694048|NCT01304693|82908198|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
46694049|NCT01304693|82908199|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
46694050|NCT01304147|82908211|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
46694051|NCT01304147|82908212|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
46694052|NCT01303445|82908218|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
46801748|NCT00092521|83020675|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
46801749|NCT00092521|83020676|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
46801750|NCT00092521|83020677|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
46801751|NCT00092521|83020674|FG000|Extension Study (Group 4)|Moved|0|||
46801752|NCT00092521|83020675|FG001|Extension Study (Group 4)|Moved|0|||
46801753|NCT00092521|83020676|FG002|Extension Study (Group 4)|Moved|0|||
46801754|NCT00092521|83020677|FG003|Extension Study (Group 4)|Moved|16|||
46801755|NCT00092521|83020674|FG000|Extension Study (Group 4)|Site Terminated|0|||
46801756|NCT00092521|83020675|FG001|Extension Study (Group 4)|Site Terminated|0|||
46801757|NCT00092521|83020676|FG002|Extension Study (Group 4)|Site Terminated|0|||
46801758|NCT00092521|83020677|FG003|Extension Study (Group 4)|Site Terminated|4|||
46801759|NCT00092521|83020674|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
46801760|NCT00092521|83020675|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
46801761|NCT00092521|83020676|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
46801762|NCT00092521|83020677|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
46801763|NCT03908970|83020687|FG000|Overall Study|Adverse Event|7|||
46801764|NCT03908970|83020688|FG001|Overall Study|Adverse Event|21|||
46801765|NCT03908970|83020687|FG000|Overall Study|Physician Decision|1|||
46801766|NCT03908970|83020688|FG001|Overall Study|Physician Decision|4|||
46801767|NCT03908970|83020687|FG000|Overall Study|Withdrawal by Subject|9|||
46801768|NCT03908970|83020688|FG001|Overall Study|Withdrawal by Subject|22|||
46801769|NCT00092443|83020696|FG000|Overall Study|Adverse Event|9|||
46801770|NCT00092443|83020697|FG001|Overall Study|Adverse Event|13|||
46801771|NCT00092443|83020696|FG000|Overall Study|Lost to Follow-up|7|||
46801772|NCT00092443|83020697|FG001|Overall Study|Lost to Follow-up|3|||
46801773|NCT00092443|83020696|FG000|Overall Study|Protocol Violation|11|||
46801774|NCT00092443|83020697|FG001|Overall Study|Protocol Violation|9|||
46801775|NCT00092443|83020696|FG000|Overall Study|Withdrawal by Subject|9|||
46801776|NCT00092443|83020697|FG001|Overall Study|Withdrawal by Subject|11|||
46801777|NCT00092443|83020696|FG000|Overall Study|Moved|5|||
46801778|NCT00092443|83020697|FG001|Overall Study|Moved|5|||
46801779|NCT00092443|83020696|FG000|Overall Study|Other|17|||
46801780|NCT00092443|83020697|FG001|Overall Study|Other|13|||
46801781|NCT00413920|83020715|FG000|Overall Study|Adverse Event|9|||
46859001|NCT03836053|83074922|FG002|Overall Study|Decision by sponsor|4|||
46859002|NCT03647137|83074951|FG000|Overall Study|Scan Limitation|2|||
46859003|NCT03647137|83074952|FG001|Overall Study|Scan Limitation|1|||
46982089|NCT02395653|83228276|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
46982090|NCT02395653|83228276|FG000|Overall Study|Investigator Decision at Screening|1|||
46982091|NCT02395653|83228276|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
46694053|NCT01303445|82908219|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
46801782|NCT00413920|83020716|FG001|Overall Study|Adverse Event|11|||
46801783|NCT00413920|83020715|FG000|Overall Study|Lack of Efficacy|11|||
46801784|NCT00413920|83020716|FG001|Overall Study|Lack of Efficacy|9|||
46801785|NCT00413920|83020715|FG000|Overall Study|Death|3|||
46859004|NCT03647137|83074953|FG002|Overall Study|Scan Limitation|1|||
46859005|NCT03647137|83074954|FG003|Overall Study|Scan Limitation|2|||
46982092|NCT02395653|83228276|FG000|Overall Study|Withdrawal by Subject|1|||
46801786|NCT00413920|83020716|FG001|Overall Study|Death|5|||
46801787|NCT00413920|83020715|FG000|Overall Study|Graft Loss|5|||
46801788|NCT00413920|83020716|FG001|Overall Study|Graft Loss|3|||
46801789|NCT00091819|83020724|FG000|Overall Study|Adverse Event|1|||
46801790|NCT00091819|83020725|FG001|Overall Study|Adverse Event|1|||
46801791|NCT00091819|83020724|FG000|Overall Study|Death|4|||
46801792|NCT00091819|83020725|FG001|Overall Study|Death|5|||
46694054|NCT01303445|82908218|FG000|Second Intervention (7 Days)|Adverse Event|0|||
46694055|NCT01303445|82908219|FG001|Second Intervention (7 Days)|Adverse Event|2|||
46694056|NCT01303445|82908218|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
46694057|NCT01303445|82908219|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
46694058|NCT01303445|82908218|FG000|Washout (14 Days)|Protocol Violation|1|||
46694059|NCT01303445|82908219|FG001|Washout (14 Days)|Protocol Violation|0|||
46694060|NCT01303445|82908218|FG000|Washout (14 Days)|Lost to Follow-up|0|||
46694061|NCT01303445|82908219|FG001|Washout (14 Days)|Lost to Follow-up|2|||
46694062|NCT01303445|82908218|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
46694063|NCT01303445|82908219|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
46694064|NCT01303445|82908218|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
46694065|NCT01303445|82908219|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
46694066|NCT01188681|82908233|FG000|Overall Study|bladder cancer|0|||
46694067|NCT01188681|82908234|FG001|Overall Study|bladder cancer|0|||
46801793|NCT00091819|83020724|FG000|Overall Study|Lost to Follow-up|26|||
46982093|NCT02395653|83228276|FG000|Overall Study|Lost to Follow-up|1|||
46982094|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
46694068|NCT01188681|82908235|FG002|Overall Study|bladder cancer|1|||
46694069|NCT01188681|82908236|FG003|Overall Study|bladder cancer|0|||
46694070|NCT01188681|82908233|FG000|Overall Study|Withdrawal by Subject|0|||
46694071|NCT01188681|82908234|FG001|Overall Study|Withdrawal by Subject|0|||
46801794|NCT00091819|83020725|FG001|Overall Study|Lost to Follow-up|23|||
46801795|NCT00091819|83020724|FG000|Overall Study|Withdrawal by Subject|5|||
46801796|NCT00091819|83020725|FG001|Overall Study|Withdrawal by Subject|8|||
46801797|NCT00091819|83020724|FG000|Overall Study|Protocol Violation|1|||
46801798|NCT00091819|83020725|FG001|Overall Study|Protocol Violation|2|||
46801799|NCT00091819|83020724|FG000|Overall Study|Other|2|||
46801800|NCT00091819|83020725|FG001|Overall Study|Other|3|||
46801801|NCT00091819|83020724|FG000|Overall Study|Never received study treatment|3|||
46801802|NCT00091819|83020725|FG001|Overall Study|Never received study treatment|4|||
46801803|NCT00540228|83020736|FG000|Overall Study|Adverse Event|2|||
46801804|NCT00540228|83020737|FG001|Overall Study|Adverse Event|0|||
46801805|NCT00540228|83020738|FG002|Overall Study|Adverse Event|0|||
46801806|NCT00540228|83020739|FG003|Overall Study|Adverse Event|0|||
46801807|NCT00540228|83020740|FG004|Overall Study|Adverse Event|0|||
46801808|NCT00540228|83020736|FG000|Overall Study|Lost to Follow-up|1|||
46801809|NCT00540228|83020737|FG001|Overall Study|Lost to Follow-up|1|||
46801810|NCT00540228|83020738|FG002|Overall Study|Lost to Follow-up|0|||
46801811|NCT00540228|83020739|FG003|Overall Study|Lost to Follow-up|0|||
46801812|NCT00540228|83020740|FG004|Overall Study|Lost to Follow-up|0|||
46694072|NCT01188681|82908235|FG002|Overall Study|Withdrawal by Subject|0|||
46694073|NCT01188681|82908236|FG003|Overall Study|Withdrawal by Subject|1|||
46694074|NCT01302899|82908252|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
46694075|NCT01302899|82908253|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
46694076|NCT01302899|82908252|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
46694077|NCT01302899|82908253|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
46694078|NCT01187901|82908265|FG000|Overall Study|Protocol Violation|1|||
46694079|NCT01187901|82908266|FG001|Overall Study|Protocol Violation|0|||
46694080|NCT01187901|82908265|FG000|Overall Study|Lost to Follow-up|1|||
46694081|NCT01187901|82908266|FG001|Overall Study|Lost to Follow-up|2|||
46694082|NCT01187901|82908265|FG000|Overall Study|Unrelated Health Reasons|1|||
46801813|NCT05013385|83020765|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
46801814|NCT04250636|83020788|FG000|Overall Study|Lost to Follow-up|2|||
46801815|NCT03989115|83020800|FG000|Overall Study|Withdrawal by Subject|2|||
46801816|NCT03989115|83020801|FG001|Overall Study|Withdrawal by Subject|1|||
46801817|NCT03989115|83020802|FG002|Overall Study|Withdrawal by Subject|3|||
46801818|NCT03989115|83020803|FG003|Overall Study|Withdrawal by Subject|0|||
46801819|NCT03989115|83020804|FG004|Overall Study|Withdrawal by Subject|17|||
46801820|NCT03989115|83020805|FG005|Overall Study|Withdrawal by Subject|1|||
46801821|NCT03989115|83020806|FG006|Overall Study|Withdrawal by Subject|0|||
46801822|NCT03989115|83020807|FG007|Overall Study|Withdrawal by Subject|0|||
46801823|NCT03989115|83020800|FG000|Overall Study|Sponsor decision to terminate the study|1|||
46801824|NCT03989115|83020801|FG001|Overall Study|Sponsor decision to terminate the study|1|||
46801825|NCT03989115|83020802|FG002|Overall Study|Sponsor decision to terminate the study|0|||
46801826|NCT03989115|83020803|FG003|Overall Study|Sponsor decision to terminate the study|1|||
46801827|NCT03989115|83020804|FG004|Overall Study|Sponsor decision to terminate the study|11|||
46801828|NCT03989115|83020805|FG005|Overall Study|Sponsor decision to terminate the study|0|||
46694083|NCT01187901|82908266|FG001|Overall Study|Unrelated Health Reasons|2|||
46694084|NCT01187901|82908265|FG000|Overall Study|Suspected Allergic Reaction|1|||
46801829|NCT03989115|83020806|FG006|Overall Study|Sponsor decision to terminate the study|2|||
46801830|NCT03989115|83020807|FG007|Overall Study|Sponsor decision to terminate the study|1|||
46801831|NCT03989115|83020800|FG000|Overall Study|Lost to Follow-up|2|||
46801832|NCT03989115|83020801|FG001|Overall Study|Lost to Follow-up|0|||
46801833|NCT03989115|83020802|FG002|Overall Study|Lost to Follow-up|0|||
46801834|NCT03989115|83020803|FG003|Overall Study|Lost to Follow-up|0|||
46801835|NCT03989115|83020804|FG004|Overall Study|Lost to Follow-up|1|||
46801836|NCT03989115|83020805|FG005|Overall Study|Lost to Follow-up|0|||
46801837|NCT03989115|83020806|FG006|Overall Study|Lost to Follow-up|0|||
46801838|NCT03989115|83020807|FG007|Overall Study|Lost to Follow-up|0|||
46694085|NCT01187901|82908266|FG001|Overall Study|Suspected Allergic Reaction|1|||
46694086|NCT01187901|82908265|FG000|Overall Study|Adverse Event|3|||
46694087|NCT01187901|82908266|FG001|Overall Study|Adverse Event|0|||
46694088|NCT01187901|82908265|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
46694089|NCT01187901|82908266|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
46694090|NCT01187901|82908265|FG000|Overall Study|Pregnancy|0|||
46694091|NCT01187901|82908266|FG001|Overall Study|Pregnancy|2|||
46694092|NCT01302119|82908274|FG000|Overall Study|Withdrawal by Subject|30|||
46694093|NCT01302119|82908275|FG001|Overall Study|Withdrawal by Subject|20|||
46694094|NCT01302119|82908274|FG000|Overall Study|Lost to Follow-up|10|||
46694095|NCT01302119|82908275|FG001|Overall Study|Lost to Follow-up|4|||
46694096|NCT01302119|82908274|FG000|Overall Study|Adverse Event|2|||
46694097|NCT01302119|82908275|FG001|Overall Study|Adverse Event|1|||
46694098|NCT01302119|82908274|FG000|Overall Study|Non-compliance|4|||
46694099|NCT01302119|82908275|FG001|Overall Study|Non-compliance|2|||
46694100|NCT01302119|82908274|FG000|Overall Study|Non-specific|4|||
46694101|NCT01302119|82908275|FG001|Overall Study|Non-specific|1|||
46694102|NCT05038982|82908283|FG000|Overall Study|Withdrawal by Subject|0|||
46694103|NCT05038982|82908284|FG001|Overall Study|Withdrawal by Subject|2|||
46694104|NCT04867785|82908303|FG000|Overall Study|Adverse Event|1|||
46694105|NCT04867785|82908304|FG001|Overall Study|Adverse Event|0|||
46694106|NCT04867785|82908305|FG002|Overall Study|Adverse Event|1|||
46694107|NCT04867785|82908306|FG003|Overall Study|Adverse Event|0|||
46694108|NCT04867785|82908307|FG004|Overall Study|Adverse Event|0|||
46694109|NCT04867785|82908308|FG005|Overall Study|Adverse Event|0|||
46694110|NCT04867785|82908309|FG006|Overall Study|Adverse Event|0|||
46694111|NCT04867785|82908310|FG007|Overall Study|Adverse Event|2|||
46694112|NCT04867785|82908303|FG000|Overall Study|Lost to Follow-up|4|||
46694113|NCT04867785|82908304|FG001|Overall Study|Lost to Follow-up|4|||
46694114|NCT04867785|82908305|FG002|Overall Study|Lost to Follow-up|3|||
46694115|NCT04867785|82908306|FG003|Overall Study|Lost to Follow-up|2|||
46694116|NCT04867785|82908307|FG004|Overall Study|Lost to Follow-up|0|||
46694117|NCT04867785|82908308|FG005|Overall Study|Lost to Follow-up|1|||
46694118|NCT04867785|82908309|FG006|Overall Study|Lost to Follow-up|0|||
46694119|NCT04867785|82908310|FG007|Overall Study|Lost to Follow-up|1|||
46694120|NCT04867785|82908303|FG000|Overall Study|Withdrawal by Subject|6|||
46694121|NCT04867785|82908304|FG001|Overall Study|Withdrawal by Subject|2|||
46694122|NCT04867785|82908305|FG002|Overall Study|Withdrawal by Subject|2|||
46694123|NCT04867785|82908306|FG003|Overall Study|Withdrawal by Subject|1|||
46694124|NCT04867785|82908307|FG004|Overall Study|Withdrawal by Subject|2|||
46859006|NCT03454893|83074965|FG000|Overall Study|Study Terminated by the Sponsor|5|||
46859007|NCT03454893|83074965|FG000|Overall Study|Did not pass screening|4|||
46694125|NCT04867785|82908308|FG005|Overall Study|Withdrawal by Subject|0|||
46694126|NCT04867785|82908309|FG006|Overall Study|Withdrawal by Subject|2|||
46694127|NCT04867785|82908310|FG007|Overall Study|Withdrawal by Subject|5|||
46694128|NCT04867785|82908303|FG000|Overall Study|Physician Decision|0|||
46694129|NCT04867785|82908304|FG001|Overall Study|Physician Decision|0|||
46694130|NCT04867785|82908305|FG002|Overall Study|Physician Decision|0|||
46694131|NCT04867785|82908306|FG003|Overall Study|Physician Decision|0|||
46694132|NCT04867785|82908307|FG004|Overall Study|Physician Decision|0|||
46694133|NCT04867785|82908308|FG005|Overall Study|Physician Decision|0|||
46694134|NCT04867785|82908309|FG006|Overall Study|Physician Decision|0|||
46694135|NCT04867785|82908310|FG007|Overall Study|Physician Decision|1|||
46694136|NCT04867785|82908303|FG000|Overall Study|Inadvertent Enrollment|0|||
46694137|NCT04867785|82908304|FG001|Overall Study|Inadvertent Enrollment|0|||
46694138|NCT04867785|82908305|FG002|Overall Study|Inadvertent Enrollment|0|||
46694139|NCT04867785|82908306|FG003|Overall Study|Inadvertent Enrollment|1|||
46694140|NCT04867785|82908307|FG004|Overall Study|Inadvertent Enrollment|1|||
46694141|NCT04867785|82908308|FG005|Overall Study|Inadvertent Enrollment|0|||
46694142|NCT04867785|82908309|FG006|Overall Study|Inadvertent Enrollment|0|||
46694143|NCT04867785|82908310|FG007|Overall Study|Inadvertent Enrollment|1|||
46694144|NCT04867785|82908303|FG000|Overall Study|Eligibility Criteria Not Met|0|||
46694145|NCT04867785|82908304|FG001|Overall Study|Eligibility Criteria Not Met|0|||
46694146|NCT04867785|82908305|FG002|Overall Study|Eligibility Criteria Not Met|0|||
46694147|NCT04867785|82908306|FG003|Overall Study|Eligibility Criteria Not Met|0|||
46694148|NCT04867785|82908307|FG004|Overall Study|Eligibility Criteria Not Met|0|||
46694149|NCT04867785|82908308|FG005|Overall Study|Eligibility Criteria Not Met|0|||
46694150|NCT04867785|82908309|FG006|Overall Study|Eligibility Criteria Not Met|0|||
46694151|NCT04867785|82908310|FG007|Overall Study|Eligibility Criteria Not Met|1|||
46694152|NCT04541004|82908337|FG000|Overall Study|Adverse Event|2|||
46694153|NCT04091646|82908344|FG000|Overall Study|Adverse Event|2|||
46801839|NCT03989115|83020800|FG000|Overall Study|Death|2|||
46801840|NCT03989115|83020801|FG001|Overall Study|Death|2|||
46801841|NCT03989115|83020802|FG002|Overall Study|Death|9|||
46801842|NCT03989115|83020803|FG003|Overall Study|Death|6|||
46801843|NCT03989115|83020804|FG004|Overall Study|Death|31|||
46801844|NCT03989115|83020805|FG005|Overall Study|Death|6|||
46801845|NCT03989115|83020806|FG006|Overall Study|Death|2|||
46801846|NCT03989115|83020807|FG007|Overall Study|Death|3|||
46801847|NCT03989115|83020800|FG000|Overall Study|Other|1|||
46801848|NCT03989115|83020801|FG001|Overall Study|Other|2|||
46801849|NCT03989115|83020802|FG002|Overall Study|Other|0|||
46801850|NCT03989115|83020803|FG003|Overall Study|Other|0|||
46801851|NCT03989115|83020804|FG004|Overall Study|Other|5|||
46801852|NCT03989115|83020805|FG005|Overall Study|Other|0|||
46801853|NCT03989115|83020806|FG006|Overall Study|Other|0|||
46801854|NCT03989115|83020807|FG007|Overall Study|Other|0|||
46801855|NCT03797898|83020836|FG000|Overall Study|Lost to Follow-up|60|||
46801856|NCT03797898|83020837|FG001|Overall Study|Lost to Follow-up|69|||
46801857|NCT03797898|83020836|FG000|Overall Study|Withdrawal by Subject|9|||
46801858|NCT03797898|83020837|FG001|Overall Study|Withdrawal by Subject|7|||
46801859|NCT03797898|83020836|FG000|Overall Study|Became ineligible|5|||
46801860|NCT03797898|83020837|FG001|Overall Study|Became ineligible|2|||
46801861|NCT03559192|83020859|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
46801862|NCT03559192|83020860|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
46859008|NCT03379792|83074975|FG000|Overall Study|Physician Decision|0|||
46859009|NCT03379792|83074976|FG001|Overall Study|Physician Decision|0|||
46859010|NCT03379792|83074977|FG002|Overall Study|Physician Decision|0|||
46859011|NCT03379792|83074978|FG003|Overall Study|Physician Decision|1|||
46859012|NCT03379792|83074979|FG004|Overall Study|Physician Decision|0|||
46859013|NCT03379792|83074980|FG005|Overall Study|Physician Decision|0|||
46859014|NCT03379792|83074975|FG000|Overall Study|Withdrawal by Subject|0|||
46859015|NCT03379792|83074976|FG001|Overall Study|Withdrawal by Subject|0|||
46982095|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
46982096|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
46694154|NCT04091646|82908345|FG001|Overall Study|Adverse Event|1|||
46694155|NCT04091646|82908344|FG000|Overall Study|Lost to Follow-up|6|||
46801863|NCT03559192|83020861|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
46801864|NCT03559192|83020859|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
46801865|NCT03559192|83020860|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
46694156|NCT04091646|82908345|FG001|Overall Study|Lost to Follow-up|2|||
46694157|NCT04091646|82908344|FG000|Overall Study|Protocol Violation|0|||
46801866|NCT03559192|83020861|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
46801867|NCT03559192|83020859|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
46801868|NCT03559192|83020860|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
46801869|NCT03559192|83020861|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
46859016|NCT03379792|83074977|FG002|Overall Study|Withdrawal by Subject|0|||
46694158|NCT04091646|82908345|FG001|Overall Study|Protocol Violation|1|||
46694159|NCT04091646|82908344|FG000|Overall Study|Withdrawal by Subject|4|||
46694160|NCT04091646|82908345|FG001|Overall Study|Withdrawal by Subject|1|||
46694161|NCT04091646|82908344|FG000|Overall Study|Participant Incarcerated|1|||
46694162|NCT04091646|82908345|FG001|Overall Study|Participant Incarcerated|0|||
46694163|NCT04040933|82908357|FG000|Overall Study|Protocol Violation|1|||
46694164|NCT04040933|82908357|FG000|Overall Study|Withdrawal by Subject|2|||
46694165|NCT03995355|82908370|FG000|Overall Study|Adverse Event|1|||
46694166|NCT03995355|82908371|FG001|Overall Study|Adverse Event|0|||
46694167|NCT03995355|82908370|FG000|Overall Study|Withdrawal by Subject|1|||
46694168|NCT03995355|82908371|FG001|Overall Study|Withdrawal by Subject|0|||
46694169|NCT03995355|82908370|FG000|Overall Study|Scheduling Issues|0|||
46694170|NCT03995355|82908371|FG001|Overall Study|Scheduling Issues|1|||
46694171|NCT03933397|82908379|FG000|Overall Study|No emergency department visit|65|||
46694172|NCT03933397|82908380|FG001|Overall Study|No emergency department visit|71|||
46694173|NCT03933397|82908379|FG000|Overall Study|Missed emergency department visit|25|||
46694174|NCT03933397|82908380|FG001|Overall Study|Missed emergency department visit|30|||
46694175|NCT03933397|82908379|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
46694176|NCT03933397|82908380|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
46694177|NCT03933397|82908379|FG000|Overall Study|Withdrawal by Subject|1|||
46694178|NCT03933397|82908380|FG001|Overall Study|Withdrawal by Subject|0|||
46694179|NCT03933397|82908379|FG000|Overall Study|Physician Decision|1|||
46694180|NCT03933397|82908380|FG001|Overall Study|Physician Decision|1|||
46694181|NCT03933397|82908379|FG000|Overall Study|missing pain score|1|||
46694182|NCT03933397|82908380|FG001|Overall Study|missing pain score|1|||
46694183|NCT03933397|82908379|FG000|Overall Study|Confirmed COVID-19|1|||
46694184|NCT03933397|82908380|FG001|Overall Study|Confirmed COVID-19|2|||
46694185|NCT03624881|82908421|FG000|Overall Study|Screen Failure|14|||
46694186|NCT03624881|82908422|FG001|Overall Study|Screen Failure|0|||
46694187|NCT03624881|82908421|FG000|Overall Study|No Catheter Inserted|6|||
46859017|NCT03379792|83074978|FG003|Overall Study|Withdrawal by Subject|0|||
46694188|NCT03624881|82908422|FG001|Overall Study|No Catheter Inserted|1|||
46694189|NCT03624881|82908421|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
46859018|NCT03379792|83074979|FG004|Overall Study|Withdrawal by Subject|1|||
46694190|NCT03624881|82908422|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
46694191|NCT03624881|82908421|FG000|Overall Study|Death|2|||
46694192|NCT03624881|82908422|FG001|Overall Study|Death|0|||
46694193|NCT03624881|82908421|FG000|Overall Study|Lost to Follow-up|10|||
46694194|NCT03624881|82908422|FG001|Overall Study|Lost to Follow-up|4|||
46694195|NCT03624881|82908421|FG000|Overall Study|Withdrawal by Subject|12|||
46694196|NCT03624881|82908422|FG001|Overall Study|Withdrawal by Subject|1|||
46694197|NCT03428997|82908445|FG000|Overall Study|Sponsor decision.|1|||
46694198|NCT03428997|82908445|FG000|Overall Study|Withdrawal by Subject|3|||
46694199|NCT03428997|82908445|FG000|Overall Study|Lost to Follow-up|4|||
46694200|NCT03118674|82908478|FG000|Overall Study|Lost to Follow-up|2|||
46694201|NCT03118674|82908478|FG000|Overall Study|Screen Faliure|8|||
46694202|NCT03118674|82908478|FG000|Overall Study|Withdrawal by Subject|5|||
46694203|NCT03069352|82908484|FG000|Overall Study|Ongoing|12|||
46694204|NCT03069352|82908485|FG001|Overall Study|Ongoing|40|||
46694205|NCT02993523|82908496|FG000|Overall Study|Withdrew Consent|0|||
46694206|NCT02993523|82908497|FG001|Overall Study|Withdrew Consent|0|||
46694207|NCT02993523|82908498|FG002|Overall Study|Withdrew Consent|2|||
46694208|NCT02993523|82908499|FG003|Overall Study|Withdrew Consent|9|||
46694209|NCT02993523|82908500|FG004|Overall Study|Withdrew Consent|0|||
46694210|NCT02993523|82908496|FG000|Overall Study|Lost to Follow-up|0|||
46694211|NCT02993523|82908497|FG001|Overall Study|Lost to Follow-up|0|||
46694212|NCT02993523|82908498|FG002|Overall Study|Lost to Follow-up|3|||
46694213|NCT02993523|82908499|FG003|Overall Study|Lost to Follow-up|6|||
46694214|NCT02993523|82908500|FG004|Overall Study|Lost to Follow-up|0|||
46694215|NCT02993523|82908496|FG000|Overall Study|Death|1|||
46694216|NCT02993523|82908497|FG001|Overall Study|Death|1|||
46694217|NCT02993523|82908498|FG002|Overall Study|Death|138|||
46694218|NCT02993523|82908499|FG003|Overall Study|Death|222|||
46694219|NCT02993523|82908500|FG004|Overall Study|Death|6|||
46694220|NCT02993523|82908496|FG000|Overall Study|Reason not Specified|0|||
46694221|NCT02993523|82908497|FG001|Overall Study|Reason not Specified|0|||
46694222|NCT02993523|82908498|FG002|Overall Study|Reason not Specified|1|||
46694223|NCT02993523|82908499|FG003|Overall Study|Reason not Specified|1|||
46694224|NCT02993523|82908500|FG004|Overall Study|Reason not Specified|0|||
46694225|NCT02795429|82908513|FG000|Overall Study|Adverse Event|1|||
46694226|NCT02795429|82908514|FG001|Overall Study|Adverse Event|2|||
46694227|NCT02795429|82908515|FG002|Overall Study|Adverse Event|1|||
46694228|NCT02795429|82908516|FG003|Overall Study|Adverse Event|2|||
46694229|NCT02795429|82908517|FG004|Overall Study|Adverse Event|1|||
46694230|NCT02795429|82908513|FG000|Overall Study|Death|1|||
46694231|NCT02795429|82908514|FG001|Overall Study|Death|0|||
46694232|NCT02795429|82908515|FG002|Overall Study|Death|1|||
46694233|NCT02795429|82908516|FG003|Overall Study|Death|2|||
46694234|NCT02795429|82908517|FG004|Overall Study|Death|1|||
46694235|NCT02795429|82908513|FG000|Overall Study|Physician Decision|0|||
46694236|NCT02795429|82908514|FG001|Overall Study|Physician Decision|0|||
46694237|NCT02795429|82908515|FG002|Overall Study|Physician Decision|2|||
46694238|NCT02795429|82908516|FG003|Overall Study|Physician Decision|1|||
46694239|NCT02795429|82908517|FG004|Overall Study|Physician Decision|5|||
46694240|NCT02795429|82908513|FG000|Overall Study|Progressive disease|3|||
46801870|NCT03559192|83020859|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
46982097|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
46694241|NCT02795429|82908514|FG001|Overall Study|Progressive disease|7|||
46694242|NCT02795429|82908515|FG002|Overall Study|Progressive disease|6|||
46694243|NCT02795429|82908516|FG003|Overall Study|Progressive disease|26|||
46694244|NCT02795429|82908517|FG004|Overall Study|Progressive disease|20|||
46694245|NCT02795429|82908513|FG000|Overall Study|Subject/guardian decision|1|||
46694246|NCT02795429|82908514|FG001|Overall Study|Subject/guardian decision|1|||
46694247|NCT02795429|82908515|FG002|Overall Study|Subject/guardian decision|1|||
46694248|NCT02795429|82908516|FG003|Overall Study|Subject/guardian decision|1|||
46694249|NCT02795429|82908517|FG004|Overall Study|Subject/guardian decision|3|||
46694250|NCT02213328|82908564|FG000|Overall Study|Withdrawal by Subject|10|||
46694251|NCT02213328|82908564|FG000|Overall Study|Physician Decision|2|||
46694252|NCT02213328|82908564|FG000|Overall Study|Lost to Follow-up|16|||
46694253|NCT02085408|82908593|FG000|Step 1: Induction|Disease Progression|19|||
46694254|NCT02085408|82908594|FG001|Step 1: Induction|Disease Progression|19|||
46694255|NCT02085408|82908593|FG000|Step 1: Induction|Adverse Event|18|||
46694256|NCT02085408|82908594|FG001|Step 1: Induction|Adverse Event|17|||
46694257|NCT02085408|82908593|FG000|Step 1: Induction|Death|33|||
46694258|NCT02085408|82908594|FG001|Step 1: Induction|Death|30|||
46694259|NCT02085408|82908593|FG000|Step 1: Induction|Withdrawal by Subject|16|||
46694260|NCT02085408|82908594|FG001|Step 1: Induction|Withdrawal by Subject|8|||
46694261|NCT02085408|82908593|FG000|Step 1: Induction|Alternative Therapy|15|||
46694262|NCT02085408|82908594|FG001|Step 1: Induction|Alternative Therapy|19|||
46694263|NCT02085408|82908593|FG000|Step 1: Induction|Complicating Disease|2|||
46694264|NCT02085408|82908594|FG001|Step 1: Induction|Complicating Disease|3|||
46694265|NCT02085408|82908593|FG000|Step 1: Induction|Other|27|||
46694266|NCT02085408|82908594|FG001|Step 1: Induction|Other|39|||
46694267|NCT02085408|82908593|FG000|Step 1: Induction|Never started treatment|6|||
46694268|NCT02085408|82908594|FG001|Step 1: Induction|Never started treatment|4|||
46694269|NCT02085408|82908593|FG000|Step 2: Consolidation|Disease Progression|5|||
46694270|NCT02085408|82908594|FG001|Step 2: Consolidation|Disease Progression|20|||
46801871|NCT03559192|83020860|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
46801872|NCT03559192|83020861|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
46801873|NCT03559192|83020859|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
46801874|NCT03559192|83020860|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
46801875|NCT03559192|83020861|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
46801876|NCT03559192|83020859|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
46801877|NCT03559192|83020860|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
46801878|NCT03559192|83020861|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
46801879|NCT03559192|83020859|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
46801880|NCT03559192|83020860|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
46801881|NCT03559192|83020861|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
46694271|NCT02085408|82908593|FG000|Step 2: Consolidation|Adverse Event|9|||
46694272|NCT02085408|82908594|FG001|Step 2: Consolidation|Adverse Event|8|||
46694273|NCT02085408|82908593|FG000|Step 2: Consolidation|Death|4|||
46694274|NCT02085408|82908594|FG001|Step 2: Consolidation|Death|3|||
46694275|NCT02085408|82908593|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
46801882|NCT03559192|83020859|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
46801883|NCT03559192|83020860|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
46801884|NCT03559192|83020861|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
46801885|NCT03559192|83020859|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
46801886|NCT03559192|83020860|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
46801887|NCT03559192|83020861|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
46801888|NCT03523585|83020872|FG000|Overall Study|Progressive Disease|174|||
46801889|NCT03523585|83020873|FG001|Overall Study|Progressive Disease|64|||
46801890|NCT03523585|83020874|FG002|Overall Study|Progressive Disease|77|||
46801891|NCT03523585|83020872|FG000|Overall Study|Adverse Event|74|||
46694276|NCT02085408|82908594|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
46694277|NCT02085408|82908593|FG000|Step 2: Consolidation|Alternative Therapy|9|||
46694278|NCT02085408|82908594|FG001|Step 2: Consolidation|Alternative Therapy|3|||
46694279|NCT02085408|82908593|FG000|Step 2: Consolidation|Complicating Disease|0|||
46694280|NCT02085408|82908594|FG001|Step 2: Consolidation|Complicating Disease|2|||
46694281|NCT02085408|82908593|FG000|Step 2: Consolidation|Other|6|||
46694282|NCT02085408|82908594|FG001|Step 2: Consolidation|Other|6|||
46694283|NCT02085408|82908593|FG000|Step 2: Consolidation|Never started treatment|4|||
46694284|NCT02085408|82908594|FG001|Step 2: Consolidation|Never started treatment|3|||
46694285|NCT02085408|82908593|FG000|Step 3: Maintenance|Disease Progression|13|||
46694286|NCT02085408|82908594|FG001|Step 3: Maintenance|Disease Progression|11|||
46694287|NCT02085408|82908593|FG000|Step 3: Maintenance|Adverse Event|2|||
46694288|NCT02085408|82908594|FG001|Step 3: Maintenance|Adverse Event|4|||
46694289|NCT02085408|82908593|FG000|Step 3: Maintenance|Death|1|||
46694290|NCT02085408|82908594|FG001|Step 3: Maintenance|Death|2|||
46694291|NCT02085408|82908593|FG000|Step 3: Maintenance|Alternative Therapy|1|||
46694292|NCT02085408|82908594|FG001|Step 3: Maintenance|Alternative Therapy|1|||
46694293|NCT02085408|82908593|FG000|Step 3: Maintenance|Complicating Disease|0|||
46694294|NCT02085408|82908594|FG001|Step 3: Maintenance|Complicating Disease|1|||
46694295|NCT02085408|82908593|FG000|Step 3: Maintenance|Other|3|||
46694296|NCT02085408|82908594|FG001|Step 3: Maintenance|Other|2|||
46694297|NCT02085408|82908593|FG000|Step 3: Maintenance|Never started treatment|5|||
46694298|NCT02085408|82908594|FG001|Step 3: Maintenance|Never started treatment|1|||
46694299|NCT01475786|82908612|FG000|Overall Study|Adverse Event|0|||
46694300|NCT01475786|82908613|FG001|Overall Study|Adverse Event|1|||
46694301|NCT01475786|82908614|FG002|Overall Study|Adverse Event|0|||
46694302|NCT01475786|82908612|FG000|Overall Study|Lost to Follow-up|1|||
46694303|NCT01475786|82908613|FG001|Overall Study|Lost to Follow-up|2|||
46694304|NCT01475786|82908614|FG002|Overall Study|Lost to Follow-up|1|||
46694305|NCT01475786|82908612|FG000|Overall Study|Withdrawal by Subject|0|||
46694306|NCT01475786|82908613|FG001|Overall Study|Withdrawal by Subject|1|||
46694307|NCT01475786|82908614|FG002|Overall Study|Withdrawal by Subject|1|||
46694308|NCT01475786|82908612|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
46694309|NCT01475786|82908613|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
46694310|NCT01475786|82908614|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
46694311|NCT01290692|82908622|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
46694312|NCT00700882|82908658|FG000|Overall Study|Never received treatment|6|||
46694313|NCT00700882|82908658|FG000|Overall Study|Ineligible|2|||
46694314|NCT00700882|82908658|FG000|Overall Study|No KIT mutation|51|||
46694315|NCT00666835|82908696|FG000|Overall Study|Withdrawal by Subject|5|||
46694316|NCT00666835|82908697|FG001|Overall Study|Withdrawal by Subject|2|||
46694317|NCT00666835|82908696|FG000|Overall Study|Lack of Efficacy|0|||
46694318|NCT00666835|82908697|FG001|Overall Study|Lack of Efficacy|1|||
46982098|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
46982099|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
46982100|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
46694319|NCT00666835|82908696|FG000|Overall Study|Incl./excl. not fulfilled|7|||
46694320|NCT00666835|82908697|FG001|Overall Study|Incl./excl. not fulfilled|2|||
46694321|NCT00666835|82908696|FG000|Overall Study|Adverse Event|7|||
46694322|NCT00666835|82908697|FG001|Overall Study|Adverse Event|6|||
46694323|NCT00666835|82908696|FG000|Overall Study|Protocol Violation|2|||
46982101|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
46694324|NCT00666835|82908697|FG001|Overall Study|Protocol Violation|0|||
46982102|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
46694325|NCT00666835|82908696|FG000|Overall Study|Death|15|||
46694326|NCT00666835|82908697|FG001|Overall Study|Death|4|||
46694327|NCT00666835|82908696|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
46694328|NCT00666835|82908697|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
46694329|NCT00666835|82908696|FG000|Overall Study|Hemoglobulin concentration|4|||
46694330|NCT00666835|82908697|FG001|Overall Study|Hemoglobulin concentration|3|||
46694331|NCT00666835|82908696|FG000|Overall Study|Planned operation|2|||
46694332|NCT00666835|82908697|FG001|Overall Study|Planned operation|0|||
46694333|NCT00666835|82908696|FG000|Overall Study|Physician Decision|1|||
46694334|NCT00666835|82908697|FG001|Overall Study|Physician Decision|2|||
46694335|NCT00551759|82908704|FG000|Overall Study|Adverse Event|7|||
46694336|NCT00551759|82908704|FG000|Overall Study|Death|5|||
46694337|NCT00551759|82908704|FG000|Overall Study|Ineligible|1|||
46694338|NCT00335140|82908708|FG000|Overall Study|Ineligible|1|||
46694339|NCT00304239|82908714|FG000|Overall Study|Protocol Deviations/Violations|15|||
46694340|NCT00304239|82908715|FG001|Overall Study|Protocol Deviations/Violations|0|||
46694341|NCT00304239|82908714|FG000|Overall Study|Adverse Event|2|||
46694342|NCT00304239|82908715|FG001|Overall Study|Adverse Event|0|||
46694343|NCT00101283|82908723|FG000|Overall Study|Withdrawal by Subject|0|||
46694344|NCT00101283|82908724|FG001|Overall Study|Withdrawal by Subject|1|||
46694345|NCT00101283|82908723|FG000|Overall Study|Insurance Refusal|0|||
46694346|NCT00101283|82908724|FG001|Overall Study|Insurance Refusal|1|||
46694347|NCT00101283|82908723|FG000|Overall Study|Prostate Cancer Recurrence|0|||
46694348|NCT00101283|82908724|FG001|Overall Study|Prostate Cancer Recurrence|1|||
46694349|NCT01302041|82908730|FG000|Overall Study|Death|5|||
46694350|NCT01302041|82908730|FG000|Overall Study|Withdrawal by Subject|4|||
46694351|NCT01302041|82908730|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
46694352|NCT01302041|82908730|FG000|Overall Study|Other-Miscellaneous Reason|2|||
46694353|NCT01301729|82908735|FG000|Overall Study|Withdrawal by Subject|2|||
46694354|NCT01301729|82908735|FG000|Overall Study|Participant did not Return for Treatment|1|||
46694355|NCT01301729|82908735|FG000|Overall Study|Violated Selection Criteria|1|||
46694356|NCT01187043|82908745|FG000|Overall Study|Adverse Event|0|||
46694357|NCT01187043|82908746|FG001|Overall Study|Adverse Event|0|||
46694358|NCT01187043|82908747|FG002|Overall Study|Adverse Event|0|||
46694359|NCT01187043|82908748|FG003|Overall Study|Adverse Event|0|||
46694360|NCT01187043|82908749|FG004|Overall Study|Adverse Event|1|||
46694361|NCT01187043|82908745|FG000|Overall Study|Unable to make scheduled visits|1|||
46694362|NCT01187043|82908746|FG001|Overall Study|Unable to make scheduled visits|0|||
46694363|NCT01187043|82908747|FG002|Overall Study|Unable to make scheduled visits|4|||
46694364|NCT01187043|82908748|FG003|Overall Study|Unable to make scheduled visits|0|||
46694365|NCT01187043|82908749|FG004|Overall Study|Unable to make scheduled visits|1|||
46694366|NCT01186809|82908761|FG000|Overall Study|Death|30|||
46694367|NCT01186419|82908767|FG000|Overall Study|Withdrawal by Subject|5|||
46694368|NCT01186419|82908768|FG001|Overall Study|Withdrawal by Subject|3|||
46694369|NCT01186419|82908767|FG000|Overall Study|Adverse Event|1|||
46694370|NCT01186419|82908768|FG001|Overall Study|Adverse Event|2|||
46694371|NCT01186419|82908767|FG000|Overall Study|Physician Decision|0|||
46694372|NCT01186419|82908768|FG001|Overall Study|Physician Decision|3|||
46694373|NCT01186419|82908767|FG000|Overall Study|Other|1|||
46694374|NCT01186419|82908768|FG001|Overall Study|Other|1|||
46694375|NCT01301027|82908775|FG000|Overall Study|Physician Decision|2|||
46694376|NCT01301027|82908776|FG001|Overall Study|Physician Decision|0|||
46694377|NCT01301027|82908775|FG000|Overall Study|Withdrawal by Subject|2|||
46694378|NCT01301027|82908776|FG001|Overall Study|Withdrawal by Subject|3|||
46694379|NCT01301027|82908775|FG000|Overall Study|Adverse Event|0|||
46694380|NCT01301027|82908776|FG001|Overall Study|Adverse Event|2|||
46694381|NCT01301027|82908775|FG000|Overall Study|Fracture|1|||
46694382|NCT01301027|82908776|FG001|Overall Study|Fracture|3|||
46694383|NCT01301027|82908775|FG000|Overall Study|Transplant|0|||
46694384|NCT01301027|82908776|FG001|Overall Study|Transplant|2|||
46694385|NCT01301027|82908775|FG000|Overall Study|Volume Overload|3|||
46694386|NCT01301027|82908776|FG001|Overall Study|Volume Overload|0|||
46694387|NCT01185639|82908782|FG000|Overall Study|Progressed and didn't receive therapy|2|||
46694388|NCT01185561|82908788|FG000|Overall Study|Lost to Follow-up|0|||
46694389|NCT01185561|82908789|FG001|Overall Study|Lost to Follow-up|4|||
46694390|NCT01185561|82908788|FG000|Overall Study|Withdrawal by Subject|2|||
46694391|NCT01185561|82908789|FG001|Overall Study|Withdrawal by Subject|8|||
46694392|NCT01185249|82908795|FG000|Overall Study|Patients discharged or change in status|42|||
46694393|NCT01184859|82908805|FG000|Period 1: Single Dose|Insufficient urine production|0|||
46694394|NCT01184859|82908806|FG001|Period 1: Single Dose|Insufficient urine production|1|||
46694395|NCT01184859|82908807|FG002|Period 1: Single Dose|Insufficient urine production|0|||
46694396|NCT01184859|82908808|FG003|Period 1: Single Dose|Insufficient urine production|0|||
46694397|NCT01184859|82908809|FG004|Period 1: Single Dose|Insufficient urine production|0|||
46694398|NCT01184859|82908805|FG000|Period 1: Single Dose|Protocol Violation|0|||
46694399|NCT01184859|82908806|FG001|Period 1: Single Dose|Protocol Violation|1|||
46694400|NCT01184859|82908807|FG002|Period 1: Single Dose|Protocol Violation|0|||
46694401|NCT01184859|82908808|FG003|Period 1: Single Dose|Protocol Violation|0|||
46694402|NCT01184859|82908809|FG004|Period 1: Single Dose|Protocol Violation|0|||
46694403|NCT01184859|82908805|FG000|Period 1: Single Dose|Adverse Event|0|||
46694404|NCT01184859|82908806|FG001|Period 1: Single Dose|Adverse Event|0|||
46694405|NCT01184859|82908807|FG002|Period 1: Single Dose|Adverse Event|0|||
46694406|NCT01184859|82908808|FG003|Period 1: Single Dose|Adverse Event|0|||
46694407|NCT01184859|82908809|FG004|Period 1: Single Dose|Adverse Event|1|||
46694408|NCT01184859|82908805|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
46694409|NCT01184859|82908806|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
46694410|NCT01184859|82908807|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
46694411|NCT01184859|82908808|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
46694412|NCT01184859|82908809|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
46694413|NCT01184859|82908805|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
46694414|NCT01184859|82908806|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
46694415|NCT01184859|82908807|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
46694416|NCT01184859|82908808|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
46694417|NCT01184859|82908809|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
46694418|NCT01184079|82908828|FG000|Overall Study|Lost to Follow-up|14|||
46694419|NCT01184079|82908829|FG001|Overall Study|Lost to Follow-up|2|||
46694420|NCT01190865|82908837|FG000|Overall Study|Withdrawal by Subject|1|||
46694421|NCT01190865|82908837|FG000|Overall Study|Non-compliance|2|||
46694422|NCT01190475|82908844|FG000|Overall Study|Withdrawal by Subject|0|||
46694423|NCT01190475|82908845|FG001|Overall Study|Withdrawal by Subject|0|||
46694424|NCT01190475|82908846|FG002|Overall Study|Withdrawal by Subject|1|||
46694425|NCT01289990|82908869|FG000|Overall Study|Death|0|||
46694426|NCT01289990|82908870|FG001|Overall Study|Death|0|||
46694427|NCT01289990|82908871|FG002|Overall Study|Death|0|||
46694428|NCT01289990|82908872|FG003|Overall Study|Death|1|||
46694429|NCT01289990|82908873|FG004|Overall Study|Death|2|||
46694430|NCT01289990|82908874|FG005|Overall Study|Death|1|||
46694431|NCT01289990|82908875|FG006|Overall Study|Death|0|||
46694432|NCT01289990|82908876|FG007|Overall Study|Death|0|||
46694433|NCT01289990|82908877|FG008|Overall Study|Death|0|||
46694434|NCT01289990|82908878|FG009|Overall Study|Death|0|||
46801892|NCT03523585|83020873|FG001|Overall Study|Adverse Event|5|||
46801893|NCT03523585|83020874|FG002|Overall Study|Adverse Event|9|||
46801894|NCT03523585|83020872|FG000|Overall Study|Withdrawal by Subject|30|||
46801895|NCT03523585|83020873|FG001|Overall Study|Withdrawal by Subject|11|||
46801896|NCT03523585|83020874|FG002|Overall Study|Withdrawal by Subject|6|||
46801897|NCT03523585|83020872|FG000|Overall Study|Clinical Progression|23|||
46694435|NCT01289990|82908879|FG010|Overall Study|Death|0|||
46694436|NCT01289990|82908880|FG011|Overall Study|Death|1|||
46694437|NCT01289990|82908881|FG012|Overall Study|Death|0|||
46694438|NCT01289990|82908869|FG000|Overall Study|Lost to Follow-up|3|||
46694439|NCT01289990|82908870|FG001|Overall Study|Lost to Follow-up|2|||
46801898|NCT03523585|83020873|FG001|Overall Study|Clinical Progression|5|||
46801899|NCT03523585|83020874|FG002|Overall Study|Clinical Progression|10|||
46801900|NCT03523585|83020872|FG000|Overall Study|Death|4|||
46694440|NCT01289990|82908871|FG002|Overall Study|Lost to Follow-up|5|||
46694441|NCT01289990|82908872|FG003|Overall Study|Lost to Follow-up|5|||
46694442|NCT01289990|82908873|FG004|Overall Study|Lost to Follow-up|3|||
46801901|NCT03523585|83020873|FG001|Overall Study|Death|0|||
46694443|NCT01289990|82908874|FG005|Overall Study|Lost to Follow-up|4|||
46694444|NCT01289990|82908875|FG006|Overall Study|Lost to Follow-up|2|||
46694445|NCT01289990|82908876|FG007|Overall Study|Lost to Follow-up|2|||
46694446|NCT01289990|82908877|FG008|Overall Study|Lost to Follow-up|1|||
46694447|NCT01289990|82908878|FG009|Overall Study|Lost to Follow-up|4|||
46694448|NCT01289990|82908879|FG010|Overall Study|Lost to Follow-up|2|||
46694449|NCT01289990|82908880|FG011|Overall Study|Lost to Follow-up|1|||
46694450|NCT01289990|82908881|FG012|Overall Study|Lost to Follow-up|2|||
46694451|NCT01289990|82908869|FG000|Overall Study|Withdrawal by Subject|15|||
46694452|NCT01289990|82908870|FG001|Overall Study|Withdrawal by Subject|14|||
46694453|NCT01289990|82908871|FG002|Overall Study|Withdrawal by Subject|12|||
46694454|NCT01289990|82908872|FG003|Overall Study|Withdrawal by Subject|13|||
46694455|NCT01289990|82908873|FG004|Overall Study|Withdrawal by Subject|8|||
46694456|NCT01289990|82908874|FG005|Overall Study|Withdrawal by Subject|7|||
46694457|NCT01289990|82908875|FG006|Overall Study|Withdrawal by Subject|13|||
46694458|NCT01289990|82908876|FG007|Overall Study|Withdrawal by Subject|9|||
46694459|NCT01289990|82908877|FG008|Overall Study|Withdrawal by Subject|12|||
46694460|NCT01289990|82908878|FG009|Overall Study|Withdrawal by Subject|13|||
46694461|NCT01289990|82908879|FG010|Overall Study|Withdrawal by Subject|11|||
46694462|NCT01289990|82908880|FG011|Overall Study|Withdrawal by Subject|13|||
46694463|NCT01289990|82908881|FG012|Overall Study|Withdrawal by Subject|16|||
46694464|NCT01289990|82908869|FG000|Overall Study|discontinued in preceding trial|18|||
46694465|NCT01289990|82908870|FG001|Overall Study|discontinued in preceding trial|20|||
46694466|NCT01289990|82908871|FG002|Overall Study|discontinued in preceding trial|41|||
46694467|NCT01289990|82908872|FG003|Overall Study|discontinued in preceding trial|17|||
46694468|NCT01289990|82908873|FG004|Overall Study|discontinued in preceding trial|11|||
46694469|NCT01289990|82908874|FG005|Overall Study|discontinued in preceding trial|12|||
46694470|NCT01289990|82908875|FG006|Overall Study|discontinued in preceding trial|18|||
46694471|NCT01289990|82908876|FG007|Overall Study|discontinued in preceding trial|8|||
46694472|NCT01289990|82908877|FG008|Overall Study|discontinued in preceding trial|17|||
46694473|NCT01289990|82908878|FG009|Overall Study|discontinued in preceding trial|21|||
46694474|NCT01289990|82908879|FG010|Overall Study|discontinued in preceding trial|17|||
46694475|NCT01289990|82908880|FG011|Overall Study|discontinued in preceding trial|17|||
46694476|NCT01289990|82908881|FG012|Overall Study|discontinued in preceding trial|24|||
46694477|NCT01289990|82908869|FG000|Overall Study|did not continue in extension|41|||
46694478|NCT01289990|82908870|FG001|Overall Study|did not continue in extension|45|||
46694479|NCT01289990|82908871|FG002|Overall Study|did not continue in extension|51|||
46694480|NCT01289990|82908872|FG003|Overall Study|did not continue in extension|51|||
46694481|NCT01289990|82908873|FG004|Overall Study|did not continue in extension|48|||
46694482|NCT01289990|82908874|FG005|Overall Study|did not continue in extension|50|||
46694483|NCT01289990|82908875|FG006|Overall Study|did not continue in extension|54|||
46694484|NCT01289990|82908876|FG007|Overall Study|did not continue in extension|36|||
46694485|NCT01289990|82908877|FG008|Overall Study|did not continue in extension|44|||
46694486|NCT01289990|82908878|FG009|Overall Study|did not continue in extension|48|||
46694487|NCT01289990|82908879|FG010|Overall Study|did not continue in extension|45|||
46694488|NCT01289990|82908880|FG011|Overall Study|did not continue in extension|34|||
46694489|NCT01289990|82908881|FG012|Overall Study|did not continue in extension|56|||
46694490|NCT01289990|82908869|FG000|Overall Study|Not treated|0|||
46694491|NCT01289990|82908870|FG001|Overall Study|Not treated|0|||
46694492|NCT01289990|82908871|FG002|Overall Study|Not treated|0|||
46694493|NCT01289990|82908872|FG003|Overall Study|Not treated|0|||
46694494|NCT01289990|82908873|FG004|Overall Study|Not treated|0|||
46694495|NCT01289990|82908874|FG005|Overall Study|Not treated|0|||
46694496|NCT01289990|82908875|FG006|Overall Study|Not treated|1|||
46694497|NCT01289990|82908876|FG007|Overall Study|Not treated|0|||
46694498|NCT01289990|82908877|FG008|Overall Study|Not treated|1|||
46694499|NCT01289990|82908878|FG009|Overall Study|Not treated|0|||
46694500|NCT01289990|82908879|FG010|Overall Study|Not treated|1|||
46694501|NCT01289990|82908880|FG011|Overall Study|Not treated|2|||
46801902|NCT03523585|83020874|FG002|Overall Study|Death|1|||
46694502|NCT01289990|82908881|FG012|Overall Study|Not treated|0|||
46694503|NCT01190007|82908909|FG000|Overall Study|Withdrawal by Subject|4|||
46694504|NCT01190007|82908909|FG000|Overall Study|Adverse Event|8|||
46694505|NCT01190007|82908909|FG000|Overall Study|Difficulty of visit for complications|1|||
46694506|NCT01190007|82908909|FG000|Overall Study|Participant was arrested|1|||
46694507|NCT01189461|82908913|FG000|Overall Study|Lack of Efficacy|13|||
46694508|NCT01189461|82908913|FG000|Overall Study|Lost to Follow-up|1|||
46694509|NCT01189461|82908913|FG000|Overall Study|Withdrawal by Subject|6|||
46801903|NCT03523585|83020872|FG000|Overall Study|Physician Decision|2|||
46801904|NCT03523585|83020873|FG001|Overall Study|Physician Decision|1|||
46982103|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
46694510|NCT01189461|82908913|FG000|Overall Study|Protocol Violation|1|||
46694511|NCT01189461|82908913|FG000|Overall Study|Adverse Event|2|||
46694512|NCT01189461|82908913|FG000|Overall Study|Did not meet entrance criteria|3|||
46694513|NCT01189461|82908913|FG000|Overall Study|Other|8|||
46801905|NCT03523585|83020874|FG002|Overall Study|Physician Decision|0|||
46801906|NCT03523585|83020872|FG000|Overall Study|Lost to Follow-up|1|||
46694514|NCT01189227|82908919|FG000|Overall Study|Study terminated due to low accrual|6|||
46694515|NCT01189227|82908920|FG001|Overall Study|Study terminated due to low accrual|3|||
46694516|NCT01300247|82908928|FG000|Overall Study|Death|1|||
46694517|NCT01300247|82908929|FG001|Overall Study|Death|1|||
46694518|NCT01300247|82908928|FG000|Overall Study|Lost to Follow-up|2|||
46694519|NCT01300247|82908929|FG001|Overall Study|Lost to Follow-up|0|||
46694520|NCT01300247|82908928|FG000|Overall Study|Withdrawal by Subject|1|||
46694521|NCT01300247|82908929|FG001|Overall Study|Withdrawal by Subject|0|||
46694522|NCT01300247|82908928|FG000|Overall Study|Non-Compliance|0|||
46694523|NCT01300247|82908929|FG001|Overall Study|Non-Compliance|1|||
46694524|NCT01289678|82908935|FG000|Overall Study|Physician Decision|6|||
46694525|NCT01289210|82908939|FG000|Overall Study|Adverse Event|1|||
46694526|NCT01183221|82908945|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
46694527|NCT01183221|82908946|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
46694528|NCT01183143|82908952|FG000|Overall Study|Protocol Violation|115|||
46694529|NCT01183143|82908952|FG000|Overall Study|Withdrawal by Subject|19|||
46694530|NCT01183143|82908952|FG000|Overall Study|Subject Questionnaires not returned|5|||
46694531|NCT01183143|82908952|FG000|Overall Study|Subjects enrolled, but not treated|11|||
46694532|NCT01183065|82908956|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
46694533|NCT01182441|82908962|FG000|Overall Study|Patient Still in Follow-up|152|||
46694534|NCT01182441|82908963|FG001|Overall Study|Patient Still in Follow-up|72|||
46694535|NCT01182441|82908962|FG000|Overall Study|Death|37|||
46694536|NCT01182441|82908963|FG001|Overall Study|Death|25|||
46694537|NCT01182441|82908962|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
46694538|NCT01182441|82908963|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
46694539|NCT01182441|82908962|FG000|Overall Study|Lost to Follow-up|5|||
46694540|NCT01182441|82908963|FG001|Overall Study|Lost to Follow-up|8|||
46694541|NCT01182441|82908962|FG000|Overall Study|Withdrawal by Subject|6|||
46694542|NCT01182441|82908963|FG001|Overall Study|Withdrawal by Subject|13|||
46694543|NCT01182441|82908962|FG000|Overall Study|Implant Not Attempted|4|||
46694544|NCT01182441|82908963|FG001|Overall Study|Implant Not Attempted|0|||
46694545|NCT01182441|82908962|FG000|Overall Study|Adverse Event|2|||
46694546|NCT01182441|82908963|FG001|Overall Study|Adverse Event|0|||
46694547|NCT01182441|82908962|FG000|Overall Study|Physician Decision|1|||
46694548|NCT01182441|82908963|FG001|Overall Study|Physician Decision|1|||
46694549|NCT01182285|82908969|FG000|First Intervention Week 1-10|Disease progression|1|||
46694550|NCT01182285|82908970|FG001|First Intervention Week 1-10|Disease progression|0|||
46694551|NCT01182285|82908971|FG002|First Intervention Week 1-10|Disease progression|0|||
46694552|NCT01182285|82908969|FG000|First Intervention Week 1-10|Adverse Event|1|||
46694553|NCT01182285|82908970|FG001|First Intervention Week 1-10|Adverse Event|0|||
46694554|NCT01182285|82908971|FG002|First Intervention Week 1-10|Adverse Event|0|||
46694555|NCT01182285|82908969|FG000|First Intervention Week 1-10|Non-compliance|1|||
46694556|NCT01182285|82908970|FG001|First Intervention Week 1-10|Non-compliance|0|||
46694557|NCT01182285|82908971|FG002|First Intervention Week 1-10|Non-compliance|0|||
46694558|NCT01182285|82908969|FG000|Third Intervention Week 11-52|Disease Progression|0|||
46694559|NCT01182285|82908970|FG001|Third Intervention Week 11-52|Disease Progression|0|||
46694560|NCT01182285|82908971|FG002|Third Intervention Week 11-52|Disease Progression|6|||
46694561|NCT01182285|82908969|FG000|Third Intervention Week 11-52|Other|0|||
46694562|NCT01182285|82908970|FG001|Third Intervention Week 11-52|Other|0|||
46694563|NCT01182285|82908971|FG002|Third Intervention Week 11-52|Other|2|||
46694564|NCT01182207|82908980|FG000|First Intervention|Positive Hepatitis Results|0|||
46694565|NCT01182207|82908981|FG001|First Intervention|Positive Hepatitis Results|1|||
46694566|NCT01182207|82908980|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
46694567|NCT01182207|82908981|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
46694568|NCT01181895|82908990|FG000|Overall Study|Adverse Event|3|||
46694569|NCT01181895|82908991|FG001|Overall Study|Adverse Event|1|||
46694570|NCT01181895|82908992|FG002|Overall Study|Adverse Event|1|||
46694571|NCT01181895|82908990|FG000|Overall Study|Lack of Efficacy|8|||
46694572|NCT01181895|82908991|FG001|Overall Study|Lack of Efficacy|9|||
46694573|NCT01181895|82908992|FG002|Overall Study|Lack of Efficacy|9|||
46694574|NCT01181895|82908990|FG000|Overall Study|Protocol Violation|2|||
46694575|NCT01181895|82908991|FG001|Overall Study|Protocol Violation|1|||
46694576|NCT01181895|82908992|FG002|Overall Study|Protocol Violation|0|||
46694577|NCT01181895|82908990|FG000|Overall Study|Lost to Follow-up|0|||
46694578|NCT01181895|82908991|FG001|Overall Study|Lost to Follow-up|1|||
46694579|NCT01181895|82908992|FG002|Overall Study|Lost to Follow-up|2|||
46694580|NCT01181895|82908990|FG000|Overall Study|Investigator Discretion|1|||
46694581|NCT01181895|82908991|FG001|Overall Study|Investigator Discretion|2|||
46694582|NCT01181895|82908992|FG002|Overall Study|Investigator Discretion|1|||
46694583|NCT01181895|82908990|FG000|Overall Study|Withdrawal by Subject|3|||
46694584|NCT01181895|82908991|FG001|Overall Study|Withdrawal by Subject|0|||
46694585|NCT01181895|82908992|FG002|Overall Study|Withdrawal by Subject|5|||
46694586|NCT01181271|82909000|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
46694587|NCT01181271|82909000|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
46694588|NCT01181271|82909000|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
46694589|NCT01181271|82909000|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
46694590|NCT01180647|82909006|FG000|Overall Study|Lost to Follow-up|5|||
46694591|NCT01180647|82909007|FG001|Overall Study|Lost to Follow-up|6|||
46694592|NCT00969553|82909022|FG000|Overall Study|Progressive disease (PD)|2|||
46694593|NCT00969553|82909023|FG001|Overall Study|Progressive disease (PD)|2|||
46694594|NCT00969553|82909024|FG002|Overall Study|Progressive disease (PD)|6|||
46694595|NCT00969553|82909025|FG003|Overall Study|Progressive disease (PD)|9|||
46694596|NCT00969553|82909026|FG004|Overall Study|Progressive disease (PD)|2|||
46694597|NCT00969553|82909027|FG005|Overall Study|Progressive disease (PD)|4|||
46694598|NCT00969553|82909028|FG006|Overall Study|Progressive disease (PD)|2|||
46694599|NCT00969553|82909029|FG007|Overall Study|Progressive disease (PD)|12|||
46694600|NCT00969553|82909030|FG008|Overall Study|Progressive disease (PD)|3|||
46694601|NCT00969553|82909022|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694602|NCT00969553|82909023|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694603|NCT00969553|82909024|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694604|NCT00969553|82909025|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694605|NCT00969553|82909026|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
46694606|NCT00969553|82909027|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694607|NCT00969553|82909028|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694608|NCT00969553|82909029|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694609|NCT00969553|82909030|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
46694610|NCT00969553|82909022|FG000|Overall Study|Other Adverse Event|0|||
46694611|NCT00969553|82909023|FG001|Overall Study|Other Adverse Event|0|||
46694612|NCT00969553|82909024|FG002|Overall Study|Other Adverse Event|0|||
46694613|NCT00969553|82909025|FG003|Overall Study|Other Adverse Event|1|||
46694614|NCT00969553|82909026|FG004|Overall Study|Other Adverse Event|0|||
46694615|NCT00969553|82909027|FG005|Overall Study|Other Adverse Event|0|||
46694616|NCT00969553|82909028|FG006|Overall Study|Other Adverse Event|1|||
46694617|NCT00969553|82909029|FG007|Overall Study|Other Adverse Event|0|||
46694618|NCT00969553|82909030|FG008|Overall Study|Other Adverse Event|0|||
46694619|NCT00969553|82909022|FG000|Overall Study|Refused cont. medication|1|||
46694620|NCT00969553|82909023|FG001|Overall Study|Refused cont. medication|1|||
46694621|NCT00969553|82909024|FG002|Overall Study|Refused cont. medication|0|||
46694622|NCT00969553|82909025|FG003|Overall Study|Refused cont. medication|2|||
46694623|NCT00969553|82909026|FG004|Overall Study|Refused cont. medication|0|||
46694624|NCT00969553|82909027|FG005|Overall Study|Refused cont. medication|0|||
46694625|NCT00969553|82909028|FG006|Overall Study|Refused cont. medication|0|||
46694626|NCT00969553|82909029|FG007|Overall Study|Refused cont. medication|1|||
46694627|NCT00969553|82909030|FG008|Overall Study|Refused cont. medication|0|||
46694628|NCT00969553|82909022|FG000|Overall Study|Not specified above|0|||
46694629|NCT00969553|82909023|FG001|Overall Study|Not specified above|0|||
46694630|NCT00969553|82909024|FG002|Overall Study|Not specified above|0|||
46694631|NCT00969553|82909025|FG003|Overall Study|Not specified above|4|||
46694632|NCT00969553|82909026|FG004|Overall Study|Not specified above|0|||
46694633|NCT00969553|82909027|FG005|Overall Study|Not specified above|0|||
46801907|NCT03523585|83020873|FG001|Overall Study|Lost to Follow-up|0|||
46801908|NCT03523585|83020874|FG002|Overall Study|Lost to Follow-up|0|||
46694634|NCT00969553|82909028|FG006|Overall Study|Not specified above|1|||
46694635|NCT00969553|82909029|FG007|Overall Study|Not specified above|1|||
46694636|NCT00969553|82909030|FG008|Overall Study|Not specified above|0|||
46694637|NCT01179477|82909058|FG000|Overall Study|Death|542|||
46694638|NCT01179477|82909058|FG000|Overall Study|Unsuccessful implant|80|||
46694639|NCT01179477|82909058|FG000|Overall Study|Non-death withdrawal|438|||
46801909|NCT03523585|83020872|FG000|Overall Study|Miscellaneous|1|||
46801910|NCT03523585|83020873|FG001|Overall Study|Miscellaneous|0|||
46801911|NCT03523585|83020874|FG002|Overall Study|Miscellaneous|0|||
46982104|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
46694640|NCT01179477|82909058|FG000|Overall Study|Did not complete final visit|27|||
46694641|NCT01179399|82909062|FG000|Overall Study|Adverse Event|1|||
46694642|NCT01179399|82909062|FG000|Overall Study|Lack of Efficacy|30|||
46801912|NCT03523585|83020872|FG000|Overall Study|Protocol Deviation|1|||
46801913|NCT03523585|83020873|FG001|Overall Study|Protocol Deviation|0|||
46859019|NCT03379792|83074980|FG005|Overall Study|Withdrawal by Subject|1|||
46694643|NCT01179399|82909062|FG000|Overall Study|Withdrawal by Subject|1|||
46694644|NCT01178853|82909068|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
46694645|NCT01178853|82909069|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
46694646|NCT01178853|82909068|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
46694647|NCT01178853|82909069|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
46694648|NCT01178853|82909068|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
46694649|NCT01178853|82909069|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
46694650|NCT01178853|82909068|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
46694651|NCT01178853|82909069|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
46694652|NCT01178853|82909068|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
46694653|NCT01178853|82909069|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
46694654|NCT01178385|82909077|FG000|Overall Study|Withdrawal by Subject|2|||
46694655|NCT01178385|82909078|FG001|Overall Study|Withdrawal by Subject|0|||
46694656|NCT01288976|82909087|FG000|Overall Study|Withdrawal by Subject|58|||
46694657|NCT01288976|82909088|FG001|Overall Study|Withdrawal by Subject|12|||
46694658|NCT01288976|82909089|FG002|Overall Study|Withdrawal by Subject|9|||
46694659|NCT01288976|82909087|FG000|Overall Study|Death|98|||
46694660|NCT01288976|82909088|FG001|Overall Study|Death|6|||
46694661|NCT01288976|82909089|FG002|Overall Study|Death|4|||
46694662|NCT01288976|82909087|FG000|Overall Study|Data unavailable|22|||
46694663|NCT01288976|82909088|FG001|Overall Study|Data unavailable|9|||
46694664|NCT01288976|82909089|FG002|Overall Study|Data unavailable|7|||
46694665|NCT00970489|82909097|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
46694666|NCT00970489|82909098|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
46694667|NCT00968617|82909104|FG000|Overall Study|Study terminated by sponsor|6|||
46801914|NCT03523585|83020874|FG002|Overall Study|Protocol Deviation|1|||
46801915|NCT03523585|83020872|FG000|Overall Study|Randomized But Not Treated|2|||
46801916|NCT03523585|83020873|FG001|Overall Study|Randomized But Not Treated|4|||
46801917|NCT03523585|83020874|FG002|Overall Study|Randomized But Not Treated|3|||
46801918|NCT03485911|83020884|FG000|Part 1|Perceived lack of efficacy|1|||
46801919|NCT03485911|83020885|FG001|Part 1|Perceived lack of efficacy|1|||
46801920|NCT03485911|83020886|FG002|Part 1|Perceived lack of efficacy|2|||
46801921|NCT03485911|83020887|FG003|Part 1|Perceived lack of efficacy|0|||
46694668|NCT00968539|82909110|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
46694669|NCT00968539|82909111|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
46694670|NCT00976573|82909120|FG000|Overall Study|Ineligible|0|||
46694671|NCT00976573|82909121|FG001|Overall Study|Ineligible|1|||
46982105|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
46982106|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
46982107|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
46982108|NCT01664923|83228282|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
46982109|NCT01664923|83228283|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
46982110|NCT01664923|83228282|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
46982111|NCT01664923|83228283|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
46694672|NCT00976573|82909120|FG000|Overall Study|Cancel prior to receiving treatment|4|||
46694673|NCT00976573|82909121|FG001|Overall Study|Cancel prior to receiving treatment|2|||
46694674|NCT00976495|82909130|FG000|Overall Study|Withdrawal by Subject|0|||
46694675|NCT00976495|82909131|FG001|Overall Study|Withdrawal by Subject|1|||
46694676|NCT00976495|82909132|FG002|Overall Study|Withdrawal by Subject|0|||
46694677|NCT01288430|82909150|FG000|Part 1|Progressive disease|2|||
46694678|NCT01288430|82909151|FG001|Part 1|Progressive disease|1|||
46694679|NCT01288430|82909152|FG002|Part 1|Progressive disease|1|||
46694680|NCT01288430|82909153|FG003|Part 1|Progressive disease|6|||
46694681|NCT01288430|82909154|FG004|Part 1|Progressive disease|2|||
46801922|NCT03485911|83020884|FG000|Part 1|Subject withdrew consent|0|||
46801923|NCT03485911|83020885|FG001|Part 1|Subject withdrew consent|1|||
46801924|NCT03485911|83020886|FG002|Part 1|Subject withdrew consent|0|||
46801925|NCT03485911|83020887|FG003|Part 1|Subject withdrew consent|1|||
46801926|NCT03485911|83020884|FG000|Part 1|Lab abnormalities/AEs|3|||
46694682|NCT01288430|82909155|FG005|Part 1|Progressive disease|4|||
46694683|NCT01288430|82909156|FG006|Part 1|Progressive disease|2|||
46694684|NCT01288430|82909157|FG007|Part 1|Progressive disease|0|||
46694685|NCT01288430|82909158|FG008|Part 1|Progressive disease|0|||
46694686|NCT01288430|82909159|FG009|Part 1|Progressive disease|0|||
46694687|NCT01288430|82909150|FG000|Part 1|Clinical disease progression|0|||
46694688|NCT01288430|82909151|FG001|Part 1|Clinical disease progression|0|||
46694689|NCT01288430|82909152|FG002|Part 1|Clinical disease progression|1|||
46694690|NCT01288430|82909153|FG003|Part 1|Clinical disease progression|0|||
46694691|NCT01288430|82909154|FG004|Part 1|Clinical disease progression|0|||
46694692|NCT01288430|82909155|FG005|Part 1|Clinical disease progression|2|||
46694693|NCT01288430|82909156|FG006|Part 1|Clinical disease progression|2|||
46694694|NCT01288430|82909157|FG007|Part 1|Clinical disease progression|0|||
46694695|NCT01288430|82909158|FG008|Part 1|Clinical disease progression|0|||
46694696|NCT01288430|82909159|FG009|Part 1|Clinical disease progression|0|||
46694697|NCT01288430|82909150|FG000|Part 1|Death due to disease progression|0|||
46694698|NCT01288430|82909151|FG001|Part 1|Death due to disease progression|0|||
46694699|NCT01288430|82909152|FG002|Part 1|Death due to disease progression|0|||
46694700|NCT01288430|82909153|FG003|Part 1|Death due to disease progression|0|||
46694701|NCT01288430|82909154|FG004|Part 1|Death due to disease progression|1|||
46694702|NCT01288430|82909155|FG005|Part 1|Death due to disease progression|0|||
46694703|NCT01288430|82909156|FG006|Part 1|Death due to disease progression|0|||
46694704|NCT01288430|82909157|FG007|Part 1|Death due to disease progression|0|||
46694705|NCT01288430|82909158|FG008|Part 1|Death due to disease progression|0|||
46694706|NCT01288430|82909159|FG009|Part 1|Death due to disease progression|0|||
46694707|NCT01288430|82909150|FG000|Part 1|Adverse Event|0|||
46694708|NCT01288430|82909151|FG001|Part 1|Adverse Event|0|||
46694709|NCT01288430|82909152|FG002|Part 1|Adverse Event|3|||
46694710|NCT01288430|82909153|FG003|Part 1|Adverse Event|1|||
46694711|NCT01288430|82909154|FG004|Part 1|Adverse Event|0|||
46982112|NCT01664923|83228282|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
46982113|NCT01664923|83228283|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
46694712|NCT01288430|82909155|FG005|Part 1|Adverse Event|0|||
46694713|NCT01288430|82909156|FG006|Part 1|Adverse Event|2|||
46694714|NCT01288430|82909157|FG007|Part 1|Adverse Event|0|||
46694715|NCT01288430|82909158|FG008|Part 1|Adverse Event|0|||
46694716|NCT01288430|82909159|FG009|Part 1|Adverse Event|0|||
46694717|NCT01288430|82909150|FG000|Part 1|Other|0|||
46694718|NCT01288430|82909151|FG001|Part 1|Other|2|||
46694719|NCT01288430|82909152|FG002|Part 1|Other|0|||
46694720|NCT01288430|82909153|FG003|Part 1|Other|0|||
46694721|NCT01288430|82909154|FG004|Part 1|Other|0|||
46694722|NCT01288430|82909155|FG005|Part 1|Other|0|||
46694723|NCT01288430|82909156|FG006|Part 1|Other|1|||
46694724|NCT01288430|82909157|FG007|Part 1|Other|0|||
46694725|NCT01288430|82909158|FG008|Part 1|Other|0|||
46694726|NCT01288430|82909159|FG009|Part 1|Other|0|||
46694727|NCT01288430|82909150|FG000|Part 2|Progressive disease|0|||
46694728|NCT01288430|82909151|FG001|Part 2|Progressive disease|0|||
46694729|NCT01288430|82909152|FG002|Part 2|Progressive disease|0|||
46694730|NCT01288430|82909153|FG003|Part 2|Progressive disease|0|||
46694731|NCT01288430|82909154|FG004|Part 2|Progressive disease|0|||
46694732|NCT01288430|82909155|FG005|Part 2|Progressive disease|0|||
46694733|NCT01288430|82909156|FG006|Part 2|Progressive disease|0|||
46694734|NCT01288430|82909157|FG007|Part 2|Progressive disease|8|||
46694735|NCT01288430|82909158|FG008|Part 2|Progressive disease|7|||
46694736|NCT01288430|82909159|FG009|Part 2|Progressive disease|2|||
46694737|NCT01288430|82909150|FG000|Part 2|Clinical disease progression|0|||
46694738|NCT01288430|82909151|FG001|Part 2|Clinical disease progression|0|||
46694739|NCT01288430|82909152|FG002|Part 2|Clinical disease progression|0|||
46694740|NCT01288430|82909153|FG003|Part 2|Clinical disease progression|0|||
46694741|NCT01288430|82909154|FG004|Part 2|Clinical disease progression|0|||
46694742|NCT01288430|82909155|FG005|Part 2|Clinical disease progression|0|||
46694743|NCT01288430|82909156|FG006|Part 2|Clinical disease progression|0|||
46694744|NCT01288430|82909157|FG007|Part 2|Clinical disease progression|2|||
46694745|NCT01288430|82909158|FG008|Part 2|Clinical disease progression|0|||
46694746|NCT01288430|82909159|FG009|Part 2|Clinical disease progression|0|||
46694747|NCT01288430|82909150|FG000|Part 2|Withdrawal by Subject|0|||
46694748|NCT01288430|82909151|FG001|Part 2|Withdrawal by Subject|0|||
46694749|NCT01288430|82909152|FG002|Part 2|Withdrawal by Subject|0|||
46694750|NCT01288430|82909153|FG003|Part 2|Withdrawal by Subject|0|||
46694751|NCT01288430|82909154|FG004|Part 2|Withdrawal by Subject|0|||
46694752|NCT01288430|82909155|FG005|Part 2|Withdrawal by Subject|0|||
46694753|NCT01288430|82909156|FG006|Part 2|Withdrawal by Subject|0|||
46694754|NCT01288430|82909157|FG007|Part 2|Withdrawal by Subject|1|||
46694755|NCT01288430|82909158|FG008|Part 2|Withdrawal by Subject|4|||
46694756|NCT01288430|82909159|FG009|Part 2|Withdrawal by Subject|0|||
46694757|NCT01288430|82909150|FG000|Part 2|Adverse Event|0|||
46694758|NCT01288430|82909151|FG001|Part 2|Adverse Event|0|||
46694759|NCT01288430|82909152|FG002|Part 2|Adverse Event|0|||
46694760|NCT01288430|82909153|FG003|Part 2|Adverse Event|0|||
46694761|NCT01288430|82909154|FG004|Part 2|Adverse Event|0|||
46694762|NCT01288430|82909155|FG005|Part 2|Adverse Event|0|||
46694763|NCT01288430|82909156|FG006|Part 2|Adverse Event|0|||
46694764|NCT01288430|82909157|FG007|Part 2|Adverse Event|1|||
46694765|NCT01288430|82909158|FG008|Part 2|Adverse Event|1|||
46694766|NCT01288430|82909159|FG009|Part 2|Adverse Event|0|||
46694767|NCT01288430|82909150|FG000|Part 2|Other|0|||
46694768|NCT01288430|82909151|FG001|Part 2|Other|0|||
46694769|NCT01288430|82909152|FG002|Part 2|Other|0|||
46694770|NCT01288430|82909153|FG003|Part 2|Other|0|||
46694771|NCT01288430|82909154|FG004|Part 2|Other|0|||
46694772|NCT01288430|82909155|FG005|Part 2|Other|0|||
46694773|NCT01288430|82909156|FG006|Part 2|Other|0|||
46694774|NCT01288430|82909157|FG007|Part 2|Other|0|||
46694775|NCT01288430|82909158|FG008|Part 2|Other|0|||
46694776|NCT01288430|82909159|FG009|Part 2|Other|1|||
46694777|NCT01287416|82909188|FG000|Pre-post Training|Withdrawal by Subject|17|||
46694778|NCT01287416|82909189|FG001|Pre-post Training|Withdrawal by Subject|24|||
46694779|NCT01287416|82909188|FG000|Pre-post Training|Lost to Follow-up|5|||
46694780|NCT01287416|82909189|FG001|Pre-post Training|Lost to Follow-up|1|||
46859020|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
46694781|NCT01287416|82909188|FG000|6 Month Follow-up|Lost to Follow-up|3|||
46694782|NCT01287416|82909189|FG001|6 Month Follow-up|Lost to Follow-up|2|||
46694783|NCT00998296|82909206|FG000|Overall Study|Progressive disease|0|||
46694784|NCT00998296|82909207|FG001|Overall Study|Progressive disease|1|||
46694785|NCT00998296|82909208|FG002|Overall Study|Progressive disease|0|||
46694786|NCT00998296|82909209|FG003|Overall Study|Progressive disease|0|||
46694787|NCT00998296|82909210|FG004|Overall Study|Progressive disease|0|||
46694788|NCT00998296|82909211|FG005|Overall Study|Progressive disease|0|||
46694789|NCT00998296|82909212|FG006|Overall Study|Progressive disease|1|||
46694790|NCT00998296|82909213|FG007|Overall Study|Progressive disease|0|||
46694791|NCT00998296|82909214|FG008|Overall Study|Progressive disease|0|||
46694792|NCT00998296|82909215|FG009|Overall Study|Progressive disease|14|||
46694793|NCT00998296|82909216|FG010|Overall Study|Progressive disease|5|||
46694794|NCT00998296|82909206|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694795|NCT00998296|82909207|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694796|NCT00998296|82909208|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694797|NCT00998296|82909209|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694798|NCT00998296|82909210|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
46694799|NCT00998296|82909211|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694800|NCT00998296|82909212|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694801|NCT00998296|82909213|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
46694802|NCT00998296|82909214|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
46694803|NCT00998296|82909215|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694804|NCT00998296|82909216|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
46694805|NCT00998296|82909206|FG000|Overall Study|Other adverse event|0|||
46694806|NCT00998296|82909207|FG001|Overall Study|Other adverse event|0|||
46694807|NCT00998296|82909208|FG002|Overall Study|Other adverse event|0|||
46694808|NCT00998296|82909209|FG003|Overall Study|Other adverse event|0|||
46694809|NCT00998296|82909210|FG004|Overall Study|Other adverse event|1|||
46694810|NCT00998296|82909211|FG005|Overall Study|Other adverse event|0|||
46694811|NCT00998296|82909212|FG006|Overall Study|Other adverse event|0|||
46694812|NCT00998296|82909213|FG007|Overall Study|Other adverse event|0|||
46694813|NCT00998296|82909214|FG008|Overall Study|Other adverse event|0|||
46694814|NCT00998296|82909215|FG009|Overall Study|Other adverse event|1|||
46694815|NCT00998296|82909216|FG010|Overall Study|Other adverse event|2|||
46694816|NCT00998296|82909206|FG000|Overall Study|Refused to continue taking trial med.|0|||
46694817|NCT00998296|82909207|FG001|Overall Study|Refused to continue taking trial med.|0|||
46694818|NCT00998296|82909208|FG002|Overall Study|Refused to continue taking trial med.|0|||
46694819|NCT00998296|82909209|FG003|Overall Study|Refused to continue taking trial med.|0|||
46801927|NCT03485911|83020885|FG001|Part 1|Lab abnormalities/AEs|1|||
46694820|NCT00998296|82909210|FG004|Overall Study|Refused to continue taking trial med.|0|||
46694821|NCT00998296|82909211|FG005|Overall Study|Refused to continue taking trial med.|0|||
46694822|NCT00998296|82909212|FG006|Overall Study|Refused to continue taking trial med.|0|||
46694823|NCT00998296|82909213|FG007|Overall Study|Refused to continue taking trial med.|0|||
46694824|NCT00998296|82909214|FG008|Overall Study|Refused to continue taking trial med.|0|||
46694825|NCT00998296|82909215|FG009|Overall Study|Refused to continue taking trial med.|2|||
46694826|NCT00998296|82909216|FG010|Overall Study|Refused to continue taking trial med.|0|||
46694827|NCT00998296|82909206|FG000|Overall Study|Reason other than those specified above|0|||
46694828|NCT00998296|82909207|FG001|Overall Study|Reason other than those specified above|0|||
46694829|NCT00998296|82909208|FG002|Overall Study|Reason other than those specified above|0|||
46694830|NCT00998296|82909209|FG003|Overall Study|Reason other than those specified above|0|||
46694831|NCT00998296|82909210|FG004|Overall Study|Reason other than those specified above|0|||
46694832|NCT00998296|82909211|FG005|Overall Study|Reason other than those specified above|0|||
46694833|NCT00998296|82909212|FG006|Overall Study|Reason other than those specified above|0|||
46694834|NCT00998296|82909213|FG007|Overall Study|Reason other than those specified above|0|||
46694835|NCT00998296|82909214|FG008|Overall Study|Reason other than those specified above|0|||
46694836|NCT00998296|82909215|FG009|Overall Study|Reason other than those specified above|1|||
46694837|NCT00998296|82909216|FG010|Overall Study|Reason other than those specified above|0|||
46694838|NCT01178073|82909248|FG000|Overall Study|Adverse Event|34|||
46694839|NCT01178073|82909249|FG001|Overall Study|Adverse Event|27|||
46694840|NCT01178073|82909250|FG002|Overall Study|Adverse Event|24|||
46694841|NCT01178073|82909248|FG000|Overall Study|Protocol Violation|1|||
46694842|NCT01178073|82909249|FG001|Overall Study|Protocol Violation|1|||
46694843|NCT01178073|82909250|FG002|Overall Study|Protocol Violation|1|||
46694844|NCT01178073|82909248|FG000|Overall Study|Lost to Follow-up|2|||
46694845|NCT01178073|82909249|FG001|Overall Study|Lost to Follow-up|0|||
46694846|NCT01178073|82909250|FG002|Overall Study|Lost to Follow-up|3|||
46694847|NCT01178073|82909248|FG000|Overall Study|Physician Decision|14|||
46694848|NCT01178073|82909249|FG001|Overall Study|Physician Decision|10|||
46694849|NCT01178073|82909250|FG002|Overall Study|Physician Decision|10|||
46694850|NCT01178073|82909248|FG000|Overall Study|Withdrawal by Subject|10|||
46694851|NCT01178073|82909249|FG001|Overall Study|Withdrawal by Subject|6|||
46982114|NCT01664923|83228282|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
46982115|NCT01664923|83228283|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
46982116|NCT01664923|83228282|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
46982117|NCT01664923|83228283|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
46694852|NCT01178073|82909250|FG002|Overall Study|Withdrawal by Subject|8|||
46694853|NCT01178073|82909248|FG000|Overall Study|Missing Completion Status|1|||
46694854|NCT01178073|82909249|FG001|Overall Study|Missing Completion Status|0|||
46694855|NCT01178073|82909250|FG002|Overall Study|Missing Completion Status|0|||
46694856|NCT00997984|82909262|FG000|Overall Study|Adverse Event|1|||
46694857|NCT00997984|82909263|FG001|Overall Study|Adverse Event|8|||
46694858|NCT00997984|82909264|FG002|Overall Study|Adverse Event|8|||
46694859|NCT00997984|82909262|FG000|Overall Study|Protocol Violation|1|||
46982118|NCT01664923|83228282|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
46982119|NCT01664923|83228283|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
46982120|NCT01664923|83228282|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
46982121|NCT01664923|83228283|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
46982122|NCT01664533|83228293|FG000|Overall Study|Death|42|||
46982123|NCT01664533|83228293|FG000|Overall Study|Lost to Follow-up|3|||
46982124|NCT01664533|83228293|FG000|Overall Study|Study termination|9|||
46982125|NCT01664533|83228293|FG000|Overall Study|Protocol Violation|3|||
46982126|NCT02584855|83228298|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
46982127|NCT02584855|83228299|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
46982128|NCT02584855|83228300|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
46982129|NCT02584855|83228301|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
46694860|NCT00997984|82909263|FG001|Overall Study|Protocol Violation|3|||
46694861|NCT00997984|82909264|FG002|Overall Study|Protocol Violation|0|||
46694862|NCT00997984|82909262|FG000|Overall Study|Withdrawal by Subject|6|||
46801928|NCT03485911|83020886|FG002|Part 1|Lab abnormalities/AEs|1|||
46801929|NCT03485911|83020887|FG003|Part 1|Lab abnormalities/AEs|0|||
46694863|NCT00997984|82909263|FG001|Overall Study|Withdrawal by Subject|9|||
46694864|NCT00997984|82909264|FG002|Overall Study|Withdrawal by Subject|5|||
46694865|NCT00997984|82909262|FG000|Overall Study|Lost to Follow-up|8|||
46982130|NCT02584855|83228302|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
46982131|NCT02584855|83228303|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
46694866|NCT00997984|82909263|FG001|Overall Study|Lost to Follow-up|5|||
46694867|NCT00997984|82909264|FG002|Overall Study|Lost to Follow-up|4|||
46694868|NCT00997984|82909262|FG000|Overall Study|Lack of Efficacy|20|||
46694869|NCT00997984|82909263|FG001|Overall Study|Lack of Efficacy|6|||
46694870|NCT00997984|82909264|FG002|Overall Study|Lack of Efficacy|3|||
46694871|NCT00997984|82909262|FG000|Overall Study|Met exclusion criteria|1|||
46694872|NCT00997984|82909263|FG001|Overall Study|Met exclusion criteria|0|||
46694873|NCT00997984|82909264|FG002|Overall Study|Met exclusion criteria|0|||
46694874|NCT00997984|82909262|FG000|Overall Study|non-compliance|0|||
46694875|NCT00997984|82909263|FG001|Overall Study|non-compliance|2|||
46694876|NCT00997984|82909264|FG002|Overall Study|non-compliance|3|||
46694877|NCT00997984|82909262|FG000|Overall Study|Wrong medication dispensed|0|||
46982132|NCT02584855|83228298|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
46982133|NCT02584855|83228299|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
46982134|NCT02584855|83228300|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
46982135|NCT02584855|83228301|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
46982136|NCT02584855|83228302|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
46694878|NCT00997984|82909263|FG001|Overall Study|Wrong medication dispensed|1|||
46694879|NCT00997984|82909264|FG002|Overall Study|Wrong medication dispensed|0|||
46694880|NCT00997984|82909262|FG000|Overall Study|Suicidal ideation|0|||
46694881|NCT00997984|82909263|FG001|Overall Study|Suicidal ideation|0|||
46694882|NCT00997984|82909264|FG002|Overall Study|Suicidal ideation|1|||
46694883|NCT00997984|82909262|FG000|Overall Study|Work schedule|0|||
46694884|NCT00997984|82909263|FG001|Overall Study|Work schedule|0|||
46694885|NCT00997984|82909264|FG002|Overall Study|Work schedule|2|||
46694886|NCT01177293|82909274|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
46694887|NCT01177293|82909275|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
46694888|NCT01177137|82909284|FG000|Overall Study|Withdrawal by Subject|10|||
46694889|NCT01177137|82909285|FG001|Overall Study|Withdrawal by Subject|10|||
46694890|NCT01177137|82909286|FG002|Overall Study|Withdrawal by Subject|2|||
46694891|NCT01177059|82909297|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
46694892|NCT01177059|82909297|FG000|Overall Study|Withdrew consent|2|||
46694893|NCT01177059|82909297|FG000|Overall Study|Lost to Follow-up|18|||
46694894|NCT01176513|82909301|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
46694895|NCT01299389|82909307|FG000|Double-blind|Adverse Event|45|||
46694896|NCT01299389|82909308|FG001|Double-blind|Adverse Event|27|||
46694897|NCT01299389|82909309|FG002|Double-blind|Adverse Event|0|||
46694898|NCT01299389|82909310|FG003|Double-blind|Adverse Event|0|||
46694899|NCT01299389|82909307|FG000|Double-blind|Lack of Efficacy|45|||
46694900|NCT01299389|82909308|FG001|Double-blind|Lack of Efficacy|21|||
46694901|NCT01299389|82909309|FG002|Double-blind|Lack of Efficacy|0|||
46694902|NCT01299389|82909310|FG003|Double-blind|Lack of Efficacy|0|||
46694903|NCT01299389|82909307|FG000|Double-blind|Lost to Follow-up|2|||
46694904|NCT01299389|82909308|FG001|Double-blind|Lost to Follow-up|1|||
46694905|NCT01299389|82909309|FG002|Double-blind|Lost to Follow-up|0|||
46694906|NCT01299389|82909310|FG003|Double-blind|Lost to Follow-up|0|||
46694907|NCT01299389|82909307|FG000|Double-blind|Withdrawal by Subject|16|||
46694908|NCT01299389|82909308|FG001|Double-blind|Withdrawal by Subject|13|||
46694909|NCT01299389|82909309|FG002|Double-blind|Withdrawal by Subject|0|||
46694910|NCT01299389|82909310|FG003|Double-blind|Withdrawal by Subject|0|||
46694911|NCT01299389|82909307|FG000|Double-blind|Other|1|||
46694912|NCT01299389|82909308|FG001|Double-blind|Other|1|||
46694913|NCT01299389|82909309|FG002|Double-blind|Other|0|||
46694914|NCT01299389|82909310|FG003|Double-blind|Other|0|||
46694915|NCT01299389|82909307|FG000|Double-blind|"fail to meet study population criteria"|0|||
46694916|NCT01299389|82909308|FG001|Double-blind|"fail to meet study population criteria"|1|||
46694917|NCT01299389|82909309|FG002|Double-blind|"fail to meet study population criteria"|0|||
46859021|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
46859022|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
46694918|NCT01299389|82909310|FG003|Double-blind|"fail to meet study population criteria"|0|||
46694919|NCT01299389|82909307|FG000|Post-observational|Other|0|||
46694920|NCT01299389|82909308|FG001|Post-observational|Other|0|||
46694921|NCT01299389|82909309|FG002|Post-observational|Other|12|||
46694922|NCT01299389|82909310|FG003|Post-observational|Other|6|||
46694923|NCT01298999|82909321|FG000|Overall Study|Physician Decision|0|||
46694924|NCT01298999|82909322|FG001|Overall Study|Physician Decision|1|||
46694925|NCT01298999|82909321|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
46694926|NCT01298999|82909322|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
46694927|NCT01007032|82909332|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
46694928|NCT01007032|82909333|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
46694929|NCT01007032|82909334|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
46694930|NCT01007032|82909335|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
46694931|NCT01007032|82909332|FG000|Overall Study|Withdrawal by Subject|0|||
46694932|NCT01007032|82909333|FG001|Overall Study|Withdrawal by Subject|0|||
46694933|NCT01007032|82909334|FG002|Overall Study|Withdrawal by Subject|0|||
46694934|NCT01007032|82909335|FG003|Overall Study|Withdrawal by Subject|1|||
46694935|NCT00976027|82909352|FG000|Overall Study|Serious Adverse Event|36|||
46694936|NCT00976027|82909353|FG001|Overall Study|Serious Adverse Event|17|||
46694937|NCT00976027|82909352|FG000|Overall Study|Adverse Event|0|||
46694938|NCT00976027|82909353|FG001|Overall Study|Adverse Event|2|||
46694939|NCT00976027|82909352|FG000|Overall Study|Protocol Violation|60|||
46694940|NCT00976027|82909353|FG001|Overall Study|Protocol Violation|27|||
46694941|NCT00976027|82909352|FG000|Overall Study|Lost to Follow-up|208|||
46694942|NCT00976027|82909353|FG001|Overall Study|Lost to Follow-up|103|||
46694943|NCT00976027|82909352|FG000|Overall Study|Withdrawal by Subject|107|||
46694944|NCT00976027|82909353|FG001|Overall Study|Withdrawal by Subject|66|||
46694945|NCT01298765|82909359|FG000|Titration Period|Adverse Event|26|||
46694946|NCT01298765|82909359|FG000|Titration Period|Death|1|||
46694947|NCT01298765|82909359|FG000|Titration Period|Lack of Efficacy|21|||
46694948|NCT01298765|82909359|FG000|Titration Period|Lost to Follow-up|9|||
46694949|NCT01298765|82909359|FG000|Titration Period|Physician Decision|1|||
46694950|NCT01298765|82909359|FG000|Titration Period|Withdrawal by Subject|10|||
46694951|NCT01298765|82909359|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
46694952|NCT01298765|82909359|FG000|Long-Term Treatment Period|Adverse Event|19|||
46694953|NCT01298765|82909359|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
46694954|NCT01298765|82909359|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
46694955|NCT01298765|82909359|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
46694956|NCT01298765|82909359|FG000|Long-Term Treatment Period|Physician Decision|1|||
46694957|NCT01298765|82909359|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
46694958|NCT00997438|82909366|FG000|Overall Study|Blood draw difficulty|2|||
46694959|NCT00997438|82909367|FG001|Overall Study|Blood draw difficulty|0|||
46694960|NCT00997438|82909368|FG002|Overall Study|Blood draw difficulty|1|||
46694961|NCT00997438|82909366|FG000|Overall Study|Withdrawal by Subject|1|||
46694962|NCT00997438|82909367|FG001|Overall Study|Withdrawal by Subject|1|||
46694963|NCT00997438|82909368|FG002|Overall Study|Withdrawal by Subject|0|||
46694964|NCT00997438|82909366|FG000|Overall Study|Exclusion criteria at visit 1|2|||
46694965|NCT00997438|82909367|FG001|Overall Study|Exclusion criteria at visit 1|2|||
46694966|NCT00997438|82909368|FG002|Overall Study|Exclusion criteria at visit 1|3|||
46694967|NCT00997126|82909379|FG000|Overall Study|Physician Decision|7|||
46694968|NCT00997126|82909380|FG001|Overall Study|Physician Decision|11|||
46694969|NCT01000636|82909386|FG000|Overall Study|Withdrawal by Subject|1|||
46982137|NCT02584855|83228303|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
46982138|NCT02584855|83228298|FG000|Open-Label Treatment Period|Adverse Event|14|||
46694970|NCT01000636|82909386|FG000|Overall Study|Adverse Event|1|||
46694971|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Adverse Event|33|||
46694972|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
46694973|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
46694974|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
46694975|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Physician Decision|6|||
46694976|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
46694977|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
46982139|NCT02584855|83228299|FG001|Open-Label Treatment Period|Adverse Event|0|||
46694978|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
46694979|NCT00965419|82909390|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
46694980|NCT00965419|82909390|FG000|Follow-up Phase|Adverse Event|9|||
46694981|NCT00965419|82909390|FG000|Follow-up Phase|Protocol Violation|4|||
46694982|NCT00965419|82909390|FG000|Follow-up Phase|Withdrawal by Subject|8|||
46694983|NCT00965419|82909390|FG000|Follow-up Phase|Physician Decision|4|||
46694984|NCT00965419|82909390|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
46694985|NCT00965419|82909390|FG000|Follow-up Phase|Lack of Efficacy|28|||
46694986|NCT01000480|82909395|FG000|Induction Phase|Adverse Event|2|||
46694987|NCT01000480|82909395|FG000|Induction Phase|Lost to Follow-up|1|||
46694988|NCT01000480|82909395|FG000|Induction Phase|Physician Decision|1|||
46694989|NCT01000480|82909395|FG000|Induction Phase|Entry Criteria Not Met|3|||
46694990|NCT01000480|82909395|FG000|Concurrent Therapy Phase|Adverse Event|4|||
46694991|NCT01000480|82909395|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
46694992|NCT01000480|82909395|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
46694993|NCT01000480|82909395|FG000|Concurrent Therapy Phase|Physician Decision|1|||
46694994|NCT00965341|82909401|FG000|Overall Study|Withdrew consent|1|||
46694995|NCT00965341|82909402|FG001|Overall Study|Withdrew consent|5|||
46694996|NCT00965341|82909401|FG000|Overall Study|Lost to Follow-up|1|||
46694997|NCT00965341|82909402|FG001|Overall Study|Lost to Follow-up|0|||
46694998|NCT00965341|82909401|FG000|Overall Study|Transportation issues|4|||
46694999|NCT00965341|82909402|FG001|Overall Study|Transportation issues|3|||
46695000|NCT01175811|82909410|FG000|Overall Study|Adverse Event|1|||
46695001|NCT01175811|82909411|FG001|Overall Study|Adverse Event|1|||
46695002|NCT01175811|82909410|FG000|Overall Study|Entry criteria not met|3|||
46695003|NCT01175811|82909411|FG001|Overall Study|Entry criteria not met|1|||
46695004|NCT01175811|82909410|FG000|Overall Study|Lack of Efficacy|1|||
46695005|NCT01175811|82909411|FG001|Overall Study|Lack of Efficacy|0|||
46695006|NCT01175811|82909410|FG000|Overall Study|Lost to Follow-up|3|||
46695007|NCT01175811|82909411|FG001|Overall Study|Lost to Follow-up|2|||
46695008|NCT01175811|82909410|FG000|Overall Study|Physician Decision|1|||
46695009|NCT01175811|82909411|FG001|Overall Study|Physician Decision|1|||
46695010|NCT01175811|82909410|FG000|Overall Study|Protocol Violation|1|||
46695011|NCT01175811|82909411|FG001|Overall Study|Protocol Violation|2|||
46695012|NCT01175811|82909410|FG000|Overall Study|Withdrawal by Subject|6|||
46695013|NCT01175811|82909411|FG001|Overall Study|Withdrawal by Subject|7|||
46695014|NCT00965263|82909419|FG000|Overall Study|Physician Decision|2|||
46695015|NCT00965263|82909420|FG001|Overall Study|Physician Decision|0|||
46695016|NCT00965263|82909419|FG000|Overall Study|Family emergency|0|||
46695017|NCT00965263|82909420|FG001|Overall Study|Family emergency|1|||
46695018|NCT00965263|82909419|FG000|Overall Study|Protocol Violation|0|||
46695019|NCT00965263|82909420|FG001|Overall Study|Protocol Violation|2|||
46695020|NCT00965185|82909446|FG000|Overall Study|Lost to Follow-up|2|||
46695021|NCT00965185|82909447|FG001|Overall Study|Lost to Follow-up|0|||
46695022|NCT00965185|82909446|FG000|Overall Study|Withdrawal by Subject|0|||
46695023|NCT00965185|82909447|FG001|Overall Study|Withdrawal by Subject|1|||
46695024|NCT01174563|82909455|FG000|Overall Study|Progressive Disease|45|||
46695025|NCT01174563|82909455|FG000|Overall Study|Death|5|||
46695026|NCT01174563|82909455|FG000|Overall Study|Investigator's Discretion|5|||
46801930|NCT03485911|83020884|FG000|Part 1|Withdrew Consent prior to dosing|0|||
46801931|NCT03485911|83020885|FG001|Part 1|Withdrew Consent prior to dosing|0|||
46801932|NCT03485911|83020886|FG002|Part 1|Withdrew Consent prior to dosing|0|||
46801933|NCT03485911|83020887|FG003|Part 1|Withdrew Consent prior to dosing|1|||
46801934|NCT03485911|83020884|FG000|Part 1|Other NOS|0|||
46801935|NCT03485911|83020885|FG001|Part 1|Other NOS|0|||
46801936|NCT03485911|83020886|FG002|Part 1|Other NOS|0|||
46801937|NCT03485911|83020887|FG003|Part 1|Other NOS|1|||
46801938|NCT03485911|83020884|FG000|Part 2|Perceived lack of efficacy|5|||
46859023|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
46695027|NCT01174563|82909455|FG000|Overall Study|Participant Withdrew Consent|3|||
46695028|NCT01174563|82909455|FG000|Overall Study|Rash Adverse Event|1|||
46695029|NCT01174563|82909455|FG000|Overall Study|Sponsor's decision|1|||
46695030|NCT01298531|82909461|FG000|Overall Study|Lack of Efficacy|0|||
46695031|NCT01298531|82909462|FG001|Overall Study|Lack of Efficacy|1|||
46695032|NCT01298531|82909461|FG000|Overall Study|Lost to Follow-up|2|||
46695033|NCT01298531|82909462|FG001|Overall Study|Lost to Follow-up|0|||
46695034|NCT01298531|82909461|FG000|Overall Study|Protocol Violation|1|||
46695035|NCT01298531|82909462|FG001|Overall Study|Protocol Violation|1|||
46695036|NCT01298531|82909461|FG000|Overall Study|Adverse Event|4|||
46695037|NCT01298531|82909462|FG001|Overall Study|Adverse Event|3|||
46695038|NCT01298531|82909461|FG000|Overall Study|Does not meet entrance criteria|0|||
46695039|NCT01298531|82909462|FG001|Overall Study|Does not meet entrance criteria|1|||
46695040|NCT01298531|82909461|FG000|Overall Study|Other|2|||
46695041|NCT01298531|82909462|FG001|Overall Study|Other|1|||
46982140|NCT02584855|83228300|FG002|Open-Label Treatment Period|Adverse Event|0|||
46801939|NCT03485911|83020885|FG001|Part 2|Perceived lack of efficacy|3|||
46801940|NCT03485911|83020886|FG002|Part 2|Perceived lack of efficacy|0|||
46801941|NCT03485911|83020887|FG003|Part 2|Perceived lack of efficacy|2|||
46801942|NCT03485911|83020884|FG000|Part 2|Subject withdrew consent|1|||
46695042|NCT01174173|82909469|FG000|Overall Study|drug-drug interaction|1|||
46695043|NCT00964795|82909474|FG000|Overall Study|Withdrawal by Subject|79|||
46695044|NCT00964795|82909474|FG000|Overall Study|Adverse Event|12|||
46695045|NCT00964795|82909474|FG000|Overall Study|Death|14|||
46695046|NCT00964795|82909474|FG000|Overall Study|Lost to Follow-up|7|||
46695047|NCT00964795|82909474|FG000|Overall Study|Termination of Study by Sponsor|169|||
46695048|NCT00964795|82909474|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
46695049|NCT00964795|82909474|FG000|Overall Study|Other|23|||
46695050|NCT01173471|82909483|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46695051|NCT01173471|82909484|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46695052|NCT01173471|82909485|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
46695053|NCT01173471|82909486|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
46695054|NCT01173471|82909483|FG000|Overall Study|Condition under investigation worsened|2|||
46695055|NCT01173471|82909484|FG001|Overall Study|Condition under investigation worsened|0|||
46695056|NCT01173471|82909485|FG002|Overall Study|Condition under investigation worsened|0|||
46695057|NCT01173471|82909486|FG003|Overall Study|Condition under investigation worsened|0|||
46695058|NCT01173471|82909483|FG000|Overall Study|Lost to Follow-up|0|||
46695059|NCT01173471|82909484|FG001|Overall Study|Lost to Follow-up|0|||
46695060|NCT01173471|82909485|FG002|Overall Study|Lost to Follow-up|1|||
46695061|NCT01173471|82909486|FG003|Overall Study|Lost to Follow-up|0|||
46695062|NCT01173471|82909483|FG000|Overall Study|Reason given as Other|0|||
46695063|NCT01173471|82909484|FG001|Overall Study|Reason given as Other|0|||
46695064|NCT01173471|82909485|FG002|Overall Study|Reason given as Other|1|||
46695065|NCT01173471|82909486|FG003|Overall Study|Reason given as Other|0|||
46695066|NCT01172847|82909496|FG000|Overall Study|Withdrawal by Subject|3|||
46695067|NCT00966355|82909509|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
46695068|NCT00966355|82909510|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
46695069|NCT00966355|82909511|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
46695070|NCT00966355|82909509|FG000|Overall Study|newly diagnosed advanced HCC|11|||
46695071|NCT00966355|82909510|FG001|Overall Study|newly diagnosed advanced HCC|12|||
46695072|NCT00966355|82909511|FG002|Overall Study|newly diagnosed advanced HCC|10|||
46695073|NCT00966355|82909509|FG000|Overall Study|Lost to Follow-up|5|||
46695074|NCT00966355|82909510|FG001|Overall Study|Lost to Follow-up|4|||
46695075|NCT00966355|82909511|FG002|Overall Study|Lost to Follow-up|3|||
46695076|NCT01172535|82909519|FG000|Overall Study|Death|3|||
46695077|NCT01172535|82909519|FG000|Overall Study|Withdrawal by Subject|2|||
46695078|NCT01172535|82909519|FG000|Overall Study|Lost to Follow-up|1|||
46695079|NCT01172535|82909519|FG000|Overall Study|Ineligible at study entry|1|||
46695080|NCT01172535|82909519|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
46695081|NCT00966277|82909528|FG000|Overall Study|Withdrawal by Subject|3|||
46695082|NCT00966277|82909529|FG001|Overall Study|Withdrawal by Subject|0|||
46695083|NCT00966277|82909528|FG000|Overall Study|Ineligible|1|||
46695084|NCT00966277|82909529|FG001|Overall Study|Ineligible|3|||
46695085|NCT00966277|82909528|FG000|Overall Study|Treatment Plan Changed|0|||
46695086|NCT00966277|82909529|FG001|Overall Study|Treatment Plan Changed|1|||
46695087|NCT01298141|82909535|FG000|Overall Study|Adverse Event|3|||
46695088|NCT01298141|82909535|FG000|Overall Study|Refusal of Required Study Procedures|1|||
46695089|NCT01298141|82909535|FG000|Overall Study|Withdrawal by Subject|6|||
46695090|NCT01298141|82909535|FG000|Overall Study|Termination of Study by the Investigator|5|||
46695091|NCT01298141|82909535|FG000|Overall Study|Other|5|||
46695092|NCT01298141|82909535|FG000|Overall Study|Lost to Follow-up|1|||
46695093|NCT01298141|82909535|FG000|Overall Study|Death|6|||
46695094|NCT01298141|82909535|FG000|Overall Study|Not treated|4|||
46695095|NCT01171989|82909542|FG000|Overall Study|Lost to Follow-up|0|||
46695096|NCT01171989|82909543|FG001|Overall Study|Lost to Follow-up|0|||
46695097|NCT01171989|82909544|FG002|Overall Study|Lost to Follow-up|1|||
46695098|NCT01297517|82909555|FG000|Overall Study|Adverse Event|21|||
46695099|NCT01297517|82909556|FG001|Overall Study|Adverse Event|7|||
46695100|NCT01297517|82909557|FG002|Overall Study|Adverse Event|16|||
46695101|NCT01297517|82909555|FG000|Overall Study|Lost to Follow-up|1|||
46695102|NCT01297517|82909556|FG001|Overall Study|Lost to Follow-up|0|||
46695103|NCT01297517|82909557|FG002|Overall Study|Lost to Follow-up|1|||
46695104|NCT01297517|82909555|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
46695105|NCT01297517|82909556|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
46695106|NCT01297517|82909557|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
46695107|NCT01297517|82909555|FG000|Overall Study|Noncompliance|1|||
46695108|NCT01297517|82909556|FG001|Overall Study|Noncompliance|0|||
46695109|NCT01297517|82909557|FG002|Overall Study|Noncompliance|0|||
46695110|NCT01297517|82909555|FG000|Overall Study|Protocol Violation|1|||
46695111|NCT01297517|82909556|FG001|Overall Study|Protocol Violation|1|||
46695112|NCT01297517|82909557|FG002|Overall Study|Protocol Violation|1|||
46695113|NCT01297517|82909555|FG000|Overall Study|Inadequate Control of IOP|1|||
46695114|NCT01297517|82909556|FG001|Overall Study|Inadequate Control of IOP|1|||
46695115|NCT01297517|82909557|FG002|Overall Study|Inadequate Control of IOP|2|||
46695116|NCT01171677|82909567|FG000|Overall Study|Withdrawal by Subject|0|||
46801943|NCT03485911|83020885|FG001|Part 2|Subject withdrew consent|0|||
46695117|NCT01171677|82909568|FG001|Overall Study|Withdrawal by Subject|3|||
46695118|NCT01171677|82909567|FG000|Overall Study|Adverse Event|1|||
46695119|NCT01171677|82909568|FG001|Overall Study|Adverse Event|0|||
46695120|NCT01171677|82909567|FG000|Overall Study|completed <70% IntenSati classes|5|||
46695121|NCT01171677|82909568|FG001|Overall Study|completed <70% IntenSati classes|0|||
46695122|NCT01171521|82909574|FG000|Overall Study|Lost to Follow-up|5|||
46695123|NCT01171521|82909574|FG000|Overall Study|screen failure|1|||
46695124|NCT01296347|82909580|FG000|Allocation|Withdrawal by Subject|1|||
46695125|NCT01296347|82909581|FG001|Allocation|Withdrawal by Subject|2|||
46695126|NCT01296347|82909580|FG000|Allocation|Lack of Efficacy|1|||
46695127|NCT01296347|82909581|FG001|Allocation|Lack of Efficacy|2|||
46695128|NCT01296347|82909580|FG000|Allocation|not received infusion|1|||
46695129|NCT01296347|82909581|FG001|Allocation|not received infusion|0|||
46695130|NCT01296347|82909580|FG000|6 Week Follow up|Death|0|||
46695131|NCT01296347|82909581|FG001|6 Week Follow up|Death|1|||
46695132|NCT01296347|82909580|FG000|3 Month Follow up|Death|1|||
46801944|NCT03485911|83020886|FG002|Part 2|Subject withdrew consent|2|||
46801945|NCT03485911|83020887|FG003|Part 2|Subject withdrew consent|1|||
46801946|NCT03485911|83020884|FG000|Part 2|Lab abnormalities/AEs|1|||
46801947|NCT03485911|83020885|FG001|Part 2|Lab abnormalities/AEs|2|||
46801948|NCT03485911|83020886|FG002|Part 2|Lab abnormalities/AEs|0|||
46801949|NCT03485911|83020887|FG003|Part 2|Lab abnormalities/AEs|0|||
46801950|NCT03485911|83020884|FG000|Part 2|Other NOS|0|||
46801951|NCT03485911|83020885|FG001|Part 2|Other NOS|1|||
46801952|NCT03485911|83020886|FG002|Part 2|Other NOS|0|||
46801953|NCT03485911|83020887|FG003|Part 2|Other NOS|0|||
46801954|NCT03485911|83020884|FG000|Part 2|Intercurrent illness/new medical condition|1|||
46801955|NCT03485911|83020885|FG001|Part 2|Intercurrent illness/new medical condition|0|||
46801956|NCT03485911|83020886|FG002|Part 2|Intercurrent illness/new medical condition|0|||
46801957|NCT03485911|83020887|FG003|Part 2|Intercurrent illness/new medical condition|0|||
46801958|NCT03485911|83020884|FG000|Part 2|Investigator judgement|1|||
46801959|NCT03485911|83020885|FG001|Part 2|Investigator judgement|0|||
46801960|NCT03485911|83020886|FG002|Part 2|Investigator judgement|0|||
46801961|NCT03485911|83020887|FG003|Part 2|Investigator judgement|0|||
46801962|NCT03485911|83020884|FG000|Part 3|Perceived lack of efficacy|2|||
46801963|NCT03485911|83020885|FG001|Part 3|Perceived lack of efficacy|2|||
46801964|NCT03485911|83020886|FG002|Part 3|Perceived lack of efficacy|2|||
46801965|NCT03485911|83020887|FG003|Part 3|Perceived lack of efficacy|0|||
46801966|NCT03485911|83020884|FG000|Part 3|Subject withdrew consent|1|||
46801967|NCT03485911|83020885|FG001|Part 3|Subject withdrew consent|4|||
46801968|NCT03485911|83020886|FG002|Part 3|Subject withdrew consent|0|||
46801969|NCT03485911|83020887|FG003|Part 3|Subject withdrew consent|1|||
46801970|NCT03485911|83020884|FG000|Part 3|Lab abnormalities/AEs|1|||
46801971|NCT03485911|83020885|FG001|Part 3|Lab abnormalities/AEs|1|||
46801972|NCT03485911|83020886|FG002|Part 3|Lab abnormalities/AEs|0|||
46801973|NCT03485911|83020887|FG003|Part 3|Lab abnormalities/AEs|2|||
46801974|NCT03485911|83020884|FG000|Part 3|Other NOS|1|||
46801975|NCT03485911|83020885|FG001|Part 3|Other NOS|1|||
46801976|NCT03485911|83020886|FG002|Part 3|Other NOS|0|||
46695133|NCT01296347|82909581|FG001|3 Month Follow up|Death|0|||
46695134|NCT01296347|82909580|FG000|3 Month Follow up|Lost to Follow-up|0|||
46695135|NCT01296347|82909581|FG001|3 Month Follow up|Lost to Follow-up|1|||
46695136|NCT01296347|82909580|FG000|6 Month Follow up|Death|2|||
46695137|NCT01296347|82909581|FG001|6 Month Follow up|Death|1|||
46695138|NCT01296347|82909580|FG000|6 Month Follow up|Lost to Follow-up|0|||
46695139|NCT01296347|82909581|FG001|6 Month Follow up|Lost to Follow-up|1|||
46695140|NCT01296347|82909580|FG000|12 Month Follow up|Lost to Follow-up|3|||
46801977|NCT03485911|83020887|FG003|Part 3|Other NOS|0|||
46801978|NCT03485911|83020884|FG000|Part 3|Intercurrent illness/new medical condition|0|||
46695141|NCT01296347|82909581|FG001|12 Month Follow up|Lost to Follow-up|1|||
46801979|NCT03485911|83020885|FG001|Part 3|Intercurrent illness/new medical condition|1|||
46801980|NCT03485911|83020886|FG002|Part 3|Intercurrent illness/new medical condition|1|||
46695142|NCT01296347|82909580|FG000|12 Month Follow up|Death|1|||
46801981|NCT03485911|83020887|FG003|Part 3|Intercurrent illness/new medical condition|0|||
46801982|NCT03485911|83020884|FG000|Part 3|Sponsor discontinuation|1|||
46801983|NCT03485911|83020885|FG001|Part 3|Sponsor discontinuation|0|||
46801984|NCT03485911|83020886|FG002|Part 3|Sponsor discontinuation|0|||
46801985|NCT03485911|83020887|FG003|Part 3|Sponsor discontinuation|0|||
46801986|NCT03485911|83020884|FG000|Part 3|Berotralstat provided by alternative means|13|||
46695143|NCT01296347|82909581|FG001|12 Month Follow up|Death|1|||
46695144|NCT01296347|82909580|FG000|12 Month Follow up|Withdrawal by Subject|0|||
46695145|NCT01296347|82909581|FG001|12 Month Follow up|Withdrawal by Subject|1|||
46695146|NCT01296035|82909590|FG000|Overall Study|Withdrawal by Subject|1|||
46695147|NCT01294787|82909594|FG000|Period 1|Adverse Event|0|||
46695148|NCT01294787|82909595|FG001|Period 1|Adverse Event|0|||
46695149|NCT01294787|82909596|FG002|Period 1|Adverse Event|0|||
46695150|NCT01294787|82909597|FG003|Period 1|Adverse Event|0|||
46695151|NCT01294787|82909598|FG004|Period 1|Adverse Event|1|||
46695152|NCT01294787|82909599|FG005|Period 1|Adverse Event|0|||
46695153|NCT01294787|82909594|FG000|Period 1|Withdrawal by Subject|0|||
46695154|NCT01294787|82909595|FG001|Period 1|Withdrawal by Subject|0|||
46695155|NCT01294787|82909596|FG002|Period 1|Withdrawal by Subject|0|||
46695156|NCT01294787|82909597|FG003|Period 1|Withdrawal by Subject|1|||
46695157|NCT01294787|82909598|FG004|Period 1|Withdrawal by Subject|1|||
46695158|NCT01294787|82909599|FG005|Period 1|Withdrawal by Subject|1|||
46695159|NCT01294787|82909594|FG000|Period 1|Administrative problem|0|||
46801987|NCT03485911|83020885|FG001|Part 3|Berotralstat provided by alternative means|13|||
46801988|NCT03485911|83020886|FG002|Part 3|Berotralstat provided by alternative means|7|||
46801989|NCT03485911|83020887|FG003|Part 3|Berotralstat provided by alternative means|7|||
46982141|NCT02584855|83228301|FG003|Open-Label Treatment Period|Adverse Event|0|||
46982142|NCT02584855|83228302|FG004|Open-Label Treatment Period|Adverse Event|0|||
46982143|NCT02584855|83228303|FG005|Open-Label Treatment Period|Adverse Event|0|||
46982144|NCT02584855|83228298|FG000|Open-Label Treatment Period|Death|2|||
46982145|NCT02584855|83228299|FG001|Open-Label Treatment Period|Death|0|||
46982146|NCT02584855|83228300|FG002|Open-Label Treatment Period|Death|0|||
46982147|NCT02584855|83228301|FG003|Open-Label Treatment Period|Death|0|||
46982148|NCT02584855|83228302|FG004|Open-Label Treatment Period|Death|0|||
46801990|NCT02886936|83020962|FG000|Overall Study|Lost to Follow-up|4|||
46801991|NCT02886936|83020963|FG001|Overall Study|Lost to Follow-up|3|||
46801992|NCT02886936|83020964|FG002|Overall Study|Lost to Follow-up|0|||
46801993|NCT02162511|83020999|FG000|Overall Study|Lack of Efficacy|0|||
46801994|NCT02162511|83021000|FG001|Overall Study|Lack of Efficacy|0|||
46801995|NCT02162511|83021001|FG002|Overall Study|Lack of Efficacy|2|||
46801996|NCT05377749|83021007|FG000|3 Weeks|Lost to Follow-up|2|||
46801997|NCT05377749|83021008|FG001|3 Weeks|Lost to Follow-up|4|||
46801998|NCT05377749|83021007|FG000|3 Weeks|Physician Decision|0|||
46801999|NCT05377749|83021008|FG001|3 Weeks|Physician Decision|1|||
46802000|NCT05216406|83021025|FG000|Overall Study|Lost to Follow-up|8|||
46802001|NCT05216406|83021026|FG001|Overall Study|Lost to Follow-up|9|||
46802002|NCT05203822|83021032|FG000|Overall Study|Adverse Event|1|||
46802003|NCT05203822|83021032|FG000|Overall Study|Withdrawal by Subject|1|||
46802004|NCT05086510|83021050|FG000|Overall Study|Lost to Follow-up|0|||
46802005|NCT05086510|83021051|FG001|Overall Study|Lost to Follow-up|2|||
46802006|NCT05086510|83021050|FG000|Overall Study|Death|0|||
46802007|NCT05086510|83021051|FG001|Overall Study|Death|2|||
46982149|NCT02584855|83228303|FG005|Open-Label Treatment Period|Death|0|||
46982150|NCT02584855|83228298|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
46982151|NCT02584855|83228299|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
46802008|NCT04718974|83021092|FG000|Overall Study|Death|0|||
46802009|NCT04718974|83021093|FG001|Overall Study|Death|2|||
46695160|NCT01294787|82909595|FG001|Period 1|Administrative problem|0|||
46695161|NCT01294787|82909596|FG002|Period 1|Administrative problem|1|||
46695162|NCT01294787|82909597|FG003|Period 1|Administrative problem|0|||
46695163|NCT01294787|82909598|FG004|Period 1|Administrative problem|0|||
46695164|NCT01294787|82909599|FG005|Period 1|Administrative problem|1|||
46695165|NCT01294787|82909594|FG000|Period 2|Adverse Event|0|||
46695166|NCT01294787|82909595|FG001|Period 2|Adverse Event|3|||
46695167|NCT01294787|82909596|FG002|Period 2|Adverse Event|0|||
46695168|NCT01294787|82909597|FG003|Period 2|Adverse Event|1|||
46695169|NCT01294787|82909598|FG004|Period 2|Adverse Event|0|||
46802010|NCT04718974|83021092|FG000|Overall Study|Lost to Follow-up|10|||
46802011|NCT04718974|83021093|FG001|Overall Study|Lost to Follow-up|20|||
46802012|NCT04718974|83021092|FG000|Overall Study|Transferred out|2|||
46802013|NCT04718974|83021093|FG001|Overall Study|Transferred out|4|||
46802014|NCT04681729|83021101|FG000|Overall Study|Lack of Efficacy|2|||
46802015|NCT04681729|83021102|FG001|Overall Study|Lack of Efficacy|2|||
46982152|NCT02584855|83228300|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
46695170|NCT01294787|82909599|FG005|Period 2|Adverse Event|0|||
46695171|NCT01294787|82909594|FG000|Period 2|No longer needs study drug|0|||
46695172|NCT01294787|82909595|FG001|Period 2|No longer needs study drug|0|||
46695173|NCT01294787|82909596|FG002|Period 2|No longer needs study drug|0|||
46695174|NCT01294787|82909597|FG003|Period 2|No longer needs study drug|1|||
46695175|NCT01294787|82909598|FG004|Period 2|No longer needs study drug|0|||
46695176|NCT01294787|82909599|FG005|Period 2|No longer needs study drug|0|||
46695177|NCT01294787|82909594|FG000|Period 3|Adverse Event|0|||
46695178|NCT01294787|82909595|FG001|Period 3|Adverse Event|0|||
46695179|NCT01294787|82909596|FG002|Period 3|Adverse Event|0|||
46695180|NCT01294787|82909597|FG003|Period 3|Adverse Event|0|||
46695181|NCT01294787|82909598|FG004|Period 3|Adverse Event|1|||
46695182|NCT01294787|82909599|FG005|Period 3|Adverse Event|0|||
46695183|NCT01294553|82909610|FG000|Overall Study|Duplicated Participants|1|||
46695184|NCT01294553|82909610|FG000|Overall Study|Protocol Violation|268|||
46695185|NCT01294397|82909615|FG000|Overall Study|Withdrawal by Subject|1|||
46695186|NCT01294397|82909615|FG000|Overall Study|Administrative Decision|1|||
46695187|NCT01293695|82909623|FG000|Overall Study|Withdrawal by Subject|7|||
46695188|NCT01293695|82909624|FG001|Overall Study|Withdrawal by Subject|1|||
46695189|NCT01293695|82909623|FG000|Overall Study|Lost to Follow-up|8|||
46695190|NCT01293695|82909624|FG001|Overall Study|Lost to Follow-up|6|||
46695191|NCT01293539|82909633|FG000|Overall Study|Physician Decision|1|||
46695192|NCT01292837|82909637|FG000|Overall Study|Adverse Event|1|||
46695193|NCT01292837|82909637|FG000|Overall Study|Further treatment determined|1|||
46695194|NCT00965731|82909643|FG000|Overall Study|Death|0|||
46695195|NCT00965731|82909644|FG001|Overall Study|Death|4|||
46695196|NCT00965731|82909643|FG000|Overall Study|Withdrawal by Subject|0|||
46695197|NCT00965731|82909644|FG001|Overall Study|Withdrawal by Subject|1|||
46695198|NCT00965731|82909643|FG000|Overall Study|Other|7|||
46695199|NCT00965731|82909644|FG001|Overall Study|Other|15|||
46695200|NCT00965575|82909657|FG000|Overall Study|subject unwillingness to swallow study c|1|||
46695201|NCT00965575|82909658|FG001|Overall Study|subject unwillingness to swallow study c|0|||
46695202|NCT00965497|82909666|FG000|Overall Study|Physician Decision|1|||
46982153|NCT02584855|83228301|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
46695203|NCT00963937|82909673|FG000|Overall Study|Protocol Violation|1|||
46695204|NCT00963937|82909674|FG001|Overall Study|Protocol Violation|1|||
46695205|NCT00963937|82909675|FG002|Overall Study|Protocol Violation|0|||
46695206|NCT00963937|82909673|FG000|Overall Study|Physician Decision|18|||
46695207|NCT00963937|82909674|FG001|Overall Study|Physician Decision|10|||
46695208|NCT00963937|82909675|FG002|Overall Study|Physician Decision|4|||
46695209|NCT01170663|82909688|FG000|Overall Study|Lost to Follow-up|3|||
46695210|NCT01170663|82909689|FG001|Overall Study|Lost to Follow-up|9|||
46695211|NCT01170663|82909688|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
46695212|NCT01170663|82909689|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
46695213|NCT01170273|82909697|FG000|Overall Study|Lost to Follow-up|6|||
46695214|NCT01170273|82909698|FG001|Overall Study|Lost to Follow-up|8|||
46859024|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
46859025|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
46859026|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Death|1|||
46859027|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Death|1|||
46859028|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Death|1|||
46859029|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Death|0|||
46859030|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Death|0|||
46859031|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Death|0|||
46859032|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
46859033|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
46695215|NCT01170273|82909697|FG000|Overall Study|Protocol Violation|1|||
46695216|NCT01170273|82909698|FG001|Overall Study|Protocol Violation|0|||
46695217|NCT01170273|82909697|FG000|Overall Study|Death|1|||
46695218|NCT01170273|82909698|FG001|Overall Study|Death|0|||
46695219|NCT01170273|82909697|FG000|Overall Study|Adverse Event|0|||
46695220|NCT01170273|82909698|FG001|Overall Study|Adverse Event|1|||
46695221|NCT01170039|82909706|FG000|Overall Study|Withdrawal by Subject|5|||
46695222|NCT01170039|82909707|FG001|Overall Study|Withdrawal by Subject|3|||
46695223|NCT01170039|82909706|FG000|Overall Study|Lack of funding, drug not available|3|||
46695224|NCT01170039|82909707|FG001|Overall Study|Lack of funding, drug not available|3|||
46695225|NCT01169649|82909713|FG000|Overall Study|Patient Not Treated|3|||
46695226|NCT01169493|82909723|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
46695227|NCT01169493|82909724|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
46695228|NCT01169493|82909725|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
46695229|NCT01169493|82909726|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
46695230|NCT01169493|82909727|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
46695231|NCT01169493|82909728|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
46695232|NCT01169493|82909723|FG000|Period 3 (6 Months)|Adverse Event|0|||
46695233|NCT01169493|82909724|FG001|Period 3 (6 Months)|Adverse Event|1|||
46982154|NCT02584855|83228302|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
46982155|NCT02584855|83228303|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
46695234|NCT01169493|82909725|FG002|Period 3 (6 Months)|Adverse Event|0|||
46695235|NCT01169493|82909726|FG003|Period 3 (6 Months)|Adverse Event|0|||
46695236|NCT01169493|82909727|FG004|Period 3 (6 Months)|Adverse Event|0|||
46695237|NCT01169493|82909728|FG005|Period 3 (6 Months)|Adverse Event|0|||
46695238|NCT01169493|82909723|FG000|Period 3 (6 Months)|Physician Decision|0|||
46695239|NCT01169493|82909724|FG001|Period 3 (6 Months)|Physician Decision|1|||
46802016|NCT04681729|83021101|FG000|Overall Study|Withdrawal by Subject|8|||
46802017|NCT04681729|83021102|FG001|Overall Study|Withdrawal by Subject|9|||
46802018|NCT04628793|83021111|FG000|Overall Study|Study terminated by sponsor|0|||
46802019|NCT04628793|83021112|FG001|Overall Study|Study terminated by sponsor|0|||
46802020|NCT04628793|83021113|FG002|Overall Study|Study terminated by sponsor|8|||
46802021|NCT04628793|83021111|FG000|Overall Study|Withdrawal by Subject|2|||
46802022|NCT04628793|83021112|FG001|Overall Study|Withdrawal by Subject|3|||
46982156|NCT02584855|83228298|FG000|Open-Label Treatment Period|Protocol Violation|1|||
46695240|NCT01169493|82909725|FG002|Period 3 (6 Months)|Physician Decision|1|||
46695241|NCT01169493|82909726|FG003|Period 3 (6 Months)|Physician Decision|0|||
46695242|NCT01169493|82909727|FG004|Period 3 (6 Months)|Physician Decision|0|||
46802023|NCT04628793|83021113|FG002|Overall Study|Withdrawal by Subject|0|||
46802024|NCT04628793|83021111|FG000|Overall Study|Lost to Follow-up|0|||
46695243|NCT01169493|82909728|FG005|Period 3 (6 Months)|Physician Decision|0|||
46695244|NCT01287104|82909740|FG000|Overall Study|Patient developed progressive disease|1|||
46695245|NCT01287104|82909741|FG001|Overall Study|Patient developed progressive disease|1|||
46695246|NCT01287104|82909742|FG002|Overall Study|Patient developed progressive disease|3|||
46695247|NCT01287104|82909743|FG003|Overall Study|Patient developed progressive disease|2|||
46695248|NCT01287104|82909740|FG000|Overall Study|Donor anaphylaxis|0|||
46695249|NCT01287104|82909741|FG001|Overall Study|Donor anaphylaxis|1|||
46695250|NCT01287104|82909742|FG002|Overall Study|Donor anaphylaxis|0|||
46802025|NCT04628793|83021112|FG001|Overall Study|Lost to Follow-up|1|||
46802026|NCT04628793|83021113|FG002|Overall Study|Lost to Follow-up|0|||
46802027|NCT04607733|83021146|FG000|Overall Study|Lost to Follow-up|1|||
46802028|NCT04607733|83021147|FG001|Overall Study|Lost to Follow-up|0|||
46802029|NCT04607733|83021148|FG002|Overall Study|Lost to Follow-up|0|||
46802030|NCT04607733|83021149|FG003|Overall Study|Lost to Follow-up|1|||
46802031|NCT04607733|83021150|FG004|Overall Study|Lost to Follow-up|1|||
46802032|NCT04607733|83021151|FG005|Overall Study|Lost to Follow-up|0|||
46802033|NCT04607733|83021146|FG000|Overall Study|Withdrawal by Subject|0|||
46802034|NCT04607733|83021147|FG001|Overall Study|Withdrawal by Subject|0|||
46802035|NCT04607733|83021148|FG002|Overall Study|Withdrawal by Subject|0|||
46802036|NCT04607733|83021149|FG003|Overall Study|Withdrawal by Subject|0|||
46802037|NCT04607733|83021150|FG004|Overall Study|Withdrawal by Subject|1|||
46802038|NCT04607733|83021151|FG005|Overall Study|Withdrawal by Subject|0|||
46802039|NCT04585009|83021173|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
46802040|NCT04585009|83021174|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802041|NCT04585009|83021175|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802042|NCT04585009|83021176|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802043|NCT04585009|83021177|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802044|NCT04585009|83021178|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802045|NCT04585009|83021179|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802046|NCT04585009|83021180|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802047|NCT04585009|83021181|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802048|NCT04585009|83021182|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802049|NCT04585009|83021183|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802050|NCT04585009|83021184|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
46802051|NCT04585009|83021173|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
46802052|NCT04585009|83021174|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802053|NCT04585009|83021175|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802054|NCT04585009|83021176|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802055|NCT04585009|83021177|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802056|NCT04585009|83021178|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802057|NCT04585009|83021179|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802058|NCT04585009|83021180|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802059|NCT04585009|83021181|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802060|NCT04585009|83021182|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802061|NCT04585009|83021183|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802062|NCT04585009|83021184|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
46802063|NCT04585009|83021173|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802064|NCT04585009|83021174|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802065|NCT04585009|83021175|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46859034|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
46859035|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
46859036|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
46859037|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
46859038|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
46859039|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
46859040|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
46859041|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
46859042|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
46859043|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
46695251|NCT01287104|82909743|FG003|Overall Study|Donor anaphylaxis|1|||
46695252|NCT01287104|82909740|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
46695253|NCT01287104|82909741|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
46802066|NCT04585009|83021176|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802067|NCT04585009|83021177|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802068|NCT04585009|83021178|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802069|NCT04585009|83021179|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802070|NCT04585009|83021180|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
46695254|NCT01287104|82909742|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
46695255|NCT01287104|82909743|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
46802071|NCT04585009|83021181|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802072|NCT04585009|83021182|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802073|NCT04585009|83021183|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802074|NCT04585009|83021184|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
46802075|NCT04585009|83021173|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802076|NCT04585009|83021174|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802077|NCT04585009|83021175|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802078|NCT04585009|83021176|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802079|NCT04585009|83021177|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
46802080|NCT04585009|83021178|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802081|NCT04585009|83021179|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802082|NCT04585009|83021180|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802083|NCT04585009|83021181|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802084|NCT04585009|83021182|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802085|NCT04585009|83021183|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802086|NCT04585009|83021184|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
46802087|NCT04585009|83021173|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802088|NCT04585009|83021174|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802089|NCT04585009|83021175|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802090|NCT04585009|83021176|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802091|NCT04585009|83021177|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802092|NCT04585009|83021178|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802093|NCT04585009|83021179|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802094|NCT04585009|83021180|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802095|NCT04585009|83021181|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802096|NCT04585009|83021182|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
46802097|NCT04585009|83021183|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802098|NCT04585009|83021184|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
46802099|NCT04585009|83021173|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802100|NCT04585009|83021174|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802101|NCT04585009|83021175|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802102|NCT04585009|83021176|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802103|NCT04585009|83021177|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802104|NCT04585009|83021178|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802105|NCT04585009|83021179|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802106|NCT04585009|83021180|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802107|NCT04585009|83021181|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802108|NCT04585009|83021182|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802109|NCT04585009|83021183|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
46802110|NCT04585009|83021184|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
46802111|NCT04439838|83021237|FG000|Overall Study|Withdrawal by Subject|0|||
46802112|NCT04439838|83021238|FG001|Overall Study|Withdrawal by Subject|0|||
46802113|NCT04439838|83021239|FG002|Overall Study|Withdrawal by Subject|0|||
46802114|NCT04439838|83021240|FG003|Overall Study|Withdrawal by Subject|0|||
46802115|NCT04439838|83021241|FG004|Overall Study|Withdrawal by Subject|0|||
46695256|NCT01287104|82909740|FG000|Overall Study|Low donor chimerism|0|||
46695257|NCT01287104|82909741|FG001|Overall Study|Low donor chimerism|1|||
46695258|NCT01287104|82909742|FG002|Overall Study|Low donor chimerism|0|||
46695259|NCT01287104|82909743|FG003|Overall Study|Low donor chimerism|0|||
46695260|NCT01287104|82909740|FG000|Overall Study|NK cells did not meet release criteria|0|||
46695261|NCT01287104|82909741|FG001|Overall Study|NK cells did not meet release criteria|1|||
46695262|NCT01287104|82909742|FG002|Overall Study|NK cells did not meet release criteria|0|||
46695263|NCT01287104|82909743|FG003|Overall Study|NK cells did not meet release criteria|0|||
46802116|NCT04439838|83021242|FG005|Overall Study|Withdrawal by Subject|0|||
46802117|NCT04439838|83021243|FG006|Overall Study|Withdrawal by Subject|0|||
46802118|NCT04439838|83021244|FG007|Overall Study|Withdrawal by Subject|0|||
46802119|NCT04439838|83021245|FG008|Overall Study|Withdrawal by Subject|1|||
46802120|NCT04096274|83021310|FG000|Phase I|Lost to Follow-up|5|||
46802121|NCT04096274|83021311|FG001|Phase I|Lost to Follow-up|5|||
46802122|NCT04096274|83021310|FG000|Phase II|Lost to Follow-up|11|||
46695264|NCT01286558|82909762|FG000|Overall Study|Adverse Event|1|||
46695265|NCT01286558|82909763|FG001|Overall Study|Adverse Event|1|||
46695266|NCT01286558|82909762|FG000|Overall Study|Withdrawal by Subject|0|||
46695267|NCT01286558|82909763|FG001|Overall Study|Withdrawal by Subject|1|||
46695268|NCT01169103|82909771|FG000|Overall Study|Lost to Follow-up|3|||
46695269|NCT01169103|82909772|FG001|Overall Study|Lost to Follow-up|3|||
46695270|NCT01169103|82909771|FG000|Overall Study|Withdrawal by Subject|3|||
46695271|NCT01169103|82909772|FG001|Overall Study|Withdrawal by Subject|1|||
46695272|NCT01286480|82909780|FG000|Overall Study|Withdrawal by Subject|5|||
46695273|NCT01286480|82909781|FG001|Overall Study|Withdrawal by Subject|3|||
46695274|NCT01286168|82909787|FG000|Overall Study|Withdrawal by Subject|1|||
46695275|NCT01286168|82909787|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
46695276|NCT01286012|82909794|FG000|Overall Study|Adverse Event|3|||
46695277|NCT01286012|82909795|FG001|Overall Study|Adverse Event|3|||
46695278|NCT01286012|82909794|FG000|Overall Study|Death|2|||
46695279|NCT01286012|82909795|FG001|Overall Study|Death|3|||
46695280|NCT01286012|82909794|FG000|Overall Study|Protocol Violation|1|||
46695281|NCT01286012|82909795|FG001|Overall Study|Protocol Violation|1|||
46695282|NCT01286012|82909794|FG000|Overall Study|Withdrawal by Subject|4|||
46695283|NCT01286012|82909795|FG001|Overall Study|Withdrawal by Subject|4|||
46695284|NCT01286012|82909794|FG000|Overall Study|Physician Decision|2|||
46695285|NCT01286012|82909795|FG001|Overall Study|Physician Decision|0|||
46695286|NCT01286012|82909794|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
46695287|NCT01286012|82909795|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
46695288|NCT00963547|82909806|FG000|Overall Study|Adverse Event|0|||
46695289|NCT00963547|82909807|FG001|Overall Study|Adverse Event|1|||
46695290|NCT00963547|82909808|FG002|Overall Study|Adverse Event|0|||
46695291|NCT00963547|82909809|FG003|Overall Study|Adverse Event|1|||
46695292|NCT00963547|82909810|FG004|Overall Study|Adverse Event|0|||
46695293|NCT00963547|82909811|FG005|Overall Study|Adverse Event|0|||
46695294|NCT00963547|82909812|FG006|Overall Study|Adverse Event|0|||
46695295|NCT00963547|82909806|FG000|Overall Study|Physician Decision|1|||
46695296|NCT00963547|82909807|FG001|Overall Study|Physician Decision|1|||
46695297|NCT00963547|82909808|FG002|Overall Study|Physician Decision|0|||
46695298|NCT00963547|82909809|FG003|Overall Study|Physician Decision|0|||
46695299|NCT00963547|82909810|FG004|Overall Study|Physician Decision|0|||
46695300|NCT00963547|82909811|FG005|Overall Study|Physician Decision|0|||
46695301|NCT00963547|82909812|FG006|Overall Study|Physician Decision|0|||
46695302|NCT00963547|82909806|FG000|Overall Study|Progressive Disease|3|||
46695303|NCT00963547|82909807|FG001|Overall Study|Progressive Disease|8|||
46695304|NCT00963547|82909808|FG002|Overall Study|Progressive Disease|9|||
46802123|NCT04096274|83021311|FG001|Phase II|Lost to Follow-up|11|||
46802124|NCT04067011|83021329|FG000|Overall Study|Not Treated|8|||
46802125|NCT04067011|83021330|FG001|Overall Study|Not Treated|7|||
46802126|NCT04067011|83021331|FG002|Overall Study|Not Treated|5|||
46802127|NCT04067011|83021329|FG000|Overall Study|Adverse Event|2|||
46802128|NCT04067011|83021330|FG001|Overall Study|Adverse Event|1|||
46802129|NCT04067011|83021331|FG002|Overall Study|Adverse Event|0|||
46802130|NCT04067011|83021329|FG000|Overall Study|Withdrawal by Subject|6|||
46802131|NCT04067011|83021330|FG001|Overall Study|Withdrawal by Subject|2|||
46802132|NCT04067011|83021331|FG002|Overall Study|Withdrawal by Subject|1|||
46802133|NCT04067011|83021329|FG000|Overall Study|Lost to Follow-up|0|||
46802134|NCT04067011|83021330|FG001|Overall Study|Lost to Follow-up|0|||
46802135|NCT04067011|83021331|FG002|Overall Study|Lost to Follow-up|1|||
46802136|NCT04067011|83021329|FG000|Overall Study|Physician Decision|1|||
46802137|NCT04067011|83021330|FG001|Overall Study|Physician Decision|1|||
46802138|NCT04067011|83021331|FG002|Overall Study|Physician Decision|0|||
46982157|NCT02584855|83228299|FG001|Open-Label Treatment Period|Protocol Violation|0|||
46695305|NCT00963547|82909809|FG003|Overall Study|Progressive Disease|5|||
46695306|NCT00963547|82909810|FG004|Overall Study|Progressive Disease|0|||
46695307|NCT00963547|82909811|FG005|Overall Study|Progressive Disease|0|||
46802139|NCT04067011|83021329|FG000|Overall Study|Other Reasons|2|||
46802140|NCT04067011|83021330|FG001|Overall Study|Other Reasons|0|||
46802141|NCT04067011|83021331|FG002|Overall Study|Other Reasons|1|||
46802142|NCT04067011|83021329|FG000|Overall Study|Missing|0|||
46802143|NCT04067011|83021330|FG001|Overall Study|Missing|2|||
46695308|NCT00963547|82909812|FG006|Overall Study|Progressive Disease|0|||
46695309|NCT00963547|82909806|FG000|Overall Study|Withdrawal by Subject|0|||
46695310|NCT00963547|82909807|FG001|Overall Study|Withdrawal by Subject|0|||
46695311|NCT00963547|82909808|FG002|Overall Study|Withdrawal by Subject|3|||
46695312|NCT00963547|82909809|FG003|Overall Study|Withdrawal by Subject|0|||
46802144|NCT04067011|83021331|FG002|Overall Study|Missing|0|||
46802145|NCT04007523|83021349|FG000|Overall Study|Withdrawal by Subject|0|||
46802146|NCT04007523|83021350|FG001|Overall Study|Withdrawal by Subject|1|||
46802147|NCT04007523|83021351|FG002|Overall Study|Withdrawal by Subject|1|||
46802148|NCT04007523|83021352|FG003|Overall Study|Withdrawal by Subject|0|||
46802149|NCT04007523|83021349|FG000|Overall Study|ICU Transfer|0|||
46695313|NCT00963547|82909810|FG004|Overall Study|Withdrawal by Subject|0|||
46695314|NCT00963547|82909811|FG005|Overall Study|Withdrawal by Subject|0|||
46695315|NCT00963547|82909812|FG006|Overall Study|Withdrawal by Subject|0|||
46802150|NCT04007523|83021350|FG001|Overall Study|ICU Transfer|1|||
46802151|NCT04007523|83021351|FG002|Overall Study|ICU Transfer|0|||
46695316|NCT00963547|82909806|FG000|Overall Study|Reason Unknown|0|||
46695317|NCT00963547|82909807|FG001|Overall Study|Reason Unknown|1|||
46695318|NCT00963547|82909808|FG002|Overall Study|Reason Unknown|0|||
46695319|NCT00963547|82909809|FG003|Overall Study|Reason Unknown|0|||
46695320|NCT00963547|82909810|FG004|Overall Study|Reason Unknown|0|||
46695321|NCT00963547|82909811|FG005|Overall Study|Reason Unknown|0|||
46695322|NCT00963547|82909812|FG006|Overall Study|Reason Unknown|0|||
46695323|NCT01285310|82909828|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
46695324|NCT01285310|82909829|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
46695325|NCT01285310|82909830|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
46695326|NCT01285310|82909831|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
46695327|NCT01285310|82909832|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
46695328|NCT01285310|82909828|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
46695329|NCT01285310|82909829|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
46695330|NCT01285310|82909830|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
46695331|NCT01285310|82909831|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
46695332|NCT01285310|82909832|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
46695333|NCT01285310|82909828|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
46695334|NCT01285310|82909829|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
46982158|NCT02584855|83228300|FG002|Open-Label Treatment Period|Protocol Violation|0|||
46982159|NCT02584855|83228301|FG003|Open-Label Treatment Period|Protocol Violation|0|||
46982160|NCT02584855|83228302|FG004|Open-Label Treatment Period|Protocol Violation|0|||
46982161|NCT02584855|83228303|FG005|Open-Label Treatment Period|Protocol Violation|0|||
46982162|NCT02584855|83228298|FG000|Open-Label Treatment Period|No PI Available|2|||
46982163|NCT02584855|83228299|FG001|Open-Label Treatment Period|No PI Available|0|||
46982164|NCT02584855|83228300|FG002|Open-Label Treatment Period|No PI Available|0|||
46982165|NCT02584855|83228301|FG003|Open-Label Treatment Period|No PI Available|0|||
46982166|NCT02584855|83228302|FG004|Open-Label Treatment Period|No PI Available|0|||
46982167|NCT02584855|83228303|FG005|Open-Label Treatment Period|No PI Available|0|||
46982168|NCT02584855|83228298|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
46982169|NCT02584855|83228299|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
46982170|NCT02584855|83228300|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
46982171|NCT02584855|83228301|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
46982172|NCT02584855|83228302|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
46982173|NCT02584855|83228303|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
46695335|NCT01285310|82909830|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
46695336|NCT01285310|82909831|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
46695337|NCT01285310|82909832|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
46695338|NCT01285310|82909828|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
46695339|NCT01285310|82909829|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
46695340|NCT01285310|82909830|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
46695341|NCT01285310|82909831|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
46695342|NCT01285310|82909832|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
46802152|NCT04007523|83021352|FG003|Overall Study|ICU Transfer|0|||
46802153|NCT04007523|83021349|FG000|Overall Study|COVID hospital closure|0|||
46802154|NCT04007523|83021350|FG001|Overall Study|COVID hospital closure|0|||
46802155|NCT04007523|83021351|FG002|Overall Study|COVID hospital closure|1|||
46802156|NCT04007523|83021352|FG003|Overall Study|COVID hospital closure|2|||
46802157|NCT04007523|83021349|FG000|Overall Study|Surgery cancelled|0|||
46802158|NCT04007523|83021350|FG001|Overall Study|Surgery cancelled|0|||
46802159|NCT04007523|83021351|FG002|Overall Study|Surgery cancelled|1|||
46802160|NCT04007523|83021352|FG003|Overall Study|Surgery cancelled|1|||
46802161|NCT04002401|83021362|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
46802162|NCT04002401|83021362|FG000|Overall Study|Death|10|||
46802163|NCT04002401|83021362|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
46802164|NCT04002401|83021362|FG000|Overall Study|Enrolled but Never Treated|1|||
46802165|NCT04002401|83021362|FG000|Overall Study|Lost to Follow-up|1|||
46802166|NCT04000724|83021369|FG000|Overall Study|Withdrawal by Subject|5|||
46802167|NCT04000724|83021370|FG001|Overall Study|Withdrawal by Subject|3|||
46802168|NCT04000724|83021371|FG002|Overall Study|Withdrawal by Subject|4|||
46859044|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
46859045|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
46859046|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
46695343|NCT01285310|82909828|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
46695344|NCT01285310|82909829|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
46802169|NCT04000724|83021369|FG000|Overall Study|Lost to Follow-up|11|||
46802170|NCT04000724|83021370|FG001|Overall Study|Lost to Follow-up|7|||
46695345|NCT01285310|82909830|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
46802171|NCT04000724|83021371|FG002|Overall Study|Lost to Follow-up|13|||
46802172|NCT03997448|83021382|FG000|Study Treatment|Disease Progression|1|||
46695346|NCT01285310|82909831|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
46695347|NCT01285310|82909832|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
46695348|NCT01285310|82909828|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
46695349|NCT01285310|82909829|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
46695350|NCT01285310|82909830|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
46695351|NCT01285310|82909831|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
46695352|NCT01285310|82909832|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
46695353|NCT01285310|82909828|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
46695354|NCT01285310|82909829|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
46695355|NCT01285310|82909830|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
46695356|NCT01285310|82909831|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
46695357|NCT01285310|82909832|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
46695358|NCT01285310|82909828|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
46695359|NCT01285310|82909829|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
46695360|NCT01285310|82909830|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
46695361|NCT01285310|82909831|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
46695362|NCT01285310|82909832|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
46695363|NCT01285310|82909828|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
46695364|NCT01285310|82909829|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
46695365|NCT01285310|82909830|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
46695366|NCT01285310|82909831|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
46695367|NCT01285310|82909832|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
46695368|NCT01285310|82909828|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
46695369|NCT01285310|82909829|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
46695370|NCT01285310|82909830|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
46695371|NCT01285310|82909831|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
46695372|NCT01285310|82909832|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
46695373|NCT01285310|82909828|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
46695374|NCT01285310|82909829|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
46695375|NCT01285310|82909830|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
46695376|NCT01285310|82909831|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
46695377|NCT01285310|82909832|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
46695378|NCT01285310|82909828|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
46695379|NCT01285310|82909829|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
46695380|NCT01285310|82909830|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
46695381|NCT01285310|82909831|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
46695382|NCT01285310|82909832|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
46695383|NCT01254630|82909874|FG000|Overall Study|Adverse Event|36|||
46695384|NCT01254630|82909875|FG001|Overall Study|Adverse Event|15|||
46695385|NCT01254630|82909876|FG002|Overall Study|Adverse Event|40|||
46695386|NCT01254630|82909877|FG003|Overall Study|Adverse Event|8|||
46695387|NCT01254630|82909874|FG000|Overall Study|Death|461|||
46695388|NCT01254630|82909875|FG001|Overall Study|Death|151|||
46695389|NCT01254630|82909876|FG002|Overall Study|Death|478|||
46695390|NCT01254630|82909877|FG003|Overall Study|Death|139|||
46695391|NCT01254630|82909874|FG000|Overall Study|Lost to Follow-up|80|||
46695392|NCT01254630|82909875|FG001|Overall Study|Lost to Follow-up|26|||
46695393|NCT01254630|82909876|FG002|Overall Study|Lost to Follow-up|89|||
46695394|NCT01254630|82909877|FG003|Overall Study|Lost to Follow-up|32|||
46695395|NCT01254630|82909874|FG000|Overall Study|Physician Decision|24|||
46695396|NCT01254630|82909875|FG001|Overall Study|Physician Decision|8|||
46695397|NCT01254630|82909876|FG002|Overall Study|Physician Decision|16|||
46695398|NCT01254630|82909877|FG003|Overall Study|Physician Decision|7|||
46695399|NCT01254630|82909874|FG000|Overall Study|Withdrawal by Subject|201|||
46695400|NCT01254630|82909875|FG001|Overall Study|Withdrawal by Subject|94|||
46695401|NCT01254630|82909876|FG002|Overall Study|Withdrawal by Subject|188|||
46695402|NCT01254630|82909877|FG003|Overall Study|Withdrawal by Subject|89|||
46695403|NCT01254630|82909874|FG000|Overall Study|Study terminated by sponsor|0|||
46695404|NCT01254630|82909875|FG001|Overall Study|Study terminated by sponsor|994|||
46695405|NCT01254630|82909876|FG002|Overall Study|Study terminated by sponsor|0|||
46695406|NCT01254630|82909877|FG003|Overall Study|Study terminated by sponsor|1010|||
46695407|NCT01254630|82909874|FG000|Overall Study|Status not recorded|0|||
46695408|NCT01254630|82909875|FG001|Overall Study|Status not recorded|0|||
46695409|NCT01254630|82909876|FG002|Overall Study|Status not recorded|1|||
46695410|NCT01254630|82909877|FG003|Overall Study|Status not recorded|0|||
46695411|NCT01284140|82909887|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
46982174|NCT02584855|83228298|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
46695412|NCT01284140|82909888|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
46695413|NCT01284140|82909887|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
46695414|NCT01284140|82909888|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
46695415|NCT01254318|82909894|FG000|Overall Study|Lost to Follow-up|5|||
46695416|NCT01254318|82909894|FG000|Overall Study|Death|47|||
46695417|NCT01284062|82909902|FG000|Overall Study|Adverse Event|4|||
46695418|NCT01284062|82909903|FG001|Overall Study|Adverse Event|5|||
46695419|NCT01284062|82909904|FG002|Overall Study|Adverse Event|0|||
46695420|NCT01284062|82909905|FG003|Overall Study|Adverse Event|5|||
46695421|NCT01284062|82909902|FG000|Overall Study|Lack of Efficacy|3|||
46695422|NCT01284062|82909903|FG001|Overall Study|Lack of Efficacy|2|||
46695423|NCT01284062|82909904|FG002|Overall Study|Lack of Efficacy|2|||
46695424|NCT01284062|82909905|FG003|Overall Study|Lack of Efficacy|1|||
46695425|NCT01284062|82909902|FG000|Overall Study|Medication error without adverse event|0|||
46695426|NCT01284062|82909903|FG001|Overall Study|Medication error without adverse event|0|||
46695427|NCT01284062|82909904|FG002|Overall Study|Medication error without adverse event|1|||
46695428|NCT01284062|82909905|FG003|Overall Study|Medication error without adverse event|0|||
46695429|NCT01284062|82909902|FG000|Overall Study|Protocol Violation|1|||
46695430|NCT01284062|82909903|FG001|Overall Study|Protocol Violation|0|||
46695431|NCT01284062|82909904|FG002|Overall Study|Protocol Violation|0|||
46695432|NCT01284062|82909905|FG003|Overall Study|Protocol Violation|2|||
46695433|NCT01284062|82909902|FG000|Overall Study|Withdrawal by Subject|3|||
46695434|NCT01284062|82909903|FG001|Overall Study|Withdrawal by Subject|1|||
46695435|NCT01284062|82909904|FG002|Overall Study|Withdrawal by Subject|2|||
46695436|NCT01284062|82909905|FG003|Overall Study|Withdrawal by Subject|5|||
46695437|NCT01284062|82909902|FG000|Overall Study|Other|0|||
46695438|NCT01284062|82909903|FG001|Overall Study|Other|0|||
46695439|NCT01284062|82909904|FG002|Overall Study|Other|0|||
46695440|NCT01284062|82909905|FG003|Overall Study|Other|1|||
46695441|NCT01284062|82909902|FG000|Overall Study|Site Closed|0|||
46695442|NCT01284062|82909903|FG001|Overall Study|Site Closed|0|||
46695443|NCT01284062|82909904|FG002|Overall Study|Site Closed|1|||
46695444|NCT01284062|82909905|FG003|Overall Study|Site Closed|0|||
46695445|NCT01253304|82909922|FG000|Overall Study|Adverse Event|0|||
46695446|NCT01253304|82909923|FG001|Overall Study|Adverse Event|0|||
46695447|NCT01253304|82909924|FG002|Overall Study|Adverse Event|0|||
46695448|NCT01253304|82909925|FG003|Overall Study|Adverse Event|1|||
46695449|NCT01253226|82909940|FG000|Overall Study|Adverse Event|0|||
46695450|NCT01253226|82909941|FG001|Overall Study|Adverse Event|0|||
46695451|NCT01253226|82909942|FG002|Overall Study|Adverse Event|1|||
46695452|NCT01253226|82909943|FG003|Overall Study|Adverse Event|0|||
46695453|NCT01253226|82909944|FG004|Overall Study|Adverse Event|0|||
46695454|NCT01253226|82909940|FG000|Overall Study|Death|0|||
46695455|NCT01253226|82909941|FG001|Overall Study|Death|1|||
46695456|NCT01253226|82909942|FG002|Overall Study|Death|0|||
46695457|NCT01253226|82909943|FG003|Overall Study|Death|0|||
46695458|NCT01253226|82909944|FG004|Overall Study|Death|0|||
46695459|NCT01253226|82909940|FG000|Overall Study|Physician Decision|0|||
46695460|NCT01253226|82909941|FG001|Overall Study|Physician Decision|0|||
46695461|NCT01253226|82909942|FG002|Overall Study|Physician Decision|0|||
46695462|NCT01253226|82909943|FG003|Overall Study|Physician Decision|0|||
46695463|NCT01253226|82909944|FG004|Overall Study|Physician Decision|2|||
46695464|NCT01253226|82909940|FG000|Overall Study|Withdrawal by Subject|0|||
46695465|NCT01253226|82909941|FG001|Overall Study|Withdrawal by Subject|0|||
46695466|NCT01253226|82909942|FG002|Overall Study|Withdrawal by Subject|0|||
46695467|NCT01253226|82909943|FG003|Overall Study|Withdrawal by Subject|1|||
46695468|NCT01253226|82909944|FG004|Overall Study|Withdrawal by Subject|0|||
46695469|NCT01252290|82909956|FG000|Overall Study|Withdrawal by Subject|1|||
46695470|NCT01252134|82909960|FG000|Period 1, 8 Hours|Personal Reasons|0|||
46695471|NCT01252134|82909961|FG001|Period 1, 8 Hours|Personal Reasons|1|||
46695472|NCT01252134|82909962|FG002|Period 1, 8 Hours|Personal Reasons|1|||
46695473|NCT01252134|82909963|FG003|Period 1, 8 Hours|Personal Reasons|0|||
46695474|NCT01252134|82909964|FG004|Period 1, 8 Hours|Personal Reasons|0|||
46695475|NCT01252134|82909965|FG005|Period 1, 8 Hours|Personal Reasons|0|||
46695476|NCT01251744|82909975|FG000|Overall Study|Lost to Follow-up|1|||
46695477|NCT01251744|82909976|FG001|Overall Study|Lost to Follow-up|0|||
46695478|NCT01251354|82909989|FG000|Overall Study|Adverse Event|1|||
46695479|NCT01251354|82909989|FG000|Overall Study|Investigator's Decision|1|||
46695480|NCT01251354|82909989|FG000|Overall Study|Disease Progression|4|||
46695481|NCT01251276|82909995|FG000|Overall Study|Protocol Violation|1|||
46695482|NCT01251276|82909996|FG001|Overall Study|Protocol Violation|0|||
46695483|NCT01251276|82909995|FG000|Overall Study|Lost to Follow-up|0|||
46695484|NCT01251276|82909996|FG001|Overall Study|Lost to Follow-up|1|||
46695485|NCT01251120|82910004|FG000|Overall Study|Lack of Efficacy|0|||
46802173|NCT03997448|83021382|FG000|Study Treatment|Symptomatic Deterioration|1|||
46695486|NCT01251120|82910005|FG001|Overall Study|Lack of Efficacy|1|||
46695487|NCT01250418|82910013|FG000|Overall Study|monitor data failure|1|||
46695488|NCT01250418|82910014|FG001|Overall Study|monitor data failure|1|||
46695489|NCT01292603|82910025|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
46695490|NCT01292603|82910026|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
46695491|NCT01292603|82910027|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
46695492|NCT01292603|82910028|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
46695493|NCT01292603|82910029|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
46695494|NCT01292603|82910030|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
46695495|NCT01292603|82910025|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
46695496|NCT01292603|82910026|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
46695497|NCT01292603|82910027|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
46695498|NCT01292603|82910028|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
46695499|NCT01292603|82910029|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
46695500|NCT01292603|82910030|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
46695501|NCT01292603|82910025|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
46695502|NCT01292603|82910026|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
46695503|NCT01292603|82910027|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
46695504|NCT01292603|82910028|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
46695505|NCT01292603|82910029|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
46695506|NCT01292603|82910030|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
46695507|NCT01292603|82910025|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
46695508|NCT01292603|82910026|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
46695509|NCT01292603|82910027|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
46695510|NCT01292603|82910028|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
46695511|NCT01292603|82910029|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
46695512|NCT01292603|82910030|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
46695513|NCT01292603|82910025|FG000|Part 1: Regular Follow-Up Period|Death|3|||
46695514|NCT01292603|82910026|FG001|Part 1: Regular Follow-Up Period|Death|1|||
46695515|NCT01292603|82910027|FG002|Part 1: Regular Follow-Up Period|Death|3|||
46695516|NCT01292603|82910028|FG003|Part 1: Regular Follow-Up Period|Death|1|||
46695517|NCT01292603|82910029|FG004|Part 1: Regular Follow-Up Period|Death|0|||
46695518|NCT01292603|82910030|FG005|Part 1: Regular Follow-Up Period|Death|0|||
46695519|NCT01292603|82910025|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
46695520|NCT01292603|82910026|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
46695521|NCT01292603|82910027|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
46695522|NCT01292603|82910028|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
46695523|NCT01292603|82910029|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
46695524|NCT01292603|82910030|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
46695525|NCT01292603|82910025|FG000|Part 2: Dose Confirmation Period|Death|0|||
46695526|NCT01292603|82910026|FG001|Part 2: Dose Confirmation Period|Death|0|||
46695527|NCT01292603|82910027|FG002|Part 2: Dose Confirmation Period|Death|0|||
46695528|NCT01292603|82910028|FG003|Part 2: Dose Confirmation Period|Death|0|||
46695529|NCT01292603|82910029|FG004|Part 2: Dose Confirmation Period|Death|1|||
46695530|NCT01292603|82910030|FG005|Part 2: Dose Confirmation Period|Death|0|||
46695531|NCT01292603|82910025|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
46695532|NCT01292603|82910026|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
46695533|NCT01292603|82910027|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
46695534|NCT01292603|82910028|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
46695535|NCT01292603|82910029|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
46695536|NCT01292603|82910030|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
46695537|NCT01292603|82910025|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
46695538|NCT01292603|82910026|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
46695539|NCT01292603|82910027|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
46695540|NCT01292603|82910028|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
46695541|NCT01292603|82910029|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
46695542|NCT01292603|82910030|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
46695543|NCT01292603|82910025|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
46695544|NCT01292603|82910026|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
46695545|NCT01292603|82910027|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
46695546|NCT01292603|82910028|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
46695547|NCT01292603|82910029|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
46695548|NCT01292603|82910030|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
46695549|NCT01292603|82910025|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
46695550|NCT01292603|82910026|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
46695551|NCT01292603|82910027|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
46695552|NCT01292603|82910028|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
46695553|NCT01292603|82910029|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
46695554|NCT01292603|82910030|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
46802174|NCT03997448|83021382|FG000|Follow up|Death|2|||
46802175|NCT03997448|83021382|FG000|Follow up|study terminated|1|||
46802176|NCT03812224|83021401|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
46802177|NCT03812224|83021402|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
46802178|NCT03812224|83021401|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
46802179|NCT03812224|83021402|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
46802180|NCT03812224|83021401|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
46802181|NCT03812224|83021402|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
46695555|NCT01292603|82910025|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
46802182|NCT03812224|83021401|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
46802183|NCT03812224|83021402|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
46802184|NCT03646123|83021421|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
46802185|NCT03646123|83021422|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
46802186|NCT03646123|83021423|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
46802187|NCT03646123|83021421|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
46695556|NCT01292603|82910026|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
46695557|NCT01292603|82910027|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
46695558|NCT01292603|82910028|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
46695559|NCT01292603|82910029|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
46695560|NCT01292603|82910030|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
46695561|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Death|0|||
46695562|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Death|0|||
46695563|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Death|0|||
46695564|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Death|0|||
46695565|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Death|6|||
46695566|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Death|3|||
46695567|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
46695568|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
46695569|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
46695570|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
46695571|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
46695572|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
46695573|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
46695574|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
46695575|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
46695576|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
46695577|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
46695578|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
46695579|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
46695580|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
46695581|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
46695582|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
46695583|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
46695584|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
46695585|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
46695586|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
46695587|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
46695588|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
46695589|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
46695590|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
46695591|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
46695592|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
46695593|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
46695594|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
46695595|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
46695596|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
46695597|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
46695598|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
46695599|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
46695600|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
46695601|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
46695602|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
46695603|NCT01292603|82910025|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
46695604|NCT01292603|82910026|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
46695605|NCT01292603|82910027|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
46695606|NCT01292603|82910028|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
46695607|NCT01292603|82910029|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
46695608|NCT01292603|82910030|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
46695609|NCT01292603|82910025|FG000|Overall Survival Status|Death|3|||
46695610|NCT01292603|82910026|FG001|Overall Survival Status|Death|1|||
46695611|NCT01292603|82910027|FG002|Overall Survival Status|Death|3|||
46695612|NCT01292603|82910028|FG003|Overall Survival Status|Death|1|||
46695613|NCT01292603|82910029|FG004|Overall Survival Status|Death|16|||
46695614|NCT01292603|82910030|FG005|Overall Survival Status|Death|10|||
46695615|NCT01292057|82910053|FG000|Overall Study|Protocol Violation|1|||
46695616|NCT01292057|82910054|FG001|Overall Study|Protocol Violation|1|||
46695617|NCT01292057|82910053|FG000|Overall Study|Lost to Follow-up|1|||
46695618|NCT01292057|82910054|FG001|Overall Study|Lost to Follow-up|1|||
46695619|NCT01291277|82910062|FG000|Overall Study|Death|2|||
46695620|NCT01291277|82910063|FG001|Overall Study|Death|2|||
46695621|NCT01291277|82910062|FG000|Overall Study|Lost to Follow-up|3|||
46695622|NCT01291277|82910063|FG001|Overall Study|Lost to Follow-up|1|||
46695623|NCT01290887|82910071|FG000|Overall Study|Adverse Event|6|||
46695624|NCT01290887|82910072|FG001|Overall Study|Adverse Event|11|||
46695625|NCT01290887|82910071|FG000|Overall Study|Lack of Efficacy|4|||
46695626|NCT01290887|82910072|FG001|Overall Study|Lack of Efficacy|5|||
46695627|NCT01290887|82910071|FG000|Overall Study|Withdrawal by Subject|26|||
46695628|NCT01290887|82910072|FG001|Overall Study|Withdrawal by Subject|32|||
46695629|NCT01290887|82910071|FG000|Overall Study|Protocol Violation|2|||
46695630|NCT01290887|82910072|FG001|Overall Study|Protocol Violation|1|||
46695631|NCT01290887|82910071|FG000|Overall Study|Lost to Follow-up|4|||
46695632|NCT01290887|82910072|FG001|Overall Study|Lost to Follow-up|4|||
46695633|NCT01290887|82910071|FG000|Overall Study|Non-compliance to study procedures|0|||
46695634|NCT01290887|82910072|FG001|Overall Study|Non-compliance to study procedures|1|||
46695635|NCT01290887|82910071|FG000|Overall Study|Non-compliance to study medications|1|||
46695636|NCT01290887|82910072|FG001|Overall Study|Non-compliance to study medications|0|||
46695637|NCT01290887|82910071|FG000|Overall Study|Sponsor closure of study|420|||
46695638|NCT01290887|82910072|FG001|Overall Study|Sponsor closure of study|476|||
46695639|NCT01290887|82910071|FG000|Overall Study|Other|3|||
46695640|NCT01290887|82910072|FG001|Overall Study|Other|6|||
46695641|NCT01290731|82910078|FG000|Overall Study|Withdrawal by Subject|1|||
46695642|NCT01290341|82910084|FG000|Overall Study|Protocol Violation|7|||
46695643|NCT01290341|82910085|FG001|Overall Study|Protocol Violation|3|||
46695644|NCT01290341|82910084|FG000|Overall Study|Adverse Event|1|||
46695645|NCT01290341|82910085|FG001|Overall Study|Adverse Event|0|||
46695646|NCT01290341|82910084|FG000|Overall Study|Lost to Follow-up|21|||
46695647|NCT01290341|82910085|FG001|Overall Study|Lost to Follow-up|10|||
46695648|NCT01290341|82910084|FG000|Overall Study|Withdrawal by Subject|19|||
46695649|NCT01290341|82910085|FG001|Overall Study|Withdrawal by Subject|5|||
46695650|NCT01290341|82910084|FG000|Overall Study|Negative baseline culture and others|44|||
46695651|NCT01290341|82910085|FG001|Overall Study|Negative baseline culture and others|11|||
46695652|NCT01290263|82910093|FG000|Overall Study|Adverse Event|0|||
46695653|NCT01290263|82910094|FG001|Overall Study|Adverse Event|0|||
46695654|NCT01290263|82910095|FG002|Overall Study|Adverse Event|0|||
46695655|NCT01290263|82910096|FG003|Overall Study|Adverse Event|1|||
46695656|NCT01290263|82910097|FG004|Overall Study|Adverse Event|1|||
46695657|NCT01290263|82910093|FG000|Overall Study|Lack of Efficacy|8|||
46695658|NCT01290263|82910094|FG001|Overall Study|Lack of Efficacy|2|||
46695659|NCT01290263|82910095|FG002|Overall Study|Lack of Efficacy|7|||
46695660|NCT01290263|82910096|FG003|Overall Study|Lack of Efficacy|24|||
46695661|NCT01290263|82910097|FG004|Overall Study|Lack of Efficacy|33|||
46695662|NCT01290263|82910093|FG000|Overall Study|Withdrawal by Subject|3|||
46695663|NCT01290263|82910094|FG001|Overall Study|Withdrawal by Subject|1|||
46695664|NCT01290263|82910095|FG002|Overall Study|Withdrawal by Subject|0|||
46695665|NCT01290263|82910096|FG003|Overall Study|Withdrawal by Subject|1|||
46695666|NCT01290263|82910097|FG004|Overall Study|Withdrawal by Subject|2|||
46695667|NCT01290263|82910093|FG000|Overall Study|Participant Non-Compliance|0|||
46695668|NCT01290263|82910094|FG001|Overall Study|Participant Non-Compliance|0|||
46695669|NCT01290263|82910095|FG002|Overall Study|Participant Non-Compliance|0|||
46695670|NCT01290263|82910096|FG003|Overall Study|Participant Non-Compliance|1|||
46695671|NCT01290263|82910097|FG004|Overall Study|Participant Non-Compliance|1|||
46695672|NCT01290029|82910105|FG000|Overall Study|Other|2|||
46695673|NCT01289639|82910112|FG000|Overall Study|Lost to Follow-up|1|||
46695674|NCT01289639|82910113|FG001|Overall Study|Lost to Follow-up|0|||
46695675|NCT01289639|82910114|FG002|Overall Study|Lost to Follow-up|0|||
46695676|NCT01289015|82910124|FG000|Overall Study|Protocol Violation|12|||
46695677|NCT01289015|82910125|FG001|Overall Study|Protocol Violation|9|||
46695678|NCT01289015|82910124|FG000|Overall Study|Adverse Event|3|||
46695679|NCT01289015|82910125|FG001|Overall Study|Adverse Event|0|||
46695680|NCT01289015|82910124|FG000|Overall Study|Lost to Follow-up|33|||
46695681|NCT01289015|82910125|FG001|Overall Study|Lost to Follow-up|17|||
46695682|NCT01289015|82910124|FG000|Overall Study|Withdrawal by Subject|17|||
46695683|NCT01289015|82910125|FG001|Overall Study|Withdrawal by Subject|8|||
46695684|NCT01289015|82910124|FG000|Overall Study|Disease progression|1|||
46695685|NCT01289015|82910125|FG001|Overall Study|Disease progression|0|||
46802188|NCT03646123|83021422|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
46695686|NCT01289015|82910124|FG000|Overall Study|Negative baseline culture and others|33|||
46695687|NCT01289015|82910125|FG001|Overall Study|Negative baseline culture and others|20|||
46695688|NCT01288937|82910133|FG000|Overall Study|Adverse Event|1|||
46695689|NCT01288937|82910134|FG001|Overall Study|Adverse Event|0|||
46695690|NCT01288469|82910143|FG000|Overall Study|Adverse Event|4|||
46695691|NCT01288469|82910144|FG001|Overall Study|Adverse Event|1|||
46695692|NCT01288469|82910145|FG002|Overall Study|Adverse Event|1|||
46695693|NCT01288469|82910143|FG000|Overall Study|Poor compliance to protocol|0|||
46695694|NCT01288469|82910144|FG001|Overall Study|Poor compliance to protocol|1|||
46695695|NCT01288469|82910145|FG002|Overall Study|Poor compliance to protocol|0|||
46695696|NCT01288469|82910143|FG000|Overall Study|Participant Moved|1|||
46695697|NCT01288469|82910144|FG001|Overall Study|Participant Moved|0|||
46695698|NCT01288469|82910145|FG002|Overall Study|Participant Moved|0|||
46695699|NCT01288469|82910143|FG000|Overall Study|Consent withdrawn by subject|1|||
46695700|NCT01288469|82910144|FG001|Overall Study|Consent withdrawn by subject|1|||
46695701|NCT01288469|82910145|FG002|Overall Study|Consent withdrawn by subject|1|||
46695702|NCT01288469|82910143|FG000|Overall Study|Exclusion criteria finally met|1|||
46695703|NCT01288469|82910144|FG001|Overall Study|Exclusion criteria finally met|0|||
46695704|NCT01288469|82910145|FG002|Overall Study|Exclusion criteria finally met|0|||
46695705|NCT01288079|82910157|FG000|Overall Study|Withdrawal by Subject|2|||
46695706|NCT01288079|82910158|FG001|Overall Study|Withdrawal by Subject|4|||
46695707|NCT01288079|82910159|FG002|Overall Study|Withdrawal by Subject|1|||
46695708|NCT01288079|82910160|FG003|Overall Study|Withdrawal by Subject|0|||
46695709|NCT01288079|82910157|FG000|Overall Study|Adverse Event|2|||
46695710|NCT01288079|82910158|FG001|Overall Study|Adverse Event|1|||
46695711|NCT01288079|82910159|FG002|Overall Study|Adverse Event|2|||
46695712|NCT01288079|82910160|FG003|Overall Study|Adverse Event|3|||
46695713|NCT01288079|82910157|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
46695714|NCT01288079|82910158|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
46695715|NCT01288079|82910159|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
46695716|NCT01288079|82910160|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
46695717|NCT01288079|82910157|FG000|Overall Study|Condition under Investigation Worsened|0|||
46695718|NCT01288079|82910158|FG001|Overall Study|Condition under Investigation Worsened|0|||
46695719|NCT01288079|82910159|FG002|Overall Study|Condition under Investigation Worsened|0|||
46695720|NCT01288079|82910160|FG003|Overall Study|Condition under Investigation Worsened|1|||
46695721|NCT01288079|82910157|FG000|Overall Study|Lack of Efficacy|2|||
46695722|NCT01288079|82910158|FG001|Overall Study|Lack of Efficacy|2|||
46695723|NCT01288079|82910159|FG002|Overall Study|Lack of Efficacy|0|||
46695724|NCT01288079|82910160|FG003|Overall Study|Lack of Efficacy|2|||
46695725|NCT01288079|82910157|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
46695726|NCT01288079|82910158|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
46695727|NCT01288079|82910159|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
46695728|NCT01288079|82910160|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
46695729|NCT01288079|82910157|FG000|Overall Study|Lost to Follow-up|1|||
46859047|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
46859048|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
46695730|NCT01288079|82910158|FG001|Overall Study|Lost to Follow-up|1|||
46695731|NCT01288079|82910159|FG002|Overall Study|Lost to Follow-up|1|||
46695732|NCT01288079|82910160|FG003|Overall Study|Lost to Follow-up|0|||
46695733|NCT01288079|82910157|FG000|Overall Study|Other or Study Termination|11|||
46695734|NCT01288079|82910158|FG001|Overall Study|Other or Study Termination|15|||
46695735|NCT01288079|82910159|FG002|Overall Study|Other or Study Termination|14|||
46695736|NCT01288079|82910160|FG003|Overall Study|Other or Study Termination|8|||
46695737|NCT01287221|82910172|FG000|Overall Study|Lack of Perceived Benefit|1|||
46695738|NCT01287221|82910173|FG001|Overall Study|Lack of Perceived Benefit|1|||
46695739|NCT01287221|82910172|FG000|Overall Study|Adverse Event|3|||
46695740|NCT01287221|82910173|FG001|Overall Study|Adverse Event|3|||
46695741|NCT01287221|82910172|FG000|Overall Study|Withdrawal by Subject|0|||
46695742|NCT01287221|82910173|FG001|Overall Study|Withdrawal by Subject|1|||
46695743|NCT01168401|82910190|FG000|Overall Study|Lost to Follow-up|1|||
46695744|NCT01168401|82910191|FG001|Overall Study|Lost to Follow-up|1|||
46695745|NCT01168401|82910192|FG002|Overall Study|Lost to Follow-up|2|||
46695746|NCT01168401|82910193|FG003|Overall Study|Lost to Follow-up|1|||
46695747|NCT01168401|82910194|FG004|Overall Study|Lost to Follow-up|0|||
46695748|NCT01168401|82910195|FG005|Overall Study|Lost to Follow-up|0|||
46695749|NCT01168401|82910196|FG006|Overall Study|Lost to Follow-up|0|||
46695750|NCT01168401|82910197|FG007|Overall Study|Lost to Follow-up|0|||
46695751|NCT01168401|82910198|FG008|Overall Study|Lost to Follow-up|0|||
46695752|NCT01168401|82910199|FG009|Overall Study|Lost to Follow-up|0|||
46695753|NCT01168401|82910200|FG010|Overall Study|Lost to Follow-up|0|||
46695754|NCT01168401|82910190|FG000|Overall Study|Withdrawal by Subject|0|||
46695755|NCT01168401|82910191|FG001|Overall Study|Withdrawal by Subject|0|||
46695756|NCT01168401|82910192|FG002|Overall Study|Withdrawal by Subject|0|||
46695757|NCT01168401|82910193|FG003|Overall Study|Withdrawal by Subject|1|||
46695758|NCT01168401|82910194|FG004|Overall Study|Withdrawal by Subject|0|||
46695759|NCT01168401|82910195|FG005|Overall Study|Withdrawal by Subject|0|||
46695760|NCT01168401|82910196|FG006|Overall Study|Withdrawal by Subject|0|||
46695761|NCT01168401|82910197|FG007|Overall Study|Withdrawal by Subject|0|||
46695762|NCT01168401|82910198|FG008|Overall Study|Withdrawal by Subject|0|||
46695763|NCT01168401|82910199|FG009|Overall Study|Withdrawal by Subject|0|||
46695764|NCT01168401|82910200|FG010|Overall Study|Withdrawal by Subject|0|||
46695765|NCT01287065|82910224|FG000|Treatment Period 1|Adverse Event|0|||
46695766|NCT01287065|82910225|FG001|Treatment Period 1|Adverse Event|0|||
46695767|NCT01287065|82910226|FG002|Treatment Period 1|Adverse Event|0|||
46695768|NCT01287065|82910227|FG003|Treatment Period 1|Adverse Event|0|||
46695769|NCT01287065|82910228|FG004|Treatment Period 1|Adverse Event|1|||
46695770|NCT01287065|82910229|FG005|Treatment Period 1|Adverse Event|0|||
46695771|NCT01287065|82910224|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46695772|NCT01287065|82910225|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46695773|NCT01287065|82910226|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46695774|NCT01287065|82910227|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46695775|NCT01287065|82910228|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46695776|NCT01287065|82910229|FG005|Treatment Period 1|Withdrawal by Subject|1|||
46695777|NCT01167153|82910239|FG000|Overall Study|Non-effective therapy|1|||
46695778|NCT01167153|82910240|FG001|Overall Study|Non-effective therapy|4|||
46695779|NCT01167153|82910239|FG000|Overall Study|AE including clinical laboratory AE|2|||
46695780|NCT01167153|82910240|FG001|Overall Study|AE including clinical laboratory AE|8|||
46695781|NCT01167153|82910239|FG000|Overall Study|Hypotension|1|||
46695782|NCT01167153|82910240|FG001|Overall Study|Hypotension|0|||
46695783|NCT01167153|82910239|FG000|Overall Study|Lost to Follow-up|7|||
46695784|NCT01167153|82910240|FG001|Overall Study|Lost to Follow-up|9|||
46695785|NCT01167153|82910239|FG000|Overall Study|Non-compliance to concomitant medication|0|||
46695786|NCT01167153|82910240|FG001|Overall Study|Non-compliance to concomitant medication|2|||
46695787|NCT01167153|82910239|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
46695788|NCT01167153|82910240|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
46695789|NCT01167153|82910239|FG000|Overall Study|Withdrawal consent|1|||
46695790|NCT01167153|82910240|FG001|Overall Study|Withdrawal consent|1|||
46695791|NCT01167153|82910239|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
46695792|NCT01167153|82910240|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
46695793|NCT01166763|82910246|FG000|Overall Study|Withdrawal by Subject|3|||
46695794|NCT01166373|82910254|FG000|Overall Study|Lost to Follow-up|3|||
46695795|NCT01166373|82910255|FG001|Overall Study|Lost to Follow-up|2|||
46695796|NCT01166373|82910256|FG002|Overall Study|Lost to Follow-up|2|||
46695797|NCT01166373|82910257|FG003|Overall Study|Lost to Follow-up|2|||
46859049|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
46695798|NCT01166373|82910254|FG000|Overall Study|Withdrawal by Subject|1|||
46695799|NCT01166373|82910255|FG001|Overall Study|Withdrawal by Subject|2|||
46695800|NCT01166373|82910256|FG002|Overall Study|Withdrawal by Subject|2|||
46695801|NCT01166373|82910257|FG003|Overall Study|Withdrawal by Subject|3|||
46695802|NCT01166373|82910254|FG000|Overall Study|Physician Decision|1|||
46695803|NCT01166373|82910255|FG001|Overall Study|Physician Decision|0|||
46695804|NCT01166373|82910256|FG002|Overall Study|Physician Decision|0|||
46695805|NCT01166373|82910257|FG003|Overall Study|Physician Decision|0|||
46695806|NCT00963235|82910269|FG000|Overall Study|Withdrawal by Subject|22|||
46695807|NCT00963235|82910269|FG000|Overall Study|Lost to Follow-up|14|||
46695808|NCT00963235|82910269|FG000|Overall Study|Failed to return|9|||
46695809|NCT00963235|82910269|FG000|Overall Study|Protocol Violation|7|||
46695810|NCT00963235|82910269|FG000|Overall Study|Adverse Event|5|||
46695811|NCT00963235|82910269|FG000|Overall Study|Physician Decision|2|||
46695812|NCT00963235|82910269|FG000|Overall Study|Other|1|||
46695813|NCT01165281|82910278|FG000|Overall Study|Adverse Event|12|||
46695814|NCT01165281|82910279|FG001|Overall Study|Adverse Event|14|||
46695815|NCT01165281|82910278|FG000|Overall Study|Death|3|||
46695816|NCT01165281|82910279|FG001|Overall Study|Death|4|||
46695817|NCT01165281|82910278|FG000|Overall Study|Lack of Efficacy|4|||
46695818|NCT01165281|82910279|FG001|Overall Study|Lack of Efficacy|1|||
46695819|NCT01165281|82910278|FG000|Overall Study|Lost to Follow-up|0|||
46695820|NCT01165281|82910279|FG001|Overall Study|Lost to Follow-up|1|||
46695821|NCT01165281|82910278|FG000|Overall Study|Physician Decision|8|||
46695822|NCT01165281|82910279|FG001|Overall Study|Physician Decision|1|||
46695823|NCT01165281|82910278|FG000|Overall Study|Protocol Violation|6|||
46695824|NCT01165281|82910279|FG001|Overall Study|Protocol Violation|5|||
46695825|NCT01165281|82910278|FG000|Overall Study|Withdrawal by Subject|8|||
46695826|NCT01165281|82910279|FG001|Overall Study|Withdrawal by Subject|7|||
46695827|NCT01165281|82910278|FG000|Overall Study|Noncompliance with Study Drug|1|||
46695828|NCT01165281|82910279|FG001|Overall Study|Noncompliance with Study Drug|4|||
46695829|NCT01165281|82910278|FG000|Overall Study|Progressive Disease|10|||
46695830|NCT01165281|82910279|FG001|Overall Study|Progressive Disease|14|||
46695831|NCT01165281|82910278|FG000|Overall Study|Other|6|||
46695832|NCT01165281|82910279|FG001|Overall Study|Other|0|||
46695833|NCT01165203|82910287|FG000|Active Phase|Serious Adverse Event|1|||
46695834|NCT01165203|82910288|FG001|Active Phase|Serious Adverse Event|0|||
46695835|NCT01165203|82910287|FG000|Active Phase|Withdrawal by Subject|2|||
46695836|NCT01165203|82910288|FG001|Active Phase|Withdrawal by Subject|1|||
46859050|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
46695837|NCT01165203|82910287|FG000|Active Phase|Migrated/moved from study area|0|||
46695838|NCT01165203|82910288|FG001|Active Phase|Migrated/moved from study area|1|||
46695839|NCT01165203|82910287|FG000|Active Phase|Lost to Follow-up|2|||
46695840|NCT01165203|82910288|FG001|Active Phase|Lost to Follow-up|0|||
46695841|NCT01165203|82910287|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
46695842|NCT01165203|82910288|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
46695843|NCT01165203|82910287|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
46695844|NCT01165203|82910288|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
46695845|NCT01165203|82910287|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
46695846|NCT01165203|82910288|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
46695847|NCT01165203|82910287|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
46695848|NCT01165203|82910288|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
46695849|NCT01165203|82910287|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
46695850|NCT01165203|82910288|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
46695851|NCT00960661|82910303|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
46695852|NCT00960661|82910304|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
46695853|NCT00960661|82910305|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
46695854|NCT00960661|82910303|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
46695855|NCT00960661|82910304|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
46695856|NCT00960661|82910305|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
46695857|NCT00960661|82910303|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
46695858|NCT00960661|82910304|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
46695859|NCT00960661|82910305|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
46695860|NCT00960661|82910303|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
46695861|NCT00960661|82910304|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
46695862|NCT00960661|82910305|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
46695863|NCT00960661|82910303|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
46695864|NCT00960661|82910304|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
46695865|NCT00960661|82910305|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
46695866|NCT00960661|82910303|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
46695867|NCT00960661|82910304|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
46695868|NCT00960661|82910305|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
46695869|NCT00960661|82910303|FG000|Interventional Phase|Adverse Event|0|||
46695870|NCT00960661|82910304|FG001|Interventional Phase|Adverse Event|17|||
46695871|NCT00960661|82910305|FG002|Interventional Phase|Adverse Event|8|||
46695872|NCT00960661|82910303|FG000|Interventional Phase|Death|0|||
46695873|NCT00960661|82910304|FG001|Interventional Phase|Death|1|||
46695874|NCT00960661|82910305|FG002|Interventional Phase|Death|0|||
46695875|NCT00960661|82910303|FG000|Interventional Phase|Lost to Follow-up|0|||
46695876|NCT00960661|82910304|FG001|Interventional Phase|Lost to Follow-up|0|||
46695877|NCT00960661|82910305|FG002|Interventional Phase|Lost to Follow-up|2|||
46695878|NCT00960661|82910303|FG000|Interventional Phase|entry criteria not met|0|||
46695879|NCT00960661|82910304|FG001|Interventional Phase|entry criteria not met|3|||
46695880|NCT00960661|82910305|FG002|Interventional Phase|entry criteria not met|0|||
46695881|NCT00960661|82910303|FG000|Interventional Phase|Protocol Violation|0|||
46802189|NCT03646123|83021423|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
46802190|NCT03646123|83021421|FG000|Overall Study|Non-compliance to study protocol|1|||
46802191|NCT03646123|83021422|FG001|Overall Study|Non-compliance to study protocol|0|||
46802192|NCT03646123|83021423|FG002|Overall Study|Non-compliance to study protocol|0|||
46802193|NCT03646123|83021421|FG000|Overall Study|Ineligible due to progression during screening|0|||
46802194|NCT03646123|83021422|FG001|Overall Study|Ineligible due to progression during screening|0|||
46802195|NCT03646123|83021423|FG002|Overall Study|Ineligible due to progression during screening|1|||
46859051|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
46695882|NCT00960661|82910304|FG001|Interventional Phase|Protocol Violation|7|||
46695883|NCT00960661|82910305|FG002|Interventional Phase|Protocol Violation|2|||
46695884|NCT00960661|82910303|FG000|Interventional Phase|Withdrawal by Subject|0|||
46695885|NCT00960661|82910304|FG001|Interventional Phase|Withdrawal by Subject|18|||
46859052|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
46695886|NCT00960661|82910305|FG002|Interventional Phase|Withdrawal by Subject|29|||
46695887|NCT00960661|82910303|FG000|Interventional Phase|Physician Decision|0|||
46695888|NCT00960661|82910304|FG001|Interventional Phase|Physician Decision|3|||
46695889|NCT00960661|82910305|FG002|Interventional Phase|Physician Decision|5|||
46695890|NCT00960661|82910303|FG000|Interventional Phase|sponsor decision|0|||
46695891|NCT00960661|82910304|FG001|Interventional Phase|sponsor decision|1|||
46695892|NCT00960661|82910305|FG002|Interventional Phase|sponsor decision|0|||
46695893|NCT00960661|82910303|FG000|Interventional Phase|Lack of Efficacy|0|||
46695894|NCT00960661|82910304|FG001|Interventional Phase|Lack of Efficacy|2|||
46695895|NCT00960661|82910305|FG002|Interventional Phase|Lack of Efficacy|0|||
46695896|NCT00960193|82910311|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
46695897|NCT00960115|82910320|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
46695898|NCT00960115|82910321|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
46695899|NCT00959647|82910327|FG000|Overall Study|Adverse Event|2|||
46695900|NCT00959647|82910327|FG000|Overall Study|Progressive disease|6|||
46695901|NCT00959647|82910327|FG000|Overall Study|Study terminated by sponsor|4|||
46695902|NCT00959647|82910327|FG000|Overall Study|Withdrawal by Subject|7|||
46695903|NCT00957931|82910331|FG000|Overall Study|Death|4|||
46802196|NCT03646123|83021421|FG000|Overall Study|Withdrawal by Subject|2|||
46802197|NCT03646123|83021422|FG001|Overall Study|Withdrawal by Subject|1|||
46802198|NCT03646123|83021423|FG002|Overall Study|Withdrawal by Subject|3|||
46802199|NCT03646123|83021421|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
46802200|NCT03646123|83021422|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
46802201|NCT03646123|83021423|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
46802202|NCT03646123|83021421|FG000|Overall Study|Death|2|||
46802203|NCT03646123|83021422|FG001|Overall Study|Death|1|||
46802204|NCT03646123|83021423|FG002|Overall Study|Death|1|||
46802205|NCT03646123|83021421|FG000|Overall Study|Lost to Follow-up|4|||
46802206|NCT03646123|83021422|FG001|Overall Study|Lost to Follow-up|7|||
46802207|NCT03646123|83021423|FG002|Overall Study|Lost to Follow-up|6|||
46802208|NCT03646123|83021421|FG000|Overall Study|Participants in long term follow-up|0|||
46802209|NCT03646123|83021422|FG001|Overall Study|Participants in long term follow-up|48|||
46802210|NCT03646123|83021423|FG002|Overall Study|Participants in long term follow-up|144|||
46802211|NCT03597503|83021433|FG000|Overall Study|Withdrawal by Subject|0|||
46802212|NCT03597503|83021434|FG001|Overall Study|Withdrawal by Subject|2|||
46802213|NCT03597503|83021433|FG000|Overall Study|Lost to Follow-up|1|||
46802214|NCT03597503|83021434|FG001|Overall Study|Lost to Follow-up|2|||
46802215|NCT03597503|83021433|FG000|Overall Study|Protocol Violation|1|||
46802216|NCT03597503|83021434|FG001|Overall Study|Protocol Violation|0|||
46802217|NCT03554317|83021440|FG000|Overall Study|Withdrawal by Subject|1|||
46802218|NCT03554317|83021440|FG000|Overall Study|PSA Progression|3|||
46802219|NCT03554317|83021440|FG000|Overall Study|Radiographic Progression|4|||
46802220|NCT03345095|83021450|FG000|Overall Study|Lack of Efficacy|184|||
46802221|NCT03345095|83021451|FG001|Overall Study|Lack of Efficacy|156|||
46802222|NCT03345095|83021450|FG000|Overall Study|Adverse Event|36|||
46802223|NCT03345095|83021451|FG001|Overall Study|Adverse Event|118|||
46802224|NCT03345095|83021450|FG000|Overall Study|Withdrawal by Subject|22|||
46802225|NCT03345095|83021451|FG001|Overall Study|Withdrawal by Subject|59|||
46802226|NCT03345095|83021450|FG000|Overall Study|Physician Decision|3|||
46695904|NCT00957853|82910338|FG000|Overall Study|Withdrawal by Subject|1|||
46695905|NCT00957853|82910339|FG001|Overall Study|Withdrawal by Subject|0|||
46695906|NCT00957853|82910340|FG002|Overall Study|Withdrawal by Subject|0|||
46802227|NCT03345095|83021451|FG001|Overall Study|Physician Decision|18|||
46802228|NCT03345095|83021450|FG000|Overall Study|Death|2|||
46802229|NCT03345095|83021451|FG001|Overall Study|Death|4|||
46802230|NCT03345095|83021450|FG000|Overall Study|Other reasons|2|||
46802231|NCT03345095|83021451|FG001|Overall Study|Other reasons|11|||
46695907|NCT00957229|82910350|FG000|Study Start|Adverse Event|0|||
46695908|NCT00957229|82910351|FG001|Study Start|Adverse Event|3|||
46802232|NCT03345095|83021450|FG000|Overall Study|Protocol Violation|0|||
46802233|NCT03345095|83021451|FG001|Overall Study|Protocol Violation|1|||
46802234|NCT03113500|83021466|FG000|Overall Study|Withdrawal by Subject|1|||
46802235|NCT03085758|83021473|FG000|Overall Study|Death|26|||
46695909|NCT00957229|82910350|FG000|Study Start|Disease Progression|1|||
46695910|NCT00957229|82910351|FG001|Study Start|Disease Progression|0|||
46695911|NCT00957229|82910350|FG000|Reallocated to or Continued Vismodegib|Death|1|||
46695912|NCT00957229|82910351|FG001|Reallocated to or Continued Vismodegib|Death|1|||
46695913|NCT00957229|82910350|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
46695914|NCT00957229|82910351|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
46695915|NCT02604511|82910357|FG000|Overall Study|Adverse Event|3|||
46695916|NCT02604511|82910357|FG000|Overall Study|Disease Progression|4|||
46695917|NCT02604511|82910357|FG000|Overall Study|Withdrawal by Subject|3|||
46695918|NCT02604511|82910357|FG000|Overall Study|Participant ineligible|1|||
46695919|NCT02604511|82910357|FG000|Overall Study|Intercurrent illness|1|||
46695920|NCT00956839|82910365|FG000|Overall Study|Lost to Follow-up|3|||
46695921|NCT00956839|82910366|FG001|Overall Study|Lost to Follow-up|0|||
46695922|NCT00956839|82910367|FG002|Overall Study|Lost to Follow-up|3|||
46695923|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
46695924|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
46695925|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
46695926|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Death|0|||
46695927|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Death|0|||
46695928|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Death|1|||
46695929|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
46695930|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
46695931|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
46695932|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
46695933|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
46695934|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
46695935|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
46695936|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
46695937|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
46695938|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Graft loss|0|||
46695939|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Graft loss|0|||
46695940|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Graft loss|7|||
46695941|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
46695942|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
46695943|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
46695944|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
46695945|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
46695946|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
46695947|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
46695948|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
46695949|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
46802236|NCT03085758|83021474|FG001|Overall Study|Death|24|||
46802237|NCT03085758|83021475|FG002|Overall Study|Death|53|||
46802238|NCT03085758|83021473|FG000|Overall Study|Lost to Follow-up|1|||
46802239|NCT03085758|83021474|FG001|Overall Study|Lost to Follow-up|1|||
46802240|NCT03085758|83021475|FG002|Overall Study|Lost to Follow-up|1|||
46802241|NCT03085758|83021473|FG000|Overall Study|Withdrawal by Subject|2|||
46802242|NCT03085758|83021474|FG001|Overall Study|Withdrawal by Subject|2|||
46802243|NCT03085758|83021475|FG002|Overall Study|Withdrawal by Subject|1|||
46802244|NCT03085758|83021473|FG000|Overall Study|Refusal to recall it up to day 90|0|||
46802245|NCT03085758|83021474|FG001|Overall Study|Refusal to recall it up to day 90|0|||
46802246|NCT03085758|83021475|FG002|Overall Study|Refusal to recall it up to day 90|1|||
46802247|NCT03085758|83021473|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
46802248|NCT03085758|83021474|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
46802249|NCT03085758|83021475|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
46859053|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
46802250|NCT03053622|83021500|FG000|Overall Study|Lost to Follow-up|0|||
46859054|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
46695950|NCT00956293|82910377|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
46695951|NCT00956293|82910378|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
46802251|NCT03053622|83021501|FG001|Overall Study|Lost to Follow-up|0|||
46802252|NCT03053622|83021502|FG002|Overall Study|Lost to Follow-up|0|||
46802253|NCT03053622|83021503|FG003|Overall Study|Lost to Follow-up|1|||
46802254|NCT02979522|83021515|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
46695952|NCT00956293|82910379|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
46695953|NCT00956293|82910377|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
46695954|NCT00956293|82910378|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
46695955|NCT00956293|82910379|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
46695956|NCT00956293|82910377|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
46695957|NCT00956293|82910378|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
46695958|NCT00956293|82910379|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
46802255|NCT02979522|83021516|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
46802256|NCT02979522|83021515|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
46802257|NCT02979522|83021516|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
46802258|NCT02971761|83021528|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
46802259|NCT02827877|83021536|FG000|Overall Study|Withdrawal by Subject|1|||
46802260|NCT02782104|83021540|FG000|Overall Study|Other|215|||
46802261|NCT02782104|83021540|FG000|Overall Study|Induction Day 28 Non Responder|9|||
46802262|NCT02782104|83021540|FG000|Overall Study|Non-Compliance with Study Drug|2|||
46802263|NCT02782104|83021540|FG000|Overall Study|Death|8|||
46802264|NCT02782104|83021540|FG000|Overall Study|Pregnancy|6|||
46802265|NCT02782104|83021540|FG000|Overall Study|Withdrawal by Subject|63|||
46802266|NCT02782104|83021540|FG000|Overall Study|Protocol Violation|7|||
46802267|NCT02782104|83021540|FG000|Overall Study|Lack of Efficacy|61|||
46802268|NCT02782104|83021540|FG000|Overall Study|Lost to Follow-up|23|||
46802269|NCT02782104|83021540|FG000|Overall Study|Adverse Event|74|||
46802270|NCT02728830|83021547|FG000|Overall Study|Exclusionary Surgery|9|||
46802271|NCT02728830|83021547|FG000|Overall Study|Exclusionary Pathology|6|||
46802272|NCT02728830|83021547|FG000|Overall Study|Physician Decision|3|||
46802273|NCT02728830|83021547|FG000|Overall Study|Withdrawal by Subject|2|||
46802274|NCT02728830|83021547|FG000|Overall Study|Lost to Follow-up|1|||
46802275|NCT02728830|83021547|FG000|Overall Study|Exclusionary Lab Values|1|||
46802276|NCT02728830|83021547|FG000|Overall Study|Contraindicated Illness|1|||
46802277|NCT02728830|83021547|FG000|Overall Study|Language Barrier|1|||
46802278|NCT02624869|83021554|FG000|Overall Study|Lost to Follow-up|0|||
46802279|NCT02624869|83021555|FG001|Overall Study|Lost to Follow-up|0|||
46802280|NCT02624869|83021556|FG002|Overall Study|Lost to Follow-up|1|||
46802281|NCT02624869|83021554|FG000|Overall Study|Withdrawal by Subject|1|||
46802282|NCT02624869|83021555|FG001|Overall Study|Withdrawal by Subject|3|||
46802283|NCT02624869|83021556|FG002|Overall Study|Withdrawal by Subject|1|||
46802284|NCT02393859|83021585|FG000|Overall Study|Decision by Sponsor|2|||
46802285|NCT02393859|83021586|FG001|Overall Study|Decision by Sponsor|4|||
46695959|NCT00956293|82910377|FG000|Main Period (Randomization)|Adverse Event|0|||
46802286|NCT02393859|83021585|FG000|Overall Study|Withdrawal by Subject|11|||
46802287|NCT02393859|83021586|FG001|Overall Study|Withdrawal by Subject|6|||
46802288|NCT02393859|83021585|FG000|Overall Study|Death|27|||
46802289|NCT02393859|83021586|FG001|Overall Study|Death|10|||
46695960|NCT00956293|82910378|FG001|Main Period (Randomization)|Adverse Event|15|||
46802290|NCT02393859|83021585|FG000|Overall Study|Lost to Follow-up|1|||
46802291|NCT02393859|83021586|FG001|Overall Study|Lost to Follow-up|1|||
46802292|NCT01921062|83021636|FG000|Overall Study|Withdrawal by Subject|0|||
46802293|NCT01921062|83021637|FG001|Overall Study|Withdrawal by Subject|7|||
46802294|NCT01921062|83021636|FG000|Overall Study|Adverse Event|5|||
46802295|NCT01921062|83021637|FG001|Overall Study|Adverse Event|6|||
46802296|NCT01921062|83021636|FG000|Overall Study|Protocol Violation|0|||
46802297|NCT01921062|83021637|FG001|Overall Study|Protocol Violation|1|||
46695961|NCT00956293|82910379|FG002|Main Period (Randomization)|Adverse Event|0|||
46695962|NCT00956293|82910377|FG000|Follow-up Period|Follow-up period was terminated.|20|||
46695963|NCT00956293|82910378|FG001|Follow-up Period|Follow-up period was terminated.|32|||
46695964|NCT00956293|82910379|FG002|Follow-up Period|Follow-up period was terminated.|0|||
46695965|NCT00955825|82910387|FG000|Overall Study|Adverse Event|15|||
46695966|NCT00955825|82910388|FG001|Overall Study|Adverse Event|2|||
46695967|NCT00955825|82910387|FG000|Overall Study|Withdrawal by Subject|4|||
46695968|NCT00955825|82910388|FG001|Overall Study|Withdrawal by Subject|6|||
46695969|NCT00955825|82910387|FG000|Overall Study|Any other reason not above-mentioned|7|||
46695970|NCT00955825|82910388|FG001|Overall Study|Any other reason not above-mentioned|9|||
46695971|NCT01164579|82910397|FG000|Overall Study|Lack of Efficacy|0|||
46695972|NCT01164579|82910398|FG001|Overall Study|Lack of Efficacy|0|||
46695973|NCT01164579|82910399|FG002|Overall Study|Lack of Efficacy|6|||
46695974|NCT01164579|82910397|FG000|Overall Study|Lost to Follow-up|1|||
46695975|NCT01164579|82910398|FG001|Overall Study|Lost to Follow-up|1|||
46695976|NCT01164579|82910399|FG002|Overall Study|Lost to Follow-up|0|||
46695977|NCT01164579|82910397|FG000|Overall Study|Withdrawal by Subject|2|||
46695978|NCT01164579|82910398|FG001|Overall Study|Withdrawal by Subject|5|||
46695979|NCT01164579|82910399|FG002|Overall Study|Withdrawal by Subject|3|||
46695980|NCT01164579|82910397|FG000|Overall Study|Protocol Violation|0|||
46695981|NCT01164579|82910398|FG001|Overall Study|Protocol Violation|1|||
46695982|NCT01164579|82910399|FG002|Overall Study|Protocol Violation|2|||
46695983|NCT01164579|82910397|FG000|Overall Study|Adverse Event|4|||
46695984|NCT01164579|82910398|FG001|Overall Study|Adverse Event|2|||
46695985|NCT01164579|82910399|FG002|Overall Study|Adverse Event|5|||
46695986|NCT01164579|82910397|FG000|Overall Study|Reason not specified|1|||
46695987|NCT01164579|82910398|FG001|Overall Study|Reason not specified|0|||
46695988|NCT01164579|82910399|FG002|Overall Study|Reason not specified|0|||
46695989|NCT00958789|82910408|FG000|Overall Study|Death|5|||
46695990|NCT00958789|82910408|FG000|Overall Study|Lost to Follow-up|14|||
46695991|NCT00958789|82910408|FG000|Overall Study|Withdrawal by Subject|17|||
46695992|NCT00958789|82910408|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
46695993|NCT00958789|82910408|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
46695994|NCT00958789|82910408|FG000|Overall Study|Subject terminated|2|||
46695995|NCT00958789|82910408|FG000|Overall Study|Revision|7|||
46695996|NCT02445391|82910419|FG000|Overall Study|No active protocol treatment|3|||
46802298|NCT01921062|83021636|FG000|Overall Study|VMIQ score > 72|4|||
46982175|NCT02584855|83228299|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
46695997|NCT02445391|82910420|FG001|Overall Study|No active protocol treatment|0|||
46695998|NCT02445391|82910421|FG002|Overall Study|No active protocol treatment|0|||
46802299|NCT01921062|83021637|FG001|Overall Study|VMIQ score > 72|1|||
46982176|NCT02584855|83228300|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
46982177|NCT02584855|83228301|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
46982178|NCT02584855|83228302|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
46695999|NCT02445391|82910419|FG000|Overall Study|Adverse Event|0|||
46696000|NCT02445391|82910420|FG001|Overall Study|Adverse Event|21|||
46696001|NCT02445391|82910421|FG002|Overall Study|Adverse Event|12|||
46696002|NCT02445391|82910419|FG000|Overall Study|Alternative therapy|0|||
46696003|NCT02445391|82910420|FG001|Overall Study|Alternative therapy|0|||
46696004|NCT02445391|82910421|FG002|Overall Study|Alternative therapy|1|||
46696005|NCT02445391|82910419|FG000|Overall Study|Disease progression|0|||
46696006|NCT02445391|82910420|FG001|Overall Study|Disease progression|7|||
46802300|NCT01921062|83021636|FG000|Overall Study|Logistic error|0|||
46802301|NCT01921062|83021637|FG001|Overall Study|Logistic error|1|||
46802302|NCT01712490|83021645|FG000|Overall Study|Ongoing|601|||
46802303|NCT01712490|83021646|FG001|Overall Study|Ongoing|586|||
46802304|NCT01712490|83021645|FG000|Overall Study|Other|11|||
46802305|NCT01712490|83021646|FG001|Overall Study|Other|11|||
46802306|NCT01712490|83021645|FG000|Overall Study|Withdrawal by Subject|36|||
46802307|NCT01712490|83021646|FG001|Overall Study|Withdrawal by Subject|44|||
46802308|NCT01712490|83021645|FG000|Overall Study|Lost to Follow-up|16|||
46802309|NCT01712490|83021646|FG001|Overall Study|Lost to Follow-up|29|||
46802310|NCT01266642|83021663|FG000|Overall Study|Protocol Violation|0|||
46802311|NCT01266642|83021664|FG001|Overall Study|Protocol Violation|1|||
46802312|NCT00947531|83021672|FG000|Overall Study|Withdrawal by Subject|10|||
46802313|NCT00947531|83021673|FG001|Overall Study|Withdrawal by Subject|7|||
46802314|NCT00947531|83021672|FG000|Overall Study|Administrative Reason|0|||
46802315|NCT00947531|83021673|FG001|Overall Study|Administrative Reason|1|||
46802316|NCT00947531|83021672|FG000|Overall Study|Adverse Event|2|||
46802317|NCT00947531|83021673|FG001|Overall Study|Adverse Event|2|||
46802318|NCT00947531|83021672|FG000|Overall Study|Lack of Efficacy|1|||
46802319|NCT00947531|83021673|FG001|Overall Study|Lack of Efficacy|0|||
46802320|NCT00947531|83021672|FG000|Overall Study|Other|1|||
46802321|NCT00947531|83021673|FG001|Overall Study|Other|1|||
46802322|NCT00630032|83021681|FG000|Overall Study|Death|55|||
46802323|NCT00630032|83021682|FG001|Overall Study|Death|49|||
46802324|NCT00630032|83021681|FG000|Overall Study|Withdrawal by Subject|3|||
46802325|NCT00630032|83021682|FG001|Overall Study|Withdrawal by Subject|2|||
46802326|NCT00630032|83021681|FG000|Overall Study|Lost to Follow-up|18|||
46802327|NCT00630032|83021682|FG001|Overall Study|Lost to Follow-up|31|||
46802328|NCT00630032|83021681|FG000|Overall Study|Protocol Violation|1|||
46802329|NCT00630032|83021682|FG001|Overall Study|Protocol Violation|0|||
46802330|NCT00630032|83021681|FG000|Overall Study|Patient has moved|1|||
46802331|NCT00630032|83021682|FG001|Overall Study|Patient has moved|1|||
46802332|NCT00630032|83021681|FG000|Overall Study|Disease progression|1|||
46802333|NCT00630032|83021682|FG001|Overall Study|Disease progression|1|||
46802334|NCT00630032|83021681|FG000|Overall Study|End of monitoring in US centers|11|||
46802335|NCT00630032|83021682|FG001|Overall Study|End of monitoring in US centers|11|||
46802336|NCT00609791|83021688|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
46696007|NCT02445391|82910421|FG002|Overall Study|Disease progression|22|||
46696008|NCT02445391|82910419|FG000|Overall Study|Complicating disease|0|||
46696009|NCT02445391|82910420|FG001|Overall Study|Complicating disease|2|||
46696010|NCT02445391|82910421|FG002|Overall Study|Complicating disease|1|||
46802337|NCT00492050|83021704|FG000|Overall Study|Adverse Event|1|||
46802338|NCT00492050|83021704|FG000|Overall Study|Lack of Efficacy|1|||
46802339|NCT00492050|83021704|FG000|Overall Study|Withdrawal by Subject|3|||
46802340|NCT00492050|83021704|FG000|Overall Study|Unable to collect SCT|2|||
46802341|NCT00492050|83021704|FG000|Overall Study|Progressive Disease|2|||
46802342|NCT00418821|83021708|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
46802343|NCT00539994|83021756|FG000|Overall Study|Lost to Follow-up|2|||
46802344|NCT00539994|83021757|FG001|Overall Study|Lost to Follow-up|1|||
46802345|NCT00539994|83021758|FG002|Overall Study|Lost to Follow-up|0|||
46802346|NCT00539994|83021756|FG000|Overall Study|Withdrawal by Subject|1|||
46802347|NCT00539994|83021757|FG001|Overall Study|Withdrawal by Subject|0|||
46802348|NCT00539994|83021758|FG002|Overall Study|Withdrawal by Subject|1|||
46802349|NCT00539994|83021756|FG000|Overall Study|Physician Decision|0|||
46859055|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
46696011|NCT02445391|82910419|FG000|Overall Study|Withdrawal by Subject|0|||
46696012|NCT02445391|82910420|FG001|Overall Study|Withdrawal by Subject|4|||
46696013|NCT02445391|82910421|FG002|Overall Study|Withdrawal by Subject|9|||
46696014|NCT02445391|82910419|FG000|Overall Study|Financial issue|0|||
46696015|NCT02445391|82910420|FG001|Overall Study|Financial issue|0|||
46696016|NCT02445391|82910421|FG002|Overall Study|Financial issue|2|||
46696017|NCT02445391|82910419|FG000|Overall Study|Still on treatment|0|||
46696018|NCT02445391|82910420|FG001|Overall Study|Still on treatment|7|||
46696019|NCT02445391|82910421|FG002|Overall Study|Still on treatment|16|||
46696020|NCT02445391|82910419|FG000|Overall Study|Not start protocol therapy|0|||
46696021|NCT02445391|82910420|FG001|Overall Study|Not start protocol therapy|12|||
46696022|NCT02445391|82910421|FG002|Overall Study|Not start protocol therapy|9|||
46696023|NCT01246986|82910437|FG000|Overall Study|Lost to Follow-up|0|||
46696024|NCT01246986|82910438|FG001|Overall Study|Lost to Follow-up|1|||
46696025|NCT01246986|82910439|FG002|Overall Study|Lost to Follow-up|3|||
46696026|NCT01246986|82910440|FG003|Overall Study|Lost to Follow-up|0|||
46696027|NCT01246986|82910441|FG004|Overall Study|Lost to Follow-up|0|||
46696028|NCT01246986|82910442|FG005|Overall Study|Lost to Follow-up|1|||
46696029|NCT01246986|82910443|FG006|Overall Study|Lost to Follow-up|0|||
46696030|NCT01246986|82910437|FG000|Overall Study|Withdrawal by Subject|3|||
46696031|NCT01246986|82910438|FG001|Overall Study|Withdrawal by Subject|4|||
46696032|NCT01246986|82910439|FG002|Overall Study|Withdrawal by Subject|3|||
46696033|NCT01246986|82910440|FG003|Overall Study|Withdrawal by Subject|0|||
46696034|NCT01246986|82910441|FG004|Overall Study|Withdrawal by Subject|4|||
46696035|NCT01246986|82910442|FG005|Overall Study|Withdrawal by Subject|0|||
46696036|NCT01246986|82910443|FG006|Overall Study|Withdrawal by Subject|0|||
46696037|NCT01164501|82910477|FG000|Overall Study|Not treated|2|||
46696038|NCT01164501|82910478|FG001|Overall Study|Not treated|0|||
46696039|NCT01164501|82910479|FG002|Overall Study|Not treated|1|||
46696040|NCT01164501|82910477|FG000|Overall Study|Adverse Event|18|||
46696041|NCT01164501|82910478|FG001|Overall Study|Adverse Event|4|||
46696042|NCT01164501|82910479|FG002|Overall Study|Adverse Event|21|||
46696043|NCT01164501|82910477|FG000|Overall Study|Lack of Efficacy|0|||
46696044|NCT01164501|82910478|FG001|Overall Study|Lack of Efficacy|0|||
46696045|NCT01164501|82910479|FG002|Overall Study|Lack of Efficacy|1|||
46696046|NCT01164501|82910477|FG000|Overall Study|Non compliant with protocol|1|||
46696047|NCT01164501|82910478|FG001|Overall Study|Non compliant with protocol|1|||
46696048|NCT01164501|82910479|FG002|Overall Study|Non compliant with protocol|4|||
46696049|NCT01164501|82910477|FG000|Overall Study|Lost to Follow-up|3|||
46696050|NCT01164501|82910478|FG001|Overall Study|Lost to Follow-up|0|||
46696051|NCT01164501|82910479|FG002|Overall Study|Lost to Follow-up|3|||
46696052|NCT01164501|82910477|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
46696053|NCT01164501|82910478|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
46696054|NCT01164501|82910479|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
46696055|NCT01164501|82910477|FG000|Overall Study|Other reason not defined above|9|||
46696056|NCT01164501|82910478|FG001|Overall Study|Other reason not defined above|1|||
46696057|NCT01164501|82910479|FG002|Overall Study|Other reason not defined above|4|||
46696058|NCT00958711|82910491|FG000|Overall Study|Withdrawal by Subject|0|||
46696059|NCT00958711|82910492|FG001|Overall Study|Withdrawal by Subject|4|||
46696060|NCT00958711|82910491|FG000|Overall Study|Physician Decision|5|||
46696061|NCT00958711|82910492|FG001|Overall Study|Physician Decision|7|||
46696062|NCT00958711|82910491|FG000|Overall Study|Lost to Follow-up|4|||
46696063|NCT00958711|82910492|FG001|Overall Study|Lost to Follow-up|1|||
46696064|NCT00958711|82910491|FG000|Overall Study|Other|2|||
46696065|NCT00958711|82910492|FG001|Overall Study|Other|5|||
46696066|NCT00958711|82910491|FG000|Overall Study|Death|1|||
46696067|NCT00958711|82910492|FG001|Overall Study|Death|2|||
46696068|NCT00958711|82910491|FG000|Overall Study|Adverse Event|1|||
46696069|NCT00958711|82910492|FG001|Overall Study|Adverse Event|2|||
46696070|NCT01163721|82910500|FG000|Overall Study|Adverse Event|5|||
46696071|NCT01163721|82910501|FG001|Overall Study|Adverse Event|6|||
46696072|NCT01163721|82910500|FG000|Overall Study|Withdrawal by Subject|3|||
46696073|NCT01163721|82910501|FG001|Overall Study|Withdrawal by Subject|4|||
46696074|NCT01163721|82910500|FG000|Overall Study|Lost to Follow-up|0|||
46696075|NCT01163721|82910501|FG001|Overall Study|Lost to Follow-up|1|||
46696076|NCT01163721|82910500|FG000|Overall Study|Physician Decision|0|||
46696077|NCT01163721|82910501|FG001|Overall Study|Physician Decision|1|||
46696078|NCT00958243|82910513|FG000|Overall Study|Withdrawal by Subject|0|||
46696079|NCT00958243|82910514|FG001|Overall Study|Withdrawal by Subject|1|||
46696080|NCT00958243|82910515|FG002|Overall Study|Withdrawal by Subject|3|||
46696081|NCT00958243|82910516|FG003|Overall Study|Withdrawal by Subject|1|||
46696082|NCT00958243|82910517|FG004|Overall Study|Withdrawal by Subject|1|||
46696083|NCT00958243|82910518|FG005|Overall Study|Withdrawal by Subject|5|||
46696084|NCT00958243|82910513|FG000|Overall Study|Lost to Follow-up|2|||
46696085|NCT00958243|82910514|FG001|Overall Study|Lost to Follow-up|5|||
46696086|NCT00958243|82910515|FG002|Overall Study|Lost to Follow-up|11|||
46696087|NCT00958243|82910516|FG003|Overall Study|Lost to Follow-up|2|||
46696088|NCT00958243|82910517|FG004|Overall Study|Lost to Follow-up|8|||
46696089|NCT00958243|82910518|FG005|Overall Study|Lost to Follow-up|5|||
46696090|NCT01241760|82910540|FG000|Overall Study|Adverse Event|1|||
46696091|NCT01241760|82910541|FG001|Overall Study|Adverse Event|0|||
46696092|NCT01241760|82910540|FG000|Overall Study|Lost to Follow-up|18|||
46696093|NCT01241760|82910541|FG001|Overall Study|Lost to Follow-up|22|||
46696094|NCT01241760|82910540|FG000|Overall Study|Withdrawal by Subject|13|||
46696095|NCT01241760|82910541|FG001|Overall Study|Withdrawal by Subject|13|||
46696096|NCT01241760|82910540|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
46696097|NCT01241760|82910541|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
46696098|NCT01241760|82910540|FG000|Overall Study|Other|1|||
46696099|NCT01241760|82910541|FG001|Overall Study|Other|1|||
46696100|NCT00958165|82910548|FG000|Overall Study|Lost to Follow-up|5|||
46696101|NCT00958165|82910548|FG000|Overall Study|Not eligible|9|||
46696102|NCT00958009|82910552|FG000|Overall Study|Adverse Event|1|||
46696103|NCT00958009|82910552|FG000|Overall Study|Subject found device difficult to use|1|||
46696104|NCT00953407|82910561|FG000|Overall Study|Failed inclusion criteria|1|||
46696105|NCT00953407|82910562|FG001|Overall Study|Failed inclusion criteria|1|||
46696106|NCT00953407|82910563|FG002|Overall Study|Failed inclusion criteria|1|||
46696107|NCT00953407|82910564|FG003|Overall Study|Failed inclusion criteria|1|||
46696108|NCT00953407|82910565|FG004|Overall Study|Failed inclusion criteria|1|||
46696109|NCT00953407|82910561|FG000|Overall Study|Lost to Follow-up|0|||
46696110|NCT00953407|82910562|FG001|Overall Study|Lost to Follow-up|0|||
46696111|NCT00953407|82910563|FG002|Overall Study|Lost to Follow-up|0|||
46696112|NCT00953407|82910564|FG003|Overall Study|Lost to Follow-up|1|||
46696113|NCT00953407|82910565|FG004|Overall Study|Lost to Follow-up|0|||
46696114|NCT00953329|82910577|FG000|Overall Study|Lack of Efficacy|1|||
46696115|NCT00953017|82910585|FG000|Overall Study|DId not show up for colonoscopy|4|||
46696116|NCT00953017|82910586|FG001|Overall Study|DId not show up for colonoscopy|4|||
46696117|NCT00953017|82910587|FG002|Overall Study|DId not show up for colonoscopy|5|||
46696118|NCT00953017|82910588|FG003|Overall Study|DId not show up for colonoscopy|4|||
46696119|NCT00953017|82910585|FG000|Overall Study|Incomplete data|1|||
46696120|NCT00953017|82910586|FG001|Overall Study|Incomplete data|1|||
46696121|NCT00953017|82910587|FG002|Overall Study|Incomplete data|0|||
46696122|NCT00953017|82910588|FG003|Overall Study|Incomplete data|0|||
46696123|NCT00953017|82910585|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
46696124|NCT00953017|82910586|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
46696125|NCT00953017|82910587|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
46696126|NCT00953017|82910588|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
46802350|NCT00539994|83021757|FG001|Overall Study|Physician Decision|0|||
46802351|NCT00539994|83021758|FG002|Overall Study|Physician Decision|1|||
46802352|NCT00098839|83021775|FG000|Overall Study|Adverse Event|5|||
46802353|NCT00098839|83021776|FG001|Overall Study|Adverse Event|2|||
46802354|NCT00098839|83021775|FG000|Overall Study|Death|1|||
46802355|NCT00098839|83021776|FG001|Overall Study|Death|2|||
46802356|NCT00098839|83021775|FG000|Overall Study|Physician Decision|4|||
46802357|NCT00098839|83021776|FG001|Overall Study|Physician Decision|14|||
46802358|NCT00098839|83021775|FG000|Overall Study|Withdrawal by Subject|1|||
46802359|NCT00098839|83021776|FG001|Overall Study|Withdrawal by Subject|0|||
46802360|NCT00098839|83021775|FG000|Overall Study|Refusal of further protocol therapy|3|||
46696127|NCT00953017|82910585|FG000|Overall Study|Brown stool prior to procedure|0|||
46696128|NCT00953017|82910586|FG001|Overall Study|Brown stool prior to procedure|0|||
46802361|NCT00098839|83021776|FG001|Overall Study|Refusal of further protocol therapy|1|||
46802362|NCT00098839|83021775|FG000|Overall Study|Relapse|6|||
46802363|NCT00098839|83021776|FG001|Overall Study|Relapse|3|||
46696129|NCT00953017|82910587|FG002|Overall Study|Brown stool prior to procedure|1|||
46696130|NCT00953017|82910588|FG003|Overall Study|Brown stool prior to procedure|0|||
46802364|NCT00098839|83021775|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
46802365|NCT00098839|83021776|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
46802366|NCT00098839|83021775|FG000|Overall Study|Ineligible|2|||
46802367|NCT00098839|83021776|FG001|Overall Study|Ineligible|0|||
46802368|NCT03811093|83021785|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
46802369|NCT03811093|83021786|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
46802370|NCT03811093|83021785|FG000|Overall Study|Unable to measure body fat percentage|2|||
46802371|NCT03811093|83021786|FG001|Overall Study|Unable to measure body fat percentage|0|||
46802372|NCT00485589|83021798|FG000|Overall Study|Death|2|||
46802373|NCT00485589|83021799|FG001|Overall Study|Death|2|||
46802374|NCT00485589|83021800|FG002|Overall Study|Death|0|||
46802375|NCT00485589|83021798|FG000|Overall Study|Failure to return|6|||
46802376|NCT00485589|83021799|FG001|Overall Study|Failure to return|5|||
46802377|NCT00485589|83021800|FG002|Overall Study|Failure to return|1|||
46802378|NCT00485589|83021798|FG000|Overall Study|Protocol Violation|1|||
46802379|NCT00485589|83021799|FG001|Overall Study|Protocol Violation|0|||
46802380|NCT00485589|83021800|FG002|Overall Study|Protocol Violation|0|||
46802381|NCT00485589|83021798|FG000|Overall Study|Violation of selection criteria at entry|0|||
46802382|NCT00485589|83021799|FG001|Overall Study|Violation of selection criteria at entry|3|||
46802383|NCT00485589|83021800|FG002|Overall Study|Violation of selection criteria at entry|1|||
46802384|NCT00485589|83021798|FG000|Overall Study|Administrative/Other|1|||
46802385|NCT00485589|83021799|FG001|Overall Study|Administrative/Other|2|||
46802386|NCT00485589|83021800|FG002|Overall Study|Administrative/Other|1|||
46802387|NCT00485589|83021798|FG000|Overall Study|Insufficient therapeutic response|10|||
46859056|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
46696131|NCT00952705|82910601|FG000|Overall Study|Lost to Follow-up|24|||
46696132|NCT00952705|82910602|FG001|Overall Study|Lost to Follow-up|8|||
46696133|NCT00952705|82910603|FG002|Overall Study|Lost to Follow-up|9|||
46696134|NCT00952705|82910601|FG000|Overall Study|Withdrawal by Subject|2|||
46696135|NCT00952705|82910602|FG001|Overall Study|Withdrawal by Subject|1|||
46696136|NCT00952705|82910603|FG002|Overall Study|Withdrawal by Subject|1|||
46696137|NCT00952705|82910601|FG000|Overall Study|Death|2|||
46802388|NCT00485589|83021799|FG001|Overall Study|Insufficient therapeutic response|3|||
46802389|NCT00485589|83021800|FG002|Overall Study|Insufficient therapeutic response|1|||
46802390|NCT00485589|83021798|FG000|Overall Study|Refused treatment/did not cooperate|1|||
46802391|NCT00485589|83021799|FG001|Overall Study|Refused treatment/did not cooperate|0|||
46802392|NCT00485589|83021800|FG002|Overall Study|Refused treatment/did not cooperate|2|||
46859057|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
46859058|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
46802393|NCT00485589|83021798|FG000|Overall Study|Withdrawal by Subject|3|||
46802394|NCT00485589|83021799|FG001|Overall Study|Withdrawal by Subject|2|||
46802395|NCT00485589|83021800|FG002|Overall Study|Withdrawal by Subject|2|||
46802396|NCT00485589|83021798|FG000|Overall Study|Adverse Event|3|||
46802397|NCT00485589|83021799|FG001|Overall Study|Adverse Event|3|||
46859059|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
46859060|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
46859061|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
46859062|NCT03370133|83074997|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
46859063|NCT03370133|83074998|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
46859064|NCT03370133|83074999|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
46859065|NCT03370133|83075000|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
46859066|NCT03370133|83075001|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
46859067|NCT03370133|83075002|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
46859068|NCT03370133|83074997|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
46859069|NCT03370133|83074998|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
46859070|NCT03370133|83074999|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
46859071|NCT03370133|83075000|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
46859072|NCT03370133|83075001|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
46859073|NCT03370133|83075002|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
46859074|NCT03370133|83074997|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
46859075|NCT03370133|83074998|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
46859076|NCT03370133|83074999|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
46859077|NCT03370133|83075000|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
46859078|NCT03370133|83075001|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
46859079|NCT03370133|83075002|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
46859080|NCT03370133|83074997|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
46859081|NCT03370133|83074998|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
46859082|NCT03370133|83074999|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
46859083|NCT03370133|83075000|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
46859084|NCT03370133|83075001|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
46859085|NCT03370133|83075002|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
46859086|NCT03370133|83074997|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
46859087|NCT03370133|83074998|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
46859088|NCT03370133|83074999|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
46859089|NCT03370133|83075000|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
46859090|NCT03370133|83075001|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
46859091|NCT03370133|83075002|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
46859092|NCT03370133|83074997|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
46859093|NCT03370133|83074998|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
46859094|NCT03370133|83074999|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
46859095|NCT03370133|83075000|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
46859096|NCT03370133|83075001|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
46859097|NCT03370133|83075002|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
46859098|NCT03370133|83074997|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
46859099|NCT03370133|83074998|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
46859100|NCT03370133|83074999|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
46859101|NCT03370133|83075000|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
46859102|NCT03370133|83075001|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
46859103|NCT03370133|83075002|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
46859104|NCT03370133|83074997|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
46859105|NCT03370133|83074998|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
46859106|NCT03370133|83074999|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
46859107|NCT03370133|83075000|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
46859108|NCT03370133|83075001|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
46859109|NCT03370133|83075002|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
46859110|NCT03227757|83075020|FG000|Overall Study|Death|7|||
46859111|NCT03227757|83075020|FG000|Overall Study|Withdrawal|5|||
46859112|NCT03227757|83075020|FG000|Overall Study|Missed visits|4|||
46859113|NCT03149549|83075037|FG000|Study Discontinuation--Treatment Period|Death|0|||
46859114|NCT03149549|83075038|FG001|Study Discontinuation--Treatment Period|Death|0|||
46859115|NCT03149549|83075039|FG002|Study Discontinuation--Treatment Period|Death|0|||
46859116|NCT03149549|83075040|FG003|Study Discontinuation--Treatment Period|Death|1|||
46859117|NCT03149549|83075041|FG004|Study Discontinuation--Treatment Period|Death|2|||
46859118|NCT03149549|83075042|FG005|Study Discontinuation--Treatment Period|Death|1|||
46859119|NCT03149549|83075043|FG006|Study Discontinuation--Treatment Period|Death|1|||
46859120|NCT03149549|83075044|FG007|Study Discontinuation--Treatment Period|Death|2|||
46859121|NCT03149549|83075045|FG008|Study Discontinuation--Treatment Period|Death|4|||
46859122|NCT03149549|83075046|FG009|Study Discontinuation--Treatment Period|Death|1|||
46859123|NCT03149549|83075047|FG010|Study Discontinuation--Treatment Period|Death|0|||
46859124|NCT03149549|83075048|FG011|Study Discontinuation--Treatment Period|Death|0|||
46859125|NCT03149549|83075049|FG012|Study Discontinuation--Treatment Period|Death|1|||
46859126|NCT03149549|83075037|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859127|NCT03149549|83075038|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859128|NCT03149549|83075039|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46696138|NCT00952705|82910602|FG001|Overall Study|Death|0|||
46696139|NCT00952705|82910603|FG002|Overall Study|Death|0|||
46696140|NCT00952705|82910601|FG000|Overall Study|Incarcerated post dose|5|||
46696141|NCT00952705|82910602|FG001|Overall Study|Incarcerated post dose|0|||
46696142|NCT00952705|82910603|FG002|Overall Study|Incarcerated post dose|0|||
46696143|NCT00952705|82910601|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
46696144|NCT00952705|82910602|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
46696145|NCT00952705|82910603|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
46696146|NCT00955357|82910617|FG000|Titration Phase|Adverse Event|9|||
46696147|NCT00955357|82910618|FG001|Titration Phase|Adverse Event|46|||
46696148|NCT00955357|82910617|FG000|Titration Phase|Lack of Efficacy|0|||
46696149|NCT00955357|82910618|FG001|Titration Phase|Lack of Efficacy|2|||
46696150|NCT00955357|82910617|FG000|Titration Phase|Protocol Violation|3|||
46696151|NCT00955357|82910618|FG001|Titration Phase|Protocol Violation|7|||
46696152|NCT00955357|82910617|FG000|Titration Phase|Lost to Follow-up|1|||
46696153|NCT00955357|82910618|FG001|Titration Phase|Lost to Follow-up|3|||
46696154|NCT00955357|82910617|FG000|Titration Phase|Withdrawal by Subject|3|||
46696155|NCT00955357|82910618|FG001|Titration Phase|Withdrawal by Subject|5|||
46696156|NCT00955357|82910617|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
46696157|NCT00955357|82910618|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
46696158|NCT00955357|82910617|FG000|Titration Phase|Study medication not tolerated|0|||
46696159|NCT00955357|82910618|FG001|Titration Phase|Study medication not tolerated|1|||
46696160|NCT00955357|82910617|FG000|Titration Phase|Non compliance to study procedures|0|||
46696161|NCT00955357|82910618|FG001|Titration Phase|Non compliance to study procedures|1|||
46696162|NCT00955357|82910617|FG000|Maintenance Phase|Adverse Event|3|||
46696163|NCT00955357|82910618|FG001|Maintenance Phase|Adverse Event|23|||
46696164|NCT00955357|82910617|FG000|Maintenance Phase|Lack of Efficacy|0|||
46696165|NCT00955357|82910618|FG001|Maintenance Phase|Lack of Efficacy|4|||
46696166|NCT00955357|82910617|FG000|Maintenance Phase|Protocol Violation|2|||
46696167|NCT00955357|82910618|FG001|Maintenance Phase|Protocol Violation|6|||
46696168|NCT00955357|82910617|FG000|Maintenance Phase|Lost to Follow-up|2|||
46696169|NCT00955357|82910618|FG001|Maintenance Phase|Lost to Follow-up|7|||
46696170|NCT00955357|82910617|FG000|Maintenance Phase|Withdrawal by Subject|4|||
46696171|NCT00955357|82910618|FG001|Maintenance Phase|Withdrawal by Subject|4|||
46696172|NCT00955357|82910617|FG000|Maintenance Phase|Patient moving out of area|0|||
46696173|NCT00955357|82910618|FG001|Maintenance Phase|Patient moving out of area|1|||
46696174|NCT00955357|82910617|FG000|Maintenance Phase|Non compliance to study procedures|1|||
46696175|NCT00955357|82910618|FG001|Maintenance Phase|Non compliance to study procedures|0|||
46696176|NCT00955279|82910627|FG000|Overall Study|Other|0|||
46696177|NCT00955279|82910628|FG001|Overall Study|Other|0|||
46696178|NCT00955279|82910629|FG002|Overall Study|Other|3|||
46696179|NCT00955279|82910627|FG000|Overall Study|Death|1|||
46696180|NCT00955279|82910628|FG001|Overall Study|Death|1|||
46696181|NCT00955279|82910629|FG002|Overall Study|Death|1|||
46696182|NCT00955279|82910627|FG000|Overall Study|Lost to Follow-up|0|||
46859129|NCT03149549|83075040|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859130|NCT03149549|83075041|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859131|NCT03149549|83075042|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859132|NCT03149549|83075043|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46696183|NCT00955279|82910628|FG001|Overall Study|Lost to Follow-up|3|||
46696184|NCT00955279|82910629|FG002|Overall Study|Lost to Follow-up|1|||
46982179|NCT02584855|83228303|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
46982180|NCT02584855|83228298|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
46982181|NCT02584855|83228299|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
46982182|NCT02584855|83228300|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
46859133|NCT03149549|83075044|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
46859134|NCT03149549|83075045|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859135|NCT03149549|83075046|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859136|NCT03149549|83075047|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859137|NCT03149549|83075048|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
46859138|NCT03149549|83075049|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
46859139|NCT03149549|83075037|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859140|NCT03149549|83075038|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859141|NCT03149549|83075039|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859142|NCT03149549|83075040|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
46859143|NCT03149549|83075041|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
46859144|NCT03149549|83075042|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
46859145|NCT03149549|83075043|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
46859146|NCT03149549|83075044|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859147|NCT03149549|83075045|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
46859148|NCT03149549|83075046|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859149|NCT03149549|83075047|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859150|NCT03149549|83075048|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859151|NCT03149549|83075049|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
46859152|NCT03149549|83075037|FG000|Study Discontinuation--Treatment Period|Other|0|||
46859153|NCT03149549|83075038|FG001|Study Discontinuation--Treatment Period|Other|0|||
46859154|NCT03149549|83075039|FG002|Study Discontinuation--Treatment Period|Other|0|||
46859155|NCT03149549|83075040|FG003|Study Discontinuation--Treatment Period|Other|0|||
46859156|NCT03149549|83075041|FG004|Study Discontinuation--Treatment Period|Other|0|||
46859157|NCT03149549|83075042|FG005|Study Discontinuation--Treatment Period|Other|0|||
46859158|NCT03149549|83075043|FG006|Study Discontinuation--Treatment Period|Other|0|||
46859159|NCT03149549|83075044|FG007|Study Discontinuation--Treatment Period|Other|1|||
46859160|NCT03149549|83075045|FG008|Study Discontinuation--Treatment Period|Other|0|||
46859161|NCT03149549|83075046|FG009|Study Discontinuation--Treatment Period|Other|1|||
46859162|NCT03149549|83075047|FG010|Study Discontinuation--Treatment Period|Other|0|||
46859163|NCT03149549|83075048|FG011|Study Discontinuation--Treatment Period|Other|0|||
46859164|NCT03149549|83075049|FG012|Study Discontinuation--Treatment Period|Other|0|||
46859165|NCT03149549|83075037|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859166|NCT03149549|83075038|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859167|NCT03149549|83075039|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859168|NCT03149549|83075040|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859169|NCT03149549|83075041|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859170|NCT03149549|83075042|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
46859171|NCT03149549|83075043|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
46859172|NCT03149549|83075044|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859173|NCT03149549|83075045|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
46859174|NCT03149549|83075046|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859175|NCT03149549|83075047|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859176|NCT03149549|83075048|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859177|NCT03149549|83075049|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
46859178|NCT03149549|83075037|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46859179|NCT03149549|83075038|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46859180|NCT03149549|83075039|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46859181|NCT03149549|83075040|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46859182|NCT03149549|83075041|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
46859183|NCT03149549|83075042|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46859184|NCT03149549|83075043|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46859185|NCT03149549|83075044|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
46859186|NCT03149549|83075045|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
46696185|NCT00955279|82910627|FG000|Overall Study|Withdrawal by Subject|2|||
46696186|NCT00955279|82910628|FG001|Overall Study|Withdrawal by Subject|0|||
46859187|NCT03149549|83075046|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46859188|NCT03149549|83075047|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
46696187|NCT00955279|82910629|FG002|Overall Study|Withdrawal by Subject|3|||
46859189|NCT03149549|83075048|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
46859190|NCT03149549|83075049|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
46859191|NCT03149549|83075037|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
46859192|NCT03149549|83075038|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
46859193|NCT03149549|83075039|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
46859194|NCT03149549|83075040|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
46859195|NCT03149549|83075041|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
46859196|NCT03149549|83075042|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
46859197|NCT03149549|83075043|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
46859198|NCT03149549|83075044|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
46859199|NCT03149549|83075045|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
46859200|NCT03149549|83075046|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
46859201|NCT03149549|83075047|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
46859202|NCT03149549|83075048|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
46859203|NCT03149549|83075049|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
46859204|NCT03149549|83075037|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
46859205|NCT03149549|83075038|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
46859206|NCT03149549|83075039|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
46859207|NCT03149549|83075040|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
46859208|NCT03149549|83075041|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
46859209|NCT03149549|83075042|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
46859210|NCT03149549|83075043|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
46859211|NCT03149549|83075044|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
46859212|NCT03149549|83075045|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
46859213|NCT03149549|83075046|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
46859214|NCT03149549|83075047|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
46859215|NCT03149549|83075048|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
46859216|NCT03149549|83075049|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
46859217|NCT03149549|83075037|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
46859218|NCT03149549|83075038|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
46859219|NCT03149549|83075039|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
46859220|NCT03149549|83075040|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
46859221|NCT03149549|83075041|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
46859222|NCT03149549|83075042|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
46859223|NCT03149549|83075043|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
46859224|NCT03149549|83075044|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
46859225|NCT03149549|83075045|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
46859226|NCT03149549|83075046|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
46859227|NCT03149549|83075047|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
46859228|NCT03149549|83075048|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
46859229|NCT03149549|83075049|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
46859230|NCT02316340|83075093|FG000|First Progression|Clinical progression|2|||
46859231|NCT02316340|83075094|FG001|First Progression|Clinical progression|1|||
46859232|NCT02316340|83075093|FG000|First Progression|Withdrawal by Subject|1|||
46859233|NCT02316340|83075094|FG001|First Progression|Withdrawal by Subject|0|||
46859234|NCT02063724|83075100|FG000|Overall Study|Disease progression|1|||
46859235|NCT01722266|83075108|FG000|Overall Study|Withdrawal by Subject|1|||
46859236|NCT01722266|83075109|FG001|Overall Study|Withdrawal by Subject|2|||
46859237|NCT01722266|83075110|FG002|Overall Study|Withdrawal by Subject|0|||
46859238|NCT01722266|83075111|FG003|Overall Study|Withdrawal by Subject|0|||
46859239|NCT01722266|83075108|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
46859240|NCT01722266|83075109|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
46859241|NCT01722266|83075110|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
46859242|NCT01722266|83075111|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
46859243|NCT01722266|83075108|FG000|Overall Study|Dropped out due to Nausea|0|||
46859244|NCT01722266|83075109|FG001|Overall Study|Dropped out due to Nausea|0|||
46859245|NCT01722266|83075110|FG002|Overall Study|Dropped out due to Nausea|2|||
46859246|NCT01722266|83075111|FG003|Overall Study|Dropped out due to Nausea|0|||
46859247|NCT00953771|83075133|FG000|Overall Study|Death|1|||
46859248|NCT00953771|83075134|FG001|Overall Study|Death|0|||
46859249|NCT00673816|83075146|FG000|Overall Study|Adverse Event|1|||
46859250|NCT00673816|83075146|FG000|Overall Study|Withdrawal by Subject|1|||
46859251|NCT00026312|83075171|FG000|Overall Study|Adverse Event|0|||
46859252|NCT00026312|83075172|FG001|Overall Study|Adverse Event|32|||
46859253|NCT00026312|83075171|FG000|Overall Study|Death|1|||
46859254|NCT00026312|83075172|FG001|Overall Study|Death|7|||
46859255|NCT00026312|83075171|FG000|Overall Study|Lack of Efficacy|19|||
46859256|NCT00026312|83075172|FG001|Overall Study|Lack of Efficacy|114|||
46859257|NCT00026312|83075171|FG000|Overall Study|Lost to Follow-up|0|||
46859258|NCT00026312|83075172|FG001|Overall Study|Lost to Follow-up|5|||
46859259|NCT00026312|83075171|FG000|Overall Study|Physician Decision|1|||
46859260|NCT00026312|83075172|FG001|Overall Study|Physician Decision|37|||
46859261|NCT00026312|83075171|FG000|Overall Study|Protocol Violation|0|||
46859262|NCT00026312|83075172|FG001|Overall Study|Protocol Violation|3|||
46859263|NCT00026312|83075171|FG000|Overall Study|Withdrawal by Subject|1|||
46859264|NCT00026312|83075172|FG001|Overall Study|Withdrawal by Subject|6|||
46859265|NCT00026312|83075171|FG000|Overall Study|Ineligible|4|||
46859266|NCT00026312|83075172|FG001|Overall Study|Ineligible|5|||
46859267|NCT00026312|83075171|FG000|Overall Study|Entry onto another COG study|0|||
46859268|NCT00026312|83075172|FG001|Overall Study|Entry onto another COG study|1|||
46859269|NCT00026312|83075171|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
46859270|NCT00026312|83075172|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
46859271|NCT03280264|83075182|FG000|Overall Study|Adverse Event|1|||
46859272|NCT03280264|83075182|FG000|Overall Study|Physician Decision|1|||
46859273|NCT03280264|83075182|FG000|Overall Study|Withdrawal by Subject|1|||
46859274|NCT00060840|83075189|FG000|Overall Study|Change in surgical plan|2|||
46859275|NCT00060840|83075190|FG001|Overall Study|Change in surgical plan|6|||
46859276|NCT00060840|83075189|FG000|Overall Study|Death|0|||
46859277|NCT00060840|83075190|FG001|Overall Study|Death|1|||
46859278|NCT00060840|83075189|FG000|Overall Study|Withdrawal by Subject|0|||
46859279|NCT00060840|83075190|FG001|Overall Study|Withdrawal by Subject|1|||
46859280|NCT00060840|83075189|FG000|Overall Study|Subinvestigator unavailable|0|||
46859281|NCT00060840|83075190|FG001|Overall Study|Subinvestigator unavailable|1|||
46859282|NCT00060840|83075189|FG000|Overall Study|Physician Decision|1|||
46859283|NCT00060840|83075190|FG001|Overall Study|Physician Decision|0|||
46859284|NCT00060840|83075189|FG000|Overall Study|Other|1|||
46859285|NCT00060840|83075190|FG001|Overall Study|Other|0|||
46859286|NCT03280108|83075198|FG000|Overall Study|Lost to Follow-up|2|||
46859287|NCT03280108|83075199|FG001|Overall Study|Lost to Follow-up|0|||
46859288|NCT00059202|83075212|FG000|Overall Study|Withdrawal by Subject|5|||
46859289|NCT00059202|83075213|FG001|Overall Study|Withdrawal by Subject|9|||
46859290|NCT00059202|83075212|FG000|Overall Study|Protocol Violation|1|||
46859291|NCT00059202|83075213|FG001|Overall Study|Protocol Violation|3|||
46859292|NCT00059202|83075212|FG000|Overall Study|drug toxicity|0|||
46859293|NCT00059202|83075213|FG001|Overall Study|drug toxicity|3|||
46859294|NCT03278626|83075222|FG000|Overall Study|Death|2|||
46859295|NCT03278626|83075222|FG000|Overall Study|Toxicity|1|||
46859296|NCT03278626|83075222|FG000|Overall Study|Disease Progression|2|||
46859297|NCT03277846|83075228|FG000|Overall Study|Inpatient stay too brief|12|||
46859298|NCT03277846|83075229|FG001|Overall Study|Inpatient stay too brief|11|||
46696188|NCT00954733|82910637|FG000|Overall Study|blood gas machine did not work|1|||
46696189|NCT00954421|82910641|FG000|Screening|screen failures|3|||
46696190|NCT00954421|82910641|FG000|6 Months of DBS|Withdrawal by Subject|1|||
46696191|NCT00954421|82910641|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
46696192|NCT01241448|82910651|FG000|Overall Study|Adverse Event|1|||
46696193|NCT01241448|82910652|FG001|Overall Study|Adverse Event|0|||
46696194|NCT01241448|82910653|FG002|Overall Study|Adverse Event|2|||
46696195|NCT01241448|82910654|FG003|Overall Study|Adverse Event|2|||
46696196|NCT01241448|82910651|FG000|Overall Study|Lost to Follow-up|2|||
46696197|NCT01241448|82910652|FG001|Overall Study|Lost to Follow-up|1|||
46696198|NCT01241448|82910653|FG002|Overall Study|Lost to Follow-up|1|||
46696199|NCT01241448|82910654|FG003|Overall Study|Lost to Follow-up|1|||
46696200|NCT01241448|82910651|FG000|Overall Study|Physician Decision|0|||
46696201|NCT01241448|82910652|FG001|Overall Study|Physician Decision|2|||
46696202|NCT01241448|82910653|FG002|Overall Study|Physician Decision|0|||
46696203|NCT01241448|82910654|FG003|Overall Study|Physician Decision|0|||
46696204|NCT01241448|82910651|FG000|Overall Study|Protocol Violation|10|||
46696205|NCT01241448|82910652|FG001|Overall Study|Protocol Violation|5|||
46696206|NCT01241448|82910653|FG002|Overall Study|Protocol Violation|3|||
46696207|NCT01241448|82910654|FG003|Overall Study|Protocol Violation|6|||
46859299|NCT00073008|83075237|FG000|Overall Study|Missing|6|||
46859300|NCT00073008|83075238|FG001|Overall Study|Missing|6|||
46859301|NCT00073008|83075237|FG000|Overall Study|Withdrawal by Subject|2|||
46859302|NCT00073008|83075238|FG001|Overall Study|Withdrawal by Subject|2|||
46859303|NCT00073008|83075237|FG000|Overall Study|Lost to Follow-up|1|||
46696208|NCT01241448|82910651|FG000|Overall Study|Sponsor Decision|17|||
46696209|NCT01241448|82910652|FG001|Overall Study|Sponsor Decision|14|||
46696210|NCT01241448|82910653|FG002|Overall Study|Sponsor Decision|12|||
46696211|NCT01241448|82910654|FG003|Overall Study|Sponsor Decision|6|||
46696212|NCT01241448|82910651|FG000|Overall Study|Withdrawal by Subject|4|||
46696213|NCT01241448|82910652|FG001|Overall Study|Withdrawal by Subject|5|||
46859304|NCT00073008|83075238|FG001|Overall Study|Lost to Follow-up|3|||
46859305|NCT00073008|83075237|FG000|Overall Study|Death|46|||
46859306|NCT00073008|83075238|FG001|Overall Study|Death|47|||
46859307|NCT00073008|83075237|FG000|Overall Study|"Other selected on Case Report Form"|7|||
46859308|NCT00073008|83075238|FG001|Overall Study|"Other selected on Case Report Form"|5|||
46859309|NCT00058422|83075244|FG000|Overall Study|Not treated|2|||
46859310|NCT00072384|83075248|FG000|Overall Study|Physician Decision|1|||
46859311|NCT00072384|83075248|FG000|Overall Study|Ineligible|8|||
46696214|NCT01241448|82910653|FG002|Overall Study|Withdrawal by Subject|3|||
46696215|NCT01241448|82910654|FG003|Overall Study|Withdrawal by Subject|6|||
46696216|NCT01241448|82910651|FG000|Overall Study|Excluded due to data integrity issues|3|||
46696217|NCT01241448|82910652|FG001|Overall Study|Excluded due to data integrity issues|2|||
46696218|NCT01241448|82910653|FG002|Overall Study|Excluded due to data integrity issues|2|||
46696219|NCT01241448|82910654|FG003|Overall Study|Excluded due to data integrity issues|2|||
46696220|NCT01240356|82910667|FG000|Overall Study|Withdrawal by Subject|2|||
46696221|NCT01240356|82910668|FG001|Overall Study|Withdrawal by Subject|0|||
46696222|NCT01240356|82910667|FG000|Overall Study|MRI contraindication|1|||
46696223|NCT01240356|82910668|FG001|Overall Study|MRI contraindication|0|||
46696224|NCT01239732|82910677|FG000|Overall Study|Termination of study per protocol|667|||
46696225|NCT01239732|82910677|FG000|Overall Study|Death|226|||
46696226|NCT01239732|82910677|FG000|Overall Study|Withdrawal by Subject|87|||
46696227|NCT01239732|82910677|FG000|Overall Study|Adverse Event|6|||
46696228|NCT01239732|82910677|FG000|Overall Study|Protocol Violation|3|||
46696229|NCT01239732|82910677|FG000|Overall Study|Participant non compliance|5|||
46696230|NCT01239732|82910677|FG000|Overall Study|Study termination by sponsor|2|||
46696231|NCT01239732|82910677|FG000|Overall Study|Investigator's decision|4|||
46696232|NCT01239732|82910677|FG000|Overall Study|Treatment failure|2|||
46696233|NCT01239732|82910677|FG000|Overall Study|Other|19|||
46696234|NCT02227147|82910683|FG000|Controlled Treatment Period|Adverse Event|4|||
46696235|NCT02227147|82910684|FG001|Controlled Treatment Period|Adverse Event|3|||
46696236|NCT02227147|82910683|FG000|Controlled Treatment Period|Other|2|||
46696237|NCT02227147|82910684|FG001|Controlled Treatment Period|Other|0|||
46696238|NCT02227147|82910683|FG000|Follow-up Period|Other|3|||
46696239|NCT02227147|82910684|FG001|Follow-up Period|Other|5|||
46696240|NCT00948025|82910696|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
46696241|NCT00948025|82910697|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
46696242|NCT00948025|82910696|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
46696243|NCT00948025|82910697|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
46696244|NCT00948025|82910696|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
46696245|NCT00948025|82910697|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
46696246|NCT00947011|82910704|FG000|Overall Study|Study was terminated,PI left institution|12|||
46696247|NCT01239342|82910712|FG000|Overall Study|Adverse Event|1|||
46696248|NCT01239342|82910713|FG001|Overall Study|Adverse Event|0|||
46696249|NCT01239342|82910712|FG000|Overall Study|Withdrawal by Subject|1|||
46696250|NCT01239342|82910713|FG001|Overall Study|Withdrawal by Subject|5|||
46696251|NCT01239342|82910712|FG000|Overall Study|Reason Unknown|1|||
46696252|NCT01239342|82910713|FG001|Overall Study|Reason Unknown|1|||
46696253|NCT00946309|82910721|FG000|Overall Study|Protocol Violation|1|||
46696254|NCT00946309|82910722|FG001|Overall Study|Protocol Violation|0|||
46696255|NCT00946309|82910721|FG000|Overall Study|Lost to Follow-up|0|||
46696256|NCT00946309|82910722|FG001|Overall Study|Lost to Follow-up|1|||
46696257|NCT00946309|82910721|FG000|Overall Study|Procedure cancelled/discontinued|0|||
46696258|NCT00946309|82910722|FG001|Overall Study|Procedure cancelled/discontinued|3|||
46696259|NCT01236534|82910731|FG000|Overall Study|Adverse Event|3|||
46696260|NCT01236534|82910732|FG001|Overall Study|Adverse Event|0|||
46696261|NCT01235598|82910740|FG000|Overall Study|Adverse Event|0|||
46696262|NCT01235598|82910741|FG001|Overall Study|Adverse Event|3|||
46859312|NCT00054132|83075254|FG000|Overall Study|Not Treated|1|||
46859313|NCT00053898|83075261|FG000|Overall Study|No follow-up data from any source|9|||
46859314|NCT00053898|83075262|FG001|Overall Study|No follow-up data from any source|12|||
46859315|NCT00053898|83075261|FG000|Overall Study|Follow-up from telephone contact only|5|||
46859316|NCT00053898|83075262|FG001|Overall Study|Follow-up from telephone contact only|1|||
46859317|NCT03256552|83075298|FG000|Overall Study|Protocol Violation|1|||
46859318|NCT03256552|83075298|FG000|Overall Study|Physician Decision|1|||
46859319|NCT03256552|83075298|FG000|Overall Study|Adverse Event|1|||
46859320|NCT03256552|83075298|FG000|Overall Study|Withdrawal by Subject|2|||
46859321|NCT00071058|83075308|FG000|Overall Study|brain tumor-removed from study|1|||
46859322|NCT00053352|83075315|FG000|Overall Study|Lost to Follow-up|0|||
46859323|NCT00053352|83075316|FG001|Overall Study|Lost to Follow-up|1|||
46696263|NCT01235598|82910740|FG000|Overall Study|Lack of Efficacy|0|||
46696264|NCT01235598|82910741|FG001|Overall Study|Lack of Efficacy|1|||
46696265|NCT01235598|82910740|FG000|Overall Study|Withdrawal by Subject|1|||
46696266|NCT01235598|82910741|FG001|Overall Study|Withdrawal by Subject|0|||
46696267|NCT01235442|82910750|FG000|Overall Study|Lost to Follow-up|12|||
46696268|NCT01235442|82910751|FG001|Overall Study|Lost to Follow-up|10|||
46696269|NCT01235442|82910750|FG000|Overall Study|Death|0|||
46696270|NCT01235442|82910751|FG001|Overall Study|Death|2|||
46859324|NCT00053352|83075315|FG000|Overall Study|Physician Decision|11|||
46696271|NCT01235442|82910750|FG000|Overall Study|Pregnancy|1|||
46696272|NCT01235442|82910751|FG001|Overall Study|Pregnancy|1|||
46859325|NCT00053352|83075316|FG001|Overall Study|Physician Decision|1|||
46859326|NCT00053352|83075315|FG000|Overall Study|Withdrawal by Subject|1|||
46859327|NCT00053352|83075316|FG001|Overall Study|Withdrawal by Subject|0|||
46696273|NCT01235442|82910750|FG000|Overall Study|Ineligibility determined|5|||
46696274|NCT01235442|82910751|FG001|Overall Study|Ineligibility determined|4|||
46696275|NCT01235442|82910750|FG000|Overall Study|Protocol Violation|3|||
46696276|NCT01235442|82910751|FG001|Overall Study|Protocol Violation|3|||
46696277|NCT01235442|82910750|FG000|Overall Study|Adverse Event|4|||
46696278|NCT01235442|82910751|FG001|Overall Study|Adverse Event|6|||
46696279|NCT01235442|82910750|FG000|Overall Study|Withdrawal by Subject|15|||
46696280|NCT01235442|82910751|FG001|Overall Study|Withdrawal by Subject|9|||
46696281|NCT01235442|82910750|FG000|Overall Study|Lack of Efficacy|1|||
46696282|NCT01235442|82910751|FG001|Overall Study|Lack of Efficacy|3|||
46696283|NCT01235442|82910750|FG000|Overall Study|Noncompliance|1|||
46696284|NCT01235442|82910751|FG001|Overall Study|Noncompliance|2|||
46696285|NCT01235442|82910750|FG000|Overall Study|Administrative decision|1|||
46696286|NCT01235442|82910751|FG001|Overall Study|Administrative decision|2|||
46696287|NCT01235442|82910750|FG000|Overall Study|Other unspecified|1|||
46696288|NCT01235442|82910751|FG001|Overall Study|Other unspecified|2|||
46696289|NCT01163253|82910759|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
46696290|NCT01163253|82910760|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
46696291|NCT01163253|82910759|FG000|Overall Study|Study Terminated by Sponsor|978|||
46696292|NCT01163253|82910760|FG001|Overall Study|Study Terminated by Sponsor|349|||
46696293|NCT01163253|82910759|FG000|Overall Study|Protocol Violation|43|||
46696294|NCT01163253|82910760|FG001|Overall Study|Protocol Violation|12|||
46696295|NCT01163253|82910759|FG000|Overall Study|Withdrawal by Subject|199|||
46696296|NCT01163253|82910760|FG001|Overall Study|Withdrawal by Subject|50|||
46696297|NCT01163253|82910759|FG000|Overall Study|Medication Error|1|||
46696298|NCT01163253|82910760|FG001|Overall Study|Medication Error|0|||
46696299|NCT01163253|82910759|FG000|Overall Study|Lost to Follow-up|125|||
46696300|NCT01163253|82910760|FG001|Overall Study|Lost to Follow-up|23|||
46696301|NCT01163253|82910759|FG000|Overall Study|Insufficient Clinical Response|423|||
46696302|NCT01163253|82910760|FG001|Overall Study|Insufficient Clinical Response|29|||
46696303|NCT01163253|82910759|FG000|Overall Study|Adverse Event|300|||
46696304|NCT01163253|82910760|FG001|Overall Study|Adverse Event|78|||
46696305|NCT01163253|82910759|FG000|Overall Study|Death|17|||
46696306|NCT01163253|82910760|FG001|Overall Study|Death|5|||
46696307|NCT01163253|82910759|FG000|Overall Study|Ongoing|13|||
46696308|NCT01163253|82910760|FG001|Overall Study|Ongoing|4|||
46696309|NCT01163253|82910759|FG000|Overall Study|Other Unspecified|170|||
46696310|NCT01163253|82910760|FG001|Overall Study|Other Unspecified|34|||
46859328|NCT00053352|83075315|FG000|Overall Study|Ineligible|8|||
46859329|NCT00053352|83075316|FG001|Overall Study|Ineligible|8|||
46859330|NCT00053352|83075315|FG000|Overall Study|Disease at new site|1|||
46859331|NCT00053352|83075316|FG001|Overall Study|Disease at new site|0|||
46859332|NCT03245398|83075325|FG000|Overall Study|Travelled to another island|1|||
46859333|NCT03245398|83075326|FG001|Overall Study|Travelled to another island|0|||
46859334|NCT03244618|83075336|FG000|Overall Study|Lost to Follow-up|3|||
46859335|NCT03244618|83075337|FG001|Overall Study|Lost to Follow-up|4|||
46859336|NCT03244618|83075336|FG000|Overall Study|Protocol Violation|4|||
46859337|NCT03244618|83075337|FG001|Overall Study|Protocol Violation|3|||
46696311|NCT01162863|82910769|FG000|Overall Study|Lack of Efficacy|1|||
46696312|NCT01162863|82910770|FG001|Overall Study|Lack of Efficacy|0|||
46696313|NCT01162863|82910771|FG002|Overall Study|Lack of Efficacy|0|||
46696314|NCT01162863|82910769|FG000|Overall Study|Adverse Event|0|||
46696315|NCT01162863|82910770|FG001|Overall Study|Adverse Event|1|||
46859338|NCT03244618|83075336|FG000|Overall Study|Withdrawal by Subject|0|||
46859339|NCT03244618|83075337|FG001|Overall Study|Withdrawal by Subject|2|||
46859340|NCT00052962|83075345|FG000|Overall Study|Not evaluable|0|||
46859341|NCT00052962|83075346|FG001|Overall Study|Not evaluable|2|||
46859342|NCT00052962|83075345|FG000|Overall Study|Not randomized/not evaluable|1|||
46859343|NCT00052962|83075346|FG001|Overall Study|Not randomized/not evaluable|0|||
46859344|NCT00051636|83075354|FG000|Period 1 - Core|Adverse Event|2|||
46859345|NCT00051636|83075355|FG001|Period 1 - Core|Adverse Event|2|||
46859346|NCT00051636|83075354|FG000|Period 1 - Core|Protocol Violation|1|||
46859347|NCT00051636|83075355|FG001|Period 1 - Core|Protocol Violation|0|||
46859348|NCT00051636|83075354|FG000|Period 1 - Core|Withdrawal by Subject|1|||
46859349|NCT00051636|83075355|FG001|Period 1 - Core|Withdrawal by Subject|2|||
46859350|NCT00051636|83075354|FG000|Period 1 - Core|Lost to Follow-up|0|||
46859351|NCT00051636|83075355|FG001|Period 1 - Core|Lost to Follow-up|2|||
46859352|NCT00051636|83075354|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
46696316|NCT01162863|82910771|FG002|Overall Study|Adverse Event|0|||
46696317|NCT01162473|82910781|FG000|Overall Study|Adverse Event|2|||
46696318|NCT01162473|82910782|FG001|Overall Study|Adverse Event|1|||
46696319|NCT01162473|82910781|FG000|Overall Study|Withdrawal by Subject|0|||
46696320|NCT01162473|82910782|FG001|Overall Study|Withdrawal by Subject|4|||
46696321|NCT01162239|82910792|FG000|Treatment Phase|Withdrawal by Subject|1|||
46696322|NCT01162239|82910793|FG001|Treatment Phase|Withdrawal by Subject|3|||
46696323|NCT01162239|82910794|FG002|Treatment Phase|Withdrawal by Subject|2|||
46859353|NCT00051636|83075355|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
46859354|NCT00051636|83075354|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
46859355|NCT00051636|83075355|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
46859356|NCT00051636|83075354|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
46859357|NCT00051636|83075355|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
46859358|NCT00051636|83075354|FG000|Period 2- Extended Observation Period|Death|4|||
46859359|NCT00051636|83075355|FG001|Period 2- Extended Observation Period|Death|5|||
46859360|NCT00051636|83075354|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
46859361|NCT00051636|83075355|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
46859362|NCT03255382|83075363|FG000|Overall Study|Adverse Event|3|||
46859363|NCT03255382|83075364|FG001|Overall Study|Adverse Event|0|||
46859364|NCT03255382|83075363|FG000|Overall Study|Lost to Follow-up|2|||
46859365|NCT03255382|83075364|FG001|Overall Study|Lost to Follow-up|0|||
46859366|NCT03255382|83075363|FG000|Overall Study|Withdrawal by Subject|2|||
46859367|NCT03255382|83075364|FG001|Overall Study|Withdrawal by Subject|0|||
46859368|NCT03255382|83075363|FG000|Overall Study|Other|6|||
46859369|NCT03255382|83075364|FG001|Overall Study|Other|0|||
46859370|NCT03254602|83075371|FG000|Overall Study|Lost to Follow-up|4|||
46859371|NCT00038142|83075377|FG000|Overall Study|Ineligible|1|||
46859372|NCT00038142|83075378|FG001|Overall Study|Ineligible|0|||
46859373|NCT00038142|83075377|FG000|Overall Study|Progressive Disease|11|||
46859374|NCT00038142|83075378|FG001|Overall Study|Progressive Disease|7|||
46859375|NCT00038142|83075377|FG000|Overall Study|Death|1|||
46859376|NCT00038142|83075378|FG001|Overall Study|Death|0|||
46859377|NCT00038142|83075377|FG000|Overall Study|Adverse Event|1|||
46859378|NCT00038142|83075378|FG001|Overall Study|Adverse Event|0|||
46859379|NCT00038142|83075377|FG000|Overall Study|Unknown Reason|8|||
46859380|NCT00038142|83075378|FG001|Overall Study|Unknown Reason|0|||
46859381|NCT00366899|83075386|FG000|Infant Series|Withdrawal by Subject|4|||
46859382|NCT00366899|83075387|FG001|Infant Series|Withdrawal by Subject|7|||
46859383|NCT00366899|83075386|FG000|Infant Series|Protocol Violation|2|||
46859384|NCT00366899|83075387|FG001|Infant Series|Protocol Violation|1|||
46859385|NCT00366899|83075386|FG000|Infant Series|Failed to return|1|||
46859386|NCT00366899|83075387|FG001|Infant Series|Failed to return|1|||
46859387|NCT00366899|83075386|FG000|Infant Series|Lost to Follow-up|0|||
46859388|NCT00366899|83075387|FG001|Infant Series|Lost to Follow-up|2|||
46696324|NCT01162239|82910795|FG003|Treatment Phase|Withdrawal by Subject|3|||
46696325|NCT01162239|82910792|FG000|Treatment Phase|Death|0|||
46696326|NCT01162239|82910793|FG001|Treatment Phase|Death|0|||
46696327|NCT01162239|82910794|FG002|Treatment Phase|Death|0|||
46696328|NCT01162239|82910795|FG003|Treatment Phase|Death|1|||
46696329|NCT01162239|82910792|FG000|Treatment Phase|Lost to Follow-up|5|||
46696330|NCT01162239|82910793|FG001|Treatment Phase|Lost to Follow-up|4|||
46696331|NCT01162239|82910794|FG002|Treatment Phase|Lost to Follow-up|2|||
46696332|NCT01162239|82910795|FG003|Treatment Phase|Lost to Follow-up|1|||
46696333|NCT01162239|82910792|FG000|Extended Follow-up|Lost to Follow-up|8|||
46696334|NCT01162239|82910793|FG001|Extended Follow-up|Lost to Follow-up|13|||
46696335|NCT01162239|82910794|FG002|Extended Follow-up|Lost to Follow-up|8|||
46696336|NCT01162239|82910795|FG003|Extended Follow-up|Lost to Follow-up|6|||
46696337|NCT01161537|82910806|FG000|Part B|Withdrawal by Subject|2|||
46696338|NCT01234350|82910817|FG000|Overall Study|Adverse Event|277|||
46696339|NCT01234350|82910818|FG001|Overall Study|Adverse Event|92|||
46696340|NCT01234350|82910817|FG000|Overall Study|Withdrawal by Subject|61|||
46696341|NCT01234350|82910818|FG001|Overall Study|Withdrawal by Subject|36|||
46696342|NCT01234350|82910817|FG000|Overall Study|Lost to Follow-up|115|||
46696343|NCT01234350|82910818|FG001|Overall Study|Lost to Follow-up|47|||
46696344|NCT01234350|82910817|FG000|Overall Study|Covers a diverse set of reasons|234|||
46859389|NCT00366899|83075386|FG000|Infant Series|Adverse Event|0|||
46859390|NCT00366899|83075387|FG001|Infant Series|Adverse Event|1|||
46859391|NCT00366899|83075386|FG000|Infant Series|Physician Decision|1|||
46859392|NCT00366899|83075387|FG001|Infant Series|Physician Decision|0|||
46859393|NCT00366899|83075386|FG000|Infant Series|Randomized but not consented|1|||
46859394|NCT00366899|83075387|FG001|Infant Series|Randomized but not consented|0|||
46696345|NCT01234350|82910818|FG001|Overall Study|Covers a diverse set of reasons|92|||
46696346|NCT01233258|82910829|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
46859395|NCT00366899|83075386|FG000|After Infant Series|Lost to Follow-up|4|||
46859396|NCT00366899|83075387|FG001|After Infant Series|Lost to Follow-up|3|||
46859397|NCT00366899|83075386|FG000|After Infant Series|Withdrawal by Subject|1|||
46696347|NCT01233258|82910830|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
46859398|NCT00366899|83075387|FG001|After Infant Series|Withdrawal by Subject|4|||
46859399|NCT00366899|83075386|FG000|After Infant Series|Adverse Event|1|||
46859400|NCT00366899|83075387|FG001|After Infant Series|Adverse Event|2|||
46859401|NCT00366899|83075386|FG000|After Infant Series|Protocol Violation|1|||
46859402|NCT00366899|83075387|FG001|After Infant Series|Protocol Violation|0|||
46859403|NCT00366899|83075386|FG000|Toddler Dose|Withdrawal by Subject|1|||
46859404|NCT00366899|83075387|FG001|Toddler Dose|Withdrawal by Subject|1|||
46859405|NCT00366899|83075386|FG000|Toddler Dose|Protocol Violation|1|||
46859406|NCT00366899|83075387|FG001|Toddler Dose|Protocol Violation|0|||
46859407|NCT03254134|83075421|FG000|Overall Study|Not eligible patients|599|||
46859408|NCT03254134|83075422|FG001|Overall Study|Not eligible patients|3630|||
46859409|NCT00037830|83075431|FG000|Overall Study|Adverse Event|2|||
46859410|NCT00037830|83075432|FG001|Overall Study|Adverse Event|0|||
46859411|NCT00037830|83075433|FG002|Overall Study|Adverse Event|0|||
46859412|NCT00037830|83075431|FG000|Overall Study|Withdrawal by Subject|4|||
46859413|NCT00037830|83075432|FG001|Overall Study|Withdrawal by Subject|5|||
46859414|NCT00037830|83075433|FG002|Overall Study|Withdrawal by Subject|1|||
46859415|NCT00037830|83075431|FG000|Overall Study|Protocol Violation|2|||
46859416|NCT00037830|83075432|FG001|Overall Study|Protocol Violation|2|||
46859417|NCT00037830|83075433|FG002|Overall Study|Protocol Violation|0|||
46859418|NCT00037830|83075431|FG000|Overall Study|Unrelated Medical Problem|2|||
46859419|NCT00037830|83075432|FG001|Overall Study|Unrelated Medical Problem|0|||
46859420|NCT00037830|83075433|FG002|Overall Study|Unrelated Medical Problem|0|||
46859421|NCT03242434|83075443|FG000|Overall Study|Death|0|||
46859422|NCT03242434|83075444|FG001|Overall Study|Death|2|||
46859423|NCT02939014|83075453|FG000|Overall Study|Lost to Follow-up|1|||
46859424|NCT02939014|83075454|FG001|Overall Study|Lost to Follow-up|0|||
46859425|NCT02939014|83075453|FG000|Overall Study|Death|4|||
46859426|NCT02939014|83075454|FG001|Overall Study|Death|3|||
46859427|NCT00051558|83075463|FG000|Overall Study|Adverse Event|30|||
46859428|NCT00051558|83075464|FG001|Overall Study|Adverse Event|18|||
46859429|NCT00051558|83075463|FG000|Overall Study|Withdrawal by Subject|29|||
46859430|NCT00051558|83075464|FG001|Overall Study|Withdrawal by Subject|42|||
46859431|NCT00051558|83075463|FG000|Overall Study|Death|9|||
46859432|NCT00051558|83075464|FG001|Overall Study|Death|15|||
46859433|NCT00051558|83075463|FG000|Overall Study|Lost to Follow-up|4|||
46859434|NCT00051558|83075464|FG001|Overall Study|Lost to Follow-up|13|||
46859435|NCT00051558|83075463|FG000|Overall Study|Protocol Violation|3|||
46859436|NCT00051558|83075464|FG001|Overall Study|Protocol Violation|4|||
46859437|NCT00051558|83075463|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
46859438|NCT00051558|83075464|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
46696348|NCT01233258|82910831|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
46696349|NCT01233258|82910832|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
46696350|NCT01233258|82910833|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
46696351|NCT01233258|82910834|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
46696352|NCT01233258|82910829|FG000|First Intervention (6 Months)|Protocol Violation|0|||
46696353|NCT01233258|82910830|FG001|First Intervention (6 Months)|Protocol Violation|0|||
46696354|NCT01233258|82910831|FG002|First Intervention (6 Months)|Protocol Violation|1|||
46696355|NCT01233258|82910832|FG003|First Intervention (6 Months)|Protocol Violation|0|||
46696356|NCT01233258|82910833|FG004|First Intervention (6 Months)|Protocol Violation|0|||
46859439|NCT00051558|83075463|FG000|Overall Study|Sponsor Decision|6|||
46859440|NCT00051558|83075464|FG001|Overall Study|Sponsor Decision|1|||
46859441|NCT00051558|83075463|FG000|Overall Study|Other|2|||
46859442|NCT00051558|83075464|FG001|Overall Study|Other|1|||
46859443|NCT00051558|83075463|FG000|Overall Study|Significant Lab Value|2|||
46859444|NCT00051558|83075464|FG001|Overall Study|Significant Lab Value|0|||
46859445|NCT00051558|83075463|FG000|Overall Study|Physician Decision|5|||
46859446|NCT00051558|83075464|FG001|Overall Study|Physician Decision|0|||
46859447|NCT03251482|83075475|FG000|Overall Study|Withdrawal by Subject|0|||
46859448|NCT03251482|83075476|FG001|Overall Study|Withdrawal by Subject|1|||
46859449|NCT03251482|83075477|FG002|Overall Study|Withdrawal by Subject|0|||
46859450|NCT03251482|83075478|FG003|Overall Study|Withdrawal by Subject|0|||
46859451|NCT03251482|83075479|FG004|Overall Study|Withdrawal by Subject|0|||
46859452|NCT03249454|83075491|FG000|Overall Study|Withdrawal by Subject|0|||
46859453|NCT03249454|83075492|FG001|Overall Study|Withdrawal by Subject|0|||
46696357|NCT01233258|82910834|FG005|First Intervention (6 Months)|Protocol Violation|0|||
46859454|NCT03249454|83075493|FG002|Overall Study|Withdrawal by Subject|0|||
46859455|NCT03249454|83075494|FG003|Overall Study|Withdrawal by Subject|0|||
46859456|NCT03249454|83075495|FG004|Overall Study|Withdrawal by Subject|0|||
46859457|NCT03249454|83075496|FG005|Overall Study|Withdrawal by Subject|0|||
46859458|NCT03249454|83075497|FG006|Overall Study|Withdrawal by Subject|0|||
46859459|NCT03249454|83075498|FG007|Overall Study|Withdrawal by Subject|0|||
46859460|NCT03249454|83075499|FG008|Overall Study|Withdrawal by Subject|0|||
46859461|NCT03249454|83075500|FG009|Overall Study|Withdrawal by Subject|1|||
46859462|NCT03249454|83075501|FG010|Overall Study|Withdrawal by Subject|1|||
46859463|NCT03732248|83075514|FG000|Overall Study|Withdrawal by Subject|1|||
46859464|NCT03732248|83075515|FG001|Overall Study|Withdrawal by Subject|0|||
46859465|NCT00310037|83075523|FG000|Overall Study|Adverse Event|7|||
46859466|NCT00310037|83075524|FG001|Overall Study|Adverse Event|14|||
46859467|NCT00310037|83075523|FG000|Overall Study|Withdrawal by Subject|4|||
46859468|NCT00310037|83075524|FG001|Overall Study|Withdrawal by Subject|3|||
46859469|NCT00310037|83075523|FG000|Overall Study|Progression|6|||
46859470|NCT00310037|83075524|FG001|Overall Study|Progression|0|||
46859471|NCT00310037|83075523|FG000|Overall Study|Non-protocol treatment|1|||
46859472|NCT00310037|83075524|FG001|Overall Study|Non-protocol treatment|0|||
46859473|NCT00309959|83075530|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
46859474|NCT03238924|83075541|FG000|Overall Study|Withdrawal by Subject|2|||
46859475|NCT03238924|83075542|FG001|Overall Study|Withdrawal by Subject|2|||
46859476|NCT03247816|83075548|FG000|Overall Study|Adverse Event|12|||
46859477|NCT03247816|83075548|FG000|Overall Study|Physician Decision|3|||
46859478|NCT03247816|83075548|FG000|Overall Study|Lack of Efficacy|1|||
46859479|NCT03247816|83075548|FG000|Overall Study|Lost to Follow-up|10|||
46696358|NCT01233258|82910829|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
46696359|NCT01233258|82910830|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
46696360|NCT01233258|82910831|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
46696361|NCT01233258|82910832|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
46696362|NCT01233258|82910833|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
46696363|NCT01233258|82910834|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
46696364|NCT01232868|82910851|FG000|Overall Study|Lost to Follow-up|2|||
46696365|NCT01232868|82910852|FG001|Overall Study|Lost to Follow-up|4|||
46696366|NCT01232790|82910858|FG000|Randomization|Withdrawal by Subject|2|||
46696367|NCT01232790|82910859|FG001|Randomization|Withdrawal by Subject|0|||
46696368|NCT01232790|82910858|FG000|Randomization|Protocol Violation|0|||
46696369|NCT01232790|82910859|FG001|Randomization|Protocol Violation|1|||
46696370|NCT01232790|82910858|FG000|Randomization|Physician Decision|0|||
46696371|NCT01232790|82910859|FG001|Randomization|Physician Decision|1|||
46696372|NCT01232790|82910858|FG000|Initial Assessment|Withdrawal by Subject|0|||
46696373|NCT01232790|82910859|FG001|Initial Assessment|Withdrawal by Subject|1|||
46696374|NCT01232790|82910858|FG000|First Crossover|Withdrawal by Subject|1|||
46696375|NCT01232790|82910859|FG001|First Crossover|Withdrawal by Subject|0|||
46696376|NCT01232790|82910858|FG000|Second Crossover|Withdrawal by Subject|1|||
46696377|NCT01232790|82910859|FG001|Second Crossover|Withdrawal by Subject|2|||
46696378|NCT01232556|82910877|FG000|Overall Study|Withdrawal by Subject|21|||
46696379|NCT01232556|82910878|FG001|Overall Study|Withdrawal by Subject|17|||
46696380|NCT01232556|82910877|FG000|Overall Study|Death|97|||
46696381|NCT01232556|82910878|FG001|Overall Study|Death|97|||
46696382|NCT01232556|82910877|FG000|Overall Study|Lost to Follow-up|0|||
46859480|NCT03247816|83075548|FG000|Overall Study|Missing Feraccru stop date|3|||
46859481|NCT00333359|83075566|FG000|Overall Study|Adverse Event|29|||
46696383|NCT01232556|82910878|FG001|Overall Study|Lost to Follow-up|2|||
46696384|NCT01232556|82910877|FG000|Overall Study|Terminated by Sponsor|35|||
46696385|NCT01232556|82910878|FG001|Overall Study|Terminated by Sponsor|51|||
46696386|NCT01232556|82910877|FG000|Overall Study|Other|6|||
46696387|NCT01232556|82910878|FG001|Overall Study|Other|4|||
46859482|NCT00333359|83075567|FG001|Overall Study|Adverse Event|35|||
46859483|NCT00333359|83075566|FG000|Overall Study|Withdrawal by Subject|19|||
46859484|NCT00333359|83075567|FG001|Overall Study|Withdrawal by Subject|37|||
46859485|NCT00333359|83075566|FG000|Overall Study|Physician Decision|2|||
46859486|NCT00333359|83075567|FG001|Overall Study|Physician Decision|2|||
46859487|NCT00333359|83075566|FG000|Overall Study|Protocol Non-compliance|2|||
46859488|NCT00333359|83075567|FG001|Overall Study|Protocol Non-compliance|8|||
46859489|NCT00333359|83075566|FG000|Overall Study|Lost to Follow-up|15|||
46859490|NCT00333359|83075567|FG001|Overall Study|Lost to Follow-up|25|||
46859491|NCT00333359|83075566|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
46859492|NCT00333359|83075567|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
46859493|NCT00333359|83075566|FG000|Overall Study|Treatment Failure|3|||
46859494|NCT00333359|83075567|FG001|Overall Study|Treatment Failure|8|||
46859495|NCT00333359|83075566|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
46859496|NCT00333359|83075567|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
46696388|NCT00946153|82910889|FG000|Phase 2|Adverse Event|0|||
46696389|NCT00946153|82910890|FG001|Phase 2|Adverse Event|0|||
46696390|NCT00946153|82910891|FG002|Phase 2|Adverse Event|0|||
46859497|NCT03246724|83075579|FG000|Overall Study|Withdrawal by Subject|5|||
46859498|NCT03246724|83075580|FG001|Overall Study|Withdrawal by Subject|2|||
46859499|NCT03246724|83075581|FG002|Overall Study|Withdrawal by Subject|4|||
46859500|NCT03246724|83075582|FG003|Overall Study|Withdrawal by Subject|2|||
46859501|NCT03246724|83075579|FG000|Overall Study|Ineligible on day of surgery|7|||
46859502|NCT03246724|83075580|FG001|Overall Study|Ineligible on day of surgery|2|||
46859503|NCT03246724|83075581|FG002|Overall Study|Ineligible on day of surgery|0|||
46859504|NCT03246724|83075582|FG003|Overall Study|Ineligible on day of surgery|3|||
46859505|NCT03246724|83075579|FG000|Overall Study|Study completed before surgical date|2|||
46859506|NCT03246724|83075580|FG001|Overall Study|Study completed before surgical date|1|||
46859507|NCT03246724|83075581|FG002|Overall Study|Study completed before surgical date|8|||
46859508|NCT03246724|83075582|FG003|Overall Study|Study completed before surgical date|1|||
46859509|NCT03246724|83075579|FG000|Overall Study|Transferred to other arm|0|||
46859510|NCT03246724|83075580|FG001|Overall Study|Transferred to other arm|0|||
46859511|NCT03246724|83075581|FG002|Overall Study|Transferred to other arm|1|||
46859512|NCT03246724|83075582|FG003|Overall Study|Transferred to other arm|0|||
46859513|NCT03246724|83075579|FG000|Overall Study|Unable to obtain medication timely|0|||
46859514|NCT03246724|83075580|FG001|Overall Study|Unable to obtain medication timely|2|||
46859515|NCT03246724|83075581|FG002|Overall Study|Unable to obtain medication timely|2|||
46859516|NCT03246724|83075582|FG003|Overall Study|Unable to obtain medication timely|1|||
46859517|NCT03246724|83075579|FG000|Overall Study|Re-consented to participate|0|||
46859518|NCT03246724|83075580|FG001|Overall Study|Re-consented to participate|0|||
46696391|NCT00946153|82910892|FG003|Phase 2|Adverse Event|0|||
46696392|NCT00946153|82910893|FG004|Phase 2|Adverse Event|6|||
46859519|NCT03246724|83075581|FG002|Overall Study|Re-consented to participate|0|||
46696393|NCT00946153|82910889|FG000|Phase 2|Need more reduction of dose|0|||
46859520|NCT03246724|83075582|FG003|Overall Study|Re-consented to participate|1|||
46859521|NCT03246646|83075594|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
46859522|NCT03246646|83075595|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
46859523|NCT03246646|83075594|FG000|Overall Study|Withdrawal by Subject|3|||
46859524|NCT03246646|83075595|FG001|Overall Study|Withdrawal by Subject|0|||
46859525|NCT03246646|83075594|FG000|Overall Study|Lost to Follow-up|7|||
46859526|NCT03246646|83075595|FG001|Overall Study|Lost to Follow-up|0|||
46859527|NCT01347112|83075603|FG000|Overall Study|Withdrawal by Subject|1|||
46859528|NCT01347112|83075604|FG001|Overall Study|Withdrawal by Subject|7|||
46859529|NCT01347112|83075603|FG000|Overall Study|Lost to Follow-up|3|||
46859530|NCT01347112|83075604|FG001|Overall Study|Lost to Follow-up|5|||
46859531|NCT00308711|83075614|FG000|Overall Study|Withdrawal by Subject|1|||
46859532|NCT00308711|83075615|FG001|Overall Study|Withdrawal by Subject|0|||
46859533|NCT00308711|83075616|FG002|Overall Study|Withdrawal by Subject|1|||
46859534|NCT00308711|83075614|FG000|Overall Study|Protocol Violation|0|||
46859535|NCT00308711|83075615|FG001|Overall Study|Protocol Violation|1|||
46859536|NCT00308711|83075616|FG002|Overall Study|Protocol Violation|1|||
46859537|NCT00308711|83075614|FG000|Overall Study|Lost to Follow-up|0|||
46859538|NCT00308711|83075615|FG001|Overall Study|Lost to Follow-up|1|||
46859539|NCT00308711|83075616|FG002|Overall Study|Lost to Follow-up|0|||
46859540|NCT00308711|83075614|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
46859541|NCT00308711|83075615|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
46859542|NCT00308711|83075616|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
46859543|NCT00308711|83075614|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
46859544|NCT00308711|83075615|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
46696394|NCT00946153|82910890|FG001|Phase 2|Need more reduction of dose|0|||
46696395|NCT00946153|82910891|FG002|Phase 2|Need more reduction of dose|0|||
46696396|NCT00946153|82910892|FG003|Phase 2|Need more reduction of dose|0|||
46696397|NCT00946153|82910893|FG004|Phase 2|Need more reduction of dose|2|||
46696398|NCT00946153|82910889|FG000|Phase 2|Physician Decision|0|||
46696399|NCT00946153|82910890|FG001|Phase 2|Physician Decision|0|||
46696400|NCT00946153|82910891|FG002|Phase 2|Physician Decision|0|||
46696401|NCT00946153|82910892|FG003|Phase 2|Physician Decision|0|||
46696402|NCT00946153|82910893|FG004|Phase 2|Physician Decision|1|||
46696403|NCT00946153|82910889|FG000|Phase 2|14 days washout for recovery due to AE|0|||
46696404|NCT00946153|82910890|FG001|Phase 2|14 days washout for recovery due to AE|0|||
46696405|NCT00946153|82910891|FG002|Phase 2|14 days washout for recovery due to AE|0|||
46696406|NCT00946153|82910892|FG003|Phase 2|14 days washout for recovery due to AE|0|||
46696407|NCT00946153|82910893|FG004|Phase 2|14 days washout for recovery due to AE|4|||
46696408|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
46859545|NCT00308711|83075616|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
46859546|NCT00308555|83075626|FG000|Overall Study|Withdrawal by Subject|1|||
46859547|NCT00308555|83075627|FG001|Overall Study|Withdrawal by Subject|0|||
46859548|NCT00308555|83075626|FG000|Overall Study|Physician Decision|2|||
46859549|NCT00308555|83075627|FG001|Overall Study|Physician Decision|0|||
46859550|NCT00050778|83075636|FG000|Overall Study|Adverse Event|13|||
46696409|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
46696410|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
46696411|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
46696412|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
46696413|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
46696414|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
46696415|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
46696416|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
46696417|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
46696418|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
46696419|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
46696420|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
46696421|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
46859551|NCT00050778|83075637|FG001|Overall Study|Adverse Event|3|||
46859552|NCT00050778|83075638|FG002|Overall Study|Adverse Event|2|||
46859553|NCT00050778|83075636|FG000|Overall Study|Death|0|||
46859554|NCT00050778|83075637|FG001|Overall Study|Death|1|||
46859555|NCT00050778|83075638|FG002|Overall Study|Death|1|||
46859556|NCT00050778|83075636|FG000|Overall Study|Lack of Efficacy|16|||
46859557|NCT00050778|83075637|FG001|Overall Study|Lack of Efficacy|2|||
46859558|NCT00050778|83075638|FG002|Overall Study|Lack of Efficacy|2|||
46859559|NCT00050778|83075636|FG000|Overall Study|Lost to Follow-up|0|||
46859560|NCT00050778|83075637|FG001|Overall Study|Lost to Follow-up|2|||
46859561|NCT00050778|83075638|FG002|Overall Study|Lost to Follow-up|4|||
46859562|NCT00050778|83075636|FG000|Overall Study|Physician Decision|3|||
46859563|NCT00050778|83075637|FG001|Overall Study|Physician Decision|0|||
46859564|NCT00050778|83075638|FG002|Overall Study|Physician Decision|2|||
46859565|NCT00050778|83075636|FG000|Overall Study|Protocol Violation|2|||
46859566|NCT00050778|83075637|FG001|Overall Study|Protocol Violation|0|||
46859567|NCT00050778|83075638|FG002|Overall Study|Protocol Violation|1|||
46859568|NCT00050778|83075636|FG000|Overall Study|Withdrawal by Subject|6|||
46859569|NCT00050778|83075637|FG001|Overall Study|Withdrawal by Subject|8|||
46859570|NCT00050778|83075638|FG002|Overall Study|Withdrawal by Subject|4|||
46696422|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
46696423|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
46696424|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
46696425|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
46696426|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
46696427|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
46982183|NCT02584855|83228301|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
46696428|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
46859571|NCT00050778|83075636|FG000|Overall Study|Randomized but not treated|4|||
46859572|NCT00050778|83075637|FG001|Overall Study|Randomized but not treated|5|||
46859573|NCT00050778|83075638|FG002|Overall Study|Randomized but not treated|2|||
46859574|NCT00050778|83075636|FG000|Overall Study|Familial and personal reasons|1|||
46859575|NCT00050778|83075637|FG001|Overall Study|Familial and personal reasons|0|||
46859576|NCT00050778|83075638|FG002|Overall Study|Familial and personal reasons|0|||
46859577|NCT00050622|83075648|FG000|Overall Study|Adverse Event|1|||
46859578|NCT00308087|83075674|FG000|Overall Study|Progressive Disease|19|||
46859579|NCT00308087|83075675|FG001|Overall Study|Progressive Disease|21|||
46859580|NCT00308087|83075674|FG000|Overall Study|Study Closure|11|||
46859581|NCT00308087|83075675|FG001|Overall Study|Study Closure|12|||
46859582|NCT00308087|83075674|FG000|Overall Study|Withdrawal by Subject|2|||
46859583|NCT00308087|83075675|FG001|Overall Study|Withdrawal by Subject|1|||
46859584|NCT00308087|83075674|FG000|Overall Study|Other|4|||
46859585|NCT00308087|83075675|FG001|Overall Study|Other|3|||
46859586|NCT00307931|83075681|FG000|Overall Study|Adverse Event|1|||
46859587|NCT02796170|83075687|FG000|Overall Study|Lost to Follow-up|3|||
46859588|NCT02796170|83075688|FG001|Overall Study|Lost to Follow-up|0|||
46859589|NCT00049842|83075696|FG000|Treatment Phase|Adverse Event|47|||
46859590|NCT00049842|83075697|FG001|Treatment Phase|Adverse Event|12|||
46859591|NCT00049842|83075696|FG000|Treatment Phase|Withdrawal by Subject|35|||
46859592|NCT00049842|83075697|FG001|Treatment Phase|Withdrawal by Subject|46|||
46859593|NCT00049842|83075696|FG000|Treatment Phase|Non-compliance with protocol|7|||
46859594|NCT00049842|83075697|FG001|Treatment Phase|Non-compliance with protocol|8|||
46859595|NCT00049842|83075696|FG000|Treatment Phase|Lost to Follow-up|4|||
46859596|NCT00049842|83075697|FG001|Treatment Phase|Lost to Follow-up|8|||
46859597|NCT00049842|83075696|FG000|Treatment Phase|Administrative|0|||
46859598|NCT00049842|83075697|FG001|Treatment Phase|Administrative|3|||
46859599|NCT00049842|83075696|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
46859600|NCT00049842|83075697|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
46859601|NCT00049842|83075696|FG000|Follow-up Phase|Adverse Event|6|||
46859602|NCT00049842|83075697|FG001|Follow-up Phase|Adverse Event|1|||
46859603|NCT00049842|83075696|FG000|Follow-up Phase|Other|1|||
46859604|NCT00049842|83075697|FG001|Follow-up Phase|Other|4|||
46859605|NCT00307151|83075707|FG000|Overall Study|Death|4|||
46859606|NCT00307151|83075708|FG001|Overall Study|Death|3|||
46859607|NCT00307151|83075709|FG002|Overall Study|Death|10|||
46859608|NCT00307151|83075710|FG003|Overall Study|Death|3|||
46859609|NCT00307151|83075707|FG000|Overall Study|Severe debilitation, unable to continue|1|||
46859610|NCT00307151|83075708|FG001|Overall Study|Severe debilitation, unable to continue|0|||
46859611|NCT00307151|83075709|FG002|Overall Study|Severe debilitation, unable to continue|0|||
46859612|NCT00307151|83075710|FG003|Overall Study|Severe debilitation, unable to continue|0|||
46859613|NCT00307151|83075707|FG000|Overall Study|Subject unable to get to clinic|1|||
46859614|NCT00307151|83075708|FG001|Overall Study|Subject unable to get to clinic|0|||
46859615|NCT00307151|83075709|FG002|Overall Study|Subject unable to get to clinic|6|||
46859616|NCT00307151|83075710|FG003|Overall Study|Subject unable to get to clinic|2|||
46859617|NCT00307151|83075707|FG000|Overall Study|Withdrew consent|0|||
46859618|NCT00307151|83075708|FG001|Overall Study|Withdrew consent|1|||
46859619|NCT00307151|83075709|FG002|Overall Study|Withdrew consent|1|||
46859620|NCT00307151|83075710|FG003|Overall Study|Withdrew consent|3|||
46859621|NCT00307151|83075707|FG000|Overall Study|Not willing to adhere to study reqs|2|||
46859622|NCT00307151|83075708|FG001|Overall Study|Not willing to adhere to study reqs|0|||
46859623|NCT00307151|83075709|FG002|Overall Study|Not willing to adhere to study reqs|2|||
46859624|NCT00307151|83075710|FG003|Overall Study|Not willing to adhere to study reqs|2|||
46859625|NCT00307151|83075707|FG000|Overall Study|Clinic unable to contact subject|3|||
46859626|NCT00307151|83075708|FG001|Overall Study|Clinic unable to contact subject|3|||
46859627|NCT00307151|83075709|FG002|Overall Study|Clinic unable to contact subject|1|||
46859628|NCT00307151|83075710|FG003|Overall Study|Clinic unable to contact subject|1|||
46859629|NCT02654132|83075722|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
46859630|NCT02654132|83075723|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
46859631|NCT02654132|83075722|FG000|Treatment Period|Disease progression|43|||
46859632|NCT02654132|83075723|FG001|Treatment Period|Disease progression|38|||
46859633|NCT02654132|83075722|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
46859634|NCT02654132|83075723|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
46859635|NCT02654132|83075722|FG000|Treatment Period|Other reasons|4|||
46859636|NCT02654132|83075723|FG001|Treatment Period|Other reasons|2|||
46859637|NCT02654132|83075722|FG000|Treatment Period|Study drug toxicity|2|||
46859638|NCT02654132|83075723|FG001|Treatment Period|Study drug toxicity|2|||
46859639|NCT02654132|83075722|FG000|Treatment Period|Withdrawal by Subject|2|||
46859640|NCT02654132|83075723|FG001|Treatment Period|Withdrawal by Subject|1|||
46859641|NCT02654132|83075722|FG000|Treatment Period|Maximum Clinical Benefit|0|||
46859642|NCT02654132|83075723|FG001|Treatment Period|Maximum Clinical Benefit|2|||
46859643|NCT02654132|83075722|FG000|Treatment Period|Participant request to discontinue|2|||
46859644|NCT02654132|83075723|FG001|Treatment Period|Participant request to discontinue|0|||
46859645|NCT02654132|83075722|FG000|Treatment Period|Administrative reasons by sponsor|0|||
46859646|NCT02654132|83075723|FG001|Treatment Period|Administrative reasons by sponsor|1|||
46859647|NCT02654132|83075722|FG000|Treatment Period|Death|1|||
46859648|NCT02654132|83075723|FG001|Treatment Period|Death|0|||
46859649|NCT03241342|83075732|FG000|Overall Study|Adverse Event|5|||
46859650|NCT03241342|83075733|FG001|Overall Study|Adverse Event|8|||
46859651|NCT03241342|83075734|FG002|Overall Study|Adverse Event|4|||
46859652|NCT03241342|83075732|FG000|Overall Study|Lack of Efficacy|0|||
46859653|NCT03241342|83075733|FG001|Overall Study|Lack of Efficacy|0|||
46859654|NCT03241342|83075734|FG002|Overall Study|Lack of Efficacy|1|||
46859655|NCT03241342|83075732|FG000|Overall Study|noncompliance with study drug|2|||
46859656|NCT03241342|83075733|FG001|Overall Study|noncompliance with study drug|1|||
46859657|NCT03241342|83075734|FG002|Overall Study|noncompliance with study drug|1|||
46859658|NCT03241342|83075732|FG000|Overall Study|sponsor decision|0|||
46859659|NCT03241342|83075733|FG001|Overall Study|sponsor decision|1|||
46859660|NCT03241342|83075734|FG002|Overall Study|sponsor decision|2|||
46859661|NCT03241342|83075732|FG000|Overall Study|not reported|15|||
46859662|NCT03241342|83075733|FG001|Overall Study|not reported|21|||
46859663|NCT03241342|83075734|FG002|Overall Study|not reported|19|||
46859664|NCT00306995|83075749|FG000|Study Part I|Withdrawal by Subject|0|||
46859665|NCT00306995|83075750|FG001|Study Part I|Withdrawal by Subject|0|||
46859666|NCT00306995|83075751|FG002|Study Part I|Withdrawal by Subject|0|||
46859667|NCT00306995|83075752|FG003|Study Part I|Withdrawal by Subject|0|||
46859668|NCT00306995|83075753|FG004|Study Part I|Withdrawal by Subject|0|||
46859669|NCT00306995|83075754|FG005|Study Part I|Withdrawal by Subject|0|||
46859670|NCT00306995|83075755|FG006|Study Part I|Withdrawal by Subject|1|||
46859671|NCT00306995|83075749|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
46859672|NCT00306995|83075750|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
46859673|NCT00306995|83075751|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
46859674|NCT00306995|83075752|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
46859675|NCT00306995|83075753|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
46859676|NCT00306995|83075754|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
46859677|NCT00306995|83075755|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
46859678|NCT00121108|83075802|FG000|Overall Study|Lost to Follow-up|10|||
46859679|NCT00121108|83075803|FG001|Overall Study|Lost to Follow-up|22|||
46859680|NCT00121108|83075802|FG000|Overall Study|Withdrawal by Subject|106|||
46859681|NCT00121108|83075803|FG001|Overall Study|Withdrawal by Subject|195|||
46859682|NCT00121108|83075802|FG000|Overall Study|Death|5|||
46859683|NCT00121108|83075803|FG001|Overall Study|Death|8|||
46859684|NCT02387996|83075810|FG000|Overall Study|Disease Progression|167|||
46859685|NCT02387996|83075810|FG000|Overall Study|Study Drug Toxicity|31|||
46859686|NCT02387996|83075810|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
46859687|NCT02387996|83075810|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
46859688|NCT02387996|83075810|FG000|Overall Study|Subject Withdrew Consent|5|||
46859689|NCT02387996|83075810|FG000|Overall Study|Lost to Follow-up|1|||
46859690|NCT02387996|83075810|FG000|Overall Study|Poor/Non-Compliance|1|||
46859691|NCT02387996|83075810|FG000|Overall Study|Other Reasons|5|||
46859692|NCT02387996|83075810|FG000|Overall Study|Death|1|||
46859693|NCT03212326|83075814|FG000|Overall Study|Physician Decision|4|||
46859694|NCT03229486|83075853|FG000|Overall Study|Protocol Violation|0|||
46859695|NCT03229486|83075854|FG001|Overall Study|Protocol Violation|1|||
46859696|NCT01779050|83075862|FG000|Overall Study|Withdrawal by Subject|1|||
46859697|NCT01779050|83075863|FG001|Overall Study|Withdrawal by Subject|0|||
46859698|NCT00306527|83075873|FG000|Overall Study|Lost to Follow-up|3|||
46859699|NCT00306527|83075874|FG001|Overall Study|Lost to Follow-up|4|||
46859700|NCT00306527|83075875|FG002|Overall Study|Lost to Follow-up|3|||
46859701|NCT00306527|83075876|FG003|Overall Study|Lost to Follow-up|0|||
46859702|NCT00306527|83075873|FG000|Overall Study|Withdrawal by Subject|2|||
46859703|NCT00306527|83075874|FG001|Overall Study|Withdrawal by Subject|3|||
46859704|NCT00306527|83075875|FG002|Overall Study|Withdrawal by Subject|0|||
46859705|NCT00306527|83075876|FG003|Overall Study|Withdrawal by Subject|3|||
46859706|NCT00306527|83075873|FG000|Overall Study|Adverse Event|0|||
46859707|NCT00306527|83075874|FG001|Overall Study|Adverse Event|0|||
46859708|NCT00306527|83075875|FG002|Overall Study|Adverse Event|1|||
46859709|NCT00306527|83075876|FG003|Overall Study|Adverse Event|1|||
46859710|NCT00306527|83075873|FG000|Overall Study|Death|1|||
46859711|NCT00306527|83075874|FG001|Overall Study|Death|0|||
46859712|NCT00306527|83075875|FG002|Overall Study|Death|1|||
46859713|NCT00306527|83075876|FG003|Overall Study|Death|2|||
46859714|NCT00306293|83075890|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
46859715|NCT00306293|83075891|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
46859716|NCT00306293|83075890|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
46859717|NCT00306293|83075891|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
46859718|NCT00306293|83075890|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
46859719|NCT00306293|83075891|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
46859720|NCT00306293|83075890|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
46859721|NCT00306293|83075891|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
46696429|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
46696430|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
46696431|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
46696432|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
46696433|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
46696434|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
46696435|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
46696436|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
46696437|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
46696438|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
46696439|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
46696440|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
46696441|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
46696442|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
46696443|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
46696444|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
46696445|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
46696446|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
46696447|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
46696448|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
46696449|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
46696450|NCT01160289|82910915|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
46696451|NCT01160289|82910916|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
46696452|NCT01160289|82910917|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
46696453|NCT01160289|82910918|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
46696454|NCT01160289|82910919|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
46696455|NCT01160289|82910920|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
46696456|NCT01160289|82910915|FG000|Post-Randomization Period|Adverse Event|0|||
46696457|NCT01160289|82910916|FG001|Post-Randomization Period|Adverse Event|4|||
46696458|NCT01160289|82910917|FG002|Post-Randomization Period|Adverse Event|4|||
46696459|NCT01160289|82910918|FG003|Post-Randomization Period|Adverse Event|2|||
46696460|NCT01160289|82910919|FG004|Post-Randomization Period|Adverse Event|0|||
46696461|NCT01160289|82910920|FG005|Post-Randomization Period|Adverse Event|0|||
46696462|NCT01160289|82910915|FG000|Post-Randomization Period|Death|0|||
46696463|NCT01160289|82910916|FG001|Post-Randomization Period|Death|0|||
46696464|NCT01160289|82910917|FG002|Post-Randomization Period|Death|0|||
46696465|NCT01160289|82910918|FG003|Post-Randomization Period|Death|1|||
46696466|NCT01160289|82910919|FG004|Post-Randomization Period|Death|0|||
46696467|NCT01160289|82910920|FG005|Post-Randomization Period|Death|0|||
46696468|NCT01160289|82910915|FG000|Post-Randomization Period|Lack of Efficacy|0|||
46982184|NCT02584855|83228302|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
46696469|NCT01160289|82910916|FG001|Post-Randomization Period|Lack of Efficacy|1|||
46696470|NCT01160289|82910917|FG002|Post-Randomization Period|Lack of Efficacy|0|||
46696471|NCT01160289|82910918|FG003|Post-Randomization Period|Lack of Efficacy|3|||
46696472|NCT01160289|82910919|FG004|Post-Randomization Period|Lack of Efficacy|0|||
46696473|NCT01160289|82910920|FG005|Post-Randomization Period|Lack of Efficacy|0|||
46696474|NCT01160289|82910915|FG000|Post-Randomization Period|Lost to Follow-up|0|||
46696475|NCT01160289|82910916|FG001|Post-Randomization Period|Lost to Follow-up|3|||
46696476|NCT01160289|82910917|FG002|Post-Randomization Period|Lost to Follow-up|2|||
46696477|NCT01160289|82910918|FG003|Post-Randomization Period|Lost to Follow-up|5|||
46696478|NCT01160289|82910919|FG004|Post-Randomization Period|Lost to Follow-up|3|||
46696479|NCT01160289|82910920|FG005|Post-Randomization Period|Lost to Follow-up|4|||
46696480|NCT01160289|82910915|FG000|Post-Randomization Period|Physician Decision|0|||
46696481|NCT01160289|82910916|FG001|Post-Randomization Period|Physician Decision|0|||
46696482|NCT01160289|82910917|FG002|Post-Randomization Period|Physician Decision|1|||
46696483|NCT01160289|82910918|FG003|Post-Randomization Period|Physician Decision|0|||
46696484|NCT01160289|82910919|FG004|Post-Randomization Period|Physician Decision|0|||
46696485|NCT01160289|82910920|FG005|Post-Randomization Period|Physician Decision|0|||
46859722|NCT00306293|83075890|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
46859723|NCT00306293|83075891|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
46859724|NCT00306293|83075890|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
46859725|NCT00306293|83075891|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
46859726|NCT00306293|83075890|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
46859727|NCT00306293|83075891|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
46859728|NCT00306293|83075890|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
46859729|NCT00306293|83075891|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
46859730|NCT00294671|83075901|FG000|Overall Study|Lack of Efficacy|11|||
46859731|NCT00294671|83075902|FG001|Overall Study|Lack of Efficacy|23|||
46696486|NCT01160289|82910915|FG000|Post-Randomization Period|Protocol Violation|0|||
46696487|NCT01160289|82910916|FG001|Post-Randomization Period|Protocol Violation|4|||
46696488|NCT01160289|82910917|FG002|Post-Randomization Period|Protocol Violation|2|||
46696489|NCT01160289|82910918|FG003|Post-Randomization Period|Protocol Violation|0|||
46696490|NCT01160289|82910919|FG004|Post-Randomization Period|Protocol Violation|1|||
46696491|NCT01160289|82910920|FG005|Post-Randomization Period|Protocol Violation|3|||
46696492|NCT01160289|82910915|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
46696493|NCT01160289|82910916|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
46696494|NCT01160289|82910917|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
46696495|NCT01160289|82910918|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
46696496|NCT01160289|82910919|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
46696497|NCT01160289|82910920|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
46696498|NCT01160289|82910915|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
46696499|NCT01160289|82910916|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
46696500|NCT01160289|82910917|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
46696501|NCT01160289|82910918|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
46696502|NCT01160289|82910919|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
46696503|NCT01160289|82910920|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
46696504|NCT01160289|82910915|FG000|Post-Randomization Period|Sponsor Decision|0|||
46696505|NCT01160289|82910916|FG001|Post-Randomization Period|Sponsor Decision|1|||
46696506|NCT01160289|82910917|FG002|Post-Randomization Period|Sponsor Decision|0|||
46696507|NCT01160289|82910918|FG003|Post-Randomization Period|Sponsor Decision|0|||
46696508|NCT01160289|82910919|FG004|Post-Randomization Period|Sponsor Decision|0|||
46696509|NCT01160289|82910920|FG005|Post-Randomization Period|Sponsor Decision|0|||
46696510|NCT01159665|82910939|FG000|Overall Study|Withdrawal by Subject|0|||
46696511|NCT01159665|82910940|FG001|Overall Study|Withdrawal by Subject|1|||
46696512|NCT01159665|82910941|FG002|Overall Study|Withdrawal by Subject|0|||
46696513|NCT01159665|82910942|FG003|Overall Study|Withdrawal by Subject|0|||
46696514|NCT01159665|82910943|FG004|Overall Study|Withdrawal by Subject|0|||
46696515|NCT01159665|82910944|FG005|Overall Study|Withdrawal by Subject|0|||
46696516|NCT01159431|82910960|FG000|Overall Study|Adverse Event|1|||
46696517|NCT01159431|82910961|FG001|Overall Study|Adverse Event|2|||
46696518|NCT01159431|82910960|FG000|Overall Study|non-compliance|1|||
46696519|NCT01159431|82910961|FG001|Overall Study|non-compliance|1|||
46696520|NCT01159431|82910960|FG000|Overall Study|Lack of Efficacy|0|||
46696521|NCT01159431|82910961|FG001|Overall Study|Lack of Efficacy|3|||
46696522|NCT01158261|82910974|FG000|Overall Study|Lost to Follow-up|9|||
46696523|NCT01158261|82910974|FG000|Overall Study|Death|7|||
46696524|NCT01158261|82910974|FG000|Overall Study|Withdrawal by Subject|1|||
46696525|NCT01157169|82910980|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
46696526|NCT01157169|82910981|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
46696527|NCT01157169|82910980|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
46696528|NCT01157169|82910981|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
46696529|NCT01231620|82910990|FG000|Overall Study|Physician Decision|3|||
46859732|NCT00294671|83075901|FG000|Overall Study|Liver transplant|7|||
46859733|NCT00294671|83075902|FG001|Overall Study|Liver transplant|9|||
46696530|NCT01231620|82910991|FG001|Overall Study|Physician Decision|5|||
46859734|NCT00294671|83075901|FG000|Overall Study|Drug related adverse event (AE)|4|||
46859735|NCT00294671|83075902|FG001|Overall Study|Drug related adverse event (AE)|2|||
46696531|NCT01231620|82910992|FG002|Overall Study|Physician Decision|10|||
46696532|NCT01231620|82910990|FG000|Overall Study|Death|12|||
46696533|NCT01231620|82910991|FG001|Overall Study|Death|14|||
46859736|NCT00294671|83075901|FG000|Overall Study|Non-drug related AE|3|||
46696534|NCT01231620|82910992|FG002|Overall Study|Death|11|||
46696535|NCT01231620|82910990|FG000|Overall Study|Adverse Event|2|||
46696536|NCT01231620|82910991|FG001|Overall Study|Adverse Event|2|||
46696537|NCT01231620|82910992|FG002|Overall Study|Adverse Event|1|||
46696538|NCT01231620|82910990|FG000|Overall Study|Withdrawal by Subject|6|||
46696539|NCT01231620|82910991|FG001|Overall Study|Withdrawal by Subject|6|||
46696540|NCT01231620|82910992|FG002|Overall Study|Withdrawal by Subject|8|||
46696541|NCT01231620|82910990|FG000|Overall Study|Lost to Follow-up|3|||
46696542|NCT01231620|82910991|FG001|Overall Study|Lost to Follow-up|4|||
46696543|NCT01231620|82910992|FG002|Overall Study|Lost to Follow-up|9|||
46696544|NCT01231464|82911002|FG000|Overall Study|Adverse Event|0|||
46696545|NCT01231464|82911003|FG001|Overall Study|Adverse Event|1|||
46696546|NCT01231464|82911002|FG000|Overall Study|Protocol Violation|1|||
46696547|NCT01231464|82911003|FG001|Overall Study|Protocol Violation|2|||
46696548|NCT01231464|82911002|FG000|Overall Study|Lost to Follow-up|1|||
46696549|NCT01231464|82911003|FG001|Overall Study|Lost to Follow-up|2|||
46696550|NCT01231464|82911002|FG000|Overall Study|Withdrawal by Subject|3|||
46696551|NCT01231464|82911003|FG001|Overall Study|Withdrawal by Subject|2|||
46696552|NCT01156311|82911013|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
46696553|NCT01156311|82911014|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
46696554|NCT01156311|82911015|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
46696555|NCT01156311|82911016|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
46696556|NCT01156311|82911013|FG000|2-Month Monotherapy Period|Physician Decision|0|||
46696557|NCT01156311|82911014|FG001|2-Month Monotherapy Period|Physician Decision|1|||
46696558|NCT01156311|82911015|FG002|2-Month Monotherapy Period|Physician Decision|0|||
46696559|NCT01156311|82911016|FG003|2-Month Monotherapy Period|Physician Decision|0|||
46696560|NCT01156311|82911013|FG000|2-Month Monotherapy Period|Other|1|||
46696561|NCT01156311|82911014|FG001|2-Month Monotherapy Period|Other|0|||
46696562|NCT01156311|82911015|FG002|2-Month Monotherapy Period|Other|0|||
46696563|NCT01156311|82911016|FG003|2-Month Monotherapy Period|Other|0|||
46696564|NCT01156311|82911013|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
46696565|NCT01156311|82911014|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
46696566|NCT01156311|82911015|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
46696567|NCT01156311|82911016|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
46696568|NCT01156311|82911013|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
46696569|NCT01156311|82911014|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
46696570|NCT01156311|82911015|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
46696571|NCT01156311|82911016|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
46696572|NCT01156311|82911013|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
46696573|NCT01156311|82911014|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
46696574|NCT01156311|82911015|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
46696575|NCT01156311|82911016|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
46696576|NCT01156311|82911013|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
46696577|NCT01156311|82911014|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
46696578|NCT01156311|82911015|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
46696579|NCT01156311|82911016|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
46696580|NCT01156311|82911013|FG000|6-month Add-on Therapy Period|Other|0|||
46696581|NCT01156311|82911014|FG001|6-month Add-on Therapy Period|Other|0|||
46696582|NCT01156311|82911015|FG002|6-month Add-on Therapy Period|Other|1|||
46696583|NCT01156311|82911016|FG003|6-month Add-on Therapy Period|Other|2|||
46696584|NCT01230060|82911027|FG000|Overall Study|Withdrawal by Subject|1|||
46696585|NCT01155531|82911035|FG000|Overall Study|Adverse Event|0|||
46696586|NCT01155531|82911036|FG001|Overall Study|Adverse Event|0|||
46696587|NCT01155531|82911037|FG002|Overall Study|Adverse Event|1|||
46696588|NCT01155531|82911038|FG003|Overall Study|Adverse Event|0|||
46696589|NCT01155531|82911035|FG000|Overall Study|Lost to Follow-up|0|||
46696590|NCT01155531|82911036|FG001|Overall Study|Lost to Follow-up|0|||
46696591|NCT01155531|82911037|FG002|Overall Study|Lost to Follow-up|0|||
46859737|NCT00294671|83075902|FG001|Overall Study|Non-drug related AE|2|||
46859738|NCT00294671|83075901|FG000|Overall Study|Lost to Follow-up|1|||
46696592|NCT01155531|82911038|FG003|Overall Study|Lost to Follow-up|1|||
46696593|NCT01155531|82911035|FG000|Overall Study|Withdrawal by Subject|1|||
46696594|NCT01155531|82911036|FG001|Overall Study|Withdrawal by Subject|0|||
46696595|NCT01155531|82911037|FG002|Overall Study|Withdrawal by Subject|1|||
46696596|NCT01155531|82911038|FG003|Overall Study|Withdrawal by Subject|0|||
46696597|NCT01155219|82911050|FG000|Overall Study|Adverse Event|3|||
46696598|NCT01155219|82911051|FG001|Overall Study|Adverse Event|1|||
46859739|NCT00294671|83075902|FG001|Overall Study|Lost to Follow-up|3|||
46696599|NCT01155219|82911050|FG000|Overall Study|non-medical reason|1|||
46696600|NCT01155219|82911051|FG001|Overall Study|non-medical reason|2|||
46696601|NCT01229436|82911057|FG000|Overall Study|Withdrawal by Subject|2|||
46696602|NCT01229436|82911057|FG000|Overall Study|Lost to Follow-up|3|||
46696603|NCT01155141|82911061|FG000|Overall Study|Withdrawal by Subject|1|||
46696604|NCT01155141|82911061|FG000|Overall Study|Screen Failure|1|||
46696605|NCT01155063|82911065|FG000|Overall Study|Adverse Event|1|||
46696606|NCT01155063|82911065|FG000|Overall Study|Withdrawal by Subject|1|||
46696607|NCT01155063|82911065|FG000|Overall Study|Study terminated by sponsor|87|||
46859740|NCT00294671|83075901|FG000|Overall Study|Non-compliance|1|||
46859741|NCT00294671|83075902|FG001|Overall Study|Non-compliance|0|||
46859742|NCT00294671|83075901|FG000|Overall Study|Death|0|||
46859743|NCT00294671|83075902|FG001|Overall Study|Death|1|||
46859744|NCT01495598|83075908|FG000|Overall Study|Death during follow up period|2|||
46859745|NCT01495598|83075908|FG000|Overall Study|Death on study|1|||
46859746|NCT01495598|83075908|FG000|Overall Study|Lost to Follow-up|3|||
46859747|NCT01495598|83075908|FG000|Overall Study|Physician Decision|8|||
46859748|NCT02937454|83075939|FG000|Overall Study|Adverse Event|0|||
46859749|NCT02937454|83075940|FG001|Overall Study|Adverse Event|1|||
46859750|NCT02937454|83075939|FG000|Overall Study|Death|98|||
46859751|NCT02937454|83075940|FG001|Overall Study|Death|95|||
46859752|NCT02937454|83075939|FG000|Overall Study|Lost to Follow-up|1|||
46859753|NCT02937454|83075940|FG001|Overall Study|Lost to Follow-up|1|||
46859754|NCT02937454|83075939|FG000|Overall Study|Physician Decision|0|||
46859755|NCT02937454|83075940|FG001|Overall Study|Physician Decision|1|||
46859756|NCT02937454|83075939|FG000|Overall Study|Protocol Violation|6|||
46859757|NCT02937454|83075940|FG001|Overall Study|Protocol Violation|10|||
46859758|NCT02937454|83075939|FG000|Overall Study|Withdrawal by Subject|27|||
46859759|NCT02937454|83075940|FG001|Overall Study|Withdrawal by Subject|15|||
46859760|NCT02937454|83075939|FG000|Overall Study|Other|8|||
46859761|NCT02937454|83075940|FG001|Overall Study|Other|5|||
46859762|NCT03211858|83075959|FG000|Overall Study|Adverse Event|8|||
46859763|NCT03211858|83075960|FG001|Overall Study|Adverse Event|6|||
46859764|NCT03211858|83075959|FG000|Overall Study|Lack of Efficacy|0|||
46859765|NCT03211858|83075960|FG001|Overall Study|Lack of Efficacy|4|||
46859766|NCT03211858|83075959|FG000|Overall Study|Poor compliance to protocol|6|||
46859767|NCT03211858|83075960|FG001|Overall Study|Poor compliance to protocol|2|||
46859768|NCT03211858|83075959|FG000|Overall Study|Non-serious Hypoglycemia|1|||
46859769|NCT03211858|83075960|FG001|Overall Study|Non-serious Hypoglycemia|0|||
46859770|NCT03211858|83075959|FG000|Overall Study|Other than specified above|22|||
46859771|NCT03211858|83075960|FG001|Overall Study|Other than specified above|21|||
46859772|NCT03211156|83075972|FG000|Overall Study|Withdrawal by Subject|0|||
46859773|NCT03211156|83075973|FG001|Overall Study|Withdrawal by Subject|2|||
46859774|NCT03211156|83075972|FG000|Overall Study|Lost to Follow-up|1|||
46859775|NCT03211156|83075973|FG001|Overall Study|Lost to Follow-up|1|||
46859776|NCT03211156|83075972|FG000|Overall Study|Adverse Event|1|||
46859777|NCT03211156|83075973|FG001|Overall Study|Adverse Event|0|||
46859778|NCT04472494|83075981|FG000|Pre-treatment|Other reasons|2|||
46859779|NCT04472494|83075982|FG001|Pre-treatment|Other reasons|0|||
46859780|NCT04472494|83075981|FG000|Treatment|Death|5|||
46859781|NCT04472494|83075982|FG001|Treatment|Death|2|||
46859782|NCT04472494|83075981|FG000|Treatment|Hospital discharge|1|||
46859783|NCT04472494|83075982|FG001|Treatment|Hospital discharge|1|||
46859784|NCT04419506|83075992|FG000|Overall Study|Adverse Event|0|||
46859785|NCT04419506|83075993|FG001|Overall Study|Adverse Event|10|||
46859786|NCT04419506|83075994|FG002|Overall Study|Adverse Event|0|||
46859787|NCT04419506|83075995|FG003|Overall Study|Adverse Event|3|||
46859788|NCT04419506|83075992|FG000|Overall Study|Withdrawal by Subject|0|||
46859789|NCT04419506|83075993|FG001|Overall Study|Withdrawal by Subject|0|||
46859790|NCT04419506|83075994|FG002|Overall Study|Withdrawal by Subject|0|||
46859791|NCT04419506|83075995|FG003|Overall Study|Withdrawal by Subject|1|||
46859792|NCT04419506|83075992|FG000|Overall Study|poor-compliance|0|||
46859793|NCT04419506|83075993|FG001|Overall Study|poor-compliance|0|||
46859794|NCT04419506|83075994|FG002|Overall Study|poor-compliance|0|||
46859795|NCT04419506|83075995|FG003|Overall Study|poor-compliance|1|||
46859796|NCT03236506|83076008|FG000|Overall Study|Death|1|||
46859797|NCT03236506|83076009|FG001|Overall Study|Death|1|||
46859798|NCT03236506|83076010|FG002|Overall Study|Death|1|||
46859799|NCT03236506|83076008|FG000|Overall Study|Withdrawal by Subject|3|||
46859800|NCT03236506|83076009|FG001|Overall Study|Withdrawal by Subject|3|||
46859801|NCT03236506|83076010|FG002|Overall Study|Withdrawal by Subject|4|||
46696608|NCT01154673|82911071|FG000|Overall Study|Lost to Follow-up|1|||
46859802|NCT03236506|83076008|FG000|Overall Study|Did not initiate treatment|2|||
46859803|NCT03236506|83076009|FG001|Overall Study|Did not initiate treatment|1|||
46859804|NCT03236506|83076010|FG002|Overall Study|Did not initiate treatment|2|||
46859805|NCT03227692|83076029|FG000|Overall Study|Protocol Violation|1|||
46859806|NCT03227692|83076030|FG001|Overall Study|Protocol Violation|1|||
46859807|NCT03227692|83076029|FG000|Overall Study|Lost to Follow-up|4|||
46696609|NCT01154673|82911072|FG001|Overall Study|Lost to Follow-up|0|||
46696610|NCT01154673|82911071|FG000|Overall Study|moved out of province|1|||
46696611|NCT01154673|82911072|FG001|Overall Study|moved out of province|0|||
46696612|NCT01154283|82911080|FG000|0-6 Weeks|Withdrawal by Subject|7|||
46696613|NCT01154283|82911081|FG001|0-6 Weeks|Withdrawal by Subject|2|||
46696614|NCT01154283|82911080|FG000|0-6 Weeks|Death|0|||
46696615|NCT01154283|82911081|FG001|0-6 Weeks|Death|1|||
46696616|NCT01154283|82911080|FG000|7-12 Weeks|Death|1|||
46696617|NCT01154283|82911081|FG001|7-12 Weeks|Death|0|||
46696618|NCT01154283|82911080|FG000|7-12 Weeks|Withdrawal by Subject|0|||
46696619|NCT01154283|82911081|FG001|7-12 Weeks|Withdrawal by Subject|1|||
46696620|NCT00944125|82911087|FG000|3 to 6 Months|Withdrawal by Subject|0|||
46696621|NCT00944125|82911088|FG001|3 to 6 Months|Withdrawal by Subject|2|||
46696622|NCT00944125|82911087|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
46696623|NCT00944125|82911088|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
46696624|NCT00912223|82911094|FG000|Overall Study|Withdrawal by Subject|1|||
46696625|NCT00912223|82911094|FG000|Overall Study|Not transplanted|1|||
46696626|NCT00912223|82911094|FG000|Overall Study|Transformed disease|1|||
46696627|NCT01154127|82911100|FG000|Period 1 (21 Days)|Adverse Event|3|||
46696628|NCT01154127|82911101|FG001|Period 1 (21 Days)|Adverse Event|4|||
46696629|NCT01154127|82911100|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
46696630|NCT01154127|82911101|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
46696631|NCT01154127|82911100|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
46696632|NCT01154127|82911101|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
46696633|NCT01154127|82911100|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
46696634|NCT01154127|82911101|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
46696635|NCT01154127|82911100|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
46696636|NCT01154127|82911101|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
46696637|NCT01228734|82911109|FG000|Overall Study|Randomized, but not treated|0|||
46696638|NCT01228734|82911110|FG001|Overall Study|Randomized, but not treated|4|||
46696639|NCT01227954|82911116|FG000|Overall Study|Protocol Violation|6|||
46696640|NCT01227954|82911116|FG000|Overall Study|No protocol treatment|7|||
46696641|NCT01153971|82911120|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
46696642|NCT01153971|82911120|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
46696643|NCT01153971|82911120|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
46696644|NCT01153971|82911120|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
46696645|NCT01153971|82911120|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
46696646|NCT01153971|82911120|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
46696647|NCT01153971|82911120|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
46696648|NCT01153893|82911126|FG000|Overall Study|Adverse Event|1|||
46696649|NCT01153893|82911127|FG001|Overall Study|Adverse Event|0|||
46696650|NCT00951379|82911135|FG000|Overall Study|Adverse Event|4|||
46696651|NCT00951379|82911136|FG001|Overall Study|Adverse Event|1|||
46696652|NCT00951379|82911135|FG000|Overall Study|Withdrawal by Subject|1|||
46696653|NCT00951379|82911136|FG001|Overall Study|Withdrawal by Subject|0|||
46696654|NCT00951379|82911135|FG000|Overall Study|Noncompliance|1|||
46696655|NCT00951379|82911136|FG001|Overall Study|Noncompliance|0|||
46696656|NCT00951379|82911135|FG000|Overall Study|Disease Progression|0|||
46696657|NCT00951379|82911136|FG001|Overall Study|Disease Progression|1|||
46696658|NCT01153815|82911152|FG000|Overall Study|Adverse Event|3|||
46696659|NCT01153815|82911153|FG001|Overall Study|Adverse Event|1|||
46696660|NCT01153815|82911152|FG000|Overall Study|Withdrawal by Subject|6|||
46696661|NCT01153815|82911153|FG001|Overall Study|Withdrawal by Subject|4|||
46696662|NCT01153425|82911161|FG000|Overall Study|Withdrawal by Subject|3|||
46696663|NCT01153425|82911162|FG001|Overall Study|Withdrawal by Subject|3|||
46696664|NCT01153347|82911173|FG000|Overall Study|Withdrawal by Subject|7|||
46696665|NCT01153347|82911174|FG001|Overall Study|Withdrawal by Subject|7|||
46696666|NCT01153347|82911175|FG002|Overall Study|Withdrawal by Subject|7|||
46696667|NCT01153347|82911176|FG003|Overall Study|Withdrawal by Subject|7|||
46696668|NCT01153347|82911173|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46696669|NCT01153347|82911174|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
46696670|NCT01153347|82911175|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
46696671|NCT01153347|82911176|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
46696672|NCT01153347|82911173|FG000|Overall Study|Adverse Event|3|||
46696673|NCT01153347|82911174|FG001|Overall Study|Adverse Event|9|||
46696674|NCT01153347|82911175|FG002|Overall Study|Adverse Event|21|||
46696675|NCT01153347|82911176|FG003|Overall Study|Adverse Event|7|||
46696676|NCT01153347|82911173|FG000|Overall Study|Severe non-compliance to protocol|6|||
46696677|NCT01153347|82911174|FG001|Overall Study|Severe non-compliance to protocol|7|||
46696678|NCT01153347|82911175|FG002|Overall Study|Severe non-compliance to protocol|4|||
46696679|NCT01153347|82911176|FG003|Overall Study|Severe non-compliance to protocol|3|||
46696680|NCT01153347|82911173|FG000|Overall Study|Condition under investigation worsened|1|||
46696681|NCT01153347|82911174|FG001|Overall Study|Condition under investigation worsened|1|||
46802398|NCT00485589|83021800|FG002|Overall Study|Adverse Event|10|||
46696682|NCT01153347|82911175|FG002|Overall Study|Condition under investigation worsened|0|||
46696683|NCT01153347|82911176|FG003|Overall Study|Condition under investigation worsened|0|||
46696684|NCT01153347|82911173|FG000|Overall Study|Lack of Efficacy|2|||
46696685|NCT01153347|82911174|FG001|Overall Study|Lack of Efficacy|2|||
46696686|NCT01153347|82911175|FG002|Overall Study|Lack of Efficacy|0|||
46696687|NCT01153347|82911176|FG003|Overall Study|Lack of Efficacy|4|||
46696688|NCT01153347|82911173|FG000|Overall Study|Study-specific withdrawal criteria|4|||
46696689|NCT01153347|82911174|FG001|Overall Study|Study-specific withdrawal criteria|3|||
46696690|NCT01153347|82911175|FG002|Overall Study|Study-specific withdrawal criteria|1|||
46696691|NCT01153347|82911176|FG003|Overall Study|Study-specific withdrawal criteria|2|||
46696692|NCT01153347|82911173|FG000|Overall Study|Lost to Follow-up|4|||
46696693|NCT01153347|82911174|FG001|Overall Study|Lost to Follow-up|9|||
46696694|NCT01153347|82911175|FG002|Overall Study|Lost to Follow-up|11|||
46696695|NCT01153347|82911176|FG003|Overall Study|Lost to Follow-up|8|||
46696696|NCT01153347|82911173|FG000|Overall Study|Other|5|||
46696697|NCT01153347|82911174|FG001|Overall Study|Other|5|||
46696698|NCT01153347|82911175|FG002|Overall Study|Other|4|||
46696699|NCT01153347|82911176|FG003|Overall Study|Other|0|||
46696700|NCT01153347|82911173|FG000|Overall Study|Death|1|||
46696701|NCT01153347|82911174|FG001|Overall Study|Death|0|||
46696702|NCT01153347|82911175|FG002|Overall Study|Death|0|||
46696703|NCT01153347|82911176|FG003|Overall Study|Death|0|||
46696704|NCT01153269|82911186|FG000|Overall Study|Withdrawal by Subject|1|||
46696705|NCT01153269|82911186|FG000|Overall Study|Antiretroviral therapy break|1|||
46696706|NCT01152021|82911195|FG000|Overall Study|Adverse Event|4|||
46696707|NCT01152021|82911196|FG001|Overall Study|Adverse Event|4|||
46859808|NCT03227692|83076030|FG001|Overall Study|Lost to Follow-up|2|||
46696708|NCT01152021|82911195|FG000|Overall Study|Study drug had expired|1|||
46696709|NCT01152021|82911196|FG001|Overall Study|Study drug had expired|0|||
46696710|NCT01152021|82911195|FG000|Overall Study|Physician Decision|1|||
46696711|NCT01152021|82911196|FG001|Overall Study|Physician Decision|1|||
46696712|NCT01152021|82911195|FG000|Overall Study|No access to study drug in Pharmacy|0|||
46696713|NCT01152021|82911196|FG001|Overall Study|No access to study drug in Pharmacy|1|||
46696714|NCT01151085|82911204|FG000|Overall Study|Lost to Follow-up|31|||
46859809|NCT03227692|83076029|FG000|Overall Study|Adverse Event|0|||
46859810|NCT03227692|83076030|FG001|Overall Study|Adverse Event|2|||
46859811|NCT03210220|83076038|FG000|Overall Study|Physician Decision|1|||
46859812|NCT03210220|83076039|FG001|Overall Study|Physician Decision|0|||
46859813|NCT03209518|83076045|FG000|Overall Study|Case Report Forms Uncollected|1|||
46859814|NCT03209518|83076045|FG000|Overall Study|Protocol Deviation|1|||
46859815|NCT03725852|83076051|FG000|Overall Study|Death|1|||
46859816|NCT03725852|83076052|FG001|Overall Study|Death|0|||
46859817|NCT03725852|83076051|FG000|Overall Study|Withdrawal by Subject|1|||
46859818|NCT03725852|83076052|FG001|Overall Study|Withdrawal by Subject|0|||
46859819|NCT03725852|83076051|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
46859820|NCT03725852|83076052|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
46859821|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
46859822|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
46859823|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
46859824|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
46859825|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
46859826|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
46859827|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
46859828|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
46859829|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
46859830|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
46859831|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
46859832|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
46859833|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
46859834|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
46859835|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
46859836|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
46859837|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
46859838|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
46859839|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
46859840|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
46859841|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
46859842|NCT00304031|83076061|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
46859843|NCT00304031|83076062|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
46859844|NCT00304031|83076063|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
46859845|NCT00304031|83076061|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
46859846|NCT00304031|83076062|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
46859847|NCT00304031|83076063|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
46859848|NCT00332189|83076078|FG000|Overall Study|Adverse Event|3|||
46859849|NCT00332189|83076078|FG000|Overall Study|Uncooperative/Noncompliant|3|||
46859850|NCT00332189|83076078|FG000|Overall Study|Withdrawal by Subject|9|||
46859851|NCT00332189|83076078|FG000|Overall Study|Lack of Efficacy|4|||
46859852|NCT00332189|83076078|FG000|Overall Study|Moved out of country|2|||
46859853|NCT00331799|83076083|FG000|Overall Study|Withdrawal by Subject|2|||
46859854|NCT00331799|83076083|FG000|Overall Study|Sedation|1|||
46859855|NCT00303719|83076089|FG000|Overall Study|Not evaluable, prior therapies|0|||
46859856|NCT00303719|83076090|FG001|Overall Study|Not evaluable, prior therapies|30|||
46859857|NCT00303719|83076089|FG000|Overall Study|Lost to Follow-up|0|||
46859858|NCT00303719|83076090|FG001|Overall Study|Lost to Follow-up|7|||
46859859|NCT00331409|83076097|FG000|Overall Study|Lack of Efficacy|4|||
46859860|NCT00303485|83076103|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
46859861|NCT00303485|83076104|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
46859862|NCT00303485|83076103|FG000|Overall Study|Failure to return|0|||
46859863|NCT00303485|83076104|FG001|Overall Study|Failure to return|1|||
46859864|NCT00303485|83076103|FG000|Overall Study|Withdrawal by Subject|1|||
46859865|NCT00303485|83076104|FG001|Overall Study|Withdrawal by Subject|0|||
46859866|NCT03235726|83076118|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859867|NCT03235726|83076119|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859868|NCT03235726|83076120|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859869|NCT03235726|83076121|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859870|NCT03235726|83076122|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
46859871|NCT03235726|83076123|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859872|NCT03235726|83076124|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859873|NCT03235726|83076125|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859874|NCT03235726|83076126|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859875|NCT03235726|83076127|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
46859876|NCT03235726|83076118|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859877|NCT03235726|83076119|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859878|NCT03235726|83076120|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859879|NCT03235726|83076121|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859880|NCT03235726|83076122|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
46859881|NCT03235726|83076123|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859882|NCT03235726|83076124|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859883|NCT03235726|83076125|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859884|NCT03235726|83076126|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859885|NCT03235726|83076127|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
46859886|NCT00303953|83076162|FG000|Overall Study|Ineligible|1|||
46859887|NCT00303953|83076162|FG000|Overall Study|Death|1|||
46859888|NCT00303953|83076162|FG000|Overall Study|Adverse Event|4|||
46859889|NCT00303953|83076162|FG000|Overall Study|Lack of Efficacy|12|||
46859890|NCT00303953|83076162|FG000|Overall Study|Physician Decision|1|||
46859891|NCT02935894|83076166|FG000|Overall Study|Subject dismissed|1|||
46859892|NCT03224182|83076172|FG000|Overall Study|Study Drug Not Instilled|6|||
46859893|NCT03224182|83076173|FG001|Overall Study|Study Drug Not Instilled|1|||
46859894|NCT03224182|83076172|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
46859895|NCT03224182|83076173|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
46859896|NCT03224182|83076172|FG000|Overall Study|Withdrew of Consent|4|||
46859897|NCT03224182|83076173|FG001|Overall Study|Withdrew of Consent|2|||
46859898|NCT03224182|83076172|FG000|Overall Study|Investigator Decision|3|||
46859899|NCT03224182|83076173|FG001|Overall Study|Investigator Decision|1|||
46859900|NCT03224182|83076172|FG000|Overall Study|Sponsor Decision|26|||
46859901|NCT03224182|83076173|FG001|Overall Study|Sponsor Decision|12|||
46982185|NCT02584855|83228303|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
46696715|NCT01151085|82911204|FG000|Overall Study|Protocol Violation|25|||
46696716|NCT01149681|82911215|FG000|Overall Study|Withdrawal by Subject|7|||
46696717|NCT01149681|82911215|FG000|Overall Study|Progressive disease|1|||
46696718|NCT01149681|82911215|FG000|Overall Study|Physician Decision|2|||
46696719|NCT01149681|82911215|FG000|Overall Study|adverse events nonrelated study drug|2|||
46696720|NCT01149369|82911222|FG000|Overall Study|Adverse Event|6|||
46696721|NCT01149369|82911223|FG001|Overall Study|Adverse Event|3|||
46696722|NCT01149057|82911229|FG000|Overall Study|Lack of Efficacy|16|||
46696723|NCT01149057|82911229|FG000|Overall Study|Adverse Event|13|||
46696724|NCT01149057|82911229|FG000|Overall Study|Withdrawal by Subject|9|||
46696725|NCT01149057|82911229|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
46696726|NCT01149057|82911229|FG000|Overall Study|B Cell Depletion|4|||
46696727|NCT01149057|82911229|FG000|Overall Study|Participant Non-Compliance|2|||
46696728|NCT01149057|82911229|FG000|Overall Study|Lost to Follow-up|1|||
46696729|NCT01149057|82911229|FG000|Overall Study|High Parathyroid Hormone Value|1|||
46696730|NCT01149057|82911229|FG000|Overall Study|Other|6|||
46696731|NCT01227564|82911236|FG000|Overall Study|No Longer Willing to Participate|4|||
46696732|NCT01227564|82911237|FG001|Overall Study|No Longer Willing to Participate|2|||
46696733|NCT01227564|82911238|FG002|Overall Study|No Longer Willing to Participate|5|||
46696734|NCT01227564|82911236|FG000|Overall Study|Participant moved to another town|0|||
46696735|NCT01227564|82911237|FG001|Overall Study|Participant moved to another town|0|||
46696736|NCT01227564|82911238|FG002|Overall Study|Participant moved to another town|1|||
46696737|NCT01148979|82911254|FG000|Overall Study|Lost to Follow-up|0|||
46696738|NCT01148979|82911255|FG001|Overall Study|Lost to Follow-up|1|||
46859902|NCT03224182|83076172|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
46859903|NCT03224182|83076173|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
46859904|NCT03224182|83076172|FG000|Overall Study|Lost to Follow-up|1|||
46859905|NCT03224182|83076173|FG001|Overall Study|Lost to Follow-up|0|||
46859906|NCT03224182|83076172|FG000|Overall Study|Participant Had Recurrence|11|||
46859907|NCT03224182|83076173|FG001|Overall Study|Participant Had Recurrence|5|||
46859908|NCT03224182|83076172|FG000|Overall Study|Death|0|||
46859909|NCT03224182|83076173|FG001|Overall Study|Death|1|||
46859910|NCT03224182|83076172|FG000|Overall Study|Reason not Specified|3|||
46859911|NCT03224182|83076173|FG001|Overall Study|Reason not Specified|3|||
46859912|NCT03224182|83076172|FG000|Overall Study|Other|1|||
46859913|NCT03224182|83076173|FG001|Overall Study|Other|0|||
46696739|NCT01148511|82911263|FG000|Exposed to Study Drug|Protocol Violation|2|||
46859914|NCT02935192|83076181|FG000|Overall Study|Withdrawal by Subject|8|||
46859915|NCT02935192|83076182|FG001|Overall Study|Withdrawal by Subject|4|||
46859916|NCT03722264|83076188|FG000|Overall Study|Physician Decision|3|||
46859917|NCT03722030|83076196|FG000|Overall Study|Withdrawal by Subject|1|||
46859918|NCT03722030|83076197|FG001|Overall Study|Withdrawal by Subject|0|||
46859919|NCT03221842|83076204|FG000|Period 1 (Open-label)|Adverse Event|4|||
46859920|NCT03221842|83076205|FG001|Period 1 (Open-label)|Adverse Event|0|||
46859921|NCT03221842|83076204|FG000|Period 1 (Open-label)|Physician Decision|2|||
46859922|NCT03221842|83076205|FG001|Period 1 (Open-label)|Physician Decision|0|||
46859923|NCT03221842|83076204|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
46859924|NCT03221842|83076205|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
46859925|NCT03221842|83076204|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
46859926|NCT03221842|83076205|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
46859927|NCT03221842|83076204|FG000|Period 1 (Open-label)|Other|2|||
46859928|NCT03221842|83076205|FG001|Period 1 (Open-label)|Other|0|||
46859929|NCT03221842|83076204|FG000|Period 2 (Randomized, Blinded)|Death|0|||
46859930|NCT03221842|83076205|FG001|Period 2 (Randomized, Blinded)|Death|1|||
46859931|NCT03221842|83076204|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
46696740|NCT01148511|82911264|FG001|Exposed to Study Drug|Protocol Violation|0|||
46696741|NCT01148511|82911265|FG002|Exposed to Study Drug|Protocol Violation|0|||
46696742|NCT01148511|82911263|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
46696743|NCT01148511|82911264|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
46696744|NCT01148511|82911265|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
46696745|NCT01148511|82911263|FG000|Randomized|Adverse Event|0|||
46696746|NCT01148511|82911264|FG001|Randomized|Adverse Event|1|||
46696747|NCT01148511|82911265|FG002|Randomized|Adverse Event|0|||
46696748|NCT01148511|82911263|FG000|Randomized|Protocol Violation|0|||
46696749|NCT01148511|82911264|FG001|Randomized|Protocol Violation|2|||
46696750|NCT01148511|82911265|FG002|Randomized|Protocol Violation|1|||
46696751|NCT01148511|82911263|FG000|Randomized|Lost to Follow-up|0|||
46696752|NCT01148511|82911264|FG001|Randomized|Lost to Follow-up|1|||
46696753|NCT01148511|82911265|FG002|Randomized|Lost to Follow-up|1|||
46696754|NCT01148511|82911263|FG000|Randomized|Consent withdrawal|0|||
46696755|NCT01148511|82911264|FG001|Randomized|Consent withdrawal|5|||
46696756|NCT01148511|82911265|FG002|Randomized|Consent withdrawal|3|||
46696757|NCT01148511|82911263|FG000|Randomized|Other|0|||
46696758|NCT01148511|82911264|FG001|Randomized|Other|1|||
46696759|NCT01148511|82911265|FG002|Randomized|Other|1|||
46696760|NCT00547339|82911276|FG000|Overall Study|Physician Decision|0|||
46696761|NCT00547339|82911277|FG001|Overall Study|Physician Decision|0|||
46696762|NCT00547339|82911278|FG002|Overall Study|Physician Decision|1|||
46696763|NCT00547339|82911279|FG003|Overall Study|Physician Decision|0|||
46696764|NCT01227252|82911302|FG000|Overall Study|Sponsor Decision|0|||
46696765|NCT01227252|82911303|FG001|Overall Study|Sponsor Decision|1|||
46696766|NCT01227252|82911304|FG002|Overall Study|Sponsor Decision|0|||
46696767|NCT01227252|82911305|FG003|Overall Study|Sponsor Decision|0|||
46696768|NCT01227252|82911302|FG000|Overall Study|Lost to Follow-up|0|||
46696769|NCT01227252|82911303|FG001|Overall Study|Lost to Follow-up|1|||
46696770|NCT01227252|82911304|FG002|Overall Study|Lost to Follow-up|0|||
46696771|NCT01227252|82911305|FG003|Overall Study|Lost to Follow-up|0|||
46696772|NCT01227252|82911302|FG000|Overall Study|Withdrawal by Subject|0|||
46696773|NCT01227252|82911303|FG001|Overall Study|Withdrawal by Subject|1|||
46696774|NCT01227252|82911304|FG002|Overall Study|Withdrawal by Subject|0|||
46859932|NCT03221842|83076205|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
46696775|NCT01227252|82911305|FG003|Overall Study|Withdrawal by Subject|0|||
46696776|NCT01227018|82911318|FG000|Overall Study|Disease progression|9|||
46696777|NCT01227018|82911318|FG000|Overall Study|Toxicity|2|||
46696778|NCT01227018|82911318|FG000|Overall Study|Withdrew after beginning treatment|4|||
46696779|NCT01226472|82911332|FG000|Overall Study|Progressive Disease|1|||
46696780|NCT01225146|82911338|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
46696781|NCT01225146|82911339|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
46696782|NCT01223196|82911349|FG000|Overall Study|Lost to Follow-up|2|||
46696783|NCT01223196|82911350|FG001|Overall Study|Lost to Follow-up|0|||
46696784|NCT01223196|82911349|FG000|Overall Study|Physician Decision|1|||
46696785|NCT01223196|82911350|FG001|Overall Study|Physician Decision|0|||
46696786|NCT01223196|82911349|FG000|Overall Study|Withdrawal by Subject|1|||
46696787|NCT01223196|82911350|FG001|Overall Study|Withdrawal by Subject|0|||
46696788|NCT01222416|82911360|FG000|Overall Study|ineligible;metastasis|3|||
46859933|NCT03364738|83076215|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
46859934|NCT03364738|83076215|FG000|Overall Study|Withdrawal by Subject|1|||
46859935|NCT03364738|83076215|FG000|Overall Study|Adverse Event|1|||
46859936|NCT00303329|83076222|FG000|Overall Study|Adverse Event|7|||
46859937|NCT00303329|83076223|FG001|Overall Study|Adverse Event|14|||
46859938|NCT00303329|83076222|FG000|Overall Study|Abnormal Laboratory Values|0|||
46859939|NCT00303329|83076223|FG001|Overall Study|Abnormal Laboratory Values|1|||
46859940|NCT00303329|83076222|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
46859941|NCT00303329|83076223|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46859942|NCT00303329|83076222|FG000|Overall Study|Condition no longer requires study drug|0|||
46859943|NCT00303329|83076223|FG001|Overall Study|Condition no longer requires study drug|8|||
46859944|NCT00303329|83076222|FG000|Overall Study|Protocol Violation|3|||
46859945|NCT00303329|83076223|FG001|Overall Study|Protocol Violation|0|||
46859946|NCT00303329|83076222|FG000|Overall Study|Withdrawal by Subject|9|||
46859947|NCT00303329|83076223|FG001|Overall Study|Withdrawal by Subject|15|||
46859948|NCT00303329|83076222|FG000|Overall Study|Lost to Follow-up|0|||
46859949|NCT00303329|83076223|FG001|Overall Study|Lost to Follow-up|1|||
46859950|NCT00303329|83076222|FG000|Overall Study|Administrative problems|1|||
46859951|NCT00303329|83076223|FG001|Overall Study|Administrative problems|0|||
46859952|NCT00303329|83076222|FG000|Overall Study|Death|2|||
46859953|NCT00303329|83076223|FG001|Overall Study|Death|12|||
46859954|NCT00303329|83076222|FG000|Overall Study|Stopped at end of core|3|||
46859955|NCT00303329|83076223|FG001|Overall Study|Stopped at end of core|9|||
46859956|NCT00303329|83076222|FG000|Overall Study|Stopped at end of extension 1|1|||
46859957|NCT00303329|83076223|FG001|Overall Study|Stopped at end of extension 1|0|||
46859958|NCT00329849|83076231|FG000|Overall Study|Withdrawal by Subject|6|||
46859959|NCT00329849|83076232|FG001|Overall Study|Withdrawal by Subject|4|||
46859960|NCT02934178|83076244|FG000|Received Vaccination 2|Death|0|||
46859961|NCT02934178|83076245|FG001|Received Vaccination 2|Death|1|||
46859962|NCT02934178|83076244|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
46859963|NCT02934178|83076245|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
46859964|NCT00329303|83076254|FG000|Overall Study|Lack of Efficacy|1|||
46859965|NCT00329303|83076255|FG001|Overall Study|Lack of Efficacy|0|||
46859966|NCT00329303|83076254|FG000|Overall Study|Decision of the sponsor|0|||
46859967|NCT00329303|83076255|FG001|Overall Study|Decision of the sponsor|1|||
46859968|NCT00329303|83076254|FG000|Overall Study|Patient no longer available|1|||
46859969|NCT00329303|83076255|FG001|Overall Study|Patient no longer available|0|||
46859970|NCT00329303|83076254|FG000|Overall Study|Patient relocated|0|||
46859971|NCT00329303|83076255|FG001|Overall Study|Patient relocated|1|||
46859972|NCT03216850|83076262|FG000|Overall Study|Pre-analytical error|6|||
46859973|NCT00302159|83076266|FG000|Overall Study|pt declined before treatment started|1|||
46859974|NCT00302159|83076266|FG000|Overall Study|pt started Avastin|1|||
46859975|NCT00302081|83076274|FG000|Overall Study|Adverse Event|6|||
46859976|NCT00302081|83076275|FG001|Overall Study|Adverse Event|5|||
46696789|NCT01222416|82911361|FG001|Overall Study|ineligible;metastasis|0|||
46696790|NCT01222416|82911360|FG000|Overall Study|Adverse Event|4|||
46696791|NCT01222416|82911361|FG001|Overall Study|Adverse Event|0|||
46859977|NCT00302081|83076276|FG002|Overall Study|Adverse Event|4|||
46859978|NCT00302081|83076274|FG000|Overall Study|Lost to Follow-up|21|||
46859979|NCT00302081|83076275|FG001|Overall Study|Lost to Follow-up|18|||
46859980|NCT00302081|83076276|FG002|Overall Study|Lost to Follow-up|28|||
46859981|NCT00302081|83076274|FG000|Overall Study|Withdrawal by Subject|8|||
46859982|NCT00302081|83076275|FG001|Overall Study|Withdrawal by Subject|12|||
46859983|NCT00302081|83076276|FG002|Overall Study|Withdrawal by Subject|8|||
46859984|NCT00302081|83076274|FG000|Overall Study|Protocol Violation|5|||
46982186|NCT02584855|83228298|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
46982187|NCT02584855|83228299|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
46982188|NCT02584855|83228300|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
46859985|NCT00302081|83076275|FG001|Overall Study|Protocol Violation|1|||
46859986|NCT00302081|83076276|FG002|Overall Study|Protocol Violation|2|||
46859987|NCT00302081|83076274|FG000|Overall Study|Lack of Efficacy|1|||
46859988|NCT00302081|83076275|FG001|Overall Study|Lack of Efficacy|0|||
46859989|NCT00302081|83076276|FG002|Overall Study|Lack of Efficacy|5|||
46859990|NCT00302081|83076274|FG000|Overall Study|Death|2|||
46859991|NCT00302081|83076275|FG001|Overall Study|Death|1|||
46859992|NCT00302081|83076276|FG002|Overall Study|Death|0|||
46859993|NCT00302081|83076274|FG000|Overall Study|Other|13|||
46696792|NCT01222416|82911360|FG000|Overall Study|Withdrawal by Subject|5|||
46696793|NCT01222416|82911361|FG001|Overall Study|Withdrawal by Subject|0|||
46696794|NCT01222416|82911360|FG000|Overall Study|scheduling|6|||
46859994|NCT00302081|83076275|FG001|Overall Study|Other|6|||
46859995|NCT00302081|83076276|FG002|Overall Study|Other|5|||
46859996|NCT00302003|83076284|FG000|Overall Study|Lack of Efficacy|62|||
46859997|NCT00302003|83076284|FG000|Overall Study|Lost to Follow-up|1|||
46859998|NCT00302003|83076284|FG000|Overall Study|Physician Decision|2|||
46859999|NCT00302003|83076284|FG000|Overall Study|Withdrawal by Subject|5|||
46860000|NCT00302003|83076284|FG000|Overall Study|Ineligible|9|||
46860001|NCT00302003|83076284|FG000|Overall Study|Protocol Violation|1|||
46860002|NCT00036270|83076290|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
46860003|NCT00036270|83076291|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
46860004|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
46860005|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
46860006|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
46860007|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
46860008|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
46860009|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
46860010|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Other|277|||
46860011|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Other|288|||
46860012|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
46860013|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
46696795|NCT01222416|82911361|FG001|Overall Study|scheduling|0|||
46696796|NCT01222416|82911360|FG000|Overall Study|missed view/scan|1|||
46696797|NCT01222416|82911361|FG001|Overall Study|missed view/scan|0|||
46696798|NCT01222416|82911360|FG000|Overall Study|Death|1|||
46696799|NCT01222416|82911361|FG001|Overall Study|Death|0|||
46696800|NCT01222104|82911367|FG000|Overall Study|Lost to Follow-up|37|||
46696801|NCT01222104|82911367|FG000|Overall Study|Death|10|||
46696802|NCT01221948|82911377|FG000|Overall Study|Physician Decision|5|||
46696803|NCT01221948|82911377|FG000|Overall Study|Withdrawal by Subject|2|||
46696804|NCT01221948|82911377|FG000|Overall Study|not disclosed|2|||
46696805|NCT01221948|82911377|FG000|Overall Study|Death|1|||
46696806|NCT01221948|82911377|FG000|Overall Study|Protocol Violation|4|||
46696807|NCT01221090|82911385|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
46696808|NCT01221090|82911386|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
46696809|NCT01221090|82911387|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
46696810|NCT01221090|82911388|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
46696811|NCT01221090|82911385|FG000|Overall Study|Withdrawal by Subject|0|||
46696812|NCT01221090|82911386|FG001|Overall Study|Withdrawal by Subject|22|||
46696813|NCT01221090|82911387|FG002|Overall Study|Withdrawal by Subject|27|||
46696814|NCT01221090|82911388|FG003|Overall Study|Withdrawal by Subject|2|||
46696815|NCT00950911|82911400|FG000|Overall Study|Adverse Event|0|||
46696816|NCT00950911|82911401|FG001|Overall Study|Adverse Event|2|||
46696817|NCT00950911|82911400|FG000|Overall Study|Death|4|||
46696818|NCT00950911|82911401|FG001|Overall Study|Death|6|||
46696819|NCT00950911|82911400|FG000|Overall Study|Disease progression|2|||
46696820|NCT00950911|82911401|FG001|Overall Study|Disease progression|2|||
46696821|NCT00950911|82911400|FG000|Overall Study|Consent withdrawn|1|||
46696822|NCT00950911|82911401|FG001|Overall Study|Consent withdrawn|3|||
46696823|NCT00950911|82911400|FG000|Overall Study|Administrative decision|3|||
46696824|NCT00950911|82911401|FG001|Overall Study|Administrative decision|1|||
46860014|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
46860015|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
46696825|NCT00950911|82911400|FG000|Overall Study|Ineligibility determined|1|||
46696826|NCT00950911|82911401|FG001|Overall Study|Ineligibility determined|0|||
46696827|NCT00950911|82911400|FG000|Overall Study|Noncompliance|1|||
46860016|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
46860017|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
46860018|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
46696828|NCT00950911|82911401|FG001|Overall Study|Noncompliance|0|||
46696829|NCT00950911|82911400|FG000|Overall Study|Poor performance status|0|||
46860019|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
46860020|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
46860021|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
46696830|NCT00950911|82911401|FG001|Overall Study|Poor performance status|1|||
46860022|NCT00036270|83076290|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
46860023|NCT00036270|83076291|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
46860024|NCT00301067|83076297|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
46860025|NCT00301067|83076298|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
46860026|NCT00301067|83076299|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
46860027|NCT00301067|83076300|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
46860028|NCT00301067|83076297|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
46860029|NCT00301067|83076298|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
46860030|NCT00301067|83076299|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
46860031|NCT00301067|83076300|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
46860032|NCT00301067|83076297|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
46860033|NCT00301067|83076298|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
46860034|NCT00301067|83076299|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
46860035|NCT00301067|83076300|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
46860036|NCT00301067|83076297|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
46860037|NCT00301067|83076298|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
46860038|NCT00301067|83076299|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
46860039|NCT00301067|83076300|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
46860040|NCT00301067|83076297|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
46860041|NCT00301067|83076298|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
46860042|NCT00301067|83076299|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
46860043|NCT00301067|83076300|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
46860044|NCT00301067|83076297|FG000|Follow up Until Death|Alive at last data cut point|1|||
46860045|NCT00301067|83076298|FG001|Follow up Until Death|Alive at last data cut point|0|||
46860046|NCT00301067|83076299|FG002|Follow up Until Death|Alive at last data cut point|0|||
46860047|NCT00301067|83076300|FG003|Follow up Until Death|Alive at last data cut point|1|||
46860048|NCT00007020|83076311|FG000|Overall Study|Death|16|||
46860049|NCT00007020|83076311|FG000|Overall Study|Lost to Follow-up|13|||
46860050|NCT00007020|83076311|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
46860051|NCT00007020|83076311|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
46860052|NCT00007020|83076311|FG000|Overall Study|Pt cared for by outside physician|4|||
46860053|NCT00007020|83076311|FG000|Overall Study|No evidence of treatment|6|||
46860054|NCT00300755|83076320|FG000|Overall Study|Adverse Event|1|||
46860055|NCT00300755|83076321|FG001|Overall Study|Adverse Event|2|||
46860056|NCT00300755|83076322|FG002|Overall Study|Adverse Event|1|||
46860057|NCT00300755|83076320|FG000|Overall Study|Withdrawal by Subject|0|||
46860058|NCT00300755|83076321|FG001|Overall Study|Withdrawal by Subject|2|||
46860059|NCT00300755|83076322|FG002|Overall Study|Withdrawal by Subject|0|||
46860060|NCT00300755|83076320|FG000|Overall Study|Protocol Violation|0|||
46860061|NCT00300755|83076321|FG001|Overall Study|Protocol Violation|0|||
46860062|NCT00300755|83076322|FG002|Overall Study|Protocol Violation|1|||
46860063|NCT00033540|83076330|FG000|Overall Study|Adverse Event|14|||
46860064|NCT00033540|83076330|FG000|Overall Study|Death|1|||
46860065|NCT00033540|83076330|FG000|Overall Study|Progression|26|||
46860066|NCT00033540|83076330|FG000|Overall Study|Withdrawal by Subject|6|||
46860067|NCT00033540|83076330|FG000|Overall Study|Other|5|||
46860068|NCT00033540|83076330|FG000|Overall Study|Ineligible|3|||
46860069|NCT00033540|83076330|FG000|Overall Study|Never received treatment|2|||
46860070|NCT00300365|83076337|FG000|Overall Study|Lost to Follow-up|1|||
46860071|NCT00300365|83076338|FG001|Overall Study|Lost to Follow-up|0|||
46860072|NCT00300365|83076337|FG000|Overall Study|Physician Decision|2|||
46860073|NCT00300365|83076338|FG001|Overall Study|Physician Decision|0|||
46982189|NCT02584855|83228301|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
46982190|NCT02584855|83228302|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
46982191|NCT02584855|83228303|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
46982192|NCT02584855|83228298|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
46982193|NCT02584855|83228299|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
46982194|NCT02584855|83228300|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
46982195|NCT02584855|83228301|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
46982196|NCT02584855|83228302|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
46982197|NCT02584855|83228303|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
46982198|NCT02584855|83228298|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46982199|NCT02584855|83228299|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46982200|NCT02584855|83228300|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46982201|NCT02584855|83228301|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46982202|NCT02584855|83228302|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
46860074|NCT00300365|83076337|FG000|Overall Study|Withdrawal by Subject|1|||
46860075|NCT00300365|83076338|FG001|Overall Study|Withdrawal by Subject|0|||
46860076|NCT00300365|83076337|FG000|Overall Study|Adverse Event|0|||
46860077|NCT00300365|83076338|FG001|Overall Study|Adverse Event|2|||
46860078|NCT00048048|83076353|FG000|Core Treatment|Withdrawal by Subject|0|||
46860079|NCT00048048|83076354|FG001|Core Treatment|Withdrawal by Subject|0|||
46860080|NCT00048048|83076355|FG002|Core Treatment|Withdrawal by Subject|1|||
46860081|NCT00048048|83076356|FG003|Core Treatment|Withdrawal by Subject|0|||
46860082|NCT00048048|83076357|FG004|Core Treatment|Withdrawal by Subject|0|||
46860083|NCT00048048|83076358|FG005|Core Treatment|Withdrawal by Subject|0|||
46860084|NCT00048048|83076359|FG006|Core Treatment|Withdrawal by Subject|0|||
46860085|NCT00048048|83076360|FG007|Core Treatment|Withdrawal by Subject|0|||
46860086|NCT00048048|83076361|FG008|Core Treatment|Withdrawal by Subject|0|||
46860087|NCT00048048|83076362|FG009|Core Treatment|Withdrawal by Subject|0|||
46860088|NCT00048048|83076363|FG010|Core Treatment|Withdrawal by Subject|0|||
46982203|NCT02584855|83228303|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
46982204|NCT02584855|83228298|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
46696831|NCT01220856|82911409|FG000|Overall Study|graft loss|3|||
46696832|NCT01220856|82911410|FG001|Overall Study|graft loss|3|||
46696833|NCT01220856|82911409|FG000|Overall Study|Lost to Follow-up|1|||
46696834|NCT01220856|82911410|FG001|Overall Study|Lost to Follow-up|0|||
46696835|NCT01218594|82911419|FG000|Overall Study|Death|1|||
46696836|NCT01218594|82911419|FG000|Overall Study|Withdrawal by Subject|3|||
46696837|NCT01218594|82911419|FG000|Overall Study|Adverse Event|2|||
46696838|NCT01218594|82911419|FG000|Overall Study|Physician Decision|6|||
46696839|NCT01610557|82911427|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
46860089|NCT00048048|83076364|FG011|Core Treatment|Withdrawal by Subject|0|||
46860090|NCT00048048|83076353|FG000|Core Treatment|Adverse Event|0|||
46860091|NCT00048048|83076354|FG001|Core Treatment|Adverse Event|0|||
46982205|NCT02584855|83228299|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
46982206|NCT02584855|83228300|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
46860092|NCT00048048|83076355|FG002|Core Treatment|Adverse Event|0|||
46982207|NCT02584855|83228301|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
46696840|NCT01610557|82911428|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
46860093|NCT00048048|83076356|FG003|Core Treatment|Adverse Event|0|||
46860094|NCT00048048|83076357|FG004|Core Treatment|Adverse Event|0|||
46860095|NCT00048048|83076358|FG005|Core Treatment|Adverse Event|0|||
46860096|NCT00048048|83076359|FG006|Core Treatment|Adverse Event|0|||
46860097|NCT00048048|83076360|FG007|Core Treatment|Adverse Event|1|||
46860098|NCT00048048|83076361|FG008|Core Treatment|Adverse Event|0|||
46860099|NCT00048048|83076362|FG009|Core Treatment|Adverse Event|0|||
46860100|NCT00048048|83076363|FG010|Core Treatment|Adverse Event|0|||
46860101|NCT00048048|83076364|FG011|Core Treatment|Adverse Event|0|||
46860102|NCT00048048|83076353|FG000|Extension Year 1|Early withdrawals|0|||
46860103|NCT00048048|83076354|FG001|Extension Year 1|Early withdrawals|0|||
46860104|NCT00048048|83076355|FG002|Extension Year 1|Early withdrawals|0|||
46860105|NCT00048048|83076356|FG003|Extension Year 1|Early withdrawals|0|||
46860106|NCT00048048|83076357|FG004|Extension Year 1|Early withdrawals|0|||
46860107|NCT00048048|83076358|FG005|Extension Year 1|Early withdrawals|0|||
46860108|NCT00048048|83076359|FG006|Extension Year 1|Early withdrawals|0|||
46860109|NCT00048048|83076360|FG007|Extension Year 1|Early withdrawals|0|||
46860110|NCT00048048|83076361|FG008|Extension Year 1|Early withdrawals|0|||
46860111|NCT00048048|83076362|FG009|Extension Year 1|Early withdrawals|2|||
46860112|NCT00048048|83076363|FG010|Extension Year 1|Early withdrawals|2|||
46860113|NCT00048048|83076364|FG011|Extension Year 1|Early withdrawals|4|||
46696841|NCT01610557|82911429|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
46696842|NCT01610557|82911430|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
46696843|NCT01610557|82911431|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
46696844|NCT01610557|82911427|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
46696845|NCT01610557|82911428|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
46696846|NCT01610557|82911429|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
46696847|NCT01610557|82911430|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
46696848|NCT01610557|82911431|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
46860114|NCT00048048|83076353|FG000|Extension Year 2|Early withdrawals|0|||
46860115|NCT00048048|83076354|FG001|Extension Year 2|Early withdrawals|0|||
46860116|NCT00048048|83076355|FG002|Extension Year 2|Early withdrawals|0|||
46860117|NCT00048048|83076356|FG003|Extension Year 2|Early withdrawals|0|||
46860118|NCT00048048|83076357|FG004|Extension Year 2|Early withdrawals|0|||
46860119|NCT00048048|83076358|FG005|Extension Year 2|Early withdrawals|0|||
46860120|NCT00048048|83076359|FG006|Extension Year 2|Early withdrawals|0|||
46860121|NCT00048048|83076360|FG007|Extension Year 2|Early withdrawals|0|||
46860122|NCT00048048|83076361|FG008|Extension Year 2|Early withdrawals|0|||
46860123|NCT00048048|83076362|FG009|Extension Year 2|Early withdrawals|0|||
46860124|NCT00048048|83076363|FG010|Extension Year 2|Early withdrawals|4|||
46860125|NCT00048048|83076364|FG011|Extension Year 2|Early withdrawals|2|||
46860126|NCT00300053|83076394|FG000|Overall Study|Patient/Caregiver Preference|2|||
46860127|NCT00300053|83076395|FG001|Overall Study|Patient/Caregiver Preference|2|||
46860128|NCT00300053|83076396|FG002|Overall Study|Patient/Caregiver Preference|3|||
46860129|NCT00300053|83076394|FG000|Overall Study|Death|0|||
46860130|NCT00300053|83076395|FG001|Overall Study|Death|0|||
46860131|NCT00300053|83076396|FG002|Overall Study|Death|3|||
46860132|NCT00300053|83076394|FG000|Overall Study|Lost to Follow-up|0|||
46860133|NCT00300053|83076395|FG001|Overall Study|Lost to Follow-up|1|||
46860134|NCT00300053|83076396|FG002|Overall Study|Lost to Follow-up|0|||
46860135|NCT00299975|83076408|FG000|Overall Study|Adverse Event|1|||
46860136|NCT00299975|83076409|FG001|Overall Study|Adverse Event|0|||
46860137|NCT00299975|83076410|FG002|Overall Study|Adverse Event|2|||
46860138|NCT00299975|83076408|FG000|Overall Study|Pregnancy|0|||
46860139|NCT00299975|83076409|FG001|Overall Study|Pregnancy|0|||
46860140|NCT00299975|83076410|FG002|Overall Study|Pregnancy|1|||
46860141|NCT00299975|83076408|FG000|Overall Study|Lack of Efficacy|1|||
46860142|NCT00299975|83076409|FG001|Overall Study|Lack of Efficacy|0|||
46860143|NCT00299975|83076410|FG002|Overall Study|Lack of Efficacy|1|||
46860144|NCT00299975|83076408|FG000|Overall Study|Lost to Follow-up|1|||
46860145|NCT00299975|83076409|FG001|Overall Study|Lost to Follow-up|0|||
46860146|NCT00299975|83076410|FG002|Overall Study|Lost to Follow-up|0|||
46860147|NCT00299975|83076408|FG000|Overall Study|Withdrawal by Subject|0|||
46860148|NCT00299975|83076409|FG001|Overall Study|Withdrawal by Subject|1|||
46860149|NCT00299975|83076410|FG002|Overall Study|Withdrawal by Subject|3|||
46860150|NCT00299975|83076408|FG000|Overall Study|Physician Decision|0|||
46860151|NCT00299975|83076409|FG001|Overall Study|Physician Decision|0|||
46860152|NCT00299975|83076410|FG002|Overall Study|Physician Decision|1|||
46860153|NCT00004980|83076420|FG000|Overall Study|Withdrawal by Subject|1|||
46860154|NCT00004980|83076421|FG001|Overall Study|Withdrawal by Subject|0|||
46860155|NCT00004980|83076420|FG000|Overall Study|memory difficulties|1|||
46860156|NCT00004980|83076421|FG001|Overall Study|memory difficulties|1|||
46860157|NCT00004980|83076420|FG000|Overall Study|Physician Decision|0|||
46860158|NCT00004980|83076421|FG001|Overall Study|Physician Decision|1|||
46860159|NCT00326963|83076427|FG000|Overall Study|Adverse Event|2|||
46860160|NCT00326963|83076427|FG000|Overall Study|Injection site reaction|1|||
46860161|NCT00326963|83076427|FG000|Overall Study|Death|1|||
46860162|NCT00326963|83076427|FG000|Overall Study|Failure to return|10|||
46860163|NCT00326963|83076427|FG000|Overall Study|Withdrawal by Subject|10|||
46860164|NCT00326963|83076427|FG000|Overall Study|Refused treatment / did not cooperate|5|||
46860165|NCT00326963|83076427|FG000|Overall Study|Violation of selection criteria at entry|2|||
46860166|NCT00326963|83076427|FG000|Overall Study|Other protocol violation|1|||
46860167|NCT00326963|83076427|FG000|Overall Study|Administrative / other|1|||
46860168|NCT00326885|83076432|FG000|Overall Study|Adverse Event|1|||
46860169|NCT00326885|83076432|FG000|Overall Study|Withdrawal by Subject|3|||
46860170|NCT00326885|83076432|FG000|Overall Study|Physician Decision|1|||
46860171|NCT00326885|83076432|FG000|Overall Study|Hospice withdrew consent|2|||
46860172|NCT00326495|83076437|FG000|Overall Study|Switched to alternative treatment|1|||
46860173|NCT00326495|83076437|FG000|Overall Study|Disease progression before treatment|1|||
46860174|NCT00326495|83076437|FG000|Overall Study|Refused further treatment|2|||
46860175|NCT00326495|83076437|FG000|Overall Study|Subject off study before assessment|1|||
46860176|NCT00326417|83076443|FG000|Overall Study|Withdrawal by Subject|0|||
46860177|NCT00326417|83076444|FG001|Overall Study|Withdrawal by Subject|0|||
46860178|NCT00326417|83076445|FG002|Overall Study|Withdrawal by Subject|1|||
46860179|NCT00326417|83076446|FG003|Overall Study|Withdrawal by Subject|0|||
46860180|NCT00326417|83076443|FG000|Overall Study|Arm Closed|7|||
46860181|NCT00326417|83076444|FG001|Overall Study|Arm Closed|0|||
46860182|NCT00326417|83076445|FG002|Overall Study|Arm Closed|0|||
46860183|NCT00326417|83076446|FG003|Overall Study|Arm Closed|3|||
46860184|NCT00326417|83076443|FG000|Overall Study|Death|7|||
46860185|NCT00326417|83076444|FG001|Overall Study|Death|0|||
46860186|NCT00326417|83076445|FG002|Overall Study|Death|0|||
46860187|NCT00326417|83076446|FG003|Overall Study|Death|0|||
46860188|NCT03825341|83076456|FG000|Overall Study|Withdrawal by Subject|0|||
46860189|NCT03825341|83076457|FG001|Overall Study|Withdrawal by Subject|1|||
46860190|NCT00297479|83076468|FG000|Overall Study|Lost to Follow-up|37|||
46860191|NCT00297479|83076469|FG001|Overall Study|Lost to Follow-up|54|||
46860192|NCT00297479|83076470|FG002|Overall Study|Lost to Follow-up|51|||
46860193|NCT00688870|83076480|FG000|Infant Series|Parent or legal guardian request|4|||
46696849|NCT00943735|82911442|FG000|Overall Study|Adverse Event|12|||
46696850|NCT00943735|82911442|FG000|Overall Study|Withdrawal by Subject|8|||
46696851|NCT00943735|82911442|FG000|Overall Study|Death|1|||
46696852|NCT00943735|82911442|FG000|Overall Study|Other|8|||
46696853|NCT00943735|82911442|FG000|Overall Study|Other|3|||
46860194|NCT00688870|83076481|FG001|Infant Series|Parent or legal guardian request|0|||
46860195|NCT00297167|83076491|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
46860196|NCT00297167|83076492|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
46860197|NCT00297167|83076493|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
46860198|NCT00297167|83076491|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
46860199|NCT00297167|83076492|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
46860200|NCT00297167|83076493|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
46860201|NCT03216226|83076502|FG000|Overall Study|Adverse Event|3|||
46860202|NCT03216226|83076503|FG001|Overall Study|Adverse Event|0|||
46860203|NCT03216226|83076502|FG000|Overall Study|Protocol Violation|1|||
46860204|NCT03216226|83076503|FG001|Overall Study|Protocol Violation|3|||
46860205|NCT03216226|83076502|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
46696854|NCT00943579|82911448|FG000|Overall Study|Adverse Event|4|||
46860206|NCT03216226|83076503|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
46860207|NCT03216226|83076502|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
46860208|NCT03216226|83076503|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
46860209|NCT03216226|83076502|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
46696855|NCT00943579|82911449|FG001|Overall Study|Adverse Event|3|||
46696856|NCT00943579|82911448|FG000|Overall Study|Lack of Efficacy|2|||
46696857|NCT00943579|82911449|FG001|Overall Study|Lack of Efficacy|2|||
46696858|NCT01147809|82911464|FG000|Phase I (168 Days)|Adverse Event|0|||
46696859|NCT01147809|82911465|FG001|Phase I (168 Days)|Adverse Event|0|||
46696860|NCT01147809|82911466|FG002|Phase I (168 Days)|Adverse Event|0|||
46696861|NCT01147809|82911467|FG003|Phase I (168 Days)|Adverse Event|1|||
46696862|NCT01147809|82911468|FG004|Phase I (168 Days)|Adverse Event|0|||
46696863|NCT01147809|82911469|FG005|Phase I (168 Days)|Adverse Event|0|||
46696864|NCT01147809|82911464|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
46696865|NCT01147809|82911465|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
46696866|NCT01147809|82911466|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
46860210|NCT03216226|83076503|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
46860211|NCT03215758|83076511|FG000|Overall Study|Technical Problems|1|||
46860212|NCT03215758|83076512|FG001|Overall Study|Technical Problems|0|||
46860213|NCT03215758|83076511|FG000|Overall Study|Protocol deviation|0|||
46860214|NCT03215758|83076512|FG001|Overall Study|Protocol deviation|1|||
46860215|NCT03215758|83076511|FG000|Overall Study|Physician Decision|0|||
46860216|NCT03215758|83076512|FG001|Overall Study|Physician Decision|1|||
46860217|NCT03215758|83076511|FG000|Overall Study|Death|0|||
46860218|NCT03215758|83076512|FG001|Overall Study|Death|1|||
46860219|NCT03215758|83076511|FG000|Overall Study|Adverse Event|1|||
46860220|NCT03215758|83076512|FG001|Overall Study|Adverse Event|2|||
46860221|NCT03215758|83076511|FG000|Overall Study|Subject/Guardian Decision|3|||
46860222|NCT03215758|83076512|FG001|Overall Study|Subject/Guardian Decision|3|||
46860223|NCT00290771|83076520|FG000|Overall Study|Disease progression|95|||
46860224|NCT00290771|83076521|FG001|Overall Study|Disease progression|73|||
46860225|NCT00290771|83076520|FG000|Overall Study|Death|11|||
46860226|NCT00290771|83076521|FG001|Overall Study|Death|10|||
46860227|NCT00290771|83076520|FG000|Overall Study|Adverse Event|12|||
46860228|NCT00290771|83076521|FG001|Overall Study|Adverse Event|6|||
46860229|NCT00290771|83076520|FG000|Overall Study|Withdrawal by Subject|5|||
46860230|NCT00290771|83076521|FG001|Overall Study|Withdrawal by Subject|6|||
46860231|NCT00290771|83076520|FG000|Overall Study|Administrative problems|2|||
46860232|NCT00290771|83076521|FG001|Overall Study|Administrative problems|1|||
46860233|NCT00290771|83076520|FG000|Overall Study|Protocol Violation|2|||
46860234|NCT00290771|83076521|FG001|Overall Study|Protocol Violation|0|||
46860235|NCT00290771|83076520|FG000|Overall Study|Lost to Follow-up|0|||
46860236|NCT00290771|83076521|FG001|Overall Study|Lost to Follow-up|1|||
46860237|NCT00274625|83076530|FG000|Overall Study|Lost to Follow-up|46|||
46860238|NCT00274625|83076531|FG001|Overall Study|Lost to Follow-up|54|||
46860239|NCT00274625|83076530|FG000|Overall Study|Excluded from analysis|14|||
46860240|NCT00274625|83076531|FG001|Overall Study|Excluded from analysis|8|||
46860241|NCT00290693|83076537|FG000|Overall Study|Withdrawal by Subject|2|||
46860242|NCT03214666|83076548|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
46860243|NCT03214666|83076549|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
46860244|NCT03214666|83076550|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
46860245|NCT03214666|83076551|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
46860246|NCT03214666|83076552|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
46860247|NCT03214666|83076553|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
46860248|NCT05131646|83076571|FG000|Overall Study|Withdrawal by Subject|1|||
46696867|NCT01147809|82911467|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
46696868|NCT01147809|82911468|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
46696869|NCT01147809|82911469|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
46696870|NCT01147809|82911464|FG000|Phase I (168 Days)|Physician Decision|0|||
46860249|NCT05131646|83076572|FG001|Overall Study|Withdrawal by Subject|0|||
46860250|NCT05131646|83076573|FG002|Overall Study|Withdrawal by Subject|0|||
46860251|NCT04784442|83076585|FG000|Overall Study|Adverse Event|1|||
46860252|NCT04784442|83076586|FG001|Overall Study|Adverse Event|0|||
46860253|NCT04784442|83076587|FG002|Overall Study|Adverse Event|2|||
46860254|NCT04784442|83076588|FG003|Overall Study|Adverse Event|1|||
46860255|NCT04784442|83076585|FG000|Overall Study|Protocol Violation|1|||
46696871|NCT01147809|82911465|FG001|Phase I (168 Days)|Physician Decision|1|||
46696872|NCT01147809|82911466|FG002|Phase I (168 Days)|Physician Decision|2|||
46696873|NCT01147809|82911467|FG003|Phase I (168 Days)|Physician Decision|0|||
46696874|NCT01147809|82911468|FG004|Phase I (168 Days)|Physician Decision|0|||
46696875|NCT01147809|82911469|FG005|Phase I (168 Days)|Physician Decision|0|||
46696876|NCT01147809|82911464|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
46696877|NCT01147809|82911465|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
46696878|NCT01147809|82911466|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
46696879|NCT01147809|82911467|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
46696880|NCT01147809|82911468|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
46696881|NCT01147809|82911469|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
46696882|NCT01147809|82911464|FG000|Phase II (168 Days)|Adverse Event|0|||
46696883|NCT01147809|82911465|FG001|Phase II (168 Days)|Adverse Event|0|||
46696884|NCT01147809|82911466|FG002|Phase II (168 Days)|Adverse Event|0|||
46696885|NCT01147809|82911467|FG003|Phase II (168 Days)|Adverse Event|0|||
46696886|NCT01147809|82911468|FG004|Phase II (168 Days)|Adverse Event|3|||
46696887|NCT01147809|82911469|FG005|Phase II (168 Days)|Adverse Event|6|||
46696888|NCT01147809|82911464|FG000|Phase II (168 Days)|Protocol Violation|0|||
46696889|NCT01147809|82911465|FG001|Phase II (168 Days)|Protocol Violation|0|||
46696890|NCT01147809|82911466|FG002|Phase II (168 Days)|Protocol Violation|0|||
46696891|NCT01147809|82911467|FG003|Phase II (168 Days)|Protocol Violation|0|||
46696892|NCT01147809|82911468|FG004|Phase II (168 Days)|Protocol Violation|0|||
46696893|NCT01147809|82911469|FG005|Phase II (168 Days)|Protocol Violation|1|||
46696894|NCT01147809|82911464|FG000|Phase II (168 Days)|Physician Decision|0|||
46696895|NCT01147809|82911465|FG001|Phase II (168 Days)|Physician Decision|0|||
46696896|NCT01147809|82911466|FG002|Phase II (168 Days)|Physician Decision|0|||
46696897|NCT01147809|82911467|FG003|Phase II (168 Days)|Physician Decision|0|||
46696898|NCT01147809|82911468|FG004|Phase II (168 Days)|Physician Decision|5|||
46696899|NCT01147809|82911469|FG005|Phase II (168 Days)|Physician Decision|11|||
46696900|NCT01147809|82911464|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
46696901|NCT01147809|82911465|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
46696902|NCT01147809|82911466|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
46696903|NCT01147809|82911467|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
46860256|NCT04784442|83076586|FG001|Overall Study|Protocol Violation|0|||
46982208|NCT02584855|83228302|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
46982209|NCT02584855|83228303|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
46982210|NCT02581345|83228318|FG000|Part 1: up to Week 16|Adverse Event|3|||
46982211|NCT02581345|83228319|FG001|Part 1: up to Week 16|Adverse Event|8|||
46982212|NCT02581345|83228320|FG002|Part 1: up to Week 16|Adverse Event|0|||
46982213|NCT02581345|83228321|FG003|Part 1: up to Week 16|Adverse Event|0|||
46982214|NCT02581345|83228318|FG000|Part 1: up to Week 16|Physician Decision|2|||
46982215|NCT02581345|83228319|FG001|Part 1: up to Week 16|Physician Decision|4|||
46982216|NCT02581345|83228320|FG002|Part 1: up to Week 16|Physician Decision|0|||
46982217|NCT02581345|83228321|FG003|Part 1: up to Week 16|Physician Decision|0|||
46982218|NCT02581345|83228318|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
46982219|NCT02581345|83228319|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
46982220|NCT02581345|83228320|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
46982221|NCT02581345|83228321|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
46982222|NCT02581345|83228318|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
46982223|NCT02581345|83228319|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
46982224|NCT02581345|83228320|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
46982225|NCT02581345|83228321|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
46982226|NCT02581345|83228318|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
46982227|NCT02581345|83228319|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
46982228|NCT02581345|83228320|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
46982229|NCT02581345|83228321|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
46982230|NCT02581345|83228318|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
46696904|NCT01147809|82911468|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
46696905|NCT01147809|82911469|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
46696906|NCT01147809|82911464|FG000|Phase II (168 Days)|Ongoing|0|||
46696907|NCT01147809|82911465|FG001|Phase II (168 Days)|Ongoing|0|||
46982231|NCT02581345|83228319|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
46982232|NCT02581345|83228320|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
46982233|NCT02581345|83228321|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
46982234|NCT02581345|83228318|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
46696908|NCT01147809|82911466|FG002|Phase II (168 Days)|Ongoing|0|||
46696909|NCT01147809|82911467|FG003|Phase II (168 Days)|Ongoing|0|||
46860257|NCT04784442|83076587|FG002|Overall Study|Protocol Violation|0|||
46860258|NCT04784442|83076588|FG003|Overall Study|Protocol Violation|0|||
46860259|NCT04784442|83076585|FG000|Overall Study|Non-compliance with study drug|1|||
46860260|NCT04784442|83076586|FG001|Overall Study|Non-compliance with study drug|0|||
46860261|NCT04784442|83076587|FG002|Overall Study|Non-compliance with study drug|0|||
46860262|NCT04784442|83076588|FG003|Overall Study|Non-compliance with study drug|0|||
46860263|NCT04731922|83076615|FG000|Overall Study|Adverse Event|0|||
46860264|NCT04731922|83076616|FG001|Overall Study|Adverse Event|0|||
46860265|NCT04731922|83076617|FG002|Overall Study|Adverse Event|0|||
46860266|NCT04731922|83076618|FG003|Overall Study|Adverse Event|0|||
46860267|NCT04731922|83076619|FG004|Overall Study|Adverse Event|0|||
46860268|NCT04731922|83076620|FG005|Overall Study|Adverse Event|0|||
46860269|NCT04731922|83076621|FG006|Overall Study|Adverse Event|0|||
46860270|NCT04731922|83076622|FG007|Overall Study|Adverse Event|0|||
46860271|NCT04731922|83076623|FG008|Overall Study|Adverse Event|0|||
46860272|NCT04731922|83076624|FG009|Overall Study|Adverse Event|0|||
46860273|NCT04731922|83076625|FG010|Overall Study|Adverse Event|1|||
46860274|NCT04731922|83076626|FG011|Overall Study|Adverse Event|0|||
46860275|NCT04731922|83076627|FG012|Overall Study|Adverse Event|0|||
46696910|NCT01147809|82911468|FG004|Phase II (168 Days)|Ongoing|1|||
46696911|NCT01147809|82911469|FG005|Phase II (168 Days)|Ongoing|0|||
46696912|NCT00943111|82911486|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
46696913|NCT00943111|82911487|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
46696914|NCT00943111|82911488|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
46696915|NCT00943111|82911486|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
46696916|NCT00943111|82911487|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
46696917|NCT00943111|82911488|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
46696918|NCT00943111|82911486|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
46696919|NCT00943111|82911487|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
46696920|NCT00943111|82911488|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
46696921|NCT00943111|82911486|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
46696922|NCT00943111|82911487|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
46860276|NCT04731922|83076628|FG013|Overall Study|Adverse Event|0|||
46860277|NCT04731922|83076629|FG014|Overall Study|Adverse Event|0|||
46860278|NCT04731922|83076630|FG015|Overall Study|Adverse Event|0|||
46860279|NCT04731922|83076631|FG016|Overall Study|Adverse Event|0|||
46860280|NCT04731922|83076615|FG000|Overall Study|Lost to Follow-up|0|||
46696923|NCT00943111|82911488|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
46696924|NCT00943111|82911486|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
46860281|NCT04731922|83076616|FG001|Overall Study|Lost to Follow-up|0|||
46860282|NCT04731922|83076617|FG002|Overall Study|Lost to Follow-up|0|||
46860283|NCT04731922|83076618|FG003|Overall Study|Lost to Follow-up|1|||
46860284|NCT04731922|83076619|FG004|Overall Study|Lost to Follow-up|0|||
46860285|NCT04731922|83076620|FG005|Overall Study|Lost to Follow-up|1|||
46696925|NCT00943111|82911487|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
46696926|NCT00943111|82911488|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
46696927|NCT00943111|82911486|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
46696928|NCT00943111|82911487|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
46696929|NCT00943111|82911488|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
46696930|NCT00943111|82911486|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
46696931|NCT00943111|82911487|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
46696932|NCT00943111|82911488|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
46696933|NCT00943111|82911486|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
46696934|NCT00943111|82911487|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
46696935|NCT00943111|82911488|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
46696936|NCT01147497|82911497|FG000|Overall Study|failed insertion|2|||
46696937|NCT01147497|82911498|FG001|Overall Study|failed insertion|0|||
46860286|NCT04731922|83076621|FG006|Overall Study|Lost to Follow-up|0|||
46860287|NCT04731922|83076622|FG007|Overall Study|Lost to Follow-up|0|||
46860288|NCT04731922|83076623|FG008|Overall Study|Lost to Follow-up|0|||
46860289|NCT04731922|83076624|FG009|Overall Study|Lost to Follow-up|0|||
46860290|NCT04731922|83076625|FG010|Overall Study|Lost to Follow-up|0|||
46860291|NCT04731922|83076626|FG011|Overall Study|Lost to Follow-up|0|||
46860292|NCT04731922|83076627|FG012|Overall Study|Lost to Follow-up|0|||
46696938|NCT01147341|82911506|FG000|Double Blind Period|Lack of Efficacy|1|||
46696939|NCT01147341|82911507|FG001|Double Blind Period|Lack of Efficacy|1|||
46696940|NCT01147341|82911506|FG000|Double Blind Period|Withdrawal by Subject|0|||
46696941|NCT01147341|82911507|FG001|Double Blind Period|Withdrawal by Subject|1|||
46696942|NCT01147341|82911506|FG000|Open Label Period|Lack of Efficacy|3|||
46696943|NCT01147341|82911507|FG001|Open Label Period|Lack of Efficacy|0|||
46696944|NCT01147341|82911506|FG000|Open Label Period|Subject moved|1|||
46696945|NCT01147341|82911507|FG001|Open Label Period|Subject moved|0|||
46860293|NCT04731922|83076628|FG013|Overall Study|Lost to Follow-up|0|||
46860294|NCT04731922|83076629|FG014|Overall Study|Lost to Follow-up|0|||
46860295|NCT04731922|83076630|FG015|Overall Study|Lost to Follow-up|0|||
46860296|NCT04731922|83076631|FG016|Overall Study|Lost to Follow-up|0|||
46860297|NCT04731922|83076615|FG000|Overall Study|Withdrawal by Subject|1|||
46860298|NCT04731922|83076616|FG001|Overall Study|Withdrawal by Subject|0|||
46860299|NCT04731922|83076617|FG002|Overall Study|Withdrawal by Subject|0|||
46860300|NCT04731922|83076618|FG003|Overall Study|Withdrawal by Subject|0|||
46860301|NCT04731922|83076619|FG004|Overall Study|Withdrawal by Subject|1|||
46860302|NCT04731922|83076620|FG005|Overall Study|Withdrawal by Subject|0|||
46860303|NCT04731922|83076621|FG006|Overall Study|Withdrawal by Subject|1|||
46696946|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
46696947|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
46696948|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
46696949|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
46696950|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
46696951|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
46860304|NCT04731922|83076622|FG007|Overall Study|Withdrawal by Subject|0|||
46860305|NCT04731922|83076623|FG008|Overall Study|Withdrawal by Subject|0|||
46860306|NCT04731922|83076624|FG009|Overall Study|Withdrawal by Subject|0|||
46860307|NCT04731922|83076625|FG010|Overall Study|Withdrawal by Subject|0|||
46860308|NCT04731922|83076626|FG011|Overall Study|Withdrawal by Subject|0|||
46860309|NCT04731922|83076627|FG012|Overall Study|Withdrawal by Subject|0|||
46860310|NCT04731922|83076628|FG013|Overall Study|Withdrawal by Subject|1|||
46860311|NCT04731922|83076629|FG014|Overall Study|Withdrawal by Subject|0|||
46860312|NCT04731922|83076630|FG015|Overall Study|Withdrawal by Subject|0|||
46860313|NCT04731922|83076631|FG016|Overall Study|Withdrawal by Subject|0|||
46860314|NCT04731922|83076615|FG000|Overall Study|Other|0|||
46860315|NCT04731922|83076616|FG001|Overall Study|Other|0|||
46860316|NCT04731922|83076617|FG002|Overall Study|Other|0|||
46860317|NCT04731922|83076618|FG003|Overall Study|Other|0|||
46860318|NCT04731922|83076619|FG004|Overall Study|Other|0|||
46860319|NCT04731922|83076620|FG005|Overall Study|Other|0|||
46860320|NCT04731922|83076621|FG006|Overall Study|Other|1|||
46860321|NCT04731922|83076622|FG007|Overall Study|Other|0|||
46860322|NCT04731922|83076623|FG008|Overall Study|Other|0|||
46860323|NCT04731922|83076624|FG009|Overall Study|Other|0|||
46860324|NCT04731922|83076625|FG010|Overall Study|Other|0|||
46860325|NCT04731922|83076626|FG011|Overall Study|Other|0|||
46860326|NCT04731922|83076627|FG012|Overall Study|Other|0|||
46860327|NCT04731922|83076628|FG013|Overall Study|Other|0|||
46860328|NCT04731922|83076629|FG014|Overall Study|Other|0|||
46860329|NCT04731922|83076630|FG015|Overall Study|Other|0|||
46860330|NCT04731922|83076631|FG016|Overall Study|Other|0|||
46860331|NCT04314843|83076686|FG000|Overall Study|Death|2|||
46860332|NCT04314843|83076687|FG001|Overall Study|Death|2|||
46860333|NCT04314843|83076686|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
46860334|NCT04314843|83076687|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
46860335|NCT04266795|83076696|FG000|Overall Study|Adverse Event|10|||
46860336|NCT04266795|83076697|FG001|Overall Study|Adverse Event|19|||
46860337|NCT04266795|83076696|FG000|Overall Study|Death|7|||
46860338|NCT04266795|83076697|FG001|Overall Study|Death|8|||
46860339|NCT04266795|83076696|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
46860340|NCT04266795|83076697|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
46860341|NCT04266795|83076696|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
46860342|NCT04266795|83076697|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
46860343|NCT04266795|83076696|FG000|Overall Study|Progressive Disease|12|||
46860344|NCT04266795|83076697|FG001|Overall Study|Progressive Disease|9|||
46860345|NCT04266795|83076696|FG000|Overall Study|Withdrawal by Patient|5|||
46860346|NCT04266795|83076697|FG001|Overall Study|Withdrawal by Patient|6|||
46860347|NCT04266795|83076696|FG000|Overall Study|Disease Relapse|3|||
46860348|NCT04266795|83076697|FG001|Overall Study|Disease Relapse|6|||
46860349|NCT04266795|83076696|FG000|Overall Study|Reason not Specified|12|||
46860350|NCT04266795|83076697|FG001|Overall Study|Reason not Specified|10|||
46860351|NCT04266795|83076696|FG000|Overall Study|Participants Ongoing on Treatment|25|||
46860352|NCT04266795|83076697|FG001|Overall Study|Participants Ongoing on Treatment|23|||
46860353|NCT04175834|83076724|FG000|Overall Study|Withdrawal by Subject|1|||
46860354|NCT04175834|83076725|FG001|Overall Study|Withdrawal by Subject|0|||
46860355|NCT04158583|83076743|FG000|Overall Study|Withdrawal by Subject|1|||
46860356|NCT04158583|83076744|FG001|Overall Study|Withdrawal by Subject|1|||
46860357|NCT04158583|83076745|FG002|Overall Study|Withdrawal by Subject|0|||
46860358|NCT04158583|83076746|FG003|Overall Study|Withdrawal by Subject|0|||
46860359|NCT04158583|83076747|FG004|Overall Study|Withdrawal by Subject|1|||
46860360|NCT04158583|83076748|FG005|Overall Study|Withdrawal by Subject|0|||
46860361|NCT04158583|83076749|FG006|Overall Study|Withdrawal by Subject|0|||
46860362|NCT04158583|83076750|FG007|Overall Study|Withdrawal by Subject|0|||
46860363|NCT04158583|83076751|FG008|Overall Study|Withdrawal by Subject|2|||
46860364|NCT04158583|83076752|FG009|Overall Study|Withdrawal by Subject|0|||
46860365|NCT04158583|83076743|FG000|Overall Study|Study Terminated by Sponsor|0|||
46696952|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
46696953|NCT00950755|82911513|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
46696954|NCT00950755|82911513|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
46696955|NCT00950755|82911513|FG000|Long-Term Follow-Up|Death|8|||
46696956|NCT01147107|82911519|FG000|Overall Study|Lack of Efficacy|5|||
46696957|NCT01147107|82911520|FG001|Overall Study|Lack of Efficacy|0|||
46696958|NCT01147107|82911519|FG000|Overall Study|Withdrawal by Subject|1|||
46696959|NCT01147107|82911520|FG001|Overall Study|Withdrawal by Subject|1|||
46696960|NCT00942409|82911526|FG000|Overall Study|Lack of Efficacy|1|||
46696961|NCT00942409|82911526|FG000|Overall Study|study drug unavailable|2|||
46696962|NCT01146951|82911532|FG000|Overall Study|Adverse Event|4|||
46860366|NCT04158583|83076744|FG001|Overall Study|Study Terminated by Sponsor|0|||
46860367|NCT04158583|83076745|FG002|Overall Study|Study Terminated by Sponsor|0|||
46696963|NCT01146951|82911533|FG001|Overall Study|Adverse Event|1|||
46696964|NCT01146873|82911541|FG000|Overall Study|Transfer out|0|||
46860368|NCT04158583|83076746|FG003|Overall Study|Study Terminated by Sponsor|1|||
46860369|NCT04158583|83076747|FG004|Overall Study|Study Terminated by Sponsor|0|||
46696965|NCT01146873|82911542|FG001|Overall Study|Transfer out|6|||
46696966|NCT01146795|82911548|FG000|Overall Study|Withdrawal by Subject|4|||
46696967|NCT01146795|82911548|FG000|Overall Study|Adverse Event|6|||
46860370|NCT04158583|83076748|FG005|Overall Study|Study Terminated by Sponsor|0|||
46860371|NCT04158583|83076749|FG006|Overall Study|Study Terminated by Sponsor|0|||
46860372|NCT04158583|83076750|FG007|Overall Study|Study Terminated by Sponsor|0|||
46860373|NCT04158583|83076751|FG008|Overall Study|Study Terminated by Sponsor|0|||
46860374|NCT04158583|83076752|FG009|Overall Study|Study Terminated by Sponsor|0|||
46696968|NCT01146795|82911548|FG000|Overall Study|Still in treatment at study closure|10|||
46860375|NCT04158583|83076743|FG000|Overall Study|Progressive Disease|1|||
46860376|NCT04158583|83076744|FG001|Overall Study|Progressive Disease|0|||
46860377|NCT04158583|83076745|FG002|Overall Study|Progressive Disease|3|||
46860378|NCT04158583|83076746|FG003|Overall Study|Progressive Disease|5|||
46860379|NCT04158583|83076747|FG004|Overall Study|Progressive Disease|0|||
46860380|NCT04158583|83076748|FG005|Overall Study|Progressive Disease|1|||
46860381|NCT04158583|83076749|FG006|Overall Study|Progressive Disease|6|||
46860382|NCT04158583|83076750|FG007|Overall Study|Progressive Disease|2|||
46860383|NCT04158583|83076751|FG008|Overall Study|Progressive Disease|1|||
46860384|NCT04158583|83076752|FG009|Overall Study|Progressive Disease|2|||
46860385|NCT04158583|83076743|FG000|Overall Study|Lost to Follow-up|0|||
46860386|NCT04158583|83076744|FG001|Overall Study|Lost to Follow-up|0|||
46860387|NCT04158583|83076745|FG002|Overall Study|Lost to Follow-up|1|||
46860388|NCT04158583|83076746|FG003|Overall Study|Lost to Follow-up|1|||
46860389|NCT04158583|83076747|FG004|Overall Study|Lost to Follow-up|1|||
46860390|NCT04158583|83076748|FG005|Overall Study|Lost to Follow-up|0|||
46860391|NCT04158583|83076749|FG006|Overall Study|Lost to Follow-up|0|||
46860392|NCT04158583|83076750|FG007|Overall Study|Lost to Follow-up|0|||
46860393|NCT04158583|83076751|FG008|Overall Study|Lost to Follow-up|0|||
46860394|NCT04158583|83076752|FG009|Overall Study|Lost to Follow-up|0|||
46860395|NCT04158583|83076743|FG000|Overall Study|Due To Patient Status|0|||
46860396|NCT04158583|83076744|FG001|Overall Study|Due To Patient Status|0|||
46860397|NCT04158583|83076745|FG002|Overall Study|Due To Patient Status|0|||
46860398|NCT04158583|83076746|FG003|Overall Study|Due To Patient Status|0|||
46860399|NCT04158583|83076747|FG004|Overall Study|Due To Patient Status|0|||
46860400|NCT04158583|83076748|FG005|Overall Study|Due To Patient Status|0|||
46860401|NCT04158583|83076749|FG006|Overall Study|Due To Patient Status|0|||
46860402|NCT04158583|83076750|FG007|Overall Study|Due To Patient Status|0|||
46860403|NCT04158583|83076751|FG008|Overall Study|Due To Patient Status|1|||
46860404|NCT04158583|83076752|FG009|Overall Study|Due To Patient Status|0|||
46860405|NCT04158583|83076743|FG000|Overall Study|Death|3|||
46860406|NCT04158583|83076744|FG001|Overall Study|Death|4|||
46860407|NCT04158583|83076745|FG002|Overall Study|Death|2|||
46860408|NCT04158583|83076746|FG003|Overall Study|Death|2|||
46860409|NCT04158583|83076747|FG004|Overall Study|Death|4|||
46860410|NCT04158583|83076748|FG005|Overall Study|Death|3|||
46860411|NCT04158583|83076749|FG006|Overall Study|Death|5|||
46860412|NCT04158583|83076750|FG007|Overall Study|Death|2|||
46860413|NCT04158583|83076751|FG008|Overall Study|Death|0|||
46860414|NCT04158583|83076752|FG009|Overall Study|Death|1|||
46982235|NCT02581345|83228319|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
46982236|NCT02581345|83228320|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
46982237|NCT02581345|83228321|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
46982238|NCT02581345|83228318|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
46982239|NCT02581345|83228319|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
46982240|NCT02581345|83228320|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
46982241|NCT02581345|83228321|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
46982242|NCT02581345|83228318|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
46982243|NCT02581345|83228319|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
46982244|NCT02581345|83228320|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
46982245|NCT02581345|83228321|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
46982246|NCT02581345|83228318|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
46982247|NCT02581345|83228319|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
46982248|NCT02581345|83228320|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
46982249|NCT02581345|83228321|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
46982250|NCT02581345|83228318|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
46982251|NCT02581345|83228319|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
46982252|NCT02581345|83228320|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
46982253|NCT02581345|83228321|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
46982254|NCT02581345|83228318|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
46982255|NCT02581345|83228319|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
46860415|NCT04158583|83076743|FG000|Overall Study|Clinical Progression Disease|0|||
46860416|NCT04158583|83076744|FG001|Overall Study|Clinical Progression Disease|0|||
46860417|NCT04158583|83076745|FG002|Overall Study|Clinical Progression Disease|0|||
46860418|NCT04158583|83076746|FG003|Overall Study|Clinical Progression Disease|1|||
46982256|NCT02581345|83228320|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
46982257|NCT02581345|83228321|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
46982258|NCT02581189|83228339|FG000|Overall Study|Failure to return|36|||
46982259|NCT02581189|83228339|FG000|Overall Study|Withdrew consent|5|||
46982260|NCT02581189|83228339|FG000|Overall Study|Death|3|||
46860419|NCT04158583|83076747|FG004|Overall Study|Clinical Progression Disease|0|||
46860420|NCT04158583|83076748|FG005|Overall Study|Clinical Progression Disease|0|||
46860421|NCT04158583|83076749|FG006|Overall Study|Clinical Progression Disease|0|||
46860422|NCT04158583|83076750|FG007|Overall Study|Clinical Progression Disease|0|||
46860423|NCT04158583|83076751|FG008|Overall Study|Clinical Progression Disease|0|||
46860424|NCT04158583|83076752|FG009|Overall Study|Clinical Progression Disease|0|||
46860425|NCT04158583|83076743|FG000|Overall Study|Clinical Progression|0|||
46982261|NCT02581189|83228339|FG000|Overall Study|Insufficient virological response|2|||
46982262|NCT02581189|83228339|FG000|Overall Study|Other, not specified|7|||
46982263|NCT02576977|83228348|FG000|Overall Study|Adverse Event|13|||
46982264|NCT02576977|83228349|FG001|Overall Study|Adverse Event|2|||
46982265|NCT02576977|83228348|FG000|Overall Study|Death|73|||
46982266|NCT02576977|83228349|FG001|Overall Study|Death|60|||
46982267|NCT02576977|83228348|FG000|Overall Study|Screen failure|1|||
46982268|NCT02576977|83228349|FG001|Overall Study|Screen failure|0|||
46982269|NCT02576977|83228348|FG000|Overall Study|Study Terminated at Selected Sites|27|||
46982270|NCT02576977|83228349|FG001|Overall Study|Study Terminated at Selected Sites|50|||
46982271|NCT02576977|83228348|FG000|Overall Study|Withdrawal by Subject|11|||
46982272|NCT02576977|83228349|FG001|Overall Study|Withdrawal by Subject|11|||
46982273|NCT02576977|83228348|FG000|Overall Study|Final Disposition Unknown|0|||
46982274|NCT02576977|83228349|FG001|Overall Study|Final Disposition Unknown|1|||
46982275|NCT02576977|83228348|FG000|Overall Study|Lost to Follow-up|1|||
46860426|NCT04158583|83076744|FG001|Overall Study|Clinical Progression|0|||
46860427|NCT04158583|83076745|FG002|Overall Study|Clinical Progression|0|||
46860428|NCT04158583|83076746|FG003|Overall Study|Clinical Progression|0|||
46860429|NCT04158583|83076747|FG004|Overall Study|Clinical Progression|1|||
46860430|NCT04158583|83076748|FG005|Overall Study|Clinical Progression|0|||
46860431|NCT04158583|83076749|FG006|Overall Study|Clinical Progression|2|||
46860432|NCT04158583|83076750|FG007|Overall Study|Clinical Progression|0|||
46860433|NCT04158583|83076751|FG008|Overall Study|Clinical Progression|0|||
46860434|NCT04158583|83076752|FG009|Overall Study|Clinical Progression|0|||
46860435|NCT04158583|83076743|FG000|Overall Study|Clinical Deterioration|0|||
46860436|NCT04158583|83076744|FG001|Overall Study|Clinical Deterioration|0|||
46860437|NCT04158583|83076745|FG002|Overall Study|Clinical Deterioration|0|||
46860438|NCT04158583|83076746|FG003|Overall Study|Clinical Deterioration|1|||
46860439|NCT04158583|83076747|FG004|Overall Study|Clinical Deterioration|0|||
46860440|NCT04158583|83076748|FG005|Overall Study|Clinical Deterioration|0|||
46860441|NCT04158583|83076749|FG006|Overall Study|Clinical Deterioration|0|||
46860442|NCT04158583|83076750|FG007|Overall Study|Clinical Deterioration|0|||
46860443|NCT04158583|83076751|FG008|Overall Study|Clinical Deterioration|0|||
46860444|NCT04158583|83076752|FG009|Overall Study|Clinical Deterioration|1|||
46860445|NCT03820986|83076793|FG000|Overall Study|Death|177|||
46860446|NCT03820986|83076794|FG001|Overall Study|Death|156|||
46860447|NCT03820986|83076793|FG000|Overall Study|Lost to Follow-up|0|||
46860448|NCT03820986|83076794|FG001|Overall Study|Lost to Follow-up|1|||
46860449|NCT03820986|83076793|FG000|Overall Study|Withdrawal by Subject|8|||
46860450|NCT03820986|83076794|FG001|Overall Study|Withdrawal by Subject|3|||
46860451|NCT03820986|83076793|FG000|Overall Study|Ongoing|149|||
46860452|NCT03820986|83076794|FG001|Overall Study|Ongoing|180|||
46860453|NCT03705351|83076802|FG000|Overall Study|Study termination|3|||
46860454|NCT03705351|83076802|FG000|Overall Study|Death|1|||
46860455|NCT03705351|83076802|FG000|Overall Study|Lack of Efficacy|2|||
46860456|NCT03705351|83076802|FG000|Overall Study|Withdrawal by Subject|1|||
46860457|NCT03436797|83076806|FG000|Main Study|Withdrawal by Subject|2|||
46860458|NCT03436797|83076806|FG000|Main Study|Adverse Event|4|||
46860459|NCT03436797|83076806|FG000|Main Study|Lost to Follow-up|1|||
46860460|NCT03436797|83076806|FG000|Main Study|Death|1|||
46860461|NCT03436797|83076806|FG000|Main Study|Non-Specific|2|||
46860462|NCT03436797|83076806|FG000|Extended Dosing|Patient decision|1|||
46860463|NCT03330847|83076822|FG000|Overall Study|Patients ongoing study|62|||
46860464|NCT03330847|83076823|FG001|Overall Study|Patients ongoing study|65|||
46860465|NCT03330847|83076824|FG002|Overall Study|Patients ongoing study|15|||
46860466|NCT02851615|83076870|FG000|Overall Study|Cognitive Issue|1|||
46982276|NCT02576977|83228349|FG001|Overall Study|Lost to Follow-up|0|||
46982277|NCT02576977|83228348|FG000|Overall Study|Progressive Disease|0|||
46982278|NCT02576977|83228349|FG001|Overall Study|Progressive Disease|1|||
46860467|NCT02851615|83076871|FG001|Overall Study|Cognitive Issue|0|||
46860468|NCT02851615|83076870|FG000|Overall Study|Lost to Follow-up|0|||
46860469|NCT02851615|83076871|FG001|Overall Study|Lost to Follow-up|4|||
46860470|NCT02735343|83076880|FG000|Overall Study|screen fail|0|||
46860471|NCT02735343|83076881|FG001|Overall Study|screen fail|2|||
46860472|NCT02475681|83076908|FG000|Overall Study|Death|16|||
46982279|NCT05150964|83228355|FG000|Overall Study|Lost to Follow-up|2|||
46696969|NCT01146561|82911552|FG000|Overall Study|Withdrawal by Subject|1|||
46696970|NCT01146561|82911552|FG000|Overall Study|Lost to Follow-up|1|||
46696971|NCT00942175|82911560|FG000|Overall Study|Adverse Event|2|||
46696972|NCT00942175|82911561|FG001|Overall Study|Adverse Event|1|||
46696973|NCT00942175|82911562|FG002|Overall Study|Adverse Event|0|||
46696974|NCT00942175|82911563|FG003|Overall Study|Adverse Event|0|||
46696975|NCT00942175|82911560|FG000|Overall Study|Protocol Violation|0|||
46696976|NCT00942175|82911561|FG001|Overall Study|Protocol Violation|1|||
46696977|NCT00942175|82911562|FG002|Overall Study|Protocol Violation|2|||
46696978|NCT00942175|82911563|FG003|Overall Study|Protocol Violation|0|||
46696979|NCT00942175|82911560|FG000|Overall Study|Pregnancy|0|||
46696980|NCT00942175|82911561|FG001|Overall Study|Pregnancy|0|||
46696981|NCT00942175|82911562|FG002|Overall Study|Pregnancy|0|||
46696982|NCT00942175|82911563|FG003|Overall Study|Pregnancy|1|||
46696983|NCT00942175|82911560|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
46696984|NCT00942175|82911561|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
46696985|NCT00942175|82911562|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
46696986|NCT00942175|82911563|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
46696987|NCT00942175|82911560|FG000|Overall Study|Low Platelet Count|0|||
46696988|NCT00942175|82911561|FG001|Overall Study|Low Platelet Count|2|||
46696989|NCT00942175|82911562|FG002|Overall Study|Low Platelet Count|0|||
46696990|NCT00942175|82911563|FG003|Overall Study|Low Platelet Count|0|||
46696991|NCT01145625|82911583|FG000|Overall Study|Lost to Follow-up|8|||
46696992|NCT01145625|82911584|FG001|Overall Study|Lost to Follow-up|9|||
46696993|NCT01145625|82911583|FG000|Overall Study|Adverse Event|6|||
46696994|NCT01145625|82911584|FG001|Overall Study|Adverse Event|4|||
46696995|NCT01145625|82911583|FG000|Overall Study|Protocol Violation|3|||
46696996|NCT01145625|82911584|FG001|Overall Study|Protocol Violation|1|||
46696997|NCT01145625|82911583|FG000|Overall Study|Withdrawal by Subject|7|||
46696998|NCT01145625|82911584|FG001|Overall Study|Withdrawal by Subject|16|||
46696999|NCT01145625|82911583|FG000|Overall Study|Pregnancy|0|||
46697000|NCT01145625|82911584|FG001|Overall Study|Pregnancy|1|||
46697001|NCT01144377|82911595|FG000|52 Week Treatment Period|Adverse Event|0|||
46697002|NCT01144377|82911596|FG001|52 Week Treatment Period|Adverse Event|0|||
46697003|NCT01144377|82911597|FG002|52 Week Treatment Period|Adverse Event|3|||
46697004|NCT01144377|82911598|FG003|52 Week Treatment Period|Adverse Event|2|||
46697005|NCT01144377|82911599|FG004|52 Week Treatment Period|Adverse Event|1|||
46697006|NCT01144377|82911595|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
46697007|NCT01144377|82911596|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
46697008|NCT01144377|82911597|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
46697009|NCT01144377|82911598|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
46860473|NCT02475681|83076909|FG001|Overall Study|Death|6|||
46860474|NCT02475681|83076910|FG002|Overall Study|Death|9|||
46860475|NCT02475681|83076908|FG000|Overall Study|Physician Decision|0|||
46860476|NCT02475681|83076909|FG001|Overall Study|Physician Decision|3|||
46860477|NCT02475681|83076910|FG002|Overall Study|Physician Decision|1|||
46860478|NCT02475681|83076908|FG000|Overall Study|Withdrawal by Subject|12|||
46860479|NCT02475681|83076909|FG001|Overall Study|Withdrawal by Subject|6|||
46860480|NCT02475681|83076910|FG002|Overall Study|Withdrawal by Subject|9|||
46860481|NCT02475681|83076908|FG000|Overall Study|Lost to Follow-up|2|||
46860482|NCT02475681|83076909|FG001|Overall Study|Lost to Follow-up|1|||
46860483|NCT02475681|83076910|FG002|Overall Study|Lost to Follow-up|3|||
46860484|NCT02475681|83076908|FG000|Overall Study|Ongoing in Study|0|||
46697010|NCT01144377|82911599|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
46697011|NCT01144377|82911595|FG000|52 Week Treatment Period|Protocol Violation|0|||
46697012|NCT01144377|82911596|FG001|52 Week Treatment Period|Protocol Violation|0|||
46697013|NCT01144377|82911597|FG002|52 Week Treatment Period|Protocol Violation|0|||
46860485|NCT02475681|83076909|FG001|Overall Study|Ongoing in Study|163|||
46860486|NCT02475681|83076910|FG002|Overall Study|Ongoing in Study|157|||
46860487|NCT02475681|83076908|FG000|Overall Study|Reasons other than above listed|2|||
46982280|NCT04952402|83228363|FG000|Overall Study|Lost to Follow-up|1|||
46982281|NCT04952402|83228364|FG001|Overall Study|Lost to Follow-up|3|||
46697014|NCT01144377|82911598|FG003|52 Week Treatment Period|Protocol Violation|0|||
46697015|NCT01144377|82911599|FG004|52 Week Treatment Period|Protocol Violation|1|||
46697016|NCT01144377|82911595|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
46860488|NCT02475681|83076909|FG001|Overall Study|Reasons other than above listed|0|||
46860489|NCT02475681|83076910|FG002|Overall Study|Reasons other than above listed|0|||
46860490|NCT02441686|83076920|FG000|Induction|Adverse Event|4|||
46982282|NCT04952402|83228363|FG000|Overall Study|Lack Of Venous Access|0|||
46860491|NCT02441686|83076920|FG000|Induction|Complicating disease|1|||
46860492|NCT02441686|83076920|FG000|Induction|Physician Decision|1|||
46860493|NCT02441686|83076920|FG000|Induction|Withdrawal by Subject|1|||
46860494|NCT02441686|83076920|FG000|Induction|Did not receive treatment|1|||
46860495|NCT02441686|83076920|FG000|Maintenance|Remaining on Treatment|23|||
46860496|NCT02441686|83076920|FG000|Maintenance|Physician Decision|1|||
46860497|NCT02441686|83076920|FG000|Maintenance|Adverse Event|3|||
46860498|NCT02441686|83076920|FG000|Maintenance|Progressive Disease|10|||
46860499|NCT02441686|83076920|FG000|Maintenance|Withdrawal by Subject|1|||
46860500|NCT02428205|83076927|FG000|Overall Study|Lack of Efficacy|1|||
46860501|NCT02428205|83076928|FG001|Overall Study|Lack of Efficacy|0|||
46860502|NCT02428205|83076927|FG000|Overall Study|Lost to Follow-up|1|||
46860503|NCT02428205|83076928|FG001|Overall Study|Lost to Follow-up|1|||
46860504|NCT02428205|83076927|FG000|Overall Study|Worse behavior|0|||
46860505|NCT02428205|83076928|FG001|Overall Study|Worse behavior|1|||
46860506|NCT02415712|83076936|FG000|Overall Study|Protocol Violation|16|||
46860507|NCT02280356|83076944|FG000|Overall Study|Not Treated|2|||
46860508|NCT02280356|83076944|FG000|Overall Study|Withdrawal by Subject|1|||
46860509|NCT02280356|83076944|FG000|Overall Study|Not evaluable|2|||
46860510|NCT01120184|83076982|FG000|Overall Study|Adverse Event|0|||
46860511|NCT01120184|83076983|FG001|Overall Study|Adverse Event|1|||
46860512|NCT01120184|83076984|FG002|Overall Study|Adverse Event|0|||
46860513|NCT01120184|83076982|FG000|Overall Study|Lost to Follow-up|13|||
46860514|NCT01120184|83076983|FG001|Overall Study|Lost to Follow-up|13|||
46860515|NCT01120184|83076984|FG002|Overall Study|Lost to Follow-up|11|||
46860516|NCT01120184|83076982|FG000|Overall Study|Physician Decision|9|||
46860517|NCT01120184|83076983|FG001|Overall Study|Physician Decision|1|||
46860518|NCT01120184|83076984|FG002|Overall Study|Physician Decision|3|||
46860519|NCT01120184|83076982|FG000|Overall Study|Reason not Specified|8|||
46860520|NCT01120184|83076983|FG001|Overall Study|Reason not Specified|3|||
46860521|NCT01120184|83076984|FG002|Overall Study|Reason not Specified|12|||
46860522|NCT01120184|83076982|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
46860523|NCT01120184|83076983|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
46860524|NCT01120184|83076984|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
46860525|NCT01120184|83076982|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
46860526|NCT01120184|83076983|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
46860527|NCT01120184|83076984|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
46860528|NCT01120184|83076982|FG000|Overall Study|Death|170|||
46860529|NCT01120184|83076983|FG001|Overall Study|Death|176|||
46860530|NCT01120184|83076984|FG002|Overall Study|Death|169|||
46860531|NCT00567580|83077006|FG000|Overall Study|Protocol Violation|28|||
46860532|NCT00567580|83077007|FG001|Overall Study|Protocol Violation|24|||
46860533|NCT00567580|83077008|FG002|Overall Study|Protocol Violation|24|||
46860534|NCT00274469|83077026|FG000|Overall Study|Death|63|||
46860535|NCT00274469|83077027|FG001|Overall Study|Death|74|||
46860536|NCT00274469|83077026|FG000|Overall Study|Did not consent to OS follow-up|16|||
46860537|NCT00274469|83077027|FG001|Overall Study|Did not consent to OS follow-up|19|||
46860538|NCT03214588|83077036|FG000|Overall Study|Adverse Event|1|||
46860539|NCT03214588|83077037|FG001|Overall Study|Adverse Event|0|||
46860540|NCT03214588|83077038|FG002|Overall Study|Adverse Event|2|||
46860541|NCT03214588|83077036|FG000|Overall Study|Reason Not Specified|0|||
46860542|NCT03214588|83077037|FG001|Overall Study|Reason Not Specified|1|||
46860543|NCT03214588|83077038|FG002|Overall Study|Reason Not Specified|0|||
46860544|NCT03166618|83077048|FG000|Overall Study|Study was Terminated|0|||
46860545|NCT03166618|83077049|FG001|Overall Study|Study was Terminated|1|||
46860546|NCT03162796|83077066|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
46860547|NCT03162796|83077067|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
46860548|NCT03162796|83077068|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
46860549|NCT03162796|83077066|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
46860550|NCT03162796|83077067|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
46860551|NCT03162796|83077068|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
46860552|NCT03162796|83077066|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
46860553|NCT03162796|83077067|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
46860554|NCT03162796|83077068|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
46860555|NCT03162796|83077066|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
46860556|NCT03162796|83077067|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
46860557|NCT03162796|83077068|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
46860558|NCT03162796|83077066|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
46860559|NCT03162796|83077067|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
46860560|NCT03162796|83077068|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
46860561|NCT03162796|83077066|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
46860562|NCT03162796|83077067|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
46860563|NCT03162796|83077068|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
46860564|NCT03162796|83077066|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
46860565|NCT03162796|83077067|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
46860566|NCT03162796|83077068|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
46860567|NCT03162796|83077066|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
46860568|NCT03162796|83077067|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
46860569|NCT03162796|83077068|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
46860570|NCT03162796|83077066|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
46860571|NCT03162796|83077067|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
46860572|NCT03162796|83077068|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
46860573|NCT03162796|83077066|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
46860574|NCT03162796|83077067|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
46860575|NCT03162796|83077068|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
46860576|NCT03162796|83077066|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
46860577|NCT03162796|83077067|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
46860578|NCT03162796|83077068|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
46860579|NCT03162328|83077081|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
46860580|NCT03162328|83077082|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
46860581|NCT03162328|83077083|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
46860582|NCT03162328|83077081|FG000|Screening Period|Withdrawal by Subject|1|||
46860583|NCT03162328|83077082|FG001|Screening Period|Withdrawal by Subject|0|||
46860584|NCT03162328|83077083|FG002|Screening Period|Withdrawal by Subject|0|||
46860585|NCT03162328|83077081|FG000|Study Period|Withdrawal by Subject|0|||
46860586|NCT03162328|83077082|FG001|Study Period|Withdrawal by Subject|0|||
46860587|NCT03162328|83077083|FG002|Study Period|Withdrawal by Subject|1|||
46860588|NCT00272987|83077097|FG000|Overall Study|Adverse Event|1|||
46860589|NCT00272987|83077098|FG001|Overall Study|Adverse Event|0|||
46860590|NCT00272987|83077099|FG002|Overall Study|Adverse Event|0|||
46860591|NCT00272987|83077097|FG000|Overall Study|Lost to Follow-up|3|||
46860592|NCT00272987|83077098|FG001|Overall Study|Lost to Follow-up|1|||
46860593|NCT00272987|83077099|FG002|Overall Study|Lost to Follow-up|1|||
46860594|NCT00272987|83077097|FG000|Overall Study|Withdrawal by Subject|1|||
46860595|NCT00272987|83077098|FG001|Overall Study|Withdrawal by Subject|0|||
46860596|NCT00272987|83077099|FG002|Overall Study|Withdrawal by Subject|3|||
46860597|NCT00272987|83077097|FG000|Overall Study|Sponsor Terminated study|0|||
46860598|NCT00272987|83077098|FG001|Overall Study|Sponsor Terminated study|1|||
46860599|NCT00272987|83077099|FG002|Overall Study|Sponsor Terminated study|1|||
46860600|NCT00272987|83077097|FG000|Overall Study|Disease progression|1|||
46860601|NCT00272987|83077098|FG001|Overall Study|Disease progression|1|||
46860602|NCT00272987|83077099|FG002|Overall Study|Disease progression|2|||
46860603|NCT00272987|83077097|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
46860604|NCT00272987|83077098|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
46860605|NCT00272987|83077099|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
46860606|NCT00272987|83077097|FG000|Overall Study|Death|1|||
46860607|NCT00272987|83077098|FG001|Overall Study|Death|0|||
46860608|NCT00272987|83077099|FG002|Overall Study|Death|0|||
46860609|NCT01730950|83077109|FG000|Overall Study|Protocol Violation|6|||
46860610|NCT01730950|83077110|FG001|Overall Study|Protocol Violation|6|||
46860611|NCT00271505|83077117|FG000|Overall Study|Screen Failure|3|||
46860612|NCT00271505|83077117|FG000|Overall Study|Adverse Event|1|||
46860613|NCT00271505|83077117|FG000|Overall Study|Death|1|||
46860614|NCT01642186|83077125|FG000|Overall Study|Death|0|||
46860615|NCT01642186|83077126|FG001|Overall Study|Death|2|||
46860616|NCT01642186|83077127|FG002|Overall Study|Death|2|||
46860617|NCT01642186|83077125|FG000|Overall Study|Lost to Follow-up|0|||
46860618|NCT01642186|83077126|FG001|Overall Study|Lost to Follow-up|0|||
46860619|NCT01642186|83077127|FG002|Overall Study|Lost to Follow-up|1|||
46860620|NCT00423514|83077137|FG000|Overall Study|Ineligible|1|||
46860621|NCT00423514|83077138|FG001|Overall Study|Ineligible|0|||
46860622|NCT00289991|83077146|FG000|Overall Study|Death|35|||
46697017|NCT01144377|82911596|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
46697018|NCT01144377|82911597|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
46697019|NCT01144377|82911598|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
46697020|NCT01144377|82911599|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
46697021|NCT01144377|82911595|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
46697022|NCT01144377|82911596|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
46697023|NCT01144377|82911597|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
46860623|NCT00289991|83077147|FG001|Overall Study|Death|38|||
46860624|NCT00289991|83077146|FG000|Overall Study|Adverse Event|15|||
46860625|NCT00289991|83077147|FG001|Overall Study|Adverse Event|13|||
46860626|NCT00289991|83077146|FG000|Overall Study|Failure of prophylaxis|1|||
46697024|NCT01144377|82911598|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
46697025|NCT01144377|82911599|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
46697026|NCT01144377|82911595|FG000|52 Week Treatment Period|Sponsor Decision|0|||
46860627|NCT00289991|83077147|FG001|Overall Study|Failure of prophylaxis|1|||
46860628|NCT00289991|83077146|FG000|Overall Study|Fungal breakthrough infection|0|||
46860629|NCT00289991|83077147|FG001|Overall Study|Fungal breakthrough infection|1|||
46860630|NCT00289991|83077146|FG000|Overall Study|Lost to Follow-up|0|||
46860631|NCT00289991|83077147|FG001|Overall Study|Lost to Follow-up|1|||
46860632|NCT00289991|83077146|FG000|Overall Study|Withdrawal by Subject|2|||
46860633|NCT00289991|83077147|FG001|Overall Study|Withdrawal by Subject|12|||
46860634|NCT00289991|83077146|FG000|Overall Study|Other|5|||
46860635|NCT00289991|83077147|FG001|Overall Study|Other|14|||
46860636|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860637|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
46860638|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860639|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860640|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860641|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
46860642|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
46860643|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
46860644|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
46860645|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
46860646|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
46860647|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
46860648|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
46860649|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
46860650|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
46860651|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
46860652|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
46860653|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
46860654|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
46860655|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
46860656|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860657|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860658|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860659|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
46860660|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860661|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
46860662|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
46860663|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
46860664|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
46860665|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
46860666|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
46860667|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
46860668|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
46860669|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
46860670|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
46860671|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
46860672|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
46860673|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
46982283|NCT04952402|83228364|FG001|Overall Study|Lack Of Venous Access|1|||
46982284|NCT04378010|83228403|FG000|Overall Study|Adverse Event|8|||
46860674|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
46860675|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
46860676|NCT00289913|83077158|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
46860677|NCT00289913|83077159|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
46860678|NCT00289913|83077160|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
46860679|NCT00289913|83077161|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
46860680|NCT00289913|83077162|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
46860681|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46982285|NCT04378010|83228404|FG001|Overall Study|Adverse Event|14|||
46982286|NCT04378010|83228405|FG002|Overall Study|Adverse Event|4|||
46860682|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860683|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
46860684|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860685|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860686|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
46860687|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
46860688|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
46860689|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
46860690|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
46860691|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
46860692|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
46860693|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
46860694|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
46860695|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
46860696|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
46860697|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
46860698|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
46860699|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
46860700|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
46860701|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
46860702|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860703|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
46860704|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860705|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860706|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
46860707|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
46860708|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
46860709|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
46860710|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
46860711|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
46860712|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
46860713|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
46860714|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
46860715|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
46860716|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
46860717|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
46860718|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
46860719|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
46860720|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
46860721|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
46860722|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
46860723|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
46860724|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
46860725|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
46860726|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
46860727|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
46860728|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
46860729|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
46860730|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
46860731|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
46860732|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
46860733|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
46860734|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
46860735|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
46860736|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
46860737|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
46860738|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
46860739|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
46860740|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
46860741|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
46860742|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
46860743|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
46982287|NCT04378010|83228403|FG000|Overall Study|Withdrawal by Subject|0|||
46860744|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
46860745|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
46860746|NCT00289913|83077158|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
46860747|NCT00289913|83077159|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
46860748|NCT00289913|83077160|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
46860749|NCT00289913|83077161|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
46860750|NCT00289913|83077162|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
46860751|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860752|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
46860753|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860754|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860755|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
46860756|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
46860757|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
46860758|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
46860759|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
46860760|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
46860761|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
46860762|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
46860763|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
46860764|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
46860765|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
46860766|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860767|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860768|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860769|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
46860770|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
46860771|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
46860772|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
46860773|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
46860774|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
46860775|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
46860776|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
46860777|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
46860778|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
46860779|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
46860780|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
46860781|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
46860782|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
46860783|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
46860784|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
46860785|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
46860786|NCT00289913|83077158|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
46860787|NCT00289913|83077159|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
46860788|NCT00289913|83077160|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
46860789|NCT00289913|83077161|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
46860790|NCT00289913|83077162|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
46860791|NCT00289289|83077180|FG000|Overall Study|Withdrawal by Subject|5|||
46860792|NCT00289289|83077181|FG001|Overall Study|Withdrawal by Subject|3|||
46860793|NCT00289289|83077182|FG002|Overall Study|Withdrawal by Subject|15|||
46860794|NCT00289289|83077180|FG000|Overall Study|Lost to Follow-up|1|||
46860795|NCT00289289|83077181|FG001|Overall Study|Lost to Follow-up|0|||
46860796|NCT00289289|83077182|FG002|Overall Study|Lost to Follow-up|1|||
46860797|NCT00289289|83077180|FG000|Overall Study|Death|4|||
46860798|NCT00289289|83077181|FG001|Overall Study|Death|2|||
46860799|NCT00289289|83077182|FG002|Overall Study|Death|5|||
46860800|NCT00289289|83077180|FG000|Overall Study|No implant attempted|0|||
46860801|NCT00289289|83077181|FG001|Overall Study|No implant attempted|0|||
46860802|NCT00289289|83077182|FG002|Overall Study|No implant attempted|1|||
46860803|NCT00289289|83077180|FG000|Overall Study|Physician Decision|1|||
46860804|NCT00289289|83077181|FG001|Overall Study|Physician Decision|0|||
46860805|NCT00289289|83077182|FG002|Overall Study|Physician Decision|6|||
46860806|NCT00289289|83077180|FG000|Overall Study|Non-study device implanted|2|||
46860807|NCT00289289|83077181|FG001|Overall Study|Non-study device implanted|1|||
46860808|NCT00289289|83077182|FG002|Overall Study|Non-study device implanted|3|||
46860809|NCT00289289|83077180|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
46860810|NCT00289289|83077181|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
46860811|NCT00289289|83077182|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
46860812|NCT00289289|83077180|FG000|Overall Study|Other Exit Reason|6|||
46860813|NCT00289289|83077181|FG001|Overall Study|Other Exit Reason|4|||
46860814|NCT00289289|83077182|FG002|Overall Study|Other Exit Reason|12|||
46860815|NCT00270257|83077191|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
46860816|NCT00270257|83077192|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
46860817|NCT00269633|83077202|FG000|Overall Study|Withdrawal by Subject|1|||
46860818|NCT00269633|83077203|FG001|Overall Study|Withdrawal by Subject|0|||
46860819|NCT00269477|83077213|FG000|Overall Study|Protocol Violation|5|||
46860820|NCT00269477|83077214|FG001|Overall Study|Protocol Violation|5|||
46860821|NCT00269477|83077215|FG002|Overall Study|Protocol Violation|1|||
46860822|NCT00269477|83077216|FG003|Overall Study|Protocol Violation|0|||
46860823|NCT00269477|83077213|FG000|Overall Study|Missed post-vaccination blood draw|0|||
46860824|NCT00269477|83077214|FG001|Overall Study|Missed post-vaccination blood draw|1|||
46860825|NCT00269477|83077215|FG002|Overall Study|Missed post-vaccination blood draw|0|||
46860826|NCT00269477|83077216|FG003|Overall Study|Missed post-vaccination blood draw|0|||
46860827|NCT00269399|83077228|FG000|Overall Study|Lack of Efficacy|27|||
46860828|NCT00269399|83077229|FG001|Overall Study|Lack of Efficacy|10|||
46860829|NCT00269399|83077228|FG000|Overall Study|Adverse Event|10|||
46860830|NCT00269399|83077229|FG001|Overall Study|Adverse Event|4|||
46860831|NCT00269399|83077228|FG000|Overall Study|Withdrawal by Subject|2|||
46860832|NCT00269399|83077229|FG001|Overall Study|Withdrawal by Subject|5|||
46860833|NCT00269399|83077228|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
46860834|NCT00269399|83077229|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
46860835|NCT00269399|83077228|FG000|Overall Study|Other|0|||
46860836|NCT00269399|83077229|FG001|Overall Study|Other|4|||
46860837|NCT00269399|83077228|FG000|Overall Study|Development of exclusion criteria|0|||
46860838|NCT00269399|83077229|FG001|Overall Study|Development of exclusion criteria|1|||
46860839|NCT00269087|83077235|FG000|Overall Study|Adverse Event|20|||
46860840|NCT00269087|83077235|FG000|Overall Study|Withdrawal by Subject|1|||
46860841|NCT00269087|83077235|FG000|Overall Study|Exacerbation of COPD|13|||
46860842|NCT00289133|83077241|FG000|Overall Study|Non-study device implanted|12|||
46860843|NCT00289133|83077242|FG001|Overall Study|Non-study device implanted|0|||
46860844|NCT00289133|83077241|FG000|Overall Study|Protocol Violation|32|||
46860845|NCT00289133|83077242|FG001|Overall Study|Protocol Violation|38|||
46860846|NCT00289133|83077241|FG000|Overall Study|Withdrawal by Subject|9|||
46860847|NCT00289133|83077242|FG001|Overall Study|Withdrawal by Subject|10|||
46860848|NCT00289133|83077241|FG000|Overall Study|Death|5|||
46860849|NCT00289133|83077242|FG001|Overall Study|Death|10|||
46860850|NCT00289133|83077241|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
46860851|NCT00289133|83077242|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
46860852|NCT00289133|83077241|FG000|Overall Study|Physician Decision|41|||
46860853|NCT00289133|83077242|FG001|Overall Study|Physician Decision|45|||
46860854|NCT00289133|83077241|FG000|Overall Study|Revision|8|||
46860855|NCT00289133|83077242|FG001|Overall Study|Revision|6|||
46860856|NCT00289133|83077241|FG000|Overall Study|Lost to Follow-up|92|||
46860857|NCT00289133|83077242|FG001|Overall Study|Lost to Follow-up|115|||
46982288|NCT04378010|83228404|FG001|Overall Study|Withdrawal by Subject|2|||
46860858|NCT00288587|83077254|FG000|Overall Study|Death|4|||
46860859|NCT00288587|83077255|FG001|Overall Study|Death|4|||
46860860|NCT00288587|83077254|FG000|Overall Study|Transplant|0|||
46860861|NCT00288587|83077255|FG001|Overall Study|Transplant|3|||
46860862|NCT00288587|83077254|FG000|Overall Study|Adverse Event|0|||
46860863|NCT00288587|83077255|FG001|Overall Study|Adverse Event|1|||
46860864|NCT00288587|83077254|FG000|Overall Study|Physician Decision|0|||
46860865|NCT00288587|83077255|FG001|Overall Study|Physician Decision|2|||
46860866|NCT00288587|83077254|FG000|Overall Study|Severe Aortic Stenosis|1|||
46860867|NCT00288587|83077255|FG001|Overall Study|Severe Aortic Stenosis|0|||
46860868|NCT00268463|83077263|FG000|Overall Study|study terminated due to low accrual|10|||
46982289|NCT04378010|83228405|FG002|Overall Study|Withdrawal by Subject|1|||
46982290|NCT04378010|83228403|FG000|Overall Study|Protocol Violation|2|||
46982291|NCT04378010|83228404|FG001|Overall Study|Protocol Violation|1|||
46802399|NCT00490971|83021819|FG000|Acute/Continuation|Adverse Event|62|||
46860869|NCT00268463|83077264|FG001|Overall Study|study terminated due to low accrual|12|||
46860870|NCT00288509|83077270|FG000|Treatment Cycle 1|Adverse Event|1|||
46860871|NCT00288509|83077270|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
46860872|NCT00288509|83077270|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
46860873|NCT00288509|83077270|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
46802400|NCT00490971|83021820|FG001|Acute/Continuation|Adverse Event|13|||
46802401|NCT00490971|83021821|FG002|Acute/Continuation|Adverse Event|0|||
46802402|NCT00490971|83021822|FG003|Acute/Continuation|Adverse Event|0|||
46802403|NCT00490971|83021823|FG004|Acute/Continuation|Adverse Event|0|||
46802404|NCT00490971|83021819|FG000|Acute/Continuation|Death|2|||
46802405|NCT00490971|83021820|FG001|Acute/Continuation|Death|0|||
46802406|NCT00490971|83021821|FG002|Acute/Continuation|Death|0|||
46802407|NCT00490971|83021822|FG003|Acute/Continuation|Death|0|||
46860874|NCT00288509|83077270|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
46860875|NCT00288509|83077270|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
46697027|NCT01144377|82911596|FG001|52 Week Treatment Period|Sponsor Decision|0|||
46697028|NCT01144377|82911597|FG002|52 Week Treatment Period|Sponsor Decision|0|||
46697029|NCT01144377|82911598|FG003|52 Week Treatment Period|Sponsor Decision|0|||
46697030|NCT01144377|82911599|FG004|52 Week Treatment Period|Sponsor Decision|1|||
46697031|NCT01144377|82911595|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
46697032|NCT01144377|82911596|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
46697033|NCT01144377|82911597|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
46697034|NCT01144377|82911598|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
46697035|NCT01144377|82911599|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
46697036|NCT01144377|82911595|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
46697037|NCT01144377|82911596|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
46697038|NCT01144377|82911597|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
46697039|NCT01144377|82911598|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
46697040|NCT01144377|82911599|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
46697041|NCT01144377|82911595|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
46697042|NCT01144377|82911596|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
46697043|NCT01144377|82911597|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
46697044|NCT01144377|82911598|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
46697045|NCT01144377|82911599|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
46697046|NCT00950599|82911621|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697047|NCT00950599|82911622|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697048|NCT00950599|82911623|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697049|NCT00950599|82911624|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
46697050|NCT00950599|82911625|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697051|NCT00950599|82911626|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697052|NCT00950599|82911627|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697053|NCT00950599|82911628|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697054|NCT00950599|82911629|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697055|NCT00950599|82911630|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
46697056|NCT00950599|82911621|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46697057|NCT00950599|82911622|FG001|Double-Blind Treatment Period|Adverse Event|1|||
46697058|NCT00950599|82911623|FG002|Double-Blind Treatment Period|Adverse Event|1|||
46697059|NCT00950599|82911624|FG003|Double-Blind Treatment Period|Adverse Event|1|||
46697060|NCT00950599|82911625|FG004|Double-Blind Treatment Period|Adverse Event|1|||
46697061|NCT00950599|82911626|FG005|Double-Blind Treatment Period|Adverse Event|1|||
46697062|NCT00950599|82911627|FG006|Double-Blind Treatment Period|Adverse Event|0|||
46697063|NCT00950599|82911628|FG007|Double-Blind Treatment Period|Adverse Event|0|||
46697064|NCT00950599|82911629|FG008|Double-Blind Treatment Period|Adverse Event|0|||
46697065|NCT00950599|82911630|FG009|Double-Blind Treatment Period|Adverse Event|0|||
46697066|NCT00950599|82911621|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
46697067|NCT00950599|82911622|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
46697068|NCT00950599|82911623|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
46697069|NCT00950599|82911624|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
46697070|NCT00950599|82911625|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
46697071|NCT00950599|82911626|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
46697072|NCT00950599|82911627|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
46697073|NCT00950599|82911628|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
46697074|NCT00950599|82911629|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
46697075|NCT00950599|82911630|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
46697076|NCT00950599|82911621|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46697077|NCT00950599|82911622|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
46697078|NCT00950599|82911623|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
46697079|NCT00950599|82911624|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
46697080|NCT00950599|82911625|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
46697081|NCT00950599|82911626|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
46697082|NCT00950599|82911627|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
46697083|NCT00950599|82911628|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
46697084|NCT00950599|82911629|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
46697085|NCT00950599|82911630|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
46697086|NCT00950599|82911621|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
46697087|NCT00950599|82911622|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
46697088|NCT00950599|82911623|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
46860876|NCT00288509|83077270|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
46860877|NCT00288509|83077270|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
46860878|NCT00288509|83077270|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
46982292|NCT04378010|83228405|FG002|Overall Study|Protocol Violation|4|||
46860879|NCT00288509|83077270|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
46860880|NCT00288509|83077270|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
46860881|NCT00288509|83077270|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
46860882|NCT00288509|83077270|FG000|Treatment Cycle 4|Physician Decision|4|||
46860883|NCT00288509|83077270|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
46860884|NCT00266825|83077276|FG000|Completed Follow-Up|Lost to Follow-up|14|||
46860885|NCT00266825|83077277|FG001|Completed Follow-Up|Lost to Follow-up|19|||
46860886|NCT00266825|83077276|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
46860887|NCT00266825|83077277|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
46860888|NCT00265889|83077285|FG000|Overall Study|Physician Decision|1|||
46860889|NCT00265889|83077285|FG000|Overall Study|Protocol Violation|1|||
46860890|NCT00265889|83077285|FG000|Overall Study|Insurance denied the request|3|||
46860891|NCT03209362|83077291|FG000|Overall Study|Adverse Event|0|||
46860892|NCT03209362|83077292|FG001|Overall Study|Adverse Event|1|||
46860893|NCT03209362|83077291|FG000|Overall Study|Lost to Follow-up|0|||
46860894|NCT03209362|83077292|FG001|Overall Study|Lost to Follow-up|1|||
46860895|NCT03209362|83077291|FG000|Overall Study|Withdrawal by Subject|2|||
46860896|NCT03209362|83077292|FG001|Overall Study|Withdrawal by Subject|0|||
46860897|NCT03209362|83077291|FG000|Overall Study|Other|0|||
46860898|NCT03209362|83077292|FG001|Overall Study|Other|1|||
46860899|NCT02932462|83077300|FG000|Overall Study|Adverse Event|1|||
46860900|NCT02932462|83077301|FG001|Overall Study|Adverse Event|2|||
46860901|NCT02932462|83077300|FG000|Overall Study|Lost to Follow-up|4|||
46860902|NCT02932462|83077301|FG001|Overall Study|Lost to Follow-up|1|||
46860903|NCT02932462|83077300|FG000|Overall Study|Protocol Violation|0|||
46860904|NCT02932462|83077301|FG001|Overall Study|Protocol Violation|5|||
46860905|NCT02932462|83077300|FG000|Overall Study|Withdrawal by Subject|1|||
46860906|NCT02932462|83077301|FG001|Overall Study|Withdrawal by Subject|4|||
46860907|NCT02932462|83077300|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46860908|NCT02932462|83077301|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46860909|NCT02932462|83077300|FG000|Overall Study|Progressive Disease|1|||
46860910|NCT02932462|83077301|FG001|Overall Study|Progressive Disease|0|||
46860911|NCT03206788|83077309|FG000|Overall Study|Withdrawal by Subject|0|||
46860912|NCT03206788|83077310|FG001|Overall Study|Withdrawal by Subject|1|||
46860913|NCT03206788|83077309|FG000|Overall Study|Adverse Event|0|||
46860914|NCT03206788|83077310|FG001|Overall Study|Adverse Event|1|||
46860915|NCT03206788|83077309|FG000|Overall Study|Physician Decision|0|||
46860916|NCT03206788|83077310|FG001|Overall Study|Physician Decision|1|||
46860917|NCT03205150|83077319|FG000|Overall Study|Protocol deviation|1|||
46860918|NCT03205150|83077320|FG001|Overall Study|Protocol deviation|3|||
46860919|NCT03205150|83077321|FG002|Overall Study|Protocol deviation|0|||
46860920|NCT03205150|83077319|FG000|Overall Study|Patient/guardian decision|0|||
46860921|NCT03205150|83077320|FG001|Overall Study|Patient/guardian decision|3|||
46860922|NCT03205150|83077321|FG002|Overall Study|Patient/guardian decision|0|||
46860923|NCT03205150|83077319|FG000|Overall Study|Adverse Event|1|||
46860924|NCT03205150|83077320|FG001|Overall Study|Adverse Event|1|||
46860925|NCT03205150|83077321|FG002|Overall Study|Adverse Event|1|||
46860926|NCT03205150|83077319|FG000|Overall Study|Lost to Follow-up|0|||
46860927|NCT03205150|83077320|FG001|Overall Study|Lost to Follow-up|0|||
46860928|NCT03205150|83077321|FG002|Overall Study|Lost to Follow-up|1|||
46860929|NCT02932306|83077332|FG000|Overall Study|Withdrawal by Subject|16|||
46860930|NCT02932306|83077333|FG001|Overall Study|Withdrawal by Subject|25|||
46860931|NCT02932306|83077332|FG000|Overall Study|Adverse Event|3|||
46860932|NCT02932306|83077333|FG001|Overall Study|Adverse Event|0|||
46860933|NCT02932306|83077332|FG000|Overall Study|Pregnancy|2|||
46860934|NCT02932306|83077333|FG001|Overall Study|Pregnancy|0|||
46860935|NCT02932306|83077332|FG000|Overall Study|Protocol Violation|1|||
46982293|NCT04378010|83228403|FG000|Overall Study|Study terminated by Sponsor|22|||
46982294|NCT04378010|83228404|FG001|Overall Study|Study terminated by Sponsor|16|||
46982295|NCT04378010|83228405|FG002|Overall Study|Study terminated by Sponsor|22|||
46860936|NCT02932306|83077333|FG001|Overall Study|Protocol Violation|1|||
46860937|NCT02932306|83077332|FG000|Overall Study|Noncompliance with Study Drug|1|||
46860938|NCT02932306|83077333|FG001|Overall Study|Noncompliance with Study Drug|1|||
46860939|NCT02932306|83077332|FG000|Overall Study|Lost to Follow-up|36|||
46860940|NCT02932306|83077333|FG001|Overall Study|Lost to Follow-up|40|||
46860941|NCT02932306|83077332|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
46860942|NCT02932306|83077333|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
46860943|NCT02932306|83077332|FG000|Overall Study|Lack of Efficacy|0|||
46860944|NCT02932306|83077333|FG001|Overall Study|Lack of Efficacy|2|||
46860945|NCT02932306|83077332|FG000|Overall Study|Worsening condition|2|||
46860946|NCT02932306|83077333|FG001|Overall Study|Worsening condition|0|||
46860947|NCT02932306|83077332|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
46860948|NCT02932306|83077333|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
46860949|NCT02932228|83077341|FG000|Overall Study|Death|8|||
46860950|NCT02932228|83077342|FG001|Overall Study|Death|23|||
46860951|NCT02932228|83077341|FG000|Overall Study|not eligible upon chart review|2|||
46860952|NCT02932228|83077342|FG001|Overall Study|not eligible upon chart review|5|||
46860953|NCT02931838|83077356|FG000|Overall Study|Reason not provided by investigator|1|||
46860954|NCT02931838|83077357|FG001|Overall Study|Reason not provided by investigator|0|||
46860955|NCT02931838|83077358|FG002|Overall Study|Reason not provided by investigator|1|||
46860956|NCT02931838|83077359|FG003|Overall Study|Reason not provided by investigator|0|||
46860957|NCT02931838|83077360|FG004|Overall Study|Reason not provided by investigator|0|||
46860958|NCT02931838|83077361|FG005|Overall Study|Reason not provided by investigator|0|||
46860959|NCT02931838|83077356|FG000|Overall Study|Poor/non-compliance|0|||
46860960|NCT02931838|83077357|FG001|Overall Study|Poor/non-compliance|0|||
46860961|NCT02931838|83077358|FG002|Overall Study|Poor/non-compliance|1|||
46860962|NCT02931838|83077359|FG003|Overall Study|Poor/non-compliance|0|||
46860963|NCT02931838|83077360|FG004|Overall Study|Poor/non-compliance|0|||
46860964|NCT02931838|83077361|FG005|Overall Study|Poor/non-compliance|0|||
46860965|NCT02931838|83077356|FG000|Overall Study|Lack of Efficacy|5|||
46860966|NCT02931838|83077357|FG001|Overall Study|Lack of Efficacy|4|||
46860967|NCT02931838|83077358|FG002|Overall Study|Lack of Efficacy|0|||
46860968|NCT02931838|83077359|FG003|Overall Study|Lack of Efficacy|0|||
46860969|NCT02931838|83077360|FG004|Overall Study|Lack of Efficacy|0|||
46860970|NCT02931838|83077361|FG005|Overall Study|Lack of Efficacy|1|||
46860971|NCT02931838|83077356|FG000|Overall Study|Lost to Follow-up|1|||
46860972|NCT02931838|83077357|FG001|Overall Study|Lost to Follow-up|0|||
46860973|NCT02931838|83077358|FG002|Overall Study|Lost to Follow-up|1|||
46860974|NCT02931838|83077359|FG003|Overall Study|Lost to Follow-up|1|||
46860975|NCT02931838|83077360|FG004|Overall Study|Lost to Follow-up|2|||
46860976|NCT02931838|83077361|FG005|Overall Study|Lost to Follow-up|0|||
46860977|NCT02931838|83077356|FG000|Overall Study|Subject request to discontinue treatment|4|||
46860978|NCT02931838|83077357|FG001|Overall Study|Subject request to discontinue treatment|3|||
46860979|NCT02931838|83077358|FG002|Overall Study|Subject request to discontinue treatment|3|||
46860980|NCT02931838|83077359|FG003|Overall Study|Subject request to discontinue treatment|0|||
46860981|NCT02931838|83077360|FG004|Overall Study|Subject request to discontinue treatment|1|||
46860982|NCT02931838|83077361|FG005|Overall Study|Subject request to discontinue treatment|0|||
46860983|NCT02931838|83077356|FG000|Overall Study|Withdrawal by Subject|1|||
46860984|NCT02931838|83077357|FG001|Overall Study|Withdrawal by Subject|2|||
46860985|NCT02931838|83077358|FG002|Overall Study|Withdrawal by Subject|0|||
46860986|NCT02931838|83077359|FG003|Overall Study|Withdrawal by Subject|1|||
46860987|NCT02931838|83077360|FG004|Overall Study|Withdrawal by Subject|0|||
46860988|NCT02931838|83077361|FG005|Overall Study|Withdrawal by Subject|0|||
46860989|NCT02931838|83077356|FG000|Overall Study|Adverse Event|2|||
46860990|NCT02931838|83077357|FG001|Overall Study|Adverse Event|1|||
46860991|NCT02931838|83077358|FG002|Overall Study|Adverse Event|2|||
46860992|NCT02931838|83077359|FG003|Overall Study|Adverse Event|1|||
46860993|NCT02931838|83077360|FG004|Overall Study|Adverse Event|3|||
46860994|NCT02931838|83077361|FG005|Overall Study|Adverse Event|1|||
46860995|NCT03201562|83077383|FG000|Overall Study|Physician Decision|0|||
46860996|NCT03201562|83077384|FG001|Overall Study|Physician Decision|0|||
46860997|NCT03201562|83077385|FG002|Overall Study|Physician Decision|1|||
46860998|NCT03201562|83077383|FG000|Overall Study|Adverse Event|0|||
46860999|NCT03201562|83077384|FG001|Overall Study|Adverse Event|0|||
46861000|NCT03201562|83077385|FG002|Overall Study|Adverse Event|1|||
46861001|NCT03201562|83077383|FG000|Overall Study|Lost to Follow-up|0|||
46861002|NCT03201562|83077384|FG001|Overall Study|Lost to Follow-up|1|||
46861003|NCT03201562|83077385|FG002|Overall Study|Lost to Follow-up|2|||
46861004|NCT03200860|83077395|FG000|Overall Study|Withdrawal by Subject|1|||
46861005|NCT03200860|83077396|FG001|Overall Study|Withdrawal by Subject|0|||
46861006|NCT03198754|83077404|FG000|Overall Study|Withdrawal by Subject|5|||
46861007|NCT03198754|83077405|FG001|Overall Study|Withdrawal by Subject|4|||
46861008|NCT03198754|83077404|FG000|Overall Study|Lost to Follow-up|4|||
46861009|NCT03198754|83077405|FG001|Overall Study|Lost to Follow-up|3|||
46861010|NCT03198754|83077404|FG000|Overall Study|Ineligible|2|||
46861011|NCT03198754|83077405|FG001|Overall Study|Ineligible|1|||
46861012|NCT03198520|83077411|FG000|Overall Study|Physician Decision|2|||
46861013|NCT03198520|83077411|FG000|Overall Study|Protocol Violation|2|||
46982296|NCT04378010|83228403|FG000|Overall Study|Subject inability to complete study visit|0|||
46861014|NCT03198520|83077411|FG000|Overall Study|Withdrawal by Subject|1|||
46861015|NCT03198520|83077411|FG000|Overall Study|Study Ended|1|||
46861016|NCT03194464|83077423|FG000|Overall Study|data not usable|2|||
46861017|NCT03192904|83077431|FG000|Overall Study|Physician Decision|3|||
46861018|NCT03192904|83077432|FG001|Overall Study|Physician Decision|1|||
46861019|NCT03192904|83077431|FG000|Overall Study|Lost to Follow-up|0|||
46861020|NCT03192904|83077432|FG001|Overall Study|Lost to Follow-up|1|||
46861021|NCT03188536|83077438|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
46861022|NCT03188536|83077438|FG000|Overall Study|Not participated/met inclusion criteria|1|||
46861023|NCT03187756|83077442|FG000|Overall Study|Termination of study|4|||
46861024|NCT03187132|83077448|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
46861025|NCT03187132|83077449|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
46861026|NCT03187132|83077448|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
46861027|NCT03187132|83077449|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
46861028|NCT03187132|83077448|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
46861029|NCT03187132|83077449|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
46861030|NCT03187132|83077448|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
46861031|NCT03187132|83077449|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
46861032|NCT03187132|83077448|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
46861033|NCT03187132|83077449|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
46861034|NCT03187132|83077448|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
46861035|NCT03187132|83077449|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
46861036|NCT03187132|83077448|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
46861037|NCT03187132|83077449|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
46861038|NCT03187132|83077448|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
46861039|NCT03187132|83077449|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
46861040|NCT03187132|83077448|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
46861041|NCT03187132|83077449|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
46861042|NCT03187132|83077448|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
46861043|NCT03187132|83077449|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
46861044|NCT03187132|83077448|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
46861045|NCT03187132|83077449|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
46861046|NCT03184558|83077455|FG000|Overall Study|Withdrawal by Subject|2|||
46861047|NCT03184558|83077455|FG000|Overall Study|Death|16|||
46861048|NCT03184558|83077455|FG000|Overall Study|Lost to Follow-up|2|||
46861049|NCT03184558|83077455|FG000|Overall Study|Other|9|||
46861050|NCT03183778|83077459|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
46861051|NCT03182686|83077465|FG000|Overall Study|Lost to Follow-up|2|||
46861052|NCT03182686|83077466|FG001|Overall Study|Lost to Follow-up|0|||
46861053|NCT03182686|83077465|FG000|Overall Study|Adverse Event|2|||
46861054|NCT03182686|83077466|FG001|Overall Study|Adverse Event|0|||
46861055|NCT03182686|83077465|FG000|Overall Study|Withdrawal by Subject|3|||
46861056|NCT03182686|83077466|FG001|Overall Study|Withdrawal by Subject|0|||
46861057|NCT03181594|83077472|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
46861058|NCT03181594|83077472|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
46861059|NCT03181594|83077472|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
46861060|NCT03181594|83077472|FG000|Initial Study Protocol (12-month FU)|Death|1|||
46861061|NCT03181594|83077472|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
46861062|NCT03181594|83077472|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
46861063|NCT03180736|83077478|FG000|Overall Study|Adverse Event|3|||
46861064|NCT03180736|83077479|FG001|Overall Study|Adverse Event|4|||
46861065|NCT03180736|83077478|FG000|Overall Study|Death|10|||
46861066|NCT03180736|83077479|FG001|Overall Study|Death|7|||
46861067|NCT03180736|83077478|FG000|Overall Study|Withdrawal by Subject|5|||
46861068|NCT03180736|83077479|FG001|Overall Study|Withdrawal by Subject|12|||
46861069|NCT03180736|83077478|FG000|Overall Study|Lost to Follow-up|1|||
46861070|NCT03180736|83077479|FG001|Overall Study|Lost to Follow-up|0|||
46861071|NCT03180736|83077478|FG000|Overall Study|Lack of Efficacy|66|||
46861072|NCT03180736|83077479|FG001|Overall Study|Lack of Efficacy|87|||
46861073|NCT03180736|83077478|FG000|Overall Study|Physician Decision|4|||
46861074|NCT03180736|83077479|FG001|Overall Study|Physician Decision|7|||
46861075|NCT03180736|83077478|FG000|Overall Study|randomized but not treated|2|||
46861076|NCT03180736|83077479|FG001|Overall Study|randomized but not treated|3|||
46861077|NCT03178942|83077492|FG000|Overall Study|Withdrawal by Subject|2|||
46861078|NCT03178942|83077493|FG001|Overall Study|Withdrawal by Subject|0|||
46861079|NCT03178942|83077492|FG000|Overall Study|Lost to Follow-up|1|||
46861080|NCT03178942|83077493|FG001|Overall Study|Lost to Follow-up|2|||
46861081|NCT03175198|83077499|FG000|Overall Study|Adverse Event|480|||
46861082|NCT03175198|83077499|FG000|Overall Study|No actual visit|120|||
46861083|NCT03175198|83077499|FG000|Overall Study|Registration rule not followed|4|||
46861084|NCT03175198|83077499|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
46861085|NCT03175198|83077499|FG000|Overall Study|Other personal reason|509|||
46861086|NCT03175198|83077499|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
46697089|NCT00950599|82911624|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
46697090|NCT00950599|82911625|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
46697091|NCT00950599|82911626|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
46982297|NCT04378010|83228404|FG001|Overall Study|Subject inability to complete study visit|0|||
46982298|NCT04378010|83228405|FG002|Overall Study|Subject inability to complete study visit|1|||
46697092|NCT00950599|82911627|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
46697093|NCT00950599|82911628|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
46697094|NCT00950599|82911629|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
46697095|NCT00950599|82911630|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
46861087|NCT03175198|83077499|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
46861088|NCT03175198|83077499|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
46861089|NCT03175198|83077499|FG000|Overall Study|To conduct invasive treatment of operation|53|||
46861090|NCT03175198|83077499|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
46861091|NCT03175120|83077505|FG000|Overall Study|Adverse Event|2|||
46861092|NCT03175120|83077506|FG001|Overall Study|Adverse Event|2|||
46861093|NCT03175120|83077505|FG000|Overall Study|Protocol Violation|5|||
46861094|NCT03175120|83077506|FG001|Overall Study|Protocol Violation|2|||
46861095|NCT03175120|83077505|FG000|Overall Study|Lost to Follow-up|1|||
46861096|NCT03175120|83077506|FG001|Overall Study|Lost to Follow-up|0|||
46861097|NCT03175120|83077505|FG000|Overall Study|Withdrawal by Subject|2|||
46861098|NCT03175120|83077506|FG001|Overall Study|Withdrawal by Subject|5|||
46861099|NCT03175120|83077505|FG000|Overall Study|Other|2|||
46861100|NCT03175120|83077506|FG001|Overall Study|Other|3|||
46982299|NCT04378010|83228403|FG000|Overall Study|Subject never dosed|0|||
46982300|NCT04378010|83228404|FG001|Overall Study|Subject never dosed|1|||
46982301|NCT04378010|83228405|FG002|Overall Study|Subject never dosed|0|||
46982302|NCT04349072|83228416|FG000|Randomization Period|Found ineligible post enrollment|0|||
46802408|NCT00490971|83021823|FG004|Acute/Continuation|Death|0|||
46802409|NCT00490971|83021819|FG000|Acute/Continuation|Lack of Efficacy|106|||
46802410|NCT00490971|83021820|FG001|Acute/Continuation|Lack of Efficacy|12|||
46861101|NCT03172702|83077512|FG000|Overall Study|Adverse Event|9|||
46861102|NCT03172702|83077512|FG000|Overall Study|Death|2|||
46861103|NCT03172702|83077512|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
46861104|NCT03172702|83077512|FG000|Overall Study|Withdrawal by Subject|5|||
46861105|NCT03172702|83077512|FG000|Overall Study|Other|2|||
46861106|NCT02795182|83077521|FG000|Overall Study|Death|5|||
46861107|NCT02795182|83077522|FG001|Overall Study|Death|4|||
46861108|NCT02795182|83077523|FG002|Overall Study|Death|4|||
46861109|NCT02795182|83077524|FG003|Overall Study|Death|18|||
46861110|NCT02795182|83077521|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
46861111|NCT02795182|83077522|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
46861112|NCT02795182|83077523|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
46861113|NCT02795182|83077524|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
46861114|NCT02795182|83077521|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
46861115|NCT02795182|83077522|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
46861116|NCT02795182|83077523|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
46861117|NCT02795182|83077524|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
46861118|NCT02795182|83077521|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
46861119|NCT02795182|83077522|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
46861120|NCT02795182|83077523|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
46861121|NCT02795182|83077524|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
46861122|NCT02795182|83077521|FG000|Overall Study|Withdrawal by Subject|4|||
46861123|NCT02795182|83077522|FG001|Overall Study|Withdrawal by Subject|0|||
46861124|NCT02795182|83077523|FG002|Overall Study|Withdrawal by Subject|0|||
46861125|NCT02795182|83077524|FG003|Overall Study|Withdrawal by Subject|3|||
46861126|NCT02795182|83077521|FG000|Overall Study|Lost to Follow-up|0|||
46861127|NCT02795182|83077522|FG001|Overall Study|Lost to Follow-up|0|||
46861128|NCT02795182|83077523|FG002|Overall Study|Lost to Follow-up|1|||
46861129|NCT02795182|83077524|FG003|Overall Study|Lost to Follow-up|1|||
46861130|NCT02795182|83077521|FG000|Overall Study|Roll Over to Long Term Extension|3|||
46861131|NCT02795182|83077522|FG001|Overall Study|Roll Over to Long Term Extension|3|||
46861132|NCT02795182|83077523|FG002|Overall Study|Roll Over to Long Term Extension|2|||
46861133|NCT02795182|83077524|FG003|Overall Study|Roll Over to Long Term Extension|5|||
46861134|NCT02795182|83077521|FG000|Overall Study|Progressive Disease|0|||
46861135|NCT02795182|83077522|FG001|Overall Study|Progressive Disease|1|||
46861136|NCT02795182|83077523|FG002|Overall Study|Progressive Disease|0|||
46861137|NCT02795182|83077524|FG003|Overall Study|Progressive Disease|4|||
46861138|NCT02795182|83077521|FG000|Overall Study|Physician Decision|0|||
46861139|NCT02795182|83077522|FG001|Overall Study|Physician Decision|0|||
46861140|NCT02795182|83077523|FG002|Overall Study|Physician Decision|0|||
46861141|NCT02795182|83077524|FG003|Overall Study|Physician Decision|1|||
46697096|NCT00950599|82911621|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46697097|NCT00950599|82911622|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46697098|NCT00950599|82911623|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46697099|NCT00950599|82911624|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46697100|NCT00950599|82911625|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
46697101|NCT00950599|82911626|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
46697102|NCT00950599|82911627|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46861142|NCT03167242|83077553|FG000|Overall Study|Patient/Guardian Decision|0|||
46861143|NCT03167242|83077554|FG001|Overall Study|Patient/Guardian Decision|1|||
46861144|NCT03167242|83077555|FG002|Overall Study|Patient/Guardian Decision|2|||
46861145|NCT03167242|83077556|FG003|Overall Study|Patient/Guardian Decision|1|||
46861146|NCT03167242|83077557|FG004|Overall Study|Patient/Guardian Decision|1|||
46861147|NCT03167242|83077558|FG005|Overall Study|Patient/Guardian Decision|1|||
46861148|NCT03167242|83077559|FG006|Overall Study|Patient/Guardian Decision|0|||
46861149|NCT03167242|83077560|FG007|Overall Study|Patient/Guardian Decision|0|||
46861150|NCT03167242|83077561|FG008|Overall Study|Patient/Guardian Decision|0|||
46861151|NCT03167242|83077562|FG009|Overall Study|Patient/Guardian Decision|0|||
46861152|NCT03167242|83077563|FG010|Overall Study|Patient/Guardian Decision|1|||
46861153|NCT03167242|83077564|FG011|Overall Study|Patient/Guardian Decision|0|||
46861154|NCT03167242|83077553|FG000|Overall Study|Lost to Follow-up|0|||
46861155|NCT03167242|83077554|FG001|Overall Study|Lost to Follow-up|0|||
46861156|NCT03167242|83077555|FG002|Overall Study|Lost to Follow-up|1|||
46861157|NCT03167242|83077556|FG003|Overall Study|Lost to Follow-up|0|||
46861158|NCT03167242|83077557|FG004|Overall Study|Lost to Follow-up|0|||
46861159|NCT03167242|83077558|FG005|Overall Study|Lost to Follow-up|1|||
46861160|NCT03167242|83077559|FG006|Overall Study|Lost to Follow-up|2|||
46861161|NCT03167242|83077560|FG007|Overall Study|Lost to Follow-up|1|||
46861162|NCT03167242|83077561|FG008|Overall Study|Lost to Follow-up|0|||
46861163|NCT03167242|83077562|FG009|Overall Study|Lost to Follow-up|0|||
46861164|NCT03167242|83077563|FG010|Overall Study|Lost to Follow-up|1|||
46861165|NCT03167242|83077564|FG011|Overall Study|Lost to Follow-up|1|||
46861166|NCT03167242|83077553|FG000|Overall Study|Reason not provided|0|||
46861167|NCT03167242|83077554|FG001|Overall Study|Reason not provided|0|||
46861168|NCT03167242|83077555|FG002|Overall Study|Reason not provided|0|||
46861169|NCT03167242|83077556|FG003|Overall Study|Reason not provided|0|||
46861170|NCT03167242|83077557|FG004|Overall Study|Reason not provided|0|||
46861171|NCT03167242|83077558|FG005|Overall Study|Reason not provided|0|||
46861172|NCT03167242|83077559|FG006|Overall Study|Reason not provided|0|||
46861173|NCT03167242|83077560|FG007|Overall Study|Reason not provided|0|||
46861174|NCT03167242|83077561|FG008|Overall Study|Reason not provided|1|||
46861175|NCT03167242|83077562|FG009|Overall Study|Reason not provided|0|||
46861176|NCT03167242|83077563|FG010|Overall Study|Reason not provided|0|||
46861177|NCT03167242|83077564|FG011|Overall Study|Reason not provided|0|||
46861178|NCT03286426|83077600|FG000|Overall Study|Physician Decision|3|||
46861179|NCT02882152|83077619|FG000|Overall Study|Lost to Follow-up|1|||
46861180|NCT02882152|83077620|FG001|Overall Study|Lost to Follow-up|0|||
46861181|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
46861182|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
46861183|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
46861184|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
46861185|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Death|58|||
46861186|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Death|65|||
46861187|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Adverse Event|28|||
46861188|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Adverse Event|40|||
46861189|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Disease Progression|22|||
46861190|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Disease Progression|35|||
46861191|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Other|25|||
46861192|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Other|33|||
46861193|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
46861194|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
46861195|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Noncompliance|8|||
46861196|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Noncompliance|8|||
46861197|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
46861198|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
46861199|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
46861200|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
46861201|NCT00286091|83077628|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
46697103|NCT00950599|82911628|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46697104|NCT00950599|82911629|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46697105|NCT00950599|82911630|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
46697106|NCT00950599|82911621|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
46861202|NCT00286091|83077629|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
46861203|NCT00286091|83077628|FG000|Open-label Treatment Phase|Physician Decision|24|||
46861204|NCT00286091|83077629|FG001|Open-label Treatment Phase|Physician Decision|21|||
46697107|NCT00950599|82911622|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
46697108|NCT00950599|82911623|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
46861205|NCT00286091|83077628|FG000|Open-label Treatment Phase|Adverse Event|5|||
46861206|NCT00286091|83077629|FG001|Open-label Treatment Phase|Adverse Event|16|||
46861207|NCT00286091|83077628|FG000|Open-label Treatment Phase|Other|11|||
46861208|NCT00286091|83077629|FG001|Open-label Treatment Phase|Other|11|||
46861209|NCT00286091|83077628|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
46861210|NCT00286091|83077629|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
46861211|NCT00286091|83077628|FG000|Open-label Treatment Phase|Death|10|||
46861212|NCT00286091|83077629|FG001|Open-label Treatment Phase|Death|7|||
46861213|NCT00286091|83077628|FG000|Open-label Treatment Phase|Disease Progression|9|||
46861214|NCT00286091|83077629|FG001|Open-label Treatment Phase|Disease Progression|3|||
46697109|NCT00950599|82911624|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
46697110|NCT00950599|82911625|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
46982303|NCT04349072|83228417|FG001|Randomization Period|Found ineligible post enrollment|1|||
46982304|NCT04349072|83228416|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
46697111|NCT00950599|82911626|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
46697112|NCT00950599|82911627|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
46697113|NCT00950599|82911628|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
46697114|NCT00950599|82911629|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
46982305|NCT04349072|83228417|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
46982306|NCT04349072|83228416|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
46982307|NCT04349072|83228417|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
46982308|NCT04349072|83228416|FG000|Treatment Period|Physician Decision|0|||
46982309|NCT04349072|83228417|FG001|Treatment Period|Physician Decision|1|||
46982310|NCT04349072|83228416|FG000|Treatment Period|Protocol Violation|0|||
46982311|NCT04349072|83228417|FG001|Treatment Period|Protocol Violation|1|||
46982312|NCT04349072|83228416|FG000|Treatment Period|Withdrawal by Subject|1|||
46982313|NCT04349072|83228417|FG001|Treatment Period|Withdrawal by Subject|1|||
46982314|NCT04240886|83228423|FG000|Treatment Phase|Death|4|||
46982315|NCT04240886|83228423|FG000|Treatment Phase|Discontinuation by Subject|1|||
46982316|NCT04240886|83228423|FG000|Treatment Phase|Adverse Event|5|||
46982317|NCT04240886|83228423|FG000|Follow-up Phase|Withdrawal by Subject|1|||
46982318|NCT04240886|83228423|FG000|Follow-up Phase|Discontinuation by Subject|1|||
46982319|NCT04240886|83228423|FG000|Follow-up Phase|Death|2|||
46982320|NCT04074161|83228439|FG000|Overall Study|Withdrawal by Subject|2|||
46982321|NCT04074161|83228440|FG001|Overall Study|Withdrawal by Subject|4|||
46697115|NCT00950599|82911630|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
46697116|NCT00950599|82911621|FG000|Follow-Up Period|Adverse Event|0|||
46697117|NCT00950599|82911622|FG001|Follow-Up Period|Adverse Event|0|||
46697118|NCT00950599|82911623|FG002|Follow-Up Period|Adverse Event|0|||
46697119|NCT00950599|82911624|FG003|Follow-Up Period|Adverse Event|0|||
46697120|NCT00950599|82911625|FG004|Follow-Up Period|Adverse Event|0|||
46697121|NCT00950599|82911626|FG005|Follow-Up Period|Adverse Event|0|||
46697122|NCT00950599|82911627|FG006|Follow-Up Period|Adverse Event|0|||
46697123|NCT00950599|82911628|FG007|Follow-Up Period|Adverse Event|0|||
46697124|NCT00950599|82911629|FG008|Follow-Up Period|Adverse Event|1|||
46697125|NCT00950599|82911630|FG009|Follow-Up Period|Adverse Event|0|||
46697126|NCT00950599|82911621|FG000|Follow-Up Period|Lack of Efficacy|0|||
46697127|NCT00950599|82911622|FG001|Follow-Up Period|Lack of Efficacy|0|||
46697128|NCT00950599|82911623|FG002|Follow-Up Period|Lack of Efficacy|0|||
46697129|NCT00950599|82911624|FG003|Follow-Up Period|Lack of Efficacy|0|||
46697130|NCT00950599|82911625|FG004|Follow-Up Period|Lack of Efficacy|0|||
46697131|NCT00950599|82911626|FG005|Follow-Up Period|Lack of Efficacy|0|||
46697132|NCT00950599|82911627|FG006|Follow-Up Period|Lack of Efficacy|0|||
46697133|NCT00950599|82911628|FG007|Follow-Up Period|Lack of Efficacy|0|||
46697134|NCT00950599|82911629|FG008|Follow-Up Period|Lack of Efficacy|3|||
46982322|NCT04074161|83228441|FG002|Overall Study|Withdrawal by Subject|1|||
46982323|NCT04074161|83228439|FG000|Overall Study|Lost to Follow-up|4|||
46982324|NCT04074161|83228440|FG001|Overall Study|Lost to Follow-up|5|||
46982325|NCT04074161|83228441|FG002|Overall Study|Lost to Follow-up|3|||
46982326|NCT03966157|83228451|FG000|Overall Study|Physician Decision|1|||
46982327|NCT03966157|83228452|FG001|Overall Study|Physician Decision|0|||
46697135|NCT00950599|82911630|FG009|Follow-Up Period|Lack of Efficacy|0|||
46697136|NCT00950599|82911621|FG000|Follow-Up Period|Lost to Follow-up|0|||
46982328|NCT03733210|83228460|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
46982329|NCT03733210|83228461|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
46982330|NCT03627468|83228469|FG000|Overall Study|Adverse Event|5|||
46982331|NCT03627468|83228470|FG001|Overall Study|Adverse Event|33|||
46982332|NCT03627468|83228469|FG000|Overall Study|Withdrawal by Subject|13|||
46982333|NCT03627468|83228470|FG001|Overall Study|Withdrawal by Subject|23|||
46697137|NCT00950599|82911622|FG001|Follow-Up Period|Lost to Follow-up|0|||
46697138|NCT00950599|82911623|FG002|Follow-Up Period|Lost to Follow-up|0|||
46697139|NCT00950599|82911624|FG003|Follow-Up Period|Lost to Follow-up|0|||
46697140|NCT00950599|82911625|FG004|Follow-Up Period|Lost to Follow-up|0|||
46982334|NCT03627468|83228469|FG000|Overall Study|Physician Decision|1|||
46982335|NCT03627468|83228470|FG001|Overall Study|Physician Decision|0|||
46982336|NCT03627468|83228469|FG000|Overall Study|Protocol Violation|0|||
46982337|NCT03627468|83228470|FG001|Overall Study|Protocol Violation|2|||
46697141|NCT00950599|82911626|FG005|Follow-Up Period|Lost to Follow-up|0|||
46697142|NCT00950599|82911627|FG006|Follow-Up Period|Lost to Follow-up|0|||
46697143|NCT00950599|82911628|FG007|Follow-Up Period|Lost to Follow-up|0|||
46697144|NCT00950599|82911629|FG008|Follow-Up Period|Lost to Follow-up|5|||
46697145|NCT00950599|82911630|FG009|Follow-Up Period|Lost to Follow-up|1|||
46697146|NCT00950599|82911621|FG000|Follow-Up Period|Physician Decision|0|||
46697147|NCT00950599|82911622|FG001|Follow-Up Period|Physician Decision|0|||
46697148|NCT00950599|82911623|FG002|Follow-Up Period|Physician Decision|0|||
46697149|NCT00950599|82911624|FG003|Follow-Up Period|Physician Decision|0|||
46697150|NCT00950599|82911625|FG004|Follow-Up Period|Physician Decision|0|||
46697151|NCT00950599|82911626|FG005|Follow-Up Period|Physician Decision|0|||
46697152|NCT00950599|82911627|FG006|Follow-Up Period|Physician Decision|0|||
46697153|NCT00950599|82911628|FG007|Follow-Up Period|Physician Decision|0|||
46697154|NCT00950599|82911629|FG008|Follow-Up Period|Physician Decision|1|||
46697155|NCT00950599|82911630|FG009|Follow-Up Period|Physician Decision|0|||
46697156|NCT00950599|82911621|FG000|Follow-Up Period|Poor/Noncompliance|0|||
46697157|NCT00950599|82911622|FG001|Follow-Up Period|Poor/Noncompliance|0|||
46697158|NCT00950599|82911623|FG002|Follow-Up Period|Poor/Noncompliance|0|||
46697159|NCT00950599|82911624|FG003|Follow-Up Period|Poor/Noncompliance|0|||
46861215|NCT00286091|83077628|FG000|Open-label Treatment Phase|Noncompliance|3|||
46861216|NCT00286091|83077629|FG001|Open-label Treatment Phase|Noncompliance|1|||
46861217|NCT00286091|83077628|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
46861218|NCT00286091|83077629|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
46861219|NCT00286091|83077628|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
46861220|NCT00286091|83077629|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
46861221|NCT00286091|83077628|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
46861222|NCT00286091|83077629|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
46861223|NCT00285857|83077637|FG000|Overall Study|Withdrawal by Subject|2|||
46861224|NCT00285857|83077637|FG000|Overall Study|Inadequate initial breast cytology|1|||
46861225|NCT00285857|83077637|FG000|Overall Study|Adverse Event|1|||
46861226|NCT00284141|83077646|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
46861227|NCT00284141|83077646|FG000|Overall Study|Adverse Event|19|||
46861228|NCT00284141|83077646|FG000|Overall Study|Participant's request|9|||
46861229|NCT00284141|83077646|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
46861230|NCT00284141|83077646|FG000|Overall Study|Clinical deterioration / death|2|||
46861231|NCT00284141|83077646|FG000|Overall Study|General decline|1|||
46861232|NCT00284141|83077646|FG000|Overall Study|Pneumonia|1|||
46861233|NCT00284141|83077646|FG000|Overall Study|Did not take study medication|2|||
46861234|NCT00284141|83077646|FG000|Overall Study|Ongoing treatment|2|||
46861235|NCT00265343|83077654|FG000|Overall Study|Adverse Event|10|||
46861236|NCT00265343|83077655|FG001|Overall Study|Adverse Event|7|||
46982338|NCT03627468|83228469|FG000|Overall Study|Lost to Follow-up|10|||
46861237|NCT00265343|83077654|FG000|Overall Study|Withdrawal by Subject|3|||
46982339|NCT03627468|83228470|FG001|Overall Study|Lost to Follow-up|16|||
46982340|NCT03627468|83228469|FG000|Overall Study|Death|1|||
46982341|NCT03627468|83228470|FG001|Overall Study|Death|0|||
46982342|NCT03627468|83228469|FG000|Overall Study|Pregnancy|1|||
46982343|NCT03627468|83228470|FG001|Overall Study|Pregnancy|1|||
46982344|NCT03627468|83228469|FG000|Overall Study|Lack of Efficacy|0|||
46982345|NCT03627468|83228470|FG001|Overall Study|Lack of Efficacy|2|||
46982346|NCT03627468|83228469|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
46982347|NCT03627468|83228470|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
46982348|NCT03595176|83228478|FG000|Overall Study|Death|0|||
46982349|NCT03595176|83228479|FG001|Overall Study|Death|2|||
46982350|NCT03595176|83228478|FG000|Overall Study|Lost to Follow-up|0|||
46982351|NCT03595176|83228479|FG001|Overall Study|Lost to Follow-up|1|||
46697160|NCT00950599|82911625|FG004|Follow-Up Period|Poor/Noncompliance|0|||
46697161|NCT00950599|82911626|FG005|Follow-Up Period|Poor/Noncompliance|0|||
46861238|NCT00265343|83077655|FG001|Overall Study|Withdrawal by Subject|9|||
46861239|NCT00265343|83077654|FG000|Overall Study|Other|8|||
46861240|NCT00265343|83077655|FG001|Overall Study|Other|3|||
46861241|NCT00283595|83077663|FG000|Overall Study|Withdrawal by Subject|1|||
46861242|NCT00283595|83077664|FG001|Overall Study|Withdrawal by Subject|2|||
46861243|NCT00265109|83077670|FG000|Overall Study|Withdrawal by Subject|5|||
46982352|NCT03052816|83228488|FG000|Overall Study|Withdrawal by Subject|1|||
46982353|NCT03052816|83228489|FG001|Overall Study|Withdrawal by Subject|0|||
46982354|NCT03052816|83228488|FG000|Overall Study|Desired opioids|2|||
46982355|NCT03052816|83228489|FG001|Overall Study|Desired opioids|0|||
46861244|NCT00265109|83077670|FG000|Overall Study|Adverse Event|1|||
46861245|NCT03235024|83077677|FG000|Overall Study|Adverse Event|2|||
46861246|NCT03235024|83077678|FG001|Overall Study|Adverse Event|2|||
46861247|NCT03235024|83077677|FG000|Overall Study|Death|1|||
46861248|NCT03235024|83077678|FG001|Overall Study|Death|0|||
46861249|NCT03235024|83077677|FG000|Overall Study|Lost to Follow-up|2|||
46861250|NCT03235024|83077678|FG001|Overall Study|Lost to Follow-up|5|||
46861251|NCT03235024|83077677|FG000|Overall Study|Protocol Violation|1|||
46861252|NCT03235024|83077678|FG001|Overall Study|Protocol Violation|0|||
46861253|NCT03235024|83077677|FG000|Overall Study|Withdrawal by Subject|0|||
46861254|NCT03235024|83077678|FG001|Overall Study|Withdrawal by Subject|3|||
46861255|NCT03233308|83077684|FG000|Overall Study|Adverse Event|1|||
46861256|NCT03233308|83077684|FG000|Overall Study|Protocol Violation|1|||
46861257|NCT00283439|83077699|FG000|Overall Study|Adverse Event|0|||
46861258|NCT00283439|83077700|FG001|Overall Study|Adverse Event|0|||
46861259|NCT00283439|83077701|FG002|Overall Study|Adverse Event|0|||
46861260|NCT00283439|83077702|FG003|Overall Study|Adverse Event|1|||
46861261|NCT00283439|83077699|FG000|Overall Study|Death|0|||
46861262|NCT00283439|83077700|FG001|Overall Study|Death|0|||
46861263|NCT00283439|83077701|FG002|Overall Study|Death|1|||
46861264|NCT00283439|83077702|FG003|Overall Study|Death|0|||
46861265|NCT00283439|83077699|FG000|Overall Study|Disease progression|0|||
46861266|NCT00283439|83077700|FG001|Overall Study|Disease progression|1|||
46982356|NCT02682238|83228508|FG000|Overall Study|Lost to Follow-up|0|||
46982357|NCT02682238|83228509|FG001|Overall Study|Lost to Follow-up|2|||
46982358|NCT02682238|83228508|FG000|Overall Study|Withdrawal by Subject|1|||
46982359|NCT02682238|83228509|FG001|Overall Study|Withdrawal by Subject|0|||
46861267|NCT00283439|83077701|FG002|Overall Study|Disease progression|0|||
46861268|NCT00283439|83077702|FG003|Overall Study|Disease progression|0|||
46861269|NCT00283439|83077699|FG000|Overall Study|Requirement for alternative therapy|1|||
46861270|NCT00283439|83077700|FG001|Overall Study|Requirement for alternative therapy|2|||
46861271|NCT00283439|83077701|FG002|Overall Study|Requirement for alternative therapy|5|||
46861272|NCT00283439|83077702|FG003|Overall Study|Requirement for alternative therapy|2|||
46861273|NCT00283439|83077699|FG000|Overall Study|Stem cell transplant|6|||
46861274|NCT00283439|83077700|FG001|Overall Study|Stem cell transplant|6|||
46861275|NCT00283439|83077701|FG002|Overall Study|Stem cell transplant|4|||
46861276|NCT00283439|83077702|FG003|Overall Study|Stem cell transplant|3|||
46861277|NCT00283439|83077699|FG000|Overall Study|Treatment discontinued|0|||
46861278|NCT00283439|83077700|FG001|Overall Study|Treatment discontinued|2|||
46861279|NCT00283439|83077701|FG002|Overall Study|Treatment discontinued|1|||
46861280|NCT00283439|83077702|FG003|Overall Study|Treatment discontinued|3|||
46861281|NCT00283439|83077699|FG000|Overall Study|Other|1|||
46861282|NCT00283439|83077700|FG001|Overall Study|Other|0|||
46861283|NCT00283439|83077701|FG002|Overall Study|Other|0|||
46861284|NCT00283439|83077702|FG003|Overall Study|Other|0|||
46861285|NCT03233230|83077716|FG000|Overall Study|Adverse Event|6|||
46861286|NCT03233230|83077717|FG001|Overall Study|Adverse Event|3|||
46861287|NCT03233230|83077718|FG002|Overall Study|Adverse Event|6|||
46861288|NCT03233230|83077719|FG003|Overall Study|Adverse Event|3|||
46861289|NCT03233230|83077716|FG000|Overall Study|Protocol Violation|1|||
46861290|NCT03233230|83077717|FG001|Overall Study|Protocol Violation|2|||
46861291|NCT03233230|83077718|FG002|Overall Study|Protocol Violation|1|||
46861292|NCT03233230|83077719|FG003|Overall Study|Protocol Violation|1|||
46982360|NCT02682238|83228508|FG000|Overall Study|Adverse Event|1|||
46697162|NCT00950599|82911627|FG006|Follow-Up Period|Poor/Noncompliance|0|||
46697163|NCT00950599|82911628|FG007|Follow-Up Period|Poor/Noncompliance|0|||
46861293|NCT03233230|83077716|FG000|Overall Study|Lack of Efficacy|1|||
46861294|NCT03233230|83077717|FG001|Overall Study|Lack of Efficacy|0|||
46861295|NCT03233230|83077718|FG002|Overall Study|Lack of Efficacy|0|||
46861296|NCT03233230|83077719|FG003|Overall Study|Lack of Efficacy|0|||
46861297|NCT03233230|83077716|FG000|Overall Study|Other|5|||
46861298|NCT03233230|83077717|FG001|Overall Study|Other|5|||
46861299|NCT03233230|83077718|FG002|Overall Study|Other|5|||
46861300|NCT03233230|83077719|FG003|Overall Study|Other|3|||
46861301|NCT03233230|83077716|FG000|Overall Study|Withdrawal by Subject|2|||
46861302|NCT03233230|83077717|FG001|Overall Study|Withdrawal by Subject|2|||
46861303|NCT03233230|83077718|FG002|Overall Study|Withdrawal by Subject|0|||
46861304|NCT03233230|83077719|FG003|Overall Study|Withdrawal by Subject|1|||
46861305|NCT03233230|83077716|FG000|Overall Study|Lost to Follow-up|0|||
46861306|NCT03233230|83077717|FG001|Overall Study|Lost to Follow-up|3|||
46861307|NCT03233230|83077718|FG002|Overall Study|Lost to Follow-up|0|||
46861308|NCT03233230|83077719|FG003|Overall Study|Lost to Follow-up|0|||
46982361|NCT02682238|83228509|FG001|Overall Study|Adverse Event|0|||
46861309|NCT00283049|83077732|FG000|Overall Study|Adverse Event|6|||
46861310|NCT00283049|83077733|FG001|Overall Study|Adverse Event|1|||
46861311|NCT00283049|83077734|FG002|Overall Study|Adverse Event|4|||
46861312|NCT00283049|83077732|FG000|Overall Study|Protocol Violation|3|||
46861313|NCT00283049|83077733|FG001|Overall Study|Protocol Violation|0|||
46861314|NCT00283049|83077734|FG002|Overall Study|Protocol Violation|3|||
46861315|NCT00283049|83077732|FG000|Overall Study|Death|1|||
46861316|NCT00283049|83077733|FG001|Overall Study|Death|1|||
46861317|NCT00283049|83077734|FG002|Overall Study|Death|1|||
46861318|NCT00283049|83077732|FG000|Overall Study|Lack of Efficacy|0|||
46861319|NCT00283049|83077733|FG001|Overall Study|Lack of Efficacy|1|||
46861320|NCT00283049|83077734|FG002|Overall Study|Lack of Efficacy|1|||
46861321|NCT00283049|83077732|FG000|Overall Study|Lost to Follow-up|4|||
46861322|NCT00283049|83077733|FG001|Overall Study|Lost to Follow-up|2|||
46861323|NCT00283049|83077734|FG002|Overall Study|Lost to Follow-up|5|||
46861324|NCT00283049|83077732|FG000|Overall Study|Withdrawal by Subject|26|||
46861325|NCT00283049|83077733|FG001|Overall Study|Withdrawal by Subject|24|||
46861326|NCT00283049|83077734|FG002|Overall Study|Withdrawal by Subject|19|||
46861327|NCT00283049|83077732|FG000|Overall Study|Discontinuation of Study|18|||
46861328|NCT00283049|83077733|FG001|Overall Study|Discontinuation of Study|16|||
46861329|NCT00283049|83077734|FG002|Overall Study|Discontinuation of Study|20|||
46861330|NCT00283049|83077732|FG000|Overall Study|No longer requires study treatment|0|||
46861331|NCT00283049|83077733|FG001|Overall Study|No longer requires study treatment|0|||
46861332|NCT00283049|83077734|FG002|Overall Study|No longer requires study treatment|1|||
46861333|NCT00264875|83077742|FG000|Overall Study|Adverse Event|6|||
46861334|NCT00264875|83077742|FG000|Overall Study|Lost to Follow-up|6|||
46861335|NCT00264875|83077742|FG000|Overall Study|Protocol Violation|11|||
46861336|NCT00264875|83077742|FG000|Overall Study|Withdrawal by Subject|7|||
46861337|NCT03152110|83077746|FG000|Overall Study|Withdrawal by Subject|3|||
46861338|NCT03151408|83077753|FG000|Overall Study|Adverse Event|24|||
46861339|NCT03151408|83077754|FG001|Overall Study|Adverse Event|23|||
46861340|NCT03151408|83077753|FG000|Overall Study|Death|46|||
46861341|NCT03151408|83077754|FG001|Overall Study|Death|26|||
46861342|NCT03151408|83077753|FG000|Overall Study|Physician Decision|13|||
46861343|NCT03151408|83077754|FG001|Overall Study|Physician Decision|19|||
46861344|NCT03151408|83077753|FG000|Overall Study|Withdrawal by Subject|16|||
46861345|NCT03151408|83077754|FG001|Overall Study|Withdrawal by Subject|20|||
46861346|NCT03151408|83077753|FG000|Overall Study|Progressive disease|45|||
46861347|NCT03151408|83077754|FG001|Overall Study|Progressive disease|61|||
46861348|NCT03151408|83077753|FG000|Overall Study|non-compliance by patient|1|||
46861349|NCT03151408|83077754|FG001|Overall Study|non-compliance by patient|0|||
46861350|NCT03151408|83077753|FG000|Overall Study|other reasons|56|||
46861351|NCT03151408|83077754|FG001|Overall Study|other reasons|52|||
46861352|NCT03151408|83077753|FG000|Overall Study|randomized and not treated|2|||
46861353|NCT03151408|83077754|FG001|Overall Study|randomized and not treated|2|||
46861354|NCT00546754|83077762|FG000|Overall Study|Serious Adverse Event|1|||
46861355|NCT00546754|83077763|FG001|Overall Study|Serious Adverse Event|1|||
46861356|NCT00546754|83077762|FG000|Overall Study|Adverse Event|11|||
46861357|NCT00546754|83077763|FG001|Overall Study|Adverse Event|16|||
46861358|NCT00546754|83077762|FG000|Overall Study|Lack of Efficacy|1|||
46861359|NCT00546754|83077763|FG001|Overall Study|Lack of Efficacy|1|||
46861360|NCT00546754|83077762|FG000|Overall Study|Lost to Follow-up|9|||
46861361|NCT00546754|83077763|FG001|Overall Study|Lost to Follow-up|15|||
46861362|NCT00546754|83077762|FG000|Overall Study|Protocol Violation|3|||
46861363|NCT00546754|83077763|FG001|Overall Study|Protocol Violation|0|||
46861364|NCT00546754|83077762|FG000|Overall Study|Withdrawal by Subject|6|||
46861365|NCT00546754|83077763|FG001|Overall Study|Withdrawal by Subject|7|||
46861366|NCT00546754|83077762|FG000|Overall Study|Dyspnea|1|||
46861367|NCT00546754|83077763|FG001|Overall Study|Dyspnea|0|||
46861368|NCT00546754|83077762|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
46861369|NCT00546754|83077763|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
46861370|NCT00546754|83077762|FG000|Overall Study|Hip Replacement|1|||
46861371|NCT00546754|83077763|FG001|Overall Study|Hip Replacement|0|||
46861372|NCT00546754|83077762|FG000|Overall Study|Suicide|1|||
46861373|NCT00546754|83077763|FG001|Overall Study|Suicide|0|||
46861374|NCT00546754|83077762|FG000|Overall Study|Missing Cooperation|1|||
46861375|NCT00546754|83077763|FG001|Overall Study|Missing Cooperation|0|||
46861376|NCT00546754|83077762|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
46861377|NCT00546754|83077763|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
46861378|NCT00546754|83077762|FG000|Overall Study|Patient's Decision|0|||
46861379|NCT00546754|83077763|FG001|Overall Study|Patient's Decision|1|||
46861380|NCT00546754|83077762|FG000|Overall Study|Missing|14|||
46861381|NCT00546754|83077763|FG001|Overall Study|Missing|7|||
46861382|NCT00282347|83077771|FG000|Treatment Period|Death|2|||
46861383|NCT00282347|83077772|FG001|Treatment Period|Death|0|||
46861384|NCT00282347|83077771|FG000|Treatment Period|Lost to Follow-up|2|||
46861385|NCT00282347|83077772|FG001|Treatment Period|Lost to Follow-up|5|||
46697164|NCT00950599|82911629|FG008|Follow-Up Period|Poor/Noncompliance|1|||
46697165|NCT00950599|82911630|FG009|Follow-Up Period|Poor/Noncompliance|0|||
46697166|NCT00950599|82911621|FG000|Follow-Up Period|Subject withdrew Consent|0|||
46697167|NCT00950599|82911622|FG001|Follow-Up Period|Subject withdrew Consent|0|||
46697168|NCT00950599|82911623|FG002|Follow-Up Period|Subject withdrew Consent|0|||
46697169|NCT00950599|82911624|FG003|Follow-Up Period|Subject withdrew Consent|0|||
46697170|NCT00950599|82911625|FG004|Follow-Up Period|Subject withdrew Consent|0|||
46697171|NCT00950599|82911626|FG005|Follow-Up Period|Subject withdrew Consent|0|||
46697172|NCT00950599|82911627|FG006|Follow-Up Period|Subject withdrew Consent|0|||
46697173|NCT00950599|82911628|FG007|Follow-Up Period|Subject withdrew Consent|0|||
46697174|NCT00950599|82911629|FG008|Follow-Up Period|Subject withdrew Consent|2|||
46861386|NCT00282347|83077771|FG000|Treatment Period|Withdrawal by Subject|1|||
46861387|NCT00282347|83077772|FG001|Treatment Period|Withdrawal by Subject|3|||
46861388|NCT00282347|83077771|FG000|Treatment Period|Physician Decision|0|||
46861389|NCT00282347|83077772|FG001|Treatment Period|Physician Decision|1|||
46861390|NCT00282347|83077771|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
46861391|NCT00282347|83077772|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
46861392|NCT00282347|83077771|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
46861393|NCT00282347|83077772|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
46861394|NCT00282347|83077771|FG000|Safety Follow-up Period|Physician Decision|1|||
46861395|NCT00282347|83077772|FG001|Safety Follow-up Period|Physician Decision|1|||
46861396|NCT00282347|83077771|FG000|Safety Follow-up Period|Protocol Deviation|0|||
46861397|NCT00282347|83077772|FG001|Safety Follow-up Period|Protocol Deviation|2|||
46697175|NCT00950599|82911630|FG009|Follow-Up Period|Subject withdrew Consent|1|||
46697176|NCT01144299|82911655|FG000|Overall Study|Lost to Follow-up|1|||
46697177|NCT01144299|82911656|FG001|Overall Study|Lost to Follow-up|0|||
46861398|NCT00282347|83077771|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
46861399|NCT00282347|83077772|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
46861400|NCT00282347|83077771|FG000|B Cell Follow-up Period|Physician Decision|1|||
46861401|NCT00282347|83077772|FG001|B Cell Follow-up Period|Physician Decision|0|||
46861402|NCT00282347|83077771|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
46861403|NCT00282347|83077772|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
46861404|NCT00405964|83077782|FG000|Overall Study|Treatment Failure|17|||
46861405|NCT00405964|83077783|FG001|Overall Study|Treatment Failure|45|||
46861406|NCT00405964|83077782|FG000|Overall Study|Adverse Event|7|||
46861407|NCT00405964|83077783|FG001|Overall Study|Adverse Event|16|||
46861408|NCT00405964|83077782|FG000|Overall Study|Lost to Follow-up|5|||
46861409|NCT00405964|83077783|FG001|Overall Study|Lost to Follow-up|5|||
46861410|NCT00405964|83077782|FG000|Overall Study|Withdrawal by Subject|19|||
46861411|NCT00405964|83077783|FG001|Overall Study|Withdrawal by Subject|23|||
46861412|NCT00405964|83077782|FG000|Overall Study|Protocol Violation|11|||
46861413|NCT00405964|83077783|FG001|Overall Study|Protocol Violation|6|||
46861414|NCT00264797|83077791|FG000|Overall Study|Withdrawal by Subject|11|||
46861415|NCT00264797|83077792|FG001|Overall Study|Withdrawal by Subject|11|||
46861416|NCT00264797|83077791|FG000|Overall Study|Lost to Follow-up|9|||
46861417|NCT00264797|83077792|FG001|Overall Study|Lost to Follow-up|17|||
46861418|NCT00264797|83077791|FG000|Overall Study|Moved from area|3|||
46861419|NCT00264797|83077792|FG001|Overall Study|Moved from area|1|||
46861420|NCT00264797|83077791|FG000|Overall Study|Practical Problems|2|||
46861421|NCT00264797|83077792|FG001|Overall Study|Practical Problems|3|||
46861422|NCT00264797|83077791|FG000|Overall Study|Incarceration|4|||
46861423|NCT00264797|83077792|FG001|Overall Study|Incarceration|5|||
46861424|NCT00264797|83077791|FG000|Overall Study|Pressure/advice from Outsiders|1|||
46861425|NCT00264797|83077792|FG001|Overall Study|Pressure/advice from Outsiders|1|||
46861426|NCT00264797|83077791|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
46861427|NCT00264797|83077792|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
46861428|NCT00264797|83077791|FG000|Overall Study|Other|3|||
46861429|NCT00264797|83077792|FG001|Overall Study|Other|4|||
46861430|NCT03148756|83077800|FG000|Overall Study|Study Terminated|0|||
46861431|NCT03148756|83077801|FG001|Overall Study|Study Terminated|1|||
46861432|NCT00282113|83077810|FG000|Overall Study|Removed at parents request|1|||
46861433|NCT00282113|83077811|FG001|Overall Study|Removed at parents request|0|||
46861434|NCT00282113|83077812|FG002|Overall Study|Removed at parents request|0|||
46861435|NCT00281957|83077822|FG000|Overall Study|Adverse Event|7|||
46861436|NCT00281957|83077823|FG001|Overall Study|Adverse Event|2|||
46861437|NCT00281957|83077822|FG000|Overall Study|Death|1|||
46861438|NCT00281957|83077823|FG001|Overall Study|Death|0|||
46861439|NCT00281957|83077822|FG000|Overall Study|Progression/relapse|47|||
46861440|NCT00281957|83077823|FG001|Overall Study|Progression/relapse|35|||
46861441|NCT00281957|83077822|FG000|Overall Study|Not protocol specified|8|||
46861442|NCT00281957|83077823|FG001|Overall Study|Not protocol specified|1|||
46861443|NCT00281957|83077822|FG000|Overall Study|Not eligible|1|||
46861444|NCT00281957|83077823|FG001|Overall Study|Not eligible|2|||
46861445|NCT00281957|83077822|FG000|Overall Study|Did not start treatment|3|||
46861446|NCT00281957|83077823|FG001|Overall Study|Did not start treatment|1|||
46861447|NCT00281957|83077822|FG000|Overall Study|Refusal unrelated to adverse events|0|||
46861448|NCT00281957|83077823|FG001|Overall Study|Refusal unrelated to adverse events|1|||
46861449|NCT00281099|83077833|FG000|Overall Study|Death|46|||
46861450|NCT00281099|83077834|FG001|Overall Study|Death|57|||
46861451|NCT00281099|83077833|FG000|Overall Study|Lost to Follow-up|10|||
46861452|NCT00281099|83077834|FG001|Overall Study|Lost to Follow-up|19|||
46861453|NCT00281099|83077833|FG000|Overall Study|Withdrawal by Subject|65|||
46861454|NCT00281099|83077834|FG001|Overall Study|Withdrawal by Subject|70|||
46861455|NCT00281099|83077833|FG000|Overall Study|Physician Decision|79|||
46861456|NCT00281099|83077834|FG001|Overall Study|Physician Decision|72|||
46861457|NCT00281099|83077833|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
46861458|NCT00281099|83077834|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
46861459|NCT00262925|83077841|FG000|Overall Study|Lack of Efficacy|3|||
46861460|NCT00262925|83077841|FG000|Overall Study|Adverse Event|4|||
46861461|NCT00262925|83077841|FG000|Overall Study|Death|2|||
46861462|NCT00262925|83077841|FG000|Overall Study|alternative therapy|1|||
46861463|NCT00262925|83077841|FG000|Overall Study|Other|1|||
46861464|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
46861465|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
46861466|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
46861467|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
46861468|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
46861469|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
46861470|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
46861471|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
46861472|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
46861473|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
46861474|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
46861475|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
46861476|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
46861477|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
46861478|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
46861479|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
46861480|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
46861481|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
46861482|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
46861483|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
46861484|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
46861485|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
46861486|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
46861487|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
46861488|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
46861489|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
46861490|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
46861491|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
46861492|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
46861493|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
46861494|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
46861495|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
46861496|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
46861497|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
46861498|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
46861499|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
46861500|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
46861501|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
46861502|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
46861503|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
46861504|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
46861505|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
46861506|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
46861507|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
46861508|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
46861509|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
46861510|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
46861511|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
46861512|NCT03720470|83077851|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
46861513|NCT03720470|83077852|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
46861514|NCT03720470|83077853|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
46861515|NCT03720470|83077854|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
46861516|NCT03720470|83077855|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
46861517|NCT03720470|83077856|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
46861518|NCT03720470|83077851|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
46861519|NCT03720470|83077852|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
46861520|NCT03720470|83077853|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
46861521|NCT03720470|83077854|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
46861522|NCT03720470|83077855|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
46861523|NCT03720470|83077856|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
46861524|NCT03720470|83077851|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
46861525|NCT03720470|83077852|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
46861526|NCT03720470|83077853|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
46861527|NCT03720470|83077854|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
46861528|NCT03720470|83077855|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
46861529|NCT03720470|83077856|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
46861530|NCT03720470|83077851|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
46861531|NCT03720470|83077852|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
46861532|NCT03720470|83077853|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
46861533|NCT03720470|83077854|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
46861534|NCT03720470|83077855|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
46861535|NCT03720470|83077856|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
46861536|NCT03720470|83077851|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
46861537|NCT03720470|83077852|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
46861538|NCT03720470|83077853|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
46861539|NCT03720470|83077854|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
46861540|NCT03720470|83077855|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
46861541|NCT03720470|83077856|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
46861542|NCT03720470|83077851|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
46861543|NCT03720470|83077852|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
46861544|NCT03720470|83077853|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
46861545|NCT03720470|83077854|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
46861546|NCT03720470|83077855|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
46861547|NCT03720470|83077856|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
46861548|NCT03720470|83077851|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
46861549|NCT03720470|83077852|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
46861550|NCT03720470|83077853|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
46861551|NCT03720470|83077854|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
46861552|NCT03720470|83077855|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
46861553|NCT03720470|83077856|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
46861554|NCT03720470|83077851|FG000|Treatment Period: Final 4 Weeks|Other|0|||
46861555|NCT03720470|83077852|FG001|Treatment Period: Final 4 Weeks|Other|1|||
46861556|NCT03720470|83077853|FG002|Treatment Period: Final 4 Weeks|Other|0|||
46861557|NCT03720470|83077854|FG003|Treatment Period: Final 4 Weeks|Other|2|||
46861558|NCT03720470|83077855|FG004|Treatment Period: Final 4 Weeks|Other|1|||
46861559|NCT03720470|83077856|FG005|Treatment Period: Final 4 Weeks|Other|0|||
46861560|NCT00262847|83077879|FG000|Overall Study|Disease Progression|309|||
46861561|NCT00262847|83077880|FG001|Overall Study|Disease Progression|274|||
46861562|NCT00262847|83077881|FG002|Overall Study|Disease Progression|195|||
46861563|NCT00262847|83077879|FG000|Overall Study|Patient Refusal|41|||
46861564|NCT00262847|83077880|FG001|Overall Study|Patient Refusal|52|||
46861565|NCT00262847|83077881|FG002|Overall Study|Patient Refusal|47|||
46861566|NCT00262847|83077879|FG000|Overall Study|Adverse Event|74|||
46861567|NCT00262847|83077880|FG001|Overall Study|Adverse Event|88|||
46861568|NCT00262847|83077881|FG002|Overall Study|Adverse Event|108|||
46861569|NCT00262847|83077879|FG000|Overall Study|Death|8|||
46861570|NCT00262847|83077880|FG001|Overall Study|Death|8|||
46861571|NCT00262847|83077881|FG002|Overall Study|Death|11|||
46861572|NCT00262847|83077879|FG000|Overall Study|Concomitant disease|3|||
46861573|NCT00262847|83077880|FG001|Overall Study|Concomitant disease|2|||
46861574|NCT00262847|83077881|FG002|Overall Study|Concomitant disease|4|||
46861575|NCT00262847|83077879|FG000|Overall Study|Other Reasons|79|||
46861576|NCT00262847|83077880|FG001|Overall Study|Other Reasons|88|||
46861577|NCT00262847|83077881|FG002|Overall Study|Other Reasons|27|||
46861578|NCT00262847|83077879|FG000|Overall Study|Did not receive study treatment|4|||
46861579|NCT00262847|83077880|FG001|Overall Study|Did not receive study treatment|1|||
46861580|NCT00262847|83077881|FG002|Overall Study|Did not receive study treatment|4|||
46861581|NCT00280397|83077892|FG000|Overall Study|Adverse Event|1|||
46861582|NCT00262301|83077901|FG000|Double-blind Phase|Lost to Follow-up|1|||
46861583|NCT00262301|83077902|FG001|Double-blind Phase|Lost to Follow-up|0|||
46861584|NCT00262301|83077903|FG002|Double-blind Phase|Lost to Follow-up|0|||
46861585|NCT00262301|83077901|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
46861586|NCT00262301|83077902|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
46861587|NCT00262301|83077903|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
46861588|NCT00279305|83077913|FG000|Overall Study|Pregnancy|1|||
46861589|NCT00279305|83077914|FG001|Overall Study|Pregnancy|0|||
46861590|NCT00279305|83077913|FG000|Overall Study|Withdrawal by Subject|2|||
46861591|NCT00279305|83077914|FG001|Overall Study|Withdrawal by Subject|0|||
46861592|NCT00279305|83077913|FG000|Overall Study|Dificulting establishing IV|1|||
46861593|NCT00279305|83077914|FG001|Overall Study|Dificulting establishing IV|0|||
46861594|NCT00279305|83077913|FG000|Overall Study|FDA Safety Alert|4|||
46861595|NCT00279305|83077914|FG001|Overall Study|FDA Safety Alert|1|||
46861596|NCT00278993|83077920|FG000|Overall Study|Adverse Event|24|||
46861597|NCT00278993|83077920|FG000|Overall Study|Withdrawal by Subject|5|||
46861598|NCT00278993|83077920|FG000|Overall Study|Progressive Disease|65|||
46861599|NCT00278993|83077920|FG000|Overall Study|Physician Decision|9|||
46861600|NCT00278993|83077920|FG000|Overall Study|Not Otherwise Specified|4|||
46861601|NCT00277355|83077926|FG000|Overall Study|Withdrawal by Subject|3|||
46861602|NCT00277355|83077927|FG001|Overall Study|Withdrawal by Subject|3|||
46697178|NCT01144299|82911655|FG000|Overall Study|Withdrawal by Subject|1|||
46697179|NCT01144299|82911656|FG001|Overall Study|Withdrawal by Subject|0|||
46697180|NCT01143207|82911662|FG000|Overall Study|Lost to Follow-up|2|||
46697181|NCT01143051|82911672|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
46697182|NCT01143051|82911673|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
46697183|NCT01143051|82911674|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
46697184|NCT01143051|82911675|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
46697185|NCT01143051|82911676|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
46697186|NCT01143051|82911677|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
46697187|NCT01143051|82911672|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
46697188|NCT01143051|82911673|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
46697189|NCT01143051|82911674|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
46697190|NCT01143051|82911675|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
46697191|NCT01143051|82911676|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
46697192|NCT01143051|82911677|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
46697193|NCT01142661|82911687|FG000|Overall Study|Adverse Event|2|||
46697194|NCT01142661|82911687|FG000|Overall Study|Withdrawal by Subject|1|||
46697195|NCT01142661|82911687|FG000|Overall Study|Physician Decision|1|||
46697196|NCT01142193|82911693|FG000|Overall Study|Adverse Event|12|||
46697197|NCT01142193|82911694|FG001|Overall Study|Adverse Event|4|||
46697198|NCT01142193|82911693|FG000|Overall Study|Lack of Efficacy|2|||
46697199|NCT01142193|82911694|FG001|Overall Study|Lack of Efficacy|1|||
46697200|NCT01142193|82911693|FG000|Overall Study|Physician Decision|1|||
46697201|NCT01142193|82911694|FG001|Overall Study|Physician Decision|1|||
46697202|NCT01142193|82911693|FG000|Overall Study|Withdrawal by Subject|4|||
46697203|NCT01142193|82911694|FG001|Overall Study|Withdrawal by Subject|3|||
46697204|NCT01142193|82911693|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
46697205|NCT01142193|82911694|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
46697206|NCT01142193|82911693|FG000|Overall Study|Other|1|||
46697207|NCT01142193|82911694|FG001|Overall Study|Other|2|||
46697208|NCT01142115|82911700|FG000|First Intervention|Lack of Efficacy|1|||
46697209|NCT01142115|82911701|FG001|First Intervention|Lack of Efficacy|1|||
46697210|NCT01142115|82911700|FG000|First Intervention|Adverse Event|1|||
46697211|NCT01142115|82911701|FG001|First Intervention|Adverse Event|0|||
46697212|NCT01140477|82911708|FG000|Overall Study|Lost to Follow-up|4|||
46697213|NCT01140477|82911709|FG001|Overall Study|Lost to Follow-up|0|||
46697214|NCT01140477|82911708|FG000|Overall Study|Withdrawal by Subject|1|||
46697215|NCT01140477|82911709|FG001|Overall Study|Withdrawal by Subject|4|||
46697216|NCT01140477|82911708|FG000|Overall Study|Surgical complication preventing implant|2|||
46697217|NCT01140477|82911709|FG001|Overall Study|Surgical complication preventing implant|0|||
46697218|NCT01140477|82911708|FG000|Overall Study|Death|1|||
46697219|NCT01140477|82911709|FG001|Overall Study|Death|1|||
46697220|NCT01140477|82911708|FG000|Overall Study|Subject explanted|0|||
46697221|NCT01140477|82911709|FG001|Overall Study|Subject explanted|1|||
46697222|NCT01139775|82911718|FG000|Overall Study|Adverse Event|0|||
46697223|NCT01139775|82911719|FG001|Overall Study|Adverse Event|6|||
46697224|NCT01139775|82911720|FG002|Overall Study|Adverse Event|2|||
46697225|NCT01139775|82911718|FG000|Overall Study|Protocol Violation|0|||
46697226|NCT01139775|82911719|FG001|Overall Study|Protocol Violation|5|||
46697227|NCT01139775|82911720|FG002|Overall Study|Protocol Violation|0|||
46697228|NCT01139775|82911718|FG000|Overall Study|Withdrawal by Subject|1|||
46697229|NCT01139775|82911719|FG001|Overall Study|Withdrawal by Subject|0|||
46697230|NCT01139775|82911720|FG002|Overall Study|Withdrawal by Subject|2|||
46697231|NCT01139775|82911718|FG000|Overall Study|Physician Decision|0|||
46697232|NCT01139775|82911719|FG001|Overall Study|Physician Decision|2|||
46861603|NCT00277355|83077926|FG000|Overall Study|Lost to Follow-up|2|||
46861604|NCT00277355|83077927|FG001|Overall Study|Lost to Follow-up|2|||
46861605|NCT00277355|83077926|FG000|Overall Study|Adverse Event|5|||
46861606|NCT00277355|83077927|FG001|Overall Study|Adverse Event|0|||
46861607|NCT00277355|83077926|FG000|Overall Study|Death|3|||
46697233|NCT01139775|82911720|FG002|Overall Study|Physician Decision|2|||
46697234|NCT01283516|82911739|FG000|Overall Study|Adverse Event|0|||
46697235|NCT01283516|82911740|FG001|Overall Study|Adverse Event|0|||
46697236|NCT01283516|82911741|FG002|Overall Study|Adverse Event|0|||
46697237|NCT01283516|82911742|FG003|Overall Study|Adverse Event|0|||
46697238|NCT01283516|82911743|FG004|Overall Study|Adverse Event|0|||
46697239|NCT01283516|82911744|FG005|Overall Study|Adverse Event|0|||
46697240|NCT01283516|82911745|FG006|Overall Study|Adverse Event|2|||
46697241|NCT01283516|82911746|FG007|Overall Study|Adverse Event|0|||
46697242|NCT01283516|82911747|FG008|Overall Study|Adverse Event|28|||
46697243|NCT01283516|82911739|FG000|Overall Study|Death|0|||
46697244|NCT01283516|82911740|FG001|Overall Study|Death|0|||
46697245|NCT01283516|82911741|FG002|Overall Study|Death|0|||
46697246|NCT01283516|82911742|FG003|Overall Study|Death|0|||
46697247|NCT01283516|82911743|FG004|Overall Study|Death|0|||
46861608|NCT00277355|83077927|FG001|Overall Study|Death|0|||
46861609|NCT00277355|83077926|FG000|Overall Study|Physician Decision|1|||
46861610|NCT00277355|83077927|FG001|Overall Study|Physician Decision|0|||
46861611|NCT00262223|83077936|FG000|Treatment Phase|Withdrawal by Subject|3|||
46861612|NCT00262223|83077937|FG001|Treatment Phase|Withdrawal by Subject|6|||
46861613|NCT00262223|83077936|FG000|Treatment Phase|Adverse Event|1|||
46861614|NCT00262223|83077937|FG001|Treatment Phase|Adverse Event|2|||
46861615|NCT00262223|83077936|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
46861616|NCT00262223|83077937|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
46861617|NCT00262223|83077936|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
46861618|NCT00262223|83077937|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
46861619|NCT00262223|83077936|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
46861620|NCT00262223|83077937|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
46861621|NCT00276419|83077946|FG000|First Intervention|Adverse Event|1|||
46861622|NCT00276419|83077947|FG001|First Intervention|Adverse Event|0|||
46861623|NCT00276419|83077946|FG000|First Intervention|Withdrawal by Subject|0|||
46861624|NCT00276419|83077947|FG001|First Intervention|Withdrawal by Subject|2|||
46861625|NCT00262067|83077968|FG000|Overall Study|Death|190|||
46861626|NCT00262067|83077969|FG001|Overall Study|Death|89|||
46861627|NCT00262067|83077970|FG002|Overall Study|Death|186|||
46861628|NCT00262067|83077971|FG003|Overall Study|Death|99|||
46861629|NCT00262067|83077968|FG000|Overall Study|Lost to Follow-up|5|||
46861630|NCT00262067|83077969|FG001|Overall Study|Lost to Follow-up|4|||
46861631|NCT00262067|83077970|FG002|Overall Study|Lost to Follow-up|7|||
46861632|NCT00262067|83077971|FG003|Overall Study|Lost to Follow-up|5|||
46861633|NCT00262067|83077968|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
46861634|NCT00262067|83077969|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
46861635|NCT00262067|83077970|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
46861636|NCT00262067|83077971|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
46861637|NCT00262067|83077968|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
46861638|NCT00262067|83077969|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
46861639|NCT00262067|83077970|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
46861640|NCT00262067|83077971|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
46861641|NCT00275561|83077983|FG000|Overall Study|Withdrawal by Subject|0|||
46697248|NCT01283516|82911744|FG005|Overall Study|Death|1|||
46697249|NCT01283516|82911745|FG006|Overall Study|Death|0|||
46697250|NCT01283516|82911746|FG007|Overall Study|Death|1|||
46697251|NCT01283516|82911747|FG008|Overall Study|Death|12|||
46697252|NCT01283516|82911739|FG000|Overall Study|Disease Progression|2|||
46697253|NCT01283516|82911740|FG001|Overall Study|Disease Progression|2|||
46697254|NCT01283516|82911741|FG002|Overall Study|Disease Progression|3|||
46697255|NCT01283516|82911742|FG003|Overall Study|Disease Progression|3|||
46697256|NCT01283516|82911743|FG004|Overall Study|Disease Progression|13|||
46697257|NCT01283516|82911744|FG005|Overall Study|Disease Progression|8|||
46697258|NCT01283516|82911745|FG006|Overall Study|Disease Progression|6|||
46697259|NCT01283516|82911746|FG007|Overall Study|Disease Progression|3|||
46697260|NCT01283516|82911747|FG008|Overall Study|Disease Progression|139|||
46697261|NCT01283516|82911739|FG000|Overall Study|Withdrawal by Subject|0|||
46697262|NCT01283516|82911740|FG001|Overall Study|Withdrawal by Subject|0|||
46697263|NCT01283516|82911741|FG002|Overall Study|Withdrawal by Subject|0|||
46861642|NCT00275561|83077984|FG001|Overall Study|Withdrawal by Subject|1|||
46697264|NCT01283516|82911742|FG003|Overall Study|Withdrawal by Subject|0|||
46802411|NCT00490971|83021821|FG002|Acute/Continuation|Lack of Efficacy|0|||
46802412|NCT00490971|83021822|FG003|Acute/Continuation|Lack of Efficacy|0|||
46802413|NCT00490971|83021823|FG004|Acute/Continuation|Lack of Efficacy|0|||
46802414|NCT00490971|83021819|FG000|Acute/Continuation|Lost to Follow-up|23|||
46802415|NCT00490971|83021820|FG001|Acute/Continuation|Lost to Follow-up|7|||
46802416|NCT00490971|83021821|FG002|Acute/Continuation|Lost to Follow-up|0|||
46802417|NCT00490971|83021822|FG003|Acute/Continuation|Lost to Follow-up|0|||
46802418|NCT00490971|83021823|FG004|Acute/Continuation|Lost to Follow-up|0|||
46802419|NCT00490971|83021819|FG000|Acute/Continuation|Protocol Violation|10|||
46697265|NCT01283516|82911743|FG004|Overall Study|Withdrawal by Subject|1|||
46697266|NCT01283516|82911744|FG005|Overall Study|Withdrawal by Subject|0|||
46697267|NCT01283516|82911745|FG006|Overall Study|Withdrawal by Subject|1|||
46697268|NCT01283516|82911746|FG007|Overall Study|Withdrawal by Subject|0|||
46697269|NCT01283516|82911747|FG008|Overall Study|Withdrawal by Subject|36|||
46697270|NCT01283516|82911739|FG000|Overall Study|Administrative problems|0|||
46697271|NCT01283516|82911740|FG001|Overall Study|Administrative problems|0|||
46697272|NCT01283516|82911741|FG002|Overall Study|Administrative problems|0|||
46697273|NCT01283516|82911742|FG003|Overall Study|Administrative problems|0|||
46697274|NCT01283516|82911743|FG004|Overall Study|Administrative problems|0|||
46697275|NCT01283516|82911744|FG005|Overall Study|Administrative problems|1|||
46697276|NCT01283516|82911745|FG006|Overall Study|Administrative problems|1|||
46697277|NCT01283516|82911746|FG007|Overall Study|Administrative problems|1|||
46697278|NCT01283516|82911747|FG008|Overall Study|Administrative problems|39|||
46697279|NCT01283516|82911739|FG000|Overall Study|Lost to Follow-up|0|||
46697280|NCT01283516|82911740|FG001|Overall Study|Lost to Follow-up|0|||
46697281|NCT01283516|82911741|FG002|Overall Study|Lost to Follow-up|0|||
46697282|NCT01283516|82911742|FG003|Overall Study|Lost to Follow-up|0|||
46697283|NCT01283516|82911743|FG004|Overall Study|Lost to Follow-up|0|||
46697284|NCT01283516|82911744|FG005|Overall Study|Lost to Follow-up|0|||
46697285|NCT01283516|82911745|FG006|Overall Study|Lost to Follow-up|0|||
46697286|NCT01283516|82911746|FG007|Overall Study|Lost to Follow-up|0|||
46697287|NCT01283516|82911747|FG008|Overall Study|Lost to Follow-up|1|||
46697288|NCT01137435|82911775|FG000|Overall Study|Lost to Follow-up|24|||
46697289|NCT01137435|82911775|FG000|Overall Study|Off label usage|4|||
46697290|NCT01283282|82911779|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
46697291|NCT01283282|82911780|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
46697292|NCT01283282|82911779|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
46697293|NCT01283282|82911780|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
46697294|NCT01283282|82911779|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
46697295|NCT01283282|82911780|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
46697296|NCT01282814|82911789|FG000|First Intervention|Emesis During Dosing Interval|0|||
46697297|NCT01282814|82911790|FG001|First Intervention|Emesis During Dosing Interval|3|||
46697298|NCT01282814|82911789|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
46697299|NCT01282814|82911790|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
46697300|NCT00941863|82911801|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
46697301|NCT00941863|82911802|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
46697302|NCT00941863|82911803|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
46697303|NCT00941863|82911804|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
46697304|NCT00941863|82911805|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
46697305|NCT00941863|82911801|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
46697306|NCT00941863|82911802|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
46697307|NCT00941863|82911803|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
46697308|NCT00941863|82911804|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
46697309|NCT00941863|82911805|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
46697310|NCT00941863|82911801|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
46697311|NCT00941863|82911802|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
46697312|NCT00941863|82911803|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
46697313|NCT00941863|82911804|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
46697314|NCT00941863|82911805|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
46697315|NCT00941863|82911801|FG000|Until Primary Completion Date (PCD)|Death|0|||
46697316|NCT00941863|82911802|FG001|Until Primary Completion Date (PCD)|Death|0|||
46697317|NCT00941863|82911803|FG002|Until Primary Completion Date (PCD)|Death|1|||
46697318|NCT00941863|82911804|FG003|Until Primary Completion Date (PCD)|Death|2|||
46697319|NCT00941863|82911805|FG004|Until Primary Completion Date (PCD)|Death|7|||
46697320|NCT00941863|82911801|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
46697321|NCT00941863|82911802|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
46697322|NCT00941863|82911803|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
46697323|NCT00941863|82911804|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
46697324|NCT00941863|82911805|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
46697325|NCT00941863|82911801|FG000|Continued After PCD|Withdrawal by Subject|0|||
46697326|NCT00941863|82911802|FG001|Continued After PCD|Withdrawal by Subject|0|||
46697327|NCT00941863|82911803|FG002|Continued After PCD|Withdrawal by Subject|0|||
46697328|NCT00941863|82911804|FG003|Continued After PCD|Withdrawal by Subject|0|||
46697329|NCT00941863|82911805|FG004|Continued After PCD|Withdrawal by Subject|1|||
46697330|NCT00941863|82911801|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
46697331|NCT00941863|82911802|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
46697332|NCT00941863|82911803|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
46697333|NCT00941863|82911804|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
46697334|NCT00941863|82911805|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
46697335|NCT01282424|82911821|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
46697336|NCT01282424|82911821|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
46697337|NCT01282424|82911821|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
46697338|NCT01282424|82911821|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
46697339|NCT01282424|82911821|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
46697340|NCT01282424|82911821|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
46697341|NCT01282424|82911821|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
46697342|NCT01282424|82911821|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
46697343|NCT01281956|82911825|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
46697344|NCT01281956|82911826|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
46697345|NCT00949975|82911839|FG000|Overall Study|Voluntary discontinuation|6|||
46697346|NCT00949975|82911840|FG001|Overall Study|Voluntary discontinuation|5|||
46697347|NCT00949975|82911841|FG002|Overall Study|Voluntary discontinuation|3|||
46697348|NCT00949975|82911842|FG003|Overall Study|Voluntary discontinuation|6|||
46697349|NCT00949975|82911839|FG000|Overall Study|Adverse Event|11|||
46861643|NCT00275561|83077983|FG000|Overall Study|Travel|1|||
46861644|NCT00275561|83077984|FG001|Overall Study|Travel|1|||
46861645|NCT00275561|83077983|FG000|Overall Study|Scheduling|1|||
46861646|NCT00275561|83077984|FG001|Overall Study|Scheduling|2|||
46861647|NCT00275561|83077983|FG000|Overall Study|Family Issues|0|||
46861648|NCT00275561|83077984|FG001|Overall Study|Family Issues|2|||
46861649|NCT00274937|83077994|FG000|Overall Study|Physician Decision|10|||
46861650|NCT00274937|83077994|FG000|Overall Study|Withdrawal by Subject|6|||
46697350|NCT00949975|82911840|FG001|Overall Study|Adverse Event|11|||
46697351|NCT00949975|82911841|FG002|Overall Study|Adverse Event|10|||
46697352|NCT00949975|82911842|FG003|Overall Study|Adverse Event|10|||
46861651|NCT00274937|83077994|FG000|Overall Study|Progressive Disease|4|||
46861652|NCT00251693|83078001|FG000|Overall Study|Adverse Event|17|||
46861653|NCT00251693|83078002|FG001|Overall Study|Adverse Event|9|||
46982362|NCT02682238|83228508|FG000|Overall Study|Non-compliance with Study Drug|1|||
46697353|NCT00949975|82911839|FG000|Overall Study|Safety reason|0|||
46697354|NCT00949975|82911840|FG001|Overall Study|Safety reason|1|||
46697355|NCT00949975|82911841|FG002|Overall Study|Safety reason|0|||
46697356|NCT00949975|82911842|FG003|Overall Study|Safety reason|0|||
46861654|NCT00251693|83078003|FG002|Overall Study|Adverse Event|9|||
46861655|NCT00251693|83078001|FG000|Overall Study|Protocol Violation|2|||
46861656|NCT00251693|83078002|FG001|Overall Study|Protocol Violation|0|||
46861657|NCT00251693|83078003|FG002|Overall Study|Protocol Violation|2|||
46861658|NCT00251693|83078001|FG000|Overall Study|Lost to Follow-up|12|||
46861659|NCT00251693|83078002|FG001|Overall Study|Lost to Follow-up|7|||
46861660|NCT00251693|83078003|FG002|Overall Study|Lost to Follow-up|8|||
46861661|NCT00251693|83078001|FG000|Overall Study|Withdrawal by Subject|11|||
46861662|NCT00251693|83078002|FG001|Overall Study|Withdrawal by Subject|17|||
46861663|NCT00251693|83078003|FG002|Overall Study|Withdrawal by Subject|14|||
46861664|NCT00251693|83078001|FG000|Overall Study|Lack of Efficacy|0|||
46861665|NCT00251693|83078002|FG001|Overall Study|Lack of Efficacy|1|||
46861666|NCT00251693|83078003|FG002|Overall Study|Lack of Efficacy|0|||
46861667|NCT00251693|83078001|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
46861668|NCT00251693|83078002|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
46861669|NCT00251693|83078003|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
46861670|NCT00251693|83078001|FG000|Overall Study|Noncompliant|0|||
46861671|NCT00251693|83078002|FG001|Overall Study|Noncompliant|0|||
46861672|NCT00251693|83078003|FG002|Overall Study|Noncompliant|2|||
46861673|NCT00251693|83078001|FG000|Overall Study|Possible Barrett's esophagus|3|||
46861674|NCT00251693|83078002|FG001|Overall Study|Possible Barrett's esophagus|5|||
46861675|NCT00251693|83078003|FG002|Overall Study|Possible Barrett's esophagus|2|||
46861676|NCT00251693|83078001|FG000|Overall Study|Subject request/subject unavailable|1|||
46861677|NCT00251693|83078002|FG001|Overall Study|Subject request/subject unavailable|2|||
46861678|NCT00251693|83078003|FG002|Overall Study|Subject request/subject unavailable|0|||
46861679|NCT00251693|83078001|FG000|Overall Study|Abnormal laboratory findings|0|||
46861680|NCT00251693|83078002|FG001|Overall Study|Abnormal laboratory findings|0|||
46861681|NCT00251693|83078003|FG002|Overall Study|Abnormal laboratory findings|1|||
46861682|NCT00250835|83078011|FG000|Overall Study|Withdrawal by Subject|1|||
46861683|NCT03716024|83078021|FG000|Overall Study|Randomized, not Treated|7|||
46982363|NCT02682238|83228509|FG001|Overall Study|Non-compliance with Study Drug|0|||
46697357|NCT00949975|82911839|FG000|Overall Study|Study-specific criteria|0|||
46697358|NCT00949975|82911840|FG001|Overall Study|Study-specific criteria|1|||
46697359|NCT00949975|82911841|FG002|Overall Study|Study-specific criteria|1|||
46861684|NCT03716024|83078022|FG001|Overall Study|Randomized, not Treated|8|||
46861685|NCT03716024|83078021|FG000|Overall Study|Adverse Event|1|||
46982364|NCT02682238|83228508|FG000|Overall Study|Non-compliance with Protocol|0|||
46982365|NCT02682238|83228509|FG001|Overall Study|Non-compliance with Protocol|2|||
46982366|NCT01719562|83228551|FG000|Overall Study|Lost to Follow-up|1|||
46861686|NCT03716024|83078022|FG001|Overall Study|Adverse Event|2|||
46982367|NCT01719562|83228552|FG001|Overall Study|Lost to Follow-up|0|||
46861687|NCT03716024|83078021|FG000|Overall Study|Treatment Failure|1|||
46861688|NCT03716024|83078022|FG001|Overall Study|Treatment Failure|0|||
46861689|NCT03716024|83078021|FG000|Overall Study|Lost to Follow-up|2|||
46982368|NCT01719562|83228551|FG000|Overall Study|Death|1|||
46697360|NCT00949975|82911842|FG003|Overall Study|Study-specific criteria|0|||
46697361|NCT00949975|82911839|FG000|Overall Study|Incorrect enrolment|5|||
46697362|NCT00949975|82911840|FG001|Overall Study|Incorrect enrolment|10|||
46982369|NCT01719562|83228552|FG001|Overall Study|Death|0|||
46861690|NCT03716024|83078022|FG001|Overall Study|Lost to Follow-up|6|||
46861691|NCT03716024|83078021|FG000|Overall Study|Withdrawal by Subject|0|||
46861692|NCT03716024|83078022|FG001|Overall Study|Withdrawal by Subject|1|||
46861693|NCT03716024|83078021|FG000|Overall Study|Missing Reason|0|||
46861694|NCT03716024|83078022|FG001|Overall Study|Missing Reason|1|||
46861695|NCT00250679|83078031|FG000|Overall Study|Adverse Event|12|||
46861696|NCT00250679|83078032|FG001|Overall Study|Adverse Event|15|||
46861697|NCT00250679|83078033|FG002|Overall Study|Adverse Event|16|||
46861698|NCT00250679|83078031|FG000|Overall Study|Protocol Violation|2|||
46861699|NCT00250679|83078032|FG001|Overall Study|Protocol Violation|4|||
46861700|NCT00250679|83078033|FG002|Overall Study|Protocol Violation|3|||
46861701|NCT00250679|83078031|FG000|Overall Study|Withdrawal by Subject|15|||
46861702|NCT00250679|83078032|FG001|Overall Study|Withdrawal by Subject|18|||
46861703|NCT00250679|83078033|FG002|Overall Study|Withdrawal by Subject|15|||
46861704|NCT00250679|83078031|FG000|Overall Study|Lost to Follow-up|3|||
46861705|NCT00250679|83078032|FG001|Overall Study|Lost to Follow-up|4|||
46861706|NCT00250679|83078033|FG002|Overall Study|Lost to Follow-up|2|||
46861707|NCT00250679|83078031|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
46861708|NCT00250679|83078032|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
46861709|NCT00250679|83078033|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
46861710|NCT00250679|83078031|FG000|Overall Study|Lack of Efficacy|0|||
46861711|NCT00250679|83078032|FG001|Overall Study|Lack of Efficacy|1|||
46861712|NCT00250679|83078033|FG002|Overall Study|Lack of Efficacy|3|||
46861713|NCT00250679|83078031|FG000|Overall Study|Technical Holter issues|1|||
46861714|NCT00250679|83078032|FG001|Overall Study|Technical Holter issues|0|||
46697363|NCT00949975|82911841|FG002|Overall Study|Incorrect enrolment|4|||
46697364|NCT00949975|82911842|FG003|Overall Study|Incorrect enrolment|7|||
46697365|NCT00949975|82911839|FG000|Overall Study|Severe non-compliance|3|||
46697366|NCT00949975|82911840|FG001|Overall Study|Severe non-compliance|1|||
46697367|NCT00949975|82911841|FG002|Overall Study|Severe non-compliance|0|||
46697368|NCT00949975|82911842|FG003|Overall Study|Severe non-compliance|2|||
46861715|NCT00250679|83078033|FG002|Overall Study|Technical Holter issues|2|||
46861716|NCT00250679|83078031|FG000|Overall Study|Moved|1|||
46861717|NCT00250679|83078032|FG001|Overall Study|Moved|1|||
46861718|NCT00250679|83078033|FG002|Overall Study|Moved|0|||
46861719|NCT00250679|83078031|FG000|Overall Study|Non-compliance|1|||
46861720|NCT00250679|83078032|FG001|Overall Study|Non-compliance|1|||
46861721|NCT00250679|83078033|FG002|Overall Study|Non-compliance|0|||
46697369|NCT00949975|82911839|FG000|Overall Study|Lost to Follow-up|1|||
46697370|NCT00949975|82911840|FG001|Overall Study|Lost to Follow-up|0|||
46697371|NCT00949975|82911841|FG002|Overall Study|Lost to Follow-up|1|||
46697372|NCT00949975|82911842|FG003|Overall Study|Lost to Follow-up|3|||
46697373|NCT00949975|82911839|FG000|Overall Study|Other|1|||
46697374|NCT00949975|82911840|FG001|Overall Study|Other|0|||
46697375|NCT00949975|82911841|FG002|Overall Study|Other|0|||
46697376|NCT00949975|82911842|FG003|Overall Study|Other|0|||
46697377|NCT00939055|82911854|FG000|Overall Study|Discontinuation prior to procedure|4|||
46697378|NCT00939055|82911855|FG001|Overall Study|Discontinuation prior to procedure|0|||
46697379|NCT01136967|82911864|FG000|Overall Study|Adverse Event|9|||
46697380|NCT01136967|82911865|FG001|Overall Study|Adverse Event|12|||
46697381|NCT01136967|82911864|FG000|Overall Study|Participant Choice|8|||
46697382|NCT01136967|82911865|FG001|Overall Study|Participant Choice|3|||
46697383|NCT01136967|82911864|FG000|Overall Study|Lost to Follow-up|0|||
46697384|NCT01136967|82911865|FG001|Overall Study|Lost to Follow-up|1|||
46697385|NCT01136967|82911864|FG000|Overall Study|Withdrawal by Subject|1|||
46861722|NCT00250679|83078031|FG000|Overall Study|various single events: hip surgery,diary|3|||
46861723|NCT00250679|83078032|FG001|Overall Study|various single events: hip surgery,diary|1|||
46861724|NCT00250679|83078033|FG002|Overall Study|various single events: hip surgery,diary|1|||
46861725|NCT00261833|83078043|FG000|Overall Study|Death|1|||
46861726|NCT00261833|83078044|FG001|Overall Study|Death|3|||
46861727|NCT00261833|83078043|FG000|Overall Study|Adverse Event|1|||
46861728|NCT00261833|83078044|FG001|Overall Study|Adverse Event|4|||
46861729|NCT00261833|83078043|FG000|Overall Study|Withdrawal by Subject|5|||
46861730|NCT00261833|83078044|FG001|Overall Study|Withdrawal by Subject|7|||
46697386|NCT01136967|82911865|FG001|Overall Study|Withdrawal by Subject|2|||
46697387|NCT01136967|82911864|FG000|Overall Study|Clinical Progression|3|||
46697388|NCT01136967|82911865|FG001|Overall Study|Clinical Progression|5|||
46697389|NCT01136967|82911864|FG000|Overall Study|Radiation|1|||
46697390|NCT01136967|82911865|FG001|Overall Study|Radiation|0|||
46697391|NCT01136967|82911864|FG000|Overall Study|Non-compliance|1|||
46697392|NCT01136967|82911865|FG001|Overall Study|Non-compliance|0|||
46697393|NCT01136967|82911864|FG000|Overall Study|Investigator's Choice|1|||
46697394|NCT01136967|82911865|FG001|Overall Study|Investigator's Choice|1|||
46861731|NCT00261833|83078043|FG000|Overall Study|Protocol Violation|0|||
46861732|NCT00261833|83078044|FG001|Overall Study|Protocol Violation|1|||
46861733|NCT00261833|83078043|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
46861734|NCT00261833|83078044|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
46861735|NCT00261833|83078043|FG000|Overall Study|Lung transplantation|1|||
46697395|NCT01136967|82911864|FG000|Overall Study|Increase in Lesion Size|0|||
46697396|NCT01136967|82911865|FG001|Overall Study|Increase in Lesion Size|2|||
46697397|NCT01136967|82911864|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
46861736|NCT00261833|83078044|FG001|Overall Study|Lung transplantation|1|||
46861737|NCT00261833|83078043|FG000|Overall Study|Missing reason|1|||
46861738|NCT00261833|83078044|FG001|Overall Study|Missing reason|0|||
46861739|NCT00261833|83078043|FG000|Overall Study|Not interested in being participant|0|||
46861740|NCT00261833|83078044|FG001|Overall Study|Not interested in being participant|1|||
46861741|NCT03713684|83078055|FG000|Overall Study|Adverse Event|1|||
46861742|NCT03713684|83078056|FG001|Overall Study|Adverse Event|3|||
46861743|NCT03713684|83078057|FG002|Overall Study|Adverse Event|1|||
46861744|NCT03713684|83078058|FG003|Overall Study|Adverse Event|0|||
46861745|NCT03713684|83078055|FG000|Overall Study|Poor compliance to protocol|2|||
46861746|NCT03713684|83078056|FG001|Overall Study|Poor compliance to protocol|1|||
46861747|NCT03713684|83078057|FG002|Overall Study|Poor compliance to protocol|0|||
46861748|NCT03713684|83078058|FG003|Overall Study|Poor compliance to protocol|1|||
46861749|NCT03713684|83078055|FG000|Overall Study|Withdrawal by Subject|14|||
46861750|NCT03713684|83078056|FG001|Overall Study|Withdrawal by Subject|6|||
46861751|NCT03713684|83078057|FG002|Overall Study|Withdrawal by Subject|14|||
46861752|NCT03713684|83078058|FG003|Overall Study|Withdrawal by Subject|16|||
46861753|NCT03713684|83078055|FG000|Overall Study|Other than specified|69|||
46861754|NCT03713684|83078056|FG001|Overall Study|Other than specified|77|||
46861755|NCT03713684|83078057|FG002|Overall Study|Other than specified|73|||
46861756|NCT03713684|83078058|FG003|Overall Study|Other than specified|70|||
46861757|NCT03711266|83078068|FG000|Overall Study|Lost to Follow-up|10|||
46861758|NCT03150862|83078080|FG000|Overall Study|Death|2|||
46861759|NCT03150862|83078081|FG001|Overall Study|Death|7|||
46861760|NCT03150862|83078082|FG002|Overall Study|Death|8|||
46861761|NCT03150862|83078083|FG003|Overall Study|Death|27|||
46861762|NCT03150862|83078084|FG004|Overall Study|Death|4|||
46861763|NCT03150862|83078085|FG005|Overall Study|Death|8|||
46861764|NCT03150862|83078086|FG006|Overall Study|Death|6|||
46861765|NCT03150862|83078087|FG007|Overall Study|Death|21|||
46861766|NCT03150862|83078080|FG000|Overall Study|Withdrawal by Subject|1|||
46861767|NCT03150862|83078081|FG001|Overall Study|Withdrawal by Subject|1|||
46861768|NCT03150862|83078082|FG002|Overall Study|Withdrawal by Subject|0|||
46861769|NCT03150862|83078083|FG003|Overall Study|Withdrawal by Subject|3|||
46861770|NCT03150862|83078084|FG004|Overall Study|Withdrawal by Subject|1|||
46861771|NCT03150862|83078085|FG005|Overall Study|Withdrawal by Subject|1|||
46861772|NCT03150862|83078086|FG006|Overall Study|Withdrawal by Subject|1|||
46861773|NCT03150862|83078087|FG007|Overall Study|Withdrawal by Subject|3|||
46861774|NCT03150862|83078080|FG000|Overall Study|Lost to Follow-up|0|||
46861775|NCT03150862|83078081|FG001|Overall Study|Lost to Follow-up|0|||
46861776|NCT03150862|83078082|FG002|Overall Study|Lost to Follow-up|1|||
46861777|NCT03150862|83078083|FG003|Overall Study|Lost to Follow-up|0|||
46861778|NCT03150862|83078084|FG004|Overall Study|Lost to Follow-up|0|||
46861779|NCT03150862|83078085|FG005|Overall Study|Lost to Follow-up|0|||
46861780|NCT03150862|83078086|FG006|Overall Study|Lost to Follow-up|0|||
46861781|NCT03150862|83078087|FG007|Overall Study|Lost to Follow-up|2|||
46982370|NCT01719562|83228551|FG000|Overall Study|New cancer diagnosis|1|||
46982371|NCT01719562|83228552|FG001|Overall Study|New cancer diagnosis|0|||
46697398|NCT01136967|82911865|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
46697399|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
46697400|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
46802420|NCT00490971|83021820|FG001|Acute/Continuation|Protocol Violation|2|||
46861782|NCT03150862|83078080|FG000|Overall Study|Sponsor's decision|0|||
46697401|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
46802421|NCT00490971|83021821|FG002|Acute/Continuation|Protocol Violation|0|||
46802422|NCT00490971|83021822|FG003|Acute/Continuation|Protocol Violation|0|||
46802423|NCT00490971|83021823|FG004|Acute/Continuation|Protocol Violation|0|||
46802424|NCT00490971|83021819|FG000|Acute/Continuation|Withdrawal by Subject|92|||
46802425|NCT00490971|83021820|FG001|Acute/Continuation|Withdrawal by Subject|24|||
46802426|NCT00490971|83021821|FG002|Acute/Continuation|Withdrawal by Subject|0|||
46802427|NCT00490971|83021822|FG003|Acute/Continuation|Withdrawal by Subject|0|||
46802428|NCT00490971|83021823|FG004|Acute/Continuation|Withdrawal by Subject|0|||
46861783|NCT03150862|83078081|FG001|Overall Study|Sponsor's decision|0|||
46861784|NCT03150862|83078082|FG002|Overall Study|Sponsor's decision|0|||
46861785|NCT03150862|83078083|FG003|Overall Study|Sponsor's decision|10|||
46861786|NCT03150862|83078084|FG004|Overall Study|Sponsor's decision|3|||
46861787|NCT03150862|83078085|FG005|Overall Study|Sponsor's decision|0|||
46982372|NCT01700439|83228558|FG000|Overall Study|Lost to Follow-up|47|||
46861788|NCT03150862|83078086|FG006|Overall Study|Sponsor's decision|1|||
46861789|NCT03150862|83078087|FG007|Overall Study|Sponsor's decision|1|||
46861790|NCT03150862|83078080|FG000|Overall Study|Change in Methylation status|0|||
46861791|NCT03150862|83078081|FG001|Overall Study|Change in Methylation status|0|||
46861792|NCT03150862|83078082|FG002|Overall Study|Change in Methylation status|0|||
46861793|NCT03150862|83078083|FG003|Overall Study|Change in Methylation status|0|||
46861794|NCT03150862|83078084|FG004|Overall Study|Change in Methylation status|1|||
46861795|NCT03150862|83078085|FG005|Overall Study|Change in Methylation status|0|||
46861796|NCT03150862|83078086|FG006|Overall Study|Change in Methylation status|0|||
46861797|NCT03150862|83078087|FG007|Overall Study|Change in Methylation status|0|||
46861798|NCT03150862|83078080|FG000|Overall Study|Roll over in to Long Term Extension|0|||
46861799|NCT03150862|83078081|FG001|Overall Study|Roll over in to Long Term Extension|0|||
46861800|NCT03150862|83078082|FG002|Overall Study|Roll over in to Long Term Extension|0|||
46861801|NCT03150862|83078083|FG003|Overall Study|Roll over in to Long Term Extension|0|||
46861802|NCT03150862|83078084|FG004|Overall Study|Roll over in to Long Term Extension|0|||
46861803|NCT03150862|83078085|FG005|Overall Study|Roll over in to Long Term Extension|0|||
46861804|NCT03150862|83078086|FG006|Overall Study|Roll over in to Long Term Extension|0|||
46861805|NCT03150862|83078087|FG007|Overall Study|Roll over in to Long Term Extension|1|||
46861806|NCT03150862|83078080|FG000|Overall Study|Progressive Disease|0|||
46861807|NCT03150862|83078081|FG001|Overall Study|Progressive Disease|0|||
46861808|NCT03150862|83078082|FG002|Overall Study|Progressive Disease|0|||
46861809|NCT03150862|83078083|FG003|Overall Study|Progressive Disease|0|||
46861810|NCT03150862|83078084|FG004|Overall Study|Progressive Disease|0|||
46861811|NCT03150862|83078085|FG005|Overall Study|Progressive Disease|0|||
46861812|NCT03150862|83078086|FG006|Overall Study|Progressive Disease|0|||
46861813|NCT03150862|83078087|FG007|Overall Study|Progressive Disease|2|||
46861814|NCT00260429|83078116|FG000|Overall Study|failure to follow appointments|1|||
46861815|NCT00260429|83078117|FG001|Overall Study|failure to follow appointments|0|||
46861816|NCT00260429|83078116|FG000|Overall Study|scheduled hand surgery|1|||
46861817|NCT00260429|83078117|FG001|Overall Study|scheduled hand surgery|0|||
46861818|NCT00379288|83078127|FG000|Overall Study|Adverse Event|5|||
46861819|NCT00379288|83078128|FG001|Overall Study|Adverse Event|6|||
46861820|NCT00379288|83078129|FG002|Overall Study|Adverse Event|2|||
46861821|NCT00379288|83078130|FG003|Overall Study|Adverse Event|0|||
46861822|NCT00379288|83078127|FG000|Overall Study|Treatment Failure|0|||
46861823|NCT00379288|83078128|FG001|Overall Study|Treatment Failure|1|||
46861824|NCT00379288|83078129|FG002|Overall Study|Treatment Failure|0|||
46861825|NCT00379288|83078130|FG003|Overall Study|Treatment Failure|1|||
46861826|NCT00379288|83078127|FG000|Overall Study|Lost to Follow-up|3|||
46861827|NCT00379288|83078128|FG001|Overall Study|Lost to Follow-up|3|||
46861828|NCT00379288|83078129|FG002|Overall Study|Lost to Follow-up|2|||
46861829|NCT00379288|83078130|FG003|Overall Study|Lost to Follow-up|0|||
46861830|NCT00379288|83078127|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
46861831|NCT00379288|83078128|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
46861832|NCT00379288|83078129|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
46861833|NCT00379288|83078130|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
46861834|NCT00379288|83078127|FG000|Overall Study|Subject withdrew-related to study drug|1|||
46861835|NCT00379288|83078128|FG001|Overall Study|Subject withdrew-related to study drug|0|||
46861836|NCT00379288|83078129|FG002|Overall Study|Subject withdrew-related to study drug|0|||
46861837|NCT00379288|83078130|FG003|Overall Study|Subject withdrew-related to study drug|1|||
46861838|NCT00379288|83078127|FG000|Overall Study|Noncompliance with protocol|8|||
46861839|NCT00379288|83078128|FG001|Overall Study|Noncompliance with protocol|6|||
46861840|NCT00379288|83078129|FG002|Overall Study|Noncompliance with protocol|2|||
46861841|NCT00379288|83078130|FG003|Overall Study|Noncompliance with protocol|1|||
46861842|NCT00379288|83078127|FG000|Overall Study|Did not meet protocol eligibility|0|||
46861843|NCT00379288|83078128|FG001|Overall Study|Did not meet protocol eligibility|1|||
46861844|NCT00379288|83078129|FG002|Overall Study|Did not meet protocol eligibility|0|||
46861845|NCT00379288|83078130|FG003|Overall Study|Did not meet protocol eligibility|2|||
46861846|NCT00379288|83078127|FG000|Overall Study|Administrative|2|||
46861847|NCT00379288|83078128|FG001|Overall Study|Administrative|2|||
46861848|NCT00379288|83078129|FG002|Overall Study|Administrative|0|||
46861849|NCT00379288|83078130|FG003|Overall Study|Administrative|1|||
46861850|NCT00243503|83078140|FG000|Overall Study|Adverse Event|11|||
46861851|NCT00243503|83078140|FG000|Overall Study|Withdrawal by Subject|1|||
46861852|NCT00243503|83078140|FG000|Overall Study|Lack of Efficacy|44|||
46861853|NCT00243503|83078140|FG000|Overall Study|Death|1|||
46861854|NCT00243503|83078140|FG000|Overall Study|Other|1|||
46861855|NCT00239837|83078147|FG000|Overall Study|Lost to Follow-up|3|||
46861856|NCT00239837|83078148|FG001|Overall Study|Lost to Follow-up|7|||
46861857|NCT00259649|83078156|FG000|Overall Study|Lost to Follow-up|7|||
46861858|NCT00259649|83078156|FG000|Overall Study|irregular menses|3|||
46861859|NCT03712280|83078164|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
46861860|NCT03712280|83078165|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
46861861|NCT03712280|83078166|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
46861862|NCT03712280|83078167|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
46861863|NCT03712280|83078164|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
46861864|NCT03712280|83078165|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
46861865|NCT03712280|83078166|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
46861866|NCT03712280|83078167|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
46861867|NCT03712280|83078164|FG000|Overall Study|Adverse Event|0|||
46861868|NCT03712280|83078165|FG001|Overall Study|Adverse Event|0|||
46697402|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
46697403|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
46697404|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
46697405|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
46697406|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
46697407|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
46697408|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
46697409|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
46697410|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
46697411|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
46697412|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
46697413|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
46697414|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
46697415|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
46697416|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
46697417|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
46861869|NCT03712280|83078166|FG002|Overall Study|Adverse Event|1|||
46861870|NCT03712280|83078167|FG003|Overall Study|Adverse Event|0|||
46861871|NCT01345240|83078182|FG000|Overall Study|Adverse Event|3|||
46861872|NCT01345240|83078183|FG001|Overall Study|Adverse Event|5|||
46861873|NCT01345240|83078184|FG002|Overall Study|Adverse Event|4|||
46861874|NCT01345240|83078185|FG003|Overall Study|Adverse Event|2|||
46861875|NCT01345240|83078186|FG004|Overall Study|Adverse Event|1|||
46861876|NCT01345240|83078182|FG000|Overall Study|Lost to Follow-up|8|||
46861877|NCT01345240|83078183|FG001|Overall Study|Lost to Follow-up|9|||
46861878|NCT01345240|83078184|FG002|Overall Study|Lost to Follow-up|14|||
46861879|NCT01345240|83078185|FG003|Overall Study|Lost to Follow-up|7|||
46861880|NCT01345240|83078186|FG004|Overall Study|Lost to Follow-up|9|||
46861881|NCT03707912|83078209|FG000|Overall Study|Violation of inclusion criteria|1|||
46861882|NCT03707912|83078210|FG001|Overall Study|Violation of inclusion criteria|0|||
46861883|NCT02883244|83078218|FG000|Overall Study|Lost to Follow-up|0|||
46861884|NCT02883244|83078219|FG001|Overall Study|Lost to Follow-up|1|||
46861885|NCT02882854|83078227|FG000|Overall Study|Lost to Follow-up|1|||
46861886|NCT02882854|83078228|FG001|Overall Study|Lost to Follow-up|2|||
46861887|NCT02882854|83078227|FG000|Overall Study|Physician Decision|0|||
46861888|NCT02882854|83078228|FG001|Overall Study|Physician Decision|1|||
46861889|NCT03707522|83078238|FG000|Overall Study|Lost to Follow-up|24|||
46697418|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
46861890|NCT03707522|83078239|FG001|Overall Study|Lost to Follow-up|27|||
46861891|NCT03707522|83078240|FG002|Overall Study|Lost to Follow-up|41|||
46861892|NCT03707522|83078241|FG003|Overall Study|Lost to Follow-up|36|||
46697419|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
46861893|NCT03150082|83078251|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
46861894|NCT03150082|83078252|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
46861895|NCT03142750|83078280|FG000|Overall Study|Lost to Follow-up|4|||
46861896|NCT03142750|83078281|FG001|Overall Study|Lost to Follow-up|1|||
46861897|NCT03149848|83078291|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
46861898|NCT03149848|83078291|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
46861899|NCT03706040|83078301|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
46861900|NCT03706040|83078302|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
46861901|NCT03706040|83078303|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
46861902|NCT03706040|83078304|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
46861903|NCT03706040|83078305|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
46861904|NCT03706040|83078306|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
46861905|NCT03706040|83078307|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
46861906|NCT03706040|83078301|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
46861907|NCT03706040|83078302|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
46861908|NCT03706040|83078303|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
46861909|NCT03706040|83078304|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
46861910|NCT03706040|83078305|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
46861911|NCT03706040|83078306|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
46861912|NCT03706040|83078307|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
46861913|NCT03706040|83078301|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
46861914|NCT03706040|83078302|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
46861915|NCT03706040|83078303|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
46861916|NCT03706040|83078304|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
46861917|NCT03706040|83078305|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
46861918|NCT03706040|83078306|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
46861919|NCT03706040|83078307|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
46861920|NCT03706040|83078301|FG000|Period A (Week 0 to Week 16)|Other|2|||
46861921|NCT03706040|83078302|FG001|Period A (Week 0 to Week 16)|Other|0|||
46861922|NCT03706040|83078303|FG002|Period A (Week 0 to Week 16)|Other|2|||
46861923|NCT03706040|83078304|FG003|Period A (Week 0 to Week 16)|Other|0|||
46861924|NCT03706040|83078305|FG004|Period A (Week 0 to Week 16)|Other|0|||
46861925|NCT03706040|83078306|FG005|Period A (Week 0 to Week 16)|Other|0|||
46861926|NCT03706040|83078307|FG006|Period A (Week 0 to Week 16)|Other|0|||
46861927|NCT03706040|83078301|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
46861928|NCT03706040|83078302|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
46861929|NCT03706040|83078303|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
46861930|NCT03706040|83078304|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
46861931|NCT03706040|83078305|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
46861932|NCT03706040|83078306|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
46861933|NCT03706040|83078307|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
46861934|NCT03706040|83078301|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
46861935|NCT03706040|83078302|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
46861936|NCT03706040|83078303|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
46861937|NCT03706040|83078304|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
46861938|NCT03706040|83078305|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
46861939|NCT03706040|83078306|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
46861940|NCT03706040|83078307|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
46861941|NCT03706040|83078301|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
46861942|NCT03706040|83078302|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
46861943|NCT03706040|83078303|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
46861944|NCT03706040|83078304|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
46861945|NCT03706040|83078305|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
46861946|NCT03706040|83078306|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
46861947|NCT03706040|83078307|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
46861948|NCT03706040|83078301|FG000|Period B (Week 16 to Week 52)|Other|0|||
46861949|NCT03706040|83078302|FG001|Period B (Week 16 to Week 52)|Other|0|||
46861950|NCT03706040|83078303|FG002|Period B (Week 16 to Week 52)|Other|0|||
46861951|NCT03706040|83078304|FG003|Period B (Week 16 to Week 52)|Other|4|||
46861952|NCT03706040|83078305|FG004|Period B (Week 16 to Week 52)|Other|5|||
46861953|NCT03706040|83078306|FG005|Period B (Week 16 to Week 52)|Other|23|||
46982373|NCT01700439|83228558|FG000|Overall Study|Withdrawal by Subject|183|||
46697420|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
46697421|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
46861954|NCT03706040|83078307|FG006|Period B (Week 16 to Week 52)|Other|17|||
46861955|NCT03770000|83078328|FG000|Overall Study|Premature discontinuation due to PD|0|||
46861956|NCT03770000|83078329|FG001|Overall Study|Premature discontinuation due to PD|0|||
46861957|NCT03770000|83078330|FG002|Overall Study|Premature discontinuation due to PD|1|||
46861958|NCT03770000|83078331|FG003|Overall Study|Premature discontinuation due to PD|3|||
46861959|NCT03770000|83078332|FG004|Overall Study|Premature discontinuation due to PD|2|||
46861960|NCT03158272|83078351|FG000|Overall Study|Disease progression|3|||
46861961|NCT03158272|83078352|FG001|Overall Study|Disease progression|3|||
46861962|NCT03158272|83078353|FG002|Overall Study|Disease progression|4|||
46861963|NCT03158272|83078354|FG003|Overall Study|Disease progression|6|||
46861964|NCT03158272|83078351|FG000|Overall Study|Death|0|||
46861965|NCT03158272|83078352|FG001|Overall Study|Death|0|||
46861966|NCT03158272|83078353|FG002|Overall Study|Death|1|||
46861967|NCT03158272|83078354|FG003|Overall Study|Death|0|||
46861968|NCT03158272|83078351|FG000|Overall Study|Other reasons|0|||
46861969|NCT03158272|83078352|FG001|Overall Study|Other reasons|0|||
46861970|NCT03158272|83078353|FG002|Overall Study|Other reasons|1|||
46861971|NCT03158272|83078354|FG003|Overall Study|Other reasons|0|||
46861972|NCT03158272|83078351|FG000|Overall Study|Adverse event unrelated to the drug|0|||
46861973|NCT03158272|83078352|FG001|Overall Study|Adverse event unrelated to the drug|1|||
46861974|NCT03158272|83078353|FG002|Overall Study|Adverse event unrelated to the drug|0|||
46861975|NCT03158272|83078354|FG003|Overall Study|Adverse event unrelated to the drug|0|||
46861976|NCT03705494|83078368|FG000|Overall Study|Lost to Follow-up|2|||
46861977|NCT03705494|83078369|FG001|Overall Study|Lost to Follow-up|1|||
46861978|NCT03705494|83078368|FG000|Overall Study|Withdrawal by Subject|5|||
46861979|NCT03705494|83078369|FG001|Overall Study|Withdrawal by Subject|2|||
46861980|NCT01431508|83078375|FG000|Overall Study|Lack of Efficacy|1|||
46861981|NCT01431508|83078375|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
46861982|NCT00654628|83078379|FG000|6-week Active Treatment Period|Adverse Event|9|||
46861983|NCT00654628|83078379|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
46861984|NCT00654628|83078379|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
46861985|NCT00654628|83078379|FG000|6-week Active Treatment Period|Out of window period|1|||
46861986|NCT00654628|83078379|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
46861987|NCT00654628|83078379|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
46861988|NCT00536380|83078386|FG000|Overall Study|Adverse Event|0|||
46861989|NCT00536380|83078387|FG001|Overall Study|Adverse Event|2|||
46861990|NCT00536380|83078388|FG002|Overall Study|Adverse Event|2|||
46861991|NCT00536380|83078386|FG000|Overall Study|Lost to Follow-up|0|||
46861992|NCT00536380|83078387|FG001|Overall Study|Lost to Follow-up|0|||
46861993|NCT00536380|83078388|FG002|Overall Study|Lost to Follow-up|1|||
46861994|NCT00536380|83078386|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
46861995|NCT00536380|83078387|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
46861996|NCT00536380|83078388|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
46861997|NCT00536380|83078386|FG000|Overall Study|Withdrawal related to study drug|7|||
46861998|NCT00536380|83078387|FG001|Overall Study|Withdrawal related to study drug|5|||
46861999|NCT00536380|83078388|FG002|Overall Study|Withdrawal related to study drug|2|||
46862000|NCT00536380|83078386|FG000|Overall Study|Noncompliance with protocol|3|||
46862001|NCT00536380|83078387|FG001|Overall Study|Noncompliance with protocol|2|||
46862002|NCT00536380|83078388|FG002|Overall Study|Noncompliance with protocol|2|||
46862003|NCT00536380|83078386|FG000|Overall Study|Did not meet protocol eligibility|0|||
46697422|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
46697423|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
46697424|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
46697425|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
46697426|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
46697427|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
46697428|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
46862004|NCT00536380|83078387|FG001|Overall Study|Did not meet protocol eligibility|0|||
46862005|NCT00536380|83078388|FG002|Overall Study|Did not meet protocol eligibility|1|||
46862006|NCT00536380|83078386|FG000|Overall Study|Administrative|0|||
46862007|NCT00536380|83078387|FG001|Overall Study|Administrative|0|||
46707545|NCT01155024|82923124|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
46862008|NCT00536380|83078388|FG002|Overall Study|Administrative|1|||
46862009|NCT00496834|83078398|FG000|Overall Study|Withdrawal by Subject|4|||
46862010|NCT00496834|83078399|FG001|Overall Study|Withdrawal by Subject|6|||
46862011|NCT00496834|83078398|FG000|Overall Study|Contraindicated medication administered|0|||
46862012|NCT00496834|83078399|FG001|Overall Study|Contraindicated medication administered|1|||
46862013|NCT00496834|83078398|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
46862014|NCT00496834|83078399|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
46862015|NCT00496834|83078398|FG000|Overall Study|Adverse Event|5|||
46862016|NCT00496834|83078399|FG001|Overall Study|Adverse Event|3|||
46862017|NCT00496834|83078398|FG000|Overall Study|IP administration violation|2|||
46862018|NCT00496834|83078399|FG001|Overall Study|IP administration violation|0|||
46862019|NCT00496834|83078398|FG000|Overall Study|Lost to Follow-up|2|||
46862020|NCT00496834|83078399|FG001|Overall Study|Lost to Follow-up|0|||
46862021|NCT00496834|83078398|FG000|Overall Study|Blood Pressure control failure|2|||
46862022|NCT00496834|83078399|FG001|Overall Study|Blood Pressure control failure|1|||
46862023|NCT05244122|83078407|FG000|Overall Study|Withdrawal by Subject|318|||
46862024|NCT00166504|83078428|FG000|Overall Study|Adverse Event|3|||
46862025|NCT00166504|83078429|FG001|Overall Study|Adverse Event|3|||
46862026|NCT00166504|83078428|FG000|Overall Study|Lost to Follow-up|1|||
46862027|NCT00166504|83078429|FG001|Overall Study|Lost to Follow-up|1|||
46862028|NCT00166504|83078428|FG000|Overall Study|Withdrawal by Subject|1|||
46862029|NCT00166504|83078429|FG001|Overall Study|Withdrawal by Subject|0|||
46862030|NCT03137992|83078435|FG000|Washout Period 1|Adverse Event|1|||
46862031|NCT03137992|83078436|FG001|Washout Period 1|Adverse Event|1|||
46862032|NCT03137992|83078437|FG002|Washout Period 1|Adverse Event|0|||
46862033|NCT03137992|83078438|FG003|Washout Period 1|Adverse Event|0|||
46862034|NCT03137992|83078439|FG004|Washout Period 1|Adverse Event|0|||
46862035|NCT03137992|83078440|FG005|Washout Period 1|Adverse Event|1|||
46862036|NCT03137992|83078435|FG000|Washout Period 1|Withdrawal by Subject|0|||
46862037|NCT03137992|83078436|FG001|Washout Period 1|Withdrawal by Subject|1|||
46697429|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
46697430|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
46697431|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
46697432|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
46697433|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
46697434|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
46697435|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
46697436|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
46697437|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
46697438|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
46697439|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
46697440|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
46697441|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
46697442|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
46697443|NCT01218516|82911873|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
46697444|NCT01218516|82911874|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
46697445|NCT01218516|82911875|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
46707546|NCT01176240|82923135|FG000|Study 306A|Lack of Efficacy|2|||
46862038|NCT03137992|83078437|FG002|Washout Period 1|Withdrawal by Subject|1|||
46862039|NCT03137992|83078438|FG003|Washout Period 1|Withdrawal by Subject|0|||
46862040|NCT03137992|83078439|FG004|Washout Period 1|Withdrawal by Subject|0|||
46862041|NCT03137992|83078440|FG005|Washout Period 1|Withdrawal by Subject|0|||
46862042|NCT03137992|83078435|FG000|Washout Period 1|Principal Investigator Discretion|0|||
46862043|NCT03137992|83078436|FG001|Washout Period 1|Principal Investigator Discretion|1|||
46862044|NCT03137992|83078437|FG002|Washout Period 1|Principal Investigator Discretion|0|||
46862045|NCT03137992|83078438|FG003|Washout Period 1|Principal Investigator Discretion|0|||
46862046|NCT03137992|83078439|FG004|Washout Period 1|Principal Investigator Discretion|0|||
46862047|NCT03137992|83078440|FG005|Washout Period 1|Principal Investigator Discretion|0|||
46862048|NCT03137992|83078435|FG000|Washout Period 1|COPD Exacerbation|1|||
46862049|NCT03137992|83078436|FG001|Washout Period 1|COPD Exacerbation|1|||
46862050|NCT03137992|83078437|FG002|Washout Period 1|COPD Exacerbation|1|||
46862051|NCT03137992|83078438|FG003|Washout Period 1|COPD Exacerbation|0|||
46862052|NCT03137992|83078439|FG004|Washout Period 1|COPD Exacerbation|1|||
46862053|NCT03137992|83078440|FG005|Washout Period 1|COPD Exacerbation|1|||
46862054|NCT03137992|83078435|FG000|Washout Period 1|Subject Noncompliance|1|||
46862055|NCT03137992|83078436|FG001|Washout Period 1|Subject Noncompliance|0|||
46862056|NCT03137992|83078437|FG002|Washout Period 1|Subject Noncompliance|0|||
46862057|NCT03137992|83078438|FG003|Washout Period 1|Subject Noncompliance|0|||
46862058|NCT03137992|83078439|FG004|Washout Period 1|Subject Noncompliance|1|||
46862059|NCT03137992|83078440|FG005|Washout Period 1|Subject Noncompliance|0|||
46862060|NCT03137992|83078435|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
46862061|NCT03137992|83078436|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
46862062|NCT03137992|83078437|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
46862063|NCT03137992|83078438|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
46862064|NCT03137992|83078439|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
46862065|NCT03137992|83078440|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
46862066|NCT03137992|83078435|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
46862067|NCT03137992|83078436|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
46862068|NCT03137992|83078437|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
46862069|NCT03137992|83078438|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
46862070|NCT03137992|83078439|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
46862071|NCT03137992|83078440|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
46862072|NCT03137992|83078435|FG000|Period 2 (Visit 3)|Adverse Event|0|||
46862073|NCT03137992|83078436|FG001|Period 2 (Visit 3)|Adverse Event|1|||
46862074|NCT03137992|83078437|FG002|Period 2 (Visit 3)|Adverse Event|0|||
46862075|NCT03137992|83078438|FG003|Period 2 (Visit 3)|Adverse Event|0|||
46862076|NCT03137992|83078439|FG004|Period 2 (Visit 3)|Adverse Event|0|||
46862077|NCT03137992|83078440|FG005|Period 2 (Visit 3)|Adverse Event|0|||
46862078|NCT03137992|83078435|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
46862079|NCT03137992|83078436|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
46862080|NCT03137992|83078437|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
46862081|NCT03137992|83078438|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
46862082|NCT03137992|83078439|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
46862083|NCT03137992|83078440|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
46862084|NCT03137992|83078435|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
46862085|NCT03137992|83078436|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
46862086|NCT03137992|83078437|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
46862087|NCT03137992|83078438|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
46862088|NCT03137992|83078439|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
46862089|NCT03137992|83078440|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
46862090|NCT03137992|83078435|FG000|Washout Period 2|COPD Exacerbation|1|||
46862091|NCT03137992|83078436|FG001|Washout Period 2|COPD Exacerbation|1|||
46862092|NCT03137992|83078437|FG002|Washout Period 2|COPD Exacerbation|0|||
46862093|NCT03137992|83078438|FG003|Washout Period 2|COPD Exacerbation|0|||
46862094|NCT03137992|83078439|FG004|Washout Period 2|COPD Exacerbation|1|||
46802429|NCT00490971|83021819|FG000|Acute/Continuation|Other|11|||
46802430|NCT00490971|83021820|FG001|Acute/Continuation|Other|4|||
46802431|NCT00490971|83021821|FG002|Acute/Continuation|Other|0|||
46802432|NCT00490971|83021822|FG003|Acute/Continuation|Other|0|||
46802433|NCT00490971|83021823|FG004|Acute/Continuation|Other|0|||
46802434|NCT00490971|83021819|FG000|Maintenance|Adverse Event|0|||
46802435|NCT00490971|83021820|FG001|Maintenance|Adverse Event|0|||
46802436|NCT00490971|83021821|FG002|Maintenance|Adverse Event|4|||
46802437|NCT00490971|83021822|FG003|Maintenance|Adverse Event|5|||
46802438|NCT00490971|83021823|FG004|Maintenance|Adverse Event|7|||
46802439|NCT00490971|83021819|FG000|Maintenance|Death|0|||
46802440|NCT00490971|83021820|FG001|Maintenance|Death|0|||
46802441|NCT00490971|83021821|FG002|Maintenance|Death|0|||
46802442|NCT00490971|83021822|FG003|Maintenance|Death|2|||
46802443|NCT00490971|83021823|FG004|Maintenance|Death|0|||
46802444|NCT00490971|83021819|FG000|Maintenance|Lost to Follow-up|0|||
46802445|NCT00490971|83021820|FG001|Maintenance|Lost to Follow-up|0|||
46862095|NCT03137992|83078440|FG005|Washout Period 2|COPD Exacerbation|0|||
46862096|NCT03137992|83078435|FG000|Washout Period 2|Subject Non-compliance|0|||
46862097|NCT03137992|83078436|FG001|Washout Period 2|Subject Non-compliance|1|||
46862098|NCT03137992|83078437|FG002|Washout Period 2|Subject Non-compliance|0|||
46862099|NCT03137992|83078438|FG003|Washout Period 2|Subject Non-compliance|0|||
46862100|NCT03137992|83078439|FG004|Washout Period 2|Subject Non-compliance|0|||
46862101|NCT03137992|83078440|FG005|Washout Period 2|Subject Non-compliance|0|||
46862102|NCT03137992|83078435|FG000|Washout Period 2|Adverse Event|0|||
46862103|NCT03137992|83078436|FG001|Washout Period 2|Adverse Event|0|||
46862104|NCT03137992|83078437|FG002|Washout Period 2|Adverse Event|0|||
46862105|NCT03137992|83078438|FG003|Washout Period 2|Adverse Event|1|||
46862106|NCT03137992|83078439|FG004|Washout Period 2|Adverse Event|1|||
46862107|NCT03137992|83078440|FG005|Washout Period 2|Adverse Event|0|||
46862108|NCT03137992|83078435|FG000|Washout Period 2|Withdrawal by Subject|1|||
46862109|NCT03137992|83078436|FG001|Washout Period 2|Withdrawal by Subject|0|||
46862110|NCT03137992|83078437|FG002|Washout Period 2|Withdrawal by Subject|0|||
46862111|NCT03137992|83078438|FG003|Washout Period 2|Withdrawal by Subject|0|||
46862112|NCT03137992|83078439|FG004|Washout Period 2|Withdrawal by Subject|1|||
46862113|NCT03137992|83078440|FG005|Washout Period 2|Withdrawal by Subject|0|||
46862114|NCT03137992|83078435|FG000|Washout Period 2|Sponsor Decision|0|||
46862115|NCT03137992|83078436|FG001|Washout Period 2|Sponsor Decision|0|||
46862116|NCT03137992|83078437|FG002|Washout Period 2|Sponsor Decision|0|||
46862117|NCT03137992|83078438|FG003|Washout Period 2|Sponsor Decision|0|||
46862118|NCT03137992|83078439|FG004|Washout Period 2|Sponsor Decision|0|||
46862119|NCT03137992|83078440|FG005|Washout Period 2|Sponsor Decision|1|||
46862120|NCT03137992|83078435|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
46862121|NCT03137992|83078436|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
46862122|NCT03137992|83078437|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
46862123|NCT03137992|83078438|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
46862124|NCT03137992|83078439|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
46862125|NCT03137992|83078440|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
46862126|NCT03137992|83078435|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
46862127|NCT03137992|83078436|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
46862128|NCT03137992|83078437|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
46862129|NCT03137992|83078438|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
46862130|NCT03137992|83078439|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
46862131|NCT03137992|83078440|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
46862132|NCT03137992|83078435|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
46862133|NCT03137992|83078436|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
46862134|NCT03137992|83078437|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
46862135|NCT03137992|83078438|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
46862136|NCT03137992|83078439|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
46862137|NCT03137992|83078440|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
46862138|NCT03137992|83078435|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
46862139|NCT03137992|83078436|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
46862140|NCT03137992|83078437|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
46862141|NCT03137992|83078438|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
46862142|NCT03137992|83078439|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
46862143|NCT03137992|83078440|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
46862144|NCT03137992|83078435|FG000|Part 2 (Open-label Extension)|Per study team|1|||
46862145|NCT03137992|83078436|FG001|Part 2 (Open-label Extension)|Per study team|0|||
46862146|NCT03137992|83078437|FG002|Part 2 (Open-label Extension)|Per study team|0|||
46862147|NCT03137992|83078438|FG003|Part 2 (Open-label Extension)|Per study team|0|||
46862148|NCT03137992|83078439|FG004|Part 2 (Open-label Extension)|Per study team|0|||
46862149|NCT03137992|83078440|FG005|Part 2 (Open-label Extension)|Per study team|0|||
46862150|NCT03137992|83078435|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
46862151|NCT03137992|83078436|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
46862152|NCT03137992|83078437|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
46862153|NCT03137992|83078438|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
46862154|NCT03137992|83078439|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
46862155|NCT03137992|83078440|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
46862156|NCT03704636|83078448|FG000|Overall Study|Inadequate Venous Flow|3|||
46862157|NCT05096312|83078463|FG000|Overall Study|Lost to Follow-up|2|||
46862158|NCT05096312|83078464|FG001|Overall Study|Lost to Follow-up|4|||
46862159|NCT05096312|83078463|FG000|Overall Study|Adverse Event|1|||
46862160|NCT05096312|83078464|FG001|Overall Study|Adverse Event|0|||
46862161|NCT04908488|83078472|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
46862162|NCT04908488|83078473|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
46862163|NCT04908488|83078472|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
46862164|NCT04908488|83078473|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
46862165|NCT04876274|83078484|FG000|Overall Study|Lost to Follow-up|9|||
46862166|NCT04876274|83078485|FG001|Overall Study|Lost to Follow-up|12|||
46982374|NCT01700439|83228558|FG000|Overall Study|Death|186|||
46862167|NCT04865354|83078493|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
46862168|NCT04865354|83078494|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
46862169|NCT04865354|83078493|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
46862170|NCT04865354|83078494|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
46862171|NCT04865354|83078493|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
46862172|NCT04865354|83078494|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
46862173|NCT04860518|83078505|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
46862174|NCT04860518|83078506|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
46862175|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
46862176|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
46862177|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
46862178|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
46862179|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
46862180|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
46862181|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46862182|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46862183|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
46862184|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
46862185|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
46862186|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
46862187|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
46862188|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
46862189|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
46862190|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
46862191|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Death|2|||
46862192|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Death|1|||
46862193|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Death|0|||
46862194|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Death|0|||
46862195|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
46862196|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
46862197|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
46862198|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
46862199|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
46862200|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
46862201|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
46862202|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
46862203|NCT03110380|83078514|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
46862204|NCT03110380|83078515|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
46862205|NCT03110380|83078516|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
46862206|NCT03110380|83078517|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
46862207|NCT03110380|83078514|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
46862208|NCT03110380|83078515|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
46862209|NCT03110380|83078516|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
46862210|NCT03110380|83078517|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
46862211|NCT03110380|83078514|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
46862212|NCT03110380|83078515|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
46862213|NCT03110380|83078516|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
46862214|NCT03110380|83078517|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
46982375|NCT01433289|83228580|FG000|Overall Study|Pregnancy|0|||
46982376|NCT01433289|83228581|FG001|Overall Study|Pregnancy|1|||
46862215|NCT03110380|83078514|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
46862216|NCT03110380|83078515|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
46862217|NCT03110380|83078516|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
46862218|NCT03110380|83078517|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
46697446|NCT01218516|82911876|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
46862219|NCT04851314|83078527|FG000|Overall Study|Unable to complete research set-up procedures|0|||
46862220|NCT04851314|83078528|FG001|Overall Study|Unable to complete research set-up procedures|2|||
46697447|NCT00938431|82911889|FG000|Overall Study|Adverse Event|5|||
46697448|NCT00938431|82911890|FG001|Overall Study|Adverse Event|8|||
46697449|NCT00938431|82911891|FG002|Overall Study|Adverse Event|6|||
46697450|NCT00938431|82911889|FG000|Overall Study|Lack of Efficacy|0|||
46697451|NCT00938431|82911890|FG001|Overall Study|Lack of Efficacy|1|||
46697452|NCT00938431|82911891|FG002|Overall Study|Lack of Efficacy|0|||
46697453|NCT00938431|82911889|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
46697454|NCT00938431|82911890|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
46862221|NCT04851314|83078527|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
46862222|NCT04851314|83078528|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
46697455|NCT00938431|82911891|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
46697456|NCT00938431|82911889|FG000|Overall Study|Dosing compliance issue|0|||
46697457|NCT00938431|82911890|FG001|Overall Study|Dosing compliance issue|0|||
46697458|NCT00938431|82911891|FG002|Overall Study|Dosing compliance issue|1|||
46697459|NCT00938431|82911889|FG000|Overall Study|Reached maximum dose early|0|||
46697460|NCT00938431|82911890|FG001|Overall Study|Reached maximum dose early|0|||
46697461|NCT00938431|82911891|FG002|Overall Study|Reached maximum dose early|1|||
46862223|NCT04848662|83078536|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
46862224|NCT04848662|83078537|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
46862225|NCT03701516|83078543|FG000|Period 1|Lost to Follow-up|0|||
46862226|NCT03701516|83078544|FG001|Period 1|Lost to Follow-up|1|||
46862227|NCT03701516|83078543|FG000|Period 1|Adverse Event|0|||
46862228|NCT03701516|83078544|FG001|Period 1|Adverse Event|2|||
46862229|NCT03701516|83078543|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
46862230|NCT03701516|83078544|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
46862231|NCT03701516|83078543|FG000|Period 1|Non Compliance to Protocol|2|||
46862232|NCT03701516|83078544|FG001|Period 1|Non Compliance to Protocol|1|||
46862233|NCT03701516|83078543|FG000|Period 1|Withdrawal by Subject|0|||
46862234|NCT03701516|83078544|FG001|Period 1|Withdrawal by Subject|1|||
46862235|NCT03701516|83078543|FG000|Period 2|failed to meet all eligibility creiteria|1|||
46862236|NCT03701516|83078544|FG001|Period 2|failed to meet all eligibility creiteria|0|||
46862237|NCT03701516|83078543|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
46862238|NCT03701516|83078544|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
46862239|NCT03700892|83078552|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
46862240|NCT03700892|83078553|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
46862241|NCT03700892|83078554|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
46862242|NCT03700736|83078565|FG000|Overall Study|Pregnancy|1|||
46862243|NCT03700736|83078566|FG001|Overall Study|Pregnancy|1|||
46862244|NCT03700736|83078565|FG000|Overall Study|Withdrawal by Subject|2|||
46862245|NCT03700736|83078566|FG001|Overall Study|Withdrawal by Subject|6|||
46862246|NCT04737278|83078577|FG000|Overall Study|Lost to Follow-up|1|||
46862247|NCT04737278|83078578|FG001|Overall Study|Lost to Follow-up|1|||
46862248|NCT04737278|83078577|FG000|Overall Study|Withdrawal by Subject|1|||
46862249|NCT04737278|83078578|FG001|Overall Study|Withdrawal by Subject|0|||
46862250|NCT04737278|83078577|FG000|Overall Study|Protocol Violation|1|||
46862251|NCT04737278|83078578|FG001|Overall Study|Protocol Violation|1|||
46862252|NCT04737278|83078577|FG000|Overall Study|failure to complete questionnaire|1|||
46862253|NCT04737278|83078578|FG001|Overall Study|failure to complete questionnaire|1|||
46862254|NCT04725500|83078584|FG000|Screening|Screen Failure|26|||
46862255|NCT04725500|83078584|FG000|Screening|Withdrawal by Subject|1|||
46697462|NCT01136811|82911903|FG000|Overall Study|Physician Decision|11|||
46697463|NCT00949117|82911909|FG000|Overall Study|Lack of Efficacy|2|||
46697464|NCT00949117|82911910|FG001|Overall Study|Lack of Efficacy|3|||
46697465|NCT00949117|82911909|FG000|Overall Study|Protocol Violation|1|||
46862256|NCT04725500|83078584|FG000|2 Week Take Home|Screen Fail|5|||
46862257|NCT04684394|83078590|FG000|Overall Study|Death|1|||
46862258|NCT04684394|83078591|FG001|Overall Study|Death|2|||
46862259|NCT04684394|83078590|FG000|Overall Study|Lost to Follow-up|1|||
46697466|NCT00949117|82911910|FG001|Overall Study|Protocol Violation|1|||
46697467|NCT00949117|82911909|FG000|Overall Study|Adverse Event|0|||
46697468|NCT00949117|82911910|FG001|Overall Study|Adverse Event|1|||
46697469|NCT00938041|82911918|FG000|Overall Study|Lost to Follow-up|6|||
46697470|NCT00938041|82911918|FG000|Overall Study|Received Alternative Therapy|1|||
46697471|NCT00938041|82911918|FG000|Overall Study|Progressive Disease|5|||
46697472|NCT00938041|82911918|FG000|Overall Study|Death|12|||
46697473|NCT00938041|82911918|FG000|Overall Study|Adrenal Insufficiency|3|||
46697474|NCT01218438|82911922|FG000|Epoch 1|Physician Decision|2|||
46697475|NCT01218438|82911922|FG000|Epoch 1|Adverse Event|1|||
46697476|NCT01218438|82911922|FG000|Epoch 3|Withdrawal by Subject|3|||
46697477|NCT01218438|82911922|FG000|Epoch 3|Adverse Event|1|||
46697478|NCT01218438|82911922|FG000|Epoch 4|Physician Decision|1|||
46697479|NCT01218438|82911922|FG000|Epoch 4|Withdrawal by Subject|2|||
46697480|NCT00935701|82911996|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
46697481|NCT01277510|82912003|FG000|Double-blind Phase|Non-compliance|0|||
46697482|NCT01277510|82912004|FG001|Double-blind Phase|Non-compliance|1|||
46862260|NCT04684394|83078591|FG001|Overall Study|Lost to Follow-up|0|||
46862261|NCT04684394|83078590|FG000|Overall Study|Withdrawal by Subject|2|||
46862262|NCT04684394|83078591|FG001|Overall Study|Withdrawal by Subject|0|||
46862263|NCT04684394|83078590|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
46862264|NCT04684394|83078591|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
46862265|NCT04674644|83078597|FG000|Overall Study|with missing data|37|||
46862266|NCT04668950|83078604|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
46862267|NCT04668950|83078605|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
46862268|NCT04668950|83078604|FG000|Overall Study|Could not confirm started study medication|15|||
46862269|NCT04668950|83078605|FG001|Overall Study|Could not confirm started study medication|15|||
46862270|NCT04668950|83078604|FG000|Overall Study|Could not confirm baseline status|6|||
46862271|NCT04668950|83078605|FG001|Overall Study|Could not confirm baseline status|2|||
46862272|NCT04668950|83078604|FG000|Overall Study|Drop out and did not start medication|15|||
46862273|NCT04668950|83078605|FG001|Overall Study|Drop out and did not start medication|17|||
46697483|NCT01277510|82912003|FG000|Double-blind Phase|Adverse Event|1|||
46697484|NCT01277510|82912004|FG001|Double-blind Phase|Adverse Event|0|||
46697485|NCT01277510|82912003|FG000|Double-blind Phase|Withdrawal by Subject|2|||
46697486|NCT01277510|82912004|FG001|Double-blind Phase|Withdrawal by Subject|0|||
46697487|NCT01277510|82912003|FG000|Double-blind Phase|Administrative decision|7|||
46707547|NCT01176240|82923136|FG001|Study 306A|Lack of Efficacy|1|||
46862274|NCT04668950|83078604|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
46697488|NCT01277510|82912004|FG001|Double-blind Phase|Administrative decision|9|||
46697489|NCT01277510|82912003|FG000|Double-blind Phase|Death|0|||
46862275|NCT04668950|83078605|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
46862276|NCT04668950|83078604|FG000|Overall Study|Other|2|||
46862277|NCT04668950|83078605|FG001|Overall Study|Other|4|||
46862278|NCT03078478|83078613|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
46862279|NCT03078478|83078614|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
46862280|NCT03078478|83078613|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
46862281|NCT03078478|83078614|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
46862282|NCT03078478|83078613|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
46862283|NCT03078478|83078614|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
46862284|NCT03078478|83078613|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
46862285|NCT03078478|83078614|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
46862286|NCT03078478|83078613|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
46862287|NCT03078478|83078614|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
46862288|NCT03078478|83078613|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
46862289|NCT03078478|83078614|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
46862290|NCT03078478|83078613|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
46862291|NCT03078478|83078614|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
46862292|NCT03078478|83078613|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
46697490|NCT01277510|82912004|FG001|Double-blind Phase|Death|1|||
46862293|NCT03078478|83078614|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
46862294|NCT02879578|83078623|FG000|Overall Study|Adverse Event|1|||
46862295|NCT02879578|83078624|FG001|Overall Study|Adverse Event|2|||
46862296|NCT02879578|83078625|FG002|Overall Study|Adverse Event|14|||
46862297|NCT02879578|83078623|FG000|Overall Study|Protocol Violation|0|||
46862298|NCT02879578|83078624|FG001|Overall Study|Protocol Violation|1|||
46862299|NCT02879578|83078625|FG002|Overall Study|Protocol Violation|1|||
46697491|NCT01277510|82912003|FG000|Double-blind Phase|Protocol-specified criteria|2|||
46697492|NCT01277510|82912004|FG001|Double-blind Phase|Protocol-specified criteria|6|||
46697493|NCT01277510|82912003|FG000|Double-blind Phase|Other|1|||
46697494|NCT01277510|82912004|FG001|Double-blind Phase|Other|1|||
46697495|NCT01277510|82912003|FG000|Open-label Phase|Administrative decision|4|||
46697496|NCT01277510|82912004|FG001|Open-label Phase|Administrative decision|3|||
46697497|NCT01277510|82912003|FG000|Open-label Phase|Protocol-specified criteria|1|||
46697498|NCT01277510|82912004|FG001|Open-label Phase|Protocol-specified criteria|0|||
46697499|NCT01277510|82912003|FG000|Open-label Phase|Never received investigational product|2|||
46697500|NCT01277510|82912004|FG001|Open-label Phase|Never received investigational product|0|||
46697501|NCT00937495|82912012|FG000|Overall Study|Protocol Violation|2|||
46697502|NCT01268306|82912016|FG000|Overall Study|Lost to Follow-up|1|||
46697503|NCT00936715|82912020|FG000|Overall Study|Investigators Discretion|1|||
46697504|NCT00936715|82912020|FG000|Overall Study|Protocol Violation|1|||
46697505|NCT00936715|82912020|FG000|Overall Study|Safety or Tolerability Reasons|4|||
46697506|NCT01267994|82912024|FG000|Overall Study|Adverse Event|2|||
46697507|NCT00934843|82912031|FG000|Overall Study|Protocol Violation|0|||
46697508|NCT00934843|82912032|FG001|Overall Study|Protocol Violation|1|||
46697509|NCT01266902|82912040|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
46862300|NCT02879578|83078623|FG000|Overall Study|Withdrawal by Subject|8|||
46862301|NCT02879578|83078624|FG001|Overall Study|Withdrawal by Subject|6|||
46862302|NCT02879578|83078625|FG002|Overall Study|Withdrawal by Subject|9|||
46862303|NCT02879578|83078623|FG000|Overall Study|Lost to Follow-up|1|||
46862304|NCT02879578|83078624|FG001|Overall Study|Lost to Follow-up|0|||
46862305|NCT02879578|83078625|FG002|Overall Study|Lost to Follow-up|4|||
46862306|NCT02879578|83078623|FG000|Overall Study|Physician Decision|0|||
46862307|NCT02879578|83078624|FG001|Overall Study|Physician Decision|0|||
46862308|NCT02879578|83078625|FG002|Overall Study|Physician Decision|4|||
46862309|NCT00045942|83078642|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
46982377|NCT01433289|83228582|FG002|Overall Study|Pregnancy|0|||
46982378|NCT01433289|83228583|FG003|Overall Study|Pregnancy|0|||
46697510|NCT01266902|82912041|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
46697511|NCT01266902|82912042|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
46982379|NCT02576587|83228627|FG000|Baseline|Equipment failure|0|||
46697512|NCT01266902|82912040|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
46697513|NCT01266902|82912041|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
46697514|NCT01266902|82912042|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
46862310|NCT00045942|83078643|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46862311|NCT00045942|83078644|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46982380|NCT02576587|83228628|FG001|Baseline|Equipment failure|1|||
46862312|NCT00045942|83078645|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46697515|NCT01266902|82912040|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
46862313|NCT00045942|83078646|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46862314|NCT00045942|83078647|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46862315|NCT00045942|83078648|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46862316|NCT00045942|83078649|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46862317|NCT00045942|83078650|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
46697516|NCT01266902|82912041|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
46697517|NCT01266902|82912042|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
46862318|NCT00045942|83078642|FG000|PKC412A2104 (Core)|Adverse Event|5|||
46862319|NCT00045942|83078643|FG001|PKC412A2104 (Core)|Adverse Event|0|||
46862320|NCT00045942|83078644|FG002|PKC412A2104 (Core)|Adverse Event|0|||
46862321|NCT00045942|83078645|FG003|PKC412A2104 (Core)|Adverse Event|0|||
46862322|NCT00045942|83078646|FG004|PKC412A2104 (Core)|Adverse Event|0|||
46862323|NCT00045942|83078647|FG005|PKC412A2104 (Core)|Adverse Event|0|||
46862324|NCT00045942|83078648|FG006|PKC412A2104 (Core)|Adverse Event|0|||
46862325|NCT00045942|83078649|FG007|PKC412A2104 (Core)|Adverse Event|0|||
46862326|NCT00045942|83078650|FG008|PKC412A2104 (Core)|Adverse Event|0|||
46862327|NCT00045942|83078642|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
46862328|NCT00045942|83078643|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862329|NCT00045942|83078644|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862330|NCT00045942|83078645|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862331|NCT00045942|83078646|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862332|NCT00045942|83078647|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862333|NCT00045942|83078648|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862334|NCT00045942|83078649|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862335|NCT00045942|83078650|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
46862336|NCT00045942|83078642|FG000|PKC412A2104 (Core)|Death|1|||
46862337|NCT00045942|83078643|FG001|PKC412A2104 (Core)|Death|0|||
46862338|NCT00045942|83078644|FG002|PKC412A2104 (Core)|Death|0|||
46862339|NCT00045942|83078645|FG003|PKC412A2104 (Core)|Death|0|||
46862340|NCT00045942|83078646|FG004|PKC412A2104 (Core)|Death|0|||
46862341|NCT00045942|83078647|FG005|PKC412A2104 (Core)|Death|0|||
46862342|NCT00045942|83078648|FG006|PKC412A2104 (Core)|Death|0|||
46862343|NCT00045942|83078649|FG007|PKC412A2104 (Core)|Death|0|||
46862344|NCT00045942|83078650|FG008|PKC412A2104 (Core)|Death|0|||
46862345|NCT00045942|83078642|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
46862346|NCT00045942|83078643|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
46862347|NCT00045942|83078644|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
46862348|NCT00045942|83078645|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
46862349|NCT00045942|83078646|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
46862350|NCT00045942|83078647|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
46862351|NCT00045942|83078648|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
46862352|NCT00045942|83078649|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
46862353|NCT00045942|83078650|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
46862354|NCT00045942|83078642|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
46862355|NCT00045942|83078643|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
46862356|NCT00045942|83078644|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
46862357|NCT00045942|83078645|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
46862358|NCT00045942|83078646|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
46862359|NCT00045942|83078647|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
46862360|NCT00045942|83078648|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
46862361|NCT00045942|83078649|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
46862362|NCT00045942|83078650|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
46862363|NCT00045942|83078642|FG000|PKC412A2104E1|Lack of Efficacy|0|||
46862364|NCT00045942|83078643|FG001|PKC412A2104E1|Lack of Efficacy|11|||
46862365|NCT00045942|83078644|FG002|PKC412A2104E1|Lack of Efficacy|11|||
46862366|NCT00045942|83078645|FG003|PKC412A2104E1|Lack of Efficacy|23|||
46862367|NCT00045942|83078646|FG004|PKC412A2104E1|Lack of Efficacy|17|||
46862368|NCT00045942|83078647|FG005|PKC412A2104E1|Lack of Efficacy|0|||
46862369|NCT00045942|83078648|FG006|PKC412A2104E1|Lack of Efficacy|0|||
46862370|NCT00045942|83078649|FG007|PKC412A2104E1|Lack of Efficacy|0|||
46862371|NCT00045942|83078650|FG008|PKC412A2104E1|Lack of Efficacy|0|||
46697518|NCT01266902|82912040|FG000|Period 1 (Main Study)|Adverse Event|3|||
46862372|NCT00045942|83078642|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
46862373|NCT00045942|83078643|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
46862374|NCT00045942|83078644|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
46862375|NCT00045942|83078645|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
46862376|NCT00045942|83078646|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
46862377|NCT00045942|83078647|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
46862378|NCT00045942|83078648|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
46862379|NCT00045942|83078649|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
46862380|NCT00045942|83078650|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
46862381|NCT00045942|83078642|FG000|PKC412A2104E1|Adverse Event|0|||
46862382|NCT00045942|83078643|FG001|PKC412A2104E1|Adverse Event|1|||
46862383|NCT00045942|83078644|FG002|PKC412A2104E1|Adverse Event|1|||
46862384|NCT00045942|83078645|FG003|PKC412A2104E1|Adverse Event|3|||
46862385|NCT00045942|83078646|FG004|PKC412A2104E1|Adverse Event|6|||
46862386|NCT00045942|83078647|FG005|PKC412A2104E1|Adverse Event|0|||
46862387|NCT00045942|83078648|FG006|PKC412A2104E1|Adverse Event|0|||
46862388|NCT00045942|83078649|FG007|PKC412A2104E1|Adverse Event|0|||
46862389|NCT00045942|83078650|FG008|PKC412A2104E1|Adverse Event|0|||
46862390|NCT00045942|83078642|FG000|PKC412A2104E1|Death|0|||
46862391|NCT00045942|83078643|FG001|PKC412A2104E1|Death|4|||
46862392|NCT00045942|83078644|FG002|PKC412A2104E1|Death|1|||
46862393|NCT00045942|83078645|FG003|PKC412A2104E1|Death|1|||
46862394|NCT00045942|83078646|FG004|PKC412A2104E1|Death|1|||
46862395|NCT00045942|83078647|FG005|PKC412A2104E1|Death|0|||
46862396|NCT00045942|83078648|FG006|PKC412A2104E1|Death|0|||
46862397|NCT00045942|83078649|FG007|PKC412A2104E1|Death|0|||
46862398|NCT00045942|83078650|FG008|PKC412A2104E1|Death|0|||
46862399|NCT00045942|83078642|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
46862400|NCT00045942|83078643|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
46862401|NCT00045942|83078644|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
46862402|NCT00045942|83078645|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
46862403|NCT00045942|83078646|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
46862404|NCT00045942|83078647|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
46862405|NCT00045942|83078648|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
46862406|NCT00045942|83078649|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
46862407|NCT00045942|83078650|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
46862408|NCT00045942|83078642|FG000|PKC412A2104E2|Lost to Follow-up|0|||
46982381|NCT02576587|83228627|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
46862409|NCT00045942|83078643|FG001|PKC412A2104E2|Lost to Follow-up|0|||
46862410|NCT00045942|83078644|FG002|PKC412A2104E2|Lost to Follow-up|0|||
46862411|NCT00045942|83078645|FG003|PKC412A2104E2|Lost to Follow-up|0|||
46862412|NCT00045942|83078646|FG004|PKC412A2104E2|Lost to Follow-up|0|||
46982382|NCT02576587|83228628|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
46982383|NCT02576587|83228627|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
46982384|NCT02576587|83228628|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
46862413|NCT00045942|83078647|FG005|PKC412A2104E2|Lost to Follow-up|0|||
46862414|NCT00045942|83078648|FG006|PKC412A2104E2|Lost to Follow-up|0|||
46862415|NCT00045942|83078649|FG007|PKC412A2104E2|Lost to Follow-up|3|||
46862416|NCT00045942|83078650|FG008|PKC412A2104E2|Lost to Follow-up|0|||
46862417|NCT00045942|83078642|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
46862418|NCT00045942|83078643|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
46862419|NCT00045942|83078644|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
46862420|NCT00045942|83078645|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
46862421|NCT00045942|83078646|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
46862422|NCT00045942|83078647|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
46862423|NCT00045942|83078648|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
46862424|NCT00045942|83078649|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
46862425|NCT00045942|83078650|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
46862426|NCT00045942|83078642|FG000|PKC412A2104E2|Lack of Efficacy|0|||
46862427|NCT00045942|83078643|FG001|PKC412A2104E2|Lack of Efficacy|0|||
46862428|NCT00045942|83078644|FG002|PKC412A2104E2|Lack of Efficacy|0|||
46862429|NCT00045942|83078645|FG003|PKC412A2104E2|Lack of Efficacy|0|||
46862430|NCT00045942|83078646|FG004|PKC412A2104E2|Lack of Efficacy|0|||
46862431|NCT00045942|83078647|FG005|PKC412A2104E2|Lack of Efficacy|3|||
46862432|NCT00045942|83078648|FG006|PKC412A2104E2|Lack of Efficacy|2|||
46862433|NCT00045942|83078649|FG007|PKC412A2104E2|Lack of Efficacy|2|||
46862434|NCT00045942|83078650|FG008|PKC412A2104E2|Lack of Efficacy|6|||
46862435|NCT00045942|83078642|FG000|PKC412A2104E2|Adverse Event|0|||
46862436|NCT00045942|83078643|FG001|PKC412A2104E2|Adverse Event|0|||
46862437|NCT00045942|83078644|FG002|PKC412A2104E2|Adverse Event|0|||
46862438|NCT00045942|83078645|FG003|PKC412A2104E2|Adverse Event|0|||
46862439|NCT00045942|83078646|FG004|PKC412A2104E2|Adverse Event|0|||
46862440|NCT00045942|83078647|FG005|PKC412A2104E2|Adverse Event|4|||
46862441|NCT00045942|83078648|FG006|PKC412A2104E2|Adverse Event|3|||
46862442|NCT00045942|83078649|FG007|PKC412A2104E2|Adverse Event|1|||
46862443|NCT00045942|83078650|FG008|PKC412A2104E2|Adverse Event|0|||
46862444|NCT00045942|83078642|FG000|PKC412A2104E2|Death|0|||
46862445|NCT00045942|83078643|FG001|PKC412A2104E2|Death|0|||
46862446|NCT00045942|83078644|FG002|PKC412A2104E2|Death|0|||
46862447|NCT00045942|83078645|FG003|PKC412A2104E2|Death|0|||
46862448|NCT00045942|83078646|FG004|PKC412A2104E2|Death|0|||
46862449|NCT00045942|83078647|FG005|PKC412A2104E2|Death|1|||
46862450|NCT00045942|83078648|FG006|PKC412A2104E2|Death|2|||
46862451|NCT00045942|83078649|FG007|PKC412A2104E2|Death|0|||
46862452|NCT00045942|83078650|FG008|PKC412A2104E2|Death|0|||
46862453|NCT04386616|83078677|FG000|Overall Study|Death|22|||
46862454|NCT04386616|83078678|FG001|Overall Study|Death|22|||
46862455|NCT04386616|83078679|FG002|Overall Study|Death|21|||
46862456|NCT04386616|83078677|FG000|Overall Study|Lost to Follow-up|5|||
46862457|NCT04386616|83078678|FG001|Overall Study|Lost to Follow-up|8|||
46862458|NCT04386616|83078679|FG002|Overall Study|Lost to Follow-up|6|||
46862459|NCT04386616|83078677|FG000|Overall Study|Withdrawal by Subject|2|||
46862460|NCT04386616|83078678|FG001|Overall Study|Withdrawal by Subject|4|||
46862461|NCT04386616|83078679|FG002|Overall Study|Withdrawal by Subject|1|||
46862462|NCT04386616|83078677|FG000|Overall Study|Adverse Event|1|||
46862463|NCT04386616|83078678|FG001|Overall Study|Adverse Event|1|||
46862464|NCT04386616|83078679|FG002|Overall Study|Adverse Event|0|||
46862465|NCT00045708|83078699|FG000|Phase 1|early progressive disease|0|||
46862466|NCT00045708|83078700|FG001|Phase 1|early progressive disease|1|||
46862467|NCT00045708|83078701|FG002|Phase 1|early progressive disease|0|||
46862468|NCT00045630|83078718|FG000|Overall Study|Adverse Event|1|||
46862469|NCT00045630|83078718|FG000|Overall Study|Refusal unrelated to adverse event|1|||
46862470|NCT00045630|83078718|FG000|Overall Study|Progression/relapse|1|||
46862471|NCT00045630|83078718|FG000|Overall Study|Death|1|||
46862472|NCT00045630|83078718|FG000|Overall Study|Ineligible|2|||
46862473|NCT00003702|83078724|FG000|Overall Study|Ineligible cell types|2|||
46862474|NCT00003702|83078725|FG001|Overall Study|Ineligible cell types|2|||
46862475|NCT00003702|83078724|FG000|Overall Study|Did not meet criteria for persistence|8|||
46862476|NCT00003702|83078725|FG001|Overall Study|Did not meet criteria for persistence|5|||
46862477|NCT00003702|83078724|FG000|Overall Study|WHO score > 6|2|||
46862478|NCT00003702|83078725|FG001|Overall Study|WHO score > 6|1|||
46862479|NCT00003702|83078724|FG000|Overall Study|Inadequate documentation of disease|1|||
46862480|NCT00003702|83078725|FG001|Overall Study|Inadequate documentation of disease|3|||
46862481|NCT00031590|83078732|FG000|Overall Study|Adverse Event|1|||
46862482|NCT00031590|83078732|FG000|Overall Study|Withdrawal by parents|2|||
46862483|NCT00239681|83078739|FG000|Overall Study|Adverse Event|100|||
46862484|NCT00239681|83078740|FG001|Overall Study|Adverse Event|99|||
46862485|NCT00239681|83078739|FG000|Overall Study|Withdrawal by Subject|458|||
46862486|NCT00239681|83078740|FG001|Overall Study|Withdrawal by Subject|489|||
46862487|NCT00239681|83078739|FG000|Overall Study|Lost to Follow-up|28|||
46862488|NCT00239681|83078740|FG001|Overall Study|Lost to Follow-up|22|||
46862489|NCT00239681|83078739|FG000|Overall Study|Protocol Violation|4|||
46862490|NCT00239681|83078740|FG001|Overall Study|Protocol Violation|4|||
46862491|NCT00239681|83078739|FG000|Overall Study|Physician Decision|13|||
46862492|NCT00239681|83078740|FG001|Overall Study|Physician Decision|17|||
46862493|NCT00239681|83078739|FG000|Overall Study|No information chacked on CaseReportForm|90|||
46862494|NCT00239681|83078740|FG001|Overall Study|No information chacked on CaseReportForm|84|||
46697519|NCT01266902|82912041|FG001|Period 1 (Main Study)|Adverse Event|11|||
46697520|NCT01266902|82912042|FG002|Period 1 (Main Study)|Adverse Event|0|||
46697521|NCT01266902|82912040|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
46697522|NCT01266902|82912041|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
46697523|NCT01266902|82912042|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
46697524|NCT01266902|82912040|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
46697525|NCT01266902|82912041|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
46697526|NCT01266902|82912042|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
46697527|NCT01266902|82912040|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
46697528|NCT01266902|82912041|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
46697529|NCT01266902|82912042|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
46697530|NCT01266902|82912040|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
46697531|NCT01266902|82912041|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
46697532|NCT01266902|82912042|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
46697533|NCT01266902|82912040|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
46697534|NCT01266902|82912041|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
46697535|NCT01266902|82912042|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
46697536|NCT01266902|82912040|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
46862495|NCT02878330|83078748|FG000|Overall Study|Death|3|||
46862496|NCT02878330|83078749|FG001|Overall Study|Death|2|||
46862497|NCT02878330|83078748|FG000|Overall Study|Lost to Follow-up|11|||
46862498|NCT02878330|83078749|FG001|Overall Study|Lost to Follow-up|26|||
46862499|NCT02878330|83078748|FG000|Overall Study|Withdrawal by Subject|11|||
46862500|NCT02878330|83078749|FG001|Overall Study|Withdrawal by Subject|21|||
46862501|NCT02878330|83078748|FG000|Overall Study|Other|4|||
46862502|NCT02878330|83078749|FG001|Overall Study|Other|7|||
46862503|NCT00238433|83078756|FG000|Overall Study|Screen failure|1|||
46862504|NCT00238433|83078756|FG000|Overall Study|Lost to Follow-up|1|||
46862505|NCT00238433|83078756|FG000|Overall Study|Death|1|||
46862506|NCT00045162|83078763|FG000|Overall Study|Ineligible|12|||
46862507|NCT00045162|83078764|FG001|Overall Study|Ineligible|8|||
46862508|NCT00045162|83078763|FG000|Overall Study|Not treated|7|||
46862509|NCT00045162|83078764|FG001|Overall Study|Not treated|2|||
46862510|NCT00045162|83078763|FG000|Overall Study|Adverse Event|55|||
46862511|NCT00045162|83078764|FG001|Overall Study|Adverse Event|50|||
46862512|NCT00045162|83078763|FG000|Overall Study|Lack of Efficacy|32|||
46862513|NCT00045162|83078764|FG001|Overall Study|Lack of Efficacy|29|||
46862514|NCT00045162|83078763|FG000|Overall Study|Death|10|||
46862515|NCT00045162|83078764|FG001|Overall Study|Death|10|||
46862516|NCT00045162|83078763|FG000|Overall Study|Withdrawal by Subject|5|||
46862517|NCT00045162|83078764|FG001|Overall Study|Withdrawal by Subject|3|||
46862518|NCT00045162|83078763|FG000|Overall Study|Other|21|||
46862519|NCT00045162|83078764|FG001|Overall Study|Other|16|||
46862520|NCT02748616|83078770|FG000|Overall Study|Lost to Follow-up|1|||
46862521|NCT02748616|83078770|FG000|Overall Study|Withdrawal by Subject|2|||
46862522|NCT02748616|83078770|FG000|Overall Study|Physician Decision|2|||
46862523|NCT02748616|83078770|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
46862524|NCT00238121|83078776|FG000|Overall Study|Withdrawal by Subject|1|||
46862525|NCT00238121|83078777|FG001|Overall Study|Withdrawal by Subject|1|||
46862526|NCT00238121|83078776|FG000|Overall Study|Adverse Event|2|||
46862527|NCT00238121|83078777|FG001|Overall Study|Adverse Event|1|||
46862528|NCT03139552|83078782|FG000|Overall Study|unable to attend tasting due to schedule|3|||
46862529|NCT03804918|83078793|FG000|Overall Study|Participant did not use the app|1|||
46862530|NCT03139240|83078801|FG000|Overall Study|Lost to Follow-up|0|||
46862531|NCT03139240|83078802|FG001|Overall Study|Lost to Follow-up|1|||
46862532|NCT03139240|83078803|FG002|Overall Study|Lost to Follow-up|1|||
46862533|NCT03139240|83078804|FG003|Overall Study|Lost to Follow-up|0|||
46862534|NCT00237809|83078816|FG000|Overall Study|Lost to Follow-up|11|||
46862535|NCT00237809|83078817|FG001|Overall Study|Lost to Follow-up|10|||
46862536|NCT00237809|83078818|FG002|Overall Study|Lost to Follow-up|9|||
46862537|NCT00237809|83078819|FG003|Overall Study|Lost to Follow-up|9|||
46862538|NCT00003498|83078829|FG000|Overall Study|Not evaluable.|4|||
46862539|NCT00003492|83078833|FG000|Overall Study|Not evaluable|6|||
46697537|NCT01266902|82912041|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
46697538|NCT01266902|82912042|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
46862540|NCT03136198|83078839|FG000|Overall Study|Withdrawal by Subject|0|||
46862541|NCT03136198|83078840|FG001|Overall Study|Withdrawal by Subject|1|||
46697539|NCT01266824|82912052|FG000|Overall Study|Study terminated prior to completion|2|||
46697540|NCT01266824|82912053|FG001|Overall Study|Study terminated prior to completion|3|||
46697541|NCT01266590|82912059|FG000|Overall Study|Adverse Event|3|||
46697542|NCT01266590|82912059|FG000|Overall Study|Lost to Follow-up|1|||
46697543|NCT01266590|82912059|FG000|Overall Study|Withdrawal by Subject|1|||
46862542|NCT00042666|83078846|FG000|Overall Study|Adverse Event|2|||
46862543|NCT00042666|83078846|FG000|Overall Study|Death|4|||
46862544|NCT00042666|83078846|FG000|Overall Study|Protocol Violation|1|||
46862545|NCT00042666|83078846|FG000|Overall Study|Participant/Physician Perception|1|||
46862546|NCT00042666|83078846|FG000|Overall Study|Progressive Disease|41|||
46862547|NCT00042666|83078846|FG000|Overall Study|Other|1|||
46862548|NCT00042666|83078846|FG000|Overall Study|Other|4|||
46862549|NCT00042432|83078853|FG000|Overall Study|Adverse Event|4|||
46862550|NCT00042432|83078854|FG001|Overall Study|Adverse Event|1|||
46862551|NCT00042432|83078853|FG000|Overall Study|Withdrawal by Subject|1|||
46862552|NCT00042432|83078854|FG001|Overall Study|Withdrawal by Subject|3|||
46862553|NCT00042432|83078853|FG000|Overall Study|Death|0|||
46862554|NCT00042432|83078854|FG001|Overall Study|Death|2|||
46862555|NCT00042432|83078853|FG000|Overall Study|Ineligibility determined|1|||
46862556|NCT00042432|83078854|FG001|Overall Study|Ineligibility determined|0|||
46862557|NCT00042432|83078853|FG000|Overall Study|Initiation of maintenance dialysis|1|||
46862558|NCT00042432|83078854|FG001|Overall Study|Initiation of maintenance dialysis|1|||
46862559|NCT00042432|83078853|FG000|Overall Study|Other|2|||
46862560|NCT00042432|83078854|FG001|Overall Study|Other|0|||
46862561|NCT00003474|83078860|FG000|Overall Study|Not Evaluable|14|||
46862562|NCT01542736|83078864|FG000|Overall Study|Death|1|||
46862563|NCT01346410|83078868|FG000|Overall Study|Death|1|||
46862564|NCT00003456|83078872|FG000|Overall Study|Not evaluable|8|||
46862565|NCT02719522|83078876|FG000|Overall Study|Implant Failure|4|||
46862566|NCT02719522|83078876|FG000|Overall Study|Death|2|||
46862567|NCT02719522|83078876|FG000|Overall Study|Lost to Follow-up|5|||
46862568|NCT00237185|83078882|FG000|Core|Adverse Event|3|||
46862569|NCT00237185|83078883|FG001|Core|Adverse Event|4|||
46862570|NCT00237185|83078882|FG000|Core|Abnormal laboratory value|0|||
46862571|NCT00237185|83078883|FG001|Core|Abnormal laboratory value|4|||
46862572|NCT00237185|83078882|FG000|Core|Abnormal test procedure results|1|||
46862573|NCT00237185|83078883|FG001|Core|Abnormal test procedure results|0|||
46862574|NCT00237185|83078882|FG000|Core|Lack of Efficacy|30|||
46862575|NCT00237185|83078883|FG001|Core|Lack of Efficacy|23|||
46862576|NCT00237185|83078882|FG000|Core|Protocol Violation|1|||
46862577|NCT00237185|83078883|FG001|Core|Protocol Violation|1|||
46862578|NCT00237185|83078882|FG000|Core|Withdrawal by Subject|4|||
46982385|NCT02576587|83228627|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
46982386|NCT02576587|83228628|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
46697544|NCT01266590|82912059|FG000|Overall Study|Physician Decision|1|||
46697545|NCT01266122|82912068|FG000|Overall Study|Lost to Follow-up|6|||
46697546|NCT01266122|82912069|FG001|Overall Study|Lost to Follow-up|6|||
46697547|NCT01265498|82912077|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
46697548|NCT01265498|82912078|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
46862579|NCT00237185|83078883|FG001|Core|Withdrawal by Subject|4|||
46862580|NCT00237185|83078882|FG000|Core|Administrative problems|0|||
46862581|NCT00237185|83078883|FG001|Core|Administrative problems|1|||
46862582|NCT00237185|83078882|FG000|Core|Death|4|||
46862583|NCT00237185|83078883|FG001|Core|Death|0|||
46862584|NCT00237185|83078882|FG000|Core|Determined ineligible post randomization|1|||
46862585|NCT00237185|83078883|FG001|Core|Determined ineligible post randomization|0|||
46862586|NCT00237185|83078882|FG000|Extension|Adverse Event|1|||
46862587|NCT00237185|83078883|FG001|Extension|Adverse Event|0|||
46862588|NCT00237185|83078882|FG000|Extension|Abnormal laboratory value|0|||
46862589|NCT00237185|83078883|FG001|Extension|Abnormal laboratory value|1|||
46862590|NCT00237185|83078882|FG000|Extension|Lack of Efficacy|9|||
46862591|NCT00237185|83078883|FG001|Extension|Lack of Efficacy|14|||
46862592|NCT00237185|83078882|FG000|Extension|Condition no longer required study drug|0|||
46982387|NCT05340751|83228693|FG000|Overall Study|Physician Decision|3|||
46862593|NCT00237185|83078883|FG001|Extension|Condition no longer required study drug|1|||
46862594|NCT00237185|83078882|FG000|Extension|Withdrawal by Subject|3|||
46862595|NCT00237185|83078883|FG001|Extension|Withdrawal by Subject|2|||
46697549|NCT01265420|82912084|FG000|Overall Study|Lost to Follow-up|1|||
46862596|NCT00237185|83078882|FG000|Extension|Lost to Follow-up|1|||
46862597|NCT00237185|83078883|FG001|Extension|Lost to Follow-up|0|||
46862598|NCT00237185|83078882|FG000|Extension|Administrative problems|1|||
46862599|NCT00237185|83078883|FG001|Extension|Administrative problems|0|||
46862600|NCT00237185|83078882|FG000|Extension|Death|1|||
46862601|NCT00237185|83078883|FG001|Extension|Death|1|||
46862602|NCT00003222|83078891|FG000|Overall Study|Physician Decision|0|||
46982388|NCT02575807|83228702|FG000|Overall Study|Death|8|||
46862603|NCT00003222|83078892|FG001|Overall Study|Physician Decision|1|||
46862604|NCT02877082|83078898|FG000|Overall Study|Trial was closed early|5|||
46862605|NCT02875834|83078906|FG000|Open-label Phase|Withdrawal by Subject|3|||
46862606|NCT02875834|83078907|FG001|Open-label Phase|Withdrawal by Subject|0|||
46862607|NCT02875834|83078908|FG002|Open-label Phase|Withdrawal by Subject|0|||
46862608|NCT02875834|83078909|FG003|Open-label Phase|Withdrawal by Subject|0|||
46862609|NCT02875834|83078906|FG000|Open-label Phase|(Not collected)|4|||
46862610|NCT02875834|83078907|FG001|Open-label Phase|(Not collected)|0|||
46862611|NCT02875834|83078908|FG002|Open-label Phase|(Not collected)|0|||
46862612|NCT02875834|83078909|FG003|Open-label Phase|(Not collected)|0|||
46862613|NCT02875834|83078906|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
46862614|NCT02875834|83078907|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
46862615|NCT02875834|83078908|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
46862616|NCT02875834|83078909|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
46862617|NCT02875834|83078906|FG000|Randomized Treatment Phase|Protocol Violation|0|||
46862618|NCT02875834|83078907|FG001|Randomized Treatment Phase|Protocol Violation|2|||
46862619|NCT02875834|83078908|FG002|Randomized Treatment Phase|Protocol Violation|0|||
46862620|NCT02875834|83078909|FG003|Randomized Treatment Phase|Protocol Violation|0|||
46862621|NCT02875834|83078906|FG000|Randomized Treatment Phase|(Not collected)|0|||
46862622|NCT02875834|83078907|FG001|Randomized Treatment Phase|(Not collected)|9|||
46862623|NCT02875834|83078908|FG002|Randomized Treatment Phase|(Not collected)|10|||
46862624|NCT02875834|83078909|FG003|Randomized Treatment Phase|(Not collected)|9|||
46862625|NCT02875366|83078921|FG000|Overall Study|Adverse Event|0|||
46862626|NCT02875366|83078922|FG001|Overall Study|Adverse Event|2|||
46862627|NCT02875366|83078921|FG000|Overall Study|Noncompliance|0|||
46862628|NCT02875366|83078922|FG001|Overall Study|Noncompliance|1|||
46862629|NCT00002850|83078931|FG000|Overall Study|Death|4|||
46862630|NCT00002850|83078932|FG001|Overall Study|Death|1|||
46862631|NCT00002850|83078933|FG002|Overall Study|Death|3|||
46862632|NCT00002850|83078931|FG000|Overall Study|Protocol Violation|1|||
46862633|NCT00002850|83078932|FG001|Overall Study|Protocol Violation|0|||
46862634|NCT00002850|83078933|FG002|Overall Study|Protocol Violation|1|||
46862635|NCT00002850|83078931|FG000|Overall Study|Withdrawal by Subject|0|||
46862636|NCT00002850|83078932|FG001|Overall Study|Withdrawal by Subject|1|||
46862637|NCT00002850|83078933|FG002|Overall Study|Withdrawal by Subject|0|||
46862638|NCT00002766|83078943|FG000|Overall Study|Withdrawal by Subject|0|||
46862639|NCT00002766|83078944|FG001|Overall Study|Withdrawal by Subject|1|||
46862640|NCT00002766|83078943|FG000|Overall Study|Patient Not Treated|1|||
46862641|NCT00002766|83078944|FG001|Overall Study|Patient Not Treated|2|||
46862642|NCT00002766|83078943|FG000|Overall Study|Adverse Event|1|||
46862643|NCT00002766|83078944|FG001|Overall Study|Adverse Event|1|||
46862644|NCT00002766|83078943|FG000|Overall Study|Protocol Violation|1|||
46862645|NCT00002766|83078944|FG001|Overall Study|Protocol Violation|0|||
46862646|NCT02306122|83078957|FG000|Initial Physician Randomization|Physician Decision|0|||
46862647|NCT02306122|83078958|FG001|Initial Physician Randomization|Physician Decision|0|||
46862648|NCT02306122|83078959|FG002|Initial Physician Randomization|Physician Decision|0|||
46862649|NCT02306122|83078960|FG003|Initial Physician Randomization|Physician Decision|0|||
46862650|NCT02306122|83078961|FG004|Initial Physician Randomization|Physician Decision|0|||
46862651|NCT02306122|83078962|FG005|Initial Physician Randomization|Physician Decision|0|||
46862652|NCT02306122|83078963|FG006|Initial Physician Randomization|Physician Decision|0|||
46862653|NCT02306122|83078964|FG007|Initial Physician Randomization|Physician Decision|0|||
46862654|NCT02306122|83078965|FG008|Initial Physician Randomization|Physician Decision|1|||
46862655|NCT02306122|83078966|FG009|Initial Physician Randomization|Physician Decision|0|||
46862656|NCT02306122|83078967|FG010|Initial Physician Randomization|Physician Decision|0|||
46862657|NCT00001962|83078985|FG000|Overall Study|Lack of Efficacy|18|||
46862658|NCT00001962|83078985|FG000|Overall Study|Lack of Accrual|6|||
46862659|NCT00001962|83078985|FG000|Overall Study|Death|1|||
46862660|NCT00001962|83078985|FG000|Overall Study|Lost to Follow-up|2|||
46862661|NCT00001962|83078985|FG000|Overall Study|Adverse Event|1|||
46862662|NCT00028002|83078989|FG000|Overall Study|Withdrawal by Subject|3|||
46862663|NCT00028002|83078989|FG000|Overall Study|Ineligible|8|||
46862664|NCT00256997|83078996|FG000|Overall Study|Protocol Violation|1|||
46862665|NCT00256997|83078997|FG001|Overall Study|Protocol Violation|4|||
46862666|NCT00256997|83078996|FG000|Overall Study|Lack of Efficacy|1|||
46862667|NCT00256997|83078997|FG001|Overall Study|Lack of Efficacy|4|||
46862668|NCT00256997|83078996|FG000|Overall Study|Death|2|||
46862669|NCT00256997|83078997|FG001|Overall Study|Death|0|||
46862670|NCT00256997|83078996|FG000|Overall Study|Adverse Event|4|||
46862671|NCT00256997|83078997|FG001|Overall Study|Adverse Event|0|||
46862672|NCT00256997|83078996|FG000|Overall Study|Lost to Follow-up|3|||
46862673|NCT00256997|83078997|FG001|Overall Study|Lost to Follow-up|5|||
46862674|NCT00256997|83078996|FG000|Overall Study|Withdrawal by Subject|13|||
46862675|NCT00256997|83078997|FG001|Overall Study|Withdrawal by Subject|3|||
46862676|NCT00256997|83078996|FG000|Overall Study|Started but not treated|2|||
46862677|NCT00256997|83078997|FG001|Overall Study|Started but not treated|0|||
46862678|NCT00256997|83078996|FG000|Overall Study|Other|5|||
46862679|NCT00256997|83078997|FG001|Overall Study|Other|8|||
46697550|NCT01264718|82912090|FG000|Overall Study|Lost to Follow-up|3|||
46697551|NCT01264718|82912091|FG001|Overall Study|Lost to Follow-up|2|||
46697552|NCT01264718|82912090|FG000|Overall Study|Withdrawal by Subject|9|||
46697553|NCT01264718|82912091|FG001|Overall Study|Withdrawal by Subject|15|||
46697554|NCT01264718|82912090|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
46697555|NCT01264718|82912091|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
46697556|NCT01264016|82912097|FG000|Overall Study|Withdrawal by Subject|1|||
46697557|NCT01264016|82912097|FG000|Overall Study|Felt faint at sight of blood|1|||
46697558|NCT01263782|82912106|FG000|Overall Study|Death|0|||
46697559|NCT01263782|82912107|FG001|Overall Study|Death|0|||
46862680|NCT00256997|83078996|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
46862681|NCT00256997|83078997|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
46862682|NCT00256997|83078996|FG000|Overall Study|Participant Non-compliant|3|||
46862683|NCT00256997|83078997|FG001|Overall Study|Participant Non-compliant|6|||
46862684|NCT00256997|83078996|FG000|Overall Study|Investigator Withdrew Participant|2|||
46862685|NCT00256997|83078997|FG001|Overall Study|Investigator Withdrew Participant|1|||
46862686|NCT00027846|83079007|FG000|Overall Study|Lost to Follow-up|0|||
46862687|NCT00027846|83079008|FG001|Overall Study|Lost to Follow-up|41|||
46862688|NCT00027846|83079009|FG002|Overall Study|Lost to Follow-up|9|||
46862689|NCT00027846|83079007|FG000|Overall Study|Withdrawal by Subject|0|||
46862690|NCT00027846|83079008|FG001|Overall Study|Withdrawal by Subject|14|||
46862691|NCT00027846|83079009|FG002|Overall Study|Withdrawal by Subject|7|||
46862692|NCT00027846|83079007|FG000|Overall Study|Ineligible for study|2|||
46862693|NCT00027846|83079008|FG001|Overall Study|Ineligible for study|6|||
46862694|NCT00027846|83079009|FG002|Overall Study|Ineligible for study|14|||
46862695|NCT00027846|83079007|FG000|Overall Study|Entry into another COG therapeutic study|0|||
46862696|NCT00027846|83079008|FG001|Overall Study|Entry into another COG therapeutic study|5|||
46862697|NCT00027846|83079009|FG002|Overall Study|Entry into another COG therapeutic study|2|||
46862698|NCT00027846|83079007|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
46862699|NCT00027846|83079008|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
46862700|NCT00027846|83079009|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
46862701|NCT00027378|83079021|FG000|Overall Study|Physician Decision|0|||
46862702|NCT00027378|83079022|FG001|Overall Study|Physician Decision|3|||
46862703|NCT00235391|83079034|FG000|Overall Study|Adverse Event|4|||
46862704|NCT00235391|83079035|FG001|Overall Study|Adverse Event|5|||
46862705|NCT00235391|83079036|FG002|Overall Study|Adverse Event|10|||
46862706|NCT00235391|83079037|FG003|Overall Study|Adverse Event|72|||
46862707|NCT00235391|83079038|FG004|Overall Study|Adverse Event|5|||
46862708|NCT00235391|83079039|FG005|Overall Study|Adverse Event|2|||
46862709|NCT00235391|83079034|FG000|Overall Study|Abnormal laboratory value(s)|3|||
46862710|NCT00235391|83079035|FG001|Overall Study|Abnormal laboratory value(s)|5|||
46862711|NCT00235391|83079036|FG002|Overall Study|Abnormal laboratory value(s)|4|||
46862712|NCT00235391|83079037|FG003|Overall Study|Abnormal laboratory value(s)|27|||
46862713|NCT00235391|83079038|FG004|Overall Study|Abnormal laboratory value(s)|1|||
46862714|NCT00235391|83079039|FG005|Overall Study|Abnormal laboratory value(s)|2|||
46862715|NCT00235391|83079034|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46862716|NCT00235391|83079035|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46862717|NCT00235391|83079036|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
46862718|NCT00235391|83079037|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
46697560|NCT01263782|82912108|FG002|Overall Study|Death|1|||
46697561|NCT01263782|82912109|FG003|Overall Study|Death|0|||
46862719|NCT00235391|83079038|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
46862720|NCT00235391|83079039|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
46862721|NCT00235391|83079034|FG000|Overall Study|Condition no longer requires treatment|3|||
46697562|NCT01263782|82912106|FG000|Overall Study|Progressive disease|0|||
46862722|NCT00235391|83079035|FG001|Overall Study|Condition no longer requires treatment|0|||
46862723|NCT00235391|83079036|FG002|Overall Study|Condition no longer requires treatment|0|||
46862724|NCT00235391|83079037|FG003|Overall Study|Condition no longer requires treatment|11|||
46862725|NCT00235391|83079038|FG004|Overall Study|Condition no longer requires treatment|1|||
46862726|NCT00235391|83079039|FG005|Overall Study|Condition no longer requires treatment|0|||
46862727|NCT00235391|83079034|FG000|Overall Study|Protocol deviation|0|||
46862728|NCT00235391|83079035|FG001|Overall Study|Protocol deviation|0|||
46862729|NCT00235391|83079036|FG002|Overall Study|Protocol deviation|1|||
46862730|NCT00235391|83079037|FG003|Overall Study|Protocol deviation|11|||
46862731|NCT00235391|83079038|FG004|Overall Study|Protocol deviation|0|||
46862732|NCT00235391|83079039|FG005|Overall Study|Protocol deviation|0|||
46862733|NCT00235391|83079034|FG000|Overall Study|Withdrawal by Subject|2|||
46862734|NCT00235391|83079035|FG001|Overall Study|Withdrawal by Subject|3|||
46862735|NCT00235391|83079036|FG002|Overall Study|Withdrawal by Subject|3|||
46862736|NCT00235391|83079037|FG003|Overall Study|Withdrawal by Subject|61|||
46862737|NCT00235391|83079038|FG004|Overall Study|Withdrawal by Subject|5|||
46862738|NCT00235391|83079039|FG005|Overall Study|Withdrawal by Subject|0|||
46862739|NCT00235391|83079034|FG000|Overall Study|Lost to Follow-up|0|||
46862740|NCT00235391|83079035|FG001|Overall Study|Lost to Follow-up|3|||
46862741|NCT00235391|83079036|FG002|Overall Study|Lost to Follow-up|3|||
46862742|NCT00235391|83079037|FG003|Overall Study|Lost to Follow-up|16|||
46862743|NCT00235391|83079038|FG004|Overall Study|Lost to Follow-up|0|||
46862744|NCT00235391|83079039|FG005|Overall Study|Lost to Follow-up|0|||
46862745|NCT00235391|83079034|FG000|Overall Study|Administrative problems|0|||
46862746|NCT00235391|83079035|FG001|Overall Study|Administrative problems|0|||
46862747|NCT00235391|83079036|FG002|Overall Study|Administrative problems|0|||
46862748|NCT00235391|83079037|FG003|Overall Study|Administrative problems|1|||
46862749|NCT00235391|83079038|FG004|Overall Study|Administrative problems|0|||
46862750|NCT00235391|83079039|FG005|Overall Study|Administrative problems|0|||
46862751|NCT00235391|83079034|FG000|Overall Study|Death|0|||
46862752|NCT00235391|83079035|FG001|Overall Study|Death|0|||
46862753|NCT00235391|83079036|FG002|Overall Study|Death|1|||
46862754|NCT00235391|83079037|FG003|Overall Study|Death|4|||
46862755|NCT00235391|83079038|FG004|Overall Study|Death|0|||
46862756|NCT00235391|83079039|FG005|Overall Study|Death|0|||
46862757|NCT00234533|83079083|FG000|Overall Study|Withdrawal by Subject|6|||
46862758|NCT00234533|83079083|FG000|Overall Study|Adverse Event|2|||
46862759|NCT00234533|83079083|FG000|Overall Study|Enrolled but not treated|3|||
46862760|NCT00026208|83079090|FG000|Overall Study|Complications of auto accident|1|||
46862761|NCT00026208|83079091|FG001|Overall Study|Complications of auto accident|0|||
46862762|NCT00025662|83079097|FG000|Overall Study|Withdrawal by Subject|2|||
46862763|NCT00025662|83079097|FG000|Overall Study|Technical failure of manipulation|1|||
46862764|NCT00025506|83079101|FG000|Overall Study|Ineligible: clerical error|1|||
46862765|NCT00025506|83079101|FG000|Overall Study|Ineligible: wrong cell type|5|||
46862766|NCT00025506|83079101|FG000|Overall Study|Ineligible: inadequate pathology|2|||
46862767|NCT00025506|83079101|FG000|Overall Study|Never Treated|2|||
46862768|NCT00024258|83079110|FG000|Overall Study|Withdrawal by Subject|1|||
46862769|NCT00024258|83079110|FG000|Overall Study|Disease Progression|8|||
46862770|NCT00023712|83079116|FG000|Overall Study|Not platinum sensitive|1|||
46862771|NCT00023712|83079117|FG001|Overall Study|Not platinum sensitive|0|||
46862772|NCT00023712|83079116|FG000|Overall Study|Never treated|1|||
46862773|NCT00023712|83079117|FG001|Overall Study|Never treated|1|||
46862774|NCT00023322|83079133|FG000|Overall Study|Lost to Follow-up|1|||
46862775|NCT04640168|83079139|FG000|Overall Study|Withdrawal by Subject|8|||
46862776|NCT04640168|83079140|FG001|Overall Study|Withdrawal by Subject|7|||
46862777|NCT04640168|83079139|FG000|Overall Study|Lost to Follow-up|1|||
46862778|NCT04640168|83079140|FG001|Overall Study|Lost to Follow-up|0|||
46862779|NCT04640168|83079139|FG000|Overall Study|Enrolled but not treated|12|||
46862780|NCT04640168|83079140|FG001|Overall Study|Enrolled but not treated|12|||
46862781|NCT00022698|83079148|FG000|Overall Study|Adverse Event|5|||
46862782|NCT00022698|83079149|FG001|Overall Study|Adverse Event|9|||
46862783|NCT00022698|83079148|FG000|Overall Study|Death|0|||
46862784|NCT00022698|83079149|FG001|Overall Study|Death|2|||
46862785|NCT00022698|83079148|FG000|Overall Study|Failure to return|0|||
46862786|NCT00022698|83079149|FG001|Overall Study|Failure to return|1|||
46862787|NCT00022698|83079148|FG000|Overall Study|Refused treatment|0|||
46862788|NCT00022698|83079149|FG001|Overall Study|Refused treatment|2|||
46862789|NCT00022698|83079148|FG000|Overall Study|Insufficient therapeutic response|2|||
46862790|NCT00022698|83079149|FG001|Overall Study|Insufficient therapeutic response|14|||
46862791|NCT00022698|83079148|FG000|Overall Study|Administrative /other|1|||
46697563|NCT01263782|82912107|FG001|Overall Study|Progressive disease|0|||
46862792|NCT00022698|83079149|FG001|Overall Study|Administrative /other|7|||
46862793|NCT05261126|83079166|FG000|Overall Study|Death|0|||
46862794|NCT05261126|83079167|FG001|Overall Study|Death|0|||
46862795|NCT05261126|83079168|FG002|Overall Study|Death|1|||
46862796|NCT05261126|83079169|FG003|Overall Study|Death|0|||
46862797|NCT05261126|83079170|FG004|Overall Study|Death|0|||
46862798|NCT05261126|83079166|FG000|Overall Study|Lost to Follow-up|0|||
46862799|NCT05261126|83079167|FG001|Overall Study|Lost to Follow-up|0|||
46862800|NCT05261126|83079168|FG002|Overall Study|Lost to Follow-up|0|||
46862801|NCT05261126|83079169|FG003|Overall Study|Lost to Follow-up|0|||
46862802|NCT05261126|83079170|FG004|Overall Study|Lost to Follow-up|1|||
46862803|NCT05261126|83079166|FG000|Overall Study|Physician Decision|1|||
46862804|NCT05261126|83079167|FG001|Overall Study|Physician Decision|0|||
46862805|NCT05261126|83079168|FG002|Overall Study|Physician Decision|0|||
46862806|NCT05261126|83079169|FG003|Overall Study|Physician Decision|0|||
46862807|NCT05261126|83079170|FG004|Overall Study|Physician Decision|0|||
46862808|NCT05261126|83079166|FG000|Overall Study|Screen Failure|0|||
46862809|NCT05261126|83079167|FG001|Overall Study|Screen Failure|0|||
46862810|NCT05261126|83079168|FG002|Overall Study|Screen Failure|0|||
46862811|NCT05261126|83079169|FG003|Overall Study|Screen Failure|0|||
46862812|NCT05261126|83079170|FG004|Overall Study|Screen Failure|1|||
46862813|NCT05261126|83079166|FG000|Overall Study|Withdrawal by Subject|1|||
46862814|NCT05261126|83079167|FG001|Overall Study|Withdrawal by Subject|0|||
46862815|NCT05261126|83079168|FG002|Overall Study|Withdrawal by Subject|1|||
46862816|NCT05261126|83079169|FG003|Overall Study|Withdrawal by Subject|1|||
46862817|NCT05261126|83079170|FG004|Overall Study|Withdrawal by Subject|0|||
46862818|NCT05261126|83079166|FG000|Overall Study|Not Recorded|0|||
46862819|NCT05261126|83079167|FG001|Overall Study|Not Recorded|0|||
46862820|NCT05261126|83079168|FG002|Overall Study|Not Recorded|0|||
46862821|NCT05261126|83079169|FG003|Overall Study|Not Recorded|1|||
46862822|NCT05261126|83079170|FG004|Overall Study|Not Recorded|0|||
46862823|NCT05116683|83079182|FG000|Overall Study|Physician Decision|4|||
46862824|NCT04585815|83079196|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
46862825|NCT04585815|83079197|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
46862826|NCT04585815|83079196|FG000|Sub-study A- Treatment Phase|Death|0|||
46862827|NCT04585815|83079197|FG001|Sub-study A- Treatment Phase|Death|1|||
46862828|NCT04585815|83079196|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
46862829|NCT04585815|83079197|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
46862830|NCT04585815|83079196|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
46862831|NCT04585815|83079197|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
46862832|NCT04585815|83079196|FG000|Sub-study A- Treatment Phase|Other|1|||
46862833|NCT04585815|83079197|FG001|Sub-study A- Treatment Phase|Other|0|||
46862834|NCT04585815|83079196|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
46862835|NCT04585815|83079197|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
46862836|NCT04585815|83079196|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
46862837|NCT04585815|83079197|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
46862838|NCT04570436|83079205|FG000|Overall Study|Adverse Event|0|||
46862839|NCT04570436|83079206|FG001|Overall Study|Adverse Event|0|||
46862840|NCT04570436|83079207|FG002|Overall Study|Adverse Event|1|||
46862841|NCT04570436|83079208|FG003|Overall Study|Adverse Event|0|||
46862842|NCT04570436|83079209|FG004|Overall Study|Adverse Event|0|||
46862843|NCT04570436|83079210|FG005|Overall Study|Adverse Event|0|||
46862844|NCT04570436|83079211|FG006|Overall Study|Adverse Event|0|||
46862845|NCT04570436|83079212|FG007|Overall Study|Adverse Event|0|||
46862846|NCT04570436|83079213|FG008|Overall Study|Adverse Event|0|||
46862847|NCT04570436|83079214|FG009|Overall Study|Adverse Event|0|||
46862848|NCT04570436|83079205|FG000|Overall Study|Physician Decision|1|||
46862849|NCT04570436|83079206|FG001|Overall Study|Physician Decision|0|||
46862850|NCT04570436|83079207|FG002|Overall Study|Physician Decision|0|||
46862851|NCT04570436|83079208|FG003|Overall Study|Physician Decision|0|||
46862852|NCT04570436|83079209|FG004|Overall Study|Physician Decision|0|||
46862853|NCT04570436|83079210|FG005|Overall Study|Physician Decision|0|||
46862854|NCT04570436|83079211|FG006|Overall Study|Physician Decision|0|||
46862855|NCT04570436|83079212|FG007|Overall Study|Physician Decision|0|||
46862856|NCT04570436|83079213|FG008|Overall Study|Physician Decision|0|||
46862857|NCT04570436|83079214|FG009|Overall Study|Physician Decision|0|||
46862858|NCT04563845|83079248|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862859|NCT04563845|83079249|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862860|NCT04563845|83079250|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862861|NCT04563845|83079251|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862862|NCT04563845|83079252|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862863|NCT04563845|83079253|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862864|NCT04563845|83079254|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862865|NCT04563845|83079255|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
46862866|NCT04563845|83079256|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862867|NCT04563845|83079257|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862868|NCT04563845|83079258|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862869|NCT04563845|83079259|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862870|NCT04563845|83079260|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862871|NCT04563845|83079261|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
46862872|NCT04563845|83079248|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862873|NCT04563845|83079249|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862874|NCT04563845|83079250|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862875|NCT04563845|83079251|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862876|NCT04563845|83079252|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
46862877|NCT04563845|83079253|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862878|NCT04563845|83079254|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862879|NCT04563845|83079255|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862880|NCT04563845|83079256|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862881|NCT04563845|83079257|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862882|NCT04563845|83079258|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862883|NCT04563845|83079259|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862884|NCT04563845|83079260|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862885|NCT04563845|83079261|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
46862886|NCT04433767|83079289|FG000|Overall Study|Adverse Event|1|||
46862887|NCT04419467|83079296|FG000|Overall Study|Not treated with IP|0|||
46862888|NCT04419467|83079297|FG001|Overall Study|Not treated with IP|0|||
46862889|NCT04419467|83079298|FG002|Overall Study|Not treated with IP|2|||
46862890|NCT04419467|83079296|FG000|Overall Study|Adverse Event|0|||
46862891|NCT04419467|83079297|FG001|Overall Study|Adverse Event|2|||
46862892|NCT04419467|83079298|FG002|Overall Study|Adverse Event|0|||
46862893|NCT04419467|83079296|FG000|Overall Study|Death|1|||
46862894|NCT04419467|83079297|FG001|Overall Study|Death|0|||
46862895|NCT04419467|83079298|FG002|Overall Study|Death|0|||
46862896|NCT04419467|83079296|FG000|Overall Study|Lost to Follow-up|0|||
46862897|NCT04419467|83079297|FG001|Overall Study|Lost to Follow-up|1|||
46862898|NCT04419467|83079298|FG002|Overall Study|Lost to Follow-up|2|||
46862899|NCT04419467|83079296|FG000|Overall Study|Withdrawal by Subject|0|||
46862900|NCT04419467|83079297|FG001|Overall Study|Withdrawal by Subject|0|||
46862901|NCT04419467|83079298|FG002|Overall Study|Withdrawal by Subject|4|||
46862902|NCT04419467|83079296|FG000|Overall Study|Pandemic related|0|||
46862903|NCT04419467|83079297|FG001|Overall Study|Pandemic related|0|||
46862904|NCT04419467|83079298|FG002|Overall Study|Pandemic related|1|||
46862905|NCT04419467|83079296|FG000|Overall Study|Reason not known|1|||
46862906|NCT04419467|83079297|FG001|Overall Study|Reason not known|0|||
46862907|NCT04419467|83079298|FG002|Overall Study|Reason not known|0|||
46862908|NCT04382326|83079317|FG000|Overall Study|Adverse Event, not serious|1|||
46862909|NCT04382326|83079318|FG001|Overall Study|Adverse Event, not serious|2|||
46862910|NCT04382326|83079317|FG000|Overall Study|Other|1|||
46862911|NCT04382326|83079318|FG001|Overall Study|Other|0|||
46862912|NCT04382326|83079317|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
46862913|NCT04382326|83079318|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
46862914|NCT04382326|83079317|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
46862915|NCT04382326|83079318|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
46862916|NCT04382326|83079317|FG000|Overall Study|Protocol Violation|29|||
46862917|NCT04382326|83079318|FG001|Overall Study|Protocol Violation|23|||
46862918|NCT04382326|83079317|FG000|Overall Study|Physician Decision|0|||
46862919|NCT04382326|83079318|FG001|Overall Study|Physician Decision|1|||
46862920|NCT04382326|83079317|FG000|Overall Study|Lost to Follow-up|48|||
46862921|NCT04382326|83079318|FG001|Overall Study|Lost to Follow-up|63|||
46862922|NCT04382326|83079317|FG000|Overall Study|Adverse Event, non-fatal|1|||
46862923|NCT04382326|83079318|FG001|Overall Study|Adverse Event, non-fatal|1|||
46862924|NCT04359901|83079326|FG000|Overall Study|Withdrawal by Subject|0|||
46862925|NCT04359901|83079327|FG001|Overall Study|Withdrawal by Subject|1|||
46862926|NCT04359901|83079326|FG000|Overall Study|Death|6|||
46862927|NCT04359901|83079327|FG001|Overall Study|Death|2|||
46862928|NCT03744676|83079342|FG000|Pre-Treatment Phase|Death|7|||
46862929|NCT03744676|83079342|FG000|Pre-Treatment Phase|Disease related complications|2|||
46862930|NCT03744676|83079342|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
46862931|NCT03744676|83079342|FG000|Pre-Treatment Phase|Other reasons|8|||
46862932|NCT03744676|83079342|FG000|Treatment Phase|Ongoing in study|18|||
46862933|NCT03744676|83079342|FG000|Treatment Phase|Death|31|||
46862934|NCT03744676|83079342|FG000|Treatment Phase|Withdrawal of consent|8|||
46862935|NCT03744676|83079342|FG000|Treatment Phase|Other reasons|6|||
46862936|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
46862937|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
46862938|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
46862939|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
46862940|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
46862941|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
46862942|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
46862943|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
46862944|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
46862945|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
46862946|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
46862947|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
46862948|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
46862949|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
46862950|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
46862951|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
46862952|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
46862953|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
46862954|NCT03605667|83079348|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
46862955|NCT03605667|83079349|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
46862956|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
46862957|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
46862958|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Other|6|||
46862959|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Other|8|||
46862960|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
46862961|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
46862962|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
46862963|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
46862964|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
46862965|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
46862966|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
46862967|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
46862968|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
46862969|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
46982389|NCT02575807|83228703|FG001|Overall Study|Death|3|||
46982390|NCT02575807|83228704|FG002|Overall Study|Death|7|||
46982391|NCT02575807|83228705|FG003|Overall Study|Death|0|||
46982392|NCT02575807|83228706|FG004|Overall Study|Death|1|||
46862970|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
46862971|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
46862972|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Death|0|||
46862973|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Death|2|||
46862974|NCT03605667|83079348|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
46982393|NCT02575807|83228702|FG000|Overall Study|Study terminated by Sponsor|0|||
46982394|NCT02575807|83228703|FG001|Overall Study|Study terminated by Sponsor|1|||
46697564|NCT01263782|82912108|FG002|Overall Study|Progressive disease|0|||
46697565|NCT01263782|82912109|FG003|Overall Study|Progressive disease|1|||
46697566|NCT01263782|82912106|FG000|Overall Study|Too early|0|||
46697567|NCT01263782|82912107|FG001|Overall Study|Too early|0|||
46697568|NCT01263782|82912108|FG002|Overall Study|Too early|1|||
46697569|NCT01263782|82912109|FG003|Overall Study|Too early|0|||
46697570|NCT01263782|82912106|FG000|Overall Study|Inevaluable|0|||
46697571|NCT01263782|82912107|FG001|Overall Study|Inevaluable|0|||
46697572|NCT01263782|82912108|FG002|Overall Study|Inevaluable|1|||
46697573|NCT01263782|82912109|FG003|Overall Study|Inevaluable|0|||
46697574|NCT01263704|82912119|FG000|Overall Study|Progressive disease|18|||
46697575|NCT01263704|82912119|FG000|Overall Study|Adverse Event|3|||
46697576|NCT01263704|82912119|FG000|Overall Study|Death|2|||
46697577|NCT01263704|82912119|FG000|Overall Study|Patient withdrew consent|2|||
46697578|NCT01263704|82912119|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
46697579|NCT01263704|82912119|FG000|Overall Study|Lost to Follow-up|1|||
46697580|NCT01263704|82912119|FG000|Overall Study|Colon metastases|1|||
46697581|NCT01263704|82912119|FG000|Overall Study|Principal Investigator (PI) decision|1|||
46697582|NCT01263470|82912129|FG000|Overall Study|Adverse Event|2|||
46697583|NCT01263470|82912130|FG001|Overall Study|Adverse Event|2|||
46697584|NCT01263470|82912131|FG002|Overall Study|Adverse Event|1|||
46697585|NCT01263470|82912132|FG003|Overall Study|Adverse Event|1|||
46697586|NCT01263470|82912133|FG004|Overall Study|Adverse Event|2|||
46697587|NCT01263470|82912134|FG005|Overall Study|Adverse Event|2|||
46697588|NCT01263470|82912129|FG000|Overall Study|Protocol Violation|0|||
46862975|NCT03605667|83079349|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
46862976|NCT03600350|83079361|FG000|Overall Study|Death|1|||
46862977|NCT03600350|83079361|FG000|Overall Study|On Follow Up|18|||
46862978|NCT03201445|83079386|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
46862979|NCT03201445|83079387|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
46862980|NCT03201445|83079386|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
46862981|NCT03201445|83079387|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
46862982|NCT03201445|83079386|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
46862983|NCT03201445|83079387|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
46862984|NCT03201445|83079386|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
46862985|NCT03201445|83079387|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
46697589|NCT01263470|82912130|FG001|Overall Study|Protocol Violation|1|||
46862986|NCT03201445|83079386|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
46697590|NCT01263470|82912131|FG002|Overall Study|Protocol Violation|0|||
46697591|NCT01263470|82912132|FG003|Overall Study|Protocol Violation|0|||
46697592|NCT01263470|82912133|FG004|Overall Study|Protocol Violation|0|||
46697593|NCT01263470|82912134|FG005|Overall Study|Protocol Violation|1|||
46697594|NCT01263470|82912129|FG000|Overall Study|Withdrawal by Subject|0|||
46862987|NCT03201445|83079387|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
46862988|NCT03201445|83079386|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
46862989|NCT03201445|83079387|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
46862990|NCT03201445|83079386|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
46862991|NCT03201445|83079387|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
46862992|NCT02839720|83079412|FG000|Overall Study|Adverse Event|2|||
46862993|NCT02839720|83079412|FG000|Overall Study|Non-compliance|2|||
46862994|NCT02839720|83079412|FG000|Overall Study|Intercurrent Illness|1|||
46862995|NCT02839720|83079412|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
46862996|NCT02642042|83079422|FG000|Overall Study|Adverse Event|22|||
46862997|NCT02642042|83079422|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
46862998|NCT02642042|83079422|FG000|Overall Study|Progression/Relapse|28|||
46862999|NCT02642042|83079422|FG000|Overall Study|Death|1|||
46863000|NCT02642042|83079422|FG000|Overall Study|Not Protocol Specified|2|||
46863001|NCT02608268|83079456|FG000|Overall Study|Adverse Event|0|||
46863002|NCT02608268|83079457|FG001|Overall Study|Adverse Event|0|||
46863003|NCT02608268|83079458|FG002|Overall Study|Adverse Event|1|||
46863004|NCT02608268|83079459|FG003|Overall Study|Adverse Event|0|||
46863005|NCT02608268|83079460|FG004|Overall Study|Adverse Event|0|||
46863006|NCT02608268|83079461|FG005|Overall Study|Adverse Event|0|||
46863007|NCT02608268|83079462|FG006|Overall Study|Adverse Event|0|||
46863008|NCT02608268|83079463|FG007|Overall Study|Adverse Event|0|||
46863009|NCT02608268|83079464|FG008|Overall Study|Adverse Event|0|||
46863010|NCT02608268|83079465|FG009|Overall Study|Adverse Event|0|||
46863011|NCT02608268|83079466|FG010|Overall Study|Adverse Event|0|||
46863012|NCT02608268|83079467|FG011|Overall Study|Adverse Event|0|||
46863013|NCT02608268|83079468|FG012|Overall Study|Adverse Event|2|||
46863014|NCT02608268|83079469|FG013|Overall Study|Adverse Event|0|||
46863015|NCT02608268|83079470|FG014|Overall Study|Adverse Event|0|||
46863016|NCT02608268|83079471|FG015|Overall Study|Adverse Event|0|||
46863017|NCT02608268|83079472|FG016|Overall Study|Adverse Event|0|||
46863018|NCT02608268|83079473|FG017|Overall Study|Adverse Event|0|||
46863019|NCT02608268|83079474|FG018|Overall Study|Adverse Event|0|||
46863020|NCT02608268|83079475|FG019|Overall Study|Adverse Event|0|||
46863021|NCT02608268|83079476|FG020|Overall Study|Adverse Event|1|||
46863022|NCT02608268|83079477|FG021|Overall Study|Adverse Event|1|||
46863023|NCT02608268|83079478|FG022|Overall Study|Adverse Event|0|||
46863024|NCT02608268|83079479|FG023|Overall Study|Adverse Event|0|||
46863025|NCT02608268|83079480|FG024|Overall Study|Adverse Event|1|||
46863026|NCT02608268|83079481|FG025|Overall Study|Adverse Event|0|||
46863027|NCT02608268|83079482|FG026|Overall Study|Adverse Event|0|||
46863028|NCT02608268|83079483|FG027|Overall Study|Adverse Event|0|||
46863029|NCT02608268|83079484|FG028|Overall Study|Adverse Event|1|||
46863030|NCT02608268|83079485|FG029|Overall Study|Adverse Event|0|||
46863031|NCT02608268|83079456|FG000|Overall Study|Death|1|||
46863032|NCT02608268|83079457|FG001|Overall Study|Death|0|||
46863033|NCT02608268|83079458|FG002|Overall Study|Death|0|||
46863034|NCT02608268|83079459|FG003|Overall Study|Death|0|||
46863035|NCT02608268|83079460|FG004|Overall Study|Death|0|||
46863036|NCT02608268|83079461|FG005|Overall Study|Death|0|||
46863037|NCT02608268|83079462|FG006|Overall Study|Death|0|||
46863038|NCT02608268|83079463|FG007|Overall Study|Death|0|||
46863039|NCT02608268|83079464|FG008|Overall Study|Death|1|||
46863040|NCT02608268|83079465|FG009|Overall Study|Death|1|||
46863041|NCT02608268|83079466|FG010|Overall Study|Death|0|||
46863042|NCT02608268|83079467|FG011|Overall Study|Death|0|||
46863043|NCT02608268|83079468|FG012|Overall Study|Death|0|||
46863044|NCT02608268|83079469|FG013|Overall Study|Death|0|||
46863045|NCT02608268|83079470|FG014|Overall Study|Death|0|||
46863046|NCT02608268|83079471|FG015|Overall Study|Death|1|||
46863047|NCT02608268|83079472|FG016|Overall Study|Death|0|||
46863048|NCT02608268|83079473|FG017|Overall Study|Death|1|||
46863049|NCT02608268|83079474|FG018|Overall Study|Death|0|||
46982395|NCT02575807|83228704|FG002|Overall Study|Study terminated by Sponsor|7|||
46863050|NCT02608268|83079475|FG019|Overall Study|Death|1|||
46863051|NCT02608268|83079476|FG020|Overall Study|Death|1|||
46863052|NCT02608268|83079477|FG021|Overall Study|Death|0|||
46863053|NCT02608268|83079478|FG022|Overall Study|Death|0|||
46863054|NCT02608268|83079479|FG023|Overall Study|Death|0|||
46863055|NCT02608268|83079480|FG024|Overall Study|Death|1|||
46863056|NCT02608268|83079481|FG025|Overall Study|Death|2|||
46863057|NCT02608268|83079482|FG026|Overall Study|Death|0|||
46863058|NCT02608268|83079483|FG027|Overall Study|Death|1|||
46863059|NCT02608268|83079484|FG028|Overall Study|Death|4|||
46863060|NCT02608268|83079485|FG029|Overall Study|Death|0|||
46863061|NCT02608268|83079456|FG000|Overall Study|Physician Decision|0|||
46863062|NCT02608268|83079457|FG001|Overall Study|Physician Decision|0|||
46863063|NCT02608268|83079458|FG002|Overall Study|Physician Decision|0|||
46863064|NCT02608268|83079459|FG003|Overall Study|Physician Decision|0|||
46863065|NCT02608268|83079460|FG004|Overall Study|Physician Decision|0|||
46863066|NCT02608268|83079461|FG005|Overall Study|Physician Decision|0|||
46863067|NCT02608268|83079462|FG006|Overall Study|Physician Decision|0|||
46982396|NCT02575807|83228705|FG003|Overall Study|Study terminated by Sponsor|0|||
46863068|NCT02608268|83079463|FG007|Overall Study|Physician Decision|0|||
46863069|NCT02608268|83079464|FG008|Overall Study|Physician Decision|0|||
46863070|NCT02608268|83079465|FG009|Overall Study|Physician Decision|0|||
46863071|NCT02608268|83079466|FG010|Overall Study|Physician Decision|1|||
46863072|NCT02608268|83079467|FG011|Overall Study|Physician Decision|0|||
46863073|NCT02608268|83079468|FG012|Overall Study|Physician Decision|0|||
46863074|NCT02608268|83079469|FG013|Overall Study|Physician Decision|1|||
46863075|NCT02608268|83079470|FG014|Overall Study|Physician Decision|0|||
46863076|NCT02608268|83079471|FG015|Overall Study|Physician Decision|0|||
46863077|NCT02608268|83079472|FG016|Overall Study|Physician Decision|0|||
46863078|NCT02608268|83079473|FG017|Overall Study|Physician Decision|0|||
46863079|NCT02608268|83079474|FG018|Overall Study|Physician Decision|0|||
46863080|NCT02608268|83079475|FG019|Overall Study|Physician Decision|0|||
46863081|NCT02608268|83079476|FG020|Overall Study|Physician Decision|0|||
46863082|NCT02608268|83079477|FG021|Overall Study|Physician Decision|0|||
46863083|NCT02608268|83079478|FG022|Overall Study|Physician Decision|1|||
46863084|NCT02608268|83079479|FG023|Overall Study|Physician Decision|1|||
46863085|NCT02608268|83079480|FG024|Overall Study|Physician Decision|1|||
46863086|NCT02608268|83079481|FG025|Overall Study|Physician Decision|0|||
46863087|NCT02608268|83079482|FG026|Overall Study|Physician Decision|0|||
46863088|NCT02608268|83079483|FG027|Overall Study|Physician Decision|2|||
46863089|NCT02608268|83079484|FG028|Overall Study|Physician Decision|1|||
46863090|NCT02608268|83079485|FG029|Overall Study|Physician Decision|1|||
46863091|NCT02608268|83079456|FG000|Overall Study|Progressive disease|12|||
46863092|NCT02608268|83079457|FG001|Overall Study|Progressive disease|8|||
46863093|NCT02608268|83079458|FG002|Overall Study|Progressive disease|13|||
46863094|NCT02608268|83079459|FG003|Overall Study|Progressive disease|5|||
46863095|NCT02608268|83079460|FG004|Overall Study|Progressive disease|2|||
46863096|NCT02608268|83079461|FG005|Overall Study|Progressive disease|4|||
46863097|NCT02608268|83079462|FG006|Overall Study|Progressive disease|6|||
46863098|NCT02608268|83079463|FG007|Overall Study|Progressive disease|2|||
46863099|NCT02608268|83079464|FG008|Overall Study|Progressive disease|5|||
46863100|NCT02608268|83079465|FG009|Overall Study|Progressive disease|6|||
46863101|NCT02608268|83079466|FG010|Overall Study|Progressive disease|5|||
46863102|NCT02608268|83079467|FG011|Overall Study|Progressive disease|5|||
46863103|NCT02608268|83079468|FG012|Overall Study|Progressive disease|4|||
46863104|NCT02608268|83079469|FG013|Overall Study|Progressive disease|11|||
46863105|NCT02608268|83079470|FG014|Overall Study|Progressive disease|6|||
46863106|NCT02608268|83079471|FG015|Overall Study|Progressive disease|3|||
46863107|NCT02608268|83079472|FG016|Overall Study|Progressive disease|5|||
46863108|NCT02608268|83079473|FG017|Overall Study|Progressive disease|5|||
46863109|NCT02608268|83079474|FG018|Overall Study|Progressive disease|5|||
46863110|NCT02608268|83079475|FG019|Overall Study|Progressive disease|2|||
46863111|NCT02608268|83079476|FG020|Overall Study|Progressive disease|10|||
46863112|NCT02608268|83079477|FG021|Overall Study|Progressive disease|4|||
46863113|NCT02608268|83079478|FG022|Overall Study|Progressive disease|5|||
46863114|NCT02608268|83079479|FG023|Overall Study|Progressive disease|5|||
46863115|NCT02608268|83079480|FG024|Overall Study|Progressive disease|3|||
46863116|NCT02608268|83079481|FG025|Overall Study|Progressive disease|11|||
46863117|NCT02608268|83079482|FG026|Overall Study|Progressive disease|16|||
46863118|NCT02608268|83079483|FG027|Overall Study|Progressive disease|11|||
46863119|NCT02608268|83079484|FG028|Overall Study|Progressive disease|10|||
46863120|NCT02608268|83079485|FG029|Overall Study|Progressive disease|15|||
46863121|NCT02608268|83079456|FG000|Overall Study|Subject/guardian decision|1|||
46863122|NCT02608268|83079457|FG001|Overall Study|Subject/guardian decision|1|||
46863123|NCT02608268|83079458|FG002|Overall Study|Subject/guardian decision|2|||
46863124|NCT02608268|83079459|FG003|Overall Study|Subject/guardian decision|0|||
46863125|NCT02608268|83079460|FG004|Overall Study|Subject/guardian decision|0|||
46863126|NCT02608268|83079461|FG005|Overall Study|Subject/guardian decision|0|||
46863127|NCT02608268|83079462|FG006|Overall Study|Subject/guardian decision|0|||
46863128|NCT02608268|83079463|FG007|Overall Study|Subject/guardian decision|0|||
46863129|NCT02608268|83079464|FG008|Overall Study|Subject/guardian decision|2|||
46863130|NCT02608268|83079465|FG009|Overall Study|Subject/guardian decision|2|||
46863131|NCT02608268|83079466|FG010|Overall Study|Subject/guardian decision|0|||
46863132|NCT02608268|83079467|FG011|Overall Study|Subject/guardian decision|1|||
46863133|NCT02608268|83079468|FG012|Overall Study|Subject/guardian decision|0|||
46863134|NCT02608268|83079469|FG013|Overall Study|Subject/guardian decision|1|||
46863135|NCT02608268|83079470|FG014|Overall Study|Subject/guardian decision|0|||
46863136|NCT02608268|83079471|FG015|Overall Study|Subject/guardian decision|1|||
46863137|NCT02608268|83079472|FG016|Overall Study|Subject/guardian decision|0|||
46863138|NCT02608268|83079473|FG017|Overall Study|Subject/guardian decision|0|||
46863139|NCT02608268|83079474|FG018|Overall Study|Subject/guardian decision|1|||
46863140|NCT02608268|83079475|FG019|Overall Study|Subject/guardian decision|0|||
46863141|NCT02608268|83079476|FG020|Overall Study|Subject/guardian decision|0|||
46863142|NCT02608268|83079477|FG021|Overall Study|Subject/guardian decision|0|||
46863143|NCT02608268|83079478|FG022|Overall Study|Subject/guardian decision|1|||
46863144|NCT02608268|83079479|FG023|Overall Study|Subject/guardian decision|0|||
46863145|NCT02608268|83079480|FG024|Overall Study|Subject/guardian decision|0|||
46863146|NCT02608268|83079481|FG025|Overall Study|Subject/guardian decision|1|||
46863147|NCT02608268|83079482|FG026|Overall Study|Subject/guardian decision|1|||
46863148|NCT02608268|83079483|FG027|Overall Study|Subject/guardian decision|1|||
46863149|NCT02608268|83079484|FG028|Overall Study|Subject/guardian decision|1|||
46863150|NCT02608268|83079485|FG029|Overall Study|Subject/guardian decision|0|||
46863151|NCT02510261|83079598|FG000|Overall Study|Adverse Event|5|||
46863152|NCT02510261|83079599|FG001|Overall Study|Adverse Event|8|||
46863153|NCT02510261|83079600|FG002|Overall Study|Adverse Event|0|||
46863154|NCT02510261|83079598|FG000|Overall Study|Physician Decision|1|||
46863155|NCT02510261|83079599|FG001|Overall Study|Physician Decision|5|||
46863156|NCT02510261|83079600|FG002|Overall Study|Physician Decision|0|||
46863157|NCT02510261|83079598|FG000|Overall Study|Death|19|||
46863158|NCT02510261|83079599|FG001|Overall Study|Death|19|||
46863159|NCT02510261|83079600|FG002|Overall Study|Death|0|||
46697595|NCT01263470|82912130|FG001|Overall Study|Withdrawal by Subject|1|||
46697596|NCT01263470|82912131|FG002|Overall Study|Withdrawal by Subject|1|||
46697597|NCT01263470|82912132|FG003|Overall Study|Withdrawal by Subject|2|||
46697598|NCT01263470|82912133|FG004|Overall Study|Withdrawal by Subject|0|||
46697599|NCT01263470|82912134|FG005|Overall Study|Withdrawal by Subject|2|||
46697600|NCT01263470|82912129|FG000|Overall Study|Lack of Efficacy|0|||
46863160|NCT02510261|83079598|FG000|Overall Study|Withdrawal by Subject|3|||
46863161|NCT02510261|83079599|FG001|Overall Study|Withdrawal by Subject|10|||
46863162|NCT02510261|83079600|FG002|Overall Study|Withdrawal by Subject|3|||
46863163|NCT02506192|83079611|FG000|Overall Study|Withdrawal by Subject|1|||
46863164|NCT02506192|83079612|FG001|Overall Study|Withdrawal by Subject|1|||
46863165|NCT02395666|83079620|FG000|Overall Study|Physician Decision|3|||
46863166|NCT02395666|83079621|FG001|Overall Study|Physician Decision|0|||
46863167|NCT02395666|83079620|FG000|Overall Study|Lost to Follow-up|1|||
46863168|NCT02395666|83079621|FG001|Overall Study|Lost to Follow-up|0|||
46863169|NCT02395666|83079620|FG000|Overall Study|Withdrawal by Subject|2|||
46863170|NCT02395666|83079621|FG001|Overall Study|Withdrawal by Subject|1|||
46863171|NCT02223819|83079631|FG000|Overall Study|Lost to Follow-up|2|||
46863172|NCT02030067|83079648|FG000|Overall Study|Disease Progression|1|||
46863173|NCT02030067|83079649|FG001|Overall Study|Disease Progression|1|||
46982397|NCT02575807|83228706|FG004|Overall Study|Study terminated by Sponsor|1|||
46982398|NCT02575807|83228702|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
46982399|NCT02575807|83228703|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
46697601|NCT01263470|82912130|FG001|Overall Study|Lack of Efficacy|0|||
46697602|NCT01263470|82912131|FG002|Overall Study|Lack of Efficacy|2|||
46697603|NCT01263470|82912132|FG003|Overall Study|Lack of Efficacy|0|||
46863174|NCT02030067|83079650|FG002|Overall Study|Disease Progression|2|||
46863175|NCT02030067|83079651|FG003|Overall Study|Disease Progression|2|||
46863176|NCT02030067|83079652|FG004|Overall Study|Disease Progression|3|||
46863177|NCT02030067|83079653|FG005|Overall Study|Disease Progression|2|||
46863178|NCT02030067|83079654|FG006|Overall Study|Disease Progression|3|||
46863179|NCT02030067|83079655|FG007|Overall Study|Disease Progression|3|||
46863180|NCT02030067|83079656|FG008|Overall Study|Disease Progression|4|||
46697604|NCT01263470|82912133|FG004|Overall Study|Lack of Efficacy|0|||
46697605|NCT01263470|82912134|FG005|Overall Study|Lack of Efficacy|0|||
46697606|NCT01263470|82912129|FG000|Overall Study|Participant Unavailability|0|||
46982400|NCT02575807|83228704|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
46982401|NCT02575807|83228705|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
46982402|NCT02575807|83228706|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
46697607|NCT01263470|82912130|FG001|Overall Study|Participant Unavailability|1|||
46697608|NCT01263470|82912131|FG002|Overall Study|Participant Unavailability|0|||
46697609|NCT01263470|82912132|FG003|Overall Study|Participant Unavailability|0|||
46697610|NCT01263470|82912133|FG004|Overall Study|Participant Unavailability|0|||
46697611|NCT01263470|82912134|FG005|Overall Study|Participant Unavailability|0|||
46697612|NCT01263470|82912129|FG000|Overall Study|Study Drug Non-compliance|0|||
46697613|NCT01263470|82912130|FG001|Overall Study|Study Drug Non-compliance|0|||
46863181|NCT02030067|83079657|FG009|Overall Study|Disease Progression|3|||
46863182|NCT02030067|83079658|FG010|Overall Study|Disease Progression|7|||
46863183|NCT02030067|83079659|FG011|Overall Study|Disease Progression|2|||
46863184|NCT02030067|83079660|FG012|Overall Study|Disease Progression|59|||
46863185|NCT02030067|83079648|FG000|Overall Study|Withdrawal by Subject|0|||
46863186|NCT02030067|83079649|FG001|Overall Study|Withdrawal by Subject|0|||
46863187|NCT02030067|83079650|FG002|Overall Study|Withdrawal by Subject|0|||
46863188|NCT02030067|83079651|FG003|Overall Study|Withdrawal by Subject|1|||
46863189|NCT02030067|83079652|FG004|Overall Study|Withdrawal by Subject|0|||
46863190|NCT02030067|83079653|FG005|Overall Study|Withdrawal by Subject|0|||
46863191|NCT02030067|83079654|FG006|Overall Study|Withdrawal by Subject|0|||
46863192|NCT02030067|83079655|FG007|Overall Study|Withdrawal by Subject|1|||
46863193|NCT02030067|83079656|FG008|Overall Study|Withdrawal by Subject|0|||
46982403|NCT02575807|83228702|FG000|Overall Study|Terminated due to physician decision|0|||
46863194|NCT02030067|83079657|FG009|Overall Study|Withdrawal by Subject|0|||
46863195|NCT02030067|83079658|FG010|Overall Study|Withdrawal by Subject|3|||
46863196|NCT02030067|83079659|FG011|Overall Study|Withdrawal by Subject|0|||
46863197|NCT02030067|83079660|FG012|Overall Study|Withdrawal by Subject|6|||
46863198|NCT02030067|83079648|FG000|Overall Study|Physician Decision|0|||
46863199|NCT02030067|83079649|FG001|Overall Study|Physician Decision|0|||
46863200|NCT02030067|83079650|FG002|Overall Study|Physician Decision|0|||
46863201|NCT02030067|83079651|FG003|Overall Study|Physician Decision|0|||
46863202|NCT02030067|83079652|FG004|Overall Study|Physician Decision|0|||
46863203|NCT02030067|83079653|FG005|Overall Study|Physician Decision|0|||
46863204|NCT02030067|83079654|FG006|Overall Study|Physician Decision|0|||
46863205|NCT02030067|83079655|FG007|Overall Study|Physician Decision|0|||
46863206|NCT02030067|83079656|FG008|Overall Study|Physician Decision|0|||
46863207|NCT02030067|83079657|FG009|Overall Study|Physician Decision|0|||
46863208|NCT02030067|83079658|FG010|Overall Study|Physician Decision|1|||
46863209|NCT02030067|83079659|FG011|Overall Study|Physician Decision|0|||
46697614|NCT01263470|82912131|FG002|Overall Study|Study Drug Non-compliance|0|||
46697615|NCT01263470|82912132|FG003|Overall Study|Study Drug Non-compliance|0|||
46697616|NCT01263470|82912133|FG004|Overall Study|Study Drug Non-compliance|1|||
46863210|NCT02030067|83079660|FG012|Overall Study|Physician Decision|3|||
46863211|NCT02030067|83079648|FG000|Overall Study|other reasons|0|||
46863212|NCT02030067|83079649|FG001|Overall Study|other reasons|0|||
46863213|NCT02030067|83079650|FG002|Overall Study|other reasons|0|||
46863214|NCT02030067|83079651|FG003|Overall Study|other reasons|0|||
46863215|NCT02030067|83079652|FG004|Overall Study|other reasons|0|||
46863216|NCT02030067|83079653|FG005|Overall Study|other reasons|1|||
46863217|NCT02030067|83079654|FG006|Overall Study|other reasons|0|||
46863218|NCT02030067|83079655|FG007|Overall Study|other reasons|0|||
46863219|NCT02030067|83079656|FG008|Overall Study|other reasons|2|||
46863220|NCT02030067|83079657|FG009|Overall Study|other reasons|0|||
46863221|NCT02030067|83079658|FG010|Overall Study|other reasons|0|||
46863222|NCT02030067|83079659|FG011|Overall Study|other reasons|0|||
46863223|NCT02030067|83079660|FG012|Overall Study|other reasons|4|||
46863224|NCT02030067|83079648|FG000|Overall Study|Adverse Event|0|||
46863225|NCT02030067|83079649|FG001|Overall Study|Adverse Event|0|||
46863226|NCT02030067|83079650|FG002|Overall Study|Adverse Event|0|||
46863227|NCT02030067|83079651|FG003|Overall Study|Adverse Event|0|||
46863228|NCT02030067|83079652|FG004|Overall Study|Adverse Event|0|||
46863229|NCT02030067|83079653|FG005|Overall Study|Adverse Event|0|||
46863230|NCT02030067|83079654|FG006|Overall Study|Adverse Event|0|||
46863231|NCT02030067|83079655|FG007|Overall Study|Adverse Event|0|||
46863232|NCT02030067|83079656|FG008|Overall Study|Adverse Event|0|||
46863233|NCT02030067|83079657|FG009|Overall Study|Adverse Event|0|||
46863234|NCT02030067|83079658|FG010|Overall Study|Adverse Event|0|||
46863235|NCT02030067|83079659|FG011|Overall Study|Adverse Event|1|||
46863236|NCT02030067|83079660|FG012|Overall Study|Adverse Event|8|||
46863237|NCT01708941|83079694|FG000|Overall Study|Adverse Event|4|||
46863238|NCT01708941|83079695|FG001|Overall Study|Adverse Event|6|||
46863239|NCT01708941|83079696|FG002|Overall Study|Adverse Event|1|||
46863240|NCT01708941|83079697|FG003|Overall Study|Adverse Event|0|||
46863241|NCT01708941|83079694|FG000|Overall Study|Death|1|||
46863242|NCT01708941|83079695|FG001|Overall Study|Death|1|||
46863243|NCT01708941|83079696|FG002|Overall Study|Death|2|||
46863244|NCT01708941|83079697|FG003|Overall Study|Death|14|||
46863245|NCT01708941|83079694|FG000|Overall Study|Withdrawal by Subject|1|||
46863246|NCT01708941|83079695|FG001|Overall Study|Withdrawal by Subject|0|||
46863247|NCT01708941|83079696|FG002|Overall Study|Withdrawal by Subject|3|||
46863248|NCT01708941|83079697|FG003|Overall Study|Withdrawal by Subject|4|||
46863249|NCT01708941|83079694|FG000|Overall Study|Disease progression|9|||
46863250|NCT01708941|83079695|FG001|Overall Study|Disease progression|10|||
46863251|NCT01708941|83079696|FG002|Overall Study|Disease progression|8|||
46863252|NCT01708941|83079697|FG003|Overall Study|Disease progression|0|||
46863253|NCT01708941|83079694|FG000|Overall Study|Alternative therapy|0|||
46863254|NCT01708941|83079695|FG001|Overall Study|Alternative therapy|0|||
46863255|NCT01708941|83079696|FG002|Overall Study|Alternative therapy|2|||
46863256|NCT01708941|83079697|FG003|Overall Study|Alternative therapy|0|||
46863257|NCT01708941|83079694|FG000|Overall Study|Ineligible and never started treatment|1|||
46863258|NCT01708941|83079695|FG001|Overall Study|Ineligible and never started treatment|0|||
46863259|NCT01708941|83079696|FG002|Overall Study|Ineligible and never started treatment|1|||
46863260|NCT01708941|83079697|FG003|Overall Study|Ineligible and never started treatment|0|||
46863261|NCT01708941|83079694|FG000|Overall Study|Never started treatment|2|||
46863262|NCT01708941|83079695|FG001|Overall Study|Never started treatment|1|||
46863263|NCT01708941|83079696|FG002|Overall Study|Never started treatment|0|||
46863264|NCT01708941|83079697|FG003|Overall Study|Never started treatment|0|||
46863265|NCT01708941|83079694|FG000|Overall Study|Ineligible|0|||
46863266|NCT01708941|83079695|FG001|Overall Study|Ineligible|0|||
46863267|NCT01708941|83079696|FG002|Overall Study|Ineligible|2|||
46863268|NCT01708941|83079697|FG003|Overall Study|Ineligible|0|||
46863269|NCT00234065|83079718|FG000|Overall Study|Adverse Event|268|||
46863270|NCT00234065|83079719|FG001|Overall Study|Adverse Event|166|||
46863271|NCT00234065|83079718|FG000|Overall Study|Withdrawal by Subject|73|||
46863272|NCT00234065|83079719|FG001|Overall Study|Withdrawal by Subject|56|||
46863273|NCT00234065|83079718|FG000|Overall Study|Physician Decision|23|||
46863274|NCT00234065|83079719|FG001|Overall Study|Physician Decision|22|||
46863275|NCT00234065|83079718|FG000|Overall Study|Not Classified|111|||
46863276|NCT00234065|83079719|FG001|Overall Study|Not Classified|112|||
46863277|NCT00233987|83079725|FG000|Overall Study|Withdrawal by Subject|1|||
46863278|NCT00233987|83079725|FG000|Overall Study|Lack of Efficacy|2|||
46863279|NCT00233987|83079725|FG000|Overall Study|Reason Under Review|1|||
46863280|NCT00233987|83079725|FG000|Overall Study|Other - Not Protocol Specified|5|||
46863281|NCT00233987|83079725|FG000|Overall Study|Eligible but No Treatment Received|2|||
46863282|NCT00233987|83079725|FG000|Overall Study|Ineligible|4|||
46863283|NCT04623242|83079734|FG000|Overall Study|Withdrawal by Subject|7|||
46863284|NCT04623242|83079735|FG001|Overall Study|Withdrawal by Subject|12|||
46863285|NCT04623242|83079736|FG002|Overall Study|Withdrawal by Subject|5|||
46863286|NCT04623242|83079737|FG003|Overall Study|Withdrawal by Subject|7|||
46863287|NCT04623242|83079738|FG004|Overall Study|Withdrawal by Subject|0|||
46863288|NCT04623242|83079734|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
46863289|NCT04623242|83079735|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
46863290|NCT04623242|83079736|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
46863291|NCT04623242|83079737|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
46863292|NCT04623242|83079738|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
46863293|NCT04623242|83079734|FG000|Overall Study|Subject unblinded to mutation status|0|||
46863294|NCT04623242|83079735|FG001|Overall Study|Subject unblinded to mutation status|0|||
46863295|NCT04623242|83079736|FG002|Overall Study|Subject unblinded to mutation status|0|||
46863296|NCT04623242|83079737|FG003|Overall Study|Subject unblinded to mutation status|13|||
46863297|NCT04623242|83079738|FG004|Overall Study|Subject unblinded to mutation status|0|||
46863298|NCT00233363|83079755|FG000|Overall Study|Adverse Event|1|||
46863299|NCT00233363|83079756|FG001|Overall Study|Adverse Event|2|||
46863300|NCT00233363|83079755|FG000|Overall Study|Lack of Efficacy|0|||
46863301|NCT00233363|83079756|FG001|Overall Study|Lack of Efficacy|2|||
46863302|NCT00233363|83079755|FG000|Overall Study|Withdrawal by Subject|1|||
46863303|NCT00233363|83079756|FG001|Overall Study|Withdrawal by Subject|1|||
46863304|NCT00233363|83079755|FG000|Overall Study|Aggravation of complication|1|||
46863305|NCT00233363|83079756|FG001|Overall Study|Aggravation of complication|0|||
46863306|NCT01147666|83079777|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
46863307|NCT01147666|83079778|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
46863308|NCT01147666|83079779|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
46863309|NCT01147666|83079780|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863310|NCT01147666|83079781|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863311|NCT01147666|83079782|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863312|NCT01147666|83079783|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863313|NCT01147666|83079784|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863314|NCT01147666|83079785|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863315|NCT01147666|83079786|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863316|NCT01147666|83079787|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863317|NCT01147666|83079788|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863318|NCT01147666|83079789|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
46863319|NCT01147666|83079790|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863320|NCT01147666|83079791|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
46863321|NCT01147666|83079777|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
46863322|NCT01147666|83079778|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
46863323|NCT01147666|83079779|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
46863324|NCT01147666|83079780|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
46863325|NCT01147666|83079781|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
46863326|NCT01147666|83079782|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
46863327|NCT01147666|83079783|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
46863328|NCT01147666|83079784|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
46863329|NCT01147666|83079785|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
46863330|NCT01147666|83079786|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
46863331|NCT01147666|83079787|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
46863332|NCT01147666|83079788|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
46863333|NCT01147666|83079789|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
46863334|NCT01147666|83079790|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
46863335|NCT01147666|83079791|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
46863336|NCT01147666|83079777|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
46863337|NCT01147666|83079778|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
46863338|NCT01147666|83079779|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
46863339|NCT01147666|83079780|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
46863340|NCT01147666|83079781|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
46863341|NCT01147666|83079782|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
46863342|NCT01147666|83079783|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
46863343|NCT01147666|83079784|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
46863344|NCT01147666|83079785|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
46863345|NCT01147666|83079786|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
46863346|NCT01147666|83079787|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
46863347|NCT01147666|83079788|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
46863348|NCT01147666|83079789|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
46863349|NCT01147666|83079790|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
46863350|NCT01147666|83079791|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
46863351|NCT01147666|83079777|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
46863352|NCT01147666|83079778|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863353|NCT01147666|83079779|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863354|NCT01147666|83079780|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
46863355|NCT01147666|83079781|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863356|NCT01147666|83079782|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863357|NCT01147666|83079783|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863358|NCT01147666|83079784|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863359|NCT01147666|83079785|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863360|NCT01147666|83079786|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863361|NCT01147666|83079787|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
46863362|NCT01147666|83079788|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863363|NCT01147666|83079789|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863364|NCT01147666|83079790|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863365|NCT01147666|83079791|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
46863366|NCT01147666|83079777|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863367|NCT01147666|83079778|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863368|NCT01147666|83079779|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863369|NCT01147666|83079780|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863370|NCT01147666|83079781|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
46863371|NCT01147666|83079782|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
46863372|NCT01147666|83079783|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863373|NCT01147666|83079784|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
46863374|NCT01147666|83079785|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863375|NCT01147666|83079786|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
46863376|NCT01147666|83079787|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863377|NCT01147666|83079788|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
46863378|NCT01147666|83079789|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863379|NCT01147666|83079790|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
46863380|NCT01147666|83079791|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
46863381|NCT01147666|83079777|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863382|NCT01147666|83079778|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863383|NCT01147666|83079779|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863384|NCT01147666|83079780|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
46863385|NCT01147666|83079781|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863386|NCT01147666|83079782|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863387|NCT01147666|83079783|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863388|NCT01147666|83079784|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863389|NCT01147666|83079785|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863390|NCT01147666|83079786|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863391|NCT01147666|83079787|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
46863392|NCT01147666|83079788|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46697617|NCT01263470|82912134|FG005|Overall Study|Study Drug Non-compliance|0|||
46863393|NCT01147666|83079789|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863394|NCT01147666|83079790|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46697618|NCT01262456|82912151|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
46697619|NCT01262456|82912152|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
46802446|NCT00490971|83021821|FG002|Maintenance|Lost to Follow-up|5|||
46802447|NCT00490971|83021822|FG003|Maintenance|Lost to Follow-up|8|||
46802448|NCT00490971|83021823|FG004|Maintenance|Lost to Follow-up|10|||
46802449|NCT00490971|83021819|FG000|Maintenance|Pregnancy|0|||
46802450|NCT00490971|83021820|FG001|Maintenance|Pregnancy|0|||
46802451|NCT00490971|83021821|FG002|Maintenance|Pregnancy|1|||
46802452|NCT00490971|83021822|FG003|Maintenance|Pregnancy|0|||
46802453|NCT00490971|83021823|FG004|Maintenance|Pregnancy|0|||
46802454|NCT00490971|83021819|FG000|Maintenance|Protocol Violation|0|||
46802455|NCT00490971|83021820|FG001|Maintenance|Protocol Violation|0|||
46802456|NCT00490971|83021821|FG002|Maintenance|Protocol Violation|4|||
46802457|NCT00490971|83021822|FG003|Maintenance|Protocol Violation|1|||
46802458|NCT00490971|83021823|FG004|Maintenance|Protocol Violation|1|||
46802459|NCT00490971|83021819|FG000|Maintenance|Withdrawal by Subject|0|||
46802460|NCT00490971|83021820|FG001|Maintenance|Withdrawal by Subject|0|||
46802461|NCT00490971|83021821|FG002|Maintenance|Withdrawal by Subject|26|||
46863395|NCT01147666|83079791|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
46863396|NCT01147666|83079777|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863397|NCT01147666|83079778|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863398|NCT01147666|83079779|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863399|NCT01147666|83079780|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863400|NCT01147666|83079781|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46697620|NCT01262456|82912153|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
46697621|NCT01262456|82912151|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
46697622|NCT01262456|82912152|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
46697623|NCT01262456|82912153|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
46697624|NCT01262456|82912151|FG000|3-Month Double-Blind Period|Adverse Event|6|||
46697625|NCT01262456|82912152|FG001|3-Month Double-Blind Period|Adverse Event|4|||
46697626|NCT01262456|82912153|FG002|3-Month Double-Blind Period|Adverse Event|8|||
46697627|NCT01262456|82912151|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
46697628|NCT01262456|82912152|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
46697629|NCT01262456|82912153|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
46863401|NCT01147666|83079782|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863402|NCT01147666|83079783|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863403|NCT01147666|83079784|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863404|NCT01147666|83079785|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863405|NCT01147666|83079786|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863406|NCT01147666|83079787|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863407|NCT01147666|83079788|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
46863408|NCT01147666|83079789|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
46863409|NCT01147666|83079790|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
46863410|NCT01147666|83079791|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
46863411|NCT01147666|83079777|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
46863412|NCT01147666|83079778|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
46863413|NCT01147666|83079779|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
46863414|NCT01147666|83079780|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
46863415|NCT01147666|83079781|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
46863416|NCT01147666|83079782|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
46863417|NCT01147666|83079783|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
46863418|NCT01147666|83079784|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
46863419|NCT01147666|83079785|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
46863420|NCT01147666|83079786|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
46863421|NCT01147666|83079787|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
46863422|NCT01147666|83079788|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
46863423|NCT01147666|83079789|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
46863424|NCT01147666|83079790|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
46863425|NCT01147666|83079791|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
46863426|NCT01147666|83079777|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863427|NCT01147666|83079778|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863428|NCT01147666|83079779|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863429|NCT01147666|83079780|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863430|NCT01147666|83079781|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
46863431|NCT01147666|83079782|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
46863432|NCT01147666|83079783|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
46863433|NCT01147666|83079784|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
46863434|NCT01147666|83079785|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863435|NCT01147666|83079786|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
46863436|NCT01147666|83079787|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863437|NCT01147666|83079788|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863438|NCT01147666|83079789|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
46863439|NCT01147666|83079790|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
46863440|NCT01147666|83079791|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
46863441|NCT01147666|83079777|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863442|NCT01147666|83079778|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863443|NCT01147666|83079779|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863444|NCT01147666|83079780|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
46863445|NCT01147666|83079781|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863446|NCT01147666|83079782|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863447|NCT01147666|83079783|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863448|NCT01147666|83079784|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863449|NCT01147666|83079785|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863450|NCT01147666|83079786|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46697630|NCT01262456|82912151|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
46863451|NCT01147666|83079787|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863452|NCT01147666|83079788|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46697631|NCT01262456|82912152|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
46697632|NCT01262456|82912153|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
46697633|NCT01262456|82912151|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
46697634|NCT01262456|82912152|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
46697635|NCT01262456|82912153|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
46863453|NCT01147666|83079789|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863454|NCT01147666|83079790|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863455|NCT01147666|83079791|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
46863456|NCT01147666|83079777|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863457|NCT01147666|83079778|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863458|NCT01147666|83079779|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863459|NCT01147666|83079780|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863460|NCT01147666|83079781|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
46863461|NCT01147666|83079782|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
46863462|NCT01147666|83079783|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863463|NCT01147666|83079784|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
46863464|NCT01147666|83079785|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863465|NCT01147666|83079786|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
46863466|NCT01147666|83079787|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863467|NCT01147666|83079788|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863468|NCT01147666|83079789|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863469|NCT01147666|83079790|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
46863470|NCT01147666|83079791|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
46863471|NCT01147666|83079777|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863472|NCT01147666|83079778|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863473|NCT01147666|83079779|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863474|NCT01147666|83079780|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
46863475|NCT01147666|83079781|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863476|NCT01147666|83079782|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863477|NCT01147666|83079783|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46697636|NCT01262456|82912151|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
46707548|NCT01176240|82923135|FG000|Study 306A|Protocol Violation|0|||
46802462|NCT00490971|83021822|FG003|Maintenance|Withdrawal by Subject|28|||
46802463|NCT00490971|83021823|FG004|Maintenance|Withdrawal by Subject|18|||
46802464|NCT00490971|83021819|FG000|Maintenance|Other|0|||
46802465|NCT00490971|83021820|FG001|Maintenance|Other|0|||
46802466|NCT00490971|83021821|FG002|Maintenance|Other|11|||
46802467|NCT00490971|83021822|FG003|Maintenance|Other|9|||
46802468|NCT00490971|83021823|FG004|Maintenance|Other|3|||
46802469|NCT00686075|83021845|FG000|Overall Study|Withdrawal by Subject|4|||
46802470|NCT00686075|83021846|FG001|Overall Study|Withdrawal by Subject|3|||
46707549|NCT01176240|82923136|FG001|Study 306A|Protocol Violation|1|||
46707550|NCT01176240|82923135|FG000|Study 306A|Withdrawal by Subject|0|||
46707551|NCT01176240|82923136|FG001|Study 306A|Withdrawal by Subject|1|||
46707552|NCT01176240|82923135|FG000|Study 306A|Stop due to diverse problems|1|||
46802471|NCT00686075|83021847|FG002|Overall Study|Withdrawal by Subject|3|||
46802472|NCT00686075|83021848|FG003|Overall Study|Withdrawal by Subject|7|||
46802473|NCT00686075|83021849|FG004|Overall Study|Withdrawal by Subject|1|||
46802474|NCT00686075|83021850|FG005|Overall Study|Withdrawal by Subject|0|||
46802475|NCT00686075|83021851|FG006|Overall Study|Withdrawal by Subject|0|||
46802476|NCT00686075|83021852|FG007|Overall Study|Withdrawal by Subject|2|||
46802477|NCT00686075|83021853|FG008|Overall Study|Withdrawal by Subject|4|||
46802478|NCT00686075|83021854|FG009|Overall Study|Withdrawal by Subject|6|||
46802479|NCT00686075|83021845|FG000|Overall Study|Lost to Follow-up|3|||
46802480|NCT00686075|83021846|FG001|Overall Study|Lost to Follow-up|6|||
46697637|NCT01262456|82912152|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
46697638|NCT01262456|82912153|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
46697639|NCT01262456|82912151|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
46697640|NCT01262456|82912152|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
46697641|NCT01262456|82912153|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
46697642|NCT01262456|82912151|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
46697643|NCT01262456|82912152|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
46697644|NCT01262456|82912153|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
46697645|NCT00932893|82912171|FG000|Overall Study|Death|115|||
46697646|NCT00932893|82912172|FG001|Overall Study|Death|24|||
46697647|NCT00932893|82912171|FG000|Overall Study|Lost to Follow-up|8|||
46697648|NCT00932893|82912172|FG001|Overall Study|Lost to Follow-up|0|||
46697649|NCT00932893|82912171|FG000|Overall Study|Withdrawal by Subject|5|||
46697650|NCT00932893|82912172|FG001|Overall Study|Withdrawal by Subject|2|||
46697651|NCT00932893|82912171|FG000|Overall Study|Other|5|||
46697652|NCT00932893|82912172|FG001|Overall Study|Other|144|||
46697653|NCT01260896|82912181|FG000|First Intervention|Withdrawn Due to Emesis|2|||
46697654|NCT01260896|82912182|FG001|First Intervention|Withdrawn Due to Emesis|0|||
46697655|NCT00932737|82912190|FG000|Overall Study|Not treated in second episode|1|||
46697656|NCT00932737|82912191|FG001|Overall Study|Not treated in second episode|0|||
46697657|NCT00932737|82912190|FG000|Overall Study|Adverse Event|0|||
46697658|NCT00932737|82912191|FG001|Overall Study|Adverse Event|1|||
46697659|NCT00939523|82912197|FG000|Overall Study|Lack of Efficacy|1|||
46697660|NCT00939523|82912197|FG000|Overall Study|Physician Decision|2|||
46697661|NCT01260584|82912205|FG000|Period 1|Protocol Violation|0|||
46697662|NCT01260584|82912206|FG001|Period 1|Protocol Violation|0|||
46697663|NCT01260584|82912207|FG002|Period 1|Protocol Violation|1|||
46697664|NCT01260584|82912208|FG003|Period 1|Protocol Violation|1|||
46697665|NCT01260584|82912205|FG000|Period 1|Adverse Event|0|||
46697666|NCT01260584|82912206|FG001|Period 1|Adverse Event|0|||
46697667|NCT01260584|82912207|FG002|Period 1|Adverse Event|1|||
46697668|NCT01260584|82912208|FG003|Period 1|Adverse Event|0|||
46697669|NCT01260584|82912205|FG000|Period 2|Protocol Violation|0|||
46697670|NCT01260584|82912206|FG001|Period 2|Protocol Violation|2|||
46697671|NCT01260584|82912207|FG002|Period 2|Protocol Violation|3|||
46697672|NCT01260584|82912208|FG003|Period 2|Protocol Violation|1|||
46863478|NCT01147666|83079784|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863479|NCT01147666|83079785|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863480|NCT01147666|83079786|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863481|NCT01147666|83079787|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
46863482|NCT01147666|83079788|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863483|NCT01147666|83079789|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863484|NCT01147666|83079790|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863485|NCT01147666|83079791|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
46863486|NCT01147666|83079777|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863487|NCT01147666|83079778|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863488|NCT01147666|83079779|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863489|NCT01147666|83079780|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46982404|NCT02575807|83228703|FG001|Overall Study|Terminated due to physician decision|0|||
46982405|NCT02575807|83228704|FG002|Overall Study|Terminated due to physician decision|1|||
46982406|NCT02575807|83228705|FG003|Overall Study|Terminated due to physician decision|0|||
46982407|NCT02575807|83228706|FG004|Overall Study|Terminated due to physician decision|0|||
46982408|NCT02575807|83228702|FG000|Overall Study|Subject ineligible - medical implant|0|||
46697673|NCT01260584|82912205|FG000|Period 2|Adverse Event|1|||
46697674|NCT01260584|82912206|FG001|Period 2|Adverse Event|0|||
46697675|NCT01260584|82912207|FG002|Period 2|Adverse Event|2|||
46697676|NCT01260584|82912208|FG003|Period 2|Adverse Event|0|||
46697677|NCT01260584|82912205|FG000|Period 2|Withdrawal by Subject|0|||
46697678|NCT01260584|82912206|FG001|Period 2|Withdrawal by Subject|1|||
46697679|NCT01260584|82912207|FG002|Period 2|Withdrawal by Subject|0|||
46697680|NCT01260584|82912208|FG003|Period 2|Withdrawal by Subject|0|||
46697681|NCT00927589|82912218|FG000|Overall Study|Death|1|||
46697682|NCT00927589|82912218|FG000|Overall Study|Physician Decision|1|||
46697683|NCT00927589|82912218|FG000|Overall Study|Withdrawal by Subject|3|||
46802481|NCT00686075|83021847|FG002|Overall Study|Lost to Follow-up|3|||
46802482|NCT00686075|83021848|FG003|Overall Study|Lost to Follow-up|2|||
46802483|NCT00686075|83021849|FG004|Overall Study|Lost to Follow-up|3|||
46802484|NCT00686075|83021850|FG005|Overall Study|Lost to Follow-up|3|||
46802485|NCT00686075|83021851|FG006|Overall Study|Lost to Follow-up|0|||
46802486|NCT00686075|83021852|FG007|Overall Study|Lost to Follow-up|0|||
46802487|NCT00686075|83021853|FG008|Overall Study|Lost to Follow-up|2|||
46802488|NCT00686075|83021854|FG009|Overall Study|Lost to Follow-up|3|||
46802489|NCT00686075|83021845|FG000|Overall Study|Other|1|||
46802490|NCT00686075|83021846|FG001|Overall Study|Other|1|||
46802491|NCT00686075|83021847|FG002|Overall Study|Other|0|||
46802492|NCT00686075|83021848|FG003|Overall Study|Other|0|||
46802493|NCT00686075|83021849|FG004|Overall Study|Other|0|||
46802494|NCT00686075|83021850|FG005|Overall Study|Other|0|||
46802495|NCT00686075|83021851|FG006|Overall Study|Other|0|||
46802496|NCT00686075|83021852|FG007|Overall Study|Other|0|||
46802497|NCT00686075|83021853|FG008|Overall Study|Other|0|||
46802498|NCT00686075|83021854|FG009|Overall Study|Other|1|||
46802499|NCT00685763|83021876|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
46802500|NCT00685763|83021876|FG000|Overall Study|Protocol Violation|1|||
46802501|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Adverse Event|14|||
46697684|NCT00927589|82912218|FG000|Overall Study|Adverse Event|2|||
46802502|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Adverse Event|27|||
46863490|NCT01147666|83079781|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863491|NCT01147666|83079782|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863492|NCT01147666|83079783|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863493|NCT01147666|83079784|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863494|NCT01147666|83079785|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863495|NCT01147666|83079786|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863496|NCT01147666|83079787|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863497|NCT01147666|83079788|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863498|NCT01147666|83079789|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
46863499|NCT01147666|83079790|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863500|NCT01147666|83079791|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
46863501|NCT01147666|83079777|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863502|NCT01147666|83079778|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863503|NCT01147666|83079779|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863504|NCT01147666|83079780|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863505|NCT01147666|83079781|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863506|NCT01147666|83079782|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863507|NCT01147666|83079783|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863508|NCT01147666|83079784|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863509|NCT01147666|83079785|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863510|NCT01147666|83079786|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863511|NCT01147666|83079787|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863512|NCT01147666|83079788|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863513|NCT01147666|83079789|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
46863514|NCT01147666|83079790|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
46863515|NCT01147666|83079791|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
46863516|NCT00256295|83079853|FG000|Overall Study|Withdrawal by Subject|3|||
46863517|NCT00256295|83079853|FG000|Overall Study|Death|1|||
46863518|NCT02877004|83079860|FG000|Overall Study|Pregnancy|0|||
46863519|NCT02877004|83079861|FG001|Overall Study|Pregnancy|0|||
46863520|NCT02877004|83079862|FG002|Overall Study|Pregnancy|1|||
46863521|NCT04617860|83079892|FG000|Overall Study|Adverse Event|0|||
46863522|NCT04617860|83079893|FG001|Overall Study|Adverse Event|2|||
46863523|NCT04617860|83079894|FG002|Overall Study|Adverse Event|2|||
46863524|NCT04617860|83079892|FG000|Overall Study|Withdrawal by Subject|0|||
46863525|NCT04617860|83079893|FG001|Overall Study|Withdrawal by Subject|0|||
46863526|NCT04617860|83079894|FG002|Overall Study|Withdrawal by Subject|2|||
46863527|NCT04617860|83079892|FG000|Overall Study|Physician Decision|0|||
46863528|NCT04617860|83079893|FG001|Overall Study|Physician Decision|1|||
46863529|NCT04617860|83079894|FG002|Overall Study|Physician Decision|0|||
46863530|NCT04617860|83079892|FG000|Overall Study|Sponsor Decision|0|||
46863531|NCT04617860|83079893|FG001|Overall Study|Sponsor Decision|3|||
46863532|NCT04617860|83079894|FG002|Overall Study|Sponsor Decision|1|||
46863533|NCT04617860|83079892|FG000|Overall Study|Termination of Study by Sponsor|8|||
46863534|NCT04617860|83079893|FG001|Overall Study|Termination of Study by Sponsor|4|||
46863535|NCT04617860|83079894|FG002|Overall Study|Termination of Study by Sponsor|13|||
46863536|NCT04608500|83079906|FG000|Overall Study|Adverse Event|2|||
46863537|NCT04608500|83079907|FG001|Overall Study|Adverse Event|0|||
46863538|NCT04608500|83079906|FG000|Overall Study|Lost to Follow-up|15|||
46863539|NCT04608500|83079907|FG001|Overall Study|Lost to Follow-up|9|||
46863540|NCT04608500|83079906|FG000|Overall Study|Participant request|11|||
46863541|NCT04608500|83079907|FG001|Overall Study|Participant request|7|||
46863542|NCT04608500|83079906|FG000|Overall Study|Protocol Violation|1|||
46863543|NCT04608500|83079907|FG001|Overall Study|Protocol Violation|0|||
46863544|NCT04608500|83079906|FG000|Overall Study|Other|6|||
46863545|NCT04608500|83079907|FG001|Overall Study|Other|2|||
46863546|NCT04585646|83079913|FG000|First Intervention|Physician Decision|1|||
46863547|NCT04585646|83079914|FG001|First Intervention|Physician Decision|0|||
46863548|NCT04585646|83079913|FG000|First Intervention|Lost to Follow-up|0|||
46982409|NCT02575807|83228703|FG001|Overall Study|Subject ineligible - medical implant|0|||
46863549|NCT04585646|83079914|FG001|First Intervention|Lost to Follow-up|3|||
46863550|NCT04585646|83079913|FG000|First Intervention|Withdrawal by Subject|0|||
46863551|NCT04585646|83079914|FG001|First Intervention|Withdrawal by Subject|1|||
46863552|NCT04584788|83079930|FG000|Overall Study|Physician Decision|8|||
46863553|NCT04584788|83079930|FG000|Overall Study|Withdrawal by Subject|1|||
46863554|NCT04584788|83079930|FG000|Overall Study|Adverse Event|3|||
46982410|NCT02575807|83228704|FG002|Overall Study|Subject ineligible - medical implant|0|||
46863555|NCT04575038|83079936|FG000|Overall Study|Withdrawal by Subject|1|||
46863556|NCT04575038|83079937|FG001|Overall Study|Withdrawal by Subject|1|||
46863557|NCT03066622|83079945|FG000|Overall Study|Lost to Follow-up|24|||
46863558|NCT03066622|83079946|FG001|Overall Study|Lost to Follow-up|25|||
46863559|NCT03066622|83079945|FG000|Overall Study|Withdrawal by Subject|2|||
46863560|NCT03066622|83079946|FG001|Overall Study|Withdrawal by Subject|1|||
46863561|NCT04501952|83079978|FG000|Overall Study|Adverse Event|0|||
46863562|NCT04501952|83079979|FG001|Overall Study|Adverse Event|3|||
46863563|NCT04501952|83079978|FG000|Overall Study|Investigator's Discretion|0|||
46697685|NCT00927589|82912218|FG000|Overall Study|Disease Progression|8|||
46697686|NCT00927589|82912218|FG000|Overall Study|Non-compliance|1|||
46697687|NCT00932425|82912224|FG000|Overall Study|Lost to Follow-up|0|||
46697688|NCT00932425|82912225|FG001|Overall Study|Lost to Follow-up|1|||
46697689|NCT00932425|82912224|FG000|Overall Study|Withdrawal by Subject|0|||
46697690|NCT00932425|82912225|FG001|Overall Study|Withdrawal by Subject|1|||
46697691|NCT05867342|82912231|FG000|Overall Study|Investigator Decision|3|||
46697692|NCT05867342|82912232|FG001|Overall Study|Investigator Decision|3|||
46697693|NCT04340362|82912267|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
46697694|NCT03980808|82912289|FG000|Overall Study|Lost to Follow-up|2|||
46697695|NCT03980808|82912290|FG001|Overall Study|Lost to Follow-up|2|||
46697696|NCT03943953|82912307|FG000|Trial of ITG 1|Lost to Follow-up|19|||
46863564|NCT04501952|83079979|FG001|Overall Study|Investigator's Discretion|1|||
46982411|NCT02575807|83228705|FG003|Overall Study|Subject ineligible - medical implant|1|||
46697697|NCT03943953|82912308|FG001|Trial of ITG 1|Lost to Follow-up|1|||
46697698|NCT03943953|82912307|FG000|Trial of ITG 2|Lost to Follow-up|8|||
46697699|NCT03943953|82912308|FG001|Trial of ITG 2|Lost to Follow-up|0|||
46697700|NCT03943953|82912307|FG000|Trial of ITG 3|Lost to Follow-up|2|||
46982412|NCT02575807|83228706|FG004|Overall Study|Subject ineligible - medical implant|0|||
46982413|NCT02575807|83228702|FG000|Overall Study|Withdrawal by Subject|0|||
46982414|NCT02575807|83228703|FG001|Overall Study|Withdrawal by Subject|0|||
46982415|NCT02575807|83228704|FG002|Overall Study|Withdrawal by Subject|1|||
46982416|NCT02575807|83228705|FG003|Overall Study|Withdrawal by Subject|1|||
46982417|NCT02575807|83228706|FG004|Overall Study|Withdrawal by Subject|2|||
46982418|NCT02575339|83228732|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
46982419|NCT02575339|83228733|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
46982420|NCT02575339|83228734|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
46982421|NCT02575339|83228732|FG000|Study Treatment|Disease Progression|5|||
46982422|NCT02575339|83228733|FG001|Study Treatment|Disease Progression|2|||
46982423|NCT02575339|83228734|FG002|Study Treatment|Disease Progression|0|||
46982424|NCT02575339|83228732|FG000|Study Treatment|Adverse Event|1|||
46982425|NCT02575339|83228733|FG001|Study Treatment|Adverse Event|2|||
46982426|NCT02575339|83228734|FG002|Study Treatment|Adverse Event|0|||
46982427|NCT02575339|83228732|FG000|Follow up|Death|6|||
46982428|NCT02575339|83228733|FG001|Follow up|Death|2|||
46982429|NCT02575339|83228734|FG002|Follow up|Death|0|||
46982430|NCT02575339|83228732|FG000|Follow up|Study Terminated|0|||
46982431|NCT02575339|83228733|FG001|Follow up|Study Terminated|2|||
46982432|NCT02575339|83228734|FG002|Follow up|Study Terminated|0|||
46982433|NCT02575339|83228732|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
46697701|NCT03943953|82912308|FG001|Trial of ITG 3|Lost to Follow-up|0|||
46697702|NCT03943953|82912307|FG000|Trial of ITG 4|Lost to Follow-up|2|||
46697703|NCT03943953|82912308|FG001|Trial of ITG 4|Lost to Follow-up|0|||
46697704|NCT03670628|82912318|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
46697705|NCT03670628|82912319|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
46697706|NCT03670628|82912318|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
46697707|NCT03670628|82912319|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
46863565|NCT04501952|83079978|FG000|Overall Study|Protocol Violation|1|||
46863566|NCT04501952|83079979|FG001|Overall Study|Protocol Violation|1|||
46863567|NCT04501952|83079978|FG000|Overall Study|Withdrew Consent|5|||
46697708|NCT03637764|82912329|FG000|Overall Study|Adverse Event|2|||
46863568|NCT04501952|83079979|FG001|Overall Study|Withdrew Consent|4|||
46697709|NCT03637764|82912330|FG001|Overall Study|Adverse Event|0|||
46697710|NCT03637764|82912331|FG002|Overall Study|Adverse Event|0|||
46697711|NCT03637764|82912332|FG003|Overall Study|Adverse Event|1|||
46697712|NCT03637764|82912329|FG000|Overall Study|Progressive Disease|23|||
46697713|NCT03637764|82912330|FG001|Overall Study|Progressive Disease|23|||
46697714|NCT03637764|82912331|FG002|Overall Study|Progressive Disease|18|||
46697715|NCT03637764|82912332|FG003|Overall Study|Progressive Disease|31|||
46697716|NCT03637764|82912329|FG000|Overall Study|Withdrawal by Subject|1|||
46697717|NCT03637764|82912330|FG001|Overall Study|Withdrawal by Subject|3|||
46697718|NCT03637764|82912331|FG002|Overall Study|Withdrawal by Subject|0|||
46697719|NCT03637764|82912332|FG003|Overall Study|Withdrawal by Subject|1|||
46697720|NCT05060003|82912381|FG000|Overall Study|ctDNA negative|7|||
46863569|NCT04501952|83079978|FG000|Overall Study|Lost to Follow-up|7|||
46863570|NCT04501952|83079979|FG001|Overall Study|Lost to Follow-up|2|||
46863571|NCT04501952|83079978|FG000|Overall Study|Randomized and Never Treated|13|||
46863572|NCT04501952|83079979|FG001|Overall Study|Randomized and Never Treated|9|||
46863573|NCT02930122|83079997|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
46863574|NCT02930122|83079998|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
46863575|NCT03697460|83080005|FG000|Overall Study|Withdrawal by Subject|3|||
46863576|NCT00070018|83080009|FG000|Overall Study|Adverse Event|2|||
46863577|NCT00070018|83080009|FG000|Overall Study|Lack of Efficacy|1|||
46863578|NCT00070018|83080009|FG000|Overall Study|Withdrawal by Subject|1|||
46863579|NCT00231413|83080020|FG000|Overall Study|Non-serious AE|0|||
46863580|NCT00231413|83080021|FG001|Overall Study|Non-serious AE|0|||
46863581|NCT00231413|83080022|FG002|Overall Study|Non-serious AE|1|||
46863582|NCT00231413|83080023|FG003|Overall Study|Non-serious AE|0|||
46863583|NCT00231413|83080024|FG004|Overall Study|Non-serious AE|0|||
46863584|NCT00231413|83080025|FG005|Overall Study|Non-serious AE|0|||
46697721|NCT04906616|82912405|FG000|Overall Study|Divorce|3|||
46697722|NCT04906616|82912406|FG001|Overall Study|Divorce|2|||
46697723|NCT04880733|82912416|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
46863585|NCT00231413|83080026|FG006|Overall Study|Non-serious AE|1|||
46863586|NCT00231413|83080020|FG000|Overall Study|Withdrawal by Subject|3|||
46863587|NCT00231413|83080021|FG001|Overall Study|Withdrawal by Subject|1|||
46863588|NCT00231413|83080022|FG002|Overall Study|Withdrawal by Subject|4|||
46863589|NCT00231413|83080023|FG003|Overall Study|Withdrawal by Subject|2|||
46863590|NCT00231413|83080024|FG004|Overall Study|Withdrawal by Subject|2|||
46863591|NCT00231413|83080025|FG005|Overall Study|Withdrawal by Subject|0|||
46863592|NCT00231413|83080026|FG006|Overall Study|Withdrawal by Subject|3|||
46697724|NCT04880733|82912417|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
46697725|NCT04880733|82912418|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
46697726|NCT04880733|82912416|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
46697727|NCT04880733|82912417|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
46863593|NCT00231413|83080020|FG000|Overall Study|Migrated/moved from study area|0|||
46863594|NCT00231413|83080021|FG001|Overall Study|Migrated/moved from study area|0|||
46863595|NCT00231413|83080022|FG002|Overall Study|Migrated/moved from study area|1|||
46863596|NCT00231413|83080023|FG003|Overall Study|Migrated/moved from study area|0|||
46863597|NCT00231413|83080024|FG004|Overall Study|Migrated/moved from study area|0|||
46697728|NCT04880733|82912418|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
46697729|NCT04880733|82912416|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
46697730|NCT04880733|82912417|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
46697731|NCT04880733|82912418|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
46697732|NCT04880733|82912416|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
46697733|NCT04880733|82912417|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
46697734|NCT04880733|82912418|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
46697735|NCT04880733|82912416|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
46697736|NCT04880733|82912417|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
46697737|NCT04880733|82912418|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
46697738|NCT04862143|82912453|FG000|Overall Study|Adverse Event|1|||
46697739|NCT04862143|82912453|FG000|Overall Study|Study terminated by sponsor|1|||
46697740|NCT04342390|82912501|FG000|Overall Study|Lost to Follow-up|3|||
46697741|NCT04342390|82912502|FG001|Overall Study|Lost to Follow-up|0|||
46697742|NCT04271280|82912508|FG000|Overall Study|Lost to Follow-up|300|||
46697743|NCT04271280|82912508|FG000|Overall Study|Death|153|||
46697744|NCT04271280|82912508|FG000|Overall Study|Withdrawal of consent by patient|59|||
46697745|NCT04271280|82912508|FG000|Overall Study|Other|51|||
46697746|NCT04271280|82912508|FG000|Overall Study|No end of study information|42|||
46697747|NCT04195906|82912532|FG000|Part 1|Adverse Event|3|||
46697748|NCT04195906|82912533|FG001|Part 1|Adverse Event|7|||
46697749|NCT04195906|82912532|FG000|Part 1|Withdrawal by Subject|0|||
46697750|NCT04195906|82912533|FG001|Part 1|Withdrawal by Subject|1|||
46697751|NCT04195906|82912532|FG000|Part 2|Adverse Event|1|||
46697752|NCT04195906|82912533|FG001|Part 2|Adverse Event|1|||
46697753|NCT04195906|82912532|FG000|Part 2|Withdrawal by Subject|0|||
46697754|NCT04195906|82912533|FG001|Part 2|Withdrawal by Subject|3|||
46697755|NCT04195906|82912532|FG000|Part 2|Other|1|||
46697756|NCT04195906|82912533|FG001|Part 2|Other|3|||
46697757|NCT03345784|82912587|FG000|Overall Study|Withdrawal by Subject|2|||
46697758|NCT03345784|82912588|FG001|Overall Study|Withdrawal by Subject|1|||
46697759|NCT03313180|82912594|FG000|Overall Study|Adverse Event|120|||
46697760|NCT03313180|82912594|FG000|Overall Study|Lost to Follow-up|3|||
46697761|NCT03313180|82912594|FG000|Overall Study|Withdrawal by Subject|39|||
46697762|NCT03313180|82912594|FG000|Overall Study|Other than listed above|15|||
46697763|NCT03313180|82912594|FG000|Overall Study|Covid-19 related|2|||
46697764|NCT03275285|82912600|FG000|Overall Study|Ongoing|45|||
46697765|NCT03275285|82912601|FG001|Overall Study|Ongoing|69|||
46697766|NCT03256344|82912615|FG000|Overall Study|Death|6|||
46697767|NCT03256344|82912616|FG001|Overall Study|Death|22|||
46697768|NCT03256344|82912615|FG000|Overall Study|Withdrawal by Subject|3|||
46697769|NCT03256344|82912616|FG001|Overall Study|Withdrawal by Subject|3|||
46697770|NCT03256344|82912615|FG000|Overall Study|Sponsor Decision|1|||
46697771|NCT03256344|82912616|FG001|Overall Study|Sponsor Decision|0|||
46697772|NCT03052608|82912624|FG000|Treatment Phase|Adverse Event|10|||
46697773|NCT03052608|82912625|FG001|Treatment Phase|Adverse Event|12|||
46697774|NCT03052608|82912624|FG000|Treatment Phase|Death|6|||
46697775|NCT03052608|82912625|FG001|Treatment Phase|Death|4|||
46697776|NCT03052608|82912624|FG000|Treatment Phase|Withdrawal by Subject|4|||
46697777|NCT03052608|82912625|FG001|Treatment Phase|Withdrawal by Subject|12|||
46697778|NCT03052608|82912624|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
46697779|NCT03052608|82912625|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
46697780|NCT03052608|82912624|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
46697781|NCT03052608|82912625|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
46697782|NCT03052608|82912624|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
46697783|NCT03052608|82912625|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
46697784|NCT03052608|82912624|FG000|Treatment Phase|Ongoing|103|||
46697785|NCT03052608|82912625|FG001|Treatment Phase|Ongoing|31|||
46697786|NCT03052608|82912624|FG000|Long-Term Follow-up Phase|Death|23|||
46697787|NCT03052608|82912625|FG001|Long-Term Follow-up Phase|Death|28|||
46697788|NCT03052608|82912624|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
46697789|NCT03052608|82912625|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
46697790|NCT03052608|82912624|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
46863598|NCT00231413|83080025|FG005|Overall Study|Migrated/moved from study area|1|||
46863599|NCT00231413|83080026|FG006|Overall Study|Migrated/moved from study area|0|||
46863600|NCT00231413|83080020|FG000|Overall Study|Lost to Follow-up|4|||
46863601|NCT00231413|83080021|FG001|Overall Study|Lost to Follow-up|4|||
46863602|NCT00231413|83080022|FG002|Overall Study|Lost to Follow-up|1|||
46863603|NCT00231413|83080023|FG003|Overall Study|Lost to Follow-up|1|||
46863604|NCT00231413|83080024|FG004|Overall Study|Lost to Follow-up|1|||
46863605|NCT00231413|83080025|FG005|Overall Study|Lost to Follow-up|4|||
46863606|NCT00231413|83080026|FG006|Overall Study|Lost to Follow-up|0|||
46863607|NCT00231413|83080020|FG000|Overall Study|Pregnancy|1|||
46863608|NCT00231413|83080021|FG001|Overall Study|Pregnancy|0|||
46863609|NCT00231413|83080022|FG002|Overall Study|Pregnancy|0|||
46863610|NCT00231413|83080023|FG003|Overall Study|Pregnancy|0|||
46863611|NCT00231413|83080024|FG004|Overall Study|Pregnancy|0|||
46863612|NCT00231413|83080025|FG005|Overall Study|Pregnancy|0|||
46863613|NCT00231413|83080026|FG006|Overall Study|Pregnancy|0|||
46863614|NCT04494646|83080044|FG000|Overall Study|Adverse Event|0|||
46863615|NCT04494646|83080045|FG001|Overall Study|Adverse Event|1|||
46863616|NCT04494646|83080044|FG000|Overall Study|Withdrawal by Subject|0|||
46863617|NCT04494646|83080045|FG001|Overall Study|Withdrawal by Subject|1|||
46863618|NCT00231179|83080053|FG000|Overall Study|Lost to Follow-up|21|||
46863619|NCT00231179|83080054|FG001|Overall Study|Lost to Follow-up|21|||
46863620|NCT00231179|83080053|FG000|Overall Study|Withdrawal by Subject|3|||
46863621|NCT00231179|83080054|FG001|Overall Study|Withdrawal by Subject|3|||
46863622|NCT03135028|83080060|FG000|Overall Study|Death|6|||
46863623|NCT03135028|83080060|FG000|Overall Study|Study Terminated by Sponsor|2|||
46863624|NCT03135028|83080060|FG000|Overall Study|Withdrew Consent|1|||
46863625|NCT00228917|83080072|FG000|Overall Study|Migrated/moved from study area|0|||
46863626|NCT00228917|83080073|FG001|Overall Study|Migrated/moved from study area|0|||
46863627|NCT00228917|83080074|FG002|Overall Study|Migrated/moved from study area|0|||
46863628|NCT00228917|83080075|FG003|Overall Study|Migrated/moved from study area|0|||
46863629|NCT00228917|83080076|FG004|Overall Study|Migrated/moved from study area|0|||
46863630|NCT00228917|83080077|FG005|Overall Study|Migrated/moved from study area|2|||
46863631|NCT00228917|83080078|FG006|Overall Study|Migrated/moved from study area|0|||
46863632|NCT00228917|83080079|FG007|Overall Study|Migrated/moved from study area|0|||
46863633|NCT00227903|83080095|FG000|Overall Study|Withdrawal by Subject|2|||
46863634|NCT00227903|83080096|FG001|Overall Study|Withdrawal by Subject|5|||
46863635|NCT00227903|83080095|FG000|Overall Study|Subject moved out of area|1|||
46863636|NCT00227903|83080096|FG001|Overall Study|Subject moved out of area|2|||
46863637|NCT00227903|83080095|FG000|Overall Study|Lost to Follow-up|1|||
46863638|NCT00227903|83080096|FG001|Overall Study|Lost to Follow-up|3|||
46863639|NCT00227903|83080095|FG000|Overall Study|Miscarriage|1|||
46863640|NCT00227903|83080096|FG001|Overall Study|Miscarriage|0|||
46863641|NCT04411628|83080106|FG000|Overall Study|Withdrawal by Subject|1|||
46863642|NCT04411628|83080107|FG001|Overall Study|Withdrawal by Subject|1|||
46863643|NCT04411628|83080108|FG002|Overall Study|Withdrawal by Subject|2|||
46863644|NCT04411628|83080109|FG003|Overall Study|Withdrawal by Subject|0|||
46863645|NCT04411628|83080106|FG000|Overall Study|Lost to Follow-up|0|||
46863646|NCT04411628|83080107|FG001|Overall Study|Lost to Follow-up|1|||
46982434|NCT02575339|83228733|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
46697791|NCT03052608|82912625|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
46982435|NCT02575339|83228734|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
46982436|NCT01712659|83228747|FG000|Dose Escalation|Physician Decision|0|||
46863647|NCT04411628|83080108|FG002|Overall Study|Lost to Follow-up|0|||
46863648|NCT04411628|83080109|FG003|Overall Study|Lost to Follow-up|0|||
46863649|NCT00227591|83080122|FG000|Overall Study|Withdrawal by Subject|1|||
46863650|NCT04512482|83080128|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
46863651|NCT04512482|83080129|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
46863652|NCT00226811|83080135|FG000|Overall Study|Death|8|||
46863653|NCT00226811|83080135|FG000|Overall Study|Adverse Event|11|||
46863654|NCT00226811|83080135|FG000|Overall Study|Lack of Efficacy|55|||
46863655|NCT00226811|83080135|FG000|Overall Study|Withdrawal by Subject|2|||
46863656|NCT00226655|83080139|FG000|Overall Study|Death|13|||
46863657|NCT00226655|83080139|FG000|Overall Study|Withdrawal by Subject|15|||
46863658|NCT00226655|83080139|FG000|Overall Study|Adverse Event|35|||
46863659|NCT00226655|83080139|FG000|Overall Study|Physician Decision|6|||
46863660|NCT00226655|83080139|FG000|Overall Study|Clinical deterioration|10|||
46863661|NCT03124108|83080155|FG000|Overall Study|Adverse Event|0|||
46863662|NCT03124108|83080156|FG001|Overall Study|Adverse Event|1|||
46863663|NCT03124108|83080157|FG002|Overall Study|Adverse Event|0|||
46863664|NCT04475588|83080169|FG000|Overall Study|Adverse Event|2|||
46863665|NCT04475588|83080170|FG001|Overall Study|Adverse Event|0|||
46863666|NCT04353596|83080179|FG000|Overall Study|Protocol Violation|4|||
46863667|NCT04353596|83080180|FG001|Overall Study|Protocol Violation|4|||
46863668|NCT04353596|83080179|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
46863669|NCT04353596|83080180|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
46863670|NCT04350788|83080188|FG000|Overall Study|Lost to Follow-up|6|||
46863671|NCT04350788|83080189|FG001|Overall Study|Lost to Follow-up|2|||
46863672|NCT04350788|83080188|FG000|Overall Study|Withdrawal by Subject|2|||
46863673|NCT04350788|83080189|FG001|Overall Study|Withdrawal by Subject|4|||
46863674|NCT04350788|83080188|FG000|Overall Study|Protocol Violation|4|||
46863675|NCT04350788|83080189|FG001|Overall Study|Protocol Violation|0|||
46863676|NCT03852316|83080200|FG000|Overall Study|Protocol Violation|1|||
46863677|NCT03852316|83080200|FG000|Overall Study|Withdrawal by Subject|2|||
46863678|NCT03852316|83080200|FG000|Overall Study|Enrolled but Device not Utilized|1|||
46863679|NCT04335812|83080206|FG000|Overall Study|Withdrawal by Subject|1|||
46863680|NCT04335812|83080207|FG001|Overall Study|Withdrawal by Subject|3|||
46863681|NCT04335812|83080206|FG000|Overall Study|Lost to Follow-up|12|||
46863682|NCT04335812|83080207|FG001|Overall Study|Lost to Follow-up|12|||
46863683|NCT04335812|83080206|FG000|Overall Study|Did not engage in the intervention|22|||
46863684|NCT04335812|83080207|FG001|Overall Study|Did not engage in the intervention|18|||
46863685|NCT03127384|83080213|FG000|Overall Study|Lost to Follow-up|4|||
46863686|NCT03127384|83080213|FG000|Overall Study|Subject request|2|||
46863687|NCT04398134|83080240|FG000|Overall Study|Adverse Event|0|||
46863688|NCT04398134|83080241|FG001|Overall Study|Adverse Event|0|||
46863689|NCT04398134|83080242|FG002|Overall Study|Adverse Event|1|||
46863690|NCT04398134|83080243|FG003|Overall Study|Adverse Event|0|||
46863691|NCT04398134|83080240|FG000|Overall Study|Withdrawal by Subject|2|||
46863692|NCT04398134|83080241|FG001|Overall Study|Withdrawal by Subject|0|||
46863693|NCT04398134|83080242|FG002|Overall Study|Withdrawal by Subject|0|||
46863694|NCT04398134|83080243|FG003|Overall Study|Withdrawal by Subject|1|||
46863695|NCT04398134|83080240|FG000|Overall Study|Study Terminated by Sponsor|30|||
46863696|NCT04398134|83080241|FG001|Overall Study|Study Terminated by Sponsor|11|||
46863697|NCT04398134|83080242|FG002|Overall Study|Study Terminated by Sponsor|32|||
46863698|NCT04398134|83080243|FG003|Overall Study|Study Terminated by Sponsor|11|||
46863699|NCT03122860|83080259|FG000|Overall Study|Discontinued Before Treatment|1|||
46863700|NCT03122860|83080260|FG001|Overall Study|Discontinued Before Treatment|1|||
46863701|NCT03122860|83080261|FG002|Overall Study|Discontinued Before Treatment|2|||
46863702|NCT03122860|83080262|FG003|Overall Study|Discontinued Before Treatment|0|||
46863703|NCT03122860|83080263|FG004|Overall Study|Discontinued Before Treatment|1|||
46863704|NCT03122860|83080264|FG005|Overall Study|Discontinued Before Treatment|0|||
46863705|NCT03122860|83080259|FG000|Overall Study|Adverse Event|1|||
46863706|NCT03122860|83080260|FG001|Overall Study|Adverse Event|0|||
46863707|NCT03122860|83080261|FG002|Overall Study|Adverse Event|1|||
46863708|NCT03122860|83080262|FG003|Overall Study|Adverse Event|1|||
46863709|NCT03122860|83080263|FG004|Overall Study|Adverse Event|0|||
46863710|NCT03122860|83080264|FG005|Overall Study|Adverse Event|0|||
46863711|NCT03122860|83080259|FG000|Overall Study|Lost to Follow-up|5|||
46697792|NCT03052608|82912624|FG000|Long-Term Follow-up Phase|Ongoing|122|||
46863712|NCT03122860|83080260|FG001|Overall Study|Lost to Follow-up|2|||
46863713|NCT03122860|83080261|FG002|Overall Study|Lost to Follow-up|3|||
46982437|NCT01712659|83228748|FG001|Dose Escalation|Physician Decision|1|||
46863714|NCT03122860|83080262|FG003|Overall Study|Lost to Follow-up|3|||
46863715|NCT03122860|83080263|FG004|Overall Study|Lost to Follow-up|5|||
46863716|NCT03122860|83080264|FG005|Overall Study|Lost to Follow-up|4|||
46863717|NCT03122860|83080259|FG000|Overall Study|Subject Non-Compliance|0|||
46863718|NCT03122860|83080260|FG001|Overall Study|Subject Non-Compliance|0|||
46863719|NCT03122860|83080261|FG002|Overall Study|Subject Non-Compliance|1|||
46863720|NCT03122860|83080262|FG003|Overall Study|Subject Non-Compliance|0|||
46863721|NCT03122860|83080263|FG004|Overall Study|Subject Non-Compliance|0|||
46863722|NCT03122860|83080264|FG005|Overall Study|Subject Non-Compliance|0|||
46863723|NCT03122860|83080259|FG000|Overall Study|Withdrawal by Subject|3|||
46863724|NCT03122860|83080260|FG001|Overall Study|Withdrawal by Subject|2|||
46863725|NCT03122860|83080261|FG002|Overall Study|Withdrawal by Subject|5|||
46863726|NCT03122860|83080262|FG003|Overall Study|Withdrawal by Subject|7|||
46863727|NCT03122860|83080263|FG004|Overall Study|Withdrawal by Subject|9|||
46863728|NCT03122860|83080264|FG005|Overall Study|Withdrawal by Subject|8|||
46863729|NCT03798366|83080281|FG000|Overall Study|Lost to Follow-up|0|||
46863730|NCT03798366|83080282|FG001|Overall Study|Lost to Follow-up|1|||
46863731|NCT04327388|83080291|FG000|Overall Study|Adverse Event|17|||
46863732|NCT04327388|83080292|FG001|Overall Study|Adverse Event|18|||
46863733|NCT04327388|83080293|FG002|Overall Study|Adverse Event|9|||
46863734|NCT04327388|83080291|FG000|Overall Study|Other|1|||
46863735|NCT04327388|83080292|FG001|Overall Study|Other|2|||
46863736|NCT04327388|83080293|FG002|Overall Study|Other|0|||
46863737|NCT04327388|83080291|FG000|Overall Study|Randomized and not treated|2|||
46863738|NCT04327388|83080292|FG001|Overall Study|Randomized and not treated|0|||
46863739|NCT04327388|83080293|FG002|Overall Study|Randomized and not treated|2|||
46863740|NCT03796728|83080301|FG000|Overall Study|Lost to Follow-up|8|||
46863741|NCT03796728|83080301|FG000|Overall Study|Reason not Specified|16|||
46863742|NCT04323800|83080307|FG000|Overall Study|Withdrawal by Subject|4|||
46863743|NCT04323800|83080308|FG001|Overall Study|Withdrawal by Subject|4|||
46863744|NCT04323800|83080307|FG000|Overall Study|Incomplete transfusion|1|||
46863745|NCT04323800|83080308|FG001|Overall Study|Incomplete transfusion|0|||
46863746|NCT04323800|83080307|FG000|Overall Study|Other|0|||
46863747|NCT04323800|83080308|FG001|Overall Study|Other|1|||
46863748|NCT04323800|83080307|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
46863749|NCT04323800|83080308|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
46863750|NCT04321460|83080316|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
46863751|NCT04321460|83080317|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
46863752|NCT03122548|83080323|FG000|Overall Study|Death|2|||
46863753|NCT03122548|83080323|FG000|Overall Study|Progression - subject went into hospice|1|||
46863754|NCT03122548|83080323|FG000|Overall Study|Study Terminated by Sponsor|2|||
46863755|NCT04459598|83080329|FG000|Overall Study|Adverse Event|1|||
46863756|NCT04459598|83080330|FG001|Overall Study|Adverse Event|1|||
46863757|NCT02929498|83080339|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
46863758|NCT02929498|83080340|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
46863759|NCT02929498|83080341|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
46863760|NCT02929498|83080339|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
46863761|NCT02929498|83080340|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
46863762|NCT02929498|83080341|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
46863763|NCT03792672|83080347|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
46863764|NCT03792672|83080348|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
46863765|NCT03792672|83080349|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
46863766|NCT03792672|83080350|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
46863767|NCT03792672|83080351|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
46863768|NCT03792672|83080352|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
46863769|NCT03792672|83080347|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
46863770|NCT03792672|83080348|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
46863771|NCT03792672|83080349|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
46863772|NCT03792672|83080350|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
46863773|NCT03792672|83080351|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
46863774|NCT03792672|83080352|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
46863775|NCT03792672|83080347|FG000|Treatment Period 4 (2 Days)|Other|1|||
46863776|NCT03792672|83080348|FG001|Treatment Period 4 (2 Days)|Other|0|||
46863777|NCT03792672|83080349|FG002|Treatment Period 4 (2 Days)|Other|0|||
46863778|NCT03792672|83080350|FG003|Treatment Period 4 (2 Days)|Other|0|||
46863779|NCT03792672|83080351|FG004|Treatment Period 4 (2 Days)|Other|0|||
46863780|NCT03792672|83080352|FG005|Treatment Period 4 (2 Days)|Other|0|||
46863781|NCT03120676|83080367|FG000|Overall Study|Not treated|1|||
46863782|NCT03120520|83080375|FG000|Overall Study|Lost to Follow-up|1|||
46863783|NCT03120520|83080376|FG001|Overall Study|Lost to Follow-up|1|||
46982438|NCT01712659|83228749|FG002|Dose Escalation|Physician Decision|0|||
46982439|NCT01712659|83228750|FG003|Dose Escalation|Physician Decision|0|||
46982440|NCT01712659|83228751|FG004|Dose Escalation|Physician Decision|0|||
46863784|NCT03120520|83080377|FG002|Overall Study|Lost to Follow-up|1|||
46863785|NCT03120520|83080378|FG003|Overall Study|Lost to Follow-up|1|||
46863786|NCT03120520|83080375|FG000|Overall Study|Withdrawal by Subject|3|||
46863787|NCT03120520|83080376|FG001|Overall Study|Withdrawal by Subject|2|||
46863788|NCT03120520|83080377|FG002|Overall Study|Withdrawal by Subject|3|||
46863789|NCT03120520|83080378|FG003|Overall Study|Withdrawal by Subject|2|||
46863790|NCT03120520|83080375|FG000|Overall Study|Other|0|||
46863791|NCT03120520|83080376|FG001|Overall Study|Other|1|||
46863792|NCT03120520|83080377|FG002|Overall Study|Other|0|||
46863793|NCT03120520|83080378|FG003|Overall Study|Other|0|||
46863794|NCT03787212|83080388|FG000|Period 1|Study Termination|2|||
46863795|NCT03787212|83080389|FG001|Period 1|Study Termination|2|||
46863796|NCT03125200|83080402|FG000|Overall Study|Study Termination|0|||
46863797|NCT03125200|83080403|FG001|Overall Study|Study Termination|0|||
46863798|NCT03125200|83080404|FG002|Overall Study|Study Termination|0|||
46863799|NCT03125200|83080405|FG003|Overall Study|Study Termination|1|||
46863800|NCT03125200|83080406|FG004|Overall Study|Study Termination|1|||
46863801|NCT03125200|83080407|FG005|Overall Study|Study Termination|2|||
46863802|NCT03125200|83080408|FG006|Overall Study|Study Termination|1|||
46863803|NCT03125200|83080402|FG000|Overall Study|Clinical Progression|0|||
46863804|NCT03125200|83080403|FG001|Overall Study|Clinical Progression|0|||
46863805|NCT03125200|83080404|FG002|Overall Study|Clinical Progression|0|||
46863806|NCT03125200|83080405|FG003|Overall Study|Clinical Progression|1|||
46863807|NCT03125200|83080406|FG004|Overall Study|Clinical Progression|0|||
46863808|NCT03125200|83080407|FG005|Overall Study|Clinical Progression|1|||
46863809|NCT03125200|83080408|FG006|Overall Study|Clinical Progression|0|||
46863810|NCT03125200|83080402|FG000|Overall Study|Progressive Disease|2|||
46863811|NCT03125200|83080403|FG001|Overall Study|Progressive Disease|1|||
46863812|NCT03125200|83080404|FG002|Overall Study|Progressive Disease|2|||
46863813|NCT03125200|83080405|FG003|Overall Study|Progressive Disease|1|||
46982441|NCT01712659|83228747|FG000|Dose Escalation|Unable to take study drug|0|||
46982442|NCT01712659|83228748|FG001|Dose Escalation|Unable to take study drug|1|||
46982443|NCT01712659|83228749|FG002|Dose Escalation|Unable to take study drug|0|||
46982444|NCT01712659|83228750|FG003|Dose Escalation|Unable to take study drug|0|||
46982445|NCT01712659|83228751|FG004|Dose Escalation|Unable to take study drug|0|||
46982446|NCT01712659|83228747|FG000|Dose Expansion|Early disease progression|1|||
46982447|NCT01712659|83228748|FG001|Dose Expansion|Early disease progression|0|||
46982448|NCT01712659|83228749|FG002|Dose Expansion|Early disease progression|0|||
46982449|NCT01712659|83228750|FG003|Dose Expansion|Early disease progression|0|||
46982450|NCT01712659|83228751|FG004|Dose Expansion|Early disease progression|0|||
46982451|NCT01712659|83228747|FG000|Dose Expansion|Physician Decision|1|||
46982452|NCT01712659|83228748|FG001|Dose Expansion|Physician Decision|0|||
46982453|NCT01712659|83228749|FG002|Dose Expansion|Physician Decision|0|||
46982454|NCT01712659|83228750|FG003|Dose Expansion|Physician Decision|0|||
46982455|NCT01712659|83228751|FG004|Dose Expansion|Physician Decision|0|||
46982456|NCT01610713|83228777|FG000|Overall Study|Adverse Event|3|||
46982457|NCT01610713|83228778|FG001|Overall Study|Adverse Event|0|||
46982458|NCT01610713|83228777|FG000|Overall Study|Lack of Efficacy|1|||
46982459|NCT01610713|83228778|FG001|Overall Study|Lack of Efficacy|0|||
46697793|NCT03052608|82912625|FG001|Long-Term Follow-up Phase|Ongoing|99|||
46697794|NCT03004183|82912636|FG000|Overall Study|Adverse Event|7|||
46697795|NCT03004183|82912636|FG000|Overall Study|Lost to Follow-up|1|||
46697796|NCT03004183|82912636|FG000|Overall Study|Physician Decision|40|||
46697797|NCT03004183|82912636|FG000|Overall Study|Withdrawal by Subject|1|||
46697798|NCT03004183|82912636|FG000|Overall Study|COVID-19|1|||
46697799|NCT02949128|82912640|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
46697800|NCT02949128|82912640|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
46697801|NCT02949128|82912640|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
46697802|NCT02949128|82912640|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
46697803|NCT02949128|82912640|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
46697804|NCT02949128|82912640|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
46697805|NCT02949128|82912640|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
46697806|NCT02949128|82912640|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
46697807|NCT02949128|82912640|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
46697808|NCT02949128|82912640|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
46697809|NCT02756845|82912650|FG000|Overall Study|Death|12|||
46697810|NCT02756845|82912651|FG001|Overall Study|Death|2|||
46697811|NCT02756845|82912650|FG000|Overall Study|Withdrawal by Subject|1|||
46982460|NCT01610713|83228777|FG000|Overall Study|low mood and poor motivation|1|||
46982461|NCT01610713|83228778|FG001|Overall Study|low mood and poor motivation|0|||
46982462|NCT01610713|83228777|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
46697812|NCT02756845|82912651|FG001|Overall Study|Withdrawal by Subject|0|||
46863814|NCT03125200|83080406|FG004|Overall Study|Progressive Disease|2|||
46982463|NCT01610713|83228778|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
46982464|NCT01610713|83228777|FG000|Overall Study|Lost to Follow-up|0|||
46982465|NCT01610713|83228778|FG001|Overall Study|Lost to Follow-up|1|||
46982466|NCT01606189|83228784|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
46982467|NCT01606189|83228785|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
46863815|NCT03125200|83080407|FG005|Overall Study|Progressive Disease|0|||
46863816|NCT03125200|83080408|FG006|Overall Study|Progressive Disease|1|||
46863817|NCT03125200|83080402|FG000|Overall Study|Lack of Efficacy|0|||
46863818|NCT03125200|83080403|FG001|Overall Study|Lack of Efficacy|0|||
46863819|NCT03125200|83080404|FG002|Overall Study|Lack of Efficacy|0|||
46697813|NCT02452697|82912676|FG000|Overall Study|Physician Decision|4|||
46697814|NCT02452697|82912677|FG001|Overall Study|Physician Decision|4|||
46863820|NCT03125200|83080405|FG003|Overall Study|Lack of Efficacy|1|||
46863821|NCT03125200|83080406|FG004|Overall Study|Lack of Efficacy|0|||
46863822|NCT03125200|83080407|FG005|Overall Study|Lack of Efficacy|0|||
46982468|NCT01606189|83228786|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
46982469|NCT01606189|83228787|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
46982470|NCT01606189|83228788|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
46982471|NCT01606189|83228789|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
46982472|NCT01606189|83228784|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
46982473|NCT01606189|83228785|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
46982474|NCT01606189|83228786|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
46982475|NCT01606189|83228787|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
46982476|NCT01606189|83228788|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
46982477|NCT01606189|83228789|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
46982478|NCT01663987|83228799|FG000|Overall Study|Adverse Event|7|||
46982479|NCT01663987|83228800|FG001|Overall Study|Adverse Event|2|||
46982480|NCT01663987|83228799|FG000|Overall Study|Lost to Follow-up|1|||
46982481|NCT01663987|83228800|FG001|Overall Study|Lost to Follow-up|1|||
46982482|NCT01663987|83228799|FG000|Overall Study|Withdrawal by Subject|2|||
46982483|NCT01663987|83228800|FG001|Overall Study|Withdrawal by Subject|3|||
46982484|NCT01663987|83228799|FG000|Overall Study|Other reason not defined above|3|||
46982485|NCT01663987|83228800|FG001|Overall Study|Other reason not defined above|0|||
46982486|NCT02380677|83228818|FG000|Overall Study|Adverse Event|0|||
46982487|NCT02380677|83228819|FG001|Overall Study|Adverse Event|0|||
46982488|NCT02380677|83228820|FG002|Overall Study|Adverse Event|0|||
46982489|NCT02380677|83228821|FG003|Overall Study|Adverse Event|1|||
46982490|NCT02380677|83228822|FG004|Overall Study|Adverse Event|1|||
46982491|NCT02380677|83228823|FG005|Overall Study|Adverse Event|4|||
46982492|NCT02380677|83228824|FG006|Overall Study|Adverse Event|2|||
46982493|NCT02380677|83228825|FG007|Overall Study|Adverse Event|2|||
46982494|NCT02380677|83228826|FG008|Overall Study|Adverse Event|2|||
46982495|NCT02380677|83228827|FG009|Overall Study|Adverse Event|1|||
46982496|NCT02380677|83228828|FG010|Overall Study|Adverse Event|2|||
46982497|NCT02380677|83228829|FG011|Overall Study|Adverse Event|1|||
46982498|NCT02380677|83228818|FG000|Overall Study|Physician Decision|1|||
46982499|NCT02380677|83228819|FG001|Overall Study|Physician Decision|0|||
46982500|NCT02380677|83228820|FG002|Overall Study|Physician Decision|1|||
46982501|NCT02380677|83228821|FG003|Overall Study|Physician Decision|1|||
46982502|NCT02380677|83228822|FG004|Overall Study|Physician Decision|0|||
46982503|NCT02380677|83228823|FG005|Overall Study|Physician Decision|0|||
46982504|NCT02380677|83228824|FG006|Overall Study|Physician Decision|0|||
46982505|NCT02380677|83228825|FG007|Overall Study|Physician Decision|0|||
46982506|NCT02380677|83228826|FG008|Overall Study|Physician Decision|0|||
46697815|NCT02452697|82912678|FG002|Overall Study|Physician Decision|3|||
46697816|NCT02452697|82912679|FG003|Overall Study|Physician Decision|2|||
46697817|NCT02452697|82912676|FG000|Overall Study|Withdrawal by Subject|1|||
46697818|NCT02452697|82912677|FG001|Overall Study|Withdrawal by Subject|0|||
46697819|NCT02452697|82912678|FG002|Overall Study|Withdrawal by Subject|0|||
46697820|NCT02452697|82912679|FG003|Overall Study|Withdrawal by Subject|0|||
46697821|NCT02452697|82912676|FG000|Overall Study|still in follow-up|2|||
46697822|NCT02452697|82912677|FG001|Overall Study|still in follow-up|2|||
46697823|NCT02452697|82912678|FG002|Overall Study|still in follow-up|1|||
46697824|NCT02452697|82912679|FG003|Overall Study|still in follow-up|3|||
46697825|NCT02325557|82912693|FG000|Overall Study|Progressive disease|1|||
46697826|NCT02325557|82912694|FG001|Overall Study|Progressive disease|0|||
46863823|NCT03125200|83080408|FG006|Overall Study|Lack of Efficacy|0|||
46863824|NCT03125200|83080402|FG000|Overall Study|Toxicity|0|||
46982507|NCT02380677|83228827|FG009|Overall Study|Physician Decision|0|||
46982508|NCT02380677|83228828|FG010|Overall Study|Physician Decision|0|||
46982509|NCT02380677|83228829|FG011|Overall Study|Physician Decision|0|||
46982510|NCT02380677|83228818|FG000|Overall Study|Lack of Efficacy|0|||
46982511|NCT02380677|83228819|FG001|Overall Study|Lack of Efficacy|1|||
46982512|NCT02380677|83228820|FG002|Overall Study|Lack of Efficacy|2|||
46863825|NCT03125200|83080403|FG001|Overall Study|Toxicity|0|||
46863826|NCT03125200|83080404|FG002|Overall Study|Toxicity|0|||
46697827|NCT02325557|82912695|FG002|Overall Study|Progressive disease|0|||
46697828|NCT02325557|82912696|FG003|Overall Study|Progressive disease|0|||
46697829|NCT02325557|82912693|FG000|Overall Study|Withdrawal by Subject|4|||
46863827|NCT03125200|83080405|FG003|Overall Study|Toxicity|1|||
46982513|NCT02380677|83228821|FG003|Overall Study|Lack of Efficacy|0|||
46982514|NCT02380677|83228822|FG004|Overall Study|Lack of Efficacy|4|||
46982515|NCT02380677|83228823|FG005|Overall Study|Lack of Efficacy|1|||
46982516|NCT02380677|83228824|FG006|Overall Study|Lack of Efficacy|1|||
46982517|NCT02380677|83228825|FG007|Overall Study|Lack of Efficacy|2|||
46697830|NCT02325557|82912694|FG001|Overall Study|Withdrawal by Subject|0|||
46697831|NCT02325557|82912695|FG002|Overall Study|Withdrawal by Subject|0|||
46697832|NCT02325557|82912696|FG003|Overall Study|Withdrawal by Subject|15|||
46697833|NCT02325557|82912693|FG000|Overall Study|Death|5|||
46697834|NCT02325557|82912694|FG001|Overall Study|Death|1|||
46697835|NCT02325557|82912695|FG002|Overall Study|Death|1|||
46697836|NCT02325557|82912696|FG003|Overall Study|Death|16|||
46697837|NCT02325557|82912693|FG000|Overall Study|Lost to Follow-up|0|||
46697838|NCT02325557|82912694|FG001|Overall Study|Lost to Follow-up|0|||
46697839|NCT02325557|82912695|FG002|Overall Study|Lost to Follow-up|1|||
46863828|NCT03125200|83080406|FG004|Overall Study|Toxicity|0|||
46863829|NCT03125200|83080407|FG005|Overall Study|Toxicity|0|||
46863830|NCT03125200|83080408|FG006|Overall Study|Toxicity|0|||
46863831|NCT03125200|83080402|FG000|Overall Study|Consent Withdrawn by Subject|0|||
46863832|NCT03125200|83080403|FG001|Overall Study|Consent Withdrawn by Subject|1|||
46863833|NCT03125200|83080404|FG002|Overall Study|Consent Withdrawn by Subject|0|||
46863834|NCT03125200|83080405|FG003|Overall Study|Consent Withdrawn by Subject|0|||
46863835|NCT03125200|83080406|FG004|Overall Study|Consent Withdrawn by Subject|1|||
46863836|NCT03125200|83080407|FG005|Overall Study|Consent Withdrawn by Subject|0|||
46863837|NCT03125200|83080408|FG006|Overall Study|Consent Withdrawn by Subject|1|||
46863838|NCT03132220|83080429|FG000|Overall Study|Lost to Follow-up|17|||
46863839|NCT03132220|83080430|FG001|Overall Study|Lost to Follow-up|8|||
46863840|NCT03132220|83080429|FG000|Overall Study|Withdrawal by Subject|1|||
46863841|NCT03132220|83080430|FG001|Overall Study|Withdrawal by Subject|4|||
46863842|NCT03119662|83080438|FG000|Overall Study|Withdrawal by Subject|0|||
46863843|NCT03119662|83080439|FG001|Overall Study|Withdrawal by Subject|1|||
46863844|NCT02728804|83080445|FG000|Overall Study|Ineligible|3|||
46863845|NCT02728804|83080445|FG000|Overall Study|Did not complete baseline questionnaire|9|||
46863846|NCT02728804|83080445|FG000|Overall Study|Death|99|||
46863847|NCT02699554|83080461|FG000|Overall Study|Lost to Follow-up|9|||
46863848|NCT03783780|83080475|FG000|Overall Study|Withdrawn prior to completion|1|||
46863849|NCT03783702|83080482|FG000|Overall Study|Lost to Follow-up|6|||
46863850|NCT03783702|83080483|FG001|Overall Study|Lost to Follow-up|8|||
46863851|NCT03783702|83080482|FG000|Overall Study|Protocol Violation|1|||
46863852|NCT03783702|83080483|FG001|Overall Study|Protocol Violation|3|||
46863853|NCT03575572|83080491|FG000|Overall Study|Withdrawal by Subject|2|||
46863854|NCT03575572|83080491|FG000|Overall Study|Physician Decision|2|||
46863855|NCT03116698|83080517|FG000|Overall Study|Adverse Event|1|||
46863856|NCT03116698|83080518|FG001|Overall Study|Adverse Event|1|||
46863857|NCT03116698|83080519|FG002|Overall Study|Adverse Event|1|||
46863858|NCT03116698|83080520|FG003|Overall Study|Adverse Event|0|||
46863859|NCT03116698|83080517|FG000|Overall Study|Withdrawal by Subject|1|||
46863860|NCT03116698|83080518|FG001|Overall Study|Withdrawal by Subject|4|||
46863861|NCT03116698|83080519|FG002|Overall Study|Withdrawal by Subject|5|||
46863862|NCT03116698|83080520|FG003|Overall Study|Withdrawal by Subject|2|||
46863863|NCT03116698|83080517|FG000|Overall Study|Lost to Follow-up|2|||
46697840|NCT02325557|82912696|FG003|Overall Study|Lost to Follow-up|1|||
46697841|NCT02325557|82912693|FG000|Overall Study|Other|0|||
46697842|NCT02325557|82912694|FG001|Overall Study|Other|0|||
46697843|NCT02325557|82912695|FG002|Overall Study|Other|0|||
46697844|NCT02325557|82912696|FG003|Overall Study|Other|5|||
46697845|NCT02213458|82912717|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
46697846|NCT02213458|82912718|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
46697847|NCT02213458|82912717|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
46697848|NCT02213458|82912718|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
46697849|NCT02213458|82912717|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
46697850|NCT02213458|82912718|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
46697851|NCT02213458|82912717|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
46697852|NCT02213458|82912718|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
46697853|NCT02213458|82912717|FG000|Overall Study|Refused re-consent|6|||
46697854|NCT02213458|82912718|FG001|Overall Study|Refused re-consent|0|||
46697855|NCT02213458|82912717|FG000|Overall Study|Lost to Follow-up|2|||
46697856|NCT02213458|82912718|FG001|Overall Study|Lost to Follow-up|2|||
46697857|NCT02213458|82912717|FG000|Overall Study|Withdrawal by Subject|26|||
46697858|NCT02213458|82912718|FG001|Overall Study|Withdrawal by Subject|8|||
46697859|NCT02003924|82912726|FG000|Double-blind Phase|Lost to Follow-up|2|||
46697860|NCT02003924|82912727|FG001|Double-blind Phase|Lost to Follow-up|1|||
46697861|NCT02003924|82912728|FG002|Double-blind Phase|Lost to Follow-up|0|||
46863864|NCT03116698|83080518|FG001|Overall Study|Lost to Follow-up|0|||
46863865|NCT03116698|83080519|FG002|Overall Study|Lost to Follow-up|0|||
46863866|NCT03116698|83080520|FG003|Overall Study|Lost to Follow-up|0|||
46863867|NCT03116698|83080517|FG000|Overall Study|Physician Decision|1|||
46863868|NCT03116698|83080518|FG001|Overall Study|Physician Decision|1|||
46863869|NCT03116698|83080519|FG002|Overall Study|Physician Decision|0|||
46697862|NCT02003924|82912726|FG000|Double-blind Phase|Protocol Violation|1|||
46697863|NCT02003924|82912727|FG001|Double-blind Phase|Protocol Violation|2|||
46697864|NCT02003924|82912728|FG002|Double-blind Phase|Protocol Violation|0|||
46697865|NCT02003924|82912726|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
46697866|NCT02003924|82912727|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
46697867|NCT02003924|82912728|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
46697868|NCT02003924|82912726|FG000|Double-blind Phase|Disease Progression|229|||
46697869|NCT02003924|82912727|FG001|Double-blind Phase|Disease Progression|247|||
46697870|NCT02003924|82912728|FG002|Double-blind Phase|Disease Progression|0|||
46697871|NCT02003924|82912726|FG000|Double-blind Phase|Adverse Event|120|||
46697872|NCT02003924|82912727|FG001|Double-blind Phase|Adverse Event|31|||
46697873|NCT02003924|82912728|FG002|Double-blind Phase|Adverse Event|0|||
46697874|NCT02003924|82912726|FG000|Double-blind Phase|Randomized But not Treated|3|||
46697875|NCT02003924|82912727|FG001|Double-blind Phase|Randomized But not Treated|3|||
46863870|NCT03116698|83080520|FG003|Overall Study|Physician Decision|0|||
46863871|NCT03116698|83080517|FG000|Overall Study|Protocol Violation|1|||
46863872|NCT03116698|83080518|FG001|Overall Study|Protocol Violation|0|||
46863873|NCT03116698|83080519|FG002|Overall Study|Protocol Violation|0|||
46863874|NCT03116698|83080520|FG003|Overall Study|Protocol Violation|0|||
46863875|NCT03116698|83080517|FG000|Overall Study|Death|0|||
46863876|NCT03116698|83080518|FG001|Overall Study|Death|0|||
46863877|NCT03116698|83080519|FG002|Overall Study|Death|2|||
46863878|NCT03116698|83080520|FG003|Overall Study|Death|0|||
46863879|NCT03116152|83080532|FG000|Overall Study|Disease Progression|49|||
46863880|NCT03116152|83080533|FG001|Overall Study|Disease Progression|47|||
46863881|NCT03116152|83080532|FG000|Overall Study|Death|5|||
46863882|NCT03116152|83080533|FG001|Overall Study|Death|2|||
46863883|NCT03116152|83080532|FG000|Overall Study|Adverse Event|21|||
46863884|NCT03116152|83080533|FG001|Overall Study|Adverse Event|7|||
46863885|NCT03116152|83080532|FG000|Overall Study|Protocol Violation|2|||
46863886|NCT03116152|83080533|FG001|Overall Study|Protocol Violation|2|||
46863887|NCT03116152|83080532|FG000|Overall Study|Withdrawal by Subject|0|||
46863888|NCT03116152|83080533|FG001|Overall Study|Withdrawal by Subject|1|||
46982518|NCT02380677|83228826|FG008|Overall Study|Lack of Efficacy|2|||
46863889|NCT03116152|83080532|FG000|Overall Study|Physician Decision|3|||
46863890|NCT03116152|83080533|FG001|Overall Study|Physician Decision|2|||
46863891|NCT03116152|83080532|FG000|Overall Study|other|11|||
46863892|NCT03116152|83080533|FG001|Overall Study|other|34|||
46863893|NCT00226499|83080544|FG000|Overall Study|Adverse Event|10|||
46697876|NCT02003924|82912728|FG002|Double-blind Phase|Randomized But not Treated|0|||
46697877|NCT02003924|82912726|FG000|Double-blind Phase|Other|29|||
46863894|NCT00226499|83080545|FG001|Overall Study|Adverse Event|6|||
46863895|NCT00226499|83080546|FG002|Overall Study|Adverse Event|3|||
46863896|NCT00226499|83080544|FG000|Overall Study|Others|1064|||
46863897|NCT00226499|83080545|FG001|Overall Study|Others|1066|||
46802503|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Adverse Event|60|||
46802504|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Adverse Event|0|||
46802505|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Adverse Event|0|||
46802506|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Pregnancy|0|||
46802507|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Pregnancy|7|||
46802508|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Pregnancy|9|||
46802509|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Pregnancy|0|||
46802510|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Pregnancy|0|||
46802511|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
46802512|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
46802513|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
46802514|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
46802515|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
46802516|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
46802517|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
46802518|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
46802519|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
46802520|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
46802521|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Death|1|||
46802522|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Death|2|||
46802523|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Death|2|||
46802524|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Death|0|||
46802525|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Death|0|||
46802526|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
46802527|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
46802528|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
46802529|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
46802530|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
46802531|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
46802532|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
46802533|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
46802534|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
46802535|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
46802536|NCT00098293|83021883|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
46863898|NCT00226499|83080546|FG002|Overall Study|Others|356|||
46863899|NCT01400776|83080560|FG000|Overall Study|Adverse Event|7|||
46863900|NCT01400776|83080561|FG001|Overall Study|Adverse Event|2|||
46863901|NCT01400776|83080562|FG002|Overall Study|Adverse Event|9|||
46863902|NCT01400776|83080563|FG003|Overall Study|Adverse Event|2|||
46863903|NCT01400776|83080560|FG000|Overall Study|Lost to Follow-up|1|||
46863904|NCT01400776|83080561|FG001|Overall Study|Lost to Follow-up|0|||
46863905|NCT01400776|83080562|FG002|Overall Study|Lost to Follow-up|4|||
46863906|NCT01400776|83080563|FG003|Overall Study|Lost to Follow-up|1|||
46863907|NCT01400776|83080560|FG000|Overall Study|Withdrew Consent|4|||
46863908|NCT01400776|83080561|FG001|Overall Study|Withdrew Consent|2|||
46863909|NCT01400776|83080562|FG002|Overall Study|Withdrew Consent|6|||
46863910|NCT01400776|83080563|FG003|Overall Study|Withdrew Consent|1|||
46863911|NCT01400776|83080560|FG000|Overall Study|Protocol Deviation|6|||
46863912|NCT01400776|83080561|FG001|Overall Study|Protocol Deviation|1|||
46863913|NCT01400776|83080562|FG002|Overall Study|Protocol Deviation|5|||
46863914|NCT01400776|83080563|FG003|Overall Study|Protocol Deviation|2|||
46863915|NCT01400776|83080560|FG000|Overall Study|Reason not Specified|3|||
46863916|NCT01400776|83080561|FG001|Overall Study|Reason not Specified|0|||
46863917|NCT01400776|83080562|FG002|Overall Study|Reason not Specified|4|||
46863918|NCT01400776|83080563|FG003|Overall Study|Reason not Specified|3|||
46863919|NCT03131596|83080575|FG000|Overall Study|Protocol Violation|3|||
46863920|NCT03131596|83080576|FG001|Overall Study|Protocol Violation|3|||
46863921|NCT03131596|83080575|FG000|Overall Study|Lost to Follow-up|3|||
46863922|NCT03131596|83080576|FG001|Overall Study|Lost to Follow-up|0|||
46863923|NCT00255047|83080590|FG000|Overall Study|Serious Adverse Events|2|||
46863924|NCT00255047|83080591|FG001|Overall Study|Serious Adverse Events|1|||
46863925|NCT00255047|83080592|FG002|Overall Study|Serious Adverse Events|2|||
46863926|NCT00255047|83080593|FG003|Overall Study|Serious Adverse Events|1|||
46863927|NCT00255047|83080590|FG000|Overall Study|Adverse Event|0|||
46863928|NCT00255047|83080591|FG001|Overall Study|Adverse Event|3|||
46863929|NCT00255047|83080592|FG002|Overall Study|Adverse Event|2|||
46863930|NCT00255047|83080593|FG003|Overall Study|Adverse Event|1|||
46863931|NCT00255047|83080590|FG000|Overall Study|Protocol Violation|13|||
46863932|NCT00255047|83080591|FG001|Overall Study|Protocol Violation|13|||
46863933|NCT00255047|83080592|FG002|Overall Study|Protocol Violation|16|||
46863934|NCT00255047|83080593|FG003|Overall Study|Protocol Violation|20|||
46863935|NCT00255047|83080590|FG000|Overall Study|Lost to Follow-up|9|||
46863936|NCT00255047|83080591|FG001|Overall Study|Lost to Follow-up|8|||
46863937|NCT00255047|83080592|FG002|Overall Study|Lost to Follow-up|5|||
46863938|NCT00255047|83080593|FG003|Overall Study|Lost to Follow-up|6|||
46863939|NCT00255047|83080590|FG000|Overall Study|Withdrawal by Subject|24|||
46863940|NCT00255047|83080591|FG001|Overall Study|Withdrawal by Subject|23|||
46863941|NCT00255047|83080592|FG002|Overall Study|Withdrawal by Subject|25|||
46863942|NCT00255047|83080593|FG003|Overall Study|Withdrawal by Subject|18|||
46863943|NCT00225251|83080605|FG000|Overall Study|Withdrawal by Subject|1|||
46863944|NCT00225251|83080606|FG001|Overall Study|Withdrawal by Subject|1|||
46863945|NCT00254501|83080614|FG000|Overall Study|Lost to Follow-up|1|||
46863946|NCT00254501|83080615|FG001|Overall Study|Lost to Follow-up|1|||
46863947|NCT00253643|83080627|FG000|Overall Study|Withdrawal by Subject|0|||
46863948|NCT00253643|83080628|FG001|Overall Study|Withdrawal by Subject|0|||
46863949|NCT00253643|83080629|FG002|Overall Study|Withdrawal by Subject|1|||
46863950|NCT00253643|83080630|FG003|Overall Study|Withdrawal by Subject|1|||
46863951|NCT00253643|83080627|FG000|Overall Study|Non-Compliance|0|||
46863952|NCT00253643|83080628|FG001|Overall Study|Non-Compliance|0|||
46863953|NCT00253643|83080629|FG002|Overall Study|Non-Compliance|0|||
46863954|NCT00253643|83080630|FG003|Overall Study|Non-Compliance|2|||
46863955|NCT00221195|83080642|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
46863956|NCT00221195|83080643|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
46863957|NCT00221195|83080642|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
46863958|NCT00221195|83080643|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
46863959|NCT00221195|83080642|FG000|Washout Period (Months 7-9)|Death|0|||
46863960|NCT00221195|83080643|FG001|Washout Period (Months 7-9)|Death|1|||
46863961|NCT00221195|83080642|FG000|Therapy 2 (Months 10-15)|Death|1|||
46863962|NCT00221195|83080643|FG001|Therapy 2 (Months 10-15)|Death|0|||
46863963|NCT00221195|83080642|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
46863964|NCT00221195|83080643|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
46863965|NCT00220805|83080652|FG000|Overall Study|Adverse Event|1|||
46863966|NCT00220805|83080653|FG001|Overall Study|Adverse Event|3|||
46863967|NCT00220805|83080652|FG000|Overall Study|Withdrawal by Subject|3|||
46863968|NCT00220805|83080653|FG001|Overall Study|Withdrawal by Subject|0|||
46863969|NCT00220805|83080652|FG000|Overall Study|Lack of Efficacy|1|||
46863970|NCT00220805|83080653|FG001|Overall Study|Lack of Efficacy|0|||
46863971|NCT00220805|83080652|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
46863972|NCT00220805|83080653|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
46863973|NCT00220727|83080661|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
46863974|NCT00220727|83080662|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
46863975|NCT03971357|83080672|FG000|Overall Study|Lack of Efficacy|0|||
46863976|NCT03971357|83080673|FG001|Overall Study|Lack of Efficacy|1|||
46863977|NCT04310566|83080679|FG000|Period 1|Study Termination due to COVID-19|15|||
46863978|NCT04310566|83080680|FG001|Period 1|Study Termination due to COVID-19|17|||
46863979|NCT04310566|83080679|FG000|Period 1|Protocol Violation|0|||
46863980|NCT04310566|83080680|FG001|Period 1|Protocol Violation|1|||
46863981|NCT04310566|83080679|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
46863982|NCT04310566|83080680|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
46863983|NCT04310566|83080679|FG000|Period 1|Lost to Follow-up|1|||
46863984|NCT04310566|83080680|FG001|Period 1|Lost to Follow-up|0|||
46863985|NCT04310566|83080679|FG000|Period 1|Withdrawal by Subject|0|||
46863986|NCT04310566|83080680|FG001|Period 1|Withdrawal by Subject|1|||
46863987|NCT04310566|83080679|FG000|Period 2|Study Termination|7|||
46863988|NCT04310566|83080680|FG001|Period 2|Study Termination|5|||
46863989|NCT00252239|83080690|FG000|Overall Study|Withdrawal by Subject|1|||
46863990|NCT00252239|83080691|FG001|Overall Study|Withdrawal by Subject|0|||
46863991|NCT00252239|83080692|FG002|Overall Study|Withdrawal by Subject|0|||
46863992|NCT00252239|83080693|FG003|Overall Study|Withdrawal by Subject|1|||
46863993|NCT00252239|83080690|FG000|Overall Study|Lost to Follow-up|0|||
46863994|NCT00252239|83080691|FG001|Overall Study|Lost to Follow-up|0|||
46863995|NCT00252239|83080692|FG002|Overall Study|Lost to Follow-up|2|||
46863996|NCT00252239|83080693|FG003|Overall Study|Lost to Follow-up|0|||
46863997|NCT03103906|83080705|FG000|Overall Study|Adverse Event|2|||
46863998|NCT03103906|83080706|FG001|Overall Study|Adverse Event|3|||
46863999|NCT03103906|83080705|FG000|Overall Study|Other|2|||
46864000|NCT03103906|83080706|FG001|Overall Study|Other|0|||
46864001|NCT04799158|83080716|FG000|Run-In Period|Adverse Event|6|||
46864002|NCT04799158|83080717|FG001|Run-In Period|Adverse Event|0|||
46864003|NCT04799158|83080718|FG002|Run-In Period|Adverse Event|0|||
46864004|NCT04799158|83080719|FG003|Run-In Period|Adverse Event|0|||
46864005|NCT04799158|83080720|FG004|Run-In Period|Adverse Event|0|||
46864006|NCT04799158|83080716|FG000|Run-In Period|Lost to Follow-up|4|||
46864007|NCT04799158|83080717|FG001|Run-In Period|Lost to Follow-up|0|||
46864008|NCT04799158|83080718|FG002|Run-In Period|Lost to Follow-up|0|||
46864009|NCT04799158|83080719|FG003|Run-In Period|Lost to Follow-up|0|||
46864010|NCT04799158|83080720|FG004|Run-In Period|Lost to Follow-up|0|||
46864011|NCT04799158|83080716|FG000|Run-In Period|Significant Protocol Deviation|1|||
46864012|NCT04799158|83080717|FG001|Run-In Period|Significant Protocol Deviation|0|||
46864013|NCT04799158|83080718|FG002|Run-In Period|Significant Protocol Deviation|0|||
46864014|NCT04799158|83080719|FG003|Run-In Period|Significant Protocol Deviation|0|||
46864015|NCT04799158|83080720|FG004|Run-In Period|Significant Protocol Deviation|0|||
46864016|NCT04799158|83080716|FG000|Run-In Period|Withdrawal by Subject|11|||
46864017|NCT04799158|83080717|FG001|Run-In Period|Withdrawal by Subject|0|||
46864018|NCT04799158|83080718|FG002|Run-In Period|Withdrawal by Subject|0|||
46864019|NCT04799158|83080719|FG003|Run-In Period|Withdrawal by Subject|0|||
46864020|NCT04799158|83080720|FG004|Run-In Period|Withdrawal by Subject|0|||
46864021|NCT04799158|83080716|FG000|Run-In Period|Miscellaneous|3|||
46864022|NCT04799158|83080717|FG001|Run-In Period|Miscellaneous|0|||
46864023|NCT04799158|83080718|FG002|Run-In Period|Miscellaneous|0|||
46864024|NCT04799158|83080719|FG003|Run-In Period|Miscellaneous|0|||
46864025|NCT04799158|83080720|FG004|Run-In Period|Miscellaneous|0|||
46864026|NCT04799158|83080716|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
46864027|NCT04799158|83080717|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
46864028|NCT04799158|83080718|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
46864029|NCT04799158|83080719|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
46864030|NCT04799158|83080720|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
46864031|NCT04799158|83080716|FG000|On-Demand Treatment Period|Adverse Event|0|||
46864032|NCT04799158|83080717|FG001|On-Demand Treatment Period|Adverse Event|1|||
46864033|NCT04799158|83080718|FG002|On-Demand Treatment Period|Adverse Event|0|||
46864034|NCT04799158|83080719|FG003|On-Demand Treatment Period|Adverse Event|0|||
46864035|NCT04799158|83080720|FG004|On-Demand Treatment Period|Adverse Event|1|||
46697878|NCT02003924|82912727|FG001|Double-blind Phase|Other|50|||
46697879|NCT02003924|82912728|FG002|Double-blind Phase|Other|0|||
46697880|NCT02003924|82912726|FG000|Open-label Phase|Lost to Follow-up|0|||
46697881|NCT02003924|82912727|FG001|Open-label Phase|Lost to Follow-up|0|||
46697882|NCT02003924|82912728|FG002|Open-label Phase|Lost to Follow-up|1|||
46697883|NCT02003924|82912726|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
46864036|NCT04799158|83080716|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
46864037|NCT04799158|83080717|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
46864038|NCT04799158|83080718|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
46864039|NCT04799158|83080719|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
46864040|NCT04799158|83080720|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
46864041|NCT04799158|83080716|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
46864042|NCT04799158|83080717|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
46864043|NCT04799158|83080718|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
46864044|NCT04799158|83080719|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
46864045|NCT04799158|83080720|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
46864046|NCT04799158|83080716|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
46864047|NCT04799158|83080717|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
46864048|NCT04799158|83080718|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
46864049|NCT04799158|83080719|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
46864050|NCT04799158|83080720|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
46864051|NCT04799158|83080716|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
46864052|NCT04799158|83080717|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
46864053|NCT04799158|83080718|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
46864054|NCT04799158|83080719|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
46864055|NCT04799158|83080720|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
46864056|NCT04799158|83080716|FG000|On-Demand Treatment Period|Miscellaneous|0|||
46864057|NCT04799158|83080717|FG001|On-Demand Treatment Period|Miscellaneous|0|||
46697884|NCT02003924|82912727|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
46697885|NCT02003924|82912728|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
46697886|NCT02003924|82912726|FG000|Open-label Phase|Disease Progression|59|||
46697887|NCT02003924|82912727|FG001|Open-label Phase|Disease Progression|0|||
46697888|NCT02003924|82912728|FG002|Open-label Phase|Disease Progression|5|||
46864058|NCT04799158|83080718|FG002|On-Demand Treatment Period|Miscellaneous|0|||
46864059|NCT04799158|83080719|FG003|On-Demand Treatment Period|Miscellaneous|0|||
46864060|NCT04799158|83080720|FG004|On-Demand Treatment Period|Miscellaneous|1|||
46864061|NCT01319422|83080733|FG000|Overall Study|Withdrawal by Subject|1|||
46864062|NCT01319422|83080734|FG001|Overall Study|Withdrawal by Subject|0|||
46864063|NCT03102034|83080742|FG000|Overall Study|Withdrawal by Subject|1|||
46864064|NCT03102034|83080743|FG001|Overall Study|Withdrawal by Subject|0|||
46864065|NCT03774576|83080749|FG000|Period 2|Adverse Event|1|||
46864066|NCT02928952|83080760|FG000|Overall Study|Lost to Follow-up|5|||
46864067|NCT02928952|83080761|FG001|Overall Study|Lost to Follow-up|5|||
46864068|NCT02928952|83080760|FG000|Overall Study|Withdrawal by Subject|5|||
46864069|NCT02928952|83080761|FG001|Overall Study|Withdrawal by Subject|1|||
46864070|NCT02928952|83080760|FG000|Overall Study|Physician Decision|0|||
46864071|NCT02928952|83080761|FG001|Overall Study|Physician Decision|1|||
46697889|NCT02003924|82912726|FG000|Open-label Phase|Adverse Event|25|||
46697890|NCT02003924|82912727|FG001|Open-label Phase|Adverse Event|0|||
46864072|NCT03773796|83080767|FG000|Overall Study|Adverse Event|1|||
46864073|NCT03773796|83080767|FG000|Overall Study|Withdrawal by Subject|1|||
46697891|NCT02003924|82912728|FG002|Open-label Phase|Adverse Event|10|||
46697892|NCT02003924|82912726|FG000|Open-label Phase|Other|7|||
46697893|NCT02003924|82912727|FG001|Open-label Phase|Other|0|||
46864074|NCT03773796|83080767|FG000|Overall Study|Lack of Efficacy|1|||
46864075|NCT02927938|83080775|FG000|Overall Study|Death|0|||
46864076|NCT02927938|83080776|FG001|Overall Study|Death|1|||
46864077|NCT02927938|83080777|FG002|Overall Study|Death|0|||
46864078|NCT02927938|83080778|FG003|Overall Study|Death|4|||
46864079|NCT02927938|83080775|FG000|Overall Study|Early Study Termination|1|||
46864080|NCT02927938|83080776|FG001|Overall Study|Early Study Termination|5|||
46864081|NCT02927938|83080777|FG002|Overall Study|Early Study Termination|4|||
46864082|NCT02927938|83080778|FG003|Overall Study|Early Study Termination|3|||
46697894|NCT02003924|82912728|FG002|Open-label Phase|Other|0|||
46697895|NCT02003924|82912726|FG000|Long-term Follow-up Phase|Death|288|||
46697896|NCT02003924|82912727|FG001|Long-term Follow-up Phase|Death|174|||
46697897|NCT02003924|82912728|FG002|Long-term Follow-up Phase|Death|4|||
46697898|NCT02003924|82912726|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
46697899|NCT02003924|82912727|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
46697900|NCT02003924|82912728|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
46697901|NCT02003924|82912726|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
46697902|NCT02003924|82912727|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
46697903|NCT02003924|82912728|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
46697904|NCT02003924|82912726|FG000|Long-term Follow-up Phase|Other|5|||
46697905|NCT02003924|82912727|FG001|Long-term Follow-up Phase|Other|2|||
46697906|NCT02003924|82912728|FG002|Long-term Follow-up Phase|Other|1|||
46697907|NCT01973452|82912737|FG000|Overall Study|Lack of Efficacy|0|||
46697908|NCT01973452|82912738|FG001|Overall Study|Lack of Efficacy|1|||
46864083|NCT03765138|83080786|FG000|Overall Study|Lost to Follow-up|1|||
46864084|NCT03768726|83080793|FG000|Treatment Phase|Adverse Event|2|||
46864085|NCT03768726|83080794|FG001|Treatment Phase|Adverse Event|2|||
46864086|NCT03768726|83080793|FG000|Treatment Phase|Lost to Follow-up|1|||
46864087|NCT03768726|83080794|FG001|Treatment Phase|Lost to Follow-up|0|||
46864088|NCT03768726|83080793|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
46864089|NCT03768726|83080794|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
46864090|NCT03768726|83080793|FG000|Treatment Phase|Withdrawal by Subject|3|||
46864091|NCT03768726|83080794|FG001|Treatment Phase|Withdrawal by Subject|1|||
46864092|NCT03768726|83080793|FG000|Follow-Up|Adverse Event|2|||
46864093|NCT03768726|83080794|FG001|Follow-Up|Adverse Event|2|||
46864094|NCT03768726|83080793|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
46864095|NCT03768726|83080794|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
46864096|NCT03768726|83080793|FG000|Follow-Up|Withdrawal by Subject|2|||
46864097|NCT03768726|83080794|FG001|Follow-Up|Withdrawal by Subject|0|||
46864098|NCT03768726|83080793|FG000|Follow-Up|Other|1|||
46864099|NCT03768726|83080794|FG001|Follow-Up|Other|0|||
46864100|NCT03769896|83080802|FG000|Open-label Phase|Lack of Efficacy|5|||
46864101|NCT03769896|83080803|FG001|Open-label Phase|Lack of Efficacy|0|||
46864102|NCT03769896|83080802|FG000|Open-label Phase|Adverse Event|3|||
46864103|NCT03769896|83080803|FG001|Open-label Phase|Adverse Event|0|||
46864104|NCT03769896|83080802|FG000|Open-label Phase|Withdrawal by Subject|1|||
46864105|NCT03769896|83080803|FG001|Open-label Phase|Withdrawal by Subject|0|||
46864106|NCT05047601|83080813|FG000|Overall Study|Lost to Follow-up|9|||
46864107|NCT05047601|83080814|FG001|Overall Study|Lost to Follow-up|11|||
46864108|NCT05047601|83080815|FG002|Overall Study|Lost to Follow-up|7|||
46864109|NCT05047601|83080813|FG000|Overall Study|Withdrawal by Subject|25|||
46864110|NCT05047601|83080814|FG001|Overall Study|Withdrawal by Subject|36|||
46864111|NCT05047601|83080815|FG002|Overall Study|Withdrawal by Subject|23|||
46864112|NCT05047601|83080813|FG000|Overall Study|Other|10|||
46864113|NCT05047601|83080814|FG001|Overall Study|Other|6|||
46864114|NCT05047601|83080815|FG002|Overall Study|Other|5|||
46864115|NCT04658784|83080825|FG000|6-month Follow-up|Lost to Follow-up|2|||
46864116|NCT04658784|83080826|FG001|6-month Follow-up|Lost to Follow-up|5|||
46864117|NCT04606394|83080832|FG000|Overall Study|Withdrawal by Subject|3|||
46864118|NCT04606394|83080832|FG000|Overall Study|Exclusion criteria screen failure|12|||
46864119|NCT04585451|83080846|FG000|Overall Study|Withdrawal by Subject|26|||
46864120|NCT04585451|83080847|FG001|Overall Study|Withdrawal by Subject|0|||
46864121|NCT04362189|83080872|FG000|Overall Study|Lost to Follow-up|0|||
46864122|NCT04362189|83080873|FG001|Overall Study|Lost to Follow-up|1|||
46864123|NCT04362189|83080872|FG000|Overall Study|Withdrawal by Subject|1|||
46864124|NCT04362189|83080873|FG001|Overall Study|Withdrawal by Subject|0|||
46864125|NCT04362189|83080872|FG000|Overall Study|FDA Clinical Hold|7|||
46864126|NCT04362189|83080873|FG001|Overall Study|FDA Clinical Hold|2|||
46864127|NCT04362189|83080872|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
46864128|NCT04362189|83080873|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
46864129|NCT04362189|83080872|FG000|Overall Study|Adverse Event|0|||
46864130|NCT04362189|83080873|FG001|Overall Study|Adverse Event|2|||
46697909|NCT01973452|82912737|FG000|Overall Study|Lost to Follow-up|1|||
46697910|NCT01973452|82912738|FG001|Overall Study|Lost to Follow-up|0|||
46864131|NCT04362189|83080872|FG000|Overall Study|Death|4|||
46864132|NCT04362189|83080873|FG001|Overall Study|Death|1|||
46697911|NCT01973452|82912737|FG000|Overall Study|Withdrawal by Subject|10|||
46697912|NCT01973452|82912738|FG001|Overall Study|Withdrawal by Subject|9|||
46697913|NCT01973452|82912737|FG000|Overall Study|Ineligible|1|||
46697914|NCT01973452|82912738|FG001|Overall Study|Ineligible|1|||
46697915|NCT01973452|82912737|FG000|Overall Study|Surgery canceled by participant|5|||
46697916|NCT01973452|82912738|FG001|Overall Study|Surgery canceled by participant|3|||
46697917|NCT01937117|82912744|FG000|Overall Study|Disease Progression|7|||
46697918|NCT01937117|82912744|FG000|Overall Study|Physician Decision|4|||
46697919|NCT01937117|82912744|FG000|Overall Study|Adverse Event|2|||
46697920|NCT01910402|82912750|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
46697921|NCT01910402|82912751|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
46697922|NCT01910402|82912752|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
46697923|NCT01910402|82912750|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
46697924|NCT01910402|82912751|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
46697925|NCT01910402|82912752|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
46697926|NCT01910402|82912750|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
46697927|NCT01910402|82912751|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
46864133|NCT04181788|83080947|FG000|TREATMENT|Adverse Event|0|||
46864134|NCT04181788|83080948|FG001|TREATMENT|Adverse Event|2|||
46864135|NCT04181788|83080949|FG002|TREATMENT|Adverse Event|1|||
46864136|NCT04181788|83080950|FG003|TREATMENT|Adverse Event|0|||
46864137|NCT04181788|83080951|FG004|TREATMENT|Adverse Event|1|||
46864138|NCT04181788|83080952|FG005|TREATMENT|Adverse Event|3|||
46864139|NCT04181788|83080947|FG000|TREATMENT|Death|0|||
46864140|NCT04181788|83080948|FG001|TREATMENT|Death|0|||
46864141|NCT04181788|83080949|FG002|TREATMENT|Death|0|||
46864142|NCT04181788|83080950|FG003|TREATMENT|Death|0|||
46864143|NCT04181788|83080951|FG004|TREATMENT|Death|8|||
46864144|NCT04181788|83080952|FG005|TREATMENT|Death|8|||
46864145|NCT04181788|83080947|FG000|TREATMENT|Physician Decision|0|||
46864146|NCT04181788|83080948|FG001|TREATMENT|Physician Decision|0|||
46864147|NCT04181788|83080949|FG002|TREATMENT|Physician Decision|0|||
46864148|NCT04181788|83080950|FG003|TREATMENT|Physician Decision|0|||
46864149|NCT04181788|83080951|FG004|TREATMENT|Physician Decision|0|||
46864150|NCT04181788|83080952|FG005|TREATMENT|Physician Decision|1|||
46864151|NCT04181788|83080947|FG000|TREATMENT|Progressive disease|3|||
46864152|NCT04181788|83080948|FG001|TREATMENT|Progressive disease|3|||
46864153|NCT04181788|83080949|FG002|TREATMENT|Progressive disease|5|||
46864154|NCT04181788|83080950|FG003|TREATMENT|Progressive disease|7|||
46864155|NCT04181788|83080951|FG004|TREATMENT|Progressive disease|20|||
46864156|NCT04181788|83080952|FG005|TREATMENT|Progressive disease|38|||
46864157|NCT04181788|83080947|FG000|TREATMENT|Global deterioration of health status|0|||
46864158|NCT04181788|83080948|FG001|TREATMENT|Global deterioration of health status|2|||
46864159|NCT04181788|83080949|FG002|TREATMENT|Global deterioration of health status|0|||
46864160|NCT04181788|83080950|FG003|TREATMENT|Global deterioration of health status|0|||
46864161|NCT04181788|83080951|FG004|TREATMENT|Global deterioration of health status|2|||
46697928|NCT01910402|82912752|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
46697929|NCT01910402|82912750|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
46697930|NCT01910402|82912751|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
46697931|NCT01910402|82912752|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
46697932|NCT01910402|82912750|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
46697933|NCT01910402|82912751|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
46697934|NCT01910402|82912752|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
46697935|NCT01910402|82912750|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
46697936|NCT01910402|82912751|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
46697937|NCT01910402|82912752|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
46697938|NCT01910402|82912750|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
46697939|NCT01910402|82912751|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
46697940|NCT01910402|82912752|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
46697941|NCT01910402|82912750|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
46864162|NCT04181788|83080952|FG005|TREATMENT|Global deterioration of health status|8|||
46864163|NCT04181788|83080947|FG000|TREATMENT|Withdrawal by Subject|1|||
46864164|NCT04181788|83080948|FG001|TREATMENT|Withdrawal by Subject|2|||
46864165|NCT04181788|83080949|FG002|TREATMENT|Withdrawal by Subject|0|||
46864166|NCT04181788|83080950|FG003|TREATMENT|Withdrawal by Subject|0|||
46864167|NCT04181788|83080951|FG004|TREATMENT|Withdrawal by Subject|3|||
46864168|NCT04181788|83080952|FG005|TREATMENT|Withdrawal by Subject|5|||
46864169|NCT04181788|83080947|FG000|TREATMENT|Other unspecified|0|||
46864170|NCT04181788|83080948|FG001|TREATMENT|Other unspecified|0|||
46864171|NCT04181788|83080949|FG002|TREATMENT|Other unspecified|0|||
46864172|NCT04181788|83080950|FG003|TREATMENT|Other unspecified|0|||
46864173|NCT04181788|83080951|FG004|TREATMENT|Other unspecified|0|||
46864174|NCT04181788|83080952|FG005|TREATMENT|Other unspecified|2|||
46864175|NCT04181788|83080947|FG000|TREATMENT|Ongoing|0|||
46864176|NCT04181788|83080948|FG001|TREATMENT|Ongoing|3|||
46864177|NCT04181788|83080949|FG002|TREATMENT|Ongoing|0|||
46864178|NCT04181788|83080950|FG003|TREATMENT|Ongoing|5|||
46864179|NCT04181788|83080951|FG004|TREATMENT|Ongoing|7|||
46864180|NCT04181788|83080952|FG005|TREATMENT|Ongoing|15|||
46864181|NCT04181788|83080947|FG000|FOLLOW-UP|Death|0|||
46864182|NCT04181788|83080948|FG001|FOLLOW-UP|Death|0|||
46864183|NCT04181788|83080949|FG002|FOLLOW-UP|Death|1|||
46864184|NCT04181788|83080950|FG003|FOLLOW-UP|Death|2|||
46864185|NCT04181788|83080951|FG004|FOLLOW-UP|Death|8|||
46864186|NCT04181788|83080952|FG005|FOLLOW-UP|Death|20|||
46864187|NCT04181788|83080947|FG000|FOLLOW-UP|Lost to Follow-up|0|||
46864188|NCT04181788|83080948|FG001|FOLLOW-UP|Lost to Follow-up|0|||
46864189|NCT04181788|83080949|FG002|FOLLOW-UP|Lost to Follow-up|0|||
46864190|NCT04181788|83080950|FG003|FOLLOW-UP|Lost to Follow-up|0|||
46864191|NCT04181788|83080951|FG004|FOLLOW-UP|Lost to Follow-up|0|||
46864192|NCT04181788|83080952|FG005|FOLLOW-UP|Lost to Follow-up|2|||
46864193|NCT04181788|83080947|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
46864194|NCT04181788|83080948|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
46864195|NCT04181788|83080949|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
46864196|NCT04181788|83080950|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
46864197|NCT04181788|83080951|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
46864198|NCT04181788|83080952|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
46864199|NCT04181788|83080947|FG000|FOLLOW-UP|Other unspecified|0|||
46864200|NCT04181788|83080948|FG001|FOLLOW-UP|Other unspecified|1|||
46864201|NCT04181788|83080949|FG002|FOLLOW-UP|Other unspecified|0|||
46864202|NCT04181788|83080950|FG003|FOLLOW-UP|Other unspecified|0|||
46864203|NCT04181788|83080951|FG004|FOLLOW-UP|Other unspecified|0|||
46864204|NCT04181788|83080952|FG005|FOLLOW-UP|Other unspecified|3|||
46864205|NCT04181788|83080947|FG000|FOLLOW-UP|Ongoing|0|||
46864206|NCT04181788|83080948|FG001|FOLLOW-UP|Ongoing|0|||
46864207|NCT04181788|83080949|FG002|FOLLOW-UP|Ongoing|1|||
46864208|NCT04181788|83080950|FG003|FOLLOW-UP|Ongoing|3|||
46864209|NCT04181788|83080951|FG004|FOLLOW-UP|Ongoing|2|||
46864210|NCT04181788|83080952|FG005|FOLLOW-UP|Ongoing|2|||
46864211|NCT04120194|83080975|FG000|Overall Study|Lost to Follow-up|11|||
46864212|NCT04120194|83080976|FG001|Overall Study|Lost to Follow-up|8|||
46864213|NCT04120194|83080975|FG000|Overall Study|Adverse Event|4|||
46864214|NCT04120194|83080976|FG001|Overall Study|Adverse Event|5|||
46864215|NCT04120194|83080975|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
46864216|NCT04120194|83080976|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
46864217|NCT04120194|83080975|FG000|Overall Study|Miscellaneous|4|||
46864218|NCT04120194|83080976|FG001|Overall Study|Miscellaneous|5|||
46864219|NCT04050670|83080982|FG000|Period 3|Physician Decision|0|||
46864220|NCT04050670|83080983|FG001|Period 3|Physician Decision|1|||
46864221|NCT04050670|83080984|FG002|Period 3|Physician Decision|0|||
46864222|NCT04016714|83081007|FG000|Overall Study|Death|1|||
46864223|NCT04016714|83081008|FG001|Overall Study|Death|0|||
46864224|NCT04016714|83081007|FG000|Overall Study|Lost to Follow-up|3|||
46864225|NCT04016714|83081008|FG001|Overall Study|Lost to Follow-up|1|||
46864226|NCT04016714|83081007|FG000|Overall Study|Physician Decision|3|||
46864227|NCT04016714|83081008|FG001|Overall Study|Physician Decision|3|||
46864228|NCT04016714|83081007|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
46864229|NCT04016714|83081008|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
46864230|NCT03997409|83081017|FG000|Overall Study|Protocol Violation|1|||
46864231|NCT03997409|83081018|FG001|Overall Study|Protocol Violation|1|||
46864232|NCT03997409|83081019|FG002|Overall Study|Protocol Violation|0|||
46864233|NCT03997409|83081017|FG000|Overall Study|Withdrawal by Subject|3|||
46864234|NCT03997409|83081018|FG001|Overall Study|Withdrawal by Subject|0|||
46864235|NCT03997409|83081019|FG002|Overall Study|Withdrawal by Subject|0|||
46864236|NCT03997409|83081017|FG000|Overall Study|Lost to Follow-up|0|||
46864237|NCT03997409|83081018|FG001|Overall Study|Lost to Follow-up|0|||
46864238|NCT03997409|83081019|FG002|Overall Study|Lost to Follow-up|1|||
46864239|NCT03946124|83081027|FG000|Overall Study|Withdrawal by Subject|19|||
46864240|NCT03812029|83081036|FG000|Overall Study|Protocol Violation|1|||
46864241|NCT03812029|83081037|FG001|Overall Study|Protocol Violation|0|||
46864242|NCT03812029|83081038|FG002|Overall Study|Protocol Violation|0|||
46864243|NCT03812029|83081039|FG003|Overall Study|Protocol Violation|1|||
46864244|NCT03812029|83081040|FG004|Overall Study|Protocol Violation|0|||
46864245|NCT03812029|83081036|FG000|Overall Study|Withdrawal by Subject|1|||
46864246|NCT03812029|83081037|FG001|Overall Study|Withdrawal by Subject|0|||
46864247|NCT03812029|83081038|FG002|Overall Study|Withdrawal by Subject|0|||
46864248|NCT03812029|83081039|FG003|Overall Study|Withdrawal by Subject|2|||
46864249|NCT03812029|83081040|FG004|Overall Study|Withdrawal by Subject|2|||
46864250|NCT03812029|83081036|FG000|Overall Study|Stopping rules|0|||
46864251|NCT03812029|83081037|FG001|Overall Study|Stopping rules|1|||
46864252|NCT03812029|83081038|FG002|Overall Study|Stopping rules|0|||
46864253|NCT03812029|83081039|FG003|Overall Study|Stopping rules|0|||
46864254|NCT03812029|83081040|FG004|Overall Study|Stopping rules|0|||
46864255|NCT03812029|83081036|FG000|Overall Study|Adverse Event|0|||
46864256|NCT03812029|83081037|FG001|Overall Study|Adverse Event|9|||
46864257|NCT03812029|83081038|FG002|Overall Study|Adverse Event|0|||
46864258|NCT03812029|83081039|FG003|Overall Study|Adverse Event|3|||
46864259|NCT03812029|83081040|FG004|Overall Study|Adverse Event|5|||
46864260|NCT03812029|83081036|FG000|Overall Study|Lost to Follow-up|0|||
46864261|NCT03812029|83081037|FG001|Overall Study|Lost to Follow-up|0|||
46864262|NCT03812029|83081038|FG002|Overall Study|Lost to Follow-up|0|||
46864263|NCT03812029|83081039|FG003|Overall Study|Lost to Follow-up|0|||
46864264|NCT03812029|83081040|FG004|Overall Study|Lost to Follow-up|3|||
46864265|NCT03747575|83081058|FG000|Overall Study|Withdrawal by Subject|6|||
46864266|NCT03747575|83081059|FG001|Overall Study|Withdrawal by Subject|3|||
46864267|NCT03747575|83081058|FG000|Overall Study|Lost to Follow-up|3|||
46864268|NCT03747575|83081059|FG001|Overall Study|Lost to Follow-up|3|||
46864269|NCT03747575|83081058|FG000|Overall Study|Adverse Event|0|||
46864270|NCT03747575|83081059|FG001|Overall Study|Adverse Event|1|||
46864271|NCT03657043|83081068|FG000|Overall Study|Withdrawal by Subject|1|||
46864272|NCT03657043|83081069|FG001|Overall Study|Withdrawal by Subject|1|||
46864273|NCT03657043|83081070|FG002|Overall Study|Withdrawal by Subject|0|||
46864274|NCT03657043|83081071|FG003|Overall Study|Withdrawal by Subject|0|||
46864275|NCT03657043|83081072|FG004|Overall Study|Withdrawal by Subject|4|||
46864276|NCT03657043|83081068|FG000|Overall Study|Study closure by Sponsor|0|||
46864277|NCT03657043|83081069|FG001|Overall Study|Study closure by Sponsor|2|||
46864278|NCT03657043|83081070|FG002|Overall Study|Study closure by Sponsor|0|||
46864279|NCT03657043|83081071|FG003|Overall Study|Study closure by Sponsor|0|||
46864280|NCT03657043|83081072|FG004|Overall Study|Study closure by Sponsor|17|||
46864281|NCT03657043|83081068|FG000|Overall Study|Lost to Follow-up|0|||
46864282|NCT03657043|83081069|FG001|Overall Study|Lost to Follow-up|0|||
46864283|NCT03657043|83081070|FG002|Overall Study|Lost to Follow-up|0|||
46864284|NCT03657043|83081071|FG003|Overall Study|Lost to Follow-up|0|||
46864285|NCT03657043|83081072|FG004|Overall Study|Lost to Follow-up|4|||
46864286|NCT03657043|83081068|FG000|Overall Study|Death|6|||
46864287|NCT03657043|83081069|FG001|Overall Study|Death|5|||
46864288|NCT03657043|83081070|FG002|Overall Study|Death|0|||
46864289|NCT03657043|83081071|FG003|Overall Study|Death|0|||
46864290|NCT03657043|83081072|FG004|Overall Study|Death|53|||
46864291|NCT03657043|83081068|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
46864292|NCT03657043|83081069|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
46864293|NCT03657043|83081070|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
46864294|NCT03657043|83081071|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
46864295|NCT03657043|83081072|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
46864296|NCT03657043|83081068|FG000|Overall Study|Adverse Event|0|||
46864297|NCT03657043|83081069|FG001|Overall Study|Adverse Event|0|||
46864298|NCT03657043|83081070|FG002|Overall Study|Adverse Event|0|||
46864299|NCT03657043|83081071|FG003|Overall Study|Adverse Event|0|||
46697942|NCT01910402|82912751|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
46697943|NCT01910402|82912752|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
46697944|NCT01910402|82912750|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
46697945|NCT01910402|82912751|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
46697946|NCT01910402|82912752|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
46697947|NCT01910402|82912750|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
46697948|NCT01910402|82912751|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
46697949|NCT01910402|82912752|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
46697950|NCT01910402|82912750|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
46697951|NCT01910402|82912751|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
46697952|NCT01910402|82912752|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
46864300|NCT03657043|83081072|FG004|Overall Study|Adverse Event|2|||
46864301|NCT03657043|83081068|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
46864302|NCT03657043|83081069|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
46864303|NCT03657043|83081070|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
46864304|NCT03657043|83081071|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
46864305|NCT03657043|83081072|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
46864306|NCT03657043|83081068|FG000|Overall Study|Withdrawal - declined follow-up|0|||
46864307|NCT03657043|83081069|FG001|Overall Study|Withdrawal - declined follow-up|0|||
46864308|NCT03657043|83081070|FG002|Overall Study|Withdrawal - declined follow-up|0|||
46864309|NCT03657043|83081071|FG003|Overall Study|Withdrawal - declined follow-up|0|||
46864310|NCT03657043|83081072|FG004|Overall Study|Withdrawal - declined follow-up|1|||
46864311|NCT03646669|83081082|FG000|Overall Study|Withdrawal by Subject|5|||
46864312|NCT03646669|83081083|FG001|Overall Study|Withdrawal by Subject|0|||
46864313|NCT03619876|83081091|FG000|Overall Study|Withdrawal by Subject|1|||
46864314|NCT03619876|83081092|FG001|Overall Study|Withdrawal by Subject|2|||
46864315|NCT03619876|83081091|FG000|Overall Study|Withdrawal due to incidental finding|0|||
46864316|NCT03619876|83081092|FG001|Overall Study|Withdrawal due to incidental finding|2|||
46864317|NCT03526861|83081114|FG000|Initial Treatment Period|Not dosed|1|||
46864318|NCT03526861|83081115|FG001|Initial Treatment Period|Not dosed|1|||
46864319|NCT03526861|83081116|FG002|Initial Treatment Period|Not dosed|1|||
46864320|NCT03526861|83081117|FG003|Initial Treatment Period|Not dosed|0|||
46864321|NCT03526861|83081118|FG004|Initial Treatment Period|Not dosed|0|||
46864322|NCT03526861|83081119|FG005|Initial Treatment Period|Not dosed|0|||
46864323|NCT03526861|83081120|FG006|Initial Treatment Period|Not dosed|0|||
46864324|NCT03526861|83081121|FG007|Initial Treatment Period|Not dosed|0|||
46864325|NCT03526861|83081122|FG008|Initial Treatment Period|Not dosed|0|||
46864326|NCT03526861|83081114|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
46864327|NCT03526861|83081115|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
46864328|NCT03526861|83081116|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
46864329|NCT03526861|83081117|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864330|NCT03526861|83081118|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864331|NCT03526861|83081119|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864332|NCT03526861|83081120|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864333|NCT03526861|83081121|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864334|NCT03526861|83081122|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864335|NCT03526861|83081114|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
46864336|NCT03526861|83081115|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
46864337|NCT03526861|83081116|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
46864338|NCT03526861|83081117|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
46864339|NCT03526861|83081118|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
46864340|NCT03526861|83081119|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
46864341|NCT03526861|83081120|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
46864342|NCT03526861|83081121|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
46982519|NCT02380677|83228827|FG009|Overall Study|Lack of Efficacy|0|||
46982520|NCT02380677|83228828|FG010|Overall Study|Lack of Efficacy|2|||
46697953|NCT01910402|82912750|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
46697954|NCT01910402|82912751|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
46697955|NCT01910402|82912752|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
46697956|NCT01910402|82912750|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
46697957|NCT01910402|82912751|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
46697958|NCT01910402|82912752|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
46697959|NCT01754402|82912766|FG000|Overall Study|Death|0|||
46697960|NCT01754402|82912767|FG001|Overall Study|Death|0|||
46697961|NCT01754402|82912768|FG002|Overall Study|Death|1|||
46697962|NCT01754402|82912766|FG000|Overall Study|Adverse Event|2|||
46697963|NCT01754402|82912767|FG001|Overall Study|Adverse Event|2|||
46697964|NCT01754402|82912768|FG002|Overall Study|Adverse Event|1|||
46697965|NCT01754402|82912766|FG000|Overall Study|Withdrawal by Subject|0|||
46697966|NCT01754402|82912767|FG001|Overall Study|Withdrawal by Subject|0|||
46697967|NCT01754402|82912768|FG002|Overall Study|Withdrawal by Subject|1|||
46697968|NCT01754402|82912766|FG000|Overall Study|Lack of Efficacy|0|||
46697969|NCT01754402|82912767|FG001|Overall Study|Lack of Efficacy|0|||
46697970|NCT01754402|82912768|FG002|Overall Study|Lack of Efficacy|1|||
46697971|NCT01740297|82912780|FG000|Overall Study|Withdrawal by Subject|4|||
46697972|NCT01740297|82912781|FG001|Overall Study|Withdrawal by Subject|16|||
46697973|NCT01740297|82912782|FG002|Overall Study|Withdrawal by Subject|17|||
46697974|NCT01740297|82912780|FG000|Overall Study|Death|8|||
46697975|NCT01740297|82912781|FG001|Overall Study|Death|46|||
46697976|NCT01740297|82912782|FG002|Overall Study|Death|40|||
46697977|NCT01740297|82912780|FG000|Overall Study|Lost to Follow-up|1|||
46697978|NCT01740297|82912781|FG001|Overall Study|Lost to Follow-up|2|||
46697979|NCT01740297|82912782|FG002|Overall Study|Lost to Follow-up|4|||
46697980|NCT01539720|82912794|FG000|Overall Study|Screen Fail|15|||
46697981|NCT01539720|82912795|FG001|Overall Study|Screen Fail|3|||
46697982|NCT01539720|82912794|FG000|Overall Study|Lost to Follow-up|14|||
46697983|NCT01539720|82912795|FG001|Overall Study|Lost to Follow-up|7|||
46697984|NCT01236560|82912807|FG000|Overall Study|Adverse Event|0|||
46697985|NCT01236560|82912808|FG001|Overall Study|Adverse Event|2|||
46697986|NCT01236560|82912809|FG002|Overall Study|Adverse Event|1|||
46697987|NCT01236560|82912810|FG003|Overall Study|Adverse Event|3|||
46697988|NCT01236560|82912811|FG004|Overall Study|Adverse Event|0|||
46697989|NCT01236560|82912812|FG005|Overall Study|Adverse Event|0|||
46697990|NCT01236560|82912807|FG000|Overall Study|Death|0|||
46697991|NCT01236560|82912808|FG001|Overall Study|Death|1|||
46697992|NCT01236560|82912809|FG002|Overall Study|Death|0|||
46697993|NCT01236560|82912810|FG003|Overall Study|Death|1|||
46697994|NCT01236560|82912811|FG004|Overall Study|Death|0|||
46697995|NCT01236560|82912812|FG005|Overall Study|Death|0|||
46697996|NCT01236560|82912807|FG000|Overall Study|Lost to Follow-up|0|||
46697997|NCT01236560|82912808|FG001|Overall Study|Lost to Follow-up|1|||
46697998|NCT01236560|82912809|FG002|Overall Study|Lost to Follow-up|1|||
46697999|NCT01236560|82912810|FG003|Overall Study|Lost to Follow-up|0|||
46698000|NCT01236560|82912811|FG004|Overall Study|Lost to Follow-up|0|||
46698001|NCT01236560|82912812|FG005|Overall Study|Lost to Follow-up|0|||
46698002|NCT01236560|82912807|FG000|Overall Study|Physician Decision|0|||
46698003|NCT01236560|82912808|FG001|Overall Study|Physician Decision|1|||
46698004|NCT01236560|82912809|FG002|Overall Study|Physician Decision|8|||
46698005|NCT01236560|82912810|FG003|Overall Study|Physician Decision|0|||
46698006|NCT01236560|82912811|FG004|Overall Study|Physician Decision|0|||
46698007|NCT01236560|82912812|FG005|Overall Study|Physician Decision|0|||
46698008|NCT01236560|82912807|FG000|Overall Study|Withdrawal by Subject|0|||
46698009|NCT01236560|82912808|FG001|Overall Study|Withdrawal by Subject|0|||
46698010|NCT01236560|82912809|FG002|Overall Study|Withdrawal by Subject|1|||
46698011|NCT01236560|82912810|FG003|Overall Study|Withdrawal by Subject|2|||
46698012|NCT01236560|82912811|FG004|Overall Study|Withdrawal by Subject|0|||
46698013|NCT01236560|82912812|FG005|Overall Study|Withdrawal by Subject|0|||
46698014|NCT01236560|82912807|FG000|Overall Study|Progressive disease|5|||
46698015|NCT01236560|82912808|FG001|Overall Study|Progressive disease|19|||
46698016|NCT01236560|82912809|FG002|Overall Study|Progressive disease|9|||
46698017|NCT01236560|82912810|FG003|Overall Study|Progressive disease|16|||
46698018|NCT01236560|82912811|FG004|Overall Study|Progressive disease|0|||
46698019|NCT01236560|82912812|FG005|Overall Study|Progressive disease|0|||
46698020|NCT00333801|82912833|FG000|Overall Study|Moved to another state|5|||
46698021|NCT00333801|82912834|FG001|Overall Study|Moved to another state|3|||
46698022|NCT00333801|82912833|FG000|Overall Study|Lost to Follow-up|2|||
46698023|NCT00333801|82912834|FG001|Overall Study|Lost to Follow-up|0|||
46698024|NCT00333801|82912833|FG000|Overall Study|Incarcerated|1|||
46698025|NCT00333801|82912834|FG001|Overall Study|Incarcerated|2|||
46698026|NCT00333801|82912833|FG000|Overall Study|Withdrawal by Subject|0|||
46698027|NCT00333801|82912834|FG001|Overall Study|Withdrawal by Subject|1|||
46698028|NCT03483116|82912844|FG000|Overall Study|Adverse Event|0|||
46698029|NCT03483116|82912845|FG001|Overall Study|Adverse Event|1|||
46698030|NCT03483116|82912846|FG002|Overall Study|Adverse Event|0|||
46698031|NCT03483116|82912847|FG003|Overall Study|Adverse Event|1|||
46698032|NCT03483116|82912844|FG000|Overall Study|Protocol Violation|1|||
46698033|NCT03483116|82912845|FG001|Overall Study|Protocol Violation|0|||
46698034|NCT03483116|82912846|FG002|Overall Study|Protocol Violation|0|||
46698035|NCT03483116|82912847|FG003|Overall Study|Protocol Violation|7|||
46698036|NCT03483116|82912844|FG000|Overall Study|Lost to Follow-up|9|||
46698037|NCT03483116|82912845|FG001|Overall Study|Lost to Follow-up|4|||
46698038|NCT03483116|82912846|FG002|Overall Study|Lost to Follow-up|9|||
46698039|NCT03483116|82912847|FG003|Overall Study|Lost to Follow-up|5|||
46698040|NCT03483116|82912844|FG000|Overall Study|Death|1|||
46698041|NCT03483116|82912845|FG001|Overall Study|Death|0|||
46698042|NCT03483116|82912846|FG002|Overall Study|Death|2|||
46698043|NCT03483116|82912847|FG003|Overall Study|Death|1|||
46698044|NCT03483116|82912844|FG000|Overall Study|Withdrawal by Subject|14|||
46698045|NCT03483116|82912845|FG001|Overall Study|Withdrawal by Subject|16|||
46698046|NCT03483116|82912846|FG002|Overall Study|Withdrawal by Subject|14|||
46698047|NCT03483116|82912847|FG003|Overall Study|Withdrawal by Subject|16|||
46698048|NCT03483116|82912844|FG000|Overall Study|Unknown other reason|3|||
46698049|NCT03483116|82912845|FG001|Overall Study|Unknown other reason|2|||
46698050|NCT03483116|82912846|FG002|Overall Study|Unknown other reason|1|||
46698051|NCT03483116|82912847|FG003|Overall Study|Unknown other reason|1|||
46698052|NCT02811861|82912878|FG000|Overall Study|Radiological Disease Progression|123|||
46698053|NCT02811861|82912879|FG001|Overall Study|Radiological Disease Progression|97|||
46698054|NCT02811861|82912880|FG002|Overall Study|Radiological Disease Progression|174|||
46698055|NCT02811861|82912878|FG000|Overall Study|Clinical Disease Progression|20|||
46698056|NCT02811861|82912879|FG001|Overall Study|Clinical Disease Progression|19|||
46698057|NCT02811861|82912880|FG002|Overall Study|Clinical Disease Progression|22|||
46698058|NCT02811861|82912878|FG000|Overall Study|Adverse Event|63|||
46698059|NCT02811861|82912879|FG001|Overall Study|Adverse Event|60|||
46698060|NCT02811861|82912880|FG002|Overall Study|Adverse Event|41|||
46698061|NCT02811861|82912878|FG000|Overall Study|Lost to Follow-up|0|||
46864343|NCT03526861|83081122|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
46864344|NCT03526861|83081114|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46698062|NCT02811861|82912879|FG001|Overall Study|Lost to Follow-up|0|||
46698063|NCT02811861|82912880|FG002|Overall Study|Lost to Follow-up|1|||
46698064|NCT02811861|82912878|FG000|Overall Study|Subject Choice|29|||
46698065|NCT02811861|82912879|FG001|Overall Study|Subject Choice|17|||
46698066|NCT02811861|82912880|FG002|Overall Study|Subject Choice|23|||
46698067|NCT02811861|82912878|FG000|Overall Study|Withdrawal by Subject|4|||
46698068|NCT02811861|82912879|FG001|Overall Study|Withdrawal by Subject|4|||
46698069|NCT02811861|82912880|FG002|Overall Study|Withdrawal by Subject|9|||
46698070|NCT02811861|82912878|FG000|Overall Study|Other|4|||
46698071|NCT02811861|82912879|FG001|Overall Study|Other|13|||
46698072|NCT02811861|82912880|FG002|Overall Study|Other|3|||
46698073|NCT02811861|82912878|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
46698074|NCT02811861|82912879|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
46698075|NCT02811861|82912880|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
46698076|NCT02811861|82912878|FG000|Overall Study|Randomized but not treated|2|||
46698077|NCT02811861|82912879|FG001|Overall Study|Randomized but not treated|3|||
46698078|NCT02811861|82912880|FG002|Overall Study|Randomized but not treated|17|||
46698079|NCT02700451|82912891|FG000|Overall Study|Protocol Violation|2|||
46698080|NCT02700451|82912892|FG001|Overall Study|Protocol Violation|2|||
46698081|NCT02700451|82912893|FG002|Overall Study|Protocol Violation|3|||
46698082|NCT02700451|82912891|FG000|Overall Study|Discontinued intervention|14|||
46698083|NCT02700451|82912892|FG001|Overall Study|Discontinued intervention|15|||
46698084|NCT02700451|82912893|FG002|Overall Study|Discontinued intervention|14|||
46698085|NCT02623426|82912904|FG000|Overall Study|Lost to Follow-up|0|||
46698086|NCT02623426|82912905|FG001|Overall Study|Lost to Follow-up|0|||
46698087|NCT02623426|82912906|FG002|Overall Study|Lost to Follow-up|1|||
46698088|NCT02623426|82912904|FG000|Overall Study|Withdrawal by Subject|1|||
46698089|NCT02623426|82912905|FG001|Overall Study|Withdrawal by Subject|2|||
46698090|NCT02623426|82912906|FG002|Overall Study|Withdrawal by Subject|2|||
46864345|NCT03526861|83081115|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864346|NCT03526861|83081116|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864347|NCT03526861|83081117|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
46864348|NCT03526861|83081118|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
46864349|NCT03526861|83081119|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864350|NCT03526861|83081120|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
46864351|NCT03526861|83081121|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864352|NCT03526861|83081122|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864353|NCT03526861|83081114|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
46864354|NCT03526861|83081115|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
46864355|NCT03526861|83081116|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
46864356|NCT03526861|83081117|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
46864357|NCT03526861|83081118|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
46864358|NCT03526861|83081119|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
46864359|NCT03526861|83081120|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
46864360|NCT03526861|83081121|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
46864361|NCT03526861|83081122|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
46864362|NCT03526861|83081114|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864363|NCT03526861|83081115|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864364|NCT03526861|83081116|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864365|NCT03526861|83081117|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
46864366|NCT03526861|83081118|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46698091|NCT02580058|82912917|FG000|Overall Study|Adverse Event|16|||
46698092|NCT02580058|82912918|FG001|Overall Study|Adverse Event|30|||
46698093|NCT02580058|82912919|FG002|Overall Study|Adverse Event|20|||
46698094|NCT02580058|82912917|FG000|Overall Study|Death|4|||
46864367|NCT03526861|83081119|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864368|NCT03526861|83081120|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864369|NCT03526861|83081121|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864370|NCT03526861|83081122|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864371|NCT03526861|83081114|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864372|NCT03526861|83081115|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46698095|NCT02580058|82912918|FG001|Overall Study|Death|4|||
46698096|NCT02580058|82912919|FG002|Overall Study|Death|5|||
46698097|NCT02580058|82912917|FG000|Overall Study|Physician Decision|1|||
46698098|NCT02580058|82912918|FG001|Overall Study|Physician Decision|3|||
46698099|NCT02580058|82912919|FG002|Overall Study|Physician Decision|11|||
46698100|NCT02580058|82912917|FG000|Overall Study|Other|5|||
46698101|NCT02580058|82912918|FG001|Overall Study|Other|1|||
46698102|NCT02580058|82912919|FG002|Overall Study|Other|3|||
46698103|NCT02580058|82912917|FG000|Overall Study|Withdrawal by Subject|4|||
46698104|NCT02580058|82912918|FG001|Overall Study|Withdrawal by Subject|7|||
46864373|NCT03526861|83081116|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864374|NCT03526861|83081117|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864375|NCT03526861|83081118|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864376|NCT03526861|83081119|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864377|NCT03526861|83081120|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864378|NCT03526861|83081121|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
46864379|NCT03526861|83081122|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
46864380|NCT03526861|83081114|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46864381|NCT03526861|83081115|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46864382|NCT03526861|83081116|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46864383|NCT03526861|83081117|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46864384|NCT03526861|83081118|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46897053|NCT00706654|83122633|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
46982521|NCT02380677|83228829|FG011|Overall Study|Lack of Efficacy|1|||
46982522|NCT02380677|83228818|FG000|Overall Study|Withdrawal by Subject|0|||
46982523|NCT02380677|83228819|FG001|Overall Study|Withdrawal by Subject|0|||
46982524|NCT02380677|83228820|FG002|Overall Study|Withdrawal by Subject|0|||
46982525|NCT02380677|83228821|FG003|Overall Study|Withdrawal by Subject|0|||
46698105|NCT02580058|82912919|FG002|Overall Study|Withdrawal by Subject|31|||
46698106|NCT02580058|82912917|FG000|Overall Study|Global Deterioration of Health Status|19|||
46698107|NCT02580058|82912918|FG001|Overall Study|Global Deterioration of Health Status|18|||
46698108|NCT02580058|82912919|FG002|Overall Study|Global Deterioration of Health Status|24|||
46698109|NCT02580058|82912917|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
46698110|NCT02580058|82912918|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46698111|NCT02580058|82912919|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
46698112|NCT02580058|82912917|FG000|Overall Study|Progressive Disease|137|||
46698113|NCT02580058|82912918|FG001|Overall Study|Progressive Disease|125|||
46982526|NCT02380677|83228822|FG004|Overall Study|Withdrawal by Subject|0|||
46982527|NCT02380677|83228823|FG005|Overall Study|Withdrawal by Subject|0|||
46982528|NCT02380677|83228824|FG006|Overall Study|Withdrawal by Subject|0|||
46698114|NCT02580058|82912919|FG002|Overall Study|Progressive Disease|94|||
46698115|NCT02580058|82912917|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46698116|NCT02580058|82912918|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46698117|NCT02580058|82912919|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46698118|NCT02539394|82912931|FG000|Overall Study|Protocol Violation|1|||
46698119|NCT02539394|82912932|FG001|Overall Study|Protocol Violation|3|||
46698120|NCT02539394|82912931|FG000|Overall Study|Lost to Follow-up|1|||
46698121|NCT02539394|82912932|FG001|Overall Study|Lost to Follow-up|2|||
46698122|NCT02539394|82912931|FG000|Overall Study|Incomplete dataset|6|||
46698123|NCT02539394|82912932|FG001|Overall Study|Incomplete dataset|6|||
46698124|NCT02412670|82912946|FG000|Overall Study|Adverse Event|4|||
46698125|NCT02412670|82912947|FG001|Overall Study|Adverse Event|1|||
46698126|NCT02412670|82912946|FG000|Overall Study|Physician Decision|1|||
46698127|NCT02412670|82912947|FG001|Overall Study|Physician Decision|0|||
46698128|NCT02412670|82912946|FG000|Overall Study|Withdrawal by Subject|1|||
46698129|NCT02412670|82912947|FG001|Overall Study|Withdrawal by Subject|0|||
46698130|NCT02412670|82912946|FG000|Overall Study|Ineligible|1|||
46698131|NCT02412670|82912947|FG001|Overall Study|Ineligible|0|||
46698132|NCT05111145|82912967|FG000|Overall Study|Commercial drug is available for participant|76|||
46698133|NCT05111145|82912967|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
46698134|NCT04823130|82912986|FG000|Overall Study|Withdrawal by Subject|2|||
46698135|NCT04823130|82912987|FG001|Overall Study|Withdrawal by Subject|3|||
46698136|NCT04823130|82912986|FG000|Overall Study|Failure to meet inclusion criteria|6|||
46698137|NCT04823130|82912987|FG001|Overall Study|Failure to meet inclusion criteria|4|||
46698138|NCT04823130|82912986|FG000|Overall Study|Other-unspecified|1|||
46698139|NCT04823130|82912987|FG001|Overall Study|Other-unspecified|0|||
46698140|NCT04402385|82913046|FG000|Overall Study|Withdrawal by Subject|4|||
46698141|NCT04402385|82913047|FG001|Overall Study|Withdrawal by Subject|4|||
46698142|NCT04402385|82913046|FG000|Overall Study|Lost to Follow-up|1|||
46698143|NCT04402385|82913047|FG001|Overall Study|Lost to Follow-up|1|||
46864385|NCT03526861|83081119|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46864386|NCT03526861|83081120|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46864387|NCT03526861|83081121|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
46864388|NCT03526861|83081122|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
46864389|NCT03526861|83081114|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864390|NCT03526861|83081115|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864391|NCT03526861|83081116|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864392|NCT03526861|83081117|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864393|NCT03526861|83081118|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864394|NCT03526861|83081119|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864395|NCT03526861|83081120|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864396|NCT03526861|83081121|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
46864397|NCT03526861|83081122|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
46864398|NCT03510884|83081146|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
46864399|NCT03510884|83081147|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
46864400|NCT03510884|83081148|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
46864401|NCT03510884|83081149|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
46864402|NCT03510884|83081146|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
46864403|NCT03510884|83081147|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
46864404|NCT03510884|83081148|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
46864405|NCT03510884|83081149|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
46864406|NCT03510884|83081146|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
46864407|NCT03510884|83081147|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
46864408|NCT03510884|83081148|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
46864409|NCT03510884|83081149|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
46864410|NCT03510884|83081146|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
46864411|NCT03510884|83081147|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
46698144|NCT04402385|82913046|FG000|Overall Study|Physician Decision|0|||
46698145|NCT04402385|82913047|FG001|Overall Study|Physician Decision|1|||
46698146|NCT03785210|82913057|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
46698147|NCT03785210|82913058|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
46698148|NCT03750968|82913066|FG000|Overall Study|Adverse Event|2|||
46698149|NCT03750968|82913067|FG001|Overall Study|Adverse Event|0|||
46698150|NCT03750968|82913066|FG000|Overall Study|Lost to Follow-up|1|||
46698151|NCT03750968|82913067|FG001|Overall Study|Lost to Follow-up|3|||
46864412|NCT03510884|83081148|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
46864413|NCT03510884|83081149|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
46864414|NCT03510884|83081146|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
46864415|NCT03510884|83081147|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
46864416|NCT03510884|83081148|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
46864417|NCT03510884|83081149|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
46864418|NCT03510884|83081146|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
46864419|NCT03510884|83081147|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
46864420|NCT03510884|83081148|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
46864421|NCT03510884|83081149|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
46864422|NCT03510884|83081146|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
46864423|NCT03510884|83081147|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
46864424|NCT03510884|83081148|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
46864425|NCT03510884|83081149|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
46864426|NCT03510884|83081146|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
46864427|NCT03510884|83081147|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
46864428|NCT03510884|83081148|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
46864429|NCT03510884|83081149|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
46864430|NCT03510884|83081146|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
46864431|NCT03510884|83081147|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
46864432|NCT03510884|83081148|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
46864433|NCT03510884|83081149|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
46864434|NCT03510884|83081146|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
46864435|NCT03510884|83081147|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
46864436|NCT03510884|83081148|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
46864437|NCT03510884|83081149|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
46864438|NCT03488472|83081183|FG000|Overall Study|disease progression additional mets|1|||
46864439|NCT03456453|83081189|FG000|Overall Study|Withdrawal by Subject|2|||
46864440|NCT03456453|83081190|FG001|Overall Study|Withdrawal by Subject|0|||
46864441|NCT03456453|83081189|FG000|Overall Study|Not released to community|1|||
46864442|NCT03456453|83081190|FG001|Overall Study|Not released to community|5|||
46864443|NCT03456453|83081189|FG000|Overall Study|Lost to Follow-up|0|||
46864444|NCT03456453|83081190|FG001|Overall Study|Lost to Follow-up|2|||
46864445|NCT03455829|83081201|FG000|Overall Study|Death|2|||
46864446|NCT03455829|83081202|FG001|Overall Study|Death|3|||
46864447|NCT03455829|83081203|FG002|Overall Study|Death|2|||
46864448|NCT03455829|83081204|FG003|Overall Study|Death|4|||
46864449|NCT03455829|83081205|FG004|Overall Study|Death|2|||
46864450|NCT03455829|83081201|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
46864451|NCT03455829|83081202|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
46864452|NCT03455829|83081203|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
46864453|NCT03455829|83081204|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
46864454|NCT03455829|83081205|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
46864455|NCT03455829|83081201|FG000|Overall Study|Disease progression|0|||
46864456|NCT03455829|83081202|FG001|Overall Study|Disease progression|0|||
46864457|NCT03455829|83081203|FG002|Overall Study|Disease progression|0|||
46864458|NCT03455829|83081204|FG003|Overall Study|Disease progression|1|||
46864459|NCT03455829|83081205|FG004|Overall Study|Disease progression|1|||
46864460|NCT03441334|83081219|FG000|Overall Study|Withdrawal by Subject|1|||
46864461|NCT03441334|83081220|FG001|Overall Study|Withdrawal by Subject|0|||
46864462|NCT03429244|83081251|FG000|Overall Study|Withdrawal by Subject|2|||
46864463|NCT03429244|83081252|FG001|Overall Study|Withdrawal by Subject|1|||
46864464|NCT03429244|83081253|FG002|Overall Study|Withdrawal by Subject|1|||
46864465|NCT03250117|83081266|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
46864466|NCT03250117|83081267|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
46864467|NCT03250117|83081268|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
46864468|NCT03250117|83081269|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
46864469|NCT03230838|83081275|FG000|Overall Study|Withdrawal by Subject|3|||
46864470|NCT03230838|83081276|FG001|Overall Study|Withdrawal by Subject|0|||
46864471|NCT03230838|83081275|FG000|Overall Study|Temperature excursion|1|||
46864472|NCT03230838|83081276|FG001|Overall Study|Temperature excursion|0|||
46864473|NCT03217136|83081284|FG000|Overall Study|Lost to Follow-up|2|||
46864474|NCT03217136|83081285|FG001|Overall Study|Lost to Follow-up|1|||
46864475|NCT03217136|83081284|FG000|Overall Study|Site Randomized Participant in Error|0|||
46864476|NCT03217136|83081285|FG001|Overall Study|Site Randomized Participant in Error|1|||
46982529|NCT02380677|83228825|FG007|Overall Study|Withdrawal by Subject|0|||
46864477|NCT03217136|83081284|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
46864478|NCT03217136|83081285|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
46864479|NCT03217136|83081284|FG000|Overall Study|Dispensing Error|1|||
46864480|NCT03217136|83081285|FG001|Overall Study|Dispensing Error|0|||
46864481|NCT03217136|83081284|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
46864482|NCT03217136|83081285|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
46864483|NCT03179761|83081293|FG000|Overall Study|Death|2|||
46864484|NCT03179761|83081294|FG001|Overall Study|Death|5|||
46864485|NCT03179761|83081293|FG000|Overall Study|Lost to Follow-up|2|||
46864486|NCT03179761|83081294|FG001|Overall Study|Lost to Follow-up|2|||
46864487|NCT03179761|83081293|FG000|Overall Study|Protocol Violation|1|||
46864488|NCT03179761|83081294|FG001|Overall Study|Protocol Violation|0|||
46864489|NCT03179761|83081293|FG000|Overall Study|Withdrawal by Subject|1|||
46864490|NCT03179761|83081294|FG001|Overall Study|Withdrawal by Subject|4|||
46864491|NCT03179761|83081293|FG000|Overall Study|Investigator Request|0|||
46864492|NCT03179761|83081294|FG001|Overall Study|Investigator Request|2|||
46864493|NCT03155841|83081302|FG000|Overall Study|Protocol Violation|3|||
46864494|NCT03155841|83081303|FG001|Overall Study|Protocol Violation|4|||
46864495|NCT03114891|83081313|FG000|First Treatment Round|Lost to Follow-up|0|||
46864496|NCT03114891|83081314|FG001|First Treatment Round|Lost to Follow-up|1|||
46864497|NCT03114891|83081315|FG002|First Treatment Round|Lost to Follow-up|1|||
46864498|NCT03114891|83081316|FG003|First Treatment Round|Lost to Follow-up|0|||
46864499|NCT03114891|83081313|FG000|First Treatment Round|Withdrawal by Subject|0|||
46864500|NCT03114891|83081314|FG001|First Treatment Round|Withdrawal by Subject|2|||
46864501|NCT03114891|83081315|FG002|First Treatment Round|Withdrawal by Subject|0|||
46864502|NCT03114891|83081316|FG003|First Treatment Round|Withdrawal by Subject|1|||
46864503|NCT03114891|83081313|FG000|3 Week Break|Lost to Follow-up|1|||
46864504|NCT03114891|83081314|FG001|3 Week Break|Lost to Follow-up|0|||
46864505|NCT03114891|83081315|FG002|3 Week Break|Lost to Follow-up|0|||
46864506|NCT03114891|83081316|FG003|3 Week Break|Lost to Follow-up|1|||
46864507|NCT03114891|83081313|FG000|3 Week Break|Withdrawal by Subject|0|||
46864508|NCT03114891|83081314|FG001|3 Week Break|Withdrawal by Subject|1|||
46864509|NCT03114891|83081315|FG002|3 Week Break|Withdrawal by Subject|0|||
46864510|NCT03114891|83081316|FG003|3 Week Break|Withdrawal by Subject|0|||
46864511|NCT03114891|83081313|FG000|Second Treatment Round|Lost to Follow-up|1|||
46864512|NCT03114891|83081314|FG001|Second Treatment Round|Lost to Follow-up|0|||
46864513|NCT03114891|83081315|FG002|Second Treatment Round|Lost to Follow-up|0|||
46864514|NCT03114891|83081316|FG003|Second Treatment Round|Lost to Follow-up|0|||
46864515|NCT03114891|83081313|FG000|Second Treatment Round|Physician Decision|1|||
46864516|NCT03114891|83081314|FG001|Second Treatment Round|Physician Decision|0|||
46864517|NCT03114891|83081315|FG002|Second Treatment Round|Physician Decision|0|||
46864518|NCT03114891|83081316|FG003|Second Treatment Round|Physician Decision|0|||
46864519|NCT03057847|83081358|FG000|Overall Study|Lost to Follow-up|16|||
46864520|NCT02946463|83081373|FG000|Primary Evaluation Period|Physician Decision|0|||
46864521|NCT02946463|83081374|FG001|Primary Evaluation Period|Physician Decision|1|||
46864522|NCT02946463|83081373|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
46864523|NCT02946463|83081374|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
46864524|NCT02761694|83081427|FG000|Overall Study|Lack of Efficacy|0|||
46864525|NCT02761694|83081428|FG001|Overall Study|Lack of Efficacy|0|||
46864526|NCT02761694|83081429|FG002|Overall Study|Lack of Efficacy|0|||
46864527|NCT02761694|83081430|FG003|Overall Study|Lack of Efficacy|0|||
46982530|NCT02380677|83228826|FG008|Overall Study|Withdrawal by Subject|0|||
46982531|NCT02380677|83228827|FG009|Overall Study|Withdrawal by Subject|1|||
46982532|NCT02380677|83228828|FG010|Overall Study|Withdrawal by Subject|0|||
46698152|NCT03619213|82913083|FG000|Overall Study|Lost to Follow-up|2|||
46698153|NCT03619213|82913084|FG001|Overall Study|Lost to Follow-up|1|||
46864528|NCT02761694|83081431|FG004|Overall Study|Lack of Efficacy|0|||
46864529|NCT02761694|83081432|FG005|Overall Study|Lack of Efficacy|0|||
46864530|NCT02761694|83081433|FG006|Overall Study|Lack of Efficacy|6|||
46864531|NCT02761694|83081434|FG007|Overall Study|Lack of Efficacy|0|||
46864532|NCT02761694|83081435|FG008|Overall Study|Lack of Efficacy|0|||
46864533|NCT02761694|83081436|FG009|Overall Study|Lack of Efficacy|1|||
46864534|NCT02761694|83081437|FG010|Overall Study|Lack of Efficacy|1|||
46864535|NCT02761694|83081438|FG011|Overall Study|Lack of Efficacy|4|||
46864536|NCT02761694|83081427|FG000|Overall Study|Death|0|||
46698154|NCT03619213|82913083|FG000|Overall Study|Withdrawal by Subject|8|||
46698155|NCT03619213|82913084|FG001|Overall Study|Withdrawal by Subject|10|||
46698156|NCT03342690|82913090|FG000|Overall Study|Missing Information|9|||
46698157|NCT03342690|82913090|FG000|Overall Study|Protocol Violation|16|||
46698158|NCT03257267|82913109|FG000|Overall Study|Adverse Event|9|||
46698159|NCT03257267|82913110|FG001|Overall Study|Adverse Event|7|||
46698160|NCT03257267|82913109|FG000|Overall Study|Death|92|||
46698161|NCT03257267|82913110|FG001|Overall Study|Death|95|||
46698162|NCT03257267|82913109|FG000|Overall Study|Lost to Follow-up|2|||
46698163|NCT03257267|82913110|FG001|Overall Study|Lost to Follow-up|2|||
46698164|NCT03257267|82913109|FG000|Overall Study|Non-compliance with Study Drug|0|||
46698165|NCT03257267|82913110|FG001|Overall Study|Non-compliance with Study Drug|1|||
46698166|NCT03257267|82913109|FG000|Overall Study|Participant Decision|34|||
46864537|NCT02761694|83081428|FG001|Overall Study|Death|0|||
46864538|NCT02761694|83081429|FG002|Overall Study|Death|0|||
46864539|NCT02761694|83081430|FG003|Overall Study|Death|0|||
46864540|NCT02761694|83081431|FG004|Overall Study|Death|0|||
46864541|NCT02761694|83081432|FG005|Overall Study|Death|0|||
46864542|NCT02761694|83081433|FG006|Overall Study|Death|2|||
46864543|NCT02761694|83081434|FG007|Overall Study|Death|0|||
46864544|NCT02761694|83081435|FG008|Overall Study|Death|2|||
46864545|NCT02761694|83081436|FG009|Overall Study|Death|2|||
46864546|NCT02761694|83081437|FG010|Overall Study|Death|1|||
46864547|NCT02761694|83081438|FG011|Overall Study|Death|0|||
46864548|NCT02761694|83081427|FG000|Overall Study|Physician Decision|0|||
46864549|NCT02761694|83081428|FG001|Overall Study|Physician Decision|0|||
46864550|NCT02761694|83081429|FG002|Overall Study|Physician Decision|0|||
46864551|NCT02761694|83081430|FG003|Overall Study|Physician Decision|0|||
46864552|NCT02761694|83081431|FG004|Overall Study|Physician Decision|0|||
46864553|NCT02761694|83081432|FG005|Overall Study|Physician Decision|0|||
46864554|NCT02761694|83081433|FG006|Overall Study|Physician Decision|1|||
46864555|NCT02761694|83081434|FG007|Overall Study|Physician Decision|0|||
46864556|NCT02761694|83081435|FG008|Overall Study|Physician Decision|0|||
46864557|NCT02761694|83081436|FG009|Overall Study|Physician Decision|0|||
46864558|NCT02761694|83081437|FG010|Overall Study|Physician Decision|0|||
46864559|NCT02761694|83081438|FG011|Overall Study|Physician Decision|0|||
46864560|NCT02761694|83081427|FG000|Overall Study|Withdrawal by Subject|0|||
46864561|NCT02761694|83081428|FG001|Overall Study|Withdrawal by Subject|0|||
46864562|NCT02761694|83081429|FG002|Overall Study|Withdrawal by Subject|0|||
46864563|NCT02761694|83081430|FG003|Overall Study|Withdrawal by Subject|1|||
46864564|NCT02761694|83081431|FG004|Overall Study|Withdrawal by Subject|0|||
46864565|NCT02761694|83081432|FG005|Overall Study|Withdrawal by Subject|0|||
46864566|NCT02761694|83081433|FG006|Overall Study|Withdrawal by Subject|4|||
46864567|NCT02761694|83081434|FG007|Overall Study|Withdrawal by Subject|0|||
46864568|NCT02761694|83081435|FG008|Overall Study|Withdrawal by Subject|2|||
46864569|NCT02761694|83081436|FG009|Overall Study|Withdrawal by Subject|1|||
46864570|NCT02761694|83081437|FG010|Overall Study|Withdrawal by Subject|0|||
46864571|NCT02761694|83081438|FG011|Overall Study|Withdrawal by Subject|0|||
46864572|NCT02761694|83081427|FG000|Overall Study|Lost to Follow-up|0|||
46864573|NCT02761694|83081428|FG001|Overall Study|Lost to Follow-up|0|||
46864574|NCT02761694|83081429|FG002|Overall Study|Lost to Follow-up|0|||
46864575|NCT02761694|83081430|FG003|Overall Study|Lost to Follow-up|0|||
46864576|NCT02761694|83081431|FG004|Overall Study|Lost to Follow-up|0|||
46864577|NCT02761694|83081432|FG005|Overall Study|Lost to Follow-up|0|||
46864578|NCT02761694|83081433|FG006|Overall Study|Lost to Follow-up|1|||
46864579|NCT02761694|83081434|FG007|Overall Study|Lost to Follow-up|0|||
46864580|NCT02761694|83081435|FG008|Overall Study|Lost to Follow-up|0|||
46864581|NCT02761694|83081436|FG009|Overall Study|Lost to Follow-up|0|||
46864582|NCT02761694|83081437|FG010|Overall Study|Lost to Follow-up|0|||
46864583|NCT02761694|83081438|FG011|Overall Study|Lost to Follow-up|1|||
46864584|NCT02761694|83081427|FG000|Overall Study|Adverse Event|0|||
46864585|NCT02761694|83081428|FG001|Overall Study|Adverse Event|0|||
46864586|NCT02761694|83081429|FG002|Overall Study|Adverse Event|0|||
46864587|NCT02761694|83081430|FG003|Overall Study|Adverse Event|0|||
46698167|NCT03257267|82913110|FG001|Overall Study|Participant Decision|42|||
46698168|NCT03257267|82913109|FG000|Overall Study|Physician Decision|1|||
46698169|NCT03257267|82913110|FG001|Overall Study|Physician Decision|3|||
46864588|NCT02761694|83081431|FG004|Overall Study|Adverse Event|0|||
46864589|NCT02761694|83081432|FG005|Overall Study|Adverse Event|0|||
46864590|NCT02761694|83081433|FG006|Overall Study|Adverse Event|1|||
46864591|NCT02761694|83081434|FG007|Overall Study|Adverse Event|0|||
46864592|NCT02761694|83081435|FG008|Overall Study|Adverse Event|1|||
46864593|NCT02761694|83081436|FG009|Overall Study|Adverse Event|0|||
46698170|NCT03257267|82913109|FG000|Overall Study|Disease Progression|98|||
46698171|NCT03257267|82913110|FG001|Overall Study|Disease Progression|117|||
46864594|NCT02761694|83081437|FG010|Overall Study|Adverse Event|0|||
46864595|NCT02761694|83081438|FG011|Overall Study|Adverse Event|1|||
46864596|NCT02761694|83081427|FG000|Overall Study|Other|4|||
46864597|NCT02761694|83081428|FG001|Overall Study|Other|4|||
46864598|NCT02761694|83081429|FG002|Overall Study|Other|1|||
46864599|NCT02761694|83081430|FG003|Overall Study|Other|2|||
46864600|NCT02761694|83081431|FG004|Overall Study|Other|3|||
46864601|NCT02761694|83081432|FG005|Overall Study|Other|3|||
46864602|NCT02761694|83081433|FG006|Overall Study|Other|18|||
46864603|NCT02761694|83081434|FG007|Overall Study|Other|8|||
46864604|NCT02761694|83081435|FG008|Overall Study|Other|0|||
46864605|NCT02761694|83081436|FG009|Overall Study|Other|1|||
46864606|NCT02761694|83081437|FG010|Overall Study|Other|1|||
46864607|NCT02761694|83081438|FG011|Overall Study|Other|0|||
46864608|NCT02574481|83081481|FG000|Overall Study|Withdrawal by Subject|29|||
46864609|NCT02574481|83081482|FG001|Overall Study|Withdrawal by Subject|15|||
46864610|NCT02574481|83081483|FG002|Overall Study|Withdrawal by Subject|4|||
46864611|NCT02574481|83081484|FG003|Overall Study|Withdrawal by Subject|1|||
46864612|NCT02574481|83081481|FG000|Overall Study|Adverse Event|5|||
46864613|NCT02574481|83081482|FG001|Overall Study|Adverse Event|1|||
46864614|NCT02574481|83081483|FG002|Overall Study|Adverse Event|1|||
46864615|NCT02574481|83081484|FG003|Overall Study|Adverse Event|0|||
46864616|NCT02574481|83081481|FG000|Overall Study|Visit Missed|15|||
46864617|NCT02574481|83081482|FG001|Overall Study|Visit Missed|7|||
46982533|NCT02380677|83228829|FG011|Overall Study|Withdrawal by Subject|3|||
46982534|NCT02380677|83228818|FG000|Overall Study|Other|0|||
46982535|NCT02380677|83228819|FG001|Overall Study|Other|0|||
46982536|NCT02380677|83228820|FG002|Overall Study|Other|0|||
46982537|NCT02380677|83228821|FG003|Overall Study|Other|1|||
46864618|NCT02574481|83081483|FG002|Overall Study|Visit Missed|5|||
46864619|NCT02574481|83081484|FG003|Overall Study|Visit Missed|0|||
46864620|NCT02574481|83081481|FG000|Overall Study|Other|7|||
46864621|NCT02574481|83081482|FG001|Overall Study|Other|2|||
46864622|NCT02574481|83081483|FG002|Overall Study|Other|0|||
46864623|NCT02574481|83081484|FG003|Overall Study|Other|0|||
46864624|NCT02574481|83081481|FG000|Overall Study|Death|48|||
46864625|NCT02574481|83081482|FG001|Overall Study|Death|26|||
46864626|NCT02574481|83081483|FG002|Overall Study|Death|12|||
46864627|NCT02574481|83081484|FG003|Overall Study|Death|4|||
46864628|NCT02574481|83081481|FG000|Overall Study|Physician Decision|5|||
46698172|NCT03257267|82913109|FG000|Overall Study|Withdrawal of Consent|8|||
46698173|NCT03257267|82913110|FG001|Overall Study|Withdrawal of Consent|26|||
46698174|NCT03257267|82913109|FG000|Overall Study|Study Ongoing|53|||
46698175|NCT03257267|82913110|FG001|Overall Study|Study Ongoing|11|||
46698176|NCT02991456|82913127|FG000|Overall Study|Adverse Event|2|||
46698177|NCT02991456|82913128|FG001|Overall Study|Adverse Event|0|||
46698178|NCT02991456|82913127|FG000|Overall Study|Lost to Follow-up|0|||
46698179|NCT02991456|82913128|FG001|Overall Study|Lost to Follow-up|2|||
46698180|NCT02991456|82913127|FG000|Overall Study|Withdrawal by Subject|1|||
46698181|NCT02991456|82913128|FG001|Overall Study|Withdrawal by Subject|0|||
46864629|NCT02574481|83081482|FG001|Overall Study|Physician Decision|2|||
46698182|NCT02842827|82913145|FG000|Overall Study|Adverse Event|0|||
46698183|NCT02842827|82913146|FG001|Overall Study|Adverse Event|1|||
46982538|NCT02380677|83228822|FG004|Overall Study|Other|1|||
46698184|NCT02842827|82913147|FG002|Overall Study|Adverse Event|0|||
46698185|NCT02842827|82913148|FG003|Overall Study|Adverse Event|1|||
46864630|NCT02574481|83081483|FG002|Overall Study|Physician Decision|0|||
46864631|NCT02574481|83081484|FG003|Overall Study|Physician Decision|0|||
46864632|NCT02574481|83081481|FG000|Overall Study|Lost to Follow-up|5|||
46864633|NCT02574481|83081482|FG001|Overall Study|Lost to Follow-up|1|||
46864634|NCT02574481|83081483|FG002|Overall Study|Lost to Follow-up|3|||
46864635|NCT02574481|83081484|FG003|Overall Study|Lost to Follow-up|0|||
46864636|NCT02376829|83081508|FG000|Overall Study|Withdrawal by Subject|27|||
46982539|NCT02380677|83228823|FG005|Overall Study|Other|1|||
46698186|NCT02842827|82913149|FG004|Overall Study|Adverse Event|0|||
46698187|NCT02842827|82913150|FG005|Overall Study|Adverse Event|1|||
46698188|NCT02842827|82913151|FG006|Overall Study|Adverse Event|0|||
46698189|NCT02842827|82913152|FG007|Overall Study|Adverse Event|0|||
46698190|NCT02842827|82913145|FG000|Overall Study|Death|1|||
46698191|NCT02842827|82913146|FG001|Overall Study|Death|0|||
46698192|NCT02842827|82913147|FG002|Overall Study|Death|2|||
46864637|NCT02376829|83081509|FG001|Overall Study|Withdrawal by Subject|44|||
46864638|NCT02297438|83081518|FG000|Overall Study|Death|79|||
46864639|NCT02297438|83081519|FG001|Overall Study|Death|86|||
46864640|NCT02297438|83081518|FG000|Overall Study|Lost to Follow-up|9|||
46864641|NCT02297438|83081519|FG001|Overall Study|Lost to Follow-up|7|||
46864642|NCT02297438|83081518|FG000|Overall Study|Withdrawal by Subject|7|||
46864643|NCT02297438|83081519|FG001|Overall Study|Withdrawal by Subject|0|||
46864644|NCT02297438|83081518|FG000|Overall Study|Other|9|||
46864645|NCT02297438|83081519|FG001|Overall Study|Other|5|||
46864646|NCT02297438|83081518|FG000|Overall Study|Ongoing|65|||
46864647|NCT02297438|83081519|FG001|Overall Study|Ongoing|73|||
46864648|NCT02297139|83081527|FG000|Overall Study|Disease progression|0|||
46864649|NCT02297139|83081528|FG001|Overall Study|Disease progression|1|||
46864650|NCT02297139|83081527|FG000|Overall Study|Study drug toxicity|0|||
46864651|NCT02297139|83081528|FG001|Overall Study|Study drug toxicity|4|||
46864652|NCT02297139|83081527|FG000|Overall Study|Participant request to discontinue study treatment|0|||
46864653|NCT02297139|83081528|FG001|Overall Study|Participant request to discontinue study treatment|1|||
46864654|NCT02297139|83081527|FG000|Overall Study|Maximum clinical benefit|1|||
46864655|NCT02297139|83081528|FG001|Overall Study|Maximum clinical benefit|0|||
46864656|NCT02297139|83081527|FG000|Overall Study|Administrative reason by sponsor|0|||
46864657|NCT02297139|83081528|FG001|Overall Study|Administrative reason by sponsor|2|||
46864658|NCT02297139|83081527|FG000|Overall Study|Other reasons|0|||
46864659|NCT02297139|83081528|FG001|Overall Study|Other reasons|8|||
46864660|NCT02100722|83081545|FG000|Overall Study|Withdrawal pre-procedure|4|||
46864661|NCT02100722|83081546|FG001|Overall Study|Withdrawal pre-procedure|9|||
46864662|NCT02100722|83081545|FG000|Overall Study|Withdrawal post-procedure|0|||
46864663|NCT02100722|83081546|FG001|Overall Study|Withdrawal post-procedure|3|||
46864664|NCT02100722|83081545|FG000|Overall Study|Lost to Follow-up|2|||
46864665|NCT02100722|83081546|FG001|Overall Study|Lost to Follow-up|2|||
46864666|NCT02100722|83081545|FG000|Overall Study|Continuing on study|751|||
46864667|NCT02100722|83081546|FG001|Overall Study|Continuing on study|729|||
46864668|NCT02028988|83081562|FG000|Overall Study|Withdrawal by Subject|2|||
46864669|NCT02004236|83081569|FG000|Overall Study|Lack of Efficacy|0|||
46864670|NCT02004236|83081570|FG001|Overall Study|Lack of Efficacy|0|||
46864671|NCT02004236|83081571|FG002|Overall Study|Lack of Efficacy|16|||
46864672|NCT01642251|83081601|FG000|Overall Study|Progressive disease|0|||
46864673|NCT01642251|83081602|FG001|Overall Study|Progressive disease|0|||
46864674|NCT01642251|83081603|FG002|Overall Study|Progressive disease|3|||
46698193|NCT02842827|82913148|FG003|Overall Study|Death|3|||
46698194|NCT02842827|82913149|FG004|Overall Study|Death|2|||
46698195|NCT02842827|82913150|FG005|Overall Study|Death|1|||
46864675|NCT01642251|83081604|FG003|Overall Study|Progressive disease|3|||
46864676|NCT01642251|83081601|FG000|Overall Study|Adverse Event|0|||
46864677|NCT01642251|83081602|FG001|Overall Study|Adverse Event|0|||
46864678|NCT01642251|83081603|FG002|Overall Study|Adverse Event|5|||
46864679|NCT01642251|83081604|FG003|Overall Study|Adverse Event|4|||
46864680|NCT01642251|83081601|FG000|Overall Study|Death|0|||
46864681|NCT01642251|83081602|FG001|Overall Study|Death|0|||
46864682|NCT01642251|83081603|FG002|Overall Study|Death|1|||
46864683|NCT01642251|83081604|FG003|Overall Study|Death|3|||
46864684|NCT01642251|83081601|FG000|Overall Study|Withdrawal by Subject|0|||
46864685|NCT01642251|83081602|FG001|Overall Study|Withdrawal by Subject|0|||
46864686|NCT01642251|83081603|FG002|Overall Study|Withdrawal by Subject|1|||
46864687|NCT01642251|83081604|FG003|Overall Study|Withdrawal by Subject|3|||
46698196|NCT02842827|82913151|FG006|Overall Study|Death|0|||
46864688|NCT01642251|83081601|FG000|Overall Study|Alternative therapy|0|||
46864689|NCT01642251|83081602|FG001|Overall Study|Alternative therapy|0|||
46864690|NCT01642251|83081603|FG002|Overall Study|Alternative therapy|0|||
46864691|NCT01642251|83081604|FG003|Overall Study|Alternative therapy|2|||
46864692|NCT01642251|83081601|FG000|Overall Study|Other complicating disease|0|||
46864693|NCT01642251|83081602|FG001|Overall Study|Other complicating disease|0|||
46864694|NCT01642251|83081603|FG002|Overall Study|Other complicating disease|1|||
46864695|NCT01642251|83081604|FG003|Overall Study|Other complicating disease|0|||
46864696|NCT01642251|83081601|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
46864697|NCT01642251|83081602|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
46698197|NCT02842827|82913152|FG007|Overall Study|Death|4|||
46698198|NCT02842827|82913145|FG000|Overall Study|Physician Decision|1|||
46698199|NCT02842827|82913146|FG001|Overall Study|Physician Decision|3|||
46698200|NCT02842827|82913147|FG002|Overall Study|Physician Decision|0|||
46864698|NCT01642251|83081603|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
46864699|NCT01642251|83081604|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
46864700|NCT01606137|83081613|FG000|Overall Study|Adverse Event|85|||
46864701|NCT01606137|83081613|FG000|Overall Study|Withdrawal by Subject|74|||
46864702|NCT01606137|83081613|FG000|Overall Study|Lack of Efficacy|56|||
46864703|NCT01606137|83081613|FG000|Overall Study|Lost to Follow-up|15|||
46864704|NCT01606137|83081613|FG000|Overall Study|Protocol Violation|1|||
46864705|NCT01606137|83081613|FG000|Overall Study|Patient non-compliance|9|||
46864706|NCT01606137|83081613|FG000|Overall Study|Death|1|||
46864707|NCT01606137|83081613|FG000|Overall Study|Decreased/no pain|4|||
46864708|NCT01606137|83081613|FG000|Overall Study|Issues with driving|4|||
46864709|NCT01606137|83081613|FG000|Overall Study|multiple sclerosis less stable|1|||
46864710|NCT01606137|83081613|FG000|Overall Study|Increased bilirubin|1|||
46864711|NCT01606137|83081613|FG000|Overall Study|Spray causes nausea|1|||
46864712|NCT01606137|83081613|FG000|Overall Study|Not enough improvement|4|||
46864713|NCT01606137|83081613|FG000|Overall Study|Wanted to try another treatment|1|||
46982540|NCT02380677|83228824|FG006|Overall Study|Other|0|||
46982541|NCT02380677|83228825|FG007|Overall Study|Other|0|||
46982542|NCT02380677|83228826|FG008|Overall Study|Other|0|||
46982543|NCT02380677|83228827|FG009|Overall Study|Other|0|||
46982544|NCT02380677|83228828|FG010|Overall Study|Other|0|||
46982545|NCT02380677|83228829|FG011|Overall Study|Other|0|||
46982546|NCT02380287|83228865|FG000|Overall Study|Adverse Event|0|||
46982547|NCT02380287|83228866|FG001|Overall Study|Adverse Event|0|||
46982548|NCT02380287|83228867|FG002|Overall Study|Adverse Event|1|||
46982549|NCT02380287|83228868|FG003|Overall Study|Adverse Event|0|||
46982550|NCT02380287|83228869|FG004|Overall Study|Adverse Event|0|||
46982551|NCT02380287|83228870|FG005|Overall Study|Adverse Event|0|||
46982552|NCT02380287|83228871|FG006|Overall Study|Adverse Event|0|||
46982553|NCT02380287|83228872|FG007|Overall Study|Adverse Event|0|||
46982554|NCT02343003|83228899|FG000|Overall Study|Withdrawal by Subject|9|||
46982555|NCT02343003|83228900|FG001|Overall Study|Withdrawal by Subject|4|||
46982556|NCT02343003|83228899|FG000|Overall Study|Lost to Follow-up|5|||
46982557|NCT02343003|83228900|FG001|Overall Study|Lost to Follow-up|1|||
46982558|NCT02343003|83228899|FG000|Overall Study|Protocol Violation|1|||
46982559|NCT02343003|83228900|FG001|Overall Study|Protocol Violation|0|||
46982560|NCT02343003|83228899|FG000|Overall Study|Death|0|||
46982561|NCT02343003|83228900|FG001|Overall Study|Death|1|||
46982562|NCT02343003|83228899|FG000|Overall Study|exclusion criteria met|1|||
46698201|NCT02842827|82913148|FG003|Overall Study|Physician Decision|0|||
46698202|NCT02842827|82913149|FG004|Overall Study|Physician Decision|1|||
46698203|NCT02842827|82913150|FG005|Overall Study|Physician Decision|4|||
46698204|NCT02842827|82913151|FG006|Overall Study|Physician Decision|2|||
46698205|NCT02842827|82913152|FG007|Overall Study|Physician Decision|1|||
46864714|NCT01606137|83081613|FG000|Overall Study|Patient leaving country|1|||
46864715|NCT01606137|83081613|FG000|Overall Study|Personal reasons|1|||
46864716|NCT01606137|83081613|FG000|Overall Study|Unable to tolerate study med. taste|1|||
46864717|NCT01606137|83081613|FG000|Overall Study|Patient moving|1|||
46864718|NCT01606137|83081613|FG000|Overall Study|Unable to collect consistent data|1|||
46864719|NCT01532518|83081620|FG000|Overall Study|Withdrawal by Subject|0|||
46864720|NCT01532518|83081621|FG001|Overall Study|Withdrawal by Subject|0|||
46864721|NCT01532518|83081622|FG002|Overall Study|Withdrawal by Subject|1|||
46864722|NCT00844285|83081650|FG000|Overall Study|Other|0|||
46864723|NCT00844285|83081651|FG001|Overall Study|Other|1|||
46864724|NCT00844285|83081652|FG002|Overall Study|Other|0|||
46982563|NCT02343003|83228900|FG001|Overall Study|exclusion criteria met|1|||
46982564|NCT02343003|83228899|FG000|Overall Study|terminated by sponsor|2|||
46982565|NCT02343003|83228900|FG001|Overall Study|terminated by sponsor|0|||
46864725|NCT00844285|83081650|FG000|Overall Study|Other than specified|95|||
46982566|NCT02394561|83228908|FG000|CORE Phase|Adverse Event|7|||
46982567|NCT02394561|83228909|FG001|CORE Phase|Adverse Event|9|||
46698206|NCT02842827|82913145|FG000|Overall Study|Protocol Defined Disease Progression|0|||
46698207|NCT02842827|82913146|FG001|Overall Study|Protocol Defined Disease Progression|0|||
46864726|NCT00844285|83081651|FG001|Overall Study|Other than specified|129|||
46864727|NCT00844285|83081652|FG002|Overall Study|Other than specified|12|||
46864728|NCT00844285|83081650|FG000|Overall Study|Site closure|256|||
46864729|NCT00844285|83081651|FG001|Overall Study|Site closure|450|||
46864730|NCT00844285|83081652|FG002|Overall Study|Site closure|50|||
46864731|NCT00844285|83081650|FG000|Overall Study|Follow-up < 8 years|16|||
46864732|NCT00844285|83081651|FG001|Overall Study|Follow-up < 8 years|23|||
46864733|NCT00844285|83081652|FG002|Overall Study|Follow-up < 8 years|4|||
46864734|NCT00844285|83081650|FG000|Overall Study|Protocol Violation|26|||
46864735|NCT00844285|83081651|FG001|Overall Study|Protocol Violation|28|||
46698208|NCT02842827|82913147|FG002|Overall Study|Protocol Defined Disease Progression|0|||
46864736|NCT00844285|83081652|FG002|Overall Study|Protocol Violation|54|||
46864737|NCT00844285|83081650|FG000|Overall Study|Death|22|||
46864738|NCT00844285|83081651|FG001|Overall Study|Death|21|||
46864739|NCT00844285|83081652|FG002|Overall Study|Death|8|||
46864740|NCT00844285|83081650|FG000|Overall Study|Withdrew Consent|344|||
46864741|NCT00844285|83081651|FG001|Overall Study|Withdrew Consent|466|||
46864742|NCT00844285|83081652|FG002|Overall Study|Withdrew Consent|70|||
46864743|NCT00844285|83081650|FG000|Overall Study|Lost to Follow-up|330|||
46864744|NCT00844285|83081651|FG001|Overall Study|Lost to Follow-up|486|||
46864745|NCT00844285|83081652|FG002|Overall Study|Lost to Follow-up|74|||
46864746|NCT00711646|83081680|FG000|Overall Study|Adverse Event|6|||
46864747|NCT00711646|83081681|FG001|Overall Study|Adverse Event|1|||
46864748|NCT00711646|83081680|FG000|Overall Study|Withdrawal by Subject|4|||
46864749|NCT00711646|83081681|FG001|Overall Study|Withdrawal by Subject|0|||
46864750|NCT00711646|83081680|FG000|Overall Study|Protocol Violation|0|||
46864751|NCT00711646|83081681|FG001|Overall Study|Protocol Violation|1|||
46864752|NCT00711646|83081680|FG000|Overall Study|Lost to Follow-up|1|||
46864753|NCT00711646|83081681|FG001|Overall Study|Lost to Follow-up|0|||
46864754|NCT00711646|83081680|FG000|Overall Study|administrative decision|0|||
46864755|NCT00711646|83081681|FG001|Overall Study|administrative decision|1|||
46864756|NCT00711646|83081680|FG000|Overall Study|patient non-compliance|1|||
46864757|NCT00711646|83081681|FG001|Overall Study|patient non-compliance|0|||
46864758|NCT00640133|83081707|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
46864759|NCT00640133|83081708|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
46864760|NCT00640133|83081707|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
46864761|NCT00640133|83081708|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
46864762|NCT00640133|83081707|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
46864763|NCT00640133|83081708|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
46864764|NCT00379340|83081721|FG000|Overall Study|Death|0|||
46864765|NCT00379340|83081722|FG001|Overall Study|Death|0|||
46698209|NCT02842827|82913148|FG003|Overall Study|Protocol Defined Disease Progression|0|||
46698210|NCT02842827|82913149|FG004|Overall Study|Protocol Defined Disease Progression|0|||
46698211|NCT02842827|82913150|FG005|Overall Study|Protocol Defined Disease Progression|1|||
46698212|NCT02842827|82913151|FG006|Overall Study|Protocol Defined Disease Progression|0|||
46698213|NCT02842827|82913152|FG007|Overall Study|Protocol Defined Disease Progression|0|||
46698214|NCT02842827|82913145|FG000|Overall Study|Participant Withdrawal of Consent|1|||
46698215|NCT02842827|82913146|FG001|Overall Study|Participant Withdrawal of Consent|2|||
46698216|NCT02842827|82913147|FG002|Overall Study|Participant Withdrawal of Consent|2|||
46864766|NCT00379340|83081723|FG002|Overall Study|Death|0|||
46864767|NCT00379340|83081724|FG003|Overall Study|Death|2|||
46864768|NCT00379340|83081725|FG004|Overall Study|Death|0|||
46864769|NCT00379340|83081721|FG000|Overall Study|Lack of Efficacy|6|||
46864770|NCT00379340|83081722|FG001|Overall Study|Lack of Efficacy|1|||
46864771|NCT00379340|83081723|FG002|Overall Study|Lack of Efficacy|0|||
46864772|NCT00379340|83081724|FG003|Overall Study|Lack of Efficacy|4|||
46864773|NCT00379340|83081725|FG004|Overall Study|Lack of Efficacy|3|||
46864774|NCT00379340|83081721|FG000|Overall Study|Physician Decision|6|||
46864775|NCT00379340|83081722|FG001|Overall Study|Physician Decision|2|||
46864776|NCT00379340|83081723|FG002|Overall Study|Physician Decision|1|||
46864777|NCT00379340|83081724|FG003|Overall Study|Physician Decision|2|||
46864778|NCT00379340|83081725|FG004|Overall Study|Physician Decision|3|||
46864779|NCT00379340|83081721|FG000|Overall Study|Withdrawal by Subject|0|||
46864780|NCT00379340|83081722|FG001|Overall Study|Withdrawal by Subject|0|||
46864781|NCT00379340|83081723|FG002|Overall Study|Withdrawal by Subject|0|||
46864782|NCT00379340|83081724|FG003|Overall Study|Withdrawal by Subject|1|||
46864783|NCT00379340|83081725|FG004|Overall Study|Withdrawal by Subject|0|||
46864784|NCT00379340|83081721|FG000|Overall Study|Refusal of further protocol therapy|1|||
46864785|NCT00379340|83081722|FG001|Overall Study|Refusal of further protocol therapy|0|||
46864786|NCT00379340|83081723|FG002|Overall Study|Refusal of further protocol therapy|1|||
46864787|NCT00379340|83081724|FG003|Overall Study|Refusal of further protocol therapy|1|||
46864788|NCT00379340|83081725|FG004|Overall Study|Refusal of further protocol therapy|7|||
46864789|NCT00379340|83081721|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
46864790|NCT00379340|83081722|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
46864791|NCT00379340|83081723|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
46864792|NCT00379340|83081724|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
46864793|NCT00379340|83081725|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
46864794|NCT00379340|83081721|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
46864795|NCT00379340|83081722|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
46864796|NCT00379340|83081723|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
46864797|NCT00379340|83081724|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
46864798|NCT00379340|83081725|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
46864799|NCT00301808|83081738|FG000|Overall Study|Adverse Event|5|||
46864800|NCT00301808|83081738|FG000|Overall Study|Death|3|||
46864801|NCT00301808|83081738|FG000|Overall Study|Lack of Efficacy|4|||
46864802|NCT04979858|83081753|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
46864803|NCT04979858|83081754|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
46864804|NCT04953728|83081760|FG000|Overall Study|Withdrawal by Subject|3|||
46864805|NCT04953728|83081760|FG000|Overall Study|Physician Decision|1|||
46864806|NCT04030598|83081810|FG000|Overall Study|Voluntary Withdrawal|0|||
46864807|NCT04030598|83081811|FG001|Overall Study|Voluntary Withdrawal|1|||
46864808|NCT04030598|83081812|FG002|Overall Study|Voluntary Withdrawal|0|||
46864809|NCT03025880|83081835|FG000|Overall Study|Adverse Event|1|||
46864810|NCT03025880|83081836|FG001|Overall Study|Adverse Event|0|||
46864811|NCT03025880|83081835|FG000|Overall Study|Death|1|||
46864812|NCT03025880|83081836|FG001|Overall Study|Death|1|||
46864813|NCT03025880|83081835|FG000|Overall Study|Withdrawal by Subject|0|||
46698217|NCT02842827|82913148|FG003|Overall Study|Participant Withdrawal of Consent|2|||
46864814|NCT03025880|83081836|FG001|Overall Study|Withdrawal by Subject|1|||
46864815|NCT03025880|83081835|FG000|Overall Study|Physician Decision|0|||
46864816|NCT03025880|83081836|FG001|Overall Study|Physician Decision|1|||
46864817|NCT03025880|83081835|FG000|Overall Study|Progressive Disease|12|||
46864818|NCT03025880|83081836|FG001|Overall Study|Progressive Disease|19|||
46864819|NCT02027376|83081853|FG000|Overall Study|Death|1|||
46864820|NCT02027376|83081854|FG001|Overall Study|Death|0|||
46864821|NCT02027376|83081855|FG002|Overall Study|Death|0|||
46864822|NCT01606436|83081865|FG000|Overall Study|Withdrawal by Subject|0|||
46864823|NCT01606436|83081866|FG001|Overall Study|Withdrawal by Subject|0|||
46864824|NCT01606436|83081867|FG002|Overall Study|Withdrawal by Subject|1|||
46864825|NCT01606436|83081868|FG003|Overall Study|Withdrawal by Subject|1|||
46864826|NCT01606436|83081869|FG004|Overall Study|Withdrawal by Subject|1|||
46864827|NCT01606436|83081870|FG005|Overall Study|Withdrawal by Subject|0|||
46864828|NCT01606436|83081865|FG000|Overall Study|Adverse Event|0|||
46864829|NCT01606436|83081866|FG001|Overall Study|Adverse Event|0|||
46864830|NCT01606436|83081867|FG002|Overall Study|Adverse Event|1|||
46864831|NCT01606436|83081868|FG003|Overall Study|Adverse Event|0|||
46698218|NCT02842827|82913149|FG004|Overall Study|Participant Withdrawal of Consent|2|||
46698219|NCT02842827|82913150|FG005|Overall Study|Participant Withdrawal of Consent|1|||
46698220|NCT02842827|82913151|FG006|Overall Study|Participant Withdrawal of Consent|2|||
46698221|NCT02842827|82913152|FG007|Overall Study|Participant Withdrawal of Consent|1|||
46698222|NCT02432274|82913178|FG000|Overall Study|Death|2|||
46698223|NCT02432274|82913179|FG001|Overall Study|Death|6|||
46698224|NCT02432274|82913180|FG002|Overall Study|Death|7|||
46698225|NCT02432274|82913181|FG003|Overall Study|Death|0|||
46864832|NCT01606436|83081869|FG004|Overall Study|Adverse Event|0|||
46864833|NCT01606436|83081870|FG005|Overall Study|Adverse Event|0|||
46864834|NCT01606436|83081865|FG000|Overall Study|Sponsor Decision|0|||
46864835|NCT01606436|83081866|FG001|Overall Study|Sponsor Decision|0|||
46864836|NCT01606436|83081867|FG002|Overall Study|Sponsor Decision|0|||
46864837|NCT01606436|83081868|FG003|Overall Study|Sponsor Decision|1|||
46864838|NCT01606436|83081869|FG004|Overall Study|Sponsor Decision|0|||
46864839|NCT01606436|83081870|FG005|Overall Study|Sponsor Decision|0|||
46864840|NCT00219557|83081890|FG000|Phase 1|Lack of Efficacy|3|||
46864841|NCT00219557|83081891|FG001|Phase 1|Lack of Efficacy|0|||
46864842|NCT00219557|83081892|FG002|Phase 1|Lack of Efficacy|0|||
46864843|NCT00219557|83081890|FG000|Phase 1|Adverse Event|2|||
46864844|NCT00219557|83081891|FG001|Phase 1|Adverse Event|0|||
46864845|NCT00219557|83081892|FG002|Phase 1|Adverse Event|0|||
46864846|NCT00219557|83081890|FG000|Phase 1|Withdrawal by Subject|1|||
46864847|NCT00219557|83081891|FG001|Phase 1|Withdrawal by Subject|0|||
46864848|NCT00219557|83081892|FG002|Phase 1|Withdrawal by Subject|0|||
46698226|NCT02432274|82913182|FG004|Overall Study|Death|27|||
46698227|NCT02432274|82913183|FG005|Overall Study|Death|7|||
46864849|NCT00219557|83081890|FG000|Phase 1|Started chemotherapy at other institute|1|||
46864850|NCT00219557|83081891|FG001|Phase 1|Started chemotherapy at other institute|0|||
46864851|NCT00219557|83081892|FG002|Phase 1|Started chemotherapy at other institute|0|||
46864852|NCT00219557|83081890|FG000|Phase 2|Lack of Efficacy|0|||
46864853|NCT00219557|83081891|FG001|Phase 2|Lack of Efficacy|21|||
46864854|NCT00219557|83081892|FG002|Phase 2|Lack of Efficacy|15|||
46864855|NCT00219557|83081890|FG000|Phase 2|Adverse Event|0|||
46864856|NCT00219557|83081891|FG001|Phase 2|Adverse Event|22|||
46698228|NCT02432274|82913184|FG006|Overall Study|Death|9|||
46698229|NCT02432274|82913185|FG007|Overall Study|Death|14|||
46864857|NCT00219557|83081892|FG002|Phase 2|Adverse Event|2|||
46864858|NCT00219557|83081890|FG000|Phase 2|Death|0|||
46864859|NCT00219557|83081891|FG001|Phase 2|Death|8|||
46864860|NCT00219557|83081892|FG002|Phase 2|Death|2|||
46864861|NCT00219557|83081890|FG000|Phase 2|Other|0|||
46864862|NCT00219557|83081891|FG001|Phase 2|Other|8|||
46864863|NCT00219557|83081892|FG002|Phase 2|Other|6|||
46864864|NCT00219557|83081890|FG000|Phase 2|Withdrawal by Subject|0|||
46864865|NCT00219557|83081891|FG001|Phase 2|Withdrawal by Subject|9|||
46864866|NCT00219557|83081892|FG002|Phase 2|Withdrawal by Subject|5|||
46864867|NCT00219557|83081890|FG000|Phase 2|Treatment not received|0|||
46864868|NCT00219557|83081891|FG001|Phase 2|Treatment not received|1|||
46864869|NCT00219557|83081892|FG002|Phase 2|Treatment not received|3|||
46864870|NCT00251927|83081907|FG000|Overall Study|Adverse Event|3|||
46864871|NCT00251927|83081908|FG001|Overall Study|Adverse Event|15|||
46864872|NCT00251927|83081907|FG000|Overall Study|Lack of Efficacy|22|||
46864873|NCT00251927|83081908|FG001|Overall Study|Lack of Efficacy|16|||
46864874|NCT00251927|83081907|FG000|Overall Study|Lost to Follow-up|22|||
46864875|NCT00251927|83081908|FG001|Overall Study|Lost to Follow-up|8|||
46864876|NCT00251927|83081907|FG000|Overall Study|Protocol Violation|1|||
46864877|NCT00251927|83081908|FG001|Overall Study|Protocol Violation|2|||
46864878|NCT00251927|83081907|FG000|Overall Study|Pregnancy|2|||
46864879|NCT00251927|83081908|FG001|Overall Study|Pregnancy|0|||
46864880|NCT00251927|83081907|FG000|Overall Study|Withdrawal by Subject|40|||
46864881|NCT00251927|83081908|FG001|Overall Study|Withdrawal by Subject|25|||
46864882|NCT00251927|83081907|FG000|Overall Study|Study-specific discont. achieved|13|||
46864883|NCT00251927|83081908|FG001|Overall Study|Study-specific discont. achieved|2|||
46864884|NCT00251927|83081907|FG000|Overall Study|Study procedure non-compliance|5|||
46864885|NCT00251927|83081908|FG001|Overall Study|Study procedure non-compliance|6|||
46864886|NCT00165503|83081915|FG000|Overall Study|Death|1|||
46864887|NCT00165503|83081915|FG000|Overall Study|Lost to Follow-up|12|||
46864888|NCT00165503|83081915|FG000|Overall Study|Unresectable|3|||
46864889|NCT00162773|83081919|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
46864890|NCT00209339|83081923|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
46864891|NCT00209339|83081923|FG000|At 12 Months Follow-up|Death|1|||
46864892|NCT00209339|83081923|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
46864893|NCT00209339|83081923|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
46864894|NCT00209339|83081923|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
46864895|NCT00209339|83081923|FG000|At 24 Months Follow-up|Death|1|||
46864896|NCT00209339|83081923|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
46864897|NCT00209339|83081923|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
46864898|NCT00209339|83081923|FG000|At 4 Years Follow-up|Death|1|||
46864899|NCT00209339|83081923|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
46864900|NCT00209339|83081923|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
46864901|NCT00209339|83081923|FG000|At 5 Years Follow-up|Death|1|||
46864902|NCT03823391|83081929|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
46864903|NCT03823391|83081930|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
46864904|NCT03823391|83081929|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
46864905|NCT03823391|83081930|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
46864906|NCT00209027|83081940|FG000|Overall Study|study terminated|10|||
46864907|NCT00209027|83081941|FG001|Overall Study|study terminated|0|||
46864908|NCT00208325|83081951|FG000|Overall Study|Death|18|||
46864909|NCT00208325|83081952|FG001|Overall Study|Death|19|||
46864910|NCT00208325|83081953|FG002|Overall Study|Death|7|||
46864911|NCT00208325|83081954|FG003|Overall Study|Death|5|||
46864912|NCT00208325|83081951|FG000|Overall Study|Withdrawal by Subject|0|||
46864913|NCT00208325|83081952|FG001|Overall Study|Withdrawal by Subject|1|||
46864914|NCT00208325|83081953|FG002|Overall Study|Withdrawal by Subject|0|||
46864915|NCT00208325|83081954|FG003|Overall Study|Withdrawal by Subject|0|||
46864916|NCT00208325|83081951|FG000|Overall Study|Revision|4|||
46864917|NCT00208325|83081952|FG001|Overall Study|Revision|1|||
46864918|NCT00208325|83081953|FG002|Overall Study|Revision|0|||
46864919|NCT00208325|83081954|FG003|Overall Study|Revision|4|||
46864920|NCT00208325|83081951|FG000|Overall Study|Lost to Follow-up|1|||
46864921|NCT00208325|83081952|FG001|Overall Study|Lost to Follow-up|0|||
46864922|NCT00208325|83081953|FG002|Overall Study|Lost to Follow-up|2|||
46864923|NCT00208325|83081954|FG003|Overall Study|Lost to Follow-up|0|||
46864924|NCT00208325|83081951|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
46864925|NCT00208325|83081952|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
46864926|NCT00208325|83081953|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
46864927|NCT00208325|83081954|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
46864928|NCT00208325|83081951|FG000|Overall Study|Does not wish to Continue in Study|5|||
46864929|NCT00208325|83081952|FG001|Overall Study|Does not wish to Continue in Study|8|||
46864930|NCT00208325|83081953|FG002|Overall Study|Does not wish to Continue in Study|3|||
46864931|NCT00208325|83081954|FG003|Overall Study|Does not wish to Continue in Study|2|||
46864932|NCT00208325|83081951|FG000|Overall Study|Other|2|||
46864933|NCT00208325|83081952|FG001|Overall Study|Other|1|||
46864934|NCT00208325|83081953|FG002|Overall Study|Other|1|||
46864935|NCT00208325|83081954|FG003|Overall Study|Other|0|||
46864936|NCT00208325|83081951|FG000|Overall Study|Mis-Randomized|17|||
46864937|NCT00208325|83081952|FG001|Overall Study|Mis-Randomized|20|||
46864938|NCT00208325|83081953|FG002|Overall Study|Mis-Randomized|0|||
46864939|NCT00208325|83081954|FG003|Overall Study|Mis-Randomized|0|||
46864940|NCT00160667|83081967|FG000|Overall Study|Adverse Event|3|||
46864941|NCT00160667|83081968|FG001|Overall Study|Adverse Event|1|||
46864942|NCT00160667|83081969|FG002|Overall Study|Adverse Event|4|||
46864943|NCT00160667|83081967|FG000|Overall Study|Withdrawal by Subject|2|||
46864944|NCT00160667|83081968|FG001|Overall Study|Withdrawal by Subject|0|||
46864945|NCT00160667|83081969|FG002|Overall Study|Withdrawal by Subject|1|||
46864946|NCT00160667|83081967|FG000|Overall Study|Lack of Efficacy|0|||
46864947|NCT00160667|83081968|FG001|Overall Study|Lack of Efficacy|1|||
46864948|NCT00160667|83081969|FG002|Overall Study|Lack of Efficacy|0|||
46864949|NCT00160667|83081967|FG000|Overall Study|Protocol Violation|0|||
46864950|NCT00160667|83081968|FG001|Overall Study|Protocol Violation|1|||
46864951|NCT00160667|83081969|FG002|Overall Study|Protocol Violation|0|||
46864952|NCT00160667|83081967|FG000|Overall Study|Patient decision|0|||
46864953|NCT00160667|83081968|FG001|Overall Study|Patient decision|0|||
46864954|NCT00160667|83081969|FG002|Overall Study|Patient decision|1|||
46864955|NCT00206375|83081981|FG000|Overall Study|Lost to Follow-up|1|||
46864956|NCT00206375|83081982|FG001|Overall Study|Lost to Follow-up|0|||
46864957|NCT00206375|83081983|FG002|Overall Study|Lost to Follow-up|0|||
46864958|NCT00206375|83081981|FG000|Overall Study|Withdrawal by Subject|2|||
46864959|NCT00206375|83081982|FG001|Overall Study|Withdrawal by Subject|1|||
46864960|NCT00206375|83081983|FG002|Overall Study|Withdrawal by Subject|3|||
46864961|NCT00206375|83081981|FG000|Overall Study|Study terminated due to lack of funds|0|||
46864962|NCT00206375|83081982|FG001|Overall Study|Study terminated due to lack of funds|1|||
46864963|NCT00206375|83081983|FG002|Overall Study|Study terminated due to lack of funds|1|||
46864964|NCT00160199|83081993|FG000|Overall Study|Adverse Event|5|||
46864965|NCT00160199|83081994|FG001|Overall Study|Adverse Event|14|||
46864966|NCT00160199|83081993|FG000|Overall Study|Lack of Efficacy|0|||
46864967|NCT00160199|83081994|FG001|Overall Study|Lack of Efficacy|1|||
46864968|NCT00160199|83081993|FG000|Overall Study|Lost to Follow-up|7|||
46864969|NCT00160199|83081994|FG001|Overall Study|Lost to Follow-up|7|||
46864970|NCT00160199|83081993|FG000|Overall Study|Withdrawal by Subject|4|||
46864971|NCT00160199|83081994|FG001|Overall Study|Withdrawal by Subject|6|||
46864972|NCT00160199|83081993|FG000|Overall Study|Administrative|0|||
46864973|NCT00160199|83081994|FG001|Overall Study|Administrative|1|||
46864974|NCT00160199|83081993|FG000|Overall Study|Protocol Violation|8|||
46864975|NCT00160199|83081994|FG001|Overall Study|Protocol Violation|8|||
46864976|NCT00157157|83082000|FG000|Overall Study|Withdrawal by Subject|6|||
46864977|NCT00157157|83082000|FG000|Overall Study|Physician Decision|1|||
46864978|NCT00157157|83082000|FG000|Overall Study|Lost to Follow-up|1|||
46864979|NCT00157157|83082000|FG000|Overall Study|Enrolled in another study|1|||
46864980|NCT00157157|83082000|FG000|Overall Study|Met exclusion criteria|1|||
46698230|NCT02432274|82913178|FG000|Overall Study|Withdrawal of Consent|0|||
46698231|NCT02432274|82913179|FG001|Overall Study|Withdrawal of Consent|0|||
46698232|NCT02432274|82913180|FG002|Overall Study|Withdrawal of Consent|0|||
46698233|NCT02432274|82913181|FG003|Overall Study|Withdrawal of Consent|0|||
46698234|NCT02432274|82913182|FG004|Overall Study|Withdrawal of Consent|2|||
46864981|NCT00157157|83082000|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
46864982|NCT00203411|83082011|FG000|Follow-up|Progressive Disease|4|||
46698235|NCT02432274|82913183|FG005|Overall Study|Withdrawal of Consent|0|||
46698236|NCT02432274|82913184|FG006|Overall Study|Withdrawal of Consent|1|||
46698237|NCT02432274|82913185|FG007|Overall Study|Withdrawal of Consent|2|||
46698238|NCT01359592|82913219|FG000|Initial Registration|Adverse Event|1|||
46698239|NCT01359592|82913220|FG001|Initial Registration|Adverse Event|0|||
46698240|NCT01359592|82913221|FG002|Initial Registration|Adverse Event|0|||
46864983|NCT00203021|83082018|FG000|Overall Study|Death|4|||
46864984|NCT00203021|83082019|FG001|Overall Study|Death|1|||
46864985|NCT00203021|83082018|FG000|Overall Study|Adverse Event|10|||
46864986|NCT00203021|83082019|FG001|Overall Study|Adverse Event|5|||
46864987|NCT00203021|83082018|FG000|Overall Study|Withdrawal by Subject|45|||
46864988|NCT00203021|83082019|FG001|Overall Study|Withdrawal by Subject|48|||
46864989|NCT00203021|83082018|FG000|Overall Study|Lost to Follow-up|9|||
46864990|NCT00203021|83082019|FG001|Overall Study|Lost to Follow-up|7|||
46864991|NCT00203021|83082018|FG000|Overall Study|Other than specified|11|||
46864992|NCT00203021|83082019|FG001|Overall Study|Other than specified|16|||
46864993|NCT00201851|83082028|FG000|Overall Study|Lost to Follow-up|2|||
46864994|NCT00201851|83082029|FG001|Overall Study|Lost to Follow-up|1|||
46864995|NCT00201851|83082030|FG002|Overall Study|Lost to Follow-up|0|||
46864996|NCT00201851|83082028|FG000|Overall Study|Ineligible post enrollment|6|||
46864997|NCT00201851|83082029|FG001|Overall Study|Ineligible post enrollment|1|||
46864998|NCT00201851|83082030|FG002|Overall Study|Ineligible post enrollment|1|||
46864999|NCT00200057|83082038|FG000|Overall Study|Lack of Efficacy|3|||
46865000|NCT00200057|83082038|FG000|Overall Study|Exited due to terminal illness of PI|2|||
46865001|NCT00200057|83082038|FG000|Overall Study|Withdrawal by Subject|1|||
46865002|NCT00200057|83082038|FG000|Overall Study|Change in medical condition|1|||
46865003|NCT00200057|83082038|FG000|Overall Study|Infection|1|||
46865004|NCT00200057|83082038|FG000|Overall Study|Death|1|||
46865005|NCT03129100|83082047|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
46865006|NCT03129100|83082048|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
46865007|NCT03129100|83082049|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
46865008|NCT03129100|83082050|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
46865009|NCT03129100|83082051|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
46865010|NCT03129100|83082052|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
46865011|NCT03129100|83082053|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
46865012|NCT03129100|83082054|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
46865013|NCT03129100|83082055|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
46698241|NCT01359592|82913222|FG003|Initial Registration|Adverse Event|0|||
46865014|NCT03129100|83082056|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
46865015|NCT03129100|83082057|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
46865016|NCT03129100|83082058|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
46698242|NCT01359592|82913219|FG000|Initial Registration|Death|1|||
46865017|NCT03129100|83082059|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
46865018|NCT03129100|83082060|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
46865019|NCT03129100|83082061|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
46865020|NCT03129100|83082062|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
46865021|NCT03129100|83082063|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
46865022|NCT03129100|83082064|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
46865023|NCT03129100|83082065|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
46865024|NCT03129100|83082066|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
46865025|NCT03129100|83082067|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
46865026|NCT03129100|83082068|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
46865027|NCT03129100|83082069|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
46865028|NCT03129100|83082070|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
46865029|NCT03129100|83082071|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
46865030|NCT03129100|83082072|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
46982568|NCT02394561|83228908|FG000|CORE Phase|Death|0|||
46982569|NCT02394561|83228909|FG001|CORE Phase|Death|1|||
46982570|NCT02394561|83228908|FG000|CORE Phase|Pregnancy|1|||
46982571|NCT02394561|83228909|FG001|CORE Phase|Pregnancy|0|||
46982572|NCT02394561|83228908|FG000|CORE Phase|Lost to Follow-up|1|||
46982573|NCT02394561|83228909|FG001|CORE Phase|Lost to Follow-up|0|||
46982574|NCT02394561|83228908|FG000|CORE Phase|Physician Decision|1|||
46982575|NCT02394561|83228909|FG001|CORE Phase|Physician Decision|1|||
46982576|NCT02394561|83228908|FG000|CORE Phase|Withdrawal by Subject|2|||
46982577|NCT02394561|83228909|FG001|CORE Phase|Withdrawal by Subject|2|||
46982578|NCT02394561|83228908|FG000|CORE Phase|Lack of Efficacy|1|||
46982579|NCT02394561|83228909|FG001|CORE Phase|Lack of Efficacy|6|||
46982580|NCT02394561|83228908|FG000|Extension Phase|Adverse Event|6|||
46982581|NCT02394561|83228909|FG001|Extension Phase|Adverse Event|1|||
46982582|NCT02394561|83228908|FG000|Extension Phase|Death|0|||
46982583|NCT02394561|83228909|FG001|Extension Phase|Death|1|||
46982584|NCT02394561|83228908|FG000|Extension Phase|Protocol Violation|1|||
46982585|NCT02394561|83228909|FG001|Extension Phase|Protocol Violation|0|||
46982586|NCT02394561|83228908|FG000|Extension Phase|Lost to Follow-up|1|||
46982587|NCT02394561|83228909|FG001|Extension Phase|Lost to Follow-up|0|||
46982588|NCT02394561|83228908|FG000|Extension Phase|Physician Decision|0|||
46982589|NCT02394561|83228909|FG001|Extension Phase|Physician Decision|2|||
46982590|NCT02394561|83228908|FG000|Extension Phase|Withdrawal by Subject|0|||
46982591|NCT02394561|83228909|FG001|Extension Phase|Withdrawal by Subject|5|||
46982592|NCT02394561|83228908|FG000|Extension Phase|Lack of Efficacy|3|||
46982593|NCT02394561|83228909|FG001|Extension Phase|Lack of Efficacy|3|||
46982594|NCT02342223|83228918|FG000|Overall Study|Lost to Follow-up|1|||
46982595|NCT02393547|83228922|FG000|Overall Study|Adverse Event|2|||
46982596|NCT02393547|83228922|FG000|Overall Study|Withdrawal by Subject|3|||
46982597|NCT02393547|83228922|FG000|Overall Study|Lost to Follow-up|1|||
46982598|NCT02574637|83228931|FG000|Double-blind Period|Adverse Event|1|||
46982599|NCT02574637|83228932|FG001|Double-blind Period|Adverse Event|0|||
46982600|NCT02574637|83228933|FG002|Double-blind Period|Adverse Event|0|||
46982601|NCT02574637|83228934|FG003|Double-blind Period|Adverse Event|0|||
46982602|NCT02574637|83228935|FG004|Double-blind Period|Adverse Event|0|||
46982603|NCT02574637|83228936|FG005|Double-blind Period|Adverse Event|0|||
46982604|NCT02574637|83228937|FG006|Double-blind Period|Adverse Event|0|||
46982605|NCT02574637|83228938|FG007|Double-blind Period|Adverse Event|0|||
46982606|NCT02574637|83228939|FG008|Double-blind Period|Adverse Event|0|||
46982607|NCT02574637|83228940|FG009|Double-blind Period|Adverse Event|0|||
46982608|NCT02574637|83228931|FG000|Double-blind Period|Lack of Efficacy|0|||
46982609|NCT02574637|83228932|FG001|Double-blind Period|Lack of Efficacy|0|||
46982610|NCT02574637|83228933|FG002|Double-blind Period|Lack of Efficacy|2|||
46982611|NCT02574637|83228934|FG003|Double-blind Period|Lack of Efficacy|0|||
46982612|NCT02574637|83228935|FG004|Double-blind Period|Lack of Efficacy|0|||
46698243|NCT01359592|82913220|FG001|Initial Registration|Death|0|||
46982613|NCT02574637|83228936|FG005|Double-blind Period|Lack of Efficacy|0|||
46982614|NCT02574637|83228937|FG006|Double-blind Period|Lack of Efficacy|0|||
46982615|NCT02574637|83228938|FG007|Double-blind Period|Lack of Efficacy|0|||
46982616|NCT02574637|83228939|FG008|Double-blind Period|Lack of Efficacy|0|||
46982617|NCT02574637|83228940|FG009|Double-blind Period|Lack of Efficacy|0|||
46982618|NCT02574637|83228931|FG000|Double-blind Period|Protocol Deviation|1|||
46982619|NCT02574637|83228932|FG001|Double-blind Period|Protocol Deviation|0|||
46982620|NCT02574637|83228933|FG002|Double-blind Period|Protocol Deviation|0|||
46982621|NCT02574637|83228934|FG003|Double-blind Period|Protocol Deviation|0|||
46982622|NCT02574637|83228935|FG004|Double-blind Period|Protocol Deviation|0|||
46982623|NCT02574637|83228936|FG005|Double-blind Period|Protocol Deviation|0|||
46865031|NCT03129100|83082047|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
46982624|NCT02574637|83228937|FG006|Double-blind Period|Protocol Deviation|0|||
46982625|NCT02574637|83228938|FG007|Double-blind Period|Protocol Deviation|0|||
46982626|NCT02574637|83228939|FG008|Double-blind Period|Protocol Deviation|0|||
46982627|NCT02574637|83228940|FG009|Double-blind Period|Protocol Deviation|0|||
46982628|NCT02574637|83228931|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
46982629|NCT02574637|83228932|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
46982630|NCT02574637|83228933|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
46982631|NCT02574637|83228934|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
46982632|NCT02574637|83228935|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
46982633|NCT02574637|83228936|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
46982634|NCT02574637|83228937|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
46982635|NCT02574637|83228938|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
46982636|NCT02574637|83228939|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
46982637|NCT02574637|83228940|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
46865032|NCT03129100|83082048|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865033|NCT03129100|83082049|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865034|NCT03129100|83082050|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865035|NCT03129100|83082051|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865036|NCT03129100|83082052|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865037|NCT03129100|83082053|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865038|NCT03129100|83082054|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865039|NCT03129100|83082055|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865040|NCT03129100|83082056|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865041|NCT03129100|83082057|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865042|NCT03129100|83082058|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865043|NCT03129100|83082059|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865044|NCT03129100|83082060|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865045|NCT03129100|83082061|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865046|NCT03129100|83082062|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865047|NCT03129100|83082063|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865048|NCT03129100|83082064|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865049|NCT03129100|83082065|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865050|NCT03129100|83082066|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865051|NCT03129100|83082067|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865052|NCT03129100|83082068|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865053|NCT03129100|83082069|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865054|NCT03129100|83082070|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865055|NCT03129100|83082071|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865056|NCT03129100|83082072|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
46865057|NCT03129100|83082047|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
46865058|NCT03129100|83082048|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
46865059|NCT03129100|83082049|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865060|NCT03129100|83082050|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865061|NCT03129100|83082051|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865062|NCT03129100|83082052|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865063|NCT03129100|83082053|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865064|NCT03129100|83082054|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865065|NCT03129100|83082055|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865066|NCT03129100|83082056|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865067|NCT03129100|83082057|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865068|NCT03129100|83082058|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865069|NCT03129100|83082059|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865070|NCT03129100|83082060|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865071|NCT03129100|83082061|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865072|NCT03129100|83082062|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865073|NCT03129100|83082063|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46982638|NCT02574637|83228931|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
46982639|NCT02574637|83228932|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
46982640|NCT02574637|83228933|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
46698244|NCT01359592|82913221|FG002|Initial Registration|Death|0|||
46698245|NCT01359592|82913222|FG003|Initial Registration|Death|0|||
46698246|NCT01359592|82913219|FG000|Initial Registration|Other reason not protocol specified|1|||
46698247|NCT01359592|82913220|FG001|Initial Registration|Other reason not protocol specified|0|||
46698248|NCT01359592|82913221|FG002|Initial Registration|Other reason not protocol specified|0|||
46698249|NCT01359592|82913222|FG003|Initial Registration|Other reason not protocol specified|0|||
46982641|NCT02574637|83228934|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
46698250|NCT01359592|82913219|FG000|Initial Registration|Ineligible|26|||
46698251|NCT01359592|82913220|FG001|Initial Registration|Ineligible|0|||
46698252|NCT01359592|82913221|FG002|Initial Registration|Ineligible|0|||
46865074|NCT03129100|83082064|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865075|NCT03129100|83082065|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46982642|NCT02574637|83228935|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
46698253|NCT01359592|82913222|FG003|Initial Registration|Ineligible|0|||
46698254|NCT01359592|82913219|FG000|PET-Directed Therapy|Adverse Event|0|||
46865076|NCT03129100|83082066|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865077|NCT03129100|83082067|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865078|NCT03129100|83082068|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865079|NCT03129100|83082069|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865080|NCT03129100|83082070|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865081|NCT03129100|83082071|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865082|NCT03129100|83082072|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
46865083|NCT03129100|83082047|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
46865084|NCT03129100|83082048|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
46865085|NCT03129100|83082049|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865086|NCT03129100|83082050|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865087|NCT03129100|83082051|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865088|NCT03129100|83082052|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865089|NCT03129100|83082053|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865090|NCT03129100|83082054|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865091|NCT03129100|83082055|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865092|NCT03129100|83082056|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865093|NCT03129100|83082057|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865094|NCT03129100|83082058|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865095|NCT03129100|83082059|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865096|NCT03129100|83082060|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865097|NCT03129100|83082061|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865098|NCT03129100|83082062|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865099|NCT03129100|83082063|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865100|NCT03129100|83082064|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865101|NCT03129100|83082065|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865102|NCT03129100|83082066|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865103|NCT03129100|83082067|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865104|NCT03129100|83082068|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865105|NCT03129100|83082069|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865106|NCT03129100|83082070|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865107|NCT03129100|83082071|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865108|NCT03129100|83082072|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
46865109|NCT03129100|83082047|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865110|NCT03129100|83082048|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
46865111|NCT03129100|83082049|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865112|NCT03129100|83082050|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865113|NCT03129100|83082051|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
46698255|NCT01359592|82913220|FG001|PET-Directed Therapy|Adverse Event|0|||
46698256|NCT01359592|82913221|FG002|PET-Directed Therapy|Adverse Event|1|||
46698257|NCT01359592|82913222|FG003|PET-Directed Therapy|Adverse Event|0|||
46698258|NCT01359592|82913219|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
46698259|NCT01359592|82913220|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
46865114|NCT03129100|83082052|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865115|NCT03129100|83082053|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865116|NCT03129100|83082054|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865117|NCT03129100|83082055|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865118|NCT03129100|83082056|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865119|NCT03129100|83082057|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865120|NCT03129100|83082058|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865121|NCT03129100|83082059|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865122|NCT03129100|83082060|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865123|NCT03129100|83082061|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865124|NCT03129100|83082062|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865125|NCT03129100|83082063|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865126|NCT03129100|83082064|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865127|NCT03129100|83082065|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865128|NCT03129100|83082066|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865129|NCT03129100|83082067|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865130|NCT03129100|83082068|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865131|NCT03129100|83082069|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865132|NCT03129100|83082070|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865133|NCT03129100|83082071|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865134|NCT03129100|83082072|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
46865135|NCT03129100|83082047|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865136|NCT03129100|83082048|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865137|NCT03129100|83082049|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
46865138|NCT03129100|83082050|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
46865139|NCT03129100|83082051|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865140|NCT03129100|83082052|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
46865141|NCT03129100|83082053|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865142|NCT03129100|83082054|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865143|NCT03129100|83082055|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865144|NCT03129100|83082056|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865145|NCT03129100|83082057|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865146|NCT03129100|83082058|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865147|NCT03129100|83082059|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865148|NCT03129100|83082060|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865149|NCT03129100|83082061|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865150|NCT03129100|83082062|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865151|NCT03129100|83082063|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865152|NCT03129100|83082064|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865153|NCT03129100|83082065|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865154|NCT03129100|83082066|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865155|NCT03129100|83082067|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865156|NCT03129100|83082068|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865157|NCT03129100|83082069|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865158|NCT03129100|83082070|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865159|NCT03129100|83082071|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865160|NCT03129100|83082072|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
46865161|NCT03129100|83082047|FG000|Period2 Extension Period (Group A and B)|Death|0|||
46865162|NCT03129100|83082048|FG001|Period2 Extension Period (Group A and B)|Death|0|||
46865163|NCT03129100|83082049|FG002|Period2 Extension Period (Group A and B)|Death|1|||
46865164|NCT03129100|83082050|FG003|Period2 Extension Period (Group A and B)|Death|0|||
46865165|NCT03129100|83082051|FG004|Period2 Extension Period (Group A and B)|Death|0|||
46865166|NCT03129100|83082052|FG005|Period2 Extension Period (Group A and B)|Death|0|||
46865167|NCT03129100|83082053|FG006|Period2 Extension Period (Group A and B)|Death|0|||
46865168|NCT03129100|83082054|FG007|Period2 Extension Period (Group A and B)|Death|0|||
46865169|NCT03129100|83082055|FG008|Period2 Extension Period (Group A and B)|Death|0|||
46698260|NCT01359592|82913221|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
46698261|NCT01359592|82913222|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
46865170|NCT03129100|83082056|FG009|Period2 Extension Period (Group A and B)|Death|0|||
46865171|NCT03129100|83082057|FG010|Period2 Extension Period (Group A and B)|Death|0|||
46865172|NCT03129100|83082058|FG011|Period2 Extension Period (Group A and B)|Death|0|||
46982643|NCT02574637|83228936|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
46982644|NCT02574637|83228937|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
46982645|NCT02574637|83228938|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
46865173|NCT03129100|83082059|FG012|Period2 Extension Period (Group A and B)|Death|0|||
46865174|NCT03129100|83082060|FG013|Period2 Extension Period (Group A and B)|Death|0|||
46865175|NCT03129100|83082061|FG014|Period2 Extension Period (Group A and B)|Death|0|||
46865176|NCT03129100|83082062|FG015|Period2 Extension Period (Group A and B)|Death|0|||
46865177|NCT03129100|83082063|FG016|Period2 Extension Period (Group A and B)|Death|0|||
46865178|NCT03129100|83082064|FG017|Period2 Extension Period (Group A and B)|Death|0|||
46865179|NCT03129100|83082065|FG018|Period2 Extension Period (Group A and B)|Death|0|||
46865180|NCT03129100|83082066|FG019|Period2 Extension Period (Group A and B)|Death|0|||
46982646|NCT02574637|83228939|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
46865181|NCT03129100|83082067|FG020|Period2 Extension Period (Group A and B)|Death|0|||
46865182|NCT03129100|83082068|FG021|Period2 Extension Period (Group A and B)|Death|0|||
46865183|NCT03129100|83082069|FG022|Period2 Extension Period (Group A and B)|Death|0|||
46865184|NCT03129100|83082070|FG023|Period2 Extension Period (Group A and B)|Death|0|||
46865185|NCT03129100|83082071|FG024|Period2 Extension Period (Group A and B)|Death|0|||
46865186|NCT03129100|83082072|FG025|Period2 Extension Period (Group A and B)|Death|0|||
46865187|NCT03129100|83082047|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865188|NCT03129100|83082048|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865189|NCT03129100|83082049|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
46865190|NCT03129100|83082050|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
46865191|NCT03129100|83082051|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
46865192|NCT03129100|83082052|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
46865193|NCT03129100|83082053|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
46865194|NCT03129100|83082054|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865195|NCT03129100|83082055|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865196|NCT03129100|83082056|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865197|NCT03129100|83082057|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865198|NCT03129100|83082058|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865199|NCT03129100|83082059|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865200|NCT03129100|83082060|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865201|NCT03129100|83082061|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865202|NCT03129100|83082062|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865203|NCT03129100|83082063|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865204|NCT03129100|83082064|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865205|NCT03129100|83082065|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865206|NCT03129100|83082066|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865207|NCT03129100|83082067|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865208|NCT03129100|83082068|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865209|NCT03129100|83082069|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46698262|NCT01359592|82913219|FG000|PET-Directed Therapy|Ineligible|0|||
46698263|NCT01359592|82913220|FG001|PET-Directed Therapy|Ineligible|0|||
46698264|NCT01359592|82913221|FG002|PET-Directed Therapy|Ineligible|24|||
46698265|NCT01359592|82913222|FG003|PET-Directed Therapy|Ineligible|0|||
46698266|NCT00699816|82913239|FG000|Overall Study|Protocol Violation|1|||
46698267|NCT00699816|82913240|FG001|Overall Study|Protocol Violation|3|||
46698268|NCT00697073|82913246|FG000|Overall Study|Withdrawal by Subject|2|||
46698269|NCT00697073|82913246|FG000|Overall Study|Pregnancy|1|||
46698270|NCT00697073|82913246|FG000|Overall Study|non compliance and other|6|||
46698271|NCT00653432|82913252|FG000|Overall Study|Adverse Event|4|||
46698272|NCT00653432|82913253|FG001|Overall Study|Adverse Event|1|||
46698273|NCT00653432|82913252|FG000|Overall Study|Withdrawal by Subject|4|||
46698274|NCT00653432|82913253|FG001|Overall Study|Withdrawal by Subject|5|||
46698275|NCT00653432|82913252|FG000|Overall Study|Lost to Follow-up|7|||
46698276|NCT00653432|82913253|FG001|Overall Study|Lost to Follow-up|6|||
46698277|NCT00653432|82913252|FG000|Overall Study|Use/Need of Con Therapy|2|||
46698278|NCT00653432|82913253|FG001|Overall Study|Use/Need of Con Therapy|1|||
46698279|NCT00653432|82913252|FG000|Overall Study|Other - Reason Not Provided|5|||
46698280|NCT00653432|82913253|FG001|Overall Study|Other - Reason Not Provided|3|||
46865210|NCT03129100|83082070|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865211|NCT03129100|83082071|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865212|NCT03129100|83082072|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
46865213|NCT03129100|83082047|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865214|NCT03129100|83082048|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865215|NCT03129100|83082049|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
46865216|NCT03129100|83082050|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865217|NCT03129100|83082051|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865218|NCT03129100|83082052|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865219|NCT03129100|83082053|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865220|NCT03129100|83082054|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865221|NCT03129100|83082055|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865222|NCT03129100|83082056|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865223|NCT03129100|83082057|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865224|NCT03129100|83082058|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46698281|NCT00446043|82913272|FG000|Overall Study|Adverse Event|9|||
46698282|NCT00446043|82913272|FG000|Overall Study|Withdrawal by Subject|70|||
46698283|NCT00446043|82913272|FG000|Overall Study|Protocol Violation|2|||
46698284|NCT00446043|82913272|FG000|Overall Study|Lost to Follow-up|42|||
46698285|NCT00446043|82913272|FG000|Overall Study|Pregnancy|2|||
46865225|NCT03129100|83082059|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865226|NCT03129100|83082060|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865227|NCT03129100|83082061|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865228|NCT03129100|83082062|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865229|NCT03129100|83082063|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865230|NCT03129100|83082064|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865231|NCT03129100|83082065|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865232|NCT03129100|83082066|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865233|NCT03129100|83082067|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865234|NCT03129100|83082068|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865235|NCT03129100|83082069|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865236|NCT03129100|83082070|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865237|NCT03129100|83082071|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865238|NCT03129100|83082072|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
46865239|NCT03129100|83082047|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865240|NCT03129100|83082048|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865241|NCT03129100|83082049|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
46865242|NCT03129100|83082050|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865243|NCT03129100|83082051|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865244|NCT03129100|83082052|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865245|NCT03129100|83082053|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865246|NCT03129100|83082054|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865247|NCT03129100|83082055|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865248|NCT03129100|83082056|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865249|NCT03129100|83082057|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865250|NCT03129100|83082058|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865251|NCT03129100|83082059|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865252|NCT03129100|83082060|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865253|NCT03129100|83082061|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865254|NCT03129100|83082062|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865255|NCT03129100|83082063|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865256|NCT03129100|83082064|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865257|NCT03129100|83082065|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865258|NCT03129100|83082066|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865259|NCT03129100|83082067|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865260|NCT03129100|83082068|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865261|NCT03129100|83082069|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865262|NCT03129100|83082070|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865263|NCT03129100|83082071|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46865264|NCT03129100|83082072|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
46982647|NCT02574637|83228940|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
46982648|NCT02574637|83228931|FG000|Double-blind Period|Reason Not Specified|0|||
46982649|NCT02574637|83228932|FG001|Double-blind Period|Reason Not Specified|0|||
46982650|NCT02574637|83228933|FG002|Double-blind Period|Reason Not Specified|0|||
46982651|NCT02574637|83228934|FG003|Double-blind Period|Reason Not Specified|1|||
46982652|NCT02574637|83228935|FG004|Double-blind Period|Reason Not Specified|0|||
46982653|NCT02574637|83228936|FG005|Double-blind Period|Reason Not Specified|0|||
46982654|NCT02574637|83228937|FG006|Double-blind Period|Reason Not Specified|0|||
46982655|NCT02574637|83228938|FG007|Double-blind Period|Reason Not Specified|0|||
46982656|NCT02574637|83228939|FG008|Double-blind Period|Reason Not Specified|0|||
46982657|NCT02574637|83228940|FG009|Double-blind Period|Reason Not Specified|0|||
46982658|NCT02574637|83228931|FG000|Open-label (OL) Period|Adverse Event|0|||
46982659|NCT02574637|83228932|FG001|Open-label (OL) Period|Adverse Event|0|||
46982660|NCT02574637|83228933|FG002|Open-label (OL) Period|Adverse Event|0|||
46865265|NCT03129100|83082047|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865266|NCT03129100|83082048|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865267|NCT03129100|83082049|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
46865268|NCT03129100|83082050|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865269|NCT03129100|83082051|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865270|NCT03129100|83082052|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46982661|NCT02574637|83228934|FG003|Open-label (OL) Period|Adverse Event|0|||
46982662|NCT02574637|83228935|FG004|Open-label (OL) Period|Adverse Event|0|||
46865271|NCT03129100|83082053|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865272|NCT03129100|83082054|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865273|NCT03129100|83082055|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865274|NCT03129100|83082056|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865275|NCT03129100|83082057|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865276|NCT03129100|83082058|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865277|NCT03129100|83082059|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865278|NCT03129100|83082060|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865279|NCT03129100|83082061|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865280|NCT03129100|83082062|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865281|NCT03129100|83082063|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865282|NCT03129100|83082064|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865283|NCT03129100|83082065|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865284|NCT03129100|83082066|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865285|NCT03129100|83082067|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865286|NCT03129100|83082068|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865287|NCT03129100|83082069|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865288|NCT03129100|83082070|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865289|NCT03129100|83082071|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865290|NCT03129100|83082072|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
46865291|NCT03129100|83082047|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865292|NCT03129100|83082048|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865293|NCT03129100|83082049|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865294|NCT03129100|83082050|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865295|NCT03129100|83082051|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
46865296|NCT03129100|83082052|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
46865297|NCT03129100|83082053|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
46865298|NCT03129100|83082054|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865299|NCT03129100|83082055|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865300|NCT03129100|83082056|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865301|NCT03129100|83082057|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865302|NCT03129100|83082058|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865303|NCT03129100|83082059|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865304|NCT03129100|83082060|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865305|NCT03129100|83082061|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865306|NCT03129100|83082062|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865307|NCT03129100|83082063|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865308|NCT03129100|83082064|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865309|NCT03129100|83082065|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865310|NCT03129100|83082066|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865311|NCT03129100|83082067|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865312|NCT03129100|83082068|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865313|NCT03129100|83082069|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865314|NCT03129100|83082070|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865315|NCT03129100|83082071|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865316|NCT03129100|83082072|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
46865317|NCT03129100|83082047|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865318|NCT03129100|83082048|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865319|NCT03129100|83082049|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865320|NCT03129100|83082050|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865321|NCT03129100|83082051|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865322|NCT03129100|83082052|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865323|NCT03129100|83082053|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865324|NCT03129100|83082054|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865325|NCT03129100|83082055|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865326|NCT03129100|83082056|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
46865327|NCT03129100|83082057|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865328|NCT03129100|83082058|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46982663|NCT02574637|83228936|FG005|Open-label (OL) Period|Adverse Event|0|||
46982664|NCT02574637|83228937|FG006|Open-label (OL) Period|Adverse Event|0|||
46982665|NCT02574637|83228938|FG007|Open-label (OL) Period|Adverse Event|0|||
46865329|NCT03129100|83082059|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865330|NCT03129100|83082060|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865331|NCT03129100|83082061|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865332|NCT03129100|83082062|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865333|NCT03129100|83082063|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865334|NCT03129100|83082064|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865335|NCT03129100|83082065|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865336|NCT03129100|83082066|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865337|NCT03129100|83082067|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865338|NCT03129100|83082068|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865339|NCT03129100|83082069|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865340|NCT03129100|83082070|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865341|NCT03129100|83082071|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865342|NCT03129100|83082072|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
46865343|NCT03129100|83082047|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865344|NCT03129100|83082048|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865345|NCT03129100|83082049|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865346|NCT03129100|83082050|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865347|NCT03129100|83082051|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865348|NCT03129100|83082052|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865349|NCT03129100|83082053|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865350|NCT03129100|83082054|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865351|NCT03129100|83082055|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865352|NCT03129100|83082056|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865353|NCT03129100|83082057|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865354|NCT03129100|83082058|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
46865355|NCT03129100|83082059|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865356|NCT03129100|83082060|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865357|NCT03129100|83082061|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865358|NCT03129100|83082062|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46982666|NCT02574637|83228939|FG008|Open-label (OL) Period|Adverse Event|1|||
46982667|NCT02574637|83228940|FG009|Open-label (OL) Period|Adverse Event|0|||
46865359|NCT03129100|83082063|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865360|NCT03129100|83082064|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865361|NCT03129100|83082065|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865362|NCT03129100|83082066|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865363|NCT03129100|83082067|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865364|NCT03129100|83082068|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865365|NCT03129100|83082069|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865366|NCT03129100|83082070|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865367|NCT03129100|83082071|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865368|NCT03129100|83082072|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
46865369|NCT03129100|83082047|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865370|NCT03129100|83082048|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865371|NCT03129100|83082049|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865372|NCT03129100|83082050|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865373|NCT03129100|83082051|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46698286|NCT00400725|82913279|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
46698287|NCT00400725|82913280|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
46865374|NCT03129100|83082052|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865375|NCT03129100|83082053|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865376|NCT03129100|83082054|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865377|NCT03129100|83082055|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865378|NCT03129100|83082056|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865379|NCT03129100|83082057|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865380|NCT03129100|83082058|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
46865381|NCT03129100|83082059|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
46865382|NCT03129100|83082060|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
46865383|NCT03129100|83082061|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
46865384|NCT03129100|83082062|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865385|NCT03129100|83082063|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865386|NCT03129100|83082064|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865387|NCT03129100|83082065|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865388|NCT03129100|83082066|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865389|NCT03129100|83082067|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865390|NCT03129100|83082068|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865391|NCT03129100|83082069|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865392|NCT03129100|83082070|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865393|NCT03129100|83082071|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865394|NCT03129100|83082072|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
46865395|NCT03129100|83082047|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865396|NCT03129100|83082048|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865397|NCT03129100|83082049|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865398|NCT03129100|83082050|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865399|NCT03129100|83082051|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865400|NCT03129100|83082052|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865401|NCT03129100|83082053|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865402|NCT03129100|83082054|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865403|NCT03129100|83082055|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865404|NCT03129100|83082056|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865405|NCT03129100|83082057|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865406|NCT03129100|83082058|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
46698288|NCT00400725|82913281|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
46698289|NCT00400725|82913279|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
46698290|NCT00400725|82913280|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
46698291|NCT00400725|82913281|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
46698292|NCT00400725|82913279|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
46698293|NCT00400725|82913280|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
46698294|NCT00400725|82913281|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
46698295|NCT00400725|82913279|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
46698296|NCT00400725|82913280|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
46698297|NCT00400725|82913281|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
46698298|NCT00400725|82913279|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
46698299|NCT00400725|82913280|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
46698300|NCT00400725|82913281|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
46698301|NCT00400725|82913279|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
46865407|NCT03129100|83082059|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865408|NCT03129100|83082060|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
46865409|NCT03129100|83082061|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
46865410|NCT03129100|83082062|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865411|NCT03129100|83082063|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865412|NCT03129100|83082064|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865413|NCT03129100|83082065|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865414|NCT03129100|83082066|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865415|NCT03129100|83082067|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865416|NCT03129100|83082068|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865417|NCT03129100|83082069|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865418|NCT03129100|83082070|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865419|NCT03129100|83082071|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865420|NCT03129100|83082072|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
46865421|NCT03129100|83082047|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865422|NCT03129100|83082048|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865423|NCT03129100|83082049|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865424|NCT03129100|83082050|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865425|NCT03129100|83082051|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865426|NCT03129100|83082052|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865427|NCT03129100|83082053|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865428|NCT03129100|83082054|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865429|NCT03129100|83082055|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865430|NCT03129100|83082056|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865431|NCT03129100|83082057|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865432|NCT03129100|83082058|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865433|NCT03129100|83082059|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865434|NCT03129100|83082060|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865435|NCT03129100|83082061|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865436|NCT03129100|83082062|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
46865437|NCT03129100|83082063|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865438|NCT03129100|83082064|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865439|NCT03129100|83082065|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865440|NCT03129100|83082066|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865441|NCT03129100|83082067|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865442|NCT03129100|83082068|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865443|NCT03129100|83082069|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865444|NCT03129100|83082070|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865445|NCT03129100|83082071|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865446|NCT03129100|83082072|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
46865447|NCT03129100|83082047|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865448|NCT03129100|83082048|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865449|NCT03129100|83082049|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865450|NCT03129100|83082050|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865451|NCT03129100|83082051|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865452|NCT03129100|83082052|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865453|NCT03129100|83082053|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865454|NCT03129100|83082054|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865455|NCT03129100|83082055|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865456|NCT03129100|83082056|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46982668|NCT02574637|83228931|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
46865457|NCT03129100|83082057|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865458|NCT03129100|83082058|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865459|NCT03129100|83082059|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
46865460|NCT03129100|83082060|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865461|NCT03129100|83082061|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
46865462|NCT03129100|83082062|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
46865463|NCT03129100|83082063|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46982669|NCT02574637|83228932|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
46698302|NCT00400725|82913280|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
46698303|NCT00400725|82913281|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
46698304|NCT00400725|82913279|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
46698305|NCT00400725|82913280|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
46865464|NCT03129100|83082064|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865465|NCT03129100|83082065|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865466|NCT03129100|83082066|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865467|NCT03129100|83082067|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865468|NCT03129100|83082068|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865469|NCT03129100|83082069|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865470|NCT03129100|83082070|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865471|NCT03129100|83082071|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865472|NCT03129100|83082072|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
46865473|NCT03129100|83082047|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865474|NCT03129100|83082048|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46982670|NCT02574637|83228933|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
46982671|NCT02574637|83228934|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
46982672|NCT02574637|83228935|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
46982673|NCT02574637|83228936|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
46982674|NCT02574637|83228937|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
46982675|NCT02574637|83228938|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
46982676|NCT02574637|83228939|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
46982677|NCT02574637|83228940|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
46982678|NCT02574637|83228931|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
46982679|NCT02574637|83228932|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
46982680|NCT02574637|83228933|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
46982681|NCT02574637|83228934|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
46982682|NCT02574637|83228935|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
46982683|NCT02574637|83228936|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
46982684|NCT02574637|83228937|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
46982685|NCT02574637|83228938|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
46982686|NCT02574637|83228939|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
46982687|NCT02574637|83228940|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
46982688|NCT02392611|83228970|FG000|Overall Study|Adverse Event|0|||
46982689|NCT02392611|83228971|FG001|Overall Study|Adverse Event|0|||
46982690|NCT02392611|83228972|FG002|Overall Study|Adverse Event|0|||
46982691|NCT02392611|83228973|FG003|Overall Study|Adverse Event|1|||
46982692|NCT02392611|83228974|FG004|Overall Study|Adverse Event|0|||
46982693|NCT02392611|83228975|FG005|Overall Study|Adverse Event|0|||
46982694|NCT02392611|83228976|FG006|Overall Study|Adverse Event|0|||
46982695|NCT02392611|83228977|FG007|Overall Study|Adverse Event|0|||
46982696|NCT02392611|83228978|FG008|Overall Study|Adverse Event|0|||
46982697|NCT02392611|83228970|FG000|Overall Study|Progressive disease|0|||
46982698|NCT02392611|83228971|FG001|Overall Study|Progressive disease|0|||
46982699|NCT02392611|83228972|FG002|Overall Study|Progressive disease|0|||
46982700|NCT02392611|83228973|FG003|Overall Study|Progressive disease|2|||
46865475|NCT03129100|83082049|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865476|NCT03129100|83082050|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865477|NCT03129100|83082051|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865478|NCT03129100|83082052|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865479|NCT03129100|83082053|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865480|NCT03129100|83082054|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865481|NCT03129100|83082055|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865482|NCT03129100|83082056|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865483|NCT03129100|83082057|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865484|NCT03129100|83082058|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865485|NCT03129100|83082059|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865486|NCT03129100|83082060|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865487|NCT03129100|83082061|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865488|NCT03129100|83082062|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865489|NCT03129100|83082063|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865490|NCT03129100|83082064|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
46865491|NCT03129100|83082065|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865492|NCT03129100|83082066|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
46865493|NCT03129100|83082067|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865494|NCT03129100|83082068|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865495|NCT03129100|83082069|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865496|NCT03129100|83082070|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865497|NCT03129100|83082071|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865498|NCT03129100|83082072|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
46865499|NCT03129100|83082047|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865500|NCT03129100|83082048|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865501|NCT03129100|83082049|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46982701|NCT02392611|83228974|FG004|Overall Study|Progressive disease|1|||
46982702|NCT02392611|83228975|FG005|Overall Study|Progressive disease|0|||
46982703|NCT02392611|83228976|FG006|Overall Study|Progressive disease|0|||
46865502|NCT03129100|83082050|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865503|NCT03129100|83082051|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865504|NCT03129100|83082052|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865505|NCT03129100|83082053|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865506|NCT03129100|83082054|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865507|NCT03129100|83082055|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865508|NCT03129100|83082056|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865509|NCT03129100|83082057|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865510|NCT03129100|83082058|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865511|NCT03129100|83082059|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865512|NCT03129100|83082060|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865513|NCT03129100|83082061|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865514|NCT03129100|83082062|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865515|NCT03129100|83082063|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865516|NCT03129100|83082064|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865517|NCT03129100|83082065|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865518|NCT03129100|83082066|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865519|NCT03129100|83082067|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
46865520|NCT03129100|83082068|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865521|NCT03129100|83082069|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865522|NCT03129100|83082070|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865523|NCT03129100|83082071|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865524|NCT03129100|83082072|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
46865525|NCT03129100|83082047|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
46865526|NCT03129100|83082048|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
46865527|NCT03129100|83082049|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
46865528|NCT03129100|83082050|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
46865529|NCT03129100|83082051|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
46865530|NCT03129100|83082052|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
46865531|NCT03129100|83082053|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
46865532|NCT03129100|83082054|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
46865533|NCT03129100|83082055|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
46865534|NCT03129100|83082056|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
46865535|NCT03129100|83082057|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
46865536|NCT03129100|83082058|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
46865537|NCT03129100|83082059|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
46865538|NCT03129100|83082060|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
46865539|NCT03129100|83082061|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
46865540|NCT03129100|83082062|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
46865541|NCT03129100|83082063|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
46865542|NCT03129100|83082064|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
46865543|NCT03129100|83082065|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
46865544|NCT03129100|83082066|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
46865545|NCT03129100|83082067|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
46865546|NCT03129100|83082068|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
46865547|NCT03129100|83082069|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
46865548|NCT03129100|83082070|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
46865549|NCT03129100|83082071|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
46865550|NCT03129100|83082072|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
46865551|NCT03129100|83082047|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865552|NCT03129100|83082048|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865553|NCT03129100|83082049|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46982704|NCT02392611|83228977|FG007|Overall Study|Progressive disease|0|||
46982705|NCT02392611|83228978|FG008|Overall Study|Progressive disease|0|||
46982706|NCT02392611|83228970|FG000|Overall Study|Death|1|||
46982707|NCT02392611|83228971|FG001|Overall Study|Death|0|||
46982708|NCT02392611|83228972|FG002|Overall Study|Death|0|||
46982709|NCT02392611|83228973|FG003|Overall Study|Death|0|||
46982710|NCT02392611|83228974|FG004|Overall Study|Death|0|||
46982711|NCT02392611|83228975|FG005|Overall Study|Death|1|||
46982712|NCT02392611|83228976|FG006|Overall Study|Death|0|||
46865554|NCT03129100|83082050|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865555|NCT03129100|83082051|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865556|NCT03129100|83082052|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865557|NCT03129100|83082053|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865558|NCT03129100|83082054|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865559|NCT03129100|83082055|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865560|NCT03129100|83082056|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865561|NCT03129100|83082057|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46982713|NCT02392611|83228977|FG007|Overall Study|Death|0|||
46982714|NCT02392611|83228978|FG008|Overall Study|Death|0|||
46982715|NCT02392611|83228970|FG000|Overall Study|Withdrawal by Subject|0|||
46865562|NCT03129100|83082058|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865563|NCT03129100|83082059|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865564|NCT03129100|83082060|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46698306|NCT00400725|82913281|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
46698307|NCT00400725|82913279|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
46698308|NCT00400725|82913280|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
46698309|NCT00400725|82913281|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
46698310|NCT00400725|82913279|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
46698311|NCT00400725|82913280|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
46698312|NCT00400725|82913281|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
46698313|NCT00932113|82913297|FG000|Overall Study|Lost to Follow-up|1|||
46698314|NCT00932113|82913298|FG001|Overall Study|Lost to Follow-up|0|||
46698315|NCT00931801|82913307|FG000|Overall Study|Adverse Event|0|||
46698316|NCT00931801|82913308|FG001|Overall Study|Adverse Event|0|||
46698317|NCT00931801|82913309|FG002|Overall Study|Adverse Event|1|||
46698318|NCT00931801|82913307|FG000|Overall Study|Lost to Follow-up|0|||
46865565|NCT03129100|83082061|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865566|NCT03129100|83082062|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865567|NCT03129100|83082063|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865568|NCT03129100|83082064|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865569|NCT03129100|83082065|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865570|NCT03129100|83082066|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865571|NCT03129100|83082067|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
46865572|NCT03129100|83082068|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865573|NCT03129100|83082069|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865574|NCT03129100|83082070|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865575|NCT03129100|83082071|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865576|NCT03129100|83082072|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
46865577|NCT03129100|83082047|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
46865578|NCT03129100|83082048|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
46865579|NCT03129100|83082049|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
46865580|NCT03129100|83082050|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
46865581|NCT03129100|83082051|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
46865582|NCT03129100|83082052|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
46865583|NCT03129100|83082053|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
46865584|NCT03129100|83082054|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
46865585|NCT03129100|83082055|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
46865586|NCT03129100|83082056|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
46865587|NCT03129100|83082057|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
46865588|NCT03129100|83082058|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
46865589|NCT03129100|83082059|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
46865590|NCT03129100|83082060|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
46865591|NCT03129100|83082061|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
46865592|NCT03129100|83082062|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
46865593|NCT03129100|83082063|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
46865594|NCT03129100|83082064|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
46865595|NCT03129100|83082065|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
46865596|NCT03129100|83082066|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
46865597|NCT03129100|83082067|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
46865598|NCT03129100|83082068|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
46865599|NCT03129100|83082069|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
46865600|NCT03129100|83082070|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
46865601|NCT03129100|83082071|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
46865602|NCT03129100|83082072|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
46865603|NCT03129100|83082047|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865604|NCT03129100|83082048|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865605|NCT03129100|83082049|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865606|NCT03129100|83082050|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865607|NCT03129100|83082051|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46698319|NCT00931801|82913308|FG001|Overall Study|Lost to Follow-up|1|||
46698320|NCT00931801|82913309|FG002|Overall Study|Lost to Follow-up|0|||
46698321|NCT00931801|82913307|FG000|Overall Study|Withdrawal by Subject|1|||
46698322|NCT00931801|82913308|FG001|Overall Study|Withdrawal by Subject|0|||
46698323|NCT00931801|82913309|FG002|Overall Study|Withdrawal by Subject|0|||
46865608|NCT03129100|83082052|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865609|NCT03129100|83082053|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865610|NCT03129100|83082054|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865611|NCT03129100|83082055|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865612|NCT03129100|83082056|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865613|NCT03129100|83082057|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865614|NCT03129100|83082058|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46698324|NCT00931801|82913307|FG000|Overall Study|Confirmed Virologic Failure|0|||
46698325|NCT00931801|82913308|FG001|Overall Study|Confirmed Virologic Failure|0|||
46698326|NCT00931801|82913309|FG002|Overall Study|Confirmed Virologic Failure|3|||
46698327|NCT00931723|82913323|FG000|Overall Study|Withdrawal by Subject|11|||
46698328|NCT00931723|82913324|FG001|Overall Study|Withdrawal by Subject|13|||
46698329|NCT00931723|82913323|FG000|Overall Study|Adverse Event|6|||
46698330|NCT00931723|82913324|FG001|Overall Study|Adverse Event|13|||
46698331|NCT00931723|82913323|FG000|Overall Study|Lithium found in blood|0|||
46698332|NCT00931723|82913324|FG001|Overall Study|Lithium found in blood|1|||
46698333|NCT00931723|82913323|FG000|Overall Study|Condition under investigation worsened|1|||
46698334|NCT00931723|82913324|FG001|Overall Study|Condition under investigation worsened|2|||
46698335|NCT00931723|82913323|FG000|Overall Study|Lost to Follow-up|1|||
46698336|NCT00931723|82913324|FG001|Overall Study|Lost to Follow-up|2|||
46698337|NCT00931723|82913323|FG000|Overall Study|Study-specific discontinuation criteria|1|||
46698338|NCT00931723|82913324|FG001|Overall Study|Study-specific discontinuation criteria|1|||
46698339|NCT00931723|82913323|FG000|Overall Study|Severe non-compliance to protocol|2|||
46865615|NCT03129100|83082059|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865616|NCT03129100|83082060|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865617|NCT03129100|83082061|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865618|NCT03129100|83082062|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865619|NCT03129100|83082063|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865620|NCT03129100|83082064|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865621|NCT03129100|83082065|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865622|NCT03129100|83082066|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865623|NCT03129100|83082067|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865624|NCT03129100|83082068|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865625|NCT03129100|83082069|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865626|NCT03129100|83082070|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
46865627|NCT03129100|83082071|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
46865628|NCT03129100|83082072|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
46865629|NCT03129100|83082047|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865630|NCT03129100|83082048|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865631|NCT03129100|83082049|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865632|NCT03129100|83082050|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865633|NCT03129100|83082051|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865634|NCT03129100|83082052|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865635|NCT03129100|83082053|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865636|NCT03129100|83082054|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865637|NCT03129100|83082055|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865638|NCT03129100|83082056|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865639|NCT03129100|83082057|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865640|NCT03129100|83082058|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865641|NCT03129100|83082059|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865642|NCT03129100|83082060|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865643|NCT03129100|83082061|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865644|NCT03129100|83082062|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865645|NCT03129100|83082063|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865646|NCT03129100|83082064|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865647|NCT03129100|83082065|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865648|NCT03129100|83082066|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865649|NCT03129100|83082067|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865650|NCT03129100|83082068|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865651|NCT03129100|83082069|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
46865652|NCT03129100|83082070|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
46865653|NCT03129100|83082071|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
46865654|NCT03129100|83082072|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
46865655|NCT03129100|83082047|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865656|NCT03129100|83082048|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865657|NCT03129100|83082049|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865658|NCT03129100|83082050|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865659|NCT03129100|83082051|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865660|NCT03129100|83082052|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865661|NCT03129100|83082053|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865662|NCT03129100|83082054|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865663|NCT03129100|83082055|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865664|NCT03129100|83082056|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865665|NCT03129100|83082057|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865666|NCT03129100|83082058|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865667|NCT03129100|83082059|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865668|NCT03129100|83082060|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865669|NCT03129100|83082061|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865670|NCT03129100|83082062|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865671|NCT03129100|83082063|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865672|NCT03129100|83082064|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865673|NCT03129100|83082065|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865674|NCT03129100|83082066|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865675|NCT03129100|83082067|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46982716|NCT02392611|83228971|FG001|Overall Study|Withdrawal by Subject|0|||
46698340|NCT00931723|82913324|FG001|Overall Study|Severe non-compliance to protocol|0|||
46865676|NCT03129100|83082068|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46982717|NCT02392611|83228972|FG002|Overall Study|Withdrawal by Subject|0|||
46698341|NCT00931723|82913323|FG000|Overall Study|Safety reasons|0|||
46865677|NCT03129100|83082069|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865678|NCT03129100|83082070|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865679|NCT03129100|83082071|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
46865680|NCT03129100|83082072|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
46865681|NCT03129100|83082047|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865682|NCT03129100|83082048|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865683|NCT03129100|83082049|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865684|NCT03129100|83082050|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865685|NCT03129100|83082051|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865686|NCT03129100|83082052|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865687|NCT03129100|83082053|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865688|NCT03129100|83082054|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865689|NCT03129100|83082055|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865690|NCT03129100|83082056|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865691|NCT03129100|83082057|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865692|NCT03129100|83082058|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865693|NCT03129100|83082059|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865694|NCT03129100|83082060|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865695|NCT03129100|83082061|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865696|NCT03129100|83082062|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865697|NCT03129100|83082063|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865698|NCT03129100|83082064|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865699|NCT03129100|83082065|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865700|NCT03129100|83082066|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865701|NCT03129100|83082067|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865702|NCT03129100|83082068|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865703|NCT03129100|83082069|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865704|NCT03129100|83082070|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865705|NCT03129100|83082071|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
46865706|NCT03129100|83082072|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
46865707|NCT03129100|83082047|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
46865708|NCT03129100|83082048|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
46865709|NCT03129100|83082049|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
46865710|NCT03129100|83082050|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
46865711|NCT03129100|83082051|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
46865712|NCT03129100|83082052|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
46865713|NCT03129100|83082053|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
46865714|NCT03129100|83082054|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
46865715|NCT03129100|83082055|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
46865716|NCT03129100|83082056|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
46865717|NCT03129100|83082057|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
46865718|NCT03129100|83082058|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
46865719|NCT03129100|83082059|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
46865720|NCT03129100|83082060|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
46865721|NCT03129100|83082061|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
46865722|NCT03129100|83082062|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
46865723|NCT03129100|83082063|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
46865724|NCT03129100|83082064|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
46865725|NCT03129100|83082065|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
46698342|NCT00931723|82913324|FG001|Overall Study|Safety reasons|1|||
46698343|NCT00931723|82913323|FG000|Overall Study|Took prohibited concomitant medication|0|||
46698344|NCT00931723|82913324|FG001|Overall Study|Took prohibited concomitant medication|1|||
46698345|NCT00931723|82913323|FG000|Overall Study|Lack or insufficient theraputic response|2|||
46865726|NCT03129100|83082066|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
46865727|NCT03129100|83082067|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
46865728|NCT03129100|83082068|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
46865729|NCT03129100|83082069|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
46865730|NCT03129100|83082070|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
46865731|NCT03129100|83082071|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
46698346|NCT00931723|82913324|FG001|Overall Study|Lack or insufficient theraputic response|5|||
46698347|NCT00931723|82913323|FG000|Overall Study|Sponsor decision|1|||
46698348|NCT00931723|82913324|FG001|Overall Study|Sponsor decision|0|||
46865732|NCT03129100|83082072|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
46865733|NCT03101020|83082111|FG000|Overall Study|Lack of time to participate|1|||
46865734|NCT03101020|83082112|FG001|Overall Study|Lack of time to participate|0|||
46865735|NCT03101020|83082111|FG000|Overall Study|Ran over by a car|0|||
46865736|NCT03101020|83082112|FG001|Overall Study|Ran over by a car|1|||
46865737|NCT03101020|83082111|FG000|Overall Study|Withdrawal by Subject|0|||
46865738|NCT03101020|83082112|FG001|Overall Study|Withdrawal by Subject|2|||
46865739|NCT03100942|83082122|FG000|Randomized Treatment Period|Withdrew Consent|4|||
46865740|NCT03100942|83082123|FG001|Randomized Treatment Period|Withdrew Consent|5|||
46865741|NCT03100942|83082124|FG002|Randomized Treatment Period|Withdrew Consent|3|||
46865742|NCT03100942|83082125|FG003|Randomized Treatment Period|Withdrew Consent|3|||
46865743|NCT03100942|83082126|FG004|Randomized Treatment Period|Withdrew Consent|0|||
46865744|NCT03100942|83082127|FG005|Randomized Treatment Period|Withdrew Consent|0|||
46865745|NCT03100942|83082128|FG006|Randomized Treatment Period|Withdrew Consent|0|||
46865746|NCT03100942|83082122|FG000|Randomized Treatment Period|Adverse Event|5|||
46865747|NCT03100942|83082123|FG001|Randomized Treatment Period|Adverse Event|2|||
46865748|NCT03100942|83082124|FG002|Randomized Treatment Period|Adverse Event|1|||
46865749|NCT03100942|83082125|FG003|Randomized Treatment Period|Adverse Event|0|||
46865750|NCT03100942|83082126|FG004|Randomized Treatment Period|Adverse Event|0|||
46865751|NCT03100942|83082127|FG005|Randomized Treatment Period|Adverse Event|0|||
46865752|NCT03100942|83082128|FG006|Randomized Treatment Period|Adverse Event|0|||
46865753|NCT03100942|83082122|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
46865754|NCT03100942|83082123|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
46865755|NCT03100942|83082124|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
46865756|NCT03100942|83082125|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
46865757|NCT03100942|83082126|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
46865758|NCT03100942|83082127|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
46865759|NCT03100942|83082128|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
46865760|NCT03100942|83082122|FG000|Randomized Treatment Period|Protocol Violation|0|||
46865761|NCT03100942|83082123|FG001|Randomized Treatment Period|Protocol Violation|1|||
46865762|NCT03100942|83082124|FG002|Randomized Treatment Period|Protocol Violation|1|||
46865763|NCT03100942|83082125|FG003|Randomized Treatment Period|Protocol Violation|1|||
46865764|NCT03100942|83082126|FG004|Randomized Treatment Period|Protocol Violation|0|||
46865765|NCT03100942|83082127|FG005|Randomized Treatment Period|Protocol Violation|0|||
46865766|NCT03100942|83082128|FG006|Randomized Treatment Period|Protocol Violation|0|||
46865767|NCT03100942|83082122|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
46865768|NCT03100942|83082123|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
46865769|NCT03100942|83082124|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
46865770|NCT03100942|83082125|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
46865771|NCT03100942|83082126|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
46865772|NCT03100942|83082127|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
46865773|NCT03100942|83082128|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
46865774|NCT03100942|83082122|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
46865775|NCT03100942|83082123|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
46865776|NCT03100942|83082124|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
46865777|NCT03100942|83082125|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
46865778|NCT03100942|83082126|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
46865779|NCT03100942|83082127|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
46865780|NCT03100942|83082128|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
46865781|NCT03100942|83082122|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
46865782|NCT03100942|83082123|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
46865783|NCT03100942|83082124|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
46865784|NCT03100942|83082125|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
46865785|NCT03100942|83082126|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
46865786|NCT03100942|83082127|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
46865787|NCT03100942|83082128|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
46865788|NCT03099694|83082143|FG000|Overall Study|Withdrawal by Subject|11|||
46865789|NCT03099694|83082144|FG001|Overall Study|Withdrawal by Subject|13|||
46865790|NCT03099694|83082143|FG000|Overall Study|Lost to Follow-up|9|||
46865791|NCT03099694|83082144|FG001|Overall Study|Lost to Follow-up|5|||
46865792|NCT03099538|83082151|FG000|Overall Study|Lack of Efficacy|3|||
46865793|NCT03099304|83082160|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
46865794|NCT03099304|83082161|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
46865795|NCT03099304|83082162|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
46865796|NCT03099304|83082163|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
46865797|NCT03099304|83082164|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
46865798|NCT03099304|83082165|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
46865799|NCT03099304|83082160|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
46865800|NCT03099304|83082161|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
46865801|NCT03099304|83082162|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
46865802|NCT03099304|83082163|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
46865803|NCT03099304|83082164|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
46865804|NCT03099304|83082165|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
46865805|NCT03099304|83082160|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
46865806|NCT03099304|83082161|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
46865807|NCT03099304|83082162|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
46865808|NCT03099304|83082163|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
46865809|NCT03099304|83082164|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
46865810|NCT03099304|83082165|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
46865811|NCT03099304|83082160|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
46865812|NCT03099304|83082161|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
46865813|NCT03099304|83082162|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
46865814|NCT03099304|83082163|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
46865815|NCT03099304|83082164|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
46865816|NCT03099304|83082165|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
46865817|NCT03099304|83082160|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
46865818|NCT03099304|83082161|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
46865819|NCT03099304|83082162|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
46865820|NCT03099304|83082163|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
46865821|NCT03099304|83082164|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
46865822|NCT03099304|83082165|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
46865823|NCT03099304|83082160|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
46865824|NCT03099304|83082161|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
46865825|NCT03099304|83082162|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
46865826|NCT03099304|83082163|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
46865827|NCT03099304|83082164|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
46865828|NCT03099304|83082165|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
46865829|NCT03099304|83082160|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
46865830|NCT03099304|83082161|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
46865831|NCT03099304|83082162|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
46865832|NCT03099304|83082163|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
46865833|NCT03099304|83082164|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
46865834|NCT03099304|83082165|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
46865835|NCT03099304|83082160|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
46865836|NCT03099304|83082161|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
46865837|NCT03099304|83082162|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
46865838|NCT03099304|83082163|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
46865839|NCT03099304|83082164|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
46865840|NCT03099304|83082165|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
46865841|NCT03099304|83082160|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
46865842|NCT03099304|83082161|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
46865843|NCT03099304|83082162|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
46865844|NCT03099304|83082163|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
46865845|NCT03099304|83082164|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
46865846|NCT03099304|83082165|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
46865847|NCT03099304|83082160|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
46865848|NCT03099304|83082161|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
46865849|NCT03099304|83082162|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
46865850|NCT03099304|83082163|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
46865851|NCT03099304|83082164|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
46865852|NCT03099304|83082165|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
46865853|NCT03099304|83082160|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
46865854|NCT03099304|83082161|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
46865855|NCT03099304|83082162|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
46865856|NCT03099304|83082163|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
46865857|NCT03099304|83082164|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
46865858|NCT03099304|83082165|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
46865859|NCT03099304|83082160|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
46865860|NCT03099304|83082161|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
46865861|NCT03099304|83082162|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
46865862|NCT03099304|83082163|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
46865863|NCT03099304|83082164|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
46865864|NCT03099304|83082165|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
46865865|NCT03099304|83082160|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
46865866|NCT03099304|83082161|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
46865867|NCT03099304|83082162|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
46865868|NCT03099304|83082163|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
46865869|NCT03099304|83082164|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
46865870|NCT03099304|83082165|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
46865871|NCT03099304|83082160|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
46865872|NCT03099304|83082161|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
46865873|NCT03099304|83082162|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
46865874|NCT03099304|83082163|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
46865875|NCT03099304|83082164|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
46865876|NCT03099304|83082165|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
46865877|NCT03099304|83082160|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
46865878|NCT03099304|83082161|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
46865879|NCT03099304|83082162|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
46865880|NCT03099304|83082163|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
46865881|NCT03099304|83082164|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
46865882|NCT03099304|83082165|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
46865883|NCT03099304|83082160|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
46865884|NCT03099304|83082161|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
46865885|NCT03099304|83082162|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
46865886|NCT03099304|83082163|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
46865887|NCT03099304|83082164|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
46865888|NCT03099304|83082165|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
46865889|NCT03099304|83082160|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
46865890|NCT03099304|83082161|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
46865891|NCT03099304|83082162|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
46865892|NCT03099304|83082163|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
46865893|NCT03099304|83082164|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
46865894|NCT03099304|83082165|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
46865895|NCT03097588|83082192|FG000|Overall Study|Adverse Event|1|||
46865896|NCT01631214|83082198|FG000|Overall Study|Withdrawal by Subject|276|||
46865897|NCT01631214|83082199|FG001|Overall Study|Withdrawal by Subject|290|||
46865898|NCT01631214|83082198|FG000|Overall Study|Death|113|||
46865899|NCT01631214|83082199|FG001|Overall Study|Death|106|||
46865900|NCT01631214|83082198|FG000|Overall Study|Lost to Follow-up|54|||
46865901|NCT01631214|83082199|FG001|Overall Study|Lost to Follow-up|40|||
46865902|NCT01631214|83082198|FG000|Overall Study|Adverse Event|45|||
46865903|NCT01631214|83082199|FG001|Overall Study|Adverse Event|45|||
46865904|NCT01631214|83082198|FG000|Overall Study|Other|22|||
46865905|NCT01631214|83082199|FG001|Overall Study|Other|19|||
46865906|NCT01631214|83082198|FG000|Overall Study|Noncompliance|16|||
46865907|NCT01631214|83082199|FG001|Overall Study|Noncompliance|15|||
46865908|NCT01631214|83082198|FG000|Overall Study|Requirement for Alternative Therapy|8|||
46865909|NCT01631214|83082199|FG001|Overall Study|Requirement for Alternative Therapy|3|||
46865910|NCT01631214|83082198|FG000|Overall Study|Protocol Deviation|4|||
46865911|NCT01631214|83082199|FG001|Overall Study|Protocol Deviation|3|||
46865912|NCT01631214|83082198|FG000|Overall Study|Ineligibility determined|5|||
46865913|NCT01631214|83082199|FG001|Overall Study|Ineligibility determined|2|||
46865914|NCT01631214|83082198|FG000|Overall Study|Administrative Decision|1|||
46865915|NCT01631214|83082199|FG001|Overall Study|Administrative Decision|0|||
46865916|NCT03093454|83082209|FG000|Overall Study|Withdrawal by Subject|1|||
46865917|NCT03093454|83082210|FG001|Overall Study|Withdrawal by Subject|1|||
46865918|NCT03093454|83082209|FG000|Overall Study|Scheduling conflict|3|||
46865919|NCT03093454|83082210|FG001|Overall Study|Scheduling conflict|1|||
46865920|NCT03093454|83082209|FG000|Overall Study|Physician Decision|2|||
46865921|NCT03093454|83082210|FG001|Overall Study|Physician Decision|1|||
46865922|NCT00468130|83082231|FG000|Overall Study|Adverse Event|2|||
46865923|NCT00468130|83082232|FG001|Overall Study|Adverse Event|1|||
46865924|NCT00468130|83082231|FG000|Overall Study|Withdrawal by Subject|0|||
46865925|NCT00468130|83082232|FG001|Overall Study|Withdrawal by Subject|1|||
46865926|NCT00911820|83082242|FG000|Overall Study|RECIST progression|12|||
46865927|NCT00911820|83082243|FG001|Overall Study|RECIST progression|8|||
46865928|NCT00911820|83082242|FG000|Overall Study|Adverse Event|8|||
46865929|NCT00911820|83082243|FG001|Overall Study|Adverse Event|8|||
46865930|NCT00911820|83082242|FG000|Overall Study|Clinical Progression|7|||
46865931|NCT00911820|83082243|FG001|Overall Study|Clinical Progression|5|||
46865932|NCT00911820|83082242|FG000|Overall Study|Physician Decision|5|||
46865933|NCT00911820|83082243|FG001|Overall Study|Physician Decision|9|||
46865934|NCT00911820|83082242|FG000|Overall Study|Decline in Performance Status|4|||
46865935|NCT00911820|83082243|FG001|Overall Study|Decline in Performance Status|2|||
46865936|NCT00911820|83082242|FG000|Overall Study|Withdrawal by Subject|3|||
46865937|NCT00911820|83082243|FG001|Overall Study|Withdrawal by Subject|4|||
46865938|NCT00911820|83082242|FG000|Overall Study|Death|1|||
46865939|NCT00911820|83082243|FG001|Overall Study|Death|2|||
46865940|NCT00911820|83082242|FG000|Overall Study|Pursue surgery|1|||
46865941|NCT00911820|83082243|FG001|Overall Study|Pursue surgery|1|||
46865942|NCT00911820|83082242|FG000|Overall Study|Pursue Radiation|1|||
46865943|NCT00911820|83082243|FG001|Overall Study|Pursue Radiation|0|||
46865944|NCT00911820|83082242|FG000|Overall Study|Still on Therapy|2|||
46865945|NCT00911820|83082243|FG001|Overall Study|Still on Therapy|2|||
46865946|NCT00911820|83082242|FG000|Overall Study|Pathology Not Confirmed|1|||
46865947|NCT00911820|83082243|FG001|Overall Study|Pathology Not Confirmed|0|||
46865948|NCT00911820|83082242|FG000|Overall Study|Withdraw before Receive Treatment|0|||
46865949|NCT00911820|83082243|FG001|Overall Study|Withdraw before Receive Treatment|2|||
46865950|NCT00246324|83082258|FG000|Overall Study|Withdrawal by Subject|1|||
46865951|NCT04234984|83082264|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
46865952|NCT04234984|83082264|FG000|Follow-up at the Second Time Point|Death|1|||
46865953|NCT04234984|83082264|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
46865954|NCT03922750|83082278|FG000|Overall Study|Unclassified|0|||
46865955|NCT03922750|83082279|FG001|Overall Study|Unclassified|0|||
46865956|NCT03922750|83082280|FG002|Overall Study|Unclassified|1|||
46865957|NCT03922750|83082278|FG000|Overall Study|Adverse Event|0|||
46865958|NCT03922750|83082279|FG001|Overall Study|Adverse Event|1|||
46865959|NCT03922750|83082280|FG002|Overall Study|Adverse Event|0|||
46865960|NCT04634253|83082302|FG000|Overall Study|Adverse Event|1|||
46865961|NCT04634253|83082303|FG001|Overall Study|Adverse Event|1|||
46865962|NCT04634253|83082304|FG002|Overall Study|Adverse Event|0|||
46865963|NCT04634253|83082302|FG000|Overall Study|Physician Decision|0|||
46865964|NCT04634253|83082303|FG001|Overall Study|Physician Decision|1|||
46865965|NCT04634253|83082304|FG002|Overall Study|Physician Decision|0|||
46865966|NCT04634253|83082302|FG000|Overall Study|Withdrawal by Subject|1|||
46865967|NCT04634253|83082303|FG001|Overall Study|Withdrawal by Subject|0|||
46865968|NCT04634253|83082304|FG002|Overall Study|Withdrawal by Subject|3|||
46865969|NCT04209634|83082371|FG000|Overall Study|Ongoing|10|||
46865970|NCT03725982|83082405|FG000|First Intervention|Withdrawal by Subject|0|||
46865971|NCT03725982|83082406|FG001|First Intervention|Withdrawal by Subject|1|||
46865972|NCT03725982|83082405|FG000|First Intervention|Physician Decision|1|||
46865973|NCT03725982|83082406|FG001|First Intervention|Physician Decision|1|||
46865974|NCT03354273|83082472|FG000|Overall Study|Adverse Event|5|||
46865975|NCT03354273|83082472|FG000|Overall Study|Screen Failure|21|||
46865976|NCT03354273|83082472|FG000|Overall Study|Withdrawal by Subject|34|||
46865977|NCT03354273|83082472|FG000|Overall Study|Technical Problems|30|||
46865978|NCT03354273|83082472|FG000|Overall Study|Lost to Follow-up|4|||
46865979|NCT03354273|83082472|FG000|Overall Study|Investigator Decision|3|||
46865980|NCT03354273|83082472|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
46865981|NCT03354273|83082472|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
46865982|NCT03354273|83082472|FG000|Overall Study|COVID-19 Restrictions|9|||
46865983|NCT03354273|83082472|FG000|Overall Study|Other|5|||
46865984|NCT02759185|83082496|FG000|Stage 1|Adverse Event|0|||
46865985|NCT02759185|83082497|FG001|Stage 1|Adverse Event|1|||
46865986|NCT02759185|83082498|FG002|Stage 1|Adverse Event|3|||
46865987|NCT02759185|83082499|FG003|Stage 1|Adverse Event|0|||
46865988|NCT02759185|83082500|FG004|Stage 1|Adverse Event|0|||
46865989|NCT02759185|83082501|FG005|Stage 1|Adverse Event|0|||
46865990|NCT02759185|83082502|FG006|Stage 1|Adverse Event|0|||
46865991|NCT02759185|83082496|FG000|Stage 1|Withdrawal by Subject|1|||
46865992|NCT02759185|83082497|FG001|Stage 1|Withdrawal by Subject|0|||
46865993|NCT02759185|83082498|FG002|Stage 1|Withdrawal by Subject|0|||
46865994|NCT02759185|83082499|FG003|Stage 1|Withdrawal by Subject|0|||
46865995|NCT02759185|83082500|FG004|Stage 1|Withdrawal by Subject|0|||
46865996|NCT02759185|83082501|FG005|Stage 1|Withdrawal by Subject|0|||
46865997|NCT02759185|83082502|FG006|Stage 1|Withdrawal by Subject|0|||
46982718|NCT02392611|83228973|FG003|Overall Study|Withdrawal by Subject|1|||
46982719|NCT02392611|83228974|FG004|Overall Study|Withdrawal by Subject|0|||
46982720|NCT02392611|83228975|FG005|Overall Study|Withdrawal by Subject|0|||
46982721|NCT02392611|83228976|FG006|Overall Study|Withdrawal by Subject|0|||
46698349|NCT00931723|82913323|FG000|Overall Study|Late hospital discharge|1|||
46865998|NCT02759185|83082496|FG000|Stage 2|Adverse Event|0|||
46698350|NCT00931723|82913324|FG001|Overall Study|Late hospital discharge|0|||
46865999|NCT02759185|83082497|FG001|Stage 2|Adverse Event|0|||
46866000|NCT02759185|83082498|FG002|Stage 2|Adverse Event|0|||
46866001|NCT02759185|83082499|FG003|Stage 2|Adverse Event|0|||
46866002|NCT02759185|83082500|FG004|Stage 2|Adverse Event|1|||
46866003|NCT02759185|83082501|FG005|Stage 2|Adverse Event|2|||
46866004|NCT02759185|83082502|FG006|Stage 2|Adverse Event|0|||
46866005|NCT02759185|83082496|FG000|Stage 2|Withdrawal by Subject|0|||
46866006|NCT02759185|83082497|FG001|Stage 2|Withdrawal by Subject|0|||
46866007|NCT02759185|83082498|FG002|Stage 2|Withdrawal by Subject|0|||
46866008|NCT02759185|83082499|FG003|Stage 2|Withdrawal by Subject|0|||
46866009|NCT02759185|83082500|FG004|Stage 2|Withdrawal by Subject|1|||
46982722|NCT02392611|83228977|FG007|Overall Study|Withdrawal by Subject|0|||
46866010|NCT02759185|83082501|FG005|Stage 2|Withdrawal by Subject|1|||
46866011|NCT02759185|83082502|FG006|Stage 2|Withdrawal by Subject|1|||
46866012|NCT01844518|83082535|FG000|Overall Study|Adverse Event|7|||
46866013|NCT01844518|83082536|FG001|Overall Study|Adverse Event|1|||
46866014|NCT01844518|83082535|FG000|Overall Study|Lack of Efficacy|17|||
46866015|NCT01844518|83082536|FG001|Overall Study|Lack of Efficacy|5|||
46866016|NCT01844518|83082535|FG000|Overall Study|Participant's request to discontinue|4|||
46866017|NCT01844518|83082536|FG001|Overall Study|Participant's request to discontinue|1|||
46866018|NCT01844518|83082535|FG000|Overall Study|Poor/Non-compliance|1|||
46866019|NCT01844518|83082536|FG001|Overall Study|Poor/Non-compliance|0|||
46866020|NCT01844518|83082535|FG000|Overall Study|No Longer Met Study Criteria|2|||
46866021|NCT01844518|83082536|FG001|Overall Study|No Longer Met Study Criteria|0|||
46866022|NCT01844518|83082535|FG000|Overall Study|Withdrawal by Subject|9|||
46866023|NCT01844518|83082536|FG001|Overall Study|Withdrawal by Subject|0|||
46866024|NCT01844518|83082535|FG000|Overall Study|Pregnancy|1|||
46866025|NCT01844518|83082536|FG001|Overall Study|Pregnancy|0|||
46866026|NCT01039584|83082605|FG000|Overall Study|Withdrawal by Subject|4|||
46866027|NCT01039584|83082606|FG001|Overall Study|Withdrawal by Subject|2|||
46866028|NCT01039584|83082607|FG002|Overall Study|Withdrawal by Subject|1|||
46866029|NCT01039584|83082605|FG000|Overall Study|Protocol Violation|10|||
46866030|NCT01039584|83082606|FG001|Overall Study|Protocol Violation|4|||
46866031|NCT01039584|83082607|FG002|Overall Study|Protocol Violation|6|||
46866032|NCT01039584|83082605|FG000|Overall Study|Lost to Follow-up|5|||
46866033|NCT01039584|83082606|FG001|Overall Study|Lost to Follow-up|3|||
46866034|NCT01039584|83082607|FG002|Overall Study|Lost to Follow-up|4|||
46866035|NCT01039584|83082605|FG000|Overall Study|Negative Baseline culture for Candida|59|||
46866036|NCT01039584|83082606|FG001|Overall Study|Negative Baseline culture for Candida|59|||
46866037|NCT01039584|83082607|FG002|Overall Study|Negative Baseline culture for Candida|24|||
46866038|NCT01039584|83082605|FG000|Overall Study|Lack of Efficacy|7|||
46866039|NCT01039584|83082606|FG001|Overall Study|Lack of Efficacy|6|||
46866040|NCT01039584|83082607|FG002|Overall Study|Lack of Efficacy|10|||
46866041|NCT01039584|83082605|FG000|Overall Study|other|1|||
46866042|NCT01039584|83082606|FG001|Overall Study|other|3|||
46866043|NCT01039584|83082607|FG002|Overall Study|other|1|||
46866044|NCT01039584|83082605|FG000|Overall Study|Pap smear with significant pathology|10|||
46866045|NCT01039584|83082606|FG001|Overall Study|Pap smear with significant pathology|10|||
46866046|NCT01039584|83082607|FG002|Overall Study|Pap smear with significant pathology|3|||
46866047|NCT01039584|83082605|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
46866048|NCT01039584|83082606|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
46866049|NCT01039584|83082607|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
46866050|NCT00920387|83082617|FG000|Stage 1|Adverse Event|1|||
46866051|NCT00920387|83082618|FG001|Stage 1|Adverse Event|0|||
46866052|NCT00920387|83082619|FG002|Stage 1|Adverse Event|0|||
46866053|NCT00679783|83082644|FG000|Overall Study|Adverse Event|0|||
46866054|NCT00679783|83082645|FG001|Overall Study|Adverse Event|0|||
46866055|NCT00679783|83082646|FG002|Overall Study|Adverse Event|0|||
46866056|NCT00679783|83082647|FG003|Overall Study|Adverse Event|3|||
46866057|NCT00679783|83082648|FG004|Overall Study|Adverse Event|0|||
46866058|NCT00679783|83082649|FG005|Overall Study|Adverse Event|0|||
46866059|NCT00679783|83082650|FG006|Overall Study|Adverse Event|1|||
46866060|NCT00679783|83082644|FG000|Overall Study|Lack of Efficacy|0|||
46866061|NCT00679783|83082645|FG001|Overall Study|Lack of Efficacy|1|||
46866062|NCT00679783|83082646|FG002|Overall Study|Lack of Efficacy|0|||
46866063|NCT00679783|83082647|FG003|Overall Study|Lack of Efficacy|2|||
46866064|NCT00679783|83082648|FG004|Overall Study|Lack of Efficacy|0|||
46866065|NCT00679783|83082649|FG005|Overall Study|Lack of Efficacy|0|||
46866066|NCT00679783|83082650|FG006|Overall Study|Lack of Efficacy|0|||
46866067|NCT00679783|83082644|FG000|Overall Study|Withdrawal by Subject|0|||
46866068|NCT00679783|83082645|FG001|Overall Study|Withdrawal by Subject|0|||
46866069|NCT00679783|83082646|FG002|Overall Study|Withdrawal by Subject|1|||
46866070|NCT00679783|83082647|FG003|Overall Study|Withdrawal by Subject|1|||
46866071|NCT00679783|83082648|FG004|Overall Study|Withdrawal by Subject|0|||
46866072|NCT00679783|83082649|FG005|Overall Study|Withdrawal by Subject|0|||
46866073|NCT00679783|83082650|FG006|Overall Study|Withdrawal by Subject|0|||
46866074|NCT00679783|83082644|FG000|Overall Study|Not Captured|0|||
46866075|NCT00679783|83082645|FG001|Overall Study|Not Captured|0|||
46698351|NCT00931411|82913332|FG000|First Intervention - 42 Days|Adverse Event|2|||
46866076|NCT00679783|83082646|FG002|Overall Study|Not Captured|0|||
46866077|NCT00679783|83082647|FG003|Overall Study|Not Captured|5|||
46866078|NCT00679783|83082648|FG004|Overall Study|Not Captured|0|||
46866079|NCT00679783|83082649|FG005|Overall Study|Not Captured|0|||
46866080|NCT00679783|83082650|FG006|Overall Study|Not Captured|0|||
46866081|NCT00679783|83082644|FG000|Overall Study|Ongoing at data cut-off|2|||
46866082|NCT00679783|83082645|FG001|Overall Study|Ongoing at data cut-off|2|||
46866083|NCT00679783|83082646|FG002|Overall Study|Ongoing at data cut-off|0|||
46866084|NCT00679783|83082647|FG003|Overall Study|Ongoing at data cut-off|9|||
46866085|NCT00679783|83082648|FG004|Overall Study|Ongoing at data cut-off|1|||
46866086|NCT00679783|83082649|FG005|Overall Study|Ongoing at data cut-off|0|||
46866087|NCT00679783|83082650|FG006|Overall Study|Ongoing at data cut-off|0|||
46866088|NCT03896490|83082672|FG000|Overall Study|Withdrawal by Subject|1|||
46866089|NCT03896490|83082673|FG001|Overall Study|Withdrawal by Subject|1|||
46866090|NCT03617172|83082681|FG000|Overall Study|Lost to Follow-up|1|||
46866091|NCT03617172|83082682|FG001|Overall Study|Lost to Follow-up|0|||
46866092|NCT03760146|83082694|FG000|Overall Study|Adverse Event|11|||
46866093|NCT03760146|83082695|FG001|Overall Study|Adverse Event|8|||
46866094|NCT03760146|83082696|FG002|Overall Study|Adverse Event|0|||
46866095|NCT03760146|83082697|FG003|Overall Study|Adverse Event|0|||
46866096|NCT03760146|83082698|FG004|Overall Study|Adverse Event|0|||
46866097|NCT03760146|83082699|FG005|Overall Study|Adverse Event|0|||
46866098|NCT03760146|83082694|FG000|Overall Study|Death|1|||
46866099|NCT03760146|83082695|FG001|Overall Study|Death|0|||
46866100|NCT03760146|83082696|FG002|Overall Study|Death|0|||
46866101|NCT03760146|83082697|FG003|Overall Study|Death|0|||
46866102|NCT03760146|83082698|FG004|Overall Study|Death|0|||
46866103|NCT03760146|83082699|FG005|Overall Study|Death|0|||
46866104|NCT03760146|83082694|FG000|Overall Study|Lost to Follow-up|41|||
46866105|NCT03760146|83082695|FG001|Overall Study|Lost to Follow-up|28|||
46866106|NCT03760146|83082696|FG002|Overall Study|Lost to Follow-up|9|||
46866107|NCT03760146|83082697|FG003|Overall Study|Lost to Follow-up|2|||
46866108|NCT03760146|83082698|FG004|Overall Study|Lost to Follow-up|14|||
46866109|NCT03760146|83082699|FG005|Overall Study|Lost to Follow-up|8|||
46866110|NCT03760146|83082694|FG000|Overall Study|No longer met eligibility criteria|3|||
46866111|NCT03760146|83082695|FG001|Overall Study|No longer met eligibility criteria|9|||
46866112|NCT03760146|83082696|FG002|Overall Study|No longer met eligibility criteria|0|||
46866113|NCT03760146|83082697|FG003|Overall Study|No longer met eligibility criteria|0|||
46866114|NCT03760146|83082698|FG004|Overall Study|No longer met eligibility criteria|1|||
46866115|NCT03760146|83082699|FG005|Overall Study|No longer met eligibility criteria|0|||
46866116|NCT03760146|83082694|FG000|Overall Study|Protocol Violation|21|||
46866117|NCT03760146|83082695|FG001|Overall Study|Protocol Violation|13|||
46866118|NCT03760146|83082696|FG002|Overall Study|Protocol Violation|1|||
46866119|NCT03760146|83082697|FG003|Overall Study|Protocol Violation|0|||
46866120|NCT03760146|83082698|FG004|Overall Study|Protocol Violation|1|||
46866121|NCT03760146|83082699|FG005|Overall Study|Protocol Violation|0|||
46866122|NCT03760146|83082694|FG000|Overall Study|Withdrawal by Subject|19|||
46866123|NCT03760146|83082695|FG001|Overall Study|Withdrawal by Subject|20|||
46866124|NCT03760146|83082696|FG002|Overall Study|Withdrawal by Subject|1|||
46866125|NCT03760146|83082697|FG003|Overall Study|Withdrawal by Subject|0|||
46866126|NCT03760146|83082698|FG004|Overall Study|Withdrawal by Subject|1|||
46866127|NCT03760146|83082699|FG005|Overall Study|Withdrawal by Subject|0|||
46866128|NCT03877068|83082719|FG000|Overall Study|Physician Decision|9|||
46866129|NCT03877068|83082720|FG001|Overall Study|Physician Decision|3|||
46866130|NCT03760068|83082730|FG000|Overall Study|Withdrawal by Subject|7|||
46866131|NCT03760068|83082731|FG001|Overall Study|Withdrawal by Subject|8|||
46866132|NCT03760068|83082730|FG000|Overall Study|Adverse Event|1|||
46866133|NCT03760068|83082731|FG001|Overall Study|Adverse Event|2|||
46866134|NCT03760068|83082730|FG000|Overall Study|Administrative Decision by Sponsor|0|||
46866135|NCT03760068|83082731|FG001|Overall Study|Administrative Decision by Sponsor|2|||
46866136|NCT03760068|83082730|FG000|Overall Study|Physician Decision|1|||
46866137|NCT03760068|83082731|FG001|Overall Study|Physician Decision|2|||
46866138|NCT03760068|83082730|FG000|Overall Study|Lost to Follow-up|4|||
46866139|NCT03760068|83082731|FG001|Overall Study|Lost to Follow-up|9|||
46866140|NCT03760068|83082730|FG000|Overall Study|Subject Moved Out of State|1|||
46866141|NCT03760068|83082731|FG001|Overall Study|Subject Moved Out of State|0|||
46866142|NCT03759600|83082738|FG000|Overall Study|Adverse Event|2|||
46866143|NCT03759600|83082738|FG000|Overall Study|Progressive Disease|15|||
46866144|NCT03759600|83082738|FG000|Overall Study|Site Terminated by Sponsor|3|||
46866145|NCT04724733|83082745|FG000|Overall Study|Lost to Follow-up|1|||
46866146|NCT04724733|83082746|FG001|Overall Study|Lost to Follow-up|1|||
46698352|NCT00931411|82913333|FG001|First Intervention - 42 Days|Adverse Event|3|||
46698353|NCT00931411|82913332|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
46698354|NCT00931411|82913333|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
46866147|NCT04724733|83082747|FG002|Overall Study|Lost to Follow-up|1|||
46866148|NCT04635839|83082757|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
46866149|NCT04635839|83082758|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
46698355|NCT00931411|82913332|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
46698356|NCT00931411|82913333|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
46698357|NCT00931255|82913345|FG000|Overall Study|Follow up biopsy not done|2|||
46866150|NCT04493502|83082766|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
46866151|NCT04493502|83082767|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
46866152|NCT04493502|83082766|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
46866153|NCT04493502|83082767|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
46866154|NCT04493502|83082766|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
46866155|NCT04493502|83082767|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
46866156|NCT04493502|83082766|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
46866157|NCT04493502|83082767|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
46866158|NCT04493502|83082766|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
46866159|NCT04493502|83082767|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
46866160|NCT04493502|83082766|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
46866161|NCT04493502|83082767|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
46866162|NCT04493502|83082766|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
46866163|NCT04493502|83082767|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
46866164|NCT04493502|83082766|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
46866165|NCT04493502|83082767|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
46866166|NCT04493502|83082766|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
46866167|NCT04493502|83082767|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
46866168|NCT04493502|83082766|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
46866169|NCT04493502|83082767|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
46866170|NCT04493502|83082766|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
46866171|NCT04493502|83082767|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
46866172|NCT04493502|83082766|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
46866173|NCT04493502|83082767|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
46866174|NCT04493502|83082766|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
46866175|NCT04493502|83082767|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
46866176|NCT04147858|83082778|FG000|Overall Study|Adverse Event|6|||
46866177|NCT04147858|83082779|FG001|Overall Study|Adverse Event|6|||
46866178|NCT04147858|83082780|FG002|Overall Study|Adverse Event|6|||
46866179|NCT04147858|83082778|FG000|Overall Study|Lack of Efficacy|3|||
46866180|NCT04147858|83082779|FG001|Overall Study|Lack of Efficacy|3|||
46866181|NCT04147858|83082780|FG002|Overall Study|Lack of Efficacy|1|||
46866182|NCT04147858|83082778|FG000|Overall Study|Lost to Follow-up|1|||
46866183|NCT04147858|83082779|FG001|Overall Study|Lost to Follow-up|6|||
46866184|NCT04147858|83082780|FG002|Overall Study|Lost to Follow-up|2|||
46866185|NCT04147858|83082778|FG000|Overall Study|Withdrawal by Subject|3|||
46866186|NCT04147858|83082779|FG001|Overall Study|Withdrawal by Subject|4|||
46866187|NCT04147858|83082780|FG002|Overall Study|Withdrawal by Subject|10|||
46866188|NCT04147858|83082778|FG000|Overall Study|Subject Noncompliance, Other|4|||
46866189|NCT04147858|83082779|FG001|Overall Study|Subject Noncompliance, Other|3|||
46866190|NCT04147858|83082780|FG002|Overall Study|Subject Noncompliance, Other|1|||
46866191|NCT04146896|83082790|FG000|Overall Study|Adverse Event|5|||
46866192|NCT04146896|83082791|FG001|Overall Study|Adverse Event|8|||
46866193|NCT04146896|83082790|FG000|Overall Study|Lack of Efficacy|3|||
46866194|NCT04146896|83082791|FG001|Overall Study|Lack of Efficacy|2|||
46866195|NCT04146896|83082790|FG000|Overall Study|Lost to Follow-up|0|||
46866196|NCT04146896|83082791|FG001|Overall Study|Lost to Follow-up|1|||
46866197|NCT04146896|83082790|FG000|Overall Study|Non-compliance|5|||
46866198|NCT04146896|83082791|FG001|Overall Study|Non-compliance|4|||
46866199|NCT04146896|83082790|FG000|Overall Study|Withdrawal by Subject|3|||
46866200|NCT04146896|83082791|FG001|Overall Study|Withdrawal by Subject|5|||
46866201|NCT04146896|83082790|FG000|Overall Study|Randomized in error|1|||
46866202|NCT04146896|83082791|FG001|Overall Study|Randomized in error|2|||
46866203|NCT04072887|83082803|FG000|Overall Study|Withdrawal by Subject|3|||
46866204|NCT04072887|83082804|FG001|Overall Study|Withdrawal by Subject|8|||
46866205|NCT04072887|83082805|FG002|Overall Study|Withdrawal by Subject|1|||
46866206|NCT04072887|83082806|FG003|Overall Study|Withdrawal by Subject|3|||
46866207|NCT04072887|83082807|FG004|Overall Study|Withdrawal by Subject|3|||
46866208|NCT04072887|83082808|FG005|Overall Study|Withdrawal by Subject|13|||
46866209|NCT04072887|83082803|FG000|Overall Study|Adverse Event|2|||
46866210|NCT04072887|83082804|FG001|Overall Study|Adverse Event|4|||
46866211|NCT04072887|83082805|FG002|Overall Study|Adverse Event|1|||
46866212|NCT04072887|83082806|FG003|Overall Study|Adverse Event|4|||
46866213|NCT04072887|83082807|FG004|Overall Study|Adverse Event|0|||
46866214|NCT04072887|83082808|FG005|Overall Study|Adverse Event|1|||
46866215|NCT04072887|83082803|FG000|Overall Study|Physician Decision|2|||
46866216|NCT04072887|83082804|FG001|Overall Study|Physician Decision|0|||
46866217|NCT04072887|83082805|FG002|Overall Study|Physician Decision|0|||
46866218|NCT04072887|83082806|FG003|Overall Study|Physician Decision|0|||
46866219|NCT04072887|83082807|FG004|Overall Study|Physician Decision|0|||
46866220|NCT04072887|83082808|FG005|Overall Study|Physician Decision|1|||
46866221|NCT04072887|83082803|FG000|Overall Study|Lost to Follow-up|1|||
46866222|NCT04072887|83082804|FG001|Overall Study|Lost to Follow-up|3|||
46866223|NCT04072887|83082805|FG002|Overall Study|Lost to Follow-up|0|||
46866224|NCT04072887|83082806|FG003|Overall Study|Lost to Follow-up|0|||
46866225|NCT04072887|83082807|FG004|Overall Study|Lost to Follow-up|0|||
46866226|NCT04072887|83082808|FG005|Overall Study|Lost to Follow-up|0|||
46866227|NCT04072887|83082803|FG000|Overall Study|Death|0|||
46866228|NCT04072887|83082804|FG001|Overall Study|Death|2|||
46866229|NCT04072887|83082805|FG002|Overall Study|Death|0|||
46866230|NCT04072887|83082806|FG003|Overall Study|Death|2|||
46866231|NCT04072887|83082807|FG004|Overall Study|Death|3|||
46866232|NCT04072887|83082808|FG005|Overall Study|Death|0|||
46866233|NCT03440047|83082901|FG000|Overall Study|Withdrawal by Subject|2|||
46866234|NCT03122119|83082932|FG000|Overall Study|Did not meet eligibility critria|1|||
46866235|NCT02613169|83082938|FG000|Overall Study|Withdrawal by Subject|4|||
46866236|NCT02613169|83082939|FG001|Overall Study|Withdrawal by Subject|1|||
46866237|NCT02613169|83082938|FG000|Overall Study|Lost to Follow-up|0|||
46866238|NCT02613169|83082939|FG001|Overall Study|Lost to Follow-up|5|||
46866239|NCT02613169|83082938|FG000|Overall Study|HIV|0|||
46866240|NCT02613169|83082939|FG001|Overall Study|HIV|2|||
46866241|NCT02613169|83082938|FG000|Overall Study|No TB infection endpoint|14|||
46866242|NCT02613169|83082939|FG001|Overall Study|No TB infection endpoint|9|||
46866243|NCT01974765|83082945|FG000|Overall Study|Withdrawal by Subject|1|||
46866244|NCT01974765|83082945|FG000|Overall Study|Death|1|||
46866245|NCT01974765|83082945|FG000|Overall Study|Adverse Event|2|||
46866246|NCT01725217|83082952|FG000|Overall Study|Withdrawal by Subject|1|||
46866247|NCT01725217|83082953|FG001|Overall Study|Withdrawal by Subject|0|||
46866248|NCT01725217|83082954|FG002|Overall Study|Withdrawal by Subject|0|||
46866249|NCT01344057|83082980|FG000|Overall Study|Premature Withdrawal|1|||
46866250|NCT00886782|83082987|FG000|Overall Study|Disease progression|3|||
46866251|NCT00886782|83082988|FG001|Overall Study|Disease progression|3|||
46866252|NCT00886782|83082989|FG002|Overall Study|Disease progression|3|||
46866253|NCT00886782|83082987|FG000|Overall Study|Study drug toxicity|0|||
46866254|NCT00886782|83082988|FG001|Overall Study|Study drug toxicity|0|||
46866255|NCT00886782|83082989|FG002|Overall Study|Study drug toxicity|1|||
46866256|NCT00886782|83082987|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
46866257|NCT00886782|83082988|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
46866258|NCT00886782|83082989|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
46866259|NCT00583024|83082997|FG000|Overall Study|Lost to Follow-up|4|||
46866260|NCT03435640|83083012|FG000|Overall Study|Withdrawal by Subject|0|||
46866261|NCT03435640|83083013|FG001|Overall Study|Withdrawal by Subject|1|||
46866262|NCT03435640|83083014|FG002|Overall Study|Withdrawal by Subject|0|||
46866263|NCT03435640|83083015|FG003|Overall Study|Withdrawal by Subject|2|||
46866264|NCT03435640|83083016|FG004|Overall Study|Withdrawal by Subject|0|||
46866265|NCT03435640|83083017|FG005|Overall Study|Withdrawal by Subject|0|||
46866266|NCT03435640|83083018|FG006|Overall Study|Withdrawal by Subject|3|||
46866267|NCT03435640|83083019|FG007|Overall Study|Withdrawal by Subject|0|||
46866268|NCT03435640|83083020|FG008|Overall Study|Withdrawal by Subject|0|||
46866269|NCT03435640|83083021|FG009|Overall Study|Withdrawal by Subject|2|||
46866270|NCT03435640|83083022|FG010|Overall Study|Withdrawal by Subject|3|||
46866271|NCT03435640|83083012|FG000|Overall Study|Lost to Follow-up|0|||
46866272|NCT03435640|83083013|FG001|Overall Study|Lost to Follow-up|0|||
46866273|NCT03435640|83083014|FG002|Overall Study|Lost to Follow-up|1|||
46866274|NCT03435640|83083015|FG003|Overall Study|Lost to Follow-up|0|||
46866275|NCT03435640|83083016|FG004|Overall Study|Lost to Follow-up|0|||
46866276|NCT03435640|83083017|FG005|Overall Study|Lost to Follow-up|0|||
46866277|NCT03435640|83083018|FG006|Overall Study|Lost to Follow-up|0|||
46866278|NCT03435640|83083019|FG007|Overall Study|Lost to Follow-up|0|||
46866279|NCT03435640|83083020|FG008|Overall Study|Lost to Follow-up|0|||
46866280|NCT03435640|83083021|FG009|Overall Study|Lost to Follow-up|0|||
46866281|NCT03435640|83083022|FG010|Overall Study|Lost to Follow-up|0|||
46866282|NCT00655876|83083050|FG000|Overall Study|Protocol Violation|9|||
46866283|NCT00655876|83083051|FG001|Overall Study|Protocol Violation|7|||
46866284|NCT03092752|83083057|FG000|Overall Study|Aged <40 years|14209|||
46866285|NCT03092752|83083057|FG000|Overall Study|At least one claim with T2DM|61299|||
46866286|NCT03092752|83083057|FG000|Overall Study|Having no claim of study drugs|29282|||
46982723|NCT02392611|83228978|FG008|Overall Study|Withdrawal by Subject|0|||
46982724|NCT02392611|83228970|FG000|Overall Study|Lost to Follow-up|0|||
46982725|NCT02392611|83228971|FG001|Overall Study|Lost to Follow-up|0|||
46982726|NCT02392611|83228972|FG002|Overall Study|Lost to Follow-up|0|||
46982727|NCT02392611|83228973|FG003|Overall Study|Lost to Follow-up|0|||
46982728|NCT02392611|83228974|FG004|Overall Study|Lost to Follow-up|0|||
46982729|NCT02392611|83228975|FG005|Overall Study|Lost to Follow-up|0|||
46982730|NCT02392611|83228976|FG006|Overall Study|Lost to Follow-up|1|||
46982731|NCT02392611|83228977|FG007|Overall Study|Lost to Follow-up|0|||
46982732|NCT02392611|83228978|FG008|Overall Study|Lost to Follow-up|0|||
46866287|NCT03092752|83083057|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
46866288|NCT03092752|83083057|FG000|Overall Study|<6 month history|245900|||
46866289|NCT03750552|83083080|FG000|Overall Study|Adverse Event|5|||
46866290|NCT03750552|83083081|FG001|Overall Study|Adverse Event|1|||
46866291|NCT03750552|83083080|FG000|Overall Study|Withdrawal by Subject|1|||
46866292|NCT03750552|83083081|FG001|Overall Study|Withdrawal by Subject|1|||
46866293|NCT03750552|83083080|FG000|Overall Study|Other|2|||
46866294|NCT03750552|83083081|FG001|Overall Study|Other|0|||
46866295|NCT03750240|83083088|FG000|Overall Study|Technical Difficulties|2|||
46866296|NCT03091738|83083092|FG000|Overall Study|Adverse Event|1|||
46866297|NCT03091738|83083092|FG000|Overall Study|Lost to Follow-up|1|||
46866298|NCT03193216|83083098|FG000|Overall Study|Lost to Follow-up|1|||
46982733|NCT02392611|83228970|FG000|Overall Study|Enrolled, not treated|0|||
46982734|NCT02392611|83228971|FG001|Overall Study|Enrolled, not treated|0|||
46982735|NCT02392611|83228972|FG002|Overall Study|Enrolled, not treated|0|||
46866299|NCT03193216|83083099|FG001|Overall Study|Lost to Follow-up|0|||
46866300|NCT03193216|83083098|FG000|Overall Study|Withdrawal by Subject|5|||
46866301|NCT03193216|83083099|FG001|Overall Study|Withdrawal by Subject|0|||
46866302|NCT03193216|83083098|FG000|Overall Study|Physician Decision|4|||
46866303|NCT03193216|83083099|FG001|Overall Study|Physician Decision|0|||
46866304|NCT03091348|83083107|FG000|Overall Study|Lost to Follow-up|2|||
46866305|NCT03091348|83083108|FG001|Overall Study|Lost to Follow-up|1|||
46866306|NCT03751098|83083115|FG000|Overall Study|Withdrawal by Subject|0|||
46866307|NCT03751098|83083116|FG001|Overall Study|Withdrawal by Subject|1|||
46866308|NCT03751020|83083127|FG000|Overall Study|Withdrawal by Subject|2|||
46866309|NCT03751020|83083128|FG001|Overall Study|Withdrawal by Subject|0|||
46866310|NCT03751020|83083129|FG002|Overall Study|Withdrawal by Subject|0|||
46866311|NCT03751020|83083127|FG000|Overall Study|Lost to Follow-up|7|||
46866312|NCT03751020|83083128|FG001|Overall Study|Lost to Follow-up|4|||
46866313|NCT03751020|83083129|FG002|Overall Study|Lost to Follow-up|10|||
46866314|NCT03090100|83083139|FG000|Overall Study|Adverse Event|9|||
46866315|NCT03090100|83083140|FG001|Overall Study|Adverse Event|11|||
46866316|NCT03090100|83083139|FG000|Overall Study|Pregnancy|1|||
46866317|NCT03090100|83083140|FG001|Overall Study|Pregnancy|1|||
46866318|NCT03090100|83083139|FG000|Overall Study|Lack of Efficacy|2|||
46866319|NCT03090100|83083140|FG001|Overall Study|Lack of Efficacy|7|||
46866320|NCT03090100|83083139|FG000|Overall Study|Lost to Follow-up|2|||
46866321|NCT03090100|83083140|FG001|Overall Study|Lost to Follow-up|2|||
46866322|NCT03090100|83083139|FG000|Overall Study|Withdrawal by Subject|7|||
46866323|NCT03090100|83083140|FG001|Overall Study|Withdrawal by Subject|19|||
46866324|NCT03090100|83083139|FG000|Overall Study|Protocol Violation|2|||
46866325|NCT03090100|83083140|FG001|Overall Study|Protocol Violation|6|||
46866326|NCT03090100|83083139|FG000|Overall Study|Non-compliance|2|||
46866327|NCT03090100|83083140|FG001|Overall Study|Non-compliance|0|||
46866328|NCT03090100|83083139|FG000|Overall Study|Other|2|||
46866329|NCT03090100|83083140|FG001|Overall Study|Other|2|||
46866330|NCT03089944|83083146|FG000|Overall Study|Lost to Follow-up|8|||
46866331|NCT03089944|83083146|FG000|Overall Study|Withdrew Consent|2|||
46866332|NCT03089944|83083146|FG000|Overall Study|Adverse Event|1|||
46866333|NCT03089944|83083146|FG000|Overall Study|Other|1|||
46866334|NCT03739866|83083169|FG000|Overall Study|Lost to Follow-up|0|||
46866335|NCT03739866|83083170|FG001|Overall Study|Lost to Follow-up|0|||
46866336|NCT03739866|83083171|FG002|Overall Study|Lost to Follow-up|0|||
46866337|NCT03739866|83083172|FG003|Overall Study|Lost to Follow-up|1|||
46866338|NCT03739866|83083173|FG004|Overall Study|Lost to Follow-up|0|||
46866339|NCT03739866|83083174|FG005|Overall Study|Lost to Follow-up|0|||
46866340|NCT03739866|83083175|FG006|Overall Study|Lost to Follow-up|0|||
46866341|NCT03739866|83083176|FG007|Overall Study|Lost to Follow-up|0|||
46866342|NCT03739866|83083169|FG000|Overall Study|Enrolled but not treated|0|||
46866343|NCT03739866|83083170|FG001|Overall Study|Enrolled but not treated|0|||
46866344|NCT03739866|83083171|FG002|Overall Study|Enrolled but not treated|1|||
46866345|NCT03739866|83083172|FG003|Overall Study|Enrolled but not treated|0|||
46866346|NCT03739866|83083173|FG004|Overall Study|Enrolled but not treated|1|||
46866347|NCT03739866|83083174|FG005|Overall Study|Enrolled but not treated|0|||
46866348|NCT03739866|83083175|FG006|Overall Study|Enrolled but not treated|0|||
46866349|NCT03739866|83083176|FG007|Overall Study|Enrolled but not treated|0|||
46866350|NCT03739242|83083200|FG000|Overall Study|Withdrawal by Subject|1|||
46866351|NCT03739242|83083201|FG001|Overall Study|Withdrawal by Subject|1|||
46866352|NCT03739242|83083200|FG000|Overall Study|Protocol Violation|0|||
46866353|NCT03739242|83083201|FG001|Overall Study|Protocol Violation|1|||
46866354|NCT02849626|83083258|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
46866355|NCT02849626|83083259|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
46866356|NCT02849626|83083260|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
46866357|NCT02849626|83083261|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
46866358|NCT02849626|83083258|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
46866359|NCT02849626|83083259|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
46866360|NCT02849626|83083260|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
46866361|NCT02849626|83083261|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
46866362|NCT02849626|83083258|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
46866363|NCT02849626|83083259|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
46866364|NCT02849626|83083260|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
46866365|NCT02849626|83083261|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
46866366|NCT02849626|83083258|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
46866367|NCT02849626|83083259|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
46866368|NCT02849626|83083260|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
46866369|NCT02849626|83083261|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
46866370|NCT02849626|83083258|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
46866371|NCT02849626|83083259|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
46866372|NCT02849626|83083260|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
46866373|NCT02849626|83083261|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
46866374|NCT02849626|83083258|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
46866375|NCT02849626|83083259|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
46866376|NCT02849626|83083260|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
46866377|NCT02849626|83083261|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
46866378|NCT02849626|83083258|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
46866379|NCT02849626|83083259|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
46866380|NCT02849626|83083260|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
46866381|NCT02849626|83083261|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
46866382|NCT02849626|83083258|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
46866383|NCT02849626|83083259|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
46866384|NCT02849626|83083260|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
46866385|NCT02849626|83083261|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
46866386|NCT02849626|83083258|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
46866387|NCT02849626|83083259|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
46866388|NCT02849626|83083260|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
46866389|NCT02849626|83083261|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
46866390|NCT02849626|83083258|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
46866391|NCT02849626|83083259|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
46866392|NCT02849626|83083260|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
46866393|NCT02849626|83083261|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
46866394|NCT02849626|83083258|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
46866395|NCT02849626|83083259|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
46866396|NCT02849626|83083260|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
46866397|NCT02849626|83083261|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
46866398|NCT03735498|83083279|FG000|Overall Study|Withdrawal by Subject|5|||
46866399|NCT03735498|83083279|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
46866400|NCT02659540|83083285|FG000|Overall Study|Adverse Event|3|||
46866401|NCT02659540|83083286|FG001|Overall Study|Adverse Event|2|||
46866402|NCT02659540|83083285|FG000|Overall Study|Death|1|||
46866403|NCT02659540|83083286|FG001|Overall Study|Death|0|||
46866404|NCT02659540|83083285|FG000|Overall Study|Progressive disease|2|||
46866405|NCT02659540|83083286|FG001|Overall Study|Progressive disease|6|||
46866406|NCT01097746|83083292|FG000|Overall Study|Adverse Event|4|||
46866407|NCT01097746|83083292|FG000|Overall Study|taken off study before any treatment given|1|||
46866408|NCT03733470|83083322|FG000|Overall Study|PI Decision|1|||
46866409|NCT03733470|83083323|FG001|Overall Study|PI Decision|1|||
46866410|NCT03732534|83083329|FG000|Overall Study|Study terminated by Sponsor|6|||
46866411|NCT03087058|83083335|FG000|Overall Study|Withdrawal by Subject|2|||
46866412|NCT03087058|83083336|FG001|Overall Study|Withdrawal by Subject|0|||
46866413|NCT03087058|83083337|FG002|Overall Study|Withdrawal by Subject|0|||
46866414|NCT03726996|83083344|FG000|Overall Study|Parent's decision|2|||
46866415|NCT03726996|83083344|FG000|Overall Study|Study early termination|2|||
46866416|NCT03882970|83083352|FG000|Overall Study|Adverse Event|5|||
46866417|NCT03882970|83083353|FG001|Overall Study|Adverse Event|7|||
46866418|NCT03882970|83083354|FG002|Overall Study|Adverse Event|3|||
46866419|NCT03882970|83083355|FG003|Overall Study|Adverse Event|1|||
46866420|NCT03882970|83083352|FG000|Overall Study|Death|1|||
46866421|NCT03882970|83083353|FG001|Overall Study|Death|2|||
46866422|NCT03882970|83083354|FG002|Overall Study|Death|1|||
46866423|NCT03882970|83083355|FG003|Overall Study|Death|1|||
46866424|NCT03882970|83083352|FG000|Overall Study|Lost to Follow-up|8|||
46866425|NCT03882970|83083353|FG001|Overall Study|Lost to Follow-up|9|||
46866426|NCT03882970|83083354|FG002|Overall Study|Lost to Follow-up|5|||
46866427|NCT03882970|83083355|FG003|Overall Study|Lost to Follow-up|5|||
46866428|NCT03882970|83083352|FG000|Overall Study|Physician Decision|0|||
46866429|NCT03882970|83083353|FG001|Overall Study|Physician Decision|2|||
46866430|NCT03882970|83083354|FG002|Overall Study|Physician Decision|2|||
46866431|NCT03882970|83083355|FG003|Overall Study|Physician Decision|2|||
46866432|NCT03882970|83083352|FG000|Overall Study|Protocol Violation|2|||
46866433|NCT03882970|83083353|FG001|Overall Study|Protocol Violation|0|||
46866434|NCT03882970|83083354|FG002|Overall Study|Protocol Violation|0|||
46866435|NCT03882970|83083355|FG003|Overall Study|Protocol Violation|0|||
46866436|NCT03882970|83083352|FG000|Overall Study|Withdrawal by Subject|8|||
46866437|NCT03882970|83083353|FG001|Overall Study|Withdrawal by Subject|17|||
46866438|NCT03882970|83083354|FG002|Overall Study|Withdrawal by Subject|7|||
46866439|NCT03882970|83083355|FG003|Overall Study|Withdrawal by Subject|22|||
46866440|NCT03882970|83083352|FG000|Overall Study|Personal Reason|2|||
46866441|NCT03882970|83083353|FG001|Overall Study|Personal Reason|3|||
46866442|NCT03882970|83083354|FG002|Overall Study|Personal Reason|1|||
46866443|NCT03882970|83083355|FG003|Overall Study|Personal Reason|3|||
46866444|NCT03730480|83083369|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
46866445|NCT03668808|83083374|FG000|First Intervention|Withdrawal by Subject|2|||
46866446|NCT03668808|83083375|FG001|First Intervention|Withdrawal by Subject|2|||
46866447|NCT02982954|83083387|FG000|Overall Study|Death|55|||
46866448|NCT02982954|83083388|FG001|Overall Study|Death|29|||
46866449|NCT02982954|83083389|FG002|Overall Study|Death|15|||
46866450|NCT02982954|83083390|FG003|Overall Study|Death|20|||
46866451|NCT02982954|83083387|FG000|Overall Study|Lost to Follow-up|2|||
46866452|NCT02982954|83083388|FG001|Overall Study|Lost to Follow-up|1|||
46866453|NCT02982954|83083389|FG002|Overall Study|Lost to Follow-up|0|||
46866454|NCT02982954|83083390|FG003|Overall Study|Lost to Follow-up|0|||
46866455|NCT02982954|83083387|FG000|Overall Study|Participant withdrew consent|7|||
46866456|NCT02982954|83083388|FG001|Overall Study|Participant withdrew consent|5|||
46866457|NCT02982954|83083389|FG002|Overall Study|Participant withdrew consent|1|||
46866458|NCT02982954|83083390|FG003|Overall Study|Participant withdrew consent|1|||
46866459|NCT02982954|83083387|FG000|Overall Study|Other reasons|42|||
46866460|NCT02982954|83083388|FG001|Overall Study|Other reasons|17|||
46866461|NCT02982954|83083389|FG002|Overall Study|Other reasons|12|||
46866462|NCT02982954|83083390|FG003|Overall Study|Other reasons|3|||
46866463|NCT02982954|83083387|FG000|Overall Study|Premature site closure|0|||
46866464|NCT02982954|83083388|FG001|Overall Study|Premature site closure|0|||
46866465|NCT02982954|83083389|FG002|Overall Study|Premature site closure|0|||
46866466|NCT02982954|83083390|FG003|Overall Study|Premature site closure|1|||
46866467|NCT03724968|83083402|FG000|Overall Study|Insurance issues|0|||
46866468|NCT03724968|83083403|FG001|Overall Study|Insurance issues|1|||
46866469|NCT03724968|83083402|FG000|Overall Study|Study closed|0|||
46866470|NCT03724968|83083403|FG001|Overall Study|Study closed|1|||
46982736|NCT02392611|83228973|FG003|Overall Study|Enrolled, not treated|2|||
46982737|NCT02392611|83228974|FG004|Overall Study|Enrolled, not treated|0|||
46982738|NCT02392611|83228975|FG005|Overall Study|Enrolled, not treated|0|||
46982739|NCT02392611|83228976|FG006|Overall Study|Enrolled, not treated|0|||
46982740|NCT02392611|83228977|FG007|Overall Study|Enrolled, not treated|0|||
46982741|NCT02392611|83228978|FG008|Overall Study|Enrolled, not treated|0|||
46982742|NCT02378961|83229002|FG000|Overall Study|Lack of Efficacy|4|||
46982743|NCT02378961|83229003|FG001|Overall Study|Lack of Efficacy|2|||
46982744|NCT02378961|83229004|FG002|Overall Study|Lack of Efficacy|0|||
46982745|NCT02378961|83229005|FG003|Overall Study|Lack of Efficacy|1|||
46982746|NCT02378961|83229002|FG000|Overall Study|Death|0|||
46982747|NCT02378961|83229003|FG001|Overall Study|Death|0|||
46982748|NCT02378961|83229004|FG002|Overall Study|Death|1|||
46982749|NCT02378961|83229005|FG003|Overall Study|Death|0|||
46982750|NCT02378883|83229015|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
46982751|NCT02378883|83229015|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
46982752|NCT02378883|83229015|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
46982753|NCT02378883|83229015|FG000|30 Day Follow-Up|Physician Decision|2|||
46982754|NCT02378883|83229015|FG000|30 Day Follow-Up|Missed Visit|2|||
46982755|NCT02378883|83229015|FG000|30 Day Follow-Up|Death|1|||
46982756|NCT02378883|83229015|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
46982757|NCT02378883|83229015|FG000|12 Months Follow-Up|Death|2|||
46982758|NCT02340975|83229026|FG000|Overall Study|Death|6|||
46982759|NCT02340975|83229027|FG001|Overall Study|Death|23|||
46982760|NCT02340975|83229028|FG002|Overall Study|Death|21|||
46982761|NCT02340975|83229029|FG003|Overall Study|Death|7|||
46982762|NCT02340975|83229030|FG004|Overall Study|Death|21|||
46982763|NCT02340975|83229031|FG005|Overall Study|Death|13|||
46982764|NCT02340975|83229026|FG000|Overall Study|Lost to Follow-up|0|||
46982765|NCT02340975|83229027|FG001|Overall Study|Lost to Follow-up|0|||
46982766|NCT02340975|83229028|FG002|Overall Study|Lost to Follow-up|0|||
46982767|NCT02340975|83229029|FG003|Overall Study|Lost to Follow-up|0|||
46982768|NCT02340975|83229030|FG004|Overall Study|Lost to Follow-up|2|||
46982769|NCT02340975|83229031|FG005|Overall Study|Lost to Follow-up|0|||
46982770|NCT02340975|83229026|FG000|Overall Study|Withdrawal by Subject|0|||
46982771|NCT02340975|83229027|FG001|Overall Study|Withdrawal by Subject|0|||
46982772|NCT02340975|83229028|FG002|Overall Study|Withdrawal by Subject|3|||
46982773|NCT02340975|83229029|FG003|Overall Study|Withdrawal by Subject|3|||
46982774|NCT02340975|83229030|FG004|Overall Study|Withdrawal by Subject|2|||
46866471|NCT03724812|83083409|FG000|Overall Study|Missed Visit|1|||
46982775|NCT02340975|83229031|FG005|Overall Study|Withdrawal by Subject|0|||
46982776|NCT02340975|83229026|FG000|Overall Study|Other|0|||
46982777|NCT02340975|83229027|FG001|Overall Study|Other|4|||
46982778|NCT02340975|83229028|FG002|Overall Study|Other|0|||
46982779|NCT02340975|83229029|FG003|Overall Study|Other|2|||
46982780|NCT02340975|83229030|FG004|Overall Study|Other|0|||
46982781|NCT02340975|83229031|FG005|Overall Study|Other|6|||
46982782|NCT02392377|83229048|FG000|Overall Study|Withdrawal by Subject|0|||
46866472|NCT03724812|83083409|FG000|Overall Study|Death|2|||
46866473|NCT03724812|83083409|FG000|Overall Study|Withdrawal by Subject|1|||
46866474|NCT03722784|83083416|FG000|Overall Study|Withdrawal by Subject|1|||
46866475|NCT03722784|83083417|FG001|Overall Study|Withdrawal by Subject|0|||
46866476|NCT03722784|83083416|FG000|Overall Study|Physician Decision|1|||
46866477|NCT03722784|83083417|FG001|Overall Study|Physician Decision|1|||
46866478|NCT03722784|83083416|FG000|Overall Study|Protocol Violation|0|||
46866479|NCT03722784|83083417|FG001|Overall Study|Protocol Violation|1|||
46866480|NCT03722238|83083426|FG000|Overall Study|Protocol Violation|1|||
46866481|NCT03722238|83083427|FG001|Overall Study|Protocol Violation|0|||
46866482|NCT03722238|83083426|FG000|Overall Study|Physician Decision|1|||
46866483|NCT03722238|83083427|FG001|Overall Study|Physician Decision|0|||
46866484|NCT03722238|83083426|FG000|Overall Study|Death|1|||
46866485|NCT03722238|83083427|FG001|Overall Study|Death|0|||
46866486|NCT03722238|83083426|FG000|Overall Study|Lost to Follow-up|6|||
46866487|NCT03722238|83083427|FG001|Overall Study|Lost to Follow-up|0|||
46866488|NCT03722238|83083426|FG000|Overall Study|Partial missing data|44|||
46866489|NCT03722238|83083427|FG001|Overall Study|Partial missing data|1|||
46866490|NCT03722238|83083426|FG000|Overall Study|Withdrawal by Subject|2|||
46866491|NCT03722238|83083427|FG001|Overall Study|Withdrawal by Subject|0|||
46866492|NCT03722238|83083426|FG000|Overall Study|Other|4|||
46866493|NCT03722238|83083427|FG001|Overall Study|Other|0|||
46866494|NCT03722238|83083426|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
46866495|NCT03722238|83083427|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
46866496|NCT03722238|83083426|FG000|Overall Study|Did not meet risk classification group criteria|90|||
46866497|NCT03722238|83083427|FG001|Overall Study|Did not meet risk classification group criteria|0|||
46866498|NCT03722238|83083426|FG000|Overall Study|Did not sign consent|17|||
46866499|NCT03722238|83083427|FG001|Overall Study|Did not sign consent|0|||
46866500|NCT03722238|83083426|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
46866501|NCT03722238|83083427|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
46866502|NCT03722238|83083426|FG000|Overall Study|Not willing to purchase study medication|142|||
46866503|NCT03722238|83083427|FG001|Overall Study|Not willing to purchase study medication|0|||
46866504|NCT03722238|83083426|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
46982783|NCT02392377|83229049|FG001|Overall Study|Withdrawal by Subject|1|||
46982784|NCT02340819|83229057|FG000|Overall Study|Adverse Event|1|||
46982785|NCT02340819|83229057|FG000|Overall Study|Withdrawal by Subject|2|||
46982786|NCT02340819|83229057|FG000|Overall Study|Discontinued with other reason|1|||
46982787|NCT02340663|83229063|FG000|Overall Study|Lost to Follow-up|1|||
46982788|NCT02340663|83229064|FG001|Overall Study|Lost to Follow-up|0|||
46982789|NCT02340663|83229063|FG000|Overall Study|Protocol Violation|1|||
46982790|NCT02340663|83229064|FG001|Overall Study|Protocol Violation|0|||
46982791|NCT02340663|83229063|FG000|Overall Study|Withdrawal by Subject|3|||
46982792|NCT02340663|83229064|FG001|Overall Study|Withdrawal by Subject|1|||
46982793|NCT02573467|83229074|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
46982794|NCT02573467|83229075|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
46982795|NCT02573467|83229076|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
46982796|NCT02573467|83229077|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
46982797|NCT02573467|83229074|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
46982798|NCT02573467|83229075|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
46982799|NCT02573467|83229076|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
46982800|NCT02573467|83229077|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
46982801|NCT02573467|83229074|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
46982802|NCT02573467|83229075|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
46982803|NCT02573467|83229076|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
46982804|NCT02573467|83229077|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
46982805|NCT02573467|83229074|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
46982806|NCT02573467|83229075|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
46866505|NCT03722238|83083427|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
46866506|NCT02927080|83083443|FG000|Overall Study|Withdrawal by Subject|0|||
46866507|NCT02927080|83083444|FG001|Overall Study|Withdrawal by Subject|0|||
46866508|NCT02927080|83083445|FG002|Overall Study|Withdrawal by Subject|0|||
46866509|NCT02927080|83083446|FG003|Overall Study|Withdrawal by Subject|0|||
46866510|NCT02927080|83083447|FG004|Overall Study|Withdrawal by Subject|1|||
46866511|NCT02927080|83083448|FG005|Overall Study|Withdrawal by Subject|0|||
46866512|NCT02927080|83083449|FG006|Overall Study|Withdrawal by Subject|1|||
46866513|NCT02927080|83083450|FG007|Overall Study|Withdrawal by Subject|1|||
46866514|NCT02927080|83083451|FG008|Overall Study|Withdrawal by Subject|0|||
46866515|NCT02927080|83083452|FG009|Overall Study|Withdrawal by Subject|2|||
46866516|NCT02927080|83083443|FG000|Overall Study|Willingness to comply with protocol|0|||
46982807|NCT02573467|83229076|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
46982808|NCT02573467|83229077|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
46982809|NCT02573467|83229074|FG000|Post-treatment Follow up Epoch|Death|1|||
46866517|NCT02927080|83083444|FG001|Overall Study|Willingness to comply with protocol|0|||
46866518|NCT02927080|83083445|FG002|Overall Study|Willingness to comply with protocol|0|||
46866519|NCT02927080|83083446|FG003|Overall Study|Willingness to comply with protocol|0|||
46866520|NCT02927080|83083447|FG004|Overall Study|Willingness to comply with protocol|0|||
46866521|NCT02927080|83083448|FG005|Overall Study|Willingness to comply with protocol|0|||
46866522|NCT02927080|83083449|FG006|Overall Study|Willingness to comply with protocol|0|||
46866523|NCT02927080|83083450|FG007|Overall Study|Willingness to comply with protocol|0|||
46866524|NCT02927080|83083451|FG008|Overall Study|Willingness to comply with protocol|0|||
46866525|NCT02927080|83083452|FG009|Overall Study|Willingness to comply with protocol|1|||
46866526|NCT02927080|83083443|FG000|Overall Study|Study terminated by Sponsor|0|||
46866527|NCT02927080|83083444|FG001|Overall Study|Study terminated by Sponsor|0|||
46866528|NCT02927080|83083445|FG002|Overall Study|Study terminated by Sponsor|0|||
46866529|NCT02927080|83083446|FG003|Overall Study|Study terminated by Sponsor|0|||
46866530|NCT02927080|83083447|FG004|Overall Study|Study terminated by Sponsor|0|||
46866531|NCT02927080|83083448|FG005|Overall Study|Study terminated by Sponsor|0|||
46866532|NCT02927080|83083449|FG006|Overall Study|Study terminated by Sponsor|6|||
46866533|NCT02927080|83083450|FG007|Overall Study|Study terminated by Sponsor|7|||
46866534|NCT02927080|83083451|FG008|Overall Study|Study terminated by Sponsor|2|||
46866535|NCT02927080|83083452|FG009|Overall Study|Study terminated by Sponsor|3|||
46982810|NCT02573467|83229075|FG001|Post-treatment Follow up Epoch|Death|1|||
46982811|NCT02573467|83229076|FG002|Post-treatment Follow up Epoch|Death|0|||
46982812|NCT02573467|83229077|FG003|Post-treatment Follow up Epoch|Death|1|||
46982813|NCT02573467|83229074|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
46866536|NCT02927080|83083443|FG000|Overall Study|Adverse Event|0|||
46866537|NCT02927080|83083444|FG001|Overall Study|Adverse Event|1|||
46866538|NCT02927080|83083445|FG002|Overall Study|Adverse Event|0|||
46866539|NCT02927080|83083446|FG003|Overall Study|Adverse Event|0|||
46866540|NCT02927080|83083447|FG004|Overall Study|Adverse Event|0|||
46866541|NCT02927080|83083448|FG005|Overall Study|Adverse Event|0|||
46982814|NCT02573467|83229075|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
46982815|NCT02573467|83229076|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
46866542|NCT02927080|83083449|FG006|Overall Study|Adverse Event|0|||
46866543|NCT02927080|83083450|FG007|Overall Study|Adverse Event|1|||
46866544|NCT02927080|83083451|FG008|Overall Study|Adverse Event|0|||
46982816|NCT02573467|83229077|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
46866545|NCT02927080|83083452|FG009|Overall Study|Adverse Event|1|||
46866546|NCT02927080|83083443|FG000|Overall Study|Other|0|||
46866547|NCT02927080|83083444|FG001|Overall Study|Other|0|||
46866548|NCT02927080|83083445|FG002|Overall Study|Other|0|||
46866549|NCT02927080|83083446|FG003|Overall Study|Other|0|||
46866550|NCT02927080|83083447|FG004|Overall Study|Other|0|||
46866551|NCT02927080|83083448|FG005|Overall Study|Other|0|||
46866552|NCT02927080|83083449|FG006|Overall Study|Other|1|||
46866553|NCT02927080|83083450|FG007|Overall Study|Other|0|||
46866554|NCT02927080|83083451|FG008|Overall Study|Other|1|||
46866555|NCT02927080|83083452|FG009|Overall Study|Other|0|||
46866556|NCT02374476|83083499|FG000|VT Induced Ablation|Screening Failures|36|||
46866557|NCT02374476|83083500|FG001|VT Induced Ablation|Screening Failures|0|||
46866558|NCT02374476|83083501|FG002|VT Induced Ablation|Screening Failures|0|||
46866559|NCT02374476|83083499|FG000|Arm Assignment|Withdrawal by Subject|0|||
46866560|NCT02374476|83083500|FG001|Arm Assignment|Withdrawal by Subject|0|||
46866561|NCT02374476|83083501|FG002|Arm Assignment|Withdrawal by Subject|1|||
46866562|NCT02918292|83083508|FG000|Study Enrollment Prior to Transplant|Death|1|||
46866563|NCT02918292|83083508|FG000|Study Follow up After Transplant|Death|6|||
46866564|NCT03720210|83083512|FG000|Overall Study|Lost to Follow-up|1|||
46866565|NCT03719586|83083520|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
46866566|NCT03719586|83083521|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
46866567|NCT03719586|83083522|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
46866568|NCT03719586|83083523|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
46866569|NCT03353350|83083549|FG000|30-week Core Treatment Period|Protocol Violation|1|||
46866570|NCT03353350|83083550|FG001|30-week Core Treatment Period|Protocol Violation|1|||
46866571|NCT03353350|83083551|FG002|30-week Core Treatment Period|Protocol Violation|1|||
46866572|NCT03353350|83083552|FG003|30-week Core Treatment Period|Protocol Violation|0|||
46866573|NCT03353350|83083549|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
46866574|NCT03353350|83083550|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
46866575|NCT03353350|83083551|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
46866576|NCT03353350|83083552|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
46866577|NCT03353350|83083549|FG000|30-week Core Treatment Period|Adverse Event|0|||
46866578|NCT03353350|83083550|FG001|30-week Core Treatment Period|Adverse Event|4|||
46866579|NCT03353350|83083551|FG002|30-week Core Treatment Period|Adverse Event|2|||
46866580|NCT03353350|83083552|FG003|30-week Core Treatment Period|Adverse Event|3|||
46866581|NCT03353350|83083549|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
46866582|NCT03353350|83083550|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
46866583|NCT03353350|83083551|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
46866584|NCT03353350|83083552|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
46866585|NCT03353350|83083549|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
46866586|NCT03353350|83083550|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
46866587|NCT03353350|83083551|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
46866588|NCT03353350|83083552|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
46866589|NCT03353350|83083549|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
46866590|NCT03353350|83083550|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
46866591|NCT03353350|83083551|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
46866592|NCT03353350|83083552|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
46866593|NCT03353350|83083549|FG000|26-week Treatment Extension Period|Adverse Event|1|||
46866594|NCT03353350|83083550|FG001|26-week Treatment Extension Period|Adverse Event|0|||
46866595|NCT03353350|83083551|FG002|26-week Treatment Extension Period|Adverse Event|0|||
46866596|NCT03353350|83083552|FG003|26-week Treatment Extension Period|Adverse Event|1|||
46866597|NCT03353350|83083549|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
46866598|NCT03353350|83083550|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
46866599|NCT03353350|83083551|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
46866600|NCT03353350|83083552|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
46866601|NCT03032068|83083566|FG000|Overall Study|Adverse Event|1|||
46866602|NCT02674516|83083586|FG000|Overall Study|Lost to Follow-up|3|||
46866603|NCT02674516|83083587|FG001|Overall Study|Lost to Follow-up|0|||
46866604|NCT02674516|83083586|FG000|Overall Study|Protocol Violation|0|||
46866605|NCT02674516|83083587|FG001|Overall Study|Protocol Violation|4|||
46866606|NCT02674516|83083586|FG000|Overall Study|Knowledge of study hypothesis|1|||
46866607|NCT02674516|83083587|FG001|Overall Study|Knowledge of study hypothesis|0|||
46866608|NCT02463448|83083593|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
46866609|NCT02463448|83083593|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
46866610|NCT02463448|83083593|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
46866611|NCT02463448|83083593|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
46866612|NCT03794544|83083601|FG000|Overall Study|Withdrawal by Subject|1|||
46982817|NCT02573467|83229074|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
46866613|NCT03794544|83083602|FG001|Overall Study|Withdrawal by Subject|1|||
46866614|NCT03794544|83083603|FG002|Overall Study|Withdrawal by Subject|0|||
46866615|NCT03794544|83083604|FG003|Overall Study|Withdrawal by Subject|0|||
46866616|NCT03794544|83083601|FG000|Overall Study|Death|0|||
46866617|NCT03794544|83083602|FG001|Overall Study|Death|0|||
46866618|NCT03794544|83083603|FG002|Overall Study|Death|0|||
46866619|NCT03794544|83083604|FG003|Overall Study|Death|1|||
46866620|NCT03794544|83083601|FG000|Overall Study|Lost to Follow-up|0|||
46866621|NCT03794544|83083602|FG001|Overall Study|Lost to Follow-up|1|||
46866622|NCT03794544|83083603|FG002|Overall Study|Lost to Follow-up|1|||
46866623|NCT03794544|83083604|FG003|Overall Study|Lost to Follow-up|0|||
46866624|NCT03794544|83083601|FG000|Overall Study|Other|0|||
46866625|NCT03794544|83083602|FG001|Overall Study|Other|1|||
46866626|NCT03794544|83083603|FG002|Overall Study|Other|0|||
46866627|NCT03794544|83083604|FG003|Overall Study|Other|0|||
46866628|NCT01804270|83083616|FG000|Overall Study|Withdrawal by Subject|1|||
46866629|NCT01804270|83083617|FG001|Overall Study|Withdrawal by Subject|1|||
46866630|NCT03107026|83083626|FG000|Overall Study|Adverse Event|2|||
46866631|NCT03107026|83083627|FG001|Overall Study|Adverse Event|14|||
46866632|NCT03107026|83083628|FG002|Overall Study|Adverse Event|23|||
46866633|NCT03107026|83083626|FG000|Overall Study|Lost to Follow-up|12|||
46866634|NCT03107026|83083627|FG001|Overall Study|Lost to Follow-up|12|||
46866635|NCT03107026|83083628|FG002|Overall Study|Lost to Follow-up|13|||
46866636|NCT03107026|83083626|FG000|Overall Study|Protocol Violation|1|||
46866637|NCT03107026|83083627|FG001|Overall Study|Protocol Violation|2|||
46866638|NCT03107026|83083628|FG002|Overall Study|Protocol Violation|0|||
46866639|NCT03107026|83083626|FG000|Overall Study|Pregnancy|1|||
46866640|NCT03107026|83083627|FG001|Overall Study|Pregnancy|0|||
46866641|NCT03107026|83083628|FG002|Overall Study|Pregnancy|0|||
46866642|NCT03107026|83083626|FG000|Overall Study|Withdrawal by Subject|13|||
46866643|NCT03107026|83083627|FG001|Overall Study|Withdrawal by Subject|5|||
46866644|NCT03107026|83083628|FG002|Overall Study|Withdrawal by Subject|17|||
46866645|NCT03107026|83083626|FG000|Overall Study|non compliance with study visits|1|||
46866646|NCT03107026|83083627|FG001|Overall Study|non compliance with study visits|2|||
46866647|NCT03107026|83083628|FG002|Overall Study|non compliance with study visits|0|||
46866648|NCT03107026|83083626|FG000|Overall Study|non-compliance with study drug|2|||
46866649|NCT03107026|83083627|FG001|Overall Study|non-compliance with study drug|2|||
46866650|NCT03107026|83083628|FG002|Overall Study|non-compliance with study drug|3|||
46866651|NCT03107026|83083626|FG000|Overall Study|Physician Decision|0|||
46866652|NCT03107026|83083627|FG001|Overall Study|Physician Decision|1|||
46866653|NCT03107026|83083628|FG002|Overall Study|Physician Decision|0|||
46866654|NCT03717480|83083636|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
46866655|NCT00005044|83083642|FG000|Overall Study|Protocol Violation|37|||
46866656|NCT00005044|83083643|FG001|Overall Study|Protocol Violation|46|||
46866657|NCT00005044|83083642|FG000|Overall Study|Withdrawal by Subject|1|||
46866658|NCT00005044|83083643|FG001|Overall Study|Withdrawal by Subject|5|||
46866659|NCT00005044|83083642|FG000|Overall Study|No protocol treatment|0|||
46866660|NCT00005044|83083643|FG001|Overall Study|No protocol treatment|1|||
46866661|NCT03084796|83083655|FG000|Overall Study|Adverse Event|4|||
46866662|NCT03084796|83083656|FG001|Overall Study|Adverse Event|5|||
46866663|NCT03084796|83083657|FG002|Overall Study|Adverse Event|6|||
46866664|NCT03084796|83083658|FG003|Overall Study|Adverse Event|2|||
46866665|NCT03084796|83083659|FG004|Overall Study|Adverse Event|3|||
46866666|NCT03084796|83083660|FG005|Overall Study|Adverse Event|5|||
46866667|NCT03084796|83083655|FG000|Overall Study|Withdrawal by Subject|3|||
46866668|NCT03084796|83083656|FG001|Overall Study|Withdrawal by Subject|5|||
46866669|NCT03084796|83083657|FG002|Overall Study|Withdrawal by Subject|2|||
46866670|NCT03084796|83083658|FG003|Overall Study|Withdrawal by Subject|1|||
46866671|NCT03084796|83083659|FG004|Overall Study|Withdrawal by Subject|3|||
46866672|NCT03084796|83083660|FG005|Overall Study|Withdrawal by Subject|0|||
46866673|NCT03084796|83083655|FG000|Overall Study|Protocol Violation|0|||
46866674|NCT03084796|83083656|FG001|Overall Study|Protocol Violation|0|||
46866675|NCT03084796|83083657|FG002|Overall Study|Protocol Violation|1|||
46866676|NCT03084796|83083658|FG003|Overall Study|Protocol Violation|0|||
46982818|NCT02573467|83229075|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
46866677|NCT03084796|83083659|FG004|Overall Study|Protocol Violation|1|||
46866678|NCT03084796|83083660|FG005|Overall Study|Protocol Violation|1|||
46866679|NCT03084796|83083655|FG000|Overall Study|Lack of Efficacy|0|||
46866680|NCT03084796|83083656|FG001|Overall Study|Lack of Efficacy|0|||
46866681|NCT03084796|83083657|FG002|Overall Study|Lack of Efficacy|1|||
46866682|NCT03084796|83083658|FG003|Overall Study|Lack of Efficacy|0|||
46866683|NCT03084796|83083659|FG004|Overall Study|Lack of Efficacy|1|||
46866684|NCT03084796|83083660|FG005|Overall Study|Lack of Efficacy|0|||
46866685|NCT03084796|83083655|FG000|Overall Study|Lost to Follow-up|0|||
46866686|NCT03084796|83083656|FG001|Overall Study|Lost to Follow-up|0|||
46982819|NCT02573467|83229076|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
46866687|NCT03084796|83083657|FG002|Overall Study|Lost to Follow-up|1|||
46866688|NCT03084796|83083658|FG003|Overall Study|Lost to Follow-up|1|||
46866689|NCT03084796|83083659|FG004|Overall Study|Lost to Follow-up|3|||
46866690|NCT03084796|83083660|FG005|Overall Study|Lost to Follow-up|1|||
46866691|NCT03084796|83083655|FG000|Overall Study|Randomization error|0|||
46866692|NCT03084796|83083656|FG001|Overall Study|Randomization error|0|||
46866693|NCT03084796|83083657|FG002|Overall Study|Randomization error|1|||
46866694|NCT03084796|83083658|FG003|Overall Study|Randomization error|0|||
46866695|NCT03084796|83083659|FG004|Overall Study|Randomization error|0|||
46866696|NCT03084796|83083660|FG005|Overall Study|Randomization error|0|||
46866697|NCT03717012|83083676|FG000|Overall Study|Due to trial termination|1|||
46866698|NCT03717012|83083677|FG001|Overall Study|Due to trial termination|2|||
46866699|NCT03717012|83083676|FG000|Overall Study|Protocol Violation|0|||
46866700|NCT03717012|83083677|FG001|Overall Study|Protocol Violation|2|||
46866701|NCT03717012|83083676|FG000|Overall Study|Adverse Event|0|||
46866702|NCT03717012|83083677|FG001|Overall Study|Adverse Event|1|||
46866703|NCT03717012|83083676|FG000|Overall Study|Lung transplant|0|||
46866704|NCT03717012|83083677|FG001|Overall Study|Lung transplant|1|||
46866705|NCT03078556|83083690|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
46866706|NCT03078556|83083691|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
46866707|NCT03078556|83083692|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
46866708|NCT03078556|83083693|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
46866709|NCT03078556|83083690|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
46866710|NCT03078556|83083691|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
46866711|NCT03078556|83083692|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
46866712|NCT03078556|83083693|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
46866713|NCT03078556|83083690|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
46866714|NCT03078556|83083691|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
46866715|NCT03078556|83083692|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
46866716|NCT03078556|83083693|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
46866717|NCT03078556|83083690|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
46866718|NCT03078556|83083691|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
46866719|NCT03078556|83083692|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
46866720|NCT03078556|83083693|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
46866721|NCT03714672|83083722|FG000|Overall Study|Adverse Event|0|||
46982820|NCT02573467|83229077|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
46866722|NCT03714672|83083723|FG001|Overall Study|Adverse Event|0|||
46982821|NCT02337387|83229092|FG000|Overall Study|Adverse Event|0|||
46866723|NCT03714672|83083724|FG002|Overall Study|Adverse Event|3|||
46866724|NCT03714672|83083725|FG003|Overall Study|Adverse Event|0|||
46866725|NCT03714672|83083722|FG000|Overall Study|Physician Decision|0|||
46866726|NCT03714672|83083723|FG001|Overall Study|Physician Decision|1|||
46866727|NCT03714672|83083724|FG002|Overall Study|Physician Decision|0|||
46866728|NCT03714672|83083725|FG003|Overall Study|Physician Decision|0|||
46866729|NCT03714672|83083722|FG000|Overall Study|Other Reason|1|||
46866730|NCT03714672|83083723|FG001|Overall Study|Other Reason|2|||
46866731|NCT03714672|83083724|FG002|Overall Study|Other Reason|1|||
46866732|NCT03714672|83083725|FG003|Overall Study|Other Reason|1|||
46866733|NCT03714672|83083722|FG000|Overall Study|Lost to Follow-up|1|||
46866734|NCT03714672|83083723|FG001|Overall Study|Lost to Follow-up|1|||
46866735|NCT03714672|83083724|FG002|Overall Study|Lost to Follow-up|0|||
46866736|NCT03714672|83083725|FG003|Overall Study|Lost to Follow-up|0|||
46866737|NCT03083470|83083741|FG000|Overall Study|Lost to Follow-up|0|||
46866738|NCT03083470|83083742|FG001|Overall Study|Lost to Follow-up|0|||
46866739|NCT03083470|83083743|FG002|Overall Study|Lost to Follow-up|0|||
46866740|NCT03083470|83083744|FG003|Overall Study|Lost to Follow-up|0|||
46866741|NCT03083470|83083745|FG004|Overall Study|Lost to Follow-up|1|||
46866742|NCT03083470|83083741|FG000|Overall Study|Withdrawal by Subject|0|||
46866743|NCT03083470|83083742|FG001|Overall Study|Withdrawal by Subject|0|||
46866744|NCT03083470|83083743|FG002|Overall Study|Withdrawal by Subject|0|||
46866745|NCT03083470|83083744|FG003|Overall Study|Withdrawal by Subject|0|||
46866746|NCT03083470|83083745|FG004|Overall Study|Withdrawal by Subject|1|||
46866747|NCT05405244|83083757|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
46866748|NCT05405244|83083758|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
46866749|NCT05405244|83083757|FG000|Washout (2 Weeks)|Adverse Event|2|||
46866750|NCT05405244|83083758|FG001|Washout (2 Weeks)|Adverse Event|0|||
46866751|NCT05405244|83083757|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
46866752|NCT05405244|83083758|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
46866753|NCT03074500|83083771|FG000|Overall Study|Lost to Follow-up|1|||
46866754|NCT03074500|83083772|FG001|Overall Study|Lost to Follow-up|0|||
46866755|NCT03074500|83083773|FG002|Overall Study|Lost to Follow-up|0|||
46866756|NCT03074500|83083771|FG000|Overall Study|Lack of Efficacy|0|||
46866757|NCT03074500|83083772|FG001|Overall Study|Lack of Efficacy|1|||
46866758|NCT03074500|83083773|FG002|Overall Study|Lack of Efficacy|0|||
46866759|NCT03074500|83083771|FG000|Overall Study|Adverse Event|0|||
46866760|NCT03074500|83083772|FG001|Overall Study|Adverse Event|0|||
46866761|NCT03074500|83083773|FG002|Overall Study|Adverse Event|1|||
46866762|NCT03715530|83083786|FG000|Overall Study|Lost to Follow-up|3|||
46866763|NCT03715530|83083787|FG001|Overall Study|Lost to Follow-up|1|||
46866764|NCT03715530|83083788|FG002|Overall Study|Lost to Follow-up|2|||
46866765|NCT03077698|83083798|FG000|Progestin Monotherapy|Stable Disease|8|||
46866766|NCT03077698|83083799|FG001|Progestin Monotherapy|Stable Disease|0|||
46866767|NCT03077698|83083798|FG000|Progestin Monotherapy|Adverse Event|1|||
46866768|NCT03077698|83083799|FG001|Progestin Monotherapy|Adverse Event|0|||
46866769|NCT03077698|83083798|FG000|Progestin Monotherapy|Death|1|||
46866770|NCT03077698|83083799|FG001|Progestin Monotherapy|Death|0|||
46866771|NCT03077698|83083798|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
46866772|NCT03077698|83083799|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
46866773|NCT03077698|83083798|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
46866774|NCT03077698|83083799|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
46866775|NCT03077698|83083798|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
46866776|NCT03077698|83083799|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
46866777|NCT03077698|83083798|FG000|Safety Follow Up|Withdrawal by Subject|2|||
46866778|NCT03077698|83083799|FG001|Safety Follow Up|Withdrawal by Subject|1|||
46866779|NCT03077698|83083798|FG000|Safety Follow Up|Transfer of care to hospice|1|||
46866780|NCT03077698|83083799|FG001|Safety Follow Up|Transfer of care to hospice|0|||
46866781|NCT03079102|83083817|FG000|Overall Study|Physician Decision|0|||
46866782|NCT03079102|83083818|FG001|Overall Study|Physician Decision|1|||
46866783|NCT02434354|83083824|FG000|Overall Study|screen fail|3|||
46866784|NCT03076996|83083828|FG000|Overall Study|Withdrawal by Subject|2|||
46866785|NCT03076996|83083828|FG000|Overall Study|Lost to Follow-up|3|||
46866786|NCT03076996|83083828|FG000|Overall Study|Literacy precluded participation|1|||
46866787|NCT03078868|83083832|FG000|Overall Study|Physician Decision|3|||
46866788|NCT04524598|83083840|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
46982822|NCT02337387|83229093|FG001|Overall Study|Adverse Event|1|||
46866789|NCT04524598|83083841|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
46866790|NCT04524598|83083842|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
46866791|NCT04524598|83083843|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
46866792|NCT04524598|83083844|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
46866793|NCT04524598|83083840|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
46866794|NCT04524598|83083841|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
46866795|NCT04524598|83083842|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866796|NCT04524598|83083843|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866797|NCT04524598|83083844|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866798|NCT04524598|83083840|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
46866799|NCT04524598|83083841|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
46866800|NCT04524598|83083842|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
46866801|NCT04524598|83083843|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
46866802|NCT04524598|83083844|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
46866803|NCT04524598|83083840|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
46866804|NCT04524598|83083841|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
46866805|NCT04524598|83083842|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
46866806|NCT04524598|83083843|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
46866807|NCT04524598|83083844|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
46866808|NCT04524598|83083840|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866809|NCT04524598|83083841|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866810|NCT04524598|83083842|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
46866811|NCT04524598|83083843|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
46866812|NCT04524598|83083844|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866813|NCT04524598|83083840|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
46866814|NCT04524598|83083841|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
46866815|NCT04524598|83083842|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
46866816|NCT04524598|83083843|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
46866817|NCT04524598|83083844|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
46866818|NCT04524598|83083840|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866819|NCT04524598|83083841|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866820|NCT04524598|83083842|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866821|NCT04524598|83083843|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
46866822|NCT04524598|83083844|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
46866823|NCT03075904|83083858|FG000|Overall Study|Physician Decision|3|||
46866824|NCT03075904|83083858|FG000|Overall Study|Need for Medication not Permitted|1|||
46866825|NCT03073798|83083862|FG000|Overall Study|Adverse Event|1|||
46866826|NCT03073798|83083862|FG000|Overall Study|Withdrawal by Subject|1|||
46866827|NCT03075826|83083867|FG000|Overall Study|Withdrawal by Subject|1|||
46866828|NCT03075826|83083867|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
46866829|NCT02865850|83083882|FG000|Overall Study|Death|15|||
46866830|NCT02865850|83083883|FG001|Overall Study|Death|19|||
46866831|NCT02865850|83083882|FG000|Overall Study|Withdrawal by Subject|3|||
46866832|NCT02865850|83083883|FG001|Overall Study|Withdrawal by Subject|2|||
46866833|NCT02865850|83083882|FG000|Overall Study|Lost to Follow-up|3|||
46866834|NCT02865850|83083883|FG001|Overall Study|Lost to Follow-up|2|||
46866835|NCT03711162|83083892|FG000|Overall Study|Adverse Event|5|||
46866836|NCT03711162|83083893|FG001|Overall Study|Adverse Event|2|||
46866837|NCT03711162|83083894|FG002|Overall Study|Adverse Event|4|||
46866838|NCT03711162|83083892|FG000|Overall Study|Death|11|||
46866839|NCT03711162|83083893|FG001|Overall Study|Death|7|||
46866840|NCT03711162|83083894|FG002|Overall Study|Death|8|||
46866841|NCT03711162|83083892|FG000|Overall Study|Lost to Follow-up|1|||
46866842|NCT03711162|83083893|FG001|Overall Study|Lost to Follow-up|0|||
46866843|NCT03711162|83083894|FG002|Overall Study|Lost to Follow-up|1|||
46866844|NCT03711162|83083892|FG000|Overall Study|Study Terminated by Sponsor|139|||
46866845|NCT03711162|83083893|FG001|Overall Study|Study Terminated by Sponsor|152|||
46866846|NCT03711162|83083894|FG002|Overall Study|Study Terminated by Sponsor|146|||
46866847|NCT03711162|83083892|FG000|Overall Study|Withdrawal by Subject|17|||
46866848|NCT03711162|83083893|FG001|Overall Study|Withdrawal by Subject|10|||
46866849|NCT03711162|83083894|FG002|Overall Study|Withdrawal by Subject|10|||
46866850|NCT03711162|83083892|FG000|Overall Study|Miscellaneous|1|||
46866851|NCT03711162|83083893|FG001|Overall Study|Miscellaneous|2|||
46866852|NCT03711162|83083894|FG002|Overall Study|Miscellaneous|2|||
46866853|NCT03711162|83083892|FG000|Overall Study|Not Treated|1|||
46866854|NCT03711162|83083893|FG001|Overall Study|Not Treated|0|||
46866855|NCT03711162|83083894|FG002|Overall Study|Not Treated|1|||
46866856|NCT03711162|83083892|FG000|Overall Study|Physician Decision|0|||
46866857|NCT03711162|83083893|FG001|Overall Study|Physician Decision|2|||
46866858|NCT03711162|83083894|FG002|Overall Study|Physician Decision|0|||
46866859|NCT03711162|83083892|FG000|Overall Study|Lack of Efficacy|0|||
46866860|NCT03711162|83083893|FG001|Overall Study|Lack of Efficacy|0|||
46866861|NCT03711162|83083894|FG002|Overall Study|Lack of Efficacy|2|||
46866862|NCT03711162|83083892|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
46866863|NCT03711162|83083893|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
46866864|NCT03711162|83083894|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
46866865|NCT03072160|83083910|FG000|Overall Study|Adverse Event|3|||
46866866|NCT03072160|83083911|FG001|Overall Study|Adverse Event|1|||
46866867|NCT03072160|83083910|FG000|Overall Study|Refused further treatment|6|||
46866868|NCT03072160|83083911|FG001|Overall Study|Refused further treatment|1|||
46866869|NCT03072160|83083910|FG000|Overall Study|Physician Decision|1|||
46866870|NCT03072160|83083911|FG001|Overall Study|Physician Decision|0|||
46866871|NCT03072160|83083910|FG000|Overall Study|Disease progression on study|1|||
46866872|NCT03072160|83083911|FG001|Overall Study|Disease progression on study|1|||
46866873|NCT03072160|83083910|FG000|Overall Study|No contact|0|||
46866874|NCT03072160|83083911|FG001|Overall Study|No contact|1|||
46866875|NCT00407602|83083949|FG000|Overall Study|Death - unrelated to device|1|||
46866876|NCT00407602|83083949|FG000|Overall Study|Device explanted|5|||
46866877|NCT00407602|83083949|FG000|Overall Study|Withdrawal by Subject|1|||
46866878|NCT03057496|83083956|FG000|Overall Study|Withdrawal by Subject|8|||
46866879|NCT03057496|83083956|FG000|Overall Study|Lost to Follow-up|5|||
46866880|NCT03057496|83083956|FG000|Overall Study|Did not use device during home trial|3|||
46866881|NCT03057496|83083956|FG000|Overall Study|Device failure|2|||
46866882|NCT03708744|83083966|FG000|Overall Study|Withdrawal by Subject|0|||
46866883|NCT03708744|83083967|FG001|Overall Study|Withdrawal by Subject|0|||
46866884|NCT03708744|83083968|FG002|Overall Study|Withdrawal by Subject|1|||
46866885|NCT03708744|83083969|FG003|Overall Study|Withdrawal by Subject|0|||
46866886|NCT02574286|83083983|FG000|Overall Study|Adverse Event|3|||
46866887|NCT02574286|83083983|FG000|Overall Study|Withdrawal by Subject|2|||
46866888|NCT02083354|83083991|FG000|Overall Study|Withdrawal by Subject|9|||
46866889|NCT02083354|83083991|FG000|Overall Study|Lost to Follow-up|1|||
46866890|NCT02083354|83083991|FG000|Overall Study|Adverse Event|3|||
46866891|NCT02083354|83083991|FG000|Overall Study|Disease progression|46|||
46866892|NCT02083354|83083991|FG000|Overall Study|Study closed/terminated|5|||
46866893|NCT04230486|83083995|FG000|Overall Study|Screen Failure|1|||
46866894|NCT01399918|83084001|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
46866895|NCT00112840|83084008|FG000|Overall Study|Physician Decision|1|||
46866896|NCT00112840|83084009|FG001|Overall Study|Physician Decision|0|||
46866897|NCT00112840|83084010|FG002|Overall Study|Physician Decision|0|||
46866898|NCT00112840|83084008|FG000|Overall Study|Withdrawal by Subject|1|||
46866899|NCT00112840|83084009|FG001|Overall Study|Withdrawal by Subject|0|||
46866900|NCT00112840|83084010|FG002|Overall Study|Withdrawal by Subject|1|||
46866901|NCT00112840|83084008|FG000|Overall Study|Protocol Violation|0|||
46866902|NCT00112840|83084009|FG001|Overall Study|Protocol Violation|0|||
46866903|NCT00112840|83084010|FG002|Overall Study|Protocol Violation|5|||
46866904|NCT02197572|83084023|FG000|Overall Study|Progressive Disease|28|||
46866905|NCT02197572|83084023|FG000|Overall Study|Withdrawal by Subject|9|||
46866906|NCT02197572|83084023|FG000|Overall Study|Adverse Event|3|||
46866907|NCT02197572|83084023|FG000|Overall Study|Reason Not Specified|4|||
46866908|NCT03176784|83084031|FG000|Overall Study|Lost to Follow-up|77|||
46866909|NCT03176784|83084032|FG001|Overall Study|Lost to Follow-up|79|||
46866910|NCT03176784|83084033|FG002|Overall Study|Lost to Follow-up|79|||
46866911|NCT03176784|83084034|FG003|Overall Study|Lost to Follow-up|49|||
46866912|NCT03176784|83084031|FG000|Overall Study|Withdrawal by Subject|28|||
46866913|NCT03176784|83084032|FG001|Overall Study|Withdrawal by Subject|34|||
46866914|NCT03176784|83084033|FG002|Overall Study|Withdrawal by Subject|34|||
46866915|NCT03176784|83084034|FG003|Overall Study|Withdrawal by Subject|21|||
46866916|NCT03049852|83084047|FG000|Overall Study|Lost to Follow-up|0|||
46866917|NCT03049852|83084048|FG001|Overall Study|Lost to Follow-up|1|||
46866918|NCT03049852|83084049|FG002|Overall Study|Lost to Follow-up|0|||
46866919|NCT05091528|83084061|FG000|Overall Study|Study Termination by Sponsor|0|||
46866920|NCT05091528|83084062|FG001|Overall Study|Study Termination by Sponsor|1|||
46866921|NCT05091528|83084063|FG002|Overall Study|Study Termination by Sponsor|0|||
46866922|NCT05091528|83084064|FG003|Overall Study|Study Termination by Sponsor|1|||
46866923|NCT01317004|83084087|FG000|Overall Study|Withdrawal by Subject|1|||
46866924|NCT01317004|83084088|FG001|Overall Study|Withdrawal by Subject|4|||
46866925|NCT01317004|83084087|FG000|Overall Study|Protocol Violation|0|||
46866926|NCT01317004|83084088|FG001|Overall Study|Protocol Violation|2|||
46866927|NCT01317004|83084087|FG000|Overall Study|Adverse Event|3|||
46866928|NCT01317004|83084088|FG001|Overall Study|Adverse Event|3|||
46866929|NCT01343056|83084098|FG000|Overall Study|Lost to Follow-up|7|||
46866930|NCT01343056|83084099|FG001|Overall Study|Lost to Follow-up|5|||
46866931|NCT01343056|83084100|FG002|Overall Study|Lost to Follow-up|3|||
46866932|NCT01343056|83084101|FG003|Overall Study|Lost to Follow-up|9|||
46866933|NCT01316692|83084115|FG000|Overall Study|Adverse Event|5|||
46866934|NCT01316692|83084115|FG000|Overall Study|Disease Progression|7|||
46866935|NCT01316380|83084122|FG000|Overall Study|Adverse Event|0|||
46866936|NCT01316380|83084123|FG001|Overall Study|Adverse Event|2|||
46866937|NCT01316380|83084124|FG002|Overall Study|Adverse Event|1|||
46866938|NCT01316380|83084122|FG000|Overall Study|Protocol Violation|0|||
46866939|NCT01316380|83084123|FG001|Overall Study|Protocol Violation|0|||
46866940|NCT01316380|83084124|FG002|Overall Study|Protocol Violation|1|||
46866941|NCT01316380|83084122|FG000|Overall Study|Withdrawal by Subject|1|||
46866942|NCT01316380|83084123|FG001|Overall Study|Withdrawal by Subject|2|||
46866943|NCT01316380|83084124|FG002|Overall Study|Withdrawal by Subject|0|||
46866944|NCT01316380|83084122|FG000|Overall Study|Other|0|||
46866945|NCT01316380|83084123|FG001|Overall Study|Other|1|||
46866946|NCT01316380|83084124|FG002|Overall Study|Other|1|||
46866947|NCT01316380|83084122|FG000|Overall Study|Not treated|1|||
46866948|NCT01316380|83084123|FG001|Overall Study|Not treated|0|||
46866949|NCT01316380|83084124|FG002|Overall Study|Not treated|0|||
46866950|NCT01316224|83084132|FG000|Overall Study|Protocol Violation|3|||
46866951|NCT01316224|83084132|FG000|Overall Study|Adverse Event|3|||
46866952|NCT01316224|83084132|FG000|Overall Study|Lack of Efficacy|1|||
46866953|NCT01316224|83084132|FG000|Overall Study|Withdrawal by Subject|1|||
46866954|NCT01316224|83084132|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
46866955|NCT01316224|83084132|FG000|Overall Study|Other|1|||
46866956|NCT04315298|83084155|FG000|Overall Study|Withdrawal by Subject|0|||
46866957|NCT04315298|83084156|FG001|Overall Study|Withdrawal by Subject|0|||
46866958|NCT04315298|83084157|FG002|Overall Study|Withdrawal by Subject|0|||
46866959|NCT04315298|83084158|FG003|Overall Study|Withdrawal by Subject|2|||
46866960|NCT04315298|83084159|FG004|Overall Study|Withdrawal by Subject|2|||
46866961|NCT04315298|83084160|FG005|Overall Study|Withdrawal by Subject|2|||
46866962|NCT04315298|83084161|FG006|Overall Study|Withdrawal by Subject|0|||
46866963|NCT04315298|83084162|FG007|Overall Study|Withdrawal by Subject|1|||
46866964|NCT04315298|83084163|FG008|Overall Study|Withdrawal by Subject|1|||
46866965|NCT04315298|83084164|FG009|Overall Study|Withdrawal by Subject|1|||
46866966|NCT04315298|83084165|FG010|Overall Study|Withdrawal by Subject|0|||
46866967|NCT04315298|83084166|FG011|Overall Study|Withdrawal by Subject|0|||
46866968|NCT04315298|83084167|FG012|Overall Study|Withdrawal by Subject|0|||
46866969|NCT04315298|83084168|FG013|Overall Study|Withdrawal by Subject|0|||
46698358|NCT00931255|82913346|FG001|Overall Study|Follow up biopsy not done|3|||
46698359|NCT00930553|82913352|FG000|Overall Study|Adverse Event|1|||
46698360|NCT00930553|82913352|FG000|Overall Study|Lack of Efficacy|7|||
46698361|NCT00930553|82913352|FG000|Overall Study|Physician Decision|39|||
46698362|NCT00930553|82913352|FG000|Overall Study|Protocol Violation|1|||
46698363|NCT00930553|82913352|FG000|Overall Study|Pregnancy|1|||
46698364|NCT00930553|82913352|FG000|Overall Study|Withdrawal by Subject|88|||
46698365|NCT00930553|82913352|FG000|Overall Study|Lost to Follow-up|25|||
46698366|NCT00930553|82913352|FG000|Overall Study|Death|9|||
46866970|NCT04315298|83084169|FG014|Overall Study|Withdrawal by Subject|0|||
46866971|NCT04315298|83084170|FG015|Overall Study|Withdrawal by Subject|0|||
46866972|NCT04315298|83084171|FG016|Overall Study|Withdrawal by Subject|0|||
46698367|NCT00930553|82913352|FG000|Overall Study|Study terminated by sponsor|24|||
46698368|NCT00930553|82913352|FG000|Overall Study|Other than specified above|28|||
46698369|NCT00929695|82913376|FG000|Overall Study|Death|2|||
46866973|NCT04315298|83084172|FG017|Overall Study|Withdrawal by Subject|0|||
46866974|NCT04315298|83084173|FG018|Overall Study|Withdrawal by Subject|0|||
46698370|NCT00929695|82913377|FG001|Overall Study|Death|1|||
46866975|NCT04315298|83084155|FG000|Overall Study|Physician Decision|0|||
46866976|NCT04315298|83084156|FG001|Overall Study|Physician Decision|0|||
46866977|NCT04315298|83084157|FG002|Overall Study|Physician Decision|0|||
46866978|NCT04315298|83084158|FG003|Overall Study|Physician Decision|0|||
46866979|NCT04315298|83084159|FG004|Overall Study|Physician Decision|1|||
46866980|NCT04315298|83084160|FG005|Overall Study|Physician Decision|0|||
46866981|NCT04315298|83084161|FG006|Overall Study|Physician Decision|0|||
46866982|NCT04315298|83084162|FG007|Overall Study|Physician Decision|0|||
46866983|NCT04315298|83084163|FG008|Overall Study|Physician Decision|0|||
46866984|NCT04315298|83084164|FG009|Overall Study|Physician Decision|0|||
46866985|NCT04315298|83084165|FG010|Overall Study|Physician Decision|0|||
46866986|NCT04315298|83084166|FG011|Overall Study|Physician Decision|0|||
46866987|NCT04315298|83084167|FG012|Overall Study|Physician Decision|0|||
46866988|NCT04315298|83084168|FG013|Overall Study|Physician Decision|0|||
46866989|NCT04315298|83084169|FG014|Overall Study|Physician Decision|0|||
46866990|NCT04315298|83084170|FG015|Overall Study|Physician Decision|0|||
46866991|NCT04315298|83084171|FG016|Overall Study|Physician Decision|0|||
46866992|NCT04315298|83084172|FG017|Overall Study|Physician Decision|0|||
46866993|NCT04315298|83084173|FG018|Overall Study|Physician Decision|0|||
46866994|NCT04315298|83084155|FG000|Overall Study|Lost to Follow-up|5|||
46866995|NCT04315298|83084156|FG001|Overall Study|Lost to Follow-up|10|||
46866996|NCT04315298|83084157|FG002|Overall Study|Lost to Follow-up|6|||
46866997|NCT04315298|83084158|FG003|Overall Study|Lost to Follow-up|8|||
46866998|NCT04315298|83084159|FG004|Overall Study|Lost to Follow-up|12|||
46866999|NCT04315298|83084160|FG005|Overall Study|Lost to Follow-up|13|||
46867000|NCT04315298|83084161|FG006|Overall Study|Lost to Follow-up|9|||
46867001|NCT04315298|83084162|FG007|Overall Study|Lost to Follow-up|16|||
46867002|NCT04315298|83084163|FG008|Overall Study|Lost to Follow-up|14|||
46867003|NCT04315298|83084164|FG009|Overall Study|Lost to Follow-up|0|||
46867004|NCT04315298|83084165|FG010|Overall Study|Lost to Follow-up|2|||
46867005|NCT04315298|83084166|FG011|Overall Study|Lost to Follow-up|1|||
46867006|NCT04315298|83084167|FG012|Overall Study|Lost to Follow-up|0|||
46867007|NCT04315298|83084168|FG013|Overall Study|Lost to Follow-up|0|||
46867008|NCT04315298|83084169|FG014|Overall Study|Lost to Follow-up|0|||
46867009|NCT04315298|83084170|FG015|Overall Study|Lost to Follow-up|2|||
46867010|NCT04315298|83084171|FG016|Overall Study|Lost to Follow-up|0|||
46867011|NCT04315298|83084172|FG017|Overall Study|Lost to Follow-up|0|||
46867012|NCT04315298|83084173|FG018|Overall Study|Lost to Follow-up|0|||
46867013|NCT04315298|83084155|FG000|Overall Study|Death|24|||
46867014|NCT04315298|83084156|FG001|Overall Study|Death|60|||
46867015|NCT04315298|83084157|FG002|Overall Study|Death|49|||
46867016|NCT04315298|83084158|FG003|Overall Study|Death|59|||
46867017|NCT04315298|83084159|FG004|Overall Study|Death|70|||
46867018|NCT04315298|83084160|FG005|Overall Study|Death|114|||
46867019|NCT04315298|83084161|FG006|Overall Study|Death|9|||
46867020|NCT04315298|83084162|FG007|Overall Study|Death|12|||
46867021|NCT04315298|83084163|FG008|Overall Study|Death|21|||
46867022|NCT04315298|83084164|FG009|Overall Study|Death|16|||
46867023|NCT04315298|83084165|FG010|Overall Study|Death|40|||
46867024|NCT04315298|83084166|FG011|Overall Study|Death|40|||
46867025|NCT04315298|83084167|FG012|Overall Study|Death|3|||
46867026|NCT04315298|83084168|FG013|Overall Study|Death|4|||
46867027|NCT04315298|83084169|FG014|Overall Study|Death|6|||
46867028|NCT04315298|83084170|FG015|Overall Study|Death|4|||
46867029|NCT04315298|83084171|FG016|Overall Study|Death|3|||
46867030|NCT04315298|83084172|FG017|Overall Study|Death|1|||
46867031|NCT04315298|83084173|FG018|Overall Study|Death|0|||
46867032|NCT04308668|83084242|FG000|Overall Study|Lost to Follow-up|32|||
46867033|NCT04308668|83084243|FG001|Overall Study|Lost to Follow-up|38|||
46867034|NCT04308668|83084242|FG000|Overall Study|Withdrawal by Subject|4|||
46867035|NCT04308668|83084243|FG001|Overall Study|Withdrawal by Subject|4|||
46867036|NCT04451330|83084251|FG000|Overall Study|Adverse Event|1|||
46867037|NCT04451330|83084252|FG001|Overall Study|Adverse Event|2|||
46867038|NCT04451330|83084251|FG000|Overall Study|Lost to Follow-up|5|||
46867039|NCT04451330|83084252|FG001|Overall Study|Lost to Follow-up|0|||
46867040|NCT04451330|83084251|FG000|Overall Study|Withdrawal by Subject|3|||
46867041|NCT04451330|83084252|FG001|Overall Study|Withdrawal by Subject|1|||
46867042|NCT04451330|83084251|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46867043|NCT04451330|83084252|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46867044|NCT04451330|83084251|FG000|Overall Study|Other than specified|0|||
46867045|NCT04451330|83084252|FG001|Overall Study|Other than specified|1|||
46867046|NCT02493426|83084258|FG000|Overall Study|Withdrawal by Subject|0|||
46867047|NCT02493426|83084259|FG001|Overall Study|Withdrawal by Subject|1|||
46867048|NCT04448756|83084268|FG000|Overall Study|Adverse Event|0|||
46867049|NCT04448756|83084269|FG001|Overall Study|Adverse Event|1|||
46867050|NCT04448756|83084270|FG002|Overall Study|Adverse Event|0|||
46867051|NCT04448756|83084268|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
46867052|NCT04448756|83084269|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
46867053|NCT04448756|83084270|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
46867054|NCT04448756|83084268|FG000|Overall Study|Withdrawal by Subject|0|||
46867055|NCT04448756|83084269|FG001|Overall Study|Withdrawal by Subject|3|||
46867056|NCT04448756|83084270|FG002|Overall Study|Withdrawal by Subject|1|||
46867057|NCT04448756|83084268|FG000|Overall Study|Death|2|||
46867058|NCT04448756|83084269|FG001|Overall Study|Death|1|||
46867059|NCT04448756|83084270|FG002|Overall Study|Death|0|||
46867060|NCT04274192|83084280|FG000|Overall Study|Protocol Violation|1|||
46867061|NCT04274192|83084281|FG001|Overall Study|Protocol Violation|0|||
46867062|NCT04387136|83084291|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
46867063|NCT04387136|83084292|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
46867064|NCT04252586|83084298|FG000|Overall Study|Withdrawal by parent/guardian|3|||
46867065|NCT04252586|83084298|FG000|Overall Study|Adverse Event|1|||
46867066|NCT04252586|83084298|FG000|Overall Study|Death|2|||
46867067|NCT04252586|83084298|FG000|Overall Study|Study terminated by sponsor|4|||
46867068|NCT04252586|83084298|FG000|Overall Study|Sponsor request|10|||
46867069|NCT04252586|83084298|FG000|Overall Study|Did not complete treatment period|1|||
46867070|NCT04247828|83084303|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
46867071|NCT04507776|83084307|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
46867072|NCT04386902|83084316|FG000|Overall Study|Withdrawal by Subject|5|||
46867073|NCT04386902|83084316|FG000|Overall Study|Technical problems in the recording|5|||
46867074|NCT04232540|83084322|FG000|Overall Study|Lost to Follow-up|1|||
46867075|NCT04232540|83084323|FG001|Overall Study|Lost to Follow-up|0|||
46867076|NCT04504032|83084331|FG000|Overall Study|Adverse Event|1|||
46867077|NCT04504032|83084332|FG001|Overall Study|Adverse Event|2|||
46867078|NCT04504032|83084331|FG000|Overall Study|Lost to Follow-up|6|||
46867079|NCT04504032|83084332|FG001|Overall Study|Lost to Follow-up|9|||
46867080|NCT04504032|83084331|FG000|Overall Study|Protocol Violation|2|||
46867081|NCT04504032|83084332|FG001|Overall Study|Protocol Violation|0|||
46867082|NCT04504032|83084331|FG000|Overall Study|Study terminated by sponsor|1|||
46867083|NCT04504032|83084332|FG001|Overall Study|Study terminated by sponsor|2|||
46867084|NCT04504032|83084331|FG000|Overall Study|Withdrawal by Subject|9|||
46867085|NCT04504032|83084332|FG001|Overall Study|Withdrawal by Subject|11|||
46867086|NCT04504032|83084331|FG000|Overall Study|Disease progression prior to dosing|15|||
46867087|NCT04504032|83084332|FG001|Overall Study|Disease progression prior to dosing|3|||
46867088|NCT04504032|83084331|FG000|Overall Study|Drug supply issues|1|||
46867089|NCT04504032|83084332|FG001|Overall Study|Drug supply issues|1|||
46867090|NCT04504032|83084331|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
46867091|NCT04504032|83084332|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
46867092|NCT04439240|83084338|FG000|Overall Study|Ineligible|2|||
46867093|NCT04439240|83084338|FG000|Overall Study|Never started treatment|2|||
46867094|NCT04439240|83084338|FG000|Overall Study|Adverse Event|12|||
46867095|NCT04439240|83084338|FG000|Overall Study|Death|2|||
46867096|NCT04439240|83084338|FG000|Overall Study|Disease progression|25|||
46867097|NCT04439240|83084338|FG000|Overall Study|Other diseases|2|||
46867098|NCT04439240|83084338|FG000|Overall Study|Withdrawal by Subject|3|||
46867099|NCT04439240|83084338|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
46867100|NCT04439240|83084338|FG000|Overall Study|Symptomatic decline|1|||
46867101|NCT04439240|83084338|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
46867102|NCT04439240|83084338|FG000|Overall Study|Clinical progression|1|||
46867103|NCT04605588|83084344|FG000|Overall Study|Withdrawal by Subject|1|||
46867104|NCT04605588|83084345|FG001|Overall Study|Withdrawal by Subject|0|||
46867105|NCT04885296|83084351|FG000|Period 1|Covid-19 Related|1|||
46867106|NCT04885296|83084352|FG001|Period 1|Covid-19 Related|0|||
46867107|NCT04885296|83084351|FG000|Period 1|Adverse Event|0|||
46867108|NCT04885296|83084352|FG001|Period 1|Adverse Event|1|||
46867109|NCT04885296|83084351|FG000|Period 1|Withdrawal by Subject|1|||
46867110|NCT04885296|83084352|FG001|Period 1|Withdrawal by Subject|1|||
46867111|NCT04885296|83084351|FG000|Period 1|Test Article No Longer Available|1|||
46867112|NCT04885296|83084352|FG001|Period 1|Test Article No Longer Available|0|||
46867113|NCT04885296|83084351|FG000|Period 1|Dispensed Study lens in Error|1|||
46867114|NCT04885296|83084352|FG001|Period 1|Dispensed Study lens in Error|0|||
46867115|NCT04885296|83084351|FG000|Period 1|Lost to Follow-up|1|||
46867116|NCT04885296|83084352|FG001|Period 1|Lost to Follow-up|0|||
46867117|NCT04885296|83084351|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
46867118|NCT04885296|83084352|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
46867119|NCT04602000|83084363|FG000|Overall Study|Withdrawal by Subject|3|||
46867120|NCT04602000|83084364|FG001|Overall Study|Withdrawal by Subject|6|||
46867121|NCT04602000|83084365|FG002|Overall Study|Withdrawal by Subject|3|||
46867122|NCT04602000|83084366|FG003|Overall Study|Withdrawal by Subject|27|||
46867123|NCT04602000|83084367|FG004|Overall Study|Withdrawal by Subject|39|||
46867124|NCT04602000|83084363|FG000|Overall Study|Physician Decision|1|||
46867125|NCT04602000|83084364|FG001|Overall Study|Physician Decision|0|||
46867126|NCT04602000|83084365|FG002|Overall Study|Physician Decision|0|||
46867127|NCT04602000|83084366|FG003|Overall Study|Physician Decision|2|||
46982823|NCT02337387|83229094|FG002|Overall Study|Adverse Event|0|||
46982824|NCT02337387|83229095|FG003|Overall Study|Adverse Event|0|||
46867128|NCT04602000|83084367|FG004|Overall Study|Physician Decision|2|||
46867129|NCT04602000|83084363|FG000|Overall Study|Death|0|||
46867130|NCT04602000|83084364|FG001|Overall Study|Death|1|||
46982825|NCT02337387|83229092|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
46867131|NCT04602000|83084365|FG002|Overall Study|Death|0|||
46867132|NCT04602000|83084366|FG003|Overall Study|Death|1|||
46867133|NCT04602000|83084367|FG004|Overall Study|Death|2|||
46867134|NCT04602000|83084363|FG000|Overall Study|Lost to Follow-up|0|||
46867135|NCT04602000|83084364|FG001|Overall Study|Lost to Follow-up|0|||
46867136|NCT04602000|83084365|FG002|Overall Study|Lost to Follow-up|0|||
46867137|NCT04602000|83084366|FG003|Overall Study|Lost to Follow-up|3|||
46867138|NCT04602000|83084367|FG004|Overall Study|Lost to Follow-up|4|||
46867139|NCT04602000|83084363|FG000|Overall Study|Other|4|||
46867140|NCT04602000|83084364|FG001|Overall Study|Other|1|||
46867141|NCT04602000|83084365|FG002|Overall Study|Other|2|||
46867142|NCT04602000|83084366|FG003|Overall Study|Other|5|||
46867143|NCT04602000|83084367|FG004|Overall Study|Other|4|||
46867144|NCT04602000|83084363|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
46867145|NCT04602000|83084364|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
46867146|NCT04602000|83084365|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
46867147|NCT04602000|83084366|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
46867148|NCT04602000|83084367|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
46867149|NCT03041116|83084383|FG000|Double-blind|Death|0|||
46867150|NCT03041116|83084384|FG001|Double-blind|Death|2|||
46867151|NCT03041116|83084383|FG000|Double-blind|Withdrawal by Subject|0|||
46867152|NCT03041116|83084384|FG001|Double-blind|Withdrawal by Subject|4|||
46867153|NCT03041116|83084383|FG000|Open-label|Death|1|||
46867154|NCT03041116|83084384|FG001|Open-label|Death|0|||
46867155|NCT03041116|83084383|FG000|Open-label|Termination of the study by Sponsor|39|||
46867156|NCT03041116|83084384|FG001|Open-label|Termination of the study by Sponsor|37|||
46867157|NCT03041116|83084383|FG000|Open-label|Withdrawal by Subject|1|||
46867158|NCT03041116|83084384|FG001|Open-label|Withdrawal by Subject|0|||
46867159|NCT04860258|83084401|FG000|Overall Study|Withdrawal by Subject|0|||
46867160|NCT04860258|83084402|FG001|Overall Study|Withdrawal by Subject|0|||
46867161|NCT04860258|83084403|FG002|Overall Study|Withdrawal by Subject|4|||
46867162|NCT04860258|83084404|FG003|Overall Study|Withdrawal by Subject|1|||
46867163|NCT04860258|83084405|FG004|Overall Study|Withdrawal by Subject|4|||
46867164|NCT04860258|83084406|FG005|Overall Study|Withdrawal by Subject|1|||
46867165|NCT04860258|83084407|FG006|Overall Study|Withdrawal by Subject|0|||
46867166|NCT03041038|83084425|FG000|Overall Study|Withdrawal by Subject|4|||
46867167|NCT03041038|83084426|FG001|Overall Study|Withdrawal by Subject|0|||
46867168|NCT03041038|83084425|FG000|Overall Study|Lost to Follow-up|1|||
46867169|NCT03041038|83084426|FG001|Overall Study|Lost to Follow-up|1|||
46867170|NCT03041038|83084425|FG000|Overall Study|Protocol Violation|1|||
46867171|NCT03041038|83084426|FG001|Overall Study|Protocol Violation|1|||
46867172|NCT04382066|83084437|FG000|Overall Study|Adverse Event|1|||
46867173|NCT04382066|83084438|FG001|Overall Study|Adverse Event|0|||
46867174|NCT04382066|83084439|FG002|Overall Study|Adverse Event|0|||
46867175|NCT04382066|83084437|FG000|Overall Study|Death|1|||
46867176|NCT04382066|83084438|FG001|Overall Study|Death|0|||
46867177|NCT04382066|83084439|FG002|Overall Study|Death|1|||
46867178|NCT04435184|83084455|FG000|Overall Study|follow-up blood draws missing|3|||
46867179|NCT04435184|83084456|FG001|Overall Study|follow-up blood draws missing|5|||
46867180|NCT03693404|83084464|FG000|Overall Study|Withdrawal by Subject|1|||
46867181|NCT03693404|83084465|FG001|Overall Study|Withdrawal by Subject|0|||
46867182|NCT03693404|83084464|FG000|Overall Study|Lost to Follow-up|0|||
46867183|NCT03693404|83084465|FG001|Overall Study|Lost to Follow-up|5|||
46867184|NCT03693404|83084464|FG000|Overall Study|Excluded from Analysis|0|||
46867185|NCT03693404|83084465|FG001|Overall Study|Excluded from Analysis|1|||
46867186|NCT03696108|83084473|FG000|Overall Study|Physician Decision|1|||
46867187|NCT03696108|83084474|FG001|Overall Study|Physician Decision|0|||
46867188|NCT03696108|83084473|FG000|Overall Study|Withdrawal by Subject|3|||
46867189|NCT03696108|83084474|FG001|Overall Study|Withdrawal by Subject|6|||
46867190|NCT04218110|83084484|FG000|Overall Study|Withdrawal by Subject|0|||
46698371|NCT00929695|82913376|FG000|Overall Study|Withdrawal by Subject|0|||
46867191|NCT04218110|83084485|FG001|Overall Study|Withdrawal by Subject|0|||
46867192|NCT04218110|83084486|FG002|Overall Study|Withdrawal by Subject|0|||
46867193|NCT04218110|83084487|FG003|Overall Study|Withdrawal by Subject|1|||
46867194|NCT04214600|83084499|FG000|Overall Study|Lost to Follow-up|9|||
46867195|NCT04214600|83084500|FG001|Overall Study|Lost to Follow-up|14|||
46867196|NCT04210310|83084509|FG000|Overall Study|Lost to Follow-up|32|||
46867197|NCT04210310|83084510|FG001|Overall Study|Lost to Follow-up|1|||
46867198|NCT04209530|83084518|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
46867199|NCT04209530|83084519|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
46867200|NCT04209530|83084518|FG000|Overall Study|Withdrawal by Subject|0|||
46867201|NCT04209530|83084519|FG001|Overall Study|Withdrawal by Subject|1|||
46867202|NCT04349098|83084527|FG000|Overall Study|Death|16|||
46867203|NCT04349098|83084528|FG001|Overall Study|Death|8|||
46867204|NCT04349098|83084527|FG000|Overall Study|Lost to Follow-up|11|||
46867205|NCT04349098|83084528|FG001|Overall Study|Lost to Follow-up|8|||
46867206|NCT04349098|83084527|FG000|Overall Study|Withdrawal by Subject|8|||
46867207|NCT04349098|83084528|FG001|Overall Study|Withdrawal by Subject|5|||
46867208|NCT04349098|83084527|FG000|Overall Study|Other|3|||
46867209|NCT04349098|83084528|FG001|Overall Study|Other|5|||
46867210|NCT04208750|83084536|FG000|Overall Study|Lost to Follow-up|16|||
46867211|NCT04208750|83084537|FG001|Overall Study|Lost to Follow-up|15|||
46867212|NCT04381988|83084545|FG000|Overall Study|The study was terminated|4|||
46867213|NCT04381988|83084546|FG001|Overall Study|The study was terminated|0|||
46867214|NCT04333498|83084554|FG000|Overall Study|Lost to Follow-up|1|||
46867215|NCT04333498|83084555|FG001|Overall Study|Lost to Follow-up|0|||
46867216|NCT04333498|83084554|FG000|Overall Study|Lost to Follow-up|0|||
46867217|NCT04333498|83084555|FG001|Overall Study|Lost to Follow-up|1|||
46867218|NCT03355664|83084563|FG000|Overall Study|Adverse Event|1|||
46867219|NCT03355664|83084564|FG001|Overall Study|Adverse Event|2|||
46867220|NCT03355664|83084563|FG000|Overall Study|Lost to Follow-up|11|||
46867221|NCT03355664|83084564|FG001|Overall Study|Lost to Follow-up|7|||
46867222|NCT03355664|83084563|FG000|Overall Study|Protocol Violation|1|||
46867223|NCT03355664|83084564|FG001|Overall Study|Protocol Violation|2|||
46867224|NCT03355664|83084563|FG000|Overall Study|Withdrawal by Subject|2|||
46867225|NCT03355664|83084564|FG001|Overall Study|Withdrawal by Subject|1|||
46867226|NCT04170686|83084572|FG000|Screening|Physician Decision|12|||
46867227|NCT04170686|83084573|FG001|Screening|Physician Decision|13|||
46867228|NCT04170686|83084572|FG000|Randomization and Treatment|Lost to Follow-up|26|||
46867229|NCT04170686|83084573|FG001|Randomization and Treatment|Lost to Follow-up|15|||
46867230|NCT03695094|83084581|FG000|Overall Study|Adverse Event|1|||
46867231|NCT03695094|83084582|FG001|Overall Study|Adverse Event|1|||
46867232|NCT03695094|83084581|FG000|Overall Study|Withdrawal by Subject|1|||
46867233|NCT03695094|83084582|FG001|Overall Study|Withdrawal by Subject|0|||
46867234|NCT04497948|83084590|FG000|Overall Study|Death|2|||
46867235|NCT04495374|83084600|FG000|Overall Study|Protocol Violation|2|||
46867236|NCT04495374|83084601|FG001|Overall Study|Protocol Violation|1|||
46867237|NCT04794270|83084607|FG000|Period 1|Non Compliance|1|||
46867238|NCT04794270|83084608|FG001|Period 1|Non Compliance|0|||
46867239|NCT04794270|83084607|FG000|Period 1|Adverse Event|1|||
46867240|NCT04794270|83084608|FG001|Period 1|Adverse Event|0|||
46867241|NCT04794270|83084607|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
46867242|NCT04794270|83084608|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
46867243|NCT04567186|83084614|FG000|Period 1|COVID-19 related|1|||
46867244|NCT04567186|83084615|FG001|Period 1|COVID-19 related|0|||
46867245|NCT04567186|83084614|FG000|Period 1|Protocol Violation|0|||
46867246|NCT04567186|83084615|FG001|Period 1|Protocol Violation|1|||
46867247|NCT04567186|83084614|FG000|Period 1|Adverse Event|0|||
46867248|NCT04567186|83084615|FG001|Period 1|Adverse Event|2|||
46867249|NCT04567186|83084614|FG000|Period 2|COVID-19 Related|0|||
46867250|NCT04567186|83084615|FG001|Period 2|COVID-19 Related|1|||
46867251|NCT04567186|83084614|FG000|Period 2|Protocol Violation|0|||
46867252|NCT04567186|83084615|FG001|Period 2|Protocol Violation|1|||
46867253|NCT04567186|83084614|FG000|Period 2|Lost to Follow-up|0|||
46867254|NCT04567186|83084615|FG001|Period 2|Lost to Follow-up|1|||
46867255|NCT04567186|83084614|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
46867256|NCT04567186|83084615|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
46867257|NCT04168190|83084626|FG000|Overall Study|Lost to Follow-up|0|||
46867258|NCT04168190|83084627|FG001|Overall Study|Lost to Follow-up|1|||
46867259|NCT04168190|83084628|FG002|Overall Study|Lost to Follow-up|0|||
46867260|NCT04168190|83084629|FG003|Overall Study|Lost to Follow-up|7|||
46867261|NCT04168190|83084630|FG004|Overall Study|Lost to Follow-up|5|||
46867262|NCT04168190|83084626|FG000|Overall Study|Withdrawal by Subject|1|||
46867263|NCT04168190|83084627|FG001|Overall Study|Withdrawal by Subject|0|||
46867264|NCT04168190|83084628|FG002|Overall Study|Withdrawal by Subject|0|||
46867265|NCT04168190|83084629|FG003|Overall Study|Withdrawal by Subject|2|||
46867266|NCT04168190|83084630|FG004|Overall Study|Withdrawal by Subject|4|||
46867267|NCT04168190|83084626|FG000|Overall Study|Death|0|||
46867268|NCT04168190|83084627|FG001|Overall Study|Death|0|||
46867269|NCT04168190|83084628|FG002|Overall Study|Death|0|||
46867270|NCT04168190|83084629|FG003|Overall Study|Death|1|||
46867271|NCT04168190|83084630|FG004|Overall Study|Death|0|||
46867272|NCT04732338|83084644|FG000|Overall Study|Lost to Follow-up|3|||
46867273|NCT04732338|83084645|FG001|Overall Study|Lost to Follow-up|3|||
46867274|NCT04194008|83084651|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
46867275|NCT04194008|83084651|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
46867276|NCT04194008|83084651|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
46867277|NCT04194008|83084651|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
46867278|NCT04194008|83084651|FG000|Treatment Phase With Nerivio|Missing data|4|||
46867279|NCT04194008|83084651|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
46867280|NCT04189952|83084664|FG000|Follow-up Period|Death|1|||
46867281|NCT04189952|83084664|FG000|Follow-up Period|Withdrawal by Subject|1|||
46867282|NCT04716426|83084670|FG000|Overall Study|Vaccination|1|||
46867283|NCT04716426|83084671|FG001|Overall Study|Vaccination|1|||
46867284|NCT04716426|83084670|FG000|Overall Study|Contamination|1|||
46867285|NCT04716426|83084671|FG001|Overall Study|Contamination|0|||
46867286|NCT03694548|83084679|FG000|Part A Survey|Protocol Violation|3|||
46867287|NCT03694548|83084680|FG001|Part A Survey|Protocol Violation|3|||
46867288|NCT03694548|83084681|FG002|Part A Survey|Protocol Violation|0|||
46867289|NCT03694548|83084679|FG000|Part B Yoga Program|Protocol Violation|0|||
46867290|NCT03694548|83084680|FG001|Part B Yoga Program|Protocol Violation|0|||
46867291|NCT03694548|83084681|FG002|Part B Yoga Program|Protocol Violation|3|||
46867292|NCT03694548|83084679|FG000|Part B Yoga Program|Did not attend intervention|0|||
46867293|NCT03694548|83084680|FG001|Part B Yoga Program|Did not attend intervention|0|||
46867294|NCT03694548|83084681|FG002|Part B Yoga Program|Did not attend intervention|8|||
46867295|NCT04166630|83084693|FG000|Overall Study|Withdrawal by Subject|0|||
46867296|NCT04166630|83084694|FG001|Overall Study|Withdrawal by Subject|1|||
46867297|NCT04164758|83084703|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
46867298|NCT04164758|83084704|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
46867299|NCT04164758|83084705|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
46867300|NCT04164758|83084703|FG000|Overall Study|Adverse Event|0|||
46867301|NCT04164758|83084704|FG001|Overall Study|Adverse Event|1|||
46867302|NCT04164758|83084705|FG002|Overall Study|Adverse Event|0|||
46867303|NCT04178720|83084715|FG000|Overall Study|Withdrawal by Subject|2|||
46867304|NCT04178720|83084716|FG001|Overall Study|Withdrawal by Subject|0|||
46867305|NCT04178720|83084715|FG000|Overall Study|Relocation|0|||
46867306|NCT04178720|83084716|FG001|Overall Study|Relocation|1|||
46867307|NCT04177862|83084727|FG000|Overall Study|Protocol Violation|2|||
46867308|NCT04177862|83084728|FG001|Overall Study|Protocol Violation|7|||
46867309|NCT04173572|83084737|FG000|Overall Study|Withdrawal by Subject|1|||
46867310|NCT04173572|83084738|FG001|Overall Study|Withdrawal by Subject|5|||
46867311|NCT04173572|83084737|FG000|Overall Study|Lost to Follow-up|3|||
46867312|NCT04173572|83084738|FG001|Overall Study|Lost to Follow-up|1|||
46867313|NCT04157738|83084746|FG000|Overall Study|Moved out of state|0|||
46867314|NCT04157738|83084747|FG001|Overall Study|Moved out of state|2|||
46867315|NCT04157738|83084746|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
46867316|NCT04157738|83084747|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
46982826|NCT02337387|83229093|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
46982827|NCT02337387|83229094|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
46982828|NCT02337387|83229095|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
46982829|NCT02574247|83229108|FG000|Overall Study|Withdrawal by Subject|1|||
46982830|NCT02574247|83229109|FG001|Overall Study|Withdrawal by Subject|0|||
46982831|NCT02574247|83229110|FG002|Overall Study|Withdrawal by Subject|0|||
46982832|NCT02574247|83229108|FG000|Overall Study|Did not meet inclusion criteria|4|||
46982833|NCT02574247|83229109|FG001|Overall Study|Did not meet inclusion criteria|3|||
46982834|NCT02574247|83229110|FG002|Overall Study|Did not meet inclusion criteria|5|||
46982835|NCT02391363|83229122|FG000|Overall Study|Lost to Follow-up|5|||
46982836|NCT02391363|83229123|FG001|Overall Study|Lost to Follow-up|5|||
46982837|NCT02391363|83229122|FG000|Overall Study|Withdrawal by Subject|6|||
46982838|NCT02391363|83229123|FG001|Overall Study|Withdrawal by Subject|3|||
46982839|NCT02569957|83229131|FG000|Overall Study|Withdrawal by Subject|0|||
46982840|NCT02569957|83229132|FG001|Overall Study|Withdrawal by Subject|1|||
46982841|NCT01649427|83229140|FG000|Overall Study|Adverse Event|1|||
46982842|NCT01649427|83229141|FG001|Overall Study|Adverse Event|1|||
46982843|NCT01649427|83229140|FG000|Overall Study|Withdrawal by Subject|8|||
46982844|NCT01649427|83229141|FG001|Overall Study|Withdrawal by Subject|7|||
46982845|NCT01649427|83229140|FG000|Overall Study|Lost to Follow-up|0|||
46982846|NCT01649427|83229141|FG001|Overall Study|Lost to Follow-up|1|||
46982847|NCT01649427|83229140|FG000|Overall Study|Graft loss|0|||
46982848|NCT01649427|83229141|FG001|Overall Study|Graft loss|1|||
46982849|NCT01649427|83229140|FG000|Overall Study|Surgical problems during nephrectomy|2|||
46982850|NCT01649427|83229141|FG001|Overall Study|Surgical problems during nephrectomy|2|||
46982851|NCT02375373|83229147|FG000|Overall Study|Withdrawal by Subject|11|||
46982852|NCT02336607|83229155|FG000|Overall Study|Physician Decision|1|||
46982853|NCT02336607|83229156|FG001|Overall Study|Physician Decision|4|||
46982854|NCT02336607|83229157|FG002|Overall Study|Physician Decision|3|||
46982855|NCT02336607|83229158|FG003|Overall Study|Physician Decision|15|||
46982856|NCT02336607|83229155|FG000|Overall Study|Lack of Efficacy|1|||
46867317|NCT04156646|83084755|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
46867318|NCT04156646|83084756|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
46867319|NCT04150250|83084767|FG000|Overall Study|Lost to Follow-up|0|||
46867320|NCT04150250|83084768|FG001|Overall Study|Lost to Follow-up|2|||
46867321|NCT04537806|83084776|FG000|Overall Study|Randomized but not treated|1|||
46867322|NCT04537806|83084777|FG001|Overall Study|Randomized but not treated|0|||
46867323|NCT04537806|83084776|FG000|Overall Study|Adverse Event|1|||
46867324|NCT04537806|83084777|FG001|Overall Study|Adverse Event|1|||
46867325|NCT04015232|83084785|FG000|Overall Study|Withdrawal by Subject|7|||
46982857|NCT02336607|83229156|FG001|Overall Study|Lack of Efficacy|0|||
46982858|NCT02336607|83229157|FG002|Overall Study|Lack of Efficacy|0|||
46982859|NCT02336607|83229158|FG003|Overall Study|Lack of Efficacy|2|||
46867326|NCT04015232|83084786|FG001|Overall Study|Withdrawal by Subject|4|||
46867327|NCT04015232|83084785|FG000|Overall Study|Protocol Violation|1|||
46867328|NCT04015232|83084786|FG001|Overall Study|Protocol Violation|0|||
46867329|NCT04015232|83084785|FG000|Overall Study|Medical Grounds|3|||
46867330|NCT04015232|83084786|FG001|Overall Study|Medical Grounds|3|||
46867331|NCT04533204|83084798|FG000|Overall Study|Unable to understand training instructions|1|||
46867332|NCT04533204|83084799|FG001|Overall Study|Unable to understand training instructions|1|||
46982860|NCT02336607|83229155|FG000|Overall Study|Lost to Follow-up|2|||
46867333|NCT04465422|83084807|FG000|Overall Study|Lost to Follow-up|0|||
46867334|NCT04465422|83084808|FG001|Overall Study|Lost to Follow-up|2|||
46867335|NCT04014062|83084818|FG000|Period I: Dosing|Medical Grounds|4|||
46867336|NCT04014062|83084819|FG001|Period I: Dosing|Medical Grounds|5|||
46867337|NCT04014062|83084818|FG000|Period I: Dosing|Withdrawal by Subject|3|||
46867338|NCT04014062|83084819|FG001|Period I: Dosing|Withdrawal by Subject|1|||
46867339|NCT04531098|83084833|FG000|Stage I|Adverse Event|0|||
46867340|NCT04531098|83084834|FG001|Stage I|Adverse Event|0|||
46867341|NCT04531098|83084835|FG002|Stage I|Adverse Event|3|||
46867342|NCT04531098|83084833|FG000|Stage I|Protocol Violation|0|||
46867343|NCT04531098|83084834|FG001|Stage I|Protocol Violation|0|||
46867344|NCT04531098|83084835|FG002|Stage I|Protocol Violation|5|||
46867345|NCT04531098|83084833|FG000|Stage I|Withdrawal by Subject|0|||
46867346|NCT04531098|83084834|FG001|Stage I|Withdrawal by Subject|5|||
46867347|NCT04531098|83084835|FG002|Stage I|Withdrawal by Subject|10|||
46867348|NCT04531098|83084833|FG000|Stage II|Adverse Event|1|||
46867349|NCT04531098|83084834|FG001|Stage II|Adverse Event|2|||
46867350|NCT04531098|83084835|FG002|Stage II|Adverse Event|0|||
46867351|NCT04531098|83084833|FG000|Stage II|Protocol Violation|1|||
46867352|NCT04531098|83084834|FG001|Stage II|Protocol Violation|2|||
46867353|NCT04531098|83084835|FG002|Stage II|Protocol Violation|0|||
46867354|NCT04531098|83084833|FG000|Stage II|Withdrawal by Subject|3|||
46867355|NCT04531098|83084834|FG001|Stage II|Withdrawal by Subject|1|||
46867356|NCT04531098|83084835|FG002|Stage II|Withdrawal by Subject|0|||
46867357|NCT04531098|83084833|FG000|Stage II|Moved from study area|8|||
46867358|NCT04531098|83084834|FG001|Stage II|Moved from study area|5|||
46867359|NCT04531098|83084835|FG002|Stage II|Moved from study area|0|||
46867360|NCT04144166|83084843|FG000|Overall Study|Discharged before study start|1|||
46867361|NCT04144166|83084843|FG000|Overall Study|Pregnancy|1|||
46867362|NCT04144166|83084843|FG000|Overall Study|Nail polish could not be removed from finger|1|||
46867363|NCT04142450|83084852|FG000|Overall Study|Screen Failure|1|||
46867364|NCT04142450|83084852|FG000|Overall Study|Lost to Follow-up|1|||
46867365|NCT04529850|83084856|FG000|Overall Study|Death|2|||
46867366|NCT04529850|83084856|FG000|Overall Study|Physician Decision|1|||
46867367|NCT04529850|83084856|FG000|Overall Study|Withdrawal by Subject|2|||
46867368|NCT04225676|83084860|FG000|Overall Study|Physician Decision|1|||
46867369|NCT04225676|83084860|FG000|Overall Study|Lack of Efficacy|1|||
46867370|NCT04225676|83084860|FG000|Overall Study|Study terminated by sponsor|3|||
46867371|NCT04142216|83084868|FG000|Overall Study|Hospitalization|0|||
46867372|NCT04142216|83084869|FG001|Overall Study|Hospitalization|2|||
46867373|NCT04142216|83084868|FG000|Overall Study|Death|3|||
46867374|NCT04142216|83084869|FG001|Overall Study|Death|1|||
46867375|NCT04142216|83084868|FG000|Overall Study|Referral to another hemodialysis unit|3|||
46867376|NCT04142216|83084869|FG001|Overall Study|Referral to another hemodialysis unit|2|||
46867377|NCT04142216|83084868|FG000|Overall Study|Use of clove|0|||
46867378|NCT04142216|83084869|FG001|Overall Study|Use of clove|1|||
46867379|NCT04140890|83084877|FG000|Overall Study|Withdrawal by Subject|0|||
46867380|NCT04140890|83084878|FG001|Overall Study|Withdrawal by Subject|1|||
46867381|NCT03700320|83084889|FG000|Overall Study|Adverse Event|5|||
46867382|NCT03700320|83084890|FG001|Overall Study|Adverse Event|31|||
46867383|NCT03700320|83084889|FG000|Overall Study|Lack of Efficacy|2|||
46867384|NCT03700320|83084890|FG001|Overall Study|Lack of Efficacy|5|||
46867385|NCT03700320|83084889|FG000|Overall Study|Withdrawal by Subject|29|||
46867386|NCT03700320|83084890|FG001|Overall Study|Withdrawal by Subject|75|||
46867387|NCT03700320|83084889|FG000|Overall Study|Lost to Follow-up|16|||
46867388|NCT03700320|83084890|FG001|Overall Study|Lost to Follow-up|23|||
46867389|NCT03700320|83084889|FG000|Overall Study|Pregnancy|2|||
46867390|NCT03700320|83084890|FG001|Overall Study|Pregnancy|4|||
46867391|NCT03700320|83084889|FG000|Overall Study|Protocol Deviation|7|||
46867392|NCT03700320|83084890|FG001|Overall Study|Protocol Deviation|31|||
46867393|NCT03700320|83084889|FG000|Overall Study|Non-compliance with Study Drug|1|||
46867394|NCT03700320|83084890|FG001|Overall Study|Non-compliance with Study Drug|3|||
46867395|NCT03700320|83084889|FG000|Overall Study|Reason not Specified|0|||
46867396|NCT03700320|83084890|FG001|Overall Study|Reason not Specified|1|||
46867397|NCT04139018|83084898|FG000|Overall Study|Screen fail|1|||
46867398|NCT04139018|83084899|FG001|Overall Study|Screen fail|0|||
46867399|NCT04139018|83084898|FG000|Overall Study|Withdrawal by Subject|2|||
46867400|NCT04139018|83084899|FG001|Overall Study|Withdrawal by Subject|0|||
46867401|NCT04139018|83084898|FG000|Overall Study|Lost to Follow-up|0|||
46867402|NCT04139018|83084899|FG001|Overall Study|Lost to Follow-up|1|||
46867403|NCT04527978|83084907|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
46867404|NCT04527978|83084908|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
46867405|NCT04136444|83084919|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
46867406|NCT04136444|83084920|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
46867407|NCT04425252|83084934|FG000|Overall Study|Withdrawal by Subject|2|||
46867408|NCT04425252|83084935|FG001|Overall Study|Withdrawal by Subject|1|||
46867409|NCT04425252|83084934|FG000|Overall Study|Lost to Follow-up|1|||
46867410|NCT04425252|83084935|FG001|Overall Study|Lost to Follow-up|0|||
46982861|NCT02336607|83229156|FG001|Overall Study|Lost to Follow-up|1|||
46867411|NCT04425252|83084934|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
46867412|NCT04425252|83084935|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
46867413|NCT03696576|83084946|FG000|Overall Study|Soreness of throat after therapy|1|||
46867414|NCT03696576|83084947|FG001|Overall Study|Soreness of throat after therapy|1|||
46867415|NCT03696576|83084946|FG000|Overall Study|Lost to Follow-up|2|||
46867416|NCT03696576|83084947|FG001|Overall Study|Lost to Follow-up|4|||
46867417|NCT04003610|83084956|FG000|Overall Study|Lost to Follow-up|0|||
46867418|NCT04003610|83084957|FG001|Overall Study|Lost to Follow-up|1|||
46867419|NCT04003610|83084958|FG002|Overall Study|Lost to Follow-up|0|||
46867420|NCT04003610|83084956|FG000|Overall Study|Death|0|||
46867421|NCT04003610|83084957|FG001|Overall Study|Death|0|||
46867422|NCT04003610|83084958|FG002|Overall Study|Death|3|||
46867423|NCT04003610|83084956|FG000|Overall Study|Study Terminated by Sponsor|0|||
46867424|NCT04003610|83084957|FG001|Overall Study|Study Terminated by Sponsor|0|||
46867425|NCT04003610|83084958|FG002|Overall Study|Study Terminated by Sponsor|3|||
46867426|NCT03999554|83084972|FG000|Overall Study|Lost to Follow-up|4|||
46867427|NCT03999554|83084973|FG001|Overall Study|Lost to Follow-up|5|||
46867428|NCT03999554|83084974|FG002|Overall Study|Lost to Follow-up|4|||
46867429|NCT03999554|83084975|FG003|Overall Study|Lost to Follow-up|5|||
46867430|NCT03999554|83084976|FG004|Overall Study|Lost to Follow-up|8|||
46867431|NCT03999554|83084972|FG000|Overall Study|Protocol Violation|0|||
46867432|NCT03999554|83084973|FG001|Overall Study|Protocol Violation|0|||
46867433|NCT03999554|83084974|FG002|Overall Study|Protocol Violation|5|||
46867434|NCT03999554|83084975|FG003|Overall Study|Protocol Violation|0|||
46867435|NCT03999554|83084976|FG004|Overall Study|Protocol Violation|0|||
46867436|NCT03999554|83084972|FG000|Overall Study|Pregnancy|0|||
46867437|NCT03999554|83084973|FG001|Overall Study|Pregnancy|0|||
46867438|NCT03999554|83084974|FG002|Overall Study|Pregnancy|1|||
46867439|NCT03999554|83084975|FG003|Overall Study|Pregnancy|0|||
46867440|NCT03999554|83084976|FG004|Overall Study|Pregnancy|0|||
46867441|NCT03999554|83084972|FG000|Overall Study|Withdrawal by Subject|2|||
46867442|NCT03999554|83084973|FG001|Overall Study|Withdrawal by Subject|2|||
46867443|NCT03999554|83084974|FG002|Overall Study|Withdrawal by Subject|2|||
46867444|NCT03999554|83084975|FG003|Overall Study|Withdrawal by Subject|1|||
46867445|NCT03999554|83084976|FG004|Overall Study|Withdrawal by Subject|1|||
46867446|NCT03999554|83084972|FG000|Overall Study|failure to comply with protocol requirements|0|||
46867447|NCT03999554|83084973|FG001|Overall Study|failure to comply with protocol requirements|0|||
46867448|NCT03999554|83084974|FG002|Overall Study|failure to comply with protocol requirements|0|||
46867449|NCT03999554|83084975|FG003|Overall Study|failure to comply with protocol requirements|1|||
46867450|NCT03999554|83084976|FG004|Overall Study|failure to comply with protocol requirements|0|||
46867451|NCT04129346|83084991|FG000|Overall Study|Death|1|||
46867452|NCT04129346|83084992|FG001|Overall Study|Death|0|||
46867453|NCT04526574|83085000|FG000|Overall Study|Protocol Violation|3|||
46867454|NCT04526574|83085001|FG001|Overall Study|Protocol Violation|1|||
46867455|NCT04526574|83085000|FG000|Overall Study|Withdrawal by Subject|12|||
46867456|NCT04526574|83085001|FG001|Overall Study|Withdrawal by Subject|9|||
46867457|NCT04526574|83085000|FG000|Overall Study|Other|1|||
46867458|NCT04526574|83085001|FG001|Overall Study|Other|2|||
46867459|NCT04526574|83085000|FG000|Overall Study|Adverse Event|1|||
46867460|NCT04526574|83085001|FG001|Overall Study|Adverse Event|1|||
46867461|NCT04526574|83085000|FG000|Overall Study|Death|2|||
46867462|NCT04526574|83085001|FG001|Overall Study|Death|3|||
46867463|NCT04526574|83085000|FG000|Overall Study|Lost to Follow-up|9|||
46867464|NCT04526574|83085001|FG001|Overall Study|Lost to Follow-up|9|||
46867465|NCT04526574|83085000|FG000|Overall Study|No longer meets eligibility criteria|8|||
46867466|NCT04526574|83085001|FG001|Overall Study|No longer meets eligibility criteria|8|||
46867467|NCT03993392|83085011|FG000|Overall Study|Withdrawal by Subject|3|||
46982862|NCT02336607|83229157|FG002|Overall Study|Lost to Follow-up|0|||
46867468|NCT03993392|83085011|FG000|Overall Study|Lost to Follow-up|2|||
46867469|NCT03993392|83085011|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
46867470|NCT04422990|83085018|FG000|Overall Study|Withdrawal by Subject|0|||
46867471|NCT04422990|83085019|FG001|Overall Study|Withdrawal by Subject|1|||
46867472|NCT04422990|83085018|FG000|Overall Study|Travel|3|||
46867473|NCT04422990|83085019|FG001|Overall Study|Travel|0|||
46867474|NCT04377308|83085030|FG000|Overall Study|Withdrawal by Subject|0|||
46867475|NCT04377308|83085031|FG001|Overall Study|Withdrawal by Subject|1|||
46867476|NCT04447404|83085039|FG000|Overall Study|Death|2|||
46867477|NCT04447404|83085040|FG001|Overall Study|Death|0|||
46867478|NCT03988166|83085046|FG000|Overall Study|Lost to Follow-up|2|||
46867479|NCT03988166|83085046|FG000|Overall Study|Death|1|||
46867480|NCT03988088|83085055|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
46867481|NCT03988088|83085056|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
46867482|NCT03988088|83085057|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
46982863|NCT02336607|83229158|FG003|Overall Study|Lost to Follow-up|21|||
46867483|NCT03988088|83085058|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
46867484|NCT03988088|83085055|FG000|Open-Label Addendum|Lost to Follow-up|0|||
46867485|NCT03988088|83085056|FG001|Open-Label Addendum|Lost to Follow-up|0|||
46867486|NCT03988088|83085057|FG002|Open-Label Addendum|Lost to Follow-up|1|||
46867487|NCT03988088|83085058|FG003|Open-Label Addendum|Lost to Follow-up|0|||
46867488|NCT03987932|83085069|FG000|Overall Study|Lost to Follow-up|2|||
46867489|NCT03987932|83085070|FG001|Overall Study|Lost to Follow-up|1|||
46867490|NCT03987932|83085071|FG002|Overall Study|Lost to Follow-up|1|||
46867491|NCT03987932|83085069|FG000|Overall Study|Non-study related elective surgery|0|||
46867492|NCT03987932|83085070|FG001|Overall Study|Non-study related elective surgery|0|||
46867493|NCT03987932|83085071|FG002|Overall Study|Non-study related elective surgery|1|||
46867494|NCT03987620|83085081|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
46867495|NCT03987620|83085082|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
46867496|NCT03987620|83085081|FG000|Overall Study|Adverse Event|3|||
46867497|NCT03987620|83085082|FG001|Overall Study|Adverse Event|0|||
46867498|NCT03987620|83085081|FG000|Overall Study|Lost to Follow-up|1|||
46867499|NCT03987620|83085082|FG001|Overall Study|Lost to Follow-up|2|||
46867500|NCT03987620|83085081|FG000|Overall Study|Physician Decision|0|||
46867501|NCT03987620|83085082|FG001|Overall Study|Physician Decision|1|||
46867502|NCT03987620|83085081|FG000|Overall Study|Pregnancy|1|||
46867503|NCT03987620|83085082|FG001|Overall Study|Pregnancy|0|||
46867504|NCT03987620|83085081|FG000|Overall Study|Withdrawal by Subject|7|||
46867505|NCT03987620|83085082|FG001|Overall Study|Withdrawal by Subject|1|||
46867506|NCT03987620|83085081|FG000|Overall Study|Other|2|||
46867507|NCT03987620|83085082|FG001|Overall Study|Other|5|||
46867508|NCT04376060|83085088|FG000|Overall Study|Physician Decision|1|||
46867509|NCT04413552|83085102|FG000|Overall Study|Adverse Event|0|||
46867510|NCT04413552|83085103|FG001|Overall Study|Adverse Event|0|||
46867511|NCT04413552|83085104|FG002|Overall Study|Adverse Event|0|||
46867512|NCT04413552|83085105|FG003|Overall Study|Adverse Event|0|||
46867513|NCT04413552|83085106|FG004|Overall Study|Adverse Event|0|||
46867514|NCT04413552|83085107|FG005|Overall Study|Adverse Event|0|||
46867515|NCT04413552|83085108|FG006|Overall Study|Adverse Event|1|||
46867516|NCT04413552|83085109|FG007|Overall Study|Adverse Event|0|||
46867517|NCT04413552|83085110|FG008|Overall Study|Adverse Event|0|||
46867518|NCT04413552|83085111|FG009|Overall Study|Adverse Event|0|||
46867519|NCT03987074|83085142|FG000|Overall Study|Withdrew Consent|1|||
46867520|NCT03987074|83085143|FG001|Overall Study|Withdrew Consent|1|||
46867521|NCT03987074|83085144|FG002|Overall Study|Withdrew Consent|0|||
46867522|NCT03987074|83085145|FG003|Overall Study|Withdrew Consent|2|||
46867523|NCT03987074|83085146|FG004|Overall Study|Withdrew Consent|1|||
46867524|NCT03987074|83085142|FG000|Overall Study|Adverse Event|2|||
46867525|NCT03987074|83085143|FG001|Overall Study|Adverse Event|1|||
46867526|NCT03987074|83085144|FG002|Overall Study|Adverse Event|0|||
46867527|NCT03987074|83085145|FG003|Overall Study|Adverse Event|0|||
46867528|NCT03987074|83085146|FG004|Overall Study|Adverse Event|1|||
46867529|NCT03987074|83085142|FG000|Overall Study|Lost to Follow-up|0|||
46867530|NCT03987074|83085143|FG001|Overall Study|Lost to Follow-up|0|||
46867531|NCT03987074|83085144|FG002|Overall Study|Lost to Follow-up|1|||
46867532|NCT03987074|83085145|FG003|Overall Study|Lost to Follow-up|1|||
46867533|NCT03987074|83085146|FG004|Overall Study|Lost to Follow-up|0|||
46867534|NCT03987074|83085142|FG000|Overall Study|Investigator's Discretion|0|||
46867535|NCT03987074|83085143|FG001|Overall Study|Investigator's Discretion|0|||
46867536|NCT03987074|83085144|FG002|Overall Study|Investigator's Discretion|0|||
46867537|NCT03987074|83085145|FG003|Overall Study|Investigator's Discretion|1|||
46867538|NCT03987074|83085146|FG004|Overall Study|Investigator's Discretion|0|||
46867539|NCT04439214|83085158|FG000|Overall Study|Adverse Event|13|||
46867540|NCT04439214|83085158|FG000|Overall Study|Disease progression|16|||
46867541|NCT04439214|83085158|FG000|Overall Study|Death|1|||
46867542|NCT04439214|83085158|FG000|Overall Study|Withdrawal by Subject|2|||
46867543|NCT04439214|83085158|FG000|Overall Study|Declining health|1|||
46867544|NCT04439214|83085158|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
46867545|NCT04439214|83085158|FG000|Overall Study|Ineligible|5|||
46867546|NCT03696342|83085164|FG000|Overall Study|Lost to Follow-up|1|||
46867547|NCT03696342|83085165|FG001|Overall Study|Lost to Follow-up|0|||
46867548|NCT04411680|83085173|FG000|Treatment Period|Adverse Event|3|||
46867549|NCT04411680|83085174|FG001|Treatment Period|Adverse Event|0|||
46867550|NCT04411680|83085173|FG000|Treatment Period|Discharged from hospital|18|||
46867551|NCT04411680|83085174|FG001|Treatment Period|Discharged from hospital|7|||
46867552|NCT04411680|83085173|FG000|Treatment Period|Missed 1 or more doses|8|||
46867553|NCT04411680|83085174|FG001|Treatment Period|Missed 1 or more doses|0|||
46867554|NCT04411680|83085173|FG000|Treatment Period|Transferred to another hospital|0|||
46867555|NCT04411680|83085174|FG001|Treatment Period|Transferred to another hospital|1|||
46867556|NCT04411680|83085173|FG000|Follow up Period|Withdrawal by Subject|2|||
46867557|NCT04411680|83085174|FG001|Follow up Period|Withdrawal by Subject|0|||
46867558|NCT04411680|83085173|FG000|Follow up Period|Lost to Follow-up|5|||
46867559|NCT04411680|83085174|FG001|Follow up Period|Lost to Follow-up|6|||
46867560|NCT04411680|83085173|FG000|Follow up Period|Death|11|||
46867561|NCT04411680|83085174|FG001|Follow up Period|Death|8|||
46867562|NCT04410198|83085180|FG000|Overall Study|Death|10|||
46982864|NCT02336607|83229155|FG000|Overall Study|Protocol Violation|0|||
46867563|NCT04410198|83085180|FG000|Overall Study|Withdrawal by Subject|7|||
46867564|NCT04410198|83085180|FG000|Overall Study|Transferred/Relocation|4|||
46867565|NCT04410198|83085180|FG000|Overall Study|Kidney Transplant|9|||
46867566|NCT04410198|83085180|FG000|Overall Study|Adverse Event|4|||
46867567|NCT04410198|83085180|FG000|Overall Study|Physician Decision|2|||
46867568|NCT04410198|83085180|FG000|Overall Study|Other than specified|1|||
46867569|NCT04161144|83085186|FG000|Overall Study|Withdrawal by Subject|0|||
46867570|NCT04161144|83085187|FG001|Overall Study|Withdrawal by Subject|1|||
46867571|NCT04161144|83085186|FG000|Overall Study|Protocol Violation|1|||
46867572|NCT04161144|83085187|FG001|Overall Study|Protocol Violation|0|||
46867573|NCT03984812|83085204|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867574|NCT03984812|83085205|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867575|NCT03984812|83085206|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
46867576|NCT03984812|83085207|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867577|NCT03984812|83085208|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867578|NCT03984812|83085209|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867579|NCT03984812|83085210|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867580|NCT03984812|83085211|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867581|NCT03984812|83085212|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867582|NCT03984812|83085213|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867583|NCT03984812|83085214|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
46867584|NCT04160988|83085241|FG000|Overall Study|poor image quality|28|||
46867585|NCT04153188|83085262|FG000|Overall Study|Lost to Follow-up|1|||
46867586|NCT04153188|83085263|FG001|Overall Study|Lost to Follow-up|1|||
46867587|NCT04153188|83085262|FG000|Overall Study|Withdrawal by Subject|2|||
46867588|NCT04153188|83085263|FG001|Overall Study|Withdrawal by Subject|0|||
46867589|NCT04153188|83085262|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
46867590|NCT04153188|83085263|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
46867591|NCT04113746|83085271|FG000|Overall Study|Lost to Follow-up|4|||
46867592|NCT04113746|83085272|FG001|Overall Study|Lost to Follow-up|4|||
46867593|NCT03611010|83085282|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
46867594|NCT03611010|83085283|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
46867595|NCT03611010|83085284|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
46867596|NCT03611010|83085285|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
46867597|NCT04357782|83085300|FG000|Overall Study|Discharged from hospital|1|||
46867598|NCT04357782|83085301|FG001|Overall Study|Discharged from hospital|0|||
46867599|NCT04357782|83085300|FG000|Overall Study|Death|0|||
46867600|NCT04357782|83085301|FG001|Overall Study|Death|2|||
46867601|NCT03980522|83085312|FG000|Treatment Period|Adverse Event|1|||
46867602|NCT03980522|83085313|FG001|Treatment Period|Adverse Event|0|||
46867603|NCT03980522|83085314|FG002|Treatment Period|Adverse Event|0|||
46867604|NCT03980522|83085315|FG003|Treatment Period|Adverse Event|0|||
46867605|NCT03980522|83085316|FG004|Treatment Period|Adverse Event|0|||
46867606|NCT04402866|83085334|FG000|Overall Study|Discontinued Prior to Treatment|0|||
46867607|NCT04402866|83085335|FG001|Overall Study|Discontinued Prior to Treatment|0|||
46867608|NCT04402866|83085336|FG002|Overall Study|Discontinued Prior to Treatment|0|||
46867609|NCT04402866|83085337|FG003|Overall Study|Discontinued Prior to Treatment|0|||
46867610|NCT04402866|83085338|FG004|Overall Study|Discontinued Prior to Treatment|2|||
46867611|NCT04402866|83085339|FG005|Overall Study|Discontinued Prior to Treatment|3|||
46867612|NCT04402866|83085334|FG000|Overall Study|Adverse Event|2|||
46867613|NCT04402866|83085335|FG001|Overall Study|Adverse Event|1|||
46867614|NCT04402866|83085336|FG002|Overall Study|Adverse Event|0|||
46867615|NCT04402866|83085337|FG003|Overall Study|Adverse Event|0|||
46867616|NCT04402866|83085338|FG004|Overall Study|Adverse Event|13|||
46867617|NCT04402866|83085339|FG005|Overall Study|Adverse Event|8|||
46867618|NCT04402866|83085334|FG000|Overall Study|Miscellaneous|0|||
46867619|NCT04402866|83085335|FG001|Overall Study|Miscellaneous|0|||
46867620|NCT04402866|83085336|FG002|Overall Study|Miscellaneous|1|||
46867621|NCT04402866|83085337|FG003|Overall Study|Miscellaneous|0|||
46982865|NCT02336607|83229156|FG001|Overall Study|Protocol Violation|1|||
46982866|NCT02336607|83229157|FG002|Overall Study|Protocol Violation|1|||
46982867|NCT02336607|83229158|FG003|Overall Study|Protocol Violation|3|||
46982868|NCT02336607|83229155|FG000|Overall Study|Adverse Event|0|||
46867622|NCT04402866|83085338|FG004|Overall Study|Miscellaneous|0|||
46867623|NCT04402866|83085339|FG005|Overall Study|Miscellaneous|0|||
46982869|NCT02336607|83229156|FG001|Overall Study|Adverse Event|2|||
46867624|NCT04402866|83085334|FG000|Overall Study|Lost to Follow-up|0|||
46867625|NCT04402866|83085335|FG001|Overall Study|Lost to Follow-up|0|||
46867626|NCT04402866|83085336|FG002|Overall Study|Lost to Follow-up|0|||
46867627|NCT04402866|83085337|FG003|Overall Study|Lost to Follow-up|0|||
46867628|NCT04402866|83085338|FG004|Overall Study|Lost to Follow-up|0|||
46867629|NCT04402866|83085339|FG005|Overall Study|Lost to Follow-up|1|||
46867630|NCT04402866|83085334|FG000|Overall Study|Withdrawal by Subject|0|||
46867631|NCT04402866|83085335|FG001|Overall Study|Withdrawal by Subject|0|||
46867632|NCT04402866|83085336|FG002|Overall Study|Withdrawal by Subject|0|||
46982870|NCT02336607|83229157|FG002|Overall Study|Adverse Event|2|||
46867633|NCT04402866|83085337|FG003|Overall Study|Withdrawal by Subject|0|||
46867634|NCT04402866|83085338|FG004|Overall Study|Withdrawal by Subject|0|||
46867635|NCT04402866|83085339|FG005|Overall Study|Withdrawal by Subject|2|||
46867636|NCT04400682|83085351|FG000|Period 1|Withdrawal by Subject|1|||
46867637|NCT04400682|83085352|FG001|Period 1|Withdrawal by Subject|4|||
46867638|NCT03066778|83085360|FG000|Overall Study|Death|195|||
46867639|NCT03066778|83085361|FG001|Overall Study|Death|205|||
46867640|NCT03066778|83085360|FG000|Overall Study|Withdrawal by Subject|5|||
46867641|NCT03066778|83085361|FG001|Overall Study|Withdrawal by Subject|7|||
46867642|NCT04348656|83085370|FG000|Overall Study|Withdrawal by Subject|2|||
46867643|NCT04348656|83085371|FG001|Overall Study|Withdrawal by Subject|0|||
46867644|NCT04348656|83085370|FG000|Overall Study|Lost to Follow-up|11|||
46867645|NCT04348656|83085371|FG001|Overall Study|Lost to Follow-up|6|||
46867646|NCT04347954|83085387|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
46867647|NCT04347954|83085388|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
46867648|NCT04347954|83085389|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
46867649|NCT04347954|83085387|FG000|Overall Study|Lost to Follow-up|0|||
46867650|NCT04347954|83085388|FG001|Overall Study|Lost to Follow-up|1|||
46867651|NCT04347954|83085389|FG002|Overall Study|Lost to Follow-up|0|||
46867652|NCT03065530|83085401|FG000|Overall Study|Lack of Efficacy|1|||
46867653|NCT03065530|83085402|FG001|Overall Study|Lack of Efficacy|1|||
46867654|NCT03065530|83085403|FG002|Overall Study|Lack of Efficacy|0|||
46867655|NCT03065530|83085404|FG003|Overall Study|Lack of Efficacy|1|||
46867656|NCT03065530|83085401|FG000|Overall Study|Protocol Violation|1|||
46867657|NCT03065530|83085402|FG001|Overall Study|Protocol Violation|0|||
46867658|NCT03065530|83085403|FG002|Overall Study|Protocol Violation|1|||
46867659|NCT03065530|83085404|FG003|Overall Study|Protocol Violation|1|||
46867660|NCT03979820|83085426|FG000|Overall Study|Protocol Violation|1|||
46867661|NCT03979820|83085427|FG001|Overall Study|Protocol Violation|0|||
46867662|NCT03979820|83085428|FG002|Overall Study|Protocol Violation|0|||
46867663|NCT03979820|83085429|FG003|Overall Study|Protocol Violation|0|||
46867664|NCT03979820|83085426|FG000|Overall Study|Withdrawal by Subject|0|||
46867665|NCT03979820|83085427|FG001|Overall Study|Withdrawal by Subject|0|||
46867666|NCT03979820|83085428|FG002|Overall Study|Withdrawal by Subject|1|||
46867667|NCT03979820|83085429|FG003|Overall Study|Withdrawal by Subject|0|||
46867668|NCT03979820|83085426|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
46867669|NCT03979820|83085427|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
46867670|NCT03979820|83085428|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
46867671|NCT03979820|83085429|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
46867672|NCT03647488|83085446|FG000|Overall Study|Progressive disease|10|||
46867673|NCT03647488|83085447|FG001|Overall Study|Progressive disease|0|||
46867674|NCT03647488|83085448|FG002|Overall Study|Progressive disease|0|||
46867675|NCT03647488|83085446|FG000|Overall Study|Adverse Event|5|||
46867676|NCT03647488|83085447|FG001|Overall Study|Adverse Event|0|||
46867677|NCT03647488|83085448|FG002|Overall Study|Adverse Event|0|||
46867678|NCT03647488|83085446|FG000|Overall Study|Clinical progression|2|||
46867679|NCT03647488|83085447|FG001|Overall Study|Clinical progression|0|||
46867680|NCT03647488|83085448|FG002|Overall Study|Clinical progression|0|||
46867681|NCT03647488|83085446|FG000|Overall Study|Participant refused to take investigational product|1|||
46867682|NCT03647488|83085447|FG001|Overall Study|Participant refused to take investigational product|0|||
46867683|NCT03647488|83085448|FG002|Overall Study|Participant refused to take investigational product|0|||
46867684|NCT03693950|83085456|FG000|Overall Study|Withdrawal by Subject|1|||
46867685|NCT03693950|83085457|FG001|Overall Study|Withdrawal by Subject|0|||
46867686|NCT04110314|83085469|FG000|Overall Study|Did not meet inclusion criteria|35255|||
46867687|NCT04110314|83085470|FG001|Overall Study|Did not meet inclusion criteria|35104|||
46867688|NCT04110314|83085471|FG002|Overall Study|Did not meet inclusion criteria|35636|||
46982871|NCT02336607|83229158|FG003|Overall Study|Adverse Event|26|||
46982872|NCT02336607|83229155|FG000|Overall Study|Withdrawal by Subject|0|||
46982873|NCT02336607|83229156|FG001|Overall Study|Withdrawal by Subject|2|||
46982874|NCT02336607|83229157|FG002|Overall Study|Withdrawal by Subject|0|||
46867689|NCT04110314|83085472|FG003|Overall Study|Did not meet inclusion criteria|35135|||
46867690|NCT04110314|83085473|FG004|Overall Study|Did not meet inclusion criteria|35247|||
46867691|NCT04110314|83085474|FG005|Overall Study|Did not meet inclusion criteria|35727|||
46867692|NCT04098458|83085486|FG000|Overall Study|Death|1|||
46867693|NCT04098458|83085486|FG000|Overall Study|did not meet study inclusion criteria|3|||
46867694|NCT03447262|83085491|FG000|Overall Study|Adverse Event|7|||
46867695|NCT03447262|83085491|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
46867696|NCT03447262|83085491|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
46867697|NCT03447262|83085491|FG000|Overall Study|Death|2|||
46867698|NCT03447262|83085491|FG000|Overall Study|Study Termination by Sponsor|455|||
46867699|NCT03447262|83085491|FG000|Overall Study|Other|4|||
46867700|NCT04094870|83085500|FG000|Overall Study|Lost to Follow-up|1|||
46867701|NCT04094870|83085501|FG001|Overall Study|Lost to Follow-up|1|||
46867702|NCT04399356|83085516|FG000|Overall Study|Lost to Follow-up|1|||
46867703|NCT04399356|83085517|FG001|Overall Study|Lost to Follow-up|1|||
46867704|NCT04399356|83085516|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
46867705|NCT04399356|83085517|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
46867706|NCT04399356|83085516|FG000|Overall Study|Withdrawal by Subject|1|||
46867707|NCT04399356|83085517|FG001|Overall Study|Withdrawal by Subject|0|||
46867708|NCT03692676|83085527|FG000|Overall Study|exclude patients with prior use|4424|||
46867709|NCT03692676|83085528|FG001|Overall Study|exclude patients with prior use|24726|||
46867710|NCT03692676|83085529|FG002|Overall Study|exclude patients with prior use|0|||
46867711|NCT03692676|83085530|FG003|Overall Study|exclude patients with prior use|0|||
46867712|NCT03692676|83085527|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
46867713|NCT03692676|83085528|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
46867714|NCT03692676|83085529|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
46867715|NCT03692676|83085530|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
46867716|NCT03692676|83085527|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
46867717|NCT03692676|83085528|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
46867718|NCT03692676|83085529|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
46867719|NCT03692676|83085530|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
46867720|NCT03692676|83085527|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
46867721|NCT03692676|83085528|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
46867722|NCT03692676|83085529|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
46867723|NCT03692676|83085530|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
46867724|NCT03692676|83085527|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
46867725|NCT03692676|83085528|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
46867726|NCT03692676|83085529|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
46867727|NCT03692676|83085530|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
46867728|NCT03692676|83085527|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
46867729|NCT03692676|83085528|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
46867730|NCT03692676|83085529|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
46867731|NCT03692676|83085530|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
46867732|NCT03692676|83085527|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
46867733|NCT03692676|83085528|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
46867734|NCT03692676|83085529|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
46867735|NCT03692676|83085530|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
46867736|NCT03692676|83085527|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
46867737|NCT03692676|83085528|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
46867738|NCT03692676|83085529|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
46867739|NCT03692676|83085530|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
46867740|NCT03692676|83085527|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
46867741|NCT03692676|83085528|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
46867742|NCT03692676|83085529|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
46867743|NCT03692676|83085530|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
46867744|NCT03692676|83085527|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
46867745|NCT03692676|83085528|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
46867746|NCT03692676|83085529|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
46867747|NCT03692676|83085530|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
46867748|NCT03692676|83085527|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
46867749|NCT03692676|83085528|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
46867750|NCT03692676|83085529|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
46867751|NCT03692676|83085530|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
46867752|NCT03692676|83085527|FG000|Overall Study|Other|0|||
46867753|NCT03692676|83085528|FG001|Overall Study|Other|805|||
46982875|NCT02336607|83229158|FG003|Overall Study|Withdrawal by Subject|20|||
46982876|NCT02374671|83229171|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
46982877|NCT02374671|83229172|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
46867754|NCT03692676|83085529|FG002|Overall Study|Other|758|||
46867755|NCT03692676|83085530|FG003|Overall Study|Other|277|||
46867756|NCT03692676|83085527|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
46867757|NCT03692676|83085528|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
46867758|NCT03692676|83085529|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
46867759|NCT03692676|83085530|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
46867760|NCT04122534|83085540|FG000|Overall Study|Lost to Follow-up|4|||
46867761|NCT04091360|83085550|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867762|NCT04091360|83085551|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867763|NCT04091360|83085552|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867764|NCT04091360|83085553|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867765|NCT04091360|83085554|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867766|NCT04091360|83085555|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867767|NCT04091360|83085556|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867768|NCT04091360|83085557|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
46867769|NCT04091360|83085558|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
46867770|NCT04091360|83085559|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
46867771|NCT04091360|83085550|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867772|NCT04091360|83085551|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867773|NCT04091360|83085552|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867774|NCT04091360|83085553|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867775|NCT04091360|83085554|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867776|NCT04091360|83085555|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867777|NCT04091360|83085556|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
46867778|NCT04091360|83085557|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
46867779|NCT04091360|83085558|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867780|NCT04091360|83085559|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
46867781|NCT04091360|83085550|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867782|NCT04091360|83085551|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867783|NCT04091360|83085552|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867784|NCT04091360|83085553|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867785|NCT04091360|83085554|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867786|NCT04091360|83085555|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867787|NCT04091360|83085556|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
46867788|NCT04091360|83085557|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867789|NCT04091360|83085558|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
46867790|NCT04091360|83085559|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
46867791|NCT04346628|83085583|FG000|Overall Study|Lost to Follow-up|4|||
46867792|NCT04346628|83085584|FG001|Overall Study|Lost to Follow-up|4|||
46867793|NCT04346628|83085583|FG000|Overall Study|Withdrew (had personal reasons)|2|||
46867794|NCT04346628|83085584|FG001|Overall Study|Withdrew (had personal reasons)|5|||
46867795|NCT04346628|83085583|FG000|Overall Study|Withdrew (medication intolerant)|0|||
46867796|NCT04346628|83085584|FG001|Overall Study|Withdrew (medication intolerant)|3|||
46867797|NCT04346628|83085583|FG000|Overall Study|Withdrew (declined intervention)|0|||
46867798|NCT04346628|83085584|FG001|Overall Study|Withdrew (declined intervention)|1|||
46867799|NCT03681470|83085590|FG000|Overall Study|Lack of Efficacy|3|||
46867800|NCT03681470|83085590|FG000|Overall Study|Lost to Follow-up|1|||
46867801|NCT03681470|83085590|FG000|Overall Study|Protocol Violation|3|||
46867802|NCT03681470|83085590|FG000|Overall Study|Withdrawal by Subject|1|||
46867803|NCT04343976|83085596|FG000|Overall Study|Withdrawal by Subject|0|||
46867804|NCT04343976|83085597|FG001|Overall Study|Withdrawal by Subject|1|||
46867805|NCT03322540|83085605|FG000|Overall Study|Death|21|||
46867806|NCT03322540|83085606|FG001|Overall Study|Death|28|||
46867807|NCT03322540|83085605|FG000|Overall Study|Lost to Follow-up|0|||
46867808|NCT03322540|83085606|FG001|Overall Study|Lost to Follow-up|1|||
46867809|NCT03322540|83085605|FG000|Overall Study|Physician Decision|7|||
46867810|NCT03322540|83085606|FG001|Overall Study|Physician Decision|6|||
46867811|NCT03322540|83085605|FG000|Overall Study|Withdrawal by Subject|3|||
46867812|NCT03322540|83085606|FG001|Overall Study|Withdrawal by Subject|1|||
46867813|NCT03322540|83085605|FG000|Overall Study|Study terminated by sponsor|0|||
46867814|NCT03322540|83085606|FG001|Overall Study|Study terminated by sponsor|1|||
46867815|NCT04339296|83085616|FG000|Overall Study|Refuse to participate after allocation|1|||
46867816|NCT04339296|83085617|FG001|Overall Study|Refuse to participate after allocation|1|||
46867817|NCT04339296|83085616|FG000|Overall Study|Withdrew after completion of baseline|2|||
46867818|NCT04339296|83085617|FG001|Overall Study|Withdrew after completion of baseline|1|||
46867819|NCT04339296|83085616|FG000|Overall Study|Lost to Follow-up|0|||
46867820|NCT04339296|83085617|FG001|Overall Study|Lost to Follow-up|4|||
46867821|NCT04339296|83085616|FG000|Overall Study|Discontinued intervention|5|||
46867822|NCT04339296|83085617|FG001|Overall Study|Discontinued intervention|3|||
46867823|NCT02025556|83085626|FG000|Overall Study|Adverse Event|0|||
46867824|NCT02025556|83085627|FG001|Overall Study|Adverse Event|4|||
46867825|NCT02025556|83085628|FG002|Overall Study|Adverse Event|2|||
46867826|NCT02025556|83085626|FG000|Overall Study|Lack of Efficacy|2|||
46867827|NCT02025556|83085627|FG001|Overall Study|Lack of Efficacy|1|||
46867828|NCT02025556|83085628|FG002|Overall Study|Lack of Efficacy|0|||
46867829|NCT02025556|83085626|FG000|Overall Study|Protocol Violation|2|||
46867830|NCT02025556|83085627|FG001|Overall Study|Protocol Violation|1|||
46867831|NCT02025556|83085628|FG002|Overall Study|Protocol Violation|0|||
46867832|NCT02025556|83085626|FG000|Overall Study|Withdrawal by Subject|0|||
46867833|NCT02025556|83085627|FG001|Overall Study|Withdrawal by Subject|3|||
46867834|NCT02025556|83085628|FG002|Overall Study|Withdrawal by Subject|6|||
46867835|NCT02025556|83085626|FG000|Overall Study|Lost to Follow-up|2|||
46867836|NCT02025556|83085627|FG001|Overall Study|Lost to Follow-up|4|||
46867837|NCT02025556|83085628|FG002|Overall Study|Lost to Follow-up|0|||
46867838|NCT02025556|83085626|FG000|Overall Study|Reason not reported|0|||
46867839|NCT02025556|83085627|FG001|Overall Study|Reason not reported|0|||
46867840|NCT02025556|83085628|FG002|Overall Study|Reason not reported|1|||
46867841|NCT04334460|83085638|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
46867842|NCT04334460|83085639|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
46867843|NCT04334460|83085638|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
46867844|NCT04334460|83085639|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
46867845|NCT04334148|83085648|FG000|Overall Study|positive nasal swab at baseline|0|||
46867846|NCT04334148|83085649|FG001|Overall Study|positive nasal swab at baseline|1|||
46867847|NCT04399122|83085657|FG000|Overall Study|Lost to Follow-up|2|||
46867848|NCT04399122|83085658|FG001|Overall Study|Lost to Follow-up|0|||
46867849|NCT04399122|83085657|FG000|Overall Study|Withdrawal by Subject|1|||
46867850|NCT04399122|83085658|FG001|Overall Study|Withdrawal by Subject|0|||
46867851|NCT04398732|83085679|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
46867852|NCT04398030|83085685|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
46867853|NCT04398030|83085686|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
46867854|NCT04398030|83085685|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
46867855|NCT04398030|83085686|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
46867856|NCT03064438|83085694|FG000|Overall Study|Lost to Follow-up|1|||
46867857|NCT03064438|83085695|FG001|Overall Study|Lost to Follow-up|0|||
46867858|NCT03064438|83085694|FG000|Overall Study|Withdrawal by Subject|0|||
46867859|NCT03064438|83085695|FG001|Overall Study|Withdrawal by Subject|1|||
46867860|NCT04327986|83085701|FG000|Overall Study|Physician Decision|2|||
46867861|NCT04327986|83085702|FG001|Overall Study|Physician Decision|0|||
46867862|NCT04327986|83085703|FG002|Overall Study|Physician Decision|0|||
46867863|NCT04327986|83085701|FG000|Overall Study|Death|1|||
46867864|NCT04327986|83085702|FG001|Overall Study|Death|0|||
46867865|NCT04327986|83085703|FG002|Overall Study|Death|0|||
46867866|NCT04322682|83085709|FG000|Overall Study|Withdrawal by Subject|33|||
46867867|NCT04322682|83085710|FG001|Overall Study|Withdrawal by Subject|47|||
46867868|NCT04322682|83085709|FG000|Overall Study|Death|5|||
46867869|NCT04322682|83085710|FG001|Overall Study|Death|9|||
46867870|NCT04322682|83085709|FG000|Overall Study|Lost to Follow-up|4|||
46867871|NCT04322682|83085710|FG001|Overall Study|Lost to Follow-up|8|||
46867872|NCT04322682|83085709|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
46867873|NCT04322682|83085710|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
46867874|NCT04322526|83085718|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
46867875|NCT04322526|83085719|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
46867876|NCT04322526|83085718|FG000|Washout (1 Week)|Lost to Follow-up|1|||
46867877|NCT04322526|83085719|FG001|Washout (1 Week)|Lost to Follow-up|2|||
46867878|NCT04115358|83085728|FG000|Overall Study|exfoliation|0|||
46867879|NCT04115358|83085729|FG001|Overall Study|exfoliation|0|||
46867880|NCT04115358|83085730|FG002|Overall Study|exfoliation|1|||
46867881|NCT04109118|83085739|FG000|Overall Study|Lost to Follow-up|3|||
46867882|NCT04105998|83085746|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
46867883|NCT04105998|83085747|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
46867884|NCT04397718|83085755|FG000|Overall Study|Death|7|||
46867885|NCT04397718|83085756|FG001|Overall Study|Death|11|||
46867886|NCT04397718|83085755|FG000|Overall Study|Lost to Follow-up|0|||
46867887|NCT04397718|83085756|FG001|Overall Study|Lost to Follow-up|4|||
46867888|NCT04105218|83085764|FG000|Overall Study|Withdrawal by Subject|3|||
46867889|NCT04105218|83085765|FG001|Overall Study|Withdrawal by Subject|2|||
46867890|NCT04105218|83085764|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
46867891|NCT04105218|83085765|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
46867892|NCT04105218|83085764|FG000|Overall Study|Failed screening tests|2|||
46867893|NCT04105218|83085765|FG001|Overall Study|Failed screening tests|1|||
46982878|NCT02374671|83229173|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
46982879|NCT02374671|83229171|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
46982880|NCT02374671|83229172|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
46982881|NCT02374671|83229173|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
46982882|NCT02374671|83229171|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
46982883|NCT02374671|83229172|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
46982884|NCT02374671|83229173|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
46982885|NCT02374671|83229171|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
46982886|NCT02374671|83229172|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
46982887|NCT02374671|83229173|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
46982888|NCT02374671|83229171|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
46982889|NCT02374671|83229172|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
46982890|NCT02374671|83229173|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
46982891|NCT02569801|83229181|FG000|Overall Study|Withdrawal by Subject|9|||
46982892|NCT02569801|83229182|FG001|Overall Study|Withdrawal by Subject|9|||
46982893|NCT02569801|83229181|FG000|Overall Study|Sponsor Decision|13|||
46982894|NCT02569801|83229182|FG001|Overall Study|Sponsor Decision|14|||
46982895|NCT02569801|83229181|FG000|Overall Study|Progressive Disease|2|||
46698372|NCT00929695|82913377|FG001|Overall Study|Withdrawal by Subject|2|||
46698373|NCT00929695|82913376|FG000|Overall Study|discharge home|4|||
46698374|NCT00929695|82913377|FG001|Overall Study|discharge home|3|||
46698375|NCT00929695|82913376|FG000|Overall Study|incorrect stratification|2|||
46698376|NCT00929695|82913377|FG001|Overall Study|incorrect stratification|0|||
46698377|NCT00927355|82913390|FG000|Overall Study|Adverse Event|1|||
46867894|NCT04317690|83085776|FG000|Overall Study|did not have complete information for primary outcome|0|||
46867895|NCT04317690|83085777|FG001|Overall Study|did not have complete information for primary outcome|4|||
46867896|NCT04317690|83085778|FG002|Overall Study|did not have complete information for primary outcome|0|||
46867897|NCT04317690|83085779|FG003|Overall Study|did not have complete information for primary outcome|2|||
46867898|NCT04317690|83085780|FG004|Overall Study|did not have complete information for primary outcome|0|||
46867899|NCT03721276|83085807|FG000|Overall Study|Lost to Follow-up|5|||
46867900|NCT03721276|83085808|FG001|Overall Study|Lost to Follow-up|3|||
46867901|NCT03721276|83085807|FG000|Overall Study|Adverse Event|0|||
46867902|NCT03721276|83085808|FG001|Overall Study|Adverse Event|1|||
46867903|NCT03269344|83085823|FG000|Overall Study|Protocol Violation|4|||
46867904|NCT03269344|83085824|FG001|Overall Study|Protocol Violation|3|||
46867905|NCT04389840|83085836|FG000|Overall Study|Adverse Event|0|||
46867906|NCT04389840|83085837|FG001|Overall Study|Adverse Event|0|||
46867907|NCT04389840|83085838|FG002|Overall Study|Adverse Event|0|||
46867908|NCT04389840|83085839|FG003|Overall Study|Adverse Event|1|||
46867909|NCT04389840|83085840|FG004|Overall Study|Adverse Event|0|||
46867910|NCT04389840|83085841|FG005|Overall Study|Adverse Event|0|||
46867911|NCT04389840|83085836|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
46867912|NCT04389840|83085837|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
46867913|NCT04389840|83085838|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
46867914|NCT04389840|83085839|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
46867915|NCT04389840|83085840|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
46867916|NCT04389840|83085841|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
46867917|NCT04389840|83085836|FG000|Overall Study|Death|0|||
46867918|NCT04389840|83085837|FG001|Overall Study|Death|1|||
46867919|NCT04389840|83085838|FG002|Overall Study|Death|0|||
46867920|NCT04389840|83085839|FG003|Overall Study|Death|0|||
46867921|NCT04389840|83085840|FG004|Overall Study|Death|0|||
46867922|NCT04389840|83085841|FG005|Overall Study|Death|0|||
46867923|NCT04307940|83085864|FG000|Overall Study|Adverse Event|1|||
46867924|NCT04307940|83085865|FG001|Overall Study|Adverse Event|0|||
46867925|NCT04307940|83085866|FG002|Overall Study|Adverse Event|0|||
46867926|NCT04307940|83085864|FG000|Overall Study|Withdrawal by Subject|2|||
46867927|NCT04307940|83085865|FG001|Overall Study|Withdrawal by Subject|3|||
46698378|NCT00927355|82913391|FG001|Overall Study|Adverse Event|1|||
46698379|NCT00923845|82913411|FG000|Induction Therapy|Poor performance status|0|||
46698380|NCT00923845|82913412|FG001|Induction Therapy|Poor performance status|2|||
46867928|NCT04307940|83085866|FG002|Overall Study|Withdrawal by Subject|1|||
46867929|NCT04307940|83085864|FG000|Overall Study|Lost to Follow-up|2|||
46867930|NCT04307940|83085865|FG001|Overall Study|Lost to Follow-up|0|||
46867931|NCT04307940|83085866|FG002|Overall Study|Lost to Follow-up|1|||
46867932|NCT02054104|83085876|FG000|Overall Study|Did not want to continue due to college classes|1|||
46867933|NCT02054104|83085877|FG001|Overall Study|Did not want to continue due to college classes|0|||
46867934|NCT02054104|83085876|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
46867935|NCT02054104|83085877|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
46867936|NCT02054104|83085876|FG000|Overall Study|No evidence of immunologic response|2|||
46867937|NCT02054104|83085877|FG001|Overall Study|No evidence of immunologic response|2|||
46867938|NCT02054104|83085876|FG000|Overall Study|Disease Progression On Study|4|||
46867939|NCT02054104|83085877|FG001|Overall Study|Disease Progression On Study|5|||
46867940|NCT02054104|83085876|FG000|Overall Study|Diagnosis of lymphoma|0|||
46867941|NCT02054104|83085877|FG001|Overall Study|Diagnosis of lymphoma|1|||
46867942|NCT02054104|83085876|FG000|Overall Study|Inconclusive response|0|||
46867943|NCT02054104|83085877|FG001|Overall Study|Inconclusive response|1|||
46867944|NCT04090242|83085885|FG000|Overall Study|Withdrawal by Subject|1|||
46867945|NCT04090242|83085886|FG001|Overall Study|Withdrawal by Subject|0|||
46867946|NCT04090164|83085895|FG000|Overall Study|incomplete data on file|245|||
46867947|NCT04090164|83085896|FG001|Overall Study|incomplete data on file|0|||
46867948|NCT04292730|83085916|FG000|Overall Study|Lost to Follow-up|8|||
46867949|NCT04292730|83085917|FG001|Overall Study|Lost to Follow-up|12|||
46867950|NCT04292730|83085918|FG002|Overall Study|Lost to Follow-up|12|||
46867951|NCT04292730|83085919|FG003|Overall Study|Lost to Follow-up|48|||
46867952|NCT04292730|83085916|FG000|Overall Study|Death|2|||
46867953|NCT04292730|83085917|FG001|Overall Study|Death|2|||
46867954|NCT04292730|83085918|FG002|Overall Study|Death|4|||
46867955|NCT04292730|83085919|FG003|Overall Study|Death|12|||
46867956|NCT04292730|83085916|FG000|Overall Study|Withdrew Consent|2|||
46867957|NCT04292730|83085917|FG001|Overall Study|Withdrew Consent|2|||
46867958|NCT04292730|83085918|FG002|Overall Study|Withdrew Consent|5|||
46867959|NCT04292730|83085919|FG003|Overall Study|Withdrew Consent|6|||
46867960|NCT04292730|83085916|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46867961|NCT04292730|83085917|FG001|Overall Study|Non-Compliance with Study Drug|1|||
46867962|NCT04292730|83085918|FG002|Overall Study|Non-Compliance with Study Drug|0|||
46867963|NCT04292730|83085919|FG003|Overall Study|Non-Compliance with Study Drug|0|||
46867964|NCT04292730|83085916|FG000|Overall Study|Protocol Violation|0|||
46867965|NCT04292730|83085917|FG001|Overall Study|Protocol Violation|0|||
46867966|NCT04292730|83085918|FG002|Overall Study|Protocol Violation|1|||
46867967|NCT04292730|83085919|FG003|Overall Study|Protocol Violation|0|||
46867968|NCT04292730|83085916|FG000|Overall Study|Randomized but not Treated|8|||
46867969|NCT04292730|83085917|FG001|Overall Study|Randomized but not Treated|4|||
46867970|NCT04292730|83085918|FG002|Overall Study|Randomized but not Treated|0|||
46867971|NCT04292730|83085919|FG003|Overall Study|Randomized but not Treated|14|||
46867972|NCT02861014|83085928|FG000|Primary Analysis|Adverse Event|7|||
46867973|NCT02861014|83085928|FG000|Primary Analysis|Death|1|||
46867974|NCT02861014|83085928|FG000|Primary Analysis|Lack of Efficacy|3|||
46867975|NCT02861014|83085928|FG000|Primary Analysis|Physician Decision|2|||
46867976|NCT02861014|83085928|FG000|Primary Analysis|Pregnancy|4|||
46867977|NCT02861014|83085928|FG000|Primary Analysis|Protocol Violation|2|||
46867978|NCT02861014|83085928|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
46867979|NCT02861014|83085928|FG000|Primary Analysis|Withdrawal by Subject|14|||
46867980|NCT02861014|83085928|FG000|Primary Analysis|Commercial ocrelizumab|3|||
46867981|NCT02861014|83085928|FG000|Safety Follow-up|Adverse Event|1|||
46867982|NCT02861014|83085928|FG000|Safety Follow-up|Pregnancy|1|||
46867983|NCT02861014|83085928|FG000|Safety Follow-up|Withdrawal by Subject|9|||
46867984|NCT02861014|83085928|FG000|Safety Follow-up|Study terminated by sponsor|1|||
46867985|NCT02861014|83085928|FG000|Safety Follow-up|Physician Decision|1|||
46867986|NCT02861014|83085928|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
46867987|NCT02861014|83085928|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
46867988|NCT04382586|83085936|FG000|Overall Study|Death|3|||
46867989|NCT04382586|83085937|FG001|Overall Study|Death|4|||
46867990|NCT04382586|83085936|FG000|Overall Study|Lost to Follow-up|11|||
46867991|NCT04382586|83085937|FG001|Overall Study|Lost to Follow-up|8|||
46867992|NCT04382586|83085936|FG000|Overall Study|Withdrawal by Subject|3|||
46867993|NCT04382586|83085937|FG001|Overall Study|Withdrawal by Subject|1|||
46867994|NCT04382586|83085936|FG000|Overall Study|Physician Decision|0|||
46867995|NCT04382586|83085937|FG001|Overall Study|Physician Decision|3|||
46867996|NCT04480710|83085947|FG000|Overall Study|Adverse Event|0|||
46867997|NCT04480710|83085948|FG001|Overall Study|Adverse Event|2|||
46867998|NCT04480710|83085949|FG002|Overall Study|Adverse Event|0|||
46867999|NCT04480710|83085950|FG003|Overall Study|Adverse Event|0|||
46868000|NCT04480710|83085947|FG000|Overall Study|Withdrawal by Subject|0|||
46868001|NCT04480710|83085948|FG001|Overall Study|Withdrawal by Subject|1|||
46868002|NCT04480710|83085949|FG002|Overall Study|Withdrawal by Subject|0|||
46868003|NCT04480710|83085950|FG003|Overall Study|Withdrawal by Subject|0|||
46868004|NCT04480710|83085947|FG000|Overall Study|Physician Decision|0|||
46868005|NCT04480710|83085948|FG001|Overall Study|Physician Decision|0|||
46868006|NCT04480710|83085949|FG002|Overall Study|Physician Decision|1|||
46868007|NCT04480710|83085950|FG003|Overall Study|Physician Decision|0|||
46868008|NCT04268316|83085969|FG000|Overall Study|Withdrawal by Subject|2|||
46868009|NCT04268316|83085970|FG001|Overall Study|Withdrawal by Subject|1|||
46868010|NCT04268316|83085971|FG002|Overall Study|Withdrawal by Subject|0|||
46868011|NCT01971970|83085981|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
46868012|NCT01971970|83085982|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
46868013|NCT01971970|83085981|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
46868014|NCT01971970|83085982|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
46868015|NCT01971970|83085981|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
46868016|NCT01971970|83085982|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
46868017|NCT01971970|83085981|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
46868018|NCT01971970|83085982|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
46868019|NCT01971970|83085981|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
46868020|NCT01971970|83085982|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
46868021|NCT01971970|83085981|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
46868022|NCT01971970|83085982|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
46868023|NCT01971970|83085981|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
46868024|NCT01971970|83085982|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
46868025|NCT04079790|83085997|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
46868026|NCT04079790|83085998|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
46868027|NCT04079790|83085999|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
46868028|NCT04079790|83086000|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
46868029|NCT04079790|83085997|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
46868030|NCT04079790|83085998|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
46868031|NCT04079790|83085999|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
46868032|NCT04079790|83086000|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
46868033|NCT04079790|83085997|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
46868034|NCT04079790|83085998|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
46868035|NCT04079790|83085999|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
46868036|NCT04079790|83086000|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
46868037|NCT04259346|83086028|FG000|Overall Study|Lost to Follow-up|1|||
46868038|NCT04259346|83086029|FG001|Overall Study|Lost to Follow-up|3|||
46868039|NCT04259346|83086028|FG000|Overall Study|Protocol Violation|1|||
46868040|NCT04259346|83086029|FG001|Overall Study|Protocol Violation|0|||
46868041|NCT04259346|83086028|FG000|Overall Study|Withdrawal by Subject|1|||
46868042|NCT04259346|83086029|FG001|Overall Study|Withdrawal by Subject|0|||
46868043|NCT04259346|83086028|FG000|Overall Study|Adverse Event|1|||
46868044|NCT04259346|83086029|FG001|Overall Study|Adverse Event|1|||
46868045|NCT04230876|83086037|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
46868046|NCT04230876|83086038|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
46868047|NCT04228302|83086050|FG000|Overall Study|Adverse Event|0|||
46868048|NCT04228302|83086051|FG001|Overall Study|Adverse Event|0|||
46868049|NCT04228302|83086052|FG002|Overall Study|Adverse Event|0|||
46868050|NCT04228302|83086053|FG003|Overall Study|Adverse Event|0|||
46868051|NCT04228302|83086054|FG004|Overall Study|Adverse Event|1|||
46868052|NCT04228302|83086055|FG005|Overall Study|Adverse Event|0|||
46868053|NCT01348100|83086076|FG000|Overall Study|Subject Withdrew Consent|0|||
46868054|NCT01348100|83086077|FG001|Overall Study|Subject Withdrew Consent|0|||
46868055|NCT01348100|83086078|FG002|Overall Study|Subject Withdrew Consent|2|||
46868056|NCT01348100|83086079|FG003|Overall Study|Subject Withdrew Consent|0|||
46868057|NCT01348100|83086080|FG004|Overall Study|Subject Withdrew Consent|1|||
46868058|NCT01348100|83086081|FG005|Overall Study|Subject Withdrew Consent|0|||
46868059|NCT01348100|83086082|FG006|Overall Study|Subject Withdrew Consent|1|||
46868060|NCT01348100|83086076|FG000|Overall Study|Protocol Deviation|0|||
46868061|NCT01348100|83086077|FG001|Overall Study|Protocol Deviation|0|||
46868062|NCT01348100|83086078|FG002|Overall Study|Protocol Deviation|0|||
46868063|NCT01348100|83086079|FG003|Overall Study|Protocol Deviation|1|||
46868064|NCT01348100|83086080|FG004|Overall Study|Protocol Deviation|0|||
46868065|NCT01348100|83086081|FG005|Overall Study|Protocol Deviation|0|||
46868066|NCT01348100|83086082|FG006|Overall Study|Protocol Deviation|0|||
46868067|NCT01348100|83086076|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46868068|NCT01348100|83086077|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46868069|NCT01348100|83086078|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46868070|NCT01348100|83086079|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46868071|NCT01348100|83086080|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46868072|NCT01348100|83086081|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
46868073|NCT01348100|83086082|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
46868074|NCT01348100|83086076|FG000|Overall Study|Lost to Follow-up|0|||
46868075|NCT01348100|83086077|FG001|Overall Study|Lost to Follow-up|0|||
46868076|NCT01348100|83086078|FG002|Overall Study|Lost to Follow-up|0|||
46868077|NCT01348100|83086079|FG003|Overall Study|Lost to Follow-up|0|||
46868078|NCT01348100|83086080|FG004|Overall Study|Lost to Follow-up|0|||
46868079|NCT01348100|83086081|FG005|Overall Study|Lost to Follow-up|0|||
46868080|NCT01348100|83086082|FG006|Overall Study|Lost to Follow-up|1|||
46868081|NCT01348100|83086076|FG000|Overall Study|Administrative Problems|0|||
46868082|NCT01348100|83086077|FG001|Overall Study|Administrative Problems|0|||
46868083|NCT01348100|83086078|FG002|Overall Study|Administrative Problems|0|||
46868084|NCT01348100|83086079|FG003|Overall Study|Administrative Problems|0|||
46868085|NCT01348100|83086080|FG004|Overall Study|Administrative Problems|0|||
46868086|NCT01348100|83086081|FG005|Overall Study|Administrative Problems|1|||
46868087|NCT01348100|83086082|FG006|Overall Study|Administrative Problems|1|||
46868088|NCT03676634|83086103|FG000|Overall Study|Red blood cell loss|1|||
46868089|NCT03676634|83086103|FG000|Overall Study|Out-of-limit pulse|2|||
46868090|NCT03675776|83086110|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
46868091|NCT03675776|83086111|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
46868092|NCT03675776|83086112|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
46868093|NCT03675776|83086110|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
46868094|NCT03675776|83086111|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
46868095|NCT03675776|83086112|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
46868096|NCT03673670|83086126|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
46868097|NCT03673670|83086127|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
46868098|NCT03673670|83086128|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
46868099|NCT03673670|83086129|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
46868100|NCT03673670|83086130|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
46868101|NCT03673670|83086131|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
46868102|NCT03673670|83086126|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
46868103|NCT03673670|83086127|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
46868104|NCT03673670|83086128|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
46868105|NCT03673670|83086129|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
46868106|NCT03673670|83086130|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
46868107|NCT03673670|83086131|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
46868108|NCT03673670|83086126|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
46868109|NCT03673670|83086127|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
46868110|NCT03673670|83086128|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
46868111|NCT03673670|83086129|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
46868112|NCT03673670|83086130|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
46868113|NCT03673670|83086131|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
46868114|NCT03673670|83086126|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
46868115|NCT03673670|83086127|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
46868116|NCT03673670|83086128|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
46868117|NCT03673670|83086129|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
46868118|NCT03673670|83086130|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
46868119|NCT03673670|83086131|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
46868120|NCT03673670|83086126|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
46868121|NCT03673670|83086127|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
46868122|NCT03673670|83086128|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
46868123|NCT03673670|83086129|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
46868124|NCT03673670|83086130|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
46868125|NCT03673670|83086131|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
46868126|NCT03673670|83086126|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
46982896|NCT02569801|83229182|FG001|Overall Study|Progressive Disease|7|||
46868127|NCT03673670|83086127|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
46868128|NCT03673670|83086128|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
46982897|NCT02569801|83229181|FG000|Overall Study|Lost to Follow-up|0|||
46982898|NCT02569801|83229182|FG001|Overall Study|Lost to Follow-up|1|||
46982899|NCT02569801|83229181|FG000|Overall Study|Death|12|||
46982900|NCT02569801|83229182|FG001|Overall Study|Death|4|||
46982901|NCT02573311|83229190|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
46982902|NCT02573311|83229191|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
46982903|NCT02573311|83229190|FG000|Disposition for Part 2|Physician Decision|25|||
46982904|NCT02573311|83229191|FG001|Disposition for Part 2|Physician Decision|7|||
46982905|NCT02573311|83229190|FG000|Disposition for Part 2|Adverse Event|36|||
46982906|NCT02573311|83229191|FG001|Disposition for Part 2|Adverse Event|5|||
46982907|NCT02573311|83229190|FG000|Disposition for Part 2|Lost to Follow-up|76|||
46982908|NCT02573311|83229191|FG001|Disposition for Part 2|Lost to Follow-up|7|||
46982909|NCT02573311|83229190|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
46982910|NCT02573311|83229191|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
46982911|NCT02573311|83229190|FG000|Disposition for Part 2|Investigator decision|0|||
46982912|NCT02573311|83229191|FG001|Disposition for Part 2|Investigator decision|1|||
46982913|NCT02573311|83229190|FG000|Disposition for Part 2|Other than specified above|13|||
46982914|NCT02573311|83229191|FG001|Disposition for Part 2|Other than specified above|3|||
46982915|NCT02571049|83229197|FG000|Screening|Did not meet entry criteria|2|||
46982916|NCT02571049|83229198|FG001|Screening|Did not meet entry criteria|2|||
46982917|NCT02571049|83229197|FG000|Randomization|No migraine attack|0|||
46982918|NCT02571049|83229198|FG001|Randomization|No migraine attack|1|||
46982919|NCT02571049|83229197|FG000|Randomization|Adverse Event|0|||
46982920|NCT02571049|83229198|FG001|Randomization|Adverse Event|1|||
46982921|NCT02573155|83229206|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
46982922|NCT02573155|83229207|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
46982923|NCT02573155|83229206|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
46982924|NCT02573155|83229207|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
46982925|NCT02573155|83229206|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
46982926|NCT02573155|83229207|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
46982927|NCT02573155|83229206|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
46982928|NCT02573155|83229207|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
46982929|NCT02573155|83229206|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
46982930|NCT02573155|83229207|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
46982931|NCT02573155|83229206|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
46982932|NCT02573155|83229207|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
46982933|NCT02573155|83229206|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
46982934|NCT02573155|83229207|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
46982935|NCT02573155|83229206|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
46982936|NCT02573155|83229207|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
46982937|NCT02568475|83229235|FG000|Overall Study|Lost to Follow-up|40|||
46982938|NCT02568475|83229236|FG001|Overall Study|Lost to Follow-up|39|||
46982939|NCT02568475|83229235|FG000|Overall Study|Withdrawal by Subject|2|||
46982940|NCT02568475|83229236|FG001|Overall Study|Withdrawal by Subject|0|||
46868129|NCT03673670|83086129|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
46868130|NCT03673670|83086130|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
46868131|NCT03673670|83086131|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
46868132|NCT03673670|83086126|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
46982941|NCT02568475|83229235|FG000|Overall Study|Discharged home|4|||
46982942|NCT02568475|83229236|FG001|Overall Study|Discharged home|4|||
46982943|NCT02568475|83229235|FG000|Overall Study|Short-term: Discharge location unknown|4|||
46982944|NCT02568475|83229236|FG001|Overall Study|Short-term: Discharge location unknown|0|||
46982945|NCT02568475|83229235|FG000|Overall Study|Transferred to another facility|1|||
46982946|NCT02568475|83229236|FG001|Overall Study|Transferred to another facility|0|||
46982947|NCT02568397|83229242|FG000|Period 2|Withdrawal by Subject|0|||
46982948|NCT02568397|83229243|FG001|Period 2|Withdrawal by Subject|1|||
46982949|NCT02568397|83229242|FG000|Period 2|Physician Decision|0|||
46982950|NCT02568397|83229243|FG001|Period 2|Physician Decision|1|||
46982951|NCT02566525|83229260|FG000|Overall Study|Protocol Violation|3|||
46982952|NCT02566525|83229261|FG001|Overall Study|Protocol Violation|5|||
46982953|NCT02336451|83229274|FG000|Overall Study|Adverse Event|1|||
46982954|NCT02336451|83229275|FG001|Overall Study|Adverse Event|2|||
46982955|NCT02336451|83229276|FG002|Overall Study|Adverse Event|0|||
46982956|NCT02336451|83229277|FG003|Overall Study|Adverse Event|6|||
46982957|NCT02336451|83229278|FG004|Overall Study|Adverse Event|4|||
46982958|NCT02336451|83229274|FG000|Overall Study|Death|6|||
46982959|NCT02336451|83229275|FG001|Overall Study|Death|2|||
46982960|NCT02336451|83229276|FG002|Overall Study|Death|3|||
46982961|NCT02336451|83229277|FG003|Overall Study|Death|6|||
46982962|NCT02336451|83229278|FG004|Overall Study|Death|6|||
46982963|NCT02336451|83229274|FG000|Overall Study|Physician Decision|9|||
46982964|NCT02336451|83229275|FG001|Overall Study|Physician Decision|6|||
46982965|NCT02336451|83229276|FG002|Overall Study|Physician Decision|7|||
46982966|NCT02336451|83229277|FG003|Overall Study|Physician Decision|16|||
46982967|NCT02336451|83229278|FG004|Overall Study|Physician Decision|3|||
46982968|NCT02336451|83229274|FG000|Overall Study|Progressive disease|23|||
46982969|NCT02336451|83229275|FG001|Overall Study|Progressive disease|26|||
46982970|NCT02336451|83229276|FG002|Overall Study|Progressive disease|2|||
46982971|NCT02336451|83229277|FG003|Overall Study|Progressive disease|14|||
46982972|NCT02336451|83229278|FG004|Overall Study|Progressive disease|4|||
46982973|NCT02336451|83229274|FG000|Overall Study|Protocol Violation|1|||
46982974|NCT02336451|83229275|FG001|Overall Study|Protocol Violation|0|||
46698381|NCT00922987|82913419|FG000|Overall Study|Insufficient clinical response|1|||
46868133|NCT03673670|83086127|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
46868134|NCT03673670|83086128|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
46868135|NCT03673670|83086129|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
46868136|NCT03673670|83086130|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
46868137|NCT03673670|83086131|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
46868138|NCT04369742|83086150|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
46868139|NCT04369742|83086151|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
46868140|NCT04369742|83086150|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
46868141|NCT04369742|83086151|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
46868142|NCT04369430|83086159|FG000|Overall Study|Adverse Event|2|||
46868143|NCT04369430|83086160|FG001|Overall Study|Adverse Event|3|||
46868144|NCT04369430|83086159|FG000|Overall Study|Death|1|||
46868145|NCT04369430|83086160|FG001|Overall Study|Death|0|||
46868146|NCT04369430|83086159|FG000|Overall Study|Withdrawal by Subject|4|||
46868147|NCT04369430|83086160|FG001|Overall Study|Withdrawal by Subject|3|||
46868148|NCT04369430|83086159|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
46868149|NCT04369430|83086160|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
46868150|NCT04369430|83086159|FG000|Overall Study|Lost to Follow-up|0|||
46868151|NCT04369430|83086160|FG001|Overall Study|Lost to Follow-up|1|||
46868152|NCT04363736|83086168|FG000|Overall Study|Withdrawal by Subject|1|||
46982975|NCT02336451|83229276|FG002|Overall Study|Protocol Violation|0|||
46868153|NCT04363736|83086169|FG001|Overall Study|Withdrawal by Subject|0|||
46868154|NCT04363736|83086168|FG000|Overall Study|Lost to Follow-up|10|||
46868155|NCT04363736|83086169|FG001|Overall Study|Lost to Follow-up|7|||
46868156|NCT04363736|83086168|FG000|Overall Study|Death|8|||
46868157|NCT04363736|83086169|FG001|Overall Study|Death|6|||
46868158|NCT04362176|83086177|FG000|Overall Study|Lost to Follow-up|5|||
46868159|NCT04362176|83086178|FG001|Overall Study|Lost to Follow-up|8|||
46868160|NCT04362176|83086177|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
46868161|NCT04362176|83086178|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
46868162|NCT04079816|83086184|FG000|Overall Study|Request of Subject|2|||
46868163|NCT04079816|83086184|FG000|Overall Study|Unable to draw samples|1|||
46868164|NCT04079114|83086188|FG000|Overall Study|Study prematuely terminated.|166|||
46868165|NCT03055936|83086196|FG000|Overall Study|Adverse Event|0|||
46868166|NCT03055936|83086197|FG001|Overall Study|Adverse Event|1|||
46868167|NCT03055936|83086198|FG002|Overall Study|Adverse Event|1|||
46868168|NCT03055936|83086199|FG003|Overall Study|Adverse Event|1|||
46868169|NCT03055936|83086196|FG000|Overall Study|Personal reason|2|||
46868170|NCT03055936|83086197|FG001|Overall Study|Personal reason|0|||
46868171|NCT03055936|83086198|FG002|Overall Study|Personal reason|1|||
46868172|NCT03055936|83086199|FG003|Overall Study|Personal reason|0|||
46868173|NCT03891524|83086241|FG000|Overall Study|Death|0|||
46868174|NCT03891524|83086242|FG001|Overall Study|Death|0|||
46868175|NCT03891524|83086243|FG002|Overall Study|Death|0|||
46868176|NCT03891524|83086244|FG003|Overall Study|Death|0|||
46868177|NCT03891524|83086245|FG004|Overall Study|Death|0|||
46868178|NCT03891524|83086246|FG005|Overall Study|Death|0|||
46868179|NCT03891524|83086247|FG006|Overall Study|Death|0|||
46868180|NCT03891524|83086248|FG007|Overall Study|Death|1|||
46868181|NCT03891524|83086241|FG000|Overall Study|Withdrawal by Subject|0|||
46868182|NCT03891524|83086242|FG001|Overall Study|Withdrawal by Subject|1|||
46868183|NCT03891524|83086243|FG002|Overall Study|Withdrawal by Subject|2|||
46868184|NCT03891524|83086244|FG003|Overall Study|Withdrawal by Subject|1|||
46868185|NCT03891524|83086245|FG004|Overall Study|Withdrawal by Subject|2|||
46868186|NCT03891524|83086246|FG005|Overall Study|Withdrawal by Subject|2|||
46868187|NCT03891524|83086247|FG006|Overall Study|Withdrawal by Subject|2|||
46868188|NCT03891524|83086248|FG007|Overall Study|Withdrawal by Subject|1|||
46868189|NCT03055624|83086283|FG000|Overall Study|Study closed|9|||
46868190|NCT01346176|83086290|FG000|Recruited|Protocol Violation|1|||
46868191|NCT01346176|83086291|FG001|Recruited|Protocol Violation|0|||
46868192|NCT01346176|83086292|FG002|Recruited|Protocol Violation|0|||
46868193|NCT01346176|83086290|FG000|Completed Advance Directive|Death|3|||
46868194|NCT01346176|83086291|FG001|Completed Advance Directive|Death|2|||
46868195|NCT01346176|83086292|FG002|Completed Advance Directive|Death|2|||
46868196|NCT01346176|83086290|FG000|Completed Advance Directive|Became Ineligible|3|||
46868197|NCT01346176|83086291|FG001|Completed Advance Directive|Became Ineligible|0|||
46868198|NCT01346176|83086292|FG002|Completed Advance Directive|Became Ineligible|1|||
46868199|NCT01346176|83086290|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
46868200|NCT01346176|83086291|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
46868201|NCT01346176|83086292|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
46868202|NCT01346176|83086290|FG000|Completed Satisfaction Survey|Death|3|||
46868203|NCT01346176|83086291|FG001|Completed Satisfaction Survey|Death|0|||
46868204|NCT01346176|83086292|FG002|Completed Satisfaction Survey|Death|2|||
46868205|NCT01346176|83086290|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
46868206|NCT01346176|83086291|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
46868207|NCT01346176|83086292|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
46868208|NCT04075604|83086303|FG000|Overall Study|Adverse Event|0|||
46868209|NCT04075604|83086304|FG001|Overall Study|Adverse Event|0|||
46868210|NCT04075604|83086305|FG002|Overall Study|Adverse Event|3|||
46868211|NCT04075604|83086303|FG000|Overall Study|Participant request to discontinue study treatment|0|||
46868212|NCT04075604|83086304|FG001|Overall Study|Participant request to discontinue study treatment|0|||
46868213|NCT04075604|83086305|FG002|Overall Study|Participant request to discontinue study treatment|1|||
46868214|NCT04075604|83086303|FG000|Overall Study|Participant withdrew consent|0|||
46868215|NCT04075604|83086304|FG001|Overall Study|Participant withdrew consent|0|||
46868216|NCT04075604|83086305|FG002|Overall Study|Participant withdrew consent|1|||
46868217|NCT04075604|83086303|FG000|Overall Study|Other reasons|1|||
46868218|NCT04075604|83086304|FG001|Overall Study|Other reasons|0|||
46868219|NCT04075604|83086305|FG002|Overall Study|Other reasons|0|||
46868220|NCT04075604|83086303|FG000|Overall Study|Disease progression|0|||
46868221|NCT04075604|83086304|FG001|Overall Study|Disease progression|1|||
46868222|NCT04075604|83086305|FG002|Overall Study|Disease progression|0|||
46868223|NCT04075604|83086303|FG000|Overall Study|Study drug toxicity|0|||
46982976|NCT02336451|83229277|FG003|Overall Study|Protocol Violation|0|||
46982977|NCT02336451|83229278|FG004|Overall Study|Protocol Violation|0|||
46868224|NCT04075604|83086304|FG001|Overall Study|Study drug toxicity|5|||
46982978|NCT02336451|83229274|FG000|Overall Study|Patient/guardian decision|2|||
46868225|NCT04075604|83086305|FG002|Overall Study|Study drug toxicity|1|||
46868226|NCT03796208|83086315|FG000|Overall Study|Withdrawal by Subject|3|||
46868227|NCT03796208|83086316|FG001|Overall Study|Withdrawal by Subject|0|||
46868228|NCT03796208|83086315|FG000|Overall Study|Loss of pregnancy|1|||
46868229|NCT03796208|83086316|FG001|Overall Study|Loss of pregnancy|1|||
46982979|NCT02336451|83229275|FG001|Overall Study|Patient/guardian decision|4|||
46982980|NCT02336451|83229276|FG002|Overall Study|Patient/guardian decision|0|||
46982981|NCT02336451|83229277|FG003|Overall Study|Patient/guardian decision|2|||
46982982|NCT02336451|83229278|FG004|Overall Study|Patient/guardian decision|1|||
46982983|NCT02374593|83229294|FG000|Overall Study|non-compliant|2|||
46982984|NCT02374593|83229295|FG001|Overall Study|non-compliant|0|||
46982985|NCT01648101|83229308|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
46982986|NCT01648101|83229309|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
46982987|NCT01648101|83229310|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
46982988|NCT01648101|83229308|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
46982989|NCT01648101|83229309|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
46982990|NCT01648101|83229310|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
46982991|NCT01648101|83229308|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
46982992|NCT01648101|83229309|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
46982993|NCT01648101|83229310|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
46982994|NCT01648101|83229308|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
46982995|NCT01648101|83229309|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
46982996|NCT01648101|83229310|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
46982997|NCT01648101|83229308|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
46982998|NCT01648101|83229309|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
46982999|NCT01648101|83229310|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
46983000|NCT01648101|83229308|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
46983001|NCT01648101|83229309|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
46983002|NCT01648101|83229310|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
46983003|NCT01648101|83229308|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
46983004|NCT01648101|83229309|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
46868230|NCT03796208|83086315|FG000|Overall Study|Changed prenatal clinics|0|||
46868231|NCT03796208|83086316|FG001|Overall Study|Changed prenatal clinics|5|||
46868232|NCT03796208|83086315|FG000|Overall Study|Lost to Follow-up|20|||
46868233|NCT03796208|83086316|FG001|Overall Study|Lost to Follow-up|16|||
46868234|NCT01318876|83086322|FG000|Day 8 Survey|email address invalid|96|||
46868235|NCT01318876|83086322|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
46868236|NCT01318876|83086322|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
46868237|NCT03668600|83086326|FG000|Overall Study|Study Terminated by the Sponsor|157|||
46868238|NCT03668600|83086326|FG000|Overall Study|Protocol Violation|1|||
46868239|NCT03668600|83086326|FG000|Overall Study|Pregnancy|1|||
46868240|NCT03668600|83086326|FG000|Overall Study|Lost to Follow-up|7|||
46868241|NCT03668600|83086326|FG000|Overall Study|Withdrawal by Subject|56|||
46868242|NCT03668600|83086326|FG000|Overall Study|Lack of Efficacy|7|||
46868243|NCT03668600|83086326|FG000|Overall Study|Adverse Event|1|||
46868244|NCT04073186|83086330|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
46868245|NCT04073186|83086330|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
46868246|NCT04073186|83086330|FG000|First Wearing Cycle|Protocol Violation|1|||
46868247|NCT04073186|83086330|FG000|First Wearing Cycle|Lens Discomfort|2|||
46868248|NCT04073186|83086330|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
46868249|NCT04073186|83086330|FG000|Second Wearing Cycle|Adverse Event|1|||
46868250|NCT03054064|83086335|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
46868251|NCT03054064|83086335|FG000|Overall Study|Investigator Decision|2|||
46868252|NCT03054064|83086335|FG000|Overall Study|Bladder Issue|1|||
46868253|NCT03054064|83086335|FG000|Overall Study|High Blood Pressure|1|||
46868254|NCT03054064|83086335|FG000|Overall Study|Change in Status|1|||
46868255|NCT03053518|83086339|FG000|Overall Study|Withdrawal by Subject|3|||
46868256|NCT03053518|83086339|FG000|Overall Study|Lost to Follow-up|2|||
46868257|NCT03053518|83086339|FG000|Overall Study|Ineligible|5|||
46868258|NCT04015336|83086343|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
46868259|NCT04071158|83086366|FG000|Overall Study|Lost to Follow-up|1|||
46868260|NCT04071158|83086367|FG001|Overall Study|Lost to Follow-up|2|||
46868261|NCT04071158|83086368|FG002|Overall Study|Lost to Follow-up|3|||
46868262|NCT04071158|83086369|FG003|Overall Study|Lost to Follow-up|3|||
46868263|NCT04071158|83086370|FG004|Overall Study|Lost to Follow-up|5|||
46868264|NCT04071158|83086366|FG000|Overall Study|Randomized but not treated|2|||
46868265|NCT04071158|83086367|FG001|Overall Study|Randomized but not treated|2|||
46868266|NCT04071158|83086368|FG002|Overall Study|Randomized but not treated|0|||
46868267|NCT04071158|83086369|FG003|Overall Study|Randomized but not treated|0|||
46868268|NCT04071158|83086370|FG004|Overall Study|Randomized but not treated|0|||
46868269|NCT01317940|83086394|FG000|Overall Study|Death|1|||
46868270|NCT01317940|83086395|FG001|Overall Study|Death|0|||
46868271|NCT01317940|83086396|FG002|Overall Study|Death|1|||
46868272|NCT01317940|83086397|FG003|Overall Study|Death|0|||
46868273|NCT01317940|83086398|FG004|Overall Study|Death|0|||
46983005|NCT01648101|83229310|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
46868274|NCT01317940|83086399|FG005|Overall Study|Death|0|||
46868275|NCT01317940|83086394|FG000|Overall Study|Lost to Follow-up|0|||
46868276|NCT01317940|83086395|FG001|Overall Study|Lost to Follow-up|0|||
46983006|NCT01648101|83229308|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
46983007|NCT01648101|83229309|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
46983008|NCT01648101|83229310|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
46983009|NCT01648101|83229308|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
46983010|NCT01648101|83229309|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
46983011|NCT01648101|83229310|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
46983012|NCT01648101|83229308|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
46983013|NCT01648101|83229309|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
46983014|NCT01648101|83229310|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
46983015|NCT01648101|83229308|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
46983016|NCT01648101|83229309|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
46983017|NCT01648101|83229310|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
46983018|NCT02336373|83229322|FG000|Overall Study|Protocol closed early|4|||
46983019|NCT02336373|83229322|FG000|Overall Study|Physician Decision|14|||
46983020|NCT02372799|83229331|FG000|Treatment Period|Adverse Event|3|||
46983021|NCT02372799|83229332|FG001|Treatment Period|Adverse Event|10|||
46983022|NCT02372799|83229333|FG002|Treatment Period|Adverse Event|6|||
46983023|NCT02372799|83229331|FG000|Treatment Period|Insufficient therapeutic response|2|||
46983024|NCT02372799|83229332|FG001|Treatment Period|Insufficient therapeutic response|2|||
46983025|NCT02372799|83229333|FG002|Treatment Period|Insufficient therapeutic response|0|||
46983026|NCT02372799|83229331|FG000|Treatment Period|Withdrawal by Subject|10|||
46983027|NCT02372799|83229332|FG001|Treatment Period|Withdrawal by Subject|10|||
46983028|NCT02372799|83229333|FG002|Treatment Period|Withdrawal by Subject|2|||
46983029|NCT02372799|83229331|FG000|Treatment Period|Lost to Follow-up|11|||
46983030|NCT02372799|83229332|FG001|Treatment Period|Lost to Follow-up|5|||
46983031|NCT02372799|83229333|FG002|Treatment Period|Lost to Follow-up|3|||
46983032|NCT02372799|83229331|FG000|Treatment Period|Protocol Violation|3|||
46983033|NCT02372799|83229332|FG001|Treatment Period|Protocol Violation|0|||
46983034|NCT02372799|83229333|FG002|Treatment Period|Protocol Violation|0|||
46868277|NCT01317940|83086396|FG002|Overall Study|Lost to Follow-up|1|||
46868278|NCT01317940|83086397|FG003|Overall Study|Lost to Follow-up|1|||
46868279|NCT01317940|83086398|FG004|Overall Study|Lost to Follow-up|1|||
46868280|NCT01317940|83086399|FG005|Overall Study|Lost to Follow-up|0|||
46868281|NCT01317940|83086394|FG000|Overall Study|Change in therapy plan|0|||
46868282|NCT01317940|83086395|FG001|Overall Study|Change in therapy plan|0|||
46868283|NCT01317940|83086396|FG002|Overall Study|Change in therapy plan|3|||
46868284|NCT01317940|83086397|FG003|Overall Study|Change in therapy plan|0|||
46868285|NCT01317940|83086398|FG004|Overall Study|Change in therapy plan|0|||
46868286|NCT01317940|83086399|FG005|Overall Study|Change in therapy plan|0|||
46868287|NCT01345786|83086418|FG000|Overall Study|Adverse Event|0|||
46868288|NCT01345786|83086419|FG001|Overall Study|Adverse Event|1|||
46868289|NCT01345786|83086420|FG002|Overall Study|Adverse Event|3|||
46868290|NCT01345786|83086421|FG003|Overall Study|Adverse Event|1|||
46868291|NCT01345786|83086418|FG000|Overall Study|Subject withdrew consent|2|||
46868292|NCT01345786|83086419|FG001|Overall Study|Subject withdrew consent|2|||
46868293|NCT01345786|83086420|FG002|Overall Study|Subject withdrew consent|1|||
46868294|NCT01345786|83086421|FG003|Overall Study|Subject withdrew consent|0|||
46868295|NCT01345786|83086418|FG000|Overall Study|Noncompliance with protocol|1|||
46868296|NCT01345786|83086419|FG001|Overall Study|Noncompliance with protocol|0|||
46868297|NCT01345786|83086420|FG002|Overall Study|Noncompliance with protocol|1|||
46868298|NCT01345786|83086421|FG003|Overall Study|Noncompliance with protocol|0|||
46868299|NCT01345786|83086418|FG000|Overall Study|Administrative|3|||
46868300|NCT01345786|83086419|FG001|Overall Study|Administrative|5|||
46868301|NCT01345786|83086420|FG002|Overall Study|Administrative|0|||
46868302|NCT01345786|83086421|FG003|Overall Study|Administrative|0|||
46868303|NCT01345786|83086418|FG000|Overall Study|Lost to Follow-up|0|||
46868304|NCT01345786|83086419|FG001|Overall Study|Lost to Follow-up|0|||
46868305|NCT01345786|83086420|FG002|Overall Study|Lost to Follow-up|0|||
46868306|NCT01345786|83086421|FG003|Overall Study|Lost to Follow-up|2|||
46868307|NCT01317550|83086435|FG000|Overall Study|Withdrawal by Subject|1|||
46868308|NCT01317550|83086436|FG001|Overall Study|Withdrawal by Subject|0|||
46868309|NCT01317550|83086437|FG002|Overall Study|Withdrawal by Subject|0|||
46868310|NCT01317550|83086438|FG003|Overall Study|Withdrawal by Subject|0|||
46868311|NCT01317550|83086435|FG000|Overall Study|Lack of compliance study med|1|||
46868312|NCT01317550|83086436|FG001|Overall Study|Lack of compliance study med|0|||
46868313|NCT01317550|83086437|FG002|Overall Study|Lack of compliance study med|0|||
46983035|NCT02372799|83229331|FG000|Treatment Period|Non-compliance with study drug|4|||
46983036|NCT02372799|83229332|FG001|Treatment Period|Non-compliance with study drug|4|||
46868314|NCT01317550|83086438|FG003|Overall Study|Lack of compliance study med|0|||
46868315|NCT01317472|83086450|FG000|Overall Study|Withdrawal by Subject|1|||
46868316|NCT01317472|83086451|FG001|Overall Study|Withdrawal by Subject|0|||
46868317|NCT01317472|83086450|FG000|Overall Study|Unrelated hospitalization|1|||
46868318|NCT01317472|83086451|FG001|Overall Study|Unrelated hospitalization|0|||
46868319|NCT01345630|83086459|FG000|Overall Study|Adverse Event|22|||
46868320|NCT01345630|83086460|FG001|Overall Study|Adverse Event|23|||
46983037|NCT02372799|83229333|FG002|Treatment Period|Non-compliance with study drug|4|||
46983038|NCT02372799|83229331|FG000|Treatment Period|Miscellaneous Reasons|1|||
46983039|NCT02372799|83229332|FG001|Treatment Period|Miscellaneous Reasons|1|||
46983040|NCT02372799|83229333|FG002|Treatment Period|Miscellaneous Reasons|0|||
46983041|NCT02372799|83229331|FG000|Down-taper Period|Lost to Follow-up|1|||
46983042|NCT02372799|83229332|FG001|Down-taper Period|Lost to Follow-up|2|||
46983043|NCT02372799|83229333|FG002|Down-taper Period|Lost to Follow-up|2|||
46983044|NCT02566993|83229343|FG000|Overall Study|Randomized but not treated|5|||
46983045|NCT02566993|83229344|FG001|Overall Study|Randomized but not treated|16|||
46983046|NCT02566993|83229343|FG000|Overall Study|Progressive disease|213|||
46983047|NCT02566993|83229344|FG001|Overall Study|Progressive disease|152|||
46983048|NCT02566993|83229343|FG000|Overall Study|Withdrawal by Subject|12|||
46983049|NCT02566993|83229344|FG001|Overall Study|Withdrawal by Subject|28|||
46983050|NCT02566993|83229343|FG000|Overall Study|Death|17|||
46983051|NCT02566993|83229344|FG001|Overall Study|Death|23|||
46983052|NCT02566993|83229343|FG000|Overall Study|Physician Decision|10|||
46983053|NCT02566993|83229344|FG001|Overall Study|Physician Decision|17|||
46983054|NCT02566993|83229343|FG000|Overall Study|Study drug-related adverse event|20|||
46983055|NCT02566993|83229344|FG001|Overall Study|Study drug-related adverse event|41|||
46983056|NCT02566993|83229343|FG000|Overall Study|Non study drug-related adverse event|9|||
46983057|NCT02566993|83229344|FG001|Overall Study|Non study drug-related adverse event|9|||
46983058|NCT02566993|83229343|FG000|Overall Study|Symptomatic deterioration|9|||
46983059|NCT02566993|83229344|FG001|Overall Study|Symptomatic deterioration|16|||
46983060|NCT02566993|83229343|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
46983061|NCT02566993|83229344|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
46983062|NCT02566993|83229343|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
46983063|NCT02566993|83229344|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
46983064|NCT02566993|83229343|FG000|Overall Study|Screening failure|2|||
46983065|NCT02566993|83229344|FG001|Overall Study|Screening failure|0|||
46983066|NCT02566993|83229343|FG000|Overall Study|Lost to Follow-up|0|||
46983067|NCT02566993|83229344|FG001|Overall Study|Lost to Follow-up|1|||
46983068|NCT02566993|83229343|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
46983069|NCT02566993|83229344|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
46983070|NCT02311881|83229355|FG000|Overall Study|Did not meet the study criteria|2|||
46983071|NCT02311881|83229356|FG001|Overall Study|Did not meet the study criteria|2|||
46983072|NCT02311881|83229357|FG002|Overall Study|Did not meet the study criteria|0|||
46983073|NCT02311881|83229355|FG000|Overall Study|Adverse Event|7|||
46983074|NCT02311881|83229356|FG001|Overall Study|Adverse Event|15|||
46983075|NCT02311881|83229357|FG002|Overall Study|Adverse Event|8|||
46983076|NCT02311881|83229355|FG000|Overall Study|Lost to Follow-up|3|||
46983077|NCT02311881|83229356|FG001|Overall Study|Lost to Follow-up|3|||
46983078|NCT02311881|83229357|FG002|Overall Study|Lost to Follow-up|2|||
46983079|NCT02311881|83229355|FG000|Overall Study|Protocol Violation|1|||
46983080|NCT02311881|83229356|FG001|Overall Study|Protocol Violation|2|||
46983081|NCT02311881|83229357|FG002|Overall Study|Protocol Violation|3|||
46983082|NCT02311881|83229355|FG000|Overall Study|Withdrawal of consent|14|||
46983083|NCT02311881|83229356|FG001|Overall Study|Withdrawal of consent|16|||
46983084|NCT02311881|83229357|FG002|Overall Study|Withdrawal of consent|17|||
46983085|NCT02311881|83229355|FG000|Overall Study|Other|0|||
46983086|NCT02311881|83229356|FG001|Overall Study|Other|0|||
46983087|NCT02311881|83229357|FG002|Overall Study|Other|1|||
46983088|NCT02311881|83229355|FG000|Overall Study|Lack of Efficacy|1|||
46983089|NCT02311881|83229356|FG001|Overall Study|Lack of Efficacy|2|||
46983090|NCT02311881|83229357|FG002|Overall Study|Lack of Efficacy|0|||
46983091|NCT02311881|83229355|FG000|Overall Study|Subject has border line pregnancy test|1|||
46983092|NCT02311881|83229356|FG001|Overall Study|Subject has border line pregnancy test|0|||
46983093|NCT02311881|83229357|FG002|Overall Study|Subject has border line pregnancy test|0|||
46983094|NCT02311881|83229355|FG000|Overall Study|Withdrawal by Subject|3|||
46983095|NCT02311881|83229356|FG001|Overall Study|Withdrawal by Subject|1|||
46983096|NCT02311881|83229357|FG002|Overall Study|Withdrawal by Subject|4|||
46983097|NCT02311881|83229355|FG000|Overall Study|Sponsor Decision|1|||
46983098|NCT02311881|83229356|FG001|Overall Study|Sponsor Decision|1|||
46983099|NCT02311881|83229357|FG002|Overall Study|Sponsor Decision|1|||
46983100|NCT02311881|83229355|FG000|Overall Study|Protocol Deviation|1|||
46983101|NCT02311881|83229356|FG001|Overall Study|Protocol Deviation|0|||
46983102|NCT02311881|83229357|FG002|Overall Study|Protocol Deviation|0|||
46983103|NCT02311881|83229355|FG000|Overall Study|Non-Compliance|1|||
46983104|NCT02311881|83229356|FG001|Overall Study|Non-Compliance|0|||
46698382|NCT00922987|82913419|FG000|Overall Study|Protocol Violation|2|||
46983105|NCT02311881|83229357|FG002|Overall Study|Non-Compliance|2|||
46983106|NCT02311881|83229355|FG000|Overall Study|Physician Decision|0|||
46983107|NCT02311881|83229356|FG001|Overall Study|Physician Decision|0|||
46983108|NCT02311881|83229357|FG002|Overall Study|Physician Decision|1|||
46983109|NCT02311881|83229355|FG000|Overall Study|Medical Monitor Discretion|0|||
46983110|NCT02311881|83229356|FG001|Overall Study|Medical Monitor Discretion|0|||
46983111|NCT02311881|83229357|FG002|Overall Study|Medical Monitor Discretion|1|||
46983112|NCT02311881|83229355|FG000|Overall Study|Participant taking another medication|0|||
46983113|NCT02311881|83229356|FG001|Overall Study|Participant taking another medication|0|||
46983114|NCT02311881|83229357|FG002|Overall Study|Participant taking another medication|1|||
46983115|NCT02311881|83229355|FG000|Overall Study|Serious Adverse Event|0|||
46983116|NCT02311881|83229356|FG001|Overall Study|Serious Adverse Event|1|||
46983117|NCT02311881|83229357|FG002|Overall Study|Serious Adverse Event|0|||
46983118|NCT02565511|83229372|FG000|Overall Study|Study terminated by Sponsor|35|||
46983119|NCT02565511|83229373|FG001|Overall Study|Study terminated by Sponsor|22|||
46983120|NCT02565511|83229374|FG002|Overall Study|Study terminated by Sponsor|235|||
46983121|NCT02565511|83229375|FG003|Overall Study|Study terminated by Sponsor|156|||
46983122|NCT02565511|83229372|FG000|Overall Study|Withdrawal by Subject|3|||
46983123|NCT02565511|83229373|FG001|Overall Study|Withdrawal by Subject|0|||
46983124|NCT02565511|83229374|FG002|Overall Study|Withdrawal by Subject|12|||
46983125|NCT02565511|83229375|FG003|Overall Study|Withdrawal by Subject|5|||
46983126|NCT02565511|83229372|FG000|Overall Study|Adverse Event|0|||
46983127|NCT02565511|83229373|FG001|Overall Study|Adverse Event|0|||
46983128|NCT02565511|83229374|FG002|Overall Study|Adverse Event|1|||
46983129|NCT02565511|83229375|FG003|Overall Study|Adverse Event|1|||
46983130|NCT02565511|83229372|FG000|Overall Study|Lost to Follow-up|4|||
46983131|NCT02565511|83229373|FG001|Overall Study|Lost to Follow-up|1|||
46983132|NCT02565511|83229374|FG002|Overall Study|Lost to Follow-up|0|||
46983133|NCT02565511|83229375|FG003|Overall Study|Lost to Follow-up|1|||
46983134|NCT02565511|83229372|FG000|Overall Study|Physician Decision|0|||
46983135|NCT02565511|83229373|FG001|Overall Study|Physician Decision|0|||
46983136|NCT02565511|83229374|FG002|Overall Study|Physician Decision|0|||
46983137|NCT02565511|83229375|FG003|Overall Study|Physician Decision|1|||
46983138|NCT02565511|83229372|FG000|Overall Study|Protocol deviation|0|||
46983139|NCT02565511|83229373|FG001|Overall Study|Protocol deviation|0|||
46983140|NCT02565511|83229374|FG002|Overall Study|Protocol deviation|3|||
46868321|NCT01345630|83086459|FG000|Overall Study|Lost to Follow-up|17|||
46868322|NCT01345630|83086460|FG001|Overall Study|Lost to Follow-up|16|||
46868323|NCT01345630|83086459|FG000|Overall Study|Protocol Violation|4|||
46868324|NCT01345630|83086460|FG001|Overall Study|Protocol Violation|1|||
46868325|NCT01345630|83086459|FG000|Overall Study|Medication error without associated AE|0|||
46868326|NCT01345630|83086460|FG001|Overall Study|Medication error without associated AE|1|||
46868327|NCT01345630|83086459|FG000|Overall Study|Study terminated by sponsor|254|||
46868328|NCT01345630|83086460|FG001|Overall Study|Study terminated by sponsor|285|||
46868329|NCT01345630|83086459|FG000|Overall Study|Other reasons|6|||
46868330|NCT01345630|83086460|FG001|Overall Study|Other reasons|8|||
46868331|NCT01345630|83086459|FG000|Overall Study|Withdrawn due to pregnancy|1|||
46868332|NCT01345630|83086460|FG001|Overall Study|Withdrawn due to pregnancy|2|||
46868333|NCT01345630|83086459|FG000|Overall Study|No longer willing to participate|9|||
46868334|NCT01345630|83086460|FG001|Overall Study|No longer willing to participate|12|||
46868335|NCT01345630|83086459|FG000|Overall Study|Insufficient clinical response|48|||
46868336|NCT01345630|83086460|FG001|Overall Study|Insufficient clinical response|11|||
46868337|NCT03693612|83086477|FG000|Overall Study|Lost to Follow-up|0|||
46868338|NCT03693612|83086478|FG001|Overall Study|Lost to Follow-up|0|||
46868339|NCT03693612|83086479|FG002|Overall Study|Lost to Follow-up|0|||
46868340|NCT03693612|83086480|FG003|Overall Study|Lost to Follow-up|0|||
46868341|NCT03693612|83086481|FG004|Overall Study|Lost to Follow-up|1|||
46868342|NCT03693612|83086482|FG005|Overall Study|Lost to Follow-up|0|||
46868343|NCT03693612|83086483|FG006|Overall Study|Lost to Follow-up|0|||
46868344|NCT03693612|83086477|FG000|Overall Study|Withdrawal by Subject|0|||
46868345|NCT03693612|83086478|FG001|Overall Study|Withdrawal by Subject|0|||
46868346|NCT03693612|83086479|FG002|Overall Study|Withdrawal by Subject|1|||
46983141|NCT02565511|83229375|FG003|Overall Study|Protocol deviation|0|||
46983142|NCT02561455|83229389|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
46983143|NCT02561455|83229390|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
46868347|NCT03693612|83086480|FG003|Overall Study|Withdrawal by Subject|0|||
46868348|NCT03693612|83086481|FG004|Overall Study|Withdrawal by Subject|2|||
46868349|NCT03693612|83086482|FG005|Overall Study|Withdrawal by Subject|0|||
46983144|NCT02561455|83229391|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
46983145|NCT02561455|83229392|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
46983146|NCT02561455|83229389|FG000|Overall Study|Withdrawal by Subject|1|||
46983147|NCT02561455|83229390|FG001|Overall Study|Withdrawal by Subject|0|||
46983148|NCT02561455|83229391|FG002|Overall Study|Withdrawal by Subject|1|||
46983149|NCT02561455|83229392|FG003|Overall Study|Withdrawal by Subject|0|||
46983150|NCT02561455|83229389|FG000|Overall Study|Disease Progression|0|||
46983151|NCT02561455|83229390|FG001|Overall Study|Disease Progression|1|||
46983152|NCT02561455|83229391|FG002|Overall Study|Disease Progression|0|||
46983153|NCT02561455|83229392|FG003|Overall Study|Disease Progression|0|||
46983154|NCT02561299|83229404|FG000|Overall Study|Death|2|||
46983155|NCT02561299|83229405|FG001|Overall Study|Death|4|||
46983156|NCT02561299|83229404|FG000|Overall Study|Lost to Follow-up|1|||
46983157|NCT02561299|83229405|FG001|Overall Study|Lost to Follow-up|0|||
46983158|NCT02561299|83229404|FG000|Overall Study|Withdrawal by Subject|2|||
46983159|NCT02561299|83229405|FG001|Overall Study|Withdrawal by Subject|2|||
46983160|NCT02566759|83229428|FG000|All Parts|Withdrawal by Subject|0|||
46983161|NCT02566759|83229429|FG001|All Parts|Withdrawal by Subject|1|||
46983162|NCT02566759|83229430|FG002|All Parts|Withdrawal by Subject|0|||
46983163|NCT02566759|83229431|FG003|All Parts|Withdrawal by Subject|0|||
46983164|NCT02566759|83229432|FG004|All Parts|Withdrawal by Subject|0|||
46983165|NCT02566759|83229433|FG005|All Parts|Withdrawal by Subject|0|||
46983166|NCT02566759|83229434|FG006|All Parts|Withdrawal by Subject|0|||
46983167|NCT02566759|83229435|FG007|All Parts|Withdrawal by Subject|0|||
46983168|NCT02566759|83229436|FG008|All Parts|Withdrawal by Subject|0|||
46983169|NCT02566759|83229437|FG009|All Parts|Withdrawal by Subject|0|||
46983170|NCT02566759|83229438|FG010|All Parts|Withdrawal by Subject|0|||
46983171|NCT02566759|83229439|FG011|All Parts|Withdrawal by Subject|0|||
46983172|NCT02566759|83229440|FG012|All Parts|Withdrawal by Subject|0|||
46983173|NCT02566759|83229441|FG013|All Parts|Withdrawal by Subject|0|||
46983174|NCT02566759|83229442|FG014|All Parts|Withdrawal by Subject|0|||
46983175|NCT02566759|83229443|FG015|All Parts|Withdrawal by Subject|0|||
46983176|NCT02566759|83229444|FG016|All Parts|Withdrawal by Subject|0|||
46983177|NCT02566759|83229428|FG000|All Parts|Adverse Event|0|||
46983178|NCT02566759|83229429|FG001|All Parts|Adverse Event|0|||
46983179|NCT02566759|83229430|FG002|All Parts|Adverse Event|0|||
46983180|NCT02566759|83229431|FG003|All Parts|Adverse Event|0|||
46983181|NCT02566759|83229432|FG004|All Parts|Adverse Event|0|||
46983182|NCT02566759|83229433|FG005|All Parts|Adverse Event|0|||
46983183|NCT02566759|83229434|FG006|All Parts|Adverse Event|0|||
46983184|NCT02566759|83229435|FG007|All Parts|Adverse Event|0|||
46983185|NCT02566759|83229436|FG008|All Parts|Adverse Event|0|||
46983186|NCT02566759|83229437|FG009|All Parts|Adverse Event|0|||
46983187|NCT02566759|83229438|FG010|All Parts|Adverse Event|0|||
46983188|NCT02566759|83229439|FG011|All Parts|Adverse Event|0|||
46983189|NCT02566759|83229440|FG012|All Parts|Adverse Event|1|||
46983190|NCT02566759|83229441|FG013|All Parts|Adverse Event|3|||
46983191|NCT02566759|83229442|FG014|All Parts|Adverse Event|0|||
46983192|NCT02566759|83229443|FG015|All Parts|Adverse Event|0|||
46983193|NCT02566759|83229444|FG016|All Parts|Adverse Event|0|||
46983194|NCT02566759|83229428|FG000|All Parts|Other|0|||
46983195|NCT02566759|83229429|FG001|All Parts|Other|0|||
46983196|NCT02566759|83229430|FG002|All Parts|Other|0|||
46983197|NCT02566759|83229431|FG003|All Parts|Other|0|||
46983198|NCT02566759|83229432|FG004|All Parts|Other|0|||
46983199|NCT02566759|83229433|FG005|All Parts|Other|0|||
46983200|NCT02566759|83229434|FG006|All Parts|Other|0|||
46983201|NCT02566759|83229435|FG007|All Parts|Other|0|||
46983202|NCT02566759|83229436|FG008|All Parts|Other|0|||
46983203|NCT02566759|83229437|FG009|All Parts|Other|0|||
46983204|NCT02566759|83229438|FG010|All Parts|Other|0|||
46983205|NCT02566759|83229439|FG011|All Parts|Other|0|||
46983206|NCT02566759|83229440|FG012|All Parts|Other|0|||
46983207|NCT02566759|83229441|FG013|All Parts|Other|2|||
46983208|NCT02566759|83229442|FG014|All Parts|Other|0|||
46983209|NCT02566759|83229443|FG015|All Parts|Other|0|||
46983210|NCT02566759|83229444|FG016|All Parts|Other|0|||
46983211|NCT02566759|83229428|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983212|NCT02566759|83229429|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983213|NCT02566759|83229430|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983214|NCT02566759|83229431|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983215|NCT02566759|83229432|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983216|NCT02566759|83229433|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983217|NCT02566759|83229434|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983218|NCT02566759|83229435|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983219|NCT02566759|83229436|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983220|NCT02566759|83229437|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983221|NCT02566759|83229438|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983222|NCT02566759|83229439|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983223|NCT02566759|83229440|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983224|NCT02566759|83229441|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983225|NCT02566759|83229442|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46983226|NCT02566759|83229443|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
46698383|NCT00922987|82913419|FG000|Overall Study|Adverse Event|1|||
46983227|NCT02566759|83229444|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
46983228|NCT02335983|83229509|FG000|Overall Study|Sponsor Decision|0|||
46983229|NCT02335983|83229510|FG001|Overall Study|Sponsor Decision|0|||
46983230|NCT02335983|83229511|FG002|Overall Study|Sponsor Decision|1|||
46983231|NCT02335983|83229512|FG003|Overall Study|Sponsor Decision|1|||
46983232|NCT02335983|83229513|FG004|Overall Study|Sponsor Decision|0|||
46983233|NCT02335983|83229514|FG005|Overall Study|Sponsor Decision|1|||
46983234|NCT02335983|83229509|FG000|Overall Study|Withdrawal by Subject|3|||
46983235|NCT02335983|83229510|FG001|Overall Study|Withdrawal by Subject|2|||
46983236|NCT02335983|83229511|FG002|Overall Study|Withdrawal by Subject|2|||
46983237|NCT02335983|83229512|FG003|Overall Study|Withdrawal by Subject|1|||
46983238|NCT02335983|83229513|FG004|Overall Study|Withdrawal by Subject|3|||
46983239|NCT02335983|83229514|FG005|Overall Study|Withdrawal by Subject|9|||
46983240|NCT02335983|83229509|FG000|Overall Study|Death|0|||
46983241|NCT02335983|83229510|FG001|Overall Study|Death|0|||
46983242|NCT02335983|83229511|FG002|Overall Study|Death|2|||
46983243|NCT02335983|83229512|FG003|Overall Study|Death|0|||
46983244|NCT02335983|83229513|FG004|Overall Study|Death|0|||
46983245|NCT02335983|83229514|FG005|Overall Study|Death|0|||
46983246|NCT02335983|83229509|FG000|Overall Study|Lost to Follow-up|0|||
46983247|NCT02335983|83229510|FG001|Overall Study|Lost to Follow-up|0|||
46983248|NCT02335983|83229511|FG002|Overall Study|Lost to Follow-up|0|||
46983249|NCT02335983|83229512|FG003|Overall Study|Lost to Follow-up|0|||
46983250|NCT02335983|83229513|FG004|Overall Study|Lost to Follow-up|0|||
46983251|NCT02335983|83229514|FG005|Overall Study|Lost to Follow-up|1|||
46983252|NCT02335983|83229509|FG000|Overall Study|Protocol Specified Criteria|5|||
46983253|NCT02335983|83229510|FG001|Overall Study|Protocol Specified Criteria|7|||
46983254|NCT02335983|83229511|FG002|Overall Study|Protocol Specified Criteria|27|||
46983255|NCT02335983|83229512|FG003|Overall Study|Protocol Specified Criteria|7|||
46983256|NCT02335983|83229513|FG004|Overall Study|Protocol Specified Criteria|5|||
46983257|NCT02335983|83229514|FG005|Overall Study|Protocol Specified Criteria|21|||
46983258|NCT04640311|83229550|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
46983259|NCT04640311|83229551|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983260|NCT04640311|83229552|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983261|NCT04640311|83229553|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983262|NCT04640311|83229554|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983263|NCT04640311|83229555|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983264|NCT04640311|83229556|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983265|NCT04640311|83229557|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983266|NCT04640311|83229558|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983267|NCT04640311|83229559|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983268|NCT04640311|83229560|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983269|NCT04640311|83229561|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983270|NCT04640311|83229562|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983271|NCT04640311|83229550|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983272|NCT04640311|83229551|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
46983273|NCT04640311|83229552|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983274|NCT04640311|83229553|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983275|NCT04640311|83229554|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983276|NCT04640311|83229555|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983277|NCT04640311|83229556|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983278|NCT04640311|83229557|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983279|NCT04640311|83229558|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983280|NCT04640311|83229559|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983281|NCT04640311|83229560|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983282|NCT04640311|83229561|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983283|NCT04640311|83229562|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
46983284|NCT04640311|83229550|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983285|NCT04640311|83229551|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
46983286|NCT04640311|83229552|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983287|NCT04640311|83229553|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983288|NCT04640311|83229554|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983289|NCT04640311|83229555|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983290|NCT04640311|83229556|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983291|NCT04640311|83229557|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983292|NCT04640311|83229558|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983293|NCT04640311|83229559|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983294|NCT04640311|83229560|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46868350|NCT03693612|83086483|FG006|Overall Study|Withdrawal by Subject|0|||
46983295|NCT04640311|83229561|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983296|NCT04640311|83229562|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983297|NCT04640311|83229550|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
46983298|NCT04640311|83229551|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
46983299|NCT04640311|83229552|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
46983300|NCT04640311|83229553|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983301|NCT04640311|83229554|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983302|NCT04640311|83229555|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983303|NCT04640311|83229556|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983304|NCT04640311|83229557|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983305|NCT04640311|83229558|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983306|NCT04640311|83229559|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983307|NCT04640311|83229560|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983308|NCT04640311|83229561|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983309|NCT04640311|83229562|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
46983310|NCT04640311|83229550|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983311|NCT04640311|83229551|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983312|NCT04640311|83229552|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
46983313|NCT04640311|83229553|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983314|NCT04640311|83229554|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983315|NCT04640311|83229555|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983316|NCT04640311|83229556|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983317|NCT04640311|83229557|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983318|NCT04640311|83229558|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983319|NCT04640311|83229559|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983320|NCT04640311|83229560|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983321|NCT04640311|83229561|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983322|NCT04640311|83229562|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
46983323|NCT04640311|83229550|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983324|NCT04640311|83229551|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983325|NCT04640311|83229552|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983326|NCT04640311|83229553|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
46983327|NCT04640311|83229554|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983328|NCT04640311|83229555|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983329|NCT04640311|83229556|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
46983330|NCT04640311|83229557|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983331|NCT04640311|83229558|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983332|NCT04640311|83229559|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983333|NCT04640311|83229560|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983334|NCT04640311|83229561|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983335|NCT04640311|83229562|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
46983336|NCT04640311|83229550|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983337|NCT04640311|83229551|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983338|NCT04640311|83229552|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983339|NCT04640311|83229553|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983340|NCT04640311|83229554|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983341|NCT04640311|83229555|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
46983342|NCT04640311|83229556|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983343|NCT04640311|83229557|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983344|NCT04640311|83229558|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
46868351|NCT03693612|83086477|FG000|Overall Study|Study Terminated by Sponsor|0|||
46868352|NCT03693612|83086478|FG001|Overall Study|Study Terminated by Sponsor|1|||
46868353|NCT03693612|83086479|FG002|Overall Study|Study Terminated by Sponsor|0|||
46868354|NCT03693612|83086480|FG003|Overall Study|Study Terminated by Sponsor|0|||
46868355|NCT03693612|83086481|FG004|Overall Study|Study Terminated by Sponsor|3|||
46868356|NCT03693612|83086482|FG005|Overall Study|Study Terminated by Sponsor|0|||
46868357|NCT03693612|83086483|FG006|Overall Study|Study Terminated by Sponsor|0|||
46868358|NCT04223232|83086499|FG000|Overall Study|Withdrawal by Subject|1|||
46868359|NCT04206384|83086503|FG000|Overall Study|Withdrawal by Subject|8|||
46983345|NCT04640311|83229559|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983346|NCT04640311|83229560|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983347|NCT04640311|83229561|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983348|NCT04640311|83229562|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
46983349|NCT04640311|83229550|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983350|NCT04640311|83229551|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983351|NCT04640311|83229552|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983352|NCT04640311|83229553|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983353|NCT04640311|83229554|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983354|NCT04640311|83229555|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983355|NCT04640311|83229556|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
46983356|NCT04640311|83229557|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983357|NCT04640311|83229558|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983358|NCT04640311|83229559|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983359|NCT04640311|83229560|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
46983360|NCT04640311|83229561|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983361|NCT04640311|83229562|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
46983362|NCT04640311|83229550|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983363|NCT04640311|83229551|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983364|NCT04640311|83229552|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983365|NCT04640311|83229553|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983366|NCT04640311|83229554|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983367|NCT04640311|83229555|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983368|NCT04640311|83229556|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983369|NCT04640311|83229557|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983370|NCT04640311|83229558|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983371|NCT04640311|83229559|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983372|NCT04640311|83229560|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983373|NCT04640311|83229561|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
46983374|NCT04640311|83229562|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
46983375|NCT02334423|83229593|FG000|Overall Study|Protocol Violation|10|||
46983376|NCT02334423|83229594|FG001|Overall Study|Protocol Violation|3|||
46983377|NCT02310789|83229600|FG000|Overall Study|Adverse Event|1|||
46983378|NCT02372253|83229606|FG000|Overall Study|Non Compliance|2|||
46983379|NCT02372253|83229607|FG001|Overall Study|Non Compliance|0|||
46983380|NCT02559895|83229619|FG000|Overall Study|Adverse Event|3|||
46983381|NCT02559895|83229620|FG001|Overall Study|Adverse Event|3|||
46868360|NCT04206384|83086503|FG000|Overall Study|Adverse Event|2|||
46868361|NCT04051944|83086509|FG000|Overall Study|Study ending|1|||
46868362|NCT04051944|83086510|FG001|Overall Study|Study ending|1|||
46868363|NCT04051944|83086509|FG000|Overall Study|Early study termination by participant|1|||
46868364|NCT04051944|83086510|FG001|Overall Study|Early study termination by participant|0|||
46983382|NCT02559895|83229621|FG002|Overall Study|Adverse Event|2|||
46983383|NCT02559895|83229622|FG003|Overall Study|Adverse Event|1|||
46983384|NCT02559895|83229619|FG000|Overall Study|Lack of Efficacy|2|||
46983385|NCT02559895|83229620|FG001|Overall Study|Lack of Efficacy|3|||
46983386|NCT02559895|83229621|FG002|Overall Study|Lack of Efficacy|2|||
46983387|NCT02559895|83229622|FG003|Overall Study|Lack of Efficacy|8|||
46983388|NCT02559895|83229619|FG000|Overall Study|Lost to Follow-up|22|||
46983389|NCT02559895|83229620|FG001|Overall Study|Lost to Follow-up|16|||
46983390|NCT02559895|83229621|FG002|Overall Study|Lost to Follow-up|12|||
46983391|NCT02559895|83229622|FG003|Overall Study|Lost to Follow-up|17|||
46983392|NCT02559895|83229619|FG000|Overall Study|Physician Decision|1|||
46983393|NCT02559895|83229620|FG001|Overall Study|Physician Decision|1|||
46983394|NCT02559895|83229621|FG002|Overall Study|Physician Decision|3|||
46983395|NCT02559895|83229622|FG003|Overall Study|Physician Decision|0|||
46983396|NCT02559895|83229619|FG000|Overall Study|Withdrawal by Subject|16|||
46983397|NCT02559895|83229620|FG001|Overall Study|Withdrawal by Subject|9|||
46983398|NCT02559895|83229621|FG002|Overall Study|Withdrawal by Subject|20|||
46983399|NCT02559895|83229622|FG003|Overall Study|Withdrawal by Subject|9|||
46983400|NCT02559895|83229619|FG000|Overall Study|Study Burden|10|||
46983401|NCT02559895|83229620|FG001|Overall Study|Study Burden|16|||
46983402|NCT02559895|83229621|FG002|Overall Study|Study Burden|12|||
46983403|NCT02559895|83229622|FG003|Overall Study|Study Burden|22|||
46983404|NCT02559895|83229619|FG000|Overall Study|Other|1|||
46983405|NCT02559895|83229620|FG001|Overall Study|Other|5|||
46983406|NCT02559895|83229621|FG002|Overall Study|Other|3|||
46983407|NCT02559895|83229622|FG003|Overall Study|Other|3|||
46983408|NCT02371629|83229634|FG000|Overall Study|Patient decision|14|||
46983409|NCT02371629|83229635|FG001|Overall Study|Patient decision|10|||
46983410|NCT02371629|83229634|FG000|Overall Study|Adverse Event|8|||
46983411|NCT02371629|83229635|FG001|Overall Study|Adverse Event|8|||
46983412|NCT02371629|83229634|FG000|Overall Study|Physician Decision|2|||
46983413|NCT02371629|83229635|FG001|Overall Study|Physician Decision|3|||
46983414|NCT02371629|83229634|FG000|Overall Study|Death|1|||
46983415|NCT02371629|83229635|FG001|Overall Study|Death|1|||
46983416|NCT02371629|83229634|FG000|Overall Study|Noncompliance with study treatment|1|||
46983417|NCT02371629|83229635|FG001|Overall Study|Noncompliance with study treatment|0|||
46983418|NCT02371629|83229634|FG000|Overall Study|Lack of Efficacy|0|||
46983419|NCT02371629|83229635|FG001|Overall Study|Lack of Efficacy|2|||
46983420|NCT02371629|83229634|FG000|Overall Study|Protocol deviation|0|||
46983421|NCT02371629|83229635|FG001|Overall Study|Protocol deviation|1|||
46983422|NCT02559817|83229646|FG000|Treatment Period|Adverse Event|1|||
46983423|NCT02559817|83229647|FG001|Treatment Period|Adverse Event|0|||
46983424|NCT02559817|83229648|FG002|Treatment Period|Adverse Event|1|||
46983425|NCT02559817|83229649|FG003|Treatment Period|Adverse Event|0|||
46983426|NCT02559817|83229650|FG004|Treatment Period|Adverse Event|0|||
46983427|NCT02559817|83229646|FG000|Treatment Period|Lack of Efficacy|0|||
46983428|NCT02559817|83229647|FG001|Treatment Period|Lack of Efficacy|1|||
46983429|NCT02559817|83229648|FG002|Treatment Period|Lack of Efficacy|0|||
46983430|NCT02559817|83229649|FG003|Treatment Period|Lack of Efficacy|0|||
46983431|NCT02559817|83229650|FG004|Treatment Period|Lack of Efficacy|0|||
46983432|NCT02559817|83229646|FG000|Treatment Period|Lost to Follow-up|0|||
46983433|NCT02559817|83229647|FG001|Treatment Period|Lost to Follow-up|1|||
46983434|NCT02559817|83229648|FG002|Treatment Period|Lost to Follow-up|0|||
46983435|NCT02559817|83229649|FG003|Treatment Period|Lost to Follow-up|1|||
46983436|NCT02559817|83229650|FG004|Treatment Period|Lost to Follow-up|0|||
46983437|NCT02559817|83229646|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
46983438|NCT02559817|83229647|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
46868365|NCT04051944|83086509|FG000|Overall Study|Withdrawal by Subject|2|||
46868366|NCT04051944|83086510|FG001|Overall Study|Withdrawal by Subject|2|||
46868367|NCT04051944|83086509|FG000|Overall Study|Lack of Efficacy|3|||
46868368|NCT04051944|83086510|FG001|Overall Study|Lack of Efficacy|0|||
46868369|NCT04051944|83086509|FG000|Overall Study|Adverse event, non- fatal|1|||
46868370|NCT04051944|83086510|FG001|Overall Study|Adverse event, non- fatal|1|||
46983439|NCT02559817|83229648|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
46868371|NCT04050618|83086518|FG000|First Intervention|Withdrawal by Subject|2|||
46983440|NCT02559817|83229649|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
46983441|NCT02559817|83229650|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
46983442|NCT02559817|83229646|FG000|Treatment Period|Protocol Violation|0|||
46983443|NCT02559817|83229647|FG001|Treatment Period|Protocol Violation|0|||
46983444|NCT02559817|83229648|FG002|Treatment Period|Protocol Violation|0|||
46983445|NCT02559817|83229649|FG003|Treatment Period|Protocol Violation|1|||
46983446|NCT02559817|83229650|FG004|Treatment Period|Protocol Violation|0|||
46983447|NCT02564887|83229664|FG000|Overall Study|Lost to Follow-up|6|||
46983448|NCT02564887|83229665|FG001|Overall Study|Lost to Follow-up|0|||
46983449|NCT02333487|83229676|FG000|Overall Study|Adverse Event|0|||
46983450|NCT02333487|83229677|FG001|Overall Study|Adverse Event|2|||
46983451|NCT02333487|83229678|FG002|Overall Study|Adverse Event|0|||
46983452|NCT02333331|83229691|FG000|Overall Study|Adverse Event|1|||
46983453|NCT02333331|83229692|FG001|Overall Study|Adverse Event|0|||
46983454|NCT02333331|83229693|FG002|Overall Study|Adverse Event|4|||
46983455|NCT02333331|83229694|FG003|Overall Study|Adverse Event|1|||
46983456|NCT02333331|83229691|FG000|Overall Study|Death|0|||
46983457|NCT02333331|83229692|FG001|Overall Study|Death|0|||
46983458|NCT02333331|83229693|FG002|Overall Study|Death|2|||
46983459|NCT02333331|83229694|FG003|Overall Study|Death|0|||
46983460|NCT02333331|83229691|FG000|Overall Study|Lost to Follow-up|0|||
46983461|NCT02333331|83229692|FG001|Overall Study|Lost to Follow-up|0|||
46983462|NCT02333331|83229693|FG002|Overall Study|Lost to Follow-up|1|||
46983463|NCT02333331|83229694|FG003|Overall Study|Lost to Follow-up|0|||
46983464|NCT02333331|83229691|FG000|Overall Study|Physician Decision|0|||
46983465|NCT02333331|83229692|FG001|Overall Study|Physician Decision|1|||
46983466|NCT02333331|83229693|FG002|Overall Study|Physician Decision|0|||
46983467|NCT02333331|83229694|FG003|Overall Study|Physician Decision|0|||
46983468|NCT02333331|83229691|FG000|Overall Study|Protocol Deviation|0|||
46983469|NCT02333331|83229692|FG001|Overall Study|Protocol Deviation|3|||
46983470|NCT02333331|83229693|FG002|Overall Study|Protocol Deviation|2|||
46983471|NCT02333331|83229694|FG003|Overall Study|Protocol Deviation|1|||
46983472|NCT02333331|83229691|FG000|Overall Study|Patient/Guardian Decision|1|||
46983473|NCT02333331|83229692|FG001|Overall Study|Patient/Guardian Decision|2|||
46983474|NCT02333331|83229693|FG002|Overall Study|Patient/Guardian Decision|9|||
46983475|NCT02333331|83229694|FG003|Overall Study|Patient/Guardian Decision|1|||
46983476|NCT02563561|83229707|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
46983477|NCT02563561|83229708|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
46983478|NCT02563561|83229709|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
46983479|NCT02563561|83229707|FG000|Overall Study|Withdrew of Consent|1|||
46983480|NCT02563561|83229708|FG001|Overall Study|Withdrew of Consent|1|||
46983481|NCT02563561|83229709|FG002|Overall Study|Withdrew of Consent|2|||
46983482|NCT02563561|83229707|FG000|Overall Study|Lost to Follow-up|1|||
46983483|NCT02563561|83229708|FG001|Overall Study|Lost to Follow-up|1|||
46983484|NCT02563561|83229709|FG002|Overall Study|Lost to Follow-up|0|||
46983485|NCT02563561|83229707|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
46983486|NCT02563561|83229708|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
46983487|NCT02563561|83229709|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
46983488|NCT02563561|83229707|FG000|Overall Study|Investigator Decision|3|||
46983489|NCT02563561|83229708|FG001|Overall Study|Investigator Decision|4|||
46983490|NCT02563561|83229709|FG002|Overall Study|Investigator Decision|2|||
46983491|NCT02563561|83229707|FG000|Overall Study|Sponsor Decision|5|||
46983492|NCT02563561|83229708|FG001|Overall Study|Sponsor Decision|2|||
46983493|NCT02563561|83229709|FG002|Overall Study|Sponsor Decision|4|||
46983494|NCT02563561|83229707|FG000|Overall Study|Other|1|||
46983495|NCT02563561|83229708|FG001|Overall Study|Other|5|||
46983496|NCT02563561|83229709|FG002|Overall Study|Other|2|||
46983497|NCT02559505|83229725|FG000|Overall Study|Lost to Follow-up|23|||
46983498|NCT02559505|83229726|FG001|Overall Study|Lost to Follow-up|20|||
46983499|NCT02559505|83229725|FG000|Overall Study|Withdrawal by Subject|4|||
46983500|NCT02559505|83229726|FG001|Overall Study|Withdrawal by Subject|2|||
46983501|NCT04191967|83229748|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
46983502|NCT04191967|83229748|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
46983503|NCT02556307|83229754|FG000|Overall Study|Premature treatment interruption|11|||
46983504|NCT02556307|83229754|FG000|Overall Study|Lost to Follow-up|36|||
46983505|NCT02556307|83229754|FG000|Overall Study|Change to triple therapy|4|||
46983506|NCT02556307|83229754|FG000|Overall Study|Enrolled but not treated|2|||
46983507|NCT04364737|83229760|FG000|Overall Study|Withdrawal by Subject|4|||
46983508|NCT04364737|83229761|FG001|Overall Study|Withdrawal by Subject|9|||
46983509|NCT04364737|83229760|FG000|Overall Study|Lost to Follow-up|1|||
46983510|NCT04364737|83229761|FG001|Overall Study|Lost to Follow-up|1|||
46983511|NCT02559115|83229767|FG000|Overall Study|Withdrawal by Subject|3|||
46983512|NCT01662895|83229785|FG000|Overall Study|Lost to Follow-up|0|||
46868372|NCT04050618|83086519|FG001|First Intervention|Withdrawal by Subject|0|||
46868373|NCT04050618|83086518|FG000|Second Intervention|Withdrawal by Subject|1|||
46868374|NCT04050618|83086519|FG001|Second Intervention|Withdrawal by Subject|0|||
46983513|NCT01662895|83229786|FG001|Overall Study|Lost to Follow-up|1|||
46983514|NCT02557399|83229794|FG000|Overall Study|Adverse Event|6|||
46868375|NCT04067492|83086536|FG000|Overall Study|Lost to Follow-up|0|||
46983515|NCT02557399|83229795|FG001|Overall Study|Adverse Event|5|||
46983516|NCT02557399|83229794|FG000|Overall Study|Protocol Violation|0|||
46983517|NCT02557399|83229795|FG001|Overall Study|Protocol Violation|1|||
46983518|NCT02557399|83229794|FG000|Overall Study|Protocol-defined stopping criteria|0|||
46983519|NCT02557399|83229795|FG001|Overall Study|Protocol-defined stopping criteria|1|||
46983520|NCT02557399|83229794|FG000|Overall Study|Withdrawal by Subject|1|||
46983521|NCT02557399|83229795|FG001|Overall Study|Withdrawal by Subject|1|||
46983522|NCT02555371|83229804|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
46868376|NCT04067492|83086537|FG001|Overall Study|Lost to Follow-up|0|||
46983523|NCT02555371|83229805|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
46983524|NCT02555371|83229806|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
46983525|NCT02555371|83229807|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
46983526|NCT02555371|83229808|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
46983527|NCT02555371|83229804|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
46983528|NCT02555371|83229805|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
46983529|NCT02555371|83229806|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
46983530|NCT02555371|83229807|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
46983531|NCT02555371|83229808|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
46983532|NCT02555371|83229804|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
46983533|NCT02555371|83229805|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
46983534|NCT02555371|83229806|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
46983535|NCT02555371|83229807|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
46983536|NCT02555371|83229808|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
46983537|NCT02555371|83229804|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
46868377|NCT04067492|83086538|FG002|Overall Study|Lost to Follow-up|0|||
46868378|NCT04067492|83086539|FG003|Overall Study|Lost to Follow-up|0|||
46868379|NCT04067492|83086540|FG004|Overall Study|Lost to Follow-up|0|||
46868380|NCT04067492|83086541|FG005|Overall Study|Lost to Follow-up|1|||
46868381|NCT04067492|83086536|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
46868382|NCT04067492|83086537|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
46983538|NCT02555371|83229805|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
46983539|NCT02555371|83229806|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
46983540|NCT02555371|83229807|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
46983541|NCT02555371|83229808|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
46983542|NCT02555371|83229804|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
46983543|NCT02555371|83229805|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
46983544|NCT02555371|83229806|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
46983545|NCT02555371|83229807|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
46983546|NCT02555371|83229808|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
46983547|NCT02555371|83229804|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
46983548|NCT02555371|83229805|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
46983549|NCT02555371|83229806|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
46983550|NCT02555371|83229807|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
46983551|NCT02555371|83229808|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
46983552|NCT02555371|83229804|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
46983553|NCT02555371|83229805|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
46983554|NCT02555371|83229806|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
46983555|NCT02555371|83229807|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
46983556|NCT02555371|83229808|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
46983557|NCT02555371|83229804|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
46983558|NCT02555371|83229805|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
46983559|NCT02555371|83229806|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
46983560|NCT02555371|83229807|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
46983561|NCT02555371|83229808|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
46983562|NCT02555371|83229804|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
46983563|NCT02555371|83229805|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
46983564|NCT02555371|83229806|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
46983565|NCT02555371|83229807|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
46983566|NCT02555371|83229808|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
46983567|NCT02555371|83229804|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
46983568|NCT02555371|83229805|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
46983569|NCT02555371|83229806|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
46983570|NCT02555371|83229807|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
46983571|NCT02555371|83229808|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
46983572|NCT02555371|83229804|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
46983573|NCT02555371|83229805|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
46983574|NCT02555371|83229806|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
46868383|NCT04067492|83086538|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
46868384|NCT04067492|83086539|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
46868385|NCT04067492|83086540|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
46868386|NCT04067492|83086541|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
46983575|NCT02555371|83229807|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
46983576|NCT02555371|83229808|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
46983577|NCT02555371|83229804|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
46983578|NCT02555371|83229805|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
46983579|NCT02555371|83229806|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
46983580|NCT02555371|83229807|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
46983581|NCT02555371|83229808|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
46983582|NCT02555371|83229804|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
46983583|NCT02555371|83229805|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
46983584|NCT02555371|83229806|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
46983585|NCT02555371|83229807|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
46983586|NCT02555371|83229808|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
46983587|NCT02555371|83229804|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
46983588|NCT02555371|83229805|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
46983589|NCT02555371|83229806|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
46983590|NCT02555371|83229807|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
46983591|NCT02555371|83229808|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
46983592|NCT02555215|83229817|FG000|Overall Study|Other|1|||
46983593|NCT02555215|83229817|FG000|Overall Study|Investigator Decision|2|||
46983594|NCT02555683|83229824|FG000|Overall Study|Physician Decision|1|||
46983595|NCT02555683|83229825|FG001|Overall Study|Physician Decision|0|||
46983596|NCT02555683|83229826|FG002|Overall Study|Physician Decision|2|||
46983597|NCT02555683|83229824|FG000|Overall Study|Lost to Follow-up|2|||
46983598|NCT02555683|83229825|FG001|Overall Study|Lost to Follow-up|1|||
46983599|NCT02555683|83229826|FG002|Overall Study|Lost to Follow-up|2|||
46983600|NCT02555683|83229824|FG000|Overall Study|Technical Problems|1|||
46983601|NCT02555683|83229825|FG001|Overall Study|Technical Problems|1|||
46983602|NCT02555683|83229826|FG002|Overall Study|Technical Problems|0|||
46983603|NCT02555683|83229824|FG000|Overall Study|Protocol deviation|0|||
46983604|NCT02555683|83229825|FG001|Overall Study|Protocol deviation|1|||
46983605|NCT02555683|83229826|FG002|Overall Study|Protocol deviation|0|||
46983606|NCT02555683|83229824|FG000|Overall Study|Lack of Efficacy|2|||
46983607|NCT02555683|83229825|FG001|Overall Study|Lack of Efficacy|0|||
46983608|NCT02555683|83229826|FG002|Overall Study|Lack of Efficacy|0|||
46983609|NCT02555683|83229824|FG000|Overall Study|Death|0|||
46983610|NCT02555683|83229825|FG001|Overall Study|Death|1|||
46983611|NCT02555683|83229826|FG002|Overall Study|Death|2|||
46983612|NCT02555683|83229824|FG000|Overall Study|Adverse Event|1|||
46983613|NCT02555683|83229825|FG001|Overall Study|Adverse Event|0|||
46983614|NCT02555683|83229826|FG002|Overall Study|Adverse Event|1|||
46983615|NCT02555683|83229824|FG000|Overall Study|Subject/guardian decision|12|||
46983616|NCT02555683|83229825|FG001|Overall Study|Subject/guardian decision|12|||
46983617|NCT02555683|83229826|FG002|Overall Study|Subject/guardian decision|22|||
46983618|NCT02555683|83229824|FG000|Overall Study|Death post Treatment/safety period|0|||
46983619|NCT02555683|83229825|FG001|Overall Study|Death post Treatment/safety period|1|||
46983620|NCT02555683|83229826|FG002|Overall Study|Death post Treatment/safety period|0|||
46983621|NCT02554981|83229834|FG000|Overall Study|Adverse Event|1|||
46983622|NCT02554981|83229834|FG000|Overall Study|Administrative Reasons|1|||
46983623|NCT02554981|83229834|FG000|Overall Study|Other Miscellaneous Reasons|3|||
46983624|NCT02556775|83229842|FG000|Overall Study|Withdrawal by Subject|1|||
46983625|NCT02556775|83229843|FG001|Overall Study|Withdrawal by Subject|0|||
46983626|NCT02556775|83229844|FG002|Overall Study|Withdrawal by Subject|1|||
46983627|NCT02556775|83229845|FG003|Overall Study|Withdrawal by Subject|0|||
46983628|NCT02556775|83229842|FG000|Overall Study|Lost to Follow-up|1|||
46983629|NCT02556775|83229843|FG001|Overall Study|Lost to Follow-up|0|||
46983630|NCT02556775|83229844|FG002|Overall Study|Lost to Follow-up|0|||
46983631|NCT02556775|83229845|FG003|Overall Study|Lost to Follow-up|0|||
46983632|NCT01662505|83229860|FG000|Overall Study|Progressive disease|6|||
46983633|NCT01662505|83229861|FG001|Overall Study|Progressive disease|1|||
46983634|NCT01662505|83229862|FG002|Overall Study|Progressive disease|5|||
46983635|NCT01662505|83229860|FG000|Overall Study|Refused cont. medication|0|||
46983636|NCT01662505|83229861|FG001|Overall Study|Refused cont. medication|0|||
46983637|NCT01662505|83229862|FG002|Overall Study|Refused cont. medication|1|||
46983638|NCT01662505|83229860|FG000|Overall Study|Not specified above|1|||
46983639|NCT01662505|83229861|FG001|Overall Study|Not specified above|3|||
46868387|NCT04067492|83086536|FG000|Overall Study|COVID-19 epidemiological situation|0|||
46983640|NCT01662505|83229862|FG002|Overall Study|Not specified above|2|||
46983641|NCT03796195|83229871|FG000|Overall Study|Study closed early|1|||
46983642|NCT02554513|83229875|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
46983643|NCT02554513|83229876|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
46983644|NCT02554903|83229890|FG000|Overall Study|Death|1|||
46983645|NCT02554903|83229891|FG001|Overall Study|Death|1|||
46983646|NCT02554903|83229890|FG000|Overall Study|Physician Decision|2|||
46983647|NCT02554903|83229891|FG001|Overall Study|Physician Decision|2|||
46983648|NCT02554903|83229890|FG000|Overall Study|Heart Transplant|1|||
46983649|NCT02554903|83229891|FG001|Overall Study|Heart Transplant|2|||
46983650|NCT02332707|83229916|FG000|Overall Study|Adverse Event|0|||
46983651|NCT02332707|83229917|FG001|Overall Study|Adverse Event|0|||
46983652|NCT02332707|83229918|FG002|Overall Study|Adverse Event|0|||
46983653|NCT02332707|83229919|FG003|Overall Study|Adverse Event|0|||
46983654|NCT02332707|83229920|FG004|Overall Study|Adverse Event|0|||
46983655|NCT02332707|83229921|FG005|Overall Study|Adverse Event|0|||
46983656|NCT02332707|83229922|FG006|Overall Study|Adverse Event|0|||
46983657|NCT02332707|83229923|FG007|Overall Study|Adverse Event|0|||
46983658|NCT02332707|83229924|FG008|Overall Study|Adverse Event|0|||
46983659|NCT02332707|83229925|FG009|Overall Study|Adverse Event|0|||
46983660|NCT02332707|83229926|FG010|Overall Study|Adverse Event|0|||
46983661|NCT02332707|83229927|FG011|Overall Study|Adverse Event|0|||
46983662|NCT02332707|83229928|FG012|Overall Study|Adverse Event|1|||
46983663|NCT02332707|83229929|FG013|Overall Study|Adverse Event|0|||
46983664|NCT02332707|83229930|FG014|Overall Study|Adverse Event|0|||
46983665|NCT02332707|83229931|FG015|Overall Study|Adverse Event|0|||
46868388|NCT04067492|83086537|FG001|Overall Study|COVID-19 epidemiological situation|0|||
46868389|NCT04067492|83086538|FG002|Overall Study|COVID-19 epidemiological situation|0|||
46868390|NCT04067492|83086539|FG003|Overall Study|COVID-19 epidemiological situation|1|||
46868391|NCT04067492|83086540|FG004|Overall Study|COVID-19 epidemiological situation|0|||
46868392|NCT04067492|83086541|FG005|Overall Study|COVID-19 epidemiological situation|0|||
46868393|NCT04375878|83086559|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
46868394|NCT04375878|83086560|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
46868395|NCT04375878|83086561|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
46868396|NCT04375878|83086562|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
46868397|NCT04375878|83086563|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
46868398|NCT04375878|83086564|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
46868399|NCT04375878|83086559|FG000|Crossover First and Second Interventions|Adverse Event|0|||
46868400|NCT04375878|83086560|FG001|Crossover First and Second Interventions|Adverse Event|0|||
46868401|NCT04375878|83086561|FG002|Crossover First and Second Interventions|Adverse Event|1|||
46868402|NCT04375878|83086562|FG003|Crossover First and Second Interventions|Adverse Event|0|||
46868403|NCT04375878|83086563|FG004|Crossover First and Second Interventions|Adverse Event|0|||
46868404|NCT04375878|83086564|FG005|Crossover First and Second Interventions|Adverse Event|0|||
46868405|NCT04375878|83086559|FG000|Extension Phase|Withdrawal by Subject|0|||
46868406|NCT04375878|83086560|FG001|Extension Phase|Withdrawal by Subject|0|||
46868407|NCT04375878|83086561|FG002|Extension Phase|Withdrawal by Subject|0|||
46868408|NCT04375878|83086562|FG003|Extension Phase|Withdrawal by Subject|0|||
46868409|NCT04375878|83086563|FG004|Extension Phase|Withdrawal by Subject|1|||
46983666|NCT02332707|83229932|FG016|Overall Study|Adverse Event|0|||
46868410|NCT04375878|83086564|FG005|Extension Phase|Withdrawal by Subject|0|||
46868411|NCT04189224|83086584|FG000|Period 2|Adverse Event|0|||
46983667|NCT02332707|83229933|FG017|Overall Study|Adverse Event|0|||
46698384|NCT00928135|82913425|FG000|Overall Study|Withdrawal by Subject|1|||
46868412|NCT04189224|83086585|FG001|Period 2|Adverse Event|1|||
46868413|NCT04186806|83086593|FG000|Period 1: 7 Days|Adverse Event|1|||
46868414|NCT04186806|83086594|FG001|Period 1: 7 Days|Adverse Event|0|||
46868415|NCT04041414|83086603|FG000|Overall Study|Lost to Follow-up|1|||
46868416|NCT04041414|83086604|FG001|Overall Study|Lost to Follow-up|2|||
46868417|NCT04370028|83086613|FG000|Overall Study|Withdrawal by Subject|695|||
46868418|NCT04370028|83086613|FG000|Overall Study|Protocol Violation|9|||
46868419|NCT04370028|83086613|FG000|Overall Study|Adverse Event|3|||
46868420|NCT04037748|83086626|FG000|Treatment Period 1|Withdrawal by Subject|3|||
46868421|NCT04037748|83086627|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46868422|NCT04037748|83086626|FG000|Treatment Period 1|Adverse Event|1|||
46868423|NCT04037748|83086627|FG001|Treatment Period 1|Adverse Event|1|||
46868424|NCT04037748|83086626|FG000|Treatment Period 1|Protocol Violation|4|||
46868425|NCT04037748|83086627|FG001|Treatment Period 1|Protocol Violation|5|||
46868426|NCT04037748|83086626|FG000|Treatment Period 2|Adverse Event|0|||
46868427|NCT04037748|83086627|FG001|Treatment Period 2|Adverse Event|1|||
46868428|NCT04037748|83086626|FG000|Treatment Period 2|Protocol Violation|2|||
46868429|NCT04037748|83086627|FG001|Treatment Period 2|Protocol Violation|0|||
46868430|NCT04036110|83086636|FG000|Overall Study|Lost to Follow-up|3|||
46868431|NCT04036110|83086637|FG001|Overall Study|Lost to Follow-up|2|||
46868432|NCT04036110|83086638|FG002|Overall Study|Lost to Follow-up|1|||
46868433|NCT04036110|83086636|FG000|Overall Study|Study Suspended|4|||
46868434|NCT04036110|83086637|FG001|Overall Study|Study Suspended|5|||
46868435|NCT04036110|83086638|FG002|Overall Study|Study Suspended|1|||
46868436|NCT03053050|83086649|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
46868437|NCT03053050|83086650|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
46868438|NCT03053050|83086651|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
46868439|NCT03053050|83086652|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
46868440|NCT03053050|83086649|FG000|Randomized Phase|Withdrew Consent|16|||
46868441|NCT03053050|83086650|FG001|Randomized Phase|Withdrew Consent|8|||
46868442|NCT03053050|83086651|FG002|Randomized Phase|Withdrew Consent|9|||
46868443|NCT03053050|83086652|FG003|Randomized Phase|Withdrew Consent|0|||
46868444|NCT03053050|83086649|FG000|Randomized Phase|Investigator's Discretion|6|||
46868445|NCT03053050|83086650|FG001|Randomized Phase|Investigator's Discretion|6|||
46868446|NCT03053050|83086651|FG002|Randomized Phase|Investigator's Discretion|3|||
46868447|NCT03053050|83086652|FG003|Randomized Phase|Investigator's Discretion|0|||
46868448|NCT03053050|83086649|FG000|Randomized Phase|Lost to Follow-up|5|||
46868449|NCT03053050|83086650|FG001|Randomized Phase|Lost to Follow-up|1|||
46868450|NCT03053050|83086651|FG002|Randomized Phase|Lost to Follow-up|1|||
46868451|NCT03053050|83086652|FG003|Randomized Phase|Lost to Follow-up|0|||
46868452|NCT03053050|83086649|FG000|Randomized Phase|Adverse Event|0|||
46868453|NCT03053050|83086650|FG001|Randomized Phase|Adverse Event|1|||
46868454|NCT03053050|83086651|FG002|Randomized Phase|Adverse Event|0|||
46868455|NCT03053050|83086652|FG003|Randomized Phase|Adverse Event|0|||
46868456|NCT03053050|83086649|FG000|Randomized Phase|Randomized but Never Treated|2|||
46868457|NCT03053050|83086650|FG001|Randomized Phase|Randomized but Never Treated|2|||
46868458|NCT03053050|83086651|FG002|Randomized Phase|Randomized but Never Treated|2|||
46868459|NCT03053050|83086652|FG003|Randomized Phase|Randomized but Never Treated|0|||
46868460|NCT03053050|83086649|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
46868461|NCT03053050|83086650|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
46868462|NCT03053050|83086651|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
46868463|NCT03053050|83086652|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
46868464|NCT03053050|83086649|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
46868465|NCT03053050|83086650|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
46868466|NCT03053050|83086651|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
46868467|NCT03053050|83086652|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
46868468|NCT03053050|83086649|FG000|Open-label Phase|Withdrew Consent|0|||
46868469|NCT03053050|83086650|FG001|Open-label Phase|Withdrew Consent|0|||
46868470|NCT03053050|83086651|FG002|Open-label Phase|Withdrew Consent|0|||
46868471|NCT03053050|83086652|FG003|Open-label Phase|Withdrew Consent|6|||
46868472|NCT03053050|83086649|FG000|Open-label Phase|Investigator's Discretion|0|||
46868473|NCT03053050|83086650|FG001|Open-label Phase|Investigator's Discretion|0|||
46868474|NCT03053050|83086651|FG002|Open-label Phase|Investigator's Discretion|0|||
46868475|NCT03053050|83086652|FG003|Open-label Phase|Investigator's Discretion|4|||
46698385|NCT00928135|82913426|FG001|Overall Study|Withdrawal by Subject|0|||
46698386|NCT00928057|82913434|FG000|Overall Study|Adverse Event|1|||
46698387|NCT00928057|82913435|FG001|Overall Study|Adverse Event|2|||
46868476|NCT04369950|83086663|FG000|Overall Study|Protocol Violation|2|||
46868477|NCT04369950|83086664|FG001|Overall Study|Protocol Violation|2|||
46868478|NCT04035564|83086672|FG000|Overall Study|Protocol Violation|1|||
46698388|NCT00928057|82913434|FG000|Overall Study|Withdrawal by Subject|1|||
46698389|NCT00928057|82913435|FG001|Overall Study|Withdrawal by Subject|0|||
46698390|NCT00928057|82913434|FG000|Overall Study|Lost to Follow-up|0|||
46698391|NCT00928057|82913435|FG001|Overall Study|Lost to Follow-up|1|||
46698392|NCT00928057|82913434|FG000|Overall Study|Protocol Violation|0|||
46698393|NCT00928057|82913435|FG001|Overall Study|Protocol Violation|1|||
46698394|NCT00927901|82913451|FG000|Treatment Period 1|Subject withdrew consent|0|||
46698395|NCT00927901|82913452|FG001|Treatment Period 1|Subject withdrew consent|0|||
46698396|NCT00927901|82913453|FG002|Treatment Period 1|Subject withdrew consent|1|||
46698397|NCT00927901|82913454|FG003|Treatment Period 1|Subject withdrew consent|0|||
46698398|NCT00927901|82913451|FG000|Treatment Period 4|Adverse Event|0|||
46698399|NCT00927901|82913452|FG001|Treatment Period 4|Adverse Event|0|||
46698400|NCT00927901|82913453|FG002|Treatment Period 4|Adverse Event|0|||
46698401|NCT00927901|82913454|FG003|Treatment Period 4|Adverse Event|1|||
46698402|NCT00927901|82913451|FG000|Treatment Period 4|Subject withdrew consent|0|||
46698403|NCT00927901|82913452|FG001|Treatment Period 4|Subject withdrew consent|0|||
46698404|NCT00927901|82913453|FG002|Treatment Period 4|Subject withdrew consent|1|||
46698405|NCT00927901|82913454|FG003|Treatment Period 4|Subject withdrew consent|0|||
46698406|NCT01218204|82913469|FG000|Part B Washout|Adverse Event|0|||
46698407|NCT01218204|82913470|FG001|Part B Washout|Adverse Event|1|||
46698408|NCT01218204|82913471|FG002|Part B Washout|Adverse Event|0|||
46698409|NCT01218204|82913472|FG003|Part B Washout|Adverse Event|0|||
46698410|NCT01218204|82913469|FG000|Part B Washout|Lost to Follow-up|0|||
46698411|NCT01218204|82913470|FG001|Part B Washout|Lost to Follow-up|2|||
46698412|NCT01218204|82913471|FG002|Part B Washout|Lost to Follow-up|0|||
46698413|NCT01218204|82913472|FG003|Part B Washout|Lost to Follow-up|0|||
46698414|NCT01218204|82913469|FG000|Part B Washout|Physician Decision|0|||
46698415|NCT01218204|82913470|FG001|Part B Washout|Physician Decision|14|||
46698416|NCT01218204|82913471|FG002|Part B Washout|Physician Decision|0|||
46698417|NCT01218204|82913472|FG003|Part B Washout|Physician Decision|0|||
46698418|NCT01218204|82913469|FG000|Part B Washout|Withdrawal by Subject|0|||
46698419|NCT01218204|82913470|FG001|Part B Washout|Withdrawal by Subject|14|||
46868479|NCT04035564|83086673|FG001|Overall Study|Protocol Violation|2|||
46868480|NCT04035564|83086672|FG000|Overall Study|No laboratory available|2|||
46868481|NCT04035564|83086673|FG001|Overall Study|No laboratory available|2|||
46868482|NCT04035564|83086672|FG000|Overall Study|Guardian declined consent|1|||
46868483|NCT04035564|83086673|FG001|Overall Study|Guardian declined consent|2|||
46698420|NCT01218204|82913471|FG002|Part B Washout|Withdrawal by Subject|0|||
46698421|NCT01218204|82913472|FG003|Part B Washout|Withdrawal by Subject|0|||
46868484|NCT02955602|83086682|FG000|Overall Study|Adverse Event|0|||
46868485|NCT02955602|83086683|FG001|Overall Study|Adverse Event|3|||
46868486|NCT02955602|83086684|FG002|Overall Study|Adverse Event|0|||
46868487|NCT02955602|83086682|FG000|Overall Study|Withdrawal of informed consent|1|||
46868488|NCT02955602|83086683|FG001|Overall Study|Withdrawal of informed consent|3|||
46868489|NCT02955602|83086684|FG002|Overall Study|Withdrawal of informed consent|2|||
46868490|NCT02955602|83086682|FG000|Overall Study|Lost to Follow-up|0|||
46868491|NCT02955602|83086683|FG001|Overall Study|Lost to Follow-up|0|||
46868492|NCT02955602|83086684|FG002|Overall Study|Lost to Follow-up|1|||
46868493|NCT02955602|83086682|FG000|Overall Study|Other|0|||
46868494|NCT02955602|83086683|FG001|Overall Study|Other|1|||
46868495|NCT02955602|83086684|FG002|Overall Study|Other|3|||
46868496|NCT04179786|83086692|FG000|Overall Study|Withdrawal by Subject|8|||
46868497|NCT04175808|83086696|FG000|Part A|Miscellaneous|2|||
46868498|NCT04175808|83086697|FG001|Part A|Miscellaneous|0|||
46868499|NCT04175808|83086698|FG002|Part A|Miscellaneous|0|||
46868500|NCT04175808|83086699|FG003|Part A|Miscellaneous|0|||
46868501|NCT04175808|83086700|FG004|Part A|Miscellaneous|0|||
46868502|NCT04175808|83086701|FG005|Part A|Miscellaneous|0|||
46868503|NCT04175808|83086702|FG006|Part A|Miscellaneous|0|||
46868504|NCT04057196|83086718|FG000|Overall Study|Withdrawal by Subject|3|||
46868505|NCT04057196|83086718|FG000|Overall Study|Death|3|||
46868506|NCT04027686|83086724|FG000|Overall Study|Lost to Follow-up|2|||
46868507|NCT04027686|83086725|FG001|Overall Study|Lost to Follow-up|0|||
46868508|NCT04027686|83086724|FG000|Overall Study|Withdrawal by Subject|0|||
46868509|NCT04027686|83086725|FG001|Overall Study|Withdrawal by Subject|1|||
46868510|NCT03052426|83086738|FG000|Overall Study|Withdrawal by Subject|0|||
46868511|NCT03052426|83086739|FG001|Overall Study|Withdrawal by Subject|1|||
46868512|NCT03052426|83086740|FG002|Overall Study|Withdrawal by Subject|0|||
46868513|NCT03052426|83086738|FG000|Overall Study|Lost to Follow-up|2|||
46868514|NCT03052426|83086739|FG001|Overall Study|Lost to Follow-up|0|||
46868515|NCT03052426|83086740|FG002|Overall Study|Lost to Follow-up|1|||
46868516|NCT03688880|83086755|FG000|Overall Study|Withdrawal by Subject|0|||
46698422|NCT01218204|82913469|FG000|Part B Washout|Reached defined stopping criteria|0|||
46698423|NCT01218204|82913470|FG001|Part B Washout|Reached defined stopping criteria|2|||
46868517|NCT03688880|83086756|FG001|Overall Study|Withdrawal by Subject|2|||
46868518|NCT03688880|83086755|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
46868519|NCT03688880|83086756|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
46868520|NCT03688880|83086755|FG000|Overall Study|Lost to Follow-up|4|||
46698424|NCT01218204|82913471|FG002|Part B Washout|Reached defined stopping criteria|0|||
46698425|NCT01218204|82913472|FG003|Part B Washout|Reached defined stopping criteria|0|||
46868521|NCT03688880|83086756|FG001|Overall Study|Lost to Follow-up|7|||
46868522|NCT03688880|83086755|FG000|Overall Study|Adverse Event|0|||
46868523|NCT03688880|83086756|FG001|Overall Study|Adverse Event|2|||
46868524|NCT03688880|83086755|FG000|Overall Study|Device deficiencies|0|||
46868525|NCT03688880|83086756|FG001|Overall Study|Device deficiencies|2|||
46868526|NCT03688880|83086755|FG000|Overall Study|Other|10|||
46868527|NCT03688880|83086756|FG001|Overall Study|Other|16|||
46698426|NCT01218204|82913469|FG000|Part B Washout|Did not meet continuation criteria|0|||
46698427|NCT01218204|82913470|FG001|Part B Washout|Did not meet continuation criteria|112|||
46698428|NCT01218204|82913471|FG002|Part B Washout|Did not meet continuation criteria|0|||
46698429|NCT01218204|82913472|FG003|Part B Washout|Did not meet continuation criteria|0|||
46698430|NCT01218204|82913469|FG000|Part B Run-in|Adverse Event|0|||
46698431|NCT01218204|82913470|FG001|Part B Run-in|Adverse Event|0|||
46698432|NCT01218204|82913471|FG002|Part B Run-in|Adverse Event|1|||
46698433|NCT01218204|82913472|FG003|Part B Run-in|Adverse Event|0|||
46698434|NCT01218204|82913469|FG000|Part B Run-in|Protocol Violation|0|||
46698435|NCT01218204|82913470|FG001|Part B Run-in|Protocol Violation|0|||
46698436|NCT01218204|82913471|FG002|Part B Run-in|Protocol Violation|2|||
46698437|NCT01218204|82913472|FG003|Part B Run-in|Protocol Violation|0|||
46698438|NCT01218204|82913469|FG000|Part B Run-in|Withdrawal by Subject|0|||
46698439|NCT01218204|82913470|FG001|Part B Run-in|Withdrawal by Subject|0|||
46698440|NCT01218204|82913471|FG002|Part B Run-in|Withdrawal by Subject|3|||
46698441|NCT01218204|82913472|FG003|Part B Run-in|Withdrawal by Subject|0|||
46698442|NCT01218204|82913469|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
46698443|NCT01218204|82913470|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
46698444|NCT01218204|82913471|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
46802537|NCT00098293|83021884|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
46698445|NCT01218204|82913472|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
46698446|NCT01218204|82913469|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
46868528|NCT03051178|83086762|FG000|Overall Study|Withdrawal by Subject|5|||
46868529|NCT03051100|83086768|FG000|Overall Study|Withdrawal by Subject|1|||
46802538|NCT00098293|83021885|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
46802539|NCT00098293|83021886|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
46802540|NCT00098293|83021887|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
46802541|NCT00098293|83021883|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
46802542|NCT00098293|83021884|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
46802543|NCT00098293|83021885|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
46802544|NCT00098293|83021886|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
46868530|NCT03051100|83086769|FG001|Overall Study|Withdrawal by Subject|0|||
46868531|NCT01343368|83086777|FG000|Overall Study|Death|1|||
46868532|NCT01343368|83086778|FG001|Overall Study|Death|0|||
46983668|NCT02332707|83229916|FG000|Overall Study|Lost to Follow-up|0|||
46983669|NCT02332707|83229917|FG001|Overall Study|Lost to Follow-up|0|||
46868533|NCT01343368|83086777|FG000|Overall Study|Lost to Follow-up|1|||
46868534|NCT01343368|83086778|FG001|Overall Study|Lost to Follow-up|0|||
46868535|NCT02955212|83086786|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
46698447|NCT01218204|82913470|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
46698448|NCT01218204|82913471|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
46698449|NCT01218204|82913472|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
46698450|NCT00926575|82913521|FG000|Overall Study|Adverse Event|1|||
46698451|NCT00926575|82913522|FG001|Overall Study|Adverse Event|1|||
46868536|NCT02955212|83086787|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
46698452|NCT00926575|82913521|FG000|Overall Study|Death|4|||
46698453|NCT00926575|82913522|FG001|Overall Study|Death|4|||
46698454|NCT00926575|82913521|FG000|Overall Study|Lost to Follow-up|1|||
46868537|NCT02955212|83086786|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
46868538|NCT02955212|83086787|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
46868539|NCT02955212|83086786|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
46868540|NCT02955212|83086787|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
46983670|NCT02332707|83229918|FG002|Overall Study|Lost to Follow-up|0|||
46868541|NCT02955212|83086786|FG000|Period 1: Double-blind Treatment Period|Other|3|||
46868542|NCT02955212|83086787|FG001|Period 1: Double-blind Treatment Period|Other|2|||
46983671|NCT02332707|83229919|FG003|Overall Study|Lost to Follow-up|0|||
46983672|NCT02332707|83229920|FG004|Overall Study|Lost to Follow-up|0|||
46698455|NCT00926575|82913522|FG001|Overall Study|Lost to Follow-up|1|||
46868543|NCT02955212|83086786|FG000|Period 2: Open-label Extension|Adverse Event|11|||
46868544|NCT02955212|83086787|FG001|Period 2: Open-label Extension|Adverse Event|7|||
46868545|NCT02955212|83086786|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
46868546|NCT02955212|83086787|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
46868547|NCT02955212|83086786|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
46868548|NCT02955212|83086787|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
46868549|NCT02955212|83086786|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
46868550|NCT02955212|83086787|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
46868551|NCT02955212|83086786|FG000|Period 2: Open-label Extension|Other|2|||
46868552|NCT02955212|83086787|FG001|Period 2: Open-label Extension|Other|4|||
46868553|NCT03050398|83086794|FG000|Overall Study|Study terminated by sponsor|8|||
46868554|NCT03662750|83086798|FG000|Overall Study|Withdrawal by Subject|1|||
46868555|NCT04052204|83086802|FG000|Overall Study|Death|1|||
46868556|NCT04052204|83086803|FG001|Overall Study|Death|0|||
46868557|NCT04052204|83086804|FG002|Overall Study|Death|0|||
46868558|NCT04052204|83086802|FG000|Overall Study|Progressive disease|1|||
46868559|NCT04052204|83086803|FG001|Overall Study|Progressive disease|0|||
46868560|NCT04052204|83086804|FG002|Overall Study|Progressive disease|0|||
46868561|NCT04052204|83086802|FG000|Overall Study|Other|1|||
46868562|NCT04052204|83086803|FG001|Overall Study|Other|0|||
46868563|NCT04052204|83086804|FG002|Overall Study|Other|0|||
46868564|NCT04050722|83086810|FG000|Overall Study|Withdrawal by Subject|1|||
46868565|NCT04050722|83086811|FG001|Overall Study|Withdrawal by Subject|0|||
46868566|NCT04049552|83086817|FG000|Overall Study|Lost to Follow-up|1|||
46868567|NCT03048058|83086825|FG000|Overall Study|Lost to Follow-up|4|||
46868568|NCT03048058|83086826|FG001|Overall Study|Lost to Follow-up|0|||
46868569|NCT03048058|83086825|FG000|Overall Study|Withdrawal by Subject|0|||
46868570|NCT03048058|83086826|FG001|Overall Study|Withdrawal by Subject|4|||
46983673|NCT02332707|83229921|FG005|Overall Study|Lost to Follow-up|1|||
46868571|NCT03047980|83086832|FG000|Overall Study|Adverse Event|1|||
46868572|NCT04048382|83086838|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
46868573|NCT04048382|83086839|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
46868574|NCT04048382|83086838|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
46868575|NCT04048382|83086839|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
46983674|NCT02332707|83229922|FG006|Overall Study|Lost to Follow-up|0|||
46983675|NCT02332707|83229923|FG007|Overall Study|Lost to Follow-up|0|||
46983676|NCT02332707|83229924|FG008|Overall Study|Lost to Follow-up|0|||
46698456|NCT00926575|82913521|FG000|Overall Study|Physician Decision|1|||
46698457|NCT00926575|82913522|FG001|Overall Study|Physician Decision|2|||
46698458|NCT00926575|82913521|FG000|Overall Study|Protocol Violation|1|||
46698459|NCT00926575|82913522|FG001|Overall Study|Protocol Violation|0|||
46698460|NCT00926575|82913521|FG000|Overall Study|Withdrawal by Subject|8|||
46698461|NCT00926575|82913522|FG001|Overall Study|Withdrawal by Subject|9|||
46698462|NCT01218126|82913532|FG000|Overall Study|Adverse Event|8|||
46698463|NCT01218126|82913533|FG001|Overall Study|Adverse Event|10|||
46698464|NCT01218126|82913534|FG002|Overall Study|Adverse Event|12|||
46698465|NCT01218126|82913535|FG003|Overall Study|Adverse Event|16|||
46698466|NCT01218126|82913532|FG000|Overall Study|Lack of Efficacy|7|||
46698467|NCT01218126|82913533|FG001|Overall Study|Lack of Efficacy|2|||
46698468|NCT01218126|82913534|FG002|Overall Study|Lack of Efficacy|2|||
46698469|NCT01218126|82913535|FG003|Overall Study|Lack of Efficacy|6|||
46698470|NCT01218126|82913532|FG000|Overall Study|Protocol Violation|5|||
46698471|NCT01218126|82913533|FG001|Overall Study|Protocol Violation|2|||
46698472|NCT01218126|82913534|FG002|Overall Study|Protocol Violation|2|||
46698473|NCT01218126|82913535|FG003|Overall Study|Protocol Violation|3|||
46698474|NCT01218126|82913532|FG000|Overall Study|Protocol-defined stopping criteria|1|||
46698475|NCT01218126|82913533|FG001|Overall Study|Protocol-defined stopping criteria|1|||
46698476|NCT01218126|82913534|FG002|Overall Study|Protocol-defined stopping criteria|0|||
46698477|NCT01218126|82913535|FG003|Overall Study|Protocol-defined stopping criteria|0|||
46698478|NCT01218126|82913532|FG000|Overall Study|Lost to Follow-up|0|||
46698479|NCT01218126|82913533|FG001|Overall Study|Lost to Follow-up|0|||
46698480|NCT01218126|82913534|FG002|Overall Study|Lost to Follow-up|0|||
46698481|NCT01218126|82913535|FG003|Overall Study|Lost to Follow-up|2|||
46698482|NCT01218126|82913532|FG000|Overall Study|Physician Decision|1|||
46698483|NCT01218126|82913533|FG001|Overall Study|Physician Decision|2|||
46698484|NCT01218126|82913534|FG002|Overall Study|Physician Decision|4|||
46698485|NCT01218126|82913535|FG003|Overall Study|Physician Decision|2|||
46698486|NCT01218126|82913532|FG000|Overall Study|Withdrawal by Subject|2|||
46698487|NCT01218126|82913533|FG001|Overall Study|Withdrawal by Subject|5|||
46698488|NCT01218126|82913534|FG002|Overall Study|Withdrawal by Subject|4|||
46698489|NCT01218126|82913535|FG003|Overall Study|Withdrawal by Subject|6|||
46698490|NCT01217892|82913549|FG000|Overall Study|Adverse Event|1|||
46698491|NCT01217892|82913550|FG001|Overall Study|Adverse Event|1|||
46698492|NCT01217892|82913551|FG002|Overall Study|Adverse Event|1|||
46698493|NCT01217892|82913552|FG003|Overall Study|Adverse Event|0|||
46698494|NCT01217892|82913549|FG000|Overall Study|Withdrawal by Subject|0|||
46868576|NCT04048382|83086838|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
46698495|NCT01217892|82913550|FG001|Overall Study|Withdrawal by Subject|2|||
46698496|NCT01217892|82913551|FG002|Overall Study|Withdrawal by Subject|1|||
46868577|NCT04048382|83086839|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
46868578|NCT04047446|83086847|FG000|Overall Study|Physician Decision|1|||
46868579|NCT04047446|83086848|FG001|Overall Study|Physician Decision|0|||
46868580|NCT03655106|83086856|FG000|Overall Study|Withdrawal by Subject|3|||
46868581|NCT03655106|83086857|FG001|Overall Study|Withdrawal by Subject|2|||
46868582|NCT03655106|83086856|FG000|Overall Study|Lost to Follow-up|2|||
46868583|NCT03655106|83086857|FG001|Overall Study|Lost to Follow-up|1|||
46868584|NCT03655106|83086856|FG000|Overall Study|Duplicate Enrollment|1|||
46868585|NCT03655106|83086857|FG001|Overall Study|Duplicate Enrollment|1|||
46868586|NCT03655106|83086856|FG000|Overall Study|Protocol Violation|3|||
46868587|NCT03655106|83086857|FG001|Overall Study|Protocol Violation|0|||
46868588|NCT03630302|83086863|FG000|Surgery|hardware issue prevented LFP recordings|1|||
46868589|NCT03630302|83086863|FG000|3 Month Visit|Adverse Event|2|||
46698497|NCT01217892|82913552|FG003|Overall Study|Withdrawal by Subject|0|||
46698498|NCT01217892|82913549|FG000|Overall Study|Lab value|1|||
46698499|NCT01217892|82913550|FG001|Overall Study|Lab value|0|||
46698500|NCT01217892|82913551|FG002|Overall Study|Lab value|1|||
46868590|NCT03630302|83086863|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
46868591|NCT04041440|83086869|FG000|Overall Study|Withdrawal by Subject|0|||
46698501|NCT01217892|82913552|FG003|Overall Study|Lab value|0|||
46698502|NCT01217892|82913549|FG000|Overall Study|Subject no longer meets study criteria|5|||
46698503|NCT01217892|82913550|FG001|Overall Study|Subject no longer meets study criteria|2|||
46698504|NCT01217892|82913551|FG002|Overall Study|Subject no longer meets study criteria|4|||
46698505|NCT01217892|82913552|FG003|Overall Study|Subject no longer meets study criteria|8|||
46698506|NCT01217892|82913549|FG000|Overall Study|Incorrect enrollment|0|||
46698507|NCT01217892|82913550|FG001|Overall Study|Incorrect enrollment|1|||
46698508|NCT01217892|82913551|FG002|Overall Study|Incorrect enrollment|1|||
46698509|NCT01217892|82913552|FG003|Overall Study|Incorrect enrollment|0|||
46698510|NCT01217892|82913549|FG000|Overall Study|Poor/Non-Compliance|0|||
46698511|NCT01217892|82913550|FG001|Overall Study|Poor/Non-Compliance|0|||
46698512|NCT01217892|82913551|FG002|Overall Study|Poor/Non-Compliance|1|||
46698513|NCT01217892|82913552|FG003|Overall Study|Poor/Non-Compliance|0|||
46698514|NCT01217814|82913565|FG000|Overall Study|Adverse Event|1|||
46698515|NCT01217814|82913566|FG001|Overall Study|Adverse Event|1|||
46698516|NCT01217814|82913567|FG002|Overall Study|Adverse Event|0|||
46698517|NCT01217814|82913565|FG000|Overall Study|Lack of Efficacy|0|||
46698518|NCT01217814|82913566|FG001|Overall Study|Lack of Efficacy|0|||
46698519|NCT01217814|82913567|FG002|Overall Study|Lack of Efficacy|1|||
46698520|NCT01217190|82913578|FG000|Second Dosing|Withdrawal by Subject|0|||
46698521|NCT01217190|82913579|FG001|Second Dosing|Withdrawal by Subject|2|||
46698522|NCT01136733|82913595|FG000|Phase 1b|Adverse Event|0|||
46698523|NCT01136733|82913596|FG001|Phase 1b|Adverse Event|3|||
46868592|NCT04041440|83086870|FG001|Overall Study|Withdrawal by Subject|1|||
46868593|NCT04041440|83086869|FG000|Overall Study|Lost to Follow-up|0|||
46868594|NCT04041440|83086870|FG001|Overall Study|Lost to Follow-up|1|||
46868595|NCT03654560|83086879|FG000|Overall Study|Death|3|||
46868596|NCT03654560|83086880|FG001|Overall Study|Death|1|||
46983677|NCT02332707|83229925|FG009|Overall Study|Lost to Follow-up|0|||
46983678|NCT02332707|83229926|FG010|Overall Study|Lost to Follow-up|2|||
46983679|NCT02332707|83229927|FG011|Overall Study|Lost to Follow-up|0|||
46983680|NCT02332707|83229928|FG012|Overall Study|Lost to Follow-up|3|||
46983681|NCT02332707|83229929|FG013|Overall Study|Lost to Follow-up|0|||
46983682|NCT02332707|83229930|FG014|Overall Study|Lost to Follow-up|0|||
46983683|NCT02332707|83229931|FG015|Overall Study|Lost to Follow-up|0|||
46983684|NCT02332707|83229932|FG016|Overall Study|Lost to Follow-up|0|||
46983685|NCT02332707|83229933|FG017|Overall Study|Lost to Follow-up|0|||
46983686|NCT02332707|83229916|FG000|Overall Study|Physician Decision|0|||
46983687|NCT02332707|83229917|FG001|Overall Study|Physician Decision|0|||
46983688|NCT02332707|83229918|FG002|Overall Study|Physician Decision|0|||
46983689|NCT02332707|83229919|FG003|Overall Study|Physician Decision|1|||
46983690|NCT02332707|83229920|FG004|Overall Study|Physician Decision|0|||
46983691|NCT02332707|83229921|FG005|Overall Study|Physician Decision|0|||
46983692|NCT02332707|83229922|FG006|Overall Study|Physician Decision|0|||
46983693|NCT02332707|83229923|FG007|Overall Study|Physician Decision|0|||
46983694|NCT02332707|83229924|FG008|Overall Study|Physician Decision|0|||
46983695|NCT02332707|83229925|FG009|Overall Study|Physician Decision|0|||
46983696|NCT02332707|83229926|FG010|Overall Study|Physician Decision|0|||
46983697|NCT02332707|83229927|FG011|Overall Study|Physician Decision|0|||
46983698|NCT02332707|83229928|FG012|Overall Study|Physician Decision|1|||
46983699|NCT02332707|83229929|FG013|Overall Study|Physician Decision|0|||
46983700|NCT02332707|83229930|FG014|Overall Study|Physician Decision|0|||
46983701|NCT02332707|83229931|FG015|Overall Study|Physician Decision|0|||
46983702|NCT02332707|83229932|FG016|Overall Study|Physician Decision|0|||
46983703|NCT02332707|83229933|FG017|Overall Study|Physician Decision|0|||
46983704|NCT02332707|83229916|FG000|Overall Study|Withdrawal by Subject|0|||
46983705|NCT02332707|83229917|FG001|Overall Study|Withdrawal by Subject|0|||
46983706|NCT02332707|83229918|FG002|Overall Study|Withdrawal by Subject|1|||
46983707|NCT02332707|83229919|FG003|Overall Study|Withdrawal by Subject|0|||
46983708|NCT02332707|83229920|FG004|Overall Study|Withdrawal by Subject|0|||
46983709|NCT02332707|83229921|FG005|Overall Study|Withdrawal by Subject|0|||
46983710|NCT02332707|83229922|FG006|Overall Study|Withdrawal by Subject|0|||
46698524|NCT01136733|82913597|FG002|Phase 1b|Adverse Event|1|||
46698525|NCT01136733|82913598|FG003|Phase 1b|Adverse Event|0|||
46698526|NCT01136733|82913599|FG004|Phase 1b|Adverse Event|0|||
46698527|NCT01136733|82913600|FG005|Phase 1b|Adverse Event|0|||
46698528|NCT01136733|82913601|FG006|Phase 1b|Adverse Event|0|||
46868597|NCT03654560|83086879|FG000|Overall Study|Lost to Follow-up|1|||
46983711|NCT02332707|83229923|FG007|Overall Study|Withdrawal by Subject|0|||
46983712|NCT02332707|83229924|FG008|Overall Study|Withdrawal by Subject|0|||
46983713|NCT02332707|83229925|FG009|Overall Study|Withdrawal by Subject|3|||
46983714|NCT02332707|83229926|FG010|Overall Study|Withdrawal by Subject|0|||
46983715|NCT02332707|83229927|FG011|Overall Study|Withdrawal by Subject|0|||
46983716|NCT02332707|83229928|FG012|Overall Study|Withdrawal by Subject|0|||
46698529|NCT01136733|82913595|FG000|Phase 1b|Participant Choice|0|||
46983717|NCT02332707|83229929|FG013|Overall Study|Withdrawal by Subject|0|||
46698530|NCT01136733|82913596|FG001|Phase 1b|Participant Choice|0|||
46983718|NCT02332707|83229930|FG014|Overall Study|Withdrawal by Subject|0|||
46983719|NCT02332707|83229931|FG015|Overall Study|Withdrawal by Subject|0|||
46983720|NCT02332707|83229932|FG016|Overall Study|Withdrawal by Subject|0|||
46698531|NCT01136733|82913597|FG002|Phase 1b|Participant Choice|1|||
46698532|NCT01136733|82913598|FG003|Phase 1b|Participant Choice|0|||
46698533|NCT01136733|82913599|FG004|Phase 1b|Participant Choice|0|||
46698534|NCT01136733|82913600|FG005|Phase 1b|Participant Choice|0|||
46698535|NCT01136733|82913601|FG006|Phase 1b|Participant Choice|0|||
46698536|NCT01136733|82913595|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
46698537|NCT01136733|82913596|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
46698538|NCT01136733|82913597|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
46698539|NCT01136733|82913598|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
46698540|NCT01136733|82913599|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
46698541|NCT01136733|82913600|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
46698542|NCT01136733|82913601|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
46698543|NCT01136733|82913595|FG000|Phase 1b|Clinical Progression|1|||
46698544|NCT01136733|82913596|FG001|Phase 1b|Clinical Progression|1|||
46698545|NCT01136733|82913597|FG002|Phase 1b|Clinical Progression|0|||
46698546|NCT01136733|82913598|FG003|Phase 1b|Clinical Progression|0|||
46698547|NCT01136733|82913599|FG004|Phase 1b|Clinical Progression|0|||
46698548|NCT01136733|82913600|FG005|Phase 1b|Clinical Progression|0|||
46698549|NCT01136733|82913601|FG006|Phase 1b|Clinical Progression|0|||
46698550|NCT01136733|82913595|FG000|Phase 2|Disease Progression|0|||
46698551|NCT01136733|82913596|FG001|Phase 2|Disease Progression|0|||
46698552|NCT01136733|82913597|FG002|Phase 2|Disease Progression|0|||
46698553|NCT01136733|82913598|FG003|Phase 2|Disease Progression|0|||
46698554|NCT01136733|82913599|FG004|Phase 2|Disease Progression|30|||
46698555|NCT01136733|82913600|FG005|Phase 2|Disease Progression|32|||
46698556|NCT01136733|82913601|FG006|Phase 2|Disease Progression|38|||
46698557|NCT01136733|82913595|FG000|Phase 2|Adverse Event|0|||
46698558|NCT01136733|82913596|FG001|Phase 2|Adverse Event|0|||
46698559|NCT01136733|82913597|FG002|Phase 2|Adverse Event|0|||
46698560|NCT01136733|82913598|FG003|Phase 2|Adverse Event|0|||
46698561|NCT01136733|82913599|FG004|Phase 2|Adverse Event|11|||
46698562|NCT01136733|82913600|FG005|Phase 2|Adverse Event|13|||
46698563|NCT01136733|82913601|FG006|Phase 2|Adverse Event|5|||
46698564|NCT01136733|82913595|FG000|Phase 2|Participant Choice|0|||
46698565|NCT01136733|82913596|FG001|Phase 2|Participant Choice|0|||
46698566|NCT01136733|82913597|FG002|Phase 2|Participant Choice|0|||
46698567|NCT01136733|82913598|FG003|Phase 2|Participant Choice|0|||
46698568|NCT01136733|82913599|FG004|Phase 2|Participant Choice|3|||
46698569|NCT01136733|82913600|FG005|Phase 2|Participant Choice|0|||
46698570|NCT01136733|82913601|FG006|Phase 2|Participant Choice|1|||
46698571|NCT01136733|82913595|FG000|Phase 2|Administrative-Withdrew Consent|0|||
46698572|NCT01136733|82913596|FG001|Phase 2|Administrative-Withdrew Consent|0|||
46698573|NCT01136733|82913597|FG002|Phase 2|Administrative-Withdrew Consent|0|||
46698574|NCT01136733|82913598|FG003|Phase 2|Administrative-Withdrew Consent|0|||
46698575|NCT01136733|82913599|FG004|Phase 2|Administrative-Withdrew Consent|1|||
46698576|NCT01136733|82913600|FG005|Phase 2|Administrative-Withdrew Consent|0|||
46698577|NCT01136733|82913601|FG006|Phase 2|Administrative-Withdrew Consent|0|||
46698578|NCT01136733|82913595|FG000|Phase 2|Other|0|||
46698579|NCT01136733|82913596|FG001|Phase 2|Other|0|||
46698580|NCT01136733|82913597|FG002|Phase 2|Other|0|||
46698581|NCT01136733|82913598|FG003|Phase 2|Other|0|||
46698582|NCT01136733|82913599|FG004|Phase 2|Other|6|||
46698583|NCT01136733|82913600|FG005|Phase 2|Other|7|||
46698584|NCT01136733|82913601|FG006|Phase 2|Other|6|||
46698585|NCT01136655|82913631|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
46698586|NCT01136655|82913631|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
46698587|NCT01136655|82913631|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
46698588|NCT01136655|82913631|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
46698589|NCT01135017|82913646|FG000|Overall Study|Adverse Event|3|||
46698590|NCT01135017|82913647|FG001|Overall Study|Adverse Event|8|||
46698591|NCT01135017|82913646|FG000|Overall Study|Other than above|3|||
46698592|NCT01135017|82913647|FG001|Overall Study|Other than above|4|||
46698593|NCT01134939|82913661|FG000|Overall Study|Adverse Event|9|||
46698594|NCT01134939|82913662|FG001|Overall Study|Adverse Event|3|||
46698595|NCT01134939|82913663|FG002|Overall Study|Adverse Event|4|||
46698596|NCT01134939|82913664|FG003|Overall Study|Adverse Event|5|||
46698597|NCT01134939|82913665|FG004|Overall Study|Adverse Event|5|||
46698598|NCT01134939|82913666|FG005|Overall Study|Adverse Event|5|||
46698599|NCT01134939|82913667|FG006|Overall Study|Adverse Event|1|||
46698600|NCT01134939|82913668|FG007|Overall Study|Adverse Event|0|||
46698601|NCT01134939|82913661|FG000|Overall Study|Lack of Efficacy|2|||
46698602|NCT01134939|82913662|FG001|Overall Study|Lack of Efficacy|5|||
46698603|NCT01134939|82913663|FG002|Overall Study|Lack of Efficacy|1|||
46698604|NCT01134939|82913664|FG003|Overall Study|Lack of Efficacy|0|||
46868598|NCT03654560|83086880|FG001|Overall Study|Lost to Follow-up|0|||
46698605|NCT01134939|82913665|FG004|Overall Study|Lack of Efficacy|3|||
46698606|NCT01134939|82913666|FG005|Overall Study|Lack of Efficacy|0|||
46698607|NCT01134939|82913667|FG006|Overall Study|Lack of Efficacy|1|||
46698608|NCT01134939|82913668|FG007|Overall Study|Lack of Efficacy|0|||
46698609|NCT01134939|82913661|FG000|Overall Study|Lost to Follow-up|2|||
46698610|NCT01134939|82913662|FG001|Overall Study|Lost to Follow-up|3|||
46698611|NCT01134939|82913663|FG002|Overall Study|Lost to Follow-up|0|||
46698612|NCT01134939|82913664|FG003|Overall Study|Lost to Follow-up|1|||
46698613|NCT01134939|82913665|FG004|Overall Study|Lost to Follow-up|2|||
46698614|NCT01134939|82913666|FG005|Overall Study|Lost to Follow-up|1|||
46698615|NCT01134939|82913667|FG006|Overall Study|Lost to Follow-up|0|||
46698616|NCT01134939|82913668|FG007|Overall Study|Lost to Follow-up|0|||
46698617|NCT01134939|82913661|FG000|Overall Study|Death|0|||
46698618|NCT01134939|82913662|FG001|Overall Study|Death|1|||
46698619|NCT01134939|82913663|FG002|Overall Study|Death|0|||
46698620|NCT01134939|82913664|FG003|Overall Study|Death|0|||
46698621|NCT01134939|82913665|FG004|Overall Study|Death|0|||
46698622|NCT01134939|82913666|FG005|Overall Study|Death|0|||
46698623|NCT01134939|82913667|FG006|Overall Study|Death|0|||
46698624|NCT01134939|82913668|FG007|Overall Study|Death|0|||
46698625|NCT01134939|82913661|FG000|Overall Study|Termination page not available|4|||
46698626|NCT01134939|82913662|FG001|Overall Study|Termination page not available|6|||
46698627|NCT01134939|82913663|FG002|Overall Study|Termination page not available|5|||
46698628|NCT01134939|82913664|FG003|Overall Study|Termination page not available|8|||
46698629|NCT01134939|82913665|FG004|Overall Study|Termination page not available|0|||
46698630|NCT01134939|82913666|FG005|Overall Study|Termination page not available|3|||
46698631|NCT01134939|82913667|FG006|Overall Study|Termination page not available|7|||
46698632|NCT01134939|82913668|FG007|Overall Study|Termination page not available|0|||
46698633|NCT01134783|82913684|FG000|Overall Study|Pregnancy|16|||
46698634|NCT01134783|82913685|FG001|Overall Study|Pregnancy|8|||
46698635|NCT01134783|82913684|FG000|Overall Study|Withdrawal by Subject|15|||
46698636|NCT01134783|82913685|FG001|Overall Study|Withdrawal by Subject|9|||
46698637|NCT01134783|82913684|FG000|Overall Study|Lost to Follow-up|5|||
46698638|NCT01134783|82913685|FG001|Overall Study|Lost to Follow-up|20|||
46698639|NCT01134705|82913697|FG000|Overall Study|Adverse Event|1|||
46698640|NCT01134705|82913698|FG001|Overall Study|Adverse Event|7|||
46698641|NCT01134705|82913697|FG000|Overall Study|Withdrawal by Subject|6|||
46698642|NCT01134705|82913698|FG001|Overall Study|Withdrawal by Subject|6|||
46698643|NCT01134705|82913697|FG000|Overall Study|Pregnancy|1|||
46698644|NCT01134705|82913698|FG001|Overall Study|Pregnancy|0|||
46698645|NCT01134705|82913697|FG000|Overall Study|Lost to Follow-up|5|||
46698646|NCT01134705|82913698|FG001|Overall Study|Lost to Follow-up|2|||
46698647|NCT01134705|82913697|FG000|Overall Study|Protocol Violation|1|||
46698648|NCT01134705|82913698|FG001|Overall Study|Protocol Violation|1|||
46698649|NCT01134705|82913697|FG000|Overall Study|Other|1|||
46698650|NCT01134705|82913698|FG001|Overall Study|Other|6|||
46698651|NCT00927823|82913704|FG000|Continuous Dosing Period|Death|0|||
46698652|NCT00927823|82913705|FG001|Continuous Dosing Period|Death|0|||
46698653|NCT00927823|82913706|FG002|Continuous Dosing Period|Death|6|||
46698654|NCT00927823|82913707|FG003|Continuous Dosing Period|Death|0|||
46698655|NCT00927823|82913704|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
46698656|NCT00927823|82913705|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
46698657|NCT00927823|82913706|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
46698658|NCT00927823|82913707|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
46698659|NCT00927823|82913704|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
46698660|NCT00927823|82913705|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
46698661|NCT00927823|82913706|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
46698662|NCT00927823|82913707|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
46698663|NCT00927823|82913704|FG000|Continuous Dosing Period|Other|1|||
46868599|NCT03629054|83086888|FG000|Period 2 (4 Days)|Not treated|0|||
46983721|NCT02332707|83229933|FG017|Overall Study|Withdrawal by Subject|0|||
46983722|NCT02370615|83229973|FG000|Overall Study|Adverse Event|1|||
46983723|NCT02370615|83229974|FG001|Overall Study|Adverse Event|0|||
46698664|NCT00927823|82913705|FG001|Continuous Dosing Period|Other|2|||
46698665|NCT00927823|82913706|FG002|Continuous Dosing Period|Other|9|||
46698666|NCT00927823|82913707|FG003|Continuous Dosing Period|Other|3|||
46698667|NCT01134627|82913726|FG000|Overall Study|Adverse Event|47|||
46698668|NCT01134627|82913727|FG001|Overall Study|Adverse Event|31|||
46868600|NCT03629054|83086889|FG001|Period 2 (4 Days)|Not treated|1|||
46698669|NCT01134627|82913726|FG000|Overall Study|Lost to Follow-up|1|||
46698670|NCT01134627|82913727|FG001|Overall Study|Lost to Follow-up|2|||
46698671|NCT01134627|82913726|FG000|Overall Study|Protocol Violation|3|||
46698672|NCT01134627|82913727|FG001|Overall Study|Protocol Violation|5|||
46698673|NCT01134627|82913726|FG000|Overall Study|Lack of Efficacy|2|||
46698674|NCT01134627|82913727|FG001|Overall Study|Lack of Efficacy|12|||
46698675|NCT01134627|82913726|FG000|Overall Study|Withdrawal by Subject|4|||
46698676|NCT01134627|82913727|FG001|Overall Study|Withdrawal by Subject|3|||
46868601|NCT03628898|83086895|FG000|Overall Study|Device deficiency|1|||
46868602|NCT03628508|83086899|FG000|Overall Study|Lost to Follow-up|1|||
46868603|NCT03045328|83086903|FG000|Overall Study|Withdrawal by Subject|2|||
46868604|NCT02154490|83086909|FG000|Overall Study|No tissue submitted|23|||
46698677|NCT01134627|82913726|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
46698678|NCT01134627|82913727|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
46698679|NCT01134627|82913726|FG000|Overall Study|Other|11|||
46698680|NCT01134627|82913727|FG001|Overall Study|Other|14|||
46698681|NCT01134393|82913733|FG000|Overall Study|Adverse Event|18|||
46698682|NCT01134393|82913733|FG000|Overall Study|Lack of Efficacy|2|||
46698683|NCT01134393|82913733|FG000|Overall Study|Protocol Violation|12|||
46698684|NCT01134393|82913733|FG000|Overall Study|Lost to Follow-up|3|||
46698685|NCT01134393|82913733|FG000|Overall Study|Withdrawal by Subject|11|||
46698686|NCT01134393|82913733|FG000|Overall Study|Other|6|||
46698687|NCT00922441|82913741|FG000|Overall Study|Protocol Violation|0|||
46698688|NCT00922441|82913742|FG001|Overall Study|Protocol Violation|0|||
46698689|NCT00922441|82913743|FG002|Overall Study|Protocol Violation|2|||
46698690|NCT00922441|82913741|FG000|Overall Study|Withdrawal by Subject|0|||
46698691|NCT00922441|82913742|FG001|Overall Study|Withdrawal by Subject|0|||
46698692|NCT00922441|82913743|FG002|Overall Study|Withdrawal by Subject|1|||
46698693|NCT01217112|82913756|FG000|Overall Study|Adverse Event|0|||
46698694|NCT01217112|82913757|FG001|Overall Study|Adverse Event|2|||
46698695|NCT01217112|82913758|FG002|Overall Study|Adverse Event|0|||
46698696|NCT01217112|82913759|FG003|Overall Study|Adverse Event|2|||
46698697|NCT01217112|82913760|FG004|Overall Study|Adverse Event|0|||
46698698|NCT01217112|82913756|FG000|Overall Study|Withdrawal by Subject|0|||
46868605|NCT02154490|83086909|FG000|Overall Study|No biomarker results|167|||
46868606|NCT02154490|83086909|FG000|Overall Study|Not assigned to a sub-study|270|||
46868607|NCT02154490|83086909|FG000|Overall Study|Did not register to a sub-study|749|||
46868608|NCT03627494|83086925|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
46868609|NCT03627494|83086926|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868610|NCT03627494|83086927|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
46868611|NCT03627494|83086928|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868612|NCT03627494|83086929|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868613|NCT03627494|83086930|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868614|NCT03627494|83086931|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868615|NCT03627494|83086932|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868616|NCT03627494|83086933|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868617|NCT03627494|83086934|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868618|NCT03627494|83086935|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868619|NCT03627494|83086936|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
46868620|NCT03627494|83086925|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868621|NCT03627494|83086926|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868622|NCT03627494|83086927|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868623|NCT03627494|83086928|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868624|NCT03627494|83086929|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868625|NCT03627494|83086930|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868626|NCT03627494|83086931|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868627|NCT03627494|83086932|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868628|NCT03627494|83086933|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
46868629|NCT03627494|83086934|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868630|NCT03627494|83086935|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868631|NCT03627494|83086936|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
46868632|NCT03627494|83086925|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
46868633|NCT03627494|83086926|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
46698699|NCT01217112|82913757|FG001|Overall Study|Withdrawal by Subject|0|||
46698700|NCT01217112|82913758|FG002|Overall Study|Withdrawal by Subject|1|||
46868634|NCT03627494|83086927|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
46868635|NCT03627494|83086928|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
46983724|NCT02307513|83229989|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
46983725|NCT02307513|83229990|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
46698701|NCT01217112|82913759|FG003|Overall Study|Withdrawal by Subject|0|||
46698702|NCT01217112|82913760|FG004|Overall Study|Withdrawal by Subject|0|||
46698703|NCT01217112|82913756|FG000|Overall Study|Physician Decision|0|||
46868636|NCT03627494|83086929|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
46868637|NCT03627494|83086930|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
46698704|NCT01217112|82913757|FG001|Overall Study|Physician Decision|0|||
46698705|NCT01217112|82913758|FG002|Overall Study|Physician Decision|0|||
46698706|NCT01217112|82913759|FG003|Overall Study|Physician Decision|0|||
46698707|NCT01217112|82913760|FG004|Overall Study|Physician Decision|1|||
46698708|NCT01216332|82913774|FG000|Overall Study|Withdrawal by Subject|4|||
46868638|NCT03627494|83086931|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
46698709|NCT01216332|82913775|FG001|Overall Study|Withdrawal by Subject|0|||
46698710|NCT00922207|82913784|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
46698711|NCT00922207|82913785|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
46698712|NCT00922207|82913786|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
46698713|NCT00922207|82913784|FG000|Overall Study|Insufficient Therapeutic Response|0|||
46698714|NCT00922207|82913785|FG001|Overall Study|Insufficient Therapeutic Response|0|||
46698715|NCT00922207|82913786|FG002|Overall Study|Insufficient Therapeutic Response|1|||
46698716|NCT00922207|82913784|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
46698717|NCT00922207|82913785|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
46698718|NCT00922207|82913786|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
46698719|NCT00922207|82913784|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
46698720|NCT00922207|82913785|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
46698721|NCT00922207|82913786|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
46698722|NCT00922207|82913784|FG000|Overall Study|Withdrew Consent|2|||
46698723|NCT00922207|82913785|FG001|Overall Study|Withdrew Consent|5|||
46698724|NCT00922207|82913786|FG002|Overall Study|Withdrew Consent|2|||
46698725|NCT00922207|82913784|FG000|Overall Study|Abnormality of Laboratory Test|0|||
46698726|NCT00922207|82913785|FG001|Overall Study|Abnormality of Laboratory Test|1|||
46698727|NCT00922207|82913786|FG002|Overall Study|Abnormality of Laboratory Test|1|||
46698728|NCT01134315|82913796|FG000|Overall Study|Adverse Event|1|||
46698729|NCT01134315|82913797|FG001|Overall Study|Adverse Event|2|||
46698730|NCT01134315|82913796|FG000|Overall Study|Other Reason|8|||
46698731|NCT01134315|82913797|FG001|Overall Study|Other Reason|17|||
46698732|NCT01216176|82913806|FG000|Overall Study|Adverse Event|0|||
46698733|NCT01216176|82913807|FG001|Overall Study|Adverse Event|8|||
46698734|NCT01216176|82913808|FG002|Overall Study|Adverse Event|0|||
46698735|NCT01216176|82913806|FG000|Overall Study|Physician Decision|0|||
46698736|NCT01216176|82913807|FG001|Overall Study|Physician Decision|0|||
46698737|NCT01216176|82913808|FG002|Overall Study|Physician Decision|1|||
46698738|NCT01133847|82913820|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
46698739|NCT01133847|82913821|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
46698740|NCT01133847|82913822|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
46698741|NCT01133847|82913820|FG000|Follow-Up Phase|Lost to Follow-up|1|||
46698742|NCT01133847|82913821|FG001|Follow-Up Phase|Lost to Follow-up|3|||
46698743|NCT01133847|82913822|FG002|Follow-Up Phase|Lost to Follow-up|7|||
46698744|NCT01133379|82913834|FG000|Overall Study|Withdrawal by Subject|0|||
46698745|NCT01133379|82913835|FG001|Overall Study|Withdrawal by Subject|1|||
46698746|NCT01133379|82913836|FG002|Overall Study|Withdrawal by Subject|1|||
46698747|NCT01133379|82913834|FG000|Overall Study|Lost to Follow-up|1|||
46698748|NCT01133379|82913835|FG001|Overall Study|Lost to Follow-up|1|||
46698749|NCT01133379|82913836|FG002|Overall Study|Lost to Follow-up|1|||
46698750|NCT01133067|82913844|FG000|Overall Study|Death|136|||
46698751|NCT01133067|82913844|FG000|Overall Study|Lost to Follow-up|3|||
46698752|NCT01132755|82913848|FG000|Overall Study|Procedure not done due to medical reason|23|||
46698753|NCT01132755|82913848|FG000|Overall Study|Protocol Violation|15|||
46698754|NCT01132755|82913848|FG000|Overall Study|Withdrawal by Subject|4|||
46698755|NCT00919711|82913854|FG000|Overall Study|Withdrawal by Subject|15|||
46698756|NCT00919711|82913855|FG001|Overall Study|Withdrawal by Subject|7|||
46698757|NCT00919711|82913854|FG000|Overall Study|Adverse Event|13|||
46698758|NCT00919711|82913855|FG001|Overall Study|Adverse Event|3|||
46698759|NCT00919711|82913854|FG000|Overall Study|Other|1|||
46698760|NCT00919711|82913855|FG001|Overall Study|Other|2|||
46698761|NCT00919711|82913854|FG000|Overall Study|Administrative Decision|0|||
46698762|NCT00919711|82913855|FG001|Overall Study|Administrative Decision|1|||
46698763|NCT00919711|82913854|FG000|Overall Study|Lost to Follow-up|2|||
46698764|NCT00919711|82913855|FG001|Overall Study|Lost to Follow-up|0|||
46698765|NCT00919711|82913854|FG000|Overall Study|Death|1|||
46698766|NCT00919711|82913855|FG001|Overall Study|Death|0|||
46698767|NCT00919711|82913854|FG000|Overall Study|Noncompliance|1|||
46698768|NCT00919711|82913855|FG001|Overall Study|Noncompliance|0|||
46698769|NCT01131585|82913863|FG000|Overall Study|Adverse Event|0|||
46698770|NCT01131585|82913864|FG001|Overall Study|Adverse Event|2|||
46698771|NCT01131585|82913863|FG000|Overall Study|Abnormal laboratory value|1|||
46698772|NCT01131585|82913864|FG001|Overall Study|Abnormal laboratory value|0|||
46698773|NCT01131585|82913863|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
46698774|NCT01131585|82913864|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
46698775|NCT01131585|82913863|FG000|Overall Study|Protocol Violation|2|||
46698776|NCT01131585|82913864|FG001|Overall Study|Protocol Violation|1|||
46698777|NCT01131585|82913863|FG000|Overall Study|Withdrawal by Subject|3|||
46698778|NCT01131585|82913864|FG001|Overall Study|Withdrawal by Subject|3|||
46698779|NCT01131585|82913863|FG000|Overall Study|Lost to Follow-up|0|||
46698780|NCT01131585|82913864|FG001|Overall Study|Lost to Follow-up|1|||
46698781|NCT01131585|82913863|FG000|Overall Study|Administrative problems|1|||
46698782|NCT01131585|82913864|FG001|Overall Study|Administrative problems|1|||
46698783|NCT01131585|82913863|FG000|Overall Study|Study termination|78|||
46698784|NCT01131585|82913864|FG001|Overall Study|Study termination|32|||
46698785|NCT01131507|82913870|FG000|Overall Study|Adverse Event|1|||
46698786|NCT01131507|82913870|FG000|Overall Study|Lost to Follow-up|1|||
46698787|NCT01131507|82913870|FG000|Overall Study|Withdrawal by Subject|1|||
46698788|NCT01131351|82913876|FG000|Overall Study|Adverse Event|0|||
46698789|NCT01131351|82913877|FG001|Overall Study|Adverse Event|2|||
46698790|NCT01131351|82913876|FG000|Overall Study|Protocol Deviation|0|||
46868639|NCT03627494|83086932|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
46868640|NCT03627494|83086933|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
46868641|NCT03627494|83086934|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
46868642|NCT03627494|83086935|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
46868643|NCT03627494|83086936|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
46868644|NCT03627416|83086977|FG000|Overall Study|Adverse Event|0|||
46868645|NCT03627416|83086978|FG001|Overall Study|Adverse Event|1|||
46868646|NCT00097539|83086991|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
46868647|NCT00097539|83086992|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
46868648|NCT00097539|83086993|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
46868649|NCT00097539|83086994|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
46868650|NCT00097539|83086995|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
46868651|NCT00097539|83086996|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
46868652|NCT00097539|83086997|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
46868653|NCT00097539|83086991|FG000|Overall Study|Withdrawal by Subject|925|||
46868654|NCT00097539|83086992|FG001|Overall Study|Withdrawal by Subject|323|||
46868655|NCT00097539|83086993|FG002|Overall Study|Withdrawal by Subject|346|||
46868656|NCT00097539|83086994|FG003|Overall Study|Withdrawal by Subject|217|||
46868657|NCT00097539|83086995|FG004|Overall Study|Withdrawal by Subject|68|||
46868658|NCT00097539|83086996|FG005|Overall Study|Withdrawal by Subject|229|||
46868659|NCT00097539|83086997|FG006|Overall Study|Withdrawal by Subject|3|||
46868660|NCT00097539|83086991|FG000|Overall Study|Participant Non-compliant|2140|||
46868661|NCT00097539|83086992|FG001|Overall Study|Participant Non-compliant|567|||
46868662|NCT00097539|83086993|FG002|Overall Study|Participant Non-compliant|1067|||
46868663|NCT00097539|83086994|FG003|Overall Study|Participant Non-compliant|353|||
46868664|NCT00097539|83086995|FG004|Overall Study|Participant Non-compliant|136|||
46868665|NCT00097539|83086996|FG005|Overall Study|Participant Non-compliant|543|||
46868666|NCT00097539|83086997|FG006|Overall Study|Participant Non-compliant|18|||
46868667|NCT00097539|83086991|FG000|Overall Study|Lack of Efficacy|249|||
46868668|NCT00097539|83086992|FG001|Overall Study|Lack of Efficacy|122|||
46868669|NCT00097539|83086993|FG002|Overall Study|Lack of Efficacy|202|||
46868670|NCT00097539|83086994|FG003|Overall Study|Lack of Efficacy|105|||
46868671|NCT00097539|83086995|FG004|Overall Study|Lack of Efficacy|45|||
46868672|NCT00097539|83086996|FG005|Overall Study|Lack of Efficacy|228|||
46868673|NCT00097539|83086997|FG006|Overall Study|Lack of Efficacy|5|||
46868674|NCT00097539|83086991|FG000|Overall Study|Adverse Event|78|||
46868675|NCT00097539|83086992|FG001|Overall Study|Adverse Event|133|||
46868676|NCT00097539|83086993|FG002|Overall Study|Adverse Event|37|||
46868677|NCT00097539|83086994|FG003|Overall Study|Adverse Event|27|||
46868678|NCT00097539|83086995|FG004|Overall Study|Adverse Event|30|||
46868679|NCT00097539|83086996|FG005|Overall Study|Adverse Event|59|||
46868680|NCT00097539|83086997|FG006|Overall Study|Adverse Event|1|||
46868681|NCT00097539|83086991|FG000|Overall Study|Death|2|||
46868682|NCT00097539|83086992|FG001|Overall Study|Death|7|||
46868683|NCT00097539|83086993|FG002|Overall Study|Death|0|||
46868684|NCT00097539|83086994|FG003|Overall Study|Death|0|||
46868685|NCT00097539|83086995|FG004|Overall Study|Death|1|||
46868686|NCT00097539|83086996|FG005|Overall Study|Death|3|||
46868687|NCT00097539|83086997|FG006|Overall Study|Death|0|||
46868688|NCT00097539|83086991|FG000|Overall Study|Reasons Other Than Above|3602|||
46868689|NCT00097539|83086992|FG001|Overall Study|Reasons Other Than Above|1382|||
46698791|NCT01131351|82913877|FG001|Overall Study|Protocol Deviation|1|||
46698792|NCT00919633|82913887|FG000|Overall Study|Adverse Event|1|||
46868690|NCT00097539|83086993|FG002|Overall Study|Reasons Other Than Above|1757|||
46868691|NCT00097539|83086994|FG003|Overall Study|Reasons Other Than Above|692|||
46983726|NCT02307513|83229989|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
46698793|NCT00919633|82913888|FG001|Overall Study|Adverse Event|9|||
46698794|NCT00919633|82913889|FG002|Overall Study|Adverse Event|12|||
46868692|NCT00097539|83086995|FG004|Overall Study|Reasons Other Than Above|361|||
46868693|NCT00097539|83086996|FG005|Overall Study|Reasons Other Than Above|1244|||
46868694|NCT00097539|83086997|FG006|Overall Study|Reasons Other Than Above|34|||
46868695|NCT00097539|83086991|FG000|Overall Study|Reason not Specified|111|||
46868696|NCT00097539|83086992|FG001|Overall Study|Reason not Specified|49|||
46868697|NCT00097539|83086993|FG002|Overall Study|Reason not Specified|53|||
46868698|NCT00097539|83086994|FG003|Overall Study|Reason not Specified|21|||
46983727|NCT02307513|83229990|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
46868699|NCT00097539|83086995|FG004|Overall Study|Reason not Specified|11|||
46868700|NCT00097539|83086996|FG005|Overall Study|Reason not Specified|40|||
46868701|NCT00097539|83086997|FG006|Overall Study|Reason not Specified|2|||
46868702|NCT03925324|83087015|FG000|Overall Study|Death|1|||
46868703|NCT03925324|83087016|FG001|Overall Study|Death|1|||
46698795|NCT00919633|82913890|FG003|Overall Study|Adverse Event|10|||
46698796|NCT00919633|82913887|FG000|Overall Study|Death|0|||
46698797|NCT00919633|82913888|FG001|Overall Study|Death|0|||
46698798|NCT00919633|82913889|FG002|Overall Study|Death|2|||
46698799|NCT00919633|82913890|FG003|Overall Study|Death|0|||
46698800|NCT00919633|82913887|FG000|Overall Study|Lack of Efficacy|17|||
46698801|NCT00919633|82913888|FG001|Overall Study|Lack of Efficacy|3|||
46698802|NCT00919633|82913889|FG002|Overall Study|Lack of Efficacy|2|||
46698803|NCT00919633|82913890|FG003|Overall Study|Lack of Efficacy|3|||
46698804|NCT00919633|82913887|FG000|Overall Study|Withdrawal by Subject|1|||
46698805|NCT00919633|82913888|FG001|Overall Study|Withdrawal by Subject|2|||
46698806|NCT00919633|82913889|FG002|Overall Study|Withdrawal by Subject|4|||
46698807|NCT00919633|82913890|FG003|Overall Study|Withdrawal by Subject|3|||
46698808|NCT00919633|82913887|FG000|Overall Study|Lost to Follow-up|3|||
46698809|NCT00919633|82913888|FG001|Overall Study|Lost to Follow-up|1|||
46698810|NCT00919633|82913889|FG002|Overall Study|Lost to Follow-up|0|||
46698811|NCT00919633|82913890|FG003|Overall Study|Lost to Follow-up|2|||
46698812|NCT00919633|82913887|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
46698813|NCT00919633|82913888|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
46698814|NCT00919633|82913889|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
46868704|NCT03042910|83087022|FG000|Overall Study|Adverse Event|1|||
46698815|NCT00919633|82913890|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
46698816|NCT00919633|82913887|FG000|Overall Study|Protocol Violation|0|||
46698817|NCT00919633|82913888|FG001|Overall Study|Protocol Violation|0|||
46698818|NCT00919633|82913889|FG002|Overall Study|Protocol Violation|0|||
46698819|NCT00919633|82913890|FG003|Overall Study|Protocol Violation|1|||
46698820|NCT00919633|82913887|FG000|Overall Study|Physician Decision|0|||
46698821|NCT00919633|82913888|FG001|Overall Study|Physician Decision|0|||
46698822|NCT00919633|82913889|FG002|Overall Study|Physician Decision|0|||
46698823|NCT00919633|82913890|FG003|Overall Study|Physician Decision|1|||
46698824|NCT00919633|82913887|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
46698825|NCT00919633|82913888|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
46698826|NCT00919633|82913889|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
46698827|NCT00919633|82913890|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
46698828|NCT00919633|82913887|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
46698829|NCT00919633|82913888|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
46698830|NCT00919633|82913889|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
46698831|NCT00919633|82913890|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
46698832|NCT01130883|82913900|FG000|Overall Study|Patient Noncompliance|6|||
46698833|NCT01130883|82913900|FG000|Overall Study|Reason Unknown|1|||
46698834|NCT01130883|82913900|FG000|Overall Study|Adverse Event|3|||
46698835|NCT00926029|82913907|FG000|Overall Study|Lost to Follow-up|2|||
46698836|NCT00926029|82913908|FG001|Overall Study|Lost to Follow-up|1|||
46983728|NCT02307513|83229989|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
46983729|NCT02307513|83229990|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
46983730|NCT02307513|83229989|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
46983731|NCT02307513|83229990|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
46983732|NCT02307513|83229989|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
46698837|NCT00926029|82913909|FG002|Overall Study|Lost to Follow-up|1|||
46698838|NCT01130493|82913919|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
46698839|NCT01130493|82913920|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
46698840|NCT01130493|82913921|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
46698841|NCT01130493|82913919|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
46698842|NCT01130493|82913920|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
46698843|NCT01130493|82913921|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
46698844|NCT01130493|82913919|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
46698845|NCT01130493|82913920|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
46698846|NCT01130493|82913921|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
46698847|NCT01130493|82913919|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
46698848|NCT01130493|82913920|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
46698849|NCT01130493|82913921|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
46698850|NCT01130493|82913919|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
46698851|NCT01130493|82913920|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
46698852|NCT01130493|82913921|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
46698853|NCT01130493|82913919|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
46698854|NCT01130493|82913920|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
46698855|NCT01130493|82913921|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
46698856|NCT01130493|82913919|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
46698857|NCT01130493|82913920|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
46698858|NCT01130493|82913921|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
46698859|NCT01130493|82913919|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
46698860|NCT01130493|82913920|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
46698861|NCT01130493|82913921|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
46698862|NCT01130493|82913919|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
46698863|NCT01130493|82913920|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
46698864|NCT01130493|82913921|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
46698865|NCT01130493|82913919|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
46698866|NCT01130493|82913920|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
46698867|NCT01130493|82913921|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
46698868|NCT01130493|82913919|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
46698869|NCT01130493|82913920|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
46698870|NCT01130493|82913921|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
46698871|NCT01130493|82913919|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
46698872|NCT01130493|82913920|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
46698873|NCT01130493|82913921|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
46698874|NCT01130493|82913919|FG000|Part 2: OLE|Adverse Event|0|||
46698875|NCT01130493|82913920|FG001|Part 2: OLE|Adverse Event|2|||
46698876|NCT01130493|82913921|FG002|Part 2: OLE|Adverse Event|1|||
46698877|NCT01130493|82913919|FG000|Part 2: OLE|Withdrawal by Subject|0|||
46698878|NCT01130493|82913920|FG001|Part 2: OLE|Withdrawal by Subject|1|||
46698879|NCT01130493|82913921|FG002|Part 2: OLE|Withdrawal by Subject|4|||
46698880|NCT01130337|82913932|FG000|Overall Study|Withdrawal by Subject|3|||
46698881|NCT01130337|82913932|FG000|Overall Study|Principal investigator decision|1|||
46698882|NCT01130337|82913932|FG000|Overall Study|Death|1|||
46698883|NCT01130337|82913932|FG000|Overall Study|Disease progression|1|||
46698884|NCT01130337|82913932|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
46698885|NCT01130337|82913932|FG000|Overall Study|Surgical resection (R2)|1|||
46698886|NCT01130103|82913938|FG000|Randomized Treatment|Adverse Event|1|||
46698887|NCT01130103|82913939|FG001|Randomized Treatment|Adverse Event|1|||
46698888|NCT01130103|82913938|FG000|Randomized Treatment|Lost to Follow-up|1|||
46698889|NCT01130103|82913939|FG001|Randomized Treatment|Lost to Follow-up|0|||
46698890|NCT01130103|82913938|FG000|Randomized Treatment|Protocol Violation|3|||
46698891|NCT01130103|82913939|FG001|Randomized Treatment|Protocol Violation|2|||
46698892|NCT01130103|82913938|FG000|Randomized Treatment|Withdrawal by Subject|1|||
46698893|NCT01130103|82913939|FG001|Randomized Treatment|Withdrawal by Subject|2|||
46698894|NCT01130103|82913938|FG000|Maintenance Treatment|Lack of Efficacy|0|||
46698895|NCT01130103|82913939|FG001|Maintenance Treatment|Lack of Efficacy|1|||
46698896|NCT01130103|82913938|FG000|Maintenance Treatment|Lost to Follow-up|1|||
46983733|NCT02307513|83229990|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
46698897|NCT01130103|82913939|FG001|Maintenance Treatment|Lost to Follow-up|1|||
46698898|NCT01130103|82913938|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
46698899|NCT01130103|82913939|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
46698900|NCT01129557|82913948|FG000|Overall Study|Adverse Event|1|||
46698901|NCT01129557|82913949|FG001|Overall Study|Adverse Event|2|||
46698902|NCT01129557|82913950|FG002|Overall Study|Adverse Event|2|||
46868705|NCT03042910|83087022|FG000|Overall Study|Disease Progression|2|||
46983734|NCT02307513|83229989|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
46698903|NCT01129557|82913948|FG000|Overall Study|Novartis terminated study early|3|||
46698904|NCT01129557|82913949|FG001|Overall Study|Novartis terminated study early|3|||
46698905|NCT01129557|82913950|FG002|Overall Study|Novartis terminated study early|2|||
46698906|NCT01129011|82913971|FG000|Overall Study|Adverse Event|20|||
46698907|NCT01129011|82913972|FG001|Overall Study|Adverse Event|30|||
46698908|NCT01129011|82913971|FG000|Overall Study|Withdrawal by Subject|24|||
46698909|NCT01129011|82913972|FG001|Overall Study|Withdrawal by Subject|8|||
46698910|NCT01129011|82913971|FG000|Overall Study|Lost to Follow-up|6|||
46698911|NCT01129011|82913972|FG001|Overall Study|Lost to Follow-up|7|||
46698912|NCT01129011|82913971|FG000|Overall Study|Duodenal Ulcer|2|||
46698913|NCT01129011|82913972|FG001|Overall Study|Duodenal Ulcer|8|||
46698914|NCT01129011|82913971|FG000|Overall Study|misc|7|||
46698915|NCT01129011|82913972|FG001|Overall Study|misc|4|||
46698916|NCT00919867|82913984|FG000|First Intervention|Withdrawal by Subject|0|||
46698917|NCT00919867|82913985|FG001|First Intervention|Withdrawal by Subject|0|||
46698918|NCT00919867|82913986|FG002|First Intervention|Withdrawal by Subject|1|||
46698919|NCT00919867|82913987|FG003|First Intervention|Withdrawal by Subject|0|||
46698920|NCT00919867|82913988|FG004|First Intervention|Withdrawal by Subject|0|||
46698921|NCT00919867|82913989|FG005|First Intervention|Withdrawal by Subject|0|||
46698922|NCT00919867|82913984|FG000|First Intervention|Physician Decision|0|||
46698923|NCT00919867|82913985|FG001|First Intervention|Physician Decision|0|||
46698924|NCT00919867|82913986|FG002|First Intervention|Physician Decision|0|||
46698925|NCT00919867|82913987|FG003|First Intervention|Physician Decision|0|||
46698926|NCT00919867|82913988|FG004|First Intervention|Physician Decision|0|||
46698927|NCT00919867|82913989|FG005|First Intervention|Physician Decision|1|||
46698928|NCT01215942|82913999|FG000|Treatment Period|Adverse Event|15|||
46698929|NCT01215942|82914000|FG001|Treatment Period|Adverse Event|26|||
46698930|NCT01215942|82913999|FG000|Treatment Period|Death|2|||
46698931|NCT01215942|82914000|FG001|Treatment Period|Death|4|||
46698932|NCT01215942|82913999|FG000|Treatment Period|Lack of Efficacy|23|||
46698933|NCT01215942|82914000|FG001|Treatment Period|Lack of Efficacy|62|||
46698934|NCT01215942|82913999|FG000|Treatment Period|Lost to Follow-up|3|||
46698935|NCT01215942|82914000|FG001|Treatment Period|Lost to Follow-up|4|||
46698936|NCT01215942|82913999|FG000|Treatment Period|Withdrawal by Subject|17|||
46698937|NCT01215942|82914000|FG001|Treatment Period|Withdrawal by Subject|40|||
46698938|NCT01215942|82913999|FG000|Treatment Period|Physician Decision|5|||
46698939|NCT01215942|82914000|FG001|Treatment Period|Physician Decision|5|||
46698940|NCT01215942|82913999|FG000|Treatment Period|Protocol Violation|0|||
46698941|NCT01215942|82914000|FG001|Treatment Period|Protocol Violation|1|||
46698942|NCT01215942|82913999|FG000|Treatment Period|Sponsor Decision|349|||
46698943|NCT01215942|82914000|FG001|Treatment Period|Sponsor Decision|530|||
46698944|NCT01215942|82913999|FG000|Post-Treatment Follow-Up Period|Death|0|||
46698945|NCT01215942|82914000|FG001|Post-Treatment Follow-Up Period|Death|1|||
46698946|NCT01215942|82913999|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
46698947|NCT01215942|82914000|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
46698948|NCT01215942|82913999|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
46698949|NCT01215942|82914000|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
46698950|NCT01215942|82913999|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
46698951|NCT01215942|82914000|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
46698952|NCT01215942|82913999|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
46698953|NCT01215942|82914000|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
46698954|NCT01128621|82914019|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
46698955|NCT01128621|82914020|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
46698956|NCT00918463|82914042|FG000|Overall Study|Death|1|||
46698957|NCT00918463|82914042|FG000|Overall Study|Lack of Efficacy|1|||
46698958|NCT01128543|82914046|FG000|Overall Study|Withdrawal by Subject|3|||
46698959|NCT01128543|82914046|FG000|Overall Study|Protocol Violation|1|||
46698960|NCT01128387|82914052|FG000|Overall Study|Physician Decision|0|||
46698961|NCT01128387|82914053|FG001|Overall Study|Physician Decision|1|||
46698962|NCT01214850|82914062|FG000|Overall Study|Withdrawal by Subject|38|||
46698963|NCT01214850|82914063|FG001|Overall Study|Withdrawal by Subject|31|||
46698964|NCT01214850|82914064|FG002|Overall Study|Withdrawal by Subject|28|||
46698965|NCT01214850|82914062|FG000|Overall Study|Lost to Follow-up|124|||
46698966|NCT01214850|82914063|FG001|Overall Study|Lost to Follow-up|98|||
46698967|NCT01214850|82914064|FG002|Overall Study|Lost to Follow-up|123|||
46698968|NCT01214850|82914062|FG000|Overall Study|Protocol Violation|5|||
46698969|NCT01214850|82914063|FG001|Overall Study|Protocol Violation|5|||
46698970|NCT01214850|82914064|FG002|Overall Study|Protocol Violation|6|||
46698971|NCT01214850|82914062|FG000|Overall Study|Adverse event or death|11|||
46698972|NCT01214850|82914063|FG001|Overall Study|Adverse event or death|8|||
46698973|NCT01214850|82914064|FG002|Overall Study|Adverse event or death|3|||
46698974|NCT01214850|82914062|FG000|Overall Study|Inappropriate enrollment|2|||
46698975|NCT01214850|82914063|FG001|Overall Study|Inappropriate enrollment|1|||
46698976|NCT01214850|82914064|FG002|Overall Study|Inappropriate enrollment|0|||
46698977|NCT01214850|82914062|FG000|Overall Study|Administrative reason|1|||
46698978|NCT01214850|82914063|FG001|Overall Study|Administrative reason|0|||
46698979|NCT01214850|82914064|FG002|Overall Study|Administrative reason|0|||
46698980|NCT01214850|82914062|FG000|Overall Study|Unable to classify|2|||
46698981|NCT01214850|82914063|FG001|Overall Study|Unable to classify|1|||
46698982|NCT01214850|82914064|FG002|Overall Study|Unable to classify|1|||
46698983|NCT01128153|82914077|FG000|Overall Study|Adverse Event|1|||
46698984|NCT01128153|82914078|FG001|Overall Study|Adverse Event|3|||
46698985|NCT01128153|82914077|FG000|Overall Study|Condition under investigation worsened|8|||
46698986|NCT01128153|82914078|FG001|Overall Study|Condition under investigation worsened|7|||
46698987|NCT01128153|82914077|FG000|Overall Study|Withdrawal by Subject|2|||
46698988|NCT01128153|82914078|FG001|Overall Study|Withdrawal by Subject|3|||
46698989|NCT01128153|82914077|FG000|Overall Study|Incorrect enrolment to study|2|||
46698990|NCT01128153|82914078|FG001|Overall Study|Incorrect enrolment to study|1|||
46698991|NCT01128153|82914077|FG000|Overall Study|Protocol Violation|2|||
46698992|NCT01128153|82914078|FG001|Overall Study|Protocol Violation|0|||
46698993|NCT01128153|82914077|FG000|Overall Study|Developed discontinuation criteria|1|||
46698994|NCT01128153|82914078|FG001|Overall Study|Developed discontinuation criteria|1|||
46698995|NCT00925015|82914087|FG000|Overall Study|Adverse Event|1|||
46698996|NCT00925015|82914088|FG001|Overall Study|Adverse Event|2|||
46698997|NCT00925015|82914089|FG002|Overall Study|Adverse Event|1|||
46698998|NCT00925015|82914087|FG000|Overall Study|Physician Decision|0|||
46698999|NCT00925015|82914088|FG001|Overall Study|Physician Decision|1|||
46699000|NCT00925015|82914089|FG002|Overall Study|Physician Decision|0|||
46699001|NCT00925015|82914087|FG000|Overall Study|Progressive Disease|7|||
46699002|NCT00925015|82914088|FG001|Overall Study|Progressive Disease|3|||
46699003|NCT00925015|82914089|FG002|Overall Study|Progressive Disease|4|||
46699004|NCT00925015|82914087|FG000|Overall Study|Withdrawal by Subject|0|||
46699005|NCT00925015|82914088|FG001|Overall Study|Withdrawal by Subject|0|||
46699006|NCT00925015|82914089|FG002|Overall Study|Withdrawal by Subject|1|||
46699007|NCT01127763|82914101|FG000|Overall Study|Adverse Event|2|||
46699008|NCT01127763|82914101|FG000|Overall Study|Withdrawal by Subject|1|||
46699009|NCT01127763|82914101|FG000|Overall Study|Physician Decision|2|||
46699010|NCT01127607|82914111|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
46699011|NCT01127607|82914112|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
46699012|NCT01127607|82914111|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
46699013|NCT01127607|82914112|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
46699014|NCT00924781|82914139|FG000|Overall Study|Study terminated by sponsor|12|||
46699015|NCT00924781|82914140|FG001|Overall Study|Study terminated by sponsor|10|||
46699016|NCT01127451|82914158|FG000|Overall Study|Other|2|||
46699017|NCT01127451|82914159|FG001|Overall Study|Other|1|||
46699018|NCT01127451|82914158|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
46699019|NCT01127451|82914159|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
46699020|NCT01127451|82914158|FG000|Overall Study|Death|22|||
46699021|NCT01127451|82914159|FG001|Overall Study|Death|17|||
46699022|NCT01127451|82914158|FG000|Overall Study|Lost to Follow-up|3|||
46699023|NCT01127451|82914159|FG001|Overall Study|Lost to Follow-up|0|||
46699024|NCT01127451|82914158|FG000|Overall Study|Administrative Reason by Sponsor|2|||
46699025|NCT01127451|82914159|FG001|Overall Study|Administrative Reason by Sponsor|2|||
46699026|NCT01127373|82914165|FG000|Overall Study|Not Treated|3|||
46699027|NCT01127373|82914165|FG000|Overall Study|Lost to Follow-up|7|||
46699028|NCT01127373|82914165|FG000|Overall Study|Withdrawal by Subject|1|||
46699029|NCT01127373|82914165|FG000|Overall Study|Disease progression|1|||
46699030|NCT01127139|82914169|FG000|Overall Study|Adverse Event|40|||
46699031|NCT01127139|82914169|FG000|Overall Study|Incompliance|12|||
46699032|NCT01127139|82914169|FG000|Overall Study|Lack of Efficacy|4|||
46699033|NCT01127139|82914169|FG000|Overall Study|Reason not specified|1|||
46699034|NCT01214616|82914180|FG000|Overall Study|Progressive disease|2|||
46699035|NCT01214616|82914181|FG001|Overall Study|Progressive disease|2|||
46699036|NCT01214616|82914182|FG002|Overall Study|Progressive disease|2|||
46699037|NCT01214616|82914183|FG003|Overall Study|Progressive disease|4|||
46699038|NCT01214616|82914180|FG000|Overall Study|Dose limiting toxicity|0|||
46699039|NCT01214616|82914181|FG001|Overall Study|Dose limiting toxicity|2|||
46699040|NCT01214616|82914182|FG002|Overall Study|Dose limiting toxicity|0|||
46699041|NCT01214616|82914183|FG003|Overall Study|Dose limiting toxicity|0|||
46699042|NCT01214616|82914180|FG000|Overall Study|Other adverse events|0|||
46699043|NCT01214616|82914181|FG001|Overall Study|Other adverse events|1|||
46699044|NCT01214616|82914182|FG002|Overall Study|Other adverse events|1|||
46699045|NCT01214616|82914183|FG003|Overall Study|Other adverse events|1|||
46699046|NCT01214616|82914180|FG000|Overall Study|Withdrawal by Subject|1|||
46699047|NCT01214616|82914181|FG001|Overall Study|Withdrawal by Subject|0|||
46699048|NCT01214616|82914182|FG002|Overall Study|Withdrawal by Subject|0|||
46699049|NCT01214616|82914183|FG003|Overall Study|Withdrawal by Subject|1|||
46699050|NCT01213836|82914203|FG000|Period 1, First Intervention|Adverse Event|2|||
46699051|NCT01213836|82914204|FG001|Period 1, First Intervention|Adverse Event|1|||
46699052|NCT01213836|82914203|FG000|Period 1, First Intervention|Protocol Violation|0|||
46699053|NCT01213836|82914204|FG001|Period 1, First Intervention|Protocol Violation|1|||
46699054|NCT01213836|82914203|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
46699055|NCT01213836|82914204|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
46699056|NCT01127061|82914215|FG000|Overall Study|Lost to Follow-up|7|||
46699057|NCT01127061|82914216|FG001|Overall Study|Lost to Follow-up|10|||
46699058|NCT01127061|82914215|FG000|Overall Study|Physician Decision|3|||
46699059|NCT01127061|82914216|FG001|Overall Study|Physician Decision|3|||
46699060|NCT00924703|82914222|FG000|Overall Study|Withdrawal by Subject|11|||
46699061|NCT00924703|82914222|FG000|Overall Study|Physician Decision|5|||
46699062|NCT00924703|82914222|FG000|Overall Study|Lost to Follow-up|3|||
46699063|NCT00924703|82914222|FG000|Overall Study|Adverse Event|2|||
46699064|NCT00924703|82914222|FG000|Overall Study|Withdrawal by Sponsor|1|||
46699065|NCT01213524|82914228|FG000|Baseline|Withdrawal by Subject|5|||
46699066|NCT01213524|82914228|FG000|Baseline|high breath alcohol levels|1|||
46699067|NCT01213524|82914228|FG000|Baseline|Physician Decision|1|||
46699068|NCT01213524|82914228|FG000|Session 2|Withdrawal by Subject|5|||
46699069|NCT01213524|82914228|FG000|Session 3|Withdrawal by Subject|4|||
46699070|NCT01213524|82914228|FG000|Session 4|Physician Decision|1|||
46699071|NCT01213524|82914228|FG000|Session 4|Withdrawal by Subject|2|||
46699072|NCT01212744|82914239|FG000|Overall Study|Withdrawal by Subject|1|||
46699073|NCT01212588|82914247|FG000|Overall Study|Physician Decision|0|||
46699074|NCT01212588|82914248|FG001|Overall Study|Physician Decision|1|||
46699075|NCT01212588|82914247|FG000|Overall Study|Protocol Violation|1|||
46699076|NCT01212588|82914248|FG001|Overall Study|Protocol Violation|1|||
46699077|NCT00918385|82914256|FG000|Monotherapy|Adverse Event|1|||
46699078|NCT00918385|82914257|FG001|Monotherapy|Adverse Event|6|||
46699079|NCT00918385|82914256|FG000|Monotherapy|Complicating illness|1|||
46699080|NCT00918385|82914257|FG001|Monotherapy|Complicating illness|0|||
46699081|NCT00918385|82914256|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
46699082|NCT00918385|82914257|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
46699083|NCT00918385|82914256|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
46699084|NCT00918385|82914257|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
46699085|NCT00918385|82914256|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
46699086|NCT00918385|82914257|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
46699087|NCT00918385|82914256|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
46699088|NCT00918385|82914257|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
46699089|NCT01211262|82914267|FG000|Overall Study|Progressive Disease|18|||
46699090|NCT01211262|82914268|FG001|Overall Study|Progressive Disease|9|||
46699091|NCT01211262|82914267|FG000|Overall Study|Adverse Event|4|||
46699092|NCT01211262|82914268|FG001|Overall Study|Adverse Event|0|||
46699093|NCT01211262|82914267|FG000|Overall Study|Withdrawal of Consent|1|||
46699094|NCT01211262|82914268|FG001|Overall Study|Withdrawal of Consent|0|||
46699095|NCT01211262|82914267|FG000|Overall Study|Other|0|||
46699096|NCT01211262|82914268|FG001|Overall Study|Other|1|||
46699097|NCT01211184|82914280|FG000|Overall Study|Withdrawal by Subject|0|||
46699098|NCT01211184|82914281|FG001|Overall Study|Withdrawal by Subject|2|||
46699099|NCT01211184|82914282|FG002|Overall Study|Withdrawal by Subject|1|||
46699100|NCT00924469|82914295|FG000|Overall Study|Adverse Event|2|||
46699101|NCT00924469|82914296|FG001|Overall Study|Adverse Event|0|||
46699102|NCT00924469|82914295|FG000|Overall Study|Withdrawal by Subject|0|||
46699103|NCT00924469|82914296|FG001|Overall Study|Withdrawal by Subject|1|||
46699104|NCT00924469|82914295|FG000|Overall Study|Lost to Follow-up|0|||
46699105|NCT00924469|82914296|FG001|Overall Study|Lost to Follow-up|1|||
46699106|NCT00924313|82914302|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
46699107|NCT01209780|82914310|FG000|Overall Study|Adverse Event|0|||
46699108|NCT01209780|82914311|FG001|Overall Study|Adverse Event|1|||
46699109|NCT01209780|82914312|FG002|Overall Study|Adverse Event|0|||
46699110|NCT01209780|82914313|FG003|Overall Study|Adverse Event|0|||
46699111|NCT01209780|82914314|FG004|Overall Study|Adverse Event|0|||
46699112|NCT01209780|82914310|FG000|Overall Study|Withdrawal by Subject|9|||
46699113|NCT01209780|82914311|FG001|Overall Study|Withdrawal by Subject|2|||
46699114|NCT01209780|82914312|FG002|Overall Study|Withdrawal by Subject|1|||
46699115|NCT01209780|82914313|FG003|Overall Study|Withdrawal by Subject|1|||
46699116|NCT01209780|82914314|FG004|Overall Study|Withdrawal by Subject|0|||
46699117|NCT01209780|82914310|FG000|Overall Study|Lost to Follow-up|17|||
46699118|NCT01209780|82914311|FG001|Overall Study|Lost to Follow-up|12|||
46699119|NCT01209780|82914312|FG002|Overall Study|Lost to Follow-up|3|||
46699120|NCT01209780|82914313|FG003|Overall Study|Lost to Follow-up|9|||
46699121|NCT01209780|82914314|FG004|Overall Study|Lost to Follow-up|4|||
46699122|NCT01209780|82914310|FG000|Overall Study|Protocol Violation|0|||
46699123|NCT01209780|82914311|FG001|Overall Study|Protocol Violation|1|||
46699124|NCT01209780|82914312|FG002|Overall Study|Protocol Violation|0|||
46699125|NCT01209780|82914313|FG003|Overall Study|Protocol Violation|0|||
46699126|NCT01209780|82914314|FG004|Overall Study|Protocol Violation|0|||
46699127|NCT01209780|82914310|FG000|Overall Study|Inappropriate enrollment|0|||
46699128|NCT01209780|82914311|FG001|Overall Study|Inappropriate enrollment|2|||
46699129|NCT01209780|82914312|FG002|Overall Study|Inappropriate enrollment|0|||
46699130|NCT01209780|82914313|FG003|Overall Study|Inappropriate enrollment|0|||
46699131|NCT01209780|82914314|FG004|Overall Study|Inappropriate enrollment|1|||
46699132|NCT00916357|82914327|FG000|Period 1|Withdrawal by Subject|1|||
46699133|NCT00916357|82914328|FG001|Period 1|Withdrawal by Subject|0|||
46699134|NCT00916357|82914329|FG002|Period 1|Withdrawal by Subject|0|||
46699135|NCT00916357|82914330|FG003|Period 1|Withdrawal by Subject|0|||
46699136|NCT00916357|82914331|FG004|Period 1|Withdrawal by Subject|0|||
46699137|NCT00916357|82914332|FG005|Period 1|Withdrawal by Subject|0|||
46699138|NCT00916357|82914327|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
46699139|NCT00916357|82914328|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
46699140|NCT00916357|82914329|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
46699141|NCT00916357|82914330|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
46699142|NCT00916357|82914331|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
46699143|NCT00916357|82914332|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
46868706|NCT03042910|83087022|FG000|Overall Study|Withdrawal by Subject|3|||
46868707|NCT03042910|83087022|FG000|Overall Study|Enrolled but not treated|1|||
46868708|NCT03059446|83087026|FG000|Overall Study|Adverse Event|11|||
46868709|NCT03059446|83087026|FG000|Overall Study|Withdrawal of Consent|16|||
46868710|NCT03059446|83087026|FG000|Overall Study|Lost to Follow-up|3|||
46699144|NCT01209624|82914341|FG000|Overall Study|Death|2|||
46699145|NCT01209624|82914341|FG000|Overall Study|Adverse Event|13|||
46699146|NCT01209624|82914341|FG000|Overall Study|Lack of Efficacy|17|||
46699147|NCT01209624|82914341|FG000|Overall Study|Lost to Follow-up|290|||
46699148|NCT01209624|82914341|FG000|Overall Study|Other|4|||
46699149|NCT00916279|82914345|FG000|Overall Study|Death|2|||
46868711|NCT03059446|83087026|FG000|Overall Study|Protocol Violation|1|||
46868712|NCT03059446|83087026|FG000|Overall Study|Study Terminated by Sponsor|131|||
46699150|NCT00916279|82914345|FG000|Overall Study|Lost to Follow-up|2|||
46699151|NCT01209078|82914364|FG000|Overall Study|Adverse Event|5|||
46699152|NCT01209078|82914365|FG001|Overall Study|Adverse Event|0|||
46699153|NCT01209078|82914364|FG000|Overall Study|Lost to Follow-up|4|||
46699154|NCT01209078|82914365|FG001|Overall Study|Lost to Follow-up|0|||
46699155|NCT01209078|82914364|FG000|Overall Study|Physician Decision|5|||
46699156|NCT01209078|82914365|FG001|Overall Study|Physician Decision|2|||
46699157|NCT01209078|82914364|FG000|Overall Study|Withdrawal by Subject|2|||
46699158|NCT01209078|82914365|FG001|Overall Study|Withdrawal by Subject|1|||
46699159|NCT01207596|82914373|FG000|Overall Study|Physician Decision|4|||
46699160|NCT01207596|82914373|FG000|Overall Study|Lack of Efficacy|1|||
46699161|NCT01207596|82914373|FG000|Overall Study|Adverse Event|3|||
46699162|NCT01207596|82914373|FG000|Overall Study|Withdrawal by Subject|1|||
46699163|NCT00915343|82914377|FG000|Part B - Open Label Period|Treatment switch|0|||
46868713|NCT03059446|83087026|FG000|Overall Study|Reason not Specified|5|||
46868714|NCT00090519|83087032|FG000|Overall Study|Adverse Event|5|||
46699164|NCT00915343|82914378|FG001|Part B - Open Label Period|Treatment switch|0|||
46699165|NCT00915343|82914379|FG002|Part B - Open Label Period|Treatment switch|1|||
46699166|NCT00915343|82914377|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
46699167|NCT00915343|82914378|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
46699168|NCT00915343|82914379|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
46699169|NCT00911989|82914391|FG000|Overall Study|Adverse Event|1|||
46699170|NCT00910273|82914397|FG000|Overall Study|Lack of Efficacy|6|||
46699171|NCT00910273|82914398|FG001|Overall Study|Lack of Efficacy|9|||
46699172|NCT00910273|82914397|FG000|Overall Study|Adverse Event|1|||
46699173|NCT00910273|82914398|FG001|Overall Study|Adverse Event|1|||
46699174|NCT00910273|82914397|FG000|Overall Study|Withdrawal by Subject|1|||
46699175|NCT00910273|82914398|FG001|Overall Study|Withdrawal by Subject|0|||
46699176|NCT00910273|82914397|FG000|Overall Study|Discontinuation of study by sponsor|8|||
46699177|NCT00910273|82914398|FG001|Overall Study|Discontinuation of study by sponsor|2|||
46699178|NCT00910273|82914397|FG000|Overall Study|Protocol Violation|1|||
46699179|NCT00910273|82914398|FG001|Overall Study|Protocol Violation|0|||
46699180|NCT00910273|82914397|FG000|Overall Study|Lost to Follow-up|1|||
46699181|NCT00910273|82914398|FG001|Overall Study|Lost to Follow-up|1|||
46699182|NCT00910039|82914404|FG000|Overall Study|Physician Decision|1|||
46699183|NCT00909181|82914412|FG000|Overall Study|Lost to Follow-up|39|||
46868715|NCT00090519|83087033|FG001|Overall Study|Adverse Event|4|||
46868716|NCT00090519|83087032|FG000|Overall Study|Death|9|||
46868717|NCT00090519|83087033|FG001|Overall Study|Death|9|||
46699184|NCT00909181|82914413|FG001|Overall Study|Lost to Follow-up|18|||
46699185|NCT00909181|82914414|FG002|Overall Study|Lost to Follow-up|33|||
46699186|NCT01286987|82914437|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
46699187|NCT01286987|82914438|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
46699188|NCT01286987|82914439|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
46699189|NCT01286987|82914440|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
46699190|NCT01286987|82914441|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
46699191|NCT01286987|82914442|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
46699192|NCT01286987|82914443|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
46699193|NCT01286987|82914444|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
46699194|NCT01286987|82914445|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
46699195|NCT01286987|82914446|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
46699196|NCT01286987|82914447|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
46699197|NCT01286987|82914448|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
46699198|NCT01286987|82914449|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
46699199|NCT01286987|82914450|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
46699200|NCT01286987|82914451|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
46699201|NCT01286987|82914437|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
46699202|NCT01286987|82914438|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
46868718|NCT00090519|83087032|FG000|Overall Study|Lost to Follow-up|26|||
46868719|NCT00090519|83087033|FG001|Overall Study|Lost to Follow-up|29|||
46868720|NCT00090519|83087032|FG000|Overall Study|Withdrawal by Subject|28|||
46868721|NCT00090519|83087033|FG001|Overall Study|Withdrawal by Subject|29|||
46868722|NCT00090519|83087032|FG000|Overall Study|Physician Decision|2|||
46868723|NCT00090519|83087033|FG001|Overall Study|Physician Decision|3|||
46868724|NCT00090519|83087032|FG000|Overall Study|Sponsor Decision|3|||
46868725|NCT00090519|83087033|FG001|Overall Study|Sponsor Decision|1|||
46868726|NCT00096993|83087063|FG000|Overall Study|Death|1|||
46868727|NCT00096993|83087064|FG001|Overall Study|Death|0|||
46868728|NCT00096993|83087063|FG000|Overall Study|Disease progression|56|||
46868729|NCT00096993|83087064|FG001|Overall Study|Disease progression|53|||
46868730|NCT00096993|83087063|FG000|Overall Study|Adverse Event|2|||
46868731|NCT00096993|83087064|FG001|Overall Study|Adverse Event|8|||
46868732|NCT00096993|83087063|FG000|Overall Study|Subject's decision|3|||
46868733|NCT00096993|83087064|FG001|Overall Study|Subject's decision|1|||
46868734|NCT00096993|83087063|FG000|Overall Study|Physician Decision|2|||
46699203|NCT01286987|82914439|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
46699204|NCT01286987|82914440|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
46699205|NCT01286987|82914441|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
46699206|NCT01286987|82914442|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
46699207|NCT01286987|82914443|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
46699208|NCT01286987|82914444|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
46699209|NCT01286987|82914445|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
46868735|NCT00096993|83087064|FG001|Overall Study|Physician Decision|1|||
46868736|NCT00096993|83087063|FG000|Overall Study|Non-compliance|0|||
46868737|NCT00096993|83087064|FG001|Overall Study|Non-compliance|1|||
46868738|NCT00096993|83087063|FG000|Overall Study|Other unspecified|1|||
46868739|NCT00096993|83087064|FG001|Overall Study|Other unspecified|1|||
46699210|NCT01286987|82914446|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
46699211|NCT01286987|82914447|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
46868740|NCT03040336|83087072|FG000|Overall Study|Death|1|||
46868741|NCT03040336|83087073|FG001|Overall Study|Death|0|||
46868742|NCT03040336|83087072|FG000|Overall Study|Withdrawal by Subject|2|||
46699212|NCT01286987|82914448|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
46699213|NCT01286987|82914449|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
46699214|NCT01286987|82914450|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
46699215|NCT01286987|82914451|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
46699216|NCT01286987|82914437|FG000|Part 1: Dose Escalation|Physician Decision|0|||
46699217|NCT01286987|82914438|FG001|Part 1: Dose Escalation|Physician Decision|0|||
46699218|NCT01286987|82914439|FG002|Part 1: Dose Escalation|Physician Decision|0|||
46699219|NCT01286987|82914440|FG003|Part 1: Dose Escalation|Physician Decision|0|||
46699220|NCT01286987|82914441|FG004|Part 1: Dose Escalation|Physician Decision|1|||
46699221|NCT01286987|82914442|FG005|Part 1: Dose Escalation|Physician Decision|0|||
46699222|NCT01286987|82914443|FG006|Part 1: Dose Escalation|Physician Decision|0|||
46699223|NCT01286987|82914444|FG007|Part 1: Dose Escalation|Physician Decision|0|||
46699224|NCT01286987|82914445|FG008|Part 1: Dose Escalation|Physician Decision|0|||
46699225|NCT01286987|82914446|FG009|Part 1: Dose Escalation|Physician Decision|0|||
46699226|NCT01286987|82914447|FG010|Part 1: Dose Escalation|Physician Decision|0|||
46699227|NCT01286987|82914448|FG011|Part 1: Dose Escalation|Physician Decision|0|||
46699228|NCT01286987|82914449|FG012|Part 1: Dose Escalation|Physician Decision|0|||
46699229|NCT01286987|82914450|FG013|Part 1: Dose Escalation|Physician Decision|0|||
46699230|NCT01286987|82914451|FG014|Part 1: Dose Escalation|Physician Decision|0|||
46699231|NCT01286987|82914437|FG000|Part 2: Dose Expansion|Death|0|||
46699232|NCT01286987|82914438|FG001|Part 2: Dose Expansion|Death|0|||
46699233|NCT01286987|82914439|FG002|Part 2: Dose Expansion|Death|0|||
46699234|NCT01286987|82914440|FG003|Part 2: Dose Expansion|Death|0|||
46699235|NCT01286987|82914441|FG004|Part 2: Dose Expansion|Death|0|||
46699236|NCT01286987|82914442|FG005|Part 2: Dose Expansion|Death|0|||
46699237|NCT01286987|82914443|FG006|Part 2: Dose Expansion|Death|0|||
46699238|NCT01286987|82914444|FG007|Part 2: Dose Expansion|Death|0|||
46699239|NCT01286987|82914445|FG008|Part 2: Dose Expansion|Death|0|||
46699240|NCT01286987|82914446|FG009|Part 2: Dose Expansion|Death|0|||
46699241|NCT01286987|82914447|FG010|Part 2: Dose Expansion|Death|0|||
46699242|NCT01286987|82914448|FG011|Part 2: Dose Expansion|Death|0|||
46699243|NCT01286987|82914449|FG012|Part 2: Dose Expansion|Death|1|||
46699244|NCT01286987|82914450|FG013|Part 2: Dose Expansion|Death|1|||
46699245|NCT01286987|82914451|FG014|Part 2: Dose Expansion|Death|0|||
46699246|NCT01286987|82914437|FG000|Part 2: Dose Expansion|Physician Decision|0|||
46699247|NCT01286987|82914438|FG001|Part 2: Dose Expansion|Physician Decision|0|||
46699248|NCT01286987|82914439|FG002|Part 2: Dose Expansion|Physician Decision|0|||
46699249|NCT01286987|82914440|FG003|Part 2: Dose Expansion|Physician Decision|0|||
46699250|NCT01286987|82914441|FG004|Part 2: Dose Expansion|Physician Decision|0|||
46699251|NCT01286987|82914442|FG005|Part 2: Dose Expansion|Physician Decision|0|||
46699252|NCT01286987|82914443|FG006|Part 2: Dose Expansion|Physician Decision|0|||
46699253|NCT01286987|82914444|FG007|Part 2: Dose Expansion|Physician Decision|0|||
46699254|NCT01286987|82914445|FG008|Part 2: Dose Expansion|Physician Decision|0|||
46699255|NCT01286987|82914446|FG009|Part 2: Dose Expansion|Physician Decision|0|||
46699256|NCT01286987|82914447|FG010|Part 2: Dose Expansion|Physician Decision|1|||
46699257|NCT01286987|82914448|FG011|Part 2: Dose Expansion|Physician Decision|1|||
46699258|NCT01286987|82914449|FG012|Part 2: Dose Expansion|Physician Decision|0|||
46699259|NCT01286987|82914450|FG013|Part 2: Dose Expansion|Physician Decision|1|||
46699260|NCT01286987|82914451|FG014|Part 2: Dose Expansion|Physician Decision|0|||
46699261|NCT01286987|82914437|FG000|Part 2: Dose Expansion|Other|0|||
46699262|NCT01286987|82914438|FG001|Part 2: Dose Expansion|Other|0|||
46699263|NCT01286987|82914439|FG002|Part 2: Dose Expansion|Other|0|||
46699264|NCT01286987|82914440|FG003|Part 2: Dose Expansion|Other|0|||
46699265|NCT01286987|82914441|FG004|Part 2: Dose Expansion|Other|0|||
46699266|NCT01286987|82914442|FG005|Part 2: Dose Expansion|Other|0|||
46699267|NCT01286987|82914443|FG006|Part 2: Dose Expansion|Other|0|||
46699268|NCT01286987|82914444|FG007|Part 2: Dose Expansion|Other|0|||
46699269|NCT01286987|82914445|FG008|Part 2: Dose Expansion|Other|0|||
46699270|NCT01286987|82914446|FG009|Part 2: Dose Expansion|Other|0|||
46699271|NCT01286987|82914447|FG010|Part 2: Dose Expansion|Other|0|||
46699272|NCT01286987|82914448|FG011|Part 2: Dose Expansion|Other|0|||
46699273|NCT01286987|82914449|FG012|Part 2: Dose Expansion|Other|0|||
46699274|NCT01286987|82914450|FG013|Part 2: Dose Expansion|Other|1|||
46699275|NCT01286987|82914451|FG014|Part 2: Dose Expansion|Other|0|||
46699276|NCT01286987|82914437|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
46699277|NCT01286987|82914438|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
46699278|NCT01286987|82914439|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
46699279|NCT01286987|82914440|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
46699280|NCT01286987|82914441|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
46699281|NCT01286987|82914442|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
46699282|NCT01286987|82914443|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
46699283|NCT01286987|82914444|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
46699284|NCT01286987|82914445|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
46699285|NCT01286987|82914446|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
46699286|NCT01286987|82914447|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
46699287|NCT01286987|82914448|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
46868743|NCT03040336|83087073|FG001|Overall Study|Withdrawal by Subject|3|||
46868744|NCT00072189|83087080|FG000|Overall Study|Withdrawal by Subject|1|||
46699288|NCT01286987|82914449|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
46983735|NCT02307513|83229990|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
46699289|NCT01286987|82914450|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
46699290|NCT01286987|82914451|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
46983736|NCT02307513|83229989|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
46699291|NCT01286987|82914437|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
46699292|NCT01286987|82914438|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
46699293|NCT01286987|82914439|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
46699294|NCT01286987|82914440|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
46699295|NCT01286987|82914441|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
46699296|NCT01286987|82914442|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
46699297|NCT01286987|82914443|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
46699298|NCT01286987|82914444|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
46699299|NCT01286987|82914445|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
46699300|NCT01286987|82914446|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
46699301|NCT01286987|82914447|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
46699302|NCT01286987|82914448|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
46699303|NCT01286987|82914449|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
46699304|NCT01286987|82914450|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
46699305|NCT01286987|82914451|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
46699306|NCT01286987|82914437|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699307|NCT01286987|82914438|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699308|NCT01286987|82914439|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699309|NCT01286987|82914440|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699310|NCT01286987|82914441|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699311|NCT01286987|82914442|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699312|NCT01286987|82914443|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699313|NCT01286987|82914444|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699314|NCT01286987|82914445|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699315|NCT01286987|82914446|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699316|NCT01286987|82914447|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
46699317|NCT01286987|82914448|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699318|NCT01286987|82914449|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699319|NCT01286987|82914450|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699320|NCT01286987|82914451|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
46699321|NCT01286753|82914494|FG000|Overall Study|Adverse Event|7|||
46699322|NCT01286753|82914495|FG001|Overall Study|Adverse Event|6|||
46699323|NCT01286753|82914494|FG000|Overall Study|Progression|11|||
46699324|NCT01286753|82914495|FG001|Overall Study|Progression|13|||
46699325|NCT01286753|82914494|FG000|Overall Study|Refused Treatment|1|||
46699326|NCT01286753|82914495|FG001|Overall Study|Refused Treatment|0|||
46699327|NCT01286753|82914494|FG000|Overall Study|Withdrawal of Consent|0|||
46699328|NCT01286753|82914495|FG001|Overall Study|Withdrawal of Consent|2|||
46699329|NCT01286753|82914494|FG000|Overall Study|Discontinued to Join Extension Study|6|||
46699330|NCT01286753|82914495|FG001|Overall Study|Discontinued to Join Extension Study|4|||
46699331|NCT01286753|82914494|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
46699332|NCT01286753|82914495|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
46699333|NCT01286129|82914504|FG000|Overall Study|Withdrawal by Subject|4|||
46868745|NCT03040024|83087087|FG000|Overall Study|Adverse Event|0|||
46868746|NCT03040024|83087088|FG001|Overall Study|Adverse Event|1|||
46868747|NCT03040024|83087089|FG002|Overall Study|Adverse Event|0|||
46868748|NCT03040024|83087087|FG000|Overall Study|Death|0|||
46868749|NCT03040024|83087088|FG001|Overall Study|Death|1|||
46868750|NCT03040024|83087089|FG002|Overall Study|Death|0|||
46868751|NCT03040024|83087087|FG000|Overall Study|Physician Decision|0|||
46868752|NCT03040024|83087088|FG001|Overall Study|Physician Decision|0|||
46868753|NCT03040024|83087089|FG002|Overall Study|Physician Decision|1|||
46983737|NCT02307513|83229990|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
46983738|NCT02307513|83229989|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
46983739|NCT02307513|83229990|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
46699334|NCT01286129|82914505|FG001|Overall Study|Withdrawal by Subject|1|||
46699335|NCT01286129|82914504|FG000|Overall Study|Could not comply with study requirements|4|||
46699336|NCT01286129|82914505|FG001|Overall Study|Could not comply with study requirements|4|||
46699337|NCT01285349|82914516|FG000|Overall Study|Lost to Follow-up|27|||
46699338|NCT01285349|82914517|FG001|Overall Study|Lost to Follow-up|20|||
46699339|NCT01285349|82914518|FG002|Overall Study|Lost to Follow-up|27|||
46699340|NCT01284959|82914530|FG000|Overall Study|Withdrawal by Subject|1|||
46699341|NCT01284959|82914531|FG001|Overall Study|Withdrawal by Subject|0|||
46868754|NCT03039790|83087117|FG000|Overall Study|Lost to Follow-up|2|||
46868755|NCT03039790|83087118|FG001|Overall Study|Lost to Follow-up|0|||
46699342|NCT01284959|82914532|FG002|Overall Study|Withdrawal by Subject|0|||
46699343|NCT01284959|82914530|FG000|Overall Study|Adverse Event|0|||
46699344|NCT01284959|82914531|FG001|Overall Study|Adverse Event|0|||
46699345|NCT01284959|82914532|FG002|Overall Study|Adverse Event|1|||
46868756|NCT03039790|83087119|FG002|Overall Study|Lost to Follow-up|1|||
46699346|NCT01284491|82914540|FG000|Overall Study|Study termination|13|||
46699347|NCT01283009|82914548|FG000|Overall Study|Death|83|||
46868757|NCT03039790|83087120|FG003|Overall Study|Lost to Follow-up|1|||
46868758|NCT03039790|83087121|FG004|Overall Study|Lost to Follow-up|0|||
46699348|NCT01283009|82914549|FG001|Overall Study|Death|78|||
46699349|NCT01283009|82914548|FG000|Overall Study|Study ended early|23|||
46699350|NCT01283009|82914549|FG001|Overall Study|Study ended early|26|||
46868759|NCT03039790|83087122|FG005|Overall Study|Lost to Follow-up|1|||
46868760|NCT03039790|83087123|FG006|Overall Study|Lost to Follow-up|1|||
46868761|NCT03039790|83087124|FG007|Overall Study|Lost to Follow-up|1|||
46868762|NCT03039790|83087125|FG008|Overall Study|Lost to Follow-up|0|||
46868763|NCT03039790|83087126|FG009|Overall Study|Lost to Follow-up|1|||
46868764|NCT03039790|83087127|FG010|Overall Study|Lost to Follow-up|1|||
46868765|NCT03039790|83087128|FG011|Overall Study|Lost to Follow-up|0|||
46868766|NCT03039790|83087129|FG012|Overall Study|Lost to Follow-up|1|||
46868767|NCT03039790|83087130|FG013|Overall Study|Lost to Follow-up|0|||
46868768|NCT03039790|83087131|FG014|Overall Study|Lost to Follow-up|3|||
46868769|NCT03039790|83087132|FG015|Overall Study|Lost to Follow-up|1|||
46868770|NCT03039790|83087133|FG016|Overall Study|Lost to Follow-up|2|||
46868771|NCT03039790|83087134|FG017|Overall Study|Lost to Follow-up|2|||
46699351|NCT01283009|82914548|FG000|Overall Study|Withdrawal by Subject|10|||
46699352|NCT01283009|82914549|FG001|Overall Study|Withdrawal by Subject|8|||
46699353|NCT01283009|82914548|FG000|Overall Study|Physician Decision|1|||
46699354|NCT01283009|82914549|FG001|Overall Study|Physician Decision|1|||
46699355|NCT01283009|82914548|FG000|Overall Study|Lost to Follow-up|1|||
46699356|NCT01283009|82914549|FG001|Overall Study|Lost to Follow-up|0|||
46699357|NCT01283009|82914548|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
46699358|NCT01283009|82914549|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
46699359|NCT01282463|82914558|FG000|Overall Study|Lost to Follow-up|1|||
46699360|NCT01282463|82914559|FG001|Overall Study|Lost to Follow-up|0|||
46699361|NCT01282463|82914560|FG002|Overall Study|Lost to Follow-up|0|||
46699362|NCT01282463|82914558|FG000|Overall Study|Withdrawal by Subject|6|||
46699363|NCT01282463|82914559|FG001|Overall Study|Withdrawal by Subject|2|||
46699364|NCT01282463|82914560|FG002|Overall Study|Withdrawal by Subject|3|||
46699365|NCT01282463|82914558|FG000|Overall Study|"Never Treated Death"|0|||
46699366|NCT01282463|82914559|FG001|Overall Study|"Never Treated Death"|1|||
46699367|NCT01282463|82914560|FG002|Overall Study|"Never Treated Death"|0|||
46699368|NCT01282463|82914558|FG000|Overall Study|"Never Treated PD"|0|||
46699369|NCT01282463|82914559|FG001|Overall Study|"Never Treated PD"|1|||
46699370|NCT01282463|82914560|FG002|Overall Study|"Never Treated PD"|0|||
46699371|NCT01282463|82914558|FG000|Overall Study|Protocol Violation|0|||
46699372|NCT01282463|82914559|FG001|Overall Study|Protocol Violation|0|||
46699373|NCT01282463|82914560|FG002|Overall Study|Protocol Violation|1|||
46699374|NCT01282463|82914558|FG000|Overall Study|Physician Decision|1|||
46699375|NCT01282463|82914559|FG001|Overall Study|Physician Decision|0|||
46699376|NCT01282463|82914560|FG002|Overall Study|Physician Decision|0|||
46699377|NCT01282229|82914576|FG000|Overall Study|Protocol Violation|2|||
46699378|NCT01281917|82914594|FG000|Overall Study|Withdrawal by Subject|1|||
46699379|NCT01281839|82914600|FG000|Overall Study|Lost to Follow-up|6|||
46868772|NCT03039790|83087135|FG018|Overall Study|Lost to Follow-up|1|||
46868773|NCT03039790|83087136|FG019|Overall Study|Lost to Follow-up|3|||
46868774|NCT03039790|83087117|FG000|Overall Study|Withdrawal of Consent|1|||
46868775|NCT03039790|83087118|FG001|Overall Study|Withdrawal of Consent|0|||
46868776|NCT03039790|83087119|FG002|Overall Study|Withdrawal of Consent|0|||
46868777|NCT03039790|83087120|FG003|Overall Study|Withdrawal of Consent|1|||
46868778|NCT03039790|83087121|FG004|Overall Study|Withdrawal of Consent|0|||
46868779|NCT03039790|83087122|FG005|Overall Study|Withdrawal of Consent|0|||
46868780|NCT03039790|83087123|FG006|Overall Study|Withdrawal of Consent|0|||
46868781|NCT03039790|83087124|FG007|Overall Study|Withdrawal of Consent|0|||
46868782|NCT03039790|83087125|FG008|Overall Study|Withdrawal of Consent|0|||
46868783|NCT03039790|83087126|FG009|Overall Study|Withdrawal of Consent|1|||
46868784|NCT03039790|83087127|FG010|Overall Study|Withdrawal of Consent|0|||
46868785|NCT03039790|83087128|FG011|Overall Study|Withdrawal of Consent|0|||
46868786|NCT03039790|83087129|FG012|Overall Study|Withdrawal of Consent|2|||
46868787|NCT03039790|83087130|FG013|Overall Study|Withdrawal of Consent|0|||
46868788|NCT03039790|83087131|FG014|Overall Study|Withdrawal of Consent|1|||
46699380|NCT01281839|82914601|FG001|Overall Study|Lost to Follow-up|3|||
46699381|NCT01281839|82914600|FG000|Overall Study|Withdrawal by Subject|4|||
46868789|NCT03039790|83087132|FG015|Overall Study|Withdrawal of Consent|5|||
46868790|NCT03039790|83087133|FG016|Overall Study|Withdrawal of Consent|3|||
46699382|NCT01281839|82914601|FG001|Overall Study|Withdrawal by Subject|10|||
46699383|NCT01281839|82914600|FG000|Overall Study|Reason not specified|0|||
46699384|NCT01281839|82914601|FG001|Overall Study|Reason not specified|1|||
46868791|NCT03039790|83087134|FG017|Overall Study|Withdrawal of Consent|0|||
46868792|NCT03039790|83087135|FG018|Overall Study|Withdrawal of Consent|2|||
46699385|NCT01281137|82914609|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
46699386|NCT01281137|82914610|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
46699387|NCT01281137|82914609|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
46868793|NCT03039790|83087136|FG019|Overall Study|Withdrawal of Consent|5|||
46868794|NCT03039790|83087117|FG000|Overall Study|Death|0|||
46868795|NCT03039790|83087118|FG001|Overall Study|Death|0|||
46699388|NCT01281137|82914610|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
46699389|NCT01281137|82914609|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
46699390|NCT01281137|82914610|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
46699391|NCT01281137|82914609|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
46699392|NCT01281137|82914610|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
46699393|NCT01281137|82914609|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
46699394|NCT01281137|82914610|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
46699395|NCT01280981|82914634|FG000|Overall Study|Withdrawal by Subject|11|||
46699396|NCT01280981|82914634|FG000|Overall Study|Protocol Violation|2|||
46699397|NCT01280981|82914634|FG000|Overall Study|Lack of Efficacy|13|||
46699398|NCT01280981|82914634|FG000|Overall Study|Lost to Follow-up|3|||
46699399|NCT01280981|82914634|FG000|Overall Study|Adverse Event|6|||
46699400|NCT01280981|82914634|FG000|Overall Study|Irregular or discontinued menses|3|||
46699401|NCT01280981|82914634|FG000|Overall Study|Failed to return|45|||
46699402|NCT01280981|82914634|FG000|Overall Study|Non-compliance with protocol|3|||
46699403|NCT01280981|82914634|FG000|Overall Study|Withdrawal of consent|3|||
46699404|NCT01280981|82914634|FG000|Overall Study|Elective surgery|2|||
46699405|NCT01280981|82914634|FG000|Overall Study|Study site closure|1|||
46699406|NCT01280903|82914640|FG000|Overall Study|Lost to Follow-up|23|||
46699407|NCT01280903|82914641|FG001|Overall Study|Lost to Follow-up|16|||
46699408|NCT01280591|82914651|FG000|Overall Study|Withdrawal by Subject|0|||
46699409|NCT01280591|82914652|FG001|Overall Study|Withdrawal by Subject|0|||
46699410|NCT01280591|82914653|FG002|Overall Study|Withdrawal by Subject|0|||
46699411|NCT01280591|82914654|FG003|Overall Study|Withdrawal by Subject|2|||
46699412|NCT01280591|82914651|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
46699413|NCT01280591|82914652|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
46699414|NCT01280591|82914653|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
46699415|NCT01280591|82914654|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
46699416|NCT01280357|82914664|FG000|Overall Study|Excluded no internal monitoring|14|||
46699417|NCT01280357|82914664|FG000|Overall Study|IInsufficient data/No data supplied|12|||
46699418|NCT01274351|82914671|FG000|Overall Study|Lost to Follow-up|1|||
46699419|NCT01274351|82914671|FG000|Overall Study|patient not compliant with the protocol|1|||
46699420|NCT01274351|82914671|FG000|Overall Study|Pregnancy|1|||
46699421|NCT01274351|82914671|FG000|Overall Study|Death|2|||
46699422|NCT01274351|82914671|FG000|Overall Study|Withdrawal by Subject|3|||
46699423|NCT01274351|82914671|FG000|Overall Study|Adverse Event|8|||
46699424|NCT01274351|82914671|FG000|Overall Study|progression of disease|3|||
46699425|NCT01274351|82914671|FG000|Overall Study|hospitalization|1|||
46699426|NCT01271933|82914675|FG000|Single-Blind Phase|Lack of Efficacy|37|||
46699427|NCT01271933|82914676|FG001|Single-Blind Phase|Lack of Efficacy|0|||
46699428|NCT01271933|82914677|FG002|Single-Blind Phase|Lack of Efficacy|0|||
46699429|NCT01271933|82914675|FG000|Single-Blind Phase|Lost to Follow-up|10|||
46699430|NCT01271933|82914676|FG001|Single-Blind Phase|Lost to Follow-up|0|||
46699431|NCT01271933|82914677|FG002|Single-Blind Phase|Lost to Follow-up|0|||
46699432|NCT01271933|82914675|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
46699433|NCT01271933|82914676|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
46699434|NCT01271933|82914677|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
46699435|NCT01271933|82914675|FG000|Single-Blind Phase|Protocol Violation|3|||
46699436|NCT01271933|82914676|FG001|Single-Blind Phase|Protocol Violation|0|||
46699437|NCT01271933|82914677|FG002|Single-Blind Phase|Protocol Violation|0|||
46699438|NCT01271933|82914675|FG000|Single-Blind Phase|Adverse Event|52|||
46699439|NCT01271933|82914676|FG001|Single-Blind Phase|Adverse Event|0|||
46699440|NCT01271933|82914677|FG002|Single-Blind Phase|Adverse Event|0|||
46699441|NCT01271933|82914675|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
46699442|NCT01271933|82914676|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
46699443|NCT01271933|82914677|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
46699444|NCT01271933|82914675|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
46699445|NCT01271933|82914676|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
46699446|NCT01271933|82914677|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
46699447|NCT01271933|82914675|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
46699448|NCT01271933|82914676|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
46699449|NCT01271933|82914677|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
46699450|NCT01271933|82914675|FG000|Double-Blind Phase|Randomized but not treated|0|||
46699451|NCT01271933|82914676|FG001|Double-Blind Phase|Randomized but not treated|0|||
46699452|NCT01271933|82914677|FG002|Double-Blind Phase|Randomized but not treated|1|||
46983740|NCT02307513|83229989|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
46983741|NCT02307513|83229990|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
46699453|NCT01271933|82914675|FG000|Double-Blind Phase|Lack of Efficacy|0|||
46699454|NCT01271933|82914676|FG001|Double-Blind Phase|Lack of Efficacy|6|||
46699455|NCT01271933|82914677|FG002|Double-Blind Phase|Lack of Efficacy|9|||
46699456|NCT01271933|82914675|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46699457|NCT01271933|82914676|FG001|Double-Blind Phase|Lost to Follow-up|1|||
46699458|NCT01271933|82914677|FG002|Double-Blind Phase|Lost to Follow-up|1|||
46699459|NCT01271933|82914675|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
46699460|NCT01271933|82914676|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
46699461|NCT01271933|82914677|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
46699462|NCT01271933|82914675|FG000|Double-Blind Phase|Adverse Event|0|||
46699463|NCT01271933|82914676|FG001|Double-Blind Phase|Adverse Event|3|||
46699464|NCT01271933|82914677|FG002|Double-Blind Phase|Adverse Event|0|||
46699465|NCT01271933|82914675|FG000|Double-Blind Phase|Participant request-personal reason|0|||
46699466|NCT01271933|82914676|FG001|Double-Blind Phase|Participant request-personal reason|1|||
46699467|NCT01271933|82914677|FG002|Double-Blind Phase|Participant request-personal reason|0|||
46699468|NCT01269125|82914690|FG000|Overall Study|Adverse Event|3|||
46699469|NCT01269125|82914691|FG001|Overall Study|Adverse Event|5|||
46699470|NCT01269125|82914692|FG002|Overall Study|Adverse Event|0|||
46699471|NCT01269125|82914690|FG000|Overall Study|Lost to Follow-up|4|||
46699472|NCT01269125|82914691|FG001|Overall Study|Lost to Follow-up|0|||
46699473|NCT01269125|82914692|FG002|Overall Study|Lost to Follow-up|0|||
46699474|NCT01268891|82914702|FG000|Overall Study|Adverse Event|3|||
46699475|NCT01268891|82914703|FG001|Overall Study|Adverse Event|7|||
46699476|NCT01268891|82914702|FG000|Overall Study|Lack of Efficacy|1|||
46699477|NCT01268891|82914703|FG001|Overall Study|Lack of Efficacy|0|||
46699478|NCT01268891|82914702|FG000|Overall Study|Withdrawal of Consent|3|||
46699479|NCT01268891|82914703|FG001|Overall Study|Withdrawal of Consent|1|||
46699480|NCT01268891|82914702|FG000|Overall Study|Administrative or other reason(s)|1|||
46699481|NCT01268891|82914703|FG001|Overall Study|Administrative or other reason(s)|0|||
46699482|NCT01268501|82914709|FG000|Overall Study|Lost to Follow-up|1|||
46699483|NCT01268501|82914709|FG000|Overall Study|Withdrawal by Subject|3|||
46699484|NCT01268501|82914709|FG000|Overall Study|Unacceptable Subjective Vision|3|||
46699485|NCT01268501|82914709|FG000|Overall Study|Handling Difficulties|2|||
46699486|NCT01268267|82914713|FG000|Overall Study|Protocol Violation|1|||
46699487|NCT01267253|82914718|FG000|Overall Study|Ineligible - required test not done|1|||
46699488|NCT01267253|82914718|FG000|Overall Study|Inevaluable-never received study treatme|2|||
46699489|NCT01266317|82914722|FG000|Overall Study|Withdrawal by Subject|2|||
46699490|NCT01266161|82914728|FG000|Overall Study|Ineligible|1|||
46699491|NCT01266161|82914729|FG001|Overall Study|Ineligible|0|||
46699492|NCT01266161|82914728|FG000|Overall Study|Lack of Efficacy|0|||
46699493|NCT01266161|82914729|FG001|Overall Study|Lack of Efficacy|1|||
46699494|NCT01266161|82914728|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
46699495|NCT01266161|82914729|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
46699496|NCT01265849|82914738|FG000|Overall Study|Randomized//Treatment not initiated|1|||
46699497|NCT01265849|82914739|FG001|Overall Study|Randomized//Treatment not initiated|4|||
46699498|NCT01265849|82914740|FG002|Overall Study|Randomized//Treatment not initiated|0|||
46699499|NCT01265849|82914738|FG000|Overall Study|Physician Decision|1|||
46699500|NCT01265849|82914739|FG001|Overall Study|Physician Decision|2|||
46699501|NCT01265849|82914740|FG002|Overall Study|Physician Decision|0|||
46699502|NCT01265849|82914738|FG000|Overall Study|Lost to Follow-up|18|||
46699503|NCT01265849|82914739|FG001|Overall Study|Lost to Follow-up|15|||
46868796|NCT03039790|83087119|FG002|Overall Study|Death|0|||
46868797|NCT03039790|83087120|FG003|Overall Study|Death|0|||
46868798|NCT03039790|83087121|FG004|Overall Study|Death|0|||
46868799|NCT03039790|83087122|FG005|Overall Study|Death|0|||
46699504|NCT01265849|82914740|FG002|Overall Study|Lost to Follow-up|5|||
46699505|NCT01265849|82914738|FG000|Overall Study|Not otherwise specified|1|||
46699506|NCT01265849|82914739|FG001|Overall Study|Not otherwise specified|6|||
46868800|NCT03039790|83087123|FG006|Overall Study|Death|0|||
46868801|NCT03039790|83087124|FG007|Overall Study|Death|0|||
46868802|NCT03039790|83087125|FG008|Overall Study|Death|0|||
46868803|NCT03039790|83087126|FG009|Overall Study|Death|0|||
46868804|NCT03039790|83087127|FG010|Overall Study|Death|0|||
46868805|NCT03039790|83087128|FG011|Overall Study|Death|0|||
46868806|NCT03039790|83087129|FG012|Overall Study|Death|0|||
46868807|NCT03039790|83087130|FG013|Overall Study|Death|0|||
46868808|NCT03039790|83087131|FG014|Overall Study|Death|0|||
46699507|NCT01265849|82914740|FG002|Overall Study|Not otherwise specified|1|||
46699508|NCT01265849|82914738|FG000|Overall Study|Withdrawal by Subject|25|||
46699509|NCT01265849|82914739|FG001|Overall Study|Withdrawal by Subject|34|||
46699510|NCT01265849|82914740|FG002|Overall Study|Withdrawal by Subject|13|||
46868809|NCT03039790|83087132|FG015|Overall Study|Death|1|||
46868810|NCT03039790|83087133|FG016|Overall Study|Death|3|||
46699511|NCT01265615|82914756|FG000|Overall Study|Protocol Violation|2|||
46699512|NCT01265615|82914757|FG001|Overall Study|Protocol Violation|2|||
46868811|NCT03039790|83087134|FG017|Overall Study|Death|0|||
46868812|NCT03039790|83087135|FG018|Overall Study|Death|2|||
46699513|NCT01265615|82914758|FG002|Overall Study|Protocol Violation|4|||
46699514|NCT01265615|82914759|FG003|Overall Study|Protocol Violation|3|||
46699515|NCT01264835|82914769|FG000|Overall Study|Lost to Follow-up|1|||
46699516|NCT01264679|82914773|FG000|Overall Study|Participation in Another Clinical Trial|1|||
46699517|NCT01264679|82914773|FG000|Overall Study|Physician Decision|1|||
46699518|NCT01264679|82914773|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
46699519|NCT01264679|82914773|FG000|Overall Study|Withdrawal by Subject|1|||
46699520|NCT01263665|82914778|FG000|Overall Study|Withdrew Consent|1|||
46699521|NCT01263665|82914778|FG000|Overall Study|Lost to Follow-up|3|||
46699522|NCT01263665|82914778|FG000|Overall Study|Death|2|||
46699523|NCT01263665|82914778|FG000|Overall Study|Amputation above the ankle|1|||
46699524|NCT01263665|82914778|FG000|Overall Study|Surgical Bypass|2|||
46699525|NCT01263509|82914784|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
46699526|NCT01263509|82914785|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
46699527|NCT01263509|82914786|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
46699528|NCT01263509|82914787|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
46699529|NCT01263509|82914784|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
46699530|NCT01263509|82914785|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
46699531|NCT01263509|82914786|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
46699532|NCT01263509|82914787|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
46699533|NCT01263509|82914784|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
46699534|NCT01263509|82914785|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
46699535|NCT01263509|82914786|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
46699536|NCT01263509|82914787|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
46699537|NCT01263509|82914784|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
46699538|NCT01263509|82914785|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
46699539|NCT01263509|82914786|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46868813|NCT03039790|83087136|FG019|Overall Study|Death|0|||
46868814|NCT03039790|83087117|FG000|Overall Study|Reason, not Specified|1|||
46868815|NCT03039790|83087118|FG001|Overall Study|Reason, not Specified|0|||
46983742|NCT02307513|83229989|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
46699540|NCT01263509|82914787|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
46699541|NCT01263509|82914784|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
46699542|NCT01263509|82914785|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
46868816|NCT03039790|83087119|FG002|Overall Study|Reason, not Specified|0|||
46868817|NCT03039790|83087120|FG003|Overall Study|Reason, not Specified|0|||
46699543|NCT01263509|82914786|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
46699544|NCT01263509|82914787|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
46699545|NCT01263197|82914795|FG000|First Intervention (Period 1)|Adverse Event|0|||
46699546|NCT01263197|82914796|FG001|First Intervention (Period 1)|Adverse Event|0|||
46699547|NCT01263197|82914797|FG002|First Intervention (Period 1)|Adverse Event|0|||
46699548|NCT01263197|82914798|FG003|First Intervention (Period 1)|Adverse Event|0|||
46699549|NCT01263197|82914799|FG004|First Intervention (Period 1)|Adverse Event|0|||
46699550|NCT01263197|82914800|FG005|First Intervention (Period 1)|Adverse Event|1|||
46699551|NCT01263197|82914795|FG000|Washout Period 1|Protocol Violation|0|||
46699552|NCT01263197|82914796|FG001|Washout Period 1|Protocol Violation|0|||
46699553|NCT01263197|82914797|FG002|Washout Period 1|Protocol Violation|0|||
46699554|NCT01263197|82914798|FG003|Washout Period 1|Protocol Violation|0|||
46699555|NCT01263197|82914799|FG004|Washout Period 1|Protocol Violation|1|||
46699556|NCT01263197|82914800|FG005|Washout Period 1|Protocol Violation|0|||
46699557|NCT01263197|82914795|FG000|Washout Period 2|Physician Decision|0|||
46699558|NCT01263197|82914796|FG001|Washout Period 2|Physician Decision|0|||
46699559|NCT01263197|82914797|FG002|Washout Period 2|Physician Decision|0|||
46699560|NCT01263197|82914798|FG003|Washout Period 2|Physician Decision|0|||
46699561|NCT01263197|82914799|FG004|Washout Period 2|Physician Decision|0|||
46699562|NCT01263197|82914800|FG005|Washout Period 2|Physician Decision|1|||
46699563|NCT01263197|82914795|FG000|Washout Period 2|Protocol Violation|0|||
46699564|NCT01263197|82914796|FG001|Washout Period 2|Protocol Violation|0|||
46699565|NCT01263197|82914797|FG002|Washout Period 2|Protocol Violation|0|||
46699566|NCT01263197|82914798|FG003|Washout Period 2|Protocol Violation|1|||
46699567|NCT01263197|82914799|FG004|Washout Period 2|Protocol Violation|0|||
46699568|NCT01263197|82914800|FG005|Washout Period 2|Protocol Violation|0|||
46699569|NCT01263197|82914795|FG000|Third Intervention (Period 3)|Adverse Event|0|||
46699570|NCT01263197|82914796|FG001|Third Intervention (Period 3)|Adverse Event|1|||
46699571|NCT01263197|82914797|FG002|Third Intervention (Period 3)|Adverse Event|0|||
46699572|NCT01263197|82914798|FG003|Third Intervention (Period 3)|Adverse Event|0|||
46699573|NCT01263197|82914799|FG004|Third Intervention (Period 3)|Adverse Event|0|||
46699574|NCT01263197|82914800|FG005|Third Intervention (Period 3)|Adverse Event|0|||
46699575|NCT01263119|82914814|FG000|Period 1|Protocol Violation|2|||
46699576|NCT01263119|82914814|FG000|Period 2|Adverse Event|2|||
46699577|NCT01262651|82914824|FG000|Overall Study|Adverse Event|40|||
46699578|NCT01262651|82914825|FG001|Overall Study|Adverse Event|35|||
46699579|NCT01262651|82914824|FG000|Overall Study|Withdrawal by Subject|15|||
46699580|NCT01262651|82914825|FG001|Overall Study|Withdrawal by Subject|11|||
46699581|NCT01262651|82914824|FG000|Overall Study|Withdrawal by Investigator|2|||
46699582|NCT01262651|82914825|FG001|Overall Study|Withdrawal by Investigator|2|||
46699583|NCT01262651|82914824|FG000|Overall Study|Met Withdrawal Criteria|1|||
46699584|NCT01262651|82914825|FG001|Overall Study|Met Withdrawal Criteria|0|||
46699585|NCT01262573|82914833|FG000|Overall Study|Withdrawal by Subject|0|||
46699586|NCT01262573|82914834|FG001|Overall Study|Withdrawal by Subject|1|||
46699587|NCT01262027|82914840|FG000|Overall Study|Adverse Event|1|||
46699588|NCT01262027|82914840|FG000|Overall Study|Withdrawal by Subject|3|||
46699589|NCT01262027|82914840|FG000|Overall Study|Protocol Violation|1|||
46699590|NCT01261793|82914847|FG000|Overall Study|Lack of Efficacy|44|||
46699591|NCT01261793|82914848|FG001|Overall Study|Lack of Efficacy|37|||
46699592|NCT01261793|82914849|FG002|Overall Study|Lack of Efficacy|32|||
46699593|NCT01261793|82914847|FG000|Overall Study|Protocol Violation|3|||
46699594|NCT01261793|82914848|FG001|Overall Study|Protocol Violation|5|||
46699595|NCT01261793|82914849|FG002|Overall Study|Protocol Violation|6|||
46699596|NCT01261793|82914847|FG000|Overall Study|Lost to Follow-up|10|||
46699597|NCT01261793|82914848|FG001|Overall Study|Lost to Follow-up|3|||
46699598|NCT01261793|82914849|FG002|Overall Study|Lost to Follow-up|7|||
46868818|NCT03039790|83087121|FG004|Overall Study|Reason, not Specified|0|||
46983743|NCT02307513|83229990|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
46983744|NCT02307513|83229989|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
46983745|NCT02307513|83229990|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
46983746|NCT02307513|83229989|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
46699599|NCT01261793|82914847|FG000|Overall Study|Withdrawal by Subject|12|||
46699600|NCT01261793|82914848|FG001|Overall Study|Withdrawal by Subject|14|||
46699601|NCT01261793|82914849|FG002|Overall Study|Withdrawal by Subject|14|||
46699602|NCT01261793|82914847|FG000|Overall Study|Death|3|||
46699603|NCT01261793|82914848|FG001|Overall Study|Death|1|||
46699604|NCT01261793|82914849|FG002|Overall Study|Death|0|||
46699605|NCT01261793|82914847|FG000|Overall Study|Adverse Event|9|||
46699606|NCT01261793|82914848|FG001|Overall Study|Adverse Event|24|||
46699607|NCT01261793|82914849|FG002|Overall Study|Adverse Event|19|||
46699608|NCT01261793|82914847|FG000|Overall Study|Patient non-availability|1|||
46699609|NCT01261793|82914848|FG001|Overall Study|Patient non-availability|1|||
46699610|NCT01261793|82914849|FG002|Overall Study|Patient non-availability|1|||
46983747|NCT02307513|83229990|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
46699611|NCT01261793|82914847|FG000|Overall Study|Suspected pregnancy|1|||
46699612|NCT01261793|82914848|FG001|Overall Study|Suspected pregnancy|1|||
46699613|NCT01261793|82914849|FG002|Overall Study|Suspected pregnancy|0|||
46699614|NCT01261793|82914847|FG000|Overall Study|Patient non-compliance|1|||
46699615|NCT01261793|82914848|FG001|Overall Study|Patient non-compliance|0|||
46699616|NCT01261793|82914849|FG002|Overall Study|Patient non-compliance|1|||
46868819|NCT03039790|83087122|FG005|Overall Study|Reason, not Specified|0|||
46868820|NCT03039790|83087123|FG006|Overall Study|Reason, not Specified|0|||
46868821|NCT03039790|83087124|FG007|Overall Study|Reason, not Specified|0|||
46699617|NCT01261793|82914847|FG000|Overall Study|Patient pregnant|1|||
46699618|NCT01261793|82914848|FG001|Overall Study|Patient pregnant|0|||
46699619|NCT01261793|82914849|FG002|Overall Study|Patient pregnant|0|||
46699620|NCT01261793|82914847|FG000|Overall Study|Outside the study area|0|||
46699621|NCT01261793|82914848|FG001|Overall Study|Outside the study area|2|||
46699622|NCT01261793|82914849|FG002|Overall Study|Outside the study area|1|||
46699623|NCT01261793|82914847|FG000|Overall Study|Lack of efficacy & patient not available|0|||
46699624|NCT01261793|82914848|FG001|Overall Study|Lack of efficacy & patient not available|1|||
46699625|NCT01261793|82914849|FG002|Overall Study|Lack of efficacy & patient not available|0|||
46699626|NCT01261793|82914847|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
46699627|NCT01261793|82914848|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
46699628|NCT01261793|82914849|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
46699629|NCT01261793|82914847|FG000|Overall Study|Randomization error|0|||
46699630|NCT01261793|82914848|FG001|Overall Study|Randomization error|1|||
46699631|NCT01261793|82914849|FG002|Overall Study|Randomization error|0|||
46699632|NCT01261793|82914847|FG000|Overall Study|Patient unable to start IV line|0|||
46699633|NCT01261793|82914848|FG001|Overall Study|Patient unable to start IV line|0|||
46699634|NCT01261793|82914849|FG002|Overall Study|Patient unable to start IV line|1|||
46699635|NCT01261325|82914860|FG000|Overall Study|Lack of Efficacy|1|||
46699636|NCT01261325|82914861|FG001|Overall Study|Lack of Efficacy|1|||
46699637|NCT01261325|82914862|FG002|Overall Study|Lack of Efficacy|0|||
46699638|NCT01261325|82914860|FG000|Overall Study|Withdrawal by Subject|2|||
46699639|NCT01261325|82914861|FG001|Overall Study|Withdrawal by Subject|2|||
46699640|NCT01261325|82914862|FG002|Overall Study|Withdrawal by Subject|4|||
46699641|NCT01261325|82914860|FG000|Overall Study|SAE, non-fatal|1|||
46699642|NCT01261325|82914861|FG001|Overall Study|SAE, non-fatal|5|||
46699643|NCT01261325|82914862|FG002|Overall Study|SAE, non-fatal|1|||
46699644|NCT01261325|82914860|FG000|Overall Study|AE, non-serious non-fatal|9|||
46699645|NCT01261325|82914861|FG001|Overall Study|AE, non-serious non-fatal|15|||
46699646|NCT01261325|82914862|FG002|Overall Study|AE, non-serious non-fatal|13|||
46699647|NCT01261325|82914860|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
46699648|NCT01261325|82914861|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
46699649|NCT01261325|82914862|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
46699650|NCT01261325|82914860|FG000|Overall Study|Non Compliance|2|||
46699651|NCT01261325|82914861|FG001|Overall Study|Non Compliance|0|||
46699652|NCT01261325|82914862|FG002|Overall Study|Non Compliance|0|||
46699653|NCT01261325|82914860|FG000|Overall Study|Patient Randomized by Mistake|0|||
46699654|NCT01261325|82914861|FG001|Overall Study|Patient Randomized by Mistake|1|||
46699655|NCT01261325|82914862|FG002|Overall Study|Patient Randomized by Mistake|0|||
46699656|NCT01261325|82914860|FG000|Overall Study|Erroneously Randomized|1|||
46699657|NCT01261325|82914861|FG001|Overall Study|Erroneously Randomized|0|||
46868822|NCT03039790|83087125|FG008|Overall Study|Reason, not Specified|0|||
46868823|NCT03039790|83087126|FG009|Overall Study|Reason, not Specified|0|||
46868824|NCT03039790|83087127|FG010|Overall Study|Reason, not Specified|0|||
46868825|NCT03039790|83087128|FG011|Overall Study|Reason, not Specified|0|||
46868826|NCT03039790|83087129|FG012|Overall Study|Reason, not Specified|0|||
46868827|NCT03039790|83087130|FG013|Overall Study|Reason, not Specified|0|||
46868828|NCT03039790|83087131|FG014|Overall Study|Reason, not Specified|0|||
46868829|NCT03039790|83087132|FG015|Overall Study|Reason, not Specified|0|||
46868830|NCT03039790|83087133|FG016|Overall Study|Reason, not Specified|2|||
46868831|NCT03039790|83087134|FG017|Overall Study|Reason, not Specified|0|||
46868832|NCT03039790|83087135|FG018|Overall Study|Reason, not Specified|1|||
46868833|NCT03039790|83087136|FG019|Overall Study|Reason, not Specified|0|||
46868834|NCT03038620|83087209|FG000|Overall Study|Lost to Follow-up|18|||
46868835|NCT03038620|83087210|FG001|Overall Study|Lost to Follow-up|23|||
46868836|NCT03038620|83087209|FG000|Overall Study|Withdrawal by Subject|0|||
46868837|NCT03038620|83087210|FG001|Overall Study|Withdrawal by Subject|15|||
46868838|NCT03038620|83087209|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
46868839|NCT03038620|83087210|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
46868840|NCT01350934|83087231|FG000|Base Study|Adverse Event|6|||
46868841|NCT01350934|83087232|FG001|Base Study|Adverse Event|0|||
46868842|NCT01350934|83087231|FG000|Base Study|Lost to Follow-up|1|||
46868843|NCT01350934|83087232|FG001|Base Study|Lost to Follow-up|0|||
46868844|NCT01350934|83087231|FG000|Base Study|Protocol Violation|1|||
46868845|NCT01350934|83087232|FG001|Base Study|Protocol Violation|1|||
46983748|NCT02307513|83229989|FG000|Long-term Extension|Physician Decision|1|||
46983749|NCT02307513|83229990|FG001|Long-term Extension|Physician Decision|0|||
46983750|NCT02332239|83230002|FG000|Overall Study|Lost to Follow-up|4|||
46699658|NCT01261325|82914862|FG002|Overall Study|Erroneously Randomized|0|||
46699659|NCT01261325|82914860|FG000|Overall Study|Screen Failure|1|||
46868846|NCT01350934|83087231|FG000|Base Study|Withdrawal by Subject|1|||
46868847|NCT01350934|83087232|FG001|Base Study|Withdrawal by Subject|2|||
46868848|NCT01350934|83087231|FG000|Base Study|Non-Compliance With Study Drug|2|||
46868849|NCT01350934|83087232|FG001|Base Study|Non-Compliance With Study Drug|0|||
46868850|NCT01350934|83087231|FG000|Extension Study|Adverse Event|2|||
46868851|NCT01350934|83087232|FG001|Extension Study|Adverse Event|1|||
46868852|NCT01350934|83087231|FG000|Extension Study|Lost to Follow-up|2|||
46868853|NCT01350934|83087232|FG001|Extension Study|Lost to Follow-up|0|||
46983751|NCT02332239|83230003|FG001|Overall Study|Lost to Follow-up|6|||
46699660|NCT01261325|82914861|FG001|Overall Study|Screen Failure|0|||
46699661|NCT01261325|82914862|FG002|Overall Study|Screen Failure|0|||
46699662|NCT01261325|82914860|FG000|Overall Study|Randomized in Error|0|||
46699663|NCT01261325|82914861|FG001|Overall Study|Randomized in Error|0|||
46699664|NCT01261325|82914862|FG002|Overall Study|Randomized in Error|1|||
46699665|NCT01261325|82914860|FG000|Overall Study|Protocol Violation|0|||
46699666|NCT01261325|82914861|FG001|Overall Study|Protocol Violation|3|||
46699667|NCT01261325|82914862|FG002|Overall Study|Protocol Violation|1|||
46699668|NCT01261325|82914860|FG000|Overall Study|Lost to Follow-up|0|||
46699669|NCT01261325|82914861|FG001|Overall Study|Lost to Follow-up|1|||
46699670|NCT01261325|82914862|FG002|Overall Study|Lost to Follow-up|3|||
46699671|NCT01261325|82914860|FG000|Overall Study|AE, serious fatal|0|||
46699672|NCT01261325|82914861|FG001|Overall Study|AE, serious fatal|0|||
46699673|NCT01261325|82914862|FG002|Overall Study|AE, serious fatal|2|||
46699674|NCT01260701|82914873|FG000|Overall Study|Adverse Event|9|||
46699675|NCT01260701|82914873|FG000|Overall Study|Withdrawal by Subject|2|||
46699676|NCT01260701|82914873|FG000|Overall Study|Progression|53|||
46699677|NCT01260701|82914873|FG000|Overall Study|Death|2|||
46699678|NCT01260701|82914873|FG000|Overall Study|Not protocol specified|3|||
46699679|NCT01260701|82914873|FG000|Overall Study|Under review|1|||
46699680|NCT01260701|82914873|FG000|Overall Study|Ineligible|4|||
46699681|NCT01260701|82914873|FG000|Overall Study|Did not begin protocol therapy|1|||
46699682|NCT01260467|82914877|FG000|Overall Study|Withdrawal by Subject|2|||
46699683|NCT01260311|82914883|FG000|Overall Study|Adverse Event|11|||
46699684|NCT01260311|82914883|FG000|Overall Study|Lack of Efficacy|4|||
46699685|NCT01260311|82914883|FG000|Overall Study|Lost to Follow-up|25|||
46699686|NCT01260311|82914883|FG000|Overall Study|Withdrawal by Subject|6|||
46699687|NCT01260311|82914883|FG000|Overall Study|Financial Constraints|77|||
46699688|NCT01260311|82914883|FG000|Overall Study|Gone to Province|2|||
46699689|NCT01260311|82914883|FG000|Overall Study|Medication Stopped|1|||
46699690|NCT01260311|82914883|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
46699691|NCT01259375|82914887|FG000|Overall Study|Adverse Event|1|||
46699692|NCT01259297|82914910|FG000|Double Blind Randomized Period|Death|1|||
46699693|NCT01259297|82914911|FG001|Double Blind Randomized Period|Death|1|||
46699694|NCT01259297|82914912|FG002|Double Blind Randomized Period|Death|1|||
46699695|NCT01259297|82914913|FG003|Double Blind Randomized Period|Death|2|||
46868854|NCT01350934|83087231|FG000|Extension Study|Protocol Violation|1|||
46868855|NCT01350934|83087232|FG001|Extension Study|Protocol Violation|1|||
46868856|NCT01350934|83087231|FG000|Extension Study|Lack of Efficacy|0|||
46868857|NCT01350934|83087232|FG001|Extension Study|Lack of Efficacy|1|||
46868858|NCT01350934|83087231|FG000|Extension Study|Withdrawal by Subject|0|||
46868859|NCT01350934|83087232|FG001|Extension Study|Withdrawal by Subject|1|||
46868860|NCT03622580|83087256|FG000|Overall Study|Death|16|||
46868861|NCT03622580|83087257|FG001|Overall Study|Death|21|||
46699696|NCT01259297|82914914|FG004|Double Blind Randomized Period|Death|1|||
46699697|NCT01259297|82914915|FG005|Double Blind Randomized Period|Death|5|||
46699698|NCT01259297|82914916|FG006|Double Blind Randomized Period|Death|2|||
46699699|NCT01259297|82914917|FG007|Double Blind Randomized Period|Death|1|||
46699700|NCT01259297|82914910|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
46699701|NCT01259297|82914911|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
46699702|NCT01259297|82914912|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
46699703|NCT01259297|82914913|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
46868862|NCT03622580|83087258|FG002|Overall Study|Death|13|||
46699704|NCT01259297|82914914|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
46699705|NCT01259297|82914915|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
46699706|NCT01259297|82914916|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
46699707|NCT01259297|82914917|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
46699708|NCT01259297|82914910|FG000|Double Blind Randomized Period|Other reasons|0|||
46699709|NCT01259297|82914911|FG001|Double Blind Randomized Period|Other reasons|1|||
46699710|NCT01259297|82914912|FG002|Double Blind Randomized Period|Other reasons|0|||
46699711|NCT01259297|82914913|FG003|Double Blind Randomized Period|Other reasons|0|||
46699712|NCT01259297|82914914|FG004|Double Blind Randomized Period|Other reasons|1|||
46699713|NCT01259297|82914915|FG005|Double Blind Randomized Period|Other reasons|2|||
46699714|NCT01259297|82914916|FG006|Double Blind Randomized Period|Other reasons|3|||
46699715|NCT01259297|82914917|FG007|Double Blind Randomized Period|Other reasons|1|||
46699716|NCT01126437|82914937|FG000|Overall Study|Not treated|11|||
46699717|NCT01126437|82914938|FG001|Overall Study|Not treated|18|||
46699718|NCT01126437|82914939|FG002|Overall Study|Not treated|19|||
46699719|NCT01126437|82914937|FG000|Overall Study|Sites with data irregularities/fraud|6|||
46699720|NCT01126437|82914938|FG001|Overall Study|Sites with data irregularities/fraud|6|||
46699721|NCT01126437|82914939|FG002|Overall Study|Sites with data irregularities/fraud|7|||
46699722|NCT01126437|82914937|FG000|Overall Study|Adverse Event|602|||
46699723|NCT01126437|82914938|FG001|Overall Study|Adverse Event|606|||
46699724|NCT01126437|82914939|FG002|Overall Study|Adverse Event|635|||
46699725|NCT01126437|82914937|FG000|Overall Study|Lack of Efficacy|65|||
46699726|NCT01126437|82914938|FG001|Overall Study|Lack of Efficacy|60|||
46699727|NCT01126437|82914939|FG002|Overall Study|Lack of Efficacy|59|||
46699728|NCT01126437|82914937|FG000|Overall Study|Protocol Violation|64|||
46699729|NCT01126437|82914938|FG001|Overall Study|Protocol Violation|66|||
46699730|NCT01126437|82914939|FG002|Overall Study|Protocol Violation|41|||
46699731|NCT01126437|82914937|FG000|Overall Study|Lost to Follow-up|52|||
46699732|NCT01126437|82914938|FG001|Overall Study|Lost to Follow-up|63|||
46699733|NCT01126437|82914939|FG002|Overall Study|Lost to Follow-up|55|||
46699734|NCT01126437|82914937|FG000|Overall Study|Withdrawal by Subject|331|||
46699735|NCT01126437|82914938|FG001|Overall Study|Withdrawal by Subject|335|||
46699736|NCT01126437|82914939|FG002|Overall Study|Withdrawal by Subject|319|||
46699737|NCT01126437|82914937|FG000|Overall Study|Other reason not specified|210|||
46699738|NCT01126437|82914938|FG001|Overall Study|Other reason not specified|176|||
46699739|NCT01126437|82914939|FG002|Overall Study|Other reason not specified|178|||
46699740|NCT01258595|82914949|FG000|Overall Study|Lost to Follow-up|1|||
46699741|NCT01258595|82914950|FG001|Overall Study|Lost to Follow-up|0|||
46699742|NCT01258595|82914949|FG000|Overall Study|Withdrawal by Subject|0|||
46699743|NCT01258595|82914950|FG001|Overall Study|Withdrawal by Subject|1|||
46699744|NCT01257737|82914958|FG000|Overall Study|Lost to Follow-up|1|||
46699745|NCT01257737|82914959|FG001|Overall Study|Lost to Follow-up|2|||
46699746|NCT01257737|82914958|FG000|Overall Study|Liver transplant|1|||
46699747|NCT01257737|82914959|FG001|Overall Study|Liver transplant|0|||
46699748|NCT01257737|82914958|FG000|Overall Study|Relocation out of the country|0|||
46699749|NCT01257737|82914959|FG001|Overall Study|Relocation out of the country|1|||
46699750|NCT01257737|82914958|FG000|Overall Study|Withdrew from study|0|||
46699751|NCT01257737|82914959|FG001|Overall Study|Withdrew from study|1|||
46699752|NCT01126359|82914966|FG000|First Intervention (20-minutes)|Physician Decision|0|||
46699753|NCT01126359|82914967|FG001|First Intervention (20-minutes)|Physician Decision|1|||
46699754|NCT01125813|82914977|FG000|Overall Study|Death|1|||
46699755|NCT01125813|82914977|FG000|Overall Study|Withdrawal by Subject|1|||
46699756|NCT01125813|82914977|FG000|Overall Study|Screen Failures|4|||
46699757|NCT00996892|82914981|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
46699758|NCT00996892|82914982|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
46699759|NCT00996892|82914983|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
46699760|NCT00996892|82914984|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
46699761|NCT00996892|82914985|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
46699762|NCT00996892|82914986|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
46699763|NCT00996892|82914987|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
46699764|NCT00996892|82914988|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
46699765|NCT00996892|82914989|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
46699766|NCT00996892|82914990|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
46699767|NCT00996892|82914991|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
46699768|NCT00996892|82914992|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
46699769|NCT00996892|82914993|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
46699770|NCT00996892|82914994|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
46699771|NCT00996892|82914995|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
46868863|NCT03622580|83087256|FG000|Overall Study|Adverse Event|6|||
46868864|NCT03622580|83087257|FG001|Overall Study|Adverse Event|6|||
46868865|NCT03622580|83087258|FG002|Overall Study|Adverse Event|5|||
46868866|NCT03622580|83087256|FG000|Overall Study|Withdrawal by Subject|12|||
46868867|NCT03622580|83087257|FG001|Overall Study|Withdrawal by Subject|7|||
46868868|NCT03622580|83087258|FG002|Overall Study|Withdrawal by Subject|19|||
46868869|NCT03622580|83087256|FG000|Overall Study|Lost to Follow-up|12|||
46868870|NCT03622580|83087257|FG001|Overall Study|Lost to Follow-up|9|||
46868871|NCT03622580|83087258|FG002|Overall Study|Lost to Follow-up|9|||
46868872|NCT03622580|83087256|FG000|Overall Study|Protocol Violation|1|||
46868873|NCT03622580|83087257|FG001|Overall Study|Protocol Violation|0|||
46868874|NCT03622580|83087258|FG002|Overall Study|Protocol Violation|1|||
46699772|NCT00996892|82914996|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
46699773|NCT00996892|82914997|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
46699774|NCT00996892|82914998|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
46699775|NCT00996892|82914999|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
46699776|NCT00996892|82915000|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
46699777|NCT00996892|82914981|FG000|Dose-Escalation Stage 1|Death|1|||
46699778|NCT00996892|82914982|FG001|Dose-Escalation Stage 1|Death|0|||
46868875|NCT03622580|83087256|FG000|Overall Study|Physician Decision|3|||
46868876|NCT03622580|83087257|FG001|Overall Study|Physician Decision|0|||
46699779|NCT00996892|82914983|FG002|Dose-Escalation Stage 1|Death|0|||
46699780|NCT00996892|82914984|FG003|Dose-Escalation Stage 1|Death|0|||
46699781|NCT00996892|82914985|FG004|Dose-Escalation Stage 1|Death|0|||
46699782|NCT00996892|82914986|FG005|Dose-Escalation Stage 1|Death|1|||
46699783|NCT00996892|82914987|FG006|Dose-Escalation Stage 1|Death|0|||
46699784|NCT00996892|82914988|FG007|Dose-Escalation Stage 1|Death|0|||
46699785|NCT00996892|82914989|FG008|Dose-Escalation Stage 1|Death|0|||
46699786|NCT00996892|82914990|FG009|Dose-Escalation Stage 1|Death|0|||
46699787|NCT00996892|82914991|FG010|Dose-Escalation Stage 1|Death|0|||
46699788|NCT00996892|82914992|FG011|Dose-Escalation Stage 1|Death|0|||
46699789|NCT00996892|82914993|FG012|Dose-Escalation Stage 1|Death|0|||
46699790|NCT00996892|82914994|FG013|Dose-Escalation Stage 1|Death|0|||
46699791|NCT00996892|82914995|FG014|Dose-Escalation Stage 1|Death|0|||
46699792|NCT00996892|82914996|FG015|Dose-Escalation Stage 1|Death|0|||
46699793|NCT00996892|82914997|FG016|Dose-Escalation Stage 1|Death|0|||
46699794|NCT00996892|82914998|FG017|Dose-Escalation Stage 1|Death|0|||
46699795|NCT00996892|82914999|FG018|Dose-Escalation Stage 1|Death|0|||
46699796|NCT00996892|82915000|FG019|Dose-Escalation Stage 1|Death|0|||
46699797|NCT00996892|82914981|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
46699798|NCT00996892|82914982|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
46699799|NCT00996892|82914983|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
46699800|NCT00996892|82914984|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
46699801|NCT00996892|82914985|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
46699802|NCT00996892|82914986|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
46699803|NCT00996892|82914987|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
46699804|NCT00996892|82914988|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
46699805|NCT00996892|82914989|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
46699806|NCT00996892|82914990|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
46699807|NCT00996892|82914991|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
46699808|NCT00996892|82914992|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
46699809|NCT00996892|82914993|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
46699810|NCT00996892|82914994|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
46699811|NCT00996892|82914995|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
46699812|NCT00996892|82914996|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
46699813|NCT00996892|82914997|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
46699814|NCT00996892|82914998|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
46699815|NCT00996892|82914999|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
46699816|NCT00996892|82915000|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
46699817|NCT00996892|82914981|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699818|NCT00996892|82914982|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
46699819|NCT00996892|82914983|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699820|NCT00996892|82914984|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
46699821|NCT00996892|82914985|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
46699822|NCT00996892|82914986|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
46699823|NCT00996892|82914987|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
46699824|NCT00996892|82914988|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699825|NCT00996892|82914989|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46868877|NCT03622580|83087258|FG002|Overall Study|Physician Decision|1|||
46868878|NCT03622580|83087256|FG000|Overall Study|Pregnancy|0|||
46868879|NCT03622580|83087257|FG001|Overall Study|Pregnancy|1|||
46868880|NCT03622580|83087258|FG002|Overall Study|Pregnancy|0|||
46868881|NCT03622580|83087256|FG000|Overall Study|Lack of Efficacy|0|||
46868882|NCT03622580|83087257|FG001|Overall Study|Lack of Efficacy|0|||
46868883|NCT03622580|83087258|FG002|Overall Study|Lack of Efficacy|1|||
46868884|NCT03622580|83087256|FG000|Overall Study|Other|2|||
46868885|NCT03622580|83087257|FG001|Overall Study|Other|0|||
46868886|NCT03622580|83087258|FG002|Overall Study|Other|3|||
46868887|NCT00461032|83087269|FG000|Overall Study|Adverse Event|5|||
46868888|NCT00461032|83087270|FG001|Overall Study|Adverse Event|6|||
46868889|NCT00461032|83087269|FG000|Overall Study|Lack of Efficacy|5|||
46868890|NCT00461032|83087270|FG001|Overall Study|Lack of Efficacy|1|||
46868891|NCT00461032|83087269|FG000|Overall Study|Lost to Follow-up|7|||
46868892|NCT00461032|83087270|FG001|Overall Study|Lost to Follow-up|12|||
46868893|NCT00461032|83087269|FG000|Overall Study|Protocol Violation|4|||
46699826|NCT00996892|82914990|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699827|NCT00996892|82914991|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699828|NCT00996892|82914992|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699829|NCT00996892|82914993|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699830|NCT00996892|82914994|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699831|NCT00996892|82914995|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699832|NCT00996892|82914996|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699833|NCT00996892|82914997|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46868894|NCT00461032|83087270|FG001|Overall Study|Protocol Violation|4|||
46868895|NCT00461032|83087269|FG000|Overall Study|Withdrawal by Subject|7|||
46868896|NCT00461032|83087270|FG001|Overall Study|Withdrawal by Subject|15|||
46868897|NCT00461032|83087269|FG000|Overall Study|Patient Moved or Relocated|2|||
46868898|NCT00461032|83087270|FG001|Overall Study|Patient Moved or Relocated|1|||
46868899|NCT00461032|83087269|FG000|Overall Study|Other|7|||
46699834|NCT00996892|82914998|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699835|NCT00996892|82914999|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46699836|NCT00996892|82915000|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
46868900|NCT00461032|83087270|FG001|Overall Study|Other|5|||
46868901|NCT00090142|83087276|FG000|Treatment Period I|Lost to Follow-up|1|||
46868902|NCT00090142|83087277|FG001|Treatment Period I|Lost to Follow-up|2|||
46868903|NCT00090142|83087276|FG000|Treatment Period I|Protocol Violation|2|||
46868904|NCT00090142|83087277|FG001|Treatment Period I|Protocol Violation|0|||
46868905|NCT00090142|83087276|FG000|Treatment Period I|Withdrawal by Subject|2|||
46699837|NCT00996892|82914981|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
46699838|NCT00996892|82914982|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
46868906|NCT00090142|83087277|FG001|Treatment Period I|Withdrawal by Subject|0|||
46868907|NCT00090142|83087276|FG000|Treatment Period I|Other|0|||
46868908|NCT00090142|83087277|FG001|Treatment Period I|Other|1|||
46868909|NCT00090142|83087276|FG000|Treatment Period II|Other|1|||
46868910|NCT00090142|83087277|FG001|Treatment Period II|Other|0|||
46699839|NCT00996892|82914983|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
46699840|NCT00996892|82914984|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
46699841|NCT00996892|82914985|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
46699842|NCT00996892|82914986|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
46699843|NCT00996892|82914987|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
46699844|NCT00996892|82914988|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
46699845|NCT00996892|82914989|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
46699846|NCT00996892|82914990|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
46699847|NCT00996892|82914991|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
46699848|NCT00996892|82914992|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
46699849|NCT00996892|82914993|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
46699850|NCT00996892|82914994|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
46868911|NCT03622112|83087294|FG000|Overall Study|Withdrawal by Subject|6|||
46868912|NCT03622112|83087295|FG001|Overall Study|Withdrawal by Subject|2|||
46868913|NCT03622112|83087296|FG002|Overall Study|Withdrawal by Subject|4|||
46868914|NCT03622112|83087297|FG003|Overall Study|Withdrawal by Subject|2|||
46868915|NCT03622112|83087298|FG004|Overall Study|Withdrawal by Subject|1|||
46868916|NCT03622112|83087299|FG005|Overall Study|Withdrawal by Subject|2|||
46868917|NCT03622112|83087300|FG006|Overall Study|Withdrawal by Subject|2|||
46868918|NCT03622112|83087294|FG000|Overall Study|Death|0|||
46868919|NCT03622112|83087295|FG001|Overall Study|Death|0|||
46868920|NCT03622112|83087296|FG002|Overall Study|Death|0|||
46868921|NCT03622112|83087297|FG003|Overall Study|Death|1|||
46868922|NCT03622112|83087298|FG004|Overall Study|Death|0|||
46868923|NCT03622112|83087299|FG005|Overall Study|Death|0|||
46868924|NCT03622112|83087300|FG006|Overall Study|Death|0|||
46868925|NCT03622112|83087294|FG000|Overall Study|Lost to Follow-up|1|||
46868926|NCT03622112|83087295|FG001|Overall Study|Lost to Follow-up|1|||
46868927|NCT03622112|83087296|FG002|Overall Study|Lost to Follow-up|0|||
46868928|NCT03622112|83087297|FG003|Overall Study|Lost to Follow-up|0|||
46868929|NCT03622112|83087298|FG004|Overall Study|Lost to Follow-up|0|||
46868930|NCT03622112|83087299|FG005|Overall Study|Lost to Follow-up|0|||
46868931|NCT03622112|83087300|FG006|Overall Study|Lost to Follow-up|0|||
46868932|NCT03622112|83087294|FG000|Overall Study|Study-specific withdrawal criteria|10|||
46868933|NCT03622112|83087295|FG001|Overall Study|Study-specific withdrawal criteria|8|||
46868934|NCT03622112|83087296|FG002|Overall Study|Study-specific withdrawal criteria|7|||
46868935|NCT03622112|83087297|FG003|Overall Study|Study-specific withdrawal criteria|6|||
46868936|NCT03622112|83087298|FG004|Overall Study|Study-specific withdrawal criteria|4|||
46868937|NCT03622112|83087299|FG005|Overall Study|Study-specific withdrawal criteria|18|||
46868938|NCT03622112|83087300|FG006|Overall Study|Study-specific withdrawal criteria|4|||
46868939|NCT03622112|83087294|FG000|Overall Study|Protocol Violation|2|||
46868940|NCT03622112|83087295|FG001|Overall Study|Protocol Violation|0|||
46868941|NCT03622112|83087296|FG002|Overall Study|Protocol Violation|1|||
46699851|NCT00996892|82914995|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
46868942|NCT03622112|83087297|FG003|Overall Study|Protocol Violation|1|||
46868943|NCT03622112|83087298|FG004|Overall Study|Protocol Violation|0|||
46868944|NCT03622112|83087299|FG005|Overall Study|Protocol Violation|0|||
46868945|NCT03622112|83087300|FG006|Overall Study|Protocol Violation|0|||
46868946|NCT03622112|83087294|FG000|Overall Study|Adverse Event|6|||
46868947|NCT03622112|83087295|FG001|Overall Study|Adverse Event|8|||
46868948|NCT03622112|83087296|FG002|Overall Study|Adverse Event|4|||
46868949|NCT03622112|83087297|FG003|Overall Study|Adverse Event|11|||
46868950|NCT03622112|83087298|FG004|Overall Study|Adverse Event|4|||
46699852|NCT00996892|82914996|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
46699853|NCT00996892|82914997|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
46699854|NCT00996892|82914998|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
46699855|NCT00996892|82914999|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
46699856|NCT00996892|82915000|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
46699857|NCT00996892|82914981|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
46699858|NCT00996892|82914982|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
46699859|NCT00996892|82914983|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
46699860|NCT00996892|82914984|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
46699861|NCT00996892|82914985|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
46699862|NCT00996892|82914986|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
46868951|NCT03622112|83087299|FG005|Overall Study|Adverse Event|20|||
46868952|NCT03622112|83087300|FG006|Overall Study|Adverse Event|2|||
46868953|NCT03622112|83087294|FG000|Overall Study|Reason not specified|0|||
46868954|NCT03622112|83087295|FG001|Overall Study|Reason not specified|1|||
46868955|NCT03622112|83087296|FG002|Overall Study|Reason not specified|0|||
46868956|NCT03622112|83087297|FG003|Overall Study|Reason not specified|1|||
46868957|NCT03622112|83087298|FG004|Overall Study|Reason not specified|1|||
46868958|NCT03622112|83087299|FG005|Overall Study|Reason not specified|2|||
46868959|NCT03622112|83087300|FG006|Overall Study|Reason not specified|1|||
46868960|NCT04032158|83087318|FG000|Overall Study|Study Termination|2|||
46868961|NCT04032158|83087319|FG001|Overall Study|Study Termination|1|||
46868962|NCT03620708|83087328|FG000|Overall Study|Lost to Follow-up|1|||
46868963|NCT03620708|83087329|FG001|Overall Study|Lost to Follow-up|1|||
46868964|NCT03620708|83087330|FG002|Overall Study|Lost to Follow-up|2|||
46868965|NCT03620708|83087328|FG000|Overall Study|Withdrawal by Subject|0|||
46868966|NCT03620708|83087329|FG001|Overall Study|Withdrawal by Subject|0|||
46868967|NCT03620708|83087330|FG002|Overall Study|Withdrawal by Subject|1|||
46868968|NCT03654326|83087340|FG000|Overall Study|Withdrawal by Subject|5|||
46868969|NCT03654326|83087341|FG001|Overall Study|Withdrawal by Subject|3|||
46868970|NCT03654326|83087340|FG000|Overall Study|Physician Decision|0|||
46868971|NCT03654326|83087341|FG001|Overall Study|Physician Decision|1|||
46868972|NCT03654326|83087340|FG000|Overall Study|Unable to adhere to study schedule|0|||
46699863|NCT00996892|82914987|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
46868973|NCT03654326|83087341|FG001|Overall Study|Unable to adhere to study schedule|1|||
46868974|NCT03654326|83087340|FG000|Overall Study|Lost to Follow-up|1|||
46868975|NCT03654326|83087341|FG001|Overall Study|Lost to Follow-up|1|||
46868976|NCT04025684|83087351|FG000|Overall Study|Withdrawal by Subject|1|||
46868977|NCT04025684|83087352|FG001|Overall Study|Withdrawal by Subject|1|||
46699864|NCT00996892|82914988|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
46699865|NCT00996892|82914989|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
46699866|NCT00996892|82914990|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
46699867|NCT00996892|82914991|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
46868978|NCT04025684|83087353|FG002|Overall Study|Withdrawal by Subject|0|||
46868979|NCT04025684|83087354|FG003|Overall Study|Withdrawal by Subject|0|||
46868980|NCT04025684|83087351|FG000|Overall Study|Multiple reasons|1|||
46868981|NCT04025684|83087352|FG001|Overall Study|Multiple reasons|3|||
46868982|NCT04025684|83087353|FG002|Overall Study|Multiple reasons|0|||
46868983|NCT04025684|83087354|FG003|Overall Study|Multiple reasons|1|||
46868984|NCT03617588|83087366|FG000|Overall Study|Withdrawal by Subject|1|||
46868985|NCT03617588|83087367|FG001|Overall Study|Withdrawal by Subject|0|||
46868986|NCT03616106|83087379|FG000|Overall Study|Removed by PI|6|||
46868987|NCT03616106|83087380|FG001|Overall Study|Removed by PI|0|||
46868988|NCT03616106|83087379|FG000|Overall Study|Withdrawal by Subject|1|||
46868989|NCT03616106|83087380|FG001|Overall Study|Withdrawal by Subject|1|||
46868990|NCT03616106|83087379|FG000|Overall Study|Lost to Follow-up|7|||
46868991|NCT03616106|83087380|FG001|Overall Study|Lost to Follow-up|0|||
46868992|NCT04019054|83087387|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
46868993|NCT04019054|83087388|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
46868994|NCT04019054|83087387|FG000|Overall Study|Withdrawal by Subject|3|||
46868995|NCT04019054|83087388|FG001|Overall Study|Withdrawal by Subject|1|||
46868996|NCT00071799|83087396|FG000|Overall Study|Adverse Event|19|||
46868997|NCT00071799|83087397|FG001|Overall Study|Adverse Event|10|||
46868998|NCT00071799|83087396|FG000|Overall Study|Protocol Violation|1|||
46868999|NCT00071799|83087397|FG001|Overall Study|Protocol Violation|7|||
46869000|NCT00071799|83087396|FG000|Overall Study|Lost to Follow-up|1|||
46869001|NCT00071799|83087397|FG001|Overall Study|Lost to Follow-up|1|||
46869002|NCT00071799|83087396|FG000|Overall Study|Withdrawal by Subject|15|||
46869003|NCT00071799|83087397|FG001|Overall Study|Withdrawal by Subject|37|||
46869004|NCT00071799|83087396|FG000|Overall Study|Physician Decision|0|||
46869005|NCT00071799|83087397|FG001|Overall Study|Physician Decision|2|||
46869006|NCT00071799|83087396|FG000|Overall Study|Lack of Efficacy|11|||
46869007|NCT00071799|83087397|FG001|Overall Study|Lack of Efficacy|18|||
46869008|NCT00071799|83087396|FG000|Overall Study|Disease Progression|23|||
46869009|NCT00071799|83087397|FG001|Overall Study|Disease Progression|20|||
46869010|NCT00071799|83087396|FG000|Overall Study|Different Central+Local Pathology Review|0|||
46869011|NCT00071799|83087397|FG001|Overall Study|Different Central+Local Pathology Review|1|||
46869012|NCT00071799|83087396|FG000|Overall Study|Not Documented|0|||
46869013|NCT00071799|83087397|FG001|Overall Study|Not Documented|2|||
46869014|NCT03615482|83087411|FG000|Overall Study|Death|1|||
46869015|NCT03615482|83087412|FG001|Overall Study|Death|0|||
46869016|NCT03615482|83087411|FG000|Overall Study|Lost to Follow-up|7|||
46869017|NCT03615482|83087412|FG001|Overall Study|Lost to Follow-up|7|||
46869018|NCT03615482|83087411|FG000|Overall Study|Physician Decision|2|||
46869019|NCT03615482|83087412|FG001|Overall Study|Physician Decision|3|||
46869020|NCT03615482|83087411|FG000|Overall Study|Withdrawal by Subject|7|||
46869021|NCT03615482|83087412|FG001|Overall Study|Withdrawal by Subject|7|||
46869022|NCT00090363|83087421|FG000|Overall Study|Lost to Follow-up|1|||
46869023|NCT00090363|83087422|FG001|Overall Study|Lost to Follow-up|2|||
46869024|NCT00090363|83087423|FG002|Overall Study|Lost to Follow-up|1|||
46869025|NCT00090363|83087421|FG000|Overall Study|Withdrawal by Subject|7|||
46869026|NCT00090363|83087422|FG001|Overall Study|Withdrawal by Subject|7|||
46869027|NCT00090363|83087423|FG002|Overall Study|Withdrawal by Subject|6|||
46869028|NCT00090363|83087421|FG000|Overall Study|Study-specific discontinuation criteria|75|||
46869029|NCT00090363|83087422|FG001|Overall Study|Study-specific discontinuation criteria|74|||
46869030|NCT00090363|83087423|FG002|Overall Study|Study-specific discontinuation criteria|62|||
46869031|NCT00090363|83087421|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46869032|NCT00090363|83087422|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46869033|NCT00090363|83087423|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
46869034|NCT00090363|83087421|FG000|Overall Study|Consent expired|7|||
46869035|NCT00090363|83087422|FG001|Overall Study|Consent expired|10|||
46869036|NCT00090363|83087423|FG002|Overall Study|Consent expired|9|||
46869037|NCT00090363|83087421|FG000|Overall Study|Reasons not specified|2|||
46869038|NCT00090363|83087422|FG001|Overall Study|Reasons not specified|1|||
46869039|NCT00090363|83087423|FG002|Overall Study|Reasons not specified|1|||
46869040|NCT00090363|83087421|FG000|Overall Study|Continuing on study off treatment|14|||
46869041|NCT00090363|83087422|FG001|Overall Study|Continuing on study off treatment|13|||
46869042|NCT00090363|83087423|FG002|Overall Study|Continuing on study off treatment|16|||
46869043|NCT03652610|83087433|FG000|Overall Study|Lost to Follow-up|1|||
46869044|NCT03652610|83087434|FG001|Overall Study|Lost to Follow-up|0|||
46869045|NCT03652610|83087433|FG000|Overall Study|Withdrawal by Subject|3|||
46869046|NCT03652610|83087434|FG001|Overall Study|Withdrawal by Subject|5|||
46869047|NCT03615404|83087440|FG000|Overall Study|Death|1|||
46869048|NCT03615404|83087440|FG000|Overall Study|vaccine did not pass quality assurance|1|||
46983752|NCT02370537|83230014|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
46869049|NCT03614156|83087447|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
46869050|NCT03614156|83087448|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
46699868|NCT00996892|82914992|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
46869051|NCT03614156|83087449|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
46869052|NCT03614156|83087450|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
46869053|NCT03614156|83087447|FG000|Open-Label Treatment Period|Adverse Event|7|||
46699869|NCT00996892|82914993|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
46699870|NCT00996892|82914994|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
46699871|NCT00996892|82914995|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
46699872|NCT00996892|82914996|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
46699873|NCT00996892|82914997|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
46699874|NCT00996892|82914998|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
46699875|NCT00996892|82914999|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
46699876|NCT00996892|82915000|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
46699877|NCT00996892|82914981|FG000|Dose-Escalation Stage 1A|Death|0|||
46699878|NCT00996892|82914982|FG001|Dose-Escalation Stage 1A|Death|0|||
46699879|NCT00996892|82914983|FG002|Dose-Escalation Stage 1A|Death|0|||
46699880|NCT00996892|82914984|FG003|Dose-Escalation Stage 1A|Death|0|||
46699881|NCT00996892|82914985|FG004|Dose-Escalation Stage 1A|Death|0|||
46699882|NCT00996892|82914986|FG005|Dose-Escalation Stage 1A|Death|0|||
46699883|NCT00996892|82914987|FG006|Dose-Escalation Stage 1A|Death|0|||
46699884|NCT00996892|82914988|FG007|Dose-Escalation Stage 1A|Death|0|||
46699885|NCT00996892|82914989|FG008|Dose-Escalation Stage 1A|Death|0|||
46699886|NCT00996892|82914990|FG009|Dose-Escalation Stage 1A|Death|2|||
46699887|NCT00996892|82914991|FG010|Dose-Escalation Stage 1A|Death|0|||
46699888|NCT00996892|82914992|FG011|Dose-Escalation Stage 1A|Death|1|||
46699889|NCT00996892|82914993|FG012|Dose-Escalation Stage 1A|Death|1|||
46699890|NCT00996892|82914994|FG013|Dose-Escalation Stage 1A|Death|0|||
46699891|NCT00996892|82914995|FG014|Dose-Escalation Stage 1A|Death|0|||
46699892|NCT00996892|82914996|FG015|Dose-Escalation Stage 1A|Death|0|||
46699893|NCT00996892|82914997|FG016|Dose-Escalation Stage 1A|Death|0|||
46699894|NCT00996892|82914998|FG017|Dose-Escalation Stage 1A|Death|0|||
46699895|NCT00996892|82914999|FG018|Dose-Escalation Stage 1A|Death|0|||
46699896|NCT00996892|82915000|FG019|Dose-Escalation Stage 1A|Death|0|||
46699897|NCT00996892|82914981|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
46699898|NCT00996892|82914982|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
46699899|NCT00996892|82914983|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
46699900|NCT00996892|82914984|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
46699901|NCT00996892|82914985|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
46699902|NCT00996892|82914986|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
46802545|NCT00098293|83021887|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
46802546|NCT00098293|83021883|FG000|Open-label (OL) Phase|Adverse Event|0|||
46802547|NCT00098293|83021884|FG001|Open-label (OL) Phase|Adverse Event|3|||
46802548|NCT00098293|83021885|FG002|Open-label (OL) Phase|Adverse Event|7|||
46802549|NCT00098293|83021886|FG003|Open-label (OL) Phase|Adverse Event|6|||
46802550|NCT00098293|83021887|FG004|Open-label (OL) Phase|Adverse Event|0|||
46802551|NCT00098293|83021883|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
46802552|NCT00098293|83021884|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
46802553|NCT00098293|83021885|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
46802554|NCT00098293|83021886|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
46802555|NCT00098293|83021887|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
46802556|NCT00098293|83021883|FG000|Open-label (OL) Phase|Pregnancy|0|||
46802557|NCT00098293|83021884|FG001|Open-label (OL) Phase|Pregnancy|1|||
46802558|NCT00098293|83021885|FG002|Open-label (OL) Phase|Pregnancy|0|||
46802559|NCT00098293|83021886|FG003|Open-label (OL) Phase|Pregnancy|3|||
46802560|NCT00098293|83021887|FG004|Open-label (OL) Phase|Pregnancy|0|||
46802561|NCT00098293|83021883|FG000|Open-label (OL) Phase|Protocol Violation|0|||
46802562|NCT00098293|83021884|FG001|Open-label (OL) Phase|Protocol Violation|6|||
46802563|NCT00098293|83021885|FG002|Open-label (OL) Phase|Protocol Violation|13|||
46802564|NCT00098293|83021886|FG003|Open-label (OL) Phase|Protocol Violation|16|||
46802565|NCT00098293|83021887|FG004|Open-label (OL) Phase|Protocol Violation|0|||
46983753|NCT02370537|83230015|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
46802566|NCT00098293|83021883|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
46802567|NCT00098293|83021884|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
46802568|NCT00098293|83021885|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
46802569|NCT00098293|83021886|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
46802570|NCT00098293|83021887|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
46699903|NCT00996892|82914987|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
46699904|NCT00996892|82914988|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
46802571|NCT00098293|83021883|FG000|Open-label (OL) Phase|Death|0|||
46802572|NCT00098293|83021884|FG001|Open-label (OL) Phase|Death|2|||
46802573|NCT00098293|83021885|FG002|Open-label (OL) Phase|Death|3|||
46802574|NCT00098293|83021886|FG003|Open-label (OL) Phase|Death|0|||
46802575|NCT00098293|83021887|FG004|Open-label (OL) Phase|Death|0|||
46802576|NCT00098293|83021883|FG000|Supplemental Phase (SP)|Death|0|||
46699905|NCT00996892|82914989|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
46699906|NCT00996892|82914990|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
46699907|NCT00996892|82914991|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
46699908|NCT00996892|82914992|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
46699909|NCT00996892|82914993|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
46699910|NCT00996892|82914994|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
46699911|NCT00996892|82914995|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
46699912|NCT00996892|82914996|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
46699913|NCT00996892|82914997|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
46699914|NCT00996892|82914998|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
46699915|NCT00996892|82914999|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
46699916|NCT00996892|82915000|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
46699917|NCT00996892|82914981|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699918|NCT00996892|82914982|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699919|NCT00996892|82914983|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699920|NCT00996892|82914984|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699921|NCT00996892|82914985|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699922|NCT00996892|82914986|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699923|NCT00996892|82914987|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699924|NCT00996892|82914988|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699925|NCT00996892|82914989|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699926|NCT00996892|82914990|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
46699927|NCT00996892|82914991|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
46699928|NCT00996892|82914992|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
46699929|NCT00996892|82914993|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
46699930|NCT00996892|82914994|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699931|NCT00996892|82914995|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699932|NCT00996892|82914996|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699933|NCT00996892|82914997|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699934|NCT00996892|82914998|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699935|NCT00996892|82914999|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699936|NCT00996892|82915000|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
46699937|NCT00996892|82914981|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
46699938|NCT00996892|82914982|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
46699939|NCT00996892|82914983|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
46699940|NCT00996892|82914984|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
46699941|NCT00996892|82914985|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
46699942|NCT00996892|82914986|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
46699943|NCT00996892|82914987|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
46699944|NCT00996892|82914988|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
46699945|NCT00996892|82914989|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
46699946|NCT00996892|82914990|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
46699947|NCT00996892|82914991|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
46699948|NCT00996892|82914992|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
46699949|NCT00996892|82914993|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
46699950|NCT00996892|82914994|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
46699951|NCT00996892|82914995|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
46699952|NCT00996892|82914996|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
46699953|NCT00996892|82914997|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
46699954|NCT00996892|82914998|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
46699955|NCT00996892|82914999|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
46699956|NCT00996892|82915000|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
46699957|NCT00996892|82914981|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
46699958|NCT00996892|82914982|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
46699959|NCT00996892|82914983|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
46699960|NCT00996892|82914984|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
46699961|NCT00996892|82914985|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
46699962|NCT00996892|82914986|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
46699963|NCT00996892|82914987|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
46699964|NCT00996892|82914988|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
46699965|NCT00996892|82914989|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
46699966|NCT00996892|82914990|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
46699967|NCT00996892|82914991|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
46699968|NCT00996892|82914992|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
46699969|NCT00996892|82914993|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
46869054|NCT03614156|83087448|FG001|Open-Label Treatment Period|Adverse Event|0|||
46699970|NCT00996892|82914994|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
46699971|NCT00996892|82914995|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
46699972|NCT00996892|82914996|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
46699973|NCT00996892|82914997|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
46699974|NCT00996892|82914998|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
46699975|NCT00996892|82914999|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
46699976|NCT00996892|82915000|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
46699977|NCT00996892|82914981|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
46699978|NCT00996892|82914982|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
46699979|NCT00996892|82914983|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
46699980|NCT00996892|82914984|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
46699981|NCT00996892|82914985|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
46699982|NCT00996892|82914986|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
46699983|NCT00996892|82914987|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
46699984|NCT00996892|82914988|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
46699985|NCT00996892|82914989|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
46699986|NCT00996892|82914990|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
46699987|NCT00996892|82914991|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
46699988|NCT00996892|82914992|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
46699989|NCT00996892|82914993|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
46699990|NCT00996892|82914994|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
46869055|NCT03614156|83087449|FG002|Open-Label Treatment Period|Adverse Event|0|||
46869056|NCT03614156|83087450|FG003|Open-Label Treatment Period|Adverse Event|0|||
46869057|NCT03614156|83087447|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
46869058|NCT03614156|83087448|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
46869059|NCT03614156|83087449|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
46869060|NCT03614156|83087450|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
46869061|NCT03614156|83087447|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
46869062|NCT03614156|83087448|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
46869063|NCT03614156|83087449|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
46869064|NCT03614156|83087450|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
46869065|NCT03614156|83087447|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
46869066|NCT03614156|83087448|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
46869067|NCT03614156|83087449|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
46869068|NCT03614156|83087450|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
46869069|NCT03614156|83087447|FG000|Open-Label Treatment Period|Protocol Violation|2|||
46869070|NCT03614156|83087448|FG001|Open-Label Treatment Period|Protocol Violation|0|||
46869071|NCT03614156|83087449|FG002|Open-Label Treatment Period|Protocol Violation|0|||
46869072|NCT03614156|83087450|FG003|Open-Label Treatment Period|Protocol Violation|0|||
46869073|NCT03614156|83087447|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
46869074|NCT03614156|83087448|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
46869075|NCT03614156|83087449|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
46869076|NCT03614156|83087450|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
46869077|NCT03614156|83087447|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
46869078|NCT03614156|83087448|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
46869079|NCT03614156|83087449|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
46869080|NCT03614156|83087450|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
46869081|NCT03614156|83087447|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
46869082|NCT03614156|83087448|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
46869083|NCT03614156|83087449|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
46869084|NCT03614156|83087450|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
46869085|NCT03614156|83087447|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46869086|NCT03614156|83087448|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
46869087|NCT03614156|83087449|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
46869088|NCT03614156|83087450|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
46869089|NCT03614156|83087447|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46869090|NCT03614156|83087448|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
46869091|NCT03614156|83087449|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
46869092|NCT03614156|83087450|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
46869093|NCT03614156|83087447|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
46869094|NCT03614156|83087448|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
46869095|NCT03614156|83087449|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
46869096|NCT03614156|83087450|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
46869097|NCT03614156|83087447|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
46869098|NCT03614156|83087448|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
46869099|NCT03614156|83087449|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
46869100|NCT03614156|83087450|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
46869101|NCT03614156|83087447|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
46869102|NCT03614156|83087448|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
46699991|NCT00996892|82914995|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
46699992|NCT00996892|82914996|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
46869103|NCT03614156|83087449|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
46869104|NCT03614156|83087450|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
46869105|NCT03614156|83087447|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
46869106|NCT03614156|83087448|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
46869107|NCT03614156|83087449|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
46869108|NCT03614156|83087450|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
46869109|NCT03614156|83087447|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
46869110|NCT03614156|83087448|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
46869111|NCT03614156|83087449|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
46869112|NCT03614156|83087450|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
46869113|NCT03614156|83087447|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
46869114|NCT03614156|83087448|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
46869115|NCT03614156|83087449|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
46869116|NCT03614156|83087450|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
46869117|NCT03614078|83087462|FG000|Overall Study|Withdrawal by Subject|2|||
46869118|NCT03614078|83087463|FG001|Overall Study|Withdrawal by Subject|2|||
46869119|NCT03614078|83087464|FG002|Overall Study|Withdrawal by Subject|3|||
46869120|NCT03614078|83087462|FG000|Overall Study|Participant Did Not Return for Visit|0|||
46869121|NCT03614078|83087463|FG001|Overall Study|Participant Did Not Return for Visit|1|||
46869122|NCT03614078|83087464|FG002|Overall Study|Participant Did Not Return for Visit|0|||
46869123|NCT03614078|83087462|FG000|Overall Study|High Neutrophils|0|||
46869124|NCT03614078|83087463|FG001|Overall Study|High Neutrophils|0|||
46869125|NCT03614078|83087464|FG002|Overall Study|High Neutrophils|2|||
46869126|NCT03614078|83087462|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
46869127|NCT03614078|83087463|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
46869128|NCT03614078|83087464|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
46869129|NCT03614078|83087462|FG000|Overall Study|Exacerbation of Psoriasis|0|||
46699993|NCT00996892|82914997|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
46699994|NCT00996892|82914998|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
46699995|NCT00996892|82914999|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
46699996|NCT00996892|82915000|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
46869130|NCT03614078|83087463|FG001|Overall Study|Exacerbation of Psoriasis|1|||
46869131|NCT03614078|83087464|FG002|Overall Study|Exacerbation of Psoriasis|0|||
46869132|NCT03614078|83087462|FG000|Overall Study|Adverse Event|0|||
46869133|NCT03614078|83087463|FG001|Overall Study|Adverse Event|2|||
46869134|NCT03614078|83087464|FG002|Overall Study|Adverse Event|0|||
46869135|NCT03614078|83087462|FG000|Overall Study|Dizziness and Rash|0|||
46869136|NCT03614078|83087463|FG001|Overall Study|Dizziness and Rash|1|||
46869137|NCT03614078|83087464|FG002|Overall Study|Dizziness and Rash|0|||
46869138|NCT03613454|83087474|FG000|Overall Study|Protocol Violation|1|||
46869139|NCT03613454|83087475|FG001|Overall Study|Protocol Violation|0|||
46869140|NCT03613454|83087474|FG000|Overall Study|Protocol Violation|0|||
46869141|NCT03613454|83087475|FG001|Overall Study|Protocol Violation|1|||
46869142|NCT03581786|83087483|FG000|Overall Study|Death|17|||
46869143|NCT03581786|83087484|FG001|Overall Study|Death|12|||
46869144|NCT03581786|83087483|FG000|Overall Study|Withdrawal by Subject|2|||
46869145|NCT03581786|83087484|FG001|Overall Study|Withdrawal by Subject|4|||
46869146|NCT03581786|83087483|FG000|Overall Study|Lost to Follow-up|1|||
46869147|NCT03581786|83087484|FG001|Overall Study|Lost to Follow-up|0|||
46869148|NCT03581786|83087483|FG000|Overall Study|reason other than specified above|0|||
46983754|NCT02370537|83230016|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
46983755|NCT02370537|83230014|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
46983756|NCT02370537|83230015|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
46983757|NCT02370537|83230016|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
46983758|NCT02370537|83230014|FG000|Part B|Not randomised to receive treatment|1|||
46983759|NCT02370537|83230015|FG001|Part B|Not randomised to receive treatment|2|||
46699997|NCT00996892|82914981|FG000|Expansion Stage 2|Adverse Event|0|||
46699998|NCT00996892|82914982|FG001|Expansion Stage 2|Adverse Event|0|||
46699999|NCT00996892|82914983|FG002|Expansion Stage 2|Adverse Event|0|||
46700000|NCT00996892|82914984|FG003|Expansion Stage 2|Adverse Event|0|||
46700001|NCT00996892|82914985|FG004|Expansion Stage 2|Adverse Event|0|||
46700002|NCT00996892|82914986|FG005|Expansion Stage 2|Adverse Event|0|||
46700003|NCT00996892|82914987|FG006|Expansion Stage 2|Adverse Event|0|||
46700004|NCT00996892|82914988|FG007|Expansion Stage 2|Adverse Event|0|||
46700005|NCT00996892|82914989|FG008|Expansion Stage 2|Adverse Event|0|||
46700006|NCT00996892|82914990|FG009|Expansion Stage 2|Adverse Event|0|||
46700007|NCT00996892|82914991|FG010|Expansion Stage 2|Adverse Event|0|||
46700008|NCT00996892|82914992|FG011|Expansion Stage 2|Adverse Event|0|||
46700009|NCT00996892|82914993|FG012|Expansion Stage 2|Adverse Event|0|||
46869149|NCT03581786|83087484|FG001|Overall Study|reason other than specified above|1|||
46869150|NCT03581786|83087483|FG000|Overall Study|Ongoing in the study|123|||
46869151|NCT03581786|83087484|FG001|Overall Study|Ongoing in the study|129|||
46869152|NCT03580382|83087492|FG000|Overall Study|Early Termination of Study|0|||
46869153|NCT03580382|83087493|FG001|Overall Study|Early Termination of Study|3|||
46869154|NCT03611582|83087500|FG000|Overall Study|Adverse Event|26|||
46869155|NCT03611582|83087501|FG001|Overall Study|Adverse Event|6|||
46869156|NCT03611582|83087500|FG000|Overall Study|Protocol Violation|0|||
46869157|NCT03611582|83087501|FG001|Overall Study|Protocol Violation|1|||
46869158|NCT03611582|83087500|FG000|Overall Study|Pregnancy|1|||
46869159|NCT03611582|83087501|FG001|Overall Study|Pregnancy|2|||
46869160|NCT03611582|83087500|FG000|Overall Study|Lack of Efficacy|0|||
46869161|NCT03611582|83087501|FG001|Overall Study|Lack of Efficacy|1|||
46869162|NCT03611582|83087500|FG000|Overall Study|At the discretion of the investigator|1|||
46869163|NCT03611582|83087501|FG001|Overall Study|At the discretion of the investigator|0|||
46869164|NCT03611582|83087500|FG000|Overall Study|Safety concern as judged by the investigator|1|||
46869165|NCT03611582|83087501|FG001|Overall Study|Safety concern as judged by the investigator|2|||
46869166|NCT03611582|83087500|FG000|Overall Study|Withdrawal by Subject|4|||
46869167|NCT03611582|83087501|FG001|Overall Study|Withdrawal by Subject|3|||
46869168|NCT03611582|83087500|FG000|Overall Study|Lost to Follow-up|18|||
46869169|NCT03611582|83087501|FG001|Overall Study|Lost to Follow-up|7|||
46869170|NCT03611582|83087500|FG000|Overall Study|other|17|||
46869171|NCT03611582|83087501|FG001|Overall Study|other|16|||
46869172|NCT04015518|83087512|FG000|Overall Study|Adverse Event|6|||
46869173|NCT04015518|83087513|FG001|Overall Study|Adverse Event|1|||
46869174|NCT04015518|83087514|FG002|Overall Study|Adverse Event|1|||
46869175|NCT04015518|83087515|FG003|Overall Study|Adverse Event|3|||
46869176|NCT04015518|83087516|FG004|Overall Study|Adverse Event|3|||
46869177|NCT04015518|83087512|FG000|Overall Study|Lack of Efficacy|1|||
46869178|NCT04015518|83087513|FG001|Overall Study|Lack of Efficacy|0|||
46869179|NCT04015518|83087514|FG002|Overall Study|Lack of Efficacy|1|||
46869180|NCT04015518|83087515|FG003|Overall Study|Lack of Efficacy|0|||
46869181|NCT04015518|83087516|FG004|Overall Study|Lack of Efficacy|4|||
46869182|NCT04015518|83087512|FG000|Overall Study|Lost to Follow-up|0|||
46869183|NCT04015518|83087513|FG001|Overall Study|Lost to Follow-up|0|||
46869184|NCT04015518|83087514|FG002|Overall Study|Lost to Follow-up|0|||
46869185|NCT04015518|83087515|FG003|Overall Study|Lost to Follow-up|0|||
46869186|NCT04015518|83087516|FG004|Overall Study|Lost to Follow-up|1|||
46869187|NCT04015518|83087512|FG000|Overall Study|Withdrawal by Subject|0|||
46869188|NCT04015518|83087513|FG001|Overall Study|Withdrawal by Subject|1|||
46869189|NCT04015518|83087514|FG002|Overall Study|Withdrawal by Subject|0|||
46869190|NCT04015518|83087515|FG003|Overall Study|Withdrawal by Subject|1|||
46869191|NCT04015518|83087516|FG004|Overall Study|Withdrawal by Subject|1|||
46983760|NCT02370537|83230016|FG002|Part B|Not randomised to receive treatment|259|||
46983761|NCT02370537|83230014|FG000|Part B|Withdrawal by Subject|0|||
46983762|NCT02370537|83230015|FG001|Part B|Withdrawal by Subject|1|||
46700010|NCT00996892|82914994|FG013|Expansion Stage 2|Adverse Event|0|||
46869192|NCT04015518|83087512|FG000|Overall Study|Patient did not come for consecutive visits|0|||
46869193|NCT04015518|83087513|FG001|Overall Study|Patient did not come for consecutive visits|1|||
46983763|NCT02370537|83230016|FG002|Part B|Withdrawal by Subject|0|||
46983764|NCT02330055|83230035|FG000|Overall Study|technical issues|2|||
46700011|NCT00996892|82914995|FG014|Expansion Stage 2|Adverse Event|0|||
46869194|NCT04015518|83087514|FG002|Overall Study|Patient did not come for consecutive visits|0|||
46869195|NCT04015518|83087515|FG003|Overall Study|Patient did not come for consecutive visits|0|||
46869196|NCT04015518|83087516|FG004|Overall Study|Patient did not come for consecutive visits|0|||
46869197|NCT04015518|83087512|FG000|Overall Study|not willing to travel due to Covid-19|0|||
46700012|NCT00996892|82914996|FG015|Expansion Stage 2|Adverse Event|0|||
46700013|NCT00996892|82914997|FG016|Expansion Stage 2|Adverse Event|0|||
46700014|NCT00996892|82914998|FG017|Expansion Stage 2|Adverse Event|0|||
46700015|NCT00996892|82914999|FG018|Expansion Stage 2|Adverse Event|3|||
46869198|NCT04015518|83087513|FG001|Overall Study|not willing to travel due to Covid-19|0|||
46869199|NCT04015518|83087514|FG002|Overall Study|not willing to travel due to Covid-19|1|||
46869200|NCT04015518|83087515|FG003|Overall Study|not willing to travel due to Covid-19|0|||
46983765|NCT02330055|83230036|FG001|Overall Study|technical issues|0|||
46700016|NCT00996892|82915000|FG019|Expansion Stage 2|Adverse Event|0|||
46700017|NCT00996892|82914981|FG000|Expansion Stage 2|Death|0|||
46700018|NCT00996892|82914982|FG001|Expansion Stage 2|Death|0|||
46700019|NCT00996892|82914983|FG002|Expansion Stage 2|Death|0|||
46700020|NCT00996892|82914984|FG003|Expansion Stage 2|Death|0|||
46700021|NCT00996892|82914985|FG004|Expansion Stage 2|Death|0|||
46869201|NCT04015518|83087516|FG004|Overall Study|not willing to travel due to Covid-19|0|||
46869202|NCT04015518|83087512|FG000|Overall Study|Patient wants to discontinue treatment|0|||
46869203|NCT04015518|83087513|FG001|Overall Study|Patient wants to discontinue treatment|0|||
46869204|NCT04015518|83087514|FG002|Overall Study|Patient wants to discontinue treatment|0|||
46869205|NCT04015518|83087515|FG003|Overall Study|Patient wants to discontinue treatment|1|||
46869206|NCT04015518|83087516|FG004|Overall Study|Patient wants to discontinue treatment|0|||
46869207|NCT04015518|83087512|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
46869208|NCT04015518|83087513|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
46869209|NCT04015518|83087514|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
46869210|NCT04015518|83087515|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
46869211|NCT04015518|83087516|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
46869212|NCT04015518|83087512|FG000|Overall Study|Pregnancy|0|||
46869213|NCT04015518|83087513|FG001|Overall Study|Pregnancy|0|||
46869214|NCT04015518|83087514|FG002|Overall Study|Pregnancy|0|||
46869215|NCT04015518|83087515|FG003|Overall Study|Pregnancy|0|||
46869216|NCT04015518|83087516|FG004|Overall Study|Pregnancy|1|||
46869217|NCT04015518|83087512|FG000|Overall Study|Personal reasons|1|||
46869218|NCT04015518|83087513|FG001|Overall Study|Personal reasons|0|||
46869219|NCT04015518|83087514|FG002|Overall Study|Personal reasons|0|||
46869220|NCT04015518|83087515|FG003|Overall Study|Personal reasons|0|||
46869221|NCT04015518|83087516|FG004|Overall Study|Personal reasons|1|||
46869222|NCT04015518|83087512|FG000|Overall Study|Withdrew consent|1|||
46869223|NCT04015518|83087513|FG001|Overall Study|Withdrew consent|0|||
46869224|NCT04015518|83087514|FG002|Overall Study|Withdrew consent|0|||
46869225|NCT04015518|83087515|FG003|Overall Study|Withdrew consent|0|||
46869226|NCT04015518|83087516|FG004|Overall Study|Withdrew consent|0|||
46869227|NCT04015518|83087512|FG000|Overall Study|Prostate carcinoma|1|||
46869228|NCT04015518|83087513|FG001|Overall Study|Prostate carcinoma|0|||
46869229|NCT04015518|83087514|FG002|Overall Study|Prostate carcinoma|0|||
46869230|NCT04015518|83087515|FG003|Overall Study|Prostate carcinoma|0|||
46869231|NCT04015518|83087516|FG004|Overall Study|Prostate carcinoma|0|||
46869232|NCT04015518|83087512|FG000|Overall Study|Could not keep appointments due to work|1|||
46869233|NCT04015518|83087513|FG001|Overall Study|Could not keep appointments due to work|0|||
46869234|NCT04015518|83087514|FG002|Overall Study|Could not keep appointments due to work|0|||
46869235|NCT04015518|83087515|FG003|Overall Study|Could not keep appointments due to work|0|||
46869236|NCT04015518|83087516|FG004|Overall Study|Could not keep appointments due to work|0|||
46983766|NCT02330055|83230035|FG000|Overall Study|participant forgot to wear device|5|||
46983767|NCT02330055|83230036|FG001|Overall Study|participant forgot to wear device|5|||
46700022|NCT00996892|82914986|FG005|Expansion Stage 2|Death|0|||
46700023|NCT00996892|82914987|FG006|Expansion Stage 2|Death|0|||
46700024|NCT00996892|82914988|FG007|Expansion Stage 2|Death|0|||
46700025|NCT00996892|82914989|FG008|Expansion Stage 2|Death|0|||
46869237|NCT03577730|83087533|FG000|Overall Study|Physician Decision|3|||
46869238|NCT03577730|83087534|FG001|Overall Study|Physician Decision|1|||
46869239|NCT03577730|83087533|FG000|Overall Study|Did not receive allocated intervention|1|||
46869240|NCT03577730|83087534|FG001|Overall Study|Did not receive allocated intervention|0|||
46869241|NCT03608774|83087542|FG000|Overall Study|Lost to Follow-up|5|||
46869242|NCT03608774|83087543|FG001|Overall Study|Lost to Follow-up|5|||
46869243|NCT03608774|83087542|FG000|Overall Study|Withdrawal by Subject|1|||
46869244|NCT03608774|83087543|FG001|Overall Study|Withdrawal by Subject|0|||
46869245|NCT03608774|83087542|FG000|Overall Study|Protocol Violation|1|||
46869246|NCT03608774|83087543|FG001|Overall Study|Protocol Violation|0|||
46869247|NCT03608774|83087542|FG000|Overall Study|Not eligible at enrollment|0|||
46869248|NCT03608774|83087543|FG001|Overall Study|Not eligible at enrollment|1|||
46869249|NCT03608774|83087542|FG000|Overall Study|Health related event|0|||
46869250|NCT03608774|83087543|FG001|Overall Study|Health related event|1|||
46869251|NCT04021524|83087551|FG000|Overall Study|Change in surgical intervention|0|||
46869252|NCT04021524|83087552|FG001|Overall Study|Change in surgical intervention|1|||
46869253|NCT03607682|83087558|FG000|Overall Study|Withdrawal by Subject|1|||
46869254|NCT03607682|83087558|FG000|Overall Study|Disease progression|1|||
46869255|NCT03606668|83087562|FG000|Overall Study|Screen Failure|1|||
46869256|NCT03606668|83087562|FG000|Overall Study|Lost to Follow-up|1|||
46869257|NCT03601052|83087566|FG000|Overall Study|Lost to Follow-up|2|||
46869258|NCT03600740|83087575|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
46869259|NCT03600428|83087581|FG000|Overall Study|Not eligible|0|||
46869260|NCT03600428|83087582|FG001|Overall Study|Not eligible|1|||
46983768|NCT02330055|83230035|FG000|Overall Study|data for less than 60 minutes|3|||
46700026|NCT00996892|82914990|FG009|Expansion Stage 2|Death|0|||
46700027|NCT00996892|82914991|FG010|Expansion Stage 2|Death|0|||
46869261|NCT03600428|83087581|FG000|Overall Study|Lost to Follow-up|5|||
46869262|NCT03600428|83087582|FG001|Overall Study|Lost to Follow-up|4|||
46700028|NCT00996892|82914992|FG011|Expansion Stage 2|Death|0|||
46700029|NCT00996892|82914993|FG012|Expansion Stage 2|Death|0|||
46700030|NCT00996892|82914994|FG013|Expansion Stage 2|Death|0|||
46700031|NCT00996892|82914995|FG014|Expansion Stage 2|Death|0|||
46700032|NCT00996892|82914996|FG015|Expansion Stage 2|Death|0|||
46700033|NCT00996892|82914997|FG016|Expansion Stage 2|Death|0|||
46700034|NCT00996892|82914998|FG017|Expansion Stage 2|Death|0|||
46700035|NCT00996892|82914999|FG018|Expansion Stage 2|Death|2|||
46700036|NCT00996892|82915000|FG019|Expansion Stage 2|Death|0|||
46700037|NCT00996892|82914981|FG000|Expansion Stage 2|Physician Decision|0|||
46700038|NCT00996892|82914982|FG001|Expansion Stage 2|Physician Decision|0|||
46700039|NCT00996892|82914983|FG002|Expansion Stage 2|Physician Decision|0|||
46700040|NCT00996892|82914984|FG003|Expansion Stage 2|Physician Decision|0|||
46700041|NCT00996892|82914985|FG004|Expansion Stage 2|Physician Decision|0|||
46700042|NCT00996892|82914986|FG005|Expansion Stage 2|Physician Decision|0|||
46700043|NCT00996892|82914987|FG006|Expansion Stage 2|Physician Decision|0|||
46700044|NCT00996892|82914988|FG007|Expansion Stage 2|Physician Decision|0|||
46700045|NCT00996892|82914989|FG008|Expansion Stage 2|Physician Decision|0|||
46700046|NCT00996892|82914990|FG009|Expansion Stage 2|Physician Decision|0|||
46700047|NCT00996892|82914991|FG010|Expansion Stage 2|Physician Decision|0|||
46700048|NCT00996892|82914992|FG011|Expansion Stage 2|Physician Decision|0|||
46700049|NCT00996892|82914993|FG012|Expansion Stage 2|Physician Decision|0|||
46700050|NCT00996892|82914994|FG013|Expansion Stage 2|Physician Decision|0|||
46700051|NCT00996892|82914995|FG014|Expansion Stage 2|Physician Decision|0|||
46700052|NCT00996892|82914996|FG015|Expansion Stage 2|Physician Decision|0|||
46700053|NCT00996892|82914997|FG016|Expansion Stage 2|Physician Decision|0|||
46700054|NCT00996892|82914998|FG017|Expansion Stage 2|Physician Decision|0|||
46700055|NCT00996892|82914999|FG018|Expansion Stage 2|Physician Decision|1|||
46700056|NCT00996892|82915000|FG019|Expansion Stage 2|Physician Decision|0|||
46700057|NCT00996892|82914981|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
46700058|NCT00996892|82914982|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
46700059|NCT00996892|82914983|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
46700060|NCT00996892|82914984|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
46700061|NCT00996892|82914985|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
46700062|NCT00996892|82914986|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
46700063|NCT00996892|82914987|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
46700064|NCT00996892|82914988|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
46700065|NCT00996892|82914989|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
46700066|NCT00996892|82914990|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
46700067|NCT00996892|82914991|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
46700068|NCT00996892|82914992|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
46700069|NCT00996892|82914993|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
46700070|NCT00996892|82914994|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
46700071|NCT00996892|82914995|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
46700072|NCT00996892|82914996|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
46700073|NCT00996892|82914997|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
46700074|NCT00996892|82914998|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
46700075|NCT00996892|82914999|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
46700076|NCT00996892|82915000|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
46700077|NCT00996892|82914981|FG000|Expansion Stage 2|Disease Progression|0|||
46700078|NCT00996892|82914982|FG001|Expansion Stage 2|Disease Progression|0|||
46700079|NCT00996892|82914983|FG002|Expansion Stage 2|Disease Progression|0|||
46700080|NCT00996892|82914984|FG003|Expansion Stage 2|Disease Progression|0|||
46700081|NCT00996892|82914985|FG004|Expansion Stage 2|Disease Progression|0|||
46700082|NCT00996892|82914986|FG005|Expansion Stage 2|Disease Progression|0|||
46700083|NCT00996892|82914987|FG006|Expansion Stage 2|Disease Progression|0|||
46700084|NCT00996892|82914988|FG007|Expansion Stage 2|Disease Progression|0|||
46700085|NCT00996892|82914989|FG008|Expansion Stage 2|Disease Progression|0|||
46700086|NCT00996892|82914990|FG009|Expansion Stage 2|Disease Progression|0|||
46700087|NCT00996892|82914991|FG010|Expansion Stage 2|Disease Progression|0|||
46700088|NCT00996892|82914992|FG011|Expansion Stage 2|Disease Progression|0|||
46700089|NCT00996892|82914993|FG012|Expansion Stage 2|Disease Progression|0|||
46700090|NCT00996892|82914994|FG013|Expansion Stage 2|Disease Progression|0|||
46700091|NCT00996892|82914995|FG014|Expansion Stage 2|Disease Progression|0|||
46700092|NCT00996892|82914996|FG015|Expansion Stage 2|Disease Progression|0|||
46700093|NCT00996892|82914997|FG016|Expansion Stage 2|Disease Progression|0|||
46700094|NCT00996892|82914998|FG017|Expansion Stage 2|Disease Progression|0|||
46802577|NCT00098293|83021884|FG001|Supplemental Phase (SP)|Death|0|||
46802578|NCT00098293|83021885|FG002|Supplemental Phase (SP)|Death|0|||
46802579|NCT00098293|83021886|FG003|Supplemental Phase (SP)|Death|0|||
46802580|NCT00098293|83021887|FG004|Supplemental Phase (SP)|Death|1|||
46802581|NCT00098293|83021883|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
46802582|NCT00098293|83021884|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
46802583|NCT00098293|83021885|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
46802584|NCT00098293|83021886|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
46802585|NCT00098293|83021887|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
46802586|NCT00098293|83021883|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
46700095|NCT00996892|82914999|FG018|Expansion Stage 2|Disease Progression|28|||
46700096|NCT00996892|82915000|FG019|Expansion Stage 2|Disease Progression|0|||
46700097|NCT00996892|82914981|FG000|Expansion Stage 2A|Adverse Event|0|||
46700098|NCT00996892|82914982|FG001|Expansion Stage 2A|Adverse Event|0|||
46700099|NCT00996892|82914983|FG002|Expansion Stage 2A|Adverse Event|0|||
46700100|NCT00996892|82914984|FG003|Expansion Stage 2A|Adverse Event|0|||
46700101|NCT00996892|82914985|FG004|Expansion Stage 2A|Adverse Event|0|||
46700102|NCT00996892|82914986|FG005|Expansion Stage 2A|Adverse Event|0|||
46700103|NCT00996892|82914987|FG006|Expansion Stage 2A|Adverse Event|0|||
46700104|NCT00996892|82914988|FG007|Expansion Stage 2A|Adverse Event|0|||
46700105|NCT00996892|82914989|FG008|Expansion Stage 2A|Adverse Event|0|||
46700106|NCT00996892|82914990|FG009|Expansion Stage 2A|Adverse Event|0|||
46700107|NCT00996892|82914991|FG010|Expansion Stage 2A|Adverse Event|0|||
46700108|NCT00996892|82914992|FG011|Expansion Stage 2A|Adverse Event|0|||
46700109|NCT00996892|82914993|FG012|Expansion Stage 2A|Adverse Event|0|||
46700110|NCT00996892|82914994|FG013|Expansion Stage 2A|Adverse Event|0|||
46700111|NCT00996892|82914995|FG014|Expansion Stage 2A|Adverse Event|0|||
46700112|NCT00996892|82914996|FG015|Expansion Stage 2A|Adverse Event|0|||
46700113|NCT00996892|82914997|FG016|Expansion Stage 2A|Adverse Event|0|||
46700114|NCT00996892|82914998|FG017|Expansion Stage 2A|Adverse Event|0|||
46700115|NCT00996892|82914999|FG018|Expansion Stage 2A|Adverse Event|0|||
46700116|NCT00996892|82915000|FG019|Expansion Stage 2A|Adverse Event|8|||
46700117|NCT00996892|82914981|FG000|Expansion Stage 2A|Physician Decision|0|||
46869263|NCT03575702|83087590|FG000|Overall Study|Withdrawal by Subject|1|||
46983769|NCT02330055|83230036|FG001|Overall Study|data for less than 60 minutes|3|||
46869264|NCT03575702|83087591|FG001|Overall Study|Withdrawal by Subject|1|||
46869265|NCT03575702|83087590|FG000|Overall Study|Lost to Follow-up|1|||
46869266|NCT03575702|83087591|FG001|Overall Study|Lost to Follow-up|2|||
46869267|NCT03575702|83087590|FG000|Overall Study|Protocol Violation|0|||
46869268|NCT03575702|83087591|FG001|Overall Study|Protocol Violation|1|||
46700118|NCT00996892|82914982|FG001|Expansion Stage 2A|Physician Decision|0|||
46869269|NCT03575702|83087590|FG000|Overall Study|Patient non compliance|4|||
46869270|NCT03575702|83087591|FG001|Overall Study|Patient non compliance|0|||
46700119|NCT00996892|82914983|FG002|Expansion Stage 2A|Physician Decision|0|||
46700120|NCT00996892|82914984|FG003|Expansion Stage 2A|Physician Decision|0|||
46700121|NCT00996892|82914985|FG004|Expansion Stage 2A|Physician Decision|0|||
46700122|NCT00996892|82914986|FG005|Expansion Stage 2A|Physician Decision|0|||
46700123|NCT00996892|82914987|FG006|Expansion Stage 2A|Physician Decision|0|||
46700124|NCT00996892|82914988|FG007|Expansion Stage 2A|Physician Decision|0|||
46869271|NCT03573908|83087599|FG000|Treatment Period|Adverse Event|4|||
46869272|NCT03573908|83087600|FG001|Treatment Period|Adverse Event|9|||
46700125|NCT00996892|82914989|FG008|Expansion Stage 2A|Physician Decision|0|||
46700126|NCT00996892|82914990|FG009|Expansion Stage 2A|Physician Decision|0|||
46700127|NCT00996892|82914991|FG010|Expansion Stage 2A|Physician Decision|0|||
46700128|NCT00996892|82914992|FG011|Expansion Stage 2A|Physician Decision|0|||
46700129|NCT00996892|82914993|FG012|Expansion Stage 2A|Physician Decision|0|||
46700130|NCT00996892|82914994|FG013|Expansion Stage 2A|Physician Decision|0|||
46700131|NCT00996892|82914995|FG014|Expansion Stage 2A|Physician Decision|0|||
46700132|NCT00996892|82914996|FG015|Expansion Stage 2A|Physician Decision|0|||
46700133|NCT00996892|82914997|FG016|Expansion Stage 2A|Physician Decision|0|||
46700134|NCT00996892|82914998|FG017|Expansion Stage 2A|Physician Decision|0|||
46700135|NCT00996892|82914999|FG018|Expansion Stage 2A|Physician Decision|0|||
46700136|NCT00996892|82915000|FG019|Expansion Stage 2A|Physician Decision|2|||
46700137|NCT00996892|82914981|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
46700138|NCT00996892|82914982|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
46700139|NCT00996892|82914983|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
46700140|NCT00996892|82914984|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
46700141|NCT00996892|82914985|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
46700142|NCT00996892|82914986|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
46700143|NCT00996892|82914987|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
46700144|NCT00996892|82914988|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
46700145|NCT00996892|82914989|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
46700146|NCT00996892|82914990|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
46700147|NCT00996892|82914991|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
46700148|NCT00996892|82914992|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
46700149|NCT00996892|82914993|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
46700150|NCT00996892|82914994|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
46700151|NCT00996892|82914995|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
46700152|NCT00996892|82914996|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
46700153|NCT00996892|82914997|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
46700154|NCT00996892|82914998|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
46700155|NCT00996892|82914999|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
46700156|NCT00996892|82915000|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
46700157|NCT00996892|82914981|FG000|Expansion Stage 2A|Disease Progression|0|||
46700158|NCT00996892|82914982|FG001|Expansion Stage 2A|Disease Progression|0|||
46700159|NCT00996892|82914983|FG002|Expansion Stage 2A|Disease Progression|0|||
46700160|NCT00996892|82914984|FG003|Expansion Stage 2A|Disease Progression|0|||
46700161|NCT00996892|82914985|FG004|Expansion Stage 2A|Disease Progression|0|||
46700162|NCT00996892|82914986|FG005|Expansion Stage 2A|Disease Progression|0|||
46700163|NCT00996892|82914987|FG006|Expansion Stage 2A|Disease Progression|0|||
46700164|NCT00996892|82914988|FG007|Expansion Stage 2A|Disease Progression|0|||
46700165|NCT00996892|82914989|FG008|Expansion Stage 2A|Disease Progression|0|||
46700166|NCT00996892|82914990|FG009|Expansion Stage 2A|Disease Progression|0|||
46700167|NCT00996892|82914991|FG010|Expansion Stage 2A|Disease Progression|0|||
46700168|NCT00996892|82914992|FG011|Expansion Stage 2A|Disease Progression|0|||
46700169|NCT00996892|82914993|FG012|Expansion Stage 2A|Disease Progression|0|||
46700170|NCT00996892|82914994|FG013|Expansion Stage 2A|Disease Progression|0|||
46700171|NCT00996892|82914995|FG014|Expansion Stage 2A|Disease Progression|0|||
46700172|NCT00996892|82914996|FG015|Expansion Stage 2A|Disease Progression|0|||
46700173|NCT00996892|82914997|FG016|Expansion Stage 2A|Disease Progression|0|||
46700174|NCT00996892|82914998|FG017|Expansion Stage 2A|Disease Progression|0|||
46700175|NCT00996892|82914999|FG018|Expansion Stage 2A|Disease Progression|0|||
46700176|NCT00996892|82915000|FG019|Expansion Stage 2A|Disease Progression|31|||
46700177|NCT01257581|82915064|FG000|Overall Study|Early Termination|3|||
46700178|NCT01257581|82915065|FG001|Overall Study|Early Termination|1|||
46700179|NCT01257581|82915066|FG002|Overall Study|Early Termination|2|||
46700180|NCT01257581|82915064|FG000|Overall Study|Death|2|||
46700181|NCT01257581|82915065|FG001|Overall Study|Death|2|||
46700182|NCT01257581|82915066|FG002|Overall Study|Death|4|||
46700183|NCT01257503|82915076|FG000|Overall Study|Lost to Follow-up|7|||
46700184|NCT01257503|82915077|FG001|Overall Study|Lost to Follow-up|10|||
46700185|NCT01257503|82915076|FG000|Overall Study|Over 5 years old at enrollment|0|||
46700186|NCT01257503|82915077|FG001|Overall Study|Over 5 years old at enrollment|1|||
46700187|NCT01257503|82915076|FG000|Overall Study|strep culture positive at enrollment|1|||
46700188|NCT01257503|82915077|FG001|Overall Study|strep culture positive at enrollment|0|||
46700189|NCT00995566|82915083|FG000|Overall Study|Adverse Event|2|||
46700190|NCT00995566|82915083|FG000|Overall Study|Early study termination|52|||
46700191|NCT01257425|82915089|FG000|Overall Study|Lack of Efficacy|3|||
46700192|NCT01257425|82915090|FG001|Overall Study|Lack of Efficacy|3|||
46700193|NCT01257425|82915089|FG000|Overall Study|Adverse Event|1|||
46700194|NCT01257425|82915090|FG001|Overall Study|Adverse Event|1|||
46700195|NCT01257425|82915089|FG000|Overall Study|Protocol Violation|1|||
46700196|NCT01257425|82915090|FG001|Overall Study|Protocol Violation|1|||
46700197|NCT01257425|82915089|FG000|Overall Study|Withdrawal by Subject|0|||
46700198|NCT01257425|82915090|FG001|Overall Study|Withdrawal by Subject|1|||
46700199|NCT01257425|82915089|FG000|Overall Study|Death|1|||
46700200|NCT01257425|82915090|FG001|Overall Study|Death|0|||
46700201|NCT00995488|82915096|FG000|Overall Study|Withdrawal by Subject|1|||
46700202|NCT01256879|82915100|FG000|Overall Study|Withdrawal by Subject|1|||
46700203|NCT01125189|82915113|FG000|Treatment Period|Lack of Efficacy|15|||
46700204|NCT01125189|82915114|FG001|Treatment Period|Lack of Efficacy|18|||
46700205|NCT01125189|82915115|FG002|Treatment Period|Lack of Efficacy|25|||
46700206|NCT01125189|82915113|FG000|Treatment Period|Adverse Event|7|||
46700207|NCT01125189|82915114|FG001|Treatment Period|Adverse Event|8|||
46700208|NCT01125189|82915115|FG002|Treatment Period|Adverse Event|8|||
46700209|NCT01125189|82915113|FG000|Treatment Period|Withdrawal by Subject|3|||
46700210|NCT01125189|82915114|FG001|Treatment Period|Withdrawal by Subject|1|||
46700211|NCT01125189|82915115|FG002|Treatment Period|Withdrawal by Subject|1|||
46700212|NCT01125189|82915113|FG000|Treatment Period|Death|1|||
46700213|NCT01125189|82915114|FG001|Treatment Period|Death|0|||
46700214|NCT01125189|82915115|FG002|Treatment Period|Death|0|||
46700215|NCT01125189|82915113|FG000|Treatment Period|Lost to Follow-up|1|||
46700216|NCT01125189|82915114|FG001|Treatment Period|Lost to Follow-up|2|||
46700217|NCT01125189|82915115|FG002|Treatment Period|Lost to Follow-up|1|||
46700218|NCT01125189|82915113|FG000|Treatment Period|Poor compliance/noncompliance|0|||
46700219|NCT01125189|82915114|FG001|Treatment Period|Poor compliance/noncompliance|1|||
46700220|NCT01125189|82915115|FG002|Treatment Period|Poor compliance/noncompliance|0|||
46700221|NCT01125189|82915113|FG000|Treatment Period|Participants requested to discontinue|1|||
46700222|NCT01125189|82915114|FG001|Treatment Period|Participants requested to discontinue|3|||
46700223|NCT01125189|82915115|FG002|Treatment Period|Participants requested to discontinue|4|||
46700224|NCT01125189|82915113|FG000|Treatment Period|Other reasons|1|||
46700225|NCT01125189|82915114|FG001|Treatment Period|Other reasons|1|||
46700226|NCT01125189|82915115|FG002|Treatment Period|Other reasons|0|||
46700227|NCT01125189|82915113|FG000|Treatment Period|Completed 24 week treatment period only|2|||
46700228|NCT01125189|82915114|FG001|Treatment Period|Completed 24 week treatment period only|1|||
46700229|NCT01125189|82915115|FG002|Treatment Period|Completed 24 week treatment period only|2|||
46700230|NCT01125189|82915113|FG000|Follow up Period|Withdrawal by Subject|3|||
46700231|NCT01125189|82915114|FG001|Follow up Period|Withdrawal by Subject|2|||
46700232|NCT01125189|82915115|FG002|Follow up Period|Withdrawal by Subject|5|||
46700233|NCT01125189|82915113|FG000|Follow up Period|Death|1|||
46700234|NCT01125189|82915114|FG001|Follow up Period|Death|0|||
46700235|NCT01125189|82915115|FG002|Follow up Period|Death|0|||
46700236|NCT01125189|82915113|FG000|Follow up Period|Lost to Follow-up|12|||
46700237|NCT01125189|82915114|FG001|Follow up Period|Lost to Follow-up|9|||
46700238|NCT01125189|82915115|FG002|Follow up Period|Lost to Follow-up|6|||
46700239|NCT01125189|82915113|FG000|Follow up Period|Other reasons|4|||
46700240|NCT01125189|82915114|FG001|Follow up Period|Other reasons|4|||
46700241|NCT01125189|82915115|FG002|Follow up Period|Other reasons|5|||
46700242|NCT01256567|82915126|FG000|Overall Study|Withdrawal by Subject|1|||
46700243|NCT00996736|82915133|FG000|Overall Study|Death|1|||
46700244|NCT00996736|82915134|FG001|Overall Study|Death|1|||
46700245|NCT00996736|82915133|FG000|Overall Study|Lost to Follow-up|15|||
46700246|NCT00996736|82915134|FG001|Overall Study|Lost to Follow-up|14|||
46700247|NCT00996736|82915133|FG000|Overall Study|Visit not within 3-month window|5|||
46700248|NCT00996736|82915134|FG001|Overall Study|Visit not within 3-month window|3|||
46700249|NCT00996658|82915142|FG000|Overall Study|Adverse Event|2|||
46700250|NCT00996658|82915143|FG001|Overall Study|Adverse Event|5|||
46700251|NCT00996658|82915142|FG000|Overall Study|Protocol Violation|0|||
46700252|NCT00996658|82915143|FG001|Overall Study|Protocol Violation|1|||
46700253|NCT00996658|82915142|FG000|Overall Study|Lost to Follow-up|2|||
46700254|NCT00996658|82915143|FG001|Overall Study|Lost to Follow-up|5|||
46700255|NCT00996658|82915142|FG000|Overall Study|Non-compliance issues|3|||
46700256|NCT00996658|82915143|FG001|Overall Study|Non-compliance issues|3|||
46700257|NCT00996658|82915142|FG000|Overall Study|Other|9|||
46700258|NCT00996658|82915143|FG001|Overall Study|Other|7|||
46700259|NCT01124643|82915149|FG000|Overall Study|Death|1|||
46700260|NCT01256411|82915157|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
46869273|NCT03573908|83087601|FG002|Treatment Period|Adverse Event|0|||
46700261|NCT01256411|82915158|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
46869274|NCT03573908|83087602|FG003|Treatment Period|Adverse Event|0|||
46700262|NCT01256411|82915159|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
46700263|NCT01256411|82915160|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
46700264|NCT01256411|82915161|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
46700265|NCT01256411|82915162|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
46700266|NCT01256411|82915157|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
46700267|NCT01256411|82915158|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
46700268|NCT01256411|82915159|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
46700269|NCT01256411|82915160|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
46700270|NCT01256411|82915161|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
46700271|NCT01256411|82915162|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
46700272|NCT01256411|82915157|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
46700273|NCT01256411|82915158|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
46700274|NCT01256411|82915159|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
46700275|NCT01256411|82915160|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
46700276|NCT01256411|82915161|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
46700277|NCT01256411|82915162|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
46700278|NCT01256411|82915157|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
46700279|NCT01256411|82915158|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
46700280|NCT01256411|82915159|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
46700281|NCT01256411|82915160|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
46700282|NCT01256411|82915161|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
46700283|NCT01256411|82915162|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
46700284|NCT01256411|82915157|FG000|Extension by Maximum Treatment|Adverse Event|4|||
46700285|NCT01256411|82915158|FG001|Extension by Maximum Treatment|Adverse Event|2|||
46700286|NCT01256411|82915159|FG002|Extension by Maximum Treatment|Adverse Event|1|||
46700287|NCT01256411|82915160|FG003|Extension by Maximum Treatment|Adverse Event|0|||
46700288|NCT01256411|82915161|FG004|Extension by Maximum Treatment|Adverse Event|0|||
46700289|NCT01256411|82915162|FG005|Extension by Maximum Treatment|Adverse Event|0|||
46700290|NCT01256411|82915157|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
46700291|NCT01256411|82915158|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
46700292|NCT01256411|82915159|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
46700293|NCT01256411|82915160|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
46700294|NCT01256411|82915161|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
46700295|NCT01256411|82915162|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
46700296|NCT01256411|82915157|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
46700297|NCT01256411|82915158|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
46700298|NCT01256411|82915159|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
46700299|NCT01256411|82915160|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
46700300|NCT01256411|82915161|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
46700301|NCT01256411|82915162|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
46700302|NCT01256411|82915157|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
46700303|NCT01256411|82915158|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
46700304|NCT01256411|82915159|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
46700305|NCT01256411|82915160|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
46700306|NCT01256411|82915161|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
46700307|NCT01256411|82915162|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
46700308|NCT01256411|82915157|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
46700309|NCT01256411|82915158|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
46700310|NCT01256411|82915159|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
46700311|NCT01256411|82915160|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
46700312|NCT01256411|82915161|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
46700313|NCT01256411|82915162|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
46700314|NCT01256411|82915157|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
46700315|NCT01256411|82915158|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
46700316|NCT01256411|82915159|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
46700317|NCT01256411|82915160|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
46700318|NCT01256411|82915161|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
46700319|NCT01256411|82915162|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
46700320|NCT00996580|82915176|FG000|Overall Study|Adverse Event|466|||
46700321|NCT00996580|82915176|FG000|Overall Study|Lost to Follow-up|480|||
46700322|NCT00996580|82915176|FG000|Overall Study|Noncompliance with the protocol|137|||
46700323|NCT00996580|82915176|FG000|Overall Study|Physician Decision|5|||
46700324|NCT00996580|82915176|FG000|Overall Study|Pregnancy|68|||
46700325|NCT00996580|82915176|FG000|Overall Study|Protocol Violation|16|||
46869275|NCT03573908|83087603|FG004|Treatment Period|Adverse Event|0|||
46700326|NCT00996580|82915176|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
46700327|NCT00996580|82915176|FG000|Overall Study|Withdrawal by Subject|217|||
46700328|NCT00996580|82915176|FG000|Overall Study|Other|29|||
46700329|NCT01124175|82915185|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
46700330|NCT01124175|82915186|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
46700331|NCT01256177|82915194|FG000|Overall Study|Withdrawal by Subject|23|||
46700332|NCT01256177|82915195|FG001|Overall Study|Withdrawal by Subject|22|||
46700333|NCT01256177|82915194|FG000|Overall Study|Lost to Follow-up|2|||
46700334|NCT01256177|82915195|FG001|Overall Study|Lost to Follow-up|2|||
46700335|NCT01256177|82915194|FG000|Overall Study|Adverse Event|8|||
46700336|NCT01256177|82915195|FG001|Overall Study|Adverse Event|9|||
46700337|NCT01256177|82915194|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
46700338|NCT01256177|82915195|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
46700339|NCT01256177|82915194|FG000|Overall Study|Condition under Investigation Worsened|1|||
46700340|NCT01256177|82915195|FG001|Overall Study|Condition under Investigation Worsened|0|||
46700341|NCT01256177|82915194|FG000|Overall Study|Lack of Efficacy|11|||
46700342|NCT01256177|82915195|FG001|Overall Study|Lack of Efficacy|2|||
46700343|NCT01256177|82915194|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
46700344|NCT01256177|82915195|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
46700345|NCT00999544|82915201|FG000|Overall Study|Withdrawal by Subject|1|||
46700346|NCT01124097|82915238|FG000|Overall Study|Withdrawal by Subject|4|||
46700347|NCT01124097|82915239|FG001|Overall Study|Withdrawal by Subject|3|||
46700348|NCT01124097|82915240|FG002|Overall Study|Withdrawal by Subject|2|||
46700349|NCT01124097|82915241|FG003|Overall Study|Withdrawal by Subject|3|||
46700350|NCT01124097|82915238|FG000|Overall Study|Lack of Efficacy|2|||
46700351|NCT01124097|82915239|FG001|Overall Study|Lack of Efficacy|3|||
46700352|NCT01124097|82915240|FG002|Overall Study|Lack of Efficacy|1|||
46700353|NCT01124097|82915241|FG003|Overall Study|Lack of Efficacy|3|||
46700354|NCT01124097|82915238|FG000|Overall Study|Adverse Event|24|||
46700355|NCT01124097|82915239|FG001|Overall Study|Adverse Event|15|||
46700356|NCT01124097|82915240|FG002|Overall Study|Adverse Event|15|||
46700357|NCT01124097|82915241|FG003|Overall Study|Adverse Event|7|||
46700358|NCT01124097|82915238|FG000|Overall Study|Protocol Violation|2|||
46700359|NCT01124097|82915239|FG001|Overall Study|Protocol Violation|0|||
46700360|NCT01124097|82915240|FG002|Overall Study|Protocol Violation|2|||
46700361|NCT01124097|82915241|FG003|Overall Study|Protocol Violation|1|||
46700362|NCT01124097|82915238|FG000|Overall Study|Physician Decision|2|||
46700363|NCT01124097|82915239|FG001|Overall Study|Physician Decision|1|||
46700364|NCT01124097|82915240|FG002|Overall Study|Physician Decision|0|||
46700365|NCT01124097|82915241|FG003|Overall Study|Physician Decision|0|||
46700366|NCT01123941|82915253|FG000|Overall Study|Lost to Follow-up|2|||
46700367|NCT01123941|82915254|FG001|Overall Study|Lost to Follow-up|1|||
46700368|NCT01123395|82915260|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
46700369|NCT01123395|82915261|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
46700370|NCT01255787|82915271|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
46700371|NCT01255787|82915272|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
46700372|NCT01255787|82915273|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
46700373|NCT01255787|82915274|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
46700374|NCT01255787|82915271|FG000|Overall Study|Major Protocol Deviation|1|||
46700375|NCT01255787|82915272|FG001|Overall Study|Major Protocol Deviation|1|||
46700376|NCT01255787|82915273|FG002|Overall Study|Major Protocol Deviation|0|||
46700377|NCT01255787|82915274|FG003|Overall Study|Major Protocol Deviation|4|||
46700378|NCT01255787|82915271|FG000|Overall Study|Lost to Follow-up|1|||
46700379|NCT01255787|82915272|FG001|Overall Study|Lost to Follow-up|2|||
46700380|NCT01255787|82915273|FG002|Overall Study|Lost to Follow-up|4|||
46700381|NCT01255787|82915274|FG003|Overall Study|Lost to Follow-up|2|||
46700382|NCT01255787|82915271|FG000|Overall Study|Withdrawal of Consent|3|||
46700383|NCT01255787|82915272|FG001|Overall Study|Withdrawal of Consent|9|||
46869276|NCT03573908|83087599|FG000|Treatment Period|Protocol Violation|1|||
46869277|NCT03573908|83087600|FG001|Treatment Period|Protocol Violation|0|||
46869278|NCT03573908|83087601|FG002|Treatment Period|Protocol Violation|0|||
46869279|NCT03573908|83087602|FG003|Treatment Period|Protocol Violation|0|||
46869280|NCT03573908|83087603|FG004|Treatment Period|Protocol Violation|0|||
46869281|NCT03573908|83087599|FG000|Treatment Period|Withdrawal by Subject|7|||
46869282|NCT03573908|83087600|FG001|Treatment Period|Withdrawal by Subject|5|||
46869283|NCT03573908|83087601|FG002|Treatment Period|Withdrawal by Subject|0|||
46869284|NCT03573908|83087602|FG003|Treatment Period|Withdrawal by Subject|0|||
46869285|NCT03573908|83087603|FG004|Treatment Period|Withdrawal by Subject|0|||
46869286|NCT03573908|83087599|FG000|Treatment Period|Lost to Follow-up|7|||
46869287|NCT03573908|83087600|FG001|Treatment Period|Lost to Follow-up|6|||
46869288|NCT03573908|83087601|FG002|Treatment Period|Lost to Follow-up|0|||
46869289|NCT03573908|83087602|FG003|Treatment Period|Lost to Follow-up|0|||
46869290|NCT03573908|83087603|FG004|Treatment Period|Lost to Follow-up|0|||
46869291|NCT03573908|83087599|FG000|Treatment Period|Pregnancy|1|||
46869292|NCT03573908|83087600|FG001|Treatment Period|Pregnancy|0|||
46869293|NCT03573908|83087601|FG002|Treatment Period|Pregnancy|0|||
46869294|NCT03573908|83087602|FG003|Treatment Period|Pregnancy|0|||
46869295|NCT03573908|83087603|FG004|Treatment Period|Pregnancy|0|||
46869296|NCT03573908|83087599|FG000|Treatment Period|Other, Not Specified|4|||
46869297|NCT03573908|83087600|FG001|Treatment Period|Other, Not Specified|6|||
46869298|NCT03573908|83087601|FG002|Treatment Period|Other, Not Specified|0|||
46869299|NCT03573908|83087602|FG003|Treatment Period|Other, Not Specified|0|||
46869300|NCT03573908|83087603|FG004|Treatment Period|Other, Not Specified|0|||
46869301|NCT03573908|83087599|FG000|Randomized Withdrawal Period|Adverse Event|0|||
46869302|NCT03573908|83087600|FG001|Randomized Withdrawal Period|Adverse Event|0|||
46869303|NCT03573908|83087601|FG002|Randomized Withdrawal Period|Adverse Event|3|||
46869304|NCT03573908|83087602|FG003|Randomized Withdrawal Period|Adverse Event|0|||
46869305|NCT03573908|83087603|FG004|Randomized Withdrawal Period|Adverse Event|0|||
46869306|NCT03573908|83087599|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46869307|NCT03573908|83087600|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46869308|NCT03573908|83087601|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46869309|NCT03573908|83087602|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
46869310|NCT03573908|83087603|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
46869311|NCT03573908|83087599|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
46869312|NCT03573908|83087600|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
46869313|NCT03573908|83087601|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
46869314|NCT03573908|83087602|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
46869315|NCT03573908|83087603|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
46869316|NCT03573908|83087599|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
46869317|NCT03573908|83087600|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
46869318|NCT03573908|83087601|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
46869319|NCT03573908|83087602|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
46869320|NCT03573908|83087603|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
46869321|NCT03573830|83087614|FG000|Overall Study|Dropped without completing treatment|0|||
46869322|NCT03573830|83087615|FG001|Overall Study|Dropped without completing treatment|7|||
46869323|NCT03573830|83087614|FG000|Overall Study|Lost to Follow-up|4|||
46869324|NCT03573830|83087615|FG001|Overall Study|Lost to Follow-up|0|||
46869325|NCT03595904|83087622|FG000|Overall Study|Protocol Violation|3|||
46869326|NCT03595904|83087623|FG001|Overall Study|Protocol Violation|1|||
46869327|NCT03595904|83087622|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
46700384|NCT01255787|82915273|FG002|Overall Study|Withdrawal of Consent|3|||
46700385|NCT01255787|82915274|FG003|Overall Study|Withdrawal of Consent|4|||
46700386|NCT01255787|82915271|FG000|Overall Study|Pregnancy|0|||
46700387|NCT01255787|82915272|FG001|Overall Study|Pregnancy|0|||
46700388|NCT01255787|82915273|FG002|Overall Study|Pregnancy|0|||
46700389|NCT01255787|82915274|FG003|Overall Study|Pregnancy|1|||
46700390|NCT01255787|82915271|FG000|Overall Study|Lack of Efficacy|2|||
46869328|NCT03595904|83087623|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
46869329|NCT03595904|83087622|FG000|Overall Study|Insurance complications|1|||
46869330|NCT03595904|83087623|FG001|Overall Study|Insurance complications|0|||
46869331|NCT03595904|83087622|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
46869332|NCT03595904|83087623|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
46869333|NCT03595280|83087632|FG000|Overall Study|Lost to Follow-up|6|||
46869334|NCT03595280|83087633|FG001|Overall Study|Lost to Follow-up|9|||
46869335|NCT03595280|83087634|FG002|Overall Study|Lost to Follow-up|15|||
46700391|NCT01255787|82915272|FG001|Overall Study|Lack of Efficacy|2|||
46700392|NCT01255787|82915273|FG002|Overall Study|Lack of Efficacy|2|||
46700393|NCT01255787|82915274|FG003|Overall Study|Lack of Efficacy|2|||
46700394|NCT01255787|82915271|FG000|Overall Study|Noncompliance with Study Drug|3|||
46700395|NCT01255787|82915272|FG001|Overall Study|Noncompliance with Study Drug|1|||
46700396|NCT01255787|82915273|FG002|Overall Study|Noncompliance with Study Drug|0|||
46700397|NCT01255787|82915274|FG003|Overall Study|Noncompliance with Study Drug|0|||
46869336|NCT03593876|83087642|FG000|Overall Study|Withdrawal by Subject|1|||
46869337|NCT03593876|83087642|FG000|Overall Study|Discharged home before intervention completion|2|||
46869338|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Adverse Event|5|||
46869339|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Adverse Event|8|||
46869340|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Adverse Event|4|||
46869341|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Adverse Event|8|||
46869342|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
46869343|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
46869344|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
46869345|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
46869346|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
46869347|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
46869348|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
46869349|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
46869350|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Physician Decision|1|||
46869351|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Physician Decision|0|||
46869352|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Physician Decision|0|||
46869353|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Physician Decision|0|||
46869354|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
46869355|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
46869356|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
46869357|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
46869358|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Pregnancy|0|||
46869359|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Pregnancy|1|||
46869360|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Pregnancy|0|||
46869361|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Pregnancy|0|||
46869362|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
46869363|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
46869364|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
46869365|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
46869366|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Death|0|||
46700398|NCT01123161|82915286|FG000|Overall Study|Lost to Follow-up|1|||
46700399|NCT01123161|82915287|FG001|Overall Study|Lost to Follow-up|0|||
46700400|NCT01123161|82915286|FG000|Overall Study|Withdrawal by Subject|1|||
46700401|NCT01123161|82915287|FG001|Overall Study|Withdrawal by Subject|0|||
46700402|NCT01255631|82915298|FG000|Overall Study|poor enrollment, no data analyzed|9|||
46700403|NCT01255631|82915299|FG001|Overall Study|poor enrollment, no data analyzed|6|||
46700404|NCT00999466|82915308|FG000|Main Part|Withdrawal by Subject|0|||
46700405|NCT00999466|82915309|FG001|Main Part|Withdrawal by Subject|0|||
46700406|NCT00999466|82915310|FG002|Main Part|Withdrawal by Subject|2|||
46700407|NCT00999466|82915308|FG000|Main Part|Adverse Event|0|||
46700408|NCT00999466|82915309|FG001|Main Part|Adverse Event|4|||
46700409|NCT00999466|82915310|FG002|Main Part|Adverse Event|2|||
46700410|NCT01255163|82915320|FG000|Overall Study|Withdrawal by Subject|1|||
46700411|NCT01255163|82915321|FG001|Overall Study|Withdrawal by Subject|0|||
46700412|NCT01255163|82915320|FG000|Overall Study|Lost to Follow-up|2|||
46700413|NCT01255163|82915321|FG001|Overall Study|Lost to Follow-up|0|||
46700414|NCT01255163|82915320|FG000|Overall Study|Adverse Event|0|||
46700415|NCT01255163|82915321|FG001|Overall Study|Adverse Event|2|||
46700416|NCT01255163|82915320|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
46700417|NCT01255163|82915321|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
46700418|NCT01123083|82915331|FG000|Overall Study|Investigator recommendation|1|||
46700419|NCT01123083|82915332|FG001|Overall Study|Investigator recommendation|1|||
46700420|NCT01123083|82915331|FG000|Overall Study|Administrative reasons|0|||
46700421|NCT01123083|82915332|FG001|Overall Study|Administrative reasons|4|||
46700422|NCT01123083|82915331|FG000|Overall Study|Lost to Follow-up|2|||
46700423|NCT01123083|82915332|FG001|Overall Study|Lost to Follow-up|6|||
46700424|NCT01123083|82915331|FG000|Overall Study|Adverse Event|1|||
46700425|NCT01123083|82915332|FG001|Overall Study|Adverse Event|0|||
46869367|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Death|1|||
46869368|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Death|0|||
46869369|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Death|0|||
46869370|NCT00071487|83087650|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
46869371|NCT00071487|83087651|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
46869372|NCT00071487|83087652|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
46869373|NCT00071487|83087653|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
46869374|NCT00071487|83087650|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
46869375|NCT00071487|83087651|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
46700426|NCT01123083|82915331|FG000|Overall Study|Withdrew for another reason not covered|0|||
46700427|NCT01123083|82915332|FG001|Overall Study|Withdrew for another reason not covered|1|||
46700428|NCT01123083|82915331|FG000|Overall Study|Participant/legal representative request|7|||
46700429|NCT01123083|82915332|FG001|Overall Study|Participant/legal representative request|3|||
46700430|NCT01254305|82915341|FG000|Overall Study|Adverse Event|6|||
46869376|NCT00071487|83087652|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
46869377|NCT00071487|83087653|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
46869378|NCT00071487|83087650|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
46869379|NCT00071487|83087651|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
46869380|NCT00071487|83087652|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
46869381|NCT00071487|83087653|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
46869382|NCT00071487|83087650|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
46869383|NCT00071487|83087651|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
46869384|NCT00071487|83087652|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
46869385|NCT00071487|83087653|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
46869386|NCT00071487|83087650|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
46869387|NCT00071487|83087651|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
46869388|NCT00071487|83087652|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
46869389|NCT00071487|83087653|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
46869390|NCT00071487|83087650|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
46869391|NCT00071487|83087651|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
46869392|NCT00071487|83087652|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
46869393|NCT00071487|83087653|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
46869394|NCT00071487|83087650|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
46869395|NCT00071487|83087651|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
46869396|NCT00071487|83087652|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
46869397|NCT00071487|83087653|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
46869398|NCT03591146|83087670|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
46869399|NCT03591146|83087671|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
46869400|NCT03591146|83087672|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
46869401|NCT03591146|83087673|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
46869402|NCT03591146|83087674|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
46869403|NCT03591146|83087670|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
46869404|NCT03591146|83087671|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
46869405|NCT03591146|83087672|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
46869406|NCT03591146|83087673|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
46869407|NCT03591146|83087674|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
46869408|NCT03591146|83087670|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
46869409|NCT03591146|83087671|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
46869410|NCT03591146|83087672|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
46869411|NCT03591146|83087673|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
46869412|NCT03591146|83087674|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
46869413|NCT03591146|83087670|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
46869414|NCT03591146|83087671|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
46700431|NCT01254305|82915342|FG001|Overall Study|Adverse Event|3|||
46700432|NCT01254305|82915343|FG002|Overall Study|Adverse Event|2|||
46700433|NCT01254305|82915341|FG000|Overall Study|Lack of Efficacy|1|||
46700434|NCT01254305|82915342|FG001|Overall Study|Lack of Efficacy|0|||
46700435|NCT01254305|82915343|FG002|Overall Study|Lack of Efficacy|1|||
46700436|NCT01254305|82915341|FG000|Overall Study|Protocol Violation|1|||
46700437|NCT01254305|82915342|FG001|Overall Study|Protocol Violation|7|||
46700438|NCT01254305|82915343|FG002|Overall Study|Protocol Violation|3|||
46700439|NCT01254305|82915341|FG000|Overall Study|Withdrawal by Subject|4|||
46700440|NCT01254305|82915342|FG001|Overall Study|Withdrawal by Subject|2|||
46869415|NCT03591146|83087672|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
46869416|NCT03591146|83087673|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
46869417|NCT03591146|83087674|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
46869418|NCT00096447|83087686|FG000|Overall Study|Never treated|1|||
46869419|NCT03590366|83087697|FG000|Overall Study|Adverse Event|0|||
46869420|NCT03590366|83087698|FG001|Overall Study|Adverse Event|3|||
46869421|NCT03590366|83087697|FG000|Overall Study|Lost to Follow-up|3|||
46869422|NCT03590366|83087698|FG001|Overall Study|Lost to Follow-up|3|||
46869423|NCT03590366|83087697|FG000|Overall Study|Withdrawal by Subject|0|||
46869424|NCT03590366|83087698|FG001|Overall Study|Withdrawal by Subject|2|||
46869425|NCT03588572|83087706|FG000|Visitation 1|Lack of Efficacy|1|||
46869426|NCT03588572|83087707|FG001|Visitation 1|Lack of Efficacy|1|||
46869427|NCT03588572|83087706|FG000|Visitation 2|Lost to Follow-up|1|||
46700441|NCT01254305|82915343|FG002|Overall Study|Withdrawal by Subject|4|||
46700442|NCT01254305|82915341|FG000|Overall Study|Lost to Follow-up|10|||
46700443|NCT01254305|82915342|FG001|Overall Study|Lost to Follow-up|6|||
46869428|NCT03588572|83087707|FG001|Visitation 2|Lost to Follow-up|1|||
46700444|NCT01254305|82915343|FG002|Overall Study|Lost to Follow-up|5|||
46700445|NCT01254305|82915341|FG000|Overall Study|Other Reasons|0|||
46700446|NCT01254305|82915342|FG001|Overall Study|Other Reasons|0|||
46700447|NCT01254305|82915343|FG002|Overall Study|Other Reasons|2|||
46700448|NCT01122927|82915354|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
46700449|NCT01122927|82915355|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
46700450|NCT01122927|82915354|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
46700451|NCT01122927|82915355|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
46700452|NCT01122927|82915354|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
46700453|NCT01122927|82915355|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
46700454|NCT01122927|82915354|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
46700455|NCT01122927|82915355|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
46700456|NCT01122927|82915354|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
46700457|NCT01122927|82915355|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
46700458|NCT01122927|82915354|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
46700459|NCT01122927|82915355|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
46700460|NCT01122927|82915354|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
46700461|NCT01122927|82915355|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
46700462|NCT01122927|82915354|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
46700463|NCT01122927|82915355|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
46869429|NCT03588572|83087706|FG000|Visitation 2|Lack of Efficacy|0|||
46869430|NCT03588572|83087707|FG001|Visitation 2|Lack of Efficacy|1|||
46869431|NCT03588572|83087706|FG000|Visitation 2|Withdrawal by Subject|1|||
46869432|NCT03588572|83087707|FG001|Visitation 2|Withdrawal by Subject|0|||
46869433|NCT03588572|83087706|FG000|Visitation 3|Lost to Follow-up|1|||
46869434|NCT03588572|83087707|FG001|Visitation 3|Lost to Follow-up|1|||
46869435|NCT03588572|83087706|FG000|Visitation 3|Physician Decision|1|||
46869436|NCT03588572|83087707|FG001|Visitation 3|Physician Decision|1|||
46869437|NCT03588572|83087706|FG000|Visitation 3|Withdrawal by Subject|1|||
46869438|NCT03588572|83087707|FG001|Visitation 3|Withdrawal by Subject|0|||
46869439|NCT00090285|83087715|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
46869440|NCT00090285|83087716|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
46869441|NCT00090285|83087717|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
46869442|NCT00090285|83087718|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
46869443|NCT00090285|83087719|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
46869444|NCT00090285|83087720|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
46869445|NCT00090285|83087715|FG000|Base Study Vaccination Period|Adverse Event|2|||
46869446|NCT00090285|83087716|FG001|Base Study Vaccination Period|Adverse Event|4|||
46983770|NCT02330055|83230035|FG000|Overall Study|participant did not sleep|0|||
46983771|NCT02330055|83230036|FG001|Overall Study|participant did not sleep|1|||
46983772|NCT02306265|83230042|FG000|Overall Study|Withdrawal by Subject|1|||
46983773|NCT02329743|83230050|FG000|Overall Study|Adverse Event|1|||
46983774|NCT02329743|83230051|FG001|Overall Study|Adverse Event|1|||
46983775|NCT02329743|83230052|FG002|Overall Study|Adverse Event|3|||
46983776|NCT02329743|83230050|FG000|Overall Study|Lost to Follow-up|1|||
46983777|NCT02329743|83230051|FG001|Overall Study|Lost to Follow-up|0|||
46983778|NCT02329743|83230052|FG002|Overall Study|Lost to Follow-up|1|||
46983779|NCT02329743|83230050|FG000|Overall Study|Withdrawal by Subject|4|||
46983780|NCT02329743|83230051|FG001|Overall Study|Withdrawal by Subject|4|||
46983781|NCT02329743|83230052|FG002|Overall Study|Withdrawal by Subject|1|||
46983782|NCT02329743|83230050|FG000|Overall Study|Other|0|||
46983783|NCT02329743|83230051|FG001|Overall Study|Other|2|||
46983784|NCT02329743|83230052|FG002|Overall Study|Other|3|||
46983785|NCT02329431|83230062|FG000|Overall Study|Lost to Follow-up|20|||
46983786|NCT02329431|83230063|FG001|Overall Study|Lost to Follow-up|13|||
46983787|NCT02328105|83230069|FG000|Overall Study|Death|6|||
46983788|NCT02328105|83230069|FG000|Overall Study|Withdrawal by Subject|1|||
46983789|NCT02328105|83230069|FG000|Overall Study|Still On Study in Follow-Up|4|||
46983790|NCT02305797|83230075|FG000|Overall Study|Adverse Event|11|||
46983791|NCT02305797|83230076|FG001|Overall Study|Adverse Event|2|||
46983792|NCT02305797|83230075|FG000|Overall Study|Withdrawal by Subject|9|||
46983793|NCT02305797|83230076|FG001|Overall Study|Withdrawal by Subject|10|||
46983794|NCT02305797|83230075|FG000|Overall Study|Lack of Efficacy|6|||
46983795|NCT02305797|83230076|FG001|Overall Study|Lack of Efficacy|0|||
46700464|NCT01122927|82915354|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
46700465|NCT01122927|82915355|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
46700466|NCT01122927|82915354|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
46700467|NCT01122927|82915355|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
46700468|NCT01122927|82915354|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
46700469|NCT01122927|82915355|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
46700470|NCT01122927|82915354|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
46700471|NCT01122927|82915355|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
46700472|NCT01254227|82915365|FG000|Overall Study|Withdrawal by Subject|6|||
46700473|NCT01254227|82915365|FG000|Overall Study|Lost to Follow-up|6|||
46700474|NCT01254227|82915365|FG000|Overall Study|Adverse Event|5|||
46700475|NCT01254227|82915365|FG000|Overall Study|Abnormal test procedure result|5|||
46700476|NCT01254227|82915365|FG000|Overall Study|Administrative problems|2|||
46700477|NCT01254227|82915365|FG000|Overall Study|Death|1|||
46700478|NCT01254227|82915365|FG000|Overall Study|Protocol deviation|1|||
46700479|NCT00995410|82915369|FG000|Overall Study|Adverse Event|51|||
46700480|NCT00995410|82915369|FG000|Overall Study|Withdrawal by Subject|7|||
46700481|NCT00995410|82915369|FG000|Overall Study|Lost to Follow-up|2|||
46700482|NCT00995410|82915369|FG000|Overall Study|Misc|28|||
46700483|NCT00995020|82915375|FG000|Overall Study|margin analysis not performed|2|||
46700484|NCT00995020|82915376|FG001|Overall Study|margin analysis not performed|5|||
46700485|NCT00995020|82915375|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
46700486|NCT00995020|82915376|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
46700487|NCT01122381|82915386|FG000|Overall Study|study terminated early|0|||
46700488|NCT01122381|82915387|FG001|Overall Study|study terminated early|1|||
46700489|NCT00996034|82915393|FG000|Overall Study|Lost to Follow-up|2|||
46700490|NCT00996034|82915393|FG000|Overall Study|withdrawn by PI|1|||
46700491|NCT01253447|82915397|FG000|Overall Study|Adverse Event|2|||
46700492|NCT01121991|82915402|FG000|Overall Study|Lack of Ovarian Response|2|||
46700493|NCT01121991|82915402|FG000|Overall Study|No Oocytes Retrieved|3|||
46700494|NCT01121991|82915402|FG000|Overall Study|No Fertilization|1|||
46700495|NCT00994240|82915408|FG000|Overall Study|Lost to Follow-up|3|||
46700496|NCT00994240|82915409|FG001|Overall Study|Lost to Follow-up|2|||
46700497|NCT00994240|82915408|FG000|Overall Study|Withdrawal by Subject|1|||
46700498|NCT00994240|82915409|FG001|Overall Study|Withdrawal by Subject|0|||
46700499|NCT00994240|82915408|FG000|Overall Study|study termination|2|||
46700500|NCT00994240|82915409|FG001|Overall Study|study termination|3|||
46700501|NCT01253369|82915415|FG000|Overall Study|Adverse Event|4|||
46700502|NCT01253369|82915415|FG000|Overall Study|Withdrawal by Subject|2|||
46700503|NCT01253369|82915415|FG000|Overall Study|Death|1|||
46700504|NCT01253369|82915415|FG000|Overall Study|Progressive disease|23|||
46700505|NCT01253369|82915415|FG000|Overall Study|Not Evaluable|3|||
46700506|NCT01121913|82915419|FG000|First Intervention Period|Adverse Event|0|||
46700507|NCT01121913|82915420|FG001|First Intervention Period|Adverse Event|0|||
46700508|NCT01121913|82915421|FG002|First Intervention Period|Adverse Event|1|||
46700509|NCT01121913|82915422|FG003|First Intervention Period|Adverse Event|0|||
46700510|NCT01121913|82915419|FG000|First Washout Period|Withdrawal by Subject|1|||
46700511|NCT01121913|82915420|FG001|First Washout Period|Withdrawal by Subject|0|||
46700512|NCT01121913|82915421|FG002|First Washout Period|Withdrawal by Subject|0|||
46700513|NCT01121913|82915422|FG003|First Washout Period|Withdrawal by Subject|0|||
46700514|NCT01121913|82915419|FG000|Second Intervention Period|Adverse Event|0|||
46700515|NCT01121913|82915420|FG001|Second Intervention Period|Adverse Event|0|||
46700516|NCT01121913|82915421|FG002|Second Intervention Period|Adverse Event|1|||
46700517|NCT01121913|82915422|FG003|Second Intervention Period|Adverse Event|0|||
46700518|NCT01121913|82915419|FG000|Second Washout Period|Withdrawal by Subject|0|||
46700519|NCT01121913|82915420|FG001|Second Washout Period|Withdrawal by Subject|0|||
46700520|NCT01121913|82915421|FG002|Second Washout Period|Withdrawal by Subject|1|||
46700521|NCT01121913|82915422|FG003|Second Washout Period|Withdrawal by Subject|0|||
46700522|NCT01121913|82915419|FG000|Third Washout Period|Adverse Event|1|||
46700523|NCT01121913|82915420|FG001|Third Washout Period|Adverse Event|0|||
46869447|NCT00090285|83087717|FG002|Base Study Vaccination Period|Adverse Event|0|||
46869448|NCT00090285|83087718|FG003|Base Study Vaccination Period|Adverse Event|0|||
46869449|NCT00090285|83087719|FG004|Base Study Vaccination Period|Adverse Event|0|||
46869450|NCT00090285|83087720|FG005|Base Study Vaccination Period|Adverse Event|0|||
46869451|NCT00090285|83087715|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
46700524|NCT01121913|82915421|FG002|Third Washout Period|Adverse Event|0|||
46700525|NCT01121913|82915422|FG003|Third Washout Period|Adverse Event|0|||
46700526|NCT00994162|82915434|FG000|Overall Study|Withdrawal by Subject|1|||
46700527|NCT00994162|82915434|FG000|Overall Study|Lost to Follow-up|2|||
46700528|NCT00994162|82915434|FG000|Overall Study|Product Complaint|1|||
46700529|NCT00994162|82915434|FG000|Overall Study|Poor Compliance|5|||
46700530|NCT00994162|82915434|FG000|Overall Study|Lack of Response|3|||
46869452|NCT00090285|83087716|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
46869453|NCT00090285|83087717|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
46700531|NCT00994162|82915434|FG000|Overall Study|Discharged from Hospital|4|||
46700532|NCT00994162|82915434|FG000|Overall Study|Death|2|||
46700533|NCT00994162|82915434|FG000|Overall Study|Care Transferred to Another Physician|2|||
46700534|NCT00994162|82915434|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
46700535|NCT00994162|82915434|FG000|Overall Study|Physician Decision|2|||
46802587|NCT00098293|83021884|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
46869454|NCT00090285|83087718|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
46869455|NCT00090285|83087719|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
46869456|NCT00090285|83087720|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
46869457|NCT00090285|83087715|FG000|Base Study Vaccination Period|Protocol Violation|2|||
46869458|NCT00090285|83087716|FG001|Base Study Vaccination Period|Protocol Violation|3|||
46869459|NCT00090285|83087717|FG002|Base Study Vaccination Period|Protocol Violation|0|||
46869460|NCT00090285|83087718|FG003|Base Study Vaccination Period|Protocol Violation|0|||
46869461|NCT00090285|83087719|FG004|Base Study Vaccination Period|Protocol Violation|0|||
46869462|NCT00090285|83087720|FG005|Base Study Vaccination Period|Protocol Violation|0|||
46869463|NCT00090285|83087715|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
46869464|NCT00090285|83087716|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
46869465|NCT00090285|83087717|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
46869466|NCT00090285|83087718|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
46869467|NCT00090285|83087719|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
46869468|NCT00090285|83087720|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
46869469|NCT00090285|83087715|FG000|Base Study Vaccination Period|Uncooperative|2|||
46869470|NCT00090285|83087716|FG001|Base Study Vaccination Period|Uncooperative|2|||
46869471|NCT00090285|83087717|FG002|Base Study Vaccination Period|Uncooperative|0|||
46869472|NCT00090285|83087718|FG003|Base Study Vaccination Period|Uncooperative|0|||
46869473|NCT00090285|83087719|FG004|Base Study Vaccination Period|Uncooperative|0|||
46869474|NCT00090285|83087720|FG005|Base Study Vaccination Period|Uncooperative|0|||
46869475|NCT00090285|83087715|FG000|Base Study Vaccination Period|Moved|20|||
46869476|NCT00090285|83087716|FG001|Base Study Vaccination Period|Moved|21|||
46869477|NCT00090285|83087717|FG002|Base Study Vaccination Period|Moved|0|||
46869478|NCT00090285|83087718|FG003|Base Study Vaccination Period|Moved|0|||
46869479|NCT00090285|83087719|FG004|Base Study Vaccination Period|Moved|0|||
46869480|NCT00090285|83087720|FG005|Base Study Vaccination Period|Moved|0|||
46869481|NCT00090285|83087715|FG000|Base Study Vaccination Period|Site Terminated|1|||
46869482|NCT00090285|83087716|FG001|Base Study Vaccination Period|Site Terminated|0|||
46869483|NCT00090285|83087717|FG002|Base Study Vaccination Period|Site Terminated|0|||
46869484|NCT00090285|83087718|FG003|Base Study Vaccination Period|Site Terminated|0|||
46869485|NCT00090285|83087719|FG004|Base Study Vaccination Period|Site Terminated|0|||
46869486|NCT00090285|83087720|FG005|Base Study Vaccination Period|Site Terminated|0|||
46869487|NCT00090285|83087715|FG000|Base Study Vaccination Period|Other|2|||
46869488|NCT00090285|83087716|FG001|Base Study Vaccination Period|Other|2|||
46869489|NCT00090285|83087717|FG002|Base Study Vaccination Period|Other|0|||
46869490|NCT00090285|83087718|FG003|Base Study Vaccination Period|Other|0|||
46869491|NCT00090285|83087719|FG004|Base Study Vaccination Period|Other|0|||
46869492|NCT00090285|83087720|FG005|Base Study Vaccination Period|Other|0|||
46869493|NCT00090285|83087715|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
46869494|NCT00090285|83087716|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
46983796|NCT02305797|83230075|FG000|Overall Study|Lost to Follow-up|5|||
46802588|NCT00098293|83021885|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
46802589|NCT00098293|83021886|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
46802590|NCT00098293|83021887|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
46802591|NCT00098293|83021883|FG000|Supplemental Phase (SP)|Other|0|||
46802592|NCT00098293|83021884|FG001|Supplemental Phase (SP)|Other|0|||
46802593|NCT00098293|83021885|FG002|Supplemental Phase (SP)|Other|0|||
46802594|NCT00098293|83021886|FG003|Supplemental Phase (SP)|Other|0|||
46802595|NCT00098293|83021887|FG004|Supplemental Phase (SP)|Other|22|||
46802596|NCT00685685|83021898|FG000|Washout Period of 7 Days|Adverse Event|2|||
46802597|NCT00685685|83021899|FG001|Washout Period of 7 Days|Adverse Event|0|||
46802598|NCT00685685|83021898|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
46802599|NCT00685685|83021899|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
46802600|NCT00684671|83021908|FG000|Overall Study|Adverse Event|1|||
46802601|NCT00684671|83021909|FG001|Overall Study|Adverse Event|0|||
46802602|NCT00684671|83021910|FG002|Overall Study|Adverse Event|0|||
46802603|NCT00684671|83021908|FG000|Overall Study|Lost to Follow-up|1|||
46802604|NCT00684671|83021909|FG001|Overall Study|Lost to Follow-up|0|||
46869495|NCT00090285|83087717|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
46869496|NCT00090285|83087718|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
46869497|NCT00090285|83087719|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
46869498|NCT00090285|83087720|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
46869499|NCT00090285|83087715|FG000|Base Study Vaccination Period|HIV positive|1|||
46802605|NCT00684671|83021910|FG002|Overall Study|Lost to Follow-up|0|||
46700536|NCT00994162|82915434|FG000|Overall Study|Surrounding Wound Erythematous|1|||
46700537|NCT00994162|82915434|FG000|Overall Study|Machine Losing Vaccum|1|||
46700538|NCT00994162|82915434|FG000|Overall Study|Patient Lived Too Far Away|1|||
46700539|NCT00994162|82915434|FG000|Overall Study|Above Knee Amputation|1|||
46700540|NCT00994162|82915434|FG000|Overall Study|Reason Not Reported By Site|1|||
46700541|NCT00993928|82915441|FG000|Overall Study|Withdrawal by Subject|4|||
46700542|NCT00993928|82915442|FG001|Overall Study|Withdrawal by Subject|7|||
46700543|NCT00993928|82915441|FG000|Overall Study|ineligible|1|||
46700544|NCT00993928|82915442|FG001|Overall Study|ineligible|0|||
46700545|NCT01253291|82915457|FG000|Overall Study|Withdrawal by Subject|1|||
46700546|NCT01253291|82915458|FG001|Overall Study|Withdrawal by Subject|1|||
46700547|NCT01253291|82915459|FG002|Overall Study|Withdrawal by Subject|0|||
46700548|NCT01253291|82915460|FG003|Overall Study|Withdrawal by Subject|0|||
46700549|NCT01253291|82915461|FG004|Overall Study|Withdrawal by Subject|0|||
46700550|NCT01253291|82915457|FG000|Overall Study|Adverse Event|0|||
46700551|NCT01253291|82915458|FG001|Overall Study|Adverse Event|1|||
46700552|NCT01253291|82915459|FG002|Overall Study|Adverse Event|0|||
46700553|NCT01253291|82915460|FG003|Overall Study|Adverse Event|0|||
46700554|NCT01253291|82915461|FG004|Overall Study|Adverse Event|0|||
46700555|NCT01253291|82915457|FG000|Overall Study|Lack of Efficacy|1|||
46700556|NCT01253291|82915458|FG001|Overall Study|Lack of Efficacy|0|||
46700557|NCT01253291|82915459|FG002|Overall Study|Lack of Efficacy|0|||
46700558|NCT01253291|82915460|FG003|Overall Study|Lack of Efficacy|0|||
46700559|NCT01253291|82915461|FG004|Overall Study|Lack of Efficacy|0|||
46700560|NCT01253291|82915457|FG000|Overall Study|Physician Decision|2|||
46700561|NCT01253291|82915458|FG001|Overall Study|Physician Decision|0|||
46700562|NCT01253291|82915459|FG002|Overall Study|Physician Decision|0|||
46700563|NCT01253291|82915460|FG003|Overall Study|Physician Decision|0|||
46700564|NCT01253291|82915461|FG004|Overall Study|Physician Decision|2|||
46700565|NCT01121757|82915476|FG000|First Drug|Death|1|||
46700566|NCT01121757|82915477|FG001|First Drug|Death|0|||
46700567|NCT01121757|82915476|FG000|First Drug|Disease Progression|0|||
46700568|NCT01121757|82915477|FG001|First Drug|Disease Progression|2|||
46700569|NCT01121757|82915476|FG000|Combination|Physician Decision|0|||
46700570|NCT01121757|82915477|FG001|Combination|Physician Decision|1|||
46700571|NCT01121757|82915476|FG000|Combination|Disease Progression|2|||
46700572|NCT01121757|82915477|FG001|Combination|Disease Progression|0|||
46700573|NCT01253135|82915485|FG000|Original Protocol|Protocol Amendment|15|||
46700574|NCT01253135|82915485|FG000|Amended Protocol|Non-compliance|1|||
46700575|NCT00993616|82915493|FG000|Overall Study|No tumor at entry|1|||
46700576|NCT00993616|82915493|FG000|Overall Study|Never treated|1|||
46700577|NCT01120899|82915503|FG000|Overall Study|Withdrawal by Subject|3|||
46700578|NCT01120275|82915507|FG000|Overall Study|Adverse Event|3|||
46700579|NCT01120275|82915507|FG000|Overall Study|Progression|27|||
46700580|NCT01120275|82915507|FG000|Overall Study|Ineligible|3|||
46700581|NCT01120275|82915507|FG000|Overall Study|Withdrawal by Subject|1|||
46700582|NCT01120275|82915507|FG000|Overall Study|Refusal|1|||
46700583|NCT01120275|82915507|FG000|Overall Study|Not specific|1|||
46700584|NCT00991510|82915514|FG000|Period I (Days 1-14)|Adverse Event|1|||
46700585|NCT00991510|82915515|FG001|Period I (Days 1-14)|Adverse Event|0|||
46869500|NCT00090285|83087716|FG001|Base Study Vaccination Period|HIV positive|1|||
46869501|NCT00090285|83087717|FG002|Base Study Vaccination Period|HIV positive|0|||
46869502|NCT00090285|83087718|FG003|Base Study Vaccination Period|HIV positive|0|||
46869503|NCT00090285|83087719|FG004|Base Study Vaccination Period|HIV positive|0|||
46869504|NCT00090285|83087720|FG005|Base Study Vaccination Period|HIV positive|0|||
46869505|NCT00090285|83087715|FG000|Base Study Follow-up Period|Adverse Event|3|||
46700586|NCT00991510|82915514|FG000|Period III (Days 29-112)|Adverse Event|1|||
46700587|NCT00991510|82915515|FG001|Period III (Days 29-112)|Adverse Event|1|||
46700588|NCT01119963|82915527|FG000|Overall Study|Lost to Follow-up|1|||
46700589|NCT01119963|82915528|FG001|Overall Study|Lost to Follow-up|1|||
46869506|NCT00090285|83087716|FG001|Base Study Follow-up Period|Adverse Event|10|||
46869507|NCT00090285|83087717|FG002|Base Study Follow-up Period|Adverse Event|0|||
46700590|NCT01252667|82915542|FG000|Overall Study|Transplant aborted post-conditioning|0|||
46700591|NCT01252667|82915543|FG001|Overall Study|Transplant aborted post-conditioning|0|||
46869508|NCT00090285|83087718|FG003|Base Study Follow-up Period|Adverse Event|0|||
46700592|NCT01252667|82915544|FG002|Overall Study|Transplant aborted post-conditioning|0|||
46700593|NCT01252667|82915545|FG003|Overall Study|Transplant aborted post-conditioning|0|||
46700594|NCT01252667|82915546|FG004|Overall Study|Transplant aborted post-conditioning|0|||
46700595|NCT01252667|82915547|FG005|Overall Study|Transplant aborted post-conditioning|1|||
46700596|NCT01119105|82915564|FG000|Overall Study|Withdrawal by Subject|1|||
46700597|NCT01119105|82915565|FG001|Overall Study|Withdrawal by Subject|1|||
46700598|NCT01119105|82915566|FG002|Overall Study|Withdrawal by Subject|1|||
46700599|NCT01119105|82915564|FG000|Overall Study|Lost to Follow-up|0|||
46700600|NCT01119105|82915565|FG001|Overall Study|Lost to Follow-up|2|||
46700601|NCT01119105|82915566|FG002|Overall Study|Lost to Follow-up|5|||
46700602|NCT01119105|82915564|FG000|Overall Study|Adverse Event|1|||
46700603|NCT01119105|82915565|FG001|Overall Study|Adverse Event|0|||
46700604|NCT01119105|82915566|FG002|Overall Study|Adverse Event|1|||
46700605|NCT01119105|82915564|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
46700606|NCT01119105|82915565|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
46700607|NCT01119105|82915566|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
46700608|NCT01119105|82915564|FG000|Overall Study|Other|1|||
46700609|NCT01119105|82915565|FG001|Overall Study|Other|1|||
46700610|NCT01119105|82915566|FG002|Overall Study|Other|0|||
46700611|NCT01118949|82915574|FG000|Overall Study|Adverse Event|5|||
46700612|NCT01118949|82915574|FG000|Overall Study|Withdrawal by Subject|4|||
46700613|NCT01252355|82915581|FG000|Overall Study|Adverse Event|9|||
46700614|NCT01252355|82915582|FG001|Overall Study|Adverse Event|17|||
46700615|NCT01252355|82915583|FG002|Overall Study|Adverse Event|22|||
46700616|NCT01252355|82915581|FG000|Overall Study|Lack of Efficacy|6|||
46700617|NCT01252355|82915582|FG001|Overall Study|Lack of Efficacy|4|||
46700618|NCT01252355|82915583|FG002|Overall Study|Lack of Efficacy|2|||
46700619|NCT01252355|82915581|FG000|Overall Study|Lost to Follow-up|0|||
46700620|NCT01252355|82915582|FG001|Overall Study|Lost to Follow-up|0|||
46700621|NCT01252355|82915583|FG002|Overall Study|Lost to Follow-up|1|||
46700622|NCT01252355|82915581|FG000|Overall Study|Poor Compliance to Protocol|1|||
46700623|NCT01252355|82915582|FG001|Overall Study|Poor Compliance to Protocol|1|||
46700624|NCT01252355|82915583|FG002|Overall Study|Poor Compliance to Protocol|1|||
46700625|NCT01252355|82915581|FG000|Overall Study|Progressive Disease|2|||
46700626|NCT01252355|82915582|FG001|Overall Study|Progressive Disease|0|||
46700627|NCT01252355|82915583|FG002|Overall Study|Progressive Disease|0|||
46700628|NCT01252355|82915581|FG000|Overall Study|Sponsor Early Termination of Study|149|||
46700629|NCT01252355|82915582|FG001|Overall Study|Sponsor Early Termination of Study|149|||
46700630|NCT01252355|82915583|FG002|Overall Study|Sponsor Early Termination of Study|146|||
46700631|NCT01252355|82915581|FG000|Overall Study|Randomized but not Treated|2|||
46700632|NCT01252355|82915582|FG001|Overall Study|Randomized but not Treated|0|||
46700633|NCT01252355|82915583|FG002|Overall Study|Randomized but not Treated|0|||
46700634|NCT01252355|82915581|FG000|Overall Study|Other Than Above|8|||
46700635|NCT01252355|82915582|FG001|Overall Study|Other Than Above|7|||
46700636|NCT01252355|82915583|FG002|Overall Study|Other Than Above|7|||
46700637|NCT01118325|82915594|FG000|Overall Study|Adverse Event|1|||
46700638|NCT01118325|82915595|FG001|Overall Study|Adverse Event|0|||
46700639|NCT01118325|82915596|FG002|Overall Study|Adverse Event|1|||
46700640|NCT01117857|82915617|FG000|Overall Study|Lost to Follow-up|4|||
46700641|NCT01117857|82915617|FG000|Overall Study|Withdrawal by Subject|4|||
46700642|NCT01117857|82915617|FG000|Overall Study|Physician Decision|1|||
46700643|NCT01251887|82915624|FG000|Overall Study|Scheduling conflict|1|||
46700644|NCT01251887|82915625|FG001|Overall Study|Scheduling conflict|2|||
46700645|NCT01251887|82915626|FG002|Overall Study|Scheduling conflict|2|||
46700646|NCT01251887|82915624|FG000|Overall Study|Physician Decision|0|||
46700647|NCT01251887|82915625|FG001|Overall Study|Physician Decision|1|||
46700648|NCT01251887|82915626|FG002|Overall Study|Physician Decision|0|||
46700649|NCT00991276|82915640|FG000|First Intervention Period|Adverse Event|0|||
46700650|NCT00991276|82915641|FG001|First Intervention Period|Adverse Event|1|||
46700651|NCT00991276|82915642|FG002|First Intervention Period|Adverse Event|0|||
46869509|NCT00090285|83087719|FG004|Base Study Follow-up Period|Adverse Event|0|||
46869510|NCT00090285|83087720|FG005|Base Study Follow-up Period|Adverse Event|0|||
46700652|NCT00991276|82915643|FG003|First Intervention Period|Adverse Event|1|||
46700653|NCT00991276|82915644|FG004|First Intervention Period|Adverse Event|0|||
46700654|NCT00991276|82915645|FG005|First Intervention Period|Adverse Event|0|||
46700655|NCT00991276|82915640|FG000|First Intervention Period|Protocol Violation|0|||
46700656|NCT00991276|82915641|FG001|First Intervention Period|Protocol Violation|0|||
46700657|NCT00991276|82915642|FG002|First Intervention Period|Protocol Violation|0|||
46700658|NCT00991276|82915643|FG003|First Intervention Period|Protocol Violation|0|||
46700659|NCT00991276|82915644|FG004|First Intervention Period|Protocol Violation|2|||
46700660|NCT00991276|82915645|FG005|First Intervention Period|Protocol Violation|0|||
46700661|NCT00991276|82915640|FG000|First Intervention Period|Insufficient clinical response|0|||
46700662|NCT00991276|82915641|FG001|First Intervention Period|Insufficient clinical response|0|||
46700663|NCT00991276|82915642|FG002|First Intervention Period|Insufficient clinical response|0|||
46700664|NCT00991276|82915643|FG003|First Intervention Period|Insufficient clinical response|0|||
46869511|NCT00090285|83087715|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
46700665|NCT00991276|82915644|FG004|First Intervention Period|Insufficient clinical response|1|||
46700666|NCT00991276|82915645|FG005|First Intervention Period|Insufficient clinical response|0|||
46700667|NCT00991276|82915640|FG000|First Intervention Period|Other|0|||
46700668|NCT00991276|82915641|FG001|First Intervention Period|Other|0|||
46700669|NCT00991276|82915642|FG002|First Intervention Period|Other|0|||
46700670|NCT00991276|82915643|FG003|First Intervention Period|Other|1|||
46700671|NCT00991276|82915644|FG004|First Intervention Period|Other|1|||
46700672|NCT00991276|82915645|FG005|First Intervention Period|Other|0|||
46700673|NCT00991276|82915640|FG000|First Intervention Period|Withdrawal by Subject|0|||
46700674|NCT00991276|82915641|FG001|First Intervention Period|Withdrawal by Subject|1|||
46700675|NCT00991276|82915642|FG002|First Intervention Period|Withdrawal by Subject|0|||
46700676|NCT00991276|82915643|FG003|First Intervention Period|Withdrawal by Subject|1|||
46700677|NCT00991276|82915644|FG004|First Intervention Period|Withdrawal by Subject|0|||
46700678|NCT00991276|82915645|FG005|First Intervention Period|Withdrawal by Subject|1|||
46700679|NCT00991276|82915640|FG000|First Intervention Period|Lost to Follow-up|0|||
46700680|NCT00991276|82915641|FG001|First Intervention Period|Lost to Follow-up|1|||
46700681|NCT00991276|82915642|FG002|First Intervention Period|Lost to Follow-up|0|||
46700682|NCT00991276|82915643|FG003|First Intervention Period|Lost to Follow-up|1|||
46700683|NCT00991276|82915644|FG004|First Intervention Period|Lost to Follow-up|0|||
46700684|NCT00991276|82915645|FG005|First Intervention Period|Lost to Follow-up|0|||
46700685|NCT00991276|82915640|FG000|Second Intervention Period|Adverse Event|0|||
46700686|NCT00991276|82915641|FG001|Second Intervention Period|Adverse Event|2|||
46869512|NCT00090285|83087716|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
46869513|NCT00090285|83087717|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
46869514|NCT00090285|83087718|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
46869515|NCT00090285|83087719|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
46869516|NCT00090285|83087720|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
46869517|NCT00090285|83087715|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
46869518|NCT00090285|83087716|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
46869519|NCT00090285|83087717|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
46869520|NCT00090285|83087718|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
46869521|NCT00090285|83087719|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
46869522|NCT00090285|83087720|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
46869523|NCT00090285|83087715|FG000|Base Study Follow-up Period|Moved|41|||
46869524|NCT00090285|83087716|FG001|Base Study Follow-up Period|Moved|36|||
46869525|NCT00090285|83087717|FG002|Base Study Follow-up Period|Moved|0|||
46983797|NCT02305797|83230076|FG001|Overall Study|Lost to Follow-up|11|||
46700687|NCT00991276|82915642|FG002|Second Intervention Period|Adverse Event|0|||
46700688|NCT00991276|82915643|FG003|Second Intervention Period|Adverse Event|1|||
46700689|NCT00991276|82915644|FG004|Second Intervention Period|Adverse Event|1|||
46869526|NCT00090285|83087718|FG003|Base Study Follow-up Period|Moved|0|||
46869527|NCT00090285|83087719|FG004|Base Study Follow-up Period|Moved|0|||
46869528|NCT00090285|83087720|FG005|Base Study Follow-up Period|Moved|0|||
46869529|NCT00090285|83087715|FG000|Base Study Follow-up Period|Other|2|||
46869530|NCT00090285|83087716|FG001|Base Study Follow-up Period|Other|0|||
46869531|NCT00090285|83087717|FG002|Base Study Follow-up Period|Other|0|||
46869532|NCT00090285|83087718|FG003|Base Study Follow-up Period|Other|0|||
46869533|NCT00090285|83087719|FG004|Base Study Follow-up Period|Other|0|||
46700690|NCT00991276|82915645|FG005|Second Intervention Period|Adverse Event|0|||
46700691|NCT00991276|82915640|FG000|Second Intervention Period|Protocol Violation|1|||
46700692|NCT00991276|82915641|FG001|Second Intervention Period|Protocol Violation|0|||
46700693|NCT00991276|82915642|FG002|Second Intervention Period|Protocol Violation|0|||
46700694|NCT00991276|82915643|FG003|Second Intervention Period|Protocol Violation|0|||
46700695|NCT00991276|82915644|FG004|Second Intervention Period|Protocol Violation|0|||
46700696|NCT00991276|82915645|FG005|Second Intervention Period|Protocol Violation|0|||
46700697|NCT00991276|82915640|FG000|Second Intervention Period|Other|0|||
46700698|NCT00991276|82915641|FG001|Second Intervention Period|Other|0|||
46869534|NCT00090285|83087720|FG005|Base Study Follow-up Period|Other|0|||
46869535|NCT00090285|83087715|FG000|Base Study Follow-up Period|Protocol Violation|1|||
46869536|NCT00090285|83087716|FG001|Base Study Follow-up Period|Protocol Violation|0|||
46869537|NCT00090285|83087717|FG002|Base Study Follow-up Period|Protocol Violation|0|||
46869538|NCT00090285|83087718|FG003|Base Study Follow-up Period|Protocol Violation|0|||
46869539|NCT00090285|83087719|FG004|Base Study Follow-up Period|Protocol Violation|0|||
46869540|NCT00090285|83087720|FG005|Base Study Follow-up Period|Protocol Violation|0|||
46869541|NCT00090285|83087715|FG000|Base Study Follow-up Period|Uncooperative|3|||
46869542|NCT00090285|83087716|FG001|Base Study Follow-up Period|Uncooperative|4|||
46869543|NCT00090285|83087717|FG002|Base Study Follow-up Period|Uncooperative|0|||
46869544|NCT00090285|83087718|FG003|Base Study Follow-up Period|Uncooperative|0|||
46869545|NCT00090285|83087719|FG004|Base Study Follow-up Period|Uncooperative|0|||
46869546|NCT00090285|83087720|FG005|Base Study Follow-up Period|Uncooperative|0|||
46869547|NCT00090285|83087715|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
46869548|NCT00090285|83087716|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
46869549|NCT00090285|83087717|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
46869550|NCT00090285|83087718|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
46700699|NCT00991276|82915642|FG002|Second Intervention Period|Other|0|||
46869551|NCT00090285|83087719|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
46869552|NCT00090285|83087720|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
46869553|NCT00090285|83087715|FG000|Extension 1|Adverse Event|0|||
46869554|NCT00090285|83087716|FG001|Extension 1|Adverse Event|0|||
46700700|NCT00991276|82915643|FG003|Second Intervention Period|Other|1|||
46700701|NCT00991276|82915644|FG004|Second Intervention Period|Other|0|||
46700702|NCT00991276|82915645|FG005|Second Intervention Period|Other|1|||
46700703|NCT00991276|82915640|FG000|Third Intervention Period|Protocol Violation|1|||
46700704|NCT00991276|82915641|FG001|Third Intervention Period|Protocol Violation|0|||
46700705|NCT00991276|82915642|FG002|Third Intervention Period|Protocol Violation|0|||
46700706|NCT00991276|82915643|FG003|Third Intervention Period|Protocol Violation|0|||
46700707|NCT00991276|82915644|FG004|Third Intervention Period|Protocol Violation|0|||
46700708|NCT00991276|82915645|FG005|Third Intervention Period|Protocol Violation|0|||
46869555|NCT00090285|83087717|FG002|Extension 1|Adverse Event|2|||
46869556|NCT00090285|83087718|FG003|Extension 1|Adverse Event|0|||
46869557|NCT00090285|83087719|FG004|Extension 1|Adverse Event|0|||
46869558|NCT00090285|83087720|FG005|Extension 1|Adverse Event|0|||
46869559|NCT00090285|83087715|FG000|Extension 1|Lost to Follow-up|0|||
46869560|NCT00090285|83087716|FG001|Extension 1|Lost to Follow-up|0|||
46869561|NCT00090285|83087717|FG002|Extension 1|Lost to Follow-up|35|||
46869562|NCT00090285|83087718|FG003|Extension 1|Lost to Follow-up|0|||
46869563|NCT00090285|83087719|FG004|Extension 1|Lost to Follow-up|0|||
46869564|NCT00090285|83087720|FG005|Extension 1|Lost to Follow-up|0|||
46869565|NCT00090285|83087715|FG000|Extension 1|Withdrawal by Subject|0|||
46869566|NCT00090285|83087716|FG001|Extension 1|Withdrawal by Subject|0|||
46869567|NCT00090285|83087717|FG002|Extension 1|Withdrawal by Subject|13|||
46869568|NCT00090285|83087718|FG003|Extension 1|Withdrawal by Subject|1|||
46869569|NCT00090285|83087719|FG004|Extension 1|Withdrawal by Subject|0|||
46869570|NCT00090285|83087720|FG005|Extension 1|Withdrawal by Subject|0|||
46869571|NCT00090285|83087715|FG000|Extension 1|Other|0|||
46869572|NCT00090285|83087716|FG001|Extension 1|Other|0|||
46869573|NCT00090285|83087717|FG002|Extension 1|Other|4|||
46869574|NCT00090285|83087718|FG003|Extension 1|Other|0|||
46869575|NCT00090285|83087719|FG004|Extension 1|Other|0|||
46869576|NCT00090285|83087720|FG005|Extension 1|Other|0|||
46869577|NCT00090285|83087715|FG000|Extension 1|Moved|0|||
46869578|NCT00090285|83087716|FG001|Extension 1|Moved|0|||
46869579|NCT00090285|83087717|FG002|Extension 1|Moved|3|||
46869580|NCT00090285|83087718|FG003|Extension 1|Moved|0|||
46700709|NCT00991276|82915640|FG000|Third Intervention Period|Other|0|||
46700710|NCT00991276|82915641|FG001|Third Intervention Period|Other|0|||
46869581|NCT00090285|83087719|FG004|Extension 1|Moved|0|||
46869582|NCT00090285|83087720|FG005|Extension 1|Moved|0|||
46869583|NCT00090285|83087715|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
46869584|NCT00090285|83087716|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
46869585|NCT00090285|83087717|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
46869586|NCT00090285|83087718|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
46869587|NCT00090285|83087719|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
46869588|NCT00090285|83087720|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
46869589|NCT00090285|83087715|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46700711|NCT00991276|82915642|FG002|Third Intervention Period|Other|0|||
46700712|NCT00991276|82915643|FG003|Third Intervention Period|Other|0|||
46700713|NCT00991276|82915644|FG004|Third Intervention Period|Other|0|||
46700714|NCT00991276|82915645|FG005|Third Intervention Period|Other|1|||
46700715|NCT00991276|82915640|FG000|Third Intervention Period|Adverse Event|0|||
46700716|NCT00991276|82915641|FG001|Third Intervention Period|Adverse Event|0|||
46700717|NCT00991276|82915642|FG002|Third Intervention Period|Adverse Event|1|||
46700718|NCT00991276|82915643|FG003|Third Intervention Period|Adverse Event|0|||
46700719|NCT00991276|82915644|FG004|Third Intervention Period|Adverse Event|0|||
46700720|NCT00991276|82915645|FG005|Third Intervention Period|Adverse Event|0|||
46700721|NCT00991276|82915640|FG000|Third Intervention Period|Withdrawal by Subject|0|||
46700722|NCT00991276|82915641|FG001|Third Intervention Period|Withdrawal by Subject|0|||
46700723|NCT00991276|82915642|FG002|Third Intervention Period|Withdrawal by Subject|0|||
46700724|NCT00991276|82915643|FG003|Third Intervention Period|Withdrawal by Subject|1|||
46700725|NCT00991276|82915644|FG004|Third Intervention Period|Withdrawal by Subject|0|||
46700726|NCT00991276|82915645|FG005|Third Intervention Period|Withdrawal by Subject|0|||
46700727|NCT00990652|82915654|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
46700728|NCT00990652|82915654|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
46700729|NCT00990340|82915661|FG000|First 14-day Treatment|Not Compliant|2|||
46700730|NCT00990340|82915662|FG001|First 14-day Treatment|Not Compliant|1|||
46869590|NCT00090285|83087716|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46869591|NCT00090285|83087717|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46869592|NCT00090285|83087718|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
46869593|NCT00090285|83087719|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
46700731|NCT00990340|82915661|FG000|First 14-day Treatment|Lost to Follow-up|2|||
46700732|NCT00990340|82915662|FG001|First 14-day Treatment|Lost to Follow-up|1|||
46869594|NCT00090285|83087720|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
46869595|NCT00090285|83087715|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46869596|NCT00090285|83087716|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46869597|NCT00090285|83087717|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46869598|NCT00090285|83087718|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
46869599|NCT00090285|83087719|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
46700733|NCT00990340|82915661|FG000|First 14-day Treatment|Protocol Violation|2|||
46700734|NCT00990340|82915662|FG001|First 14-day Treatment|Protocol Violation|2|||
46700735|NCT01207440|82915677|FG000|Overall Study|Adverse Event|46|||
46700736|NCT01207440|82915678|FG001|Overall Study|Adverse Event|11|||
46700737|NCT01207440|82915679|FG002|Overall Study|Adverse Event|7|||
46700738|NCT01207440|82915680|FG003|Overall Study|Adverse Event|2|||
46700739|NCT01207440|82915681|FG004|Overall Study|Adverse Event|6|||
46700740|NCT01207440|82915682|FG005|Overall Study|Adverse Event|6|||
46700741|NCT01207440|82915683|FG006|Overall Study|Adverse Event|2|||
46700742|NCT01207440|82915677|FG000|Overall Study|Death|6|||
46700743|NCT01207440|82915678|FG001|Overall Study|Death|3|||
46700744|NCT01207440|82915679|FG002|Overall Study|Death|2|||
46700745|NCT01207440|82915680|FG003|Overall Study|Death|2|||
46700746|NCT01207440|82915681|FG004|Overall Study|Death|7|||
46700747|NCT01207440|82915682|FG005|Overall Study|Death|5|||
46700748|NCT01207440|82915683|FG006|Overall Study|Death|1|||
46700749|NCT01207440|82915677|FG000|Overall Study|Lack of Efficacy|13|||
46700750|NCT01207440|82915678|FG001|Overall Study|Lack of Efficacy|2|||
46700751|NCT01207440|82915679|FG002|Overall Study|Lack of Efficacy|5|||
46700752|NCT01207440|82915680|FG003|Overall Study|Lack of Efficacy|1|||
46700753|NCT01207440|82915681|FG004|Overall Study|Lack of Efficacy|2|||
46700754|NCT01207440|82915682|FG005|Overall Study|Lack of Efficacy|3|||
46700755|NCT01207440|82915683|FG006|Overall Study|Lack of Efficacy|0|||
46700756|NCT01207440|82915677|FG000|Overall Study|Lost to Follow-up|0|||
46700757|NCT01207440|82915678|FG001|Overall Study|Lost to Follow-up|0|||
46700758|NCT01207440|82915679|FG002|Overall Study|Lost to Follow-up|2|||
46700759|NCT01207440|82915680|FG003|Overall Study|Lost to Follow-up|1|||
46700760|NCT01207440|82915681|FG004|Overall Study|Lost to Follow-up|0|||
46700761|NCT01207440|82915682|FG005|Overall Study|Lost to Follow-up|0|||
46700762|NCT01207440|82915683|FG006|Overall Study|Lost to Follow-up|0|||
46700763|NCT01207440|82915677|FG000|Overall Study|Non-compliance with Study Drug|3|||
46700764|NCT01207440|82915678|FG001|Overall Study|Non-compliance with Study Drug|0|||
46700765|NCT01207440|82915679|FG002|Overall Study|Non-compliance with Study Drug|1|||
46700766|NCT01207440|82915680|FG003|Overall Study|Non-compliance with Study Drug|0|||
46700767|NCT01207440|82915681|FG004|Overall Study|Non-compliance with Study Drug|0|||
46700768|NCT01207440|82915682|FG005|Overall Study|Non-compliance with Study Drug|0|||
46700769|NCT01207440|82915683|FG006|Overall Study|Non-compliance with Study Drug|0|||
46700770|NCT01207440|82915677|FG000|Overall Study|Physician Decision|6|||
46700771|NCT01207440|82915678|FG001|Overall Study|Physician Decision|5|||
46700772|NCT01207440|82915679|FG002|Overall Study|Physician Decision|5|||
46700773|NCT01207440|82915680|FG003|Overall Study|Physician Decision|0|||
46700774|NCT01207440|82915681|FG004|Overall Study|Physician Decision|1|||
46700775|NCT01207440|82915682|FG005|Overall Study|Physician Decision|0|||
46700776|NCT01207440|82915683|FG006|Overall Study|Physician Decision|0|||
46700777|NCT01207440|82915677|FG000|Overall Study|Progressive Disease|19|||
46700778|NCT01207440|82915678|FG001|Overall Study|Progressive Disease|10|||
46700779|NCT01207440|82915679|FG002|Overall Study|Progressive Disease|19|||
46700780|NCT01207440|82915680|FG003|Overall Study|Progressive Disease|7|||
46700781|NCT01207440|82915681|FG004|Overall Study|Progressive Disease|23|||
46700782|NCT01207440|82915682|FG005|Overall Study|Progressive Disease|27|||
46700783|NCT01207440|82915683|FG006|Overall Study|Progressive Disease|0|||
46700784|NCT01207440|82915677|FG000|Overall Study|Protocol Violation|2|||
46869600|NCT00090285|83087720|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
46869601|NCT00090285|83087715|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
46983798|NCT02305797|83230075|FG000|Overall Study|Pregnancy|0|||
46983799|NCT02305797|83230076|FG001|Overall Study|Pregnancy|2|||
46700785|NCT01207440|82915678|FG001|Overall Study|Protocol Violation|0|||
46700786|NCT01207440|82915679|FG002|Overall Study|Protocol Violation|0|||
46700787|NCT01207440|82915680|FG003|Overall Study|Protocol Violation|0|||
46700788|NCT01207440|82915681|FG004|Overall Study|Protocol Violation|0|||
46700789|NCT01207440|82915682|FG005|Overall Study|Protocol Violation|0|||
46700790|NCT01207440|82915683|FG006|Overall Study|Protocol Violation|0|||
46700791|NCT01207440|82915677|FG000|Overall Study|Site Terminated by Sponsor|69|||
46700792|NCT01207440|82915678|FG001|Overall Study|Site Terminated by Sponsor|19|||
46983800|NCT02305797|83230075|FG000|Overall Study|Noncompliance|14|||
46700793|NCT01207440|82915679|FG002|Overall Study|Site Terminated by Sponsor|12|||
46700794|NCT01207440|82915680|FG003|Overall Study|Site Terminated by Sponsor|2|||
46700795|NCT01207440|82915681|FG004|Overall Study|Site Terminated by Sponsor|3|||
46700796|NCT01207440|82915682|FG005|Overall Study|Site Terminated by Sponsor|0|||
46700797|NCT01207440|82915683|FG006|Overall Study|Site Terminated by Sponsor|2|||
46700798|NCT01207440|82915677|FG000|Overall Study|Withdrawal by Subject|29|||
46700799|NCT01207440|82915678|FG001|Overall Study|Withdrawal by Subject|4|||
46700800|NCT01207440|82915679|FG002|Overall Study|Withdrawal by Subject|5|||
46700801|NCT01207440|82915680|FG003|Overall Study|Withdrawal by Subject|3|||
46700802|NCT01207440|82915681|FG004|Overall Study|Withdrawal by Subject|2|||
46700803|NCT01207440|82915682|FG005|Overall Study|Withdrawal by Subject|2|||
46700804|NCT01207440|82915683|FG006|Overall Study|Withdrawal by Subject|0|||
46700805|NCT01207440|82915677|FG000|Overall Study|Reason Not Specified|10|||
46700806|NCT01207440|82915678|FG001|Overall Study|Reason Not Specified|10|||
46700807|NCT01207440|82915679|FG002|Overall Study|Reason Not Specified|7|||
46700808|NCT01207440|82915680|FG003|Overall Study|Reason Not Specified|0|||
46700809|NCT01207440|82915681|FG004|Overall Study|Reason Not Specified|4|||
46700810|NCT01207440|82915682|FG005|Overall Study|Reason Not Specified|3|||
46700811|NCT01207440|82915683|FG006|Overall Study|Reason Not Specified|0|||
46700812|NCT00990184|82915705|FG000|Overall Study|Physician Decision|1|||
46700813|NCT00986830|82915711|FG000|Overall Study|Death|1|||
46700814|NCT00986830|82915711|FG000|Overall Study|Lost to Follow-up|1|||
46869602|NCT00090285|83087716|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
46869603|NCT00090285|83087717|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
46869604|NCT00090285|83087718|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
46869605|NCT00090285|83087719|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
46869606|NCT00090285|83087720|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
46869607|NCT00070941|83087738|FG000|Overall Study|Adverse Event|10|||
46869608|NCT00070941|83087739|FG001|Overall Study|Adverse Event|8|||
46869609|NCT00070941|83087740|FG002|Overall Study|Adverse Event|4|||
46869610|NCT00070707|83087750|FG000|Overall Study|Adverse Event|1|||
46869611|NCT00070707|83087751|FG001|Overall Study|Adverse Event|2|||
46869612|NCT00070707|83087750|FG000|Overall Study|Lack of Efficacy|4|||
46869613|NCT00070707|83087751|FG001|Overall Study|Lack of Efficacy|1|||
46869614|NCT00070707|83087750|FG000|Overall Study|Protocol Violation|8|||
46869615|NCT00070707|83087751|FG001|Overall Study|Protocol Violation|4|||
46700815|NCT00986830|82915711|FG000|Overall Study|Lack of Efficacy|1|||
46700816|NCT00986830|82915711|FG000|Overall Study|Unable to access sinus with device|5|||
46700817|NCT00990106|82915717|FG000|Overall Study|"too busy to continue"|1|||
46700818|NCT00990106|82915718|FG001|Overall Study|"too busy to continue"|2|||
46700819|NCT00990106|82915717|FG000|Overall Study|Lost to Follow-up|1|||
46700820|NCT00990106|82915718|FG001|Overall Study|Lost to Follow-up|3|||
46700821|NCT00990106|82915717|FG000|Overall Study|Withdrawal by Subject|2|||
46700822|NCT00990106|82915718|FG001|Overall Study|Withdrawal by Subject|1|||
46700823|NCT00990106|82915717|FG000|Overall Study|opted for open label prazosin|1|||
46700824|NCT00990106|82915718|FG001|Overall Study|opted for open label prazosin|1|||
46700825|NCT00990106|82915717|FG000|Overall Study|relocation/deployment|4|||
46700826|NCT00990106|82915718|FG001|Overall Study|relocation/deployment|1|||
46700827|NCT00990106|82915717|FG000|Overall Study|started exclusionary medication|0|||
46700828|NCT00990106|82915718|FG001|Overall Study|started exclusionary medication|1|||
46700829|NCT00990106|82915717|FG000|Overall Study|planned major surgery|0|||
46700830|NCT00990106|82915718|FG001|Overall Study|planned major surgery|1|||
46700831|NCT00990106|82915717|FG000|Overall Study|scheduling conflicts|0|||
46700832|NCT00990106|82915718|FG001|Overall Study|scheduling conflicts|2|||
46700833|NCT00983476|82915727|FG000|Overall Study|Did not receive intervention|17|||
46700834|NCT00983476|82915728|FG001|Overall Study|Did not receive intervention|22|||
46700835|NCT00983476|82915729|FG002|Overall Study|Did not receive intervention|0|||
46700836|NCT00982228|82915773|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
46700837|NCT00982228|82915774|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
46700838|NCT00982228|82915773|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
46700839|NCT00982228|82915774|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
46869616|NCT00070707|83087750|FG000|Overall Study|Unrelated to Study Medication|1|||
46869617|NCT00070707|83087751|FG001|Overall Study|Unrelated to Study Medication|0|||
46700840|NCT00982228|82915773|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
46700841|NCT00982228|82915774|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
46700842|NCT00982228|82915773|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
46869618|NCT03036124|83087759|FG000|Overall Study|Lost to Follow-up|0|||
46869619|NCT03036124|83087760|FG001|Overall Study|Lost to Follow-up|2|||
46869620|NCT03036124|83087759|FG000|Overall Study|Withdrawal by Subject|5|||
46869621|NCT03036124|83087760|FG001|Overall Study|Withdrawal by Subject|4|||
46700843|NCT00982228|82915774|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
46700844|NCT00982228|82915773|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
46700845|NCT00982228|82915774|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
46700846|NCT00982228|82915773|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
46700847|NCT00982228|82915774|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
46700848|NCT00982228|82915773|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
46700849|NCT00982228|82915774|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
46700850|NCT00982228|82915773|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
46700851|NCT00982228|82915774|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
46700852|NCT00982228|82915773|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
46700853|NCT00982228|82915774|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
46700854|NCT00982228|82915773|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
46700855|NCT00982228|82915774|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
46700856|NCT01260350|82915800|FG000|Overall Study|Lack of Efficacy|0|||
46700857|NCT01260350|82915801|FG001|Overall Study|Lack of Efficacy|0|||
46700858|NCT01260350|82915802|FG002|Overall Study|Lack of Efficacy|0|||
46700859|NCT01260350|82915803|FG003|Overall Study|Lack of Efficacy|0|||
46700860|NCT01260350|82915804|FG004|Overall Study|Lack of Efficacy|0|||
46700861|NCT01260350|82915805|FG005|Overall Study|Lack of Efficacy|0|||
46700862|NCT01260350|82915806|FG006|Overall Study|Lack of Efficacy|0|||
46700863|NCT01260350|82915807|FG007|Overall Study|Lack of Efficacy|0|||
46700864|NCT01260350|82915808|FG008|Overall Study|Lack of Efficacy|0|||
46700865|NCT01260350|82915809|FG009|Overall Study|Lack of Efficacy|0|||
46700866|NCT01260350|82915810|FG010|Overall Study|Lack of Efficacy|0|||
46700867|NCT01260350|82915811|FG011|Overall Study|Lack of Efficacy|0|||
46700868|NCT01260350|82915812|FG012|Overall Study|Lack of Efficacy|0|||
46700869|NCT01260350|82915813|FG013|Overall Study|Lack of Efficacy|0|||
46700870|NCT01260350|82915814|FG014|Overall Study|Lack of Efficacy|0|||
46700871|NCT01260350|82915815|FG015|Overall Study|Lack of Efficacy|0|||
46700872|NCT01260350|82915816|FG016|Overall Study|Lack of Efficacy|0|||
46700873|NCT01260350|82915817|FG017|Overall Study|Lack of Efficacy|1|||
46700874|NCT01260350|82915818|FG018|Overall Study|Lack of Efficacy|0|||
46700875|NCT01260350|82915819|FG019|Overall Study|Lack of Efficacy|0|||
46700876|NCT01260350|82915820|FG020|Overall Study|Lack of Efficacy|3|||
46700877|NCT01260350|82915821|FG021|Overall Study|Lack of Efficacy|0|||
46700878|NCT01260350|82915800|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700879|NCT01260350|82915801|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700880|NCT01260350|82915802|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700881|NCT01260350|82915803|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700882|NCT01260350|82915804|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700883|NCT01260350|82915805|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700884|NCT01260350|82915806|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700885|NCT01260350|82915807|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700886|NCT01260350|82915808|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
46700887|NCT01260350|82915809|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700888|NCT01260350|82915810|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700889|NCT01260350|82915811|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700890|NCT01260350|82915812|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700891|NCT01260350|82915813|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700892|NCT01260350|82915814|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700893|NCT01260350|82915815|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700894|NCT01260350|82915816|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700895|NCT01260350|82915817|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700896|NCT01260350|82915818|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700897|NCT01260350|82915819|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46869622|NCT00070317|83087766|FG000|Overall Study|Inevaluable (Never Treated)|1|||
46700898|NCT01260350|82915820|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700899|NCT01260350|82915821|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
46700900|NCT01260194|82915875|FG000|Overall Study|Withdrawal of Consent|1|||
46700901|NCT01259726|82915883|FG000|Overall Study|Death|1|||
46700902|NCT01259726|82915884|FG001|Overall Study|Death|0|||
46700903|NCT01259726|82915885|FG002|Overall Study|Death|0|||
46700904|NCT01259726|82915886|FG003|Overall Study|Death|0|||
46700905|NCT01259726|82915883|FG000|Overall Study|Physician Decision|2|||
46983801|NCT02305797|83230076|FG001|Overall Study|Noncompliance|12|||
46869623|NCT00070317|83087766|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
46869624|NCT00070317|83087766|FG000|Overall Study|Ineligible required test not done|1|||
46869625|NCT00070317|83087766|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
46869626|NCT00070317|83087766|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
46869627|NCT03649412|83087772|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
46869628|NCT03649412|83087773|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
46869629|NCT03649412|83087772|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
46869630|NCT03649412|83087773|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
46869631|NCT03649412|83087772|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
46869632|NCT03649412|83087773|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
46869633|NCT03649412|83087772|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
46869634|NCT03649412|83087773|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
46869635|NCT03649412|83087772|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
46869636|NCT03649412|83087773|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
46983802|NCT02305797|83230075|FG000|Overall Study|Reason not collected|0|||
46983803|NCT02305797|83230076|FG001|Overall Study|Reason not collected|1|||
46983804|NCT01646073|83230084|FG000|Period A (12 Weeks)|Adverse Event|0|||
46983805|NCT01646073|83230085|FG001|Period A (12 Weeks)|Adverse Event|2|||
46983806|NCT01646073|83230084|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
46983807|NCT01646073|83230085|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
46983808|NCT01646073|83230084|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
46983809|NCT01646073|83230085|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
46983810|NCT01646073|83230084|FG000|Period A (12 Weeks)|Protocol Violation|0|||
46983811|NCT01646073|83230085|FG001|Period A (12 Weeks)|Protocol Violation|1|||
46983812|NCT01646073|83230084|FG000|Period A (12 Weeks)|Other|0|||
46700906|NCT01259726|82915884|FG001|Overall Study|Physician Decision|0|||
46700907|NCT01259726|82915885|FG002|Overall Study|Physician Decision|1|||
46700908|NCT01259726|82915886|FG003|Overall Study|Physician Decision|1|||
46700909|NCT01259726|82915883|FG000|Overall Study|Withdrawal by Subject|1|||
46700910|NCT01259726|82915884|FG001|Overall Study|Withdrawal by Subject|3|||
46700911|NCT01259726|82915885|FG002|Overall Study|Withdrawal by Subject|2|||
46700912|NCT01259726|82915886|FG003|Overall Study|Withdrawal by Subject|1|||
46700913|NCT01259726|82915883|FG000|Overall Study|Lost to Follow-up|1|||
46700914|NCT01259726|82915884|FG001|Overall Study|Lost to Follow-up|1|||
46700915|NCT01259726|82915885|FG002|Overall Study|Lost to Follow-up|1|||
46700916|NCT01259726|82915886|FG003|Overall Study|Lost to Follow-up|3|||
46700917|NCT01259492|82915900|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
46700918|NCT01259492|82915901|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
46700919|NCT01259492|82915902|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
46700920|NCT01259492|82915903|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
46700921|NCT01259492|82915900|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
46700922|NCT01259492|82915901|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
46700923|NCT01259492|82915902|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
46700924|NCT01259492|82915903|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
46700925|NCT01259492|82915900|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
46700926|NCT01259492|82915901|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
46700927|NCT01259492|82915902|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
46869637|NCT03649412|83087772|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
46983813|NCT01646073|83230085|FG001|Period A (12 Weeks)|Other|1|||
46983814|NCT01646073|83230084|FG000|Period B (12 Weeks)|Adverse Event|0|||
46983815|NCT01646073|83230085|FG001|Period B (12 Weeks)|Adverse Event|7|||
46700928|NCT01259492|82915903|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
46700929|NCT01259492|82915900|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
46700930|NCT01259492|82915901|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
46700931|NCT01259492|82915902|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
46700932|NCT01259492|82915903|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
46700933|NCT01259492|82915900|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
46700934|NCT01259492|82915901|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
46700935|NCT01259492|82915902|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
46700936|NCT01259492|82915903|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
46700937|NCT01259492|82915900|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
46700938|NCT01259492|82915901|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
46700939|NCT01259492|82915902|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
46700940|NCT01259492|82915903|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
46700941|NCT01259492|82915900|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
46700942|NCT01259492|82915901|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
46700943|NCT01259492|82915902|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
46700944|NCT01259492|82915903|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
46700945|NCT01259492|82915900|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
46700946|NCT01259492|82915901|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
46700947|NCT01259492|82915902|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
46700948|NCT01259492|82915903|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
46700949|NCT01259492|82915900|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
46700950|NCT01259492|82915901|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
46700951|NCT01259492|82915902|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
46700952|NCT01259492|82915903|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
46700953|NCT01259492|82915900|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
46700954|NCT01259492|82915901|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
46700955|NCT01259492|82915902|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
46700956|NCT01259492|82915903|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
46700957|NCT01259492|82915900|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
46700958|NCT01259492|82915901|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
46700959|NCT01259492|82915902|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
46700960|NCT01259492|82915903|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
46700961|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
46700962|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
46700963|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
46700964|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
46700965|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
46700966|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
46700967|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
46700968|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
46700969|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
46700970|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
46700971|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
46700972|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
46700973|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
46700974|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
46700975|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
46700976|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
46700977|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
46700978|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
46700979|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
46700980|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
46700981|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
46700982|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
46700983|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
46700984|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
46700985|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
46700986|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
46700987|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
46700988|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
46700989|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
46700990|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
46700991|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
46700992|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
46700993|NCT01259492|82915900|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
46700994|NCT01259492|82915901|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
46700995|NCT01259492|82915902|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
46700996|NCT01259492|82915903|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
46983816|NCT01646073|83230084|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
46700997|NCT01117623|82915920|FG000|Overall Study|Adverse Event|0|||
46700998|NCT01117623|82915921|FG001|Overall Study|Adverse Event|2|||
46700999|NCT01117623|82915922|FG002|Overall Study|Adverse Event|4|||
46701000|NCT01117623|82915923|FG003|Overall Study|Adverse Event|0|||
46701001|NCT01117623|82915924|FG004|Overall Study|Adverse Event|2|||
46701002|NCT01117623|82915925|FG005|Overall Study|Adverse Event|0|||
46701003|NCT01117623|82915926|FG006|Overall Study|Adverse Event|0|||
46701004|NCT01117623|82915927|FG007|Overall Study|Adverse Event|2|||
46701005|NCT01117623|82915920|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
46701006|NCT01117623|82915921|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
46701007|NCT01117623|82915922|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
46701008|NCT01117623|82915923|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
46701009|NCT01117623|82915924|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
46701010|NCT01117623|82915925|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
46701011|NCT01117623|82915926|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
46701012|NCT01117623|82915927|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
46701013|NCT01117623|82915920|FG000|Overall Study|Withdrawal by Subject|0|||
46802606|NCT00684671|83021908|FG000|Overall Study|Alcoholic dependance|1|||
46869638|NCT03649412|83087773|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
46869639|NCT03587636|83087818|FG000|Overall Study|Lost to Follow-up|2|||
46869640|NCT03587636|83087819|FG001|Overall Study|Lost to Follow-up|5|||
46869641|NCT03586544|83087837|FG000|First Intervention|Adverse Event|0|||
46869642|NCT03586544|83087838|FG001|First Intervention|Adverse Event|1|||
46869643|NCT03586544|83087837|FG000|Second Intervention|Withdrawal by Subject|0|||
46869644|NCT03586544|83087838|FG001|Second Intervention|Withdrawal by Subject|1|||
46869645|NCT03585296|83087844|FG000|Overall Study|Adverse Event|1|||
46869646|NCT03585296|83087844|FG000|Overall Study|Lost to Follow-up|2|||
46869647|NCT03585296|83087844|FG000|Overall Study|Withdrawal by Subject|2|||
46869648|NCT03589768|83087852|FG000|Overall Study|Death|1|||
46869649|NCT03589768|83087853|FG001|Overall Study|Death|0|||
46869650|NCT03589768|83087854|FG002|Overall Study|Death|8|||
46869651|NCT03589768|83087855|FG003|Overall Study|Death|3|||
46869652|NCT03589768|83087852|FG000|Overall Study|Withdrawal by Subject|2|||
46869653|NCT03589768|83087853|FG001|Overall Study|Withdrawal by Subject|0|||
46869654|NCT03589768|83087854|FG002|Overall Study|Withdrawal by Subject|0|||
46869655|NCT03589768|83087855|FG003|Overall Study|Withdrawal by Subject|0|||
46869656|NCT03589768|83087852|FG000|Overall Study|Protocol Violation|1|||
46869657|NCT03589768|83087853|FG001|Overall Study|Protocol Violation|0|||
46869658|NCT03589768|83087854|FG002|Overall Study|Protocol Violation|0|||
46869659|NCT03589768|83087855|FG003|Overall Study|Protocol Violation|0|||
46869660|NCT02892422|83087865|FG000|Overall Study|Enrolled not treated|4|||
46869661|NCT02892422|83087865|FG000|Overall Study|Adverse Event|38|||
46869662|NCT02892422|83087865|FG000|Overall Study|Lack of Efficacy|32|||
46869663|NCT02892422|83087865|FG000|Overall Study|Non-compliance with study drug|11|||
46869664|NCT02892422|83087865|FG000|Overall Study|Protocol Violation|4|||
46869665|NCT02892422|83087865|FG000|Overall Study|Withdrawal by Subject|56|||
46869666|NCT02892422|83087865|FG000|Overall Study|Lost to Follow-up|5|||
46869667|NCT02892422|83087865|FG000|Overall Study|sponsor information 16159A results|21|||
46869668|NCT02892422|83087865|FG000|Overall Study|withdrawal of consent|13|||
46869669|NCT02892422|83087865|FG000|Overall Study|exclusion criteria met|3|||
46869670|NCT02892422|83087865|FG000|Overall Study|moving elsewhere|4|||
46869671|NCT02892422|83087865|FG000|Overall Study|non-compliance|10|||
46869672|NCT02892422|83087865|FG000|Overall Study|patient legally incapable|1|||
46869673|NCT02892422|83087865|FG000|Overall Study|patient decision|7|||
46869674|NCT02892422|83087865|FG000|Overall Study|Investigator decision|1|||
46869675|NCT03571646|83087871|FG000|Overall Study|Adverse Event|1|||
46869676|NCT03571646|83087872|FG001|Overall Study|Adverse Event|0|||
46869677|NCT03571646|83087871|FG000|Overall Study|Withdrawal by Subject|1|||
46869678|NCT03571646|83087872|FG001|Overall Study|Withdrawal by Subject|1|||
46869679|NCT03645434|83087878|FG000|Period 1|Adverse Event|0|||
46701014|NCT01117623|82915921|FG001|Overall Study|Withdrawal by Subject|0|||
46701015|NCT01117623|82915922|FG002|Overall Study|Withdrawal by Subject|2|||
46701016|NCT01117623|82915923|FG003|Overall Study|Withdrawal by Subject|0|||
46701017|NCT01117623|82915924|FG004|Overall Study|Withdrawal by Subject|0|||
46802607|NCT00684671|83021909|FG001|Overall Study|Alcoholic dependance|0|||
46802608|NCT00684671|83021910|FG002|Overall Study|Alcoholic dependance|0|||
46802609|NCT03859323|83021931|FG000|Overall Study|Lost to Follow-up|0|||
46802610|NCT03859323|83021932|FG001|Overall Study|Lost to Follow-up|0|||
46802611|NCT03859323|83021933|FG002|Overall Study|Lost to Follow-up|0|||
46802612|NCT03859323|83021934|FG003|Overall Study|Lost to Follow-up|0|||
46802613|NCT03859323|83021935|FG004|Overall Study|Lost to Follow-up|0|||
46802614|NCT03859323|83021936|FG005|Overall Study|Lost to Follow-up|0|||
46802615|NCT03859323|83021937|FG006|Overall Study|Lost to Follow-up|1|||
46869680|NCT03645434|83087879|FG001|Period 1|Adverse Event|0|||
46869681|NCT03645434|83087880|FG002|Period 1|Adverse Event|0|||
46869682|NCT03645434|83087881|FG003|Period 1|Adverse Event|1|||
46869683|NCT03645434|83087882|FG004|Period 1|Adverse Event|0|||
46869684|NCT03645434|83087883|FG005|Period 1|Adverse Event|0|||
46701018|NCT01117623|82915925|FG005|Overall Study|Withdrawal by Subject|1|||
46701019|NCT01117623|82915926|FG006|Overall Study|Withdrawal by Subject|1|||
46701020|NCT01117623|82915927|FG007|Overall Study|Withdrawal by Subject|1|||
46701021|NCT01117623|82915920|FG000|Overall Study|Non-compliance with study medication|0|||
46701022|NCT01117623|82915921|FG001|Overall Study|Non-compliance with study medication|0|||
46701023|NCT01117623|82915922|FG002|Overall Study|Non-compliance with study medication|0|||
46701024|NCT01117623|82915923|FG003|Overall Study|Non-compliance with study medication|0|||
46701025|NCT01117623|82915924|FG004|Overall Study|Non-compliance with study medication|0|||
46701026|NCT01117623|82915925|FG005|Overall Study|Non-compliance with study medication|0|||
46701027|NCT01117623|82915926|FG006|Overall Study|Non-compliance with study medication|0|||
46701028|NCT01117623|82915927|FG007|Overall Study|Non-compliance with study medication|1|||
46701029|NCT01117623|82915920|FG000|Overall Study|Invest. text: completed all planned txs|0|||
46701030|NCT01117623|82915921|FG001|Overall Study|Invest. text: completed all planned txs|0|||
46701031|NCT01117623|82915922|FG002|Overall Study|Invest. text: completed all planned txs|0|||
46701032|NCT01117623|82915923|FG003|Overall Study|Invest. text: completed all planned txs|0|||
46701033|NCT01117623|82915924|FG004|Overall Study|Invest. text: completed all planned txs|0|||
46701034|NCT01117623|82915925|FG005|Overall Study|Invest. text: completed all planned txs|1|||
46701035|NCT01117623|82915926|FG006|Overall Study|Invest. text: completed all planned txs|0|||
46701036|NCT01117623|82915927|FG007|Overall Study|Invest. text: completed all planned txs|0|||
46701037|NCT01116687|82915947|FG000|Overall Study|Withdrawal by Subject|4|||
46701038|NCT01114737|82915953|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
46701039|NCT01114737|82915954|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
46701040|NCT01114737|82915953|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
46701041|NCT01114737|82915954|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
46701042|NCT01114737|82915953|FG000|Randomized Treatment Period|Pregnancy|1|||
46701043|NCT01114737|82915954|FG001|Randomized Treatment Period|Pregnancy|0|||
46701044|NCT01114737|82915953|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
46701045|NCT01114737|82915954|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
46701046|NCT01114737|82915953|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
46701047|NCT01114737|82915954|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
46701048|NCT01114737|82915953|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
46701049|NCT01114737|82915954|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
46701050|NCT01113879|82915977|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
46701051|NCT01113879|82915978|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
46701052|NCT00979576|82915989|FG000|Combination Treatment Phase|Progressive disease|3|||
46701053|NCT00979576|82915990|FG001|Combination Treatment Phase|Progressive disease|1|||
46701054|NCT00979576|82915991|FG002|Combination Treatment Phase|Progressive disease|5|||
46701055|NCT00979576|82915989|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
46701056|NCT00979576|82915990|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
46701057|NCT00979576|82915991|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
46701058|NCT00979576|82915989|FG000|Combination Treatment Phase|Adverse Event|0|||
46701059|NCT00979576|82915990|FG001|Combination Treatment Phase|Adverse Event|2|||
46701060|NCT00979576|82915991|FG002|Combination Treatment Phase|Adverse Event|2|||
46701061|NCT00979576|82915989|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
46701062|NCT00979576|82915990|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
46701063|NCT00979576|82915991|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
46701064|NCT00979420|82916004|FG000|Overall Study|Adverse Event|1|||
46701065|NCT00979420|82916005|FG001|Overall Study|Adverse Event|0|||
46701066|NCT00979420|82916006|FG002|Overall Study|Adverse Event|0|||
46701067|NCT00979420|82916007|FG003|Overall Study|Adverse Event|0|||
46701068|NCT00979420|82916004|FG000|Overall Study|Lack of Efficacy|3|||
46701069|NCT00979420|82916005|FG001|Overall Study|Lack of Efficacy|0|||
46701070|NCT00979420|82916006|FG002|Overall Study|Lack of Efficacy|1|||
46701071|NCT00979420|82916007|FG003|Overall Study|Lack of Efficacy|1|||
46701072|NCT00979420|82916004|FG000|Overall Study|Other reasons not related to Viramune|3|||
46701073|NCT00979420|82916005|FG001|Overall Study|Other reasons not related to Viramune|0|||
46701074|NCT00979420|82916006|FG002|Overall Study|Other reasons not related to Viramune|0|||
46701075|NCT00979420|82916007|FG003|Overall Study|Other reasons not related to Viramune|1|||
46701076|NCT02702180|82916018|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
46701077|NCT02702180|82916019|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
46869685|NCT03645434|83087878|FG000|Period 1|COPD exacerbation|0|||
46869686|NCT03645434|83087879|FG001|Period 1|COPD exacerbation|0|||
46701078|NCT02702180|82916020|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46701079|NCT02702180|82916018|FG000|Double-blind Treatment Period|Adverse Event|0|||
46701080|NCT02702180|82916019|FG001|Double-blind Treatment Period|Adverse Event|0|||
46701081|NCT02702180|82916020|FG002|Double-blind Treatment Period|Adverse Event|1|||
46701082|NCT02702180|82916018|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
46701083|NCT02702180|82916019|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
46701084|NCT02702180|82916020|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
46701085|NCT02702180|82916018|FG000|Double-blind Treatment Period|Protocol Violation|0|||
46701086|NCT02702180|82916019|FG001|Double-blind Treatment Period|Protocol Violation|0|||
46701087|NCT02702180|82916020|FG002|Double-blind Treatment Period|Protocol Violation|2|||
46701088|NCT02702180|82916018|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
46701089|NCT02702180|82916019|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
46701090|NCT02702180|82916020|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
46701091|NCT02702180|82916018|FG000|Open-label Treatment Period|Withdrawn in error|0|||
46701092|NCT02702180|82916019|FG001|Open-label Treatment Period|Withdrawn in error|0|||
46701093|NCT02702180|82916020|FG002|Open-label Treatment Period|Withdrawn in error|1|||
46701094|NCT00980980|82916032|FG000|Overall Study|Withdrawal by Hospital|0|||
46701095|NCT00980980|82916033|FG001|Overall Study|Withdrawal by Hospital|1|||
46701096|NCT00980980|82916034|FG002|Overall Study|Withdrawal by Hospital|0|||
46701097|NCT00980200|82916045|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
46701098|NCT00980200|82916046|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
46869687|NCT03645434|83087880|FG002|Period 1|COPD exacerbation|0|||
46869688|NCT03645434|83087881|FG003|Period 1|COPD exacerbation|0|||
46869689|NCT03645434|83087882|FG004|Period 1|COPD exacerbation|1|||
46869690|NCT03645434|83087883|FG005|Period 1|COPD exacerbation|0|||
46869691|NCT00089505|83087895|FG000|Overall Study|Death|4|||
46869692|NCT00089505|83087896|FG001|Overall Study|Death|1|||
46869693|NCT00089505|83087897|FG002|Overall Study|Death|5|||
46869694|NCT00089505|83087898|FG003|Overall Study|Death|8|||
46869695|NCT00089505|83087895|FG000|Overall Study|Withdrawal by Subject|3|||
46869696|NCT00089505|83087896|FG001|Overall Study|Withdrawal by Subject|0|||
46869697|NCT00089505|83087897|FG002|Overall Study|Withdrawal by Subject|6|||
46869698|NCT00089505|83087898|FG003|Overall Study|Withdrawal by Subject|6|||
46869699|NCT00089505|83087895|FG000|Overall Study|Lost to Follow-up|1|||
46869700|NCT00089505|83087896|FG001|Overall Study|Lost to Follow-up|1|||
46869701|NCT00089505|83087897|FG002|Overall Study|Lost to Follow-up|9|||
46869702|NCT00089505|83087898|FG003|Overall Study|Lost to Follow-up|7|||
46869703|NCT00089505|83087895|FG000|Overall Study|Physician Decision|1|||
46869704|NCT00089505|83087896|FG001|Overall Study|Physician Decision|0|||
46869705|NCT00089505|83087897|FG002|Overall Study|Physician Decision|0|||
46869706|NCT00089505|83087898|FG003|Overall Study|Physician Decision|0|||
46869707|NCT00089505|83087895|FG000|Overall Study|Protocol Violation|0|||
46869708|NCT00089505|83087896|FG001|Overall Study|Protocol Violation|0|||
46869709|NCT00089505|83087897|FG002|Overall Study|Protocol Violation|1|||
46869710|NCT00089505|83087898|FG003|Overall Study|Protocol Violation|0|||
46869711|NCT04009824|83087913|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
46869712|NCT04009824|83087914|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
46869713|NCT04009824|83087915|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
46869714|NCT04009824|83087916|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
46869715|NCT04009824|83087917|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
46869716|NCT03555890|83087933|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46869717|NCT03555890|83087934|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46869718|NCT03555890|83087935|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46869719|NCT03555890|83087936|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
46869720|NCT03688074|83087948|FG000|Overall Study|Adverse Event|0|||
46869721|NCT03688074|83087949|FG001|Overall Study|Adverse Event|1|||
46869722|NCT03688074|83087948|FG000|Overall Study|Other|1|||
46869723|NCT03688074|83087949|FG001|Overall Study|Other|0|||
46869724|NCT03630120|83087959|FG000|Overall Study|Disease progression|0|||
46983817|NCT01646073|83230085|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
46983818|NCT01646073|83230084|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
46983819|NCT01646073|83230085|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
46701099|NCT00980200|82916047|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
46701100|NCT00980200|82916048|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
46701101|NCT00980200|82916049|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
46701102|NCT00980200|82916045|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
46701103|NCT00980200|82916046|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
46701104|NCT00980200|82916047|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
46701105|NCT00980200|82916048|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
46701106|NCT00980200|82916049|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
46869725|NCT03630120|83087960|FG001|Overall Study|Disease progression|1|||
46869726|NCT03630120|83087961|FG002|Overall Study|Disease progression|1|||
46869727|NCT03630120|83087962|FG003|Overall Study|Disease progression|1|||
46869728|NCT03555266|83087974|FG000|Overall Study|Protocol Violation|6|||
46983820|NCT02328027|83230096|FG000|Overall Study|Withdrawal by Subject|0|||
46983821|NCT02328027|83230097|FG001|Overall Study|Withdrawal by Subject|1|||
46701107|NCT00979654|82916061|FG000|Overall Study|Lost to Follow-up|1|||
46701108|NCT00979654|82916061|FG000|Overall Study|Withdrawal by Subject|22|||
46869729|NCT03555266|83087975|FG001|Overall Study|Protocol Violation|4|||
46869730|NCT03656874|83087983|FG000|Overall Study|Lost to Follow-up|3|||
46701109|NCT00979654|82916061|FG000|Overall Study|Death|1|||
46869731|NCT03656874|83087984|FG001|Overall Study|Lost to Follow-up|17|||
46983822|NCT02551159|83230107|FG000|Overall Study|Death|352|||
46983823|NCT02551159|83230108|FG001|Overall Study|Death|174|||
46701110|NCT00979654|82916061|FG000|Overall Study|Lack of Efficacy|6|||
46701111|NCT00979654|82916061|FG000|Overall Study|Adverse Event|1|||
46701112|NCT00979654|82916061|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
46701113|NCT00979654|82916061|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
46701114|NCT00979654|82916061|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
46701115|NCT00979654|82916061|FG000|Overall Study|Serious Adverse Event|1|||
46701116|NCT00979654|82916061|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
46701117|NCT00978562|82916065|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
46701118|NCT02865460|82916073|FG000|Overall Study|Adverse Event|1|||
46701119|NCT02865460|82916074|FG001|Overall Study|Adverse Event|0|||
46701120|NCT02865460|82916073|FG000|Overall Study|Withdrawal by Subject|1|||
46701121|NCT02865460|82916074|FG001|Overall Study|Withdrawal by Subject|1|||
46701122|NCT02865460|82916073|FG000|Overall Study|Lost to Follow-up|7|||
46701123|NCT02865460|82916074|FG001|Overall Study|Lost to Follow-up|4|||
46701124|NCT02865460|82916073|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
46701125|NCT02865460|82916074|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
46701126|NCT01206816|82916087|FG000|Overall Study|Protocol Violation|0|||
46701127|NCT01206816|82916088|FG001|Overall Study|Protocol Violation|0|||
46701128|NCT01206816|82916089|FG002|Overall Study|Protocol Violation|1|||
46701129|NCT01206816|82916090|FG003|Overall Study|Protocol Violation|0|||
46701130|NCT01206816|82916091|FG004|Overall Study|Protocol Violation|0|||
46701131|NCT01206816|82916092|FG005|Overall Study|Protocol Violation|0|||
46701132|NCT01206816|82916093|FG006|Overall Study|Protocol Violation|0|||
46701133|NCT01206816|82916087|FG000|Overall Study|Withdrawal by Subject|0|||
46701134|NCT01206816|82916088|FG001|Overall Study|Withdrawal by Subject|0|||
46701135|NCT01206816|82916089|FG002|Overall Study|Withdrawal by Subject|1|||
46701136|NCT01206816|82916090|FG003|Overall Study|Withdrawal by Subject|0|||
46701137|NCT01206816|82916091|FG004|Overall Study|Withdrawal by Subject|0|||
46701138|NCT01206816|82916092|FG005|Overall Study|Withdrawal by Subject|0|||
46701139|NCT01206816|82916093|FG006|Overall Study|Withdrawal by Subject|0|||
46701140|NCT01206816|82916087|FG000|Overall Study|Progressive disease|3|||
46701141|NCT01206816|82916088|FG001|Overall Study|Progressive disease|3|||
46701142|NCT01206816|82916089|FG002|Overall Study|Progressive disease|13|||
46701143|NCT01206816|82916090|FG003|Overall Study|Progressive disease|3|||
46701144|NCT01206816|82916091|FG004|Overall Study|Progressive disease|3|||
46701145|NCT01206816|82916092|FG005|Overall Study|Progressive disease|16|||
46701146|NCT01206816|82916093|FG006|Overall Study|Progressive disease|3|||
46701147|NCT01206816|82916087|FG000|Overall Study|Other AE|0|||
46701148|NCT01206816|82916088|FG001|Overall Study|Other AE|0|||
46701149|NCT01206816|82916089|FG002|Overall Study|Other AE|4|||
46701150|NCT01206816|82916090|FG003|Overall Study|Other AE|0|||
46701151|NCT01206816|82916091|FG004|Overall Study|Other AE|0|||
46701152|NCT01206816|82916092|FG005|Overall Study|Other AE|3|||
46701153|NCT01206816|82916093|FG006|Overall Study|Other AE|2|||
46701154|NCT01206816|82916087|FG000|Overall Study|other than stated above|0|||
46701155|NCT01206816|82916088|FG001|Overall Study|other than stated above|0|||
46701156|NCT01206816|82916089|FG002|Overall Study|other than stated above|1|||
46701157|NCT01206816|82916090|FG003|Overall Study|other than stated above|0|||
46701158|NCT01206816|82916091|FG004|Overall Study|other than stated above|0|||
46701159|NCT01206816|82916092|FG005|Overall Study|other than stated above|0|||
46701160|NCT01206816|82916093|FG006|Overall Study|other than stated above|1|||
46869732|NCT03554486|83087992|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
46869733|NCT03554486|83087993|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
46869734|NCT03554486|83087994|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
46869735|NCT03554486|83087992|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
46869736|NCT03554486|83087993|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
46869737|NCT03554486|83087994|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
46869738|NCT03554486|83087992|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
46869739|NCT03554486|83087993|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
46869740|NCT03554486|83087994|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
46869741|NCT03571256|83088004|FG000|Overall Study|Adverse Event|3|||
46701161|NCT01206582|82916115|FG000|Overall Study|Withdrew prior to study|1|||
46983824|NCT02551159|83230109|FG002|Overall Study|Death|161|||
46983825|NCT02551159|83230107|FG000|Overall Study|Withdrawal by Subject|8|||
46701162|NCT01206582|82916116|FG001|Overall Study|Withdrew prior to study|0|||
46701163|NCT01206582|82916115|FG000|Overall Study|Discontinued intervention before week 8|1|||
46701164|NCT01206582|82916116|FG001|Overall Study|Discontinued intervention before week 8|2|||
46701165|NCT01259102|82916127|FG000|Overall Study|Adverse Event|1|||
46701166|NCT01259102|82916128|FG001|Overall Study|Adverse Event|0|||
46701167|NCT01259102|82916129|FG002|Overall Study|Adverse Event|1|||
46701168|NCT01259102|82916130|FG003|Overall Study|Adverse Event|1|||
46701169|NCT01259102|82916131|FG004|Overall Study|Adverse Event|0|||
46701170|NCT01259102|82916127|FG000|Overall Study|Other|0|||
46701171|NCT01259102|82916128|FG001|Overall Study|Other|0|||
46701172|NCT01259102|82916129|FG002|Overall Study|Other|1|||
46983826|NCT02551159|83230108|FG001|Overall Study|Withdrawal by Subject|5|||
46701173|NCT01259102|82916130|FG003|Overall Study|Other|1|||
46701174|NCT01259102|82916131|FG004|Overall Study|Other|1|||
46701175|NCT00978250|82916147|FG000|Overall Study|Late determination of ineligibility|0|||
46701176|NCT00978250|82916148|FG001|Overall Study|Late determination of ineligibility|1|||
46701177|NCT00978250|82916149|FG002|Overall Study|Late determination of ineligibility|0|||
46701178|NCT00978250|82916150|FG003|Overall Study|Late determination of ineligibility|1|||
46701179|NCT01259024|82916162|FG000|Overall Study|Physician Decision|1|||
46701180|NCT01257698|82916168|FG000|Overall Study|Protocol Violation|4|||
46701181|NCT01257698|82916169|FG001|Overall Study|Protocol Violation|0|||
46701182|NCT01257542|82916177|FG000|Overall Study|Protocol Violation|3|||
46701183|NCT01257542|82916178|FG001|Overall Study|Protocol Violation|5|||
46701184|NCT01257542|82916177|FG000|Overall Study|Withdrawal by Subject|0|||
46701185|NCT01257542|82916178|FG001|Overall Study|Withdrawal by Subject|2|||
46701186|NCT01257230|82916187|FG000|Overall Study|Not Treated|0|||
46701187|NCT01257230|82916188|FG001|Overall Study|Not Treated|0|||
46701188|NCT01257230|82916189|FG002|Overall Study|Not Treated|1|||
46701189|NCT01257230|82916187|FG000|Overall Study|Adverse Event|2|||
46701190|NCT01257230|82916188|FG001|Overall Study|Adverse Event|0|||
46701191|NCT01257230|82916189|FG002|Overall Study|Adverse Event|0|||
46701192|NCT01257230|82916187|FG000|Overall Study|Lack of Efficacy|0|||
46701193|NCT01257230|82916188|FG001|Overall Study|Lack of Efficacy|1|||
46701194|NCT01257230|82916189|FG002|Overall Study|Lack of Efficacy|0|||
46701195|NCT01257230|82916187|FG000|Overall Study|Protocol Violation|3|||
46701196|NCT01257230|82916188|FG001|Overall Study|Protocol Violation|0|||
46701197|NCT01257230|82916189|FG002|Overall Study|Protocol Violation|1|||
46701198|NCT01257230|82916187|FG000|Overall Study|Withdrawal by Subject|0|||
46701199|NCT01257230|82916188|FG001|Overall Study|Withdrawal by Subject|4|||
46701200|NCT01257230|82916189|FG002|Overall Study|Withdrawal by Subject|1|||
46701201|NCT01257230|82916187|FG000|Overall Study|Other reason not defined above|1|||
46701202|NCT01257230|82916188|FG001|Overall Study|Other reason not defined above|5|||
46701203|NCT01257230|82916189|FG002|Overall Study|Other reason not defined above|3|||
46701204|NCT01113801|82916202|FG000|Overall Study|Adverse Event|4|||
46701205|NCT01113801|82916203|FG001|Overall Study|Adverse Event|0|||
46701206|NCT01113801|82916204|FG002|Overall Study|Adverse Event|2|||
46701207|NCT01113801|82916205|FG003|Overall Study|Adverse Event|6|||
46701208|NCT01113801|82916202|FG000|Overall Study|Death|4|||
46701209|NCT01113801|82916203|FG001|Overall Study|Death|5|||
46701210|NCT01113801|82916204|FG002|Overall Study|Death|3|||
46701211|NCT01113801|82916205|FG003|Overall Study|Death|4|||
46701212|NCT01113801|82916202|FG000|Overall Study|Protocol Violation|0|||
46701213|NCT01113801|82916203|FG001|Overall Study|Protocol Violation|1|||
46701214|NCT01113801|82916204|FG002|Overall Study|Protocol Violation|0|||
46701215|NCT01113801|82916205|FG003|Overall Study|Protocol Violation|0|||
46701216|NCT01113801|82916202|FG000|Overall Study|Withdrawal by Subject|9|||
46701217|NCT01113801|82916203|FG001|Overall Study|Withdrawal by Subject|7|||
46701218|NCT01113801|82916204|FG002|Overall Study|Withdrawal by Subject|7|||
46701219|NCT01113801|82916205|FG003|Overall Study|Withdrawal by Subject|8|||
46869742|NCT03571256|83088005|FG001|Overall Study|Adverse Event|0|||
46869743|NCT03571256|83088006|FG002|Overall Study|Adverse Event|1|||
46869744|NCT03571256|83088004|FG000|Overall Study|Withdrawal by Subject|3|||
46869745|NCT03571256|83088005|FG001|Overall Study|Withdrawal by Subject|1|||
46869746|NCT03571256|83088006|FG002|Overall Study|Withdrawal by Subject|1|||
46869747|NCT03571256|83088004|FG000|Overall Study|Other than specified|0|||
46701220|NCT01113801|82916202|FG000|Overall Study|Physician Decision|2|||
46701221|NCT01113801|82916203|FG001|Overall Study|Physician Decision|2|||
46701222|NCT01113801|82916204|FG002|Overall Study|Physician Decision|3|||
46701223|NCT01113801|82916205|FG003|Overall Study|Physician Decision|3|||
46701224|NCT01113801|82916202|FG000|Overall Study|Sponsor Decision|15|||
46701225|NCT01113801|82916203|FG001|Overall Study|Sponsor Decision|21|||
46701226|NCT01113801|82916204|FG002|Overall Study|Sponsor Decision|20|||
46701227|NCT01113801|82916205|FG003|Overall Study|Sponsor Decision|15|||
46701228|NCT01113801|82916202|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
46701229|NCT01113801|82916203|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
46701230|NCT01113801|82916204|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
46701231|NCT01113801|82916205|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
46701232|NCT01256684|82916218|FG000|Overall Study|Adverse Event|1|||
46869748|NCT03571256|83088005|FG001|Overall Study|Other than specified|1|||
46701233|NCT01256684|82916219|FG001|Overall Study|Adverse Event|4|||
46701234|NCT01256684|82916220|FG002|Overall Study|Adverse Event|2|||
46701235|NCT01256684|82916218|FG000|Overall Study|Withdrawal by Subject|4|||
46701236|NCT01256684|82916219|FG001|Overall Study|Withdrawal by Subject|0|||
46869749|NCT03571256|83088006|FG002|Overall Study|Other than specified|1|||
46701237|NCT01256684|82916220|FG002|Overall Study|Withdrawal by Subject|2|||
46701238|NCT01256684|82916218|FG000|Overall Study|Physician Decision|0|||
46701239|NCT01256684|82916219|FG001|Overall Study|Physician Decision|1|||
46701240|NCT01256684|82916220|FG002|Overall Study|Physician Decision|0|||
46701241|NCT01256684|82916218|FG000|Overall Study|Lack of Efficacy|0|||
46701242|NCT01256684|82916219|FG001|Overall Study|Lack of Efficacy|1|||
46701243|NCT01256684|82916220|FG002|Overall Study|Lack of Efficacy|1|||
46701244|NCT01256684|82916218|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
46701245|NCT01256684|82916219|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
46701246|NCT01256684|82916220|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
46701247|NCT01204710|82916230|FG000|Randomization Treatment|Lost to Follow-up|1|||
46701248|NCT01204710|82916231|FG001|Randomization Treatment|Lost to Follow-up|0|||
46701249|NCT01204710|82916230|FG000|Randomization Treatment|Withdrawal by Subject|6|||
46701250|NCT01204710|82916231|FG001|Randomization Treatment|Withdrawal by Subject|5|||
46701251|NCT01204710|82916230|FG000|Randomization Treatment|Physician Decision|3|||
46701252|NCT01204710|82916231|FG001|Randomization Treatment|Physician Decision|2|||
46701253|NCT01204710|82916230|FG000|Randomization Treatment|Entry criteria not met|0|||
46701254|NCT01204710|82916231|FG001|Randomization Treatment|Entry criteria not met|1|||
46701255|NCT01204710|82916230|FG000|Randomization Treatment|Adverse Event|4|||
46701256|NCT01204710|82916231|FG001|Randomization Treatment|Adverse Event|2|||
46701257|NCT01204710|82916230|FG000|Randomization Treatment|Sponsor Decision|0|||
46701258|NCT01204710|82916231|FG001|Randomization Treatment|Sponsor Decision|1|||
46701259|NCT01204710|82916230|FG000|Randomization Treatment|Worsening of General condition|0|||
46701260|NCT01204710|82916231|FG001|Randomization Treatment|Worsening of General condition|1|||
46701261|NCT01204710|82916230|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
46701262|NCT01204710|82916231|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
46701263|NCT01204710|82916230|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
46701264|NCT01204710|82916231|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
46701265|NCT01204710|82916230|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
46701266|NCT01204710|82916231|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
46701267|NCT01204710|82916230|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
46701268|NCT01204710|82916231|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
46701269|NCT01256450|82916246|FG000|Open-label Titration|Adverse Event|39|||
46701270|NCT01256450|82916247|FG001|Open-label Titration|Adverse Event|0|||
46701271|NCT01256450|82916248|FG002|Open-label Titration|Adverse Event|0|||
46701272|NCT01256450|82916246|FG000|Open-label Titration|Lost to Follow-up|7|||
46701273|NCT01256450|82916247|FG001|Open-label Titration|Lost to Follow-up|0|||
46701274|NCT01256450|82916248|FG002|Open-label Titration|Lost to Follow-up|0|||
46701275|NCT01256450|82916246|FG000|Open-label Titration|Lack of analgesic effect|30|||
46701276|NCT01256450|82916247|FG001|Open-label Titration|Lack of analgesic effect|0|||
46701277|NCT01256450|82916248|FG002|Open-label Titration|Lack of analgesic effect|0|||
46701278|NCT01256450|82916246|FG000|Open-label Titration|Non-compliance|9|||
46701279|NCT01256450|82916247|FG001|Open-label Titration|Non-compliance|0|||
46701280|NCT01256450|82916248|FG002|Open-label Titration|Non-compliance|0|||
46701281|NCT01256450|82916246|FG000|Open-label Titration|Screen failure|1|||
46701282|NCT01256450|82916247|FG001|Open-label Titration|Screen failure|0|||
46701283|NCT01256450|82916248|FG002|Open-label Titration|Screen failure|0|||
46701284|NCT01256450|82916246|FG000|Open-label Titration|Other|13|||
46701285|NCT01256450|82916247|FG001|Open-label Titration|Other|0|||
46701286|NCT01256450|82916248|FG002|Open-label Titration|Other|0|||
46701287|NCT01256450|82916246|FG000|Double-blind Treatment|Adverse Event|0|||
46701288|NCT01256450|82916247|FG001|Double-blind Treatment|Adverse Event|8|||
46869750|NCT03571256|83088004|FG000|Overall Study|Protocol Violation|0|||
46701289|NCT01256450|82916248|FG002|Double-blind Treatment|Adverse Event|6|||
46869751|NCT03571256|83088005|FG001|Overall Study|Protocol Violation|1|||
46869752|NCT03571256|83088006|FG002|Overall Study|Protocol Violation|1|||
46869753|NCT03570554|83088020|FG000|Overall Study|Non-compliance with study drug|0|||
46869754|NCT03570554|83088021|FG001|Overall Study|Non-compliance with study drug|0|||
46869755|NCT03570554|83088022|FG002|Overall Study|Non-compliance with study drug|1|||
46869756|NCT03570554|83088023|FG003|Overall Study|Non-compliance with study drug|0|||
46869757|NCT03570554|83088020|FG000|Overall Study|Adverse Event|0|||
46701290|NCT01256450|82916246|FG000|Double-blind Treatment|Lost to Follow-up|0|||
46701291|NCT01256450|82916247|FG001|Double-blind Treatment|Lost to Follow-up|1|||
46701292|NCT01256450|82916248|FG002|Double-blind Treatment|Lost to Follow-up|7|||
46869758|NCT03570554|83088021|FG001|Overall Study|Adverse Event|0|||
46869759|NCT03570554|83088022|FG002|Overall Study|Adverse Event|0|||
46983827|NCT02551159|83230109|FG002|Overall Study|Withdrawal by Subject|16|||
46983828|NCT02551159|83230107|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
46983829|NCT02551159|83230108|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
46983830|NCT02551159|83230109|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
46983831|NCT02305563|83230122|FG000|Treatment Period|Disease progression|0|||
46983832|NCT02305563|83230123|FG001|Treatment Period|Disease progression|0|||
46983833|NCT02305563|83230124|FG002|Treatment Period|Disease progression|15|||
46701293|NCT01256450|82916246|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
46701294|NCT01256450|82916247|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
46701295|NCT01256450|82916248|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
46701296|NCT01256450|82916246|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
46701297|NCT01256450|82916247|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
46701298|NCT01256450|82916248|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
46701299|NCT01256450|82916246|FG000|Double-blind Treatment|Non-compliance|0|||
46701300|NCT01256450|82916247|FG001|Double-blind Treatment|Non-compliance|5|||
46701301|NCT01256450|82916248|FG002|Double-blind Treatment|Non-compliance|4|||
46701302|NCT01256450|82916246|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
46701303|NCT01256450|82916247|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
46701304|NCT01256450|82916248|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
46701305|NCT01256450|82916246|FG000|Double-blind Treatment|Other|0|||
46701306|NCT01256450|82916247|FG001|Double-blind Treatment|Other|9|||
46701307|NCT01256450|82916248|FG002|Double-blind Treatment|Other|12|||
46701308|NCT01204398|82916255|FG000|Overall Study|Adverse Event|1|||
46701309|NCT01111851|82916261|FG000|Overall Study|All planned PET scans were not obtained.|2|||
46701310|NCT01111851|82916262|FG001|Overall Study|All planned PET scans were not obtained.|0|||
46701311|NCT01256294|82916268|FG000|Overall Study|Adverse Event|1|||
46701312|NCT01256294|82916269|FG001|Overall Study|Adverse Event|0|||
46983834|NCT02305563|83230125|FG003|Treatment Period|Disease progression|6|||
46983835|NCT02305563|83230126|FG004|Treatment Period|Disease progression|6|||
46983836|NCT02305563|83230122|FG000|Treatment Period|Study drug toxicity|0|||
46983837|NCT02305563|83230123|FG001|Treatment Period|Study drug toxicity|0|||
46869760|NCT03570554|83088023|FG003|Overall Study|Adverse Event|1|||
46869761|NCT04004208|83088035|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46869762|NCT04004208|83088036|FG001|Overall Study|Withdrawal by parent/guardian|1|||
46869763|NCT04004208|83088035|FG000|Overall Study|Death|3|||
46983838|NCT02305563|83230124|FG002|Treatment Period|Study drug toxicity|0|||
46983839|NCT02305563|83230125|FG003|Treatment Period|Study drug toxicity|1|||
46869764|NCT04004208|83088036|FG001|Overall Study|Death|0|||
46869765|NCT04004208|83088035|FG000|Overall Study|COVID-19 pandemic|1|||
46869766|NCT04004208|83088036|FG001|Overall Study|COVID-19 pandemic|0|||
46869767|NCT04004208|83088035|FG000|Overall Study|Physician Decision|1|||
46869768|NCT04004208|83088036|FG001|Overall Study|Physician Decision|0|||
46869769|NCT04004208|83088035|FG000|Overall Study|Adverse Event|1|||
46869770|NCT04004208|83088036|FG001|Overall Study|Adverse Event|1|||
46869771|NCT03643952|83088042|FG000|Overall Study|Lack of Efficacy|1|||
46869772|NCT03035032|83088054|FG000|Overall Study|Adverse Event|2|||
46869773|NCT03035032|83088054|FG000|Overall Study|Death|9|||
46983840|NCT02305563|83230126|FG004|Treatment Period|Study drug toxicity|2|||
46983841|NCT02305563|83230122|FG000|Treatment Period|Death|0|||
46983842|NCT02305563|83230123|FG001|Treatment Period|Death|0|||
46869774|NCT03035032|83088054|FG000|Overall Study|Lost to Follow-up|1|||
46869775|NCT03035032|83088054|FG000|Overall Study|Progressive Disease|22|||
46983843|NCT02305563|83230124|FG002|Treatment Period|Death|1|||
46983844|NCT02305563|83230125|FG003|Treatment Period|Death|2|||
46701313|NCT01256294|82916268|FG000|Overall Study|Withdrawal by Subject|1|||
46701314|NCT01256294|82916269|FG001|Overall Study|Withdrawal by Subject|1|||
46701315|NCT01256294|82916268|FG000|Overall Study|Protocol deviation|2|||
46701316|NCT01256294|82916269|FG001|Overall Study|Protocol deviation|1|||
46869776|NCT03035032|83088054|FG000|Overall Study|Protocol Violation|2|||
46869777|NCT03035032|83088054|FG000|Overall Study|Withdrawal by Subject|2|||
46869778|NCT03035032|83088054|FG000|Overall Study|Physician Decision|5|||
46983845|NCT02305563|83230126|FG004|Treatment Period|Death|1|||
46983846|NCT02305563|83230122|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
46983847|NCT02305563|83230123|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
46983848|NCT02305563|83230124|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
46983849|NCT02305563|83230125|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
46983850|NCT02305563|83230126|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
46983851|NCT02305563|83230122|FG000|Treatment Period|Participant request to stop therapy|0|||
46983852|NCT02305563|83230123|FG001|Treatment Period|Participant request to stop therapy|2|||
46983853|NCT02305563|83230124|FG002|Treatment Period|Participant request to stop therapy|0|||
46983854|NCT02305563|83230125|FG003|Treatment Period|Participant request to stop therapy|1|||
46983855|NCT02305563|83230126|FG004|Treatment Period|Participant request to stop therapy|0|||
46983856|NCT02305563|83230122|FG000|Treatment Period|Participant withdrew consent|0|||
46983857|NCT02305563|83230123|FG001|Treatment Period|Participant withdrew consent|0|||
46983858|NCT02305563|83230124|FG002|Treatment Period|Participant withdrew consent|1|||
46983859|NCT02305563|83230125|FG003|Treatment Period|Participant withdrew consent|1|||
46983860|NCT02305563|83230126|FG004|Treatment Period|Participant withdrew consent|1|||
46983861|NCT02305563|83230122|FG000|Treatment Period|Maximum clinical benefit|0|||
46983862|NCT02305563|83230123|FG001|Treatment Period|Maximum clinical benefit|0|||
46983863|NCT02305563|83230124|FG002|Treatment Period|Maximum clinical benefit|0|||
46983864|NCT02305563|83230125|FG003|Treatment Period|Maximum clinical benefit|0|||
46983865|NCT02305563|83230126|FG004|Treatment Period|Maximum clinical benefit|1|||
46983866|NCT02305563|83230122|FG000|Treatment Period|Poor/non-compliance|0|||
46983867|NCT02305563|83230123|FG001|Treatment Period|Poor/non-compliance|0|||
46983868|NCT02305563|83230124|FG002|Treatment Period|Poor/non-compliance|0|||
46983869|NCT02305563|83230125|FG003|Treatment Period|Poor/non-compliance|0|||
46983870|NCT02305563|83230126|FG004|Treatment Period|Poor/non-compliance|1|||
46983871|NCT02305563|83230122|FG000|Treatment Period|Administrative reason by Sponsor|0|||
46983872|NCT02305563|83230123|FG001|Treatment Period|Administrative reason by Sponsor|0|||
46983873|NCT02305563|83230124|FG002|Treatment Period|Administrative reason by Sponsor|0|||
46983874|NCT02305563|83230125|FG003|Treatment Period|Administrative reason by Sponsor|0|||
46983875|NCT02305563|83230126|FG004|Treatment Period|Administrative reason by Sponsor|1|||
46983876|NCT02305563|83230122|FG000|Treatment Period|other reason|2|||
46983877|NCT02305563|83230123|FG001|Treatment Period|other reason|0|||
46983878|NCT02305563|83230124|FG002|Treatment Period|other reason|2|||
46983879|NCT02305563|83230125|FG003|Treatment Period|other reason|2|||
46983880|NCT02305563|83230126|FG004|Treatment Period|other reason|1|||
46983881|NCT02305563|83230122|FG000|Treatment Period|Randomized but not treated|0|||
46983882|NCT02305563|83230123|FG001|Treatment Period|Randomized but not treated|0|||
46983883|NCT02305563|83230124|FG002|Treatment Period|Randomized but not treated|0|||
46983884|NCT02305563|83230125|FG003|Treatment Period|Randomized but not treated|0|||
46983885|NCT02305563|83230126|FG004|Treatment Period|Randomized but not treated|2|||
46983886|NCT02305563|83230122|FG000|Treatment Period|added ULO, then disease progression|0|||
46983887|NCT02305563|83230123|FG001|Treatment Period|added ULO, then disease progression|0|||
46983888|NCT02305563|83230124|FG002|Treatment Period|added ULO, then disease progression|0|||
46983889|NCT02305563|83230125|FG003|Treatment Period|added ULO, then disease progression|0|||
46983890|NCT02305563|83230126|FG004|Treatment Period|added ULO, then disease progression|4|||
46983891|NCT02305563|83230122|FG000|Treatment Period|added ULO; then other reason|0|||
46983892|NCT02305563|83230123|FG001|Treatment Period|added ULO; then other reason|0|||
46983893|NCT02305563|83230124|FG002|Treatment Period|added ULO; then other reason|0|||
46983894|NCT02305563|83230125|FG003|Treatment Period|added ULO; then other reason|0|||
46983895|NCT02305563|83230126|FG004|Treatment Period|added ULO; then other reason|1|||
46983896|NCT02305563|83230122|FG000|Treatment Period|added ULO, then request to stop|0|||
46983897|NCT02305563|83230123|FG001|Treatment Period|added ULO, then request to stop|0|||
46983898|NCT02305563|83230124|FG002|Treatment Period|added ULO, then request to stop|0|||
46983899|NCT02305563|83230125|FG003|Treatment Period|added ULO, then request to stop|0|||
46983900|NCT02305563|83230126|FG004|Treatment Period|added ULO, then request to stop|1|||
46983901|NCT02305563|83230122|FG000|Follow-up Period|Death|0|||
46983902|NCT02305563|83230123|FG001|Follow-up Period|Death|0|||
46983903|NCT02305563|83230124|FG002|Follow-up Period|Death|5|||
46983904|NCT02305563|83230125|FG003|Follow-up Period|Death|4|||
46983905|NCT02305563|83230126|FG004|Follow-up Period|Death|7|||
46983906|NCT02305563|83230122|FG000|Follow-up Period|Participant withdrew consent|0|||
46983907|NCT02305563|83230123|FG001|Follow-up Period|Participant withdrew consent|0|||
46983908|NCT02305563|83230124|FG002|Follow-up Period|Participant withdrew consent|2|||
46983909|NCT02305563|83230125|FG003|Follow-up Period|Participant withdrew consent|1|||
46983910|NCT02305563|83230126|FG004|Follow-up Period|Participant withdrew consent|0|||
46983911|NCT02305563|83230122|FG000|Follow-up Period|other reason|0|||
46983912|NCT02305563|83230123|FG001|Follow-up Period|other reason|0|||
46983913|NCT02305563|83230124|FG002|Follow-up Period|other reason|0|||
46983914|NCT02305563|83230125|FG003|Follow-up Period|other reason|0|||
46983915|NCT02305563|83230126|FG004|Follow-up Period|other reason|1|||
46983916|NCT02305563|83230122|FG000|Follow-up Period|Followup no longer required per protocol|3|||
46983917|NCT02305563|83230123|FG001|Follow-up Period|Followup no longer required per protocol|3|||
46983918|NCT02305563|83230124|FG002|Follow-up Period|Followup no longer required per protocol|4|||
46983919|NCT02305563|83230125|FG003|Follow-up Period|Followup no longer required per protocol|1|||
46983920|NCT02305563|83230126|FG004|Follow-up Period|Followup no longer required per protocol|4|||
46701317|NCT01256060|82916275|FG000|Overall Study|Lost to Follow-up|0|||
46701318|NCT01256060|82916276|FG001|Overall Study|Lost to Follow-up|1|||
46701319|NCT01256060|82916277|FG002|Overall Study|Lost to Follow-up|0|||
46701320|NCT01256060|82916278|FG003|Overall Study|Lost to Follow-up|0|||
46701321|NCT01255904|82916286|FG000|Overall Study|Physician Decision|1|||
46701322|NCT01255904|82916287|FG001|Overall Study|Physician Decision|4|||
46701323|NCT01255670|82916295|FG000|Overall Study|Adverse Event|10|||
46701324|NCT01255670|82916296|FG001|Overall Study|Adverse Event|10|||
46701325|NCT01255670|82916295|FG000|Overall Study|Lost to Follow-up|16|||
46701326|NCT01255670|82916296|FG001|Overall Study|Lost to Follow-up|10|||
46701327|NCT01255592|82916304|FG000|Overall Study|Adverse Event|5|||
46701328|NCT01255592|82916305|FG001|Overall Study|Adverse Event|0|||
46701329|NCT01255592|82916304|FG000|Overall Study|Withdrawal by Subject|1|||
46701330|NCT01255592|82916305|FG001|Overall Study|Withdrawal by Subject|0|||
46701331|NCT01255592|82916304|FG000|Overall Study|Other|0|||
46983921|NCT02327325|83230145|FG000|Overall Study|Withdrawal by Subject|1|||
46983922|NCT02327325|83230146|FG001|Overall Study|Withdrawal by Subject|4|||
46983923|NCT02327325|83230147|FG002|Overall Study|Withdrawal by Subject|4|||
46983924|NCT02327325|83230145|FG000|Overall Study|Excluded by Study Team|0|||
46983925|NCT02327325|83230146|FG001|Overall Study|Excluded by Study Team|0|||
46983926|NCT02327325|83230147|FG002|Overall Study|Excluded by Study Team|1|||
46983927|NCT02304705|83230157|FG000|Overall Study|Withdrawal by Subject|2|||
46983928|NCT02304705|83230158|FG001|Overall Study|Withdrawal by Subject|0|||
46983929|NCT02304705|83230157|FG000|Overall Study|Physician Decision|2|||
46983930|NCT02304705|83230158|FG001|Overall Study|Physician Decision|4|||
46983931|NCT02304705|83230157|FG000|Overall Study|Death|0|||
46983932|NCT02304705|83230158|FG001|Overall Study|Death|1|||
46983933|NCT02304705|83230157|FG000|Overall Study|Lost to Follow-up|0|||
46983934|NCT02304705|83230158|FG001|Overall Study|Lost to Follow-up|2|||
46983935|NCT02553499|83230178|FG000|Overall Study|Adverse Event|0|||
46983936|NCT02553499|83230179|FG001|Overall Study|Adverse Event|0|||
46983937|NCT02553499|83230180|FG002|Overall Study|Adverse Event|0|||
46983938|NCT02553499|83230181|FG003|Overall Study|Adverse Event|0|||
46983939|NCT02553499|83230182|FG004|Overall Study|Adverse Event|0|||
46983940|NCT02553499|83230183|FG005|Overall Study|Adverse Event|0|||
46983941|NCT02553499|83230184|FG006|Overall Study|Adverse Event|1|||
46983942|NCT02553499|83230185|FG007|Overall Study|Adverse Event|1|||
46983943|NCT02553499|83230186|FG008|Overall Study|Adverse Event|0|||
46983944|NCT02553499|83230187|FG009|Overall Study|Adverse Event|0|||
46983945|NCT02553499|83230188|FG010|Overall Study|Adverse Event|0|||
46983946|NCT02553499|83230189|FG011|Overall Study|Adverse Event|0|||
46983947|NCT02553499|83230190|FG012|Overall Study|Adverse Event|0|||
46983948|NCT02553499|83230191|FG013|Overall Study|Adverse Event|1|||
46983949|NCT02553499|83230178|FG000|Overall Study|Death|0|||
46983950|NCT02553499|83230179|FG001|Overall Study|Death|1|||
46983951|NCT02553499|83230180|FG002|Overall Study|Death|1|||
46983952|NCT02553499|83230181|FG003|Overall Study|Death|0|||
46983953|NCT02553499|83230182|FG004|Overall Study|Death|1|||
46983954|NCT02553499|83230183|FG005|Overall Study|Death|2|||
46983955|NCT02553499|83230184|FG006|Overall Study|Death|0|||
46983956|NCT02553499|83230185|FG007|Overall Study|Death|0|||
46983957|NCT02553499|83230186|FG008|Overall Study|Death|0|||
46983958|NCT02553499|83230187|FG009|Overall Study|Death|0|||
46983959|NCT02553499|83230188|FG010|Overall Study|Death|1|||
46983960|NCT02553499|83230189|FG011|Overall Study|Death|0|||
46983961|NCT02553499|83230190|FG012|Overall Study|Death|0|||
46983962|NCT02553499|83230191|FG013|Overall Study|Death|0|||
46983963|NCT02553499|83230178|FG000|Overall Study|Lost to Follow-up|0|||
46983964|NCT02553499|83230179|FG001|Overall Study|Lost to Follow-up|0|||
46983965|NCT02553499|83230180|FG002|Overall Study|Lost to Follow-up|0|||
46983966|NCT02553499|83230181|FG003|Overall Study|Lost to Follow-up|0|||
46983967|NCT02553499|83230182|FG004|Overall Study|Lost to Follow-up|0|||
46983968|NCT02553499|83230183|FG005|Overall Study|Lost to Follow-up|0|||
46701332|NCT01255592|82916305|FG001|Overall Study|Other|1|||
46701333|NCT01255436|82916314|FG000|Overall Study|Lost to Follow-up|178|||
46701334|NCT01255436|82916315|FG001|Overall Study|Lost to Follow-up|191|||
46983969|NCT02553499|83230184|FG006|Overall Study|Lost to Follow-up|1|||
46983970|NCT02553499|83230185|FG007|Overall Study|Lost to Follow-up|0|||
46983971|NCT02553499|83230186|FG008|Overall Study|Lost to Follow-up|0|||
46983972|NCT02553499|83230187|FG009|Overall Study|Lost to Follow-up|0|||
46983973|NCT02553499|83230188|FG010|Overall Study|Lost to Follow-up|0|||
46802616|NCT03859323|83021938|FG007|Overall Study|Lost to Follow-up|0|||
46983974|NCT02553499|83230189|FG011|Overall Study|Lost to Follow-up|0|||
46983975|NCT02553499|83230190|FG012|Overall Study|Lost to Follow-up|0|||
46983976|NCT02553499|83230191|FG013|Overall Study|Lost to Follow-up|0|||
46983977|NCT02553499|83230178|FG000|Overall Study|Physician Decision|0|||
46983978|NCT02553499|83230179|FG001|Overall Study|Physician Decision|1|||
46983979|NCT02553499|83230180|FG002|Overall Study|Physician Decision|1|||
46983980|NCT02553499|83230181|FG003|Overall Study|Physician Decision|0|||
46983981|NCT02553499|83230182|FG004|Overall Study|Physician Decision|1|||
46983982|NCT02553499|83230183|FG005|Overall Study|Physician Decision|0|||
46983983|NCT02553499|83230184|FG006|Overall Study|Physician Decision|0|||
46983984|NCT02553499|83230185|FG007|Overall Study|Physician Decision|1|||
46983985|NCT02553499|83230186|FG008|Overall Study|Physician Decision|1|||
46983986|NCT02553499|83230187|FG009|Overall Study|Physician Decision|2|||
46983987|NCT02553499|83230188|FG010|Overall Study|Physician Decision|1|||
46983988|NCT02553499|83230189|FG011|Overall Study|Physician Decision|3|||
46701335|NCT01255436|82916314|FG000|Overall Study|Death, stroke, or MI|4|||
46701336|NCT01255436|82916315|FG001|Overall Study|Death, stroke, or MI|3|||
46701337|NCT01203930|82916323|FG000|Overall Study|Disease Progression|0|||
46701338|NCT01203930|82916324|FG001|Overall Study|Disease Progression|4|||
46701339|NCT01203930|82916323|FG000|Overall Study|Death|3|||
46701340|NCT01203930|82916324|FG001|Overall Study|Death|1|||
46701341|NCT01203930|82916323|FG000|Overall Study|Withdrew Consent|1|||
46701342|NCT01203930|82916324|FG001|Overall Study|Withdrew Consent|10|||
46701343|NCT01203930|82916323|FG000|Overall Study|Investigator Request|0|||
46701344|NCT01203930|82916324|FG001|Overall Study|Investigator Request|8|||
46701345|NCT01203930|82916323|FG000|Overall Study|Study Terminated by Sponsor|0|||
46701346|NCT01203930|82916324|FG001|Overall Study|Study Terminated by Sponsor|12|||
46701347|NCT01203930|82916323|FG000|Overall Study|Poor tolerance of study drug|0|||
46983989|NCT02553499|83230190|FG012|Overall Study|Physician Decision|1|||
46701348|NCT01203930|82916324|FG001|Overall Study|Poor tolerance of study drug|1|||
46701349|NCT01203930|82916323|FG000|Overall Study|Adverse Event|17|||
46701350|NCT01203930|82916324|FG001|Overall Study|Adverse Event|5|||
46701351|NCT01254890|82916334|FG000|Overall Study|Ineligible|0|||
46701352|NCT01254890|82916335|FG001|Overall Study|Ineligible|3|||
46701353|NCT01254890|82916334|FG000|Overall Study|Withdrawal by Subject|1|||
46701354|NCT01254890|82916335|FG001|Overall Study|Withdrawal by Subject|2|||
46701355|NCT01254890|82916334|FG000|Overall Study|Disease Progression|0|||
46701356|NCT01254890|82916335|FG001|Overall Study|Disease Progression|5|||
46701357|NCT01203852|82916340|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
46701358|NCT01203852|82916340|FG000|Washout 2 Weeks|Physician Decision|46|||
46701359|NCT01105533|82916347|FG000|Overall Study|Death|0|||
46701360|NCT01105533|82916348|FG001|Overall Study|Death|0|||
46701361|NCT01105533|82916349|FG002|Overall Study|Death|0|||
46701362|NCT01105533|82916350|FG003|Overall Study|Death|0|||
46701363|NCT01105533|82916351|FG004|Overall Study|Death|1|||
46701364|NCT01105533|82916352|FG005|Overall Study|Death|0|||
46701365|NCT01105533|82916353|FG006|Overall Study|Death|0|||
46701366|NCT01105533|82916354|FG007|Overall Study|Death|0|||
46701367|NCT01105533|82916355|FG008|Overall Study|Death|0|||
46701368|NCT01105533|82916347|FG000|Overall Study|Lack of Efficacy|1|||
46701369|NCT01105533|82916348|FG001|Overall Study|Lack of Efficacy|1|||
46701370|NCT01105533|82916349|FG002|Overall Study|Lack of Efficacy|3|||
46701371|NCT01105533|82916350|FG003|Overall Study|Lack of Efficacy|3|||
46701372|NCT01105533|82916351|FG004|Overall Study|Lack of Efficacy|4|||
46701373|NCT01105533|82916352|FG005|Overall Study|Lack of Efficacy|5|||
46701374|NCT01105533|82916353|FG006|Overall Study|Lack of Efficacy|3|||
46983990|NCT02553499|83230191|FG013|Overall Study|Physician Decision|0|||
46983991|NCT02553499|83230178|FG000|Overall Study|Progressive Disease|0|||
46983992|NCT02553499|83230179|FG001|Overall Study|Progressive Disease|0|||
46869779|NCT03629184|83088060|FG000|Overall Study|Withdrawal by Subject|2|||
46869780|NCT03629184|83088061|FG001|Overall Study|Withdrawal by Subject|1|||
46869781|NCT03629184|83088060|FG000|Overall Study|Physician Decision|1|||
46869782|NCT03629184|83088061|FG001|Overall Study|Physician Decision|0|||
46869783|NCT03549338|83088079|FG000|Overall Study|Progressive Disease|1|||
46701375|NCT01105533|82916354|FG007|Overall Study|Lack of Efficacy|2|||
46869784|NCT03549338|83088080|FG001|Overall Study|Progressive Disease|0|||
46869785|NCT03549338|83088081|FG002|Overall Study|Progressive Disease|0|||
46701376|NCT01105533|82916355|FG008|Overall Study|Lack of Efficacy|9|||
46701377|NCT01105533|82916347|FG000|Overall Study|Adverse Event|0|||
46701378|NCT01105533|82916348|FG001|Overall Study|Adverse Event|0|||
46701379|NCT01105533|82916349|FG002|Overall Study|Adverse Event|0|||
46701380|NCT01105533|82916350|FG003|Overall Study|Adverse Event|0|||
46701381|NCT01105533|82916351|FG004|Overall Study|Adverse Event|1|||
46701382|NCT01105533|82916352|FG005|Overall Study|Adverse Event|2|||
46983993|NCT02553499|83230180|FG002|Overall Study|Progressive Disease|0|||
46983994|NCT02553499|83230181|FG003|Overall Study|Progressive Disease|2|||
46983995|NCT02553499|83230182|FG004|Overall Study|Progressive Disease|1|||
46983996|NCT02553499|83230183|FG005|Overall Study|Progressive Disease|1|||
46701383|NCT01105533|82916353|FG006|Overall Study|Adverse Event|2|||
46701384|NCT01105533|82916354|FG007|Overall Study|Adverse Event|0|||
46701385|NCT01105533|82916355|FG008|Overall Study|Adverse Event|1|||
46701386|NCT01105533|82916347|FG000|Overall Study|Other|0|||
46701387|NCT01105533|82916348|FG001|Overall Study|Other|0|||
46701388|NCT01105533|82916349|FG002|Overall Study|Other|0|||
46983997|NCT02553499|83230184|FG006|Overall Study|Progressive Disease|1|||
46701389|NCT01105533|82916350|FG003|Overall Study|Other|0|||
46701390|NCT01105533|82916351|FG004|Overall Study|Other|1|||
46983998|NCT02553499|83230185|FG007|Overall Study|Progressive Disease|0|||
46983999|NCT02553499|83230186|FG008|Overall Study|Progressive Disease|0|||
46984000|NCT02553499|83230187|FG009|Overall Study|Progressive Disease|1|||
46984001|NCT02553499|83230188|FG010|Overall Study|Progressive Disease|0|||
46984002|NCT02553499|83230189|FG011|Overall Study|Progressive Disease|0|||
46984003|NCT02553499|83230190|FG012|Overall Study|Progressive Disease|2|||
46984004|NCT02553499|83230191|FG013|Overall Study|Progressive Disease|1|||
46984005|NCT02553499|83230178|FG000|Overall Study|Study Terminated by Sponsor|0|||
46701391|NCT01105533|82916352|FG005|Overall Study|Other|0|||
46701392|NCT01105533|82916353|FG006|Overall Study|Other|3|||
46701393|NCT01105533|82916354|FG007|Overall Study|Other|1|||
46701394|NCT01105533|82916355|FG008|Overall Study|Other|2|||
46701395|NCT01105533|82916347|FG000|Overall Study|Physician Decision|0|||
46701396|NCT01105533|82916348|FG001|Overall Study|Physician Decision|0|||
46701397|NCT01105533|82916349|FG002|Overall Study|Physician Decision|0|||
46701398|NCT01105533|82916350|FG003|Overall Study|Physician Decision|0|||
46701399|NCT01105533|82916351|FG004|Overall Study|Physician Decision|0|||
46701400|NCT01105533|82916352|FG005|Overall Study|Physician Decision|0|||
46701401|NCT01105533|82916353|FG006|Overall Study|Physician Decision|0|||
46701402|NCT01105533|82916354|FG007|Overall Study|Physician Decision|1|||
46701403|NCT01105533|82916355|FG008|Overall Study|Physician Decision|0|||
46701404|NCT01203072|82916373|FG000|Overall Study|Adverse Event|5|||
46701405|NCT01203072|82916374|FG001|Overall Study|Adverse Event|3|||
46701406|NCT01203072|82916375|FG002|Overall Study|Adverse Event|2|||
46701407|NCT01203072|82916376|FG003|Overall Study|Adverse Event|4|||
46701408|NCT01203072|82916377|FG004|Overall Study|Adverse Event|2|||
46701409|NCT01203072|82916373|FG000|Overall Study|Lack of Efficacy|1|||
46701410|NCT01203072|82916374|FG001|Overall Study|Lack of Efficacy|0|||
46701411|NCT01203072|82916375|FG002|Overall Study|Lack of Efficacy|0|||
46701412|NCT01203072|82916376|FG003|Overall Study|Lack of Efficacy|0|||
46701413|NCT01203072|82916377|FG004|Overall Study|Lack of Efficacy|0|||
46701414|NCT01203072|82916373|FG000|Overall Study|Lost to Follow-up|0|||
46701415|NCT01203072|82916374|FG001|Overall Study|Lost to Follow-up|1|||
46701416|NCT01203072|82916375|FG002|Overall Study|Lost to Follow-up|0|||
46701417|NCT01203072|82916376|FG003|Overall Study|Lost to Follow-up|0|||
46701418|NCT01203072|82916377|FG004|Overall Study|Lost to Follow-up|0|||
46701419|NCT01203072|82916373|FG000|Overall Study|Protocol Violation|2|||
46701420|NCT01203072|82916374|FG001|Overall Study|Protocol Violation|0|||
46701421|NCT01203072|82916375|FG002|Overall Study|Protocol Violation|0|||
46701422|NCT01203072|82916376|FG003|Overall Study|Protocol Violation|0|||
46701423|NCT01203072|82916377|FG004|Overall Study|Protocol Violation|1|||
46701424|NCT01203072|82916373|FG000|Overall Study|Withdrawal by Subject|2|||
46701425|NCT01203072|82916374|FG001|Overall Study|Withdrawal by Subject|2|||
46701426|NCT01203072|82916375|FG002|Overall Study|Withdrawal by Subject|1|||
46701427|NCT01203072|82916376|FG003|Overall Study|Withdrawal by Subject|2|||
46701428|NCT01203072|82916377|FG004|Overall Study|Withdrawal by Subject|3|||
46701429|NCT01105377|82916391|FG000|Overall Study|Withdrawal by Subject|0|||
46701430|NCT01105377|82916392|FG001|Overall Study|Withdrawal by Subject|1|||
46701431|NCT01105065|82916398|FG000|Overall Study|Adverse Event|5|||
46701432|NCT01105065|82916398|FG000|Overall Study|Technical Problems|1|||
46701433|NCT01111539|82916404|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
46701434|NCT01111539|82916405|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46701435|NCT01111539|82916406|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46701436|NCT01111539|82916407|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46701437|NCT01111539|82916408|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
46701438|NCT01111539|82916404|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
46701439|NCT01111539|82916405|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46701440|NCT01111539|82916406|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46701441|NCT01111539|82916407|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46701442|NCT01111539|82916408|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
46701443|NCT01111539|82916404|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
46701444|NCT01111539|82916405|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46701445|NCT01111539|82916406|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46701446|NCT01111539|82916407|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46701447|NCT01111539|82916408|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
46701448|NCT01111539|82916404|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
46701449|NCT01111539|82916405|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
46701450|NCT01111539|82916406|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
46984006|NCT02553499|83230179|FG001|Overall Study|Study Terminated by Sponsor|0|||
46701451|NCT01111539|82916407|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
46701452|NCT01111539|82916408|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
46701453|NCT01111539|82916404|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
46984007|NCT02553499|83230180|FG002|Overall Study|Study Terminated by Sponsor|0|||
46701454|NCT01111539|82916405|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
46984008|NCT02553499|83230181|FG003|Overall Study|Study Terminated by Sponsor|0|||
46701455|NCT01111539|82916406|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
46701456|NCT01111539|82916407|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
46701457|NCT01111539|82916408|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
46701458|NCT01111539|82916404|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
46701459|NCT01111539|82916405|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46701460|NCT01111539|82916406|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46701461|NCT01111539|82916407|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46701462|NCT01111539|82916408|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
46701463|NCT01111539|82916404|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
46701464|NCT01111539|82916405|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
46701465|NCT01111539|82916406|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
46701466|NCT01111539|82916407|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
46701467|NCT01111539|82916408|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
46701468|NCT01111539|82916404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
46701469|NCT01111539|82916405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
46701470|NCT01111539|82916406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
46701471|NCT01111539|82916407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
46701472|NCT01111539|82916408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
46701473|NCT01111539|82916404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46701474|NCT01111539|82916405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46701475|NCT01111539|82916406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
46701476|NCT01111539|82916407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
46701477|NCT01111539|82916408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
46701478|NCT01111539|82916404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
46701479|NCT01111539|82916405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
46701480|NCT01111539|82916406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
46701481|NCT01111539|82916407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
46701482|NCT01111539|82916408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
46701483|NCT01111539|82916404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
46701484|NCT01111539|82916405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
46701485|NCT01111539|82916406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
46701486|NCT01111539|82916407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
46701487|NCT01111539|82916408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
46701488|NCT01111539|82916404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
46869786|NCT03549338|83088079|FG000|Overall Study|Clinical Progression|0|||
46984009|NCT02553499|83230182|FG004|Overall Study|Study Terminated by Sponsor|0|||
46984010|NCT02553499|83230183|FG005|Overall Study|Study Terminated by Sponsor|0|||
46984011|NCT02553499|83230184|FG006|Overall Study|Study Terminated by Sponsor|0|||
46984012|NCT02553499|83230185|FG007|Overall Study|Study Terminated by Sponsor|0|||
46984013|NCT02553499|83230186|FG008|Overall Study|Study Terminated by Sponsor|1|||
46984014|NCT02553499|83230187|FG009|Overall Study|Study Terminated by Sponsor|0|||
46984015|NCT02553499|83230188|FG010|Overall Study|Study Terminated by Sponsor|0|||
46984016|NCT02553499|83230189|FG011|Overall Study|Study Terminated by Sponsor|0|||
46984017|NCT02553499|83230190|FG012|Overall Study|Study Terminated by Sponsor|0|||
46984018|NCT02553499|83230191|FG013|Overall Study|Study Terminated by Sponsor|0|||
46984019|NCT02553499|83230178|FG000|Overall Study|Withdrawal by Subject|2|||
46984020|NCT02553499|83230179|FG001|Overall Study|Withdrawal by Subject|0|||
46984021|NCT02553499|83230180|FG002|Overall Study|Withdrawal by Subject|0|||
46869787|NCT03549338|83088080|FG001|Overall Study|Clinical Progression|1|||
46869788|NCT03549338|83088081|FG002|Overall Study|Clinical Progression|0|||
46869789|NCT03629028|83088089|FG000|Overall Study|Lost to Follow-up|26|||
46869790|NCT03629028|83088090|FG001|Overall Study|Lost to Follow-up|23|||
46869791|NCT03629028|83088089|FG000|Overall Study|Pregnancy|4|||
46869792|NCT03629028|83088090|FG001|Overall Study|Pregnancy|2|||
46869793|NCT03629028|83088089|FG000|Overall Study|intolerance to examination|2|||
46869794|NCT03629028|83088090|FG001|Overall Study|intolerance to examination|0|||
46869795|NCT03549104|83088108|FG000|Overall Study|Physician Decision|2|||
46869796|NCT03549104|83088109|FG001|Overall Study|Physician Decision|0|||
46869797|NCT03549104|83088108|FG000|Overall Study|Withdrawal by Subject|5|||
46869798|NCT03549104|83088109|FG001|Overall Study|Withdrawal by Subject|2|||
46869799|NCT03549104|83088108|FG000|Overall Study|Covid shelter in place|1|||
46869800|NCT03549104|83088109|FG001|Overall Study|Covid shelter in place|2|||
46869801|NCT02892344|83088117|FG000|Overall Study|Protocol deviation|3|||
46869802|NCT02892344|83088118|FG001|Overall Study|Protocol deviation|4|||
46869803|NCT02892344|83088117|FG000|Overall Study|Adverse Event|1|||
46869804|NCT02892344|83088118|FG001|Overall Study|Adverse Event|8|||
46869805|NCT02892344|83088117|FG000|Overall Study|Lost to Follow-up|0|||
46869806|NCT02892344|83088118|FG001|Overall Study|Lost to Follow-up|1|||
46869807|NCT02892344|83088117|FG000|Overall Study|Non-compliance with study treatment|0|||
46869808|NCT02892344|83088118|FG001|Overall Study|Non-compliance with study treatment|1|||
46869809|NCT02892344|83088117|FG000|Overall Study|Physician Decision|0|||
46869810|NCT02892344|83088118|FG001|Overall Study|Physician Decision|2|||
46869811|NCT02892344|83088117|FG000|Overall Study|Subject/guardian decision|0|||
46869812|NCT02892344|83088118|FG001|Overall Study|Subject/guardian decision|4|||
46869813|NCT02892344|83088117|FG000|Overall Study|Technical problems|0|||
46869814|NCT02892344|83088118|FG001|Overall Study|Technical problems|1|||
46869815|NCT03567980|83088124|FG000|Overall Study|Adverse Event|1|||
46869816|NCT02894840|83088132|FG000|Overall Study|Lost to Follow-up|1|||
46869817|NCT02894840|83088133|FG001|Overall Study|Lost to Follow-up|0|||
46869818|NCT02894840|83088134|FG002|Overall Study|Lost to Follow-up|3|||
46869819|NCT02894840|83088135|FG003|Overall Study|Lost to Follow-up|0|||
46869820|NCT03358030|83088154|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
46869821|NCT03358030|83088155|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
46869822|NCT03358030|83088156|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
46869823|NCT03358030|83088157|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
46869824|NCT03358030|83088154|FG000|Overall Study|Ineligibility|0|||
46869825|NCT03358030|83088155|FG001|Overall Study|Ineligibility|0|||
46869826|NCT03358030|83088156|FG002|Overall Study|Ineligibility|0|||
46869827|NCT03358030|83088157|FG003|Overall Study|Ineligibility|2|||
46869828|NCT03358030|83088154|FG000|Overall Study|Voluntary Withdrawal|1|||
46869829|NCT03358030|83088155|FG001|Overall Study|Voluntary Withdrawal|1|||
46869830|NCT03358030|83088156|FG002|Overall Study|Voluntary Withdrawal|3|||
46869831|NCT03358030|83088157|FG003|Overall Study|Voluntary Withdrawal|1|||
46869832|NCT03358030|83088154|FG000|Overall Study|Other|0|||
46869833|NCT03358030|83088155|FG001|Overall Study|Other|0|||
46869834|NCT03358030|83088156|FG002|Overall Study|Other|1|||
46869835|NCT03358030|83088157|FG003|Overall Study|Other|0|||
46869836|NCT03566810|83088171|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
46869837|NCT03566810|83088172|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
46869838|NCT03566810|83088173|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
46869839|NCT03566810|83088174|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
46869840|NCT03628716|83088197|FG000|Overall Study|Adverse Event|1|||
46869841|NCT03628716|83088198|FG001|Overall Study|Adverse Event|1|||
46869842|NCT03628716|83088197|FG000|Overall Study|Death|1|||
46869843|NCT03628716|83088198|FG001|Overall Study|Death|0|||
46869844|NCT03628716|83088197|FG000|Overall Study|Lack of Efficacy|15|||
46869845|NCT03628716|83088198|FG001|Overall Study|Lack of Efficacy|20|||
46869846|NCT03628716|83088197|FG000|Overall Study|Withdrawal by Subject|1|||
46869847|NCT03628716|83088198|FG001|Overall Study|Withdrawal by Subject|2|||
46869848|NCT03628716|83088197|FG000|Overall Study|Study Terminated by Sponsor|1|||
46869849|NCT03628716|83088198|FG001|Overall Study|Study Terminated by Sponsor|0|||
46869850|NCT04002960|83088206|FG000|Overall Study|Withdrawn prior to Completion|2|||
46869851|NCT04002648|83088212|FG000|Overall Study|Lost to Follow-up|2|||
46869852|NCT04002648|83088213|FG001|Overall Study|Lost to Follow-up|0|||
46869853|NCT00088413|83088234|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
46869854|NCT00088413|83088235|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
46869855|NCT00088413|83088236|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
46869856|NCT00088413|83088237|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
46869857|NCT00088413|83088234|FG000|Overall Study|Adverse Events/Side Effects|0|||
46707553|NCT01176240|82923136|FG001|Study 306A|Stop due to diverse problems|0|||
46869858|NCT00088413|83088235|FG001|Overall Study|Adverse Events/Side Effects|1|||
46869859|NCT00088413|83088236|FG002|Overall Study|Adverse Events/Side Effects|1|||
46869860|NCT00088413|83088237|FG003|Overall Study|Adverse Events/Side Effects|0|||
46869861|NCT00088413|83088234|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
46701489|NCT01111539|82916405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
46701490|NCT01111539|82916406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
46701491|NCT01111539|82916407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
46701492|NCT01111539|82916408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
46701493|NCT01111539|82916404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
46701494|NCT01111539|82916405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
46701495|NCT01111539|82916406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
46701496|NCT01111539|82916407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
46701497|NCT01111539|82916408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
46701498|NCT01111539|82916404|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46701499|NCT01111539|82916405|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46701500|NCT01111539|82916406|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46701501|NCT01111539|82916407|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
46701502|NCT01111539|82916408|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
46701503|NCT01111149|82916421|FG000|Overall Study|Protocol Violation|1|||
46701504|NCT01111149|82916422|FG001|Overall Study|Protocol Violation|1|||
46701505|NCT01111149|82916423|FG002|Overall Study|Protocol Violation|2|||
46701506|NCT01111149|82916421|FG000|Overall Study|Withdrawal by Subject|1|||
46701507|NCT01111149|82916422|FG001|Overall Study|Withdrawal by Subject|0|||
46701508|NCT01111149|82916423|FG002|Overall Study|Withdrawal by Subject|2|||
46701509|NCT01254656|82916434|FG000|Overall Study|Discontinued due to termination of study|40|||
46701510|NCT01254656|82916435|FG001|Overall Study|Discontinued due to termination of study|39|||
46701511|NCT01254656|82916436|FG002|Overall Study|Discontinued due to termination of study|13|||
46701512|NCT01254656|82916434|FG000|Overall Study|Lack of Efficacy|3|||
46701513|NCT01254656|82916435|FG001|Overall Study|Lack of Efficacy|0|||
46701514|NCT01254656|82916436|FG002|Overall Study|Lack of Efficacy|0|||
46701515|NCT01254656|82916434|FG000|Overall Study|Lost to Follow-up|1|||
46701516|NCT01254656|82916435|FG001|Overall Study|Lost to Follow-up|0|||
46701517|NCT01254656|82916436|FG002|Overall Study|Lost to Follow-up|2|||
46701518|NCT01254656|82916434|FG000|Overall Study|Withdrawal by Subject|2|||
46701519|NCT01254656|82916435|FG001|Overall Study|Withdrawal by Subject|2|||
46701520|NCT01254656|82916436|FG002|Overall Study|Withdrawal by Subject|1|||
46701521|NCT01254656|82916434|FG000|Overall Study|Pregnancy|0|||
46701522|NCT01254656|82916435|FG001|Overall Study|Pregnancy|0|||
46701523|NCT01254656|82916436|FG002|Overall Study|Pregnancy|2|||
46701524|NCT01254656|82916434|FG000|Overall Study|Adverse Event|1|||
46701525|NCT01254656|82916435|FG001|Overall Study|Adverse Event|1|||
46701526|NCT01254656|82916436|FG002|Overall Study|Adverse Event|0|||
46701527|NCT01254656|82916434|FG000|Overall Study|Death|0|||
46701528|NCT01254656|82916435|FG001|Overall Study|Death|1|||
46701529|NCT01254656|82916436|FG002|Overall Study|Death|0|||
46701530|NCT01110915|82916446|FG000|Overall Study|Death|2|||
46701531|NCT01110915|82916447|FG001|Overall Study|Death|1|||
46701532|NCT01110915|82916446|FG000|Overall Study|Lost to Follow-up|1|||
46701533|NCT01110915|82916447|FG001|Overall Study|Lost to Follow-up|0|||
46701534|NCT01110915|82916446|FG000|Overall Study|Withdrawal by Subject|7|||
46701535|NCT01110915|82916447|FG001|Overall Study|Withdrawal by Subject|1|||
46701536|NCT01254344|82916456|FG000|Overall Study|Adverse Event|2|||
46701537|NCT01254344|82916457|FG001|Overall Study|Adverse Event|5|||
46701538|NCT01254344|82916456|FG000|Overall Study|Physician Decision|7|||
46701539|NCT01254344|82916457|FG001|Overall Study|Physician Decision|4|||
46701540|NCT01254344|82916456|FG000|Overall Study|Protocol Violation|1|||
46701541|NCT01254344|82916457|FG001|Overall Study|Protocol Violation|4|||
46701542|NCT01254344|82916456|FG000|Overall Study|Withdrawal by Subject|3|||
46701543|NCT01254344|82916457|FG001|Overall Study|Withdrawal by Subject|6|||
46701544|NCT01102803|82916465|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
46701545|NCT01102803|82916466|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
46701546|NCT01102803|82916465|FG000|Post to Follow-Up|Lost to Follow-up|1|||
46701547|NCT01102803|82916466|FG001|Post to Follow-Up|Lost to Follow-up|3|||
46701548|NCT01254188|82916474|FG000|Overall Study|Disease Progression|6|||
46701549|NCT01254188|82916474|FG000|Overall Study|Protocol Violation|6|||
46701550|NCT01254188|82916474|FG000|Overall Study|Pregnancy|2|||
46701551|NCT01254188|82916474|FG000|Overall Study|Death|4|||
46984022|NCT02553499|83230181|FG003|Overall Study|Withdrawal by Subject|0|||
46984023|NCT02553499|83230182|FG004|Overall Study|Withdrawal by Subject|0|||
46984024|NCT02553499|83230183|FG005|Overall Study|Withdrawal by Subject|0|||
46701552|NCT01254188|82916474|FG000|Overall Study|Lost to Follow-up|5|||
46701553|NCT01254188|82916474|FG000|Overall Study|Withdrawal by Subject|7|||
46701554|NCT01254188|82916474|FG000|Overall Study|Adverse Event|43|||
46701555|NCT01254188|82916474|FG000|Overall Study|per investigator discretion|20|||
46701556|NCT01109979|82916480|FG000|Overall Study|Physician Decision|2|||
46701557|NCT01109979|82916481|FG001|Overall Study|Physician Decision|0|||
46701558|NCT01109979|82916480|FG000|Overall Study|Withdrawal by Subject|0|||
46701559|NCT01109979|82916481|FG001|Overall Study|Withdrawal by Subject|1|||
46701560|NCT01102491|82916489|FG000|Overall Study|Protocol Violation|11|||
46984025|NCT02553499|83230184|FG006|Overall Study|Withdrawal by Subject|0|||
46984026|NCT02553499|83230185|FG007|Overall Study|Withdrawal by Subject|1|||
46984027|NCT02553499|83230186|FG008|Overall Study|Withdrawal by Subject|1|||
46984028|NCT02553499|83230187|FG009|Overall Study|Withdrawal by Subject|0|||
46701561|NCT01102491|82916490|FG001|Overall Study|Protocol Violation|12|||
46701562|NCT01102257|82916498|FG000|Overall Study|Adverse Event|1|||
46701563|NCT01102257|82916499|FG001|Overall Study|Adverse Event|0|||
46701564|NCT01102257|82916498|FG000|Overall Study|Adverse Event|1|||
46701565|NCT01102257|82916499|FG001|Overall Study|Adverse Event|0|||
46701566|NCT01253564|82916505|FG000|Overall Study|Disease Progression|22|||
46701567|NCT01253564|82916505|FG000|Overall Study|Withdrawal by Subject|1|||
46701568|NCT01253564|82916505|FG000|Overall Study|Serious Adverse Event|1|||
46701569|NCT01108809|82916509|FG000|Overall Study|Adverse Event|3|||
46701570|NCT01108809|82916509|FG000|Overall Study|Lost to Follow-up|1|||
46701571|NCT01253408|82916517|FG000|Overall Study|Adverse Event|0|||
46701572|NCT01253408|82916518|FG001|Overall Study|Adverse Event|1|||
46701573|NCT01253408|82916519|FG002|Overall Study|Adverse Event|0|||
46701574|NCT01253174|82916527|FG000|Period 1|Randomized but not treated|0|||
46701575|NCT01253174|82916528|FG001|Period 1|Randomized but not treated|1|||
46701576|NCT01253174|82916529|FG002|Period 1|Randomized but not treated|1|||
46701577|NCT01253174|82916530|FG003|Period 1|Randomized but not treated|0|||
46701578|NCT01253174|82916531|FG004|Period 1|Randomized but not treated|1|||
46701579|NCT01253174|82916532|FG005|Period 1|Randomized but not treated|0|||
46701580|NCT01253174|82916527|FG000|Period 2|Adverse Event|0|||
46701581|NCT01253174|82916528|FG001|Period 2|Adverse Event|0|||
46701582|NCT01253174|82916529|FG002|Period 2|Adverse Event|1|||
46701583|NCT01253174|82916530|FG003|Period 2|Adverse Event|0|||
46701584|NCT01253174|82916531|FG004|Period 2|Adverse Event|0|||
46701585|NCT01253174|82916532|FG005|Period 2|Adverse Event|0|||
46701586|NCT01253174|82916527|FG000|Period 3|Withdrawal by Subject|0|||
46701587|NCT01253174|82916528|FG001|Period 3|Withdrawal by Subject|1|||
46701588|NCT01253174|82916529|FG002|Period 3|Withdrawal by Subject|0|||
46701589|NCT01253174|82916530|FG003|Period 3|Withdrawal by Subject|0|||
46701590|NCT01253174|82916531|FG004|Period 3|Withdrawal by Subject|1|||
46701591|NCT01253174|82916532|FG005|Period 3|Withdrawal by Subject|0|||
46701592|NCT01253174|82916527|FG000|Period 3|Pregnancy|0|||
46701593|NCT01253174|82916528|FG001|Period 3|Pregnancy|0|||
46701594|NCT01253174|82916529|FG002|Period 3|Pregnancy|1|||
46869862|NCT00088413|83088235|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
46869863|NCT00088413|83088236|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
46869864|NCT00088413|83088237|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
46869865|NCT00088413|83088234|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
46869866|NCT00088413|83088235|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
46869867|NCT00088413|83088236|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
46984029|NCT02553499|83230188|FG010|Overall Study|Withdrawal by Subject|1|||
46984030|NCT02553499|83230189|FG011|Overall Study|Withdrawal by Subject|0|||
46869868|NCT00088413|83088237|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
46869869|NCT00088413|83088234|FG000|Overall Study|Death|0|||
46869870|NCT00088413|83088235|FG001|Overall Study|Death|1|||
46869871|NCT00088413|83088236|FG002|Overall Study|Death|0|||
46869872|NCT00088413|83088237|FG003|Overall Study|Death|0|||
46869873|NCT00088413|83088234|FG000|Overall Study|Progressive disease|9|||
46869874|NCT00088413|83088235|FG001|Overall Study|Progressive disease|11|||
46869875|NCT00088413|83088236|FG002|Overall Study|Progressive disease|8|||
46869876|NCT00088413|83088237|FG003|Overall Study|Progressive disease|14|||
46869877|NCT00088413|83088234|FG000|Overall Study|Other|0|||
46869878|NCT00088413|83088235|FG001|Overall Study|Other|1|||
46869879|NCT00088413|83088236|FG002|Overall Study|Other|0|||
46869880|NCT00088413|83088237|FG003|Overall Study|Other|0|||
46984031|NCT02553499|83230190|FG012|Overall Study|Withdrawal by Subject|0|||
46701595|NCT01253174|82916530|FG003|Period 3|Pregnancy|0|||
46701596|NCT01253174|82916531|FG004|Period 3|Pregnancy|0|||
46701597|NCT01253174|82916532|FG005|Period 3|Pregnancy|0|||
46701598|NCT01108731|82916543|FG000|Overall Study|Withdrawal by Subject|1|||
46701599|NCT01108731|82916544|FG001|Overall Study|Withdrawal by Subject|1|||
46701600|NCT01108731|82916543|FG000|Overall Study|Adverse Event|3|||
46701601|NCT01108731|82916544|FG001|Overall Study|Adverse Event|3|||
46701602|NCT01253018|82916552|FG000|Overall Study|Lost to Follow-up|1|||
46701603|NCT01253018|82916553|FG001|Overall Study|Lost to Follow-up|1|||
46701604|NCT01253018|82916552|FG000|Overall Study|Robot Repair Issues|2|||
46701605|NCT01253018|82916553|FG001|Overall Study|Robot Repair Issues|0|||
46701606|NCT01253018|82916552|FG000|Overall Study|Withdrawal by Subject|1|||
46701607|NCT01253018|82916553|FG001|Overall Study|Withdrawal by Subject|1|||
46701608|NCT01108341|82916560|FG000|Overall Study|Death|2|||
46701609|NCT01108341|82916560|FG000|Overall Study|Withdrawal by Subject|1|||
46701610|NCT01108341|82916560|FG000|Overall Study|Lost to Follow-up|1|||
46701611|NCT01108341|82916560|FG000|Overall Study|Other|1|||
46701612|NCT01108263|82916566|FG000|Overall Study|Adverse Event|0|||
46869881|NCT00088413|83088234|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
46701613|NCT01108263|82916567|FG001|Overall Study|Adverse Event|1|||
46701614|NCT01108185|82916573|FG000|Overall Study|Non-compliance|15|||
46701615|NCT01108185|82916573|FG000|Overall Study|Lost to Follow-up|12|||
46701616|NCT01252940|82916579|FG000|Main Study Phase|Randomized but not treated|4|||
46701617|NCT01252940|82916580|FG001|Main Study Phase|Randomized but not treated|2|||
46701618|NCT01252940|82916579|FG000|Main Study Phase|Adverse Event|3|||
46701619|NCT01252940|82916580|FG001|Main Study Phase|Adverse Event|1|||
46701620|NCT01252940|82916579|FG000|Main Study Phase|Lack of Efficacy|1|||
46701621|NCT01252940|82916580|FG001|Main Study Phase|Lack of Efficacy|0|||
46701622|NCT01252940|82916579|FG000|Main Study Phase|Lost to Follow-up|6|||
46701623|NCT01252940|82916580|FG001|Main Study Phase|Lost to Follow-up|1|||
46701624|NCT01252940|82916579|FG000|Main Study Phase|Physician Decision|1|||
46701625|NCT01252940|82916580|FG001|Main Study Phase|Physician Decision|0|||
46701626|NCT01252940|82916579|FG000|Main Study Phase|Protocol Violation|4|||
46701627|NCT01252940|82916580|FG001|Main Study Phase|Protocol Violation|2|||
46701628|NCT01252940|82916579|FG000|Main Study Phase|Withdrawal by Subject|6|||
46701629|NCT01252940|82916580|FG001|Main Study Phase|Withdrawal by Subject|5|||
46701630|NCT01252940|82916579|FG000|Main Study Phase|Subject Non-compliance|1|||
46701631|NCT01252940|82916580|FG001|Main Study Phase|Subject Non-compliance|1|||
46701632|NCT01252940|82916579|FG000|Extension Phase|Adverse Event|2|||
46701633|NCT01252940|82916580|FG001|Extension Phase|Adverse Event|1|||
46701634|NCT01252940|82916579|FG000|Extension Phase|Lack of Efficacy|1|||
46701635|NCT01252940|82916580|FG001|Extension Phase|Lack of Efficacy|0|||
46701636|NCT01252940|82916579|FG000|Extension Phase|Lost to Follow-up|5|||
46701637|NCT01252940|82916580|FG001|Extension Phase|Lost to Follow-up|0|||
46701638|NCT01252940|82916579|FG000|Extension Phase|Physician Decision|0|||
46701639|NCT01252940|82916580|FG001|Extension Phase|Physician Decision|1|||
46701640|NCT01252940|82916579|FG000|Extension Phase|Subject Non-compliance|1|||
46701641|NCT01252940|82916580|FG001|Extension Phase|Subject Non-compliance|0|||
46701642|NCT01252940|82916579|FG000|Extension Phase|Withdrawal by Subject|1|||
46701643|NCT01252940|82916580|FG001|Extension Phase|Withdrawal by Subject|1|||
46701644|NCT01252238|82916590|FG000|Overall Study|Sponsor terminated study|4|||
46701645|NCT01252238|82916591|FG001|Overall Study|Sponsor terminated study|4|||
46869882|NCT00088413|83088235|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
46869883|NCT00088413|83088236|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
46869884|NCT00088413|83088237|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
46869885|NCT03995784|83088249|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
46869886|NCT00086385|83088264|FG000|Overall Study|Death|2|||
46869887|NCT00086385|83088265|FG001|Overall Study|Death|2|||
46869888|NCT00086385|83088266|FG002|Overall Study|Death|1|||
46869889|NCT00086385|83088267|FG003|Overall Study|Death|1|||
46869890|NCT03993288|83088279|FG000|Overall Study|Lost to Follow-up|2|||
46869891|NCT03993288|83088280|FG001|Overall Study|Lost to Follow-up|1|||
46869892|NCT03993288|83088279|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
46869893|NCT03993288|83088280|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
46869894|NCT03993288|83088279|FG000|Overall Study|wrong randomization|0|||
46869895|NCT03993288|83088280|FG001|Overall Study|wrong randomization|1|||
46869896|NCT03993288|83088279|FG000|Overall Study|improper enrollment|0|||
46869897|NCT03993288|83088280|FG001|Overall Study|improper enrollment|1|||
46869898|NCT03993288|83088279|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
46869899|NCT03993288|83088280|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
46869900|NCT03993288|83088279|FG000|Overall Study|developed SAE|2|||
46869901|NCT03993288|83088280|FG001|Overall Study|developed SAE|0|||
46869902|NCT03993288|83088279|FG000|Overall Study|consent withdrawal|1|||
46869903|NCT03993288|83088280|FG001|Overall Study|consent withdrawal|0|||
46701646|NCT01252238|82916592|FG002|Overall Study|Sponsor terminated study|4|||
46701647|NCT01101477|82916606|FG000|Overall Study|Protocol Violation|5|||
46701648|NCT01101477|82916607|FG001|Overall Study|Protocol Violation|3|||
46701649|NCT01101477|82916608|FG002|Overall Study|Protocol Violation|1|||
46701650|NCT01251770|82916618|FG000|Overall Study|Protocol Violation|13|||
46701651|NCT01251770|82916619|FG001|Overall Study|Protocol Violation|7|||
46701652|NCT01101321|82916625|FG000|Period 1|Withdrawal by Subject|1|||
46701653|NCT01101321|82916626|FG001|Period 1|Withdrawal by Subject|1|||
46701654|NCT01101321|82916625|FG000|Period 1|Adverse Event|3|||
46701655|NCT01101321|82916626|FG001|Period 1|Adverse Event|3|||
46701656|NCT01101165|82916632|FG000|Period 1|Adverse Event|1|||
46701657|NCT01101165|82916633|FG001|Period 1|Adverse Event|2|||
46701658|NCT01101165|82916632|FG000|Period 1|Withdrawal by Subject|0|||
46701659|NCT01101165|82916633|FG001|Period 1|Withdrawal by Subject|2|||
46701660|NCT01101165|82916632|FG000|Period 1|Positive Drug Screen|0|||
46701661|NCT01101165|82916633|FG001|Period 1|Positive Drug Screen|1|||
46701662|NCT01101165|82916632|FG000|Period 1|Lost to Follow-up|1|||
46701663|NCT01101165|82916633|FG001|Period 1|Lost to Follow-up|0|||
46701664|NCT01101165|82916632|FG000|Period 2|Withdrawal by Subject|3|||
46701665|NCT01101165|82916633|FG001|Period 2|Withdrawal by Subject|1|||
46701666|NCT01101165|82916632|FG000|Period 2|Adverse Event|1|||
46701667|NCT01101165|82916633|FG001|Period 2|Adverse Event|0|||
46701668|NCT01100853|82916641|FG000|Overall Study|Lost to Follow-up|11|||
46701669|NCT01100853|82916642|FG001|Overall Study|Lost to Follow-up|6|||
46701670|NCT01100853|82916641|FG000|Overall Study|Received <4 study injections|10|||
46701671|NCT01100853|82916642|FG001|Overall Study|Received <4 study injections|13|||
46701672|NCT01100853|82916641|FG000|Overall Study|Withdrawal by Subject|6|||
46701673|NCT01100853|82916642|FG001|Overall Study|Withdrawal by Subject|4|||
46701674|NCT01100307|82916650|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
46701675|NCT01100307|82916651|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
46869904|NCT03993288|83088279|FG000|Overall Study|did not follow the treatment schedule|1|||
46869905|NCT03993288|83088280|FG001|Overall Study|did not follow the treatment schedule|0|||
46869906|NCT03993288|83088279|FG000|Overall Study|did not follow the treatment regimen|1|||
46869907|NCT03993288|83088280|FG001|Overall Study|did not follow the treatment regimen|0|||
46869908|NCT03993288|83088279|FG000|Overall Study|Adverse Event|1|||
46869909|NCT03993288|83088280|FG001|Overall Study|Adverse Event|0|||
46869910|NCT03993288|83088279|FG000|Overall Study|Withdrawal by Subject|1|||
46869911|NCT03993288|83088280|FG001|Overall Study|Withdrawal by Subject|1|||
46869912|NCT03991494|83088286|FG000|Overall Study|Progressive Disease|4|||
46869913|NCT00086307|83088295|FG000|Overall Study|Lack of Efficacy|1|||
46869914|NCT00086307|83088296|FG001|Overall Study|Lack of Efficacy|1|||
46869915|NCT00086307|83088297|FG002|Overall Study|Lack of Efficacy|2|||
46869916|NCT00086307|83088295|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
46869917|NCT00086307|83088296|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
46869918|NCT00086307|83088297|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
46869919|NCT00086307|83088295|FG000|Overall Study|Nausea and headaches|0|||
46869920|NCT00086307|83088296|FG001|Overall Study|Nausea and headaches|0|||
46869921|NCT00086307|83088297|FG002|Overall Study|Nausea and headaches|1|||
46869922|NCT00086307|83088295|FG000|Overall Study|Constipation and sleepiness|0|||
46869923|NCT00086307|83088296|FG001|Overall Study|Constipation and sleepiness|0|||
46869924|NCT00086307|83088297|FG002|Overall Study|Constipation and sleepiness|1|||
46869925|NCT00086307|83088295|FG000|Overall Study|Suicidal ideation|0|||
46701676|NCT01100307|82916650|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
46701677|NCT01100307|82916651|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
46869926|NCT00086307|83088296|FG001|Overall Study|Suicidal ideation|0|||
46701678|NCT01100307|82916650|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
46701679|NCT01100307|82916651|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
46701680|NCT01100307|82916650|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
46701681|NCT01100307|82916651|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
46701682|NCT01100307|82916650|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
46701683|NCT01100307|82916651|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
46701684|NCT01100307|82916650|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
46701685|NCT01100307|82916651|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
46701686|NCT01100073|82916659|FG000|Overall Study|Lack of Efficacy|4|||
46701687|NCT01100073|82916659|FG000|Overall Study|Insufficient Tolerability|21|||
46701688|NCT01100073|82916659|FG000|Overall Study|Withdrawal by Subject|13|||
46701689|NCT01100073|82916659|FG000|Overall Study|Lost to Follow-up|39|||
46701690|NCT01100073|82916659|FG000|Overall Study|Lack of effect + patient's wish|2|||
46701691|NCT01100073|82916659|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
46701692|NCT01100073|82916659|FG000|Overall Study|Other|8|||
46701693|NCT01100073|82916659|FG000|Overall Study|Missing|5|||
46701694|NCT01099917|82916663|FG000|Overall Study|Adverse Event|3|||
46701695|NCT01099917|82916663|FG000|Overall Study|Not Treated|24|||
46701696|NCT01099215|82916669|FG000|Overall Study|Withdrawal by Subject|1|||
46701697|NCT01099215|82916670|FG001|Overall Study|Withdrawal by Subject|0|||
46701698|NCT01099215|82916669|FG000|Overall Study|Adverse Event|0|||
46701699|NCT01099215|82916670|FG001|Overall Study|Adverse Event|1|||
46701700|NCT01097655|82916676|FG000|Overall Study|Withdrawal by Subject|1|||
46701701|NCT01097655|82916676|FG000|Overall Study|Subject Documented Twice|1|||
46701702|NCT01097655|82916676|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
46701703|NCT01107405|82916685|FG000|Overall Study|Adverse Event|1|||
46701704|NCT01107405|82916686|FG001|Overall Study|Adverse Event|1|||
46701705|NCT01107405|82916687|FG002|Overall Study|Adverse Event|0|||
46701706|NCT01107405|82916688|FG003|Overall Study|Adverse Event|0|||
46701707|NCT01107405|82916689|FG004|Overall Study|Adverse Event|2|||
46701708|NCT01107405|82916685|FG000|Overall Study|Withdrawal by Subject|1|||
46701709|NCT01107405|82916686|FG001|Overall Study|Withdrawal by Subject|0|||
46701710|NCT01107405|82916687|FG002|Overall Study|Withdrawal by Subject|1|||
46701711|NCT01107405|82916688|FG003|Overall Study|Withdrawal by Subject|2|||
46701712|NCT01107405|82916689|FG004|Overall Study|Withdrawal by Subject|1|||
46701713|NCT01107405|82916685|FG000|Overall Study|Protocol Violation|0|||
46701714|NCT01107405|82916686|FG001|Overall Study|Protocol Violation|0|||
46701715|NCT01107405|82916687|FG002|Overall Study|Protocol Violation|1|||
46701716|NCT01107405|82916688|FG003|Overall Study|Protocol Violation|1|||
46701717|NCT01107405|82916689|FG004|Overall Study|Protocol Violation|0|||
46701718|NCT01097577|82916703|FG000|Overall Study|Adverse Event|0|||
46701719|NCT01097577|82916704|FG001|Overall Study|Adverse Event|1|||
46701720|NCT01097421|82916710|FG000|Overall Study|Adverse Event|8|||
46701721|NCT01097421|82916710|FG000|Overall Study|Protocol Violation|2|||
46701722|NCT01097421|82916710|FG000|Overall Study|Lost to Follow-up|1|||
46701723|NCT01097421|82916710|FG000|Overall Study|Withdrawal by Subject|3|||
46701724|NCT01251614|82916717|FG000|Overall Study|Adverse Event|1|||
46701725|NCT01251614|82916718|FG001|Overall Study|Adverse Event|0|||
46701726|NCT01251614|82916719|FG002|Overall Study|Adverse Event|1|||
46701727|NCT01251614|82916717|FG000|Overall Study|Lack of Efficacy|1|||
46701728|NCT01251614|82916718|FG001|Overall Study|Lack of Efficacy|9|||
46701729|NCT01251614|82916719|FG002|Overall Study|Lack of Efficacy|4|||
46701730|NCT01251614|82916717|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
46701731|NCT01251614|82916718|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
46701732|NCT01251614|82916719|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
46701733|NCT01251614|82916717|FG000|Overall Study|Pregnancy|0|||
46701734|NCT01251614|82916718|FG001|Overall Study|Pregnancy|0|||
46701735|NCT01251614|82916719|FG002|Overall Study|Pregnancy|2|||
46701736|NCT01251614|82916717|FG000|Overall Study|Loss of Disease Control|0|||
46701737|NCT01251614|82916718|FG001|Overall Study|Loss of Disease Control|1|||
46701738|NCT01251614|82916719|FG002|Overall Study|Loss of Disease Control|0|||
46701739|NCT01251614|82916717|FG000|Overall Study|Withdrawal by Subject|0|||
46701740|NCT01251614|82916718|FG001|Overall Study|Withdrawal by Subject|2|||
46701741|NCT01251614|82916719|FG002|Overall Study|Withdrawal by Subject|1|||
46869927|NCT00086307|83088297|FG002|Overall Study|Suicidal ideation|1|||
46869928|NCT00086307|83088295|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
46869929|NCT00086307|83088296|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
46869930|NCT00086307|83088297|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
46869931|NCT00086307|83088295|FG000|Overall Study|Withdrawal by Subject|0|||
46701742|NCT01251614|82916717|FG000|Overall Study|Lost to Follow-up|0|||
46701743|NCT01251614|82916718|FG001|Overall Study|Lost to Follow-up|1|||
46701744|NCT01251614|82916719|FG002|Overall Study|Lost to Follow-up|0|||
46701745|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
46701746|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
46701747|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
46701748|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
46701749|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
46701750|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
46701751|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
46701752|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
46701753|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
46701754|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
46701755|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
46701756|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
46701757|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
46701758|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
46701759|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
46701760|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
46701761|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
46701762|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
46701763|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
46701764|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
46701765|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
46701766|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
46701767|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
46701768|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
46701769|NCT01106625|82916740|FG000|Core Period: Baseline to Week 26|Other|8|||
46701770|NCT01106625|82916741|FG001|Core Period: Baseline to Week 26|Other|7|||
46701771|NCT01106625|82916742|FG002|Core Period: Baseline to Week 26|Other|4|||
46701772|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
46701773|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
46701774|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
46701775|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
46701776|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
46701777|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
46701778|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
46701779|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
46701780|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
46701781|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46869932|NCT00086307|83088296|FG001|Overall Study|Withdrawal by Subject|0|||
46869933|NCT00086307|83088297|FG002|Overall Study|Withdrawal by Subject|2|||
46869934|NCT03624972|83088308|FG000|Overall Study|Lost to Follow-up|2|||
46869935|NCT03624972|83088309|FG001|Overall Study|Lost to Follow-up|0|||
46869936|NCT03624972|83088310|FG002|Overall Study|Lost to Follow-up|0|||
46869937|NCT03624972|83088308|FG000|Overall Study|Withdrawal by Subject|0|||
46869938|NCT03624972|83088309|FG001|Overall Study|Withdrawal by Subject|2|||
46869939|NCT03624972|83088310|FG002|Overall Study|Withdrawal by Subject|0|||
46869940|NCT03988842|83088319|FG000|Overall Study|Death|1|||
46869941|NCT02668822|83088326|FG000|Overall Study|Protocol Violation|2|||
46869942|NCT02668822|83088327|FG001|Overall Study|Protocol Violation|0|||
46869943|NCT02668822|83088326|FG000|Overall Study|Study Terminated by Sponsor|7|||
46701782|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
46701783|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
46701784|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
46701785|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46701786|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
46869944|NCT02668822|83088327|FG001|Overall Study|Study Terminated by Sponsor|9|||
46869945|NCT02524288|83088333|FG000|Overall Study|Adverse Event|115|||
46869946|NCT02524288|83088333|FG000|Overall Study|Lost to Follow-up|216|||
46869947|NCT02524288|83088333|FG000|Overall Study|Non-Compliance With Protocol|32|||
46869948|NCT02524288|83088333|FG000|Overall Study|Non-Compliance With Study Drug|14|||
46869949|NCT02524288|83088333|FG000|Overall Study|Pregnancy Wish|6|||
46869950|NCT02524288|83088333|FG000|Overall Study|Protocol Violation|6|||
46869951|NCT02524288|83088333|FG000|Overall Study|Screen Failure|2|||
46869952|NCT02524288|83088333|FG000|Overall Study|Site Discontinued Study Participation|1|||
46869953|NCT02524288|83088333|FG000|Overall Study|Study Terminated By Sponsor|1417|||
46869954|NCT02524288|83088333|FG000|Overall Study|Subject Moved|32|||
46869955|NCT02524288|83088333|FG000|Overall Study|Withdrawal by Subject|76|||
46869956|NCT02524288|83088333|FG000|Overall Study|Pregnancy|22|||
46869957|NCT02524288|83088333|FG000|Overall Study|Physician Decision|2|||
46701787|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
46701788|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
46701789|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
46701790|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
46701791|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
46701792|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
46701793|NCT01106625|82916740|FG000|Extension Period: Week 26 to Week 52|Other|5|||
46701794|NCT01106625|82916741|FG001|Extension Period: Week 26 to Week 52|Other|5|||
46701795|NCT01106625|82916742|FG002|Extension Period: Week 26 to Week 52|Other|4|||
46701796|NCT01251380|82916753|FG000|Overall Study|Other (Not otherwise specified)|12|||
46701797|NCT01251380|82916753|FG000|Overall Study|Withdrawal by Subject|6|||
46701798|NCT01251380|82916753|FG000|Overall Study|Lack of Efficacy|1|||
46701799|NCT01251380|82916753|FG000|Overall Study|Adverse Event|1|||
46701800|NCT01251380|82916753|FG000|Overall Study|Lost to Follow-up|2|||
46701801|NCT01251146|82916764|FG000|Overall Study|Lost to Follow-up|3|||
46701802|NCT01251146|82916765|FG001|Overall Study|Lost to Follow-up|10|||
46869958|NCT03624504|83088337|FG000|Overall Study|Unsuccessful Implant|1|||
46869959|NCT02954952|83088344|FG000|Overall Study|Withdrawal by Subject|1|||
46869960|NCT02954952|83088345|FG001|Overall Study|Withdrawal by Subject|0|||
46869961|NCT02954952|83088346|FG002|Overall Study|Withdrawal by Subject|0|||
46869962|NCT02954952|83088344|FG000|Overall Study|No data collected|0|||
46869963|NCT02954952|83088345|FG001|Overall Study|No data collected|1|||
46869964|NCT02954952|83088346|FG002|Overall Study|No data collected|0|||
46869965|NCT03547154|83088356|FG000|Overall Study|Disease Progression/Recurrence|6|||
46869966|NCT03547154|83088357|FG001|Overall Study|Disease Progression/Recurrence|14|||
46869967|NCT03547154|83088356|FG000|Overall Study|Adverse Event|26|||
46869968|NCT03547154|83088357|FG001|Overall Study|Adverse Event|31|||
46869969|NCT03547154|83088356|FG000|Overall Study|Protocol Violation|6|||
46869970|NCT03547154|83088357|FG001|Overall Study|Protocol Violation|1|||
46869971|NCT03547154|83088356|FG000|Overall Study|Physician Decision|4|||
46869972|NCT03547154|83088357|FG001|Overall Study|Physician Decision|3|||
46869973|NCT03547154|83088356|FG000|Overall Study|Insufficient Therapeutic Response|13|||
46869974|NCT03547154|83088357|FG001|Overall Study|Insufficient Therapeutic Response|10|||
46869975|NCT03547154|83088356|FG000|Overall Study|Withdrawal by Subject|10|||
46869976|NCT03547154|83088357|FG001|Overall Study|Withdrawal by Subject|6|||
46869977|NCT03547154|83088356|FG000|Overall Study|Not Selected|0|||
46869978|NCT03547154|83088357|FG001|Overall Study|Not Selected|1|||
46869979|NCT03547154|83088356|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
46869980|NCT03547154|83088357|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
46869981|NCT02275546|83088363|FG000|Treatment Period 2|Withdrawal by Subject|2|||
46869982|NCT02275546|83088364|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46869983|NCT02275546|83088363|FG000|Treatment Period 2|Protocol Violation|0|||
46869984|NCT02275546|83088364|FG001|Treatment Period 2|Protocol Violation|1|||
46869985|NCT03624192|83088370|FG000|Overall Study|Lost to Follow-up|1|||
46869986|NCT03624192|83088371|FG001|Overall Study|Lost to Follow-up|1|||
46869987|NCT03034954|83088381|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
46869988|NCT03034954|83088382|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
46701803|NCT01096017|82916771|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
46701804|NCT01096017|82916772|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
46701805|NCT01106157|82916780|FG000|Overall Study|Withdrawal by Subject|1|||
46869989|NCT03546842|83088388|FG000|Overall Study|Protocol Violation|1|||
46869990|NCT03546842|83088388|FG000|Overall Study|Withdrawal by Subject|2|||
46869991|NCT03640052|83088392|FG000|Overall Study|Lost to Follow-up|0|||
46869992|NCT03640052|83088393|FG001|Overall Study|Lost to Follow-up|1|||
46869993|NCT03640052|83088394|FG002|Overall Study|Lost to Follow-up|0|||
46869994|NCT03640052|83088395|FG003|Overall Study|Lost to Follow-up|0|||
46869995|NCT03640052|83088396|FG004|Overall Study|Lost to Follow-up|0|||
46869996|NCT00068601|83088410|FG000|Overall Study|Ineligible|11|||
46869997|NCT00068601|83088411|FG001|Overall Study|Ineligible|13|||
46869998|NCT00068601|83088410|FG000|Overall Study|Not evaluable: withdrew consent|5|||
46869999|NCT00068601|83088411|FG001|Overall Study|Not evaluable: withdrew consent|4|||
46870000|NCT00068601|83088410|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
46870001|NCT00068601|83088411|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
46870002|NCT00068601|83088410|FG000|Overall Study|Death|11|||
46870003|NCT00068601|83088411|FG001|Overall Study|Death|3|||
46870004|NCT00068601|83088410|FG000|Overall Study|Lost to Follow-up|3|||
46870005|NCT00068601|83088411|FG001|Overall Study|Lost to Follow-up|2|||
46870006|NCT00068601|83088410|FG000|Overall Study|Missing primary outcome data|30|||
46870007|NCT00068601|83088411|FG001|Overall Study|Missing primary outcome data|34|||
46870008|NCT03638258|83088420|FG000|Overall Study|Adverse Event|1|||
46870009|NCT03638258|83088421|FG001|Overall Study|Adverse Event|0|||
46870010|NCT03638258|83088422|FG002|Overall Study|Adverse Event|2|||
46870011|NCT03638258|83088420|FG000|Overall Study|Lost to Follow-up|2|||
46870012|NCT03638258|83088421|FG001|Overall Study|Lost to Follow-up|4|||
46870013|NCT03638258|83088422|FG002|Overall Study|Lost to Follow-up|5|||
46870014|NCT03638258|83088420|FG000|Overall Study|Pregnancy|0|||
46870015|NCT03638258|83088421|FG001|Overall Study|Pregnancy|0|||
46870016|NCT03638258|83088422|FG002|Overall Study|Pregnancy|1|||
46870017|NCT03638258|83088420|FG000|Overall Study|Protocol Violation|0|||
46870018|NCT03638258|83088421|FG001|Overall Study|Protocol Violation|0|||
46870019|NCT03638258|83088422|FG002|Overall Study|Protocol Violation|1|||
46870020|NCT03638258|83088420|FG000|Overall Study|Withdrawal by Subject|4|||
46870021|NCT03638258|83088421|FG001|Overall Study|Withdrawal by Subject|5|||
46870022|NCT03638258|83088422|FG002|Overall Study|Withdrawal by Subject|12|||
46870023|NCT03638258|83088420|FG000|Overall Study|Lack of Efficacy|0|||
46870024|NCT03638258|83088421|FG001|Overall Study|Lack of Efficacy|0|||
46870025|NCT03638258|83088422|FG002|Overall Study|Lack of Efficacy|2|||
46870026|NCT01670656|83088436|FG000|Overall Study|Non-compliance with study drug|0|||
46870027|NCT01670656|83088437|FG001|Overall Study|Non-compliance with study drug|0|||
46870028|NCT01670656|83088438|FG002|Overall Study|Non-compliance with study drug|3|||
46870029|NCT01670656|83088439|FG003|Overall Study|Non-compliance with study drug|0|||
46870030|NCT01670656|83088440|FG004|Overall Study|Non-compliance with study drug|1|||
46870031|NCT01670656|83088436|FG000|Overall Study|Pregnancy|0|||
46870032|NCT01670656|83088437|FG001|Overall Study|Pregnancy|0|||
46870033|NCT01670656|83088438|FG002|Overall Study|Pregnancy|0|||
46870034|NCT01670656|83088439|FG003|Overall Study|Pregnancy|0|||
46870035|NCT01670656|83088440|FG004|Overall Study|Pregnancy|1|||
46870036|NCT01670656|83088436|FG000|Overall Study|Withdrawal by Subject|1|||
46870037|NCT01670656|83088437|FG001|Overall Study|Withdrawal by Subject|1|||
46870038|NCT01670656|83088438|FG002|Overall Study|Withdrawal by Subject|0|||
46870039|NCT01670656|83088439|FG003|Overall Study|Withdrawal by Subject|0|||
46870040|NCT01670656|83088440|FG004|Overall Study|Withdrawal by Subject|0|||
46870041|NCT01670656|83088436|FG000|Overall Study|Non-compliance with protocol|0|||
46870042|NCT01670656|83088437|FG001|Overall Study|Non-compliance with protocol|3|||
46870043|NCT01670656|83088438|FG002|Overall Study|Non-compliance with protocol|1|||
46870044|NCT01670656|83088439|FG003|Overall Study|Non-compliance with protocol|1|||
46870045|NCT01670656|83088440|FG004|Overall Study|Non-compliance with protocol|2|||
46870046|NCT01670656|83088436|FG000|Overall Study|Adverse Event|2|||
46870047|NCT01670656|83088437|FG001|Overall Study|Adverse Event|2|||
46870048|NCT01670656|83088438|FG002|Overall Study|Adverse Event|2|||
46870049|NCT01670656|83088439|FG003|Overall Study|Adverse Event|3|||
46870050|NCT01670656|83088440|FG004|Overall Study|Adverse Event|3|||
46870051|NCT01670656|83088436|FG000|Overall Study|Subject withdrew consent|0|||
46870052|NCT01670656|83088437|FG001|Overall Study|Subject withdrew consent|1|||
46870053|NCT01670656|83088438|FG002|Overall Study|Subject withdrew consent|2|||
46870054|NCT01670656|83088439|FG003|Overall Study|Subject withdrew consent|1|||
46870055|NCT01670656|83088440|FG004|Overall Study|Subject withdrew consent|1|||
46870056|NCT01670656|83088436|FG000|Overall Study|Lost to Follow-up|0|||
46870057|NCT01670656|83088437|FG001|Overall Study|Lost to Follow-up|0|||
46870058|NCT01670656|83088438|FG002|Overall Study|Lost to Follow-up|0|||
46870059|NCT01670656|83088439|FG003|Overall Study|Lost to Follow-up|0|||
46870060|NCT01670656|83088440|FG004|Overall Study|Lost to Follow-up|3|||
46870061|NCT01670656|83088436|FG000|Overall Study|Subject moved|0|||
46870062|NCT01670656|83088437|FG001|Overall Study|Subject moved|0|||
46870063|NCT01670656|83088438|FG002|Overall Study|Subject moved|0|||
46870064|NCT01670656|83088439|FG003|Overall Study|Subject moved|1|||
46984032|NCT02553499|83230191|FG013|Overall Study|Withdrawal by Subject|0|||
46870065|NCT01670656|83088440|FG004|Overall Study|Subject moved|0|||
46870066|NCT00068445|83088454|FG000|Randomization|Cancel|1|||
46870067|NCT00068445|83088455|FG001|Randomization|Cancel|3|||
46870068|NCT00068445|83088454|FG000|Randomization|Ineligible|1|||
46870069|NCT00068445|83088455|FG001|Randomization|Ineligible|1|||
46870070|NCT00068445|83088454|FG000|Treatment|Refused Further Treatment|13|||
46870071|NCT00068445|83088455|FG001|Treatment|Refused Further Treatment|10|||
46870072|NCT00068445|83088454|FG000|Treatment|Adverse Event|7|||
46870073|NCT00068445|83088455|FG001|Treatment|Adverse Event|1|||
46870074|NCT00068445|83088454|FG000|Treatment|Other (Specifics not available)|9|||
46870075|NCT00068445|83088455|FG001|Treatment|Other (Specifics not available)|5|||
46870076|NCT03653208|83088470|FG000|Overall Study|Withdrawal by Subject|0|||
46870077|NCT03653208|83088471|FG001|Overall Study|Withdrawal by Subject|0|||
46984033|NCT02553421|83230224|FG000|Overall Study|Lost to Follow-up|21|||
46701806|NCT01106157|82916781|FG001|Overall Study|Withdrawal by Subject|0|||
46701807|NCT01094301|82916787|FG000|Trial Stage|Withdrawal by Subject|1|||
46701808|NCT01094301|82916787|FG000|Implant Stage|Adverse Event|1|||
46701809|NCT01094301|82916787|FG000|Implant Stage|Protocol Violation|1|||
46701810|NCT01094301|82916787|FG000|Implant Stage|Withdrawal by Subject|2|||
46701811|NCT01094301|82916787|FG000|Implant Stage|No return of pain|4|||
46701812|NCT01093755|82916795|FG000|Overall Study|Withdrawal by Subject|3|||
46701813|NCT01093755|82916796|FG001|Overall Study|Withdrawal by Subject|4|||
46701814|NCT01093599|82916804|FG000|Overall Study|Lost to Follow-up|32|||
46701815|NCT01093599|82916805|FG001|Overall Study|Lost to Follow-up|46|||
46701816|NCT01092663|82916813|FG000|Overall Study|Withdrawal by Subject|3|||
46701817|NCT01092663|82916814|FG001|Overall Study|Withdrawal by Subject|2|||
46701818|NCT01092663|82916813|FG000|Overall Study|Glucose >300mg/dL|1|||
46701819|NCT01092663|82916814|FG001|Overall Study|Glucose >300mg/dL|0|||
46701820|NCT01092663|82916813|FG000|Overall Study|High fasting triglyceride|2|||
46701821|NCT01092663|82916814|FG001|Overall Study|High fasting triglyceride|0|||
46701822|NCT01092663|82916813|FG000|Overall Study|Adverse Event|1|||
46984034|NCT02553421|83230225|FG001|Overall Study|Lost to Follow-up|1|||
46701823|NCT01092663|82916814|FG001|Overall Study|Adverse Event|1|||
46701824|NCT01092663|82916813|FG000|Overall Study|Protocol Violation|0|||
46701825|NCT01092663|82916814|FG001|Overall Study|Protocol Violation|1|||
46701826|NCT01078623|82916825|FG000|Treatment Period 1|Adverse Event|1|||
46701827|NCT01078623|82916826|FG001|Treatment Period 1|Adverse Event|1|||
46701828|NCT01078623|82916827|FG002|Treatment Period 1|Adverse Event|1|||
46701829|NCT01078623|82916828|FG003|Treatment Period 1|Adverse Event|0|||
46701830|NCT01078623|82916829|FG004|Treatment Period 1|Adverse Event|0|||
46701831|NCT01078623|82916830|FG005|Treatment Period 1|Adverse Event|0|||
46701832|NCT01078623|82916831|FG006|Treatment Period 1|Adverse Event|1|||
46701833|NCT01078623|82916832|FG007|Treatment Period 1|Adverse Event|0|||
46701834|NCT01078623|82916833|FG008|Treatment Period 1|Adverse Event|1|||
46701835|NCT01078623|82916834|FG009|Treatment Period 1|Adverse Event|1|||
46701836|NCT01078623|82916835|FG010|Treatment Period 1|Adverse Event|0|||
46701837|NCT01078623|82916836|FG011|Treatment Period 1|Adverse Event|0|||
46701838|NCT01078623|82916837|FG012|Treatment Period 1|Adverse Event|0|||
46701839|NCT01078623|82916838|FG013|Treatment Period 1|Adverse Event|0|||
46701840|NCT01078623|82916839|FG014|Treatment Period 1|Adverse Event|0|||
46701841|NCT01078623|82916840|FG015|Treatment Period 1|Adverse Event|0|||
46701842|NCT01078623|82916841|FG016|Treatment Period 1|Adverse Event|0|||
46701843|NCT01078623|82916842|FG017|Treatment Period 1|Adverse Event|0|||
46701844|NCT01078623|82916843|FG018|Treatment Period 1|Adverse Event|0|||
46701845|NCT01078623|82916844|FG019|Treatment Period 1|Adverse Event|0|||
46701846|NCT01078623|82916825|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46701847|NCT01078623|82916826|FG001|Treatment Period 1|Withdrawal by Subject|0|||
46701848|NCT01078623|82916827|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46701849|NCT01078623|82916828|FG003|Treatment Period 1|Withdrawal by Subject|0|||
46701850|NCT01078623|82916829|FG004|Treatment Period 1|Withdrawal by Subject|0|||
46701851|NCT01078623|82916830|FG005|Treatment Period 1|Withdrawal by Subject|0|||
46701852|NCT01078623|82916831|FG006|Treatment Period 1|Withdrawal by Subject|0|||
46701853|NCT01078623|82916832|FG007|Treatment Period 1|Withdrawal by Subject|1|||
46701854|NCT01078623|82916833|FG008|Treatment Period 1|Withdrawal by Subject|0|||
46701855|NCT01078623|82916834|FG009|Treatment Period 1|Withdrawal by Subject|0|||
46701856|NCT01078623|82916835|FG010|Treatment Period 1|Withdrawal by Subject|1|||
46701857|NCT01078623|82916836|FG011|Treatment Period 1|Withdrawal by Subject|0|||
46870078|NCT03653208|83088472|FG002|Overall Study|Withdrawal by Subject|0|||
46870079|NCT03653208|83088473|FG003|Overall Study|Withdrawal by Subject|0|||
46870080|NCT03653208|83088474|FG004|Overall Study|Withdrawal by Subject|1|||
46870081|NCT03653208|83088475|FG005|Overall Study|Withdrawal by Subject|0|||
46870082|NCT03653208|83088476|FG006|Overall Study|Withdrawal by Subject|0|||
46870083|NCT03653208|83088477|FG007|Overall Study|Withdrawal by Subject|1|||
46870084|NCT03653208|83088478|FG008|Overall Study|Withdrawal by Subject|1|||
46870085|NCT03545984|83088500|FG000|Overall Study|CSF cases not present during rotation|11|||
46870086|NCT03545984|83088501|FG001|Overall Study|CSF cases not present during rotation|9|||
46870087|NCT03033784|83088509|FG000|Overall Study|Anxiety related to MRI scanner|0|||
46870088|NCT03033784|83088510|FG001|Overall Study|Anxiety related to MRI scanner|1|||
46870089|NCT03033784|83088511|FG002|Overall Study|Anxiety related to MRI scanner|0|||
46870090|NCT03033784|83088512|FG003|Overall Study|Anxiety related to MRI scanner|0|||
46984035|NCT02553421|83230224|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
46701858|NCT01078623|82916837|FG012|Treatment Period 1|Withdrawal by Subject|0|||
46701859|NCT01078623|82916838|FG013|Treatment Period 1|Withdrawal by Subject|0|||
46701860|NCT01078623|82916839|FG014|Treatment Period 1|Withdrawal by Subject|0|||
46701861|NCT01078623|82916840|FG015|Treatment Period 1|Withdrawal by Subject|0|||
46701862|NCT01078623|82916841|FG016|Treatment Period 1|Withdrawal by Subject|0|||
46701863|NCT01078623|82916842|FG017|Treatment Period 1|Withdrawal by Subject|0|||
46701864|NCT01078623|82916843|FG018|Treatment Period 1|Withdrawal by Subject|0|||
46701865|NCT01078623|82916844|FG019|Treatment Period 1|Withdrawal by Subject|0|||
46701866|NCT01078623|82916825|FG000|Treatment Period 1|Protocol Violation|0|||
46701867|NCT01078623|82916826|FG001|Treatment Period 1|Protocol Violation|0|||
46701868|NCT01078623|82916827|FG002|Treatment Period 1|Protocol Violation|0|||
46701869|NCT01078623|82916828|FG003|Treatment Period 1|Protocol Violation|0|||
46701870|NCT01078623|82916829|FG004|Treatment Period 1|Protocol Violation|0|||
46701871|NCT01078623|82916830|FG005|Treatment Period 1|Protocol Violation|1|||
46701872|NCT01078623|82916831|FG006|Treatment Period 1|Protocol Violation|0|||
46701873|NCT01078623|82916832|FG007|Treatment Period 1|Protocol Violation|0|||
46701874|NCT01078623|82916833|FG008|Treatment Period 1|Protocol Violation|0|||
46701875|NCT01078623|82916834|FG009|Treatment Period 1|Protocol Violation|0|||
46701876|NCT01078623|82916835|FG010|Treatment Period 1|Protocol Violation|0|||
46701877|NCT01078623|82916836|FG011|Treatment Period 1|Protocol Violation|0|||
46701878|NCT01078623|82916837|FG012|Treatment Period 1|Protocol Violation|0|||
46701879|NCT01078623|82916838|FG013|Treatment Period 1|Protocol Violation|0|||
46701880|NCT01078623|82916839|FG014|Treatment Period 1|Protocol Violation|0|||
46701881|NCT01078623|82916840|FG015|Treatment Period 1|Protocol Violation|0|||
46701882|NCT01078623|82916841|FG016|Treatment Period 1|Protocol Violation|0|||
46701883|NCT01078623|82916842|FG017|Treatment Period 1|Protocol Violation|0|||
46701884|NCT01078623|82916843|FG018|Treatment Period 1|Protocol Violation|0|||
46701885|NCT01078623|82916844|FG019|Treatment Period 1|Protocol Violation|0|||
46701886|NCT01078623|82916825|FG000|Treatment Period 2|Adverse Event|0|||
46701887|NCT01078623|82916826|FG001|Treatment Period 2|Adverse Event|0|||
46701888|NCT01078623|82916827|FG002|Treatment Period 2|Adverse Event|0|||
46701889|NCT01078623|82916828|FG003|Treatment Period 2|Adverse Event|0|||
46701890|NCT01078623|82916829|FG004|Treatment Period 2|Adverse Event|0|||
46701891|NCT01078623|82916830|FG005|Treatment Period 2|Adverse Event|0|||
46701892|NCT01078623|82916831|FG006|Treatment Period 2|Adverse Event|1|||
46701893|NCT01078623|82916832|FG007|Treatment Period 2|Adverse Event|0|||
46701894|NCT01078623|82916833|FG008|Treatment Period 2|Adverse Event|0|||
46701895|NCT01078623|82916834|FG009|Treatment Period 2|Adverse Event|0|||
46701896|NCT01078623|82916835|FG010|Treatment Period 2|Adverse Event|0|||
46701897|NCT01078623|82916836|FG011|Treatment Period 2|Adverse Event|0|||
46701898|NCT01078623|82916837|FG012|Treatment Period 2|Adverse Event|0|||
46701899|NCT01078623|82916838|FG013|Treatment Period 2|Adverse Event|0|||
46701900|NCT01078623|82916839|FG014|Treatment Period 2|Adverse Event|0|||
46701901|NCT01078623|82916840|FG015|Treatment Period 2|Adverse Event|0|||
46701902|NCT01078623|82916841|FG016|Treatment Period 2|Adverse Event|0|||
46870091|NCT03033784|83088513|FG004|Overall Study|Anxiety related to MRI scanner|0|||
46870092|NCT03033784|83088514|FG005|Overall Study|Anxiety related to MRI scanner|0|||
46870093|NCT03033784|83088515|FG006|Overall Study|Anxiety related to MRI scanner|0|||
46870094|NCT03033784|83088516|FG007|Overall Study|Anxiety related to MRI scanner|0|||
46870095|NCT03033784|83088517|FG008|Overall Study|Anxiety related to MRI scanner|0|||
46870096|NCT03033784|83088518|FG009|Overall Study|Anxiety related to MRI scanner|0|||
46870097|NCT03033784|83088519|FG010|Overall Study|Anxiety related to MRI scanner|0|||
46870098|NCT03033784|83088520|FG011|Overall Study|Anxiety related to MRI scanner|0|||
46701903|NCT01078623|82916842|FG017|Treatment Period 2|Adverse Event|0|||
46701904|NCT01078623|82916843|FG018|Treatment Period 2|Adverse Event|1|||
46701905|NCT01078623|82916844|FG019|Treatment Period 2|Adverse Event|0|||
46701906|NCT01078623|82916825|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46701907|NCT01078623|82916826|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46870099|NCT03033784|83088521|FG012|Overall Study|Anxiety related to MRI scanner|0|||
46870100|NCT03033784|83088509|FG000|Overall Study|Withdrawal by Subject|0|||
46870101|NCT03033784|83088510|FG001|Overall Study|Withdrawal by Subject|0|||
46870102|NCT03033784|83088511|FG002|Overall Study|Withdrawal by Subject|0|||
46870103|NCT03033784|83088512|FG003|Overall Study|Withdrawal by Subject|0|||
46870104|NCT03033784|83088513|FG004|Overall Study|Withdrawal by Subject|0|||
46870105|NCT03033784|83088514|FG005|Overall Study|Withdrawal by Subject|0|||
46870106|NCT03033784|83088515|FG006|Overall Study|Withdrawal by Subject|0|||
46870107|NCT03033784|83088516|FG007|Overall Study|Withdrawal by Subject|0|||
46701908|NCT01078623|82916827|FG002|Treatment Period 2|Withdrawal by Subject|0|||
46701909|NCT01078623|82916828|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46701910|NCT01078623|82916829|FG004|Treatment Period 2|Withdrawal by Subject|0|||
46870108|NCT03033784|83088517|FG008|Overall Study|Withdrawal by Subject|0|||
46870109|NCT03033784|83088518|FG009|Overall Study|Withdrawal by Subject|0|||
46870110|NCT03033784|83088519|FG010|Overall Study|Withdrawal by Subject|0|||
46701911|NCT01078623|82916830|FG005|Treatment Period 2|Withdrawal by Subject|1|||
46701912|NCT01078623|82916831|FG006|Treatment Period 2|Withdrawal by Subject|0|||
46701913|NCT01078623|82916832|FG007|Treatment Period 2|Withdrawal by Subject|0|||
46701914|NCT01078623|82916833|FG008|Treatment Period 2|Withdrawal by Subject|0|||
46701915|NCT01078623|82916834|FG009|Treatment Period 2|Withdrawal by Subject|0|||
46701916|NCT01078623|82916835|FG010|Treatment Period 2|Withdrawal by Subject|0|||
46701917|NCT01078623|82916836|FG011|Treatment Period 2|Withdrawal by Subject|0|||
46701918|NCT01078623|82916837|FG012|Treatment Period 2|Withdrawal by Subject|0|||
46701919|NCT01078623|82916838|FG013|Treatment Period 2|Withdrawal by Subject|0|||
46701920|NCT01078623|82916839|FG014|Treatment Period 2|Withdrawal by Subject|0|||
46701921|NCT01078623|82916840|FG015|Treatment Period 2|Withdrawal by Subject|0|||
46870111|NCT03033784|83088520|FG011|Overall Study|Withdrawal by Subject|0|||
46870112|NCT03033784|83088521|FG012|Overall Study|Withdrawal by Subject|2|||
46870113|NCT00038649|83088532|FG000|Overall Study|Adverse Event|9|||
46870114|NCT03544268|83088538|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
46870115|NCT03544268|83088539|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
46870116|NCT03652818|83088550|FG000|Overall Study|Adverse Event|1|||
46870117|NCT03652818|83088551|FG001|Overall Study|Adverse Event|0|||
46870118|NCT03652818|83088552|FG002|Overall Study|Adverse Event|0|||
46870119|NCT03652818|83088553|FG003|Overall Study|Adverse Event|0|||
46870120|NCT03652818|83088554|FG004|Overall Study|Adverse Event|0|||
46870121|NCT03652818|83088550|FG000|Overall Study|Physician Decision|1|||
46870122|NCT03652818|83088551|FG001|Overall Study|Physician Decision|0|||
46701922|NCT01078623|82916841|FG016|Treatment Period 2|Withdrawal by Subject|0|||
46870123|NCT03652818|83088552|FG002|Overall Study|Physician Decision|0|||
46870124|NCT03652818|83088553|FG003|Overall Study|Physician Decision|0|||
46870125|NCT03652818|83088554|FG004|Overall Study|Physician Decision|0|||
46701923|NCT01078623|82916842|FG017|Treatment Period 2|Withdrawal by Subject|0|||
46701924|NCT01078623|82916843|FG018|Treatment Period 2|Withdrawal by Subject|0|||
46701925|NCT01078623|82916844|FG019|Treatment Period 2|Withdrawal by Subject|0|||
46701926|NCT01078623|82916825|FG000|Treatment Period 3|Adverse Event|0|||
46701927|NCT01078623|82916826|FG001|Treatment Period 3|Adverse Event|0|||
46701928|NCT01078623|82916827|FG002|Treatment Period 3|Adverse Event|0|||
46701929|NCT01078623|82916828|FG003|Treatment Period 3|Adverse Event|0|||
46701930|NCT01078623|82916829|FG004|Treatment Period 3|Adverse Event|1|||
46701931|NCT01078623|82916830|FG005|Treatment Period 3|Adverse Event|0|||
46701932|NCT01078623|82916831|FG006|Treatment Period 3|Adverse Event|0|||
46701933|NCT01078623|82916832|FG007|Treatment Period 3|Adverse Event|0|||
46701934|NCT01078623|82916833|FG008|Treatment Period 3|Adverse Event|0|||
46701935|NCT01078623|82916834|FG009|Treatment Period 3|Adverse Event|0|||
46701936|NCT01078623|82916835|FG010|Treatment Period 3|Adverse Event|0|||
46701937|NCT01078623|82916836|FG011|Treatment Period 3|Adverse Event|0|||
46701938|NCT01078623|82916837|FG012|Treatment Period 3|Adverse Event|0|||
46701939|NCT01078623|82916838|FG013|Treatment Period 3|Adverse Event|1|||
46701940|NCT01078623|82916839|FG014|Treatment Period 3|Adverse Event|0|||
46701941|NCT01078623|82916840|FG015|Treatment Period 3|Adverse Event|0|||
46701942|NCT01078623|82916841|FG016|Treatment Period 3|Adverse Event|0|||
46701943|NCT01078623|82916842|FG017|Treatment Period 3|Adverse Event|0|||
46701944|NCT01078623|82916843|FG018|Treatment Period 3|Adverse Event|0|||
46701945|NCT01078623|82916844|FG019|Treatment Period 3|Adverse Event|0|||
46701946|NCT01078623|82916825|FG000|Treatment Period 4|Adverse Event|0|||
46701947|NCT01078623|82916826|FG001|Treatment Period 4|Adverse Event|0|||
46701948|NCT01078623|82916827|FG002|Treatment Period 4|Adverse Event|1|||
46701949|NCT01078623|82916828|FG003|Treatment Period 4|Adverse Event|0|||
46701950|NCT01078623|82916829|FG004|Treatment Period 4|Adverse Event|0|||
46870126|NCT03652818|83088550|FG000|Overall Study|Lost to Follow-up|0|||
46870127|NCT03652818|83088551|FG001|Overall Study|Lost to Follow-up|1|||
46870128|NCT03652818|83088552|FG002|Overall Study|Lost to Follow-up|2|||
46870129|NCT03652818|83088553|FG003|Overall Study|Lost to Follow-up|1|||
46870130|NCT03652818|83088554|FG004|Overall Study|Lost to Follow-up|1|||
46870131|NCT03619902|83088566|FG000|Overall Study|Termination of Study by Investigator|1|||
46870132|NCT03619902|83088566|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
46870133|NCT00620464|83088572|FG000|Overall Study|Adverse Event|15|||
46870134|NCT00620464|83088573|FG001|Overall Study|Adverse Event|17|||
46870135|NCT00620464|83088572|FG000|Overall Study|Lost to Follow-up|1|||
46870136|NCT00620464|83088573|FG001|Overall Study|Lost to Follow-up|1|||
46870137|NCT00620464|83088572|FG000|Overall Study|Planning Pregnancy|1|||
46870138|NCT00620464|83088573|FG001|Overall Study|Planning Pregnancy|4|||
46870139|NCT00620464|83088572|FG000|Overall Study|Personal|2|||
46870140|NCT00620464|83088573|FG001|Overall Study|Personal|2|||
46870141|NCT00620464|83088572|FG000|Overall Study|Used prohibited medication|1|||
46870142|NCT00620464|83088573|FG001|Overall Study|Used prohibited medication|0|||
46870143|NCT03652662|83088581|FG000|Overall Study|Withdrawal by Subject|2|||
46870144|NCT03652662|83088582|FG001|Overall Study|Withdrawal by Subject|1|||
46870145|NCT03652662|83088581|FG000|Overall Study|Lost to Follow-up|1|||
46870146|NCT03652662|83088582|FG001|Overall Study|Lost to Follow-up|0|||
46870147|NCT03560258|83088591|FG000|Overall Study|Lost to Follow-up|3|||
46870148|NCT03560258|83088592|FG001|Overall Study|Lost to Follow-up|0|||
46870149|NCT03560258|83088593|FG002|Overall Study|Lost to Follow-up|0|||
46870150|NCT03560258|83088591|FG000|Overall Study|Protocol Violation|0|||
46870151|NCT03560258|83088592|FG001|Overall Study|Protocol Violation|1|||
46870152|NCT03560258|83088593|FG002|Overall Study|Protocol Violation|0|||
46870153|NCT03560258|83088591|FG000|Overall Study|Withdrawal by Subject|0|||
46870154|NCT03560258|83088592|FG001|Overall Study|Withdrawal by Subject|0|||
46870155|NCT03560258|83088593|FG002|Overall Study|Withdrawal by Subject|1|||
46870156|NCT02768662|83088601|FG000|Overall Study|Adverse Event|1|||
46870157|NCT02768662|83088601|FG000|Overall Study|Lost to Follow-up|4|||
46870158|NCT02768662|83088601|FG000|Overall Study|Withdrawal by Subject|3|||
46701951|NCT01078623|82916830|FG005|Treatment Period 4|Adverse Event|0|||
46701952|NCT01078623|82916831|FG006|Treatment Period 4|Adverse Event|0|||
46701953|NCT01078623|82916832|FG007|Treatment Period 4|Adverse Event|0|||
46870159|NCT02768662|83088601|FG000|Overall Study|Study terminated by Sponsor|78|||
46870160|NCT03539432|83088607|FG000|Overall Study|Lost to Follow-up|0|||
46870161|NCT03539432|83088608|FG001|Overall Study|Lost to Follow-up|1|||
46870162|NCT03615924|83088616|FG000|Overall Study|Withdrawal by Subject|2|||
46870163|NCT03615924|83088617|FG001|Overall Study|Withdrawal by Subject|5|||
46870164|NCT03615924|83088616|FG000|Overall Study|Death|3|||
46870165|NCT03615924|83088617|FG001|Overall Study|Death|1|||
46870166|NCT03615924|83088616|FG000|Overall Study|Lost to Follow-up|1|||
46870167|NCT03615924|83088617|FG001|Overall Study|Lost to Follow-up|0|||
46870168|NCT03615924|83088616|FG000|Overall Study|Randomized in error|1|||
46870169|NCT03615924|83088617|FG001|Overall Study|Randomized in error|0|||
46870170|NCT03615924|83088616|FG000|Overall Study|Study termination by Sponsor|94|||
46870171|NCT03615924|83088617|FG001|Overall Study|Study termination by Sponsor|86|||
46870172|NCT03535844|83088625|FG000|Overall Study|Withdrawal by Subject|0|||
46870173|NCT03535844|83088626|FG001|Overall Study|Withdrawal by Subject|1|||
46870174|NCT03533114|83088634|FG000|Overall|Adverse Event|16|||
46701954|NCT01078623|82916833|FG008|Treatment Period 4|Adverse Event|0|||
46701955|NCT01078623|82916834|FG009|Treatment Period 4|Adverse Event|0|||
46701956|NCT01078623|82916835|FG010|Treatment Period 4|Adverse Event|0|||
46701957|NCT01078623|82916836|FG011|Treatment Period 4|Adverse Event|0|||
46870175|NCT03533114|83088635|FG001|Overall|Adverse Event|11|||
46870176|NCT03533114|83088634|FG000|Overall|Consent Withdrawal by Participant|7|||
46870177|NCT03533114|83088635|FG001|Overall|Consent Withdrawal by Participant|6|||
46870178|NCT03533114|83088634|FG000|Overall|Lack of Efficacy|5|||
46870179|NCT03533114|83088635|FG001|Overall|Lack of Efficacy|3|||
46870180|NCT03533114|83088634|FG000|Overall|Lost to Follow-up|1|||
46870181|NCT03533114|83088635|FG001|Overall|Lost to Follow-up|1|||
46870182|NCT03533114|83088634|FG000|Overall|Physician Decision|0|||
46870183|NCT03533114|83088635|FG001|Overall|Physician Decision|2|||
46870184|NCT03533114|83088634|FG000|Overall|Protocol deviation|1|||
46870185|NCT03533114|83088635|FG001|Overall|Protocol deviation|1|||
46701958|NCT01078623|82916837|FG012|Treatment Period 4|Adverse Event|0|||
46870186|NCT03533114|83088634|FG000|Overall|Failure to meet randomization criteria|1|||
46870187|NCT03533114|83088635|FG001|Overall|Failure to meet randomization criteria|2|||
46870188|NCT03533114|83088634|FG000|Overall|Non-Compliance with study drug|0|||
46870189|NCT03533114|83088635|FG001|Overall|Non-Compliance with study drug|1|||
46870190|NCT03533114|83088634|FG000|Overall|Other|0|||
46870191|NCT03533114|83088635|FG001|Overall|Other|1|||
46870192|NCT03533114|83088634|FG000|Open Label Titration and Optimization|Adverse Event|11|||
46870193|NCT03533114|83088635|FG001|Open Label Titration and Optimization|Adverse Event|8|||
46870194|NCT03533114|83088634|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
46870195|NCT03533114|83088635|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
46870196|NCT03533114|83088634|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
46870197|NCT03533114|83088635|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
46870198|NCT03533114|83088634|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
46870199|NCT03533114|83088635|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
46870200|NCT03533114|83088634|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
46870201|NCT03533114|83088635|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
46870202|NCT03533114|83088634|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
46870203|NCT03533114|83088635|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
46870204|NCT03533114|83088634|FG000|Stable Dose|Adverse Event|0|||
46870205|NCT03533114|83088635|FG001|Stable Dose|Adverse Event|2|||
46870206|NCT03533114|83088634|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
46870207|NCT03533114|83088635|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
46870208|NCT03533114|83088634|FG000|Stable Dose|Lack of Efficacy|1|||
46870209|NCT03533114|83088635|FG001|Stable Dose|Lack of Efficacy|0|||
46870210|NCT03533114|83088634|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
46870211|NCT03533114|83088635|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
46870212|NCT03533114|83088634|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
46870213|NCT03533114|83088635|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
46870214|NCT03533114|83088634|FG000|Open-Label Safety Extension|Adverse Event|3|||
46870215|NCT03533114|83088635|FG001|Open-Label Safety Extension|Adverse Event|0|||
46870216|NCT03533114|83088634|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
46870217|NCT03533114|83088635|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
46870218|NCT03533114|83088634|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
46870219|NCT03533114|83088635|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
46870220|NCT03533114|83088634|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
46870221|NCT03533114|83088635|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
46870222|NCT03533114|83088634|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
46870223|NCT03533114|83088635|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
46870224|NCT03033394|83088643|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
46870225|NCT03033394|83088643|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
46870226|NCT03033394|83088643|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
46870227|NCT03033394|83088643|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
46870228|NCT03033394|83088643|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
46870229|NCT03981822|83088660|FG000|Overall Study|Lost to Follow-up|0|||
46870230|NCT03981822|83088661|FG001|Overall Study|Lost to Follow-up|1|||
46870231|NCT03981822|83088662|FG002|Overall Study|Lost to Follow-up|1|||
46870232|NCT03981822|83088663|FG003|Overall Study|Lost to Follow-up|0|||
46870233|NCT03981822|83088664|FG004|Overall Study|Lost to Follow-up|6|||
46870234|NCT03981822|83088665|FG005|Overall Study|Lost to Follow-up|4|||
46870235|NCT03981822|83088666|FG006|Overall Study|Lost to Follow-up|4|||
46870236|NCT03981822|83088667|FG007|Overall Study|Lost to Follow-up|2|||
46870237|NCT03981822|83088660|FG000|Overall Study|Withdrawal by Subject|0|||
46870238|NCT03981822|83088661|FG001|Overall Study|Withdrawal by Subject|1|||
46870239|NCT03981822|83088662|FG002|Overall Study|Withdrawal by Subject|0|||
46870240|NCT03981822|83088663|FG003|Overall Study|Withdrawal by Subject|0|||
46870241|NCT03981822|83088664|FG004|Overall Study|Withdrawal by Subject|0|||
46870242|NCT03981822|83088665|FG005|Overall Study|Withdrawal by Subject|1|||
46870243|NCT03981822|83088666|FG006|Overall Study|Withdrawal by Subject|0|||
46870244|NCT03981822|83088667|FG007|Overall Study|Withdrawal by Subject|2|||
46870245|NCT03981822|83088660|FG000|Overall Study|COVID-19 Related|0|||
46870246|NCT03981822|83088661|FG001|Overall Study|COVID-19 Related|0|||
46870247|NCT03981822|83088662|FG002|Overall Study|COVID-19 Related|0|||
46870248|NCT03981822|83088663|FG003|Overall Study|COVID-19 Related|0|||
46870249|NCT03981822|83088664|FG004|Overall Study|COVID-19 Related|2|||
46870250|NCT03981822|83088665|FG005|Overall Study|COVID-19 Related|1|||
46870251|NCT03981822|83088666|FG006|Overall Study|COVID-19 Related|2|||
46870252|NCT03981822|83088667|FG007|Overall Study|COVID-19 Related|1|||
46870253|NCT03650556|83088679|FG000|Overall Study|Death|2|||
46870254|NCT03650556|83088679|FG000|Overall Study|Withdrawal by Subject|20|||
46870255|NCT03650556|83088679|FG000|Overall Study|Physician Decision|2|||
46984036|NCT02553421|83230225|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
46984037|NCT02553421|83230224|FG000|Overall Study|Improper Device Placement|3|||
46870256|NCT03650556|83088679|FG000|Overall Study|Lost to Follow-up|8|||
46870257|NCT03650556|83088679|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
46870258|NCT03650556|83088679|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
46870259|NCT03531632|83088687|FG000|Overall Study|Adverse Event|0|||
46870260|NCT03531632|83088688|FG001|Overall Study|Adverse Event|0|||
46870261|NCT03531632|83088689|FG002|Overall Study|Adverse Event|1|||
46870262|NCT03531632|83088687|FG000|Overall Study|Death|4|||
46870263|NCT03531632|83088688|FG001|Overall Study|Death|0|||
46870264|NCT03531632|83088689|FG002|Overall Study|Death|14|||
46870265|NCT03531632|83088687|FG000|Overall Study|Study Terminated|1|||
46870266|NCT03531632|83088688|FG001|Overall Study|Study Terminated|3|||
46870267|NCT03531632|83088689|FG002|Overall Study|Study Terminated|11|||
46870268|NCT03979638|83088700|FG000|Period 1|Physician Decision|1|||
46870269|NCT03979638|83088701|FG001|Period 1|Physician Decision|1|||
46870270|NCT03979638|83088700|FG000|Period 1|Withdrawal by Subject|4|||
46870271|NCT03979638|83088701|FG001|Period 1|Withdrawal by Subject|3|||
46870272|NCT03979638|83088700|FG000|Period 1|Study terminated by Sponsor|1|||
46870273|NCT03979638|83088701|FG001|Period 1|Study terminated by Sponsor|3|||
46870274|NCT03979638|83088700|FG000|Period 1|Protocol Violation|1|||
46870275|NCT03979638|83088701|FG001|Period 1|Protocol Violation|0|||
46870276|NCT03979638|83088700|FG000|Period 2|Study terminated by Sponsor|1|||
46870277|NCT03979638|83088701|FG001|Period 2|Study terminated by Sponsor|1|||
46870278|NCT03655054|83088716|FG000|Overall Study|Lost to Follow-up|1|||
46870279|NCT03615144|83088722|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
46870280|NCT03615144|83088723|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
46870281|NCT03682302|83088733|FG000|Overall Study|Lost to Follow-up|1|||
46870282|NCT03682302|83088734|FG001|Overall Study|Lost to Follow-up|2|||
46870283|NCT03682302|83088735|FG002|Overall Study|Lost to Follow-up|0|||
46870284|NCT03682302|83088736|FG003|Overall Study|Lost to Follow-up|1|||
46870285|NCT03682302|83088733|FG000|Overall Study|Study drug was not administered|0|||
46870286|NCT03682302|83088734|FG001|Overall Study|Study drug was not administered|0|||
46870287|NCT03682302|83088735|FG002|Overall Study|Study drug was not administered|1|||
46870288|NCT03682302|83088736|FG003|Overall Study|Study drug was not administered|1|||
46870289|NCT03522506|83088750|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46870290|NCT03522506|83088751|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46870291|NCT03522506|83088752|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
46870292|NCT03522506|83088753|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
46870293|NCT03522506|83088750|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
46870294|NCT03522506|83088751|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
46870295|NCT03522506|83088752|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
46701959|NCT01078623|82916838|FG013|Treatment Period 4|Adverse Event|0|||
46701960|NCT01078623|82916839|FG014|Treatment Period 4|Adverse Event|0|||
46701961|NCT01078623|82916840|FG015|Treatment Period 4|Adverse Event|0|||
46701962|NCT01078623|82916841|FG016|Treatment Period 4|Adverse Event|0|||
46701963|NCT01078623|82916842|FG017|Treatment Period 4|Adverse Event|0|||
46701964|NCT01078623|82916843|FG018|Treatment Period 4|Adverse Event|0|||
46701965|NCT01078623|82916844|FG019|Treatment Period 4|Adverse Event|0|||
46701966|NCT01078623|82916825|FG000|Treatment Period 4|Withdrawal by Subject|0|||
46701967|NCT01078623|82916826|FG001|Treatment Period 4|Withdrawal by Subject|0|||
46701968|NCT01078623|82916827|FG002|Treatment Period 4|Withdrawal by Subject|0|||
46870296|NCT03522506|83088753|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
46870297|NCT02892734|83088784|FG000|Treatment on Study|Progressive Disease|2|||
46870298|NCT02892734|83088784|FG000|Follow up for 2 Years|Death|2|||
46870299|NCT02892734|83088784|FG000|Follow up for 2 Years|Study closed early|1|||
46870300|NCT00055497|83088792|FG000|Overall Study|Adverse Event|1|||
46870301|NCT00055497|83088793|FG001|Overall Study|Adverse Event|1|||
46870302|NCT00055497|83088794|FG002|Overall Study|Adverse Event|1|||
46870303|NCT00055497|83088795|FG003|Overall Study|Adverse Event|28|||
46870304|NCT00055497|83088792|FG000|Overall Study|Withdrawal by Subject|3|||
46870305|NCT00055497|83088793|FG001|Overall Study|Withdrawal by Subject|1|||
46870306|NCT00055497|83088794|FG002|Overall Study|Withdrawal by Subject|1|||
46870307|NCT00055497|83088795|FG003|Overall Study|Withdrawal by Subject|15|||
46701969|NCT01078623|82916828|FG003|Treatment Period 4|Withdrawal by Subject|0|||
46701970|NCT01078623|82916829|FG004|Treatment Period 4|Withdrawal by Subject|0|||
46701971|NCT01078623|82916830|FG005|Treatment Period 4|Withdrawal by Subject|0|||
46701972|NCT01078623|82916831|FG006|Treatment Period 4|Withdrawal by Subject|0|||
46701973|NCT01078623|82916832|FG007|Treatment Period 4|Withdrawal by Subject|0|||
46701974|NCT01078623|82916833|FG008|Treatment Period 4|Withdrawal by Subject|0|||
46701975|NCT01078623|82916834|FG009|Treatment Period 4|Withdrawal by Subject|0|||
46701976|NCT01078623|82916835|FG010|Treatment Period 4|Withdrawal by Subject|0|||
46701977|NCT01078623|82916836|FG011|Treatment Period 4|Withdrawal by Subject|0|||
46870308|NCT00055497|83088792|FG000|Overall Study|Lost to Follow-up|0|||
46870309|NCT00055497|83088793|FG001|Overall Study|Lost to Follow-up|1|||
46870310|NCT00055497|83088794|FG002|Overall Study|Lost to Follow-up|0|||
46870311|NCT00055497|83088795|FG003|Overall Study|Lost to Follow-up|5|||
46870312|NCT00055497|83088792|FG000|Overall Study|Protocol Violation|0|||
46870313|NCT00055497|83088793|FG001|Overall Study|Protocol Violation|0|||
46870314|NCT00055497|83088794|FG002|Overall Study|Protocol Violation|0|||
46870315|NCT00055497|83088795|FG003|Overall Study|Protocol Violation|3|||
46870316|NCT00055497|83088792|FG000|Overall Study|Lack of Efficacy|1|||
46870317|NCT00055497|83088793|FG001|Overall Study|Lack of Efficacy|0|||
46870318|NCT00055497|83088794|FG002|Overall Study|Lack of Efficacy|0|||
46870319|NCT00055497|83088795|FG003|Overall Study|Lack of Efficacy|27|||
46870320|NCT00055497|83088792|FG000|Overall Study|Administrative Reasons|0|||
46870321|NCT00055497|83088793|FG001|Overall Study|Administrative Reasons|0|||
46870322|NCT00055497|83088794|FG002|Overall Study|Administrative Reasons|0|||
46870323|NCT00055497|83088795|FG003|Overall Study|Administrative Reasons|1|||
46870324|NCT00055497|83088792|FG000|Overall Study|Other|0|||
46870325|NCT00055497|83088793|FG001|Overall Study|Other|0|||
46870326|NCT00055497|83088794|FG002|Overall Study|Other|0|||
46870327|NCT00055497|83088795|FG003|Overall Study|Other|11|||
46870328|NCT03615066|83088813|FG000|Main Study|Withdrew Consent|0|||
46870329|NCT03615066|83088814|FG001|Main Study|Withdrew Consent|1|||
46870330|NCT03615066|83088815|FG002|Main Study|Withdrew Consent|1|||
46870331|NCT03615066|83088813|FG000|Main Study|Lost to Follow-up|0|||
46870332|NCT03615066|83088814|FG001|Main Study|Lost to Follow-up|0|||
46870333|NCT03615066|83088815|FG002|Main Study|Lost to Follow-up|1|||
46870334|NCT03615066|83088813|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
46870335|NCT03615066|83088814|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
46870336|NCT03615066|83088815|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
46870337|NCT03615066|83088813|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
46870338|NCT03615066|83088814|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
46870339|NCT03615066|83088815|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
46870340|NCT03615066|83088813|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
46870341|NCT03615066|83088814|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
46870342|NCT03615066|83088815|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
46870343|NCT03527966|83088829|FG000|Overall Study|Lost to Follow-up|3|||
46870344|NCT03527966|83088830|FG001|Overall Study|Lost to Follow-up|0|||
46870345|NCT03808545|83088838|FG000|Overall Study|Withdrawal by Subject|1|||
46870346|NCT03808545|83088839|FG001|Overall Study|Withdrawal by Subject|1|||
46870347|NCT03807843|83088848|FG000|Overall Study|Lost to Follow-up|1|||
46870348|NCT03807843|83088849|FG001|Overall Study|Lost to Follow-up|0|||
46870349|NCT03519932|83088855|FG000|First Intervention|Adverse Event|1|||
46870350|NCT03519932|83088856|FG001|First Intervention|Adverse Event|3|||
46870351|NCT03806127|83088869|FG000|Overall Study|Withdrawal by Subject|4|||
46870352|NCT03806127|83088870|FG001|Overall Study|Withdrawal by Subject|5|||
46870353|NCT03806127|83088869|FG000|Overall Study|Protocol Violation|3|||
46870354|NCT03806127|83088870|FG001|Overall Study|Protocol Violation|1|||
46870355|NCT03806127|83088869|FG000|Overall Study|Adverse Event|3|||
46870356|NCT03806127|83088870|FG001|Overall Study|Adverse Event|0|||
46870357|NCT03806127|83088869|FG000|Overall Study|Unable to Complete Procedures|0|||
46870358|NCT03806127|83088870|FG001|Overall Study|Unable to Complete Procedures|1|||
46870359|NCT03806127|83088869|FG000|Overall Study|Pregnancy|0|||
46870360|NCT03806127|83088870|FG001|Overall Study|Pregnancy|1|||
46870361|NCT03806127|83088869|FG000|Overall Study|Lost to Follow-up|5|||
46984038|NCT02553421|83230225|FG001|Overall Study|Improper Device Placement|0|||
46984039|NCT02549287|83230234|FG000|Overall Study|Lost to Follow-up|65|||
46984040|NCT02549287|83230235|FG001|Overall Study|Lost to Follow-up|26|||
46984041|NCT02549287|83230234|FG000|Overall Study|Withdrawal by Subject|15|||
46984042|NCT02549287|83230235|FG001|Overall Study|Withdrawal by Subject|6|||
46984043|NCT02553265|83230241|FG000|Enrollment|Death|0|||
46984044|NCT02553265|83230242|FG001|Enrollment|Death|0|||
46984045|NCT02553265|83230243|FG002|Enrollment|Death|1|||
46984046|NCT02553265|83230241|FG000|First Intervention (28 Days)|Adverse Event|1|||
46984047|NCT02553265|83230242|FG001|First Intervention (28 Days)|Adverse Event|0|||
46984048|NCT02553265|83230243|FG002|First Intervention (28 Days)|Adverse Event|0|||
46984049|NCT02553265|83230241|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
46984050|NCT02553265|83230242|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
46984051|NCT02553265|83230243|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
46984052|NCT02553265|83230241|FG000|Second Intervention (28 Days)|Adverse Event|1|||
46984053|NCT02553265|83230242|FG001|Second Intervention (28 Days)|Adverse Event|0|||
46984054|NCT02553265|83230243|FG002|Second Intervention (28 Days)|Adverse Event|0|||
46870362|NCT03806127|83088870|FG001|Overall Study|Lost to Follow-up|1|||
46870363|NCT03806127|83088869|FG000|Overall Study|Physician Decision|1|||
46984055|NCT02553265|83230241|FG000|Third Intervention (28 Days)|Adverse Event|1|||
46984056|NCT02553265|83230242|FG001|Third Intervention (28 Days)|Adverse Event|0|||
46870364|NCT03806127|83088870|FG001|Overall Study|Physician Decision|1|||
46870365|NCT03806127|83088869|FG000|Overall Study|Could Not Come Due to Covid|1|||
46870366|NCT03806127|83088870|FG001|Overall Study|Could Not Come Due to Covid|0|||
46870367|NCT03806127|83088869|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
46870368|NCT03806127|83088870|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
46870369|NCT03806127|83088869|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
46870370|NCT03806127|83088870|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
46870371|NCT03806127|83088869|FG000|Overall Study|Covid 19 Restrictions|2|||
46870372|NCT03806127|83088870|FG001|Overall Study|Covid 19 Restrictions|0|||
46870373|NCT03806127|83088869|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
46870374|NCT03806127|83088870|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
46870375|NCT03806127|83088869|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
46870376|NCT03806127|83088870|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
46870377|NCT03650400|83088878|FG000|Overall Study|Study terminated by sponsor|0|||
46870378|NCT03650400|83088879|FG001|Overall Study|Study terminated by sponsor|5|||
46870379|NCT00038103|83088887|FG000|Overall Study|Adverse Event|5|||
46870380|NCT00038103|83088888|FG001|Overall Study|Adverse Event|6|||
46870381|NCT00038103|83088887|FG000|Overall Study|Lack of Efficacy|48|||
46870382|NCT00038103|83088888|FG001|Overall Study|Lack of Efficacy|41|||
46870383|NCT00038103|83088887|FG000|Overall Study|Withdrawal by Subject|0|||
46870384|NCT00038103|83088888|FG001|Overall Study|Withdrawal by Subject|3|||
46870385|NCT00038103|83088887|FG000|Overall Study|Lost to Follow-up|0|||
46870386|NCT00038103|83088888|FG001|Overall Study|Lost to Follow-up|3|||
46870387|NCT00038103|83088887|FG000|Overall Study|Protocol Violation|0|||
46870388|NCT00038103|83088888|FG001|Overall Study|Protocol Violation|2|||
46870389|NCT00038103|83088887|FG000|Overall Study|Sponsor Decision|0|||
46870390|NCT00038103|83088888|FG001|Overall Study|Sponsor Decision|1|||
46870391|NCT00038103|83088887|FG000|Overall Study|Randomized/never treated|2|||
46870392|NCT00038103|83088888|FG001|Overall Study|Randomized/never treated|0|||
46870393|NCT03680742|83088894|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
46870394|NCT03678870|83088900|FG000|Overall Study|prescribed non- protocol medications|10|||
46870395|NCT03678870|83088901|FG001|Overall Study|prescribed non- protocol medications|6|||
46870396|NCT03678870|83088900|FG000|Overall Study|Lost to Follow-up|3|||
46870397|NCT03678870|83088901|FG001|Overall Study|Lost to Follow-up|2|||
46870398|NCT03805971|83088907|FG000|Overall Study|Withdrawal by Subject|1|||
46870399|NCT03805971|83088907|FG000|Overall Study|Protocol Violation|2|||
46870400|NCT03032380|83088914|FG000|Overall Study|Adverse Event|0|||
46870401|NCT03032380|83088915|FG001|Overall Study|Adverse Event|1|||
46870402|NCT03032380|83088914|FG000|Overall Study|Lack of Efficacy|1|||
46870403|NCT03032380|83088915|FG001|Overall Study|Lack of Efficacy|0|||
46870404|NCT03032380|83088914|FG000|Overall Study|Withdrawal by Subject|2|||
46870405|NCT03032380|83088915|FG001|Overall Study|Withdrawal by Subject|3|||
46870406|NCT03032380|83088914|FG000|Overall Study|Recovery|0|||
46870407|NCT03032380|83088915|FG001|Overall Study|Recovery|1|||
46870408|NCT03032380|83088914|FG000|Overall Study|Death|39|||
46870409|NCT03032380|83088915|FG001|Overall Study|Death|34|||
46870410|NCT03032380|83088914|FG000|Overall Study|Other - Miscellaneous|0|||
46870411|NCT03032380|83088915|FG001|Overall Study|Other - Miscellaneous|1|||
46870412|NCT03519854|83088939|FG000|Overall Study|Technical Error|0|||
46870413|NCT03519854|83088940|FG001|Overall Study|Technical Error|0|||
46870414|NCT03519854|83088941|FG002|Overall Study|Technical Error|1|||
46870415|NCT03519854|83088942|FG003|Overall Study|Technical Error|0|||
46870416|NCT03519854|83088943|FG004|Overall Study|Technical Error|0|||
46870417|NCT03519854|83088944|FG005|Overall Study|Technical Error|0|||
46870418|NCT03519854|83088945|FG006|Overall Study|Technical Error|0|||
46870419|NCT03519854|83088946|FG007|Overall Study|Technical Error|0|||
46870420|NCT03519854|83088947|FG008|Overall Study|Technical Error|0|||
46870421|NCT03519854|83088948|FG009|Overall Study|Technical Error|0|||
46870422|NCT03519854|83088949|FG010|Overall Study|Technical Error|0|||
46870423|NCT03519854|83088950|FG011|Overall Study|Technical Error|0|||
46870424|NCT03519854|83088951|FG012|Overall Study|Technical Error|0|||
46870425|NCT03519854|83088952|FG013|Overall Study|Technical Error|0|||
46870426|NCT03519854|83088953|FG014|Overall Study|Technical Error|0|||
46870427|NCT03519854|83088954|FG015|Overall Study|Technical Error|0|||
46870428|NCT03519854|83088955|FG016|Overall Study|Technical Error|0|||
46870429|NCT03519854|83088956|FG017|Overall Study|Technical Error|0|||
46984057|NCT02553265|83230243|FG002|Third Intervention (28 Days)|Adverse Event|0|||
46870430|NCT03479216|83088996|FG000|Overall Study|Withdrawal by Subject|3|||
46870431|NCT03479216|83088997|FG001|Overall Study|Withdrawal by Subject|2|||
46870432|NCT03479216|83088996|FG000|Overall Study|Physician Decision|2|||
46870433|NCT03479216|83088997|FG001|Overall Study|Physician Decision|3|||
46870434|NCT03518840|83089003|FG000|Overall Study|Lost to Follow-up|6|||
46870435|NCT03436082|83089012|FG000|Overall Study|Did not undergo procedure|1|||
46870436|NCT03436082|83089013|FG001|Overall Study|Did not undergo procedure|0|||
46870437|NCT03677934|83089021|FG000|Overall Study|Adverse Event|1|||
46870438|NCT03677934|83089022|FG001|Overall Study|Adverse Event|1|||
46870439|NCT03677934|83089021|FG000|Overall Study|Death|8|||
46870440|NCT03677934|83089022|FG001|Overall Study|Death|4|||
46870441|NCT03677934|83089021|FG000|Overall Study|Lost to Follow-up|3|||
46870442|NCT03677934|83089022|FG001|Overall Study|Lost to Follow-up|0|||
46984058|NCT02553265|83230241|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
46870443|NCT03677934|83089021|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46870444|NCT03677934|83089022|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46870445|NCT03677934|83089021|FG000|Overall Study|Physician Decision|0|||
46870446|NCT03677934|83089022|FG001|Overall Study|Physician Decision|1|||
46870447|NCT03677934|83089021|FG000|Overall Study|Withdrawal by Subject|1|||
46870448|NCT03677934|83089022|FG001|Overall Study|Withdrawal by Subject|7|||
46870449|NCT03435692|83089034|FG000|Overall Study|Lack of Efficacy|2|||
46870450|NCT03435692|83089035|FG001|Overall Study|Lack of Efficacy|2|||
46870451|NCT03435692|83089036|FG002|Overall Study|Lack of Efficacy|0|||
46870452|NCT03475316|83089050|FG000|6 Month Intervention|Adverse Event|2|||
46870453|NCT03475316|83089051|FG001|6 Month Intervention|Adverse Event|1|||
46870454|NCT03475316|83089050|FG000|6 Month Intervention|Withdrawal by Subject|2|||
46870455|NCT03475316|83089051|FG001|6 Month Intervention|Withdrawal by Subject|0|||
46870456|NCT03475316|83089050|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
46870457|NCT03475316|83089051|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
46870458|NCT03475316|83089050|FG000|9 Months|Study stopped due to COVID pandemic|3|||
46870459|NCT03475316|83089051|FG001|9 Months|Study stopped due to COVID pandemic|4|||
46870460|NCT03673956|83089061|FG000|Overall Study|Lost to Follow-up|1|||
46870461|NCT03673956|83089062|FG001|Overall Study|Lost to Follow-up|0|||
46870462|NCT03673956|83089063|FG002|Overall Study|Lost to Follow-up|0|||
46870463|NCT03673956|83089064|FG003|Overall Study|Lost to Follow-up|0|||
46870464|NCT03673956|83089061|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
46870465|NCT03673956|83089062|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
46870466|NCT03673956|83089063|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
46870467|NCT03673956|83089064|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
46870468|NCT03673098|83089076|FG000|Overall Study|Lost to Follow-up|2|||
46870469|NCT03673098|83089077|FG001|Overall Study|Lost to Follow-up|3|||
46870470|NCT03673098|83089076|FG000|Overall Study|Withdrawal by Subject|6|||
46870471|NCT03673098|83089077|FG001|Overall Study|Withdrawal by Subject|1|||
46870472|NCT03673098|83089076|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
46870473|NCT03673098|83089077|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
46870474|NCT03435224|83089090|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
46870475|NCT03672396|83089094|FG000|Overall Study|Withdrawal by Subject|4|||
46870476|NCT03672396|83089094|FG000|Overall Study|Physician Decision|1|||
46870477|NCT03672396|83089094|FG000|Overall Study|Adverse Event|1|||
46870478|NCT03434834|83089098|FG000|Overall Study|unable to swallow OCT probe|16|||
46870479|NCT03605862|83089104|FG000|Overall Study|Withdrawal by Subject|12|||
46870480|NCT03605862|83089105|FG001|Overall Study|Withdrawal by Subject|9|||
46870481|NCT03605862|83089104|FG000|Overall Study|Adverse Event|2|||
46870482|NCT03605862|83089105|FG001|Overall Study|Adverse Event|1|||
46870483|NCT03605862|83089104|FG000|Overall Study|Physician Decision|3|||
46870484|NCT03605862|83089105|FG001|Overall Study|Physician Decision|1|||
46870485|NCT03605862|83089104|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
46870486|NCT03605862|83089105|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
46870487|NCT03672006|83089114|FG000|Overall Study|exclusion criteria met|0|||
46870488|NCT03672006|83089115|FG001|Overall Study|exclusion criteria met|1|||
46870489|NCT03512288|83089125|FG000|Overall Study|Adverse Event|1|||
46870490|NCT03512288|83089126|FG001|Overall Study|Adverse Event|0|||
46870491|NCT03512288|83089125|FG000|Overall Study|Lost to Follow-up|12|||
46870492|NCT03512288|83089126|FG001|Overall Study|Lost to Follow-up|15|||
46870493|NCT03512288|83089125|FG000|Overall Study|Physician Decision|0|||
46870494|NCT03512288|83089126|FG001|Overall Study|Physician Decision|2|||
46707554|NCT01176240|82923135|FG000|Study 306B|Lack of Efficacy|5|||
46870495|NCT03512288|83089125|FG000|Overall Study|Protocol Violation|6|||
46870496|NCT03512288|83089126|FG001|Overall Study|Protocol Violation|4|||
46870497|NCT03512288|83089125|FG000|Overall Study|Medication error without associated adverse event|1|||
46870498|NCT03512288|83089126|FG001|Overall Study|Medication error without associated adverse event|0|||
46870499|NCT03512288|83089125|FG000|Overall Study|No longer met eligibility criteria|5|||
46870500|NCT03512288|83089126|FG001|Overall Study|No longer met eligibility criteria|2|||
46870501|NCT03512288|83089125|FG000|Overall Study|Withdrawal by parent/guardian|14|||
46870502|NCT03512288|83089126|FG001|Overall Study|Withdrawal by parent/guardian|18|||
46870503|NCT03512288|83089125|FG000|Overall Study|Other|1|||
46870504|NCT03512288|83089126|FG001|Overall Study|Other|1|||
46870505|NCT03512288|83089125|FG000|Overall Study|Randomized but not treated|1|||
46870506|NCT03512288|83089126|FG001|Overall Study|Randomized but not treated|1|||
46870507|NCT03031678|83089132|FG000|Overall Study|Study closed prior to completion|1|||
46870508|NCT03669588|83089142|FG000|Overall Study|Adverse Event|1|||
46870509|NCT03669588|83089143|FG001|Overall Study|Adverse Event|0|||
46870510|NCT03669588|83089142|FG000|Overall Study|Physician Decision|0|||
46870511|NCT03669588|83089143|FG001|Overall Study|Physician Decision|1|||
46870512|NCT03669588|83089142|FG000|Overall Study|Protocol Violation|1|||
46870513|NCT03669588|83089143|FG001|Overall Study|Protocol Violation|0|||
46870514|NCT03669588|83089142|FG000|Overall Study|Sponsor Decision|1|||
46870515|NCT03669588|83089143|FG001|Overall Study|Sponsor Decision|1|||
46870516|NCT03669588|83089142|FG000|Overall Study|Withdrawal by Subject|1|||
46870517|NCT03669588|83089143|FG001|Overall Study|Withdrawal by Subject|4|||
46870518|NCT03669588|83089142|FG000|Overall Study|Rescue Therapy Needed|0|||
46870519|NCT03669588|83089143|FG001|Overall Study|Rescue Therapy Needed|1|||
46870520|NCT03598140|83089151|FG000|Overall Study|enrolled but didn't start|1|||
46870521|NCT03598140|83089152|FG001|Overall Study|enrolled but didn't start|0|||
46870522|NCT03644550|83089158|FG000|Overall Study|Withdrawal by Subject|3|||
46870523|NCT03644550|83089158|FG000|Overall Study|Progressive disease|15|||
46870524|NCT00054717|83089165|FG000|Overall Study|Randomized but not treated|2|||
46870525|NCT00054717|83089166|FG001|Overall Study|Randomized but not treated|8|||
46870526|NCT00054717|83089165|FG000|Overall Study|Adverse Event|70|||
46870527|NCT00054717|83089166|FG001|Overall Study|Adverse Event|22|||
46870528|NCT00054717|83089165|FG000|Overall Study|Protocol Violation|18|||
46870529|NCT00054717|83089166|FG001|Overall Study|Protocol Violation|19|||
46870530|NCT00054717|83089165|FG000|Overall Study|Lost to Follow-up|23|||
46870531|NCT00054717|83089166|FG001|Overall Study|Lost to Follow-up|13|||
46870532|NCT00054717|83089165|FG000|Overall Study|Withdrawal by Subject|32|||
46870533|NCT00054717|83089166|FG001|Overall Study|Withdrawal by Subject|20|||
46870534|NCT00054717|83089165|FG000|Overall Study|Other reason not defined above|117|||
46870535|NCT00054717|83089166|FG001|Overall Study|Other reason not defined above|217|||
46870536|NCT03430856|83089175|FG000|Overall Study|Adverse Event|0|||
46870537|NCT03430856|83089176|FG001|Overall Study|Adverse Event|1|||
46870538|NCT03430856|83089177|FG002|Overall Study|Adverse Event|0|||
46870539|NCT03430856|83089175|FG000|Overall Study|Rescue criteria|1|||
46870540|NCT03430856|83089176|FG001|Overall Study|Rescue criteria|1|||
46870541|NCT03430856|83089177|FG002|Overall Study|Rescue criteria|0|||
46870542|NCT03430856|83089175|FG000|Overall Study|Voluntary withdrawal of consent|1|||
46870543|NCT03430856|83089176|FG001|Overall Study|Voluntary withdrawal of consent|1|||
46870544|NCT03430856|83089177|FG002|Overall Study|Voluntary withdrawal of consent|1|||
46870545|NCT03731364|83089193|FG000|Overall Study|Adverse Event|0|||
46870546|NCT03731364|83089194|FG001|Overall Study|Adverse Event|0|||
46870547|NCT03731364|83089195|FG002|Overall Study|Adverse Event|1|||
46870548|NCT03731364|83089196|FG003|Overall Study|Adverse Event|2|||
46870549|NCT03731364|83089197|FG004|Overall Study|Adverse Event|1|||
46870550|NCT03510182|83089209|FG000|Overall Study|Withdrawal by Subject|2|||
46870551|NCT00066807|83089215|FG000|Overall Study|Study was terminated early|14|||
46870552|NCT00066807|83089216|FG001|Overall Study|Study was terminated early|15|||
46870553|NCT03428750|83089224|FG000|Overall Study|Withdrawal by Subject|11|||
46870554|NCT03428750|83089225|FG001|Overall Study|Withdrawal by Subject|10|||
46870555|NCT03428750|83089224|FG000|Overall Study|Lost to Follow-up|3|||
46870556|NCT03428750|83089225|FG001|Overall Study|Lost to Follow-up|9|||
46870557|NCT03428750|83089224|FG000|Overall Study|Adverse Event|9|||
46870558|NCT03428750|83089225|FG001|Overall Study|Adverse Event|1|||
46870559|NCT03428750|83089224|FG000|Overall Study|Protocol Violation|1|||
46870560|NCT03428750|83089225|FG001|Overall Study|Protocol Violation|0|||
46870561|NCT03428750|83089224|FG000|Overall Study|Administrative|0|||
46870562|NCT03428750|83089225|FG001|Overall Study|Administrative|1|||
46870563|NCT03666858|83089254|FG000|Cohort 1|Adverse Event|1|||
46870564|NCT03666858|83089255|FG001|Cohort 1|Adverse Event|0|||
46870565|NCT03666858|83089254|FG000|Cohort 2|Adverse Event|0|||
46870566|NCT03666858|83089255|FG001|Cohort 2|Adverse Event|1|||
46870567|NCT00054639|83089261|FG000|Overall Study|Lack of Efficacy|1|||
46870568|NCT00054639|83089261|FG000|Overall Study|Physician Decision|1|||
46870569|NCT03428360|83089265|FG000|Overall Study|Informed consent withdrawn|5|||
46870570|NCT03428360|83089265|FG000|Overall Study|Withdrawal by Subject|4|||
46870571|NCT03428360|83089265|FG000|Overall Study|Lost to Follow-up|5|||
46870572|NCT03428360|83089265|FG000|Overall Study|Physician Decision|2|||
46870573|NCT03428360|83089265|FG000|Overall Study|Informed consent withdrawn|5|||
46870574|NCT03428360|83089265|FG000|Overall Study|Study terminated by sponsor|10|||
46870575|NCT03428360|83089265|FG000|Overall Study|Non-compliant with study|1|||
46870576|NCT03428360|83089265|FG000|Overall Study|Non-compliant with study drug|3|||
46870577|NCT03428360|83089265|FG000|Overall Study|Death|3|||
46870578|NCT03428360|83089265|FG000|Overall Study|Adverse Event|1|||
46870579|NCT03428360|83089265|FG000|Overall Study|Not on antiepileptic drug|1|||
46870580|NCT03427892|83089273|FG000|Overall Study|Lost to Follow-up|2|||
46870581|NCT03595332|83089279|FG000|Overall Study|Lost to Follow-up|16|||
46870582|NCT03595332|83089280|FG001|Overall Study|Lost to Follow-up|22|||
46870583|NCT03595332|83089279|FG000|Overall Study|Unable to retrieve ID from school|0|||
46870584|NCT03595332|83089280|FG001|Overall Study|Unable to retrieve ID from school|2|||
46870585|NCT03427268|83089289|FG000|Overall Study|Progressive disease|25|||
46870586|NCT03427268|83089289|FG000|Overall Study|Never treated|2|||
46870587|NCT03427268|83089289|FG000|Overall Study|Compassionate use|1|||
46870588|NCT03427268|83089289|FG000|Overall Study|Withdrawal by Subject|1|||
46870589|NCT03427268|83089289|FG000|Overall Study|Adverse Event|3|||
46870590|NCT03509948|83089293|FG000|Overall Study|Protocol Violation|0|||
46870591|NCT03509948|83089294|FG001|Overall Study|Protocol Violation|1|||
46870592|NCT03466658|83089300|FG000|Overall Study|Withdrawal by Subject|3|||
46870593|NCT03425396|83089311|FG000|Overall Study|Lost to Follow-up|2|||
46870594|NCT03425396|83089312|FG001|Overall Study|Lost to Follow-up|5|||
46870595|NCT03425396|83089313|FG002|Overall Study|Lost to Follow-up|2|||
46870596|NCT03425396|83089314|FG003|Overall Study|Lost to Follow-up|0|||
46870597|NCT03425396|83089315|FG004|Overall Study|Lost to Follow-up|0|||
46870598|NCT03425396|83089311|FG000|Overall Study|Withdrawal by Subject|0|||
46870599|NCT03425396|83089312|FG001|Overall Study|Withdrawal by Subject|1|||
46870600|NCT03425396|83089313|FG002|Overall Study|Withdrawal by Subject|0|||
46870601|NCT03425396|83089314|FG003|Overall Study|Withdrawal by Subject|1|||
46870602|NCT03425396|83089315|FG004|Overall Study|Withdrawal by Subject|0|||
46870603|NCT03425396|83089311|FG000|Overall Study|Other|0|||
46870604|NCT03425396|83089312|FG001|Overall Study|Other|1|||
46870605|NCT03425396|83089313|FG002|Overall Study|Other|1|||
46870606|NCT03425396|83089314|FG003|Overall Study|Other|0|||
46870607|NCT03425396|83089315|FG004|Overall Study|Other|1|||
46870608|NCT00032487|83089329|FG000|Overall Study|Withdrawal by Subject|67|||
46870609|NCT00032487|83089330|FG001|Overall Study|Withdrawal by Subject|43|||
46870610|NCT00032487|83089329|FG000|Overall Study|Adverse Event|3|||
46870611|NCT00032487|83089330|FG001|Overall Study|Adverse Event|7|||
46870612|NCT00032487|83089329|FG000|Overall Study|Lost to Follow-up|57|||
46870613|NCT00032487|83089330|FG001|Overall Study|Lost to Follow-up|58|||
46870614|NCT00032487|83089329|FG000|Overall Study|Had other reason|12|||
46870615|NCT00032487|83089330|FG001|Overall Study|Had other reason|12|||
46870616|NCT03641508|83089338|FG000|First Injection|Lost to Follow-up|2|||
46870617|NCT03641508|83089339|FG001|First Injection|Lost to Follow-up|0|||
46870618|NCT03465878|83089347|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
46870619|NCT03465878|83089348|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
46870620|NCT03465878|83089349|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
46870621|NCT03465878|83089350|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
46870622|NCT03465878|83089347|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
46870623|NCT03465878|83089348|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
46870624|NCT03465878|83089349|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
46870625|NCT03465878|83089350|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
46870626|NCT03465878|83089347|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
46870627|NCT03465878|83089348|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
46870628|NCT03465878|83089349|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
46870629|NCT03465878|83089350|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
46870630|NCT03637374|83089378|FG000|Overall Study|Death|2|||
46870631|NCT03637374|83089379|FG001|Overall Study|Death|0|||
46870632|NCT03421730|83089385|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870633|NCT03421730|83089386|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
46870634|NCT03421730|83089387|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870635|NCT03421730|83089388|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870636|NCT03421730|83089389|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870637|NCT03421730|83089390|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870638|NCT03421730|83089391|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870639|NCT03421730|83089392|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870640|NCT03421730|83089393|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870641|NCT03421730|83089394|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870642|NCT03421730|83089395|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870643|NCT03421730|83089396|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
46870644|NCT03421730|83089385|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870645|NCT03421730|83089386|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870646|NCT03421730|83089387|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870647|NCT03421730|83089388|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870648|NCT03421730|83089389|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
46870649|NCT03421730|83089390|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870650|NCT03421730|83089391|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870651|NCT03421730|83089392|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870652|NCT03421730|83089393|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870653|NCT03421730|83089394|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870654|NCT03421730|83089395|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870655|NCT03421730|83089396|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
46870656|NCT00054327|83089416|FG000|Overall Study|Engraftment failure|1|||
46870657|NCT00054327|83089417|FG001|Overall Study|Engraftment failure|0|||
46870658|NCT00054327|83089418|FG002|Overall Study|Engraftment failure|0|||
46870659|NCT00054327|83089419|FG003|Overall Study|Engraftment failure|0|||
46870660|NCT00054327|83089420|FG004|Overall Study|Engraftment failure|0|||
46870661|NCT00054327|83089421|FG005|Overall Study|Engraftment failure|0|||
46870662|NCT03503162|83089435|FG000|Overall Study|did not meet eligibility|1|||
46870663|NCT03029650|83089439|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
46870664|NCT03029650|83089440|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
46984059|NCT02553265|83230242|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
46984060|NCT02553265|83230243|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
46984061|NCT02561195|83230260|FG000|Vaccination 1 to 3|Adverse Event|4|||
46984062|NCT02561195|83230261|FG001|Vaccination 1 to 3|Adverse Event|5|||
46984063|NCT02561195|83230262|FG002|Vaccination 1 to 3|Adverse Event|0|||
46984064|NCT02561195|83230263|FG003|Vaccination 1 to 3|Adverse Event|3|||
46984065|NCT02561195|83230264|FG004|Vaccination 1 to 3|Adverse Event|4|||
46984066|NCT02561195|83230265|FG005|Vaccination 1 to 3|Adverse Event|0|||
46984067|NCT02561195|83230266|FG006|Vaccination 1 to 3|Adverse Event|0|||
46984068|NCT02561195|83230267|FG007|Vaccination 1 to 3|Adverse Event|0|||
46984069|NCT02561195|83230268|FG008|Vaccination 1 to 3|Adverse Event|0|||
46984070|NCT02561195|83230269|FG009|Vaccination 1 to 3|Adverse Event|0|||
46984071|NCT02561195|83230270|FG010|Vaccination 1 to 3|Adverse Event|0|||
46984072|NCT02561195|83230271|FG011|Vaccination 1 to 3|Adverse Event|0|||
46984073|NCT02561195|83230272|FG012|Vaccination 1 to 3|Adverse Event|0|||
46984074|NCT02561195|83230273|FG013|Vaccination 1 to 3|Adverse Event|0|||
46984075|NCT02561195|83230260|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
46984076|NCT02561195|83230261|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
46984077|NCT02561195|83230262|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
46984078|NCT02561195|83230263|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
46984079|NCT02561195|83230264|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
46984080|NCT02561195|83230265|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
46984081|NCT02561195|83230266|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
46984082|NCT02561195|83230267|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
46984083|NCT02561195|83230268|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
46984084|NCT02561195|83230269|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
46984085|NCT02561195|83230270|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
46984086|NCT02561195|83230271|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
46984087|NCT02561195|83230272|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
46984088|NCT02561195|83230273|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
46984089|NCT02561195|83230260|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984090|NCT02561195|83230261|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
46984091|NCT02561195|83230262|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984092|NCT02561195|83230263|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
46984093|NCT02561195|83230264|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
46984094|NCT02561195|83230265|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
46984095|NCT02561195|83230266|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984096|NCT02561195|83230267|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984097|NCT02561195|83230268|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984098|NCT02561195|83230269|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984099|NCT02561195|83230270|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984100|NCT02561195|83230271|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984101|NCT02561195|83230272|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984102|NCT02561195|83230273|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
46984103|NCT02561195|83230260|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
46984104|NCT02561195|83230261|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
46984105|NCT02561195|83230262|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
46984106|NCT02561195|83230263|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
46870665|NCT03029650|83089439|FG000|Washout (1 Week)|Physician Decision|0|||
46984107|NCT02561195|83230264|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
46984108|NCT02561195|83230265|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
46984109|NCT02561195|83230266|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
46984110|NCT02561195|83230267|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
46984111|NCT02561195|83230268|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
46984112|NCT02561195|83230269|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
46984113|NCT02561195|83230270|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
46984114|NCT02561195|83230271|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
46984115|NCT02561195|83230272|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
46984116|NCT02561195|83230273|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
46870666|NCT03029650|83089440|FG001|Washout (1 Week)|Physician Decision|1|||
46984117|NCT02561195|83230260|FG000|Vaccination 1 to 3|Other|7|||
46984118|NCT02561195|83230261|FG001|Vaccination 1 to 3|Other|3|||
46984119|NCT02561195|83230262|FG002|Vaccination 1 to 3|Other|1|||
46984120|NCT02561195|83230263|FG003|Vaccination 1 to 3|Other|7|||
46870667|NCT03462680|83089452|FG000|Overall Study|Withdrawal by Subject|3|||
46870668|NCT03462680|83089453|FG001|Overall Study|Withdrawal by Subject|5|||
46870669|NCT03636906|83089462|FG000|Overall Study|Adverse Event|0|||
46870670|NCT03636906|83089463|FG001|Overall Study|Adverse Event|0|||
46870671|NCT03636906|83089464|FG002|Overall Study|Adverse Event|1|||
46870672|NCT03636906|83089462|FG000|Overall Study|Lost to Follow-up|1|||
46870673|NCT03636906|83089463|FG001|Overall Study|Lost to Follow-up|0|||
46870674|NCT03636906|83089464|FG002|Overall Study|Lost to Follow-up|0|||
46870675|NCT03636906|83089462|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
46870676|NCT03636906|83089463|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
46870677|NCT03636906|83089464|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
46870678|NCT03636906|83089462|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
46870679|NCT03636906|83089463|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46870680|NCT03636906|83089464|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
46870681|NCT03636906|83089462|FG000|Overall Study|Other|0|||
46870682|NCT03636906|83089463|FG001|Overall Study|Other|0|||
46870683|NCT03636906|83089464|FG002|Overall Study|Other|1|||
46870684|NCT03028870|83089482|FG000|Overall Study|Adverse Event|7|||
46870685|NCT03028870|83089483|FG001|Overall Study|Adverse Event|4|||
46870686|NCT03028870|83089484|FG002|Overall Study|Adverse Event|3|||
46870687|NCT03028870|83089485|FG003|Overall Study|Adverse Event|3|||
46870688|NCT03028870|83089482|FG000|Overall Study|Withdrawal by Subject|1|||
46870689|NCT03028870|83089483|FG001|Overall Study|Withdrawal by Subject|1|||
46870690|NCT03028870|83089484|FG002|Overall Study|Withdrawal by Subject|1|||
46870691|NCT03028870|83089485|FG003|Overall Study|Withdrawal by Subject|2|||
46870692|NCT03028870|83089482|FG000|Overall Study|Lost to Follow-up|1|||
46870693|NCT03028870|83089483|FG001|Overall Study|Lost to Follow-up|0|||
46870694|NCT03028870|83089484|FG002|Overall Study|Lost to Follow-up|0|||
46870695|NCT03028870|83089485|FG003|Overall Study|Lost to Follow-up|0|||
46870696|NCT03028870|83089482|FG000|Overall Study|Lack of Efficacy|3|||
46870697|NCT03028870|83089483|FG001|Overall Study|Lack of Efficacy|0|||
46870698|NCT03028870|83089484|FG002|Overall Study|Lack of Efficacy|0|||
46870699|NCT03028870|83089485|FG003|Overall Study|Lack of Efficacy|0|||
46870700|NCT03028870|83089482|FG000|Overall Study|Administrative|5|||
46870701|NCT03028870|83089483|FG001|Overall Study|Administrative|5|||
46870702|NCT03028870|83089484|FG002|Overall Study|Administrative|12|||
46870703|NCT03028870|83089485|FG003|Overall Study|Administrative|4|||
46870704|NCT03663582|83089495|FG000|Overall Study|Physician Decision|1|||
46870705|NCT03502616|83089501|FG000|Up to Week 16|Withdrawal by Subject|1|||
46870706|NCT03502616|83089502|FG001|Up to Week 16|Withdrawal by Subject|2|||
46870707|NCT03502616|83089501|FG000|Up to Week 16|Lost to Follow-up|0|||
46870708|NCT03502616|83089502|FG001|Up to Week 16|Lost to Follow-up|1|||
46870709|NCT03502616|83089501|FG000|Up to Week 16|Randomized, but not treated|1|||
46870710|NCT03502616|83089502|FG001|Up to Week 16|Randomized, but not treated|0|||
46870711|NCT03502616|83089501|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
46984121|NCT02561195|83230264|FG004|Vaccination 1 to 3|Other|5|||
46984122|NCT02561195|83230265|FG005|Vaccination 1 to 3|Other|1|||
46984123|NCT02561195|83230266|FG006|Vaccination 1 to 3|Other|0|||
46984124|NCT02561195|83230267|FG007|Vaccination 1 to 3|Other|0|||
46984125|NCT02561195|83230268|FG008|Vaccination 1 to 3|Other|0|||
46870712|NCT03502616|83089502|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
46870713|NCT03502616|83089501|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
46870714|NCT03502616|83089502|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
46870715|NCT03028012|83089523|FG000|Overall Study|Lost to Follow-up|2|||
46870716|NCT03028012|83089524|FG001|Overall Study|Lost to Follow-up|3|||
46870717|NCT03028012|83089525|FG002|Overall Study|Lost to Follow-up|3|||
46870718|NCT03635190|83089534|FG000|Overall Study|Lost to Follow-up|4|||
46870719|NCT03635190|83089534|FG000|Overall Study|Death|3|||
46870720|NCT03635190|83089534|FG000|Overall Study|Withdrawal by Subject|1|||
46870721|NCT03635190|83089534|FG000|Overall Study|Patient moved and did not return for follow up|1|||
46870722|NCT03634800|83089541|FG000|Overall Study|Adverse Event|1|||
46870723|NCT03634800|83089541|FG000|Overall Study|Disease Progression|4|||
46870724|NCT03634800|83089541|FG000|Overall Study|Withdrawal by Subject|1|||
46870725|NCT03027466|83089549|FG000|Overall Study|Opting out of the app|1869|||
46984126|NCT02561195|83230269|FG009|Vaccination 1 to 3|Other|0|||
46984127|NCT02561195|83230270|FG010|Vaccination 1 to 3|Other|0|||
46984128|NCT02561195|83230271|FG011|Vaccination 1 to 3|Other|0|||
46984129|NCT02561195|83230272|FG012|Vaccination 1 to 3|Other|0|||
46984130|NCT02561195|83230273|FG013|Vaccination 1 to 3|Other|0|||
46870726|NCT03027466|83089550|FG001|Overall Study|Opting out of the app|1819|||
46870727|NCT03027466|83089551|FG002|Overall Study|Opting out of the app|1743|||
46870728|NCT03027466|83089552|FG003|Overall Study|Opting out of the app|1821|||
46870729|NCT03662334|83089564|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
46870730|NCT03662334|83089565|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
46870731|NCT02955186|83089573|FG000|Overall Study|Withdrawal by Subject|6|||
46870732|NCT02955186|83089574|FG001|Overall Study|Withdrawal by Subject|2|||
46870733|NCT02955186|83089573|FG000|Overall Study|Protocol Violation|1|||
46870734|NCT02955186|83089574|FG001|Overall Study|Protocol Violation|0|||
46984131|NCT02561195|83230260|FG000|Vaccination 1 to 3|Protocol Violation|1|||
46870735|NCT03502070|83089580|FG000|Overall Study|Withdrawal by Subject|1|||
46870736|NCT03502070|83089580|FG000|Overall Study|Screen Failure|1|||
46870737|NCT03586830|83089588|FG000|Overall Study|Site terminated by Sponsor|1|||
46870738|NCT03586830|83089589|FG001|Overall Study|Site terminated by Sponsor|4|||
46870739|NCT03586830|83089590|FG002|Overall Study|Site terminated by Sponsor|3|||
46870740|NCT03586830|83089591|FG003|Overall Study|Site terminated by Sponsor|3|||
46870741|NCT03586830|83089588|FG000|Overall Study|Lost to Follow-up|0|||
46870742|NCT03586830|83089589|FG001|Overall Study|Lost to Follow-up|2|||
46870743|NCT03586830|83089590|FG002|Overall Study|Lost to Follow-up|2|||
46870744|NCT03586830|83089591|FG003|Overall Study|Lost to Follow-up|1|||
46870745|NCT03586830|83089588|FG000|Overall Study|Withdrawal by Subject|1|||
46870746|NCT03586830|83089589|FG001|Overall Study|Withdrawal by Subject|0|||
46870747|NCT03586830|83089590|FG002|Overall Study|Withdrawal by Subject|3|||
46870748|NCT03586830|83089591|FG003|Overall Study|Withdrawal by Subject|1|||
46870749|NCT03026530|83089603|FG000|Overall Study|Lost to Follow-up|19|||
46870750|NCT03026530|83089604|FG001|Overall Study|Lost to Follow-up|24|||
46870751|NCT03026530|83089603|FG000|Overall Study|Protocol Violation|2|||
46870752|NCT03026530|83089604|FG001|Overall Study|Protocol Violation|5|||
46870753|NCT03418376|83089614|FG000|Overall Study|Musculoskeletal injury|1|||
46870754|NCT03418376|83089615|FG001|Overall Study|Musculoskeletal injury|2|||
46870755|NCT03418376|83089616|FG002|Overall Study|Musculoskeletal injury|1|||
46870756|NCT03418376|83089617|FG003|Overall Study|Musculoskeletal injury|0|||
46870757|NCT03418376|83089614|FG000|Overall Study|Personal reasons|0|||
46870758|NCT03418376|83089615|FG001|Overall Study|Personal reasons|2|||
46870759|NCT03418376|83089616|FG002|Overall Study|Personal reasons|2|||
46870760|NCT03418376|83089617|FG003|Overall Study|Personal reasons|1|||
46870761|NCT03418376|83089614|FG000|Overall Study|Exacerbation|0|||
46870762|NCT03418376|83089615|FG001|Overall Study|Exacerbation|1|||
46870763|NCT03418376|83089616|FG002|Overall Study|Exacerbation|0|||
46870764|NCT03418376|83089617|FG003|Overall Study|Exacerbation|0|||
46870765|NCT03585504|83089629|FG000|Overall Study|Lost to Follow-up|26|||
46870766|NCT03585504|83089630|FG001|Overall Study|Lost to Follow-up|29|||
46870767|NCT03417830|83089638|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
46870768|NCT03417830|83089639|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
46870769|NCT03576768|83089650|FG000|Overall Study|Lost to Follow-up|3|||
46870770|NCT03576768|83089651|FG001|Overall Study|Lost to Follow-up|3|||
46870771|NCT03576768|83089652|FG002|Overall Study|Lost to Follow-up|0|||
46870772|NCT03576768|83089653|FG003|Overall Study|Lost to Follow-up|0|||
46870773|NCT03576066|83089665|FG000|Overall Study|Noncompliance with study drug|0|||
46870774|NCT03576066|83089666|FG001|Overall Study|Noncompliance with study drug|1|||
46870775|NCT03557034|83089678|FG000|Overall Study|Withdrawal by Subject|1|||
46870776|NCT03557034|83089679|FG001|Overall Study|Withdrawal by Subject|0|||
46870777|NCT03583554|83089685|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
46701978|NCT01078623|82916837|FG012|Treatment Period 4|Withdrawal by Subject|0|||
46701979|NCT01078623|82916838|FG013|Treatment Period 4|Withdrawal by Subject|0|||
46701980|NCT01078623|82916839|FG014|Treatment Period 4|Withdrawal by Subject|0|||
46701981|NCT01078623|82916840|FG015|Treatment Period 4|Withdrawal by Subject|1|||
46701982|NCT01078623|82916841|FG016|Treatment Period 4|Withdrawal by Subject|0|||
46701983|NCT01078623|82916842|FG017|Treatment Period 4|Withdrawal by Subject|0|||
46701984|NCT01078623|82916843|FG018|Treatment Period 4|Withdrawal by Subject|0|||
46701985|NCT01078623|82916844|FG019|Treatment Period 4|Withdrawal by Subject|0|||
46701986|NCT01092507|82916858|FG000|Overall Study|Withdrawal by Subject|2|||
46701987|NCT01092507|82916859|FG001|Overall Study|Withdrawal by Subject|0|||
46870778|NCT03583554|83089686|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
46870779|NCT03583554|83089687|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
46870780|NCT03948178|83089698|FG000|Overall Study|Protocol Violation|1|||
46870781|NCT03948178|83089698|FG000|Overall Study|Lost to Follow-up|2|||
46870782|NCT03948178|83089698|FG000|Overall Study|Withdrawal by Subject|2|||
46870783|NCT03948178|83089698|FG000|Overall Study|Reason not known|2|||
46870784|NCT03948178|83089698|FG000|Overall Study|Personal reason|14|||
46870785|NCT03948178|83089698|FG000|Overall Study|Disease progression|30|||
46701988|NCT01078545|82916865|FG000|Overall Study|Lost to Follow-up|13|||
46701989|NCT01078545|82916865|FG000|Overall Study|Physician Decision|6|||
46701990|NCT01078545|82916865|FG000|Overall Study|Withdrawal by Subject|3|||
46701991|NCT01078545|82916865|FG000|Overall Study|Death|3|||
46701992|NCT01078545|82916865|FG000|Overall Study|Participant moved to another physician|1|||
46870786|NCT03948178|83089698|FG000|Overall Study|Adverse Event|12|||
46870787|NCT03948178|83089698|FG000|Overall Study|Sponsor terminated study|164|||
46870788|NCT03520920|83089705|FG000|Overall Study|Death|13|||
46870789|NCT03520920|83089706|FG001|Overall Study|Death|1|||
46870790|NCT03520920|83089707|FG002|Overall Study|Death|0|||
46870791|NCT03520920|83089705|FG000|Overall Study|Withdrawal by Subject|2|||
46870792|NCT03520920|83089706|FG001|Overall Study|Withdrawal by Subject|1|||
46870793|NCT03520920|83089707|FG002|Overall Study|Withdrawal by Subject|0|||
46870794|NCT03520920|83089705|FG000|Overall Study|Study Terminated by the Sponsor|5|||
46870795|NCT03520920|83089706|FG001|Overall Study|Study Terminated by the Sponsor|14|||
46701993|NCT01202760|82916872|FG000|Overall Study|Entry Criteria Not Met|0|||
46870796|NCT03520920|83089707|FG002|Overall Study|Study Terminated by the Sponsor|5|||
46870797|NCT02953340|83089723|FG000|Overall Study|Death|0|||
46870798|NCT02953340|83089724|FG001|Overall Study|Death|1|||
46870799|NCT02953340|83089723|FG000|Overall Study|Investigator Decision|3|||
46870800|NCT02953340|83089724|FG001|Overall Study|Investigator Decision|3|||
46870801|NCT02953340|83089723|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
46870802|NCT02953340|83089724|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
46870803|NCT02953340|83089723|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
46870804|NCT02953340|83089724|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
46870805|NCT02953340|83089723|FG000|Overall Study|Withdrawal by Subject|9|||
46870806|NCT02953340|83089724|FG001|Overall Study|Withdrawal by Subject|9|||
46870807|NCT02953340|83089723|FG000|Overall Study|Sponsor decision|0|||
46870808|NCT02953340|83089724|FG001|Overall Study|Sponsor decision|2|||
46870809|NCT02953340|83089723|FG000|Overall Study|Lost to Follow-up|3|||
46870810|NCT02953340|83089724|FG001|Overall Study|Lost to Follow-up|2|||
46870811|NCT02953340|83089723|FG000|Overall Study|Reason not specified|2|||
46870812|NCT02953340|83089724|FG001|Overall Study|Reason not specified|2|||
46870813|NCT03554772|83089740|FG000|Overall Study|Lost to Follow-up|0|||
46870814|NCT03554772|83089741|FG001|Overall Study|Lost to Follow-up|0|||
46870815|NCT03554772|83089742|FG002|Overall Study|Lost to Follow-up|0|||
46870816|NCT03554772|83089743|FG003|Overall Study|Lost to Follow-up|2|||
46870817|NCT03573804|83089753|FG000|Overall Study|claustrophobia or MRI table problems|10|||
46870818|NCT03417440|83089771|FG000|Overall Study|Lost to Follow-up|0|||
46870819|NCT03417440|83089772|FG001|Overall Study|Lost to Follow-up|1|||
46870820|NCT03417440|83089773|FG002|Overall Study|Lost to Follow-up|0|||
46870821|NCT03417440|83089774|FG003|Overall Study|Lost to Follow-up|0|||
46870822|NCT03417440|83089775|FG004|Overall Study|Lost to Follow-up|1|||
46870823|NCT03417440|83089776|FG005|Overall Study|Lost to Follow-up|0|||
46870824|NCT03417440|83089777|FG006|Overall Study|Lost to Follow-up|0|||
46870825|NCT03417440|83089778|FG007|Overall Study|Lost to Follow-up|0|||
46870826|NCT03417440|83089771|FG000|Overall Study|Withdrawal by Subject|2|||
46870827|NCT03417440|83089772|FG001|Overall Study|Withdrawal by Subject|0|||
46870828|NCT03417440|83089773|FG002|Overall Study|Withdrawal by Subject|2|||
46870829|NCT03417440|83089774|FG003|Overall Study|Withdrawal by Subject|1|||
46870830|NCT03417440|83089775|FG004|Overall Study|Withdrawal by Subject|1|||
46870831|NCT03417440|83089776|FG005|Overall Study|Withdrawal by Subject|0|||
46870832|NCT03417440|83089777|FG006|Overall Study|Withdrawal by Subject|0|||
46870833|NCT03417440|83089778|FG007|Overall Study|Withdrawal by Subject|1|||
46870834|NCT03458702|83089801|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
46870835|NCT03458702|83089802|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
46870836|NCT03458702|83089801|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
46870837|NCT03458702|83089802|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
46870838|NCT03454412|83089808|FG000|Baseline Assesment|Physician Decision|12|||
46870839|NCT03452540|83089812|FG000|Overall Study|Adverse Event|1|||
46870840|NCT03452540|83089812|FG000|Overall Study|Withdrawal by Subject|1|||
46870841|NCT03452540|83089812|FG000|Overall Study|Other SAE and AE|2|||
46870842|NCT03573336|83089819|FG000|Overall Study|Study terminated|2|||
46870843|NCT03573336|83089820|FG001|Overall Study|Study terminated|4|||
46870844|NCT03573336|83089821|FG002|Overall Study|Study terminated|2|||
46870845|NCT03500198|83089831|FG000|Overall Study|Lost to Follow-up|0|||
46870846|NCT03500198|83089832|FG001|Overall Study|Lost to Follow-up|1|||
46870847|NCT03553758|83089840|FG000|Overall Study|Lost to Follow-up|1|||
46870848|NCT03552198|83089850|FG000|Overall Study|Lost to Follow-up|42|||
46870849|NCT03552198|83089851|FG001|Overall Study|Lost to Follow-up|48|||
46870850|NCT03552198|83089852|FG002|Overall Study|Lost to Follow-up|15|||
46870851|NCT03552198|83089853|FG003|Overall Study|Lost to Follow-up|19|||
46870852|NCT03552198|83089850|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
46870853|NCT03552198|83089851|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
46870854|NCT03552198|83089852|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
46870855|NCT03552198|83089853|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
46870856|NCT03552198|83089850|FG000|Overall Study|Did not receive air alerts|1|||
46984132|NCT02561195|83230261|FG001|Vaccination 1 to 3|Protocol Violation|0|||
46870857|NCT03552198|83089851|FG001|Overall Study|Did not receive air alerts|0|||
46870858|NCT03552198|83089852|FG002|Overall Study|Did not receive air alerts|0|||
46870859|NCT03552198|83089853|FG003|Overall Study|Did not receive air alerts|1|||
46870860|NCT02954354|83089866|FG000|Overall Study|Adverse Event|2|||
46870861|NCT02954354|83089867|FG001|Overall Study|Adverse Event|2|||
46870862|NCT02954354|83089868|FG002|Overall Study|Adverse Event|4|||
46870863|NCT02954354|83089866|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
46870864|NCT02954354|83089867|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
46870865|NCT02954354|83089868|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
46870866|NCT02954354|83089866|FG000|Overall Study|Lack of Efficacy|0|||
46984133|NCT02561195|83230262|FG002|Vaccination 1 to 3|Protocol Violation|1|||
46870867|NCT02954354|83089867|FG001|Overall Study|Lack of Efficacy|2|||
46870868|NCT02954354|83089868|FG002|Overall Study|Lack of Efficacy|0|||
46870869|NCT02954354|83089866|FG000|Overall Study|Withdrawal by Subject|17|||
46870870|NCT02954354|83089867|FG001|Overall Study|Withdrawal by Subject|9|||
46870871|NCT02954354|83089868|FG002|Overall Study|Withdrawal by Subject|11|||
46870872|NCT02954354|83089866|FG000|Overall Study|Lost to Follow-up|12|||
46870873|NCT02954354|83089867|FG001|Overall Study|Lost to Follow-up|5|||
46870874|NCT02954354|83089868|FG002|Overall Study|Lost to Follow-up|0|||
46870875|NCT02954354|83089866|FG000|Overall Study|Miscellaneous|2|||
46870876|NCT02954354|83089867|FG001|Overall Study|Miscellaneous|2|||
46870877|NCT02954354|83089868|FG002|Overall Study|Miscellaneous|1|||
46870878|NCT03519516|83089880|FG000|Overall Study|Adverse Event|0|||
46870879|NCT03519516|83089881|FG001|Overall Study|Adverse Event|1|||
46870880|NCT03519204|83089889|FG000|Overall Study|Lost to Follow-up|3|||
46870881|NCT03519204|83089890|FG001|Overall Study|Lost to Follow-up|8|||
46870882|NCT03519204|83089889|FG000|Overall Study|Withdrawal by Subject|9|||
46870883|NCT03519204|83089890|FG001|Overall Study|Withdrawal by Subject|7|||
46870884|NCT03519204|83089889|FG000|Overall Study|Other Miscellaneous Reasons|1|||
46870885|NCT03519204|83089890|FG001|Overall Study|Other Miscellaneous Reasons|0|||
46870886|NCT03518658|83089902|FG000|Overall Study|Other|51|||
46870887|NCT03518658|83089903|FG001|Overall Study|Other|0|||
46870888|NCT03518112|83089911|FG000|Overall Study|Withdrawal by Subject|1|||
46870889|NCT03517566|83089920|FG000|Overall Study|Adverse Event|5|||
46870890|NCT03517566|83089921|FG001|Overall Study|Adverse Event|2|||
46870891|NCT03517566|83089922|FG002|Overall Study|Adverse Event|2|||
46870892|NCT03517566|83089923|FG003|Overall Study|Adverse Event|8|||
46870893|NCT03517566|83089924|FG004|Overall Study|Adverse Event|7|||
46870894|NCT03517566|83089920|FG000|Overall Study|Lack of Efficacy|3|||
46870895|NCT03517566|83089921|FG001|Overall Study|Lack of Efficacy|2|||
46870896|NCT03517566|83089922|FG002|Overall Study|Lack of Efficacy|1|||
46870897|NCT03517566|83089923|FG003|Overall Study|Lack of Efficacy|1|||
46870898|NCT03517566|83089924|FG004|Overall Study|Lack of Efficacy|4|||
46870899|NCT03517566|83089920|FG000|Overall Study|Lost to Follow-up|3|||
46870900|NCT03517566|83089921|FG001|Overall Study|Lost to Follow-up|1|||
46870901|NCT03517566|83089922|FG002|Overall Study|Lost to Follow-up|1|||
46870902|NCT03517566|83089923|FG003|Overall Study|Lost to Follow-up|1|||
46870903|NCT03517566|83089924|FG004|Overall Study|Lost to Follow-up|0|||
46870904|NCT03517566|83089920|FG000|Overall Study|Physician Decision|1|||
46870905|NCT03517566|83089921|FG001|Overall Study|Physician Decision|1|||
46870906|NCT03517566|83089922|FG002|Overall Study|Physician Decision|0|||
46870907|NCT03517566|83089923|FG003|Overall Study|Physician Decision|1|||
46870908|NCT03517566|83089924|FG004|Overall Study|Physician Decision|0|||
46870909|NCT03517566|83089920|FG000|Overall Study|Pregnancy|0|||
46870910|NCT03517566|83089921|FG001|Overall Study|Pregnancy|1|||
46870911|NCT03517566|83089922|FG002|Overall Study|Pregnancy|0|||
46870912|NCT03517566|83089923|FG003|Overall Study|Pregnancy|0|||
46870913|NCT03517566|83089924|FG004|Overall Study|Pregnancy|0|||
46870914|NCT03517566|83089920|FG000|Overall Study|Protocol Deviation|0|||
46870915|NCT03517566|83089921|FG001|Overall Study|Protocol Deviation|1|||
46870916|NCT03517566|83089922|FG002|Overall Study|Protocol Deviation|0|||
46870917|NCT03517566|83089923|FG003|Overall Study|Protocol Deviation|1|||
46870918|NCT03517566|83089924|FG004|Overall Study|Protocol Deviation|1|||
46870919|NCT03517566|83089920|FG000|Overall Study|Study terminated by Sponsor|11|||
46870920|NCT03517566|83089921|FG001|Overall Study|Study terminated by Sponsor|5|||
46870921|NCT03517566|83089922|FG002|Overall Study|Study terminated by Sponsor|6|||
46870922|NCT03517566|83089923|FG003|Overall Study|Study terminated by Sponsor|14|||
46870923|NCT03517566|83089924|FG004|Overall Study|Study terminated by Sponsor|12|||
46870924|NCT03517566|83089920|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
46870925|NCT03517566|83089921|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
46870926|NCT03517566|83089922|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
46870927|NCT03517566|83089923|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
46870928|NCT03517566|83089924|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
46870929|NCT03916744|83089940|FG000|Overall Study|Withdrawal by Subject|0|||
46870930|NCT03916744|83089941|FG001|Overall Study|Withdrawal by Subject|1|||
46870931|NCT03916744|83089942|FG002|Overall Study|Withdrawal by Subject|2|||
46870932|NCT03639610|83089957|FG000|Overall Study|Adverse Event|7|||
46870933|NCT03639610|83089958|FG001|Overall Study|Adverse Event|1|||
46870934|NCT03639610|83089959|FG002|Overall Study|Adverse Event|0|||
46984134|NCT02561195|83230263|FG003|Vaccination 1 to 3|Protocol Violation|2|||
46707555|NCT01176240|82923136|FG001|Study 306B|Lack of Efficacy|3|||
46870935|NCT03639610|83089957|FG000|Overall Study|Physician Decision|3|||
46870936|NCT03639610|83089958|FG001|Overall Study|Physician Decision|1|||
46870937|NCT03639610|83089959|FG002|Overall Study|Physician Decision|0|||
46870938|NCT03639610|83089957|FG000|Overall Study|Disease progression|8|||
46870939|NCT03639610|83089958|FG001|Overall Study|Disease progression|5|||
46870940|NCT03639610|83089959|FG002|Overall Study|Disease progression|3|||
46870941|NCT03639610|83089957|FG000|Overall Study|Study terminated by sponsor|2|||
46870942|NCT03639610|83089958|FG001|Overall Study|Study terminated by sponsor|1|||
46870943|NCT03639610|83089959|FG002|Overall Study|Study terminated by sponsor|1|||
46870944|NCT03639610|83089957|FG000|Overall Study|Patient request to stop treatment|1|||
46870945|NCT03639610|83089958|FG001|Overall Study|Patient request to stop treatment|2|||
46870946|NCT03639610|83089959|FG002|Overall Study|Patient request to stop treatment|0|||
46870947|NCT02954406|83089977|FG000|Overall Study|Adverse Event|0|||
46870948|NCT02954406|83089978|FG001|Overall Study|Adverse Event|1|||
46870949|NCT02954406|83089979|FG002|Overall Study|Adverse Event|0|||
46870950|NCT02954406|83089980|FG003|Overall Study|Adverse Event|0|||
46870951|NCT02954406|83089981|FG004|Overall Study|Adverse Event|1|||
46870952|NCT02954406|83089982|FG005|Overall Study|Adverse Event|0|||
46870953|NCT02954406|83089983|FG006|Overall Study|Adverse Event|0|||
46870954|NCT02954406|83089984|FG007|Overall Study|Adverse Event|0|||
46870955|NCT02954406|83089985|FG008|Overall Study|Adverse Event|1|||
46870956|NCT02954406|83089986|FG009|Overall Study|Adverse Event|1|||
46870957|NCT02954406|83089987|FG010|Overall Study|Adverse Event|0|||
46870958|NCT02954406|83089977|FG000|Overall Study|Progressive Disease|3|||
46870959|NCT02954406|83089978|FG001|Overall Study|Progressive Disease|4|||
46870960|NCT02954406|83089979|FG002|Overall Study|Progressive Disease|3|||
46870961|NCT02954406|83089980|FG003|Overall Study|Progressive Disease|4|||
46870962|NCT02954406|83089981|FG004|Overall Study|Progressive Disease|3|||
46870963|NCT02954406|83089982|FG005|Overall Study|Progressive Disease|3|||
46870964|NCT02954406|83089983|FG006|Overall Study|Progressive Disease|2|||
46870965|NCT02954406|83089984|FG007|Overall Study|Progressive Disease|2|||
46870966|NCT02954406|83089985|FG008|Overall Study|Progressive Disease|1|||
46870967|NCT02954406|83089986|FG009|Overall Study|Progressive Disease|1|||
46870968|NCT02954406|83089987|FG010|Overall Study|Progressive Disease|0|||
46870969|NCT02954406|83089977|FG000|Overall Study|Symptomatic Deterioration|0|||
46870970|NCT02954406|83089978|FG001|Overall Study|Symptomatic Deterioration|1|||
46870971|NCT02954406|83089979|FG002|Overall Study|Symptomatic Deterioration|0|||
46870972|NCT02954406|83089980|FG003|Overall Study|Symptomatic Deterioration|0|||
46870973|NCT02954406|83089981|FG004|Overall Study|Symptomatic Deterioration|0|||
46870974|NCT02954406|83089982|FG005|Overall Study|Symptomatic Deterioration|0|||
46870975|NCT02954406|83089983|FG006|Overall Study|Symptomatic Deterioration|0|||
46870976|NCT02954406|83089984|FG007|Overall Study|Symptomatic Deterioration|0|||
46870977|NCT02954406|83089985|FG008|Overall Study|Symptomatic Deterioration|0|||
46870978|NCT02954406|83089986|FG009|Overall Study|Symptomatic Deterioration|0|||
46870979|NCT02954406|83089987|FG010|Overall Study|Symptomatic Deterioration|0|||
46870980|NCT02954406|83089977|FG000|Overall Study|Death|0|||
46870981|NCT02954406|83089978|FG001|Overall Study|Death|0|||
46870982|NCT02954406|83089979|FG002|Overall Study|Death|0|||
46870983|NCT02954406|83089980|FG003|Overall Study|Death|0|||
46870984|NCT02954406|83089981|FG004|Overall Study|Death|1|||
46870985|NCT02954406|83089982|FG005|Overall Study|Death|0|||
46870986|NCT02954406|83089983|FG006|Overall Study|Death|0|||
46870987|NCT02954406|83089984|FG007|Overall Study|Death|0|||
46870988|NCT02954406|83089985|FG008|Overall Study|Death|1|||
46870989|NCT02954406|83089986|FG009|Overall Study|Death|1|||
46870990|NCT02954406|83089987|FG010|Overall Study|Death|0|||
46870991|NCT02954406|83089977|FG000|Overall Study|Reason Not Specified|0|||
46870992|NCT02954406|83089978|FG001|Overall Study|Reason Not Specified|0|||
46701994|NCT01202760|82916873|FG001|Overall Study|Entry Criteria Not Met|3|||
46701995|NCT01202760|82916874|FG002|Overall Study|Entry Criteria Not Met|1|||
46870993|NCT02954406|83089979|FG002|Overall Study|Reason Not Specified|3|||
46870994|NCT02954406|83089980|FG003|Overall Study|Reason Not Specified|2|||
46870995|NCT02954406|83089981|FG004|Overall Study|Reason Not Specified|2|||
46870996|NCT02954406|83089982|FG005|Overall Study|Reason Not Specified|0|||
46870997|NCT02954406|83089983|FG006|Overall Study|Reason Not Specified|1|||
46870998|NCT02954406|83089984|FG007|Overall Study|Reason Not Specified|0|||
46870999|NCT02954406|83089985|FG008|Overall Study|Reason Not Specified|1|||
46871000|NCT02954406|83089986|FG009|Overall Study|Reason Not Specified|0|||
46871001|NCT02954406|83089987|FG010|Overall Study|Reason Not Specified|0|||
46871002|NCT03514914|83090017|FG000|Overall Study|Death|3|||
46871003|NCT03514914|83090018|FG001|Overall Study|Death|3|||
46871004|NCT03514914|83090017|FG000|Overall Study|Lost to Follow-up|117|||
46871005|NCT03514914|83090018|FG001|Overall Study|Lost to Follow-up|89|||
46871006|NCT03513588|83090027|FG000|Overall Study|Lost to Follow-up|0|||
46871007|NCT03513588|83090028|FG001|Overall Study|Lost to Follow-up|1|||
46871008|NCT03513588|83090029|FG002|Overall Study|Lost to Follow-up|1|||
46871009|NCT03513588|83090027|FG000|Overall Study|Study dosing paused by sponsor|1|||
46871010|NCT03513588|83090028|FG001|Overall Study|Study dosing paused by sponsor|1|||
46871011|NCT03513588|83090029|FG002|Overall Study|Study dosing paused by sponsor|0|||
46871012|NCT03513588|83090027|FG000|Overall Study|Death|0|||
46871013|NCT03513588|83090028|FG001|Overall Study|Death|0|||
46871014|NCT03513588|83090029|FG002|Overall Study|Death|1|||
46871015|NCT03512028|83090041|FG000|Overall Study|Withdrawal by Subject|2|||
46871016|NCT03512028|83090042|FG001|Overall Study|Withdrawal by Subject|0|||
46871017|NCT03512028|83090041|FG000|Overall Study|Protocol Violation|2|||
46871018|NCT03512028|83090042|FG001|Overall Study|Protocol Violation|0|||
46871019|NCT03511326|83090048|FG000|Overall Study|Withdrawal by Subject|1|||
46871020|NCT03508830|83090054|FG000|Overall Study|Withdrawal by Subject|3|||
46871021|NCT03508830|83090055|FG001|Overall Study|Withdrawal by Subject|4|||
46871022|NCT03508830|83090054|FG000|Overall Study|Physician Decision|2|||
46871023|NCT03508830|83090055|FG001|Overall Study|Physician Decision|2|||
46871024|NCT03508050|83090063|FG000|Overall Study|Pleural adhesions|1|||
46871025|NCT03508050|83090064|FG001|Overall Study|Pleural adhesions|0|||
46871026|NCT03508050|83090063|FG000|Overall Study|Mucus plug|1|||
46871027|NCT03508050|83090064|FG001|Overall Study|Mucus plug|0|||
46871028|NCT03508050|83090063|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
46871029|NCT03508050|83090064|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
46871030|NCT03508050|83090063|FG000|Overall Study|Sustained desaturation|0|||
46871031|NCT03508050|83090064|FG001|Overall Study|Sustained desaturation|1|||
46871032|NCT03569202|83090073|FG000|Part 3|Physician Decision|1|||
46871033|NCT03569202|83090074|FG001|Part 3|Physician Decision|0|||
46871034|NCT03569202|83090073|FG000|Part 3|Other|1|||
46871035|NCT03569202|83090074|FG001|Part 3|Other|1|||
46871036|NCT03568500|83090083|FG000|Overall Study|Lost to Follow-up|1|||
46871037|NCT03568500|83090084|FG001|Overall Study|Lost to Follow-up|1|||
46871038|NCT03568500|83090085|FG002|Overall Study|Lost to Follow-up|2|||
46871039|NCT03568500|83090083|FG000|Overall Study|Adverse Event|1|||
46871040|NCT03568500|83090084|FG001|Overall Study|Adverse Event|1|||
46871041|NCT03568500|83090085|FG002|Overall Study|Adverse Event|2|||
46871042|NCT03568500|83090083|FG000|Overall Study|Physician Decision|1|||
46871043|NCT03568500|83090084|FG001|Overall Study|Physician Decision|0|||
46871044|NCT03568500|83090085|FG002|Overall Study|Physician Decision|0|||
46871045|NCT03568500|83090083|FG000|Overall Study|Withdrawal by Subject|4|||
46871046|NCT03568500|83090084|FG001|Overall Study|Withdrawal by Subject|2|||
46871047|NCT03568500|83090085|FG002|Overall Study|Withdrawal by Subject|0|||
46871048|NCT03568500|83090083|FG000|Overall Study|Technical Problems|2|||
46871049|NCT03568500|83090084|FG001|Overall Study|Technical Problems|1|||
46871050|NCT03568500|83090085|FG002|Overall Study|Technical Problems|0|||
46871051|NCT03568500|83090083|FG000|Overall Study|Participant Noncompliance|1|||
46871052|NCT03568500|83090084|FG001|Overall Study|Participant Noncompliance|1|||
46871053|NCT03568500|83090085|FG002|Overall Study|Participant Noncompliance|0|||
46871054|NCT03727230|83090098|FG000|Overall Study|Lost to Follow-up|12|||
46871055|NCT03504852|83090115|FG000|Overall Study|Withdrawal of informed consent|2|||
46871056|NCT03504852|83090116|FG001|Overall Study|Withdrawal of informed consent|1|||
46871057|NCT03504852|83090117|FG002|Overall Study|Withdrawal of informed consent|0|||
46871058|NCT03504852|83090115|FG000|Overall Study|Withdrawal by Subject|5|||
46871059|NCT03504852|83090116|FG001|Overall Study|Withdrawal by Subject|5|||
46871060|NCT03504852|83090117|FG002|Overall Study|Withdrawal by Subject|1|||
46871061|NCT03504852|83090115|FG000|Overall Study|Lost to Follow-up|4|||
46871062|NCT03504852|83090116|FG001|Overall Study|Lost to Follow-up|1|||
46871063|NCT03504852|83090117|FG002|Overall Study|Lost to Follow-up|0|||
46871064|NCT03504852|83090115|FG000|Overall Study|New therapy for study indication|1|||
46871065|NCT03504852|83090116|FG001|Overall Study|New therapy for study indication|0|||
46871066|NCT03504852|83090117|FG002|Overall Study|New therapy for study indication|0|||
46871067|NCT03504852|83090115|FG000|Overall Study|Lack of Efficacy|1|||
46871068|NCT03504852|83090116|FG001|Overall Study|Lack of Efficacy|2|||
46871069|NCT03504852|83090117|FG002|Overall Study|Lack of Efficacy|0|||
46871070|NCT03504852|83090115|FG000|Overall Study|Death|0|||
46871071|NCT03504852|83090116|FG001|Overall Study|Death|1|||
46871072|NCT03504852|83090117|FG002|Overall Study|Death|0|||
46871073|NCT03504852|83090115|FG000|Overall Study|Adverse Event|4|||
46871074|NCT03504852|83090116|FG001|Overall Study|Adverse Event|8|||
46871075|NCT03504852|83090117|FG002|Overall Study|Adverse Event|2|||
46871076|NCT03025828|83090127|FG000|Overall Study|Lost to Follow-up|1|||
46871077|NCT03546816|83090133|FG000|Overall Study|Adverse Event|5|||
46871078|NCT03546816|83090134|FG001|Overall Study|Adverse Event|3|||
46871079|NCT03546816|83090133|FG000|Overall Study|Lack of Efficacy|2|||
46984135|NCT02561195|83230264|FG004|Vaccination 1 to 3|Protocol Violation|5|||
46871080|NCT03546816|83090134|FG001|Overall Study|Lack of Efficacy|4|||
46871081|NCT03546816|83090133|FG000|Overall Study|Pregnancy|1|||
46871082|NCT03546816|83090134|FG001|Overall Study|Pregnancy|0|||
46871083|NCT03546816|83090133|FG000|Overall Study|Physician Decision|2|||
46871084|NCT03546816|83090134|FG001|Overall Study|Physician Decision|0|||
46871085|NCT03546816|83090133|FG000|Overall Study|Withdrawal by Subject|8|||
46871086|NCT03546816|83090134|FG001|Overall Study|Withdrawal by Subject|10|||
46871087|NCT03546816|83090133|FG000|Overall Study|Lost to Follow-up|3|||
46871088|NCT03546816|83090134|FG001|Overall Study|Lost to Follow-up|2|||
46871089|NCT03024970|83090142|FG000|First Intervention|Adverse Event|1|||
46871090|NCT03024970|83090143|FG001|First Intervention|Adverse Event|0|||
46871091|NCT03024970|83090142|FG000|Second Intervention|Lost to Follow-up|1|||
46871092|NCT03024970|83090143|FG001|Second Intervention|Lost to Follow-up|0|||
46871093|NCT03500094|83090149|FG000|Overall Study|Withdrawal by Subject|1|||
46871094|NCT03500094|83090149|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
46871095|NCT03500094|83090149|FG000|Overall Study|Lost to Follow-up|1|||
46871096|NCT03566550|83090157|FG000|Overall Study|Withdrawal by Subject|0|||
46871097|NCT03566550|83090158|FG001|Overall Study|Withdrawal by Subject|1|||
46871098|NCT03566238|83090167|FG000|Overall Study|Adverse Event|0|||
46871099|NCT03566238|83090168|FG001|Overall Study|Adverse Event|1|||
46871100|NCT03566238|83090169|FG002|Overall Study|Adverse Event|0|||
46871101|NCT03566238|83090167|FG000|Overall Study|Lack of Efficacy|4|||
46871102|NCT03566238|83090168|FG001|Overall Study|Lack of Efficacy|2|||
46871103|NCT03566238|83090169|FG002|Overall Study|Lack of Efficacy|5|||
46871104|NCT03566238|83090167|FG000|Overall Study|Other|1|||
46871105|NCT03566238|83090168|FG001|Overall Study|Other|0|||
46871106|NCT03566238|83090169|FG002|Overall Study|Other|0|||
46871107|NCT02894502|83090180|FG000|Baseline|Withdrawal by Subject|24|||
46871108|NCT02894502|83090181|FG001|Baseline|Withdrawal by Subject|31|||
46871109|NCT02894502|83090182|FG002|Baseline|Withdrawal by Subject|36|||
46871110|NCT02894502|83090180|FG000|Baseline|Death|3|||
46871111|NCT02894502|83090181|FG001|Baseline|Death|1|||
46871112|NCT02894502|83090182|FG002|Baseline|Death|9|||
46871113|NCT02894502|83090180|FG000|First Follow up|Withdrawal by Subject|32|||
46871114|NCT02894502|83090181|FG001|First Follow up|Withdrawal by Subject|29|||
46871115|NCT02894502|83090182|FG002|First Follow up|Withdrawal by Subject|37|||
46871116|NCT02894502|83090180|FG000|First Follow up|Death|2|||
46871117|NCT02894502|83090181|FG001|First Follow up|Death|2|||
46871118|NCT02894502|83090182|FG002|First Follow up|Death|3|||
46871119|NCT02894502|83090180|FG000|Second Follow up|Withdrawal by Subject|13|||
46701996|NCT01202760|82916872|FG000|Overall Study|Adverse Event|11|||
46701997|NCT01202760|82916873|FG001|Overall Study|Adverse Event|9|||
46701998|NCT01202760|82916874|FG002|Overall Study|Adverse Event|10|||
46701999|NCT01202760|82916872|FG000|Overall Study|Death|2|||
46702000|NCT01202760|82916873|FG001|Overall Study|Death|1|||
46702001|NCT01202760|82916874|FG002|Overall Study|Death|0|||
46871120|NCT02894502|83090181|FG001|Second Follow up|Withdrawal by Subject|15|||
46871121|NCT02894502|83090182|FG002|Second Follow up|Withdrawal by Subject|13|||
46871122|NCT02894502|83090180|FG000|Second Follow up|Death|2|||
46871123|NCT02894502|83090181|FG001|Second Follow up|Death|3|||
46871124|NCT02894502|83090182|FG002|Second Follow up|Death|1|||
46871125|NCT02894502|83090180|FG000|Third Follow up|Withdrawal by Subject|5|||
46871126|NCT02894502|83090181|FG001|Third Follow up|Withdrawal by Subject|6|||
46871127|NCT02894502|83090182|FG002|Third Follow up|Withdrawal by Subject|3|||
46871128|NCT02894502|83090180|FG000|Third Follow up|Death|1|||
46871129|NCT02894502|83090181|FG001|Third Follow up|Death|1|||
46871130|NCT02894502|83090182|FG002|Third Follow up|Death|0|||
46871131|NCT03449030|83090203|FG000|Overall Study|Withdrawal by Subject|0|||
46871132|NCT03449030|83090204|FG001|Overall Study|Withdrawal by Subject|0|||
46871133|NCT03449030|83090205|FG002|Overall Study|Withdrawal by Subject|0|||
46871134|NCT03449030|83090206|FG003|Overall Study|Withdrawal by Subject|1|||
46871135|NCT03449030|83090207|FG004|Overall Study|Withdrawal by Subject|1|||
46871136|NCT03449030|83090208|FG005|Overall Study|Withdrawal by Subject|1|||
46702002|NCT01202760|82916872|FG000|Overall Study|Lack of Efficacy|6|||
46871137|NCT03449030|83090209|FG006|Overall Study|Withdrawal by Subject|1|||
46871138|NCT03449030|83090210|FG007|Overall Study|Withdrawal by Subject|2|||
46702003|NCT01202760|82916873|FG001|Overall Study|Lack of Efficacy|8|||
46871139|NCT03449030|83090211|FG008|Overall Study|Withdrawal by Subject|0|||
46871140|NCT03449030|83090212|FG009|Overall Study|Withdrawal by Subject|0|||
46871141|NCT03449030|83090203|FG000|Overall Study|Symptomatic Deterioration|0|||
46871142|NCT03449030|83090204|FG001|Overall Study|Symptomatic Deterioration|1|||
46871143|NCT03449030|83090205|FG002|Overall Study|Symptomatic Deterioration|0|||
46871144|NCT03449030|83090206|FG003|Overall Study|Symptomatic Deterioration|0|||
46871145|NCT03449030|83090207|FG004|Overall Study|Symptomatic Deterioration|0|||
46871146|NCT03449030|83090208|FG005|Overall Study|Symptomatic Deterioration|1|||
46871147|NCT03449030|83090209|FG006|Overall Study|Symptomatic Deterioration|1|||
46871148|NCT03449030|83090210|FG007|Overall Study|Symptomatic Deterioration|0|||
46702004|NCT01202760|82916874|FG002|Overall Study|Lack of Efficacy|7|||
46871149|NCT03449030|83090211|FG008|Overall Study|Symptomatic Deterioration|2|||
46871150|NCT03449030|83090212|FG009|Overall Study|Symptomatic Deterioration|0|||
46871151|NCT03449030|83090203|FG000|Overall Study|Progressive Disease|1|||
46871152|NCT03449030|83090204|FG001|Overall Study|Progressive Disease|0|||
46871153|NCT03449030|83090205|FG002|Overall Study|Progressive Disease|1|||
46871154|NCT03449030|83090206|FG003|Overall Study|Progressive Disease|4|||
46871155|NCT03449030|83090207|FG004|Overall Study|Progressive Disease|5|||
46871156|NCT03449030|83090208|FG005|Overall Study|Progressive Disease|3|||
46871157|NCT03449030|83090209|FG006|Overall Study|Progressive Disease|0|||
46871158|NCT03449030|83090210|FG007|Overall Study|Progressive Disease|1|||
46871159|NCT03449030|83090211|FG008|Overall Study|Progressive Disease|1|||
46871160|NCT03449030|83090212|FG009|Overall Study|Progressive Disease|1|||
46871161|NCT03449030|83090203|FG000|Overall Study|Adverse Event|0|||
46871162|NCT03449030|83090204|FG001|Overall Study|Adverse Event|0|||
46871163|NCT03449030|83090205|FG002|Overall Study|Adverse Event|0|||
46871164|NCT03449030|83090206|FG003|Overall Study|Adverse Event|0|||
46871165|NCT03449030|83090207|FG004|Overall Study|Adverse Event|0|||
46871166|NCT03449030|83090208|FG005|Overall Study|Adverse Event|2|||
46871167|NCT03449030|83090209|FG006|Overall Study|Adverse Event|0|||
46871168|NCT03449030|83090210|FG007|Overall Study|Adverse Event|0|||
46871169|NCT03449030|83090211|FG008|Overall Study|Adverse Event|0|||
46871170|NCT03449030|83090212|FG009|Overall Study|Adverse Event|0|||
46871171|NCT03449030|83090203|FG000|Overall Study|Death|0|||
46871172|NCT03449030|83090204|FG001|Overall Study|Death|0|||
46871173|NCT03449030|83090205|FG002|Overall Study|Death|0|||
46871174|NCT03449030|83090206|FG003|Overall Study|Death|0|||
46871175|NCT03449030|83090207|FG004|Overall Study|Death|1|||
46871176|NCT03449030|83090208|FG005|Overall Study|Death|0|||
46871177|NCT03449030|83090209|FG006|Overall Study|Death|0|||
46871178|NCT03449030|83090210|FG007|Overall Study|Death|0|||
46871179|NCT03449030|83090211|FG008|Overall Study|Death|0|||
46871180|NCT03449030|83090212|FG009|Overall Study|Death|0|||
46871181|NCT03448406|83090237|FG000|Overall Study|Noncompliance of scheduled visits|1|||
46871182|NCT03448406|83090238|FG001|Overall Study|Noncompliance of scheduled visits|2|||
46871183|NCT03448406|83090237|FG000|Overall Study|Withdrawal by Subject|1|||
46871184|NCT03448406|83090238|FG001|Overall Study|Withdrawal by Subject|2|||
46871185|NCT03448406|83090237|FG000|Overall Study|Protocol Violation|1|||
46871186|NCT03448406|83090238|FG001|Overall Study|Protocol Violation|0|||
46871187|NCT03448406|83090237|FG000|Overall Study|Adverse Event|8|||
46871188|NCT03448406|83090238|FG001|Overall Study|Adverse Event|9|||
46871189|NCT03499028|83090246|FG000|Overall Study|Lost to Follow-up|12|||
46871190|NCT03499028|83090247|FG001|Overall Study|Lost to Follow-up|9|||
46871191|NCT03499028|83090246|FG000|Overall Study|Withdrawal by Subject|5|||
46871192|NCT03499028|83090247|FG001|Overall Study|Withdrawal by Subject|8|||
46871193|NCT03499028|83090246|FG000|Overall Study|Unplanned SNF discharge|5|||
46871194|NCT03499028|83090247|FG001|Overall Study|Unplanned SNF discharge|8|||
46871195|NCT03498560|83090255|FG000|Overall Study|Found Ineligible|2|||
46871196|NCT03498560|83090255|FG000|Overall Study|Withdrawal by Subject|14|||
46871197|NCT03498560|83090255|FG000|Overall Study|Lost to Follow-up|4|||
46871198|NCT03498560|83090255|FG000|Overall Study|Death|1|||
46871199|NCT00064701|83090263|FG000|One Year Post-transplant|Did not receive study drug|7|||
46871200|NCT00064701|83090264|FG001|One Year Post-transplant|Did not receive study drug|12|||
46871201|NCT00064701|83090265|FG002|One Year Post-transplant|Did not receive study drug|11|||
46871202|NCT00064701|83090263|FG000|One Year Post-transplant|Adverse Event|23|||
46871203|NCT00064701|83090264|FG001|One Year Post-transplant|Adverse Event|19|||
46871204|NCT00064701|83090265|FG002|One Year Post-transplant|Adverse Event|37|||
46871205|NCT00064701|83090263|FG000|One Year Post-transplant|Rejection|0|||
46871206|NCT00064701|83090264|FG001|One Year Post-transplant|Rejection|1|||
46871207|NCT00064701|83090265|FG002|One Year Post-transplant|Rejection|16|||
46871208|NCT00064701|83090263|FG000|One Year Post-transplant|Non-compliance|4|||
46871209|NCT00064701|83090264|FG001|One Year Post-transplant|Non-compliance|2|||
46871210|NCT00064701|83090265|FG002|One Year Post-transplant|Non-compliance|5|||
46871211|NCT00064701|83090263|FG000|One Year Post-transplant|Graft Failure|3|||
46871212|NCT00064701|83090264|FG001|One Year Post-transplant|Graft Failure|2|||
46871213|NCT00064701|83090265|FG002|One Year Post-transplant|Graft Failure|1|||
46871214|NCT00064701|83090263|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
46871215|NCT00064701|83090264|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
46871216|NCT00064701|83090265|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
46871217|NCT00064701|83090263|FG000|One Year Post-transplant|Lost to Follow-up|1|||
46871218|NCT00064701|83090264|FG001|One Year Post-transplant|Lost to Follow-up|0|||
46871219|NCT00064701|83090265|FG002|One Year Post-transplant|Lost to Follow-up|0|||
46871220|NCT00064701|83090263|FG000|One Year Post-transplant|Converted to rapamycin|1|||
46984136|NCT02561195|83230265|FG005|Vaccination 1 to 3|Protocol Violation|2|||
46871221|NCT00064701|83090264|FG001|One Year Post-transplant|Converted to rapamycin|0|||
46871222|NCT00064701|83090265|FG002|One Year Post-transplant|Converted to rapamycin|0|||
46871223|NCT00064701|83090263|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
46871224|NCT00064701|83090264|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
46871225|NCT00064701|83090265|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
46871226|NCT00064701|83090263|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
46871227|NCT00064701|83090264|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
46871228|NCT00064701|83090265|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
46871229|NCT00064701|83090263|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
46871230|NCT00064701|83090264|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
46871231|NCT00064701|83090265|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
46871232|NCT00064701|83090263|FG000|One Year Post-transplant|Poor absorption|0|||
46871233|NCT00064701|83090264|FG001|One Year Post-transplant|Poor absorption|1|||
46871234|NCT00064701|83090265|FG002|One Year Post-transplant|Poor absorption|0|||
46871235|NCT00064701|83090263|FG000|One Year Post-transplant|Pancreas transplant|0|||
46871236|NCT00064701|83090264|FG001|One Year Post-transplant|Pancreas transplant|0|||
46871237|NCT00064701|83090265|FG002|One Year Post-transplant|Pancreas transplant|1|||
46871238|NCT00064701|83090263|FG000|Clinical Continuation Phase|Adverse Event|12|||
46871239|NCT00064701|83090264|FG001|Clinical Continuation Phase|Adverse Event|21|||
46871240|NCT00064701|83090265|FG002|Clinical Continuation Phase|Adverse Event|14|||
46871241|NCT00064701|83090263|FG000|Clinical Continuation Phase|Non-compliance|8|||
46871242|NCT00064701|83090264|FG001|Clinical Continuation Phase|Non-compliance|6|||
46702005|NCT01202760|82916872|FG000|Overall Study|Lost to Follow-up|0|||
46702006|NCT01202760|82916873|FG001|Overall Study|Lost to Follow-up|2|||
46702007|NCT01202760|82916874|FG002|Overall Study|Lost to Follow-up|1|||
46871243|NCT00064701|83090265|FG002|Clinical Continuation Phase|Non-compliance|7|||
46871244|NCT00064701|83090263|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
46871245|NCT00064701|83090264|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
46871246|NCT00064701|83090265|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
46871247|NCT00064701|83090263|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
46871248|NCT00064701|83090264|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
46871249|NCT00064701|83090265|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
46871250|NCT00064701|83090263|FG000|Clinical Continuation Phase|Graft Failure|5|||
46871251|NCT00064701|83090264|FG001|Clinical Continuation Phase|Graft Failure|5|||
46871252|NCT00064701|83090265|FG002|Clinical Continuation Phase|Graft Failure|2|||
46871253|NCT00064701|83090263|FG000|Clinical Continuation Phase|Rejection|1|||
46871254|NCT00064701|83090264|FG001|Clinical Continuation Phase|Rejection|2|||
46871255|NCT00064701|83090265|FG002|Clinical Continuation Phase|Rejection|2|||
46871256|NCT00064701|83090263|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
46871257|NCT00064701|83090264|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
46871258|NCT00064701|83090265|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
46871259|NCT00064701|83090263|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
46871260|NCT00064701|83090264|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
46871261|NCT00064701|83090265|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
46871262|NCT00064701|83090263|FG000|Clinical Continuation Phase|Physician Decision|1|||
46871263|NCT00064701|83090264|FG001|Clinical Continuation Phase|Physician Decision|3|||
46871264|NCT00064701|83090265|FG002|Clinical Continuation Phase|Physician Decision|0|||
46871265|NCT00064701|83090263|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
46871266|NCT00064701|83090264|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
46871267|NCT00064701|83090265|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
46871268|NCT00064701|83090263|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
46871269|NCT00064701|83090264|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
46871270|NCT00064701|83090265|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
46871271|NCT00064701|83090263|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
46871272|NCT00064701|83090264|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
46871273|NCT00064701|83090265|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
46871274|NCT00064701|83090263|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
46871275|NCT00064701|83090264|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
46871276|NCT00064701|83090265|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
46871277|NCT00064701|83090263|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
46871278|NCT00064701|83090264|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
46871279|NCT00064701|83090265|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
46871280|NCT00064701|83090263|FG000|Clinical Continuation Phase|Patient opted out|0|||
46871281|NCT00064701|83090264|FG001|Clinical Continuation Phase|Patient opted out|0|||
46871282|NCT00064701|83090265|FG002|Clinical Continuation Phase|Patient opted out|1|||
46871283|NCT00064077|83090277|FG000|Overall Study|Improper prior treatment|1|||
46871284|NCT00064077|83090278|FG001|Overall Study|Improper prior treatment|0|||
46871285|NCT00064077|83090279|FG002|Overall Study|Improper prior treatment|0|||
46871286|NCT00064077|83090280|FG003|Overall Study|Improper prior treatment|0|||
46871287|NCT00064077|83090277|FG000|Overall Study|Poor risk|2|||
46702008|NCT01202760|82916872|FG000|Overall Study|Parent / Caregiver Decision|0|||
46984137|NCT02561195|83230266|FG006|Vaccination 1 to 3|Protocol Violation|0|||
46871288|NCT00064077|83090278|FG001|Overall Study|Poor risk|0|||
46871289|NCT00064077|83090279|FG002|Overall Study|Poor risk|1|||
46702009|NCT01202760|82916873|FG001|Overall Study|Parent / Caregiver Decision|1|||
46871290|NCT00064077|83090280|FG003|Overall Study|Poor risk|1|||
46871291|NCT00064077|83090277|FG000|Overall Study|Pathology|10|||
46871292|NCT00064077|83090278|FG001|Overall Study|Pathology|7|||
46871293|NCT00064077|83090279|FG002|Overall Study|Pathology|3|||
46871294|NCT00064077|83090280|FG003|Overall Study|Pathology|4|||
46871295|NCT00064077|83090277|FG000|Overall Study|No surgery|0|||
46871296|NCT00064077|83090278|FG001|Overall Study|No surgery|0|||
46871297|NCT00064077|83090279|FG002|Overall Study|No surgery|1|||
46871298|NCT00064077|83090280|FG003|Overall Study|No surgery|0|||
46871299|NCT00064077|83090277|FG000|Overall Study|No tumor|0|||
46871300|NCT00064077|83090278|FG001|Overall Study|No tumor|0|||
46871301|NCT00064077|83090279|FG002|Overall Study|No tumor|1|||
46871302|NCT00064077|83090280|FG003|Overall Study|No tumor|0|||
46871303|NCT00064077|83090277|FG000|Overall Study|Other reasons|2|||
46871304|NCT00064077|83090278|FG001|Overall Study|Other reasons|2|||
46871305|NCT00064077|83090279|FG002|Overall Study|Other reasons|1|||
46871306|NCT00064077|83090280|FG003|Overall Study|Other reasons|2|||
46871307|NCT00063999|83090292|FG000|Overall Study|Withdrawal by Subject|1|||
46871308|NCT00063999|83090293|FG001|Overall Study|Withdrawal by Subject|0|||
46871309|NCT00063999|83090292|FG000|Overall Study|Ineligible|44|||
46871310|NCT00063999|83090293|FG001|Overall Study|Ineligible|24|||
46871311|NCT03131440|83090338|FG000|Overall Study|Withdrawal by Subject|1|||
46871312|NCT03131440|83090339|FG001|Overall Study|Withdrawal by Subject|3|||
46871313|NCT03131440|83090340|FG002|Overall Study|Withdrawal by Subject|0|||
46871314|NCT03131440|83090341|FG003|Overall Study|Withdrawal by Subject|0|||
46871315|NCT03131440|83090342|FG004|Overall Study|Withdrawal by Subject|1|||
46871316|NCT03131440|83090343|FG005|Overall Study|Withdrawal by Subject|0|||
46871317|NCT03131440|83090344|FG006|Overall Study|Withdrawal by Subject|0|||
46871318|NCT03131440|83090345|FG007|Overall Study|Withdrawal by Subject|1|||
46871319|NCT03131440|83090346|FG008|Overall Study|Withdrawal by Subject|1|||
46871320|NCT03131440|83090347|FG009|Overall Study|Withdrawal by Subject|1|||
46871321|NCT03131440|83090348|FG010|Overall Study|Withdrawal by Subject|0|||
46871322|NCT03131440|83090349|FG011|Overall Study|Withdrawal by Subject|1|||
46871323|NCT03131440|83090350|FG012|Overall Study|Withdrawal by Subject|1|||
46871324|NCT03131440|83090351|FG013|Overall Study|Withdrawal by Subject|0|||
46871325|NCT03131440|83090352|FG014|Overall Study|Withdrawal by Subject|1|||
46871326|NCT03131440|83090353|FG015|Overall Study|Withdrawal by Subject|0|||
46871327|NCT03131440|83090354|FG016|Overall Study|Withdrawal by Subject|0|||
46871328|NCT03131440|83090355|FG017|Overall Study|Withdrawal by Subject|0|||
46871329|NCT03131440|83090356|FG018|Overall Study|Withdrawal by Subject|1|||
46871330|NCT03131440|83090357|FG019|Overall Study|Withdrawal by Subject|0|||
46871331|NCT03131440|83090358|FG020|Overall Study|Withdrawal by Subject|1|||
46871332|NCT03131440|83090359|FG021|Overall Study|Withdrawal by Subject|1|||
46871333|NCT03131440|83090360|FG022|Overall Study|Withdrawal by Subject|1|||
46871334|NCT03131440|83090361|FG023|Overall Study|Withdrawal by Subject|0|||
46871335|NCT03131440|83090362|FG024|Overall Study|Withdrawal by Subject|0|||
46871336|NCT03131440|83090363|FG025|Overall Study|Withdrawal by Subject|0|||
46871337|NCT03131440|83090364|FG026|Overall Study|Withdrawal by Subject|0|||
46871338|NCT03131440|83090365|FG027|Overall Study|Withdrawal by Subject|0|||
46871339|NCT03131440|83090366|FG028|Overall Study|Withdrawal by Subject|0|||
46871340|NCT03131440|83090367|FG029|Overall Study|Withdrawal by Subject|0|||
46871341|NCT03131440|83090368|FG030|Overall Study|Withdrawal by Subject|1|||
46871342|NCT03131440|83090369|FG031|Overall Study|Withdrawal by Subject|0|||
46871343|NCT03131440|83090338|FG000|Overall Study|Lost to Follow-up|0|||
46871344|NCT03131440|83090339|FG001|Overall Study|Lost to Follow-up|0|||
46871345|NCT03131440|83090340|FG002|Overall Study|Lost to Follow-up|0|||
46871346|NCT03131440|83090341|FG003|Overall Study|Lost to Follow-up|0|||
46984138|NCT02561195|83230267|FG007|Vaccination 1 to 3|Protocol Violation|0|||
46802617|NCT03859323|83021939|FG008|Overall Study|Lost to Follow-up|0|||
46802618|NCT03859323|83021940|FG009|Overall Study|Lost to Follow-up|0|||
46802619|NCT03859323|83021941|FG010|Overall Study|Lost to Follow-up|0|||
46802620|NCT03859323|83021942|FG011|Overall Study|Lost to Follow-up|0|||
46802621|NCT03859323|83021943|FG012|Overall Study|Lost to Follow-up|0|||
46802622|NCT03859323|83021931|FG000|Overall Study|Withdrawal by Subject|0|||
46802623|NCT03859323|83021932|FG001|Overall Study|Withdrawal by Subject|0|||
46802624|NCT03859323|83021933|FG002|Overall Study|Withdrawal by Subject|1|||
46802625|NCT03859323|83021934|FG003|Overall Study|Withdrawal by Subject|0|||
46802626|NCT03859323|83021935|FG004|Overall Study|Withdrawal by Subject|0|||
46871347|NCT03131440|83090342|FG004|Overall Study|Lost to Follow-up|0|||
46871348|NCT03131440|83090343|FG005|Overall Study|Lost to Follow-up|1|||
46871349|NCT03131440|83090344|FG006|Overall Study|Lost to Follow-up|0|||
46871350|NCT03131440|83090345|FG007|Overall Study|Lost to Follow-up|0|||
46871351|NCT03131440|83090346|FG008|Overall Study|Lost to Follow-up|0|||
46871352|NCT03131440|83090347|FG009|Overall Study|Lost to Follow-up|0|||
46871353|NCT03131440|83090348|FG010|Overall Study|Lost to Follow-up|0|||
46871354|NCT03131440|83090349|FG011|Overall Study|Lost to Follow-up|0|||
46802627|NCT03859323|83021936|FG005|Overall Study|Withdrawal by Subject|1|||
46871355|NCT03131440|83090350|FG012|Overall Study|Lost to Follow-up|0|||
46871356|NCT03131440|83090351|FG013|Overall Study|Lost to Follow-up|0|||
46871357|NCT03131440|83090352|FG014|Overall Study|Lost to Follow-up|0|||
46871358|NCT03131440|83090353|FG015|Overall Study|Lost to Follow-up|0|||
46871359|NCT03131440|83090354|FG016|Overall Study|Lost to Follow-up|0|||
46871360|NCT03131440|83090355|FG017|Overall Study|Lost to Follow-up|0|||
46871361|NCT03131440|83090356|FG018|Overall Study|Lost to Follow-up|0|||
46871362|NCT03131440|83090357|FG019|Overall Study|Lost to Follow-up|2|||
46871363|NCT03131440|83090358|FG020|Overall Study|Lost to Follow-up|1|||
46871364|NCT03131440|83090359|FG021|Overall Study|Lost to Follow-up|0|||
46871365|NCT03131440|83090360|FG022|Overall Study|Lost to Follow-up|1|||
46871366|NCT03131440|83090361|FG023|Overall Study|Lost to Follow-up|0|||
46871367|NCT03131440|83090362|FG024|Overall Study|Lost to Follow-up|1|||
46871368|NCT03131440|83090363|FG025|Overall Study|Lost to Follow-up|0|||
46871369|NCT03131440|83090364|FG026|Overall Study|Lost to Follow-up|0|||
46871370|NCT03131440|83090365|FG027|Overall Study|Lost to Follow-up|2|||
46871371|NCT03131440|83090366|FG028|Overall Study|Lost to Follow-up|0|||
46871372|NCT03131440|83090367|FG029|Overall Study|Lost to Follow-up|2|||
46871373|NCT03131440|83090368|FG030|Overall Study|Lost to Follow-up|0|||
46871374|NCT03131440|83090369|FG031|Overall Study|Lost to Follow-up|0|||
46871375|NCT03131440|83090338|FG000|Overall Study|Death|0|||
46871376|NCT03131440|83090339|FG001|Overall Study|Death|0|||
46871377|NCT03131440|83090340|FG002|Overall Study|Death|0|||
46871378|NCT03131440|83090341|FG003|Overall Study|Death|0|||
46871379|NCT03131440|83090342|FG004|Overall Study|Death|0|||
46871380|NCT03131440|83090343|FG005|Overall Study|Death|0|||
46871381|NCT03131440|83090344|FG006|Overall Study|Death|0|||
46871382|NCT03131440|83090345|FG007|Overall Study|Death|0|||
46871383|NCT03131440|83090346|FG008|Overall Study|Death|0|||
46871384|NCT03131440|83090347|FG009|Overall Study|Death|0|||
46871385|NCT03131440|83090348|FG010|Overall Study|Death|0|||
46871386|NCT03131440|83090349|FG011|Overall Study|Death|0|||
46871387|NCT03131440|83090350|FG012|Overall Study|Death|0|||
46871388|NCT03131440|83090351|FG013|Overall Study|Death|0|||
46871389|NCT03131440|83090352|FG014|Overall Study|Death|0|||
46871390|NCT03131440|83090353|FG015|Overall Study|Death|0|||
46871391|NCT03131440|83090354|FG016|Overall Study|Death|0|||
46871392|NCT03131440|83090355|FG017|Overall Study|Death|0|||
46871393|NCT03131440|83090356|FG018|Overall Study|Death|0|||
46871394|NCT03131440|83090357|FG019|Overall Study|Death|0|||
46871395|NCT03131440|83090358|FG020|Overall Study|Death|0|||
46871396|NCT03131440|83090359|FG021|Overall Study|Death|0|||
46871397|NCT03131440|83090360|FG022|Overall Study|Death|0|||
46871398|NCT03131440|83090361|FG023|Overall Study|Death|0|||
46871399|NCT03131440|83090362|FG024|Overall Study|Death|0|||
46871400|NCT03131440|83090363|FG025|Overall Study|Death|1|||
46871401|NCT03131440|83090364|FG026|Overall Study|Death|0|||
46871402|NCT03131440|83090365|FG027|Overall Study|Death|0|||
46871403|NCT03131440|83090366|FG028|Overall Study|Death|0|||
46871404|NCT03131440|83090367|FG029|Overall Study|Death|0|||
46871405|NCT03131440|83090368|FG030|Overall Study|Death|0|||
46871406|NCT03131440|83090369|FG031|Overall Study|Death|0|||
46871407|NCT02915302|83090414|FG000|Overall Study|Adverse Event|3|||
46871408|NCT02915302|83090415|FG001|Overall Study|Adverse Event|0|||
46871409|NCT02915302|83090414|FG000|Overall Study|Protocol Violation|20|||
46871410|NCT02915302|83090415|FG001|Overall Study|Protocol Violation|27|||
46871411|NCT02915302|83090414|FG000|Overall Study|Lost to Follow-up|19|||
46871412|NCT02915302|83090415|FG001|Overall Study|Lost to Follow-up|22|||
46871413|NCT02915302|83090414|FG000|Overall Study|Withdrawal by Subject|22|||
46871414|NCT02915302|83090415|FG001|Overall Study|Withdrawal by Subject|29|||
46871415|NCT02915302|83090414|FG000|Overall Study|Other|1|||
46871416|NCT02915302|83090415|FG001|Overall Study|Other|0|||
46871417|NCT03023878|83090421|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
46871418|NCT03023878|83090421|FG000|Pre-Study Run-In Period|Death|1|||
46871419|NCT03023878|83090421|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
46871420|NCT03023878|83090421|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
46871421|NCT03023878|83090421|FG000|Treatment Period|Disease Progression|1|||
46871422|NCT03023878|83090421|FG000|Treatment Period|Withdrawal by Subject|1|||
46871423|NCT03023878|83090421|FG000|Treatment Period|Adverse Event|1|||
46871424|NCT03023878|83090421|FG000|Long Term Follow-Up Period|Death|2|||
46871425|NCT03022630|83090427|FG000|Overall Study|Death|9|||
46871426|NCT03022630|83090428|FG001|Overall Study|Death|7|||
46871427|NCT03022630|83090427|FG000|Overall Study|Withdrawal by Subject|0|||
46871428|NCT03022630|83090428|FG001|Overall Study|Withdrawal by Subject|5|||
46871429|NCT03023722|83090439|FG000|Overall Study|No follow-up assessment|4|||
46871430|NCT03022084|83090445|FG000|Overall Study|Lost to Follow-up|2|||
46871431|NCT03022084|83090446|FG001|Overall Study|Lost to Follow-up|3|||
46871432|NCT03021304|83090452|FG000|Overall Study|Lack of Efficacy|1|||
46871433|NCT03496298|83090463|FG000|Overall Study|Adverse Event|49|||
46871434|NCT03496298|83090464|FG001|Overall Study|Adverse Event|68|||
46871435|NCT03496298|83090465|FG002|Overall Study|Adverse Event|79|||
46871436|NCT03496298|83090463|FG000|Overall Study|Study terminated by Sponsor|1050|||
46871437|NCT03496298|83090464|FG001|Overall Study|Study terminated by Sponsor|1063|||
46871438|NCT03496298|83090465|FG002|Overall Study|Study terminated by Sponsor|1071|||
46871439|NCT03496298|83090463|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
46871440|NCT03496298|83090464|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
46871441|NCT03496298|83090465|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
46871442|NCT03496298|83090463|FG000|Overall Study|Withdrawal by Subject|176|||
46871443|NCT03496298|83090464|FG001|Overall Study|Withdrawal by Subject|154|||
46871444|NCT03496298|83090465|FG002|Overall Study|Withdrawal by Subject|151|||
46871445|NCT03496298|83090463|FG000|Overall Study|Other|29|||
46871446|NCT03496298|83090464|FG001|Overall Study|Other|20|||
46871447|NCT03496298|83090465|FG002|Overall Study|Other|23|||
46871448|NCT03496298|83090463|FG000|Overall Study|Randomized and not treated|1|||
46871449|NCT03496298|83090464|FG001|Overall Study|Randomized and not treated|1|||
46871450|NCT03496298|83090465|FG002|Overall Study|Randomized and not treated|1|||
46871451|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
46871452|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
46871453|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
46871454|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
46871455|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
46871456|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
46871457|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
46871458|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
46871459|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
46871460|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
46871461|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
46871462|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
46871463|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
46871464|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
46871465|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
46871466|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
46871467|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
46871468|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
46871469|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
46871470|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
46871471|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
46871472|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
46871473|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
46871474|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
46871475|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
46871476|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
46871477|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
46871478|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
46871479|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
46871480|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
46871481|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
46871482|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
46871483|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
46871484|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871485|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
46871486|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
46871487|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
46871488|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871489|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871490|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871491|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871492|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871493|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871494|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
46871495|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871496|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871497|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871498|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871499|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
46871500|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871501|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871502|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871503|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871504|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871505|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
46871506|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
46871507|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871508|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871509|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871510|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871511|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871512|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871513|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871514|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871515|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871516|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
46871517|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
46871518|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
46871519|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
46871520|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
46871521|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
46871522|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
46871523|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
46871524|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
46871525|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
46871526|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
46871527|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
46871528|NCT02914522|83090478|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871529|NCT02914522|83090479|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
46871530|NCT02914522|83090480|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871531|NCT02914522|83090481|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871532|NCT02914522|83090482|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
46871533|NCT02914522|83090483|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
46871534|NCT02914522|83090484|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871535|NCT02914522|83090485|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871536|NCT02914522|83090486|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871537|NCT02914522|83090487|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871538|NCT02914522|83090488|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
46871539|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
46871540|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
46871541|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
46871542|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
46871543|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
46871544|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
46871545|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
46871546|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
46871547|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
46871548|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
46871549|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
46871550|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
46871551|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
46871552|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
46871553|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
46871554|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
46871555|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
46871556|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
46871557|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
46871558|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
46871559|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
46871560|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
46871561|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
46871562|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
46871563|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
46871564|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
46871565|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
46871566|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
46984139|NCT02561195|83230268|FG008|Vaccination 1 to 3|Protocol Violation|0|||
46871567|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
46871568|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
46871569|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
46871570|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
46871571|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
46871572|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
46871573|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
46871574|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
46871575|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
46871576|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
46871577|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
46871578|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
46871579|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
46871580|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
46871581|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
46871582|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
46871583|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
46871584|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
46871585|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
46871586|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
46871587|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
46702010|NCT01202760|82916874|FG002|Overall Study|Parent / Caregiver Decision|0|||
46871588|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
46871589|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
46871590|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
46871591|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
46871592|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
46871593|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
46871594|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871595|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871596|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871597|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871598|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871599|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871600|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871601|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
46871602|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
46871603|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871604|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
46871605|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871606|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871607|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871608|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871609|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871610|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871611|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871612|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871613|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
46702011|NCT01202760|82916872|FG000|Overall Study|Withdrawal by Subject|17|||
46702012|NCT01202760|82916873|FG001|Overall Study|Withdrawal by Subject|18|||
46871614|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
46871615|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
46871616|NCT02914522|83090478|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871617|NCT02914522|83090479|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871618|NCT02914522|83090480|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871619|NCT02914522|83090481|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871620|NCT02914522|83090482|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871621|NCT02914522|83090483|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871622|NCT02914522|83090484|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46702013|NCT01202760|82916874|FG002|Overall Study|Withdrawal by Subject|14|||
46702014|NCT01202760|82916872|FG000|Overall Study|Physician Decision|0|||
46871623|NCT02914522|83090485|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871624|NCT02914522|83090486|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871625|NCT02914522|83090487|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
46871626|NCT02914522|83090488|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
46871627|NCT02924428|83090517|FG000|Overall Study|Adverse Event|1|||
46871628|NCT02924428|83090518|FG001|Overall Study|Adverse Event|0|||
46871629|NCT02924428|83090517|FG000|Overall Study|Physician Decision|1|||
46871630|NCT02924428|83090518|FG001|Overall Study|Physician Decision|0|||
46871631|NCT02924428|83090517|FG000|Overall Study|Lost to Follow-up|2|||
46871632|NCT02924428|83090518|FG001|Overall Study|Lost to Follow-up|4|||
46871633|NCT02924428|83090517|FG000|Overall Study|Pregnancy|0|||
46871634|NCT02924428|83090518|FG001|Overall Study|Pregnancy|1|||
46871635|NCT00062751|83090529|FG000|Overall Study|Disease progression|24|||
46871636|NCT00062751|83090530|FG001|Overall Study|Disease progression|17|||
46871637|NCT00062751|83090531|FG002|Overall Study|Disease progression|24|||
46871638|NCT00062751|83090532|FG003|Overall Study|Disease progression|2|||
46871639|NCT00062751|83090533|FG004|Overall Study|Disease progression|2|||
46871640|NCT00062751|83090529|FG000|Overall Study|Adverse Event|4|||
46871641|NCT00062751|83090530|FG001|Overall Study|Adverse Event|7|||
46871642|NCT00062751|83090531|FG002|Overall Study|Adverse Event|2|||
46871643|NCT00062751|83090532|FG003|Overall Study|Adverse Event|2|||
46871644|NCT00062751|83090533|FG004|Overall Study|Adverse Event|2|||
46871645|NCT00062751|83090529|FG000|Overall Study|Other|2|||
46871646|NCT00062751|83090530|FG001|Overall Study|Other|3|||
46871647|NCT00062751|83090531|FG002|Overall Study|Other|1|||
46871648|NCT00062751|83090532|FG003|Overall Study|Other|0|||
46871649|NCT00062751|83090533|FG004|Overall Study|Other|1|||
46871650|NCT00062751|83090529|FG000|Overall Study|Withdrawal by Subject|1|||
46871651|NCT00062751|83090530|FG001|Overall Study|Withdrawal by Subject|2|||
46871652|NCT00062751|83090531|FG002|Overall Study|Withdrawal by Subject|2|||
46871653|NCT00062751|83090532|FG003|Overall Study|Withdrawal by Subject|1|||
46871654|NCT00062751|83090533|FG004|Overall Study|Withdrawal by Subject|0|||
46871655|NCT00062751|83090529|FG000|Overall Study|Symptomatic deterioration|1|||
46871656|NCT00062751|83090530|FG001|Overall Study|Symptomatic deterioration|1|||
46871657|NCT00062751|83090531|FG002|Overall Study|Symptomatic deterioration|0|||
46871658|NCT00062751|83090532|FG003|Overall Study|Symptomatic deterioration|0|||
46871659|NCT00062751|83090533|FG004|Overall Study|Symptomatic deterioration|1|||
46871660|NCT00062751|83090529|FG000|Overall Study|Death|1|||
46871661|NCT00062751|83090530|FG001|Overall Study|Death|0|||
46871662|NCT00062751|83090531|FG002|Overall Study|Death|1|||
46871663|NCT00062751|83090532|FG003|Overall Study|Death|0|||
46871664|NCT00062751|83090533|FG004|Overall Study|Death|0|||
46871665|NCT00062439|83090550|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
46871666|NCT00062439|83090550|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
46871667|NCT00062439|83090550|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
46871668|NCT00062439|83090550|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
46871669|NCT00062439|83090550|FG000|Post Chemoradiation Assessment|Death|1|||
46871670|NCT00062439|83090550|FG000|Post Chemoradiation Assessment|Disease progression|2|||
46871671|NCT00062439|83090550|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
46871672|NCT00062439|83090550|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
46871673|NCT00062439|83090550|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
46871674|NCT00062439|83090550|FG000|Surgery|Physician Decision|4|||
46871675|NCT00062439|83090550|FG000|Surgery|Death|1|||
46871676|NCT00062439|83090550|FG000|Surgery|Adverse Event|2|||
46871677|NCT00062439|83090550|FG000|Consolidation Chemotherapy|Adverse Event|2|||
46871678|NCT00051363|83090561|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
46871679|NCT00051363|83090562|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
46871680|NCT00051363|83090561|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
46871681|NCT00051363|83090562|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
46871682|NCT00051363|83090561|FG000|Overall Study|Death|2|||
46871683|NCT00051363|83090562|FG001|Overall Study|Death|2|||
46871684|NCT00051363|83090561|FG000|Overall Study|Excluded Pre-Randomization|2|||
46871685|NCT00051363|83090562|FG001|Overall Study|Excluded Pre-Randomization|5|||
46871686|NCT00031551|83090570|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
46871687|NCT00031551|83090571|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
46871688|NCT00049257|83090581|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
46871689|NCT00049257|83090581|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
46871690|NCT00049257|83090581|FG000|Carboplatin, Paclitaxel|Death|2|||
46871691|NCT00049257|83090581|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
46871692|NCT03020992|83090585|FG000|Overall Study|Adverse Event|5|||
46871693|NCT03020992|83090585|FG000|Overall Study|Withdrawal by Subject|1|||
46871694|NCT03020914|83090592|FG000|Overall Study|Surgery Cancelled|1|||
46871695|NCT03020914|83090593|FG001|Overall Study|Surgery Cancelled|0|||
46871696|NCT03018340|83090601|FG000|Overall Study|Adverse Event|1|||
46871697|NCT03018340|83090602|FG001|Overall Study|Adverse Event|2|||
46871698|NCT03018340|83090601|FG000|Overall Study|Withdrawal by Subject|0|||
46871699|NCT03018340|83090602|FG001|Overall Study|Withdrawal by Subject|8|||
46871700|NCT03018340|83090601|FG000|Overall Study|Lack of Efficacy|0|||
46871701|NCT03018340|83090602|FG001|Overall Study|Lack of Efficacy|1|||
46871702|NCT03018340|83090601|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
46871703|NCT03018340|83090602|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
46871704|NCT03018340|83090601|FG000|Overall Study|Lost to Follow-up|1|||
46871705|NCT03018340|83090602|FG001|Overall Study|Lost to Follow-up|7|||
46871706|NCT03018340|83090601|FG000|Overall Study|Protocol Violation|3|||
46871707|NCT03018340|83090602|FG001|Overall Study|Protocol Violation|7|||
46871708|NCT03018340|83090601|FG000|Overall Study|Not further specified|0|||
46871709|NCT03018340|83090602|FG001|Overall Study|Not further specified|1|||
46871710|NCT03016078|83090612|FG000|Overall Study|Protocol Violation|1|||
46871711|NCT03016078|83090612|FG000|Overall Study|Protocol Violation|1|||
46871712|NCT00048165|83090618|FG000|Completed 6 Months Study|Administration/Other|8|||
46871713|NCT00048165|83090619|FG001|Completed 6 Months Study|Administration/Other|8|||
46871714|NCT00048165|83090618|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
46871715|NCT00048165|83090619|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
46871716|NCT00048165|83090618|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
46871717|NCT00048165|83090619|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
46871718|NCT00048165|83090618|FG000|Completed 6 Months Study|Death|12|||
46871719|NCT00048165|83090619|FG001|Completed 6 Months Study|Death|6|||
46871720|NCT00048165|83090618|FG000|Completed 6 Months Study|Insufficient therapy|1|||
46871721|NCT00048165|83090619|FG001|Completed 6 Months Study|Insufficient therapy|4|||
46871722|NCT00048165|83090618|FG000|Completed 6 Months Study|Other violation|4|||
46871723|NCT00048165|83090619|FG001|Completed 6 Months Study|Other violation|6|||
46871724|NCT00048165|83090618|FG000|Completed 6 Months Study|Refused treatment|5|||
46871725|NCT00048165|83090619|FG001|Completed 6 Months Study|Refused treatment|5|||
46871726|NCT00048165|83090618|FG000|Completed 6 Months Study|Violation criteria|0|||
46871727|NCT00048165|83090619|FG001|Completed 6 Months Study|Violation criteria|2|||
46871728|NCT00048165|83090618|FG000|Completed 6 Months Study|Did not receive study drug|6|||
46871729|NCT00048165|83090619|FG001|Completed 6 Months Study|Did not receive study drug|6|||
46871730|NCT00048165|83090618|FG000|Completed 12 Months Study|Administration/Other|0|||
46871731|NCT00048165|83090619|FG001|Completed 12 Months Study|Administration/Other|2|||
46871732|NCT00048165|83090618|FG000|Completed 12 Months Study|Death|2|||
46871733|NCT00048165|83090619|FG001|Completed 12 Months Study|Death|1|||
46871734|NCT00048165|83090618|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
46871735|NCT00048165|83090619|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
46871736|NCT00059787|83090627|FG000|Overall Study|Adverse Event|13|||
46871737|NCT00059787|83090627|FG000|Overall Study|disease progression|2|||
46871738|NCT00059787|83090627|FG000|Overall Study|ineligible|1|||
46871739|NCT00059787|83090627|FG000|Overall Study|Other|4|||
46871740|NCT00058539|83090632|FG000|Overall Study|Disease progression|24|||
46871741|NCT00058539|83090632|FG000|Overall Study|Adverse Event|3|||
46871742|NCT00058539|83090632|FG000|Overall Study|Withdrawal by Subject|5|||
46871743|NCT00058539|83090632|FG000|Overall Study|Physician Decision|9|||
46871744|NCT00058539|83090632|FG000|Overall Study|Death|1|||
46871745|NCT03015532|83090644|FG000|Overall Study|Adverse Event|0|||
46871746|NCT03015532|83090645|FG001|Overall Study|Adverse Event|0|||
46871747|NCT03015532|83090646|FG002|Overall Study|Adverse Event|0|||
46702015|NCT01202760|82916873|FG001|Overall Study|Physician Decision|1|||
46871748|NCT03015532|83090647|FG003|Overall Study|Adverse Event|0|||
46871749|NCT03015532|83090648|FG004|Overall Study|Adverse Event|0|||
46871750|NCT03015532|83090649|FG005|Overall Study|Adverse Event|2|||
46871751|NCT03015532|83090650|FG006|Overall Study|Adverse Event|1|||
46871752|NCT03015532|83090651|FG007|Overall Study|Adverse Event|0|||
46871753|NCT03015532|83090644|FG000|Overall Study|Withdrawal by Subject|0|||
46871754|NCT03015532|83090645|FG001|Overall Study|Withdrawal by Subject|0|||
46871755|NCT03015532|83090646|FG002|Overall Study|Withdrawal by Subject|0|||
46871756|NCT03015532|83090647|FG003|Overall Study|Withdrawal by Subject|0|||
46871757|NCT03015532|83090648|FG004|Overall Study|Withdrawal by Subject|0|||
46871758|NCT03015532|83090649|FG005|Overall Study|Withdrawal by Subject|0|||
46871759|NCT03015532|83090650|FG006|Overall Study|Withdrawal by Subject|1|||
46871760|NCT03015532|83090651|FG007|Overall Study|Withdrawal by Subject|0|||
46871761|NCT00047463|83090673|FG000|Overall Study|Withdrawal by Subject|0|||
46871762|NCT00047463|83090674|FG001|Overall Study|Withdrawal by Subject|3|||
46871763|NCT03015220|83090687|FG000|Overall Study|Withdrawal by Subject|3|||
46871764|NCT03015220|83090688|FG001|Overall Study|Withdrawal by Subject|2|||
46871765|NCT03015220|83090689|FG002|Overall Study|Withdrawal by Subject|2|||
46871766|NCT03015220|83090690|FG003|Overall Study|Withdrawal by Subject|2|||
46871767|NCT03015220|83090687|FG000|Overall Study|Lost to Follow-up|0|||
46871768|NCT03015220|83090688|FG001|Overall Study|Lost to Follow-up|0|||
46871769|NCT03015220|83090689|FG002|Overall Study|Lost to Follow-up|1|||
46871770|NCT03015220|83090690|FG003|Overall Study|Lost to Follow-up|0|||
46871771|NCT00022659|83090700|FG000|Overall Study|Ineligible: wrong primary|1|||
46871772|NCT00022659|83090700|FG000|Overall Study|Never treated|1|||
46871773|NCT03014674|83090711|FG000|Overall Study|Withdrawal by Subject|1|||
46871774|NCT03014674|83090712|FG001|Overall Study|Withdrawal by Subject|0|||
46871775|NCT03014674|83090713|FG002|Overall Study|Withdrawal by Subject|0|||
46871776|NCT03018106|83090723|FG000|Overall Study|Lost to Follow-up|0|||
46871777|NCT03018106|83090724|FG001|Overall Study|Lost to Follow-up|1|||
46871778|NCT03018028|83090733|FG000|Overall Study|Withdrawal by Subject|3|||
46871779|NCT03018028|83090734|FG001|Overall Study|Withdrawal by Subject|0|||
46871780|NCT03018028|83090735|FG002|Overall Study|Withdrawal by Subject|1|||
46871781|NCT03018028|83090736|FG003|Overall Study|Withdrawal by Subject|2|||
46871782|NCT03018028|83090737|FG004|Overall Study|Withdrawal by Subject|0|||
46871783|NCT03010462|83090751|FG000|Overall Study|Withdrawal by Subject|3|||
46871784|NCT03010462|83090752|FG001|Overall Study|Withdrawal by Subject|1|||
46871785|NCT00021255|83090761|FG000|Overall Study|Death|1|||
46871786|NCT00021255|83090762|FG001|Overall Study|Death|0|||
46871787|NCT00021255|83090763|FG002|Overall Study|Death|2|||
46871788|NCT00021255|83090761|FG000|Overall Study|Breast cancer relapse|5|||
46871789|NCT00021255|83090762|FG001|Overall Study|Breast cancer relapse|18|||
46871790|NCT00021255|83090763|FG002|Overall Study|Breast cancer relapse|11|||
46871791|NCT00021255|83090761|FG000|Overall Study|Second primary malignancy|0|||
46871792|NCT00021255|83090762|FG001|Overall Study|Second primary malignancy|4|||
46871793|NCT00021255|83090763|FG002|Overall Study|Second primary malignancy|1|||
46871794|NCT00021255|83090761|FG000|Overall Study|Withdrawal by Subject|41|||
46871795|NCT00021255|83090762|FG001|Overall Study|Withdrawal by Subject|64|||
46871796|NCT00021255|83090763|FG002|Overall Study|Withdrawal by Subject|26|||
46871797|NCT00021255|83090761|FG000|Overall Study|Lost to Follow-up|0|||
46871798|NCT00021255|83090762|FG001|Overall Study|Lost to Follow-up|2|||
46871799|NCT00021255|83090763|FG002|Overall Study|Lost to Follow-up|3|||
46871800|NCT00021255|83090761|FG000|Overall Study|Cardiac toxicity|0|||
46871801|NCT00021255|83090762|FG001|Overall Study|Cardiac toxicity|61|||
46871802|NCT00021255|83090763|FG002|Overall Study|Cardiac toxicity|32|||
46871803|NCT00021255|83090761|FG000|Overall Study|Herceptin toxicity|0|||
46871804|NCT00021255|83090762|FG001|Overall Study|Herceptin toxicity|22|||
46871805|NCT00021255|83090763|FG002|Overall Study|Herceptin toxicity|6|||
46871806|NCT00021255|83090761|FG000|Overall Study|Adverse Event|46|||
46871807|NCT00021255|83090762|FG001|Overall Study|Adverse Event|30|||
46871808|NCT00021255|83090763|FG002|Overall Study|Adverse Event|18|||
46871809|NCT00021255|83090761|FG000|Overall Study|Protocol Violation|0|||
46871810|NCT00021255|83090762|FG001|Overall Study|Protocol Violation|2|||
46871811|NCT00021255|83090763|FG002|Overall Study|Protocol Violation|0|||
46871812|NCT00021255|83090761|FG000|Overall Study|Other than specified above|0|||
46871813|NCT00021255|83090762|FG001|Overall Study|Other than specified above|38|||
46871814|NCT00021255|83090763|FG002|Overall Study|Other than specified above|19|||
46871815|NCT00021255|83090761|FG000|Overall Study|Missing|0|||
46871816|NCT00021255|83090762|FG001|Overall Study|Missing|27|||
46871817|NCT00021255|83090763|FG002|Overall Study|Missing|13|||
46871818|NCT00021255|83090761|FG000|Overall Study|Randomized but not treated|28|||
46871819|NCT00021255|83090762|FG001|Overall Study|Randomized but not treated|2|||
46871820|NCT00021255|83090763|FG002|Overall Study|Randomized but not treated|18|||
46871821|NCT03012334|83090781|FG000|Period 1|Withdrawal by Subject|0|||
46871822|NCT03012334|83090782|FG001|Period 1|Withdrawal by Subject|0|||
46871823|NCT03012334|83090783|FG002|Period 1|Withdrawal by Subject|0|||
46871824|NCT03012334|83090784|FG003|Period 1|Withdrawal by Subject|0|||
46871825|NCT03012334|83090785|FG004|Period 1|Withdrawal by Subject|0|||
46871826|NCT03012334|83090786|FG005|Period 1|Withdrawal by Subject|0|||
46871827|NCT03012334|83090787|FG006|Period 1|Withdrawal by Subject|0|||
46871828|NCT03012334|83090788|FG007|Period 1|Withdrawal by Subject|0|||
46871829|NCT03012334|83090789|FG008|Period 1|Withdrawal by Subject|0|||
46871830|NCT03012334|83090790|FG009|Period 1|Withdrawal by Subject|1|||
46871831|NCT03012334|83090781|FG000|Period 2|Withdrawal by Subject|0|||
46871832|NCT03012334|83090782|FG001|Period 2|Withdrawal by Subject|1|||
46871833|NCT03012334|83090783|FG002|Period 2|Withdrawal by Subject|0|||
46871834|NCT03012334|83090784|FG003|Period 2|Withdrawal by Subject|0|||
46871835|NCT03012334|83090785|FG004|Period 2|Withdrawal by Subject|0|||
46871836|NCT03012334|83090786|FG005|Period 2|Withdrawal by Subject|0|||
46871837|NCT03012334|83090787|FG006|Period 2|Withdrawal by Subject|0|||
46871838|NCT03012334|83090788|FG007|Period 2|Withdrawal by Subject|0|||
46871839|NCT03012334|83090789|FG008|Period 2|Withdrawal by Subject|0|||
46871840|NCT03012334|83090790|FG009|Period 2|Withdrawal by Subject|0|||
46871841|NCT03012334|83090781|FG000|Period 2|Protocol Violation|0|||
46871842|NCT03012334|83090782|FG001|Period 2|Protocol Violation|0|||
46871843|NCT03012334|83090783|FG002|Period 2|Protocol Violation|1|||
46871844|NCT03012334|83090784|FG003|Period 2|Protocol Violation|0|||
46871845|NCT03012334|83090785|FG004|Period 2|Protocol Violation|0|||
46871846|NCT03012334|83090786|FG005|Period 2|Protocol Violation|0|||
46871847|NCT03012334|83090787|FG006|Period 2|Protocol Violation|0|||
46871848|NCT03012334|83090788|FG007|Period 2|Protocol Violation|1|||
46871849|NCT03012334|83090789|FG008|Period 2|Protocol Violation|0|||
46871850|NCT03012334|83090790|FG009|Period 2|Protocol Violation|0|||
46871851|NCT03012334|83090781|FG000|Period 4|Non-Compliance|0|||
46871852|NCT03012334|83090782|FG001|Period 4|Non-Compliance|0|||
46871853|NCT03012334|83090783|FG002|Period 4|Non-Compliance|0|||
46871854|NCT03012334|83090784|FG003|Period 4|Non-Compliance|0|||
46871855|NCT03012334|83090785|FG004|Period 4|Non-Compliance|0|||
46871856|NCT03012334|83090786|FG005|Period 4|Non-Compliance|0|||
46871857|NCT03012334|83090787|FG006|Period 4|Non-Compliance|1|||
46871858|NCT03012334|83090788|FG007|Period 4|Non-Compliance|0|||
46871859|NCT03012334|83090789|FG008|Period 4|Non-Compliance|0|||
46871860|NCT03012334|83090790|FG009|Period 4|Non-Compliance|0|||
46871861|NCT03012334|83090781|FG000|Period 4|Adverse Event|0|||
46871862|NCT03012334|83090782|FG001|Period 4|Adverse Event|0|||
46871863|NCT03012334|83090783|FG002|Period 4|Adverse Event|0|||
46871864|NCT03012334|83090784|FG003|Period 4|Adverse Event|0|||
46871865|NCT03012334|83090785|FG004|Period 4|Adverse Event|0|||
46871866|NCT03012334|83090786|FG005|Period 4|Adverse Event|0|||
46871867|NCT03012334|83090787|FG006|Period 4|Adverse Event|0|||
46871868|NCT03012334|83090788|FG007|Period 4|Adverse Event|0|||
46871869|NCT03012334|83090789|FG008|Period 4|Adverse Event|1|||
46871870|NCT03012334|83090790|FG009|Period 4|Adverse Event|0|||
46871871|NCT03565068|83090812|FG000|Overall Study|Protocol Violation|0|||
46871872|NCT03565068|83090813|FG001|Overall Study|Protocol Violation|0|||
46871873|NCT03565068|83090814|FG002|Overall Study|Protocol Violation|0|||
46871874|NCT03565068|83090815|FG003|Overall Study|Protocol Violation|0|||
46871875|NCT03565068|83090816|FG004|Overall Study|Protocol Violation|1|||
46871876|NCT03565068|83090817|FG005|Overall Study|Protocol Violation|0|||
46871877|NCT03565068|83090818|FG006|Overall Study|Protocol Violation|0|||
46871878|NCT03565068|83090819|FG007|Overall Study|Protocol Violation|1|||
46871879|NCT03565068|83090820|FG008|Overall Study|Protocol Violation|0|||
46871880|NCT03565068|83090812|FG000|Overall Study|Sponsor decision|0|||
46871881|NCT03565068|83090813|FG001|Overall Study|Sponsor decision|0|||
46871882|NCT03565068|83090814|FG002|Overall Study|Sponsor decision|0|||
46871883|NCT03565068|83090815|FG003|Overall Study|Sponsor decision|0|||
46871884|NCT03565068|83090816|FG004|Overall Study|Sponsor decision|1|||
46871885|NCT03565068|83090817|FG005|Overall Study|Sponsor decision|1|||
46871886|NCT03565068|83090818|FG006|Overall Study|Sponsor decision|0|||
46871887|NCT03565068|83090819|FG007|Overall Study|Sponsor decision|0|||
46871888|NCT03565068|83090820|FG008|Overall Study|Sponsor decision|0|||
46871889|NCT03565068|83090812|FG000|Overall Study|Withdrawal by Subject|0|||
46871890|NCT03565068|83090813|FG001|Overall Study|Withdrawal by Subject|0|||
46871891|NCT03565068|83090814|FG002|Overall Study|Withdrawal by Subject|1|||
46871892|NCT03565068|83090815|FG003|Overall Study|Withdrawal by Subject|0|||
46871893|NCT03565068|83090816|FG004|Overall Study|Withdrawal by Subject|2|||
46871894|NCT03565068|83090817|FG005|Overall Study|Withdrawal by Subject|0|||
46871895|NCT03565068|83090818|FG006|Overall Study|Withdrawal by Subject|1|||
46871896|NCT03565068|83090819|FG007|Overall Study|Withdrawal by Subject|5|||
46871897|NCT03565068|83090820|FG008|Overall Study|Withdrawal by Subject|1|||
46871898|NCT03565068|83090812|FG000|Overall Study|Physician Decision|0|||
46871899|NCT03565068|83090813|FG001|Overall Study|Physician Decision|0|||
46871900|NCT03565068|83090814|FG002|Overall Study|Physician Decision|0|||
46871901|NCT03565068|83090815|FG003|Overall Study|Physician Decision|0|||
46871902|NCT03565068|83090816|FG004|Overall Study|Physician Decision|0|||
46871903|NCT03565068|83090817|FG005|Overall Study|Physician Decision|0|||
46871904|NCT03565068|83090818|FG006|Overall Study|Physician Decision|0|||
46871905|NCT03565068|83090819|FG007|Overall Study|Physician Decision|1|||
46871906|NCT03565068|83090820|FG008|Overall Study|Physician Decision|0|||
46871907|NCT03565068|83090812|FG000|Overall Study|Lost to Follow-up|0|||
46871908|NCT03565068|83090813|FG001|Overall Study|Lost to Follow-up|0|||
46871909|NCT03565068|83090814|FG002|Overall Study|Lost to Follow-up|0|||
46871910|NCT03565068|83090815|FG003|Overall Study|Lost to Follow-up|0|||
46871911|NCT03565068|83090816|FG004|Overall Study|Lost to Follow-up|0|||
46871912|NCT03565068|83090817|FG005|Overall Study|Lost to Follow-up|0|||
46871913|NCT03565068|83090818|FG006|Overall Study|Lost to Follow-up|0|||
46871914|NCT03565068|83090819|FG007|Overall Study|Lost to Follow-up|1|||
46871915|NCT03565068|83090820|FG008|Overall Study|Lost to Follow-up|0|||
46871916|NCT00010803|83090879|FG000|Overall Study|Withdrawal by Subject|97|||
46871917|NCT00010803|83090880|FG001|Overall Study|Withdrawal by Subject|98|||
46871918|NCT02914834|83090888|FG000|Overall Study|Study halted due to COVID|1|||
46871919|NCT02914834|83090889|FG001|Overall Study|Study halted due to COVID|1|||
46871920|NCT02914834|83090888|FG000|Overall Study|1 subject withdrew|0|||
46871921|NCT02914834|83090889|FG001|Overall Study|1 subject withdrew|1|||
46871922|NCT03497130|83090897|FG000|Overall Study|Lost to Follow-up|1|||
46871923|NCT03497130|83090898|FG001|Overall Study|Lost to Follow-up|1|||
46871924|NCT03006562|83090906|FG000|Overall Study|Lost to Follow-up|0|||
46871925|NCT03006562|83090907|FG001|Overall Study|Lost to Follow-up|1|||
46871926|NCT03007966|83090915|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
46871927|NCT03007966|83090916|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
46871928|NCT03007888|83090923|FG000|First Intervention (14 Days)|Adverse Event|1|||
46871929|NCT03007888|83090924|FG001|First Intervention (14 Days)|Adverse Event|0|||
46871930|NCT03541044|83090933|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
46871931|NCT03541044|83090934|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
46871932|NCT03541044|83090933|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
46871933|NCT03541044|83090934|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
46871934|NCT00009945|83090944|FG000|Overall Study|no follow up data|7|||
46871935|NCT00009945|83090945|FG001|Overall Study|no follow up data|5|||
46871936|NCT03540030|83090953|FG000|Overall Study|Withdrawal by Subject|2|||
46871937|NCT03540030|83090954|FG001|Overall Study|Withdrawal by Subject|1|||
46871938|NCT03540030|83090953|FG000|Overall Study|screen fail|7|||
46871939|NCT03540030|83090954|FG001|Overall Study|screen fail|1|||
46871940|NCT03540030|83090953|FG000|Overall Study|never had surgery after signing consent|9|||
46871941|NCT03540030|83090954|FG001|Overall Study|never had surgery after signing consent|1|||
46871942|NCT03003676|83090962|FG000|Overall Study|Lack of Efficacy|5|||
46871943|NCT03003676|83090963|FG001|Overall Study|Lack of Efficacy|7|||
46871944|NCT03003676|83090962|FG000|Overall Study|Withdrawal by Subject|0|||
46871945|NCT03003676|83090963|FG001|Overall Study|Withdrawal by Subject|1|||
46871946|NCT03003676|83090962|FG000|Overall Study|Hepatitis B infection|1|||
46871947|NCT03003676|83090963|FG001|Overall Study|Hepatitis B infection|0|||
46871948|NCT00047385|83090973|FG000|Overall Study|Death before any screening|2|||
46871949|NCT00047385|83090974|FG001|Overall Study|Death before any screening|5|||
46871950|NCT00047385|83090973|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
46871951|NCT00047385|83090974|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
46871952|NCT00047385|83090973|FG000|Overall Study|Eligible for screening but had no screen|260|||
46871953|NCT00047385|83090974|FG001|Overall Study|Eligible for screening but had no screen|492|||
46871954|NCT03002818|83090980|FG000|Overall Study|Decision of the investigator|1|||
46871955|NCT03002194|83090984|FG000|Overall Study|Lost to Follow-up|6|||
46871956|NCT03002194|83090984|FG000|Overall Study|Adverse Event|1|||
46871957|NCT03002194|83090984|FG000|Overall Study|Lack of Efficacy|1|||
46871958|NCT03002194|83090984|FG000|Overall Study|Withdrawal by Subject|2|||
46871959|NCT02912650|83090992|FG000|Overall Study|Withdrawal by Subject|1|||
46871960|NCT02912650|83090993|FG001|Overall Study|Withdrawal by Subject|0|||
46871961|NCT02912650|83090994|FG002|Overall Study|Withdrawal by Subject|1|||
46871962|NCT02912650|83090995|FG003|Overall Study|Withdrawal by Subject|5|||
46871963|NCT02912650|83090992|FG000|Overall Study|Adverse Event|0|||
46871964|NCT02912650|83090993|FG001|Overall Study|Adverse Event|0|||
46871965|NCT02912650|83090994|FG002|Overall Study|Adverse Event|1|||
46871966|NCT02912650|83090995|FG003|Overall Study|Adverse Event|0|||
46871967|NCT03004924|83091008|FG000|Overall Study|Adverse Event|6|||
46871968|NCT03004924|83091009|FG001|Overall Study|Adverse Event|5|||
46871969|NCT03004924|83091010|FG002|Overall Study|Adverse Event|10|||
46871970|NCT03004924|83091008|FG000|Overall Study|Protocol Violation|4|||
46871971|NCT03004924|83091009|FG001|Overall Study|Protocol Violation|0|||
46871972|NCT03004924|83091010|FG002|Overall Study|Protocol Violation|1|||
46871973|NCT03004924|83091008|FG000|Overall Study|Withdrawal by Subject|5|||
46871974|NCT03004924|83091009|FG001|Overall Study|Withdrawal by Subject|3|||
46871975|NCT03004924|83091010|FG002|Overall Study|Withdrawal by Subject|5|||
46871976|NCT03004924|83091008|FG000|Overall Study|Lost to Follow-up|6|||
46871977|NCT03004924|83091009|FG001|Overall Study|Lost to Follow-up|1|||
46871978|NCT03004924|83091010|FG002|Overall Study|Lost to Follow-up|4|||
46871979|NCT03004924|83091008|FG000|Overall Study|Lack of Efficacy|2|||
46871980|NCT03004924|83091009|FG001|Overall Study|Lack of Efficacy|4|||
46871981|NCT03004924|83091010|FG002|Overall Study|Lack of Efficacy|2|||
46871982|NCT03004924|83091008|FG000|Overall Study|Physician Decision|1|||
46871983|NCT03004924|83091009|FG001|Overall Study|Physician Decision|0|||
46871984|NCT03004924|83091010|FG002|Overall Study|Physician Decision|1|||
46871985|NCT03004924|83091008|FG000|Overall Study|Withdrawal by parent/guardian|1|||
46871986|NCT03004924|83091009|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46871987|NCT03004924|83091010|FG002|Overall Study|Withdrawal by parent/guardian|2|||
46871988|NCT03004924|83091008|FG000|Overall Study|Screen Failure|1|||
46871989|NCT03004924|83091009|FG001|Overall Study|Screen Failure|0|||
46871990|NCT03004924|83091010|FG002|Overall Study|Screen Failure|0|||
46871991|NCT03004924|83091008|FG000|Overall Study|Pregnancy|0|||
46871992|NCT03004924|83091009|FG001|Overall Study|Pregnancy|1|||
46871993|NCT03004924|83091010|FG002|Overall Study|Pregnancy|0|||
46871994|NCT03004924|83091008|FG000|Overall Study|Terminated by Sponsor|0|||
46871995|NCT03004924|83091009|FG001|Overall Study|Terminated by Sponsor|0|||
46871996|NCT03004924|83091010|FG002|Overall Study|Terminated by Sponsor|1|||
46871997|NCT03004924|83091008|FG000|Overall Study|Missed Study Visit|0|||
46871998|NCT03004924|83091009|FG001|Overall Study|Missed Study Visit|0|||
46871999|NCT03004924|83091010|FG002|Overall Study|Missed Study Visit|2|||
46872000|NCT03004924|83091008|FG000|Overall Study|HSV1 Positive|1|||
46872001|NCT03004924|83091009|FG001|Overall Study|HSV1 Positive|0|||
46872002|NCT03004924|83091010|FG002|Overall Study|HSV1 Positive|0|||
46872003|NCT03002038|83091021|FG000|Overall Study|Adverse Event|3|||
46872004|NCT03002038|83091022|FG001|Overall Study|Adverse Event|1|||
46872005|NCT03002038|83091021|FG000|Overall Study|Withdrawal by Subject|8|||
46872006|NCT03002038|83091022|FG001|Overall Study|Withdrawal by Subject|4|||
46872007|NCT03002038|83091021|FG000|Overall Study|Immigration to another region|0|||
46872008|NCT03002038|83091022|FG001|Overall Study|Immigration to another region|2|||
46872009|NCT02911948|83091030|FG000|Overall Study|Protocol Violation|0|||
46872010|NCT02911948|83091031|FG001|Overall Study|Protocol Violation|1|||
46872011|NCT02911948|83091030|FG000|Overall Study|Withdrawal by Subject|0|||
46872012|NCT02911948|83091031|FG001|Overall Study|Withdrawal by Subject|2|||
46872013|NCT02911948|83091030|FG000|Overall Study|Lack of Efficacy|0|||
46872014|NCT02911948|83091031|FG001|Overall Study|Lack of Efficacy|1|||
46872015|NCT02911948|83091030|FG000|Overall Study|Unclassified|0|||
46872016|NCT02911948|83091031|FG001|Overall Study|Unclassified|3|||
46872017|NCT02996968|83091039|FG000|Overall Study|Withdrawal by Subject|1|||
46872018|NCT02996968|83091040|FG001|Overall Study|Withdrawal by Subject|0|||
46872019|NCT00027027|83091051|FG000|Overall Study|Adverse Event|0|||
46872020|NCT00027027|83091052|FG001|Overall Study|Adverse Event|0|||
46872021|NCT00027027|83091053|FG002|Overall Study|Adverse Event|1|||
46872022|NCT00027027|83091054|FG003|Overall Study|Adverse Event|0|||
46872023|NCT00027027|83091055|FG004|Overall Study|Adverse Event|1|||
46872024|NCT00027027|83091051|FG000|Overall Study|Admitted for Signs of PD|0|||
46872025|NCT00027027|83091052|FG001|Overall Study|Admitted for Signs of PD|0|||
46872026|NCT00027027|83091053|FG002|Overall Study|Admitted for Signs of PD|0|||
46872027|NCT00027027|83091054|FG003|Overall Study|Admitted for Signs of PD|0|||
46872028|NCT00027027|83091055|FG004|Overall Study|Admitted for Signs of PD|1|||
46872029|NCT00027027|83091051|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
46872030|NCT00027027|83091052|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
46872031|NCT00027027|83091053|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
46872032|NCT00027027|83091054|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
46872033|NCT00027027|83091055|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
46872034|NCT00027027|83091051|FG000|Overall Study|PD Requiring Surgery|0|||
46872035|NCT00027027|83091052|FG001|Overall Study|PD Requiring Surgery|0|||
46872036|NCT00027027|83091053|FG002|Overall Study|PD Requiring Surgery|1|||
46872037|NCT00027027|83091054|FG003|Overall Study|PD Requiring Surgery|0|||
46872038|NCT00027027|83091055|FG004|Overall Study|PD Requiring Surgery|0|||
46872039|NCT00027027|83091051|FG000|Overall Study|Physician Decision Due To PD|2|||
46872040|NCT00027027|83091052|FG001|Overall Study|Physician Decision Due To PD|3|||
46872041|NCT00027027|83091053|FG002|Overall Study|Physician Decision Due To PD|2|||
46872042|NCT00027027|83091054|FG003|Overall Study|Physician Decision Due To PD|3|||
46872043|NCT00027027|83091055|FG004|Overall Study|Physician Decision Due To PD|5|||
46872044|NCT00027027|83091051|FG000|Overall Study|Withdrawal by Subject|0|||
46872045|NCT00027027|83091052|FG001|Overall Study|Withdrawal by Subject|0|||
46872046|NCT00027027|83091053|FG002|Overall Study|Withdrawal by Subject|0|||
46872047|NCT00027027|83091054|FG003|Overall Study|Withdrawal by Subject|0|||
46872048|NCT00027027|83091055|FG004|Overall Study|Withdrawal by Subject|1|||
46872049|NCT00046839|83091073|FG000|Overall Study|Ineligible / No protocol treatment|0|||
46872050|NCT00046839|83091074|FG001|Overall Study|Ineligible / No protocol treatment|2|||
46872051|NCT00046839|83091073|FG000|Overall Study|Withdrawal of consent|1|||
46872052|NCT00046839|83091074|FG001|Overall Study|Withdrawal of consent|0|||
46872053|NCT00006903|83091083|FG000|Overall Study|Still receiving treatment|0|||
46872054|NCT00006903|83091084|FG001|Overall Study|Still receiving treatment|0|||
46872055|NCT00006903|83091085|FG002|Overall Study|Still receiving treatment|1|||
46872056|NCT00006903|83091083|FG000|Overall Study|Refused further treatment|0|||
46872057|NCT00006903|83091084|FG001|Overall Study|Refused further treatment|2|||
46872058|NCT00006903|83091085|FG002|Overall Study|Refused further treatment|1|||
46872059|NCT00006903|83091083|FG000|Overall Study|Adverse Event|0|||
46872060|NCT00006903|83091084|FG001|Overall Study|Adverse Event|0|||
46872061|NCT00006903|83091085|FG002|Overall Study|Adverse Event|1|||
46872062|NCT00006903|83091083|FG000|Overall Study|Death|0|||
46872063|NCT00006903|83091084|FG001|Overall Study|Death|1|||
46872064|NCT00006903|83091085|FG002|Overall Study|Death|0|||
46872065|NCT00006903|83091083|FG000|Overall Study|Patient never treated|0|||
46872066|NCT00006903|83091084|FG001|Overall Study|Patient never treated|0|||
46872067|NCT00006903|83091085|FG002|Overall Study|Patient never treated|1|||
46872068|NCT00006903|83091083|FG000|Overall Study|Ineligible|10|||
46872069|NCT00006903|83091084|FG001|Overall Study|Ineligible|1|||
46872070|NCT00006903|83091085|FG002|Overall Study|Ineligible|2|||
46872071|NCT00026793|83091093|FG000|Overall Study|Death on study due to underlying disease|4|||
46872072|NCT00026793|83091093|FG000|Overall Study|Physician Decision|2|||
46872073|NCT00026793|83091093|FG000|Overall Study|Off study|2|||
46872074|NCT03539484|83091104|FG000|Overall Study|Death|1|||
46872075|NCT03539484|83091105|FG001|Overall Study|Death|0|||
46872076|NCT03539484|83091106|FG002|Overall Study|Death|0|||
46872077|NCT03539484|83091107|FG003|Overall Study|Death|2|||
46872078|NCT03539484|83091108|FG004|Overall Study|Death|8|||
46872079|NCT03539484|83091109|FG005|Overall Study|Death|3|||
46872080|NCT03539484|83091110|FG006|Overall Study|Death|0|||
46872081|NCT03539484|83091104|FG000|Overall Study|Lost to Follow-up|0|||
46872082|NCT03539484|83091105|FG001|Overall Study|Lost to Follow-up|1|||
46872083|NCT03539484|83091106|FG002|Overall Study|Lost to Follow-up|0|||
46872084|NCT03539484|83091107|FG003|Overall Study|Lost to Follow-up|0|||
46872085|NCT03539484|83091108|FG004|Overall Study|Lost to Follow-up|1|||
46872086|NCT03539484|83091109|FG005|Overall Study|Lost to Follow-up|0|||
46872087|NCT03539484|83091110|FG006|Overall Study|Lost to Follow-up|0|||
46872088|NCT03539484|83091104|FG000|Overall Study|Withdrawal by Subject|0|||
46872089|NCT03539484|83091105|FG001|Overall Study|Withdrawal by Subject|0|||
46872090|NCT03539484|83091106|FG002|Overall Study|Withdrawal by Subject|0|||
46872091|NCT03539484|83091107|FG003|Overall Study|Withdrawal by Subject|0|||
46872092|NCT03539484|83091108|FG004|Overall Study|Withdrawal by Subject|2|||
46872093|NCT03539484|83091109|FG005|Overall Study|Withdrawal by Subject|0|||
46872094|NCT03539484|83091110|FG006|Overall Study|Withdrawal by Subject|1|||
46872095|NCT03539484|83091104|FG000|Overall Study|Study Terminated by Sponsor|0|||
46872096|NCT03539484|83091105|FG001|Overall Study|Study Terminated by Sponsor|0|||
46872097|NCT03539484|83091106|FG002|Overall Study|Study Terminated by Sponsor|1|||
46872098|NCT03539484|83091107|FG003|Overall Study|Study Terminated by Sponsor|1|||
46872099|NCT03539484|83091108|FG004|Overall Study|Study Terminated by Sponsor|2|||
46872100|NCT03539484|83091109|FG005|Overall Study|Study Terminated by Sponsor|2|||
46872101|NCT03539484|83091110|FG006|Overall Study|Study Terminated by Sponsor|1|||
46872102|NCT03561090|83091133|FG000|Overall Study|Adverse Event|11|||
46872103|NCT03561090|83091134|FG001|Overall Study|Adverse Event|7|||
46872104|NCT03561090|83091133|FG000|Overall Study|Non-Compliance With Study Drug|2|||
46872105|NCT03561090|83091134|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46872106|NCT03561090|83091133|FG000|Overall Study|Protocol Violation|2|||
46872107|NCT03561090|83091134|FG001|Overall Study|Protocol Violation|2|||
46872108|NCT03561090|83091133|FG000|Overall Study|Withdrawal by Subject|7|||
46872109|NCT03561090|83091134|FG001|Overall Study|Withdrawal by Subject|7|||
46872110|NCT03561090|83091133|FG000|Overall Study|Lost to Follow-up|7|||
46872111|NCT03561090|83091134|FG001|Overall Study|Lost to Follow-up|2|||
46872112|NCT03561090|83091133|FG000|Overall Study|Study Terminated by Sponsor|10|||
46872113|NCT03561090|83091134|FG001|Overall Study|Study Terminated by Sponsor|15|||
46872114|NCT03561090|83091133|FG000|Overall Study|Randomized by Mistake|1|||
46802628|NCT03859323|83021937|FG006|Overall Study|Withdrawal by Subject|0|||
46802629|NCT03859323|83021938|FG007|Overall Study|Withdrawal by Subject|0|||
46802630|NCT03859323|83021939|FG008|Overall Study|Withdrawal by Subject|0|||
46802631|NCT03859323|83021940|FG009|Overall Study|Withdrawal by Subject|1|||
46802632|NCT03859323|83021941|FG010|Overall Study|Withdrawal by Subject|1|||
46802633|NCT03859323|83021942|FG011|Overall Study|Withdrawal by Subject|2|||
46802634|NCT03859323|83021943|FG012|Overall Study|Withdrawal by Subject|1|||
46802635|NCT03859323|83021931|FG000|Overall Study|Pregnancy|0|||
46802636|NCT03859323|83021932|FG001|Overall Study|Pregnancy|0|||
46872115|NCT03561090|83091134|FG001|Overall Study|Randomized by Mistake|1|||
46872116|NCT03561090|83091133|FG000|Overall Study|Other Not Specified|0|||
46872117|NCT03561090|83091134|FG001|Overall Study|Other Not Specified|2|||
46872118|NCT02996500|83091148|FG000|Overall Study|Adverse Event|1|||
46872119|NCT02996500|83091149|FG001|Overall Study|Adverse Event|1|||
46872120|NCT02996500|83091150|FG002|Overall Study|Adverse Event|4|||
46872121|NCT02996500|83091151|FG003|Overall Study|Adverse Event|3|||
46872122|NCT02996500|83091152|FG004|Overall Study|Adverse Event|1|||
46872123|NCT02996500|83091153|FG005|Overall Study|Adverse Event|2|||
46872124|NCT02996500|83091148|FG000|Overall Study|Lack of Efficacy|0|||
46872125|NCT02996500|83091149|FG001|Overall Study|Lack of Efficacy|0|||
46872126|NCT02996500|83091150|FG002|Overall Study|Lack of Efficacy|0|||
46872127|NCT02996500|83091151|FG003|Overall Study|Lack of Efficacy|0|||
46872128|NCT02996500|83091152|FG004|Overall Study|Lack of Efficacy|2|||
46872129|NCT02996500|83091153|FG005|Overall Study|Lack of Efficacy|0|||
46872130|NCT02996500|83091148|FG000|Overall Study|Lost to Follow-up|1|||
46872131|NCT02996500|83091149|FG001|Overall Study|Lost to Follow-up|0|||
46872132|NCT02996500|83091150|FG002|Overall Study|Lost to Follow-up|0|||
46872133|NCT02996500|83091151|FG003|Overall Study|Lost to Follow-up|0|||
46872134|NCT02996500|83091152|FG004|Overall Study|Lost to Follow-up|0|||
46872135|NCT02996500|83091153|FG005|Overall Study|Lost to Follow-up|1|||
46872136|NCT02996500|83091148|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
46872137|NCT02996500|83091149|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
46872138|NCT02996500|83091150|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
46872139|NCT02996500|83091151|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
46872140|NCT02996500|83091152|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
46872141|NCT02996500|83091153|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
46872142|NCT02996500|83091148|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46872143|NCT02996500|83091149|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46872144|NCT02996500|83091150|FG002|Overall Study|Non-Compliance With Study Drug|0|||
46872145|NCT02996500|83091151|FG003|Overall Study|Non-Compliance With Study Drug|0|||
46872146|NCT02996500|83091152|FG004|Overall Study|Non-Compliance With Study Drug|0|||
46872147|NCT02996500|83091153|FG005|Overall Study|Non-Compliance With Study Drug|1|||
46872148|NCT02996500|83091148|FG000|Overall Study|Progressive Disease|1|||
46872149|NCT02996500|83091149|FG001|Overall Study|Progressive Disease|0|||
46872150|NCT02996500|83091150|FG002|Overall Study|Progressive Disease|0|||
46872151|NCT02996500|83091151|FG003|Overall Study|Progressive Disease|0|||
46872152|NCT02996500|83091152|FG004|Overall Study|Progressive Disease|0|||
46872153|NCT02996500|83091153|FG005|Overall Study|Progressive Disease|0|||
46872154|NCT02996500|83091148|FG000|Overall Study|Other|2|||
46872155|NCT02996500|83091149|FG001|Overall Study|Other|0|||
46872156|NCT02996500|83091150|FG002|Overall Study|Other|2|||
46872157|NCT02996500|83091151|FG003|Overall Study|Other|0|||
46872158|NCT02996500|83091152|FG004|Overall Study|Other|0|||
46872159|NCT02996500|83091153|FG005|Overall Study|Other|0|||
46872160|NCT02996500|83091148|FG000|Overall Study|Protocol Violation|0|||
46872161|NCT02996500|83091149|FG001|Overall Study|Protocol Violation|0|||
46872162|NCT02996500|83091150|FG002|Overall Study|Protocol Violation|0|||
46872163|NCT02996500|83091151|FG003|Overall Study|Protocol Violation|1|||
46872164|NCT02996500|83091152|FG004|Overall Study|Protocol Violation|0|||
46872165|NCT02996500|83091153|FG005|Overall Study|Protocol Violation|0|||
46872166|NCT02996500|83091148|FG000|Overall Study|Withdrawal by Subject|3|||
46872167|NCT02996500|83091149|FG001|Overall Study|Withdrawal by Subject|0|||
46872168|NCT02996500|83091150|FG002|Overall Study|Withdrawal by Subject|3|||
46872169|NCT02996500|83091151|FG003|Overall Study|Withdrawal by Subject|0|||
46872170|NCT02996500|83091152|FG004|Overall Study|Withdrawal by Subject|2|||
46872171|NCT02996500|83091153|FG005|Overall Study|Withdrawal by Subject|0|||
46872172|NCT00006489|83091175|FG000|Overall Study|Adverse Event|3|||
46872173|NCT00006489|83091176|FG001|Overall Study|Adverse Event|2|||
46872174|NCT00006489|83091177|FG002|Overall Study|Adverse Event|4|||
46872175|NCT00006489|83091178|FG003|Overall Study|Adverse Event|3|||
46872176|NCT00006489|83091175|FG000|Overall Study|Withdrawal by Subject|10|||
46872177|NCT00006489|83091176|FG001|Overall Study|Withdrawal by Subject|9|||
46872178|NCT00006489|83091177|FG002|Overall Study|Withdrawal by Subject|9|||
46872179|NCT00006489|83091178|FG003|Overall Study|Withdrawal by Subject|6|||
46872180|NCT00006489|83091175|FG000|Overall Study|Scheduling Conflict|0|||
46872181|NCT00006489|83091176|FG001|Overall Study|Scheduling Conflict|3|||
46872182|NCT00006489|83091177|FG002|Overall Study|Scheduling Conflict|2|||
46872183|NCT00006489|83091178|FG003|Overall Study|Scheduling Conflict|1|||
46872184|NCT00006489|83091175|FG000|Overall Study|Death|0|||
46872185|NCT00006489|83091176|FG001|Overall Study|Death|0|||
46872186|NCT00006489|83091177|FG002|Overall Study|Death|0|||
46872187|NCT00006489|83091178|FG003|Overall Study|Death|1|||
46872188|NCT03535974|83091191|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
46872189|NCT03535974|83091192|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
46872190|NCT03535974|83091193|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
46872191|NCT03535974|83091191|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
46872192|NCT03535974|83091192|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
46872193|NCT03535974|83091193|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
46872194|NCT00025233|83091201|FG000|Overall Study|Ineligible: wrong cell type|1|||
46872195|NCT00025233|83091201|FG000|Overall Study|Ineligible: wrong primary|1|||
46872196|NCT00025233|83091201|FG000|Overall Study|Ineligible: improper prior treatment|1|||
46872197|NCT00025233|83091201|FG000|Overall Study|Never treated|1|||
46872198|NCT00025155|83091211|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
46872199|NCT00025155|83091211|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
46872200|NCT02998996|83091226|FG000|Overall Study|Lost to Follow-up|0|||
46872201|NCT02998996|83091227|FG001|Overall Study|Lost to Follow-up|0|||
46872202|NCT02998996|83091228|FG002|Overall Study|Lost to Follow-up|1|||
46872203|NCT02998996|83091229|FG003|Overall Study|Lost to Follow-up|0|||
46872204|NCT02998996|83091230|FG004|Overall Study|Lost to Follow-up|0|||
46872205|NCT02998996|83091231|FG005|Overall Study|Lost to Follow-up|0|||
46872206|NCT02998996|83091226|FG000|Overall Study|Pregnancy|0|||
46872207|NCT02998996|83091227|FG001|Overall Study|Pregnancy|1|||
46872208|NCT02998996|83091228|FG002|Overall Study|Pregnancy|0|||
46872209|NCT02998996|83091229|FG003|Overall Study|Pregnancy|0|||
46872210|NCT02998996|83091230|FG004|Overall Study|Pregnancy|0|||
46872211|NCT02998996|83091231|FG005|Overall Study|Pregnancy|0|||
46872212|NCT02998996|83091226|FG000|Overall Study|Family reasons|0|||
46872213|NCT02998996|83091227|FG001|Overall Study|Family reasons|0|||
46872214|NCT02998996|83091228|FG002|Overall Study|Family reasons|0|||
46872215|NCT02998996|83091229|FG003|Overall Study|Family reasons|0|||
46872216|NCT02998996|83091230|FG004|Overall Study|Family reasons|1|||
46872217|NCT02998996|83091231|FG005|Overall Study|Family reasons|0|||
46872218|NCT02994940|83091247|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
46872219|NCT02994940|83091248|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
46872220|NCT02994940|83091247|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
46872221|NCT02994940|83091248|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
46872222|NCT02994940|83091247|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
46872223|NCT02994940|83091248|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
46872224|NCT02994394|83091256|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
46872225|NCT02994394|83091257|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
46872226|NCT02994394|83091258|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
46872227|NCT02994394|83091259|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
46872228|NCT02994394|83091260|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
46872229|NCT02994394|83091261|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
46872230|NCT02994394|83091256|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
46872231|NCT02994394|83091257|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
46872232|NCT02994394|83091258|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
46872233|NCT02994394|83091259|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
46872234|NCT02994394|83091260|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
46872235|NCT02994394|83091261|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
46872236|NCT02998840|83091279|FG000|Overall Study|Lost to Follow-up|1|||
46872237|NCT02998840|83091280|FG001|Overall Study|Lost to Follow-up|1|||
46872238|NCT02998840|83091281|FG002|Overall Study|Lost to Follow-up|2|||
46872239|NCT02998840|83091282|FG003|Overall Study|Lost to Follow-up|3|||
46872240|NCT02998840|83091279|FG000|Overall Study|Withdrawal by Subject|1|||
46872241|NCT02998840|83091280|FG001|Overall Study|Withdrawal by Subject|1|||
46872242|NCT02998840|83091281|FG002|Overall Study|Withdrawal by Subject|0|||
46872243|NCT02998840|83091282|FG003|Overall Study|Withdrawal by Subject|1|||
46872244|NCT02998840|83091279|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
46872245|NCT02998840|83091280|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
46872246|NCT02998840|83091281|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
46872247|NCT02998840|83091282|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
46872248|NCT00023673|83091293|FG000|Overall Study|Ineligible / no protocol treatment|0|||
46872249|NCT00023673|83091294|FG001|Overall Study|Ineligible / no protocol treatment|0|||
46872250|NCT00023673|83091295|FG002|Overall Study|Ineligible / no protocol treatment|0|||
46872251|NCT00023673|83091296|FG003|Overall Study|Ineligible / no protocol treatment|1|||
46872252|NCT00023673|83091293|FG000|Overall Study|Patient withdrew consent|0|||
46872253|NCT00023673|83091294|FG001|Overall Study|Patient withdrew consent|0|||
46872254|NCT00023673|83091295|FG002|Overall Study|Patient withdrew consent|0|||
46872255|NCT00023673|83091296|FG003|Overall Study|Patient withdrew consent|1|||
46872256|NCT01069900|83091308|FG000|Overall Study|Technical problems|0|||
46872257|NCT01069900|83091309|FG001|Overall Study|Technical problems|1|||
46872258|NCT01069900|83091308|FG000|Overall Study|Lost to Follow-up|7|||
46872259|NCT01069900|83091309|FG001|Overall Study|Lost to Follow-up|1|||
46872260|NCT01069900|83091308|FG000|Overall Study|Withdrawal by Subject|6|||
46872261|NCT01069900|83091309|FG001|Overall Study|Withdrawal by Subject|1|||
46872262|NCT01069900|83091308|FG000|Overall Study|Protocol Violation|4|||
46872263|NCT01069900|83091309|FG001|Overall Study|Protocol Violation|1|||
46872264|NCT01069900|83091308|FG000|Overall Study|Insufficient Therapeutic effect|1|||
46872265|NCT01069900|83091309|FG001|Overall Study|Insufficient Therapeutic effect|0|||
46872266|NCT01069120|83091317|FG000|Overall Study|Study prematurely terminated|27|||
46872267|NCT00006237|83091325|FG000|Overall Study|Adverse Event|39|||
46872268|NCT00006237|83091326|FG001|Overall Study|Adverse Event|29|||
46872269|NCT00006237|83091325|FG000|Overall Study|Death|1|||
46872270|NCT00006237|83091326|FG001|Overall Study|Death|0|||
46872271|NCT00006237|83091325|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
46872272|NCT00006237|83091326|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
46872273|NCT00006237|83091325|FG000|Overall Study|Progression/relapse|54|||
46872274|NCT00006237|83091326|FG001|Overall Study|Progression/relapse|2|||
46872275|NCT00006237|83091325|FG000|Overall Study|Not eligible|9|||
46872276|NCT00006237|83091326|FG001|Overall Study|Not eligible|20|||
46872277|NCT00006237|83091325|FG000|Overall Study|Withdrawal by Subject|0|||
46872278|NCT00006237|83091326|FG001|Overall Study|Withdrawal by Subject|1|||
46872279|NCT00006237|83091325|FG000|Overall Study|Not protocol specified|14|||
46872280|NCT00006237|83091326|FG001|Overall Study|Not protocol specified|5|||
46872281|NCT02993926|83091335|FG000|Enantone Treatment Phase|Adverse Event|1|||
46872282|NCT02993926|83091336|FG001|Enantone Treatment Phase|Adverse Event|0|||
46872283|NCT02993926|83091337|FG002|Enantone Treatment Phase|Adverse Event|0|||
46872284|NCT02993926|83091335|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
46872285|NCT02993926|83091336|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
46872286|NCT02993926|83091337|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
46872287|NCT02993926|83091335|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
46872288|NCT02993926|83091336|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
46872289|NCT02993926|83091337|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
46872290|NCT02993926|83091335|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
46872291|NCT02993926|83091336|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
46872292|NCT02993926|83091337|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
46872293|NCT02993224|83091347|FG000|Core Phase - Period 1|Adverse Event|4|||
46872294|NCT02993224|83091347|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
46872295|NCT02993224|83091347|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
46872296|NCT02993224|83091347|FG000|Core Phase- Period 2|Adverse Event|1|||
46872297|NCT02993224|83091347|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
46872298|NCT02993224|83091347|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
46872299|NCT02993224|83091347|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
46872300|NCT02993224|83091347|FG000|Extension Phase|Adverse Event|3|||
46872301|NCT02993224|83091347|FG000|Extension Phase|Withdrawal by Subject|3|||
46872302|NCT02993224|83091347|FG000|Extension Phase|Lost to Follow-up|2|||
46872303|NCT02993224|83091347|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
46872304|NCT03495908|83091355|FG000|Overall Study|Withdrawal by Subject|3|||
46872305|NCT03495908|83091356|FG001|Overall Study|Withdrawal by Subject|1|||
46872306|NCT03495908|83091355|FG000|Overall Study|Lost to Follow-up|1|||
46872307|NCT03495908|83091356|FG001|Overall Study|Lost to Follow-up|4|||
46872308|NCT03495908|83091355|FG000|Overall Study|Adverse Event|0|||
46872309|NCT03495908|83091356|FG001|Overall Study|Adverse Event|2|||
46872310|NCT03495908|83091355|FG000|Overall Study|Death|1|||
46872311|NCT03495908|83091356|FG001|Overall Study|Death|0|||
46872312|NCT03495908|83091355|FG000|Overall Study|Physician Decision|5|||
46872313|NCT03495908|83091356|FG001|Overall Study|Physician Decision|4|||
46872314|NCT03495908|83091355|FG000|Overall Study|No documented reason|0|||
46872315|NCT03495908|83091356|FG001|Overall Study|No documented reason|2|||
46872316|NCT02992288|83091368|FG000|Overall Study|Adverse Event|8|||
46872317|NCT02992288|83091369|FG001|Overall Study|Adverse Event|2|||
46872318|NCT02992288|83091370|FG002|Overall Study|Adverse Event|2|||
46872319|NCT02992288|83091371|FG003|Overall Study|Adverse Event|2|||
46702016|NCT01202760|82916874|FG002|Overall Study|Physician Decision|0|||
46702017|NCT01202760|82916872|FG000|Overall Study|Protocol Violation|7|||
46702018|NCT01202760|82916873|FG001|Overall Study|Protocol Violation|5|||
46702019|NCT01202760|82916874|FG002|Overall Study|Protocol Violation|2|||
46702020|NCT01202760|82916872|FG000|Overall Study|Sponsor Decision|4|||
46702021|NCT01202760|82916873|FG001|Overall Study|Sponsor Decision|4|||
46702022|NCT01202760|82916874|FG002|Overall Study|Sponsor Decision|0|||
46702023|NCT01091259|82916894|FG000|Overall Study|Adverse Event|3|||
46702024|NCT01091259|82916894|FG000|Overall Study|Lack of Efficacy|2|||
46702025|NCT01091103|82916898|FG000|Overall Study|Adverse Event|1|||
46872320|NCT02992288|83091372|FG004|Overall Study|Adverse Event|2|||
46872321|NCT02992288|83091373|FG005|Overall Study|Adverse Event|7|||
46872322|NCT02992288|83091368|FG000|Overall Study|Non-compliance with study drug|0|||
46872323|NCT02992288|83091369|FG001|Overall Study|Non-compliance with study drug|1|||
46702026|NCT01091103|82916898|FG000|Overall Study|Progressive Disease|3|||
46702027|NCT01078389|82916906|FG000|Overall Study|Adverse Event|10|||
46702028|NCT01078389|82916907|FG001|Overall Study|Adverse Event|6|||
46707556|NCT01176240|82923135|FG000|Study 306B|Adverse Event|10|||
46872324|NCT02992288|83091370|FG002|Overall Study|Non-compliance with study drug|1|||
46872325|NCT02992288|83091371|FG003|Overall Study|Non-compliance with study drug|0|||
46872326|NCT02992288|83091372|FG004|Overall Study|Non-compliance with study drug|1|||
46872327|NCT02992288|83091373|FG005|Overall Study|Non-compliance with study drug|0|||
46872328|NCT02992288|83091368|FG000|Overall Study|Physician Decision|3|||
46872329|NCT02992288|83091369|FG001|Overall Study|Physician Decision|0|||
46872330|NCT02992288|83091370|FG002|Overall Study|Physician Decision|1|||
46872331|NCT02992288|83091371|FG003|Overall Study|Physician Decision|0|||
46872332|NCT02992288|83091372|FG004|Overall Study|Physician Decision|0|||
46872333|NCT02992288|83091373|FG005|Overall Study|Physician Decision|1|||
46872334|NCT02992288|83091368|FG000|Overall Study|Death|2|||
46872335|NCT02992288|83091369|FG001|Overall Study|Death|0|||
46872336|NCT02992288|83091370|FG002|Overall Study|Death|2|||
46872337|NCT02992288|83091371|FG003|Overall Study|Death|1|||
46872338|NCT02992288|83091372|FG004|Overall Study|Death|2|||
46872339|NCT02992288|83091373|FG005|Overall Study|Death|0|||
46872340|NCT02992288|83091368|FG000|Overall Study|Lost to Follow-up|0|||
46872341|NCT02992288|83091369|FG001|Overall Study|Lost to Follow-up|0|||
46872342|NCT02992288|83091370|FG002|Overall Study|Lost to Follow-up|0|||
46872343|NCT02992288|83091371|FG003|Overall Study|Lost to Follow-up|1|||
46872344|NCT02992288|83091372|FG004|Overall Study|Lost to Follow-up|0|||
46872345|NCT02992288|83091373|FG005|Overall Study|Lost to Follow-up|0|||
46872346|NCT02992288|83091368|FG000|Overall Study|Protocol Violation|0|||
46872347|NCT02992288|83091369|FG001|Overall Study|Protocol Violation|0|||
46872348|NCT02992288|83091370|FG002|Overall Study|Protocol Violation|0|||
46872349|NCT02992288|83091371|FG003|Overall Study|Protocol Violation|0|||
46872350|NCT02992288|83091372|FG004|Overall Study|Protocol Violation|0|||
46872351|NCT02992288|83091373|FG005|Overall Study|Protocol Violation|1|||
46872352|NCT02992288|83091368|FG000|Overall Study|Withdrawal by Subject|4|||
46872353|NCT02992288|83091369|FG001|Overall Study|Withdrawal by Subject|2|||
46872354|NCT02992288|83091370|FG002|Overall Study|Withdrawal by Subject|1|||
46872355|NCT02992288|83091371|FG003|Overall Study|Withdrawal by Subject|5|||
46872356|NCT02992288|83091372|FG004|Overall Study|Withdrawal by Subject|3|||
46872357|NCT02992288|83091373|FG005|Overall Study|Withdrawal by Subject|4|||
46872358|NCT02992132|83091390|FG000|Overall Study|Adverse Event|4|||
46872359|NCT02992132|83091391|FG001|Overall Study|Adverse Event|1|||
46872360|NCT02992132|83091392|FG002|Overall Study|Adverse Event|3|||
46872361|NCT02992132|83091390|FG000|Overall Study|Lack of Efficacy|2|||
46872362|NCT02992132|83091391|FG001|Overall Study|Lack of Efficacy|0|||
46984140|NCT02561195|83230269|FG009|Vaccination 1 to 3|Protocol Violation|0|||
46984141|NCT02561195|83230270|FG010|Vaccination 1 to 3|Protocol Violation|0|||
46984142|NCT02561195|83230271|FG011|Vaccination 1 to 3|Protocol Violation|0|||
46984143|NCT02561195|83230272|FG012|Vaccination 1 to 3|Protocol Violation|0|||
46984144|NCT02561195|83230273|FG013|Vaccination 1 to 3|Protocol Violation|0|||
46984145|NCT02561195|83230260|FG000|Vaccination 1 to 3|Death|2|||
46984146|NCT02561195|83230261|FG001|Vaccination 1 to 3|Death|1|||
46984147|NCT02561195|83230262|FG002|Vaccination 1 to 3|Death|0|||
46984148|NCT02561195|83230263|FG003|Vaccination 1 to 3|Death|2|||
46984149|NCT02561195|83230264|FG004|Vaccination 1 to 3|Death|0|||
46984150|NCT02561195|83230265|FG005|Vaccination 1 to 3|Death|0|||
46984151|NCT02561195|83230266|FG006|Vaccination 1 to 3|Death|0|||
46984152|NCT02561195|83230267|FG007|Vaccination 1 to 3|Death|0|||
46984153|NCT02561195|83230268|FG008|Vaccination 1 to 3|Death|0|||
46984154|NCT02561195|83230269|FG009|Vaccination 1 to 3|Death|0|||
46984155|NCT02561195|83230270|FG010|Vaccination 1 to 3|Death|0|||
46984156|NCT02561195|83230271|FG011|Vaccination 1 to 3|Death|0|||
46984157|NCT02561195|83230272|FG012|Vaccination 1 to 3|Death|0|||
46984158|NCT02561195|83230273|FG013|Vaccination 1 to 3|Death|0|||
46984159|NCT02561195|83230260|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
46984160|NCT02561195|83230261|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
46984161|NCT02561195|83230262|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
46984162|NCT02561195|83230263|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
46984163|NCT02561195|83230264|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
46984164|NCT02561195|83230265|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
46984165|NCT02561195|83230266|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
46984166|NCT02561195|83230267|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
46984167|NCT02561195|83230268|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
46872363|NCT02992132|83091392|FG002|Overall Study|Lack of Efficacy|0|||
46872364|NCT02992132|83091390|FG000|Overall Study|Non-compliance with study drug|2|||
46872365|NCT02992132|83091391|FG001|Overall Study|Non-compliance with study drug|0|||
46872366|NCT02992132|83091392|FG002|Overall Study|Non-compliance with study drug|0|||
46872367|NCT02992132|83091390|FG000|Overall Study|Progressive disease|1|||
46872368|NCT02992132|83091391|FG001|Overall Study|Progressive disease|0|||
46872369|NCT02992132|83091392|FG002|Overall Study|Progressive disease|0|||
46872370|NCT02992132|83091390|FG000|Overall Study|Protocol Violation|2|||
46872371|NCT02992132|83091391|FG001|Overall Study|Protocol Violation|2|||
46872372|NCT02992132|83091392|FG002|Overall Study|Protocol Violation|0|||
46984168|NCT02561195|83230269|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
46872373|NCT02992132|83091390|FG000|Overall Study|Caregiver withdrew consent|2|||
46872374|NCT02992132|83091391|FG001|Overall Study|Caregiver withdrew consent|3|||
46872375|NCT02992132|83091392|FG002|Overall Study|Caregiver withdrew consent|2|||
46872376|NCT02992132|83091390|FG000|Overall Study|Withdrawal by Subject|0|||
46872377|NCT02992132|83091391|FG001|Overall Study|Withdrawal by Subject|2|||
46872378|NCT02992132|83091392|FG002|Overall Study|Withdrawal by Subject|1|||
46872379|NCT02992132|83091390|FG000|Overall Study|Physician Decision|0|||
46872380|NCT02992132|83091391|FG001|Overall Study|Physician Decision|0|||
46872381|NCT02992132|83091392|FG002|Overall Study|Physician Decision|1|||
46872382|NCT03444584|83091402|FG000|Overall Study|Withdrawal by Subject|0|||
46872383|NCT03444584|83091403|FG001|Overall Study|Withdrawal by Subject|1|||
46872384|NCT03444584|83091402|FG000|Overall Study|Other|0|||
46872385|NCT03444584|83091403|FG001|Overall Study|Other|1|||
46872386|NCT02989168|83091412|FG000|Overall Study|Withdrawal by Subject|2|||
46872387|NCT02989168|83091413|FG001|Overall Study|Withdrawal by Subject|0|||
46872388|NCT02989168|83091412|FG000|Overall Study|Physician Decision|0|||
46872389|NCT02989168|83091413|FG001|Overall Study|Physician Decision|1|||
46872390|NCT02989168|83091412|FG000|Overall Study|Adverse Event|1|||
46872391|NCT02989168|83091413|FG001|Overall Study|Adverse Event|2|||
46872392|NCT02989168|83091412|FG000|Overall Study|Sponsor stopped study.|1|||
46872393|NCT02989168|83091413|FG001|Overall Study|Sponsor stopped study.|0|||
46872394|NCT02988622|83091421|FG000|Overall Study|Lost to Follow-up|17|||
46872395|NCT03412604|83091427|FG000|Overall Study|Withdrawal by Subject|1|||
46872396|NCT02991430|83091434|FG000|Treatment Period 1|Adverse Event|1|||
46872397|NCT02991430|83091435|FG001|Treatment Period 1|Adverse Event|0|||
46872398|NCT02991430|83091436|FG002|Treatment Period 1|Adverse Event|2|||
46872399|NCT02991430|83091434|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46872400|NCT02991430|83091435|FG001|Treatment Period 1|Withdrawal by Subject|4|||
46872401|NCT02991430|83091436|FG002|Treatment Period 1|Withdrawal by Subject|0|||
46872402|NCT02991430|83091434|FG000|Treatment Period 2|Study Termination|6|||
46872403|NCT02991430|83091435|FG001|Treatment Period 2|Study Termination|3|||
46872404|NCT02991430|83091436|FG002|Treatment Period 2|Study Termination|3|||
46872405|NCT02991430|83091434|FG000|Treatment Period 2|Lost to Follow-up|0|||
46872406|NCT02991430|83091435|FG001|Treatment Period 2|Lost to Follow-up|0|||
46872407|NCT02991430|83091436|FG002|Treatment Period 2|Lost to Follow-up|1|||
46872408|NCT02991430|83091434|FG000|Post-treatment Observation Period|Study Termination|3|||
46872409|NCT02991430|83091435|FG001|Post-treatment Observation Period|Study Termination|6|||
46872410|NCT02991430|83091436|FG002|Post-treatment Observation Period|Study Termination|5|||
46872411|NCT03411902|83091446|FG000|Overall Study|Lost to Follow-up|3|||
46872412|NCT03411902|83091447|FG001|Overall Study|Lost to Follow-up|0|||
46872413|NCT03494816|83091453|FG000|Overall Study|Protocol Violation|2|||
46872414|NCT03494816|83091453|FG000|Overall Study|Physician Decision|2|||
46872415|NCT03494816|83091453|FG000|Overall Study|Did not start trial treatment|1|||
46872416|NCT03494816|83091453|FG000|Overall Study|Adverse Event|1|||
46872417|NCT03492554|83091463|FG000|Overall Study|Protocol Violation|0|||
46872418|NCT03492554|83091464|FG001|Overall Study|Protocol Violation|14|||
46872419|NCT04936334|83091509|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
46872420|NCT04822597|83091519|FG000|Overall Study|Withdrawal by Subject|0|||
46872421|NCT04822597|83091520|FG001|Overall Study|Withdrawal by Subject|1|||
46872422|NCT04822597|83091521|FG002|Overall Study|Withdrawal by Subject|1|||
46984169|NCT02561195|83230270|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
46984170|NCT02561195|83230271|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
46984171|NCT02561195|83230272|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
46984172|NCT02561195|83230273|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
46984173|NCT02561195|83230260|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
46984174|NCT02561195|83230261|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
46984175|NCT02561195|83230262|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
46984176|NCT02561195|83230263|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
46984177|NCT02561195|83230264|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
46984178|NCT02561195|83230265|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
46702029|NCT01078389|82916906|FG000|Overall Study|Major Protocol Deviation|2|||
46702030|NCT01078389|82916907|FG001|Overall Study|Major Protocol Deviation|0|||
46702031|NCT01078389|82916906|FG000|Overall Study|Lost to Follow-up|23|||
46984179|NCT02561195|83230266|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
46984180|NCT02561195|83230267|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
46984181|NCT02561195|83230268|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
46872423|NCT04822597|83091522|FG003|Overall Study|Withdrawal by Subject|0|||
46702032|NCT01078389|82916907|FG001|Overall Study|Lost to Follow-up|23|||
46872424|NCT04822597|83091519|FG000|Overall Study|Physician Decision|0|||
46872425|NCT04822597|83091520|FG001|Overall Study|Physician Decision|0|||
46872426|NCT04822597|83091521|FG002|Overall Study|Physician Decision|1|||
46872427|NCT04822597|83091522|FG003|Overall Study|Physician Decision|1|||
46872428|NCT04822597|83091519|FG000|Overall Study|Subject withdrawn after enrollment|0|||
46872429|NCT04822597|83091520|FG001|Overall Study|Subject withdrawn after enrollment|1|||
46872430|NCT04822597|83091521|FG002|Overall Study|Subject withdrawn after enrollment|0|||
46872431|NCT04822597|83091522|FG003|Overall Study|Subject withdrawn after enrollment|1|||
46872432|NCT04822597|83091519|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
46872433|NCT04822597|83091520|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
46872434|NCT04822597|83091521|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
46872435|NCT04822597|83091522|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
46872436|NCT04639245|83091532|FG000|Overall Study|Death|1|||
46872437|NCT04599465|83091536|FG000|Overall Study|Physician Decision|1|||
46872438|NCT04599465|83091536|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
46872439|NCT04104646|83091583|FG000|Overall Study|Withdrawal by Subject|1|||
46872440|NCT04104646|83091584|FG001|Overall Study|Withdrawal by Subject|1|||
46872441|NCT04104646|83091583|FG000|Overall Study|Lost to Follow-up|1|||
46872442|NCT04104646|83091584|FG001|Overall Study|Lost to Follow-up|0|||
46872443|NCT04104646|83091583|FG000|Overall Study|Physician Decision|2|||
46872444|NCT04104646|83091584|FG001|Overall Study|Physician Decision|0|||
46872445|NCT03919669|83091595|FG000|Overall Study|Withdrawal by Subject|1|||
46872446|NCT03919669|83091596|FG001|Overall Study|Withdrawal by Subject|0|||
46872447|NCT03919669|83091597|FG002|Overall Study|Withdrawal by Subject|0|||
46872448|NCT03772665|83091608|FG000|Overall Study|Protocol Violation|1|||
46872449|NCT03772665|83091609|FG001|Overall Study|Protocol Violation|0|||
46872450|NCT03024996|83091647|FG000|Overall Study|Death|57|||
46872451|NCT03024996|83091648|FG001|Overall Study|Death|55|||
46872452|NCT03024996|83091647|FG000|Overall Study|Disease relapse|1|||
46872453|NCT03024996|83091648|FG001|Overall Study|Disease relapse|0|||
46872454|NCT03024996|83091647|FG000|Overall Study|Lost to Follow-up|5|||
46872455|NCT03024996|83091648|FG001|Overall Study|Lost to Follow-up|10|||
46872456|NCT03024996|83091647|FG000|Overall Study|Other|3|||
46872457|NCT03024996|83091648|FG001|Overall Study|Other|3|||
46872458|NCT03024996|83091647|FG000|Overall Study|Physician Decision|0|||
46872459|NCT03024996|83091648|FG001|Overall Study|Physician Decision|1|||
46872460|NCT03024996|83091647|FG000|Overall Study|Study terminated by sponsor|303|||
46872461|NCT03024996|83091648|FG001|Overall Study|Study terminated by sponsor|283|||
46872462|NCT03024996|83091647|FG000|Overall Study|Withdrawal by Subject|21|||
46872463|NCT03024996|83091648|FG001|Overall Study|Withdrawal by Subject|36|||
46872464|NCT02642965|83091672|FG000|Overall Study|Lack of Efficacy|4|||
46872465|NCT02642965|83091672|FG000|Overall Study|Physician Decision|9|||
46872466|NCT03443414|83091709|FG000|Overall Study|Adverse Event|6|||
46872467|NCT03443414|83091710|FG001|Overall Study|Adverse Event|0|||
46872468|NCT03443414|83091711|FG002|Overall Study|Adverse Event|4|||
46872469|NCT03443414|83091712|FG003|Overall Study|Adverse Event|2|||
46872470|NCT03443414|83091713|FG004|Overall Study|Adverse Event|3|||
46872471|NCT03443414|83091709|FG000|Overall Study|Withdrawal by Subject|3|||
46872472|NCT03443414|83091710|FG001|Overall Study|Withdrawal by Subject|2|||
46872473|NCT03443414|83091711|FG002|Overall Study|Withdrawal by Subject|2|||
46872474|NCT03443414|83091712|FG003|Overall Study|Withdrawal by Subject|2|||
46872475|NCT03443414|83091713|FG004|Overall Study|Withdrawal by Subject|1|||
46872476|NCT03443414|83091709|FG000|Overall Study|Death|0|||
46872477|NCT03443414|83091710|FG001|Overall Study|Death|1|||
46872478|NCT03443414|83091711|FG002|Overall Study|Death|0|||
46872479|NCT03443414|83091712|FG003|Overall Study|Death|1|||
46872480|NCT03443414|83091713|FG004|Overall Study|Death|0|||
46872481|NCT03443414|83091709|FG000|Overall Study|Reason not specified|2|||
46872482|NCT03443414|83091710|FG001|Overall Study|Reason not specified|0|||
46872483|NCT03443414|83091711|FG002|Overall Study|Reason not specified|0|||
46872484|NCT03443414|83091712|FG003|Overall Study|Reason not specified|0|||
46872485|NCT03443414|83091713|FG004|Overall Study|Reason not specified|1|||
46872486|NCT02991118|83091727|FG000|Overall Study|Death|3|||
46872487|NCT02991118|83091728|FG001|Overall Study|Death|8|||
46872488|NCT02991118|83091727|FG000|Overall Study|Protocol Violation|0|||
46872489|NCT02991118|83091728|FG001|Overall Study|Protocol Violation|3|||
46872490|NCT02991118|83091727|FG000|Overall Study|Physician Decision|0|||
46872491|NCT02991118|83091728|FG001|Overall Study|Physician Decision|1|||
46872492|NCT02991118|83091727|FG000|Overall Study|Moved out of the country|0|||
46872493|NCT02991118|83091728|FG001|Overall Study|Moved out of the country|1|||
46872494|NCT02991118|83091727|FG000|Overall Study|Adverse Event|2|||
46872495|NCT02991118|83091728|FG001|Overall Study|Adverse Event|2|||
46872496|NCT02991118|83091727|FG000|Overall Study|Withdrawal by Subject|1|||
46872497|NCT02991118|83091728|FG001|Overall Study|Withdrawal by Subject|7|||
46872498|NCT02991118|83091727|FG000|Overall Study|Could not attend study visits|0|||
46872499|NCT02991118|83091728|FG001|Overall Study|Could not attend study visits|1|||
46872500|NCT02991118|83091727|FG000|Overall Study|Lost to Follow-up|1|||
46872501|NCT02991118|83091728|FG001|Overall Study|Lost to Follow-up|9|||
46872502|NCT03491150|83091736|FG000|Overall Study|Adverse Event|1|||
46872503|NCT03491150|83091737|FG001|Overall Study|Adverse Event|0|||
46872504|NCT03491150|83091736|FG000|Overall Study|Study Terminated by Sponsor|74|||
46872505|NCT03491150|83091737|FG001|Overall Study|Study Terminated by Sponsor|70|||
46872506|NCT03491150|83091736|FG000|Overall Study|Other|0|||
46872507|NCT03491150|83091737|FG001|Overall Study|Other|1|||
46872508|NCT03491150|83091736|FG000|Overall Study|Withdrawal by Subject|1|||
46872509|NCT03491150|83091737|FG001|Overall Study|Withdrawal by Subject|2|||
46872510|NCT02991040|83091743|FG000|Overall Study|Withdrawal by Subject|2|||
46872511|NCT02991040|83091743|FG000|Overall Study|Lost to Follow-up|2|||
46872512|NCT02910466|83091749|FG000|Overall Study|Adverse Event|1|||
46872513|NCT02910466|83091749|FG000|Overall Study|Withdrawal by Subject|3|||
46872514|NCT02910466|83091749|FG000|Overall Study|Lost to Follow-up|5|||
46872515|NCT02910466|83091749|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
46872516|NCT02910466|83091749|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
46872517|NCT03415178|83091755|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
46872518|NCT03415178|83091756|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
46872519|NCT03415178|83091755|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
46872520|NCT03415178|83091756|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
46872521|NCT01068730|83091766|FG000|Period 3|Personal reason|1|||
46872522|NCT01068730|83091767|FG001|Period 3|Personal reason|0|||
46872523|NCT01068730|83091768|FG002|Period 3|Personal reason|0|||
46872524|NCT01068730|83091769|FG003|Period 3|Personal reason|0|||
46872525|NCT01068730|83091766|FG000|Period 4|Family emergency|0|||
46872526|NCT01068730|83091767|FG001|Period 4|Family emergency|1|||
46872527|NCT01068730|83091768|FG002|Period 4|Family emergency|0|||
46872528|NCT01068730|83091769|FG003|Period 4|Family emergency|0|||
46872529|NCT01068652|83091788|FG000|Overall Study|Adverse Event|4|||
46872530|NCT01068652|83091789|FG001|Overall Study|Adverse Event|0|||
46872531|NCT01068652|83091788|FG000|Overall Study|Lack of Efficacy|0|||
46872532|NCT01068652|83091789|FG001|Overall Study|Lack of Efficacy|2|||
46872533|NCT01068652|83091788|FG000|Overall Study|Lost to Follow-up|2|||
46872534|NCT01068652|83091789|FG001|Overall Study|Lost to Follow-up|1|||
46872535|NCT01068652|83091788|FG000|Overall Study|Protocol Violation|3|||
46872536|NCT01068652|83091789|FG001|Overall Study|Protocol Violation|6|||
46872537|NCT01068652|83091788|FG000|Overall Study|Withdrawal criteria|1|||
46872538|NCT01068652|83091789|FG001|Overall Study|Withdrawal criteria|2|||
46702033|NCT01078389|82916906|FG000|Overall Study|Voluntary Withdrawal|20|||
46702034|NCT01078389|82916907|FG001|Overall Study|Voluntary Withdrawal|36|||
46702035|NCT01078389|82916906|FG000|Overall Study|Other|9|||
46702036|NCT01078389|82916907|FG001|Overall Study|Other|2|||
46702037|NCT01090323|82916915|FG000|Overall Study|Adverse Event|12|||
46702038|NCT01090323|82916916|FG001|Overall Study|Adverse Event|2|||
46702039|NCT01090323|82916915|FG000|Overall Study|Abnormal Lab Values|3|||
46702040|NCT01090323|82916916|FG001|Overall Study|Abnormal Lab Values|1|||
46702041|NCT01090323|82916915|FG000|Overall Study|Abnormal Test Procedure Results|2|||
46702042|NCT01090323|82916916|FG001|Overall Study|Abnormal Test Procedure Results|0|||
46702043|NCT01090323|82916915|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
46872539|NCT01068652|83091788|FG000|Overall Study|Patient was not eligible|1|||
46872540|NCT01068652|83091789|FG001|Overall Study|Patient was not eligible|0|||
46872541|NCT01068652|83091788|FG000|Overall Study|Unclassified|7|||
46872542|NCT01068652|83091789|FG001|Overall Study|Unclassified|4|||
46872543|NCT02921776|83091801|FG000|Overall Study|patient deterioration, fatigue|2|||
46872544|NCT02921776|83091802|FG001|Overall Study|patient deterioration, fatigue|6|||
46872545|NCT02921776|83091803|FG002|Overall Study|patient deterioration, fatigue|0|||
46872546|NCT02921776|83091804|FG003|Overall Study|patient deterioration, fatigue|0|||
46872547|NCT02921776|83091805|FG004|Overall Study|patient deterioration, fatigue|0|||
46872548|NCT02921776|83091806|FG005|Overall Study|patient deterioration, fatigue|0|||
46872549|NCT02921776|83091807|FG006|Overall Study|patient deterioration, fatigue|0|||
46872550|NCT02921776|83091808|FG007|Overall Study|patient deterioration, fatigue|0|||
46872551|NCT02921776|83091801|FG000|Overall Study|Withdrawal by Subject|0|||
46872552|NCT02921776|83091802|FG001|Overall Study|Withdrawal by Subject|2|||
46872553|NCT02921776|83091803|FG002|Overall Study|Withdrawal by Subject|0|||
46872554|NCT02921776|83091804|FG003|Overall Study|Withdrawal by Subject|1|||
46872555|NCT02921776|83091805|FG004|Overall Study|Withdrawal by Subject|1|||
46872556|NCT02921776|83091806|FG005|Overall Study|Withdrawal by Subject|0|||
46872557|NCT02921776|83091807|FG006|Overall Study|Withdrawal by Subject|8|||
46872558|NCT02921776|83091808|FG007|Overall Study|Withdrawal by Subject|1|||
46702044|NCT01090323|82916916|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46872559|NCT02921776|83091801|FG000|Overall Study|Death|0|||
46872560|NCT02921776|83091802|FG001|Overall Study|Death|0|||
46872561|NCT02921776|83091803|FG002|Overall Study|Death|0|||
46872562|NCT02921776|83091804|FG003|Overall Study|Death|2|||
46872563|NCT02921776|83091805|FG004|Overall Study|Death|0|||
46872564|NCT02921776|83091806|FG005|Overall Study|Death|0|||
46702045|NCT01090323|82916915|FG000|Overall Study|Condition no longer requires drug|5|||
46702046|NCT01090323|82916916|FG001|Overall Study|Condition no longer requires drug|4|||
46702047|NCT01090323|82916915|FG000|Overall Study|Protocol Violation|2|||
46872565|NCT02921776|83091807|FG006|Overall Study|Death|0|||
46872566|NCT02921776|83091808|FG007|Overall Study|Death|0|||
46872567|NCT02921776|83091801|FG000|Overall Study|extubation or early discharge|0|||
46872568|NCT02921776|83091802|FG001|Overall Study|extubation or early discharge|0|||
46872569|NCT02921776|83091803|FG002|Overall Study|extubation or early discharge|0|||
46872570|NCT02921776|83091804|FG003|Overall Study|extubation or early discharge|5|||
46872571|NCT02921776|83091805|FG004|Overall Study|extubation or early discharge|5|||
46872572|NCT02921776|83091806|FG005|Overall Study|extubation or early discharge|0|||
46872573|NCT02921776|83091807|FG006|Overall Study|extubation or early discharge|0|||
46872574|NCT02921776|83091808|FG007|Overall Study|extubation or early discharge|0|||
46872575|NCT02921776|83091801|FG000|Overall Study|Lost to Follow-up|0|||
46872576|NCT02921776|83091802|FG001|Overall Study|Lost to Follow-up|0|||
46872577|NCT02921776|83091803|FG002|Overall Study|Lost to Follow-up|0|||
46872578|NCT02921776|83091804|FG003|Overall Study|Lost to Follow-up|0|||
46872579|NCT02921776|83091805|FG004|Overall Study|Lost to Follow-up|0|||
46872580|NCT02921776|83091806|FG005|Overall Study|Lost to Follow-up|2|||
46872581|NCT02921776|83091807|FG006|Overall Study|Lost to Follow-up|3|||
46872582|NCT02921776|83091808|FG007|Overall Study|Lost to Follow-up|6|||
46872583|NCT02922634|83091832|FG000|Overall Study|Withdrawal by Subject|5|||
46872584|NCT02922634|83091832|FG000|Overall Study|Did not have their surgery|5|||
46872585|NCT00023595|83091848|FG000|5 Year Follow up|Lost to Follow-up|2|||
46872586|NCT00023595|83091849|FG001|5 Year Follow up|Lost to Follow-up|2|||
46872587|NCT00023595|83091850|FG002|5 Year Follow up|Lost to Follow-up|1|||
46872588|NCT00023595|83091851|FG003|5 Year Follow up|Lost to Follow-up|7|||
46872589|NCT00023595|83091852|FG004|5 Year Follow up|Lost to Follow-up|3|||
46872590|NCT00023595|83091848|FG000|10 Year Follow up|Lost to Follow-up|12|||
46872591|NCT00023595|83091849|FG001|10 Year Follow up|Lost to Follow-up|10|||
46872592|NCT00023595|83091850|FG002|10 Year Follow up|Lost to Follow-up|3|||
46872593|NCT00023595|83091851|FG003|10 Year Follow up|Lost to Follow-up|0|||
46872594|NCT00023595|83091852|FG004|10 Year Follow up|Lost to Follow-up|0|||
46872595|NCT05246397|83091890|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
46872596|NCT05172570|83091897|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
46872597|NCT05172570|83091898|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
46872598|NCT05172570|83091899|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
46872599|NCT05172570|83091897|FG000|Overall Study|PI Decision due to equipment shortages|0|||
46872600|NCT05172570|83091898|FG001|Overall Study|PI Decision due to equipment shortages|0|||
46872601|NCT05172570|83091899|FG002|Overall Study|PI Decision due to equipment shortages|1|||
46872602|NCT05107492|83091913|FG000|Overall Study|Lost to Follow-up|1|||
46872603|NCT05107492|83091914|FG001|Overall Study|Lost to Follow-up|0|||
46872604|NCT05024747|83091920|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
46872605|NCT05024747|83091921|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
46872606|NCT05024747|83091920|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
46872607|NCT05024747|83091921|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
46872608|NCT05024747|83091920|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
46872609|NCT05024747|83091921|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
46872610|NCT04853992|83091929|FG000|Treatment Period A|Adverse Event|0|||
46872611|NCT04853992|83091930|FG001|Treatment Period A|Adverse Event|1|||
46872612|NCT04853992|83091929|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
46872613|NCT04853992|83091930|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
46872614|NCT04661839|83091940|FG000|Overall Study|Not Treated|0|||
46872615|NCT04661839|83091941|FG001|Overall Study|Not Treated|0|||
46872616|NCT04661839|83091942|FG002|Overall Study|Not Treated|1|||
46872617|NCT04661839|83091943|FG003|Overall Study|Not Treated|0|||
46872618|NCT04661839|83091940|FG000|Overall Study|Lost to Follow-up|1|||
46872619|NCT04661839|83091941|FG001|Overall Study|Lost to Follow-up|0|||
46872620|NCT04661839|83091942|FG002|Overall Study|Lost to Follow-up|0|||
46872621|NCT04661839|83091943|FG003|Overall Study|Lost to Follow-up|1|||
46872622|NCT04470427|83091992|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
46872623|NCT04470427|83091993|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
46872624|NCT04470427|83091994|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
46872625|NCT04470427|83091995|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
46872626|NCT04470427|83091996|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
46872627|NCT04470427|83091997|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
46872628|NCT04470427|83091992|FG000|Part B :Open-label|Other than specified|0|||
46872629|NCT04470427|83091993|FG001|Part B :Open-label|Other than specified|0|||
46872630|NCT04470427|83091994|FG002|Part B :Open-label|Other than specified|788|||
46872631|NCT04470427|83091995|FG003|Part B :Open-label|Other than specified|0|||
46872632|NCT04470427|83091996|FG004|Part B :Open-label|Other than specified|523|||
46872633|NCT04470427|83091997|FG005|Part B :Open-label|Other than specified|0|||
46872634|NCT04470427|83091992|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
46984182|NCT02561195|83230269|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
46872635|NCT04470427|83091993|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
46872636|NCT04470427|83091994|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
46984183|NCT02561195|83230270|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
46872637|NCT04470427|83091995|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
46872638|NCT04470427|83091996|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
46872639|NCT04470427|83091997|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
46872640|NCT04470427|83091992|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
46872641|NCT04470427|83091993|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
46872642|NCT04470427|83091994|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
46872643|NCT04470427|83091995|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
46872644|NCT04470427|83091996|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
46872645|NCT04470427|83091997|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
46872646|NCT04433117|83092014|FG000|Overall Study|Withdrawal by Subject|1|||
46872647|NCT04433117|83092015|FG001|Overall Study|Withdrawal by Subject|0|||
46872656|NCT04313881|83092032|FG000|Overall Study|Death|138|||
46872657|NCT04313881|83092033|FG001|Overall Study|Death|126|||
46872658|NCT04313881|83092032|FG000|Overall Study|Study terminated by sponsor|108|||
46872659|NCT04313881|83092033|FG001|Overall Study|Study terminated by sponsor|129|||
46872660|NCT04313881|83092032|FG000|Overall Study|Consent withdrawn|19|||
46872661|NCT04313881|83092033|FG001|Overall Study|Consent withdrawn|15|||
46872662|NCT04313881|83092032|FG000|Overall Study|Reason not Specified|3|||
46872663|NCT04313881|83092033|FG001|Overall Study|Reason not Specified|1|||
46872664|NCT04115059|83092078|FG000|Overall Study|Withdrawal by Subject|1|||
46872665|NCT04115059|83092078|FG000|Overall Study|Lack of Efficacy|2|||
46872666|NCT03845140|83092088|FG000|Overall Study|Participant travelled outside study area|0|||
46872667|NCT03845140|83092089|FG001|Overall Study|Participant travelled outside study area|1|||
46872668|NCT03845140|83092090|FG002|Overall Study|Participant travelled outside study area|0|||
46872669|NCT03845140|83092091|FG003|Overall Study|Participant travelled outside study area|0|||
46872670|NCT03845140|83092092|FG004|Overall Study|Participant travelled outside study area|0|||
46872671|NCT03845140|83092093|FG005|Overall Study|Participant travelled outside study area|0|||
46872672|NCT03816176|83092154|FG000|Overall Study|Miscellaneous|5|||
46872673|NCT03816176|83092154|FG000|Overall Study|Lack of Efficacy|4|||
46872674|NCT03816176|83092154|FG000|Overall Study|Adverse Event|3|||
46872675|NCT03738228|83092160|FG000|Overall Study|Never received study treatment|2|||
46872676|NCT03738228|83092161|FG001|Overall Study|Never received study treatment|2|||
46872677|NCT03696953|83092169|FG000|Overall Study|Withdrawal by Subject|6|||
46872678|NCT03696953|83092170|FG001|Overall Study|Withdrawal by Subject|1|||
46872679|NCT03696953|83092169|FG000|Overall Study|missed GBS swabs|2|||
46872680|NCT03696953|83092170|FG001|Overall Study|missed GBS swabs|2|||
46872681|NCT03696953|83092169|FG000|Overall Study|lost study bottle containing capsules|2|||
46872682|NCT03696953|83092170|FG001|Overall Study|lost study bottle containing capsules|0|||
46872683|NCT03696953|83092169|FG000|Overall Study|Premature birth|1|||
46872684|NCT03696953|83092170|FG001|Overall Study|Premature birth|4|||
46872685|NCT03696953|83092169|FG000|Overall Study|Gestational hypertension|1|||
46872686|NCT03696953|83092170|FG001|Overall Study|Gestational hypertension|1|||
46872687|NCT03696953|83092169|FG000|Overall Study|Gestational diabetes|2|||
46872688|NCT03696953|83092170|FG001|Overall Study|Gestational diabetes|1|||
46872689|NCT03696953|83092169|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
46872690|NCT03696953|83092170|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
46872691|NCT03696953|83092169|FG000|Overall Study|Changed prenatal provider|1|||
46872692|NCT03696953|83092170|FG001|Overall Study|Changed prenatal provider|1|||
46872693|NCT03610724|83092176|FG000|Overall Study|Death|17|||
46872694|NCT03610724|83092176|FG000|Overall Study|Lost to Follow-up|1|||
46872695|NCT03610724|83092176|FG000|Overall Study|Physician Decision|1|||
46872696|NCT03610724|83092176|FG000|Overall Study|Died prior to infusion|1|||
46897054|NCT00706654|83122634|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
46897055|NCT00706654|83122631|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
46897056|NCT00706654|83122632|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
46897057|NCT00706654|83122633|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
46897058|NCT00706654|83122634|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
46897059|NCT00706654|83122631|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
46897060|NCT00706654|83122632|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
46897061|NCT00706654|83122633|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
46897062|NCT00706654|83122634|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
46897063|NCT00706654|83122631|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
46897064|NCT00706654|83122632|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
46897065|NCT00706654|83122633|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
46872697|NCT03319368|83092197|FG000|Overall Study|Discharge swabs not collected from resident|57|||
46872698|NCT03319368|83092198|FG001|Overall Study|Discharge swabs not collected from resident|46|||
46872699|NCT03149029|83092206|FG000|Overall Study|Adverse Event|2|||
46872700|NCT03149029|83092207|FG001|Overall Study|Adverse Event|0|||
46872701|NCT02656680|83092230|FG000|Overall Study|Lost to Follow-up|0|||
46872702|NCT02656680|83092231|FG001|Overall Study|Lost to Follow-up|1|||
46872703|NCT02656680|83092232|FG002|Overall Study|Lost to Follow-up|7|||
46872704|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Adverse Event|6|||
46872705|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Adverse Event|14|||
46872706|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Death|3|||
46872707|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Death|1|||
46872708|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
46872709|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
46872710|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
46872711|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
46872712|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
46872713|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
46872714|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
46872715|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
46872716|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
46872717|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
46872718|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Physician Decision|2|||
46872719|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Physician Decision|4|||
46872720|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Pregnancy|2|||
46872721|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Pregnancy|1|||
46872722|NCT02275780|83092272|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
46872723|NCT02275780|83092273|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
46872724|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
46872725|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
46872726|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
46872727|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
46872728|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
46872729|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
46872730|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
46872731|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
46872732|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
46872733|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
46872734|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
46872735|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
46872736|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
46872737|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
46872738|NCT02275780|83092272|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
46872739|NCT02275780|83092273|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
46872740|NCT02275780|83092272|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
46872741|NCT02275780|83092273|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
46872742|NCT02275780|83092272|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
46872743|NCT02275780|83092273|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
46872744|NCT02275780|83092272|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
46872745|NCT02275780|83092273|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
46872746|NCT02275780|83092272|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
46872747|NCT02275780|83092273|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
46872748|NCT02275780|83092272|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
46872749|NCT02275780|83092273|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
46872750|NCT02275780|83092272|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
46872751|NCT02275780|83092273|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
46872752|NCT02275780|83092272|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
46872753|NCT02275780|83092273|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
46872754|NCT02275780|83092272|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
46872755|NCT02275780|83092273|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
46872756|NCT02275780|83092272|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
46984184|NCT02561195|83230271|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
46984185|NCT02561195|83230272|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
46872757|NCT02275780|83092273|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
46872758|NCT02275780|83092272|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
46872759|NCT02275780|83092273|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
46872760|NCT02275780|83092272|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
46984186|NCT02561195|83230273|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
46872761|NCT02275780|83092273|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
46872762|NCT02275780|83092272|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
46872763|NCT02275780|83092273|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
46872764|NCT02275780|83092272|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
46872765|NCT02275780|83092273|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
46872766|NCT01751776|83092288|FG000|Overall Study|Adverse Event|0|||
46872767|NCT01751776|83092289|FG001|Overall Study|Adverse Event|0|||
46872768|NCT01751776|83092290|FG002|Overall Study|Adverse Event|0|||
46872769|NCT01751776|83092291|FG003|Overall Study|Adverse Event|0|||
46872770|NCT01751776|83092292|FG004|Overall Study|Adverse Event|0|||
46872771|NCT01751776|83092293|FG005|Overall Study|Adverse Event|0|||
46872772|NCT01751776|83092294|FG006|Overall Study|Adverse Event|4|||
46872773|NCT01751776|83092295|FG007|Overall Study|Adverse Event|2|||
46872774|NCT01751776|83092288|FG000|Overall Study|Consent withdrawn|0|||
46872775|NCT01751776|83092289|FG001|Overall Study|Consent withdrawn|0|||
46872776|NCT01751776|83092290|FG002|Overall Study|Consent withdrawn|0|||
46872777|NCT01751776|83092291|FG003|Overall Study|Consent withdrawn|0|||
46872778|NCT01751776|83092292|FG004|Overall Study|Consent withdrawn|0|||
46872779|NCT01751776|83092293|FG005|Overall Study|Consent withdrawn|0|||
46872780|NCT01751776|83092294|FG006|Overall Study|Consent withdrawn|0|||
46872781|NCT01751776|83092295|FG007|Overall Study|Consent withdrawn|1|||
46872782|NCT01751776|83092288|FG000|Overall Study|Other reason not specified above|0|||
46872783|NCT01751776|83092289|FG001|Overall Study|Other reason not specified above|0|||
46872784|NCT01751776|83092290|FG002|Overall Study|Other reason not specified above|0|||
46872785|NCT01751776|83092291|FG003|Overall Study|Other reason not specified above|0|||
46872786|NCT01751776|83092292|FG004|Overall Study|Other reason not specified above|0|||
46872787|NCT01751776|83092293|FG005|Overall Study|Other reason not specified above|0|||
46872788|NCT01751776|83092294|FG006|Overall Study|Other reason not specified above|0|||
46872789|NCT01751776|83092295|FG007|Overall Study|Other reason not specified above|1|||
46872790|NCT01441583|83092338|FG000|Overall Study|Withdrawal by Subject|1|||
46872791|NCT01441583|83092339|FG001|Overall Study|Withdrawal by Subject|1|||
46872792|NCT01441583|83092340|FG002|Overall Study|Withdrawal by Subject|1|||
46872793|NCT01441583|83092338|FG000|Overall Study|Death|1|||
46872794|NCT01441583|83092339|FG001|Overall Study|Death|0|||
46872795|NCT01441583|83092340|FG002|Overall Study|Death|4|||
46872796|NCT01441583|83092338|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
46872797|NCT01441583|83092339|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
46872798|NCT01441583|83092340|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
46872799|NCT00753545|83092350|FG000|Overall Study|Death|98|||
46872800|NCT00753545|83092351|FG001|Overall Study|Death|112|||
46872801|NCT00753545|83092350|FG000|Overall Study|Lost to Follow-up|2|||
46872802|NCT00753545|83092351|FG001|Overall Study|Lost to Follow-up|3|||
46872803|NCT00753545|83092350|FG000|Overall Study|Protocol Violation|1|||
46872804|NCT00753545|83092351|FG001|Overall Study|Protocol Violation|0|||
46872805|NCT00753545|83092350|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
46872806|NCT00753545|83092351|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
46872807|NCT00605085|83092368|FG000|Overall Study|Withdrawal by Subject|8|||
46872808|NCT00605085|83092369|FG001|Overall Study|Withdrawal by Subject|5|||
46872809|NCT00605085|83092368|FG000|Overall Study|Adverse Event|9|||
46872810|NCT00605085|83092369|FG001|Overall Study|Adverse Event|5|||
46872811|NCT00605085|83092368|FG000|Overall Study|Pregnancy|2|||
46872812|NCT00605085|83092369|FG001|Overall Study|Pregnancy|0|||
46872813|NCT00605085|83092368|FG000|Overall Study|Protocol Violation|3|||
46872814|NCT00605085|83092369|FG001|Overall Study|Protocol Violation|2|||
46872815|NCT00605085|83092368|FG000|Overall Study|Lost to Follow-up|10|||
46872816|NCT00605085|83092369|FG001|Overall Study|Lost to Follow-up|5|||
46872817|NCT00605085|83092368|FG000|Overall Study|administrative reasons|18|||
46872818|NCT00605085|83092369|FG001|Overall Study|administrative reasons|8|||
46702048|NCT01090323|82916916|FG001|Overall Study|Protocol Violation|1|||
46702049|NCT01090323|82916915|FG000|Overall Study|Withdrew consent|33|||
46872819|NCT00604708|83092377|FG000|Overall Study|Withdrawal by Subject|9|||
46872820|NCT00604708|83092378|FG001|Overall Study|Withdrawal by Subject|10|||
46872821|NCT00604708|83092377|FG000|Overall Study|Protocol Violation|2|||
46872822|NCT00604708|83092378|FG001|Overall Study|Protocol Violation|8|||
46872823|NCT00604708|83092377|FG000|Overall Study|Lost to Follow-up|5|||
46872824|NCT00604708|83092378|FG001|Overall Study|Lost to Follow-up|5|||
46872825|NCT00604708|83092377|FG000|Overall Study|administrative reasons|9|||
46872826|NCT00604708|83092378|FG001|Overall Study|administrative reasons|11|||
46872827|NCT00604708|83092377|FG000|Overall Study|Adverse Event|6|||
46872828|NCT00604708|83092378|FG001|Overall Study|Adverse Event|6|||
46872829|NCT00594958|83092387|FG000|Overall Study|Withdrawal by Subject|1|||
46872830|NCT00594958|83092388|FG001|Overall Study|Withdrawal by Subject|0|||
46872831|NCT00594958|83092389|FG002|Overall Study|Withdrawal by Subject|1|||
46872832|NCT00594958|83092387|FG000|Overall Study|Adverse Event|4|||
46984187|NCT02561195|83230260|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46872833|NCT00594958|83092388|FG001|Overall Study|Adverse Event|1|||
46802637|NCT03859323|83021933|FG002|Overall Study|Pregnancy|0|||
46802638|NCT03859323|83021934|FG003|Overall Study|Pregnancy|0|||
46802639|NCT03859323|83021935|FG004|Overall Study|Pregnancy|0|||
46802640|NCT03859323|83021936|FG005|Overall Study|Pregnancy|0|||
46802641|NCT03859323|83021937|FG006|Overall Study|Pregnancy|0|||
46802642|NCT03859323|83021938|FG007|Overall Study|Pregnancy|0|||
46802643|NCT03859323|83021939|FG008|Overall Study|Pregnancy|0|||
46802644|NCT03859323|83021940|FG009|Overall Study|Pregnancy|1|||
46802645|NCT03859323|83021941|FG010|Overall Study|Pregnancy|0|||
46802646|NCT03859323|83021942|FG011|Overall Study|Pregnancy|0|||
46802647|NCT03859323|83021943|FG012|Overall Study|Pregnancy|0|||
46802648|NCT03857841|83021986|FG000|Overall Study|Death|1|||
46802649|NCT03857841|83021987|FG001|Overall Study|Death|0|||
46802650|NCT03857841|83021988|FG002|Overall Study|Death|0|||
46802651|NCT03857841|83021989|FG003|Overall Study|Death|0|||
46802652|NCT03857841|83021986|FG000|Overall Study|Study Terminated by Sponsor|1|||
46802653|NCT03857841|83021987|FG001|Overall Study|Study Terminated by Sponsor|0|||
46802654|NCT03857841|83021988|FG002|Overall Study|Study Terminated by Sponsor|0|||
46802655|NCT03857841|83021989|FG003|Overall Study|Study Terminated by Sponsor|0|||
46802656|NCT00500331|83022006|FG000|Overall Study|Adverse Event|0|||
46802657|NCT00500331|83022007|FG001|Overall Study|Adverse Event|2|||
46802658|NCT00500331|83022008|FG002|Overall Study|Adverse Event|0|||
46802659|NCT00500331|83022009|FG003|Overall Study|Adverse Event|1|||
46802660|NCT00500331|83022010|FG004|Overall Study|Adverse Event|2|||
46802661|NCT00500331|83022011|FG005|Overall Study|Adverse Event|2|||
46802662|NCT00500331|83022012|FG006|Overall Study|Adverse Event|0|||
46802663|NCT00500331|83022006|FG000|Overall Study|Lost to Follow-up|1|||
46802664|NCT00500331|83022007|FG001|Overall Study|Lost to Follow-up|1|||
46802665|NCT00500331|83022008|FG002|Overall Study|Lost to Follow-up|1|||
46802666|NCT00500331|83022009|FG003|Overall Study|Lost to Follow-up|2|||
46802667|NCT00500331|83022010|FG004|Overall Study|Lost to Follow-up|1|||
46802668|NCT00500331|83022011|FG005|Overall Study|Lost to Follow-up|0|||
46802669|NCT00500331|83022012|FG006|Overall Study|Lost to Follow-up|0|||
46802670|NCT00500331|83022006|FG000|Overall Study|Protocol Violation|3|||
46802671|NCT00500331|83022007|FG001|Overall Study|Protocol Violation|1|||
46802672|NCT00500331|83022008|FG002|Overall Study|Protocol Violation|1|||
46802673|NCT00500331|83022009|FG003|Overall Study|Protocol Violation|0|||
46802674|NCT00500331|83022010|FG004|Overall Study|Protocol Violation|1|||
46802675|NCT00500331|83022011|FG005|Overall Study|Protocol Violation|1|||
46802676|NCT00500331|83022012|FG006|Overall Study|Protocol Violation|1|||
46802677|NCT00500331|83022006|FG000|Overall Study|Withdrawal by Subject|4|||
46802678|NCT00500331|83022007|FG001|Overall Study|Withdrawal by Subject|0|||
46802679|NCT00500331|83022008|FG002|Overall Study|Withdrawal by Subject|1|||
46802680|NCT00500331|83022009|FG003|Overall Study|Withdrawal by Subject|5|||
46802681|NCT00500331|83022010|FG004|Overall Study|Withdrawal by Subject|0|||
46802682|NCT00500331|83022011|FG005|Overall Study|Withdrawal by Subject|1|||
46802683|NCT00500331|83022012|FG006|Overall Study|Withdrawal by Subject|1|||
46802684|NCT00500331|83022006|FG000|Overall Study|Lack of Efficacy|3|||
46802685|NCT00500331|83022007|FG001|Overall Study|Lack of Efficacy|1|||
46802686|NCT00500331|83022008|FG002|Overall Study|Lack of Efficacy|0|||
46802687|NCT00500331|83022009|FG003|Overall Study|Lack of Efficacy|0|||
46802688|NCT00500331|83022010|FG004|Overall Study|Lack of Efficacy|0|||
46802689|NCT00500331|83022011|FG005|Overall Study|Lack of Efficacy|0|||
46802690|NCT00500331|83022012|FG006|Overall Study|Lack of Efficacy|0|||
46802691|NCT00500331|83022006|FG000|Overall Study|Liver function test abnormality|0|||
46802692|NCT00500331|83022007|FG001|Overall Study|Liver function test abnormality|0|||
46802693|NCT00500331|83022008|FG002|Overall Study|Liver function test abnormality|1|||
46802694|NCT00500331|83022009|FG003|Overall Study|Liver function test abnormality|0|||
46802695|NCT00500331|83022010|FG004|Overall Study|Liver function test abnormality|0|||
46802696|NCT00500331|83022011|FG005|Overall Study|Liver function test abnormality|0|||
46802697|NCT00500331|83022012|FG006|Overall Study|Liver function test abnormality|0|||
46802698|NCT00500331|83022006|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
46802699|NCT00500331|83022007|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
46802700|NCT00500331|83022008|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
46802701|NCT00500331|83022009|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
46802702|NCT00500331|83022010|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
46802703|NCT00500331|83022011|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
46802704|NCT00500331|83022012|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
46802705|NCT00500331|83022006|FG000|Overall Study|Didn't return for continuation of study|1|||
46802706|NCT00500331|83022007|FG001|Overall Study|Didn't return for continuation of study|0|||
46802707|NCT00500331|83022008|FG002|Overall Study|Didn't return for continuation of study|0|||
46802708|NCT00500331|83022009|FG003|Overall Study|Didn't return for continuation of study|0|||
46802709|NCT00500331|83022010|FG004|Overall Study|Didn't return for continuation of study|0|||
46802710|NCT00500331|83022011|FG005|Overall Study|Didn't return for continuation of study|0|||
46802711|NCT00500331|83022012|FG006|Overall Study|Didn't return for continuation of study|0|||
46802712|NCT00500331|83022006|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
46872834|NCT00594958|83092389|FG002|Overall Study|Adverse Event|2|||
46872835|NCT00594958|83092387|FG000|Overall Study|Pregnancy|0|||
46872836|NCT00594958|83092388|FG001|Overall Study|Pregnancy|2|||
46872837|NCT00594958|83092389|FG002|Overall Study|Pregnancy|0|||
46872838|NCT00594958|83092387|FG000|Overall Study|Protocol Violation|1|||
46872839|NCT00594958|83092388|FG001|Overall Study|Protocol Violation|0|||
46872840|NCT00594958|83092389|FG002|Overall Study|Protocol Violation|2|||
46872841|NCT00594958|83092387|FG000|Overall Study|Lost to Follow-up|5|||
46872842|NCT00594958|83092388|FG001|Overall Study|Lost to Follow-up|0|||
46872843|NCT00594958|83092389|FG002|Overall Study|Lost to Follow-up|3|||
46872844|NCT00594958|83092387|FG000|Overall Study|administrative|3|||
46872845|NCT00594958|83092388|FG001|Overall Study|administrative|0|||
46872846|NCT00594958|83092389|FG002|Overall Study|administrative|2|||
46872847|NCT02920528|83092400|FG000|Overall Study|Incomplete Data|1|||
46872848|NCT02920528|83092401|FG001|Overall Study|Incomplete Data|1|||
46872849|NCT02920528|83092402|FG002|Overall Study|Incomplete Data|1|||
46872850|NCT02920528|83092400|FG000|Overall Study|Adverse Event|0|||
46872851|NCT02920528|83092401|FG001|Overall Study|Adverse Event|0|||
46872852|NCT02920528|83092402|FG002|Overall Study|Adverse Event|3|||
46872853|NCT02920528|83092400|FG000|Overall Study|Did not meet inclusion criteria|2|||
46872854|NCT02920528|83092401|FG001|Overall Study|Did not meet inclusion criteria|0|||
46872855|NCT02920528|83092402|FG002|Overall Study|Did not meet inclusion criteria|1|||
46872856|NCT01068418|83092410|FG000|Overall Study|Physician Decision|12|||
46872857|NCT01068262|83092418|FG000|Overall Study|Adverse Event|2|||
46872858|NCT01068262|83092419|FG001|Overall Study|Adverse Event|0|||
46872859|NCT01068262|83092420|FG002|Overall Study|Adverse Event|1|||
46872860|NCT01068262|83092421|FG003|Overall Study|Adverse Event|0|||
46872861|NCT01068262|83092418|FG000|Overall Study|Protocol Violation|1|||
46872862|NCT01068262|83092419|FG001|Overall Study|Protocol Violation|0|||
46872863|NCT01068262|83092420|FG002|Overall Study|Protocol Violation|0|||
46872864|NCT01068262|83092421|FG003|Overall Study|Protocol Violation|0|||
46872865|NCT01068262|83092418|FG000|Overall Study|Withdrawal by Subject|0|||
46872866|NCT01068262|83092419|FG001|Overall Study|Withdrawal by Subject|1|||
46872867|NCT01068262|83092420|FG002|Overall Study|Withdrawal by Subject|0|||
46872868|NCT01068262|83092421|FG003|Overall Study|Withdrawal by Subject|0|||
46872869|NCT02920450|83092434|FG000|Overall Study|Death|1|||
46872870|NCT02920450|83092435|FG001|Overall Study|Death|0|||
46872871|NCT02920450|83092436|FG002|Overall Study|Death|0|||
46872872|NCT02920450|83092437|FG003|Overall Study|Death|0|||
46872873|NCT02920450|83092434|FG000|Overall Study|Withdrawal by Subject|1|||
46872874|NCT02920450|83092435|FG001|Overall Study|Withdrawal by Subject|0|||
46872875|NCT02920450|83092436|FG002|Overall Study|Withdrawal by Subject|0|||
46872876|NCT02920450|83092437|FG003|Overall Study|Withdrawal by Subject|0|||
46872877|NCT01066936|83092448|FG000|Overall Study|Death|2|||
46872878|NCT01066936|83092448|FG000|Overall Study|Device revised/removed|1|||
46872879|NCT01066936|83092448|FG000|Overall Study|Lost to Follow-up|3|||
46872880|NCT01066936|83092448|FG000|Overall Study|Withdrawal by Subject|4|||
46872881|NCT02919436|83092456|FG000|Overall Study|Did not undergo surgery|16|||
46872882|NCT02919436|83092457|FG001|Overall Study|Did not undergo surgery|20|||
46872883|NCT02919436|83092456|FG000|Overall Study|Enrolled before trial registration|44|||
46872884|NCT02919436|83092457|FG001|Overall Study|Enrolled before trial registration|33|||
46872885|NCT03804879|83092467|FG000|Overall Study|Adverse Event|3|||
46872886|NCT03804879|83092468|FG001|Overall Study|Adverse Event|0|||
46872887|NCT03804879|83092467|FG000|Overall Study|Study Terminated By Sponsor|10|||
46872888|NCT03804879|83092468|FG001|Overall Study|Study Terminated By Sponsor|12|||
46872889|NCT03804879|83092467|FG000|Overall Study|Withdrawal by Subject|3|||
46872890|NCT03804879|83092468|FG001|Overall Study|Withdrawal by Subject|1|||
46872891|NCT03803475|83092475|FG000|Overall Study|Physician Decision|1|||
46872892|NCT00005937|83092479|FG000|Overall Study|Lack of Efficacy|5|||
46872893|NCT03443024|83092487|FG000|Overall Study|Adverse Event|2|||
46872894|NCT03443024|83092488|FG001|Overall Study|Adverse Event|4|||
46872895|NCT03443024|83092489|FG002|Overall Study|Adverse Event|3|||
46872896|NCT03443024|83092490|FG003|Overall Study|Adverse Event|1|||
46872897|NCT03443024|83092487|FG000|Overall Study|Lost to Follow-up|9|||
46872898|NCT03443024|83092488|FG001|Overall Study|Lost to Follow-up|9|||
46872899|NCT03443024|83092489|FG002|Overall Study|Lost to Follow-up|7|||
46872900|NCT03443024|83092490|FG003|Overall Study|Lost to Follow-up|5|||
46872901|NCT03443024|83092487|FG000|Overall Study|Withdrawal by Subject|8|||
46872902|NCT03443024|83092488|FG001|Overall Study|Withdrawal by Subject|15|||
46872903|NCT03443024|83092489|FG002|Overall Study|Withdrawal by Subject|9|||
46872904|NCT03443024|83092490|FG003|Overall Study|Withdrawal by Subject|23|||
46872905|NCT03443024|83092487|FG000|Overall Study|Physician Decision|1|||
46872906|NCT03443024|83092488|FG001|Overall Study|Physician Decision|2|||
46872907|NCT03443024|83092489|FG002|Overall Study|Physician Decision|0|||
46872908|NCT03443024|83092490|FG003|Overall Study|Physician Decision|1|||
46872909|NCT03443024|83092487|FG000|Overall Study|Sponsor Decision|1|||
46872910|NCT03443024|83092488|FG001|Overall Study|Sponsor Decision|1|||
46984188|NCT02561195|83230261|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46872911|NCT03443024|83092489|FG002|Overall Study|Sponsor Decision|0|||
46872912|NCT03443024|83092490|FG003|Overall Study|Sponsor Decision|0|||
46872913|NCT03443024|83092487|FG000|Overall Study|Protocol Deviation|0|||
46872914|NCT03443024|83092488|FG001|Overall Study|Protocol Deviation|0|||
46872915|NCT03443024|83092489|FG002|Overall Study|Protocol Deviation|0|||
46872916|NCT03443024|83092490|FG003|Overall Study|Protocol Deviation|2|||
46872917|NCT02908516|83092502|FG000|Overall Study|Study Terminated|3|||
46872918|NCT02908516|83092503|FG001|Overall Study|Study Terminated|3|||
46872919|NCT02907892|83092511|FG000|Overall Study|Lost to Follow-up|27|||
46872920|NCT02907892|83092512|FG001|Overall Study|Lost to Follow-up|40|||
46872921|NCT02906644|83092520|FG000|First 2 Weeks|Withdrawal by Subject|0|||
46872922|NCT02906644|83092521|FG001|First 2 Weeks|Withdrawal by Subject|2|||
46872923|NCT02906644|83092520|FG000|First 2 Weeks|Physician Decision|1|||
46872924|NCT02906644|83092521|FG001|First 2 Weeks|Physician Decision|1|||
46872925|NCT02906644|83092520|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
46872926|NCT02906644|83092521|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
46872927|NCT02906644|83092520|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
46872928|NCT02906644|83092521|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
46872929|NCT03410108|83092528|FG000|Overall Study|Ongoing|41|||
46872930|NCT03410108|83092528|FG000|Overall Study|Adverse Event|4|||
46872931|NCT03410108|83092528|FG000|Overall Study|Progressive Disease|58|||
46872932|NCT03410108|83092528|FG000|Overall Study|Withdrawal by Subject|1|||
46872933|NCT02982772|83092537|FG000|Intervention|Lost to Follow-up|19|||
46872934|NCT02982772|83092538|FG001|Intervention|Lost to Follow-up|13|||
46872935|NCT02982772|83092537|FG000|1M Follow-Up|Lost to Follow-up|21|||
46872936|NCT02982772|83092538|FG001|1M Follow-Up|Lost to Follow-up|18|||
46872937|NCT02982772|83092537|FG000|3M Follow-Up|Lost to Follow-up|17|||
46872938|NCT02982772|83092538|FG001|3M Follow-Up|Lost to Follow-up|11|||
46872939|NCT02982772|83092537|FG000|6M Follow-Up|Lost to Follow-up|11|||
46872940|NCT02982772|83092538|FG001|6M Follow-Up|Lost to Follow-up|9|||
46872941|NCT02982772|83092537|FG000|12M Follow-Up|Lost to Follow-up|11|||
46872942|NCT02982772|83092538|FG001|12M Follow-Up|Lost to Follow-up|5|||
46872943|NCT03488108|83092548|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
46872944|NCT03488108|83092549|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
46984189|NCT02561195|83230262|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46984190|NCT02561195|83230263|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46984191|NCT02561195|83230264|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46984192|NCT02561195|83230265|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46984193|NCT02561195|83230266|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46984194|NCT02561195|83230267|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46984195|NCT02561195|83230268|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
46984196|NCT02561195|83230269|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
46984197|NCT02561195|83230270|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
46984198|NCT02561195|83230271|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
46984199|NCT02561195|83230272|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
46984200|NCT02561195|83230273|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
46984201|NCT02561195|83230260|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984202|NCT02561195|83230261|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984203|NCT02561195|83230262|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984204|NCT02561195|83230263|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984205|NCT02561195|83230264|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984206|NCT02561195|83230265|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984207|NCT02561195|83230266|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984208|NCT02561195|83230267|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984209|NCT02561195|83230268|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984210|NCT02561195|83230269|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984211|NCT02561195|83230270|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984212|NCT02561195|83230271|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984213|NCT02561195|83230272|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
46984214|NCT02561195|83230273|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
46984215|NCT02561195|83230260|FG000|Extension Stage (Vaccination 4)|Death|0|||
46984216|NCT02561195|83230261|FG001|Extension Stage (Vaccination 4)|Death|0|||
46984217|NCT02561195|83230262|FG002|Extension Stage (Vaccination 4)|Death|0|||
46984218|NCT02561195|83230263|FG003|Extension Stage (Vaccination 4)|Death|0|||
46802713|NCT00500331|83022007|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
46802714|NCT00500331|83022008|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
46802715|NCT00500331|83022009|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
46802716|NCT00500331|83022010|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
46802717|NCT00500331|83022011|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
46802718|NCT00500331|83022012|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
46802719|NCT00500331|83022006|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
46872945|NCT03488108|83092548|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
46872946|NCT03488108|83092549|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
46872947|NCT03440918|83092559|FG000|Overall Study|Protocol Violation|0|||
46872948|NCT03440918|83092560|FG001|Overall Study|Protocol Violation|16|||
46872949|NCT03486392|83092571|FG000|Overall Study|Lost to Follow-up|0|||
46872950|NCT03486392|83092572|FG001|Overall Study|Lost to Follow-up|0|||
46872951|NCT03486392|83092573|FG002|Overall Study|Lost to Follow-up|8|||
46872952|NCT03486392|83092574|FG003|Overall Study|Lost to Follow-up|5|||
46872953|NCT03486392|83092575|FG004|Overall Study|Lost to Follow-up|2|||
46872954|NCT03486392|83092571|FG000|Overall Study|Withdrawal by Subject|3|||
46872955|NCT03486392|83092572|FG001|Overall Study|Withdrawal by Subject|0|||
46872956|NCT03486392|83092573|FG002|Overall Study|Withdrawal by Subject|6|||
46872957|NCT03486392|83092574|FG003|Overall Study|Withdrawal by Subject|4|||
46872958|NCT03486392|83092575|FG004|Overall Study|Withdrawal by Subject|1|||
46872959|NCT03486392|83092571|FG000|Overall Study|Death|0|||
46872960|NCT03486392|83092572|FG001|Overall Study|Death|0|||
46872961|NCT03486392|83092573|FG002|Overall Study|Death|0|||
46872962|NCT03486392|83092574|FG003|Overall Study|Death|0|||
46872963|NCT03486392|83092575|FG004|Overall Study|Death|1|||
46872964|NCT02981602|83092592|FG000|Overall Study|Adverse Event|0|||
46872965|NCT02981602|83092593|FG001|Overall Study|Adverse Event|0|||
46872966|NCT02981602|83092594|FG002|Overall Study|Adverse Event|0|||
46872967|NCT02981602|83092595|FG003|Overall Study|Adverse Event|1|||
46872968|NCT02981602|83092596|FG004|Overall Study|Adverse Event|0|||
46872969|NCT02981524|83092609|FG000|Overall Study|Progressive Disease|14|||
46872970|NCT02981524|83092609|FG000|Overall Study|Death (unrelated)|1|||
46872971|NCT02981524|83092609|FG000|Overall Study|Treatment Related Toxicity|1|||
46872972|NCT02981524|83092609|FG000|Overall Study|Withdrawal by Subject|1|||
46872973|NCT03486314|83092613|FG000|Part A|Adverse Event|1|||
46872974|NCT03486314|83092614|FG001|Part A|Adverse Event|0|||
46872975|NCT03486314|83092615|FG002|Part A|Adverse Event|0|||
46872976|NCT03486314|83092613|FG000|Part A|Symptomatic Deterioration|2|||
46872977|NCT03486314|83092614|FG001|Part A|Symptomatic Deterioration|0|||
46872978|NCT03486314|83092615|FG002|Part A|Symptomatic Deterioration|0|||
46872979|NCT02905006|83092629|FG000|Overall Study|Adverse Event|1|||
46872980|NCT02905006|83092630|FG001|Overall Study|Adverse Event|1|||
46872981|NCT02905006|83092631|FG002|Overall Study|Adverse Event|1|||
46872982|NCT02905006|83092632|FG003|Overall Study|Adverse Event|1|||
46872983|NCT02905006|83092633|FG004|Overall Study|Adverse Event|0|||
46872984|NCT02905006|83092634|FG005|Overall Study|Adverse Event|1|||
46872985|NCT02905006|83092629|FG000|Overall Study|Lack of Efficacy|1|||
46872986|NCT02905006|83092630|FG001|Overall Study|Lack of Efficacy|0|||
46872987|NCT02905006|83092631|FG002|Overall Study|Lack of Efficacy|0|||
46872988|NCT02905006|83092632|FG003|Overall Study|Lack of Efficacy|0|||
46872989|NCT02905006|83092633|FG004|Overall Study|Lack of Efficacy|0|||
46872990|NCT02905006|83092634|FG005|Overall Study|Lack of Efficacy|0|||
46872991|NCT02905006|83092629|FG000|Overall Study|Protocol Violation|2|||
46872992|NCT02905006|83092630|FG001|Overall Study|Protocol Violation|0|||
46872993|NCT02905006|83092631|FG002|Overall Study|Protocol Violation|0|||
46872994|NCT02905006|83092632|FG003|Overall Study|Protocol Violation|0|||
46872995|NCT02905006|83092633|FG004|Overall Study|Protocol Violation|0|||
46872996|NCT02905006|83092634|FG005|Overall Study|Protocol Violation|0|||
46872997|NCT02905006|83092629|FG000|Overall Study|Lost to Follow-up|0|||
46872998|NCT02905006|83092630|FG001|Overall Study|Lost to Follow-up|0|||
46872999|NCT02905006|83092631|FG002|Overall Study|Lost to Follow-up|0|||
46873000|NCT02905006|83092632|FG003|Overall Study|Lost to Follow-up|1|||
46873001|NCT02905006|83092633|FG004|Overall Study|Lost to Follow-up|1|||
46873002|NCT02905006|83092634|FG005|Overall Study|Lost to Follow-up|0|||
46873003|NCT02905006|83092629|FG000|Overall Study|Withdrawal by Subject|0|||
46873004|NCT02905006|83092630|FG001|Overall Study|Withdrawal by Subject|0|||
46873005|NCT02905006|83092631|FG002|Overall Study|Withdrawal by Subject|1|||
46873006|NCT02905006|83092632|FG003|Overall Study|Withdrawal by Subject|1|||
46873007|NCT02905006|83092633|FG004|Overall Study|Withdrawal by Subject|0|||
46873008|NCT02905006|83092634|FG005|Overall Study|Withdrawal by Subject|1|||
46873009|NCT02905006|83092629|FG000|Overall Study|Screening exclusion criteria met|1|||
46873010|NCT02905006|83092630|FG001|Overall Study|Screening exclusion criteria met|0|||
46873011|NCT02905006|83092631|FG002|Overall Study|Screening exclusion criteria met|0|||
46873012|NCT02905006|83092632|FG003|Overall Study|Screening exclusion criteria met|0|||
46873013|NCT02905006|83092633|FG004|Overall Study|Screening exclusion criteria met|0|||
46873014|NCT02905006|83092634|FG005|Overall Study|Screening exclusion criteria met|0|||
46873015|NCT02905006|83092629|FG000|Overall Study|Lab withdrawal criterion met|0|||
46873016|NCT02905006|83092630|FG001|Overall Study|Lab withdrawal criterion met|1|||
46873017|NCT02905006|83092631|FG002|Overall Study|Lab withdrawal criterion met|2|||
46873018|NCT02905006|83092632|FG003|Overall Study|Lab withdrawal criterion met|2|||
46873019|NCT02905006|83092633|FG004|Overall Study|Lab withdrawal criterion met|2|||
46873020|NCT02905006|83092634|FG005|Overall Study|Lab withdrawal criterion met|1|||
46873021|NCT02905006|83092629|FG000|Overall Study|Positive for Tuberculosis|0|||
46873022|NCT02905006|83092630|FG001|Overall Study|Positive for Tuberculosis|1|||
46873023|NCT02905006|83092631|FG002|Overall Study|Positive for Tuberculosis|0|||
46702050|NCT01090323|82916916|FG001|Overall Study|Withdrew consent|11|||
46802720|NCT00500331|83022007|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
46802721|NCT00500331|83022008|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
46802722|NCT00500331|83022009|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
46802723|NCT00500331|83022010|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
46802724|NCT00500331|83022011|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
46802725|NCT00500331|83022012|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
46802726|NCT00500331|83022006|FG000|Overall Study|Participant was randomized by mistake|1|||
46802727|NCT00500331|83022007|FG001|Overall Study|Participant was randomized by mistake|0|||
46802728|NCT00500331|83022008|FG002|Overall Study|Participant was randomized by mistake|0|||
46802729|NCT00500331|83022009|FG003|Overall Study|Participant was randomized by mistake|0|||
46802730|NCT00500331|83022010|FG004|Overall Study|Participant was randomized by mistake|0|||
46802731|NCT00500331|83022011|FG005|Overall Study|Participant was randomized by mistake|0|||
46802732|NCT00500331|83022012|FG006|Overall Study|Participant was randomized by mistake|0|||
46802733|NCT00500331|83022006|FG000|Overall Study|Diabetologist nurse in the study|0|||
46802734|NCT00500331|83022007|FG001|Overall Study|Diabetologist nurse in the study|0|||
46802735|NCT00500331|83022008|FG002|Overall Study|Diabetologist nurse in the study|1|||
46802736|NCT00500331|83022009|FG003|Overall Study|Diabetologist nurse in the study|0|||
46802737|NCT00500331|83022010|FG004|Overall Study|Diabetologist nurse in the study|0|||
46802738|NCT00500331|83022011|FG005|Overall Study|Diabetologist nurse in the study|0|||
46802739|NCT00500331|83022012|FG006|Overall Study|Diabetologist nurse in the study|0|||
46802740|NCT00500331|83022006|FG000|Overall Study|State ban of biological samples export|0|||
46802741|NCT00500331|83022007|FG001|Overall Study|State ban of biological samples export|0|||
46802742|NCT00500331|83022008|FG002|Overall Study|State ban of biological samples export|0|||
46802743|NCT00500331|83022009|FG003|Overall Study|State ban of biological samples export|1|||
46802744|NCT00500331|83022010|FG004|Overall Study|State ban of biological samples export|0|||
46802745|NCT00500331|83022011|FG005|Overall Study|State ban of biological samples export|0|||
46802746|NCT00500331|83022012|FG006|Overall Study|State ban of biological samples export|0|||
46802747|NCT00500331|83022006|FG000|Overall Study|Protocol violated|0|||
46802748|NCT00500331|83022007|FG001|Overall Study|Protocol violated|0|||
46802749|NCT00500331|83022008|FG002|Overall Study|Protocol violated|0|||
46802750|NCT00500331|83022009|FG003|Overall Study|Protocol violated|1|||
46802751|NCT00500331|83022010|FG004|Overall Study|Protocol violated|0|||
46802752|NCT00500331|83022011|FG005|Overall Study|Protocol violated|0|||
46802753|NCT00500331|83022012|FG006|Overall Study|Protocol violated|0|||
46802754|NCT00499863|83022031|FG000|Overall Study|Lack of Efficacy|21|||
46802755|NCT00499863|83022032|FG001|Overall Study|Lack of Efficacy|27|||
46802756|NCT00499863|83022031|FG000|Overall Study|Protocol Violation|12|||
46802757|NCT00499863|83022032|FG001|Overall Study|Protocol Violation|7|||
46802758|NCT00499863|83022031|FG000|Overall Study|Withdrawal by Subject|6|||
46802759|NCT00499863|83022032|FG001|Overall Study|Withdrawal by Subject|4|||
46802760|NCT00499863|83022031|FG000|Overall Study|Adverse Event|8|||
46802761|NCT00499863|83022032|FG001|Overall Study|Adverse Event|2|||
46802762|NCT00499863|83022031|FG000|Overall Study|Sponsor decision|2|||
46802763|NCT00499863|83022032|FG001|Overall Study|Sponsor decision|2|||
46802764|NCT00499863|83022031|FG000|Overall Study|Lost to Follow-up|1|||
46802765|NCT00499863|83022032|FG001|Overall Study|Lost to Follow-up|1|||
46802766|NCT00484185|83022038|FG000|Overall Study|Lost to Follow-up|44|||
46873024|NCT02905006|83092632|FG003|Overall Study|Positive for Tuberculosis|0|||
46873025|NCT02905006|83092633|FG004|Overall Study|Positive for Tuberculosis|0|||
46873026|NCT02905006|83092634|FG005|Overall Study|Positive for Tuberculosis|0|||
46873027|NCT02905006|83092629|FG000|Overall Study|Subject positive for Hep B|0|||
46873028|NCT02905006|83092630|FG001|Overall Study|Subject positive for Hep B|0|||
46873029|NCT02905006|83092631|FG002|Overall Study|Subject positive for Hep B|1|||
46873030|NCT02905006|83092632|FG003|Overall Study|Subject positive for Hep B|0|||
46873031|NCT02905006|83092633|FG004|Overall Study|Subject positive for Hep B|0|||
46873032|NCT02905006|83092634|FG005|Overall Study|Subject positive for Hep B|0|||
46873033|NCT02905006|83092629|FG000|Overall Study|Patient moved abroad|0|||
46873034|NCT02905006|83092630|FG001|Overall Study|Patient moved abroad|0|||
46873035|NCT02905006|83092631|FG002|Overall Study|Patient moved abroad|0|||
46873036|NCT02905006|83092632|FG003|Overall Study|Patient moved abroad|1|||
46873037|NCT02905006|83092633|FG004|Overall Study|Patient moved abroad|0|||
46873038|NCT02905006|83092634|FG005|Overall Study|Patient moved abroad|0|||
46873039|NCT02905006|83092629|FG000|Overall Study|Patient randomized by mistake|0|||
46873040|NCT02905006|83092630|FG001|Overall Study|Patient randomized by mistake|0|||
46873041|NCT02905006|83092631|FG002|Overall Study|Patient randomized by mistake|0|||
46873042|NCT02905006|83092632|FG003|Overall Study|Patient randomized by mistake|0|||
46873043|NCT02905006|83092633|FG004|Overall Study|Patient randomized by mistake|0|||
46873044|NCT02905006|83092634|FG005|Overall Study|Patient randomized by mistake|1|||
46873045|NCT01066780|83092672|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
46873046|NCT01066780|83092673|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
46873047|NCT02975206|83092680|FG000|Overall Study|Withdrawal by Subject|14|||
46873048|NCT02975206|83092681|FG001|Overall Study|Withdrawal by Subject|11|||
46873049|NCT02975206|83092682|FG002|Overall Study|Withdrawal by Subject|11|||
46873050|NCT02975206|83092680|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
46873051|NCT02975206|83092681|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
46873052|NCT02975206|83092682|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
46873053|NCT01066156|83092690|FG000|Overall Study|ineligible|2|||
46873054|NCT01066156|83092690|FG000|Overall Study|Lost to Follow-up|7|||
46873055|NCT01066156|83092690|FG000|Overall Study|Withdrawal by Subject|1|||
46873056|NCT02980042|83092696|FG000|Overall Study|Lost to Follow-up|5|||
46873057|NCT02980042|83092697|FG001|Overall Study|Lost to Follow-up|0|||
46873058|NCT02980042|83092696|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
46873059|NCT02980042|83092697|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
46873060|NCT01066000|83092715|FG000|Overall Study|Protocol Violation|4|||
46873061|NCT01066000|83092715|FG000|Overall Study|Death|3|||
46873062|NCT01066000|83092715|FG000|Overall Study|Withdrawal by Subject|1|||
46873063|NCT01066000|83092715|FG000|Overall Study|Adverse Event|1|||
46873064|NCT01065844|83092719|FG000|Overall Study|Adverse Event|5|||
46873065|NCT00004635|83092725|FG000|Period One|refused|2|||
46873066|NCT00004635|83092726|FG001|Period One|refused|1|||
46873067|NCT00004635|83092725|FG000|Period One|Withdrawal by Subject|1|||
46873068|NCT00004635|83092726|FG001|Period One|Withdrawal by Subject|1|||
46873069|NCT00004635|83092725|FG000|Period One|Protocol Violation|1|||
46873070|NCT00004635|83092726|FG001|Period One|Protocol Violation|0|||
46873071|NCT00004635|83092725|FG000|Period One|PSA did not go <5 ng/mL|1|||
46873072|NCT00004635|83092726|FG001|Period One|PSA did not go <5 ng/mL|0|||
46873073|NCT00004635|83092725|FG000|Period One|second malignancy|1|||
46873074|NCT00004635|83092726|FG001|Period One|second malignancy|0|||
46873075|NCT00004635|83092725|FG000|Period One|progressed|0|||
46873076|NCT00004635|83092726|FG001|Period One|progressed|2|||
46984219|NCT02561195|83230264|FG004|Extension Stage (Vaccination 4)|Death|0|||
46873077|NCT00004635|83092725|FG000|Period One|health problem|0|||
46873078|NCT00004635|83092726|FG001|Period One|health problem|1|||
46873079|NCT00004635|83092725|FG000|Period One|discrepancy in data entry|0|||
46984220|NCT02561195|83230265|FG005|Extension Stage (Vaccination 4)|Death|0|||
46984221|NCT02561195|83230266|FG006|Extension Stage (Vaccination 4)|Death|0|||
46873080|NCT00004635|83092726|FG001|Period One|discrepancy in data entry|1|||
46873081|NCT00004635|83092725|FG000|Period Two|progression|2|||
46873082|NCT00004635|83092726|FG001|Period Two|progression|3|||
46873083|NCT00004635|83092725|FG000|Period Two|Adverse Event|1|||
46873084|NCT00004635|83092726|FG001|Period Two|Adverse Event|0|||
46873085|NCT00004635|83092725|FG000|Period Two|refused|0|||
46873086|NCT00004635|83092726|FG001|Period Two|refused|2|||
46984222|NCT02561195|83230267|FG007|Extension Stage (Vaccination 4)|Death|0|||
46873087|NCT00004635|83092725|FG000|Period Two|health problem|1|||
46873088|NCT00004635|83092726|FG001|Period Two|health problem|1|||
46873089|NCT00004635|83092725|FG000|Period Two|travel issues|0|||
46873090|NCT00004635|83092726|FG001|Period Two|travel issues|1|||
46873091|NCT00004635|83092725|FG000|Period Two|secondary malignancy|1|||
46873092|NCT00004635|83092726|FG001|Period Two|secondary malignancy|1|||
46873093|NCT00004635|83092725|FG000|Period Two|Lost to Follow-up|1|||
46873094|NCT00004635|83092726|FG001|Period Two|Lost to Follow-up|0|||
46873095|NCT00004635|83092725|FG000|Period Two|discrepancy in data entry|0|||
46873096|NCT00004635|83092726|FG001|Period Two|discrepancy in data entry|1|||
46873097|NCT00004563|83092737|FG000|Overall Study|Withdrawal by Subject|20|||
46873098|NCT00004563|83092738|FG001|Overall Study|Withdrawal by Subject|16|||
46873099|NCT00004563|83092737|FG000|Overall Study|Lack of Efficacy|3|||
46873100|NCT00004563|83092738|FG001|Overall Study|Lack of Efficacy|5|||
46873101|NCT00004563|83092737|FG000|Overall Study|Death|2|||
46873102|NCT00004563|83092738|FG001|Overall Study|Death|3|||
46873103|NCT00003645|83092746|FG000|Overall Study|Death|4|||
46873104|NCT00003645|83092747|FG001|Overall Study|Death|1|||
46873105|NCT00003645|83092746|FG000|Overall Study|Lost to Follow-up|7|||
46873106|NCT00003645|83092747|FG001|Overall Study|Lost to Follow-up|8|||
46873107|NCT00003645|83092746|FG000|Overall Study|Withdrawal by Subject|1|||
46873108|NCT00003645|83092747|FG001|Overall Study|Withdrawal by Subject|3|||
46873109|NCT00003537|83092755|FG000|Overall Study|Not evalauable|1|||
46873110|NCT00003531|83092759|FG000|Overall Study|Not evaluable|10|||
46873111|NCT02918968|83092765|FG000|1st Line AAT|Progressive disease|9|||
46873112|NCT02918968|83092766|FG001|1st Line AAT|Progressive disease|4|||
46873113|NCT02918968|83092765|FG000|1st Line AAT|Adverse Event|12|||
46873114|NCT02918968|83092766|FG001|1st Line AAT|Adverse Event|3|||
46873115|NCT02918968|83092765|FG000|1st Line AAT|Physician Decision|4|||
46873116|NCT02918968|83092766|FG001|1st Line AAT|Physician Decision|2|||
46873117|NCT02918968|83092765|FG000|1st Line AAT|Withdrawal by Subject|2|||
46873118|NCT02918968|83092766|FG001|1st Line AAT|Withdrawal by Subject|1|||
46873119|NCT02918968|83092765|FG000|1st Line AAT|Lost to Follow-up|0|||
46873120|NCT02918968|83092766|FG001|1st Line AAT|Lost to Follow-up|1|||
46873121|NCT02918968|83092765|FG000|1st Line AAT|Death|1|||
46873122|NCT02918968|83092766|FG001|1st Line AAT|Death|0|||
46873123|NCT02918968|83092765|FG000|1st Line AAT|Miscellaneous|1|||
46873124|NCT02918968|83092766|FG001|1st Line AAT|Miscellaneous|0|||
46873125|NCT02918968|83092765|FG000|2nd Line AAT|Progressive disease|21|||
46873126|NCT02918968|83092766|FG001|2nd Line AAT|Progressive disease|3|||
46873127|NCT02918968|83092765|FG000|2nd Line AAT|Adverse Event|2|||
46873128|NCT02918968|83092766|FG001|2nd Line AAT|Adverse Event|5|||
46873129|NCT02918968|83092765|FG000|2nd Line AAT|Physician Decision|0|||
46873130|NCT02918968|83092766|FG001|2nd Line AAT|Physician Decision|1|||
46873131|NCT02918968|83092765|FG000|2nd Line AAT|Withdrawal by Subject|2|||
46873132|NCT02918968|83092766|FG001|2nd Line AAT|Withdrawal by Subject|2|||
46873133|NCT02918968|83092765|FG000|2nd Line AAT|Death|0|||
46873134|NCT02918968|83092766|FG001|2nd Line AAT|Death|1|||
46873135|NCT01065766|83092774|FG000|Overall Study|Assessed before the contracted date|1|||
46873136|NCT01065766|83092774|FG000|Overall Study|Contraindication to administration|6|||
46873137|NCT01065766|83092774|FG000|Overall Study|Violated dosage/administration|25|||
46873138|NCT01063972|83092780|FG000|Overall Study|Death|12|||
46873139|NCT01063972|83092781|FG001|Overall Study|Death|11|||
46873140|NCT01063972|83092780|FG000|Overall Study|Incarcerated|2|||
46873141|NCT01063972|83092781|FG001|Overall Study|Incarcerated|1|||
46873142|NCT00003483|83092787|FG000|Overall Study|Not evaluable|1|||
46873143|NCT00003477|83092791|FG000|Overall Study|Not evalauable|4|||
46873144|NCT00003471|83092795|FG000|Overall Study|Not evaluable|4|||
46873145|NCT04185220|83092801|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
46702051|NCT01090323|82916915|FG000|Overall Study|Lost to Follow-up|11|||
46702052|NCT01090323|82916916|FG001|Overall Study|Lost to Follow-up|6|||
46702053|NCT01090323|82916915|FG000|Overall Study|Administrative problems|6|||
46873146|NCT04185220|83092802|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
46873147|NCT04185220|83092801|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
46873148|NCT04185220|83092802|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
46873149|NCT00002931|83092809|FG000|Overall Study|rapidly progressing disease during|2|||
46702054|NCT01090323|82916916|FG001|Overall Study|Administrative problems|4|||
46873150|NCT02918266|83092824|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
46873151|NCT02918266|83092825|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873152|NCT02918266|83092826|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873153|NCT02918266|83092827|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873154|NCT02918266|83092828|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873155|NCT02918266|83092829|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873156|NCT02918266|83092830|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
46873157|NCT02918266|83092831|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873158|NCT02918266|83092832|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
46873159|NCT02918266|83092833|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873160|NCT02918266|83092834|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
46873161|NCT00041067|83092854|FG000|Overall Study|Adverse Event|20|||
46873162|NCT00041067|83092854|FG000|Overall Study|Progression|19|||
46873163|NCT00041067|83092854|FG000|Overall Study|Patient refusal|12|||
46873164|NCT00041067|83092854|FG000|Overall Study|Other reasons|23|||
46873165|NCT00041067|83092854|FG000|Overall Study|Ineligible|2|||
46873166|NCT01063036|83092859|FG000|Participants Treated With Study Drug|Adverse Event|1|||
46873167|NCT01063036|83092859|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
46873168|NCT01063036|83092859|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
46873169|NCT01063036|83092859|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
46873170|NCT01063036|83092859|FG000|Participants Treated With Study Drug|Pregnancy|1|||
46873171|NCT01063036|83092859|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
46873172|NCT01063036|83092859|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
46873173|NCT01063036|83092859|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
46873174|NCT00040365|83092863|FG000|Overall Study|Death|1|||
46873175|NCT00040365|83092863|FG000|Overall Study|Progressive disease|7|||
46873176|NCT00040365|83092863|FG000|Overall Study|Lost to Follow-up|3|||
46873177|NCT02974114|83092870|FG000|Overall Study|Other (Not specified)|0|||
46873178|NCT02974114|83092871|FG001|Overall Study|Other (Not specified)|1|||
46873179|NCT02974114|83092872|FG002|Overall Study|Other (Not specified)|2|||
46873180|NCT00001959|83092882|FG000|Overall Study|newly diagnosed colon cancer|1|||
46873181|NCT00001959|83092882|FG000|Overall Study|disabling sedation|1|||
46873182|NCT00001959|83092882|FG000|Overall Study|non-compliance|1|||
46873183|NCT00001941|83092886|FG000|Overall Study|not treated- rapidly progressing disease|0|||
46873184|NCT00001941|83092887|FG001|Overall Study|not treated- rapidly progressing disease|0|||
46873185|NCT00001941|83092888|FG002|Overall Study|not treated- rapidly progressing disease|0|||
46873186|NCT00001941|83092889|FG003|Overall Study|not treated- rapidly progressing disease|0|||
46873187|NCT00001941|83092890|FG004|Overall Study|not treated- rapidly progressing disease|1|||
46873188|NCT01061866|83092895|FG000|Overall Study|Adverse Event|2|||
46873189|NCT01061008|83092901|FG000|Overall Study|Badiocephalic fistula failed|3|||
46873190|NCT01061008|83092902|FG001|Overall Study|Badiocephalic fistula failed|2|||
46873191|NCT01061008|83092901|FG000|Overall Study|Death|1|||
46873192|NCT01061008|83092902|FG001|Overall Study|Death|0|||
46873193|NCT01061008|83092901|FG000|Overall Study|Withdrawal by Subject|1|||
46873194|NCT01061008|83092902|FG001|Overall Study|Withdrawal by Subject|3|||
46873195|NCT01061008|83092901|FG000|Overall Study|Unable to exercise following surgery|1|||
46873196|NCT01061008|83092902|FG001|Overall Study|Unable to exercise following surgery|0|||
46873197|NCT01061008|83092901|FG000|Overall Study|Adverse Event|0|||
46873198|NCT01061008|83092902|FG001|Overall Study|Adverse Event|1|||
46873199|NCT00039741|83092912|FG000|Overall Study|Death|0|||
46873200|NCT00039741|83092913|FG001|Overall Study|Death|1|||
46873201|NCT00039741|83092914|FG002|Overall Study|Death|0|||
46873202|NCT00039741|83092915|FG003|Overall Study|Death|0|||
46873203|NCT00039741|83092912|FG000|Overall Study|Lost to Follow-up|3|||
46873204|NCT00039741|83092913|FG001|Overall Study|Lost to Follow-up|1|||
46873205|NCT00039741|83092914|FG002|Overall Study|Lost to Follow-up|5|||
46873206|NCT00039741|83092915|FG003|Overall Study|Lost to Follow-up|2|||
46702055|NCT01090323|82916915|FG000|Overall Study|Death|1|||
46702056|NCT01090323|82916916|FG001|Overall Study|Death|2|||
46873207|NCT00039741|83092912|FG000|Overall Study|Confounding medical condition|1|||
46873208|NCT00039741|83092913|FG001|Overall Study|Confounding medical condition|0|||
46873209|NCT00039741|83092914|FG002|Overall Study|Confounding medical condition|0|||
46873210|NCT00039741|83092915|FG003|Overall Study|Confounding medical condition|0|||
46873211|NCT00039741|83092912|FG000|Overall Study|Not able to get to clinic|5|||
46873212|NCT00039741|83092913|FG001|Overall Study|Not able to get to clinic|2|||
46873213|NCT00039741|83092914|FG002|Overall Study|Not able to get to clinic|0|||
46873214|NCT00039741|83092915|FG003|Overall Study|Not able to get to clinic|3|||
46873215|NCT00039741|83092912|FG000|Overall Study|Moved|3|||
46873216|NCT00039741|83092913|FG001|Overall Study|Moved|2|||
46702057|NCT01090323|82916915|FG000|Overall Study|Stopped end of core|7|||
46702058|NCT01090323|82916916|FG001|Overall Study|Stopped end of core|0|||
46873217|NCT00039741|83092914|FG002|Overall Study|Moved|3|||
46702059|NCT01090323|82916915|FG000|Overall Study|Stopped end of extension 1#|3|||
46873218|NCT00039741|83092915|FG003|Overall Study|Moved|6|||
46702060|NCT01090323|82916916|FG001|Overall Study|Stopped end of extension 1#|1|||
46873219|NCT00039741|83092912|FG000|Overall Study|Non-compliance with protocol|1|||
46873220|NCT00039741|83092913|FG001|Overall Study|Non-compliance with protocol|0|||
46873221|NCT00039741|83092914|FG002|Overall Study|Non-compliance with protocol|1|||
46873222|NCT00039741|83092915|FG003|Overall Study|Non-compliance with protocol|0|||
46873223|NCT00039741|83092912|FG000|Overall Study|Withdrew consent|0|||
46873224|NCT00039741|83092913|FG001|Overall Study|Withdrew consent|5|||
46702061|NCT01078155|82916922|FG000|Overall Study|Adverse Event|7|||
46873225|NCT00039741|83092914|FG002|Overall Study|Withdrew consent|0|||
46873226|NCT00039741|83092915|FG003|Overall Study|Withdrew consent|1|||
46873227|NCT00039741|83092912|FG000|Overall Study|Missed final visit|2|||
46873228|NCT00039741|83092913|FG001|Overall Study|Missed final visit|1|||
46873229|NCT00039741|83092914|FG002|Overall Study|Missed final visit|2|||
46873230|NCT00039741|83092915|FG003|Overall Study|Missed final visit|2|||
46873231|NCT02973802|83092925|FG000|Overall Study|Lost to Follow-up|1|||
46873232|NCT02973802|83092925|FG000|Overall Study|Withdrawal by Subject|1|||
46873233|NCT02973100|83092934|FG000|Overall Study|Adverse Event|1|||
46873234|NCT02973100|83092935|FG001|Overall Study|Adverse Event|2|||
46873235|NCT02973100|83092936|FG002|Overall Study|Adverse Event|1|||
46873236|NCT02973100|83092937|FG003|Overall Study|Adverse Event|2|||
46873237|NCT02973100|83092934|FG000|Overall Study|Lost to Follow-up|3|||
46873238|NCT02973100|83092935|FG001|Overall Study|Lost to Follow-up|1|||
46873239|NCT02973100|83092936|FG002|Overall Study|Lost to Follow-up|1|||
46873240|NCT02973100|83092937|FG003|Overall Study|Lost to Follow-up|0|||
46873241|NCT02973100|83092934|FG000|Overall Study|Withdrawal by Subject|3|||
46873242|NCT02973100|83092935|FG001|Overall Study|Withdrawal by Subject|5|||
46873243|NCT02973100|83092936|FG002|Overall Study|Withdrawal by Subject|1|||
46873244|NCT02973100|83092937|FG003|Overall Study|Withdrawal by Subject|4|||
46873245|NCT02973100|83092934|FG000|Overall Study|Notification of change in address|0|||
46873246|NCT02973100|83092935|FG001|Overall Study|Notification of change in address|0|||
46873247|NCT02973100|83092936|FG002|Overall Study|Notification of change in address|0|||
46873248|NCT02973100|83092937|FG003|Overall Study|Notification of change in address|1|||
46873249|NCT02973100|83092934|FG000|Overall Study|Failed to attend Safety followup period|0|||
46873250|NCT02973100|83092935|FG001|Overall Study|Failed to attend Safety followup period|0|||
46873251|NCT02973100|83092936|FG002|Overall Study|Failed to attend Safety followup period|1|||
46873252|NCT02973100|83092937|FG003|Overall Study|Failed to attend Safety followup period|0|||
46873253|NCT01060540|83092952|FG000|Overall Study|Withdrawal by Subject|10|||
46873254|NCT01060540|83092953|FG001|Overall Study|Withdrawal by Subject|20|||
46873255|NCT01060540|83092952|FG000|Overall Study|Lost to Follow-up|52|||
46873256|NCT01060540|83092953|FG001|Overall Study|Lost to Follow-up|43|||
46873257|NCT01060540|83092952|FG000|Overall Study|Death|2|||
46873258|NCT01060540|83092953|FG001|Overall Study|Death|1|||
46873259|NCT01060540|83092952|FG000|Overall Study|Physician Decision|0|||
46873260|NCT01060540|83092953|FG001|Overall Study|Physician Decision|1|||
46873261|NCT02972632|83092978|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
46873262|NCT02972632|83092978|FG000|Overall Study|Lost to Follow-up|4|||
46873263|NCT02972632|83092978|FG000|Overall Study|Voluntary Withdrawal|10|||
46873264|NCT01060150|83092982|FG000|Overall Study|Adverse Event|6|||
46873265|NCT01060150|83092982|FG000|Overall Study|Lost to Follow-up|1|||
46873266|NCT01060150|83092982|FG000|Overall Study|Protocol Violation|6|||
46873267|NCT01060150|83092982|FG000|Overall Study|Withdrawal by Subject|8|||
46873268|NCT01060150|83092982|FG000|Overall Study|Enrolled, but not treated|2|||
46873269|NCT02972242|83092988|FG000|Overall Study|Withdrawal by Subject|1|||
46873270|NCT02972242|83092989|FG001|Overall Study|Withdrawal by Subject|0|||
46873271|NCT02970292|83092997|FG000|Overall Study|Physician Decision|1|||
46873272|NCT02970292|83092998|FG001|Overall Study|Physician Decision|1|||
46873273|NCT02970292|83092997|FG000|Overall Study|Withdrawal by Subject|11|||
46873274|NCT02970292|83092998|FG001|Overall Study|Withdrawal by Subject|5|||
46873275|NCT02970292|83092997|FG000|Overall Study|Noncompliance with study drug|2|||
46873276|NCT02970292|83092998|FG001|Overall Study|Noncompliance with study drug|2|||
46873277|NCT02970292|83092997|FG000|Overall Study|Adverse Event|5|||
46873278|NCT02970292|83092998|FG001|Overall Study|Adverse Event|0|||
46873279|NCT02970292|83092997|FG000|Overall Study|Lack of Efficacy|1|||
46873280|NCT02970292|83092998|FG001|Overall Study|Lack of Efficacy|0|||
46873281|NCT02970292|83092997|FG000|Overall Study|Lost to Follow-up|1|||
46873282|NCT02970292|83092998|FG001|Overall Study|Lost to Follow-up|0|||
46873283|NCT02970292|83092997|FG000|Overall Study|Protocol Violation|2|||
46873284|NCT02970292|83092998|FG001|Overall Study|Protocol Violation|0|||
46873285|NCT02970292|83092997|FG000|Overall Study|Other|1|||
46873286|NCT02970292|83092998|FG001|Overall Study|Other|0|||
46873287|NCT02971228|83093004|FG000|Overall Study|Withdrawal by Subject|1|||
46873288|NCT02971228|83093005|FG001|Overall Study|Withdrawal by Subject|1|||
46873289|NCT02971228|83093006|FG002|Overall Study|Withdrawal by Subject|0|||
46873290|NCT02971228|83093007|FG003|Overall Study|Withdrawal by Subject|0|||
46873291|NCT02971228|83093008|FG004|Overall Study|Withdrawal by Subject|0|||
46873292|NCT02971228|83093004|FG000|Overall Study|Logistical challenges|0|||
46873293|NCT02971228|83093005|FG001|Overall Study|Logistical challenges|1|||
46873294|NCT02971228|83093006|FG002|Overall Study|Logistical challenges|0|||
46873295|NCT02971228|83093007|FG003|Overall Study|Logistical challenges|0|||
46873296|NCT02971228|83093008|FG004|Overall Study|Logistical challenges|0|||
46873297|NCT01060072|83093021|FG000|Overall Study|Adverse Event|1|||
46873298|NCT01060072|83093022|FG001|Overall Study|Adverse Event|1|||
46873299|NCT01060072|83093021|FG000|Overall Study|Physician Decision|0|||
46873300|NCT01060072|83093022|FG001|Overall Study|Physician Decision|2|||
46873301|NCT01060072|83093021|FG000|Overall Study|Protocol Violation|0|||
46873302|NCT01060072|83093022|FG001|Overall Study|Protocol Violation|1|||
46873303|NCT01060072|83093021|FG000|Overall Study|Acute cholecystitis|1|||
46873304|NCT01060072|83093022|FG001|Overall Study|Acute cholecystitis|0|||
46873305|NCT01060072|83093021|FG000|Overall Study|Excluded Medications|0|||
46873306|NCT01060072|83093022|FG001|Overall Study|Excluded Medications|1|||
46873307|NCT02969590|83093030|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
46873308|NCT02969590|83093031|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
46873309|NCT02969590|83093032|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
46873310|NCT03345849|83093044|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
46873311|NCT03345849|83093045|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
46873312|NCT03345849|83093046|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
46873313|NCT03345849|83093047|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
46873314|NCT03345849|83093044|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
46873315|NCT03345849|83093045|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
46873316|NCT03345849|83093046|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
46873317|NCT03345849|83093047|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
46873318|NCT03345849|83093044|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
46873319|NCT03345849|83093045|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
46873320|NCT03345849|83093046|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
46873321|NCT03345849|83093047|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
46873322|NCT03345849|83093044|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
46873323|NCT03345849|83093045|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
46873324|NCT03345849|83093046|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
46873325|NCT03345849|83093047|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
46873326|NCT03345849|83093044|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
46873327|NCT03345849|83093045|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
46873328|NCT03345849|83093046|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
46873329|NCT03345849|83093047|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
46873330|NCT03345849|83093044|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
46873331|NCT03345849|83093045|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
46873332|NCT03345849|83093046|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
46873333|NCT03345849|83093047|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
46873334|NCT03345849|83093044|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
46873335|NCT03345849|83093045|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
46873336|NCT03345849|83093046|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
46873337|NCT03345849|83093047|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
46873338|NCT03345849|83093044|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
46873339|NCT03345849|83093045|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
46873340|NCT03345849|83093046|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
46873341|NCT03345849|83093047|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
46873342|NCT03345849|83093044|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
46873343|NCT03345849|83093045|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
46873344|NCT03345849|83093046|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
46873345|NCT03345849|83093047|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
46873346|NCT03345849|83093044|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
46873347|NCT03345849|83093045|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
46873348|NCT03345849|83093046|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
46873349|NCT03345849|83093047|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
46873350|NCT03345849|83093044|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
46873351|NCT03345849|83093045|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
46873352|NCT03345849|83093046|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
46873353|NCT03345849|83093047|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
46873354|NCT03011307|83093057|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
46873355|NCT03011307|83093058|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
46873356|NCT03011307|83093057|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
46873357|NCT03011307|83093058|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
46873358|NCT03011307|83093057|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
46873359|NCT03011307|83093058|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
46873360|NCT03798717|83093070|FG000|Overall Study|Failed Screening|0|||
46873361|NCT03798717|83093071|FG001|Overall Study|Failed Screening|0|||
46873362|NCT03798717|83093072|FG002|Overall Study|Failed Screening|0|||
46873363|NCT03798717|83093073|FG003|Overall Study|Failed Screening|0|||
46873364|NCT03798717|83093074|FG004|Overall Study|Failed Screening|0|||
46873365|NCT03798717|83093075|FG005|Overall Study|Failed Screening|1|||
46873366|NCT03798717|83093070|FG000|Overall Study|Physician Decision|1|||
46873367|NCT03798717|83093071|FG001|Overall Study|Physician Decision|0|||
46873368|NCT03798717|83093072|FG002|Overall Study|Physician Decision|1|||
46873369|NCT03798717|83093073|FG003|Overall Study|Physician Decision|0|||
46873370|NCT03798717|83093074|FG004|Overall Study|Physician Decision|0|||
46873371|NCT03798717|83093075|FG005|Overall Study|Physician Decision|0|||
46873372|NCT03798717|83093070|FG000|Overall Study|Withdrawal by Subject|0|||
46873373|NCT03798717|83093071|FG001|Overall Study|Withdrawal by Subject|0|||
46873374|NCT03798717|83093072|FG002|Overall Study|Withdrawal by Subject|0|||
46873375|NCT03798717|83093073|FG003|Overall Study|Withdrawal by Subject|1|||
46873376|NCT03798717|83093074|FG004|Overall Study|Withdrawal by Subject|0|||
46873377|NCT03798717|83093075|FG005|Overall Study|Withdrawal by Subject|0|||
46873378|NCT03798717|83093070|FG000|Overall Study|Lost to Follow-up|1|||
46873379|NCT03798717|83093071|FG001|Overall Study|Lost to Follow-up|0|||
46873380|NCT03798717|83093072|FG002|Overall Study|Lost to Follow-up|0|||
46873381|NCT03798717|83093073|FG003|Overall Study|Lost to Follow-up|1|||
46873382|NCT03798717|83093074|FG004|Overall Study|Lost to Follow-up|0|||
46873383|NCT03798717|83093075|FG005|Overall Study|Lost to Follow-up|0|||
46873384|NCT03798717|83093070|FG000|Overall Study|Adverse Event|0|||
46873385|NCT03798717|83093071|FG001|Overall Study|Adverse Event|1|||
46873386|NCT03798717|83093072|FG002|Overall Study|Adverse Event|0|||
46873387|NCT03798717|83093073|FG003|Overall Study|Adverse Event|0|||
46873388|NCT03798717|83093074|FG004|Overall Study|Adverse Event|0|||
46873389|NCT03798717|83093075|FG005|Overall Study|Adverse Event|0|||
46873390|NCT03798717|83093070|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
46873391|NCT03798717|83093071|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
46873392|NCT03798717|83093072|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
46873393|NCT03798717|83093073|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
46873394|NCT03798717|83093074|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
46873395|NCT03798717|83093075|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
46873396|NCT03798483|83093084|FG000|Overall Study|Lost to Follow-up|2|||
46873397|NCT03792477|83093097|FG000|Overall Study|Adverse Event|0|||
46873398|NCT03792477|83093098|FG001|Overall Study|Adverse Event|0|||
46873399|NCT03792477|83093099|FG002|Overall Study|Adverse Event|0|||
46873400|NCT03792477|83093100|FG003|Overall Study|Adverse Event|1|||
46873401|NCT03792477|83093101|FG004|Overall Study|Adverse Event|0|||
46873402|NCT03792477|83093097|FG000|Overall Study|Lost to Follow-up|0|||
46873403|NCT03792477|83093098|FG001|Overall Study|Lost to Follow-up|0|||
46873404|NCT03792477|83093099|FG002|Overall Study|Lost to Follow-up|2|||
46873405|NCT03792477|83093100|FG003|Overall Study|Lost to Follow-up|0|||
46873406|NCT03792477|83093101|FG004|Overall Study|Lost to Follow-up|0|||
46873407|NCT03792477|83093097|FG000|Overall Study|Other|0|||
46873408|NCT03792477|83093098|FG001|Overall Study|Other|0|||
46873409|NCT03792477|83093099|FG002|Overall Study|Other|0|||
46873410|NCT03792477|83093100|FG003|Overall Study|Other|0|||
46873411|NCT03792477|83093101|FG004|Overall Study|Other|1|||
46873412|NCT03790917|83093107|FG000|Overall Study|Death|1|||
46873413|NCT03788967|83093114|FG000|Overall Study|Lost to Follow-up|14|||
46873414|NCT03788967|83093115|FG001|Overall Study|Lost to Follow-up|10|||
46873415|NCT03788967|83093114|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
46873416|NCT03788967|83093115|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
46873417|NCT03788967|83093114|FG000|Overall Study|Participant Withdrawal of Consent|13|||
46873418|NCT03788967|83093115|FG001|Overall Study|Participant Withdrawal of Consent|5|||
46873419|NCT03788967|83093114|FG000|Overall Study|Adverse Event|1|||
46873420|NCT03788967|83093115|FG001|Overall Study|Adverse Event|1|||
46873421|NCT03788967|83093114|FG000|Overall Study|COVID-19|1|||
46873422|NCT03788967|83093115|FG001|Overall Study|COVID-19|2|||
46873423|NCT03782571|83093123|FG000|Period 1|Withdrawal by Subject|1|||
46873424|NCT03782571|83093124|FG001|Period 1|Withdrawal by Subject|0|||
46873425|NCT03782571|83093125|FG002|Period 1|Withdrawal by Subject|0|||
46873426|NCT03782571|83093126|FG003|Period 1|Withdrawal by Subject|0|||
46873427|NCT03782571|83093123|FG000|Period 3|Subject Unable to Attend V5|1|||
46873428|NCT03782571|83093124|FG001|Period 3|Subject Unable to Attend V5|0|||
46873429|NCT03782571|83093125|FG002|Period 3|Subject Unable to Attend V5|0|||
46873430|NCT03782571|83093126|FG003|Period 3|Subject Unable to Attend V5|0|||
46873431|NCT03782571|83093123|FG000|Period 3|Adverse Event|1|||
46873432|NCT03782571|83093124|FG001|Period 3|Adverse Event|0|||
46873433|NCT03782571|83093125|FG002|Period 3|Adverse Event|0|||
46873434|NCT03782571|83093126|FG003|Period 3|Adverse Event|0|||
46873435|NCT03783039|83093140|FG000|Overall Study|Death|2|||
46873436|NCT03783039|83093141|FG001|Overall Study|Death|1|||
46873437|NCT03776175|83093151|FG000|Treatment Period (42 Days)|Adverse Event|0|||
46873438|NCT03776175|83093152|FG001|Treatment Period (42 Days)|Adverse Event|1|||
46873439|NCT03776175|83093153|FG002|Treatment Period (42 Days)|Adverse Event|1|||
46873440|NCT03776175|83093154|FG003|Treatment Period (42 Days)|Adverse Event|0|||
46873441|NCT03776175|83093151|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
46873442|NCT03776175|83093152|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
46873443|NCT03776175|83093153|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
46873444|NCT03776175|83093154|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
46873445|NCT03776175|83093151|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
46873446|NCT03776175|83093152|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
46873447|NCT03776175|83093153|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
46873448|NCT03776175|83093154|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
46873449|NCT03776175|83093151|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
46873450|NCT03776175|83093152|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
46873451|NCT03776175|83093153|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
46873452|NCT03776175|83093154|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
46873453|NCT03776175|83093151|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
46873454|NCT03776175|83093152|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
46873455|NCT03776175|83093153|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
46873456|NCT03776175|83093154|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
46873457|NCT03776175|83093151|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
46873458|NCT03776175|83093152|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
46873459|NCT03776175|83093153|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
46873460|NCT03776175|83093154|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
46873461|NCT02903914|83093172|FG000|Overall Study|Adverse Event|0|||
46873462|NCT02903914|83093173|FG001|Overall Study|Adverse Event|0|||
46873463|NCT02903914|83093174|FG002|Overall Study|Adverse Event|1|||
46873464|NCT02903914|83093175|FG003|Overall Study|Adverse Event|0|||
46873465|NCT02903914|83093176|FG004|Overall Study|Adverse Event|0|||
46873466|NCT02903914|83093177|FG005|Overall Study|Adverse Event|1|||
46873467|NCT02903914|83093178|FG006|Overall Study|Adverse Event|2|||
46873468|NCT02903914|83093179|FG007|Overall Study|Adverse Event|1|||
46873469|NCT02903914|83093172|FG000|Overall Study|Withdrawal by Subject|3|||
46873470|NCT02903914|83093173|FG001|Overall Study|Withdrawal by Subject|1|||
46873471|NCT02903914|83093174|FG002|Overall Study|Withdrawal by Subject|28|||
46873472|NCT02903914|83093175|FG003|Overall Study|Withdrawal by Subject|0|||
46873473|NCT02903914|83093176|FG004|Overall Study|Withdrawal by Subject|1|||
46873474|NCT02903914|83093177|FG005|Overall Study|Withdrawal by Subject|1|||
46873475|NCT02903914|83093178|FG006|Overall Study|Withdrawal by Subject|12|||
46873476|NCT02903914|83093179|FG007|Overall Study|Withdrawal by Subject|0|||
46873477|NCT02903914|83093172|FG000|Overall Study|Progressive Disease|1|||
46873478|NCT02903914|83093173|FG001|Overall Study|Progressive Disease|0|||
46873479|NCT02903914|83093174|FG002|Overall Study|Progressive Disease|4|||
46702062|NCT01078155|82916922|FG000|Overall Study|Lack of Efficacy|16|||
46873480|NCT02903914|83093175|FG003|Overall Study|Progressive Disease|0|||
46873481|NCT02903914|83093176|FG004|Overall Study|Progressive Disease|0|||
46873482|NCT02903914|83093177|FG005|Overall Study|Progressive Disease|0|||
46873483|NCT02903914|83093178|FG006|Overall Study|Progressive Disease|2|||
46873484|NCT02903914|83093179|FG007|Overall Study|Progressive Disease|4|||
46873485|NCT02903914|83093172|FG000|Overall Study|Death|0|||
46873486|NCT02903914|83093173|FG001|Overall Study|Death|0|||
46873487|NCT02903914|83093174|FG002|Overall Study|Death|9|||
46873488|NCT02903914|83093175|FG003|Overall Study|Death|0|||
46873489|NCT02903914|83093176|FG004|Overall Study|Death|1|||
46873490|NCT02903914|83093177|FG005|Overall Study|Death|3|||
46873491|NCT02903914|83093178|FG006|Overall Study|Death|24|||
46873492|NCT02903914|83093179|FG007|Overall Study|Death|0|||
46873493|NCT02903914|83093172|FG000|Overall Study|Lost to Follow-up|0|||
46873494|NCT02903914|83093173|FG001|Overall Study|Lost to Follow-up|1|||
46873495|NCT02903914|83093174|FG002|Overall Study|Lost to Follow-up|0|||
46873496|NCT02903914|83093175|FG003|Overall Study|Lost to Follow-up|0|||
46873497|NCT02903914|83093176|FG004|Overall Study|Lost to Follow-up|2|||
46873498|NCT02903914|83093177|FG005|Overall Study|Lost to Follow-up|0|||
46873499|NCT02903914|83093178|FG006|Overall Study|Lost to Follow-up|1|||
46873500|NCT02903914|83093179|FG007|Overall Study|Lost to Follow-up|0|||
46873501|NCT02903914|83093172|FG000|Overall Study|Physician Decision|0|||
46873502|NCT02903914|83093173|FG001|Overall Study|Physician Decision|0|||
46873503|NCT02903914|83093174|FG002|Overall Study|Physician Decision|1|||
46873504|NCT02903914|83093175|FG003|Overall Study|Physician Decision|0|||
46873505|NCT02903914|83093176|FG004|Overall Study|Physician Decision|0|||
46873506|NCT02903914|83093177|FG005|Overall Study|Physician Decision|0|||
46873507|NCT02903914|83093178|FG006|Overall Study|Physician Decision|1|||
46873508|NCT02903914|83093179|FG007|Overall Study|Physician Decision|0|||
46873509|NCT02903914|83093172|FG000|Overall Study|Symptomatic Deterioration|0|||
46873510|NCT02903914|83093173|FG001|Overall Study|Symptomatic Deterioration|0|||
46873511|NCT02903914|83093174|FG002|Overall Study|Symptomatic Deterioration|1|||
46873512|NCT02903914|83093175|FG003|Overall Study|Symptomatic Deterioration|0|||
46873513|NCT02903914|83093176|FG004|Overall Study|Symptomatic Deterioration|0|||
46873514|NCT02903914|83093177|FG005|Overall Study|Symptomatic Deterioration|0|||
46873515|NCT02903914|83093178|FG006|Overall Study|Symptomatic Deterioration|0|||
46873516|NCT02903914|83093179|FG007|Overall Study|Symptomatic Deterioration|0|||
46873517|NCT02903914|83093172|FG000|Overall Study|New Cancer Therapy|2|||
46873518|NCT02903914|83093173|FG001|Overall Study|New Cancer Therapy|2|||
46873519|NCT02903914|83093174|FG002|Overall Study|New Cancer Therapy|21|||
46873520|NCT02903914|83093175|FG003|Overall Study|New Cancer Therapy|4|||
46873521|NCT02903914|83093176|FG004|Overall Study|New Cancer Therapy|3|||
46873522|NCT02903914|83093177|FG005|Overall Study|New Cancer Therapy|6|||
46984223|NCT02561195|83230268|FG008|Extension Stage (Vaccination 4)|Death|0|||
46984224|NCT02561195|83230269|FG009|Extension Stage (Vaccination 4)|Death|1|||
46984225|NCT02561195|83230270|FG010|Extension Stage (Vaccination 4)|Death|0|||
46984226|NCT02561195|83230271|FG011|Extension Stage (Vaccination 4)|Death|0|||
46984227|NCT02561195|83230272|FG012|Extension Stage (Vaccination 4)|Death|0|||
46984228|NCT02561195|83230273|FG013|Extension Stage (Vaccination 4)|Death|0|||
46984229|NCT02561195|83230260|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984230|NCT02561195|83230261|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984231|NCT02561195|83230262|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984232|NCT02561195|83230263|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984233|NCT02561195|83230264|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984234|NCT02561195|83230265|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984235|NCT02561195|83230266|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
46984236|NCT02561195|83230267|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
46984237|NCT02561195|83230268|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984238|NCT02561195|83230269|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
46984239|NCT02561195|83230270|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
46984240|NCT02561195|83230271|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
46984241|NCT02561195|83230272|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
46984242|NCT02561195|83230273|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
46984243|NCT02561195|83230260|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46984244|NCT02561195|83230261|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46984245|NCT02561195|83230262|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46984246|NCT02561195|83230263|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46984247|NCT02561195|83230264|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46984248|NCT02561195|83230265|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46873523|NCT02903914|83093178|FG006|Overall Study|New Cancer Therapy|55|||
46873524|NCT02903914|83093179|FG007|Overall Study|New Cancer Therapy|0|||
46873525|NCT02903914|83093172|FG000|Overall Study|Reasoning not specified|2|||
46873526|NCT02903914|83093173|FG001|Overall Study|Reasoning not specified|3|||
46873527|NCT02903914|83093174|FG002|Overall Study|Reasoning not specified|20|||
46873528|NCT02903914|83093175|FG003|Overall Study|Reasoning not specified|3|||
46873529|NCT02903914|83093176|FG004|Overall Study|Reasoning not specified|3|||
46873530|NCT02903914|83093177|FG005|Overall Study|Reasoning not specified|3|||
46873531|NCT02903914|83093178|FG006|Overall Study|Reasoning not specified|20|||
46873532|NCT02903914|83093179|FG007|Overall Study|Reasoning not specified|0|||
46873533|NCT02969044|83093201|FG000|Overall Study|Withdrawal by Subject|2|||
46873534|NCT02969044|83093202|FG001|Overall Study|Withdrawal by Subject|6|||
46873535|NCT02969044|83093201|FG000|Overall Study|Adverse Event|3|||
46873536|NCT02969044|83093202|FG001|Overall Study|Adverse Event|0|||
46873537|NCT02967562|83093210|FG000|Overall Study|Consent not obtained|1|||
46873538|NCT02967562|83093211|FG001|Overall Study|Consent not obtained|0|||
46873539|NCT02967562|83093210|FG000|Overall Study|High leak precluding analysis|1|||
46873540|NCT02967562|83093211|FG001|Overall Study|High leak precluding analysis|1|||
46873541|NCT02968576|83093217|FG000|Overall Study|Pregnancy|0|||
46873542|NCT02968576|83093218|FG001|Overall Study|Pregnancy|1|||
46873543|NCT02966002|83093222|FG000|Overall Study|Withdrawal by Subject|2|||
46873544|NCT02966002|83093222|FG000|Overall Study|Adverse Event|1|||
46873545|NCT02966002|83093222|FG000|Overall Study|Lost to Follow-up|1|||
46873546|NCT02965846|83093229|FG000|Overall Study|Lost to Follow-up|1|||
46873547|NCT02965846|83093230|FG001|Overall Study|Lost to Follow-up|0|||
46873548|NCT02965846|83093231|FG002|Overall Study|Lost to Follow-up|0|||
46873549|NCT02965846|83093229|FG000|Overall Study|Withdrawal by Subject|0|||
46873550|NCT02965846|83093230|FG001|Overall Study|Withdrawal by Subject|1|||
46873551|NCT02965846|83093231|FG002|Overall Study|Withdrawal by Subject|0|||
46873552|NCT02965846|83093229|FG000|Overall Study|Study Terminated By Sponsor|4|||
46873553|NCT02965846|83093230|FG001|Overall Study|Study Terminated By Sponsor|4|||
46873554|NCT02965846|83093231|FG002|Overall Study|Study Terminated By Sponsor|0|||
46873555|NCT02965846|83093229|FG000|Overall Study|Participants not randomized|0|||
46873556|NCT02965846|83093230|FG001|Overall Study|Participants not randomized|0|||
46873557|NCT02965846|83093231|FG002|Overall Study|Participants not randomized|33|||
46873558|NCT02900170|83093237|FG000|Overall Study|Lost to Follow-up|8|||
46873559|NCT02900092|83093241|FG000|Overall Study|Adverse Event|1|||
46873560|NCT02902120|83093249|FG000|Overall Study|Lack of Efficacy|1|||
46873561|NCT02965456|83093255|FG000|Overall Study|Lost to Follow-up|40|||
46873562|NCT02965456|83093256|FG001|Overall Study|Lost to Follow-up|18|||
46873563|NCT02965456|83093255|FG000|Overall Study|Subject Request|22|||
46873564|NCT02965456|83093256|FG001|Overall Study|Subject Request|13|||
46873565|NCT02965456|83093255|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
46873566|NCT02965456|83093256|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
46873567|NCT02965456|83093255|FG000|Overall Study|Adverse Event|3|||
46873568|NCT02965456|83093256|FG001|Overall Study|Adverse Event|0|||
46873569|NCT02965456|83093255|FG000|Overall Study|Noncompliance with Study Drug|1|||
46873570|NCT02965456|83093256|FG001|Overall Study|Noncompliance with Study Drug|1|||
46873571|NCT02965456|83093255|FG000|Overall Study|Worsening Condition|0|||
46873572|NCT02965456|83093256|FG001|Overall Study|Worsening Condition|2|||
46873573|NCT02965456|83093255|FG000|Overall Study|Lack of Efficacy|1|||
46873574|NCT02965456|83093256|FG001|Overall Study|Lack of Efficacy|0|||
46873575|NCT02965456|83093255|FG000|Overall Study|Physician Decision|0|||
46873576|NCT02965456|83093256|FG001|Overall Study|Physician Decision|1|||
46873577|NCT02965456|83093255|FG000|Overall Study|Pregnancy|1|||
46873578|NCT02965456|83093256|FG001|Overall Study|Pregnancy|0|||
46873579|NCT02965456|83093255|FG000|Overall Study|Protocol Violation|0|||
46873580|NCT02965456|83093256|FG001|Overall Study|Protocol Violation|1|||
46873581|NCT02965456|83093255|FG000|Overall Study|Participant ran out of study drug|0|||
46873582|NCT02965456|83093256|FG001|Overall Study|Participant ran out of study drug|1|||
46873583|NCT02965378|83093264|FG000|Overall Study|Progression|16|||
46873584|NCT02965378|83093265|FG001|Overall Study|Progression|4|||
46873585|NCT02965378|83093264|FG000|Overall Study|Adverse Event|5|||
46873586|NCT02965378|83093265|FG001|Overall Study|Adverse Event|2|||
46873587|NCT02965378|83093264|FG000|Overall Study|Death|2|||
46873588|NCT02965378|83093265|FG001|Overall Study|Death|0|||
46873589|NCT02965378|83093264|FG000|Overall Study|Refusal|2|||
46984249|NCT02561195|83230266|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46873590|NCT02965378|83093265|FG001|Overall Study|Refusal|1|||
46873591|NCT02965378|83093264|FG000|Overall Study|Not protocol specified|0|||
46873592|NCT02965378|83093265|FG001|Overall Study|Not protocol specified|2|||
46873593|NCT03772041|83093273|FG000|Overall Study|Adverse Event|8|||
46873594|NCT03772041|83093274|FG001|Overall Study|Adverse Event|3|||
46873595|NCT03772041|83093273|FG000|Overall Study|Withdrawal by Subject|0|||
46873596|NCT03772041|83093274|FG001|Overall Study|Withdrawal by Subject|2|||
46873597|NCT03772041|83093273|FG000|Overall Study|Protocol Violation|4|||
46873598|NCT03772041|83093274|FG001|Overall Study|Protocol Violation|2|||
46873599|NCT03772041|83093273|FG000|Overall Study|Physician Decision|2|||
46873600|NCT03772041|83093274|FG001|Overall Study|Physician Decision|3|||
46873601|NCT02899156|83093282|FG000|Overall Study|Death|1|||
46873602|NCT02899156|83093283|FG001|Overall Study|Death|0|||
46873603|NCT02899156|83093282|FG000|Overall Study|Physician Decision|0|||
46873604|NCT02899156|83093283|FG001|Overall Study|Physician Decision|1|||
46873605|NCT03773133|83093289|FG000|Overall Study|Screen Failure|8|||
46873606|NCT02969356|83093294|FG000|Overall Study|Adverse Event|7|||
46873607|NCT02969356|83093294|FG000|Overall Study|Consent withdrawn|2|||
46873608|NCT02969356|83093294|FG000|Overall Study|Lost to Follow-up|3|||
46873609|NCT02969356|83093294|FG000|Overall Study|Did not need to be reinjected|6|||
46873610|NCT02969356|83093294|FG000|Overall Study|Personal reasons|5|||
46873611|NCT02898454|83093301|FG000|Overall Study|Adverse Event|4|||
46873612|NCT02898454|83093302|FG001|Overall Study|Adverse Event|1|||
46873613|NCT02898454|83093303|FG002|Overall Study|Adverse Event|2|||
46873614|NCT02898454|83093301|FG000|Overall Study|Protocol Violation|1|||
46873615|NCT02898454|83093302|FG001|Overall Study|Protocol Violation|0|||
46873616|NCT02898454|83093303|FG002|Overall Study|Protocol Violation|1|||
46873617|NCT02898454|83093301|FG000|Overall Study|Lack of Efficacy|4|||
46873618|NCT02898454|83093302|FG001|Overall Study|Lack of Efficacy|1|||
46873619|NCT02898454|83093303|FG002|Overall Study|Lack of Efficacy|0|||
46873620|NCT02898454|83093301|FG000|Overall Study|Withdrawal by Subject|6|||
46873621|NCT02898454|83093302|FG001|Overall Study|Withdrawal by Subject|3|||
46873622|NCT02898454|83093303|FG002|Overall Study|Withdrawal by Subject|3|||
46873623|NCT02898454|83093301|FG000|Overall Study|Lost to Follow-up|1|||
46873624|NCT02898454|83093302|FG001|Overall Study|Lost to Follow-up|0|||
46873625|NCT02898454|83093303|FG002|Overall Study|Lost to Follow-up|0|||
46873626|NCT02898454|83093301|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
46873627|NCT02898454|83093302|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
46873628|NCT02898454|83093303|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
46873629|NCT03772587|83093321|FG000|Overall Study|COVID-19|0|||
46873630|NCT03772587|83093322|FG001|Overall Study|COVID-19|0|||
46873631|NCT03772587|83093323|FG002|Overall Study|COVID-19|1|||
46873632|NCT03772587|83093324|FG003|Overall Study|COVID-19|1|||
46873633|NCT03772587|83093325|FG004|Overall Study|COVID-19|0|||
46873634|NCT03772587|83093321|FG000|Overall Study|Withdrawal by Subject|1|||
46873635|NCT03772587|83093322|FG001|Overall Study|Withdrawal by Subject|0|||
46873636|NCT03772587|83093323|FG002|Overall Study|Withdrawal by Subject|0|||
46873637|NCT03772587|83093324|FG003|Overall Study|Withdrawal by Subject|0|||
46873638|NCT03772587|83093325|FG004|Overall Study|Withdrawal by Subject|0|||
46873639|NCT02963506|83093352|FG000|Double-Blind Period|Adverse Event|0|||
46873640|NCT02963506|83093353|FG001|Double-Blind Period|Adverse Event|0|||
46873641|NCT02963506|83093354|FG002|Double-Blind Period|Adverse Event|1|||
46873642|NCT02963506|83093355|FG003|Double-Blind Period|Adverse Event|0|||
46873643|NCT02963506|83093356|FG004|Double-Blind Period|Adverse Event|0|||
46873644|NCT02963506|83093357|FG005|Double-Blind Period|Adverse Event|0|||
46873645|NCT02963506|83093358|FG006|Double-Blind Period|Adverse Event|0|||
46873646|NCT02963506|83093359|FG007|Double-Blind Period|Adverse Event|0|||
46873647|NCT02963506|83093360|FG008|Double-Blind Period|Adverse Event|0|||
46873648|NCT02963506|83093361|FG009|Double-Blind Period|Adverse Event|0|||
46873649|NCT02963506|83093362|FG010|Double-Blind Period|Adverse Event|0|||
46873650|NCT02963506|83093363|FG011|Double-Blind Period|Adverse Event|0|||
46873651|NCT02963506|83093364|FG012|Double-Blind Period|Adverse Event|0|||
46873652|NCT02963506|83093352|FG000|Double-Blind Period|Death|0|||
46873653|NCT02963506|83093353|FG001|Double-Blind Period|Death|0|||
46873654|NCT02963506|83093354|FG002|Double-Blind Period|Death|0|||
46873655|NCT02963506|83093355|FG003|Double-Blind Period|Death|1|||
46873656|NCT02963506|83093356|FG004|Double-Blind Period|Death|0|||
46873657|NCT02963506|83093357|FG005|Double-Blind Period|Death|0|||
46873658|NCT02963506|83093358|FG006|Double-Blind Period|Death|0|||
46873659|NCT02963506|83093359|FG007|Double-Blind Period|Death|0|||
46873660|NCT02963506|83093360|FG008|Double-Blind Period|Death|0|||
46873661|NCT02963506|83093361|FG009|Double-Blind Period|Death|0|||
46873662|NCT02963506|83093362|FG010|Double-Blind Period|Death|0|||
46873663|NCT02963506|83093363|FG011|Double-Blind Period|Death|0|||
46873664|NCT02963506|83093364|FG012|Double-Blind Period|Death|0|||
46873665|NCT02963506|83093352|FG000|Double-Blind Period|Lost to Follow-up|0|||
46873666|NCT02963506|83093353|FG001|Double-Blind Period|Lost to Follow-up|1|||
46873667|NCT02963506|83093354|FG002|Double-Blind Period|Lost to Follow-up|0|||
46873668|NCT02963506|83093355|FG003|Double-Blind Period|Lost to Follow-up|0|||
46873669|NCT02963506|83093356|FG004|Double-Blind Period|Lost to Follow-up|0|||
46873670|NCT02963506|83093357|FG005|Double-Blind Period|Lost to Follow-up|0|||
46873671|NCT02963506|83093358|FG006|Double-Blind Period|Lost to Follow-up|0|||
46873672|NCT02963506|83093359|FG007|Double-Blind Period|Lost to Follow-up|0|||
46873673|NCT02963506|83093360|FG008|Double-Blind Period|Lost to Follow-up|0|||
46873674|NCT02963506|83093361|FG009|Double-Blind Period|Lost to Follow-up|0|||
46873675|NCT02963506|83093362|FG010|Double-Blind Period|Lost to Follow-up|0|||
46873676|NCT02963506|83093363|FG011|Double-Blind Period|Lost to Follow-up|0|||
46873677|NCT02963506|83093364|FG012|Double-Blind Period|Lost to Follow-up|0|||
46873678|NCT02963506|83093352|FG000|Double-Blind Period|Withdrawal by Subject|0|||
46873679|NCT02963506|83093353|FG001|Double-Blind Period|Withdrawal by Subject|0|||
46873680|NCT02963506|83093354|FG002|Double-Blind Period|Withdrawal by Subject|1|||
46873681|NCT02963506|83093355|FG003|Double-Blind Period|Withdrawal by Subject|1|||
46873682|NCT02963506|83093356|FG004|Double-Blind Period|Withdrawal by Subject|0|||
46873683|NCT02963506|83093357|FG005|Double-Blind Period|Withdrawal by Subject|0|||
46873684|NCT02963506|83093358|FG006|Double-Blind Period|Withdrawal by Subject|0|||
46873685|NCT02963506|83093359|FG007|Double-Blind Period|Withdrawal by Subject|0|||
46873686|NCT02963506|83093360|FG008|Double-Blind Period|Withdrawal by Subject|0|||
46873687|NCT02963506|83093361|FG009|Double-Blind Period|Withdrawal by Subject|0|||
46873688|NCT02963506|83093362|FG010|Double-Blind Period|Withdrawal by Subject|0|||
46873689|NCT02963506|83093363|FG011|Double-Blind Period|Withdrawal by Subject|0|||
46873690|NCT02963506|83093364|FG012|Double-Blind Period|Withdrawal by Subject|0|||
46873691|NCT02963506|83093352|FG000|Double-Blind Period|No compliance|0|||
46873692|NCT02963506|83093353|FG001|Double-Blind Period|No compliance|1|||
46873693|NCT02963506|83093354|FG002|Double-Blind Period|No compliance|0|||
46873694|NCT02963506|83093355|FG003|Double-Blind Period|No compliance|0|||
46873695|NCT02963506|83093356|FG004|Double-Blind Period|No compliance|0|||
46873696|NCT02963506|83093357|FG005|Double-Blind Period|No compliance|0|||
46873697|NCT02963506|83093358|FG006|Double-Blind Period|No compliance|0|||
46873698|NCT02963506|83093359|FG007|Double-Blind Period|No compliance|0|||
46873699|NCT02963506|83093360|FG008|Double-Blind Period|No compliance|0|||
46873700|NCT02963506|83093361|FG009|Double-Blind Period|No compliance|0|||
46873701|NCT02963506|83093362|FG010|Double-Blind Period|No compliance|0|||
46873702|NCT02963506|83093363|FG011|Double-Blind Period|No compliance|0|||
46873703|NCT02963506|83093364|FG012|Double-Blind Period|No compliance|0|||
46873704|NCT02963506|83093352|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873705|NCT02963506|83093353|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
46873706|NCT02963506|83093354|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873707|NCT02963506|83093355|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873708|NCT02963506|83093356|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873709|NCT02963506|83093357|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873710|NCT02963506|83093358|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873711|NCT02963506|83093359|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873712|NCT02963506|83093360|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873713|NCT02963506|83093361|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873714|NCT02963506|83093362|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873715|NCT02963506|83093363|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873716|NCT02963506|83093364|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
46873717|NCT02963506|83093352|FG000|Dose-Blind Period|Adverse Event|0|||
46873718|NCT02963506|83093353|FG001|Dose-Blind Period|Adverse Event|0|||
46873719|NCT02963506|83093354|FG002|Dose-Blind Period|Adverse Event|0|||
46873720|NCT02963506|83093355|FG003|Dose-Blind Period|Adverse Event|0|||
46873721|NCT02963506|83093356|FG004|Dose-Blind Period|Adverse Event|0|||
46873722|NCT02963506|83093357|FG005|Dose-Blind Period|Adverse Event|1|||
46873723|NCT02963506|83093358|FG006|Dose-Blind Period|Adverse Event|3|||
46873724|NCT02963506|83093359|FG007|Dose-Blind Period|Adverse Event|2|||
46873725|NCT02963506|83093360|FG008|Dose-Blind Period|Adverse Event|2|||
46873726|NCT02963506|83093361|FG009|Dose-Blind Period|Adverse Event|2|||
46873727|NCT02963506|83093362|FG010|Dose-Blind Period|Adverse Event|1|||
46873728|NCT02963506|83093363|FG011|Dose-Blind Period|Adverse Event|1|||
46873729|NCT02963506|83093364|FG012|Dose-Blind Period|Adverse Event|6|||
46873730|NCT02963506|83093352|FG000|Dose-Blind Period|Lack of Efficacy|0|||
46873731|NCT02963506|83093353|FG001|Dose-Blind Period|Lack of Efficacy|0|||
46873732|NCT02963506|83093354|FG002|Dose-Blind Period|Lack of Efficacy|0|||
46873733|NCT02963506|83093355|FG003|Dose-Blind Period|Lack of Efficacy|0|||
46873734|NCT02963506|83093356|FG004|Dose-Blind Period|Lack of Efficacy|0|||
46873735|NCT02963506|83093357|FG005|Dose-Blind Period|Lack of Efficacy|0|||
46873736|NCT02963506|83093358|FG006|Dose-Blind Period|Lack of Efficacy|0|||
46873737|NCT02963506|83093359|FG007|Dose-Blind Period|Lack of Efficacy|1|||
46873738|NCT02963506|83093360|FG008|Dose-Blind Period|Lack of Efficacy|0|||
46873739|NCT02963506|83093361|FG009|Dose-Blind Period|Lack of Efficacy|1|||
46873740|NCT02963506|83093362|FG010|Dose-Blind Period|Lack of Efficacy|0|||
46873741|NCT02963506|83093363|FG011|Dose-Blind Period|Lack of Efficacy|0|||
46873742|NCT02963506|83093364|FG012|Dose-Blind Period|Lack of Efficacy|0|||
46873743|NCT02963506|83093352|FG000|Dose-Blind Period|Lost to Follow-up|0|||
46873744|NCT02963506|83093353|FG001|Dose-Blind Period|Lost to Follow-up|0|||
46873745|NCT02963506|83093354|FG002|Dose-Blind Period|Lost to Follow-up|0|||
46873746|NCT02963506|83093355|FG003|Dose-Blind Period|Lost to Follow-up|0|||
46873747|NCT02963506|83093356|FG004|Dose-Blind Period|Lost to Follow-up|0|||
46873748|NCT02963506|83093357|FG005|Dose-Blind Period|Lost to Follow-up|1|||
46873749|NCT02963506|83093358|FG006|Dose-Blind Period|Lost to Follow-up|0|||
46873750|NCT02963506|83093359|FG007|Dose-Blind Period|Lost to Follow-up|0|||
46873751|NCT02963506|83093360|FG008|Dose-Blind Period|Lost to Follow-up|1|||
46873752|NCT02963506|83093361|FG009|Dose-Blind Period|Lost to Follow-up|0|||
46873753|NCT02963506|83093362|FG010|Dose-Blind Period|Lost to Follow-up|0|||
46873754|NCT02963506|83093363|FG011|Dose-Blind Period|Lost to Follow-up|1|||
46873755|NCT02963506|83093364|FG012|Dose-Blind Period|Lost to Follow-up|0|||
46873756|NCT02963506|83093352|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
46873757|NCT02963506|83093353|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
46873758|NCT02963506|83093354|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
46873759|NCT02963506|83093355|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
46984250|NCT02561195|83230267|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46873760|NCT02963506|83093356|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
46873761|NCT02963506|83093357|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
46873762|NCT02963506|83093358|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
46873763|NCT02963506|83093359|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
46873764|NCT02963506|83093360|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
46873765|NCT02963506|83093361|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
46873766|NCT02963506|83093362|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
46873767|NCT02963506|83093363|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
46873768|NCT02963506|83093364|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
46873769|NCT02963506|83093352|FG000|Dose-Blind Period|Sponsor decision|0|||
46873770|NCT02963506|83093353|FG001|Dose-Blind Period|Sponsor decision|0|||
46873771|NCT02963506|83093354|FG002|Dose-Blind Period|Sponsor decision|0|||
46873772|NCT02963506|83093355|FG003|Dose-Blind Period|Sponsor decision|0|||
46873773|NCT02963506|83093356|FG004|Dose-Blind Period|Sponsor decision|0|||
46873774|NCT02963506|83093357|FG005|Dose-Blind Period|Sponsor decision|1|||
46873775|NCT02963506|83093358|FG006|Dose-Blind Period|Sponsor decision|0|||
46873776|NCT02963506|83093359|FG007|Dose-Blind Period|Sponsor decision|0|||
46873777|NCT02963506|83093360|FG008|Dose-Blind Period|Sponsor decision|0|||
46873778|NCT02963506|83093361|FG009|Dose-Blind Period|Sponsor decision|0|||
46873779|NCT02963506|83093362|FG010|Dose-Blind Period|Sponsor decision|0|||
46873780|NCT02963506|83093363|FG011|Dose-Blind Period|Sponsor decision|0|||
46873781|NCT02963506|83093364|FG012|Dose-Blind Period|Sponsor decision|0|||
46873782|NCT02963506|83093352|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873783|NCT02963506|83093353|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873784|NCT02963506|83093354|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873785|NCT02963506|83093355|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873786|NCT02963506|83093356|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873787|NCT02963506|83093357|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873788|NCT02963506|83093358|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873789|NCT02963506|83093359|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873790|NCT02963506|83093360|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873791|NCT02963506|83093361|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873792|NCT02963506|83093362|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873793|NCT02963506|83093363|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
46873794|NCT02963506|83093364|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
46873795|NCT01345162|83093383|FG000|Overall Study|Protocol Violation|2|||
46873796|NCT01345162|83093384|FG001|Overall Study|Protocol Violation|4|||
46873797|NCT01345318|83093390|FG000|Overall Study|Adverse Event|16|||
46873798|NCT01345318|83093390|FG000|Overall Study|Lack of Efficacy|17|||
46873799|NCT01345318|83093390|FG000|Overall Study|Lost to Follow-up|2|||
46873800|NCT01345318|83093390|FG000|Overall Study|Protocol Violation|1|||
46873801|NCT01345318|83093390|FG000|Overall Study|Withdrawal by Subject|41|||
46873802|NCT01345318|83093390|FG000|Overall Study|Other|3|||
46873803|NCT02961244|83093397|FG000|Overall Study|Protocol Violation|0|||
46873804|NCT02961244|83093398|FG001|Overall Study|Protocol Violation|1|||
46873805|NCT02961244|83093397|FG000|Overall Study|Withdrawal by Subject|1|||
46873806|NCT02961244|83093398|FG001|Overall Study|Withdrawal by Subject|2|||
46873807|NCT02961244|83093397|FG000|Overall Study|Surgery plan change after study approval|0|||
46873808|NCT02961244|83093398|FG001|Overall Study|Surgery plan change after study approval|2|||
46873809|NCT02961244|83093397|FG000|Overall Study|Lost to Follow-up|0|||
46873810|NCT02961244|83093398|FG001|Overall Study|Lost to Follow-up|2|||
46873811|NCT02961244|83093397|FG000|Overall Study|İnadequate data|0|||
46873812|NCT02961244|83093398|FG001|Overall Study|İnadequate data|2|||
46873813|NCT03771963|83093404|FG000|Overall Study|Lost to Follow-up|22|||
46873814|NCT03771963|83093404|FG000|Overall Study|Withdrawal of Consent|10|||
46873815|NCT02962648|83093408|FG000|Overall Study|Withdrawal by Subject|3|||
46873816|NCT02962648|83093408|FG000|Overall Study|Lost to Follow-up|3|||
46873817|NCT02962648|83093408|FG000|Overall Study|Physician Decision|1|||
46873818|NCT02962648|83093408|FG000|Overall Study|Subject had problems with transportation|2|||
46873819|NCT02962882|83093412|FG000|Overall Study|Adverse Event|2|||
46702063|NCT01078155|82916922|FG000|Overall Study|Participant's Decision|6|||
46873820|NCT02962882|83093412|FG000|Overall Study|Withdrawal by Subject|2|||
46873821|NCT02962882|83093412|FG000|Overall Study|Transfer from ICU|32|||
46873822|NCT02961790|83093421|FG000|Overall Study|Canceled|4|||
46873823|NCT02961790|83093422|FG001|Overall Study|Canceled|5|||
46873824|NCT02961790|83093423|FG002|Overall Study|Canceled|1|||
46873825|NCT02961790|83093424|FG003|Overall Study|Canceled|4|||
46984251|NCT02561195|83230268|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46873826|NCT02961790|83093421|FG000|Overall Study|without baseline data|4|||
46873827|NCT02961790|83093422|FG001|Overall Study|without baseline data|0|||
46873828|NCT02961790|83093423|FG002|Overall Study|without baseline data|1|||
46873829|NCT02961790|83093424|FG003|Overall Study|without baseline data|0|||
46873830|NCT02961790|83093421|FG000|Overall Study|without post baseline data|7|||
46873831|NCT02961790|83093422|FG001|Overall Study|without post baseline data|6|||
46873832|NCT02961790|83093423|FG002|Overall Study|without post baseline data|4|||
46873833|NCT02961790|83093424|FG003|Overall Study|without post baseline data|1|||
46873834|NCT02960854|83093446|FG000|Overall Study|Not Disclosed|2|||
46873835|NCT02960854|83093447|FG001|Overall Study|Not Disclosed|2|||
46873836|NCT02960854|83093446|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
46873837|NCT02960854|83093447|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
46873838|NCT02960854|83093446|FG000|Overall Study|Subject Withdrew Consent|0|||
46873839|NCT02960854|83093447|FG001|Overall Study|Subject Withdrew Consent|1|||
46873840|NCT02960854|83093446|FG000|Overall Study|Death|4|||
46873841|NCT02960854|83093447|FG001|Overall Study|Death|6|||
46873842|NCT01344538|83093455|FG000|Overall Study|Adverse Event|1|||
46873843|NCT01344538|83093456|FG001|Overall Study|Adverse Event|1|||
46873844|NCT01344538|83093455|FG000|Overall Study|Lost to Follow-up|1|||
46873845|NCT01344538|83093456|FG001|Overall Study|Lost to Follow-up|0|||
46873846|NCT01344460|83093462|FG000|Overall Study|Withdrawal by Subject|1|||
46873847|NCT01344460|83093462|FG000|Overall Study|Lost to Follow-up|2|||
46873848|NCT03764631|83093472|FG000|Overall Study|Personal Reasons|3|||
46873849|NCT03764631|83093473|FG001|Overall Study|Personal Reasons|2|||
46873850|NCT03764631|83093472|FG000|Overall Study|Switching Therapy|3|||
46873851|NCT03764631|83093473|FG001|Overall Study|Switching Therapy|3|||
46873852|NCT03764631|83093472|FG000|Overall Study|Adverse Event|0|||
46873853|NCT03764631|83093473|FG001|Overall Study|Adverse Event|1|||
46873854|NCT03764631|83093472|FG000|Overall Study|Lost to Follow-up|33|||
46873855|NCT03764631|83093473|FG001|Overall Study|Lost to Follow-up|41|||
46873856|NCT03764631|83093472|FG000|Overall Study|No data as study site was closed|2|||
46873857|NCT03764631|83093473|FG001|Overall Study|No data as study site was closed|6|||
46873858|NCT02956486|83093492|FG000|Core Phase|Adverse Event|51|||
46873859|NCT02956486|83093493|FG001|Core Phase|Adverse Event|88|||
46873860|NCT02956486|83093494|FG002|Core Phase|Adverse Event|0|||
46873861|NCT02956486|83093492|FG000|Core Phase|Lost to Follow-up|8|||
46873862|NCT02956486|83093493|FG001|Core Phase|Lost to Follow-up|6|||
46873863|NCT02956486|83093494|FG002|Core Phase|Lost to Follow-up|0|||
46873864|NCT02956486|83093492|FG000|Core Phase|Inadequate therapeutic effect|4|||
46873865|NCT02956486|83093493|FG001|Core Phase|Inadequate therapeutic effect|5|||
46873866|NCT02956486|83093494|FG002|Core Phase|Inadequate therapeutic effect|0|||
46873867|NCT02956486|83093492|FG000|Core Phase|Withdrawal by Subject|101|||
46873868|NCT02956486|83093493|FG001|Core Phase|Withdrawal by Subject|104|||
46873869|NCT02956486|83093494|FG002|Core Phase|Withdrawal by Subject|0|||
46873870|NCT02956486|83093492|FG000|Core Phase|Study terminated by sponsor|888|||
46873871|NCT02956486|83093493|FG001|Core Phase|Study terminated by sponsor|848|||
46873872|NCT02956486|83093494|FG002|Core Phase|Study terminated by sponsor|0|||
46873873|NCT02956486|83093492|FG000|Core Phase|Other|27|||
46873874|NCT02956486|83093493|FG001|Core Phase|Other|18|||
46873875|NCT02956486|83093494|FG002|Core Phase|Other|0|||
46873876|NCT02956486|83093492|FG000|Core Phase|Not treated|0|||
46873877|NCT02956486|83093493|FG001|Core Phase|Not treated|3|||
46873878|NCT02956486|83093494|FG002|Core Phase|Not treated|0|||
46873879|NCT02956486|83093492|FG000|Extension Phase|Adverse Event|0|||
46873880|NCT02956486|83093493|FG001|Extension Phase|Adverse Event|0|||
46873881|NCT02956486|83093494|FG002|Extension Phase|Adverse Event|2|||
46873882|NCT02956486|83093492|FG000|Extension Phase|Study terminated by sponsor|0|||
46873883|NCT02956486|83093493|FG001|Extension Phase|Study terminated by sponsor|0|||
46873884|NCT02956486|83093494|FG002|Extension Phase|Study terminated by sponsor|16|||
46873885|NCT02956486|83093492|FG000|Extension Phase|Not Treated|0|||
46702064|NCT01078155|82916922|FG000|Overall Study|Lost to Follow-up|15|||
46873886|NCT02956486|83093493|FG001|Extension Phase|Not Treated|0|||
46873887|NCT02956486|83093494|FG002|Extension Phase|Not Treated|1|||
46873888|NCT03445533|83093509|FG000|Overall Study|Progressive Disease|48|||
46873889|NCT03445533|83093510|FG001|Overall Study|Progressive Disease|81|||
46873890|NCT03445533|83093509|FG000|Overall Study|Adverse Event|60|||
46873891|NCT03445533|83093510|FG001|Overall Study|Adverse Event|64|||
46873892|NCT03445533|83093509|FG000|Overall Study|Death|9|||
46873893|NCT03445533|83093510|FG001|Overall Study|Death|19|||
46873894|NCT03445533|83093509|FG000|Overall Study|Miscellaneous|0|||
46873895|NCT03445533|83093510|FG001|Overall Study|Miscellaneous|16|||
46873896|NCT03445533|83093509|FG000|Overall Study|Withdrawal by Subject|3|||
46873897|NCT03445533|83093510|FG001|Overall Study|Withdrawal by Subject|4|||
46873898|NCT03445533|83093509|FG000|Overall Study|Physician Decision|1|||
46873899|NCT03445533|83093510|FG001|Overall Study|Physician Decision|3|||
46873900|NCT03445533|83093509|FG000|Overall Study|Sponsor Decision|0|||
46873901|NCT03445533|83093510|FG001|Overall Study|Sponsor Decision|1|||
46873902|NCT03445533|83093509|FG000|Overall Study|Lost to Follow-up|0|||
46873903|NCT03445533|83093510|FG001|Overall Study|Lost to Follow-up|1|||
46873904|NCT03445533|83093509|FG000|Overall Study|Never Received any Study Treatment|7|||
46873905|NCT03445533|83093510|FG001|Overall Study|Never Received any Study Treatment|4|||
46873906|NCT01337050|83093519|FG000|Overall Study|Death|0|||
46873907|NCT01337050|83093520|FG001|Overall Study|Death|0|||
46873908|NCT01337050|83093521|FG002|Overall Study|Death|4|||
46873909|NCT01337050|83093519|FG000|Overall Study|Other|4|||
46873910|NCT01337050|83093520|FG001|Overall Study|Other|6|||
46873911|NCT01337050|83093521|FG002|Overall Study|Other|8|||
46873912|NCT01337050|83093519|FG000|Overall Study|Participants refused further follow-up|0|||
46873913|NCT01337050|83093520|FG001|Overall Study|Participants refused further follow-up|7|||
46873914|NCT01337050|83093521|FG002|Overall Study|Participants refused further follow-up|7|||
46873915|NCT01336972|83093533|FG000|Overall Study|Adverse Event|1|||
46873916|NCT01336972|83093534|FG001|Overall Study|Adverse Event|1|||
46873917|NCT01336972|83093535|FG002|Overall Study|Adverse Event|0|||
46873918|NCT03762681|83093552|FG000|Part 1|Withdrawal by Subject|0|||
46873919|NCT03762681|83093553|FG001|Part 1|Withdrawal by Subject|0|||
46873920|NCT03762681|83093554|FG002|Part 1|Withdrawal by Subject|0|||
46873921|NCT03762681|83093555|FG003|Part 1|Withdrawal by Subject|1|||
46873922|NCT03762681|83093556|FG004|Part 1|Withdrawal by Subject|0|||
46873923|NCT03762681|83093557|FG005|Part 1|Withdrawal by Subject|0|||
46873924|NCT03762681|83093558|FG006|Part 1|Withdrawal by Subject|0|||
46873925|NCT03762681|83093559|FG007|Part 1|Withdrawal by Subject|0|||
46873926|NCT03762681|83093552|FG000|Part 2a|Pandemic Travel Restrictions|0|||
46873927|NCT03762681|83093553|FG001|Part 2a|Pandemic Travel Restrictions|0|||
46873928|NCT03762681|83093554|FG002|Part 2a|Pandemic Travel Restrictions|0|||
46873929|NCT03762681|83093555|FG003|Part 2a|Pandemic Travel Restrictions|0|||
46873930|NCT03762681|83093556|FG004|Part 2a|Pandemic Travel Restrictions|0|||
46873931|NCT03762681|83093557|FG005|Part 2a|Pandemic Travel Restrictions|0|||
46873932|NCT03762681|83093558|FG006|Part 2a|Pandemic Travel Restrictions|0|||
46873933|NCT03762681|83093559|FG007|Part 2a|Pandemic Travel Restrictions|1|||
46873934|NCT03764475|83093588|FG000|Overall Study|Adverse Event|11|||
46873935|NCT03764475|83093589|FG001|Overall Study|Adverse Event|2|||
46873936|NCT03764475|83093588|FG000|Overall Study|Lost to Follow-up|24|||
46873937|NCT03764475|83093589|FG001|Overall Study|Lost to Follow-up|10|||
46873938|NCT03764475|83093588|FG000|Overall Study|Withdrawal by Subject|26|||
46873939|NCT03764475|83093589|FG001|Overall Study|Withdrawal by Subject|10|||
46873940|NCT03764475|83093588|FG000|Overall Study|Lack of Efficacy|3|||
46873941|NCT03764475|83093589|FG001|Overall Study|Lack of Efficacy|0|||
46873942|NCT03764475|83093588|FG000|Overall Study|COVID-19 Disruption|2|||
46873943|NCT03764475|83093589|FG001|Overall Study|COVID-19 Disruption|0|||
46873944|NCT02872012|83093604|FG000|Overall Study|Withdrawal by Subject|1|||
46873945|NCT02872012|83093605|FG001|Overall Study|Withdrawal by Subject|0|||
46873946|NCT02872012|83093606|FG002|Overall Study|Withdrawal by Subject|0|||
46873947|NCT02872012|83093607|FG003|Overall Study|Withdrawal by Subject|0|||
46873948|NCT02872012|83093608|FG004|Overall Study|Withdrawal by Subject|0|||
46873949|NCT02959138|83093625|FG000|Overall Study|Enrolled but Never Treated|0|||
46873950|NCT02959138|83093626|FG001|Overall Study|Enrolled but Never Treated|1|||
46873951|NCT02959138|83093627|FG002|Overall Study|Enrolled but Never Treated|0|||
46873952|NCT01344226|83093639|FG000|Overall Study|Protocol Violation|2|||
46873953|NCT01344226|83093639|FG000|Overall Study|Withdrawal by Subject|3|||
46873954|NCT01344226|83093639|FG000|Overall Study|Lack of Efficacy|3|||
46702065|NCT01201356|82916926|FG000|Overall Study|Adverse Event|170|||
46702066|NCT01201356|82916926|FG000|Overall Study|Abnormal laboratory value(s)|51|||
46702067|NCT01201356|82916926|FG000|Overall Study|Abnormal test procedure result(s)|3|||
46873955|NCT02869438|83093645|FG000|Overall Study|Lost to Follow-up|1|||
46873956|NCT02869438|83093646|FG001|Overall Study|Lost to Follow-up|0|||
46873957|NCT02869438|83093645|FG000|Overall Study|Adverse Event|1|||
46873958|NCT02869438|83093646|FG001|Overall Study|Adverse Event|0|||
46873959|NCT02869438|83093645|FG000|Overall Study|Withdrawal by Subject|1|||
46873960|NCT02869438|83093646|FG001|Overall Study|Withdrawal by Subject|2|||
46873961|NCT02868892|83093652|FG000|Overall Study|Investigator left site and no follow-up|6|||
46873962|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Death|1|||
46873963|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Death|1|||
46873964|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Death|0|||
46873965|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Death|0|||
46873966|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Death|1|||
46873967|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Death|0|||
46873968|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Death|0|||
46873969|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Death|0|||
46873970|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Death|0|||
46873971|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Death|0|||
46873972|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
46873973|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
46873974|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
46873975|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
46873976|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
46873977|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
46873978|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
46873979|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
46873980|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
46873981|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
46873982|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873983|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873984|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873985|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873986|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
46873987|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873988|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873989|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873990|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873991|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
46873992|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
46873993|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46873994|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46873995|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46873996|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46873997|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46873998|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46873999|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46874000|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46874001|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
46874002|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
46874003|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
46874004|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
46874005|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
46874006|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
46874007|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
46874008|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
46874009|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
46874010|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
46874011|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
46874012|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
46874013|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874014|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874015|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
46874016|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874017|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874018|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874019|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874020|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874021|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
46874022|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
46874023|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
46874024|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
46874025|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
46874026|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
46874027|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
46874028|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
46874029|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
46874030|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
46874031|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
46874032|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
46874033|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
46874034|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
46874035|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46897066|NCT00706654|83122634|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
46874036|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
46874037|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874038|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874039|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874040|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874041|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874042|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
46874043|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
46874044|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
46874045|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
46874046|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
46874047|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
46874048|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
46874049|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
46874050|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
46874051|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
46874052|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
46874053|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
46874054|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874055|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
46874056|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
46874057|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874058|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874059|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874060|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874061|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874062|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874063|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874064|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
46874065|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874066|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
46874067|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874068|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874069|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874070|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874071|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874072|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
46874073|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
46874074|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
46874075|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
46874076|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
46874077|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
46874078|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
46874079|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
46874080|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
46874081|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
46874082|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874083|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874084|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874085|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
46874086|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
46874087|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874088|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874089|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874090|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874091|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874092|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
46874093|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874094|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
46874095|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
46874096|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
46874097|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874098|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874099|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874100|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874101|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874102|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
46874103|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874104|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874105|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874106|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
46874107|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874108|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874109|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874110|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874111|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
46874112|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874113|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874114|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874115|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874116|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
46874117|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874118|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874119|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874120|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874121|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874122|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874123|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
46874124|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874125|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874126|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
46874127|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874128|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874129|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874130|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874131|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
46874132|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
46874133|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46874134|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46984252|NCT02561195|83230269|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46984253|NCT02561195|83230270|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
46984254|NCT02561195|83230271|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
46874135|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46874136|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
46874137|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46874138|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46874139|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46874140|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46874141|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
46874142|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
46874143|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
46874144|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
46874145|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
46874146|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
46874147|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
46874148|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
46874149|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
46874150|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
46874151|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
46874152|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Other|5|||
46874153|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Other|1|||
46874154|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Other|0|||
46874155|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Other|3|||
46874156|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Other|0|||
46874157|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Other|0|||
46874158|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Other|0|||
46874159|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Other|0|||
46874160|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Other|0|||
46874161|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Other|0|||
46874162|NCT03352557|83093661|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874163|NCT03352557|83093662|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874164|NCT03352557|83093663|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874165|NCT03352557|83093664|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874166|NCT03352557|83093665|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
46874167|NCT03352557|83093666|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874168|NCT03352557|83093667|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874169|NCT03352557|83093668|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874170|NCT03352557|83093669|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874171|NCT03352557|83093670|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
46874172|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Death|0|||
46874173|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Death|0|||
46874174|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Death|0|||
46874175|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Death|0|||
46874176|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Death|0|||
46874177|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Death|1|||
46874178|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Death|0|||
46874179|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Death|1|||
46874180|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Death|1|||
46874181|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Death|1|||
46874182|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874183|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874184|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874185|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874186|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874187|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
46874188|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874189|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874190|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874191|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
46874192|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874193|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874194|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46984255|NCT02561195|83230272|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
46984256|NCT02561195|83230273|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
46984257|NCT02561195|83230260|FG000|Extension Stage (Vaccination 4)|Other|0|||
46874195|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874196|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874197|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874198|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874199|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874200|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
46707557|NCT01176240|82923136|FG001|Study 306B|Adverse Event|5|||
46874201|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
46874202|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
46874203|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
46874204|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
46874205|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
46874206|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
46874207|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
46874208|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
46874209|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
46874210|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
46874211|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
46874212|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874213|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874214|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874215|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874216|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874217|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
46874218|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
46874219|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
46874220|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
46874221|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
46874222|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874223|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874224|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874225|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874226|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874227|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
46874228|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874229|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
46874230|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
46874231|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
46874232|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
46874233|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
46874234|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
46874235|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
46874236|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
46874237|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
46874238|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
46874239|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
46874240|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
46874241|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
46874242|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874243|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874244|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874245|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874246|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874247|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874248|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874249|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
46874250|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
46874251|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
46874252|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874253|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874254|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874255|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874256|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874257|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874258|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874259|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
46874260|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874261|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
46874262|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874263|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874264|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874265|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874266|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874267|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874268|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874269|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
46874270|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874271|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
46874272|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874273|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874274|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874275|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874276|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874277|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874278|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874279|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
46874280|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
46874281|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
46874282|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874283|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874284|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874285|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874286|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874287|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
46874288|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874289|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874290|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
46874291|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
46874292|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874293|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874294|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874295|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874296|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874297|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874298|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874299|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874300|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
46874301|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
46874302|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874303|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874304|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874305|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874306|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874307|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874308|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874309|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
46874310|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
46874311|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
46874312|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874313|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874314|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874315|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874316|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874317|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874318|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874319|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
46874320|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
46874321|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
46874322|NCT03352557|83093661|FG000|LTE Period: Week 80 to Week 173|Other|0|||
46874323|NCT03352557|83093662|FG001|LTE Period: Week 80 to Week 173|Other|0|||
46874324|NCT03352557|83093663|FG002|LTE Period: Week 80 to Week 173|Other|0|||
46874325|NCT03352557|83093664|FG003|LTE Period: Week 80 to Week 173|Other|0|||
46874326|NCT03352557|83093665|FG004|LTE Period: Week 80 to Week 173|Other|0|||
46874327|NCT03352557|83093666|FG005|LTE Period: Week 80 to Week 173|Other|0|||
46874328|NCT03352557|83093667|FG006|LTE Period: Week 80 to Week 173|Other|0|||
46874329|NCT03352557|83093668|FG007|LTE Period: Week 80 to Week 173|Other|1|||
46874330|NCT03352557|83093669|FG008|LTE Period: Week 80 to Week 173|Other|0|||
46874331|NCT03352557|83093670|FG009|LTE Period: Week 80 to Week 173|Other|0|||
46874332|NCT02866942|83093695|FG000|Overall Study|Invalid consent|1|||
46984258|NCT02561195|83230261|FG001|Extension Stage (Vaccination 4)|Other|0|||
46984259|NCT02561195|83230262|FG002|Extension Stage (Vaccination 4)|Other|0|||
46984260|NCT02561195|83230263|FG003|Extension Stage (Vaccination 4)|Other|0|||
46874333|NCT01336894|83093749|FG000|Follow-up|Study terminated prematurely|2|||
46874334|NCT01336894|83093750|FG001|Follow-up|Study terminated prematurely|7|||
46874335|NCT02572167|83093759|FG000|Overall Study|Withdrawal by Subject|0|||
46874336|NCT02572167|83093760|FG001|Overall Study|Withdrawal by Subject|3|||
46874337|NCT02572167|83093761|FG002|Overall Study|Withdrawal by Subject|0|||
46874338|NCT02572167|83093759|FG000|Overall Study|Lost to Follow-up|2|||
46874339|NCT02572167|83093760|FG001|Overall Study|Lost to Follow-up|5|||
46874340|NCT02572167|83093761|FG002|Overall Study|Lost to Follow-up|3|||
46874341|NCT02572167|83093759|FG000|Overall Study|Death|0|||
46874342|NCT02572167|83093760|FG001|Overall Study|Death|8|||
46874343|NCT02572167|83093761|FG002|Overall Study|Death|3|||
46874344|NCT02572167|83093759|FG000|Overall Study|Did not meet inclusion criteria|0|||
46874345|NCT02572167|83093760|FG001|Overall Study|Did not meet inclusion criteria|0|||
46874346|NCT02572167|83093761|FG002|Overall Study|Did not meet inclusion criteria|1|||
46874347|NCT02572167|83093759|FG000|Overall Study|Study closure by Sponsor|4|||
46874348|NCT02572167|83093760|FG001|Overall Study|Study closure by Sponsor|40|||
46874349|NCT02572167|83093761|FG002|Overall Study|Study closure by Sponsor|24|||
46874350|NCT01336738|83093775|FG000|Overall Study|Adverse Event|0|||
46874351|NCT01336738|83093776|FG001|Overall Study|Adverse Event|3|||
46874352|NCT01336738|83093777|FG002|Overall Study|Adverse Event|2|||
46874353|NCT01336738|83093778|FG003|Overall Study|Adverse Event|1|||
46874354|NCT01336738|83093779|FG004|Overall Study|Adverse Event|3|||
46874355|NCT01336738|83093775|FG000|Overall Study|Lost to Follow-up|2|||
46874356|NCT01336738|83093776|FG001|Overall Study|Lost to Follow-up|1|||
46874357|NCT01336738|83093777|FG002|Overall Study|Lost to Follow-up|2|||
46874358|NCT01336738|83093778|FG003|Overall Study|Lost to Follow-up|2|||
46874359|NCT01336738|83093779|FG004|Overall Study|Lost to Follow-up|2|||
46874360|NCT01336738|83093775|FG000|Overall Study|Did not meet entrance criteria|0|||
46874361|NCT01336738|83093776|FG001|Overall Study|Did not meet entrance criteria|1|||
46874362|NCT01336738|83093777|FG002|Overall Study|Did not meet entrance criteria|0|||
46874363|NCT01336738|83093778|FG003|Overall Study|Did not meet entrance criteria|0|||
46874364|NCT01336738|83093779|FG004|Overall Study|Did not meet entrance criteria|0|||
46874365|NCT01336738|83093775|FG000|Overall Study|Protocol Violation|0|||
46874366|NCT01336738|83093776|FG001|Overall Study|Protocol Violation|1|||
46984261|NCT02561195|83230264|FG004|Extension Stage (Vaccination 4)|Other|0|||
46874367|NCT01336738|83093777|FG002|Overall Study|Protocol Violation|0|||
46874368|NCT01336738|83093778|FG003|Overall Study|Protocol Violation|0|||
46874369|NCT01336738|83093779|FG004|Overall Study|Protocol Violation|0|||
46874370|NCT01336738|83093775|FG000|Overall Study|Withdrawal by Subject|2|||
46874371|NCT01336738|83093776|FG001|Overall Study|Withdrawal by Subject|0|||
46874372|NCT01336738|83093777|FG002|Overall Study|Withdrawal by Subject|2|||
46874373|NCT01336738|83093778|FG003|Overall Study|Withdrawal by Subject|1|||
46874374|NCT01336738|83093779|FG004|Overall Study|Withdrawal by Subject|1|||
46874375|NCT01336738|83093775|FG000|Overall Study|Other|3|||
46984262|NCT02561195|83230265|FG005|Extension Stage (Vaccination 4)|Other|0|||
46707558|NCT01176240|82923135|FG000|Study 306B|Protocol Violation|2|||
46874376|NCT01336738|83093776|FG001|Overall Study|Other|3|||
46874377|NCT01336738|83093777|FG002|Overall Study|Other|2|||
46874378|NCT01336738|83093778|FG003|Overall Study|Other|3|||
46874379|NCT01336738|83093779|FG004|Overall Study|Other|4|||
46874380|NCT02865538|83093796|FG000|Overall Study|Withdrawal by Subject|0|||
46874381|NCT02865538|83093797|FG001|Overall Study|Withdrawal by Subject|0|||
46874382|NCT02865538|83093798|FG002|Overall Study|Withdrawal by Subject|1|||
46874383|NCT02865538|83093799|FG003|Overall Study|Withdrawal by Subject|0|||
46874384|NCT02865538|83093800|FG004|Overall Study|Withdrawal by Subject|0|||
46874385|NCT02865538|83093796|FG000|Overall Study|Lost to Follow-up|1|||
46874386|NCT02865538|83093797|FG001|Overall Study|Lost to Follow-up|0|||
46874387|NCT02865538|83093798|FG002|Overall Study|Lost to Follow-up|0|||
46874388|NCT02865538|83093799|FG003|Overall Study|Lost to Follow-up|0|||
46874389|NCT02865538|83093800|FG004|Overall Study|Lost to Follow-up|0|||
46874390|NCT02860546|83093812|FG000|Overall Study|Clinical Progression|6|||
46874391|NCT02860546|83093812|FG000|Overall Study|Radiological Progression|12|||
46874392|NCT01982955|83093821|FG000|Overall Study|Randomized but not treated|0|||
46874393|NCT01982955|83093822|FG001|Overall Study|Randomized but not treated|0|||
46874394|NCT01982955|83093823|FG002|Overall Study|Randomized but not treated|0|||
46874395|NCT01982955|83093824|FG003|Overall Study|Randomized but not treated|1|||
46874396|NCT01982955|83093825|FG004|Overall Study|Randomized but not treated|0|||
46874397|NCT00396279|83093838|FG000|Overall Study|Ongoing in study|26|||
46874398|NCT00396279|83093838|FG000|Overall Study|Disease progression|2|||
46874399|NCT00396279|83093838|FG000|Overall Study|Withdrawal by Subject|1|||
46874400|NCT00396279|83093838|FG000|Overall Study|Physician Decision|1|||
46874401|NCT01347866|83093859|FG000|Overall Study|Death|0|||
46874402|NCT01347866|83093860|FG001|Overall Study|Death|0|||
46874403|NCT01347866|83093861|FG002|Overall Study|Death|0|||
46874404|NCT01347866|83093862|FG003|Overall Study|Death|1|||
46874405|NCT01347866|83093863|FG004|Overall Study|Death|2|||
46874406|NCT01347866|83093864|FG005|Overall Study|Death|2|||
46874407|NCT01347866|83093865|FG006|Overall Study|Death|1|||
46874408|NCT01347866|83093866|FG007|Overall Study|Death|0|||
46874409|NCT01347866|83093867|FG008|Overall Study|Death|4|||
46874410|NCT01347866|83093868|FG009|Overall Study|Death|1|||
46874411|NCT01347866|83093869|FG010|Overall Study|Death|3|||
46874412|NCT01347866|83093870|FG011|Overall Study|Death|1|||
46874413|NCT01347866|83093871|FG012|Overall Study|Death|2|||
46874414|NCT01347866|83093872|FG013|Overall Study|Death|0|||
46874415|NCT01347866|83093873|FG014|Overall Study|Death|0|||
46874416|NCT01347866|83093874|FG015|Overall Study|Death|1|||
46874417|NCT01347866|83093875|FG016|Overall Study|Death|0|||
46874418|NCT01347866|83093859|FG000|Overall Study|Lost to Follow-up|0|||
46874419|NCT01347866|83093860|FG001|Overall Study|Lost to Follow-up|0|||
46874420|NCT01347866|83093861|FG002|Overall Study|Lost to Follow-up|0|||
46874421|NCT01347866|83093862|FG003|Overall Study|Lost to Follow-up|0|||
46874422|NCT01347866|83093863|FG004|Overall Study|Lost to Follow-up|0|||
46874423|NCT01347866|83093864|FG005|Overall Study|Lost to Follow-up|0|||
46874424|NCT01347866|83093865|FG006|Overall Study|Lost to Follow-up|0|||
46874425|NCT01347866|83093866|FG007|Overall Study|Lost to Follow-up|1|||
46874426|NCT01347866|83093867|FG008|Overall Study|Lost to Follow-up|1|||
46874427|NCT01347866|83093868|FG009|Overall Study|Lost to Follow-up|0|||
46874428|NCT01347866|83093869|FG010|Overall Study|Lost to Follow-up|0|||
46984263|NCT02561195|83230266|FG006|Extension Stage (Vaccination 4)|Other|0|||
46984264|NCT02561195|83230267|FG007|Extension Stage (Vaccination 4)|Other|0|||
46984265|NCT02561195|83230268|FG008|Extension Stage (Vaccination 4)|Other|0|||
46984266|NCT02561195|83230269|FG009|Extension Stage (Vaccination 4)|Other|0|||
46874429|NCT01347866|83093870|FG011|Overall Study|Lost to Follow-up|0|||
46874430|NCT01347866|83093871|FG012|Overall Study|Lost to Follow-up|0|||
46874431|NCT01347866|83093872|FG013|Overall Study|Lost to Follow-up|0|||
46874432|NCT01347866|83093873|FG014|Overall Study|Lost to Follow-up|0|||
46702068|NCT01201356|82916926|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
46802767|NCT00484185|83022038|FG000|Overall Study|Other|20|||
46802768|NCT00484185|83022038|FG000|Overall Study|Randomized but not treated|5|||
46802769|NCT00484185|83022038|FG000|Overall Study|Death|2|||
46802770|NCT00097981|83022044|FG000|Overall Study|Adverse Event|31|||
46802771|NCT00097981|83022045|FG001|Overall Study|Adverse Event|44|||
46802772|NCT00097981|83022044|FG000|Overall Study|Withdrawal by Subject|10|||
46802773|NCT00097981|83022045|FG001|Overall Study|Withdrawal by Subject|8|||
46802774|NCT00097981|83022044|FG000|Overall Study|Protocol Violation|1|||
46802775|NCT00097981|83022045|FG001|Overall Study|Protocol Violation|1|||
46802776|NCT00097981|83022044|FG000|Overall Study|Death|2|||
46802777|NCT00097981|83022045|FG001|Overall Study|Death|4|||
46802778|NCT00097981|83022044|FG000|Overall Study|Physician Decision|7|||
46802779|NCT00097981|83022045|FG001|Overall Study|Physician Decision|1|||
46802780|NCT00097981|83022044|FG000|Overall Study|Disease Progression|8|||
46802781|NCT00097981|83022045|FG001|Overall Study|Disease Progression|2|||
46874433|NCT01347866|83093874|FG015|Overall Study|Lost to Follow-up|0|||
46874434|NCT01347866|83093875|FG016|Overall Study|Lost to Follow-up|0|||
46874435|NCT01347866|83093859|FG000|Overall Study|Other|3|||
46874436|NCT01347866|83093860|FG001|Overall Study|Other|1|||
46874437|NCT01347866|83093861|FG002|Overall Study|Other|1|||
46874438|NCT01347866|83093862|FG003|Overall Study|Other|4|||
46874439|NCT01347866|83093863|FG004|Overall Study|Other|5|||
46874440|NCT01347866|83093864|FG005|Overall Study|Other|0|||
46874441|NCT01347866|83093865|FG006|Overall Study|Other|5|||
46874442|NCT01347866|83093866|FG007|Overall Study|Other|3|||
46874443|NCT01347866|83093867|FG008|Overall Study|Other|22|||
46874444|NCT01347866|83093868|FG009|Overall Study|Other|5|||
46874445|NCT01347866|83093869|FG010|Overall Study|Other|0|||
46874446|NCT01347866|83093870|FG011|Overall Study|Other|3|||
46874447|NCT01347866|83093871|FG012|Overall Study|Other|4|||
46874448|NCT01347866|83093872|FG013|Overall Study|Other|4|||
46874449|NCT01347866|83093873|FG014|Overall Study|Other|2|||
46874450|NCT01347866|83093874|FG015|Overall Study|Other|3|||
46874451|NCT01347866|83093875|FG016|Overall Study|Other|0|||
46874452|NCT01347866|83093859|FG000|Overall Study|Subject refused further follow-up|2|||
46874453|NCT01347866|83093860|FG001|Overall Study|Subject refused further follow-up|0|||
46874454|NCT01347866|83093861|FG002|Overall Study|Subject refused further follow-up|0|||
46874455|NCT01347866|83093862|FG003|Overall Study|Subject refused further follow-up|2|||
46874456|NCT01347866|83093863|FG004|Overall Study|Subject refused further follow-up|0|||
46874457|NCT01347866|83093864|FG005|Overall Study|Subject refused further follow-up|1|||
46874458|NCT01347866|83093865|FG006|Overall Study|Subject refused further follow-up|0|||
46874459|NCT01347866|83093866|FG007|Overall Study|Subject refused further follow-up|0|||
46874460|NCT01347866|83093867|FG008|Overall Study|Subject refused further follow-up|4|||
46874461|NCT01347866|83093868|FG009|Overall Study|Subject refused further follow-up|1|||
46874462|NCT01347866|83093869|FG010|Overall Study|Subject refused further follow-up|0|||
46874463|NCT01347866|83093870|FG011|Overall Study|Subject refused further follow-up|0|||
46874464|NCT01347866|83093871|FG012|Overall Study|Subject refused further follow-up|1|||
46874465|NCT01347866|83093872|FG013|Overall Study|Subject refused further follow-up|3|||
46874466|NCT01347866|83093873|FG014|Overall Study|Subject refused further follow-up|1|||
46874467|NCT01347866|83093874|FG015|Overall Study|Subject refused further follow-up|0|||
46874468|NCT01347866|83093875|FG016|Overall Study|Subject refused further follow-up|2|||
46874469|NCT01347710|83093946|FG000|Overall Study|Withdrawal by Subject|2|||
46874470|NCT01347710|83093946|FG000|Overall Study|Adverse Event|4|||
46874471|NCT01347710|83093946|FG000|Overall Study|Angio or SPECT not completed|18|||
46874472|NCT01347710|83093946|FG000|Overall Study|issue with vitals prior to dosing|1|||
46874473|NCT01347710|83093946|FG000|Overall Study|Lost to Follow-up|1|||
46874474|NCT01347710|83093946|FG000|Overall Study|Physician Decision|2|||
46874475|NCT01347710|83093946|FG000|Overall Study|Other|3|||
46874476|NCT03485222|83093956|FG000|Overall Study|Death|0|||
46874477|NCT03485222|83093957|FG001|Overall Study|Death|1|||
46874478|NCT03485222|83093956|FG000|Overall Study|Lost to Follow-up|2|||
46874479|NCT03485222|83093957|FG001|Overall Study|Lost to Follow-up|1|||
46874480|NCT01347554|83093965|FG000|Overall Study|Lack of Efficacy|7|||
46874481|NCT01347554|83093966|FG001|Overall Study|Lack of Efficacy|11|||
46874482|NCT03482882|83093972|FG000|Overall Study|Adverse Event|3|||
46874483|NCT03482882|83093972|FG000|Overall Study|Lost to Follow-up|1|||
46874484|NCT03482882|83093972|FG000|Overall Study|Protocol Violation|2|||
46874485|NCT03482882|83093972|FG000|Overall Study|Not further specified|1|||
46874486|NCT03480932|83093979|FG000|Overall Study|Death|1|||
46874487|NCT03480932|83093980|FG001|Overall Study|Death|1|||
46702069|NCT01201356|82916926|FG000|Overall Study|Condition no longer requires study drug|12|||
46874488|NCT03480932|83093981|FG002|Overall Study|Death|0|||
46874489|NCT03480932|83093979|FG000|Overall Study|Lost to Follow-up|0|||
46874490|NCT03480932|83093980|FG001|Overall Study|Lost to Follow-up|2|||
46874491|NCT03480932|83093981|FG002|Overall Study|Lost to Follow-up|3|||
46874492|NCT03480932|83093979|FG000|Overall Study|Incarcerated|2|||
46874493|NCT03480932|83093980|FG001|Overall Study|Incarcerated|2|||
46874494|NCT03480932|83093981|FG002|Overall Study|Incarcerated|2|||
46874495|NCT03387020|83093992|FG000|Overall Study|Adverse Event|0|||
46874496|NCT03387020|83093993|FG001|Overall Study|Adverse Event|2|||
46874497|NCT03387020|83093994|FG002|Overall Study|Adverse Event|0|||
46874498|NCT03387020|83093992|FG000|Overall Study|Withdrawal by Subject|2|||
46874499|NCT03387020|83093993|FG001|Overall Study|Withdrawal by Subject|0|||
46874500|NCT03387020|83093994|FG002|Overall Study|Withdrawal by Subject|0|||
46874501|NCT03386474|83094014|FG000|Overall Study|Death|1|||
46874502|NCT03386474|83094015|FG001|Overall Study|Death|0|||
46874503|NCT03386474|83094014|FG000|Overall Study|Adverse Event|0|||
46874504|NCT03386474|83094015|FG001|Overall Study|Adverse Event|1|||
46874505|NCT03405818|83094026|FG000|Overall Study|Withdrawal by Subject|4|||
46874506|NCT03405818|83094026|FG000|Overall Study|Lost to Follow-up|4|||
46874507|NCT03403634|83094030|FG000|Overall Study|Disease progression|3|||
46874508|NCT03403634|83094030|FG000|Overall Study|Did not meet eligibility criteria|4|||
46874509|NCT03403400|83094037|FG000|Overall Study|Lost to Follow-up|1|||
46874510|NCT03403400|83094038|FG001|Overall Study|Lost to Follow-up|0|||
46874511|NCT03403400|83094039|FG002|Overall Study|Lost to Follow-up|1|||
46874512|NCT03403400|83094037|FG000|Overall Study|Hospitalization|1|||
46874513|NCT03403400|83094038|FG001|Overall Study|Hospitalization|0|||
46874514|NCT03403400|83094039|FG002|Overall Study|Hospitalization|0|||
46874515|NCT03403400|83094037|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
46874516|NCT03403400|83094038|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
46874517|NCT03403400|83094039|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
46874518|NCT02863354|83094064|FG000|Year 1|Lost to Follow-up|1|||
46874519|NCT02863354|83094065|FG001|Year 1|Lost to Follow-up|1|||
46874520|NCT02863354|83094064|FG000|Year 1|Withdrawal by Subject|3|||
46874521|NCT02863354|83094065|FG001|Year 1|Withdrawal by Subject|0|||
46874522|NCT02863354|83094064|FG000|Year 1|Death|0|||
46874523|NCT02863354|83094065|FG001|Year 1|Death|1|||
46874524|NCT02863354|83094064|FG000|Year 2|Lost to Follow-up|2|||
46874525|NCT02863354|83094065|FG001|Year 2|Lost to Follow-up|2|||
46874526|NCT03480152|83094073|FG000|Phase I|Signed consent. Died before treatment.|1|||
46874527|NCT03480152|83094074|FG001|Phase I|Signed consent. Died before treatment.|0|||
46874528|NCT03480152|83094075|FG002|Phase I|Signed consent. Died before treatment.|0|||
46874529|NCT02859454|83094083|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
46874530|NCT02862730|83094090|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
46874531|NCT02862730|83094091|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
46874532|NCT02862730|83094092|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
46874533|NCT02862730|83094093|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
46874534|NCT02862730|83094094|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
46874535|NCT02862730|83094095|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
46874536|NCT02862730|83094096|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
46874537|NCT02862730|83094090|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
46874538|NCT02862730|83094091|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
46874539|NCT02862730|83094092|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
46874540|NCT02862730|83094093|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
46874541|NCT02862730|83094094|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
46874542|NCT02862730|83094095|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
46984267|NCT02561195|83230270|FG010|Extension Stage (Vaccination 4)|Other|2|||
46984268|NCT02561195|83230271|FG011|Extension Stage (Vaccination 4)|Other|2|||
46984269|NCT02561195|83230272|FG012|Extension Stage (Vaccination 4)|Other|1|||
46984270|NCT02561195|83230273|FG013|Extension Stage (Vaccination 4)|Other|0|||
46984271|NCT02561195|83230260|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984272|NCT02561195|83230261|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984273|NCT02561195|83230262|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984274|NCT02561195|83230263|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984275|NCT02561195|83230264|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984276|NCT02561195|83230265|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984277|NCT02561195|83230266|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
46984278|NCT02561195|83230267|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984279|NCT02561195|83230268|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984280|NCT02561195|83230269|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984281|NCT02561195|83230270|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
46984282|NCT02561195|83230271|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
46984283|NCT02561195|83230272|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
46984284|NCT02561195|83230273|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
46984285|NCT01663103|83230307|FG000|Overall Study|Withdrawal by Subject|1|||
46984286|NCT01663103|83230308|FG001|Overall Study|Withdrawal by Subject|2|||
46984287|NCT01663103|83230307|FG000|Overall Study|Adverse Event|1|||
46984288|NCT01663103|83230308|FG001|Overall Study|Adverse Event|0|||
46984289|NCT01663103|83230307|FG000|Overall Study|dog bite|1|||
46984290|NCT01663103|83230308|FG001|Overall Study|dog bite|0|||
46984291|NCT02560025|83230327|FG000|Overall Study|Ineligible after consent/ registration|3|||
46984292|NCT02566889|83230342|FG000|Overall Study|Withdrawal by Subject|3|||
46984293|NCT02566889|83230343|FG001|Overall Study|Withdrawal by Subject|1|||
46984294|NCT02566889|83230342|FG000|Overall Study|Adverse Event|4|||
46984295|NCT02566889|83230343|FG001|Overall Study|Adverse Event|2|||
46984296|NCT02566889|83230342|FG000|Overall Study|Other|6|||
46874543|NCT02862730|83094096|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
46874544|NCT02862730|83094090|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
46984297|NCT02566889|83230343|FG001|Overall Study|Other|2|||
46984298|NCT02566577|83230350|FG000|Overall Study|Withdrawal by Subject|1|||
46984299|NCT02566577|83230351|FG001|Overall Study|Withdrawal by Subject|1|||
46984300|NCT02566577|83230350|FG000|Overall Study|Equipment failure|1|||
46984301|NCT02566577|83230351|FG001|Overall Study|Equipment failure|1|||
46984302|NCT02566577|83230350|FG000|Overall Study|Physical limitation|1|||
46984303|NCT02566577|83230351|FG001|Overall Study|Physical limitation|0|||
46984304|NCT02559713|83230363|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
46984305|NCT01358981|83230374|FG000|Period 1|Withdrawal by Subject|0|||
46984306|NCT01358981|83230375|FG001|Period 1|Withdrawal by Subject|0|||
46874545|NCT02862730|83094091|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
46874546|NCT02862730|83094092|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
46874547|NCT02862730|83094093|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
46874548|NCT02862730|83094094|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
46874549|NCT02862730|83094095|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
46874550|NCT02862730|83094096|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
46874551|NCT02862730|83094090|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
46874552|NCT02862730|83094091|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
46874553|NCT02862730|83094092|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
46874554|NCT02862730|83094093|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
46874555|NCT02862730|83094094|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
46874556|NCT02862730|83094095|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
46874557|NCT02862730|83094096|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
46874558|NCT03353792|83094113|FG000|Overall Study|Lost to Follow-up|1|||
46874559|NCT03353792|83094114|FG001|Overall Study|Lost to Follow-up|0|||
46874560|NCT03353792|83094113|FG000|Overall Study|Participant Unable to Manage Device|1|||
46874561|NCT03353792|83094114|FG001|Overall Study|Participant Unable to Manage Device|0|||
46702070|NCT01201356|82916926|FG000|Overall Study|Withdrawal by Subject|144|||
46702071|NCT01201356|82916926|FG000|Overall Study|Lost to Follow-up|50|||
46702072|NCT01201356|82916926|FG000|Overall Study|administrative problems|74|||
46702073|NCT01201356|82916926|FG000|Overall Study|Death|16|||
46874562|NCT02862574|83094123|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46874563|NCT02862574|83094124|FG001|Double-Blind Treatment Period|Adverse Event|1|||
46874564|NCT02862574|83094125|FG002|Double-Blind Treatment Period|Adverse Event|0|||
46874565|NCT02862574|83094123|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
46874566|NCT02862574|83094124|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
46874567|NCT02862574|83094125|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
46874568|NCT02862574|83094123|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
46874569|NCT02862574|83094124|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
46874570|NCT02862574|83094125|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
46874571|NCT02862106|83094140|FG000|Overall Study|Adverse Event|4|||
46874572|NCT02862106|83094141|FG001|Overall Study|Adverse Event|0|||
46874573|NCT02862106|83094140|FG000|Overall Study|Protocol Violation|16|||
46874574|NCT02862106|83094141|FG001|Overall Study|Protocol Violation|1|||
46874575|NCT02862106|83094140|FG000|Overall Study|Lost to Follow-up|15|||
46874576|NCT02862106|83094141|FG001|Overall Study|Lost to Follow-up|5|||
46874577|NCT02862106|83094140|FG000|Overall Study|Withdrawal by Subject|2|||
46874578|NCT02862106|83094141|FG001|Overall Study|Withdrawal by Subject|0|||
46874579|NCT02862106|83094140|FG000|Overall Study|Subjects moved to other city|1|||
46874580|NCT02862106|83094141|FG001|Overall Study|Subjects moved to other city|0|||
46874581|NCT04157296|83094156|FG000|Overall Study|Withdrawal by Subject|0|||
46874582|NCT04157296|83094157|FG001|Overall Study|Withdrawal by Subject|1|||
46874583|NCT04157296|83094156|FG000|Overall Study|Did not obtain second fMRI.|0|||
46874584|NCT04157296|83094157|FG001|Overall Study|Did not obtain second fMRI.|1|||
46874585|NCT04157296|83094156|FG000|Overall Study|MRI failed/no second fMRI|0|||
46874586|NCT04157296|83094157|FG001|Overall Study|MRI failed/no second fMRI|1|||
46874587|NCT02859142|83094165|FG000|Overall Study|Adverse Event|1|||
46874588|NCT02859142|83094166|FG001|Overall Study|Adverse Event|2|||
46874589|NCT02859142|83094165|FG000|Overall Study|Lost to Follow-up|1|||
46874590|NCT02859142|83094166|FG001|Overall Study|Lost to Follow-up|4|||
46874591|NCT02859142|83094165|FG000|Overall Study|Withdrawal by Subject|2|||
46874592|NCT02859142|83094166|FG001|Overall Study|Withdrawal by Subject|0|||
46874593|NCT02859142|83094165|FG000|Overall Study|Scheduling difficulties|0|||
46874594|NCT02859142|83094166|FG001|Overall Study|Scheduling difficulties|3|||
46874595|NCT03351608|83094177|FG000|Overall Study|Lost to Follow-up|0|||
46874596|NCT03351608|83094178|FG001|Overall Study|Lost to Follow-up|1|||
46874597|NCT03351608|83094179|FG002|Overall Study|Lost to Follow-up|1|||
46874598|NCT03351608|83094180|FG003|Overall Study|Lost to Follow-up|1|||
46874599|NCT03351608|83094181|FG004|Overall Study|Lost to Follow-up|1|||
46874600|NCT03351608|83094177|FG000|Overall Study|Physician Decision|1|||
46874601|NCT03351608|83094178|FG001|Overall Study|Physician Decision|0|||
46874602|NCT03351608|83094179|FG002|Overall Study|Physician Decision|0|||
46874603|NCT03351608|83094180|FG003|Overall Study|Physician Decision|2|||
46702074|NCT01201356|82916926|FG000|Overall Study|Protocol Violation|12|||
46874604|NCT03351608|83094181|FG004|Overall Study|Physician Decision|1|||
46702075|NCT01200810|82916932|FG000|Overall Study|Physician Decision|1|||
46874605|NCT03351608|83094177|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
46874606|NCT03351608|83094178|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
46874607|NCT03351608|83094179|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
46984307|NCT01358981|83230376|FG002|Period 1|Withdrawal by Subject|0|||
46702076|NCT01200810|82916933|FG001|Overall Study|Physician Decision|0|||
46702077|NCT01200810|82916932|FG000|Overall Study|Withdrawal by Subject|1|||
46702078|NCT01200810|82916933|FG001|Overall Study|Withdrawal by Subject|2|||
46874608|NCT03351608|83094180|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
46874609|NCT03351608|83094181|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
46874610|NCT03351608|83094177|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46874611|NCT03351608|83094178|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46874612|NCT03351608|83094179|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46874613|NCT03351608|83094180|FG003|Overall Study|Withdrawal by parent/guardian|1|||
46874614|NCT03351608|83094181|FG004|Overall Study|Withdrawal by parent/guardian|0|||
46874615|NCT03351608|83094177|FG000|Overall Study|Other|0|||
46874616|NCT03351608|83094178|FG001|Overall Study|Other|1|||
46874617|NCT03351608|83094179|FG002|Overall Study|Other|1|||
46874618|NCT03351608|83094180|FG003|Overall Study|Other|3|||
46874619|NCT03351608|83094181|FG004|Overall Study|Other|0|||
46874620|NCT02857816|83094204|FG000|Overall Study|Screen Failure|33|||
46874621|NCT02857816|83094204|FG000|Overall Study|Withdrawal by Subject|4|||
46874622|NCT02857816|83094204|FG000|Overall Study|Lost to Follow-up|1|||
46874623|NCT02858440|83094209|FG000|Overall Study|Lost to Follow-up|3|||
46874624|NCT02858440|83094209|FG000|Overall Study|Protocol Violation|2|||
46874625|NCT02858440|83094209|FG000|Overall Study|Consent withdrawal|3|||
46874626|NCT02858440|83094209|FG000|Overall Study|Migrated/moved from study area|4|||
46874627|NCT03382418|83094216|FG000|Overall Study|Withdrawal by Subject|1|||
46874628|NCT03382418|83094217|FG001|Overall Study|Withdrawal by Subject|0|||
46874629|NCT03382418|83094218|FG002|Overall Study|Withdrawal by Subject|0|||
46874630|NCT03382418|83094216|FG000|Overall Study|Lost to Follow-up|2|||
46874631|NCT03382418|83094217|FG001|Overall Study|Lost to Follow-up|3|||
46874632|NCT03382418|83094218|FG002|Overall Study|Lost to Follow-up|0|||
46874633|NCT02858362|83094230|FG000|Overall Study|Protocol Violation|0|||
46874634|NCT02858362|83094231|FG001|Overall Study|Protocol Violation|1|||
46874635|NCT02858362|83094232|FG002|Overall Study|Protocol Violation|0|||
46874636|NCT02858362|83094230|FG000|Overall Study|Withdrawal by Subject|1|||
46874637|NCT02858362|83094231|FG001|Overall Study|Withdrawal by Subject|0|||
46874638|NCT02858362|83094232|FG002|Overall Study|Withdrawal by Subject|0|||
46874639|NCT02858362|83094230|FG000|Overall Study|Early Study Termination|0|||
46874640|NCT02858362|83094231|FG001|Overall Study|Early Study Termination|0|||
46874641|NCT02858362|83094232|FG002|Overall Study|Early Study Termination|3|||
46874642|NCT02858362|83094230|FG000|Overall Study|Lost to Follow-up|1|||
46874643|NCT02858362|83094231|FG001|Overall Study|Lost to Follow-up|0|||
46874644|NCT02858362|83094232|FG002|Overall Study|Lost to Follow-up|0|||
46874645|NCT03350750|83094247|FG000|Overall Study|Death|1|||
46874646|NCT03350750|83094248|FG001|Overall Study|Death|1|||
46874647|NCT03394508|83094258|FG000|Overall Study|Protocol Violation|0|||
46874648|NCT03394508|83094259|FG001|Overall Study|Protocol Violation|3|||
46874649|NCT03394508|83094258|FG000|Overall Study|Lost to Follow-up|1|||
46874650|NCT03394508|83094259|FG001|Overall Study|Lost to Follow-up|0|||
46874651|NCT02856880|83094269|FG000|Overall Study|Withdrawal of consent|1|||
46874652|NCT03393806|83094290|FG000|Overall Study|Physician Decision|1|||
46874653|NCT03393806|83094291|FG001|Overall Study|Physician Decision|0|||
46874654|NCT02856802|83094300|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
46874655|NCT02856802|83094301|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
46874656|NCT02856802|83094300|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
46874657|NCT02856802|83094301|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
46874658|NCT02856802|83094300|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
46874659|NCT02856802|83094301|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
46874660|NCT02856802|83094300|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
46874661|NCT02856802|83094301|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
46874662|NCT02856802|83094300|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
46874663|NCT02856802|83094301|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
46874664|NCT02856802|83094300|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
46874665|NCT02856802|83094301|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
46874666|NCT03380390|83094311|FG000|Overall Study|Adverse Event|3|||
46874667|NCT03350672|83094318|FG000|Overall Study|Withdrawal by Subject|7|||
46874668|NCT03350672|83094319|FG001|Overall Study|Withdrawal by Subject|0|||
46984308|NCT01358981|83230377|FG003|Period 1|Withdrawal by Subject|1|||
46984309|NCT01358981|83230378|FG004|Period 1|Withdrawal by Subject|0|||
46874669|NCT03350672|83094320|FG002|Overall Study|Withdrawal by Subject|0|||
46874670|NCT03392168|83094332|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
46874671|NCT03392168|83094333|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
46874672|NCT03392168|83094334|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
46874673|NCT03392168|83094335|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
46874674|NCT03392168|83094332|FG000|Period 2: Cohort 2|Other|0|||
46874675|NCT03392168|83094333|FG001|Period 2: Cohort 2|Other|1|||
46874676|NCT03392168|83094334|FG002|Period 2: Cohort 2|Other|0|||
46874677|NCT03392168|83094335|FG003|Period 2: Cohort 2|Other|0|||
46874678|NCT03391232|83094346|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
46874679|NCT03391232|83094347|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
46874680|NCT03391232|83094346|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
46984310|NCT01358981|83230379|FG005|Period 1|Withdrawal by Subject|0|||
46874681|NCT03391232|83094347|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
46874682|NCT03379376|83094355|FG000|Overall Study|Lost to Follow-up|2|||
46874683|NCT03379376|83094355|FG000|Overall Study|Did not wish to complete follow up|1|||
46874684|NCT03379376|83094355|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
46874685|NCT03379376|83094355|FG000|Overall Study|Death|1|||
46874686|NCT03349034|83094361|FG000|Overall Study|catheters dislodged during transport|2|||
46874687|NCT03349034|83094362|FG001|Overall Study|catheters dislodged during transport|0|||
46874688|NCT03349034|83094361|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
46702079|NCT01200810|82916932|FG000|Overall Study|Sponsor stopped making study drug|3|||
46702080|NCT01200810|82916933|FG001|Overall Study|Sponsor stopped making study drug|3|||
46874689|NCT03349034|83094362|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
46874690|NCT03349034|83094361|FG000|Overall Study|soft tissue flap used|1|||
46874691|NCT03349034|83094362|FG001|Overall Study|soft tissue flap used|0|||
46874692|NCT03349034|83094361|FG000|Overall Study|Other|0|||
46874693|NCT03349034|83094362|FG001|Overall Study|Other|1|||
46874694|NCT00358215|83094372|FG000|Overall Study|Ineligibility determined|4|||
46874695|NCT00358215|83094373|FG001|Overall Study|Ineligibility determined|3|||
46874696|NCT00358215|83094372|FG000|Overall Study|Adverse Event|83|||
46874697|NCT00358215|83094373|FG001|Overall Study|Adverse Event|65|||
46874698|NCT00358215|83094372|FG000|Overall Study|Withdrawal by Subject|111|||
46874699|NCT00358215|83094373|FG001|Overall Study|Withdrawal by Subject|102|||
46874700|NCT00358215|83094372|FG000|Overall Study|Participant request|65|||
46874701|NCT00358215|83094373|FG001|Overall Study|Participant request|64|||
46874702|NCT00358215|83094372|FG000|Overall Study|Physician Decision|47|||
46874703|NCT00358215|83094373|FG001|Overall Study|Physician Decision|39|||
46874704|NCT00358215|83094372|FG000|Overall Study|Lost to Follow-up|16|||
46874705|NCT00358215|83094373|FG001|Overall Study|Lost to Follow-up|22|||
46874706|NCT00358215|83094372|FG000|Overall Study|Death|265|||
46874707|NCT00358215|83094373|FG001|Overall Study|Death|281|||
46874708|NCT00358215|83094372|FG000|Overall Study|Protocol Violation|64|||
46874709|NCT00358215|83094373|FG001|Overall Study|Protocol Violation|59|||
46874710|NCT00358215|83094372|FG000|Overall Study|Pregnancy|1|||
46874711|NCT00358215|83094373|FG001|Overall Study|Pregnancy|0|||
46874712|NCT00358215|83094372|FG000|Overall Study|Other|21|||
46874713|NCT00358215|83094373|FG001|Overall Study|Other|14|||
46874714|NCT00358215|83094372|FG000|Overall Study|Did not receive investigational product|2|||
46874715|NCT00358215|83094373|FG001|Overall Study|Did not receive investigational product|3|||
46874716|NCT02855164|83094387|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
46874717|NCT02855164|83094388|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
46874718|NCT02855164|83094389|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
46874719|NCT02855164|83094390|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
46874720|NCT02855164|83094391|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
46874721|NCT02855164|83094392|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
46874722|NCT02855164|83094393|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
46874723|NCT02855164|83094394|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
46874724|NCT02855164|83094387|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
46874725|NCT02855164|83094388|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
46874726|NCT02855164|83094389|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
46874727|NCT02855164|83094390|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
46874728|NCT02855164|83094391|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
46874729|NCT02855164|83094392|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
46874730|NCT02855164|83094393|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
46702081|NCT01200342|82916939|FG000|Overall Study|Disease Progression|1|||
46802782|NCT00097981|83022044|FG000|Overall Study|Transplant planned|28|||
46802783|NCT00097981|83022045|FG001|Overall Study|Transplant planned|27|||
46802784|NCT00097981|83022044|FG000|Overall Study|Other|19|||
46802785|NCT00097981|83022045|FG001|Overall Study|Other|13|||
46802786|NCT00572195|83022051|FG000|Overall Study|Withdrawal by Subject|50|||
46802787|NCT00572195|83022051|FG000|Overall Study|Death|9|||
46802788|NCT00572195|83022051|FG000|Overall Study|Adverse Event|4|||
46802789|NCT00572195|83022051|FG000|Overall Study|Lost to Follow-up|5|||
46802790|NCT00572039|83022057|FG000|Overall Study|Withdrawal by Subject|9|||
46802791|NCT00572039|83022058|FG001|Overall Study|Withdrawal by Subject|6|||
46802792|NCT00572039|83022057|FG000|Overall Study|Death|2|||
46802793|NCT00572039|83022058|FG001|Overall Study|Death|3|||
46802794|NCT00572039|83022057|FG000|Overall Study|Ill|5|||
46802795|NCT00572039|83022058|FG001|Overall Study|Ill|1|||
46802796|NCT00684593|83022068|FG000|Overall Study|Adverse Event|0|||
46802797|NCT00684593|83022069|FG001|Overall Study|Adverse Event|2|||
46802798|NCT00685373|83022075|FG000|Overall Study|Adverse Event|3|||
46802799|NCT00685373|83022075|FG000|Overall Study|Withdrawal by Subject|5|||
46802800|NCT00685373|83022075|FG000|Overall Study|Lack of Efficacy|3|||
46802801|NCT00685373|83022075|FG000|Overall Study|Condition no longer requires study drug|1|||
46802802|NCT00685373|83022075|FG000|Overall Study|Lost to Follow-up|2|||
46802803|NCT00685373|83022075|FG000|Overall Study|Protocol Violation|1|||
46802804|NCT00684515|83022082|FG000|Overall Study|Adverse Event|3|||
46874731|NCT02855164|83094394|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
46874732|NCT02855164|83094387|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
46874733|NCT02855164|83094388|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
46874734|NCT02855164|83094389|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
46874735|NCT02855164|83094390|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
46874736|NCT02855164|83094391|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
46874737|NCT02855164|83094392|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
46874738|NCT02855164|83094393|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
46874739|NCT02855164|83094394|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
46874740|NCT02855164|83094387|FG000|Part C (Randomized Set)|Adverse Event|0|||
46874741|NCT02855164|83094388|FG001|Part C (Randomized Set)|Adverse Event|0|||
46874742|NCT02855164|83094389|FG002|Part C (Randomized Set)|Adverse Event|0|||
46874743|NCT02855164|83094390|FG003|Part C (Randomized Set)|Adverse Event|0|||
46874744|NCT02855164|83094391|FG004|Part C (Randomized Set)|Adverse Event|0|||
46874745|NCT02855164|83094392|FG005|Part C (Randomized Set)|Adverse Event|5|||
46874746|NCT02855164|83094393|FG006|Part C (Randomized Set)|Adverse Event|9|||
46874747|NCT02855164|83094394|FG007|Part C (Randomized Set)|Adverse Event|2|||
46874748|NCT02855164|83094387|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
46874749|NCT02855164|83094388|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
46874750|NCT02855164|83094389|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
46874751|NCT02855164|83094390|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
46874752|NCT02855164|83094391|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
46874753|NCT02855164|83094392|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
46874754|NCT02855164|83094393|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
46874755|NCT02855164|83094394|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
46874756|NCT02855164|83094387|FG000|Part C (Randomized Set)|Physician Decision|0|||
46874757|NCT02855164|83094388|FG001|Part C (Randomized Set)|Physician Decision|0|||
46874758|NCT02855164|83094389|FG002|Part C (Randomized Set)|Physician Decision|0|||
46874759|NCT02855164|83094390|FG003|Part C (Randomized Set)|Physician Decision|0|||
46874760|NCT02855164|83094391|FG004|Part C (Randomized Set)|Physician Decision|0|||
46874761|NCT02855164|83094392|FG005|Part C (Randomized Set)|Physician Decision|1|||
46874762|NCT02855164|83094393|FG006|Part C (Randomized Set)|Physician Decision|0|||
46874763|NCT02855164|83094394|FG007|Part C (Randomized Set)|Physician Decision|1|||
46874764|NCT02855164|83094387|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
46874765|NCT02855164|83094388|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
46874766|NCT02855164|83094389|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
46874767|NCT02855164|83094390|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
46874768|NCT02855164|83094391|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
46874769|NCT02855164|83094392|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
46874770|NCT02855164|83094393|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
46874771|NCT02855164|83094394|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
46874772|NCT01002742|83094434|FG000|Overall Study|Determined to be ineligible|0|||
46874773|NCT01002742|83094435|FG001|Overall Study|Determined to be ineligible|1|||
46874774|NCT02853760|83094441|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
46874775|NCT02853760|83094442|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
46874776|NCT02853760|83094443|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
46874777|NCT02853760|83094444|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
46874778|NCT02853760|83094445|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
46874779|NCT02853760|83094446|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
46874780|NCT02852434|83094456|FG000|Overall Study|Withdrawal by Subject|0|||
46874781|NCT02852434|83094457|FG001|Overall Study|Withdrawal by Subject|1|||
46874782|NCT02852434|83094456|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
46874783|NCT02852434|83094457|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
46874784|NCT02850016|83094465|FG000|Overall Study|Withdrawal by Subject|1|||
46874785|NCT02850016|83094466|FG001|Overall Study|Withdrawal by Subject|2|||
46874786|NCT02849704|83094474|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
46874787|NCT02849704|83094475|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
46874788|NCT02849704|83094474|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
46874789|NCT02849704|83094475|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
46874790|NCT02849704|83094474|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
46874791|NCT02849704|83094475|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
46802805|NCT00684515|83022083|FG001|Overall Study|Adverse Event|3|||
46802806|NCT00684515|83022084|FG002|Overall Study|Adverse Event|1|||
46802807|NCT00684515|83022082|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
46802808|NCT00684515|83022083|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
46802809|NCT00684515|83022084|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
46802810|NCT00490815|83022094|FG000|Overall Study|Adverse Event|2|||
46802811|NCT00490815|83022095|FG001|Overall Study|Adverse Event|3|||
46802812|NCT00490815|83022094|FG000|Overall Study|Withdrawal by Subject|4|||
46874792|NCT03347396|83094496|FG000|Part A (26 Weeks)|Adverse Event|1|||
46874793|NCT03347396|83094497|FG001|Part A (26 Weeks)|Adverse Event|0|||
46874794|NCT03347396|83094496|FG000|Part A (26 Weeks)|Death|0|||
46874795|NCT03347396|83094497|FG001|Part A (26 Weeks)|Death|1|||
46874796|NCT03347396|83094496|FG000|Part B (149 Weeks)|Adverse Event|1|||
46874797|NCT03347396|83094497|FG001|Part B (149 Weeks)|Adverse Event|1|||
46874798|NCT03347396|83094496|FG000|Part B (149 Weeks)|Death|1|||
46874799|NCT03347396|83094497|FG001|Part B (149 Weeks)|Death|0|||
46874800|NCT03335150|83094508|FG000|Overall Study|Withdrawal by Subject|10|||
46874801|NCT03335150|83094509|FG001|Overall Study|Withdrawal by Subject|4|||
46874802|NCT03335150|83094508|FG000|Overall Study|Adverse Event|0|||
46874803|NCT03335150|83094509|FG001|Overall Study|Adverse Event|1|||
46874804|NCT03334448|83094515|FG000|Washout|Personal Reason|0|||
46874805|NCT03334448|83094516|FG001|Washout|Personal Reason|1|||
46874806|NCT03334448|83094517|FG002|Washout|Personal Reason|0|||
46874807|NCT03334448|83094518|FG003|Washout|Personal Reason|0|||
46874808|NCT03334448|83094515|FG000|Washout|Protocol Violation|0|||
46874809|NCT03334448|83094516|FG001|Washout|Protocol Violation|0|||
46874810|NCT03334448|83094517|FG002|Washout|Protocol Violation|0|||
46874811|NCT03334448|83094518|FG003|Washout|Protocol Violation|1|||
46874812|NCT02849080|83094526|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
46874813|NCT02849080|83094527|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
46874814|NCT02849080|83094528|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
46874815|NCT02849080|83094529|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
46874816|NCT02849080|83094526|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
46874817|NCT02849080|83094527|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
46874818|NCT02849080|83094528|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
46874819|NCT02849080|83094529|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
46874820|NCT02849080|83094526|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
46874821|NCT02849080|83094527|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
46874822|NCT02849080|83094528|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
46874823|NCT02849080|83094529|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
46874824|NCT02849080|83094526|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
46874825|NCT02849080|83094527|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
46874826|NCT02849080|83094528|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
46874827|NCT02849080|83094529|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
46874828|NCT02849080|83094526|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
46874829|NCT02849080|83094527|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
46874830|NCT02849080|83094528|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
46874831|NCT02849080|83094529|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
46874832|NCT02849080|83094526|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
46874833|NCT02849080|83094527|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
46874834|NCT02849080|83094528|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
46874835|NCT02849080|83094529|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
46874836|NCT03346070|83094546|FG000|Overall Study|Death|0|||
46874837|NCT03346070|83094547|FG001|Overall Study|Death|0|||
46874838|NCT03346070|83094548|FG002|Overall Study|Death|0|||
46874839|NCT03346070|83094549|FG003|Overall Study|Death|0|||
46874840|NCT03346070|83094550|FG004|Overall Study|Death|1|||
46874841|NCT03346070|83094546|FG000|Overall Study|Lost to Follow-up|0|||
46874842|NCT03346070|83094547|FG001|Overall Study|Lost to Follow-up|1|||
46874843|NCT03346070|83094548|FG002|Overall Study|Lost to Follow-up|2|||
46874844|NCT03346070|83094549|FG003|Overall Study|Lost to Follow-up|0|||
46874845|NCT03346070|83094550|FG004|Overall Study|Lost to Follow-up|0|||
46874846|NCT03346070|83094546|FG000|Overall Study|Physician Decision|0|||
46874847|NCT03346070|83094547|FG001|Overall Study|Physician Decision|0|||
46874848|NCT03346070|83094548|FG002|Overall Study|Physician Decision|0|||
46874849|NCT03346070|83094549|FG003|Overall Study|Physician Decision|1|||
46874850|NCT03346070|83094550|FG004|Overall Study|Physician Decision|1|||
46874851|NCT03346070|83094546|FG000|Overall Study|Withdrawal by Subject|1|||
46874852|NCT03346070|83094547|FG001|Overall Study|Withdrawal by Subject|0|||
46874853|NCT03346070|83094548|FG002|Overall Study|Withdrawal by Subject|0|||
46874854|NCT03346070|83094549|FG003|Overall Study|Withdrawal by Subject|1|||
46874855|NCT03346070|83094550|FG004|Overall Study|Withdrawal by Subject|0|||
46874856|NCT03346070|83094546|FG000|Overall Study|Study medication not received as planned|2|||
46874857|NCT03346070|83094547|FG001|Overall Study|Study medication not received as planned|3|||
46802813|NCT00490815|83022095|FG001|Overall Study|Withdrawal by Subject|0|||
46874858|NCT03346070|83094548|FG002|Overall Study|Study medication not received as planned|2|||
46874859|NCT03346070|83094549|FG003|Overall Study|Study medication not received as planned|3|||
46802814|NCT00490815|83022094|FG000|Overall Study|Lost to Follow-up|1|||
46802815|NCT00490815|83022095|FG001|Overall Study|Lost to Follow-up|3|||
46802816|NCT00490815|83022094|FG000|Overall Study|Death|1|||
46802817|NCT00490815|83022095|FG001|Overall Study|Death|3|||
46802818|NCT03855189|83022104|FG000|Overall Study|Adverse Event|5|||
46802819|NCT03855189|83022105|FG001|Overall Study|Adverse Event|2|||
46802820|NCT03855189|83022106|FG002|Overall Study|Adverse Event|4|||
46802821|NCT03855189|83022104|FG000|Overall Study|Treatment Failure|1|||
46984311|NCT01358981|83230380|FG006|Period 1|Withdrawal by Subject|0|||
46874860|NCT03346070|83094550|FG004|Overall Study|Study medication not received as planned|2|||
46874861|NCT03346070|83094546|FG000|Overall Study|Screen Failure|0|||
46874862|NCT03346070|83094547|FG001|Overall Study|Screen Failure|0|||
46874863|NCT03346070|83094548|FG002|Overall Study|Screen Failure|0|||
46874864|NCT03346070|83094549|FG003|Overall Study|Screen Failure|1|||
46874865|NCT03346070|83094550|FG004|Overall Study|Screen Failure|1|||
46874866|NCT02951780|83094573|FG000|Period 1|Adverse Event|0|||
46874867|NCT02951780|83094574|FG001|Period 1|Adverse Event|0|||
46874868|NCT02951780|83094575|FG002|Period 1|Adverse Event|0|||
46874869|NCT02951780|83094576|FG003|Period 1|Adverse Event|1|||
46874870|NCT02951780|83094577|FG004|Period 1|Adverse Event|0|||
46874871|NCT02951780|83094578|FG005|Period 1|Adverse Event|0|||
46874872|NCT02951780|83094579|FG006|Period 1|Adverse Event|0|||
46874873|NCT02951780|83094580|FG007|Period 1|Adverse Event|0|||
46874874|NCT02951780|83094581|FG008|Period 1|Adverse Event|0|||
46874875|NCT02951780|83094573|FG000|Period 1|Scheduling Conflicts|0|||
46874876|NCT02951780|83094574|FG001|Period 1|Scheduling Conflicts|0|||
46874877|NCT02951780|83094575|FG002|Period 1|Scheduling Conflicts|0|||
46874878|NCT02951780|83094576|FG003|Period 1|Scheduling Conflicts|0|||
46874879|NCT02951780|83094577|FG004|Period 1|Scheduling Conflicts|0|||
46874880|NCT02951780|83094578|FG005|Period 1|Scheduling Conflicts|0|||
46874881|NCT02951780|83094579|FG006|Period 1|Scheduling Conflicts|0|||
46874882|NCT02951780|83094580|FG007|Period 1|Scheduling Conflicts|1|||
46874883|NCT02951780|83094581|FG008|Period 1|Scheduling Conflicts|0|||
46874884|NCT02951780|83094573|FG000|Period 2|Scheduling Conflicts|0|||
46874885|NCT02951780|83094574|FG001|Period 2|Scheduling Conflicts|0|||
46874886|NCT02951780|83094575|FG002|Period 2|Scheduling Conflicts|0|||
46874887|NCT02951780|83094576|FG003|Period 2|Scheduling Conflicts|0|||
46874888|NCT02951780|83094577|FG004|Period 2|Scheduling Conflicts|0|||
46874889|NCT02951780|83094578|FG005|Period 2|Scheduling Conflicts|0|||
46874890|NCT02951780|83094579|FG006|Period 2|Scheduling Conflicts|0|||
46874891|NCT02951780|83094580|FG007|Period 2|Scheduling Conflicts|1|||
46874892|NCT02951780|83094581|FG008|Period 2|Scheduling Conflicts|0|||
46874893|NCT03334214|83094603|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
46874894|NCT03334214|83094604|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
46874895|NCT03334214|83094603|FG000|Overall Study|Withdrawal by Subject|0|||
46874896|NCT03334214|83094604|FG001|Overall Study|Withdrawal by Subject|1|||
46874897|NCT03334214|83094603|FG000|Overall Study|Other|1|||
46874898|NCT03334214|83094604|FG001|Overall Study|Other|0|||
46874899|NCT02250664|83094614|FG000|Overall Study|Lost to Follow-up|18|||
46874900|NCT02250664|83094615|FG001|Overall Study|Lost to Follow-up|28|||
46874901|NCT02250664|83094616|FG002|Overall Study|Lost to Follow-up|33|||
46874902|NCT02250664|83094614|FG000|Overall Study|Personal Reasons|7|||
46874903|NCT02250664|83094615|FG001|Overall Study|Personal Reasons|8|||
46874904|NCT02250664|83094616|FG002|Overall Study|Personal Reasons|14|||
46874905|NCT02250664|83094614|FG000|Overall Study|Adverse Event|6|||
46874906|NCT02250664|83094615|FG001|Overall Study|Adverse Event|3|||
46874907|NCT02250664|83094616|FG002|Overall Study|Adverse Event|8|||
46874908|NCT02250664|83094614|FG000|Overall Study|Incarcerated|2|||
46874909|NCT02250664|83094615|FG001|Overall Study|Incarcerated|1|||
46874910|NCT02250664|83094616|FG002|Overall Study|Incarcerated|2|||
46874911|NCT02250664|83094614|FG000|Overall Study|Withdrawal by Subject|0|||
46874912|NCT02250664|83094615|FG001|Overall Study|Withdrawal by Subject|1|||
46874913|NCT02250664|83094616|FG002|Overall Study|Withdrawal by Subject|2|||
46874914|NCT02250664|83094614|FG000|Overall Study|Death|0|||
46874915|NCT02250664|83094615|FG001|Overall Study|Death|1|||
46874916|NCT02250664|83094616|FG002|Overall Study|Death|1|||
46874917|NCT02250664|83094614|FG000|Overall Study|Physician Decision|1|||
46874918|NCT02250664|83094615|FG001|Overall Study|Physician Decision|3|||
46874919|NCT02250664|83094616|FG002|Overall Study|Physician Decision|1|||
46874920|NCT02250664|83094614|FG000|Overall Study|Protocol Violation|1|||
46874921|NCT02250664|83094615|FG001|Overall Study|Protocol Violation|0|||
46874922|NCT02250664|83094616|FG002|Overall Study|Protocol Violation|1|||
46874923|NCT02250664|83094614|FG000|Overall Study|Reason unknown|1|||
46874924|NCT02250664|83094615|FG001|Overall Study|Reason unknown|0|||
46874925|NCT02250664|83094616|FG002|Overall Study|Reason unknown|0|||
46874926|NCT02646982|83094626|FG000|Overall Study|Adverse Event|1|||
46874927|NCT02646982|83094627|FG001|Overall Study|Adverse Event|1|||
46874928|NCT02646982|83094626|FG000|Overall Study|Withdrawal by Subject|2|||
46874929|NCT02646982|83094627|FG001|Overall Study|Withdrawal by Subject|1|||
46874930|NCT02845336|83094635|FG000|Overall Study|Lost to Follow-up|3|||
46874931|NCT02845336|83094636|FG001|Overall Study|Lost to Follow-up|1|||
46874932|NCT02845336|83094635|FG000|Overall Study|Inability to get medication|2|||
46874933|NCT02845336|83094636|FG001|Overall Study|Inability to get medication|0|||
46874934|NCT02844946|83094644|FG000|Overall Study|Lost to Follow-up|7|||
46874935|NCT02844946|83094645|FG001|Overall Study|Lost to Follow-up|0|||
46874936|NCT02951156|83094654|FG000|Overall Study|Death|3|||
46874937|NCT02951156|83094655|FG001|Overall Study|Death|8|||
46874938|NCT02951156|83094656|FG002|Overall Study|Death|5|||
46874939|NCT02951156|83094654|FG000|Overall Study|Progressive disease|1|||
46874940|NCT02951156|83094655|FG001|Overall Study|Progressive disease|0|||
46874941|NCT02951156|83094656|FG002|Overall Study|Progressive disease|1|||
46874942|NCT02951156|83094654|FG000|Overall Study|Withdrawal by Subject|0|||
46874943|NCT02951156|83094655|FG001|Overall Study|Withdrawal by Subject|0|||
46874944|NCT02951156|83094656|FG002|Overall Study|Withdrawal by Subject|1|||
46874945|NCT02951156|83094654|FG000|Overall Study|Study terminated by sponsor|0|||
46874946|NCT02951156|83094655|FG001|Overall Study|Study terminated by sponsor|0|||
46874947|NCT02951156|83094656|FG002|Overall Study|Study terminated by sponsor|1|||
46874948|NCT02951156|83094654|FG000|Overall Study|Other|5|||
46874949|NCT02951156|83094655|FG001|Overall Study|Other|1|||
46874950|NCT02951156|83094656|FG002|Overall Study|Other|2|||
46874951|NCT03345914|83094668|FG000|Overall Study|Transition to another study at week 16|80|||
46874952|NCT03345914|83094669|FG001|Overall Study|Transition to another study at week 16|86|||
46874953|NCT03345914|83094670|FG002|Overall Study|Transition to another study at week 16|78|||
46874954|NCT03345914|83094668|FG000|Overall Study|Transition to OLE during follow-up|37|||
46874955|NCT03345914|83094669|FG001|Overall Study|Transition to OLE during follow-up|33|||
46874956|NCT03345914|83094670|FG002|Overall Study|Transition to OLE during follow-up|39|||
46874957|NCT03345914|83094668|FG000|Overall Study|Physician Decision|0|||
46874958|NCT03345914|83094669|FG001|Overall Study|Physician Decision|1|||
46874959|NCT03345914|83094670|FG002|Overall Study|Physician Decision|1|||
46874960|NCT03345914|83094668|FG000|Overall Study|Withdrawal by Subject|5|||
46874961|NCT03345914|83094669|FG001|Overall Study|Withdrawal by Subject|1|||
46874962|NCT03345914|83094670|FG002|Overall Study|Withdrawal by Subject|2|||
46874963|NCT03345914|83094668|FG000|Overall Study|Other|1|||
46874964|NCT03345914|83094669|FG001|Overall Study|Other|1|||
46874965|NCT03345914|83094670|FG002|Overall Study|Other|1|||
46874966|NCT03345914|83094668|FG000|Overall Study|Ongoing|0|||
46874967|NCT03345914|83094669|FG001|Overall Study|Ongoing|0|||
46874968|NCT03345914|83094670|FG002|Overall Study|Ongoing|1|||
46874969|NCT03369704|83094680|FG000|Treatment Epoch|technical problems|1|||
46874970|NCT03369704|83094681|FG001|Treatment Epoch|technical problems|0|||
46874971|NCT03369704|83094680|FG000|Treatment Epoch|Protocol Violation|1|||
46874972|NCT03369704|83094681|FG001|Treatment Epoch|Protocol Violation|0|||
46874973|NCT03369704|83094680|FG000|Treatment Epoch|Lost to Follow-up|0|||
46874974|NCT03369704|83094681|FG001|Treatment Epoch|Lost to Follow-up|1|||
46874975|NCT03369704|83094680|FG000|Treatment Epoch|Lack of Efficacy|0|||
46874976|NCT03369704|83094681|FG001|Treatment Epoch|Lack of Efficacy|2|||
46874977|NCT03369704|83094680|FG000|Treatment Epoch|Adverse Event|2|||
46874978|NCT03369704|83094681|FG001|Treatment Epoch|Adverse Event|0|||
46874979|NCT03369704|83094680|FG000|Follow-up Epoch|Lost to Follow-up|1|||
46874980|NCT03369704|83094681|FG001|Follow-up Epoch|Lost to Follow-up|0|||
46874981|NCT03366428|83094687|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
46874982|NCT03366428|83094687|FG000|Overall Study|Adverse Event|12|||
46874983|NCT03366428|83094687|FG000|Overall Study|Clinical progression|2|||
46874984|NCT03366428|83094687|FG000|Overall Study|Withdrawal by Subject|4|||
46874985|NCT02839876|83094695|FG000|Overall Study|Protocol Violation|10|||
46874986|NCT02839876|83094696|FG001|Overall Study|Protocol Violation|11|||
46874987|NCT03366194|83094702|FG000|Overall Study|Lost to Follow-up|2|||
46874988|NCT02839798|83094707|FG000|Overall Study|Withdrawal by Subject|2|||
46874989|NCT03345836|83094714|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
46874990|NCT03345836|83094715|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
46874991|NCT03345836|83094716|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
46874992|NCT03345836|83094717|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
46874993|NCT03345836|83094718|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
46874994|NCT03345836|83094719|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
46874995|NCT03345836|83094714|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
46874996|NCT03345836|83094715|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
46874997|NCT03345836|83094716|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
46874998|NCT03345836|83094717|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
46874999|NCT03345836|83094718|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
46875000|NCT03345836|83094719|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
46875001|NCT03345836|83094714|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
46875002|NCT03345836|83094715|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
46875003|NCT03345836|83094716|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
46875004|NCT03345836|83094717|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
46875005|NCT03345836|83094718|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
46875006|NCT03345836|83094719|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
46875007|NCT03345836|83094714|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
46875008|NCT03345836|83094715|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
46875009|NCT03345836|83094716|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
46875010|NCT03345836|83094717|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
46875011|NCT03345836|83094718|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
46875012|NCT03345836|83094719|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
46875013|NCT03345836|83094714|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
46875014|NCT03345836|83094715|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
46875015|NCT03345836|83094716|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
46875016|NCT03345836|83094717|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
46875017|NCT03345836|83094718|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
46875018|NCT03345836|83094719|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
46875019|NCT03345836|83094714|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
46875020|NCT03345836|83094715|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
46875021|NCT03345836|83094716|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
46875022|NCT03345836|83094717|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
46875023|NCT03345836|83094718|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
46875024|NCT03345836|83094719|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
46875025|NCT03345836|83094714|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
46875026|NCT03345836|83094715|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
46875027|NCT03345836|83094716|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
46875028|NCT03345836|83094717|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
46875029|NCT03345836|83094718|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
46875030|NCT03345836|83094719|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
46875031|NCT03345836|83094714|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
46875032|NCT03345836|83094715|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
46875033|NCT03345836|83094716|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
46875034|NCT03345836|83094717|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
46875035|NCT03345836|83094718|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
46875036|NCT03345836|83094719|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
46875037|NCT03345836|83094714|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
46875038|NCT03345836|83094715|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
46875039|NCT03345836|83094716|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
46875040|NCT03345836|83094717|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
46875041|NCT03345836|83094718|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
46875042|NCT03345836|83094719|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
46875043|NCT03345836|83094714|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
46875044|NCT03345836|83094715|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
46875045|NCT03345836|83094716|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
46875046|NCT03345836|83094717|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
46875047|NCT03345836|83094718|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
46875048|NCT03345836|83094719|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
46875049|NCT03345836|83094714|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
46875050|NCT03345836|83094715|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
46875051|NCT03345836|83094716|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
46875052|NCT03345836|83094717|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
46875053|NCT03345836|83094718|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
46875054|NCT03345836|83094719|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
46875055|NCT02839330|83094739|FG000|Overall Study|Adverse Event|0|||
46875056|NCT02839330|83094740|FG001|Overall Study|Adverse Event|1|||
46875057|NCT02839330|83094741|FG002|Overall Study|Adverse Event|2|||
46875058|NCT02839330|83094742|FG003|Overall Study|Adverse Event|2|||
46984312|NCT02548585|83230412|FG000|Overall Study|Withdrawal by Subject|0|||
46875059|NCT02839330|83094739|FG000|Overall Study|Death|4|||
46875060|NCT02839330|83094740|FG001|Overall Study|Death|6|||
46875061|NCT02839330|83094741|FG002|Overall Study|Death|1|||
46875062|NCT02839330|83094742|FG003|Overall Study|Death|1|||
46875063|NCT02839330|83094739|FG000|Overall Study|Withdrawal by Subject|27|||
46875064|NCT02839330|83094740|FG001|Overall Study|Withdrawal by Subject|19|||
46875065|NCT02839330|83094741|FG002|Overall Study|Withdrawal by Subject|11|||
46875066|NCT02839330|83094742|FG003|Overall Study|Withdrawal by Subject|13|||
46875067|NCT02839330|83094739|FG000|Overall Study|Lost to Follow-up|22|||
46875068|NCT02839330|83094740|FG001|Overall Study|Lost to Follow-up|27|||
46875069|NCT02839330|83094741|FG002|Overall Study|Lost to Follow-up|29|||
46875070|NCT02839330|83094742|FG003|Overall Study|Lost to Follow-up|25|||
46875071|NCT02839330|83094739|FG000|Overall Study|Administrative Reason|0|||
46875072|NCT02839330|83094740|FG001|Overall Study|Administrative Reason|0|||
46875073|NCT02839330|83094741|FG002|Overall Study|Administrative Reason|0|||
46875074|NCT02839330|83094742|FG003|Overall Study|Administrative Reason|1|||
46875075|NCT02839330|83094739|FG000|Overall Study|Protocol Violation|1|||
46875076|NCT02839330|83094740|FG001|Overall Study|Protocol Violation|2|||
46875077|NCT02839330|83094741|FG002|Overall Study|Protocol Violation|2|||
46875078|NCT02839330|83094742|FG003|Overall Study|Protocol Violation|3|||
46875079|NCT02839330|83094739|FG000|Overall Study|Other reason, not specified|4|||
46875080|NCT02839330|83094740|FG001|Overall Study|Other reason, not specified|3|||
46875081|NCT02839330|83094741|FG002|Overall Study|Other reason, not specified|3|||
46875082|NCT02839330|83094742|FG003|Overall Study|Other reason, not specified|6|||
46875083|NCT03363776|83094756|FG000|Overall Study|Progressive disease|2|||
46875084|NCT03363776|83094757|FG001|Overall Study|Progressive disease|3|||
46875085|NCT03363776|83094758|FG002|Overall Study|Progressive disease|1|||
46875086|NCT03363776|83094756|FG000|Overall Study|Study drug toxicity|0|||
46875087|NCT03363776|83094757|FG001|Overall Study|Study drug toxicity|0|||
46875088|NCT03363776|83094758|FG002|Overall Study|Study drug toxicity|1|||
46875089|NCT03363776|83094756|FG000|Overall Study|Death|1|||
46875090|NCT03363776|83094757|FG001|Overall Study|Death|0|||
46875091|NCT03363776|83094758|FG002|Overall Study|Death|0|||
46875092|NCT03360344|83094769|FG000|Overall Study|Withdrawal by Subject|0|||
46875093|NCT03360344|83094770|FG001|Overall Study|Withdrawal by Subject|1|||
46875094|NCT03360344|83094771|FG002|Overall Study|Withdrawal by Subject|1|||
46875095|NCT02838628|83094781|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
46875096|NCT02838628|83094782|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
46875097|NCT02838628|83094781|FG000|Recurrence Follow-up Period|Adverse Event|1|||
46875098|NCT02838628|83094782|FG001|Recurrence Follow-up Period|Adverse Event|0|||
46875099|NCT02838628|83094781|FG000|Recurrence Follow-up Period|Non-compliance|0|||
46875100|NCT02838628|83094782|FG001|Recurrence Follow-up Period|Non-compliance|1|||
46875101|NCT02838628|83094781|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
46875102|NCT02838628|83094782|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
46875103|NCT02838628|83094781|FG000|Recurrence Follow-up Period|Other un-specified|1|||
46875104|NCT02838628|83094782|FG001|Recurrence Follow-up Period|Other un-specified|1|||
46875105|NCT02835820|83094791|FG000|Overall Study|Baseline Screen Failure|0|||
46875106|NCT02835820|83094792|FG001|Overall Study|Baseline Screen Failure|3|||
46875107|NCT03359174|83094798|FG000|Overall Study|Adverse Event|1|||
46875108|NCT02832622|83094802|FG000|Overall Study|MPP not programmed|1259|||
46875109|NCT02832622|83094802|FG000|Overall Study|Withdrawal by Subject|123|||
46875110|NCT02832622|83094802|FG000|Overall Study|Death|119|||
46875111|NCT02832622|83094802|FG000|Overall Study|Unsuccessful CRT implant|93|||
46875112|NCT02832622|83094802|FG000|Overall Study|Lost to Follow-up|45|||
46875113|NCT02832622|83094802|FG000|Overall Study|Patient non-compliance|42|||
46875114|NCT02832622|83094802|FG000|Overall Study|Withdrawal by other reasons|25|||
46875115|NCT02832622|83094802|FG000|Overall Study|System explant|24|||
46875116|NCT02832622|83094802|FG000|Overall Study|Physician Decision|6|||
46875117|NCT00093015|83094809|FG000|Overall Study|Withdrawal by Subject|194|||
46875118|NCT00093015|83094810|FG001|Overall Study|Withdrawal by Subject|171|||
46875119|NCT00093015|83094809|FG000|Overall Study|Lost to Follow-up|96|||
46875120|NCT00093015|83094810|FG001|Overall Study|Lost to Follow-up|108|||
46875121|NCT00093015|83094809|FG000|Overall Study|Death|375|||
46875122|NCT00093015|83094810|FG001|Overall Study|Death|385|||
46875123|NCT03358238|83094818|FG000|Overall Study|Withdrawal by Subject|0|||
46875124|NCT03358238|83094819|FG001|Overall Study|Withdrawal by Subject|1|||
46875125|NCT03342638|83094831|FG000|Overall Study|Withdrawal by Subject|1|||
46875126|NCT03342638|83094832|FG001|Overall Study|Withdrawal by Subject|0|||
46875127|NCT03342638|83094831|FG000|Overall Study|Physician Decision|0|||
46875128|NCT03342638|83094832|FG001|Overall Study|Physician Decision|1|||
46875129|NCT03342560|83094838|FG000|Overall Study|Lost to Follow-up|2|||
46875130|NCT03355742|83094855|FG000|Overall Study|Lost to Follow-up|4|||
46875131|NCT03355742|83094855|FG000|Overall Study|Withdrawal by Subject|29|||
46875132|NCT03355742|83094855|FG000|Overall Study|Physician Decision|6|||
46875133|NCT03355742|83094855|FG000|Overall Study|Death|55|||
46875134|NCT03355742|83094855|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
46875135|NCT03341312|83094859|FG000|Period 1|Withdrawal by Subject|0|||
46875136|NCT03341312|83094860|FG001|Period 1|Withdrawal by Subject|1|||
46875137|NCT03341312|83094861|FG002|Period 1|Withdrawal by Subject|0|||
46875138|NCT03341312|83094862|FG003|Period 1|Withdrawal by Subject|0|||
46875139|NCT02949908|83094874|FG000|Overall Study|Study termination|2|||
46875140|NCT01358734|83094881|FG000|Overall Study|Adverse Event|4|||
46875141|NCT01358734|83094882|FG001|Overall Study|Adverse Event|7|||
46875142|NCT01358734|83094883|FG002|Overall Study|Adverse Event|3|||
46875143|NCT01358734|83094881|FG000|Overall Study|Lack of Efficacy|0|||
46875144|NCT01358734|83094882|FG001|Overall Study|Lack of Efficacy|1|||
46875145|NCT01358734|83094883|FG002|Overall Study|Lack of Efficacy|3|||
46875146|NCT01358734|83094881|FG000|Overall Study|Withdrawal by Subject|1|||
46875147|NCT01358734|83094882|FG001|Overall Study|Withdrawal by Subject|6|||
46875148|NCT01358734|83094883|FG002|Overall Study|Withdrawal by Subject|3|||
46875149|NCT01358734|83094881|FG000|Overall Study|Death|3|||
46875150|NCT01358734|83094882|FG001|Overall Study|Death|7|||
46875151|NCT01358734|83094883|FG002|Overall Study|Death|2|||
46875152|NCT01358734|83094881|FG000|Overall Study|Progressive Disease|5|||
46875153|NCT01358734|83094882|FG001|Overall Study|Progressive Disease|13|||
46875154|NCT01358734|83094883|FG002|Overall Study|Progressive Disease|16|||
46875155|NCT01358734|83094881|FG000|Overall Study|Non-compliance with study drug|0|||
46875156|NCT01358734|83094882|FG001|Overall Study|Non-compliance with study drug|0|||
46875157|NCT01358734|83094883|FG002|Overall Study|Non-compliance with study drug|1|||
46875158|NCT01358734|83094881|FG000|Overall Study|Other|2|||
46875159|NCT01358734|83094882|FG001|Overall Study|Other|5|||
46875160|NCT01358734|83094883|FG002|Overall Study|Other|4|||
46875161|NCT01358734|83094881|FG000|Overall Study|Protocol Violation|0|||
46875162|NCT01358734|83094882|FG001|Overall Study|Protocol Violation|0|||
46875163|NCT01358734|83094883|FG002|Overall Study|Protocol Violation|2|||
46875164|NCT01341652|83094893|FG000|Overall Study|Incorrect Random Assignment|0|||
46875165|NCT01341652|83094894|FG001|Overall Study|Incorrect Random Assignment|1|||
46875166|NCT01341652|83094893|FG000|Overall Study|ineligible; presence metastatic disease|0|||
46875167|NCT01341652|83094894|FG001|Overall Study|ineligible; presence metastatic disease|1|||
46875168|NCT02828644|83094902|FG000|Overall Study|Lost to Follow-up|23|||
46875169|NCT02828644|83094903|FG001|Overall Study|Lost to Follow-up|22|||
46875170|NCT02949362|83094912|FG000|Retrospective Period|Inform consent not signed by participant|4|||
46875171|NCT02949362|83094913|FG001|Retrospective Period|Inform consent not signed by participant|1|||
46875172|NCT02949362|83094914|FG002|Retrospective Period|Inform consent not signed by participant|0|||
46875173|NCT02949362|83094915|FG003|Retrospective Period|Inform consent not signed by participant|0|||
46875174|NCT02949362|83094912|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
46875175|NCT02949362|83094913|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
46875176|NCT02949362|83094914|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
46875177|NCT02949362|83094915|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
46875178|NCT02949362|83094912|FG000|Prospective Period|Other|0|||
46875179|NCT02949362|83094913|FG001|Prospective Period|Other|0|||
46875180|NCT02949362|83094914|FG002|Prospective Period|Other|0|||
46875181|NCT02949362|83094915|FG003|Prospective Period|Other|4|||
46875182|NCT02947022|83094927|FG000|Overall Study|Study Stopped|1|||
46875183|NCT03338972|83094938|FG000|Overall Study|Death|1|||
46875184|NCT03338972|83094939|FG001|Overall Study|Death|1|||
46875185|NCT03338972|83094940|FG002|Overall Study|Death|0|||
46875186|NCT03338972|83094941|FG003|Overall Study|Death|0|||
46875187|NCT03338972|83094938|FG000|Overall Study|Withdrawal by Subject|1|||
46875188|NCT03338972|83094939|FG001|Overall Study|Withdrawal by Subject|0|||
46875189|NCT03338972|83094940|FG002|Overall Study|Withdrawal by Subject|0|||
46875190|NCT03338972|83094941|FG003|Overall Study|Withdrawal by Subject|0|||
46875191|NCT03338816|83094957|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
46875192|NCT03338816|83094958|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
46875193|NCT03338816|83094959|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
46984313|NCT02548585|83230413|FG001|Overall Study|Withdrawal by Subject|0|||
46984314|NCT02548585|83230414|FG002|Overall Study|Withdrawal by Subject|0|||
46984315|NCT02548585|83230415|FG003|Overall Study|Withdrawal by Subject|0|||
46984316|NCT02548585|83230416|FG004|Overall Study|Withdrawal by Subject|0|||
46875194|NCT03338816|83094960|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
46875195|NCT03338816|83094957|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
46875196|NCT03338816|83094958|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
46875197|NCT03338816|83094959|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
46875198|NCT03338816|83094960|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
46875199|NCT03338816|83094957|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
46875200|NCT03338816|83094958|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
46984317|NCT02548585|83230417|FG005|Overall Study|Withdrawal by Subject|1|||
46875201|NCT03338816|83094959|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
46875202|NCT03338816|83094960|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
46984318|NCT02548585|83230418|FG006|Overall Study|Withdrawal by Subject|0|||
46875203|NCT03338816|83094957|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
46875204|NCT03338816|83094958|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
46875205|NCT03338816|83094959|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
46875206|NCT03338816|83094960|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
46875207|NCT03338816|83094957|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
46875208|NCT03338816|83094958|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
46875209|NCT03338816|83094959|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
46875210|NCT03338816|83094960|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
46875211|NCT03338816|83094957|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
46875212|NCT03338816|83094958|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
46875213|NCT03338816|83094959|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
46875214|NCT03338816|83094960|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
46875215|NCT03338816|83094957|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
46875216|NCT03338816|83094958|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
46875217|NCT03338816|83094959|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
46875218|NCT03338816|83094960|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
46875219|NCT03337490|83094972|FG000|Overall Study|Withdrawal by Subject|1|||
46875220|NCT03337490|83094973|FG001|Overall Study|Withdrawal by Subject|0|||
46875221|NCT03337490|83094974|FG002|Overall Study|Withdrawal by Subject|0|||
46875222|NCT03337490|83094972|FG000|Overall Study|Lack of Efficacy|10|||
46875223|NCT03337490|83094973|FG001|Overall Study|Lack of Efficacy|12|||
46875224|NCT03337490|83094974|FG002|Overall Study|Lack of Efficacy|35|||
46875225|NCT03337490|83094972|FG000|Overall Study|Physician Decision|0|||
46875226|NCT03337490|83094973|FG001|Overall Study|Physician Decision|1|||
46875227|NCT03337490|83094974|FG002|Overall Study|Physician Decision|0|||
46875228|NCT03337490|83094972|FG000|Overall Study|Lost to Follow-up|0|||
46875229|NCT03337490|83094973|FG001|Overall Study|Lost to Follow-up|1|||
46875230|NCT03337490|83094974|FG002|Overall Study|Lost to Follow-up|0|||
46875231|NCT02944448|83094984|FG000|Overall Study|Adverse Event|37|||
46875232|NCT02944448|83094985|FG001|Overall Study|Adverse Event|6|||
46875233|NCT02944448|83094984|FG000|Overall Study|Lack of Efficacy|8|||
46875234|NCT02944448|83094985|FG001|Overall Study|Lack of Efficacy|5|||
46875235|NCT02944448|83094984|FG000|Overall Study|Lost to Follow-up|3|||
46875236|NCT02944448|83094985|FG001|Overall Study|Lost to Follow-up|1|||
46875237|NCT02944448|83094984|FG000|Overall Study|Protocol Violation|25|||
46875238|NCT02944448|83094985|FG001|Overall Study|Protocol Violation|7|||
46875239|NCT02944448|83094984|FG000|Overall Study|Withdrawal by Subject|14|||
46875240|NCT02944448|83094985|FG001|Overall Study|Withdrawal by Subject|4|||
46875241|NCT02944448|83094984|FG000|Overall Study|Sponsor did not supply drug in time|0|||
46875242|NCT02944448|83094985|FG001|Overall Study|Sponsor did not supply drug in time|1|||
46875243|NCT02944448|83094984|FG000|Overall Study|Noncompliant with dosing|1|||
46875244|NCT02944448|83094985|FG001|Overall Study|Noncompliant with dosing|0|||
46875245|NCT02944448|83094984|FG000|Overall Study|Abnormal laboratory values|1|||
46875246|NCT02944448|83094985|FG001|Overall Study|Abnormal laboratory values|0|||
46875247|NCT02943668|83094992|FG000|Overall Study|Disease Progression|1|||
46875248|NCT02891408|83095027|FG000|Overall Study|Lost to Follow-up|0|||
46875249|NCT02891408|83095028|FG001|Overall Study|Lost to Follow-up|0|||
46875250|NCT02891408|83095029|FG002|Overall Study|Lost to Follow-up|1|||
46875251|NCT02891408|83095030|FG003|Overall Study|Lost to Follow-up|0|||
46875252|NCT02891408|83095031|FG004|Overall Study|Lost to Follow-up|0|||
46875253|NCT02891408|83095032|FG005|Overall Study|Lost to Follow-up|0|||
46875254|NCT02891408|83095033|FG006|Overall Study|Lost to Follow-up|0|||
46875255|NCT03283670|83095059|FG000|Placebo Gas|Withdrawal by Subject|2|||
46875256|NCT03283670|83095059|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
46875257|NCT03283670|83095059|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
46875258|NCT01358578|83095080|FG000|Induction Period|Adverse Event|2|||
46875259|NCT01358578|83095081|FG001|Induction Period|Adverse Event|4|||
46875260|NCT01358578|83095082|FG002|Induction Period|Adverse Event|2|||
46875261|NCT01358578|83095083|FG003|Induction Period|Adverse Event|6|||
46875262|NCT01358578|83095084|FG004|Induction Period|Adverse Event|0|||
46875263|NCT01358578|83095085|FG005|Induction Period|Adverse Event|0|||
46875264|NCT01358578|83095080|FG000|Induction Period|Lack of Efficacy|0|||
46984319|NCT02548585|83230412|FG000|Overall Study|Lost to Follow-up|1|||
46984320|NCT02548585|83230413|FG001|Overall Study|Lost to Follow-up|0|||
46984321|NCT02548585|83230414|FG002|Overall Study|Lost to Follow-up|0|||
46875265|NCT01358578|83095081|FG001|Induction Period|Lack of Efficacy|0|||
46875266|NCT01358578|83095082|FG002|Induction Period|Lack of Efficacy|9|||
46875267|NCT01358578|83095083|FG003|Induction Period|Lack of Efficacy|1|||
46875268|NCT01358578|83095084|FG004|Induction Period|Lack of Efficacy|0|||
46875269|NCT01358578|83095085|FG005|Induction Period|Lack of Efficacy|0|||
46875270|NCT01358578|83095080|FG000|Induction Period|Lost to Follow-up|0|||
46875271|NCT01358578|83095081|FG001|Induction Period|Lost to Follow-up|0|||
46875272|NCT01358578|83095082|FG002|Induction Period|Lost to Follow-up|1|||
46984322|NCT02548585|83230415|FG003|Overall Study|Lost to Follow-up|0|||
46875273|NCT01358578|83095083|FG003|Induction Period|Lost to Follow-up|4|||
46875274|NCT01358578|83095084|FG004|Induction Period|Lost to Follow-up|0|||
46875275|NCT01358578|83095085|FG005|Induction Period|Lost to Follow-up|0|||
46875276|NCT01358578|83095080|FG000|Induction Period|Physician Decision|2|||
46875277|NCT01358578|83095081|FG001|Induction Period|Physician Decision|1|||
46875278|NCT01358578|83095082|FG002|Induction Period|Physician Decision|2|||
46875279|NCT01358578|83095083|FG003|Induction Period|Physician Decision|0|||
46875280|NCT01358578|83095084|FG004|Induction Period|Physician Decision|0|||
46875281|NCT01358578|83095085|FG005|Induction Period|Physician Decision|0|||
46875282|NCT01358578|83095080|FG000|Induction Period|Protocol Deviation|3|||
46875283|NCT01358578|83095081|FG001|Induction Period|Protocol Deviation|5|||
46875284|NCT01358578|83095082|FG002|Induction Period|Protocol Deviation|0|||
46875285|NCT01358578|83095083|FG003|Induction Period|Protocol Deviation|3|||
46875286|NCT01358578|83095084|FG004|Induction Period|Protocol Deviation|0|||
46875287|NCT01358578|83095085|FG005|Induction Period|Protocol Deviation|0|||
46875288|NCT01358578|83095080|FG000|Induction Period|technical problems|0|||
46875289|NCT01358578|83095081|FG001|Induction Period|technical problems|0|||
46875290|NCT01358578|83095082|FG002|Induction Period|technical problems|1|||
46875291|NCT01358578|83095083|FG003|Induction Period|technical problems|1|||
46875292|NCT01358578|83095084|FG004|Induction Period|technical problems|0|||
46875293|NCT01358578|83095085|FG005|Induction Period|technical problems|0|||
46875294|NCT01358578|83095080|FG000|Induction Period|Withdrawal by Subject|5|||
46875295|NCT01358578|83095081|FG001|Induction Period|Withdrawal by Subject|5|||
46875296|NCT01358578|83095082|FG002|Induction Period|Withdrawal by Subject|10|||
46875297|NCT01358578|83095083|FG003|Induction Period|Withdrawal by Subject|6|||
46875298|NCT01358578|83095084|FG004|Induction Period|Withdrawal by Subject|0|||
46875299|NCT01358578|83095085|FG005|Induction Period|Withdrawal by Subject|0|||
46875300|NCT01358578|83095080|FG000|Maintenance Period|Adverse Event|2|||
46875301|NCT01358578|83095081|FG001|Maintenance Period|Adverse Event|7|||
46875302|NCT01358578|83095082|FG002|Maintenance Period|Adverse Event|0|||
46875303|NCT01358578|83095083|FG003|Maintenance Period|Adverse Event|6|||
46875304|NCT01358578|83095084|FG004|Maintenance Period|Adverse Event|4|||
46875305|NCT01358578|83095085|FG005|Maintenance Period|Adverse Event|3|||
46875306|NCT01358578|83095080|FG000|Maintenance Period|Lack of Efficacy|10|||
46875307|NCT01358578|83095081|FG001|Maintenance Period|Lack of Efficacy|2|||
46875308|NCT01358578|83095082|FG002|Maintenance Period|Lack of Efficacy|0|||
46875309|NCT01358578|83095083|FG003|Maintenance Period|Lack of Efficacy|11|||
46875310|NCT01358578|83095084|FG004|Maintenance Period|Lack of Efficacy|3|||
46875311|NCT01358578|83095085|FG005|Maintenance Period|Lack of Efficacy|0|||
46875312|NCT01358578|83095080|FG000|Maintenance Period|Lost to Follow-up|4|||
46875313|NCT01358578|83095081|FG001|Maintenance Period|Lost to Follow-up|0|||
46875314|NCT01358578|83095082|FG002|Maintenance Period|Lost to Follow-up|0|||
46875315|NCT01358578|83095083|FG003|Maintenance Period|Lost to Follow-up|5|||
46875316|NCT01358578|83095084|FG004|Maintenance Period|Lost to Follow-up|1|||
46875317|NCT01358578|83095085|FG005|Maintenance Period|Lost to Follow-up|1|||
46875318|NCT01358578|83095080|FG000|Maintenance Period|Non-compliance with study treatment|3|||
46875319|NCT01358578|83095081|FG001|Maintenance Period|Non-compliance with study treatment|1|||
46875320|NCT01358578|83095082|FG002|Maintenance Period|Non-compliance with study treatment|0|||
46875321|NCT01358578|83095083|FG003|Maintenance Period|Non-compliance with study treatment|2|||
46875322|NCT01358578|83095084|FG004|Maintenance Period|Non-compliance with study treatment|1|||
46875323|NCT01358578|83095085|FG005|Maintenance Period|Non-compliance with study treatment|2|||
46875324|NCT01358578|83095080|FG000|Maintenance Period|Physician Decision|0|||
46875325|NCT01358578|83095081|FG001|Maintenance Period|Physician Decision|1|||
46875326|NCT01358578|83095082|FG002|Maintenance Period|Physician Decision|0|||
46875327|NCT01358578|83095083|FG003|Maintenance Period|Physician Decision|1|||
46875328|NCT01358578|83095084|FG004|Maintenance Period|Physician Decision|0|||
46875329|NCT01358578|83095085|FG005|Maintenance Period|Physician Decision|0|||
46875330|NCT01358578|83095080|FG000|Maintenance Period|Pregnancy|1|||
46875331|NCT01358578|83095081|FG001|Maintenance Period|Pregnancy|0|||
46875332|NCT01358578|83095082|FG002|Maintenance Period|Pregnancy|0|||
46875333|NCT01358578|83095083|FG003|Maintenance Period|Pregnancy|0|||
46875334|NCT01358578|83095084|FG004|Maintenance Period|Pregnancy|0|||
46875335|NCT01358578|83095085|FG005|Maintenance Period|Pregnancy|0|||
46875336|NCT01358578|83095080|FG000|Maintenance Period|Protocol deviation|7|||
46875337|NCT01358578|83095081|FG001|Maintenance Period|Protocol deviation|4|||
46875338|NCT01358578|83095082|FG002|Maintenance Period|Protocol deviation|0|||
46875339|NCT01358578|83095083|FG003|Maintenance Period|Protocol deviation|2|||
46875340|NCT01358578|83095084|FG004|Maintenance Period|Protocol deviation|2|||
46875341|NCT01358578|83095085|FG005|Maintenance Period|Protocol deviation|2|||
46875342|NCT01358578|83095080|FG000|Maintenance Period|Withdrawal by Subject|12|||
46875343|NCT01358578|83095081|FG001|Maintenance Period|Withdrawal by Subject|7|||
46875344|NCT01358578|83095082|FG002|Maintenance Period|Withdrawal by Subject|2|||
46875345|NCT01358578|83095083|FG003|Maintenance Period|Withdrawal by Subject|15|||
46875346|NCT01358578|83095084|FG004|Maintenance Period|Withdrawal by Subject|6|||
46875347|NCT01358578|83095085|FG005|Maintenance Period|Withdrawal by Subject|3|||
46875348|NCT01358578|83095080|FG000|Follow-up Period|Adverse Event|1|||
46875349|NCT01358578|83095081|FG001|Follow-up Period|Adverse Event|1|||
46875350|NCT01358578|83095082|FG002|Follow-up Period|Adverse Event|0|||
46875351|NCT01358578|83095083|FG003|Follow-up Period|Adverse Event|0|||
46875352|NCT01358578|83095084|FG004|Follow-up Period|Adverse Event|0|||
46875353|NCT01358578|83095085|FG005|Follow-up Period|Adverse Event|0|||
46875354|NCT01358578|83095080|FG000|Follow-up Period|Lack of Efficacy|3|||
46875355|NCT01358578|83095081|FG001|Follow-up Period|Lack of Efficacy|0|||
46875356|NCT01358578|83095082|FG002|Follow-up Period|Lack of Efficacy|4|||
46875357|NCT01358578|83095083|FG003|Follow-up Period|Lack of Efficacy|1|||
46875358|NCT01358578|83095084|FG004|Follow-up Period|Lack of Efficacy|0|||
46875359|NCT01358578|83095085|FG005|Follow-up Period|Lack of Efficacy|0|||
46875360|NCT01358578|83095080|FG000|Follow-up Period|Lost to Follow-up|0|||
46875361|NCT01358578|83095081|FG001|Follow-up Period|Lost to Follow-up|1|||
46875362|NCT01358578|83095082|FG002|Follow-up Period|Lost to Follow-up|0|||
46875363|NCT01358578|83095083|FG003|Follow-up Period|Lost to Follow-up|4|||
46875364|NCT01358578|83095084|FG004|Follow-up Period|Lost to Follow-up|0|||
46875365|NCT01358578|83095085|FG005|Follow-up Period|Lost to Follow-up|0|||
46875366|NCT01358578|83095080|FG000|Follow-up Period|non- compliance with study treatment|1|||
46875367|NCT01358578|83095081|FG001|Follow-up Period|non- compliance with study treatment|0|||
46875368|NCT01358578|83095082|FG002|Follow-up Period|non- compliance with study treatment|0|||
46875369|NCT01358578|83095083|FG003|Follow-up Period|non- compliance with study treatment|0|||
46875370|NCT01358578|83095084|FG004|Follow-up Period|non- compliance with study treatment|0|||
46875371|NCT01358578|83095085|FG005|Follow-up Period|non- compliance with study treatment|0|||
46875372|NCT01358578|83095080|FG000|Follow-up Period|Pregnancy|1|||
46875373|NCT01358578|83095081|FG001|Follow-up Period|Pregnancy|0|||
46875374|NCT01358578|83095082|FG002|Follow-up Period|Pregnancy|0|||
46875375|NCT01358578|83095083|FG003|Follow-up Period|Pregnancy|0|||
46875376|NCT01358578|83095084|FG004|Follow-up Period|Pregnancy|0|||
46875377|NCT01358578|83095085|FG005|Follow-up Period|Pregnancy|0|||
46875378|NCT01358578|83095080|FG000|Follow-up Period|Withdrawal by Subject|3|||
46875379|NCT01358578|83095081|FG001|Follow-up Period|Withdrawal by Subject|3|||
46875380|NCT01358578|83095082|FG002|Follow-up Period|Withdrawal by Subject|1|||
46875381|NCT01358578|83095083|FG003|Follow-up Period|Withdrawal by Subject|12|||
46875382|NCT01358578|83095084|FG004|Follow-up Period|Withdrawal by Subject|0|||
46984323|NCT02548585|83230416|FG004|Overall Study|Lost to Follow-up|0|||
46984324|NCT02548585|83230417|FG005|Overall Study|Lost to Follow-up|0|||
46984325|NCT02548585|83230418|FG006|Overall Study|Lost to Follow-up|0|||
46984326|NCT02548585|83230412|FG000|Overall Study|Other|1|||
46984327|NCT02548585|83230413|FG001|Overall Study|Other|0|||
46984328|NCT02548585|83230414|FG002|Overall Study|Other|0|||
46984329|NCT02548585|83230415|FG003|Overall Study|Other|2|||
46984330|NCT02548585|83230416|FG004|Overall Study|Other|3|||
46984331|NCT02548585|83230417|FG005|Overall Study|Other|0|||
46984332|NCT02548585|83230418|FG006|Overall Study|Other|1|||
46984333|NCT02548585|83230412|FG000|Overall Study|Randomized but not treated|0|||
46984334|NCT02548585|83230413|FG001|Overall Study|Randomized but not treated|0|||
46984335|NCT02548585|83230414|FG002|Overall Study|Randomized but not treated|0|||
46984336|NCT02548585|83230415|FG003|Overall Study|Randomized but not treated|0|||
46984337|NCT02548585|83230416|FG004|Overall Study|Randomized but not treated|0|||
46984338|NCT02548585|83230417|FG005|Overall Study|Randomized but not treated|1|||
46984339|NCT02548585|83230418|FG006|Overall Study|Randomized but not treated|0|||
46984340|NCT02547649|83230462|FG000|Overall Study|Lost to Follow-up|3|||
46984341|NCT02547649|83230463|FG001|Overall Study|Lost to Follow-up|1|||
46984342|NCT02547649|83230464|FG002|Overall Study|Lost to Follow-up|1|||
46984343|NCT02547649|83230462|FG000|Overall Study|Not vaccinated|0|||
46984344|NCT02547649|83230463|FG001|Overall Study|Not vaccinated|0|||
46984345|NCT02547649|83230464|FG002|Overall Study|Not vaccinated|1|||
46875383|NCT01358578|83095085|FG005|Follow-up Period|Withdrawal by Subject|0|||
46875384|NCT01358578|83095080|FG000|Follow-up Period|Physician Decision|1|||
46875385|NCT01358578|83095081|FG001|Follow-up Period|Physician Decision|1|||
46875386|NCT01358578|83095082|FG002|Follow-up Period|Physician Decision|0|||
46875387|NCT01358578|83095083|FG003|Follow-up Period|Physician Decision|2|||
46875388|NCT01358578|83095084|FG004|Follow-up Period|Physician Decision|0|||
46984346|NCT02547649|83230462|FG000|Overall Study|Withdrawal by Subject|0|||
46984347|NCT02547649|83230463|FG001|Overall Study|Withdrawal by Subject|4|||
46984348|NCT02547649|83230464|FG002|Overall Study|Withdrawal by Subject|2|||
46875389|NCT01358578|83095085|FG005|Follow-up Period|Physician Decision|0|||
46875390|NCT02833948|83095115|FG000|Overall Study|Death|2|||
46875391|NCT02833948|83095116|FG001|Overall Study|Death|3|||
46984349|NCT02535715|83230484|FG000|Overall Study|Withdrawal by Subject|0|||
46984350|NCT02535715|83230485|FG001|Overall Study|Withdrawal by Subject|0|||
46984351|NCT02535715|83230486|FG002|Overall Study|Withdrawal by Subject|1|||
46875392|NCT02833948|83095115|FG000|Overall Study|were not scanned|8|||
46875393|NCT02833948|83095116|FG001|Overall Study|were not scanned|13|||
46875394|NCT02833948|83095115|FG000|Overall Study|scans could not be evaluated|5|||
46875395|NCT02833948|83095116|FG001|Overall Study|scans could not be evaluated|2|||
46875396|NCT02828020|83095129|FG000|Treatment Period|Adverse Event|3|||
46875397|NCT02828020|83095130|FG001|Treatment Period|Adverse Event|1|||
46875398|NCT02828020|83095131|FG002|Treatment Period|Adverse Event|1|||
46875399|NCT02828020|83095129|FG000|Treatment Period|Withdrawal of Consent|10|||
46875400|NCT02828020|83095130|FG001|Treatment Period|Withdrawal of Consent|14|||
46875401|NCT02828020|83095131|FG002|Treatment Period|Withdrawal of Consent|9|||
46875402|NCT02828020|83095129|FG000|Treatment Period|Lost to Follow-up|21|||
46875403|NCT02828020|83095130|FG001|Treatment Period|Lost to Follow-up|24|||
46875404|NCT02828020|83095131|FG002|Treatment Period|Lost to Follow-up|18|||
46875405|NCT02828020|83095129|FG000|Treatment Period|Lack of Qualifying Event|44|||
46875406|NCT02828020|83095130|FG001|Treatment Period|Lack of Qualifying Event|53|||
46875407|NCT02828020|83095131|FG002|Treatment Period|Lack of Qualifying Event|43|||
46875408|NCT02828020|83095129|FG000|Treatment Period|Pregnancy|0|||
46875409|NCT02828020|83095130|FG001|Treatment Period|Pregnancy|2|||
46875410|NCT02828020|83095131|FG002|Treatment Period|Pregnancy|0|||
46875411|NCT02828020|83095129|FG000|Treatment Period|Protocol Violation|2|||
46875412|NCT02828020|83095130|FG001|Treatment Period|Protocol Violation|4|||
46875413|NCT02828020|83095131|FG002|Treatment Period|Protocol Violation|7|||
46875414|NCT02828020|83095129|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
46875415|NCT02828020|83095130|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
46875416|NCT02828020|83095131|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
46875417|NCT02828020|83095129|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
46875418|NCT02828020|83095130|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
46875419|NCT02828020|83095131|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
46875420|NCT02828020|83095129|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
46875421|NCT02828020|83095130|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
46875422|NCT02828020|83095131|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
46875423|NCT02828020|83095129|FG000|Safety Follow-up Period|Protocol Violation|0|||
46875424|NCT02828020|83095130|FG001|Safety Follow-up Period|Protocol Violation|2|||
46875425|NCT02828020|83095131|FG002|Safety Follow-up Period|Protocol Violation|1|||
46875426|NCT02828020|83095129|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
46875427|NCT02828020|83095130|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
46875428|NCT02828020|83095131|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
46875429|NCT02827708|83095141|FG000|Overall Study|Lost to Follow-up|3|||
46875430|NCT02827708|83095142|FG001|Overall Study|Lost to Follow-up|1|||
46875431|NCT02827708|83095141|FG000|Overall Study|Withdrawal by Subject|1|||
46875432|NCT02827708|83095142|FG001|Overall Study|Withdrawal by Subject|2|||
46875433|NCT02827708|83095141|FG000|Overall Study|Death|1|||
46875434|NCT02827708|83095142|FG001|Overall Study|Death|2|||
46875435|NCT03760185|83095148|FG000|Overall Study|Lost to Follow-up|1|||
46875436|NCT03760185|83095149|FG001|Overall Study|Lost to Follow-up|1|||
46875437|NCT02891174|83095159|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
46875438|NCT02891174|83095160|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
46875439|NCT02891174|83095159|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
46875440|NCT02891174|83095160|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
46875441|NCT02891174|83095159|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
46875442|NCT02891174|83095160|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
46875443|NCT02891174|83095159|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
46875444|NCT02891174|83095160|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
46875445|NCT02891174|83095159|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
46875446|NCT02891174|83095160|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
46875447|NCT02891174|83095159|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
46875448|NCT02891174|83095160|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
46875449|NCT02891174|83095159|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
46875450|NCT02891174|83095160|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
46875451|NCT01751984|83095181|FG000|Overall Study|Adverse Event|5|||
46875452|NCT01751984|83095182|FG001|Overall Study|Adverse Event|3|||
46875453|NCT01751984|83095181|FG000|Overall Study|Withdrawal by Subject|0|||
46875454|NCT01751984|83095182|FG001|Overall Study|Withdrawal by Subject|1|||
46875455|NCT01751984|83095181|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
46875456|NCT01751984|83095182|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
46875457|NCT03330236|83095190|FG000|Overall Study|Death|2|||
46875458|NCT03330236|83095191|FG001|Overall Study|Death|1|||
46875459|NCT03330236|83095190|FG000|Overall Study|Withdrawal by Subject|2|||
46875460|NCT03330236|83095191|FG001|Overall Study|Withdrawal by Subject|4|||
46875461|NCT03330236|83095190|FG000|Overall Study|Lost to Follow-up|0|||
46875462|NCT03330236|83095191|FG001|Overall Study|Lost to Follow-up|2|||
46875463|NCT03330236|83095190|FG000|Overall Study|Physician Decision|2|||
46875464|NCT03330236|83095191|FG001|Overall Study|Physician Decision|0|||
46875465|NCT03330236|83095190|FG000|Overall Study|Protocol Violation|4|||
46875466|NCT03330236|83095191|FG001|Overall Study|Protocol Violation|3|||
46875467|NCT03330236|83095190|FG000|Overall Study|SedLine malfunction/blinding|19|||
46875468|NCT03330236|83095191|FG001|Overall Study|SedLine malfunction/blinding|14|||
46875469|NCT03330236|83095190|FG000|Overall Study|Volatile anesthetics used|11|||
46875470|NCT03330236|83095191|FG001|Overall Study|Volatile anesthetics used|8|||
46875471|NCT03330236|83095190|FG000|Overall Study|Surgery aborted/converted to open|60|||
46875472|NCT03330236|83095191|FG001|Overall Study|Surgery aborted/converted to open|52|||
46875473|NCT03330002|83095197|FG000|Overall Study|Lost to Follow-up|15|||
46875474|NCT03330002|83095197|FG000|Overall Study|Death|7|||
46875475|NCT02948582|83095201|FG000|Washout Period 1|Adverse Event|0|||
46875476|NCT02948582|83095202|FG001|Washout Period 1|Adverse Event|2|||
46875477|NCT02948582|83095203|FG002|Washout Period 1|Adverse Event|0|||
46875478|NCT02948582|83095204|FG003|Washout Period 1|Adverse Event|0|||
46875479|NCT02948582|83095205|FG004|Washout Period 1|Adverse Event|0|||
46875480|NCT02948582|83095206|FG005|Washout Period 1|Adverse Event|0|||
46875481|NCT02948582|83095201|FG000|Washout Period 1|Protocol Violation|0|||
46875482|NCT02948582|83095202|FG001|Washout Period 1|Protocol Violation|0|||
46875483|NCT02948582|83095203|FG002|Washout Period 1|Protocol Violation|0|||
46875484|NCT02948582|83095204|FG003|Washout Period 1|Protocol Violation|0|||
46875485|NCT02948582|83095205|FG004|Washout Period 1|Protocol Violation|0|||
46875486|NCT02948582|83095206|FG005|Washout Period 1|Protocol Violation|1|||
46875487|NCT02948582|83095201|FG000|Washout Period 2|Adverse Event|0|||
46875488|NCT02948582|83095202|FG001|Washout Period 2|Adverse Event|1|||
46875489|NCT02948582|83095203|FG002|Washout Period 2|Adverse Event|0|||
46875490|NCT02948582|83095204|FG003|Washout Period 2|Adverse Event|0|||
46875491|NCT02948582|83095205|FG004|Washout Period 2|Adverse Event|0|||
46875492|NCT02948582|83095206|FG005|Washout Period 2|Adverse Event|0|||
46875493|NCT02948582|83095201|FG000|Washout Period 2|personal reasons|0|||
46875494|NCT02948582|83095202|FG001|Washout Period 2|personal reasons|0|||
46875495|NCT02948582|83095203|FG002|Washout Period 2|personal reasons|0|||
46875496|NCT02948582|83095204|FG003|Washout Period 2|personal reasons|1|||
46875497|NCT02948582|83095205|FG004|Washout Period 2|personal reasons|0|||
46875498|NCT02948582|83095206|FG005|Washout Period 2|personal reasons|0|||
46875499|NCT02948582|83095201|FG000|Washout Period 4|Adverse Event|1|||
46875500|NCT02948582|83095202|FG001|Washout Period 4|Adverse Event|0|||
46875501|NCT02948582|83095203|FG002|Washout Period 4|Adverse Event|1|||
46875502|NCT02948582|83095204|FG003|Washout Period 4|Adverse Event|0|||
46875503|NCT02948582|83095205|FG004|Washout Period 4|Adverse Event|0|||
46875504|NCT02948582|83095206|FG005|Washout Period 4|Adverse Event|0|||
46875505|NCT03756285|83095222|FG000|Overall Study|Lost to Follow-up|0|||
46875506|NCT03756285|83095223|FG001|Overall Study|Lost to Follow-up|1|||
46875507|NCT03756285|83095222|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
46875508|NCT03756285|83095223|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
46875509|NCT03756285|83095222|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
46875510|NCT03756285|83095223|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
46875511|NCT02825992|83095230|FG000|Overall Study|Withdrawal by Subject|4|||
46875512|NCT02825992|83095230|FG000|Overall Study|Lost to Follow-up|2|||
46875513|NCT02825992|83095230|FG000|Overall Study|Procedure terminated|2|||
46875514|NCT01339000|83095242|FG000|Overall Study|study closed due to lack of drug supply|1|||
46875515|NCT01339000|83095243|FG001|Overall Study|study closed due to lack of drug supply|0|||
46875516|NCT03755661|83095254|FG000|Overall Study|Lost to Follow-up|1|||
46875517|NCT03755661|83095255|FG001|Overall Study|Lost to Follow-up|0|||
46875518|NCT03752151|83095261|FG000|Overall Study|Withdrawal by Subject|1|||
46875519|NCT03752151|83095261|FG000|Overall Study|Protocol Violation|1|||
46875520|NCT01336634|83095269|FG000|Overall Study|Study closed/terminated|5|||
46875521|NCT01336634|83095270|FG001|Overall Study|Study closed/terminated|6|||
46875522|NCT01336634|83095271|FG002|Overall Study|Study closed/terminated|6|||
46875523|NCT01336634|83095269|FG000|Overall Study|Lost to Follow-up|2|||
46875524|NCT01336634|83095270|FG001|Overall Study|Lost to Follow-up|1|||
46875525|NCT01336634|83095271|FG002|Overall Study|Lost to Follow-up|1|||
46875526|NCT01336634|83095269|FG000|Overall Study|Physician Decision|1|||
46875527|NCT01336634|83095270|FG001|Overall Study|Physician Decision|1|||
46875528|NCT01336634|83095271|FG002|Overall Study|Physician Decision|0|||
46875529|NCT01336634|83095269|FG000|Overall Study|Withdrawal by Subject|6|||
46875530|NCT01336634|83095270|FG001|Overall Study|Withdrawal by Subject|0|||
46875531|NCT01336634|83095271|FG002|Overall Study|Withdrawal by Subject|2|||
46875532|NCT02947100|83095286|FG000|Overall Study|study terminated early|3|||
46875533|NCT02947100|83095286|FG000|Overall Study|did not meet inclusion criteria|1|||
46875534|NCT03329846|83095292|FG000|Overall Study|Disease progression|4|||
46875535|NCT03329846|83095293|FG001|Overall Study|Disease progression|6|||
46875536|NCT03329846|83095292|FG000|Overall Study|Study drug toxicity|1|||
46875537|NCT03329846|83095293|FG001|Overall Study|Study drug toxicity|0|||
46875538|NCT03329846|83095292|FG000|Overall Study|Participant request to discontinue treatment|0|||
46875539|NCT03329846|83095293|FG001|Overall Study|Participant request to discontinue treatment|1|||
46875540|NCT03329846|83095292|FG000|Overall Study|Participant withdrew consent|1|||
46875541|NCT03329846|83095293|FG001|Overall Study|Participant withdrew consent|0|||
46875542|NCT03329846|83095292|FG000|Overall Study|Other reasons|2|||
46875543|NCT03329846|83095293|FG001|Overall Study|Other reasons|2|||
46875544|NCT03325010|83095301|FG000|Overall Study|Adverse Event|3|||
46875545|NCT03325010|83095302|FG001|Overall Study|Adverse Event|8|||
46875546|NCT03325010|83095301|FG000|Overall Study|Protocol Violation|1|||
46875547|NCT03325010|83095302|FG001|Overall Study|Protocol Violation|8|||
46875548|NCT03325010|83095301|FG000|Overall Study|Withdrawal by Subject|1|||
46875549|NCT03325010|83095302|FG001|Overall Study|Withdrawal by Subject|3|||
46875550|NCT03325010|83095301|FG000|Overall Study|Lost to Follow-up|1|||
46875551|NCT03325010|83095302|FG001|Overall Study|Lost to Follow-up|0|||
46875552|NCT03325010|83095301|FG000|Overall Study|Physician Decision|1|||
46875553|NCT03325010|83095302|FG001|Overall Study|Physician Decision|1|||
46875554|NCT03325010|83095301|FG000|Overall Study|Lack of Efficacy|2|||
46875555|NCT03325010|83095302|FG001|Overall Study|Lack of Efficacy|0|||
46875556|NCT02824432|83095310|FG000|Overall Study|Major Protocol Deviation|1|||
46875557|NCT02824432|83095311|FG001|Overall Study|Major Protocol Deviation|0|||
46875558|NCT02823964|83095317|FG000|Overall Study|Adverse Event|2|||
46875559|NCT02823964|83095317|FG000|Overall Study|Physician Decision|1|||
46875560|NCT02823964|83095317|FG000|Overall Study|Lack of Efficacy|1|||
46875561|NCT02823964|83095317|FG000|Overall Study|Withdrawal by Subject|1|||
46875562|NCT01338610|83095324|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
46875563|NCT01338610|83095325|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
46875564|NCT01338610|83095326|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
46875565|NCT01338610|83095324|FG000|Overall Study|Protocol Violation|1|||
46875566|NCT01338610|83095325|FG001|Overall Study|Protocol Violation|0|||
46702082|NCT01199016|82916943|FG000|Overall Study|No longer meets eligibility criteria|4|||
46875567|NCT01338610|83095326|FG002|Overall Study|Protocol Violation|1|||
46875568|NCT01338610|83095324|FG000|Overall Study|Adverse Event|3|||
46875569|NCT01338610|83095325|FG001|Overall Study|Adverse Event|0|||
46875570|NCT01338610|83095326|FG002|Overall Study|Adverse Event|0|||
46875571|NCT01355302|83095333|FG000|Phase 1b|Death|4|||
46875572|NCT01355302|83095334|FG001|Phase 1b|Death|0|||
46875573|NCT01355302|83095335|FG002|Phase 1b|Death|0|||
46875574|NCT01355302|83095333|FG000|Phase 1b|Study terminated by sponsor|2|||
46875575|NCT01355302|83095334|FG001|Phase 1b|Study terminated by sponsor|0|||
46702083|NCT01199016|82916943|FG000|Overall Study|Entrance criteria|5|||
46875576|NCT01355302|83095335|FG002|Phase 1b|Study terminated by sponsor|0|||
46875577|NCT01355068|83095343|FG000|First Intervention Period|Adverse Event|0|||
46875578|NCT01355068|83095344|FG001|First Intervention Period|Adverse Event|1|||
46875579|NCT01355068|83095343|FG000|First Intervention Period|Withdrawal by Subject|0|||
46875580|NCT01355068|83095344|FG001|First Intervention Period|Withdrawal by Subject|1|||
46875581|NCT03756129|83095356|FG000|Overall Study|Adverse Event|1|||
46875582|NCT03756129|83095357|FG001|Overall Study|Adverse Event|1|||
46875583|NCT03756129|83095358|FG002|Overall Study|Adverse Event|0|||
46875584|NCT03756129|83095359|FG003|Overall Study|Adverse Event|2|||
46875585|NCT03756129|83095360|FG004|Overall Study|Adverse Event|0|||
46875586|NCT03756129|83095361|FG005|Overall Study|Adverse Event|0|||
46875587|NCT03756129|83095356|FG000|Overall Study|Withdrawal by Subject|2|||
46875588|NCT03756129|83095357|FG001|Overall Study|Withdrawal by Subject|1|||
46875589|NCT03756129|83095358|FG002|Overall Study|Withdrawal by Subject|3|||
46875590|NCT03756129|83095359|FG003|Overall Study|Withdrawal by Subject|1|||
46875591|NCT03756129|83095360|FG004|Overall Study|Withdrawal by Subject|1|||
46875592|NCT03756129|83095361|FG005|Overall Study|Withdrawal by Subject|3|||
46875593|NCT03756129|83095356|FG000|Overall Study|Lost to Follow-up|0|||
46875594|NCT03756129|83095357|FG001|Overall Study|Lost to Follow-up|0|||
46875595|NCT03756129|83095358|FG002|Overall Study|Lost to Follow-up|0|||
46875596|NCT03756129|83095359|FG003|Overall Study|Lost to Follow-up|0|||
46875597|NCT03756129|83095360|FG004|Overall Study|Lost to Follow-up|0|||
46875598|NCT03756129|83095361|FG005|Overall Study|Lost to Follow-up|1|||
46875599|NCT03756129|83095356|FG000|Overall Study|Physician Decision|0|||
46875600|NCT03756129|83095357|FG001|Overall Study|Physician Decision|0|||
46875601|NCT03756129|83095358|FG002|Overall Study|Physician Decision|0|||
46875602|NCT03756129|83095359|FG003|Overall Study|Physician Decision|0|||
46875603|NCT03756129|83095360|FG004|Overall Study|Physician Decision|0|||
46875604|NCT03756129|83095361|FG005|Overall Study|Physician Decision|1|||
46875605|NCT02822794|83095387|FG000|Overall Study|Withdrew Consent|1|||
46875606|NCT02822794|83095388|FG001|Overall Study|Withdrew Consent|0|||
46875607|NCT01338298|83095403|FG000|Overall Study|Withdrawal by Subject|1|||
46875608|NCT01338298|83095404|FG001|Overall Study|Withdrawal by Subject|1|||
46875609|NCT01338298|83095403|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
46875610|NCT01338298|83095404|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
46875611|NCT01338298|83095403|FG000|Overall Study|Administrative error|0|||
46875612|NCT01338298|83095404|FG001|Overall Study|Administrative error|1|||
46875613|NCT01338298|83095403|FG000|Overall Study|Positive symptom worsening|1|||
46875614|NCT01338298|83095404|FG001|Overall Study|Positive symptom worsening|0|||
46875615|NCT01338298|83095403|FG000|Overall Study|Depressive symptoms and nausea|1|||
46875616|NCT01338298|83095404|FG001|Overall Study|Depressive symptoms and nausea|0|||
46875617|NCT01338298|83095403|FG000|Overall Study|Non-adherence|1|||
46875618|NCT01338298|83095404|FG001|Overall Study|Non-adherence|0|||
46875619|NCT01354132|83095412|FG000|Randomization|Physician Decision|1|||
46875620|NCT01354132|83095413|FG001|Randomization|Physician Decision|0|||
46875621|NCT01354132|83095412|FG000|Randomization|Withdrawal by Subject|0|||
46875622|NCT01354132|83095413|FG001|Randomization|Withdrawal by Subject|1|||
46875623|NCT01354132|83095412|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
46875624|NCT01354132|83095413|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
46875625|NCT01354132|83095412|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
46875626|NCT01354132|83095413|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
46875627|NCT01354132|83095412|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
46875628|NCT01354132|83095413|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
46875629|NCT01353898|83095428|FG000|Overall Study|Study site terminated|0|||
46875630|NCT01353898|83095429|FG001|Overall Study|Study site terminated|0|||
46875631|NCT01353898|83095430|FG002|Overall Study|Study site terminated|0|||
46875632|NCT01353898|83095431|FG003|Overall Study|Study site terminated|0|||
46875633|NCT01353898|83095432|FG004|Overall Study|Study site terminated|0|||
46875634|NCT01353898|83095433|FG005|Overall Study|Study site terminated|1|||
46875635|NCT01372150|83095450|FG000|Overall Study|Lack of Efficacy|3|||
46875636|NCT01372150|83095451|FG001|Overall Study|Lack of Efficacy|0|||
46875637|NCT01372150|83095452|FG002|Overall Study|Lack of Efficacy|1|||
46875638|NCT01372150|83095450|FG000|Overall Study|Lost to Follow-up|4|||
46875639|NCT01372150|83095451|FG001|Overall Study|Lost to Follow-up|5|||
46875640|NCT01372150|83095452|FG002|Overall Study|Lost to Follow-up|6|||
46875641|NCT01372150|83095450|FG000|Overall Study|Protocol Violation|1|||
46875642|NCT01372150|83095451|FG001|Overall Study|Protocol Violation|0|||
46875643|NCT01372150|83095452|FG002|Overall Study|Protocol Violation|3|||
46875644|NCT01372150|83095450|FG000|Overall Study|Withdrawal by Subject|2|||
46875645|NCT01372150|83095451|FG001|Overall Study|Withdrawal by Subject|7|||
46875646|NCT01372150|83095452|FG002|Overall Study|Withdrawal by Subject|2|||
46875647|NCT01372150|83095450|FG000|Overall Study|Other|1|||
46875648|NCT01372150|83095451|FG001|Overall Study|Other|0|||
46875649|NCT01372150|83095452|FG002|Overall Study|Other|2|||
46875650|NCT01372150|83095450|FG000|Overall Study|Adverse Event|2|||
46875651|NCT01372150|83095451|FG001|Overall Study|Adverse Event|1|||
46875652|NCT01372150|83095452|FG002|Overall Study|Adverse Event|2|||
46875653|NCT01372150|83095450|FG000|Overall Study|Randomized but not treated|0|||
46875654|NCT01372150|83095451|FG001|Overall Study|Randomized but not treated|1|||
46875655|NCT01372150|83095452|FG002|Overall Study|Randomized but not treated|0|||
46875656|NCT03329690|83095465|FG000|Overall Study|Progressive disease per RECIST|85|||
46875657|NCT03329690|83095466|FG001|Overall Study|Progressive disease per RECIST|44|||
46875658|NCT03329690|83095467|FG002|Overall Study|Progressive disease per RECIST|6|||
46875659|NCT03329690|83095468|FG003|Overall Study|Progressive disease per RECIST|16|||
46875660|NCT03329690|83095469|FG004|Overall Study|Progressive disease per RECIST|20|||
46875661|NCT03329690|83095465|FG000|Overall Study|Clinical progression|7|||
46875662|NCT03329690|83095466|FG001|Overall Study|Clinical progression|4|||
46875663|NCT03329690|83095467|FG002|Overall Study|Clinical progression|1|||
46875664|NCT03329690|83095468|FG003|Overall Study|Clinical progression|1|||
46875665|NCT03329690|83095469|FG004|Overall Study|Clinical progression|1|||
46875666|NCT03329690|83095465|FG000|Overall Study|Adverse Event|22|||
46875667|NCT03329690|83095466|FG001|Overall Study|Adverse Event|4|||
46875668|NCT03329690|83095467|FG002|Overall Study|Adverse Event|0|||
46875669|NCT03329690|83095468|FG003|Overall Study|Adverse Event|1|||
46875670|NCT03329690|83095469|FG004|Overall Study|Adverse Event|2|||
46875671|NCT03329690|83095465|FG000|Overall Study|Death|2|||
46875672|NCT03329690|83095466|FG001|Overall Study|Death|0|||
46875673|NCT03329690|83095467|FG002|Overall Study|Death|0|||
46875674|NCT03329690|83095468|FG003|Overall Study|Death|1|||
46875675|NCT03329690|83095469|FG004|Overall Study|Death|0|||
46875676|NCT03329690|83095465|FG000|Overall Study|Withdrawal by Subject|2|||
46875677|NCT03329690|83095466|FG001|Overall Study|Withdrawal by Subject|3|||
46875678|NCT03329690|83095467|FG002|Overall Study|Withdrawal by Subject|0|||
46875679|NCT03329690|83095468|FG003|Overall Study|Withdrawal by Subject|1|||
46875680|NCT03329690|83095469|FG004|Overall Study|Withdrawal by Subject|0|||
46875681|NCT03329690|83095465|FG000|Overall Study|Physician Decision|1|||
46875682|NCT03329690|83095466|FG001|Overall Study|Physician Decision|0|||
46875683|NCT03329690|83095467|FG002|Overall Study|Physician Decision|0|||
46875684|NCT03329690|83095468|FG003|Overall Study|Physician Decision|0|||
46875685|NCT03329690|83095469|FG004|Overall Study|Physician Decision|1|||
46875686|NCT03329690|83095465|FG000|Overall Study|Miscellaneous|6|||
46875687|NCT03329690|83095466|FG001|Overall Study|Miscellaneous|0|||
46875688|NCT03329690|83095467|FG002|Overall Study|Miscellaneous|0|||
46875689|NCT03329690|83095468|FG003|Overall Study|Miscellaneous|0|||
46875690|NCT03329690|83095469|FG004|Overall Study|Miscellaneous|0|||
46875691|NCT03329690|83095465|FG000|Overall Study|Did not receive treatment|1|||
46875692|NCT03329690|83095466|FG001|Overall Study|Did not receive treatment|0|||
46875693|NCT03329690|83095467|FG002|Overall Study|Did not receive treatment|0|||
46875694|NCT03329690|83095468|FG003|Overall Study|Did not receive treatment|1|||
46875695|NCT03329690|83095469|FG004|Overall Study|Did not receive treatment|0|||
46875696|NCT03328832|83095489|FG000|Overall Study|Lost to Follow-up|0|||
46875697|NCT03328832|83095490|FG001|Overall Study|Lost to Follow-up|1|||
46875698|NCT02820844|83095498|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
46875699|NCT02820844|83095499|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
46875700|NCT02820844|83095500|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
46875701|NCT02820844|83095501|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
46875702|NCT02820844|83095502|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
46875703|NCT02820844|83095503|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
46702084|NCT01199016|82916943|FG000|Overall Study|Protocol Violation|9|||
46702085|NCT01199016|82916943|FG000|Overall Study|Other|13|||
46875704|NCT02820844|83095498|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
46875705|NCT02820844|83095499|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
46875706|NCT02820844|83095500|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
46875707|NCT02820844|83095501|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
46702086|NCT01199016|82916943|FG000|Overall Study|Withdrawal by Subject|21|||
46702087|NCT01199016|82916943|FG000|Overall Study|Lost to Follow-up|25|||
46702088|NCT01198548|82916947|FG000|Overall Study|Disease Progression|9|||
46875708|NCT02820844|83095502|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
46702089|NCT01198548|82916947|FG000|Overall Study|Administrative Decision|1|||
46875709|NCT02820844|83095503|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
46875710|NCT02820844|83095498|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
46875711|NCT02820844|83095499|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
46875712|NCT02820844|83095500|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
46875713|NCT02820844|83095501|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
46875714|NCT02820844|83095502|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
46702090|NCT01198470|82916951|FG000|Overall Study|Adverse Event|2|||
46702091|NCT00977938|82916959|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
46875715|NCT02820844|83095503|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
46875716|NCT02820844|83095498|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
46875717|NCT02820844|83095499|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
46875718|NCT02820844|83095500|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
46875719|NCT02820844|83095501|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
46875720|NCT02820844|83095502|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
46875721|NCT02820844|83095503|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
46875722|NCT02820844|83095498|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
46875723|NCT02820844|83095499|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
46875724|NCT02820844|83095500|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
46875725|NCT02820844|83095501|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
46875726|NCT02820844|83095502|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
46875727|NCT02820844|83095503|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
46875728|NCT02820844|83095498|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
46875729|NCT02820844|83095499|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
46875730|NCT02820844|83095500|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
46875731|NCT02820844|83095501|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
46875732|NCT02820844|83095502|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
46875733|NCT02820844|83095503|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
46875734|NCT02820844|83095498|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
46875735|NCT02820844|83095499|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
46875736|NCT02820844|83095500|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
46875737|NCT02820844|83095501|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
46875738|NCT02820844|83095502|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
46875739|NCT02820844|83095503|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
46875740|NCT02820844|83095498|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875741|NCT02820844|83095499|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875742|NCT02820844|83095500|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
46875743|NCT02820844|83095501|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
46875744|NCT02820844|83095502|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875745|NCT02820844|83095503|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875746|NCT02820844|83095498|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
46875747|NCT02820844|83095499|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
46875748|NCT02820844|83095500|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
46875749|NCT02820844|83095501|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
46875750|NCT02820844|83095502|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
46875751|NCT02820844|83095503|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
46875752|NCT02820844|83095498|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875753|NCT02820844|83095499|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875754|NCT02820844|83095500|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875755|NCT02820844|83095501|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875756|NCT02820844|83095502|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
46875757|NCT02820844|83095503|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
46875758|NCT02942576|83095522|FG000|Overall Study|Adverse Event|28|||
46875759|NCT02942576|83095523|FG001|Overall Study|Adverse Event|6|||
46875760|NCT02942576|83095522|FG000|Overall Study|Withdrawal by Subject|7|||
46875761|NCT02942576|83095523|FG001|Overall Study|Withdrawal by Subject|5|||
46875762|NCT02942576|83095522|FG000|Overall Study|Physician Decision|1|||
46875763|NCT02942576|83095523|FG001|Overall Study|Physician Decision|4|||
46875764|NCT02942576|83095522|FG000|Overall Study|Other|10|||
46875765|NCT02942576|83095523|FG001|Overall Study|Other|8|||
46875766|NCT02820298|83095531|FG000|Overall Study|Withdrawal by Subject|0|||
46875767|NCT02820298|83095532|FG001|Overall Study|Withdrawal by Subject|1|||
46875768|NCT02820298|83095531|FG000|Overall Study|Physician Decision|1|||
46875769|NCT02820298|83095532|FG001|Overall Study|Physician Decision|0|||
46875770|NCT02820298|83095531|FG000|Overall Study|Protocol Violation|0|||
46875771|NCT02820298|83095532|FG001|Overall Study|Protocol Violation|1|||
46875772|NCT02819440|83095546|FG000|Overall Study|Adverse Event|3|||
46875773|NCT02819440|83095547|FG001|Overall Study|Adverse Event|1|||
46875774|NCT02819440|83095546|FG000|Overall Study|Lost to Follow-up|1|||
46875775|NCT02819440|83095547|FG001|Overall Study|Lost to Follow-up|3|||
46875776|NCT02819440|83095546|FG000|Overall Study|Withdrawal by Subject|9|||
46875777|NCT02819440|83095547|FG001|Overall Study|Withdrawal by Subject|8|||
46875778|NCT03814720|83095558|FG000|Overall Study|Lost to Follow-up|0|||
46875779|NCT03814720|83095559|FG001|Overall Study|Lost to Follow-up|1|||
46875780|NCT03814720|83095560|FG002|Overall Study|Lost to Follow-up|0|||
46875781|NCT03814720|83095561|FG003|Overall Study|Lost to Follow-up|0|||
46875782|NCT03814720|83095562|FG004|Overall Study|Lost to Follow-up|0|||
46984352|NCT02336815|83230499|FG000|Overall Study|Disease Progression|45|||
46875783|NCT02818036|83095578|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
46875784|NCT02818036|83095579|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
46875785|NCT02818036|83095578|FG000|Overall Study|Withdrawal by Subject|1|||
46875786|NCT02818036|83095579|FG001|Overall Study|Withdrawal by Subject|0|||
46875787|NCT01287741|83095587|FG000|Overall Study|Withdrawal by Subject|35|||
46875788|NCT01287741|83095588|FG001|Overall Study|Withdrawal by Subject|38|||
46875789|NCT01287741|83095587|FG000|Overall Study|Protocol Violation|2|||
46875790|NCT01287741|83095588|FG001|Overall Study|Protocol Violation|0|||
46875791|NCT01287741|83095587|FG000|Overall Study|Physician Decision|15|||
46875792|NCT01287741|83095588|FG001|Overall Study|Physician Decision|23|||
46875793|NCT01287741|83095587|FG000|Overall Study|Non-compliance|8|||
46875794|NCT01287741|83095588|FG001|Overall Study|Non-compliance|6|||
46875795|NCT01287741|83095587|FG000|Overall Study|Lost to Follow-up|10|||
46875796|NCT01287741|83095588|FG001|Overall Study|Lost to Follow-up|8|||
46875797|NCT01287741|83095587|FG000|Overall Study|Death|32|||
46875798|NCT01287741|83095588|FG001|Overall Study|Death|44|||
46875799|NCT01287741|83095587|FG000|Overall Study|Adverse Event|4|||
46875800|NCT01287741|83095588|FG001|Overall Study|Adverse Event|6|||
46875801|NCT01287741|83095587|FG000|Overall Study|Study terminated by Sponsor|307|||
46875802|NCT01287741|83095588|FG001|Overall Study|Study terminated by Sponsor|315|||
46875803|NCT01287741|83095587|FG000|Overall Study|Progressive disease|190|||
46875804|NCT01287741|83095588|FG001|Overall Study|Progressive disease|166|||
46875805|NCT01287741|83095587|FG000|Overall Study|Reason not specified|23|||
46875806|NCT01287741|83095588|FG001|Overall Study|Reason not specified|9|||
46875807|NCT05372315|83095601|FG000|Overall Study|Withdrawal by Subject|1|||
46875808|NCT05372315|83095602|FG001|Overall Study|Withdrawal by Subject|0|||
46875809|NCT04760314|83095621|FG000|Induction Period|Withdrawal by Subject|0|||
46875810|NCT04760314|83095622|FG001|Induction Period|Withdrawal by Subject|1|||
46875811|NCT04760314|83095623|FG002|Induction Period|Withdrawal by Subject|1|||
46875812|NCT04760314|83095624|FG003|Induction Period|Withdrawal by Subject|0|||
46875813|NCT04760314|83095625|FG004|Induction Period|Withdrawal by Subject|0|||
46875814|NCT04760314|83095626|FG005|Induction Period|Withdrawal by Subject|0|||
46875815|NCT04760314|83095627|FG006|Induction Period|Withdrawal by Subject|0|||
46875816|NCT04760314|83095628|FG007|Induction Period|Withdrawal by Subject|0|||
46875817|NCT04760314|83095629|FG008|Induction Period|Withdrawal by Subject|0|||
46875818|NCT04760314|83095630|FG009|Induction Period|Withdrawal by Subject|0|||
46875819|NCT04760314|83095631|FG010|Induction Period|Withdrawal by Subject|0|||
46875820|NCT04760314|83095621|FG000|Induction Period|Adverse Event|0|||
46875821|NCT04760314|83095622|FG001|Induction Period|Adverse Event|0|||
46875822|NCT04760314|83095623|FG002|Induction Period|Adverse Event|2|||
46875823|NCT04760314|83095624|FG003|Induction Period|Adverse Event|0|||
46875824|NCT04760314|83095625|FG004|Induction Period|Adverse Event|0|||
46875825|NCT04760314|83095626|FG005|Induction Period|Adverse Event|0|||
46875826|NCT04760314|83095627|FG006|Induction Period|Adverse Event|0|||
46875827|NCT04760314|83095628|FG007|Induction Period|Adverse Event|0|||
46875828|NCT04760314|83095629|FG008|Induction Period|Adverse Event|0|||
46875829|NCT04760314|83095630|FG009|Induction Period|Adverse Event|0|||
46875830|NCT04760314|83095631|FG010|Induction Period|Adverse Event|0|||
46875831|NCT04760314|83095621|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
46875832|NCT04760314|83095622|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
46875833|NCT04760314|83095623|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
46875834|NCT04760314|83095624|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
46875835|NCT04760314|83095625|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
46875836|NCT04760314|83095626|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
46875837|NCT04760314|83095627|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
46875838|NCT04760314|83095628|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
46875839|NCT04760314|83095629|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
46875840|NCT04760314|83095630|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
46875841|NCT04760314|83095631|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
46875842|NCT04760314|83095621|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875843|NCT04760314|83095622|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875844|NCT04760314|83095623|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875845|NCT04760314|83095624|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
46875846|NCT04760314|83095625|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875847|NCT04760314|83095626|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
46984353|NCT02336815|83230500|FG001|Overall Study|Disease Progression|70|||
46875848|NCT04760314|83095627|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
46875849|NCT04760314|83095628|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875850|NCT04760314|83095629|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875851|NCT04760314|83095630|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875852|NCT04760314|83095631|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
46875853|NCT04760314|83095621|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875854|NCT04760314|83095622|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875855|NCT04760314|83095623|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875856|NCT04760314|83095624|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875857|NCT04760314|83095625|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
46875858|NCT04760314|83095626|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875859|NCT04760314|83095627|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875860|NCT04760314|83095628|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875861|NCT04760314|83095629|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875862|NCT04760314|83095630|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875863|NCT04760314|83095631|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
46875864|NCT04760314|83095621|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
46875865|NCT04760314|83095622|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
46875866|NCT04760314|83095623|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
46875867|NCT04760314|83095624|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
46875868|NCT04760314|83095625|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
46875869|NCT04760314|83095626|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
46875870|NCT04760314|83095627|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
46875871|NCT04760314|83095628|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
46875872|NCT04760314|83095629|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
46875873|NCT04760314|83095630|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
46875874|NCT04760314|83095631|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
46875875|NCT04760314|83095621|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875876|NCT04760314|83095622|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875877|NCT04760314|83095623|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875878|NCT04760314|83095624|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875879|NCT04760314|83095625|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875880|NCT04760314|83095626|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875881|NCT04760314|83095627|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875882|NCT04760314|83095628|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
46875883|NCT04760314|83095629|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
46875884|NCT04760314|83095630|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
46875885|NCT04760314|83095631|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
46875886|NCT04760314|83095621|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875887|NCT04760314|83095622|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875888|NCT04760314|83095623|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875889|NCT04760314|83095624|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875890|NCT04760314|83095625|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875891|NCT04760314|83095626|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875892|NCT04760314|83095627|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875893|NCT04760314|83095628|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
46875894|NCT04760314|83095629|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
46875895|NCT04760314|83095630|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
46875896|NCT04760314|83095631|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
46875897|NCT04760314|83095621|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875898|NCT04760314|83095622|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875899|NCT04760314|83095623|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875900|NCT04760314|83095624|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875901|NCT04760314|83095625|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875902|NCT04760314|83095626|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875903|NCT04760314|83095627|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46702092|NCT00977938|82916960|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
46875904|NCT04760314|83095628|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
46875905|NCT04760314|83095629|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875906|NCT04760314|83095630|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875907|NCT04760314|83095631|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
46875908|NCT04760314|83095621|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875909|NCT04760314|83095622|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875910|NCT04760314|83095623|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875911|NCT04760314|83095624|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875912|NCT04760314|83095625|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875913|NCT04760314|83095626|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875914|NCT04760314|83095627|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875915|NCT04760314|83095628|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875916|NCT04760314|83095629|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
46875917|NCT04760314|83095630|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
46875918|NCT04760314|83095631|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
46875919|NCT04493684|83095674|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
46875920|NCT04493684|83095675|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875921|NCT04493684|83095676|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
46875922|NCT04493684|83095677|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875923|NCT04493684|83095678|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875924|NCT04493684|83095679|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
46875925|NCT04493684|83095680|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875926|NCT04493684|83095681|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875927|NCT04493684|83095682|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875928|NCT04493684|83095683|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875929|NCT04493684|83095684|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875930|NCT04493684|83095685|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875931|NCT04493684|83095686|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875932|NCT04493684|83095687|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875933|NCT04493684|83095688|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875934|NCT04493684|83095689|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875935|NCT04493684|83095690|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
46875936|NCT04493684|83095674|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
46875937|NCT04493684|83095675|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875938|NCT04493684|83095676|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875939|NCT04493684|83095677|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875940|NCT04493684|83095678|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875941|NCT04493684|83095679|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875942|NCT04493684|83095680|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875943|NCT04493684|83095681|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875944|NCT04493684|83095682|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875945|NCT04493684|83095683|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875946|NCT04493684|83095684|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875947|NCT04493684|83095685|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875948|NCT04493684|83095686|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875949|NCT04493684|83095687|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875950|NCT04493684|83095688|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875951|NCT04493684|83095689|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875952|NCT04493684|83095690|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
46875953|NCT04493684|83095674|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875954|NCT04493684|83095675|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875955|NCT04493684|83095676|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875956|NCT04493684|83095677|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875957|NCT04493684|83095678|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875958|NCT04493684|83095679|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875959|NCT04493684|83095680|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
46875960|NCT04493684|83095681|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875961|NCT04493684|83095682|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875962|NCT04493684|83095683|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875963|NCT04493684|83095684|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875964|NCT04493684|83095685|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875965|NCT04493684|83095686|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875966|NCT04493684|83095687|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875967|NCT04493684|83095688|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875968|NCT04493684|83095689|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875969|NCT04493684|83095690|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
46875970|NCT04493684|83095674|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
46875971|NCT04493684|83095675|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875972|NCT04493684|83095676|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875973|NCT04493684|83095677|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46984354|NCT02336815|83230499|FG000|Overall Study|Adverse Event|18|||
46875974|NCT04493684|83095678|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875975|NCT04493684|83095679|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875976|NCT04493684|83095680|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875977|NCT04493684|83095681|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875978|NCT04493684|83095682|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875979|NCT04493684|83095683|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875980|NCT04493684|83095684|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875981|NCT04493684|83095685|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875982|NCT04493684|83095686|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875983|NCT04493684|83095687|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875984|NCT04493684|83095688|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875985|NCT04493684|83095689|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875986|NCT04493684|83095690|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
46875987|NCT04493684|83095674|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875988|NCT04493684|83095675|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46984355|NCT02336815|83230500|FG001|Overall Study|Adverse Event|39|||
46984356|NCT02336815|83230499|FG000|Overall Study|Physician Decision|11|||
46984357|NCT02336815|83230500|FG001|Overall Study|Physician Decision|4|||
46984358|NCT02336815|83230499|FG000|Overall Study|Withdrawal by Subject|3|||
46875989|NCT04493684|83095676|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875990|NCT04493684|83095677|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875991|NCT04493684|83095678|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875992|NCT04493684|83095679|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
46875993|NCT04493684|83095680|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875994|NCT04493684|83095681|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875995|NCT04493684|83095682|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875996|NCT04493684|83095683|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875997|NCT04493684|83095684|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875998|NCT04493684|83095685|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46875999|NCT04493684|83095686|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46876000|NCT04493684|83095687|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46876001|NCT04493684|83095688|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46876002|NCT04493684|83095689|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46876003|NCT04493684|83095690|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
46876004|NCT04493684|83095674|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876005|NCT04493684|83095675|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876006|NCT04493684|83095676|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876007|NCT04493684|83095677|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876008|NCT04493684|83095678|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876009|NCT04493684|83095679|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876010|NCT04493684|83095680|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876011|NCT04493684|83095681|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876012|NCT04493684|83095682|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876013|NCT04493684|83095683|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876014|NCT04493684|83095684|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876015|NCT04493684|83095685|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
46876016|NCT04493684|83095686|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876017|NCT04493684|83095687|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876018|NCT04493684|83095688|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876019|NCT04493684|83095689|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876020|NCT04493684|83095690|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
46876021|NCT04493684|83095674|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876022|NCT04493684|83095675|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876023|NCT04493684|83095676|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876024|NCT04493684|83095677|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876025|NCT04493684|83095678|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876026|NCT04493684|83095679|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876027|NCT04493684|83095680|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876028|NCT04493684|83095681|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876029|NCT04493684|83095682|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876030|NCT04493684|83095683|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46984359|NCT02336815|83230500|FG001|Overall Study|Withdrawal by Subject|2|||
46984360|NCT02336815|83230499|FG000|Overall Study|Lost to Follow-up|1|||
46984361|NCT02336815|83230500|FG001|Overall Study|Lost to Follow-up|3|||
46876031|NCT04493684|83095684|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876032|NCT04493684|83095685|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876033|NCT04493684|83095686|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876034|NCT04493684|83095687|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876035|NCT04493684|83095688|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876036|NCT04493684|83095689|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
46876037|NCT04493684|83095690|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
46876038|NCT04493684|83095674|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876039|NCT04493684|83095675|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876040|NCT04493684|83095676|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876041|NCT04493684|83095677|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876042|NCT04493684|83095678|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876043|NCT04493684|83095679|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876044|NCT04493684|83095680|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876045|NCT04493684|83095681|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876046|NCT04493684|83095682|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876047|NCT04493684|83095683|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876048|NCT04493684|83095684|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876049|NCT04493684|83095685|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876050|NCT04493684|83095686|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876051|NCT04493684|83095687|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876052|NCT04493684|83095688|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876053|NCT04493684|83095689|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
46876054|NCT04493684|83095690|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
46876055|NCT04289298|83095755|FG000|Overall Study|Lost to Follow-up|5|||
46876056|NCT04289298|83095756|FG001|Overall Study|Lost to Follow-up|0|||
46876057|NCT04289298|83095755|FG000|Overall Study|Withdrawal by Subject|2|||
46876058|NCT04289298|83095756|FG001|Overall Study|Withdrawal by Subject|0|||
46876059|NCT04116710|83095767|FG000|Overall Study|Death|4|||
46876060|NCT04116710|83095768|FG001|Overall Study|Death|6|||
46876061|NCT04116710|83095769|FG002|Overall Study|Death|3|||
46876062|NCT04116710|83095770|FG003|Overall Study|Death|1|||
46876063|NCT04116710|83095767|FG000|Overall Study|Withdrawal by Subject|0|||
46876064|NCT04116710|83095768|FG001|Overall Study|Withdrawal by Subject|0|||
46876065|NCT04116710|83095769|FG002|Overall Study|Withdrawal by Subject|0|||
46876066|NCT04116710|83095770|FG003|Overall Study|Withdrawal by Subject|1|||
46876067|NCT02946515|83095809|FG000|Overall Study|Lost to Follow-up|2|||
46876068|NCT02946515|83095810|FG001|Overall Study|Lost to Follow-up|1|||
46876069|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
46876070|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
46876071|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
46876072|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
46876073|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
46876074|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
46876075|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
46876076|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
46876077|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
46876078|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
46876079|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
46876080|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
46876081|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
46876082|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
46876083|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
46876084|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
46876085|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
46876086|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
46876087|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
46876088|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
46876089|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
46876090|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
46876091|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
46876092|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
46876093|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
46876094|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
46876095|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
46876096|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
46876097|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
46984362|NCT02336815|83230499|FG000|Overall Study|Other|1|||
46876098|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
46876099|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
46876100|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
46876101|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
46876102|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
46876103|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
46876104|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
46876105|NCT02586623|83095819|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
46876106|NCT02586623|83095820|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
46876107|NCT02586623|83095821|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
46876108|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
46876109|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
46876110|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
46876111|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
46876112|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
46876113|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
46876114|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
46876115|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
46876116|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
46876117|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
46876118|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
46876119|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
46876120|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
46876121|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
46876122|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
46876123|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
46876124|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
46876125|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
46876126|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
46876127|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
46876128|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
46876129|NCT02586623|83095819|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
46876130|NCT02586623|83095820|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
46876131|NCT02586623|83095821|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
46876132|NCT01819831|83095828|FG000|Overall Study|Withdrawal by Subject|1|||
46876133|NCT00078949|83095845|FG000|Overall Study|No treated|4|||
46876134|NCT00078949|83095846|FG001|Overall Study|No treated|5|||
46876135|NCT00078949|83095847|FG002|Overall Study|No treated|3|||
46876136|NCT00078949|83095848|FG003|Overall Study|No treated|3|||
46876137|NCT03739203|83095863|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
46876138|NCT03739203|83095864|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
46876139|NCT03739203|83095865|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
46876140|NCT03739203|83095863|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
46876141|NCT03739203|83095864|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
46876142|NCT03739203|83095865|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
46876143|NCT03739203|83095863|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
46876144|NCT03739203|83095864|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
46876145|NCT03739203|83095865|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
46876146|NCT03739203|83095863|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
46876147|NCT03739203|83095864|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
46876148|NCT03739203|83095865|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
46876149|NCT03739203|83095863|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
46876150|NCT03739203|83095864|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
46876151|NCT03739203|83095865|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
46876152|NCT03739203|83095863|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
46876153|NCT03739203|83095864|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
46876154|NCT03739203|83095865|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
46876155|NCT03739203|83095863|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
46876156|NCT03739203|83095864|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
46876157|NCT03739203|83095865|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
46876158|NCT03739203|83095863|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
46876159|NCT03739203|83095864|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
46876160|NCT03739203|83095865|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
46876161|NCT03739203|83095863|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
46876162|NCT03739203|83095864|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
46876163|NCT03739203|83095865|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
46876164|NCT03739203|83095863|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
46876165|NCT03739203|83095864|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
46876166|NCT03739203|83095865|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
46876167|NCT03739203|83095863|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
46876168|NCT03739203|83095864|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
46876169|NCT03739203|83095865|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
46876170|NCT02942264|83095882|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
46876171|NCT02942264|83095883|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
46876172|NCT02942264|83095884|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
46876173|NCT02942264|83095885|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
46876174|NCT02942264|83095886|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
46876175|NCT02942264|83095887|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
46876176|NCT02942264|83095888|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
46876177|NCT02942264|83095889|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
46876178|NCT02942264|83095890|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
46984363|NCT02336815|83230500|FG001|Overall Study|Other|5|||
46876179|NCT02942264|83095882|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46876180|NCT02942264|83095883|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46876181|NCT02942264|83095884|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46876182|NCT02942264|83095885|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46876183|NCT02942264|83095886|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46876184|NCT02942264|83095887|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46876185|NCT02942264|83095888|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46984364|NCT02543203|83230510|FG000|Overall Study|Unpalatable Fragrance|2|||
46984365|NCT02543203|83230511|FG001|Overall Study|Unpalatable Fragrance|2|||
46984366|NCT02543203|83230510|FG000|Overall Study|Lost to Follow-up|1|||
46984367|NCT02543203|83230511|FG001|Overall Study|Lost to Follow-up|0|||
46984368|NCT02543203|83230510|FG000|Overall Study|Increased Irritability|1|||
46984369|NCT02543203|83230511|FG001|Overall Study|Increased Irritability|0|||
46984370|NCT02543203|83230510|FG000|Overall Study|Family|1|||
46984371|NCT02543203|83230511|FG001|Overall Study|Family|2|||
46876186|NCT02942264|83095889|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
46876187|NCT02942264|83095890|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
46876188|NCT03322514|83095917|FG000|Overall Study|Withdrawal by Subject|1|||
46876189|NCT03322514|83095918|FG001|Overall Study|Withdrawal by Subject|1|||
46876190|NCT03325712|83095932|FG000|Overall Study|Protocol Violation|0|||
46876191|NCT03325712|83095933|FG001|Overall Study|Protocol Violation|0|||
46876192|NCT03325712|83095934|FG002|Overall Study|Protocol Violation|0|||
46876193|NCT03325712|83095935|FG003|Overall Study|Protocol Violation|0|||
46876194|NCT03325712|83095936|FG004|Overall Study|Protocol Violation|1|||
46876195|NCT03325712|83095937|FG005|Overall Study|Protocol Violation|0|||
46876196|NCT03325712|83095938|FG006|Overall Study|Protocol Violation|0|||
46876197|NCT03325712|83095939|FG007|Overall Study|Protocol Violation|0|||
46876198|NCT03325712|83095932|FG000|Overall Study|Adverse Event|0|||
46876199|NCT03325712|83095933|FG001|Overall Study|Adverse Event|0|||
46876200|NCT03325712|83095934|FG002|Overall Study|Adverse Event|0|||
46876201|NCT03325712|83095935|FG003|Overall Study|Adverse Event|0|||
46876202|NCT03325712|83095936|FG004|Overall Study|Adverse Event|1|||
46984372|NCT02543203|83230510|FG000|Overall Study|Negative Behavior|1|||
46876203|NCT03325712|83095937|FG005|Overall Study|Adverse Event|0|||
46984373|NCT02543203|83230511|FG001|Overall Study|Negative Behavior|0|||
46984374|NCT02543203|83230510|FG000|Overall Study|Withdrawal by Subject|0|||
46984375|NCT02543203|83230511|FG001|Overall Study|Withdrawal by Subject|1|||
46876204|NCT03325712|83095938|FG006|Overall Study|Adverse Event|0|||
46876205|NCT03325712|83095939|FG007|Overall Study|Adverse Event|0|||
46876206|NCT03325556|83095967|FG000|Open-label Period|Lack of Response in OL period|70|||
46876207|NCT03325556|83095968|FG001|Open-label Period|Lack of Response in OL period|0|||
46876208|NCT03325556|83095969|FG002|Open-label Period|Lack of Response in OL period|0|||
46876209|NCT03325556|83095967|FG000|Open-label Period|Adverse Event|27|||
46876210|NCT03325556|83095968|FG001|Open-label Period|Adverse Event|0|||
46876211|NCT03325556|83095969|FG002|Open-label Period|Adverse Event|0|||
46876212|NCT03325556|83095967|FG000|Open-label Period|Death|1|||
46876213|NCT03325556|83095968|FG001|Open-label Period|Death|0|||
46876214|NCT03325556|83095969|FG002|Open-label Period|Death|0|||
46876215|NCT03325556|83095967|FG000|Open-label Period|Lost to Follow-up|1|||
46876216|NCT03325556|83095968|FG001|Open-label Period|Lost to Follow-up|0|||
46876217|NCT03325556|83095969|FG002|Open-label Period|Lost to Follow-up|0|||
46876218|NCT03325556|83095967|FG000|Open-label Period|Non-compliance with study drug|5|||
46876219|NCT03325556|83095968|FG001|Open-label Period|Non-compliance with study drug|0|||
46876220|NCT03325556|83095969|FG002|Open-label Period|Non-compliance with study drug|0|||
46876221|NCT03325556|83095967|FG000|Open-label Period|Use of prohibited medication|1|||
46876222|NCT03325556|83095968|FG001|Open-label Period|Use of prohibited medication|0|||
46876223|NCT03325556|83095969|FG002|Open-label Period|Use of prohibited medication|0|||
46876224|NCT03325556|83095967|FG000|Open-label Period|Protocol Violation|4|||
46876225|NCT03325556|83095968|FG001|Open-label Period|Protocol Violation|0|||
46876226|NCT03325556|83095969|FG002|Open-label Period|Protocol Violation|0|||
46876227|NCT03325556|83095967|FG000|Open-label Period|Withdrawal by Subject|17|||
46876228|NCT03325556|83095968|FG001|Open-label Period|Withdrawal by Subject|0|||
46876229|NCT03325556|83095969|FG002|Open-label Period|Withdrawal by Subject|0|||
46876230|NCT03325556|83095967|FG000|Open-label Period|Not otherwise specified|8|||
46876231|NCT03325556|83095968|FG001|Open-label Period|Not otherwise specified|0|||
46876232|NCT03325556|83095969|FG002|Open-label Period|Not otherwise specified|0|||
46876233|NCT03325556|83095967|FG000|Open-label Period|Administrative discont. at study termination|41|||
46876234|NCT03325556|83095968|FG001|Open-label Period|Administrative discont. at study termination|0|||
46876235|NCT03325556|83095969|FG002|Open-label Period|Administrative discont. at study termination|0|||
46876236|NCT03325556|83095967|FG000|Double-blind Period|Relapse|0|||
46876237|NCT03325556|83095968|FG001|Double-blind Period|Relapse|15|||
46876238|NCT03325556|83095969|FG002|Double-blind Period|Relapse|34|||
46876239|NCT03325556|83095967|FG000|Double-blind Period|Adverse Event|0|||
46876240|NCT03325556|83095968|FG001|Double-blind Period|Adverse Event|3|||
46876241|NCT03325556|83095969|FG002|Double-blind Period|Adverse Event|1|||
46876242|NCT03325556|83095967|FG000|Double-blind Period|Noncompliance with study drug|0|||
46876243|NCT03325556|83095968|FG001|Double-blind Period|Noncompliance with study drug|0|||
46876244|NCT03325556|83095969|FG002|Double-blind Period|Noncompliance with study drug|1|||
46876245|NCT03325556|83095967|FG000|Double-blind Period|Use of prohibited medication|0|||
46876246|NCT03325556|83095968|FG001|Double-blind Period|Use of prohibited medication|1|||
46876247|NCT03325556|83095969|FG002|Double-blind Period|Use of prohibited medication|0|||
46876248|NCT03325556|83095967|FG000|Double-blind Period|Physician Decision|0|||
46876249|NCT03325556|83095968|FG001|Double-blind Period|Physician Decision|0|||
46876250|NCT03325556|83095969|FG002|Double-blind Period|Physician Decision|1|||
46876251|NCT03325556|83095967|FG000|Double-blind Period|Withdrawal by Subject|0|||
46876252|NCT03325556|83095968|FG001|Double-blind Period|Withdrawal by Subject|6|||
46876253|NCT03325556|83095969|FG002|Double-blind Period|Withdrawal by Subject|4|||
46876254|NCT03325556|83095967|FG000|Double-blind Period|Not otherwise specified|0|||
46876255|NCT03325556|83095968|FG001|Double-blind Period|Not otherwise specified|1|||
46876256|NCT03325556|83095969|FG002|Double-blind Period|Not otherwise specified|5|||
46876257|NCT03325556|83095967|FG000|Double-blind Period|Administrative discont. at study termination|0|||
46876258|NCT03325556|83095968|FG001|Double-blind Period|Administrative discont. at study termination|35|||
46876259|NCT03325556|83095969|FG002|Double-blind Period|Administrative discont. at study termination|31|||
46876260|NCT03320564|83095976|FG000|Overall Study|Protocol Violation|1|||
46876261|NCT03325166|83095980|FG000|Overall Study|Adverse Event|1|||
46876262|NCT02888756|83095987|FG000|Analytical Treatment Interruption|Physician Decision|10|||
46876263|NCT02888756|83095988|FG001|Analytical Treatment Interruption|Physician Decision|6|||
46876264|NCT02888756|83095989|FG002|Analytical Treatment Interruption|Physician Decision|5|||
46876265|NCT03305666|83095999|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
46876266|NCT03305666|83096000|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
46876267|NCT03304184|83096008|FG000|Overall Study|Withdrawal by Subject|1|||
46876268|NCT03304184|83096009|FG001|Overall Study|Withdrawal by Subject|2|||
46876269|NCT03736785|83096019|FG000|Overall Study|Adverse Event|1|||
46876270|NCT03736785|83096020|FG001|Overall Study|Adverse Event|1|||
46876271|NCT03736785|83096021|FG002|Overall Study|Adverse Event|1|||
46876272|NCT03736785|83096019|FG000|Overall Study|Death|1|||
46876273|NCT03736785|83096020|FG001|Overall Study|Death|0|||
46876274|NCT03736785|83096021|FG002|Overall Study|Death|1|||
46876275|NCT03736785|83096019|FG000|Overall Study|Lost to Follow-up|0|||
46876276|NCT03736785|83096020|FG001|Overall Study|Lost to Follow-up|2|||
46876277|NCT03736785|83096021|FG002|Overall Study|Lost to Follow-up|3|||
46876278|NCT03736785|83096019|FG000|Overall Study|Non compliance with study drug|1|||
46876279|NCT03736785|83096020|FG001|Overall Study|Non compliance with study drug|1|||
46876280|NCT03736785|83096021|FG002|Overall Study|Non compliance with study drug|0|||
46876281|NCT03736785|83096019|FG000|Overall Study|Physician Decision|0|||
46876282|NCT03736785|83096020|FG001|Overall Study|Physician Decision|1|||
46876283|NCT03736785|83096021|FG002|Overall Study|Physician Decision|1|||
46876284|NCT03736785|83096019|FG000|Overall Study|Protocol Violation|1|||
46876285|NCT03736785|83096020|FG001|Overall Study|Protocol Violation|4|||
46876286|NCT03736785|83096021|FG002|Overall Study|Protocol Violation|3|||
46876287|NCT03736785|83096019|FG000|Overall Study|Sponsor Decision|1|||
46876288|NCT03736785|83096020|FG001|Overall Study|Sponsor Decision|0|||
46876289|NCT03736785|83096021|FG002|Overall Study|Sponsor Decision|0|||
46876290|NCT03736785|83096019|FG000|Overall Study|Unknown/Missing data|3|||
46876291|NCT03736785|83096020|FG001|Overall Study|Unknown/Missing data|2|||
46876292|NCT03736785|83096021|FG002|Overall Study|Unknown/Missing data|1|||
46876293|NCT03736785|83096019|FG000|Overall Study|Withdrawal by Subject|9|||
46876294|NCT03736785|83096020|FG001|Overall Study|Withdrawal by Subject|6|||
46876295|NCT03736785|83096021|FG002|Overall Study|Withdrawal by Subject|4|||
46876296|NCT03734991|83096032|FG000|Overall Study|Adverse Event|4|||
46876297|NCT03734991|83096033|FG001|Overall Study|Adverse Event|0|||
46876298|NCT03734991|83096032|FG000|Overall Study|Lost to Follow-up|4|||
46876299|NCT03734991|83096033|FG001|Overall Study|Lost to Follow-up|0|||
46876300|NCT03734991|83096032|FG000|Overall Study|Physician Decision|0|||
46876301|NCT03734991|83096033|FG001|Overall Study|Physician Decision|1|||
46876302|NCT03734991|83096032|FG000|Overall Study|Pregnancy|1|||
46876303|NCT03734991|83096033|FG001|Overall Study|Pregnancy|0|||
46876304|NCT03734991|83096032|FG000|Overall Study|Withdrawal by Subject|6|||
46876305|NCT03734991|83096033|FG001|Overall Study|Withdrawal by Subject|3|||
46876306|NCT03734991|83096032|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
46876307|NCT03734991|83096033|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
46876308|NCT03734991|83096032|FG000|Overall Study|Other|2|||
46876309|NCT03734991|83096033|FG001|Overall Study|Other|2|||
46876310|NCT03303092|83096042|FG000|Overall Study|Adverse Event|1|||
46876311|NCT03303092|83096043|FG001|Overall Study|Adverse Event|0|||
46876312|NCT03303092|83096044|FG002|Overall Study|Adverse Event|1|||
46876313|NCT03303092|83096042|FG000|Overall Study|Protocol Violation|1|||
46876314|NCT03303092|83096043|FG001|Overall Study|Protocol Violation|5|||
46876315|NCT03303092|83096044|FG002|Overall Study|Protocol Violation|1|||
46876316|NCT03303092|83096042|FG000|Overall Study|Withdrawal by Subject|1|||
46876317|NCT03303092|83096043|FG001|Overall Study|Withdrawal by Subject|1|||
46876318|NCT03303092|83096044|FG002|Overall Study|Withdrawal by Subject|3|||
46876319|NCT03302936|83096054|FG000|Overall Study|Protocol Violation|3|||
46876320|NCT03302936|83096055|FG001|Overall Study|Protocol Violation|4|||
46876321|NCT03733899|83096065|FG000|Period 1|Protocol Violation|0|||
46876322|NCT03733899|83096066|FG001|Period 1|Protocol Violation|0|||
46876323|NCT03733899|83096067|FG002|Period 1|Protocol Violation|0|||
46876324|NCT03733899|83096068|FG003|Period 1|Protocol Violation|0|||
46876325|NCT03733899|83096069|FG004|Period 1|Protocol Violation|0|||
46702093|NCT00977938|82916961|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
46702094|NCT00977938|82916962|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
46876326|NCT03733899|83096070|FG005|Period 1|Protocol Violation|1|||
46876327|NCT03733899|83096065|FG000|Period 2|Unscuccessful Treatment|0|||
46876328|NCT03733899|83096066|FG001|Period 2|Unscuccessful Treatment|1|||
46876329|NCT03733899|83096067|FG002|Period 2|Unscuccessful Treatment|0|||
46876330|NCT03733899|83096068|FG003|Period 2|Unscuccessful Treatment|0|||
46876331|NCT03733899|83096069|FG004|Period 2|Unscuccessful Treatment|0|||
46702095|NCT00977938|82916959|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
46876332|NCT03733899|83096070|FG005|Period 2|Unscuccessful Treatment|0|||
46876333|NCT03733899|83096065|FG000|Period 3|Withdrawal by Subject|1|||
46876334|NCT03733899|83096066|FG001|Period 3|Withdrawal by Subject|0|||
46876335|NCT03733899|83096067|FG002|Period 3|Withdrawal by Subject|0|||
46876336|NCT03733899|83096068|FG003|Period 3|Withdrawal by Subject|0|||
46876337|NCT03733899|83096069|FG004|Period 3|Withdrawal by Subject|0|||
46876338|NCT03733899|83096070|FG005|Period 3|Withdrawal by Subject|0|||
46876339|NCT03727347|83096083|FG000|Overall Study|Withdrawal by Subject|2|||
46876340|NCT03727347|83096083|FG000|Overall Study|Lost to Follow-up|1|||
46876341|NCT03915626|83096096|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
46876342|NCT03301844|83096108|FG000|Overall Study|suspected colon cancer|1|||
46876343|NCT03301844|83096109|FG001|Overall Study|suspected colon cancer|1|||
46876344|NCT03313310|83096117|FG000|Phase 2|Lost to Follow-up|4|||
46876345|NCT03313310|83096118|FG001|Phase 2|Lost to Follow-up|0|||
46876346|NCT03313310|83096117|FG000|Phase 3|Lost to Follow-up|0|||
46876347|NCT03313310|83096118|FG001|Phase 3|Lost to Follow-up|1|||
46876348|NCT03313076|83096128|FG000|Overall Study|Withdrawal by Subject|2|||
46876349|NCT03313076|83096129|FG001|Overall Study|Withdrawal by Subject|0|||
46876350|NCT03313076|83096130|FG002|Overall Study|Withdrawal by Subject|0|||
46876351|NCT03313076|83096131|FG003|Overall Study|Withdrawal by Subject|0|||
46876352|NCT03313076|83096128|FG000|Overall Study|Lost to Follow-up|0|||
46876353|NCT03313076|83096129|FG001|Overall Study|Lost to Follow-up|2|||
46876354|NCT03313076|83096130|FG002|Overall Study|Lost to Follow-up|2|||
46876355|NCT03313076|83096131|FG003|Overall Study|Lost to Follow-up|2|||
46876356|NCT02940626|83096149|FG000|Overall Study|Death|40|||
46876357|NCT02940626|83096150|FG001|Overall Study|Death|32|||
46876358|NCT02940626|83096149|FG000|Overall Study|Lost to Follow-up|5|||
46876359|NCT02940626|83096150|FG001|Overall Study|Lost to Follow-up|2|||
46876360|NCT02940626|83096149|FG000|Overall Study|Withdrawal by Subject|1|||
46876361|NCT02940626|83096150|FG001|Overall Study|Withdrawal by Subject|0|||
46876362|NCT02940626|83096149|FG000|Overall Study|Transfer to Hospice Care|1|||
46876363|NCT02940626|83096150|FG001|Overall Study|Transfer to Hospice Care|0|||
46876364|NCT02940626|83096149|FG000|Overall Study|Prohibited Concomitant Medication|0|||
46876365|NCT02940626|83096150|FG001|Overall Study|Prohibited Concomitant Medication|1|||
46876366|NCT03300050|83096163|FG000|Overall Study|Lost to Follow-up|2|||
46876367|NCT03300050|83096164|FG001|Overall Study|Lost to Follow-up|1|||
46876368|NCT03300050|83096165|FG002|Overall Study|Lost to Follow-up|0|||
46876369|NCT03300050|83096166|FG003|Overall Study|Lost to Follow-up|0|||
46876370|NCT03300050|83096167|FG004|Overall Study|Lost to Follow-up|1|||
46876371|NCT03300050|83096163|FG000|Overall Study|Withdrawal by Subject|1|||
46876372|NCT03300050|83096164|FG001|Overall Study|Withdrawal by Subject|1|||
46876373|NCT03300050|83096165|FG002|Overall Study|Withdrawal by Subject|1|||
46876374|NCT03300050|83096166|FG003|Overall Study|Withdrawal by Subject|0|||
46876375|NCT03300050|83096167|FG004|Overall Study|Withdrawal by Subject|0|||
46876376|NCT03300050|83096163|FG000|Overall Study|Death|0|||
46876377|NCT03300050|83096164|FG001|Overall Study|Death|0|||
46876378|NCT03300050|83096165|FG002|Overall Study|Death|1|||
46876379|NCT03300050|83096166|FG003|Overall Study|Death|0|||
46876380|NCT03300050|83096167|FG004|Overall Study|Death|0|||
46876381|NCT03300050|83096163|FG000|Overall Study|Not Eligible at Randomization|0|||
46876382|NCT03300050|83096164|FG001|Overall Study|Not Eligible at Randomization|0|||
46876383|NCT03300050|83096165|FG002|Overall Study|Not Eligible at Randomization|1|||
46876384|NCT03300050|83096166|FG003|Overall Study|Not Eligible at Randomization|1|||
46876385|NCT03300050|83096167|FG004|Overall Study|Not Eligible at Randomization|0|||
46876386|NCT03725085|83096179|FG000|Overall Study|Lost to Follow-up|2|||
46876387|NCT02940392|83096184|FG000|Overall Study|Lost to Follow-up|3|||
46876388|NCT02940392|83096184|FG000|Overall Study|Retreatment|3|||
46876389|NCT02940392|83096184|FG000|Overall Study|Death|2|||
46876390|NCT03298412|83096197|FG000|Run-in Period|Other, Not Specified|1|||
46876391|NCT03298412|83096197|FG000|Run-in Period|Disease Progression|1|||
46876392|NCT03298412|83096197|FG000|Run-in Period|Ineligibility Determined|1|||
46876393|NCT03298412|83096197|FG000|Run-in Period|Decision by Sponsor|6|||
46876394|NCT03297398|83096204|FG000|Overall Study|Sponsor's decision|6|||
46984376|NCT02546323|83230527|FG000|Overall Study|Withdrawal by Subject|36|||
46984377|NCT02546323|83230528|FG001|Overall Study|Withdrawal by Subject|33|||
46984378|NCT02546323|83230527|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
46984379|NCT02546323|83230528|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
46984380|NCT02546323|83230527|FG000|Overall Study|Adverse Event|17|||
46984381|NCT02546323|83230528|FG001|Overall Study|Adverse Event|11|||
46702096|NCT00977938|82916960|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
46702097|NCT00977938|82916961|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
46707559|NCT01176240|82923136|FG001|Study 306B|Protocol Violation|3|||
46876395|NCT03297398|83096205|FG001|Overall Study|Sponsor's decision|9|||
46876396|NCT03297398|83096206|FG002|Overall Study|Sponsor's decision|7|||
46876397|NCT03297398|83096204|FG000|Overall Study|Adverse Event|1|||
46876398|NCT03297398|83096205|FG001|Overall Study|Adverse Event|4|||
46876399|NCT03297398|83096206|FG002|Overall Study|Adverse Event|4|||
46876400|NCT03297398|83096204|FG000|Overall Study|Withdrawal by Subject|1|||
46876401|NCT03297398|83096205|FG001|Overall Study|Withdrawal by Subject|2|||
46876402|NCT03297398|83096206|FG002|Overall Study|Withdrawal by Subject|2|||
46876403|NCT03297398|83096204|FG000|Overall Study|Protocol Violation|0|||
46876404|NCT03297398|83096205|FG001|Overall Study|Protocol Violation|2|||
46876405|NCT03297398|83096206|FG002|Overall Study|Protocol Violation|0|||
46876406|NCT03297398|83096204|FG000|Overall Study|Physician Decision|0|||
46876407|NCT03297398|83096205|FG001|Overall Study|Physician Decision|0|||
46876408|NCT03297398|83096206|FG002|Overall Study|Physician Decision|1|||
46876409|NCT03297398|83096204|FG000|Overall Study|Lost to Follow-up|0|||
46984382|NCT02546323|83230527|FG000|Overall Study|Patient Specific Reasons|1|||
46876410|NCT03297398|83096205|FG001|Overall Study|Lost to Follow-up|0|||
46876411|NCT03297398|83096206|FG002|Overall Study|Lost to Follow-up|1|||
46876412|NCT03293654|83096217|FG000|Overall Study|Lost to Follow-up|0|||
46876413|NCT03293654|83096218|FG001|Overall Study|Lost to Follow-up|1|||
46876414|NCT03293654|83096219|FG002|Overall Study|Lost to Follow-up|0|||
46876415|NCT03312218|83096229|FG000|Overall Study|Never signed in to access the app|54|||
46876416|NCT03312218|83096230|FG001|Overall Study|Never signed in to access the app|58|||
46876417|NCT03930615|83096238|FG000|Overall Study|Death|9|||
46876418|NCT03930615|83096239|FG001|Overall Study|Death|3|||
46876419|NCT03930615|83096238|FG000|Overall Study|Lost to Follow-up|1|||
46876420|NCT03930615|83096239|FG001|Overall Study|Lost to Follow-up|2|||
46876421|NCT03930615|83096238|FG000|Overall Study|Physician Decision|3|||
46876422|NCT03930615|83096239|FG001|Overall Study|Physician Decision|4|||
46876423|NCT03930615|83096238|FG000|Overall Study|Withdrawal by Subject|13|||
46876424|NCT03930615|83096239|FG001|Overall Study|Withdrawal by Subject|2|||
46876425|NCT03930615|83096238|FG000|Overall Study|Not treated|1|||
46876426|NCT03930615|83096239|FG001|Overall Study|Not treated|1|||
46876427|NCT03292640|83096247|FG000|Overall Study|Withdrawal by Subject|17|||
46876428|NCT03292640|83096248|FG001|Overall Study|Withdrawal by Subject|16|||
46876429|NCT03292640|83096247|FG000|Overall Study|Adverse Event|20|||
46876430|NCT03292640|83096248|FG001|Overall Study|Adverse Event|2|||
46876431|NCT03292640|83096247|FG000|Overall Study|Lost to Follow-up|24|||
46876432|NCT03292640|83096248|FG001|Overall Study|Lost to Follow-up|24|||
46876433|NCT03292406|83096261|FG000|Overall Study|Progressive Disease|6|||
46876434|NCT03292406|83096262|FG001|Overall Study|Progressive Disease|3|||
46876435|NCT03292406|83096263|FG002|Overall Study|Progressive Disease|4|||
46876436|NCT03292406|83096261|FG000|Overall Study|Adverse Event|7|||
46876437|NCT03292406|83096262|FG001|Overall Study|Adverse Event|1|||
46876438|NCT03292406|83096263|FG002|Overall Study|Adverse Event|4|||
46876439|NCT03292406|83096261|FG000|Overall Study|Withdrawal by Subject|0|||
46876440|NCT03292406|83096262|FG001|Overall Study|Withdrawal by Subject|7|||
46876441|NCT03292406|83096263|FG002|Overall Study|Withdrawal by Subject|2|||
46876442|NCT03292406|83096261|FG000|Overall Study|Protocol Violation|0|||
46876443|NCT03292406|83096262|FG001|Overall Study|Protocol Violation|1|||
46876444|NCT03292406|83096263|FG002|Overall Study|Protocol Violation|1|||
46876445|NCT03292406|83096261|FG000|Overall Study|Other|0|||
46876446|NCT03292406|83096262|FG001|Overall Study|Other|1|||
46876447|NCT03292406|83096263|FG002|Overall Study|Other|2|||
46876448|NCT03292016|83096300|FG000|Second Washout|Adverse Event|0|||
46702098|NCT00977938|82916962|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
46702099|NCT00977938|82916959|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
46876449|NCT03292016|83096301|FG001|Second Washout|Adverse Event|1|||
46876450|NCT03292016|83096302|FG002|Second Washout|Adverse Event|0|||
46876451|NCT03292016|83096303|FG003|Second Washout|Adverse Event|0|||
46876452|NCT03292016|83096304|FG004|Second Washout|Adverse Event|0|||
46876453|NCT03292016|83096305|FG005|Second Washout|Adverse Event|0|||
46876454|NCT03289676|83096315|FG000|Overall Study|Withdrawal by Subject|2|||
46876455|NCT03289676|83096316|FG001|Overall Study|Withdrawal by Subject|0|||
46876456|NCT03289676|83096315|FG000|Overall Study|Protocol Violation|2|||
46876457|NCT03289676|83096316|FG001|Overall Study|Protocol Violation|0|||
46702100|NCT00977938|82916960|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
46876458|NCT03289676|83096315|FG000|Overall Study|Lost to Follow-up|0|||
46876459|NCT03289676|83096316|FG001|Overall Study|Lost to Follow-up|1|||
46876460|NCT03287804|83096332|FG000|Overall Study|Death|1|||
46876461|NCT03287804|83096332|FG000|Overall Study|Physician Decision|2|||
46876462|NCT03287804|83096332|FG000|Overall Study|Progressive disease|8|||
46876463|NCT03286400|83096337|FG000|Overall Study|Death|10|||
46876464|NCT03286400|83096337|FG000|Overall Study|Lost to Follow-up|10|||
46876465|NCT03286400|83096337|FG000|Overall Study|Physician Decision|1|||
46876466|NCT03286400|83096337|FG000|Overall Study|Scheduling difficulty|4|||
46876467|NCT03310970|83096341|FG000|Overall Study|Withdrawal by Subject|0|||
46876468|NCT03310970|83096342|FG001|Overall Study|Withdrawal by Subject|1|||
46876469|NCT03285308|83096351|FG000|Overall Study|Adverse Event|3|||
46876470|NCT03285308|83096352|FG001|Overall Study|Adverse Event|7|||
46876471|NCT03285308|83096351|FG000|Overall Study|Withdrawal by Subject|8|||
46876472|NCT03285308|83096352|FG001|Overall Study|Withdrawal by Subject|9|||
46876473|NCT03285308|83096351|FG000|Overall Study|Lost to Follow-up|3|||
46876474|NCT03285308|83096352|FG001|Overall Study|Lost to Follow-up|1|||
46876475|NCT03285308|83096351|FG000|Overall Study|Protocol Deviation|6|||
46876476|NCT03285308|83096352|FG001|Overall Study|Protocol Deviation|5|||
46876477|NCT03285308|83096351|FG000|Overall Study|Reason not Specified|0|||
46876478|NCT03285308|83096352|FG001|Overall Study|Reason not Specified|1|||
46876479|NCT03723915|83096368|FG000|Screening|Failed to meet screening requirements.|2|||
46876480|NCT03723915|83096368|FG000|On Treatment|Failed to meet treatment requirements|2|||
46876481|NCT03281876|83096374|FG000|Overall Study|Adverse Event|4|||
46876482|NCT03281876|83096375|FG001|Overall Study|Adverse Event|15|||
46876483|NCT03281876|83096374|FG000|Overall Study|Lost to Follow-up|1|||
46876484|NCT03281876|83096375|FG001|Overall Study|Lost to Follow-up|4|||
46876485|NCT03281876|83096374|FG000|Overall Study|Withdrawal by Subject|11|||
46876486|NCT03281876|83096375|FG001|Overall Study|Withdrawal by Subject|15|||
46876487|NCT03281876|83096374|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
46876488|NCT03281876|83096375|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
46876489|NCT03281876|83096374|FG000|Overall Study|OTHER|5|||
46876490|NCT03281876|83096375|FG001|Overall Study|OTHER|5|||
46876491|NCT03310580|83096384|FG000|Overall Study|Adverse Event|0|||
46876492|NCT03310580|83096385|FG001|Overall Study|Adverse Event|1|||
46876493|NCT03310580|83096386|FG002|Overall Study|Adverse Event|0|||
46876494|NCT03415022|83096409|FG000|Overall Study|Withdrawal by Subject|1|||
46876495|NCT03415022|83096410|FG001|Overall Study|Withdrawal by Subject|2|||
46876496|NCT03415022|83096409|FG000|Overall Study|COVID-19 Suspension|2|||
46876497|NCT03415022|83096410|FG001|Overall Study|COVID-19 Suspension|3|||
46876498|NCT03415022|83096409|FG000|Overall Study|Lost to Follow-up|2|||
46876499|NCT03415022|83096410|FG001|Overall Study|Lost to Follow-up|0|||
46876500|NCT02816398|83096416|FG000|Overall Study|Death|5|||
46876501|NCT02816398|83096416|FG000|Overall Study|Lack of Efficacy|8|||
46876502|NCT02816398|83096416|FG000|Overall Study|Lost to Follow-up|1|||
46876503|NCT02812186|83096422|FG000|Period 1|Post randomization screen failure|5|||
46876504|NCT02812186|83096423|FG001|Period 1|Post randomization screen failure|9|||
46876505|NCT02812186|83096422|FG000|Period 1|nonevaluable data sets|6|||
46876506|NCT02812186|83096423|FG001|Period 1|nonevaluable data sets|6|||
46876507|NCT02811640|83096432|FG000|Overall Study|Technology malfunction|2|||
46876508|NCT03310268|83096439|FG000|Overall Study|(Not specified)|1|||
46876509|NCT03310268|83096440|FG001|Overall Study|(Not specified)|5|||
46876510|NCT03310268|83096441|FG002|Overall Study|(Not specified)|0|||
46876511|NCT02810392|83096451|FG000|Overall Study|Subject too ill to continue|1|||
46876512|NCT02810392|83096452|FG001|Overall Study|Subject too ill to continue|0|||
46876513|NCT02810392|83096451|FG000|Overall Study|COVID 19 research restrictions|0|||
46876514|NCT02810392|83096452|FG001|Overall Study|COVID 19 research restrictions|1|||
46876515|NCT02815540|83096458|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
46876516|NCT03280550|83096464|FG000|Overall Study|Withdrawal by Subject|2|||
46876517|NCT03280550|83096465|FG001|Overall Study|Withdrawal by Subject|2|||
46876518|NCT03280550|83096464|FG000|Overall Study|Physician Decision|0|||
46876519|NCT03280550|83096465|FG001|Overall Study|Physician Decision|1|||
46876520|NCT03276026|83096473|FG000|Overall Study|Protocol Violation|1|||
46876521|NCT03276026|83096474|FG001|Overall Study|Protocol Violation|0|||
46876522|NCT01589523|83096480|FG000|Overall Study|Withdrawal by Subject|1|||
46876523|NCT03277352|83096486|FG000|Overall Study|Study Terminated By Sponsor|2|||
46876524|NCT03277352|83096486|FG000|Overall Study|Withdrawal by Subject|4|||
46876525|NCT03277352|83096486|FG000|Overall Study|Death|4|||
46876526|NCT03276728|83096499|FG000|Overall Study|Lost to Follow-up|0|||
46876527|NCT03276728|83096500|FG001|Overall Study|Lost to Follow-up|0|||
46876528|NCT03276728|83096501|FG002|Overall Study|Lost to Follow-up|2|||
46876529|NCT03276728|83096502|FG003|Overall Study|Lost to Follow-up|2|||
46876530|NCT03276728|83096503|FG004|Overall Study|Lost to Follow-up|0|||
46876531|NCT03276728|83096504|FG005|Overall Study|Lost to Follow-up|0|||
46876532|NCT03276728|83096505|FG006|Overall Study|Lost to Follow-up|0|||
46876533|NCT03276728|83096506|FG007|Overall Study|Lost to Follow-up|0|||
46876534|NCT03276728|83096499|FG000|Overall Study|Withdrawal by Subject|0|||
46876535|NCT03276728|83096500|FG001|Overall Study|Withdrawal by Subject|0|||
46876536|NCT03276728|83096501|FG002|Overall Study|Withdrawal by Subject|0|||
46876537|NCT03276728|83096502|FG003|Overall Study|Withdrawal by Subject|3|||
46984383|NCT02546323|83230528|FG001|Overall Study|Patient Specific Reasons|2|||
46984384|NCT02546323|83230527|FG000|Overall Study|Lost to Follow-up|2|||
46876538|NCT03276728|83096503|FG004|Overall Study|Withdrawal by Subject|0|||
46876539|NCT03276728|83096504|FG005|Overall Study|Withdrawal by Subject|0|||
46876540|NCT03276728|83096505|FG006|Overall Study|Withdrawal by Subject|0|||
46876541|NCT03276728|83096506|FG007|Overall Study|Withdrawal by Subject|0|||
46876542|NCT03276728|83096499|FG000|Overall Study|Decision by sponsor|0|||
46876543|NCT03276728|83096500|FG001|Overall Study|Decision by sponsor|0|||
46876544|NCT03276728|83096501|FG002|Overall Study|Decision by sponsor|0|||
46876545|NCT03276728|83096502|FG003|Overall Study|Decision by sponsor|0|||
46876546|NCT03276728|83096503|FG004|Overall Study|Decision by sponsor|1|||
46876547|NCT03276728|83096504|FG005|Overall Study|Decision by sponsor|0|||
46876548|NCT03276728|83096505|FG006|Overall Study|Decision by sponsor|2|||
46876549|NCT03276728|83096506|FG007|Overall Study|Decision by sponsor|1|||
46876550|NCT03275246|83096526|FG000|Overall Study|Protocol Violation|5|||
46876551|NCT03275246|83096526|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
46876552|NCT02940860|83096532|FG000|Overall Study|Non-serious AE|1|||
46876553|NCT02940860|83096533|FG001|Overall Study|Non-serious AE|2|||
46876554|NCT02940860|83096532|FG000|Overall Study|Serious AE|7|||
46876555|NCT02940860|83096533|FG001|Overall Study|Serious AE|3|||
46876556|NCT02940860|83096532|FG000|Overall Study|Withdrawal by Subject|19|||
46876557|NCT02940860|83096533|FG001|Overall Study|Withdrawal by Subject|9|||
46876558|NCT02940860|83096532|FG000|Overall Study|Lost to Follow-up|13|||
46876559|NCT02940860|83096533|FG001|Overall Study|Lost to Follow-up|7|||
46876560|NCT02940860|83096532|FG000|Overall Study|Physician Decision|5|||
46876561|NCT02940860|83096533|FG001|Overall Study|Physician Decision|3|||
46876562|NCT02940860|83096532|FG000|Overall Study|Sponsor Decision|0|||
46876563|NCT02940860|83096533|FG001|Overall Study|Sponsor Decision|1|||
46876564|NCT02940860|83096532|FG000|Overall Study|Protocol Violation|0|||
46876565|NCT02940860|83096533|FG001|Overall Study|Protocol Violation|2|||
46876566|NCT02940860|83096532|FG000|Overall Study|Death|3|||
46876567|NCT02940860|83096533|FG001|Overall Study|Death|2|||
46876568|NCT02940860|83096532|FG000|Overall Study|Moved, poor venous access, transport|6|||
46876569|NCT02940860|83096533|FG001|Overall Study|Moved, poor venous access, transport|4|||
46876570|NCT02940860|83096532|FG000|Overall Study|Not treated|2|||
46876571|NCT02940860|83096533|FG001|Overall Study|Not treated|2|||
46876572|NCT03309020|83096543|FG000|Overall Study|Death|1|||
46876573|NCT03309020|83096544|FG001|Overall Study|Death|0|||
46876574|NCT03309020|83096543|FG000|Overall Study|Did not undergo surgery|2|||
46876575|NCT03309020|83096544|FG001|Overall Study|Did not undergo surgery|1|||
46876576|NCT02806960|83096552|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
46876577|NCT02806960|83096553|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
46876578|NCT02806960|83096554|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
46876579|NCT02806960|83096555|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
46876580|NCT03718143|83096565|FG000|Overall Study|Death|1|||
46876581|NCT03718143|83096566|FG001|Overall Study|Death|0|||
46876582|NCT03718143|83096567|FG002|Overall Study|Death|0|||
46876583|NCT03718143|83096565|FG000|Overall Study|Progression of Disease|1|||
46876584|NCT03718143|83096566|FG001|Overall Study|Progression of Disease|0|||
46876585|NCT03718143|83096567|FG002|Overall Study|Progression of Disease|0|||
46876586|NCT03718143|83096565|FG000|Overall Study|Withdrawal of Informed Consent|1|||
46876587|NCT03718143|83096566|FG001|Overall Study|Withdrawal of Informed Consent|2|||
46876588|NCT03718143|83096567|FG002|Overall Study|Withdrawal of Informed Consent|1|||
46876589|NCT03274466|83096577|FG000|Overall Study|Withdrawal by Subject|7|||
46876590|NCT03274466|83096578|FG001|Overall Study|Withdrawal by Subject|3|||
46876591|NCT03274466|83096577|FG000|Overall Study|Protocol Specified Withdrawal|5|||
46876592|NCT03274466|83096578|FG001|Overall Study|Protocol Specified Withdrawal|11|||
46876593|NCT03274466|83096577|FG000|Overall Study|Lost to Follow-up|5|||
46876594|NCT03274466|83096578|FG001|Overall Study|Lost to Follow-up|7|||
46876595|NCT03274466|83096577|FG000|Overall Study|Subject Non-compliance|0|||
46876596|NCT03274466|83096578|FG001|Overall Study|Subject Non-compliance|1|||
46876597|NCT03274466|83096577|FG000|Overall Study|Adverse Event|3|||
46876598|NCT03274466|83096578|FG001|Overall Study|Adverse Event|3|||
46876599|NCT03274466|83096577|FG000|Overall Study|Physician Decision|0|||
46876600|NCT03274466|83096578|FG001|Overall Study|Physician Decision|1|||
46876601|NCT03274466|83096577|FG000|Overall Study|Protocol Violation|3|||
46876602|NCT03274466|83096578|FG001|Overall Study|Protocol Violation|3|||
46876603|NCT02806726|83096584|FG000|Overall Study|Lost to Follow-up|1|||
46876604|NCT02806414|83096589|FG000|Overall Study|Lost to Follow-up|2|||
46876605|NCT02806024|83096595|FG000|Overall Study|Night Delivery|1|||
46876606|NCT02806024|83096596|FG001|Overall Study|Night Delivery|1|||
46876607|NCT02806024|83096595|FG000|Overall Study|DVT during antepartum admission|0|||
46876608|NCT02806024|83096596|FG001|Overall Study|DVT during antepartum admission|1|||
46876609|NCT02805790|83096604|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
46876610|NCT02805790|83096605|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
46876611|NCT02802592|83096611|FG000|Overall Study|Study terminated due to loss of funding|4|||
46876612|NCT02803138|83096616|FG000|Overall Study|Failure to return|38|||
46876613|NCT02803138|83096616|FG000|Overall Study|Insufficient virological response|2|||
46876614|NCT02803138|83096616|FG000|Overall Study|Withdrawn consent|1|||
46876615|NCT02803138|83096616|FG000|Overall Study|Death|1|||
46876616|NCT02803138|83096616|FG000|Overall Study|Other, not specified|28|||
46876617|NCT02801578|83096622|FG000|Overall Study|Adverse Event|2|||
46876618|NCT02799472|83096628|FG000|Overall Study|Withdrawal by Subject|2|||
46876619|NCT02799472|83096629|FG001|Overall Study|Withdrawal by Subject|4|||
46876620|NCT02799472|83096628|FG000|Overall Study|Lack of Efficacy|2|||
46876621|NCT02799472|83096629|FG001|Overall Study|Lack of Efficacy|0|||
46876622|NCT02799472|83096628|FG000|Overall Study|Lost to Follow-up|0|||
46876623|NCT02799472|83096629|FG001|Overall Study|Lost to Follow-up|1|||
46876624|NCT03245450|83096642|FG000|Overall Study|Radiological disease progression|3|||
46876625|NCT03245450|83096643|FG001|Overall Study|Radiological disease progression|3|||
46876626|NCT03245450|83096644|FG002|Overall Study|Radiological disease progression|2|||
46876627|NCT03245450|83096645|FG003|Overall Study|Radiological disease progression|2|||
46876628|NCT03245450|83096646|FG004|Overall Study|Radiological disease progression|7|||
46876629|NCT03245450|83096647|FG005|Overall Study|Radiological disease progression|6|||
46876630|NCT03245450|83096648|FG006|Overall Study|Radiological disease progression|6|||
46876631|NCT03245450|83096642|FG000|Overall Study|Clinical disease progression|0|||
46876632|NCT03245450|83096643|FG001|Overall Study|Clinical disease progression|0|||
46876633|NCT03245450|83096644|FG002|Overall Study|Clinical disease progression|1|||
46876634|NCT03245450|83096645|FG003|Overall Study|Clinical disease progression|0|||
46876635|NCT03245450|83096646|FG004|Overall Study|Clinical disease progression|0|||
46876636|NCT03245450|83096647|FG005|Overall Study|Clinical disease progression|2|||
46876637|NCT03245450|83096648|FG006|Overall Study|Clinical disease progression|0|||
46876638|NCT03245450|83096642|FG000|Overall Study|Other|0|||
46876639|NCT03245450|83096643|FG001|Overall Study|Other|0|||
46876640|NCT03245450|83096644|FG002|Overall Study|Other|0|||
46876641|NCT03245450|83096645|FG003|Overall Study|Other|1|||
46876642|NCT03245450|83096646|FG004|Overall Study|Other|1|||
46876643|NCT03245450|83096647|FG005|Overall Study|Other|1|||
46876644|NCT03245450|83096648|FG006|Overall Study|Other|1|||
46876645|NCT03245450|83096642|FG000|Overall Study|Withdrawal by Subject|0|||
46876646|NCT03245450|83096643|FG001|Overall Study|Withdrawal by Subject|1|||
46876647|NCT03245450|83096644|FG002|Overall Study|Withdrawal by Subject|0|||
46876648|NCT03245450|83096645|FG003|Overall Study|Withdrawal by Subject|0|||
46876649|NCT03245450|83096646|FG004|Overall Study|Withdrawal by Subject|0|||
46876650|NCT03245450|83096647|FG005|Overall Study|Withdrawal by Subject|0|||
46876651|NCT03245450|83096648|FG006|Overall Study|Withdrawal by Subject|0|||
46876652|NCT03245450|83096642|FG000|Overall Study|Adverse Event|0|||
46876653|NCT03245450|83096643|FG001|Overall Study|Adverse Event|0|||
46876654|NCT03245450|83096644|FG002|Overall Study|Adverse Event|0|||
46876655|NCT03245450|83096645|FG003|Overall Study|Adverse Event|0|||
46876656|NCT03245450|83096646|FG004|Overall Study|Adverse Event|1|||
46876657|NCT03245450|83096647|FG005|Overall Study|Adverse Event|0|||
46876658|NCT03245450|83096648|FG006|Overall Study|Adverse Event|2|||
46876659|NCT03712917|83096673|FG000|Overall Study|Pregnancy|0|||
46876660|NCT03712917|83096674|FG001|Overall Study|Pregnancy|0|||
46876661|NCT03712917|83096675|FG002|Overall Study|Pregnancy|1|||
46876662|NCT03712917|83096673|FG000|Overall Study|Adverse Event|0|||
46876663|NCT03712917|83096674|FG001|Overall Study|Adverse Event|4|||
46876664|NCT03712917|83096675|FG002|Overall Study|Adverse Event|3|||
46876665|NCT03712917|83096673|FG000|Overall Study|Lost to Follow-up|9|||
46876666|NCT03712917|83096674|FG001|Overall Study|Lost to Follow-up|4|||
46876667|NCT03712917|83096675|FG002|Overall Study|Lost to Follow-up|5|||
46876668|NCT02748694|83096698|FG000|Overall Study|Voluntary Withdrawal|0|||
46876669|NCT02748694|83096699|FG001|Overall Study|Voluntary Withdrawal|0|||
46876670|NCT02748694|83096700|FG002|Overall Study|Voluntary Withdrawal|0|||
46876671|NCT02748694|83096701|FG003|Overall Study|Voluntary Withdrawal|0|||
46876672|NCT02748694|83096702|FG004|Overall Study|Voluntary Withdrawal|0|||
46876673|NCT02748694|83096703|FG005|Overall Study|Voluntary Withdrawal|0|||
46876674|NCT02748694|83096704|FG006|Overall Study|Voluntary Withdrawal|0|||
46876675|NCT02748694|83096705|FG007|Overall Study|Voluntary Withdrawal|0|||
46876676|NCT02748694|83096706|FG008|Overall Study|Voluntary Withdrawal|0|||
46876677|NCT02748694|83096707|FG009|Overall Study|Voluntary Withdrawal|0|||
46876678|NCT02748694|83096708|FG010|Overall Study|Voluntary Withdrawal|0|||
46876679|NCT02748694|83096709|FG011|Overall Study|Voluntary Withdrawal|0|||
46876680|NCT02748694|83096710|FG012|Overall Study|Voluntary Withdrawal|0|||
46876681|NCT02748694|83096711|FG013|Overall Study|Voluntary Withdrawal|0|||
46876682|NCT02748694|83096712|FG014|Overall Study|Voluntary Withdrawal|2|||
46876683|NCT02800642|83096768|FG000|Overall Study|Death|3|||
46876684|NCT02800642|83096768|FG000|Overall Study|Other|10|||
46876685|NCT02800642|83096768|FG000|Overall Study|Physician Decision|2|||
46876686|NCT02800642|83096768|FG000|Overall Study|Adverse Event|6|||
46876687|NCT02800642|83096768|FG000|Overall Study|Withdrawal by Subject|3|||
46876688|NCT02800642|83096768|FG000|Overall Study|Lost to Follow-up|1|||
46876689|NCT02799784|83096772|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
46876690|NCT02799784|83096773|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
46876691|NCT02799784|83096772|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
46876692|NCT02799784|83096773|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
46702101|NCT00977938|82916961|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
46702102|NCT00977938|82916962|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
46702103|NCT00977938|82916959|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
46702104|NCT00977938|82916960|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
46876693|NCT02799784|83096772|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
46876694|NCT02799784|83096773|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
46876695|NCT02799784|83096772|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
46876696|NCT02799784|83096773|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
46876697|NCT02799784|83096772|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
46876698|NCT02799784|83096773|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
46876699|NCT02799784|83096772|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
46876700|NCT02799784|83096773|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
46876701|NCT02054806|83096779|FG000|Overall Study|Sponsor Decision|31|||
46876702|NCT02054806|83096779|FG000|Overall Study|Withdrawal by Subject|43|||
46876703|NCT02054806|83096779|FG000|Overall Study|Protocol Violation|2|||
46876704|NCT02054806|83096779|FG000|Overall Study|Lost to Follow-up|10|||
46876705|NCT02054806|83096779|FG000|Overall Study|Death|391|||
46876706|NCT01333072|83096812|FG000|Overall Study|Lost to Follow-up|3|||
46876707|NCT01333072|83096813|FG001|Overall Study|Lost to Follow-up|0|||
46702105|NCT00977938|82916961|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
46876708|NCT01333072|83096812|FG000|Overall Study|Adverse Event|2|||
46876709|NCT01333072|83096813|FG001|Overall Study|Adverse Event|4|||
46876710|NCT01333072|83096812|FG000|Overall Study|Physician Decision|1|||
46876711|NCT01333072|83096813|FG001|Overall Study|Physician Decision|0|||
46876712|NCT01315353|83096822|FG000|Overall Study|Death|2|||
46876713|NCT01315353|83096823|FG001|Overall Study|Death|1|||
46876714|NCT01315353|83096824|FG002|Overall Study|Death|0|||
46876715|NCT01315353|83096822|FG000|Overall Study|Withdrawal by Subject|2|||
46876716|NCT01315353|83096823|FG001|Overall Study|Withdrawal by Subject|6|||
46876717|NCT01315353|83096824|FG002|Overall Study|Withdrawal by Subject|1|||
46876718|NCT01315353|83096822|FG000|Overall Study|Lost to Follow-up|13|||
46876719|NCT01315353|83096823|FG001|Overall Study|Lost to Follow-up|6|||
46876720|NCT01315353|83096824|FG002|Overall Study|Lost to Follow-up|6|||
46876721|NCT01315353|83096822|FG000|Overall Study|Unwilling to adhere to requirements|5|||
46876722|NCT01315353|83096823|FG001|Overall Study|Unwilling to adhere to requirements|5|||
46876723|NCT01315353|83096824|FG002|Overall Study|Unwilling to adhere to requirements|4|||
46876724|NCT01315353|83096822|FG000|Overall Study|Site closing|7|||
46876725|NCT01315353|83096823|FG001|Overall Study|Site closing|4|||
46702106|NCT00977938|82916962|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
46707560|NCT01176240|82923135|FG000|Study 306B|Withdrawal by Subject|4|||
46876726|NCT01315353|83096824|FG002|Overall Study|Site closing|0|||
46876727|NCT01315353|83096822|FG000|Overall Study|Taken off study by site in error|0|||
46876728|NCT01315353|83096823|FG001|Overall Study|Taken off study by site in error|1|||
46876729|NCT01315353|83096824|FG002|Overall Study|Taken off study by site in error|0|||
46876730|NCT01315353|83096822|FG000|Overall Study|Inadvertent randomization/assignment|0|||
46876731|NCT01315353|83096823|FG001|Overall Study|Inadvertent randomization/assignment|0|||
46876732|NCT01315353|83096824|FG002|Overall Study|Inadvertent randomization/assignment|2|||
46876733|NCT03517540|83096836|FG000|Overall Study|Protocol Violation|2|||
46876734|NCT03517540|83096837|FG001|Overall Study|Protocol Violation|0|||
46876735|NCT03517540|83096838|FG002|Overall Study|Protocol Violation|0|||
46876736|NCT03517540|83096839|FG003|Overall Study|Protocol Violation|1|||
46876737|NCT03517540|83096836|FG000|Overall Study|Adverse Event|9|||
46876738|NCT03517540|83096837|FG001|Overall Study|Adverse Event|3|||
46876739|NCT03517540|83096838|FG002|Overall Study|Adverse Event|8|||
46876740|NCT03517540|83096839|FG003|Overall Study|Adverse Event|1|||
46876741|NCT03517540|83096836|FG000|Overall Study|Withdrawal by Subject|3|||
46876742|NCT03517540|83096837|FG001|Overall Study|Withdrawal by Subject|4|||
46876743|NCT03517540|83096838|FG002|Overall Study|Withdrawal by Subject|1|||
46876744|NCT03517540|83096839|FG003|Overall Study|Withdrawal by Subject|3|||
46876745|NCT02799082|83096851|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
46876746|NCT02799082|83096852|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
46876747|NCT02799082|83096851|FG000|Overall Study|Protocol Violation|0|||
46876748|NCT02799082|83096852|FG001|Overall Study|Protocol Violation|1|||
46876749|NCT03710889|83096858|FG000|Overall Study|Adverse Event|2|||
46876750|NCT03710889|83096858|FG000|Overall Study|Protocol Deviation|1|||
46876751|NCT02797678|83096862|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
46876752|NCT02797678|83096863|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
46876753|NCT02797678|83096864|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
46876754|NCT02797678|83096865|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
46876755|NCT02797678|83096862|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
46876756|NCT02797678|83096863|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
46876757|NCT02797678|83096864|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
46876758|NCT02797678|83096865|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
46876759|NCT02797678|83096862|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
46876760|NCT02797678|83096863|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
46876761|NCT02797678|83096864|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
46876762|NCT02797678|83096865|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
46876763|NCT03308786|83096878|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
46876764|NCT03274076|83096885|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
46876765|NCT03274076|83096886|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
46876766|NCT03274076|83096887|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
46876767|NCT03274076|83096888|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
46876768|NCT03274076|83096885|FG000|24 Weeks Open Label|Adverse Event|0|||
46876769|NCT03274076|83096886|FG001|24 Weeks Open Label|Adverse Event|0|||
46876770|NCT03274076|83096887|FG002|24 Weeks Open Label|Adverse Event|2|||
46876771|NCT03274076|83096888|FG003|24 Weeks Open Label|Adverse Event|0|||
46876772|NCT03274076|83096885|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
46876773|NCT03274076|83096886|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
46876774|NCT03274076|83096887|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
46876775|NCT03274076|83096888|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
46876776|NCT02797522|83096918|FG000|Overall Study|Study Terminated by Sponsor|0|||
46876777|NCT02797522|83096919|FG001|Overall Study|Study Terminated by Sponsor|0|||
46876778|NCT02797522|83096920|FG002|Overall Study|Study Terminated by Sponsor|0|||
46876779|NCT02797522|83096921|FG003|Overall Study|Study Terminated by Sponsor|0|||
46876780|NCT02797522|83096922|FG004|Overall Study|Study Terminated by Sponsor|0|||
46876781|NCT02797522|83096923|FG005|Overall Study|Study Terminated by Sponsor|0|||
46876782|NCT02797522|83096924|FG006|Overall Study|Study Terminated by Sponsor|0|||
46876783|NCT02797522|83096925|FG007|Overall Study|Study Terminated by Sponsor|4|||
46876784|NCT02797522|83096926|FG008|Overall Study|Study Terminated by Sponsor|2|||
46876785|NCT02797522|83096927|FG009|Overall Study|Study Terminated by Sponsor|4|||
46876786|NCT02797522|83096928|FG010|Overall Study|Study Terminated by Sponsor|1|||
46876787|NCT02659514|83096958|FG000|Overall Study|Adverse Event|3|||
46876788|NCT02659514|83096959|FG001|Overall Study|Adverse Event|12|||
46876789|NCT02659514|83096958|FG000|Overall Study|Disease Progression|23|||
46876790|NCT02659514|83096959|FG001|Overall Study|Disease Progression|13|||
46876791|NCT02659514|83096958|FG000|Overall Study|Withdrawal by Subject|0|||
46876792|NCT02659514|83096959|FG001|Overall Study|Withdrawal by Subject|4|||
46876793|NCT02659514|83096958|FG000|Overall Study|Lost to Follow-up|0|||
46876794|NCT02659514|83096959|FG001|Overall Study|Lost to Follow-up|1|||
46876795|NCT02659514|83096958|FG000|Overall Study|Death|6|||
46876796|NCT02659514|83096959|FG001|Overall Study|Death|1|||
46876797|NCT02659514|83096958|FG000|Overall Study|Reason Unspecified|0|||
46876798|NCT02659514|83096959|FG001|Overall Study|Reason Unspecified|3|||
46876799|NCT04570670|83096967|FG000|Overall Study|Withdrawal by Subject|1|||
46876800|NCT04570670|83096968|FG001|Overall Study|Withdrawal by Subject|0|||
46876801|NCT02797132|83096974|FG000|Part A (15 Days)|Adverse Event|1|||
46876802|NCT02797132|83096974|FG000|Part B (24 Weeks)|Adverse Event|3|||
46876803|NCT03270644|83096987|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
46876804|NCT03270644|83096987|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
46876805|NCT03269552|83096998|FG000|Overall Study|Adverse Event|2|||
46876806|NCT02796664|83097005|FG000|Overall Study|Withdrawal by Subject|0|||
46876807|NCT02796664|83097006|FG001|Overall Study|Withdrawal by Subject|3|||
46876808|NCT02796664|83097005|FG000|Overall Study|Noncompliance|1|||
46876809|NCT02796664|83097006|FG001|Overall Study|Noncompliance|1|||
46876810|NCT02796664|83097005|FG000|Overall Study|Death|0|||
46876811|NCT02796664|83097006|FG001|Overall Study|Death|1|||
46876812|NCT04233879|83097016|FG000|Overall Study|Death|2|||
46876813|NCT04233879|83097017|FG001|Overall Study|Death|0|||
46876814|NCT04233879|83097016|FG000|Overall Study|Lost to Follow-up|3|||
46876815|NCT04233879|83097017|FG001|Overall Study|Lost to Follow-up|8|||
46876816|NCT04233879|83097016|FG000|Overall Study|Physician Decision|4|||
46876817|NCT04233879|83097017|FG001|Overall Study|Physician Decision|4|||
46876818|NCT04233879|83097016|FG000|Overall Study|Withdrawal by Subject|7|||
46876819|NCT04233879|83097017|FG001|Overall Study|Withdrawal by Subject|10|||
46876820|NCT04233879|83097016|FG000|Overall Study|Other|281|||
46876821|NCT04233879|83097017|FG001|Overall Study|Other|279|||
46876822|NCT01370356|83097025|FG000|Overall Study|Death|1|||
46876823|NCT01370356|83097026|FG001|Overall Study|Death|0|||
46876824|NCT01370356|83097025|FG000|Overall Study|Lack of Efficacy|6|||
46876825|NCT01370356|83097026|FG001|Overall Study|Lack of Efficacy|28|||
46876826|NCT01370356|83097025|FG000|Overall Study|Lost to Follow-up|76|||
46876827|NCT01370356|83097026|FG001|Overall Study|Lost to Follow-up|81|||
46876828|NCT01370356|83097025|FG000|Overall Study|Withdrawal by Subject|54|||
46876829|NCT01370356|83097026|FG001|Overall Study|Withdrawal by Subject|59|||
46876830|NCT01370356|83097025|FG000|Overall Study|Reason not specified|39|||
46876831|NCT01370356|83097026|FG001|Overall Study|Reason not specified|43|||
46876832|NCT01370356|83097025|FG000|Overall Study|Protocol Violation|3|||
46876833|NCT01370356|83097026|FG001|Overall Study|Protocol Violation|3|||
46876834|NCT01370356|83097025|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
46876835|NCT01370356|83097026|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
46876836|NCT01370356|83097025|FG000|Overall Study|AE Not Related to Study Drug|1|||
46876837|NCT01370356|83097026|FG001|Overall Study|AE Not Related to Study Drug|4|||
46876838|NCT02794870|83097034|FG000|Overall Study|Withdrawal by Subject|2|||
46876839|NCT02794870|83097035|FG001|Overall Study|Withdrawal by Subject|0|||
46876840|NCT01370590|83097043|FG000|Period 1|Adverse Event|8|||
46876841|NCT01370590|83097044|FG001|Period 1|Adverse Event|4|||
46876842|NCT01370590|83097043|FG000|Period 1|Lost to Follow-up|2|||
46876843|NCT01370590|83097044|FG001|Period 1|Lost to Follow-up|2|||
46876844|NCT01370590|83097043|FG000|Period 1|Protocol Violation|2|||
46876845|NCT01370590|83097044|FG001|Period 1|Protocol Violation|2|||
46876846|NCT01370590|83097043|FG000|Period 1|Withdrawal by Subject|4|||
46876847|NCT01370590|83097044|FG001|Period 1|Withdrawal by Subject|2|||
46876848|NCT01370590|83097043|FG000|Period 1|Could not access randomization system|0|||
46876849|NCT01370590|83097044|FG001|Period 1|Could not access randomization system|1|||
46876850|NCT01370590|83097043|FG000|Crossover Washout Period|Adverse Event|1|||
46876851|NCT01370590|83097044|FG001|Crossover Washout Period|Adverse Event|4|||
46876852|NCT01370590|83097043|FG000|Crossover Washout Period|Lost to Follow-up|2|||
46876853|NCT01370590|83097044|FG001|Crossover Washout Period|Lost to Follow-up|0|||
46876854|NCT01370590|83097043|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
46876855|NCT01370590|83097044|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
46876856|NCT01370590|83097043|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
46876857|NCT01370590|83097044|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
46876858|NCT01370590|83097043|FG000|Period 2|Adverse Event|0|||
46876859|NCT01370590|83097044|FG001|Period 2|Adverse Event|1|||
46876860|NCT01370590|83097043|FG000|Period 2|Withdrawal by Subject|1|||
46876861|NCT01370590|83097044|FG001|Period 2|Withdrawal by Subject|1|||
46876862|NCT05200455|83097055|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
46876863|NCT04646109|83097062|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
46876864|NCT04646109|83097063|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
46876865|NCT04502979|83097072|FG000|Overall Study|Lost to Follow-up|1|||
46876866|NCT04502979|83097073|FG001|Overall Study|Lost to Follow-up|3|||
46876867|NCT04502979|83097072|FG000|Overall Study|Withdrawal by Subject|2|||
46876868|NCT04502979|83097073|FG001|Overall Study|Withdrawal by Subject|1|||
46876869|NCT04590027|83097081|FG000|Overall Study|Lost to Follow-up|17|||
46876870|NCT04590027|83097082|FG001|Overall Study|Lost to Follow-up|14|||
46876871|NCT04590027|83097081|FG000|Overall Study|Protocol Violation|0|||
46876872|NCT04590027|83097082|FG001|Overall Study|Protocol Violation|3|||
46876873|NCT04587453|83097094|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
46876874|NCT04587453|83097095|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
46876875|NCT02793232|83097112|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
46876876|NCT02793232|83097113|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
46876877|NCT02793232|83097114|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
46876878|NCT02793232|83097115|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
46876879|NCT02793232|83097116|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
46876880|NCT02793232|83097117|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
46876881|NCT02793232|83097118|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
46876882|NCT02793232|83097119|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
46876883|NCT02793232|83097120|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
46876884|NCT04584645|83097156|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
46876885|NCT04584645|83097157|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
46876886|NCT03695367|83097183|FG000|Overall Study|Missed the Day 28 visit.|1|||
46876887|NCT03695367|83097184|FG001|Overall Study|Missed the Day 28 visit.|0|||
46876888|NCT03695367|83097183|FG000|Overall Study|Lost to Follow-up|0|||
46876889|NCT03695367|83097184|FG001|Overall Study|Lost to Follow-up|1|||
46876890|NCT03695367|83097183|FG000|Overall Study|Withdrawal by Subject|0|||
46876891|NCT03695367|83097184|FG001|Overall Study|Withdrawal by Subject|1|||
46876892|NCT03695367|83097183|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
46876893|NCT03695367|83097184|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
46876894|NCT02794480|83097192|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
46876895|NCT02794480|83097193|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
46876896|NCT02794480|83097194|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
46876897|NCT02794480|83097195|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
46876898|NCT02794480|83097192|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
46876899|NCT02794480|83097193|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
46876900|NCT02794480|83097194|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
46876901|NCT02794480|83097195|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
46876902|NCT02794480|83097192|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46876903|NCT02794480|83097193|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46876904|NCT02794480|83097194|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46876905|NCT02794480|83097195|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
46876906|NCT02794480|83097192|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46876907|NCT02794480|83097193|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
46876908|NCT02794480|83097194|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46876909|NCT02794480|83097195|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
46876910|NCT02794480|83097192|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
46876911|NCT02794480|83097193|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46876912|NCT02794480|83097194|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46876913|NCT02794480|83097195|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
46876914|NCT04558125|83097203|FG000|Overall Study|Death|1|||
46876915|NCT02793622|83097209|FG000|Overall Study|Lost to Follow-up|31|||
46876916|NCT02793622|83097210|FG001|Overall Study|Lost to Follow-up|19|||
46876917|NCT02793622|83097209|FG000|Overall Study|Withdrawal by Subject|21|||
46876918|NCT02793622|83097210|FG001|Overall Study|Withdrawal by Subject|17|||
46876919|NCT02793622|83097209|FG000|Overall Study|Adverse Event|0|||
46876920|NCT02793622|83097210|FG001|Overall Study|Adverse Event|1|||
46876921|NCT02793622|83097209|FG000|Overall Study|Protocol Violation|1|||
46876922|NCT02793622|83097210|FG001|Overall Study|Protocol Violation|5|||
46876923|NCT04493931|83097223|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
46876924|NCT04493931|83097224|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
46876925|NCT04493931|83097225|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
46876926|NCT04493931|83097226|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
46876927|NCT04493931|83097227|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
46876928|NCT04493931|83097228|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
46876929|NCT04493931|83097229|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
46876930|NCT04493931|83097223|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
46876931|NCT04493931|83097224|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
46876932|NCT04493931|83097225|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
46876933|NCT04493931|83097226|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
46876934|NCT04493931|83097227|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
46876935|NCT04493931|83097228|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
46876936|NCT04493931|83097229|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
46876937|NCT04493931|83097223|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
46876938|NCT04493931|83097224|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
46876939|NCT04493931|83097225|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
46876940|NCT04493931|83097226|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
46876941|NCT04493931|83097227|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
46876942|NCT04493931|83097228|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
46876943|NCT04493931|83097229|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
46876944|NCT04493931|83097223|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
46876945|NCT04493931|83097224|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
46876946|NCT04493931|83097225|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
46876947|NCT04493931|83097226|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
46876948|NCT04493931|83097227|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
46876949|NCT04493931|83097228|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
46876950|NCT04493931|83097229|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
46876951|NCT03437278|83097262|FG000|Overall Study|Adverse Event|0|||
46876952|NCT03437278|83097263|FG001|Overall Study|Adverse Event|0|||
46876953|NCT03437278|83097264|FG002|Overall Study|Adverse Event|1|||
46876954|NCT03437278|83097262|FG000|Overall Study|Progressive disease|1|||
46876955|NCT03437278|83097263|FG001|Overall Study|Progressive disease|0|||
46876956|NCT03437278|83097264|FG002|Overall Study|Progressive disease|0|||
46876957|NCT03437278|83097262|FG000|Overall Study|Physician Decision|1|||
46876958|NCT03437278|83097263|FG001|Overall Study|Physician Decision|0|||
46876959|NCT03437278|83097264|FG002|Overall Study|Physician Decision|1|||
46876960|NCT05935878|83097276|FG000|Overall Study|Death|1|||
46876961|NCT05935878|83097277|FG001|Overall Study|Death|2|||
46876962|NCT05935878|83097276|FG000|Overall Study|Withdrawal by Subject|5|||
46876963|NCT05935878|83097277|FG001|Overall Study|Withdrawal by Subject|5|||
46876964|NCT05935878|83097276|FG000|Overall Study|Revision of implant|1|||
46876965|NCT05935878|83097277|FG001|Overall Study|Revision of implant|1|||
46876966|NCT05935878|83097276|FG000|Overall Study|Mobile bearing dislocation|0|||
46876967|NCT05935878|83097277|FG001|Overall Study|Mobile bearing dislocation|1|||
46876968|NCT05382104|83097302|FG000|Period 2 (2 Days)|Adverse Event|0|||
46876969|NCT05382104|83097303|FG001|Period 2 (2 Days)|Adverse Event|1|||
46876970|NCT05382104|83097304|FG002|Period 2 (2 Days)|Adverse Event|0|||
46876971|NCT05382104|83097305|FG003|Period 2 (2 Days)|Adverse Event|0|||
46876972|NCT05382104|83097306|FG004|Period 2 (2 Days)|Adverse Event|0|||
46876973|NCT05382104|83097307|FG005|Period 2 (2 Days)|Adverse Event|0|||
46876974|NCT05277337|83097317|FG000|Overall Study|Lost to Follow-up|2|||
46876975|NCT05277337|83097318|FG001|Overall Study|Lost to Follow-up|0|||
46876976|NCT05277337|83097317|FG000|Overall Study|Withdrawal by Subject|1|||
46876977|NCT05277337|83097318|FG001|Overall Study|Withdrawal by Subject|0|||
46876978|NCT05173974|83097325|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
46876979|NCT05173974|83097326|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
46876980|NCT05173974|83097327|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
46876981|NCT05173974|83097328|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
46876982|NCT05173974|83097325|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
46876983|NCT05173974|83097326|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
46876984|NCT05173974|83097327|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
46876985|NCT05173974|83097328|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
46876986|NCT04718194|83097362|FG000|Overall Study|Withdrawal by Subject|3|||
46876987|NCT04718194|83097363|FG001|Overall Study|Withdrawal by Subject|0|||
46876988|NCT04718194|83097362|FG000|Overall Study|Lost to Follow-up|3|||
46876989|NCT04718194|83097363|FG001|Overall Study|Lost to Follow-up|0|||
46876990|NCT04652453|83097372|FG000|Overall Study|Death|8|||
46876991|NCT04652453|83097373|FG001|Overall Study|Death|2|||
46876992|NCT04652453|83097374|FG002|Overall Study|Death|0|||
46876993|NCT04652453|83097372|FG000|Overall Study|Hospice|5|||
46876994|NCT04652453|83097373|FG001|Overall Study|Hospice|5|||
46876995|NCT04652453|83097374|FG002|Overall Study|Hospice|0|||
46876996|NCT04652453|83097372|FG000|Overall Study|Withdrawal by Subject|2|||
46876997|NCT04652453|83097373|FG001|Overall Study|Withdrawal by Subject|0|||
46876998|NCT04652453|83097374|FG002|Overall Study|Withdrawal by Subject|0|||
46876999|NCT04530136|83097382|FG000|Overall Study|Lost to Follow-up|2|||
46877000|NCT04530136|83097383|FG001|Overall Study|Lost to Follow-up|3|||
46877001|NCT04530136|83097382|FG000|Overall Study|Withdrawal by Subject|1|||
46877002|NCT04530136|83097383|FG001|Overall Study|Withdrawal by Subject|0|||
46877003|NCT04530136|83097382|FG000|Overall Study|Death|0|||
46877004|NCT04530136|83097383|FG001|Overall Study|Death|1|||
46877005|NCT04040439|83097406|FG000|Overall Study|Invalid registration|11|||
46877006|NCT04040439|83097406|FG000|Overall Study|No IC* on publication of study results|2|||
46877007|NCT03752970|83097413|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
46877008|NCT03752970|83097414|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
46877009|NCT03752970|83097415|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
46877010|NCT03752970|83097413|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
46877011|NCT03752970|83097414|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
46877012|NCT03752970|83097415|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
46877013|NCT03752970|83097413|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
46877014|NCT03752970|83097414|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
46877015|NCT03752970|83097415|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
46984385|NCT02546323|83230528|FG001|Overall Study|Lost to Follow-up|3|||
46877016|NCT03752970|83097413|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
46877017|NCT03752970|83097414|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
46877018|NCT03752970|83097415|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
46877019|NCT03752970|83097413|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
46877020|NCT03752970|83097414|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
46877021|NCT03752970|83097415|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
46877022|NCT03681184|83097431|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
46877023|NCT03681184|83097432|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
46877024|NCT03681184|83097431|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
46877025|NCT03681184|83097432|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
46877026|NCT03681184|83097431|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
46877027|NCT03681184|83097432|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
46877028|NCT03317405|83097450|FG000|Overall Study|Withdrawal by Subject|1|||
46984386|NCT02546323|83230527|FG000|Overall Study|Non-compliance with Study Drug|2|||
46984387|NCT02546323|83230528|FG001|Overall Study|Non-compliance with Study Drug|2|||
46984388|NCT02546323|83230527|FG000|Overall Study|Met Withdrawal Criteria|2|||
46984389|NCT02546323|83230528|FG001|Overall Study|Met Withdrawal Criteria|14|||
46984390|NCT02545933|83230537|FG000|Overall Study|Adverse Event|3|||
46984391|NCT02545933|83230538|FG001|Overall Study|Adverse Event|0|||
46984392|NCT02545933|83230539|FG002|Overall Study|Adverse Event|0|||
46984393|NCT02545933|83230537|FG000|Overall Study|Withdrawal by Subject|2|||
46984394|NCT02545933|83230538|FG001|Overall Study|Withdrawal by Subject|3|||
46984395|NCT02545933|83230539|FG002|Overall Study|Withdrawal by Subject|3|||
46984396|NCT02545933|83230537|FG000|Overall Study|Protocol Violation|1|||
46984397|NCT02545933|83230538|FG001|Overall Study|Protocol Violation|0|||
46984398|NCT02545933|83230539|FG002|Overall Study|Protocol Violation|1|||
46984399|NCT01661179|83230547|FG000|Overall Study|Death|1|||
46984400|NCT01661179|83230547|FG000|Overall Study|Withdrawal by Subject|1|||
46984401|NCT01661179|83230547|FG000|Overall Study|Other Eligibility criteria|4|||
46984402|NCT02545543|83230553|FG000|Overall Study|Lost to Follow-up|67|||
46984403|NCT02545543|83230554|FG001|Overall Study|Lost to Follow-up|25|||
46984404|NCT02545543|83230553|FG000|Overall Study|Physician Decision|3|||
46984405|NCT02545543|83230554|FG001|Overall Study|Physician Decision|0|||
46984406|NCT02545543|83230553|FG000|Overall Study|Withdrawal by Subject|9|||
46984407|NCT02545543|83230554|FG001|Overall Study|Withdrawal by Subject|8|||
46984408|NCT02545543|83230553|FG000|Overall Study|Noncomplaince|1|||
46984409|NCT02545543|83230554|FG001|Overall Study|Noncomplaince|0|||
46702107|NCT00977938|82916959|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
46702108|NCT00977938|82916960|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
46702109|NCT00977938|82916961|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
46702110|NCT00977938|82916962|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
46702111|NCT00977938|82916959|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
46984410|NCT02545543|83230553|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
46984411|NCT02545543|83230554|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
46984412|NCT02545075|83230564|FG000|Randomization|Lost to Follow-up|0|||
46984413|NCT02545075|83230565|FG001|Randomization|Lost to Follow-up|1|||
46984414|NCT02545075|83230564|FG000|Randomization|Withdrawal by Subject|0|||
46984415|NCT02545075|83230565|FG001|Randomization|Withdrawal by Subject|6|||
46984416|NCT02545075|83230564|FG000|Treatment|Disease progression|71|||
46984417|NCT02545075|83230565|FG001|Treatment|Disease progression|32|||
46984418|NCT02545075|83230564|FG000|Treatment|Participant dicontinued study treatment|7|||
46984419|NCT02545075|83230565|FG001|Treatment|Participant dicontinued study treatment|9|||
46984420|NCT02545075|83230564|FG000|Treatment|Withdrawal by Subject|1|||
46984421|NCT02545075|83230565|FG001|Treatment|Withdrawal by Subject|0|||
46984422|NCT02545075|83230564|FG000|Treatment|Adverse event not related to study drug|1|||
46984423|NCT02545075|83230565|FG001|Treatment|Adverse event not related to study drug|0|||
46984424|NCT02545075|83230564|FG000|Treatment|Death|1|||
46984425|NCT02545075|83230565|FG001|Treatment|Death|0|||
46984426|NCT02545075|83230564|FG000|Treatment|Participant drug toxicity|1|||
46984427|NCT02545075|83230565|FG001|Treatment|Participant drug toxicity|0|||
46984428|NCT02545075|83230564|FG000|Treatment|Completed treatment|40|||
46984429|NCT02545075|83230565|FG001|Treatment|Completed treatment|12|||
46984430|NCT02544763|83230583|FG000|Overall Study|Adverse Event|8|||
46984431|NCT02544763|83230584|FG001|Overall Study|Adverse Event|8|||
46984432|NCT02544763|83230585|FG002|Overall Study|Adverse Event|0|||
46984433|NCT02544763|83230583|FG000|Overall Study|Withdrawn by parent/guardian|1|||
46984434|NCT02544763|83230584|FG001|Overall Study|Withdrawn by parent/guardian|1|||
46984435|NCT02544763|83230585|FG002|Overall Study|Withdrawn by parent/guardian|1|||
46984436|NCT02544763|83230583|FG000|Overall Study|Met withdrawal criteria|0|||
46984437|NCT02544763|83230584|FG001|Overall Study|Met withdrawal criteria|2|||
46702112|NCT00977938|82916960|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
46877029|NCT03317405|83097451|FG001|Overall Study|Withdrawal by Subject|0|||
46877030|NCT03317405|83097452|FG002|Overall Study|Withdrawal by Subject|0|||
46877031|NCT03317405|83097450|FG000|Overall Study|Physician Decision|0|||
46877032|NCT03317405|83097451|FG001|Overall Study|Physician Decision|0|||
46877033|NCT03317405|83097452|FG002|Overall Study|Physician Decision|1|||
46877034|NCT03317405|83097450|FG000|Overall Study|Surgery Rescheduled|0|||
46877035|NCT03317405|83097451|FG001|Overall Study|Surgery Rescheduled|1|||
46877036|NCT03317405|83097452|FG002|Overall Study|Surgery Rescheduled|0|||
46877037|NCT03273907|83097468|FG000|Overall Study|Death|1|||
46877038|NCT03273907|83097468|FG000|Overall Study|Lost to Follow-up|4|||
46877039|NCT03273907|83097468|FG000|Overall Study|Withdrawal by Subject|2|||
46877040|NCT03273907|83097468|FG000|Overall Study|COVID 19|2|||
46877041|NCT03247972|83097474|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
46877042|NCT03247972|83097474|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
46877043|NCT03103321|83097483|FG000|Overall Study|Protocol Violation|1|||
46877044|NCT03103321|83097484|FG001|Overall Study|Protocol Violation|1|||
46877045|NCT03103321|83097485|FG002|Overall Study|Protocol Violation|1|||
46877046|NCT03103321|83097486|FG003|Overall Study|Protocol Violation|0|||
46877047|NCT02788981|83097498|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
46877048|NCT02788981|83097499|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
46877049|NCT02744612|83097507|FG000|Overall Study|Withdrawal by Subject|0|||
46877050|NCT02744612|83097508|FG001|Overall Study|Withdrawal by Subject|2|||
46877051|NCT02362035|83097514|FG000|Overall Study|Death|67|||
46877052|NCT02362035|83097514|FG000|Overall Study|Lost to Follow-up|3|||
46877053|NCT02362035|83097514|FG000|Overall Study|Adverse Event|1|||
46877054|NCT02362035|83097514|FG000|Overall Study|Physician Decision|1|||
46877055|NCT02362035|83097514|FG000|Overall Study|Subject started another cancer therapy|10|||
46877056|NCT02362035|83097514|FG000|Overall Study|Study terminated by sponsor|45|||
46877057|NCT02362035|83097514|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
46877058|NCT02362035|83097514|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
46877059|NCT02362035|83097514|FG000|Overall Study|Disease progression|11|||
46877060|NCT02362035|83097514|FG000|Overall Study|Withdrawal by Subject|20|||
46877061|NCT01600755|83097526|FG000|Overall Study|Withdrawal by Subject|6|||
46877062|NCT04553913|83097552|FG000|Overall Study|patient's block resolved prior to PACU|1|||
46877063|NCT04553913|83097552|FG000|Overall Study|did not use the device properly|5|||
46877064|NCT04490499|83097557|FG000|Overall Study|Withdrawal by Subject|2|||
46877065|NCT01332994|83097561|FG000|Overall Study|Adverse Event|34|||
46877066|NCT01332994|83097561|FG000|Overall Study|Death|1|||
46877067|NCT01332994|83097561|FG000|Overall Study|Lack of Efficacy|1|||
46877068|NCT01332994|83097561|FG000|Overall Study|Lost to Follow-up|4|||
46877069|NCT01332994|83097561|FG000|Overall Study|Protocol Violation|6|||
46877070|NCT01332994|83097561|FG000|Overall Study|Withdrawal by Subject|15|||
46877071|NCT01332994|83097561|FG000|Overall Study|Administrative Problem|2|||
46877072|NCT01332994|83097561|FG000|Overall Study|Other|8|||
46877073|NCT03698331|83097567|FG000|Overall Study|Adverse Event|2|||
46877074|NCT03698331|83097568|FG001|Overall Study|Adverse Event|3|||
46877075|NCT03698331|83097567|FG000|Overall Study|Withdrawal by Subject|1|||
46877076|NCT03698331|83097568|FG001|Overall Study|Withdrawal by Subject|1|||
46877077|NCT03698331|83097567|FG000|Overall Study|Lost to Follow-up|0|||
46877078|NCT03698331|83097568|FG001|Overall Study|Lost to Follow-up|2|||
46877079|NCT03698331|83097567|FG000|Overall Study|Non-compliance with study drug|1|||
46877080|NCT03698331|83097568|FG001|Overall Study|Non-compliance with study drug|0|||
46877081|NCT04889625|83097574|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
46877082|NCT04889625|83097575|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
46877083|NCT04889625|83097574|FG000|Period 1|Subject out of window|0|||
46877084|NCT04889625|83097575|FG001|Period 1|Subject out of window|1|||
46877085|NCT04889625|83097574|FG000|Period 1|Wrong add power dispensed|0|||
46877086|NCT04889625|83097575|FG001|Period 1|Wrong add power dispensed|1|||
46877087|NCT04889625|83097574|FG000|Period 1|Discontinued due to fitting guide error|1|||
46877088|NCT04889625|83097575|FG001|Period 1|Discontinued due to fitting guide error|1|||
46877089|NCT04889625|83097574|FG000|Period 2|Test article no longer available|1|||
46877090|NCT04889625|83097575|FG001|Period 2|Test article no longer available|0|||
46877091|NCT04889625|83097574|FG000|Period 2|Incorrect lens dispensed|1|||
46877092|NCT04889625|83097575|FG001|Period 2|Incorrect lens dispensed|0|||
46877093|NCT04889625|83097574|FG000|Period 2|Wrong add power dispensed|0|||
46877094|NCT04889625|83097575|FG001|Period 2|Wrong add power dispensed|1|||
46877095|NCT04883541|83097583|FG000|Overall Study|Not attending regular yoga class|16|||
46877096|NCT04883541|83097584|FG001|Overall Study|Not attending regular yoga class|0|||
46877097|NCT04883541|83097583|FG000|Overall Study|Not attending the pregnancy school|0|||
46877098|NCT04883541|83097584|FG001|Overall Study|Not attending the pregnancy school|9|||
46877099|NCT04882995|83097592|FG000|Overall Study|Withdrawal by Subject|1|||
46877100|NCT04882995|83097593|FG001|Overall Study|Withdrawal by Subject|2|||
46877101|NCT04882995|83097592|FG000|Overall Study|Protocol Violation|4|||
46877102|NCT04882995|83097593|FG001|Overall Study|Protocol Violation|4|||
46877103|NCT04882995|83097592|FG000|Overall Study|Surgery postponed due to COVID|1|||
46877104|NCT04882995|83097593|FG001|Overall Study|Surgery postponed due to COVID|1|||
46877105|NCT04483011|83097601|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
46877106|NCT04483011|83097602|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
46877107|NCT04545567|83097612|FG000|Overall Study|tested positive for SARS-co-V2|1|||
46877108|NCT04545567|83097613|FG001|Overall Study|tested positive for SARS-co-V2|1|||
46877109|NCT04545567|83097612|FG000|Overall Study|Withdrawal by Subject|0|||
46877110|NCT04545567|83097613|FG001|Overall Study|Withdrawal by Subject|1|||
46877111|NCT04534491|83097619|FG000|Overall Study|Not completed end-of-study interview|24|||
46877112|NCT04534491|83097619|FG000|Overall Study|Non-users|70|||
46877113|NCT04534491|83097619|FG000|Overall Study|Non-verifiable users|58|||
46877114|NCT03694821|83097626|FG000|Overall Study|Study terminated|4|||
46877115|NCT03694821|83097627|FG001|Overall Study|Study terminated|8|||
46877116|NCT03694821|83097628|FG002|Overall Study|Study terminated|4|||
46877117|NCT04531527|83097636|FG000|Overall Study|Found to be Ineligible|3|||
46877118|NCT04474197|83097644|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
46877119|NCT04474197|83097645|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
46877120|NCT04474197|83097646|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
46877121|NCT04474197|83097647|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
46877122|NCT02079766|83097664|FG000|Overall Study|Physician Decision|1|||
46877123|NCT02079766|83097665|FG001|Overall Study|Physician Decision|0|||
46877124|NCT02079766|83097664|FG000|Overall Study|Withdrawal by Subject|1|||
46877125|NCT02079766|83097665|FG001|Overall Study|Withdrawal by Subject|0|||
46877126|NCT04841577|83097673|FG000|Overall Study|Adverse Event|5|||
46984438|NCT02544763|83230585|FG002|Overall Study|Met withdrawal criteria|0|||
46984439|NCT02544763|83230583|FG000|Overall Study|Physician Decision|0|||
46877127|NCT04841577|83097674|FG001|Overall Study|Adverse Event|10|||
46877128|NCT04841577|83097673|FG000|Overall Study|Lost to Follow-up|8|||
46877129|NCT04841577|83097674|FG001|Overall Study|Lost to Follow-up|7|||
46877130|NCT04841577|83097673|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
46877131|NCT04841577|83097674|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
46877132|NCT04841577|83097673|FG000|Overall Study|Other|0|||
46877133|NCT04841577|83097674|FG001|Overall Study|Other|1|||
46877134|NCT04529109|83097680|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
46877135|NCT04529109|83097681|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
46877136|NCT04528641|83097693|FG000|Overall Study|Withdrawal by Subject|0|||
46877137|NCT04528641|83097694|FG001|Overall Study|Withdrawal by Subject|0|||
46877138|NCT04528641|83097695|FG002|Overall Study|Withdrawal by Subject|0|||
46877139|NCT04528641|83097696|FG003|Overall Study|Withdrawal by Subject|1|||
46877140|NCT04528641|83097697|FG004|Overall Study|Withdrawal by Subject|0|||
46877141|NCT04528641|83097698|FG005|Overall Study|Withdrawal by Subject|1|||
46877142|NCT04527471|83097717|FG000|Overall Study|Adverse Event|1|||
46877143|NCT04527471|83097718|FG001|Overall Study|Adverse Event|0|||
46877144|NCT04527471|83097717|FG000|Overall Study|Lost to Follow-up|1|||
46877145|NCT04527471|83097718|FG001|Overall Study|Lost to Follow-up|0|||
46877146|NCT04471935|83097724|FG000|Overall Study|Withdrawal by Subject|1|||
46877147|NCT04471935|83097724|FG000|Overall Study|Deemed ineligible to participate|1|||
46877148|NCT04468347|83097732|FG000|Overall Study|Withdrawal by Subject|0|||
46877149|NCT04468347|83097733|FG001|Overall Study|Withdrawal by Subject|1|||
46877150|NCT04468347|83097734|FG002|Overall Study|Withdrawal by Subject|3|||
46877151|NCT04468347|83097735|FG003|Overall Study|Withdrawal by Subject|3|||
46877152|NCT04468347|83097732|FG000|Overall Study|Lost to Follow-up|0|||
46877153|NCT04468347|83097733|FG001|Overall Study|Lost to Follow-up|0|||
46877154|NCT04468347|83097734|FG002|Overall Study|Lost to Follow-up|1|||
46984440|NCT02544763|83230584|FG001|Overall Study|Physician Decision|1|||
46984441|NCT02544763|83230585|FG002|Overall Study|Physician Decision|0|||
46877155|NCT04468347|83097735|FG003|Overall Study|Lost to Follow-up|1|||
46877156|NCT04468347|83097732|FG000|Overall Study|Physician Decision|1|||
46877157|NCT04468347|83097733|FG001|Overall Study|Physician Decision|0|||
46877158|NCT04468347|83097734|FG002|Overall Study|Physician Decision|2|||
46877159|NCT04468347|83097735|FG003|Overall Study|Physician Decision|0|||
46877160|NCT04468347|83097732|FG000|Overall Study|Protocol Violation|1|||
46877161|NCT04468347|83097733|FG001|Overall Study|Protocol Violation|0|||
46877162|NCT04468347|83097734|FG002|Overall Study|Protocol Violation|0|||
46984442|NCT02544763|83230583|FG000|Overall Study|Difficulties taking IMP|1|||
46877163|NCT04468347|83097735|FG003|Overall Study|Protocol Violation|0|||
46877164|NCT04822701|83097751|FG000|Overall Study|Not treated|2|||
46877165|NCT04822701|83097752|FG001|Overall Study|Not treated|0|||
46877166|NCT04822701|83097751|FG000|Overall Study|Lost to Follow-up|1|||
46877167|NCT04822701|83097752|FG001|Overall Study|Lost to Follow-up|0|||
46877168|NCT04822701|83097751|FG000|Overall Study|Withdrawal by Subject|1|||
46877169|NCT04822701|83097752|FG001|Overall Study|Withdrawal by Subject|0|||
46877170|NCT04461795|83097758|FG000|Overall Study|Lost to Follow-up|2|||
46877171|NCT04461795|83097758|FG000|Overall Study|Withdrawal by Subject|2|||
46877172|NCT04461795|83097758|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
46877173|NCT04461015|83097765|FG000|Overall Study|IV access lost during the study|0|||
46877174|NCT04461015|83097766|FG001|Overall Study|IV access lost during the study|1|||
46877175|NCT04461015|83097765|FG000|Overall Study|Withdrawal by Subject|0|||
46877176|NCT04461015|83097766|FG001|Overall Study|Withdrawal by Subject|1|||
46877177|NCT04810221|83097772|FG000|Overall Study|Physician Decision|3|||
46877178|NCT03694353|83097776|FG000|Overall Study|Withdrawal by Subject|1|||
46877179|NCT03694353|83097776|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
46877180|NCT04521777|83097780|FG000|Overall Study|Death|2|||
46877181|NCT04521777|83097780|FG000|Overall Study|Withdrawal by Subject|2|||
46877182|NCT03700671|83097786|FG000|Overall Study|Lack of Efficacy|1|||
46877183|NCT03700671|83097787|FG001|Overall Study|Lack of Efficacy|2|||
46877184|NCT04764669|83097799|FG000|Overall Study|Adverse Event|1|||
46877185|NCT04764669|83097800|FG001|Overall Study|Adverse Event|0|||
46877186|NCT04764669|83097801|FG002|Overall Study|Adverse Event|1|||
46877187|NCT04764669|83097802|FG003|Overall Study|Adverse Event|0|||
46877188|NCT04764669|83097799|FG000|Overall Study|Subject Choice|0|||
46877189|NCT04764669|83097800|FG001|Overall Study|Subject Choice|0|||
46877190|NCT04764669|83097801|FG002|Overall Study|Subject Choice|1|||
46877191|NCT04764669|83097802|FG003|Overall Study|Subject Choice|0|||
46877192|NCT04764669|83097799|FG000|Overall Study|Withdrawal by Subject|2|||
46877193|NCT04764669|83097800|FG001|Overall Study|Withdrawal by Subject|0|||
46877194|NCT04764669|83097801|FG002|Overall Study|Withdrawal by Subject|0|||
46877195|NCT04764669|83097802|FG003|Overall Study|Withdrawal by Subject|0|||
46877196|NCT04438785|83097814|FG000|Overall Study|change of weight, give up intervention|2|||
46877197|NCT04438785|83097815|FG001|Overall Study|change of weight, give up intervention|10|||
46877198|NCT04741503|83097823|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
46877199|NCT04741503|83097824|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
46877200|NCT04741503|83097825|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
46877201|NCT04741503|83097823|FG000|Initial Enrollment|Overquotas removed|0|||
46877202|NCT04741503|83097824|FG001|Initial Enrollment|Overquotas removed|0|||
46877203|NCT04741503|83097825|FG002|Initial Enrollment|Overquotas removed|186|||
46877204|NCT04741503|83097823|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
46877205|NCT04741503|83097824|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
46877206|NCT04741503|83097825|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
46877207|NCT04734873|83097834|FG000|Overall Study|Lost to Follow-up|1|||
46877208|NCT04734873|83097835|FG001|Overall Study|Lost to Follow-up|3|||
46877209|NCT04734873|83097836|FG002|Overall Study|Lost to Follow-up|2|||
46877210|NCT04734873|83097834|FG000|Overall Study|Randomized but not dosed|1|||
46877211|NCT04734873|83097835|FG001|Overall Study|Randomized but not dosed|0|||
46877212|NCT04734873|83097836|FG002|Overall Study|Randomized but not dosed|1|||
46877213|NCT04435665|83097848|FG000|Overall Study|Lost to Follow-up|0|||
46877214|NCT04435665|83097849|FG001|Overall Study|Lost to Follow-up|0|||
46877215|NCT04435665|83097850|FG002|Overall Study|Lost to Follow-up|0|||
46877216|NCT04435665|83097851|FG003|Overall Study|Lost to Follow-up|1|||
46877217|NCT04428411|83097861|FG000|Overall Study|Lost to Follow-up|114|||
46877218|NCT04422561|83097870|FG000|Overall Study|Lost to Follow-up|25|||
46877219|NCT04422561|83097871|FG001|Overall Study|Lost to Follow-up|11|||
46877220|NCT01369498|83097881|FG000|Overall Study|Lack of Efficacy|9|||
46877221|NCT01369498|83097882|FG001|Overall Study|Lack of Efficacy|9|||
46877222|NCT01369498|83097883|FG002|Overall Study|Lack of Efficacy|1|||
46877223|NCT01369498|83097884|FG003|Overall Study|Lack of Efficacy|3|||
46877224|NCT01369498|83097881|FG000|Overall Study|Adverse Event|1|||
46877225|NCT01369498|83097882|FG001|Overall Study|Adverse Event|2|||
46877226|NCT01369498|83097883|FG002|Overall Study|Adverse Event|0|||
46877227|NCT01369498|83097884|FG003|Overall Study|Adverse Event|1|||
46877228|NCT01369498|83097881|FG000|Overall Study|Withdrawal of Consent|0|||
46877229|NCT01369498|83097882|FG001|Overall Study|Withdrawal of Consent|1|||
46877230|NCT01369498|83097883|FG002|Overall Study|Withdrawal of Consent|1|||
46877231|NCT01369498|83097884|FG003|Overall Study|Withdrawal of Consent|1|||
46877232|NCT01369498|83097881|FG000|Overall Study|Death|0|||
46877233|NCT01369498|83097882|FG001|Overall Study|Death|0|||
46877234|NCT01369498|83097883|FG002|Overall Study|Death|1|||
46877235|NCT01369498|83097884|FG003|Overall Study|Death|0|||
46877236|NCT01369498|83097881|FG000|Overall Study|Investigator's Discretion|1|||
46877237|NCT01369498|83097882|FG001|Overall Study|Investigator's Discretion|0|||
46877238|NCT01369498|83097883|FG002|Overall Study|Investigator's Discretion|1|||
46877239|NCT01369498|83097884|FG003|Overall Study|Investigator's Discretion|3|||
46877240|NCT01369498|83097881|FG000|Overall Study|Unknown Reason|1|||
46877241|NCT01369498|83097882|FG001|Overall Study|Unknown Reason|0|||
46877242|NCT01369498|83097883|FG002|Overall Study|Unknown Reason|11|||
46877243|NCT01369498|83097884|FG003|Overall Study|Unknown Reason|6|||
46877244|NCT01369498|83097881|FG000|Overall Study|Disease Progression|0|||
46877245|NCT01369498|83097882|FG001|Overall Study|Disease Progression|0|||
46877246|NCT01369498|83097883|FG002|Overall Study|Disease Progression|0|||
46877247|NCT01369498|83097884|FG003|Overall Study|Disease Progression|1|||
46877248|NCT04709835|83097898|FG000|Overall Study|Withdrawal by Subject|0|||
46877249|NCT04709835|83097899|FG001|Overall Study|Withdrawal by Subject|1|||
46877250|NCT04709835|83097900|FG002|Overall Study|Withdrawal by Subject|0|||
46877251|NCT04407507|83097914|FG000|Overall Study|Withdrawal by Subject|0|||
46877252|NCT04407507|83097915|FG001|Overall Study|Withdrawal by Subject|1|||
46877253|NCT04698993|83097923|FG000|Overall Study|PCR results not accessible|2|||
46877254|NCT04698993|83097924|FG001|Overall Study|PCR results not accessible|7|||
46877255|NCT04698993|83097923|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
46877256|NCT04698993|83097924|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
46877257|NCT04359771|83097932|FG000|Overall Study|Lack of Efficacy|2|||
46877258|NCT04359771|83097933|FG001|Overall Study|Lack of Efficacy|2|||
46877259|NCT04356573|83097941|FG000|Overall Study|Didn't Qualify|1|||
46877260|NCT04356573|83097942|FG001|Overall Study|Didn't Qualify|0|||
46877261|NCT04352127|83097958|FG000|Overall Study|Unable to obtain readings|4|||
46877262|NCT04352127|83097959|FG001|Overall Study|Unable to obtain readings|1|||
46877263|NCT04351269|83097968|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
46877264|NCT04351269|83097969|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
46877265|NCT04351269|83097970|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
46877266|NCT04351269|83097968|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
46877267|NCT04351269|83097969|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
46877268|NCT04351269|83097970|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
46877269|NCT04351269|83097968|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
46877270|NCT04351269|83097969|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
46877271|NCT04351269|83097970|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
46877272|NCT04351269|83097968|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
46877273|NCT04351269|83097969|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
46877274|NCT04351269|83097970|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
46877275|NCT04351269|83097968|FG000|Overall Study|Lost to Follow-up|1|||
46877276|NCT04351269|83097969|FG001|Overall Study|Lost to Follow-up|3|||
46877277|NCT04351269|83097970|FG002|Overall Study|Lost to Follow-up|0|||
46877278|NCT04348851|83097985|FG000|Post-Test 1|Withdrawal by Subject|0|||
46877279|NCT04348851|83097986|FG001|Post-Test 1|Withdrawal by Subject|1|||
46877280|NCT04348851|83097987|FG002|Post-Test 1|Withdrawal by Subject|0|||
46877281|NCT04348851|83097988|FG003|Post-Test 1|Withdrawal by Subject|0|||
46877282|NCT04348851|83097985|FG000|Post-Test 1|Lost to Follow-up|0|||
46877283|NCT04348851|83097986|FG001|Post-Test 1|Lost to Follow-up|1|||
46877284|NCT04348851|83097987|FG002|Post-Test 1|Lost to Follow-up|0|||
46877285|NCT04348851|83097988|FG003|Post-Test 1|Lost to Follow-up|0|||
46877286|NCT04348851|83097985|FG000|Post-Test 2|Stroke survivor death|0|||
46877287|NCT04348851|83097986|FG001|Post-Test 2|Stroke survivor death|1|||
46877288|NCT04348851|83097987|FG002|Post-Test 2|Stroke survivor death|0|||
46877289|NCT04348851|83097988|FG003|Post-Test 2|Stroke survivor death|1|||
46877290|NCT04346199|83098000|FG000|Overall Study|Death|8|||
46877291|NCT04346199|83098001|FG001|Overall Study|Death|9|||
46877292|NCT04346199|83098000|FG000|Overall Study|Lost to Follow-up|0|||
46877293|NCT04346199|83098001|FG001|Overall Study|Lost to Follow-up|1|||
46877294|NCT04346199|83098000|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
46877295|NCT04346199|83098001|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
46877296|NCT04346199|83098000|FG000|Overall Study|Withdrawal by Subject|5|||
46877297|NCT04346199|83098001|FG001|Overall Study|Withdrawal by Subject|1|||
46877298|NCT04345653|83098007|FG000|Overall Study|Withdrawal by Subject|2|||
46877299|NCT04342689|83098014|FG000|Overall Study|Withdrawal by Subject|32|||
46877300|NCT04342689|83098015|FG001|Overall Study|Withdrawal by Subject|33|||
46877301|NCT04342689|83098014|FG000|Overall Study|Lost to Follow-up|10|||
46877302|NCT04342689|83098015|FG001|Overall Study|Lost to Follow-up|12|||
46877303|NCT04169061|83098023|FG000|Overall Study|Adverse Event|2|||
46877304|NCT04169061|83098023|FG000|Overall Study|Death|1|||
46877305|NCT04169061|83098023|FG000|Overall Study|Withdrawal by Subject|1|||
46877306|NCT04169061|83098023|FG000|Overall Study|Protocol Violation|1|||
46877307|NCT02792218|83098029|FG000|Overall Study|Patient/guardian decision|15|||
46877308|NCT02792218|83098030|FG001|Overall Study|Patient/guardian decision|42|||
46877309|NCT02792218|83098029|FG000|Overall Study|Adverse Event|15|||
46877310|NCT02792218|83098030|FG001|Overall Study|Adverse Event|14|||
46877311|NCT02792218|83098029|FG000|Overall Study|Lost to Follow-up|10|||
46877312|NCT02792218|83098030|FG001|Overall Study|Lost to Follow-up|5|||
46877313|NCT02792218|83098029|FG000|Overall Study|Lack of Efficacy|1|||
46877314|NCT02792218|83098030|FG001|Overall Study|Lack of Efficacy|12|||
46877315|NCT02792218|83098029|FG000|Overall Study|Physician Decision|4|||
46877316|NCT02792218|83098030|FG001|Overall Study|Physician Decision|4|||
46877317|NCT02792218|83098029|FG000|Overall Study|Protocol deviation|3|||
46877318|NCT02792218|83098030|FG001|Overall Study|Protocol deviation|2|||
46877319|NCT02792218|83098029|FG000|Overall Study|New therapy for study indication|0|||
46877320|NCT02792218|83098030|FG001|Overall Study|New therapy for study indication|1|||
46877321|NCT02792218|83098029|FG000|Overall Study|Non-compliance with study treatment|0|||
46877322|NCT02792218|83098030|FG001|Overall Study|Non-compliance with study treatment|1|||
46877323|NCT02792218|83098029|FG000|Overall Study|Pregnancy|1|||
46877324|NCT02792218|83098030|FG001|Overall Study|Pregnancy|0|||
46877325|NCT00153101|83098041|FG000|Overall Study|Lost to Follow-up|14|||
46877326|NCT00153101|83098042|FG001|Overall Study|Lost to Follow-up|14|||
46877327|NCT00153101|83098043|FG002|Overall Study|Lost to Follow-up|12|||
46877328|NCT00153101|83098044|FG003|Overall Study|Lost to Follow-up|5|||
46877329|NCT00153101|83098045|FG004|Overall Study|Lost to Follow-up|5|||
46877330|NCT00153101|83098041|FG000|Overall Study|Withdrawal by Subject|3|||
46877331|NCT00153101|83098042|FG001|Overall Study|Withdrawal by Subject|4|||
46877332|NCT00153101|83098043|FG002|Overall Study|Withdrawal by Subject|3|||
46877333|NCT00153101|83098044|FG003|Overall Study|Withdrawal by Subject|3|||
46877334|NCT00153101|83098045|FG004|Overall Study|Withdrawal by Subject|5|||
46877335|NCT04401579|83098061|FG000|Overall Study|Death|23|||
46877336|NCT04401579|83098062|FG001|Overall Study|Death|36|||
46877337|NCT04401579|83098061|FG000|Overall Study|Lost to Follow-up|40|||
46877338|NCT04401579|83098062|FG001|Overall Study|Lost to Follow-up|41|||
46877339|NCT04401579|83098061|FG000|Overall Study|Withdrawal by Subject|8|||
46877340|NCT04401579|83098062|FG001|Overall Study|Withdrawal by Subject|16|||
46877341|NCT04401579|83098061|FG000|Overall Study|Physician Decision|1|||
46877342|NCT04401579|83098062|FG001|Overall Study|Physician Decision|2|||
46877343|NCT04401579|83098061|FG000|Overall Study|Became ineligible after enrollment|1|||
46877344|NCT04401579|83098062|FG001|Overall Study|Became ineligible after enrollment|1|||
46877345|NCT04401579|83098061|FG000|Overall Study|Enrolled but treatment not administered|7|||
46877346|NCT04401579|83098062|FG001|Overall Study|Enrolled but treatment not administered|9|||
46877347|NCT04401579|83098061|FG000|Overall Study|Adverse Event|2|||
46877348|NCT04401579|83098062|FG001|Overall Study|Adverse Event|1|||
46877349|NCT04401579|83098061|FG000|Overall Study|Scheduling error|1|||
46877350|NCT04401579|83098062|FG001|Overall Study|Scheduling error|2|||
46877351|NCT04401579|83098061|FG000|Overall Study|Transferred to another hospital|1|||
46877352|NCT04401579|83098062|FG001|Overall Study|Transferred to another hospital|2|||
46877353|NCT04161807|83098068|FG000|Overall Study|Withdrawal by Subject|2|||
46877354|NCT04161807|83098068|FG000|Overall Study|Performed only 1 treatment|2|||
46877355|NCT04401423|83098074|FG000|Overall Study|Withdrawal by Subject|3|||
46877356|NCT04401423|83098075|FG001|Overall Study|Withdrawal by Subject|1|||
46877357|NCT04401423|83098074|FG000|Overall Study|Physician Decision|2|||
46877358|NCT04401423|83098075|FG001|Overall Study|Physician Decision|1|||
46877359|NCT04399161|83098086|FG000|Overall Study|Withdrawal by Subject|1|||
46984443|NCT02544763|83230584|FG001|Overall Study|Difficulties taking IMP|0|||
46984444|NCT02544763|83230585|FG002|Overall Study|Difficulties taking IMP|0|||
46984445|NCT02556203|83230595|FG000|Overall Study|Withdrawal by Subject|21|||
46984446|NCT02556203|83230596|FG001|Overall Study|Withdrawal by Subject|21|||
46984447|NCT02556203|83230595|FG000|Overall Study|Lost to Follow-up|5|||
46877360|NCT04399161|83098087|FG001|Overall Study|Withdrawal by Subject|0|||
46877361|NCT04399161|83098088|FG002|Overall Study|Withdrawal by Subject|2|||
46877362|NCT04399161|83098086|FG000|Overall Study|Protocol Violation|1|||
46877363|NCT04399161|83098087|FG001|Overall Study|Protocol Violation|2|||
46877364|NCT04399161|83098088|FG002|Overall Study|Protocol Violation|0|||
46877365|NCT02076178|83098098|FG000|Oral Phase|Adverse Event|0|||
46877366|NCT02076178|83098099|FG001|Oral Phase|Adverse Event|7|||
46877367|NCT02076178|83098098|FG000|Oral Phase|Withdrawal by Subject|0|||
46877368|NCT02076178|83098099|FG001|Oral Phase|Withdrawal by Subject|4|||
46877369|NCT02076178|83098098|FG000|Oral Phase|Physician Decision|0|||
46877370|NCT02076178|83098099|FG001|Oral Phase|Physician Decision|1|||
46877371|NCT02076178|83098098|FG000|Injection Phase|Protocol defined stopping criteria|1|||
46877372|NCT02076178|83098099|FG001|Injection Phase|Protocol defined stopping criteria|0|||
46877373|NCT02076178|83098098|FG000|Injection Phase|Withdrawal by Subject|0|||
46877374|NCT02076178|83098099|FG001|Injection Phase|Withdrawal by Subject|3|||
46877375|NCT02076178|83098098|FG000|Injection Phase|Physician Decision|0|||
46877376|NCT02076178|83098099|FG001|Injection Phase|Physician Decision|3|||
46877377|NCT02076178|83098098|FG000|Injection Phase|Lost to Follow-up|0|||
46877378|NCT02076178|83098099|FG001|Injection Phase|Lost to Follow-up|1|||
46984448|NCT02556203|83230596|FG001|Overall Study|Lost to Follow-up|5|||
46877379|NCT00149825|83098109|FG000|Overall Study|Intolerance to medication side effects|1|||
46984449|NCT02556203|83230595|FG000|Overall Study|Adverse Event|1|||
46984450|NCT02556203|83230596|FG001|Overall Study|Adverse Event|0|||
46984451|NCT02558231|83230613|FG000|Overall Study|Death|4|||
46984452|NCT02558231|83230614|FG001|Overall Study|Death|12|||
46984453|NCT02558231|83230613|FG000|Overall Study|Lost to Follow-up|7|||
46984454|NCT02558231|83230614|FG001|Overall Study|Lost to Follow-up|4|||
46984455|NCT02558231|83230613|FG000|Overall Study|Withdrawal by Subject|7|||
46984456|NCT02558231|83230614|FG001|Overall Study|Withdrawal by Subject|4|||
46984457|NCT02558231|83230613|FG000|Overall Study|Physician Decision|7|||
46984458|NCT02558231|83230614|FG001|Overall Study|Physician Decision|5|||
46984459|NCT02558231|83230613|FG000|Overall Study|Sponsor Decision|0|||
46984460|NCT02558231|83230614|FG001|Overall Study|Sponsor Decision|1|||
46984461|NCT02554877|83230624|FG000|Overall Study|Adverse Event|2|||
46984462|NCT02554877|83230625|FG001|Overall Study|Adverse Event|0|||
46984463|NCT02554877|83230626|FG002|Overall Study|Adverse Event|0|||
46984464|NCT02554877|83230627|FG003|Overall Study|Adverse Event|1|||
46984465|NCT02554877|83230624|FG000|Overall Study|Lost to Follow-up|1|||
46984466|NCT02554877|83230625|FG001|Overall Study|Lost to Follow-up|1|||
46984467|NCT02554877|83230626|FG002|Overall Study|Lost to Follow-up|1|||
46984468|NCT02554877|83230627|FG003|Overall Study|Lost to Follow-up|2|||
46984469|NCT02554877|83230624|FG000|Overall Study|Did not meet entrance criteria|0|||
46984470|NCT02554877|83230625|FG001|Overall Study|Did not meet entrance criteria|0|||
46984471|NCT02554877|83230626|FG002|Overall Study|Did not meet entrance criteria|1|||
46984472|NCT02554877|83230627|FG003|Overall Study|Did not meet entrance criteria|0|||
46984473|NCT02554877|83230624|FG000|Overall Study|No longer met eligibility criteria|1|||
46984474|NCT02554877|83230625|FG001|Overall Study|No longer met eligibility criteria|0|||
46984475|NCT02554877|83230626|FG002|Overall Study|No longer met eligibility criteria|1|||
46984476|NCT02554877|83230627|FG003|Overall Study|No longer met eligibility criteria|1|||
46984477|NCT02554877|83230624|FG000|Overall Study|Protocol Violation|3|||
46984478|NCT02554877|83230625|FG001|Overall Study|Protocol Violation|1|||
46984479|NCT02554877|83230626|FG002|Overall Study|Protocol Violation|1|||
46984480|NCT02554877|83230627|FG003|Overall Study|Protocol Violation|0|||
46984481|NCT02554877|83230624|FG000|Overall Study|Other|1|||
46984482|NCT02554877|83230625|FG001|Overall Study|Other|3|||
46984483|NCT02554877|83230626|FG002|Overall Study|Other|0|||
46984484|NCT02554877|83230627|FG003|Overall Study|Other|3|||
46984485|NCT02554877|83230624|FG000|Overall Study|Insufficient clinical response|4|||
46984486|NCT02554877|83230625|FG001|Overall Study|Insufficient clinical response|0|||
46984487|NCT02554877|83230626|FG002|Overall Study|Insufficient clinical response|0|||
46984488|NCT02554877|83230627|FG003|Overall Study|Insufficient clinical response|0|||
46984489|NCT02554877|83230624|FG000|Overall Study|No longer willing to participate|0|||
46984490|NCT02554877|83230625|FG001|Overall Study|No longer willing to participate|2|||
46984491|NCT02554877|83230626|FG002|Overall Study|No longer willing to participate|2|||
46984492|NCT02554877|83230627|FG003|Overall Study|No longer willing to participate|0|||
46877380|NCT00149825|83098110|FG001|Overall Study|Intolerance to medication side effects|2|||
46877381|NCT00149825|83098109|FG000|Overall Study|Time commitments|2|||
46877382|NCT00149825|83098110|FG001|Overall Study|Time commitments|1|||
46877383|NCT00149825|83098109|FG000|Overall Study|Not liking insomnia therapy|1|||
46877384|NCT00149825|83098110|FG001|Overall Study|Not liking insomnia therapy|0|||
46877385|NCT00149825|83098109|FG000|Overall Study|Other|1|||
46877386|NCT00149825|83098110|FG001|Overall Study|Other|0|||
46877387|NCT04397757|83098118|FG000|Overall Study|Death|3|||
46877388|NCT04397757|83098119|FG001|Overall Study|Death|11|||
46877389|NCT04397757|83098118|FG000|Overall Study|Withdrawal by Subject|2|||
46877390|NCT04397757|83098119|FG001|Overall Study|Withdrawal by Subject|0|||
46984493|NCT02554721|83230642|FG000|Overall Study|Adverse Event|1|||
46984494|NCT02554721|83230643|FG001|Overall Study|Adverse Event|0|||
46984495|NCT02554721|83230644|FG002|Overall Study|Adverse Event|0|||
46984496|NCT02554721|83230645|FG003|Overall Study|Adverse Event|0|||
46984497|NCT02554721|83230646|FG004|Overall Study|Adverse Event|1|||
46984498|NCT02554721|83230642|FG000|Overall Study|Noncompliance|0|||
46877391|NCT04397757|83098118|FG000|Overall Study|Lost to Follow-up|4|||
46877392|NCT04397757|83098119|FG001|Overall Study|Lost to Follow-up|3|||
46877393|NCT02792062|83098136|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
46984499|NCT02554721|83230643|FG001|Overall Study|Noncompliance|0|||
46984500|NCT02554721|83230644|FG002|Overall Study|Noncompliance|0|||
46984501|NCT02554721|83230645|FG003|Overall Study|Noncompliance|0|||
46984502|NCT02554721|83230646|FG004|Overall Study|Noncompliance|1|||
46984503|NCT02552225|83230657|FG000|Overall Study|Withdrawal by Subject|1|||
46984504|NCT02552225|83230658|FG001|Overall Study|Withdrawal by Subject|0|||
46984505|NCT02552147|83230664|FG000|First Intervention (7 Days)|Protocol Violation|1|||
46984506|NCT02552147|83230665|FG001|First Intervention (7 Days)|Protocol Violation|0|||
46984507|NCT02552147|83230664|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
46984508|NCT02552147|83230665|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
46984509|NCT01662635|83230671|FG000|Overall Study|scarce samples for evaluation|30|||
46984510|NCT02534935|83230680|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
46877394|NCT02792062|83098137|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
46984511|NCT02534935|83230681|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
46984512|NCT02534935|83230682|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
46984513|NCT02534935|83230680|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
46984514|NCT02534935|83230681|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
46984515|NCT02534935|83230682|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
46984516|NCT02534935|83230680|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
46984517|NCT02534935|83230681|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
46984518|NCT02534935|83230682|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
46984519|NCT02534935|83230680|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
46984520|NCT02534935|83230681|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
46984521|NCT02534935|83230682|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
46984522|NCT02534935|83230680|FG000|Stage 1: 24 Months|Adverse Event|0|||
46984523|NCT02534935|83230681|FG001|Stage 1: 24 Months|Adverse Event|2|||
46984524|NCT02534935|83230682|FG002|Stage 1: 24 Months|Adverse Event|0|||
46984525|NCT02534935|83230680|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
46984526|NCT02534935|83230681|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
46984527|NCT02534935|83230682|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
46984528|NCT02534935|83230680|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
46984529|NCT02534935|83230681|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
46984530|NCT02534935|83230682|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
46984531|NCT02544451|83230711|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
46984532|NCT02544451|83230712|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
46984533|NCT02544451|83230713|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
46984534|NCT02544451|83230714|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
46984535|NCT02544451|83230711|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
46984536|NCT02544451|83230712|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
46984537|NCT02544451|83230713|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
46984538|NCT02544451|83230714|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
46984539|NCT02544451|83230711|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
46984540|NCT02544451|83230712|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
46984541|NCT02544451|83230713|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
46984542|NCT02544451|83230714|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
46984543|NCT02544451|83230711|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
46984544|NCT02544451|83230712|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
46984545|NCT02544451|83230713|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
46984546|NCT02544451|83230714|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
46984547|NCT02544451|83230711|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
46984548|NCT02544451|83230712|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
46984549|NCT02544451|83230713|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
46984550|NCT02544451|83230714|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
46984551|NCT02544451|83230711|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
46877395|NCT02792062|83098138|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
46877396|NCT02792062|83098139|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
46877397|NCT02792062|83098140|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
46877398|NCT02792062|83098141|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
46877399|NCT00196937|83098152|FG000|Overall Study|Serious Adverse Event|1|||
46877400|NCT00196937|83098153|FG001|Overall Study|Serious Adverse Event|0|||
46877401|NCT00196937|83098154|FG002|Overall Study|Serious Adverse Event|0|||
46877402|NCT00196937|83098152|FG000|Overall Study|Non-serious adverse event|1|||
46877403|NCT00196937|83098153|FG001|Overall Study|Non-serious adverse event|1|||
46877404|NCT00196937|83098154|FG002|Overall Study|Non-serious adverse event|1|||
46877405|NCT00196937|83098152|FG000|Overall Study|Withdrawal by Subject|0|||
46877406|NCT00196937|83098153|FG001|Overall Study|Withdrawal by Subject|0|||
46877407|NCT00196937|83098154|FG002|Overall Study|Withdrawal by Subject|2|||
46877408|NCT00196937|83098152|FG000|Overall Study|Lost to Follow-up|4|||
46877409|NCT00196937|83098153|FG001|Overall Study|Lost to Follow-up|3|||
46877410|NCT00196937|83098154|FG002|Overall Study|Lost to Follow-up|3|||
46877411|NCT00196937|83098152|FG000|Overall Study|Other|3|||
46877412|NCT00196937|83098153|FG001|Overall Study|Other|1|||
46877413|NCT00196937|83098154|FG002|Overall Study|Other|1|||
46984552|NCT02544451|83230712|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
46984553|NCT02544451|83230713|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
46984554|NCT02544451|83230714|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
46984555|NCT02544373|83230734|FG000|Overall Study|Lost to Follow-up|5|||
46984556|NCT02544373|83230735|FG001|Overall Study|Lost to Follow-up|3|||
46984557|NCT02544373|83230734|FG000|Overall Study|Withdrawal by Subject|8|||
46984558|NCT02544373|83230735|FG001|Overall Study|Withdrawal by Subject|2|||
46984559|NCT02551991|83230747|FG000|Overall Study|Death|5|||
46984560|NCT02551991|83230748|FG001|Overall Study|Death|7|||
46984561|NCT02551991|83230749|FG002|Overall Study|Death|8|||
46984562|NCT02551991|83230750|FG003|Overall Study|Death|7|||
46984563|NCT02551991|83230751|FG004|Overall Study|Death|17|||
46984564|NCT02551991|83230747|FG000|Overall Study|Withdrawal by Subject|1|||
46984565|NCT02551991|83230748|FG001|Overall Study|Withdrawal by Subject|0|||
46984566|NCT02551991|83230749|FG002|Overall Study|Withdrawal by Subject|0|||
46984567|NCT02551991|83230750|FG003|Overall Study|Withdrawal by Subject|0|||
46984568|NCT02551991|83230751|FG004|Overall Study|Withdrawal by Subject|2|||
46984569|NCT02551991|83230747|FG000|Overall Study|Lost to Follow-up|0|||
46984570|NCT02551991|83230748|FG001|Overall Study|Lost to Follow-up|0|||
46984571|NCT02551991|83230749|FG002|Overall Study|Lost to Follow-up|1|||
46984572|NCT02551991|83230750|FG003|Overall Study|Lost to Follow-up|0|||
46984573|NCT02551991|83230751|FG004|Overall Study|Lost to Follow-up|0|||
46984574|NCT02551991|83230747|FG000|Overall Study|Sponsor Decision|1|||
46984575|NCT02551991|83230748|FG001|Overall Study|Sponsor Decision|0|||
46984576|NCT02551991|83230749|FG002|Overall Study|Sponsor Decision|1|||
46984577|NCT02551991|83230750|FG003|Overall Study|Sponsor Decision|0|||
46984578|NCT02551991|83230751|FG004|Overall Study|Sponsor Decision|5|||
46984579|NCT02551991|83230747|FG000|Overall Study|Other|0|||
46984580|NCT02551991|83230748|FG001|Overall Study|Other|0|||
46984581|NCT02551991|83230749|FG002|Overall Study|Other|0|||
46984582|NCT02551991|83230750|FG003|Overall Study|Other|0|||
46877414|NCT04397445|83098163|FG000|Overall Study|Withdrawal by Subject|1|||
46877415|NCT04397445|83098164|FG001|Overall Study|Withdrawal by Subject|0|||
46877416|NCT04397445|83098165|FG002|Overall Study|Withdrawal by Subject|0|||
46877417|NCT04397445|83098166|FG003|Overall Study|Withdrawal by Subject|0|||
46877418|NCT00191945|83098183|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
46877419|NCT00191945|83098184|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
46984583|NCT02551991|83230751|FG004|Overall Study|Other|1|||
46984584|NCT01661933|83230764|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
46702113|NCT00977938|82916961|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
46702114|NCT00977938|82916962|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
46702115|NCT02716675|82916977|FG000|Overall Study|Death|2|||
46877420|NCT00191945|83098183|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
46877421|NCT00191945|83098184|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
46877422|NCT00191945|83098183|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
46877423|NCT00191945|83098184|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
46877424|NCT00191945|83098183|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
46877425|NCT00191945|83098184|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
46877426|NCT01369342|83098194|FG000|Overall Study|Withdrawal by Subject|7|||
46877427|NCT01369342|83098195|FG001|Overall Study|Withdrawal by Subject|7|||
46877428|NCT01369342|83098196|FG002|Overall Study|Withdrawal by Subject|2|||
46877429|NCT01369342|83098194|FG000|Overall Study|Lost to Follow-up|5|||
46877430|NCT01369342|83098195|FG001|Overall Study|Lost to Follow-up|2|||
46877431|NCT01369342|83098196|FG002|Overall Study|Lost to Follow-up|1|||
46877432|NCT01369342|83098194|FG000|Overall Study|Not Treated|1|||
46877433|NCT01369342|83098195|FG001|Overall Study|Not Treated|0|||
46877434|NCT01369342|83098196|FG002|Overall Study|Not Treated|0|||
46877435|NCT00191477|83098206|FG000|Overall Study|Tumor Recurrence|49|||
46877436|NCT00191477|83098207|FG001|Overall Study|Tumor Recurrence|48|||
46877437|NCT00191477|83098206|FG000|Overall Study|Death, Study Disease|1|||
46877438|NCT00191477|83098207|FG001|Overall Study|Death, Study Disease|1|||
46877439|NCT00191477|83098206|FG000|Overall Study|Death, Other Cause|3|||
46877440|NCT00191477|83098207|FG001|Overall Study|Death, Other Cause|6|||
46877441|NCT00191477|83098206|FG000|Overall Study|Lost to Follow-up|23|||
46877442|NCT00191477|83098207|FG001|Overall Study|Lost to Follow-up|21|||
46877443|NCT00191477|83098206|FG000|Overall Study|Protocol Violation|1|||
46877444|NCT00191477|83098207|FG001|Overall Study|Protocol Violation|1|||
46877445|NCT00191477|83098206|FG000|Overall Study|Treatment Change|2|||
46877446|NCT00191477|83098207|FG001|Overall Study|Treatment Change|0|||
46877447|NCT00191477|83098206|FG000|Overall Study|Withdrawal by Subject|2|||
46877448|NCT00191477|83098207|FG001|Overall Study|Withdrawal by Subject|0|||
46877449|NCT00191477|83098206|FG000|Overall Study|Other|2|||
46877450|NCT00191477|83098207|FG001|Overall Study|Other|0|||
46984585|NCT01661933|83230764|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
46984586|NCT02544217|83230776|FG000|Overall Study|Withdrawal by Subject|1|||
46984587|NCT02544217|83230777|FG001|Overall Study|Withdrawal by Subject|1|||
46877451|NCT00191477|83098206|FG000|Overall Study|Not Eligible|41|||
46877452|NCT00191477|83098207|FG001|Overall Study|Not Eligible|38|||
46984588|NCT02544217|83230778|FG002|Overall Study|Withdrawal by Subject|0|||
46984589|NCT02544217|83230779|FG003|Overall Study|Withdrawal by Subject|0|||
46984590|NCT02544217|83230780|FG004|Overall Study|Withdrawal by Subject|0|||
46984591|NCT02544217|83230781|FG005|Overall Study|Withdrawal by Subject|0|||
46984592|NCT02533999|83230850|FG000|Overall Study|Lost to Follow-up|3|||
46984593|NCT02533999|83230851|FG001|Overall Study|Lost to Follow-up|5|||
46702116|NCT02716675|82916978|FG001|Overall Study|Death|3|||
46984594|NCT02533999|83230850|FG000|Overall Study|Protocol Violation|3|||
46984595|NCT02533999|83230851|FG001|Overall Study|Protocol Violation|0|||
46984596|NCT02533999|83230850|FG000|Overall Study|Adverse Event|0|||
46984597|NCT02533999|83230851|FG001|Overall Study|Adverse Event|1|||
46984598|NCT02533999|83230850|FG000|Overall Study|Randomized but intervention not received|0|||
46984599|NCT02533999|83230851|FG001|Overall Study|Randomized but intervention not received|1|||
46984600|NCT02533531|83230857|FG000|Overall Study|Device did not turn on|1|||
46984601|NCT02533453|83230861|FG000|Overall Study|Adverse Event|6|||
46984602|NCT02533453|83230861|FG000|Overall Study|Protocol Violation|1|||
46984603|NCT02533453|83230861|FG000|Overall Study|Withdrawal by Subject|2|||
46984604|NCT02533375|83230865|FG000|Overall Study|Lack of Efficacy|3|||
46984605|NCT02533375|83230865|FG000|Overall Study|Adverse Event|2|||
46984606|NCT02551055|83230876|FG000|Overall Study|Death|2|||
46984607|NCT02551055|83230877|FG001|Overall Study|Death|4|||
46984608|NCT02551055|83230878|FG002|Overall Study|Death|2|||
46984609|NCT02551055|83230879|FG003|Overall Study|Death|2|||
46984610|NCT02551055|83230880|FG004|Overall Study|Death|2|||
46984611|NCT02551055|83230881|FG005|Overall Study|Death|1|||
46984612|NCT02551055|83230882|FG006|Overall Study|Death|2|||
46984613|NCT02551055|83230883|FG007|Overall Study|Death|0|||
46984614|NCT02551055|83230876|FG000|Overall Study|Study Terminated by Sponsor|1|||
46984615|NCT02551055|83230877|FG001|Overall Study|Study Terminated by Sponsor|1|||
46984616|NCT02551055|83230878|FG002|Overall Study|Study Terminated by Sponsor|0|||
46984617|NCT02551055|83230879|FG003|Overall Study|Study Terminated by Sponsor|2|||
46984618|NCT02551055|83230880|FG004|Overall Study|Study Terminated by Sponsor|2|||
46984619|NCT02551055|83230881|FG005|Overall Study|Study Terminated by Sponsor|0|||
46984620|NCT02551055|83230882|FG006|Overall Study|Study Terminated by Sponsor|0|||
46984621|NCT02551055|83230883|FG007|Overall Study|Study Terminated by Sponsor|0|||
46984622|NCT02551055|83230876|FG000|Overall Study|Withdrawal by Subject|1|||
46984623|NCT02551055|83230877|FG001|Overall Study|Withdrawal by Subject|1|||
46984624|NCT02551055|83230878|FG002|Overall Study|Withdrawal by Subject|0|||
46984625|NCT02551055|83230879|FG003|Overall Study|Withdrawal by Subject|1|||
46984626|NCT02551055|83230880|FG004|Overall Study|Withdrawal by Subject|2|||
46984627|NCT02551055|83230881|FG005|Overall Study|Withdrawal by Subject|0|||
46984628|NCT02551055|83230882|FG006|Overall Study|Withdrawal by Subject|0|||
46984629|NCT02551055|83230883|FG007|Overall Study|Withdrawal by Subject|0|||
46984630|NCT02551055|83230876|FG000|Overall Study|Reason not specified|0|||
46984631|NCT02551055|83230877|FG001|Overall Study|Reason not specified|0|||
46984632|NCT02551055|83230878|FG002|Overall Study|Reason not specified|0|||
46984633|NCT02551055|83230879|FG003|Overall Study|Reason not specified|0|||
46984634|NCT02551055|83230880|FG004|Overall Study|Reason not specified|1|||
46984635|NCT02551055|83230881|FG005|Overall Study|Reason not specified|0|||
46984636|NCT02551055|83230882|FG006|Overall Study|Reason not specified|1|||
46984637|NCT02551055|83230883|FG007|Overall Study|Reason not specified|0|||
46984638|NCT02542943|83230904|FG000|Overall Study|Lost to Follow-up|1|||
46984639|NCT02542943|83230905|FG001|Overall Study|Lost to Follow-up|0|||
46984640|NCT02542943|83230906|FG002|Overall Study|Lost to Follow-up|0|||
46984641|NCT02542943|83230904|FG000|Overall Study|Withdrawal by Subject|0|||
46984642|NCT02542943|83230905|FG001|Overall Study|Withdrawal by Subject|1|||
46984643|NCT02542943|83230906|FG002|Overall Study|Withdrawal by Subject|0|||
46984644|NCT02542865|83230917|FG000|Overall Study|Identified as screen failure|1|||
46877453|NCT00191477|83098206|FG000|Overall Study|Pathological Specimen Lost|1|||
46877454|NCT00191477|83098207|FG001|Overall Study|Pathological Specimen Lost|0|||
46877455|NCT00191477|83098206|FG000|Overall Study|Discontinued Prior to Instillation|13|||
46877456|NCT00191477|83098207|FG001|Overall Study|Discontinued Prior to Instillation|14|||
46877457|NCT04320615|83098215|FG000|Overall Study|Withdrawal by Subject|4|||
46877458|NCT04320615|83098216|FG001|Overall Study|Withdrawal by Subject|10|||
46877459|NCT04320615|83098215|FG000|Overall Study|Physician Decision|2|||
46877460|NCT04320615|83098216|FG001|Overall Study|Physician Decision|0|||
46877461|NCT04320615|83098215|FG000|Overall Study|Other|2|||
46877462|NCT04320615|83098216|FG001|Overall Study|Other|0|||
46877463|NCT04320615|83098215|FG000|Overall Study|Lost to Follow-up|5|||
46877464|NCT04320615|83098216|FG001|Overall Study|Lost to Follow-up|23|||
46877465|NCT04320615|83098215|FG000|Overall Study|Death|35|||
46877466|NCT04320615|83098216|FG001|Overall Study|Death|71|||
46877467|NCT00149747|83098228|FG000|Overall Study|Death|1|||
46984645|NCT02542865|83230918|FG001|Overall Study|Identified as screen failure|0|||
46877468|NCT00149747|83098229|FG001|Overall Study|Death|0|||
46984646|NCT02542865|83230917|FG000|Overall Study|Withdrawal by Subject|16|||
46984647|NCT02542865|83230918|FG001|Overall Study|Withdrawal by Subject|0|||
46984648|NCT03644927|83230924|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
46984649|NCT03644927|83230925|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
46984650|NCT02542631|83230932|FG000|Overall Study|Adverse Event|1|||
46877469|NCT00149747|83098228|FG000|Overall Study|Withdrawal by Subject|3|||
46877470|NCT00149747|83098229|FG001|Overall Study|Withdrawal by Subject|3|||
46877471|NCT00187889|83098237|FG000|Overall Study|Withdrawal by Subject|6|||
46877472|NCT00187889|83098238|FG001|Overall Study|Withdrawal by Subject|4|||
46984651|NCT02542631|83230933|FG001|Overall Study|Adverse Event|1|||
46984652|NCT02542631|83230932|FG000|Overall Study|Sponsor Termination|1|||
46984653|NCT02542631|83230933|FG001|Overall Study|Sponsor Termination|0|||
46984654|NCT02542631|83230932|FG000|Overall Study|Withdrawal by Subject|11|||
46984655|NCT02542631|83230933|FG001|Overall Study|Withdrawal by Subject|16|||
46984656|NCT02542631|83230932|FG000|Overall Study|Protocol Violation|1|||
46984657|NCT02542631|83230933|FG001|Overall Study|Protocol Violation|1|||
46984658|NCT02542631|83230932|FG000|Overall Study|Physician Decision|6|||
46984659|NCT02542631|83230933|FG001|Overall Study|Physician Decision|4|||
46984660|NCT02542631|83230932|FG000|Overall Study|Lost to Follow-up|6|||
46984661|NCT02542631|83230933|FG001|Overall Study|Lost to Follow-up|5|||
46984662|NCT02542631|83230932|FG000|Overall Study|Death|1|||
46984663|NCT02542631|83230933|FG001|Overall Study|Death|2|||
46984664|NCT02542631|83230932|FG000|Overall Study|Other|2|||
46984665|NCT02542631|83230933|FG001|Overall Study|Other|1|||
46984666|NCT02542631|83230932|FG000|Overall Study|Used Prohibited Medication|2|||
46984667|NCT02542631|83230933|FG001|Overall Study|Used Prohibited Medication|1|||
46984668|NCT02542397|83230939|FG000|Overall Study|Death|2|||
46984669|NCT02542397|83230939|FG000|Overall Study|Physician Decision|6|||
46984670|NCT02542397|83230939|FG000|Overall Study|Withdrawal by Subject|6|||
46984671|NCT02542397|83230939|FG000|Overall Study|Lost to Follow-up|2|||
46984672|NCT02549339|83230946|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
46984673|NCT02549339|83230947|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
46984674|NCT02549339|83230946|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
46984675|NCT02549339|83230947|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
46984676|NCT02549339|83230946|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
46984677|NCT02549339|83230947|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
46984678|NCT02549339|83230946|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
46984679|NCT02549339|83230947|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
46984680|NCT02549339|83230946|FG000|12-month Follow-up|Lack of Efficacy|0|||
46984681|NCT02549339|83230947|FG001|12-month Follow-up|Lack of Efficacy|2|||
46984682|NCT02549339|83230946|FG000|12-month Follow-up|Withdrawal by Subject|8|||
46984683|NCT02549339|83230947|FG001|12-month Follow-up|Withdrawal by Subject|3|||
46984684|NCT02549339|83230946|FG000|12-month Follow-up|Lost to Follow-up|1|||
46984685|NCT02549339|83230947|FG001|12-month Follow-up|Lost to Follow-up|3|||
46984686|NCT02549339|83230946|FG000|12-month Follow-up|Other|0|||
46984687|NCT02549339|83230947|FG001|12-month Follow-up|Other|3|||
46984688|NCT02549027|83230955|FG000|Washout After Period 4|Withdrawal by Subject|0|||
46984689|NCT02549027|83230956|FG001|Washout After Period 4|Withdrawal by Subject|1|||
46984690|NCT02549027|83230957|FG002|Washout After Period 4|Withdrawal by Subject|1|||
46984691|NCT02549027|83230958|FG003|Washout After Period 4|Withdrawal by Subject|1|||
46984692|NCT02549027|83230959|FG004|Washout After Period 4|Withdrawal by Subject|0|||
46984693|NCT02549027|83230960|FG005|Washout After Period 4|Withdrawal by Subject|0|||
46984694|NCT02549027|83230955|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
46984695|NCT02549027|83230956|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
46984696|NCT02549027|83230957|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
46984697|NCT02549027|83230958|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
46984698|NCT02549027|83230959|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
46984699|NCT02549027|83230960|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
46984700|NCT02529553|83230988|FG000|Overall Study|Progressive Disease|1|||
46984701|NCT02529553|83230989|FG001|Overall Study|Progressive Disease|0|||
46984702|NCT02529553|83230990|FG002|Overall Study|Progressive Disease|1|||
46984703|NCT02529553|83230991|FG003|Overall Study|Progressive Disease|3|||
46984704|NCT02529553|83230992|FG004|Overall Study|Progressive Disease|2|||
46984705|NCT02529553|83230993|FG005|Overall Study|Progressive Disease|3|||
46984706|NCT02529553|83230994|FG006|Overall Study|Progressive Disease|3|||
46984707|NCT02529553|83230995|FG007|Overall Study|Progressive Disease|5|||
46984708|NCT02529553|83230996|FG008|Overall Study|Progressive Disease|3|||
46984709|NCT02529553|83230988|FG000|Overall Study|Physician Decision|0|||
46984710|NCT02529553|83230989|FG001|Overall Study|Physician Decision|1|||
46984711|NCT02529553|83230990|FG002|Overall Study|Physician Decision|0|||
46984712|NCT02529553|83230991|FG003|Overall Study|Physician Decision|0|||
46984713|NCT02529553|83230992|FG004|Overall Study|Physician Decision|1|||
46984714|NCT02529553|83230993|FG005|Overall Study|Physician Decision|0|||
46984715|NCT02529553|83230994|FG006|Overall Study|Physician Decision|0|||
46984716|NCT02529553|83230995|FG007|Overall Study|Physician Decision|0|||
46984717|NCT02529553|83230996|FG008|Overall Study|Physician Decision|0|||
46984718|NCT02529553|83230988|FG000|Overall Study|Withdrawal by Subject|0|||
46984719|NCT02529553|83230989|FG001|Overall Study|Withdrawal by Subject|0|||
46984720|NCT02529553|83230990|FG002|Overall Study|Withdrawal by Subject|0|||
46984721|NCT02529553|83230991|FG003|Overall Study|Withdrawal by Subject|0|||
46984722|NCT02529553|83230992|FG004|Overall Study|Withdrawal by Subject|0|||
46984723|NCT02529553|83230993|FG005|Overall Study|Withdrawal by Subject|1|||
46984724|NCT02529553|83230994|FG006|Overall Study|Withdrawal by Subject|0|||
46984725|NCT02529553|83230995|FG007|Overall Study|Withdrawal by Subject|1|||
46984726|NCT02529553|83230996|FG008|Overall Study|Withdrawal by Subject|0|||
46877473|NCT00148343|83098247|FG000|Overall Study|Withdrawal by Subject|12|||
46877474|NCT00148343|83098248|FG001|Overall Study|Withdrawal by Subject|7|||
46877475|NCT00148343|83098247|FG000|Overall Study|Physician Decision|3|||
46877476|NCT00148343|83098248|FG001|Overall Study|Physician Decision|4|||
46877477|NCT04150341|83098254|FG000|Overall Study|Physician Decision|0|||
46877478|NCT04150341|83098255|FG001|Overall Study|Physician Decision|0|||
46877479|NCT04150341|83098256|FG002|Overall Study|Physician Decision|1|||
46877480|NCT04150341|83098257|FG003|Overall Study|Physician Decision|0|||
46877481|NCT04150341|83098258|FG004|Overall Study|Physician Decision|0|||
46877482|NCT04150341|83098259|FG005|Overall Study|Physician Decision|0|||
46877483|NCT04150341|83098254|FG000|Overall Study|Adverse Event|0|||
46877484|NCT04150341|83098255|FG001|Overall Study|Adverse Event|0|||
46877485|NCT04150341|83098256|FG002|Overall Study|Adverse Event|0|||
46877486|NCT04150341|83098257|FG003|Overall Study|Adverse Event|0|||
46877487|NCT04150341|83098258|FG004|Overall Study|Adverse Event|1|||
46877488|NCT04150341|83098259|FG005|Overall Study|Adverse Event|0|||
46877489|NCT00148109|83098271|FG000|Overall Study|Lack of Efficacy|10|||
46877490|NCT00148109|83098272|FG001|Overall Study|Lack of Efficacy|18|||
46877491|NCT00148109|83098271|FG000|Overall Study|Adverse Event|0|||
46877492|NCT00148109|83098272|FG001|Overall Study|Adverse Event|2|||
46877493|NCT00148109|83098271|FG000|Overall Study|Withdrawal by Subject|2|||
46877494|NCT00148109|83098272|FG001|Overall Study|Withdrawal by Subject|0|||
46877495|NCT00186485|83098278|FG000|Overall Study|Lost to Follow-up|3|||
46877496|NCT00147251|83098284|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
46877497|NCT00147251|83098285|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
46877498|NCT04390191|83098295|FG000|Overall Study|Withdrawal by Subject|1|||
46877499|NCT04390191|83098296|FG001|Overall Study|Withdrawal by Subject|0|||
46877500|NCT04405076|83098308|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
46877501|NCT04405076|83098309|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
46877502|NCT04405076|83098310|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
46877503|NCT04405076|83098311|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
46877504|NCT04405076|83098312|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
46877505|NCT04405076|83098313|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
46877506|NCT04405076|83098314|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
46877507|NCT04405076|83098315|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
46877508|NCT04405076|83098316|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
46877509|NCT04405076|83098308|FG000|Part A (Blinded Phase)|Physician Decision|1|||
46877510|NCT04405076|83098309|FG001|Part A (Blinded Phase)|Physician Decision|2|||
46877511|NCT04405076|83098310|FG002|Part A (Blinded Phase)|Physician Decision|0|||
46877512|NCT04405076|83098311|FG003|Part A (Blinded Phase)|Physician Decision|0|||
46877513|NCT04405076|83098312|FG004|Part A (Blinded Phase)|Physician Decision|0|||
46877514|NCT04405076|83098313|FG005|Part A (Blinded Phase)|Physician Decision|0|||
46877515|NCT04405076|83098314|FG006|Part A (Blinded Phase)|Physician Decision|0|||
46877516|NCT04405076|83098315|FG007|Part A (Blinded Phase)|Physician Decision|0|||
46877517|NCT04405076|83098316|FG008|Part A (Blinded Phase)|Physician Decision|0|||
46877518|NCT04405076|83098308|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
46877519|NCT04405076|83098309|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
46984727|NCT02547935|83231020|FG000|Overall Study|Other|0|||
46702117|NCT02716675|82916979|FG002|Overall Study|Death|0|||
46702118|NCT02716675|82916977|FG000|Overall Study|Physician Decision|2|||
46702119|NCT02716675|82916978|FG001|Overall Study|Physician Decision|1|||
46702120|NCT02716675|82916979|FG002|Overall Study|Physician Decision|1|||
46702121|NCT02716675|82916977|FG000|Overall Study|Lost to Follow-up|100|||
46702122|NCT02716675|82916978|FG001|Overall Study|Lost to Follow-up|87|||
46702123|NCT02716675|82916979|FG002|Overall Study|Lost to Follow-up|99|||
46702124|NCT02716675|82916977|FG000|Overall Study|Withdrawal by Subject|22|||
46702125|NCT02716675|82916978|FG001|Overall Study|Withdrawal by Subject|25|||
46702126|NCT02716675|82916979|FG002|Overall Study|Withdrawal by Subject|20|||
46702127|NCT02716675|82916977|FG000|Overall Study|Protocol Violation|0|||
46702128|NCT02716675|82916978|FG001|Overall Study|Protocol Violation|3|||
46702129|NCT02716675|82916979|FG002|Overall Study|Protocol Violation|1|||
46702130|NCT02716675|82916977|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
46702131|NCT02716675|82916978|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
46702132|NCT02716675|82916979|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
46702133|NCT02716675|82916977|FG000|Overall Study|Other|38|||
46702134|NCT02716675|82916978|FG001|Overall Study|Other|47|||
46702135|NCT02716675|82916979|FG002|Overall Study|Other|48|||
46702136|NCT00977548|82916992|FG000|Overall Study|Ineligible|4|||
46702137|NCT00977548|82916992|FG000|Overall Study|Adverse Event|8|||
46702138|NCT00977548|82916992|FG000|Overall Study|Withdrawal by Subject|1|||
46702139|NCT01090011|82916996|FG000|Overall Study|Progressive disease|128|||
46702140|NCT01090011|82916996|FG000|Overall Study|Adverse Event|32|||
46702141|NCT01090011|82916996|FG000|Overall Study|Protocol Violation|1|||
46702142|NCT01090011|82916996|FG000|Overall Study|Refusal to start/continue medication|5|||
46702143|NCT01090011|82916996|FG000|Overall Study|Other reason not defined above|5|||
46702144|NCT01251653|82917017|FG000|Overall Study|Progressive Disease|1|||
46702145|NCT01251653|82917018|FG001|Overall Study|Progressive Disease|7|||
46702146|NCT01251653|82917019|FG002|Overall Study|Progressive Disease|16|||
46702147|NCT01251653|82917020|FG003|Overall Study|Progressive Disease|4|||
46702148|NCT01251653|82917021|FG004|Overall Study|Progressive Disease|0|||
46702149|NCT01251653|82917022|FG005|Overall Study|Progressive Disease|17|||
46702150|NCT01251653|82917023|FG006|Overall Study|Progressive Disease|14|||
46702151|NCT01251653|82917024|FG007|Overall Study|Progressive Disease|7|||
46702152|NCT01251653|82917025|FG008|Overall Study|Progressive Disease|5|||
46702153|NCT01251653|82917017|FG000|Overall Study|Dose-limiting toxicity|0|||
46702154|NCT01251653|82917018|FG001|Overall Study|Dose-limiting toxicity|1|||
46702155|NCT01251653|82917019|FG002|Overall Study|Dose-limiting toxicity|1|||
46702156|NCT01251653|82917020|FG003|Overall Study|Dose-limiting toxicity|1|||
46702157|NCT01251653|82917021|FG004|Overall Study|Dose-limiting toxicity|0|||
46702158|NCT01251653|82917022|FG005|Overall Study|Dose-limiting toxicity|0|||
46702159|NCT01251653|82917023|FG006|Overall Study|Dose-limiting toxicity|2|||
46702160|NCT01251653|82917024|FG007|Overall Study|Dose-limiting toxicity|0|||
46702161|NCT01251653|82917025|FG008|Overall Study|Dose-limiting toxicity|0|||
46702162|NCT01251653|82917017|FG000|Overall Study|Adverse Event|1|||
46702163|NCT01251653|82917018|FG001|Overall Study|Adverse Event|0|||
46702164|NCT01251653|82917019|FG002|Overall Study|Adverse Event|2|||
46702165|NCT01251653|82917020|FG003|Overall Study|Adverse Event|1|||
46702166|NCT01251653|82917021|FG004|Overall Study|Adverse Event|1|||
46702167|NCT01251653|82917022|FG005|Overall Study|Adverse Event|0|||
46702168|NCT01251653|82917023|FG006|Overall Study|Adverse Event|2|||
46702169|NCT01251653|82917024|FG007|Overall Study|Adverse Event|2|||
46702170|NCT01251653|82917025|FG008|Overall Study|Adverse Event|1|||
46702171|NCT01251653|82917017|FG000|Overall Study|Withdrawal by Subject|1|||
46702172|NCT01251653|82917018|FG001|Overall Study|Withdrawal by Subject|0|||
46702173|NCT01251653|82917019|FG002|Overall Study|Withdrawal by Subject|1|||
46877520|NCT04405076|83098310|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
46702174|NCT01251653|82917020|FG003|Overall Study|Withdrawal by Subject|0|||
46702175|NCT01251653|82917021|FG004|Overall Study|Withdrawal by Subject|1|||
46702176|NCT01251653|82917022|FG005|Overall Study|Withdrawal by Subject|1|||
46702177|NCT01251653|82917023|FG006|Overall Study|Withdrawal by Subject|0|||
46702178|NCT01251653|82917024|FG007|Overall Study|Withdrawal by Subject|1|||
46702179|NCT01251653|82917025|FG008|Overall Study|Withdrawal by Subject|0|||
46702180|NCT01251653|82917017|FG000|Overall Study|Other reason not mentioned above|0|||
46702181|NCT01251653|82917018|FG001|Overall Study|Other reason not mentioned above|0|||
46877521|NCT04405076|83098311|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
46702182|NCT01251653|82917019|FG002|Overall Study|Other reason not mentioned above|0|||
46702183|NCT01251653|82917020|FG003|Overall Study|Other reason not mentioned above|0|||
46702184|NCT01251653|82917021|FG004|Overall Study|Other reason not mentioned above|0|||
46702185|NCT01251653|82917022|FG005|Overall Study|Other reason not mentioned above|0|||
46702186|NCT01251653|82917023|FG006|Overall Study|Other reason not mentioned above|0|||
46702187|NCT01251653|82917024|FG007|Overall Study|Other reason not mentioned above|2|||
46702188|NCT01251653|82917025|FG008|Overall Study|Other reason not mentioned above|0|||
46984728|NCT02547935|83231021|FG001|Overall Study|Other|1|||
46702189|NCT00910663|82917063|FG000|Period 1|Withdrawal by Subject|0|||
46702190|NCT00910663|82917064|FG001|Period 1|Withdrawal by Subject|1|||
46702191|NCT01077375|82917072|FG000|Overall Study|Adverse Event|2|||
46702192|NCT01077375|82917073|FG001|Overall Study|Adverse Event|15|||
46702193|NCT01077375|82917072|FG000|Overall Study|Lack of Efficacy|6|||
46702194|NCT01077375|82917073|FG001|Overall Study|Lack of Efficacy|8|||
46702195|NCT01077375|82917072|FG000|Overall Study|Withdrawal by Subject|0|||
46702196|NCT01077375|82917073|FG001|Overall Study|Withdrawal by Subject|6|||
46702197|NCT01077375|82917072|FG000|Overall Study|Lost to Follow-up|2|||
46702198|NCT01077375|82917073|FG001|Overall Study|Lost to Follow-up|5|||
46702199|NCT01077375|82917072|FG000|Overall Study|Other Reason|0|||
46702200|NCT01077375|82917073|FG001|Overall Study|Other Reason|1|||
46702201|NCT01250873|82917081|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
46702202|NCT01250873|82917081|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
46702203|NCT01250171|82917090|FG000|Overall Study|Administrative reasons|1|||
46702204|NCT01250171|82917091|FG001|Overall Study|Administrative reasons|0|||
46702205|NCT01250171|82917092|FG002|Overall Study|Administrative reasons|0|||
46702206|NCT01077063|82917102|FG000|Overall Study|Adverse Event|3|||
46984729|NCT02547935|83231022|FG002|Overall Study|Other|0|||
46984730|NCT02547935|83231020|FG000|Overall Study|Withdrawal by Subject|2|||
46984731|NCT02547935|83231021|FG001|Overall Study|Withdrawal by Subject|3|||
46984732|NCT02547935|83231022|FG002|Overall Study|Withdrawal by Subject|4|||
46984733|NCT02547935|83231020|FG000|Overall Study|Screen Failure|2|||
46984734|NCT02547935|83231021|FG001|Overall Study|Screen Failure|0|||
46984735|NCT02547935|83231022|FG002|Overall Study|Screen Failure|0|||
46984736|NCT02547935|83231020|FG000|Overall Study|Physician Decision|0|||
46984737|NCT02547935|83231021|FG001|Overall Study|Physician Decision|1|||
46984738|NCT02547935|83231022|FG002|Overall Study|Physician Decision|0|||
46984739|NCT02547935|83231020|FG000|Overall Study|Lost to Follow-up|0|||
46984740|NCT02547935|83231021|FG001|Overall Study|Lost to Follow-up|2|||
46984741|NCT02547935|83231022|FG002|Overall Study|Lost to Follow-up|1|||
46984742|NCT02547935|83231020|FG000|Overall Study|Death|1|||
46984743|NCT02547935|83231021|FG001|Overall Study|Death|1|||
46984744|NCT02547935|83231022|FG002|Overall Study|Death|0|||
46877522|NCT04405076|83098312|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
46984745|NCT02554019|83231035|FG000|Overall Study|Withdrawal by Subject|1|||
46984746|NCT02554019|83231036|FG001|Overall Study|Withdrawal by Subject|0|||
46984747|NCT02554019|83231037|FG002|Overall Study|Withdrawal by Subject|2|||
46984748|NCT02554019|83231035|FG000|Overall Study|Adverse Event|1|||
46984749|NCT02554019|83231036|FG001|Overall Study|Adverse Event|0|||
46984750|NCT02554019|83231037|FG002|Overall Study|Adverse Event|0|||
46702207|NCT01077063|82917103|FG001|Overall Study|Adverse Event|0|||
46984751|NCT02327169|83231060|FG000|Overall Study|Progressive Disease|1|||
46984752|NCT02327169|83231061|FG001|Overall Study|Progressive Disease|3|||
46984753|NCT02327169|83231062|FG002|Overall Study|Progressive Disease|4|||
46984754|NCT02327169|83231063|FG003|Overall Study|Progressive Disease|3|||
46984755|NCT02327169|83231064|FG004|Overall Study|Progressive Disease|4|||
46984756|NCT02327169|83231065|FG005|Overall Study|Progressive Disease|3|||
46984757|NCT02327169|83231066|FG006|Overall Study|Progressive Disease|3|||
46984758|NCT02327169|83231067|FG007|Overall Study|Progressive Disease|3|||
46984759|NCT02327169|83231068|FG008|Overall Study|Progressive Disease|4|||
46984760|NCT02327169|83231069|FG009|Overall Study|Progressive Disease|4|||
46984761|NCT02327169|83231070|FG010|Overall Study|Progressive Disease|4|||
46984762|NCT02327169|83231071|FG011|Overall Study|Progressive Disease|3|||
46984763|NCT02327169|83231072|FG012|Overall Study|Progressive Disease|1|||
46984764|NCT02327169|83231073|FG013|Overall Study|Progressive Disease|3|||
46984765|NCT02327169|83231074|FG014|Overall Study|Progressive Disease|3|||
46984766|NCT02327169|83231060|FG000|Overall Study|Adverse Event|2|||
46984767|NCT02327169|83231061|FG001|Overall Study|Adverse Event|0|||
46984768|NCT02327169|83231062|FG002|Overall Study|Adverse Event|1|||
46984769|NCT02327169|83231063|FG003|Overall Study|Adverse Event|0|||
46984770|NCT02327169|83231064|FG004|Overall Study|Adverse Event|1|||
46984771|NCT02327169|83231065|FG005|Overall Study|Adverse Event|0|||
46984772|NCT02327169|83231066|FG006|Overall Study|Adverse Event|0|||
46984773|NCT02327169|83231067|FG007|Overall Study|Adverse Event|0|||
46984774|NCT02327169|83231068|FG008|Overall Study|Adverse Event|0|||
46984775|NCT02327169|83231069|FG009|Overall Study|Adverse Event|2|||
46984776|NCT02327169|83231070|FG010|Overall Study|Adverse Event|0|||
46984777|NCT02327169|83231071|FG011|Overall Study|Adverse Event|3|||
46984778|NCT02327169|83231072|FG012|Overall Study|Adverse Event|0|||
46984779|NCT02327169|83231073|FG013|Overall Study|Adverse Event|2|||
46984780|NCT02327169|83231074|FG014|Overall Study|Adverse Event|1|||
46984781|NCT02327169|83231060|FG000|Overall Study|Symptomatic Deterioration|0|||
46984782|NCT02327169|83231061|FG001|Overall Study|Symptomatic Deterioration|0|||
46984783|NCT02327169|83231062|FG002|Overall Study|Symptomatic Deterioration|1|||
46984784|NCT02327169|83231063|FG003|Overall Study|Symptomatic Deterioration|0|||
46984785|NCT02327169|83231064|FG004|Overall Study|Symptomatic Deterioration|1|||
46984786|NCT02327169|83231065|FG005|Overall Study|Symptomatic Deterioration|1|||
46984787|NCT02327169|83231066|FG006|Overall Study|Symptomatic Deterioration|0|||
46984788|NCT02327169|83231067|FG007|Overall Study|Symptomatic Deterioration|0|||
46984789|NCT02327169|83231068|FG008|Overall Study|Symptomatic Deterioration|2|||
46984790|NCT02327169|83231069|FG009|Overall Study|Symptomatic Deterioration|1|||
46984791|NCT02327169|83231070|FG010|Overall Study|Symptomatic Deterioration|0|||
46984792|NCT02327169|83231071|FG011|Overall Study|Symptomatic Deterioration|0|||
46984793|NCT02327169|83231072|FG012|Overall Study|Symptomatic Deterioration|0|||
46984794|NCT02327169|83231073|FG013|Overall Study|Symptomatic Deterioration|2|||
46984795|NCT02327169|83231074|FG014|Overall Study|Symptomatic Deterioration|1|||
46984796|NCT02327169|83231060|FG000|Overall Study|Reason Not Specified|0|||
46984797|NCT02327169|83231061|FG001|Overall Study|Reason Not Specified|0|||
46984798|NCT02327169|83231062|FG002|Overall Study|Reason Not Specified|1|||
46984799|NCT02327169|83231063|FG003|Overall Study|Reason Not Specified|0|||
46984800|NCT02327169|83231064|FG004|Overall Study|Reason Not Specified|0|||
46984801|NCT02327169|83231065|FG005|Overall Study|Reason Not Specified|0|||
46984802|NCT02327169|83231066|FG006|Overall Study|Reason Not Specified|0|||
46984803|NCT02327169|83231067|FG007|Overall Study|Reason Not Specified|0|||
46984804|NCT02327169|83231068|FG008|Overall Study|Reason Not Specified|0|||
46702208|NCT01077063|82917102|FG000|Overall Study|Death|1|||
46702209|NCT01077063|82917103|FG001|Overall Study|Death|1|||
46702210|NCT01077063|82917102|FG000|Overall Study|Withdrawal by Subject|0|||
46702211|NCT01077063|82917103|FG001|Overall Study|Withdrawal by Subject|2|||
46702212|NCT01248065|82917111|FG000|Overall Study|Lost to Follow-up|3|||
46877523|NCT04405076|83098313|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
46877524|NCT04405076|83098314|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
46877525|NCT04405076|83098315|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
46877526|NCT04405076|83098316|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
46877527|NCT04405076|83098308|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
46984805|NCT02327169|83231069|FG009|Overall Study|Reason Not Specified|1|||
46984806|NCT02327169|83231070|FG010|Overall Study|Reason Not Specified|2|||
46984807|NCT02327169|83231071|FG011|Overall Study|Reason Not Specified|1|||
46984808|NCT02327169|83231072|FG012|Overall Study|Reason Not Specified|0|||
46984809|NCT02327169|83231073|FG013|Overall Study|Reason Not Specified|0|||
46984810|NCT02327169|83231074|FG014|Overall Study|Reason Not Specified|2|||
46984811|NCT02327169|83231060|FG000|Overall Study|Withdrawal by Subject|1|||
46984812|NCT02327169|83231061|FG001|Overall Study|Withdrawal by Subject|0|||
46984813|NCT02327169|83231062|FG002|Overall Study|Withdrawal by Subject|0|||
46984814|NCT02327169|83231063|FG003|Overall Study|Withdrawal by Subject|0|||
46984815|NCT02327169|83231064|FG004|Overall Study|Withdrawal by Subject|1|||
46984816|NCT02327169|83231065|FG005|Overall Study|Withdrawal by Subject|0|||
46984817|NCT02327169|83231066|FG006|Overall Study|Withdrawal by Subject|0|||
46984818|NCT02327169|83231067|FG007|Overall Study|Withdrawal by Subject|1|||
46984819|NCT02327169|83231068|FG008|Overall Study|Withdrawal by Subject|0|||
46984820|NCT02327169|83231069|FG009|Overall Study|Withdrawal by Subject|0|||
46984821|NCT02327169|83231070|FG010|Overall Study|Withdrawal by Subject|0|||
46984822|NCT02327169|83231071|FG011|Overall Study|Withdrawal by Subject|0|||
46984823|NCT02327169|83231072|FG012|Overall Study|Withdrawal by Subject|0|||
46984824|NCT02327169|83231073|FG013|Overall Study|Withdrawal by Subject|0|||
46984825|NCT02327169|83231074|FG014|Overall Study|Withdrawal by Subject|3|||
46984826|NCT02327169|83231060|FG000|Overall Study|Lost to Follow-up|0|||
46984827|NCT02327169|83231061|FG001|Overall Study|Lost to Follow-up|0|||
46984828|NCT02327169|83231062|FG002|Overall Study|Lost to Follow-up|0|||
46984829|NCT02327169|83231063|FG003|Overall Study|Lost to Follow-up|0|||
46984830|NCT02327169|83231064|FG004|Overall Study|Lost to Follow-up|1|||
46984831|NCT02327169|83231065|FG005|Overall Study|Lost to Follow-up|0|||
46984832|NCT02327169|83231066|FG006|Overall Study|Lost to Follow-up|0|||
46984833|NCT02327169|83231067|FG007|Overall Study|Lost to Follow-up|0|||
46984834|NCT02327169|83231068|FG008|Overall Study|Lost to Follow-up|0|||
46984835|NCT02327169|83231069|FG009|Overall Study|Lost to Follow-up|0|||
46984836|NCT02327169|83231070|FG010|Overall Study|Lost to Follow-up|0|||
46984837|NCT02327169|83231071|FG011|Overall Study|Lost to Follow-up|0|||
46984838|NCT02327169|83231072|FG012|Overall Study|Lost to Follow-up|0|||
46984839|NCT02327169|83231073|FG013|Overall Study|Lost to Follow-up|0|||
46984840|NCT02327169|83231074|FG014|Overall Study|Lost to Follow-up|0|||
46984841|NCT02327013|83231119|FG000|Overall Study|Adverse Event|4|||
46984842|NCT02327013|83231120|FG001|Overall Study|Adverse Event|4|||
46984843|NCT02327013|83231121|FG002|Overall Study|Adverse Event|3|||
46984844|NCT02327013|83231122|FG003|Overall Study|Adverse Event|0|||
46984845|NCT02327013|83231123|FG004|Overall Study|Adverse Event|1|||
46984846|NCT02327013|83231119|FG000|Overall Study|Lack of Efficacy|2|||
46984847|NCT02327013|83231120|FG001|Overall Study|Lack of Efficacy|0|||
46984848|NCT02327013|83231121|FG002|Overall Study|Lack of Efficacy|5|||
46984849|NCT02327013|83231122|FG003|Overall Study|Lack of Efficacy|0|||
46984850|NCT02327013|83231123|FG004|Overall Study|Lack of Efficacy|1|||
46984851|NCT02327013|83231119|FG000|Overall Study|Non-compliance with IMP|1|||
46984852|NCT02327013|83231120|FG001|Overall Study|Non-compliance with IMP|2|||
46984853|NCT02327013|83231121|FG002|Overall Study|Non-compliance with IMP|7|||
46984854|NCT02327013|83231122|FG003|Overall Study|Non-compliance with IMP|0|||
46984855|NCT02327013|83231123|FG004|Overall Study|Non-compliance with IMP|0|||
46984856|NCT02327013|83231119|FG000|Overall Study|Withdrawal of Consent|1|||
46984857|NCT02327013|83231120|FG001|Overall Study|Withdrawal of Consent|0|||
46984858|NCT02327013|83231121|FG002|Overall Study|Withdrawal of Consent|3|||
46984859|NCT02327013|83231122|FG003|Overall Study|Withdrawal of Consent|0|||
46984860|NCT02327013|83231123|FG004|Overall Study|Withdrawal of Consent|0|||
46984861|NCT02327013|83231119|FG000|Overall Study|Lost to Follow-up|2|||
46984862|NCT02327013|83231120|FG001|Overall Study|Lost to Follow-up|4|||
46984863|NCT02327013|83231121|FG002|Overall Study|Lost to Follow-up|5|||
46984864|NCT02327013|83231122|FG003|Overall Study|Lost to Follow-up|0|||
46984865|NCT02327013|83231123|FG004|Overall Study|Lost to Follow-up|0|||
46984866|NCT02327013|83231119|FG000|Overall Study|Administrative or other reason(s)|1|||
46984867|NCT02327013|83231120|FG001|Overall Study|Administrative or other reason(s)|5|||
46984868|NCT02327013|83231121|FG002|Overall Study|Administrative or other reason(s)|11|||
46984869|NCT02327013|83231122|FG003|Overall Study|Administrative or other reason(s)|1|||
46984870|NCT02327013|83231123|FG004|Overall Study|Administrative or other reason(s)|1|||
46984871|NCT02327013|83231119|FG000|Overall Study|Protocol Violation|0|||
46984872|NCT02327013|83231120|FG001|Overall Study|Protocol Violation|0|||
46984873|NCT02327013|83231121|FG002|Overall Study|Protocol Violation|3|||
46984874|NCT02327013|83231122|FG003|Overall Study|Protocol Violation|0|||
46984875|NCT02327013|83231123|FG004|Overall Study|Protocol Violation|1|||
46984876|NCT02327013|83231119|FG000|Overall Study|Withdrawal before treatment|2|||
46984877|NCT02327013|83231120|FG001|Overall Study|Withdrawal before treatment|1|||
46984878|NCT02327013|83231121|FG002|Overall Study|Withdrawal before treatment|5|||
46984879|NCT02327013|83231122|FG003|Overall Study|Withdrawal before treatment|0|||
46984880|NCT02327013|83231123|FG004|Overall Study|Withdrawal before treatment|0|||
46984881|NCT02301975|83231146|FG000|Overall Study|Adverse Event|8|||
46984882|NCT02301975|83231147|FG001|Overall Study|Adverse Event|3|||
46984883|NCT02301975|83231148|FG002|Overall Study|Adverse Event|2|||
46984884|NCT02301975|83231146|FG000|Overall Study|Lack of Efficacy|1|||
46984885|NCT02301975|83231147|FG001|Overall Study|Lack of Efficacy|1|||
46984886|NCT02301975|83231148|FG002|Overall Study|Lack of Efficacy|1|||
46984887|NCT02301975|83231146|FG000|Overall Study|Protocol Violation|3|||
46984888|NCT02301975|83231147|FG001|Overall Study|Protocol Violation|5|||
46984889|NCT02301975|83231148|FG002|Overall Study|Protocol Violation|3|||
46984890|NCT02301975|83231146|FG000|Overall Study|Lost to Follow-up|0|||
46984891|NCT02301975|83231147|FG001|Overall Study|Lost to Follow-up|2|||
46984892|NCT02301975|83231148|FG002|Overall Study|Lost to Follow-up|2|||
46984893|NCT02301975|83231146|FG000|Overall Study|Physician Decision|4|||
46984894|NCT02301975|83231147|FG001|Overall Study|Physician Decision|2|||
46984895|NCT02301975|83231148|FG002|Overall Study|Physician Decision|3|||
46984896|NCT02301975|83231146|FG000|Overall Study|Withdrawal by Subject|15|||
46984897|NCT02301975|83231147|FG001|Overall Study|Withdrawal by Subject|12|||
46984898|NCT02301975|83231148|FG002|Overall Study|Withdrawal by Subject|11|||
46984899|NCT02301897|83231159|FG000|Treatment Course 1|Non-Compliance|0|||
46984900|NCT02301897|83231160|FG001|Treatment Course 1|Non-Compliance|0|||
46984901|NCT02301897|83231161|FG002|Treatment Course 1|Non-Compliance|1|||
46984902|NCT02301897|83231159|FG000|Treatment Course 1|Adverse Event|1|||
46984903|NCT02301897|83231160|FG001|Treatment Course 1|Adverse Event|1|||
46984904|NCT02301897|83231161|FG002|Treatment Course 1|Adverse Event|0|||
46984905|NCT02301897|83231159|FG000|Treatment Course 1|Lost to Follow-up|1|||
46984906|NCT02301897|83231160|FG001|Treatment Course 1|Lost to Follow-up|2|||
46984907|NCT02301897|83231161|FG002|Treatment Course 1|Lost to Follow-up|1|||
46984908|NCT02301897|83231159|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
46984909|NCT02301897|83231160|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
46984910|NCT02301897|83231161|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
46984911|NCT02301897|83231159|FG000|Treatment Course 1|Withdrawal by Subject|0|||
46984912|NCT02301897|83231160|FG001|Treatment Course 1|Withdrawal by Subject|0|||
46984913|NCT02301897|83231161|FG002|Treatment Course 1|Withdrawal by Subject|2|||
46877528|NCT04405076|83098309|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877529|NCT04405076|83098310|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877530|NCT04405076|83098311|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877531|NCT04405076|83098312|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877532|NCT04405076|83098313|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877533|NCT04405076|83098314|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877534|NCT04405076|83098315|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877535|NCT04405076|83098316|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
46877536|NCT04405076|83098308|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
46877537|NCT04405076|83098309|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
46877538|NCT04405076|83098310|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
46877539|NCT04405076|83098311|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
46877540|NCT04405076|83098312|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
46877541|NCT04405076|83098313|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
46877542|NCT04405076|83098314|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
46877543|NCT04405076|83098315|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
46877544|NCT04405076|83098316|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
46877545|NCT04405076|83098308|FG000|Part A (Blinded Phase)|Other than Specified|0|||
46877546|NCT04405076|83098309|FG001|Part A (Blinded Phase)|Other than Specified|0|||
46877547|NCT04405076|83098310|FG002|Part A (Blinded Phase)|Other than Specified|3|||
46877548|NCT04405076|83098311|FG003|Part A (Blinded Phase)|Other than Specified|0|||
46877549|NCT04405076|83098312|FG004|Part A (Blinded Phase)|Other than Specified|0|||
46877550|NCT04405076|83098313|FG005|Part A (Blinded Phase)|Other than Specified|0|||
46877551|NCT04405076|83098314|FG006|Part A (Blinded Phase)|Other than Specified|0|||
46877552|NCT04405076|83098315|FG007|Part A (Blinded Phase)|Other than Specified|0|||
46877553|NCT04405076|83098316|FG008|Part A (Blinded Phase)|Other than Specified|0|||
46877554|NCT04405076|83098308|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
46877555|NCT04405076|83098309|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
46877556|NCT04405076|83098310|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
46877557|NCT04405076|83098311|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
46877558|NCT04405076|83098312|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
46877559|NCT04405076|83098313|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
46877560|NCT04405076|83098314|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
46984914|NCT02301897|83231159|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
46984915|NCT02301897|83231160|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
46984916|NCT02301897|83231161|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
46984917|NCT02301897|83231159|FG000|Treatment Course 2|Lost to Follow-up|0|||
46984918|NCT02301897|83231160|FG001|Treatment Course 2|Lost to Follow-up|2|||
46702213|NCT01248065|82917112|FG001|Overall Study|Lost to Follow-up|5|||
46877561|NCT04405076|83098315|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
46984919|NCT02301897|83231161|FG002|Treatment Course 2|Lost to Follow-up|0|||
46984920|NCT02301897|83231159|FG000|Treatment Course 2|Pregnancy|0|||
46984921|NCT02301897|83231160|FG001|Treatment Course 2|Pregnancy|1|||
46984922|NCT02301897|83231161|FG002|Treatment Course 2|Pregnancy|1|||
46984923|NCT02301897|83231159|FG000|Treatment Course 2|Withdrawal by Subject|0|||
46984924|NCT02301897|83231160|FG001|Treatment Course 2|Withdrawal by Subject|2|||
46984925|NCT02301897|83231161|FG002|Treatment Course 2|Withdrawal by Subject|0|||
46984926|NCT02301897|83231159|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
46984927|NCT02301897|83231160|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
46984928|NCT02301897|83231161|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
46877562|NCT04405076|83098316|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
46877563|NCT04405076|83098308|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877564|NCT04405076|83098309|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877565|NCT04405076|83098310|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877566|NCT04405076|83098311|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877567|NCT04405076|83098312|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
46877568|NCT04405076|83098313|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877569|NCT04405076|83098314|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877570|NCT04405076|83098315|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877571|NCT04405076|83098316|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
46877572|NCT04405076|83098308|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
46877573|NCT04405076|83098309|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
46877574|NCT04405076|83098310|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
46877575|NCT04405076|83098311|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
46877576|NCT04405076|83098312|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
46877577|NCT04405076|83098313|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
46877578|NCT04405076|83098314|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
46877579|NCT04405076|83098315|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
46877580|NCT04405076|83098316|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
46877581|NCT04405076|83098308|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
46877582|NCT04405076|83098309|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
46877583|NCT04405076|83098310|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
46877584|NCT04405076|83098311|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
46877585|NCT04405076|83098312|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
46877586|NCT04405076|83098313|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
46877587|NCT04405076|83098314|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
46877588|NCT04405076|83098315|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
46877589|NCT04405076|83098316|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
46877590|NCT04405076|83098308|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877591|NCT04405076|83098309|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877592|NCT04405076|83098310|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877593|NCT04405076|83098311|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877594|NCT04405076|83098312|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877595|NCT04405076|83098313|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877596|NCT04405076|83098314|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
46877597|NCT04405076|83098315|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877598|NCT04405076|83098316|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
46877599|NCT04311177|83098344|FG000|Overall Study|Adverse Event|3|||
46877600|NCT04311177|83098345|FG001|Overall Study|Adverse Event|1|||
46877601|NCT04311177|83098344|FG000|Overall Study|Physician Decision|4|||
46877602|NCT04311177|83098345|FG001|Overall Study|Physician Decision|3|||
46877603|NCT04311177|83098344|FG000|Overall Study|Withdrawal by Subject|1|||
46877604|NCT04311177|83098345|FG001|Overall Study|Withdrawal by Subject|0|||
46877605|NCT03267212|83098351|FG000|First Intervention|Lost to Follow-up|0|||
46877606|NCT03267212|83098352|FG001|First Intervention|Lost to Follow-up|2|||
46877607|NCT03267212|83098351|FG000|First Intervention|Withdrawal by Subject|1|||
46984929|NCT02301429|83231169|FG000|Overall Study|not acceptable vascular anatomy|3|||
46984930|NCT02300259|83231176|FG000|Period 1|Adverse Event|0|||
46702214|NCT01248065|82917111|FG000|Overall Study|Withdrawal by Subject|14|||
46984931|NCT02300259|83231177|FG001|Period 1|Adverse Event|0|||
46984932|NCT02300259|83231178|FG002|Period 1|Adverse Event|1|||
46984933|NCT02300259|83231176|FG000|Period 1|Withdrawal by Subject|0|||
46984934|NCT02300259|83231177|FG001|Period 1|Withdrawal by Subject|0|||
46984935|NCT02300259|83231178|FG002|Period 1|Withdrawal by Subject|1|||
46984936|NCT02300259|83231176|FG000|Period 2|Adverse Event|1|||
46984937|NCT02300259|83231177|FG001|Period 2|Adverse Event|0|||
46984938|NCT02300259|83231178|FG002|Period 2|Adverse Event|0|||
46984939|NCT02300259|83231176|FG000|Period 2|Withdrawal by Subject|0|||
46984940|NCT02300259|83231177|FG001|Period 2|Withdrawal by Subject|0|||
46984941|NCT02300259|83231178|FG002|Period 2|Withdrawal by Subject|1|||
46984942|NCT02367885|83231200|FG000|Overall Study|Lost to Follow-up|1|||
46984943|NCT02367885|83231201|FG001|Overall Study|Lost to Follow-up|0|||
46984944|NCT02367885|83231202|FG002|Overall Study|Lost to Follow-up|0|||
46984945|NCT02367885|83231200|FG000|Overall Study|Withdrawal by Subject|1|||
46984946|NCT02367885|83231201|FG001|Overall Study|Withdrawal by Subject|0|||
46984947|NCT02367885|83231202|FG002|Overall Study|Withdrawal by Subject|0|||
46984948|NCT02367729|83231215|FG000|Overall Study|Organic disorder diagnosed|2|||
46984949|NCT02367729|83231216|FG001|Overall Study|Organic disorder diagnosed|1|||
46984950|NCT02367729|83231215|FG000|Overall Study|Adverse Event|1|||
46984951|NCT02367729|83231216|FG001|Overall Study|Adverse Event|2|||
46984952|NCT02367729|83231215|FG000|Overall Study|Withdrawal by Subject|0|||
46984953|NCT02367729|83231216|FG001|Overall Study|Withdrawal by Subject|5|||
46984954|NCT02366637|83231223|FG000|First Intervention Period|Adverse Event|0|||
46984955|NCT02366637|83231224|FG001|First Intervention Period|Adverse Event|1|||
46984956|NCT02366637|83231223|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
46984957|NCT02366637|83231224|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
46984958|NCT02366637|83231223|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
46984959|NCT02366637|83231224|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
46984960|NCT02300103|83231230|FG000|Overall Study|Lack of Efficacy|3|||
46984961|NCT02300103|83231230|FG000|Overall Study|Protocol Violation|1|||
46984962|NCT02300103|83231230|FG000|Overall Study|Withdrew Consent|2|||
46984963|NCT02326467|83231234|FG000|Overall Study|Withdrawal by Subject|1|||
46984964|NCT02299635|83231239|FG000|Overall Study|Adverse Event|2|||
46984965|NCT02299635|83231239|FG000|Overall Study|Death|1|||
46984966|NCT02299635|83231239|FG000|Overall Study|Global deterioration of health status|1|||
46984967|NCT02299635|83231239|FG000|Overall Study|Objective progression or relapse|10|||
46877608|NCT03267212|83098352|FG001|First Intervention|Withdrawal by Subject|1|||
46877609|NCT03267212|83098351|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
46877610|NCT03267212|83098352|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
46877611|NCT04292535|83098372|FG000|Overall Study|Withdrawal by Subject|0|||
46877612|NCT04292535|83098373|FG001|Overall Study|Withdrawal by Subject|0|||
46877613|NCT04292535|83098374|FG002|Overall Study|Withdrawal by Subject|0|||
46877614|NCT04292535|83098375|FG003|Overall Study|Withdrawal by Subject|0|||
46877615|NCT04292535|83098376|FG004|Overall Study|Withdrawal by Subject|0|||
46877616|NCT04292535|83098377|FG005|Overall Study|Withdrawal by Subject|0|||
46877617|NCT04292535|83098378|FG006|Overall Study|Withdrawal by Subject|0|||
46877618|NCT04292535|83098379|FG007|Overall Study|Withdrawal by Subject|1|||
46877619|NCT04292535|83098380|FG008|Overall Study|Withdrawal by Subject|0|||
46877620|NCT04292535|83098381|FG009|Overall Study|Withdrawal by Subject|0|||
46877621|NCT04292535|83098382|FG010|Overall Study|Withdrawal by Subject|0|||
46877622|NCT04292535|83098383|FG011|Overall Study|Withdrawal by Subject|0|||
46877623|NCT04292535|83098384|FG012|Overall Study|Withdrawal by Subject|0|||
46877624|NCT04292535|83098385|FG013|Overall Study|Withdrawal by Subject|0|||
46877625|NCT04292535|83098372|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877626|NCT04292535|83098373|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877627|NCT04292535|83098374|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877628|NCT04292535|83098375|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877629|NCT04292535|83098376|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877630|NCT04292535|83098377|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877631|NCT04292535|83098378|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877632|NCT04292535|83098379|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
46877633|NCT04292535|83098380|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877634|NCT04292535|83098381|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877635|NCT04292535|83098382|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877636|NCT04292535|83098383|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
46877637|NCT04292535|83098384|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
46984968|NCT02299635|83231239|FG000|Overall Study|Withdrawal by Subject|2|||
46984969|NCT02299635|83231239|FG000|Overall Study|Other|3|||
46984970|NCT02366091|83231247|FG000|Overall Study|Withdrawal by Subject|3|||
46984971|NCT02366091|83231248|FG001|Overall Study|Withdrawal by Subject|7|||
46984972|NCT02366091|83231249|FG002|Overall Study|Withdrawal by Subject|3|||
46877638|NCT04292535|83098385|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
46984973|NCT02366091|83231250|FG003|Overall Study|Withdrawal by Subject|1|||
46984974|NCT02326155|83231262|FG000|Overall Study|Adverse Event|21|||
46984975|NCT02326155|83231263|FG001|Overall Study|Adverse Event|5|||
46984976|NCT02326155|83231262|FG000|Overall Study|Death|3|||
46984977|NCT02326155|83231263|FG001|Overall Study|Death|0|||
46984978|NCT02326155|83231262|FG000|Overall Study|Lack of Efficacy|49|||
46877639|NCT04292535|83098372|FG000|Overall Study|Report of Dizziness|0|||
46877640|NCT04292535|83098373|FG001|Overall Study|Report of Dizziness|0|||
46877641|NCT04292535|83098374|FG002|Overall Study|Report of Dizziness|0|||
46877642|NCT04292535|83098375|FG003|Overall Study|Report of Dizziness|0|||
46877643|NCT04292535|83098376|FG004|Overall Study|Report of Dizziness|0|||
46877644|NCT04292535|83098377|FG005|Overall Study|Report of Dizziness|0|||
46877645|NCT04292535|83098378|FG006|Overall Study|Report of Dizziness|0|||
46877646|NCT04292535|83098379|FG007|Overall Study|Report of Dizziness|0|||
46877647|NCT04292535|83098380|FG008|Overall Study|Report of Dizziness|0|||
46877648|NCT04292535|83098381|FG009|Overall Study|Report of Dizziness|0|||
46877649|NCT04292535|83098382|FG010|Overall Study|Report of Dizziness|0|||
46877650|NCT04292535|83098383|FG011|Overall Study|Report of Dizziness|0|||
46877651|NCT04292535|83098384|FG012|Overall Study|Report of Dizziness|0|||
46877652|NCT04292535|83098385|FG013|Overall Study|Report of Dizziness|1|||
46877653|NCT04292535|83098372|FG000|Overall Study|Equipment Failure|0|||
46877654|NCT04292535|83098373|FG001|Overall Study|Equipment Failure|0|||
46877655|NCT04292535|83098374|FG002|Overall Study|Equipment Failure|0|||
46877656|NCT04292535|83098375|FG003|Overall Study|Equipment Failure|0|||
46877657|NCT04292535|83098376|FG004|Overall Study|Equipment Failure|0|||
46877658|NCT04292535|83098377|FG005|Overall Study|Equipment Failure|0|||
46877659|NCT04292535|83098378|FG006|Overall Study|Equipment Failure|0|||
46877660|NCT04292535|83098379|FG007|Overall Study|Equipment Failure|0|||
46877661|NCT04292535|83098380|FG008|Overall Study|Equipment Failure|0|||
46877662|NCT04292535|83098381|FG009|Overall Study|Equipment Failure|0|||
46877663|NCT04292535|83098382|FG010|Overall Study|Equipment Failure|0|||
46877664|NCT04292535|83098383|FG011|Overall Study|Equipment Failure|1|||
46877665|NCT04292535|83098384|FG012|Overall Study|Equipment Failure|0|||
46877666|NCT04292535|83098385|FG013|Overall Study|Equipment Failure|0|||
46877667|NCT04385199|83098417|FG000|Overall Study|Withdrawal by Subject|1|||
46877668|NCT04385199|83098418|FG001|Overall Study|Withdrawal by Subject|0|||
46877669|NCT04284813|83098424|FG000|Overall Study|Withdrawal by Subject|1|||
46877670|NCT03263780|83098428|FG000|Overall Study|Withdrawal by Subject|3|||
46877671|NCT03263780|83098428|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
46877672|NCT02791438|83098434|FG000|Treatment Period|Adverse Event|1|||
46877673|NCT02791438|83098435|FG001|Treatment Period|Adverse Event|0|||
46877674|NCT02791438|83098434|FG000|Treatment Period|Withdrawal by Subject|0|||
46877675|NCT02791438|83098435|FG001|Treatment Period|Withdrawal by Subject|1|||
46877676|NCT02791438|83098434|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
46877677|NCT02791438|83098435|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
46877678|NCT03712124|83098443|FG000|Overall Study|Protocol Violation|1|||
46877679|NCT03712124|83098444|FG001|Overall Study|Protocol Violation|0|||
46877680|NCT02791516|83098458|FG000|Overall Study|Withdrawal by Subject|1|||
46877681|NCT02791516|83098459|FG001|Overall Study|Withdrawal by Subject|1|||
46877682|NCT03263702|83098467|FG000|Overall Study|Lost to Follow-up|2|||
46877683|NCT03263702|83098468|FG001|Overall Study|Lost to Follow-up|2|||
46877684|NCT03263702|83098467|FG000|Overall Study|Withdrawal by Subject|1|||
46877685|NCT03263702|83098468|FG001|Overall Study|Withdrawal by Subject|2|||
46877686|NCT04130919|83098477|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
46877687|NCT04130919|83098478|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
46877688|NCT04130919|83098479|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
46877689|NCT04130919|83098480|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
46877690|NCT04130919|83098481|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
46877691|NCT04130919|83098482|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
46877692|NCT04130919|83098477|FG000|Blinded Treatment Phase|Adverse Event|0|||
46877693|NCT04130919|83098478|FG001|Blinded Treatment Phase|Adverse Event|0|||
46877694|NCT04130919|83098479|FG002|Blinded Treatment Phase|Adverse Event|1|||
46877695|NCT04130919|83098480|FG003|Blinded Treatment Phase|Adverse Event|0|||
46877696|NCT04130919|83098481|FG004|Blinded Treatment Phase|Adverse Event|0|||
46877697|NCT04130919|83098482|FG005|Blinded Treatment Phase|Adverse Event|0|||
46877698|NCT04130919|83098477|FG000|Blinded Treatment Phase|Disease worsening|0|||
46877699|NCT04130919|83098478|FG001|Blinded Treatment Phase|Disease worsening|0|||
46877700|NCT04130919|83098479|FG002|Blinded Treatment Phase|Disease worsening|1|||
46877701|NCT04130919|83098480|FG003|Blinded Treatment Phase|Disease worsening|0|||
46877702|NCT04130919|83098481|FG004|Blinded Treatment Phase|Disease worsening|0|||
46877703|NCT04130919|83098482|FG005|Blinded Treatment Phase|Disease worsening|0|||
46877704|NCT04130919|83098477|FG000|Blinded Treatment Phase|Investigator's decision|0|||
46877705|NCT04130919|83098478|FG001|Blinded Treatment Phase|Investigator's decision|1|||
46877706|NCT04130919|83098479|FG002|Blinded Treatment Phase|Investigator's decision|0|||
46877707|NCT04130919|83098480|FG003|Blinded Treatment Phase|Investigator's decision|0|||
46877708|NCT04130919|83098481|FG004|Blinded Treatment Phase|Investigator's decision|0|||
46877709|NCT04130919|83098482|FG005|Blinded Treatment Phase|Investigator's decision|0|||
46984979|NCT02326155|83231263|FG001|Overall Study|Lack of Efficacy|5|||
46984980|NCT02326155|83231262|FG000|Overall Study|Lost to Follow-up|14|||
46984981|NCT02326155|83231263|FG001|Overall Study|Lost to Follow-up|3|||
46984982|NCT02326155|83231262|FG000|Overall Study|Protocol Violation|2|||
46984983|NCT02326155|83231263|FG001|Overall Study|Protocol Violation|0|||
46984984|NCT02326155|83231262|FG000|Overall Study|Withdrawal by Subject|34|||
46984985|NCT02326155|83231263|FG001|Overall Study|Withdrawal by Subject|11|||
46984986|NCT02326155|83231262|FG000|Overall Study|Disease progression|37|||
46877710|NCT04130919|83098477|FG000|Blinded Treatment Phase|Withdrew consent|1|||
46877711|NCT04130919|83098478|FG001|Blinded Treatment Phase|Withdrew consent|0|||
46877712|NCT04130919|83098479|FG002|Blinded Treatment Phase|Withdrew consent|0|||
46877713|NCT04130919|83098480|FG003|Blinded Treatment Phase|Withdrew consent|0|||
46877714|NCT04130919|83098481|FG004|Blinded Treatment Phase|Withdrew consent|0|||
46877715|NCT04130919|83098482|FG005|Blinded Treatment Phase|Withdrew consent|0|||
46877716|NCT04130919|83098477|FG000|Open-label Treatment Phase|Withdrew consent|0|||
46877717|NCT04130919|83098478|FG001|Open-label Treatment Phase|Withdrew consent|0|||
46877718|NCT04130919|83098479|FG002|Open-label Treatment Phase|Withdrew consent|0|||
46877719|NCT04130919|83098480|FG003|Open-label Treatment Phase|Withdrew consent|1|||
46877720|NCT04130919|83098481|FG004|Open-label Treatment Phase|Withdrew consent|1|||
46877721|NCT04130919|83098482|FG005|Open-label Treatment Phase|Withdrew consent|1|||
46877722|NCT04130919|83098477|FG000|Open-label Treatment Phase|Disease worsening|0|||
46877723|NCT04130919|83098478|FG001|Open-label Treatment Phase|Disease worsening|0|||
46877724|NCT04130919|83098479|FG002|Open-label Treatment Phase|Disease worsening|0|||
46877725|NCT04130919|83098480|FG003|Open-label Treatment Phase|Disease worsening|1|||
46877726|NCT04130919|83098481|FG004|Open-label Treatment Phase|Disease worsening|0|||
46877727|NCT04130919|83098482|FG005|Open-label Treatment Phase|Disease worsening|1|||
46877728|NCT04130919|83098477|FG000|Open-label Treatment Phase|Investigator's decision|0|||
46877729|NCT04130919|83098478|FG001|Open-label Treatment Phase|Investigator's decision|0|||
46877730|NCT04130919|83098479|FG002|Open-label Treatment Phase|Investigator's decision|0|||
46877731|NCT04130919|83098480|FG003|Open-label Treatment Phase|Investigator's decision|1|||
46877732|NCT04130919|83098481|FG004|Open-label Treatment Phase|Investigator's decision|0|||
46877733|NCT04130919|83098482|FG005|Open-label Treatment Phase|Investigator's decision|0|||
46877734|NCT04130919|83098477|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
46877735|NCT04130919|83098478|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
46877736|NCT04130919|83098479|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
46877737|NCT04130919|83098480|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
46877738|NCT04130919|83098481|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
46877739|NCT04130919|83098482|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
46877740|NCT04130919|83098477|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
46877741|NCT04130919|83098478|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
46877742|NCT04130919|83098479|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
46877743|NCT04130919|83098480|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
46877744|NCT04130919|83098481|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
46877745|NCT04130919|83098482|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
46877746|NCT04128267|83098496|FG000|Overall Study|Withdrawal by Subject|6|||
46877747|NCT04128267|83098496|FG000|Overall Study|Death|2|||
46984987|NCT02326155|83231263|FG001|Overall Study|Disease progression|4|||
46984988|NCT02326155|83231262|FG000|Overall Study|Study close|188|||
46984989|NCT02326155|83231263|FG001|Overall Study|Study close|21|||
46702215|NCT01248065|82917112|FG001|Overall Study|Withdrawal by Subject|11|||
46702216|NCT01248065|82917111|FG000|Overall Study|Adverse Event|3|||
46984990|NCT02326155|83231262|FG000|Overall Study|except for study close|46|||
46984991|NCT02326155|83231263|FG001|Overall Study|except for study close|13|||
46877748|NCT04128267|83098496|FG000|Overall Study|Disease progression|1|||
46984992|NCT02299167|83231269|FG000|Overall Study|patients were excluded from the study|11|||
46984993|NCT01647711|83231278|FG000|Overall Study|Progressive disease|6|||
46984994|NCT01647711|83231279|FG001|Overall Study|Progressive disease|2|||
46984995|NCT01647711|83231280|FG002|Overall Study|Progressive disease|6|||
46984996|NCT01647711|83231281|FG003|Overall Study|Progressive disease|8|||
46984997|NCT01647711|83231282|FG004|Overall Study|Progressive disease|2|||
46984998|NCT01647711|83231278|FG000|Overall Study|Other adverse event|0|||
46984999|NCT01647711|83231279|FG001|Overall Study|Other adverse event|0|||
46985000|NCT01647711|83231280|FG002|Overall Study|Other adverse event|2|||
46985001|NCT01647711|83231281|FG003|Overall Study|Other adverse event|0|||
46985002|NCT01647711|83231282|FG004|Overall Study|Other adverse event|2|||
46985003|NCT01647711|83231278|FG000|Overall Study|Protocol Violation|0|||
46985004|NCT01647711|83231279|FG001|Overall Study|Protocol Violation|0|||
46985005|NCT01647711|83231280|FG002|Overall Study|Protocol Violation|0|||
46985006|NCT01647711|83231281|FG003|Overall Study|Protocol Violation|0|||
46985007|NCT01647711|83231282|FG004|Overall Study|Protocol Violation|1|||
46702217|NCT01248065|82917112|FG001|Overall Study|Adverse Event|0|||
46702218|NCT01248065|82917111|FG000|Overall Study|Third treatment failure event|3|||
46702219|NCT01248065|82917112|FG001|Overall Study|Third treatment failure event|1|||
46702220|NCT01248065|82917111|FG000|Overall Study|Other|3|||
46702221|NCT01248065|82917112|FG001|Overall Study|Other|5|||
46702222|NCT01250756|82917120|FG000|Infant Series|Withdrawal by Subject|4|||
46702223|NCT01250756|82917121|FG001|Infant Series|Withdrawal by Subject|5|||
46702224|NCT01250756|82917120|FG000|Infant Series|Randomized, Not Vaccinated|2|||
46702225|NCT01250756|82917121|FG001|Infant Series|Randomized, Not Vaccinated|2|||
46702226|NCT01250756|82917120|FG000|Infant Series|Other|22|||
46702227|NCT01250756|82917121|FG001|Infant Series|Other|0|||
46702228|NCT01250756|82917120|FG000|After Infant Series|Adverse Event|5|||
46985008|NCT01647711|83231278|FG000|Overall Study|Refused to continue taking medication|0|||
46702229|NCT01250756|82917121|FG001|After Infant Series|Adverse Event|2|||
46702230|NCT01250756|82917120|FG000|After Infant Series|Withdrawal by Subject|4|||
46702231|NCT01250756|82917121|FG001|After Infant Series|Withdrawal by Subject|1|||
46702232|NCT01250756|82917120|FG000|After Infant Series|Other|2|||
46702233|NCT01250756|82917121|FG001|After Infant Series|Other|1|||
46702234|NCT01250756|82917120|FG000|Toddler Dose|Adverse Event|0|||
46702235|NCT01250756|82917121|FG001|Toddler Dose|Adverse Event|1|||
46702236|NCT01250756|82917120|FG000|After Toddler Dose|Adverse Event|0|||
46702237|NCT01250756|82917121|FG001|After Toddler Dose|Adverse Event|1|||
46702238|NCT01250054|82917133|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
46702239|NCT01250054|82917134|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
46702240|NCT00977470|82917142|FG000|Overall Study|Lack of Efficacy|32|||
46877749|NCT04128267|83098496|FG000|Overall Study|Participant had other medical issues|4|||
46877750|NCT04128267|83098496|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
46702241|NCT00977470|82917143|FG001|Overall Study|Lack of Efficacy|30|||
46702242|NCT00977470|82917142|FG000|Overall Study|Physician Decision|2|||
46702243|NCT00977470|82917143|FG001|Overall Study|Physician Decision|0|||
46702244|NCT00977470|82917142|FG000|Overall Study|Adverse Event|1|||
46702245|NCT00977470|82917143|FG001|Overall Study|Adverse Event|2|||
46877751|NCT03691779|83098500|FG000|Part B (24 Weeks)|Adverse Event|0|||
46702246|NCT00977470|82917142|FG000|Overall Study|Protocol Violation|1|||
46702247|NCT00977470|82917143|FG001|Overall Study|Protocol Violation|0|||
46702248|NCT00977470|82917142|FG000|Overall Study|Withdrawal by Subject|0|||
46702249|NCT00977470|82917143|FG001|Overall Study|Withdrawal by Subject|2|||
46702250|NCT00977470|82917142|FG000|Overall Study|Death|0|||
46702251|NCT00977470|82917143|FG001|Overall Study|Death|2|||
46985009|NCT01647711|83231279|FG001|Overall Study|Refused to continue taking medication|0|||
46802822|NCT03855189|83022105|FG001|Overall Study|Treatment Failure|1|||
46702252|NCT00977470|82917142|FG000|Overall Study|clinical decline|0|||
46702253|NCT00977470|82917143|FG001|Overall Study|clinical decline|1|||
46702254|NCT00977470|82917142|FG000|Overall Study|prolonged recovery post-surgery|0|||
46702255|NCT00977470|82917143|FG001|Overall Study|prolonged recovery post-surgery|1|||
46702256|NCT00977470|82917142|FG000|Overall Study|Still on-study|2|||
46702257|NCT00977470|82917143|FG001|Overall Study|Still on-study|0|||
46702258|NCT01245374|82917149|FG000|Overall Study|Protocol Violation|1|||
46702259|NCT01245374|82917149|FG000|Overall Study|Withdrawal by Subject|3|||
46702260|NCT00977314|82917156|FG000|Overall Study|Withdrawal by Subject|1|||
46702261|NCT00977314|82917157|FG001|Overall Study|Withdrawal by Subject|0|||
46702262|NCT00977314|82917156|FG000|Overall Study|Physician Decision|1|||
46702263|NCT00977314|82917157|FG001|Overall Study|Physician Decision|0|||
46702264|NCT01087203|82917165|FG000|Overall Study|Lost to Follow-up|2|||
46702265|NCT01087203|82917166|FG001|Overall Study|Lost to Follow-up|0|||
46702266|NCT01087203|82917165|FG000|Overall Study|Withdrawal by Subject|2|||
46702267|NCT01087203|82917166|FG001|Overall Study|Withdrawal by Subject|6|||
46702268|NCT01087203|82917165|FG000|Overall Study|Lack of Efficacy|1|||
46702269|NCT01087203|82917166|FG001|Overall Study|Lack of Efficacy|2|||
46702270|NCT01087203|82917165|FG000|Overall Study|Study terminated by sponsor|27|||
46702271|NCT01087203|82917166|FG001|Overall Study|Study terminated by sponsor|27|||
46702272|NCT01246583|82917177|FG000|Overall Study|Lost to Follow-up|0|||
46702273|NCT01246583|82917178|FG001|Overall Study|Lost to Follow-up|0|||
46702274|NCT01246583|82917179|FG002|Overall Study|Lost to Follow-up|0|||
46702275|NCT01246583|82917180|FG003|Overall Study|Lost to Follow-up|1|||
46702276|NCT01246583|82917177|FG000|Overall Study|Protocol Violation|0|||
46702277|NCT01246583|82917178|FG001|Overall Study|Protocol Violation|0|||
46702278|NCT01246583|82917179|FG002|Overall Study|Protocol Violation|1|||
46702279|NCT01246583|82917180|FG003|Overall Study|Protocol Violation|0|||
46702280|NCT01246583|82917177|FG000|Overall Study|Withdrawal by Subject|1|||
46877752|NCT03691779|83098501|FG001|Part B (24 Weeks)|Adverse Event|1|||
46702281|NCT01246583|82917178|FG001|Overall Study|Withdrawal by Subject|0|||
46877753|NCT03691779|83098500|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
46702282|NCT01246583|82917179|FG002|Overall Study|Withdrawal by Subject|0|||
46702283|NCT01246583|82917180|FG003|Overall Study|Withdrawal by Subject|0|||
46702284|NCT01084239|82917193|FG000|28-Day Follow-up|Lost to Follow-up|4|||
46702285|NCT01084239|82917194|FG001|28-Day Follow-up|Lost to Follow-up|9|||
46702286|NCT01244906|82917202|FG000|Overall Study|Death|2|||
46702287|NCT01244906|82917202|FG000|Overall Study|Progression of disease post treatment|6|||
46702288|NCT01080807|82917208|FG000|Overall Study|Adverse Event|9|||
46702289|NCT01080807|82917209|FG001|Overall Study|Adverse Event|1|||
46702290|NCT01080807|82917208|FG000|Overall Study|Lack of Efficacy|0|||
46702291|NCT01080807|82917209|FG001|Overall Study|Lack of Efficacy|1|||
46702292|NCT01080807|82917208|FG000|Overall Study|Withdrawal by Subject|7|||
46702293|NCT01080807|82917209|FG001|Overall Study|Withdrawal by Subject|2|||
46702294|NCT01080807|82917208|FG000|Overall Study|Protocol Violation|7|||
46702295|NCT01080807|82917209|FG001|Overall Study|Protocol Violation|6|||
46702296|NCT01080807|82917208|FG000|Overall Study|Lost to Follow-up|6|||
46702297|NCT01080807|82917209|FG001|Overall Study|Lost to Follow-up|4|||
46702298|NCT01080807|82917208|FG000|Overall Study|Noncompliance with drug administration|1|||
46702299|NCT01080807|82917209|FG001|Overall Study|Noncompliance with drug administration|1|||
46702300|NCT01080807|82917208|FG000|Overall Study|Noncompliance to study procedures|1|||
46702301|NCT01080807|82917209|FG001|Overall Study|Noncompliance to study procedures|1|||
46702302|NCT01080807|82917208|FG000|Overall Study|Began working day shift|0|||
46702303|NCT01080807|82917209|FG001|Overall Study|Began working day shift|2|||
46702304|NCT01080807|82917208|FG000|Overall Study|Laid off or terminated from job|1|||
46702305|NCT01080807|82917209|FG001|Overall Study|Laid off or terminated from job|2|||
46702306|NCT01080807|82917208|FG000|Overall Study|Stopped working consistent night shifts|0|||
46702307|NCT01080807|82917209|FG001|Overall Study|Stopped working consistent night shifts|1|||
46702308|NCT01080807|82917208|FG000|Overall Study|Work schedule changing|1|||
46702309|NCT01080807|82917209|FG001|Overall Study|Work schedule changing|1|||
46702310|NCT01080807|82917208|FG000|Overall Study|Work schedule and travel|0|||
46702311|NCT01080807|82917209|FG001|Overall Study|Work schedule and travel|1|||
46702312|NCT01080807|82917208|FG000|Overall Study|Switched to first shift|1|||
46702313|NCT01080807|82917209|FG001|Overall Study|Switched to first shift|0|||
46702314|NCT01080807|82917208|FG000|Overall Study|Moved away without notifying center|1|||
46702315|NCT01080807|82917209|FG001|Overall Study|Moved away without notifying center|0|||
46702316|NCT01076361|82917215|FG000|Overall Study|22 leads were excluded from analysis|21|||
46702317|NCT01079949|82917221|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
46702318|NCT01079949|82917222|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
46702319|NCT01079949|82917221|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
46702320|NCT01079949|82917222|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
46702321|NCT01079949|82917221|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
46702322|NCT01079949|82917222|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
46702323|NCT01079949|82917221|FG000|Overall Study|Randomized but not treated|1|||
46702324|NCT01079949|82917222|FG001|Overall Study|Randomized but not treated|0|||
46702325|NCT00909727|82917230|FG000|Overall Study|Adverse Event|1|||
46702326|NCT00909727|82917231|FG001|Overall Study|Adverse Event|0|||
46702327|NCT00909727|82917230|FG000|Overall Study|Wrong Genotype|1|||
46985010|NCT01647711|83231280|FG002|Overall Study|Refused to continue taking medication|0|||
46702328|NCT00909727|82917231|FG001|Overall Study|Wrong Genotype|0|||
46702329|NCT00909727|82917230|FG000|Overall Study|Withdrawal of Consent|1|||
46702330|NCT00909727|82917231|FG001|Overall Study|Withdrawal of Consent|0|||
46702331|NCT00909727|82917230|FG000|Overall Study|Prohibited Medication|1|||
46702332|NCT00909727|82917231|FG001|Overall Study|Prohibited Medication|0|||
46702333|NCT00977080|82917241|FG000|Overall Study|Adverse Event|2|||
46985011|NCT01647711|83231281|FG003|Overall Study|Refused to continue taking medication|2|||
46702334|NCT00977080|82917242|FG001|Overall Study|Adverse Event|7|||
46702335|NCT00977080|82917243|FG002|Overall Study|Adverse Event|7|||
46702336|NCT00977080|82917244|FG003|Overall Study|Adverse Event|7|||
46802823|NCT03855189|83022106|FG002|Overall Study|Treatment Failure|2|||
46877754|NCT03691779|83098501|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
46877755|NCT04258995|83098510|FG000|Overall Study|Lost to Follow-up|1|||
46877756|NCT04258995|83098511|FG001|Overall Study|Lost to Follow-up|1|||
46877757|NCT04247061|83098517|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
46877758|NCT04247061|83098517|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
46877759|NCT04247061|83098517|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
46877760|NCT04241133|83098523|FG000|Overall Study|COVID19 Precautions|14|||
46877761|NCT04241133|83098524|FG001|Overall Study|COVID19 Precautions|34|||
46707561|NCT01176240|82923136|FG001|Study 306B|Withdrawal by Subject|1|||
46702337|NCT00977080|82917241|FG000|Overall Study|Withdrawal by Subject|1|||
46702338|NCT00977080|82917242|FG001|Overall Study|Withdrawal by Subject|5|||
46702339|NCT00977080|82917243|FG002|Overall Study|Withdrawal by Subject|1|||
46702340|NCT00977080|82917244|FG003|Overall Study|Withdrawal by Subject|5|||
46702341|NCT00977080|82917241|FG000|Overall Study|Protocol Violation|7|||
46877762|NCT04123665|83098532|FG000|Overall Study|Withdrawal by Subject|7|||
46877763|NCT04123665|83098533|FG001|Overall Study|Withdrawal by Subject|0|||
46877764|NCT04123665|83098532|FG000|Overall Study|Lost to Follow-up|1|||
46877765|NCT04123665|83098533|FG001|Overall Study|Lost to Follow-up|0|||
46877766|NCT04232943|83098542|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
46877767|NCT04232943|83098543|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
46877768|NCT04232943|83098544|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
46702342|NCT00977080|82917242|FG001|Overall Study|Protocol Violation|3|||
46702343|NCT00977080|82917243|FG002|Overall Study|Protocol Violation|4|||
46702344|NCT00977080|82917244|FG003|Overall Study|Protocol Violation|3|||
46702345|NCT00977080|82917241|FG000|Overall Study|Noncompliance|0|||
46702346|NCT00977080|82917242|FG001|Overall Study|Noncompliance|2|||
46985012|NCT01647711|83231282|FG004|Overall Study|Refused to continue taking medication|1|||
46985013|NCT01647711|83231278|FG000|Overall Study|Other reason not defined|0|||
46985014|NCT01647711|83231279|FG001|Overall Study|Other reason not defined|1|||
46985015|NCT01647711|83231280|FG002|Overall Study|Other reason not defined|1|||
46985016|NCT01647711|83231281|FG003|Overall Study|Other reason not defined|1|||
46985017|NCT01647711|83231282|FG004|Overall Study|Other reason not defined|0|||
46985018|NCT02547233|83231298|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
46985019|NCT02547233|83231299|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
46985020|NCT02547233|83231298|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
46985021|NCT02547233|83231299|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
46702347|NCT00977080|82917243|FG002|Overall Study|Noncompliance|1|||
46985022|NCT02547233|83231298|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
46985023|NCT02547233|83231299|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
46985024|NCT02547233|83231298|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
46985025|NCT02547233|83231299|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
46985026|NCT02547233|83231298|FG000|12-month Follow-up|Withdrawal by Subject|10|||
46985027|NCT02547233|83231299|FG001|12-month Follow-up|Withdrawal by Subject|10|||
46985028|NCT02547233|83231298|FG000|12-month Follow-up|Lost to Follow-up|3|||
46985029|NCT02547233|83231299|FG001|12-month Follow-up|Lost to Follow-up|3|||
46985030|NCT02547233|83231298|FG000|12-month Follow-up|Lack of Efficacy|1|||
46985031|NCT02547233|83231299|FG001|12-month Follow-up|Lack of Efficacy|2|||
46985032|NCT02547233|83231298|FG000|12-month Follow-up|Protocol Violation|0|||
46985033|NCT02547233|83231299|FG001|12-month Follow-up|Protocol Violation|1|||
46985034|NCT02547233|83231298|FG000|12-month Follow-up|Other|0|||
46985035|NCT02547233|83231299|FG001|12-month Follow-up|Other|1|||
46985036|NCT05476679|83231312|FG000|Overall Study|Withdrawal by Subject|0|||
46985037|NCT05476679|83231313|FG001|Overall Study|Withdrawal by Subject|0|||
46985038|NCT05476679|83231314|FG002|Overall Study|Withdrawal by Subject|0|||
46985039|NCT05476679|83231315|FG003|Overall Study|Withdrawal by Subject|1|||
46985040|NCT05476679|83231316|FG004|Overall Study|Withdrawal by Subject|0|||
46985041|NCT05476679|83231312|FG000|Overall Study|Lost to Follow-up|0|||
46985042|NCT05476679|83231313|FG001|Overall Study|Lost to Follow-up|0|||
46702348|NCT00977080|82917244|FG003|Overall Study|Noncompliance|0|||
46702349|NCT00977080|82917241|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
46702350|NCT00977080|82917242|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
46702351|NCT00977080|82917243|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
46702352|NCT00977080|82917244|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
46702353|NCT00977080|82917241|FG000|Overall Study|Required kidney transplantation|1|||
46702354|NCT00977080|82917242|FG001|Overall Study|Required kidney transplantation|3|||
46702355|NCT00977080|82917243|FG002|Overall Study|Required kidney transplantation|3|||
46985043|NCT05476679|83231314|FG002|Overall Study|Lost to Follow-up|0|||
46985044|NCT05476679|83231315|FG003|Overall Study|Lost to Follow-up|1|||
46985045|NCT05476679|83231316|FG004|Overall Study|Lost to Follow-up|0|||
46985046|NCT02546765|83231334|FG000|Overall Study|Withdrawal by Subject|0|||
46985047|NCT02546765|83231335|FG001|Overall Study|Withdrawal by Subject|1|||
46877769|NCT04232943|83098542|FG000|Overall Study|Withdrawal by Subject|1|||
46702356|NCT00977080|82917244|FG003|Overall Study|Required kidney transplantation|1|||
46702357|NCT00977080|82917241|FG000|Overall Study|Travel for family reasons|1|||
46702358|NCT00977080|82917242|FG001|Overall Study|Travel for family reasons|0|||
46702359|NCT00977080|82917243|FG002|Overall Study|Travel for family reasons|0|||
46702360|NCT00977080|82917244|FG003|Overall Study|Travel for family reasons|0|||
46702361|NCT00975676|82917256|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
46702362|NCT00975676|82917257|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
46702363|NCT00975286|82917270|FG000|Overall Study|Adverse Event|9|||
46702364|NCT00975286|82917271|FG001|Overall Study|Adverse Event|19|||
46702365|NCT00975286|82917270|FG000|Overall Study|Protocol Violation|1|||
46702366|NCT00975286|82917271|FG001|Overall Study|Protocol Violation|2|||
46702367|NCT00975286|82917270|FG000|Overall Study|Withdrawal by Subject|0|||
46702368|NCT00975286|82917271|FG001|Overall Study|Withdrawal by Subject|2|||
46702369|NCT00975286|82917270|FG000|Overall Study|Familial and Personal Reasons|2|||
46702370|NCT00975286|82917271|FG001|Overall Study|Familial and Personal Reasons|2|||
46702371|NCT00975286|82917270|FG000|Overall Study|Poor Compliance to Protocol|0|||
46702372|NCT00975286|82917271|FG001|Overall Study|Poor Compliance to Protocol|2|||
46702373|NCT00975286|82917270|FG000|Overall Study|Sponsor Decision|0|||
46702374|NCT00975286|82917271|FG001|Overall Study|Sponsor Decision|2|||
46702375|NCT00907777|82917279|FG000|Overall Study|Withdrawal by Subject|0|||
46702376|NCT00907777|82917280|FG001|Overall Study|Withdrawal by Subject|1|||
46702377|NCT00908011|82917288|FG000|Overall Study|Withdrawal by Subject|2|||
46702378|NCT00908011|82917289|FG001|Overall Study|Withdrawal by Subject|2|||
46702379|NCT00976456|82917297|FG000|Overall Study|Adverse Event|17|||
46702380|NCT00976456|82917298|FG001|Overall Study|Adverse Event|22|||
46702381|NCT00976456|82917297|FG000|Overall Study|Death|7|||
46702382|NCT00976456|82917298|FG001|Overall Study|Death|9|||
46702383|NCT00976456|82917297|FG000|Overall Study|Lack of Efficacy|5|||
46702384|NCT00976456|82917298|FG001|Overall Study|Lack of Efficacy|2|||
46702385|NCT00976456|82917297|FG000|Overall Study|Withdrawal by Subject|3|||
46702386|NCT00976456|82917298|FG001|Overall Study|Withdrawal by Subject|1|||
46702387|NCT00976456|82917297|FG000|Overall Study|screening failure, unknown|11|||
46702388|NCT00976456|82917298|FG001|Overall Study|screening failure, unknown|4|||
46702389|NCT01243151|82917309|FG000|Overall Study|Adverse Event|0|||
46702390|NCT01243151|82917310|FG001|Overall Study|Adverse Event|1|||
46702391|NCT01243151|82917311|FG002|Overall Study|Adverse Event|0|||
46702392|NCT01243151|82917312|FG003|Overall Study|Adverse Event|0|||
46702393|NCT01243151|82917313|FG004|Overall Study|Adverse Event|0|||
46985048|NCT02546765|83231336|FG002|Overall Study|Withdrawal by Subject|0|||
46702394|NCT01243151|82917309|FG000|Overall Study|Protocol Violation|0|||
46702395|NCT01243151|82917310|FG001|Overall Study|Protocol Violation|0|||
46702396|NCT01243151|82917311|FG002|Overall Study|Protocol Violation|1|||
46702397|NCT01243151|82917312|FG003|Overall Study|Protocol Violation|0|||
46702398|NCT01243151|82917313|FG004|Overall Study|Protocol Violation|0|||
46702399|NCT01243151|82917309|FG000|Overall Study|Other|0|||
46702400|NCT01243151|82917310|FG001|Overall Study|Other|0|||
46702401|NCT01243151|82917311|FG002|Overall Study|Other|0|||
46702402|NCT01243151|82917312|FG003|Overall Study|Other|1|||
46702403|NCT01243151|82917313|FG004|Overall Study|Other|0|||
46702404|NCT01243151|82917309|FG000|Overall Study|Randomized but not treated|0|||
46702405|NCT01243151|82917310|FG001|Overall Study|Randomized but not treated|0|||
46702406|NCT01243151|82917311|FG002|Overall Study|Randomized but not treated|0|||
46702407|NCT01243151|82917312|FG003|Overall Study|Randomized but not treated|1|||
46702408|NCT01243151|82917313|FG004|Overall Study|Randomized but not treated|0|||
46702409|NCT00993148|82917337|FG000|Overall Study|Lost to Follow-up|2|||
46702410|NCT00993148|82917337|FG000|Overall Study|never initiated treatment|1|||
46702411|NCT00907621|82917343|FG000|Overall Study|Lost to Follow-up|6|||
46702412|NCT00907621|82917344|FG001|Overall Study|Lost to Follow-up|3|||
46702413|NCT00907621|82917343|FG000|Overall Study|intercurrent febrile illness|1|||
46702414|NCT00907621|82917344|FG001|Overall Study|intercurrent febrile illness|1|||
46702415|NCT03517111|82917364|FG000|Enrolled|Withdrawal by Subject|0|||
46702416|NCT03517111|82917365|FG001|Enrolled|Withdrawal by Subject|1|||
46702417|NCT03517111|82917366|FG002|Enrolled|Withdrawal by Subject|0|||
46702418|NCT03517111|82917364|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
46702419|NCT03517111|82917365|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
46702420|NCT03517111|82917366|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
46702421|NCT03517111|82917364|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
46702422|NCT03517111|82917365|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
46702423|NCT03517111|82917366|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
46702424|NCT03517111|82917364|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
46702425|NCT03517111|82917365|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
46702426|NCT03517111|82917366|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
46702427|NCT03517111|82917364|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
46702428|NCT03517111|82917365|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
46702429|NCT03517111|82917366|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
46702430|NCT00907153|82917378|FG000|Overall Study|Lost to Follow-up|1|||
46702431|NCT00907153|82917379|FG001|Overall Study|Lost to Follow-up|1|||
46702432|NCT00907153|82917378|FG000|Overall Study|Withdrawal by Subject|1|||
46702433|NCT00907153|82917379|FG001|Overall Study|Withdrawal by Subject|3|||
46702434|NCT00904033|82917389|FG000|Overall Study|Withdrawal by Subject|1|||
46702435|NCT00904033|82917390|FG001|Overall Study|Withdrawal by Subject|1|||
46702436|NCT00904033|82917391|FG002|Overall Study|Withdrawal by Subject|0|||
46702437|NCT00904033|82917392|FG003|Overall Study|Withdrawal by Subject|0|||
46702438|NCT00904033|82917389|FG000|Overall Study|Physician Decision|0|||
46702439|NCT00904033|82917390|FG001|Overall Study|Physician Decision|0|||
46702440|NCT00904033|82917391|FG002|Overall Study|Physician Decision|1|||
46702441|NCT00904033|82917392|FG003|Overall Study|Physician Decision|0|||
46702442|NCT00904033|82917389|FG000|Overall Study|Unable to obtain final blood draw|0|||
46702443|NCT00904033|82917390|FG001|Overall Study|Unable to obtain final blood draw|0|||
46702444|NCT00904033|82917391|FG002|Overall Study|Unable to obtain final blood draw|0|||
46702445|NCT00904033|82917392|FG003|Overall Study|Unable to obtain final blood draw|2|||
46702446|NCT00903877|82917403|FG000|Overall Study|Did not meet study criteria|33|||
46702447|NCT00903877|82917403|FG000|Overall Study|Withdrawal by Subject|3|||
46702448|NCT00903877|82917403|FG000|Overall Study|Adverse Event|2|||
46702449|NCT00903877|82917403|FG000|Overall Study|Lost to Follow-up|1|||
46702450|NCT00903877|82917403|FG000|Overall Study|Participation put on hold|4|||
46702451|NCT01241591|82917411|FG000|Overall Study|Lack of Efficacy|5|||
46702452|NCT01241591|82917412|FG001|Overall Study|Lack of Efficacy|2|||
46702453|NCT01241591|82917413|FG002|Overall Study|Lack of Efficacy|2|||
46702454|NCT01241591|82917414|FG003|Overall Study|Lack of Efficacy|3|||
46702455|NCT01241591|82917411|FG000|Overall Study|Protocol Violation|5|||
46702456|NCT01241591|82917412|FG001|Overall Study|Protocol Violation|2|||
46702457|NCT01241591|82917413|FG002|Overall Study|Protocol Violation|3|||
46702458|NCT01241591|82917414|FG003|Overall Study|Protocol Violation|0|||
46702459|NCT01241591|82917411|FG000|Overall Study|Lost to Follow-up|1|||
46702460|NCT01241591|82917412|FG001|Overall Study|Lost to Follow-up|2|||
46702461|NCT01241591|82917413|FG002|Overall Study|Lost to Follow-up|2|||
46702462|NCT01241591|82917414|FG003|Overall Study|Lost to Follow-up|2|||
46702463|NCT01241591|82917411|FG000|Overall Study|Screen Failure|3|||
46702464|NCT01241591|82917412|FG001|Overall Study|Screen Failure|2|||
46702465|NCT01241591|82917413|FG002|Overall Study|Screen Failure|1|||
46702466|NCT01241591|82917414|FG003|Overall Study|Screen Failure|0|||
46702467|NCT01241591|82917411|FG000|Overall Study|Withdrawal by Subject|6|||
46702468|NCT01241591|82917412|FG001|Overall Study|Withdrawal by Subject|4|||
46702469|NCT01241591|82917413|FG002|Overall Study|Withdrawal by Subject|2|||
46702470|NCT01241591|82917414|FG003|Overall Study|Withdrawal by Subject|2|||
46702471|NCT01241591|82917411|FG000|Overall Study|Other|0|||
46702472|NCT01241591|82917412|FG001|Overall Study|Other|1|||
46702473|NCT01241591|82917413|FG002|Overall Study|Other|0|||
46702474|NCT01241591|82917414|FG003|Overall Study|Other|1|||
46702475|NCT01241591|82917411|FG000|Overall Study|Adverse Event|3|||
46702476|NCT01241591|82917412|FG001|Overall Study|Adverse Event|11|||
46702477|NCT01241591|82917413|FG002|Overall Study|Adverse Event|12|||
46702478|NCT01241591|82917414|FG003|Overall Study|Adverse Event|4|||
46702479|NCT00906373|82917426|FG000|Overall Study|Withdrawal by Subject|0|||
46702480|NCT00906373|82917427|FG001|Overall Study|Withdrawal by Subject|5|||
46702481|NCT00906373|82917426|FG000|Overall Study|Other|0|||
46702482|NCT00906373|82917427|FG001|Overall Study|Other|1|||
46702483|NCT00906373|82917426|FG000|Overall Study|Still on treatment at cutoff date|0|||
46702484|NCT00906373|82917427|FG001|Overall Study|Still on treatment at cutoff date|2|||
46702485|NCT00905437|82917440|FG000|Overall Study|Adverse Event|3|||
46877770|NCT04232943|83098543|FG001|Overall Study|Withdrawal by Subject|1|||
46877771|NCT04232943|83098544|FG002|Overall Study|Withdrawal by Subject|0|||
46985049|NCT02546765|83231337|FG003|Overall Study|Withdrawal by Subject|0|||
46985050|NCT02553629|83231360|FG000|Overall Study|Logistic reasons|3|||
46702486|NCT00905437|82917441|FG001|Overall Study|Adverse Event|2|||
46702487|NCT00905437|82917440|FG000|Overall Study|Lost to Follow-up|0|||
46702488|NCT00905437|82917441|FG001|Overall Study|Lost to Follow-up|1|||
46702489|NCT00905437|82917440|FG000|Overall Study|Withdrawal by Subject|0|||
46702490|NCT00905437|82917441|FG001|Overall Study|Withdrawal by Subject|1|||
46702491|NCT00905437|82917440|FG000|Overall Study|Other|5|||
46702492|NCT00905437|82917441|FG001|Overall Study|Other|6|||
46702493|NCT01238861|82917453|FG000|Overall Study|Lost to Follow-up|4|||
46702494|NCT01238861|82917454|FG001|Overall Study|Lost to Follow-up|2|||
46702495|NCT01238861|82917455|FG002|Overall Study|Lost to Follow-up|3|||
46702496|NCT01238861|82917456|FG003|Overall Study|Lost to Follow-up|1|||
46702497|NCT01238861|82917457|FG004|Overall Study|Lost to Follow-up|1|||
46702498|NCT01238861|82917458|FG005|Overall Study|Lost to Follow-up|2|||
46702499|NCT01238861|82917453|FG000|Overall Study|Unplanned surgery|1|||
46702500|NCT01238861|82917454|FG001|Overall Study|Unplanned surgery|0|||
46985051|NCT02553629|83231361|FG001|Overall Study|Logistic reasons|6|||
46702501|NCT01238861|82917455|FG002|Overall Study|Unplanned surgery|0|||
46702502|NCT01238861|82917456|FG003|Overall Study|Unplanned surgery|0|||
46702503|NCT01238861|82917457|FG004|Overall Study|Unplanned surgery|0|||
46702504|NCT01238861|82917458|FG005|Overall Study|Unplanned surgery|0|||
46702505|NCT01238861|82917453|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
46702506|NCT01238861|82917454|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
46702507|NCT01238861|82917455|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
46702508|NCT01238861|82917456|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
46702509|NCT01238861|82917457|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
46702510|NCT01238861|82917458|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
46702511|NCT01238861|82917453|FG000|Overall Study|Incorrect enrollment/randomization|0|||
46702512|NCT01238861|82917454|FG001|Overall Study|Incorrect enrollment/randomization|0|||
46877772|NCT03694275|83098555|FG000|Overall Study|Adverse Event|0|||
46877773|NCT03694275|83098556|FG001|Overall Study|Adverse Event|1|||
46877774|NCT03694275|83098555|FG000|Overall Study|Reason not Specified|0|||
46877775|NCT03694275|83098556|FG001|Overall Study|Reason not Specified|1|||
46877776|NCT04230213|83098563|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
46877777|NCT04230213|83098564|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
46877778|NCT04230213|83098565|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
46877779|NCT04230213|83098563|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
46877780|NCT04230213|83098564|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
46877781|NCT04230213|83098565|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
46877782|NCT04230213|83098563|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
46877783|NCT04230213|83098564|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
46877784|NCT04230213|83098565|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
46877785|NCT04230213|83098563|FG000|TP2: Week 10 to Week 16|Other|0|||
46877786|NCT04230213|83098564|FG001|TP2: Week 10 to Week 16|Other|2|||
46877787|NCT04230213|83098565|FG002|TP2: Week 10 to Week 16|Other|1|||
46877788|NCT04230213|83098563|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
46877789|NCT04230213|83098564|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
46877790|NCT04230213|83098565|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
46877791|NCT04230213|83098563|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
46877792|NCT04230213|83098564|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
46877793|NCT04230213|83098565|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
46877794|NCT04230213|83098563|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
46877795|NCT04230213|83098564|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
46877796|NCT04230213|83098565|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
46877797|NCT04230213|83098563|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
46877798|NCT04230213|83098564|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
46877799|NCT04230213|83098565|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
46877800|NCT04230213|83098563|FG000|TP3: Week 16 to Week 22|Other|0|||
46877801|NCT04230213|83098564|FG001|TP3: Week 16 to Week 22|Other|1|||
46877802|NCT04230213|83098565|FG002|TP3: Week 16 to Week 22|Other|3|||
46877803|NCT04230213|83098563|FG000|TP4: Week 22 to Week 32|Other|0|||
46877804|NCT04230213|83098564|FG001|TP4: Week 22 to Week 32|Other|5|||
46877805|NCT04230213|83098565|FG002|TP4: Week 22 to Week 32|Other|5|||
46877806|NCT04230213|83098563|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
46877807|NCT04230213|83098564|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
46877808|NCT04230213|83098565|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
46877809|NCT04230213|83098563|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
46877810|NCT04230213|83098564|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
46877811|NCT04230213|83098565|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
46877812|NCT04230213|83098563|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
46877813|NCT04230213|83098564|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
46877814|NCT04230213|83098565|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
46877815|NCT04230213|83098563|FG000|Follow up: Week 32 to Week 36|Other|0|||
46877816|NCT04230213|83098564|FG001|Follow up: Week 32 to Week 36|Other|1|||
46877817|NCT04230213|83098565|FG002|Follow up: Week 32 to Week 36|Other|1|||
46877818|NCT04222725|83098577|FG000|Overall Study|Adverse Event|0|||
46877819|NCT04222725|83098578|FG001|Overall Study|Adverse Event|1|||
46877820|NCT04222725|83098579|FG002|Overall Study|Adverse Event|0|||
46877821|NCT04222725|83098580|FG003|Overall Study|Adverse Event|0|||
46877822|NCT04213989|83098592|FG000|Overall Study|Withdrawal by Subject|3|||
46877823|NCT04213989|83098593|FG001|Overall Study|Withdrawal by Subject|2|||
46877824|NCT04213989|83098592|FG000|Overall Study|Physician Decision|1|||
46877825|NCT04213989|83098593|FG001|Overall Study|Physician Decision|0|||
46702513|NCT01238861|82917455|FG002|Overall Study|Incorrect enrollment/randomization|1|||
46702514|NCT01238861|82917456|FG003|Overall Study|Incorrect enrollment/randomization|0|||
46877826|NCT04213989|83098592|FG000|Overall Study|Lost to Follow-up|0|||
46877827|NCT04213989|83098593|FG001|Overall Study|Lost to Follow-up|4|||
46877828|NCT03242252|83098602|FG000|Overall Study|At the Participant's own Request|18|||
46877829|NCT03242252|83098603|FG001|Overall Study|At the Participant's own Request|10|||
46877830|NCT03242252|83098604|FG002|Overall Study|At the Participant's own Request|15|||
46702515|NCT01238861|82917457|FG004|Overall Study|Incorrect enrollment/randomization|1|||
46702516|NCT01238861|82917458|FG005|Overall Study|Incorrect enrollment/randomization|0|||
46702517|NCT01238861|82917453|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
46702518|NCT01238861|82917454|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
46702519|NCT01238861|82917455|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
46702520|NCT01238861|82917456|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
46702521|NCT01238861|82917457|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
46702522|NCT01238861|82917458|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
46702523|NCT01238861|82917453|FG000|Overall Study|Subject moved out of state/area|0|||
46702524|NCT01238861|82917454|FG001|Overall Study|Subject moved out of state/area|0|||
46702525|NCT01238861|82917455|FG002|Overall Study|Subject moved out of state/area|1|||
46702526|NCT01238861|82917456|FG003|Overall Study|Subject moved out of state/area|1|||
46702527|NCT01238861|82917457|FG004|Overall Study|Subject moved out of state/area|0|||
46702528|NCT01238861|82917458|FG005|Overall Study|Subject moved out of state/area|0|||
46702529|NCT01238861|82917453|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
46702530|NCT01238861|82917454|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
46702531|NCT01238861|82917455|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
46702532|NCT01238861|82917456|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
46702533|NCT01238861|82917457|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
46702534|NCT01238861|82917458|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
46702535|NCT01238861|82917453|FG000|Overall Study|Personal problems|0|||
46702536|NCT01238861|82917454|FG001|Overall Study|Personal problems|0|||
46702537|NCT01238861|82917455|FG002|Overall Study|Personal problems|0|||
46702538|NCT01238861|82917456|FG003|Overall Study|Personal problems|1|||
46702539|NCT01238861|82917457|FG004|Overall Study|Personal problems|0|||
46702540|NCT01238861|82917458|FG005|Overall Study|Personal problems|0|||
46702541|NCT01238861|82917453|FG000|Overall Study|Unable to continue visits|0|||
46702542|NCT01238861|82917454|FG001|Overall Study|Unable to continue visits|0|||
46702543|NCT01238861|82917455|FG002|Overall Study|Unable to continue visits|0|||
46702544|NCT01238861|82917456|FG003|Overall Study|Unable to continue visits|1|||
46702545|NCT01238861|82917457|FG004|Overall Study|Unable to continue visits|0|||
46702546|NCT01238861|82917458|FG005|Overall Study|Unable to continue visits|1|||
46702547|NCT01238861|82917453|FG000|Overall Study|Serious adverse event|0|||
46702548|NCT01238861|82917454|FG001|Overall Study|Serious adverse event|0|||
46702549|NCT01238861|82917455|FG002|Overall Study|Serious adverse event|0|||
46702550|NCT01238861|82917456|FG003|Overall Study|Serious adverse event|0|||
46702551|NCT01238861|82917457|FG004|Overall Study|Serious adverse event|0|||
46702552|NCT01238861|82917458|FG005|Overall Study|Serious adverse event|1|||
46702553|NCT01238861|82917453|FG000|Overall Study|Lack of compliance|0|||
46702554|NCT01238861|82917454|FG001|Overall Study|Lack of compliance|0|||
46702555|NCT01238861|82917455|FG002|Overall Study|Lack of compliance|0|||
46702556|NCT01238861|82917456|FG003|Overall Study|Lack of compliance|0|||
46702557|NCT01238861|82917457|FG004|Overall Study|Lack of compliance|0|||
46702558|NCT01238861|82917458|FG005|Overall Study|Lack of compliance|1|||
46702559|NCT01238861|82917453|FG000|Overall Study|Adverse Event|0|||
46702560|NCT01238861|82917454|FG001|Overall Study|Adverse Event|1|||
46702561|NCT01238861|82917455|FG002|Overall Study|Adverse Event|0|||
46702562|NCT01238861|82917456|FG003|Overall Study|Adverse Event|0|||
46702563|NCT01238861|82917457|FG004|Overall Study|Adverse Event|0|||
46702564|NCT01238861|82917458|FG005|Overall Study|Adverse Event|0|||
46702565|NCT01238861|82917453|FG000|Overall Study|Withdrawal by Subject|6|||
46702566|NCT01238861|82917454|FG001|Overall Study|Withdrawal by Subject|5|||
46702567|NCT01238861|82917455|FG002|Overall Study|Withdrawal by Subject|4|||
46702568|NCT01238861|82917456|FG003|Overall Study|Withdrawal by Subject|8|||
46702569|NCT01238861|82917457|FG004|Overall Study|Withdrawal by Subject|10|||
46702570|NCT01238861|82917458|FG005|Overall Study|Withdrawal by Subject|9|||
46702571|NCT00903409|82917481|FG000|Overall Study|Adverse Event|11|||
46702572|NCT00903409|82917482|FG001|Overall Study|Adverse Event|9|||
46702573|NCT00903409|82917481|FG000|Overall Study|Non-compliance with Protocol|1|||
46702574|NCT00903409|82917482|FG001|Overall Study|Non-compliance with Protocol|1|||
46702575|NCT00903409|82917481|FG000|Overall Study|Laboratory Abnormality|2|||
46702576|NCT00903409|82917482|FG001|Overall Study|Laboratory Abnormality|0|||
46702577|NCT00903409|82917481|FG000|Overall Study|Withdrawal by Subject|8|||
46702578|NCT00903409|82917482|FG001|Overall Study|Withdrawal by Subject|8|||
46702579|NCT00903409|82917481|FG000|Overall Study|Other|2|||
46702580|NCT00903409|82917482|FG001|Overall Study|Other|3|||
46702581|NCT00903409|82917481|FG000|Overall Study|Lost to Follow-up|2|||
46702582|NCT00903409|82917482|FG001|Overall Study|Lost to Follow-up|6|||
46702583|NCT01237223|82917496|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
46702584|NCT01237223|82917497|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
46702585|NCT01237223|82917498|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
46702586|NCT01237223|82917499|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
46702587|NCT01237223|82917500|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
46702588|NCT01237223|82917501|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
46702589|NCT01237223|82917496|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
46702590|NCT01237223|82917497|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
46702591|NCT01237223|82917498|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
46702592|NCT01237223|82917499|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
46702593|NCT01237223|82917500|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
46702594|NCT01237223|82917501|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
46702595|NCT01237223|82917496|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
46702596|NCT01237223|82917497|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
46702597|NCT01237223|82917498|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
46702598|NCT01237223|82917499|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
46702599|NCT01237223|82917500|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
46702600|NCT01237223|82917501|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
46702601|NCT01237223|82917496|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
46702602|NCT01237223|82917497|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
46702603|NCT01237223|82917498|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
46702604|NCT01237223|82917499|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
46702605|NCT01237223|82917500|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
46702606|NCT01237223|82917501|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
46702607|NCT01237223|82917496|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
46702608|NCT01237223|82917497|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
46702609|NCT01237223|82917498|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
46702610|NCT01237223|82917499|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
46702611|NCT01237223|82917500|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
46702612|NCT01237223|82917501|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
46702613|NCT01237223|82917496|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
46702614|NCT01237223|82917497|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
46702615|NCT01237223|82917498|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
46702616|NCT01237223|82917499|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
46702617|NCT01237223|82917500|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
46702618|NCT01237223|82917501|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
46702619|NCT01237223|82917496|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
46702620|NCT01237223|82917497|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
46702621|NCT01237223|82917498|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
46702622|NCT01237223|82917499|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
46702623|NCT01237223|82917500|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
46702624|NCT01237223|82917501|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
46702625|NCT01237223|82917496|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
46702626|NCT01237223|82917497|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
46702627|NCT01237223|82917498|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
46702628|NCT01237223|82917499|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
46702629|NCT01237223|82917500|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
46702630|NCT01237223|82917501|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
46702631|NCT01237223|82917496|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
46702632|NCT01237223|82917497|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
46702633|NCT01237223|82917498|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
46702634|NCT01237223|82917499|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
46702635|NCT01237223|82917500|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
46702636|NCT01237223|82917501|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
46707562|NCT01176240|82923135|FG000|Study 306B|Physician Decision|2|||
46877831|NCT03242252|83098602|FG000|Overall Study|Adverse Event|8|||
46877832|NCT03242252|83098603|FG001|Overall Study|Adverse Event|6|||
46877833|NCT03242252|83098604|FG002|Overall Study|Adverse Event|9|||
46702637|NCT01237223|82917496|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
46702638|NCT01237223|82917497|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
46702639|NCT01237223|82917498|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
46702640|NCT01237223|82917499|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
46702641|NCT01237223|82917500|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
46702642|NCT01237223|82917501|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
46702643|NCT01236755|82917517|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
46702644|NCT01236755|82917517|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
46702645|NCT01236755|82917517|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
46702646|NCT01236755|82917517|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
46702647|NCT01236365|82917524|FG000|Overall Study|Lost to Follow-up|0|||
46702648|NCT01236365|82917525|FG001|Overall Study|Lost to Follow-up|2|||
46702649|NCT01236365|82917524|FG000|Overall Study|Moved Out of State|1|||
46702650|NCT01236365|82917525|FG001|Overall Study|Moved Out of State|0|||
46702651|NCT01236365|82917524|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
46702652|NCT01236365|82917525|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
46702653|NCT01235975|82917545|FG000|Overall Study|Serious Adverse Event|0|||
46702654|NCT01235975|82917546|FG001|Overall Study|Serious Adverse Event|1|||
46702655|NCT01235975|82917545|FG000|Overall Study|Withdrawal by Subject|8|||
46702656|NCT01235975|82917546|FG001|Overall Study|Withdrawal by Subject|2|||
46702657|NCT01235975|82917545|FG000|Overall Study|Migrated/moved from study area|2|||
46702658|NCT01235975|82917546|FG001|Overall Study|Migrated/moved from study area|1|||
46702659|NCT01235975|82917545|FG000|Overall Study|Lost to Follow-up|7|||
46702660|NCT01235975|82917546|FG001|Overall Study|Lost to Follow-up|3|||
46702661|NCT00903331|82917554|FG000|Overall Study|Death|4|||
46702662|NCT00903331|82917555|FG001|Overall Study|Death|8|||
46702663|NCT00903331|82917554|FG000|Overall Study|Withdrawal of consent|1|||
46702664|NCT00903331|82917555|FG001|Overall Study|Withdrawal of consent|8|||
46702665|NCT00903331|82917554|FG000|Overall Study|Lung transplant|0|||
46702666|NCT00903331|82917555|FG001|Overall Study|Lung transplant|2|||
46702667|NCT01235741|82917564|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
46702668|NCT01235741|82917565|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
46702669|NCT01235741|82917566|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
46702670|NCT01235741|82917564|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
46702671|NCT01235741|82917565|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
46702672|NCT01235741|82917566|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
46702673|NCT01235741|82917564|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
46702674|NCT01235741|82917565|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
46877834|NCT03242252|83098602|FG000|Overall Study|Poor Compliance to Protocol|0|||
46702675|NCT01235741|82917566|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
46702676|NCT01235741|82917564|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
46702677|NCT01235741|82917565|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
46702678|NCT01235741|82917566|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
46702679|NCT01235741|82917564|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
46702680|NCT01235741|82917565|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
46702681|NCT01235741|82917566|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
46702682|NCT01235741|82917564|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
46702683|NCT01235741|82917565|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
46702684|NCT01235741|82917566|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
46702685|NCT01235741|82917564|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
46702686|NCT01235741|82917565|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
46877835|NCT03242252|83098603|FG001|Overall Study|Poor Compliance to Protocol|2|||
46702687|NCT01235741|82917566|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
46702688|NCT01235741|82917564|FG000|Randomized to Treatment|Adverse Event|0|||
46702689|NCT01235741|82917565|FG001|Randomized to Treatment|Adverse Event|1|||
46702690|NCT01235741|82917566|FG002|Randomized to Treatment|Adverse Event|1|||
46702691|NCT01235741|82917564|FG000|Randomized to Treatment|Sponsor terminated study|0|||
46702692|NCT01235741|82917565|FG001|Randomized to Treatment|Sponsor terminated study|35|||
46702693|NCT01235741|82917566|FG002|Randomized to Treatment|Sponsor terminated study|34|||
46702694|NCT01235741|82917564|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
46702695|NCT01235741|82917565|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
46702696|NCT01235741|82917566|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
46702697|NCT01235741|82917564|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
46702698|NCT01235741|82917565|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
46702699|NCT01235741|82917566|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
46702700|NCT01235741|82917564|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
46702701|NCT01235741|82917565|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
46702702|NCT01235741|82917566|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
46702703|NCT01235507|82917578|FG000|Overall Study|Adverse Event|1|||
46702704|NCT01235507|82917578|FG000|Overall Study|Withdrawal by Subject|1|||
46702705|NCT01235351|82917584|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
46702706|NCT01235351|82917585|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
46702707|NCT01076205|82917595|FG000|Overall Study|Adverse Drug Reaction|299|||
46702708|NCT01076205|82917595|FG000|Overall Study|Lack of Effectiveness|1423|||
46702709|NCT01076205|82917595|FG000|Overall Study|Other Reason|1075|||
46702710|NCT01076205|82917595|FG000|Overall Study|Unknown Reason|71|||
46702711|NCT01076205|82917595|FG000|Overall Study|Lost to Follow-up|3151|||
46702712|NCT01234883|82917617|FG000|Overall Study|Early treatment release|8|||
46702713|NCT01234883|82917618|FG001|Overall Study|Early treatment release|10|||
46702714|NCT01234883|82917617|FG000|Overall Study|Parent/guardian withdrew consent|1|||
46702715|NCT01234883|82917618|FG001|Overall Study|Parent/guardian withdrew consent|2|||
46702716|NCT01234883|82917617|FG000|Overall Study|Technical difficulties with IV infusion|0|||
46702717|NCT01234883|82917618|FG001|Overall Study|Technical difficulties with IV infusion|1|||
46702718|NCT01234883|82917617|FG000|Overall Study|Inclusion/exclusion failure|1|||
46702719|NCT01234883|82917618|FG001|Overall Study|Inclusion/exclusion failure|0|||
46702720|NCT01234649|82917626|FG000|Overall Study|Withdrawal by Subject|32|||
46702721|NCT01234649|82917627|FG001|Overall Study|Withdrawal by Subject|26|||
46702722|NCT01234649|82917626|FG000|Overall Study|Pregnancy|6|||
46702723|NCT01234649|82917627|FG001|Overall Study|Pregnancy|6|||
46702724|NCT01234649|82917626|FG000|Overall Study|intolerant to side effects|4|||
46702725|NCT01234649|82917627|FG001|Overall Study|intolerant to side effects|3|||
46702726|NCT01234649|82917626|FG000|Overall Study|Allergic reaction|1|||
46702727|NCT01234649|82917627|FG001|Overall Study|Allergic reaction|0|||
46702728|NCT01234649|82917626|FG000|Overall Study|Lack of Efficacy|0|||
46702729|NCT01234649|82917627|FG001|Overall Study|Lack of Efficacy|3|||
46702730|NCT01075815|82917635|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
46702731|NCT01075815|82917636|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
46702732|NCT01075815|82917635|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
46702733|NCT01075815|82917636|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
46702734|NCT01075815|82917635|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
46702735|NCT01075815|82917636|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
46702736|NCT01075191|82917642|FG000|Overall Study|Death|1|||
46702737|NCT01075191|82917642|FG000|Overall Study|Intensification|3|||
46702738|NCT01075191|82917642|FG000|Overall Study|Co-morbidities|1|||
46702739|NCT01075191|82917642|FG000|Overall Study|Adverse Event|4|||
46702740|NCT01075191|82917642|FG000|Overall Study|Noncompliance|3|||
46702741|NCT01075191|82917642|FG000|Overall Study|Therapy Break|3|||
46702742|NCT01075191|82917642|FG000|Overall Study|Patient's Wish|2|||
46702743|NCT01075191|82917642|FG000|Overall Study|Unknown Reasons|1|||
46702744|NCT00905359|82917648|FG000|Overall Study|Lost to Follow-up|17|||
46702745|NCT00905359|82917649|FG001|Overall Study|Lost to Follow-up|10|||
46702746|NCT00905359|82917648|FG000|Overall Study|Death|2|||
46702747|NCT00905359|82917649|FG001|Overall Study|Death|0|||
46702748|NCT00905359|82917648|FG000|Overall Study|Withdrawal consent|5|||
46702749|NCT00905359|82917649|FG001|Overall Study|Withdrawal consent|6|||
46702750|NCT01072149|82917655|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702751|NCT01072149|82917656|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702752|NCT01072149|82917657|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
46702753|NCT01072149|82917658|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702754|NCT01072149|82917659|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702755|NCT01072149|82917660|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702756|NCT01072149|82917661|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702757|NCT01072149|82917662|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702758|NCT01072149|82917663|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702759|NCT01072149|82917664|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702760|NCT01072149|82917665|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46877836|NCT03242252|83098604|FG002|Overall Study|Poor Compliance to Protocol|3|||
46877837|NCT03242252|83098602|FG000|Overall Study|Study Terminated by Sponsor|1|||
46877838|NCT03242252|83098603|FG001|Overall Study|Study Terminated by Sponsor|0|||
46877839|NCT03242252|83098604|FG002|Overall Study|Study Terminated by Sponsor|0|||
46877840|NCT03242252|83098602|FG000|Overall Study|Reason not Specified|4|||
46877841|NCT03242252|83098603|FG001|Overall Study|Reason not Specified|4|||
46877842|NCT03242252|83098604|FG002|Overall Study|Reason not Specified|1|||
46877843|NCT03242252|83098602|FG000|Overall Study|Lost to Follow-up|5|||
46877844|NCT03242252|83098603|FG001|Overall Study|Lost to Follow-up|1|||
46877845|NCT03242252|83098604|FG002|Overall Study|Lost to Follow-up|4|||
46877846|NCT04109391|83098621|FG000|Overall Study|Adverse Event|2|||
46877847|NCT04109391|83098622|FG001|Overall Study|Adverse Event|2|||
46877848|NCT04109391|83098623|FG002|Overall Study|Adverse Event|0|||
46877849|NCT04109391|83098621|FG000|Overall Study|Withdrawal by Subject|2|||
46877850|NCT04109391|83098622|FG001|Overall Study|Withdrawal by Subject|0|||
46877851|NCT04109391|83098623|FG002|Overall Study|Withdrawal by Subject|0|||
46877852|NCT04109391|83098621|FG000|Overall Study|Pregnancy|1|||
46877853|NCT04109391|83098622|FG001|Overall Study|Pregnancy|0|||
46877854|NCT04109391|83098623|FG002|Overall Study|Pregnancy|0|||
46877855|NCT04109391|83098621|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
46877856|NCT04109391|83098622|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
46877857|NCT04109391|83098623|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
46877858|NCT04109391|83098621|FG000|Overall Study|Lost to Follow-up|0|||
46877859|NCT04109391|83098622|FG001|Overall Study|Lost to Follow-up|0|||
46877860|NCT04109391|83098623|FG002|Overall Study|Lost to Follow-up|1|||
46877861|NCT04109391|83098621|FG000|Overall Study|Lack of Efficacy|2|||
46877862|NCT04109391|83098622|FG001|Overall Study|Lack of Efficacy|2|||
46877863|NCT04109391|83098623|FG002|Overall Study|Lack of Efficacy|3|||
46877864|NCT04106817|83098634|FG000|Overall Study|Lost to Follow-up|1|||
46877865|NCT04106817|83098635|FG001|Overall Study|Lost to Follow-up|0|||
46877866|NCT04106817|83098636|FG002|Overall Study|Lost to Follow-up|0|||
46877867|NCT04097925|83098644|FG000|Overall Study|Withdrawal by Subject|1|||
46877868|NCT04195893|83098648|FG000|Second Intervention|Withdrawal by Subject|1|||
46877869|NCT04195893|83098649|FG001|Second Intervention|Withdrawal by Subject|0|||
46877870|NCT04195581|83098655|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
46877871|NCT04195581|83098655|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
46985052|NCT02546609|83231370|FG000|Overall Study|Withdrawal by Subject|0|||
46702761|NCT01072149|82917666|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702762|NCT01072149|82917667|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702763|NCT01072149|82917668|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702764|NCT01072149|82917669|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702765|NCT01072149|82917670|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702766|NCT01072149|82917671|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702767|NCT01072149|82917672|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
46702768|NCT01072149|82917655|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702769|NCT01072149|82917656|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702770|NCT01072149|82917657|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702771|NCT01072149|82917658|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702772|NCT01072149|82917659|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702773|NCT01072149|82917660|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702774|NCT01072149|82917661|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702775|NCT01072149|82917662|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702776|NCT01072149|82917663|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702777|NCT01072149|82917664|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702778|NCT01072149|82917665|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702779|NCT01072149|82917666|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702780|NCT01072149|82917667|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702781|NCT01072149|82917668|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702782|NCT01072149|82917669|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702783|NCT01072149|82917670|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702784|NCT01072149|82917671|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
46702785|NCT01072149|82917672|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
46877872|NCT04195581|83098655|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
46877873|NCT04195581|83098655|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
46877874|NCT04195581|83098655|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
46877875|NCT04195581|83098655|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
46985053|NCT02546609|83231371|FG001|Overall Study|Withdrawal by Subject|1|||
46877876|NCT04096365|83098673|FG000|Overall Study|Adverse Event|1|||
46702786|NCT01072149|82917655|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702787|NCT01072149|82917656|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702788|NCT01072149|82917657|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702789|NCT01072149|82917658|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702790|NCT01072149|82917659|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702791|NCT01072149|82917660|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702792|NCT01072149|82917661|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702793|NCT01072149|82917662|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702794|NCT01072149|82917663|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702795|NCT01072149|82917664|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702796|NCT01072149|82917665|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
46702797|NCT01072149|82917666|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702798|NCT01072149|82917667|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702799|NCT01072149|82917668|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702800|NCT01072149|82917669|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702801|NCT01072149|82917670|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702802|NCT01072149|82917671|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702803|NCT01072149|82917672|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
46702804|NCT01072149|82917655|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702805|NCT01072149|82917656|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
46702806|NCT01072149|82917657|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702807|NCT01072149|82917658|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702808|NCT01072149|82917659|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702809|NCT01072149|82917660|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702810|NCT01072149|82917661|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702811|NCT01072149|82917662|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702812|NCT01072149|82917663|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702813|NCT01072149|82917664|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702814|NCT01072149|82917665|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702815|NCT01072149|82917666|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702816|NCT01072149|82917667|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702817|NCT01072149|82917668|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702818|NCT01072149|82917669|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702819|NCT01072149|82917670|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702820|NCT01072149|82917671|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702821|NCT01072149|82917672|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
46702822|NCT01072149|82917655|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702823|NCT01072149|82917656|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702824|NCT01072149|82917657|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
46702825|NCT01072149|82917658|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702826|NCT01072149|82917659|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702827|NCT01072149|82917660|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702828|NCT01072149|82917661|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702829|NCT01072149|82917662|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702830|NCT01072149|82917663|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702831|NCT01072149|82917664|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702832|NCT01072149|82917665|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702833|NCT01072149|82917666|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702834|NCT01072149|82917667|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702835|NCT01072149|82917668|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702836|NCT01072149|82917669|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702837|NCT01072149|82917670|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702838|NCT01072149|82917671|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702839|NCT01072149|82917672|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
46702840|NCT01072149|82917655|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702841|NCT01072149|82917656|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702842|NCT01072149|82917657|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702843|NCT01072149|82917658|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702844|NCT01072149|82917659|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702845|NCT01072149|82917660|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702846|NCT01072149|82917661|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702847|NCT01072149|82917662|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
46702848|NCT01072149|82917663|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702849|NCT01072149|82917664|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702850|NCT01072149|82917665|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702851|NCT01072149|82917666|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702852|NCT01072149|82917667|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702853|NCT01072149|82917668|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702854|NCT01072149|82917669|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702855|NCT01072149|82917670|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702856|NCT01072149|82917671|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702857|NCT01072149|82917672|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
46702858|NCT01072149|82917655|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
46702859|NCT01072149|82917656|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
46702860|NCT01072149|82917657|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
46702861|NCT01072149|82917658|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
46702862|NCT01072149|82917659|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
46702863|NCT01072149|82917660|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
46702864|NCT01072149|82917661|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
46702865|NCT01072149|82917662|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
46702866|NCT01072149|82917663|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
46702867|NCT01072149|82917664|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
46702868|NCT01072149|82917665|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
46702869|NCT01072149|82917666|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
46702870|NCT01072149|82917667|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
46702871|NCT01072149|82917668|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
46702872|NCT01072149|82917669|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
46702873|NCT01072149|82917670|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
46702874|NCT01072149|82917671|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
46702875|NCT01072149|82917672|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
46702876|NCT01072149|82917655|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702877|NCT01072149|82917656|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702878|NCT01072149|82917657|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702879|NCT01072149|82917658|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702880|NCT01072149|82917659|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702881|NCT01072149|82917660|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702882|NCT01072149|82917661|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702883|NCT01072149|82917662|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702884|NCT01072149|82917663|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702885|NCT01072149|82917664|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702886|NCT01072149|82917665|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702887|NCT01072149|82917666|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702888|NCT01072149|82917667|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702889|NCT01072149|82917668|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702890|NCT01072149|82917669|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702891|NCT01072149|82917670|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
46702892|NCT01072149|82917671|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702893|NCT01072149|82917672|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
46702894|NCT01072149|82917655|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
46702895|NCT01072149|82917656|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
46702896|NCT01072149|82917657|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
46702897|NCT01072149|82917658|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
46702898|NCT01072149|82917659|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
46702899|NCT01072149|82917660|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
46702900|NCT01072149|82917661|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
46702901|NCT01072149|82917662|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
46702902|NCT01072149|82917663|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
46702903|NCT01072149|82917664|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
46702904|NCT01072149|82917665|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
46702905|NCT01072149|82917666|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
46702906|NCT01072149|82917667|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
46702907|NCT01072149|82917668|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
46702908|NCT01072149|82917669|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
46702909|NCT01072149|82917670|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
46702910|NCT01072149|82917671|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
46702911|NCT01072149|82917672|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
46702912|NCT01072149|82917655|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702913|NCT01072149|82917656|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702914|NCT01072149|82917657|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702915|NCT01072149|82917658|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702916|NCT01072149|82917659|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702917|NCT01072149|82917660|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702918|NCT01072149|82917661|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702919|NCT01072149|82917662|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702920|NCT01072149|82917663|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702921|NCT01072149|82917664|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702922|NCT01072149|82917665|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702923|NCT01072149|82917666|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702924|NCT01072149|82917667|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
46702925|NCT01072149|82917668|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702926|NCT01072149|82917669|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702927|NCT01072149|82917670|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702928|NCT01072149|82917671|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702929|NCT01072149|82917672|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
46702930|NCT01072149|82917655|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702931|NCT01072149|82917656|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702932|NCT01072149|82917657|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
46702933|NCT01072149|82917658|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702934|NCT01072149|82917659|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702935|NCT01072149|82917660|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702936|NCT01072149|82917661|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702937|NCT01072149|82917662|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702938|NCT01072149|82917663|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702939|NCT01072149|82917664|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702940|NCT01072149|82917665|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702941|NCT01072149|82917666|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702942|NCT01072149|82917667|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702943|NCT01072149|82917668|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
46702944|NCT01072149|82917669|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702945|NCT01072149|82917670|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702946|NCT01072149|82917671|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702947|NCT01072149|82917672|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
46702948|NCT01071915|82917682|FG000|Overall Study|Adverse Event|3|||
46702949|NCT01071915|82917682|FG000|Overall Study|Physician Decision|2|||
46702950|NCT01071915|82917682|FG000|Overall Study|Withdrawal by Subject|2|||
46702951|NCT01071915|82917682|FG000|Overall Study|Miscellaneous Reasons|2|||
46702952|NCT00904969|82917686|FG000|Overall Study|Lost to Follow-up|4|||
46702953|NCT00904969|82917686|FG000|Overall Study|Withdrawal by Subject|3|||
46702954|NCT00904969|82917686|FG000|Overall Study|Additional Treatments|11|||
46702955|NCT00904969|82917686|FG000|Overall Study|Case Aborted; Subject Exited|1|||
46702956|NCT01070979|82917708|FG000|Overall Study|Adverse Event|2|||
46702957|NCT01070979|82917709|FG001|Overall Study|Adverse Event|3|||
46702958|NCT01070979|82917710|FG002|Overall Study|Adverse Event|3|||
46702959|NCT01070979|82917708|FG000|Overall Study|Lost to Follow-up|2|||
46702960|NCT01070979|82917709|FG001|Overall Study|Lost to Follow-up|1|||
46702961|NCT01070979|82917710|FG002|Overall Study|Lost to Follow-up|1|||
46702962|NCT01070979|82917708|FG000|Overall Study|Protocol Violation|0|||
46702963|NCT01070979|82917709|FG001|Overall Study|Protocol Violation|2|||
46702964|NCT01070979|82917710|FG002|Overall Study|Protocol Violation|6|||
46702965|NCT01070979|82917708|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
46702966|NCT01070979|82917709|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
46702967|NCT01070979|82917710|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
46702968|NCT01070979|82917708|FG000|Overall Study|Withdrawal by Subject|3|||
46702969|NCT01070979|82917709|FG001|Overall Study|Withdrawal by Subject|1|||
46702970|NCT01070979|82917710|FG002|Overall Study|Withdrawal by Subject|1|||
46702971|NCT01070979|82917708|FG000|Overall Study|No study drug taken|0|||
46702972|NCT01070979|82917709|FG001|Overall Study|No study drug taken|1|||
46702973|NCT01070979|82917710|FG002|Overall Study|No study drug taken|0|||
46702974|NCT01234337|82917720|FG000|Overall Study|Adverse Event|58|||
46702975|NCT01234337|82917721|FG001|Overall Study|Adverse Event|21|||
46702976|NCT01234337|82917720|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
46702977|NCT01234337|82917721|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
46702978|NCT01234337|82917720|FG000|Overall Study|Investi. decision not protocol driven|5|||
46702979|NCT01234337|82917721|FG001|Overall Study|Investi. decision not protocol driven|6|||
46877877|NCT04094883|83098677|FG000|Overall Study|Withdrawal by Subject|1|||
46877878|NCT01368562|83098681|FG000|Overall Study|Adverse Event|1|||
46877879|NCT01368562|83098681|FG000|Overall Study|Disease progression|1|||
46877880|NCT01368562|83098681|FG000|Overall Study|Lost to Follow-up|1|||
46877881|NCT01368562|83098681|FG000|Overall Study|Death|6|||
46877882|NCT01368562|83098681|FG000|Overall Study|Unresponsive to treatment|5|||
46877883|NCT01368562|83098681|FG000|Overall Study|Other|3|||
46877884|NCT01368562|83098681|FG000|Overall Study|Other than specified|2|||
46877885|NCT03242018|83098688|FG000|Overall Study|Adverse Event|7|||
46877886|NCT03242018|83098689|FG001|Overall Study|Adverse Event|7|||
46877887|NCT03242018|83098690|FG002|Overall Study|Adverse Event|6|||
46877888|NCT03242018|83098688|FG000|Overall Study|Lost to Follow-up|2|||
46877889|NCT03242018|83098689|FG001|Overall Study|Lost to Follow-up|2|||
46877890|NCT03242018|83098690|FG002|Overall Study|Lost to Follow-up|2|||
46877891|NCT03242018|83098688|FG000|Overall Study|At the Participant's Own Request|5|||
46877892|NCT03242018|83098689|FG001|Overall Study|At the Participant's Own Request|1|||
46877893|NCT03242018|83098690|FG002|Overall Study|At the Participant's Own Request|4|||
46877894|NCT03242018|83098688|FG000|Overall Study|Reason Not Specified|3|||
46877895|NCT03242018|83098689|FG001|Overall Study|Reason Not Specified|4|||
46877896|NCT03242018|83098690|FG002|Overall Study|Reason Not Specified|1|||
46877897|NCT03242018|83098688|FG000|Overall Study|Study Terminated by Sponsor|1|||
46877898|NCT03242018|83098689|FG001|Overall Study|Study Terminated by Sponsor|0|||
46877899|NCT03242018|83098690|FG002|Overall Study|Study Terminated by Sponsor|1|||
46877900|NCT02789176|83098703|FG000|Overall Study|Death|0|||
46877901|NCT02789176|83098704|FG001|Overall Study|Death|0|||
46877902|NCT02789176|83098705|FG002|Overall Study|Death|3|||
46877903|NCT02789176|83098706|FG003|Overall Study|Death|0|||
46877904|NCT02789176|83098703|FG000|Overall Study|Withdrawal by Subject|0|||
46877905|NCT02789176|83098704|FG001|Overall Study|Withdrawal by Subject|0|||
46877906|NCT02789176|83098705|FG002|Overall Study|Withdrawal by Subject|1|||
46877907|NCT02789176|83098706|FG003|Overall Study|Withdrawal by Subject|0|||
46877908|NCT02789176|83098703|FG000|Overall Study|Lost to Follow-up|8|||
46877909|NCT02789176|83098704|FG001|Overall Study|Lost to Follow-up|2|||
46877910|NCT02789176|83098705|FG002|Overall Study|Lost to Follow-up|6|||
46877911|NCT02789176|83098706|FG003|Overall Study|Lost to Follow-up|1|||
46702980|NCT01234337|82917720|FG000|Overall Study|Non-compliant with study medication|3|||
46702981|NCT01234337|82917721|FG001|Overall Study|Non-compliant with study medication|2|||
46702982|NCT01234337|82917720|FG000|Overall Study|Randomized but not treated|6|||
46877912|NCT03259490|83098718|FG000|Period 1|Withdrawal by Subject|0|||
46877913|NCT03259490|83098719|FG001|Period 1|Withdrawal by Subject|1|||
46702983|NCT01234337|82917721|FG001|Overall Study|Randomized but not treated|4|||
46702984|NCT01234337|82917720|FG000|Overall Study|Lost to Follow-up|0|||
46877914|NCT03259490|83098718|FG000|Period 2|Protocol Violation|1|||
46877915|NCT03259490|83098719|FG001|Period 2|Protocol Violation|0|||
46877916|NCT03259334|83098728|FG000|Overall Study|Adverse Event|3|||
46877917|NCT03259334|83098729|FG001|Overall Study|Adverse Event|8|||
46877918|NCT03259334|83098730|FG002|Overall Study|Adverse Event|5|||
46877919|NCT03259334|83098728|FG000|Overall Study|Withdrawal by Subject|4|||
46877920|NCT03259334|83098729|FG001|Overall Study|Withdrawal by Subject|2|||
46877921|NCT03259334|83098730|FG002|Overall Study|Withdrawal by Subject|4|||
46877922|NCT03259334|83098728|FG000|Overall Study|Physician Decision|1|||
46877923|NCT03259334|83098729|FG001|Overall Study|Physician Decision|0|||
46877924|NCT03259334|83098730|FG002|Overall Study|Physician Decision|0|||
46877925|NCT03259334|83098728|FG000|Overall Study|Lost to Follow-up|0|||
46877926|NCT03259334|83098729|FG001|Overall Study|Lost to Follow-up|2|||
46877927|NCT03259334|83098730|FG002|Overall Study|Lost to Follow-up|1|||
46877928|NCT03259334|83098728|FG000|Overall Study|Protocol Deviation|0|||
46877929|NCT03259334|83098729|FG001|Overall Study|Protocol Deviation|3|||
46877930|NCT03259334|83098730|FG002|Overall Study|Protocol Deviation|2|||
46877931|NCT03259334|83098728|FG000|Overall Study|Lack of Efficacy|2|||
46877932|NCT03259334|83098729|FG001|Overall Study|Lack of Efficacy|0|||
46877933|NCT03259334|83098730|FG002|Overall Study|Lack of Efficacy|1|||
46877934|NCT03259334|83098728|FG000|Overall Study|Randomized but never treated|0|||
46877935|NCT03259334|83098729|FG001|Overall Study|Randomized but never treated|2|||
46877936|NCT03259334|83098730|FG002|Overall Study|Randomized but never treated|0|||
46877937|NCT01331824|83098738|FG000|Overall Study|Adverse Event|2|||
46877938|NCT01331824|83098738|FG000|Overall Study|Death|1|||
46877939|NCT01331824|83098738|FG000|Overall Study|Disease Progression|9|||
46877940|NCT01331824|83098738|FG000|Overall Study|Withdrawal by Subject|1|||
46877941|NCT03258710|83098742|FG000|Overall Study|Adverse Event|1|||
46877942|NCT03258710|83098742|FG000|Overall Study|Protocol-defined stopping criteria|1|||
46877943|NCT03258710|83098742|FG000|Overall Study|Physician Decision|1|||
46877944|NCT03240692|83098746|FG000|Overall Study|Physician Decision|1|||
46877945|NCT03240692|83098746|FG000|Overall Study|Withdrawal by Subject|1|||
46877946|NCT03233048|83098750|FG000|Overall Study|Withdrawal by Subject|1|||
46877947|NCT02937740|83098756|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
46877948|NCT02937740|83098757|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
46877949|NCT02937740|83098756|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
46877950|NCT02937740|83098757|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
46877951|NCT02937740|83098756|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
46877952|NCT02937740|83098757|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
46877953|NCT02937740|83098756|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
46877954|NCT02937740|83098757|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
46877955|NCT02937740|83098756|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
46877956|NCT02937740|83098757|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
46877957|NCT02937740|83098756|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
46877958|NCT02937740|83098757|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
46877959|NCT04173741|83098780|FG000|Overall Study|IVC measurement cannot be done|1|||
46877960|NCT04173741|83098781|FG001|Overall Study|IVC measurement cannot be done|1|||
46877961|NCT03231800|83098789|FG000|Overall Study|Lost to Follow-up|0|||
46877962|NCT03231800|83098790|FG001|Overall Study|Lost to Follow-up|2|||
46702985|NCT01234337|82917721|FG001|Overall Study|Lost to Follow-up|1|||
46702986|NCT01234337|82917720|FG000|Overall Study|Protocol Violation|2|||
46702987|NCT01234337|82917721|FG001|Overall Study|Protocol Violation|3|||
46702988|NCT01234337|82917720|FG000|Overall Study|Withdrawal by Subject|11|||
46702989|NCT01234337|82917721|FG001|Overall Study|Withdrawal by Subject|9|||
46877963|NCT03231800|83098789|FG000|Overall Study|Protocol Violation|1|||
46877964|NCT03231800|83098790|FG001|Overall Study|Protocol Violation|1|||
46877965|NCT03231800|83098789|FG000|Overall Study|reason not provided|2|||
46877966|NCT03231800|83098790|FG001|Overall Study|reason not provided|0|||
46877967|NCT04085601|83098798|FG000|Overall Study|Lost to Follow-up|1|||
46877968|NCT04085601|83098799|FG001|Overall Study|Lost to Follow-up|0|||
46877969|NCT04085601|83098798|FG000|Overall Study|Death|1|||
46877970|NCT04085601|83098799|FG001|Overall Study|Death|1|||
46702990|NCT01234337|82917720|FG000|Overall Study|Death|0|||
46877971|NCT03230864|83098808|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
46877972|NCT03230864|83098809|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
46877973|NCT03230864|83098810|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
46877974|NCT03230864|83098811|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
46877975|NCT03230864|83098808|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
46877976|NCT03230864|83098809|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
46877977|NCT03230864|83098810|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
46877978|NCT03230864|83098811|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
46877979|NCT03230864|83098808|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
46985054|NCT02546609|83231372|FG002|Overall Study|Withdrawal by Subject|2|||
46985055|NCT02546609|83231370|FG000|Overall Study|Adverse Event|0|||
46985056|NCT02546609|83231371|FG001|Overall Study|Adverse Event|6|||
46985057|NCT02546609|83231372|FG002|Overall Study|Adverse Event|1|||
46985058|NCT02546609|83231370|FG000|Overall Study|Protocol Violation|0|||
46985059|NCT02546609|83231371|FG001|Overall Study|Protocol Violation|1|||
46985060|NCT02546609|83231372|FG002|Overall Study|Protocol Violation|1|||
46985061|NCT02546609|83231370|FG000|Overall Study|Lost to Follow-up|2|||
46985062|NCT02546609|83231371|FG001|Overall Study|Lost to Follow-up|3|||
46985063|NCT02546609|83231372|FG002|Overall Study|Lost to Follow-up|1|||
46985064|NCT02546609|83231370|FG000|Overall Study|travel or work schedule restriction|0|||
46985065|NCT02546609|83231371|FG001|Overall Study|travel or work schedule restriction|0|||
46985066|NCT02546609|83231372|FG002|Overall Study|travel or work schedule restriction|2|||
46985067|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
46985068|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
46985069|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
46985070|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
46985071|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
46985072|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
46985073|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Death|1|||
46985074|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Death|3|||
46985075|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
46985076|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
46702991|NCT01234337|82917721|FG001|Overall Study|Death|1|||
46702992|NCT01234337|82917720|FG000|Overall Study|Switch to commercial drug|0|||
46702993|NCT01234337|82917721|FG001|Overall Study|Switch to commercial drug|1|||
46877980|NCT03230864|83098809|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
46985077|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
46985078|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
46985079|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
46985080|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
46985081|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
46985082|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
46985083|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
46985084|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
46985085|NCT02553317|83231382|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
46985086|NCT02553317|83231383|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
46985087|NCT02325219|83231393|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
46985088|NCT02325219|83231394|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
46985089|NCT02325219|83231395|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
46985090|NCT02325219|83231396|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
46985091|NCT02325219|83231397|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
46985092|NCT02325219|83231393|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
46985093|NCT02325219|83231394|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
46985094|NCT02325219|83231395|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
46985095|NCT02325219|83231396|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
46702994|NCT01070043|82917729|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
46877981|NCT03230864|83098810|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
46877982|NCT03230864|83098811|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
46877983|NCT03230864|83098808|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
46877984|NCT03230864|83098809|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
46877985|NCT03230864|83098810|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
46877986|NCT03230864|83098811|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
46877987|NCT03230864|83098808|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
46877988|NCT03230864|83098809|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
46877989|NCT03230864|83098810|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
46877990|NCT03230864|83098811|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
46877991|NCT03230864|83098808|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
46877992|NCT03230864|83098809|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
46877993|NCT03230864|83098810|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
46877994|NCT03230864|83098811|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
46877995|NCT03230864|83098808|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
46877996|NCT03230864|83098809|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
46877997|NCT03230864|83098810|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
46985096|NCT02325219|83231397|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
46985097|NCT02325219|83231393|FG000|Controlled Period (Week 0 - 16)|Other|0|||
46985098|NCT02325219|83231394|FG001|Controlled Period (Week 0 - 16)|Other|0|||
46985099|NCT02325219|83231395|FG002|Controlled Period (Week 0 - 16)|Other|1|||
46985100|NCT02325219|83231396|FG003|Controlled Period (Week 0 - 16)|Other|0|||
46985101|NCT02325219|83231397|FG004|Controlled Period (Week 0 - 16)|Other|0|||
46985102|NCT02325219|83231393|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
46985103|NCT02325219|83231394|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
46985104|NCT02325219|83231395|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
46985105|NCT02325219|83231396|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
46985106|NCT02325219|83231397|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
46985107|NCT02325219|83231393|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
46985108|NCT02325219|83231394|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
46985109|NCT02325219|83231395|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
46985110|NCT02325219|83231396|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
46985111|NCT02325219|83231397|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
46985112|NCT02325219|83231393|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
46985113|NCT02325219|83231394|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
46985114|NCT02325219|83231395|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
46985115|NCT02325219|83231396|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
46985116|NCT02325219|83231397|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
46985117|NCT02297841|83231413|FG000|Overall Study|Withdrawal by Subject|1|||
46985118|NCT02297841|83231413|FG000|Overall Study|Protocol Violation|7|||
46985119|NCT02324361|83231419|FG000|Overall Study|Lost to Follow-up|5|||
46985120|NCT02324361|83231420|FG001|Overall Study|Lost to Follow-up|2|||
46985121|NCT02365233|83231429|FG000|Overall Study|IRB withheld the data|1|||
46985122|NCT02365233|83231430|FG001|Overall Study|IRB withheld the data|2|||
46985123|NCT02365233|83231431|FG002|Overall Study|IRB withheld the data|2|||
46985124|NCT02324205|83231439|FG000|Overall Study|Withdrawal by Subject|37|||
46985125|NCT02324049|83231443|FG000|Part C|Study terminated|11|||
46985126|NCT02364999|83231449|FG000|Overall Study|Death|136|||
46985127|NCT02364999|83231450|FG001|Overall Study|Death|138|||
46985128|NCT02364999|83231449|FG000|Overall Study|Lost to Follow-up|10|||
46985129|NCT02364999|83231450|FG001|Overall Study|Lost to Follow-up|15|||
46985130|NCT02364999|83231449|FG000|Overall Study|Protocol Violation|3|||
46985131|NCT02364999|83231450|FG001|Overall Study|Protocol Violation|2|||
46985132|NCT02364999|83231449|FG000|Overall Study|Withdrawal by Subject|14|||
46985133|NCT02364999|83231450|FG001|Overall Study|Withdrawal by Subject|14|||
46985134|NCT02364999|83231449|FG000|Overall Study|Other|0|||
46985135|NCT02364999|83231450|FG001|Overall Study|Other|1|||
46985136|NCT02364999|83231449|FG000|Overall Study|Randomized but did not receive treatment|2|||
46985137|NCT02364999|83231450|FG001|Overall Study|Randomized but did not receive treatment|3|||
46985138|NCT02322879|83231459|FG000|First Intervention|Physician Decision|1|||
46985139|NCT02322879|83231460|FG001|First Intervention|Physician Decision|0|||
46985140|NCT02322411|83231468|FG000|Overall Study|Lost to Follow-up|4|||
46985141|NCT02322411|83231469|FG001|Overall Study|Lost to Follow-up|7|||
46985142|NCT02322411|83231468|FG000|Overall Study|Withdrawal by Subject|1|||
46985143|NCT02322411|83231469|FG001|Overall Study|Withdrawal by Subject|0|||
46985144|NCT02322021|83231479|FG000|Core Phase|Adverse Event|1|||
46985145|NCT02322021|83231480|FG001|Core Phase|Adverse Event|3|||
46985146|NCT02322021|83231481|FG002|Core Phase|Adverse Event|4|||
46985147|NCT02322021|83231482|FG003|Core Phase|Adverse Event|2|||
46985148|NCT02322021|83231483|FG004|Core Phase|Adverse Event|0|||
46985149|NCT02322021|83231479|FG000|Core Phase|Participant Choice|4|||
46985150|NCT02322021|83231480|FG001|Core Phase|Participant Choice|5|||
46985151|NCT02322021|83231481|FG002|Core Phase|Participant Choice|4|||
46985152|NCT02322021|83231482|FG003|Core Phase|Participant Choice|2|||
46985153|NCT02322021|83231483|FG004|Core Phase|Participant Choice|0|||
46985154|NCT02322021|83231479|FG000|Core Phase|Lost to Follow-up|0|||
46985155|NCT02322021|83231480|FG001|Core Phase|Lost to Follow-up|0|||
46985156|NCT02322021|83231481|FG002|Core Phase|Lost to Follow-up|0|||
46985157|NCT02322021|83231482|FG003|Core Phase|Lost to Follow-up|1|||
46985158|NCT02322021|83231483|FG004|Core Phase|Lost to Follow-up|0|||
46985159|NCT02322021|83231479|FG000|Core Phase|Other|0|||
46985160|NCT02322021|83231480|FG001|Core Phase|Other|0|||
46985161|NCT02322021|83231481|FG002|Core Phase|Other|1|||
46985162|NCT02322021|83231482|FG003|Core Phase|Other|0|||
46985163|NCT02322021|83231483|FG004|Core Phase|Other|0|||
46985164|NCT02322021|83231479|FG000|Extension Phase|Adverse Event|0|||
46985165|NCT02322021|83231480|FG001|Extension Phase|Adverse Event|0|||
46985166|NCT02322021|83231481|FG002|Extension Phase|Adverse Event|0|||
46985167|NCT02322021|83231482|FG003|Extension Phase|Adverse Event|0|||
46985168|NCT02322021|83231483|FG004|Extension Phase|Adverse Event|3|||
46985169|NCT02322021|83231479|FG000|Extension Phase|Participant Choice|0|||
46985170|NCT02322021|83231480|FG001|Extension Phase|Participant Choice|0|||
46985171|NCT02322021|83231481|FG002|Extension Phase|Participant Choice|0|||
46985172|NCT02322021|83231482|FG003|Extension Phase|Participant Choice|0|||
46985173|NCT02322021|83231483|FG004|Extension Phase|Participant Choice|6|||
46985174|NCT02322021|83231479|FG000|Extension Phase|Other|0|||
46985175|NCT02322021|83231480|FG001|Extension Phase|Other|0|||
46985176|NCT02322021|83231481|FG002|Extension Phase|Other|0|||
46985177|NCT02322021|83231482|FG003|Extension Phase|Other|0|||
46985178|NCT02322021|83231483|FG004|Extension Phase|Other|3|||
46985179|NCT02322021|83231479|FG000|Extension Phase|Lost to Follow-up|0|||
46985180|NCT02322021|83231480|FG001|Extension Phase|Lost to Follow-up|0|||
46985181|NCT02322021|83231481|FG002|Extension Phase|Lost to Follow-up|0|||
46985182|NCT02322021|83231482|FG003|Extension Phase|Lost to Follow-up|0|||
46985183|NCT02322021|83231483|FG004|Extension Phase|Lost to Follow-up|1|||
46985184|NCT02322021|83231479|FG000|Extension Phase|Study terminated by sponsor|0|||
46985185|NCT02322021|83231480|FG001|Extension Phase|Study terminated by sponsor|0|||
46985186|NCT02322021|83231481|FG002|Extension Phase|Study terminated by sponsor|0|||
46985187|NCT02322021|83231482|FG003|Extension Phase|Study terminated by sponsor|0|||
46985188|NCT02322021|83231483|FG004|Extension Phase|Study terminated by sponsor|28|||
46985189|NCT02363439|83231498|FG000|Overall Study|Lack of Efficacy|4|||
46985190|NCT02363283|83231502|FG000|Overall Study|Withdrawal by Subject|1|||
46985191|NCT02363283|83231502|FG000|Overall Study|Not eligible due to transaminitis|1|||
46702995|NCT01070043|82917730|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
46702996|NCT01070043|82917731|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
46702997|NCT01070043|82917729|FG000|Double-Blind Treatment|Adverse Event|0|||
46702998|NCT01070043|82917730|FG001|Double-Blind Treatment|Adverse Event|0|||
46877998|NCT03230864|83098811|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
46877999|NCT03230864|83098808|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
46985192|NCT02321319|83231506|FG000|Overall Study|Product discontinued|5|||
46985193|NCT02294175|83231512|FG000|Overall Study|Withdrawal by Subject|1|||
46985194|NCT02294175|83231513|FG001|Overall Study|Withdrawal by Subject|2|||
46985195|NCT02294175|83231512|FG000|Overall Study|pt taking excluded medication|3|||
46985196|NCT02294175|83231513|FG001|Overall Study|pt taking excluded medication|1|||
46985197|NCT02294175|83231512|FG000|Overall Study|Protocol Violation|1|||
46985198|NCT02294175|83231513|FG001|Overall Study|Protocol Violation|0|||
46985199|NCT02294175|83231512|FG000|Overall Study|Lost to Follow-up|0|||
46985200|NCT02294175|83231513|FG001|Overall Study|Lost to Follow-up|1|||
46985201|NCT02294175|83231512|FG000|Overall Study|wound healed|0|||
46985202|NCT02294175|83231513|FG001|Overall Study|wound healed|2|||
46985203|NCT02088541|83231524|FG000|Overall Study|Adverse Event|3|||
46985204|NCT02088541|83231525|FG001|Overall Study|Adverse Event|0|||
46985205|NCT02088541|83231526|FG002|Overall Study|Adverse Event|3|||
46985206|NCT02088541|83231527|FG003|Overall Study|Adverse Event|3|||
46985207|NCT02088541|83231528|FG004|Overall Study|Adverse Event|0|||
46985208|NCT02088541|83231524|FG000|Overall Study|Death|51|||
46985209|NCT02088541|83231525|FG001|Overall Study|Death|21|||
46985210|NCT02088541|83231526|FG002|Overall Study|Death|85|||
46985211|NCT02088541|83231527|FG003|Overall Study|Death|28|||
46985212|NCT02088541|83231528|FG004|Overall Study|Death|38|||
46985213|NCT02088541|83231524|FG000|Overall Study|Lost to Follow-up|2|||
46985214|NCT02088541|83231525|FG001|Overall Study|Lost to Follow-up|0|||
46985215|NCT02088541|83231526|FG002|Overall Study|Lost to Follow-up|1|||
46985216|NCT02088541|83231527|FG003|Overall Study|Lost to Follow-up|0|||
46985217|NCT02088541|83231528|FG004|Overall Study|Lost to Follow-up|0|||
46985218|NCT02088541|83231524|FG000|Overall Study|Physician Decision|2|||
46985219|NCT02088541|83231525|FG001|Overall Study|Physician Decision|1|||
46985220|NCT02088541|83231526|FG002|Overall Study|Physician Decision|2|||
46985221|NCT02088541|83231527|FG003|Overall Study|Physician Decision|0|||
46985222|NCT02088541|83231528|FG004|Overall Study|Physician Decision|2|||
46985223|NCT02088541|83231524|FG000|Overall Study|Disease progression|7|||
46985224|NCT02088541|83231525|FG001|Overall Study|Disease progression|1|||
46985225|NCT02088541|83231526|FG002|Overall Study|Disease progression|2|||
46985226|NCT02088541|83231527|FG003|Overall Study|Disease progression|3|||
46985227|NCT02088541|83231528|FG004|Overall Study|Disease progression|1|||
46985228|NCT02088541|83231524|FG000|Overall Study|Study terminated by sponsor|1|||
46985229|NCT02088541|83231525|FG001|Overall Study|Study terminated by sponsor|1|||
46985230|NCT02088541|83231526|FG002|Overall Study|Study terminated by sponsor|12|||
46985231|NCT02088541|83231527|FG003|Overall Study|Study terminated by sponsor|2|||
46985232|NCT02088541|83231528|FG004|Overall Study|Study terminated by sponsor|6|||
46985233|NCT02088541|83231524|FG000|Overall Study|Withdrawal by Subject|3|||
46985234|NCT02088541|83231525|FG001|Overall Study|Withdrawal by Subject|2|||
46985235|NCT02088541|83231526|FG002|Overall Study|Withdrawal by Subject|9|||
46985236|NCT02088541|83231527|FG003|Overall Study|Withdrawal by Subject|7|||
46985237|NCT02088541|83231528|FG004|Overall Study|Withdrawal by Subject|10|||
46985238|NCT02088541|83231524|FG000|Overall Study|Other|2|||
46985239|NCT02088541|83231525|FG001|Overall Study|Other|1|||
46985240|NCT02088541|83231526|FG002|Overall Study|Other|3|||
46985241|NCT02088541|83231527|FG003|Overall Study|Other|1|||
46985242|NCT02088541|83231528|FG004|Overall Study|Other|1|||
46985243|NCT02294019|83231538|FG000|Overall Study|Adverse Event|2|||
46985244|NCT02294019|83231538|FG000|Overall Study|Protocol Violation|68|||
46985245|NCT02294019|83231538|FG000|Overall Study|Lost to Follow-up|31|||
46985246|NCT02294019|83231538|FG000|Overall Study|Other|1|||
46985247|NCT02294019|83231538|FG000|Overall Study|Withdrawal by Subject|1|||
46985248|NCT02320149|83231544|FG000|Overall Study|Adverse Event|3|||
46985249|NCT02320149|83231545|FG001|Overall Study|Adverse Event|7|||
46985250|NCT02320149|83231544|FG000|Overall Study|Withdrawal of Consent|28|||
46985251|NCT02320149|83231545|FG001|Overall Study|Withdrawal of Consent|32|||
46985252|NCT02320149|83231544|FG000|Overall Study|Lost to Follow-up|21|||
46985253|NCT02320149|83231545|FG001|Overall Study|Lost to Follow-up|34|||
46985254|NCT02320149|83231544|FG000|Overall Study|Protocol Violation|2|||
46985255|NCT02320149|83231545|FG001|Overall Study|Protocol Violation|1|||
46985256|NCT02320149|83231544|FG000|Overall Study|Noncompliance with Study Treatment|7|||
46985257|NCT02320149|83231545|FG001|Overall Study|Noncompliance with Study Treatment|2|||
46985258|NCT02320149|83231544|FG000|Overall Study|Lack of Efficacy|0|||
46985259|NCT02320149|83231545|FG001|Overall Study|Lack of Efficacy|1|||
46985260|NCT02320149|83231544|FG000|Overall Study|Other Miscellaneous Reasons|2|||
46985261|NCT02320149|83231545|FG001|Overall Study|Other Miscellaneous Reasons|3|||
46985262|NCT02540083|83231551|FG000|Overall Study|Withdrawal by Subject|16|||
46985263|NCT02293863|83231558|FG000|Overall Study|Death|4|||
46985264|NCT02293863|83231559|FG001|Overall Study|Death|6|||
46985265|NCT02293863|83231560|FG002|Overall Study|Death|4|||
46985266|NCT02293863|83231558|FG000|Overall Study|Lost to Follow-up|2|||
46985267|NCT02293863|83231559|FG001|Overall Study|Lost to Follow-up|2|||
46985268|NCT02293863|83231560|FG002|Overall Study|Lost to Follow-up|2|||
46985269|NCT02293863|83231558|FG000|Overall Study|Withdrawal by Subject|3|||
46985270|NCT02293863|83231559|FG001|Overall Study|Withdrawal by Subject|3|||
46985271|NCT02293863|83231560|FG002|Overall Study|Withdrawal by Subject|1|||
46985272|NCT02293863|83231558|FG000|Overall Study|Reason Not Specified|0|||
46985273|NCT02293863|83231559|FG001|Overall Study|Reason Not Specified|2|||
46985274|NCT02293863|83231560|FG002|Overall Study|Reason Not Specified|2|||
46985275|NCT02293395|83231572|FG000|Overall Study|Lost to Follow-up|1|||
46985276|NCT02293395|83231573|FG001|Overall Study|Lost to Follow-up|0|||
46985277|NCT02293395|83231572|FG000|Overall Study|Withdrawal by Subject|8|||
46985278|NCT02293395|83231573|FG001|Overall Study|Withdrawal by Subject|7|||
46985279|NCT02025985|83231584|FG000|Overall Study|Consent withdrawn|0|||
46985280|NCT02025985|83231585|FG001|Overall Study|Consent withdrawn|0|||
46985281|NCT02025985|83231586|FG002|Overall Study|Consent withdrawn|1|||
46985282|NCT02025985|83231587|FG003|Overall Study|Consent withdrawn|0|||
46985283|NCT02025985|83231588|FG004|Overall Study|Consent withdrawn|0|||
46985284|NCT02025985|83231584|FG000|Overall Study|Termination of study by Sponsor|4|||
46985285|NCT02025985|83231585|FG001|Overall Study|Termination of study by Sponsor|3|||
46985286|NCT02025985|83231586|FG002|Overall Study|Termination of study by Sponsor|1|||
46985287|NCT02025985|83231587|FG003|Overall Study|Termination of study by Sponsor|1|||
46985288|NCT02025985|83231588|FG004|Overall Study|Termination of study by Sponsor|3|||
46985289|NCT02025985|83231584|FG000|Overall Study|Death|21|||
46985290|NCT02025985|83231585|FG001|Overall Study|Death|20|||
46985291|NCT02025985|83231586|FG002|Overall Study|Death|23|||
46985292|NCT02025985|83231587|FG003|Overall Study|Death|20|||
46985293|NCT02025985|83231588|FG004|Overall Study|Death|17|||
46985294|NCT02528305|83231602|FG000|Overall Study|Withdrawal by Subject|1|||
46985295|NCT02528305|83231602|FG000|Overall Study|Adverse Event|1|||
46985296|NCT02528305|83231602|FG000|Overall Study|Physician Decision|1|||
46985297|NCT02532517|83231608|FG000|Overall Study|Did not complete 24-Month visit|4|||
46985298|NCT02532517|83231608|FG000|Overall Study|Failed Angiographic eligibility|1|||
46985299|NCT02532517|83231608|FG000|Overall Study|Lost to Follow-up|4|||
46985300|NCT02532517|83231608|FG000|Overall Study|Withdrawal by Subject|4|||
46985301|NCT02532517|83231608|FG000|Overall Study|Death|4|||
46985302|NCT02545049|83231614|FG000|Overall Study|Withdrawal by Subject|1|||
46985303|NCT02545049|83231615|FG001|Overall Study|Withdrawal by Subject|7|||
46985304|NCT02545049|83231614|FG000|Overall Study|Lost to Follow-up|4|||
46985305|NCT02545049|83231615|FG001|Overall Study|Lost to Follow-up|6|||
46985306|NCT02545049|83231614|FG000|Overall Study|GCP violations|37|||
46985307|NCT02545049|83231615|FG001|Overall Study|GCP violations|48|||
46985308|NCT02532283|83231623|FG000|Overall Study|Adverse Event|0|||
46985309|NCT02532283|83231624|FG001|Overall Study|Adverse Event|1|||
46985310|NCT02532283|83231623|FG000|Overall Study|Death|1|||
46985311|NCT02532283|83231624|FG001|Overall Study|Death|0|||
46985312|NCT02532283|83231623|FG000|Overall Study|Lost to Follow-up|0|||
46985313|NCT02532283|83231624|FG001|Overall Study|Lost to Follow-up|1|||
46985314|NCT02532283|83231623|FG000|Overall Study|Withdrawal by Subject|8|||
46985315|NCT02532283|83231624|FG001|Overall Study|Withdrawal by Subject|3|||
46985316|NCT01295125|83231645|FG000|Overall Study|Study stopped prematurely|9|||
46985317|NCT02540291|83231653|FG000|Overall Study|Death|7|||
46985318|NCT02540291|83231654|FG001|Overall Study|Death|7|||
46985319|NCT02540291|83231655|FG002|Overall Study|Death|5|||
46985320|NCT02540291|83231656|FG003|Overall Study|Death|7|||
46985321|NCT02540291|83231653|FG000|Overall Study|Lost to Follow-up|0|||
46985322|NCT02540291|83231654|FG001|Overall Study|Lost to Follow-up|0|||
46985323|NCT02540291|83231655|FG002|Overall Study|Lost to Follow-up|1|||
46985324|NCT02540291|83231656|FG003|Overall Study|Lost to Follow-up|0|||
46985325|NCT02540291|83231653|FG000|Overall Study|Withdrawal Of Consent|0|||
46985326|NCT02540291|83231654|FG001|Overall Study|Withdrawal Of Consent|1|||
46985327|NCT02540291|83231655|FG002|Overall Study|Withdrawal Of Consent|0|||
46985328|NCT02540291|83231656|FG003|Overall Study|Withdrawal Of Consent|0|||
46985329|NCT02540291|83231653|FG000|Overall Study|Study Terminated By Sponsor|1|||
46985330|NCT02540291|83231654|FG001|Overall Study|Study Terminated By Sponsor|0|||
46985331|NCT02540291|83231655|FG002|Overall Study|Study Terminated By Sponsor|0|||
46985332|NCT02540291|83231656|FG003|Overall Study|Study Terminated By Sponsor|0|||
46985333|NCT02540291|83231653|FG000|Overall Study|Other|0|||
46985334|NCT02540291|83231654|FG001|Overall Study|Other|0|||
46985335|NCT02540291|83231655|FG002|Overall Study|Other|1|||
46985336|NCT02540291|83231656|FG003|Overall Study|Other|0|||
46702999|NCT01070043|82917731|FG002|Double-Blind Treatment|Adverse Event|2|||
46703000|NCT01074255|82917737|FG000|Overall Study|Did not receive EMEND|2|||
46703001|NCT01073943|82917743|FG000|Overall Study|Withdrawal by Subject|8|||
46703002|NCT01073943|82917744|FG001|Overall Study|Withdrawal by Subject|2|||
46703003|NCT01073943|82917743|FG000|Overall Study|Protocol Violation|2|||
46985337|NCT02540213|83231668|FG000|Overall Study|Death/adverse event|18|||
46985338|NCT02540213|83231668|FG000|Overall Study|Administrative reasons|3|||
46985339|NCT02540213|83231668|FG000|Overall Study|Kidney transplant|3|||
46985340|NCT02540213|83231668|FG000|Overall Study|Lack of Efficacy|6|||
46985341|NCT02540213|83231668|FG000|Overall Study|Consent withdrawn|7|||
46985342|NCT02540213|83231668|FG000|Overall Study|Enrolled but not treated|2|||
46985343|NCT02552303|83231676|FG000|Allocation|Withdrawal by Subject|2|||
46985344|NCT02552303|83231677|FG001|Allocation|Withdrawal by Subject|1|||
46703004|NCT01073943|82917744|FG001|Overall Study|Protocol Violation|1|||
46703005|NCT01073943|82917743|FG000|Overall Study|Adverse Event|1|||
46703006|NCT01073943|82917744|FG001|Overall Study|Adverse Event|1|||
46985345|NCT02552303|83231678|FG002|Allocation|Withdrawal by Subject|1|||
46985346|NCT02552303|83231679|FG003|Allocation|Withdrawal by Subject|1|||
46985347|NCT02552303|83231676|FG000|Allocation|ineligible|1|||
46985348|NCT02552303|83231677|FG001|Allocation|ineligible|1|||
46985349|NCT02552303|83231678|FG002|Allocation|ineligible|0|||
46985350|NCT02552303|83231679|FG003|Allocation|ineligible|0|||
46985351|NCT02552303|83231676|FG000|Follow-Up|Lost to Follow-up|0|||
46985352|NCT02552303|83231677|FG001|Follow-Up|Lost to Follow-up|0|||
46985353|NCT02552303|83231678|FG002|Follow-Up|Lost to Follow-up|1|||
46985354|NCT02552303|83231679|FG003|Follow-Up|Lost to Follow-up|0|||
46985355|NCT02552303|83231676|FG000|Follow-Up|ineligible|0|||
46985356|NCT02552303|83231677|FG001|Follow-Up|ineligible|2|||
46985357|NCT02552303|83231678|FG002|Follow-Up|ineligible|0|||
46985358|NCT02552303|83231679|FG003|Follow-Up|ineligible|0|||
46985359|NCT01660711|83231689|FG000|Overall Study|Adverse Event|7|||
46985360|NCT01660711|83231689|FG000|Overall Study|Withdrawal by Subject|1|||
46985361|NCT02544113|83231695|FG000|Overall Study|Death|3|||
46985362|NCT02544113|83231696|FG001|Overall Study|Death|4|||
46985363|NCT02538965|83231702|FG000|Treatment Period|Other = Death due to disease progression|1|||
46985364|NCT02538965|83231702|FG000|Treatment Period|Adverse Event|2|||
46985365|NCT02538965|83231702|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
46985366|NCT02538965|83231702|FG000|Treatment Period|Treatment Failure|9|||
46985367|NCT02538965|83231702|FG000|Treatment Period|Disease Progression|1|||
46985368|NCT02538965|83231702|FG000|Treatment Period|Physician Decision|2|||
46985369|NCT02538965|83231702|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
46985370|NCT02538965|83231702|FG000|Follow-Up Period|Withdrawal by Parent|4|||
46985371|NCT02543801|83231710|FG000|Overall Study|Protocol Violation|1|||
46985372|NCT02543801|83231711|FG001|Overall Study|Protocol Violation|2|||
46985373|NCT02543801|83231712|FG002|Overall Study|Protocol Violation|0|||
46985374|NCT02543801|83231713|FG003|Overall Study|Protocol Violation|0|||
46985375|NCT02535065|83231723|FG000|Overall Study|Death|13|||
46985376|NCT02535065|83231723|FG000|Overall Study|Lost to Follow-up|1|||
46985377|NCT02535065|83231723|FG000|Overall Study|Withdrawal by Subject|6|||
46985378|NCT02530619|83231727|FG000|Registered for Study|Withdrawal by Subject|2|||
46985379|NCT02530619|83231727|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
46985380|NCT02530619|83231727|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
46985381|NCT02530619|83231727|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
46985382|NCT02530619|83231727|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
46985383|NCT02530619|83231727|FG000|Follow-up Period (6 Months)|Death|4|||
46985384|NCT02530619|83231727|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
46985385|NCT02530619|83231727|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
46985386|NCT02530385|83231733|FG000|Overall Study|Withdrawal by Subject|0|||
46985387|NCT02530385|83231734|FG001|Overall Study|Withdrawal by Subject|1|||
46985388|NCT02362425|83231744|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
46985389|NCT02362425|83231745|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
46985390|NCT02362425|83231746|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
46985391|NCT02362425|83231747|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
46985392|NCT02362425|83231744|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
46985393|NCT02362425|83231745|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
46985394|NCT02362425|83231746|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
46985395|NCT02362425|83231747|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
46985396|NCT02362425|83231744|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
46985397|NCT02362425|83231745|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
46985398|NCT02362425|83231746|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
46703007|NCT01073943|82917743|FG000|Overall Study|Lost to Follow-up|0|||
46703008|NCT01073943|82917744|FG001|Overall Study|Lost to Follow-up|2|||
46703009|NCT01073943|82917743|FG000|Overall Study|Power outage; colonoscopy not done|1|||
46878000|NCT03230864|83098809|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
46878001|NCT03230864|83098810|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
46878002|NCT03230864|83098811|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
46878003|NCT03230864|83098808|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
46878004|NCT03230864|83098809|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
46878005|NCT03230864|83098810|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
46878006|NCT03230864|83098811|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
46878007|NCT03230864|83098808|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
46878008|NCT03230864|83098809|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
46985399|NCT02362425|83231747|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
46985400|NCT02362425|83231744|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
46985401|NCT02362425|83231745|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
46985402|NCT02362425|83231746|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
46985403|NCT02362425|83231747|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
46985404|NCT02362425|83231744|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
46985405|NCT02362425|83231745|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
46985406|NCT02362425|83231746|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
46985407|NCT02362425|83231747|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
46703010|NCT01073943|82917744|FG001|Overall Study|Power outage; colonoscopy not done|0|||
46985408|NCT02362425|83231744|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
46985409|NCT02362425|83231745|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
46985410|NCT02362425|83231746|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
46985411|NCT02362425|83231747|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
46985412|NCT02362425|83231744|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
46985413|NCT02362425|83231745|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
46985414|NCT02362425|83231746|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
46985415|NCT02362425|83231747|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
46985416|NCT02362425|83231744|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
46985417|NCT02362425|83231745|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
46985418|NCT02362425|83231746|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
46985419|NCT02362425|83231747|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
46985420|NCT02362269|83231760|FG000|Overall Study|Moved|1|||
46985421|NCT02362269|83231761|FG001|Overall Study|Moved|0|||
46985422|NCT02362269|83231760|FG000|Overall Study|Lost to Follow-up|0|||
46985423|NCT02362269|83231761|FG001|Overall Study|Lost to Follow-up|6|||
46985424|NCT02529995|83231769|FG000|Part A|Ongoing Study at Data Cut-off|14|||
46985425|NCT02529995|83231770|FG001|Part A|Ongoing Study at Data Cut-off|16|||
46985426|NCT02529995|83231769|FG000|Part A|Discontinued Study|1|||
46985427|NCT02529995|83231770|FG001|Part A|Discontinued Study|0|||
46985428|NCT02529995|83231769|FG000|Part B|Ongoing Study at Data Cut-off|0|||
46985429|NCT02529995|83231770|FG001|Part B|Ongoing Study at Data Cut-off|7|||
46985430|NCT02529995|83231769|FG000|Part B|Discontinued Study|6|||
46985431|NCT02529995|83231770|FG001|Part B|Discontinued Study|5|||
46985432|NCT02529137|83231776|FG000|Overall Study|Discontinuation for different reasons|8|||
46985433|NCT02319759|83231783|FG000|Week 0 - 16|Lack of Efficacy|1|||
46985434|NCT02319759|83231784|FG001|Week 0 - 16|Lack of Efficacy|0|||
46985435|NCT02319759|83231785|FG002|Week 0 - 16|Lack of Efficacy|0|||
46985436|NCT02319759|83231786|FG003|Week 0 - 16|Lack of Efficacy|0|||
46985437|NCT02319759|83231787|FG004|Week 0 - 16|Lack of Efficacy|0|||
46985438|NCT02319759|83231783|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
46985439|NCT02319759|83231784|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
46985440|NCT02319759|83231785|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
46985441|NCT02319759|83231786|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
46985442|NCT02319759|83231787|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
46985443|NCT02319759|83231783|FG000|Week 16 - 24|Lack of Efficacy|1|||
46985444|NCT02319759|83231784|FG001|Week 16 - 24|Lack of Efficacy|0|||
46985445|NCT02319759|83231785|FG002|Week 16 - 24|Lack of Efficacy|1|||
46985446|NCT02319759|83231786|FG003|Week 16 - 24|Lack of Efficacy|0|||
46985447|NCT02319759|83231787|FG004|Week 16 - 24|Lack of Efficacy|0|||
46985448|NCT02319759|83231783|FG000|Week 16 - 24|Lost to Follow-up|1|||
46985449|NCT02319759|83231784|FG001|Week 16 - 24|Lost to Follow-up|0|||
46985450|NCT02319759|83231785|FG002|Week 16 - 24|Lost to Follow-up|0|||
46985451|NCT02319759|83231786|FG003|Week 16 - 24|Lost to Follow-up|0|||
46985452|NCT02319759|83231787|FG004|Week 16 - 24|Lost to Follow-up|0|||
46985453|NCT02319759|83231783|FG000|Week 16 - 24|Withdrawal by Subject|0|||
46985454|NCT02319759|83231784|FG001|Week 16 - 24|Withdrawal by Subject|0|||
46985455|NCT02319759|83231785|FG002|Week 16 - 24|Withdrawal by Subject|2|||
46985456|NCT02319759|83231786|FG003|Week 16 - 24|Withdrawal by Subject|0|||
46985457|NCT02319759|83231787|FG004|Week 16 - 24|Withdrawal by Subject|0|||
46985458|NCT02319759|83231783|FG000|Week 24 - 56|Adverse Event|0|||
46985459|NCT02319759|83231784|FG001|Week 24 - 56|Adverse Event|0|||
46985460|NCT02319759|83231785|FG002|Week 24 - 56|Adverse Event|2|||
46985461|NCT02319759|83231786|FG003|Week 24 - 56|Adverse Event|0|||
46985462|NCT02319759|83231787|FG004|Week 24 - 56|Adverse Event|0|||
46985463|NCT02319759|83231783|FG000|Week 24 - 56|Lack of Efficacy|0|||
46985464|NCT02319759|83231784|FG001|Week 24 - 56|Lack of Efficacy|0|||
46985465|NCT02319759|83231785|FG002|Week 24 - 56|Lack of Efficacy|0|||
46985466|NCT02319759|83231786|FG003|Week 24 - 56|Lack of Efficacy|2|||
46985467|NCT02319759|83231787|FG004|Week 24 - 56|Lack of Efficacy|1|||
46985468|NCT02319759|83231783|FG000|Week 24 - 56|Withdrawal by Subject|0|||
46985469|NCT02319759|83231784|FG001|Week 24 - 56|Withdrawal by Subject|1|||
46985470|NCT02319759|83231785|FG002|Week 24 - 56|Withdrawal by Subject|0|||
46985471|NCT02319759|83231786|FG003|Week 24 - 56|Withdrawal by Subject|0|||
46985472|NCT02319759|83231787|FG004|Week 24 - 56|Withdrawal by Subject|0|||
46985473|NCT02319759|83231783|FG000|Week 24 - 56|Lost to Follow-up|0|||
46985474|NCT02319759|83231784|FG001|Week 24 - 56|Lost to Follow-up|0|||
46985475|NCT02319759|83231785|FG002|Week 24 - 56|Lost to Follow-up|0|||
46985476|NCT02319759|83231786|FG003|Week 24 - 56|Lost to Follow-up|0|||
46985477|NCT02319759|83231787|FG004|Week 24 - 56|Lost to Follow-up|1|||
46985478|NCT02293005|83231800|FG000|Overall Study|Adverse Event|2|||
46985479|NCT02293005|83231800|FG000|Overall Study|Death|4|||
46985480|NCT02293005|83231800|FG000|Overall Study|Lost to Follow-up|1|||
46985481|NCT02293005|83231800|FG000|Overall Study|Withdrawal by Subject|2|||
46985482|NCT02293005|83231800|FG000|Overall Study|Progression|17|||
46985483|NCT02319525|83231806|FG000|Overall Study|Withdrawal by Subject|2|||
46985484|NCT02319525|83231807|FG001|Overall Study|Withdrawal by Subject|1|||
46985485|NCT02292927|83231815|FG000|Overall Study|Protocol Violation|13|||
46878009|NCT03230864|83098810|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
46878010|NCT03230864|83098811|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
46878011|NCT04085367|83098823|FG000|Overall Study|Adverse Event|1|||
46878012|NCT04085367|83098824|FG001|Overall Study|Adverse Event|1|||
46878013|NCT04085367|83098823|FG000|Overall Study|Withdrawal by Subject|13|||
46878014|NCT04085367|83098824|FG001|Overall Study|Withdrawal by Subject|4|||
46878015|NCT04085367|83098823|FG000|Overall Study|Lost to Follow-up|3|||
46878016|NCT04085367|83098824|FG001|Overall Study|Lost to Follow-up|1|||
46878017|NCT04085367|83098823|FG000|Overall Study|Other unspecified|2|||
46878018|NCT04085367|83098824|FG001|Overall Study|Other unspecified|1|||
46878019|NCT04085367|83098823|FG000|Overall Study|Status Unknown|1|||
46878020|NCT04085367|83098824|FG001|Overall Study|Status Unknown|1|||
46878021|NCT03228836|83098830|FG000|Overall Study|Adverse Event|3|||
46878022|NCT03228836|83098830|FG000|Overall Study|Withdrawal by Subject|1|||
46878023|NCT03228836|83098830|FG000|Overall Study|Death|1|||
46878024|NCT03228836|83098830|FG000|Overall Study|Physician Decision|1|||
46878025|NCT03228836|83098830|FG000|Overall Study|Disease Progression|7|||
46878026|NCT03228836|83098830|FG000|Overall Study|Other|4|||
46878027|NCT02937350|83098837|FG000|Overall Study|Withdrawal by Subject|0|||
46878028|NCT02937350|83098838|FG001|Overall Study|Withdrawal by Subject|1|||
46878029|NCT02937350|83098839|FG002|Overall Study|Withdrawal by Subject|0|||
46878030|NCT04085289|83098848|FG000|Overall Study|Withdrawal by Subject|0|||
46878031|NCT04085289|83098849|FG001|Overall Study|Withdrawal by Subject|0|||
46878032|NCT04085289|83098850|FG002|Overall Study|Withdrawal by Subject|1|||
46878033|NCT04080297|83098859|FG000|Overall Study|Adverse Event|1|||
46878034|NCT04080297|83098860|FG001|Overall Study|Adverse Event|3|||
46878035|NCT04080297|83098859|FG000|Overall Study|concurrent illness|1|||
46878036|NCT04080297|83098860|FG001|Overall Study|concurrent illness|0|||
46878037|NCT04013529|83098868|FG000|Overall Study|Withdrawal by Subject|1|||
46878038|NCT04013529|83098869|FG001|Overall Study|Withdrawal by Subject|1|||
46878039|NCT04011735|83098878|FG000|Overall Study|Withdrawal by Subject|1|||
46878040|NCT04011735|83098879|FG001|Overall Study|Withdrawal by Subject|0|||
46878041|NCT04011735|83098880|FG002|Overall Study|Withdrawal by Subject|1|||
46878042|NCT04011735|83098878|FG000|Overall Study|Met exclusion criteria after study entry|0|||
46878043|NCT04011735|83098879|FG001|Overall Study|Met exclusion criteria after study entry|1|||
46878044|NCT04011735|83098880|FG002|Overall Study|Met exclusion criteria after study entry|0|||
46878045|NCT04009629|83098892|FG000|Overall Study|Withdrawal by Subject|2|||
46878046|NCT04009629|83098893|FG001|Overall Study|Withdrawal by Subject|0|||
46878047|NCT03694197|83098902|FG000|Overall Study|Adverse Event|9|||
46878048|NCT03694197|83098902|FG000|Overall Study|Protocol became inconvenient to participate|1|||
46878049|NCT03694197|83098902|FG000|Overall Study|Physician Decision|4|||
46878050|NCT03694197|83098902|FG000|Overall Study|Study terminated by sponsor|1350|||
46878051|NCT03694197|83098902|FG000|Overall Study|Participant moved|5|||
46878052|NCT03694197|83098902|FG000|Overall Study|Participant withdrew consent|10|||
46878053|NCT03694197|83098902|FG000|Overall Study|Related to IMP administration|1|||
46878054|NCT03694197|83098902|FG000|Overall Study|Not disclosed|5|||
46878055|NCT04365699|83098909|FG000|Overall Study|Death|2|||
46878056|NCT04365699|83098910|FG001|Overall Study|Death|5|||
46878057|NCT04365699|83098911|FG002|Overall Study|Death|15|||
46878058|NCT04005885|83098919|FG000|First Intervention|Withdrawal by Subject|1|||
46878059|NCT04005885|83098920|FG001|First Intervention|Withdrawal by Subject|1|||
46878060|NCT04005885|83098919|FG000|Second Intervention|Withdrawal by Subject|0|||
46878061|NCT04005885|83098920|FG001|Second Intervention|Withdrawal by Subject|2|||
46878062|NCT04003623|83098933|FG000|Overall Study|Withdrawal by Subject|1|||
46878063|NCT04003623|83098934|FG001|Overall Study|Withdrawal by Subject|0|||
46878064|NCT04480424|83098942|FG000|Overall Study|Withdrawal by Subject|0|||
46878065|NCT04480424|83098943|FG001|Overall Study|Withdrawal by Subject|2|||
46878066|NCT04480424|83098942|FG000|Overall Study|Lost to Follow-up|3|||
46878067|NCT04480424|83098943|FG001|Overall Study|Lost to Follow-up|3|||
46878068|NCT04480424|83098942|FG000|Overall Study|Death|14|||
46878069|NCT04480424|83098943|FG001|Overall Study|Death|16|||
46878070|NCT04480424|83098942|FG000|Overall Study|Reason not Specified|5|||
46985486|NCT02292927|83231816|FG001|Overall Study|Protocol Violation|7|||
46878071|NCT04480424|83098943|FG001|Overall Study|Reason not Specified|5|||
46878072|NCT03256526|83098952|FG000|Overall Study|Adverse Event|1|||
46878073|NCT03256526|83098953|FG001|Overall Study|Adverse Event|0|||
46985487|NCT02292849|83231828|FG000|Overall Study|Lost to Follow-up|0|||
46703011|NCT01073943|82917743|FG000|Overall Study|Subject forgot|0|||
46878074|NCT03256526|83098954|FG002|Overall Study|Adverse Event|1|||
46878075|NCT03256526|83098952|FG000|Overall Study|Lost to Follow-up|1|||
46878076|NCT03256526|83098953|FG001|Overall Study|Lost to Follow-up|0|||
46878077|NCT03256526|83098954|FG002|Overall Study|Lost to Follow-up|2|||
46878078|NCT03255980|83098966|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
46878079|NCT03255980|83098967|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
46878080|NCT03255980|83098968|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
46985488|NCT02292849|83231829|FG001|Overall Study|Lost to Follow-up|2|||
46878081|NCT03255980|83098969|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
46985489|NCT02292849|83231830|FG002|Overall Study|Lost to Follow-up|2|||
46985490|NCT02292849|83231828|FG000|Overall Study|Physician Decision|4|||
46985491|NCT02292849|83231829|FG001|Overall Study|Physician Decision|0|||
46985492|NCT02292849|83231830|FG002|Overall Study|Physician Decision|0|||
46985493|NCT02318667|83231838|FG000|Overall Study|Adverse Event|1|||
46985494|NCT02318667|83231838|FG000|Overall Study|Lack of Efficacy|6|||
46985495|NCT02318667|83231838|FG000|Overall Study|Protocol Violation|2|||
46985496|NCT02292771|83231848|FG000|Overall Study|Withdrawal by Subject|2|||
46985497|NCT02292771|83231849|FG001|Overall Study|Withdrawal by Subject|1|||
46985498|NCT02292771|83231848|FG000|Overall Study|Lost to Follow-up|2|||
46985499|NCT02292771|83231849|FG001|Overall Study|Lost to Follow-up|1|||
46985500|NCT02291913|83231859|FG000|Overall Study|Progressive Disease|32|||
46985501|NCT02291913|83231859|FG000|Overall Study|Adverse Event|11|||
46985502|NCT02291913|83231859|FG000|Overall Study|Death|2|||
46985503|NCT02291913|83231859|FG000|Overall Study|Physician Decision|1|||
46985504|NCT02291913|83231859|FG000|Overall Study|Withdrawal by Subject|1|||
46985505|NCT02291913|83231859|FG000|Overall Study|Protocol Violation|1|||
46985506|NCT02291679|83231866|FG000|Overall Study|Adverse Event|2|||
46985507|NCT02291679|83231867|FG001|Overall Study|Adverse Event|12|||
46985508|NCT02291679|83231868|FG002|Overall Study|Adverse Event|19|||
46985509|NCT02291679|83231866|FG000|Overall Study|Protocol Violation|5|||
46985510|NCT02291679|83231867|FG001|Overall Study|Protocol Violation|1|||
46985511|NCT02291679|83231868|FG002|Overall Study|Protocol Violation|7|||
46985512|NCT02291679|83231866|FG000|Overall Study|Withdrew Consent|18|||
46985513|NCT02291679|83231867|FG001|Overall Study|Withdrew Consent|10|||
46985514|NCT02291679|83231868|FG002|Overall Study|Withdrew Consent|15|||
46985515|NCT02291679|83231866|FG000|Overall Study|Lost to Follow-up|12|||
46985516|NCT02291679|83231867|FG001|Overall Study|Lost to Follow-up|10|||
46985517|NCT02291679|83231868|FG002|Overall Study|Lost to Follow-up|9|||
46985518|NCT02291679|83231866|FG000|Overall Study|Insufficient Therapeutic Response|5|||
46985519|NCT02291679|83231867|FG001|Overall Study|Insufficient Therapeutic Response|5|||
46985520|NCT02291679|83231868|FG002|Overall Study|Insufficient Therapeutic Response|7|||
46985521|NCT02291679|83231866|FG000|Overall Study|Other|2|||
46985522|NCT02291679|83231867|FG001|Overall Study|Other|4|||
46985523|NCT02291679|83231868|FG002|Overall Study|Other|2|||
46985524|NCT02291601|83231875|FG000|Abdomen|Did not qualify|333|||
46985525|NCT02291601|83231876|FG001|Abdomen|Did not qualify|54|||
46985526|NCT02291601|83231877|FG002|Abdomen|Did not qualify|339|||
46985527|NCT02291601|83231875|FG000|Groin|Did not qualify|183|||
46985528|NCT02291601|83231876|FG001|Groin|Did not qualify|30|||
46985529|NCT02291601|83231877|FG002|Groin|Did not qualify|177|||
46985530|NCT02360475|83231892|FG000|Overall Study|Lost to Follow-up|4|||
46985531|NCT02360475|83231893|FG001|Overall Study|Lost to Follow-up|12|||
46985532|NCT02360475|83231894|FG002|Overall Study|Lost to Follow-up|6|||
46985533|NCT02360475|83231895|FG003|Overall Study|Lost to Follow-up|4|||
46985534|NCT02360475|83231892|FG000|Overall Study|Withdrawal by Subject|0|||
46985535|NCT02360475|83231893|FG001|Overall Study|Withdrawal by Subject|1|||
46985536|NCT02360475|83231894|FG002|Overall Study|Withdrawal by Subject|2|||
46985537|NCT02360475|83231895|FG003|Overall Study|Withdrawal by Subject|0|||
46985538|NCT02360475|83231892|FG000|Overall Study|Migrated/moved from study area|0|||
46985539|NCT02360475|83231893|FG001|Overall Study|Migrated/moved from study area|0|||
46985540|NCT02360475|83231894|FG002|Overall Study|Migrated/moved from study area|0|||
46878082|NCT03255980|83098966|FG000|Overall Study|Adverse Event|1|||
46878083|NCT03255980|83098967|FG001|Overall Study|Adverse Event|1|||
46985541|NCT02360475|83231895|FG003|Overall Study|Migrated/moved from study area|1|||
46985542|NCT02360397|83231905|FG000|Overall Study|Incomplete screening|3|||
46985543|NCT02360397|83231905|FG000|Overall Study|Adverse Event|1|||
46985544|NCT02317809|83231910|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
46985545|NCT02317809|83231911|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
46985546|NCT02317809|83231910|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
46985547|NCT02317809|83231911|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
46985548|NCT02359851|83231920|FG000|Overall Study|Death|1|||
46985549|NCT02359851|83231920|FG000|Overall Study|Disease progression|1|||
46985550|NCT01607905|83231931|FG000|Overall Study|Withdrawal by participant|7|||
46985551|NCT01607905|83231932|FG001|Overall Study|Withdrawal by participant|2|||
46985552|NCT01607905|83231933|FG002|Overall Study|Withdrawal by participant|4|||
46985553|NCT01607905|83231934|FG003|Overall Study|Withdrawal by participant|6|||
46985554|NCT01607905|83231935|FG004|Overall Study|Withdrawal by participant|0|||
46985555|NCT01607905|83231936|FG005|Overall Study|Withdrawal by participant|4|||
46985556|NCT01607905|83231937|FG006|Overall Study|Withdrawal by participant|12|||
46985557|NCT01607905|83231931|FG000|Overall Study|Incidence or severity of AEs|5|||
46985558|NCT01607905|83231932|FG001|Overall Study|Incidence or severity of AEs|1|||
46985559|NCT01607905|83231933|FG002|Overall Study|Incidence or severity of AEs|1|||
46985560|NCT01607905|83231934|FG003|Overall Study|Incidence or severity of AEs|3|||
46985561|NCT01607905|83231935|FG004|Overall Study|Incidence or severity of AEs|0|||
46985562|NCT01607905|83231936|FG005|Overall Study|Incidence or severity of AEs|2|||
46985563|NCT01607905|83231937|FG006|Overall Study|Incidence or severity of AEs|8|||
46985564|NCT01607905|83231931|FG000|Overall Study|Disease progression|44|||
46985565|NCT01607905|83231932|FG001|Overall Study|Disease progression|16|||
46985566|NCT01607905|83231933|FG002|Overall Study|Disease progression|15|||
46985567|NCT01607905|83231934|FG003|Overall Study|Disease progression|11|||
46985568|NCT01607905|83231935|FG004|Overall Study|Disease progression|6|||
46985569|NCT01607905|83231936|FG005|Overall Study|Disease progression|7|||
46985570|NCT01607905|83231937|FG006|Overall Study|Disease progression|21|||
46985571|NCT01607905|83231931|FG000|Overall Study|Non-compliance with study procedures|0|||
46985572|NCT01607905|83231932|FG001|Overall Study|Non-compliance with study procedures|0|||
46985573|NCT01607905|83231933|FG002|Overall Study|Non-compliance with study procedures|0|||
46985574|NCT01607905|83231934|FG003|Overall Study|Non-compliance with study procedures|0|||
46985575|NCT01607905|83231935|FG004|Overall Study|Non-compliance with study procedures|0|||
46985576|NCT01607905|83231936|FG005|Overall Study|Non-compliance with study procedures|0|||
46985577|NCT01607905|83231937|FG006|Overall Study|Non-compliance with study procedures|1|||
46985578|NCT01607905|83231931|FG000|Overall Study|Death|1|||
46985579|NCT01607905|83231932|FG001|Overall Study|Death|1|||
46985580|NCT01607905|83231933|FG002|Overall Study|Death|1|||
46985581|NCT01607905|83231934|FG003|Overall Study|Death|1|||
46985582|NCT01607905|83231935|FG004|Overall Study|Death|0|||
46985583|NCT01607905|83231936|FG005|Overall Study|Death|0|||
46985584|NCT01607905|83231937|FG006|Overall Study|Death|3|||
46985585|NCT01607905|83231931|FG000|Overall Study|Other treatments become available|1|||
46985586|NCT01607905|83231932|FG001|Overall Study|Other treatments become available|0|||
46985587|NCT01607905|83231933|FG002|Overall Study|Other treatments become available|0|||
46985588|NCT01607905|83231934|FG003|Overall Study|Other treatments become available|0|||
46985589|NCT01607905|83231935|FG004|Overall Study|Other treatments become available|0|||
46985590|NCT01607905|83231936|FG005|Overall Study|Other treatments become available|0|||
46703012|NCT01073943|82917744|FG001|Overall Study|Subject forgot|1|||
46703013|NCT01073943|82917743|FG000|Overall Study|Unable to return for follow-up|0|||
46985591|NCT01607905|83231937|FG006|Overall Study|Other treatments become available|1|||
46878084|NCT03255980|83098968|FG002|Overall Study|Adverse Event|0|||
46703014|NCT01073943|82917744|FG001|Overall Study|Unable to return for follow-up|1|||
46703015|NCT01073943|82917743|FG000|Overall Study|Could not tolerate prep|1|||
46703016|NCT01073943|82917744|FG001|Overall Study|Could not tolerate prep|0|||
46703017|NCT01073865|82917752|FG000|Overall Study|Reasons other than below|19|||
46703018|NCT01073865|82917753|FG001|Overall Study|Reasons other than below|31|||
46703019|NCT01073865|82917752|FG000|Overall Study|Lost to Follow-up|1|||
46703020|NCT01073865|82917753|FG001|Overall Study|Lost to Follow-up|1|||
46703021|NCT01073865|82917752|FG000|Overall Study|Death|3|||
46703022|NCT01073865|82917753|FG001|Overall Study|Death|2|||
46703023|NCT01073865|82917752|FG000|Overall Study|Withdrawal by Subject|5|||
46703024|NCT01073865|82917753|FG001|Overall Study|Withdrawal by Subject|5|||
46703025|NCT04862065|82917762|FG000|Screening|Protocol Violation|54|||
46703026|NCT04862065|82917763|FG001|Screening|Protocol Violation|0|||
46703027|NCT04862065|82917764|FG002|Screening|Protocol Violation|0|||
46703028|NCT04862065|82917762|FG000|Screening|Insufficient Sample|1|||
46703029|NCT04862065|82917763|FG001|Screening|Insufficient Sample|0|||
46703030|NCT04862065|82917764|FG002|Screening|Insufficient Sample|0|||
46703031|NCT04862065|82917762|FG000|Follow-Up|Lost to Follow-up|3|||
46703032|NCT04862065|82917763|FG001|Follow-Up|Lost to Follow-up|0|||
46703033|NCT04862065|82917764|FG002|Follow-Up|Lost to Follow-up|0|||
46703034|NCT01073631|82917770|FG000|Overall Study|Death|82|||
46703035|NCT01073631|82917770|FG000|Overall Study|Adverse Event|24|||
46703036|NCT01073631|82917770|FG000|Overall Study|Other|63|||
46703037|NCT01073163|82917774|FG000|Overall Study|Adverse Event|1|||
46703038|NCT01073163|82917774|FG000|Overall Study|Disease Progression|1|||
46703039|NCT01073163|82917774|FG000|Overall Study|Early termination|1|||
46703040|NCT01072929|82917785|FG000|Overall Study|Adverse Event|8|||
46703041|NCT01072929|82917786|FG001|Overall Study|Adverse Event|11|||
46703042|NCT01072929|82917787|FG002|Overall Study|Adverse Event|2|||
46703043|NCT01072929|82917785|FG000|Overall Study|Lack of Efficacy|7|||
46703044|NCT01072929|82917786|FG001|Overall Study|Lack of Efficacy|4|||
46703045|NCT01072929|82917787|FG002|Overall Study|Lack of Efficacy|0|||
46703046|NCT01072929|82917785|FG000|Overall Study|Withdrawal by Subject|7|||
46703047|NCT01072929|82917786|FG001|Overall Study|Withdrawal by Subject|15|||
46703048|NCT01072929|82917787|FG002|Overall Study|Withdrawal by Subject|3|||
46703049|NCT01072929|82917785|FG000|Overall Study|Protocol Violation|13|||
46703050|NCT01072929|82917786|FG001|Overall Study|Protocol Violation|11|||
46703051|NCT01072929|82917787|FG002|Overall Study|Protocol Violation|2|||
46703052|NCT01072929|82917785|FG000|Overall Study|Lost to Follow-up|8|||
46703053|NCT01072929|82917786|FG001|Overall Study|Lost to Follow-up|4|||
46703054|NCT01072929|82917787|FG002|Overall Study|Lost to Follow-up|1|||
46703055|NCT01072929|82917785|FG000|Overall Study|Noncompliance with study medication|0|||
46703056|NCT01072929|82917786|FG001|Overall Study|Noncompliance with study medication|3|||
46703057|NCT01072929|82917787|FG002|Overall Study|Noncompliance with study medication|0|||
46703058|NCT01072929|82917785|FG000|Overall Study|Noncompliance with study procedures|1|||
46703059|NCT01072929|82917786|FG001|Overall Study|Noncompliance with study procedures|0|||
46703060|NCT01072929|82917787|FG002|Overall Study|Noncompliance with study procedures|1|||
46703061|NCT01072929|82917785|FG000|Overall Study|Other|0|||
46878085|NCT03255980|83098969|FG003|Overall Study|Adverse Event|1|||
46878086|NCT03255980|83098966|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
46878087|NCT03255980|83098967|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
46878088|NCT03255980|83098968|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
46878089|NCT03255980|83098969|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
46985592|NCT01607905|83231931|FG000|Overall Study|Investigator discretion|0|||
46985593|NCT01607905|83231932|FG001|Overall Study|Investigator discretion|0|||
46985594|NCT01607905|83231933|FG002|Overall Study|Investigator discretion|0|||
46985595|NCT01607905|83231934|FG003|Overall Study|Investigator discretion|0|||
46985596|NCT01607905|83231935|FG004|Overall Study|Investigator discretion|0|||
46985597|NCT01607905|83231936|FG005|Overall Study|Investigator discretion|1|||
46985598|NCT01607905|83231937|FG006|Overall Study|Investigator discretion|0|||
46985599|NCT01607905|83231931|FG000|Overall Study|Other|1|||
46985600|NCT01607905|83231932|FG001|Overall Study|Other|0|||
46985601|NCT01607905|83231933|FG002|Overall Study|Other|0|||
46985602|NCT01607905|83231934|FG003|Overall Study|Other|0|||
46985603|NCT01607905|83231935|FG004|Overall Study|Other|0|||
46985604|NCT01607905|83231936|FG005|Overall Study|Other|0|||
46985605|NCT01607905|83231937|FG006|Overall Study|Other|1|||
46985606|NCT01607905|83231931|FG000|Overall Study|Randomized but not treated|1|||
46703062|NCT01072929|82917786|FG001|Overall Study|Other|3|||
46703063|NCT01072929|82917787|FG002|Overall Study|Other|0|||
46703064|NCT01231607|82917801|FG000|Overall Study|Adverse Event|0|||
46703065|NCT01231607|82917802|FG001|Overall Study|Adverse Event|8|||
46703066|NCT01231607|82917803|FG002|Overall Study|Adverse Event|4|||
46703067|NCT01231607|82917804|FG003|Overall Study|Adverse Event|4|||
46703068|NCT01231607|82917805|FG004|Overall Study|Adverse Event|5|||
46703069|NCT01231607|82917801|FG000|Overall Study|Lost to Follow-up|13|||
46703070|NCT01231607|82917802|FG001|Overall Study|Lost to Follow-up|11|||
46703071|NCT01231607|82917803|FG002|Overall Study|Lost to Follow-up|10|||
46703072|NCT01231607|82917804|FG003|Overall Study|Lost to Follow-up|10|||
46802824|NCT03855189|83022104|FG000|Overall Study|Noncompliance with Protocol|0|||
46802825|NCT03855189|83022105|FG001|Overall Study|Noncompliance with Protocol|1|||
46802826|NCT03855189|83022106|FG002|Overall Study|Noncompliance with Protocol|0|||
46802827|NCT03855189|83022104|FG000|Overall Study|Did Not Return|4|||
46802828|NCT03855189|83022105|FG001|Overall Study|Did Not Return|3|||
46802829|NCT03855189|83022106|FG002|Overall Study|Did Not Return|0|||
46802830|NCT03853551|83022114|FG000|Overall Study|Death|2|||
46802831|NCT03853551|83022114|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
46802832|NCT00423670|83022125|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
46802833|NCT00423670|83022126|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
46802834|NCT00423670|83022127|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
46802835|NCT00423670|83022128|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
46802836|NCT00423670|83022129|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
46802837|NCT00423670|83022130|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
46703073|NCT01231607|82917805|FG004|Overall Study|Lost to Follow-up|4|||
46703074|NCT01231607|82917801|FG000|Overall Study|Physician Decision|4|||
46703075|NCT01231607|82917802|FG001|Overall Study|Physician Decision|4|||
46703076|NCT01231607|82917803|FG002|Overall Study|Physician Decision|3|||
46703077|NCT01231607|82917804|FG003|Overall Study|Physician Decision|5|||
46703078|NCT01231607|82917805|FG004|Overall Study|Physician Decision|4|||
46703079|NCT01231607|82917801|FG000|Overall Study|Protocol Violation|3|||
46703080|NCT01231607|82917802|FG001|Overall Study|Protocol Violation|2|||
46703081|NCT01231607|82917803|FG002|Overall Study|Protocol Violation|0|||
46703082|NCT01231607|82917804|FG003|Overall Study|Protocol Violation|2|||
46703083|NCT01231607|82917805|FG004|Overall Study|Protocol Violation|2|||
46703084|NCT01231607|82917801|FG000|Overall Study|Withdrawal by Subject|9|||
46703085|NCT01231607|82917802|FG001|Overall Study|Withdrawal by Subject|9|||
46703086|NCT01231607|82917803|FG002|Overall Study|Withdrawal by Subject|14|||
46703087|NCT01231607|82917804|FG003|Overall Study|Withdrawal by Subject|17|||
46703088|NCT01231607|82917805|FG004|Overall Study|Withdrawal by Subject|9|||
46703089|NCT01231373|82917824|FG000|Overall Study|Withdrew consent prior to randomization|2|||
46703090|NCT01231373|82917825|FG001|Overall Study|Withdrew consent prior to randomization|1|||
46703091|NCT01231373|82917826|FG002|Overall Study|Withdrew consent prior to randomization|0|||
46703092|NCT01231373|82917827|FG003|Overall Study|Withdrew consent prior to randomization|0|||
46703093|NCT01231373|82917824|FG000|Overall Study|Lost to Follow-up|0|||
46703094|NCT01231373|82917825|FG001|Overall Study|Lost to Follow-up|0|||
46703095|NCT01231373|82917826|FG002|Overall Study|Lost to Follow-up|0|||
46703096|NCT01231373|82917827|FG003|Overall Study|Lost to Follow-up|1|||
46703097|NCT01231373|82917824|FG000|Overall Study|Withdrew Consent|1|||
46703098|NCT01231373|82917825|FG001|Overall Study|Withdrew Consent|0|||
46703099|NCT01231373|82917826|FG002|Overall Study|Withdrew Consent|0|||
46703100|NCT01231373|82917827|FG003|Overall Study|Withdrew Consent|0|||
46703101|NCT00975130|82917839|FG000|Study Part 1|Adverse Event|150|||
46703102|NCT00975130|82917840|FG001|Study Part 1|Adverse Event|0|||
46703103|NCT00975130|82917841|FG002|Study Part 1|Adverse Event|0|||
46703104|NCT00975130|82917839|FG000|Study Part 1|Lost to Follow-up|19|||
46703105|NCT00975130|82917840|FG001|Study Part 1|Lost to Follow-up|0|||
46703106|NCT00975130|82917841|FG002|Study Part 1|Lost to Follow-up|0|||
46703107|NCT00975130|82917839|FG000|Study Part 1|Withdrawal by Subject|61|||
46703108|NCT00975130|82917840|FG001|Study Part 1|Withdrawal by Subject|0|||
46703109|NCT00975130|82917841|FG002|Study Part 1|Withdrawal by Subject|0|||
46703110|NCT00975130|82917839|FG000|Study Part 1|Protocol Violation|13|||
46703111|NCT00975130|82917840|FG001|Study Part 1|Protocol Violation|0|||
46703112|NCT00975130|82917841|FG002|Study Part 1|Protocol Violation|0|||
46703113|NCT00975130|82917839|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
46703114|NCT00975130|82917840|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
46703115|NCT00975130|82917841|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
46703116|NCT00975130|82917839|FG000|Study Part 1|Administrative|4|||
46703117|NCT00975130|82917840|FG001|Study Part 1|Administrative|0|||
46703118|NCT00975130|82917841|FG002|Study Part 1|Administrative|0|||
46703119|NCT00975130|82917839|FG000|Study Part 1|Withdrew Consent|24|||
46703120|NCT00975130|82917840|FG001|Study Part 1|Withdrew Consent|0|||
46703121|NCT00975130|82917841|FG002|Study Part 1|Withdrew Consent|0|||
46703122|NCT00975130|82917839|FG000|Study Part 2|Adverse Event|0|||
46703123|NCT00975130|82917840|FG001|Study Part 2|Adverse Event|14|||
46703124|NCT00975130|82917841|FG002|Study Part 2|Adverse Event|7|||
46703125|NCT00975130|82917839|FG000|Study Part 2|Lost to Follow-up|0|||
46703126|NCT00975130|82917840|FG001|Study Part 2|Lost to Follow-up|0|||
46703127|NCT00975130|82917841|FG002|Study Part 2|Lost to Follow-up|1|||
46703128|NCT00975130|82917839|FG000|Study Part 2|Withdrawal by Subject|0|||
46703129|NCT00975130|82917840|FG001|Study Part 2|Withdrawal by Subject|13|||
46703130|NCT00975130|82917841|FG002|Study Part 2|Withdrawal by Subject|5|||
46703131|NCT00975130|82917839|FG000|Study Part 2|Withdrew Consent|0|||
46703132|NCT00975130|82917840|FG001|Study Part 2|Withdrew Consent|6|||
46703133|NCT00975130|82917841|FG002|Study Part 2|Withdrew Consent|2|||
46703134|NCT00975130|82917839|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
46703135|NCT00975130|82917840|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
46703136|NCT00975130|82917841|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
46703137|NCT00975130|82917839|FG000|Study Part 2|Administrative|0|||
46703138|NCT00975130|82917840|FG001|Study Part 2|Administrative|1|||
46703139|NCT00975130|82917841|FG002|Study Part 2|Administrative|0|||
46703140|NCT00975130|82917839|FG000|Study Part 2|Protocol Violation|0|||
46703141|NCT00975130|82917840|FG001|Study Part 2|Protocol Violation|0|||
46703142|NCT00975130|82917841|FG002|Study Part 2|Protocol Violation|1|||
46703143|NCT01230827|82917858|FG000|Overall Study|Lost to Follow-up|0|||
46703144|NCT01230827|82917859|FG001|Overall Study|Lost to Follow-up|0|||
46703145|NCT01230827|82917860|FG002|Overall Study|Lost to Follow-up|1|||
46703146|NCT01230827|82917861|FG003|Overall Study|Lost to Follow-up|3|||
46703147|NCT01230827|82917858|FG000|Overall Study|Withdrawal by Subject|1|||
46703148|NCT01230827|82917859|FG001|Overall Study|Withdrawal by Subject|0|||
46703149|NCT01230827|82917860|FG002|Overall Study|Withdrawal by Subject|3|||
46703150|NCT01230827|82917861|FG003|Overall Study|Withdrawal by Subject|2|||
46703151|NCT01230827|82917858|FG000|Overall Study|Lack of Efficacy|14|||
46703152|NCT01230827|82917859|FG001|Overall Study|Lack of Efficacy|1|||
46703153|NCT01230827|82917860|FG002|Overall Study|Lack of Efficacy|2|||
46703154|NCT01230827|82917861|FG003|Overall Study|Lack of Efficacy|3|||
46703155|NCT01230827|82917858|FG000|Overall Study|Adverse Event|4|||
46703156|NCT01230827|82917859|FG001|Overall Study|Adverse Event|2|||
46703157|NCT01230827|82917860|FG002|Overall Study|Adverse Event|3|||
46703158|NCT01230827|82917861|FG003|Overall Study|Adverse Event|7|||
46703159|NCT01230827|82917858|FG000|Overall Study|Recovery|0|||
46703160|NCT01230827|82917859|FG001|Overall Study|Recovery|6|||
46703161|NCT01230827|82917860|FG002|Overall Study|Recovery|0|||
46703162|NCT01230827|82917861|FG003|Overall Study|Recovery|0|||
46703163|NCT01230827|82917858|FG000|Overall Study|Study terminated by Sponsor|0|||
46703164|NCT01230827|82917859|FG001|Overall Study|Study terminated by Sponsor|2|||
46703165|NCT01230827|82917860|FG002|Overall Study|Study terminated by Sponsor|56|||
46703166|NCT01230827|82917861|FG003|Overall Study|Study terminated by Sponsor|63|||
46703167|NCT01230749|82917873|FG000|Overall Study|Adverse Event|0|||
46703168|NCT01230749|82917874|FG001|Overall Study|Adverse Event|0|||
46703169|NCT01230749|82917875|FG002|Overall Study|Adverse Event|0|||
46703170|NCT01230749|82917876|FG003|Overall Study|Adverse Event|1|||
46703171|NCT01230749|82917873|FG000|Overall Study|Physician Decision|0|||
46703172|NCT01230749|82917874|FG001|Overall Study|Physician Decision|0|||
46703173|NCT01230749|82917875|FG002|Overall Study|Physician Decision|1|||
46703174|NCT01230749|82917876|FG003|Overall Study|Physician Decision|0|||
46703175|NCT01230749|82917873|FG000|Overall Study|Withdrawal by Subject|0|||
46703176|NCT01230749|82917874|FG001|Overall Study|Withdrawal by Subject|1|||
46703177|NCT01230749|82917875|FG002|Overall Study|Withdrawal by Subject|0|||
46703178|NCT01230749|82917876|FG003|Overall Study|Withdrawal by Subject|0|||
46703179|NCT01230749|82917873|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
46985607|NCT01607905|83231932|FG001|Overall Study|Randomized but not treated|0|||
46703180|NCT01230749|82917874|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
46985608|NCT01607905|83231933|FG002|Overall Study|Randomized but not treated|0|||
46985609|NCT01607905|83231934|FG003|Overall Study|Randomized but not treated|0|||
46985610|NCT01607905|83231935|FG004|Overall Study|Randomized but not treated|1|||
46985611|NCT01607905|83231936|FG005|Overall Study|Randomized but not treated|1|||
46985612|NCT01607905|83231937|FG006|Overall Study|Randomized but not treated|0|||
46985613|NCT02536963|83231995|FG000|Overall Study|Withdrawal by Subject|18|||
46985614|NCT02531035|83232001|FG000|Overall Study|Death|0|||
46985615|NCT02531035|83232002|FG001|Overall Study|Death|1|||
46985616|NCT02531035|83232001|FG000|Overall Study|Protocol Violation|1|||
46985617|NCT02531035|83232002|FG001|Overall Study|Protocol Violation|1|||
46985618|NCT02531035|83232001|FG000|Overall Study|Noncompliance with study drug|8|||
46985619|NCT02531035|83232002|FG001|Overall Study|Noncompliance with study drug|3|||
46985620|NCT02531035|83232001|FG000|Overall Study|Physician Decision|1|||
46985621|NCT02531035|83232002|FG001|Overall Study|Physician Decision|0|||
46985622|NCT02531035|83232001|FG000|Overall Study|Adverse Event|16|||
46985623|NCT02531035|83232002|FG001|Overall Study|Adverse Event|45|||
46985624|NCT02531035|83232001|FG000|Overall Study|Other|3|||
46985625|NCT02531035|83232002|FG001|Overall Study|Other|2|||
46985626|NCT02531035|83232001|FG000|Overall Study|Withdrawal by Subject|42|||
46985627|NCT02531035|83232002|FG001|Overall Study|Withdrawal by Subject|32|||
46985628|NCT02531035|83232001|FG000|Overall Study|Lost to Follow-up|8|||
46985629|NCT02531035|83232002|FG001|Overall Study|Lost to Follow-up|10|||
46985630|NCT02531035|83232001|FG000|Overall Study|Randomized, not treated|2|||
46985631|NCT02531035|83232002|FG001|Overall Study|Randomized, not treated|1|||
46985632|NCT01659853|83232018|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
46985633|NCT01659853|83232019|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
46985634|NCT01659853|83232018|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
46985635|NCT01659853|83232019|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
46985636|NCT01660243|83232031|FG000|Overall Study|Adverse Event|1|||
46985637|NCT01660243|83232032|FG001|Overall Study|Adverse Event|0|||
46985638|NCT01660243|83232033|FG002|Overall Study|Adverse Event|1|||
46985639|NCT01660243|83232034|FG003|Overall Study|Adverse Event|0|||
46985640|NCT01660243|83232031|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
46985641|NCT01660243|83232032|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
46985642|NCT01660243|83232033|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
46985643|NCT01660243|83232034|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
46985644|NCT01660243|83232031|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
46985645|NCT01660243|83232032|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
46878090|NCT03255980|83098966|FG000|Overall Study|Lost to Follow-up|1|||
46878091|NCT03255980|83098967|FG001|Overall Study|Lost to Follow-up|1|||
46878092|NCT03255980|83098968|FG002|Overall Study|Lost to Follow-up|0|||
46878093|NCT03255980|83098969|FG003|Overall Study|Lost to Follow-up|3|||
46878094|NCT03255980|83098966|FG000|Overall Study|Withdrawal by Subject|0|||
46878095|NCT03255980|83098967|FG001|Overall Study|Withdrawal by Subject|1|||
46878096|NCT03255980|83098968|FG002|Overall Study|Withdrawal by Subject|0|||
46878097|NCT03255980|83098969|FG003|Overall Study|Withdrawal by Subject|3|||
46878098|NCT03228212|83098979|FG000|Period 1|Adverse Event|1|||
46878099|NCT03228212|83098980|FG001|Period 1|Adverse Event|0|||
46878100|NCT03228212|83098979|FG000|Period 1|no longer meets eligibility criteria|0|||
46878101|NCT03228212|83098980|FG001|Period 1|no longer meets eligibility criteria|1|||
46878102|NCT03228212|83098979|FG000|Period 2|Lost to Follow-up|1|||
46878103|NCT03228212|83098980|FG001|Period 2|Lost to Follow-up|0|||
46878104|NCT04000815|83098989|FG000|Overall Study|Lost to Follow-up|9|||
46878105|NCT04000815|83098990|FG001|Overall Study|Lost to Follow-up|2|||
46878106|NCT04000815|83098991|FG002|Overall Study|Lost to Follow-up|3|||
46878107|NCT04000815|83098989|FG000|Overall Study|Withdrawal by Subject|4|||
46878108|NCT04000815|83098990|FG001|Overall Study|Withdrawal by Subject|3|||
46878109|NCT04000815|83098991|FG002|Overall Study|Withdrawal by Subject|2|||
46878110|NCT04000815|83098989|FG000|Overall Study|Right ovarian cyst occured|1|||
46878111|NCT04000815|83098990|FG001|Overall Study|Right ovarian cyst occured|0|||
46878112|NCT04000815|83098991|FG002|Overall Study|Right ovarian cyst occured|0|||
46878113|NCT04000815|83098989|FG000|Overall Study|Hypertension occured on follow up|0|||
46878114|NCT04000815|83098990|FG001|Overall Study|Hypertension occured on follow up|0|||
46878115|NCT04000815|83098991|FG002|Overall Study|Hypertension occured on follow up|2|||
46878116|NCT04000581|83099001|FG000|Overall Study|Withdrawal by Subject|0|||
46878117|NCT04000581|83099002|FG001|Overall Study|Withdrawal by Subject|1|||
46878118|NCT03848403|83099008|FG000|Period 2 (Day 8)|Adverse Event|1|||
46878119|NCT03848403|83099009|FG001|Period 2 (Day 8)|Adverse Event|2|||
46878120|NCT03848403|83099010|FG002|Period 2 (Day 8)|Adverse Event|2|||
46878121|NCT03848403|83099008|FG000|Period 2 (Day 8)|Physician Decision|0|||
46878122|NCT03848403|83099009|FG001|Period 2 (Day 8)|Physician Decision|1|||
46878123|NCT03848403|83099010|FG002|Period 2 (Day 8)|Physician Decision|0|||
46878124|NCT03848403|83099008|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
46878125|NCT03848403|83099009|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
46878126|NCT03848403|83099010|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
46878127|NCT04054011|83099018|FG000|Overall Study|COVID|3|||
46878128|NCT04053465|83099026|FG000|Overall Study|Withdrawal by Subject|4|||
46878129|NCT04053465|83099027|FG001|Overall Study|Withdrawal by Subject|4|||
46878130|NCT00143507|83099035|FG000|Overall Study|Death|572|||
46878131|NCT00143507|83099036|FG001|Overall Study|Death|547|||
46878132|NCT00143507|83099035|FG000|Overall Study|Withdrawal by Subject|114|||
46878133|NCT00143507|83099036|FG001|Overall Study|Withdrawal by Subject|102|||
46878134|NCT00143507|83099035|FG000|Overall Study|Lost to Follow-up|1|||
46878135|NCT00143507|83099036|FG001|Overall Study|Lost to Follow-up|0|||
46878136|NCT00143507|83099035|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
46878137|NCT00143507|83099036|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
46878138|NCT03988803|83099042|FG000|Period 2|Prematurely discontinued from medication|2|||
46878139|NCT03988803|83099042|FG000|Period 2|Adverse Event|1|||
46878140|NCT00181883|83099050|FG000|Overall Study|Lack of Efficacy|2|||
46878141|NCT00181883|83099050|FG000|Overall Study|Treatment Limiting AEs|3|||
46878142|NCT00181883|83099050|FG000|Overall Study|Withdrawal by Subject|4|||
46878143|NCT00181883|83099050|FG000|Overall Study|Lost to Follow-up|1|||
46878144|NCT00180713|83099056|FG000|Overall Study|Withdrawal by Subject|2|||
46878145|NCT00180713|83099057|FG001|Overall Study|Withdrawal by Subject|0|||
46878146|NCT00180713|83099056|FG000|Overall Study|Adverse Event|3|||
46878147|NCT00180713|83099057|FG001|Overall Study|Adverse Event|3|||
46878148|NCT03988023|83099065|FG000|Overall Study|Non-compliance|3|||
46878149|NCT03988023|83099066|FG001|Overall Study|Non-compliance|0|||
46878150|NCT03988023|83099065|FG000|Overall Study|Withdrawal by Subject|39|||
46878151|NCT03988023|83099066|FG001|Overall Study|Withdrawal by Subject|37|||
46878152|NCT03988023|83099065|FG000|Overall Study|Adverse Event|0|||
46878153|NCT03988023|83099066|FG001|Overall Study|Adverse Event|2|||
46878154|NCT03988023|83099065|FG000|Overall Study|Physician Decision|0|||
46878155|NCT03988023|83099066|FG001|Overall Study|Physician Decision|1|||
46878156|NCT03988023|83099065|FG000|Overall Study|Lost to Follow-up|5|||
46878157|NCT03988023|83099066|FG001|Overall Study|Lost to Follow-up|8|||
46878158|NCT03988023|83099065|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
46878159|NCT03988023|83099066|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
46878160|NCT03988023|83099065|FG000|Overall Study|Lack of Efficacy|3|||
46878161|NCT03988023|83099066|FG001|Overall Study|Lack of Efficacy|1|||
46878162|NCT03988023|83099065|FG000|Overall Study|COVID-19 pandemic|225|||
46878163|NCT03988023|83099066|FG001|Overall Study|COVID-19 pandemic|227|||
46878164|NCT04052139|83099075|FG000|Overall Study|Lost to Follow-up|2|||
46878165|NCT04052139|83099076|FG001|Overall Study|Lost to Follow-up|0|||
46878166|NCT04052139|83099077|FG002|Overall Study|Lost to Follow-up|0|||
46878167|NCT04052139|83099075|FG000|Overall Study|Withdrawal by Subject|1|||
46878168|NCT04052139|83099076|FG001|Overall Study|Withdrawal by Subject|0|||
46878169|NCT04052139|83099077|FG002|Overall Study|Withdrawal by Subject|0|||
46878170|NCT03984825|83099085|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
46878171|NCT03984825|83099085|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
46878172|NCT03984825|83099085|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
46878173|NCT03981861|83099094|FG000|Overall Study|Withdrawal by Subject|3|||
46878174|NCT01332266|83099103|FG000|Phase 1b|Death|3|||
46878175|NCT01332266|83099104|FG001|Phase 1b|Death|3|||
46878176|NCT01332266|83099105|FG002|Phase 1b|Death|2|||
46878177|NCT01332266|83099106|FG003|Phase 1b|Death|0|||
46878178|NCT01332266|83099107|FG004|Phase 1b|Death|0|||
46878179|NCT01332266|83099103|FG000|Phase 1b|Lost to Follow-up|0|||
46878180|NCT01332266|83099104|FG001|Phase 1b|Lost to Follow-up|1|||
46878181|NCT01332266|83099105|FG002|Phase 1b|Lost to Follow-up|0|||
46878182|NCT01332266|83099106|FG003|Phase 1b|Lost to Follow-up|0|||
46878183|NCT01332266|83099107|FG004|Phase 1b|Lost to Follow-up|0|||
46878184|NCT01332266|83099103|FG000|Phase 1b|Withdrawal by Subject|1|||
46878185|NCT01332266|83099104|FG001|Phase 1b|Withdrawal by Subject|1|||
46878186|NCT01332266|83099105|FG002|Phase 1b|Withdrawal by Subject|1|||
46878187|NCT01332266|83099106|FG003|Phase 1b|Withdrawal by Subject|0|||
46878188|NCT01332266|83099107|FG004|Phase 1b|Withdrawal by Subject|0|||
46878189|NCT01332266|83099103|FG000|Phase 2|Death|0|||
46878190|NCT01332266|83099104|FG001|Phase 2|Death|0|||
46878191|NCT01332266|83099105|FG002|Phase 2|Death|0|||
46878192|NCT01332266|83099106|FG003|Phase 2|Death|33|||
46878193|NCT01332266|83099107|FG004|Phase 2|Death|36|||
46878194|NCT01332266|83099103|FG000|Phase 2|Lost to Follow-up|0|||
46878195|NCT01332266|83099104|FG001|Phase 2|Lost to Follow-up|0|||
46878196|NCT01332266|83099105|FG002|Phase 2|Lost to Follow-up|0|||
46878197|NCT01332266|83099106|FG003|Phase 2|Lost to Follow-up|2|||
46878198|NCT01332266|83099107|FG004|Phase 2|Lost to Follow-up|0|||
46878199|NCT01332266|83099103|FG000|Phase 2|Physician Decision|0|||
46878200|NCT01332266|83099104|FG001|Phase 2|Physician Decision|0|||
46985646|NCT01660243|83232033|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
46985647|NCT01660243|83232034|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
46985648|NCT01660243|83232031|FG000|Overall Study|Randomization error|0|||
46985649|NCT01660243|83232032|FG001|Overall Study|Randomization error|0|||
46985650|NCT01660243|83232033|FG002|Overall Study|Randomization error|0|||
46985651|NCT01660243|83232034|FG003|Overall Study|Randomization error|1|||
46985652|NCT02531113|83232044|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
46985653|NCT02531113|83232044|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
46985654|NCT02531113|83232044|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
46985655|NCT02531113|83232044|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
46985656|NCT02531113|83232044|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
46878201|NCT01332266|83099105|FG002|Phase 2|Physician Decision|0|||
46878202|NCT01332266|83099106|FG003|Phase 2|Physician Decision|3|||
46878203|NCT01332266|83099107|FG004|Phase 2|Physician Decision|1|||
46878204|NCT01332266|83099103|FG000|Phase 2|Symptomatic deterioration|0|||
46878205|NCT01332266|83099104|FG001|Phase 2|Symptomatic deterioration|0|||
46878206|NCT01332266|83099105|FG002|Phase 2|Symptomatic deterioration|0|||
46878207|NCT01332266|83099106|FG003|Phase 2|Symptomatic deterioration|0|||
46878208|NCT01332266|83099107|FG004|Phase 2|Symptomatic deterioration|1|||
46878209|NCT01332266|83099103|FG000|Phase 2|Progression Disease|0|||
46878210|NCT01332266|83099104|FG001|Phase 2|Progression Disease|0|||
46878211|NCT01332266|83099105|FG002|Phase 2|Progression Disease|0|||
46878212|NCT01332266|83099106|FG003|Phase 2|Progression Disease|2|||
46878213|NCT01332266|83099107|FG004|Phase 2|Progression Disease|1|||
46985657|NCT02531113|83232044|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
46985658|NCT02531113|83232044|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
46985659|NCT02531113|83232044|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
46985660|NCT02522767|83232054|FG000|Double-blind|Withdrawal by Subject|8|||
46985661|NCT02522767|83232055|FG001|Double-blind|Withdrawal by Subject|11|||
46985662|NCT02522767|83232054|FG000|Double-blind|Lost to Follow-up|1|||
46985663|NCT02522767|83232055|FG001|Double-blind|Lost to Follow-up|0|||
46985664|NCT02522767|83232054|FG000|Double-blind|Adverse Event|1|||
46985665|NCT02522767|83232055|FG001|Double-blind|Adverse Event|10|||
46985666|NCT02522767|83232054|FG000|Double-blind|Protocol Violation|0|||
46985667|NCT02522767|83232055|FG001|Double-blind|Protocol Violation|1|||
46985668|NCT02522767|83232054|FG000|Double-blind|Lack of Efficacy|0|||
46985669|NCT02522767|83232055|FG001|Double-blind|Lack of Efficacy|2|||
46985670|NCT02522767|83232054|FG000|Double-blind|Protocol Deviation|1|||
46985671|NCT02522767|83232055|FG001|Double-blind|Protocol Deviation|0|||
46985672|NCT02522767|83232054|FG000|Open-label|Withdrawal by Subject|2|||
46985673|NCT02522767|83232055|FG001|Open-label|Withdrawal by Subject|3|||
46985674|NCT02522767|83232054|FG000|Open-label|Lost to Follow-up|0|||
46985675|NCT02522767|83232055|FG001|Open-label|Lost to Follow-up|1|||
46985676|NCT02522767|83232054|FG000|Open-label|Adverse Event|2|||
46985677|NCT02522767|83232055|FG001|Open-label|Adverse Event|1|||
46985678|NCT02522767|83232054|FG000|Open-label|Lack of Efficacy|1|||
46985679|NCT02522767|83232055|FG001|Open-label|Lack of Efficacy|1|||
46985680|NCT02522767|83232054|FG000|Open-label|Protocol Violation|0|||
46985681|NCT02522767|83232055|FG001|Open-label|Protocol Violation|1|||
46985682|NCT02522377|83232065|FG000|Overall Study|Withdrawal by Subject|1|||
46985683|NCT02522377|83232066|FG001|Overall Study|Withdrawal by Subject|0|||
46985684|NCT02522377|83232065|FG000|Overall Study|Remission Achieved|3|||
46985685|NCT02522377|83232066|FG001|Overall Study|Remission Achieved|0|||
46985686|NCT01657903|83232072|FG000|Overall Study|Lost to Follow-up|1|||
46985687|NCT01657903|83232072|FG000|Overall Study|Withdrawal by Subject|1|||
46985688|NCT01656733|83232085|FG000|Overall Study|No permission to collect birth outcomes|0|||
46985689|NCT01656733|83232086|FG001|Overall Study|No permission to collect birth outcomes|1|||
46985690|NCT01656733|83232085|FG000|Overall Study|Delivery at another hospital|0|||
46985691|NCT01656733|83232086|FG001|Overall Study|Delivery at another hospital|2|||
46985692|NCT01656733|83232085|FG000|Overall Study|Spontaneous abortion|0|||
46985693|NCT01656733|83232086|FG001|Overall Study|Spontaneous abortion|1|||
46985694|NCT01656967|83232094|FG000|Overall Study|faulty monitor|1|||
46985695|NCT01656967|83232095|FG001|Overall Study|faulty monitor|0|||
46985696|NCT01656967|83232094|FG000|Overall Study|unsuccessful ETT insertion|3|||
46985697|NCT01656967|83232095|FG001|Overall Study|unsuccessful ETT insertion|2|||
46985698|NCT01656889|83232107|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
46985699|NCT01656889|83232108|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
46985700|NCT01656889|83232107|FG000|Treatment Period, 12 Weeks|Death|0|||
46985701|NCT01656889|83232108|FG001|Treatment Period, 12 Weeks|Death|1|||
46985702|NCT01656889|83232107|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
46985703|NCT01656889|83232108|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
46985704|NCT01656889|83232107|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
46985705|NCT01656889|83232108|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
46985706|NCT01656889|83232107|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
46985707|NCT01656889|83232108|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
46985708|NCT01656889|83232107|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
46985709|NCT01656889|83232108|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
46985710|NCT01656889|83232107|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
46985711|NCT01656889|83232108|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
46985712|NCT01656889|83232107|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
46985713|NCT01656889|83232108|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
46985714|NCT01656889|83232107|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
46985715|NCT01656889|83232108|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
46985716|NCT01656889|83232107|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
46985717|NCT01656889|83232108|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
46985718|NCT02522299|83232116|FG000|Overall Study|Adverse Event|2|||
46703181|NCT01230749|82917875|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
46703182|NCT01230749|82917876|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
46703183|NCT00903175|82917891|FG000|Period 1 - First Line|Adverse Event|36|||
46985719|NCT02522299|83232117|FG001|Overall Study|Adverse Event|0|||
46985720|NCT02522299|83232116|FG000|Overall Study|Physician Decision|0|||
46985721|NCT02522299|83232117|FG001|Overall Study|Physician Decision|1|||
46985722|NCT02522299|83232116|FG000|Overall Study|Withdrawal by Subject|2|||
46985723|NCT02522299|83232117|FG001|Overall Study|Withdrawal by Subject|0|||
46985724|NCT01365091|83232141|FG000|Period 1|Adverse Event|1|||
46985725|NCT01365091|83232142|FG001|Period 1|Adverse Event|0|||
46985726|NCT01365091|83232143|FG002|Period 1|Adverse Event|2|||
46985727|NCT01365091|83232144|FG003|Period 1|Adverse Event|3|||
46985728|NCT01365091|83232141|FG000|Period 1|Positive test result for drugs of abuse|1|||
46985729|NCT01365091|83232142|FG001|Period 1|Positive test result for drugs of abuse|0|||
46985730|NCT01365091|83232143|FG002|Period 1|Positive test result for drugs of abuse|0|||
46985731|NCT01365091|83232144|FG003|Period 1|Positive test result for drugs of abuse|0|||
46985732|NCT01365091|83232141|FG000|Period 1|No longer met study criteria|0|||
46985733|NCT01365091|83232142|FG001|Period 1|No longer met study criteria|1|||
46985734|NCT01365091|83232143|FG002|Period 1|No longer met study criteria|0|||
46985735|NCT01365091|83232144|FG003|Period 1|No longer met study criteria|0|||
46985736|NCT01365091|83232141|FG000|Period 1|Withdrawal by Subject|0|||
46985737|NCT01365091|83232142|FG001|Period 1|Withdrawal by Subject|1|||
46985738|NCT01365091|83232143|FG002|Period 1|Withdrawal by Subject|0|||
46985739|NCT01365091|83232144|FG003|Period 1|Withdrawal by Subject|0|||
46985740|NCT01365091|83232141|FG000|Period 1|Personal reasons|0|||
46985741|NCT01365091|83232142|FG001|Period 1|Personal reasons|0|||
46985742|NCT01365091|83232143|FG002|Period 1|Personal reasons|1|||
46985743|NCT01365091|83232144|FG003|Period 1|Personal reasons|0|||
46985744|NCT01365091|83232141|FG000|Period 2|Withdrawal by Subject|1|||
46985745|NCT01365091|83232142|FG001|Period 2|Withdrawal by Subject|0|||
46985746|NCT01365091|83232143|FG002|Period 2|Withdrawal by Subject|0|||
46985747|NCT01365091|83232144|FG003|Period 2|Withdrawal by Subject|0|||
46985748|NCT01365091|83232141|FG000|Period 2|Adverse Event|0|||
46985749|NCT01365091|83232142|FG001|Period 2|Adverse Event|0|||
46985750|NCT01365091|83232143|FG002|Period 2|Adverse Event|1|||
46985751|NCT01365091|83232144|FG003|Period 2|Adverse Event|0|||
46985752|NCT01364467|83232170|FG000|Overall Study|Lost to Follow-up|1|||
46985753|NCT01364467|83232171|FG001|Overall Study|Lost to Follow-up|2|||
46985754|NCT02520661|83232179|FG000|Overall Study|Lost to Follow-up|7|||
46985755|NCT02520661|83232180|FG001|Overall Study|Lost to Follow-up|3|||
46985756|NCT02520661|83232179|FG000|Overall Study|Admitted from ED|49|||
46985757|NCT02520661|83232180|FG001|Overall Study|Admitted from ED|48|||
46985758|NCT02520661|83232179|FG000|Overall Study|ED greater than 24 hours|29|||
46985759|NCT02520661|83232180|FG001|Overall Study|ED greater than 24 hours|38|||
46985760|NCT02520661|83232179|FG000|Overall Study|other ineligibility|14|||
46985761|NCT02520661|83232180|FG001|Overall Study|other ineligibility|22|||
46985762|NCT02520661|83232179|FG000|Overall Study|Withdrawal by Subject|7|||
46985763|NCT02520661|83232180|FG001|Overall Study|Withdrawal by Subject|16|||
46985764|NCT01364389|83232193|FG000|Overall Study|Withdrawal by Subject|0|||
46985765|NCT01364389|83232194|FG001|Overall Study|Withdrawal by Subject|1|||
46985766|NCT01364389|83232195|FG002|Overall Study|Withdrawal by Subject|0|||
46985767|NCT01364389|83232193|FG000|Overall Study|Protocol deviation|0|||
46985768|NCT01364389|83232194|FG001|Overall Study|Protocol deviation|0|||
46985769|NCT01364389|83232195|FG002|Overall Study|Protocol deviation|1|||
46985770|NCT01364389|83232193|FG000|Overall Study|Administrative problems|1|||
46985771|NCT01364389|83232194|FG001|Overall Study|Administrative problems|0|||
46985772|NCT01364389|83232195|FG002|Overall Study|Administrative problems|0|||
46985773|NCT01364389|83232193|FG000|Overall Study|Adverse Event|1|||
46985774|NCT01364389|83232194|FG001|Overall Study|Adverse Event|0|||
46985775|NCT01364389|83232195|FG002|Overall Study|Adverse Event|0|||
46878214|NCT01332266|83099103|FG000|Phase 2|Withdrawal by Subject|0|||
46878215|NCT01332266|83099104|FG001|Phase 2|Withdrawal by Subject|0|||
46878216|NCT01332266|83099105|FG002|Phase 2|Withdrawal by Subject|0|||
46878217|NCT01332266|83099106|FG003|Phase 2|Withdrawal by Subject|2|||
46878218|NCT01332266|83099107|FG004|Phase 2|Withdrawal by Subject|2|||
46878219|NCT03255824|83099122|FG000|Overall Study|Under-sedation|2|||
46878220|NCT03255824|83099123|FG001|Overall Study|Under-sedation|1|||
46878221|NCT03238352|83099132|FG000|Overall Study|Lost to Follow-up|0|||
46878222|NCT03238352|83099133|FG001|Overall Study|Lost to Follow-up|2|||
46878223|NCT03238352|83099134|FG002|Overall Study|Lost to Follow-up|1|||
46878224|NCT03238352|83099132|FG000|Overall Study|Withdrawal by Subject|0|||
46878225|NCT03238352|83099133|FG001|Overall Study|Withdrawal by Subject|1|||
46878226|NCT03238352|83099134|FG002|Overall Study|Withdrawal by Subject|0|||
46878227|NCT00180479|83099148|FG000|Overall Study|Death|4|||
46878228|NCT00180479|83099149|FG001|Overall Study|Death|2|||
46878229|NCT00180479|83099148|FG000|Overall Study|Lost to Follow-up|9|||
46985776|NCT01364233|83232203|FG000|Overall Study|Lost to Follow-up|1|||
46985777|NCT02291289|83232211|FG000|Induction Treatment|Not Dosed|2|||
46985778|NCT02291289|83232212|FG001|Induction Treatment|Not Dosed|0|||
46985779|NCT02291289|83232213|FG002|Induction Treatment|Not Dosed|0|||
46985780|NCT02291289|83232214|FG003|Induction Treatment|Not Dosed|9|||
46985781|NCT02291289|83232215|FG004|Induction Treatment|Not Dosed|0|||
46878230|NCT00180479|83099149|FG001|Overall Study|Lost to Follow-up|7|||
46985782|NCT02291289|83232216|FG005|Induction Treatment|Not Dosed|0|||
46985783|NCT02291289|83232217|FG006|Induction Treatment|Not Dosed|0|||
46985784|NCT02291289|83232218|FG007|Induction Treatment|Not Dosed|0|||
46985785|NCT02291289|83232219|FG008|Induction Treatment|Not Dosed|0|||
46985786|NCT02291289|83232220|FG009|Induction Treatment|Not Dosed|1|||
46985787|NCT02291289|83232221|FG010|Induction Treatment|Not Dosed|0|||
46985788|NCT02291289|83232222|FG011|Induction Treatment|Not Dosed|0|||
46985789|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985790|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985791|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985792|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985793|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
46985794|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
46985795|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985796|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985797|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985798|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
46985799|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
46985800|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
46985801|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
46985802|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
46985803|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
46985804|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
46985805|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
46985806|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
46985807|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
46985808|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
46985809|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
46985810|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
46985811|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
46985812|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
46985813|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Death|0|||
46985814|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Death|23|||
46985815|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Death|13|||
46985816|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Death|0|||
46985817|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Death|185|||
46985818|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Death|100|||
46985819|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Death|0|||
46985820|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Death|1|||
46985821|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Death|1|||
46985822|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Death|0|||
46985823|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Death|26|||
46985824|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Death|11|||
46878231|NCT00180479|83099148|FG000|Overall Study|Withdrawal by Subject|3|||
46878232|NCT00180479|83099149|FG001|Overall Study|Withdrawal by Subject|3|||
46878233|NCT00180479|83099148|FG000|Overall Study|Informed consent not signed|0|||
46878234|NCT00180479|83099149|FG001|Overall Study|Informed consent not signed|1|||
46878235|NCT03224234|83099159|FG000|Main Study|Lost to Follow-up|5|||
46878236|NCT03224234|83099160|FG001|Main Study|Lost to Follow-up|5|||
46878237|NCT02955069|83099174|FG000|Overall Study|Adverse Event|7|||
46878238|NCT02955069|83099175|FG001|Overall Study|Adverse Event|2|||
46878239|NCT02955069|83099174|FG000|Overall Study|Death|7|||
46878240|NCT02955069|83099175|FG001|Overall Study|Death|3|||
46878241|NCT02955069|83099174|FG000|Overall Study|Physician Decision|10|||
46878242|NCT02955069|83099175|FG001|Overall Study|Physician Decision|2|||
46878243|NCT02955069|83099174|FG000|Overall Study|Progressive disease|64|||
46878244|NCT02955069|83099175|FG001|Overall Study|Progressive disease|13|||
46878245|NCT02955069|83099174|FG000|Overall Study|Study terminated by sponsor|4|||
46878246|NCT02955069|83099175|FG001|Overall Study|Study terminated by sponsor|0|||
46878247|NCT02955069|83099174|FG000|Overall Study|Subject/Guardian decision|3|||
46878248|NCT02955069|83099175|FG001|Overall Study|Subject/Guardian decision|1|||
46878249|NCT03254108|83099188|FG000|Overall Study|Adverse Event|0|||
46878250|NCT03254108|83099189|FG001|Overall Study|Adverse Event|2|||
46878251|NCT03254108|83099190|FG002|Overall Study|Adverse Event|0|||
46878252|NCT03254108|83099191|FG003|Overall Study|Adverse Event|1|||
46985825|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Adverse Event|0|||
46985826|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Adverse Event|0|||
46985827|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Adverse Event|0|||
46985828|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Adverse Event|0|||
46985829|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Adverse Event|1|||
46985830|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Adverse Event|0|||
46878253|NCT03254108|83099192|FG004|Overall Study|Adverse Event|1|||
46878254|NCT03254108|83099188|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
46878255|NCT03254108|83099189|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
46878256|NCT03254108|83099190|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
46878257|NCT03254108|83099191|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
46878258|NCT03254108|83099192|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
46878259|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
46878260|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
46878261|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
46878262|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
46878263|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
46878264|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
46878265|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
46878266|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
46878267|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
46878268|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
46878269|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
46878270|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
46878271|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
46878272|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
46878273|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
46878274|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
46878275|NCT03773978|83099216|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
46878276|NCT03773978|83099217|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
46878277|NCT03773978|83099216|FG000|DBW Period|Adverse Event|2|||
46878278|NCT03773978|83099217|FG001|DBW Period|Adverse Event|2|||
46878279|NCT03773978|83099216|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
46878280|NCT03773978|83099217|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
46878281|NCT03773978|83099216|FG000|DBW Period|Withdrawal by Subject|2|||
46878282|NCT03773978|83099217|FG001|DBW Period|Withdrawal by Subject|1|||
46878283|NCT03773978|83099216|FG000|DBW Period|Due to epidemic or pandemic|5|||
46878284|NCT03773978|83099217|FG001|DBW Period|Due to epidemic or pandemic|6|||
46878285|NCT03773978|83099216|FG000|DBW Period|Study team decision|1|||
46878286|NCT03773978|83099217|FG001|DBW Period|Study team decision|0|||
46878287|NCT03682107|83099233|FG000|Overall Study|Withdrawal by Subject|0|||
46878288|NCT03682107|83099234|FG001|Overall Study|Withdrawal by Subject|1|||
46878289|NCT03682107|83099235|FG002|Overall Study|Withdrawal by Subject|0|||
46878290|NCT03682107|83099236|FG003|Overall Study|Withdrawal by Subject|0|||
46878291|NCT03682107|83099237|FG004|Overall Study|Withdrawal by Subject|0|||
46878292|NCT03673046|83099251|FG000|Overall Study|Adverse Event|1|||
46878293|NCT03673046|83099252|FG001|Overall Study|Adverse Event|1|||
46878294|NCT03673046|83099251|FG000|Overall Study|Withdrawal by Subject|8|||
46878295|NCT03673046|83099252|FG001|Overall Study|Withdrawal by Subject|2|||
46878296|NCT02956005|83099258|FG000|Overall Study|Not eligible|1|||
46878297|NCT02956005|83099258|FG000|Overall Study|Withdrawal by Subject|3|||
46878298|NCT02956005|83099258|FG000|Overall Study|Physician Decision|12|||
46878299|NCT03253094|83099268|FG000|Overall Study|Adverse Event|2|||
46878300|NCT03253094|83099269|FG001|Overall Study|Adverse Event|0|||
46878301|NCT03253094|83099270|FG002|Overall Study|Adverse Event|0|||
46878302|NCT03253094|83099271|FG003|Overall Study|Adverse Event|0|||
46878303|NCT03253094|83099272|FG004|Overall Study|Adverse Event|0|||
46878304|NCT03253094|83099273|FG005|Overall Study|Adverse Event|0|||
46985831|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Adverse Event|0|||
46985832|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Adverse Event|0|||
46985833|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Adverse Event|0|||
46985834|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Adverse Event|0|||
46985835|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Adverse Event|0|||
46985836|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Adverse Event|0|||
46985837|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
46985838|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
46878305|NCT03253094|83099268|FG000|Overall Study|Lack of Efficacy|0|||
46878306|NCT03253094|83099269|FG001|Overall Study|Lack of Efficacy|0|||
46878307|NCT03253094|83099270|FG002|Overall Study|Lack of Efficacy|2|||
46985839|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
46985840|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
46985841|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
46985842|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
46878308|NCT03253094|83099271|FG003|Overall Study|Lack of Efficacy|1|||
46878309|NCT03253094|83099272|FG004|Overall Study|Lack of Efficacy|2|||
46878310|NCT03253094|83099273|FG005|Overall Study|Lack of Efficacy|1|||
46878311|NCT03253094|83099268|FG000|Overall Study|Lost to Follow-up|0|||
46985843|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
46985844|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
46985845|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
46985846|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
46985847|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
46985848|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
46985849|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Other|0|||
46985850|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Other|0|||
46985851|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Other|1|||
46985852|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Other|0|||
46985853|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Other|29|||
46985854|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Other|8|||
46985855|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Other|0|||
46985856|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Other|0|||
46985857|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Other|1|||
46985858|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Other|0|||
46985859|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Other|0|||
46985860|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Other|0|||
46985861|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Physician Decision|0|||
46985862|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Physician Decision|0|||
46985863|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Physician Decision|0|||
46985864|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Physician Decision|0|||
46985865|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Physician Decision|2|||
46985866|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Physician Decision|0|||
46985867|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Physician Decision|0|||
46985868|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Physician Decision|0|||
46985869|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Physician Decision|0|||
46985870|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Physician Decision|0|||
46985871|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Physician Decision|0|||
46985872|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Physician Decision|1|||
46985873|NCT02291289|83232211|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
46985874|NCT02291289|83232212|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
46985875|NCT02291289|83232213|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
46985876|NCT02291289|83232214|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
46985877|NCT02291289|83232215|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
46985878|NCT02291289|83232216|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
46985879|NCT02291289|83232217|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
46985880|NCT02291289|83232218|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
46985881|NCT02291289|83232219|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
46985882|NCT02291289|83232220|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
46985883|NCT02291289|83232221|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
46985884|NCT02291289|83232222|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
46985885|NCT02291289|83232211|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
46985886|NCT02291289|83232212|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
46985887|NCT02291289|83232213|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
46985888|NCT02291289|83232214|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
46985889|NCT02291289|83232215|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
46985890|NCT02291289|83232216|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
46985891|NCT02291289|83232217|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
46985892|NCT02291289|83232218|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
46985893|NCT02291289|83232219|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
46985894|NCT02291289|83232220|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
46985895|NCT02291289|83232221|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
46985896|NCT02291289|83232222|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
46985897|NCT02317575|83232247|FG000|Period 1|Difficulty with venous cannulation|0|||
46985898|NCT02317575|83232248|FG001|Period 1|Difficulty with venous cannulation|1|||
46985899|NCT02317575|83232249|FG002|Period 1|Difficulty with venous cannulation|0|||
46985900|NCT02317575|83232250|FG003|Period 1|Difficulty with venous cannulation|0|||
46985901|NCT02317575|83232251|FG004|Period 1|Difficulty with venous cannulation|0|||
46985902|NCT02317575|83232247|FG000|Period 1|Withdrawal by Subject|1|||
46985903|NCT02317575|83232248|FG001|Period 1|Withdrawal by Subject|0|||
46985904|NCT02317575|83232249|FG002|Period 1|Withdrawal by Subject|0|||
46985905|NCT02317575|83232250|FG003|Period 1|Withdrawal by Subject|0|||
46985906|NCT02317575|83232251|FG004|Period 1|Withdrawal by Subject|0|||
46985907|NCT02316717|83232272|FG000|Overall Study|Adverse Event|2|||
46985908|NCT02316717|83232273|FG001|Overall Study|Adverse Event|2|||
46985909|NCT02316717|83232274|FG002|Overall Study|Adverse Event|0|||
46985910|NCT02316717|83232272|FG000|Overall Study|Lost to Follow-up|1|||
46985911|NCT02316717|83232273|FG001|Overall Study|Lost to Follow-up|2|||
46985912|NCT02316717|83232274|FG002|Overall Study|Lost to Follow-up|1|||
46985913|NCT02316717|83232272|FG000|Overall Study|Non compliance|3|||
46985914|NCT02316717|83232273|FG001|Overall Study|Non compliance|1|||
46985915|NCT02316717|83232274|FG002|Overall Study|Non compliance|0|||
46985916|NCT02316717|83232272|FG000|Overall Study|Protocol Violation|2|||
46985917|NCT02316717|83232273|FG001|Overall Study|Protocol Violation|0|||
46985918|NCT02316717|83232274|FG002|Overall Study|Protocol Violation|0|||
46985919|NCT02316717|83232272|FG000|Overall Study|Withdrawal by Subject|2|||
46985920|NCT02316717|83232273|FG001|Overall Study|Withdrawal by Subject|1|||
46985921|NCT02316717|83232274|FG002|Overall Study|Withdrawal by Subject|1|||
46985922|NCT02316717|83232272|FG000|Overall Study|Death|0|||
46985923|NCT02316717|83232273|FG001|Overall Study|Death|0|||
46985924|NCT02316717|83232274|FG002|Overall Study|Death|1|||
46985925|NCT02316717|83232272|FG000|Overall Study|Physician Decision|0|||
46985926|NCT02316717|83232273|FG001|Overall Study|Physician Decision|1|||
46985927|NCT02316717|83232274|FG002|Overall Study|Physician Decision|0|||
46985928|NCT02316717|83232272|FG000|Overall Study|TBC|1|||
46985929|NCT02316717|83232273|FG001|Overall Study|TBC|0|||
46985930|NCT02316717|83232274|FG002|Overall Study|TBC|0|||
46985931|NCT02290821|83232287|FG000|Overall Study|Withdrawal by Subject|1|||
46985932|NCT02290821|83232288|FG001|Overall Study|Withdrawal by Subject|1|||
46985933|NCT02290821|83232287|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
46985934|NCT02290821|83232288|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
46985935|NCT02290821|83232287|FG000|Overall Study|Lost to Follow-up|3|||
46985936|NCT02290821|83232288|FG001|Overall Study|Lost to Follow-up|2|||
46985937|NCT02289963|83232296|FG000|Overall Study|Adverse Event|1|||
46985938|NCT02289963|83232297|FG001|Overall Study|Adverse Event|2|||
46985939|NCT02289963|83232296|FG000|Overall Study|Poor compliance to protocol|1|||
46985940|NCT02289963|83232297|FG001|Overall Study|Poor compliance to protocol|0|||
46985941|NCT02289963|83232296|FG000|Overall Study|Withdrawal by Subject|1|||
46985942|NCT02289963|83232297|FG001|Overall Study|Withdrawal by Subject|0|||
46985943|NCT02289963|83232296|FG000|Overall Study|Last injection missed|2|||
46985944|NCT02289963|83232297|FG001|Overall Study|Last injection missed|2|||
46985945|NCT02289963|83232296|FG000|Overall Study|End treatment visit outside visit window|0|||
46985946|NCT02289963|83232297|FG001|Overall Study|End treatment visit outside visit window|4|||
46985947|NCT02289963|83232296|FG000|Overall Study|Other than specified above|0|||
46985948|NCT02289963|83232297|FG001|Overall Study|Other than specified above|2|||
46985949|NCT02358369|83232306|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
46985950|NCT02358369|83232307|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
46985951|NCT02358369|83232308|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
46985952|NCT02358369|83232309|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
46985953|NCT02358369|83232310|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
46985954|NCT02358369|83232306|FG000|Treatment Period A/B|Adverse Event|0|||
46985955|NCT02358369|83232307|FG001|Treatment Period A/B|Adverse Event|0|||
46985956|NCT02358369|83232308|FG002|Treatment Period A/B|Adverse Event|1|||
46985957|NCT02358369|83232309|FG003|Treatment Period A/B|Adverse Event|2|||
46985958|NCT02358369|83232310|FG004|Treatment Period A/B|Adverse Event|0|||
46985959|NCT02358369|83232306|FG000|Treatment Period A/B|Death|0|||
46985960|NCT02358369|83232307|FG001|Treatment Period A/B|Death|0|||
46985961|NCT02358369|83232308|FG002|Treatment Period A/B|Death|1|||
46985962|NCT02358369|83232309|FG003|Treatment Period A/B|Death|0|||
46985963|NCT02358369|83232310|FG004|Treatment Period A/B|Death|0|||
46985964|NCT02358369|83232306|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
46985965|NCT02358369|83232307|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
46985966|NCT02358369|83232308|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
46878312|NCT03253094|83099269|FG001|Overall Study|Lost to Follow-up|0|||
46878313|NCT03253094|83099270|FG002|Overall Study|Lost to Follow-up|1|||
46878314|NCT03253094|83099271|FG003|Overall Study|Lost to Follow-up|1|||
46878315|NCT03253094|83099272|FG004|Overall Study|Lost to Follow-up|0|||
46878316|NCT03253094|83099273|FG005|Overall Study|Lost to Follow-up|1|||
46878317|NCT03253094|83099268|FG000|Overall Study|Physician Decision|1|||
46985967|NCT02358369|83232309|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
46985968|NCT02358369|83232310|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
46985969|NCT02358369|83232306|FG000|Treatment Period C|Adverse Event|0|||
46985970|NCT02358369|83232307|FG001|Treatment Period C|Adverse Event|0|||
46985971|NCT02358369|83232308|FG002|Treatment Period C|Adverse Event|0|||
46985972|NCT02358369|83232309|FG003|Treatment Period C|Adverse Event|0|||
46985973|NCT02358369|83232310|FG004|Treatment Period C|Adverse Event|7|||
46985974|NCT02316171|83232322|FG000|Overall Study|difficulties with urinary catheter|1|||
46985975|NCT02316171|83232323|FG001|Overall Study|difficulties with urinary catheter|0|||
46703184|NCT00903175|82917892|FG001|Period 1 - First Line|Adverse Event|50|||
46878318|NCT03253094|83099269|FG001|Overall Study|Physician Decision|0|||
46985976|NCT02316171|83232324|FG002|Overall Study|difficulties with urinary catheter|0|||
46985977|NCT02316171|83232325|FG003|Overall Study|difficulties with urinary catheter|0|||
46985978|NCT02289729|83232331|FG000|Overall Study|Lack of Efficacy|3|||
46985979|NCT02289729|83232331|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
46985980|NCT02289729|83232331|FG000|Overall Study|Withdrawal by Subject|1|||
46985981|NCT02289729|83232331|FG000|Overall Study|Death|1|||
46985982|NCT02315625|83232337|FG000|First Intervention|Disease Progression|1|||
46985983|NCT02315625|83232338|FG001|First Intervention|Disease Progression|0|||
46985984|NCT02315625|83232337|FG000|Second Intervention|Physician Decision|2|||
46985985|NCT02315625|83232338|FG001|Second Intervention|Physician Decision|1|||
46878319|NCT03253094|83099270|FG002|Overall Study|Physician Decision|0|||
46878320|NCT03253094|83099271|FG003|Overall Study|Physician Decision|1|||
46878321|NCT03253094|83099272|FG004|Overall Study|Physician Decision|0|||
46878322|NCT03253094|83099273|FG005|Overall Study|Physician Decision|2|||
46878323|NCT03253094|83099268|FG000|Overall Study|Withdrawal by Subject|1|||
46878324|NCT03253094|83099269|FG001|Overall Study|Withdrawal by Subject|2|||
46878325|NCT03253094|83099270|FG002|Overall Study|Withdrawal by Subject|1|||
46878326|NCT03253094|83099271|FG003|Overall Study|Withdrawal by Subject|0|||
46878327|NCT03253094|83099272|FG004|Overall Study|Withdrawal by Subject|3|||
46878328|NCT03253094|83099273|FG005|Overall Study|Withdrawal by Subject|0|||
46878329|NCT03253094|83099268|FG000|Overall Study|Other|0|||
46878330|NCT03253094|83099269|FG001|Overall Study|Other|1|||
46878331|NCT03253094|83099270|FG002|Overall Study|Other|2|||
46878332|NCT03253094|83099271|FG003|Overall Study|Other|1|||
46878333|NCT03253094|83099272|FG004|Overall Study|Other|0|||
46878334|NCT03253094|83099273|FG005|Overall Study|Other|0|||
46878335|NCT03654885|83099289|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
46878336|NCT03654885|83099290|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
46878337|NCT03654885|83099289|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
46878338|NCT03654885|83099290|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
46878339|NCT03654885|83099289|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
46878340|NCT03654885|83099290|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
46878341|NCT03654885|83099289|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
46878342|NCT03654885|83099290|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
46878343|NCT03654885|83099289|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
46878344|NCT03654885|83099290|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
46878345|NCT03654885|83099289|FG000|Overall Study|Adverse Event in Study Eye|3|||
46878346|NCT03654885|83099290|FG001|Overall Study|Adverse Event in Study Eye|0|||
46878347|NCT03654885|83099289|FG000|Overall Study|Consent Withdrawn|1|||
46878348|NCT03654885|83099290|FG001|Overall Study|Consent Withdrawn|0|||
46878349|NCT03654885|83099289|FG000|Overall Study|Death|3|||
46878350|NCT03654885|83099290|FG001|Overall Study|Death|1|||
46878351|NCT03654885|83099289|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
46878352|NCT03654885|83099290|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
46878353|NCT03654885|83099289|FG000|Overall Study|Lost to Follow-up|3|||
46878354|NCT03654885|83099290|FG001|Overall Study|Lost to Follow-up|3|||
46878355|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
46878356|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
46878357|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
46878358|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
46878359|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
46878360|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
46878361|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
46878362|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
46878363|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
46878364|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
46878365|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
46878366|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
46878367|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Death|3|||
46878368|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Death|1|||
46878369|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
46878370|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
46878371|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Adverse Event|7|||
46878372|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Adverse Event|8|||
46878373|NCT03236246|83099298|FG000|24-Week Dose Titration Period|Captured as Other|1|||
46878374|NCT03236246|83099299|FG001|24-Week Dose Titration Period|Captured as Other|2|||
46878375|NCT03236246|83099298|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
46878376|NCT03236246|83099299|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
46878377|NCT03236246|83099298|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
46878378|NCT03236246|83099299|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
46878379|NCT03236246|83099298|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
46878380|NCT03236246|83099299|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
46878381|NCT03236246|83099298|FG000|24-Week Dose Maintenance Period|Death|0|||
46878382|NCT03236246|83099299|FG001|24-Week Dose Maintenance Period|Death|1|||
46878383|NCT03236246|83099298|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
46878384|NCT03236246|83099299|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
46878385|NCT02937584|83099305|FG000|Period 1|Adverse Event|1|||
46878386|NCT02937584|83099306|FG001|Period 1|Adverse Event|2|||
46878387|NCT02937584|83099305|FG000|Washout|Adverse Event|0|||
46878388|NCT02937584|83099306|FG001|Washout|Adverse Event|1|||
46878389|NCT00179621|83099315|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
46878390|NCT00179621|83099316|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
46878391|NCT00179621|83099317|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
46878392|NCT00179621|83099318|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
46878393|NCT00179621|83099315|FG000|Double-Blind Period|Adverse Event|2|||
46878394|NCT00179621|83099316|FG001|Double-Blind Period|Adverse Event|7|||
46878395|NCT00179621|83099317|FG002|Double-Blind Period|Adverse Event|4|||
46878396|NCT00179621|83099318|FG003|Double-Blind Period|Adverse Event|0|||
46878397|NCT00179621|83099315|FG000|Double-Blind Period|Withdrawal by Subject|2|||
46878398|NCT00179621|83099316|FG001|Double-Blind Period|Withdrawal by Subject|1|||
46878399|NCT00179621|83099317|FG002|Double-Blind Period|Withdrawal by Subject|3|||
46878400|NCT00179621|83099318|FG003|Double-Blind Period|Withdrawal by Subject|0|||
46878401|NCT00179621|83099315|FG000|Double-Blind Period|Death|0|||
46878402|NCT00179621|83099316|FG001|Double-Blind Period|Death|1|||
46878403|NCT00179621|83099317|FG002|Double-Blind Period|Death|2|||
46878404|NCT00179621|83099318|FG003|Double-Blind Period|Death|0|||
46878405|NCT00179621|83099315|FG000|Double-Blind Period|Protocol Violation|1|||
46878406|NCT00179621|83099316|FG001|Double-Blind Period|Protocol Violation|0|||
46878407|NCT00179621|83099317|FG002|Double-Blind Period|Protocol Violation|0|||
46878408|NCT00179621|83099318|FG003|Double-Blind Period|Protocol Violation|0|||
46878409|NCT00179621|83099315|FG000|Double-Blind Period|Other|0|||
46878410|NCT00179621|83099316|FG001|Double-Blind Period|Other|2|||
46878411|NCT00179621|83099317|FG002|Double-Blind Period|Other|2|||
46878412|NCT00179621|83099318|FG003|Double-Blind Period|Other|0|||
46878413|NCT00179621|83099315|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
46878414|NCT00179621|83099316|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
46878415|NCT00179621|83099317|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
46878416|NCT00179621|83099318|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
46878417|NCT00179621|83099315|FG000|Open-Label Period|Adverse Event|0|||
46878418|NCT00179621|83099316|FG001|Open-Label Period|Adverse Event|6|||
46878419|NCT00179621|83099317|FG002|Open-Label Period|Adverse Event|5|||
46878420|NCT00179621|83099318|FG003|Open-Label Period|Adverse Event|6|||
46878421|NCT00179621|83099315|FG000|Open-Label Period|Withdrawal by Subject|0|||
46878422|NCT00179621|83099316|FG001|Open-Label Period|Withdrawal by Subject|2|||
46878423|NCT00179621|83099317|FG002|Open-Label Period|Withdrawal by Subject|2|||
46878424|NCT00179621|83099318|FG003|Open-Label Period|Withdrawal by Subject|2|||
46878425|NCT00179621|83099315|FG000|Open-Label Period|Death|0|||
46878426|NCT00179621|83099316|FG001|Open-Label Period|Death|0|||
46878427|NCT00179621|83099317|FG002|Open-Label Period|Death|1|||
46878428|NCT00179621|83099318|FG003|Open-Label Period|Death|2|||
46878429|NCT00179621|83099315|FG000|Open-Label Period|Other|0|||
46878430|NCT00179621|83099316|FG001|Open-Label Period|Other|1|||
46878431|NCT00179621|83099317|FG002|Open-Label Period|Other|1|||
46878432|NCT00179621|83099318|FG003|Open-Label Period|Other|2|||
46878433|NCT00179309|83099329|FG000|Treatment|Toxicity|2|||
46878434|NCT00179309|83099330|FG001|Treatment|Toxicity|3|||
46878435|NCT00179309|83099329|FG000|Treatment|Withdrawal by Subject|1|||
46878436|NCT00179309|83099330|FG001|Treatment|Withdrawal by Subject|2|||
46878437|NCT00179309|83099329|FG000|Treatment|Allergy|1|||
46878438|NCT00179309|83099330|FG001|Treatment|Allergy|0|||
46878439|NCT00178685|83099351|FG000|Overall Study|Death|3|||
46878440|NCT00178685|83099352|FG001|Overall Study|Death|3|||
46878441|NCT00178685|83099353|FG002|Overall Study|Death|6|||
46878442|NCT00178685|83099351|FG000|Overall Study|Lost to Follow-up|100|||
46878443|NCT00178685|83099352|FG001|Overall Study|Lost to Follow-up|187|||
46878444|NCT00178685|83099353|FG002|Overall Study|Lost to Follow-up|183|||
46878445|NCT00178685|83099351|FG000|Overall Study|Withdrawal by Subject|8|||
46878446|NCT00178685|83099352|FG001|Overall Study|Withdrawal by Subject|14|||
46878447|NCT00178685|83099353|FG002|Overall Study|Withdrawal by Subject|7|||
46878448|NCT02933528|83099361|FG000|Overall Study|Lost to Follow-up|2|||
46878449|NCT00177671|83099367|FG000|Overall Study|Withdrawal by Subject|5|||
46878450|NCT00177671|83099368|FG001|Overall Study|Withdrawal by Subject|6|||
46878451|NCT00177671|83099367|FG000|Overall Study|medical complications|2|||
46878452|NCT00177671|83099368|FG001|Overall Study|medical complications|0|||
46878453|NCT00177671|83099367|FG000|Overall Study|Adverse Event|6|||
46878454|NCT00177671|83099368|FG001|Overall Study|Adverse Event|0|||
46878455|NCT00177671|83099367|FG000|Overall Study|Physician Decision|12|||
46878456|NCT00177671|83099368|FG001|Overall Study|Physician Decision|8|||
46878457|NCT02933060|83099376|FG000|Overall Study|Withdrawal by Subject|0|||
46878458|NCT02933060|83099377|FG001|Overall Study|Withdrawal by Subject|1|||
46878459|NCT03235154|83099383|FG000|Overall Study|Withdrawal by Subject|1|||
46878460|NCT03235154|83099383|FG000|Overall Study|Adverse Event|1|||
46878461|NCT03235154|83099383|FG000|Overall Study|Lost to Follow-up|2|||
46878462|NCT03234608|83099391|FG000|Overall Study|Lost to Follow-up|23|||
46878463|NCT03234608|83099392|FG001|Overall Study|Lost to Follow-up|21|||
46878464|NCT03248882|83099403|FG000|Overall Study|Adverse Event|3|||
46878465|NCT03248882|83099404|FG001|Overall Study|Adverse Event|3|||
46878466|NCT03248882|83099405|FG002|Overall Study|Adverse Event|2|||
46878467|NCT03248882|83099406|FG003|Overall Study|Adverse Event|6|||
46878468|NCT03248882|83099407|FG004|Overall Study|Adverse Event|9|||
46878469|NCT03248882|83099403|FG000|Overall Study|Lost to Follow-up|0|||
46878470|NCT03248882|83099404|FG001|Overall Study|Lost to Follow-up|0|||
46878471|NCT03248882|83099405|FG002|Overall Study|Lost to Follow-up|0|||
46878472|NCT03248882|83099406|FG003|Overall Study|Lost to Follow-up|0|||
46878473|NCT03248882|83099407|FG004|Overall Study|Lost to Follow-up|1|||
46878474|NCT03248882|83099403|FG000|Overall Study|Protocol Violation|2|||
46878475|NCT03248882|83099404|FG001|Overall Study|Protocol Violation|0|||
46878476|NCT03248882|83099405|FG002|Overall Study|Protocol Violation|2|||
46878477|NCT03248882|83099406|FG003|Overall Study|Protocol Violation|0|||
46878478|NCT03248882|83099407|FG004|Overall Study|Protocol Violation|1|||
46878479|NCT03248882|83099403|FG000|Overall Study|Withdrawal by Subject|2|||
46878480|NCT03248882|83099404|FG001|Overall Study|Withdrawal by Subject|2|||
46878481|NCT03248882|83099405|FG002|Overall Study|Withdrawal by Subject|3|||
46878482|NCT03248882|83099406|FG003|Overall Study|Withdrawal by Subject|4|||
46878483|NCT03248882|83099407|FG004|Overall Study|Withdrawal by Subject|2|||
46878484|NCT03233438|83099421|FG000|Overall Study|Lost to Follow-up|4|||
46878485|NCT03233438|83099422|FG001|Overall Study|Lost to Follow-up|9|||
46878486|NCT03233438|83099421|FG000|Overall Study|Withdrawal by Subject|2|||
46878487|NCT03233438|83099422|FG001|Overall Study|Withdrawal by Subject|1|||
46878488|NCT03233438|83099421|FG000|Overall Study|No recording of dalbavancin|0|||
46878489|NCT03233438|83099422|FG001|Overall Study|No recording of dalbavancin|1|||
46878490|NCT01368406|83099430|FG000|Overall Study|Lost to Follow-up|8|||
46878491|NCT01368406|83099431|FG001|Overall Study|Lost to Follow-up|4|||
46878492|NCT01368406|83099430|FG000|Overall Study|Withdrawal by Subject|8|||
46878493|NCT01368406|83099431|FG001|Overall Study|Withdrawal by Subject|4|||
46878494|NCT01368406|83099430|FG000|Overall Study|relapse of the disease|3|||
46878495|NCT01368406|83099431|FG001|Overall Study|relapse of the disease|2|||
46878496|NCT01368406|83099430|FG000|Overall Study|started working|2|||
46878497|NCT01368406|83099431|FG001|Overall Study|started working|3|||
46878498|NCT00175877|83099437|FG000|Overall Study|Adverse Event|136|||
46878499|NCT00175877|83099437|FG000|Overall Study|Withdrawal by Subject|141|||
46878500|NCT00175877|83099437|FG000|Overall Study|Lost to Follow-up|9|||
46878501|NCT00175877|83099437|FG000|Overall Study|Lack of Efficacy|26|||
46878502|NCT00175877|83099437|FG000|Overall Study|Protocol Violation|15|||
46878503|NCT00175877|83099437|FG000|Overall Study|Other Reason|20|||
46878504|NCT00175877|83099437|FG000|Overall Study|AE & Other|1|||
46878505|NCT00175877|83099437|FG000|Overall Study|Withdrawal by subject & Other|1|||
46878506|NCT03247556|83099444|FG000|Overall Study|Adverse Event|1|||
46878507|NCT03247556|83099445|FG001|Overall Study|Adverse Event|4|||
46878508|NCT03247556|83099446|FG002|Overall Study|Adverse Event|5|||
46878509|NCT03247556|83099444|FG000|Overall Study|Lost to Follow-up|5|||
46878510|NCT03247556|83099445|FG001|Overall Study|Lost to Follow-up|5|||
46878511|NCT03247556|83099446|FG002|Overall Study|Lost to Follow-up|4|||
46878512|NCT03247556|83099444|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
46878513|NCT03247556|83099445|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
46878514|NCT03247556|83099446|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
46878515|NCT03247556|83099444|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
46878516|NCT03247556|83099445|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
46878517|NCT03247556|83099446|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
46878518|NCT03247556|83099444|FG000|Overall Study|Protocol Violation|2|||
46878519|NCT03247556|83099445|FG001|Overall Study|Protocol Violation|0|||
46878520|NCT03247556|83099446|FG002|Overall Study|Protocol Violation|1|||
46878521|NCT03247556|83099444|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
46878522|NCT03247556|83099445|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
46878523|NCT03247556|83099446|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
46878524|NCT03216746|83099458|FG000|Overall Study|Lost to Follow-up|6|||
46878525|NCT03216746|83099459|FG001|Overall Study|Lost to Follow-up|8|||
46878526|NCT03216746|83099460|FG002|Overall Study|Lost to Follow-up|5|||
46878527|NCT03216746|83099461|FG003|Overall Study|Lost to Follow-up|6|||
46878528|NCT02787304|83099475|FG000|Overall Study|Adverse Event|9|||
46878529|NCT02787304|83099476|FG001|Overall Study|Adverse Event|3|||
46878530|NCT02787304|83099477|FG002|Overall Study|Adverse Event|8|||
46878531|NCT02787304|83099478|FG003|Overall Study|Adverse Event|1|||
46878532|NCT02787304|83099475|FG000|Overall Study|Withdrawal by Subject|1|||
46878533|NCT02787304|83099476|FG001|Overall Study|Withdrawal by Subject|4|||
46878534|NCT02787304|83099477|FG002|Overall Study|Withdrawal by Subject|0|||
46878535|NCT02787304|83099478|FG003|Overall Study|Withdrawal by Subject|0|||
46878536|NCT02787304|83099475|FG000|Overall Study|Lost to Follow-up|1|||
46878537|NCT02787304|83099476|FG001|Overall Study|Lost to Follow-up|0|||
46878538|NCT02787304|83099477|FG002|Overall Study|Lost to Follow-up|0|||
46878539|NCT02787304|83099478|FG003|Overall Study|Lost to Follow-up|1|||
46878540|NCT02787304|83099475|FG000|Overall Study|Noncompliance with study drug|0|||
46878541|NCT02787304|83099476|FG001|Overall Study|Noncompliance with study drug|0|||
46878542|NCT02787304|83099477|FG002|Overall Study|Noncompliance with study drug|1|||
46878543|NCT02787304|83099478|FG003|Overall Study|Noncompliance with study drug|0|||
46878544|NCT02787304|83099475|FG000|Overall Study|Physician Decision|0|||
46878545|NCT02787304|83099476|FG001|Overall Study|Physician Decision|0|||
46878546|NCT02787304|83099477|FG002|Overall Study|Physician Decision|1|||
46878547|NCT02787304|83099478|FG003|Overall Study|Physician Decision|0|||
46878548|NCT02787304|83099475|FG000|Overall Study|Study terminated by sponsor|25|||
46878549|NCT02787304|83099476|FG001|Overall Study|Study terminated by sponsor|31|||
46878550|NCT02787304|83099477|FG002|Overall Study|Study terminated by sponsor|31|||
46878551|NCT02787304|83099478|FG003|Overall Study|Study terminated by sponsor|32|||
46878552|NCT02932904|83099492|FG000|Overall Study|Reason not Specified|1|||
46878553|NCT02932904|83099493|FG001|Overall Study|Reason not Specified|0|||
46878554|NCT02932904|83099494|FG002|Overall Study|Reason not Specified|2|||
46878555|NCT02932904|83099495|FG003|Overall Study|Reason not Specified|2|||
46878556|NCT02932904|83099492|FG000|Overall Study|Noncompliance with Study Drug|2|||
46878557|NCT02932904|83099493|FG001|Overall Study|Noncompliance with Study Drug|3|||
46878558|NCT02932904|83099494|FG002|Overall Study|Noncompliance with Study Drug|3|||
46878559|NCT02932904|83099495|FG003|Overall Study|Noncompliance with Study Drug|4|||
46878560|NCT02932904|83099492|FG000|Overall Study|Pregnancy|0|||
46878561|NCT02932904|83099493|FG001|Overall Study|Pregnancy|1|||
46878562|NCT02932904|83099494|FG002|Overall Study|Pregnancy|1|||
46878563|NCT02932904|83099495|FG003|Overall Study|Pregnancy|0|||
46878564|NCT02932904|83099492|FG000|Overall Study|Study Termination|0|||
46878565|NCT02932904|83099493|FG001|Overall Study|Study Termination|1|||
46878566|NCT02932904|83099494|FG002|Overall Study|Study Termination|0|||
46878567|NCT02932904|83099495|FG003|Overall Study|Study Termination|0|||
46878568|NCT02932904|83099492|FG000|Overall Study|Voluntary Withdrawal|2|||
46878569|NCT02932904|83099493|FG001|Overall Study|Voluntary Withdrawal|1|||
46878570|NCT02932904|83099494|FG002|Overall Study|Voluntary Withdrawal|4|||
46878571|NCT02932904|83099495|FG003|Overall Study|Voluntary Withdrawal|2|||
46878572|NCT02932904|83099492|FG000|Overall Study|Lost to Follow-up|5|||
46878573|NCT02932904|83099493|FG001|Overall Study|Lost to Follow-up|3|||
46878574|NCT02932904|83099494|FG002|Overall Study|Lost to Follow-up|6|||
46878575|NCT02932904|83099495|FG003|Overall Study|Lost to Follow-up|0|||
46878576|NCT02932904|83099492|FG000|Overall Study|Significant Protocol Deviation|2|||
46878577|NCT02932904|83099493|FG001|Overall Study|Significant Protocol Deviation|3|||
46878578|NCT02932904|83099494|FG002|Overall Study|Significant Protocol Deviation|6|||
46878579|NCT02932904|83099495|FG003|Overall Study|Significant Protocol Deviation|1|||
46878580|NCT02932904|83099492|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
46878581|NCT02932904|83099493|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
46878582|NCT02932904|83099494|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
46878583|NCT02932904|83099495|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
46878584|NCT02932904|83099492|FG000|Overall Study|Randomized But Not Treated|1|||
46878585|NCT02932904|83099493|FG001|Overall Study|Randomized But Not Treated|1|||
46878586|NCT02932904|83099494|FG002|Overall Study|Randomized But Not Treated|0|||
46878587|NCT02932904|83099495|FG003|Overall Study|Randomized But Not Treated|2|||
46878588|NCT00688376|83099510|FG000|Double-Blind Phase|Adverse Event|4|||
46878589|NCT00688376|83099511|FG001|Double-Blind Phase|Adverse Event|4|||
46878590|NCT00688376|83099510|FG000|Double-Blind Phase|Protocol Violation|1|||
46878591|NCT00688376|83099511|FG001|Double-Blind Phase|Protocol Violation|2|||
46878592|NCT00688376|83099510|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
46878593|NCT00688376|83099511|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
46878594|NCT00688376|83099510|FG000|Double-Blind Phase|Not treated|0|||
46878595|NCT00688376|83099511|FG001|Double-Blind Phase|Not treated|1|||
46878596|NCT00688376|83099510|FG000|Blinded Extension Phase|Adverse Event|3|||
46878597|NCT00688376|83099511|FG001|Blinded Extension Phase|Adverse Event|4|||
46878598|NCT00688376|83099510|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
46878599|NCT00688376|83099511|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
46878600|NCT00688376|83099510|FG000|Blinded Extension Phase|Physician Decision|1|||
46878601|NCT00688376|83099511|FG001|Blinded Extension Phase|Physician Decision|0|||
46878602|NCT00688376|83099510|FG000|Blinded Extension Phase|Other|1|||
46878603|NCT00688376|83099511|FG001|Blinded Extension Phase|Other|0|||
46878604|NCT03214952|83099519|FG000|Overall Study|Protocol Deviation|45|||
46878605|NCT03214952|83099519|FG000|Overall Study|Case Report Forms Uncollected|13|||
46878606|NCT01367704|83099525|FG000|Overall Study|Lost to Follow-up|47|||
46878607|NCT01367704|83099526|FG001|Overall Study|Lost to Follow-up|161|||
46878608|NCT03214094|83099532|FG000|Overall Study|Case Report Forms Uncollected|14|||
46878609|NCT03214094|83099532|FG000|Overall Study|Protocol Deviation|46|||
46878610|NCT05299359|83099543|FG000|Overall Study|Ongoing in Study|149|||
46878611|NCT05299359|83099543|FG000|Overall Study|Other|1|||
46878612|NCT05069155|83099560|FG000|Overall Study|Withdrawal by Subject|1|||
46878613|NCT05069155|83099561|FG001|Overall Study|Withdrawal by Subject|3|||
46985986|NCT02315625|83232337|FG000|Second Intervention|Study closure|1|||
46878614|NCT04875533|83099569|FG000|Overall Study|Adverse Event|6|||
46878615|NCT04875533|83099570|FG001|Overall Study|Adverse Event|4|||
46878616|NCT04875533|83099569|FG000|Overall Study|Protocol Violation|4|||
46878617|NCT04875533|83099570|FG001|Overall Study|Protocol Violation|0|||
46878618|NCT04875533|83099569|FG000|Overall Study|Withdrawal by Subject|8|||
46878619|NCT04875533|83099570|FG001|Overall Study|Withdrawal by Subject|5|||
46878620|NCT04875533|83099569|FG000|Overall Study|No longer meets eligibility criteria|1|||
46878621|NCT04875533|83099570|FG001|Overall Study|No longer meets eligibility criteria|0|||
46878622|NCT04875533|83099569|FG000|Overall Study|Other|0|||
46878623|NCT04875533|83099570|FG001|Overall Study|Other|2|||
46878624|NCT04854551|83099580|FG000|Overall Study|Withdrawal by Subject|1|||
46878625|NCT04854551|83099581|FG001|Overall Study|Withdrawal by Subject|1|||
46878626|NCT04672941|83099588|FG000|Overall Study|Investigator decision|1|||
46878627|NCT04672941|83099588|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
46878628|NCT04672941|83099588|FG000|Overall Study|COVID-19 related but no adverse event|1|||
46878629|NCT04672941|83099588|FG000|Overall Study|Adverse Event|2|||
46878630|NCT04672941|83099588|FG000|Overall Study|Lost to Follow-up|2|||
46878631|NCT04599972|83099613|FG000|Overall Study|Withdrawal by Subject|6|||
46878632|NCT04599972|83099614|FG001|Overall Study|Withdrawal by Subject|1|||
46878633|NCT04599972|83099613|FG000|Overall Study|Adverse Event|1|||
46878634|NCT04599972|83099614|FG001|Overall Study|Adverse Event|1|||
46878635|NCT04599972|83099613|FG000|Overall Study|Lost to Follow-up|1|||
46878636|NCT04599972|83099614|FG001|Overall Study|Lost to Follow-up|6|||
46878637|NCT04599972|83099613|FG000|Overall Study|Protocol Violation|1|||
46878638|NCT04599972|83099614|FG001|Overall Study|Protocol Violation|0|||
46878639|NCT04599972|83099613|FG000|Overall Study|Other reason|1|||
46878640|NCT04599972|83099614|FG001|Overall Study|Other reason|0|||
46878641|NCT04599933|83099622|FG000|Overall Study|Adverse Event|4|||
46878642|NCT04599933|83099623|FG001|Overall Study|Adverse Event|1|||
46878643|NCT04599933|83099622|FG000|Overall Study|Withdrawal by Subject|4|||
46878644|NCT04599933|83099623|FG001|Overall Study|Withdrawal by Subject|2|||
46878645|NCT04599933|83099622|FG000|Overall Study|Lost to Follow-up|0|||
46878646|NCT04599933|83099623|FG001|Overall Study|Lost to Follow-up|1|||
46878647|NCT04599933|83099622|FG000|Overall Study|Physician Decision|0|||
46878648|NCT04599933|83099623|FG001|Overall Study|Physician Decision|1|||
46878649|NCT04599933|83099622|FG000|Overall Study|Screen Failure|1|||
46878650|NCT04599933|83099623|FG001|Overall Study|Screen Failure|2|||
46878651|NCT04558918|83099631|FG000|Randomized Treatment Period|Pregnancy|1|||
46878652|NCT04558918|83099632|FG001|Randomized Treatment Period|Pregnancy|0|||
46878653|NCT04558918|83099631|FG000|Extension Treatment Period|Pregnancy|1|||
46878654|NCT04558918|83099632|FG001|Extension Treatment Period|Pregnancy|0|||
46878655|NCT04558918|83099631|FG000|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|28|||
46878656|NCT04558918|83099632|FG001|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|14|||
46878657|NCT04498910|83099642|FG000|Overall Study|Lost to Follow-up|0|||
46878658|NCT04498910|83099643|FG001|Overall Study|Lost to Follow-up|1|||
46878659|NCT04498910|83099642|FG000|Overall Study|Withdrawal by Subject|2|||
46878660|NCT04498910|83099643|FG001|Overall Study|Withdrawal by Subject|1|||
46878661|NCT04498910|83099642|FG000|Overall Study|Adverse Event|1|||
46878662|NCT04498910|83099643|FG001|Overall Study|Adverse Event|0|||
46878663|NCT04439344|83099650|FG000|Overall Study|Never started threapy|3|||
46878664|NCT04439344|83099650|FG000|Overall Study|Ineligible|3|||
46878665|NCT04439344|83099650|FG000|Overall Study|Adverse Event|13|||
46878666|NCT04439344|83099650|FG000|Overall Study|Death|2|||
46878667|NCT04439344|83099650|FG000|Overall Study|Disease progression|29|||
46878668|NCT04439344|83099650|FG000|Overall Study|Withdrawal by Subject|2|||
46878669|NCT04439344|83099650|FG000|Overall Study|Alternative therapy|1|||
46878670|NCT04439110|83099654|FG000|Overall Study|Ineligible|2|||
46878671|NCT04439110|83099654|FG000|Overall Study|Adverse Event|4|||
46878672|NCT04439110|83099654|FG000|Overall Study|Death|2|||
46878673|NCT04439110|83099654|FG000|Overall Study|Disease proression|25|||
46878674|NCT04439110|83099654|FG000|Overall Study|Withdrawal by Subject|1|||
46878675|NCT04439110|83099654|FG000|Overall Study|Alternative therapy|1|||
46878676|NCT04439110|83099654|FG000|Overall Study|Other complicating disease|1|||
46878677|NCT04439110|83099654|FG000|Overall Study|Personal reasons|1|||
46878678|NCT04439110|83099654|FG000|Overall Study|Still on treatment|1|||
46878679|NCT04392167|83099658|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
46878680|NCT03689894|83099732|FG000|Overall Study|Adverse Event|1|||
46878681|NCT03640754|83099739|FG000|Overall Study|Withdrawal by Subject|1|||
46878682|NCT03640754|83099740|FG001|Overall Study|Withdrawal by Subject|0|||
46878683|NCT03640754|83099739|FG000|Overall Study|Lost to Follow-up|0|||
46878684|NCT03640754|83099740|FG001|Overall Study|Lost to Follow-up|1|||
46878685|NCT03255018|83099761|FG000|Overall Study|Death on study|0|||
46878686|NCT03255018|83099762|FG001|Overall Study|Death on study|5|||
46878687|NCT03255018|83099761|FG000|Overall Study|Withdrawal by Subject|0|||
46878688|NCT03255018|83099762|FG001|Overall Study|Withdrawal by Subject|2|||
46878689|NCT03204188|83099768|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
46878690|NCT03204188|83099768|FG000|Immunotherapy Phase (1 Year)|Death|1|||
46878691|NCT03204188|83099768|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
46878692|NCT03204188|83099768|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
46878693|NCT03000530|83099790|FG000|Overall Study|Adverse Event|0|||
46878694|NCT03000530|83099791|FG001|Overall Study|Adverse Event|0|||
46878695|NCT03000530|83099792|FG002|Overall Study|Adverse Event|2|||
46878696|NCT03000530|83099790|FG000|Overall Study|Lost to Follow-up|0|||
46878697|NCT03000530|83099791|FG001|Overall Study|Lost to Follow-up|3|||
46878698|NCT03000530|83099792|FG002|Overall Study|Lost to Follow-up|1|||
46878699|NCT03000530|83099790|FG000|Overall Study|Withdrawal by Subject|0|||
46878700|NCT03000530|83099791|FG001|Overall Study|Withdrawal by Subject|2|||
46878701|NCT03000530|83099792|FG002|Overall Study|Withdrawal by Subject|1|||
46878702|NCT02978781|83099806|FG000|Part A|Adverse Event|1|||
46878703|NCT02978781|83099807|FG001|Part A|Adverse Event|1|||
46878704|NCT02978781|83099808|FG002|Part A|Adverse Event|0|||
46878705|NCT02978781|83099809|FG003|Part A|Adverse Event|0|||
46878706|NCT02978781|83099810|FG004|Part A|Adverse Event|0|||
46878707|NCT02978781|83099806|FG000|Part A|Withdrawal by Subject|0|||
46878708|NCT02978781|83099807|FG001|Part A|Withdrawal by Subject|1|||
46878709|NCT02978781|83099808|FG002|Part A|Withdrawal by Subject|0|||
46878710|NCT02978781|83099809|FG003|Part A|Withdrawal by Subject|0|||
46878711|NCT02978781|83099810|FG004|Part A|Withdrawal by Subject|0|||
46878712|NCT02978781|83099806|FG000|Part B|Withdrawal by Subject|0|||
46878713|NCT02978781|83099807|FG001|Part B|Withdrawal by Subject|0|||
46878714|NCT02978781|83099808|FG002|Part B|Withdrawal by Subject|0|||
46878715|NCT02978781|83099809|FG003|Part B|Withdrawal by Subject|1|||
46878716|NCT02978781|83099810|FG004|Part B|Withdrawal by Subject|0|||
46878717|NCT02978781|83099806|FG000|Part C|Adverse Event|0|||
46878718|NCT02978781|83099807|FG001|Part C|Adverse Event|0|||
46878719|NCT02978781|83099808|FG002|Part C|Adverse Event|0|||
46878720|NCT02978781|83099809|FG003|Part C|Adverse Event|0|||
46878721|NCT02978781|83099810|FG004|Part C|Adverse Event|2|||
46878722|NCT02978781|83099806|FG000|Part C|Withdrawal by Subject|0|||
46878723|NCT02978781|83099807|FG001|Part C|Withdrawal by Subject|0|||
46878724|NCT02978781|83099808|FG002|Part C|Withdrawal by Subject|0|||
46878725|NCT02978781|83099809|FG003|Part C|Withdrawal by Subject|0|||
46878726|NCT02978781|83099810|FG004|Part C|Withdrawal by Subject|1|||
46878727|NCT02978781|83099806|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
46878728|NCT02978781|83099807|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
46878729|NCT02978781|83099808|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
46878730|NCT02978781|83099809|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
46878731|NCT02978781|83099810|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
46878732|NCT02549092|83099853|FG000|Treatment Period|Adverse Event|2|||
46878733|NCT02549092|83099854|FG001|Treatment Period|Adverse Event|2|||
46878734|NCT02549092|83099853|FG000|Treatment Period|Withdrawal by Subject|1|||
46878735|NCT02549092|83099854|FG001|Treatment Period|Withdrawal by Subject|3|||
46878736|NCT02549092|83099853|FG000|Treatment Period|Lack of Efficacy|0|||
46878737|NCT02549092|83099854|FG001|Treatment Period|Lack of Efficacy|2|||
46878738|NCT02549092|83099853|FG000|Extension/Transition Period|Adverse Event|1|||
46878739|NCT02549092|83099854|FG001|Extension/Transition Period|Adverse Event|1|||
46878740|NCT02549092|83099853|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
46878741|NCT02549092|83099854|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
46878742|NCT02549092|83099853|FG000|Extension/Transition Period|Other, Not Specified|4|||
46878743|NCT02549092|83099854|FG001|Extension/Transition Period|Other, Not Specified|2|||
46878744|NCT02543281|83099866|FG000|Overall Study|Lost to Follow-up|0|||
46878745|NCT02543281|83099867|FG001|Overall Study|Lost to Follow-up|0|||
46878746|NCT02543281|83099868|FG002|Overall Study|Lost to Follow-up|1|||
46878747|NCT02429791|83099878|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
46878748|NCT02429791|83099879|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
46878749|NCT02429791|83099878|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
46878750|NCT02429791|83099879|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
46878751|NCT02429791|83099878|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
46878752|NCT02429791|83099879|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
46878753|NCT02429791|83099878|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
46878754|NCT02429791|83099879|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
46878755|NCT02429791|83099878|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
46985987|NCT02315625|83232338|FG001|Second Intervention|Study closure|0|||
46878756|NCT02429791|83099879|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
46878757|NCT02429791|83099878|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
46878758|NCT02429791|83099879|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
46878759|NCT02429791|83099878|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
46878760|NCT02429791|83099879|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
46878761|NCT02429791|83099878|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
46878762|NCT02429791|83099879|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
46878763|NCT02429791|83099878|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
46878764|NCT02429791|83099879|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
46878765|NCT02429791|83099878|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
46878766|NCT02429791|83099879|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
46878767|NCT02429791|83099878|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
46878768|NCT02429791|83099879|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
46878769|NCT02429791|83099878|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
46878770|NCT02429791|83099879|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
46878771|NCT02422797|83099894|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
46878772|NCT02422797|83099895|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
46878773|NCT02422797|83099894|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
46878774|NCT02422797|83099895|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
46878775|NCT02422797|83099894|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
46878776|NCT02422797|83099895|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
46878777|NCT02422797|83099894|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
46878778|NCT02422797|83099895|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
46878779|NCT02422797|83099894|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
46878780|NCT02422797|83099895|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
46878781|NCT02422797|83099894|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
46878782|NCT02422797|83099895|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
46878783|NCT02422797|83099894|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
46878784|NCT02422797|83099895|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
46878785|NCT02422797|83099894|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
46878786|NCT02422797|83099895|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
46878787|NCT02422797|83099894|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
46878788|NCT02422797|83099895|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
46878789|NCT02422797|83099894|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
46878790|NCT02422797|83099895|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
46878791|NCT02422797|83099894|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
46878792|NCT02422797|83099895|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
46878793|NCT02422797|83099894|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
46878794|NCT02422797|83099895|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
46878795|NCT02422797|83099894|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
46878796|NCT02422797|83099895|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
46878797|NCT02422797|83099894|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
46878798|NCT02422797|83099895|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
46878799|NCT02181738|83099915|FG000|Overall Study|Participant Withdrew Consent|2|||
46878800|NCT02181738|83099916|FG001|Overall Study|Participant Withdrew Consent|1|||
46878801|NCT02181738|83099917|FG002|Overall Study|Participant Withdrew Consent|1|||
46878802|NCT02181738|83099918|FG003|Overall Study|Participant Withdrew Consent|1|||
46878803|NCT02181738|83099915|FG000|Overall Study|Lost to Follow-up|1|||
46878804|NCT02181738|83099916|FG001|Overall Study|Lost to Follow-up|2|||
46878805|NCT02181738|83099917|FG002|Overall Study|Lost to Follow-up|1|||
46878806|NCT02181738|83099918|FG003|Overall Study|Lost to Follow-up|1|||
46878807|NCT02181738|83099915|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
46878808|NCT02181738|83099916|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
46878809|NCT02181738|83099917|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
46878810|NCT02181738|83099918|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
46878811|NCT02181738|83099915|FG000|Overall Study|Poor/Non-Compliance|1|||
46878812|NCT02181738|83099916|FG001|Overall Study|Poor/Non-Compliance|0|||
46878813|NCT02181738|83099917|FG002|Overall Study|Poor/Non-Compliance|2|||
46878814|NCT02181738|83099918|FG003|Overall Study|Poor/Non-Compliance|1|||
46878815|NCT02181738|83099915|FG000|Overall Study|Disease Progression|28|||
46878816|NCT02181738|83099916|FG001|Overall Study|Disease Progression|35|||
46878817|NCT02181738|83099917|FG002|Overall Study|Disease Progression|40|||
46878818|NCT02181738|83099918|FG003|Overall Study|Disease Progression|0|||
46878819|NCT02181738|83099915|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
46985988|NCT02315625|83232337|FG000|Second Intervention|Disease Progression|1|||
46985989|NCT02315625|83232338|FG001|Second Intervention|Disease Progression|0|||
46985990|NCT02357979|83232348|FG000|Overall Study|Lost to Follow-up|5|||
46985991|NCT02357979|83232349|FG001|Overall Study|Lost to Follow-up|5|||
46878820|NCT02181738|83099916|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
46878821|NCT02181738|83099917|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
46878822|NCT02181738|83099918|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
46878823|NCT02181738|83099915|FG000|Overall Study|Study Drug Toxicity|6|||
46878824|NCT02181738|83099916|FG001|Overall Study|Study Drug Toxicity|11|||
46878825|NCT02181738|83099917|FG002|Overall Study|Study Drug Toxicity|8|||
46878826|NCT02181738|83099918|FG003|Overall Study|Study Drug Toxicity|1|||
46878827|NCT02181738|83099915|FG000|Overall Study|Other Reasons|14|||
46878828|NCT02181738|83099916|FG001|Overall Study|Other Reasons|16|||
46878829|NCT02181738|83099917|FG002|Overall Study|Other Reasons|28|||
46878830|NCT02181738|83099918|FG003|Overall Study|Other Reasons|0|||
46878831|NCT02181738|83099915|FG000|Overall Study|Maximum Clinical Benefit|3|||
46878832|NCT02181738|83099916|FG001|Overall Study|Maximum Clinical Benefit|0|||
46878833|NCT02181738|83099917|FG002|Overall Study|Maximum Clinical Benefit|1|||
46878834|NCT02181738|83099918|FG003|Overall Study|Maximum Clinical Benefit|0|||
46878835|NCT02181738|83099915|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
46878836|NCT02181738|83099916|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
46878837|NCT02181738|83099917|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
46878838|NCT02181738|83099918|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
46878839|NCT01367236|83099985|FG000|Overall Study|Withdrawal by Subject|3|||
46878840|NCT01367236|83099986|FG001|Overall Study|Withdrawal by Subject|1|||
46878841|NCT03681951|83100000|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
46878842|NCT03681951|83100001|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
46878843|NCT03681951|83100002|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
46878844|NCT03681951|83100003|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
46878845|NCT03681951|83100004|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
46878846|NCT03681951|83100005|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
46878847|NCT03681951|83100006|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
46878848|NCT03681951|83100007|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
46878849|NCT03681951|83100000|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
46878850|NCT03681951|83100001|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
46878851|NCT03681951|83100002|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
46878852|NCT03681951|83100003|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
46878853|NCT03681951|83100004|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
46878854|NCT03681951|83100005|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
46878855|NCT03681951|83100006|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
46878856|NCT03681951|83100007|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
46878857|NCT03681951|83100000|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
46878858|NCT03681951|83100001|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
46878859|NCT03681951|83100002|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
46878860|NCT03681951|83100003|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
46878861|NCT03681951|83100004|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
46878862|NCT03681951|83100005|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
46878863|NCT03681951|83100006|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
46878864|NCT03681951|83100007|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
46878865|NCT03681405|83100032|FG000|Overall Study|Found to be ineligible after randomized|1|||
46878866|NCT03681405|83100033|FG001|Overall Study|Found to be ineligible after randomized|0|||
46878867|NCT00174785|83100043|FG000|Overall Study|Adverse Event|293|||
46878868|NCT00174785|83100044|FG001|Overall Study|Adverse Event|191|||
46878869|NCT00174785|83100043|FG000|Overall Study|Protocol Violation|14|||
46878870|NCT00174785|83100044|FG001|Overall Study|Protocol Violation|14|||
46878871|NCT00174785|83100043|FG000|Overall Study|Withdrawal by Subject|173|||
46878872|NCT00174785|83100044|FG001|Overall Study|Withdrawal by Subject|175|||
46878873|NCT00174785|83100043|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
46878874|NCT00174785|83100044|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
46878875|NCT00174785|83100043|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
46878876|NCT00174785|83100044|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
46878877|NCT00174785|83100043|FG000|Overall Study|Other prohibited medication|5|||
46878878|NCT00174785|83100044|FG001|Overall Study|Other prohibited medication|3|||
46878879|NCT00174785|83100043|FG000|Overall Study|Family request|6|||
46878880|NCT00174785|83100044|FG001|Overall Study|Family request|8|||
46878881|NCT00174785|83100043|FG000|Overall Study|Not pre-specified/Not coded|56|||
46878882|NCT00174785|83100044|FG001|Overall Study|Not pre-specified/Not coded|70|||
46878883|NCT03681093|83100053|FG000|Overall Study|Subject decision|0|||
46878884|NCT03681093|83100054|FG001|Overall Study|Subject decision|2|||
46878885|NCT03681093|83100055|FG002|Overall Study|Subject decision|1|||
46878886|NCT00166517|83100065|FG000|Overall Study|Lost to Follow-up|1|||
46878887|NCT00166517|83100066|FG001|Overall Study|Lost to Follow-up|0|||
46878888|NCT00166517|83100065|FG000|Overall Study|Protocol Violation|4|||
46878889|NCT00166517|83100066|FG001|Overall Study|Protocol Violation|1|||
46878890|NCT00166517|83100065|FG000|Overall Study|Withdrawal by Subject|0|||
46878891|NCT00166517|83100066|FG001|Overall Study|Withdrawal by Subject|1|||
46878892|NCT00166439|83100072|FG000|Overall Study|Ineligible|5|||
46878893|NCT00138671|83100078|FG000|Overall Study|Death|0|||
46878894|NCT00138671|83100079|FG001|Overall Study|Death|3|||
46878895|NCT00138671|83100078|FG000|Overall Study|Adverse Event|6|||
46878896|NCT00138671|83100079|FG001|Overall Study|Adverse Event|3|||
46878897|NCT00138671|83100078|FG000|Overall Study|Lost to Follow-up|1|||
46878898|NCT00138671|83100079|FG001|Overall Study|Lost to Follow-up|2|||
46878899|NCT00138671|83100078|FG000|Overall Study|Withdrawal by Subject|3|||
46878900|NCT00138671|83100079|FG001|Overall Study|Withdrawal by Subject|5|||
46878901|NCT00138671|83100078|FG000|Overall Study|Other|3|||
46878902|NCT00138671|83100079|FG001|Overall Study|Other|3|||
46878903|NCT01367158|83100098|FG000|Overall Study|Withdrew consent|0|||
46878904|NCT01367158|83100099|FG001|Overall Study|Withdrew consent|2|||
46878905|NCT01367158|83100100|FG002|Overall Study|Withdrew consent|1|||
46878906|NCT01367158|83100101|FG003|Overall Study|Withdrew consent|0|||
46878907|NCT01367158|83100102|FG004|Overall Study|Withdrew consent|2|||
46878908|NCT01367158|83100103|FG005|Overall Study|Withdrew consent|0|||
46878909|NCT01367158|83100104|FG006|Overall Study|Withdrew consent|0|||
46878910|NCT01367158|83100105|FG007|Overall Study|Withdrew consent|1|||
46878911|NCT01367158|83100106|FG008|Overall Study|Withdrew consent|0|||
46878912|NCT01367158|83100107|FG009|Overall Study|Withdrew consent|0|||
46878913|NCT01367158|83100108|FG010|Overall Study|Withdrew consent|0|||
46878914|NCT01367158|83100098|FG000|Overall Study|Lost to Follow-up|0|||
46878915|NCT01367158|83100099|FG001|Overall Study|Lost to Follow-up|0|||
46878916|NCT01367158|83100100|FG002|Overall Study|Lost to Follow-up|0|||
46878917|NCT01367158|83100101|FG003|Overall Study|Lost to Follow-up|1|||
46878918|NCT01367158|83100102|FG004|Overall Study|Lost to Follow-up|0|||
46878919|NCT01367158|83100103|FG005|Overall Study|Lost to Follow-up|2|||
46878920|NCT01367158|83100104|FG006|Overall Study|Lost to Follow-up|0|||
46878921|NCT01367158|83100105|FG007|Overall Study|Lost to Follow-up|1|||
46878922|NCT01367158|83100106|FG008|Overall Study|Lost to Follow-up|0|||
46878923|NCT01367158|83100107|FG009|Overall Study|Lost to Follow-up|0|||
46878924|NCT01367158|83100108|FG010|Overall Study|Lost to Follow-up|1|||
46878925|NCT01367158|83100098|FG000|Overall Study|Protocol Violation|0|||
46878926|NCT01367158|83100099|FG001|Overall Study|Protocol Violation|1|||
46878927|NCT01367158|83100100|FG002|Overall Study|Protocol Violation|0|||
46878928|NCT01367158|83100101|FG003|Overall Study|Protocol Violation|0|||
46878929|NCT01367158|83100102|FG004|Overall Study|Protocol Violation|0|||
46878930|NCT01367158|83100103|FG005|Overall Study|Protocol Violation|0|||
46878931|NCT01367158|83100104|FG006|Overall Study|Protocol Violation|0|||
46878932|NCT01367158|83100105|FG007|Overall Study|Protocol Violation|0|||
46878933|NCT01367158|83100106|FG008|Overall Study|Protocol Violation|0|||
46878934|NCT01367158|83100107|FG009|Overall Study|Protocol Violation|0|||
46878935|NCT01367158|83100108|FG010|Overall Study|Protocol Violation|0|||
46878936|NCT00130637|83100143|FG000|Overall Study|Adverse Event|2|||
46878937|NCT00130637|83100143|FG000|Overall Study|Withdrawal by Subject|1|||
46878938|NCT03679767|83100151|FG000|Overall Study|Death|16|||
46878939|NCT03679767|83100152|FG001|Overall Study|Death|11|||
46878940|NCT03679767|83100153|FG002|Overall Study|Death|17|||
46878941|NCT03679767|83100154|FG003|Overall Study|Death|10|||
46878942|NCT03679767|83100151|FG000|Overall Study|Lost to Follow-up|1|||
46878943|NCT03679767|83100152|FG001|Overall Study|Lost to Follow-up|1|||
46878944|NCT03679767|83100153|FG002|Overall Study|Lost to Follow-up|1|||
46878945|NCT03679767|83100154|FG003|Overall Study|Lost to Follow-up|1|||
46878946|NCT03679767|83100151|FG000|Overall Study|Withdrawal by Subject|0|||
46878947|NCT03679767|83100152|FG001|Overall Study|Withdrawal by Subject|0|||
46878948|NCT03679767|83100153|FG002|Overall Study|Withdrawal by Subject|0|||
46878949|NCT03679767|83100154|FG003|Overall Study|Withdrawal by Subject|1|||
46985992|NCT02357901|83232358|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
46985993|NCT02357901|83232359|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
46878950|NCT03679767|83100151|FG000|Overall Study|Follow-up Completed|18|||
46878951|NCT03679767|83100152|FG001|Overall Study|Follow-up Completed|11|||
46878952|NCT03679767|83100153|FG002|Overall Study|Follow-up Completed|11|||
46878953|NCT03679767|83100154|FG003|Overall Study|Follow-up Completed|20|||
46878954|NCT03679767|83100151|FG000|Overall Study|Entered Hospice Care|0|||
46878955|NCT03679767|83100152|FG001|Overall Study|Entered Hospice Care|0|||
46878956|NCT03679767|83100153|FG002|Overall Study|Entered Hospice Care|0|||
46878957|NCT03679767|83100154|FG003|Overall Study|Entered Hospice Care|1|||
46878958|NCT03679767|83100151|FG000|Overall Study|Progressive Disease|0|||
46878959|NCT03679767|83100152|FG001|Overall Study|Progressive Disease|0|||
46878960|NCT03679767|83100153|FG002|Overall Study|Progressive Disease|0|||
46878961|NCT03679767|83100154|FG003|Overall Study|Progressive Disease|1|||
46878962|NCT00130247|83100168|FG000|Overall Study|Pregnancy|1|||
46878963|NCT00130247|83100169|FG001|Overall Study|Pregnancy|0|||
46878964|NCT00130247|83100168|FG000|Overall Study|Post-randomization exclusion|1|||
46878965|NCT00130247|83100169|FG001|Overall Study|Post-randomization exclusion|2|||
46878966|NCT00130247|83100168|FG000|Overall Study|Not compliant with DOT|0|||
46878967|NCT00130247|83100169|FG001|Overall Study|Not compliant with DOT|2|||
46878968|NCT03678285|83100175|FG000|Overall Study|Adverse Event|2|||
46878969|NCT03678285|83100175|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
46878970|NCT03678285|83100175|FG000|Overall Study|Dehydrated prior to start of workout|1|||
46878971|NCT04032171|83100181|FG000|Overall Study|Study Termination|1|||
46878972|NCT04032171|83100182|FG001|Overall Study|Study Termination|0|||
46878973|NCT00137423|83100190|FG000|Overall Study|Adverse Event|7|||
46878974|NCT00137423|83100191|FG001|Overall Study|Adverse Event|9|||
46878975|NCT00137423|83100190|FG000|Overall Study|consent withdrawn|1|||
46878976|NCT00137423|83100191|FG001|Overall Study|consent withdrawn|1|||
46878977|NCT00137423|83100190|FG000|Overall Study|Lack of Efficacy|31|||
46878978|NCT00137423|83100191|FG001|Overall Study|Lack of Efficacy|33|||
46878979|NCT00137423|83100190|FG000|Overall Study|Death|0|||
46878980|NCT00137423|83100191|FG001|Overall Study|Death|1|||
46878981|NCT02786836|83100201|FG000|Overall Study|Death|1|||
46878982|NCT02786836|83100201|FG000|Overall Study|Lack of Efficacy|2|||
46878983|NCT02786836|83100201|FG000|Overall Study|Protocol Violation|3|||
46878984|NCT02786836|83100201|FG000|Overall Study|Withdrawal by Subject|3|||
46878985|NCT02786836|83100201|FG000|Overall Study|Liver Transplantation|2|||
46878986|NCT02786836|83100201|FG000|Overall Study|Device or Pharmacy Issues|3|||
46878987|NCT00137267|83100208|FG000|Overall Study|Lost to Follow-up|15|||
46878988|NCT00137267|83100209|FG001|Overall Study|Lost to Follow-up|21|||
46878989|NCT00137111|83100219|FG000|Total Therapy|Death|35|||
46878990|NCT00137111|83100220|FG001|Total Therapy|Death|0|||
46878991|NCT00137111|83100221|FG002|Total Therapy|Death|0|||
46878992|NCT00137111|83100222|FG003|Total Therapy|Death|0|||
46878993|NCT00137111|83100219|FG000|Total Therapy|Non Compliance|5|||
46878994|NCT00137111|83100220|FG001|Total Therapy|Non Compliance|0|||
46878995|NCT00137111|83100221|FG002|Total Therapy|Non Compliance|0|||
46878996|NCT00137111|83100222|FG003|Total Therapy|Non Compliance|0|||
46878997|NCT00136955|83100229|FG000|Overall Study|Adverse Event|8|||
46878998|NCT00136955|83100229|FG000|Overall Study|Lost to Follow-up|1|||
46878999|NCT00136955|83100229|FG000|Overall Study|Withdrawal by Subject|2|||
46879000|NCT00136955|83100229|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
46879001|NCT00135707|83100235|FG000|Overall Study|Lost to Follow-up|94|||
46879002|NCT00135707|83100236|FG001|Overall Study|Lost to Follow-up|89|||
46879003|NCT00135707|83100235|FG000|Overall Study|Withdrawal by Subject|0|||
46879004|NCT00135707|83100236|FG001|Overall Study|Withdrawal by Subject|1|||
46879005|NCT00135707|83100235|FG000|Overall Study|Institutional review board request|1|||
46879006|NCT00135707|83100236|FG001|Overall Study|Institutional review board request|0|||
46879007|NCT00129623|83100248|FG000|Overall Study|Adverse Event|3|||
46879008|NCT00129623|83100249|FG001|Overall Study|Adverse Event|7|||
46879009|NCT00129623|83100248|FG000|Overall Study|Refused Treatment|5|||
46879010|NCT00129623|83100249|FG001|Overall Study|Refused Treatment|3|||
46879011|NCT00129623|83100248|FG000|Overall Study|Failure to Return|1|||
46879012|NCT00129623|83100249|FG001|Overall Study|Failure to Return|1|||
46879013|NCT00129623|83100248|FG000|Overall Study|Relocated job out of state|1|||
46879014|NCT00129623|83100249|FG001|Overall Study|Relocated job out of state|0|||
46879015|NCT00129623|83100248|FG000|Overall Study|Uncertainty to return|0|||
46879016|NCT00129623|83100249|FG001|Overall Study|Uncertainty to return|1|||
46879017|NCT00129545|83100260|FG000|Overall Study|Death|5|||
46879018|NCT00129545|83100261|FG001|Overall Study|Death|60|||
46879019|NCT00129545|83100262|FG002|Overall Study|Death|44|||
46879020|NCT00129545|83100260|FG000|Overall Study|Withdrawal by Subject|3|||
46879021|NCT00129545|83100261|FG001|Overall Study|Withdrawal by Subject|18|||
46879022|NCT00129545|83100262|FG002|Overall Study|Withdrawal by Subject|44|||
46879023|NCT00129545|83100260|FG000|Overall Study|Lost to Follow-up|2|||
46879024|NCT00129545|83100261|FG001|Overall Study|Lost to Follow-up|22|||
46879025|NCT00129545|83100262|FG002|Overall Study|Lost to Follow-up|13|||
46879026|NCT00129545|83100260|FG000|Overall Study|Physician Decision|0|||
46879027|NCT00129545|83100261|FG001|Overall Study|Physician Decision|3|||
46879028|NCT00129545|83100262|FG002|Overall Study|Physician Decision|10|||
46879029|NCT00129545|83100260|FG000|Overall Study|Device not implanted|16|||
46879030|NCT00129545|83100261|FG001|Overall Study|Device not implanted|61|||
46879031|NCT00129545|83100262|FG002|Overall Study|Device not implanted|0|||
46879032|NCT00129467|83100272|FG000|Received Intervention|Death|1|||
46879033|NCT00129467|83100273|FG001|Received Intervention|Death|1|||
46879034|NCT00129467|83100272|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
46879035|NCT00129467|83100273|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
46879036|NCT00129467|83100272|FG000|Received Intervention|Delirium|2|||
46879037|NCT00129467|83100273|FG001|Received Intervention|Delirium|0|||
46879038|NCT00129467|83100272|FG000|Received Intervention|Withdrawal by Subject|1|||
46879039|NCT00129467|83100273|FG001|Received Intervention|Withdrawal by Subject|0|||
46879040|NCT00129467|83100272|FG000|Received Intervention|Nausea|1|||
46879041|NCT00129467|83100273|FG001|Received Intervention|Nausea|0|||
46879042|NCT00129467|83100272|FG000|Received Intervention|Intolerance to citalopram|0|||
46879043|NCT00129467|83100273|FG001|Received Intervention|Intolerance to citalopram|1|||
46879044|NCT00129467|83100272|FG000|Received Intervention|Dizzyness, fatigue|0|||
46879045|NCT00129467|83100273|FG001|Received Intervention|Dizzyness, fatigue|1|||
46879046|NCT00129467|83100272|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
46879047|NCT00129467|83100273|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
46879048|NCT00129467|83100272|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
46879049|NCT00129467|83100273|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
46879050|NCT00129311|83100281|FG000|Overall Study|Withdrawal by Subject|12|||
46879051|NCT00129311|83100282|FG001|Overall Study|Withdrawal by Subject|19|||
46879052|NCT00133991|83100288|FG000|Overall Study|Death|4|||
46879053|NCT02784106|83100294|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
46879054|NCT02784106|83100295|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
46879055|NCT02784106|83100296|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
46879056|NCT02784106|83100297|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
46879057|NCT02784106|83100294|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
46879058|NCT02784106|83100295|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
46879059|NCT02784106|83100296|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
46879060|NCT02784106|83100297|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
46879061|NCT02784106|83100294|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
46879062|NCT02784106|83100295|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
46879063|NCT02784106|83100296|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
46879064|NCT02784106|83100297|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
46879065|NCT02784106|83100294|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
46879066|NCT02784106|83100295|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
46879067|NCT02784106|83100296|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
46879068|NCT02784106|83100297|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
46879069|NCT02784106|83100294|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
46879070|NCT02784106|83100295|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
46879071|NCT02784106|83100296|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
46879072|NCT02784106|83100297|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
46879073|NCT02784106|83100294|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
46879074|NCT02784106|83100295|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
46879075|NCT02784106|83100296|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
46879076|NCT02784106|83100297|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
46879077|NCT02785900|83100308|FG000|Overall Study|Study Termination by Sponsor|64|||
46985994|NCT02357901|83232360|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
46985995|NCT02357901|83232361|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
46985996|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
46985997|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
46879078|NCT02785900|83100309|FG001|Overall Study|Study Termination by Sponsor|81|||
46879079|NCT02785900|83100308|FG000|Overall Study|Death|46|||
46879080|NCT02785900|83100309|FG001|Overall Study|Death|32|||
46879081|NCT02785900|83100308|FG000|Overall Study|Withdrawal by Subject|4|||
46879082|NCT02785900|83100309|FG001|Overall Study|Withdrawal by Subject|8|||
46879083|NCT02785900|83100308|FG000|Overall Study|Physician Decision|3|||
46879084|NCT02785900|83100309|FG001|Overall Study|Physician Decision|2|||
46879085|NCT00127205|83100318|FG000|Overall Study|Adverse Event|228|||
46879086|NCT00127205|83100319|FG001|Overall Study|Adverse Event|387|||
46879087|NCT00127205|83100320|FG002|Overall Study|Adverse Event|273|||
46879088|NCT00127205|83100318|FG000|Overall Study|Death|8|||
46879089|NCT00127205|83100319|FG001|Overall Study|Death|6|||
46879090|NCT00127205|83100320|FG002|Overall Study|Death|5|||
46985998|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
46985999|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
46986000|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
46986001|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
46986002|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
46986003|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
46879091|NCT00127205|83100318|FG000|Overall Study|Withdrawal by Subject|318|||
46879092|NCT00127205|83100319|FG001|Overall Study|Withdrawal by Subject|310|||
46879093|NCT00127205|83100320|FG002|Overall Study|Withdrawal by Subject|172|||
46879094|NCT00127205|83100318|FG000|Overall Study|Other-non protocol specified|142|||
46879095|NCT00127205|83100319|FG001|Overall Study|Other-non protocol specified|129|||
46879096|NCT00127205|83100320|FG002|Overall Study|Other-non protocol specified|77|||
46879097|NCT00127205|83100318|FG000|Overall Study|Data not reported|6|||
46879098|NCT00127205|83100319|FG001|Overall Study|Data not reported|10|||
46879099|NCT00127205|83100320|FG002|Overall Study|Data not reported|1|||
46879100|NCT00127205|83100318|FG000|Overall Study|Progression|127|||
46879101|NCT00127205|83100319|FG001|Overall Study|Progression|131|||
46879102|NCT00127205|83100320|FG002|Overall Study|Progression|84|||
46879103|NCT02785588|83100330|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
46879104|NCT02785588|83100330|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
46879105|NCT03670641|83100334|FG000|Overall Study|Lost to Follow-up|3|||
46879106|NCT04029519|83100341|FG000|Overall Study|Protocol Violation|1|||
46879107|NCT04029519|83100341|FG000|Overall Study|Withdrawal by Subject|3|||
46879108|NCT04029519|83100341|FG000|Overall Study|Lost to Follow-up|1|||
46879109|NCT03669861|83100345|FG000|Overall Study|Disease Flare|5|||
46879110|NCT03669861|83100345|FG000|Overall Study|Lack of Efficacy|2|||
46879111|NCT00127127|83100353|FG000|Overall Study|Adverse Event|0|||
46879112|NCT00127127|83100354|FG001|Overall Study|Adverse Event|2|||
46879113|NCT00127127|83100355|FG002|Overall Study|Adverse Event|0|||
46879114|NCT00127127|83100356|FG003|Overall Study|Adverse Event|1|||
46986004|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
46986005|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
46986006|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
46986007|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
46986008|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
46986009|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
46986010|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
46986011|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
46986012|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
46986013|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
46986014|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
46986015|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
46986016|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
46986017|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
46986018|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
46986019|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
46986020|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
46986021|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
46986022|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
46986023|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
46986024|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
46986025|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
46986026|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
46986027|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
46986028|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
46986029|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
46986030|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
46986031|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
46986032|NCT02357901|83232358|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
46986033|NCT02357901|83232359|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
46986034|NCT02357901|83232360|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
46986035|NCT02357901|83232361|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
46986036|NCT01601847|83232371|FG000|Overall Study|Death|1|||
46986037|NCT01601847|83232372|FG001|Overall Study|Death|0|||
46879115|NCT00127127|83100353|FG000|Overall Study|Lack of Efficacy|1|||
46879116|NCT00127127|83100354|FG001|Overall Study|Lack of Efficacy|3|||
46879117|NCT00127127|83100355|FG002|Overall Study|Lack of Efficacy|0|||
46879118|NCT00127127|83100356|FG003|Overall Study|Lack of Efficacy|2|||
46879119|NCT03669549|83100393|FG000|Overall Study|Adverse Event|4|||
46879120|NCT03669549|83100393|FG000|Overall Study|Withdrawal by Subject|1|||
46879121|NCT03669549|83100393|FG000|Overall Study|Study terminated by the Sponsor|1|||
46879122|NCT00126659|83100404|FG000|Overall Study|Adverse Event|0|||
46879123|NCT00126659|83100405|FG001|Overall Study|Adverse Event|0|||
46879124|NCT00126659|83100406|FG002|Overall Study|Adverse Event|2|||
46879125|NCT03669081|83100414|FG000|Overall Study|Data could not be validated|1|||
46879126|NCT03669081|83100415|FG001|Overall Study|Data could not be validated|1|||
46879127|NCT03667053|83100424|FG000|Overall Study|Withdrawal by Subject|1|||
46879128|NCT03667053|83100425|FG001|Overall Study|Withdrawal by Subject|0|||
46879129|NCT03667053|83100426|FG002|Overall Study|Withdrawal by Subject|0|||
46879130|NCT03631407|83100443|FG000|Overall Study|Withdrawal by Subject|3|||
46879131|NCT03631407|83100444|FG001|Overall Study|Withdrawal by Subject|2|||
46879132|NCT03631407|83100443|FG000|Overall Study|Sponsor Decision|0|||
46879133|NCT03631407|83100444|FG001|Overall Study|Sponsor Decision|2|||
46879134|NCT03631407|83100443|FG000|Overall Study|Death|16|||
46879135|NCT03631407|83100444|FG001|Overall Study|Death|16|||
46879136|NCT03631407|83100443|FG000|Overall Study|Randomized by mistake without study treatment|1|||
46879137|NCT03631407|83100444|FG001|Overall Study|Randomized by mistake without study treatment|0|||
46879138|NCT03630393|83100461|FG000|Overall Study|Death|1|||
46879139|NCT03630393|83100462|FG001|Overall Study|Death|0|||
46879140|NCT03628599|83100479|FG000|Overall Study|Adverse Event|0|||
46879141|NCT03628599|83100480|FG001|Overall Study|Adverse Event|1|||
46879142|NCT03627195|83100506|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
46879143|NCT03627195|83100507|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
46879144|NCT03627195|83100508|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
46879145|NCT03627195|83100509|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
46879146|NCT03627195|83100510|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
46879147|NCT03627195|83100511|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
46879148|NCT00126581|83100527|FG000|Overall Study|Adverse Event|3|||
46879149|NCT00126581|83100528|FG001|Overall Study|Adverse Event|7|||
46879150|NCT00126581|83100527|FG000|Overall Study|Death|3|||
46879151|NCT00126581|83100528|FG001|Overall Study|Death|2|||
46879152|NCT00126581|83100527|FG000|Overall Study|Withdrawal by Subject|1|||
46879153|NCT00126581|83100528|FG001|Overall Study|Withdrawal by Subject|4|||
46879154|NCT00126581|83100527|FG000|Overall Study|Alternative therapy|3|||
46879155|NCT00126581|83100528|FG001|Overall Study|Alternative therapy|3|||
46879156|NCT00126581|83100527|FG000|Overall Study|Other illness/MD discretion|3|||
46879157|NCT00126581|83100528|FG001|Overall Study|Other illness/MD discretion|4|||
46879158|NCT03704584|83100538|FG000|Overall Study|Withdrawal by Subject|1|||
46879159|NCT03704584|83100539|FG001|Overall Study|Withdrawal by Subject|0|||
46879160|NCT03662997|83100549|FG000|Overall Study|Adverse Event|0|||
46879161|NCT03662997|83100550|FG001|Overall Study|Adverse Event|2|||
46879162|NCT03662997|83100551|FG002|Overall Study|Adverse Event|0|||
46879163|NCT03662997|83100552|FG003|Overall Study|Adverse Event|0|||
46879164|NCT03648879|83100564|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
46879165|NCT03647709|83100568|FG000|Overall Study|Lost to Follow-up|5|||
46879166|NCT03647709|83100568|FG000|Overall Study|Physician Decision|6|||
46879167|NCT03647709|83100568|FG000|Overall Study|Withdrawal by Subject|3|||
46879168|NCT03661983|83100574|FG000|Open Label Stabilization Phase|Adverse Event|5|||
46879169|NCT03661983|83100575|FG001|Open Label Stabilization Phase|Adverse Event|0|||
46879170|NCT03661983|83100576|FG002|Open Label Stabilization Phase|Adverse Event|0|||
46879171|NCT03661983|83100577|FG003|Open Label Stabilization Phase|Adverse Event|0|||
46879172|NCT03661983|83100574|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
46879173|NCT03661983|83100575|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
46802838|NCT00423670|83022131|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
46802839|NCT00423670|83022132|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
46802840|NCT00423670|83022125|FG000|Treatment Period|Adverse Event|8|||
46802841|NCT00423670|83022126|FG001|Treatment Period|Adverse Event|12|||
46802842|NCT00423670|83022127|FG002|Treatment Period|Adverse Event|15|||
46802843|NCT00423670|83022128|FG003|Treatment Period|Adverse Event|20|||
46802844|NCT00423670|83022129|FG004|Treatment Period|Adverse Event|9|||
46802845|NCT00423670|83022130|FG005|Treatment Period|Adverse Event|4|||
46802846|NCT00423670|83022131|FG006|Treatment Period|Adverse Event|7|||
46802847|NCT00423670|83022132|FG007|Treatment Period|Adverse Event|2|||
46802848|NCT00423670|83022125|FG000|Treatment Period|Protocol-defined clinical event|0|||
46802849|NCT00423670|83022126|FG001|Treatment Period|Protocol-defined clinical event|7|||
46802850|NCT00423670|83022127|FG002|Treatment Period|Protocol-defined clinical event|4|||
46802851|NCT00423670|83022128|FG003|Treatment Period|Protocol-defined clinical event|12|||
46802852|NCT00423670|83022129|FG004|Treatment Period|Protocol-defined clinical event|5|||
46802853|NCT00423670|83022130|FG005|Treatment Period|Protocol-defined clinical event|4|||
46802854|NCT00423670|83022131|FG006|Treatment Period|Protocol-defined clinical event|16|||
46802855|NCT00423670|83022132|FG007|Treatment Period|Protocol-defined clinical event|15|||
46802856|NCT00423670|83022125|FG000|Treatment Period|Lost to Follow-up|2|||
46802857|NCT00423670|83022126|FG001|Treatment Period|Lost to Follow-up|1|||
46879174|NCT03661983|83100576|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
46879175|NCT03661983|83100577|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
46879176|NCT03661983|83100574|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
46879177|NCT03661983|83100575|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
46879178|NCT03661983|83100576|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
46879179|NCT03661983|83100577|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
46879180|NCT03661983|83100574|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
46879181|NCT03661983|83100575|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
46879182|NCT03661983|83100576|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
46879183|NCT03661983|83100577|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
46879184|NCT03661983|83100574|FG000|Double-blind Randomized Phase|Adverse Event|0|||
46879185|NCT03661983|83100575|FG001|Double-blind Randomized Phase|Adverse Event|1|||
46879186|NCT03661983|83100576|FG002|Double-blind Randomized Phase|Adverse Event|0|||
46879187|NCT03661983|83100577|FG003|Double-blind Randomized Phase|Adverse Event|0|||
46879188|NCT03661983|83100574|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
46879189|NCT03661983|83100575|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
46879190|NCT03661983|83100576|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
46879191|NCT03661983|83100577|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
46879192|NCT03661983|83100574|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
46879193|NCT03661983|83100575|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
46879194|NCT03661983|83100576|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
46879195|NCT03661983|83100577|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
46879196|NCT03661983|83100574|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
46879197|NCT03661983|83100575|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
46879198|NCT03661983|83100576|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
46879199|NCT03661983|83100577|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
46879200|NCT02783170|83100588|FG000|Overall Study|Randomized but not Vaccinated|1|||
46879201|NCT02783170|83100589|FG001|Overall Study|Randomized but not Vaccinated|0|||
46879202|NCT03646305|83100600|FG000|Overall Study|Lost to Follow-up|4|||
46879203|NCT03646305|83100601|FG001|Overall Study|Lost to Follow-up|2|||
46879204|NCT03646305|83100602|FG002|Overall Study|Lost to Follow-up|2|||
46879205|NCT03646305|83100603|FG003|Overall Study|Lost to Follow-up|1|||
46879206|NCT03646305|83100600|FG000|Overall Study|Withdrawal by Subject|1|||
46879207|NCT03646305|83100601|FG001|Overall Study|Withdrawal by Subject|0|||
46879208|NCT03646305|83100602|FG002|Overall Study|Withdrawal by Subject|0|||
46879209|NCT03646305|83100603|FG003|Overall Study|Withdrawal by Subject|1|||
46879210|NCT02782780|83100619|FG000|Overall Study|dropped out after randomization.|7|||
46879211|NCT02782780|83100620|FG001|Overall Study|dropped out after randomization.|5|||
46879212|NCT02782780|83100619|FG000|Overall Study|Protocol Violation|0|||
46879213|NCT02782780|83100620|FG001|Overall Study|Protocol Violation|2|||
46879214|NCT00126503|83100632|FG000|Overall Study|disease progression|23|||
46879215|NCT00126503|83100633|FG001|Overall Study|disease progression|14|||
46879216|NCT00126503|83100632|FG000|Overall Study|Withdrawal by Subject|0|||
46879217|NCT00126503|83100633|FG001|Overall Study|Withdrawal by Subject|1|||
46879218|NCT00126503|83100632|FG000|Overall Study|alternative therapy|1|||
46879219|NCT00126503|83100633|FG001|Overall Study|alternative therapy|1|||
46879220|NCT00126503|83100632|FG000|Overall Study|other complicating disease|4|||
46879221|NCT00126503|83100633|FG001|Overall Study|other complicating disease|1|||
46879222|NCT00126503|83100632|FG000|Overall Study|Death|3|||
46879223|NCT00126503|83100633|FG001|Overall Study|Death|0|||
46879224|NCT00126503|83100632|FG000|Overall Study|Adverse Event|13|||
46879225|NCT00126503|83100633|FG001|Overall Study|Adverse Event|3|||
46879226|NCT00126503|83100632|FG000|Overall Study|non-compliant|1|||
46879227|NCT00126503|83100633|FG001|Overall Study|non-compliant|0|||
46879228|NCT00126503|83100632|FG000|Overall Study|Physician Decision|2|||
46879229|NCT00126503|83100633|FG001|Overall Study|Physician Decision|1|||
46879230|NCT00126425|83100645|FG000|Overall Study|Withdrawal by Subject|17|||
46879231|NCT00126425|83100646|FG001|Overall Study|Withdrawal by Subject|1|||
46879232|NCT00126425|83100645|FG000|Overall Study|Lost to Follow-up|8|||
46879233|NCT00126425|83100646|FG001|Overall Study|Lost to Follow-up|4|||
46879234|NCT00126425|83100645|FG000|Overall Study|Protocol Violation|9|||
46879235|NCT00126425|83100646|FG001|Overall Study|Protocol Violation|6|||
46879236|NCT00126425|83100645|FG000|Overall Study|Adverse Event|1|||
46879237|NCT00126425|83100646|FG001|Overall Study|Adverse Event|0|||
46802858|NCT00423670|83022127|FG002|Treatment Period|Lost to Follow-up|3|||
46802859|NCT00423670|83022128|FG003|Treatment Period|Lost to Follow-up|1|||
46802860|NCT00423670|83022129|FG004|Treatment Period|Lost to Follow-up|6|||
46802861|NCT00423670|83022130|FG005|Treatment Period|Lost to Follow-up|0|||
46802862|NCT00423670|83022131|FG006|Treatment Period|Lost to Follow-up|3|||
46802863|NCT00423670|83022132|FG007|Treatment Period|Lost to Follow-up|1|||
46802864|NCT00423670|83022125|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
46802865|NCT00423670|83022126|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
46802866|NCT00423670|83022127|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
46802867|NCT00423670|83022128|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
46879238|NCT00126425|83100645|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
46879239|NCT00126425|83100646|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
46879240|NCT00126425|83100645|FG000|Overall Study|Other|5|||
46879241|NCT00126425|83100646|FG001|Overall Study|Other|0|||
46879242|NCT00126191|83100654|FG000|Overall Study|Physician Decision|0|||
46879243|NCT00126191|83100655|FG001|Overall Study|Physician Decision|1|||
46879244|NCT00126191|83100654|FG000|Overall Study|Death|0|||
46879245|NCT00126191|83100655|FG001|Overall Study|Death|1|||
46879246|NCT00124943|83100665|FG000|Phase II|Adverse Event|0|||
46879247|NCT00124943|83100666|FG001|Phase II|Adverse Event|2|||
46879248|NCT00124943|83100667|FG002|Phase II|Adverse Event|0|||
46879249|NCT00124943|83100668|FG003|Phase II|Adverse Event|1|||
46879250|NCT00124943|83100665|FG000|Phase II|Protocol Violation|0|||
46879251|NCT00124943|83100666|FG001|Phase II|Protocol Violation|0|||
46879252|NCT00124943|83100667|FG002|Phase II|Protocol Violation|0|||
46879253|NCT00124943|83100668|FG003|Phase II|Protocol Violation|1|||
46879254|NCT00124943|83100665|FG000|Phase II|Lost to Follow-up|0|||
46879255|NCT00124943|83100666|FG001|Phase II|Lost to Follow-up|0|||
46879256|NCT00124943|83100667|FG002|Phase II|Lost to Follow-up|0|||
46879257|NCT00124943|83100668|FG003|Phase II|Lost to Follow-up|1|||
46879258|NCT00124943|83100665|FG000|Phase II|Withdrawal by Subject|0|||
46879259|NCT00124943|83100666|FG001|Phase II|Withdrawal by Subject|0|||
46879260|NCT00124943|83100667|FG002|Phase II|Withdrawal by Subject|0|||
46879261|NCT00124943|83100668|FG003|Phase II|Withdrawal by Subject|2|||
46879262|NCT00124709|83100680|FG000|Overall Study|Randomized but did not take medication|3|||
46879263|NCT00124709|83100681|FG001|Overall Study|Randomized but did not take medication|1|||
46879264|NCT00124709|83100680|FG000|Overall Study|Adverse Event|3|||
46879265|NCT00124709|83100681|FG001|Overall Study|Adverse Event|0|||
46879266|NCT00124709|83100680|FG000|Overall Study|Lack of Efficacy|5|||
46879267|NCT00124709|83100681|FG001|Overall Study|Lack of Efficacy|10|||
46879268|NCT00124709|83100680|FG000|Overall Study|Protocol Violation|3|||
46879269|NCT00124709|83100681|FG001|Overall Study|Protocol Violation|5|||
46879270|NCT00124709|83100680|FG000|Overall Study|Withdrawal by Subject|127|||
46879271|NCT00124709|83100681|FG001|Overall Study|Withdrawal by Subject|136|||
46879272|NCT00124709|83100680|FG000|Overall Study|Lost to Follow-up|114|||
46879273|NCT00124709|83100681|FG001|Overall Study|Lost to Follow-up|120|||
46879274|NCT00108862|83100689|FG000|Overall Study|Death|31|||
46879275|NCT00108862|83100690|FG001|Overall Study|Death|37|||
46879276|NCT00108862|83100689|FG000|Overall Study|Withdrawal by Subject|10|||
46879277|NCT00108862|83100690|FG001|Overall Study|Withdrawal by Subject|6|||
46879278|NCT00108862|83100689|FG000|Overall Study|Lost to Follow-up|27|||
46879279|NCT00108862|83100690|FG001|Overall Study|Lost to Follow-up|19|||
46879280|NCT00564850|83100696|FG000|Overall Study|Protocol Violation|2|||
46879281|NCT00108628|83100702|FG000|Overall Study|Withdrawal by Subject|17|||
46879282|NCT00108628|83100703|FG001|Overall Study|Withdrawal by Subject|9|||
46879283|NCT00108628|83100702|FG000|Overall Study|Lack of Efficacy|2|||
46879284|NCT00108628|83100703|FG001|Overall Study|Lack of Efficacy|1|||
46879285|NCT00108628|83100702|FG000|Overall Study|Death|1|||
46879286|NCT00108628|83100703|FG001|Overall Study|Death|0|||
46879287|NCT02715856|83100711|FG000|Overall Study|Software Issues|12|||
46879288|NCT02715856|83100712|FG001|Overall Study|Software Issues|7|||
46879289|NCT02715856|83100711|FG000|Overall Study|Death|6|||
46879290|NCT02715856|83100712|FG001|Overall Study|Death|5|||
46879291|NCT02715856|83100711|FG000|Overall Study|Non- Compliant|0|||
46879292|NCT02715856|83100712|FG001|Overall Study|Non- Compliant|40|||
46879293|NCT00108160|83100720|FG000|Overall Study|Lost to Follow-up|25|||
46879294|NCT00108160|83100721|FG001|Overall Study|Lost to Follow-up|12|||
46879295|NCT00108160|83100720|FG000|Overall Study|Death|1|||
46879296|NCT00108160|83100721|FG001|Overall Study|Death|2|||
46879297|NCT00108160|83100720|FG000|Overall Study|Withdrawal by Subject|4|||
46879298|NCT00108160|83100721|FG001|Overall Study|Withdrawal by Subject|2|||
46879299|NCT00108160|83100720|FG000|Overall Study|Protocol Violation|9|||
46879300|NCT00108160|83100721|FG001|Overall Study|Protocol Violation|5|||
46879301|NCT01366846|83100733|FG000|Overall Study|Withdrawal by Subject|2|||
46879302|NCT01366846|83100734|FG001|Overall Study|Withdrawal by Subject|0|||
46879303|NCT01366846|83100735|FG002|Overall Study|Withdrawal by Subject|0|||
46879304|NCT01366846|83100736|FG003|Overall Study|Withdrawal by Subject|0|||
46879305|NCT01366846|83100733|FG000|Overall Study|Communication Difficulties|1|||
46879306|NCT01366846|83100734|FG001|Overall Study|Communication Difficulties|4|||
46879307|NCT01366846|83100735|FG002|Overall Study|Communication Difficulties|0|||
46879308|NCT01366846|83100736|FG003|Overall Study|Communication Difficulties|1|||
46879309|NCT01366846|83100733|FG000|Overall Study|Scheduling Conflicts|0|||
46879310|NCT01366846|83100734|FG001|Overall Study|Scheduling Conflicts|0|||
46879311|NCT01366846|83100735|FG002|Overall Study|Scheduling Conflicts|1|||
46879312|NCT01366846|83100736|FG003|Overall Study|Scheduling Conflicts|0|||
46879313|NCT00108082|83100752|FG000|Overall Study|Adverse Event|14|||
46879314|NCT00108082|83100753|FG001|Overall Study|Adverse Event|12|||
46879315|NCT00108082|83100754|FG002|Overall Study|Adverse Event|17|||
46879316|NCT00108082|83100752|FG000|Overall Study|Lost to Follow-up|6|||
46879317|NCT00108082|83100753|FG001|Overall Study|Lost to Follow-up|3|||
46879318|NCT00108082|83100754|FG002|Overall Study|Lost to Follow-up|7|||
46879319|NCT00108082|83100752|FG000|Overall Study|Consent Withdrawn|3|||
46879320|NCT00108082|83100753|FG001|Overall Study|Consent Withdrawn|3|||
46879321|NCT00108082|83100754|FG002|Overall Study|Consent Withdrawn|5|||
46879322|NCT00108082|83100752|FG000|Overall Study|Protocol Violation|1|||
46879323|NCT00108082|83100753|FG001|Overall Study|Protocol Violation|2|||
46879324|NCT00108082|83100754|FG002|Overall Study|Protocol Violation|0|||
46879325|NCT00108082|83100752|FG000|Overall Study|Lack of Efficacy|3|||
46879326|NCT00108082|83100753|FG001|Overall Study|Lack of Efficacy|1|||
46879327|NCT00108082|83100754|FG002|Overall Study|Lack of Efficacy|2|||
46879328|NCT00108082|83100752|FG000|Overall Study|Amendment 4: > Month 12|5|||
46879329|NCT00108082|83100753|FG001|Overall Study|Amendment 4: > Month 12|7|||
46879330|NCT00108082|83100754|FG002|Overall Study|Amendment 4: > Month 12|5|||
46879331|NCT00108082|83100752|FG000|Overall Study|Woman of Child-bearing Potential|2|||
46879332|NCT00108082|83100753|FG001|Overall Study|Woman of Child-bearing Potential|0|||
46879333|NCT00108082|83100754|FG002|Overall Study|Woman of Child-bearing Potential|2|||
46879334|NCT00108082|83100752|FG000|Overall Study|Incorrectly Randomized|0|||
46879335|NCT00108082|83100753|FG001|Overall Study|Incorrectly Randomized|0|||
46879336|NCT00108082|83100754|FG002|Overall Study|Incorrectly Randomized|2|||
46879337|NCT00108082|83100752|FG000|Overall Study|Non-compliance|1|||
46879338|NCT00108082|83100753|FG001|Overall Study|Non-compliance|0|||
46879339|NCT00108082|83100754|FG002|Overall Study|Non-compliance|2|||
46879340|NCT00108082|83100752|FG000|Overall Study|Stopped Study Medication|0|||
46879341|NCT00108082|83100753|FG001|Overall Study|Stopped Study Medication|0|||
46879342|NCT00108082|83100754|FG002|Overall Study|Stopped Study Medication|1|||
46879343|NCT00108082|83100752|FG000|Overall Study|Site Closed Study|0|||
46879344|NCT00108082|83100753|FG001|Overall Study|Site Closed Study|2|||
46879345|NCT00108082|83100754|FG002|Overall Study|Site Closed Study|0|||
46879346|NCT00108082|83100752|FG000|Overall Study|Protocol Amendment|0|||
46879347|NCT00108082|83100753|FG001|Overall Study|Protocol Amendment|1|||
46879348|NCT00108082|83100754|FG002|Overall Study|Protocol Amendment|0|||
46879349|NCT00108082|83100752|FG000|Overall Study|Study Medication Not Tapered|0|||
46879350|NCT00108082|83100753|FG001|Overall Study|Study Medication Not Tapered|1|||
46879351|NCT00108082|83100754|FG002|Overall Study|Study Medication Not Tapered|0|||
46879352|NCT00108082|83100752|FG000|Overall Study|Subject Left Site Location|1|||
46879353|NCT00108082|83100753|FG001|Overall Study|Subject Left Site Location|0|||
46879354|NCT00108082|83100754|FG002|Overall Study|Subject Left Site Location|0|||
46879355|NCT00108082|83100752|FG000|Overall Study|Investigator Not at Site|1|||
46879356|NCT00108082|83100753|FG001|Overall Study|Investigator Not at Site|0|||
46879357|NCT00108082|83100754|FG002|Overall Study|Investigator Not at Site|0|||
46879358|NCT00108082|83100752|FG000|Overall Study|Blood Pressure Not Controlled|1|||
46879359|NCT00108082|83100753|FG001|Overall Study|Blood Pressure Not Controlled|0|||
46879360|NCT00108082|83100754|FG002|Overall Study|Blood Pressure Not Controlled|0|||
46879361|NCT00104728|83100766|FG000|Overall Study|screen failures|19|||
46879362|NCT02781844|83100774|FG000|Treatment Period 1|Adverse Event|0|||
46879363|NCT02781844|83100775|FG001|Treatment Period 1|Adverse Event|0|||
46879364|NCT02781844|83100776|FG002|Treatment Period 1|Adverse Event|0|||
46879365|NCT02781844|83100777|FG003|Treatment Period 1|Adverse Event|0|||
46879366|NCT02781844|83100778|FG004|Treatment Period 1|Adverse Event|0|||
46879367|NCT02781844|83100779|FG005|Treatment Period 1|Adverse Event|1|||
46879368|NCT02781844|83100780|FG006|Treatment Period 1|Adverse Event|0|||
46879369|NCT02781844|83100781|FG007|Treatment Period 1|Adverse Event|0|||
46879370|NCT02775916|83100799|FG000|Overall Study|Adverse Event|1|||
46879371|NCT02775916|83100800|FG001|Overall Study|Adverse Event|0|||
46879372|NCT02775916|83100799|FG000|Overall Study|Subject/Guardian Decision|2|||
46879373|NCT02775916|83100800|FG001|Overall Study|Subject/Guardian Decision|0|||
46879374|NCT00122681|83100808|FG000|Overall Study|Adverse Event|20|||
46879375|NCT00122681|83100809|FG001|Overall Study|Adverse Event|16|||
46986038|NCT01601847|83232371|FG000|Overall Study|Withdrawal by Subject|11|||
46986039|NCT01601847|83232372|FG001|Overall Study|Withdrawal by Subject|7|||
46986040|NCT01601847|83232371|FG000|Overall Study|Lost to Follow-up|1|||
46986041|NCT01601847|83232372|FG001|Overall Study|Lost to Follow-up|3|||
46879376|NCT00122681|83100808|FG000|Overall Study|Lost to Follow-up|1080|||
46879377|NCT00122681|83100809|FG001|Overall Study|Lost to Follow-up|1097|||
46879378|NCT00122681|83100808|FG000|Overall Study|Protocol Violation|7|||
46879379|NCT00122681|83100809|FG001|Overall Study|Protocol Violation|10|||
46879380|NCT00122681|83100808|FG000|Overall Study|Withdrawal by Subject|257|||
46879381|NCT00122681|83100809|FG001|Overall Study|Withdrawal by Subject|251|||
46879382|NCT00122681|83100808|FG000|Overall Study|Personal reasons|150|||
46879383|NCT00122681|83100809|FG001|Overall Study|Personal reasons|147|||
46879384|NCT02774278|83100823|FG000|Overall Study|Lack of Efficacy|199|||
46879385|NCT02774278|83100823|FG000|Overall Study|Death|29|||
46879386|NCT02774278|83100823|FG000|Overall Study|Adverse event/intercurrent illness|16|||
46879387|NCT02774278|83100823|FG000|Overall Study|Refused treatment/did not cooperate|9|||
46879388|NCT02774278|83100823|FG000|Overall Study|Administrative reasons|6|||
46986042|NCT02515669|83232382|FG000|228 Week Open-Label Phase|Other|0|||
46986043|NCT02515669|83232383|FG001|228 Week Open-Label Phase|Other|0|||
46986044|NCT02515669|83232384|FG002|228 Week Open-Label Phase|Other|1|||
46986045|NCT02515669|83232385|FG003|228 Week Open-Label Phase|Other|4|||
46986046|NCT02515669|83232382|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
46986047|NCT02515669|83232383|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
46986048|NCT02515669|83232384|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
46879389|NCT02774278|83100823|FG000|Overall Study|Withdrawal by Subject|3|||
46879390|NCT02774278|83100823|FG000|Overall Study|Protocol Violation|2|||
46879391|NCT00122135|83100829|FG000|Overall Study|Withdrawal by Subject|3|||
46879392|NCT00122135|83100830|FG001|Overall Study|Withdrawal by Subject|0|||
46879393|NCT03645057|83100840|FG000|Randomization to Baseline|Lost to Follow-up|1|||
46879394|NCT03645057|83100841|FG001|Randomization to Baseline|Lost to Follow-up|0|||
46879395|NCT03645057|83100842|FG002|Randomization to Baseline|Lost to Follow-up|1|||
46879396|NCT03645057|83100843|FG003|Randomization to Baseline|Lost to Follow-up|0|||
46879397|NCT03645057|83100840|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
46879398|NCT03645057|83100841|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
46879399|NCT03645057|83100842|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
46879400|NCT03645057|83100843|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
46879401|NCT03645057|83100840|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
46879402|NCT03645057|83100841|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
46879403|NCT03645057|83100842|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
46879404|NCT03645057|83100843|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
46879405|NCT03645057|83100840|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
46879406|NCT03645057|83100841|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
46879407|NCT03645057|83100842|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
46879408|NCT03645057|83100843|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
46879409|NCT00132041|83100849|FG000|Baseline|Ineligible|6|||
46879410|NCT00132041|83100849|FG000|3 Months Post Ablation|Transplant|1|||
46879411|NCT00132041|83100849|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
46879412|NCT00132041|83100849|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
46879413|NCT00132041|83100849|FG000|6 Months Post Ablation|Death|2|||
46986049|NCT02515669|83232385|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
46986050|NCT02515669|83232382|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
46986051|NCT02515669|83232383|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
46986052|NCT02515669|83232384|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
46986053|NCT02515669|83232385|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
46986054|NCT02515669|83232382|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
46986055|NCT02515669|83232383|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
46986056|NCT02515669|83232384|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
46986057|NCT02515669|83232385|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
46986058|NCT02515669|83232382|FG000|228 Week Open-Label Phase|Missing|0|||
46986059|NCT02515669|83232383|FG001|228 Week Open-Label Phase|Missing|2|||
46986060|NCT02515669|83232384|FG002|228 Week Open-Label Phase|Missing|2|||
46986061|NCT02515669|83232385|FG003|228 Week Open-Label Phase|Missing|2|||
46986062|NCT02515279|83232415|FG000|Overall Study|Adverse Event|7|||
46986063|NCT02515279|83232415|FG000|Overall Study|Lack of Efficacy|31|||
46986064|NCT02515279|83232415|FG000|Overall Study|Lost to Follow-up|9|||
46986065|NCT02515279|83232415|FG000|Overall Study|Withdrawal by Subject|18|||
46986066|NCT02515279|83232415|FG000|Overall Study|End-of-treatment visit not attended|17|||
46986067|NCT02515279|83232415|FG000|Overall Study|Other|22|||
46986068|NCT02515045|83232421|FG000|Overall Study|Adverse Event|0|||
46986069|NCT02515045|83232422|FG001|Overall Study|Adverse Event|3|||
46986070|NCT02515045|83232423|FG002|Overall Study|Adverse Event|3|||
46986071|NCT02515045|83232421|FG000|Overall Study|Lost to Follow-up|0|||
46986072|NCT02515045|83232422|FG001|Overall Study|Lost to Follow-up|1|||
46986073|NCT02515045|83232423|FG002|Overall Study|Lost to Follow-up|1|||
46986074|NCT02514577|83232433|FG000|Overall Study|Lost to Follow-up|6|||
46986075|NCT02514577|83232434|FG001|Overall Study|Lost to Follow-up|6|||
46986076|NCT02514577|83232433|FG000|Overall Study|Protocol Violation|1|||
46986077|NCT02514577|83232434|FG001|Overall Study|Protocol Violation|0|||
46986078|NCT02514577|83232433|FG000|Overall Study|Withdrawal by Subject|6|||
46986079|NCT02514577|83232434|FG001|Overall Study|Withdrawal by Subject|6|||
46986080|NCT02514577|83232433|FG000|Overall Study|Adverse Event|1|||
46986081|NCT02514577|83232434|FG001|Overall Study|Adverse Event|1|||
46986082|NCT02513485|83232442|FG000|Overall Study|Adverse Event|1|||
46986083|NCT02513485|83232443|FG001|Overall Study|Adverse Event|0|||
46986084|NCT02289417|83232452|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
46879414|NCT00132041|83100849|FG000|6 Months Post Ablation|Transplant|6|||
46879415|NCT00132041|83100849|FG000|9 Months Post Ablation|Death|1|||
46879416|NCT00132041|83100849|FG000|9 Months Post Ablation|Transplant|1|||
46879417|NCT00132041|83100849|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
46986085|NCT02289417|83232453|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
46986086|NCT02289417|83232454|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
46986087|NCT02289417|83232455|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
46986088|NCT02289417|83232456|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
46879418|NCT00132041|83100849|FG000|12 Months Post Ablation|Death|1|||
46879419|NCT00132041|83100849|FG000|12 Months Post Ablation|Transplant|1|||
46879420|NCT00132041|83100849|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
46879421|NCT00132041|83100849|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
46879422|NCT00132041|83100849|FG000|15 Months Post Ablation|Death|1|||
46879423|NCT00132041|83100849|FG000|15 Months Post Ablation|Transplant|5|||
46879424|NCT00132041|83100849|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
46879425|NCT00132041|83100849|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
46879426|NCT00132041|83100849|FG000|18 Months Post Ablation|Transplant|1|||
46879427|NCT00132041|83100849|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
46879428|NCT00132041|83100849|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
46879429|NCT03643575|83100859|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
46879430|NCT03643575|83100860|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
46879431|NCT03643575|83100861|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
46879432|NCT03643575|83100862|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
46879433|NCT03643575|83100863|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
46879434|NCT03643575|83100864|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
46879435|NCT03643575|83100859|FG000|Washout: 7 Days|Adverse Event|1|||
46879436|NCT03643575|83100860|FG001|Washout: 7 Days|Adverse Event|0|||
46879437|NCT03643575|83100861|FG002|Washout: 7 Days|Adverse Event|0|||
46879438|NCT03643575|83100862|FG003|Washout: 7 Days|Adverse Event|0|||
46879439|NCT03643575|83100863|FG004|Washout: 7 Days|Adverse Event|0|||
46879440|NCT03643575|83100864|FG005|Washout: 7 Days|Adverse Event|0|||
46879441|NCT03643575|83100859|FG000|Washout: 7 Days|Non compliance check in|0|||
46879442|NCT03643575|83100860|FG001|Washout: 7 Days|Non compliance check in|1|||
46879443|NCT03643575|83100861|FG002|Washout: 7 Days|Non compliance check in|0|||
46879444|NCT03643575|83100862|FG003|Washout: 7 Days|Non compliance check in|0|||
46879445|NCT03643575|83100863|FG004|Washout: 7 Days|Non compliance check in|0|||
46879446|NCT03643575|83100864|FG005|Washout: 7 Days|Non compliance check in|0|||
46879447|NCT02768194|83100872|FG000|Period 1|Adverse Event|0|||
46879448|NCT02768194|83100873|FG001|Period 1|Adverse Event|0|||
46879449|NCT02768194|83100874|FG002|Period 1|Adverse Event|0|||
46879450|NCT02768194|83100875|FG003|Period 1|Adverse Event|1|||
46879451|NCT02768194|83100876|FG004|Period 1|Adverse Event|0|||
46879452|NCT02768194|83100877|FG005|Period 1|Adverse Event|0|||
46879453|NCT02768194|83100872|FG000|Period 2|Other (Reason not specified)|1|||
46879454|NCT02768194|83100873|FG001|Period 2|Other (Reason not specified)|0|||
46879455|NCT02768194|83100874|FG002|Period 2|Other (Reason not specified)|0|||
46879456|NCT02768194|83100875|FG003|Period 2|Other (Reason not specified)|0|||
46879457|NCT02768194|83100876|FG004|Period 2|Other (Reason not specified)|0|||
46879458|NCT02768194|83100877|FG005|Period 2|Other (Reason not specified)|0|||
46879459|NCT02768194|83100872|FG000|Period 3|Other (Reason not specified)|0|||
46879460|NCT02768194|83100873|FG001|Period 3|Other (Reason not specified)|1|||
46879461|NCT02768194|83100874|FG002|Period 3|Other (Reason not specified)|0|||
46879462|NCT02768194|83100875|FG003|Period 3|Other (Reason not specified)|0|||
46879463|NCT02768194|83100876|FG004|Period 3|Other (Reason not specified)|0|||
46879464|NCT02768194|83100877|FG005|Period 3|Other (Reason not specified)|0|||
46879465|NCT00130793|83100887|FG000|Overall Study|Lost to Follow-up|1|||
46879466|NCT00130793|83100888|FG001|Overall Study|Lost to Follow-up|4|||
46879467|NCT00130793|83100887|FG000|Overall Study|Withdrew consent|2|||
46879468|NCT00130793|83100888|FG001|Overall Study|Withdrew consent|0|||
46879469|NCT03818399|83100895|FG000|Overall Study|Lost to Follow-up|11|||
46879470|NCT03818399|83100895|FG000|Overall Study|Withdrawal by Subject|1|||
46879471|NCT03818399|83100895|FG000|Overall Study|Protocol Violation|2|||
46879472|NCT03642873|83100899|FG000|Third Intervention (1 Day)|Screen failure|0|||
46879473|NCT03642873|83100900|FG001|Third Intervention (1 Day)|Screen failure|0|||
46879474|NCT03642873|83100901|FG002|Third Intervention (1 Day)|Screen failure|0|||
46879475|NCT03642873|83100902|FG003|Third Intervention (1 Day)|Screen failure|0|||
46879476|NCT03642873|83100903|FG004|Third Intervention (1 Day)|Screen failure|1|||
46879477|NCT03642873|83100904|FG005|Third Intervention (1 Day)|Screen failure|0|||
46879478|NCT03818321|83100918|FG000|Overall Study|Withdrawal by Subject|1|||
46879479|NCT03818321|83100919|FG001|Overall Study|Withdrawal by Subject|2|||
46879480|NCT03616977|83100925|FG000|Period 1|Physician Decision|0|||
46986089|NCT02289417|83232457|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
46879481|NCT03616977|83100926|FG001|Period 1|Physician Decision|1|||
46879482|NCT03616977|83100925|FG000|Period 3|Adverse Event|1|||
46879483|NCT03616977|83100926|FG001|Period 3|Adverse Event|1|||
46879484|NCT02767570|83100935|FG000|Overall Study|Lost to Follow-up|3|||
46879485|NCT02767570|83100936|FG001|Overall Study|Lost to Follow-up|0|||
46879486|NCT02767570|83100935|FG000|Overall Study|COVID shutdown|2|||
46879487|NCT02767570|83100936|FG001|Overall Study|COVID shutdown|5|||
46879488|NCT02767570|83100935|FG000|Overall Study|Increased pain|2|||
46879489|NCT02767570|83100936|FG001|Overall Study|Increased pain|0|||
46879490|NCT02767570|83100935|FG000|Overall Study|Withdrawal by Subject|1|||
46879491|NCT02767570|83100936|FG001|Overall Study|Withdrawal by Subject|3|||
46879492|NCT02767570|83100935|FG000|Overall Study|Unrelated medical issue|1|||
46879493|NCT02767570|83100936|FG001|Overall Study|Unrelated medical issue|1|||
46879494|NCT02767570|83100935|FG000|Overall Study|Received intra-articular injection|0|||
46879495|NCT02767570|83100936|FG001|Overall Study|Received intra-articular injection|1|||
46879496|NCT03816761|83100945|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
46879497|NCT03816761|83100946|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
46879498|NCT03816761|83100947|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
46879499|NCT03816761|83100948|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
46879500|NCT03816761|83100949|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
46879501|NCT03816761|83100950|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
46879502|NCT03816761|83100945|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
46879503|NCT03816761|83100946|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
46879504|NCT03816761|83100947|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
46879505|NCT03816761|83100948|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
46879506|NCT03816761|83100949|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
46879507|NCT03816761|83100950|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
46879508|NCT02770612|83100972|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
46879509|NCT03575871|83100979|FG000|Overall Study|Adverse Event|5|||
46879510|NCT03575871|83100980|FG001|Overall Study|Adverse Event|5|||
46879511|NCT03575871|83100981|FG002|Overall Study|Adverse Event|8|||
46879512|NCT03575871|83100979|FG000|Overall Study|Death|1|||
46879513|NCT03575871|83100980|FG001|Overall Study|Death|0|||
46879514|NCT03575871|83100981|FG002|Overall Study|Death|0|||
46879515|NCT03575871|83100979|FG000|Overall Study|Lack of Efficacy|5|||
46879516|NCT03575871|83100980|FG001|Overall Study|Lack of Efficacy|4|||
46879517|NCT03575871|83100981|FG002|Overall Study|Lack of Efficacy|7|||
46879518|NCT03575871|83100979|FG000|Overall Study|Lost to Follow-up|1|||
46879519|NCT03575871|83100980|FG001|Overall Study|Lost to Follow-up|1|||
46879520|NCT03575871|83100981|FG002|Overall Study|Lost to Follow-up|1|||
46879521|NCT03575871|83100979|FG000|Overall Study|Protocol Deviation|1|||
46879522|NCT03575871|83100980|FG001|Overall Study|Protocol Deviation|1|||
46879523|NCT03575871|83100981|FG002|Overall Study|Protocol Deviation|1|||
46879524|NCT03575871|83100979|FG000|Overall Study|Withdrawal by Subject|6|||
46879525|NCT03575871|83100980|FG001|Overall Study|Withdrawal by Subject|1|||
46879526|NCT03575871|83100981|FG002|Overall Study|Withdrawal by Subject|9|||
46879527|NCT03575871|83100979|FG000|Overall Study|Other than specified|2|||
46879528|NCT03575871|83100980|FG001|Overall Study|Other than specified|2|||
46879529|NCT03575871|83100981|FG002|Overall Study|Other than specified|0|||
46879530|NCT03642717|83100989|FG000|Overall Study|Lost to Follow-up|2|||
46879531|NCT03642717|83100989|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
46879532|NCT03642717|83100989|FG000|Overall Study|Taken study drug prior to contract date|3|||
46879533|NCT02766478|83100996|FG000|Overall Study|Withdrawal by Subject|1|||
46879534|NCT02766478|83100997|FG001|Overall Study|Withdrawal by Subject|1|||
46879535|NCT02766400|83101005|FG000|Overall Study|Death|1|||
46879536|NCT02766400|83101006|FG001|Overall Study|Death|2|||
46879537|NCT02766400|83101005|FG000|Overall Study|Withdrawal by Subject|1|||
46879538|NCT02766400|83101006|FG001|Overall Study|Withdrawal by Subject|0|||
46879539|NCT00104650|83101015|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
46879540|NCT00104650|83101016|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
46879541|NCT00104650|83101017|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
46879542|NCT00104650|83101015|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
46879543|NCT00104650|83101016|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
46879544|NCT00104650|83101017|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
46879545|NCT00104650|83101015|FG000|Treatment Period (25 Weeks)|Death|7|||
46879546|NCT00104650|83101016|FG001|Treatment Period (25 Weeks)|Death|5|||
46703185|NCT00903175|82917891|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
46703186|NCT00903175|82917892|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
46879547|NCT00104650|83101017|FG002|Treatment Period (25 Weeks)|Death|6|||
46703187|NCT00903175|82917891|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
46879548|NCT00104650|83101015|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
46879549|NCT00104650|83101016|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
46879550|NCT00104650|83101017|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
46879551|NCT00104650|83101015|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
46879552|NCT00104650|83101016|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
46879553|NCT00104650|83101017|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
46879554|NCT00104650|83101015|FG000|Treatment Period (25 Weeks)|Other|1|||
46879555|NCT00104650|83101016|FG001|Treatment Period (25 Weeks)|Other|0|||
46879556|NCT00104650|83101017|FG002|Treatment Period (25 Weeks)|Other|0|||
46879557|NCT00104650|83101015|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
46879558|NCT00104650|83101016|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
46879559|NCT00104650|83101017|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
46879560|NCT00104650|83101015|FG000|Follow-up Period|Physician Decision|1|||
46879561|NCT00104650|83101016|FG001|Follow-up Period|Physician Decision|1|||
46879562|NCT00104650|83101017|FG002|Follow-up Period|Physician Decision|0|||
46879563|NCT00104650|83101015|FG000|Follow-up Period|Adverse Event|1|||
46879564|NCT00104650|83101016|FG001|Follow-up Period|Adverse Event|0|||
46879565|NCT00104650|83101017|FG002|Follow-up Period|Adverse Event|1|||
46879566|NCT00104650|83101015|FG000|Follow-up Period|Withdrawal by Subject|0|||
46879567|NCT00104650|83101016|FG001|Follow-up Period|Withdrawal by Subject|3|||
46879568|NCT00104650|83101017|FG002|Follow-up Period|Withdrawal by Subject|3|||
46879569|NCT00104650|83101015|FG000|Follow-up Period|Death|6|||
46879570|NCT00104650|83101016|FG001|Follow-up Period|Death|6|||
46879571|NCT00104650|83101017|FG002|Follow-up Period|Death|4|||
46879572|NCT00104650|83101015|FG000|Follow-up Period|Disease progression|3|||
46879573|NCT00104650|83101016|FG001|Follow-up Period|Disease progression|1|||
46879574|NCT00104650|83101017|FG002|Follow-up Period|Disease progression|0|||
46879575|NCT00104650|83101015|FG000|Follow-up Period|Lost to Follow-up|0|||
46879576|NCT00104650|83101016|FG001|Follow-up Period|Lost to Follow-up|1|||
46879577|NCT00104650|83101017|FG002|Follow-up Period|Lost to Follow-up|2|||
46879578|NCT00104650|83101015|FG000|Follow-up Period|Other|0|||
46879579|NCT00104650|83101016|FG001|Follow-up Period|Other|1|||
46879580|NCT00104650|83101017|FG002|Follow-up Period|Other|0|||
46879581|NCT03732807|83101032|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
46879582|NCT03732807|83101033|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
46879583|NCT03732807|83101034|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
46879584|NCT03732807|83101035|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
46879585|NCT03732807|83101036|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
46879586|NCT03732807|83101037|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
46879587|NCT03732807|83101038|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
46879588|NCT03732807|83101032|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
46879589|NCT03732807|83101033|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
46879590|NCT03732807|83101034|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
46879591|NCT03732807|83101035|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
46879592|NCT03732807|83101036|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
46879593|NCT03732807|83101037|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
46879594|NCT03732807|83101038|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
46879595|NCT03732807|83101032|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
46879596|NCT03732807|83101033|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
46879597|NCT03732807|83101034|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
46879598|NCT03732807|83101035|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
46879599|NCT03732807|83101036|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
46879600|NCT03732807|83101037|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
46879601|NCT03732807|83101038|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
46879602|NCT03732807|83101032|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
46879603|NCT03732807|83101033|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
46879604|NCT03732807|83101034|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
46879605|NCT03732807|83101035|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
46879606|NCT03732807|83101036|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
46879607|NCT03732807|83101037|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
46879608|NCT03732807|83101038|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
46879609|NCT03732807|83101032|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
46879610|NCT03732807|83101033|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
46879611|NCT03732807|83101034|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
46879612|NCT03732807|83101035|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
46879613|NCT03732807|83101036|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
46879614|NCT03732807|83101037|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
46879615|NCT03732807|83101038|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
46879616|NCT03732807|83101032|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
46879617|NCT03732807|83101033|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
46879618|NCT03732807|83101034|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
46879619|NCT03732807|83101035|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
46879620|NCT03732807|83101036|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
46879621|NCT03732807|83101037|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
46879622|NCT03732807|83101038|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
46879623|NCT03732807|83101032|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
46879624|NCT03732807|83101033|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
46879625|NCT03732807|83101034|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
46879626|NCT03732807|83101035|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
46879627|NCT03732807|83101036|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
46879628|NCT03732807|83101037|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
46879629|NCT03732807|83101038|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
46986090|NCT02289417|83232458|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
46986091|NCT02289417|83232459|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
46986092|NCT02289417|83232460|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
46986093|NCT02289417|83232452|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
46986094|NCT02289417|83232453|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
46986095|NCT02289417|83232454|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
46986096|NCT02289417|83232455|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
46986097|NCT02289417|83232456|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
46986098|NCT02289417|83232457|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
46879630|NCT03732807|83101032|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
46879631|NCT03732807|83101033|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
46879632|NCT03732807|83101034|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
46879633|NCT03732807|83101035|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
46879634|NCT03732807|83101036|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
46879635|NCT03732807|83101037|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
46879636|NCT03732807|83101038|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
46879637|NCT03732807|83101032|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
46879638|NCT03732807|83101033|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
46879639|NCT03732807|83101034|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
46879640|NCT03732807|83101035|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
46879641|NCT03732807|83101036|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
46879642|NCT03732807|83101037|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
46879643|NCT03732807|83101038|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
46879644|NCT03732807|83101032|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
46879645|NCT03732807|83101033|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
46879646|NCT03732807|83101034|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
46879647|NCT03732807|83101035|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
46879648|NCT03732807|83101036|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
46879649|NCT03732807|83101037|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
46879650|NCT03732807|83101038|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
46879651|NCT03732807|83101032|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
46879652|NCT03732807|83101033|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
46879653|NCT03732807|83101034|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
46879654|NCT03732807|83101035|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
46879655|NCT03732807|83101036|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
46879656|NCT03732807|83101037|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
46879657|NCT03732807|83101038|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
46879658|NCT03732807|83101032|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
46879659|NCT03732807|83101033|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
46879660|NCT03732807|83101034|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
46879661|NCT03732807|83101035|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
46879662|NCT03732807|83101036|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
46879663|NCT03732807|83101037|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
46879664|NCT03732807|83101038|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
46879665|NCT03732807|83101032|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
46879666|NCT03732807|83101033|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
46879667|NCT03732807|83101034|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
46879668|NCT03732807|83101035|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
46879669|NCT03732807|83101036|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
46879670|NCT03732807|83101037|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
46879671|NCT03732807|83101038|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
46879672|NCT03732807|83101032|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
46879673|NCT03732807|83101033|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
46879674|NCT03732807|83101034|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
46879675|NCT03732807|83101035|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
46879676|NCT03732807|83101036|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
46879677|NCT03732807|83101037|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
46879678|NCT03732807|83101038|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
46879679|NCT00104416|83101057|FG000|Double-Blind Phase|Adverse Event|2|||
46879680|NCT00104416|83101058|FG001|Double-Blind Phase|Adverse Event|1|||
46879681|NCT00104416|83101059|FG002|Double-Blind Phase|Adverse Event|0|||
46879682|NCT00104416|83101060|FG003|Double-Blind Phase|Adverse Event|0|||
46879683|NCT00104416|83101061|FG004|Double-Blind Phase|Adverse Event|0|||
46879684|NCT00104416|83101057|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46879685|NCT00104416|83101058|FG001|Double-Blind Phase|Lost to Follow-up|1|||
46879686|NCT00104416|83101059|FG002|Double-Blind Phase|Lost to Follow-up|0|||
46879687|NCT00104416|83101060|FG003|Double-Blind Phase|Lost to Follow-up|0|||
46879688|NCT00104416|83101061|FG004|Double-Blind Phase|Lost to Follow-up|0|||
46879689|NCT00104416|83101057|FG000|Double-Blind Phase|Protocol Violation|0|||
46879690|NCT00104416|83101058|FG001|Double-Blind Phase|Protocol Violation|1|||
46879691|NCT00104416|83101059|FG002|Double-Blind Phase|Protocol Violation|0|||
46879692|NCT00104416|83101060|FG003|Double-Blind Phase|Protocol Violation|0|||
46879693|NCT00104416|83101061|FG004|Double-Blind Phase|Protocol Violation|0|||
46879694|NCT00104416|83101057|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
46879695|NCT00104416|83101058|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
46879696|NCT00104416|83101059|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
46879697|NCT00104416|83101060|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
46879698|NCT00104416|83101061|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
46879699|NCT00104416|83101057|FG000|Double-Blind Phase|Pregnancy|1|||
46879700|NCT00104416|83101058|FG001|Double-Blind Phase|Pregnancy|0|||
46879701|NCT00104416|83101059|FG002|Double-Blind Phase|Pregnancy|0|||
46879702|NCT00104416|83101060|FG003|Double-Blind Phase|Pregnancy|0|||
46879703|NCT00104416|83101061|FG004|Double-Blind Phase|Pregnancy|0|||
46879704|NCT00104416|83101057|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
46879705|NCT00104416|83101058|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
46879706|NCT00104416|83101059|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
46879707|NCT00104416|83101060|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
46879708|NCT00104416|83101061|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
46879709|NCT00104416|83101057|FG000|Continuation Phase|Adverse Event|0|||
46879710|NCT00104416|83101058|FG001|Continuation Phase|Adverse Event|0|||
46879711|NCT00104416|83101059|FG002|Continuation Phase|Adverse Event|2|||
46879712|NCT00104416|83101060|FG003|Continuation Phase|Adverse Event|0|||
46879713|NCT00104416|83101061|FG004|Continuation Phase|Adverse Event|2|||
46879714|NCT00104416|83101057|FG000|Continuation Phase|Lost to Follow-up|0|||
46879715|NCT00104416|83101058|FG001|Continuation Phase|Lost to Follow-up|0|||
46879716|NCT00104416|83101059|FG002|Continuation Phase|Lost to Follow-up|1|||
46879717|NCT00104416|83101060|FG003|Continuation Phase|Lost to Follow-up|0|||
46879718|NCT00104416|83101061|FG004|Continuation Phase|Lost to Follow-up|1|||
46879719|NCT00104416|83101057|FG000|Continuation Phase|Withdrawal by Subject|0|||
46879720|NCT00104416|83101058|FG001|Continuation Phase|Withdrawal by Subject|0|||
46879721|NCT00104416|83101059|FG002|Continuation Phase|Withdrawal by Subject|2|||
46879722|NCT00104416|83101060|FG003|Continuation Phase|Withdrawal by Subject|1|||
46879723|NCT00104416|83101061|FG004|Continuation Phase|Withdrawal by Subject|1|||
46879724|NCT00104416|83101057|FG000|Continuation Phase|Pregnancy|0|||
46879725|NCT00104416|83101058|FG001|Continuation Phase|Pregnancy|0|||
46879726|NCT00104416|83101059|FG002|Continuation Phase|Pregnancy|1|||
46879727|NCT00104416|83101060|FG003|Continuation Phase|Pregnancy|1|||
46879728|NCT00104416|83101061|FG004|Continuation Phase|Pregnancy|0|||
46879729|NCT00104416|83101057|FG000|Continuation Phase|Non-compliance|0|||
46879730|NCT00104416|83101058|FG001|Continuation Phase|Non-compliance|0|||
46879731|NCT00104416|83101059|FG002|Continuation Phase|Non-compliance|0|||
46879732|NCT00104416|83101060|FG003|Continuation Phase|Non-compliance|0|||
46986099|NCT02289417|83232458|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
46986100|NCT02289417|83232459|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
46986101|NCT02289417|83232460|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
46986102|NCT02289417|83232452|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46986103|NCT02289417|83232453|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
46986104|NCT02289417|83232454|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46986105|NCT02289417|83232455|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46986106|NCT02289417|83232456|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46879733|NCT00104416|83101061|FG004|Continuation Phase|Non-compliance|1|||
46879734|NCT03639987|83101075|FG000|Overall Study|Study terminated by sponsor|26|||
46879735|NCT03639987|83101076|FG001|Overall Study|Study terminated by sponsor|25|||
46879736|NCT03639987|83101075|FG000|Overall Study|Lost to Follow-up|0|||
46879737|NCT03639987|83101076|FG001|Overall Study|Lost to Follow-up|1|||
46879738|NCT03639675|83101082|FG000|Overall Study|Withdrawal by Subject|1|||
46879739|NCT03635775|83101090|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
46879740|NCT03635775|83101091|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
46879741|NCT03635775|83101092|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
46879742|NCT03635775|83101093|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
46879743|NCT03610581|83101105|FG000|Overall Study|Study terminated by sponsor|2|||
46879744|NCT03610581|83101106|FG001|Overall Study|Study terminated by sponsor|0|||
46879745|NCT03610581|83101105|FG000|Overall Study|Other|0|||
46879746|NCT03610581|83101106|FG001|Overall Study|Other|1|||
46879747|NCT03610581|83101105|FG000|Overall Study|Withdrawal by Subject|1|||
46879748|NCT03610581|83101106|FG001|Overall Study|Withdrawal by Subject|0|||
46879749|NCT03610269|83101112|FG000|Overall Study|Physician Decision|10|||
46879750|NCT03610269|83101112|FG000|Overall Study|Protocol Violation|1|||
46879751|NCT03610269|83101112|FG000|Overall Study|Unable to draw blood|1|||
46879752|NCT03610269|83101112|FG000|Overall Study|Screen fail|4|||
46879753|NCT00121667|83101120|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
46879754|NCT00121667|83101121|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
46879755|NCT00121667|83101122|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
46879756|NCT00121667|83101123|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
46879757|NCT00121667|83101120|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
46879758|NCT00121667|83101121|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
46879759|NCT00121667|83101122|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
46986107|NCT02289417|83232457|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46986108|NCT02289417|83232458|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46986109|NCT02289417|83232459|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46986110|NCT02289417|83232460|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
46986111|NCT02289417|83232452|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
46986112|NCT02289417|83232453|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986113|NCT02289417|83232454|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986114|NCT02289417|83232455|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986115|NCT02289417|83232456|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986116|NCT02289417|83232457|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986117|NCT02289417|83232458|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986118|NCT02289417|83232459|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986119|NCT02289417|83232460|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
46986120|NCT02289417|83232452|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
46986121|NCT02289417|83232453|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
46986122|NCT02289417|83232454|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
46986123|NCT02289417|83232455|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
46986124|NCT02289417|83232456|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
46986125|NCT02289417|83232457|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
46986126|NCT02289417|83232458|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
46986127|NCT02289417|83232459|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
46986128|NCT02289417|83232460|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
46986129|NCT02289417|83232452|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986130|NCT02289417|83232453|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986131|NCT02289417|83232454|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
46986132|NCT02289417|83232455|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986133|NCT02289417|83232456|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986134|NCT02289417|83232457|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986135|NCT02289417|83232458|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986136|NCT02289417|83232459|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986137|NCT02289417|83232460|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
46986138|NCT02289417|83232452|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
46986139|NCT02289417|83232453|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
46986140|NCT02289417|83232454|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
46986141|NCT02289417|83232455|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
46986142|NCT02289417|83232456|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
46986143|NCT02289417|83232457|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
46986144|NCT02289417|83232458|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
46986145|NCT02289417|83232459|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
46986146|NCT02289417|83232460|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
46986147|NCT02289417|83232452|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
46986148|NCT02289417|83232453|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
46986149|NCT02289417|83232454|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
46986150|NCT02289417|83232455|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
46986151|NCT02289417|83232456|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
46986152|NCT02289417|83232457|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
46986153|NCT02289417|83232458|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
46986154|NCT02289417|83232459|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
46986155|NCT02289417|83232460|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
46986156|NCT02289417|83232452|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986157|NCT02289417|83232453|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986158|NCT02289417|83232454|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986159|NCT02289417|83232455|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986160|NCT02289417|83232456|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986161|NCT02289417|83232457|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986162|NCT02289417|83232458|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
46986163|NCT02289417|83232459|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986164|NCT02289417|83232460|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
46986165|NCT02289417|83232452|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
46986166|NCT02289417|83232453|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
46986167|NCT02289417|83232454|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
46703188|NCT00903175|82917892|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
46703189|NCT00903175|82917891|FG000|Period 1 - First Line|Protocol Violation|3|||
46703190|NCT00903175|82917892|FG001|Period 1 - First Line|Protocol Violation|3|||
46703191|NCT00903175|82917891|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
46703192|NCT00903175|82917892|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
46986168|NCT02289417|83232455|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
46986169|NCT02289417|83232456|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
46986170|NCT02289417|83232457|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
46986171|NCT02289417|83232458|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
46986172|NCT02289417|83232459|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
46986173|NCT02289417|83232460|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
46986174|NCT02289417|83232452|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
46986175|NCT02289417|83232453|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
46986176|NCT02289417|83232454|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
46986177|NCT02289417|83232455|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
46986178|NCT02289417|83232456|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
46986179|NCT02289417|83232457|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
46986180|NCT02289417|83232458|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
46986181|NCT02289417|83232459|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
46986182|NCT02289417|83232460|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
46986183|NCT02289417|83232452|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
46986184|NCT02289417|83232453|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
46986185|NCT02289417|83232454|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
46986186|NCT02289417|83232455|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
46986187|NCT02289417|83232456|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
46986188|NCT02289417|83232457|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
46986189|NCT02289417|83232458|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
46986190|NCT02289417|83232459|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
46986191|NCT02289417|83232460|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
46986192|NCT02289417|83232452|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
46986193|NCT02289417|83232453|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
46986194|NCT02289417|83232454|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
46986195|NCT02289417|83232455|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
46986196|NCT02289417|83232456|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
46986197|NCT02289417|83232457|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
46986198|NCT02289417|83232458|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
46986199|NCT02289417|83232459|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
46986200|NCT02289417|83232460|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
46986201|NCT02289417|83232452|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986202|NCT02289417|83232453|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986203|NCT02289417|83232454|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986204|NCT02289417|83232455|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986205|NCT02289417|83232456|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986206|NCT02289417|83232457|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986207|NCT02289417|83232458|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986208|NCT02289417|83232459|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
46986209|NCT02289417|83232460|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
46986210|NCT02512861|83232478|FG000|Overall Study|Protocol Violation|3|||
46986211|NCT02512861|83232479|FG001|Overall Study|Protocol Violation|7|||
46986212|NCT02512861|83232478|FG000|Overall Study|Physician Decision|3|||
46986213|NCT02512861|83232479|FG001|Overall Study|Physician Decision|1|||
46986214|NCT02512861|83232478|FG000|Overall Study|Withdrawal by Subject|0|||
46879760|NCT00121667|83101123|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
46879761|NCT00121667|83101120|FG000|Short Term (ST) Period|Adverse Event|5|||
46879762|NCT00121667|83101121|FG001|Short Term (ST) Period|Adverse Event|6|||
46879763|NCT00121667|83101122|FG002|Short Term (ST) Period|Adverse Event|5|||
46879764|NCT00121667|83101123|FG003|Short Term (ST) Period|Adverse Event|3|||
46879765|NCT00121667|83101120|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
46879766|NCT00121667|83101121|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
46879767|NCT00121667|83101122|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
46879768|NCT00121667|83101123|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
46879769|NCT00121667|83101120|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
46879770|NCT00121667|83101121|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
46879771|NCT00121667|83101122|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
46879772|NCT00121667|83101123|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
46879773|NCT00121667|83101120|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
46879774|NCT00121667|83101121|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
46879775|NCT00121667|83101122|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
46879776|NCT00121667|83101123|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
46879777|NCT00121667|83101120|FG000|Short Term (ST) Period|Other Reason|3|||
46986215|NCT02512861|83232479|FG001|Overall Study|Withdrawal by Subject|1|||
46986216|NCT02288559|83232489|FG000|Overall Study|Adverse Event|1|||
46986217|NCT02288559|83232490|FG001|Overall Study|Adverse Event|1|||
46986218|NCT02288559|83232491|FG002|Overall Study|Adverse Event|5|||
46986219|NCT02288559|83232492|FG003|Overall Study|Adverse Event|0|||
46986220|NCT02288559|83232489|FG000|Overall Study|Death|0|||
46986221|NCT02288559|83232490|FG001|Overall Study|Death|0|||
46879778|NCT00121667|83101121|FG001|Short Term (ST) Period|Other Reason|0|||
46879779|NCT00121667|83101122|FG002|Short Term (ST) Period|Other Reason|0|||
46879780|NCT00121667|83101123|FG003|Short Term (ST) Period|Other Reason|0|||
46879781|NCT00121667|83101120|FG000|Short Term (ST) Period|Death|0|||
46879782|NCT00121667|83101121|FG001|Short Term (ST) Period|Death|0|||
46879783|NCT00121667|83101122|FG002|Short Term (ST) Period|Death|0|||
46879784|NCT00121667|83101123|FG003|Short Term (ST) Period|Death|1|||
46879785|NCT00121667|83101120|FG000|Short Term (ST) Period|Pregnancy|0|||
46879786|NCT00121667|83101121|FG001|Short Term (ST) Period|Pregnancy|0|||
46879787|NCT00121667|83101122|FG002|Short Term (ST) Period|Pregnancy|0|||
46879788|NCT00121667|83101123|FG003|Short Term (ST) Period|Pregnancy|1|||
46879789|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
46879790|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
46879791|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
46879792|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
46879793|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
46879794|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
46879795|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
46879796|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
46879797|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
46879798|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
46879799|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
46879800|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
46879801|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
46879802|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
46879803|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
46879804|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
46879805|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
46879806|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
46879807|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
46879808|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
46879809|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
46879810|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
46879811|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
46879812|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
46879813|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
46879814|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
46879815|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
46879816|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
46879817|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
46879818|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
46879819|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
46879820|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
46879821|NCT00121667|83101120|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
46879822|NCT00121667|83101121|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
46879823|NCT00121667|83101122|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
46879824|NCT00121667|83101123|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
46879825|NCT02954601|83101137|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
46879826|NCT02954601|83101138|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
46879827|NCT02954601|83101139|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
46879828|NCT02954601|83101140|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
46879829|NCT03633903|83101152|FG000|Overall Study|Withdrawal by Subject|1|||
46879830|NCT03633903|83101153|FG001|Overall Study|Withdrawal by Subject|2|||
46879831|NCT03633903|83101152|FG000|Overall Study|Lost to Follow-up|5|||
46879832|NCT03633903|83101153|FG001|Overall Study|Lost to Follow-up|5|||
46879833|NCT03607695|83101159|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
46879834|NCT03607695|83101159|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
46879835|NCT03557775|83101166|FG000|Overall Study|Withdrawal by Subject|1|||
46879836|NCT03557775|83101167|FG001|Overall Study|Withdrawal by Subject|2|||
46879837|NCT03557775|83101168|FG002|Overall Study|Withdrawal by Subject|4|||
46879838|NCT03557775|83101166|FG000|Overall Study|Physician Decision|0|||
46879839|NCT03557775|83101167|FG001|Overall Study|Physician Decision|1|||
46879840|NCT03557775|83101168|FG002|Overall Study|Physician Decision|0|||
46879841|NCT00121199|83101176|FG000|Overall Study|Adverse Event|11|||
46879842|NCT00121199|83101176|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
46703193|NCT00903175|82917891|FG000|Period 1 - First Line|Administrative problems|12|||
46703194|NCT00903175|82917892|FG001|Period 1 - First Line|Administrative problems|13|||
46703195|NCT00903175|82917891|FG000|Period 1 - First Line|Death|17|||
46879843|NCT00121199|83101176|FG000|Overall Study|Progression/Relapse|1|||
46879844|NCT00121199|83101176|FG000|Overall Study|Death|3|||
46879845|NCT00121199|83101176|FG000|Overall Study|Other - Not Protocol Specified|3|||
46879846|NCT00121199|83101176|FG000|Overall Study|Ineligible|9|||
46879847|NCT00119405|83101180|FG000|Overall Study|Withdrawal by Subject|1|||
46879848|NCT00119015|83101186|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
46879849|NCT00119015|83101187|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
46879850|NCT00119015|83101188|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
46879851|NCT01981850|83101201|FG000|Main Phase Stage 1|Death|2|||
46879852|NCT01981850|83101202|FG001|Main Phase Stage 1|Death|0|||
46879853|NCT01981850|83101203|FG002|Main Phase Stage 1|Death|0|||
46879854|NCT01981850|83101204|FG003|Main Phase Stage 1|Death|0|||
46879855|NCT01981850|83101205|FG004|Main Phase Stage 1|Death|0|||
46879856|NCT01981850|83101206|FG005|Main Phase Stage 1|Death|0|||
46986222|NCT02288559|83232491|FG002|Overall Study|Death|1|||
46986223|NCT02288559|83232492|FG003|Overall Study|Death|0|||
46986224|NCT02288559|83232489|FG000|Overall Study|Lost to Follow-up|0|||
46986225|NCT02288559|83232490|FG001|Overall Study|Lost to Follow-up|0|||
46986226|NCT02288559|83232491|FG002|Overall Study|Lost to Follow-up|0|||
46986227|NCT02288559|83232492|FG003|Overall Study|Lost to Follow-up|1|||
46986228|NCT02288559|83232489|FG000|Overall Study|Withdrawal by Subject|0|||
46986229|NCT02288559|83232490|FG001|Overall Study|Withdrawal by Subject|0|||
46986230|NCT02288559|83232491|FG002|Overall Study|Withdrawal by Subject|2|||
46986231|NCT02288559|83232492|FG003|Overall Study|Withdrawal by Subject|1|||
46986232|NCT02288559|83232489|FG000|Overall Study|Reason Not Specified|0|||
46986233|NCT02288559|83232490|FG001|Overall Study|Reason Not Specified|0|||
46986234|NCT02288559|83232491|FG002|Overall Study|Reason Not Specified|3|||
46986235|NCT02288559|83232492|FG003|Overall Study|Reason Not Specified|0|||
46986236|NCT02288325|83232504|FG000|Run-in Period|Adverse Event|48|||
46986237|NCT02288325|83232505|FG001|Run-in Period|Adverse Event|0|||
46986238|NCT02288325|83232506|FG002|Run-in Period|Adverse Event|0|||
46986239|NCT02288325|83232504|FG000|Run-in Period|Lack of Efficacy|16|||
46986240|NCT02288325|83232505|FG001|Run-in Period|Lack of Efficacy|0|||
46986241|NCT02288325|83232506|FG002|Run-in Period|Lack of Efficacy|0|||
46986242|NCT02288325|83232504|FG000|Run-in Period|Withdrawal of Consent|28|||
46986243|NCT02288325|83232505|FG001|Run-in Period|Withdrawal of Consent|0|||
46986244|NCT02288325|83232506|FG002|Run-in Period|Withdrawal of Consent|0|||
46986245|NCT02288325|83232504|FG000|Run-in Period|Lost to Follow-up|25|||
46986246|NCT02288325|83232505|FG001|Run-in Period|Lost to Follow-up|0|||
46986247|NCT02288325|83232506|FG002|Run-in Period|Lost to Follow-up|0|||
46986248|NCT02288325|83232504|FG000|Run-in Period|Protocol Violation|17|||
46703196|NCT00903175|82917892|FG001|Period 1 - First Line|Death|10|||
46879857|NCT01981850|83101207|FG006|Main Phase Stage 1|Death|0|||
46879858|NCT01981850|83101208|FG007|Main Phase Stage 1|Death|0|||
46879859|NCT01981850|83101209|FG008|Main Phase Stage 1|Death|0|||
46879860|NCT01981850|83101210|FG009|Main Phase Stage 1|Death|0|||
46879861|NCT01981850|83101201|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
46879862|NCT01981850|83101202|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46986249|NCT02288325|83232505|FG001|Run-in Period|Protocol Violation|0|||
46986250|NCT02288325|83232506|FG002|Run-in Period|Protocol Violation|0|||
46986251|NCT02288325|83232504|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
46986252|NCT02288325|83232505|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
46703197|NCT00903175|82917891|FG000|Period 2 - Second Line|Missing|1|||
46703198|NCT00903175|82917892|FG001|Period 2 - Second Line|Missing|0|||
46703199|NCT00903175|82917891|FG000|Period 2 - Second Line|Adverse Event|16|||
46703200|NCT00903175|82917892|FG001|Period 2 - Second Line|Adverse Event|20|||
46703201|NCT00903175|82917891|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
46703202|NCT00903175|82917892|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
46703203|NCT00903175|82917891|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
46703204|NCT00903175|82917892|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
46703205|NCT00903175|82917891|FG000|Period 2 - Second Line|Administrative problems|19|||
46703206|NCT00903175|82917892|FG001|Period 2 - Second Line|Administrative problems|9|||
46703207|NCT00903175|82917891|FG000|Period 2 - Second Line|Death|5|||
46703208|NCT00903175|82917892|FG001|Period 2 - Second Line|Death|2|||
46703209|NCT01229735|82917900|FG000|Overall Study|Lack of Efficacy|8|||
46986253|NCT02288325|83232506|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
46986254|NCT02288325|83232504|FG000|Run-in Period|Reason not Specified|8|||
46986255|NCT02288325|83232505|FG001|Run-in Period|Reason not Specified|0|||
46986256|NCT02288325|83232506|FG002|Run-in Period|Reason not Specified|0|||
46986257|NCT02288325|83232504|FG000|Stabilization Period|Adverse Event|13|||
46986258|NCT02288325|83232505|FG001|Stabilization Period|Adverse Event|0|||
46986259|NCT02288325|83232506|FG002|Stabilization Period|Adverse Event|0|||
46703210|NCT01229735|82917901|FG001|Overall Study|Lack of Efficacy|8|||
46703211|NCT01229735|82917900|FG000|Overall Study|Protocol Violation|13|||
46879863|NCT01981850|83101203|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46879864|NCT01981850|83101204|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46879865|NCT01981850|83101205|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46986260|NCT02288325|83232504|FG000|Stabilization Period|Lack of Efficacy|22|||
46986261|NCT02288325|83232505|FG001|Stabilization Period|Lack of Efficacy|0|||
46986262|NCT02288325|83232506|FG002|Stabilization Period|Lack of Efficacy|0|||
46986263|NCT02288325|83232504|FG000|Stabilization Period|Withdrawal of Consent|23|||
46986264|NCT02288325|83232505|FG001|Stabilization Period|Withdrawal of Consent|0|||
46986265|NCT02288325|83232506|FG002|Stabilization Period|Withdrawal of Consent|0|||
46986266|NCT02288325|83232504|FG000|Stabilization Period|Lost to Follow-up|12|||
46986267|NCT02288325|83232505|FG001|Stabilization Period|Lost to Follow-up|0|||
46986268|NCT02288325|83232506|FG002|Stabilization Period|Lost to Follow-up|0|||
46986269|NCT02288325|83232504|FG000|Stabilization Period|Protocol Violation|8|||
46986270|NCT02288325|83232505|FG001|Stabilization Period|Protocol Violation|0|||
46986271|NCT02288325|83232506|FG002|Stabilization Period|Protocol Violation|0|||
46986272|NCT02288325|83232504|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
46986273|NCT02288325|83232505|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
46986274|NCT02288325|83232506|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
46986275|NCT02288325|83232504|FG000|Stabilization Period|Reason not Specified|15|||
46986276|NCT02288325|83232505|FG001|Stabilization Period|Reason not Specified|0|||
46986277|NCT02288325|83232506|FG002|Stabilization Period|Reason not Specified|0|||
46986278|NCT02288325|83232504|FG000|Double-blind Treatment Period|Adverse Event|0|||
46986279|NCT02288325|83232505|FG001|Double-blind Treatment Period|Adverse Event|2|||
46986280|NCT02288325|83232506|FG002|Double-blind Treatment Period|Adverse Event|5|||
46986281|NCT02288325|83232504|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
46986282|NCT02288325|83232505|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
46986283|NCT02288325|83232506|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
46986284|NCT02288325|83232504|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
46986285|NCT02288325|83232505|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
46986286|NCT02288325|83232506|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
46986287|NCT02288325|83232504|FG000|Double-blind Treatment Period|Protocol Violation|0|||
46986288|NCT02288325|83232505|FG001|Double-blind Treatment Period|Protocol Violation|1|||
46986289|NCT02288325|83232506|FG002|Double-blind Treatment Period|Protocol Violation|2|||
46986290|NCT02288325|83232504|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
46986291|NCT02288325|83232505|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
46986292|NCT02288325|83232506|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
46986293|NCT02288325|83232504|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
46986294|NCT02288325|83232505|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
46986295|NCT02288325|83232506|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
46986296|NCT02509117|83232523|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986297|NCT02509117|83232524|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
46986298|NCT02509117|83232525|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986299|NCT02509117|83232526|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986300|NCT02509117|83232527|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986301|NCT02509117|83232528|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986302|NCT02509117|83232529|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986303|NCT02509117|83232530|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986304|NCT02509117|83232531|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986305|NCT02509117|83232532|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
46986306|NCT02509117|83232523|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986307|NCT02509117|83232524|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986308|NCT02509117|83232525|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986309|NCT02509117|83232526|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986310|NCT02509117|83232527|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986311|NCT02509117|83232528|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986312|NCT02509117|83232529|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986313|NCT02509117|83232530|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46879866|NCT01981850|83101206|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46879867|NCT01981850|83101207|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46879868|NCT01981850|83101208|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46879869|NCT01981850|83101209|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46879870|NCT01981850|83101210|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
46879871|NCT01981850|83101201|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
46879872|NCT01981850|83101202|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
46879873|NCT01981850|83101203|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
46879874|NCT01981850|83101204|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
46703212|NCT01229735|82917901|FG001|Overall Study|Protocol Violation|8|||
46703213|NCT01229735|82917900|FG000|Overall Study|Lost to Follow-up|0|||
46703214|NCT01229735|82917901|FG001|Overall Study|Lost to Follow-up|2|||
46879875|NCT01981850|83101205|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
46879876|NCT01981850|83101206|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
46986314|NCT02509117|83232531|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
46986315|NCT02509117|83232532|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
46986316|NCT02509117|83232523|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986317|NCT02509117|83232524|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986318|NCT02509117|83232525|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986319|NCT02509117|83232526|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986320|NCT02509117|83232527|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986321|NCT02509117|83232528|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986322|NCT02509117|83232529|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986323|NCT02509117|83232530|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986324|NCT02509117|83232531|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
46986325|NCT02509117|83232532|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
46986326|NCT01654549|83232572|FG000|Overall Study|H.pylori eradication not successful|0|||
46986327|NCT01654549|83232573|FG001|Overall Study|H.pylori eradication not successful|1|||
46986328|NCT02508649|83232587|FG000|Overall Study|Withdrawal by Subject|4|||
46986329|NCT02508649|83232588|FG001|Overall Study|Withdrawal by Subject|6|||
46986330|NCT02508649|83232589|FG002|Overall Study|Withdrawal by Subject|5|||
46986331|NCT02508649|83232590|FG003|Overall Study|Withdrawal by Subject|6|||
46986332|NCT02508649|83232587|FG000|Overall Study|Investigator withdrew the subject|1|||
46986333|NCT02508649|83232588|FG001|Overall Study|Investigator withdrew the subject|2|||
46986334|NCT02508649|83232589|FG002|Overall Study|Investigator withdrew the subject|1|||
46986335|NCT02508649|83232590|FG003|Overall Study|Investigator withdrew the subject|0|||
46986336|NCT02508649|83232587|FG000|Overall Study|Post randomization screening failure|12|||
46986337|NCT02508649|83232588|FG001|Overall Study|Post randomization screening failure|4|||
46986338|NCT02508649|83232589|FG002|Overall Study|Post randomization screening failure|9|||
46986339|NCT02508649|83232590|FG003|Overall Study|Post randomization screening failure|3|||
46986340|NCT02508649|83232587|FG000|Overall Study|Lost to Follow-up|1|||
46986341|NCT02508649|83232588|FG001|Overall Study|Lost to Follow-up|1|||
46986342|NCT02508649|83232589|FG002|Overall Study|Lost to Follow-up|0|||
46986343|NCT02508649|83232590|FG003|Overall Study|Lost to Follow-up|1|||
46986344|NCT02505217|83232605|FG000|Overall Study|Withdrawal by Subject|1|||
46986345|NCT02505217|83232606|FG001|Overall Study|Withdrawal by Subject|2|||
46986346|NCT02504827|83232612|FG000|Overall Study|Could not produce sputum|1|||
46986347|NCT02504671|83232622|FG000|Overall Study|Withdrawal by Subject|1|||
46986348|NCT02504671|83232623|FG001|Overall Study|Withdrawal by Subject|5|||
46986349|NCT02504671|83232624|FG002|Overall Study|Withdrawal by Subject|4|||
46986350|NCT02504671|83232625|FG003|Overall Study|Withdrawal by Subject|4|||
46986351|NCT02504671|83232626|FG004|Overall Study|Withdrawal by Subject|5|||
46986352|NCT02504671|83232627|FG005|Overall Study|Withdrawal by Subject|3|||
46986353|NCT02504671|83232622|FG000|Overall Study|Lack of Efficacy|1|||
46986354|NCT02504671|83232623|FG001|Overall Study|Lack of Efficacy|3|||
46986355|NCT02504671|83232624|FG002|Overall Study|Lack of Efficacy|1|||
46986356|NCT02504671|83232625|FG003|Overall Study|Lack of Efficacy|0|||
46986357|NCT02504671|83232626|FG004|Overall Study|Lack of Efficacy|4|||
46986358|NCT02504671|83232627|FG005|Overall Study|Lack of Efficacy|4|||
46986359|NCT02504671|83232622|FG000|Overall Study|Adverse Event|1|||
46986360|NCT02504671|83232623|FG001|Overall Study|Adverse Event|1|||
46986361|NCT02504671|83232624|FG002|Overall Study|Adverse Event|0|||
46986362|NCT02504671|83232625|FG003|Overall Study|Adverse Event|1|||
46986363|NCT02504671|83232626|FG004|Overall Study|Adverse Event|0|||
46986364|NCT02504671|83232627|FG005|Overall Study|Adverse Event|2|||
46986365|NCT02504671|83232622|FG000|Overall Study|Protocol Violation|2|||
46986366|NCT02504671|83232623|FG001|Overall Study|Protocol Violation|1|||
46986367|NCT02504671|83232624|FG002|Overall Study|Protocol Violation|0|||
46986368|NCT02504671|83232625|FG003|Overall Study|Protocol Violation|0|||
46986369|NCT02504671|83232626|FG004|Overall Study|Protocol Violation|0|||
46986370|NCT02504671|83232627|FG005|Overall Study|Protocol Violation|1|||
46986371|NCT02504671|83232622|FG000|Overall Study|Lost to Follow-up|0|||
46986372|NCT02504671|83232623|FG001|Overall Study|Lost to Follow-up|0|||
46986373|NCT02504671|83232624|FG002|Overall Study|Lost to Follow-up|2|||
46986374|NCT02504671|83232625|FG003|Overall Study|Lost to Follow-up|0|||
46986375|NCT02504671|83232626|FG004|Overall Study|Lost to Follow-up|0|||
46986376|NCT02504671|83232627|FG005|Overall Study|Lost to Follow-up|1|||
46986377|NCT02504671|83232622|FG000|Overall Study|Protocol defined stopping criteria|7|||
46986378|NCT02504671|83232623|FG001|Overall Study|Protocol defined stopping criteria|4|||
46986379|NCT02504671|83232624|FG002|Overall Study|Protocol defined stopping criteria|3|||
46986380|NCT02504671|83232625|FG003|Overall Study|Protocol defined stopping criteria|5|||
46986381|NCT02504671|83232626|FG004|Overall Study|Protocol defined stopping criteria|3|||
46986382|NCT02504671|83232627|FG005|Overall Study|Protocol defined stopping criteria|3|||
46986383|NCT02314143|83232644|FG000|Overall Study|Adverse Event|0|||
46986384|NCT02314143|83232645|FG001|Overall Study|Adverse Event|6|||
46986385|NCT02314143|83232646|FG002|Overall Study|Adverse Event|4|||
46986386|NCT02314143|83232644|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
46986387|NCT02314143|83232645|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
46986388|NCT02314143|83232646|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
46986389|NCT02314143|83232644|FG000|Overall Study|Physician Decision|2|||
46986390|NCT02314143|83232645|FG001|Overall Study|Physician Decision|1|||
46986391|NCT02314143|83232646|FG002|Overall Study|Physician Decision|0|||
46986392|NCT02314143|83232644|FG000|Overall Study|Withdrawal by Subject|1|||
46986393|NCT02314143|83232645|FG001|Overall Study|Withdrawal by Subject|0|||
46986394|NCT02314143|83232646|FG002|Overall Study|Withdrawal by Subject|1|||
46986395|NCT02288091|83232655|FG000|Overall Study|Lost to Follow-up|1|||
46986396|NCT02288091|83232655|FG000|Overall Study|Screen fail|7|||
46986397|NCT02503501|83232661|FG000|Overall Study|Physician Decision|1|||
46986398|NCT02503501|83232662|FG001|Overall Study|Physician Decision|0|||
46986399|NCT02503501|83232661|FG000|Overall Study|Protocol Violation|0|||
46986400|NCT02503501|83232662|FG001|Overall Study|Protocol Violation|1|||
46986401|NCT02503501|83232661|FG000|Overall Study|Withdrawal by Subject|0|||
46986402|NCT02503501|83232662|FG001|Overall Study|Withdrawal by Subject|2|||
46986403|NCT02502097|83232672|FG000|Period 1|Adverse Event|0|||
46986404|NCT02502097|83232673|FG001|Period 1|Adverse Event|0|||
46986405|NCT02502097|83232674|FG002|Period 1|Adverse Event|1|||
46986406|NCT02502097|83232675|FG003|Period 1|Adverse Event|0|||
46986407|NCT02502097|83232672|FG000|Wash Out Period|Adverse Event|0|||
46986408|NCT02502097|83232673|FG001|Wash Out Period|Adverse Event|1|||
46986409|NCT02502097|83232674|FG002|Wash Out Period|Adverse Event|1|||
46986410|NCT02502097|83232675|FG003|Wash Out Period|Adverse Event|1|||
46986411|NCT02502097|83232672|FG000|Period 2|Adverse Event|0|||
46986412|NCT02502097|83232673|FG001|Period 2|Adverse Event|0|||
46986413|NCT02502097|83232674|FG002|Period 2|Adverse Event|1|||
46986414|NCT02502097|83232675|FG003|Period 2|Adverse Event|0|||
46986415|NCT02501629|83232684|FG000|Overall Study|Death|0|||
46986416|NCT02501629|83232685|FG001|Overall Study|Death|1|||
46986417|NCT02501629|83232684|FG000|Overall Study|Withdrawn from study by sponsor|1|||
46986418|NCT02501629|83232685|FG001|Overall Study|Withdrawn from study by sponsor|0|||
46986419|NCT02501629|83232684|FG000|Overall Study|Early termination by sponsor|1|||
46986420|NCT02501629|83232685|FG001|Overall Study|Early termination by sponsor|0|||
46986421|NCT02501629|83232684|FG000|Overall Study|Withdrawal by Subject|3|||
46986422|NCT02501629|83232685|FG001|Overall Study|Withdrawal by Subject|5|||
46986423|NCT02501629|83232684|FG000|Overall Study|Subject did not return to site|0|||
46986424|NCT02501629|83232685|FG001|Overall Study|Subject did not return to site|1|||
46986425|NCT02501473|83232698|FG000|Overall Study|Study Terminated|2|||
46986426|NCT02501473|83232699|FG001|Overall Study|Study Terminated|3|||
46986427|NCT02501473|83232700|FG002|Overall Study|Study Terminated|7|||
46986428|NCT02501473|83232701|FG003|Overall Study|Study Terminated|9|||
46986429|NCT02501473|83232702|FG004|Overall Study|Study Terminated|2|||
46986430|NCT02501473|83232703|FG005|Overall Study|Study Terminated|10|||
46986431|NCT02501473|83232704|FG006|Overall Study|Study Terminated|1|||
46986432|NCT02501473|83232705|FG007|Overall Study|Study Terminated|0|||
46986433|NCT02501473|83232698|FG000|Overall Study|Withdrawal by Subject|0|||
46986434|NCT02501473|83232699|FG001|Overall Study|Withdrawal by Subject|0|||
46986435|NCT02501473|83232700|FG002|Overall Study|Withdrawal by Subject|3|||
46986436|NCT02501473|83232701|FG003|Overall Study|Withdrawal by Subject|3|||
46986437|NCT02501473|83232702|FG004|Overall Study|Withdrawal by Subject|2|||
46986438|NCT02501473|83232703|FG005|Overall Study|Withdrawal by Subject|2|||
46986439|NCT02501473|83232704|FG006|Overall Study|Withdrawal by Subject|0|||
46986440|NCT02501473|83232705|FG007|Overall Study|Withdrawal by Subject|0|||
46986441|NCT02501473|83232698|FG000|Overall Study|Death|0|||
46986442|NCT02501473|83232699|FG001|Overall Study|Death|0|||
46986443|NCT02501473|83232700|FG002|Overall Study|Death|1|||
46986444|NCT02501473|83232701|FG003|Overall Study|Death|1|||
46986445|NCT02501473|83232702|FG004|Overall Study|Death|0|||
46986446|NCT02501473|83232703|FG005|Overall Study|Death|1|||
46986447|NCT02501473|83232704|FG006|Overall Study|Death|0|||
46986448|NCT02501473|83232705|FG007|Overall Study|Death|0|||
46986449|NCT02501473|83232698|FG000|Overall Study|Lost to Follow-up|1|||
46703215|NCT01229735|82917900|FG000|Overall Study|Withdrawal by Subject|18|||
46703216|NCT01229735|82917901|FG001|Overall Study|Withdrawal by Subject|17|||
46703217|NCT01229735|82917900|FG000|Overall Study|Other Reason|13|||
46703218|NCT01229735|82917901|FG001|Overall Study|Other Reason|10|||
46986450|NCT02501473|83232699|FG001|Overall Study|Lost to Follow-up|0|||
46986451|NCT02501473|83232700|FG002|Overall Study|Lost to Follow-up|1|||
46986452|NCT02501473|83232701|FG003|Overall Study|Lost to Follow-up|0|||
46986453|NCT02501473|83232702|FG004|Overall Study|Lost to Follow-up|0|||
46986454|NCT02501473|83232703|FG005|Overall Study|Lost to Follow-up|1|||
46986455|NCT02501473|83232704|FG006|Overall Study|Lost to Follow-up|0|||
46986456|NCT02501473|83232705|FG007|Overall Study|Lost to Follow-up|0|||
46986457|NCT02501473|83232698|FG000|Overall Study|Reason not specified|0|||
46986458|NCT02501473|83232699|FG001|Overall Study|Reason not specified|0|||
46986459|NCT02501473|83232700|FG002|Overall Study|Reason not specified|1|||
46986460|NCT02501473|83232701|FG003|Overall Study|Reason not specified|1|||
46986461|NCT02501473|83232702|FG004|Overall Study|Reason not specified|0|||
46986462|NCT02501473|83232703|FG005|Overall Study|Reason not specified|0|||
46986463|NCT02501473|83232704|FG006|Overall Study|Reason not specified|0|||
46986464|NCT02501473|83232705|FG007|Overall Study|Reason not specified|0|||
46986465|NCT02501161|83232723|FG000|Overall Study|Adverse Event|2|||
46986466|NCT02501161|83232724|FG001|Overall Study|Adverse Event|6|||
46986467|NCT02501161|83232723|FG000|Overall Study|Lost to Follow-up|7|||
46986468|NCT02501161|83232724|FG001|Overall Study|Lost to Follow-up|4|||
46986469|NCT02501161|83232723|FG000|Overall Study|Withdrawal by Subject|10|||
46986470|NCT02501161|83232724|FG001|Overall Study|Withdrawal by Subject|15|||
46986471|NCT02501161|83232723|FG000|Overall Study|Other|3|||
46986472|NCT02501161|83232724|FG001|Overall Study|Other|0|||
46986473|NCT02500537|83232732|FG000|Overall Study|Death|2|||
46986474|NCT02500537|83232733|FG001|Overall Study|Death|0|||
46986475|NCT02500537|83232732|FG000|Overall Study|Lost to Follow-up|0|||
46986476|NCT02500537|83232733|FG001|Overall Study|Lost to Follow-up|1|||
46986477|NCT02500537|83232732|FG000|Overall Study|Withdrawal by Subject|1|||
46986478|NCT02500537|83232733|FG001|Overall Study|Withdrawal by Subject|0|||
46986479|NCT02498821|83232742|FG000|Overall Study|Screen failure|3|||
46986480|NCT02498821|83232743|FG001|Overall Study|Screen failure|5|||
46986481|NCT02313909|83232751|FG000|Overall Study|Consent withdrawn by participant|33|||
46986482|NCT02313909|83232752|FG001|Overall Study|Consent withdrawn by participant|33|||
46986483|NCT02313909|83232751|FG000|Overall Study|Lost to Follow-up|24|||
46986484|NCT02313909|83232752|FG001|Overall Study|Lost to Follow-up|17|||
46986485|NCT02287467|83232760|FG000|Overall Study|Protocol Violation|12|||
46986486|NCT02287467|83232761|FG001|Overall Study|Protocol Violation|9|||
46986487|NCT02287233|83232773|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
46986488|NCT02287233|83232774|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
46986489|NCT02287233|83232775|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
46986490|NCT02287233|83232773|FG000|Overall Study|Adverse Event Related to Progression|0|||
46986491|NCT02287233|83232774|FG001|Overall Study|Adverse Event Related to Progression|2|||
46986492|NCT02287233|83232775|FG002|Overall Study|Adverse Event Related to Progression|8|||
46986493|NCT02287233|83232773|FG000|Overall Study|Physician Decision|1|||
46986494|NCT02287233|83232774|FG001|Overall Study|Physician Decision|2|||
46986495|NCT02287233|83232775|FG002|Overall Study|Physician Decision|4|||
46986496|NCT02287233|83232773|FG000|Overall Study|Progressive Disease with Death|0|||
46986497|NCT02287233|83232774|FG001|Overall Study|Progressive Disease with Death|0|||
46986498|NCT02287233|83232775|FG002|Overall Study|Progressive Disease with Death|10|||
46986499|NCT02287233|83232773|FG000|Overall Study|Progressive Disease Without Death|2|||
46986500|NCT02287233|83232774|FG001|Overall Study|Progressive Disease Without Death|3|||
46986501|NCT02287233|83232775|FG002|Overall Study|Progressive Disease Without Death|20|||
46986502|NCT02287233|83232773|FG000|Overall Study|Withdrawal by Subject|1|||
46986503|NCT02287233|83232774|FG001|Overall Study|Withdrawal by Subject|1|||
46986504|NCT02287233|83232775|FG002|Overall Study|Withdrawal by Subject|7|||
46986505|NCT02287233|83232773|FG000|Overall Study|Other|3|||
46986506|NCT02287233|83232774|FG001|Overall Study|Other|0|||
46986507|NCT02287233|83232775|FG002|Overall Study|Other|15|||
46986508|NCT02287233|83232773|FG000|Overall Study|Did Not Receive Treatment|0|||
46986509|NCT02287233|83232774|FG001|Overall Study|Did Not Receive Treatment|0|||
46986510|NCT02287233|83232775|FG002|Overall Study|Did Not Receive Treatment|2|||
46986511|NCT01646385|83232788|FG000|Overall Study|Death|202|||
46986512|NCT01646385|83232789|FG001|Overall Study|Death|222|||
46986513|NCT01646385|83232788|FG000|Overall Study|Switched to alternate biologic|636|||
46986514|NCT01646385|83232789|FG001|Overall Study|Switched to alternate biologic|649|||
46986515|NCT02286843|83232795|FG000|Overall Study|Not Treated|4|||
46986516|NCT02286843|83232795|FG000|Overall Study|Protocol Violation|1|||
46986517|NCT02286843|83232795|FG000|Overall Study|Withdrawal by Subject|1|||
46986518|NCT02282163|83232799|FG000|Overall Study|Protocol Violation|1|||
46986519|NCT02281773|83232817|FG000|Overall Study|Adverse Event|6|||
46986520|NCT02281773|83232818|FG001|Overall Study|Adverse Event|1|||
46986521|NCT02281773|83232819|FG002|Overall Study|Adverse Event|4|||
46986522|NCT02281773|83232820|FG003|Overall Study|Adverse Event|8|||
46986523|NCT02281773|83232821|FG004|Overall Study|Adverse Event|9|||
46986524|NCT02281773|83232817|FG000|Overall Study|Protocol Violation|1|||
46986525|NCT02281773|83232818|FG001|Overall Study|Protocol Violation|0|||
46986526|NCT02281773|83232819|FG002|Overall Study|Protocol Violation|0|||
46986527|NCT02281773|83232820|FG003|Overall Study|Protocol Violation|2|||
46986528|NCT02281773|83232821|FG004|Overall Study|Protocol Violation|2|||
46986529|NCT02281773|83232817|FG000|Overall Study|Lost to Follow-up|2|||
46986530|NCT02281773|83232818|FG001|Overall Study|Lost to Follow-up|2|||
46986531|NCT02281773|83232819|FG002|Overall Study|Lost to Follow-up|6|||
46986532|NCT02281773|83232820|FG003|Overall Study|Lost to Follow-up|2|||
46703219|NCT01229735|82917900|FG000|Overall Study|SAE, non-fatal|0|||
46986533|NCT02281773|83232821|FG004|Overall Study|Lost to Follow-up|10|||
46986534|NCT02281773|83232817|FG000|Overall Study|Withdrawal by Subject|2|||
46986535|NCT02281773|83232818|FG001|Overall Study|Withdrawal by Subject|8|||
46986536|NCT02281773|83232819|FG002|Overall Study|Withdrawal by Subject|6|||
46986537|NCT02281773|83232820|FG003|Overall Study|Withdrawal by Subject|6|||
46986538|NCT02281773|83232821|FG004|Overall Study|Withdrawal by Subject|8|||
46986539|NCT02281773|83232817|FG000|Overall Study|Other Reason|0|||
46986540|NCT02281773|83232818|FG001|Overall Study|Other Reason|4|||
46986541|NCT02281773|83232819|FG002|Overall Study|Other Reason|2|||
46986542|NCT02281773|83232820|FG003|Overall Study|Other Reason|3|||
46986543|NCT02281773|83232821|FG004|Overall Study|Other Reason|1|||
46986544|NCT02285361|83232833|FG000|Overall Study|Protocol Violation|43|||
46986545|NCT02285361|83232833|FG000|Overall Study|Lost to Follow-up|5|||
46986546|NCT02285361|83232833|FG000|Overall Study|Not taken GIOTRIF|2|||
46986547|NCT02285361|83232833|FG000|Overall Study|Consented prior to the contract date|1|||
46986548|NCT02354235|83232839|FG000|Overall Study|Adverse Event|2|||
46986549|NCT02354235|83232840|FG001|Overall Study|Adverse Event|2|||
46986550|NCT02354235|83232839|FG000|Overall Study|Physician Decision|0|||
46986551|NCT02354235|83232840|FG001|Overall Study|Physician Decision|1|||
46986552|NCT02354235|83232839|FG000|Overall Study|Withdrawal by Subject|1|||
46986553|NCT02354235|83232840|FG001|Overall Study|Withdrawal by Subject|3|||
46986554|NCT02354235|83232839|FG000|Overall Study|Conflict with the stopping criteria|0|||
46986555|NCT02354235|83232840|FG001|Overall Study|Conflict with the stopping criteria|1|||
46986556|NCT02280291|83232850|FG000|Overall Study|Lost to Follow-up|2|||
46986557|NCT02280291|83232851|FG001|Overall Study|Lost to Follow-up|1|||
46986558|NCT02280291|83232852|FG002|Overall Study|Lost to Follow-up|3|||
46986559|NCT02280291|83232853|FG003|Overall Study|Lost to Follow-up|8|||
46986560|NCT02280291|83232850|FG000|Overall Study|Protocol Violation|1|||
46986561|NCT02280291|83232851|FG001|Overall Study|Protocol Violation|0|||
46986562|NCT02280291|83232852|FG002|Overall Study|Protocol Violation|0|||
46986563|NCT02280291|83232853|FG003|Overall Study|Protocol Violation|0|||
46986564|NCT02280291|83232850|FG000|Overall Study|Other|1|||
46986565|NCT02280291|83232851|FG001|Overall Study|Other|1|||
46986566|NCT02280291|83232852|FG002|Overall Study|Other|0|||
46986567|NCT02280291|83232853|FG003|Overall Study|Other|0|||
46986568|NCT02284893|83232867|FG000|26 Week (Short Term)|Adverse Event|1|||
46986569|NCT02284893|83232868|FG001|26 Week (Short Term)|Adverse Event|9|||
46986570|NCT02284893|83232867|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
46986571|NCT02284893|83232868|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
46986572|NCT02284893|83232867|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
46986573|NCT02284893|83232868|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
46986574|NCT02284893|83232867|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
46986575|NCT02284893|83232868|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
46986576|NCT02284893|83232867|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
46986577|NCT02284893|83232868|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
46986578|NCT02284893|83232867|FG000|26 Week (Short Term)|Other|1|||
46986579|NCT02284893|83232868|FG001|26 Week (Short Term)|Other|1|||
46986580|NCT02284893|83232867|FG000|52 Week (Long Term)|Adverse Event|3|||
46986581|NCT02284893|83232868|FG001|52 Week (Long Term)|Adverse Event|1|||
46986582|NCT02284893|83232867|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
46986583|NCT02284893|83232868|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
46986584|NCT02284893|83232867|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
46986585|NCT02284893|83232868|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
46986586|NCT02284893|83232867|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
46986587|NCT02284893|83232868|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
46986588|NCT02284893|83232867|FG000|52 Week (Long Term)|Non-Compliance|2|||
46986589|NCT02284893|83232868|FG001|52 Week (Long Term)|Non-Compliance|3|||
46986590|NCT02284347|83232874|FG000|Overall Study|Lost to Follow-up|2|||
46986591|NCT02284347|83232874|FG000|Overall Study|Withdrawn prior to treatment|1|||
46986592|NCT02279043|83232881|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
46986593|NCT02279043|83232882|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
46986594|NCT02279043|83232883|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
46986595|NCT02279043|83232881|FG000|Overall Study|Lost to Follow-up|46|||
46986596|NCT02279043|83232882|FG001|Overall Study|Lost to Follow-up|88|||
46986597|NCT02279043|83232883|FG002|Overall Study|Lost to Follow-up|0|||
46986598|NCT02283411|83232889|FG000|Overall Study|Withdrawal by Subject|3|||
46986599|NCT02283411|83232889|FG000|Overall Study|Screen Failed|28|||
46986600|NCT02351817|83232893|FG000|Period 1|Adverse Event|1|||
46986601|NCT02351817|83232894|FG001|Period 1|Adverse Event|2|||
46986602|NCT02351817|83232893|FG000|Period 1|Lack of Efficacy|0|||
46986603|NCT02351817|83232894|FG001|Period 1|Lack of Efficacy|1|||
46986604|NCT02351817|83232893|FG000|Period 2|Adverse Event|0|||
46986605|NCT02351817|83232894|FG001|Period 2|Adverse Event|2|||
46986606|NCT02351817|83232893|FG000|Period 2|Protocol Violation|1|||
46986607|NCT02351817|83232894|FG001|Period 2|Protocol Violation|0|||
46986608|NCT02351349|83232903|FG000|Overall Study|Withdrawal by Subject|2|||
46986609|NCT02351349|83232904|FG001|Overall Study|Withdrawal by Subject|3|||
46986610|NCT02484547|83232918|FG000|Placebo-Controlled Period|Adverse Event|10|||
46986611|NCT02484547|83232919|FG001|Placebo-Controlled Period|Adverse Event|13|||
46986612|NCT02484547|83232920|FG002|Placebo-Controlled Period|Adverse Event|20|||
46986613|NCT02484547|83232921|FG003|Placebo-Controlled Period|Adverse Event|0|||
46986614|NCT02484547|83232922|FG004|Placebo-Controlled Period|Adverse Event|0|||
46986615|NCT02484547|83232923|FG005|Placebo-Controlled Period|Adverse Event|0|||
46986616|NCT02484547|83232924|FG006|Placebo-Controlled Period|Adverse Event|0|||
46986617|NCT02484547|83232918|FG000|Placebo-Controlled Period|Change of Treatment|0|||
46986618|NCT02484547|83232919|FG001|Placebo-Controlled Period|Change of Treatment|0|||
46986619|NCT02484547|83232920|FG002|Placebo-Controlled Period|Change of Treatment|1|||
46986620|NCT02484547|83232921|FG003|Placebo-Controlled Period|Change of Treatment|0|||
46986621|NCT02484547|83232922|FG004|Placebo-Controlled Period|Change of Treatment|0|||
46986622|NCT02484547|83232923|FG005|Placebo-Controlled Period|Change of Treatment|0|||
46986623|NCT02484547|83232924|FG006|Placebo-Controlled Period|Change of Treatment|0|||
46986624|NCT02484547|83232918|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
46986625|NCT02484547|83232919|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
46986626|NCT02484547|83232920|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
46986627|NCT02484547|83232921|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
46986628|NCT02484547|83232922|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
46986629|NCT02484547|83232923|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
46986630|NCT02484547|83232924|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
46986631|NCT02484547|83232918|FG000|Placebo-Controlled Period|Death|5|||
46986632|NCT02484547|83232919|FG001|Placebo-Controlled Period|Death|0|||
46986633|NCT02484547|83232920|FG002|Placebo-Controlled Period|Death|6|||
46986634|NCT02484547|83232921|FG003|Placebo-Controlled Period|Death|0|||
46986635|NCT02484547|83232922|FG004|Placebo-Controlled Period|Death|0|||
46986636|NCT02484547|83232923|FG005|Placebo-Controlled Period|Death|0|||
46986637|NCT02484547|83232924|FG006|Placebo-Controlled Period|Death|0|||
46986638|NCT02484547|83232918|FG000|Placebo-Controlled Period|Disease Progression|2|||
46986639|NCT02484547|83232919|FG001|Placebo-Controlled Period|Disease Progression|0|||
46986640|NCT02484547|83232920|FG002|Placebo-Controlled Period|Disease Progression|1|||
46986641|NCT02484547|83232921|FG003|Placebo-Controlled Period|Disease Progression|0|||
46986642|NCT02484547|83232922|FG004|Placebo-Controlled Period|Disease Progression|0|||
46986643|NCT02484547|83232923|FG005|Placebo-Controlled Period|Disease Progression|0|||
46986644|NCT02484547|83232924|FG006|Placebo-Controlled Period|Disease Progression|0|||
46986645|NCT02484547|83232918|FG000|Placebo-Controlled Period|Investigator Decision|2|||
46986646|NCT02484547|83232919|FG001|Placebo-Controlled Period|Investigator Decision|2|||
46986647|NCT02484547|83232920|FG002|Placebo-Controlled Period|Investigator Decision|5|||
46986648|NCT02484547|83232921|FG003|Placebo-Controlled Period|Investigator Decision|0|||
46986649|NCT02484547|83232922|FG004|Placebo-Controlled Period|Investigator Decision|0|||
46986650|NCT02484547|83232923|FG005|Placebo-Controlled Period|Investigator Decision|0|||
46986651|NCT02484547|83232924|FG006|Placebo-Controlled Period|Investigator Decision|0|||
46986652|NCT02484547|83232918|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
46986653|NCT02484547|83232919|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
46986654|NCT02484547|83232920|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
46986655|NCT02484547|83232921|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
46986656|NCT02484547|83232922|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
46986657|NCT02484547|83232923|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
46986658|NCT02484547|83232924|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
46986659|NCT02484547|83232918|FG000|Placebo-Controlled Period|Relocation|1|||
46986660|NCT02484547|83232919|FG001|Placebo-Controlled Period|Relocation|1|||
46986661|NCT02484547|83232920|FG002|Placebo-Controlled Period|Relocation|1|||
46986662|NCT02484547|83232921|FG003|Placebo-Controlled Period|Relocation|0|||
46986663|NCT02484547|83232922|FG004|Placebo-Controlled Period|Relocation|0|||
46986664|NCT02484547|83232923|FG005|Placebo-Controlled Period|Relocation|0|||
46986665|NCT02484547|83232924|FG006|Placebo-Controlled Period|Relocation|0|||
46986666|NCT02484547|83232918|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
46986667|NCT02484547|83232919|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
46986668|NCT02484547|83232920|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
46986669|NCT02484547|83232921|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
46986670|NCT02484547|83232922|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
46986671|NCT02484547|83232923|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
46986672|NCT02484547|83232924|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
46986673|NCT02484547|83232918|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
46986674|NCT02484547|83232919|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
46986675|NCT02484547|83232920|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
46986676|NCT02484547|83232921|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46879877|NCT01981850|83101207|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
46986677|NCT02484547|83232922|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46986678|NCT02484547|83232923|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46986679|NCT02484547|83232924|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46986680|NCT02484547|83232918|FG000|Placebo-Controlled Period|Reason not Specified|216|||
46986681|NCT02484547|83232919|FG001|Placebo-Controlled Period|Reason not Specified|194|||
46986682|NCT02484547|83232920|FG002|Placebo-Controlled Period|Reason not Specified|183|||
46986683|NCT02484547|83232921|FG003|Placebo-Controlled Period|Reason not Specified|0|||
46986684|NCT02484547|83232922|FG004|Placebo-Controlled Period|Reason not Specified|0|||
46986685|NCT02484547|83232923|FG005|Placebo-Controlled Period|Reason not Specified|0|||
46986686|NCT02484547|83232924|FG006|Placebo-Controlled Period|Reason not Specified|0|||
46986687|NCT02484547|83232918|FG000|Long-Term Extension Period|Adverse Event|0|||
46986688|NCT02484547|83232919|FG001|Long-Term Extension Period|Adverse Event|0|||
46986689|NCT02484547|83232920|FG002|Long-Term Extension Period|Adverse Event|0|||
46986690|NCT02484547|83232921|FG003|Long-Term Extension Period|Adverse Event|0|||
46986691|NCT02484547|83232922|FG004|Long-Term Extension Period|Adverse Event|1|||
46986692|NCT02484547|83232923|FG005|Long-Term Extension Period|Adverse Event|3|||
46986693|NCT02484547|83232924|FG006|Long-Term Extension Period|Adverse Event|2|||
46986694|NCT02484547|83232918|FG000|Long-Term Extension Period|Death|0|||
46986695|NCT02484547|83232919|FG001|Long-Term Extension Period|Death|0|||
46986696|NCT02484547|83232920|FG002|Long-Term Extension Period|Death|0|||
46986697|NCT02484547|83232921|FG003|Long-Term Extension Period|Death|0|||
46986698|NCT02484547|83232922|FG004|Long-Term Extension Period|Death|0|||
46986699|NCT02484547|83232923|FG005|Long-Term Extension Period|Death|3|||
46986700|NCT02484547|83232924|FG006|Long-Term Extension Period|Death|0|||
46986701|NCT02484547|83232918|FG000|Long-Term Extension Period|Disease Progression|0|||
46986702|NCT02484547|83232919|FG001|Long-Term Extension Period|Disease Progression|0|||
46986703|NCT02484547|83232920|FG002|Long-Term Extension Period|Disease Progression|0|||
46986704|NCT02484547|83232921|FG003|Long-Term Extension Period|Disease Progression|0|||
46986705|NCT02484547|83232922|FG004|Long-Term Extension Period|Disease Progression|2|||
46986706|NCT02484547|83232923|FG005|Long-Term Extension Period|Disease Progression|4|||
46986707|NCT02484547|83232924|FG006|Long-Term Extension Period|Disease Progression|0|||
46986708|NCT02484547|83232918|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
46986709|NCT02484547|83232919|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
46986710|NCT02484547|83232920|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
46986711|NCT02484547|83232921|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
46986712|NCT02484547|83232922|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
46986713|NCT02484547|83232923|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
46986714|NCT02484547|83232924|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
46986715|NCT02484547|83232918|FG000|Long-Term Extension Period|Loss of Capacity|0|||
46986716|NCT02484547|83232919|FG001|Long-Term Extension Period|Loss of Capacity|0|||
46986717|NCT02484547|83232920|FG002|Long-Term Extension Period|Loss of Capacity|0|||
46986718|NCT02484547|83232921|FG003|Long-Term Extension Period|Loss of Capacity|0|||
46986719|NCT02484547|83232922|FG004|Long-Term Extension Period|Loss of Capacity|1|||
46986720|NCT02484547|83232923|FG005|Long-Term Extension Period|Loss of Capacity|0|||
46986721|NCT02484547|83232924|FG006|Long-Term Extension Period|Loss of Capacity|0|||
46879878|NCT01981850|83101208|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
46879879|NCT01981850|83101209|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
46879880|NCT01981850|83101210|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
46879881|NCT01981850|83101201|FG000|Main Phase Stage 1|Various reasons|0|||
46879882|NCT01981850|83101202|FG001|Main Phase Stage 1|Various reasons|0|||
46879883|NCT01981850|83101203|FG002|Main Phase Stage 1|Various reasons|2|||
46879884|NCT01981850|83101204|FG003|Main Phase Stage 1|Various reasons|0|||
46879885|NCT01981850|83101205|FG004|Main Phase Stage 1|Various reasons|0|||
46879886|NCT01981850|83101206|FG005|Main Phase Stage 1|Various reasons|0|||
46879887|NCT01981850|83101207|FG006|Main Phase Stage 1|Various reasons|0|||
46879888|NCT01981850|83101208|FG007|Main Phase Stage 1|Various reasons|0|||
46879889|NCT01981850|83101209|FG008|Main Phase Stage 1|Various reasons|0|||
46879890|NCT01981850|83101210|FG009|Main Phase Stage 1|Various reasons|0|||
46879891|NCT01981850|83101201|FG000|Main Phase Stage 2|Adverse Event|0|||
46879892|NCT01981850|83101202|FG001|Main Phase Stage 2|Adverse Event|0|||
46879893|NCT01981850|83101203|FG002|Main Phase Stage 2|Adverse Event|0|||
46879894|NCT01981850|83101204|FG003|Main Phase Stage 2|Adverse Event|0|||
46879895|NCT01981850|83101205|FG004|Main Phase Stage 2|Adverse Event|6|||
46879896|NCT01981850|83101206|FG005|Main Phase Stage 2|Adverse Event|5|||
46879897|NCT01981850|83101207|FG006|Main Phase Stage 2|Adverse Event|7|||
46879898|NCT01981850|83101208|FG007|Main Phase Stage 2|Adverse Event|0|||
46879899|NCT01981850|83101209|FG008|Main Phase Stage 2|Adverse Event|0|||
46879900|NCT01981850|83101210|FG009|Main Phase Stage 2|Adverse Event|0|||
46879901|NCT01981850|83101201|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
46986722|NCT02484547|83232918|FG000|Long-Term Extension Period|Change of Treatment|0|||
46986723|NCT02484547|83232919|FG001|Long-Term Extension Period|Change of Treatment|0|||
46879902|NCT01981850|83101202|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
46879903|NCT01981850|83101203|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
46879904|NCT01981850|83101204|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
46879905|NCT01981850|83101205|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
46986724|NCT02484547|83232920|FG002|Long-Term Extension Period|Change of Treatment|0|||
46986725|NCT02484547|83232921|FG003|Long-Term Extension Period|Change of Treatment|0|||
46986726|NCT02484547|83232922|FG004|Long-Term Extension Period|Change of Treatment|0|||
46986727|NCT02484547|83232923|FG005|Long-Term Extension Period|Change of Treatment|0|||
46986728|NCT02484547|83232924|FG006|Long-Term Extension Period|Change of Treatment|1|||
46879906|NCT01981850|83101206|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
46986729|NCT02484547|83232918|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
46986730|NCT02484547|83232919|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
46986731|NCT02484547|83232920|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
46986732|NCT02484547|83232921|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
46986733|NCT02484547|83232922|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
46986734|NCT02484547|83232923|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
46986735|NCT02484547|83232924|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
46986736|NCT02484547|83232918|FG000|Long-Term Extension Period|Investigator Decision|0|||
46986737|NCT02484547|83232919|FG001|Long-Term Extension Period|Investigator Decision|0|||
46986738|NCT02484547|83232920|FG002|Long-Term Extension Period|Investigator Decision|0|||
46986739|NCT02484547|83232921|FG003|Long-Term Extension Period|Investigator Decision|2|||
46986740|NCT02484547|83232922|FG004|Long-Term Extension Period|Investigator Decision|1|||
46986741|NCT02484547|83232923|FG005|Long-Term Extension Period|Investigator Decision|0|||
46986742|NCT02484547|83232924|FG006|Long-Term Extension Period|Investigator Decision|1|||
46986743|NCT02484547|83232918|FG000|Long-Term Extension Period|Relocation|0|||
46986744|NCT02484547|83232919|FG001|Long-Term Extension Period|Relocation|0|||
46986745|NCT02484547|83232920|FG002|Long-Term Extension Period|Relocation|0|||
46986746|NCT02484547|83232921|FG003|Long-Term Extension Period|Relocation|1|||
46986747|NCT02484547|83232922|FG004|Long-Term Extension Period|Relocation|1|||
46986748|NCT02484547|83232923|FG005|Long-Term Extension Period|Relocation|0|||
46986749|NCT02484547|83232924|FG006|Long-Term Extension Period|Relocation|0|||
46986750|NCT02484547|83232918|FG000|Long-Term Extension Period|Study Visit Burden|0|||
46986751|NCT02484547|83232919|FG001|Long-Term Extension Period|Study Visit Burden|0|||
46986752|NCT02484547|83232920|FG002|Long-Term Extension Period|Study Visit Burden|0|||
46986753|NCT02484547|83232921|FG003|Long-Term Extension Period|Study Visit Burden|2|||
46986754|NCT02484547|83232922|FG004|Long-Term Extension Period|Study Visit Burden|0|||
46986755|NCT02484547|83232923|FG005|Long-Term Extension Period|Study Visit Burden|0|||
46986756|NCT02484547|83232924|FG006|Long-Term Extension Period|Study Visit Burden|3|||
46986757|NCT02484547|83232918|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
46986758|NCT02484547|83232919|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
46986759|NCT02484547|83232920|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
46986760|NCT02484547|83232921|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
46986761|NCT02484547|83232922|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
46986762|NCT02484547|83232923|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
46986763|NCT02484547|83232924|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
46986764|NCT02484547|83232918|FG000|Long-Term Extension Period|Reason not Specified|0|||
46986765|NCT02484547|83232919|FG001|Long-Term Extension Period|Reason not Specified|0|||
46986766|NCT02484547|83232920|FG002|Long-Term Extension Period|Reason not Specified|0|||
46986767|NCT02484547|83232921|FG003|Long-Term Extension Period|Reason not Specified|119|||
46986768|NCT02484547|83232922|FG004|Long-Term Extension Period|Reason not Specified|117|||
46986769|NCT02484547|83232923|FG005|Long-Term Extension Period|Reason not Specified|223|||
46986770|NCT02484547|83232924|FG006|Long-Term Extension Period|Reason not Specified|231|||
46986771|NCT02517541|83232936|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
46986772|NCT02517541|83232936|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
46986773|NCT02517541|83232936|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
46986774|NCT02517541|83232936|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
46986775|NCT02517541|83232936|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
46986776|NCT02517541|83232936|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
46986777|NCT02496091|83232942|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46986778|NCT02483611|83232950|FG000|Overall Study|Protocol Violation|0|||
46986779|NCT02483611|83232951|FG001|Overall Study|Protocol Violation|0|||
46986780|NCT02483611|83232952|FG002|Overall Study|Protocol Violation|1|||
46986781|NCT02483533|83232962|FG000|Overall Study|Lack of Efficacy|50|||
46986782|NCT02483533|83232963|FG001|Overall Study|Lack of Efficacy|50|||
46986783|NCT02482129|83232971|FG000|Overall Study|Adverse Event-prior to treatment|0|||
46986784|NCT02482129|83232972|FG001|Overall Study|Adverse Event-prior to treatment|1|||
46986785|NCT02482129|83232971|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
46986786|NCT02482129|83232972|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
46986787|NCT02482129|83232971|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
46986788|NCT02482129|83232972|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
46986789|NCT02482129|83232971|FG000|Overall Study|Criteria not met-prior to treatment|1|||
46986790|NCT02482129|83232972|FG001|Overall Study|Criteria not met-prior to treatment|0|||
46986791|NCT02482129|83232971|FG000|Overall Study|Adverse Event|1|||
46986792|NCT02482129|83232972|FG001|Overall Study|Adverse Event|0|||
46986793|NCT02482129|83232971|FG000|Overall Study|Withdrawal by Subject|2|||
46986794|NCT02482129|83232972|FG001|Overall Study|Withdrawal by Subject|0|||
46986795|NCT02482129|83232971|FG000|Overall Study|Criteria not met|1|||
46986796|NCT02482129|83232972|FG001|Overall Study|Criteria not met|0|||
46986797|NCT02495857|83232983|FG000|Overall Study|Adverse Event|5|||
46986798|NCT02495857|83232984|FG001|Overall Study|Adverse Event|0|||
46986799|NCT02495857|83232985|FG002|Overall Study|Adverse Event|1|||
46986800|NCT02495857|83232983|FG000|Overall Study|Withdrawal by Subject|9|||
46986801|NCT02495857|83232984|FG001|Overall Study|Withdrawal by Subject|6|||
46986802|NCT02495857|83232985|FG002|Overall Study|Withdrawal by Subject|10|||
46986803|NCT02495857|83232983|FG000|Overall Study|Physician Decision|0|||
46986804|NCT02495857|83232984|FG001|Overall Study|Physician Decision|1|||
46986805|NCT02495857|83232985|FG002|Overall Study|Physician Decision|0|||
46986806|NCT02495857|83232983|FG000|Overall Study|Protocol Violation|1|||
46986807|NCT02495857|83232984|FG001|Overall Study|Protocol Violation|1|||
46986808|NCT02495857|83232985|FG002|Overall Study|Protocol Violation|2|||
46986809|NCT02495857|83232983|FG000|Overall Study|Lost to Follow-up|4|||
46986810|NCT02495857|83232984|FG001|Overall Study|Lost to Follow-up|5|||
46986811|NCT02495857|83232985|FG002|Overall Study|Lost to Follow-up|3|||
46986812|NCT02495857|83232983|FG000|Overall Study|Other|3|||
46986813|NCT02495857|83232984|FG001|Overall Study|Other|3|||
46986814|NCT02495857|83232985|FG002|Overall Study|Other|2|||
46986815|NCT02495389|83232993|FG000|Overall Study|Withdrawal by Subject|40|||
46986816|NCT02495233|83232999|FG000|Overall Study|Miscellaneous|0|||
46986817|NCT02495233|83233000|FG001|Overall Study|Miscellaneous|1|||
46986818|NCT02495077|83233008|FG000|Overall Study|Adverse Event|0|||
46986819|NCT02495077|83233009|FG001|Overall Study|Adverse Event|1|||
46986820|NCT02495077|83233010|FG002|Overall Study|Adverse Event|1|||
46986821|NCT02495077|83233011|FG003|Overall Study|Adverse Event|0|||
46986822|NCT02495077|83233008|FG000|Overall Study|Death|3|||
46986823|NCT02495077|83233009|FG001|Overall Study|Death|5|||
46986824|NCT02495077|83233010|FG002|Overall Study|Death|0|||
46986825|NCT02495077|83233011|FG003|Overall Study|Death|0|||
46986826|NCT02495077|83233008|FG000|Overall Study|Lost to Follow-up|6|||
46986827|NCT02495077|83233009|FG001|Overall Study|Lost to Follow-up|4|||
46986828|NCT02495077|83233010|FG002|Overall Study|Lost to Follow-up|0|||
46986829|NCT02495077|83233011|FG003|Overall Study|Lost to Follow-up|0|||
46986830|NCT02495077|83233008|FG000|Overall Study|Physician Decision|2|||
46986831|NCT02495077|83233009|FG001|Overall Study|Physician Decision|1|||
46986832|NCT02495077|83233010|FG002|Overall Study|Physician Decision|4|||
46986833|NCT02495077|83233011|FG003|Overall Study|Physician Decision|0|||
46986834|NCT02495077|83233008|FG000|Overall Study|Protocol Violation|0|||
46986835|NCT02495077|83233009|FG001|Overall Study|Protocol Violation|1|||
46986836|NCT02495077|83233010|FG002|Overall Study|Protocol Violation|0|||
46986837|NCT02495077|83233011|FG003|Overall Study|Protocol Violation|0|||
46986838|NCT02495077|83233008|FG000|Overall Study|Screen Failure|0|||
46986839|NCT02495077|83233009|FG001|Overall Study|Screen Failure|0|||
46986840|NCT02495077|83233010|FG002|Overall Study|Screen Failure|0|||
46986841|NCT02495077|83233011|FG003|Overall Study|Screen Failure|48|||
46986842|NCT02495077|83233008|FG000|Overall Study|Withdrawal by Subject|7|||
46986843|NCT02495077|83233009|FG001|Overall Study|Withdrawal by Subject|7|||
46986844|NCT02495077|83233010|FG002|Overall Study|Withdrawal by Subject|7|||
46986845|NCT02495077|83233011|FG003|Overall Study|Withdrawal by Subject|0|||
46986846|NCT02495077|83233008|FG000|Overall Study|Covid-19 research restrictions|1|||
46986847|NCT02495077|83233009|FG001|Overall Study|Covid-19 research restrictions|0|||
46986848|NCT02495077|83233010|FG002|Overall Study|Covid-19 research restrictions|0|||
46986849|NCT02495077|83233011|FG003|Overall Study|Covid-19 research restrictions|0|||
46986850|NCT02495077|83233008|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
46986851|NCT02495077|83233009|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
46986852|NCT02495077|83233010|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
46986853|NCT02495077|83233011|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
46986854|NCT02495077|83233008|FG000|Overall Study|Incarcerated|0|||
46986855|NCT02495077|83233009|FG001|Overall Study|Incarcerated|1|||
46986856|NCT02495077|83233010|FG002|Overall Study|Incarcerated|0|||
46986857|NCT02495077|83233011|FG003|Overall Study|Incarcerated|0|||
46986858|NCT02495077|83233008|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
46986859|NCT02495077|83233009|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
46986860|NCT02495077|83233010|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
46986861|NCT02495077|83233011|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
46986862|NCT02495077|83233008|FG000|Overall Study|Timing of transplant and randomization|0|||
46986863|NCT02495077|83233009|FG001|Overall Study|Timing of transplant and randomization|0|||
46986864|NCT02495077|83233010|FG002|Overall Study|Timing of transplant and randomization|5|||
46986865|NCT02495077|83233011|FG003|Overall Study|Timing of transplant and randomization|0|||
46986866|NCT02278341|83233019|FG000|Overall Study|Randomized but never received study drug|1|||
46986867|NCT02278341|83233020|FG001|Overall Study|Randomized but never received study drug|1|||
46986868|NCT02278341|83233019|FG000|Overall Study|Adverse Event|3|||
46986869|NCT02278341|83233020|FG001|Overall Study|Adverse Event|0|||
46986870|NCT02278341|83233019|FG000|Overall Study|Death|68|||
46986871|NCT02278341|83233020|FG001|Overall Study|Death|56|||
46986872|NCT02278341|83233019|FG000|Overall Study|Withdrawal by Subject|30|||
46986873|NCT02278341|83233020|FG001|Overall Study|Withdrawal by Subject|19|||
46986874|NCT02278341|83233019|FG000|Overall Study|Lost to Follow-up|0|||
46986875|NCT02278341|83233020|FG001|Overall Study|Lost to Follow-up|1|||
46986876|NCT02278341|83233019|FG000|Overall Study|Physician Decision|1|||
46986877|NCT02278341|83233020|FG001|Overall Study|Physician Decision|1|||
46986878|NCT02278341|83233019|FG000|Overall Study|Miscellaneous|15|||
46986879|NCT02278341|83233020|FG001|Overall Study|Miscellaneous|14|||
46986880|NCT02282631|83233029|FG000|Overall Study|Lost to Follow-up|2|||
46986881|NCT02282631|83233030|FG001|Overall Study|Lost to Follow-up|0|||
46986882|NCT02278263|83233045|FG000|Overall Study|Protocol Violation|7|||
46986883|NCT02278263|83233046|FG001|Overall Study|Protocol Violation|0|||
46986884|NCT02278263|83233047|FG002|Overall Study|Protocol Violation|9|||
46986885|NCT02349789|83233058|FG000|Overall Study|Withdrawal by Subject|2|||
46986886|NCT02349711|83233064|FG000|Overall Study|Withdrawal by Subject|2|||
46986887|NCT02349711|83233065|FG001|Overall Study|Withdrawal by Subject|1|||
46986888|NCT02349711|83233064|FG000|Overall Study|Lost to Follow-up|1|||
46986889|NCT02349711|83233065|FG001|Overall Study|Lost to Follow-up|1|||
46986890|NCT02494921|83233076|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
46986891|NCT02494921|83233077|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
46986892|NCT02494921|83233078|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
46986893|NCT02494921|83233079|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
46986894|NCT02494921|83233080|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
46986895|NCT02494921|83233076|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
46986896|NCT02494921|83233077|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
46986897|NCT02494921|83233078|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
46986898|NCT02494921|83233079|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
46986899|NCT02494921|83233080|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
46986900|NCT02494921|83233076|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
46986901|NCT02494921|83233077|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
46986902|NCT02494921|83233078|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
46986903|NCT02494921|83233079|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
46986904|NCT02494921|83233080|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
46986905|NCT01653847|83233100|FG000|Overall Study|Withdrawal by Subject|1|||
46986906|NCT01653847|83233101|FG001|Overall Study|Withdrawal by Subject|0|||
46986907|NCT02493751|83233109|FG000|Overall Study|Withdrawal by Subject|2|||
46986908|NCT02493751|83233110|FG001|Overall Study|Withdrawal by Subject|8|||
46986909|NCT02493751|83233109|FG000|Overall Study|Death|6|||
46986910|NCT02493751|83233110|FG001|Overall Study|Death|13|||
46986911|NCT02493751|83233109|FG000|Overall Study|Lost to Follow-up|2|||
46986912|NCT02493751|83233110|FG001|Overall Study|Lost to Follow-up|3|||
46986913|NCT02493751|83233109|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
46986914|NCT02493751|83233110|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
46986915|NCT02493517|83233119|FG000|Overall Study|Protocol Violation|1|||
46986916|NCT02493517|83233120|FG001|Overall Study|Protocol Violation|2|||
46986917|NCT02493517|83233119|FG000|Overall Study|Withdrawal by Subject|1|||
46986918|NCT02493517|83233120|FG001|Overall Study|Withdrawal by Subject|2|||
46986919|NCT02493517|83233119|FG000|Overall Study|Adverse Event|0|||
46986920|NCT02493517|83233120|FG001|Overall Study|Adverse Event|2|||
46986921|NCT02493517|83233119|FG000|Overall Study|Missed study visit|0|||
46986922|NCT02493517|83233120|FG001|Overall Study|Missed study visit|1|||
46986923|NCT02493361|83233128|FG000|Overall Study|Withdrawal by Subject|3|||
46986924|NCT02493127|83233134|FG000|Overall Study|Lost to Follow-up|1|||
46986925|NCT02493127|83233135|FG001|Overall Study|Lost to Follow-up|1|||
46986926|NCT02478463|83233143|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
46986927|NCT02478463|83233143|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
46986928|NCT02478463|83233143|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
46986929|NCT02491411|83233149|FG000|Overall Study|Physician Decision|4|||
46986930|NCT02517463|83233155|FG000|Overall Study|Lost to Follow-up|5|||
46986931|NCT02517463|83233156|FG001|Overall Study|Lost to Follow-up|2|||
46986932|NCT02516605|83233167|FG000|Overall Study|Protocol Violation|0|||
46986933|NCT02516605|83233168|FG001|Overall Study|Protocol Violation|0|||
46986934|NCT02516605|83233169|FG002|Overall Study|Protocol Violation|0|||
46986935|NCT02516605|83233170|FG003|Overall Study|Protocol Violation|0|||
46986936|NCT02516605|83233171|FG004|Overall Study|Protocol Violation|1|||
46986937|NCT02516605|83233167|FG000|Overall Study|Withdrawal by Subject|0|||
46986938|NCT02516605|83233168|FG001|Overall Study|Withdrawal by Subject|0|||
46986939|NCT02516605|83233169|FG002|Overall Study|Withdrawal by Subject|0|||
46986940|NCT02516605|83233170|FG003|Overall Study|Withdrawal by Subject|1|||
46986941|NCT02516605|83233171|FG004|Overall Study|Withdrawal by Subject|0|||
46986942|NCT02490475|83233191|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
46986943|NCT02490475|83233192|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
46986944|NCT02490475|83233193|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
46986945|NCT02490475|83233194|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
46986946|NCT02490475|83233191|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
46986947|NCT02490475|83233192|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
46986948|NCT02490475|83233193|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
46986949|NCT02490475|83233194|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
46986950|NCT02490475|83233191|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
46986951|NCT02490475|83233192|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
46986952|NCT02490475|83233193|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
46986953|NCT02490475|83233194|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
46986954|NCT02490475|83233191|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
46986955|NCT02490475|83233192|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
46986956|NCT02490475|83233193|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
46986957|NCT02490475|83233194|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
46986958|NCT02490475|83233191|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
46986959|NCT02490475|83233192|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
46986960|NCT02490475|83233193|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
46986961|NCT02490475|83233194|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
46986962|NCT02490475|83233191|FG000|Period 2: Extension Phase|Refused Treatment|0|||
46986963|NCT02490475|83233192|FG001|Period 2: Extension Phase|Refused Treatment|0|||
46986964|NCT02490475|83233193|FG002|Period 2: Extension Phase|Refused Treatment|0|||
46986965|NCT02490475|83233194|FG003|Period 2: Extension Phase|Refused Treatment|1|||
46986966|NCT02490475|83233191|FG000|Period 2: Extension Phase|Adverse Event|0|||
46986967|NCT02490475|83233192|FG001|Period 2: Extension Phase|Adverse Event|0|||
46986968|NCT02490475|83233193|FG002|Period 2: Extension Phase|Adverse Event|1|||
46986969|NCT02490475|83233194|FG003|Period 2: Extension Phase|Adverse Event|0|||
46986970|NCT02477839|83233217|FG000|Overall Study|Adverse Event|0|||
46986971|NCT02477839|83233218|FG001|Overall Study|Adverse Event|1|||
46986972|NCT02477839|83233217|FG000|Overall Study|Protocol Violation|0|||
46986973|NCT02477839|83233218|FG001|Overall Study|Protocol Violation|2|||
46986974|NCT02477839|83233217|FG000|Overall Study|Withdrawal by Subject|3|||
46986975|NCT02477839|83233218|FG001|Overall Study|Withdrawal by Subject|3|||
46986976|NCT02477839|83233217|FG000|Overall Study|Participant had PGS during V6|0|||
46986977|NCT02477839|83233218|FG001|Overall Study|Participant had PGS during V6|1|||
46986978|NCT02477839|83233217|FG000|Overall Study|Parents decided to stop medication|0|||
46986979|NCT02477839|83233218|FG001|Overall Study|Parents decided to stop medication|1|||
46986980|NCT02477839|83233217|FG000|Overall Study|Lack of tolerability|0|||
46986981|NCT02477839|83233218|FG001|Overall Study|Lack of tolerability|1|||
46986982|NCT02477839|83233217|FG000|Overall Study|Exclusion criterion|0|||
46986983|NCT02477839|83233218|FG001|Overall Study|Exclusion criterion|1|||
46986984|NCT02489773|83233228|FG000|Overall Study|Lost to Follow-up|4|||
46986985|NCT02489773|83233229|FG001|Overall Study|Lost to Follow-up|1|||
46986986|NCT02489773|83233228|FG000|Overall Study|Physician Decision|1|||
46986987|NCT02489773|83233229|FG001|Overall Study|Physician Decision|0|||
46986988|NCT02489773|83233228|FG000|Overall Study|Withdrawal by Subject|1|||
46986989|NCT02489773|83233229|FG001|Overall Study|Withdrawal by Subject|0|||
46986990|NCT02489773|83233228|FG000|Overall Study|Leave the country or the state|1|||
46986991|NCT02489773|83233229|FG001|Overall Study|Leave the country or the state|1|||
46986992|NCT02488915|83233235|FG000|Overall Study|Death|21|||
46986993|NCT02488915|83233235|FG000|Overall Study|Lost to Follow-up|4|||
46986994|NCT02488915|83233235|FG000|Overall Study|Withdrawal by Subject|1|||
46986995|NCT02488681|83233239|FG000|Overall Study|Implant unsuccessful|7|||
46986996|NCT02477605|83233245|FG000|Overall Study|Discontinued prior to treatment|1|||
46986997|NCT02477605|83233246|FG001|Overall Study|Discontinued prior to treatment|0|||
46986998|NCT02477605|83233245|FG000|Overall Study|Lost to Follow-up|0|||
46986999|NCT02477605|83233246|FG001|Overall Study|Lost to Follow-up|2|||
46987000|NCT02477605|83233245|FG000|Overall Study|Withdrawal by Subject|0|||
46987001|NCT02477605|83233246|FG001|Overall Study|Withdrawal by Subject|1|||
46987002|NCT02477605|83233245|FG000|Overall Study|Administered gas during surgery|0|||
46987003|NCT02477605|83233246|FG001|Overall Study|Administered gas during surgery|1|||
46987004|NCT02477527|83233256|FG000|Overall Study|Lost to Follow-up|2|||
46987005|NCT02477527|83233256|FG000|Overall Study|Withdrawal by Subject|1|||
46987006|NCT02477527|83233256|FG000|Overall Study|Screen Failure|3|||
46987007|NCT02477215|83233264|FG000|Dose Escalation Phase|Physician Decision|1|||
46987008|NCT02477215|83233265|FG001|Dose Escalation Phase|Physician Decision|2|||
46987009|NCT02477215|83233266|FG002|Dose Escalation Phase|Physician Decision|0|||
46987010|NCT02477215|83233264|FG000|Fixed Dose Phase|Physician Decision|0|||
46987011|NCT02477215|83233265|FG001|Fixed Dose Phase|Physician Decision|7|||
46987012|NCT02477215|83233266|FG002|Fixed Dose Phase|Physician Decision|0|||
46987013|NCT02487199|83233279|FG000|Overall Study|Withdrew Consent|0|||
46987014|NCT02487199|83233280|FG001|Overall Study|Withdrew Consent|1|||
46987015|NCT02475733|83233288|FG000|Overall Study|Withdrawal by Subject|1|||
46987016|NCT02475733|83233289|FG001|Overall Study|Withdrawal by Subject|0|||
46987017|NCT02475733|83233288|FG000|Overall Study|Physician Decision|1|||
46987018|NCT02475733|83233289|FG001|Overall Study|Physician Decision|0|||
46987019|NCT02486653|83233297|FG000|Overall Study|Withdrawal by Subject|1|||
46987020|NCT02486653|83233298|FG001|Overall Study|Withdrawal by Subject|3|||
46987021|NCT02486653|83233297|FG000|Overall Study|Protocol Violation|1|||
46987022|NCT02486653|83233298|FG001|Overall Study|Protocol Violation|0|||
46987023|NCT02486653|83233297|FG000|Overall Study|surgery cancelled|4|||
46987024|NCT02486653|83233298|FG001|Overall Study|surgery cancelled|1|||
46987025|NCT02475655|83233306|FG000|Overall Study|Lost to Follow-up|0|||
46987026|NCT02475655|83233307|FG001|Overall Study|Lost to Follow-up|1|||
46987027|NCT02475265|83233313|FG000|Overall Study|Physician Decision|1|||
46987028|NCT02475265|83233313|FG000|Overall Study|Withdrawal by Subject|2|||
46987029|NCT02485717|83233320|FG000|Overall Study|Lost to Follow-up|6|||
46987030|NCT02485717|83233321|FG001|Overall Study|Lost to Follow-up|0|||
46987031|NCT02485717|83233322|FG002|Overall Study|Lost to Follow-up|0|||
46987032|NCT02485717|83233320|FG000|Overall Study|Withdrawal by Subject|0|||
46987033|NCT02485717|83233321|FG001|Overall Study|Withdrawal by Subject|0|||
46987034|NCT02485717|83233322|FG002|Overall Study|Withdrawal by Subject|1|||
46987035|NCT02485717|83233320|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
46987036|NCT02485717|83233321|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
46987037|NCT02485717|83233322|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
46987038|NCT02485717|83233320|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
46987039|NCT02485717|83233321|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
46987040|NCT02485717|83233322|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
46987041|NCT02451007|83233330|FG000|Overall Study|Withdrawal by Subject|4|||
46987042|NCT02451007|83233330|FG000|Overall Study|Adverse Event|1|||
46987043|NCT02451007|83233330|FG000|Overall Study|Disease Progression|2|||
46987044|NCT02485483|83233336|FG000|Overall Study|Depression at baseline|15|||
46987045|NCT02485483|83233337|FG001|Overall Study|Depression at baseline|0|||
46987046|NCT02485483|83233336|FG000|Overall Study|Discontinued after baseline|39|||
46987047|NCT02485483|83233337|FG001|Overall Study|Discontinued after baseline|0|||
46987048|NCT02473471|83233343|FG000|Overall Study|poor oral hygiene|2|||
46987049|NCT02473471|83233343|FG000|Overall Study|Lost to Follow-up|1|||
46987050|NCT02450539|83233355|FG000|Overall Study|Withdrawal by Subject|12|||
46987051|NCT02450539|83233356|FG001|Overall Study|Withdrawal by Subject|6|||
46987052|NCT02450539|83233355|FG000|Overall Study|Lost to Follow-up|4|||
46987053|NCT02450539|83233356|FG001|Overall Study|Lost to Follow-up|1|||
46987054|NCT02449915|83233367|FG000|Overall Study|Exclusion criteria - drug use|1|||
46987055|NCT02449915|83233368|FG001|Overall Study|Exclusion criteria - drug use|0|||
46987056|NCT02449915|83233367|FG000|Overall Study|Withdrawal by Subject|0|||
46987057|NCT02449915|83233368|FG001|Overall Study|Withdrawal by Subject|2|||
46987058|NCT02449915|83233367|FG000|Overall Study|Intraoperative surgical findings|1|||
46987059|NCT02449915|83233368|FG001|Overall Study|Intraoperative surgical findings|1|||
46987060|NCT02449915|83233367|FG000|Overall Study|Abnormal preop lab|0|||
46987061|NCT02449915|83233368|FG001|Overall Study|Abnormal preop lab|1|||
46987062|NCT02420119|83233374|FG000|Overall Study|insufficient laboratory data|5|||
46987063|NCT02473393|83233382|FG000|Overall Study|Adverse Event|0|||
46987064|NCT02473393|83233383|FG001|Overall Study|Adverse Event|0|||
46987065|NCT02473393|83233384|FG002|Overall Study|Adverse Event|1|||
46987066|NCT02473393|83233385|FG003|Overall Study|Adverse Event|0|||
46987067|NCT02473393|83233382|FG000|Overall Study|Withdrawal by Subject|0|||
46987068|NCT02473393|83233383|FG001|Overall Study|Withdrawal by Subject|0|||
46987069|NCT02473393|83233384|FG002|Overall Study|Withdrawal by Subject|1|||
46987070|NCT02473393|83233385|FG003|Overall Study|Withdrawal by Subject|1|||
46987071|NCT02419573|83233397|FG000|Overall Study|Lost to Follow-up|3|||
46987072|NCT02419573|83233398|FG001|Overall Study|Lost to Follow-up|0|||
46987073|NCT02419573|83233397|FG000|Overall Study|Withdrawal by Subject|1|||
46987074|NCT02419573|83233398|FG001|Overall Study|Withdrawal by Subject|0|||
46987075|NCT02472847|83233406|FG000|Overall Study|Withdrawal by Subject|1|||
46987076|NCT02472847|83233407|FG001|Overall Study|Withdrawal by Subject|5|||
46987077|NCT02472145|83233416|FG000|Overall Study|Death|10|||
46987078|NCT02472145|83233417|FG001|Overall Study|Death|101|||
46987079|NCT02472145|83233418|FG002|Overall Study|Death|99|||
46987080|NCT02472145|83233416|FG000|Overall Study|Lost to Follow-up|0|||
46987081|NCT02472145|83233417|FG001|Overall Study|Lost to Follow-up|1|||
46987082|NCT02472145|83233418|FG002|Overall Study|Lost to Follow-up|0|||
46987083|NCT02472145|83233416|FG000|Overall Study|Withdrawal by Subject|0|||
46987084|NCT02472145|83233417|FG001|Overall Study|Withdrawal by Subject|9|||
46987085|NCT02472145|83233418|FG002|Overall Study|Withdrawal by Subject|13|||
46987086|NCT02472145|83233416|FG000|Overall Study|Sponsor decision|0|||
46987087|NCT02472145|83233417|FG001|Overall Study|Sponsor decision|3|||
46987088|NCT02472145|83233418|FG002|Overall Study|Sponsor decision|2|||
46987089|NCT02472145|83233416|FG000|Overall Study|Other|0|||
46987090|NCT02472145|83233417|FG001|Overall Study|Other|45|||
46987091|NCT02472145|83233418|FG002|Overall Study|Other|43|||
46987092|NCT02448043|83233427|FG000|Overall Study|Withdrawal by Subject|2|||
46987093|NCT02448043|83233428|FG001|Overall Study|Withdrawal by Subject|2|||
46987094|NCT02448043|83233427|FG000|Overall Study|Protocol Violation|1|||
46987095|NCT02448043|83233428|FG001|Overall Study|Protocol Violation|2|||
46987096|NCT02447887|83233437|FG000|Overall Study|Study was terminated|3|||
46987097|NCT02471755|83233443|FG000|Overall Study|Withdrawal by Subject|1|||
46987098|NCT02471755|83233444|FG001|Overall Study|Withdrawal by Subject|0|||
46987099|NCT02471755|83233443|FG000|Overall Study|Lost to Follow-up|0|||
46987100|NCT02471755|83233444|FG001|Overall Study|Lost to Follow-up|1|||
46987101|NCT02470429|83233452|FG000|Overall Study|Adverse Event|1|||
46987102|NCT02470429|83233453|FG001|Overall Study|Adverse Event|0|||
46987103|NCT02470429|83233452|FG000|Overall Study|Withdrawal by Subject|1|||
46987104|NCT02470429|83233453|FG001|Overall Study|Withdrawal by Subject|0|||
46987105|NCT02447497|83233464|FG000|Overall Study|Did not meet treatment day baseline.|6|||
46987106|NCT02447497|83233465|FG001|Overall Study|Did not meet treatment day baseline.|5|||
46987107|NCT02447497|83233466|FG002|Overall Study|Did not meet treatment day baseline.|2|||
46987108|NCT02447497|83233467|FG003|Overall Study|Did not meet treatment day baseline.|2|||
46987109|NCT02447497|83233464|FG000|Overall Study|Dressing was compromised|0|||
46987110|NCT02447497|83233465|FG001|Overall Study|Dressing was compromised|1|||
46987111|NCT02447497|83233466|FG002|Overall Study|Dressing was compromised|0|||
46987112|NCT02447497|83233467|FG003|Overall Study|Dressing was compromised|0|||
46987113|NCT02417935|83233487|FG000|Treatment Period|Adverse Event|12|||
46987114|NCT02417935|83233488|FG001|Treatment Period|Adverse Event|10|||
46987115|NCT02417935|83233487|FG000|Treatment Period|Lost to Follow-up|1|||
46987116|NCT02417935|83233488|FG001|Treatment Period|Lost to Follow-up|0|||
46987117|NCT02417935|83233487|FG000|Treatment Period|Entry Criteria not met|0|||
46987118|NCT02417935|83233488|FG001|Treatment Period|Entry Criteria not met|1|||
46987119|NCT02417935|83233487|FG000|Treatment Period|Protocol Violation|2|||
46987120|NCT02417935|83233488|FG001|Treatment Period|Protocol Violation|1|||
46987121|NCT02417935|83233487|FG000|Treatment Period|Withdrawal by Subject|3|||
46987122|NCT02417935|83233488|FG001|Treatment Period|Withdrawal by Subject|3|||
46987123|NCT02417935|83233487|FG000|Treatment Period|Physician Decision|3|||
46987124|NCT02417935|83233488|FG001|Treatment Period|Physician Decision|1|||
46879907|NCT01981850|83101207|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
46879908|NCT01981850|83101208|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
46879909|NCT01981850|83101209|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
46879910|NCT01981850|83101210|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
46879911|NCT01981850|83101201|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
46879912|NCT01981850|83101202|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
46879913|NCT01981850|83101203|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
46879914|NCT01981850|83101204|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
46879915|NCT01981850|83101205|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
46879916|NCT01981850|83101206|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
46879917|NCT01981850|83101207|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
46879918|NCT01981850|83101208|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
46879919|NCT01981850|83101209|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
46879920|NCT01981850|83101210|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
46879921|NCT01981850|83101201|FG000|Main Phase Stage 2|Various reasons|0|||
46879922|NCT01981850|83101202|FG001|Main Phase Stage 2|Various reasons|0|||
46879923|NCT01981850|83101203|FG002|Main Phase Stage 2|Various reasons|0|||
46879924|NCT01981850|83101204|FG003|Main Phase Stage 2|Various reasons|0|||
46879925|NCT01981850|83101205|FG004|Main Phase Stage 2|Various reasons|2|||
46879926|NCT01981850|83101206|FG005|Main Phase Stage 2|Various reasons|0|||
46879927|NCT01981850|83101207|FG006|Main Phase Stage 2|Various reasons|1|||
46879928|NCT01981850|83101208|FG007|Main Phase Stage 2|Various reasons|0|||
46879929|NCT01981850|83101209|FG008|Main Phase Stage 2|Various reasons|0|||
46879930|NCT01981850|83101210|FG009|Main Phase Stage 2|Various reasons|0|||
46879931|NCT01981850|83101201|FG000|Main Phase Stage 2|Progressive Disease|0|||
46879932|NCT01981850|83101202|FG001|Main Phase Stage 2|Progressive Disease|0|||
46879933|NCT01981850|83101203|FG002|Main Phase Stage 2|Progressive Disease|0|||
46879934|NCT01981850|83101204|FG003|Main Phase Stage 2|Progressive Disease|0|||
46879935|NCT01981850|83101205|FG004|Main Phase Stage 2|Progressive Disease|0|||
46879936|NCT01981850|83101206|FG005|Main Phase Stage 2|Progressive Disease|6|||
46879937|NCT01981850|83101207|FG006|Main Phase Stage 2|Progressive Disease|6|||
46879938|NCT01981850|83101208|FG007|Main Phase Stage 2|Progressive Disease|0|||
46879939|NCT01981850|83101209|FG008|Main Phase Stage 2|Progressive Disease|0|||
46879940|NCT01981850|83101210|FG009|Main Phase Stage 2|Progressive Disease|0|||
46879941|NCT01981850|83101201|FG000|Open Label Extension (OLE)|Adverse Event|0|||
46879942|NCT01981850|83101202|FG001|Open Label Extension (OLE)|Adverse Event|0|||
46987125|NCT02417233|83233497|FG000|Overall Study|Death|4|||
46987126|NCT02417233|83233498|FG001|Overall Study|Death|10|||
46987127|NCT02417233|83233499|FG002|Overall Study|Death|14|||
46987128|NCT02417233|83233497|FG000|Overall Study|Lost to Follow-up|27|||
46987129|NCT02417233|83233498|FG001|Overall Study|Lost to Follow-up|39|||
46987130|NCT02417233|83233499|FG002|Overall Study|Lost to Follow-up|34|||
46987131|NCT02417233|83233497|FG000|Overall Study|Protocol Violation|2|||
46987132|NCT02417233|83233498|FG001|Overall Study|Protocol Violation|0|||
46987133|NCT02417233|83233499|FG002|Overall Study|Protocol Violation|2|||
46987134|NCT02417233|83233497|FG000|Overall Study|Withdrawal by Subject|2|||
46987135|NCT02417233|83233498|FG001|Overall Study|Withdrawal by Subject|1|||
46987136|NCT02417233|83233499|FG002|Overall Study|Withdrawal by Subject|8|||
46987137|NCT02417233|83233497|FG000|Overall Study|Relocation out of study area|1|||
46987138|NCT02417233|83233498|FG001|Overall Study|Relocation out of study area|0|||
46987139|NCT02417233|83233499|FG002|Overall Study|Relocation out of study area|1|||
46987140|NCT02417233|83233497|FG000|Overall Study|Mentally unstable|0|||
46987141|NCT02417233|83233498|FG001|Overall Study|Mentally unstable|1|||
46987142|NCT02417233|83233499|FG002|Overall Study|Mentally unstable|0|||
46987143|NCT02416453|83233519|FG000|Overall Study|Adverse Event|0|||
46987144|NCT02416453|83233520|FG001|Overall Study|Adverse Event|0|||
46987145|NCT02416453|83233521|FG002|Overall Study|Adverse Event|0|||
46987146|NCT02416453|83233522|FG003|Overall Study|Adverse Event|2|||
46987147|NCT02416453|83233523|FG004|Overall Study|Adverse Event|0|||
46987148|NCT02416453|83233524|FG005|Overall Study|Adverse Event|1|||
46987149|NCT02416453|83233525|FG006|Overall Study|Adverse Event|0|||
46987150|NCT02416453|83233526|FG007|Overall Study|Adverse Event|0|||
46987151|NCT02416453|83233527|FG008|Overall Study|Adverse Event|0|||
46987152|NCT02416453|83233528|FG009|Overall Study|Adverse Event|0|||
46987153|NCT02416453|83233529|FG010|Overall Study|Adverse Event|0|||
46987154|NCT02416453|83233519|FG000|Overall Study|Lost to Follow-up|1|||
46987155|NCT02416453|83233520|FG001|Overall Study|Lost to Follow-up|3|||
46987156|NCT02416453|83233521|FG002|Overall Study|Lost to Follow-up|0|||
46987157|NCT02416453|83233522|FG003|Overall Study|Lost to Follow-up|8|||
46987158|NCT02416453|83233523|FG004|Overall Study|Lost to Follow-up|0|||
46987159|NCT02416453|83233524|FG005|Overall Study|Lost to Follow-up|5|||
46987160|NCT02416453|83233525|FG006|Overall Study|Lost to Follow-up|1|||
46987161|NCT02416453|83233526|FG007|Overall Study|Lost to Follow-up|3|||
46987162|NCT02416453|83233527|FG008|Overall Study|Lost to Follow-up|1|||
46987163|NCT02416453|83233528|FG009|Overall Study|Lost to Follow-up|0|||
46987164|NCT02416453|83233529|FG010|Overall Study|Lost to Follow-up|0|||
46987165|NCT02416453|83233519|FG000|Overall Study|Physician Decision|0|||
46987166|NCT02416453|83233520|FG001|Overall Study|Physician Decision|0|||
46987167|NCT02416453|83233521|FG002|Overall Study|Physician Decision|0|||
46987168|NCT02416453|83233522|FG003|Overall Study|Physician Decision|0|||
46987169|NCT02416453|83233523|FG004|Overall Study|Physician Decision|0|||
46987170|NCT02416453|83233524|FG005|Overall Study|Physician Decision|1|||
46987171|NCT02416453|83233525|FG006|Overall Study|Physician Decision|1|||
46987172|NCT02416453|83233526|FG007|Overall Study|Physician Decision|1|||
46987173|NCT02416453|83233527|FG008|Overall Study|Physician Decision|0|||
46987174|NCT02416453|83233528|FG009|Overall Study|Physician Decision|0|||
46987175|NCT02416453|83233529|FG010|Overall Study|Physician Decision|0|||
46987176|NCT02416453|83233519|FG000|Overall Study|Withdrawal by Subject|2|||
46987177|NCT02416453|83233520|FG001|Overall Study|Withdrawal by Subject|0|||
46987178|NCT02416453|83233521|FG002|Overall Study|Withdrawal by Subject|0|||
46987179|NCT02416453|83233522|FG003|Overall Study|Withdrawal by Subject|5|||
46987180|NCT02416453|83233523|FG004|Overall Study|Withdrawal by Subject|1|||
46987181|NCT02416453|83233524|FG005|Overall Study|Withdrawal by Subject|8|||
46987182|NCT02416453|83233525|FG006|Overall Study|Withdrawal by Subject|0|||
46987183|NCT02416453|83233526|FG007|Overall Study|Withdrawal by Subject|8|||
46987184|NCT02416453|83233527|FG008|Overall Study|Withdrawal by Subject|4|||
46987185|NCT02416453|83233528|FG009|Overall Study|Withdrawal by Subject|0|||
46987186|NCT02416453|83233529|FG010|Overall Study|Withdrawal by Subject|0|||
46987187|NCT02416453|83233519|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987188|NCT02416453|83233520|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987189|NCT02416453|83233521|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
46879943|NCT01981850|83101203|FG002|Open Label Extension (OLE)|Adverse Event|0|||
46987190|NCT02416453|83233522|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987191|NCT02416453|83233523|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987192|NCT02416453|83233524|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987193|NCT02416453|83233525|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987194|NCT02416453|83233526|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987195|NCT02416453|83233527|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987196|NCT02416453|83233528|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987197|NCT02416453|83233529|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
46987198|NCT02416453|83233519|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987199|NCT02416453|83233520|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987200|NCT02416453|83233521|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987201|NCT02416453|83233522|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987202|NCT02416453|83233523|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987203|NCT02416453|83233524|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
46987204|NCT02416453|83233525|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987205|NCT02416453|83233526|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987206|NCT02416453|83233527|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987207|NCT02416453|83233528|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987208|NCT02416453|83233529|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
46987209|NCT02469961|83233561|FG000|Overall Study|Physician Decision|4|||
46987210|NCT02469961|83233562|FG001|Overall Study|Physician Decision|1|||
46987211|NCT02415595|83233577|FG000|Overall Study|Administrative reason by sponsor|39|||
46987212|NCT02415595|83233578|FG001|Overall Study|Administrative reason by sponsor|40|||
46987213|NCT02415595|83233579|FG002|Overall Study|Administrative reason by sponsor|41|||
46987214|NCT02415595|83233580|FG003|Overall Study|Administrative reason by sponsor|39|||
46987215|NCT02415595|83233577|FG000|Overall Study|Adverse Event|1|||
46987216|NCT02415595|83233578|FG001|Overall Study|Adverse Event|3|||
46987217|NCT02415595|83233579|FG002|Overall Study|Adverse Event|5|||
46987218|NCT02415595|83233580|FG003|Overall Study|Adverse Event|10|||
46987219|NCT02415595|83233577|FG000|Overall Study|Lack of Efficacy|4|||
46987220|NCT02415595|83233578|FG001|Overall Study|Lack of Efficacy|4|||
46987221|NCT02415595|83233579|FG002|Overall Study|Lack of Efficacy|0|||
46987222|NCT02415595|83233580|FG003|Overall Study|Lack of Efficacy|0|||
46987223|NCT02415595|83233577|FG000|Overall Study|Lost to Follow-up|1|||
46987224|NCT02415595|83233578|FG001|Overall Study|Lost to Follow-up|3|||
46987225|NCT02415595|83233579|FG002|Overall Study|Lost to Follow-up|1|||
46987226|NCT02415595|83233580|FG003|Overall Study|Lost to Follow-up|1|||
46987227|NCT02415595|83233577|FG000|Overall Study|Poor/Non-compliance|1|||
46987228|NCT02415595|83233578|FG001|Overall Study|Poor/Non-compliance|0|||
46987229|NCT02415595|83233579|FG002|Overall Study|Poor/Non-compliance|1|||
46987230|NCT02415595|83233580|FG003|Overall Study|Poor/Non-compliance|0|||
46987231|NCT02415595|83233577|FG000|Overall Study|Reached stopping criteria|0|||
46987232|NCT02415595|83233578|FG001|Overall Study|Reached stopping criteria|1|||
46987233|NCT02415595|83233579|FG002|Overall Study|Reached stopping criteria|1|||
46987234|NCT02415595|83233580|FG003|Overall Study|Reached stopping criteria|0|||
46987235|NCT02415595|83233577|FG000|Overall Study|Withdrawal by Subject|4|||
46987236|NCT02415595|83233578|FG001|Overall Study|Withdrawal by Subject|0|||
46987237|NCT02415595|83233579|FG002|Overall Study|Withdrawal by Subject|1|||
46987238|NCT02415595|83233580|FG003|Overall Study|Withdrawal by Subject|3|||
46987239|NCT02415595|83233577|FG000|Overall Study|Other|0|||
46987240|NCT02415595|83233578|FG001|Overall Study|Other|1|||
46987241|NCT02415595|83233579|FG002|Overall Study|Other|1|||
46987242|NCT02415595|83233580|FG003|Overall Study|Other|0|||
46987243|NCT02446717|83233596|FG000|Overall Study|Adverse Event|0|||
46987244|NCT02446717|83233597|FG001|Overall Study|Adverse Event|0|||
46987245|NCT02446717|83233598|FG002|Overall Study|Adverse Event|1|||
46987246|NCT02446717|83233599|FG003|Overall Study|Adverse Event|0|||
46987247|NCT02446717|83233600|FG004|Overall Study|Adverse Event|0|||
46987248|NCT02446717|83233596|FG000|Overall Study|Lost to Follow-up|0|||
46987249|NCT02446717|83233597|FG001|Overall Study|Lost to Follow-up|1|||
46987250|NCT02446717|83233598|FG002|Overall Study|Lost to Follow-up|1|||
46987251|NCT02446717|83233599|FG003|Overall Study|Lost to Follow-up|0|||
46987252|NCT02446717|83233600|FG004|Overall Study|Lost to Follow-up|1|||
46987253|NCT02446717|83233596|FG000|Overall Study|Withdrew consent|0|||
46987254|NCT02446717|83233597|FG001|Overall Study|Withdrew consent|0|||
46987255|NCT02446717|83233598|FG002|Overall Study|Withdrew consent|0|||
46987256|NCT02446717|83233599|FG003|Overall Study|Withdrew consent|1|||
46987257|NCT02446717|83233600|FG004|Overall Study|Withdrew consent|0|||
46987258|NCT02469415|83233612|FG000|Overall Study|Withdrawal by Subject|1|||
46987259|NCT02469415|83233612|FG000|Overall Study|Investigational agent placed on hold|2|||
46987260|NCT02446171|83233620|FG000|Overall Study|Withdrawal by Subject|0|||
46987261|NCT02446171|83233621|FG001|Overall Study|Withdrawal by Subject|0|||
46987262|NCT02446171|83233622|FG002|Overall Study|Withdrawal by Subject|2|||
46987263|NCT02446171|83233623|FG003|Overall Study|Withdrawal by Subject|0|||
46987264|NCT02446015|83233637|FG000|Overall Study|Adverse Event|0|||
46987265|NCT02446015|83233638|FG001|Overall Study|Adverse Event|1|||
46987266|NCT02446015|83233637|FG000|Overall Study|Withdrawal by Subject|1|||
46987267|NCT02446015|83233638|FG001|Overall Study|Withdrawal by Subject|0|||
46987268|NCT02415127|83233647|FG000|Overall Study|Adverse Event|1|||
46987269|NCT02415127|83233648|FG001|Overall Study|Adverse Event|0|||
46987270|NCT02468557|83233654|FG000|Overall Study|Adverse Event|1|||
46987271|NCT02468557|83233654|FG000|Overall Study|Death|1|||
46987272|NCT02468557|83233654|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
46987273|NCT02468557|83233654|FG000|Overall Study|All Enrolled but Never Dosed|4|||
46987274|NCT02413489|83233665|FG000|Overall Study|Death|11|||
46987275|NCT02413489|83233666|FG001|Overall Study|Death|3|||
46987276|NCT02413489|83233667|FG002|Overall Study|Death|4|||
46987277|NCT02413489|83233665|FG000|Overall Study|Withdrawal by Subject|2|||
46987278|NCT02413489|83233666|FG001|Overall Study|Withdrawal by Subject|0|||
46987279|NCT02413489|83233667|FG002|Overall Study|Withdrawal by Subject|0|||
46987280|NCT02413489|83233665|FG000|Overall Study|Study Terminated By Sponsor|2|||
46987281|NCT02413489|83233666|FG001|Overall Study|Study Terminated By Sponsor|13|||
46987282|NCT02413489|83233667|FG002|Overall Study|Study Terminated By Sponsor|1|||
46987283|NCT02413333|83233679|FG000|Period 1|Adverse Event|1|||
46987284|NCT02413333|83233680|FG001|Period 1|Adverse Event|0|||
46987285|NCT02413333|83233679|FG000|Period 1|Reason Not Specified|0|||
46987286|NCT02413333|83233680|FG001|Period 1|Reason Not Specified|1|||
46987287|NCT02413333|83233679|FG000|Period 2|Protocol Deviation|1|||
46987288|NCT02413333|83233680|FG001|Period 2|Protocol Deviation|0|||
46987289|NCT02413255|83233703|FG000|Overall Study|Voluntary Withdrawal|0|||
46987290|NCT02413255|83233704|FG001|Overall Study|Voluntary Withdrawal|0|||
46987291|NCT02413255|83233705|FG002|Overall Study|Voluntary Withdrawal|0|||
46987292|NCT02413255|83233706|FG003|Overall Study|Voluntary Withdrawal|0|||
46987293|NCT02413255|83233707|FG004|Overall Study|Voluntary Withdrawal|0|||
46987294|NCT02413255|83233708|FG005|Overall Study|Voluntary Withdrawal|0|||
46987295|NCT02413255|83233709|FG006|Overall Study|Voluntary Withdrawal|0|||
46987296|NCT02413255|83233710|FG007|Overall Study|Voluntary Withdrawal|0|||
46987297|NCT02413255|83233711|FG008|Overall Study|Voluntary Withdrawal|0|||
46987298|NCT02413255|83233712|FG009|Overall Study|Voluntary Withdrawal|0|||
46987299|NCT02413255|83233713|FG010|Overall Study|Voluntary Withdrawal|0|||
46987300|NCT02413255|83233714|FG011|Overall Study|Voluntary Withdrawal|0|||
46987301|NCT02413255|83233715|FG012|Overall Study|Voluntary Withdrawal|0|||
46987302|NCT02413255|83233716|FG013|Overall Study|Voluntary Withdrawal|0|||
46987303|NCT02413255|83233717|FG014|Overall Study|Voluntary Withdrawal|1|||
46987304|NCT02413255|83233718|FG015|Overall Study|Voluntary Withdrawal|0|||
46987305|NCT02413255|83233719|FG016|Overall Study|Voluntary Withdrawal|0|||
46987306|NCT02444533|83233772|FG000|Overall Study|Not able to complete forms|0|||
46987307|NCT02444533|83233773|FG001|Overall Study|Not able to complete forms|2|||
46987308|NCT02444533|83233772|FG000|Overall Study|Only gave post-procedure complications|2|||
46987309|NCT02444533|83233773|FG001|Overall Study|Only gave post-procedure complications|2|||
46987310|NCT01651039|83233779|FG000|Overall Study|Non-evaluables|5|||
46987311|NCT01651039|83233779|FG000|Overall Study|Physician Decision|2|||
46987312|NCT01651039|83233779|FG000|Overall Study|Withdrawal by Subject|1|||
46987313|NCT01651039|83233779|FG000|Overall Study|Progressive Disease|22|||
46987314|NCT02349633|83233797|FG000|Overall Study|Death|0|||
46987315|NCT02349633|83233798|FG001|Overall Study|Death|1|||
46987316|NCT02349633|83233799|FG002|Overall Study|Death|0|||
46987317|NCT02349633|83233800|FG003|Overall Study|Death|0|||
46987318|NCT02349633|83233801|FG004|Overall Study|Death|0|||
46987319|NCT02349633|83233802|FG005|Overall Study|Death|1|||
46987320|NCT02349633|83233803|FG006|Overall Study|Death|1|||
46987321|NCT02349633|83233804|FG007|Overall Study|Death|1|||
46987322|NCT02349633|83233805|FG008|Overall Study|Death|0|||
46987323|NCT02349633|83233806|FG009|Overall Study|Death|1|||
46987324|NCT02349633|83233807|FG010|Overall Study|Death|0|||
46987325|NCT02349633|83233808|FG011|Overall Study|Death|0|||
46987326|NCT02349633|83233809|FG012|Overall Study|Death|0|||
46987327|NCT02349633|83233810|FG013|Overall Study|Death|0|||
46987328|NCT02349633|83233797|FG000|Overall Study|Withdrawal by Subject|0|||
46987329|NCT02349633|83233798|FG001|Overall Study|Withdrawal by Subject|0|||
46987330|NCT02349633|83233799|FG002|Overall Study|Withdrawal by Subject|0|||
46987331|NCT02349633|83233800|FG003|Overall Study|Withdrawal by Subject|1|||
46987332|NCT02349633|83233801|FG004|Overall Study|Withdrawal by Subject|0|||
46987333|NCT02349633|83233802|FG005|Overall Study|Withdrawal by Subject|0|||
46987334|NCT02349633|83233803|FG006|Overall Study|Withdrawal by Subject|0|||
46987335|NCT02349633|83233804|FG007|Overall Study|Withdrawal by Subject|2|||
46987336|NCT02349633|83233805|FG008|Overall Study|Withdrawal by Subject|2|||
46987337|NCT02349633|83233806|FG009|Overall Study|Withdrawal by Subject|1|||
46987338|NCT02349633|83233807|FG010|Overall Study|Withdrawal by Subject|0|||
46987339|NCT02349633|83233808|FG011|Overall Study|Withdrawal by Subject|0|||
46987340|NCT02349633|83233809|FG012|Overall Study|Withdrawal by Subject|0|||
46987341|NCT02349633|83233810|FG013|Overall Study|Withdrawal by Subject|0|||
46987342|NCT02349633|83233797|FG000|Overall Study|Withdrawal of informed consent|0|||
46987343|NCT02349633|83233798|FG001|Overall Study|Withdrawal of informed consent|0|||
46987344|NCT02349633|83233799|FG002|Overall Study|Withdrawal of informed consent|0|||
46987345|NCT02349633|83233800|FG003|Overall Study|Withdrawal of informed consent|1|||
46987346|NCT02349633|83233801|FG004|Overall Study|Withdrawal of informed consent|1|||
46987347|NCT02349633|83233802|FG005|Overall Study|Withdrawal of informed consent|0|||
46987348|NCT02349633|83233803|FG006|Overall Study|Withdrawal of informed consent|0|||
46987349|NCT02349633|83233804|FG007|Overall Study|Withdrawal of informed consent|3|||
46987350|NCT02349633|83233805|FG008|Overall Study|Withdrawal of informed consent|0|||
46987351|NCT02349633|83233806|FG009|Overall Study|Withdrawal of informed consent|0|||
46987352|NCT02349633|83233807|FG010|Overall Study|Withdrawal of informed consent|0|||
46987353|NCT02349633|83233808|FG011|Overall Study|Withdrawal of informed consent|0|||
46987354|NCT02349633|83233809|FG012|Overall Study|Withdrawal of informed consent|0|||
46987355|NCT02349633|83233810|FG013|Overall Study|Withdrawal of informed consent|0|||
46987356|NCT02349633|83233797|FG000|Overall Study|Transition to compassionate use|0|||
46987357|NCT02349633|83233798|FG001|Overall Study|Transition to compassionate use|0|||
46987358|NCT02349633|83233799|FG002|Overall Study|Transition to compassionate use|0|||
46987359|NCT02349633|83233800|FG003|Overall Study|Transition to compassionate use|0|||
46987360|NCT02349633|83233801|FG004|Overall Study|Transition to compassionate use|1|||
46987361|NCT02349633|83233802|FG005|Overall Study|Transition to compassionate use|0|||
46987362|NCT02349633|83233803|FG006|Overall Study|Transition to compassionate use|0|||
46987363|NCT02349633|83233804|FG007|Overall Study|Transition to compassionate use|3|||
46987364|NCT02349633|83233805|FG008|Overall Study|Transition to compassionate use|0|||
46987365|NCT02349633|83233806|FG009|Overall Study|Transition to compassionate use|1|||
46987366|NCT02349633|83233807|FG010|Overall Study|Transition to compassionate use|0|||
46987367|NCT02349633|83233808|FG011|Overall Study|Transition to compassionate use|0|||
46987368|NCT02349633|83233809|FG012|Overall Study|Transition to compassionate use|0|||
46987369|NCT02349633|83233810|FG013|Overall Study|Transition to compassionate use|0|||
46987370|NCT02349633|83233797|FG000|Overall Study|Early termination of survival follow-up|0|||
46987371|NCT02349633|83233798|FG001|Overall Study|Early termination of survival follow-up|0|||
46987372|NCT02349633|83233799|FG002|Overall Study|Early termination of survival follow-up|0|||
46987373|NCT02349633|83233800|FG003|Overall Study|Early termination of survival follow-up|0|||
46987374|NCT02349633|83233801|FG004|Overall Study|Early termination of survival follow-up|0|||
46987375|NCT02349633|83233802|FG005|Overall Study|Early termination of survival follow-up|0|||
46987376|NCT02349633|83233803|FG006|Overall Study|Early termination of survival follow-up|0|||
46987377|NCT02349633|83233804|FG007|Overall Study|Early termination of survival follow-up|4|||
46987378|NCT02349633|83233805|FG008|Overall Study|Early termination of survival follow-up|0|||
46987379|NCT02349633|83233806|FG009|Overall Study|Early termination of survival follow-up|0|||
46987380|NCT02349633|83233807|FG010|Overall Study|Early termination of survival follow-up|0|||
46987381|NCT02349633|83233808|FG011|Overall Study|Early termination of survival follow-up|0|||
46987382|NCT02349633|83233809|FG012|Overall Study|Early termination of survival follow-up|0|||
46987383|NCT02349633|83233810|FG013|Overall Study|Early termination of survival follow-up|0|||
46987384|NCT02349633|83233797|FG000|Overall Study|Termination by sponsor|0|||
46987385|NCT02349633|83233798|FG001|Overall Study|Termination by sponsor|0|||
46987386|NCT02349633|83233799|FG002|Overall Study|Termination by sponsor|0|||
46987387|NCT02349633|83233800|FG003|Overall Study|Termination by sponsor|0|||
46987388|NCT02349633|83233801|FG004|Overall Study|Termination by sponsor|0|||
46987389|NCT02349633|83233802|FG005|Overall Study|Termination by sponsor|0|||
46987390|NCT02349633|83233803|FG006|Overall Study|Termination by sponsor|0|||
46987391|NCT02349633|83233804|FG007|Overall Study|Termination by sponsor|1|||
46987392|NCT02349633|83233805|FG008|Overall Study|Termination by sponsor|0|||
46987393|NCT02349633|83233806|FG009|Overall Study|Termination by sponsor|2|||
46987394|NCT02349633|83233807|FG010|Overall Study|Termination by sponsor|0|||
46987395|NCT02349633|83233808|FG011|Overall Study|Termination by sponsor|0|||
46987396|NCT02349633|83233809|FG012|Overall Study|Termination by sponsor|0|||
46987397|NCT02349633|83233810|FG013|Overall Study|Termination by sponsor|0|||
46987398|NCT02349633|83233797|FG000|Overall Study|Other|0|||
46987399|NCT02349633|83233798|FG001|Overall Study|Other|0|||
46987400|NCT02349633|83233799|FG002|Overall Study|Other|0|||
46987401|NCT02349633|83233800|FG003|Overall Study|Other|0|||
46987402|NCT02349633|83233801|FG004|Overall Study|Other|0|||
46987403|NCT02349633|83233802|FG005|Overall Study|Other|0|||
46987404|NCT02349633|83233803|FG006|Overall Study|Other|0|||
46987405|NCT02349633|83233804|FG007|Overall Study|Other|2|||
46987406|NCT02349633|83233805|FG008|Overall Study|Other|0|||
46987407|NCT02349633|83233806|FG009|Overall Study|Other|0|||
46987408|NCT02349633|83233807|FG010|Overall Study|Other|0|||
46987409|NCT02349633|83233808|FG011|Overall Study|Other|0|||
46987410|NCT02349633|83233809|FG012|Overall Study|Other|0|||
46987411|NCT02349633|83233810|FG013|Overall Study|Other|0|||
46987412|NCT02275611|83233875|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
46987413|NCT02275611|83233876|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
46987414|NCT02275611|83233877|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
46987415|NCT02275611|83233878|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
46987416|NCT02275065|83233895|FG000|Overall Study|Randomized but not treated|1|||
46987417|NCT02275065|83233896|FG001|Overall Study|Randomized but not treated|0|||
46987418|NCT02275065|83233897|FG002|Overall Study|Randomized but not treated|1|||
46987419|NCT02275065|83233898|FG003|Overall Study|Randomized but not treated|1|||
46987420|NCT02275065|83233899|FG004|Overall Study|Randomized but not treated|0|||
46987421|NCT02273973|83233913|FG000|Overall Study|Adverse Event|4|||
46987422|NCT02273973|83233914|FG001|Overall Study|Adverse Event|0|||
46987423|NCT02273973|83233913|FG000|Overall Study|Withdrawal by Subject|2|||
46987424|NCT02273973|83233914|FG001|Overall Study|Withdrawal by Subject|3|||
46987425|NCT02273973|83233913|FG000|Overall Study|Death|1|||
46987426|NCT02273973|83233914|FG001|Overall Study|Death|0|||
46987427|NCT02273973|83233913|FG000|Overall Study|Non-compliance|1|||
46987428|NCT02273973|83233914|FG001|Overall Study|Non-compliance|0|||
46987429|NCT02273973|83233913|FG000|Overall Study|Protocol Violation|1|||
46987430|NCT02273973|83233914|FG001|Overall Study|Protocol Violation|0|||
46987431|NCT02273973|83233913|FG000|Overall Study|Progression of disease|0|||
46987432|NCT02273973|83233914|FG001|Overall Study|Progression of disease|2|||
46987433|NCT02273973|83233913|FG000|Overall Study|Lost to Follow-up|0|||
46987434|NCT02273973|83233914|FG001|Overall Study|Lost to Follow-up|1|||
46987435|NCT02273973|83233913|FG000|Overall Study|Physician Decision|0|||
46987436|NCT02273973|83233914|FG001|Overall Study|Physician Decision|1|||
46987437|NCT02273973|83233913|FG000|Overall Study|Reason not specified|0|||
46987438|NCT02273973|83233914|FG001|Overall Study|Reason not specified|1|||
46987439|NCT02273739|83233924|FG000|Overall Study|Progression of Disease|3|||
46987440|NCT02273739|83233925|FG001|Overall Study|Progression of Disease|4|||
46987441|NCT02273739|83233926|FG002|Overall Study|Progression of Disease|5|||
46987442|NCT02273739|83233927|FG003|Overall Study|Progression of Disease|2|||
46987443|NCT02273739|83233924|FG000|Overall Study|Death|0|||
46987444|NCT02273739|83233925|FG001|Overall Study|Death|0|||
46987445|NCT02273739|83233926|FG002|Overall Study|Death|0|||
46987446|NCT02273739|83233927|FG003|Overall Study|Death|2|||
46987447|NCT02273739|83233924|FG000|Overall Study|Adverse Event|0|||
46987448|NCT02273739|83233925|FG001|Overall Study|Adverse Event|0|||
46987449|NCT02273739|83233926|FG002|Overall Study|Adverse Event|0|||
46987450|NCT02273739|83233927|FG003|Overall Study|Adverse Event|1|||
46987451|NCT02273739|83233924|FG000|Overall Study|Withdrawal by Subject|0|||
46987452|NCT02273739|83233925|FG001|Overall Study|Withdrawal by Subject|0|||
46987453|NCT02273739|83233926|FG002|Overall Study|Withdrawal by Subject|2|||
46987454|NCT02273739|83233927|FG003|Overall Study|Withdrawal by Subject|1|||
46987455|NCT02273739|83233924|FG000|Overall Study|Physician Decision|0|||
46987456|NCT02273739|83233925|FG001|Overall Study|Physician Decision|0|||
46987457|NCT02273739|83233926|FG002|Overall Study|Physician Decision|0|||
46987458|NCT02273739|83233927|FG003|Overall Study|Physician Decision|1|||
46987459|NCT02273037|83233944|FG000|Overall Study|Lost to Follow-up|1|||
46987460|NCT02273037|83233945|FG001|Overall Study|Lost to Follow-up|0|||
46987461|NCT02273037|83233944|FG000|Overall Study|Delivered before monitoring initiated|1|||
46987462|NCT02273037|83233945|FG001|Overall Study|Delivered before monitoring initiated|3|||
46987463|NCT02273037|83233944|FG000|Overall Study|Breech delivery|2|||
46987464|NCT02273037|83233945|FG001|Overall Study|Breech delivery|3|||
46987465|NCT02273037|83233944|FG000|Overall Study|Multiple delivery|2|||
46987466|NCT02273037|83233945|FG001|Overall Study|Multiple delivery|2|||
46987467|NCT02273037|83233944|FG000|Overall Study|Other complication|2|||
46987468|NCT02273037|83233945|FG001|Overall Study|Other complication|0|||
46987469|NCT02465515|83233955|FG000|Overall Study|Investigator site closed|4|||
46987470|NCT02465515|83233956|FG001|Overall Study|Investigator site closed|5|||
46987471|NCT02465515|83233955|FG000|Overall Study|Withdrawal by Subject|74|||
46987472|NCT02465515|83233956|FG001|Overall Study|Withdrawal by Subject|43|||
46987473|NCT02465515|83233955|FG000|Overall Study|Physician Decision|8|||
46987474|NCT02465515|83233956|FG001|Overall Study|Physician Decision|12|||
46987475|NCT02465515|83233955|FG000|Overall Study|Lost to Follow-up|68|||
46987476|NCT02465515|83233956|FG001|Overall Study|Lost to Follow-up|51|||
46987477|NCT02412631|83233964|FG000|Overall Study|Adverse Event|1|||
46987478|NCT02412631|83233965|FG001|Overall Study|Adverse Event|2|||
46987479|NCT02412631|83233964|FG000|Overall Study|Lost to Follow-up|5|||
46987480|NCT02412631|83233965|FG001|Overall Study|Lost to Follow-up|9|||
46987481|NCT02412631|83233964|FG000|Overall Study|Withdrawal by Subject|9|||
46987482|NCT02412631|83233965|FG001|Overall Study|Withdrawal by Subject|3|||
46987483|NCT02412631|83233964|FG000|Overall Study|Early stop by FDA|5|||
46987484|NCT02412631|83233965|FG001|Overall Study|Early stop by FDA|2|||
46987485|NCT02412631|83233964|FG000|Overall Study|Unspecified reason|6|||
46987486|NCT02412631|83233965|FG001|Overall Study|Unspecified reason|8|||
46987487|NCT02272803|83233973|FG000|Overall Study|Disease progression|16|||
46987488|NCT02272803|83233974|FG001|Overall Study|Disease progression|8|||
46987489|NCT02272803|83233973|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
46987490|NCT02272803|83233974|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
46987491|NCT02272803|83233973|FG000|Overall Study|Study drug toxicity|4|||
46987492|NCT02272803|83233974|FG001|Overall Study|Study drug toxicity|9|||
46987493|NCT02272803|83233973|FG000|Overall Study|Participant request to discontinue study treatment|3|||
46987494|NCT02272803|83233974|FG001|Overall Study|Participant request to discontinue study treatment|7|||
46879944|NCT01981850|83101204|FG003|Open Label Extension (OLE)|Adverse Event|0|||
46879945|NCT01981850|83101205|FG004|Open Label Extension (OLE)|Adverse Event|0|||
46879946|NCT01981850|83101206|FG005|Open Label Extension (OLE)|Adverse Event|0|||
46879947|NCT01981850|83101207|FG006|Open Label Extension (OLE)|Adverse Event|0|||
46879948|NCT01981850|83101208|FG007|Open Label Extension (OLE)|Adverse Event|2|||
46879949|NCT01981850|83101209|FG008|Open Label Extension (OLE)|Adverse Event|1|||
46879950|NCT01981850|83101210|FG009|Open Label Extension (OLE)|Adverse Event|8|||
46879951|NCT01981850|83101201|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
46879952|NCT01981850|83101202|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
46879953|NCT01981850|83101203|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
46879954|NCT01981850|83101204|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
46879955|NCT01981850|83101205|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
46879956|NCT01981850|83101206|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
46879957|NCT01981850|83101207|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
46879958|NCT01981850|83101208|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
46879959|NCT01981850|83101209|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
46879960|NCT01981850|83101210|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
46879961|NCT01981850|83101201|FG000|Open Label Extension (OLE)|Various reasons|0|||
46987495|NCT02272803|83233973|FG000|Overall Study|Maximum clinical benefit|4|||
46987496|NCT02272803|83233974|FG001|Overall Study|Maximum clinical benefit|2|||
46879962|NCT01981850|83101202|FG001|Open Label Extension (OLE)|Various reasons|0|||
46879963|NCT01981850|83101203|FG002|Open Label Extension (OLE)|Various reasons|0|||
46987497|NCT02272803|83233973|FG000|Overall Study|Poor/non-compliance|2|||
46987498|NCT02272803|83233974|FG001|Overall Study|Poor/non-compliance|2|||
46987499|NCT02272803|83233973|FG000|Overall Study|Withdrawal by Subject|2|||
46987500|NCT02272803|83233974|FG001|Overall Study|Withdrawal by Subject|1|||
46987501|NCT02272803|83233973|FG000|Overall Study|Death|0|||
46987502|NCT02272803|83233974|FG001|Overall Study|Death|1|||
46987503|NCT02272803|83233973|FG000|Overall Study|Other reasons|1|||
46987504|NCT02272803|83233974|FG001|Overall Study|Other reasons|3|||
46987505|NCT02272803|83233973|FG000|Overall Study|Administrative reason by sponsor|5|||
46987506|NCT02272803|83233974|FG001|Overall Study|Administrative reason by sponsor|4|||
46987507|NCT02272725|83233982|FG000|Overall Study|equipment malfunction|2|||
46987508|NCT02272725|83233983|FG001|Overall Study|equipment malfunction|0|||
46987509|NCT01650805|83233991|FG000|Overall Study|Withdrawal by Subject|1|||
46987510|NCT01650805|83233992|FG001|Overall Study|Withdrawal by Subject|0|||
46987511|NCT02442349|83233998|FG000|Overall Study|Death|14|||
46987512|NCT02442349|83233998|FG000|Overall Study|Withdrawal by Subject|8|||
46987513|NCT02442349|83233998|FG000|Overall Study|On-going Study at Data Cut-off|149|||
46987514|NCT02411539|83234004|FG000|Overall Study|Lost to Follow-up|2|||
46987515|NCT02411539|83234005|FG001|Overall Study|Lost to Follow-up|0|||
46987516|NCT02411539|83234004|FG000|Overall Study|Confounding medical condition|0|||
46987517|NCT02411539|83234005|FG001|Overall Study|Confounding medical condition|1|||
46987518|NCT02465437|83234018|FG000|Overall Study|Physician Decision|0|||
46987519|NCT02465437|83234019|FG001|Overall Study|Physician Decision|0|||
46987520|NCT02465437|83234020|FG002|Overall Study|Physician Decision|1|||
46987521|NCT02465437|83234021|FG003|Overall Study|Physician Decision|0|||
46987522|NCT02465437|83234018|FG000|Overall Study|Withdrawal by Subject|1|||
46987523|NCT02465437|83234019|FG001|Overall Study|Withdrawal by Subject|0|||
46987524|NCT02465437|83234020|FG002|Overall Study|Withdrawal by Subject|0|||
46987525|NCT02465437|83234021|FG003|Overall Study|Withdrawal by Subject|1|||
46987526|NCT02465437|83234018|FG000|Overall Study|Adverse Event|0|||
46987527|NCT02465437|83234019|FG001|Overall Study|Adverse Event|1|||
46987528|NCT02465437|83234020|FG002|Overall Study|Adverse Event|0|||
46987529|NCT02465437|83234021|FG003|Overall Study|Adverse Event|0|||
46987530|NCT02442271|83234029|FG000|Overall Study|Adverse Event|1|||
46987531|NCT02442271|83234029|FG000|Overall Study|Withdrew Consent|1|||
46987532|NCT02442271|83234029|FG000|Overall Study|Lost to Follow-up|1|||
46987533|NCT02442271|83234029|FG000|Overall Study|Other|1|||
46987534|NCT02465203|83234050|FG000|Overall Study|Protocol Violation|1|||
46987535|NCT02465203|83234051|FG001|Overall Study|Protocol Violation|1|||
46987536|NCT02465203|83234052|FG002|Overall Study|Protocol Violation|1|||
46987537|NCT02465203|83234050|FG000|Overall Study|Study terminated by sponsor|50|||
46987538|NCT02465203|83234051|FG001|Overall Study|Study terminated by sponsor|34|||
46987539|NCT02465203|83234052|FG002|Overall Study|Study terminated by sponsor|11|||
46987540|NCT02465203|83234050|FG000|Overall Study|New therapy for study indication|4|||
46987541|NCT02465203|83234051|FG001|Overall Study|New therapy for study indication|0|||
46987542|NCT02465203|83234052|FG002|Overall Study|New therapy for study indication|0|||
46987543|NCT02465203|83234050|FG000|Overall Study|Patient/guardian decision|1|||
46987544|NCT02465203|83234051|FG001|Overall Study|Patient/guardian decision|1|||
46987545|NCT02465203|83234052|FG002|Overall Study|Patient/guardian decision|1|||
46987546|NCT02463409|83234059|FG000|Overall Study|Withdrawal by Subject|1|||
46987547|NCT02463409|83234059|FG000|Overall Study|Screen failure|1|||
46987548|NCT02528357|83234082|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987549|NCT02528357|83234083|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
46987550|NCT02528357|83234084|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46703220|NCT01229735|82917901|FG001|Overall Study|SAE, non-fatal|4|||
46703221|NCT01229735|82917900|FG000|Overall Study|AE, non-serious non-fatal|13|||
46703222|NCT01229735|82917901|FG001|Overall Study|AE, non-serious non-fatal|17|||
46703223|NCT01229735|82917900|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
46703224|NCT01229735|82917901|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
46703225|NCT00974974|82917920|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
46703226|NCT00974974|82917921|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
46703227|NCT00974974|82917920|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
46987551|NCT02528357|83234085|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987552|NCT02528357|83234086|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987553|NCT02528357|83234087|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987554|NCT02528357|83234088|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987555|NCT02528357|83234089|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987556|NCT02528357|83234090|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987557|NCT02528357|83234091|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987558|NCT02528357|83234092|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987559|NCT02528357|83234093|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987560|NCT02528357|83234094|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987561|NCT02528357|83234095|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987562|NCT02528357|83234096|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987563|NCT02528357|83234097|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987564|NCT02528357|83234098|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987565|NCT02528357|83234099|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987566|NCT02528357|83234100|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
46987567|NCT02528357|83234082|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987568|NCT02528357|83234083|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987569|NCT02528357|83234084|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987570|NCT02528357|83234085|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
46987571|NCT02528357|83234086|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987572|NCT02528357|83234087|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
46987573|NCT02528357|83234088|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987574|NCT02528357|83234089|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
46987575|NCT02528357|83234090|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987576|NCT02528357|83234091|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987577|NCT02528357|83234092|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987578|NCT02528357|83234093|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987579|NCT02528357|83234094|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987580|NCT02528357|83234095|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987581|NCT02528357|83234096|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987582|NCT02528357|83234097|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987583|NCT02528357|83234098|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987584|NCT02528357|83234099|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987585|NCT02528357|83234100|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
46987586|NCT02528357|83234082|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987587|NCT02528357|83234083|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987588|NCT02528357|83234084|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
46987589|NCT02528357|83234085|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987590|NCT02528357|83234086|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
46987591|NCT02528357|83234087|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987592|NCT02528357|83234088|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
46987593|NCT02528357|83234089|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
46987594|NCT02528357|83234090|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987595|NCT02528357|83234091|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987596|NCT02528357|83234092|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987597|NCT02528357|83234093|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987598|NCT02528357|83234094|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987599|NCT02528357|83234095|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987600|NCT02528357|83234096|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987601|NCT02528357|83234097|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987602|NCT02528357|83234098|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987603|NCT02528357|83234099|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987604|NCT02528357|83234100|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
46987605|NCT02528357|83234082|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987606|NCT02528357|83234083|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987607|NCT02528357|83234084|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987608|NCT02528357|83234085|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987609|NCT02528357|83234086|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
46987610|NCT02528357|83234087|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987611|NCT02528357|83234088|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987612|NCT02528357|83234089|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987613|NCT02528357|83234090|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987614|NCT02528357|83234091|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987615|NCT02528357|83234092|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987616|NCT02528357|83234093|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987617|NCT02528357|83234094|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987618|NCT02528357|83234095|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987619|NCT02528357|83234096|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987620|NCT02528357|83234097|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987621|NCT02528357|83234098|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987622|NCT02528357|83234099|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987623|NCT02528357|83234100|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987624|NCT02528357|83234082|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987625|NCT02528357|83234083|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987626|NCT02528357|83234084|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987627|NCT02528357|83234085|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987628|NCT02528357|83234086|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987629|NCT02528357|83234087|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987630|NCT02528357|83234088|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987631|NCT02528357|83234089|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987632|NCT02528357|83234090|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987633|NCT02528357|83234091|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987634|NCT02528357|83234092|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987635|NCT02528357|83234093|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987636|NCT02528357|83234094|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987637|NCT02528357|83234095|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
46987638|NCT02528357|83234096|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
46987639|NCT02528357|83234097|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987640|NCT02528357|83234098|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987641|NCT02528357|83234099|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987642|NCT02528357|83234100|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
46987643|NCT02528357|83234082|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987644|NCT02528357|83234083|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987645|NCT02528357|83234084|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987646|NCT02528357|83234085|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987647|NCT02528357|83234086|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987648|NCT02528357|83234087|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987649|NCT02528357|83234088|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987650|NCT02528357|83234089|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987651|NCT02528357|83234090|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987652|NCT02528357|83234091|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987653|NCT02528357|83234092|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987654|NCT02528357|83234093|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987655|NCT02528357|83234094|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987656|NCT02528357|83234095|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
46987657|NCT02528357|83234096|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987658|NCT02528357|83234097|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987659|NCT02528357|83234098|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987660|NCT02528357|83234099|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987661|NCT02528357|83234100|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
46987662|NCT02528357|83234082|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987663|NCT02528357|83234083|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987664|NCT02528357|83234084|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987665|NCT02528357|83234085|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987666|NCT02528357|83234086|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987667|NCT02528357|83234087|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987668|NCT02528357|83234088|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987669|NCT02528357|83234089|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987670|NCT02528357|83234090|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987671|NCT02528357|83234091|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987672|NCT02528357|83234092|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
46987673|NCT02528357|83234093|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987674|NCT02528357|83234094|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
46987675|NCT02528357|83234095|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
46987676|NCT02528357|83234096|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
46987677|NCT02528357|83234097|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987678|NCT02528357|83234098|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987679|NCT02528357|83234099|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987680|NCT02528357|83234100|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
46987681|NCT02528357|83234082|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987682|NCT02528357|83234083|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987683|NCT02528357|83234084|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987684|NCT02528357|83234085|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987685|NCT02528357|83234086|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987686|NCT02528357|83234087|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987687|NCT02528357|83234088|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987688|NCT02528357|83234089|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987689|NCT02528357|83234090|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
46987690|NCT02528357|83234091|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
46987691|NCT02528357|83234092|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987692|NCT02528357|83234093|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
46987693|NCT02528357|83234094|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
46987694|NCT02528357|83234095|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
46987695|NCT02528357|83234096|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
46987696|NCT02528357|83234097|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987697|NCT02528357|83234098|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987698|NCT02528357|83234099|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987699|NCT02528357|83234100|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987700|NCT02528357|83234082|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987701|NCT02528357|83234083|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987702|NCT02528357|83234084|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987703|NCT02528357|83234085|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987704|NCT02528357|83234086|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987705|NCT02528357|83234087|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987706|NCT02528357|83234088|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987707|NCT02528357|83234089|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987708|NCT02528357|83234090|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987709|NCT02528357|83234091|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987710|NCT02528357|83234092|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987711|NCT02528357|83234093|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987712|NCT02528357|83234094|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987713|NCT02528357|83234095|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987714|NCT02528357|83234096|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987715|NCT02528357|83234097|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46707563|NCT01176240|82923136|FG001|Study 306B|Physician Decision|1|||
46987716|NCT02528357|83234098|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
46987717|NCT02528357|83234099|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987718|NCT02528357|83234100|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
46987719|NCT02528357|83234082|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987720|NCT02528357|83234083|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987721|NCT02528357|83234084|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987722|NCT02528357|83234085|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987723|NCT02528357|83234086|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987724|NCT02528357|83234087|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987725|NCT02528357|83234088|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987726|NCT02528357|83234089|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987727|NCT02528357|83234090|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987728|NCT02528357|83234091|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987729|NCT02528357|83234092|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987730|NCT02528357|83234093|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987731|NCT02528357|83234094|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987732|NCT02528357|83234095|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987733|NCT02528357|83234096|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987734|NCT02528357|83234097|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
46987735|NCT02528357|83234098|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
46987736|NCT02528357|83234099|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
46987737|NCT02528357|83234100|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
46987738|NCT02463331|83234142|FG000|Overall Study|Adverse Event|4|||
46987739|NCT02463331|83234143|FG001|Overall Study|Adverse Event|2|||
46987740|NCT02463331|83234142|FG000|Overall Study|Lost to Follow-up|1|||
46987741|NCT02463331|83234143|FG001|Overall Study|Lost to Follow-up|1|||
46987742|NCT02463331|83234142|FG000|Overall Study|Pregnancy|2|||
46987743|NCT02463331|83234143|FG001|Overall Study|Pregnancy|3|||
46987744|NCT02463331|83234142|FG000|Overall Study|Lack of Efficacy|6|||
46987745|NCT02463331|83234143|FG001|Overall Study|Lack of Efficacy|0|||
46987746|NCT02463331|83234142|FG000|Overall Study|Physician Decision|3|||
46987747|NCT02463331|83234143|FG001|Overall Study|Physician Decision|0|||
46987748|NCT02410837|83234149|FG000|Overall Study|Death|387|||
46987749|NCT02410837|83234149|FG000|Overall Study|Lost to Follow-up|50|||
46987750|NCT02410837|83234149|FG000|Overall Study|Withdrawal by Subject|44|||
46987751|NCT02410837|83234149|FG000|Overall Study|Physician Decision|6|||
46987752|NCT02410837|83234149|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
46987753|NCT02314247|83234155|FG000|Overall Study|Adverse Event|2|||
46987754|NCT02314247|83234156|FG001|Overall Study|Adverse Event|1|||
46987755|NCT02314247|83234157|FG002|Overall Study|Adverse Event|0|||
46987756|NCT02314247|83234155|FG000|Overall Study|Withdrawal by Subject|1|||
46987757|NCT02314247|83234156|FG001|Overall Study|Withdrawal by Subject|3|||
46987758|NCT02314247|83234157|FG002|Overall Study|Withdrawal by Subject|1|||
46987759|NCT02314247|83234155|FG000|Overall Study|Progression of Disease|6|||
46987760|NCT02314247|83234156|FG001|Overall Study|Progression of Disease|2|||
46987761|NCT02314247|83234157|FG002|Overall Study|Progression of Disease|0|||
46987762|NCT02463097|83234167|FG000|Overall Study|Withdrawal by Subject|1|||
46987763|NCT02441179|83234173|FG000|Overall Study|Withdrawal by Subject|1|||
46987764|NCT02441179|83234174|FG001|Overall Study|Withdrawal by Subject|1|||
46987765|NCT02462473|83234181|FG000|Overall Study|Death|1|||
46987766|NCT02462473|83234181|FG000|Overall Study|Other|3|||
46987767|NCT02440789|83234194|FG000|Overall Study|Withdrawal by Subject|3|||
46987768|NCT02440789|83234194|FG000|Overall Study|Not willing to adhere to reqs|1|||
46987769|NCT02462083|83234198|FG000|Overall Study|Sponsor request|39|||
46987770|NCT02462083|83234198|FG000|Overall Study|Withdrawal by Subject|87|||
46879964|NCT01981850|83101204|FG003|Open Label Extension (OLE)|Various reasons|0|||
46879965|NCT01981850|83101205|FG004|Open Label Extension (OLE)|Various reasons|0|||
46879966|NCT01981850|83101206|FG005|Open Label Extension (OLE)|Various reasons|0|||
46879967|NCT01981850|83101207|FG006|Open Label Extension (OLE)|Various reasons|0|||
46879968|NCT01981850|83101208|FG007|Open Label Extension (OLE)|Various reasons|3|||
46879969|NCT01981850|83101209|FG008|Open Label Extension (OLE)|Various reasons|1|||
46879970|NCT01981850|83101210|FG009|Open Label Extension (OLE)|Various reasons|3|||
46879971|NCT01981850|83101201|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
46879972|NCT01981850|83101202|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
46879973|NCT01981850|83101203|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
46879974|NCT01981850|83101204|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
46879975|NCT01981850|83101205|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
46879976|NCT01981850|83101206|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
46879977|NCT01981850|83101207|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
46879978|NCT01981850|83101208|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
46987771|NCT02462083|83234198|FG000|Overall Study|Lost to Follow-up|41|||
46987772|NCT02462083|83234198|FG000|Overall Study|Lack of Efficacy|151|||
46987773|NCT02462083|83234198|FG000|Overall Study|Pregnancy|1|||
46987774|NCT02462083|83234198|FG000|Overall Study|Protocol Violation|6|||
46987775|NCT02462083|83234198|FG000|Overall Study|Adverse Event|33|||
46987776|NCT02462083|83234198|FG000|Overall Study|Worsening condition|16|||
46987777|NCT02462083|83234198|FG000|Overall Study|Other than specified|45|||
46987778|NCT02538341|83234204|FG000|Overall Study|Lost to Follow-up|51|||
46987779|NCT02538341|83234205|FG001|Overall Study|Lost to Follow-up|46|||
46987780|NCT02538341|83234204|FG000|Overall Study|Withdrawal by Subject|3|||
46987781|NCT02538341|83234205|FG001|Overall Study|Withdrawal by Subject|1|||
46987782|NCT02538341|83234204|FG000|Overall Study|Death|2|||
46987783|NCT02538341|83234205|FG001|Overall Study|Death|0|||
46987784|NCT02538107|83234211|FG000|Overall Study|Did not receive any Mircera dose|11|||
46987785|NCT02538107|83234211|FG000|Overall Study|Missing|5|||
46987786|NCT02538107|83234211|FG000|Overall Study|Necessity of dialysis|20|||
46987787|NCT02538107|83234211|FG000|Overall Study|Administration of other ESA|11|||
46987788|NCT02538107|83234211|FG000|Overall Study|No further treatment necessary|18|||
46987789|NCT02538107|83234211|FG000|Overall Study|Withdrawal by Subject|17|||
46987790|NCT02538107|83234211|FG000|Overall Study|Death|4|||
46987791|NCT02538107|83234211|FG000|Overall Study|Administrative reason|5|||
46987792|NCT02538107|83234211|FG000|Overall Study|Adverse Event|4|||
46987793|NCT02538107|83234211|FG000|Overall Study|Surgery|1|||
46987794|NCT02538107|83234211|FG000|Overall Study|Other|7|||
46987795|NCT02538107|83234211|FG000|Overall Study|Not recorded|7|||
46987796|NCT02538029|83234228|FG000|Overall Study|unable to complete cognitive assessments|1|||
46987797|NCT02538029|83234229|FG001|Overall Study|unable to complete cognitive assessments|0|||
46987798|NCT02538029|83234230|FG002|Overall Study|unable to complete cognitive assessments|1|||
46987799|NCT02272413|83234242|FG000|Randomized Through Treatment Start|Not treated|3|||
46987800|NCT02272413|83234243|FG001|Randomized Through Treatment Start|Not treated|5|||
46987801|NCT02272413|83234242|FG000|Pre-switch Period|Adverse Event|38|||
46987802|NCT02272413|83234243|FG001|Pre-switch Period|Adverse Event|37|||
46987803|NCT02272413|83234242|FG000|Pre-switch Period|Death|26|||
46987804|NCT02272413|83234243|FG001|Pre-switch Period|Death|26|||
46987805|NCT02272413|83234242|FG000|Pre-switch Period|Withdrawal by Subject|27|||
46987806|NCT02272413|83234243|FG001|Pre-switch Period|Withdrawal by Subject|15|||
46987807|NCT02272413|83234242|FG000|Pre-switch Period|Physician Decision|6|||
46987808|NCT02272413|83234243|FG001|Pre-switch Period|Physician Decision|18|||
46987809|NCT02272413|83234242|FG000|Pre-switch Period|Progressive disease|185|||
46987810|NCT02272413|83234243|FG001|Pre-switch Period|Progressive disease|173|||
46987811|NCT02272413|83234242|FG000|Pre-switch Period|Lost to Follow-up|0|||
46987812|NCT02272413|83234243|FG001|Pre-switch Period|Lost to Follow-up|2|||
46987813|NCT02272413|83234242|FG000|Pre-switch Period|Protocol Violation|1|||
46987814|NCT02272413|83234243|FG001|Pre-switch Period|Protocol Violation|0|||
46987815|NCT02272413|83234242|FG000|Pre-switch Period|Other than listed|10|||
46987816|NCT02272413|83234243|FG001|Pre-switch Period|Other than listed|11|||
46987817|NCT02272413|83234242|FG000|Post-switch Period|Adverse Event|4|||
46987818|NCT02272413|83234243|FG001|Post-switch Period|Adverse Event|4|||
46987819|NCT02272413|83234242|FG000|Post-switch Period|Death|3|||
46987820|NCT02272413|83234243|FG001|Post-switch Period|Death|2|||
46987821|NCT02272413|83234242|FG000|Post-switch Period|Withdrawal by Subject|1|||
46987822|NCT02272413|83234243|FG001|Post-switch Period|Withdrawal by Subject|2|||
46987823|NCT02272413|83234242|FG000|Post-switch Period|Physician Decision|1|||
46987824|NCT02272413|83234243|FG001|Post-switch Period|Physician Decision|1|||
46987825|NCT02272413|83234242|FG000|Post-switch Period|Progressive disease|21|||
46987826|NCT02272413|83234243|FG001|Post-switch Period|Progressive disease|21|||
46987827|NCT02272413|83234242|FG000|Post-switch Period|Study terminated by sponsor|8|||
46987828|NCT02272413|83234243|FG001|Post-switch Period|Study terminated by sponsor|11|||
46987829|NCT02272413|83234242|FG000|Post-switch Period|Other than listed|4|||
46987830|NCT02272413|83234243|FG001|Post-switch Period|Other than listed|5|||
46987831|NCT02396381|83234255|FG000|Overall Study|Adverse Event|3|||
46987832|NCT02396381|83234256|FG001|Overall Study|Adverse Event|2|||
46987833|NCT02396381|83234255|FG000|Overall Study|Withdrawal by Subject|33|||
46987834|NCT02396381|83234256|FG001|Overall Study|Withdrawal by Subject|24|||
46987835|NCT02396381|83234255|FG000|Overall Study|Lost to Follow-up|49|||
46987836|NCT02396381|83234256|FG001|Overall Study|Lost to Follow-up|31|||
46987837|NCT02396381|83234255|FG000|Overall Study|Protocol Violation|1|||
46987838|NCT02396381|83234256|FG001|Overall Study|Protocol Violation|0|||
46987839|NCT02396381|83234255|FG000|Overall Study|Site terminated by sponsor|7|||
46987840|NCT02396381|83234256|FG001|Overall Study|Site terminated by sponsor|8|||
46987841|NCT02396381|83234255|FG000|Overall Study|Physician Decision|5|||
46987842|NCT02396381|83234256|FG001|Overall Study|Physician Decision|5|||
46987843|NCT02396381|83234255|FG000|Overall Study|Pregnancy|2|||
46987844|NCT02396381|83234256|FG001|Overall Study|Pregnancy|0|||
46987845|NCT02396381|83234255|FG000|Overall Study|Non-compliance with study procedures|1|||
46987846|NCT02396381|83234256|FG001|Overall Study|Non-compliance with study procedures|0|||
46987847|NCT02396381|83234255|FG000|Overall Study|Moved out of town/state|1|||
46987848|NCT02396381|83234256|FG001|Overall Study|Moved out of town/state|3|||
46987849|NCT02396381|83234255|FG000|Overall Study|Could not complete visit|1|||
46987850|NCT02396381|83234256|FG001|Overall Study|Could not complete visit|0|||
46987851|NCT02396381|83234255|FG000|Overall Study|Possible conflict of interest|1|||
46987852|NCT02396381|83234256|FG001|Overall Study|Possible conflict of interest|0|||
46987853|NCT02396381|83234255|FG000|Overall Study|Randomization/Screening Error|3|||
46987854|NCT02396381|83234256|FG001|Overall Study|Randomization/Screening Error|1|||
46987855|NCT02532647|83234268|FG000|Overall Study|Did not receive trial medication|1|||
46987856|NCT02532647|83234269|FG001|Overall Study|Did not receive trial medication|0|||
46987857|NCT02532647|83234270|FG002|Overall Study|Did not receive trial medication|1|||
46987858|NCT02537015|83234278|FG000|Overall Study|Adverse Event|3|||
46987859|NCT02537015|83234278|FG000|Overall Study|Withdrawal by Subject|2|||
46987860|NCT02537015|83234278|FG000|Overall Study|Other Miscellaneous Reasons|1|||
46987861|NCT02271945|83234284|FG000|Overall Study|Death|3|||
46987862|NCT02271945|83234285|FG001|Overall Study|Death|3|||
46987863|NCT02271945|83234284|FG000|Overall Study|Withdrawal by Subject|1|||
46987864|NCT02271945|83234285|FG001|Overall Study|Withdrawal by Subject|1|||
46987865|NCT02271945|83234284|FG000|Overall Study|Other|1|||
46987866|NCT02271945|83234285|FG001|Overall Study|Other|1|||
46987867|NCT01660763|83234293|FG000|Overall Study|Lack of Efficacy|45|||
46987868|NCT01660763|83234294|FG001|Overall Study|Lack of Efficacy|50|||
46987869|NCT01660763|83234293|FG000|Overall Study|Adverse Event|22|||
46987870|NCT01660763|83234294|FG001|Overall Study|Adverse Event|7|||
46987871|NCT01660763|83234293|FG000|Overall Study|Protocol Violation|1|||
46987872|NCT01660763|83234294|FG001|Overall Study|Protocol Violation|0|||
46987873|NCT01660763|83234293|FG000|Overall Study|Withdrawal by Subject|4|||
46987874|NCT01660763|83234294|FG001|Overall Study|Withdrawal by Subject|0|||
46987875|NCT01660763|83234293|FG000|Overall Study|Patient ready for early discharge|28|||
46987876|NCT01660763|83234294|FG001|Overall Study|Patient ready for early discharge|4|||
46987877|NCT02268045|83234302|FG000|Overall Study|Death|4|||
46987878|NCT02268045|83234303|FG001|Overall Study|Death|4|||
46987879|NCT02268045|83234302|FG000|Overall Study|Disease Progression|2|||
46987880|NCT02268045|83234303|FG001|Overall Study|Disease Progression|1|||
46987881|NCT02268045|83234302|FG000|Overall Study|Adverse Event|7|||
46987882|NCT02268045|83234303|FG001|Overall Study|Adverse Event|7|||
46987883|NCT02268045|83234302|FG000|Overall Study|Withdrawal by Subject|2|||
46987884|NCT02268045|83234303|FG001|Overall Study|Withdrawal by Subject|6|||
46987885|NCT02268045|83234302|FG000|Overall Study|Physician Decision|0|||
46987886|NCT02268045|83234303|FG001|Overall Study|Physician Decision|1|||
46987887|NCT02268045|83234302|FG000|Overall Study|Protocol Violation|1|||
46987888|NCT02268045|83234303|FG001|Overall Study|Protocol Violation|1|||
46987889|NCT02536781|83234313|FG000|Overall Study|Lost to Follow-up|2|||
46987890|NCT02536781|83234314|FG001|Overall Study|Lost to Follow-up|0|||
46987891|NCT02267187|83234320|FG000|Overall Study|Physician Decision|2|||
46987892|NCT02267187|83234320|FG000|Overall Study|Screen fail|3|||
46987893|NCT02532179|83234324|FG000|Overall Study|Lost to Follow-up|1|||
46987894|NCT02532179|83234324|FG000|Overall Study|Pregnancy|1|||
46987895|NCT02532179|83234324|FG000|Overall Study|Subject received depot steroid injection|1|||
46987896|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
46987897|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
46987898|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
46987899|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
46987900|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
46987901|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
46987902|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
46987903|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
46987904|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
46987905|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
46987906|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
46879979|NCT01981850|83101209|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
46879980|NCT01981850|83101210|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
46987907|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
46987908|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
46987909|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
46987910|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
46987911|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
46987912|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
46987913|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
46987914|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
46987915|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
46987916|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
46987917|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
46987918|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
46987919|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
46987920|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
46987921|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
46987922|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
46987923|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
46987924|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
46987925|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
46987926|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
46987927|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
46987928|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
46987929|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
46987930|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
46987931|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
46987932|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
46987933|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
46987934|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
46987935|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
46987936|NCT02409667|83234328|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
46987937|NCT02409667|83234329|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
46987938|NCT02409667|83234330|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
46987939|NCT02409667|83234331|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
46987940|NCT02409667|83234332|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
46987941|NCT02409667|83234328|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
46987942|NCT02409667|83234329|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
46987943|NCT02409667|83234330|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
46987944|NCT02409667|83234331|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
46987945|NCT02409667|83234332|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
46987946|NCT02409667|83234328|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
46987947|NCT02409667|83234329|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
46987948|NCT02409667|83234330|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
46987949|NCT02409667|83234331|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
46987950|NCT02409667|83234332|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
46987951|NCT02409667|83234328|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
46987952|NCT02409667|83234329|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
46987953|NCT02409667|83234330|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
46987954|NCT02409667|83234331|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
46987955|NCT02409667|83234332|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
46987956|NCT02409667|83234328|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
46987957|NCT02409667|83234329|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
46987958|NCT02409667|83234330|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
46987959|NCT02409667|83234331|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
46987960|NCT02409667|83234332|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
46987961|NCT02409667|83234328|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
46987962|NCT02409667|83234329|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
46987963|NCT02409667|83234330|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
46987964|NCT02409667|83234331|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
46987965|NCT02409667|83234332|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
46987966|NCT02409667|83234328|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
46987967|NCT02409667|83234329|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
46987968|NCT02409667|83234330|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
46987969|NCT02409667|83234331|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
46987970|NCT02409667|83234332|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
46987971|NCT02409667|83234328|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
46987972|NCT02409667|83234329|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
46987973|NCT02409667|83234330|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
46987974|NCT02409667|83234331|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
46987975|NCT02409667|83234332|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
46987976|NCT01641939|83234346|FG000|Overall Study|Death|90|||
46987977|NCT01641939|83234347|FG001|Overall Study|Death|187|||
46987978|NCT01641939|83234348|FG002|Overall Study|Death|61|||
46987979|NCT01641939|83234346|FG000|Overall Study|Lost to Follow-up|3|||
46987980|NCT01641939|83234347|FG001|Overall Study|Lost to Follow-up|2|||
46987981|NCT01641939|83234348|FG002|Overall Study|Lost to Follow-up|1|||
46987982|NCT01641939|83234346|FG000|Overall Study|Withdrawal by Subject|14|||
46987983|NCT01641939|83234347|FG001|Overall Study|Withdrawal by Subject|11|||
46987984|NCT01641939|83234348|FG002|Overall Study|Withdrawal by Subject|5|||
46987985|NCT01641939|83234346|FG000|Overall Study|Study Terminated by Sponsor|10|||
46987986|NCT01641939|83234347|FG001|Overall Study|Study Terminated by Sponsor|28|||
46987987|NCT01641939|83234348|FG002|Overall Study|Study Terminated by Sponsor|3|||
46987988|NCT01641861|83234360|FG000|Overall Study|Lost to Follow-up|21|||
46987989|NCT01641861|83234361|FG001|Overall Study|Lost to Follow-up|16|||
46987990|NCT01641861|83234360|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
46987991|NCT01641861|83234361|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
46987992|NCT01641861|83234360|FG000|Overall Study|Died due to drowning|0|||
46987993|NCT01641861|83234361|FG001|Overall Study|Died due to drowning|1|||
46987994|NCT02409355|83234369|FG000|Overall Study|Withdrawal by Subject|1|||
46987995|NCT02409355|83234370|FG001|Overall Study|Withdrawal by Subject|0|||
46987996|NCT02409355|83234369|FG000|Overall Study|Death|1|||
46987997|NCT02409355|83234370|FG001|Overall Study|Death|1|||
46987998|NCT02409355|83234369|FG000|Overall Study|Study terminated by Sponsor|2|||
46879981|NCT01981850|83101201|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46879982|NCT01981850|83101202|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46707564|NCT01176240|82923135|FG000|Study 306B|Supine Hypertension|1|||
46879983|NCT01981850|83101203|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46987999|NCT02409355|83234370|FG001|Overall Study|Study terminated by Sponsor|3|||
46988000|NCT02408887|83234378|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
46988001|NCT02408887|83234379|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
46988002|NCT02408887|83234378|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
46988003|NCT02408887|83234379|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
46988004|NCT02266875|83234387|FG000|Overall Study|Withdrawal by Subject|9|||
46988005|NCT02266875|83234388|FG001|Overall Study|Withdrawal by Subject|0|||
46988006|NCT02266875|83234387|FG000|Overall Study|Lost to Follow-up|2|||
46988007|NCT02266875|83234388|FG001|Overall Study|Lost to Follow-up|0|||
46988008|NCT02438371|83234396|FG000|Overall Study|Lost to Follow-up|3|||
46988009|NCT02438371|83234397|FG001|Overall Study|Lost to Follow-up|2|||
46988010|NCT02438371|83234396|FG000|Overall Study|Withdrawal by Subject|1|||
46988011|NCT02438371|83234397|FG001|Overall Study|Withdrawal by Subject|1|||
46988012|NCT02438137|83234405|FG000|Overall Study|Lost to Follow-up|3|||
46988013|NCT02438137|83234406|FG001|Overall Study|Lost to Follow-up|2|||
46988014|NCT02438137|83234405|FG000|Overall Study|Adverse Event|1|||
46988015|NCT02438137|83234406|FG001|Overall Study|Adverse Event|0|||
46988016|NCT02438137|83234405|FG000|Overall Study|Withdrawal by Subject|4|||
46988017|NCT02438137|83234406|FG001|Overall Study|Withdrawal by Subject|3|||
46988018|NCT02438137|83234405|FG000|Overall Study|Physician Decision|0|||
46988019|NCT02438137|83234406|FG001|Overall Study|Physician Decision|1|||
46988020|NCT02437903|83234414|FG000|Overall Study|Adverse Event|1|||
46988021|NCT02437903|83234414|FG000|Overall Study|Withdrawal by Subject|1|||
46988022|NCT02437903|83234414|FG000|Overall Study|Lost to Follow-up|3|||
46988023|NCT02437513|83234419|FG000|Overall Study|Withdrawal by Subject|2|||
46988024|NCT02460991|83234425|FG000|Overall Study|Withdrawal by Subject|0|||
46988025|NCT02460991|83234426|FG001|Overall Study|Withdrawal by Subject|2|||
46988026|NCT02407249|83234437|FG000|Overall Study|Did not complete 12-month follow-up|13|||
46988027|NCT02407249|83234437|FG000|Overall Study|Not treated|13|||
46988028|NCT02460679|83234441|FG000|Overall Study|Investigator Decision|1|||
46988029|NCT02460679|83234441|FG000|Overall Study|Withdrawal by Subject|4|||
46988030|NCT02459899|83234449|FG000|Overall Study|Adverse Event|1|||
46988031|NCT02459899|83234450|FG001|Overall Study|Adverse Event|1|||
46988032|NCT02459899|83234451|FG002|Overall Study|Adverse Event|0|||
46988033|NCT02459899|83234452|FG003|Overall Study|Adverse Event|0|||
46988034|NCT02459899|83234449|FG000|Overall Study|Lost to Follow-up|1|||
46988035|NCT02459899|83234450|FG001|Overall Study|Lost to Follow-up|2|||
46988036|NCT02459899|83234451|FG002|Overall Study|Lost to Follow-up|0|||
46988037|NCT02459899|83234452|FG003|Overall Study|Lost to Follow-up|1|||
46988038|NCT02459899|83234449|FG000|Overall Study|Non-compliance with the treatment|0|||
46988039|NCT02459899|83234450|FG001|Overall Study|Non-compliance with the treatment|0|||
46988040|NCT02459899|83234451|FG002|Overall Study|Non-compliance with the treatment|0|||
46988041|NCT02459899|83234452|FG003|Overall Study|Non-compliance with the treatment|1|||
46988042|NCT02459899|83234449|FG000|Overall Study|Withdrawal by Subject|1|||
46988043|NCT02459899|83234450|FG001|Overall Study|Withdrawal by Subject|3|||
46988044|NCT02459899|83234451|FG002|Overall Study|Withdrawal by Subject|0|||
46988045|NCT02459899|83234452|FG003|Overall Study|Withdrawal by Subject|0|||
46988046|NCT02436889|83234464|FG000|Overall Study|No improvement in symptoms|1|||
46988047|NCT02436889|83234465|FG001|Overall Study|No improvement in symptoms|0|||
46988048|NCT02436889|83234464|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
46988049|NCT02436889|83234465|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
46988050|NCT02436811|83234474|FG000|Overall Study|Lost to Follow-up|2|||
46988051|NCT02436811|83234475|FG001|Overall Study|Lost to Follow-up|9|||
46988052|NCT02436811|83234476|FG002|Overall Study|Lost to Follow-up|7|||
46988053|NCT02436577|83234490|FG000|Overall Study|Protocol Deviation|0|||
46988054|NCT02436577|83234491|FG001|Overall Study|Protocol Deviation|1|||
46988055|NCT02436577|83234492|FG002|Overall Study|Protocol Deviation|0|||
46988056|NCT02436577|83234493|FG003|Overall Study|Protocol Deviation|0|||
46988057|NCT02436577|83234494|FG004|Overall Study|Protocol Deviation|0|||
46988058|NCT02436577|83234495|FG005|Overall Study|Protocol Deviation|0|||
46988059|NCT02265705|83234505|FG000|Treatment Period Week 0-24|Adverse Event|3|||
46988060|NCT02265705|83234506|FG001|Treatment Period Week 0-24|Adverse Event|2|||
46988061|NCT02265705|83234507|FG002|Treatment Period Week 0-24|Adverse Event|0|||
46988062|NCT02265705|83234508|FG003|Treatment Period Week 0-24|Adverse Event|0|||
46988063|NCT02265705|83234509|FG004|Treatment Period Week 0-24|Adverse Event|0|||
46988064|NCT02265705|83234510|FG005|Treatment Period Week 0-24|Adverse Event|0|||
46988065|NCT02265705|83234511|FG006|Treatment Period Week 0-24|Adverse Event|0|||
46988066|NCT02265705|83234505|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
46988067|NCT02265705|83234506|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
46988068|NCT02265705|83234507|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
46988069|NCT02265705|83234508|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
46988070|NCT02265705|83234509|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
46988071|NCT02265705|83234510|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
46988072|NCT02265705|83234511|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
46988073|NCT02265705|83234505|FG000|Treatment Period Week 0-24|Physician Decision|1|||
46988074|NCT02265705|83234506|FG001|Treatment Period Week 0-24|Physician Decision|0|||
46988075|NCT02265705|83234507|FG002|Treatment Period Week 0-24|Physician Decision|0|||
46988076|NCT02265705|83234508|FG003|Treatment Period Week 0-24|Physician Decision|0|||
46988077|NCT02265705|83234509|FG004|Treatment Period Week 0-24|Physician Decision|0|||
46703228|NCT00974974|82917921|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
46707565|NCT01176240|82923136|FG001|Study 306B|Supine Hypertension|2|||
46879984|NCT01981850|83101204|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46879985|NCT01981850|83101205|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46988078|NCT02265705|83234510|FG005|Treatment Period Week 0-24|Physician Decision|0|||
46879986|NCT01981850|83101206|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46879987|NCT01981850|83101207|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46879988|NCT01981850|83101208|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46879989|NCT01981850|83101209|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
46879990|NCT01981850|83101210|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
46879991|NCT01981850|83101201|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
46879992|NCT01981850|83101202|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
46879993|NCT01981850|83101203|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
46879994|NCT01981850|83101204|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
46879995|NCT01981850|83101205|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
46879996|NCT01981850|83101206|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
46879997|NCT01981850|83101207|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
46879998|NCT01981850|83101208|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
46703229|NCT00974974|82917920|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
46879999|NCT01981850|83101209|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
46880000|NCT01981850|83101210|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
46880001|NCT03557307|83101242|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
46880002|NCT03557307|83101242|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
46880003|NCT03557307|83101242|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
46880004|NCT03557307|83101242|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
46880005|NCT03557307|83101242|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
46880006|NCT03557307|83101242|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
46880007|NCT03557307|83101242|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
46880008|NCT03557307|83101242|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
46880009|NCT03557307|83101242|FG000|Period 2: Maintenance Phase|Death|3|||
46880010|NCT03557307|83101242|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
46880011|NCT03557307|83101242|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
46880012|NCT03557307|83101242|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
46880013|NCT03557307|83101242|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
46880014|NCT03557307|83101242|FG000|Period 2: Maintenance Phase|other|3|||
46880015|NCT00118703|83101254|FG000|Overall Study|Protocol Violation|1|||
46880016|NCT00118703|83101255|FG001|Overall Study|Protocol Violation|0|||
46880017|NCT00118703|83101254|FG000|Overall Study|Adverse Event|1|||
46880018|NCT00118703|83101255|FG001|Overall Study|Adverse Event|1|||
46880019|NCT00118703|83101254|FG000|Overall Study|Participant took two different treatment|0|||
46880020|NCT00118703|83101255|FG001|Overall Study|Participant took two different treatment|1|||
46880021|NCT00118703|83101254|FG000|Overall Study|Withdrawal by Subject|2|||
46880022|NCT00118703|83101255|FG001|Overall Study|Withdrawal by Subject|5|||
46880023|NCT00118703|83101254|FG000|Overall Study|Lost to Follow-up|1|||
46880024|NCT00118703|83101255|FG001|Overall Study|Lost to Follow-up|2|||
46880025|NCT00104104|83101263|FG000|Overall Study|Adverse Event|8|||
46880026|NCT00104104|83101264|FG001|Overall Study|Adverse Event|8|||
46880027|NCT00104104|83101263|FG000|Overall Study|Abnormal laboratory value(s)|20|||
46988079|NCT02265705|83234511|FG006|Treatment Period Week 0-24|Physician Decision|0|||
46988080|NCT02265705|83234505|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
46988081|NCT02265705|83234506|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
46988082|NCT02265705|83234507|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
46988083|NCT02265705|83234508|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
46988084|NCT02265705|83234509|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
46988085|NCT02265705|83234510|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
46988086|NCT02265705|83234511|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
46988087|NCT02265705|83234505|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
46988088|NCT02265705|83234506|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
46880028|NCT00104104|83101264|FG001|Overall Study|Abnormal laboratory value(s)|14|||
46880029|NCT00104104|83101263|FG000|Overall Study|Lack of Efficacy|0|||
46880030|NCT00104104|83101264|FG001|Overall Study|Lack of Efficacy|3|||
46880031|NCT00104104|83101263|FG000|Overall Study|Condition no longer requires study drug|7|||
46988089|NCT02265705|83234507|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
46988090|NCT02265705|83234508|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
46988091|NCT02265705|83234509|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
46880032|NCT00104104|83101264|FG001|Overall Study|Condition no longer requires study drug|4|||
46703230|NCT00974974|82917921|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
46703231|NCT00974974|82917920|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
46703232|NCT00974974|82917921|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
46703233|NCT00974974|82917920|FG000|IR CD-LD Dose Adjustment|Various|0|||
46703234|NCT00974974|82917921|FG001|IR CD-LD Dose Adjustment|Various|9|||
46703235|NCT00974974|82917920|FG000|IPX066 Dose Conversion|Adverse Event|23|||
46703236|NCT00974974|82917921|FG001|IPX066 Dose Conversion|Adverse Event|0|||
46703237|NCT00974974|82917920|FG000|IPX066 Dose Conversion|Death|2|||
46703238|NCT00974974|82917921|FG001|IPX066 Dose Conversion|Death|0|||
46703239|NCT00974974|82917920|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
46703240|NCT00974974|82917921|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
46703241|NCT00974974|82917920|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
46703242|NCT00974974|82917921|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
46703243|NCT00974974|82917920|FG000|IPX066 Dose Conversion|Various|3|||
46703244|NCT00974974|82917921|FG001|IPX066 Dose Conversion|Various|0|||
46703245|NCT00974974|82917920|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
46703246|NCT00974974|82917921|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
46703247|NCT00974974|82917920|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
46703248|NCT00974974|82917921|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
46703249|NCT00974974|82917920|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
46703250|NCT00974974|82917921|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
46703251|NCT00974974|82917920|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
46703252|NCT00974974|82917921|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
46703253|NCT00974974|82917920|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
46703254|NCT00974974|82917921|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
46703255|NCT00974974|82917920|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
46703256|NCT00974974|82917921|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
46703257|NCT00974974|82917920|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
46703258|NCT00974974|82917921|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
46703259|NCT00974974|82917920|FG000|Maintenance - Double Blind Treatment|Various|4|||
46703260|NCT00974974|82917921|FG001|Maintenance - Double Blind Treatment|Various|0|||
46703261|NCT01233869|82917931|FG000|Initial Treatment Period (24 Months)|Death|1|||
46703262|NCT01233869|82917932|FG001|Initial Treatment Period (24 Months)|Death|0|||
46703263|NCT01233869|82917933|FG002|Initial Treatment Period (24 Months)|Death|0|||
46703264|NCT01233869|82917934|FG003|Initial Treatment Period (24 Months)|Death|0|||
46703265|NCT01233869|82917931|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
46703266|NCT01233869|82917932|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
46703267|NCT01233869|82917933|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
46703268|NCT01233869|82917934|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
46703269|NCT01233869|82917931|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
46703270|NCT01233869|82917932|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
46880033|NCT00104104|83101263|FG000|Overall Study|Protocol Violation|5|||
46703271|NCT01233869|82917933|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
46703272|NCT01233869|82917934|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
46703273|NCT01233869|82917931|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
46703274|NCT01233869|82917932|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
46703275|NCT01233869|82917933|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
46703276|NCT01233869|82917934|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
46703277|NCT01233869|82917931|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
46703278|NCT01233869|82917932|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
46703279|NCT01233869|82917933|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
46703280|NCT01233869|82917934|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
46703281|NCT01233869|82917931|FG000|Extended Treatment Period (46 Months)|Other|3|||
46703282|NCT01233869|82917932|FG001|Extended Treatment Period (46 Months)|Other|0|||
46703283|NCT01233869|82917933|FG002|Extended Treatment Period (46 Months)|Other|0|||
46703284|NCT01233869|82917934|FG003|Extended Treatment Period (46 Months)|Other|3|||
46703285|NCT01233869|82917931|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
46703286|NCT01233869|82917932|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
46703287|NCT01233869|82917933|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
46703288|NCT01233869|82917934|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
46703289|NCT00992992|82917944|FG000|Overall Study|Lost to Follow-up|3|||
46703290|NCT00992992|82917944|FG000|Overall Study|Death|16|||
46703291|NCT00992992|82917944|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
46703292|NCT00992992|82917944|FG000|Overall Study|Sponsor Closed the Study|4|||
46703293|NCT00992836|82917948|FG000|Overall Study|Lost to Follow-up|1|||
46703294|NCT00992836|82917948|FG000|Overall Study|Withdrawal by Subject|2|||
46703295|NCT00992836|82917948|FG000|Overall Study|Protocol Violation|2|||
46703296|NCT00992446|82917958|FG000|Overall Study|Disease Progression|1|||
46703297|NCT00992446|82917958|FG000|Overall Study|Withdrawal by Subject|2|||
46703298|NCT00992446|82917958|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
46703299|NCT04344301|82917964|FG000|Overall Study|Withdrawal by Subject|1|||
46703300|NCT04344301|82917965|FG001|Overall Study|Withdrawal by Subject|0|||
46703301|NCT04344301|82917964|FG000|Overall Study|Death|0|||
46703302|NCT04344301|82917965|FG001|Overall Study|Death|1|||
46703303|NCT00970294|82917972|FG000|Overall Study|Physician Decision|4|||
46703304|NCT00970294|82917972|FG000|Overall Study|Withdrawal by Subject|1|||
46703305|NCT00969436|82917979|FG000|Overall Study|Protocol Violation|1|||
46703306|NCT00969436|82917980|FG001|Overall Study|Protocol Violation|3|||
46703307|NCT00969436|82917981|FG002|Overall Study|Protocol Violation|0|||
46703308|NCT00969436|82917979|FG000|Overall Study|Migrated/moved from study area|12|||
46703309|NCT00969436|82917980|FG001|Overall Study|Migrated/moved from study area|10|||
46703310|NCT00969436|82917981|FG002|Overall Study|Migrated/moved from study area|2|||
46703311|NCT00969436|82917979|FG000|Overall Study|Father - serious health problem|0|||
46703312|NCT00969436|82917980|FG001|Overall Study|Father - serious health problem|0|||
46703313|NCT00969436|82917981|FG002|Overall Study|Father - serious health problem|1|||
46703314|NCT00969436|82917979|FG000|Overall Study|Parents personal problem|0|||
46703315|NCT00969436|82917980|FG001|Overall Study|Parents personal problem|0|||
46703316|NCT00969436|82917981|FG002|Overall Study|Parents personal problem|1|||
46703317|NCT00969436|82917979|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
46703318|NCT00969436|82917980|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
46703319|NCT00969436|82917981|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
46703320|NCT00969436|82917979|FG000|Overall Study|Withdrawal by Subject|3|||
46703321|NCT00969436|82917980|FG001|Overall Study|Withdrawal by Subject|0|||
46703322|NCT00969436|82917981|FG002|Overall Study|Withdrawal by Subject|2|||
46703323|NCT00969436|82917979|FG000|Overall Study|Lost to Follow-up|8|||
46703324|NCT00969436|82917980|FG001|Overall Study|Lost to Follow-up|8|||
46703325|NCT00969436|82917981|FG002|Overall Study|Lost to Follow-up|5|||
46703326|NCT00900757|82917989|FG000|Overall Study|screen failure|19|||
46988092|NCT02265705|83234510|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
46703327|NCT00969280|82917995|FG000|Overall Study|Protocol Violation|2|||
46703328|NCT00969280|82917996|FG001|Overall Study|Protocol Violation|1|||
46703329|NCT00969280|82917995|FG000|Overall Study|Withdrawal by Subject|0|||
46703330|NCT00969280|82917996|FG001|Overall Study|Withdrawal by Subject|1|||
46703331|NCT00969280|82917995|FG000|Overall Study|infection of influenza A(H1N1)|0|||
46703332|NCT00969280|82917996|FG001|Overall Study|infection of influenza A(H1N1)|1|||
46703333|NCT00969124|82918002|FG000|Overall Study|Protocol Violation|2|||
46703334|NCT00969124|82918002|FG000|Overall Study|Inadequate bowel preparation|15|||
46703335|NCT00969124|82918002|FG000|Overall Study|Inability to reach cecum|9|||
46703336|NCT00969124|82918002|FG000|Overall Study|Previously unrecognized disease|3|||
46703337|NCT00969124|82918002|FG000|Overall Study|Technical error|1|||
46703338|NCT00900601|82918007|FG000|Overall Study|Physician Decision|1|||
46703339|NCT00901927|82918034|FG000|Overall Study|Lack of Efficacy|1|||
46703340|NCT00901927|82918034|FG000|Overall Study|Protocol Violation|3|||
46703341|NCT00901927|82918034|FG000|Overall Study|Withdrawal by Subject|2|||
46703342|NCT00968968|82918040|FG000|Overall Study|Study closed/terminated|10|||
46703343|NCT00968968|82918041|FG001|Overall Study|Study closed/terminated|10|||
46703344|NCT00968968|82918040|FG000|Overall Study|Protocol defined stopping criteria|3|||
46703345|NCT00968968|82918041|FG001|Overall Study|Protocol defined stopping criteria|1|||
46703346|NCT00968968|82918040|FG000|Overall Study|Withdrawal by Subject|2|||
46703347|NCT00968968|82918041|FG001|Overall Study|Withdrawal by Subject|0|||
46703348|NCT00968968|82918040|FG000|Overall Study|Physician Decision|1|||
46703349|NCT00968968|82918041|FG001|Overall Study|Physician Decision|2|||
46703350|NCT00968968|82918040|FG000|Overall Study|Lost to Follow-up|0|||
46703351|NCT00968968|82918041|FG001|Overall Study|Lost to Follow-up|1|||
46703352|NCT00973102|82918050|FG000|Overall Study|Protocol Violation|1|||
46703353|NCT00973102|82918051|FG001|Overall Study|Protocol Violation|0|||
46703354|NCT00973102|82918050|FG000|Overall Study|Prisoner|0|||
46703355|NCT00973102|82918051|FG001|Overall Study|Prisoner|1|||
46703356|NCT00901459|82918057|FG000|Overall Study|Withdrawal by Subject|6|||
46703357|NCT00896233|82918068|FG000|Overall Study|Claustrophobia during MRI|1|||
46703358|NCT00899431|82918093|FG000|Overall Study|Physician Decision|1|||
46703359|NCT00899431|82918094|FG001|Overall Study|Physician Decision|0|||
46703360|NCT00899431|82918095|FG002|Overall Study|Physician Decision|0|||
46703361|NCT00899353|82918106|FG000|Overall Study|Adverse Event|2|||
46703362|NCT00899353|82918106|FG000|Overall Study|Lost to Follow-up|1|||
46703363|NCT00899353|82918106|FG000|Overall Study|Withdrawal by Subject|2|||
46703364|NCT00898807|82918129|FG000|Overall Study|Withdrawal by Subject|5|||
46703365|NCT00898807|82918130|FG001|Overall Study|Withdrawal by Subject|3|||
46703366|NCT00898807|82918129|FG000|Overall Study|Family pressure to discontinue|2|||
46703367|NCT00898807|82918130|FG001|Overall Study|Family pressure to discontinue|2|||
46703368|NCT00898807|82918129|FG000|Overall Study|Lost to Follow-up|1|||
46703369|NCT00898807|82918130|FG001|Overall Study|Lost to Follow-up|3|||
46703370|NCT00898807|82918129|FG000|Overall Study|Death|0|||
46703371|NCT00898807|82918130|FG001|Overall Study|Death|1|||
46703372|NCT01229267|82918141|FG000|Overall Study|Adverse Event|4|||
46703373|NCT01229267|82918142|FG001|Overall Study|Adverse Event|6|||
46703374|NCT01229267|82918143|FG002|Overall Study|Adverse Event|3|||
46703375|NCT01229267|82918144|FG003|Overall Study|Adverse Event|2|||
46703376|NCT01229267|82918145|FG004|Overall Study|Adverse Event|10|||
46703377|NCT01229267|82918141|FG000|Overall Study|Death|40|||
46703378|NCT01229267|82918142|FG001|Overall Study|Death|37|||
46703379|NCT01229267|82918143|FG002|Overall Study|Death|35|||
46703380|NCT01229267|82918144|FG003|Overall Study|Death|13|||
46703381|NCT01229267|82918145|FG004|Overall Study|Death|103|||
46703382|NCT01229267|82918141|FG000|Overall Study|Withdrawal by Subject|23|||
46703383|NCT01229267|82918142|FG001|Overall Study|Withdrawal by Subject|22|||
46703384|NCT01229267|82918143|FG002|Overall Study|Withdrawal by Subject|32|||
46703385|NCT01229267|82918144|FG003|Overall Study|Withdrawal by Subject|14|||
46703386|NCT01229267|82918145|FG004|Overall Study|Withdrawal by Subject|59|||
46703387|NCT01229267|82918141|FG000|Overall Study|Protocol Violation|0|||
46703388|NCT01229267|82918142|FG001|Overall Study|Protocol Violation|1|||
46703389|NCT01229267|82918143|FG002|Overall Study|Protocol Violation|0|||
46703390|NCT01229267|82918144|FG003|Overall Study|Protocol Violation|0|||
46703391|NCT01229267|82918145|FG004|Overall Study|Protocol Violation|0|||
46703392|NCT01229267|82918141|FG000|Overall Study|Progressive disease|0|||
46703393|NCT01229267|82918142|FG001|Overall Study|Progressive disease|0|||
46703394|NCT01229267|82918143|FG002|Overall Study|Progressive disease|0|||
46703395|NCT01229267|82918144|FG003|Overall Study|Progressive disease|0|||
46703396|NCT01229267|82918145|FG004|Overall Study|Progressive disease|1|||
46703397|NCT01229267|82918141|FG000|Overall Study|Physician Decision|8|||
46703398|NCT01229267|82918142|FG001|Overall Study|Physician Decision|11|||
46703399|NCT01229267|82918143|FG002|Overall Study|Physician Decision|8|||
46703400|NCT01229267|82918144|FG003|Overall Study|Physician Decision|3|||
46880034|NCT00104104|83101264|FG001|Overall Study|Protocol Violation|2|||
46988093|NCT02265705|83234511|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
46988094|NCT02265705|83234505|FG000|Rescue Period|Withdrawal by Subject|0|||
46703401|NCT01229267|82918145|FG004|Overall Study|Physician Decision|25|||
46703402|NCT01229267|82918141|FG000|Overall Study|Lost to Follow-up|6|||
46703403|NCT01229267|82918142|FG001|Overall Study|Lost to Follow-up|5|||
46703404|NCT01229267|82918143|FG002|Overall Study|Lost to Follow-up|8|||
46703405|NCT01229267|82918144|FG003|Overall Study|Lost to Follow-up|3|||
46703406|NCT01229267|82918145|FG004|Overall Study|Lost to Follow-up|22|||
46703407|NCT00897715|82918154|FG000|Overall Study|Lost to Follow-up|0|||
46880035|NCT00104104|83101263|FG000|Overall Study|Withdrawal by Subject|11|||
46703408|NCT00897715|82918155|FG001|Overall Study|Lost to Follow-up|1|||
46703409|NCT00897715|82918154|FG000|Overall Study|Physician Decision|1|||
46703410|NCT00897715|82918155|FG001|Overall Study|Physician Decision|0|||
46703411|NCT00897715|82918154|FG000|Overall Study|increased risk of infection|1|||
46703412|NCT00897715|82918155|FG001|Overall Study|increased risk of infection|0|||
46703413|NCT01229111|82918161|FG000|Overall Study|Death|1|||
46703414|NCT00894361|82918167|FG000|Overall Study|deaths and less than 2 years followup|24|||
46703415|NCT00894361|82918168|FG001|Overall Study|deaths and less than 2 years followup|64|||
46703416|NCT01228175|82918178|FG000|Overall Study|Lost to Follow-up|64|||
46703417|NCT01228175|82918179|FG001|Overall Study|Lost to Follow-up|50|||
46703418|NCT01228175|82918178|FG000|Overall Study|Withdrawal by Subject|1|||
46703419|NCT01228175|82918179|FG001|Overall Study|Withdrawal by Subject|2|||
46703420|NCT01228175|82918178|FG000|Overall Study|Physician Decision|1|||
46703421|NCT01228175|82918179|FG001|Overall Study|Physician Decision|1|||
46703422|NCT01228019|82918185|FG000|Overall Study|Dose Violation|70|||
46703423|NCT01228019|82918185|FG000|Overall Study|Duplicate enrollment|1|||
46703424|NCT01228019|82918185|FG000|Overall Study|Missing pre-treatment data|72|||
46703425|NCT01228019|82918185|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
46703426|NCT01228019|82918185|FG000|Overall Study|Violation of Entry Criterion|9|||
46703427|NCT02987959|82918189|FG000|Overall Study|Grantor stopped supply of drugs|6|||
46703428|NCT01227707|82918193|FG000|Overall Study|Adverse Event|10|||
46703429|NCT01227707|82918193|FG000|Overall Study|Progression of disease|3|||
46703430|NCT01227707|82918193|FG000|Overall Study|Withdrawal by Subject|1|||
46703431|NCT01227707|82918193|FG000|Overall Study|Patient non-compliance|3|||
46703432|NCT01227707|82918193|FG000|Overall Study|Medical decision|6|||
46703433|NCT01227707|82918193|FG000|Overall Study|Death|1|||
46703434|NCT00895843|82918199|FG000|Overall Study|Protocol Violation|12|||
46703435|NCT00895843|82918200|FG001|Overall Study|Protocol Violation|12|||
46703436|NCT00895453|82918209|FG000|Overall Study|Lost to Follow-up|25|||
46703437|NCT00895453|82918210|FG001|Overall Study|Lost to Follow-up|25|||
46703438|NCT00895453|82918211|FG002|Overall Study|Lost to Follow-up|23|||
46703439|NCT00893971|82918219|FG000|Overall Study|Physician Decision|3|||
46703440|NCT00893737|82918232|FG000|Overall Study|Adverse Event|4|||
46703441|NCT00893737|82918232|FG000|Overall Study|Withdrawal by Subject|2|||
46703442|NCT00893737|82918232|FG000|Overall Study|Lost to Follow-up|6|||
46703443|NCT00893113|82918238|FG000|Overall Study|Lost to Follow-up|4|||
46703444|NCT00893113|82918239|FG001|Overall Study|Lost to Follow-up|8|||
46703445|NCT00893113|82918238|FG000|Overall Study|Early Termination|1|||
46703446|NCT00893113|82918239|FG001|Overall Study|Early Termination|1|||
46703447|NCT00893113|82918238|FG000|Overall Study|Withdrew Consent|8|||
46703448|NCT00893113|82918239|FG001|Overall Study|Withdrew Consent|7|||
46703449|NCT00892957|82918247|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
46703450|NCT00892957|82918248|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
46703451|NCT00892957|82918247|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
46703452|NCT00892957|82918248|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
46703453|NCT00968812|82918271|FG000|Overall Study|Adverse Event|30|||
46703454|NCT00968812|82918272|FG001|Overall Study|Adverse Event|46|||
46703455|NCT00968812|82918273|FG002|Overall Study|Adverse Event|33|||
46703456|NCT00968812|82918271|FG000|Overall Study|Death|2|||
46703457|NCT00968812|82918272|FG001|Overall Study|Death|2|||
46703458|NCT00968812|82918273|FG002|Overall Study|Death|1|||
46703459|NCT00968812|82918271|FG000|Overall Study|Lack of Efficacy|9|||
46703460|NCT00968812|82918272|FG001|Overall Study|Lack of Efficacy|7|||
46703461|NCT00968812|82918273|FG002|Overall Study|Lack of Efficacy|16|||
46703462|NCT00968812|82918271|FG000|Overall Study|Lost to Follow-up|17|||
46703463|NCT00968812|82918272|FG001|Overall Study|Lost to Follow-up|12|||
46703464|NCT00968812|82918273|FG002|Overall Study|Lost to Follow-up|11|||
46703465|NCT00968812|82918271|FG000|Overall Study|Physician Decision|8|||
46703466|NCT00968812|82918272|FG001|Overall Study|Physician Decision|5|||
46703467|NCT00968812|82918273|FG002|Overall Study|Physician Decision|9|||
46703468|NCT00968812|82918271|FG000|Overall Study|Protocol Violation|7|||
46703469|NCT00968812|82918272|FG001|Overall Study|Protocol Violation|4|||
46703470|NCT00968812|82918273|FG002|Overall Study|Protocol Violation|3|||
46703471|NCT00968812|82918271|FG000|Overall Study|Withdrawal by Subject|17|||
46703472|NCT00968812|82918272|FG001|Overall Study|Withdrawal by Subject|23|||
46703473|NCT00968812|82918273|FG002|Overall Study|Withdrawal by Subject|25|||
46703474|NCT00968812|82918271|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
46988095|NCT02265705|83234506|FG001|Rescue Period|Withdrawal by Subject|0|||
46988096|NCT02265705|83234507|FG002|Rescue Period|Withdrawal by Subject|1|||
46988097|NCT02265705|83234508|FG003|Rescue Period|Withdrawal by Subject|0|||
46988098|NCT02265705|83234509|FG004|Rescue Period|Withdrawal by Subject|0|||
46988099|NCT02265705|83234510|FG005|Rescue Period|Withdrawal by Subject|0|||
46988100|NCT02265705|83234511|FG006|Rescue Period|Withdrawal by Subject|0|||
46988101|NCT02265705|83234505|FG000|Rescue Period|Death|0|||
46988102|NCT02265705|83234506|FG001|Rescue Period|Death|0|||
46988103|NCT02265705|83234507|FG002|Rescue Period|Death|1|||
46988104|NCT02265705|83234508|FG003|Rescue Period|Death|0|||
46988105|NCT02265705|83234509|FG004|Rescue Period|Death|0|||
46988106|NCT02265705|83234510|FG005|Rescue Period|Death|0|||
46988107|NCT02265705|83234511|FG006|Rescue Period|Death|0|||
46703475|NCT00968812|82918272|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
46703476|NCT00968812|82918273|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
46703477|NCT00968812|82918271|FG000|Overall Study|Noncompliance with study drug|4|||
46703478|NCT00968812|82918272|FG001|Overall Study|Noncompliance with study drug|1|||
46703479|NCT00968812|82918273|FG002|Overall Study|Noncompliance with study drug|6|||
46703480|NCT00968812|82918271|FG000|Overall Study|Unable to take rescue therapy|12|||
46703481|NCT00968812|82918272|FG001|Overall Study|Unable to take rescue therapy|12|||
46703482|NCT00968812|82918273|FG002|Overall Study|Unable to take rescue therapy|17|||
46703483|NCT00968812|82918271|FG000|Overall Study|Other|25|||
46703484|NCT00968812|82918272|FG001|Overall Study|Other|37|||
46703485|NCT00968812|82918273|FG002|Overall Study|Other|40|||
46703486|NCT00992056|82918286|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
46703487|NCT00992056|82918287|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
46703488|NCT00992056|82918286|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
46703489|NCT00992056|82918287|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
46703490|NCT00972322|82918295|FG000|Overall Study|Adverse Event|2|||
46703491|NCT00972322|82918296|FG001|Overall Study|Adverse Event|1|||
46703492|NCT00972322|82918295|FG000|Overall Study|Positive drug screen|0|||
46703493|NCT00972322|82918296|FG001|Overall Study|Positive drug screen|1|||
46703494|NCT00972322|82918295|FG000|Overall Study|Lost to Follow-up|0|||
46703495|NCT00972322|82918296|FG001|Overall Study|Lost to Follow-up|1|||
46703496|NCT00972322|82918295|FG000|Overall Study|Consistently high glucose values|1|||
46703497|NCT00972322|82918296|FG001|Overall Study|Consistently high glucose values|0|||
46703498|NCT00967798|82918304|FG000|Overall Study|Withdrawal by Subject|5|||
46703499|NCT00967798|82918305|FG001|Overall Study|Withdrawal by Subject|2|||
46703500|NCT00967798|82918304|FG000|Overall Study|Lost to Follow-up|4|||
46703501|NCT00967798|82918305|FG001|Overall Study|Lost to Follow-up|1|||
46703502|NCT00965458|82918313|FG000|Overall Study|Adverse Event|1|||
46703503|NCT00965458|82918314|FG001|Overall Study|Adverse Event|0|||
46703504|NCT00965458|82918313|FG000|Overall Study|Lost to Follow-up|1|||
46703505|NCT00965458|82918314|FG001|Overall Study|Lost to Follow-up|3|||
46703506|NCT00965458|82918313|FG000|Overall Study|Withdrawal by Subject|0|||
46703507|NCT00965458|82918314|FG001|Overall Study|Withdrawal by Subject|1|||
46703508|NCT00972244|82918327|FG000|Overall Study|Incorrect Enrolment|1|||
46703509|NCT00972244|82918328|FG001|Overall Study|Incorrect Enrolment|0|||
46703510|NCT00972244|82918329|FG002|Overall Study|Incorrect Enrolment|0|||
46703511|NCT00972244|82918330|FG003|Overall Study|Incorrect Enrolment|0|||
46703512|NCT00972244|82918331|FG004|Overall Study|Incorrect Enrolment|0|||
46703513|NCT00972244|82918327|FG000|Overall Study|Adverse Event|0|||
46703514|NCT00972244|82918328|FG001|Overall Study|Adverse Event|1|||
46703515|NCT00972244|82918329|FG002|Overall Study|Adverse Event|1|||
46703516|NCT00972244|82918330|FG003|Overall Study|Adverse Event|0|||
46703517|NCT00972244|82918331|FG004|Overall Study|Adverse Event|0|||
46703518|NCT00972244|82918327|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
46703519|NCT00972244|82918328|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
46703520|NCT00972244|82918329|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
46703521|NCT00972244|82918330|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
46703522|NCT00972244|82918331|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
46703523|NCT00972244|82918327|FG000|Overall Study|Withdrawal by Subject|1|||
46703524|NCT00972244|82918328|FG001|Overall Study|Withdrawal by Subject|2|||
46703525|NCT00972244|82918329|FG002|Overall Study|Withdrawal by Subject|1|||
46703526|NCT00972244|82918330|FG003|Overall Study|Withdrawal by Subject|0|||
46703527|NCT00972244|82918331|FG004|Overall Study|Withdrawal by Subject|1|||
46703528|NCT00972244|82918327|FG000|Overall Study|Safety|0|||
46703529|NCT00972244|82918328|FG001|Overall Study|Safety|0|||
46988108|NCT02265705|83234505|FG000|Rescue Period|Lack of Efficacy|0|||
46703530|NCT00972244|82918329|FG002|Overall Study|Safety|0|||
46703531|NCT00972244|82918330|FG003|Overall Study|Safety|0|||
46703532|NCT00972244|82918331|FG004|Overall Study|Safety|1|||
46703533|NCT00972244|82918327|FG000|Overall Study|Death|1|||
46703534|NCT00972244|82918328|FG001|Overall Study|Death|0|||
46703535|NCT00972244|82918329|FG002|Overall Study|Death|0|||
46703536|NCT00972244|82918330|FG003|Overall Study|Death|0|||
46703537|NCT00972244|82918331|FG004|Overall Study|Death|0|||
46703538|NCT00972244|82918327|FG000|Overall Study|Various|0|||
46703539|NCT00972244|82918328|FG001|Overall Study|Various|0|||
46703540|NCT00972244|82918329|FG002|Overall Study|Various|0|||
46703541|NCT00972244|82918330|FG003|Overall Study|Various|0|||
46703542|NCT00972244|82918331|FG004|Overall Study|Various|2|||
46703543|NCT00892723|82918346|FG000|Overall Study|Lost to Follow-up|1|||
46703544|NCT00892723|82918347|FG001|Overall Study|Lost to Follow-up|3|||
46703545|NCT00892723|82918348|FG002|Overall Study|Lost to Follow-up|1|||
46703546|NCT00892723|82918346|FG000|Overall Study|Withdrawal by Subject|1|||
46703547|NCT00892723|82918347|FG001|Overall Study|Withdrawal by Subject|1|||
46703548|NCT00892723|82918348|FG002|Overall Study|Withdrawal by Subject|1|||
46703549|NCT03811912|82918391|FG000|Overall Study|Withdrew Consent|4|||
46703550|NCT03811912|82918392|FG001|Overall Study|Withdrew Consent|2|||
46703551|NCT00971932|82918398|FG000|Overall Study|Withdrawal by Subject|1|||
46703552|NCT00971932|82918398|FG000|Overall Study|Investigator's decision|2|||
46988109|NCT02265705|83234506|FG001|Rescue Period|Lack of Efficacy|0|||
46703553|NCT00971932|82918398|FG000|Overall Study|Ongoing|4|||
46703554|NCT00970684|82918402|FG000|Overall Study|Lack of Efficacy|5|||
46703555|NCT00970684|82918402|FG000|Overall Study|Adverse Event|4|||
46703556|NCT00970684|82918402|FG000|Overall Study|Withdrawal by Subject|1|||
46703557|NCT00967330|82918408|FG000|Overall Study|Protocol Violation|3|||
46703558|NCT00967330|82918409|FG001|Overall Study|Protocol Violation|4|||
46703559|NCT00967330|82918408|FG000|Overall Study|Regular|10|||
46703560|NCT00967330|82918409|FG001|Overall Study|Regular|3|||
46703561|NCT00967330|82918408|FG000|Overall Study|Withdrawal by Subject|6|||
46703562|NCT00967330|82918409|FG001|Overall Study|Withdrawal by Subject|0|||
46703563|NCT00967330|82918408|FG000|Overall Study|Lost to Follow-up|1|||
46703564|NCT00967330|82918409|FG001|Overall Study|Lost to Follow-up|1|||
46703565|NCT00967330|82918408|FG000|Overall Study|Death|102|||
46703566|NCT00967330|82918409|FG001|Overall Study|Death|51|||
46703567|NCT00967330|82918408|FG000|Overall Study|Severe protocol deviation|0|||
46703568|NCT00967330|82918409|FG001|Overall Study|Severe protocol deviation|1|||
46703569|NCT00967018|82918415|FG000|Overall Study|Adverse Event|2|||
46703570|NCT00967018|82918415|FG000|Overall Study|Physician Decision|7|||
46703571|NCT00967018|82918415|FG000|Overall Study|Lost to Follow-up|2|||
46703572|NCT00967018|82918415|FG000|Overall Study|Withdrawal by Subject|1|||
46703573|NCT00967018|82918415|FG000|Overall Study|Miscellaneous Reasons|9|||
46703574|NCT00965146|82918419|FG000|Overall Study|Death|7|||
46703575|NCT00965146|82918419|FG000|Overall Study|Lost to Follow-up|22|||
46703576|NCT00965146|82918419|FG000|Overall Study|Withdrawal by Subject|17|||
46703577|NCT00965146|82918419|FG000|Overall Study|Unable to return|1|||
46703578|NCT00965146|82918419|FG000|Overall Study|Unwilling to return|11|||
46703579|NCT00965146|82918419|FG000|Overall Study|Intercurrent illness|1|||
46703580|NCT00965146|82918419|FG000|Overall Study|Revision / Removal of Study Implant|6|||
46703581|NCT00965146|82918419|FG000|Overall Study|Overall Study Termination|145|||
46703582|NCT00966940|82918425|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
46703583|NCT00966940|82918426|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
46703584|NCT00966940|82918425|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
46703585|NCT00966940|82918426|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
46703586|NCT00965848|82918432|FG000|Overall Study|Protocol Violation|3|||
46703587|NCT00965848|82918433|FG001|Overall Study|Protocol Violation|0|||
46703588|NCT00965848|82918434|FG002|Overall Study|Protocol Violation|1|||
46703589|NCT00965848|82918432|FG000|Overall Study|Death|11|||
46703590|NCT00965848|82918433|FG001|Overall Study|Death|1|||
46703591|NCT00965848|82918434|FG002|Overall Study|Death|5|||
46703592|NCT00965848|82918432|FG000|Overall Study|Lost to Follow-up|0|||
46703593|NCT00965848|82918433|FG001|Overall Study|Lost to Follow-up|0|||
46703594|NCT00965848|82918434|FG002|Overall Study|Lost to Follow-up|1|||
46703595|NCT00965848|82918432|FG000|Overall Study|Withdrawal by Subject|1|||
46703596|NCT00965848|82918433|FG001|Overall Study|Withdrawal by Subject|0|||
46703597|NCT00965848|82918434|FG002|Overall Study|Withdrawal by Subject|0|||
46703598|NCT00965848|82918432|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
46703599|NCT00965848|82918433|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
46703600|NCT00965848|82918434|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
46703601|NCT00965848|82918432|FG000|Overall Study|Not Clinically Evaluable|7|||
46703602|NCT00965848|82918433|FG001|Overall Study|Not Clinically Evaluable|1|||
46703603|NCT00965848|82918434|FG002|Overall Study|Not Clinically Evaluable|1|||
46703604|NCT00965848|82918432|FG000|Overall Study|Other|5|||
46703605|NCT00965848|82918433|FG001|Overall Study|Other|0|||
46703606|NCT00965848|82918434|FG002|Overall Study|Other|1|||
46703607|NCT00961636|82918445|FG000|Overall Study|Adverse Event|35|||
46703608|NCT00961636|82918446|FG001|Overall Study|Adverse Event|54|||
46703609|NCT00961636|82918447|FG002|Overall Study|Adverse Event|13|||
46703610|NCT00961636|82918445|FG000|Overall Study|Flushing Symptoms|29|||
46703611|NCT00961636|82918446|FG001|Overall Study|Flushing Symptoms|46|||
46703612|NCT00961636|82918447|FG002|Overall Study|Flushing Symptoms|3|||
46703613|NCT00961636|82918445|FG000|Overall Study|Lost to Follow-up|2|||
46703614|NCT00961636|82918446|FG001|Overall Study|Lost to Follow-up|3|||
46703615|NCT00961636|82918447|FG002|Overall Study|Lost to Follow-up|1|||
46703616|NCT00961636|82918445|FG000|Overall Study|Physician Decision|3|||
46703617|NCT00961636|82918446|FG001|Overall Study|Physician Decision|1|||
46703618|NCT00961636|82918447|FG002|Overall Study|Physician Decision|1|||
46703619|NCT00961636|82918445|FG000|Overall Study|Protocol Violation|9|||
46703620|NCT00961636|82918446|FG001|Overall Study|Protocol Violation|5|||
46703621|NCT00961636|82918447|FG002|Overall Study|Protocol Violation|1|||
46703622|NCT00961636|82918445|FG000|Overall Study|Withdrawal by Subject|29|||
46703623|NCT00961636|82918446|FG001|Overall Study|Withdrawal by Subject|22|||
46703624|NCT00961636|82918447|FG002|Overall Study|Withdrawal by Subject|13|||
46703625|NCT00964678|82918455|FG000|Overall Study|Physician Decision|4|||
46703626|NCT00964366|82918462|FG000|Overall Study|Did not qualify at Day 1|1|||
46703627|NCT00964366|82918463|FG001|Overall Study|Did not qualify at Day 1|0|||
46703628|NCT00964366|82918462|FG000|Overall Study|Withdrawal by Subject|0|||
46703629|NCT00964366|82918463|FG001|Overall Study|Withdrawal by Subject|1|||
46703630|NCT00960154|82918471|FG000|Overall Study|Study termination|25|||
46703631|NCT00960154|82918472|FG001|Overall Study|Study termination|25|||
46703632|NCT00960076|82918480|FG000|Overall Study|Adverse Event|1|||
46703633|NCT00960076|82918481|FG001|Overall Study|Adverse Event|7|||
46703634|NCT00960076|82918480|FG000|Overall Study|No longer met study criteria|1|||
46703635|NCT00960076|82918481|FG001|Overall Study|No longer met study criteria|5|||
46703636|NCT00960076|82918480|FG000|Overall Study|Withdrawal by Subject|1|||
46703637|NCT00960076|82918481|FG001|Overall Study|Withdrawal by Subject|2|||
46703638|NCT00960076|82918480|FG000|Overall Study|Lost to Follow-up|3|||
46703639|NCT00960076|82918481|FG001|Overall Study|Lost to Follow-up|3|||
46703640|NCT00960076|82918480|FG000|Overall Study|Severe non-compliance to protocol|1|||
46703641|NCT00960076|82918481|FG001|Overall Study|Severe non-compliance to protocol|2|||
46703642|NCT00960076|82918480|FG000|Overall Study|Hyperglycemia|1|||
46703643|NCT00960076|82918481|FG001|Overall Study|Hyperglycemia|5|||
46703644|NCT00960076|82918480|FG000|Overall Study|Did not attend the termination visit|0|||
46703645|NCT00960076|82918481|FG001|Overall Study|Did not attend the termination visit|1|||
46703646|NCT01227629|82918497|FG000|Overall Study|Adverse Event|2|||
46703647|NCT01227629|82918498|FG001|Overall Study|Adverse Event|2|||
46703648|NCT01227629|82918499|FG002|Overall Study|Adverse Event|1|||
46703649|NCT01227629|82918500|FG003|Overall Study|Adverse Event|6|||
46703650|NCT01227629|82918501|FG004|Overall Study|Adverse Event|1|||
46703651|NCT01227629|82918502|FG005|Overall Study|Adverse Event|1|||
46703652|NCT01227629|82918503|FG006|Overall Study|Adverse Event|6|||
46703653|NCT01227629|82918504|FG007|Overall Study|Adverse Event|6|||
46703654|NCT01227629|82918505|FG008|Overall Study|Adverse Event|4|||
46703655|NCT01227629|82918506|FG009|Overall Study|Adverse Event|0|||
46703656|NCT01227629|82918497|FG000|Overall Study|Protocol Violation|0|||
46703657|NCT01227629|82918498|FG001|Overall Study|Protocol Violation|0|||
46703658|NCT01227629|82918499|FG002|Overall Study|Protocol Violation|0|||
46703659|NCT01227629|82918500|FG003|Overall Study|Protocol Violation|1|||
46703660|NCT01227629|82918501|FG004|Overall Study|Protocol Violation|0|||
46988110|NCT02265705|83234507|FG002|Rescue Period|Lack of Efficacy|1|||
46703661|NCT01227629|82918502|FG005|Overall Study|Protocol Violation|0|||
46988111|NCT02265705|83234508|FG003|Rescue Period|Lack of Efficacy|0|||
46703662|NCT01227629|82918503|FG006|Overall Study|Protocol Violation|0|||
46703663|NCT01227629|82918504|FG007|Overall Study|Protocol Violation|0|||
46703664|NCT01227629|82918505|FG008|Overall Study|Protocol Violation|0|||
46703665|NCT01227629|82918506|FG009|Overall Study|Protocol Violation|0|||
46703666|NCT01227629|82918497|FG000|Overall Study|Lost to Follow-up|0|||
46703667|NCT01227629|82918498|FG001|Overall Study|Lost to Follow-up|0|||
46703668|NCT01227629|82918499|FG002|Overall Study|Lost to Follow-up|0|||
46703669|NCT01227629|82918500|FG003|Overall Study|Lost to Follow-up|0|||
46703670|NCT01227629|82918501|FG004|Overall Study|Lost to Follow-up|1|||
46703671|NCT01227629|82918502|FG005|Overall Study|Lost to Follow-up|0|||
46703672|NCT01227629|82918503|FG006|Overall Study|Lost to Follow-up|0|||
46703673|NCT01227629|82918504|FG007|Overall Study|Lost to Follow-up|0|||
46703674|NCT01227629|82918505|FG008|Overall Study|Lost to Follow-up|0|||
46703675|NCT01227629|82918506|FG009|Overall Study|Lost to Follow-up|0|||
46703676|NCT01227629|82918497|FG000|Overall Study|Withdrawal by Subject|0|||
46703677|NCT01227629|82918498|FG001|Overall Study|Withdrawal by Subject|0|||
46703678|NCT01227629|82918499|FG002|Overall Study|Withdrawal by Subject|0|||
46703679|NCT01227629|82918500|FG003|Overall Study|Withdrawal by Subject|0|||
46703680|NCT01227629|82918501|FG004|Overall Study|Withdrawal by Subject|0|||
46703681|NCT01227629|82918502|FG005|Overall Study|Withdrawal by Subject|0|||
46703682|NCT01227629|82918503|FG006|Overall Study|Withdrawal by Subject|2|||
46703683|NCT01227629|82918504|FG007|Overall Study|Withdrawal by Subject|0|||
46703684|NCT01227629|82918505|FG008|Overall Study|Withdrawal by Subject|0|||
46703685|NCT01227629|82918506|FG009|Overall Study|Withdrawal by Subject|1|||
46703686|NCT01227629|82918497|FG000|Overall Study|Other|0|||
46703687|NCT01227629|82918498|FG001|Overall Study|Other|0|||
46703688|NCT01227629|82918499|FG002|Overall Study|Other|0|||
46703689|NCT01227629|82918500|FG003|Overall Study|Other|1|||
46703690|NCT01227629|82918501|FG004|Overall Study|Other|0|||
46703691|NCT01227629|82918502|FG005|Overall Study|Other|0|||
46703692|NCT01227629|82918503|FG006|Overall Study|Other|0|||
46703693|NCT01227629|82918504|FG007|Overall Study|Other|0|||
46703694|NCT01227629|82918505|FG008|Overall Study|Other|2|||
46703695|NCT01227629|82918506|FG009|Overall Study|Other|1|||
46703696|NCT00963820|82918552|FG000|Dose Escalation Phase|Progressive Disease|3|||
46703697|NCT00963820|82918553|FG001|Dose Escalation Phase|Progressive Disease|3|||
46703698|NCT00963820|82918554|FG002|Dose Escalation Phase|Progressive Disease|3|||
46703699|NCT00963820|82918555|FG003|Dose Escalation Phase|Progressive Disease|3|||
46703700|NCT00963820|82918556|FG004|Dose Escalation Phase|Progressive Disease|4|||
46703701|NCT00963820|82918557|FG005|Dose Escalation Phase|Progressive Disease|3|||
46703702|NCT00963820|82918558|FG006|Dose Escalation Phase|Progressive Disease|3|||
46703703|NCT00963820|82918559|FG007|Dose Escalation Phase|Progressive Disease|2|||
46703704|NCT00963820|82918560|FG008|Dose Escalation Phase|Progressive Disease|0|||
46703705|NCT00963820|82918561|FG009|Dose Escalation Phase|Progressive Disease|0|||
46703706|NCT00963820|82918562|FG010|Dose Escalation Phase|Progressive Disease|0|||
46703707|NCT00963820|82918563|FG011|Dose Escalation Phase|Progressive Disease|0|||
46703708|NCT00963820|82918552|FG000|Dose Escalation Phase|Adverse Event|0|||
46703709|NCT00963820|82918553|FG001|Dose Escalation Phase|Adverse Event|0|||
46703710|NCT00963820|82918554|FG002|Dose Escalation Phase|Adverse Event|0|||
46703711|NCT00963820|82918555|FG003|Dose Escalation Phase|Adverse Event|0|||
46703712|NCT00963820|82918556|FG004|Dose Escalation Phase|Adverse Event|0|||
46703713|NCT00963820|82918557|FG005|Dose Escalation Phase|Adverse Event|0|||
46703714|NCT00963820|82918558|FG006|Dose Escalation Phase|Adverse Event|3|||
46703715|NCT00963820|82918559|FG007|Dose Escalation Phase|Adverse Event|1|||
46703716|NCT00963820|82918560|FG008|Dose Escalation Phase|Adverse Event|0|||
46703717|NCT00963820|82918561|FG009|Dose Escalation Phase|Adverse Event|0|||
46703718|NCT00963820|82918562|FG010|Dose Escalation Phase|Adverse Event|0|||
46703719|NCT00963820|82918563|FG011|Dose Escalation Phase|Adverse Event|0|||
46703720|NCT00963820|82918552|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
46703721|NCT00963820|82918553|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
46703722|NCT00963820|82918554|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
46703723|NCT00963820|82918555|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
46703724|NCT00963820|82918556|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
46703725|NCT00963820|82918557|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
46703726|NCT00963820|82918558|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
46703727|NCT00963820|82918559|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
46703728|NCT00963820|82918560|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
46703729|NCT00963820|82918561|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
46703730|NCT00963820|82918562|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
46703731|NCT00963820|82918563|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
46703732|NCT00963820|82918552|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703733|NCT00963820|82918553|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703734|NCT00963820|82918554|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703735|NCT00963820|82918555|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703736|NCT00963820|82918556|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703737|NCT00963820|82918557|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703738|NCT00963820|82918558|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
46703739|NCT00963820|82918559|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703740|NCT00963820|82918560|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703741|NCT00963820|82918561|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703742|NCT00963820|82918562|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703743|NCT00963820|82918563|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
46703744|NCT00963820|82918552|FG000|Expansion Phase|Progressive Disease|0|||
46703745|NCT00963820|82918553|FG001|Expansion Phase|Progressive Disease|0|||
46703746|NCT00963820|82918554|FG002|Expansion Phase|Progressive Disease|0|||
46703747|NCT00963820|82918555|FG003|Expansion Phase|Progressive Disease|0|||
46703748|NCT00963820|82918556|FG004|Expansion Phase|Progressive Disease|0|||
46703749|NCT00963820|82918557|FG005|Expansion Phase|Progressive Disease|0|||
46703750|NCT00963820|82918558|FG006|Expansion Phase|Progressive Disease|0|||
46703751|NCT00963820|82918559|FG007|Expansion Phase|Progressive Disease|0|||
46703752|NCT00963820|82918560|FG008|Expansion Phase|Progressive Disease|8|||
46703753|NCT00963820|82918561|FG009|Expansion Phase|Progressive Disease|6|||
46703754|NCT00963820|82918562|FG010|Expansion Phase|Progressive Disease|4|||
46703755|NCT00963820|82918563|FG011|Expansion Phase|Progressive Disease|2|||
46703756|NCT00963820|82918552|FG000|Expansion Phase|Adverse Event|0|||
46703757|NCT00963820|82918553|FG001|Expansion Phase|Adverse Event|0|||
46703758|NCT00963820|82918554|FG002|Expansion Phase|Adverse Event|0|||
46703759|NCT00963820|82918555|FG003|Expansion Phase|Adverse Event|0|||
46703760|NCT00963820|82918556|FG004|Expansion Phase|Adverse Event|0|||
46703761|NCT00963820|82918557|FG005|Expansion Phase|Adverse Event|0|||
46703762|NCT00963820|82918558|FG006|Expansion Phase|Adverse Event|0|||
46703763|NCT00963820|82918559|FG007|Expansion Phase|Adverse Event|0|||
46703764|NCT00963820|82918560|FG008|Expansion Phase|Adverse Event|1|||
46703765|NCT00963820|82918561|FG009|Expansion Phase|Adverse Event|3|||
46703766|NCT00963820|82918562|FG010|Expansion Phase|Adverse Event|0|||
46703767|NCT00963820|82918563|FG011|Expansion Phase|Adverse Event|0|||
46703768|NCT00963820|82918552|FG000|Expansion Phase|Withdrawal by Subject|0|||
46703769|NCT00963820|82918553|FG001|Expansion Phase|Withdrawal by Subject|0|||
46703770|NCT00963820|82918554|FG002|Expansion Phase|Withdrawal by Subject|0|||
46703771|NCT00963820|82918555|FG003|Expansion Phase|Withdrawal by Subject|0|||
46703772|NCT00963820|82918556|FG004|Expansion Phase|Withdrawal by Subject|0|||
46703773|NCT00963820|82918557|FG005|Expansion Phase|Withdrawal by Subject|0|||
46703774|NCT00963820|82918558|FG006|Expansion Phase|Withdrawal by Subject|0|||
46703775|NCT00963820|82918559|FG007|Expansion Phase|Withdrawal by Subject|0|||
46703776|NCT00963820|82918560|FG008|Expansion Phase|Withdrawal by Subject|1|||
46703777|NCT00963820|82918561|FG009|Expansion Phase|Withdrawal by Subject|0|||
46703778|NCT00963820|82918562|FG010|Expansion Phase|Withdrawal by Subject|1|||
46703779|NCT00963820|82918563|FG011|Expansion Phase|Withdrawal by Subject|1|||
46703780|NCT00963820|82918552|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703781|NCT00963820|82918553|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703782|NCT00963820|82918554|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703783|NCT00963820|82918555|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703784|NCT00963820|82918556|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703785|NCT00963820|82918557|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703786|NCT00963820|82918558|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703787|NCT00963820|82918559|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703788|NCT00963820|82918560|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703789|NCT00963820|82918561|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703790|NCT00963820|82918562|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
46703791|NCT00963820|82918563|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
46703792|NCT01227395|82918582|FG000|Overall Study|Protocol Violation|0|||
46703793|NCT01227395|82918583|FG001|Overall Study|Protocol Violation|1|||
46703794|NCT01226459|82918610|FG000|Overall Study|Adverse Event|2|||
46703795|NCT01226459|82918611|FG001|Overall Study|Adverse Event|8|||
46703796|NCT01226459|82918610|FG000|Overall Study|Protocol Violation|4|||
46703797|NCT01226459|82918611|FG001|Overall Study|Protocol Violation|3|||
46703798|NCT01226459|82918610|FG000|Overall Study|Withdrawal by Subject|10|||
46703799|NCT01226459|82918611|FG001|Overall Study|Withdrawal by Subject|13|||
46703800|NCT01226459|82918610|FG000|Overall Study|Lost to Follow-up|4|||
46703801|NCT01226459|82918611|FG001|Overall Study|Lost to Follow-up|8|||
46703802|NCT01226459|82918610|FG000|Overall Study|Pregnancy|1|||
46703803|NCT01226459|82918611|FG001|Overall Study|Pregnancy|0|||
46703804|NCT01225991|82918617|FG000|Overall Study|Withdrawal by Subject|6|||
46703805|NCT00959374|82918621|FG000|Overall Study|Withdrawal by Subject|2|||
46703806|NCT00959374|82918621|FG000|Overall Study|Lost to Follow-up|14|||
46703807|NCT00959374|82918621|FG000|Overall Study|Death|1|||
46703808|NCT00959374|82918621|FG000|Overall Study|Protocol Violation|1|||
46703809|NCT00959374|82918621|FG000|Overall Study|Implant Removed/Not Replaced|4|||
46703810|NCT00959374|82918621|FG000|Overall Study|Physician Decision|1|||
46703811|NCT01225835|82918631|FG000|Overall Study|Completed protocol|2|||
46703812|NCT01225835|82918632|FG001|Overall Study|Completed protocol|1|||
46703813|NCT01225835|82918631|FG000|Overall Study|Did not meet hCG criterion|2|||
46703814|NCT01225835|82918632|FG001|Overall Study|Did not meet hCG criterion|0|||
46703815|NCT01225835|82918631|FG000|Overall Study|Adverse Event|2|||
46703816|NCT01225835|82918632|FG001|Overall Study|Adverse Event|1|||
46703817|NCT01225835|82918631|FG000|Overall Study|Other|1|||
46703818|NCT01225835|82918632|FG001|Overall Study|Other|1|||
46703819|NCT00962650|82918644|FG000|Overall Study|Transgastric DP was not completed|2|||
46703820|NCT00958828|82918652|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
46703821|NCT00958828|82918653|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
46703822|NCT00958828|82918652|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
46703823|NCT00958828|82918653|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
46703824|NCT00960934|82918665|FG000|Overall Study|Adverse Event|2|||
46703825|NCT00960934|82918666|FG001|Overall Study|Adverse Event|3|||
46703826|NCT00960934|82918667|FG002|Overall Study|Adverse Event|3|||
46703827|NCT00960934|82918668|FG003|Overall Study|Adverse Event|2|||
46703828|NCT00960934|82918669|FG004|Overall Study|Adverse Event|4|||
46703829|NCT00960934|82918670|FG005|Overall Study|Adverse Event|3|||
46703830|NCT00960934|82918665|FG000|Overall Study|Lack of Efficacy|1|||
46703831|NCT00960934|82918666|FG001|Overall Study|Lack of Efficacy|0|||
46703832|NCT00960934|82918667|FG002|Overall Study|Lack of Efficacy|0|||
46703833|NCT00960934|82918668|FG003|Overall Study|Lack of Efficacy|0|||
46703834|NCT00960934|82918669|FG004|Overall Study|Lack of Efficacy|0|||
46988112|NCT02265705|83234509|FG004|Rescue Period|Lack of Efficacy|0|||
46988113|NCT02265705|83234510|FG005|Rescue Period|Lack of Efficacy|0|||
46988114|NCT02265705|83234511|FG006|Rescue Period|Lack of Efficacy|0|||
46988115|NCT02265705|83234505|FG000|Open Label Period|Adverse Event|0|||
46988116|NCT02265705|83234506|FG001|Open Label Period|Adverse Event|0|||
46703835|NCT00960934|82918670|FG005|Overall Study|Lack of Efficacy|0|||
46703836|NCT00960934|82918665|FG000|Overall Study|Lost to Follow-up|0|||
46988117|NCT02265705|83234507|FG002|Open Label Period|Adverse Event|0|||
46988118|NCT02265705|83234508|FG003|Open Label Period|Adverse Event|2|||
46988119|NCT02265705|83234509|FG004|Open Label Period|Adverse Event|2|||
46703837|NCT00960934|82918666|FG001|Overall Study|Lost to Follow-up|1|||
46703838|NCT00960934|82918667|FG002|Overall Study|Lost to Follow-up|0|||
46703839|NCT00960934|82918668|FG003|Overall Study|Lost to Follow-up|0|||
46703840|NCT00960934|82918669|FG004|Overall Study|Lost to Follow-up|0|||
46703841|NCT00960934|82918670|FG005|Overall Study|Lost to Follow-up|0|||
46703842|NCT00960934|82918665|FG000|Overall Study|Other|2|||
46988120|NCT02265705|83234510|FG005|Open Label Period|Adverse Event|0|||
46703843|NCT00960934|82918666|FG001|Overall Study|Other|1|||
46703844|NCT00960934|82918667|FG002|Overall Study|Other|5|||
46703845|NCT00960934|82918668|FG003|Overall Study|Other|4|||
46703846|NCT00960934|82918669|FG004|Overall Study|Other|2|||
46703847|NCT00960934|82918670|FG005|Overall Study|Other|2|||
46703848|NCT00960934|82918665|FG000|Overall Study|Physician Decision|0|||
46703849|NCT00960934|82918666|FG001|Overall Study|Physician Decision|1|||
46703850|NCT00960934|82918667|FG002|Overall Study|Physician Decision|0|||
46703851|NCT00960934|82918668|FG003|Overall Study|Physician Decision|0|||
46703852|NCT00960934|82918669|FG004|Overall Study|Physician Decision|0|||
46703853|NCT00960934|82918670|FG005|Overall Study|Physician Decision|0|||
46703854|NCT00960934|82918665|FG000|Overall Study|Progressive Disease|1|||
46703855|NCT00960934|82918666|FG001|Overall Study|Progressive Disease|1|||
46703856|NCT00960934|82918667|FG002|Overall Study|Progressive Disease|0|||
46703857|NCT00960934|82918668|FG003|Overall Study|Progressive Disease|0|||
46703858|NCT00960934|82918669|FG004|Overall Study|Progressive Disease|1|||
46703859|NCT00960934|82918670|FG005|Overall Study|Progressive Disease|1|||
46703860|NCT00960934|82918665|FG000|Overall Study|Protocol Violation|3|||
46703861|NCT00960934|82918666|FG001|Overall Study|Protocol Violation|4|||
46703862|NCT00960934|82918667|FG002|Overall Study|Protocol Violation|0|||
46703863|NCT00960934|82918668|FG003|Overall Study|Protocol Violation|3|||
46703864|NCT00960934|82918669|FG004|Overall Study|Protocol Violation|3|||
46703865|NCT00960934|82918670|FG005|Overall Study|Protocol Violation|2|||
46703866|NCT00960934|82918665|FG000|Overall Study|Withdrawal by Subject|5|||
46703867|NCT00960934|82918666|FG001|Overall Study|Withdrawal by Subject|6|||
46703868|NCT00960934|82918667|FG002|Overall Study|Withdrawal by Subject|4|||
46703869|NCT00960934|82918668|FG003|Overall Study|Withdrawal by Subject|5|||
46703870|NCT00960934|82918669|FG004|Overall Study|Withdrawal by Subject|5|||
46703871|NCT00960934|82918670|FG005|Overall Study|Withdrawal by Subject|7|||
46703872|NCT00960934|82918665|FG000|Overall Study|Study Terminated by Sponsor|50|||
46703873|NCT00960934|82918666|FG001|Overall Study|Study Terminated by Sponsor|46|||
46703874|NCT00960934|82918667|FG002|Overall Study|Study Terminated by Sponsor|52|||
46703875|NCT00960934|82918668|FG003|Overall Study|Study Terminated by Sponsor|50|||
46703876|NCT00960934|82918669|FG004|Overall Study|Study Terminated by Sponsor|49|||
46703877|NCT00960934|82918670|FG005|Overall Study|Study Terminated by Sponsor|49|||
46703878|NCT00892177|82918687|FG000|Phase II|Ineligible|0|||
46703879|NCT00892177|82918688|FG001|Phase II|Ineligible|0|||
46703880|NCT00892177|82918689|FG002|Phase II|Ineligible|0|||
46703881|NCT00892177|82918690|FG003|Phase II|Ineligible|0|||
46703882|NCT00892177|82918691|FG004|Phase II|Ineligible|1|||
46703883|NCT00892177|82918692|FG005|Phase II|Ineligible|1|||
46703884|NCT00892177|82918687|FG000|Phase II|Withdrawal by Subject|0|||
46703885|NCT00892177|82918688|FG001|Phase II|Withdrawal by Subject|0|||
46703886|NCT00892177|82918689|FG002|Phase II|Withdrawal by Subject|0|||
46703887|NCT00892177|82918690|FG003|Phase II|Withdrawal by Subject|0|||
46703888|NCT00892177|82918691|FG004|Phase II|Withdrawal by Subject|4|||
46703889|NCT00892177|82918692|FG005|Phase II|Withdrawal by Subject|1|||
46703890|NCT00962104|82918709|FG000|Overall Study|Adverse Event|10|||
46703891|NCT00962104|82918710|FG001|Overall Study|Adverse Event|3|||
46703892|NCT00962104|82918709|FG000|Overall Study|Entry Criteria Not Met|1|||
46703893|NCT00962104|82918710|FG001|Overall Study|Entry Criteria Not Met|2|||
46703894|NCT00962104|82918709|FG000|Overall Study|Lack of Efficacy|0|||
46703895|NCT00962104|82918710|FG001|Overall Study|Lack of Efficacy|1|||
46703896|NCT00962104|82918709|FG000|Overall Study|Lost to Follow-up|10|||
46703897|NCT00962104|82918710|FG001|Overall Study|Lost to Follow-up|4|||
46703898|NCT00962104|82918709|FG000|Overall Study|Physician Decision|1|||
46703899|NCT00962104|82918710|FG001|Overall Study|Physician Decision|0|||
46703900|NCT00962104|82918709|FG000|Overall Study|Protocol Violation|6|||
46703901|NCT00962104|82918710|FG001|Overall Study|Protocol Violation|8|||
46703902|NCT00962104|82918709|FG000|Overall Study|Sponsor Decision|0|||
46703903|NCT00962104|82918710|FG001|Overall Study|Sponsor Decision|1|||
46703904|NCT00962104|82918709|FG000|Overall Study|Withdrawal by Subject|10|||
46703905|NCT00962104|82918710|FG001|Overall Study|Withdrawal by Subject|6|||
46703906|NCT00962104|82918709|FG000|Overall Study|Other|2|||
46703907|NCT00962104|82918710|FG001|Overall Study|Other|0|||
46703908|NCT02821000|82918716|FG000|Overall Study|Death|44|||
46703909|NCT02821000|82918716|FG000|Overall Study|Withdrawal by Subject|1|||
46703910|NCT02821000|82918716|FG000|Overall Study|Ongoing in Study|58|||
46703911|NCT00892099|82918723|FG000|Overall Study|Death|1|||
46703912|NCT00892099|82918724|FG001|Overall Study|Death|0|||
46703913|NCT00892099|82918725|FG002|Overall Study|Death|1|||
46703914|NCT00892099|82918723|FG000|Overall Study|Adverse Event|1|||
46703915|NCT00892099|82918724|FG001|Overall Study|Adverse Event|0|||
46703916|NCT00892099|82918725|FG002|Overall Study|Adverse Event|0|||
46703917|NCT00892099|82918723|FG000|Overall Study|replocated|1|||
46988121|NCT02265705|83234511|FG006|Open Label Period|Adverse Event|0|||
46703918|NCT00892099|82918724|FG001|Overall Study|replocated|0|||
46703919|NCT00892099|82918725|FG002|Overall Study|replocated|2|||
46703920|NCT00892099|82918723|FG000|Overall Study|Prolonged hospitalization|1|||
46703921|NCT00892099|82918724|FG001|Overall Study|Prolonged hospitalization|0|||
46703922|NCT00892099|82918725|FG002|Overall Study|Prolonged hospitalization|1|||
46703923|NCT00892099|82918723|FG000|Overall Study|no further details|1|||
46703924|NCT00892099|82918724|FG001|Overall Study|no further details|0|||
46703925|NCT00892099|82918725|FG002|Overall Study|no further details|1|||
46703926|NCT00892099|82918723|FG000|Overall Study|kidney function recovered|0|||
46703927|NCT00892099|82918724|FG001|Overall Study|kidney function recovered|1|||
46703928|NCT00892099|82918725|FG002|Overall Study|kidney function recovered|0|||
46703929|NCT00892099|82918723|FG000|Overall Study|investigator decision|0|||
46703930|NCT00892099|82918724|FG001|Overall Study|investigator decision|0|||
46703931|NCT00892099|82918725|FG002|Overall Study|investigator decision|1|||
46703932|NCT00892099|82918723|FG000|Overall Study|Lost to Follow-up|0|||
46703933|NCT00892099|82918724|FG001|Overall Study|Lost to Follow-up|0|||
46703934|NCT00892099|82918725|FG002|Overall Study|Lost to Follow-up|1|||
46703935|NCT00960856|82918733|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
46703936|NCT00960856|82918734|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
46703937|NCT00960856|82918735|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
46703938|NCT00960856|82918736|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
46703939|NCT00960856|82918733|FG000|Washout Period of 7 Days|Adverse Event|0|||
46880036|NCT00104104|83101264|FG001|Overall Study|Withdrawal by Subject|15|||
46880037|NCT00104104|83101263|FG000|Overall Study|Lost to Follow-up|3|||
46880038|NCT00104104|83101264|FG001|Overall Study|Lost to Follow-up|7|||
46880039|NCT00104104|83101263|FG000|Overall Study|Administrative problems|12|||
46880040|NCT00104104|83101264|FG001|Overall Study|Administrative problems|13|||
46703940|NCT00960856|82918734|FG001|Washout Period of 7 Days|Adverse Event|0|||
46703941|NCT00960856|82918735|FG002|Washout Period of 7 Days|Adverse Event|1|||
46703942|NCT00960856|82918736|FG003|Washout Period of 7 Days|Adverse Event|0|||
46880041|NCT00104104|83101263|FG000|Overall Study|Death|9|||
46880042|NCT00104104|83101264|FG001|Overall Study|Death|6|||
46703943|NCT00958438|82918749|FG000|Overall Study|Protocol Violation|3|||
46703944|NCT00958438|82918750|FG001|Overall Study|Protocol Violation|2|||
46703945|NCT00958438|82918751|FG002|Overall Study|Protocol Violation|2|||
46703946|NCT00958438|82918749|FG000|Overall Study|Withdrawal by Subject|4|||
46703947|NCT00958438|82918750|FG001|Overall Study|Withdrawal by Subject|2|||
46880043|NCT03557151|83101272|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
46880044|NCT03557151|83101273|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
46880045|NCT03557151|83101272|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
46880046|NCT03557151|83101273|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
46703948|NCT00958438|82918751|FG002|Overall Study|Withdrawal by Subject|1|||
46880047|NCT03557151|83101272|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
46880048|NCT03557151|83101273|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
46880049|NCT00115739|83101281|FG000|Overall Study|Lost to Follow-up|3|||
46880050|NCT01347086|83101297|FG000|Overall Study|failed screening visit|0|||
46880051|NCT01347086|83101298|FG001|Overall Study|failed screening visit|0|||
46880052|NCT01347086|83101299|FG002|Overall Study|failed screening visit|1|||
46880053|NCT01347086|83101300|FG003|Overall Study|failed screening visit|0|||
46880054|NCT01347086|83101301|FG004|Overall Study|failed screening visit|0|||
46880055|NCT01347086|83101302|FG005|Overall Study|failed screening visit|0|||
46880056|NCT01347086|83101303|FG006|Overall Study|failed screening visit|1|||
46880057|NCT01347086|83101304|FG007|Overall Study|failed screening visit|1|||
46880058|NCT01347086|83101305|FG008|Overall Study|failed screening visit|0|||
46880059|NCT01347086|83101306|FG009|Overall Study|failed screening visit|1|||
46880060|NCT03605745|83101338|FG000|Overall Study|Study was terminated for business reasons|47|||
46880061|NCT03246152|83101342|FG000|Overall Study|Lost to Follow-up|2|||
46880062|NCT03246152|83101342|FG000|Overall Study|Protocol Violation|1|||
46880063|NCT03571581|83101346|FG000|Overall Study|Death|2|||
46880064|NCT03571581|83101346|FG000|Overall Study|Withdrawal by Subject|2|||
46880065|NCT00115349|83101355|FG000|Overall Study|Study closed due to low enrollment.|11|||
46880066|NCT00115349|83101356|FG001|Overall Study|Study closed due to low enrollment.|9|||
46880067|NCT00115037|83101364|FG000|Phase1|Lost to Follow-up|16|||
46880068|NCT00115037|83101365|FG001|Phase1|Lost to Follow-up|23|||
46880069|NCT00115037|83101366|FG002|Phase1|Lost to Follow-up|0|||
46880070|NCT00115037|83101367|FG003|Phase1|Lost to Follow-up|0|||
46880071|NCT00115037|83101368|FG004|Phase1|Lost to Follow-up|0|||
46880072|NCT00115037|83101369|FG005|Phase1|Lost to Follow-up|0|||
46880073|NCT00115037|83101364|FG000|Phase1|Withdrawal by Subject|9|||
46880074|NCT00115037|83101365|FG001|Phase1|Withdrawal by Subject|4|||
46880075|NCT00115037|83101366|FG002|Phase1|Withdrawal by Subject|0|||
46880076|NCT00115037|83101367|FG003|Phase1|Withdrawal by Subject|0|||
46880077|NCT00115037|83101368|FG004|Phase1|Withdrawal by Subject|0|||
46880078|NCT00115037|83101369|FG005|Phase1|Withdrawal by Subject|0|||
46880079|NCT00115037|83101364|FG000|Phase2|Death|0|||
46880080|NCT00115037|83101365|FG001|Phase2|Death|0|||
46880081|NCT00115037|83101366|FG002|Phase2|Death|1|||
46880082|NCT00115037|83101367|FG003|Phase2|Death|0|||
46880083|NCT00115037|83101368|FG004|Phase2|Death|0|||
46880084|NCT00115037|83101369|FG005|Phase2|Death|1|||
46880085|NCT00115037|83101364|FG000|Phase2|Withdrawal by Subject|0|||
46880086|NCT00115037|83101365|FG001|Phase2|Withdrawal by Subject|0|||
46880087|NCT00115037|83101366|FG002|Phase2|Withdrawal by Subject|2|||
46880088|NCT00115037|83101367|FG003|Phase2|Withdrawal by Subject|1|||
46880089|NCT00115037|83101368|FG004|Phase2|Withdrawal by Subject|2|||
46880090|NCT00115037|83101369|FG005|Phase2|Withdrawal by Subject|1|||
46880091|NCT00115037|83101364|FG000|Phase2|Lost to Follow-up|0|||
46880092|NCT00115037|83101365|FG001|Phase2|Lost to Follow-up|0|||
46880093|NCT00115037|83101366|FG002|Phase2|Lost to Follow-up|12|||
46880094|NCT00115037|83101367|FG003|Phase2|Lost to Follow-up|14|||
46880095|NCT00115037|83101368|FG004|Phase2|Lost to Follow-up|4|||
46880096|NCT00115037|83101369|FG005|Phase2|Lost to Follow-up|10|||
46880097|NCT03214640|83101387|FG000|Overall Study|Protocol Violation|1|||
46880098|NCT03214640|83101388|FG001|Overall Study|Protocol Violation|2|||
46880099|NCT03214640|83101389|FG002|Overall Study|Protocol Violation|1|||
46880100|NCT03214640|83101390|FG003|Overall Study|Protocol Violation|4|||
46880101|NCT03214406|83101402|FG000|Overall Study|did not meet enrollment criteria|9|||
46880102|NCT03214406|83101403|FG001|Overall Study|did not meet enrollment criteria|13|||
46988122|NCT02265705|83234505|FG000|Open Label Period|Physician Decision|0|||
46988123|NCT02265705|83234506|FG001|Open Label Period|Physician Decision|0|||
46988124|NCT02265705|83234507|FG002|Open Label Period|Physician Decision|0|||
46988125|NCT02265705|83234508|FG003|Open Label Period|Physician Decision|0|||
46988126|NCT02265705|83234509|FG004|Open Label Period|Physician Decision|1|||
46988127|NCT02265705|83234510|FG005|Open Label Period|Physician Decision|0|||
46988128|NCT02265705|83234511|FG006|Open Label Period|Physician Decision|0|||
46988129|NCT02265705|83234505|FG000|Open Label Period|Withdrawal by Subject|0|||
46988130|NCT02265705|83234506|FG001|Open Label Period|Withdrawal by Subject|0|||
46988131|NCT02265705|83234507|FG002|Open Label Period|Withdrawal by Subject|0|||
46988132|NCT02265705|83234508|FG003|Open Label Period|Withdrawal by Subject|0|||
46988133|NCT02265705|83234509|FG004|Open Label Period|Withdrawal by Subject|2|||
46988134|NCT02265705|83234510|FG005|Open Label Period|Withdrawal by Subject|0|||
46988135|NCT02265705|83234511|FG006|Open Label Period|Withdrawal by Subject|0|||
46988136|NCT02265705|83234505|FG000|Follow-up Period|Sponsor Decision|0|||
46988137|NCT02265705|83234506|FG001|Follow-up Period|Sponsor Decision|0|||
46880103|NCT03214406|83101402|FG000|Overall Study|Withdrawal by Subject|1|||
46880104|NCT03214406|83101403|FG001|Overall Study|Withdrawal by Subject|0|||
46880105|NCT03214406|83101402|FG000|Overall Study|Lost to Follow-up|0|||
46880106|NCT03214406|83101403|FG001|Overall Study|Lost to Follow-up|2|||
46880107|NCT03213938|83101411|FG000|Overall Study|Lost to Follow-up|4|||
46880108|NCT03213938|83101412|FG001|Overall Study|Lost to Follow-up|3|||
46880109|NCT03213938|83101411|FG000|Overall Study|Lack of Efficacy|1|||
46880110|NCT03213938|83101412|FG001|Overall Study|Lack of Efficacy|0|||
46880111|NCT03213938|83101411|FG000|Overall Study|Decline to participate|5|||
46988138|NCT02265705|83234507|FG002|Follow-up Period|Sponsor Decision|0|||
46988139|NCT02265705|83234508|FG003|Follow-up Period|Sponsor Decision|0|||
46988140|NCT02265705|83234509|FG004|Follow-up Period|Sponsor Decision|0|||
46703949|NCT00958438|82918749|FG000|Overall Study|Adverse Event|0|||
46703950|NCT00958438|82918750|FG001|Overall Study|Adverse Event|3|||
46802868|NCT00423670|83022129|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
46802869|NCT00423670|83022130|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
46802870|NCT00423670|83022131|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
46802871|NCT00423670|83022132|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
46802872|NCT00423670|83022125|FG000|Treatment Period|Investigator decision|0|||
46802873|NCT00423670|83022126|FG001|Treatment Period|Investigator decision|0|||
46802874|NCT00423670|83022127|FG002|Treatment Period|Investigator decision|0|||
46802875|NCT00423670|83022128|FG003|Treatment Period|Investigator decision|0|||
46802876|NCT00423670|83022129|FG004|Treatment Period|Investigator decision|0|||
46802877|NCT00423670|83022130|FG005|Treatment Period|Investigator decision|0|||
46802878|NCT00423670|83022131|FG006|Treatment Period|Investigator decision|0|||
46880112|NCT03213938|83101412|FG001|Overall Study|Decline to participate|4|||
46880113|NCT03213938|83101411|FG000|Overall Study|Without reason|4|||
46880114|NCT03213938|83101412|FG001|Overall Study|Without reason|5|||
46880115|NCT03604497|83101418|FG000|Overall Study|Protocol Violation|52|||
46880116|NCT03213626|83101426|FG000|Overall Study|Adverse Event|1|||
46880117|NCT03213626|83101426|FG000|Overall Study|Progressive Disease|6|||
46880118|NCT03604341|83101432|FG000|Overall Study|Withdrawal by Subject|1|||
46880119|NCT03604341|83101433|FG001|Overall Study|Withdrawal by Subject|1|||
46880120|NCT03604341|83101432|FG000|Overall Study|Adverse Event|1|||
46880121|NCT03604341|83101433|FG001|Overall Study|Adverse Event|0|||
46880122|NCT03604341|83101432|FG000|Overall Study|Protocol Violation|0|||
46880123|NCT03604341|83101433|FG001|Overall Study|Protocol Violation|1|||
46880124|NCT03603639|83101439|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
46880125|NCT03603639|83101440|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
46880126|NCT03603639|83101441|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
46880127|NCT03603639|83101442|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
46880128|NCT03603639|83101443|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
46880129|NCT03603639|83101444|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
46880130|NCT03603639|83101439|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
46880131|NCT03603639|83101440|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
46880132|NCT03603639|83101441|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
46880133|NCT03603639|83101442|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
46880134|NCT03603639|83101443|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
46880135|NCT03603639|83101444|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
46880136|NCT00114959|83101454|FG000|Overall Study|Lack of Efficacy|6|||
46880137|NCT00114959|83101454|FG000|Overall Study|Physician Decision|1|||
46880138|NCT00114959|83101454|FG000|Overall Study|Death|1|||
46880139|NCT02778100|83101460|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
46880140|NCT02778100|83101461|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
46880141|NCT00118157|83101469|FG000|Overall Study|Adverse Event|2|||
46880142|NCT00118157|83101469|FG000|Overall Study|Death|8|||
46880143|NCT00118157|83101469|FG000|Overall Study|Withdrawal by Subject|2|||
46880144|NCT02762500|83101476|FG000|Overall Study|Lack of Efficacy|1|||
46880145|NCT02762500|83101477|FG001|Overall Study|Lack of Efficacy|0|||
46880146|NCT02762500|83101476|FG000|Overall Study|Withdrawal by Subject|1|||
46880147|NCT02762500|83101477|FG001|Overall Study|Withdrawal by Subject|1|||
46880148|NCT02762500|83101476|FG000|Overall Study|Adverse Event|0|||
46880149|NCT02762500|83101477|FG001|Overall Study|Adverse Event|2|||
46880150|NCT03552549|83101485|FG000|Overall Study|Disease progression|25|||
46880151|NCT03552549|83101486|FG001|Overall Study|Disease progression|17|||
46880152|NCT03552549|83101485|FG000|Overall Study|Adverse event in first 12 months|12|||
46880153|NCT03552549|83101486|FG001|Overall Study|Adverse event in first 12 months|8|||
46880154|NCT03552549|83101485|FG000|Overall Study|Withdrawal by Subject|7|||
46880155|NCT03552549|83101486|FG001|Overall Study|Withdrawal by Subject|7|||
46880156|NCT03552549|83101485|FG000|Overall Study|Unknown (no reason provided)|4|||
46880157|NCT03552549|83101486|FG001|Overall Study|Unknown (no reason provided)|2|||
46880158|NCT03552549|83101485|FG000|Overall Study|Not in participant's best interest|2|||
46880159|NCT03552549|83101486|FG001|Overall Study|Not in participant's best interest|1|||
46880160|NCT03552549|83101485|FG000|Overall Study|Did not complete study treatment|2|||
46880161|NCT03552549|83101486|FG001|Overall Study|Did not complete study treatment|3|||
46880162|NCT03552549|83101485|FG000|Overall Study|Did not meet eligibility criteria|1|||
46880163|NCT03552549|83101486|FG001|Overall Study|Did not meet eligibility criteria|0|||
46880164|NCT03552549|83101485|FG000|Overall Study|Administrative|0|||
46880165|NCT03552549|83101486|FG001|Overall Study|Administrative|14|||
46880166|NCT00117845|83101492|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
46880167|NCT02761642|83101496|FG000|Overall Study|Did not Receive Study Treatment|3|||
46880168|NCT02761642|83101496|FG000|Overall Study|Adverse Event|13|||
46880169|NCT02761642|83101496|FG000|Overall Study|Withdrawal by Subject|2|||
46880170|NCT02761642|83101496|FG000|Overall Study|Non-compliant|7|||
46880171|NCT02761642|83101496|FG000|Overall Study|Death|3|||
46988141|NCT02265705|83234510|FG005|Follow-up Period|Sponsor Decision|1|||
46988142|NCT02265705|83234511|FG006|Follow-up Period|Sponsor Decision|6|||
46988143|NCT02265705|83234505|FG000|Follow-up Period|Adverse Event|0|||
46988144|NCT02265705|83234506|FG001|Follow-up Period|Adverse Event|0|||
46703951|NCT00958438|82918751|FG002|Overall Study|Adverse Event|0|||
46880172|NCT02761642|83101496|FG000|Overall Study|Lack of Efficacy|20|||
46880173|NCT02761642|83101496|FG000|Overall Study|Physician Decision|1|||
46880174|NCT02761642|83101496|FG000|Overall Study|Reason Unspecified|21|||
46880175|NCT00113555|83101500|FG000|Overall Study|Baseline Failure|59|||
46880176|NCT00113555|83101500|FG000|Overall Study|Permanently Explanted|7|||
46880177|NCT00113555|83101500|FG000|Overall Study|Death|1|||
46880178|NCT00113555|83101500|FG000|Overall Study|Missed Followup|4|||
46880179|NCT00113555|83101500|FG000|Overall Study|Lost to Follow-up|8|||
46880180|NCT03189524|83101508|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
46988145|NCT02265705|83234507|FG002|Follow-up Period|Adverse Event|0|||
46880181|NCT03189524|83101509|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
46880182|NCT03189524|83101510|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
46880183|NCT03189524|83101508|FG000|Overall Study|Death|2|||
46880184|NCT03189524|83101509|FG001|Overall Study|Death|2|||
46880185|NCT03189524|83101510|FG002|Overall Study|Death|1|||
46880186|NCT03189524|83101508|FG000|Overall Study|Lost to Follow-up|1|||
46880187|NCT03189524|83101509|FG001|Overall Study|Lost to Follow-up|0|||
46880188|NCT03189524|83101510|FG002|Overall Study|Lost to Follow-up|8|||
46880189|NCT03189524|83101508|FG000|Overall Study|Withdrawal by Subject|1|||
46880190|NCT03189524|83101509|FG001|Overall Study|Withdrawal by Subject|1|||
46880191|NCT03189524|83101510|FG002|Overall Study|Withdrawal by Subject|3|||
46880192|NCT03189524|83101508|FG000|Overall Study|Progressive Disease|0|||
46880193|NCT03189524|83101509|FG001|Overall Study|Progressive Disease|2|||
46880194|NCT03189524|83101510|FG002|Overall Study|Progressive Disease|0|||
46880195|NCT03600909|83101525|FG000|Overall Study|Not treated|0|||
46880196|NCT03600909|83101526|FG001|Overall Study|Not treated|3|||
46880197|NCT03600909|83101527|FG002|Overall Study|Not treated|0|||
46880198|NCT03212690|83101535|FG000|Overall Study|Protocol Violation|1|||
46880199|NCT03188120|83101539|FG000|Overall Study|Adverse Event|4|||
46880200|NCT03188120|83101539|FG000|Overall Study|Insufficient Effectiveness|8|||
46880201|NCT03188120|83101539|FG000|Overall Study|Improved|12|||
46880202|NCT03188120|83101539|FG000|Overall Study|Lost to Follow-up|7|||
46880203|NCT03188120|83101539|FG000|Overall Study|Other than specified|3|||
46880204|NCT03188120|83101539|FG000|Overall Study|No visit after the first visit|13|||
46880205|NCT02895945|83101545|FG000|Overall Study|Physician Decision|2|||
46880206|NCT02895945|83101546|FG001|Overall Study|Physician Decision|1|||
46880207|NCT02777554|83101554|FG000|Overall Study|Adverse Event|4|||
46880208|NCT02777554|83101555|FG001|Overall Study|Adverse Event|4|||
46880209|NCT02777554|83101556|FG002|Overall Study|Adverse Event|0|||
46880210|NCT02777554|83101557|FG003|Overall Study|Adverse Event|1|||
46880211|NCT02777554|83101558|FG004|Overall Study|Adverse Event|0|||
46880212|NCT02777554|83101559|FG005|Overall Study|Adverse Event|0|||
46880213|NCT02777554|83101554|FG000|Overall Study|Withdrawal by Subject|3|||
46880214|NCT02777554|83101555|FG001|Overall Study|Withdrawal by Subject|1|||
46880215|NCT02777554|83101556|FG002|Overall Study|Withdrawal by Subject|1|||
46880216|NCT02777554|83101557|FG003|Overall Study|Withdrawal by Subject|0|||
46880217|NCT02777554|83101558|FG004|Overall Study|Withdrawal by Subject|0|||
46880218|NCT02777554|83101559|FG005|Overall Study|Withdrawal by Subject|0|||
46880219|NCT02777554|83101554|FG000|Overall Study|Discharged early due to hurricane|22|||
46880220|NCT02777554|83101555|FG001|Overall Study|Discharged early due to hurricane|20|||
46880221|NCT02777554|83101556|FG002|Overall Study|Discharged early due to hurricane|0|||
46880222|NCT02777554|83101557|FG003|Overall Study|Discharged early due to hurricane|0|||
46880223|NCT02777554|83101558|FG004|Overall Study|Discharged early due to hurricane|0|||
46880224|NCT02777554|83101559|FG005|Overall Study|Discharged early due to hurricane|0|||
46880225|NCT02777554|83101554|FG000|Overall Study|Other - Miscellaneous|1|||
46880226|NCT02777554|83101555|FG001|Overall Study|Other - Miscellaneous|0|||
46880227|NCT02777554|83101556|FG002|Overall Study|Other - Miscellaneous|0|||
46880228|NCT02777554|83101557|FG003|Overall Study|Other - Miscellaneous|0|||
46880229|NCT02777554|83101558|FG004|Overall Study|Other - Miscellaneous|0|||
46880230|NCT02777554|83101559|FG005|Overall Study|Other - Miscellaneous|0|||
46880231|NCT03550209|83101583|FG000|Overall Study|Lost to Follow-up|1|||
46880232|NCT03550209|83101584|FG001|Overall Study|Lost to Follow-up|0|||
46880233|NCT03550209|83101585|FG002|Overall Study|Lost to Follow-up|1|||
46880234|NCT03550209|83101586|FG003|Overall Study|Lost to Follow-up|0|||
46880235|NCT03550209|83101583|FG000|Overall Study|Withdrawal by Subject|0|||
46880236|NCT03550209|83101584|FG001|Overall Study|Withdrawal by Subject|3|||
46880237|NCT03550209|83101585|FG002|Overall Study|Withdrawal by Subject|1|||
46880238|NCT03550209|83101586|FG003|Overall Study|Withdrawal by Subject|2|||
46880239|NCT03550209|83101583|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
46880240|NCT03550209|83101584|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
46880241|NCT03550209|83101585|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
46880242|NCT03550209|83101586|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
46880243|NCT03032510|83101598|FG000|Overall Study|Adverse Event|5|||
46880244|NCT03032510|83101599|FG001|Overall Study|Adverse Event|2|||
46880245|NCT03032510|83101598|FG000|Overall Study|Lost to Follow-up|8|||
46703952|NCT00958438|82918749|FG000|Overall Study|Physician Decision|1|||
46880246|NCT03032510|83101599|FG001|Overall Study|Lost to Follow-up|7|||
46880247|NCT03032510|83101598|FG000|Overall Study|Withdrawal by Subject|8|||
46880248|NCT03032510|83101599|FG001|Overall Study|Withdrawal by Subject|7|||
46880249|NCT03032510|83101598|FG000|Overall Study|Subject noncompliance|4|||
46880250|NCT03032510|83101599|FG001|Overall Study|Subject noncompliance|2|||
46880251|NCT03032510|83101598|FG000|Overall Study|Physician Decision|2|||
46880252|NCT03032510|83101599|FG001|Overall Study|Physician Decision|0|||
46880253|NCT03599349|83101609|FG000|Overall Study|Lost to Follow-up|1|||
46880254|NCT03599193|83101619|FG000|Overall Study|Adverse Event|0|||
46880255|NCT03599193|83101620|FG001|Overall Study|Adverse Event|2|||
46880256|NCT03599193|83101619|FG000|Overall Study|Withdrawal by Subject|1|||
46880257|NCT03599193|83101620|FG001|Overall Study|Withdrawal by Subject|0|||
46880258|NCT03599193|83101619|FG000|Overall Study|Protocol Violation|1|||
46880259|NCT03599193|83101620|FG001|Overall Study|Protocol Violation|0|||
46880260|NCT03599193|83101619|FG000|Overall Study|Lost to Follow-up|0|||
46880261|NCT03599193|83101620|FG001|Overall Study|Lost to Follow-up|1|||
46880262|NCT03166124|83101629|FG000|Treatment Period 1|Adverse Event|0|||
46880263|NCT03166124|83101630|FG001|Treatment Period 1|Adverse Event|0|||
46880264|NCT03166124|83101631|FG002|Treatment Period 1|Adverse Event|1|||
46880265|NCT03166124|83101632|FG003|Treatment Period 1|Adverse Event|0|||
46880266|NCT03166124|83101629|FG000|Wash-out Period|Withdrawal by Subject|0|||
46880267|NCT03166124|83101630|FG001|Wash-out Period|Withdrawal by Subject|1|||
46880268|NCT03166124|83101631|FG002|Wash-out Period|Withdrawal by Subject|0|||
46880269|NCT03166124|83101632|FG003|Wash-out Period|Withdrawal by Subject|1|||
46880270|NCT03166124|83101629|FG000|Wash-out Period|Adverse Event|0|||
46880271|NCT03166124|83101630|FG001|Wash-out Period|Adverse Event|1|||
46880272|NCT03166124|83101631|FG002|Wash-out Period|Adverse Event|1|||
46880273|NCT03166124|83101632|FG003|Wash-out Period|Adverse Event|0|||
46880274|NCT03567291|83101643|FG000|Period I|Adverse Event|14|||
46880275|NCT03567291|83101644|FG001|Period I|Adverse Event|0|||
46880276|NCT03567291|83101645|FG002|Period I|Adverse Event|0|||
46880277|NCT03567291|83101646|FG003|Period I|Adverse Event|0|||
46880278|NCT03567291|83101643|FG000|Period I|Protocol Violation|1|||
46880279|NCT03567291|83101644|FG001|Period I|Protocol Violation|0|||
46880280|NCT03567291|83101645|FG002|Period I|Protocol Violation|0|||
46880281|NCT03567291|83101646|FG003|Period I|Protocol Violation|0|||
46880282|NCT03567291|83101643|FG000|Period I|Withdrawal by Subject|23|||
46880283|NCT03567291|83101644|FG001|Period I|Withdrawal by Subject|0|||
46880284|NCT03567291|83101645|FG002|Period I|Withdrawal by Subject|0|||
46880285|NCT03567291|83101646|FG003|Period I|Withdrawal by Subject|0|||
46880286|NCT03567291|83101643|FG000|Period I|Lost to Follow-up|2|||
46880287|NCT03567291|83101644|FG001|Period I|Lost to Follow-up|0|||
46880288|NCT03567291|83101645|FG002|Period I|Lost to Follow-up|0|||
46880289|NCT03567291|83101646|FG003|Period I|Lost to Follow-up|0|||
46880290|NCT03567291|83101643|FG000|Period I|Terminated by sponsor|44|||
46880291|NCT03567291|83101644|FG001|Period I|Terminated by sponsor|0|||
46880292|NCT03567291|83101645|FG002|Period I|Terminated by sponsor|0|||
46880293|NCT03567291|83101646|FG003|Period I|Terminated by sponsor|0|||
46880294|NCT03567291|83101643|FG000|Period I|Missing or unknown|7|||
46880295|NCT03567291|83101644|FG001|Period I|Missing or unknown|0|||
46880296|NCT03567291|83101645|FG002|Period I|Missing or unknown|0|||
46880297|NCT03567291|83101646|FG003|Period I|Missing or unknown|0|||
46880298|NCT03567291|83101643|FG000|Period II|Adverse Event|0|||
46880299|NCT03567291|83101644|FG001|Period II|Adverse Event|1|||
46880300|NCT03567291|83101645|FG002|Period II|Adverse Event|0|||
46880301|NCT03567291|83101646|FG003|Period II|Adverse Event|0|||
46880302|NCT03567291|83101643|FG000|Period II|Missing or unknown|0|||
46880303|NCT03567291|83101644|FG001|Period II|Missing or unknown|2|||
46880304|NCT03567291|83101645|FG002|Period II|Missing or unknown|1|||
46880305|NCT03567291|83101646|FG003|Period II|Missing or unknown|0|||
46880306|NCT03567291|83101643|FG000|Period III|Adverse Event|0|||
46880307|NCT03567291|83101644|FG001|Period III|Adverse Event|0|||
46880308|NCT03567291|83101645|FG002|Period III|Adverse Event|0|||
46880309|NCT03567291|83101646|FG003|Period III|Adverse Event|4|||
46880310|NCT03567291|83101643|FG000|Period III|Withdrawal by Subject|0|||
46880311|NCT03567291|83101644|FG001|Period III|Withdrawal by Subject|0|||
46880312|NCT03567291|83101645|FG002|Period III|Withdrawal by Subject|0|||
46880313|NCT03567291|83101646|FG003|Period III|Withdrawal by Subject|4|||
46880314|NCT03567291|83101643|FG000|Period III|Lost to Follow-up|0|||
46880315|NCT03567291|83101644|FG001|Period III|Lost to Follow-up|0|||
46880316|NCT03567291|83101645|FG002|Period III|Lost to Follow-up|0|||
46880317|NCT03567291|83101646|FG003|Period III|Lost to Follow-up|1|||
46880318|NCT03567291|83101643|FG000|Period III|Terminated by sponsor|0|||
46880319|NCT03567291|83101644|FG001|Period III|Terminated by sponsor|0|||
46880320|NCT03567291|83101645|FG002|Period III|Terminated by sponsor|0|||
46880321|NCT03567291|83101646|FG003|Period III|Terminated by sponsor|68|||
46880322|NCT03567291|83101643|FG000|Period III|Missing or unknown|0|||
46880323|NCT03567291|83101644|FG001|Period III|Missing or unknown|0|||
46880324|NCT03567291|83101645|FG002|Period III|Missing or unknown|0|||
46880325|NCT03567291|83101646|FG003|Period III|Missing or unknown|8|||
46880326|NCT02777242|83101652|FG000|Overall Study|Other|2|||
46880327|NCT02777242|83101652|FG000|Overall Study|Lost to Follow-up|1|||
46880328|NCT02777242|83101652|FG000|Overall Study|Multiple|1|||
46880329|NCT02777242|83101652|FG000|Overall Study|Sponsor's request|1|||
46880330|NCT02777242|83101652|FG000|Overall Study|Withdrawal by Subject|1|||
46880331|NCT03212144|83101658|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
46880332|NCT03212144|83101659|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
46880333|NCT03212144|83101658|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
46880334|NCT03212144|83101659|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
46880335|NCT03566979|83101669|FG000|Overall Study|Withdrawal by Subject|2|||
46880336|NCT03566979|83101670|FG001|Overall Study|Withdrawal by Subject|0|||
46880337|NCT03566979|83101671|FG002|Overall Study|Withdrawal by Subject|1|||
46880338|NCT03566979|83101672|FG003|Overall Study|Withdrawal by Subject|1|||
46880339|NCT03566979|83101669|FG000|Overall Study|Lost to Follow-up|2|||
46880340|NCT03566979|83101670|FG001|Overall Study|Lost to Follow-up|7|||
46880341|NCT03566979|83101671|FG002|Overall Study|Lost to Follow-up|9|||
46880342|NCT03566979|83101672|FG003|Overall Study|Lost to Follow-up|5|||
46880343|NCT03566979|83101669|FG000|Overall Study|Adverse Event|1|||
46880344|NCT03566979|83101670|FG001|Overall Study|Adverse Event|0|||
46880345|NCT03566979|83101671|FG002|Overall Study|Adverse Event|0|||
46880346|NCT03566979|83101672|FG003|Overall Study|Adverse Event|0|||
46880347|NCT00116831|83101684|FG000|Overall Study|Adverse Event|14|||
46880348|NCT00116831|83101685|FG001|Overall Study|Adverse Event|16|||
46880349|NCT00116831|83101684|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
46880350|NCT00116831|83101685|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
46880351|NCT00116831|83101684|FG000|Overall Study|Lost to Follow-up|8|||
46880352|NCT00116831|83101685|FG001|Overall Study|Lost to Follow-up|6|||
46880353|NCT00116831|83101684|FG000|Overall Study|Protocol Violation|3|||
46880354|NCT00116831|83101685|FG001|Overall Study|Protocol Violation|6|||
46880355|NCT00116831|83101684|FG000|Overall Study|Hypoglycaemic events|1|||
46880356|NCT00116831|83101685|FG001|Overall Study|Hypoglycaemic events|0|||
46880357|NCT00116831|83101684|FG000|Overall Study|Low haemoglobin on screening|1|||
46880358|NCT00116831|83101685|FG001|Overall Study|Low haemoglobin on screening|0|||
46880359|NCT00116831|83101684|FG000|Overall Study|Withdrawn investigational product|1|||
46880360|NCT00116831|83101685|FG001|Overall Study|Withdrawn investigational product|0|||
46880361|NCT00116831|83101684|FG000|Overall Study|Withdrawal by Subject|32|||
46880362|NCT00116831|83101685|FG001|Overall Study|Withdrawal by Subject|32|||
46880363|NCT00116831|83101684|FG000|Overall Study|Insufficient therapeutic effect|0|||
46880364|NCT00116831|83101685|FG001|Overall Study|Insufficient therapeutic effect|1|||
46880365|NCT00116831|83101684|FG000|Overall Study|Missing data for participant|1|||
46880366|NCT00116831|83101685|FG001|Overall Study|Missing data for participant|0|||
46880367|NCT02777086|83101693|FG000|Overall Study|Lost to Follow-up|96|||
46880368|NCT02777086|83101694|FG001|Overall Study|Lost to Follow-up|99|||
46880369|NCT03549429|83101702|FG000|Overall Study|Protocol Violation|5|||
46880370|NCT03549429|83101703|FG001|Overall Study|Protocol Violation|3|||
46880371|NCT02784704|83101713|FG000|Overall Study|Adverse Event|4|||
46880372|NCT02784704|83101714|FG001|Overall Study|Adverse Event|2|||
46880373|NCT02784704|83101713|FG000|Overall Study|Lost to Follow-up|6|||
46880374|NCT02784704|83101714|FG001|Overall Study|Lost to Follow-up|4|||
46880375|NCT02784704|83101713|FG000|Overall Study|Withdrawal by Subject|1|||
46880376|NCT02784704|83101714|FG001|Overall Study|Withdrawal by Subject|3|||
46880377|NCT02784704|83101713|FG000|Overall Study|Subject Non Compliance|2|||
46880378|NCT02784704|83101714|FG001|Overall Study|Subject Non Compliance|0|||
46880379|NCT03566823|83101725|FG000|Overall Study|Lack of Efficacy|0|||
46880380|NCT03566823|83101726|FG001|Overall Study|Lack of Efficacy|1|||
46880381|NCT03566823|83101727|FG002|Overall Study|Lack of Efficacy|0|||
46880382|NCT03566823|83101725|FG000|Overall Study|Withdrawal by Subject|1|||
46880383|NCT03566823|83101726|FG001|Overall Study|Withdrawal by Subject|2|||
46880384|NCT03566823|83101727|FG002|Overall Study|Withdrawal by Subject|0|||
46880385|NCT03566823|83101725|FG000|Overall Study|Adverse Event|1|||
46880386|NCT03566823|83101726|FG001|Overall Study|Adverse Event|0|||
46880387|NCT03566823|83101727|FG002|Overall Study|Adverse Event|2|||
46880388|NCT03549117|83101737|FG000|Overall Study|Withdrawal by Subject|1|||
46880389|NCT03549117|83101738|FG001|Overall Study|Withdrawal by Subject|0|||
46880390|NCT03183908|83101746|FG000|Overall Study|Missing Symptom Diary Data|0|||
46880391|NCT03183908|83101747|FG001|Overall Study|Missing Symptom Diary Data|2|||
46880392|NCT03565887|83101759|FG000|Overall Study|Adverse Event|1|||
46880393|NCT03565887|83101760|FG001|Overall Study|Adverse Event|0|||
46880394|NCT03565887|83101759|FG000|Overall Study|Withdrawal by Subject|0|||
46880395|NCT03565887|83101760|FG001|Overall Study|Withdrawal by Subject|2|||
46880396|NCT03183518|83101766|FG000|Overall Study|Other (Not specified)|2|||
46880397|NCT03183518|83101766|FG000|Overall Study|Other (Withdrawal of consent)|1|||
46880398|NCT00116753|83101774|FG000|Overall Study|Adverse Event|16|||
46880399|NCT00116753|83101775|FG001|Overall Study|Adverse Event|10|||
46880400|NCT00116753|83101776|FG002|Overall Study|Adverse Event|7|||
46880401|NCT00116753|83101774|FG000|Overall Study|Withdrawal by Subject|11|||
46880402|NCT00116753|83101775|FG001|Overall Study|Withdrawal by Subject|12|||
46880403|NCT00116753|83101776|FG002|Overall Study|Withdrawal by Subject|8|||
46880404|NCT00116753|83101774|FG000|Overall Study|Lost to Follow-up|0|||
46880405|NCT00116753|83101775|FG001|Overall Study|Lost to Follow-up|2|||
46880406|NCT00116753|83101776|FG002|Overall Study|Lost to Follow-up|1|||
46880407|NCT00116753|83101774|FG000|Overall Study|Protocol Violation|0|||
46880408|NCT00116753|83101775|FG001|Overall Study|Protocol Violation|0|||
46880409|NCT00116753|83101776|FG002|Overall Study|Protocol Violation|1|||
46880410|NCT00116753|83101774|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
46880411|NCT00116753|83101775|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
46880412|NCT00116753|83101776|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
46880413|NCT00116753|83101774|FG000|Overall Study|Disease Progression|3|||
46880414|NCT00116753|83101775|FG001|Overall Study|Disease Progression|4|||
46880415|NCT00116753|83101776|FG002|Overall Study|Disease Progression|3|||
46880416|NCT00116753|83101774|FG000|Overall Study|Abnormal Echocardiogram|0|||
46880417|NCT00116753|83101775|FG001|Overall Study|Abnormal Echocardiogram|0|||
46880418|NCT00116753|83101776|FG002|Overall Study|Abnormal Echocardiogram|1|||
46880419|NCT00116753|83101774|FG000|Overall Study|Progressive Parkinson's Disease|1|||
46880420|NCT00116753|83101775|FG001|Overall Study|Progressive Parkinson's Disease|0|||
46880421|NCT00116753|83101776|FG002|Overall Study|Progressive Parkinson's Disease|0|||
46880422|NCT00116753|83101774|FG000|Overall Study|Dosing Error|0|||
46880423|NCT00116753|83101775|FG001|Overall Study|Dosing Error|1|||
46880424|NCT00116753|83101776|FG002|Overall Study|Dosing Error|0|||
46880425|NCT00113399|83101786|FG000|Overall Study|Death|1|||
46880426|NCT00113399|83101787|FG001|Overall Study|Death|1|||
46880427|NCT00113399|83101786|FG000|Overall Study|Withdrawal by Subject|1|||
46880428|NCT00113399|83101787|FG001|Overall Study|Withdrawal by Subject|2|||
46880429|NCT00113399|83101786|FG000|Overall Study|Complete Response|0|||
46880430|NCT00113399|83101787|FG001|Overall Study|Complete Response|1|||
46880431|NCT00113399|83101786|FG000|Overall Study|Other|0|||
46880432|NCT00113399|83101787|FG001|Overall Study|Other|1|||
46880433|NCT00113087|83101795|FG000|Overall Study|Death or Transplant|14|||
46880434|NCT00113087|83101796|FG001|Overall Study|Death or Transplant|16|||
46880435|NCT00113087|83101795|FG000|Overall Study|Family or MD withdrew subject|10|||
46880436|NCT00113087|83101796|FG001|Overall Study|Family or MD withdrew subject|5|||
46880437|NCT00112463|83101802|FG000|Overall Study|Physician Decision|1|||
46880438|NCT00112463|83101802|FG000|Overall Study|Progression|30|||
46880439|NCT00112463|83101802|FG000|Overall Study|Second Primary|1|||
46880440|NCT00112463|83101802|FG000|Overall Study|Toxicity|3|||
46880441|NCT00112463|83101802|FG000|Overall Study|Withdrawal by Subject|2|||
46880442|NCT00112463|83101802|FG000|Overall Study|Never started treatment|2|||
46880443|NCT03548415|83101812|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
46880444|NCT03548415|83101813|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
46880445|NCT03548415|83101814|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
46880446|NCT03548415|83101815|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
46880447|NCT03548415|83101816|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
46880448|NCT00112385|83101832|FG000|Overall Study|Lost to Follow-up|1|||
46880449|NCT00112385|83101833|FG001|Overall Study|Lost to Follow-up|0|||
46880450|NCT00112385|83101832|FG000|Overall Study|Withdrawal by Subject|0|||
46880451|NCT00112385|83101833|FG001|Overall Study|Withdrawal by Subject|1|||
46880452|NCT03548337|83101841|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
46880453|NCT03548337|83101842|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
46880454|NCT03548337|83101841|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
46880455|NCT03548337|83101842|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
46880456|NCT03548337|83101841|FG000|Infant Series|Lost to Follow-up|2|||
46880457|NCT03548337|83101842|FG001|Infant Series|Lost to Follow-up|1|||
46880458|NCT03548337|83101841|FG000|Infant Series|Adverse Event|0|||
46880459|NCT03548337|83101842|FG001|Infant Series|Adverse Event|2|||
46880460|NCT03548337|83101841|FG000|Infant Series|Randomized but Not Vaccinated|1|||
46880461|NCT03548337|83101842|FG001|Infant Series|Randomized but Not Vaccinated|0|||
46880462|NCT03548337|83101841|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
46880463|NCT03548337|83101842|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
46880464|NCT03596151|83101854|FG000|Overall Study|Withdrawal by Subject|1|||
46880465|NCT03547635|83101861|FG000|Overall Study|Adverse Event|5|||
46880466|NCT03547635|83101862|FG001|Overall Study|Adverse Event|2|||
46880467|NCT03547635|83101863|FG002|Overall Study|Adverse Event|3|||
46880468|NCT03547635|83101861|FG000|Overall Study|Lost to Follow-up|1|||
46880469|NCT03547635|83101862|FG001|Overall Study|Lost to Follow-up|3|||
46880470|NCT03547635|83101863|FG002|Overall Study|Lost to Follow-up|4|||
46880471|NCT03547635|83101861|FG000|Overall Study|Withdrawal by Subject|1|||
46880472|NCT03547635|83101862|FG001|Overall Study|Withdrawal by Subject|0|||
46880473|NCT03547635|83101863|FG002|Overall Study|Withdrawal by Subject|0|||
46880474|NCT03547635|83101861|FG000|Overall Study|Withdrawal By PI|0|||
46880475|NCT03547635|83101862|FG001|Overall Study|Withdrawal By PI|1|||
46880476|NCT03547635|83101863|FG002|Overall Study|Withdrawal By PI|0|||
46880477|NCT03547635|83101861|FG000|Overall Study|Withdrawal by Sponsor|0|||
46880478|NCT03547635|83101862|FG001|Overall Study|Withdrawal by Sponsor|0|||
46880479|NCT03547635|83101863|FG002|Overall Study|Withdrawal by Sponsor|1|||
46988146|NCT02265705|83234508|FG003|Follow-up Period|Adverse Event|0|||
46988147|NCT02265705|83234509|FG004|Follow-up Period|Adverse Event|0|||
46988148|NCT02265705|83234510|FG005|Follow-up Period|Adverse Event|0|||
46703953|NCT00958438|82918750|FG001|Overall Study|Physician Decision|0|||
46880480|NCT03547635|83101861|FG000|Overall Study|Errant Randomization before Treatment|0|||
46880481|NCT03547635|83101862|FG001|Overall Study|Errant Randomization before Treatment|1|||
46880482|NCT03547635|83101863|FG002|Overall Study|Errant Randomization before Treatment|0|||
46880483|NCT03547635|83101861|FG000|Overall Study|Withdrawal by Subject|1|||
46880484|NCT03547635|83101862|FG001|Overall Study|Withdrawal by Subject|0|||
46880485|NCT03547635|83101863|FG002|Overall Study|Withdrawal by Subject|0|||
46880486|NCT03182738|83101917|FG000|Overall Study|Lost to Follow-up|9|||
46880487|NCT03182738|83101918|FG001|Overall Study|Lost to Follow-up|3|||
46880488|NCT03182738|83101917|FG000|Overall Study|Pregnancy|0|||
46880489|NCT03182738|83101918|FG001|Overall Study|Pregnancy|1|||
46880490|NCT03182738|83101917|FG000|Overall Study|Withdrawal by Subject|0|||
46880491|NCT03182738|83101918|FG001|Overall Study|Withdrawal by Subject|1|||
46880492|NCT03547167|83101926|FG000|Overall Study|Withdrawal by Subject|34|||
46880493|NCT03547167|83101927|FG001|Overall Study|Withdrawal by Subject|12|||
46880494|NCT03547167|83101926|FG000|Overall Study|Screen Failure|0|||
46880495|NCT03547167|83101927|FG001|Overall Study|Screen Failure|1|||
46880496|NCT03547167|83101926|FG000|Overall Study|Lost to Follow-up|59|||
46880497|NCT03547167|83101927|FG001|Overall Study|Lost to Follow-up|15|||
46880498|NCT03547167|83101926|FG000|Overall Study|Death|4|||
46880499|NCT03547167|83101927|FG001|Overall Study|Death|2|||
46880500|NCT03560739|83101941|FG000|Overall Study|Adverse Event|0|||
46880501|NCT03560739|83101942|FG001|Overall Study|Adverse Event|1|||
46880502|NCT03560739|83101943|FG002|Overall Study|Adverse Event|0|||
46880503|NCT03560739|83101944|FG003|Overall Study|Adverse Event|0|||
46880504|NCT00101686|83101964|FG000|Overall Study|Progressive Disease|37|||
46880505|NCT00101686|83101965|FG001|Overall Study|Progressive Disease|28|||
46880506|NCT00101686|83101966|FG002|Overall Study|Progressive Disease|37|||
46880507|NCT00101686|83101967|FG003|Overall Study|Progressive Disease|38|||
46880508|NCT00101686|83101968|FG004|Overall Study|Progressive Disease|28|||
46880509|NCT00101686|83101969|FG005|Overall Study|Progressive Disease|25|||
46988149|NCT02265705|83234511|FG006|Follow-up Period|Adverse Event|3|||
46988150|NCT02265705|83234505|FG000|Follow-up Period|Physician Decision|0|||
46988151|NCT02265705|83234506|FG001|Follow-up Period|Physician Decision|0|||
46988152|NCT02265705|83234507|FG002|Follow-up Period|Physician Decision|0|||
46988153|NCT02265705|83234508|FG003|Follow-up Period|Physician Decision|0|||
46988154|NCT02265705|83234509|FG004|Follow-up Period|Physician Decision|0|||
46988155|NCT02265705|83234510|FG005|Follow-up Period|Physician Decision|0|||
46988156|NCT02265705|83234511|FG006|Follow-up Period|Physician Decision|1|||
46988157|NCT02265705|83234505|FG000|Follow-up Period|Withdrawal by Subject|0|||
46988158|NCT02265705|83234506|FG001|Follow-up Period|Withdrawal by Subject|0|||
46988159|NCT02265705|83234507|FG002|Follow-up Period|Withdrawal by Subject|0|||
46988160|NCT02265705|83234508|FG003|Follow-up Period|Withdrawal by Subject|0|||
46988161|NCT02265705|83234509|FG004|Follow-up Period|Withdrawal by Subject|0|||
46988162|NCT02265705|83234510|FG005|Follow-up Period|Withdrawal by Subject|0|||
46988163|NCT02265705|83234511|FG006|Follow-up Period|Withdrawal by Subject|1|||
46988164|NCT02459665|83234526|FG000|Overall Study|Withdrawal by Subject|0|||
46988165|NCT02459665|83234527|FG001|Overall Study|Withdrawal by Subject|1|||
46988166|NCT02459665|83234528|FG002|Overall Study|Withdrawal by Subject|1|||
46988167|NCT02459665|83234529|FG003|Overall Study|Withdrawal by Subject|2|||
46988168|NCT02265237|83234550|FG000|As Treated (Overall Study)|Adverse Event|1|||
46988169|NCT02265237|83234551|FG001|As Treated (Overall Study)|Adverse Event|1|||
46988170|NCT02265237|83234552|FG002|As Treated (Overall Study)|Adverse Event|0|||
46988171|NCT02265237|83234553|FG003|As Treated (Overall Study)|Adverse Event|0|||
46988172|NCT02265237|83234550|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
46988173|NCT02265237|83234551|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
46988174|NCT02265237|83234552|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
46988175|NCT02265237|83234553|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
46988176|NCT02265237|83234550|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
46988177|NCT02265237|83234551|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
46988178|NCT02265237|83234552|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
46988179|NCT02265237|83234553|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
46988180|NCT02265237|83234550|FG000|As Treated (Overall Study)|Other|2|||
46988181|NCT02265237|83234551|FG001|As Treated (Overall Study)|Other|0|||
46988182|NCT02265237|83234552|FG002|As Treated (Overall Study)|Other|3|||
46988183|NCT02265237|83234553|FG003|As Treated (Overall Study)|Other|1|||
46988184|NCT02263365|83234566|FG000|Overall Study|Physician Decision|22|||
46988185|NCT02263365|83234567|FG001|Overall Study|Physician Decision|18|||
46988186|NCT02261493|83234577|FG000|Overall Study|Noncompliance|0|||
46988187|NCT02261493|83234578|FG001|Overall Study|Noncompliance|0|||
46703954|NCT00958438|82918751|FG002|Overall Study|Physician Decision|1|||
46703955|NCT00958438|82918749|FG000|Overall Study|Other than specified above|2|||
46988188|NCT02261493|83234579|FG002|Overall Study|Noncompliance|2|||
46988189|NCT02261493|83234577|FG000|Overall Study|Physician Decision|0|||
46988190|NCT02261493|83234578|FG001|Overall Study|Physician Decision|1|||
46880510|NCT00101686|83101970|FG006|Overall Study|Progressive Disease|5|||
46988191|NCT02261493|83234579|FG002|Overall Study|Physician Decision|0|||
46988192|NCT02261493|83234577|FG000|Overall Study|Undisclosed alcohol abuse|0|||
46988193|NCT02261493|83234578|FG001|Overall Study|Undisclosed alcohol abuse|1|||
46988194|NCT02261493|83234579|FG002|Overall Study|Undisclosed alcohol abuse|0|||
46988195|NCT02261493|83234577|FG000|Overall Study|Protocol Violation|1|||
46880511|NCT00101686|83101971|FG007|Overall Study|Progressive Disease|7|||
46880512|NCT00101686|83101972|FG008|Overall Study|Progressive Disease|10|||
46988196|NCT02261493|83234578|FG001|Overall Study|Protocol Violation|0|||
46988197|NCT02261493|83234579|FG002|Overall Study|Protocol Violation|0|||
46988198|NCT02261493|83234577|FG000|Overall Study|Personal Reasons|14|||
46988199|NCT02261493|83234578|FG001|Overall Study|Personal Reasons|14|||
46988200|NCT02261493|83234579|FG002|Overall Study|Personal Reasons|16|||
46988201|NCT02261493|83234577|FG000|Overall Study|Lost to Follow-up|14|||
46988202|NCT02261493|83234578|FG001|Overall Study|Lost to Follow-up|27|||
46988203|NCT02261493|83234579|FG002|Overall Study|Lost to Follow-up|8|||
46988204|NCT02261493|83234577|FG000|Overall Study|Pregnancy|1|||
46988205|NCT02261493|83234578|FG001|Overall Study|Pregnancy|2|||
46988206|NCT02261493|83234579|FG002|Overall Study|Pregnancy|0|||
46988207|NCT02261493|83234577|FG000|Overall Study|Lack of Efficacy|0|||
46988208|NCT02261493|83234578|FG001|Overall Study|Lack of Efficacy|1|||
46988209|NCT02261493|83234579|FG002|Overall Study|Lack of Efficacy|0|||
46988210|NCT02261493|83234577|FG000|Overall Study|Adverse Event|0|||
46988211|NCT02261493|83234578|FG001|Overall Study|Adverse Event|1|||
46988212|NCT02261493|83234579|FG002|Overall Study|Adverse Event|0|||
46988213|NCT02260791|83234589|FG000|Overall Study|Lost to Follow-up|4|||
46988214|NCT02260791|83234590|FG001|Overall Study|Lost to Follow-up|4|||
46988215|NCT02260791|83234589|FG000|Overall Study|Lack of Efficacy|2|||
46988216|NCT02260791|83234590|FG001|Overall Study|Lack of Efficacy|1|||
46988217|NCT02260791|83234589|FG000|Overall Study|Adverse Event|13|||
46988218|NCT02260791|83234590|FG001|Overall Study|Adverse Event|9|||
46988219|NCT02260791|83234589|FG000|Overall Study|Death|1|||
46988220|NCT02260791|83234590|FG001|Overall Study|Death|0|||
46988221|NCT02260791|83234589|FG000|Overall Study|Withdrawal by Subject|11|||
46988222|NCT02260791|83234590|FG001|Overall Study|Withdrawal by Subject|16|||
46988223|NCT02260791|83234589|FG000|Overall Study|Screen failure|0|||
46988224|NCT02260791|83234590|FG001|Overall Study|Screen failure|1|||
46988225|NCT02260791|83234589|FG000|Overall Study|Protocol deviation|2|||
46988226|NCT02260791|83234590|FG001|Overall Study|Protocol deviation|3|||
46988227|NCT02260635|83234598|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
46988228|NCT02260635|83234599|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
46988229|NCT02260635|83234598|FG000|Open-Label Extension|Study Termination|25|||
46988230|NCT02260635|83234599|FG001|Open-Label Extension|Study Termination|25|||
46988231|NCT02260635|83234598|FG000|Open-Label Extension|Withdrawal by Subject|1|||
46988232|NCT02260635|83234599|FG001|Open-Label Extension|Withdrawal by Subject|0|||
46988233|NCT02258529|83234607|FG000|Overall Study|Study Terminated by Sponsor|9|||
46988234|NCT02258529|83234607|FG000|Overall Study|Adverse Event|1|||
46988235|NCT02256969|83234614|FG000|Overall Study|Screenfailed or withdrew|2|||
46988236|NCT02256969|83234615|FG001|Overall Study|Screenfailed or withdrew|1|||
46988237|NCT02256969|83234616|FG002|Overall Study|Screenfailed or withdrew|1|||
46988238|NCT02256891|83234626|FG000|Overall Study|Death|0|||
46988239|NCT02256891|83234627|FG001|Overall Study|Death|2|||
46988240|NCT02256891|83234626|FG000|Overall Study|Lost to Follow-up|0|||
46988241|NCT02256891|83234627|FG001|Overall Study|Lost to Follow-up|3|||
46988242|NCT02256891|83234626|FG000|Overall Study|Physician Decision|7|||
46988243|NCT02256891|83234627|FG001|Overall Study|Physician Decision|3|||
46988244|NCT02256891|83234626|FG000|Overall Study|Screen Fail|5|||
46988245|NCT02256891|83234627|FG001|Overall Study|Screen Fail|4|||
46988246|NCT02256891|83234626|FG000|Overall Study|Equipment Malfunction|0|||
46988247|NCT02256891|83234627|FG001|Overall Study|Equipment Malfunction|1|||
46988248|NCT02256267|83234635|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
46988249|NCT02256267|83234635|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
46988250|NCT01641471|83234644|FG000|Overall Study|Withdrawal by Subject|19|||
46988251|NCT01641471|83234645|FG001|Overall Study|Withdrawal by Subject|19|||
46988252|NCT01641471|83234644|FG000|Overall Study|Lost to Follow-up|2|||
46988253|NCT01641471|83234645|FG001|Overall Study|Lost to Follow-up|4|||
46988254|NCT01641471|83234644|FG000|Overall Study|Protocol Violation|2|||
46988255|NCT01641471|83234645|FG001|Overall Study|Protocol Violation|4|||
46988256|NCT02255565|83234654|FG000|Overall Study|Withdrawal by Subject|0|||
46988257|NCT02255565|83234655|FG001|Overall Study|Withdrawal by Subject|1|||
46988258|NCT02255565|83234656|FG002|Overall Study|Withdrawal by Subject|0|||
46988259|NCT01640301|83234699|FG000|Overall Study|Death|0|||
46988260|NCT01640301|83234700|FG001|Overall Study|Death|8|||
46988261|NCT01642407|83234708|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
46988262|NCT01642407|83234708|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
46988263|NCT01642407|83234708|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
46988264|NCT02255097|83234712|FG000|Overall Study|Death|151|||
46988265|NCT02255097|83234712|FG000|Overall Study|Lost to Follow-up|5|||
46988266|NCT02255097|83234712|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
46988267|NCT02255097|83234712|FG000|Overall Study|Withdrawal by Subject|7|||
46988268|NCT02255097|83234712|FG000|Overall Study|Allocated but not treated|1|||
46988269|NCT02254551|83234717|FG000|Dose Escalation|Physician Decision|1|||
46988270|NCT02254551|83234717|FG000|Dose Escalation|Dose-limiting toxicity|2|||
46988271|NCT01641237|83234724|FG000|Period II|Withdrawal by Subject|1|||
46988272|NCT01641237|83234725|FG001|Period II|Withdrawal by Subject|0|||
46988273|NCT01641237|83234726|FG002|Period II|Withdrawal by Subject|0|||
46988274|NCT01641237|83234727|FG003|Period II|Withdrawal by Subject|0|||
46988275|NCT01641237|83234724|FG000|Period III|Lost to Follow-up|1|||
46988276|NCT01641237|83234725|FG001|Period III|Lost to Follow-up|0|||
46988277|NCT01641237|83234726|FG002|Period III|Lost to Follow-up|0|||
46988278|NCT01641237|83234727|FG003|Period III|Lost to Follow-up|0|||
46988279|NCT01639833|83234739|FG000|Overall Study|Death|4|||
46988280|NCT01639833|83234740|FG001|Overall Study|Death|2|||
46988281|NCT01639833|83234739|FG000|Overall Study|Withdrawal by Subject|2|||
46988282|NCT01639833|83234740|FG001|Overall Study|Withdrawal by Subject|2|||
46988283|NCT01639131|83234746|FG000|Overall Study|Disease Progression|6|||
46988284|NCT01641159|83234752|FG000|Overall Study|Lost to Follow-up|2|||
46988285|NCT01641159|83234753|FG001|Overall Study|Lost to Follow-up|1|||
46988286|NCT01641159|83234752|FG000|Overall Study|Withdrawal by Subject|0|||
46988287|NCT01641159|83234753|FG001|Overall Study|Withdrawal by Subject|1|||
46988288|NCT01641081|83234759|FG000|Period 1|Sponsor request (potential unblinding)|0|||
46988289|NCT01641081|83234760|FG001|Period 1|Sponsor request (potential unblinding)|0|||
46988290|NCT01641081|83234761|FG002|Period 1|Sponsor request (potential unblinding)|0|||
46988291|NCT01641081|83234762|FG003|Period 1|Sponsor request (potential unblinding)|0|||
46988292|NCT01641081|83234763|FG004|Period 1|Sponsor request (potential unblinding)|0|||
46988293|NCT01641081|83234764|FG005|Period 1|Sponsor request (potential unblinding)|0|||
46988294|NCT01641081|83234765|FG006|Period 1|Sponsor request (potential unblinding)|1|||
46988295|NCT01641081|83234766|FG007|Period 1|Sponsor request (potential unblinding)|0|||
46988296|NCT01641081|83234767|FG008|Period 1|Sponsor request (potential unblinding)|0|||
46988297|NCT01641081|83234768|FG009|Period 1|Sponsor request (potential unblinding)|0|||
46988298|NCT01641081|83234759|FG000|Period 1|Protocol Violation|0|||
46988299|NCT01641081|83234760|FG001|Period 1|Protocol Violation|0|||
46988300|NCT01641081|83234761|FG002|Period 1|Protocol Violation|0|||
46988301|NCT01641081|83234762|FG003|Period 1|Protocol Violation|0|||
46880513|NCT00101686|83101973|FG009|Overall Study|Progressive Disease|8|||
46880514|NCT00101686|83101964|FG000|Overall Study|initiation other anti-cancer treatment|4|||
46880515|NCT00101686|83101965|FG001|Overall Study|initiation other anti-cancer treatment|3|||
46880516|NCT00101686|83101966|FG002|Overall Study|initiation other anti-cancer treatment|4|||
46880517|NCT00101686|83101967|FG003|Overall Study|initiation other anti-cancer treatment|3|||
46880518|NCT00101686|83101968|FG004|Overall Study|initiation other anti-cancer treatment|1|||
46880519|NCT00101686|83101969|FG005|Overall Study|initiation other anti-cancer treatment|1|||
46880520|NCT00101686|83101970|FG006|Overall Study|initiation other anti-cancer treatment|2|||
46988302|NCT01641081|83234763|FG004|Period 1|Protocol Violation|1|||
46988303|NCT01641081|83234764|FG005|Period 1|Protocol Violation|0|||
46988304|NCT01641081|83234765|FG006|Period 1|Protocol Violation|0|||
46988305|NCT01641081|83234766|FG007|Period 1|Protocol Violation|1|||
46703956|NCT00958438|82918750|FG001|Overall Study|Other than specified above|3|||
46703957|NCT00958438|82918751|FG002|Overall Study|Other than specified above|2|||
46988306|NCT01641081|83234767|FG008|Period 1|Protocol Violation|0|||
46988307|NCT01641081|83234768|FG009|Period 1|Protocol Violation|0|||
46988308|NCT01641081|83234759|FG000|Period 1|Adverse Event|1|||
46707566|NCT01176240|82923135|FG000|Study 306B|Lost to Follow-up|0|||
46707567|NCT01176240|82923136|FG001|Study 306B|Lost to Follow-up|1|||
46880521|NCT00101686|83101971|FG007|Overall Study|initiation other anti-cancer treatment|2|||
46880522|NCT00101686|83101972|FG008|Overall Study|initiation other anti-cancer treatment|3|||
46703958|NCT00958360|82918761|FG000|Overall Study|Withdrawal by Subject|3|||
46703959|NCT00958360|82918762|FG001|Overall Study|Withdrawal by Subject|1|||
46703960|NCT00958360|82918761|FG000|Overall Study|Death|6|||
46703961|NCT00958360|82918762|FG001|Overall Study|Death|7|||
46703962|NCT00958360|82918761|FG000|Overall Study|Physician Decision|2|||
46703963|NCT00958360|82918762|FG001|Overall Study|Physician Decision|1|||
46703964|NCT00958360|82918761|FG000|Overall Study|Lost to Follow-up|0|||
46703965|NCT00958360|82918762|FG001|Overall Study|Lost to Follow-up|1|||
46703966|NCT00888433|82918770|FG000|Overall Study|Withdrawal by Subject|1|||
46703967|NCT00888433|82918771|FG001|Overall Study|Withdrawal by Subject|2|||
46703968|NCT00888433|82918770|FG000|Overall Study|Missed Visit|2|||
46703969|NCT00888433|82918771|FG001|Overall Study|Missed Visit|1|||
46703970|NCT01243424|82918779|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
46703971|NCT01243424|82918780|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
46703972|NCT01243424|82918779|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
46703973|NCT01243424|82918780|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
46703974|NCT01243424|82918779|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
46703975|NCT01243424|82918780|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
46703976|NCT01243424|82918779|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
46703977|NCT01243424|82918780|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
46703978|NCT01243424|82918779|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
46703979|NCT01243424|82918780|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
46703980|NCT01243424|82918779|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
46703981|NCT01243424|82918780|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
46703982|NCT01243424|82918779|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
46703983|NCT01243424|82918780|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
46703984|NCT01243424|82918779|FG000|Discontinuation From Treatment|Not treated|5|||
46703985|NCT01243424|82918780|FG001|Discontinuation From Treatment|Not treated|4|||
46703986|NCT01243424|82918779|FG000|Discontinuation From Treatment|Adverse Event|457|||
46703987|NCT01243424|82918780|FG001|Discontinuation From Treatment|Adverse Event|523|||
46703988|NCT01243424|82918779|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
46703989|NCT01243424|82918780|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
46880523|NCT00101686|83101973|FG009|Overall Study|initiation other anti-cancer treatment|3|||
46880524|NCT00101686|83101964|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
46880525|NCT00101686|83101965|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
46880526|NCT00101686|83101966|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
46880527|NCT00101686|83101967|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
46988309|NCT01641081|83234760|FG001|Period 1|Adverse Event|0|||
46880528|NCT00101686|83101968|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
46988310|NCT01641081|83234761|FG002|Period 1|Adverse Event|0|||
46880529|NCT00101686|83101969|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
46988311|NCT01641081|83234762|FG003|Period 1|Adverse Event|0|||
46988312|NCT01641081|83234763|FG004|Period 1|Adverse Event|0|||
46703990|NCT01243424|82918779|FG000|Discontinuation From Treatment|Protocol Violation|46|||
46703991|NCT01243424|82918780|FG001|Discontinuation From Treatment|Protocol Violation|47|||
46988313|NCT01641081|83234764|FG005|Period 1|Adverse Event|0|||
46988314|NCT01641081|83234765|FG006|Period 1|Adverse Event|0|||
46988315|NCT01641081|83234766|FG007|Period 1|Adverse Event|2|||
46880530|NCT00101686|83101970|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
46880531|NCT00101686|83101971|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
46880532|NCT00101686|83101972|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
46880533|NCT00101686|83101973|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
46988316|NCT01641081|83234767|FG008|Period 1|Adverse Event|0|||
46988317|NCT01641081|83234768|FG009|Period 1|Adverse Event|0|||
46988318|NCT01641081|83234759|FG000|Period 2|Adverse Event|0|||
46880534|NCT00101686|83101964|FG000|Overall Study|unacceptable toxicity|3|||
46880535|NCT00101686|83101965|FG001|Overall Study|unacceptable toxicity|9|||
46880536|NCT00101686|83101966|FG002|Overall Study|unacceptable toxicity|10|||
46880537|NCT00101686|83101967|FG003|Overall Study|unacceptable toxicity|6|||
46880538|NCT00101686|83101968|FG004|Overall Study|unacceptable toxicity|16|||
46880539|NCT00101686|83101969|FG005|Overall Study|unacceptable toxicity|10|||
46880540|NCT00101686|83101970|FG006|Overall Study|unacceptable toxicity|4|||
46988319|NCT01641081|83234760|FG001|Period 2|Adverse Event|0|||
46988320|NCT01641081|83234761|FG002|Period 2|Adverse Event|0|||
46880541|NCT00101686|83101971|FG007|Overall Study|unacceptable toxicity|2|||
46988321|NCT01641081|83234762|FG003|Period 2|Adverse Event|0|||
46988322|NCT01641081|83234763|FG004|Period 2|Adverse Event|0|||
46880542|NCT00101686|83101972|FG008|Overall Study|unacceptable toxicity|1|||
46880543|NCT00101686|83101973|FG009|Overall Study|unacceptable toxicity|4|||
46988323|NCT01641081|83234764|FG005|Period 2|Adverse Event|1|||
46988324|NCT01641081|83234765|FG006|Period 2|Adverse Event|0|||
46988325|NCT01641081|83234766|FG007|Period 2|Adverse Event|0|||
46988326|NCT01641081|83234767|FG008|Period 2|Adverse Event|0|||
46988327|NCT01641081|83234768|FG009|Period 2|Adverse Event|0|||
46988328|NCT01641081|83234759|FG000|Period 2|Withdrawal by Subject|0|||
46988329|NCT01641081|83234760|FG001|Period 2|Withdrawal by Subject|0|||
46988330|NCT01641081|83234761|FG002|Period 2|Withdrawal by Subject|0|||
46988331|NCT01641081|83234762|FG003|Period 2|Withdrawal by Subject|1|||
46988332|NCT01641081|83234763|FG004|Period 2|Withdrawal by Subject|0|||
46988333|NCT01641081|83234764|FG005|Period 2|Withdrawal by Subject|0|||
46988334|NCT01641081|83234765|FG006|Period 2|Withdrawal by Subject|2|||
46988335|NCT01641081|83234766|FG007|Period 2|Withdrawal by Subject|0|||
46988336|NCT01641081|83234767|FG008|Period 2|Withdrawal by Subject|0|||
46988337|NCT01641081|83234768|FG009|Period 2|Withdrawal by Subject|0|||
46988338|NCT01641081|83234759|FG000|Period 2|Protocol Violation|1|||
46988339|NCT01641081|83234760|FG001|Period 2|Protocol Violation|0|||
46988340|NCT01641081|83234761|FG002|Period 2|Protocol Violation|0|||
46988341|NCT01641081|83234762|FG003|Period 2|Protocol Violation|0|||
46988342|NCT01641081|83234763|FG004|Period 2|Protocol Violation|0|||
46988343|NCT01641081|83234764|FG005|Period 2|Protocol Violation|0|||
46988344|NCT01641081|83234765|FG006|Period 2|Protocol Violation|0|||
46988345|NCT01641081|83234766|FG007|Period 2|Protocol Violation|0|||
46988346|NCT01641081|83234767|FG008|Period 2|Protocol Violation|0|||
46988347|NCT01641081|83234768|FG009|Period 2|Protocol Violation|0|||
46988348|NCT01641081|83234759|FG000|Period 3|Adverse Event|0|||
46988349|NCT01641081|83234760|FG001|Period 3|Adverse Event|0|||
46988350|NCT01641081|83234761|FG002|Period 3|Adverse Event|1|||
46988351|NCT01641081|83234762|FG003|Period 3|Adverse Event|0|||
46988352|NCT01641081|83234763|FG004|Period 3|Adverse Event|0|||
46988353|NCT01641081|83234764|FG005|Period 3|Adverse Event|0|||
46988354|NCT01641081|83234765|FG006|Period 3|Adverse Event|0|||
46988355|NCT01641081|83234766|FG007|Period 3|Adverse Event|0|||
46988356|NCT01641081|83234767|FG008|Period 3|Adverse Event|0|||
46988357|NCT01641081|83234768|FG009|Period 3|Adverse Event|0|||
46988358|NCT01641081|83234759|FG000|Period 3|Withdrawal by Subject|0|||
46988359|NCT01641081|83234760|FG001|Period 3|Withdrawal by Subject|0|||
46988360|NCT01641081|83234761|FG002|Period 3|Withdrawal by Subject|0|||
46988361|NCT01641081|83234762|FG003|Period 3|Withdrawal by Subject|0|||
46988362|NCT01641081|83234763|FG004|Period 3|Withdrawal by Subject|0|||
46988363|NCT01641081|83234764|FG005|Period 3|Withdrawal by Subject|0|||
46988364|NCT01641081|83234765|FG006|Period 3|Withdrawal by Subject|0|||
46988365|NCT01641081|83234766|FG007|Period 3|Withdrawal by Subject|0|||
46988366|NCT01641081|83234767|FG008|Period 3|Withdrawal by Subject|1|||
46988367|NCT01641081|83234768|FG009|Period 3|Withdrawal by Subject|0|||
46988368|NCT01641081|83234759|FG000|Period 4|Adverse Event|0|||
46988369|NCT01641081|83234760|FG001|Period 4|Adverse Event|1|||
46988370|NCT01641081|83234761|FG002|Period 4|Adverse Event|0|||
46988371|NCT01641081|83234762|FG003|Period 4|Adverse Event|1|||
46988372|NCT01641081|83234763|FG004|Period 4|Adverse Event|0|||
46988373|NCT01641081|83234764|FG005|Period 4|Adverse Event|0|||
46988374|NCT01641081|83234765|FG006|Period 4|Adverse Event|0|||
46880544|NCT00101686|83101964|FG000|Overall Study|Randomized but did not receive treament|1|||
46880545|NCT00101686|83101965|FG001|Overall Study|Randomized but did not receive treament|6|||
46880546|NCT00101686|83101966|FG002|Overall Study|Randomized but did not receive treament|2|||
46880547|NCT00101686|83101967|FG003|Overall Study|Randomized but did not receive treament|2|||
46880548|NCT00101686|83101968|FG004|Overall Study|Randomized but did not receive treament|2|||
46880549|NCT00101686|83101969|FG005|Overall Study|Randomized but did not receive treament|2|||
46880550|NCT00101686|83101970|FG006|Overall Study|Randomized but did not receive treament|0|||
46880551|NCT00101686|83101971|FG007|Overall Study|Randomized but did not receive treament|1|||
46880552|NCT00101686|83101972|FG008|Overall Study|Randomized but did not receive treament|0|||
46880553|NCT00101686|83101973|FG009|Overall Study|Randomized but did not receive treament|1|||
46880554|NCT00101686|83101964|FG000|Overall Study|intercurrent non-cancer related illness|0|||
46988375|NCT01641081|83234766|FG007|Period 4|Adverse Event|0|||
46880555|NCT00101686|83101965|FG001|Overall Study|intercurrent non-cancer related illness|0|||
46880556|NCT00101686|83101966|FG002|Overall Study|intercurrent non-cancer related illness|2|||
46988376|NCT01641081|83234767|FG008|Period 4|Adverse Event|0|||
46880557|NCT00101686|83101967|FG003|Overall Study|intercurrent non-cancer related illness|0|||
46988377|NCT01641081|83234768|FG009|Period 4|Adverse Event|0|||
46988378|NCT01641081|83234759|FG000|Period 5|Adverse Event|0|||
46988379|NCT01641081|83234760|FG001|Period 5|Adverse Event|0|||
46988380|NCT01641081|83234761|FG002|Period 5|Adverse Event|2|||
46988381|NCT01641081|83234762|FG003|Period 5|Adverse Event|0|||
46988382|NCT01641081|83234763|FG004|Period 5|Adverse Event|0|||
46988383|NCT01641081|83234764|FG005|Period 5|Adverse Event|0|||
46988384|NCT01641081|83234765|FG006|Period 5|Adverse Event|0|||
46988385|NCT01641081|83234766|FG007|Period 5|Adverse Event|0|||
46988386|NCT01641081|83234767|FG008|Period 5|Adverse Event|0|||
46988387|NCT01641081|83234768|FG009|Period 5|Adverse Event|0|||
46988388|NCT01640925|83234782|FG000|Overall Study|Withdrawal by Subject|1|||
46988389|NCT01640925|83234783|FG001|Overall Study|Withdrawal by Subject|0|||
46988390|NCT01640925|83234782|FG000|Overall Study|Previously enrolled in this trial|13|||
46988391|NCT01640925|83234783|FG001|Overall Study|Previously enrolled in this trial|11|||
46988392|NCT01638429|83234789|FG000|Overall Study|Withdrawal by Subject|1|||
46988393|NCT01639755|83234797|FG000|Overall Study|Study Ongoing|15|||
46988394|NCT01639755|83234797|FG000|Overall Study|Patient had device explantation|4|||
46988395|NCT01601535|83234807|FG000|Phase 1|Adverse Event|1|||
46988396|NCT01601535|83234808|FG001|Phase 1|Adverse Event|0|||
46880558|NCT00101686|83101968|FG004|Overall Study|intercurrent non-cancer related illness|1|||
46880559|NCT00101686|83101969|FG005|Overall Study|intercurrent non-cancer related illness|3|||
46880560|NCT00101686|83101970|FG006|Overall Study|intercurrent non-cancer related illness|1|||
46880561|NCT00101686|83101971|FG007|Overall Study|intercurrent non-cancer related illness|0|||
46880562|NCT00101686|83101972|FG008|Overall Study|intercurrent non-cancer related illness|1|||
46880563|NCT00101686|83101973|FG009|Overall Study|intercurrent non-cancer related illness|1|||
46880564|NCT00101686|83101964|FG000|Overall Study|Physician Decision|10|||
46880565|NCT00101686|83101965|FG001|Overall Study|Physician Decision|13|||
46880566|NCT00101686|83101966|FG002|Overall Study|Physician Decision|6|||
46880567|NCT00101686|83101967|FG003|Overall Study|Physician Decision|7|||
46880568|NCT00101686|83101968|FG004|Overall Study|Physician Decision|8|||
46880569|NCT00101686|83101969|FG005|Overall Study|Physician Decision|9|||
46880570|NCT00101686|83101970|FG006|Overall Study|Physician Decision|5|||
46880571|NCT00101686|83101971|FG007|Overall Study|Physician Decision|5|||
46880572|NCT00101686|83101972|FG008|Overall Study|Physician Decision|1|||
46880573|NCT00101686|83101973|FG009|Overall Study|Physician Decision|1|||
46880574|NCT00101686|83101964|FG000|Overall Study|Other|1|||
46880575|NCT00101686|83101965|FG001|Overall Study|Other|4|||
46880576|NCT00101686|83101966|FG002|Overall Study|Other|1|||
46880577|NCT00101686|83101967|FG003|Overall Study|Other|6|||
46880578|NCT00101686|83101968|FG004|Overall Study|Other|2|||
46880579|NCT00101686|83101969|FG005|Overall Study|Other|12|||
46880580|NCT00101686|83101970|FG006|Overall Study|Other|1|||
46880581|NCT00101686|83101971|FG007|Overall Study|Other|5|||
46880582|NCT00101686|83101972|FG008|Overall Study|Other|3|||
46880583|NCT00101686|83101973|FG009|Overall Study|Other|3|||
46880584|NCT00101686|83101964|FG000|Overall Study|Withdrawal by Subject|9|||
46880585|NCT00101686|83101965|FG001|Overall Study|Withdrawal by Subject|8|||
46880586|NCT00101686|83101966|FG002|Overall Study|Withdrawal by Subject|6|||
46880587|NCT00101686|83101967|FG003|Overall Study|Withdrawal by Subject|8|||
46880588|NCT00101686|83101968|FG004|Overall Study|Withdrawal by Subject|8|||
46880589|NCT00101686|83101969|FG005|Overall Study|Withdrawal by Subject|7|||
46880590|NCT00101686|83101970|FG006|Overall Study|Withdrawal by Subject|7|||
46880591|NCT00101686|83101971|FG007|Overall Study|Withdrawal by Subject|7|||
46880592|NCT00101686|83101972|FG008|Overall Study|Withdrawal by Subject|8|||
46880593|NCT00101686|83101973|FG009|Overall Study|Withdrawal by Subject|9|||
46880594|NCT00101452|83101993|FG000|Overall Study|Adverse Event|2|||
46880595|NCT00101452|83101994|FG001|Overall Study|Adverse Event|0|||
46880596|NCT00101452|83101995|FG002|Overall Study|Adverse Event|1|||
46880597|NCT00101452|83101993|FG000|Overall Study|Lost to Follow-up|13|||
46880598|NCT00101452|83101994|FG001|Overall Study|Lost to Follow-up|8|||
46880599|NCT00101452|83101995|FG002|Overall Study|Lost to Follow-up|14|||
46880600|NCT00101452|83101993|FG000|Overall Study|Withdrawal by Subject|10|||
46880601|NCT00101452|83101994|FG001|Overall Study|Withdrawal by Subject|14|||
46880602|NCT00101452|83101995|FG002|Overall Study|Withdrawal by Subject|9|||
46880603|NCT00101452|83101993|FG000|Overall Study|Baseline Fail|2|||
46880604|NCT00101452|83101994|FG001|Overall Study|Baseline Fail|1|||
46880605|NCT00101452|83101995|FG002|Overall Study|Baseline Fail|2|||
46880606|NCT00101452|83101993|FG000|Overall Study|Physician Decision|0|||
46880607|NCT00101452|83101994|FG001|Overall Study|Physician Decision|3|||
46880608|NCT00101452|83101995|FG002|Overall Study|Physician Decision|2|||
46880609|NCT00101452|83101993|FG000|Overall Study|Protocol Violation|2|||
46880610|NCT00101452|83101994|FG001|Overall Study|Protocol Violation|1|||
46880611|NCT00101452|83101995|FG002|Overall Study|Protocol Violation|3|||
46880612|NCT00101452|83101993|FG000|Overall Study|Other|15|||
46880613|NCT00101452|83101994|FG001|Overall Study|Other|16|||
46988397|NCT01601535|83234809|FG002|Phase 1|Adverse Event|2|||
46988398|NCT01601535|83234810|FG003|Phase 1|Adverse Event|1|||
46988399|NCT01601535|83234811|FG004|Phase 1|Adverse Event|0|||
46988400|NCT01601535|83234812|FG005|Phase 1|Adverse Event|0|||
46988401|NCT01601535|83234807|FG000|Phase 1|Withdrawal by Subject|2|||
46988402|NCT01601535|83234808|FG001|Phase 1|Withdrawal by Subject|1|||
46988403|NCT01601535|83234809|FG002|Phase 1|Withdrawal by Subject|1|||
46988404|NCT01601535|83234810|FG003|Phase 1|Withdrawal by Subject|2|||
46988405|NCT01601535|83234811|FG004|Phase 1|Withdrawal by Subject|0|||
46988406|NCT01601535|83234812|FG005|Phase 1|Withdrawal by Subject|0|||
46988407|NCT01601535|83234807|FG000|Phase 1|Progressive Disease|2|||
46988408|NCT01601535|83234808|FG001|Phase 1|Progressive Disease|3|||
46988409|NCT01601535|83234809|FG002|Phase 1|Progressive Disease|2|||
46988410|NCT01601535|83234810|FG003|Phase 1|Progressive Disease|1|||
46988411|NCT01601535|83234811|FG004|Phase 1|Progressive Disease|0|||
46988412|NCT01601535|83234812|FG005|Phase 1|Progressive Disease|0|||
46988413|NCT01601535|83234807|FG000|Phase 1|Started Another Treatment|1|||
46988414|NCT01601535|83234808|FG001|Phase 1|Started Another Treatment|2|||
46988415|NCT01601535|83234809|FG002|Phase 1|Started Another Treatment|0|||
46988416|NCT01601535|83234810|FG003|Phase 1|Started Another Treatment|0|||
46988417|NCT01601535|83234811|FG004|Phase 1|Started Another Treatment|0|||
46988418|NCT01601535|83234812|FG005|Phase 1|Started Another Treatment|0|||
46988419|NCT01601535|83234807|FG000|Phase 2|Adverse Event|0|||
46988420|NCT01601535|83234808|FG001|Phase 2|Adverse Event|0|||
46988421|NCT01601535|83234809|FG002|Phase 2|Adverse Event|0|||
46988422|NCT01601535|83234810|FG003|Phase 2|Adverse Event|0|||
46988423|NCT01601535|83234811|FG004|Phase 2|Adverse Event|5|||
46988424|NCT01601535|83234812|FG005|Phase 2|Adverse Event|1|||
46880614|NCT00101452|83101995|FG002|Overall Study|Other|12|||
46880615|NCT03546621|83102011|FG000|Overall Study|Withdrawal by Subject|0|||
46880616|NCT03546621|83102012|FG001|Overall Study|Withdrawal by Subject|1|||
46880617|NCT03546621|83102013|FG002|Overall Study|Withdrawal by Subject|2|||
46880618|NCT03546621|83102014|FG003|Overall Study|Withdrawal by Subject|1|||
46988425|NCT01601535|83234807|FG000|Phase 2|Withdrawal by Subject|0|||
46988426|NCT01601535|83234808|FG001|Phase 2|Withdrawal by Subject|0|||
46988427|NCT01601535|83234809|FG002|Phase 2|Withdrawal by Subject|0|||
46988428|NCT01601535|83234810|FG003|Phase 2|Withdrawal by Subject|0|||
46988429|NCT01601535|83234811|FG004|Phase 2|Withdrawal by Subject|8|||
46988430|NCT01601535|83234812|FG005|Phase 2|Withdrawal by Subject|2|||
46988431|NCT01601535|83234807|FG000|Phase 2|Progressive Disease|0|||
46988432|NCT01601535|83234808|FG001|Phase 2|Progressive Disease|0|||
46988433|NCT01601535|83234809|FG002|Phase 2|Progressive Disease|0|||
46988434|NCT01601535|83234810|FG003|Phase 2|Progressive Disease|0|||
46988435|NCT01601535|83234811|FG004|Phase 2|Progressive Disease|5|||
46988436|NCT01601535|83234812|FG005|Phase 2|Progressive Disease|7|||
46988437|NCT01601535|83234807|FG000|Phase 2|Started Another Treatment|0|||
46988438|NCT01601535|83234808|FG001|Phase 2|Started Another Treatment|0|||
46988439|NCT01601535|83234809|FG002|Phase 2|Started Another Treatment|0|||
46988440|NCT01601535|83234810|FG003|Phase 2|Started Another Treatment|0|||
46988441|NCT01601535|83234811|FG004|Phase 2|Started Another Treatment|1|||
46988442|NCT01601535|83234812|FG005|Phase 2|Started Another Treatment|2|||
46988443|NCT01638819|83234837|FG000|Overall Study|Lost to Follow-up|1|||
46988444|NCT01638819|83234838|FG001|Overall Study|Lost to Follow-up|0|||
46988445|NCT01363713|83234843|FG000|Overall Study|Adverse Event|1|||
46988446|NCT01363713|83234843|FG000|Overall Study|Protocol Violation|3|||
46988447|NCT01363713|83234843|FG000|Overall Study|Withdrawal by Subject|2|||
46988448|NCT01637961|83234847|FG000|Overall Study|Ineligible: wrong primary|1|||
46988449|NCT01637961|83234847|FG000|Overall Study|Ineligible: inadequate pathology|1|||
46988450|NCT04183335|83234859|FG000|Overall Study|Adverse Event|1|||
46988451|NCT04183335|83234860|FG001|Overall Study|Adverse Event|0|||
46988452|NCT04183335|83234859|FG000|Overall Study|Withdrawal by Subject|12|||
46988453|NCT04183335|83234860|FG001|Overall Study|Withdrawal by Subject|3|||
46988454|NCT04199793|83234868|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
46988455|NCT04199793|83234869|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
46988456|NCT04199793|83234868|FG000|Overall Study|Withdrawal by Subject|1|||
46988457|NCT04199793|83234869|FG001|Overall Study|Withdrawal by Subject|1|||
46988458|NCT01636947|83234877|FG000|Overall Study|Not Treated|2|||
46988459|NCT01636947|83234878|FG001|Overall Study|Not Treated|2|||
46988460|NCT01636947|83234877|FG000|Overall Study|Lost to Follow-up|4|||
46988461|NCT01636947|83234878|FG001|Overall Study|Lost to Follow-up|0|||
46988462|NCT01636947|83234877|FG000|Overall Study|Protocol Violation|1|||
46988463|NCT01636947|83234878|FG001|Overall Study|Protocol Violation|1|||
46988464|NCT01636947|83234877|FG000|Overall Study|Withdrawal by Subject|3|||
46988465|NCT01636947|83234878|FG001|Overall Study|Withdrawal by Subject|3|||
46988466|NCT01636947|83234877|FG000|Overall Study|Adverse Event|1|||
46988467|NCT01636947|83234878|FG001|Overall Study|Adverse Event|1|||
46988468|NCT01636947|83234877|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
46988469|NCT01636947|83234878|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
46988470|NCT01635933|83234886|FG000|Overall Study|Adverse Event|1|||
46988471|NCT01635933|83234887|FG001|Overall Study|Adverse Event|0|||
46988472|NCT01635933|83234886|FG000|Overall Study|Lost to Follow-up|0|||
46988473|NCT01635933|83234887|FG001|Overall Study|Lost to Follow-up|5|||
46988474|NCT01635933|83234886|FG000|Overall Study|Subject decision|1|||
46988475|NCT01635933|83234887|FG001|Overall Study|Subject decision|1|||
46988476|NCT01635933|83234886|FG000|Overall Study|Noncompliance|0|||
46988477|NCT01635933|83234887|FG001|Overall Study|Noncompliance|1|||
46988478|NCT01635933|83234886|FG000|Overall Study|No longer had transportation|0|||
46988479|NCT01635933|83234887|FG001|Overall Study|No longer had transportation|1|||
46988480|NCT01635855|83234893|FG000|Overall Study|Withdrawal by Subject|4|||
46988481|NCT03052725|83234899|FG000|Overall Study|Adverse Event|2|||
46988482|NCT03052725|83234900|FG001|Overall Study|Adverse Event|0|||
46988483|NCT03052725|83234899|FG000|Overall Study|Withdrawal by Subject|3|||
46703992|NCT01243424|82918779|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
46703993|NCT01243424|82918780|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
46703994|NCT01243424|82918779|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
46703995|NCT01243424|82918780|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
46703996|NCT01243424|82918779|FG000|Discontinuation From Treatment|Other than listed above|230|||
46703997|NCT01243424|82918780|FG001|Discontinuation From Treatment|Other than listed above|211|||
46703998|NCT00887809|82918789|FG000|Overall Study|Patient Not Treated|3|||
46703999|NCT00887809|82918790|FG001|Overall Study|Patient Not Treated|0|||
46704000|NCT00887809|82918789|FG000|Overall Study|Death|1|||
46704001|NCT00887809|82918790|FG001|Overall Study|Death|0|||
46704002|NCT00958126|82918804|FG000|Overall Study|Serious Adverse Event|0|||
46704003|NCT00958126|82918805|FG001|Overall Study|Serious Adverse Event|2|||
46704004|NCT00958126|82918806|FG002|Overall Study|Serious Adverse Event|0|||
46704005|NCT00958126|82918807|FG003|Overall Study|Serious Adverse Event|0|||
46704006|NCT00958126|82918808|FG004|Overall Study|Serious Adverse Event|0|||
46704007|NCT00958126|82918809|FG005|Overall Study|Serious Adverse Event|0|||
46880619|NCT03546621|83102011|FG000|Overall Study|Lost to Follow-up|0|||
46704008|NCT00958126|82918810|FG006|Overall Study|Serious Adverse Event|1|||
46704009|NCT00958126|82918811|FG007|Overall Study|Serious Adverse Event|0|||
46704010|NCT00958126|82918804|FG000|Overall Study|Withdrawal by Subject|0|||
46704011|NCT00958126|82918805|FG001|Overall Study|Withdrawal by Subject|2|||
46704012|NCT00958126|82918806|FG002|Overall Study|Withdrawal by Subject|0|||
46704013|NCT00958126|82918807|FG003|Overall Study|Withdrawal by Subject|0|||
46704014|NCT00958126|82918808|FG004|Overall Study|Withdrawal by Subject|0|||
46704015|NCT00958126|82918809|FG005|Overall Study|Withdrawal by Subject|0|||
46704016|NCT00958126|82918810|FG006|Overall Study|Withdrawal by Subject|0|||
46704017|NCT00958126|82918811|FG007|Overall Study|Withdrawal by Subject|0|||
46704018|NCT00958126|82918804|FG000|Overall Study|Moved away from study area|0|||
46704019|NCT00958126|82918805|FG001|Overall Study|Moved away from study area|0|||
46988484|NCT03052725|83234900|FG001|Overall Study|Withdrawal by Subject|4|||
46988485|NCT03052725|83234899|FG000|Overall Study|Pregnancy|0|||
46988486|NCT03052725|83234900|FG001|Overall Study|Pregnancy|1|||
46988487|NCT03052725|83234899|FG000|Overall Study|Site closure|0|||
46988488|NCT03052725|83234900|FG001|Overall Study|Site closure|1|||
46988489|NCT03052725|83234899|FG000|Overall Study|Study terminated by sponsor|143|||
46988490|NCT03052725|83234900|FG001|Overall Study|Study terminated by sponsor|144|||
46988491|NCT01635153|83234924|FG000|Overall Study|Lost to Follow-up|40|||
46988492|NCT01635153|83234925|FG001|Overall Study|Lost to Follow-up|43|||
46988493|NCT01636713|83234934|FG000|Overall Study|Adverse Event|16|||
46988494|NCT01636713|83234935|FG001|Overall Study|Adverse Event|16|||
46988495|NCT01636713|83234936|FG002|Overall Study|Adverse Event|7|||
46988496|NCT01636713|83234934|FG000|Overall Study|Lack of Efficacy|6|||
46988497|NCT01636713|83234935|FG001|Overall Study|Lack of Efficacy|6|||
46988498|NCT01636713|83234936|FG002|Overall Study|Lack of Efficacy|2|||
46988499|NCT01636713|83234934|FG000|Overall Study|Protocol Violation|3|||
46988500|NCT01636713|83234935|FG001|Overall Study|Protocol Violation|0|||
46988501|NCT01636713|83234936|FG002|Overall Study|Protocol Violation|1|||
46988502|NCT01636713|83234934|FG000|Overall Study|Lost to Follow-up|0|||
46988503|NCT01636713|83234935|FG001|Overall Study|Lost to Follow-up|0|||
46988504|NCT01636713|83234936|FG002|Overall Study|Lost to Follow-up|1|||
46988505|NCT01636713|83234934|FG000|Overall Study|Withdrawal by Subject|5|||
46988506|NCT01636713|83234935|FG001|Overall Study|Withdrawal by Subject|4|||
46988507|NCT01636713|83234936|FG002|Overall Study|Withdrawal by Subject|8|||
46988508|NCT01636713|83234934|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
46988509|NCT01636713|83234935|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
46988510|NCT01636713|83234936|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
46988511|NCT01600053|83234944|FG000|Overall Study|Adverse Event|2|||
46988512|NCT01600053|83234944|FG000|Overall Study|trial will not meet the interim endpoint|9|||
46988513|NCT01068249|83234948|FG000|Overall Study|Death|1|||
46988514|NCT01068249|83234948|FG000|Overall Study|Withdrawal by Subject|3|||
46988515|NCT02246673|83234984|FG000|Overall Study|Sponsor Decision|1|||
46988516|NCT02246673|83234985|FG001|Overall Study|Sponsor Decision|0|||
46988517|NCT02246673|83234986|FG002|Overall Study|Sponsor Decision|0|||
46988518|NCT02246673|83234987|FG003|Overall Study|Sponsor Decision|0|||
46988519|NCT02246673|83234988|FG004|Overall Study|Sponsor Decision|0|||
46988520|NCT02246673|83234984|FG000|Overall Study|Withdrawal by Subject|0|||
46988521|NCT02246673|83234985|FG001|Overall Study|Withdrawal by Subject|0|||
46988522|NCT02246673|83234986|FG002|Overall Study|Withdrawal by Subject|0|||
46988523|NCT02246673|83234987|FG003|Overall Study|Withdrawal by Subject|0|||
46988524|NCT02246673|83234988|FG004|Overall Study|Withdrawal by Subject|1|||
46988525|NCT02246673|83234984|FG000|Overall Study|Lost to Follow-up|0|||
46988526|NCT02246673|83234985|FG001|Overall Study|Lost to Follow-up|0|||
46704020|NCT00958126|82918806|FG002|Overall Study|Moved away from study area|1|||
46802879|NCT00423670|83022132|FG007|Treatment Period|Investigator decision|1|||
46988527|NCT02246673|83234986|FG002|Overall Study|Lost to Follow-up|0|||
46988528|NCT02246673|83234987|FG003|Overall Study|Lost to Follow-up|1|||
46988529|NCT02246673|83234988|FG004|Overall Study|Lost to Follow-up|0|||
46988530|NCT02246673|83234984|FG000|Overall Study|Protocol Violation|0|||
46988531|NCT02246673|83234985|FG001|Overall Study|Protocol Violation|0|||
46988532|NCT02246673|83234986|FG002|Overall Study|Protocol Violation|0|||
46988533|NCT02246673|83234987|FG003|Overall Study|Protocol Violation|1|||
46988534|NCT02246673|83234988|FG004|Overall Study|Protocol Violation|0|||
46988535|NCT02246439|83235050|FG000|Overall Study|Adverse Event|3|||
46988536|NCT02246439|83235051|FG001|Overall Study|Adverse Event|0|||
46988537|NCT02246439|83235050|FG000|Overall Study|Lost to Follow-up|7|||
46988538|NCT02246439|83235051|FG001|Overall Study|Lost to Follow-up|5|||
46988539|NCT02246439|83235050|FG000|Overall Study|Protocol Violation|0|||
46988540|NCT02246439|83235051|FG001|Overall Study|Protocol Violation|2|||
46988541|NCT02246439|83235050|FG000|Overall Study|Physician Decision|0|||
46988542|NCT02246439|83235051|FG001|Overall Study|Physician Decision|1|||
46988543|NCT02246439|83235050|FG000|Overall Study|Unkonwn|1|||
46988544|NCT02246439|83235051|FG001|Overall Study|Unkonwn|3|||
46988545|NCT02246439|83235050|FG000|Overall Study|Withdrawal by Subject|1|||
46988546|NCT02246439|83235051|FG001|Overall Study|Withdrawal by Subject|0|||
46988547|NCT02245737|83235060|FG000|Overall Study|Adverse Event|23|||
46988548|NCT02245737|83235061|FG001|Overall Study|Adverse Event|26|||
46988549|NCT02245737|83235062|FG002|Overall Study|Adverse Event|33|||
46988550|NCT02245737|83235060|FG000|Overall Study|Condition Worsened|9|||
46988551|NCT02245737|83235061|FG001|Overall Study|Condition Worsened|10|||
46988552|NCT02245737|83235062|FG002|Overall Study|Condition Worsened|9|||
46988553|NCT02245737|83235060|FG000|Overall Study|Death|2|||
46988554|NCT02245737|83235061|FG001|Overall Study|Death|4|||
46988555|NCT02245737|83235062|FG002|Overall Study|Death|4|||
46988556|NCT02245737|83235060|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
46988557|NCT02245737|83235061|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
46988558|NCT02245737|83235062|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
46988559|NCT02245737|83235060|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
46988560|NCT02245737|83235061|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
46988561|NCT02245737|83235062|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
46988562|NCT02245737|83235060|FG000|Overall Study|Lost to Follow-up|2|||
46988563|NCT02245737|83235061|FG001|Overall Study|Lost to Follow-up|5|||
46988564|NCT02245737|83235062|FG002|Overall Study|Lost to Follow-up|4|||
46988565|NCT02245737|83235060|FG000|Overall Study|Other-determined by Investigator|9|||
46988566|NCT02245737|83235061|FG001|Overall Study|Other-determined by Investigator|10|||
46988567|NCT02245737|83235062|FG002|Overall Study|Other-determined by Investigator|10|||
46988568|NCT02245737|83235060|FG000|Overall Study|Physician Decision|6|||
46988569|NCT02245737|83235061|FG001|Overall Study|Physician Decision|3|||
46988570|NCT02245737|83235062|FG002|Overall Study|Physician Decision|6|||
46988571|NCT02245737|83235060|FG000|Overall Study|Protocol Violation|3|||
46988572|NCT02245737|83235061|FG001|Overall Study|Protocol Violation|2|||
46988573|NCT02245737|83235062|FG002|Overall Study|Protocol Violation|3|||
46988574|NCT02245737|83235060|FG000|Overall Study|Withdrawal by Subject|40|||
46988575|NCT02245737|83235061|FG001|Overall Study|Withdrawal by Subject|41|||
46988576|NCT02245737|83235062|FG002|Overall Study|Withdrawal by Subject|44|||
46988577|NCT02245737|83235060|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
46988578|NCT02245737|83235061|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
46988579|NCT02245737|83235062|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
46988580|NCT02245737|83235060|FG000|Overall Study|Sponsor Decision|445|||
46988581|NCT02245737|83235061|FG001|Overall Study|Sponsor Decision|430|||
46988582|NCT02245737|83235062|FG002|Overall Study|Sponsor Decision|432|||
46988583|NCT02244957|83235074|FG000|Overall Study|Lack of Efficacy|1|||
46988584|NCT02244957|83235075|FG001|Overall Study|Lack of Efficacy|0|||
46988585|NCT02243865|83235085|FG000|Overall Study|Protocol Violation|1|||
46988586|NCT02243865|83235086|FG001|Overall Study|Protocol Violation|3|||
46988587|NCT02243865|83235085|FG000|Overall Study|Lost to Follow-up|1|||
46988588|NCT02243865|83235086|FG001|Overall Study|Lost to Follow-up|1|||
46988589|NCT02243865|83235085|FG000|Overall Study|Withdrawal by Subject|1|||
46988590|NCT02243865|83235086|FG001|Overall Study|Withdrawal by Subject|0|||
46988591|NCT02243865|83235085|FG000|Overall Study|Adverse Event|1|||
46988592|NCT02243865|83235086|FG001|Overall Study|Adverse Event|1|||
46988593|NCT02243631|83235096|FG000|Overall Study|no synovial fluid on second aspirate|0|||
46988594|NCT02243631|83235097|FG001|Overall Study|no synovial fluid on second aspirate|1|||
46988595|NCT02242305|83235105|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
46988596|NCT02242305|83235106|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
46988597|NCT02242305|83235105|FG000|Overall Study|Adverse Event|1|||
46988598|NCT02242305|83235106|FG001|Overall Study|Adverse Event|0|||
46988599|NCT02242305|83235105|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
46988600|NCT02242305|83235106|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
46988601|NCT02242305|83235105|FG000|Overall Study|Subject withdraws inform consent|0|||
46988602|NCT02242305|83235106|FG001|Overall Study|Subject withdraws inform consent|4|||
46988603|NCT02242305|83235105|FG000|Overall Study|Lost to Follow-up|2|||
46988604|NCT02242305|83235106|FG001|Overall Study|Lost to Follow-up|0|||
46988605|NCT02240121|83235114|FG000|Overall Study|Protocol Violation|1|||
46988606|NCT02240121|83235115|FG001|Overall Study|Protocol Violation|2|||
46988607|NCT02240121|83235114|FG000|Overall Study|Physician Decision|0|||
46988608|NCT02240121|83235115|FG001|Overall Study|Physician Decision|1|||
46988609|NCT02240121|83235114|FG000|Overall Study|Change in protocol interpretation|1|||
46988610|NCT02240121|83235115|FG001|Overall Study|Change in protocol interpretation|0|||
46988611|NCT02240121|83235114|FG000|Overall Study|Lack of Efficacy|2|||
46988612|NCT02240121|83235115|FG001|Overall Study|Lack of Efficacy|3|||
46988613|NCT02240121|83235114|FG000|Overall Study|Site closed|1|||
46988614|NCT02240121|83235115|FG001|Overall Study|Site closed|1|||
46988615|NCT02240121|83235114|FG000|Overall Study|Pregnancy|1|||
46988616|NCT02240121|83235115|FG001|Overall Study|Pregnancy|0|||
46988617|NCT02240121|83235114|FG000|Overall Study|Adverse Event|2|||
46988618|NCT02240121|83235115|FG001|Overall Study|Adverse Event|4|||
46988619|NCT02240121|83235114|FG000|Overall Study|Withdrawal by Subject|6|||
46988620|NCT02240121|83235115|FG001|Overall Study|Withdrawal by Subject|2|||
46988621|NCT02240121|83235114|FG000|Overall Study|Lost to Follow-up|3|||
46988622|NCT02240121|83235115|FG001|Overall Study|Lost to Follow-up|4|||
46988623|NCT02240121|83235114|FG000|Overall Study|Other than specified|1|||
46988624|NCT02240121|83235115|FG001|Overall Study|Other than specified|3|||
46988625|NCT02239263|83235121|FG000|Overall Study|Protocol Violation|6|||
46988626|NCT02238483|83235129|FG000|Overall Study|Withdrawal by Subject|2|||
46988627|NCT02238483|83235130|FG001|Overall Study|Withdrawal by Subject|7|||
46988628|NCT02238483|83235129|FG000|Overall Study|Lost to Follow-up|1|||
46988629|NCT02238483|83235130|FG001|Overall Study|Lost to Follow-up|1|||
46988630|NCT02238483|83235129|FG000|Overall Study|Protocol Violation|1|||
46988631|NCT02238483|83235130|FG001|Overall Study|Protocol Violation|2|||
46988632|NCT02238483|83235129|FG000|Overall Study|Death|1|||
46988633|NCT02238483|83235130|FG001|Overall Study|Death|0|||
46988634|NCT02238483|83235129|FG000|Overall Study|Adverse Event|7|||
46988635|NCT02238483|83235130|FG001|Overall Study|Adverse Event|3|||
46988636|NCT02238483|83235129|FG000|Overall Study|Withdrawn due to physician decision|1|||
46988637|NCT02238483|83235130|FG001|Overall Study|Withdrawn due to physician decision|0|||
46988638|NCT02238483|83235129|FG000|Overall Study|Completion status not recorded|1|||
46988639|NCT02238483|83235130|FG001|Overall Study|Completion status not recorded|1|||
46988640|NCT02238483|83235129|FG000|Overall Study|Illness in family member|1|||
46988641|NCT02238483|83235130|FG001|Overall Study|Illness in family member|0|||
46988642|NCT01632891|83235138|FG000|Overall Study|Lost to Follow-up|0|||
46988643|NCT01632891|83235139|FG001|Overall Study|Lost to Follow-up|1|||
46988644|NCT01632891|83235138|FG000|Overall Study|Withdrawal by Subject|1|||
46988645|NCT01632891|83235139|FG001|Overall Study|Withdrawal by Subject|0|||
46988646|NCT02208999|83235151|FG000|Overall Study|Lost to Follow-up|1|||
46988647|NCT02208843|83235170|FG000|Overall Study|Clinical symptoms of progression|2|||
46988648|NCT02208843|83235170|FG000|Overall Study|Progression disease according to RECIST|24|||
46988649|NCT02208843|83235170|FG000|Overall Study|Adverse Event|12|||
46988650|NCT02208843|83235170|FG000|Overall Study|Protocol Violation|1|||
46988651|NCT02208843|83235170|FG000|Overall Study|Withdrawal by Subject|1|||
46988652|NCT02208843|83235170|FG000|Overall Study|Switched to commercial afatinib|20|||
46988653|NCT02208063|83235176|FG000|Overall Study|Death|3|||
46988654|NCT02208063|83235177|FG001|Overall Study|Death|5|||
46988655|NCT02208063|83235176|FG000|Overall Study|Not Specified in report|3|||
46988656|NCT02208063|83235177|FG001|Overall Study|Not Specified in report|4|||
46988657|NCT02208063|83235176|FG000|Overall Study|Withdrawal by Subject|5|||
46988658|NCT02208063|83235177|FG001|Overall Study|Withdrawal by Subject|2|||
46988659|NCT02208063|83235176|FG000|Overall Study|Lost to Follow-up|1|||
46988660|NCT02208063|83235177|FG001|Overall Study|Lost to Follow-up|0|||
46988661|NCT02207907|83235185|FG000|Overall Study|Lost to Follow-up|3|||
46988662|NCT02207907|83235186|FG001|Overall Study|Lost to Follow-up|1|||
46988663|NCT02207907|83235185|FG000|Overall Study|Withdrawal by Subject|5|||
46988664|NCT02207907|83235186|FG001|Overall Study|Withdrawal by Subject|6|||
46988665|NCT02207907|83235185|FG000|Overall Study|Did not meet study criteria|3|||
46988666|NCT02207907|83235186|FG001|Overall Study|Did not meet study criteria|0|||
46988667|NCT02207907|83235185|FG000|Overall Study|Pregnancy|0|||
46988668|NCT02207907|83235186|FG001|Overall Study|Pregnancy|1|||
46988669|NCT02207829|83235195|FG000|Overall Study|Adverse Event|10|||
46988670|NCT02207829|83235196|FG001|Overall Study|Adverse Event|9|||
46988671|NCT02207829|83235195|FG000|Overall Study|Lack of Efficacy|7|||
46988672|NCT02207829|83235196|FG001|Overall Study|Lack of Efficacy|5|||
46988673|NCT02207829|83235195|FG000|Overall Study|Lost to Follow-up|2|||
46988674|NCT02207829|83235196|FG001|Overall Study|Lost to Follow-up|2|||
46988675|NCT02207829|83235195|FG000|Overall Study|Protocol deviation|5|||
46988676|NCT02207829|83235196|FG001|Overall Study|Protocol deviation|4|||
46988677|NCT02207829|83235195|FG000|Overall Study|Withdrew consent|18|||
46988678|NCT02207829|83235196|FG001|Overall Study|Withdrew consent|14|||
46988679|NCT02237157|83235202|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
46988680|NCT02237157|83235203|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
46988681|NCT02237157|83235204|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
46988682|NCT02237157|83235205|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
46988683|NCT02237157|83235202|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
46988684|NCT02237157|83235203|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
46988685|NCT02237157|83235204|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
46988686|NCT02237157|83235205|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
46988687|NCT02237001|83235212|FG000|Overall Study|Lost to Follow-up|2|||
46988688|NCT02237001|83235212|FG000|Overall Study|Withdrawal by Subject|1|||
46988689|NCT02237001|83235212|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
46988690|NCT02237001|83235212|FG000|Overall Study|Re-operation|4|||
46988691|NCT02237001|83235212|FG000|Overall Study|Incarceration|1|||
46988692|NCT02236611|83235218|FG000|Overall Study|Adverse Event|10|||
46988693|NCT02236611|83235219|FG001|Overall Study|Adverse Event|16|||
46988694|NCT02236611|83235218|FG000|Overall Study|Lack of Efficacy|4|||
46988695|NCT02236611|83235219|FG001|Overall Study|Lack of Efficacy|7|||
46988696|NCT02236611|83235218|FG000|Overall Study|Lost to Follow-up|0|||
46988697|NCT02236611|83235219|FG001|Overall Study|Lost to Follow-up|2|||
46988698|NCT02236611|83235218|FG000|Overall Study|Protocol deviation|3|||
46988699|NCT02236611|83235219|FG001|Overall Study|Protocol deviation|5|||
46988700|NCT02236611|83235218|FG000|Overall Study|Withdrew consent|9|||
46988701|NCT02236611|83235219|FG001|Overall Study|Withdrew consent|4|||
46988702|NCT02234583|83235227|FG000|Overall Study|Adverse Event|172|||
46988703|NCT02234583|83235228|FG001|Overall Study|Adverse Event|156|||
46988704|NCT02234583|83235227|FG000|Overall Study|Withdrawal by Subject|109|||
46988705|NCT02234583|83235228|FG001|Overall Study|Withdrawal by Subject|157|||
46988706|NCT02234583|83235227|FG000|Overall Study|Lost to Follow-up|0|||
46988707|NCT02234583|83235228|FG001|Overall Study|Lost to Follow-up|1|||
46988708|NCT02234583|83235227|FG000|Overall Study|Lack of Efficacy|58|||
46988709|NCT02234583|83235228|FG001|Overall Study|Lack of Efficacy|103|||
46988710|NCT02234583|83235227|FG000|Overall Study|Protocol Violation|35|||
46988711|NCT02234583|83235228|FG001|Overall Study|Protocol Violation|42|||
46988712|NCT02234583|83235227|FG000|Overall Study|Other|39|||
46988713|NCT02234583|83235228|FG001|Overall Study|Other|97|||
46988714|NCT03686397|83235242|FG000|Overall Study|Lack of Efficacy|3|||
46988715|NCT03686397|83235243|FG001|Overall Study|Lack of Efficacy|5|||
46988716|NCT03686397|83235242|FG000|Overall Study|Adverse Event|0|||
46988717|NCT03686397|83235243|FG001|Overall Study|Adverse Event|1|||
46988718|NCT03686397|83235242|FG000|Overall Study|Protocol Violation|0|||
46988719|NCT03686397|83235243|FG001|Overall Study|Protocol Violation|1|||
46988720|NCT03686397|83235242|FG000|Overall Study|Withdrawal by Subject|0|||
46988721|NCT03686397|83235243|FG001|Overall Study|Withdrawal by Subject|1|||
46988722|NCT03686397|83235242|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
46988723|NCT03686397|83235243|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
46988724|NCT02233803|83235249|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
46988725|NCT02233803|83235250|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
46988726|NCT02233803|83235249|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
46988727|NCT02233803|83235250|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
46988728|NCT02233803|83235249|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
46988729|NCT02233803|83235250|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
46988730|NCT02233803|83235249|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
46988731|NCT02233803|83235250|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
46988732|NCT02233803|83235249|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
46988733|NCT02233803|83235250|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
46988734|NCT02233803|83235249|FG000|Washout Period (4-Wks)|Physician Decision|1|||
46988735|NCT02233803|83235250|FG001|Washout Period (4-Wks)|Physician Decision|0|||
46988736|NCT02233803|83235249|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
46988737|NCT02233803|83235250|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
46988738|NCT02233803|83235249|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
46988739|NCT02233803|83235250|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
46988740|NCT02233803|83235249|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
46988741|NCT02233803|83235250|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
46988742|NCT02233647|83235258|FG000|Overall Study|Adverse Event|1|||
46988743|NCT02233413|83235264|FG000|Overall Study|Lost to Follow-up|7|||
46988744|NCT02233413|83235265|FG001|Overall Study|Lost to Follow-up|9|||
46988745|NCT02233413|83235264|FG000|Overall Study|Withdrawal by Subject|4|||
46988746|NCT02233413|83235265|FG001|Overall Study|Withdrawal by Subject|5|||
46988747|NCT01632579|83235271|FG000|Washout Period|Adverse Event|1|||
46988748|NCT01632579|83235272|FG001|Washout Period|Adverse Event|0|||
46988749|NCT01632579|83235273|FG002|Washout Period|Adverse Event|0|||
46988750|NCT01632579|83235274|FG003|Washout Period|Adverse Event|0|||
46988751|NCT01632579|83235275|FG004|Washout Period|Adverse Event|0|||
46988752|NCT01632579|83235276|FG005|Washout Period|Adverse Event|0|||
46988753|NCT01632579|83235277|FG006|Washout Period|Adverse Event|0|||
46988754|NCT01632579|83235278|FG007|Washout Period|Adverse Event|0|||
46988755|NCT01632579|83235279|FG008|Washout Period|Adverse Event|0|||
46988756|NCT01632579|83235271|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
46988757|NCT01632579|83235272|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
46988758|NCT01632579|83235273|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
46988759|NCT01632579|83235274|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
46988760|NCT01632579|83235275|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
46988761|NCT01632579|83235276|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
46988762|NCT01632579|83235277|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
46988763|NCT01632579|83235278|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
46988764|NCT01632579|83235279|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
46988765|NCT01632345|83235308|FG000|Treatment: Part I|Adverse Event|1|||
46988766|NCT01632345|83235309|FG001|Treatment: Part I|Adverse Event|4|||
46988767|NCT01632345|83235310|FG002|Treatment: Part I|Adverse Event|2|||
46988768|NCT01632345|83235311|FG003|Treatment: Part I|Adverse Event|1|||
46988769|NCT01632345|83235312|FG004|Treatment: Part I|Adverse Event|3|||
46988770|NCT01632345|83235313|FG005|Treatment: Part I|Adverse Event|0|||
46988771|NCT01632345|83235314|FG006|Treatment: Part I|Adverse Event|0|||
46988772|NCT01632345|83235308|FG000|Treatment: Part I|Lack of Efficacy|0|||
46988773|NCT01632345|83235309|FG001|Treatment: Part I|Lack of Efficacy|1|||
46988774|NCT01632345|83235310|FG002|Treatment: Part I|Lack of Efficacy|0|||
46988775|NCT01632345|83235311|FG003|Treatment: Part I|Lack of Efficacy|1|||
46988776|NCT01632345|83235312|FG004|Treatment: Part I|Lack of Efficacy|1|||
46988777|NCT01632345|83235313|FG005|Treatment: Part I|Lack of Efficacy|0|||
46988778|NCT01632345|83235314|FG006|Treatment: Part I|Lack of Efficacy|0|||
46988779|NCT01632345|83235308|FG000|Treatment: Part I|Lost to Follow-up|3|||
46988780|NCT01632345|83235309|FG001|Treatment: Part I|Lost to Follow-up|2|||
46704021|NCT00958126|82918807|FG003|Overall Study|Moved away from study area|1|||
46704022|NCT00958126|82918808|FG004|Overall Study|Moved away from study area|0|||
46704023|NCT00958126|82918809|FG005|Overall Study|Moved away from study area|0|||
46704024|NCT00958126|82918810|FG006|Overall Study|Moved away from study area|0|||
46704025|NCT00958126|82918811|FG007|Overall Study|Moved away from study area|0|||
46704026|NCT00958126|82918804|FG000|Overall Study|Lost to Follow-up|1|||
46704027|NCT00958126|82918805|FG001|Overall Study|Lost to Follow-up|5|||
46704028|NCT00958126|82918806|FG002|Overall Study|Lost to Follow-up|9|||
46704029|NCT00958126|82918807|FG003|Overall Study|Lost to Follow-up|8|||
46704030|NCT00958126|82918808|FG004|Overall Study|Lost to Follow-up|0|||
46704031|NCT00958126|82918809|FG005|Overall Study|Lost to Follow-up|0|||
46704032|NCT00958126|82918810|FG006|Overall Study|Lost to Follow-up|0|||
46704033|NCT00958126|82918811|FG007|Overall Study|Lost to Follow-up|0|||
46704034|NCT00958126|82918804|FG000|Overall Study|Sponsor/Investigator decision|0|||
46704035|NCT00958126|82918805|FG001|Overall Study|Sponsor/Investigator decision|0|||
46704036|NCT00958126|82918806|FG002|Overall Study|Sponsor/Investigator decision|0|||
46704037|NCT00958126|82918807|FG003|Overall Study|Sponsor/Investigator decision|1|||
46704038|NCT00958126|82918808|FG004|Overall Study|Sponsor/Investigator decision|0|||
46704039|NCT00958126|82918809|FG005|Overall Study|Sponsor/Investigator decision|0|||
46704040|NCT00958126|82918810|FG006|Overall Study|Sponsor/Investigator decision|0|||
46704041|NCT00958126|82918811|FG007|Overall Study|Sponsor/Investigator decision|0|||
46704042|NCT00958126|82918804|FG000|Overall Study|Other Reason|0|||
46704043|NCT00958126|82918805|FG001|Overall Study|Other Reason|0|||
46704044|NCT00958126|82918806|FG002|Overall Study|Other Reason|0|||
46704045|NCT00958126|82918807|FG003|Overall Study|Other Reason|1|||
46704046|NCT00958126|82918808|FG004|Overall Study|Other Reason|0|||
46704047|NCT00958126|82918809|FG005|Overall Study|Other Reason|1|||
46704048|NCT00958126|82918810|FG006|Overall Study|Other Reason|0|||
46704049|NCT00958126|82918811|FG007|Overall Study|Other Reason|0|||
46704050|NCT00887341|82918835|FG000|Overall Study|Refused treatment|1|||
46704051|NCT00887341|82918836|FG001|Overall Study|Refused treatment|0|||
46704052|NCT00887341|82918835|FG000|Overall Study|Withdrawal by Subject|1|||
46704053|NCT00887341|82918836|FG001|Overall Study|Withdrawal by Subject|1|||
46704054|NCT00887341|82918835|FG000|Overall Study|Adverse Event|0|||
46704055|NCT00887341|82918836|FG001|Overall Study|Adverse Event|1|||
46704056|NCT00887341|82918835|FG000|Overall Study|Lost to Follow-up|0|||
46704057|NCT00887341|82918836|FG001|Overall Study|Lost to Follow-up|1|||
46704058|NCT00886795|82918842|FG000|Overall Study|Lack of Efficacy|1|||
46704059|NCT00889681|82918859|FG000|Overall Study|Not meeting qualification Criteria|2|||
46704060|NCT00889681|82918859|FG000|Overall Study|Insurance disapproval|1|||
46704061|NCT00957658|82918863|FG000|Overall Study|Death|1|||
46704062|NCT00957658|82918863|FG000|Overall Study|Lost to Follow-up|4|||
46704063|NCT00957658|82918863|FG000|Overall Study|Withdrawal by Subject|12|||
46704064|NCT00957658|82918863|FG000|Overall Study|Revision|1|||
46704065|NCT00957658|82918863|FG000|Overall Study|Incomplete 2 yr data|28|||
46704066|NCT00957658|82918863|FG000|Overall Study|Site termination|10|||
46704067|NCT00957658|82918863|FG000|Overall Study|unwilling/unable to return|2|||
46704068|NCT00957658|82918863|FG000|Overall Study|surgery cancelled|2|||
46704069|NCT00957658|82918863|FG000|Overall Study|Protocol Violation|5|||
46988781|NCT01632345|83235310|FG002|Treatment: Part I|Lost to Follow-up|1|||
46988782|NCT01632345|83235311|FG003|Treatment: Part I|Lost to Follow-up|3|||
46704070|NCT00953680|82918869|FG000|Period 1|Withdrawal by Subject|0|||
46988783|NCT01632345|83235312|FG004|Treatment: Part I|Lost to Follow-up|4|||
46988784|NCT01632345|83235313|FG005|Treatment: Part I|Lost to Follow-up|0|||
46704071|NCT00953680|82918870|FG001|Period 1|Withdrawal by Subject|1|||
46704072|NCT00890929|82918876|FG000|Overall Study|Death before treatment|2|||
46704073|NCT00890929|82918876|FG000|Overall Study|Withdrawal by Subject|3|||
46704074|NCT00890929|82918876|FG000|Overall Study|Physician Decision|1|||
46704075|NCT00886639|82918880|FG000|Overall Study|acute exacerbation|14|||
46704076|NCT00886639|82918880|FG000|Overall Study|non-compliance|2|||
46704077|NCT00889603|82918884|FG000|Overall Study|Adverse Event|7|||
46704078|NCT00889603|82918884|FG000|Overall Study|Death|3|||
46704079|NCT00889603|82918884|FG000|Overall Study|Lost to Follow-up|19|||
46704080|NCT00889603|82918884|FG000|Overall Study|No longer willing to participant in stud|4|||
46704081|NCT00889603|82918884|FG000|Overall Study|Other|4|||
46704082|NCT00886483|82918890|FG000|Overall Study|Lost to Follow-up|0|||
46704083|NCT00886483|82918891|FG001|Overall Study|Lost to Follow-up|1|||
46704084|NCT00886483|82918890|FG000|Overall Study|Pursue medications|1|||
46704085|NCT00886483|82918891|FG001|Overall Study|Pursue medications|2|||
46704086|NCT00886483|82918890|FG000|Overall Study|Distance to center, poor grades|1|||
46704087|NCT00886483|82918891|FG001|Overall Study|Distance to center, poor grades|0|||
46704088|NCT00886015|82918907|FG000|Overall Study|Death|0|||
46704089|NCT00886015|82918908|FG001|Overall Study|Death|2|||
46704090|NCT00890695|82918916|FG000|Overall Study|Protocol Violation|1|||
46704091|NCT00890695|82918917|FG001|Overall Study|Protocol Violation|0|||
46704092|NCT00957580|82918926|FG000|Overall Study|Ongoing at data cut-off|0|||
46704093|NCT00957580|82918927|FG001|Overall Study|Ongoing at data cut-off|1|||
46704094|NCT00957580|82918928|FG002|Overall Study|Ongoing at data cut-off|0|||
46704095|NCT00957580|82918926|FG000|Overall Study|Enrolled but not treated|0|||
46704096|NCT00957580|82918927|FG001|Overall Study|Enrolled but not treated|1|||
46704097|NCT00957580|82918928|FG002|Overall Study|Enrolled but not treated|0|||
46704098|NCT00957424|82918949|FG000|Overall Study|Lost to Follow-up|19|||
46704099|NCT00957424|82918949|FG000|Overall Study|Protocol Violation|3|||
46704100|NCT00957424|82918949|FG000|Overall Study|Withdrawal by Subject|1|||
46704101|NCT01061151|82918957|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
46704102|NCT01061151|82918958|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
46704103|NCT01061151|82918959|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
46704104|NCT01061151|82918960|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
46704105|NCT01061151|82918957|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
46704106|NCT01061151|82918958|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
46704107|NCT01061151|82918959|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
46704108|NCT01061151|82918960|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
46704109|NCT01061151|82918957|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
46704110|NCT01061151|82918958|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
46704111|NCT01061151|82918959|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
46704112|NCT01061151|82918960|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
46704113|NCT01061151|82918957|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
46704114|NCT01061151|82918958|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
46704115|NCT01061151|82918959|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
46704116|NCT01061151|82918960|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
46704117|NCT01061151|82918957|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
46704118|NCT01061151|82918958|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
46704119|NCT01061151|82918959|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
46704120|NCT01061151|82918960|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
46704121|NCT01061151|82918957|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
46704122|NCT01061151|82918958|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
46704123|NCT01061151|82918959|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
46704124|NCT01061151|82918960|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
46704125|NCT01061151|82918957|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
46704126|NCT01061151|82918958|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
46704127|NCT01061151|82918959|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
46704128|NCT01061151|82918960|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
46704129|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
46704130|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
46704131|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
46704132|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
46988785|NCT01632345|83235314|FG006|Treatment: Part I|Lost to Follow-up|0|||
46704133|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
46704134|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
46704135|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
46704136|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
46704137|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
46704138|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
46704139|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
46704140|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
46704141|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
46704142|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
46704143|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
46704144|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
46704145|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
46704146|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
46704147|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
46704148|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
46704149|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
46704150|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
46704151|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
46704152|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
46704153|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
46704154|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
46704155|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
46704156|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
46704157|NCT01061151|82918957|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
46704158|NCT01061151|82918958|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
46704159|NCT01061151|82918959|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
46704160|NCT01061151|82918960|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
46704161|NCT01241552|82918984|FG000|Overall Study|Lack of Efficacy|1|||
46704162|NCT01241552|82918985|FG001|Overall Study|Lack of Efficacy|0|||
46704163|NCT01241552|82918986|FG002|Overall Study|Lack of Efficacy|0|||
46704164|NCT01241552|82918987|FG003|Overall Study|Lack of Efficacy|0|||
46704165|NCT01241552|82918984|FG000|Overall Study|Death|26|||
46704166|NCT01241552|82918985|FG001|Overall Study|Death|30|||
46704167|NCT01241552|82918986|FG002|Overall Study|Death|20|||
46704168|NCT01241552|82918987|FG003|Overall Study|Death|25|||
46704169|NCT01241552|82918984|FG000|Overall Study|Adverse Event|1|||
46704170|NCT01241552|82918985|FG001|Overall Study|Adverse Event|1|||
46704171|NCT01241552|82918986|FG002|Overall Study|Adverse Event|0|||
46704172|NCT01241552|82918987|FG003|Overall Study|Adverse Event|0|||
46704173|NCT01241552|82918984|FG000|Overall Study|Technical Problems|2|||
46704174|NCT01241552|82918985|FG001|Overall Study|Technical Problems|0|||
46704175|NCT01241552|82918986|FG002|Overall Study|Technical Problems|2|||
46704176|NCT01241552|82918987|FG003|Overall Study|Technical Problems|2|||
46704177|NCT01241552|82918984|FG000|Overall Study|Progressive Disease|0|||
46704178|NCT01241552|82918985|FG001|Overall Study|Progressive Disease|0|||
46704179|NCT01241552|82918986|FG002|Overall Study|Progressive Disease|1|||
46704180|NCT01241552|82918987|FG003|Overall Study|Progressive Disease|2|||
46704181|NCT01241552|82918984|FG000|Overall Study|Protocol Violation|0|||
46704182|NCT01241552|82918985|FG001|Overall Study|Protocol Violation|2|||
46988786|NCT01632345|83235308|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
46988787|NCT01632345|83235309|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
46704183|NCT01241552|82918986|FG002|Overall Study|Protocol Violation|6|||
46704184|NCT01241552|82918987|FG003|Overall Study|Protocol Violation|1|||
46704185|NCT01241552|82918984|FG000|Overall Study|Withdrawal by Subject|7|||
46704186|NCT01241552|82918985|FG001|Overall Study|Withdrawal by Subject|15|||
46988788|NCT01632345|83235310|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
46704187|NCT01241552|82918986|FG002|Overall Study|Withdrawal by Subject|14|||
46704188|NCT01241552|82918987|FG003|Overall Study|Withdrawal by Subject|15|||
46988789|NCT01632345|83235311|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
46988790|NCT01632345|83235312|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
46988791|NCT01632345|83235313|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
46988792|NCT01632345|83235314|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
46988793|NCT01632345|83235308|FG000|Treatment: Part I|Physician Decision|2|||
46988794|NCT01632345|83235309|FG001|Treatment: Part I|Physician Decision|1|||
46988795|NCT01632345|83235310|FG002|Treatment: Part I|Physician Decision|0|||
46988796|NCT01632345|83235311|FG003|Treatment: Part I|Physician Decision|0|||
46988797|NCT01632345|83235312|FG004|Treatment: Part I|Physician Decision|1|||
46988798|NCT01632345|83235313|FG005|Treatment: Part I|Physician Decision|0|||
46988799|NCT01632345|83235314|FG006|Treatment: Part I|Physician Decision|0|||
46988800|NCT01632345|83235308|FG000|Treatment: Part I|Pregnancy|0|||
46988801|NCT01632345|83235309|FG001|Treatment: Part I|Pregnancy|1|||
46988802|NCT01632345|83235310|FG002|Treatment: Part I|Pregnancy|0|||
46704189|NCT01241552|82918984|FG000|Overall Study|Physician Decision|2|||
46704190|NCT01241552|82918985|FG001|Overall Study|Physician Decision|4|||
46704191|NCT01241552|82918986|FG002|Overall Study|Physician Decision|2|||
46704192|NCT01241552|82918987|FG003|Overall Study|Physician Decision|3|||
46704193|NCT01241552|82918984|FG000|Overall Study|Lost to Follow-up|2|||
46704194|NCT01241552|82918985|FG001|Overall Study|Lost to Follow-up|11|||
46704195|NCT01241552|82918986|FG002|Overall Study|Lost to Follow-up|15|||
46704196|NCT01241552|82918987|FG003|Overall Study|Lost to Follow-up|16|||
46704197|NCT00948922|82919000|FG000|Overall Study|Did not start study treatment|2|||
46704198|NCT00948922|82919001|FG001|Overall Study|Did not start study treatment|5|||
46704199|NCT00948922|82919002|FG002|Overall Study|Did not start study treatment|0|||
46704200|NCT00948922|82919000|FG000|Overall Study|Withdrawal by Subject|0|||
46704201|NCT00948922|82919001|FG001|Overall Study|Withdrawal by Subject|2|||
46704202|NCT00948922|82919002|FG002|Overall Study|Withdrawal by Subject|1|||
46704203|NCT00948922|82919000|FG000|Overall Study|Death|3|||
46704204|NCT00948922|82919001|FG001|Overall Study|Death|0|||
46704205|NCT00948922|82919002|FG002|Overall Study|Death|0|||
46704206|NCT00948922|82919000|FG000|Overall Study|Disease progression|0|||
46704207|NCT00948922|82919001|FG001|Overall Study|Disease progression|1|||
46704208|NCT00948922|82919002|FG002|Overall Study|Disease progression|0|||
46704209|NCT00948922|82919000|FG000|Overall Study|Insurance issues|1|||
46704210|NCT00948922|82919001|FG001|Overall Study|Insurance issues|0|||
46704211|NCT00948922|82919002|FG002|Overall Study|Insurance issues|0|||
46704212|NCT00948922|82919000|FG000|Overall Study|Transplant eligibility issues|2|||
46704213|NCT00948922|82919001|FG001|Overall Study|Transplant eligibility issues|3|||
46704214|NCT00948922|82919002|FG002|Overall Study|Transplant eligibility issues|0|||
46704215|NCT00948922|82919000|FG000|Overall Study|Not evaluable at time of analysis|0|||
46704216|NCT00948922|82919001|FG001|Overall Study|Not evaluable at time of analysis|3|||
46704217|NCT00948922|82919002|FG002|Overall Study|Not evaluable at time of analysis|0|||
46704218|NCT01239992|82919014|FG000|Overall Study|Withdrawal by Subject|2|||
46704219|NCT01239680|82919020|FG000|Overall Study|Withdrawal by Subject|2|||
46704220|NCT01239680|82919021|FG001|Overall Study|Withdrawal by Subject|0|||
46704221|NCT01238900|82919027|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
46704222|NCT01238900|82919027|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
46704223|NCT01238822|82919032|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
46704224|NCT01238588|82919042|FG000|Overall Study|Withdrawal by Subject|1|||
46704225|NCT01238588|82919042|FG000|Overall Study|Physician Decision|2|||
46704226|NCT01047501|82919049|FG000|Overall Study|Adverse Event|7|||
46704227|NCT01047501|82919050|FG001|Overall Study|Adverse Event|8|||
46704228|NCT01047501|82919051|FG002|Overall Study|Adverse Event|5|||
46704229|NCT01047501|82919049|FG000|Overall Study|Withdrew Consent|6|||
46704230|NCT01047501|82919050|FG001|Overall Study|Withdrew Consent|2|||
46704231|NCT01047501|82919051|FG002|Overall Study|Withdrew Consent|4|||
46704232|NCT01047501|82919049|FG000|Overall Study|Lost to Follow-up|0|||
46704233|NCT01047501|82919050|FG001|Overall Study|Lost to Follow-up|1|||
46988803|NCT01632345|83235311|FG003|Treatment: Part I|Pregnancy|0|||
46988804|NCT01632345|83235312|FG004|Treatment: Part I|Pregnancy|0|||
46704234|NCT01047501|82919051|FG002|Overall Study|Lost to Follow-up|1|||
46704235|NCT01047501|82919049|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
46704236|NCT01047501|82919050|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
46704237|NCT01047501|82919051|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
46704238|NCT01047501|82919049|FG000|Overall Study|Death|1|||
46704239|NCT01047501|82919050|FG001|Overall Study|Death|0|||
46704240|NCT01047501|82919051|FG002|Overall Study|Death|0|||
46704241|NCT01047501|82919049|FG000|Overall Study|Other discontinuation|1|||
46704242|NCT01047501|82919050|FG001|Overall Study|Other discontinuation|0|||
46704243|NCT01047501|82919051|FG002|Overall Study|Other discontinuation|1|||
46704244|NCT01047501|82919049|FG000|Overall Study|Investigator judgement|0|||
46704245|NCT01047501|82919050|FG001|Overall Study|Investigator judgement|0|||
46704246|NCT01047501|82919051|FG002|Overall Study|Investigator judgement|1|||
46704247|NCT01238120|82919063|FG000|Overall Study|Withdrawal by Subject|4|||
46988805|NCT01632345|83235313|FG005|Treatment: Part I|Pregnancy|0|||
46988806|NCT01632345|83235314|FG006|Treatment: Part I|Pregnancy|0|||
46704248|NCT01238120|82919064|FG001|Overall Study|Withdrawal by Subject|1|||
46704249|NCT01238120|82919065|FG002|Overall Study|Withdrawal by Subject|2|||
46704250|NCT01238120|82919066|FG003|Overall Study|Withdrawal by Subject|5|||
46704251|NCT01238120|82919063|FG000|Overall Study|Lost to Follow-up|2|||
46704252|NCT01238120|82919064|FG001|Overall Study|Lost to Follow-up|0|||
46704253|NCT01238120|82919065|FG002|Overall Study|Lost to Follow-up|1|||
46704254|NCT01238120|82919066|FG003|Overall Study|Lost to Follow-up|1|||
46704255|NCT01238120|82919063|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
46704256|NCT01238120|82919064|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
46704257|NCT01238120|82919065|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
46704258|NCT01238120|82919066|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
46704259|NCT01237340|82919076|FG000|Overall Study|Adverse Event|3|||
46704260|NCT01237340|82919076|FG000|Overall Study|Withdrawal by Subject|1|||
46704261|NCT01237340|82919076|FG000|Overall Study|Early termination of the trial|36|||
46704262|NCT01045707|82919085|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
46704263|NCT01045707|82919086|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
46704264|NCT01045707|82919085|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
46704265|NCT01045707|82919086|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
46704266|NCT01045707|82919085|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
46704267|NCT01045707|82919086|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
46704268|NCT01045707|82919085|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
46704269|NCT01045707|82919086|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
46704270|NCT01045707|82919085|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
46704271|NCT01045707|82919086|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
46704272|NCT01045707|82919085|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
46704273|NCT01045707|82919086|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
46704274|NCT01045707|82919085|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
46704275|NCT01045707|82919086|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
46704276|NCT01045707|82919085|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
46704277|NCT01045707|82919086|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
46704278|NCT01045707|82919085|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
46704279|NCT01045707|82919086|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
46704280|NCT01054599|82919094|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
46704281|NCT01054599|82919095|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
46704282|NCT01054599|82919094|FG000|Overall Study|Protocol Violation|1|||
46704283|NCT01054599|82919095|FG001|Overall Study|Protocol Violation|0|||
46704284|NCT01054599|82919094|FG000|Overall Study|Spells/seizure-like episodes|1|||
46704285|NCT01054599|82919095|FG001|Overall Study|Spells/seizure-like episodes|1|||
46704286|NCT01054599|82919094|FG000|Overall Study|Timing/scheduling difficulties|1|||
46704287|NCT01054599|82919095|FG001|Overall Study|Timing/scheduling difficulties|1|||
46704288|NCT01054599|82919094|FG000|Overall Study|Visual impairment, WTAR <80|0|||
46704289|NCT01054599|82919095|FG001|Overall Study|Visual impairment, WTAR <80|1|||
46704290|NCT01054599|82919094|FG000|Overall Study|Lost to Follow-up|0|||
46704291|NCT01054599|82919095|FG001|Overall Study|Lost to Follow-up|2|||
46704292|NCT01054599|82919094|FG000|Overall Study|Adverse Event|0|||
46704293|NCT01054599|82919095|FG001|Overall Study|Adverse Event|1|||
46704294|NCT01054599|82919094|FG000|Overall Study|Withdrawal by Subject|0|||
46704295|NCT01054599|82919095|FG001|Overall Study|Withdrawal by Subject|1|||
46704296|NCT00948766|82919103|FG000|Core Study|Adverse Event|73|||
46704297|NCT00948766|82919104|FG001|Core Study|Adverse Event|51|||
46704298|NCT00948766|82919103|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
46704299|NCT00948766|82919104|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
46704300|NCT00948766|82919103|FG000|Core Study|Patient Withdrew Consent|27|||
46704301|NCT00948766|82919104|FG001|Core Study|Patient Withdrew Consent|46|||
46988807|NCT01632345|83235308|FG000|Treatment: Part I|Protocol Deviation|0|||
46988808|NCT01632345|83235309|FG001|Treatment: Part I|Protocol Deviation|0|||
46988809|NCT01632345|83235310|FG002|Treatment: Part I|Protocol Deviation|1|||
46988810|NCT01632345|83235311|FG003|Treatment: Part I|Protocol Deviation|1|||
46988811|NCT01632345|83235312|FG004|Treatment: Part I|Protocol Deviation|0|||
46988812|NCT01632345|83235313|FG005|Treatment: Part I|Protocol Deviation|0|||
46988813|NCT01632345|83235314|FG006|Treatment: Part I|Protocol Deviation|0|||
46988814|NCT01632345|83235308|FG000|Treatment: Part I|Withdrawal by Subject|3|||
46988815|NCT01632345|83235309|FG001|Treatment: Part I|Withdrawal by Subject|4|||
46988816|NCT01632345|83235310|FG002|Treatment: Part I|Withdrawal by Subject|4|||
46988817|NCT01632345|83235311|FG003|Treatment: Part I|Withdrawal by Subject|1|||
46988818|NCT01632345|83235312|FG004|Treatment: Part I|Withdrawal by Subject|4|||
46988819|NCT01632345|83235313|FG005|Treatment: Part I|Withdrawal by Subject|0|||
46988820|NCT01632345|83235314|FG006|Treatment: Part I|Withdrawal by Subject|0|||
46988821|NCT01632345|83235308|FG000|Treatment: Part II|Adverse Event|0|||
46988822|NCT01632345|83235309|FG001|Treatment: Part II|Adverse Event|0|||
46988823|NCT01632345|83235310|FG002|Treatment: Part II|Adverse Event|0|||
46988824|NCT01632345|83235311|FG003|Treatment: Part II|Adverse Event|0|||
46988825|NCT01632345|83235312|FG004|Treatment: Part II|Adverse Event|0|||
46988826|NCT01632345|83235313|FG005|Treatment: Part II|Adverse Event|3|||
46988827|NCT01632345|83235314|FG006|Treatment: Part II|Adverse Event|8|||
46988828|NCT01632345|83235308|FG000|Treatment: Part II|Lost to Follow-up|0|||
46988829|NCT01632345|83235309|FG001|Treatment: Part II|Lost to Follow-up|0|||
46988830|NCT01632345|83235310|FG002|Treatment: Part II|Lost to Follow-up|0|||
46988831|NCT01632345|83235311|FG003|Treatment: Part II|Lost to Follow-up|0|||
46988832|NCT01632345|83235312|FG004|Treatment: Part II|Lost to Follow-up|0|||
46988833|NCT01632345|83235313|FG005|Treatment: Part II|Lost to Follow-up|3|||
46988834|NCT01632345|83235314|FG006|Treatment: Part II|Lost to Follow-up|1|||
46988835|NCT01632345|83235308|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
46988836|NCT01632345|83235309|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
46988837|NCT01632345|83235310|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
46988838|NCT01632345|83235311|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
46988839|NCT01632345|83235312|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
46988840|NCT01632345|83235313|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
46988841|NCT01632345|83235314|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
46988842|NCT01632345|83235308|FG000|Treatment: Part II|Withdrawal by Subject|0|||
46988843|NCT01632345|83235309|FG001|Treatment: Part II|Withdrawal by Subject|0|||
46988844|NCT01632345|83235310|FG002|Treatment: Part II|Withdrawal by Subject|0|||
46988845|NCT01632345|83235311|FG003|Treatment: Part II|Withdrawal by Subject|0|||
46988846|NCT01632345|83235312|FG004|Treatment: Part II|Withdrawal by Subject|0|||
46988847|NCT01632345|83235313|FG005|Treatment: Part II|Withdrawal by Subject|2|||
46988848|NCT01632345|83235314|FG006|Treatment: Part II|Withdrawal by Subject|2|||
46988849|NCT02232243|83235332|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
46988850|NCT02232243|83235333|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
46988851|NCT02232243|83235334|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
46988852|NCT02205333|83235352|FG000|Overall Study|Death|5|||
46988853|NCT02205333|83235353|FG001|Overall Study|Death|6|||
46988854|NCT02205333|83235354|FG002|Overall Study|Death|2|||
46988855|NCT02205333|83235355|FG003|Overall Study|Death|6|||
46988856|NCT02205333|83235356|FG004|Overall Study|Death|5|||
46988857|NCT02205333|83235357|FG005|Overall Study|Death|3|||
46988858|NCT02205333|83235358|FG006|Overall Study|Death|3|||
46988859|NCT02205333|83235359|FG007|Overall Study|Death|2|||
46988860|NCT02205333|83235360|FG008|Overall Study|Death|0|||
46802880|NCT00423670|83022125|FG000|Treatment Period|Non-compliance with protocol|3|||
46988861|NCT02205333|83235352|FG000|Overall Study|Withdrawal by Subject|1|||
46988862|NCT02205333|83235353|FG001|Overall Study|Withdrawal by Subject|0|||
46988863|NCT02205333|83235354|FG002|Overall Study|Withdrawal by Subject|0|||
46988864|NCT02205333|83235355|FG003|Overall Study|Withdrawal by Subject|1|||
46988865|NCT02205333|83235356|FG004|Overall Study|Withdrawal by Subject|0|||
46988866|NCT02205333|83235357|FG005|Overall Study|Withdrawal by Subject|0|||
46988867|NCT02205333|83235358|FG006|Overall Study|Withdrawal by Subject|2|||
46988868|NCT02205333|83235359|FG007|Overall Study|Withdrawal by Subject|0|||
46988869|NCT02205333|83235360|FG008|Overall Study|Withdrawal by Subject|0|||
46988870|NCT02230683|83235380|FG000|Overall Study|Adverse Event|1|||
46988871|NCT02230527|83235392|FG000|Overall Study|Withdrawal by Subject|1|||
46988872|NCT02230527|83235393|FG001|Overall Study|Withdrawal by Subject|1|||
46988873|NCT02230527|83235392|FG000|Overall Study|Death|1|||
46988874|NCT02230527|83235393|FG001|Overall Study|Death|0|||
46988875|NCT02230527|83235392|FG000|Overall Study|Lost to Follow-up|2|||
46988876|NCT02230527|83235393|FG001|Overall Study|Lost to Follow-up|1|||
46988877|NCT02230527|83235392|FG000|Overall Study|Other|1|||
46988878|NCT02230527|83235393|FG001|Overall Study|Other|0|||
46988879|NCT02204319|83235399|FG000|Overall Study|Pregnancy|1|||
46988880|NCT02204319|83235399|FG000|Overall Study|Withdrawal by Subject|2|||
46988881|NCT02204007|83235406|FG000|Overall Study|Surgery Canceled|1|||
46988882|NCT02204007|83235407|FG001|Overall Study|Surgery Canceled|1|||
46988883|NCT02203851|83235413|FG000|Overall Study|Lost to Follow-up|4|||
46988884|NCT02203851|83235413|FG000|Overall Study|Withdrawal by Subject|6|||
46988885|NCT02203851|83235413|FG000|Overall Study|Other|1|||
46988886|NCT02228967|83235426|FG000|Overall Study|Lost to Follow-up|146|||
46988887|NCT02228967|83235427|FG001|Overall Study|Lost to Follow-up|142|||
46988888|NCT02228967|83235426|FG000|Overall Study|Withdrawal by Subject|13|||
46988889|NCT02228967|83235427|FG001|Overall Study|Withdrawal by Subject|18|||
46988890|NCT02227875|83235435|FG000|Overall Study|Protocol Violation|10|||
46988891|NCT02227875|83235436|FG001|Overall Study|Protocol Violation|7|||
46988892|NCT02227875|83235435|FG000|Overall Study|Other|1|||
46988893|NCT02227875|83235436|FG001|Overall Study|Other|3|||
46988894|NCT02227875|83235435|FG000|Overall Study|Physician Decision|1|||
46988895|NCT02227875|83235436|FG001|Overall Study|Physician Decision|0|||
46988896|NCT02227875|83235435|FG000|Overall Study|Adverse Event|3|||
46988897|NCT02227875|83235436|FG001|Overall Study|Adverse Event|0|||
46988898|NCT02227875|83235435|FG000|Overall Study|Withdrawal by Subject|12|||
46988899|NCT02227875|83235436|FG001|Overall Study|Withdrawal by Subject|13|||
46988900|NCT02227875|83235435|FG000|Overall Study|Lost to Follow-up|10|||
46988901|NCT02227875|83235436|FG001|Overall Study|Lost to Follow-up|10|||
46988902|NCT02203149|83235447|FG000|Part 1|Adverse Event|0|||
46988903|NCT02203149|83235448|FG001|Part 1|Adverse Event|1|||
46988904|NCT02203149|83235449|FG002|Part 1|Adverse Event|0|||
46988905|NCT02203149|83235450|FG003|Part 1|Adverse Event|0|||
46988906|NCT02203149|83235451|FG004|Part 1|Adverse Event|0|||
46988907|NCT02203149|83235447|FG000|Part 2|Death|0|||
46988908|NCT02203149|83235448|FG001|Part 2|Death|0|||
46988909|NCT02203149|83235449|FG002|Part 2|Death|1|||
46988910|NCT02203149|83235450|FG003|Part 2|Death|1|||
46988911|NCT02203149|83235451|FG004|Part 2|Death|0|||
46988912|NCT02203149|83235447|FG000|Part 2|Withdrawal by Subject|0|||
46988913|NCT02203149|83235448|FG001|Part 2|Withdrawal by Subject|0|||
46988914|NCT02203149|83235449|FG002|Part 2|Withdrawal by Subject|0|||
46988915|NCT02203149|83235450|FG003|Part 2|Withdrawal by Subject|1|||
46988916|NCT02203149|83235451|FG004|Part 2|Withdrawal by Subject|0|||
46988917|NCT02203149|83235447|FG000|Part 2|Adverse Event|0|||
46988918|NCT02203149|83235448|FG001|Part 2|Adverse Event|0|||
46988919|NCT02203149|83235449|FG002|Part 2|Adverse Event|0|||
46988920|NCT02203149|83235450|FG003|Part 2|Adverse Event|1|||
46988921|NCT02203149|83235451|FG004|Part 2|Adverse Event|1|||
46880620|NCT03546621|83102012|FG001|Overall Study|Lost to Follow-up|1|||
46880621|NCT03546621|83102013|FG002|Overall Study|Lost to Follow-up|0|||
46988922|NCT02203071|83235475|FG000|Overall Study|Lost to Follow-up|3|||
46988923|NCT02203071|83235476|FG001|Overall Study|Lost to Follow-up|1|||
46988924|NCT02202837|83235484|FG000|Overall Study|Enbrel treatment discontinued|36|||
46988925|NCT02202837|83235485|FG001|Overall Study|Enbrel treatment discontinued|4|||
46988926|NCT02202837|83235484|FG000|Overall Study|Other|10|||
46880622|NCT03546621|83102014|FG003|Overall Study|Lost to Follow-up|0|||
46988927|NCT02202837|83235485|FG001|Overall Study|Other|0|||
46988928|NCT02202837|83235484|FG000|Overall Study|Lost to Follow-up|7|||
46988929|NCT02202837|83235485|FG001|Overall Study|Lost to Follow-up|1|||
46988930|NCT02202759|83235494|FG000|Overall Study|Study Terminated by Sponsor|3|||
46988931|NCT02202759|83235495|FG001|Overall Study|Study Terminated by Sponsor|3|||
46988932|NCT02202759|83235496|FG002|Overall Study|Study Terminated by Sponsor|3|||
46988933|NCT02202759|83235494|FG000|Overall Study|Withdrawal by Subject|2|||
46880623|NCT03546621|83102011|FG000|Overall Study|Adverse Event|0|||
46880624|NCT03546621|83102012|FG001|Overall Study|Adverse Event|1|||
46880625|NCT03546621|83102013|FG002|Overall Study|Adverse Event|0|||
46880626|NCT03546621|83102014|FG003|Overall Study|Adverse Event|1|||
46880627|NCT03546621|83102011|FG000|Overall Study|Progressive disease|0|||
46880628|NCT03546621|83102012|FG001|Overall Study|Progressive disease|0|||
46880629|NCT03546621|83102013|FG002|Overall Study|Progressive disease|0|||
46880630|NCT03546621|83102014|FG003|Overall Study|Progressive disease|1|||
46880631|NCT02761330|83102024|FG000|Treatment Week 1|Withdrawal by Subject|0|||
46880632|NCT02761330|83102025|FG001|Treatment Week 1|Withdrawal by Subject|0|||
46880633|NCT02761330|83102026|FG002|Treatment Week 1|Withdrawal by Subject|0|||
46880634|NCT02761330|83102027|FG003|Treatment Week 1|Withdrawal by Subject|1|||
46880635|NCT02761330|83102028|FG004|Treatment Week 1|Withdrawal by Subject|0|||
46880636|NCT02761330|83102029|FG005|Treatment Week 1|Withdrawal by Subject|1|||
46880637|NCT03559257|83102045|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
46880638|NCT03559257|83102046|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
46880639|NCT03559257|83102045|FG000|Double Blind Treatment Period|Protocol Violation|1|||
46880640|NCT03559257|83102046|FG001|Double Blind Treatment Period|Protocol Violation|4|||
46880641|NCT03559257|83102045|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
46880642|NCT03559257|83102046|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
46880643|NCT03559257|83102045|FG000|Double Blind Treatment Period|Adverse Event|0|||
46880644|NCT03559257|83102046|FG001|Double Blind Treatment Period|Adverse Event|1|||
46880645|NCT03559257|83102045|FG000|Double Blind Treatment Period|Screen Failure|0|||
46880646|NCT03559257|83102046|FG001|Double Blind Treatment Period|Screen Failure|1|||
46880647|NCT03559257|83102045|FG000|Open-label Treatment Period|Adverse Event|1|||
46880648|NCT03559257|83102046|FG001|Open-label Treatment Period|Adverse Event|4|||
46880649|NCT03559257|83102045|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
46880650|NCT03559257|83102046|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
46704302|NCT00948766|82919103|FG000|Core Study|Lost to Follow-up|3|||
46704303|NCT00948766|82919104|FG001|Core Study|Lost to Follow-up|2|||
46704304|NCT00948766|82919103|FG000|Core Study|Administrative Problems|2|||
46704305|NCT00948766|82919104|FG001|Core Study|Administrative Problems|2|||
46704306|NCT00948766|82919103|FG000|Core Study|Death|1|||
46704307|NCT00948766|82919104|FG001|Core Study|Death|1|||
46704308|NCT00948766|82919103|FG000|Core Study|Protocol Deviation|8|||
46704309|NCT00948766|82919104|FG001|Core Study|Protocol Deviation|10|||
46704310|NCT00948766|82919103|FG000|Extension Study|Adverse Event|43|||
46704311|NCT00948766|82919104|FG001|Extension Study|Adverse Event|0|||
46988934|NCT02202759|83235495|FG001|Overall Study|Withdrawal by Subject|1|||
46988935|NCT02202759|83235496|FG002|Overall Study|Withdrawal by Subject|1|||
46988936|NCT02202759|83235494|FG000|Overall Study|Reason not Specified|4|||
46988937|NCT02202759|83235495|FG001|Overall Study|Reason not Specified|11|||
46988938|NCT02202759|83235496|FG002|Overall Study|Reason not Specified|10|||
46704312|NCT00948766|82919103|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
46704313|NCT00948766|82919104|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
46704314|NCT00948766|82919103|FG000|Extension Study|Study Drug No Longer Required|1|||
46704315|NCT00948766|82919104|FG001|Extension Study|Study Drug No Longer Required|0|||
46704316|NCT00948766|82919103|FG000|Extension Study|Patient Withdrew Consent|32|||
46704317|NCT00948766|82919104|FG001|Extension Study|Patient Withdrew Consent|0|||
46704318|NCT00948766|82919103|FG000|Extension Study|Lost to Follow-up|8|||
46880651|NCT03559257|83102045|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
46880652|NCT03559257|83102046|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
46880653|NCT03559257|83102045|FG000|Open-label Treatment Period|Protocol Violation|2|||
46880654|NCT03559257|83102046|FG001|Open-label Treatment Period|Protocol Violation|0|||
46880655|NCT03559257|83102045|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
46880656|NCT03559257|83102046|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
46880657|NCT03559257|83102045|FG000|Open-label Treatment Period|Physician Decision|0|||
46880658|NCT03559257|83102046|FG001|Open-label Treatment Period|Physician Decision|1|||
46988939|NCT02226549|83235505|FG000|Overall Study|Randomized but Never Treated|1|||
46704319|NCT00948766|82919104|FG001|Extension Study|Lost to Follow-up|0|||
46704320|NCT00948766|82919103|FG000|Extension Study|Administrative Problems|1|||
46704321|NCT00948766|82919104|FG001|Extension Study|Administrative Problems|0|||
46704322|NCT00948766|82919103|FG000|Extension Study|Death|4|||
46704323|NCT00948766|82919104|FG001|Extension Study|Death|0|||
46704324|NCT01053663|82919114|FG000|Overall Study|Death|2|||
46704325|NCT01053663|82919114|FG000|Overall Study|Lost to Follow-up|1|||
46704326|NCT01053663|82919114|FG000|Overall Study|Poor IV Access|1|||
46704327|NCT01053663|82919114|FG000|Overall Study|Transferred to Another Hospital|1|||
46704328|NCT01053663|82919114|FG000|Overall Study|Negative Influenza Diagnosis|1|||
46704329|NCT01235546|82919126|FG000|Overall Study|Staff error, medication not administered|1|||
46704330|NCT01235546|82919127|FG001|Overall Study|Staff error, medication not administered|0|||
46704331|NCT01235546|82919126|FG000|Overall Study|Protocol Violation|1|||
46704332|NCT01235546|82919127|FG001|Overall Study|Protocol Violation|1|||
46704333|NCT01053429|82919142|FG000|Overall Study|Adverse Event|64|||
46704334|NCT01053429|82919142|FG000|Overall Study|Other|309|||
46704335|NCT01233284|82919146|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
46704336|NCT01233284|82919147|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46704337|NCT01233284|82919148|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46704338|NCT01233284|82919149|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46704339|NCT01233284|82919150|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46704340|NCT01233284|82919146|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
46704341|NCT01233284|82919147|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
46704342|NCT01233284|82919148|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
46704343|NCT01233284|82919149|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
46704344|NCT01233284|82919150|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
46704345|NCT01233284|82919146|FG000|Period 1 (4 Weeks)|Other|0|||
46704346|NCT01233284|82919147|FG001|Period 1 (4 Weeks)|Other|0|||
46704347|NCT01233284|82919148|FG002|Period 1 (4 Weeks)|Other|1|||
46704348|NCT01233284|82919149|FG003|Period 1 (4 Weeks)|Other|0|||
46704349|NCT01233284|82919150|FG004|Period 1 (4 Weeks)|Other|0|||
46704350|NCT01233284|82919146|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46704351|NCT01233284|82919147|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46704352|NCT01233284|82919148|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
46704353|NCT01233284|82919149|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46704354|NCT01233284|82919150|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
46704355|NCT01233284|82919146|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
46704356|NCT01233284|82919147|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
46704357|NCT01233284|82919148|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
46704358|NCT01233284|82919149|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
46704359|NCT01233284|82919150|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
46704360|NCT01233284|82919146|FG000|Period 3 (4 Weeks)|Other|0|||
46704361|NCT01233284|82919147|FG001|Period 3 (4 Weeks)|Other|0|||
46704362|NCT01233284|82919148|FG002|Period 3 (4 Weeks)|Other|0|||
46704363|NCT01233284|82919149|FG003|Period 3 (4 Weeks)|Other|1|||
46704364|NCT01233284|82919150|FG004|Period 3 (4 Weeks)|Other|0|||
46704365|NCT01233284|82919146|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
46802881|NCT00423670|83022126|FG001|Treatment Period|Non-compliance with protocol|1|||
46802882|NCT00423670|83022127|FG002|Treatment Period|Non-compliance with protocol|1|||
46802883|NCT00423670|83022128|FG003|Treatment Period|Non-compliance with protocol|3|||
46802884|NCT00423670|83022129|FG004|Treatment Period|Non-compliance with protocol|2|||
46802885|NCT00423670|83022130|FG005|Treatment Period|Non-compliance with protocol|0|||
46802886|NCT00423670|83022131|FG006|Treatment Period|Non-compliance with protocol|2|||
46802887|NCT00423670|83022132|FG007|Treatment Period|Non-compliance with protocol|2|||
46802888|NCT00423670|83022125|FG000|Follow-up Period|Lost to Follow-up|0|||
46802889|NCT00423670|83022126|FG001|Follow-up Period|Lost to Follow-up|12|||
46802890|NCT00423670|83022127|FG002|Follow-up Period|Lost to Follow-up|8|||
46802891|NCT00423670|83022128|FG003|Follow-up Period|Lost to Follow-up|3|||
46704366|NCT01233284|82919147|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
46704367|NCT01233284|82919148|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
46802892|NCT00423670|83022129|FG004|Follow-up Period|Lost to Follow-up|1|||
46704368|NCT01233284|82919149|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
46704369|NCT01233284|82919150|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
46704370|NCT01233284|82919146|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
46704371|NCT01233284|82919147|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
46704372|NCT01233284|82919148|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
46704373|NCT01233284|82919149|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
46704374|NCT01233284|82919150|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
46704375|NCT00948688|82919160|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
46704376|NCT00948688|82919161|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
46704377|NCT00948688|82919160|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
46704378|NCT00948688|82919161|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
46704379|NCT00948688|82919160|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
46704380|NCT00948688|82919161|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
46704381|NCT01233050|82919170|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
46704382|NCT01233050|82919171|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
46704383|NCT01232894|82919179|FG000|Overall Study|Lost to Follow-up|0|||
46704384|NCT01232894|82919180|FG001|Overall Study|Lost to Follow-up|1|||
46704385|NCT01232894|82919179|FG000|Overall Study|Death|1|||
46704386|NCT01232894|82919180|FG001|Overall Study|Death|0|||
46704387|NCT01232894|82919179|FG000|Overall Study|Protocol Violation|1|||
46704388|NCT01232894|82919180|FG001|Overall Study|Protocol Violation|1|||
46704389|NCT01232894|82919179|FG000|Overall Study|Withdrawal by Subject|8|||
46704390|NCT01232894|82919180|FG001|Overall Study|Withdrawal by Subject|5|||
46704391|NCT01232894|82919179|FG000|Overall Study|Physician Decision|2|||
46704392|NCT01232894|82919180|FG001|Overall Study|Physician Decision|1|||
46704393|NCT01049217|82919188|FG000|Overall Study|Adverse Event|2|||
46704394|NCT01049217|82919189|FG001|Overall Study|Adverse Event|1|||
46704395|NCT01049217|82919188|FG000|Overall Study|Lack of Efficacy|1|||
46704396|NCT01049217|82919189|FG001|Overall Study|Lack of Efficacy|1|||
46704397|NCT01049217|82919188|FG000|Overall Study|Lost to Follow-up|3|||
46704398|NCT01049217|82919189|FG001|Overall Study|Lost to Follow-up|8|||
46704399|NCT01049217|82919188|FG000|Overall Study|Withdrawal by Subject|4|||
46704400|NCT01049217|82919189|FG001|Overall Study|Withdrawal by Subject|3|||
46704401|NCT01049217|82919188|FG000|Overall Study|Protocol Violation|1|||
46704402|NCT01049217|82919189|FG001|Overall Study|Protocol Violation|3|||
46704403|NCT01049217|82919188|FG000|Overall Study|Pregnancy|1|||
46704404|NCT01049217|82919189|FG001|Overall Study|Pregnancy|0|||
46704405|NCT01049217|82919188|FG000|Overall Study|Study Terminated by Sponsor|43|||
46704406|NCT01049217|82919189|FG001|Overall Study|Study Terminated by Sponsor|43|||
46704407|NCT01049217|82919188|FG000|Overall Study|Other|1|||
46704408|NCT01049217|82919189|FG001|Overall Study|Other|2|||
46988940|NCT02226549|83235506|FG001|Overall Study|Randomized but Never Treated|0|||
46988941|NCT02226549|83235505|FG000|Overall Study|Lost to Follow-up|0|||
46988942|NCT02226549|83235506|FG001|Overall Study|Lost to Follow-up|1|||
46704409|NCT01049217|82919188|FG000|Overall Study|Randomized but not Treated|0|||
46704410|NCT01049217|82919189|FG001|Overall Study|Randomized but not Treated|2|||
46704411|NCT01232738|82919195|FG000|Overall Study|Death|3|||
46704412|NCT01232738|82919195|FG000|Overall Study|Physician Decision|2|||
46704413|NCT01232738|82919195|FG000|Overall Study|Lost to Follow-up|1|||
46704414|NCT01232738|82919195|FG000|Overall Study|Withdrawal by Subject|2|||
46704415|NCT01232738|82919195|FG000|Overall Study|Adverse Event|5|||
46988943|NCT02226003|83235515|FG000|Overall Study|Lost to Follow-up|2|||
46704416|NCT00957268|82919208|FG000|Overall Study|Voluntary Withdrawal|0|||
46704417|NCT00957268|82919209|FG001|Overall Study|Voluntary Withdrawal|0|||
46704418|NCT00957268|82919210|FG002|Overall Study|Voluntary Withdrawal|1|||
46704419|NCT00957268|82919211|FG003|Overall Study|Voluntary Withdrawal|0|||
46704420|NCT00957268|82919212|FG004|Overall Study|Voluntary Withdrawal|0|||
46704421|NCT01230788|82919224|FG000|Overall Study|Prescribed exclusion drug|1|||
46704422|NCT01230710|82919228|FG000|Overall Study|Disease Progression|41|||
46704423|NCT01230710|82919228|FG000|Overall Study|Lost to Follow-up|3|||
46704424|NCT01230710|82919228|FG000|Overall Study|Death|4|||
46704425|NCT01230710|82919228|FG000|Overall Study|Withdrawal of Consent|1|||
46704426|NCT01230554|82919232|FG000|Overall Study|Lost to Follow-up|2|||
46704427|NCT01230554|82919232|FG000|Overall Study|Inability to maintain visit schedule|1|||
46704428|NCT01040793|82919236|FG000|Overall Study|Adverse Event|5|||
46704429|NCT01040793|82919237|FG001|Overall Study|Adverse Event|3|||
46704430|NCT01040793|82919238|FG002|Overall Study|Adverse Event|0|||
46704431|NCT01040793|82919239|FG003|Overall Study|Adverse Event|2|||
46704432|NCT01040793|82919240|FG004|Overall Study|Adverse Event|2|||
46704433|NCT01040793|82919241|FG005|Overall Study|Adverse Event|1|||
46704434|NCT01040793|82919236|FG000|Overall Study|Protocol Violation|1|||
46704435|NCT01040793|82919237|FG001|Overall Study|Protocol Violation|1|||
46704436|NCT01040793|82919238|FG002|Overall Study|Protocol Violation|1|||
46704437|NCT01040793|82919239|FG003|Overall Study|Protocol Violation|0|||
46704438|NCT01040793|82919240|FG004|Overall Study|Protocol Violation|1|||
46704439|NCT01040793|82919241|FG005|Overall Study|Protocol Violation|0|||
46704440|NCT01040793|82919236|FG000|Overall Study|Lost to Follow-up|0|||
46704441|NCT01040793|82919237|FG001|Overall Study|Lost to Follow-up|1|||
46704442|NCT01040793|82919238|FG002|Overall Study|Lost to Follow-up|1|||
46704443|NCT01040793|82919239|FG003|Overall Study|Lost to Follow-up|0|||
46704444|NCT01040793|82919240|FG004|Overall Study|Lost to Follow-up|0|||
46704445|NCT01040793|82919241|FG005|Overall Study|Lost to Follow-up|0|||
46704446|NCT01040793|82919236|FG000|Overall Study|Withdrawal by Subject|0|||
46704447|NCT01040793|82919237|FG001|Overall Study|Withdrawal by Subject|0|||
46704448|NCT01040793|82919238|FG002|Overall Study|Withdrawal by Subject|0|||
46704449|NCT01040793|82919239|FG003|Overall Study|Withdrawal by Subject|2|||
46704450|NCT01040793|82919240|FG004|Overall Study|Withdrawal by Subject|0|||
46704451|NCT01040793|82919241|FG005|Overall Study|Withdrawal by Subject|0|||
46704452|NCT01040793|82919236|FG000|Overall Study|Other reasons not listed above|0|||
46704453|NCT01040793|82919237|FG001|Overall Study|Other reasons not listed above|0|||
46704454|NCT01040793|82919238|FG002|Overall Study|Other reasons not listed above|1|||
46704455|NCT01040793|82919239|FG003|Overall Study|Other reasons not listed above|0|||
46704456|NCT01040793|82919240|FG004|Overall Study|Other reasons not listed above|1|||
46704457|NCT01040793|82919241|FG005|Overall Study|Other reasons not listed above|0|||
46704458|NCT00948064|82919254|FG000|Phase I|No treatment received|1|||
46704459|NCT00948064|82919255|FG001|Phase I|No treatment received|0|||
46704460|NCT00948064|82919256|FG002|Phase I|No treatment received|0|||
46704461|NCT00948064|82919254|FG000|Phase II|Physician Decision|0|||
46704462|NCT00948064|82919255|FG001|Phase II|Physician Decision|0|||
46704463|NCT00948064|82919256|FG002|Phase II|Physician Decision|1|||
46704464|NCT00948064|82919254|FG000|Phase II|Withdrawal by Subject|0|||
46704465|NCT00948064|82919255|FG001|Phase II|Withdrawal by Subject|1|||
46704466|NCT00948064|82919256|FG002|Phase II|Withdrawal by Subject|0|||
46988944|NCT02226003|83235516|FG001|Overall Study|Lost to Follow-up|1|||
46704467|NCT00953524|82919270|FG000|Overall Study|Adverse Event|2|||
46704468|NCT00953524|82919271|FG001|Overall Study|Adverse Event|0|||
46704469|NCT00953524|82919272|FG002|Overall Study|Adverse Event|1|||
46704470|NCT00953524|82919273|FG003|Overall Study|Adverse Event|2|||
46704471|NCT00953524|82919270|FG000|Overall Study|Protocol Violation|18|||
46704472|NCT00953524|82919271|FG001|Overall Study|Protocol Violation|10|||
46704473|NCT00953524|82919272|FG002|Overall Study|Protocol Violation|11|||
46704474|NCT00953524|82919273|FG003|Overall Study|Protocol Violation|6|||
46704475|NCT00953524|82919270|FG000|Overall Study|Lost to Follow-up|0|||
46704476|NCT00953524|82919271|FG001|Overall Study|Lost to Follow-up|1|||
46704477|NCT00953524|82919272|FG002|Overall Study|Lost to Follow-up|1|||
46704478|NCT00953524|82919273|FG003|Overall Study|Lost to Follow-up|0|||
46704479|NCT00953524|82919270|FG000|Overall Study|Withdrawal by Subject|2|||
46704480|NCT00953524|82919271|FG001|Overall Study|Withdrawal by Subject|4|||
46704481|NCT00953524|82919272|FG002|Overall Study|Withdrawal by Subject|1|||
46704482|NCT00953524|82919273|FG003|Overall Study|Withdrawal by Subject|0|||
46704483|NCT01040403|82919292|FG000|Overall Study|Adverse Event|10|||
46704484|NCT01040403|82919292|FG000|Overall Study|Protocol Violation|2|||
46802893|NCT00423670|83022130|FG005|Follow-up Period|Lost to Follow-up|0|||
46802894|NCT00423670|83022131|FG006|Follow-up Period|Lost to Follow-up|5|||
46802895|NCT00423670|83022132|FG007|Follow-up Period|Lost to Follow-up|0|||
46802896|NCT00423670|83022125|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
46802897|NCT00423670|83022126|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
46802898|NCT00423670|83022127|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
46802899|NCT00423670|83022128|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
46802900|NCT00423670|83022129|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
46802901|NCT00423670|83022130|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
46802902|NCT00423670|83022131|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
46802903|NCT00423670|83022132|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
46802904|NCT00423670|83022125|FG000|Follow-up Period|Non-compliance with protocol|2|||
46802905|NCT00423670|83022126|FG001|Follow-up Period|Non-compliance with protocol|0|||
46802906|NCT00423670|83022127|FG002|Follow-up Period|Non-compliance with protocol|1|||
46802907|NCT00423670|83022128|FG003|Follow-up Period|Non-compliance with protocol|1|||
46802908|NCT00423670|83022129|FG004|Follow-up Period|Non-compliance with protocol|0|||
46802909|NCT00423670|83022130|FG005|Follow-up Period|Non-compliance with protocol|0|||
46802910|NCT00423670|83022131|FG006|Follow-up Period|Non-compliance with protocol|3|||
46802911|NCT00423670|83022132|FG007|Follow-up Period|Non-compliance with protocol|2|||
46802912|NCT00483717|83022155|FG000|Overall Study|Protocol Violation|5|||
46802913|NCT00483717|83022156|FG001|Overall Study|Protocol Violation|7|||
46802914|NCT00483717|83022155|FG000|Overall Study|Time of dosing missing|1|||
46802915|NCT00483717|83022156|FG001|Overall Study|Time of dosing missing|1|||
46802916|NCT00483717|83022155|FG000|Overall Study|No treatment for migraine|16|||
46802917|NCT00483717|83022156|FG001|Overall Study|No treatment for migraine|13|||
46802918|NCT00483717|83022155|FG000|Overall Study|Lost to Follow-up|1|||
46802919|NCT00483717|83022156|FG001|Overall Study|Lost to Follow-up|0|||
46802920|NCT00483717|83022155|FG000|Overall Study|Withdrawal by Subject|1|||
46802921|NCT00483717|83022156|FG001|Overall Study|Withdrawal by Subject|0|||
46802922|NCT00406354|83022165|FG000|All Randomized Patients|Protocol Violation|0|||
46802923|NCT00406354|83022166|FG001|All Randomized Patients|Protocol Violation|0|||
46802924|NCT00406354|83022167|FG002|All Randomized Patients|Protocol Violation|1|||
46802925|NCT00406354|83022165|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
46802926|NCT00406354|83022166|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
46802927|NCT00406354|83022167|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
46802928|NCT00406354|83022165|FG000|All Randomized and Treated Patients|Adverse Event|6|||
46802929|NCT00406354|83022166|FG001|All Randomized and Treated Patients|Adverse Event|2|||
46802930|NCT00406354|83022167|FG002|All Randomized and Treated Patients|Adverse Event|1|||
46802931|NCT00406354|83022165|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
46802932|NCT00406354|83022166|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
46802933|NCT00406354|83022167|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
46802934|NCT00406354|83022165|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
46802935|NCT00406354|83022166|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
46802936|NCT00406354|83022167|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
46802937|NCT00406354|83022165|FG000|All Randomized and Treated Patients|Physician Decision|0|||
46802938|NCT00406354|83022166|FG001|All Randomized and Treated Patients|Physician Decision|0|||
46880659|NCT02892513|83102057|FG000|Overall Study|Withdrawal by Subject|0|||
46880660|NCT02892513|83102058|FG001|Overall Study|Withdrawal by Subject|1|||
46880661|NCT03558555|83102066|FG000|Overall Study|Lost to Follow-up|2|||
46802939|NCT00406354|83022167|FG002|All Randomized and Treated Patients|Physician Decision|1|||
46802940|NCT00483405|83022175|FG000|Overall Study|Adverse Event|8|||
46802941|NCT00483405|83022175|FG000|Overall Study|Lack of Efficacy|14|||
46802942|NCT00483405|83022175|FG000|Overall Study|Death|3|||
46802943|NCT00483405|83022175|FG000|Overall Study|Withdrawal by Subject|2|||
46802944|NCT00483405|83022175|FG000|Overall Study|Other complicating disease|1|||
46802945|NCT00483327|83022183|FG000|Overall Study|Adverse Event|1|||
46802946|NCT00483327|83022183|FG000|Overall Study|Withdrawal by Subject|3|||
46802947|NCT00483327|83022183|FG000|Overall Study|Lost to Follow-up|4|||
46802948|NCT00483327|83022183|FG000|Overall Study|Patient Non Compliance|2|||
46880662|NCT03558555|83102067|FG001|Overall Study|Lost to Follow-up|1|||
46880663|NCT03541317|83102075|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
46880664|NCT03541317|83102076|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
46880665|NCT03541317|83102077|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
46988945|NCT02226003|83235517|FG002|Overall Study|Lost to Follow-up|3|||
46802949|NCT00684203|83022195|FG000|Overall Study|Adverse Event|6|||
46704485|NCT01040403|82919292|FG000|Overall Study|Lost to Follow-up|1|||
46704486|NCT01040403|82919292|FG000|Overall Study|Not treated|1|||
46704487|NCT01040403|82919292|FG000|Overall Study|Other reason not defined above|6|||
46704488|NCT00957034|82919314|FG000|Overall Study|Adverse Event|0|||
46704489|NCT00957034|82919315|FG001|Overall Study|Adverse Event|1|||
46704490|NCT00957034|82919316|FG002|Overall Study|Adverse Event|1|||
46704491|NCT00957034|82919314|FG000|Overall Study|Sponsor Terminated Study|6|||
46704492|NCT00957034|82919315|FG001|Overall Study|Sponsor Terminated Study|1|||
46880666|NCT03541317|83102078|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
46880667|NCT03541317|83102079|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
46880668|NCT03541317|83102080|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
46880669|NCT03557931|83102095|FG000|Overall Study|Adverse Event|4|||
46880670|NCT03557931|83102096|FG001|Overall Study|Adverse Event|6|||
46880671|NCT03557931|83102097|FG002|Overall Study|Adverse Event|1|||
46880672|NCT03557931|83102095|FG000|Overall Study|Lost to Follow-up|4|||
46880673|NCT03557931|83102096|FG001|Overall Study|Lost to Follow-up|4|||
46880674|NCT03557931|83102097|FG002|Overall Study|Lost to Follow-up|1|||
46880675|NCT03557931|83102095|FG000|Overall Study|Protocol Violation|1|||
46880676|NCT03557931|83102096|FG001|Overall Study|Protocol Violation|4|||
46880677|NCT03557931|83102097|FG002|Overall Study|Protocol Violation|1|||
46880678|NCT03557931|83102095|FG000|Overall Study|Withdrawal by Subject|14|||
46880679|NCT03557931|83102096|FG001|Overall Study|Withdrawal by Subject|0|||
46880680|NCT03557931|83102097|FG002|Overall Study|Withdrawal by Subject|7|||
46880681|NCT03557931|83102095|FG000|Overall Study|Miscellaneous|8|||
46880682|NCT03557931|83102096|FG001|Overall Study|Miscellaneous|5|||
46880683|NCT03557931|83102097|FG002|Overall Study|Miscellaneous|3|||
46880684|NCT03522675|83102107|FG000|Overall Study|Screen fail|1|||
46880685|NCT03522675|83102107|FG000|Overall Study|Non-reactive to histamine|1|||
46880686|NCT00294047|83102117|FG000|Month 48|Adverse Event|28|||
46880687|NCT00294047|83102118|FG001|Month 48|Adverse Event|13|||
46880688|NCT00294047|83102117|FG000|Month 48|Protocol Violation|4|||
46880689|NCT00294047|83102118|FG001|Month 48|Protocol Violation|4|||
46880690|NCT00294047|83102117|FG000|Month 48|Withdrawal by Subject|111|||
46880691|NCT00294047|83102118|FG001|Month 48|Withdrawal by Subject|115|||
46880692|NCT00294047|83102117|FG000|Month 48|Lost to Follow-up|272|||
46880693|NCT00294047|83102118|FG001|Month 48|Lost to Follow-up|287|||
46880694|NCT00294047|83102117|FG000|Month 48|Other|10|||
46880695|NCT00294047|83102118|FG001|Month 48|Other|14|||
46880696|NCT00294047|83102117|FG000|Month 84|Adverse Event|4|||
46880697|NCT00294047|83102118|FG001|Month 84|Adverse Event|2|||
46880698|NCT00294047|83102117|FG000|Month 84|Protocol Violation|1|||
46880699|NCT00294047|83102118|FG001|Month 84|Protocol Violation|1|||
46880700|NCT00294047|83102117|FG000|Month 84|Withdrawal by Subject|33|||
46880701|NCT00294047|83102118|FG001|Month 84|Withdrawal by Subject|31|||
46880702|NCT00294047|83102117|FG000|Month 84|Lost to Follow-up|187|||
46880703|NCT00294047|83102118|FG001|Month 84|Lost to Follow-up|190|||
46880704|NCT00294047|83102117|FG000|Month 84|Absent Cervix|2|||
46880705|NCT00294047|83102118|FG001|Month 84|Absent Cervix|0|||
46880706|NCT00294047|83102117|FG000|Month 84|Work related reasons|4|||
46880707|NCT00294047|83102118|FG001|Month 84|Work related reasons|2|||
46880708|NCT00294047|83102117|FG000|Month 84|Center closed, subject did not transfer|1|||
46880709|NCT00294047|83102118|FG001|Month 84|Center closed, subject did not transfer|0|||
46880710|NCT00294047|83102117|FG000|Month 84|Family problems|2|||
46880711|NCT00294047|83102118|FG001|Month 84|Family problems|2|||
46880712|NCT00294047|83102117|FG000|Month 84|Lack of time|3|||
46880713|NCT00294047|83102118|FG001|Month 84|Lack of time|1|||
46880714|NCT00294047|83102117|FG000|Month 84|Personal reason|2|||
46880715|NCT00294047|83102118|FG001|Month 84|Personal reason|4|||
46880716|NCT00294047|83102117|FG000|Month 84|Subject does not want male physician|1|||
46880717|NCT00294047|83102118|FG001|Month 84|Subject does not want male physician|0|||
46880718|NCT00294047|83102117|FG000|Month 84|Transport reimbursement delayed|0|||
46880719|NCT00294047|83102118|FG001|Month 84|Transport reimbursement delayed|1|||
46880720|NCT00294047|83102117|FG000|Month 84|Unable to reach study site|1|||
46880721|NCT00294047|83102118|FG001|Month 84|Unable to reach study site|0|||
46704493|NCT00957034|82919316|FG002|Overall Study|Sponsor Terminated Study|5|||
46704494|NCT00957034|82919314|FG000|Overall Study|Withdrawal by Subject|0|||
46880722|NCT00294047|83102117|FG000|Month 84|Under investigation locally|1|||
46880723|NCT00294047|83102118|FG001|Month 84|Under investigation locally|0|||
46880724|NCT00294047|83102117|FG000|Month 84|Visit missed|0|||
46880725|NCT00294047|83102118|FG001|Month 84|Visit missed|1|||
46880726|NCT00294047|83102117|FG000|Month 84|No consent for Month 84 Follow-up|731|||
46880727|NCT00294047|83102118|FG001|Month 84|No consent for Month 84 Follow-up|754|||
46880728|NCT00293813|83102128|FG000|Overall Study|Physician Decision|0|||
46704495|NCT00957034|82919315|FG001|Overall Study|Withdrawal by Subject|2|||
46880729|NCT00293813|83102129|FG001|Overall Study|Physician Decision|1|||
46880730|NCT00293813|83102130|FG002|Overall Study|Physician Decision|0|||
46880731|NCT00293813|83102128|FG000|Overall Study|Adverse Event|3|||
46880732|NCT00293813|83102129|FG001|Overall Study|Adverse Event|1|||
46880733|NCT00293813|83102130|FG002|Overall Study|Adverse Event|1|||
46880734|NCT00293813|83102128|FG000|Overall Study|Withdrawal by Subject|7|||
46880735|NCT00293813|83102129|FG001|Overall Study|Withdrawal by Subject|4|||
46880736|NCT00293813|83102130|FG002|Overall Study|Withdrawal by Subject|4|||
46880737|NCT00293813|83102128|FG000|Overall Study|Lost to Follow-up|3|||
46880738|NCT00293813|83102129|FG001|Overall Study|Lost to Follow-up|2|||
46880739|NCT00293813|83102130|FG002|Overall Study|Lost to Follow-up|3|||
46880740|NCT00293813|83102128|FG000|Overall Study|Noncompliance|0|||
46880741|NCT00293813|83102129|FG001|Overall Study|Noncompliance|1|||
46880742|NCT00293813|83102130|FG002|Overall Study|Noncompliance|0|||
46880743|NCT00293579|83102138|FG000|Overall Study|Withdrawal by Subject|1|||
46880744|NCT00293423|83102145|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
46880745|NCT00293423|83102146|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
46880746|NCT00293423|83102145|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
46880747|NCT00293423|83102146|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
46880748|NCT00293423|83102145|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
46988946|NCT02226003|83235515|FG000|Overall Study|Withdrawal by Subject|0|||
46988947|NCT02226003|83235516|FG001|Overall Study|Withdrawal by Subject|0|||
46988948|NCT02226003|83235517|FG002|Overall Study|Withdrawal by Subject|3|||
46988949|NCT02225223|83235527|FG000|Overall Study|Death|10|||
46988950|NCT02225223|83235528|FG001|Overall Study|Death|1|||
46988951|NCT02225223|83235527|FG000|Overall Study|Lost to Follow-up|5|||
46988952|NCT02225223|83235528|FG001|Overall Study|Lost to Follow-up|0|||
46988953|NCT02225223|83235527|FG000|Overall Study|Other|1|||
46988954|NCT02225223|83235528|FG001|Overall Study|Other|2|||
46988955|NCT02225223|83235527|FG000|Overall Study|Physician Decision|1|||
46988956|NCT02225223|83235528|FG001|Overall Study|Physician Decision|0|||
46988957|NCT02225223|83235527|FG000|Overall Study|Withdrawal by Subject|2|||
46988958|NCT02225223|83235528|FG001|Overall Study|Withdrawal by Subject|2|||
46988959|NCT01634139|83235537|FG000|Overall Study|Non compliant with protocol|1|||
46988960|NCT01634139|83235538|FG001|Overall Study|Non compliant with protocol|0|||
46988961|NCT01634139|83235539|FG002|Overall Study|Non compliant with protocol|0|||
46988962|NCT01634139|83235537|FG000|Overall Study|Consent withdrawn not due to AE|4|||
46988963|NCT01634139|83235538|FG001|Overall Study|Consent withdrawn not due to AE|3|||
46988964|NCT01634139|83235539|FG002|Overall Study|Consent withdrawn not due to AE|2|||
46988965|NCT01634139|83235537|FG000|Overall Study|Other|4|||
46988966|NCT01634139|83235538|FG001|Overall Study|Other|0|||
46988967|NCT01634139|83235539|FG002|Overall Study|Other|3|||
46988968|NCT01634139|83235537|FG000|Overall Study|Lost to Follow-up|0|||
46988969|NCT01634139|83235538|FG001|Overall Study|Lost to Follow-up|2|||
46988970|NCT01634139|83235539|FG002|Overall Study|Lost to Follow-up|0|||
46988971|NCT01634139|83235537|FG000|Overall Study|Not treated|1|||
46988972|NCT01634139|83235538|FG001|Overall Study|Not treated|1|||
46988973|NCT01634139|83235539|FG002|Overall Study|Not treated|0|||
46988974|NCT02224755|83235549|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
46988975|NCT02224755|83235550|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
46988976|NCT02224755|83235549|FG000|Two Year Follow up Post-implant|Death|103|||
46988977|NCT02224755|83235550|FG001|Two Year Follow up Post-implant|Death|98|||
46988978|NCT02224755|83235549|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
46988979|NCT02224755|83235550|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
46988980|NCT02224755|83235549|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
46988981|NCT02224755|83235550|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
46988982|NCT02224755|83235549|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
46988983|NCT02224755|83235550|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
46988984|NCT02404441|83235570|FG000|Phase 1 Part|Adverse Event|1|||
46988985|NCT02404441|83235571|FG001|Phase 1 Part|Adverse Event|0|||
46988986|NCT02404441|83235572|FG002|Phase 1 Part|Adverse Event|0|||
46988987|NCT02404441|83235573|FG003|Phase 1 Part|Adverse Event|0|||
46988988|NCT02404441|83235574|FG004|Phase 1 Part|Adverse Event|0|||
46988989|NCT02404441|83235575|FG005|Phase 1 Part|Adverse Event|0|||
46988990|NCT02404441|83235576|FG006|Phase 1 Part|Adverse Event|0|||
46988991|NCT02404441|83235577|FG007|Phase 1 Part|Adverse Event|0|||
46988992|NCT02404441|83235578|FG008|Phase 1 Part|Adverse Event|0|||
46988993|NCT02404441|83235579|FG009|Phase 1 Part|Adverse Event|0|||
46988994|NCT02404441|83235570|FG000|Phase 1 Part|Physician Decision|0|||
46988995|NCT02404441|83235571|FG001|Phase 1 Part|Physician Decision|1|||
46988996|NCT02404441|83235572|FG002|Phase 1 Part|Physician Decision|0|||
46988997|NCT02404441|83235573|FG003|Phase 1 Part|Physician Decision|0|||
46988998|NCT02404441|83235574|FG004|Phase 1 Part|Physician Decision|0|||
46988999|NCT02404441|83235575|FG005|Phase 1 Part|Physician Decision|0|||
46989000|NCT02404441|83235576|FG006|Phase 1 Part|Physician Decision|0|||
46989001|NCT02404441|83235577|FG007|Phase 1 Part|Physician Decision|0|||
46989002|NCT02404441|83235578|FG008|Phase 1 Part|Physician Decision|0|||
46989003|NCT02404441|83235579|FG009|Phase 1 Part|Physician Decision|0|||
46989004|NCT02404441|83235570|FG000|Phase 1 Part|Progressive Disease|14|||
46989005|NCT02404441|83235571|FG001|Phase 1 Part|Progressive Disease|11|||
46989006|NCT02404441|83235572|FG002|Phase 1 Part|Progressive Disease|7|||
46989007|NCT02404441|83235573|FG003|Phase 1 Part|Progressive Disease|6|||
46989008|NCT02404441|83235574|FG004|Phase 1 Part|Progressive Disease|9|||
46989009|NCT02404441|83235575|FG005|Phase 1 Part|Progressive Disease|0|||
46989010|NCT02404441|83235576|FG006|Phase 1 Part|Progressive Disease|0|||
46989011|NCT02404441|83235577|FG007|Phase 1 Part|Progressive Disease|0|||
46989012|NCT02404441|83235578|FG008|Phase 1 Part|Progressive Disease|0|||
46989013|NCT02404441|83235579|FG009|Phase 1 Part|Progressive Disease|0|||
46989014|NCT02404441|83235570|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
46989015|NCT02404441|83235571|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
46989016|NCT02404441|83235572|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
46989017|NCT02404441|83235573|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
46989018|NCT02404441|83235574|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
46989019|NCT02404441|83235575|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
46989020|NCT02404441|83235576|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
46989021|NCT02404441|83235577|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
46989022|NCT02404441|83235578|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
46989023|NCT02404441|83235579|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
46989024|NCT02404441|83235570|FG000|Phase 1 Part|Death|1|||
46989025|NCT02404441|83235571|FG001|Phase 1 Part|Death|1|||
46989026|NCT02404441|83235572|FG002|Phase 1 Part|Death|1|||
46989027|NCT02404441|83235573|FG003|Phase 1 Part|Death|0|||
46989028|NCT02404441|83235574|FG004|Phase 1 Part|Death|1|||
46989029|NCT02404441|83235575|FG005|Phase 1 Part|Death|0|||
46989030|NCT02404441|83235576|FG006|Phase 1 Part|Death|0|||
46989031|NCT02404441|83235577|FG007|Phase 1 Part|Death|0|||
46989032|NCT02404441|83235578|FG008|Phase 1 Part|Death|0|||
46989033|NCT02404441|83235579|FG009|Phase 1 Part|Death|0|||
46989034|NCT02404441|83235570|FG000|Phase 2 Part|Adverse Event|0|||
46989035|NCT02404441|83235571|FG001|Phase 2 Part|Adverse Event|0|||
46989036|NCT02404441|83235572|FG002|Phase 2 Part|Adverse Event|0|||
46989037|NCT02404441|83235573|FG003|Phase 2 Part|Adverse Event|0|||
46989038|NCT02404441|83235574|FG004|Phase 2 Part|Adverse Event|0|||
46989039|NCT02404441|83235575|FG005|Phase 2 Part|Adverse Event|2|||
46989040|NCT02404441|83235576|FG006|Phase 2 Part|Adverse Event|3|||
46989041|NCT02404441|83235577|FG007|Phase 2 Part|Adverse Event|3|||
46989042|NCT02404441|83235578|FG008|Phase 2 Part|Adverse Event|6|||
46989043|NCT02404441|83235579|FG009|Phase 2 Part|Adverse Event|1|||
46989044|NCT02404441|83235570|FG000|Phase 2 Part|Physician Decision|0|||
46989045|NCT02404441|83235571|FG001|Phase 2 Part|Physician Decision|0|||
46989046|NCT02404441|83235572|FG002|Phase 2 Part|Physician Decision|0|||
46989047|NCT02404441|83235573|FG003|Phase 2 Part|Physician Decision|0|||
46989048|NCT02404441|83235574|FG004|Phase 2 Part|Physician Decision|0|||
46989049|NCT02404441|83235575|FG005|Phase 2 Part|Physician Decision|7|||
46989050|NCT02404441|83235576|FG006|Phase 2 Part|Physician Decision|9|||
46989051|NCT02404441|83235577|FG007|Phase 2 Part|Physician Decision|2|||
46989052|NCT02404441|83235578|FG008|Phase 2 Part|Physician Decision|1|||
46989053|NCT02404441|83235579|FG009|Phase 2 Part|Physician Decision|3|||
46989054|NCT02404441|83235570|FG000|Phase 2 Part|Progressive disease|0|||
46989055|NCT02404441|83235571|FG001|Phase 2 Part|Progressive disease|0|||
46989056|NCT02404441|83235572|FG002|Phase 2 Part|Progressive disease|0|||
46989057|NCT02404441|83235573|FG003|Phase 2 Part|Progressive disease|0|||
46989058|NCT02404441|83235574|FG004|Phase 2 Part|Progressive disease|0|||
46989059|NCT02404441|83235575|FG005|Phase 2 Part|Progressive disease|43|||
46989060|NCT02404441|83235576|FG006|Phase 2 Part|Progressive disease|32|||
46989061|NCT02404441|83235577|FG007|Phase 2 Part|Progressive disease|31|||
46989062|NCT02404441|83235578|FG008|Phase 2 Part|Progressive disease|39|||
46989063|NCT02404441|83235579|FG009|Phase 2 Part|Progressive disease|27|||
46989064|NCT02404441|83235570|FG000|Phase 2 Part|Subject/guardian decision|0|||
46989065|NCT02404441|83235571|FG001|Phase 2 Part|Subject/guardian decision|0|||
46989066|NCT02404441|83235572|FG002|Phase 2 Part|Subject/guardian decision|0|||
46989067|NCT02404441|83235573|FG003|Phase 2 Part|Subject/guardian decision|0|||
46989068|NCT02404441|83235574|FG004|Phase 2 Part|Subject/guardian decision|0|||
46989069|NCT02404441|83235575|FG005|Phase 2 Part|Subject/guardian decision|3|||
46989070|NCT02404441|83235576|FG006|Phase 2 Part|Subject/guardian decision|9|||
46989071|NCT02404441|83235577|FG007|Phase 2 Part|Subject/guardian decision|0|||
46989072|NCT02404441|83235578|FG008|Phase 2 Part|Subject/guardian decision|3|||
46989073|NCT02404441|83235579|FG009|Phase 2 Part|Subject/guardian decision|2|||
46989074|NCT02404441|83235570|FG000|Phase 2 Part|Death|0|||
46704496|NCT00957034|82919316|FG002|Overall Study|Withdrawal by Subject|0|||
46704497|NCT00953056|82919330|FG000|Overall Study|Withdrew Consent|0|||
46704498|NCT00953056|82919331|FG001|Overall Study|Withdrew Consent|0|||
46704499|NCT00953056|82919332|FG002|Overall Study|Withdrew Consent|0|||
46704500|NCT00953056|82919333|FG003|Overall Study|Withdrew Consent|0|||
46704501|NCT00953056|82919334|FG004|Overall Study|Withdrew Consent|2|||
46704502|NCT00953056|82919335|FG005|Overall Study|Withdrew Consent|3|||
46704503|NCT00953056|82919330|FG000|Overall Study|Serious Adverse Event|0|||
46704504|NCT00953056|82919331|FG001|Overall Study|Serious Adverse Event|0|||
46704505|NCT00953056|82919332|FG002|Overall Study|Serious Adverse Event|0|||
46704506|NCT00953056|82919333|FG003|Overall Study|Serious Adverse Event|0|||
46704507|NCT00953056|82919334|FG004|Overall Study|Serious Adverse Event|0|||
46704508|NCT00953056|82919335|FG005|Overall Study|Serious Adverse Event|1|||
46704509|NCT00952822|82919360|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
46704510|NCT00952822|82919361|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
46704511|NCT00952822|82919362|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
46704512|NCT00952822|82919363|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
46704513|NCT00952822|82919360|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
46704514|NCT00952822|82919361|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
46704515|NCT00952822|82919362|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
46989075|NCT02404441|83235571|FG001|Phase 2 Part|Death|0|||
46989076|NCT02404441|83235572|FG002|Phase 2 Part|Death|0|||
46989077|NCT02404441|83235573|FG003|Phase 2 Part|Death|0|||
46704516|NCT00952822|82919363|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
46704517|NCT01038297|82919377|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
46989078|NCT02404441|83235574|FG004|Phase 2 Part|Death|0|||
46989079|NCT02404441|83235575|FG005|Phase 2 Part|Death|4|||
46704518|NCT01038297|82919378|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
46704519|NCT01038297|82919379|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
46704520|NCT00955708|82919396|FG000|Overall Study|Death|269|||
46704521|NCT00955708|82919396|FG000|Overall Study|Lost to Follow-up|72|||
46704522|NCT00955708|82919396|FG000|Overall Study|Physician Decision|36|||
46704523|NCT00955708|82919396|FG000|Overall Study|Protocol Violation|134|||
46704524|NCT00955708|82919396|FG000|Overall Study|Registry Conclusion|186|||
46704525|NCT00955708|82919396|FG000|Overall Study|Product removed from service|94|||
46704526|NCT00955708|82919396|FG000|Overall Study|Patient Refused to participate further|116|||
46704527|NCT00955708|82919396|FG000|Overall Study|Closure of study location|60|||
46704528|NCT00955708|82919396|FG000|Overall Study|Patient changed care provider/moved|91|||
46704529|NCT01037985|82919400|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
46704530|NCT01037985|82919401|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
46704531|NCT01037985|82919400|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
46880749|NCT00293423|83102146|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
46880750|NCT00293423|83102145|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
46880751|NCT00293423|83102146|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
46880752|NCT00293423|83102145|FG000|Surgical Resection|processing error during surgical resection|1|||
46880753|NCT00293423|83102146|FG001|Surgical Resection|processing error during surgical resection|0|||
46880754|NCT00293423|83102145|FG000|Surgical Resection|Withdrawal by Subject|4|||
46880755|NCT00293423|83102146|FG001|Surgical Resection|Withdrawal by Subject|0|||
46880756|NCT00293423|83102145|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
46880757|NCT00293423|83102146|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
46989080|NCT02404441|83235576|FG006|Phase 2 Part|Death|8|||
46704532|NCT01037985|82919401|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
46704533|NCT01037985|82919400|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
46704534|NCT01037985|82919401|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
46989081|NCT02404441|83235577|FG007|Phase 2 Part|Death|4|||
46989082|NCT02404441|83235578|FG008|Phase 2 Part|Death|10|||
46989083|NCT02404441|83235579|FG009|Phase 2 Part|Death|9|||
46989084|NCT02101281|83235625|FG000|Overall Study|Adverse Event|0|||
46989085|NCT02101281|83235626|FG001|Overall Study|Adverse Event|1|||
46989086|NCT02224599|83235638|FG000|Overall Study|Physician Decision|1|||
46989087|NCT02224599|83235638|FG000|Overall Study|Progression of Disease|1|||
46989088|NCT02201901|83235645|FG000|Overall Study|Randomized but never treated|0|||
46989089|NCT02201901|83235646|FG001|Overall Study|Randomized but never treated|1|||
46989090|NCT02201901|83235647|FG002|Overall Study|Randomized but never treated|0|||
46989091|NCT02201901|83235645|FG000|Overall Study|Lack of Efficacy|7|||
46989092|NCT02201901|83235646|FG001|Overall Study|Lack of Efficacy|1|||
46989093|NCT02201901|83235647|FG002|Overall Study|Lack of Efficacy|6|||
46989094|NCT02201901|83235645|FG000|Overall Study|Death|3|||
46989095|NCT02201901|83235646|FG001|Overall Study|Death|3|||
46989096|NCT02201901|83235647|FG002|Overall Study|Death|3|||
46989097|NCT02201901|83235645|FG000|Overall Study|Lost to Follow-up|2|||
46989098|NCT02201901|83235646|FG001|Overall Study|Lost to Follow-up|3|||
46989099|NCT02201901|83235647|FG002|Overall Study|Lost to Follow-up|2|||
46989100|NCT02201901|83235645|FG000|Overall Study|Withdrew Consent|2|||
46989101|NCT02201901|83235646|FG001|Overall Study|Withdrew Consent|0|||
46989102|NCT02201901|83235647|FG002|Overall Study|Withdrew Consent|2|||
46989103|NCT02201901|83235645|FG000|Overall Study|Adverse Event|1|||
46989104|NCT02201901|83235646|FG001|Overall Study|Adverse Event|1|||
46989105|NCT02201901|83235647|FG002|Overall Study|Adverse Event|0|||
46704535|NCT01037985|82919400|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
46989106|NCT02201277|83235658|FG000|Overall Study|Death|3|||
46989107|NCT02201277|83235659|FG001|Overall Study|Death|4|||
46707568|NCT01176240|82923135|FG000|Study 306B|withdrew prior to dosing|2|||
46880758|NCT03538743|83102161|FG000|Overall Study|Adverse Event|0|||
46880759|NCT03538743|83102162|FG001|Overall Study|Adverse Event|0|||
46880760|NCT03538743|83102163|FG002|Overall Study|Adverse Event|1|||
46880761|NCT03538743|83102164|FG003|Overall Study|Adverse Event|1|||
46880762|NCT03538743|83102165|FG004|Overall Study|Adverse Event|0|||
46880763|NCT03538743|83102166|FG005|Overall Study|Adverse Event|0|||
46880764|NCT03538743|83102167|FG006|Overall Study|Adverse Event|0|||
46880765|NCT03538743|83102168|FG007|Overall Study|Adverse Event|0|||
46880766|NCT03538743|83102169|FG008|Overall Study|Adverse Event|0|||
46880767|NCT03538743|83102161|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
46880768|NCT03538743|83102162|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
46880769|NCT03538743|83102163|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
46880770|NCT03538743|83102164|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
46880771|NCT03538743|83102165|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
46880772|NCT03538743|83102166|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
46880773|NCT03538743|83102167|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
46880774|NCT03538743|83102168|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
46880775|NCT03538743|83102169|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
46880776|NCT03538743|83102161|FG000|Overall Study|Withdrawal by Subject|0|||
46880777|NCT03538743|83102162|FG001|Overall Study|Withdrawal by Subject|0|||
46880778|NCT03538743|83102163|FG002|Overall Study|Withdrawal by Subject|0|||
46880779|NCT03538743|83102164|FG003|Overall Study|Withdrawal by Subject|1|||
46880780|NCT03538743|83102165|FG004|Overall Study|Withdrawal by Subject|0|||
46880781|NCT03538743|83102166|FG005|Overall Study|Withdrawal by Subject|0|||
46880782|NCT03538743|83102167|FG006|Overall Study|Withdrawal by Subject|0|||
46880783|NCT03538743|83102168|FG007|Overall Study|Withdrawal by Subject|0|||
46880784|NCT03538743|83102169|FG008|Overall Study|Withdrawal by Subject|0|||
46880785|NCT03521817|83102199|FG000|Overall Study|Protocol Violation|0|||
46880786|NCT03521817|83102200|FG001|Overall Study|Protocol Violation|1|||
46880787|NCT03538431|83102206|FG000|Overall Study|Physician Decision|0|||
46880788|NCT03538431|83102207|FG001|Overall Study|Physician Decision|1|||
46880789|NCT03538431|83102206|FG000|Overall Study|Withdrawal by Subject|1|||
46880790|NCT03538431|83102207|FG001|Overall Study|Withdrawal by Subject|0|||
46880791|NCT03521193|83102217|FG000|Overall Study|Withdrawal by Subject|8|||
46880792|NCT03521193|83102218|FG001|Overall Study|Withdrawal by Subject|0|||
46880793|NCT03521193|83102217|FG000|Overall Study|non compliant to ASA treatment|8|||
46880794|NCT03521193|83102218|FG001|Overall Study|non compliant to ASA treatment|0|||
46880795|NCT00293267|83102227|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
46880796|NCT00293267|83102228|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
46880797|NCT00293267|83102227|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
46880798|NCT00293267|83102228|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
46880799|NCT00293267|83102227|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
46880800|NCT00293267|83102228|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
46880801|NCT00293267|83102227|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
46880802|NCT00293267|83102228|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
46880803|NCT00293267|83102227|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
46880804|NCT00293267|83102228|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
46880805|NCT00293267|83102227|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
46880806|NCT00293267|83102228|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
46880807|NCT00293267|83102227|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
46880808|NCT00293267|83102228|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
46880809|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
46880810|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
46880811|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
46880812|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
46880813|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
46989108|NCT02201277|83235658|FG000|Overall Study|Lost to Follow-up|2|||
46989109|NCT02201277|83235659|FG001|Overall Study|Lost to Follow-up|1|||
46880814|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
46880815|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
46880816|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
46989110|NCT02201277|83235658|FG000|Overall Study|Failed retrieval|1|||
46880817|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Death|3|||
46880818|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Death|0|||
46897105|NCT03527173|83122679|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
46989111|NCT02201277|83235659|FG001|Overall Study|Failed retrieval|0|||
46880819|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
46880820|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
46880821|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
46880822|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
46880823|NCT00293267|83102227|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
46880824|NCT00293267|83102228|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
46880825|NCT00293267|83102227|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
46880826|NCT00293267|83102228|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
46880827|NCT00293267|83102227|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
46880828|NCT00293267|83102228|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
46880829|NCT00293267|83102227|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
46880830|NCT00293267|83102228|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
46880831|NCT00293267|83102227|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
46880832|NCT00293267|83102228|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
46880833|NCT00293267|83102227|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
46880834|NCT00293267|83102228|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
46880835|NCT00293267|83102227|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
46880836|NCT00293267|83102228|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
46880837|NCT00293267|83102227|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
46880838|NCT00293267|83102228|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
46880839|NCT00293267|83102227|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
46880840|NCT00293267|83102228|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
46880841|NCT00293267|83102227|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
46880842|NCT00293267|83102228|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
46880843|NCT00293267|83102227|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
46880844|NCT00293267|83102228|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
46880845|NCT00293267|83102227|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
46880846|NCT00293267|83102228|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
46880847|NCT00293267|83102227|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
46880848|NCT00293267|83102228|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
46880849|NCT00293267|83102227|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
46880850|NCT00293267|83102228|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
46880851|NCT03520959|83102238|FG000|Overall Study|Study terminated by Sponsor|0|||
46880852|NCT03520959|83102239|FG001|Overall Study|Study terminated by Sponsor|1|||
46880853|NCT03537261|83102247|FG000|Overall Study|Lost to Follow-up|4|||
46880854|NCT03537261|83102248|FG001|Overall Study|Lost to Follow-up|5|||
46880855|NCT03537261|83102247|FG000|Overall Study|Withdrawal by Subject|4|||
46880856|NCT03537261|83102248|FG001|Overall Study|Withdrawal by Subject|6|||
46880857|NCT03537261|83102247|FG000|Overall Study|Did not return study questionnaires|0|||
46880858|NCT03537261|83102248|FG001|Overall Study|Did not return study questionnaires|1|||
46880859|NCT03536949|83102256|FG000|Overall Study|Adverse Event|4|||
46880860|NCT03536949|83102257|FG001|Overall Study|Adverse Event|0|||
46880861|NCT03536949|83102256|FG000|Overall Study|Lost to Follow-up|2|||
46880862|NCT03536949|83102257|FG001|Overall Study|Lost to Follow-up|1|||
46880863|NCT03536949|83102256|FG000|Overall Study|Withdrawal by Subject|6|||
46880864|NCT03536949|83102257|FG001|Overall Study|Withdrawal by Subject|0|||
46880865|NCT03536949|83102256|FG000|Overall Study|Non-compliance|2|||
46880866|NCT03536949|83102257|FG001|Overall Study|Non-compliance|1|||
46880867|NCT03588741|83102263|FG000|Overall Study|Withdrawal by Subject|1|||
46880868|NCT00111917|83102269|FG000|Overall Study|Withdrawal by Subject|1|||
46880869|NCT00111917|83102270|FG001|Overall Study|Withdrawal by Subject|1|||
46880870|NCT03520569|83102280|FG000|Overall Study|Withdrawal by Subject|1|||
46880871|NCT00111839|83102293|FG000|Overall Study|Disease Progression|30|||
46880872|NCT00111839|83102294|FG001|Overall Study|Disease Progression|33|||
46880873|NCT00111839|83102295|FG002|Overall Study|Disease Progression|33|||
46880874|NCT00111839|83102293|FG000|Overall Study|Adverse Event|5|||
46880875|NCT00111839|83102294|FG001|Overall Study|Adverse Event|3|||
46880876|NCT00111839|83102295|FG002|Overall Study|Adverse Event|1|||
46880877|NCT00111839|83102293|FG000|Overall Study|Protocol Violation|2|||
46880878|NCT00111839|83102294|FG001|Overall Study|Protocol Violation|4|||
46880879|NCT00111839|83102295|FG002|Overall Study|Protocol Violation|2|||
46880880|NCT00111839|83102293|FG000|Overall Study|Death|1|||
46880881|NCT00111839|83102294|FG001|Overall Study|Death|1|||
46880882|NCT00111839|83102295|FG002|Overall Study|Death|6|||
46880883|NCT00111839|83102293|FG000|Overall Study|Withdrawal by Subject|2|||
46880884|NCT00111839|83102294|FG001|Overall Study|Withdrawal by Subject|2|||
46880885|NCT00111839|83102295|FG002|Overall Study|Withdrawal by Subject|2|||
46880886|NCT00111839|83102293|FG000|Overall Study|Lost to Follow-up|1|||
46880887|NCT00111839|83102294|FG001|Overall Study|Lost to Follow-up|0|||
46880888|NCT00111839|83102295|FG002|Overall Study|Lost to Follow-up|0|||
46880889|NCT00111839|83102293|FG000|Overall Study|Logistical Constraint|1|||
46880890|NCT00111839|83102294|FG001|Overall Study|Logistical Constraint|0|||
46880891|NCT00111839|83102295|FG002|Overall Study|Logistical Constraint|0|||
46880892|NCT00111839|83102293|FG000|Overall Study|Other|6|||
46880893|NCT00111839|83102294|FG001|Overall Study|Other|3|||
46880894|NCT00111839|83102295|FG002|Overall Study|Other|3|||
46880895|NCT00111839|83102293|FG000|Overall Study|Randomized but Not Treated|0|||
46880896|NCT00111839|83102294|FG001|Overall Study|Randomized but Not Treated|0|||
46880897|NCT00111839|83102295|FG002|Overall Study|Randomized but Not Treated|2|||
46880898|NCT00111761|83102305|FG000|Part 1|Physician Decision|0|||
46880899|NCT00111761|83102306|FG001|Part 1|Physician Decision|1|||
46880900|NCT00111761|83102305|FG000|Part 1|Death|0|||
46880901|NCT00111761|83102306|FG001|Part 1|Death|2|||
46880902|NCT00111761|83102305|FG000|Part 1|Other|0|||
46880903|NCT00111761|83102306|FG001|Part 1|Other|1|||
46880904|NCT00111761|83102305|FG000|Part 1|Withdrawal by Subject|0|||
46880905|NCT00111761|83102306|FG001|Part 1|Withdrawal by Subject|1|||
46880906|NCT00111761|83102305|FG000|Part 2|Adverse Event|1|||
46880907|NCT00111761|83102306|FG001|Part 2|Adverse Event|0|||
46880908|NCT00111761|83102305|FG000|Part 2|Physician Decision|1|||
46880909|NCT00111761|83102306|FG001|Part 2|Physician Decision|0|||
46880910|NCT00111761|83102305|FG000|Part 2|Death|1|||
46880911|NCT00111761|83102306|FG001|Part 2|Death|0|||
46880912|NCT00111761|83102305|FG000|Part 2|Disease progression|3|||
46880913|NCT00111761|83102306|FG001|Part 2|Disease progression|0|||
46880914|NCT00111761|83102305|FG000|Part 2|Protocol-specified criteria|1|||
46880915|NCT00111761|83102306|FG001|Part 2|Protocol-specified criteria|0|||
46880916|NCT00111761|83102305|FG000|Part 2|Other|1|||
46880917|NCT00111761|83102306|FG001|Part 2|Other|0|||
46880918|NCT03519867|83102322|FG000|Overall Study|Adverse Event|1|||
46880919|NCT03519867|83102323|FG001|Overall Study|Adverse Event|1|||
46880920|NCT03519867|83102324|FG002|Overall Study|Adverse Event|0|||
46880921|NCT03519867|83102325|FG003|Overall Study|Adverse Event|0|||
46880922|NCT03519867|83102326|FG004|Overall Study|Adverse Event|0|||
46880923|NCT03519867|83102327|FG005|Overall Study|Adverse Event|0|||
46880924|NCT03519867|83102328|FG006|Overall Study|Adverse Event|0|||
46880925|NCT03519867|83102329|FG007|Overall Study|Adverse Event|0|||
46880926|NCT03519867|83102330|FG008|Overall Study|Adverse Event|0|||
46880927|NCT03519867|83102331|FG009|Overall Study|Adverse Event|0|||
46880928|NCT03519867|83102322|FG000|Overall Study|Protocol Violation|0|||
46880929|NCT03519867|83102323|FG001|Overall Study|Protocol Violation|0|||
46880930|NCT03519867|83102324|FG002|Overall Study|Protocol Violation|0|||
46880931|NCT03519867|83102325|FG003|Overall Study|Protocol Violation|0|||
46880932|NCT03519867|83102326|FG004|Overall Study|Protocol Violation|0|||
46880933|NCT03519867|83102327|FG005|Overall Study|Protocol Violation|1|||
46880934|NCT03519867|83102328|FG006|Overall Study|Protocol Violation|0|||
46880935|NCT03519867|83102329|FG007|Overall Study|Protocol Violation|0|||
46880936|NCT03519867|83102330|FG008|Overall Study|Protocol Violation|0|||
46880937|NCT03519867|83102331|FG009|Overall Study|Protocol Violation|0|||
46880938|NCT03519867|83102322|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46880939|NCT03519867|83102323|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46880940|NCT03519867|83102324|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46880941|NCT03519867|83102325|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46880942|NCT03519867|83102326|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46880943|NCT03519867|83102327|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46880944|NCT03519867|83102328|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
46880945|NCT03519867|83102329|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46989112|NCT02201277|83235658|FG000|Overall Study|Physician Decision|1|||
46989113|NCT02201277|83235659|FG001|Overall Study|Physician Decision|0|||
46989114|NCT02224053|83235669|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
46989115|NCT02224053|83235669|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
46989116|NCT02224053|83235669|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
46989117|NCT02224053|83235669|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
46989118|NCT02224053|83235669|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
46989119|NCT02457793|83235681|FG000|Overall Study|Reason not specified|0|||
46880946|NCT03519867|83102330|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46880947|NCT03519867|83102331|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
46989120|NCT02457793|83235682|FG001|Overall Study|Reason not specified|0|||
46880948|NCT03519867|83102322|FG000|Overall Study|Admin. of other reversal agent|1|||
46880949|NCT03519867|83102323|FG001|Overall Study|Admin. of other reversal agent|1|||
46880950|NCT03519867|83102324|FG002|Overall Study|Admin. of other reversal agent|0|||
46880951|NCT03519867|83102325|FG003|Overall Study|Admin. of other reversal agent|0|||
46880952|NCT03519867|83102326|FG004|Overall Study|Admin. of other reversal agent|0|||
46880953|NCT03519867|83102327|FG005|Overall Study|Admin. of other reversal agent|1|||
46880954|NCT03519867|83102328|FG006|Overall Study|Admin. of other reversal agent|0|||
46880955|NCT03519867|83102329|FG007|Overall Study|Admin. of other reversal agent|0|||
46880956|NCT03519867|83102330|FG008|Overall Study|Admin. of other reversal agent|0|||
46880957|NCT03519867|83102331|FG009|Overall Study|Admin. of other reversal agent|0|||
46989121|NCT02457793|83235683|FG002|Overall Study|Reason not specified|0|||
46989122|NCT02457793|83235684|FG003|Overall Study|Reason not specified|1|||
46989123|NCT02457793|83235685|FG004|Overall Study|Reason not specified|1|||
46989124|NCT02457793|83235686|FG005|Overall Study|Reason not specified|1|||
46989125|NCT02457793|83235681|FG000|Overall Study|Withdrawal by Subject|0|||
46989126|NCT02457793|83235682|FG001|Overall Study|Withdrawal by Subject|4|||
46989127|NCT02457793|83235683|FG002|Overall Study|Withdrawal by Subject|2|||
46989128|NCT02457793|83235684|FG003|Overall Study|Withdrawal by Subject|2|||
46989129|NCT02457793|83235685|FG004|Overall Study|Withdrawal by Subject|2|||
46989130|NCT02457793|83235686|FG005|Overall Study|Withdrawal by Subject|2|||
46989131|NCT02457793|83235681|FG000|Overall Study|Adverse Event|0|||
46989132|NCT02457793|83235682|FG001|Overall Study|Adverse Event|0|||
46989133|NCT02457793|83235683|FG002|Overall Study|Adverse Event|0|||
46989134|NCT02457793|83235684|FG003|Overall Study|Adverse Event|1|||
46989135|NCT02457793|83235685|FG004|Overall Study|Adverse Event|0|||
46989136|NCT02457793|83235686|FG005|Overall Study|Adverse Event|0|||
46989137|NCT02457793|83235681|FG000|Overall Study|Physician Decision|1|||
46989138|NCT02457793|83235682|FG001|Overall Study|Physician Decision|0|||
46989139|NCT02457793|83235683|FG002|Overall Study|Physician Decision|1|||
46989140|NCT02457793|83235684|FG003|Overall Study|Physician Decision|1|||
46989141|NCT02457793|83235685|FG004|Overall Study|Physician Decision|1|||
46989142|NCT02457793|83235686|FG005|Overall Study|Physician Decision|3|||
46989143|NCT01650259|83235703|FG000|Overall Study|Improvement|105|||
46989144|NCT01650259|83235704|FG001|Overall Study|Improvement|0|||
46989145|NCT01650259|83235703|FG000|Overall Study|Adverse Event|127|||
46989146|NCT01650259|83235704|FG001|Overall Study|Adverse Event|0|||
46989147|NCT01650259|83235703|FG000|Overall Study|Lack of Efficacy|143|||
46989148|NCT01650259|83235704|FG001|Overall Study|Lack of Efficacy|0|||
46989149|NCT01650259|83235703|FG000|Overall Study|Lost to Follow-up|435|||
46989150|NCT01650259|83235704|FG001|Overall Study|Lost to Follow-up|0|||
46989151|NCT01650259|83235703|FG000|Overall Study|Patients had no visit after entry|70|||
46989152|NCT01650259|83235704|FG001|Overall Study|Patients had no visit after entry|0|||
46989153|NCT01650259|83235703|FG000|Overall Study|CRF not collected|98|||
46989154|NCT01650259|83235704|FG001|Overall Study|CRF not collected|82|||
46989155|NCT01650259|83235703|FG000|Overall Study|Not treated|1|||
46989156|NCT01650259|83235704|FG001|Overall Study|Not treated|7|||
46989157|NCT01650259|83235703|FG000|Overall Study|Other than listed|64|||
46989158|NCT01650259|83235704|FG001|Overall Study|Other than listed|146|||
46989159|NCT02434939|83235710|FG000|Overall Study|Lack of Efficacy|34|||
46880958|NCT03519867|83102322|FG000|Overall Study|Reason not provided|1|||
46880959|NCT03519867|83102323|FG001|Overall Study|Reason not provided|1|||
46880960|NCT03519867|83102324|FG002|Overall Study|Reason not provided|1|||
46880961|NCT03519867|83102325|FG003|Overall Study|Reason not provided|1|||
46880962|NCT03519867|83102326|FG004|Overall Study|Reason not provided|0|||
46880963|NCT03519867|83102327|FG005|Overall Study|Reason not provided|1|||
46880964|NCT03519867|83102328|FG006|Overall Study|Reason not provided|0|||
46880965|NCT03519867|83102329|FG007|Overall Study|Reason not provided|1|||
46880966|NCT03519867|83102330|FG008|Overall Study|Reason not provided|1|||
46880967|NCT03519867|83102331|FG009|Overall Study|Reason not provided|0|||
46880968|NCT03519087|83102355|FG000|Clinic Evaluation|Physician Decision|15|||
46880969|NCT03519087|83102356|FG001|Clinic Evaluation|Physician Decision|18|||
46880970|NCT03519087|83102357|FG002|Clinic Evaluation|Physician Decision|0|||
46880971|NCT03519087|83102358|FG003|Clinic Evaluation|Physician Decision|0|||
46880972|NCT03519087|83102359|FG004|Clinic Evaluation|Physician Decision|0|||
46880973|NCT03519087|83102355|FG000|Clinic Evaluation|Protocol Violation|1|||
46880974|NCT03519087|83102356|FG001|Clinic Evaluation|Protocol Violation|0|||
46880975|NCT03519087|83102357|FG002|Clinic Evaluation|Protocol Violation|0|||
46880976|NCT03519087|83102358|FG003|Clinic Evaluation|Protocol Violation|0|||
46880977|NCT03519087|83102359|FG004|Clinic Evaluation|Protocol Violation|0|||
46880978|NCT03519087|83102355|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
46880979|NCT03519087|83102356|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
46880980|NCT03519087|83102357|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
46880981|NCT03519087|83102358|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
46880982|NCT03519087|83102359|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
46989160|NCT02434939|83235711|FG001|Overall Study|Lack of Efficacy|48|||
46989161|NCT02434939|83235710|FG000|Overall Study|Withdrawal by Subject|3|||
46880983|NCT03519087|83102355|FG000|Re-randomization for Treatment|Not appropriate|2|||
46880984|NCT03519087|83102356|FG001|Re-randomization for Treatment|Not appropriate|3|||
46880985|NCT03519087|83102357|FG002|Re-randomization for Treatment|Not appropriate|0|||
46989162|NCT02434939|83235711|FG001|Overall Study|Withdrawal by Subject|0|||
46880986|NCT03519087|83102358|FG003|Re-randomization for Treatment|Not appropriate|0|||
46880987|NCT03519087|83102359|FG004|Re-randomization for Treatment|Not appropriate|0|||
46880988|NCT03519087|83102355|FG000|Laboratory Testing|Lost to Follow-up|0|||
46989163|NCT02434939|83235710|FG000|Overall Study|Adverse Event|0|||
46989164|NCT02434939|83235711|FG001|Overall Study|Adverse Event|1|||
46989165|NCT02434471|83235718|FG000|Overall Study|Physician Decision|9|||
46989166|NCT02457637|83235723|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
46989167|NCT02457325|83235730|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
46989168|NCT02457325|83235731|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
46989169|NCT02434081|83235737|FG000|Overall Study|Death (never started treatment)|2|||
46989170|NCT02434081|83235737|FG000|Overall Study|Death|2|||
46989171|NCT02434081|83235737|FG000|Overall Study|Progression|20|||
46989172|NCT02434081|83235737|FG000|Overall Study|Adverse Event|20|||
46989173|NCT02434081|83235737|FG000|Overall Study|Physician Decision|2|||
46989174|NCT02434081|83235737|FG000|Overall Study|Withdrawal by Subject|1|||
46989175|NCT02434081|83235737|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
46989176|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
46989177|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
46989178|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
46989179|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
46989180|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
46989181|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
46989182|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
46989183|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
46989184|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
46989185|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
46989186|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
46989187|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
46989188|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
46989189|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
46989190|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
46989191|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
46989192|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
46989193|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
46989194|NCT02222493|83235743|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
46989195|NCT02222493|83235744|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
46989196|NCT02222493|83235743|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
46989197|NCT02222493|83235744|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
46989198|NCT02222493|83235743|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
46989199|NCT02222493|83235744|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
46989200|NCT02222493|83235743|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
46989201|NCT02222493|83235744|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
46989202|NCT02222493|83235743|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
46989203|NCT02222493|83235744|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
46989204|NCT02222493|83235743|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
46989205|NCT02222493|83235744|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
46989206|NCT02222493|83235743|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
46989207|NCT02222493|83235744|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
46989208|NCT02222493|83235743|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
46989209|NCT02222493|83235744|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
46989210|NCT02222493|83235743|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
46989211|NCT02222493|83235744|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
46989212|NCT02222493|83235743|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
46989213|NCT02222493|83235744|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
46989214|NCT02222493|83235743|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
46989215|NCT02222493|83235744|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
46989216|NCT02222493|83235743|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
46989217|NCT02222493|83235744|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
46989218|NCT02222493|83235743|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
46989219|NCT02222493|83235744|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
46989220|NCT02433379|83235763|FG000|Overall Study|Screen Failures|55|||
46989221|NCT02433379|83235763|FG000|Overall Study|Death|57|||
46989222|NCT02433379|83235763|FG000|Overall Study|Total Withdrawals|209|||
46989223|NCT02199795|83235771|FG000|Overall Study|no longer met inclusion criteria|1|||
46989224|NCT02199795|83235772|FG001|Overall Study|no longer met inclusion criteria|0|||
46989225|NCT02199795|83235771|FG000|Overall Study|withdrew due to shoulder pain|1|||
46989226|NCT02199795|83235772|FG001|Overall Study|withdrew due to shoulder pain|0|||
46989227|NCT02403817|83235780|FG000|Overall Study|Withdrawal by Subject|5|||
46989228|NCT02403817|83235781|FG001|Overall Study|Withdrawal by Subject|0|||
46989229|NCT02403271|83235787|FG000|Period 1|Other varied reasons|1|||
46989230|NCT02403271|83235788|FG001|Period 1|Other varied reasons|0|||
46989231|NCT02403271|83235787|FG000|Period 2|Withdrawal by Subject|0|||
46989232|NCT02403271|83235788|FG001|Period 2|Withdrawal by Subject|14|||
46989233|NCT02403271|83235787|FG000|Period 2|Death|0|||
46704536|NCT01037985|82919401|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
46704537|NCT00955474|82919413|FG000|Overall Study|Physician Decision|7|||
46704538|NCT00955474|82919414|FG001|Overall Study|Physician Decision|5|||
46704539|NCT01229150|82919426|FG000|Overall Study|Toxicity|2|||
46704540|NCT01229150|82919427|FG001|Overall Study|Toxicity|2|||
46704541|NCT01229150|82919428|FG002|Overall Study|Toxicity|0|||
46704542|NCT01229150|82919429|FG003|Overall Study|Toxicity|0|||
46704543|NCT00952588|82919445|FG000|Overall Study|Death|28|||
46704544|NCT00952588|82919446|FG001|Overall Study|Death|13|||
46704545|NCT00952588|82919445|FG000|Overall Study|Withdrawal by Subject|2|||
46704546|NCT00952588|82919446|FG001|Overall Study|Withdrawal by Subject|5|||
46704547|NCT00952588|82919445|FG000|Overall Study|Adverse Event|2|||
46704548|NCT00952588|82919446|FG001|Overall Study|Adverse Event|3|||
46704549|NCT00952588|82919445|FG000|Overall Study|Lost to Follow-up|2|||
46704550|NCT00952588|82919446|FG001|Overall Study|Lost to Follow-up|0|||
46704551|NCT00952588|82919445|FG000|Overall Study|Physician Decision|0|||
46880989|NCT03519087|83102356|FG001|Laboratory Testing|Lost to Follow-up|0|||
46880990|NCT03519087|83102357|FG002|Laboratory Testing|Lost to Follow-up|2|||
46880991|NCT03519087|83102358|FG003|Laboratory Testing|Lost to Follow-up|3|||
46880992|NCT03519087|83102359|FG004|Laboratory Testing|Lost to Follow-up|6|||
46989234|NCT02403271|83235788|FG001|Period 2|Death|84|||
46989235|NCT02403271|83235787|FG000|Period 2|Lost to Follow-up|0|||
46989236|NCT02403271|83235788|FG001|Period 2|Lost to Follow-up|2|||
46989237|NCT02403271|83235787|FG000|Period 2|Study Terminated by Sponsor|0|||
46989238|NCT02403271|83235788|FG001|Period 2|Study Terminated by Sponsor|14|||
46989239|NCT02403271|83235787|FG000|Period 2|Other varied reasons|0|||
46989240|NCT02403271|83235788|FG001|Period 2|Other varied reasons|10|||
46989241|NCT02219685|83235796|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
46989242|NCT02219685|83235797|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
46989243|NCT02219685|83235796|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
46989244|NCT02219685|83235797|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
46989245|NCT02457247|83235809|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
46989246|NCT02457247|83235810|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
46989247|NCT02457247|83235811|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
46989248|NCT02457247|83235812|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
46989249|NCT02457247|83235809|FG000|Period 1|Significant Protocol Deviation|1|||
46989250|NCT02457247|83235810|FG001|Period 1|Significant Protocol Deviation|1|||
46989251|NCT02457247|83235811|FG002|Period 1|Significant Protocol Deviation|0|||
46989252|NCT02457247|83235812|FG003|Period 1|Significant Protocol Deviation|0|||
46989253|NCT02457247|83235809|FG000|Period 1|Voluntary Withdrawal|1|||
46989254|NCT02457247|83235810|FG001|Period 1|Voluntary Withdrawal|0|||
46989255|NCT02457247|83235811|FG002|Period 1|Voluntary Withdrawal|0|||
46989256|NCT02457247|83235812|FG003|Period 1|Voluntary Withdrawal|0|||
46989257|NCT02457247|83235809|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
46989258|NCT02457247|83235810|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
46989259|NCT02457247|83235811|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
46989260|NCT02457247|83235812|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
46989261|NCT02457247|83235809|FG000|Period 2|Significant Protocol Deviation|1|||
46989262|NCT02457247|83235810|FG001|Period 2|Significant Protocol Deviation|0|||
46989263|NCT02457247|83235811|FG002|Period 2|Significant Protocol Deviation|0|||
46880993|NCT03519087|83102355|FG000|Laboratory Testing|Protocol Violation|0|||
46880994|NCT03519087|83102356|FG001|Laboratory Testing|Protocol Violation|0|||
46989264|NCT02457247|83235812|FG003|Period 2|Significant Protocol Deviation|0|||
46989265|NCT02457247|83235809|FG000|Period 2|Lost to Follow-up|0|||
46989266|NCT02457247|83235810|FG001|Period 2|Lost to Follow-up|1|||
46989267|NCT02457247|83235811|FG002|Period 2|Lost to Follow-up|0|||
46989268|NCT02457247|83235812|FG003|Period 2|Lost to Follow-up|0|||
46989269|NCT02457247|83235809|FG000|Period 2|Voluntary Withdrawal|1|||
46989270|NCT02457247|83235810|FG001|Period 2|Voluntary Withdrawal|1|||
46989271|NCT02457247|83235811|FG002|Period 2|Voluntary Withdrawal|0|||
46989272|NCT02457247|83235812|FG003|Period 2|Voluntary Withdrawal|0|||
46989273|NCT02401867|83235828|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
46989274|NCT02401867|83235828|FG000|Analysis|Cervical assay could not be conducted|9|||
46989275|NCT02198235|83235836|FG000|Overall Study|Lost to Follow-up|3|||
46880995|NCT03519087|83102357|FG002|Laboratory Testing|Protocol Violation|0|||
46880996|NCT03519087|83102358|FG003|Laboratory Testing|Protocol Violation|1|||
46989276|NCT02198235|83235837|FG001|Overall Study|Lost to Follow-up|2|||
46989277|NCT02198235|83235838|FG002|Overall Study|Lost to Follow-up|2|||
46989278|NCT02253147|83235846|FG000|Overall Study|Protocol Violation|30|||
46989279|NCT02253147|83235846|FG000|Overall Study|Did not consent to study extension|9|||
46989280|NCT02253147|83235846|FG000|Overall Study|Conditional re-treatment at W52|5|||
46704552|NCT00952588|82919446|FG001|Overall Study|Physician Decision|1|||
46704553|NCT00952588|82919445|FG000|Overall Study|Lack of Efficacy|2|||
46704554|NCT00952588|82919446|FG001|Overall Study|Lack of Efficacy|2|||
46704555|NCT01227902|82919456|FG000|Overall Study|Adverse Event|12|||
46989281|NCT02253147|83235846|FG000|Overall Study|Lost to Follow-up|2|||
46989282|NCT02253147|83235846|FG000|Overall Study|Withdrawal by Subject|1|||
46989283|NCT02217501|83235854|FG000|Overall Study|Death|3|||
46989284|NCT02217501|83235855|FG001|Overall Study|Death|4|||
46989285|NCT01649869|83235863|FG000|Overall Study|Family member illness|1|||
46989286|NCT01649869|83235864|FG001|Overall Study|Family member illness|0|||
46989287|NCT01649869|83235863|FG000|Overall Study|Required treatment outside protocol|1|||
46989288|NCT01649869|83235864|FG001|Overall Study|Required treatment outside protocol|0|||
46989289|NCT01649869|83235863|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
46989290|NCT01649869|83235864|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
46989291|NCT02197377|83235874|FG000|Overall Study|Insertion Failure|0|||
46880997|NCT03519087|83102359|FG004|Laboratory Testing|Protocol Violation|0|||
46880998|NCT02763046|83102378|FG000|Overall Study|Adverse Event|5|||
46880999|NCT02763046|83102379|FG001|Overall Study|Adverse Event|4|||
46881000|NCT02763046|83102380|FG002|Overall Study|Adverse Event|0|||
46881001|NCT02763046|83102378|FG000|Overall Study|Lack of Efficacy|1|||
46881002|NCT02763046|83102379|FG001|Overall Study|Lack of Efficacy|1|||
46881003|NCT02763046|83102380|FG002|Overall Study|Lack of Efficacy|3|||
46881004|NCT02763046|83102378|FG000|Overall Study|Physician Decision|1|||
46881005|NCT02763046|83102379|FG001|Overall Study|Physician Decision|0|||
46881006|NCT02763046|83102380|FG002|Overall Study|Physician Decision|1|||
46881007|NCT02763046|83102378|FG000|Overall Study|Subject/guardian decision|2|||
46881008|NCT02763046|83102379|FG001|Overall Study|Subject/guardian decision|0|||
46881009|NCT02763046|83102380|FG002|Overall Study|Subject/guardian decision|4|||
46881010|NCT03518073|83102397|FG000|Overall Study|Adverse Event|2|||
46881011|NCT03518073|83102398|FG001|Overall Study|Adverse Event|4|||
46881012|NCT03518073|83102399|FG002|Overall Study|Adverse Event|2|||
46881013|NCT03518073|83102397|FG000|Overall Study|Death|2|||
46881014|NCT03518073|83102398|FG001|Overall Study|Death|1|||
46881015|NCT03518073|83102399|FG002|Overall Study|Death|3|||
46881016|NCT03518073|83102397|FG000|Overall Study|Lost to Follow-up|1|||
46881017|NCT03518073|83102398|FG001|Overall Study|Lost to Follow-up|0|||
46881018|NCT03518073|83102399|FG002|Overall Study|Lost to Follow-up|1|||
46881019|NCT03518073|83102397|FG000|Overall Study|Physician Decision|5|||
46881020|NCT03518073|83102398|FG001|Overall Study|Physician Decision|0|||
46881021|NCT03518073|83102399|FG002|Overall Study|Physician Decision|2|||
46881022|NCT03518073|83102397|FG000|Overall Study|Progressive disease|1|||
46881023|NCT03518073|83102398|FG001|Overall Study|Progressive disease|1|||
46881024|NCT03518073|83102399|FG002|Overall Study|Progressive disease|1|||
46881025|NCT03518073|83102397|FG000|Overall Study|Protocol Violation|1|||
46881026|NCT03518073|83102398|FG001|Overall Study|Protocol Violation|0|||
46881027|NCT03518073|83102399|FG002|Overall Study|Protocol Violation|0|||
46881028|NCT03518073|83102397|FG000|Overall Study|Withdrawal by Subject|30|||
46881029|NCT03518073|83102398|FG001|Overall Study|Withdrawal by Subject|34|||
46881030|NCT03518073|83102399|FG002|Overall Study|Withdrawal by Subject|29|||
46881031|NCT03518073|83102397|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
46881032|NCT03518073|83102398|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
46881033|NCT03518073|83102399|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
46881034|NCT03518073|83102397|FG000|Overall Study|Covid-19|1|||
46881035|NCT03518073|83102398|FG001|Overall Study|Covid-19|2|||
46881036|NCT03518073|83102399|FG002|Overall Study|Covid-19|1|||
46881037|NCT02759692|83102409|FG000|Period 1|Test article no longer available|1|||
46881038|NCT02759692|83102410|FG001|Period 1|Test article no longer available|1|||
46989292|NCT02197377|83235875|FG001|Overall Study|Insertion Failure|3|||
46989293|NCT02400307|83235883|FG000|Overall Study|Enrolled and Never Dosed|1|||
46881039|NCT02759692|83102409|FG000|Period 1|No longer meets eligibility criteria.|1|||
46881040|NCT02759692|83102410|FG001|Period 1|No longer meets eligibility criteria.|0|||
46881041|NCT02759692|83102409|FG000|Period 1|Miss-Randomized|1|||
46881042|NCT02759692|83102410|FG001|Period 1|Miss-Randomized|1|||
46881043|NCT02759692|83102409|FG000|Period 2|Lost to Follow-up|1|||
46881044|NCT02759692|83102410|FG001|Period 2|Lost to Follow-up|0|||
46881045|NCT02759692|83102409|FG000|Period 2|Test article no longer available|0|||
46881046|NCT02759692|83102410|FG001|Period 2|Test article no longer available|1|||
46989294|NCT02400307|83235884|FG001|Overall Study|Enrolled and Never Dosed|0|||
46881047|NCT03586167|83102418|FG000|Overall Study|Other|1|||
46881048|NCT03586167|83102419|FG001|Overall Study|Other|0|||
46881049|NCT02762578|83102427|FG000|Overall Study|Adverse Event|1|||
46881050|NCT02762578|83102428|FG001|Overall Study|Adverse Event|6|||
46881051|NCT02762578|83102427|FG000|Overall Study|Protocol Violation|4|||
46881052|NCT02762578|83102428|FG001|Overall Study|Protocol Violation|2|||
46881053|NCT02762578|83102427|FG000|Overall Study|Withdrawal by Subject|4|||
46881054|NCT02762578|83102428|FG001|Overall Study|Withdrawal by Subject|2|||
46881055|NCT02762578|83102427|FG000|Overall Study|Unclassified|6|||
46881056|NCT02762578|83102428|FG001|Overall Study|Unclassified|0|||
46881057|NCT03514641|83102438|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
46881058|NCT03514641|83102439|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
46881059|NCT03514641|83102440|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
46881060|NCT03514641|83102441|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
46881061|NCT03514641|83102438|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
46881062|NCT03514641|83102439|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
46881063|NCT03514641|83102440|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
46881064|NCT03514641|83102441|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
46881065|NCT03514641|83102438|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
46881066|NCT03514641|83102439|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
46881067|NCT03514641|83102440|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
46881068|NCT03514641|83102441|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
46881069|NCT03514641|83102438|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
46881070|NCT03514641|83102439|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
46881071|NCT03514641|83102440|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
46881072|NCT03514641|83102441|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
46881073|NCT03514641|83102438|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
46881074|NCT03514641|83102439|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
46881075|NCT03514641|83102440|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
46881076|NCT03514641|83102441|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
46881077|NCT03514641|83102438|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
46881078|NCT03514641|83102439|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
46881079|NCT03514641|83102440|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
46881080|NCT03514641|83102441|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
46881081|NCT03514641|83102438|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
46881082|NCT03514641|83102439|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
46881083|NCT03514641|83102440|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
46881084|NCT03514641|83102441|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
46881085|NCT03514641|83102438|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
46881086|NCT03514641|83102439|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
46881087|NCT03514641|83102440|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
46881088|NCT03514641|83102441|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
46881089|NCT03514641|83102438|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
46881090|NCT03514641|83102439|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
46881091|NCT03514641|83102440|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
46881092|NCT03514641|83102441|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
46881093|NCT03514641|83102438|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
46881094|NCT03514641|83102439|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
46881095|NCT03514641|83102440|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
46881096|NCT03514641|83102441|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
46881097|NCT03514641|83102438|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
46881098|NCT03514641|83102439|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
46881099|NCT03514641|83102440|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
46881100|NCT03514641|83102441|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
46881101|NCT03514641|83102438|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
46881102|NCT03514641|83102439|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
46881103|NCT03514641|83102440|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
46881104|NCT03514641|83102441|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
46881105|NCT00100828|83102453|FG000|Overall Study|Physician Decision|6|||
46881106|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
46881107|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
46881108|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
46881109|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
46881110|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
46881111|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
46881112|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
46881113|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
46881114|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
46881115|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
46881116|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
46881117|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
46881118|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
46881119|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
46881120|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
46881121|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
46881122|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
46881123|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
46881124|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
46881125|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
46881126|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
46881127|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
46881128|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
46881129|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
46881130|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
46881131|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
46881132|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
46881133|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
46881134|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
46881135|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
46881136|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
46881137|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
46881138|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
46881139|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
46881140|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
46881141|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
46881142|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
46881143|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
46881144|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
46881145|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
46881146|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
46881147|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
46881148|NCT00100048|83102462|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
46881149|NCT00100048|83102463|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
46881150|NCT00100048|83102464|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
46881151|NCT00100048|83102465|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
46881152|NCT00100048|83102466|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
46881153|NCT00100048|83102467|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
46881154|NCT02757430|83102492|FG000|Overall Study|Physician Decision|6|||
46881155|NCT02757430|83102492|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
46881156|NCT02757430|83102492|FG000|Overall Study|No informed consent|1|||
46881157|NCT02757430|83102492|FG000|Overall Study|No procedure performed|2|||
46881158|NCT02757352|83102508|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
46881159|NCT02757352|83102509|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881160|NCT02757352|83102510|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
46881161|NCT02757352|83102511|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881162|NCT02757352|83102512|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881163|NCT02757352|83102513|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881164|NCT02757352|83102514|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881165|NCT02757352|83102515|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881166|NCT02757352|83102516|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881167|NCT02757352|83102517|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
46881168|NCT02757352|83102508|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881169|NCT02757352|83102509|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881170|NCT02757352|83102510|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
46881171|NCT02757352|83102511|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881172|NCT02757352|83102512|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881173|NCT02757352|83102513|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881174|NCT02757352|83102514|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881175|NCT02757352|83102515|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881176|NCT02757352|83102516|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881177|NCT02757352|83102517|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
46881178|NCT02757352|83102508|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
46881179|NCT02757352|83102509|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
46881180|NCT02757352|83102510|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
46897106|NCT00707980|83122685|FG000|Overall Study|Adverse Event|49|||
46881181|NCT02757352|83102511|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
46881182|NCT02757352|83102512|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
46881183|NCT02757352|83102513|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
46881184|NCT02757352|83102514|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
46881185|NCT02757352|83102515|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
46881186|NCT02757352|83102516|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
46881187|NCT02757352|83102517|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
46881188|NCT02757352|83102508|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881189|NCT02757352|83102509|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
46881190|NCT02757352|83102510|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881191|NCT02757352|83102511|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881192|NCT02757352|83102512|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881193|NCT02757352|83102513|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881194|NCT02757352|83102514|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881195|NCT02757352|83102515|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881196|NCT02757352|83102516|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881197|NCT02757352|83102517|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
46881198|NCT02757352|83102508|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881199|NCT02757352|83102509|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
46881200|NCT02757352|83102510|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881201|NCT02757352|83102511|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881202|NCT02757352|83102512|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881203|NCT02757352|83102513|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881204|NCT02757352|83102514|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881205|NCT02757352|83102515|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881206|NCT02757352|83102516|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881207|NCT02757352|83102517|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881208|NCT02757352|83102508|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
46881209|NCT02757352|83102509|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
46881210|NCT02757352|83102510|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
46881211|NCT02757352|83102511|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881212|NCT02757352|83102512|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881213|NCT02757352|83102513|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881214|NCT02757352|83102514|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881215|NCT02757352|83102515|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881216|NCT02757352|83102516|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881217|NCT02757352|83102517|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881218|NCT02757352|83102508|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
46881219|NCT02757352|83102509|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
46881220|NCT02757352|83102510|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
46881221|NCT02757352|83102511|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
46881222|NCT02757352|83102512|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
46881223|NCT02757352|83102513|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
46881224|NCT02757352|83102514|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
46881225|NCT02757352|83102515|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
46881226|NCT02757352|83102516|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
46881227|NCT02757352|83102517|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
46881228|NCT02757352|83102508|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881229|NCT02757352|83102509|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881230|NCT02757352|83102510|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881231|NCT02757352|83102511|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
46881232|NCT02757352|83102512|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881233|NCT02757352|83102513|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
46881234|NCT02757352|83102514|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881235|NCT02757352|83102515|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881236|NCT02757352|83102516|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881237|NCT02757352|83102517|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
46881238|NCT02757352|83102508|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881239|NCT02757352|83102509|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881240|NCT02757352|83102510|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46989295|NCT02196675|83235893|FG000|Overall Study|Withdrawal by Subject|1|||
46989296|NCT02196675|83235894|FG001|Overall Study|Withdrawal by Subject|0|||
46989297|NCT02196675|83235895|FG002|Overall Study|Withdrawal by Subject|0|||
46881241|NCT02757352|83102511|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
46881242|NCT02757352|83102512|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
46881243|NCT02757352|83102513|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
46881244|NCT02757352|83102514|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881245|NCT02757352|83102515|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881246|NCT02757352|83102516|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881247|NCT02757352|83102517|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
46881248|NCT02757352|83102508|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881249|NCT02757352|83102509|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881250|NCT02757352|83102510|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881251|NCT02757352|83102511|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881252|NCT02757352|83102512|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
46881253|NCT02757352|83102513|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881254|NCT02757352|83102514|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881255|NCT02757352|83102515|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881256|NCT02757352|83102516|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881257|NCT02757352|83102517|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
46881258|NCT02757352|83102508|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881259|NCT02757352|83102509|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881260|NCT02757352|83102510|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881261|NCT02757352|83102511|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881262|NCT02757352|83102512|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881263|NCT02757352|83102513|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
46881264|NCT02757352|83102514|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881265|NCT02757352|83102515|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881266|NCT02757352|83102516|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881267|NCT02757352|83102517|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
46881268|NCT02757352|83102508|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881269|NCT02757352|83102509|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881270|NCT02757352|83102510|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881271|NCT02757352|83102511|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
46881272|NCT02757352|83102512|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
46881273|NCT02757352|83102513|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
46881274|NCT02757352|83102514|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881275|NCT02757352|83102515|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881276|NCT02757352|83102516|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881277|NCT02757352|83102517|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
46881278|NCT02757352|83102508|FG000|Follow-Up Period|Adverse Event|0|||
46881279|NCT02757352|83102509|FG001|Follow-Up Period|Adverse Event|0|||
46881280|NCT02757352|83102510|FG002|Follow-Up Period|Adverse Event|0|||
46989298|NCT02196675|83235893|FG000|Overall Study|Intra-operative surgical exclusion|1|||
46989299|NCT02196675|83235894|FG001|Overall Study|Intra-operative surgical exclusion|1|||
46989300|NCT02196675|83235895|FG002|Overall Study|Intra-operative surgical exclusion|0|||
46989301|NCT02196675|83235893|FG000|Overall Study|Protocol Violation|0|||
46989302|NCT02196675|83235894|FG001|Overall Study|Protocol Violation|1|||
46989303|NCT02196675|83235895|FG002|Overall Study|Protocol Violation|0|||
46989304|NCT02196675|83235893|FG000|Overall Study|Death|0|||
46881281|NCT02757352|83102511|FG003|Follow-Up Period|Adverse Event|0|||
46881282|NCT02757352|83102512|FG004|Follow-Up Period|Adverse Event|0|||
46881283|NCT02757352|83102513|FG005|Follow-Up Period|Adverse Event|0|||
46881284|NCT02757352|83102514|FG006|Follow-Up Period|Adverse Event|1|||
46881285|NCT02757352|83102515|FG007|Follow-Up Period|Adverse Event|0|||
46881286|NCT02757352|83102516|FG008|Follow-Up Period|Adverse Event|2|||
46881287|NCT02757352|83102517|FG009|Follow-Up Period|Adverse Event|0|||
46881288|NCT02757352|83102508|FG000|Follow-Up Period|Lost to Follow-up|0|||
46881289|NCT02757352|83102509|FG001|Follow-Up Period|Lost to Follow-up|0|||
46881290|NCT02757352|83102510|FG002|Follow-Up Period|Lost to Follow-up|0|||
46881291|NCT02757352|83102511|FG003|Follow-Up Period|Lost to Follow-up|0|||
46881292|NCT02757352|83102512|FG004|Follow-Up Period|Lost to Follow-up|0|||
46881293|NCT02757352|83102513|FG005|Follow-Up Period|Lost to Follow-up|0|||
46881294|NCT02757352|83102514|FG006|Follow-Up Period|Lost to Follow-up|0|||
46881295|NCT02757352|83102515|FG007|Follow-Up Period|Lost to Follow-up|0|||
46881296|NCT02757352|83102516|FG008|Follow-Up Period|Lost to Follow-up|1|||
46881297|NCT02757352|83102517|FG009|Follow-Up Period|Lost to Follow-up|0|||
46881298|NCT02757352|83102508|FG000|Follow-Up Period|Lack of Efficacy|0|||
46881299|NCT02757352|83102509|FG001|Follow-Up Period|Lack of Efficacy|0|||
46881300|NCT02757352|83102510|FG002|Follow-Up Period|Lack of Efficacy|0|||
46881301|NCT02757352|83102511|FG003|Follow-Up Period|Lack of Efficacy|0|||
46989305|NCT02196675|83235894|FG001|Overall Study|Death|0|||
46989306|NCT02196675|83235895|FG002|Overall Study|Death|1|||
46881302|NCT02757352|83102512|FG004|Follow-Up Period|Lack of Efficacy|0|||
46881303|NCT02757352|83102513|FG005|Follow-Up Period|Lack of Efficacy|0|||
46881304|NCT02757352|83102514|FG006|Follow-Up Period|Lack of Efficacy|0|||
46881305|NCT02757352|83102515|FG007|Follow-Up Period|Lack of Efficacy|0|||
46881306|NCT02757352|83102516|FG008|Follow-Up Period|Lack of Efficacy|1|||
46881307|NCT02757352|83102517|FG009|Follow-Up Period|Lack of Efficacy|1|||
46881308|NCT02757352|83102508|FG000|Follow-Up Period|Withdrawal by Subject|0|||
46881309|NCT02757352|83102509|FG001|Follow-Up Period|Withdrawal by Subject|0|||
46881310|NCT02757352|83102510|FG002|Follow-Up Period|Withdrawal by Subject|0|||
46881311|NCT02757352|83102511|FG003|Follow-Up Period|Withdrawal by Subject|0|||
46881312|NCT02757352|83102512|FG004|Follow-Up Period|Withdrawal by Subject|0|||
46881313|NCT02757352|83102513|FG005|Follow-Up Period|Withdrawal by Subject|0|||
46881314|NCT02757352|83102514|FG006|Follow-Up Period|Withdrawal by Subject|0|||
46881315|NCT02757352|83102515|FG007|Follow-Up Period|Withdrawal by Subject|1|||
46881316|NCT02757352|83102516|FG008|Follow-Up Period|Withdrawal by Subject|6|||
46881317|NCT02757352|83102517|FG009|Follow-Up Period|Withdrawal by Subject|2|||
46881318|NCT04588480|83102550|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
46881319|NCT04588480|83102551|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
46881320|NCT04588480|83102552|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
46881321|NCT04588480|83102550|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
46881322|NCT04588480|83102551|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
46881323|NCT04588480|83102552|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
46881324|NCT02756650|83102559|FG000|Overall Study|Physician Decision|1|||
46881325|NCT02756650|83102559|FG000|Overall Study|Adverse Event|1|||
46881326|NCT00110357|83102565|FG000|Overall Study|Deterioration without progression|2|||
46881327|NCT00110357|83102566|FG001|Overall Study|Deterioration without progression|0|||
46881328|NCT00110357|83102565|FG000|Overall Study|Disease progression/relapse|20|||
46881329|NCT00110357|83102566|FG001|Overall Study|Disease progression/relapse|15|||
46881330|NCT00110357|83102565|FG000|Overall Study|Study Closure|1|||
46881331|NCT00110357|83102566|FG001|Overall Study|Study Closure|0|||
46881332|NCT00110357|83102565|FG000|Overall Study|Study Drug Toxicity|1|||
46881333|NCT00110357|83102566|FG001|Overall Study|Study Drug Toxicity|3|||
46881334|NCT00110357|83102565|FG000|Overall Study|Withdrawal by Subject|3|||
46881335|NCT00110357|83102566|FG001|Overall Study|Withdrawal by Subject|1|||
46881336|NCT02752906|83102601|FG000|Overall Study|Protocol Violation|2|||
46881337|NCT02752906|83102602|FG001|Overall Study|Protocol Violation|1|||
46881338|NCT02752906|83102601|FG000|Overall Study|Withdrawal by Subject|2|||
46881339|NCT02752906|83102602|FG001|Overall Study|Withdrawal by Subject|2|||
46881340|NCT02752906|83102601|FG000|Overall Study|Lost to Follow-up|3|||
46881341|NCT02752906|83102602|FG001|Overall Study|Lost to Follow-up|2|||
46881342|NCT02756338|83102608|FG000|Overall Study|Withdrawn by Investigator|1|||
46881343|NCT02756338|83102608|FG000|Overall Study|Device Replaced with Pacemaker|4|||
46881344|NCT00293033|83102612|FG000|Open-label Titration Period|Adverse Event|10|||
46881345|NCT00293033|83102612|FG000|Open-label Titration Period|Death|3|||
46881346|NCT00293033|83102612|FG000|Open-label Titration Period|Lack of Efficacy|5|||
46881347|NCT00293033|83102612|FG000|Open-label Titration Period|Protocol Violation|2|||
46881348|NCT00293033|83102612|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
46881349|NCT00293033|83102612|FG000|Open-label Titration Period|Noncompliance and other|27|||
46881350|NCT00293033|83102612|FG000|Double-blind Treatment Period|Adverse Event|3|||
46881351|NCT00293033|83102612|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
46881352|NCT00293033|83102612|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
46881353|NCT00293033|83102612|FG000|Double-blind Treatment Period|Noncompliance|4|||
46881354|NCT02756182|83102620|FG000|Overall Study|StudyTechnical Difficulties|4|||
46881355|NCT03823703|83102629|FG000|Overall Study|Sponsor request|0|||
46881356|NCT03823703|83102630|FG001|Overall Study|Sponsor request|3|||
46881357|NCT03823703|83102631|FG002|Overall Study|Sponsor request|4|||
46881358|NCT03823703|83102629|FG000|Overall Study|Adverse Event|3|||
46881359|NCT03823703|83102630|FG001|Overall Study|Adverse Event|1|||
46881360|NCT03823703|83102631|FG002|Overall Study|Adverse Event|0|||
46881361|NCT03823703|83102629|FG000|Overall Study|Withdrawal by Subject|0|||
46881362|NCT03823703|83102630|FG001|Overall Study|Withdrawal by Subject|1|||
46881363|NCT03823703|83102631|FG002|Overall Study|Withdrawal by Subject|0|||
46881364|NCT00109577|83102641|FG000|Overall Study|Withdrawal by Subject|3|||
46881365|NCT00109577|83102642|FG001|Overall Study|Withdrawal by Subject|3|||
46881366|NCT02755090|83102650|FG000|Overall Study|equipment malfunction|1|||
46881367|NCT02755090|83102651|FG001|Overall Study|equipment malfunction|0|||
46881368|NCT00109343|83102660|FG000|Overall Study|Adverse Event|1|||
46704556|NCT01227902|82919457|FG001|Overall Study|Adverse Event|8|||
46881369|NCT00109343|83102661|FG001|Overall Study|Adverse Event|0|||
46881370|NCT00109343|83102662|FG002|Overall Study|Adverse Event|2|||
46881371|NCT00109343|83102660|FG000|Overall Study|Lack of Efficacy|1|||
46881372|NCT00109343|83102661|FG001|Overall Study|Lack of Efficacy|0|||
46881373|NCT00109343|83102662|FG002|Overall Study|Lack of Efficacy|0|||
46881374|NCT00109343|83102660|FG000|Overall Study|Lost to Follow-up|35|||
46881375|NCT00109343|83102661|FG001|Overall Study|Lost to Follow-up|20|||
46881376|NCT00109343|83102662|FG002|Overall Study|Lost to Follow-up|14|||
46881377|NCT00109343|83102660|FG000|Overall Study|Protocol Violation|1|||
46881378|NCT00109343|83102661|FG001|Overall Study|Protocol Violation|2|||
46881379|NCT00109343|83102662|FG002|Overall Study|Protocol Violation|2|||
46881380|NCT00109343|83102660|FG000|Overall Study|Withdrawal by Subject|15|||
46881381|NCT00109343|83102661|FG001|Overall Study|Withdrawal by Subject|11|||
46881382|NCT00109343|83102662|FG002|Overall Study|Withdrawal by Subject|10|||
46881383|NCT00109343|83102660|FG000|Overall Study|Subject Moved|6|||
46881384|NCT00109343|83102661|FG001|Overall Study|Subject Moved|2|||
46881385|NCT00109343|83102662|FG002|Overall Study|Subject Moved|1|||
46881386|NCT00109343|83102660|FG000|Overall Study|Other|5|||
46881387|NCT00109343|83102661|FG001|Overall Study|Other|2|||
46881388|NCT00109343|83102662|FG002|Overall Study|Other|1|||
46881389|NCT00108485|83102672|FG000|Overall Study|Withdrawal by Subject|3|||
46881390|NCT00108485|83102673|FG001|Overall Study|Withdrawal by Subject|0|||
46881391|NCT00108485|83102672|FG000|Overall Study|Lost to Follow-up|0|||
46881392|NCT00108485|83102673|FG001|Overall Study|Lost to Follow-up|2|||
46881393|NCT00107783|83102681|FG000|Overall Study|Adverse Event|0|||
46881394|NCT00107783|83102682|FG001|Overall Study|Adverse Event|2|||
46881395|NCT00107783|83102681|FG000|Overall Study|Death|0|||
46881396|NCT00107783|83102682|FG001|Overall Study|Death|1|||
46881397|NCT00107783|83102681|FG000|Overall Study|Withdrawal by Subject|2|||
46881398|NCT00107783|83102682|FG001|Overall Study|Withdrawal by Subject|0|||
46881399|NCT00107783|83102681|FG000|Overall Study|Second hip replacement|1|||
46881400|NCT00107783|83102682|FG001|Overall Study|Second hip replacement|1|||
46881401|NCT00095303|83102690|FG000|Main Study|Lost to Follow-up|91|||
46881402|NCT00095303|83102691|FG001|Main Study|Lost to Follow-up|87|||
46881403|NCT00095303|83102690|FG000|Follow Up Study|Lost to Follow-up|59|||
46881404|NCT00095303|83102691|FG001|Follow Up Study|Lost to Follow-up|58|||
46881405|NCT00105521|83102701|FG000|Overall Study|Other|1|||
46881406|NCT00105521|83102702|FG001|Overall Study|Other|1|||
46881407|NCT00105521|83102703|FG002|Overall Study|Other|2|||
46881408|NCT00105521|83102704|FG003|Overall Study|Other|0|||
46881409|NCT00105521|83102701|FG000|Overall Study|Adverse Event|10|||
46881410|NCT00105521|83102702|FG001|Overall Study|Adverse Event|4|||
46881411|NCT00105521|83102703|FG002|Overall Study|Adverse Event|10|||
46881412|NCT00105521|83102704|FG003|Overall Study|Adverse Event|8|||
46881413|NCT00105521|83102701|FG000|Overall Study|Withdrawal by Subject|1|||
46881414|NCT00105521|83102702|FG001|Overall Study|Withdrawal by Subject|0|||
46881415|NCT00105521|83102703|FG002|Overall Study|Withdrawal by Subject|1|||
46881416|NCT00105521|83102704|FG003|Overall Study|Withdrawal by Subject|4|||
46881417|NCT00105521|83102701|FG000|Overall Study|Lack of Efficacy|0|||
46881418|NCT00105521|83102702|FG001|Overall Study|Lack of Efficacy|0|||
46881419|NCT00105521|83102703|FG002|Overall Study|Lack of Efficacy|0|||
46881420|NCT00105521|83102704|FG003|Overall Study|Lack of Efficacy|1|||
46881421|NCT00105521|83102701|FG000|Overall Study|Protocol Violation|3|||
46881422|NCT00105521|83102702|FG001|Overall Study|Protocol Violation|5|||
46881423|NCT00105521|83102703|FG002|Overall Study|Protocol Violation|4|||
46881424|NCT00105521|83102704|FG003|Overall Study|Protocol Violation|4|||
46881425|NCT00105521|83102701|FG000|Overall Study|Lost to Follow-up|0|||
46881426|NCT00105521|83102702|FG001|Overall Study|Lost to Follow-up|1|||
46881427|NCT00105521|83102703|FG002|Overall Study|Lost to Follow-up|0|||
46881428|NCT00105521|83102704|FG003|Overall Study|Lost to Follow-up|0|||
46881429|NCT00291551|83102714|FG000|Overall Study|Death|7|||
46881430|NCT00291551|83102714|FG000|Overall Study|Withdrawal by Subject|6|||
46881431|NCT02752048|83102743|FG000|Overall Study|Withdrawal by Subject|0|||
46881432|NCT02752048|83102744|FG001|Overall Study|Withdrawal by Subject|0|||
46881433|NCT02752048|83102745|FG002|Overall Study|Withdrawal by Subject|3|||
46881434|NCT00095147|83102760|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
46881435|NCT00095147|83102761|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
46881436|NCT00095147|83102762|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
46881437|NCT00095147|83102763|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
46881438|NCT00095147|83102764|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
46881439|NCT00095147|83102760|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
46881440|NCT00095147|83102761|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
46881441|NCT00095147|83102762|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
46881442|NCT00095147|83102763|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
46881443|NCT00095147|83102764|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
46881444|NCT00095147|83102760|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
46881445|NCT00095147|83102761|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
46881446|NCT00095147|83102762|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
46881447|NCT00095147|83102763|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
46881448|NCT00095147|83102764|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
46881449|NCT00095147|83102760|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
46881450|NCT00095147|83102761|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
46897107|NCT00707980|83122685|FG000|Overall Study|Lack of Efficacy|35|||
46881451|NCT00095147|83102762|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
46881452|NCT00095147|83102763|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
46881453|NCT00095147|83102764|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
46881454|NCT00095147|83102760|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
46881455|NCT00095147|83102761|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
46881456|NCT00095147|83102762|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
46881457|NCT00095147|83102763|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
46881458|NCT00095147|83102764|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
46881459|NCT00095147|83102760|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
46881460|NCT00095147|83102761|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
46881461|NCT00095147|83102762|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
46881462|NCT00095147|83102763|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
46881463|NCT00095147|83102764|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
46881464|NCT00095147|83102760|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
46881465|NCT00095147|83102761|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
46881466|NCT00095147|83102762|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
46881467|NCT00095147|83102763|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
46881468|NCT00095147|83102764|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
46881469|NCT00095147|83102760|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
46881470|NCT00095147|83102761|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
46881471|NCT00095147|83102762|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
46881472|NCT00095147|83102763|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
46881473|NCT00095147|83102764|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
46881474|NCT00095147|83102760|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
46881475|NCT00095147|83102761|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
46881476|NCT00095147|83102762|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
46881477|NCT00095147|83102763|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
46881478|NCT00095147|83102764|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
46881479|NCT00095147|83102760|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
46881480|NCT00095147|83102761|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
46881481|NCT00095147|83102762|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
46881482|NCT00095147|83102763|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
46881483|NCT00095147|83102764|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
46881484|NCT00095147|83102760|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
46881485|NCT00095147|83102761|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
46881486|NCT00095147|83102762|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
46881487|NCT00095147|83102763|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
46881488|NCT00095147|83102764|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
46881489|NCT00095147|83102760|FG000|Long-term Extension Period|Death|0|||
46881490|NCT00095147|83102761|FG001|Long-term Extension Period|Death|0|||
46881491|NCT00095147|83102762|FG002|Long-term Extension Period|Death|0|||
46881492|NCT00095147|83102763|FG003|Long-term Extension Period|Death|0|||
46881493|NCT00095147|83102764|FG004|Long-term Extension Period|Death|3|||
46881494|NCT00095147|83102760|FG000|Long-term Extension Period|Adverse Event|0|||
46881495|NCT00095147|83102761|FG001|Long-term Extension Period|Adverse Event|0|||
46881496|NCT00095147|83102762|FG002|Long-term Extension Period|Adverse Event|0|||
46881497|NCT00095147|83102763|FG003|Long-term Extension Period|Adverse Event|0|||
46881498|NCT00095147|83102764|FG004|Long-term Extension Period|Adverse Event|11|||
46881499|NCT00095147|83102760|FG000|Long-term Extension Period|Lack of Efficacy|0|||
46881500|NCT00095147|83102761|FG001|Long-term Extension Period|Lack of Efficacy|0|||
46881501|NCT00095147|83102762|FG002|Long-term Extension Period|Lack of Efficacy|0|||
46881502|NCT00095147|83102763|FG003|Long-term Extension Period|Lack of Efficacy|0|||
46881503|NCT00095147|83102764|FG004|Long-term Extension Period|Lack of Efficacy|9|||
46881504|NCT00095147|83102760|FG000|Long-term Extension Period|Lost to Follow-up|0|||
46881505|NCT00095147|83102761|FG001|Long-term Extension Period|Lost to Follow-up|0|||
46881506|NCT00095147|83102762|FG002|Long-term Extension Period|Lost to Follow-up|0|||
46881507|NCT00095147|83102763|FG003|Long-term Extension Period|Lost to Follow-up|0|||
46881508|NCT00095147|83102764|FG004|Long-term Extension Period|Lost to Follow-up|6|||
46881509|NCT00095147|83102760|FG000|Long-term Extension Period|Withdrawal of consent|0|||
46881510|NCT00095147|83102761|FG001|Long-term Extension Period|Withdrawal of consent|0|||
46881511|NCT00095147|83102762|FG002|Long-term Extension Period|Withdrawal of consent|0|||
46881512|NCT00095147|83102763|FG003|Long-term Extension Period|Withdrawal of consent|0|||
46881513|NCT00095147|83102764|FG004|Long-term Extension Period|Withdrawal of consent|12|||
46881514|NCT00095147|83102760|FG000|Long-term Extension Period|Pregnancy|0|||
46881515|NCT00095147|83102761|FG001|Long-term Extension Period|Pregnancy|0|||
46989307|NCT02399449|83235905|FG000|Overall Study|Withdrawal by Subject|3|||
46881516|NCT00095147|83102762|FG002|Long-term Extension Period|Pregnancy|0|||
46881517|NCT00095147|83102763|FG003|Long-term Extension Period|Pregnancy|0|||
46881518|NCT00095147|83102764|FG004|Long-term Extension Period|Pregnancy|1|||
46881519|NCT00095147|83102760|FG000|Long-term Extension Period|No longer meets study criteria|0|||
46881520|NCT00095147|83102761|FG001|Long-term Extension Period|No longer meets study criteria|0|||
46881521|NCT00095147|83102762|FG002|Long-term Extension Period|No longer meets study criteria|0|||
46881522|NCT00095147|83102763|FG003|Long-term Extension Period|No longer meets study criteria|0|||
46881523|NCT00095147|83102764|FG004|Long-term Extension Period|No longer meets study criteria|1|||
46881524|NCT00095147|83102760|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
46881525|NCT00095147|83102761|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
46881526|NCT00095147|83102762|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
46881527|NCT00095147|83102763|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
46881528|NCT00095147|83102764|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
46881529|NCT00095147|83102760|FG000|Long-term Extension Period|Leaving country|0|||
46881530|NCT00095147|83102761|FG001|Long-term Extension Period|Leaving country|0|||
46881531|NCT00095147|83102762|FG002|Long-term Extension Period|Leaving country|0|||
46881532|NCT00095147|83102763|FG003|Long-term Extension Period|Leaving country|0|||
46881533|NCT00095147|83102764|FG004|Long-term Extension Period|Leaving country|1|||
46881534|NCT02751502|83102782|FG000|Overall Study|Lack of funding|4|||
46881535|NCT02257918|83102789|FG000|Overall Study|Lost to Follow-up|4|||
46881536|NCT02257918|83102790|FG001|Overall Study|Lost to Follow-up|1|||
46881537|NCT02257918|83102791|FG002|Overall Study|Lost to Follow-up|0|||
46881538|NCT02257918|83102789|FG000|Overall Study|Withdrawal by Subject|0|||
46881539|NCT02257918|83102790|FG001|Overall Study|Withdrawal by Subject|0|||
46881540|NCT02257918|83102791|FG002|Overall Study|Withdrawal by Subject|1|||
46881541|NCT02257918|83102789|FG000|Overall Study|Pregnancy|0|||
46881542|NCT02257918|83102790|FG001|Overall Study|Pregnancy|0|||
46881543|NCT02257918|83102791|FG002|Overall Study|Pregnancy|1|||
46881544|NCT02751424|83102808|FG000|Part 2|Adverse Event|0|||
46881545|NCT02751424|83102809|FG001|Part 2|Adverse Event|0|||
46881546|NCT02751424|83102810|FG002|Part 2|Adverse Event|0|||
46881547|NCT02751424|83102811|FG003|Part 2|Adverse Event|0|||
46881548|NCT02751424|83102812|FG004|Part 2|Adverse Event|0|||
46881549|NCT02751424|83102813|FG005|Part 2|Adverse Event|0|||
46881550|NCT02751424|83102814|FG006|Part 2|Adverse Event|0|||
46881551|NCT02751424|83102815|FG007|Part 2|Adverse Event|5|||
46881552|NCT02751424|83102816|FG008|Part 2|Adverse Event|0|||
46881553|NCT00094835|83102846|FG000|Overall Study|Physician Decision|1|||
46881554|NCT00094835|83102847|FG001|Overall Study|Physician Decision|0|||
46881555|NCT00094835|83102848|FG002|Overall Study|Physician Decision|0|||
46881556|NCT00094835|83102849|FG003|Overall Study|Physician Decision|0|||
46881557|NCT00094835|83102850|FG004|Overall Study|Physician Decision|0|||
46881558|NCT00094835|83102851|FG005|Overall Study|Physician Decision|1|||
46881559|NCT00094835|83102852|FG006|Overall Study|Physician Decision|0|||
46881560|NCT00094835|83102846|FG000|Overall Study|Withdrawal by Subject|0|||
46881561|NCT00094835|83102847|FG001|Overall Study|Withdrawal by Subject|0|||
46881562|NCT00094835|83102848|FG002|Overall Study|Withdrawal by Subject|0|||
46881563|NCT00094835|83102849|FG003|Overall Study|Withdrawal by Subject|0|||
46881564|NCT00094835|83102850|FG004|Overall Study|Withdrawal by Subject|0|||
46881565|NCT00094835|83102851|FG005|Overall Study|Withdrawal by Subject|0|||
46881566|NCT00094835|83102852|FG006|Overall Study|Withdrawal by Subject|1|||
46881567|NCT00094835|83102846|FG000|Overall Study|Lost to Follow-up|0|||
46881568|NCT00094835|83102847|FG001|Overall Study|Lost to Follow-up|0|||
46881569|NCT00094835|83102848|FG002|Overall Study|Lost to Follow-up|0|||
46881570|NCT00094835|83102849|FG003|Overall Study|Lost to Follow-up|0|||
46881571|NCT00094835|83102850|FG004|Overall Study|Lost to Follow-up|1|||
46881572|NCT00094835|83102851|FG005|Overall Study|Lost to Follow-up|0|||
46881573|NCT00094835|83102852|FG006|Overall Study|Lost to Follow-up|0|||
46881574|NCT00094835|83102846|FG000|Overall Study|Death|1|||
46881575|NCT00094835|83102847|FG001|Overall Study|Death|0|||
46881576|NCT00094835|83102848|FG002|Overall Study|Death|0|||
46881577|NCT00094835|83102849|FG003|Overall Study|Death|0|||
46881578|NCT00094835|83102850|FG004|Overall Study|Death|1|||
46881579|NCT00094835|83102851|FG005|Overall Study|Death|0|||
46881580|NCT00094835|83102852|FG006|Overall Study|Death|0|||
46881581|NCT00094835|83102846|FG000|Overall Study|Non-compliance|1|||
46881582|NCT00094835|83102847|FG001|Overall Study|Non-compliance|2|||
46881583|NCT00094835|83102848|FG002|Overall Study|Non-compliance|2|||
46881584|NCT00094835|83102849|FG003|Overall Study|Non-compliance|0|||
46881585|NCT00094835|83102850|FG004|Overall Study|Non-compliance|2|||
46881586|NCT00094835|83102851|FG005|Overall Study|Non-compliance|2|||
46881587|NCT00094835|83102852|FG006|Overall Study|Non-compliance|1|||
46881588|NCT00094835|83102846|FG000|Overall Study|Other|1|||
46881589|NCT00094835|83102847|FG001|Overall Study|Other|1|||
46881590|NCT00094835|83102848|FG002|Overall Study|Other|1|||
46881591|NCT00094835|83102849|FG003|Overall Study|Other|1|||
46881592|NCT00094835|83102850|FG004|Overall Study|Other|0|||
46881593|NCT00094835|83102851|FG005|Overall Study|Other|0|||
46881594|NCT00094835|83102852|FG006|Overall Study|Other|0|||
46881595|NCT00094757|83102876|FG000|Overall Study|Adverse Event|11|||
46881596|NCT00094757|83102877|FG001|Overall Study|Adverse Event|9|||
46881597|NCT00094757|83102878|FG002|Overall Study|Adverse Event|6|||
46881598|NCT00094757|83102876|FG000|Overall Study|Lack of Efficacy|11|||
46881599|NCT00094757|83102877|FG001|Overall Study|Lack of Efficacy|15|||
46881600|NCT00094757|83102878|FG002|Overall Study|Lack of Efficacy|8|||
46881601|NCT00094757|83102876|FG000|Overall Study|Lost to Follow-up|3|||
46881602|NCT00094757|83102877|FG001|Overall Study|Lost to Follow-up|5|||
46881603|NCT00094757|83102878|FG002|Overall Study|Lost to Follow-up|6|||
46881604|NCT00094757|83102876|FG000|Overall Study|Patient Moved|2|||
46881605|NCT00094757|83102877|FG001|Overall Study|Patient Moved|1|||
46881606|NCT00094757|83102878|FG002|Overall Study|Patient Moved|1|||
46881607|NCT00094757|83102876|FG000|Overall Study|Protocol Violation|8|||
46881608|NCT00094757|83102877|FG001|Overall Study|Protocol Violation|5|||
46881609|NCT00094757|83102878|FG002|Overall Study|Protocol Violation|3|||
46881610|NCT00094757|83102876|FG000|Overall Study|Withdrawal by Subject|14|||
46881611|NCT00094757|83102877|FG001|Overall Study|Withdrawal by Subject|21|||
46881612|NCT00094757|83102878|FG002|Overall Study|Withdrawal by Subject|5|||
46881613|NCT00094757|83102876|FG000|Overall Study|Other|3|||
46881614|NCT00094757|83102877|FG001|Overall Study|Other|3|||
46881615|NCT00094757|83102878|FG002|Overall Study|Other|1|||
46881616|NCT00094757|83102876|FG000|Overall Study|Protocol specified discontinuation|1|||
46881617|NCT00094757|83102877|FG001|Overall Study|Protocol specified discontinuation|3|||
46881618|NCT00094757|83102878|FG002|Overall Study|Protocol specified discontinuation|0|||
46881619|NCT04378114|83102886|FG000|Overall Study|Withdrawal by Subject|5|||
46881620|NCT00082433|83102895|FG000|Overall Study|Adverse Event|12|||
46881621|NCT00082433|83102896|FG001|Overall Study|Adverse Event|17|||
46881622|NCT00082433|83102895|FG000|Overall Study|Death|8|||
46881623|NCT00082433|83102896|FG001|Overall Study|Death|18|||
46881624|NCT00082433|83102895|FG000|Overall Study|Disease Progression/Relapse|270|||
46881625|NCT00082433|83102896|FG001|Overall Study|Disease Progression/Relapse|388|||
46881626|NCT00082433|83102895|FG000|Overall Study|Physician Decision|50|||
46881627|NCT00082433|83102896|FG001|Overall Study|Physician Decision|61|||
46881628|NCT00082433|83102895|FG000|Overall Study|Lost to Follow-up|1|||
46881629|NCT00082433|83102896|FG001|Overall Study|Lost to Follow-up|2|||
46881630|NCT00082433|83102895|FG000|Overall Study|Study Drug Toxicity|179|||
46881631|NCT00082433|83102896|FG001|Overall Study|Study Drug Toxicity|66|||
46881632|NCT00082433|83102895|FG000|Overall Study|Withdrawal by Subject|55|||
46881633|NCT00082433|83102896|FG001|Overall Study|Withdrawal by Subject|30|||
46881634|NCT00082433|83102895|FG000|Overall Study|Still On Treatment|2|||
46881635|NCT00082433|83102896|FG001|Overall Study|Still On Treatment|1|||
46881636|NCT00082433|83102895|FG000|Overall Study|Not Treated|12|||
46881637|NCT00082433|83102896|FG001|Overall Study|Not Treated|11|||
46881638|NCT00082433|83102895|FG000|Overall Study|Ineligible|2|||
46881639|NCT00082433|83102896|FG001|Overall Study|Ineligible|1|||
46881640|NCT00082433|83102895|FG000|Overall Study|Noncompliance|2|||
46881641|NCT00082433|83102896|FG001|Overall Study|Noncompliance|1|||
46881642|NCT00082433|83102895|FG000|Overall Study|New primary cancer|1|||
46881643|NCT00082433|83102896|FG001|Overall Study|New primary cancer|0|||
46881644|NCT00082433|83102895|FG000|Overall Study|Impending surgery|0|||
46881645|NCT00082433|83102896|FG001|Overall Study|Impending surgery|1|||
46881646|NCT00094445|83102902|FG000|Overall Study|Withdrawal by Subject|3|||
46881647|NCT00094445|83102902|FG000|Overall Study|Lost to Follow-up|1|||
46881648|NCT00094445|83102902|FG000|Overall Study|Progressive Disease|2|||
46881649|NCT00082355|83102906|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
46881650|NCT00082355|83102906|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
46881651|NCT00082355|83102906|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
46881652|NCT00094055|83102910|FG000|Overall Study|Adverse Event|11|||
46881653|NCT00094055|83102910|FG000|Overall Study|Death|4|||
46881654|NCT00094055|83102910|FG000|Overall Study|Lack of Efficacy|17|||
46881655|NCT00094055|83102910|FG000|Overall Study|Lost to Follow-up|2|||
46881656|NCT00094055|83102910|FG000|Overall Study|progressive disease|2|||
46881657|NCT00094055|83102910|FG000|Overall Study|clinical progression|1|||
46881658|NCT00094055|83102910|FG000|Overall Study|roll-over to another study|14|||
46881659|NCT00094055|83102910|FG000|Overall Study|Withdrawal by Subject|9|||
46881660|NCT00099983|83102916|FG000|Overall Study|Lost to Follow-up|2|||
46881661|NCT00099983|83102917|FG001|Overall Study|Lost to Follow-up|3|||
46881662|NCT00099983|83102916|FG000|Overall Study|Missing Source Documents|14|||
46881663|NCT00099983|83102917|FG001|Overall Study|Missing Source Documents|15|||
46881664|NCT00099983|83102916|FG000|Overall Study|Withdrawal by Subject|3|||
46881665|NCT00099983|83102917|FG001|Overall Study|Withdrawal by Subject|2|||
46989308|NCT02399449|83235906|FG001|Overall Study|Withdrawal by Subject|9|||
46989309|NCT02399449|83235905|FG000|Overall Study|Physician Decision|0|||
46989310|NCT02399449|83235906|FG001|Overall Study|Physician Decision|1|||
46881666|NCT00099983|83102916|FG000|Overall Study|Adverse Event|1|||
46881667|NCT00099983|83102917|FG001|Overall Study|Adverse Event|1|||
46881668|NCT00099983|83102916|FG000|Overall Study|Lack of Efficacy|0|||
46989311|NCT02217345|83235914|FG000|Overall Study|Lost to Follow-up|2|||
46881669|NCT00099983|83102917|FG001|Overall Study|Lack of Efficacy|1|||
46881670|NCT00099983|83102916|FG000|Overall Study|Unable to return for appointments|1|||
46881671|NCT00099983|83102917|FG001|Overall Study|Unable to return for appointments|1|||
46881672|NCT00099983|83102916|FG000|Overall Study|Moved|1|||
46881673|NCT00099983|83102917|FG001|Overall Study|Moved|0|||
46881674|NCT00099983|83102916|FG000|Overall Study|Other psychiatric problem|1|||
46881675|NCT00099983|83102917|FG001|Overall Study|Other psychiatric problem|0|||
46881676|NCT00099983|83102916|FG000|Overall Study|Incarcerated|0|||
46881677|NCT00099983|83102917|FG001|Overall Study|Incarcerated|1|||
46881678|NCT00099983|83102916|FG000|Overall Study|Intolerant of burden of visits|0|||
46881679|NCT00099983|83102917|FG001|Overall Study|Intolerant of burden of visits|1|||
46881680|NCT00099983|83102916|FG000|Overall Study|Other issue|1|||
46881681|NCT00099983|83102917|FG001|Overall Study|Other issue|0|||
46881682|NCT00099359|83102926|FG000|Overall Study|Death|11|||
46881683|NCT00099359|83102927|FG001|Overall Study|Death|15|||
46881684|NCT00099359|83102928|FG002|Overall Study|Death|17|||
46881685|NCT00099359|83102926|FG000|Overall Study|Withdrawal by Subject|19|||
46881686|NCT00099359|83102927|FG001|Overall Study|Withdrawal by Subject|19|||
46881687|NCT00099359|83102928|FG002|Overall Study|Withdrawal by Subject|23|||
46881688|NCT00099359|83102926|FG000|Overall Study|Lost to Follow-up|15|||
46881689|NCT00099359|83102927|FG001|Overall Study|Lost to Follow-up|24|||
46881690|NCT00099359|83102928|FG002|Overall Study|Lost to Follow-up|24|||
46881691|NCT00099359|83102926|FG000|Overall Study|moved out of area|9|||
46881692|NCT00099359|83102927|FG001|Overall Study|moved out of area|7|||
46881693|NCT00099359|83102928|FG002|Overall Study|moved out of area|4|||
46881694|NCT00092495|83102950|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
46881695|NCT00092495|83102951|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
46881696|NCT00092495|83102952|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
46881697|NCT00092495|83102953|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
46881698|NCT00092495|83102954|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
46881699|NCT00092495|83102950|FG000|Base Study Vaccination Period|Extended|0|||
46881700|NCT00092495|83102951|FG001|Base Study Vaccination Period|Extended|0|||
46881701|NCT00092495|83102952|FG002|Base Study Vaccination Period|Extended|0|||
46881702|NCT00092495|83102953|FG003|Base Study Vaccination Period|Extended|1|||
46881703|NCT00092495|83102954|FG004|Base Study Vaccination Period|Extended|0|||
46881704|NCT00092495|83102950|FG000|Base Study Vaccination Period|*Clinical AE|1|||
46881705|NCT00092495|83102951|FG001|Base Study Vaccination Period|*Clinical AE|0|||
46881706|NCT00092495|83102952|FG002|Base Study Vaccination Period|*Clinical AE|1|||
46881707|NCT00092495|83102953|FG003|Base Study Vaccination Period|*Clinical AE|2|||
46881708|NCT00092495|83102954|FG004|Base Study Vaccination Period|*Clinical AE|0|||
46881709|NCT00092495|83102950|FG000|Base Study Vaccination Period|*Other reasons|1|||
46881710|NCT00092495|83102951|FG001|Base Study Vaccination Period|*Other reasons|0|||
46881711|NCT00092495|83102952|FG002|Base Study Vaccination Period|*Other reasons|0|||
46881712|NCT00092495|83102953|FG003|Base Study Vaccination Period|*Other reasons|1|||
46881713|NCT00092495|83102954|FG004|Base Study Vaccination Period|*Other reasons|0|||
46881714|NCT00092495|83102950|FG000|Base Study Vaccination Period|*Pregnancy|0|||
46881715|NCT00092495|83102951|FG001|Base Study Vaccination Period|*Pregnancy|2|||
46881716|NCT00092495|83102952|FG002|Base Study Vaccination Period|*Pregnancy|5|||
46881717|NCT00092495|83102953|FG003|Base Study Vaccination Period|*Pregnancy|7|||
46881718|NCT00092495|83102954|FG004|Base Study Vaccination Period|*Pregnancy|0|||
46881719|NCT00092495|83102950|FG000|Base Study Vaccination Period|Adverse Event|1|||
46881720|NCT00092495|83102951|FG001|Base Study Vaccination Period|Adverse Event|0|||
46881721|NCT00092495|83102952|FG002|Base Study Vaccination Period|Adverse Event|0|||
46881722|NCT00092495|83102953|FG003|Base Study Vaccination Period|Adverse Event|3|||
46881723|NCT00092495|83102954|FG004|Base Study Vaccination Period|Adverse Event|0|||
46881724|NCT00092495|83102950|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
46881725|NCT00092495|83102951|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
46881726|NCT00092495|83102952|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
46881727|NCT00092495|83102953|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
46881728|NCT00092495|83102954|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
46881729|NCT00092495|83102950|FG000|Base Study Vaccination Period|Moved|3|||
46881730|NCT00092495|83102951|FG001|Base Study Vaccination Period|Moved|1|||
46881731|NCT00092495|83102952|FG002|Base Study Vaccination Period|Moved|2|||
46881732|NCT00092495|83102953|FG003|Base Study Vaccination Period|Moved|2|||
46881733|NCT00092495|83102954|FG004|Base Study Vaccination Period|Moved|0|||
46989312|NCT02217345|83235915|FG001|Overall Study|Lost to Follow-up|1|||
46881734|NCT00092495|83102950|FG000|Base Study Vaccination Period|Other|1|||
46881735|NCT00092495|83102951|FG001|Base Study Vaccination Period|Other|1|||
46989313|NCT02217345|83235914|FG000|Overall Study|Withdrawal by Subject|3|||
46881736|NCT00092495|83102952|FG002|Base Study Vaccination Period|Other|0|||
46881737|NCT00092495|83102953|FG003|Base Study Vaccination Period|Other|2|||
46881738|NCT00092495|83102954|FG004|Base Study Vaccination Period|Other|0|||
46881739|NCT00092495|83102950|FG000|Base Study Vaccination Period|Pregnancy|2|||
46881740|NCT00092495|83102951|FG001|Base Study Vaccination Period|Pregnancy|0|||
46881741|NCT00092495|83102952|FG002|Base Study Vaccination Period|Pregnancy|0|||
46881742|NCT00092495|83102953|FG003|Base Study Vaccination Period|Pregnancy|0|||
46881743|NCT00092495|83102954|FG004|Base Study Vaccination Period|Pregnancy|0|||
46881744|NCT00092495|83102950|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
46881745|NCT00092495|83102951|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
46881746|NCT00092495|83102952|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
46881747|NCT00092495|83102953|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
46881748|NCT00092495|83102954|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
46881749|NCT00092495|83102950|FG000|Base Study Vaccination Period|Protocol Violation|1|||
46881750|NCT00092495|83102951|FG001|Base Study Vaccination Period|Protocol Violation|0|||
46881751|NCT00092495|83102952|FG002|Base Study Vaccination Period|Protocol Violation|0|||
46881752|NCT00092495|83102953|FG003|Base Study Vaccination Period|Protocol Violation|0|||
46881753|NCT00092495|83102954|FG004|Base Study Vaccination Period|Protocol Violation|0|||
46881754|NCT00092495|83102950|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
46881755|NCT00092495|83102951|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
46881756|NCT00092495|83102952|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
46881757|NCT00092495|83102953|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
46881758|NCT00092495|83102954|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
46881759|NCT00092495|83102950|FG000|Base Study Follow-up Period|Extended|0|||
46881760|NCT00092495|83102951|FG001|Base Study Follow-up Period|Extended|0|||
46881761|NCT00092495|83102952|FG002|Base Study Follow-up Period|Extended|1|||
46881762|NCT00092495|83102953|FG003|Base Study Follow-up Period|Extended|2|||
46881763|NCT00092495|83102954|FG004|Base Study Follow-up Period|Extended|0|||
46881764|NCT00092495|83102950|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
46881765|NCT00092495|83102951|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
46881766|NCT00092495|83102952|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
46881767|NCT00092495|83102953|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
46881768|NCT00092495|83102954|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
46881769|NCT00092495|83102950|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
46881770|NCT00092495|83102951|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
46881771|NCT00092495|83102952|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
46881772|NCT00092495|83102953|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
46881773|NCT00092495|83102954|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
46881774|NCT00092417|83102969|FG000|Overall Study|Lost to Follow-up|2|||
46881775|NCT00092417|83102970|FG001|Overall Study|Lost to Follow-up|0|||
46881776|NCT00092417|83102969|FG000|Overall Study|Withdrawal by Subject|2|||
46881777|NCT00092417|83102970|FG001|Overall Study|Withdrawal by Subject|1|||
46881778|NCT00092417|83102969|FG000|Overall Study|Other|1|||
46881779|NCT00092417|83102970|FG001|Overall Study|Other|0|||
46881780|NCT00091949|83102978|FG000|Overall Study|Withdrawal by Subject|117|||
46881781|NCT00091949|83102979|FG001|Overall Study|Withdrawal by Subject|110|||
46881782|NCT00091949|83102978|FG000|Overall Study|Lost to Follow-up|58|||
46881783|NCT00091949|83102979|FG001|Overall Study|Lost to Follow-up|41|||
46881784|NCT02258542|83102989|FG000|Overall Study|eg. not made to the visit|7|||
46881785|NCT02258542|83102990|FG001|Overall Study|eg. not made to the visit|4|||
46881786|NCT02258542|83102991|FG002|Overall Study|eg. not made to the visit|0|||
46881787|NCT02258542|83102992|FG003|Overall Study|eg. not made to the visit|1|||
46881788|NCT02258542|83102989|FG000|Overall Study|study specific discount. criteria|1|||
46881789|NCT02258542|83102990|FG001|Overall Study|study specific discount. criteria|1|||
46881790|NCT02258542|83102991|FG002|Overall Study|study specific discount. criteria|0|||
46881791|NCT02258542|83102992|FG003|Overall Study|study specific discount. criteria|0|||
46881792|NCT02258542|83102989|FG000|Overall Study|Withdrawal by Subject|20|||
46881793|NCT02258542|83102990|FG001|Overall Study|Withdrawal by Subject|20|||
46881794|NCT02258542|83102991|FG002|Overall Study|Withdrawal by Subject|7|||
46881795|NCT02258542|83102992|FG003|Overall Study|Withdrawal by Subject|1|||
46881796|NCT02258542|83102989|FG000|Overall Study|Lost to Follow-up|5|||
46881797|NCT02258542|83102990|FG001|Overall Study|Lost to Follow-up|12|||
46881798|NCT02258542|83102991|FG002|Overall Study|Lost to Follow-up|1|||
46881799|NCT02258542|83102992|FG003|Overall Study|Lost to Follow-up|2|||
46881800|NCT02258542|83102989|FG000|Overall Study|Death|5|||
46881801|NCT02258542|83102990|FG001|Overall Study|Death|4|||
46881802|NCT02258542|83102991|FG002|Overall Study|Death|0|||
46881803|NCT02258542|83102992|FG003|Overall Study|Death|1|||
46881804|NCT02258542|83102989|FG000|Overall Study|Adverse Event|3|||
46881805|NCT02258542|83102990|FG001|Overall Study|Adverse Event|4|||
46881806|NCT02258542|83102991|FG002|Overall Study|Adverse Event|0|||
46881807|NCT02258542|83102992|FG003|Overall Study|Adverse Event|0|||
46881808|NCT02258542|83102989|FG000|Overall Study|Protocol Violation|1|||
46881809|NCT02258542|83102990|FG001|Overall Study|Protocol Violation|2|||
46881810|NCT02258542|83102991|FG002|Overall Study|Protocol Violation|0|||
46881811|NCT02258542|83102992|FG003|Overall Study|Protocol Violation|0|||
46881812|NCT02258542|83102989|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46881813|NCT02258542|83102990|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
46881814|NCT02258542|83102991|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
46881815|NCT02258542|83102992|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
46881816|NCT00091793|83103022|FG000|Overall Study|Adverse Event|1|||
46881817|NCT00091793|83103023|FG001|Overall Study|Adverse Event|2|||
46881818|NCT00091793|83103022|FG000|Overall Study|Withdrawal by Subject|10|||
46881819|NCT00091793|83103023|FG001|Overall Study|Withdrawal by Subject|15|||
46881820|NCT00091793|83103022|FG000|Overall Study|Ineligibility determined|2|||
46881821|NCT00091793|83103023|FG001|Overall Study|Ineligibility determined|0|||
46881822|NCT00091793|83103022|FG000|Overall Study|Lost to Follow-up|7|||
46881823|NCT00091793|83103023|FG001|Overall Study|Lost to Follow-up|5|||
46881824|NCT00091793|83103022|FG000|Overall Study|Noncompliance|2|||
46881825|NCT00091793|83103023|FG001|Overall Study|Noncompliance|0|||
46881826|NCT00091793|83103022|FG000|Overall Study|Other|2|||
46881827|NCT00091793|83103023|FG001|Overall Study|Other|0|||
46881828|NCT00098813|83103029|FG000|Overall Study|Death|8|||
46881829|NCT00098813|83103029|FG000|Overall Study|Protocol Violation|1|||
46881830|NCT00098813|83103029|FG000|Overall Study|Withdrawal by Subject|7|||
46881831|NCT00098813|83103029|FG000|Overall Study|Progression of Disease|1|||
46881832|NCT00098813|83103029|FG000|Overall Study|Other complicating disease|1|||
46881833|NCT00098813|83103029|FG000|Overall Study|Reversal of RAI resistance|1|||
46881834|NCT00090857|83103035|FG000|Overall Study|Lost to Follow-up|0|||
46881835|NCT00090857|83103036|FG001|Overall Study|Lost to Follow-up|1|||
46881836|NCT00090857|83103035|FG000|Overall Study|Withdrawal by Subject|2|||
46881837|NCT00090857|83103036|FG001|Overall Study|Withdrawal by Subject|0|||
46881838|NCT00090857|83103035|FG000|Overall Study|Adverse Event|2|||
46881839|NCT00090857|83103036|FG001|Overall Study|Adverse Event|2|||
46881840|NCT00090779|83103048|FG000|Step 1|Withdrawal by Subject|4|||
46881841|NCT00090779|83103049|FG001|Step 1|Withdrawal by Subject|2|||
46881842|NCT00090779|83103048|FG000|Step 1|Lost to Follow-up|3|||
46881843|NCT00090779|83103049|FG001|Step 1|Lost to Follow-up|2|||
46881844|NCT00090779|83103048|FG000|Step 1|Death|0|||
46881845|NCT00090779|83103049|FG001|Step 1|Death|2|||
46881846|NCT00090779|83103048|FG000|Step 1|Physician Decision|1|||
46881847|NCT00090779|83103049|FG001|Step 1|Physician Decision|0|||
46881848|NCT00090779|83103048|FG000|Step 1|Pregnancy|1|||
46881849|NCT00090779|83103049|FG001|Step 1|Pregnancy|0|||
46881850|NCT00090779|83103048|FG000|Step 1|Non-compliance to study requirements|0|||
46881851|NCT00090779|83103049|FG001|Step 1|Non-compliance to study requirements|1|||
46881852|NCT00090779|83103048|FG000|Step 1|Subject relocated|2|||
46881853|NCT00090779|83103049|FG001|Step 1|Subject relocated|8|||
46881854|NCT00090779|83103048|FG000|Step 2|Off study per study closure|6|||
46881855|NCT00090779|83103049|FG001|Step 2|Off study per study closure|16|||
46881856|NCT00090779|83103048|FG000|Step 2|Subject relocated|0|||
46881857|NCT00090779|83103049|FG001|Step 2|Subject relocated|1|||
46881858|NCT00090779|83103048|FG000|Step 2|Non-compliance to study requirements|0|||
46881859|NCT00090779|83103049|FG001|Step 2|Non-compliance to study requirements|1|||
46881860|NCT00090779|83103048|FG000|Step 3|Initiation of ART and off extended study|3|||
46881861|NCT00090779|83103049|FG001|Step 3|Initiation of ART and off extended study|2|||
46881862|NCT00090779|83103048|FG000|Step 3|Off extended study due to study closure|4|||
46881863|NCT00090779|83103049|FG001|Step 3|Off extended study due to study closure|3|||
46881864|NCT00098345|83103055|FG000|Overall Study|Adverse Event|7|||
46881865|NCT00098345|83103055|FG000|Overall Study|Withdrawal by Subject|2|||
46881866|NCT00098345|83103055|FG000|Overall Study|progression|4|||
46881867|NCT02224456|83103059|FG000|Overall Study|Lack of Efficacy|1|||
46881868|NCT02224456|83103059|FG000|Overall Study|Lost to Follow-up|15|||
46881869|NCT02224456|83103059|FG000|Overall Study|Withdrawal by Subject|9|||
46881870|NCT02224456|83103059|FG000|Overall Study|Physician Decision|3|||
46881871|NCT02224456|83103059|FG000|Overall Study|Death|2|||
46881872|NCT02224456|83103059|FG000|Overall Study|Pregnancy|4|||
46881873|NCT02224456|83103059|FG000|Overall Study|Protocol Violation|1|||
46881874|NCT02224456|83103059|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
46881875|NCT00097721|83103065|FG000|Overall Study|Adverse Event|8|||
46881876|NCT00097721|83103066|FG001|Overall Study|Adverse Event|1|||
46881877|NCT00097721|83103065|FG000|Overall Study|Withdrawal by Subject|6|||
46881878|NCT00097721|83103066|FG001|Overall Study|Withdrawal by Subject|1|||
46881879|NCT00097721|83103065|FG000|Overall Study|Progressive Disease|55|||
46881880|NCT00097721|83103066|FG001|Overall Study|Progressive Disease|27|||
46881881|NCT00097721|83103065|FG000|Overall Study|Physician Decision|1|||
46881882|NCT00097721|83103066|FG001|Overall Study|Physician Decision|3|||
46881883|NCT00097721|83103065|FG000|Overall Study|Reason not given|1|||
46881884|NCT00097721|83103066|FG001|Overall Study|Reason not given|1|||
46881885|NCT03553498|83103074|FG000|Overall Study|Missing primary outcome|1|||
46881886|NCT03553498|83103075|FG001|Overall Study|Missing primary outcome|2|||
46881887|NCT00096941|83103081|FG000|Overall Study|disease progression|3|||
46881888|NCT00096785|83103087|FG000|Overall Study|Lost to Follow-up|1|||
46881889|NCT00096785|83103088|FG001|Overall Study|Lost to Follow-up|0|||
46881890|NCT00096785|83103087|FG000|Overall Study|Withdrawal by Subject|0|||
46881891|NCT00096785|83103088|FG001|Overall Study|Withdrawal by Subject|1|||
46881892|NCT00096785|83103087|FG000|Overall Study|Relocated|1|||
46881893|NCT00096785|83103088|FG001|Overall Study|Relocated|0|||
46881894|NCT03285178|83103123|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
46881895|NCT03285178|83103124|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
46881896|NCT03285178|83103125|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
46881897|NCT03285178|83103126|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
46881898|NCT03285178|83103127|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
46881899|NCT03285178|83103128|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
46881900|NCT03285178|83103129|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
46881901|NCT03285178|83103123|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
46881902|NCT03285178|83103124|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
46881903|NCT03285178|83103125|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
46881904|NCT03285178|83103126|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
46881905|NCT03285178|83103127|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
46881906|NCT03285178|83103128|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
46881907|NCT03285178|83103129|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
46989314|NCT02217345|83235915|FG001|Overall Study|Withdrawal by Subject|2|||
46989315|NCT02217345|83235914|FG000|Overall Study|Adverse Event|2|||
46989316|NCT02217345|83235915|FG001|Overall Study|Adverse Event|1|||
46989317|NCT02217345|83235914|FG000|Overall Study|Physician Decision|0|||
46989318|NCT02217345|83235915|FG001|Overall Study|Physician Decision|1|||
46989319|NCT02251743|83235923|FG000|Overall Study|Withdrawal by Subject|1|||
46989320|NCT02251743|83235924|FG001|Overall Study|Withdrawal by Subject|1|||
46989321|NCT02428855|83235930|FG000|Overall Study|Withdrawal by Subject|2|||
46989322|NCT02428699|83235934|FG000|Washout Period 1|Screen Failure|1|||
46989323|NCT02428699|83235935|FG001|Washout Period 1|Screen Failure|2|||
46989324|NCT02428231|83235948|FG000|Overall Study|Other|10|||
46989325|NCT02428231|83235949|FG001|Overall Study|Other|16|||
46989326|NCT02428231|83235948|FG000|Overall Study|Required Symptomatic Therapy|0|||
46989327|NCT02428231|83235949|FG001|Overall Study|Required Symptomatic Therapy|1|||
46989328|NCT02428231|83235948|FG000|Overall Study|Adverse Event|3|||
46989329|NCT02428231|83235949|FG001|Overall Study|Adverse Event|0|||
46989330|NCT02397889|83235957|FG000|Overall Study|Physician Decision|1|||
46989331|NCT02397889|83235958|FG001|Overall Study|Physician Decision|0|||
46989332|NCT02397655|83235964|FG000|Overall Study|data not completed|1301|||
46989333|NCT02396953|83235971|FG000|Overall Study|Withdrawal by Subject|0|||
46989334|NCT02396953|83235972|FG001|Overall Study|Withdrawal by Subject|0|||
46989335|NCT02396953|83235973|FG002|Overall Study|Withdrawal by Subject|1|||
46989336|NCT02396953|83235971|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
46989337|NCT02396953|83235972|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
46989338|NCT02396953|83235973|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
46989339|NCT02396953|83235971|FG000|Overall Study|Personal Reasons|1|||
46989340|NCT02396953|83235972|FG001|Overall Study|Personal Reasons|1|||
46989341|NCT02396953|83235973|FG002|Overall Study|Personal Reasons|0|||
46989342|NCT02387983|83235988|FG000|Overall Study|Adverse Event|4|||
46989343|NCT02387983|83235988|FG000|Overall Study|Protocol Violation|1|||
46989344|NCT02387983|83235988|FG000|Overall Study|Withdrawal by Subject|2|||
46989345|NCT02395627|83235995|FG000|Overall Study|Withdrawal by Subject|0|||
46704557|NCT01227902|82919458|FG002|Overall Study|Adverse Event|11|||
46881908|NCT03285178|83103123|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
46881909|NCT03285178|83103124|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
46881910|NCT03285178|83103125|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
46881911|NCT03285178|83103126|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
46881912|NCT03285178|83103127|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
46881913|NCT03285178|83103128|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
46881914|NCT03285178|83103129|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
46881915|NCT03285178|83103123|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
46881916|NCT03285178|83103124|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
46881917|NCT03285178|83103125|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
46881918|NCT03285178|83103126|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
46881919|NCT03285178|83103127|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
46881920|NCT03285178|83103128|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
46881921|NCT03285178|83103129|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
46989346|NCT02395627|83235996|FG001|Overall Study|Withdrawal by Subject|2|||
46989347|NCT02395627|83235997|FG002|Overall Study|Withdrawal by Subject|0|||
46989348|NCT02395627|83235995|FG000|Overall Study|Did not receive pembrolizumab|3|||
46989349|NCT02395627|83235996|FG001|Overall Study|Did not receive pembrolizumab|1|||
46704558|NCT01227902|82919459|FG003|Overall Study|Adverse Event|4|||
46704559|NCT01227902|82919456|FG000|Overall Study|Lack of Efficacy|1|||
46989350|NCT02395627|83235997|FG002|Overall Study|Did not receive pembrolizumab|0|||
46989351|NCT02395471|83236009|FG000|Overall Study|Lost to Follow-up|2|||
46989352|NCT02395471|83236010|FG001|Overall Study|Lost to Follow-up|0|||
46989353|NCT02395471|83236009|FG000|Overall Study|Withdrawal by Subject|2|||
46989354|NCT02395471|83236010|FG001|Overall Study|Withdrawal by Subject|1|||
46989355|NCT02395471|83236009|FG000|Overall Study|Physician Decision|1|||
46989356|NCT02395471|83236010|FG001|Overall Study|Physician Decision|0|||
46989357|NCT02395471|83236009|FG000|Overall Study|Protocol Violation|0|||
46989358|NCT02395471|83236010|FG001|Overall Study|Protocol Violation|1|||
46989359|NCT02395471|83236009|FG000|Overall Study|Failure to swollow sponge twice|1|||
46989360|NCT02395471|83236010|FG001|Overall Study|Failure to swollow sponge twice|0|||
46989361|NCT02395471|83236009|FG000|Overall Study|Patient did not return for procedure|0|||
46989362|NCT02395471|83236010|FG001|Overall Study|Patient did not return for procedure|1|||
46989363|NCT02395471|83236009|FG000|Overall Study|Subject not eligible|1|||
46989364|NCT02395471|83236010|FG001|Overall Study|Subject not eligible|0|||
46989365|NCT02395081|83236028|FG000|Overall Study|Withdrawal by Subject|1|||
46989366|NCT02395081|83236029|FG001|Overall Study|Withdrawal by Subject|1|||
46989367|NCT02395081|83236030|FG002|Overall Study|Withdrawal by Subject|0|||
46989368|NCT02395081|83236028|FG000|Overall Study|Moved where blood couldn't be collected|4|||
46989369|NCT02395081|83236029|FG001|Overall Study|Moved where blood couldn't be collected|1|||
46989370|NCT02395081|83236030|FG002|Overall Study|Moved where blood couldn't be collected|3|||
46989371|NCT02395081|83236028|FG000|Overall Study|Fetal Loss|2|||
46989372|NCT02395081|83236029|FG001|Overall Study|Fetal Loss|3|||
46989373|NCT02395081|83236030|FG002|Overall Study|Fetal Loss|1|||
46989374|NCT02394925|83236041|FG000|Overall Study|Adverse Event|1|||
46989375|NCT02394925|83236041|FG000|Overall Study|Lens Discomfort|3|||
46989376|NCT02394925|83236041|FG000|Overall Study|Lens handling difficulities|5|||
46989377|NCT02394925|83236041|FG000|Overall Study|Lost to Follow-up|9|||
46989378|NCT02394925|83236041|FG000|Overall Study|Protocol Violation|5|||
46989379|NCT02394925|83236041|FG000|Overall Study|No longer meet eligibility criteria|1|||
46989380|NCT02394925|83236041|FG000|Overall Study|Unsatisfactory Visual Response|5|||
46989381|NCT02427607|83236045|FG000|Overall Study|Withdrawal by Subject|1|||
46989382|NCT02425111|83236049|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
46989383|NCT02425111|83236049|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
46989384|NCT02425111|83236049|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
46989385|NCT02425111|83236049|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
46989386|NCT02425111|83236049|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
46989387|NCT02425111|83236049|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
46989388|NCT02424565|83236054|FG000|Period 1 (D0)|Protocol Violation|0|||
46989389|NCT02424565|83236055|FG001|Period 1 (D0)|Protocol Violation|1|||
46989390|NCT02424253|83236063|FG000|Overall Study|Other, unspecified|1|||
46989391|NCT02424253|83236064|FG001|Overall Study|Other, unspecified|0|||
46989392|NCT02424253|83236063|FG000|Overall Study|Compliance problems|1|||
46989393|NCT02424253|83236064|FG001|Overall Study|Compliance problems|0|||
46989394|NCT02424253|83236063|FG000|Overall Study|Physician Decision|2|||
46989395|NCT02424253|83236064|FG001|Overall Study|Physician Decision|0|||
46989396|NCT02424253|83236063|FG000|Overall Study|Lack of Efficacy|0|||
46989397|NCT02424253|83236064|FG001|Overall Study|Lack of Efficacy|7|||
46989398|NCT02424253|83236063|FG000|Overall Study|Adverse Event|2|||
46989399|NCT02424253|83236064|FG001|Overall Study|Adverse Event|0|||
46989400|NCT02424253|83236063|FG000|Overall Study|Consent withdrawn by subject|4|||
46989401|NCT02424253|83236064|FG001|Overall Study|Consent withdrawn by subject|1|||
46989402|NCT02424253|83236063|FG000|Overall Study|Lost to Follow-up|1|||
46989403|NCT02424253|83236064|FG001|Overall Study|Lost to Follow-up|1|||
46989404|NCT02393755|83236072|FG000|Overall Study|Withdrawal by Subject|0|||
46989405|NCT02393755|83236073|FG001|Overall Study|Withdrawal by Subject|3|||
46989406|NCT02393755|83236072|FG000|Overall Study|Adverse Event|0|||
46989407|NCT02393755|83236073|FG001|Overall Study|Adverse Event|2|||
46989408|NCT02393755|83236072|FG000|Overall Study|Physician Decision|0|||
46989409|NCT02393755|83236073|FG001|Overall Study|Physician Decision|2|||
46989410|NCT02393209|83236080|FG000|Overall Study|Study Terminated by Sponsor|1|||
46989411|NCT02393209|83236081|FG001|Overall Study|Study Terminated by Sponsor|1|||
46989412|NCT02393209|83236082|FG002|Overall Study|Study Terminated by Sponsor|0|||
46989413|NCT02393209|83236083|FG003|Overall Study|Study Terminated by Sponsor|0|||
46989414|NCT02393209|83236080|FG000|Overall Study|Withdrawal by Patient|1|||
46989415|NCT02393209|83236081|FG001|Overall Study|Withdrawal by Patient|0|||
46989416|NCT02393209|83236082|FG002|Overall Study|Withdrawal by Patient|0|||
46989417|NCT02393209|83236083|FG003|Overall Study|Withdrawal by Patient|0|||
46989418|NCT02393209|83236080|FG000|Overall Study|Death|2|||
46989419|NCT02393209|83236081|FG001|Overall Study|Death|2|||
46989420|NCT02393209|83236082|FG002|Overall Study|Death|0|||
46989421|NCT02393209|83236083|FG003|Overall Study|Death|0|||
46989422|NCT02393209|83236080|FG000|Overall Study|Death due to Disease Progression|2|||
46989423|NCT02393209|83236081|FG001|Overall Study|Death due to Disease Progression|2|||
46989424|NCT02393209|83236082|FG002|Overall Study|Death due to Disease Progression|0|||
46989425|NCT02393209|83236083|FG003|Overall Study|Death due to Disease Progression|0|||
46989426|NCT02393209|83236080|FG000|Overall Study|Death from Legionella Infection|0|||
46989427|NCT02393209|83236081|FG001|Overall Study|Death from Legionella Infection|1|||
46989428|NCT02393209|83236082|FG002|Overall Study|Death from Legionella Infection|0|||
46989429|NCT02393209|83236083|FG003|Overall Study|Death from Legionella Infection|0|||
46989430|NCT02393209|83236080|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
46989431|NCT02393209|83236081|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
46989432|NCT02393209|83236082|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
46989433|NCT02393209|83236083|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
46989434|NCT02393209|83236080|FG000|Overall Study|Lost to Follow-up|0|||
46989435|NCT02393209|83236081|FG001|Overall Study|Lost to Follow-up|1|||
46989436|NCT02393209|83236082|FG002|Overall Study|Lost to Follow-up|0|||
46989437|NCT02393209|83236083|FG003|Overall Study|Lost to Follow-up|0|||
46989438|NCT02424097|83236094|FG000|Overall Study|Lost to Follow-up|1|||
46989439|NCT02424097|83236095|FG001|Overall Study|Lost to Follow-up|2|||
46989440|NCT02392507|83236101|FG000|Induction Regimen|Death|3|||
46989441|NCT02392507|83236101|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
46989442|NCT02392507|83236101|FG000|Induction Regimen|Physician Decision|1|||
46989443|NCT02392507|83236101|FG000|Induction Regimen|Withdrawal by Subject|2|||
46989444|NCT02392507|83236101|FG000|Maintenance Regimen|Death|1|||
46989445|NCT02392507|83236101|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
46989446|NCT02386345|83236110|FG000|Overall Study|Not treated|14|||
46989447|NCT02386345|83236110|FG000|Overall Study|Lost to Follow-up|1|||
46989448|NCT02386345|83236110|FG000|Overall Study|Adverse Event|5|||
46989449|NCT02386345|83236110|FG000|Overall Study|Repeat Procedure|10|||
46989450|NCT02386345|83236110|FG000|Overall Study|Did not complete 12-month follow-up|72|||
46989451|NCT01651117|83236118|FG000|Overall Study|Death|2|||
46989452|NCT01651117|83236119|FG001|Overall Study|Death|3|||
46989453|NCT01651117|83236120|FG002|Overall Study|Death|2|||
46989454|NCT01651117|83236121|FG003|Overall Study|Death|2|||
46989455|NCT02386189|83236136|FG000|Overall Study|Lost to Follow-up|2|||
46989456|NCT02386189|83236137|FG001|Overall Study|Lost to Follow-up|3|||
46989457|NCT02386189|83236136|FG000|Overall Study|Withdrawal by Subject|1|||
46989458|NCT02386189|83236137|FG001|Overall Study|Withdrawal by Subject|0|||
46989459|NCT02386189|83236136|FG000|Overall Study|Death|1|||
46989460|NCT02386189|83236137|FG001|Overall Study|Death|0|||
46989461|NCT02385799|83236145|FG000|Overall Study|Lost to Follow-up|1|||
46989462|NCT02385799|83236146|FG001|Overall Study|Lost to Follow-up|2|||
46989463|NCT02385799|83236145|FG000|Overall Study|Adverse Event|4|||
46989464|NCT02385799|83236146|FG001|Overall Study|Adverse Event|2|||
46989465|NCT02385799|83236145|FG000|Overall Study|Withdrawal by Subject|0|||
46989466|NCT02385799|83236146|FG001|Overall Study|Withdrawal by Subject|4|||
46989467|NCT02422303|83236154|FG000|Overall Study|Lost to Follow-up|1|||
46989468|NCT02422303|83236155|FG001|Overall Study|Lost to Follow-up|1|||
46989469|NCT02392195|83236161|FG000|Overall Study|Lost to Follow-up|4|||
46989470|NCT02392195|83236161|FG000|Overall Study|Withdrawal by Subject|4|||
46989471|NCT02391961|83236167|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
46989472|NCT02391961|83236168|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
46989473|NCT02391961|83236167|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
46989474|NCT02391961|83236168|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
46989475|NCT02391961|83236167|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
46989476|NCT02391961|83236168|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
46989477|NCT02384941|83236177|FG000|Overall Study|Adverse Event|11|||
46989478|NCT02384941|83236178|FG001|Overall Study|Adverse Event|13|||
46989479|NCT02384941|83236179|FG002|Overall Study|Adverse Event|17|||
46989480|NCT02384941|83236177|FG000|Overall Study|Lost to Follow-up|3|||
46989481|NCT02384941|83236178|FG001|Overall Study|Lost to Follow-up|2|||
46989482|NCT02384941|83236179|FG002|Overall Study|Lost to Follow-up|1|||
46989483|NCT02384941|83236177|FG000|Overall Study|Non-Compliance With Study Drug|2|||
46989484|NCT02384941|83236178|FG001|Overall Study|Non-Compliance With Study Drug|0|||
46989485|NCT02384941|83236179|FG002|Overall Study|Non-Compliance With Study Drug|1|||
46989486|NCT02384941|83236177|FG000|Overall Study|Physician Decision|1|||
46989487|NCT02384941|83236178|FG001|Overall Study|Physician Decision|1|||
46989488|NCT02384941|83236179|FG002|Overall Study|Physician Decision|0|||
46989489|NCT02384941|83236177|FG000|Overall Study|Protocol Violation|3|||
46989490|NCT02384941|83236178|FG001|Overall Study|Protocol Violation|0|||
46989491|NCT02384941|83236179|FG002|Overall Study|Protocol Violation|0|||
46989492|NCT02384941|83236177|FG000|Overall Study|Withdrawal by Subject|26|||
46989493|NCT02384941|83236178|FG001|Overall Study|Withdrawal by Subject|19|||
46989494|NCT02384941|83236179|FG002|Overall Study|Withdrawal by Subject|20|||
46989495|NCT02384941|83236177|FG000|Overall Study|Pregnancy|0|||
46989496|NCT02384941|83236178|FG001|Overall Study|Pregnancy|0|||
46989497|NCT02384941|83236179|FG002|Overall Study|Pregnancy|1|||
46989498|NCT02384941|83236177|FG000|Overall Study|Other than specified above|4|||
46989499|NCT02384941|83236178|FG001|Overall Study|Other than specified above|0|||
46989500|NCT02384941|83236179|FG002|Overall Study|Other than specified above|1|||
46989501|NCT02384395|83236188|FG000|Overall Study|Physician Decision|4|||
46989502|NCT02384395|83236188|FG000|Overall Study|Withdrawal by Subject|3|||
46989503|NCT02384395|83236188|FG000|Overall Study|Lost to Follow-up|3|||
46989504|NCT02420353|83236194|FG000|Overall Study|Withdrawal by Subject|0|||
46989505|NCT02420353|83236195|FG001|Overall Study|Withdrawal by Subject|1|||
46989506|NCT02391337|83236203|FG000|6 Months Follow-up|Death|5|||
46989507|NCT02391337|83236204|FG001|6 Months Follow-up|Death|4|||
46989508|NCT02391337|83236203|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
46989509|NCT02391337|83236204|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
46989510|NCT02391337|83236203|FG000|12 Months Follow-up|Death|2|||
46989511|NCT02391337|83236204|FG001|12 Months Follow-up|Death|0|||
46989512|NCT02391337|83236203|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
46989513|NCT02391337|83236204|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
46989514|NCT02391337|83236203|FG000|12 Months Follow-up|Lost to Follow-up|0|||
46989515|NCT02391337|83236204|FG001|12 Months Follow-up|Lost to Follow-up|2|||
46989516|NCT02382991|83236212|FG000|Overall Study|Adverse Event|1|||
46989517|NCT02382991|83236213|FG001|Overall Study|Adverse Event|2|||
46989518|NCT02382991|83236212|FG000|Overall Study|Lost to Follow-up|1|||
46989519|NCT02382991|83236213|FG001|Overall Study|Lost to Follow-up|0|||
46989520|NCT02382991|83236212|FG000|Overall Study|Withdrawal by Subject|0|||
46989521|NCT02382991|83236213|FG001|Overall Study|Withdrawal by Subject|1|||
46989522|NCT02390557|83236221|FG000|Wave 2|Survey non-respondent|72|||
46989523|NCT02390557|83236222|FG001|Wave 2|Survey non-respondent|41|||
46989524|NCT02390557|83236223|FG002|Wave 2|Survey non-respondent|23|||
46989525|NCT01649791|83236231|FG000|Overall Study|Disease Progression|2|||
46989526|NCT01649791|83236231|FG000|Overall Study|Adverse Event|1|||
46989527|NCT01649557|83236238|FG000|Overall Study|Lost to Follow-up|5|||
46989528|NCT01649557|83236239|FG001|Overall Study|Lost to Follow-up|0|||
46989529|NCT01649557|83236240|FG002|Overall Study|Lost to Follow-up|3|||
46989530|NCT01649557|83236238|FG000|Overall Study|Adverse Event|7|||
46989531|NCT01649557|83236239|FG001|Overall Study|Adverse Event|5|||
46989532|NCT01649557|83236240|FG002|Overall Study|Adverse Event|1|||
46989533|NCT01649557|83236238|FG000|Overall Study|Met withdrawal criteria|4|||
46989534|NCT01649557|83236239|FG001|Overall Study|Met withdrawal criteria|0|||
46989535|NCT01649557|83236240|FG002|Overall Study|Met withdrawal criteria|0|||
46989536|NCT01649557|83236238|FG000|Overall Study|Physician Decision|8|||
46989537|NCT01649557|83236239|FG001|Overall Study|Physician Decision|2|||
46989538|NCT01649557|83236240|FG002|Overall Study|Physician Decision|1|||
46989539|NCT01649557|83236238|FG000|Overall Study|Withdrawal by Subject|15|||
46989540|NCT01649557|83236239|FG001|Overall Study|Withdrawal by Subject|5|||
46989541|NCT01649557|83236240|FG002|Overall Study|Withdrawal by Subject|4|||
46989542|NCT01649557|83236238|FG000|Overall Study|Protocol deviation|0|||
46989543|NCT01649557|83236239|FG001|Overall Study|Protocol deviation|2|||
46989544|NCT01649557|83236240|FG002|Overall Study|Protocol deviation|0|||
46989545|NCT01649557|83236238|FG000|Overall Study|Lack of Efficacy|5|||
46989546|NCT01649557|83236239|FG001|Overall Study|Lack of Efficacy|0|||
46989547|NCT01649557|83236240|FG002|Overall Study|Lack of Efficacy|0|||
46989548|NCT02390245|83236248|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
46989549|NCT02390245|83236249|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
46989550|NCT02390245|83236250|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
46989551|NCT02390245|83236248|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
46989552|NCT02390245|83236249|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
46989553|NCT02390245|83236250|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
46989554|NCT02390167|83236259|FG000|Overall Study|Lost to Follow-up|1|||
46989555|NCT02347657|83236269|FG000|Overall Study|Physician Decision|0|||
46989556|NCT02347657|83236270|FG001|Overall Study|Physician Decision|1|||
46989557|NCT02347657|83236269|FG000|Overall Study|Adverse Event|8|||
46989558|NCT02347657|83236270|FG001|Overall Study|Adverse Event|4|||
46989559|NCT02347657|83236269|FG000|Overall Study|Withdrawal by Subject|6|||
46989560|NCT02347657|83236270|FG001|Overall Study|Withdrawal by Subject|7|||
46989561|NCT02347657|83236269|FG000|Overall Study|Randomized but not treated|1|||
46989562|NCT02347657|83236270|FG001|Overall Study|Randomized but not treated|0|||
46989563|NCT02347657|83236269|FG000|Overall Study|Other|3|||
46989564|NCT02347657|83236270|FG001|Overall Study|Other|3|||
46989565|NCT02347189|83236277|FG000|Overall Study|No implant attempted of study device|9|||
46989566|NCT02347189|83236277|FG000|Overall Study|No primary outcome data available|2|||
46989567|NCT02382133|83236292|FG000|Overall Study|Death|22|||
46989568|NCT02382133|83236292|FG000|Overall Study|transfer out of ICU|4|||
46989569|NCT02382133|83236292|FG000|Overall Study|Physician Decision|2|||
46989570|NCT02382133|83236292|FG000|Overall Study|arterial catheter loss|4|||
46989571|NCT02382133|83236292|FG000|Overall Study|pressure injury both sites|1|||
46989572|NCT02346877|83236298|FG000|Overall Study|Adverse Event|1|||
46989573|NCT02346877|83236299|FG001|Overall Study|Adverse Event|0|||
46989574|NCT02346877|83236298|FG000|Overall Study|Administrative Decision|1|||
46989575|NCT02346877|83236299|FG001|Overall Study|Administrative Decision|0|||
46989576|NCT02346877|83236298|FG000|Overall Study|Sponsor Decision|12|||
46989577|NCT02346877|83236299|FG001|Overall Study|Sponsor Decision|0|||
46989578|NCT02346877|83236298|FG000|Overall Study|Missing|5|||
46989579|NCT02346877|83236299|FG001|Overall Study|Missing|0|||
46989580|NCT02346721|83236305|FG000|Overall Study|Withdrew Consent|3|||
46989581|NCT02346721|83236305|FG000|Overall Study|Lack of Efficacy|1|||
46989582|NCT02389621|83236313|FG000|Treatment Period|Withdrawal by Subject|1|||
46989583|NCT02389621|83236314|FG001|Treatment Period|Withdrawal by Subject|1|||
46989584|NCT02389621|83236313|FG000|Posttreatment Period|Adverse Event|3|||
46989585|NCT02389621|83236314|FG001|Posttreatment Period|Adverse Event|1|||
46989586|NCT02389621|83236313|FG000|Posttreatment Period|Withdrawal by Subject|3|||
46989587|NCT02389621|83236314|FG001|Posttreatment Period|Withdrawal by Subject|2|||
46989588|NCT02389621|83236313|FG000|Posttreatment Period|Lost to Follow-up|1|||
46989589|NCT02389621|83236314|FG001|Posttreatment Period|Lost to Follow-up|1|||
46989590|NCT02389621|83236313|FG000|Posttreatment Period|Other - Miscellaneous|2|||
46989591|NCT02389621|83236314|FG001|Posttreatment Period|Other - Miscellaneous|0|||
46989592|NCT02388997|83236326|FG000|Overall Study|Adverse Event|1|||
46989593|NCT02388997|83236327|FG001|Overall Study|Adverse Event|2|||
46989594|NCT02388997|83236326|FG000|Overall Study|Withdrawal by Subject|2|||
46989595|NCT02388997|83236327|FG001|Overall Study|Withdrawal by Subject|1|||
46989596|NCT02388997|83236326|FG000|Overall Study|Lung function exclusion criteria|0|||
46989597|NCT02388997|83236327|FG001|Overall Study|Lung function exclusion criteria|2|||
46989598|NCT02388997|83236326|FG000|Overall Study|Tested positive for virus during run-in|0|||
46989599|NCT02388997|83236327|FG001|Overall Study|Tested positive for virus during run-in|1|||
46989600|NCT02388763|83236333|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
46989601|NCT02388763|83236334|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
46989602|NCT02388763|83236333|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
46989603|NCT02388763|83236334|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
46989604|NCT02388295|83236346|FG000|Dose Escalation Week 1|Adverse Event|1|||
46989605|NCT02388295|83236347|FG001|Dose Escalation Week 1|Adverse Event|2|||
46989606|NCT02388295|83236348|FG002|Dose Escalation Week 1|Adverse Event|1|||
46989607|NCT02388295|83236346|FG000|Dose Escalation Week 1|Determined not eligible|1|||
46989608|NCT02388295|83236347|FG001|Dose Escalation Week 1|Determined not eligible|1|||
46989609|NCT02388295|83236348|FG002|Dose Escalation Week 1|Determined not eligible|1|||
46989610|NCT02388295|83236346|FG000|Dose Escalation Week 2|Protocol Violation|0|||
46989611|NCT02388295|83236347|FG001|Dose Escalation Week 2|Protocol Violation|1|||
46989612|NCT02388295|83236348|FG002|Dose Escalation Week 2|Protocol Violation|0|||
46989613|NCT02388295|83236346|FG000|Dose Escalation Week 2|Determined not eligible|1|||
46989614|NCT02388295|83236347|FG001|Dose Escalation Week 2|Determined not eligible|1|||
46989615|NCT02388295|83236348|FG002|Dose Escalation Week 2|Determined not eligible|1|||
46989616|NCT02388295|83236346|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
46989617|NCT02388295|83236347|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
46989618|NCT02388295|83236348|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
46989619|NCT02345161|83236358|FG000|Overall Study|Withdrawal by Subject|25|||
46989620|NCT02345161|83236359|FG001|Overall Study|Withdrawal by Subject|33|||
46989621|NCT02345161|83236358|FG000|Overall Study|Adverse Event|16|||
46989622|NCT02345161|83236359|FG001|Overall Study|Adverse Event|19|||
46989623|NCT02345161|83236358|FG000|Overall Study|Physician Decision|4|||
46989624|NCT02345161|83236359|FG001|Overall Study|Physician Decision|4|||
46989625|NCT02345161|83236358|FG000|Overall Study|Lost to Follow-up|0|||
46989626|NCT02345161|83236359|FG001|Overall Study|Lost to Follow-up|1|||
46989627|NCT02251275|83236375|FG000|Overall Study|Adverse Event|23|||
46989628|NCT02251275|83236376|FG001|Overall Study|Adverse Event|60|||
46989629|NCT02251275|83236377|FG002|Overall Study|Adverse Event|28|||
46989630|NCT02251275|83236378|FG003|Overall Study|Adverse Event|0|||
46989631|NCT02251275|83236379|FG004|Overall Study|Adverse Event|0|||
46989632|NCT02251275|83236375|FG000|Overall Study|Lost to Follow-up|5|||
46989633|NCT02251275|83236376|FG001|Overall Study|Lost to Follow-up|6|||
46989634|NCT02251275|83236377|FG002|Overall Study|Lost to Follow-up|4|||
46989635|NCT02251275|83236378|FG003|Overall Study|Lost to Follow-up|0|||
46989636|NCT02251275|83236379|FG004|Overall Study|Lost to Follow-up|0|||
46989637|NCT02251275|83236375|FG000|Overall Study|Physician Decision|19|||
46989638|NCT02251275|83236376|FG001|Overall Study|Physician Decision|30|||
46989639|NCT02251275|83236377|FG002|Overall Study|Physician Decision|26|||
46989640|NCT02251275|83236378|FG003|Overall Study|Physician Decision|0|||
46989641|NCT02251275|83236379|FG004|Overall Study|Physician Decision|1|||
46989642|NCT02251275|83236375|FG000|Overall Study|Protocol Deviation|0|||
46989643|NCT02251275|83236376|FG001|Overall Study|Protocol Deviation|0|||
46989644|NCT02251275|83236377|FG002|Overall Study|Protocol Deviation|1|||
46989645|NCT02251275|83236378|FG003|Overall Study|Protocol Deviation|0|||
46989646|NCT02251275|83236379|FG004|Overall Study|Protocol Deviation|0|||
46989647|NCT02251275|83236375|FG000|Overall Study|Withdrawal by Subject|25|||
46989648|NCT02251275|83236376|FG001|Overall Study|Withdrawal by Subject|51|||
46989649|NCT02251275|83236377|FG002|Overall Study|Withdrawal by Subject|35|||
46989650|NCT02251275|83236378|FG003|Overall Study|Withdrawal by Subject|1|||
46989651|NCT02251275|83236379|FG004|Overall Study|Withdrawal by Subject|0|||
46989652|NCT02379637|83236393|FG000|Overall Study|Protocol Violation|0|||
46989653|NCT02379637|83236394|FG001|Overall Study|Protocol Violation|1|||
46989654|NCT02379637|83236393|FG000|Overall Study|Adverse Event|1|||
46989655|NCT02379637|83236394|FG001|Overall Study|Adverse Event|0|||
46989656|NCT02379637|83236393|FG000|Overall Study|Withdrawal by Subject|1|||
46989657|NCT02379637|83236394|FG001|Overall Study|Withdrawal by Subject|0|||
46989658|NCT02195583|83236400|FG000|Overall Study|Lost to Follow-up|1|||
46989659|NCT02195583|83236400|FG000|Overall Study|Withdrawal by Subject|4|||
46989660|NCT02195583|83236400|FG000|Overall Study|Adverse Event|2|||
46989661|NCT02195583|83236400|FG000|Overall Study|Other Reason|2|||
46989662|NCT02379091|83236419|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
46989663|NCT02379091|83236420|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
46989664|NCT02379091|83236421|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
46989665|NCT02379091|83236422|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
46989666|NCT02379091|83236419|FG000|Overall Study|Principal Investigator Discretion|0|||
46989667|NCT02379091|83236420|FG001|Overall Study|Principal Investigator Discretion|1|||
46989668|NCT02379091|83236421|FG002|Overall Study|Principal Investigator Discretion|0|||
46989669|NCT02379091|83236422|FG003|Overall Study|Principal Investigator Discretion|0|||
46989670|NCT02379091|83236419|FG000|Overall Study|Lost to Follow-up|0|||
46989671|NCT02379091|83236420|FG001|Overall Study|Lost to Follow-up|0|||
46989672|NCT02379091|83236421|FG002|Overall Study|Lost to Follow-up|0|||
46989673|NCT02379091|83236422|FG003|Overall Study|Lost to Follow-up|1|||
46989674|NCT02379091|83236419|FG000|Overall Study|Voluntary Withdrawal|2|||
46989675|NCT02379091|83236420|FG001|Overall Study|Voluntary Withdrawal|5|||
46989676|NCT02379091|83236421|FG002|Overall Study|Voluntary Withdrawal|2|||
46989677|NCT02379091|83236422|FG003|Overall Study|Voluntary Withdrawal|4|||
46989678|NCT02379091|83236419|FG000|Overall Study|Study Termination|7|||
46989679|NCT02379091|83236420|FG001|Overall Study|Study Termination|2|||
46989680|NCT02379091|83236421|FG002|Overall Study|Study Termination|5|||
46989681|NCT02379091|83236422|FG003|Overall Study|Study Termination|8|||
46989682|NCT02379091|83236419|FG000|Overall Study|Lack of Efficacy|3|||
46989683|NCT02379091|83236420|FG001|Overall Study|Lack of Efficacy|0|||
46989684|NCT02379091|83236421|FG002|Overall Study|Lack of Efficacy|0|||
46989685|NCT02379091|83236422|FG003|Overall Study|Lack of Efficacy|0|||
46989686|NCT02378935|83236441|FG000|Overall Study|Lack of Efficacy|10|||
46989687|NCT02378935|83236442|FG001|Overall Study|Lack of Efficacy|0|||
46989688|NCT02378935|83236443|FG002|Overall Study|Lack of Efficacy|2|||
46989689|NCT02378935|83236444|FG003|Overall Study|Lack of Efficacy|6|||
46989690|NCT02378935|83236445|FG004|Overall Study|Lack of Efficacy|0|||
46989691|NCT02378935|83236446|FG005|Overall Study|Lack of Efficacy|0|||
46989692|NCT02378935|83236447|FG006|Overall Study|Lack of Efficacy|0|||
46989693|NCT02378935|83236441|FG000|Overall Study|Death|0|||
46989694|NCT02378935|83236442|FG001|Overall Study|Death|0|||
46989695|NCT02378935|83236443|FG002|Overall Study|Death|1|||
46989696|NCT02378935|83236444|FG003|Overall Study|Death|0|||
46989697|NCT02378935|83236445|FG004|Overall Study|Death|0|||
46989698|NCT02378935|83236446|FG005|Overall Study|Death|0|||
46989699|NCT02378935|83236447|FG006|Overall Study|Death|0|||
46989700|NCT02250651|83236466|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
46989701|NCT02250651|83236467|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
46989702|NCT02250651|83236468|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
46989703|NCT02250651|83236466|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
46989704|NCT02250651|83236467|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
46989705|NCT02250651|83236468|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
46989706|NCT02250651|83236466|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
46989707|NCT02250651|83236467|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
46989708|NCT02250651|83236468|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
46989709|NCT02250651|83236466|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
46989710|NCT02250651|83236467|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
46989711|NCT02250651|83236468|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
46989712|NCT02250651|83236466|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
46989713|NCT02250651|83236467|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
46989714|NCT02250651|83236468|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
46989715|NCT02250651|83236466|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
46989716|NCT02250651|83236467|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
46989717|NCT02250651|83236468|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
46704560|NCT01227902|82919457|FG001|Overall Study|Lack of Efficacy|2|||
46989718|NCT02250651|83236466|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
46989719|NCT02250651|83236467|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
46989720|NCT02250651|83236468|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
46989721|NCT02250651|83236466|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
46989722|NCT02250651|83236467|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
46989723|NCT02250651|83236468|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
46989724|NCT02250651|83236466|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
46989725|NCT02250651|83236467|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
46989726|NCT02250651|83236468|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
46989727|NCT02250651|83236466|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
46989728|NCT02250651|83236467|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
46989729|NCT02250651|83236468|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
46989730|NCT02250651|83236466|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
46989731|NCT02250651|83236467|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
46989732|NCT02250651|83236468|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
46989733|NCT02250651|83236466|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
46989734|NCT02250651|83236467|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
46989735|NCT02250651|83236468|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
46989736|NCT02250651|83236466|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
46989737|NCT02250651|83236467|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
46989738|NCT02250651|83236468|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
46989739|NCT02250651|83236466|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
46989740|NCT02250651|83236467|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
46989741|NCT02250651|83236468|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
46989742|NCT02250651|83236466|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
46989743|NCT02250651|83236467|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
46989744|NCT02250651|83236468|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
46989745|NCT02377921|83236478|FG000|Overall Study|Subject non-compliance|1|||
46989746|NCT02377921|83236479|FG001|Overall Study|Subject non-compliance|1|||
46989747|NCT02311153|83236487|FG000|Overall Study|Lost to Follow-up|5|||
46989748|NCT02311153|83236488|FG001|Overall Study|Lost to Follow-up|7|||
46989749|NCT02195427|83236496|FG000|Overall Study|Did not consent to study extension|13|||
46989750|NCT02195427|83236497|FG001|Overall Study|Did not consent to study extension|9|||
46989751|NCT02195427|83236496|FG000|Overall Study|Withdrawal by Subject|4|||
46989752|NCT02195427|83236497|FG001|Overall Study|Withdrawal by Subject|2|||
46989753|NCT02195427|83236496|FG000|Overall Study|Lost to Follow-up|0|||
46989754|NCT02195427|83236497|FG001|Overall Study|Lost to Follow-up|1|||
46989755|NCT02195427|83236496|FG000|Overall Study|Protocol Violation|7|||
46989756|NCT02195427|83236497|FG001|Overall Study|Protocol Violation|14|||
46989757|NCT02195427|83236496|FG000|Overall Study|Conditional re-treatment at W52|2|||
46989758|NCT02195427|83236497|FG001|Overall Study|Conditional re-treatment at W52|1|||
46989759|NCT02214225|83236510|FG000|Overall Study|Lost to Follow-up|46|||
46989760|NCT02214225|83236511|FG001|Overall Study|Lost to Follow-up|18|||
46989761|NCT02214225|83236512|FG002|Overall Study|Lost to Follow-up|18|||
46989762|NCT02214225|83236510|FG000|Overall Study|Withdrawal by Subject|2|||
46989763|NCT02214225|83236511|FG001|Overall Study|Withdrawal by Subject|0|||
46989764|NCT02214225|83236512|FG002|Overall Study|Withdrawal by Subject|2|||
46989765|NCT02214225|83236510|FG000|Overall Study|Death|5|||
46989766|NCT02214225|83236511|FG001|Overall Study|Death|0|||
46989767|NCT02214225|83236512|FG002|Overall Study|Death|1|||
46989768|NCT02214225|83236510|FG000|Overall Study|randomized in error, not vaccinated|2|||
46989769|NCT02214225|83236511|FG001|Overall Study|randomized in error, not vaccinated|1|||
46989770|NCT02214225|83236512|FG002|Overall Study|randomized in error, not vaccinated|1|||
46989771|NCT02250183|83236543|FG000|Overall Study|Withdrawal by Subject|2|||
46989772|NCT02250183|83236543|FG000|Overall Study|Adverse Event|5|||
46989773|NCT02250183|83236543|FG000|Overall Study|Lost to Follow-up|1|||
46989774|NCT02249949|83236550|FG000|Overall Study|Cancelled prior to treatment|2|||
46989775|NCT02249091|83236556|FG000|Overall Study|Lack of Efficacy|8|||
46989776|NCT02249091|83236557|FG001|Overall Study|Lack of Efficacy|3|||
46989777|NCT02249091|83236556|FG000|Overall Study|Physician Decision|4|||
46989778|NCT02249091|83236557|FG001|Overall Study|Physician Decision|1|||
46989779|NCT02249091|83236556|FG000|Overall Study|Withdrawal by Subject|2|||
46989780|NCT02249091|83236557|FG001|Overall Study|Withdrawal by Subject|2|||
46989781|NCT02249091|83236556|FG000|Overall Study|Death|3|||
46989782|NCT02249091|83236557|FG001|Overall Study|Death|4|||
46989783|NCT02249091|83236556|FG000|Overall Study|Adverse Event|1|||
46989784|NCT02249091|83236557|FG001|Overall Study|Adverse Event|0|||
46989785|NCT02249091|83236556|FG000|Overall Study|Stable disease with following SCT|0|||
46989786|NCT02249091|83236557|FG001|Overall Study|Stable disease with following SCT|1|||
46704561|NCT01227902|82919458|FG002|Overall Study|Lack of Efficacy|2|||
46989787|NCT02249091|83236556|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
46989788|NCT02249091|83236557|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
46989789|NCT02249091|83236556|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
46704562|NCT01227902|82919459|FG003|Overall Study|Lack of Efficacy|1|||
46989790|NCT02249091|83236557|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
46989791|NCT02249091|83236556|FG000|Overall Study|Refractory AML|1|||
46989792|NCT02249091|83236557|FG001|Overall Study|Refractory AML|1|||
46989793|NCT02248857|83236566|FG000|3 Month|Withdrawal by Subject|9|||
46989794|NCT02248857|83236567|FG001|3 Month|Withdrawal by Subject|3|||
46989795|NCT02248857|83236568|FG002|3 Month|Withdrawal by Subject|4|||
46989796|NCT02248857|83236566|FG000|3 Month|Unable to reach for 3 month|35|||
46989797|NCT02248857|83236567|FG001|3 Month|Unable to reach for 3 month|29|||
46989798|NCT02248857|83236568|FG002|3 Month|Unable to reach for 3 month|26|||
46989799|NCT02248857|83236566|FG000|3 Month|Partially completed, unable to finish|2|||
46989800|NCT02248857|83236567|FG001|3 Month|Partially completed, unable to finish|2|||
46989801|NCT02248857|83236568|FG002|3 Month|Partially completed, unable to finish|1|||
46989802|NCT02248857|83236566|FG000|6 Month|Lost to Follow-up|27|||
46989803|NCT02248857|83236567|FG001|6 Month|Lost to Follow-up|26|||
46989804|NCT02248857|83236568|FG002|6 Month|Lost to Follow-up|15|||
46989805|NCT02248857|83236566|FG000|6 Month|Partially completed, unable to finish|0|||
46989806|NCT02248857|83236567|FG001|6 Month|Partially completed, unable to finish|1|||
46989807|NCT02248857|83236568|FG002|6 Month|Partially completed, unable to finish|0|||
46989808|NCT02248857|83236566|FG000|6 Month|Withdrawal by Subject|0|||
46989809|NCT02248857|83236567|FG001|6 Month|Withdrawal by Subject|2|||
46989810|NCT02248857|83236568|FG002|6 Month|Withdrawal by Subject|2|||
46989811|NCT02248857|83236566|FG000|6 Month|Death|1|||
46989812|NCT02248857|83236567|FG001|6 Month|Death|0|||
46989813|NCT02248857|83236568|FG002|6 Month|Death|0|||
46989814|NCT02213055|83236578|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
46989815|NCT02213055|83236579|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
46989816|NCT02213055|83236578|FG000|Overall Study|Protocol was not Followed during Study|1|||
46989817|NCT02213055|83236579|FG001|Overall Study|Protocol was not Followed during Study|0|||
46989818|NCT02213055|83236578|FG000|Overall Study|Documentation Issue at Enrollment|1|||
46989819|NCT02213055|83236579|FG001|Overall Study|Documentation Issue at Enrollment|0|||
46989820|NCT02213055|83236578|FG000|Overall Study|Documentation Issue during Study|10|||
46989821|NCT02213055|83236579|FG001|Overall Study|Documentation Issue during Study|0|||
46989822|NCT02213055|83236578|FG000|Overall Study|Did not have Live Lice|8|||
46989823|NCT02213055|83236579|FG001|Overall Study|Did not have Live Lice|0|||
46989824|NCT02213055|83236578|FG000|Overall Study|Had another Treatment during the Study|3|||
46989825|NCT02213055|83236579|FG001|Overall Study|Had another Treatment during the Study|0|||
46989826|NCT02213055|83236578|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
46989827|NCT02213055|83236579|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
46989828|NCT02213055|83236578|FG000|Overall Study|Did not Return to School|5|||
46989829|NCT02213055|83236579|FG001|Overall Study|Did not Return to School|0|||
46989830|NCT02310763|83236588|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
46989831|NCT02310763|83236589|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
46989832|NCT02310763|83236590|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
46989833|NCT02310763|83236588|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
46989834|NCT02310763|83236589|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
46989835|NCT02310763|83236590|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
46989836|NCT02310763|83236588|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
46989837|NCT02310763|83236589|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
46989838|NCT02310763|83236590|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
46989839|NCT02310763|83236588|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
46989840|NCT02310763|83236589|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
46989841|NCT02310763|83236590|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
46989842|NCT02310763|83236588|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
46989843|NCT02310763|83236589|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
46989844|NCT02310763|83236590|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
46989845|NCT02342743|83236616|FG000|Baseline Period|Withdrawal by Subject|3|||
46989846|NCT02342743|83236616|FG000|Baseline Period|Lost to Follow-up|2|||
46989847|NCT02342743|83236616|FG000|Baseline Period|Change in prophylactic medication|3|||
46989848|NCT02342743|83236616|FG000|Baseline Period|Screening failure regarding baseline|7|||
46989849|NCT02342743|83236616|FG000|Treatment Period|Withdrawal by Subject|2|||
46989850|NCT02342743|83236616|FG000|Treatment Period|Lost to Follow-up|8|||
46989851|NCT02342743|83236616|FG000|Treatment Period|Change in prophylactic medication|1|||
46989852|NCT02377063|83236620|FG000|Overall Study|Non-compliance|5|||
46989853|NCT02309515|83236626|FG000|Overall Study|Withdrawal by Subject|0|||
46989854|NCT02309515|83236627|FG001|Overall Study|Withdrawal by Subject|1|||
46989855|NCT02309359|83236638|FG000|Overall Study|Adverse Event|4|||
46989856|NCT02309359|83236639|FG001|Overall Study|Adverse Event|5|||
46989857|NCT02309359|83236640|FG002|Overall Study|Adverse Event|5|||
46989858|NCT02309359|83236641|FG003|Overall Study|Adverse Event|4|||
46989859|NCT02309359|83236642|FG004|Overall Study|Adverse Event|4|||
46989860|NCT02309359|83236638|FG000|Overall Study|Death|1|||
46989861|NCT02309359|83236639|FG001|Overall Study|Death|0|||
46881922|NCT03285178|83103123|FG000|Single-Blind Run-In Period|Physician Decision|2|||
46989862|NCT02309359|83236640|FG002|Overall Study|Death|0|||
46989863|NCT02309359|83236641|FG003|Overall Study|Death|0|||
46989864|NCT02309359|83236642|FG004|Overall Study|Death|0|||
46989865|NCT02309359|83236638|FG000|Overall Study|Withdrawal by Subject|2|||
46989866|NCT02309359|83236639|FG001|Overall Study|Withdrawal by Subject|2|||
46989867|NCT02309359|83236640|FG002|Overall Study|Withdrawal by Subject|4|||
46989868|NCT02309359|83236641|FG003|Overall Study|Withdrawal by Subject|4|||
46989869|NCT02309359|83236642|FG004|Overall Study|Withdrawal by Subject|0|||
46989870|NCT02309359|83236638|FG000|Overall Study|Lack of Efficacy|3|||
46989871|NCT02309359|83236639|FG001|Overall Study|Lack of Efficacy|1|||
46989872|NCT02309359|83236640|FG002|Overall Study|Lack of Efficacy|0|||
46989873|NCT02309359|83236641|FG003|Overall Study|Lack of Efficacy|0|||
46989874|NCT02309359|83236642|FG004|Overall Study|Lack of Efficacy|3|||
46989875|NCT02309359|83236638|FG000|Overall Study|Lost to Follow-up|0|||
46989876|NCT02309359|83236639|FG001|Overall Study|Lost to Follow-up|0|||
46989877|NCT02309359|83236640|FG002|Overall Study|Lost to Follow-up|0|||
46989878|NCT02309359|83236641|FG003|Overall Study|Lost to Follow-up|1|||
46989879|NCT02309359|83236642|FG004|Overall Study|Lost to Follow-up|0|||
46989880|NCT02309359|83236638|FG000|Overall Study|Other|2|||
46989881|NCT02309359|83236639|FG001|Overall Study|Other|0|||
46989882|NCT02309359|83236640|FG002|Overall Study|Other|2|||
46989883|NCT02309359|83236641|FG003|Overall Study|Other|3|||
46989884|NCT02309359|83236642|FG004|Overall Study|Other|2|||
46989885|NCT02247531|83236658|FG000|Overall Study|Adverse Event|3|||
46989886|NCT02247531|83236659|FG001|Overall Study|Adverse Event|4|||
46989887|NCT02247531|83236660|FG002|Overall Study|Adverse Event|9|||
46989888|NCT02247531|83236658|FG000|Overall Study|Death|8|||
46989889|NCT02247531|83236659|FG001|Overall Study|Death|9|||
46989890|NCT02247531|83236660|FG002|Overall Study|Death|5|||
46989891|NCT02247531|83236658|FG000|Overall Study|Lost to Follow-up|1|||
46989892|NCT02247531|83236659|FG001|Overall Study|Lost to Follow-up|8|||
46989893|NCT02247531|83236660|FG002|Overall Study|Lost to Follow-up|3|||
46989894|NCT02247531|83236658|FG000|Overall Study|Non-compliance|2|||
46989895|NCT02247531|83236659|FG001|Overall Study|Non-compliance|2|||
46989896|NCT02247531|83236660|FG002|Overall Study|Non-compliance|0|||
46989897|NCT02247531|83236658|FG000|Overall Study|Withdrawal by Subject|26|||
46989898|NCT02247531|83236659|FG001|Overall Study|Withdrawal by Subject|31|||
46989899|NCT02247531|83236660|FG002|Overall Study|Withdrawal by Subject|25|||
46989900|NCT02247531|83236658|FG000|Overall Study|Study Terminated by Sponsor|64|||
46989901|NCT02247531|83236659|FG001|Overall Study|Study Terminated by Sponsor|66|||
46989902|NCT02247531|83236660|FG002|Overall Study|Study Terminated by Sponsor|62|||
46989903|NCT02247531|83236658|FG000|Overall Study|Physician Decision|0|||
46989904|NCT02247531|83236659|FG001|Overall Study|Physician Decision|2|||
46989905|NCT02247531|83236660|FG002|Overall Study|Physician Decision|2|||
46989906|NCT02247531|83236658|FG000|Overall Study|Unspecified Reason|2|||
46989907|NCT02247531|83236659|FG001|Overall Study|Unspecified Reason|3|||
46989908|NCT02247531|83236660|FG002|Overall Study|Unspecified Reason|4|||
46989909|NCT02375971|83236671|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
46989910|NCT02375971|83236672|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
46989911|NCT02375971|83236673|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
46989912|NCT02375971|83236671|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
46989913|NCT02375971|83236672|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
46989914|NCT02375971|83236673|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
46989915|NCT02375971|83236671|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
46989916|NCT02375971|83236672|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
46989917|NCT02375971|83236673|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
46989918|NCT02375971|83236671|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
46989919|NCT02375971|83236672|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
46989920|NCT02375971|83236673|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
46989921|NCT02375971|83236671|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
46989922|NCT02375971|83236672|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
46989923|NCT02375971|83236673|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
46989924|NCT02375971|83236671|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
46989925|NCT02375971|83236672|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
46989926|NCT02375971|83236673|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
46704563|NCT01227902|82919456|FG000|Overall Study|Protocol Violation|1|||
46802950|NCT00684203|83022196|FG001|Overall Study|Adverse Event|4|||
46989927|NCT02375971|83236671|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
46989928|NCT02375971|83236672|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
46989929|NCT02375971|83236673|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
46989930|NCT02375971|83236671|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
46989931|NCT02375971|83236672|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
46989932|NCT02375971|83236673|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
46989933|NCT02308735|83236685|FG000|Overall Study|Physician Decision|2|||
46989934|NCT02308735|83236686|FG001|Overall Study|Physician Decision|0|||
46989935|NCT02308735|83236687|FG002|Overall Study|Physician Decision|0|||
46989936|NCT02308735|83236688|FG003|Overall Study|Physician Decision|2|||
46989937|NCT02212197|83236701|FG000|Overall Study|Need for radiotherapy|1|||
46989938|NCT02212197|83236702|FG001|Overall Study|Need for radiotherapy|0|||
46989939|NCT02212197|83236703|FG002|Overall Study|Need for radiotherapy|0|||
46989940|NCT02193165|83236714|FG000|4 Week Product Use|Lost to Follow-up|1|||
46989941|NCT02193165|83236715|FG001|4 Week Product Use|Lost to Follow-up|1|||
46989942|NCT02193165|83236716|FG002|4 Week Product Use|Lost to Follow-up|1|||
46989943|NCT02193165|83236714|FG000|6 Week Product Use|Lost to Follow-up|0|||
46989944|NCT02193165|83236715|FG001|6 Week Product Use|Lost to Follow-up|1|||
46989945|NCT02193165|83236716|FG002|6 Week Product Use|Lost to Follow-up|0|||
46989946|NCT01617460|83236724|FG000|Overall Study|Adverse Event|10|||
46989947|NCT01617460|83236724|FG000|Overall Study|Physician Decision|16|||
46989948|NCT01617460|83236724|FG000|Overall Study|Protocol Violation|5|||
46989949|NCT01617460|83236724|FG000|Overall Study|Withdrawal by Subject|9|||
46989950|NCT01890148|83236728|FG000|Overall Study|Adverse Event|1|||
46989951|NCT01889602|83236735|FG000|First Intervention|Adverse Event|1|||
46989952|NCT01889602|83236736|FG001|First Intervention|Adverse Event|1|||
46989953|NCT01889602|83236737|FG002|First Intervention|Adverse Event|1|||
46989954|NCT01889602|83236735|FG000|First Intervention|Protocol Violation|0|||
46989955|NCT01889602|83236736|FG001|First Intervention|Protocol Violation|1|||
46989956|NCT01889602|83236737|FG002|First Intervention|Protocol Violation|1|||
46989957|NCT01889602|83236735|FG000|First Intervention|Study ending|0|||
46989958|NCT01889602|83236736|FG001|First Intervention|Study ending|1|||
46989959|NCT01889602|83236737|FG002|First Intervention|Study ending|0|||
46989960|NCT01889602|83236735|FG000|Second Intervention|Adverse Event|0|||
46989961|NCT01889602|83236736|FG001|Second Intervention|Adverse Event|0|||
46989962|NCT01889602|83236737|FG002|Second Intervention|Adverse Event|1|||
46989963|NCT01889602|83236735|FG000|Second Intervention|Study ending|1|||
46989964|NCT01889602|83236736|FG001|Second Intervention|Study ending|0|||
46989965|NCT01889602|83236737|FG002|Second Intervention|Study ending|0|||
46989966|NCT01889602|83236735|FG000|Second Intervention|Withdrawal by Subject|0|||
46989967|NCT01889602|83236736|FG001|Second Intervention|Withdrawal by Subject|0|||
46989968|NCT01889602|83236737|FG002|Second Intervention|Withdrawal by Subject|1|||
46989969|NCT01889602|83236735|FG000|Third Intervention|Protocol Violation|1|||
46989970|NCT01889602|83236736|FG001|Third Intervention|Protocol Violation|0|||
46989971|NCT01889602|83236737|FG002|Third Intervention|Protocol Violation|0|||
46989972|NCT01889602|83236735|FG000|Third Intervention|Withdrawal by Subject|2|||
46989973|NCT01889602|83236736|FG001|Third Intervention|Withdrawal by Subject|2|||
46989974|NCT01889602|83236737|FG002|Third Intervention|Withdrawal by Subject|0|||
46989975|NCT01935700|83236755|FG000|Overall Study|Withdrawal by Subject|1|||
46989976|NCT01935700|83236756|FG001|Overall Study|Withdrawal by Subject|0|||
46989977|NCT01935700|83236755|FG000|Overall Study|Physician Decision|4|||
46989978|NCT01935700|83236756|FG001|Overall Study|Physician Decision|0|||
46989979|NCT01618162|83236766|FG000|Overall Study|Protocol Violation|13|||
46989980|NCT01618162|83236767|FG001|Overall Study|Protocol Violation|10|||
46989981|NCT01618162|83236766|FG000|Overall Study|Adverse Event|9|||
46989982|NCT01618162|83236767|FG001|Overall Study|Adverse Event|2|||
46989983|NCT01618162|83236766|FG000|Overall Study|Withdrawal Criteria|2|||
46989984|NCT01618162|83236767|FG001|Overall Study|Withdrawal Criteria|10|||
46989985|NCT01618162|83236766|FG000|Overall Study|Unclassified|14|||
46989986|NCT01618162|83236767|FG001|Overall Study|Unclassified|13|||
46989987|NCT02193087|83236777|FG000|Overall Study|Adverse Event|2|||
46989988|NCT02193087|83236778|FG001|Overall Study|Adverse Event|0|||
46989989|NCT02193087|83236779|FG002|Overall Study|Adverse Event|0|||
46989990|NCT02193087|83236780|FG003|Overall Study|Adverse Event|11|||
46989991|NCT02193087|83236777|FG000|Overall Study|Lost to Follow-up|14|||
46989992|NCT02193087|83236778|FG001|Overall Study|Lost to Follow-up|6|||
46989993|NCT02193087|83236779|FG002|Overall Study|Lost to Follow-up|4|||
46989994|NCT02193087|83236780|FG003|Overall Study|Lost to Follow-up|37|||
46989995|NCT02193087|83236777|FG000|Overall Study|Protocol Violation|2|||
46989996|NCT02193087|83236778|FG001|Overall Study|Protocol Violation|0|||
46989997|NCT02193087|83236779|FG002|Overall Study|Protocol Violation|1|||
46989998|NCT02193087|83236780|FG003|Overall Study|Protocol Violation|2|||
46989999|NCT02193087|83236777|FG000|Overall Study|Withdrawal by Subject|10|||
46990000|NCT02193087|83236778|FG001|Overall Study|Withdrawal by Subject|3|||
46990001|NCT02193087|83236779|FG002|Overall Study|Withdrawal by Subject|1|||
46990002|NCT02193087|83236780|FG003|Overall Study|Withdrawal by Subject|19|||
46990003|NCT02193087|83236777|FG000|Overall Study|Other Reason Not Specified|7|||
46990004|NCT02193087|83236778|FG001|Overall Study|Other Reason Not Specified|2|||
46990005|NCT02193087|83236779|FG002|Overall Study|Other Reason Not Specified|1|||
46990006|NCT02193087|83236780|FG003|Overall Study|Other Reason Not Specified|9|||
46990007|NCT02193087|83236777|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
46990008|NCT02193087|83236778|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
46990009|NCT02193087|83236779|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
46990010|NCT02193087|83236780|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
46990011|NCT01617070|83236797|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
46990012|NCT02341417|83236810|FG000|Overall Study|Withdrawal by Subject|0|||
46990013|NCT02341417|83236811|FG001|Overall Study|Withdrawal by Subject|2|||
46990014|NCT02341417|83236812|FG002|Overall Study|Withdrawal by Subject|0|||
46990015|NCT02341417|83236810|FG000|Overall Study|Decision by sponsor|2|||
46990016|NCT02341417|83236811|FG001|Overall Study|Decision by sponsor|0|||
46990017|NCT02341417|83236812|FG002|Overall Study|Decision by sponsor|0|||
46990018|NCT02341417|83236810|FG000|Overall Study|Death|0|||
46990019|NCT02341417|83236811|FG001|Overall Study|Death|0|||
46990020|NCT02341417|83236812|FG002|Overall Study|Death|1|||
46990021|NCT01888900|83236823|FG000|Overall Study|failed treatment|0|||
46990022|NCT01888900|83236824|FG001|Overall Study|failed treatment|2|||
46990023|NCT02340949|83236834|FG000|Overall Study|Adverse Event|4|||
46990024|NCT02340949|83236835|FG001|Overall Study|Adverse Event|2|||
46990025|NCT02340949|83236834|FG000|Overall Study|Withdrawal by Subject|2|||
46990026|NCT02340949|83236835|FG001|Overall Study|Withdrawal by Subject|0|||
46990027|NCT02340949|83236834|FG000|Overall Study|Progression disease|6|||
46990028|NCT02340949|83236835|FG001|Overall Study|Progression disease|2|||
46990029|NCT02340949|83236834|FG000|Overall Study|Death|3|||
46990030|NCT02340949|83236835|FG001|Overall Study|Death|0|||
46990031|NCT02340949|83236834|FG000|Overall Study|Physician Decision|1|||
46990032|NCT02340949|83236835|FG001|Overall Study|Physician Decision|0|||
46990033|NCT01646203|83236844|FG000|Overall Study|Adverse Event|2|||
46990034|NCT01646203|83236845|FG001|Overall Study|Adverse Event|0|||
46990035|NCT01646203|83236846|FG002|Overall Study|Adverse Event|1|||
46990036|NCT01646203|83236844|FG000|Overall Study|Withdrawal by Subject|0|||
46990037|NCT01646203|83236845|FG001|Overall Study|Withdrawal by Subject|1|||
46990038|NCT01646203|83236846|FG002|Overall Study|Withdrawal by Subject|0|||
46990039|NCT01646203|83236844|FG000|Overall Study|Physician's Decision|0|||
46990040|NCT01646203|83236845|FG001|Overall Study|Physician's Decision|1|||
46990041|NCT01646203|83236846|FG002|Overall Study|Physician's Decision|0|||
46990042|NCT02375347|83236859|FG000|Overall Study|Protocol Violation|1|||
46990043|NCT02374957|83236865|FG000|Overall Study|Patient did not complete forms correctly|1|||
46990044|NCT02374957|83236866|FG001|Overall Study|Patient did not complete forms correctly|0|||
46990045|NCT02374255|83236876|FG000|Overall Study|Withdrawal by Subject|2|||
46990046|NCT02374255|83236877|FG001|Overall Study|Withdrawal by Subject|0|||
46990047|NCT02374255|83236878|FG002|Overall Study|Withdrawal by Subject|0|||
46990048|NCT02374255|83236879|FG003|Overall Study|Withdrawal by Subject|0|||
46990049|NCT02308033|83236897|FG000|Overall Study|Normal Gram stain at Baseline|13|||
46990050|NCT02308033|83236898|FG001|Overall Study|Normal Gram stain at Baseline|10|||
46990051|NCT02308033|83236897|FG000|Overall Study|Positive for STD at Baseline|7|||
46990052|NCT02308033|83236898|FG001|Overall Study|Positive for STD at Baseline|4|||
46990053|NCT02308033|83236897|FG000|Overall Study|Lost to Follow-up|6|||
46990054|NCT02308033|83236898|FG001|Overall Study|Lost to Follow-up|5|||
46990055|NCT02211261|83236915|FG000|Overall Study|Withdrawal by Subject|0|||
46990056|NCT02211261|83236916|FG001|Overall Study|Withdrawal by Subject|0|||
46990057|NCT02211261|83236917|FG002|Overall Study|Withdrawal by Subject|1|||
46990058|NCT02211261|83236918|FG003|Overall Study|Withdrawal by Subject|0|||
46990059|NCT02211261|83236919|FG004|Overall Study|Withdrawal by Subject|2|||
46990060|NCT02211261|83236920|FG005|Overall Study|Withdrawal by Subject|0|||
46990061|NCT02211261|83236921|FG006|Overall Study|Withdrawal by Subject|0|||
46990062|NCT02211261|83236922|FG007|Overall Study|Withdrawal by Subject|0|||
46990063|NCT02211261|83236923|FG008|Overall Study|Withdrawal by Subject|0|||
46990064|NCT02211261|83236924|FG009|Overall Study|Withdrawal by Subject|0|||
46990065|NCT02211261|83236925|FG010|Overall Study|Withdrawal by Subject|0|||
46990066|NCT02211261|83236915|FG000|Overall Study|Other|0|||
46990067|NCT02211261|83236916|FG001|Overall Study|Other|0|||
46990068|NCT02211261|83236917|FG002|Overall Study|Other|0|||
46990069|NCT02211261|83236918|FG003|Overall Study|Other|0|||
46990070|NCT02211261|83236919|FG004|Overall Study|Other|0|||
46990071|NCT02211261|83236920|FG005|Overall Study|Other|1|||
46990072|NCT02211261|83236921|FG006|Overall Study|Other|0|||
46990073|NCT02211261|83236922|FG007|Overall Study|Other|0|||
46990074|NCT02211261|83236923|FG008|Overall Study|Other|0|||
46990075|NCT02211261|83236924|FG009|Overall Study|Other|2|||
46990076|NCT02211261|83236925|FG010|Overall Study|Other|0|||
46990077|NCT02211261|83236915|FG000|Overall Study|Lost to Follow-up|0|||
46990078|NCT02211261|83236916|FG001|Overall Study|Lost to Follow-up|0|||
46990079|NCT02211261|83236917|FG002|Overall Study|Lost to Follow-up|0|||
46990080|NCT02211261|83236918|FG003|Overall Study|Lost to Follow-up|0|||
46990081|NCT02211261|83236919|FG004|Overall Study|Lost to Follow-up|0|||
46881923|NCT03285178|83103124|FG001|Single-Blind Run-In Period|Physician Decision|0|||
46990082|NCT02211261|83236920|FG005|Overall Study|Lost to Follow-up|0|||
46990083|NCT02211261|83236921|FG006|Overall Study|Lost to Follow-up|0|||
46990084|NCT02211261|83236922|FG007|Overall Study|Lost to Follow-up|1|||
46990085|NCT02211261|83236923|FG008|Overall Study|Lost to Follow-up|0|||
46990086|NCT02211261|83236924|FG009|Overall Study|Lost to Follow-up|0|||
46990087|NCT02211261|83236925|FG010|Overall Study|Lost to Follow-up|0|||
46990088|NCT02170077|83236961|FG000|Overall Study|Withdrawal by Subject|3|||
46990089|NCT02170077|83236962|FG001|Overall Study|Withdrawal by Subject|4|||
46990090|NCT02170077|83236963|FG002|Overall Study|Withdrawal by Subject|2|||
46990091|NCT02170077|83236961|FG000|Overall Study|Adverse Event|4|||
46990092|NCT02170077|83236962|FG001|Overall Study|Adverse Event|4|||
46990093|NCT02170077|83236963|FG002|Overall Study|Adverse Event|4|||
46990094|NCT02170077|83236961|FG000|Overall Study|Lost to Follow-up|0|||
46990095|NCT02170077|83236962|FG001|Overall Study|Lost to Follow-up|1|||
46990096|NCT02170077|83236963|FG002|Overall Study|Lost to Follow-up|0|||
46990097|NCT02170077|83236961|FG000|Overall Study|Exclusion criteria|2|||
46990098|NCT02170077|83236962|FG001|Overall Study|Exclusion criteria|2|||
46990099|NCT02170077|83236963|FG002|Overall Study|Exclusion criteria|5|||
46990100|NCT02170077|83236961|FG000|Overall Study|Exacerbation of seizures|0|||
46990101|NCT02170077|83236962|FG001|Overall Study|Exacerbation of seizures|2|||
46990102|NCT02170077|83236963|FG002|Overall Study|Exacerbation of seizures|1|||
46990103|NCT02210091|83236973|FG000|Overall Study|Physician Decision|0|||
46990104|NCT02210091|83236974|FG001|Overall Study|Physician Decision|1|||
46990105|NCT02210091|83236973|FG000|Overall Study|Withdrawal by Sponsor|0|||
46990106|NCT02210091|83236974|FG001|Overall Study|Withdrawal by Sponsor|1|||
46990107|NCT02338999|83236998|FG000|First Intervention|Withdrawal by Subject|3|||
46990108|NCT02338999|83236999|FG001|First Intervention|Withdrawal by Subject|1|||
46990109|NCT02338999|83236998|FG000|Washout Period|Withdrawal by Subject|0|||
46990110|NCT02338999|83236999|FG001|Washout Period|Withdrawal by Subject|2|||
46990111|NCT02338999|83236998|FG000|Second Intervention|Withdrawal by Subject|0|||
46990112|NCT02338999|83236999|FG001|Second Intervention|Withdrawal by Subject|2|||
46990113|NCT02169219|83237005|FG000|Overall Study|Lack of Efficacy|6|||
46990114|NCT02191605|83237019|FG000|Overall Study|Lost to Follow-up|9|||
46990115|NCT02191605|83237020|FG001|Overall Study|Lost to Follow-up|4|||
46990116|NCT02191605|83237021|FG002|Overall Study|Lost to Follow-up|7|||
46990117|NCT02191605|83237022|FG003|Overall Study|Lost to Follow-up|3|||
46990118|NCT02191605|83237023|FG004|Overall Study|Lost to Follow-up|4|||
46990119|NCT02191137|83237035|FG000|Treatment|Death|4|||
46990120|NCT02191137|83237035|FG000|Treatment|Withdrawal by Subject|3|||
46990121|NCT02191137|83237035|FG000|Treatment|Adverse Event|2|||
46990122|NCT02191137|83237035|FG000|Treatment|Other|1|||
46990123|NCT02191137|83237035|FG000|Follow-up|Lost to Follow-up|2|||
46990124|NCT02191137|83237035|FG000|Follow-up|Ongoing/unknown|2|||
46990125|NCT02191137|83237035|FG000|Follow-up|Adverse Event|1|||
46990126|NCT02168439|83237041|FG000|Overall Study|Protocol Violation|0|||
46990127|NCT02168439|83237042|FG001|Overall Study|Protocol Violation|2|||
46990128|NCT02190591|83237050|FG000|Overall Study|Withdrawal by Subject|1|||
46990129|NCT02190591|83237051|FG001|Overall Study|Withdrawal by Subject|8|||
46990130|NCT02190591|83237050|FG000|Overall Study|Protocol Violation|1|||
46990131|NCT02190591|83237051|FG001|Overall Study|Protocol Violation|0|||
46990132|NCT02190591|83237050|FG000|Overall Study|did not use peanut ball as instructed|0|||
46990133|NCT02190591|83237051|FG001|Overall Study|did not use peanut ball as instructed|2|||
46990134|NCT02190591|83237050|FG000|Overall Study|face presentation so she was ineligible|0|||
46990135|NCT02190591|83237051|FG001|Overall Study|face presentation so she was ineligible|1|||
46990136|NCT02190435|83237059|FG000|Overall Study|First 12 patients were lead-ins|12|||
46990137|NCT02190435|83237060|FG001|Overall Study|First 12 patients were lead-ins|0|||
46990138|NCT02190435|83237059|FG000|Overall Study|3 consented screen fails|3|||
46990139|NCT02190435|83237060|FG001|Overall Study|3 consented screen fails|0|||
46990140|NCT02338843|83237068|FG000|Overall Study|Adverse Event|2|||
46881924|NCT03285178|83103125|FG002|Single-Blind Run-In Period|Physician Decision|0|||
46881925|NCT03285178|83103126|FG003|Single-Blind Run-In Period|Physician Decision|0|||
46881926|NCT03285178|83103127|FG004|Single-Blind Run-In Period|Physician Decision|0|||
46990141|NCT02338843|83237069|FG001|Overall Study|Adverse Event|1|||
46990142|NCT02338843|83237068|FG000|Overall Study|Death|40|||
46990143|NCT02338843|83237069|FG001|Overall Study|Death|53|||
46990144|NCT02338843|83237068|FG000|Overall Study|Physician Decision|1|||
46990145|NCT02338843|83237069|FG001|Overall Study|Physician Decision|0|||
46990146|NCT02338843|83237068|FG000|Overall Study|Withdrawal by Subject|0|||
46990147|NCT02338843|83237069|FG001|Overall Study|Withdrawal by Subject|2|||
46990148|NCT02338843|83237068|FG000|Overall Study|Subject Recovered|0|||
46990149|NCT02338843|83237069|FG001|Overall Study|Subject Recovered|2|||
46990150|NCT02338843|83237068|FG000|Overall Study|Discontinued prior to randomizat|1|||
46990151|NCT02338843|83237069|FG001|Overall Study|Discontinued prior to randomizat|0|||
46990152|NCT02190279|83237078|FG000|Overall Study|Withdrawal consent|1|||
46990153|NCT02190279|83237079|FG001|Overall Study|Withdrawal consent|0|||
46990154|NCT02190279|83237080|FG002|Overall Study|Withdrawal consent|1|||
46990155|NCT02190279|83237078|FG000|Overall Study|Lost to Follow-up|2|||
46990156|NCT02190279|83237079|FG001|Overall Study|Lost to Follow-up|0|||
46990157|NCT02190279|83237080|FG002|Overall Study|Lost to Follow-up|0|||
46990158|NCT02190279|83237078|FG000|Overall Study|Refused further treatment|0|||
46990159|NCT02190279|83237079|FG001|Overall Study|Refused further treatment|0|||
46990160|NCT02190279|83237080|FG002|Overall Study|Refused further treatment|1|||
46990161|NCT02190279|83237078|FG000|Overall Study|Screening failure|0|||
46990162|NCT02190279|83237079|FG001|Overall Study|Screening failure|0|||
46990163|NCT02190279|83237080|FG002|Overall Study|Screening failure|1|||
46990164|NCT02135445|83237092|FG000|Overall Study|Lost to Follow-up|1|||
46990165|NCT02135445|83237093|FG001|Overall Study|Lost to Follow-up|0|||
46990166|NCT02135445|83237092|FG000|Overall Study|Withdrawal by Subject|1|||
46990167|NCT02135445|83237093|FG001|Overall Study|Withdrawal by Subject|0|||
46990168|NCT02374099|83237101|FG000|Overall Study|Adverse Event|1|||
46990169|NCT02374099|83237102|FG001|Overall Study|Adverse Event|0|||
46990170|NCT02374099|83237101|FG000|Overall Study|Progressive Disease|35|||
46990171|NCT02374099|83237102|FG001|Overall Study|Progressive Disease|40|||
46990172|NCT02374099|83237101|FG000|Overall Study|Withdrawal by Subject|5|||
46990173|NCT02374099|83237102|FG001|Overall Study|Withdrawal by Subject|1|||
46990174|NCT02374099|83237101|FG000|Overall Study|Miscellaneous|2|||
46990175|NCT02374099|83237102|FG001|Overall Study|Miscellaneous|3|||
46990176|NCT02374099|83237101|FG000|Overall Study|Randomized, but not treated|2|||
46990177|NCT02374099|83237102|FG001|Overall Study|Randomized, but not treated|1|||
46990178|NCT02374099|83237101|FG000|Overall Study|Study Terminated by Sponsor|3|||
46990179|NCT02374099|83237102|FG001|Overall Study|Study Terminated by Sponsor|4|||
46990180|NCT02134977|83237108|FG000|Overall Study|Protocol Deviation|102|||
46990181|NCT02374021|83237114|FG000|Overall Study|Adverse Event|1|||
46990182|NCT02374021|83237115|FG001|Overall Study|Adverse Event|0|||
46990183|NCT02374021|83237114|FG000|Overall Study|Lost to Follow-up|3|||
46990184|NCT02374021|83237115|FG001|Overall Study|Lost to Follow-up|2|||
46990185|NCT02374021|83237114|FG000|Overall Study|Physician Decision|0|||
46990186|NCT02374021|83237115|FG001|Overall Study|Physician Decision|3|||
46990187|NCT02374021|83237114|FG000|Overall Study|Withdrawal by Subject|6|||
46990188|NCT02374021|83237115|FG001|Overall Study|Withdrawal by Subject|5|||
46990189|NCT02374021|83237114|FG000|Overall Study|Poor Adherence|0|||
46990190|NCT02374021|83237115|FG001|Overall Study|Poor Adherence|1|||
46990191|NCT02374021|83237114|FG000|Overall Study|Scan protocol not followed|0|||
46990192|NCT02374021|83237115|FG001|Overall Study|Scan protocol not followed|1|||
46990193|NCT02374021|83237114|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
46990194|NCT02374021|83237115|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
46990195|NCT02372383|83237123|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
46990196|NCT02372383|83237124|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
46990197|NCT02372383|83237125|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
46990198|NCT01648699|83237135|FG000|Overall Study|Death|1|||
46990199|NCT01648699|83237135|FG000|Overall Study|Lost to Follow-up|2|||
46990200|NCT01648699|83237135|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
46990201|NCT02134353|83237150|FG000|Overall Study|Adverse Event|10|||
46990202|NCT02134353|83237151|FG001|Overall Study|Adverse Event|6|||
46990203|NCT02134353|83237150|FG000|Overall Study|Lost to Follow-up|1|||
46990204|NCT02134353|83237151|FG001|Overall Study|Lost to Follow-up|1|||
46990205|NCT02134353|83237150|FG000|Overall Study|Lack of Efficacy|2|||
46990206|NCT02134353|83237151|FG001|Overall Study|Lack of Efficacy|1|||
46990207|NCT02134353|83237150|FG000|Overall Study|Withdrawal by Subject|12|||
46990208|NCT02134353|83237151|FG001|Overall Study|Withdrawal by Subject|13|||
46990209|NCT02134353|83237150|FG000|Overall Study|Death|0|||
46990210|NCT02134353|83237151|FG001|Overall Study|Death|1|||
46990211|NCT02134353|83237150|FG000|Overall Study|Pregnancy|0|||
46990212|NCT02134353|83237151|FG001|Overall Study|Pregnancy|1|||
46990213|NCT02134353|83237150|FG000|Overall Study|Relocation|1|||
46990214|NCT02134353|83237151|FG001|Overall Study|Relocation|0|||
46990215|NCT02134353|83237150|FG000|Overall Study|Other - Patient's Choice|0|||
46704564|NCT01227902|82919457|FG001|Overall Study|Protocol Violation|0|||
46704565|NCT01227902|82919458|FG002|Overall Study|Protocol Violation|0|||
46704566|NCT01227902|82919459|FG003|Overall Study|Protocol Violation|0|||
46897184|NCT03163446|83122796|FG000|Overall Study|Physician Decision|1|||
46704567|NCT01227902|82919456|FG000|Overall Study|Lost to Follow-up|0|||
46704568|NCT01227902|82919457|FG001|Overall Study|Lost to Follow-up|0|||
46897185|NCT03163446|83122797|FG001|Overall Study|Physician Decision|1|||
46897186|NCT03163446|83122796|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
46897187|NCT03163446|83122797|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
46897188|NCT03722485|83122811|FG000|Overall Study|Withdrawal by Subject|1|||
46897189|NCT03722485|83122812|FG001|Overall Study|Withdrawal by Subject|0|||
46897190|NCT03722485|83122811|FG000|Overall Study|Adverse Event|0|||
46897191|NCT03722485|83122812|FG001|Overall Study|Adverse Event|2|||
46897192|NCT03722485|83122811|FG000|Overall Study|subject discharged prior to study completion|1|||
46897193|NCT03722485|83122812|FG001|Overall Study|subject discharged prior to study completion|5|||
46897194|NCT03722485|83122811|FG000|Overall Study|eligibility criteria not met|2|||
46990216|NCT02134353|83237151|FG001|Overall Study|Other - Patient's Choice|1|||
46990217|NCT01646125|83237159|FG000|Overall Study|Untreated|2|||
46990218|NCT01646125|83237160|FG001|Overall Study|Untreated|5|||
46990219|NCT01646125|83237159|FG000|Overall Study|Adverse Event|2|||
46990220|NCT01646125|83237160|FG001|Overall Study|Adverse Event|1|||
46990221|NCT01646125|83237159|FG000|Overall Study|Death|1|||
46990222|NCT01646125|83237160|FG001|Overall Study|Death|1|||
46990223|NCT01646125|83237159|FG000|Overall Study|Physician Decision|1|||
46990224|NCT01646125|83237160|FG001|Overall Study|Physician Decision|3|||
46990225|NCT01646125|83237159|FG000|Overall Study|Progressive disease|22|||
46990226|NCT01646125|83237160|FG001|Overall Study|Progressive disease|16|||
46990227|NCT01646125|83237159|FG000|Overall Study|Study terminated by sponsor|2|||
46990228|NCT01646125|83237160|FG001|Overall Study|Study terminated by sponsor|1|||
46990229|NCT01646125|83237159|FG000|Overall Study|Subject/Guardian decision|1|||
46990230|NCT01646125|83237160|FG001|Overall Study|Subject/Guardian decision|1|||
46990231|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
46990232|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
46990233|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
46990234|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
46990235|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
46990236|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
46990237|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
46990238|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
46990239|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
46990240|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
46990241|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
46990242|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
46990243|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
46990244|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
46990245|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
46990246|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
46990247|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
46990248|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
46990249|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
46990250|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
46990251|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
46990252|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
46990253|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
46990254|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
46990255|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
46990256|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
46990257|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
46990258|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
46990259|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
46990260|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
46990261|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
46990262|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
46990263|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
46990264|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
46990265|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
46990266|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
46990267|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
46990268|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
46990269|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
46990270|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
46990271|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
46990272|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
46990273|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
46990274|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
46990275|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
46990276|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
46990277|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
46990278|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
46704569|NCT01227902|82919458|FG002|Overall Study|Lost to Follow-up|1|||
46704570|NCT01227902|82919459|FG003|Overall Study|Lost to Follow-up|2|||
46704571|NCT01227902|82919456|FG000|Overall Study|Physician Decision|0|||
46990279|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
46990280|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
46990281|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
46990282|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
46990283|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
46990284|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
46990285|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
46990286|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
46990287|NCT01362790|83237173|FG000|Pilot Phase & Phase 2|Death on study|0|||
46990288|NCT01362790|83237174|FG001|Pilot Phase & Phase 2|Death on study|0|||
46990289|NCT01362790|83237175|FG002|Pilot Phase & Phase 2|Death on study|0|||
46990290|NCT01362790|83237176|FG003|Pilot Phase & Phase 2|Death on study|1|||
46990291|NCT01362790|83237177|FG004|Pilot Phase & Phase 2|Death on study|0|||
46990292|NCT01362790|83237178|FG005|Pilot Phase & Phase 2|Death on study|0|||
46990293|NCT01362790|83237179|FG006|Pilot Phase & Phase 2|Death on study|0|||
46990294|NCT01362790|83237173|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
46990295|NCT01362790|83237174|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
46990296|NCT01362790|83237175|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
46990297|NCT01362790|83237176|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
46990298|NCT01362790|83237177|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
46990299|NCT01362790|83237178|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
46990300|NCT01362790|83237179|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
46990301|NCT01362790|83237173|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
46990302|NCT01362790|83237174|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
46990303|NCT01362790|83237175|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
46990304|NCT01362790|83237176|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
46990305|NCT01362790|83237177|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
46990306|NCT01362790|83237178|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
46990307|NCT01362790|83237179|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
46990308|NCT01362790|83237173|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
46990309|NCT01362790|83237174|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
46990310|NCT01362790|83237175|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
46990311|NCT01362790|83237176|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
46990312|NCT01362790|83237177|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
46990313|NCT01362790|83237178|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
46990314|NCT01362790|83237179|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
46990315|NCT02167893|83237199|FG000|Overall Study|Investigator transferred|85|||
46990316|NCT02167893|83237199|FG000|Overall Study|Investigator health reasons|10|||
46990317|NCT02167893|83237199|FG000|Overall Study|Case report forms not collected|68|||
46990318|NCT02167035|83237205|FG000|Overall Study|Adverse Event|2|||
46990319|NCT02167035|83237206|FG001|Overall Study|Adverse Event|2|||
46990320|NCT02167035|83237205|FG000|Overall Study|Lost to Follow-up|3|||
46990321|NCT02167035|83237206|FG001|Overall Study|Lost to Follow-up|3|||
46990322|NCT02167035|83237205|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
46990323|NCT02167035|83237206|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
46990324|NCT01615198|83237216|FG000|Overall Study|Withdrawal by Subject|5|||
46990325|NCT01615198|83237217|FG001|Overall Study|Withdrawal by Subject|5|||
46990326|NCT01615198|83237216|FG000|Overall Study|Protocol deviation|1|||
46990327|NCT01615198|83237217|FG001|Overall Study|Protocol deviation|1|||
46990328|NCT01615198|83237216|FG000|Overall Study|Physician Decision|5|||
46990329|NCT01615198|83237217|FG001|Overall Study|Physician Decision|1|||
46990330|NCT01615198|83237216|FG000|Overall Study|Lost to Follow-up|1|||
46990331|NCT01615198|83237217|FG001|Overall Study|Lost to Follow-up|1|||
46990332|NCT01615198|83237216|FG000|Overall Study|Lack of Efficacy|1|||
46990333|NCT01615198|83237217|FG001|Overall Study|Lack of Efficacy|6|||
46990334|NCT01615198|83237216|FG000|Overall Study|Adverse Event|11|||
46990335|NCT01615198|83237217|FG001|Overall Study|Adverse Event|5|||
46990336|NCT02337907|83237229|FG000|Overall Study|Other than listed|1|||
46990337|NCT02337907|83237230|FG001|Overall Study|Other than listed|0|||
46990338|NCT02337907|83237231|FG002|Overall Study|Other than listed|0|||
46990339|NCT02337907|83237232|FG003|Overall Study|Other than listed|1|||
46990340|NCT02337907|83237233|FG004|Overall Study|Other than listed|1|||
46990341|NCT02337907|83237234|FG005|Overall Study|Other than listed|0|||
46990342|NCT02337907|83237229|FG000|Overall Study|Withdrawal by Subject|2|||
46990343|NCT02337907|83237230|FG001|Overall Study|Withdrawal by Subject|3|||
46990344|NCT02337907|83237231|FG002|Overall Study|Withdrawal by Subject|0|||
46990345|NCT02337907|83237232|FG003|Overall Study|Withdrawal by Subject|2|||
46990346|NCT02337907|83237233|FG004|Overall Study|Withdrawal by Subject|5|||
46990347|NCT02337907|83237234|FG005|Overall Study|Withdrawal by Subject|0|||
46990348|NCT02337907|83237229|FG000|Overall Study|Lost to Follow-up|0|||
46990349|NCT02337907|83237230|FG001|Overall Study|Lost to Follow-up|0|||
46990350|NCT02337907|83237231|FG002|Overall Study|Lost to Follow-up|0|||
46990351|NCT02337907|83237232|FG003|Overall Study|Lost to Follow-up|0|||
46990352|NCT02337907|83237233|FG004|Overall Study|Lost to Follow-up|0|||
46990353|NCT02337907|83237234|FG005|Overall Study|Lost to Follow-up|1|||
46990354|NCT02337907|83237229|FG000|Overall Study|Adverse Event|1|||
46990355|NCT02337907|83237230|FG001|Overall Study|Adverse Event|1|||
46990356|NCT02337907|83237231|FG002|Overall Study|Adverse Event|1|||
46990357|NCT02337907|83237232|FG003|Overall Study|Adverse Event|1|||
46990358|NCT02337907|83237233|FG004|Overall Study|Adverse Event|4|||
46990359|NCT02337907|83237234|FG005|Overall Study|Adverse Event|0|||
46990360|NCT01913470|83237251|FG000|Overall Study|Lost to Follow-up|0|||
46990361|NCT01913470|83237252|FG001|Overall Study|Lost to Follow-up|1|||
46990362|NCT01913470|83237251|FG000|Overall Study|Physician Decision|0|||
46990363|NCT01913470|83237252|FG001|Overall Study|Physician Decision|1|||
46990364|NCT01913470|83237251|FG000|Overall Study|Withdrawal by Subject|0|||
46990365|NCT01913470|83237252|FG001|Overall Study|Withdrawal by Subject|1|||
46990366|NCT02372071|83237259|FG000|Overall Study|Protocol Violation|18|||
46990367|NCT02337751|83237266|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
46990368|NCT02337751|83237267|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
46881927|NCT03285178|83103128|FG005|Single-Blind Run-In Period|Physician Decision|0|||
46881928|NCT03285178|83103129|FG006|Single-Blind Run-In Period|Physician Decision|0|||
46881929|NCT03285178|83103123|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
46881930|NCT03285178|83103124|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
46990369|NCT02337751|83237266|FG000|Overall Study|Voluntary Withdrawal|6|||
46990370|NCT02337751|83237267|FG001|Overall Study|Voluntary Withdrawal|8|||
46990371|NCT02337751|83237266|FG000|Overall Study|Lack of Efficacy|2|||
46990372|NCT02337751|83237267|FG001|Overall Study|Lack of Efficacy|5|||
46990373|NCT02337751|83237266|FG000|Overall Study|Investigator's Judgement|1|||
46990374|NCT02337751|83237267|FG001|Overall Study|Investigator's Judgement|0|||
46990375|NCT02166333|83237278|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
46990376|NCT02166333|83237279|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
46990377|NCT02166333|83237280|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
46990378|NCT02166333|83237281|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
46990379|NCT02166333|83237282|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
46990380|NCT02166333|83237283|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
46990381|NCT02166333|83237278|FG000|Stage 1|Death|4|||
46990382|NCT02166333|83237279|FG001|Stage 1|Death|0|||
46990383|NCT02166333|83237280|FG002|Stage 1|Death|2|||
46990384|NCT02166333|83237281|FG003|Stage 1|Death|0|||
46990385|NCT02166333|83237282|FG004|Stage 1|Death|3|||
46990386|NCT02166333|83237283|FG005|Stage 1|Death|2|||
46990387|NCT02166333|83237278|FG000|Stage 1|Lost to Follow-up|12|||
46990388|NCT02166333|83237279|FG001|Stage 1|Lost to Follow-up|0|||
46990389|NCT02166333|83237280|FG002|Stage 1|Lost to Follow-up|6|||
46990390|NCT02166333|83237281|FG003|Stage 1|Lost to Follow-up|0|||
46990391|NCT02166333|83237282|FG004|Stage 1|Lost to Follow-up|3|||
46990392|NCT02166333|83237283|FG005|Stage 1|Lost to Follow-up|3|||
46990393|NCT02166333|83237278|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
46990394|NCT02166333|83237279|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
46990395|NCT02166333|83237280|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
46990396|NCT02166333|83237281|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
46990397|NCT02166333|83237282|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
46990398|NCT02166333|83237283|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
46990399|NCT02166333|83237278|FG000|Stage 2|Death|4|||
46990400|NCT02166333|83237279|FG001|Stage 2|Death|2|||
46990401|NCT02166333|83237280|FG002|Stage 2|Death|1|||
46990402|NCT02166333|83237281|FG003|Stage 2|Death|0|||
46990403|NCT02166333|83237282|FG004|Stage 2|Death|0|||
46990404|NCT02166333|83237283|FG005|Stage 2|Death|1|||
46990405|NCT02166333|83237278|FG000|Stage 2|Lost to Follow-up|23|||
46990406|NCT02166333|83237279|FG001|Stage 2|Lost to Follow-up|4|||
46990407|NCT02166333|83237280|FG002|Stage 2|Lost to Follow-up|11|||
46990408|NCT02166333|83237281|FG003|Stage 2|Lost to Follow-up|9|||
46881931|NCT03285178|83103125|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
46881932|NCT03285178|83103126|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
46881933|NCT03285178|83103127|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
46881934|NCT03285178|83103128|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
46881935|NCT03285178|83103129|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
46881936|NCT03285178|83103123|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46881937|NCT03285178|83103124|FG001|Double-Blind Treatment Period|Adverse Event|0|||
46881938|NCT03285178|83103125|FG002|Double-Blind Treatment Period|Adverse Event|0|||
46990409|NCT02166333|83237282|FG004|Stage 2|Lost to Follow-up|3|||
46990410|NCT02166333|83237283|FG005|Stage 2|Lost to Follow-up|6|||
46990411|NCT02132949|83237297|FG000|Overall Study|Death|7|||
46990412|NCT02132949|83237298|FG001|Overall Study|Death|13|||
46990413|NCT02132949|83237297|FG000|Overall Study|Lost to Follow-up|14|||
46990414|NCT02132949|83237298|FG001|Overall Study|Lost to Follow-up|4|||
46990415|NCT02132949|83237297|FG000|Overall Study|Withdrawal by Subject|6|||
46990416|NCT02132949|83237298|FG001|Overall Study|Withdrawal by Subject|5|||
46990417|NCT02132949|83237297|FG000|Overall Study|Noncompliance|5|||
46990418|NCT02132949|83237298|FG001|Overall Study|Noncompliance|1|||
46990419|NCT02132949|83237297|FG000|Overall Study|Physician Decision|3|||
46990420|NCT02132949|83237298|FG001|Overall Study|Physician Decision|1|||
46990421|NCT02132949|83237297|FG000|Overall Study|Disease Progression|3|||
46990422|NCT02132949|83237298|FG001|Overall Study|Disease Progression|0|||
46990423|NCT02132949|83237297|FG000|Overall Study|Adverse Event|2|||
46990424|NCT02132949|83237298|FG001|Overall Study|Adverse Event|1|||
46990425|NCT02132949|83237297|FG000|Overall Study|Withdrew Prior to Treatment|1|||
46990426|NCT02132949|83237298|FG001|Overall Study|Withdrew Prior to Treatment|2|||
46990427|NCT02132949|83237297|FG000|Overall Study|Reason Unspecified|0|||
46990428|NCT02132949|83237298|FG001|Overall Study|Reason Unspecified|1|||
46990429|NCT02165397|83237307|FG000|Overall Study|Death|7|||
46990430|NCT02165397|83237308|FG001|Overall Study|Death|10|||
46990431|NCT02165397|83237309|FG002|Overall Study|Death|8|||
46990432|NCT02165397|83237307|FG000|Overall Study|Lost to Follow-up|1|||
46990433|NCT02165397|83237308|FG001|Overall Study|Lost to Follow-up|3|||
46990434|NCT02165397|83237309|FG002|Overall Study|Lost to Follow-up|0|||
46990435|NCT02165397|83237307|FG000|Overall Study|Withdrawal by Subject|6|||
46990436|NCT02165397|83237308|FG001|Overall Study|Withdrawal by Subject|6|||
46990437|NCT02165397|83237309|FG002|Overall Study|Withdrawal by Subject|1|||
46990438|NCT02165397|83237307|FG000|Overall Study|Other, Not Specified|0|||
46990439|NCT02165397|83237308|FG001|Overall Study|Other, Not Specified|0|||
46990440|NCT02165397|83237309|FG002|Overall Study|Other, Not Specified|1|||
46990441|NCT02132637|83237321|FG000|Study Period 1|Withdrawal by Subject|0|||
46990442|NCT02132637|83237322|FG001|Study Period 1|Withdrawal by Subject|4|||
46990443|NCT02132637|83237321|FG000|Study Period 1|Physician Decision|1|||
46990444|NCT02132637|83237322|FG001|Study Period 1|Physician Decision|0|||
46990445|NCT02132637|83237321|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
46990446|NCT02132637|83237322|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
46990447|NCT02132637|83237321|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
46990448|NCT02132637|83237322|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
46990449|NCT02164929|83237332|FG000|Overall Study|Converted to open procedure|1|||
46990450|NCT02164929|83237333|FG001|Overall Study|Converted to open procedure|0|||
46990451|NCT02164929|83237334|FG002|Overall Study|Converted to open procedure|0|||
46990452|NCT02164929|83237335|FG003|Overall Study|Converted to open procedure|2|||
46990453|NCT02164929|83237332|FG000|Overall Study|Failed regional block|0|||
46990454|NCT02164929|83237333|FG001|Overall Study|Failed regional block|0|||
46990455|NCT02164929|83237334|FG002|Overall Study|Failed regional block|1|||
46990456|NCT02164929|83237335|FG003|Overall Study|Failed regional block|0|||
46990457|NCT01888432|83237347|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
46990458|NCT01888432|83237348|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
46990459|NCT01888432|83237347|FG000|12-month Analysis (FAS)|Physician Decision|1|||
46990460|NCT01888432|83237348|FG001|12-month Analysis (FAS)|Physician Decision|1|||
46990461|NCT01888432|83237347|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
46990462|NCT01888432|83237348|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
46990463|NCT01888432|83237347|FG000|12-month Analysis (FAS)|Death|4|||
46990464|NCT01888432|83237348|FG001|12-month Analysis (FAS)|Death|3|||
46990465|NCT01888432|83237347|FG000|24-month Analysis (FAS)|Graft loss|0|||
46990466|NCT01888432|83237348|FG001|24-month Analysis (FAS)|Graft loss|1|||
46990467|NCT01888432|83237347|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
46990468|NCT01888432|83237348|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
46990469|NCT01888432|83237347|FG000|24-month Analysis (FAS)|Physician Decision|2|||
46990470|NCT01888432|83237348|FG001|24-month Analysis (FAS)|Physician Decision|4|||
46990471|NCT01888432|83237347|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
46990472|NCT01888432|83237348|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
46990473|NCT01888432|83237347|FG000|24-month Analysis (FAS)|Death|8|||
46990474|NCT01888432|83237348|FG001|24-month Analysis (FAS)|Death|4|||
46990475|NCT01888432|83237347|FG000|36-month Analysis (Extension)|Death|1|||
46990476|NCT01888432|83237348|FG001|36-month Analysis (Extension)|Death|0|||
46990477|NCT02188719|83237360|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
46990478|NCT02188719|83237361|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
46990479|NCT02188719|83237362|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
46990480|NCT02188719|83237363|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
46990481|NCT01934140|83237373|FG000|Persistence Phase (Year 6-10)|Other|24|||
46990482|NCT01934140|83237374|FG001|Persistence Phase (Year 6-10)|Other|6|||
46990483|NCT01934140|83237373|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
46990484|NCT01934140|83237374|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
46990485|NCT01934140|83237373|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
46990486|NCT01934140|83237374|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
46990487|NCT01934140|83237373|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
46990488|NCT01934140|83237374|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
46990489|NCT01934140|83237373|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
46990490|NCT01934140|83237374|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
46990491|NCT01934140|83237373|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
46990492|NCT01934140|83237374|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
46990493|NCT01934140|83237373|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
46990494|NCT01934140|83237374|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
46990495|NCT01934140|83237373|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
46990496|NCT01934140|83237374|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
46990497|NCT01933672|83237382|FG000|Metformin Run-in Period|Adverse Event|1|||
46990498|NCT01933672|83237383|FG001|Metformin Run-in Period|Adverse Event|0|||
46990499|NCT01933672|83237384|FG002|Metformin Run-in Period|Adverse Event|0|||
46990500|NCT01933672|83237385|FG003|Metformin Run-in Period|Adverse Event|0|||
46990501|NCT01933672|83237386|FG004|Metformin Run-in Period|Adverse Event|0|||
46990502|NCT01933672|83237387|FG005|Metformin Run-in Period|Adverse Event|0|||
46990503|NCT01933672|83237388|FG006|Metformin Run-in Period|Adverse Event|0|||
46990504|NCT01933672|83237382|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
46990505|NCT01933672|83237383|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
46990506|NCT01933672|83237384|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
46990507|NCT01933672|83237385|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
46990508|NCT01933672|83237386|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
46990509|NCT01933672|83237387|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
46990510|NCT01933672|83237388|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
46990511|NCT01933672|83237382|FG000|Metformin Run-in Period|Other|5|||
46990512|NCT01933672|83237383|FG001|Metformin Run-in Period|Other|0|||
46990513|NCT01933672|83237384|FG002|Metformin Run-in Period|Other|0|||
46990514|NCT01933672|83237385|FG003|Metformin Run-in Period|Other|0|||
46990515|NCT01933672|83237386|FG004|Metformin Run-in Period|Other|0|||
46990516|NCT01933672|83237387|FG005|Metformin Run-in Period|Other|0|||
46990517|NCT01933672|83237388|FG006|Metformin Run-in Period|Other|0|||
46990518|NCT01933672|83237382|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990519|NCT01933672|83237383|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990520|NCT01933672|83237384|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990521|NCT01933672|83237385|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990522|NCT01933672|83237386|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
46990523|NCT01933672|83237387|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990524|NCT01933672|83237388|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990525|NCT01933672|83237382|FG000|First Intervention Period (12-16 Days)|Other|0|||
46990526|NCT01933672|83237383|FG001|First Intervention Period (12-16 Days)|Other|0|||
46990527|NCT01933672|83237384|FG002|First Intervention Period (12-16 Days)|Other|1|||
46990528|NCT01933672|83237385|FG003|First Intervention Period (12-16 Days)|Other|0|||
46990529|NCT01933672|83237386|FG004|First Intervention Period (12-16 Days)|Other|0|||
46990530|NCT01933672|83237387|FG005|First Intervention Period (12-16 Days)|Other|1|||
46990531|NCT01933672|83237388|FG006|First Intervention Period (12-16 Days)|Other|0|||
46990532|NCT01933672|83237382|FG000|Second Intervention Period (12-16 Days)|Other|0|||
46990533|NCT01933672|83237383|FG001|Second Intervention Period (12-16 Days)|Other|1|||
46990534|NCT01933672|83237384|FG002|Second Intervention Period (12-16 Days)|Other|1|||
46990535|NCT01933672|83237385|FG003|Second Intervention Period (12-16 Days)|Other|0|||
46990536|NCT01933672|83237386|FG004|Second Intervention Period (12-16 Days)|Other|0|||
46990537|NCT01933672|83237387|FG005|Second Intervention Period (12-16 Days)|Other|0|||
46990538|NCT01933672|83237388|FG006|Second Intervention Period (12-16 Days)|Other|0|||
46990539|NCT01933672|83237382|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990540|NCT01933672|83237383|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990541|NCT01933672|83237384|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990542|NCT01933672|83237385|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
46990543|NCT01933672|83237386|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990544|NCT01933672|83237387|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990545|NCT01933672|83237388|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
46990546|NCT01933672|83237382|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
46990547|NCT01933672|83237383|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
46990548|NCT01933672|83237384|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
46990549|NCT01933672|83237385|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
46990550|NCT01933672|83237386|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
46990551|NCT01933672|83237387|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
46990552|NCT01933672|83237388|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
46990553|NCT02164539|83237407|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
46990554|NCT02164539|83237408|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
46990555|NCT02164539|83237409|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
46990556|NCT02164539|83237410|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
46990557|NCT02164539|83237411|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
46990558|NCT02164539|83237412|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
46990559|NCT02164539|83237413|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
46990560|NCT02164539|83237407|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
46990561|NCT02164539|83237408|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
46990562|NCT02164539|83237409|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
46990563|NCT02164539|83237410|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
46990564|NCT02164539|83237411|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
46990565|NCT02164539|83237412|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
46990566|NCT02164539|83237413|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
46990567|NCT02164539|83237407|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
46990568|NCT02164539|83237408|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
46990569|NCT02164539|83237409|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
46990570|NCT02164539|83237410|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
46990571|NCT02164539|83237411|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
46990572|NCT02164539|83237412|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
46990573|NCT02164539|83237413|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
46990574|NCT02164539|83237407|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
46990575|NCT02164539|83237408|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
46990576|NCT02164539|83237409|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
46990577|NCT02164539|83237410|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
46990578|NCT02164539|83237411|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
46990579|NCT02164539|83237412|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
46990580|NCT02164539|83237413|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
46990581|NCT02164539|83237407|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
46990582|NCT02164539|83237408|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
46990583|NCT02164539|83237409|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
46990584|NCT02164539|83237410|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
46990585|NCT02164539|83237411|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
46990586|NCT02164539|83237412|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
46990587|NCT02164539|83237413|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
46990588|NCT02164539|83237407|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
46990589|NCT02164539|83237408|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
46990590|NCT02164539|83237409|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
46990591|NCT02164539|83237410|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
46990592|NCT02164539|83237411|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
46990593|NCT02164539|83237412|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
46990594|NCT02164539|83237413|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
46990595|NCT02188485|83237430|FG000|Overall Study|Withdrawal by Subject|2|||
46990596|NCT02188485|83237431|FG001|Overall Study|Withdrawal by Subject|1|||
46990597|NCT02188485|83237430|FG000|Overall Study|PI withdrew, lack of capacity|0|||
46990598|NCT02188485|83237431|FG001|Overall Study|PI withdrew, lack of capacity|2|||
46990599|NCT02132247|83237439|FG000|Overall Study|Protocol Violation|1|||
46990600|NCT02132247|83237440|FG001|Overall Study|Protocol Violation|0|||
46990601|NCT01629381|83237448|FG000|Overall Study|Withdrawal by Subject|2|||
46990602|NCT01629381|83237449|FG001|Overall Study|Withdrawal by Subject|5|||
46990603|NCT02131311|83237459|FG000|Overall Study|Adverse Event|2|||
46990604|NCT02131311|83237459|FG000|Overall Study|Protocol Violation|1|||
46990605|NCT02131311|83237459|FG000|Overall Study|Lost to Follow-up|1|||
46990606|NCT01628913|83237466|FG000|Overall Study|Adverse Event|12|||
46990607|NCT01628913|83237467|FG001|Overall Study|Adverse Event|5|||
46990608|NCT01628913|83237466|FG000|Overall Study|Disease Progression|11|||
46990609|NCT01628913|83237467|FG001|Overall Study|Disease Progression|14|||
46990610|NCT01628913|83237466|FG000|Overall Study|Protocol Violation|1|||
46990611|NCT01628913|83237467|FG001|Overall Study|Protocol Violation|0|||
46990612|NCT01628913|83237466|FG000|Overall Study|Death|1|||
46990613|NCT01628913|83237467|FG001|Overall Study|Death|0|||
46990614|NCT01628913|83237466|FG000|Overall Study|study terminated by Sponsor|4|||
46990615|NCT01628913|83237467|FG001|Overall Study|study terminated by Sponsor|9|||
46990616|NCT01628913|83237466|FG000|Overall Study|Withdrawal by Subject|1|||
46990617|NCT01628913|83237467|FG001|Overall Study|Withdrawal by Subject|0|||
46990618|NCT01628913|83237466|FG000|Overall Study|Physician Decision|1|||
46990619|NCT01628913|83237467|FG001|Overall Study|Physician Decision|3|||
46990620|NCT02164383|83237475|FG000|Overall Study|Lost to Follow-up|1|||
46990621|NCT02164383|83237476|FG001|Overall Study|Lost to Follow-up|0|||
46990622|NCT02131233|83237484|FG000|Overall Study|Not Treated|2|||
46990623|NCT02131233|83237485|FG001|Overall Study|Not Treated|3|||
46990624|NCT02131233|83237484|FG000|Overall Study|Adverse Event|7|||
46990625|NCT02131233|83237485|FG001|Overall Study|Adverse Event|6|||
46990626|NCT02131233|83237484|FG000|Overall Study|Death|0|||
46990627|NCT02131233|83237485|FG001|Overall Study|Death|1|||
46990628|NCT02131233|83237484|FG000|Overall Study|Lack of Efficacy|6|||
46990629|NCT02131233|83237485|FG001|Overall Study|Lack of Efficacy|3|||
46990630|NCT02131233|83237484|FG000|Overall Study|Lost to Follow-up|14|||
46990631|NCT02131233|83237485|FG001|Overall Study|Lost to Follow-up|13|||
46990632|NCT02131233|83237484|FG000|Overall Study|Non-Compliance With Study Drug|8|||
46990633|NCT02131233|83237485|FG001|Overall Study|Non-Compliance With Study Drug|5|||
46990634|NCT02131233|83237484|FG000|Overall Study|Physician Decision|7|||
46990635|NCT02131233|83237485|FG001|Overall Study|Physician Decision|0|||
46990636|NCT02131233|83237484|FG000|Overall Study|Pregnancy|4|||
46990637|NCT02131233|83237485|FG001|Overall Study|Pregnancy|0|||
46990638|NCT02131233|83237484|FG000|Overall Study|Withdrawal by Subject|18|||
46990639|NCT02131233|83237485|FG001|Overall Study|Withdrawal by Subject|11|||
46990640|NCT02131155|83237493|FG000|Overall Study|Adverse Event|1|||
46990641|NCT02131155|83237494|FG001|Overall Study|Adverse Event|0|||
46990642|NCT02131155|83237493|FG000|Overall Study|Treatment completed|1|||
46990643|NCT02131155|83237494|FG001|Overall Study|Treatment completed|0|||
46990644|NCT02131155|83237493|FG000|Overall Study|Primary tumour recurrence|2|||
46990645|NCT02131155|83237494|FG001|Overall Study|Primary tumour recurrence|1|||
46990646|NCT02131155|83237493|FG000|Overall Study|Refused to continue study medication|1|||
46990647|NCT02131155|83237494|FG001|Overall Study|Refused to continue study medication|0|||
46990648|NCT02131155|83237493|FG000|Overall Study|Study early termination|20|||
46990649|NCT02131155|83237494|FG001|Overall Study|Study early termination|10|||
46990650|NCT01933594|83237506|FG000|Overall Study|Lost to Follow-up|1|||
46990651|NCT01933594|83237507|FG001|Overall Study|Lost to Follow-up|0|||
46990652|NCT01933594|83237508|FG002|Overall Study|Lost to Follow-up|0|||
46990653|NCT01933594|83237509|FG003|Overall Study|Lost to Follow-up|0|||
46990654|NCT01933594|83237510|FG004|Overall Study|Lost to Follow-up|1|||
46990655|NCT01933594|83237511|FG005|Overall Study|Lost to Follow-up|0|||
46990656|NCT01933594|83237506|FG000|Overall Study|Ineligible for subsequent study step|0|||
46990657|NCT01933594|83237507|FG001|Overall Study|Ineligible for subsequent study step|0|||
46990658|NCT01933594|83237508|FG002|Overall Study|Ineligible for subsequent study step|0|||
46990659|NCT01933594|83237509|FG003|Overall Study|Ineligible for subsequent study step|0|||
46990660|NCT01933594|83237510|FG004|Overall Study|Ineligible for subsequent study step|1|||
46990661|NCT01933594|83237511|FG005|Overall Study|Ineligible for subsequent study step|0|||
46990662|NCT01932970|83237529|FG000|Overall Study|Withdrawal by Subject|5|||
46990663|NCT01932970|83237529|FG000|Overall Study|Death|1|||
46990664|NCT01932970|83237529|FG000|Overall Study|Lost to Follow-up|2|||
46990665|NCT01932970|83237529|FG000|Overall Study|Protocol Specified Criteria|10|||
46990666|NCT01912768|83237535|FG000|Overall Study|Adverse Event|2|||
46990667|NCT01912768|83237536|FG001|Overall Study|Adverse Event|0|||
46990668|NCT01912768|83237535|FG000|Overall Study|Lost to Follow-up|2|||
46990669|NCT01912768|83237536|FG001|Overall Study|Lost to Follow-up|1|||
46990670|NCT01912768|83237535|FG000|Overall Study|Withdrawal by Subject|5|||
46990671|NCT01912768|83237536|FG001|Overall Study|Withdrawal by Subject|3|||
46990672|NCT01912768|83237535|FG000|Overall Study|Randomized in error|1|||
46990673|NCT01912768|83237536|FG001|Overall Study|Randomized in error|0|||
46990674|NCT02305849|83237546|FG000|Overall Study|Adverse Event|10|||
46990675|NCT02305849|83237547|FG001|Overall Study|Adverse Event|12|||
46990676|NCT02305849|83237548|FG002|Overall Study|Adverse Event|7|||
46990677|NCT02305849|83237549|FG003|Overall Study|Adverse Event|3|||
46990678|NCT02305849|83237546|FG000|Overall Study|Lack of Efficacy|10|||
46990679|NCT02305849|83237547|FG001|Overall Study|Lack of Efficacy|6|||
46990680|NCT02305849|83237548|FG002|Overall Study|Lack of Efficacy|3|||
46990681|NCT02305849|83237549|FG003|Overall Study|Lack of Efficacy|9|||
46990682|NCT02305849|83237546|FG000|Overall Study|Withdrawal by Subject|2|||
46990683|NCT02305849|83237547|FG001|Overall Study|Withdrawal by Subject|2|||
46990684|NCT02305849|83237548|FG002|Overall Study|Withdrawal by Subject|1|||
46990685|NCT02305849|83237549|FG003|Overall Study|Withdrawal by Subject|4|||
46990686|NCT02305849|83237546|FG000|Overall Study|Lost to Follow-up|0|||
46990687|NCT02305849|83237547|FG001|Overall Study|Lost to Follow-up|2|||
46990688|NCT02305849|83237548|FG002|Overall Study|Lost to Follow-up|0|||
46990689|NCT02305849|83237549|FG003|Overall Study|Lost to Follow-up|0|||
46990690|NCT02305849|83237546|FG000|Overall Study|Protocol Violation|3|||
46990691|NCT02305849|83237547|FG001|Overall Study|Protocol Violation|2|||
46990692|NCT02305849|83237548|FG002|Overall Study|Protocol Violation|1|||
46990693|NCT02305849|83237549|FG003|Overall Study|Protocol Violation|1|||
46990694|NCT02305849|83237546|FG000|Overall Study|Lab data met discontinuation criteria|0|||
46990695|NCT02305849|83237547|FG001|Overall Study|Lab data met discontinuation criteria|1|||
46990696|NCT02305849|83237548|FG002|Overall Study|Lab data met discontinuation criteria|2|||
46990697|NCT02305849|83237549|FG003|Overall Study|Lab data met discontinuation criteria|1|||
46990698|NCT02305849|83237546|FG000|Overall Study|Miscellaneous|1|||
46990699|NCT02305849|83237547|FG001|Overall Study|Miscellaneous|2|||
46990700|NCT02305849|83237548|FG002|Overall Study|Miscellaneous|4|||
46990701|NCT02305849|83237549|FG003|Overall Study|Miscellaneous|1|||
46990702|NCT02305849|83237546|FG000|Overall Study|Not fulfill eligibility criteria|1|||
46990703|NCT02305849|83237547|FG001|Overall Study|Not fulfill eligibility criteria|1|||
46990704|NCT02305849|83237548|FG002|Overall Study|Not fulfill eligibility criteria|0|||
46990705|NCT02305849|83237549|FG003|Overall Study|Not fulfill eligibility criteria|0|||
46990706|NCT02371759|83237588|FG000|Overall Study|Protocol Violation|3|||
46990707|NCT02371759|83237589|FG001|Overall Study|Protocol Violation|1|||
46990708|NCT02371759|83237590|FG002|Overall Study|Protocol Violation|1|||
46990709|NCT02371759|83237591|FG003|Overall Study|Protocol Violation|0|||
46990710|NCT02371759|83237592|FG004|Overall Study|Protocol Violation|3|||
46990711|NCT02371759|83237593|FG005|Overall Study|Protocol Violation|1|||
46990712|NCT02371759|83237594|FG006|Overall Study|Protocol Violation|0|||
46990713|NCT02371759|83237595|FG007|Overall Study|Protocol Violation|3|||
46990714|NCT02371759|83237588|FG000|Overall Study|Withdrawal by Subject|0|||
46990715|NCT02371759|83237589|FG001|Overall Study|Withdrawal by Subject|0|||
46990716|NCT02371759|83237590|FG002|Overall Study|Withdrawal by Subject|0|||
46990717|NCT02371759|83237591|FG003|Overall Study|Withdrawal by Subject|0|||
46990718|NCT02371759|83237592|FG004|Overall Study|Withdrawal by Subject|0|||
46990719|NCT02371759|83237593|FG005|Overall Study|Withdrawal by Subject|0|||
46990720|NCT02371759|83237594|FG006|Overall Study|Withdrawal by Subject|0|||
46990721|NCT02371759|83237595|FG007|Overall Study|Withdrawal by Subject|1|||
46990722|NCT02531633|83237618|FG000|Part A (52 Weeks)|Sponsor request|24|||
46990723|NCT02531633|83237619|FG001|Part A (52 Weeks)|Sponsor request|24|||
46990724|NCT02531633|83237620|FG002|Part A (52 Weeks)|Sponsor request|18|||
46990725|NCT02531633|83237621|FG003|Part A (52 Weeks)|Sponsor request|18|||
46990726|NCT02531633|83237622|FG004|Part A (52 Weeks)|Sponsor request|19|||
46990727|NCT02531633|83237623|FG005|Part A (52 Weeks)|Sponsor request|0|||
46990728|NCT02531633|83237624|FG006|Part A (52 Weeks)|Sponsor request|0|||
46990729|NCT02531633|83237625|FG007|Part A (52 Weeks)|Sponsor request|0|||
46990730|NCT02531633|83237626|FG008|Part A (52 Weeks)|Sponsor request|0|||
46990731|NCT02531633|83237627|FG009|Part A (52 Weeks)|Sponsor request|0|||
46990732|NCT02531633|83237618|FG000|Part A (52 Weeks)|Protocol Violation|1|||
46990733|NCT02531633|83237619|FG001|Part A (52 Weeks)|Protocol Violation|0|||
46990734|NCT02531633|83237620|FG002|Part A (52 Weeks)|Protocol Violation|0|||
46990735|NCT02531633|83237621|FG003|Part A (52 Weeks)|Protocol Violation|0|||
46990736|NCT02531633|83237622|FG004|Part A (52 Weeks)|Protocol Violation|0|||
46990737|NCT02531633|83237623|FG005|Part A (52 Weeks)|Protocol Violation|0|||
46990738|NCT02531633|83237624|FG006|Part A (52 Weeks)|Protocol Violation|0|||
46990739|NCT02531633|83237625|FG007|Part A (52 Weeks)|Protocol Violation|0|||
46990740|NCT02531633|83237626|FG008|Part A (52 Weeks)|Protocol Violation|0|||
46990741|NCT02531633|83237627|FG009|Part A (52 Weeks)|Protocol Violation|0|||
46990742|NCT02531633|83237618|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
46990743|NCT02531633|83237619|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
46990744|NCT02531633|83237620|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
46990745|NCT02531633|83237621|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
46990746|NCT02531633|83237622|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
46990747|NCT02531633|83237623|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
46990748|NCT02531633|83237624|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
46990749|NCT02531633|83237625|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
46990750|NCT02531633|83237626|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
46990751|NCT02531633|83237627|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
46990752|NCT02531633|83237618|FG000|Part A (52 Weeks)|Physician Decision|1|||
46990753|NCT02531633|83237619|FG001|Part A (52 Weeks)|Physician Decision|4|||
46990754|NCT02531633|83237620|FG002|Part A (52 Weeks)|Physician Decision|3|||
46990755|NCT02531633|83237621|FG003|Part A (52 Weeks)|Physician Decision|1|||
46990756|NCT02531633|83237622|FG004|Part A (52 Weeks)|Physician Decision|0|||
46990757|NCT02531633|83237623|FG005|Part A (52 Weeks)|Physician Decision|0|||
46990758|NCT02531633|83237624|FG006|Part A (52 Weeks)|Physician Decision|0|||
46990759|NCT02531633|83237625|FG007|Part A (52 Weeks)|Physician Decision|0|||
46990760|NCT02531633|83237626|FG008|Part A (52 Weeks)|Physician Decision|0|||
46990761|NCT02531633|83237627|FG009|Part A (52 Weeks)|Physician Decision|0|||
46990762|NCT02531633|83237618|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
46990763|NCT02531633|83237619|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
46990764|NCT02531633|83237620|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
46990765|NCT02531633|83237621|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
46990766|NCT02531633|83237622|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
46990767|NCT02531633|83237623|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
46990768|NCT02531633|83237624|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
46990769|NCT02531633|83237625|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
46990770|NCT02531633|83237626|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
46990771|NCT02531633|83237627|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
46990772|NCT02531633|83237618|FG000|Part A (52 Weeks)|Other|2|||
46990773|NCT02531633|83237619|FG001|Part A (52 Weeks)|Other|0|||
46990774|NCT02531633|83237620|FG002|Part A (52 Weeks)|Other|0|||
46990775|NCT02531633|83237621|FG003|Part A (52 Weeks)|Other|0|||
46990776|NCT02531633|83237622|FG004|Part A (52 Weeks)|Other|0|||
46990777|NCT02531633|83237623|FG005|Part A (52 Weeks)|Other|0|||
46990778|NCT02531633|83237624|FG006|Part A (52 Weeks)|Other|0|||
46990779|NCT02531633|83237625|FG007|Part A (52 Weeks)|Other|0|||
46990780|NCT02531633|83237626|FG008|Part A (52 Weeks)|Other|0|||
46990781|NCT02531633|83237627|FG009|Part A (52 Weeks)|Other|0|||
46990782|NCT02531633|83237618|FG000|Part B (104 Weeks)|Sponsor request|0|||
46990783|NCT02531633|83237619|FG001|Part B (104 Weeks)|Sponsor request|0|||
46990784|NCT02531633|83237620|FG002|Part B (104 Weeks)|Sponsor request|0|||
46990785|NCT02531633|83237621|FG003|Part B (104 Weeks)|Sponsor request|0|||
46990786|NCT02531633|83237622|FG004|Part B (104 Weeks)|Sponsor request|0|||
46990787|NCT02531633|83237623|FG005|Part B (104 Weeks)|Sponsor request|8|||
46990788|NCT02531633|83237624|FG006|Part B (104 Weeks)|Sponsor request|5|||
46990789|NCT02531633|83237625|FG007|Part B (104 Weeks)|Sponsor request|3|||
46990790|NCT02531633|83237626|FG008|Part B (104 Weeks)|Sponsor request|5|||
46990791|NCT02531633|83237627|FG009|Part B (104 Weeks)|Sponsor request|4|||
46990792|NCT02531633|83237618|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
46990793|NCT02531633|83237619|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
46990794|NCT02531633|83237620|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
46990795|NCT02531633|83237621|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
46990796|NCT02531633|83237622|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
46990797|NCT02531633|83237623|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
46990798|NCT02531633|83237624|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
46990799|NCT02531633|83237625|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
46990800|NCT02531633|83237626|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
46990801|NCT02531633|83237627|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
46990802|NCT02536313|83237669|FG000|Overall Study|Lack of Efficacy|0|||
46990803|NCT02536313|83237670|FG001|Overall Study|Lack of Efficacy|1|||
46990804|NCT02187861|83237682|FG000|Overall Study|Adverse Event|2|||
46990805|NCT02187861|83237683|FG001|Overall Study|Adverse Event|1|||
46990806|NCT02187861|83237684|FG002|Overall Study|Adverse Event|2|||
46990807|NCT02187861|83237685|FG003|Overall Study|Adverse Event|1|||
46990808|NCT02187861|83237682|FG000|Overall Study|Death|0|||
46990809|NCT02187861|83237683|FG001|Overall Study|Death|3|||
46990810|NCT02187861|83237684|FG002|Overall Study|Death|1|||
46990811|NCT02187861|83237685|FG003|Overall Study|Death|2|||
46990812|NCT02187861|83237682|FG000|Overall Study|Physician Decision|0|||
46990813|NCT02187861|83237683|FG001|Overall Study|Physician Decision|1|||
46990814|NCT02187861|83237684|FG002|Overall Study|Physician Decision|0|||
46990815|NCT02187861|83237685|FG003|Overall Study|Physician Decision|3|||
46990816|NCT02187861|83237682|FG000|Overall Study|Progressive Disease|4|||
46990817|NCT02187861|83237683|FG001|Overall Study|Progressive Disease|42|||
46990818|NCT02187861|83237684|FG002|Overall Study|Progressive Disease|19|||
46990819|NCT02187861|83237685|FG003|Overall Study|Progressive Disease|22|||
46990820|NCT02187861|83237682|FG000|Overall Study|Withdrawal by Subject|0|||
46990821|NCT02187861|83237683|FG001|Overall Study|Withdrawal by Subject|0|||
46990822|NCT02187861|83237684|FG002|Overall Study|Withdrawal by Subject|3|||
46990823|NCT02187861|83237685|FG003|Overall Study|Withdrawal by Subject|3|||
46881939|NCT03285178|83103126|FG003|Double-Blind Treatment Period|Adverse Event|0|||
46881940|NCT03285178|83103127|FG004|Double-Blind Treatment Period|Adverse Event|0|||
46881941|NCT03285178|83103128|FG005|Double-Blind Treatment Period|Adverse Event|0|||
46881942|NCT03285178|83103129|FG006|Double-Blind Treatment Period|Adverse Event|2|||
46881943|NCT03285178|83103123|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46881944|NCT03285178|83103124|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
46881945|NCT03285178|83103125|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
46881946|NCT03285178|83103126|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
46881947|NCT03285178|83103127|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
46881948|NCT03285178|83103128|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
46881949|NCT03285178|83103129|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
46881950|NCT03285178|83103123|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46881951|NCT03285178|83103124|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46881952|NCT03285178|83103125|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46881953|NCT03285178|83103126|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46881954|NCT03285178|83103127|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46881955|NCT03285178|83103128|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
46881956|NCT03285178|83103129|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46881957|NCT03285178|83103123|FG000|Double-Blind Treatment Period|COVID-19|0|||
46881958|NCT03285178|83103124|FG001|Double-Blind Treatment Period|COVID-19|0|||
46881959|NCT03285178|83103125|FG002|Double-Blind Treatment Period|COVID-19|1|||
46881960|NCT03285178|83103126|FG003|Double-Blind Treatment Period|COVID-19|0|||
46881961|NCT03285178|83103127|FG004|Double-Blind Treatment Period|COVID-19|0|||
46881962|NCT03285178|83103128|FG005|Double-Blind Treatment Period|COVID-19|0|||
46881963|NCT03285178|83103129|FG006|Double-Blind Treatment Period|COVID-19|0|||
46881964|NCT00090545|83103153|FG000|Overall Study|Disease progression on study|21|||
46881965|NCT00090545|83103154|FG001|Overall Study|Disease progression on study|17|||
46881966|NCT00090545|83103153|FG000|Overall Study|Refused further treatment|1|||
46881967|NCT00090545|83103154|FG001|Overall Study|Refused further treatment|4|||
46881968|NCT00090545|83103153|FG000|Overall Study|Death|0|||
46990824|NCT02187861|83237682|FG000|Overall Study|Other|0|||
46990825|NCT02187861|83237683|FG001|Overall Study|Other|1|||
46990826|NCT02187861|83237684|FG002|Overall Study|Other|7|||
46704572|NCT01227902|82919457|FG001|Overall Study|Physician Decision|1|||
46990827|NCT02187861|83237685|FG003|Overall Study|Other|1|||
46990828|NCT02163993|83237700|FG000|Treatment Period|Adverse Event|0|||
46990829|NCT02163993|83237701|FG001|Treatment Period|Adverse Event|1|||
46990830|NCT02163993|83237702|FG002|Treatment Period|Adverse Event|0|||
46704573|NCT01227902|82919458|FG002|Overall Study|Physician Decision|1|||
46990831|NCT02163993|83237703|FG003|Treatment Period|Adverse Event|0|||
46990832|NCT02163993|83237704|FG004|Treatment Period|Adverse Event|1|||
46990833|NCT02163993|83237700|FG000|Treatment Period|Lost to Follow-up|2|||
46990834|NCT02163993|83237701|FG001|Treatment Period|Lost to Follow-up|3|||
46990835|NCT02163993|83237702|FG002|Treatment Period|Lost to Follow-up|1|||
46990836|NCT02163993|83237703|FG003|Treatment Period|Lost to Follow-up|3|||
46990837|NCT02163993|83237704|FG004|Treatment Period|Lost to Follow-up|1|||
46990838|NCT02163993|83237700|FG000|Treatment Period|Physician Decision|1|||
46990839|NCT02163993|83237701|FG001|Treatment Period|Physician Decision|0|||
46990840|NCT02163993|83237702|FG002|Treatment Period|Physician Decision|0|||
46990841|NCT02163993|83237703|FG003|Treatment Period|Physician Decision|0|||
46990842|NCT02163993|83237704|FG004|Treatment Period|Physician Decision|0|||
46990843|NCT02163993|83237700|FG000|Treatment Period|Protocol Violation|2|||
46990844|NCT02163993|83237701|FG001|Treatment Period|Protocol Violation|1|||
46990845|NCT02163993|83237702|FG002|Treatment Period|Protocol Violation|0|||
46990846|NCT02163993|83237703|FG003|Treatment Period|Protocol Violation|1|||
46990847|NCT02163993|83237704|FG004|Treatment Period|Protocol Violation|2|||
46990848|NCT02163993|83237700|FG000|Treatment Period|Withdrawal by Subject|6|||
46990849|NCT02163993|83237701|FG001|Treatment Period|Withdrawal by Subject|4|||
46990850|NCT02163993|83237702|FG002|Treatment Period|Withdrawal by Subject|1|||
46990851|NCT02163993|83237703|FG003|Treatment Period|Withdrawal by Subject|4|||
46990852|NCT02163993|83237704|FG004|Treatment Period|Withdrawal by Subject|1|||
46990853|NCT02163993|83237700|FG000|Treatment Period|Not treated|1|||
46990854|NCT02163993|83237701|FG001|Treatment Period|Not treated|0|||
46990855|NCT02163993|83237702|FG002|Treatment Period|Not treated|0|||
46990856|NCT02163993|83237703|FG003|Treatment Period|Not treated|1|||
46990857|NCT02163993|83237704|FG004|Treatment Period|Not treated|2|||
46990858|NCT02163993|83237700|FG000|Post-treatment Period|Adverse Event|0|||
46990859|NCT02163993|83237701|FG001|Post-treatment Period|Adverse Event|0|||
46990860|NCT02163993|83237702|FG002|Post-treatment Period|Adverse Event|1|||
46990861|NCT02163993|83237703|FG003|Post-treatment Period|Adverse Event|0|||
46990862|NCT02163993|83237704|FG004|Post-treatment Period|Adverse Event|0|||
46990863|NCT02163993|83237700|FG000|Post-treatment Period|Lost to Follow-up|2|||
46990864|NCT02163993|83237701|FG001|Post-treatment Period|Lost to Follow-up|2|||
46990865|NCT02163993|83237702|FG002|Post-treatment Period|Lost to Follow-up|3|||
46990866|NCT02163993|83237703|FG003|Post-treatment Period|Lost to Follow-up|1|||
46990867|NCT02163993|83237704|FG004|Post-treatment Period|Lost to Follow-up|0|||
46990868|NCT02163993|83237700|FG000|Post-treatment Period|Protocol Violation|0|||
46990869|NCT02163993|83237701|FG001|Post-treatment Period|Protocol Violation|0|||
46990870|NCT02163993|83237702|FG002|Post-treatment Period|Protocol Violation|0|||
46990871|NCT02163993|83237703|FG003|Post-treatment Period|Protocol Violation|0|||
46990872|NCT02163993|83237704|FG004|Post-treatment Period|Protocol Violation|1|||
46990873|NCT02163993|83237700|FG000|Post-treatment Period|Withdrawal by Subject|2|||
46990874|NCT02163993|83237701|FG001|Post-treatment Period|Withdrawal by Subject|4|||
46990875|NCT02163993|83237702|FG002|Post-treatment Period|Withdrawal by Subject|0|||
46990876|NCT02163993|83237703|FG003|Post-treatment Period|Withdrawal by Subject|1|||
46990877|NCT02163993|83237704|FG004|Post-treatment Period|Withdrawal by Subject|2|||
46990878|NCT02163915|83237730|FG000|Overall Study|Withdrawal by Subject|2|||
46990879|NCT02163915|83237731|FG001|Overall Study|Withdrawal by Subject|0|||
46990880|NCT02163915|83237732|FG002|Overall Study|Withdrawal by Subject|2|||
46990881|NCT02163915|83237733|FG003|Overall Study|Withdrawal by Subject|2|||
46990882|NCT02163915|83237734|FG004|Overall Study|Withdrawal by Subject|2|||
46990883|NCT02163915|83237730|FG000|Overall Study|Study termination|1|||
46990884|NCT02163915|83237731|FG001|Overall Study|Study termination|0|||
46990885|NCT02163915|83237732|FG002|Overall Study|Study termination|0|||
46990886|NCT02163915|83237733|FG003|Overall Study|Study termination|0|||
46990887|NCT02163915|83237734|FG004|Overall Study|Study termination|2|||
46990888|NCT02163915|83237730|FG000|Overall Study|Physician Decision|0|||
46990889|NCT02163915|83237731|FG001|Overall Study|Physician Decision|0|||
46990890|NCT02163915|83237732|FG002|Overall Study|Physician Decision|0|||
46990891|NCT02163915|83237733|FG003|Overall Study|Physician Decision|1|||
46990892|NCT02163915|83237734|FG004|Overall Study|Physician Decision|0|||
46990893|NCT02163759|83237753|FG000|Overall Study|Withdrawal by Subject|1|||
46990894|NCT02163759|83237754|FG001|Overall Study|Withdrawal by Subject|5|||
46990895|NCT02163759|83237755|FG002|Overall Study|Withdrawal by Subject|1|||
46990896|NCT02163759|83237753|FG000|Overall Study|Adverse Event|0|||
46990897|NCT02163759|83237754|FG001|Overall Study|Adverse Event|0|||
46990898|NCT02163759|83237755|FG002|Overall Study|Adverse Event|1|||
46990899|NCT02163759|83237753|FG000|Overall Study|Death|0|||
46990900|NCT02163759|83237754|FG001|Overall Study|Death|0|||
46990901|NCT02163759|83237755|FG002|Overall Study|Death|1|||
46990902|NCT02371369|83237768|FG000|Part 1|Physician Decision|0|||
46990903|NCT02371369|83237769|FG001|Part 1|Physician Decision|3|||
46990904|NCT02371369|83237768|FG000|Part 1|Adverse Event|8|||
46990905|NCT02371369|83237769|FG001|Part 1|Adverse Event|0|||
46990906|NCT02371369|83237768|FG000|Part 1|Withdrawal by Subject|1|||
46990907|NCT02371369|83237769|FG001|Part 1|Withdrawal by Subject|6|||
46990908|NCT02371369|83237768|FG000|Part 1|Disease progression|0|||
46990909|NCT02371369|83237769|FG001|Part 1|Disease progression|1|||
46990910|NCT02371369|83237768|FG000|Part 1|Protocol Violation|0|||
46990911|NCT02371369|83237769|FG001|Part 1|Protocol Violation|1|||
46990912|NCT02371369|83237768|FG000|Part 2|Adverse Event|6|||
46990913|NCT02371369|83237769|FG001|Part 2|Adverse Event|5|||
46990914|NCT02371369|83237768|FG000|Part 2|Withdrawal by Subject|16|||
46990915|NCT02371369|83237769|FG001|Part 2|Withdrawal by Subject|6|||
46990916|NCT02371369|83237768|FG000|Part 2|Investigator decision|1|||
46990917|NCT02371369|83237769|FG001|Part 2|Investigator decision|2|||
46990918|NCT02371369|83237768|FG000|Part 2|Death|0|||
46990919|NCT02371369|83237769|FG001|Part 2|Death|1|||
46990920|NCT02371369|83237768|FG000|Part 2|Disease progression|1|||
46990921|NCT02371369|83237769|FG001|Part 2|Disease progression|0|||
46990922|NCT02371369|83237768|FG000|Part 2|Subject Noncompliance|1|||
46990923|NCT02371369|83237769|FG001|Part 2|Subject Noncompliance|0|||
46990924|NCT02371369|83237768|FG000|Part 2|Lost to Follow-up|1|||
46990925|NCT02371369|83237769|FG001|Part 2|Lost to Follow-up|1|||
46990926|NCT02371369|83237768|FG000|Part 2|Subject transitioned to commercial supply|6|||
46990927|NCT02371369|83237769|FG001|Part 2|Subject transitioned to commercial supply|4|||
46990928|NCT02371369|83237768|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
46990929|NCT02371369|83237769|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
46990930|NCT02371369|83237768|FG000|Part 2|Surgical resection of tumor|1|||
46990931|NCT02371369|83237769|FG001|Part 2|Surgical resection of tumor|1|||
46881969|NCT00090545|83103154|FG001|Overall Study|Death|1|||
46881970|NCT00090545|83103153|FG000|Overall Study|Adverse Event|0|||
46990932|NCT02371369|83237768|FG000|Part 2|Other|0|||
46990933|NCT02371369|83237769|FG001|Part 2|Other|1|||
46990934|NCT02187783|83237791|FG000|Overall Study|Adverse Event|8|||
46990935|NCT02187783|83237791|FG000|Overall Study|Death|3|||
46990936|NCT02187783|83237791|FG000|Overall Study|Progressive disease|80|||
46990937|NCT02187783|83237791|FG000|Overall Study|Protocol Violation|3|||
46990938|NCT02187783|83237791|FG000|Overall Study|Physician Decision|2|||
46990939|NCT02187783|83237791|FG000|Overall Study|Withdrawal by Subject|9|||
46990940|NCT02187783|83237791|FG000|Overall Study|Study terminated by sponsor|1|||
46990941|NCT02337361|83237797|FG000|3-month Follow-up|Lost to Follow-up|19|||
46990942|NCT02337361|83237798|FG001|3-month Follow-up|Lost to Follow-up|14|||
46990943|NCT02337361|83237797|FG000|6-month Follow-up|Lost to Follow-up|2|||
46990944|NCT02337361|83237798|FG001|6-month Follow-up|Lost to Follow-up|4|||
46990945|NCT02336737|83237805|FG000|Overall Study|Withdrawal by Subject|5|||
46990946|NCT02336737|83237805|FG000|Overall Study|Physician Decision|8|||
46990947|NCT02130765|83237814|FG000|Overall Study|Did not receive treatment|4|||
46990948|NCT02130765|83237815|FG001|Overall Study|Did not receive treatment|0|||
46990949|NCT02130765|83237816|FG002|Overall Study|Did not receive treatment|0|||
46990950|NCT02130765|83237817|FG003|Overall Study|Did not receive treatment|0|||
46990951|NCT02305381|83237832|FG000|Overall Study|Unclassified|5|||
46990952|NCT02305381|83237833|FG001|Overall Study|Unclassified|5|||
46990953|NCT02305381|83237834|FG002|Overall Study|Unclassified|7|||
46990954|NCT02336425|83237846|FG000|Overall Study|Study terminated.|2|||
46990955|NCT02336425|83237847|FG001|Overall Study|Study terminated.|2|||
46990956|NCT02336425|83237848|FG002|Overall Study|Study terminated.|3|||
46990957|NCT02336425|83237849|FG003|Overall Study|Study terminated.|3|||
46990958|NCT02163447|83237862|FG000|Overall Study|Withdrawal by Subject|2|||
46990959|NCT02163447|83237863|FG001|Overall Study|Withdrawal by Subject|0|||
46990960|NCT02163447|83237864|FG002|Overall Study|Withdrawal by Subject|1|||
46990961|NCT02163447|83237862|FG000|Overall Study|Lost to Follow-up|1|||
46990962|NCT02163447|83237863|FG001|Overall Study|Lost to Follow-up|3|||
46990963|NCT02163447|83237864|FG002|Overall Study|Lost to Follow-up|0|||
46990964|NCT02163447|83237862|FG000|Overall Study|Moved out of study area|2|||
46990965|NCT02163447|83237863|FG001|Overall Study|Moved out of study area|3|||
46990966|NCT02163447|83237864|FG002|Overall Study|Moved out of study area|2|||
46990967|NCT02163447|83237862|FG000|Overall Study|Became HIV infected at time of delivery|1|||
46990968|NCT02163447|83237863|FG001|Overall Study|Became HIV infected at time of delivery|0|||
46990969|NCT02163447|83237864|FG002|Overall Study|Became HIV infected at time of delivery|0|||
46990970|NCT02370667|83237885|FG000|Overall Study|Lost to Follow-up|0|||
46881971|NCT00090545|83103154|FG001|Overall Study|Adverse Event|2|||
46881972|NCT03249376|83103164|FG000|Overall Study|Adverse Event|11|||
46990971|NCT02370667|83237886|FG001|Overall Study|Lost to Follow-up|1|||
46990972|NCT02370667|83237887|FG002|Overall Study|Lost to Follow-up|0|||
46990973|NCT02130297|83237895|FG000|Overall Study|Lost to Follow-up|4|||
46990974|NCT01931956|83237903|FG000|Overall Study|Death|42|||
46990975|NCT01931956|83237904|FG001|Overall Study|Death|7|||
46990976|NCT01931956|83237905|FG002|Overall Study|Death|379|||
46990977|NCT01931956|83237906|FG003|Overall Study|Death|96|||
46990978|NCT01931956|83237903|FG000|Overall Study|Withdrawal by Subject|5|||
46990979|NCT01931956|83237904|FG001|Overall Study|Withdrawal by Subject|0|||
46990980|NCT01931956|83237905|FG002|Overall Study|Withdrawal by Subject|70|||
46990981|NCT01931956|83237906|FG003|Overall Study|Withdrawal by Subject|30|||
46990982|NCT01931956|83237903|FG000|Overall Study|Lost to Follow-up|2|||
46990983|NCT01931956|83237904|FG001|Overall Study|Lost to Follow-up|0|||
46990984|NCT01931956|83237905|FG002|Overall Study|Lost to Follow-up|11|||
46990985|NCT01931956|83237906|FG003|Overall Study|Lost to Follow-up|7|||
46990986|NCT01931956|83237903|FG000|Overall Study|Expected|2|||
46990987|NCT01931956|83237904|FG001|Overall Study|Expected|0|||
46990988|NCT01931956|83237905|FG002|Overall Study|Expected|6|||
46990989|NCT01931956|83237906|FG003|Overall Study|Expected|0|||
46990990|NCT01931956|83237903|FG000|Overall Study|Not due|0|||
46990991|NCT01931956|83237904|FG001|Overall Study|Not due|0|||
46990992|NCT01931956|83237905|FG002|Overall Study|Not due|21|||
46990993|NCT01931956|83237906|FG003|Overall Study|Not due|0|||
46990994|NCT01887418|83237932|FG000|Overall Study|Travelling difficulties|0|||
46990995|NCT01887418|83237933|FG001|Overall Study|Travelling difficulties|0|||
46990996|NCT01887418|83237934|FG002|Overall Study|Travelling difficulties|1|||
46990997|NCT01886716|83237946|FG000|Week 1|Lost to Follow-up|0|||
46990998|NCT01886716|83237947|FG001|Week 1|Lost to Follow-up|0|||
46990999|NCT01886716|83237948|FG002|Week 1|Lost to Follow-up|2|||
46991000|NCT01886716|83237949|FG003|Week 1|Lost to Follow-up|2|||
46991001|NCT01886716|83237946|FG000|Week 2|Lost to Follow-up|3|||
46991002|NCT01886716|83237947|FG001|Week 2|Lost to Follow-up|2|||
46991003|NCT01886716|83237948|FG002|Week 2|Lost to Follow-up|1|||
46991004|NCT01886716|83237949|FG003|Week 2|Lost to Follow-up|3|||
46991005|NCT01886716|83237946|FG000|Week 3|Lost to Follow-up|1|||
46991006|NCT01886716|83237947|FG001|Week 3|Lost to Follow-up|1|||
46991007|NCT01886716|83237948|FG002|Week 3|Lost to Follow-up|0|||
46991008|NCT01886716|83237949|FG003|Week 3|Lost to Follow-up|1|||
46991009|NCT01912612|83237961|FG000|Overall Study|Adverse Event|4|||
46991010|NCT01912612|83237962|FG001|Overall Study|Adverse Event|0|||
46991011|NCT01912612|83237963|FG002|Overall Study|Adverse Event|0|||
46991012|NCT01912612|83237961|FG000|Overall Study|Withdrew consent|1|||
46991013|NCT01912612|83237962|FG001|Overall Study|Withdrew consent|0|||
46991014|NCT01912612|83237963|FG002|Overall Study|Withdrew consent|0|||
46991015|NCT01912612|83237961|FG000|Overall Study|Study design change|0|||
46991016|NCT01912612|83237962|FG001|Overall Study|Study design change|0|||
46991017|NCT01912612|83237963|FG002|Overall Study|Study design change|3|||
46991018|NCT02370511|83237972|FG000|Overall Study|Death|10|||
46991019|NCT02370511|83237973|FG001|Overall Study|Death|7|||
46991020|NCT02370511|83237974|FG002|Overall Study|Death|1|||
46991021|NCT02370511|83237972|FG000|Overall Study|Withdrawal by Subject|2|||
46991022|NCT02370511|83237973|FG001|Overall Study|Withdrawal by Subject|0|||
46991023|NCT02370511|83237974|FG002|Overall Study|Withdrawal by Subject|0|||
46991024|NCT02370511|83237972|FG000|Overall Study|Lost to Follow-up|0|||
46991025|NCT02370511|83237973|FG001|Overall Study|Lost to Follow-up|4|||
46991026|NCT02370511|83237974|FG002|Overall Study|Lost to Follow-up|0|||
46991027|NCT02303041|83237984|FG000|Overall Study|Adverse Event|1|||
46991028|NCT02303041|83237985|FG001|Overall Study|Adverse Event|2|||
46991029|NCT02302807|83237993|FG000|Overall Study|Withdrawal by Subject|28|||
46991030|NCT02302807|83237994|FG001|Overall Study|Withdrawal by Subject|11|||
46991031|NCT02302807|83237993|FG000|Overall Study|Lost to Follow-up|4|||
46991032|NCT02302807|83237994|FG001|Overall Study|Lost to Follow-up|6|||
46991033|NCT02302807|83237993|FG000|Overall Study|Death|397|||
46991034|NCT02302807|83237994|FG001|Overall Study|Death|385|||
46991035|NCT02302807|83237993|FG000|Overall Study|Study Terminated By Sponsor|35|||
46991036|NCT02302807|83237994|FG001|Overall Study|Study Terminated By Sponsor|64|||
46991037|NCT02302807|83237993|FG000|Overall Study|Physician Decision|0|||
46991038|NCT02302807|83237994|FG001|Overall Study|Physician Decision|1|||
46881973|NCT03249376|83103165|FG001|Overall Study|Adverse Event|5|||
46881974|NCT03249376|83103164|FG000|Overall Study|Lack of Efficacy|2|||
46881975|NCT03249376|83103165|FG001|Overall Study|Lack of Efficacy|4|||
46881976|NCT03249376|83103164|FG000|Overall Study|Protocol Violation|3|||
46881977|NCT03249376|83103165|FG001|Overall Study|Protocol Violation|2|||
46881978|NCT03249376|83103164|FG000|Overall Study|Physician Decision|0|||
46991039|NCT02335489|83238013|FG000|Overall Study|Sponsor terminated study|4|||
46991040|NCT02335489|83238013|FG000|Overall Study|Lost to Follow-up|1|||
46991041|NCT02335489|83238013|FG000|Overall Study|Withdrawal by Subject|2|||
46991042|NCT02335489|83238013|FG000|Overall Study|Physician Decision|2|||
46991043|NCT02335489|83238013|FG000|Overall Study|Lack of Efficacy|1|||
46991044|NCT02527343|83238019|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
46881979|NCT03249376|83103165|FG001|Overall Study|Physician Decision|2|||
46881980|NCT03249376|83103164|FG000|Overall Study|Withdrawal by Subject|3|||
46991045|NCT02527343|83238020|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
46991046|NCT02527343|83238021|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
46991047|NCT02527343|83238022|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
46991048|NCT02527343|83238023|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
46991049|NCT02527343|83238024|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
46991050|NCT02527343|83238019|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
46991051|NCT02527343|83238020|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
46991052|NCT02527343|83238021|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
46991053|NCT02527343|83238022|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
46991054|NCT02527343|83238023|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
46991055|NCT02527343|83238024|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
46991056|NCT02527343|83238019|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
46991057|NCT02527343|83238020|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
46991058|NCT02527343|83238021|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
46991059|NCT02527343|83238022|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
46991060|NCT02527343|83238023|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
46991061|NCT02527343|83238024|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
46991062|NCT02527343|83238019|FG000|RT Period: Weeks 1 to 52|Other|4|||
46991063|NCT02527343|83238020|FG001|RT Period: Weeks 1 to 52|Other|3|||
46704574|NCT01227902|82919459|FG003|Overall Study|Physician Decision|0|||
46704575|NCT01227902|82919456|FG000|Overall Study|Withdrawal by Subject|4|||
46991064|NCT02527343|83238021|FG002|RT Period: Weeks 1 to 52|Other|0|||
46991065|NCT02527343|83238022|FG003|RT Period: Weeks 1 to 52|Other|0|||
46991066|NCT02527343|83238023|FG004|RT Period: Weeks 1 to 52|Other|0|||
46991067|NCT02527343|83238024|FG005|RT Period: Weeks 1 to 52|Other|0|||
46704576|NCT01227902|82919457|FG001|Overall Study|Withdrawal by Subject|2|||
46704577|NCT01227902|82919458|FG002|Overall Study|Withdrawal by Subject|4|||
46704578|NCT01227902|82919459|FG003|Overall Study|Withdrawal by Subject|3|||
46704579|NCT00946192|82919473|FG000|Overall Study|Lost to Follow-up|6|||
46704580|NCT00946192|82919474|FG001|Overall Study|Lost to Follow-up|11|||
46704581|NCT00946192|82919475|FG002|Overall Study|Lost to Follow-up|9|||
46704582|NCT00946192|82919473|FG000|Overall Study|Withdrawal by Subject|10|||
46704583|NCT00946192|82919474|FG001|Overall Study|Withdrawal by Subject|7|||
46704584|NCT00946192|82919475|FG002|Overall Study|Withdrawal by Subject|3|||
46704585|NCT00946192|82919473|FG000|Overall Study|Did not start medication|2|||
46704586|NCT00946192|82919474|FG001|Overall Study|Did not start medication|0|||
46704587|NCT00946192|82919475|FG002|Overall Study|Did not start medication|0|||
46704588|NCT01037127|82919485|FG000|Overall Study|Lost to Follow-up|2|||
46704589|NCT01037127|82919486|FG001|Overall Study|Lost to Follow-up|4|||
46704590|NCT01037127|82919485|FG000|Overall Study|Physician Decision|1|||
46704591|NCT01037127|82919486|FG001|Overall Study|Physician Decision|0|||
46704592|NCT01037127|82919485|FG000|Overall Study|Study Closed Terminated|2|||
46704593|NCT01037127|82919486|FG001|Overall Study|Study Closed Terminated|17|||
46704594|NCT00946114|82919504|FG000|Overall Study|Death|5|||
46704595|NCT00946114|82919505|FG001|Overall Study|Death|2|||
46704596|NCT00946114|82919504|FG000|Overall Study|Other|1|||
46704597|NCT00946114|82919505|FG001|Overall Study|Other|0|||
46704598|NCT00946114|82919504|FG000|Overall Study|Withdrawal by Subject|2|||
46704599|NCT00946114|82919505|FG001|Overall Study|Withdrawal by Subject|0|||
46704600|NCT01038921|82919513|FG000|Overall Study|Withdrawal by Subject|1|||
46704601|NCT01038921|82919514|FG001|Overall Study|Withdrawal by Subject|0|||
46704602|NCT01038921|82919513|FG000|Overall Study|Physician Decision|1|||
46704603|NCT01038921|82919514|FG001|Overall Study|Physician Decision|0|||
46704604|NCT01038687|82919523|FG000|Overall Study|Adverse Event|0|||
46704605|NCT01038687|82919524|FG001|Overall Study|Adverse Event|2|||
46704606|NCT01038687|82919525|FG002|Overall Study|Adverse Event|1|||
46704607|NCT01081912|82919533|FG000|Conversion/Titration|Adverse Event|47|||
46704608|NCT01081912|82919534|FG001|Conversion/Titration|Adverse Event|0|||
46704609|NCT01081912|82919535|FG002|Conversion/Titration|Adverse Event|0|||
46881981|NCT03249376|83103165|FG001|Overall Study|Withdrawal by Subject|9|||
46704610|NCT01081912|82919533|FG000|Conversion/Titration|Lack of Efficacy|17|||
46704611|NCT01081912|82919534|FG001|Conversion/Titration|Lack of Efficacy|0|||
46704612|NCT01081912|82919535|FG002|Conversion/Titration|Lack of Efficacy|0|||
46704613|NCT01081912|82919533|FG000|Conversion/Titration|Lost to Follow-up|5|||
46802951|NCT00684203|83022197|FG002|Overall Study|Adverse Event|8|||
46704614|NCT01081912|82919534|FG001|Conversion/Titration|Lost to Follow-up|0|||
46704615|NCT01081912|82919535|FG002|Conversion/Titration|Lost to Follow-up|0|||
46704616|NCT01081912|82919533|FG000|Conversion/Titration|Physician Decision|2|||
46881982|NCT03249376|83103164|FG000|Overall Study|LTFU|2|||
46881983|NCT03249376|83103165|FG001|Overall Study|LTFU|1|||
46704617|NCT01081912|82919534|FG001|Conversion/Titration|Physician Decision|0|||
46704618|NCT01081912|82919535|FG002|Conversion/Titration|Physician Decision|0|||
46704619|NCT01081912|82919533|FG000|Conversion/Titration|Protocol Violation|67|||
46704620|NCT01081912|82919534|FG001|Conversion/Titration|Protocol Violation|0|||
46704621|NCT01081912|82919535|FG002|Conversion/Titration|Protocol Violation|0|||
46991068|NCT02527343|83238019|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
46991069|NCT02527343|83238020|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
46881984|NCT00070109|83103176|FG000|Overall Study|Death|1|||
46881985|NCT00070109|83103177|FG001|Overall Study|Death|1|||
46881986|NCT00070109|83103178|FG002|Overall Study|Death|0|||
46881987|NCT00070109|83103179|FG003|Overall Study|Death|0|||
46881988|NCT00070109|83103180|FG004|Overall Study|Death|1|||
46881989|NCT00070109|83103176|FG000|Overall Study|Lack of Efficacy|6|||
46881990|NCT00070109|83103177|FG001|Overall Study|Lack of Efficacy|4|||
46881991|NCT00070109|83103178|FG002|Overall Study|Lack of Efficacy|5|||
46881992|NCT00070109|83103179|FG003|Overall Study|Lack of Efficacy|15|||
46881993|NCT00070109|83103180|FG004|Overall Study|Lack of Efficacy|5|||
46881994|NCT00070109|83103176|FG000|Overall Study|Physician Decision|1|||
46881995|NCT00070109|83103177|FG001|Overall Study|Physician Decision|0|||
46881996|NCT00070109|83103178|FG002|Overall Study|Physician Decision|0|||
46881997|NCT00070109|83103179|FG003|Overall Study|Physician Decision|0|||
46881998|NCT00070109|83103180|FG004|Overall Study|Physician Decision|0|||
46991070|NCT02527343|83238021|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
46991071|NCT02527343|83238022|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
46991072|NCT02527343|83238023|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
46991073|NCT02527343|83238024|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
46991074|NCT02527343|83238019|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
46991075|NCT02527343|83238020|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
46991076|NCT02527343|83238021|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
46991077|NCT02527343|83238022|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
46991078|NCT02527343|83238023|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
46991079|NCT02527343|83238024|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
46991080|NCT02527343|83238019|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
46991081|NCT02527343|83238020|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
46991082|NCT02527343|83238021|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
46881999|NCT00070109|83103176|FG000|Overall Study|Withdrawal by Subject|0|||
46882000|NCT00070109|83103177|FG001|Overall Study|Withdrawal by Subject|1|||
46882001|NCT00070109|83103178|FG002|Overall Study|Withdrawal by Subject|1|||
46882002|NCT00070109|83103179|FG003|Overall Study|Withdrawal by Subject|0|||
46882003|NCT00070109|83103180|FG004|Overall Study|Withdrawal by Subject|0|||
46704622|NCT01081912|82919533|FG000|Conversion/Titration|Withdrawal by Subject|23|||
46704623|NCT01081912|82919534|FG001|Conversion/Titration|Withdrawal by Subject|0|||
46704624|NCT01081912|82919535|FG002|Conversion/Titration|Withdrawal by Subject|0|||
46704625|NCT01081912|82919533|FG000|Conversion/Titration|Non-Compliance|47|||
46704626|NCT01081912|82919534|FG001|Conversion/Titration|Non-Compliance|0|||
46704627|NCT01081912|82919535|FG002|Conversion/Titration|Non-Compliance|0|||
46704628|NCT01081912|82919533|FG000|Maintenance Treatment|Adverse Event|0|||
46704629|NCT01081912|82919534|FG001|Maintenance Treatment|Adverse Event|2|||
46704630|NCT01081912|82919535|FG002|Maintenance Treatment|Adverse Event|12|||
46704631|NCT01081912|82919533|FG000|Maintenance Treatment|Lack of Efficacy|0|||
46704632|NCT01081912|82919534|FG001|Maintenance Treatment|Lack of Efficacy|14|||
46704633|NCT01081912|82919535|FG002|Maintenance Treatment|Lack of Efficacy|64|||
46704634|NCT01081912|82919533|FG000|Maintenance Treatment|Lost to Follow-up|0|||
46704635|NCT01081912|82919534|FG001|Maintenance Treatment|Lost to Follow-up|1|||
46704636|NCT01081912|82919535|FG002|Maintenance Treatment|Lost to Follow-up|0|||
46704637|NCT01081912|82919533|FG000|Maintenance Treatment|Physician Decision|0|||
46704638|NCT01081912|82919534|FG001|Maintenance Treatment|Physician Decision|0|||
46704639|NCT01081912|82919535|FG002|Maintenance Treatment|Physician Decision|1|||
46704640|NCT01081912|82919533|FG000|Maintenance Treatment|Protocol Violation|0|||
46704641|NCT01081912|82919534|FG001|Maintenance Treatment|Protocol Violation|1|||
46704642|NCT01081912|82919535|FG002|Maintenance Treatment|Protocol Violation|2|||
46704643|NCT01081912|82919533|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
46704644|NCT01081912|82919534|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
46704645|NCT01081912|82919535|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
46704646|NCT01081912|82919533|FG000|Maintenance Treatment|Non-Compliance|0|||
46704647|NCT01081912|82919534|FG001|Maintenance Treatment|Non-Compliance|4|||
46704648|NCT01081912|82919535|FG002|Maintenance Treatment|Non-Compliance|7|||
46704649|NCT01081912|82919533|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
46704650|NCT01081912|82919534|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
46704651|NCT01081912|82919535|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
46704652|NCT01038609|82919547|FG000|Overall Study|Adverse Event|0|||
46704653|NCT01038609|82919548|FG001|Overall Study|Adverse Event|0|||
46704654|NCT01038609|82919549|FG002|Overall Study|Adverse Event|1|||
46704655|NCT01038609|82919550|FG003|Overall Study|Adverse Event|0|||
46704656|NCT01038609|82919551|FG004|Overall Study|Adverse Event|0|||
46704657|NCT01038609|82919547|FG000|Overall Study|Dosing Error|0|||
46704658|NCT01038609|82919548|FG001|Overall Study|Dosing Error|0|||
46704659|NCT01038609|82919549|FG002|Overall Study|Dosing Error|0|||
46704660|NCT01038609|82919550|FG003|Overall Study|Dosing Error|1|||
46704661|NCT01038609|82919551|FG004|Overall Study|Dosing Error|1|||
46704662|NCT01038609|82919547|FG000|Overall Study|Death in the Family|1|||
46704663|NCT01038609|82919548|FG001|Overall Study|Death in the Family|0|||
46882004|NCT00070109|83103176|FG000|Overall Study|Adverse Event|0|||
46704664|NCT01038609|82919549|FG002|Overall Study|Death in the Family|0|||
46704665|NCT01038609|82919550|FG003|Overall Study|Death in the Family|0|||
46704666|NCT01038609|82919551|FG004|Overall Study|Death in the Family|0|||
46704667|NCT01038609|82919547|FG000|Overall Study|Refusal of Blood Draws|0|||
46704668|NCT01038609|82919548|FG001|Overall Study|Refusal of Blood Draws|1|||
46704669|NCT01038609|82919549|FG002|Overall Study|Refusal of Blood Draws|0|||
46704670|NCT01038609|82919550|FG003|Overall Study|Refusal of Blood Draws|0|||
46704671|NCT01038609|82919551|FG004|Overall Study|Refusal of Blood Draws|0|||
46704672|NCT02357134|82919567|FG000|Overall Study|Lost to Follow-up|1|||
46704673|NCT02357134|82919568|FG001|Overall Study|Lost to Follow-up|0|||
46704674|NCT02357134|82919569|FG002|Overall Study|Lost to Follow-up|0|||
46704675|NCT02357134|82919570|FG003|Overall Study|Lost to Follow-up|0|||
46704676|NCT00745420|82919580|FG000|Overall Study|Ineligible|1|||
46704677|NCT02853370|82919584|FG000|Overall Study|Physician Decision|1|||
46704678|NCT02853370|82919584|FG000|Overall Study|Lack of Efficacy|2|||
46704679|NCT02853370|82919584|FG000|Overall Study|Death|1|||
46704680|NCT02853370|82919584|FG000|Overall Study|Adverse Event|4|||
46704681|NCT02853370|82919584|FG000|Overall Study|Withdrawal by Subject|3|||
46704682|NCT01879072|82919589|FG000|Overall Study|Withdrawal by Subject|121|||
46704683|NCT01879072|82919589|FG000|Overall Study|Not Transplanted|30|||
46704684|NCT00954538|82919595|FG000|Part III|Withdrawal by Subject|0|||
46704685|NCT00954538|82919596|FG001|Part III|Withdrawal by Subject|0|||
46704686|NCT00954538|82919597|FG002|Part III|Withdrawal by Subject|0|||
46704687|NCT00954538|82919598|FG003|Part III|Withdrawal by Subject|0|||
46704688|NCT00954538|82919599|FG004|Part III|Withdrawal by Subject|1|||
46704689|NCT00954538|82919600|FG005|Part III|Withdrawal by Subject|0|||
46704690|NCT00943852|82919609|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704691|NCT00943852|82919610|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704692|NCT00943852|82919611|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704693|NCT00943852|82919612|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
46704694|NCT00943852|82919613|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704695|NCT00943852|82919614|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704696|NCT00943852|82919615|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704697|NCT00943852|82919616|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704698|NCT00943852|82919617|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704699|NCT00943852|82919618|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
46704700|NCT00943852|82919609|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704701|NCT00943852|82919610|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704702|NCT00943852|82919611|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704703|NCT00943852|82919612|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704704|NCT00943852|82919613|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704705|NCT00943852|82919614|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
46704706|NCT00943852|82919615|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704707|NCT00943852|82919616|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704708|NCT00943852|82919617|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704709|NCT00943852|82919618|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
46704710|NCT00943852|82919609|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704711|NCT00943852|82919610|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704712|NCT00943852|82919611|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704713|NCT00943852|82919612|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704714|NCT00943852|82919613|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704715|NCT00943852|82919614|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704716|NCT00943852|82919615|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
46704717|NCT00943852|82919616|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704718|NCT00943852|82919617|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704719|NCT00943852|82919618|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
46704720|NCT00943852|82919609|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704721|NCT00943852|82919610|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704722|NCT00943852|82919611|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704723|NCT00943852|82919612|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704724|NCT00943852|82919613|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704725|NCT00943852|82919614|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704726|NCT00943852|82919615|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704727|NCT00943852|82919616|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
46704728|NCT00943852|82919617|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704729|NCT00943852|82919618|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
46704730|NCT00943852|82919609|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
46704731|NCT00943852|82919610|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
46704732|NCT00943852|82919611|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
46704733|NCT00943852|82919612|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
46704734|NCT00943852|82919613|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
46704735|NCT00943852|82919614|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
46704736|NCT00943852|82919615|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
46704737|NCT00943852|82919616|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
46704738|NCT00943852|82919617|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
46704739|NCT00943852|82919618|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
46704740|NCT00952276|82919633|FG000|Overall Study|Withdrawal by Subject|1|||
46704741|NCT00952276|82919634|FG001|Overall Study|Withdrawal by Subject|0|||
46704742|NCT00952276|82919635|FG002|Overall Study|Withdrawal by Subject|0|||
46704743|NCT00952276|82919636|FG003|Overall Study|Withdrawal by Subject|1|||
46704744|NCT00952276|82919637|FG004|Overall Study|Withdrawal by Subject|0|||
46704745|NCT00943384|82919649|FG000|Overall Study|Dispositioned prior to treatment|23|||
46704746|NCT00943384|82919649|FG000|Overall Study|Treated off protocol-protocol violation|5|||
46704747|NCT00943384|82919649|FG000|Overall Study|Lost to Follow-up|16|||
46704748|NCT00943384|82919649|FG000|Overall Study|Withdrawal by Subject|5|||
46704749|NCT00943306|82919653|FG000|Overall Study|Physician Decision|1|||
46704750|NCT00943306|82919653|FG000|Overall Study|Death|1|||
46704751|NCT00943306|82919653|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
46704752|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
46704753|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
46704754|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
46704755|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
46704756|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
46704757|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
46704758|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
46704759|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
46704760|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
46704761|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
46704762|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
46704763|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
46704764|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
46704765|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
46704766|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
46704767|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
46704768|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
46704769|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
46704770|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
46704771|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
46704772|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
46704773|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
46704774|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
46704775|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
46704776|NCT01198002|82919660|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
46704777|NCT01198002|82919661|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
46704778|NCT01198002|82919662|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
46704779|NCT01198002|82919660|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
46704780|NCT01198002|82919661|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
46704781|NCT01198002|82919662|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
46704782|NCT01198002|82919660|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
46704783|NCT01198002|82919661|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
46704784|NCT01198002|82919662|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
46704785|NCT01198002|82919660|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
46882005|NCT00070109|83103177|FG001|Overall Study|Adverse Event|0|||
46704786|NCT01198002|82919661|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
46704787|NCT01198002|82919662|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
46704788|NCT01198002|82919660|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
46882006|NCT00070109|83103178|FG002|Overall Study|Adverse Event|2|||
46704789|NCT01198002|82919661|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
46704790|NCT01198002|82919662|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
46704791|NCT01198002|82919660|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
46704792|NCT01198002|82919661|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
46704793|NCT01198002|82919662|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
46704794|NCT01198002|82919660|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
46704795|NCT01198002|82919661|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
46704796|NCT01198002|82919662|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
46704797|NCT01197534|82919695|FG000|Overall Study|Not reported|16|||
46704798|NCT01197534|82919696|FG001|Overall Study|Not reported|10|||
46704799|NCT01197534|82919697|FG002|Overall Study|Not reported|16|||
46704800|NCT01197534|82919695|FG000|Overall Study|Enrolment in long term extension|57|||
46704801|NCT01197534|82919696|FG001|Overall Study|Enrolment in long term extension|66|||
46704802|NCT01197534|82919697|FG002|Overall Study|Enrolment in long term extension|119|||
46704803|NCT01197534|82919695|FG000|Overall Study|Severe non-compliance to protocol|3|||
46704804|NCT01197534|82919696|FG001|Overall Study|Severe non-compliance to protocol|4|||
46704805|NCT01197534|82919697|FG002|Overall Study|Severe non-compliance to protocol|1|||
46704806|NCT01197534|82919695|FG000|Overall Study|Lack of therapeutic response|9|||
46704807|NCT01197534|82919696|FG001|Overall Study|Lack of therapeutic response|4|||
46704808|NCT01197534|82919697|FG002|Overall Study|Lack of therapeutic response|9|||
46704809|NCT01197534|82919695|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
46704810|NCT01197534|82919696|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
46704811|NCT01197534|82919697|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
46704812|NCT01197534|82919695|FG000|Overall Study|Lost to Follow-up|1|||
46704813|NCT01197534|82919696|FG001|Overall Study|Lost to Follow-up|4|||
46704814|NCT01197534|82919697|FG002|Overall Study|Lost to Follow-up|2|||
46704815|NCT01197534|82919695|FG000|Overall Study|Adverse Event|35|||
46704816|NCT01197534|82919696|FG001|Overall Study|Adverse Event|36|||
46704817|NCT01197534|82919697|FG002|Overall Study|Adverse Event|24|||
46704818|NCT01197378|82919708|FG000|Overall Study|Adverse Event|3|||
46704819|NCT01197378|82919708|FG000|Overall Study|Withdrawal by Subject|1|||
46704820|NCT01197378|82919708|FG000|Overall Study|Physician Decision|1|||
46704821|NCT01197378|82919708|FG000|Overall Study|Other|2|||
46704822|NCT01197300|82919714|FG000|Overall Study|Lost to Follow-up|0|||
46704823|NCT01197300|82919715|FG001|Overall Study|Lost to Follow-up|1|||
46704824|NCT01197300|82919714|FG000|Overall Study|Protocol Violation|0|||
46704825|NCT01197300|82919715|FG001|Overall Study|Protocol Violation|1|||
46704826|NCT01196988|82919730|FG000|Overall Study|Adverse Event|1|||
46704827|NCT01196988|82919731|FG001|Overall Study|Adverse Event|2|||
46882007|NCT00070109|83103179|FG003|Overall Study|Adverse Event|4|||
46882008|NCT00070109|83103180|FG004|Overall Study|Adverse Event|2|||
46882009|NCT00070109|83103176|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
46882010|NCT00070109|83103177|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
46882011|NCT00070109|83103178|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
46882012|NCT00070109|83103179|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
46882013|NCT00070109|83103180|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
46882014|NCT00090233|83103201|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
46704828|NCT01196988|82919732|FG002|Overall Study|Adverse Event|0|||
46704829|NCT01196988|82919733|FG003|Overall Study|Adverse Event|0|||
46704830|NCT01196988|82919730|FG000|Overall Study|Withdrawal by Subject|5|||
46704831|NCT01196988|82919731|FG001|Overall Study|Withdrawal by Subject|1|||
46704832|NCT01196988|82919732|FG002|Overall Study|Withdrawal by Subject|4|||
46704833|NCT01196988|82919733|FG003|Overall Study|Withdrawal by Subject|0|||
46704834|NCT01196988|82919730|FG000|Overall Study|Lost to Follow-up|16|||
46704835|NCT01196988|82919731|FG001|Overall Study|Lost to Follow-up|29|||
46704836|NCT01196988|82919732|FG002|Overall Study|Lost to Follow-up|21|||
46704837|NCT01196988|82919733|FG003|Overall Study|Lost to Follow-up|1|||
46704838|NCT01196988|82919730|FG000|Overall Study|Other|2|||
46704839|NCT01196988|82919731|FG001|Overall Study|Other|0|||
46704840|NCT01196988|82919732|FG002|Overall Study|Other|0|||
46704841|NCT01196988|82919733|FG003|Overall Study|Other|0|||
46704842|NCT01196052|82919744|FG000|Overall Study|Adverse Event|9|||
46704843|NCT01196052|82919744|FG000|Overall Study|Lost to Follow-up|1|||
46704844|NCT01196052|82919744|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
46704845|NCT01196052|82919744|FG000|Overall Study|Reason not Specified|5|||
46704846|NCT01196052|82919744|FG000|Overall Study|Withdrawal by Subject|6|||
46704847|NCT01195662|82919751|FG000|Double Blind Treatment Period|Adverse Event|4|||
46704848|NCT01195662|82919752|FG001|Double Blind Treatment Period|Adverse Event|1|||
46704849|NCT01195662|82919753|FG002|Double Blind Treatment Period|Adverse Event|2|||
46704850|NCT01195662|82919751|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
46704851|NCT01195662|82919752|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
46704852|NCT01195662|82919753|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
46704853|NCT01195662|82919751|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
46704854|NCT01195662|82919752|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
46704855|NCT01195662|82919753|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
46704856|NCT01195662|82919751|FG000|Double Blind Treatment Period|Administrative reason|2|||
46704857|NCT01195662|82919752|FG001|Double Blind Treatment Period|Administrative reason|1|||
46704858|NCT01195662|82919753|FG002|Double Blind Treatment Period|Administrative reason|1|||
46704859|NCT01195662|82919751|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
46704860|NCT01195662|82919752|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
46704861|NCT01195662|82919753|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
46704862|NCT01195662|82919751|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
46704863|NCT01195662|82919752|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
46704864|NCT01195662|82919753|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
46704865|NCT01195662|82919751|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
46704866|NCT01195662|82919752|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
46704867|NCT01195662|82919753|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
46704868|NCT01195662|82919751|FG000|Double Blind Treatment Period|Non-specified|3|||
46704869|NCT01195662|82919752|FG001|Double Blind Treatment Period|Non-specified|0|||
46704870|NCT01195662|82919753|FG002|Double Blind Treatment Period|Non-specified|0|||
46704871|NCT01195662|82919751|FG000|Double Blind Treatment Period|Missing disposition information|0|||
46704872|NCT01195662|82919752|FG001|Double Blind Treatment Period|Missing disposition information|1|||
46704873|NCT01195662|82919753|FG002|Double Blind Treatment Period|Missing disposition information|1|||
46704874|NCT01195662|82919751|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
46704875|NCT01195662|82919752|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
46704876|NCT01195662|82919753|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
46704877|NCT01195662|82919751|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
46704878|NCT01195662|82919752|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
46704879|NCT01195662|82919753|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
46704880|NCT01195272|82919762|FG000|Overall Study|Adverse Event|1|||
46704881|NCT01195272|82919762|FG000|Overall Study|Lack of Efficacy|3|||
46882015|NCT00090233|83103202|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
46882016|NCT00090233|83103201|FG000|Overall Study|Adverse Event|214|||
46704882|NCT01194804|82919766|FG000|Overall Study|Withdrawal by Subject|1|||
46704883|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
46704884|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
46704885|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
46704886|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
46704887|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
46704888|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
46704889|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
46704890|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
46704891|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
46704892|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
46704893|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
46882017|NCT00090233|83103202|FG001|Overall Study|Adverse Event|198|||
46704894|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
46704895|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
46704896|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
46704897|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
46882018|NCT00090233|83103201|FG000|Overall Study|Lost to Follow-up|68|||
46882019|NCT00090233|83103202|FG001|Overall Study|Lost to Follow-up|95|||
46704898|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
46704899|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
46704900|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
46704901|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
46704902|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
46704903|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
46704904|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
46704905|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
46704906|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
46704907|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Other|0|||
46704908|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Other|1|||
46704909|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Other|0|||
46704910|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Other|0|||
46704911|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
46704912|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
46704913|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
46704914|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
46704915|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
46704916|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
46704917|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
46704918|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
46704919|NCT01194414|82919790|FG000|24 Weeks Double Blind Period|Death|0|||
46704920|NCT01194414|82919791|FG001|24 Weeks Double Blind Period|Death|1|||
46704921|NCT01194414|82919792|FG002|24 Weeks Double Blind Period|Death|0|||
46704922|NCT01194414|82919793|FG003|24 Weeks Double Blind Period|Death|0|||
46704923|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
46704924|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
46704925|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
46704926|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
46704927|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
46704928|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
46704929|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
46704930|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
46704931|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
46704932|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
46704933|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
46704934|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
46704935|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
46704936|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
46704937|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
46704938|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
46704939|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
46704940|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
46704941|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
46704942|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
46704943|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
46704944|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
46704945|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
46704946|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
46704947|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Other|2|||
46704948|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Other|1|||
46704949|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Other|0|||
46704950|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Other|0|||
46704951|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
46704952|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
46882020|NCT00090233|83103201|FG000|Overall Study|Protocol Violation|960|||
46882021|NCT00090233|83103202|FG001|Overall Study|Protocol Violation|1022|||
46882022|NCT00090233|83103201|FG000|Overall Study|Withdrawal by Subject|182|||
46704953|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
46704954|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
46704955|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
46704956|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
46704957|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
46704958|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
46704959|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
46704960|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
46704961|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
46704962|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
46704963|NCT01194414|82919790|FG000|72 Weeks Open Label Extension|Death|1|||
46704964|NCT01194414|82919791|FG001|72 Weeks Open Label Extension|Death|2|||
46704965|NCT01194414|82919792|FG002|72 Weeks Open Label Extension|Death|0|||
46704966|NCT01194414|82919793|FG003|72 Weeks Open Label Extension|Death|2|||
46704967|NCT01194258|82919805|FG000|Titration Period|Withdrawal by Subject|6|||
46704968|NCT01194258|82919806|FG001|Titration Period|Withdrawal by Subject|0|||
46704969|NCT01194258|82919807|FG002|Titration Period|Withdrawal by Subject|0|||
46704970|NCT01194258|82919808|FG003|Titration Period|Withdrawal by Subject|0|||
46704971|NCT01194258|82919809|FG004|Titration Period|Withdrawal by Subject|0|||
46704972|NCT01194258|82919805|FG000|Titration Period|Lost to Follow-up|2|||
46704973|NCT01194258|82919806|FG001|Titration Period|Lost to Follow-up|0|||
46704974|NCT01194258|82919807|FG002|Titration Period|Lost to Follow-up|0|||
46704975|NCT01194258|82919808|FG003|Titration Period|Lost to Follow-up|0|||
46704976|NCT01194258|82919809|FG004|Titration Period|Lost to Follow-up|0|||
46704977|NCT01194258|82919805|FG000|Titration Period|Titration failure|3|||
46704978|NCT01194258|82919806|FG001|Titration Period|Titration failure|0|||
46704979|NCT01194258|82919807|FG002|Titration Period|Titration failure|0|||
46704980|NCT01194258|82919808|FG003|Titration Period|Titration failure|0|||
46704981|NCT01194258|82919809|FG004|Titration Period|Titration failure|0|||
46704982|NCT01194258|82919805|FG000|Period 1 (12 Weeks)|Death|0|||
46704983|NCT01194258|82919806|FG001|Period 1 (12 Weeks)|Death|0|||
46704984|NCT01194258|82919807|FG002|Period 1 (12 Weeks)|Death|0|||
46704985|NCT01194258|82919808|FG003|Period 1 (12 Weeks)|Death|0|||
46704986|NCT01194258|82919809|FG004|Period 1 (12 Weeks)|Death|1|||
46704987|NCT01194258|82919805|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46704988|NCT01194258|82919806|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46704989|NCT01194258|82919807|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46704990|NCT01194258|82919808|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
46704991|NCT01194258|82919809|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
46704992|NCT01194258|82919805|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
46704993|NCT01194258|82919806|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
46704994|NCT01194258|82919807|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
46704995|NCT01194258|82919808|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
46704996|NCT01194258|82919809|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
46704997|NCT01194258|82919805|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46704998|NCT01194258|82919806|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46704999|NCT01194258|82919807|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
46705000|NCT01194258|82919808|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46705001|NCT01194258|82919809|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
46882023|NCT00090233|83103202|FG001|Overall Study|Withdrawal by Subject|211|||
46882024|NCT00090233|83103201|FG000|Overall Study|Moved|203|||
46882025|NCT00090233|83103202|FG001|Overall Study|Moved|189|||
46705002|NCT01193556|82919822|FG000|Overall Study|Study termination|26|||
46705003|NCT01193556|82919823|FG001|Overall Study|Study termination|25|||
46705004|NCT00951496|82919836|FG000|Overall Study|Did not initiate study treatment|10|||
46705005|NCT00951496|82919837|FG001|Overall Study|Did not initiate study treatment|8|||
46705006|NCT00951496|82919838|FG002|Overall Study|Did not initiate study treatment|13|||
46705007|NCT01193244|82919851|FG000|Overall Study|Withdrawal by Subject|79|||
46882026|NCT00090233|83103201|FG000|Overall Study|Other|1211|||
46705008|NCT01193244|82919852|FG001|Overall Study|Withdrawal by Subject|97|||
46705009|NCT01193244|82919851|FG000|Overall Study|Other|303|||
46705010|NCT01193244|82919852|FG001|Overall Study|Other|278|||
46705011|NCT01193244|82919851|FG000|Overall Study|Lost to Follow-up|6|||
46705012|NCT01193244|82919852|FG001|Overall Study|Lost to Follow-up|15|||
46705013|NCT01192152|82919858|FG000|Period 1|left prematurely (while on treatment B)|0|||
46705014|NCT01192152|82919859|FG001|Period 1|left prematurely (while on treatment B)|1|||
46705015|NCT01192152|82919858|FG000|Period 3|family emergency|1|||
46705016|NCT01192152|82919859|FG001|Period 3|family emergency|0|||
46705017|NCT01191840|82919869|FG000|Overall Study|withdrew consent|2|||
46705018|NCT01191840|82919870|FG001|Overall Study|withdrew consent|1|||
46705019|NCT01191840|82919869|FG000|Overall Study|Subject discontinued treatment|1|||
46705020|NCT01191840|82919870|FG001|Overall Study|Subject discontinued treatment|2|||
46705021|NCT01191840|82919869|FG000|Overall Study|Lost to Follow-up|4|||
46705022|NCT01191840|82919870|FG001|Overall Study|Lost to Follow-up|6|||
46705023|NCT01191840|82919869|FG000|Overall Study|Non Staph Infection|4|||
46705024|NCT01191840|82919870|FG001|Overall Study|Non Staph Infection|3|||
46705025|NCT01191840|82919869|FG000|Overall Study|ineligible at enrollment|1|||
46705026|NCT01191840|82919870|FG001|Overall Study|ineligible at enrollment|0|||
46705027|NCT01191840|82919869|FG000|Overall Study|IRB approval lapse|0|||
46705028|NCT01191840|82919870|FG001|Overall Study|IRB approval lapse|2|||
46705029|NCT01191840|82919869|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
46705030|NCT01191840|82919870|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
46705031|NCT01191840|82919869|FG000|Overall Study|Withdrawal by Subject|2|||
46705032|NCT01191840|82919870|FG001|Overall Study|Withdrawal by Subject|0|||
46705033|NCT00943072|82919882|FG000|Overall Study|Adverse Event|0|||
46705034|NCT00943072|82919883|FG001|Overall Study|Adverse Event|3|||
46705035|NCT00943072|82919882|FG000|Overall Study|Death|0|||
46705036|NCT00943072|82919883|FG001|Overall Study|Death|2|||
46705037|NCT00943072|82919882|FG000|Overall Study|Withdrawal by Subject|3|||
46705038|NCT00943072|82919883|FG001|Overall Study|Withdrawal by Subject|1|||
46705039|NCT00943072|82919882|FG000|Overall Study|Protocol Violation|0|||
46705040|NCT00943072|82919883|FG001|Overall Study|Protocol Violation|1|||
46705041|NCT00943072|82919882|FG000|Overall Study|Lost to Follow-up|1|||
46705042|NCT00943072|82919883|FG001|Overall Study|Lost to Follow-up|2|||
46705043|NCT00943072|82919882|FG000|Overall Study|Lack of Efficacy|0|||
46705044|NCT00943072|82919883|FG001|Overall Study|Lack of Efficacy|4|||
46705045|NCT00943072|82919882|FG000|Overall Study|Other|1|||
46705046|NCT00943072|82919883|FG001|Overall Study|Other|1|||
46705047|NCT00942994|82919893|FG000|Overall Study|Adverse Event|7|||
46705048|NCT00942994|82919894|FG001|Overall Study|Adverse Event|4|||
46705049|NCT00942994|82919893|FG000|Overall Study|Abnormal laboratory value(s)|1|||
46705050|NCT00942994|82919894|FG001|Overall Study|Abnormal laboratory value(s)|0|||
46705051|NCT00942994|82919893|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46705052|NCT00942994|82919894|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
46705053|NCT00942994|82919893|FG000|Overall Study|Patient withdrew consent|5|||
46705054|NCT00942994|82919894|FG001|Overall Study|Patient withdrew consent|8|||
46705055|NCT00942994|82919893|FG000|Overall Study|Lost to Follow-up|1|||
46705056|NCT00942994|82919894|FG001|Overall Study|Lost to Follow-up|4|||
46705057|NCT00942994|82919893|FG000|Overall Study|Protocol deviation|1|||
46705058|NCT00942994|82919894|FG001|Overall Study|Protocol deviation|2|||
46705059|NCT00942604|82919902|FG000|Overall Study|Protocol Violation|1|||
46705060|NCT00942604|82919903|FG001|Overall Study|Protocol Violation|1|||
46705061|NCT00942604|82919902|FG000|Overall Study|Adverse Event|0|||
46705062|NCT00942604|82919903|FG001|Overall Study|Adverse Event|1|||
46705063|NCT00942604|82919902|FG000|Overall Study|Withdrawal by Subject|0|||
46705064|NCT00942604|82919903|FG001|Overall Study|Withdrawal by Subject|1|||
46705065|NCT00942604|82919902|FG000|Overall Study|Patient relocation|1|||
46705066|NCT00942604|82919903|FG001|Overall Study|Patient relocation|1|||
46705067|NCT01188564|82919911|FG000|Double-blind Phase|randomized not treated|1|||
46705068|NCT01188564|82919912|FG001|Double-blind Phase|randomized not treated|0|||
46705069|NCT01187550|82919920|FG000|Overall Study|Protocol Violation|3|||
46705070|NCT01187550|82919921|FG001|Overall Study|Protocol Violation|1|||
46705071|NCT01187550|82919920|FG000|Overall Study|Other|3|||
46705072|NCT01187550|82919921|FG001|Overall Study|Other|0|||
46705073|NCT01187550|82919920|FG000|Overall Study|Randomized but not treated|8|||
46705074|NCT01187550|82919921|FG001|Overall Study|Randomized but not treated|0|||
46705075|NCT01186770|82919931|FG000|Overall Study|Ineligibility|0|||
46705076|NCT01186770|82919932|FG001|Overall Study|Ineligibility|0|||
46705077|NCT01186770|82919933|FG002|Overall Study|Ineligibility|2|||
46705078|NCT01186770|82919934|FG003|Overall Study|Ineligibility|0|||
46705079|NCT01186770|82919931|FG000|Overall Study|Protocol Violation|7|||
46705080|NCT01186770|82919932|FG001|Overall Study|Protocol Violation|9|||
46705081|NCT01186770|82919933|FG002|Overall Study|Protocol Violation|12|||
46705082|NCT01186770|82919934|FG003|Overall Study|Protocol Violation|14|||
46705083|NCT01186770|82919931|FG000|Overall Study|Adverse Event|2|||
46705084|NCT01186770|82919932|FG001|Overall Study|Adverse Event|9|||
46705085|NCT01186770|82919933|FG002|Overall Study|Adverse Event|7|||
46705086|NCT01186770|82919934|FG003|Overall Study|Adverse Event|9|||
46705087|NCT01186770|82919931|FG000|Overall Study|Withdrawal by Subject|15|||
46705088|NCT01186770|82919932|FG001|Overall Study|Withdrawal by Subject|13|||
46705089|NCT01186770|82919933|FG002|Overall Study|Withdrawal by Subject|11|||
46705090|NCT01186770|82919934|FG003|Overall Study|Withdrawal by Subject|17|||
46705091|NCT01186770|82919931|FG000|Overall Study|Lost to Follow-up|10|||
46705092|NCT01186770|82919932|FG001|Overall Study|Lost to Follow-up|6|||
46705093|NCT01186770|82919933|FG002|Overall Study|Lost to Follow-up|14|||
46705094|NCT01186770|82919934|FG003|Overall Study|Lost to Follow-up|9|||
46705095|NCT01186770|82919931|FG000|Overall Study|Insufficient response to treatment|7|||
46705096|NCT01186770|82919932|FG001|Overall Study|Insufficient response to treatment|8|||
46705097|NCT01186770|82919933|FG002|Overall Study|Insufficient response to treatment|5|||
46705098|NCT01186770|82919934|FG003|Overall Study|Insufficient response to treatment|7|||
46705099|NCT01186770|82919931|FG000|Overall Study|Other than specified|0|||
46705100|NCT01186770|82919932|FG001|Overall Study|Other than specified|1|||
46705101|NCT01186770|82919933|FG002|Overall Study|Other than specified|1|||
46705102|NCT01186770|82919934|FG003|Overall Study|Other than specified|2|||
46705103|NCT01186692|82919944|FG000|Overall Study|Not Catheterized|11|||
46705104|NCT01186692|82919944|FG000|Overall Study|Futher testing contraindicated implant|19|||
46705105|NCT01186692|82919944|FG000|Overall Study|Adverse Event|2|||
46705106|NCT01186458|82919952|FG000|Overall Study|Adverse Event|1|||
46705107|NCT01185834|82919956|FG000|Overall Study|Lost to Follow-up|2|||
46705108|NCT01185834|82919956|FG000|Overall Study|Discomfort|4|||
46705109|NCT01185834|82919956|FG000|Overall Study|Biomicroscopy|4|||
46705110|NCT01185834|82919956|FG000|Overall Study|Time/Job Conflict|2|||
46705111|NCT01185834|82919956|FG000|Overall Study|Early exit - Site error|2|||
46705112|NCT01185600|82919962|FG000|Overall Study|Adverse Event|1|||
46705113|NCT01185600|82919963|FG001|Overall Study|Adverse Event|1|||
46705114|NCT01185600|82919962|FG000|Overall Study|Death|0|||
46705115|NCT01185600|82919963|FG001|Overall Study|Death|1|||
46705116|NCT01185600|82919962|FG000|Overall Study|Lost to Follow-up|0|||
46705117|NCT01185600|82919963|FG001|Overall Study|Lost to Follow-up|5|||
46705118|NCT01185600|82919962|FG000|Overall Study|Physician Decision|29|||
46705119|NCT01185600|82919963|FG001|Overall Study|Physician Decision|35|||
46882027|NCT00090233|83103202|FG001|Overall Study|Other|1160|||
46882028|NCT00090233|83103201|FG000|Overall Study|Data not available at data cut-off point|1552|||
46882029|NCT00090233|83103202|FG001|Overall Study|Data not available at data cut-off point|1563|||
46882030|NCT00069953|83103212|FG000|Overall Study|Protocol Violation|2|||
46882031|NCT02750800|83103222|FG000|Overall Study|Adverse Event|18|||
46882032|NCT02750800|83103222|FG000|Overall Study|Lost to Follow-up|12|||
46882033|NCT02750800|83103222|FG000|Overall Study|Investigator decision|53|||
46882034|NCT02750800|83103222|FG000|Overall Study|Patient request|12|||
46882035|NCT02750800|83103222|FG000|Overall Study|Other, not specified|3|||
46882036|NCT01329562|83103242|FG000|Overall Study|Protocol Violation|5|||
46882037|NCT01329562|83103243|FG001|Overall Study|Protocol Violation|3|||
46882038|NCT01329562|83103242|FG000|Overall Study|Lost to Follow-up|1|||
46705120|NCT01185600|82919962|FG000|Overall Study|Withdrawal by Subject|1|||
46705121|NCT01185600|82919963|FG001|Overall Study|Withdrawal by Subject|1|||
46705122|NCT01185600|82919962|FG000|Overall Study|Hold by DSMB|1|||
46882039|NCT01329562|83103243|FG001|Overall Study|Lost to Follow-up|1|||
46882040|NCT01329562|83103242|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
46882041|NCT01329562|83103243|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
46882042|NCT01329562|83103242|FG000|Overall Study|Physician Decision|0|||
46882043|NCT01329562|83103243|FG001|Overall Study|Physician Decision|1|||
46882044|NCT00069641|83103254|FG000|Overall Study|Death|1|||
46882045|NCT00069641|83103255|FG001|Overall Study|Death|0|||
46882046|NCT00069641|83103256|FG002|Overall Study|Death|1|||
46882047|NCT03653026|83103267|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
46882048|NCT03653026|83103268|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
46882049|NCT03653026|83103269|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
46882050|NCT03653026|83103270|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
46882051|NCT03653026|83103267|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
46882052|NCT03653026|83103268|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
46882053|NCT03653026|83103269|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46882054|NCT03653026|83103270|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
46882055|NCT03653026|83103267|FG000|Part 1: Placebo-controlled Period|Other|0|||
46882056|NCT03653026|83103268|FG001|Part 1: Placebo-controlled Period|Other|3|||
46882057|NCT03653026|83103269|FG002|Part 1: Placebo-controlled Period|Other|0|||
46882058|NCT03653026|83103270|FG003|Part 1: Placebo-controlled Period|Other|0|||
46882059|NCT03653026|83103267|FG000|Part 2: Open-label Extension|Adverse Event|0|||
46882060|NCT03653026|83103268|FG001|Part 2: Open-label Extension|Adverse Event|0|||
46882061|NCT03653026|83103269|FG002|Part 2: Open-label Extension|Adverse Event|1|||
46882062|NCT03653026|83103270|FG003|Part 2: Open-label Extension|Adverse Event|1|||
46882063|NCT03653026|83103267|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
46882064|NCT03653026|83103268|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
46882065|NCT03653026|83103269|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
46882066|NCT03653026|83103270|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
46882067|NCT03653026|83103267|FG000|Part 2: Open-label Extension|Other|0|||
46882068|NCT03653026|83103268|FG001|Part 2: Open-label Extension|Other|0|||
46882069|NCT03653026|83103269|FG002|Part 2: Open-label Extension|Other|1|||
46882070|NCT03653026|83103270|FG003|Part 2: Open-label Extension|Other|2|||
46882071|NCT01329328|83103281|FG000|Overall Study|Withdrawal by Subject|2|||
46882072|NCT01329328|83103282|FG001|Overall Study|Withdrawal by Subject|4|||
46882073|NCT01329328|83103283|FG002|Overall Study|Withdrawal by Subject|3|||
46882074|NCT01337986|83103293|FG000|Overall Study|Adverse Event|2|||
46882075|NCT01337986|83103294|FG001|Overall Study|Adverse Event|2|||
46882076|NCT01337986|83103293|FG000|Overall Study|Lost to Follow-up|1|||
46882077|NCT01337986|83103294|FG001|Overall Study|Lost to Follow-up|0|||
46882078|NCT01337986|83103293|FG000|Overall Study|Protocol Violation|0|||
46882079|NCT01337986|83103294|FG001|Overall Study|Protocol Violation|3|||
46882080|NCT01337674|83103318|FG000|Treatment Period 1|Adverse Event|0|||
46882081|NCT01337674|83103319|FG001|Treatment Period 1|Adverse Event|1|||
46882082|NCT01337674|83103320|FG002|Treatment Period 1|Adverse Event|0|||
46882083|NCT01337674|83103321|FG003|Treatment Period 1|Adverse Event|0|||
46882084|NCT01337674|83103318|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
46882085|NCT01337674|83103319|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
46882086|NCT01337674|83103320|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
46882087|NCT01337674|83103321|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
46882088|NCT01337674|83103318|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46882089|NCT01337674|83103319|FG001|Treatment Period 2|Withdrawal by Subject|0|||
46882090|NCT01337674|83103320|FG002|Treatment Period 2|Withdrawal by Subject|1|||
46882091|NCT01337674|83103321|FG003|Treatment Period 2|Withdrawal by Subject|0|||
46882092|NCT02750410|83103336|FG000|Double-Blind Treatment Period|Adverse Event|2|||
46882093|NCT02750410|83103337|FG001|Double-Blind Treatment Period|Adverse Event|2|||
46882094|NCT02750410|83103336|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46882095|NCT02750410|83103337|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
46882096|NCT02750410|83103336|FG000|Open-Label Extension Period|Adverse Event|5|||
46882097|NCT02750410|83103337|FG001|Open-Label Extension Period|Adverse Event|3|||
46882098|NCT02750410|83103336|FG000|Open-Label Extension Period|Protocol Violation|0|||
46882099|NCT02750410|83103337|FG001|Open-Label Extension Period|Protocol Violation|1|||
46882100|NCT02750410|83103336|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
46991083|NCT02527343|83238022|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
46991084|NCT02527343|83238023|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
46882101|NCT02750410|83103337|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
46882102|NCT02750332|83103347|FG000|Treatment Period 1|Withdrawal by Subject|0|||
46882103|NCT02750332|83103348|FG001|Treatment Period 1|Withdrawal by Subject|1|||
46882104|NCT01337596|83103363|FG000|Overall Study|Withdrawal by Subject|0|||
46882105|NCT01337596|83103364|FG001|Overall Study|Withdrawal by Subject|0|||
46882106|NCT01337596|83103365|FG002|Overall Study|Withdrawal by Subject|0|||
46882107|NCT01337596|83103366|FG003|Overall Study|Withdrawal by Subject|0|||
46882108|NCT01337596|83103367|FG004|Overall Study|Withdrawal by Subject|2|||
46991085|NCT02527343|83238024|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
46882109|NCT01337596|83103368|FG005|Overall Study|Withdrawal by Subject|0|||
46882110|NCT01337596|83103369|FG006|Overall Study|Withdrawal by Subject|0|||
46882111|NCT01337596|83103370|FG007|Overall Study|Withdrawal by Subject|0|||
46882112|NCT01337596|83103371|FG008|Overall Study|Withdrawal by Subject|0|||
46882113|NCT00069095|83103400|FG000|Primary Treatment Phase|Ongoing|0|||
46882114|NCT00069095|83103401|FG001|Primary Treatment Phase|Ongoing|0|||
46882115|NCT00069095|83103402|FG002|Primary Treatment Phase|Ongoing|5|||
46882116|NCT00069095|83103403|FG003|Primary Treatment Phase|Ongoing|7|||
46882117|NCT00069095|83103404|FG004|Primary Treatment Phase|Ongoing|7|||
46882118|NCT00069095|83103405|FG005|Primary Treatment Phase|Ongoing|4|||
46882119|NCT00069095|83103400|FG000|Primary Treatment Phase|Admin/Other|29|||
46882120|NCT00069095|83103401|FG001|Primary Treatment Phase|Admin/Other|38|||
46882121|NCT00069095|83103402|FG002|Primary Treatment Phase|Admin/Other|31|||
46882122|NCT00069095|83103403|FG003|Primary Treatment Phase|Admin/Other|45|||
46882123|NCT00069095|83103404|FG004|Primary Treatment Phase|Admin/Other|48|||
46882124|NCT00069095|83103405|FG005|Primary Treatment Phase|Admin/Other|42|||
46882125|NCT00069095|83103400|FG000|Primary Treatment Phase|Adverse Event|99|||
46882126|NCT00069095|83103401|FG001|Primary Treatment Phase|Adverse Event|92|||
46882127|NCT00069095|83103402|FG002|Primary Treatment Phase|Adverse Event|71|||
46882128|NCT00069095|83103403|FG003|Primary Treatment Phase|Adverse Event|72|||
46882129|NCT00069095|83103404|FG004|Primary Treatment Phase|Adverse Event|109|||
46882130|NCT00069095|83103405|FG005|Primary Treatment Phase|Adverse Event|101|||
46882131|NCT00069095|83103400|FG000|Primary Treatment Phase|Death|14|||
46882132|NCT00069095|83103401|FG001|Primary Treatment Phase|Death|8|||
46882133|NCT00069095|83103402|FG002|Primary Treatment Phase|Death|2|||
46882134|NCT00069095|83103403|FG003|Primary Treatment Phase|Death|5|||
46882135|NCT00069095|83103404|FG004|Primary Treatment Phase|Death|8|||
46882136|NCT00069095|83103405|FG005|Primary Treatment Phase|Death|8|||
46882137|NCT00069095|83103400|FG000|Primary Treatment Phase|Failure to return|5|||
46882138|NCT00069095|83103401|FG001|Primary Treatment Phase|Failure to return|5|||
46882139|NCT00069095|83103402|FG002|Primary Treatment Phase|Failure to return|0|||
46882140|NCT00069095|83103403|FG003|Primary Treatment Phase|Failure to return|0|||
46882141|NCT00069095|83103404|FG004|Primary Treatment Phase|Failure to return|0|||
46882142|NCT00069095|83103405|FG005|Primary Treatment Phase|Failure to return|2|||
46882143|NCT00069095|83103400|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
46882144|NCT00069095|83103401|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
46882145|NCT00069095|83103402|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
46882146|NCT00069095|83103403|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
46882147|NCT00069095|83103404|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
46882148|NCT00069095|83103405|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
46882149|NCT00069095|83103400|FG000|Primary Treatment Phase|Refused treatment|15|||
46882150|NCT00069095|83103401|FG001|Primary Treatment Phase|Refused treatment|26|||
46882151|NCT00069095|83103402|FG002|Primary Treatment Phase|Refused treatment|17|||
46882152|NCT00069095|83103403|FG003|Primary Treatment Phase|Refused treatment|31|||
46882153|NCT00069095|83103404|FG004|Primary Treatment Phase|Refused treatment|24|||
46882154|NCT00069095|83103405|FG005|Primary Treatment Phase|Refused treatment|27|||
46882155|NCT00069095|83103400|FG000|Primary Treatment Phase|Withdrew|2|||
46882156|NCT00069095|83103401|FG001|Primary Treatment Phase|Withdrew|3|||
46882157|NCT00069095|83103402|FG002|Primary Treatment Phase|Withdrew|8|||
46882158|NCT00069095|83103403|FG003|Primary Treatment Phase|Withdrew|2|||
46882159|NCT00069095|83103404|FG004|Primary Treatment Phase|Withdrew|4|||
46882160|NCT00069095|83103405|FG005|Primary Treatment Phase|Withdrew|9|||
46882161|NCT00069095|83103400|FG000|Primary Treatment Phase|Other Violation|0|||
46882162|NCT00069095|83103401|FG001|Primary Treatment Phase|Other Violation|1|||
46882163|NCT00069095|83103402|FG002|Primary Treatment Phase|Other Violation|1|||
46882164|NCT00069095|83103403|FG003|Primary Treatment Phase|Other Violation|1|||
46882165|NCT00069095|83103404|FG004|Primary Treatment Phase|Other Violation|0|||
46882166|NCT00069095|83103405|FG005|Primary Treatment Phase|Other Violation|1|||
46882167|NCT00069095|83103400|FG000|Primary Treatment Phase|Violation criteria|0|||
46882168|NCT00069095|83103401|FG001|Primary Treatment Phase|Violation criteria|2|||
46882169|NCT00069095|83103402|FG002|Primary Treatment Phase|Violation criteria|4|||
46882170|NCT00069095|83103403|FG003|Primary Treatment Phase|Violation criteria|3|||
46882171|NCT00069095|83103404|FG004|Primary Treatment Phase|Violation criteria|1|||
46882172|NCT00069095|83103405|FG005|Primary Treatment Phase|Violation criteria|5|||
46882173|NCT00069095|83103400|FG000|Post-study Treatment Phase|Missing reason|1|||
46882174|NCT00069095|83103401|FG001|Post-study Treatment Phase|Missing reason|3|||
46882175|NCT00069095|83103402|FG002|Post-study Treatment Phase|Missing reason|12|||
46882176|NCT00069095|83103403|FG003|Post-study Treatment Phase|Missing reason|8|||
46882177|NCT00069095|83103404|FG004|Post-study Treatment Phase|Missing reason|18|||
46882178|NCT00069095|83103405|FG005|Post-study Treatment Phase|Missing reason|17|||
46882179|NCT00069095|83103400|FG000|Post-study Treatment Phase|Adverse Event|2|||
46882180|NCT00069095|83103401|FG001|Post-study Treatment Phase|Adverse Event|3|||
46882181|NCT00069095|83103402|FG002|Post-study Treatment Phase|Adverse Event|1|||
46882182|NCT00069095|83103403|FG003|Post-study Treatment Phase|Adverse Event|0|||
46882183|NCT00069095|83103404|FG004|Post-study Treatment Phase|Adverse Event|5|||
46882184|NCT00069095|83103405|FG005|Post-study Treatment Phase|Adverse Event|1|||
46882185|NCT00069095|83103400|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
46882186|NCT00069095|83103401|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
46882187|NCT00069095|83103402|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
46882188|NCT00069095|83103403|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
46882189|NCT00069095|83103404|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
46882190|NCT00069095|83103405|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
46882191|NCT00069095|83103400|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
46882192|NCT00069095|83103401|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
46882193|NCT00069095|83103402|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
46882194|NCT00069095|83103403|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
46882195|NCT00069095|83103404|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
46882196|NCT00069095|83103405|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
46882197|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
46882198|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
46882199|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
46882200|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
46882201|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
46882202|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
46882203|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant had complete response|1|||
46882204|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant had complete response|1|||
46882205|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant had complete response|0|||
46882206|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant had complete response|0|||
46882207|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant had complete response|0|||
46882208|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant had complete response|0|||
46882209|NCT00069095|83103400|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
46882210|NCT00069095|83103401|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
46882211|NCT00069095|83103402|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
46882212|NCT00069095|83103403|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
46882213|NCT00069095|83103404|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
46882214|NCT00069095|83103405|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
46882215|NCT00069095|83103400|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
46882216|NCT00069095|83103401|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
46882217|NCT00069095|83103402|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
46882218|NCT00069095|83103403|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
46882219|NCT00069095|83103404|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
46882220|NCT00069095|83103405|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
46882221|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
46882222|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
46882223|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
46882224|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
46882225|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
46882226|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
46882227|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
46882228|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
46882229|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
46882230|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
46882231|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
46882232|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
46882233|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
46882234|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
46882235|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
46882236|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
46882237|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
46882238|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
46882239|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
46882240|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
46882241|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
46882242|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
46882243|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
46882244|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
46882245|NCT00069095|83103400|FG000|Post-study Treatment Phase|Surgery|0|||
46882246|NCT00069095|83103401|FG001|Post-study Treatment Phase|Surgery|0|||
46882247|NCT00069095|83103402|FG002|Post-study Treatment Phase|Surgery|0|||
46882248|NCT00069095|83103403|FG003|Post-study Treatment Phase|Surgery|1|||
46882249|NCT00069095|83103404|FG004|Post-study Treatment Phase|Surgery|1|||
46882250|NCT00069095|83103405|FG005|Post-study Treatment Phase|Surgery|0|||
46882251|NCT00069095|83103400|FG000|Post-study Treatment Phase|Death|0|||
46882252|NCT00069095|83103401|FG001|Post-study Treatment Phase|Death|0|||
46882253|NCT00069095|83103402|FG002|Post-study Treatment Phase|Death|0|||
46882254|NCT00069095|83103403|FG003|Post-study Treatment Phase|Death|0|||
46882255|NCT00069095|83103404|FG004|Post-study Treatment Phase|Death|1|||
46882256|NCT00069095|83103405|FG005|Post-study Treatment Phase|Death|0|||
46882257|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
46882258|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
46882259|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
46882260|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
46882261|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
46882262|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
46882263|NCT00069095|83103400|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
46882264|NCT00069095|83103401|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
46882265|NCT00069095|83103402|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
46882266|NCT00069095|83103403|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
46882267|NCT00069095|83103404|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
46882268|NCT00069095|83103405|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
46882269|NCT00069095|83103400|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
46882270|NCT00069095|83103401|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
46882271|NCT00069095|83103402|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
46882272|NCT00069095|83103403|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
46882273|NCT00069095|83103404|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
46882274|NCT00069095|83103405|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
46882275|NCT00069095|83103400|FG000|Post-study Treatment Phase|Investigator decision|0|||
46882276|NCT00069095|83103401|FG001|Post-study Treatment Phase|Investigator decision|0|||
46882277|NCT00069095|83103402|FG002|Post-study Treatment Phase|Investigator decision|0|||
46882278|NCT00069095|83103403|FG003|Post-study Treatment Phase|Investigator decision|0|||
46882279|NCT00069095|83103404|FG004|Post-study Treatment Phase|Investigator decision|0|||
46882280|NCT00069095|83103405|FG005|Post-study Treatment Phase|Investigator decision|1|||
46882281|NCT00069095|83103400|FG000|Follow-up Phase|Death|174|||
46882282|NCT00069095|83103401|FG001|Follow-up Phase|Death|206|||
46882283|NCT00069095|83103402|FG002|Follow-up Phase|Death|120|||
46882284|NCT00069095|83103403|FG003|Follow-up Phase|Death|112|||
46882285|NCT00069095|83103404|FG004|Follow-up Phase|Death|92|||
46882286|NCT00069095|83103405|FG005|Follow-up Phase|Death|101|||
46882287|NCT00086411|83103421|FG000|Overall Study|Lost to Follow-up|11|||
46882288|NCT00086411|83103422|FG001|Overall Study|Lost to Follow-up|11|||
46882289|NCT00086411|83103423|FG002|Overall Study|Lost to Follow-up|13|||
46882290|NCT00086411|83103424|FG003|Overall Study|Lost to Follow-up|12|||
46882291|NCT00068237|83103435|FG000|Overall Study|Ineligible|3|||
46882292|NCT00068237|83103435|FG000|Overall Study|No protocol treatment received|2|||
46882293|NCT00055601|83103441|FG000|Overall Study|Protocol Violation|1|||
46882294|NCT00055601|83103442|FG001|Overall Study|Protocol Violation|1|||
46882295|NCT00055601|83103441|FG000|Overall Study|No protocol treatment received|1|||
46882296|NCT00055601|83103442|FG001|Overall Study|No protocol treatment received|1|||
46882297|NCT03806231|83103450|FG000|Overall Study|Physician Decision|1|||
46882298|NCT03806231|83103451|FG001|Overall Study|Physician Decision|0|||
46882299|NCT03806231|83103450|FG000|Overall Study|Withdrawal by Subject|1|||
46882300|NCT03806231|83103451|FG001|Overall Study|Withdrawal by Subject|0|||
46882301|NCT00054275|83103457|FG000|Overall Study|Withdrawal by Subject|4|||
46882302|NCT00054275|83103457|FG000|Overall Study|Adverse Event|5|||
46882303|NCT00054275|83103457|FG000|Overall Study|Progressive disease in cycle 1|1|||
46882304|NCT00054275|83103457|FG000|Overall Study|Physician Decision|1|||
46882305|NCT00053417|83103465|FG000|Overall Study|Adverse Event|1|||
46882306|NCT00053417|83103466|FG001|Overall Study|Adverse Event|0|||
46882307|NCT00053417|83103467|FG002|Overall Study|Adverse Event|1|||
46882308|NCT00053417|83103468|FG003|Overall Study|Adverse Event|5|||
46882309|NCT00053417|83103465|FG000|Overall Study|Non-Compliance|0|||
46882310|NCT00053417|83103466|FG001|Overall Study|Non-Compliance|0|||
46882311|NCT00053417|83103467|FG002|Overall Study|Non-Compliance|0|||
46882312|NCT00053417|83103468|FG003|Overall Study|Non-Compliance|1|||
46882313|NCT00053417|83103465|FG000|Overall Study|Withdrawal by Subject|0|||
46882314|NCT00053417|83103466|FG001|Overall Study|Withdrawal by Subject|1|||
46882315|NCT00053417|83103467|FG002|Overall Study|Withdrawal by Subject|0|||
46882316|NCT00053417|83103468|FG003|Overall Study|Withdrawal by Subject|0|||
46882317|NCT00053417|83103465|FG000|Overall Study|Lost to Follow-up|1|||
46882318|NCT00053417|83103466|FG001|Overall Study|Lost to Follow-up|1|||
46882319|NCT00053417|83103467|FG002|Overall Study|Lost to Follow-up|0|||
46882320|NCT00053417|83103468|FG003|Overall Study|Lost to Follow-up|0|||
46882321|NCT00052715|83103478|FG000|Overall Study|wrong histology|1|||
46882322|NCT00051311|83103484|FG000|Overall Study|Starting new study|0|||
46882323|NCT00051311|83103485|FG001|Overall Study|Starting new study|1|||
46882324|NCT00051311|83103484|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
46882325|NCT00051311|83103485|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
46882326|NCT00051311|83103484|FG000|Overall Study|Death of recipient|8|||
46882327|NCT00051311|83103485|FG001|Overall Study|Death of recipient|8|||
46882328|NCT00051311|83103484|FG000|Overall Study|Recipient taken off study|4|||
46882329|NCT00051311|83103485|FG001|Overall Study|Recipient taken off study|4|||
46882330|NCT00049673|83103491|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
46882331|NCT00049673|83103492|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
46882332|NCT00049127|83103503|FG000|Overall Study|Withdrawal by Subject|0|||
46882333|NCT00049127|83103504|FG001|Overall Study|Withdrawal by Subject|0|||
46882334|NCT00049127|83103505|FG002|Overall Study|Withdrawal by Subject|1|||
46882335|NCT00049127|83103506|FG003|Overall Study|Withdrawal by Subject|0|||
46882336|NCT00049127|83103507|FG004|Overall Study|Withdrawal by Subject|0|||
46882337|NCT00066365|83103521|FG000|Overall Study|Adverse Event|1|||
46882338|NCT00066365|83103522|FG001|Overall Study|Adverse Event|0|||
46882339|NCT00066365|83103521|FG000|Overall Study|Lack of Efficacy|15|||
46882340|NCT00066365|83103522|FG001|Overall Study|Lack of Efficacy|12|||
46882341|NCT00066365|83103521|FG000|Overall Study|Physician Decision|1|||
46882342|NCT00066365|83103522|FG001|Overall Study|Physician Decision|0|||
46882343|NCT00066365|83103521|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
46882344|NCT00066365|83103522|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
46882345|NCT00066365|83103521|FG000|Overall Study|Ineligible|4|||
46882346|NCT00066365|83103522|FG001|Overall Study|Ineligible|2|||
46882347|NCT00048581|83103532|FG000|Double-Blind Period|Adverse Event|9|||
46882348|NCT00048581|83103533|FG001|Double-Blind Period|Adverse Event|5|||
46882349|NCT00048581|83103534|FG002|Double-Blind Period|Adverse Event|0|||
46882350|NCT00048581|83103532|FG000|Double-Blind Period|Lack of Efficacy|14|||
46882351|NCT00048581|83103533|FG001|Double-Blind Period|Lack of Efficacy|27|||
46882352|NCT00048581|83103534|FG002|Double-Blind Period|Lack of Efficacy|0|||
46882353|NCT00048581|83103532|FG000|Double-Blind Period|Lost to Follow-up|5|||
46882354|NCT00048581|83103533|FG001|Double-Blind Period|Lost to Follow-up|0|||
46882355|NCT00048581|83103534|FG002|Double-Blind Period|Lost to Follow-up|0|||
46882356|NCT00048581|83103532|FG000|Double-Blind Period|Withdrawal by Subject|5|||
46882357|NCT00048581|83103533|FG001|Double-Blind Period|Withdrawal by Subject|2|||
46882358|NCT00048581|83103534|FG002|Double-Blind Period|Withdrawal by Subject|0|||
46882359|NCT00048581|83103532|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
46882360|NCT00048581|83103533|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
46882361|NCT00048581|83103534|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
46882362|NCT00048581|83103532|FG000|Double-Blind Period|Investigator Decision|1|||
46882363|NCT00048581|83103533|FG001|Double-Blind Period|Investigator Decision|0|||
46882364|NCT00048581|83103534|FG002|Double-Blind Period|Investigator Decision|0|||
46882365|NCT00048581|83103532|FG000|Open-Label Period|Death|0|||
46882366|NCT00048581|83103533|FG001|Open-Label Period|Death|0|||
46882367|NCT00048581|83103534|FG002|Open-Label Period|Death|4|||
46882368|NCT00048581|83103532|FG000|Open-Label Period|Adverse Event|0|||
46882369|NCT00048581|83103533|FG001|Open-Label Period|Adverse Event|0|||
46882370|NCT00048581|83103534|FG002|Open-Label Period|Adverse Event|37|||
46882371|NCT00048581|83103532|FG000|Open-Label Period|Lack of Efficacy|0|||
46882372|NCT00048581|83103533|FG001|Open-Label Period|Lack of Efficacy|0|||
46882373|NCT00048581|83103534|FG002|Open-Label Period|Lack of Efficacy|69|||
46882374|NCT00048581|83103532|FG000|Open-Label Period|Lost to Follow-up|0|||
46882375|NCT00048581|83103533|FG001|Open-Label Period|Lost to Follow-up|0|||
46882376|NCT00048581|83103534|FG002|Open-Label Period|Lost to Follow-up|14|||
46882377|NCT00048581|83103532|FG000|Open-Label Period|Withdrawal by Subject|0|||
46882378|NCT00048581|83103533|FG001|Open-Label Period|Withdrawal by Subject|0|||
46882379|NCT00048581|83103534|FG002|Open-Label Period|Withdrawal by Subject|20|||
46882380|NCT00048581|83103532|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
46882381|NCT00048581|83103533|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
46882382|NCT00048581|83103534|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
46882383|NCT00048581|83103532|FG000|Open-Label Period|Poor/Non-compliance|0|||
46882384|NCT00048581|83103533|FG001|Open-Label Period|Poor/Non-compliance|0|||
46882385|NCT00048581|83103534|FG002|Open-Label Period|Poor/Non-compliance|5|||
46882386|NCT00048581|83103532|FG000|Open-Label Period|Pregnancy|0|||
46882387|NCT00048581|83103533|FG001|Open-Label Period|Pregnancy|0|||
46882388|NCT00048581|83103534|FG002|Open-Label Period|Pregnancy|7|||
46882389|NCT00048581|83103532|FG000|Open-Label Period|Study Site Closure|0|||
46882390|NCT00048581|83103533|FG001|Open-Label Period|Study Site Closure|0|||
46882391|NCT00048581|83103534|FG002|Open-Label Period|Study Site Closure|2|||
46882392|NCT00048581|83103532|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
46882393|NCT00048581|83103533|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
46882394|NCT00048581|83103534|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
46882395|NCT00048581|83103532|FG000|Open-Label Period|Problem With Transportation To Site|0|||
46882396|NCT00048581|83103533|FG001|Open-Label Period|Problem With Transportation To Site|0|||
46882397|NCT00048581|83103534|FG002|Open-Label Period|Problem With Transportation To Site|1|||
46882398|NCT00048581|83103532|FG000|Open-Label Period|Primary Investigator Retired|0|||
46882399|NCT00048581|83103533|FG001|Open-Label Period|Primary Investigator Retired|0|||
46882400|NCT00048581|83103534|FG002|Open-Label Period|Primary Investigator Retired|2|||
46882401|NCT00048581|83103532|FG000|Open-Label Period|Study Ended By Sponsor|0|||
46882402|NCT00048581|83103533|FG001|Open-Label Period|Study Ended By Sponsor|0|||
46882403|NCT00048581|83103534|FG002|Open-Label Period|Study Ended By Sponsor|1|||
46882404|NCT00048347|83103547|FG000|Overall Study|Screen failure|2|||
46882405|NCT00065507|83103553|FG000|Overall Study|Death|16|||
46882406|NCT00065507|83103554|FG001|Overall Study|Death|17|||
46882407|NCT00065507|83103553|FG000|Overall Study|Adverse Event|4|||
46882408|NCT00065507|83103554|FG001|Overall Study|Adverse Event|3|||
46882409|NCT00065507|83103553|FG000|Overall Study|Lack of Efficacy|0|||
46882410|NCT00065507|83103554|FG001|Overall Study|Lack of Efficacy|6|||
46882411|NCT00065507|83103553|FG000|Overall Study|Poor/Non-compliance|3|||
46882412|NCT00065507|83103554|FG001|Overall Study|Poor/Non-compliance|2|||
46882413|NCT00065507|83103553|FG000|Overall Study|Lost to Follow-up|3|||
46882414|NCT00065507|83103554|FG001|Overall Study|Lost to Follow-up|0|||
46882415|NCT00065507|83103553|FG000|Overall Study|Subject Withdrew Consent|2|||
46882416|NCT00065507|83103554|FG001|Overall Study|Subject Withdrew Consent|1|||
46882417|NCT00065507|83103553|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
46882418|NCT00065507|83103554|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
46882419|NCT00065429|83103571|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
46882420|NCT00065429|83103572|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
46882421|NCT00065429|83103573|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
46882422|NCT00065429|83103574|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
46882423|NCT00065429|83103575|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
46882424|NCT00065429|83103576|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
46882425|NCT00065429|83103577|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
46882426|NCT00065429|83103571|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
46882427|NCT00065429|83103572|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
46882428|NCT00065429|83103573|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
46882429|NCT00065429|83103574|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
46882430|NCT00065429|83103575|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
46882431|NCT00065429|83103576|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
46882432|NCT00065429|83103577|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
46882433|NCT00065429|83103571|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
46882434|NCT00065429|83103572|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
46882435|NCT00065429|83103573|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
46705123|NCT01185600|82919963|FG001|Overall Study|Hold by DSMB|2|||
46882436|NCT00065429|83103574|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
46882437|NCT00065429|83103575|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
46882438|NCT00065429|83103576|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
46882439|NCT00065429|83103577|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
46882440|NCT00065429|83103571|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
46882441|NCT00065429|83103572|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
46882442|NCT00065429|83103573|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
46882443|NCT00065429|83103574|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
46882444|NCT00065429|83103575|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
46882445|NCT00065429|83103576|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
46882446|NCT00065429|83103577|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
46882447|NCT00065429|83103571|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
46882448|NCT00065429|83103572|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
46882449|NCT00065429|83103573|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
46882450|NCT00065429|83103574|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
46882451|NCT00065429|83103575|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
46882452|NCT00065429|83103576|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
46882453|NCT00065429|83103577|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
46882454|NCT00065429|83103571|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
46882455|NCT00065429|83103572|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
46882456|NCT00065429|83103573|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
46882457|NCT00065429|83103574|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
46882458|NCT00065429|83103575|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
46882459|NCT00065429|83103576|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
46882460|NCT00065429|83103577|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
46882461|NCT00065429|83103571|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
46882462|NCT00065429|83103572|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
46882463|NCT00065429|83103573|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
46882464|NCT00065429|83103574|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
46882465|NCT00065429|83103575|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
46882466|NCT00065429|83103576|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
46882467|NCT00065429|83103577|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
46882468|NCT00048035|83103594|FG000|Core Period|Early Withdrawals|4|||
46882469|NCT00048035|83103595|FG001|Core Period|Early Withdrawals|2|||
46882470|NCT00048035|83103596|FG002|Core Period|Early Withdrawals|1|||
46882471|NCT00048035|83103597|FG003|Core Period|Early Withdrawals|1|||
46882472|NCT00048035|83103598|FG004|Core Period|Early Withdrawals|1|||
46882473|NCT00048035|83103599|FG005|Core Period|Early Withdrawals|1|||
46882474|NCT00048035|83103600|FG006|Core Period|Early Withdrawals|0|||
46882475|NCT00048035|83103601|FG007|Core Period|Early Withdrawals|0|||
46882476|NCT00048035|83103594|FG000|Extension Year 1|Early Withdrawals|0|||
46882477|NCT00048035|83103595|FG001|Extension Year 1|Early Withdrawals|0|||
46882478|NCT00048035|83103596|FG002|Extension Year 1|Early Withdrawals|0|||
46882479|NCT00048035|83103597|FG003|Extension Year 1|Early Withdrawals|0|||
46882480|NCT00048035|83103598|FG004|Extension Year 1|Early Withdrawals|0|||
46882481|NCT00048035|83103599|FG005|Extension Year 1|Early Withdrawals|0|||
46882482|NCT00048035|83103600|FG006|Extension Year 1|Early Withdrawals|11|||
46882483|NCT00048035|83103601|FG007|Extension Year 1|Early Withdrawals|11|||
46882484|NCT00048035|83103594|FG000|Extension Year 2|Early Withdrawals|0|||
46882485|NCT00048035|83103595|FG001|Extension Year 2|Early Withdrawals|0|||
46882486|NCT00048035|83103596|FG002|Extension Year 2|Early Withdrawals|0|||
46882487|NCT00048035|83103597|FG003|Extension Year 2|Early Withdrawals|0|||
46882488|NCT00048035|83103598|FG004|Extension Year 2|Early Withdrawals|0|||
46882489|NCT00048035|83103599|FG005|Extension Year 2|Early Withdrawals|0|||
46882490|NCT00048035|83103600|FG006|Extension Year 2|Early Withdrawals|3|||
46882491|NCT00048035|83103601|FG007|Extension Year 2|Early Withdrawals|3|||
46882492|NCT00047879|83103618|FG000|Overall Study|Progressive disease|4|||
46882493|NCT00047879|83103619|FG001|Overall Study|Progressive disease|3|||
46882494|NCT00064337|83103625|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
46882495|NCT00064337|83103625|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
46882496|NCT00064337|83103625|FG000|PBSCC or Induction/PBSCC|Progression|3|||
46882497|NCT00064337|83103625|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
46882498|NCT00064337|83103625|FG000|PBSCC or Induction/PBSCC|Death|2|||
46882499|NCT00064337|83103625|FG000|Transplant|Adverse Event|9|||
46882500|NCT00064337|83103625|FG000|Transplant|Not protocol-specified|5|||
46882501|NCT00064337|83103625|FG000|Transplant|Death|3|||
46882502|NCT00064337|83103625|FG000|Transplant|Patient Refusal|2|||
46882503|NCT00064337|83103625|FG000|Transplant|Progression|2|||
46882504|NCT00064337|83103625|FG000|Maintenance|Adverse Event|3|||
46882505|NCT00064337|83103625|FG000|Maintenance|Progression|2|||
46882506|NCT00064337|83103625|FG000|Maintenance|On treatment at time of analysis|2|||
46882507|NCT00064337|83103625|FG000|Maintenance|Not protocol-specified|2|||
46882508|NCT00064337|83103625|FG000|Maintenance|Death|1|||
46882509|NCT00064259|83103632|FG000|Overall Study|Adverse Event|1|||
46882510|NCT00064259|83103633|FG001|Overall Study|Adverse Event|0|||
46882511|NCT00064259|83103634|FG002|Overall Study|Adverse Event|0|||
46882512|NCT00064259|83103635|FG003|Overall Study|Adverse Event|1|||
46882513|NCT00044213|83103644|FG000|Overall Study|Withdrawal by Subject|50|||
46882514|NCT00044213|83103645|FG001|Overall Study|Withdrawal by Subject|65|||
46882515|NCT00044213|83103646|FG002|Overall Study|Withdrawal by Subject|91|||
46882516|NCT00044213|83103647|FG003|Overall Study|Withdrawal by Subject|83|||
46882517|NCT00044213|83103644|FG000|Overall Study|Death|42|||
46882518|NCT00044213|83103645|FG001|Overall Study|Death|42|||
46882519|NCT00044213|83103646|FG002|Overall Study|Death|42|||
46882520|NCT00044213|83103647|FG003|Overall Study|Death|49|||
46882521|NCT00044213|83103644|FG000|Overall Study|Lost to Follow-up|8|||
46882522|NCT00044213|83103645|FG001|Overall Study|Lost to Follow-up|5|||
46882523|NCT00044213|83103646|FG002|Overall Study|Lost to Follow-up|5|||
46882524|NCT00044213|83103647|FG003|Overall Study|Lost to Follow-up|4|||
46882525|NCT00064025|83103657|FG000|Overall Study|Ineligible|4|||
46882526|NCT00064025|83103657|FG000|Overall Study|Inevaluable|3|||
46882527|NCT00043979|83103665|FG000|Period 1|recipient with progressive disease|7|||
46882528|NCT00043979|83103666|FG001|Period 1|recipient with progressive disease|4|||
46882529|NCT00043979|83103667|FG002|Period 1|recipient with progressive disease|3|||
46882530|NCT00039377|83103684|FG000|Initial Registration|Adverse Event|2|||
46882531|NCT00039377|83103685|FG001|Initial Registration|Adverse Event|0|||
46882532|NCT00039377|83103686|FG002|Initial Registration|Adverse Event|0|||
46882533|NCT00039377|83103687|FG003|Initial Registration|Adverse Event|0|||
46882534|NCT00039377|83103684|FG000|Initial Registration|Relapsed|6|||
46882535|NCT00039377|83103685|FG001|Initial Registration|Relapsed|0|||
46882536|NCT00039377|83103686|FG002|Initial Registration|Relapsed|0|||
46882537|NCT00039377|83103687|FG003|Initial Registration|Relapsed|0|||
46882538|NCT00039377|83103684|FG000|Initial Registration|Received non-protocol therapy|11|||
46882539|NCT00039377|83103685|FG001|Initial Registration|Received non-protocol therapy|0|||
46882540|NCT00039377|83103686|FG002|Initial Registration|Received non-protocol therapy|0|||
46882541|NCT00039377|83103687|FG003|Initial Registration|Received non-protocol therapy|0|||
46882542|NCT00039377|83103684|FG000|Initial Registration|Withdrawal by Subject|3|||
46882543|NCT00039377|83103685|FG001|Initial Registration|Withdrawal by Subject|0|||
46882544|NCT00039377|83103686|FG002|Initial Registration|Withdrawal by Subject|0|||
46882545|NCT00039377|83103687|FG003|Initial Registration|Withdrawal by Subject|0|||
46882546|NCT00154102|83103697|FG000|Overall Study|investigational study phase ongoing|7|||
46882547|NCT00154102|83103698|FG001|Overall Study|investigational study phase ongoing|2|||
46882548|NCT03687502|83103721|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
46882549|NCT03687502|83103721|FG000|Overall Study|Lumason not available|1|||
46882550|NCT03654976|83103729|FG000|Overall Study|Withdrawal by Subject|12|||
46882551|NCT03654976|83103730|FG001|Overall Study|Withdrawal by Subject|11|||
46882552|NCT03654976|83103729|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
46882553|NCT03654976|83103730|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
46882554|NCT03654976|83103729|FG000|Overall Study|Adverse Event|5|||
46882555|NCT03654976|83103730|FG001|Overall Study|Adverse Event|0|||
46882556|NCT03654976|83103729|FG000|Overall Study|Lost to Follow-up|2|||
46882557|NCT03654976|83103730|FG001|Overall Study|Lost to Follow-up|0|||
46882558|NCT03654976|83103729|FG000|Overall Study|Lack of Efficacy|0|||
46882559|NCT03654976|83103730|FG001|Overall Study|Lack of Efficacy|1|||
46882560|NCT00035555|83103739|FG000|Overall Study|Adverse Event|5|||
46882561|NCT00035555|83103740|FG001|Overall Study|Adverse Event|8|||
46882562|NCT00035555|83103741|FG002|Overall Study|Adverse Event|9|||
46882563|NCT00035555|83103739|FG000|Overall Study|Allograft loss|1|||
46882564|NCT00035555|83103740|FG001|Overall Study|Allograft loss|1|||
46882565|NCT00035555|83103741|FG002|Overall Study|Allograft loss|2|||
46882566|NCT00035555|83103739|FG000|Overall Study|Death|0|||
46882567|NCT00035555|83103740|FG001|Overall Study|Death|0|||
46882568|NCT00035555|83103741|FG002|Overall Study|Death|2|||
46882569|NCT00035555|83103739|FG000|Overall Study|Lost to Follow-up|0|||
46882570|NCT00035555|83103740|FG001|Overall Study|Lost to Follow-up|0|||
46882571|NCT00035555|83103741|FG002|Overall Study|Lost to Follow-up|1|||
46882572|NCT00035555|83103739|FG000|Overall Study|Noncompliance|0|||
46882573|NCT00035555|83103740|FG001|Overall Study|Noncompliance|1|||
46882574|NCT00035555|83103741|FG002|Overall Study|Noncompliance|1|||
46882575|NCT00035555|83103739|FG000|Overall Study|Prohibited medication|1|||
46882576|NCT00035555|83103740|FG001|Overall Study|Prohibited medication|1|||
46882577|NCT00035555|83103741|FG002|Overall Study|Prohibited medication|0|||
46882578|NCT00035555|83103739|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
46882579|NCT00035555|83103740|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
46882580|NCT00035555|83103741|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
46882581|NCT00035555|83103739|FG000|Overall Study|Withdrawal by Subject|2|||
46882582|NCT00035555|83103740|FG001|Overall Study|Withdrawal by Subject|0|||
46882583|NCT00035555|83103741|FG002|Overall Study|Withdrawal by Subject|2|||
46882584|NCT00035555|83103739|FG000|Overall Study|Investigator deemed not a good candidate|0|||
46882585|NCT00035555|83103740|FG001|Overall Study|Investigator deemed not a good candidate|0|||
46882586|NCT00035555|83103741|FG002|Overall Study|Investigator deemed not a good candidate|1|||
46882587|NCT00035555|83103739|FG000|Overall Study|Received cyclosporin in error|0|||
46882588|NCT00035555|83103740|FG001|Overall Study|Received cyclosporin in error|0|||
46882589|NCT00035555|83103741|FG002|Overall Study|Received cyclosporin in error|1|||
46882590|NCT03894046|83103753|FG000|Overall Study|Protocol Violation|1|||
46882591|NCT03894046|83103754|FG001|Overall Study|Protocol Violation|0|||
46882592|NCT03894046|83103755|FG002|Overall Study|Protocol Violation|0|||
46882593|NCT03894046|83103753|FG000|Overall Study|Adverse Event|0|||
46882594|NCT03894046|83103754|FG001|Overall Study|Adverse Event|1|||
46882595|NCT03894046|83103755|FG002|Overall Study|Adverse Event|0|||
46882596|NCT03894046|83103753|FG000|Overall Study|Withdrawal by Subject|2|||
46882597|NCT03894046|83103754|FG001|Overall Study|Withdrawal by Subject|3|||
46882598|NCT03894046|83103755|FG002|Overall Study|Withdrawal by Subject|1|||
46882599|NCT03894046|83103753|FG000|Overall Study|Death|15|||
46882600|NCT03894046|83103754|FG001|Overall Study|Death|21|||
46882601|NCT03894046|83103755|FG002|Overall Study|Death|4|||
46882602|NCT03894046|83103753|FG000|Overall Study|No growth of ABC|2|||
46882603|NCT03894046|83103754|FG001|Overall Study|No growth of ABC|1|||
46882604|NCT03894046|83103755|FG002|Overall Study|No growth of ABC|0|||
46882605|NCT03894046|83103753|FG000|Overall Study|Physician Decision|1|||
46882606|NCT03894046|83103754|FG001|Overall Study|Physician Decision|1|||
46882607|NCT03894046|83103755|FG002|Overall Study|Physician Decision|1|||
46882608|NCT03894046|83103753|FG000|Overall Study|Prohibited concomitant medication|1|||
46882609|NCT03894046|83103754|FG001|Overall Study|Prohibited concomitant medication|0|||
46882610|NCT03894046|83103755|FG002|Overall Study|Prohibited concomitant medication|0|||
46882611|NCT03894046|83103753|FG000|Overall Study|Transferred to other arm/group|1|||
46882612|NCT03894046|83103754|FG001|Overall Study|Transferred to other arm/group|1|||
46882613|NCT03894046|83103755|FG002|Overall Study|Transferred to other arm/group|0|||
46705124|NCT01185522|82919972|FG000|Overall Study|Lack of Efficacy|28|||
46705125|NCT01185522|82919972|FG000|Overall Study|Lost to Follow-up|19|||
46705126|NCT01185522|82919972|FG000|Overall Study|Withdrawal by Subject|10|||
46705127|NCT01185522|82919972|FG000|Overall Study|Poor tolerance|39|||
46705128|NCT01185522|82919972|FG000|Overall Study|Other reasons|12|||
46705129|NCT01185366|82919979|FG000|First Line Therapy|Insurance Coverage Denied|1|||
46705130|NCT01185366|82919980|FG001|First Line Therapy|Insurance Coverage Denied|1|||
46705131|NCT01185366|82919979|FG000|First Line Therapy|Withdrawal by Subject|1|||
46705132|NCT01185366|82919980|FG001|First Line Therapy|Withdrawal by Subject|0|||
46705133|NCT01185366|82919979|FG000|First Line Therapy|Lack of Metastatic Site|1|||
46705134|NCT01185366|82919980|FG001|First Line Therapy|Lack of Metastatic Site|0|||
46705135|NCT01185366|82919979|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
46705136|NCT01185366|82919980|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
46705137|NCT01185366|82919979|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
46705138|NCT01185366|82919980|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
46705139|NCT01185366|82919979|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
46705140|NCT01185366|82919980|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
46705141|NCT01185366|82919979|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
46705142|NCT01185366|82919980|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
46705143|NCT01185288|82919990|FG000|Overall Study|Adverse Event|7|||
46705144|NCT01185288|82919991|FG001|Overall Study|Adverse Event|6|||
46705145|NCT01185288|82919990|FG000|Overall Study|Withdrawal by Subject|6|||
46705146|NCT01185288|82919991|FG001|Overall Study|Withdrawal by Subject|4|||
46705147|NCT01185288|82919990|FG000|Overall Study|Lost to Follow-up|2|||
46705148|NCT01185288|82919991|FG001|Overall Study|Lost to Follow-up|5|||
46705149|NCT01185288|82919990|FG000|Overall Study|Lack of Efficacy|2|||
46705150|NCT01185288|82919991|FG001|Overall Study|Lack of Efficacy|0|||
46705151|NCT01185288|82919990|FG000|Overall Study|Investigator discretion|1|||
46705152|NCT01185288|82919991|FG001|Overall Study|Investigator discretion|0|||
46705153|NCT01185288|82919990|FG000|Overall Study|Did not meet inclusion criteria|1|||
46705154|NCT01185288|82919991|FG001|Overall Study|Did not meet inclusion criteria|0|||
46705155|NCT01185288|82919990|FG000|Overall Study|Noncompliance|0|||
46705156|NCT01185288|82919991|FG001|Overall Study|Noncompliance|1|||
46705157|NCT01184508|82919999|FG000|Overall Study|Adverse Event|4|||
46882614|NCT00033371|83103764|FG000|Overall Study|Adverse Event|1|||
46882615|NCT00033371|83103765|FG001|Overall Study|Adverse Event|5|||
46882616|NCT00033371|83103764|FG000|Overall Study|Lost to Follow-up|2|||
46882617|NCT00033371|83103765|FG001|Overall Study|Lost to Follow-up|1|||
46882618|NCT00033371|83103764|FG000|Overall Study|Withdrawal by Subject|3|||
46882619|NCT00033371|83103765|FG001|Overall Study|Withdrawal by Subject|3|||
46882620|NCT00033371|83103764|FG000|Overall Study|Disease Progression|0|||
46882621|NCT00033371|83103765|FG001|Overall Study|Disease Progression|1|||
46882622|NCT00081731|83103777|FG000|Overall Study|scientific integrity issue|8|||
46705158|NCT01184508|82920000|FG001|Overall Study|Adverse Event|6|||
46705159|NCT01184508|82919999|FG000|Overall Study|Lack of Efficacy|1|||
46705160|NCT01184508|82920000|FG001|Overall Study|Lack of Efficacy|1|||
46705161|NCT01184508|82919999|FG000|Overall Study|Lost to Follow-up|1|||
46882623|NCT00081731|83103778|FG001|Overall Study|scientific integrity issue|8|||
46705162|NCT01184508|82920000|FG001|Overall Study|Lost to Follow-up|1|||
46705163|NCT01184508|82919999|FG000|Overall Study|Physician Decision|1|||
46882624|NCT00079937|83103786|FG000|Overall Study|Adverse Event|2|||
46705164|NCT01184508|82920000|FG001|Overall Study|Physician Decision|0|||
46882625|NCT00079937|83103787|FG001|Overall Study|Adverse Event|1|||
46882626|NCT00079937|83103786|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
46882627|NCT00079937|83103787|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
46882628|NCT00079937|83103786|FG000|Overall Study|Subject no longer requires study drug|3|||
46882629|NCT00079937|83103787|FG001|Overall Study|Subject no longer requires study drug|0|||
46882630|NCT00079937|83103786|FG000|Overall Study|Protocol Violation|8|||
46882631|NCT00079937|83103787|FG001|Overall Study|Protocol Violation|6|||
46882632|NCT00079937|83103786|FG000|Overall Study|Withdrawal by Subject|21|||
46882633|NCT00079937|83103787|FG001|Overall Study|Withdrawal by Subject|7|||
46882634|NCT00079937|83103786|FG000|Overall Study|Lost to Follow-up|12|||
46882635|NCT00079937|83103787|FG001|Overall Study|Lost to Follow-up|5|||
46882636|NCT00079937|83103786|FG000|Overall Study|Administrative problems|22|||
46882637|NCT00079937|83103787|FG001|Overall Study|Administrative problems|11|||
46882638|NCT00909610|83103795|FG000|Period: First Intervention|Adverse Event|0|||
46882639|NCT00909610|83103796|FG001|Period: First Intervention|Adverse Event|1|||
46882640|NCT00909610|83103795|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
46882641|NCT00909610|83103796|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
46882642|NCT00909610|83103795|FG000|Period: Second Intervention|Adverse Event|1|||
46882643|NCT00909610|83103796|FG001|Period: Second Intervention|Adverse Event|0|||
46882644|NCT03126110|83103818|FG000|Phase 1|Death|2|||
46882645|NCT03126110|83103819|FG001|Phase 1|Death|2|||
46882646|NCT03126110|83103820|FG002|Phase 1|Death|4|||
46882647|NCT03126110|83103821|FG003|Phase 1|Death|3|||
46882648|NCT03126110|83103822|FG004|Phase 1|Death|4|||
46882649|NCT03126110|83103823|FG005|Phase 1|Death|4|||
46882650|NCT03126110|83103824|FG006|Phase 1|Death|3|||
46882651|NCT03126110|83103825|FG007|Phase 1|Death|4|||
46882652|NCT03126110|83103826|FG008|Phase 1|Death|5|||
46882653|NCT03126110|83103827|FG009|Phase 1|Death|2|||
46882654|NCT03126110|83103828|FG010|Phase 1|Death|6|||
46882655|NCT03126110|83103829|FG011|Phase 1|Death|0|||
46882656|NCT03126110|83103830|FG012|Phase 1|Death|0|||
46882657|NCT03126110|83103831|FG013|Phase 1|Death|0|||
46882658|NCT03126110|83103832|FG014|Phase 1|Death|0|||
46882659|NCT03126110|83103833|FG015|Phase 1|Death|0|||
46882660|NCT03126110|83103834|FG016|Phase 1|Death|0|||
46882661|NCT03126110|83103818|FG000|Phase 1|Lost to Follow-up|0|||
46882662|NCT03126110|83103819|FG001|Phase 1|Lost to Follow-up|1|||
46882663|NCT03126110|83103820|FG002|Phase 1|Lost to Follow-up|0|||
46882664|NCT03126110|83103821|FG003|Phase 1|Lost to Follow-up|0|||
46882665|NCT03126110|83103822|FG004|Phase 1|Lost to Follow-up|0|||
46882666|NCT03126110|83103823|FG005|Phase 1|Lost to Follow-up|0|||
46882667|NCT03126110|83103824|FG006|Phase 1|Lost to Follow-up|0|||
46882668|NCT03126110|83103825|FG007|Phase 1|Lost to Follow-up|0|||
46882669|NCT03126110|83103826|FG008|Phase 1|Lost to Follow-up|1|||
46882670|NCT03126110|83103827|FG009|Phase 1|Lost to Follow-up|0|||
46882671|NCT03126110|83103828|FG010|Phase 1|Lost to Follow-up|0|||
46882672|NCT03126110|83103829|FG011|Phase 1|Lost to Follow-up|0|||
46882673|NCT03126110|83103830|FG012|Phase 1|Lost to Follow-up|0|||
46882674|NCT03126110|83103831|FG013|Phase 1|Lost to Follow-up|0|||
46882675|NCT03126110|83103832|FG014|Phase 1|Lost to Follow-up|0|||
46882676|NCT03126110|83103833|FG015|Phase 1|Lost to Follow-up|0|||
46882677|NCT03126110|83103834|FG016|Phase 1|Lost to Follow-up|0|||
46882678|NCT03126110|83103818|FG000|Phase 1|Withdrawal by Subject|1|||
46882679|NCT03126110|83103819|FG001|Phase 1|Withdrawal by Subject|0|||
46882680|NCT03126110|83103820|FG002|Phase 1|Withdrawal by Subject|0|||
46882681|NCT03126110|83103821|FG003|Phase 1|Withdrawal by Subject|1|||
46882682|NCT03126110|83103822|FG004|Phase 1|Withdrawal by Subject|1|||
46882683|NCT03126110|83103823|FG005|Phase 1|Withdrawal by Subject|0|||
46882684|NCT03126110|83103824|FG006|Phase 1|Withdrawal by Subject|0|||
46882685|NCT03126110|83103825|FG007|Phase 1|Withdrawal by Subject|0|||
46882686|NCT03126110|83103826|FG008|Phase 1|Withdrawal by Subject|2|||
46882687|NCT03126110|83103827|FG009|Phase 1|Withdrawal by Subject|1|||
46882688|NCT03126110|83103828|FG010|Phase 1|Withdrawal by Subject|0|||
46882689|NCT03126110|83103829|FG011|Phase 1|Withdrawal by Subject|0|||
46882690|NCT03126110|83103830|FG012|Phase 1|Withdrawal by Subject|0|||
46882691|NCT03126110|83103831|FG013|Phase 1|Withdrawal by Subject|0|||
46882692|NCT03126110|83103832|FG014|Phase 1|Withdrawal by Subject|0|||
46882693|NCT03126110|83103833|FG015|Phase 1|Withdrawal by Subject|0|||
46882694|NCT03126110|83103834|FG016|Phase 1|Withdrawal by Subject|0|||
46882695|NCT03126110|83103818|FG000|Phase 1|Safety follow-up no longer necessary|1|||
46882696|NCT03126110|83103819|FG001|Phase 1|Safety follow-up no longer necessary|0|||
46882697|NCT03126110|83103820|FG002|Phase 1|Safety follow-up no longer necessary|0|||
46882698|NCT03126110|83103821|FG003|Phase 1|Safety follow-up no longer necessary|0|||
46882699|NCT03126110|83103822|FG004|Phase 1|Safety follow-up no longer necessary|0|||
46882700|NCT03126110|83103823|FG005|Phase 1|Safety follow-up no longer necessary|0|||
46882701|NCT03126110|83103824|FG006|Phase 1|Safety follow-up no longer necessary|0|||
46882702|NCT03126110|83103825|FG007|Phase 1|Safety follow-up no longer necessary|0|||
46882703|NCT03126110|83103826|FG008|Phase 1|Safety follow-up no longer necessary|0|||
46882704|NCT03126110|83103827|FG009|Phase 1|Safety follow-up no longer necessary|0|||
46882705|NCT03126110|83103828|FG010|Phase 1|Safety follow-up no longer necessary|0|||
46882706|NCT03126110|83103829|FG011|Phase 1|Safety follow-up no longer necessary|0|||
46882707|NCT03126110|83103830|FG012|Phase 1|Safety follow-up no longer necessary|0|||
46882708|NCT03126110|83103831|FG013|Phase 1|Safety follow-up no longer necessary|0|||
46882709|NCT03126110|83103832|FG014|Phase 1|Safety follow-up no longer necessary|0|||
46882710|NCT03126110|83103833|FG015|Phase 1|Safety follow-up no longer necessary|0|||
46882711|NCT03126110|83103834|FG016|Phase 1|Safety follow-up no longer necessary|0|||
46882712|NCT03126110|83103818|FG000|Phase 1|Survival follow-up no longer necessary|0|||
46882713|NCT03126110|83103819|FG001|Phase 1|Survival follow-up no longer necessary|0|||
46882714|NCT03126110|83103820|FG002|Phase 1|Survival follow-up no longer necessary|1|||
46882715|NCT03126110|83103821|FG003|Phase 1|Survival follow-up no longer necessary|0|||
46882716|NCT03126110|83103822|FG004|Phase 1|Survival follow-up no longer necessary|0|||
46882717|NCT03126110|83103823|FG005|Phase 1|Survival follow-up no longer necessary|0|||
46882718|NCT03126110|83103824|FG006|Phase 1|Survival follow-up no longer necessary|0|||
46882719|NCT03126110|83103825|FG007|Phase 1|Survival follow-up no longer necessary|0|||
46882720|NCT03126110|83103826|FG008|Phase 1|Survival follow-up no longer necessary|0|||
46882721|NCT03126110|83103827|FG009|Phase 1|Survival follow-up no longer necessary|0|||
46882722|NCT03126110|83103828|FG010|Phase 1|Survival follow-up no longer necessary|0|||
46882723|NCT03126110|83103829|FG011|Phase 1|Survival follow-up no longer necessary|0|||
46882724|NCT03126110|83103830|FG012|Phase 1|Survival follow-up no longer necessary|0|||
46882725|NCT03126110|83103831|FG013|Phase 1|Survival follow-up no longer necessary|0|||
46882726|NCT03126110|83103832|FG014|Phase 1|Survival follow-up no longer necessary|0|||
46882727|NCT03126110|83103833|FG015|Phase 1|Survival follow-up no longer necessary|0|||
46882728|NCT03126110|83103834|FG016|Phase 1|Survival follow-up no longer necessary|0|||
46882729|NCT03126110|83103818|FG000|Phase 2|Study terminated by the sponsor|0|||
46882730|NCT03126110|83103819|FG001|Phase 2|Study terminated by the sponsor|0|||
46882731|NCT03126110|83103820|FG002|Phase 2|Study terminated by the sponsor|0|||
46882732|NCT03126110|83103821|FG003|Phase 2|Study terminated by the sponsor|0|||
46882733|NCT03126110|83103822|FG004|Phase 2|Study terminated by the sponsor|0|||
46882734|NCT03126110|83103823|FG005|Phase 2|Study terminated by the sponsor|0|||
46882735|NCT03126110|83103824|FG006|Phase 2|Study terminated by the sponsor|0|||
46882736|NCT03126110|83103825|FG007|Phase 2|Study terminated by the sponsor|0|||
46882737|NCT03126110|83103826|FG008|Phase 2|Study terminated by the sponsor|0|||
46882738|NCT03126110|83103827|FG009|Phase 2|Study terminated by the sponsor|0|||
46882739|NCT03126110|83103828|FG010|Phase 2|Study terminated by the sponsor|0|||
46882740|NCT03126110|83103829|FG011|Phase 2|Study terminated by the sponsor|0|||
46882741|NCT03126110|83103830|FG012|Phase 2|Study terminated by the sponsor|0|||
46882742|NCT03126110|83103831|FG013|Phase 2|Study terminated by the sponsor|4|||
46882743|NCT03126110|83103832|FG014|Phase 2|Study terminated by the sponsor|0|||
46882744|NCT03126110|83103833|FG015|Phase 2|Study terminated by the sponsor|0|||
46882745|NCT03126110|83103834|FG016|Phase 2|Study terminated by the sponsor|0|||
46882746|NCT03126110|83103818|FG000|Phase 2|Withdrawal by Subject|0|||
46882747|NCT03126110|83103819|FG001|Phase 2|Withdrawal by Subject|0|||
46882748|NCT03126110|83103820|FG002|Phase 2|Withdrawal by Subject|0|||
46882749|NCT03126110|83103821|FG003|Phase 2|Withdrawal by Subject|0|||
46882750|NCT03126110|83103822|FG004|Phase 2|Withdrawal by Subject|0|||
46882751|NCT03126110|83103823|FG005|Phase 2|Withdrawal by Subject|0|||
46882752|NCT03126110|83103824|FG006|Phase 2|Withdrawal by Subject|0|||
46882753|NCT03126110|83103825|FG007|Phase 2|Withdrawal by Subject|0|||
46882754|NCT03126110|83103826|FG008|Phase 2|Withdrawal by Subject|0|||
46882755|NCT03126110|83103827|FG009|Phase 2|Withdrawal by Subject|0|||
46882756|NCT03126110|83103828|FG010|Phase 2|Withdrawal by Subject|0|||
46882757|NCT03126110|83103829|FG011|Phase 2|Withdrawal by Subject|1|||
46882758|NCT03126110|83103830|FG012|Phase 2|Withdrawal by Subject|3|||
46882759|NCT03126110|83103831|FG013|Phase 2|Withdrawal by Subject|3|||
46882760|NCT03126110|83103832|FG014|Phase 2|Withdrawal by Subject|2|||
46882761|NCT03126110|83103833|FG015|Phase 2|Withdrawal by Subject|1|||
46882762|NCT03126110|83103834|FG016|Phase 2|Withdrawal by Subject|0|||
46882763|NCT03126110|83103818|FG000|Phase 2|Lost to Follow-up|0|||
46882764|NCT03126110|83103819|FG001|Phase 2|Lost to Follow-up|0|||
46882765|NCT03126110|83103820|FG002|Phase 2|Lost to Follow-up|0|||
46882766|NCT03126110|83103821|FG003|Phase 2|Lost to Follow-up|0|||
46882767|NCT03126110|83103822|FG004|Phase 2|Lost to Follow-up|0|||
46882768|NCT03126110|83103823|FG005|Phase 2|Lost to Follow-up|0|||
46882769|NCT03126110|83103824|FG006|Phase 2|Lost to Follow-up|0|||
46882770|NCT03126110|83103825|FG007|Phase 2|Lost to Follow-up|0|||
46882771|NCT03126110|83103826|FG008|Phase 2|Lost to Follow-up|0|||
46882772|NCT03126110|83103827|FG009|Phase 2|Lost to Follow-up|0|||
46991086|NCT02527343|83238019|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
46882773|NCT03126110|83103828|FG010|Phase 2|Lost to Follow-up|0|||
46882774|NCT03126110|83103829|FG011|Phase 2|Lost to Follow-up|1|||
46882775|NCT03126110|83103830|FG012|Phase 2|Lost to Follow-up|1|||
46882776|NCT03126110|83103831|FG013|Phase 2|Lost to Follow-up|1|||
46882777|NCT03126110|83103832|FG014|Phase 2|Lost to Follow-up|2|||
46882778|NCT03126110|83103833|FG015|Phase 2|Lost to Follow-up|0|||
46882779|NCT03126110|83103834|FG016|Phase 2|Lost to Follow-up|0|||
46882780|NCT03126110|83103818|FG000|Phase 2|Death|0|||
46882781|NCT03126110|83103819|FG001|Phase 2|Death|0|||
46882782|NCT03126110|83103820|FG002|Phase 2|Death|0|||
46882783|NCT03126110|83103821|FG003|Phase 2|Death|0|||
46882784|NCT03126110|83103822|FG004|Phase 2|Death|0|||
46882785|NCT03126110|83103823|FG005|Phase 2|Death|0|||
46882786|NCT03126110|83103824|FG006|Phase 2|Death|0|||
46882787|NCT03126110|83103825|FG007|Phase 2|Death|0|||
46882788|NCT03126110|83103826|FG008|Phase 2|Death|0|||
46882789|NCT03126110|83103827|FG009|Phase 2|Death|0|||
46882790|NCT03126110|83103828|FG010|Phase 2|Death|0|||
46882791|NCT03126110|83103829|FG011|Phase 2|Death|6|||
46882792|NCT03126110|83103830|FG012|Phase 2|Death|12|||
46882793|NCT03126110|83103831|FG013|Phase 2|Death|25|||
46882794|NCT03126110|83103832|FG014|Phase 2|Death|11|||
46882795|NCT03126110|83103833|FG015|Phase 2|Death|3|||
46882796|NCT03126110|83103834|FG016|Phase 2|Death|2|||
46882797|NCT03126110|83103818|FG000|Phase 2|Progressive Disease|0|||
46882798|NCT03126110|83103819|FG001|Phase 2|Progressive Disease|0|||
46882799|NCT03126110|83103820|FG002|Phase 2|Progressive Disease|0|||
46882800|NCT03126110|83103821|FG003|Phase 2|Progressive Disease|0|||
46882801|NCT03126110|83103822|FG004|Phase 2|Progressive Disease|0|||
46882802|NCT03126110|83103823|FG005|Phase 2|Progressive Disease|0|||
46882803|NCT03126110|83103824|FG006|Phase 2|Progressive Disease|0|||
46882804|NCT03126110|83103825|FG007|Phase 2|Progressive Disease|0|||
46882805|NCT03126110|83103826|FG008|Phase 2|Progressive Disease|0|||
46882806|NCT03126110|83103827|FG009|Phase 2|Progressive Disease|0|||
46882807|NCT03126110|83103828|FG010|Phase 2|Progressive Disease|0|||
46882808|NCT03126110|83103829|FG011|Phase 2|Progressive Disease|0|||
46882809|NCT03126110|83103830|FG012|Phase 2|Progressive Disease|0|||
46882810|NCT03126110|83103831|FG013|Phase 2|Progressive Disease|1|||
46882811|NCT03126110|83103832|FG014|Phase 2|Progressive Disease|0|||
46882812|NCT03126110|83103833|FG015|Phase 2|Progressive Disease|0|||
46882813|NCT03126110|83103834|FG016|Phase 2|Progressive Disease|0|||
46882814|NCT03126110|83103818|FG000|Phase 2|Started new treatment|0|||
46882815|NCT03126110|83103819|FG001|Phase 2|Started new treatment|0|||
46882816|NCT03126110|83103820|FG002|Phase 2|Started new treatment|0|||
46882817|NCT03126110|83103821|FG003|Phase 2|Started new treatment|0|||
46882818|NCT03126110|83103822|FG004|Phase 2|Started new treatment|0|||
46882819|NCT03126110|83103823|FG005|Phase 2|Started new treatment|0|||
46882820|NCT03126110|83103824|FG006|Phase 2|Started new treatment|0|||
46882821|NCT03126110|83103825|FG007|Phase 2|Started new treatment|0|||
46882822|NCT03126110|83103826|FG008|Phase 2|Started new treatment|0|||
46882823|NCT03126110|83103827|FG009|Phase 2|Started new treatment|0|||
46882824|NCT03126110|83103828|FG010|Phase 2|Started new treatment|0|||
46882825|NCT03126110|83103829|FG011|Phase 2|Started new treatment|0|||
46882826|NCT03126110|83103830|FG012|Phase 2|Started new treatment|0|||
46882827|NCT03126110|83103831|FG013|Phase 2|Started new treatment|0|||
46882828|NCT03126110|83103832|FG014|Phase 2|Started new treatment|1|||
46882829|NCT03126110|83103833|FG015|Phase 2|Started new treatment|0|||
46882830|NCT03126110|83103834|FG016|Phase 2|Started new treatment|0|||
46882831|NCT00905164|83103884|FG000|Period 1|Protocol Violation|0|||
46882832|NCT00905164|83103885|FG001|Period 1|Protocol Violation|1|||
46882833|NCT03181958|83103892|FG000|Overall Study|Lost to Follow-up|17|||
46882834|NCT03181958|83103893|FG001|Overall Study|Lost to Follow-up|21|||
46882835|NCT03181958|83103894|FG002|Overall Study|Lost to Follow-up|15|||
46882836|NCT03165110|83103902|FG000|Overall Study|Anroid phone software incompatibility|1|||
46882837|NCT00079781|83103909|FG000|Pre-implant Period|Withdrawal by Subject|2|||
46882838|NCT00079781|83103910|FG001|Pre-implant Period|Withdrawal by Subject|0|||
46882839|NCT00079781|83103911|FG002|Pre-implant Period|Withdrawal by Subject|0|||
46882840|NCT00079781|83103909|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
46882841|NCT00079781|83103910|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
46882842|NCT00079781|83103911|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
46882843|NCT00079781|83103909|FG000|Follow-up Period|Withdrawal by Subject|3|||
46882844|NCT00079781|83103910|FG001|Follow-up Period|Withdrawal by Subject|0|||
46882845|NCT00079781|83103911|FG002|Follow-up Period|Withdrawal by Subject|1|||
46882846|NCT00079781|83103909|FG000|Follow-up Period|Lost to Follow-up|1|||
46882847|NCT00079781|83103910|FG001|Follow-up Period|Lost to Follow-up|0|||
46882848|NCT00079781|83103911|FG002|Follow-up Period|Lost to Follow-up|0|||
46882849|NCT00079781|83103909|FG000|Follow-up Period|Death|0|||
46882850|NCT00079781|83103910|FG001|Follow-up Period|Death|0|||
46882851|NCT00079781|83103911|FG002|Follow-up Period|Death|1|||
46882852|NCT03176966|83103919|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
46882853|NCT03176966|83103920|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
46882854|NCT03176966|83103919|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
46882855|NCT03176966|83103920|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
46882856|NCT03176966|83103919|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
46991087|NCT02527343|83238020|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
46882857|NCT03176966|83103920|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
46882858|NCT03176966|83103919|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
46882859|NCT03176966|83103920|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
46882860|NCT03176966|83103919|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
46882861|NCT03176966|83103920|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
46882862|NCT03176966|83103919|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
46882863|NCT03176966|83103920|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
46882864|NCT03176966|83103919|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
46882865|NCT03176966|83103920|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
46882866|NCT03175562|83103926|FG000|Overall Study|Adverse Event|1|||
46882867|NCT03175562|83103926|FG000|Overall Study|Lost to Follow-up|3|||
46882868|NCT03175562|83103926|FG000|Overall Study|Withdrawal by Subject|7|||
46882869|NCT03175562|83103926|FG000|Overall Study|Other (Not Specified)|5|||
46882870|NCT00079391|83103933|FG000|Overall Study|Withdrawal by Subject|1|||
46882871|NCT03209570|83103941|FG000|Overall Study|Death|1|||
46882872|NCT03209570|83103942|FG001|Overall Study|Death|0|||
46882873|NCT03209570|83103941|FG000|Overall Study|Incomplete Data|8|||
46882874|NCT03209570|83103942|FG001|Overall Study|Incomplete Data|10|||
46882875|NCT03209570|83103941|FG000|Overall Study|Protocol Violation|1|||
46882876|NCT03209570|83103942|FG001|Overall Study|Protocol Violation|0|||
46882877|NCT03209570|83103941|FG000|Overall Study|Withdrawal by Subject|0|||
46882878|NCT03209570|83103942|FG001|Overall Study|Withdrawal by Subject|3|||
46882879|NCT03209492|83103948|FG000|Overall Study|Case Report Forms Uncollected|5|||
46882880|NCT03208244|83103952|FG000|Overall Study|Death|1|||
46882881|NCT03175172|83103956|FG000|Overall Study|Death|3|||
46882882|NCT03175172|83103956|FG000|Overall Study|Withdrawal by Subject|3|||
46882883|NCT03175172|83103956|FG000|Overall Study|Lost to Follow-up|1|||
46882884|NCT03175172|83103956|FG000|Overall Study|Study Terminated by Sponsor|3|||
46882885|NCT03172364|83103962|FG000|Overall Study|Adverse Event|1|||
46882886|NCT03172364|83103963|FG001|Overall Study|Adverse Event|1|||
46882887|NCT03172364|83103962|FG000|Overall Study|Protocol Violation|1|||
46882888|NCT03172364|83103963|FG001|Overall Study|Protocol Violation|0|||
46882889|NCT00078767|83103971|FG000|Overall Study|Withdrawal by Subject|1|||
46882890|NCT00078767|83103972|FG001|Overall Study|Withdrawal by Subject|1|||
46882891|NCT03208088|83103978|FG000|Period 2|Withdrawal by Subject|0|||
46882892|NCT03208088|83103979|FG001|Period 2|Withdrawal by Subject|0|||
46882893|NCT03208088|83103980|FG002|Period 2|Withdrawal by Subject|0|||
46882894|NCT03208088|83103981|FG003|Period 2|Withdrawal by Subject|0|||
46882895|NCT03208088|83103982|FG004|Period 2|Withdrawal by Subject|0|||
46882896|NCT03208088|83103983|FG005|Period 2|Withdrawal by Subject|0|||
46882897|NCT03208088|83103984|FG006|Period 2|Withdrawal by Subject|0|||
46882898|NCT03208088|83103985|FG007|Period 2|Withdrawal by Subject|0|||
46882899|NCT03208088|83103986|FG008|Period 2|Withdrawal by Subject|1|||
46882900|NCT03208088|83103987|FG009|Period 2|Withdrawal by Subject|0|||
46882901|NCT03208088|83103978|FG000|Period 3|Unsatisfactory Test Article|0|||
46882902|NCT03208088|83103979|FG001|Period 3|Unsatisfactory Test Article|0|||
46882903|NCT03208088|83103980|FG002|Period 3|Unsatisfactory Test Article|0|||
46882904|NCT03208088|83103981|FG003|Period 3|Unsatisfactory Test Article|1|||
46882905|NCT03208088|83103982|FG004|Period 3|Unsatisfactory Test Article|0|||
46882906|NCT03208088|83103983|FG005|Period 3|Unsatisfactory Test Article|0|||
46882907|NCT03208088|83103984|FG006|Period 3|Unsatisfactory Test Article|0|||
46882908|NCT03208088|83103985|FG007|Period 3|Unsatisfactory Test Article|0|||
46882909|NCT03208088|83103986|FG008|Period 3|Unsatisfactory Test Article|0|||
46882910|NCT03208088|83103987|FG009|Period 3|Unsatisfactory Test Article|0|||
46882911|NCT03208088|83103978|FG000|Period 4|Unsatisfactory Test Article|0|||
46882912|NCT03208088|83103979|FG001|Period 4|Unsatisfactory Test Article|0|||
46882913|NCT03208088|83103980|FG002|Period 4|Unsatisfactory Test Article|0|||
46882914|NCT03208088|83103981|FG003|Period 4|Unsatisfactory Test Article|1|||
46882915|NCT03208088|83103982|FG004|Period 4|Unsatisfactory Test Article|0|||
46882916|NCT03208088|83103983|FG005|Period 4|Unsatisfactory Test Article|0|||
46882917|NCT03208088|83103984|FG006|Period 4|Unsatisfactory Test Article|0|||
46882918|NCT03208088|83103985|FG007|Period 4|Unsatisfactory Test Article|0|||
46882919|NCT03208088|83103986|FG008|Period 4|Unsatisfactory Test Article|0|||
46882920|NCT03208088|83103987|FG009|Period 4|Unsatisfactory Test Article|0|||
46882921|NCT00078377|83104002|FG000|Overall Study|Adverse Event|2|||
46882922|NCT00078377|83104003|FG001|Overall Study|Adverse Event|5|||
46882923|NCT00078377|83104004|FG002|Overall Study|Adverse Event|1|||
46882924|NCT00078377|83104002|FG000|Overall Study|Lack of Efficacy|2|||
46882925|NCT00078377|83104003|FG001|Overall Study|Lack of Efficacy|0|||
46882926|NCT00078377|83104004|FG002|Overall Study|Lack of Efficacy|2|||
46882927|NCT00078377|83104002|FG000|Overall Study|Lost to Follow-up|0|||
46882928|NCT00078377|83104003|FG001|Overall Study|Lost to Follow-up|1|||
46882929|NCT00078377|83104004|FG002|Overall Study|Lost to Follow-up|1|||
46882930|NCT00078377|83104002|FG000|Overall Study|Physician Decision|2|||
46882931|NCT00078377|83104003|FG001|Overall Study|Physician Decision|0|||
46882932|NCT00078377|83104004|FG002|Overall Study|Physician Decision|0|||
46882933|NCT00078377|83104002|FG000|Overall Study|Withdrawal by Subject|3|||
46882934|NCT00078377|83104003|FG001|Overall Study|Withdrawal by Subject|4|||
46882935|NCT00078377|83104004|FG002|Overall Study|Withdrawal by Subject|4|||
46882936|NCT00078377|83104002|FG000|Overall Study|Miscellaneous|2|||
46882937|NCT00078377|83104003|FG001|Overall Study|Miscellaneous|6|||
46882938|NCT00078377|83104004|FG002|Overall Study|Miscellaneous|1|||
46882939|NCT00886600|83104017|FG000|Double-blind Monotherapy|Adverse Event|1|||
46882940|NCT00886600|83104018|FG001|Double-blind Monotherapy|Adverse Event|1|||
46882941|NCT00886600|83104019|FG002|Double-blind Monotherapy|Adverse Event|1|||
46882942|NCT00886600|83104020|FG003|Double-blind Monotherapy|Adverse Event|1|||
46882943|NCT00886600|83104017|FG000|Double-blind Monotherapy|Protocol Violation|0|||
46882944|NCT00886600|83104018|FG001|Double-blind Monotherapy|Protocol Violation|0|||
46882945|NCT00886600|83104019|FG002|Double-blind Monotherapy|Protocol Violation|0|||
46882946|NCT00886600|83104020|FG003|Double-blind Monotherapy|Protocol Violation|1|||
46882947|NCT00886600|83104017|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
46882948|NCT00886600|83104018|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
46882949|NCT00886600|83104019|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
46882950|NCT00886600|83104020|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
46882951|NCT00886600|83104017|FG000|Combination Therapy Period|Adverse Event|0|||
46882952|NCT00886600|83104018|FG001|Combination Therapy Period|Adverse Event|0|||
46882953|NCT00886600|83104019|FG002|Combination Therapy Period|Adverse Event|1|||
46882954|NCT00886600|83104020|FG003|Combination Therapy Period|Adverse Event|0|||
46882955|NCT00886600|83104017|FG000|Combination Therapy Period|Protocol Violation|0|||
46882956|NCT00886600|83104018|FG001|Combination Therapy Period|Protocol Violation|0|||
46882957|NCT00886600|83104019|FG002|Combination Therapy Period|Protocol Violation|1|||
46882958|NCT00886600|83104020|FG003|Combination Therapy Period|Protocol Violation|0|||
46882959|NCT03172130|83104028|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
46882960|NCT03172130|83104029|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
46882961|NCT00870688|83104045|FG000|Overall Study|Lost to Follow-up|2|||
46882962|NCT00870688|83104045|FG000|Overall Study|Death, Unrelated|1|||
46882963|NCT00870688|83104045|FG000|Overall Study|Granules in the Stools|1|||
46882964|NCT00869128|83104048|FG000|Overall Study|lack of Compliance|6|||
46882965|NCT00869128|83104049|FG001|Overall Study|lack of Compliance|6|||
46882966|NCT00077675|83104055|FG000|Overall Study|Adverse Event|1|||
46882967|NCT00077675|83104056|FG001|Overall Study|Adverse Event|2|||
46882968|NCT00077675|83104055|FG000|Overall Study|Lost to Follow-up|6|||
46882969|NCT00077675|83104056|FG001|Overall Study|Lost to Follow-up|3|||
46882970|NCT00077675|83104055|FG000|Overall Study|Withdrawal by Subject|1|||
46882971|NCT00077675|83104056|FG001|Overall Study|Withdrawal by Subject|0|||
46882972|NCT00077675|83104055|FG000|Overall Study|Other|0|||
46882973|NCT00077675|83104056|FG001|Overall Study|Other|1|||
46882974|NCT00077675|83104055|FG000|Overall Study|Never received study treatment|3|||
46882975|NCT00077675|83104056|FG001|Overall Study|Never received study treatment|3|||
46882976|NCT02576444|83104073|FG000|Overall Study|Death|1|||
46882977|NCT02576444|83104074|FG001|Overall Study|Death|1|||
46882978|NCT02576444|83104075|FG002|Overall Study|Death|0|||
46882979|NCT02576444|83104076|FG003|Overall Study|Death|0|||
46882980|NCT02576444|83104073|FG000|Overall Study|Withdrawal by Subject|0|||
46882981|NCT02576444|83104074|FG001|Overall Study|Withdrawal by Subject|0|||
46882982|NCT02576444|83104075|FG002|Overall Study|Withdrawal by Subject|2|||
46882983|NCT02576444|83104076|FG003|Overall Study|Withdrawal by Subject|0|||
46882984|NCT02576444|83104073|FG000|Overall Study|Adverse Event|0|||
46882985|NCT02576444|83104074|FG001|Overall Study|Adverse Event|0|||
46882986|NCT02576444|83104075|FG002|Overall Study|Adverse Event|1|||
46882987|NCT02576444|83104076|FG003|Overall Study|Adverse Event|0|||
46882988|NCT02576444|83104073|FG000|Overall Study|Physician Decision|0|||
46882989|NCT02576444|83104074|FG001|Overall Study|Physician Decision|0|||
46882990|NCT02576444|83104075|FG002|Overall Study|Physician Decision|1|||
46882991|NCT02576444|83104076|FG003|Overall Study|Physician Decision|0|||
46882992|NCT00850174|83104087|FG000|Washout: One Week|Withdrawal by Subject|0|||
46882993|NCT00850174|83104088|FG001|Washout: One Week|Withdrawal by Subject|2|||
46882994|NCT00850174|83104087|FG000|Second Intervention|Withdrawal by Subject|1|||
46882995|NCT00850174|83104088|FG001|Second Intervention|Withdrawal by Subject|0|||
46882996|NCT00077207|83104099|FG000|Overall Study|Adverse Event|5|||
46882997|NCT00077207|83104099|FG000|Overall Study|Lack of Efficacy|12|||
46991088|NCT02527343|83238021|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
46991089|NCT02527343|83238022|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
46991090|NCT02527343|83238023|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
46991091|NCT02527343|83238024|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
46882998|NCT00077207|83104099|FG000|Overall Study|Physician Decision|6|||
46882999|NCT00077207|83104099|FG000|Overall Study|Withdrawal by Subject|6|||
46883000|NCT00077207|83104099|FG000|Overall Study|Ineligible|1|||
46883001|NCT03206918|83104104|FG000|Overall Study|Death|11|||
46883002|NCT03206918|83104104|FG000|Overall Study|Withdrawal by Subject|5|||
46883003|NCT03206918|83104104|FG000|Overall Study|Study terminated by sponsor|12|||
46883004|NCT03206918|83104104|FG000|Overall Study|Lost to Follow-up|3|||
46991092|NCT02527343|83238019|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
46991093|NCT02527343|83238020|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
46883005|NCT03206918|83104104|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
46883006|NCT03206216|83104111|FG000|Overall Study|Withdrawal by Subject|0|||
46883007|NCT03206216|83104112|FG001|Overall Study|Withdrawal by Subject|1|||
46883008|NCT03169244|83104120|FG000|Overall Study|Lost to Follow-up|1|||
46883009|NCT03169244|83104121|FG001|Overall Study|Lost to Follow-up|2|||
46883010|NCT03169244|83104120|FG000|Overall Study|Adverse Event|1|||
46883011|NCT03169244|83104121|FG001|Overall Study|Adverse Event|0|||
46883012|NCT03169244|83104120|FG000|Overall Study|Withdrawal by Subject|2|||
46883013|NCT03169244|83104121|FG001|Overall Study|Withdrawal by Subject|2|||
46883014|NCT03169244|83104120|FG000|Overall Study|Physician Decision|1|||
46883015|NCT03169244|83104121|FG001|Overall Study|Physician Decision|0|||
46883016|NCT02486042|83104129|FG000|Overall Study|Physician Decision|1|||
46883017|NCT02486042|83104130|FG001|Overall Study|Physician Decision|7|||
46883018|NCT02486042|83104129|FG000|Overall Study|Hospital transfer|2|||
46883019|NCT02486042|83104130|FG001|Overall Study|Hospital transfer|2|||
46883020|NCT02486042|83104129|FG000|Overall Study|Withdrawal by Subject|0|||
46883021|NCT02486042|83104130|FG001|Overall Study|Withdrawal by Subject|2|||
46883022|NCT00057941|83104138|FG000|Overall Study|Death|1|||
46883023|NCT00057941|83104139|FG001|Overall Study|Death|2|||
46883024|NCT00057941|83104138|FG000|Overall Study|Adverse Event|7|||
46883025|NCT00057941|83104139|FG001|Overall Study|Adverse Event|9|||
46883026|NCT00057941|83104138|FG000|Overall Study|Lack of Efficacy|54|||
46883027|NCT00057941|83104139|FG001|Overall Study|Lack of Efficacy|53|||
46883028|NCT00057941|83104138|FG000|Overall Study|Withdrawal by Subject|6|||
46883029|NCT00057941|83104139|FG001|Overall Study|Withdrawal by Subject|1|||
46883030|NCT00057941|83104138|FG000|Overall Study|still on treatment|3|||
46883031|NCT00057941|83104139|FG001|Overall Study|still on treatment|1|||
46883032|NCT00057941|83104138|FG000|Overall Study|insurance, symptomatic deterioration|1|||
46883033|NCT00057941|83104139|FG001|Overall Study|insurance, symptomatic deterioration|3|||
46883034|NCT00057941|83104138|FG000|Overall Study|Ineligible|2|||
46883035|NCT00057941|83104139|FG001|Overall Study|Ineligible|5|||
46883036|NCT00075881|83104154|FG000|Overall Study|Lack of Efficacy|18|||
46883037|NCT00075881|83104154|FG000|Overall Study|Adverse Event|7|||
46883038|NCT00075881|83104154|FG000|Overall Study|Death|1|||
46883039|NCT00075881|83104154|FG000|Overall Study|Withdrawal by Subject|2|||
46883040|NCT00075881|83104154|FG000|Overall Study|Protocol Violation|4|||
46883041|NCT00075881|83104154|FG000|Overall Study|other complicating disease|3|||
46883042|NCT00075881|83104154|FG000|Overall Study|other|4|||
46883043|NCT00075881|83104154|FG000|Overall Study|missing data|2|||
46883044|NCT00075881|83104154|FG000|Overall Study|Ineligible|1|||
46883045|NCT00075881|83104154|FG000|Overall Study|never start protocol therapy|1|||
46883046|NCT00838630|83104162|FG000|First Intervention|Adverse Event|1|||
46883047|NCT00838630|83104163|FG001|First Intervention|Adverse Event|0|||
46883048|NCT00838630|83104162|FG000|Washout: 7 Days|Protocol Violation|1|||
46883049|NCT00838630|83104163|FG001|Washout: 7 Days|Protocol Violation|0|||
46883050|NCT02996474|83104167|FG000|Overall Study|Physician Decision|5|||
46883051|NCT03667924|83104174|FG000|Baseline Completed|Lost to Follow-up|0|||
46883052|NCT03667924|83104175|FG001|Baseline Completed|Lost to Follow-up|2|||
46883053|NCT03667924|83104176|FG002|Baseline Completed|Lost to Follow-up|0|||
46883054|NCT03667924|83104174|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
46883055|NCT03667924|83104175|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
46883056|NCT03667924|83104176|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
46883057|NCT03667924|83104174|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
46883058|NCT03667924|83104175|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
46883059|NCT03667924|83104176|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
46883060|NCT03667924|83104174|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
46883061|NCT03667924|83104175|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
46883062|NCT03667924|83104176|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
46883063|NCT03667924|83104174|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
46883064|NCT03667924|83104175|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
46883065|NCT03667924|83104176|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
46883066|NCT03667924|83104174|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
46883067|NCT03667924|83104175|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
46883068|NCT03667924|83104176|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
46883069|NCT03667924|83104174|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
46883070|NCT03667924|83104175|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
46883071|NCT03667924|83104176|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
46883072|NCT03205046|83104188|FG000|Overall Study|Death|10|||
46883073|NCT03205046|83104189|FG001|Overall Study|Death|6|||
46883074|NCT03205046|83104188|FG000|Overall Study|Withdrawal by Subject|1|||
46883075|NCT03205046|83104189|FG001|Overall Study|Withdrawal by Subject|2|||
46883076|NCT03205046|83104188|FG000|Overall Study|Lost to Follow-up|0|||
46883077|NCT03205046|83104189|FG001|Overall Study|Lost to Follow-up|1|||
46883078|NCT03205046|83104188|FG000|Overall Study|Study terminated by sponsor|2|||
46883079|NCT03205046|83104189|FG001|Overall Study|Study terminated by sponsor|1|||
46883080|NCT02339090|83104197|FG000|Overall Study|Adverse Event|1|||
46883081|NCT02339090|83104198|FG001|Overall Study|Adverse Event|0|||
46883082|NCT02339090|83104197|FG000|Overall Study|Lost to Follow-up|0|||
46883083|NCT02339090|83104198|FG001|Overall Study|Lost to Follow-up|1|||
46883084|NCT02339090|83104197|FG000|Overall Study|Non-compliance With Study Drug|0|||
46883085|NCT02339090|83104198|FG001|Overall Study|Non-compliance With Study Drug|1|||
46883086|NCT02339090|83104197|FG000|Overall Study|Withdrawal by Subject|2|||
46883087|NCT02339090|83104198|FG001|Overall Study|Withdrawal by Subject|1|||
46883088|NCT02339090|83104197|FG000|Overall Study|Poor Growth|3|||
46883089|NCT02339090|83104198|FG001|Overall Study|Poor Growth|0|||
46883090|NCT02339090|83104197|FG000|Overall Study|Randomized but not treated|0|||
46883091|NCT02339090|83104198|FG001|Overall Study|Randomized but not treated|2|||
46883092|NCT03331562|83104217|FG000|Overall Study|Adverse Event|2|||
46883093|NCT03331562|83104218|FG001|Overall Study|Adverse Event|0|||
46883094|NCT03331562|83104217|FG000|Overall Study|Death|1|||
46883095|NCT03331562|83104218|FG001|Overall Study|Death|0|||
46883096|NCT02038634|83104230|FG000|Overall Study|Lost to Follow-up|0|||
46883097|NCT02038634|83104231|FG001|Overall Study|Lost to Follow-up|1|||
46883098|NCT00836056|83104239|FG000|First Intervention|Adverse Event|1|||
46883099|NCT00836056|83104240|FG001|First Intervention|Adverse Event|0|||
46883100|NCT03200912|83104247|FG000|Overall Study|Adverse Event|3|||
46883101|NCT03200912|83104248|FG001|Overall Study|Adverse Event|0|||
46883102|NCT03200912|83104249|FG002|Overall Study|Adverse Event|0|||
46883103|NCT03200912|83104247|FG000|Overall Study|Withdrawal by Subject|1|||
46883104|NCT03200912|83104248|FG001|Overall Study|Withdrawal by Subject|2|||
46883105|NCT03200912|83104249|FG002|Overall Study|Withdrawal by Subject|4|||
46883106|NCT03200912|83104247|FG000|Overall Study|Non-compliance with study drug|0|||
46883107|NCT03200912|83104248|FG001|Overall Study|Non-compliance with study drug|1|||
46883108|NCT03200912|83104249|FG002|Overall Study|Non-compliance with study drug|0|||
46883109|NCT00835666|83104259|FG000|Washout|Protocol Violation|1|||
46883110|NCT00835666|83104260|FG001|Washout|Protocol Violation|0|||
46883111|NCT00835666|83104259|FG000|Washout|Withdrawal by Subject|1|||
46883112|NCT00835666|83104260|FG001|Washout|Withdrawal by Subject|0|||
46883113|NCT03200366|83104274|FG000|Patient Navigation Intervention Given|Death|0|||
46883114|NCT03200366|83104275|FG001|Patient Navigation Intervention Given|Death|2|||
46883115|NCT03200366|83104276|FG002|Patient Navigation Intervention Given|Death|0|||
46883116|NCT03200366|83104274|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
46883117|NCT03200366|83104275|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
46883118|NCT03200366|83104276|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
46883119|NCT03200366|83104274|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
46883120|NCT03200366|83104275|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
46883121|NCT03200366|83104276|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
46883122|NCT03200366|83104274|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
46883123|NCT03200366|83104275|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
46883124|NCT03200366|83104276|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
46883125|NCT03200366|83104274|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
46883126|NCT03200366|83104275|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
46883127|NCT03200366|83104276|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
46883128|NCT03200366|83104274|FG000|6 Month Post-Baseline Interview|Death|1|||
46883129|NCT03200366|83104275|FG001|6 Month Post-Baseline Interview|Death|1|||
46883130|NCT03200366|83104276|FG002|6 Month Post-Baseline Interview|Death|1|||
46883131|NCT03200366|83104274|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
46883132|NCT03200366|83104275|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
46883133|NCT03200366|83104276|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
46883134|NCT03200366|83104274|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
46883135|NCT03200366|83104275|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
46883136|NCT03200366|83104276|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
46883137|NCT03200366|83104274|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
46883138|NCT03200366|83104275|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
46883139|NCT03200366|83104276|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
46883140|NCT03200366|83104274|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
46883141|NCT03200366|83104275|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
46883142|NCT03200366|83104276|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
46883143|NCT03200366|83104274|FG000|9 Month Post-Baseline Interview|Death|1|||
46883144|NCT03200366|83104275|FG001|9 Month Post-Baseline Interview|Death|1|||
46883145|NCT03200366|83104276|FG002|9 Month Post-Baseline Interview|Death|1|||
46883146|NCT03200366|83104274|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
46883147|NCT03200366|83104275|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
46883148|NCT03200366|83104276|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
46883149|NCT03200366|83104274|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
46883150|NCT03200366|83104275|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
46883151|NCT03200366|83104276|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
46883152|NCT03200366|83104274|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
46883153|NCT03200366|83104275|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
46883154|NCT03200366|83104276|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
46883155|NCT00835354|83104288|FG000|First Intervention|Adverse Event|0|||
46883156|NCT00835354|83104289|FG001|First Intervention|Adverse Event|1|||
46883157|NCT00835042|83104320|FG000|First Intervention|Withdrawal by Subject|3|||
46883158|NCT00835042|83104321|FG001|First Intervention|Withdrawal by Subject|0|||
46883159|NCT00835042|83104320|FG000|First Intervention|Adverse Event|1|||
46883160|NCT00835042|83104321|FG001|First Intervention|Adverse Event|2|||
46883161|NCT00835042|83104320|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
46883162|NCT00835042|83104321|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
46883163|NCT00834418|83104358|FG000|Overall Study|Adverse Event|0|||
46883164|NCT00834418|83104359|FG001|Overall Study|Adverse Event|2|||
46883165|NCT00834340|83104365|FG000|Washout|Adverse Event|1|||
46883166|NCT00834340|83104366|FG001|Washout|Adverse Event|0|||
46883167|NCT00834340|83104365|FG000|Washout|Withdrawal by Subject|1|||
46883168|NCT00834340|83104366|FG001|Washout|Withdrawal by Subject|0|||
46883169|NCT00151996|83104372|FG000|Overall Study|Adverse Event|3|||
46883170|NCT00151996|83104373|FG001|Overall Study|Adverse Event|2|||
46883171|NCT00151996|83104372|FG000|Overall Study|Withdrawal by Subject|1|||
46883172|NCT00151996|83104373|FG001|Overall Study|Withdrawal by Subject|1|||
46883173|NCT00151996|83104372|FG000|Overall Study|Protocol Violation|1|||
46883174|NCT00151996|83104373|FG001|Overall Study|Protocol Violation|2|||
46883175|NCT00151996|83104372|FG000|Overall Study|Sponsor's decision|0|||
46883176|NCT00151996|83104373|FG001|Overall Study|Sponsor's decision|2|||
46883177|NCT00830206|83104381|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
46883178|NCT00830206|83104382|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
46883179|NCT00829504|83104388|FG000|First Intervention|Adverse Event|1|||
46883180|NCT00829504|83104389|FG001|First Intervention|Adverse Event|0|||
46883181|NCT00829504|83104388|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
46883182|NCT00829504|83104389|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
46883183|NCT00829504|83104388|FG000|Second Intervention|Physician Decision|1|||
46883184|NCT00829504|83104389|FG001|Second Intervention|Physician Decision|0|||
46883185|NCT00829426|83104395|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
46883186|NCT00829426|83104396|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
46883187|NCT00152464|83104402|FG000|Overall Study|Adverse Event|3|||
46883188|NCT00152464|83104403|FG001|Overall Study|Adverse Event|6|||
46883189|NCT00152464|83104402|FG000|Overall Study|Lost to Follow-up|8|||
46883190|NCT00152464|83104403|FG001|Overall Study|Lost to Follow-up|4|||
46883191|NCT00152464|83104402|FG000|Overall Study|Protocol Violation|3|||
46883192|NCT00152464|83104403|FG001|Overall Study|Protocol Violation|1|||
46883193|NCT00152464|83104402|FG000|Overall Study|Withdrawal by Subject|21|||
46883194|NCT00152464|83104403|FG001|Overall Study|Withdrawal by Subject|22|||
46883195|NCT00152464|83104402|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
46883196|NCT00152464|83104403|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
46883197|NCT00152464|83104402|FG000|Overall Study|Eczema deterioration|0|||
46883198|NCT00152464|83104403|FG001|Overall Study|Eczema deterioration|1|||
46883199|NCT00152464|83104402|FG000|Overall Study|Parent decision|1|||
46883200|NCT00152464|83104403|FG001|Overall Study|Parent decision|1|||
46883201|NCT00152464|83104402|FG000|Overall Study|Investigator decision|1|||
46883202|NCT00152464|83104403|FG001|Overall Study|Investigator decision|0|||
46883203|NCT00152464|83104402|FG000|Overall Study|Lack of Efficacy|1|||
46883204|NCT00152464|83104403|FG001|Overall Study|Lack of Efficacy|0|||
46883205|NCT00152464|83104402|FG000|Overall Study|Eczema poorly controlled|1|||
46883206|NCT00152464|83104403|FG001|Overall Study|Eczema poorly controlled|0|||
46883207|NCT00152464|83104402|FG000|Overall Study|Patient relocated|1|||
46883208|NCT00152464|83104403|FG001|Overall Study|Patient relocated|0|||
46883209|NCT00674440|83104409|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
46883210|NCT00674440|83104409|FG000|Overall Study|did not have surgery, so unevaluable|7|||
46883211|NCT00674440|83104409|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
46705165|NCT01184508|82919999|FG000|Overall Study|Protocol Violation|3|||
46883212|NCT02742766|83104433|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883213|NCT02742766|83104434|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883214|NCT02742766|83104435|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883215|NCT02742766|83104436|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883216|NCT02742766|83104437|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883217|NCT02742766|83104438|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883218|NCT02742766|83104439|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883219|NCT02742766|83104440|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883220|NCT02742766|83104441|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883221|NCT02742766|83104442|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883222|NCT02742766|83104443|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46991094|NCT02527343|83238021|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
46991095|NCT02527343|83238022|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
46991096|NCT02527343|83238023|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
46991097|NCT02527343|83238024|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
46991098|NCT02527343|83238019|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
46991099|NCT02527343|83238020|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
46991100|NCT02527343|83238021|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
46991101|NCT02527343|83238022|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
46991102|NCT02527343|83238023|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
46991103|NCT02527343|83238024|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
46991104|NCT02527343|83238019|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
46991105|NCT02527343|83238020|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
46991106|NCT02527343|83238021|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
46991107|NCT02527343|83238022|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
46991108|NCT02527343|83238023|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
46991109|NCT02527343|83238024|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
46991110|NCT02527343|83238019|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
46991111|NCT02527343|83238020|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
46991112|NCT02527343|83238021|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
46991113|NCT02527343|83238022|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
46991114|NCT02527343|83238023|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
46991115|NCT02527343|83238024|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
46991116|NCT02527343|83238019|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
46991117|NCT02527343|83238020|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
46991118|NCT02527343|83238021|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
46991119|NCT02527343|83238022|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
46991120|NCT02527343|83238023|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
46991121|NCT02527343|83238024|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
46991122|NCT01931566|83238042|FG000|Overall Study|Randomized But Not Treated|6|||
46991123|NCT01931566|83238043|FG001|Overall Study|Randomized But Not Treated|9|||
46991124|NCT01931566|83238044|FG002|Overall Study|Randomized But Not Treated|14|||
46991125|NCT01931566|83238042|FG000|Overall Study|Adverse Event|37|||
46991126|NCT01931566|83238043|FG001|Overall Study|Adverse Event|167|||
46991127|NCT01931566|83238044|FG002|Overall Study|Adverse Event|132|||
46991128|NCT01931566|83238042|FG000|Overall Study|Major Protocol Deviation|5|||
46991129|NCT01931566|83238043|FG001|Overall Study|Major Protocol Deviation|14|||
46991130|NCT01931566|83238044|FG002|Overall Study|Major Protocol Deviation|21|||
46991131|NCT01931566|83238042|FG000|Overall Study|Lost to Follow-up|3|||
46991132|NCT01931566|83238043|FG001|Overall Study|Lost to Follow-up|26|||
46991133|NCT01931566|83238044|FG002|Overall Study|Lost to Follow-up|23|||
46991134|NCT01931566|83238042|FG000|Overall Study|Voluntary Withdrawal|78|||
46991135|NCT01931566|83238043|FG001|Overall Study|Voluntary Withdrawal|245|||
46991136|NCT01931566|83238044|FG002|Overall Study|Voluntary Withdrawal|225|||
46883223|NCT02742766|83104444|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883224|NCT02742766|83104445|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883225|NCT02742766|83104446|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
46991137|NCT01931566|83238042|FG000|Overall Study|Study Termination|289|||
46991138|NCT01931566|83238043|FG001|Overall Study|Study Termination|968|||
46991139|NCT01931566|83238044|FG002|Overall Study|Study Termination|1037|||
46991140|NCT01931566|83238042|FG000|Overall Study|Reason Not Specified|11|||
46991141|NCT01931566|83238043|FG001|Overall Study|Reason Not Specified|47|||
46991142|NCT01931566|83238044|FG002|Overall Study|Reason Not Specified|53|||
46991143|NCT01931566|83238042|FG000|Overall Study|Missing|0|||
46991144|NCT01931566|83238043|FG001|Overall Study|Missing|0|||
46705166|NCT01184508|82920000|FG001|Overall Study|Protocol Violation|1|||
46883226|NCT02742766|83104447|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883227|NCT02742766|83104448|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883228|NCT02742766|83104449|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883229|NCT02742766|83104450|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46991145|NCT01931566|83238044|FG002|Overall Study|Missing|1|||
46991146|NCT01912456|83238055|FG000|Period 1|Physician Decision|0|||
46991147|NCT01912456|83238056|FG001|Period 1|Physician Decision|0|||
46991148|NCT01912456|83238057|FG002|Period 1|Physician Decision|1|||
46991149|NCT01912456|83238058|FG003|Period 1|Physician Decision|0|||
46991150|NCT01912456|83238055|FG000|Period 1|non-compliance|1|||
46991151|NCT01912456|83238056|FG001|Period 1|non-compliance|0|||
46991152|NCT01912456|83238057|FG002|Period 1|non-compliance|0|||
46991153|NCT01912456|83238058|FG003|Period 1|non-compliance|1|||
46991154|NCT01912456|83238055|FG000|Period 1|Adverse Event|1|||
46991155|NCT01912456|83238056|FG001|Period 1|Adverse Event|0|||
46991156|NCT01912456|83238057|FG002|Period 1|Adverse Event|0|||
46991157|NCT01912456|83238058|FG003|Period 1|Adverse Event|1|||
46991158|NCT01912456|83238055|FG000|Period 1|Withdrawal by Subject|0|||
46991159|NCT01912456|83238056|FG001|Period 1|Withdrawal by Subject|1|||
46705167|NCT01184508|82919999|FG000|Overall Study|Sponsor Decision|5|||
46705168|NCT01184508|82920000|FG001|Overall Study|Sponsor Decision|2|||
46705169|NCT01184508|82919999|FG000|Overall Study|Withdrawal by Subject|1|||
46705170|NCT01184508|82920000|FG001|Overall Study|Withdrawal by Subject|3|||
46705171|NCT01184508|82919999|FG000|Overall Study|Randomized, Not Treated|0|||
46705172|NCT01184508|82920000|FG001|Overall Study|Randomized, Not Treated|1|||
46705173|NCT01184118|82920007|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
46705174|NCT01184118|82920007|FG000|Overall Study|No physiologic confirmation of asthma|8|||
46705175|NCT01184118|82920007|FG000|Overall Study|FEV1 <60% predicted|2|||
46705176|NCT01184118|82920007|FG000|Overall Study|Exclusionary medical condition|2|||
46705177|NCT01184118|82920007|FG000|Overall Study|Withdrawal by Subject|5|||
46705178|NCT01183884|82920011|FG000|Overall Study|Progressive Disease|26|||
46705179|NCT01183884|82920011|FG000|Overall Study|Adverse Event|3|||
46705180|NCT01183884|82920011|FG000|Overall Study|Withdrawal by Subject|1|||
46705181|NCT01183884|82920011|FG000|Overall Study|Other Complicating Disease|3|||
46705182|NCT01183884|82920011|FG000|Overall Study|Not Treated|1|||
46705183|NCT01183884|82920011|FG000|Overall Study|Other|4|||
46705184|NCT01183260|82920017|FG000|Overall Study|Intraop screen failure|2|||
46705185|NCT01183260|82920018|FG001|Overall Study|Intraop screen failure|0|||
46705186|NCT01183260|82920017|FG000|Overall Study|Withdrawal by Subject|1|||
46705187|NCT01183260|82920018|FG001|Overall Study|Withdrawal by Subject|1|||
46705188|NCT01183260|82920017|FG000|Overall Study|Revised within 30 days|0|||
46705189|NCT01183260|82920018|FG001|Overall Study|Revised within 30 days|1|||
46705190|NCT01183260|82920017|FG000|Overall Study|Death|1|||
46705191|NCT01183260|82920018|FG001|Overall Study|Death|0|||
46705192|NCT01191762|82920026|FG000|Overall Study|Adverse Event|1|||
46705193|NCT01191762|82920027|FG001|Overall Study|Adverse Event|0|||
46705194|NCT01190514|82920033|FG000|First Intervention (Period 1)|Adverse Event|1|||
46705195|NCT01190514|82920034|FG001|First Intervention (Period 1)|Adverse Event|0|||
46705196|NCT01190514|82920035|FG002|First Intervention (Period 1)|Adverse Event|0|||
46705197|NCT01190514|82920036|FG003|First Intervention (Period 1)|Adverse Event|0|||
46705198|NCT01190514|82920033|FG000|Third Intervention (Period 3)|Adverse Event|1|||
46705199|NCT01190514|82920034|FG001|Third Intervention (Period 3)|Adverse Event|0|||
46705200|NCT01190514|82920035|FG002|Third Intervention (Period 3)|Adverse Event|0|||
46705201|NCT01190514|82920036|FG003|Third Intervention (Period 3)|Adverse Event|0|||
46705202|NCT01190436|82920046|FG000|Overall Study|Lost to Follow-up|35|||
46705203|NCT01190436|82920046|FG000|Overall Study|Other|4|||
46705204|NCT01035255|82920053|FG000|Overall Study|Death|724|||
46705205|NCT01035255|82920054|FG001|Overall Study|Death|844|||
46705206|NCT01035255|82920053|FG000|Overall Study|Lost to Follow-up|2|||
46705207|NCT01035255|82920054|FG001|Overall Study|Lost to Follow-up|5|||
46705208|NCT01035255|82920053|FG000|Overall Study|patient's request|15|||
46705209|NCT01035255|82920054|FG001|Overall Study|patient's request|13|||
46705210|NCT01190124|82920063|FG000|Overall Study|Death|3|||
46705211|NCT01190124|82920064|FG001|Overall Study|Death|0|||
46705212|NCT01190124|82920065|FG002|Overall Study|Death|0|||
46705213|NCT01190124|82920063|FG000|Overall Study|Therapeutic Failure|12|||
46705214|NCT01190124|82920064|FG001|Overall Study|Therapeutic Failure|0|||
46705215|NCT01190124|82920065|FG002|Overall Study|Therapeutic Failure|1|||
46705216|NCT01190124|82920063|FG000|Overall Study|Lost to Follow-up|2|||
46705217|NCT01190124|82920064|FG001|Overall Study|Lost to Follow-up|0|||
46705218|NCT01190124|82920065|FG002|Overall Study|Lost to Follow-up|0|||
46705219|NCT01189890|82920078|FG000|Overall Study|Adverse Event|3|||
46705220|NCT01189890|82920079|FG001|Overall Study|Adverse Event|4|||
46705221|NCT01189890|82920078|FG000|Overall Study|Lack of Efficacy|7|||
46705222|NCT01189890|82920079|FG001|Overall Study|Lack of Efficacy|2|||
46705223|NCT01189890|82920078|FG000|Overall Study|Lost to Follow-up|1|||
46705224|NCT01189890|82920079|FG001|Overall Study|Lost to Follow-up|7|||
46705225|NCT01189890|82920078|FG000|Overall Study|Protocol Violation|1|||
46705226|NCT01189890|82920079|FG001|Overall Study|Protocol Violation|5|||
46705227|NCT01189890|82920078|FG000|Overall Study|Withdrawal by Subject|15|||
46705228|NCT01189890|82920079|FG001|Overall Study|Withdrawal by Subject|11|||
46705229|NCT01189890|82920078|FG000|Overall Study|Non Compliance|0|||
46705230|NCT01189890|82920079|FG001|Overall Study|Non Compliance|1|||
46705231|NCT01189890|82920078|FG000|Overall Study|Physician Decision|5|||
46705232|NCT01189890|82920079|FG001|Overall Study|Physician Decision|4|||
46705233|NCT01189890|82920078|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
46705234|NCT01189890|82920079|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
46705235|NCT01189812|82920087|FG000|Overall Study|Withdrawal by Subject|2|||
46705236|NCT01189812|82920088|FG001|Overall Study|Withdrawal by Subject|3|||
46705237|NCT01189812|82920087|FG000|Overall Study|Adverse Event|1|||
46705238|NCT01189812|82920088|FG001|Overall Study|Adverse Event|0|||
46705239|NCT01189812|82920087|FG000|Overall Study|Out of Window|4|||
46705240|NCT01189812|82920088|FG001|Overall Study|Out of Window|3|||
46705241|NCT01189812|82920087|FG000|Overall Study|Moved out of State|1|||
46705242|NCT01189812|82920088|FG001|Overall Study|Moved out of State|2|||
46705243|NCT00950950|82920096|FG000|Overall Study|Adverse Event|1|||
46883230|NCT02742766|83104451|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
46883231|NCT02742766|83104433|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883232|NCT02742766|83104434|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883233|NCT02742766|83104435|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883234|NCT02742766|83104436|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883235|NCT02742766|83104437|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883236|NCT02742766|83104438|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883237|NCT02742766|83104439|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883238|NCT02742766|83104440|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883239|NCT02742766|83104441|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883240|NCT02742766|83104442|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883241|NCT02742766|83104443|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883242|NCT02742766|83104444|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883243|NCT02742766|83104445|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
46883244|NCT02742766|83104446|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
46883245|NCT02742766|83104447|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883246|NCT02742766|83104448|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
46883247|NCT02742766|83104449|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883248|NCT02742766|83104450|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883249|NCT02742766|83104451|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
46883250|NCT01468922|83104529|FG000|Overall Study|Screening failure|0|||
46705244|NCT00950950|82920097|FG001|Overall Study|Adverse Event|0|||
46705245|NCT00950950|82920096|FG000|Overall Study|Withdrawal by Subject|0|||
46883251|NCT01468922|83104530|FG001|Overall Study|Screening failure|0|||
46883252|NCT01468922|83104531|FG002|Overall Study|Screening failure|0|||
46883253|NCT01468922|83104532|FG003|Overall Study|Screening failure|0|||
46883254|NCT01468922|83104533|FG004|Overall Study|Screening failure|0|||
46883255|NCT01468922|83104534|FG005|Overall Study|Screening failure|0|||
46883256|NCT01468922|83104535|FG006|Overall Study|Screening failure|0|||
46883257|NCT01468922|83104536|FG007|Overall Study|Screening failure|0|||
46883258|NCT01468922|83104537|FG008|Overall Study|Screening failure|1|||
46883259|NCT01468922|83104529|FG000|Overall Study|Per patient choice|1|||
46883260|NCT01468922|83104530|FG001|Overall Study|Per patient choice|0|||
46883261|NCT01468922|83104531|FG002|Overall Study|Per patient choice|0|||
46883262|NCT01468922|83104532|FG003|Overall Study|Per patient choice|0|||
46883263|NCT01468922|83104533|FG004|Overall Study|Per patient choice|0|||
46883264|NCT01468922|83104534|FG005|Overall Study|Per patient choice|0|||
46883265|NCT01468922|83104535|FG006|Overall Study|Per patient choice|0|||
46883266|NCT01468922|83104536|FG007|Overall Study|Per patient choice|0|||
46705246|NCT00950950|82920097|FG001|Overall Study|Withdrawal by Subject|1|||
46705247|NCT00950872|82920104|FG000|Overall Study|Withdrawal by Subject|1|||
46705248|NCT00950872|82920104|FG000|Overall Study|Did not have surgery|2|||
46705249|NCT01189500|82920108|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
46705250|NCT01189500|82920108|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
46705251|NCT00938860|82920117|FG000|Overall Study|Adverse Event|2|||
46883267|NCT01468922|83104537|FG008|Overall Study|Per patient choice|0|||
46883268|NCT01468922|83104529|FG000|Overall Study|Switched to alternative treatment|1|||
46883269|NCT01468922|83104530|FG001|Overall Study|Switched to alternative treatment|0|||
46883270|NCT01468922|83104531|FG002|Overall Study|Switched to alternative treatment|0|||
46883271|NCT01468922|83104532|FG003|Overall Study|Switched to alternative treatment|0|||
46883272|NCT01468922|83104533|FG004|Overall Study|Switched to alternative treatment|1|||
46883273|NCT01468922|83104534|FG005|Overall Study|Switched to alternative treatment|0|||
46883274|NCT01468922|83104535|FG006|Overall Study|Switched to alternative treatment|0|||
46883275|NCT01468922|83104536|FG007|Overall Study|Switched to alternative treatment|0|||
46883276|NCT01468922|83104537|FG008|Overall Study|Switched to alternative treatment|0|||
46883277|NCT01468922|83104529|FG000|Overall Study|Enrolled on new protocol|0|||
46883278|NCT01468922|83104530|FG001|Overall Study|Enrolled on new protocol|0|||
46883279|NCT01468922|83104531|FG002|Overall Study|Enrolled on new protocol|0|||
46883280|NCT01468922|83104532|FG003|Overall Study|Enrolled on new protocol|0|||
46883281|NCT01468922|83104533|FG004|Overall Study|Enrolled on new protocol|1|||
46883282|NCT01468922|83104534|FG005|Overall Study|Enrolled on new protocol|0|||
46883283|NCT01468922|83104535|FG006|Overall Study|Enrolled on new protocol|0|||
46883284|NCT01468922|83104536|FG007|Overall Study|Enrolled on new protocol|0|||
46883285|NCT01468922|83104537|FG008|Overall Study|Enrolled on new protocol|0|||
46883286|NCT01468922|83104529|FG000|Overall Study|Adverse Event|0|||
46883287|NCT01468922|83104530|FG001|Overall Study|Adverse Event|0|||
46883288|NCT01468922|83104531|FG002|Overall Study|Adverse Event|0|||
46883289|NCT01468922|83104532|FG003|Overall Study|Adverse Event|0|||
46883290|NCT01468922|83104533|FG004|Overall Study|Adverse Event|0|||
46883291|NCT01468922|83104534|FG005|Overall Study|Adverse Event|0|||
46883292|NCT01468922|83104535|FG006|Overall Study|Adverse Event|0|||
46883293|NCT01468922|83104536|FG007|Overall Study|Adverse Event|1|||
46883294|NCT01468922|83104537|FG008|Overall Study|Adverse Event|0|||
46883295|NCT01468922|83104529|FG000|Overall Study|Infection of blood|0|||
46883296|NCT01468922|83104530|FG001|Overall Study|Infection of blood|0|||
46883297|NCT01468922|83104531|FG002|Overall Study|Infection of blood|0|||
46883298|NCT01468922|83104532|FG003|Overall Study|Infection of blood|0|||
46883299|NCT01468922|83104533|FG004|Overall Study|Infection of blood|0|||
46883300|NCT01468922|83104534|FG005|Overall Study|Infection of blood|0|||
46883301|NCT01468922|83104535|FG006|Overall Study|Infection of blood|0|||
46883302|NCT01468922|83104536|FG007|Overall Study|Infection of blood|1|||
46883303|NCT01468922|83104537|FG008|Overall Study|Infection of blood|0|||
46883304|NCT01468922|83104529|FG000|Overall Study|Patient choice - surgery|0|||
46883305|NCT01468922|83104530|FG001|Overall Study|Patient choice - surgery|0|||
46883306|NCT01468922|83104531|FG002|Overall Study|Patient choice - surgery|0|||
46883307|NCT01468922|83104532|FG003|Overall Study|Patient choice - surgery|0|||
46883308|NCT01468922|83104533|FG004|Overall Study|Patient choice - surgery|0|||
46883309|NCT01468922|83104534|FG005|Overall Study|Patient choice - surgery|0|||
46883310|NCT01468922|83104535|FG006|Overall Study|Patient choice - surgery|0|||
46883311|NCT01468922|83104536|FG007|Overall Study|Patient choice - surgery|1|||
46883312|NCT01468922|83104537|FG008|Overall Study|Patient choice - surgery|0|||
46883313|NCT01468922|83104529|FG000|Overall Study|Refused further treatment|0|||
46883314|NCT01468922|83104530|FG001|Overall Study|Refused further treatment|0|||
46883315|NCT01468922|83104531|FG002|Overall Study|Refused further treatment|0|||
46883316|NCT01468922|83104532|FG003|Overall Study|Refused further treatment|0|||
46883317|NCT01468922|83104533|FG004|Overall Study|Refused further treatment|0|||
46883318|NCT01468922|83104534|FG005|Overall Study|Refused further treatment|0|||
46883319|NCT01468922|83104535|FG006|Overall Study|Refused further treatment|0|||
46883320|NCT01468922|83104536|FG007|Overall Study|Refused further treatment|1|||
46883321|NCT01468922|83104537|FG008|Overall Study|Refused further treatment|0|||
46883322|NCT01381094|83104560|FG000|Overall Study|Adverse Event|1|||
46883323|NCT01381094|83104561|FG001|Overall Study|Adverse Event|2|||
46883324|NCT01381094|83104562|FG002|Overall Study|Adverse Event|0|||
46883325|NCT01381094|83104563|FG003|Overall Study|Adverse Event|1|||
46883326|NCT01381094|83104564|FG004|Overall Study|Adverse Event|0|||
46883327|NCT01381094|83104560|FG000|Overall Study|Lost to Follow-up|0|||
46883328|NCT01381094|83104561|FG001|Overall Study|Lost to Follow-up|0|||
46883329|NCT01381094|83104562|FG002|Overall Study|Lost to Follow-up|0|||
46883330|NCT01381094|83104563|FG003|Overall Study|Lost to Follow-up|0|||
46883331|NCT01381094|83104564|FG004|Overall Study|Lost to Follow-up|1|||
46883332|NCT01381094|83104560|FG000|Overall Study|Withdrawal of informed consent|0|||
46883333|NCT01381094|83104561|FG001|Overall Study|Withdrawal of informed consent|1|||
46705252|NCT00938860|82920118|FG001|Overall Study|Adverse Event|1|||
46883334|NCT01381094|83104562|FG002|Overall Study|Withdrawal of informed consent|0|||
46883335|NCT01381094|83104563|FG003|Overall Study|Withdrawal of informed consent|0|||
46883336|NCT01381094|83104564|FG004|Overall Study|Withdrawal of informed consent|0|||
46883337|NCT01381094|83104560|FG000|Overall Study|Participant given Aranesp injection|1|||
46883338|NCT01381094|83104561|FG001|Overall Study|Participant given Aranesp injection|0|||
46991160|NCT01912456|83238057|FG002|Period 1|Withdrawal by Subject|1|||
46991161|NCT01912456|83238058|FG003|Period 1|Withdrawal by Subject|1|||
46883339|NCT01381094|83104562|FG002|Overall Study|Participant given Aranesp injection|0|||
46883340|NCT01381094|83104563|FG003|Overall Study|Participant given Aranesp injection|0|||
46883341|NCT01381094|83104564|FG004|Overall Study|Participant given Aranesp injection|0|||
46883342|NCT03197558|83104576|FG000|Overall Study|Tubes not placed|1|||
46883343|NCT03197324|83104582|FG000|Overall Study|Adverse Event|0|||
46883344|NCT03197324|83104583|FG001|Overall Study|Adverse Event|1|||
46883345|NCT03162614|83104595|FG000|Overall Study|Lost to Follow-up|2|||
46883346|NCT03162614|83104596|FG001|Overall Study|Lost to Follow-up|1|||
46883347|NCT03162614|83104597|FG002|Overall Study|Lost to Follow-up|1|||
46883348|NCT03162614|83104598|FG003|Overall Study|Lost to Follow-up|1|||
46883349|NCT03162614|83104599|FG004|Overall Study|Lost to Follow-up|2|||
46883350|NCT03162614|83104600|FG005|Overall Study|Lost to Follow-up|0|||
46883351|NCT03162614|83104595|FG000|Overall Study|Protocol Violation|0|||
46991162|NCT01912456|83238055|FG000|Period 2|Lack of Efficacy|0|||
46991163|NCT01912456|83238056|FG001|Period 2|Lack of Efficacy|2|||
46991164|NCT01912456|83238057|FG002|Period 2|Lack of Efficacy|0|||
46991165|NCT01912456|83238058|FG003|Period 2|Lack of Efficacy|0|||
46991166|NCT01912456|83238055|FG000|Period 2|Adverse Event|0|||
46991167|NCT01912456|83238056|FG001|Period 2|Adverse Event|0|||
46991168|NCT01912456|83238057|FG002|Period 2|Adverse Event|0|||
46991169|NCT01912456|83238058|FG003|Period 2|Adverse Event|1|||
46991170|NCT01885936|83238070|FG000|Overall Study|Withdrawal by Subject|1|||
46991171|NCT01885936|83238071|FG001|Overall Study|Withdrawal by Subject|0|||
46991172|NCT01912222|83238080|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
46991173|NCT01912222|83238081|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
46991174|NCT01912222|83238082|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
46991175|NCT01912222|83238080|FG000|Part B: Treatment Period|Progressive disease|10|||
46991176|NCT01912222|83238081|FG001|Part B: Treatment Period|Progressive disease|12|||
46991177|NCT01912222|83238082|FG002|Part B: Treatment Period|Progressive disease|15|||
46991178|NCT01912222|83238080|FG000|Part B: Treatment Period|Adverse Event|1|||
46991179|NCT01912222|83238081|FG001|Part B: Treatment Period|Adverse Event|2|||
46991180|NCT01912222|83238082|FG002|Part B: Treatment Period|Adverse Event|3|||
46991181|NCT01912222|83238080|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
46991182|NCT01912222|83238081|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
46991183|NCT01912222|83238082|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
46991184|NCT02525861|83238093|FG000|Overall Study|Adverse Event|1|||
46991185|NCT02525861|83238094|FG001|Overall Study|Adverse Event|0|||
46991186|NCT02525861|83238093|FG000|Overall Study|Withdrawal by Subject|0|||
46991187|NCT02525861|83238094|FG001|Overall Study|Withdrawal by Subject|1|||
46991188|NCT02525861|83238093|FG000|Overall Study|Physician Decision|0|||
46991189|NCT02525861|83238094|FG001|Overall Study|Physician Decision|1|||
46991190|NCT02524847|83238102|FG000|Overall Study|Adverse Event|4|||
46991191|NCT02524847|83238102|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
46991192|NCT02524847|83238102|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
46991193|NCT02524847|83238102|FG000|Overall Study|Death|1|||
46991194|NCT02524847|83238102|FG000|Overall Study|Reason not Specified|1|||
46991195|NCT02129205|83238117|FG000|Overall Study|Withdrawal by Subject|0|||
46991196|NCT02129205|83238118|FG001|Overall Study|Withdrawal by Subject|0|||
46991197|NCT02129205|83238119|FG002|Overall Study|Withdrawal by Subject|0|||
46991198|NCT02129205|83238120|FG003|Overall Study|Withdrawal by Subject|0|||
46991199|NCT02129205|83238121|FG004|Overall Study|Withdrawal by Subject|1|||
46991200|NCT02129205|83238122|FG005|Overall Study|Withdrawal by Subject|1|||
46991201|NCT02129205|83238123|FG006|Overall Study|Withdrawal by Subject|1|||
46991202|NCT02129205|83238124|FG007|Overall Study|Withdrawal by Subject|0|||
46991203|NCT02129205|83238125|FG008|Overall Study|Withdrawal by Subject|1|||
46991204|NCT02129205|83238126|FG009|Overall Study|Withdrawal by Subject|0|||
46991205|NCT02129205|83238117|FG000|Overall Study|Other|1|||
46991206|NCT02129205|83238118|FG001|Overall Study|Other|0|||
46991207|NCT02129205|83238119|FG002|Overall Study|Other|0|||
46991208|NCT02129205|83238120|FG003|Overall Study|Other|0|||
46991209|NCT02129205|83238121|FG004|Overall Study|Other|2|||
46991210|NCT02129205|83238122|FG005|Overall Study|Other|3|||
46991211|NCT02129205|83238123|FG006|Overall Study|Other|3|||
46991212|NCT02129205|83238124|FG007|Overall Study|Other|2|||
46991213|NCT02129205|83238125|FG008|Overall Study|Other|1|||
46991214|NCT02129205|83238126|FG009|Overall Study|Other|0|||
46991215|NCT02128269|83238150|FG000|Treatment Period|Adverse Event|1|||
46991216|NCT02128269|83238150|FG000|Treatment Period|Physician Decision|1|||
46991217|NCT01626885|83238154|FG000|Overall Study|Adverse Event|8|||
46991218|NCT01626885|83238154|FG000|Overall Study|Withdrawal by Subject|4|||
46991219|NCT02524379|83238158|FG000|Overall Study|Death|1|||
46991220|NCT02524145|83238165|FG000|Overall Study|Withdrawal by Subject|2|||
46991221|NCT02524145|83238166|FG001|Overall Study|Withdrawal by Subject|2|||
46991222|NCT02524145|83238167|FG002|Overall Study|Withdrawal by Subject|3|||
46991223|NCT01658813|83238175|FG000|Overall Study|Disease progression|3|||
46991224|NCT02187471|83238187|FG000|Overall Study|Protocol Violation|4|||
46991225|NCT02187471|83238188|FG001|Overall Study|Protocol Violation|5|||
46991226|NCT02187471|83238189|FG002|Overall Study|Protocol Violation|4|||
46991227|NCT02187471|83238190|FG003|Overall Study|Protocol Violation|4|||
46991228|NCT02187471|83238187|FG000|Overall Study|Missing|0|||
46991229|NCT02187471|83238188|FG001|Overall Study|Missing|0|||
46991230|NCT02187471|83238189|FG002|Overall Study|Missing|0|||
46991231|NCT02187471|83238190|FG003|Overall Study|Missing|1|||
46991232|NCT02187471|83238187|FG000|Overall Study|Lack of Efficacy|18|||
46883352|NCT03162614|83104596|FG001|Overall Study|Protocol Violation|1|||
46883353|NCT03162614|83104597|FG002|Overall Study|Protocol Violation|0|||
46883354|NCT03162614|83104598|FG003|Overall Study|Protocol Violation|1|||
46883355|NCT03162614|83104599|FG004|Overall Study|Protocol Violation|0|||
46883356|NCT03162614|83104600|FG005|Overall Study|Protocol Violation|0|||
46883357|NCT03162614|83104595|FG000|Overall Study|Withdrawal by Subject|2|||
46883358|NCT03162614|83104596|FG001|Overall Study|Withdrawal by Subject|1|||
46883359|NCT03162614|83104597|FG002|Overall Study|Withdrawal by Subject|1|||
46883360|NCT03162614|83104598|FG003|Overall Study|Withdrawal by Subject|1|||
46883361|NCT03162614|83104599|FG004|Overall Study|Withdrawal by Subject|0|||
46883362|NCT03162614|83104600|FG005|Overall Study|Withdrawal by Subject|0|||
46883363|NCT03162614|83104595|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
46883364|NCT03162614|83104596|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
46883365|NCT03162614|83104597|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
46883366|NCT03162614|83104598|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
46883367|NCT03162614|83104599|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
46883368|NCT03162614|83104600|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
46883369|NCT03160898|83104618|FG000|Overall Study|Adverse Event|4|||
46883370|NCT03160898|83104619|FG001|Overall Study|Adverse Event|8|||
46883371|NCT03160898|83104620|FG002|Overall Study|Adverse Event|7|||
46883372|NCT03160898|83104621|FG003|Overall Study|Adverse Event|10|||
46883373|NCT03160898|83104618|FG000|Overall Study|Death|1|||
46883374|NCT03160898|83104619|FG001|Overall Study|Death|0|||
46883375|NCT03160898|83104620|FG002|Overall Study|Death|0|||
46883376|NCT03160898|83104621|FG003|Overall Study|Death|1|||
46883377|NCT03160898|83104618|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
46883378|NCT03160898|83104619|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
46883379|NCT03160898|83104620|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
46883380|NCT03160898|83104621|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
46883381|NCT03160898|83104618|FG000|Overall Study|Lost to Follow-up|1|||
46883382|NCT03160898|83104619|FG001|Overall Study|Lost to Follow-up|1|||
46883383|NCT03160898|83104620|FG002|Overall Study|Lost to Follow-up|1|||
46883384|NCT03160898|83104621|FG003|Overall Study|Lost to Follow-up|2|||
46883385|NCT03160898|83104618|FG000|Overall Study|Physician Decision|1|||
46883386|NCT03160898|83104619|FG001|Overall Study|Physician Decision|0|||
46883387|NCT03160898|83104620|FG002|Overall Study|Physician Decision|0|||
46883388|NCT03160898|83104621|FG003|Overall Study|Physician Decision|1|||
46883389|NCT03160898|83104618|FG000|Overall Study|Progressive Disease|4|||
46883390|NCT03160898|83104619|FG001|Overall Study|Progressive Disease|1|||
46883391|NCT03160898|83104620|FG002|Overall Study|Progressive Disease|2|||
46883392|NCT03160898|83104621|FG003|Overall Study|Progressive Disease|1|||
46883393|NCT03160898|83104618|FG000|Overall Study|Protocol Violation|1|||
46883394|NCT03160898|83104619|FG001|Overall Study|Protocol Violation|0|||
46883395|NCT03160898|83104620|FG002|Overall Study|Protocol Violation|2|||
46883396|NCT03160898|83104621|FG003|Overall Study|Protocol Violation|0|||
46883397|NCT03160898|83104618|FG000|Overall Study|Sponsor Discretion|2|||
46883398|NCT03160898|83104619|FG001|Overall Study|Sponsor Discretion|0|||
46883399|NCT03160898|83104620|FG002|Overall Study|Sponsor Discretion|0|||
46883400|NCT03160898|83104621|FG003|Overall Study|Sponsor Discretion|0|||
46883401|NCT03160898|83104618|FG000|Overall Study|Withdrawal by Subject|1|||
46883402|NCT03160898|83104619|FG001|Overall Study|Withdrawal by Subject|3|||
46883403|NCT03160898|83104620|FG002|Overall Study|Withdrawal by Subject|2|||
46883404|NCT03160898|83104621|FG003|Overall Study|Withdrawal by Subject|1|||
46883405|NCT03160898|83104618|FG000|Overall Study|Other|2|||
46883406|NCT03160898|83104619|FG001|Overall Study|Other|0|||
46883407|NCT03160898|83104620|FG002|Overall Study|Other|2|||
46883408|NCT03160898|83104621|FG003|Overall Study|Other|2|||
46883409|NCT03193736|83104632|FG000|Overall Study|Death|2|||
46883410|NCT03193736|83104632|FG000|Overall Study|Withdrawal by Subject|1|||
46883411|NCT03193736|83104632|FG000|Overall Study|Lost to Follow-up|1|||
46883412|NCT03193736|83104632|FG000|Overall Study|implant not received|1|||
46883413|NCT03192488|83104640|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
46883414|NCT03192488|83104641|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
46883415|NCT03192488|83104642|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
46883416|NCT03192488|83104643|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
46883417|NCT03192488|83104644|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
46883418|NCT03192488|83104645|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
46705253|NCT00938860|82920117|FG000|Overall Study|Abnormal laboratory values|2|||
46883419|NCT03192488|83104640|FG000|Third Intervention (d1)|Adverse Event|0|||
46883420|NCT03192488|83104641|FG001|Third Intervention (d1)|Adverse Event|0|||
46883421|NCT03192488|83104642|FG002|Third Intervention (d1)|Adverse Event|0|||
46883422|NCT03192488|83104643|FG003|Third Intervention (d1)|Adverse Event|0|||
46883423|NCT03192488|83104644|FG004|Third Intervention (d1)|Adverse Event|1|||
46883424|NCT03192488|83104645|FG005|Third Intervention (d1)|Adverse Event|0|||
46883425|NCT01642004|83104661|FG000|Randomization|Adverse Event unrelated to study drug|1|||
46883426|NCT01642004|83104662|FG001|Randomization|Adverse Event unrelated to study drug|0|||
46883427|NCT01642004|83104661|FG000|Randomization|Participant withdrew consent|1|||
46883428|NCT01642004|83104662|FG001|Randomization|Participant withdrew consent|6|||
46883429|NCT01642004|83104661|FG000|Randomization|No longer meets study criteria|2|||
46883430|NCT01642004|83104662|FG001|Randomization|No longer meets study criteria|2|||
46883431|NCT01642004|83104661|FG000|Treatment|Disease progression|95|||
46883432|NCT01642004|83104662|FG001|Treatment|Disease progression|79|||
46883433|NCT01642004|83104661|FG000|Treatment|Study drug toxicity|10|||
46883434|NCT01642004|83104662|FG001|Treatment|Study drug toxicity|13|||
46883435|NCT01642004|83104661|FG000|Treatment|Death|1|||
46883436|NCT01642004|83104662|FG001|Treatment|Death|1|||
46883437|NCT01642004|83104661|FG000|Treatment|Adverse event unrelated to study drug|9|||
46883438|NCT01642004|83104662|FG001|Treatment|Adverse event unrelated to study drug|13|||
46883439|NCT01642004|83104661|FG000|Treatment|Maximum clinical benefit|1|||
46883440|NCT01642004|83104662|FG001|Treatment|Maximum clinical benefit|9|||
46883441|NCT01642004|83104661|FG000|Treatment|Poor/non-compliance|1|||
46883442|NCT01642004|83104662|FG001|Treatment|Poor/non-compliance|0|||
46883443|NCT01642004|83104661|FG000|Treatment|No longer meets study criteria|1|||
46883444|NCT01642004|83104662|FG001|Treatment|No longer meets study criteria|2|||
46883445|NCT01642004|83104661|FG000|Treatment|Other reasons|2|||
46883446|NCT01642004|83104662|FG001|Treatment|Other reasons|0|||
46883447|NCT01642004|83104661|FG000|Treatment|Not reported|0|||
46883448|NCT01642004|83104662|FG001|Treatment|Not reported|3|||
46883449|NCT01642004|83104661|FG000|Treatment|Participant request to discontinue study treatment|6|||
46883450|NCT01642004|83104662|FG001|Treatment|Participant request to discontinue study treatment|4|||
46883451|NCT01642004|83104661|FG000|Treatment|Participant withdrew consent|5|||
46883452|NCT01642004|83104662|FG001|Treatment|Participant withdrew consent|5|||
46883453|NCT00042289|83104718|FG000|Overall Study|Lost to Follow-up|3|||
46883454|NCT00042289|83104719|FG001|Overall Study|Lost to Follow-up|0|||
46883455|NCT00042289|83104720|FG002|Overall Study|Lost to Follow-up|0|||
46883456|NCT00042289|83104721|FG003|Overall Study|Lost to Follow-up|1|||
46883457|NCT00042289|83104722|FG004|Overall Study|Lost to Follow-up|3|||
46883458|NCT00042289|83104723|FG005|Overall Study|Lost to Follow-up|3|||
46883459|NCT00042289|83104724|FG006|Overall Study|Lost to Follow-up|6|||
46883460|NCT00042289|83104725|FG007|Overall Study|Lost to Follow-up|1|||
46883461|NCT00042289|83104726|FG008|Overall Study|Lost to Follow-up|1|||
46883462|NCT00042289|83104727|FG009|Overall Study|Lost to Follow-up|0|||
46883463|NCT00042289|83104728|FG010|Overall Study|Lost to Follow-up|0|||
46883464|NCT00042289|83104729|FG011|Overall Study|Lost to Follow-up|0|||
46883465|NCT00042289|83104730|FG012|Overall Study|Lost to Follow-up|0|||
46883466|NCT00042289|83104731|FG013|Overall Study|Lost to Follow-up|0|||
46883467|NCT00042289|83104732|FG014|Overall Study|Lost to Follow-up|0|||
46883468|NCT00042289|83104733|FG015|Overall Study|Lost to Follow-up|1|||
46883469|NCT00042289|83104734|FG016|Overall Study|Lost to Follow-up|1|||
46883470|NCT00042289|83104735|FG017|Overall Study|Lost to Follow-up|0|||
46883471|NCT00042289|83104736|FG018|Overall Study|Lost to Follow-up|3|||
46883472|NCT00042289|83104737|FG019|Overall Study|Lost to Follow-up|2|||
46883473|NCT00042289|83104738|FG020|Overall Study|Lost to Follow-up|0|||
46883474|NCT00042289|83104739|FG021|Overall Study|Lost to Follow-up|0|||
46883475|NCT00042289|83104740|FG022|Overall Study|Lost to Follow-up|0|||
46883476|NCT00042289|83104741|FG023|Overall Study|Lost to Follow-up|0|||
46883477|NCT00042289|83104742|FG024|Overall Study|Lost to Follow-up|0|||
46883478|NCT00042289|83104743|FG025|Overall Study|Lost to Follow-up|0|||
46883479|NCT00042289|83104744|FG026|Overall Study|Lost to Follow-up|2|||
46883480|NCT00042289|83104745|FG027|Overall Study|Lost to Follow-up|2|||
46883481|NCT00042289|83104746|FG028|Overall Study|Lost to Follow-up|2|||
46883482|NCT00042289|83104747|FG029|Overall Study|Lost to Follow-up|0|||
46883483|NCT00042289|83104748|FG030|Overall Study|Lost to Follow-up|0|||
46883484|NCT00042289|83104749|FG031|Overall Study|Lost to Follow-up|2|||
46883485|NCT00042289|83104750|FG032|Overall Study|Lost to Follow-up|1|||
46883486|NCT00042289|83104751|FG033|Overall Study|Lost to Follow-up|1|||
46883487|NCT00042289|83104752|FG034|Overall Study|Lost to Follow-up|1|||
46883488|NCT00042289|83104753|FG035|Overall Study|Lost to Follow-up|2|||
46883489|NCT00042289|83104754|FG036|Overall Study|Lost to Follow-up|1|||
46883490|NCT00042289|83104755|FG037|Overall Study|Lost to Follow-up|1|||
46883491|NCT00042289|83104756|FG038|Overall Study|Lost to Follow-up|0|||
46883492|NCT00042289|83104757|FG039|Overall Study|Lost to Follow-up|5|||
46883493|NCT00042289|83104758|FG040|Overall Study|Lost to Follow-up|0|||
46883494|NCT00042289|83104759|FG041|Overall Study|Lost to Follow-up|2|||
46883495|NCT00042289|83104760|FG042|Overall Study|Lost to Follow-up|2|||
46883496|NCT00042289|83104761|FG043|Overall Study|Lost to Follow-up|0|||
46883497|NCT00042289|83104762|FG044|Overall Study|Lost to Follow-up|0|||
46883498|NCT00042289|83104763|FG045|Overall Study|Lost to Follow-up|1|||
46883499|NCT00042289|83104764|FG046|Overall Study|Lost to Follow-up|0|||
46883500|NCT00042289|83104718|FG000|Overall Study|Other reason|0|||
46883501|NCT00042289|83104719|FG001|Overall Study|Other reason|0|||
46883502|NCT00042289|83104720|FG002|Overall Study|Other reason|0|||
46883503|NCT00042289|83104721|FG003|Overall Study|Other reason|2|||
46883504|NCT00042289|83104722|FG004|Overall Study|Other reason|0|||
46883505|NCT00042289|83104723|FG005|Overall Study|Other reason|0|||
46883506|NCT00042289|83104724|FG006|Overall Study|Other reason|0|||
46883507|NCT00042289|83104725|FG007|Overall Study|Other reason|0|||
46883508|NCT00042289|83104726|FG008|Overall Study|Other reason|0|||
46883509|NCT00042289|83104727|FG009|Overall Study|Other reason|0|||
46883510|NCT00042289|83104728|FG010|Overall Study|Other reason|0|||
46883511|NCT00042289|83104729|FG011|Overall Study|Other reason|0|||
46883512|NCT00042289|83104730|FG012|Overall Study|Other reason|0|||
46883513|NCT00042289|83104731|FG013|Overall Study|Other reason|0|||
46883514|NCT00042289|83104732|FG014|Overall Study|Other reason|0|||
46883515|NCT00042289|83104733|FG015|Overall Study|Other reason|0|||
46883516|NCT00042289|83104734|FG016|Overall Study|Other reason|0|||
46883517|NCT00042289|83104735|FG017|Overall Study|Other reason|0|||
46883518|NCT00042289|83104736|FG018|Overall Study|Other reason|1|||
46883519|NCT00042289|83104737|FG019|Overall Study|Other reason|0|||
46883520|NCT00042289|83104738|FG020|Overall Study|Other reason|0|||
46883521|NCT00042289|83104739|FG021|Overall Study|Other reason|0|||
46883522|NCT00042289|83104740|FG022|Overall Study|Other reason|0|||
46883523|NCT00042289|83104741|FG023|Overall Study|Other reason|1|||
46883524|NCT00042289|83104742|FG024|Overall Study|Other reason|0|||
46883525|NCT00042289|83104743|FG025|Overall Study|Other reason|0|||
46883526|NCT00042289|83104744|FG026|Overall Study|Other reason|1|||
46883527|NCT00042289|83104745|FG027|Overall Study|Other reason|0|||
46883528|NCT00042289|83104746|FG028|Overall Study|Other reason|3|||
46883529|NCT00042289|83104747|FG029|Overall Study|Other reason|0|||
46883530|NCT00042289|83104748|FG030|Overall Study|Other reason|0|||
46883531|NCT00042289|83104749|FG031|Overall Study|Other reason|1|||
46883532|NCT00042289|83104750|FG032|Overall Study|Other reason|0|||
46883533|NCT00042289|83104751|FG033|Overall Study|Other reason|1|||
46883534|NCT00042289|83104752|FG034|Overall Study|Other reason|0|||
46883535|NCT00042289|83104753|FG035|Overall Study|Other reason|2|||
46883536|NCT00042289|83104754|FG036|Overall Study|Other reason|0|||
46883537|NCT00042289|83104755|FG037|Overall Study|Other reason|0|||
46883538|NCT00042289|83104756|FG038|Overall Study|Other reason|0|||
46883539|NCT00042289|83104757|FG039|Overall Study|Other reason|0|||
46883540|NCT00042289|83104758|FG040|Overall Study|Other reason|0|||
46883541|NCT00042289|83104759|FG041|Overall Study|Other reason|0|||
46883542|NCT00042289|83104760|FG042|Overall Study|Other reason|0|||
46883543|NCT00042289|83104761|FG043|Overall Study|Other reason|1|||
46883544|NCT00042289|83104762|FG044|Overall Study|Other reason|0|||
46883545|NCT00042289|83104763|FG045|Overall Study|Other reason|0|||
46883546|NCT00042289|83104764|FG046|Overall Study|Other reason|0|||
46883547|NCT00042289|83104718|FG000|Overall Study|Severe debilitation, unable to continue|0|||
46883548|NCT00042289|83104719|FG001|Overall Study|Severe debilitation, unable to continue|0|||
46883549|NCT00042289|83104720|FG002|Overall Study|Severe debilitation, unable to continue|0|||
46883550|NCT00042289|83104721|FG003|Overall Study|Severe debilitation, unable to continue|0|||
46883551|NCT00042289|83104722|FG004|Overall Study|Severe debilitation, unable to continue|0|||
46883552|NCT00042289|83104723|FG005|Overall Study|Severe debilitation, unable to continue|0|||
46883553|NCT00042289|83104724|FG006|Overall Study|Severe debilitation, unable to continue|0|||
46883554|NCT00042289|83104725|FG007|Overall Study|Severe debilitation, unable to continue|0|||
46883555|NCT00042289|83104726|FG008|Overall Study|Severe debilitation, unable to continue|0|||
46883556|NCT00042289|83104727|FG009|Overall Study|Severe debilitation, unable to continue|0|||
46883557|NCT00042289|83104728|FG010|Overall Study|Severe debilitation, unable to continue|0|||
46883558|NCT00042289|83104729|FG011|Overall Study|Severe debilitation, unable to continue|0|||
46883559|NCT00042289|83104730|FG012|Overall Study|Severe debilitation, unable to continue|0|||
46883560|NCT00042289|83104731|FG013|Overall Study|Severe debilitation, unable to continue|0|||
46883561|NCT00042289|83104732|FG014|Overall Study|Severe debilitation, unable to continue|0|||
46883562|NCT00042289|83104733|FG015|Overall Study|Severe debilitation, unable to continue|0|||
46883563|NCT00042289|83104734|FG016|Overall Study|Severe debilitation, unable to continue|0|||
46883564|NCT00042289|83104735|FG017|Overall Study|Severe debilitation, unable to continue|0|||
46883565|NCT00042289|83104736|FG018|Overall Study|Severe debilitation, unable to continue|0|||
46883566|NCT00042289|83104737|FG019|Overall Study|Severe debilitation, unable to continue|0|||
46883567|NCT00042289|83104738|FG020|Overall Study|Severe debilitation, unable to continue|0|||
46883568|NCT00042289|83104739|FG021|Overall Study|Severe debilitation, unable to continue|1|||
46883569|NCT00042289|83104740|FG022|Overall Study|Severe debilitation, unable to continue|0|||
46883570|NCT00042289|83104741|FG023|Overall Study|Severe debilitation, unable to continue|1|||
46883571|NCT00042289|83104742|FG024|Overall Study|Severe debilitation, unable to continue|0|||
46883572|NCT00042289|83104743|FG025|Overall Study|Severe debilitation, unable to continue|0|||
46883573|NCT00042289|83104744|FG026|Overall Study|Severe debilitation, unable to continue|0|||
46883574|NCT00042289|83104745|FG027|Overall Study|Severe debilitation, unable to continue|1|||
46883575|NCT00042289|83104746|FG028|Overall Study|Severe debilitation, unable to continue|0|||
46883576|NCT00042289|83104747|FG029|Overall Study|Severe debilitation, unable to continue|0|||
46883577|NCT00042289|83104748|FG030|Overall Study|Severe debilitation, unable to continue|0|||
46883578|NCT00042289|83104749|FG031|Overall Study|Severe debilitation, unable to continue|1|||
46883579|NCT00042289|83104750|FG032|Overall Study|Severe debilitation, unable to continue|1|||
46883580|NCT00042289|83104751|FG033|Overall Study|Severe debilitation, unable to continue|0|||
46883581|NCT00042289|83104752|FG034|Overall Study|Severe debilitation, unable to continue|0|||
46883582|NCT00042289|83104753|FG035|Overall Study|Severe debilitation, unable to continue|0|||
46883583|NCT00042289|83104754|FG036|Overall Study|Severe debilitation, unable to continue|0|||
46883584|NCT00042289|83104755|FG037|Overall Study|Severe debilitation, unable to continue|0|||
46883585|NCT00042289|83104756|FG038|Overall Study|Severe debilitation, unable to continue|0|||
46883586|NCT00042289|83104757|FG039|Overall Study|Severe debilitation, unable to continue|0|||
46883587|NCT00042289|83104758|FG040|Overall Study|Severe debilitation, unable to continue|0|||
46883588|NCT00042289|83104759|FG041|Overall Study|Severe debilitation, unable to continue|0|||
46883589|NCT00042289|83104760|FG042|Overall Study|Severe debilitation, unable to continue|0|||
46883590|NCT00042289|83104761|FG043|Overall Study|Severe debilitation, unable to continue|0|||
46883591|NCT00042289|83104762|FG044|Overall Study|Severe debilitation, unable to continue|0|||
46883592|NCT00042289|83104763|FG045|Overall Study|Severe debilitation, unable to continue|0|||
46883593|NCT00042289|83104764|FG046|Overall Study|Severe debilitation, unable to continue|0|||
46883594|NCT00042289|83104718|FG000|Overall Study|Site closed|0|||
46883595|NCT00042289|83104719|FG001|Overall Study|Site closed|0|||
46883596|NCT00042289|83104720|FG002|Overall Study|Site closed|0|||
46883597|NCT00042289|83104721|FG003|Overall Study|Site closed|0|||
46883598|NCT00042289|83104722|FG004|Overall Study|Site closed|0|||
46883599|NCT00042289|83104723|FG005|Overall Study|Site closed|0|||
46883600|NCT00042289|83104724|FG006|Overall Study|Site closed|0|||
46883601|NCT00042289|83104725|FG007|Overall Study|Site closed|0|||
46883602|NCT00042289|83104726|FG008|Overall Study|Site closed|0|||
46883603|NCT00042289|83104727|FG009|Overall Study|Site closed|0|||
46883604|NCT00042289|83104728|FG010|Overall Study|Site closed|0|||
46883605|NCT00042289|83104729|FG011|Overall Study|Site closed|0|||
46883606|NCT00042289|83104730|FG012|Overall Study|Site closed|0|||
46883607|NCT00042289|83104731|FG013|Overall Study|Site closed|0|||
46883608|NCT00042289|83104732|FG014|Overall Study|Site closed|0|||
46883609|NCT00042289|83104733|FG015|Overall Study|Site closed|0|||
46883610|NCT00042289|83104734|FG016|Overall Study|Site closed|0|||
46883611|NCT00042289|83104735|FG017|Overall Study|Site closed|0|||
46883612|NCT00042289|83104736|FG018|Overall Study|Site closed|0|||
46883613|NCT00042289|83104737|FG019|Overall Study|Site closed|0|||
46883614|NCT00042289|83104738|FG020|Overall Study|Site closed|0|||
46883615|NCT00042289|83104739|FG021|Overall Study|Site closed|0|||
46883616|NCT00042289|83104740|FG022|Overall Study|Site closed|0|||
46883617|NCT00042289|83104741|FG023|Overall Study|Site closed|0|||
46883618|NCT00042289|83104742|FG024|Overall Study|Site closed|0|||
46883619|NCT00042289|83104743|FG025|Overall Study|Site closed|0|||
46883620|NCT00042289|83104744|FG026|Overall Study|Site closed|0|||
46883621|NCT00042289|83104745|FG027|Overall Study|Site closed|0|||
46883622|NCT00042289|83104746|FG028|Overall Study|Site closed|0|||
46883623|NCT00042289|83104747|FG029|Overall Study|Site closed|0|||
46883624|NCT00042289|83104748|FG030|Overall Study|Site closed|0|||
46883625|NCT00042289|83104749|FG031|Overall Study|Site closed|3|||
46883626|NCT00042289|83104750|FG032|Overall Study|Site closed|0|||
46883627|NCT00042289|83104751|FG033|Overall Study|Site closed|0|||
46883628|NCT00042289|83104752|FG034|Overall Study|Site closed|0|||
46883629|NCT00042289|83104753|FG035|Overall Study|Site closed|0|||
46883630|NCT00042289|83104754|FG036|Overall Study|Site closed|1|||
46883631|NCT00042289|83104755|FG037|Overall Study|Site closed|0|||
46883632|NCT00042289|83104756|FG038|Overall Study|Site closed|0|||
46883633|NCT00042289|83104757|FG039|Overall Study|Site closed|0|||
46883634|NCT00042289|83104758|FG040|Overall Study|Site closed|0|||
46883635|NCT00042289|83104759|FG041|Overall Study|Site closed|0|||
46883636|NCT00042289|83104760|FG042|Overall Study|Site closed|1|||
46883637|NCT00042289|83104761|FG043|Overall Study|Site closed|0|||
46883638|NCT00042289|83104762|FG044|Overall Study|Site closed|0|||
46883639|NCT00042289|83104763|FG045|Overall Study|Site closed|0|||
46883640|NCT00042289|83104764|FG046|Overall Study|Site closed|0|||
46883641|NCT00042289|83104718|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
46883642|NCT00042289|83104719|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
46883643|NCT00042289|83104720|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
46883644|NCT00042289|83104721|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
46883645|NCT00042289|83104722|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
46883646|NCT00042289|83104723|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
46883647|NCT00042289|83104724|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
46883648|NCT00042289|83104725|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
46883649|NCT00042289|83104726|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
46883650|NCT00042289|83104727|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
46883651|NCT00042289|83104728|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
46883652|NCT00042289|83104729|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
46883653|NCT00042289|83104730|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
46883654|NCT00042289|83104731|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
46883655|NCT00042289|83104732|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
46883656|NCT00042289|83104733|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
46883657|NCT00042289|83104734|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
46883658|NCT00042289|83104735|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
46883659|NCT00042289|83104736|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
46883660|NCT00042289|83104737|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
46883661|NCT00042289|83104738|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
46883662|NCT00042289|83104739|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
46883663|NCT00042289|83104740|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
46883664|NCT00042289|83104741|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
46883665|NCT00042289|83104742|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
46883666|NCT00042289|83104743|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
46883667|NCT00042289|83104744|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
46883668|NCT00042289|83104745|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
46883669|NCT00042289|83104746|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
46883670|NCT00042289|83104747|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
46883671|NCT00042289|83104748|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
46883672|NCT00042289|83104749|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
46883673|NCT00042289|83104750|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
46883674|NCT00042289|83104751|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
46883675|NCT00042289|83104752|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
46883676|NCT00042289|83104753|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
46883677|NCT00042289|83104754|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
46883678|NCT00042289|83104755|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
46883679|NCT00042289|83104756|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
46883680|NCT00042289|83104757|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
46883681|NCT00042289|83104758|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
46883682|NCT00042289|83104759|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
46883683|NCT00042289|83104760|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
46883684|NCT00042289|83104761|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
46883685|NCT00042289|83104762|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
46883686|NCT00042289|83104763|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
46883687|NCT00042289|83104764|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
46883688|NCT00042289|83104718|FG000|Overall Study|Protocol Violation|0|||
46883689|NCT00042289|83104719|FG001|Overall Study|Protocol Violation|0|||
46883690|NCT00042289|83104720|FG002|Overall Study|Protocol Violation|0|||
46883691|NCT00042289|83104721|FG003|Overall Study|Protocol Violation|0|||
46883692|NCT00042289|83104722|FG004|Overall Study|Protocol Violation|0|||
46883693|NCT00042289|83104723|FG005|Overall Study|Protocol Violation|1|||
46883694|NCT00042289|83104724|FG006|Overall Study|Protocol Violation|0|||
46883695|NCT00042289|83104725|FG007|Overall Study|Protocol Violation|1|||
46883696|NCT00042289|83104726|FG008|Overall Study|Protocol Violation|0|||
46883697|NCT00042289|83104727|FG009|Overall Study|Protocol Violation|0|||
46883698|NCT00042289|83104728|FG010|Overall Study|Protocol Violation|0|||
46883699|NCT00042289|83104729|FG011|Overall Study|Protocol Violation|0|||
46883700|NCT00042289|83104730|FG012|Overall Study|Protocol Violation|0|||
46883701|NCT00042289|83104731|FG013|Overall Study|Protocol Violation|0|||
46883702|NCT00042289|83104732|FG014|Overall Study|Protocol Violation|0|||
46883703|NCT00042289|83104733|FG015|Overall Study|Protocol Violation|0|||
46883704|NCT00042289|83104734|FG016|Overall Study|Protocol Violation|0|||
46883705|NCT00042289|83104735|FG017|Overall Study|Protocol Violation|0|||
46883706|NCT00042289|83104736|FG018|Overall Study|Protocol Violation|0|||
46883707|NCT00042289|83104737|FG019|Overall Study|Protocol Violation|0|||
46883708|NCT00042289|83104738|FG020|Overall Study|Protocol Violation|0|||
46883709|NCT00042289|83104739|FG021|Overall Study|Protocol Violation|0|||
46883710|NCT00042289|83104740|FG022|Overall Study|Protocol Violation|0|||
46883711|NCT00042289|83104741|FG023|Overall Study|Protocol Violation|1|||
46883712|NCT00042289|83104742|FG024|Overall Study|Protocol Violation|1|||
46883713|NCT00042289|83104743|FG025|Overall Study|Protocol Violation|0|||
46883714|NCT00042289|83104744|FG026|Overall Study|Protocol Violation|2|||
46883715|NCT00042289|83104745|FG027|Overall Study|Protocol Violation|0|||
46883716|NCT00042289|83104746|FG028|Overall Study|Protocol Violation|0|||
46883717|NCT00042289|83104747|FG029|Overall Study|Protocol Violation|0|||
46883718|NCT00042289|83104748|FG030|Overall Study|Protocol Violation|1|||
46883719|NCT00042289|83104749|FG031|Overall Study|Protocol Violation|0|||
46883720|NCT00042289|83104750|FG032|Overall Study|Protocol Violation|0|||
46883721|NCT00042289|83104751|FG033|Overall Study|Protocol Violation|0|||
46883722|NCT00042289|83104752|FG034|Overall Study|Protocol Violation|0|||
46883723|NCT00042289|83104753|FG035|Overall Study|Protocol Violation|0|||
46883724|NCT00042289|83104754|FG036|Overall Study|Protocol Violation|0|||
46883725|NCT00042289|83104755|FG037|Overall Study|Protocol Violation|0|||
46883726|NCT00042289|83104756|FG038|Overall Study|Protocol Violation|0|||
46883727|NCT00042289|83104757|FG039|Overall Study|Protocol Violation|0|||
46883728|NCT00042289|83104758|FG040|Overall Study|Protocol Violation|0|||
46883729|NCT00042289|83104759|FG041|Overall Study|Protocol Violation|1|||
46883730|NCT00042289|83104760|FG042|Overall Study|Protocol Violation|1|||
46883731|NCT00042289|83104761|FG043|Overall Study|Protocol Violation|1|||
46883732|NCT00042289|83104762|FG044|Overall Study|Protocol Violation|0|||
46883733|NCT00042289|83104763|FG045|Overall Study|Protocol Violation|0|||
46883734|NCT00042289|83104764|FG046|Overall Study|Protocol Violation|0|||
46883735|NCT00042289|83104718|FG000|Overall Study|Withdrawal by Subject|4|||
46883736|NCT00042289|83104719|FG001|Overall Study|Withdrawal by Subject|1|||
46883737|NCT00042289|83104720|FG002|Overall Study|Withdrawal by Subject|0|||
46883738|NCT00042289|83104721|FG003|Overall Study|Withdrawal by Subject|2|||
46883739|NCT00042289|83104722|FG004|Overall Study|Withdrawal by Subject|0|||
46883740|NCT00042289|83104723|FG005|Overall Study|Withdrawal by Subject|2|||
46883741|NCT00042289|83104724|FG006|Overall Study|Withdrawal by Subject|0|||
46883742|NCT00042289|83104725|FG007|Overall Study|Withdrawal by Subject|0|||
46883743|NCT00042289|83104726|FG008|Overall Study|Withdrawal by Subject|0|||
46883744|NCT00042289|83104727|FG009|Overall Study|Withdrawal by Subject|1|||
46883745|NCT00042289|83104728|FG010|Overall Study|Withdrawal by Subject|0|||
46883746|NCT00042289|83104729|FG011|Overall Study|Withdrawal by Subject|0|||
46883747|NCT00042289|83104730|FG012|Overall Study|Withdrawal by Subject|2|||
46883748|NCT00042289|83104731|FG013|Overall Study|Withdrawal by Subject|0|||
46883749|NCT00042289|83104732|FG014|Overall Study|Withdrawal by Subject|0|||
46883750|NCT00042289|83104733|FG015|Overall Study|Withdrawal by Subject|0|||
46883751|NCT00042289|83104734|FG016|Overall Study|Withdrawal by Subject|0|||
46883752|NCT00042289|83104735|FG017|Overall Study|Withdrawal by Subject|0|||
46883753|NCT00042289|83104736|FG018|Overall Study|Withdrawal by Subject|0|||
46883754|NCT00042289|83104737|FG019|Overall Study|Withdrawal by Subject|0|||
46883755|NCT00042289|83104738|FG020|Overall Study|Withdrawal by Subject|0|||
46883756|NCT00042289|83104739|FG021|Overall Study|Withdrawal by Subject|1|||
46883757|NCT00042289|83104740|FG022|Overall Study|Withdrawal by Subject|1|||
46883758|NCT00042289|83104741|FG023|Overall Study|Withdrawal by Subject|1|||
46883759|NCT00042289|83104742|FG024|Overall Study|Withdrawal by Subject|0|||
46883760|NCT00042289|83104743|FG025|Overall Study|Withdrawal by Subject|0|||
46883761|NCT00042289|83104744|FG026|Overall Study|Withdrawal by Subject|1|||
46883762|NCT00042289|83104745|FG027|Overall Study|Withdrawal by Subject|0|||
46883763|NCT00042289|83104746|FG028|Overall Study|Withdrawal by Subject|2|||
46883764|NCT00042289|83104747|FG029|Overall Study|Withdrawal by Subject|0|||
46883765|NCT00042289|83104748|FG030|Overall Study|Withdrawal by Subject|0|||
46883766|NCT00042289|83104749|FG031|Overall Study|Withdrawal by Subject|1|||
46883767|NCT00042289|83104750|FG032|Overall Study|Withdrawal by Subject|2|||
46883768|NCT00042289|83104751|FG033|Overall Study|Withdrawal by Subject|1|||
46883769|NCT00042289|83104752|FG034|Overall Study|Withdrawal by Subject|0|||
46883770|NCT00042289|83104753|FG035|Overall Study|Withdrawal by Subject|0|||
46883771|NCT00042289|83104754|FG036|Overall Study|Withdrawal by Subject|0|||
46883772|NCT00042289|83104755|FG037|Overall Study|Withdrawal by Subject|1|||
46883773|NCT00042289|83104756|FG038|Overall Study|Withdrawal by Subject|0|||
46883774|NCT00042289|83104757|FG039|Overall Study|Withdrawal by Subject|0|||
46883775|NCT00042289|83104758|FG040|Overall Study|Withdrawal by Subject|0|||
46883776|NCT00042289|83104759|FG041|Overall Study|Withdrawal by Subject|0|||
46883777|NCT00042289|83104760|FG042|Overall Study|Withdrawal by Subject|1|||
46883778|NCT00042289|83104761|FG043|Overall Study|Withdrawal by Subject|0|||
46883779|NCT00042289|83104762|FG044|Overall Study|Withdrawal by Subject|0|||
46883780|NCT00042289|83104763|FG045|Overall Study|Withdrawal by Subject|0|||
46883781|NCT00042289|83104764|FG046|Overall Study|Withdrawal by Subject|0|||
46883782|NCT02886728|83104936|FG000|Overall Study|Withdrew Consent|31|||
46883783|NCT02886728|83104937|FG001|Overall Study|Withdrew Consent|13|||
46883784|NCT02886728|83104938|FG002|Overall Study|Withdrew Consent|11|||
46883785|NCT02886728|83104939|FG003|Overall Study|Withdrew Consent|47|||
46883786|NCT02886728|83104936|FG000|Overall Study|Lost to Follow-up|12|||
46883787|NCT02886728|83104937|FG001|Overall Study|Lost to Follow-up|6|||
46883788|NCT02886728|83104938|FG002|Overall Study|Lost to Follow-up|13|||
46883789|NCT02886728|83104939|FG003|Overall Study|Lost to Follow-up|12|||
46883790|NCT02886728|83104936|FG000|Overall Study|Adverse Event|13|||
46883791|NCT02886728|83104937|FG001|Overall Study|Adverse Event|5|||
46883792|NCT02886728|83104938|FG002|Overall Study|Adverse Event|5|||
46883793|NCT02886728|83104939|FG003|Overall Study|Adverse Event|11|||
46883794|NCT02886728|83104936|FG000|Overall Study|Investigator's Discretion|11|||
46883795|NCT02886728|83104937|FG001|Overall Study|Investigator's Discretion|7|||
46883796|NCT02886728|83104938|FG002|Overall Study|Investigator's Discretion|5|||
46883797|NCT02886728|83104939|FG003|Overall Study|Investigator's Discretion|11|||
46883798|NCT02886728|83104936|FG000|Overall Study|Death|3|||
46883799|NCT02886728|83104937|FG001|Overall Study|Death|1|||
46883800|NCT02886728|83104938|FG002|Overall Study|Death|0|||
46883801|NCT02886728|83104939|FG003|Overall Study|Death|0|||
46883802|NCT02886728|83104936|FG000|Overall Study|Protocol Violation|0|||
46883803|NCT02886728|83104937|FG001|Overall Study|Protocol Violation|0|||
46883804|NCT02886728|83104938|FG002|Overall Study|Protocol Violation|0|||
46883805|NCT02886728|83104939|FG003|Overall Study|Protocol Violation|4|||
46883806|NCT02886728|83104936|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46883807|NCT02886728|83104937|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46883808|NCT02886728|83104938|FG002|Overall Study|Non-Compliance with Study Drug|1|||
46883809|NCT02886728|83104939|FG003|Overall Study|Non-Compliance with Study Drug|0|||
46883810|NCT02886728|83104936|FG000|Overall Study|Pregnancy|0|||
46883811|NCT02886728|83104937|FG001|Overall Study|Pregnancy|0|||
46883812|NCT02886728|83104938|FG002|Overall Study|Pregnancy|1|||
46883813|NCT02886728|83104939|FG003|Overall Study|Pregnancy|0|||
46883814|NCT02886728|83104936|FG000|Overall Study|Randomized but Not Dosed|1|||
46883815|NCT02886728|83104937|FG001|Overall Study|Randomized but Not Dosed|0|||
46883816|NCT02886728|83104938|FG002|Overall Study|Randomized but Not Dosed|0|||
46883817|NCT02886728|83104939|FG003|Overall Study|Randomized but Not Dosed|2|||
46883818|NCT00039871|83104949|FG000|Overall Study|Adverse Event|165|||
46883819|NCT00039871|83104949|FG000|Overall Study|Lost to Follow-up|18|||
46883820|NCT00039871|83104949|FG000|Overall Study|Protocol Violation|24|||
46883821|NCT00039871|83104949|FG000|Overall Study|Withdrawal by Subject|97|||
46883822|NCT00039871|83104949|FG000|Overall Study|Did not meet eligibility criteria|11|||
46883823|NCT00039871|83104949|FG000|Overall Study|Administrative|1|||
46883824|NCT00039871|83104949|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
46883825|NCT00039871|83104949|FG000|Overall Study|Never entered follow-up|7|||
46883826|NCT00015457|83104953|FG000|First Intervention|Adverse Event|0|||
46883827|NCT00015457|83104954|FG001|First Intervention|Adverse Event|2|||
46883828|NCT00015457|83104953|FG000|First Intervention|Lack of Efficacy|0|||
46883829|NCT00015457|83104954|FG001|First Intervention|Lack of Efficacy|1|||
46883830|NCT00015457|83104953|FG000|Second Intervention|Withdrawal by Subject|1|||
46883831|NCT00015457|83104954|FG001|Second Intervention|Withdrawal by Subject|0|||
46883832|NCT03191630|83104967|FG000|Overall Study|Lost to Follow-up|7|||
46883833|NCT03191630|83104968|FG001|Overall Study|Lost to Follow-up|7|||
46883834|NCT03191552|83104979|FG000|Overall Study|Lost to Follow-up|1|||
46883835|NCT03191552|83104980|FG001|Overall Study|Lost to Follow-up|0|||
46883836|NCT03191552|83104981|FG002|Overall Study|Lost to Follow-up|0|||
46883837|NCT03191552|83104979|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
46883838|NCT03191552|83104980|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
46883839|NCT03191552|83104981|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
46883840|NCT03191396|83104995|FG000|Overall Study|Lost to Follow-up|0|||
46883841|NCT03191396|83104996|FG001|Overall Study|Lost to Follow-up|3|||
46883842|NCT03191396|83104995|FG000|Overall Study|Withdrawal by Subject|3|||
46883843|NCT03191396|83104996|FG001|Overall Study|Withdrawal by Subject|2|||
46883844|NCT00007345|83105004|FG000|Overall Study|Refused further treatment|0|||
46883845|NCT00007345|83105005|FG001|Overall Study|Refused further treatment|7|||
46883846|NCT00007345|83105004|FG000|Overall Study|Switched to alternative treatment|0|||
46883847|NCT00007345|83105005|FG001|Overall Study|Switched to alternative treatment|3|||
46883848|NCT00007345|83105004|FG000|Overall Study|Intercurrent illness|1|||
46883849|NCT00007345|83105005|FG001|Overall Study|Intercurrent illness|0|||
46883850|NCT00007345|83105004|FG000|Overall Study|Death on study|1|||
46883851|NCT00007345|83105005|FG001|Overall Study|Death on study|1|||
46883852|NCT03405662|83105013|FG000|Overall Study|COVID-19 restriction|1|||
46883853|NCT03405662|83105014|FG001|Overall Study|COVID-19 restriction|0|||
46883854|NCT03405662|83105013|FG000|Overall Study|unblinding|0|||
46883855|NCT03405662|83105014|FG001|Overall Study|unblinding|1|||
46883856|NCT03405662|83105013|FG000|Overall Study|placement in memory care facility|0|||
46883857|NCT03405662|83105014|FG001|Overall Study|placement in memory care facility|2|||
46883858|NCT00031447|83105022|FG000|Overall Study|Lost to Follow-up|0|||
46883859|NCT00031447|83105023|FG001|Overall Study|Lost to Follow-up|1|||
46883860|NCT00031447|83105022|FG000|Overall Study|Non-compliant|1|||
46883861|NCT00031447|83105023|FG001|Overall Study|Non-compliant|1|||
46883862|NCT00031447|83105022|FG000|Overall Study|Re-activation of Disease|2|||
46883863|NCT00031447|83105023|FG001|Overall Study|Re-activation of Disease|1|||
46883864|NCT00031447|83105022|FG000|Overall Study|Disruption of blinded study drug supply|7|||
46883865|NCT00031447|83105023|FG001|Overall Study|Disruption of blinded study drug supply|4|||
46883866|NCT00006409|83105035|FG000|Baseline|Protocol Violation|48|||
46883867|NCT00006409|83105036|FG001|Baseline|Protocol Violation|70|||
46883868|NCT00006409|83105037|FG002|Baseline|Protocol Violation|0|||
46883869|NCT00006409|83105038|FG003|Baseline|Protocol Violation|0|||
46883870|NCT00006409|83105039|FG004|Baseline|Protocol Violation|0|||
46883871|NCT00006409|83105040|FG005|Baseline|Protocol Violation|0|||
46883872|NCT00006409|83105035|FG000|Post-2 Year Intervention|Protocol Violation|0|||
46897269|NCT01316900|83122980|FG002|Overall Study|Lost to Follow-up|1|||
46883873|NCT00006409|83105036|FG001|Post-2 Year Intervention|Protocol Violation|0|||
46883874|NCT00006409|83105037|FG002|Post-2 Year Intervention|Protocol Violation|251|||
46883875|NCT00006409|83105038|FG003|Post-2 Year Intervention|Protocol Violation|168|||
46883876|NCT00006409|83105039|FG004|Post-2 Year Intervention|Protocol Violation|0|||
46883877|NCT00006409|83105040|FG005|Post-2 Year Intervention|Protocol Violation|0|||
46883878|NCT00006409|83105035|FG000|Post-3 Year Intervention|Protocol Violation|0|||
46883879|NCT00006409|83105036|FG001|Post-3 Year Intervention|Protocol Violation|0|||
46883880|NCT00006409|83105037|FG002|Post-3 Year Intervention|Protocol Violation|0|||
46883881|NCT00006409|83105038|FG003|Post-3 Year Intervention|Protocol Violation|0|||
46883882|NCT00006409|83105039|FG004|Post-3 Year Intervention|Protocol Violation|62|||
46883883|NCT00006409|83105040|FG005|Post-3 Year Intervention|Protocol Violation|62|||
46883884|NCT00006289|83105056|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
46883885|NCT00006289|83105057|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
46883886|NCT00006289|83105056|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
46883887|NCT00006289|83105057|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
46883888|NCT00005947|83105075|FG000|Overall Study|Death|54|||
46883889|NCT00005947|83105076|FG001|Overall Study|Death|40|||
46883890|NCT00005947|83105075|FG000|Overall Study|Patient Refused to Continue|2|||
46883891|NCT00005947|83105076|FG001|Overall Study|Patient Refused to Continue|1|||
46883892|NCT00005947|83105075|FG000|Overall Study|Site Closure|1|||
46883893|NCT00005947|83105076|FG001|Overall Study|Site Closure|0|||
46883894|NCT00005047|83105088|FG000|Overall Study|Withdrawal by Subject|12|||
46883895|NCT00005047|83105089|FG001|Overall Study|Withdrawal by Subject|0|||
46883896|NCT00005047|83105090|FG002|Overall Study|Withdrawal by Subject|0|||
46883897|NCT00005047|83105091|FG003|Overall Study|Withdrawal by Subject|0|||
46883898|NCT00005047|83105088|FG000|Overall Study|Adverse Event|5|||
46883899|NCT00005047|83105089|FG001|Overall Study|Adverse Event|0|||
46883900|NCT00005047|83105090|FG002|Overall Study|Adverse Event|0|||
46883901|NCT00005047|83105091|FG003|Overall Study|Adverse Event|0|||
46883902|NCT00005047|83105088|FG000|Overall Study|Lost to Follow-up|1|||
46883903|NCT00005047|83105089|FG001|Overall Study|Lost to Follow-up|0|||
46883904|NCT00005047|83105090|FG002|Overall Study|Lost to Follow-up|0|||
46883905|NCT00005047|83105091|FG003|Overall Study|Lost to Follow-up|0|||
46883906|NCT00005047|83105088|FG000|Overall Study|Lack of Efficacy|1|||
46883907|NCT00005047|83105089|FG001|Overall Study|Lack of Efficacy|0|||
46883908|NCT00005047|83105090|FG002|Overall Study|Lack of Efficacy|0|||
46883909|NCT00005047|83105091|FG003|Overall Study|Lack of Efficacy|0|||
46883910|NCT00003901|83105101|FG000|Overall Study|Adverse Event|1|||
46883911|NCT00003901|83105101|FG000|Overall Study|Withdrawal by Subject|1|||
46883912|NCT00003901|83105101|FG000|Overall Study|Ineligible|6|||
46883913|NCT00003901|83105101|FG000|Overall Study|CT Scan not within protocol requirement|2|||
46883914|NCT00003901|83105101|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
46883915|NCT00003901|83105101|FG000|Overall Study|Medical problems|6|||
46883916|NCT00003895|83105110|FG000|Overall Study|Adverse Event|4|||
46883917|NCT00003895|83105111|FG001|Overall Study|Adverse Event|0|||
46883918|NCT00003895|83105110|FG000|Overall Study|Lack of Efficacy|1|||
46883919|NCT00003895|83105111|FG001|Overall Study|Lack of Efficacy|1|||
46883920|NCT00003895|83105110|FG000|Overall Study|Patient Vacation|2|||
46883921|NCT00003895|83105111|FG001|Overall Study|Patient Vacation|0|||
46883922|NCT00003895|83105110|FG000|Overall Study|Withdrawal by Subject|0|||
46883923|NCT00003895|83105111|FG001|Overall Study|Withdrawal by Subject|3|||
46883924|NCT03800173|83105122|FG000|Overall Study|Lost to Follow-up|0|||
46883925|NCT03800173|83105123|FG001|Overall Study|Lost to Follow-up|0|||
46883926|NCT03800173|83105124|FG002|Overall Study|Lost to Follow-up|0|||
46883927|NCT03800173|83105125|FG003|Overall Study|Lost to Follow-up|0|||
46883928|NCT03800173|83105126|FG004|Overall Study|Lost to Follow-up|1|||
46883929|NCT00003631|83105145|FG000|Overall Study|Patient not treated|1|||
46883930|NCT00003631|83105146|FG001|Overall Study|Patient not treated|0|||
46883931|NCT00003631|83105147|FG002|Overall Study|Patient not treated|1|||
46883932|NCT00003631|83105145|FG000|Overall Study|Protocol Violation|1|||
46883933|NCT00003631|83105146|FG001|Overall Study|Protocol Violation|0|||
46883934|NCT00003631|83105147|FG002|Overall Study|Protocol Violation|0|||
46883935|NCT00003631|83105145|FG000|Overall Study|Adverse Event|1|||
46883936|NCT00003631|83105146|FG001|Overall Study|Adverse Event|1|||
46883937|NCT00003631|83105147|FG002|Overall Study|Adverse Event|5|||
46883938|NCT00003631|83105145|FG000|Overall Study|Death|0|||
46883939|NCT00003631|83105146|FG001|Overall Study|Death|0|||
46883940|NCT00003631|83105147|FG002|Overall Study|Death|1|||
46883941|NCT00003631|83105145|FG000|Overall Study|Evaluable for toxicity only|0|||
46883942|NCT00003631|83105146|FG001|Overall Study|Evaluable for toxicity only|0|||
46883943|NCT00003631|83105147|FG002|Overall Study|Evaluable for toxicity only|2|||
46883944|NCT00003535|83105155|FG000|Overall Study|Not evaluable|5|||
46883945|NCT00003511|83105159|FG000|Overall Study|Not evaluable|4|||
46883946|NCT00003499|83105163|FG000|Overall Study|Not evaluable|8|||
46883947|NCT00003487|83105167|FG000|Overall Study|Not evaluable|2|||
46883948|NCT00003475|83105171|FG000|Overall Study|Not evaluable|13|||
46883949|NCT00003457|83105176|FG000|Overall Study|Not evaluable|9|||
46883950|NCT00030901|83105182|FG000|Initial Registration|Ineligible|167|||
46883951|NCT00030901|83105183|FG001|Initial Registration|Ineligible|0|||
46883952|NCT00030901|83105184|FG002|Initial Registration|Ineligible|0|||
46883953|NCT00030901|83105182|FG000|Randomization|Adverse Event|0|||
46883954|NCT00030901|83105183|FG001|Randomization|Adverse Event|11|||
46883955|NCT00030901|83105184|FG002|Randomization|Adverse Event|7|||
46883956|NCT00030901|83105182|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
46883957|NCT00030901|83105183|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
46883958|NCT00030901|83105184|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
46883959|NCT00030901|83105182|FG000|Randomization|Progression/Relapse|0|||
46883960|NCT00030901|83105183|FG001|Randomization|Progression/Relapse|22|||
46883961|NCT00030901|83105184|FG002|Randomization|Progression/Relapse|21|||
46883962|NCT00030901|83105182|FG000|Randomization|Death|0|||
46883963|NCT00030901|83105183|FG001|Randomization|Death|1|||
46883964|NCT00030901|83105184|FG002|Randomization|Death|3|||
46883965|NCT00030901|83105182|FG000|Randomization|Other|0|||
46883966|NCT00030901|83105183|FG001|Randomization|Other|36|||
46883967|NCT00030901|83105184|FG002|Randomization|Other|33|||
46883968|NCT00030901|83105182|FG000|Randomization|Ineligible|0|||
46883969|NCT00030901|83105183|FG001|Randomization|Ineligible|15|||
46883970|NCT00030901|83105184|FG002|Randomization|Ineligible|14|||
46883971|NCT00003199|83105190|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
46883972|NCT00003199|83105190|FG000|Overall Study|Lack of insurance clearance|2|||
46883973|NCT00003199|83105190|FG000|Overall Study|Screen fail|15|||
46883974|NCT00030823|83105194|FG000|Overall Study|Withdrawal by Subject|1|||
46883975|NCT00001849|83105198|FG000|Overall Study|Death|4|||
46883976|NCT00001849|83105198|FG000|Overall Study|Lost to Follow-up|2|||
46883977|NCT00001849|83105198|FG000|Overall Study|Withdrawal by Subject|2|||
46883978|NCT00001849|83105198|FG000|Overall Study|tumor remained occult|6|||
46883979|NCT01342952|83105215|FG000|Overall Study|Adverse Event|0|||
46883980|NCT01342952|83105216|FG001|Overall Study|Adverse Event|5|||
46883981|NCT01342952|83105217|FG002|Overall Study|Adverse Event|1|||
46883982|NCT01342952|83105218|FG003|Overall Study|Adverse Event|0|||
46883983|NCT01342952|83105215|FG000|Overall Study|Lost to Follow-up|0|||
46883984|NCT01342952|83105216|FG001|Overall Study|Lost to Follow-up|2|||
46883985|NCT01342952|83105217|FG002|Overall Study|Lost to Follow-up|0|||
46883986|NCT01342952|83105218|FG003|Overall Study|Lost to Follow-up|0|||
46883987|NCT01342952|83105215|FG000|Overall Study|Withdrawal by Subject|1|||
46883988|NCT01342952|83105216|FG001|Overall Study|Withdrawal by Subject|1|||
46883989|NCT01342952|83105217|FG002|Overall Study|Withdrawal by Subject|0|||
46883990|NCT01342952|83105218|FG003|Overall Study|Withdrawal by Subject|0|||
46883991|NCT01342952|83105215|FG000|Overall Study|Physician Decision|3|||
46883992|NCT01342952|83105216|FG001|Overall Study|Physician Decision|3|||
46883993|NCT01342952|83105217|FG002|Overall Study|Physician Decision|1|||
46883994|NCT01342952|83105218|FG003|Overall Study|Physician Decision|0|||
46883995|NCT02886884|83105245|FG000|Follow-up|Withdrawal by Subject|0|||
46883996|NCT02886884|83105246|FG001|Follow-up|Withdrawal by Subject|0|||
46883997|NCT02886884|83105247|FG002|Follow-up|Withdrawal by Subject|0|||
46883998|NCT02886884|83105248|FG003|Follow-up|Withdrawal by Subject|1|||
46883999|NCT01240694|83105267|FG000|Overall Study|Adverse Event|9|||
46884000|NCT01240694|83105267|FG000|Overall Study|Lack of Efficacy|6|||
46884001|NCT01240694|83105267|FG000|Overall Study|Withdrawal by Subject|6|||
46884002|NCT01240694|83105267|FG000|Overall Study|Protocol Violation|2|||
46884003|NCT01240694|83105267|FG000|Overall Study|Lost to Follow-up|2|||
46884004|NCT01240694|83105267|FG000|Overall Study|Other than specified|3|||
46884005|NCT01240694|83105267|FG000|Overall Study|Withdrawn due to early study termination|107|||
46884006|NCT03162224|83105274|FG000|Overall Study|Death|4|||
46884007|NCT03162224|83105275|FG001|Overall Study|Death|5|||
46884008|NCT03162224|83105276|FG002|Overall Study|Death|8|||
46884009|NCT03162224|83105274|FG000|Overall Study|Withdrawal by Subject|1|||
46884010|NCT03162224|83105275|FG001|Overall Study|Withdrawal by Subject|0|||
46884011|NCT03162224|83105276|FG002|Overall Study|Withdrawal by Subject|1|||
46884012|NCT03162224|83105274|FG000|Overall Study|Lost to Follow-up|0|||
46884013|NCT03162224|83105275|FG001|Overall Study|Lost to Follow-up|1|||
46884014|NCT03162224|83105276|FG002|Overall Study|Lost to Follow-up|0|||
46884015|NCT03162224|83105274|FG000|Overall Study|Other|6|||
46884016|NCT03162224|83105275|FG001|Overall Study|Other|2|||
46884017|NCT03162224|83105276|FG002|Overall Study|Other|1|||
46884018|NCT02886338|83105315|FG000|Overall Study|Withdrawal by Subject|1|||
46884019|NCT00004124|83105321|FG000|Overall Study|Received no protocol therapy|12|||
46884020|NCT00004124|83105322|FG001|Overall Study|Received no protocol therapy|20|||
46884021|NCT00383552|83105332|FG000|Overall Study|Adverse Event|7|||
46884022|NCT00383552|83105333|FG001|Overall Study|Adverse Event|6|||
46884023|NCT00383552|83105334|FG002|Overall Study|Adverse Event|9|||
46884024|NCT00383552|83105335|FG003|Overall Study|Adverse Event|6|||
46884025|NCT00383552|83105332|FG000|Overall Study|Lack of Efficacy|4|||
46884026|NCT00383552|83105333|FG001|Overall Study|Lack of Efficacy|13|||
46884027|NCT00383552|83105334|FG002|Overall Study|Lack of Efficacy|29|||
46884028|NCT00383552|83105335|FG003|Overall Study|Lack of Efficacy|42|||
46884029|NCT00383552|83105332|FG000|Overall Study|Lost to Follow-up|0|||
46884030|NCT00383552|83105333|FG001|Overall Study|Lost to Follow-up|1|||
46884031|NCT00383552|83105334|FG002|Overall Study|Lost to Follow-up|5|||
46884032|NCT00383552|83105335|FG003|Overall Study|Lost to Follow-up|1|||
46884033|NCT00383552|83105332|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
46884034|NCT00383552|83105333|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
46884035|NCT00383552|83105334|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
46884036|NCT00383552|83105335|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
46884037|NCT00383552|83105332|FG000|Overall Study|Did not wish to continue (related)|1|||
46884038|NCT00383552|83105333|FG001|Overall Study|Did not wish to continue (related)|0|||
46884039|NCT00383552|83105334|FG002|Overall Study|Did not wish to continue (related)|2|||
46884040|NCT00383552|83105335|FG003|Overall Study|Did not wish to continue (related)|3|||
46884041|NCT00383552|83105332|FG000|Overall Study|Noncompliance with the protocol|11|||
46884042|NCT00383552|83105333|FG001|Overall Study|Noncompliance with the protocol|6|||
46884043|NCT00383552|83105334|FG002|Overall Study|Noncompliance with the protocol|8|||
46884044|NCT00383552|83105335|FG003|Overall Study|Noncompliance with the protocol|10|||
46705254|NCT00938860|82920118|FG001|Overall Study|Abnormal laboratory values|2|||
46705255|NCT00938860|82920117|FG000|Overall Study|Withdrawal by Subject|11|||
46705256|NCT00938860|82920118|FG001|Overall Study|Withdrawal by Subject|8|||
46705257|NCT00938860|82920117|FG000|Overall Study|Lost to Follow-up|4|||
46884045|NCT00383552|83105332|FG000|Overall Study|Did not meet protocol eligibility|8|||
46884046|NCT00383552|83105333|FG001|Overall Study|Did not meet protocol eligibility|6|||
46884047|NCT00383552|83105334|FG002|Overall Study|Did not meet protocol eligibility|2|||
46884048|NCT00383552|83105335|FG003|Overall Study|Did not meet protocol eligibility|3|||
46884049|NCT00383552|83105332|FG000|Overall Study|Administrative|1|||
46884050|NCT00383552|83105333|FG001|Overall Study|Administrative|0|||
46884051|NCT00383552|83105334|FG002|Overall Study|Administrative|1|||
46884052|NCT00383552|83105335|FG003|Overall Study|Administrative|1|||
46884053|NCT03158012|83105352|FG000|Overall Study|Withdrawal by Subject|0|||
46884054|NCT03158012|83105353|FG001|Overall Study|Withdrawal by Subject|1|||
46884055|NCT01776424|83105362|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
46884056|NCT01776424|83105363|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
46884057|NCT01776424|83105364|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
46884058|NCT01776424|83105362|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
46884059|NCT01776424|83105363|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
46884060|NCT01776424|83105364|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
46884061|NCT01776424|83105362|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
46884062|NCT01776424|83105363|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
46884063|NCT01776424|83105364|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
46884064|NCT01776424|83105362|FG000|LTOLE Part (Open Label)|Refused|5|||
46884065|NCT01776424|83105363|FG001|LTOLE Part (Open Label)|Refused|2|||
46884066|NCT01776424|83105364|FG002|LTOLE Part (Open Label)|Refused|11|||
46884067|NCT01776424|83105362|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
46884068|NCT01776424|83105363|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
46884069|NCT01776424|83105364|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
46884070|NCT03799627|83105390|FG000|Overall Study|Adverse Event|1|||
46884071|NCT03799627|83105391|FG001|Overall Study|Adverse Event|2|||
46884072|NCT03799627|83105392|FG002|Overall Study|Adverse Event|0|||
46884073|NCT03799627|83105393|FG003|Overall Study|Adverse Event|0|||
46884074|NCT03799627|83105394|FG004|Overall Study|Adverse Event|2|||
46884075|NCT03799627|83105395|FG005|Overall Study|Adverse Event|5|||
46884076|NCT03799627|83105396|FG006|Overall Study|Adverse Event|0|||
46884077|NCT03799627|83105397|FG007|Overall Study|Adverse Event|2|||
46884078|NCT03799627|83105398|FG008|Overall Study|Adverse Event|0|||
46884079|NCT03799627|83105390|FG000|Overall Study|Physician Decision|2|||
46884080|NCT03799627|83105391|FG001|Overall Study|Physician Decision|2|||
46884081|NCT03799627|83105392|FG002|Overall Study|Physician Decision|0|||
46884082|NCT03799627|83105393|FG003|Overall Study|Physician Decision|0|||
46884083|NCT03799627|83105394|FG004|Overall Study|Physician Decision|2|||
46884084|NCT03799627|83105395|FG005|Overall Study|Physician Decision|2|||
46884085|NCT03799627|83105396|FG006|Overall Study|Physician Decision|0|||
46884086|NCT03799627|83105397|FG007|Overall Study|Physician Decision|0|||
46884087|NCT03799627|83105398|FG008|Overall Study|Physician Decision|0|||
46884088|NCT03799627|83105390|FG000|Overall Study|Withdrawal by Subject|1|||
46884089|NCT03799627|83105391|FG001|Overall Study|Withdrawal by Subject|1|||
46884090|NCT03799627|83105392|FG002|Overall Study|Withdrawal by Subject|0|||
46884091|NCT03799627|83105393|FG003|Overall Study|Withdrawal by Subject|2|||
46884092|NCT03799627|83105394|FG004|Overall Study|Withdrawal by Subject|0|||
46884093|NCT03799627|83105395|FG005|Overall Study|Withdrawal by Subject|3|||
46884094|NCT03799627|83105396|FG006|Overall Study|Withdrawal by Subject|0|||
46884095|NCT03799627|83105397|FG007|Overall Study|Withdrawal by Subject|0|||
46705258|NCT00938860|82920118|FG001|Overall Study|Lost to Follow-up|4|||
46884096|NCT03799627|83105398|FG008|Overall Study|Withdrawal by Subject|0|||
46884097|NCT03799627|83105390|FG000|Overall Study|Lack of Efficacy|0|||
46884098|NCT03799627|83105391|FG001|Overall Study|Lack of Efficacy|0|||
46705259|NCT00938860|82920117|FG000|Overall Study|Administration problems|2|||
46884099|NCT03799627|83105392|FG002|Overall Study|Lack of Efficacy|0|||
46884100|NCT03799627|83105393|FG003|Overall Study|Lack of Efficacy|1|||
46884101|NCT03799627|83105394|FG004|Overall Study|Lack of Efficacy|0|||
46884102|NCT03799627|83105395|FG005|Overall Study|Lack of Efficacy|0|||
46884103|NCT03799627|83105396|FG006|Overall Study|Lack of Efficacy|0|||
46884104|NCT03799627|83105397|FG007|Overall Study|Lack of Efficacy|0|||
46884105|NCT03799627|83105398|FG008|Overall Study|Lack of Efficacy|0|||
46884106|NCT03799627|83105390|FG000|Overall Study|Lost to Follow-up|0|||
46884107|NCT03799627|83105391|FG001|Overall Study|Lost to Follow-up|0|||
46884108|NCT03799627|83105392|FG002|Overall Study|Lost to Follow-up|0|||
46884109|NCT03799627|83105393|FG003|Overall Study|Lost to Follow-up|0|||
46884110|NCT03799627|83105394|FG004|Overall Study|Lost to Follow-up|0|||
46884111|NCT03799627|83105395|FG005|Overall Study|Lost to Follow-up|0|||
46884112|NCT03799627|83105396|FG006|Overall Study|Lost to Follow-up|1|||
46884113|NCT03799627|83105397|FG007|Overall Study|Lost to Follow-up|0|||
46884114|NCT03799627|83105398|FG008|Overall Study|Lost to Follow-up|1|||
46884115|NCT03799627|83105390|FG000|Overall Study|Death|0|||
46884116|NCT03799627|83105391|FG001|Overall Study|Death|0|||
46884117|NCT03799627|83105392|FG002|Overall Study|Death|0|||
46884118|NCT03799627|83105393|FG003|Overall Study|Death|1|||
46884119|NCT03799627|83105394|FG004|Overall Study|Death|0|||
46884120|NCT03799627|83105395|FG005|Overall Study|Death|0|||
46884121|NCT03799627|83105396|FG006|Overall Study|Death|0|||
46884122|NCT03799627|83105397|FG007|Overall Study|Death|0|||
46884123|NCT03799627|83105398|FG008|Overall Study|Death|0|||
46884124|NCT03799627|83105390|FG000|Overall Study|Study Drug Put on Hold|1|||
46884125|NCT03799627|83105391|FG001|Overall Study|Study Drug Put on Hold|0|||
46884126|NCT03799627|83105392|FG002|Overall Study|Study Drug Put on Hold|0|||
46884127|NCT03799627|83105393|FG003|Overall Study|Study Drug Put on Hold|0|||
46884128|NCT03799627|83105394|FG004|Overall Study|Study Drug Put on Hold|0|||
46884129|NCT03799627|83105395|FG005|Overall Study|Study Drug Put on Hold|0|||
46884130|NCT03799627|83105396|FG006|Overall Study|Study Drug Put on Hold|0|||
46884131|NCT03799627|83105397|FG007|Overall Study|Study Drug Put on Hold|0|||
46884132|NCT03799627|83105398|FG008|Overall Study|Study Drug Put on Hold|0|||
46884133|NCT03799627|83105390|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
46884134|NCT03799627|83105391|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
46884135|NCT03799627|83105392|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
46884136|NCT03799627|83105393|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
46884137|NCT03799627|83105394|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
46884138|NCT03799627|83105395|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
46884139|NCT03799627|83105396|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
46884140|NCT03799627|83105397|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
46884141|NCT03799627|83105398|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
46884142|NCT03799627|83105390|FG000|Overall Study|Kidney Transplantation|1|||
46884143|NCT03799627|83105391|FG001|Overall Study|Kidney Transplantation|0|||
46884144|NCT03799627|83105392|FG002|Overall Study|Kidney Transplantation|0|||
46884145|NCT03799627|83105393|FG003|Overall Study|Kidney Transplantation|1|||
46884146|NCT03799627|83105394|FG004|Overall Study|Kidney Transplantation|1|||
46884147|NCT03799627|83105395|FG005|Overall Study|Kidney Transplantation|0|||
46884148|NCT03799627|83105396|FG006|Overall Study|Kidney Transplantation|0|||
46884149|NCT03799627|83105397|FG007|Overall Study|Kidney Transplantation|0|||
46884150|NCT03799627|83105398|FG008|Overall Study|Kidney Transplantation|0|||
46884151|NCT03799627|83105390|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
46884152|NCT03799627|83105391|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
46884153|NCT03799627|83105392|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
46884154|NCT03799627|83105393|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
46884155|NCT03799627|83105394|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
46884156|NCT03799627|83105395|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
46884157|NCT03799627|83105396|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
46884158|NCT03799627|83105397|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
46884159|NCT03799627|83105398|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
46884160|NCT03799627|83105390|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884161|NCT03799627|83105391|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
46884162|NCT03799627|83105392|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884163|NCT03799627|83105393|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884164|NCT03799627|83105394|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884165|NCT03799627|83105395|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884166|NCT03799627|83105396|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884167|NCT03799627|83105397|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884168|NCT03799627|83105398|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
46884169|NCT03799627|83105390|FG000|Overall Study|Met Exclusion Criteria|0|||
46884170|NCT03799627|83105391|FG001|Overall Study|Met Exclusion Criteria|0|||
46884171|NCT03799627|83105392|FG002|Overall Study|Met Exclusion Criteria|0|||
46884172|NCT03799627|83105393|FG003|Overall Study|Met Exclusion Criteria|1|||
46884173|NCT03799627|83105394|FG004|Overall Study|Met Exclusion Criteria|0|||
46884174|NCT03799627|83105395|FG005|Overall Study|Met Exclusion Criteria|0|||
46884175|NCT03799627|83105396|FG006|Overall Study|Met Exclusion Criteria|0|||
46884176|NCT03799627|83105397|FG007|Overall Study|Met Exclusion Criteria|0|||
46884177|NCT03799627|83105398|FG008|Overall Study|Met Exclusion Criteria|0|||
46884178|NCT03799627|83105390|FG000|Overall Study|Investigational Product Noncompliance|0|||
46884179|NCT03799627|83105391|FG001|Overall Study|Investigational Product Noncompliance|0|||
46884180|NCT03799627|83105392|FG002|Overall Study|Investigational Product Noncompliance|0|||
46884181|NCT03799627|83105393|FG003|Overall Study|Investigational Product Noncompliance|1|||
46884182|NCT03799627|83105394|FG004|Overall Study|Investigational Product Noncompliance|0|||
46884183|NCT03799627|83105395|FG005|Overall Study|Investigational Product Noncompliance|0|||
46884184|NCT03799627|83105396|FG006|Overall Study|Investigational Product Noncompliance|0|||
46884185|NCT03799627|83105397|FG007|Overall Study|Investigational Product Noncompliance|0|||
46884186|NCT03799627|83105398|FG008|Overall Study|Investigational Product Noncompliance|0|||
46884187|NCT03799627|83105390|FG000|Overall Study|Participant Relocation|0|||
46884188|NCT03799627|83105391|FG001|Overall Study|Participant Relocation|0|||
46884189|NCT03799627|83105392|FG002|Overall Study|Participant Relocation|0|||
46884190|NCT03799627|83105393|FG003|Overall Study|Participant Relocation|1|||
46884191|NCT03799627|83105394|FG004|Overall Study|Participant Relocation|0|||
46884192|NCT03799627|83105395|FG005|Overall Study|Participant Relocation|1|||
46884193|NCT03799627|83105396|FG006|Overall Study|Participant Relocation|0|||
46884194|NCT03799627|83105397|FG007|Overall Study|Participant Relocation|0|||
46884195|NCT03799627|83105398|FG008|Overall Study|Participant Relocation|0|||
46884196|NCT03799627|83105390|FG000|Overall Study|Eurofin Issue|0|||
46884197|NCT03799627|83105391|FG001|Overall Study|Eurofin Issue|0|||
46884198|NCT03799627|83105392|FG002|Overall Study|Eurofin Issue|0|||
46884199|NCT03799627|83105393|FG003|Overall Study|Eurofin Issue|0|||
46884200|NCT03799627|83105394|FG004|Overall Study|Eurofin Issue|1|||
46884201|NCT03799627|83105395|FG005|Overall Study|Eurofin Issue|0|||
46884202|NCT03799627|83105396|FG006|Overall Study|Eurofin Issue|0|||
46884203|NCT03799627|83105397|FG007|Overall Study|Eurofin Issue|0|||
46884204|NCT03799627|83105398|FG008|Overall Study|Eurofin Issue|0|||
46884205|NCT03799627|83105390|FG000|Overall Study|Noncompliance with Site Instructions|0|||
46884206|NCT03799627|83105391|FG001|Overall Study|Noncompliance with Site Instructions|0|||
46884207|NCT03799627|83105392|FG002|Overall Study|Noncompliance with Site Instructions|0|||
46884208|NCT03799627|83105393|FG003|Overall Study|Noncompliance with Site Instructions|0|||
46884209|NCT03799627|83105394|FG004|Overall Study|Noncompliance with Site Instructions|1|||
46884210|NCT03799627|83105395|FG005|Overall Study|Noncompliance with Site Instructions|0|||
46884211|NCT03799627|83105396|FG006|Overall Study|Noncompliance with Site Instructions|0|||
46884212|NCT03799627|83105397|FG007|Overall Study|Noncompliance with Site Instructions|0|||
46884213|NCT03799627|83105398|FG008|Overall Study|Noncompliance with Site Instructions|0|||
46884214|NCT03799627|83105390|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884215|NCT03799627|83105391|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884216|NCT03799627|83105392|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884217|NCT03799627|83105393|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884218|NCT03799627|83105394|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
46884219|NCT03799627|83105395|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884220|NCT03799627|83105396|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884221|NCT03799627|83105397|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884222|NCT03799627|83105398|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
46884223|NCT03799627|83105390|FG000|Overall Study|Changes In Hemoglobin Values|1|||
46884224|NCT03799627|83105391|FG001|Overall Study|Changes In Hemoglobin Values|2|||
46884225|NCT03799627|83105392|FG002|Overall Study|Changes In Hemoglobin Values|1|||
46884226|NCT03799627|83105393|FG003|Overall Study|Changes In Hemoglobin Values|0|||
46884227|NCT03799627|83105394|FG004|Overall Study|Changes In Hemoglobin Values|0|||
46884228|NCT03799627|83105395|FG005|Overall Study|Changes In Hemoglobin Values|2|||
46884229|NCT03799627|83105396|FG006|Overall Study|Changes In Hemoglobin Values|1|||
46884230|NCT03799627|83105397|FG007|Overall Study|Changes In Hemoglobin Values|0|||
46884231|NCT03799627|83105398|FG008|Overall Study|Changes In Hemoglobin Values|1|||
46884232|NCT00756574|83105439|FG000|Overall Study|Withdrawal by Subject|9|||
46884233|NCT00756574|83105440|FG001|Overall Study|Withdrawal by Subject|7|||
46884234|NCT00756574|83105439|FG000|Overall Study|Lost to Follow-up|4|||
46884235|NCT00756574|83105440|FG001|Overall Study|Lost to Follow-up|4|||
46884236|NCT02743780|83105449|FG000|Part 3 (7 Days)|Adverse Event|0|||
46884237|NCT02743780|83105450|FG001|Part 3 (7 Days)|Adverse Event|0|||
46884238|NCT02743780|83105451|FG002|Part 3 (7 Days)|Adverse Event|1|||
46884239|NCT02743780|83105452|FG003|Part 3 (7 Days)|Adverse Event|0|||
46884240|NCT02743780|83105453|FG004|Part 3 (7 Days)|Adverse Event|0|||
46884241|NCT02880956|83105477|FG000|Overall Study|Adverse Event|3|||
46884242|NCT02880956|83105478|FG001|Overall Study|Adverse Event|6|||
46884243|NCT02880956|83105479|FG002|Overall Study|Adverse Event|5|||
46884244|NCT02880956|83105480|FG003|Overall Study|Adverse Event|4|||
46884245|NCT02880956|83105477|FG000|Overall Study|Withdrawal by Subject|9|||
46884246|NCT02880956|83105478|FG001|Overall Study|Withdrawal by Subject|4|||
46884247|NCT02880956|83105479|FG002|Overall Study|Withdrawal by Subject|6|||
46884248|NCT02880956|83105480|FG003|Overall Study|Withdrawal by Subject|11|||
46884249|NCT02880956|83105477|FG000|Overall Study|Lost to Follow-up|0|||
46884250|NCT02880956|83105478|FG001|Overall Study|Lost to Follow-up|1|||
46884251|NCT02880956|83105479|FG002|Overall Study|Lost to Follow-up|0|||
46884252|NCT02880956|83105480|FG003|Overall Study|Lost to Follow-up|0|||
46884253|NCT02880956|83105477|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
46884254|NCT02880956|83105478|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
46884255|NCT02880956|83105479|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
46884256|NCT02880956|83105480|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
46884257|NCT02880956|83105477|FG000|Overall Study|Other, Not Specified|4|||
46884258|NCT02880956|83105478|FG001|Overall Study|Other, Not Specified|2|||
46884259|NCT02880956|83105479|FG002|Overall Study|Other, Not Specified|0|||
46884260|NCT02880956|83105480|FG003|Overall Study|Other, Not Specified|3|||
46884261|NCT01352416|83105497|FG000|Overall Study|Physician Decision|1|||
46884262|NCT01352416|83105498|FG001|Overall Study|Physician Decision|2|||
46884263|NCT01352416|83105499|FG002|Overall Study|Physician Decision|2|||
46884264|NCT01352416|83105500|FG003|Overall Study|Physician Decision|1|||
46884265|NCT00439738|83105512|FG000|Overall Study|Withdrawal by Subject|16|||
46884266|NCT00439738|83105513|FG001|Overall Study|Withdrawal by Subject|13|||
46884267|NCT00439738|83105512|FG000|Overall Study|Adverse Event|6|||
46884268|NCT00439738|83105513|FG001|Overall Study|Adverse Event|4|||
46884269|NCT00439738|83105512|FG000|Overall Study|Lost to Follow-up|5|||
46884270|NCT00439738|83105513|FG001|Overall Study|Lost to Follow-up|6|||
46884271|NCT00439738|83105512|FG000|Overall Study|Protocol Violation|6|||
46884272|NCT00439738|83105513|FG001|Overall Study|Protocol Violation|3|||
46884273|NCT00439738|83105512|FG000|Overall Study|Lack of Efficacy|2|||
46884274|NCT00439738|83105513|FG001|Overall Study|Lack of Efficacy|2|||
46884275|NCT00439738|83105512|FG000|Overall Study|Abnormal Lab Values|1|||
46884276|NCT00439738|83105513|FG001|Overall Study|Abnormal Lab Values|0|||
46884277|NCT00338104|83105520|FG000|Overall Study|Protocol Violation|2|||
46884278|NCT00338104|83105521|FG001|Overall Study|Protocol Violation|1|||
46884279|NCT00338104|83105522|FG002|Overall Study|Protocol Violation|3|||
46884280|NCT05593913|83105527|FG000|Overall Study|Insufficient image quality|39|||
46884281|NCT05166603|83105557|FG000|Overall Study|Withdrawal by Subject|68|||
46884282|NCT05166603|83105558|FG001|Overall Study|Withdrawal by Subject|0|||
46884283|NCT05049122|83105564|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
46884284|NCT05049122|83105564|FG000|Overall Study|Participant moved|1|||
46884285|NCT05049122|83105564|FG000|Overall Study|At the direction of the doctor|1|||
46884286|NCT04969263|83105572|FG000|Overall Study|Death|1|||
46884287|NCT04969263|83105572|FG000|Overall Study|Lost to Follow-up|2|||
46884288|NCT04969263|83105572|FG000|Overall Study|Withdrawal by Subject|5|||
46884289|NCT04969263|83105572|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
46884290|NCT04964063|83105576|FG000|Overall Study|Adverse Event|4|||
46884291|NCT04964063|83105576|FG000|Overall Study|Lost to Follow-up|47|||
46884292|NCT04964063|83105576|FG000|Overall Study|Withdrawal by Subject|5|||
46884293|NCT04964063|83105576|FG000|Overall Study|Baseline Tasks Expired|41|||
46884294|NCT04964063|83105576|FG000|Overall Study|Participant withdrawn in error|1|||
46884295|NCT04642079|83105584|FG000|Overall Study|Lost to Follow-up|2|||
46884296|NCT04642079|83105585|FG001|Overall Study|Lost to Follow-up|5|||
46884297|NCT04642079|83105586|FG002|Overall Study|Lost to Follow-up|2|||
46884298|NCT04642079|83105587|FG003|Overall Study|Lost to Follow-up|0|||
46884299|NCT04642079|83105584|FG000|Overall Study|Withdrawal by Subject|0|||
46884300|NCT04642079|83105585|FG001|Overall Study|Withdrawal by Subject|4|||
46884301|NCT04642079|83105586|FG002|Overall Study|Withdrawal by Subject|1|||
46884302|NCT04642079|83105587|FG003|Overall Study|Withdrawal by Subject|2|||
46884303|NCT04642079|83105584|FG000|Overall Study|Other|0|||
46884304|NCT04642079|83105585|FG001|Overall Study|Other|0|||
46884305|NCT04642079|83105586|FG002|Overall Study|Other|0|||
46884306|NCT04642079|83105587|FG003|Overall Study|Other|1|||
46884307|NCT04642079|83105584|FG000|Overall Study|No longer met eligibility criteria|1|||
46884308|NCT04642079|83105585|FG001|Overall Study|No longer met eligibility criteria|0|||
46884309|NCT04642079|83105586|FG002|Overall Study|No longer met eligibility criteria|1|||
46884310|NCT04642079|83105587|FG003|Overall Study|No longer met eligibility criteria|1|||
46884311|NCT04232124|83105632|FG000|Overall Study|Lost to Follow-up|3|||
46884312|NCT03529110|83105642|FG000|Overall Study|Progressive Disease|66|||
46884313|NCT03529110|83105643|FG001|Overall Study|Progressive Disease|158|||
46884314|NCT03529110|83105642|FG000|Overall Study|Clinical Progression|4|||
46884315|NCT03529110|83105643|FG001|Overall Study|Clinical Progression|12|||
46884316|NCT03529110|83105642|FG000|Overall Study|Adverse Event|35|||
46884317|NCT03529110|83105643|FG001|Overall Study|Adverse Event|17|||
46884318|NCT03529110|83105642|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
46884319|NCT03529110|83105643|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
46884320|NCT03529110|83105642|FG000|Overall Study|Lack of Efficacy|3|||
46884321|NCT03529110|83105643|FG001|Overall Study|Lack of Efficacy|3|||
46884322|NCT03529110|83105642|FG000|Overall Study|Physician Decision|2|||
46884323|NCT03529110|83105643|FG001|Overall Study|Physician Decision|8|||
46884324|NCT03529110|83105642|FG000|Overall Study|Miscellaneous|2|||
46884325|NCT03529110|83105643|FG001|Overall Study|Miscellaneous|5|||
46884326|NCT03358472|83105652|FG000|Overall Study|Death|6|||
46884327|NCT03358472|83105653|FG001|Overall Study|Death|3|||
46884328|NCT03358472|83105654|FG002|Overall Study|Death|10|||
46884329|NCT03358472|83105652|FG000|Overall Study|Physician Decision|0|||
46884330|NCT03358472|83105653|FG001|Overall Study|Physician Decision|1|||
46884331|NCT03358472|83105654|FG002|Overall Study|Physician Decision|0|||
46884332|NCT03358472|83105652|FG000|Overall Study|Withdrawal by Subject|0|||
46884333|NCT03358472|83105653|FG001|Overall Study|Withdrawal by Subject|0|||
46884334|NCT03358472|83105654|FG002|Overall Study|Withdrawal by Subject|1|||
46884335|NCT03358472|83105652|FG000|Overall Study|On-going at clinical cut off date|9|||
46884336|NCT03358472|83105653|FG001|Overall Study|On-going at clinical cut off date|6|||
46884337|NCT03358472|83105654|FG002|Overall Study|On-going at clinical cut off date|5|||
46884338|NCT03099382|83105670|FG000|Overall Study|Protocol Violation|2|||
46884339|NCT03099382|83105671|FG001|Overall Study|Protocol Violation|3|||
46884340|NCT02939287|83105680|FG000|Overall Study|met exclusion criteria|1|||
46884341|NCT02939287|83105681|FG001|Overall Study|met exclusion criteria|1|||
46884342|NCT02939287|83105682|FG002|Overall Study|met exclusion criteria|1|||
46884343|NCT02939287|83105680|FG000|Overall Study|Did not complete survey|2|||
46884344|NCT02939287|83105681|FG001|Overall Study|Did not complete survey|2|||
46884345|NCT02939287|83105682|FG002|Overall Study|Did not complete survey|0|||
46884346|NCT02939287|83105680|FG000|Overall Study|Withdrawal by Subject|1|||
46884347|NCT02939287|83105681|FG001|Overall Study|Withdrawal by Subject|1|||
46884348|NCT02939287|83105682|FG002|Overall Study|Withdrawal by Subject|0|||
46884349|NCT02771275|83105707|FG000|Overall Study|Reoperation|3|||
46884350|NCT02771275|83105707|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
46884351|NCT02564900|83105735|FG000|Dose Escalation|Progressive disease per RECIST|2|||
46884352|NCT02564900|83105736|FG001|Dose Escalation|Progressive disease per RECIST|3|||
46884353|NCT02564900|83105737|FG002|Dose Escalation|Progressive disease per RECIST|3|||
46884354|NCT02564900|83105738|FG003|Dose Escalation|Progressive disease per RECIST|3|||
46884355|NCT02564900|83105739|FG004|Dose Escalation|Progressive disease per RECIST|3|||
46884356|NCT02564900|83105740|FG005|Dose Escalation|Progressive disease per RECIST|1|||
46884357|NCT02564900|83105741|FG006|Dose Escalation|Progressive disease per RECIST|0|||
46884358|NCT02564900|83105742|FG007|Dose Escalation|Progressive disease per RECIST|0|||
46884359|NCT02564900|83105743|FG008|Dose Escalation|Progressive disease per RECIST|0|||
46884360|NCT02564900|83105744|FG009|Dose Escalation|Progressive disease per RECIST|0|||
46884361|NCT02564900|83105745|FG010|Dose Escalation|Progressive disease per RECIST|0|||
46884362|NCT02564900|83105746|FG011|Dose Escalation|Progressive disease per RECIST|0|||
46884363|NCT02564900|83105747|FG012|Dose Escalation|Progressive disease per RECIST|0|||
46884364|NCT02564900|83105748|FG013|Dose Escalation|Progressive disease per RECIST|0|||
46884365|NCT02564900|83105749|FG014|Dose Escalation|Progressive disease per RECIST|0|||
46884366|NCT02564900|83105735|FG000|Dose Escalation|Ongoing|1|||
46884367|NCT02564900|83105736|FG001|Dose Escalation|Ongoing|0|||
46884368|NCT02564900|83105737|FG002|Dose Escalation|Ongoing|0|||
46884369|NCT02564900|83105738|FG003|Dose Escalation|Ongoing|2|||
46884370|NCT02564900|83105739|FG004|Dose Escalation|Ongoing|2|||
46884371|NCT02564900|83105740|FG005|Dose Escalation|Ongoing|2|||
46884372|NCT02564900|83105741|FG006|Dose Escalation|Ongoing|0|||
46884373|NCT02564900|83105742|FG007|Dose Escalation|Ongoing|0|||
46884374|NCT02564900|83105743|FG008|Dose Escalation|Ongoing|0|||
46884375|NCT02564900|83105744|FG009|Dose Escalation|Ongoing|0|||
46884376|NCT02564900|83105745|FG010|Dose Escalation|Ongoing|0|||
46884377|NCT02564900|83105746|FG011|Dose Escalation|Ongoing|0|||
46884378|NCT02564900|83105747|FG012|Dose Escalation|Ongoing|0|||
46884379|NCT02564900|83105748|FG013|Dose Escalation|Ongoing|0|||
46884380|NCT02564900|83105749|FG014|Dose Escalation|Ongoing|0|||
46884381|NCT02564900|83105735|FG000|Dose Escalation|Adverse Event|0|||
46884382|NCT02564900|83105736|FG001|Dose Escalation|Adverse Event|0|||
46884383|NCT02564900|83105737|FG002|Dose Escalation|Adverse Event|0|||
46884384|NCT02564900|83105738|FG003|Dose Escalation|Adverse Event|1|||
46884385|NCT02564900|83105739|FG004|Dose Escalation|Adverse Event|1|||
46884386|NCT02564900|83105740|FG005|Dose Escalation|Adverse Event|3|||
46884387|NCT02564900|83105741|FG006|Dose Escalation|Adverse Event|0|||
46884388|NCT02564900|83105742|FG007|Dose Escalation|Adverse Event|0|||
46884389|NCT02564900|83105743|FG008|Dose Escalation|Adverse Event|0|||
46884390|NCT02564900|83105744|FG009|Dose Escalation|Adverse Event|0|||
46884391|NCT02564900|83105745|FG010|Dose Escalation|Adverse Event|0|||
46884392|NCT02564900|83105746|FG011|Dose Escalation|Adverse Event|0|||
46884393|NCT02564900|83105747|FG012|Dose Escalation|Adverse Event|0|||
46884394|NCT02564900|83105748|FG013|Dose Escalation|Adverse Event|0|||
46884395|NCT02564900|83105749|FG014|Dose Escalation|Adverse Event|0|||
46884396|NCT02564900|83105735|FG000|Dose Expansion|Progressive disease per RECIST|0|||
46884397|NCT02564900|83105736|FG001|Dose Expansion|Progressive disease per RECIST|0|||
46884398|NCT02564900|83105737|FG002|Dose Expansion|Progressive disease per RECIST|0|||
46884399|NCT02564900|83105738|FG003|Dose Expansion|Progressive disease per RECIST|0|||
46884400|NCT02564900|83105739|FG004|Dose Expansion|Progressive disease per RECIST|0|||
46884401|NCT02564900|83105740|FG005|Dose Expansion|Progressive disease per RECIST|0|||
46884402|NCT02564900|83105741|FG006|Dose Expansion|Progressive disease per RECIST|19|||
46884403|NCT02564900|83105742|FG007|Dose Expansion|Progressive disease per RECIST|17|||
46884404|NCT02564900|83105743|FG008|Dose Expansion|Progressive disease per RECIST|8|||
46884405|NCT02564900|83105744|FG009|Dose Expansion|Progressive disease per RECIST|16|||
46884406|NCT02564900|83105745|FG010|Dose Expansion|Progressive disease per RECIST|13|||
46884407|NCT02564900|83105746|FG011|Dose Expansion|Progressive disease per RECIST|19|||
46884408|NCT02564900|83105747|FG012|Dose Expansion|Progressive disease per RECIST|10|||
46884409|NCT02564900|83105748|FG013|Dose Expansion|Progressive disease per RECIST|13|||
46884410|NCT02564900|83105749|FG014|Dose Expansion|Progressive disease per RECIST|11|||
46884411|NCT02564900|83105735|FG000|Dose Expansion|Clinical progression|0|||
46884412|NCT02564900|83105736|FG001|Dose Expansion|Clinical progression|0|||
46884413|NCT02564900|83105737|FG002|Dose Expansion|Clinical progression|0|||
46884414|NCT02564900|83105738|FG003|Dose Expansion|Clinical progression|0|||
46884415|NCT02564900|83105739|FG004|Dose Expansion|Clinical progression|0|||
46884416|NCT02564900|83105740|FG005|Dose Expansion|Clinical progression|0|||
46884417|NCT02564900|83105741|FG006|Dose Expansion|Clinical progression|5|||
46884418|NCT02564900|83105742|FG007|Dose Expansion|Clinical progression|12|||
46884419|NCT02564900|83105743|FG008|Dose Expansion|Clinical progression|0|||
46884420|NCT02564900|83105744|FG009|Dose Expansion|Clinical progression|3|||
46884421|NCT02564900|83105745|FG010|Dose Expansion|Clinical progression|2|||
46884422|NCT02564900|83105746|FG011|Dose Expansion|Clinical progression|0|||
46884423|NCT02564900|83105747|FG012|Dose Expansion|Clinical progression|1|||
46884424|NCT02564900|83105748|FG013|Dose Expansion|Clinical progression|3|||
46884425|NCT02564900|83105749|FG014|Dose Expansion|Clinical progression|1|||
46884426|NCT02564900|83105735|FG000|Dose Expansion|Adverse Event|0|||
46884427|NCT02564900|83105736|FG001|Dose Expansion|Adverse Event|0|||
46884428|NCT02564900|83105737|FG002|Dose Expansion|Adverse Event|0|||
46884429|NCT02564900|83105738|FG003|Dose Expansion|Adverse Event|0|||
46884430|NCT02564900|83105739|FG004|Dose Expansion|Adverse Event|0|||
46884431|NCT02564900|83105740|FG005|Dose Expansion|Adverse Event|0|||
46884432|NCT02564900|83105741|FG006|Dose Expansion|Adverse Event|9|||
46884433|NCT02564900|83105742|FG007|Dose Expansion|Adverse Event|22|||
46884434|NCT02564900|83105743|FG008|Dose Expansion|Adverse Event|0|||
46884435|NCT02564900|83105744|FG009|Dose Expansion|Adverse Event|11|||
46884436|NCT02564900|83105745|FG010|Dose Expansion|Adverse Event|0|||
46884437|NCT02564900|83105746|FG011|Dose Expansion|Adverse Event|5|||
46884438|NCT02564900|83105747|FG012|Dose Expansion|Adverse Event|2|||
46884439|NCT02564900|83105748|FG013|Dose Expansion|Adverse Event|2|||
46884440|NCT02564900|83105749|FG014|Dose Expansion|Adverse Event|1|||
46884441|NCT02564900|83105735|FG000|Dose Expansion|Ongoing|0|||
46884442|NCT02564900|83105736|FG001|Dose Expansion|Ongoing|0|||
46884443|NCT02564900|83105737|FG002|Dose Expansion|Ongoing|0|||
46884444|NCT02564900|83105738|FG003|Dose Expansion|Ongoing|0|||
46705260|NCT00938860|82920118|FG001|Overall Study|Administration problems|0|||
46884445|NCT02564900|83105739|FG004|Dose Expansion|Ongoing|0|||
46884446|NCT02564900|83105740|FG005|Dose Expansion|Ongoing|0|||
46884447|NCT02564900|83105741|FG006|Dose Expansion|Ongoing|9|||
46884448|NCT02564900|83105742|FG007|Dose Expansion|Ongoing|10|||
46884449|NCT02564900|83105743|FG008|Dose Expansion|Ongoing|11|||
46884450|NCT02564900|83105744|FG009|Dose Expansion|Ongoing|3|||
46884451|NCT02564900|83105745|FG010|Dose Expansion|Ongoing|0|||
46884452|NCT02564900|83105746|FG011|Dose Expansion|Ongoing|0|||
46884453|NCT02564900|83105747|FG012|Dose Expansion|Ongoing|4|||
46884454|NCT02564900|83105748|FG013|Dose Expansion|Ongoing|0|||
46884455|NCT02564900|83105749|FG014|Dose Expansion|Ongoing|6|||
46884456|NCT02564900|83105735|FG000|Dose Expansion|Death|0|||
46884457|NCT02564900|83105736|FG001|Dose Expansion|Death|0|||
46884458|NCT02564900|83105737|FG002|Dose Expansion|Death|0|||
46884459|NCT02564900|83105738|FG003|Dose Expansion|Death|0|||
46884460|NCT02564900|83105739|FG004|Dose Expansion|Death|0|||
46884461|NCT02564900|83105740|FG005|Dose Expansion|Death|0|||
46884462|NCT02564900|83105741|FG006|Dose Expansion|Death|1|||
46884463|NCT02564900|83105742|FG007|Dose Expansion|Death|0|||
46884464|NCT02564900|83105743|FG008|Dose Expansion|Death|0|||
46884465|NCT02564900|83105744|FG009|Dose Expansion|Death|0|||
46884466|NCT02564900|83105745|FG010|Dose Expansion|Death|1|||
46884467|NCT02564900|83105746|FG011|Dose Expansion|Death|0|||
46884468|NCT02564900|83105747|FG012|Dose Expansion|Death|1|||
46884469|NCT02564900|83105748|FG013|Dose Expansion|Death|1|||
46884470|NCT02564900|83105749|FG014|Dose Expansion|Death|0|||
46884471|NCT02564900|83105735|FG000|Dose Expansion|Withdrawal by Subject|0|||
46884472|NCT02564900|83105736|FG001|Dose Expansion|Withdrawal by Subject|0|||
46884473|NCT02564900|83105737|FG002|Dose Expansion|Withdrawal by Subject|0|||
46884474|NCT02564900|83105738|FG003|Dose Expansion|Withdrawal by Subject|0|||
46884475|NCT02564900|83105739|FG004|Dose Expansion|Withdrawal by Subject|0|||
46884476|NCT02564900|83105740|FG005|Dose Expansion|Withdrawal by Subject|0|||
46884477|NCT02564900|83105741|FG006|Dose Expansion|Withdrawal by Subject|4|||
46884478|NCT02564900|83105742|FG007|Dose Expansion|Withdrawal by Subject|0|||
46884479|NCT02564900|83105743|FG008|Dose Expansion|Withdrawal by Subject|0|||
46884480|NCT02564900|83105744|FG009|Dose Expansion|Withdrawal by Subject|0|||
46884481|NCT02564900|83105745|FG010|Dose Expansion|Withdrawal by Subject|1|||
46884482|NCT02564900|83105746|FG011|Dose Expansion|Withdrawal by Subject|0|||
46884483|NCT02564900|83105747|FG012|Dose Expansion|Withdrawal by Subject|0|||
46884484|NCT02564900|83105748|FG013|Dose Expansion|Withdrawal by Subject|1|||
46884485|NCT02564900|83105749|FG014|Dose Expansion|Withdrawal by Subject|1|||
46884486|NCT02564900|83105735|FG000|Dose Expansion|Other|0|||
46884487|NCT02564900|83105736|FG001|Dose Expansion|Other|0|||
46884488|NCT02564900|83105737|FG002|Dose Expansion|Other|0|||
46884489|NCT02564900|83105738|FG003|Dose Expansion|Other|0|||
46884490|NCT02564900|83105739|FG004|Dose Expansion|Other|0|||
46884491|NCT02564900|83105740|FG005|Dose Expansion|Other|0|||
46884492|NCT02564900|83105741|FG006|Dose Expansion|Other|1|||
46884493|NCT02564900|83105742|FG007|Dose Expansion|Other|0|||
46884494|NCT02564900|83105743|FG008|Dose Expansion|Other|1|||
46884495|NCT02564900|83105744|FG009|Dose Expansion|Other|0|||
46884496|NCT02564900|83105745|FG010|Dose Expansion|Other|0|||
46884497|NCT02564900|83105746|FG011|Dose Expansion|Other|0|||
46884498|NCT02564900|83105747|FG012|Dose Expansion|Other|0|||
46884499|NCT02564900|83105748|FG013|Dose Expansion|Other|0|||
46884500|NCT02564900|83105749|FG014|Dose Expansion|Other|1|||
46884501|NCT02564900|83105735|FG000|Dose Expansion|Did not receive treatment|0|||
46884502|NCT02564900|83105736|FG001|Dose Expansion|Did not receive treatment|0|||
46884503|NCT02564900|83105737|FG002|Dose Expansion|Did not receive treatment|0|||
46884504|NCT02564900|83105738|FG003|Dose Expansion|Did not receive treatment|0|||
46884505|NCT02564900|83105739|FG004|Dose Expansion|Did not receive treatment|0|||
46884506|NCT02564900|83105740|FG005|Dose Expansion|Did not receive treatment|0|||
46884507|NCT02564900|83105741|FG006|Dose Expansion|Did not receive treatment|1|||
46884508|NCT02564900|83105742|FG007|Dose Expansion|Did not receive treatment|1|||
46884509|NCT02564900|83105743|FG008|Dose Expansion|Did not receive treatment|0|||
46884510|NCT02564900|83105744|FG009|Dose Expansion|Did not receive treatment|0|||
46884511|NCT02564900|83105745|FG010|Dose Expansion|Did not receive treatment|0|||
46884512|NCT02564900|83105746|FG011|Dose Expansion|Did not receive treatment|0|||
46884513|NCT02564900|83105747|FG012|Dose Expansion|Did not receive treatment|0|||
46884514|NCT02564900|83105748|FG013|Dose Expansion|Did not receive treatment|0|||
46884515|NCT02564900|83105749|FG014|Dose Expansion|Did not receive treatment|1|||
46884516|NCT02470091|83105792|FG000|Overall Study|Withdrawal by Subject|1|||
46884517|NCT02470091|83105793|FG001|Overall Study|Withdrawal by Subject|0|||
46884518|NCT02470091|83105792|FG000|Overall Study|Ineligible|0|||
46884519|NCT02470091|83105793|FG001|Overall Study|Ineligible|2|||
46884520|NCT02432196|83105801|FG000|Overall Study|Exit - did not receive study device|1|||
46884521|NCT02432196|83105801|FG000|Overall Study|Death|2|||
46884522|NCT02432196|83105801|FG000|Overall Study|Reoperation|3|||
46884523|NCT02163733|83105820|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
46884524|NCT02163733|83105821|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
46884525|NCT02163733|83105822|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
46884526|NCT02163733|83105820|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
46991233|NCT02187471|83238188|FG001|Overall Study|Lack of Efficacy|9|||
46884527|NCT02163733|83105821|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
46897270|NCT01316900|83122981|FG003|Overall Study|Lost to Follow-up|1|||
46884528|NCT02163733|83105822|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
46884529|NCT01391832|83105840|FG000|Overall Study|Withdrawal by Subject|21|||
46884530|NCT01391832|83105841|FG001|Overall Study|Withdrawal by Subject|22|||
46884531|NCT01391832|83105840|FG000|Overall Study|Lost to Follow-up|0|||
46884532|NCT01391832|83105841|FG001|Overall Study|Lost to Follow-up|1|||
46884533|NCT05590000|83105847|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
46884534|NCT05333965|83105855|FG000|First Intervention|Adverse Event|0|||
46884535|NCT05333965|83105856|FG001|First Intervention|Adverse Event|1|||
46884536|NCT05333965|83105855|FG000|First Intervention|Withdrawal by Subject|0|||
46884537|NCT05333965|83105856|FG001|First Intervention|Withdrawal by Subject|1|||
46884538|NCT05109702|83105873|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
46884539|NCT05109702|83105874|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
46884540|NCT05109702|83105875|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
46884541|NCT05109702|83105873|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
46884542|NCT05109702|83105874|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
46884543|NCT05109702|83105875|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
46884544|NCT05109702|83105873|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
46884545|NCT05109702|83105874|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
46884546|NCT05109702|83105875|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
46884547|NCT05109702|83105873|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
46884548|NCT05109702|83105874|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
46884549|NCT05109702|83105875|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
46884550|NCT05109702|83105873|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
46884551|NCT05109702|83105874|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
46884552|NCT05109702|83105875|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
46884553|NCT04699461|83105884|FG000|Overall Study|Withdrawal by Subject|1|||
46884554|NCT04699461|83105885|FG001|Overall Study|Withdrawal by Subject|0|||
46884555|NCT04699461|83105884|FG000|Overall Study|Study termination by sponsor|2|||
46884556|NCT04699461|83105885|FG001|Overall Study|Study termination by sponsor|1|||
46884557|NCT04699461|83105884|FG000|Overall Study|Death|1|||
46884558|NCT04699461|83105885|FG001|Overall Study|Death|0|||
46884559|NCT04699461|83105884|FG000|Overall Study|Radiographic progression|0|||
46884560|NCT04699461|83105885|FG001|Overall Study|Radiographic progression|1|||
46884561|NCT04399551|83105891|FG000|Overall Study|Adverse Event|15|||
46884562|NCT04399551|83105891|FG000|Overall Study|Withdrawal by Subject|6|||
46884563|NCT04399551|83105891|FG000|Overall Study|Physician Decision|3|||
46884564|NCT04399551|83105891|FG000|Overall Study|Lost to Follow-up|2|||
46884565|NCT04399551|83105891|FG000|Overall Study|Protocol Deviation|2|||
46884566|NCT04343235|83105922|FG000|Overall Study|Lost to Follow-up|3|||
46884567|NCT04343235|83105923|FG001|Overall Study|Lost to Follow-up|2|||
46884568|NCT04338321|83105931|FG000|Overall Study|Adverse Event|4|||
46884569|NCT04338321|83105932|FG001|Overall Study|Adverse Event|10|||
46705261|NCT00938860|82920117|FG000|Overall Study|Death|1|||
46705262|NCT00938860|82920118|FG001|Overall Study|Death|1|||
46884570|NCT04338321|83105931|FG000|Overall Study|Death|1|||
46884571|NCT04338321|83105932|FG001|Overall Study|Death|1|||
46884572|NCT04338321|83105931|FG000|Overall Study|Lost to Follow-up|4|||
46884573|NCT04338321|83105932|FG001|Overall Study|Lost to Follow-up|9|||
46884574|NCT04338321|83105931|FG000|Overall Study|Withdrawal by Subject|45|||
46884575|NCT04338321|83105932|FG001|Overall Study|Withdrawal by Subject|69|||
46884576|NCT04338321|83105931|FG000|Overall Study|Physician Decision|5|||
46884577|NCT04338321|83105932|FG001|Overall Study|Physician Decision|9|||
46884578|NCT04338321|83105931|FG000|Overall Study|Other|3|||
46884579|NCT04338321|83105932|FG001|Overall Study|Other|10|||
46884580|NCT04303780|83105940|FG000|Overall Study|Death|104|||
46884581|NCT04303780|83105941|FG001|Overall Study|Death|85|||
46884582|NCT04303780|83105940|FG000|Overall Study|Lost to Follow-up|5|||
46884583|NCT04303780|83105941|FG001|Overall Study|Lost to Follow-up|2|||
46884584|NCT04303780|83105940|FG000|Overall Study|Withdrawal by Subject|12|||
46884585|NCT04303780|83105941|FG001|Overall Study|Withdrawal by Subject|39|||
46884586|NCT04303780|83105940|FG000|Overall Study|Ongoing in study|50|||
46884587|NCT04303780|83105941|FG001|Overall Study|Ongoing in study|45|||
46884588|NCT03910673|83105967|FG000|Overall Study|Adverse Event|0|||
46884589|NCT03910673|83105968|FG001|Overall Study|Adverse Event|0|||
46884590|NCT03910673|83105969|FG002|Overall Study|Adverse Event|0|||
46884591|NCT03910673|83105970|FG003|Overall Study|Adverse Event|2|||
46884592|NCT03910673|83105971|FG004|Overall Study|Adverse Event|0|||
46884593|NCT03781167|83105981|FG000|Overall Study|Adverse Event|23|||
46884594|NCT03781167|83105982|FG001|Overall Study|Adverse Event|25|||
46884595|NCT03781167|83105981|FG000|Overall Study|Withdrew consent|16|||
46884596|NCT03781167|83105982|FG001|Overall Study|Withdrew consent|12|||
46884597|NCT03781167|83105981|FG000|Overall Study|Lost to Follow-up|0|||
46884598|NCT03781167|83105982|FG001|Overall Study|Lost to Follow-up|1|||
46884599|NCT03781167|83105981|FG000|Overall Study|Lack of Efficacy|4|||
46884600|NCT03781167|83105982|FG001|Overall Study|Lack of Efficacy|5|||
46884601|NCT03781167|83105981|FG000|Overall Study|Difficulty with drug delivery system|2|||
46884602|NCT03781167|83105982|FG001|Overall Study|Difficulty with drug delivery system|3|||
46884603|NCT03781167|83105981|FG000|Overall Study|Other, not specified|2|||
46884604|NCT03781167|83105982|FG001|Overall Study|Other, not specified|2|||
46884605|NCT03689712|83106030|FG000|Overall Study|Adverse Event|1|||
46884606|NCT03689712|83106031|FG001|Overall Study|Adverse Event|0|||
46884607|NCT03689712|83106030|FG000|Overall Study|Death|20|||
46884608|NCT03689712|83106031|FG001|Overall Study|Death|10|||
46884609|NCT03689712|83106030|FG000|Overall Study|Lost to Follow-up|6|||
46884610|NCT03689712|83106031|FG001|Overall Study|Lost to Follow-up|6|||
46884611|NCT03689712|83106030|FG000|Overall Study|Other|1|||
46884612|NCT03689712|83106031|FG001|Overall Study|Other|0|||
46884613|NCT03689712|83106030|FG000|Overall Study|Patient Non-Compliance|0|||
46884614|NCT03689712|83106031|FG001|Overall Study|Patient Non-Compliance|1|||
46884615|NCT03689712|83106030|FG000|Overall Study|Withdrawal by Subject|20|||
46884616|NCT03689712|83106031|FG001|Overall Study|Withdrawal by Subject|4|||
46884617|NCT03689712|83106030|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
46884618|NCT03689712|83106031|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
46884619|NCT03689712|83106030|FG000|Overall Study|Randomized but not Treated|13|||
46884620|NCT03689712|83106031|FG001|Overall Study|Randomized but not Treated|7|||
46884621|NCT03689712|83106030|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
46884622|NCT03689712|83106031|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
46884623|NCT03679624|83106039|FG000|Overall Study|Adverse Event|1|||
46884624|NCT03679624|83106040|FG001|Overall Study|Adverse Event|0|||
46884625|NCT03399552|83106055|FG000|Overall Study|No evidence of disease|1|||
46884626|NCT03399552|83106055|FG000|Overall Study|Unevaluable|1|||
46884627|NCT03312231|83106090|FG000|Overall Study|Lost to Follow-up|2|||
46884628|NCT03312231|83106091|FG001|Overall Study|Lost to Follow-up|6|||
46884629|NCT03312231|83106092|FG002|Overall Study|Lost to Follow-up|1|||
46884630|NCT03312231|83106093|FG003|Overall Study|Lost to Follow-up|3|||
46884631|NCT03312231|83106094|FG004|Overall Study|Lost to Follow-up|1|||
46884632|NCT03312231|83106090|FG000|Overall Study|Withdrawal by Subject|0|||
46884633|NCT03312231|83106091|FG001|Overall Study|Withdrawal by Subject|3|||
46884634|NCT03312231|83106092|FG002|Overall Study|Withdrawal by Subject|1|||
46884635|NCT03312231|83106093|FG003|Overall Study|Withdrawal by Subject|0|||
46884636|NCT03312231|83106094|FG004|Overall Study|Withdrawal by Subject|0|||
46884637|NCT03312231|83106090|FG000|Overall Study|Death|0|||
46991234|NCT02187471|83238189|FG002|Overall Study|Lack of Efficacy|13|||
46884638|NCT03312231|83106091|FG001|Overall Study|Death|1|||
46884639|NCT03312231|83106092|FG002|Overall Study|Death|1|||
46884640|NCT03312231|83106093|FG003|Overall Study|Death|0|||
46884641|NCT03312231|83106094|FG004|Overall Study|Death|0|||
46884642|NCT03312231|83106090|FG000|Overall Study|Study Vaccination not Received|1|||
46884643|NCT03312231|83106091|FG001|Overall Study|Study Vaccination not Received|1|||
46884644|NCT03312231|83106092|FG002|Overall Study|Study Vaccination not Received|1|||
46884645|NCT03312231|83106093|FG003|Overall Study|Study Vaccination not Received|0|||
46884646|NCT03312231|83106094|FG004|Overall Study|Study Vaccination not Received|0|||
46884647|NCT03294590|83106108|FG000|Overall Study|Lost to Follow-up|105|||
46884648|NCT03294590|83106109|FG001|Overall Study|Lost to Follow-up|107|||
46884649|NCT03292731|83106120|FG000|Overall Study|Protocol Violation|4|||
46884650|NCT03292731|83106121|FG001|Overall Study|Protocol Violation|11|||
46884651|NCT03292731|83106122|FG002|Overall Study|Protocol Violation|1|||
46884652|NCT03277313|83106147|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
46884653|NCT03277313|83106148|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
46884654|NCT03277313|83106147|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
46884655|NCT03277313|83106148|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
46884656|NCT03277313|83106147|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
46884657|NCT03277313|83106148|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
46884658|NCT03277313|83106147|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
46884659|NCT03277313|83106148|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
46884660|NCT03277313|83106147|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
46884661|NCT03277313|83106148|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
46884662|NCT03206073|83106160|FG000|Overall Study|Participant Noncompliance|0|||
46884663|NCT03206073|83106161|FG001|Overall Study|Participant Noncompliance|1|||
46884664|NCT03206073|83106162|FG002|Overall Study|Participant Noncompliance|0|||
46884665|NCT03206073|83106163|FG003|Overall Study|Participant Noncompliance|0|||
46884666|NCT03206073|83106160|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
46884667|NCT03206073|83106161|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
46884668|NCT03206073|83106162|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
46884669|NCT03206073|83106163|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
46884670|NCT03206073|83106160|FG000|Overall Study|Death|0|||
46884671|NCT03206073|83106161|FG001|Overall Study|Death|0|||
46884672|NCT03206073|83106162|FG002|Overall Study|Death|1|||
46884673|NCT03206073|83106163|FG003|Overall Study|Death|0|||
46884674|NCT03206073|83106160|FG000|Overall Study|Taken off active treatment|0|||
46884675|NCT03206073|83106161|FG001|Overall Study|Taken off active treatment|0|||
46884676|NCT03206073|83106162|FG002|Overall Study|Taken off active treatment|3|||
46884677|NCT03206073|83106163|FG003|Overall Study|Taken off active treatment|0|||
46884678|NCT03193801|83106173|FG000|Overall Study|Physician Decision|2|||
46884679|NCT03193801|83106173|FG000|Overall Study|Withdrawal by Subject|1|||
46884680|NCT02973997|83106179|FG000|Overall Study|Withdrawal by Subject|4|||
46884681|NCT02973997|83106180|FG001|Overall Study|Withdrawal by Subject|0|||
46884682|NCT02973997|83106179|FG000|Overall Study|Adverse Event|4|||
46884683|NCT02973997|83106180|FG001|Overall Study|Adverse Event|1|||
46884684|NCT02973997|83106179|FG000|Overall Study|Disease Progression|11|||
46884685|NCT02973997|83106180|FG001|Overall Study|Disease Progression|20|||
46884686|NCT02973997|83106179|FG000|Overall Study|Alternative Therapy|3|||
46884687|NCT02973997|83106180|FG001|Overall Study|Alternative Therapy|0|||
46884688|NCT02973997|83106179|FG000|Overall Study|Other complicating disease|0|||
46884689|NCT02973997|83106180|FG001|Overall Study|Other complicating disease|1|||
46884690|NCT02973997|83106179|FG000|Overall Study|Death|0|||
46884691|NCT02973997|83106180|FG001|Overall Study|Death|1|||
46884692|NCT02941926|83106188|FG000|Core Phase|Progressive disease|1109|||
46884693|NCT02941926|83106188|FG000|Core Phase|Adverse Event|504|||
46884694|NCT02941926|83106188|FG000|Core Phase|Subject/guardian decision|127|||
46884695|NCT02941926|83106188|FG000|Core Phase|Physician Decision|112|||
46884696|NCT02941926|83106188|FG000|Core Phase|Death|46|||
46884697|NCT02941926|83106188|FG000|Core Phase|Protocol deviation|34|||
46884698|NCT02941926|83106188|FG000|Core Phase|Lost to Follow-up|8|||
46884699|NCT02941926|83106188|FG000|Core Phase|Technical problems|5|||
46884700|NCT02941926|83106188|FG000|Extension Phase|Physician Decision|155|||
46884701|NCT02941926|83106188|FG000|Extension Phase|Progressive disease|115|||
46884702|NCT02941926|83106188|FG000|Extension Phase|Adverse Event|13|||
46884703|NCT02941926|83106188|FG000|Extension Phase|Subject/Guardian decision|12|||
46884704|NCT02941926|83106188|FG000|Extension Phase|Death|6|||
46884705|NCT02846415|83106199|FG000|Overall Study|Lost to Follow-up|2|||
46884706|NCT02846415|83106200|FG001|Overall Study|Lost to Follow-up|0|||
46884707|NCT02846415|83106199|FG000|Overall Study|Withdrawal by Subject|1|||
46884708|NCT02846415|83106200|FG001|Overall Study|Withdrawal by Subject|1|||
46884709|NCT02485639|83106214|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
46884710|NCT02485639|83106214|FG000|Overall Study|Early termination|4|||
46884711|NCT02485639|83106214|FG000|Overall Study|Withdrawal by Subject|4|||
46884712|NCT02418949|83106222|FG000|Overall Study|Withdrawal by Subject|1|||
46884713|NCT02418949|83106223|FG001|Overall Study|Withdrawal by Subject|0|||
46884714|NCT02418949|83106224|FG002|Overall Study|Withdrawal by Subject|1|||
46884715|NCT02418949|83106225|FG003|Overall Study|Withdrawal by Subject|1|||
46884716|NCT02418949|83106222|FG000|Overall Study|Lost to Follow-up|1|||
46884717|NCT02418949|83106223|FG001|Overall Study|Lost to Follow-up|0|||
46884718|NCT02418949|83106224|FG002|Overall Study|Lost to Follow-up|1|||
46884719|NCT02418949|83106225|FG003|Overall Study|Lost to Follow-up|0|||
46884720|NCT02418949|83106222|FG000|Overall Study|Physician Decision|1|||
46884721|NCT02418949|83106223|FG001|Overall Study|Physician Decision|1|||
46884722|NCT02418949|83106224|FG002|Overall Study|Physician Decision|1|||
46884723|NCT02418949|83106225|FG003|Overall Study|Physician Decision|0|||
46884724|NCT02383433|83106235|FG000|Overall Study|Disease progression|2|||
46884725|NCT02336074|83106250|FG000|Overall Study|Adverse Event|0|||
46884726|NCT02336074|83106251|FG001|Overall Study|Adverse Event|2|||
46884727|NCT02229825|83106278|FG000|Overall Study|Personal Reasons|0|||
46884728|NCT02229825|83106279|FG001|Overall Study|Personal Reasons|1|||
46884729|NCT02229825|83106278|FG000|Overall Study|Refused continuing medication|7|||
46884730|NCT02229825|83106279|FG001|Overall Study|Refused continuing medication|6|||
46884731|NCT02229825|83106278|FG000|Overall Study|Lost to Follow-up|1|||
46884732|NCT02229825|83106279|FG001|Overall Study|Lost to Follow-up|2|||
46884733|NCT02229825|83106278|FG000|Overall Study|Protocol Violation|1|||
46884734|NCT02229825|83106279|FG001|Overall Study|Protocol Violation|1|||
46884735|NCT02229825|83106278|FG000|Overall Study|Lack of Efficacy|4|||
46884736|NCT02229825|83106279|FG001|Overall Study|Lack of Efficacy|10|||
46884737|NCT02229825|83106278|FG000|Overall Study|Adverse Event|11|||
46884738|NCT02229825|83106279|FG001|Overall Study|Adverse Event|9|||
46884739|NCT02229825|83106278|FG000|Overall Study|Not treated|0|||
46884740|NCT02229825|83106279|FG001|Overall Study|Not treated|1|||
46884741|NCT02057718|83106298|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
46884742|NCT02057718|83106299|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
46884743|NCT02057718|83106298|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
46884744|NCT02057718|83106299|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
46884745|NCT02057718|83106298|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
46884746|NCT02057718|83106299|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
46884747|NCT02057718|83106298|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
46884748|NCT02057718|83106299|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
46884749|NCT02057718|83106298|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
46884750|NCT02057718|83106299|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
46884751|NCT02057718|83106298|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
46884752|NCT02057718|83106299|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
46884753|NCT02057718|83106298|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
46884754|NCT02057718|83106299|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
46884755|NCT02057718|83106298|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
46884756|NCT02057718|83106299|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
46884757|NCT02057718|83106298|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
46884758|NCT02057718|83106299|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
46884759|NCT02057718|83106298|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
46884760|NCT02057718|83106299|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
46884761|NCT02057718|83106298|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
46884762|NCT02057718|83106299|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
46884763|NCT01750281|83106308|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
46884764|NCT01750281|83106309|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
46884765|NCT01750281|83106310|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
46884766|NCT01750281|83106308|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
46884767|NCT01750281|83106309|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
46884768|NCT01750281|83106310|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
46884769|NCT01750281|83106308|FG000|Overall Study|Did not receive treatment|0|||
46884770|NCT01750281|83106309|FG001|Overall Study|Did not receive treatment|1|||
46884771|NCT01750281|83106310|FG002|Overall Study|Did not receive treatment|0|||
46884772|NCT01205061|83106320|FG000|Overall Study|Adverse Event|4|||
46884773|NCT01205061|83106320|FG000|Overall Study|Withdrawal by Subject|11|||
46884774|NCT01205061|83106320|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
46884775|NCT01205061|83106320|FG000|Overall Study|Lost to Follow-up|9|||
46884776|NCT01205061|83106320|FG000|Overall Study|Other|1|||
46884777|NCT01108237|83106328|FG000|Overall Study|No alignment data|2|||
46884778|NCT01108237|83106329|FG001|Overall Study|No alignment data|15|||
46884779|NCT01108237|83106328|FG000|Overall Study|Did not meet criteria for analysis|7|||
46884780|NCT01108237|83106329|FG001|Overall Study|Did not meet criteria for analysis|0|||
46884781|NCT00736450|83106358|FG000|Overall Study|Not ABC gene eligible|19|||
46884782|NCT00736450|83106358|FG000|Overall Study|Withdrawal by Subject|5|||
46884783|NCT00736450|83106358|FG000|Overall Study|Physician Decision|1|||
46884784|NCT00571662|83106379|FG000|Overall Study|Withdrawal by Subject|2|||
46884785|NCT00571662|83106379|FG000|Overall Study|psychiatric instability|1|||
46884786|NCT00571662|83106379|FG000|Overall Study|Adverse Event|5|||
46884787|NCT04500769|83106402|FG000|Overall Study|Withdrawal by Subject|5|||
46884788|NCT04446377|83106408|FG000|Overall Study|Withdrawal by Subject|6|||
46884789|NCT04446377|83106409|FG001|Overall Study|Withdrawal by Subject|1|||
46884790|NCT04446377|83106408|FG000|Overall Study|Physician Decision|1|||
46884791|NCT04446377|83106409|FG001|Overall Study|Physician Decision|1|||
46884792|NCT04446377|83106408|FG000|Overall Study|Lost to Follow-up|0|||
46884793|NCT04446377|83106409|FG001|Overall Study|Lost to Follow-up|2|||
46884794|NCT04446377|83106408|FG000|Overall Study|Not eligible|0|||
46884795|NCT04446377|83106409|FG001|Overall Study|Not eligible|1|||
46884796|NCT04398368|83106419|FG000|Overall Study|Withdrawal by Subject|2|||
46884797|NCT04275297|83106425|FG000|Overall Study|Lost to Follow-up|1|||
46884798|NCT04275297|83106426|FG001|Overall Study|Lost to Follow-up|1|||
46884799|NCT04247282|83106436|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
46884800|NCT04247282|83106437|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
46884801|NCT04247282|83106438|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
46884802|NCT04247282|83106439|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
46884803|NCT04247282|83106436|FG000|Overall Study|Refused further treatment|0|||
46884804|NCT04247282|83106437|FG001|Overall Study|Refused further treatment|1|||
46884805|NCT04247282|83106438|FG002|Overall Study|Refused further treatment|0|||
46884806|NCT04247282|83106439|FG003|Overall Study|Refused further treatment|0|||
46884807|NCT04224688|83106450|FG000|Overall Study|Withdrawal by Subject|1|||
46884808|NCT04224688|83106451|FG001|Overall Study|Withdrawal by Subject|3|||
46884809|NCT04224688|83106450|FG000|Overall Study|Lack of Efficacy|1|||
46884810|NCT04224688|83106451|FG001|Overall Study|Lack of Efficacy|1|||
46884811|NCT04224688|83106450|FG000|Overall Study|Adverse event, not fatal|0|||
46884812|NCT04224688|83106451|FG001|Overall Study|Adverse event, not fatal|2|||
46884813|NCT04224688|83106450|FG000|Overall Study|COVID-19|0|||
46884814|NCT04224688|83106451|FG001|Overall Study|COVID-19|1|||
46884815|NCT04200456|83106459|FG000|Overall Study|Physician Decision|0|||
46884816|NCT04200456|83106460|FG001|Overall Study|Physician Decision|1|||
46884817|NCT04200456|83106459|FG000|Overall Study|Withdrawal by Subject|2|||
46884818|NCT04200456|83106460|FG001|Overall Study|Withdrawal by Subject|2|||
46884819|NCT04200456|83106459|FG000|Overall Study|Lack of Efficacy|1|||
46884820|NCT04200456|83106460|FG001|Overall Study|Lack of Efficacy|1|||
46884821|NCT04200456|83106459|FG000|Overall Study|Adverse event, non-fatal|0|||
46884822|NCT04200456|83106460|FG001|Overall Study|Adverse event, non-fatal|1|||
46884823|NCT04200456|83106459|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
46884824|NCT04200456|83106460|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
46884825|NCT03766685|83106470|FG000|Overall Study|Lost to Follow-up|1|||
46884826|NCT03766685|83106471|FG001|Overall Study|Lost to Follow-up|1|||
46884827|NCT03766685|83106472|FG002|Overall Study|Lost to Follow-up|0|||
46884828|NCT03766685|83106473|FG003|Overall Study|Lost to Follow-up|0|||
46884829|NCT03766685|83106470|FG000|Overall Study|Adverse Event, not fatal|0|||
46884830|NCT03766685|83106471|FG001|Overall Study|Adverse Event, not fatal|1|||
46884831|NCT03766685|83106472|FG002|Overall Study|Adverse Event, not fatal|0|||
46884832|NCT03766685|83106473|FG003|Overall Study|Adverse Event, not fatal|1|||
46884833|NCT03766685|83106470|FG000|Overall Study|Withdrawal by Subject|0|||
46884834|NCT03766685|83106471|FG001|Overall Study|Withdrawal by Subject|2|||
46884835|NCT03766685|83106472|FG002|Overall Study|Withdrawal by Subject|0|||
46884836|NCT03766685|83106473|FG003|Overall Study|Withdrawal by Subject|0|||
46884837|NCT03766685|83106470|FG000|Overall Study|Protocol Violation|0|||
46884838|NCT03766685|83106471|FG001|Overall Study|Protocol Violation|1|||
46884839|NCT03766685|83106472|FG002|Overall Study|Protocol Violation|0|||
46884840|NCT03766685|83106473|FG003|Overall Study|Protocol Violation|0|||
46884841|NCT03766685|83106470|FG000|Overall Study|Non-compliance|0|||
46884842|NCT03766685|83106471|FG001|Overall Study|Non-compliance|2|||
46884843|NCT03766685|83106472|FG002|Overall Study|Non-compliance|0|||
46884844|NCT03766685|83106473|FG003|Overall Study|Non-compliance|0|||
46884845|NCT03654274|83106487|FG000|Overall Study|Adverse Event|19|||
46884846|NCT03654274|83106488|FG001|Overall Study|Adverse Event|23|||
46884847|NCT03654274|83106489|FG002|Overall Study|Adverse Event|24|||
46884848|NCT03654274|83106487|FG000|Overall Study|Protocol Deviation|0|||
46884849|NCT03654274|83106488|FG001|Overall Study|Protocol Deviation|2|||
46884850|NCT03654274|83106489|FG002|Overall Study|Protocol Deviation|0|||
46884851|NCT03654274|83106487|FG000|Overall Study|Lost to Follow-up|8|||
46884852|NCT03654274|83106488|FG001|Overall Study|Lost to Follow-up|6|||
46884853|NCT03654274|83106489|FG002|Overall Study|Lost to Follow-up|5|||
46884854|NCT03654274|83106487|FG000|Overall Study|Withdrawal by Subject|46|||
46884855|NCT03654274|83106488|FG001|Overall Study|Withdrawal by Subject|25|||
46884856|NCT03654274|83106489|FG002|Overall Study|Withdrawal by Subject|33|||
46884857|NCT03654274|83106487|FG000|Overall Study|Lack of Efficacy|4|||
46884858|NCT03654274|83106488|FG001|Overall Study|Lack of Efficacy|5|||
46884859|NCT03654274|83106489|FG002|Overall Study|Lack of Efficacy|7|||
46884860|NCT03654274|83106487|FG000|Overall Study|Pregnancy|2|||
46884861|NCT03654274|83106488|FG001|Overall Study|Pregnancy|2|||
46884862|NCT03654274|83106489|FG002|Overall Study|Pregnancy|1|||
46884863|NCT03654274|83106487|FG000|Overall Study|Other|27|||
46884864|NCT03654274|83106488|FG001|Overall Study|Other|29|||
46884865|NCT03654274|83106489|FG002|Overall Study|Other|32|||
46884866|NCT03654274|83106487|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
46884867|NCT03654274|83106488|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
46884868|NCT03654274|83106489|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
46884869|NCT03533686|83106507|FG000|Overall Study|Withdrawal by Subject|1|||
46884870|NCT03533686|83106508|FG001|Overall Study|Withdrawal by Subject|0|||
46884871|NCT03533686|83106509|FG002|Overall Study|Withdrawal by Subject|0|||
46884872|NCT03533686|83106510|FG003|Overall Study|Withdrawal by Subject|3|||
46884873|NCT03533686|83106511|FG004|Overall Study|Withdrawal by Subject|5|||
46884874|NCT03533686|83106512|FG005|Overall Study|Withdrawal by Subject|1|||
46884875|NCT03533686|83106507|FG000|Overall Study|Lost to Follow-up|0|||
46884876|NCT03533686|83106508|FG001|Overall Study|Lost to Follow-up|1|||
46884877|NCT03533686|83106509|FG002|Overall Study|Lost to Follow-up|0|||
46884878|NCT03533686|83106510|FG003|Overall Study|Lost to Follow-up|0|||
46884879|NCT03533686|83106511|FG004|Overall Study|Lost to Follow-up|2|||
46884880|NCT03533686|83106512|FG005|Overall Study|Lost to Follow-up|0|||
46884881|NCT03533686|83106507|FG000|Overall Study|Screen Failure|0|||
46884882|NCT03533686|83106508|FG001|Overall Study|Screen Failure|0|||
46884883|NCT03533686|83106509|FG002|Overall Study|Screen Failure|0|||
46884884|NCT03533686|83106510|FG003|Overall Study|Screen Failure|2|||
46884885|NCT03533686|83106511|FG004|Overall Study|Screen Failure|0|||
46884886|NCT03533686|83106512|FG005|Overall Study|Screen Failure|0|||
46884887|NCT03154359|83106570|FG000|Overall Study|Adverse Event|1|||
46884888|NCT03154359|83106570|FG000|Overall Study|Lack of Efficacy|2|||
46884889|NCT03154359|83106570|FG000|Overall Study|Lost to Follow-up|3|||
46884890|NCT03154359|83106570|FG000|Overall Study|Physician Decision|3|||
46884891|NCT03154359|83106570|FG000|Overall Study|Protocol Violation|4|||
46884892|NCT03154359|83106570|FG000|Overall Study|Withdrawal by Subject|5|||
46884893|NCT03154359|83106570|FG000|Overall Study|Disruption of study due to COVID-19|4|||
46884894|NCT03135834|83106589|FG000|Stage 1|Adverse Event|1|||
46884895|NCT03135834|83106590|FG001|Stage 1|Adverse Event|2|||
46884896|NCT03135834|83106591|FG002|Stage 1|Adverse Event|2|||
46884897|NCT03135834|83106592|FG003|Stage 1|Adverse Event|1|||
46884898|NCT03135834|83106589|FG000|Stage 1|Death|1|||
46884899|NCT03135834|83106590|FG001|Stage 1|Death|0|||
46884900|NCT03135834|83106591|FG002|Stage 1|Death|0|||
46884901|NCT03135834|83106592|FG003|Stage 1|Death|0|||
46884902|NCT03135834|83106589|FG000|Stage 1|Lost to Follow-up|17|||
46884903|NCT03135834|83106590|FG001|Stage 1|Lost to Follow-up|24|||
46884904|NCT03135834|83106591|FG002|Stage 1|Lost to Follow-up|21|||
46884905|NCT03135834|83106592|FG003|Stage 1|Lost to Follow-up|38|||
46884906|NCT03135834|83106589|FG000|Stage 1|No longer met eligibility criteria|1|||
46884907|NCT03135834|83106590|FG001|Stage 1|No longer met eligibility criteria|6|||
46884908|NCT03135834|83106591|FG002|Stage 1|No longer met eligibility criteria|2|||
46884909|NCT03135834|83106592|FG003|Stage 1|No longer met eligibility criteria|5|||
46884910|NCT03135834|83106589|FG000|Stage 1|Other|0|||
46884911|NCT03135834|83106590|FG001|Stage 1|Other|2|||
46884912|NCT03135834|83106591|FG002|Stage 1|Other|1|||
46884913|NCT03135834|83106592|FG003|Stage 1|Other|0|||
46884914|NCT03135834|83106589|FG000|Stage 1|Physician Decision|0|||
46884915|NCT03135834|83106590|FG001|Stage 1|Physician Decision|1|||
46884916|NCT03135834|83106591|FG002|Stage 1|Physician Decision|0|||
46884917|NCT03135834|83106592|FG003|Stage 1|Physician Decision|0|||
46884918|NCT03135834|83106589|FG000|Stage 1|Pregnancy|0|||
46884919|NCT03135834|83106590|FG001|Stage 1|Pregnancy|4|||
46884920|NCT03135834|83106591|FG002|Stage 1|Pregnancy|2|||
46884921|NCT03135834|83106592|FG003|Stage 1|Pregnancy|4|||
46884922|NCT03135834|83106589|FG000|Stage 1|Protocol Violation|1|||
46884923|NCT03135834|83106590|FG001|Stage 1|Protocol Violation|1|||
46884924|NCT03135834|83106591|FG002|Stage 1|Protocol Violation|2|||
46884925|NCT03135834|83106592|FG003|Stage 1|Protocol Violation|1|||
46884926|NCT03135834|83106589|FG000|Stage 1|Withdrawal by parent/guardian|2|||
46884927|NCT03135834|83106590|FG001|Stage 1|Withdrawal by parent/guardian|10|||
46884928|NCT03135834|83106591|FG002|Stage 1|Withdrawal by parent/guardian|2|||
46884929|NCT03135834|83106592|FG003|Stage 1|Withdrawal by parent/guardian|1|||
46884930|NCT03135834|83106589|FG000|Stage 1|Withdrawal by Subject|16|||
46884931|NCT03135834|83106590|FG001|Stage 1|Withdrawal by Subject|22|||
46884932|NCT03135834|83106591|FG002|Stage 1|Withdrawal by Subject|7|||
46884933|NCT03135834|83106592|FG003|Stage 1|Withdrawal by Subject|10|||
46884934|NCT03135834|83106589|FG000|Stage 1|Randomized but not Vaccinated|0|||
46884935|NCT03135834|83106590|FG001|Stage 1|Randomized but not Vaccinated|3|||
46884936|NCT03135834|83106591|FG002|Stage 1|Randomized but not Vaccinated|1|||
46884937|NCT03135834|83106592|FG003|Stage 1|Randomized but not Vaccinated|6|||
46884938|NCT03135834|83106589|FG000|Stage 2|Lost to Follow-up|0|||
46884939|NCT03135834|83106590|FG001|Stage 2|Lost to Follow-up|1|||
46884940|NCT03135834|83106591|FG002|Stage 2|Lost to Follow-up|0|||
46884941|NCT03135834|83106592|FG003|Stage 2|Lost to Follow-up|0|||
46884942|NCT03135834|83106589|FG000|Stage 2|Withdrawal by Subject|0|||
46884943|NCT03135834|83106590|FG001|Stage 2|Withdrawal by Subject|1|||
46884944|NCT03135834|83106591|FG002|Stage 2|Withdrawal by Subject|0|||
46884945|NCT03135834|83106592|FG003|Stage 2|Withdrawal by Subject|0|||
46884946|NCT03135834|83106589|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
46884947|NCT03135834|83106590|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
46884948|NCT03135834|83106591|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
46884949|NCT03135834|83106592|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
46884950|NCT03135834|83106589|FG000|Stage 2|Did not receive Booster Vaccination|1|||
46884951|NCT03135834|83106590|FG001|Stage 2|Did not receive Booster Vaccination|1|||
46884952|NCT03135834|83106591|FG002|Stage 2|Did not receive Booster Vaccination|0|||
46884953|NCT03135834|83106592|FG003|Stage 2|Did not receive Booster Vaccination|0|||
46884954|NCT03130777|83106625|FG000|Overall Study|Death|0|||
46884955|NCT03130777|83106626|FG001|Overall Study|Death|1|||
46884956|NCT03130777|83106625|FG000|Overall Study|Did not meet eligibility criteria|1|||
46884957|NCT03130777|83106626|FG001|Overall Study|Did not meet eligibility criteria|0|||
46884958|NCT02207725|83106667|FG000|Overall Study|Did Not Receive Treatment|0|||
46884959|NCT02207725|83106668|FG001|Overall Study|Did Not Receive Treatment|1|||
46884960|NCT02207725|83106669|FG002|Overall Study|Did Not Receive Treatment|1|||
46884961|NCT02207725|83106670|FG003|Overall Study|Did Not Receive Treatment|1|||
46884962|NCT00968799|83106704|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
46884963|NCT02883452|83106714|FG000|Overall Study|Withdrawal by Subject|1|||
46884964|NCT02883452|83106715|FG001|Overall Study|Withdrawal by Subject|1|||
46884965|NCT02883452|83106716|FG002|Overall Study|Withdrawal by Subject|3|||
46884966|NCT02883452|83106717|FG003|Overall Study|Withdrawal by Subject|0|||
46884967|NCT02883452|83106718|FG004|Overall Study|Withdrawal by Subject|2|||
46884968|NCT02883452|83106719|FG005|Overall Study|Withdrawal by Subject|5|||
46884969|NCT02883452|83106714|FG000|Overall Study|Disease progression|1|||
46884970|NCT02883452|83106715|FG001|Overall Study|Disease progression|0|||
46884971|NCT02883452|83106716|FG002|Overall Study|Disease progression|0|||
46884972|NCT02883452|83106717|FG003|Overall Study|Disease progression|1|||
46884973|NCT02883452|83106718|FG004|Overall Study|Disease progression|4|||
46884974|NCT02883452|83106719|FG005|Overall Study|Disease progression|5|||
46884975|NCT02883452|83106714|FG000|Overall Study|Adverse Event|2|||
46884976|NCT02883452|83106715|FG001|Overall Study|Adverse Event|1|||
46884977|NCT02883452|83106716|FG002|Overall Study|Adverse Event|1|||
46884978|NCT02883452|83106717|FG003|Overall Study|Adverse Event|1|||
46884979|NCT02883452|83106718|FG004|Overall Study|Adverse Event|1|||
46884980|NCT02883452|83106719|FG005|Overall Study|Adverse Event|3|||
46884981|NCT02883452|83106714|FG000|Overall Study|Physician Decision|0|||
46884982|NCT02883452|83106715|FG001|Overall Study|Physician Decision|0|||
46884983|NCT02883452|83106716|FG002|Overall Study|Physician Decision|0|||
46884984|NCT02883452|83106717|FG003|Overall Study|Physician Decision|0|||
46884985|NCT02883452|83106718|FG004|Overall Study|Physician Decision|4|||
46884986|NCT02883452|83106719|FG005|Overall Study|Physician Decision|1|||
46884987|NCT02883452|83106714|FG000|Overall Study|Death|1|||
46884988|NCT02883452|83106715|FG001|Overall Study|Death|0|||
46884989|NCT02883452|83106716|FG002|Overall Study|Death|1|||
46884990|NCT02883452|83106717|FG003|Overall Study|Death|0|||
46884991|NCT02883452|83106718|FG004|Overall Study|Death|0|||
46884992|NCT02883452|83106719|FG005|Overall Study|Death|0|||
46884993|NCT02883452|83106714|FG000|Overall Study|Other|0|||
46884994|NCT02883452|83106715|FG001|Overall Study|Other|0|||
46884995|NCT02883452|83106716|FG002|Overall Study|Other|0|||
46884996|NCT02883452|83106717|FG003|Overall Study|Other|0|||
46884997|NCT02883452|83106718|FG004|Overall Study|Other|0|||
46884998|NCT02883452|83106719|FG005|Overall Study|Other|1|||
46884999|NCT00151372|83106736|FG000|Overall Study|Death|12|||
46885000|NCT00151372|83106737|FG001|Overall Study|Death|11|||
46885001|NCT00151372|83106736|FG000|Overall Study|Lost to Follow-up|5|||
46885002|NCT00151372|83106737|FG001|Overall Study|Lost to Follow-up|5|||
46885003|NCT00151372|83106736|FG000|Overall Study|Too sick medically to continue|5|||
46885004|NCT00151372|83106737|FG001|Overall Study|Too sick medically to continue|6|||
46885005|NCT00151372|83106736|FG000|Overall Study|Withdrawal by Subject|7|||
46885006|NCT00151372|83106737|FG001|Overall Study|Withdrawal by Subject|7|||
46885007|NCT02603809|83106749|FG000|Overall Study|Withdrawal by Subject|4|||
46885008|NCT02603809|83106750|FG001|Overall Study|Withdrawal by Subject|1|||
46885009|NCT02603809|83106751|FG002|Overall Study|Withdrawal by Subject|2|||
46885010|NCT02603809|83106752|FG003|Overall Study|Withdrawal by Subject|3|||
46885011|NCT02603809|83106753|FG004|Overall Study|Withdrawal by Subject|3|||
46885012|NCT02603809|83106754|FG005|Overall Study|Withdrawal by Subject|4|||
46885013|NCT02603809|83106749|FG000|Overall Study|Lost to Follow-up|2|||
46885014|NCT02603809|83106750|FG001|Overall Study|Lost to Follow-up|3|||
46885015|NCT02603809|83106751|FG002|Overall Study|Lost to Follow-up|1|||
46885016|NCT02603809|83106752|FG003|Overall Study|Lost to Follow-up|4|||
46885017|NCT02603809|83106753|FG004|Overall Study|Lost to Follow-up|2|||
46885018|NCT02603809|83106754|FG005|Overall Study|Lost to Follow-up|2|||
46885019|NCT02603809|83106749|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
46885020|NCT02603809|83106750|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
46885021|NCT02603809|83106751|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
46885022|NCT02603809|83106752|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
46885023|NCT02603809|83106753|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
46885024|NCT02603809|83106754|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
46885025|NCT02603809|83106749|FG000|Overall Study|Physician Decision|0|||
46885026|NCT02603809|83106750|FG001|Overall Study|Physician Decision|0|||
46885027|NCT02603809|83106751|FG002|Overall Study|Physician Decision|0|||
46885028|NCT02603809|83106752|FG003|Overall Study|Physician Decision|1|||
46885029|NCT02603809|83106753|FG004|Overall Study|Physician Decision|2|||
46885030|NCT02603809|83106754|FG005|Overall Study|Physician Decision|1|||
46885031|NCT02603809|83106749|FG000|Overall Study|Adverse Event|3|||
46885032|NCT02603809|83106750|FG001|Overall Study|Adverse Event|0|||
46885033|NCT02603809|83106751|FG002|Overall Study|Adverse Event|2|||
46885034|NCT02603809|83106752|FG003|Overall Study|Adverse Event|2|||
46885035|NCT02603809|83106753|FG004|Overall Study|Adverse Event|1|||
46885036|NCT02603809|83106754|FG005|Overall Study|Adverse Event|1|||
46885037|NCT02603809|83106749|FG000|Overall Study|Lack of Efficacy|0|||
46885038|NCT02603809|83106750|FG001|Overall Study|Lack of Efficacy|1|||
46885039|NCT02603809|83106751|FG002|Overall Study|Lack of Efficacy|0|||
46885040|NCT02603809|83106752|FG003|Overall Study|Lack of Efficacy|0|||
46885041|NCT02603809|83106753|FG004|Overall Study|Lack of Efficacy|0|||
46885042|NCT02603809|83106754|FG005|Overall Study|Lack of Efficacy|1|||
46885043|NCT02741596|83106785|FG000|Overall Study|Adverse Event|1|||
46885044|NCT02741596|83106786|FG001|Overall Study|Adverse Event|5|||
46885045|NCT02741596|83106785|FG000|Overall Study|Lost to Follow-up|1|||
46885046|NCT02741596|83106786|FG001|Overall Study|Lost to Follow-up|1|||
46885047|NCT02741596|83106785|FG000|Overall Study|Physician Decision|2|||
46885048|NCT02741596|83106786|FG001|Overall Study|Physician Decision|1|||
46885049|NCT02741596|83106785|FG000|Overall Study|Pregnancy|3|||
46885050|NCT02741596|83106786|FG001|Overall Study|Pregnancy|1|||
46885051|NCT02741596|83106785|FG000|Overall Study|Other (Unspecified)|0|||
46885052|NCT02741596|83106786|FG001|Overall Study|Other (Unspecified)|3|||
46885053|NCT02741596|83106785|FG000|Overall Study|Subject withdrawn-Other|17|||
46885054|NCT02741596|83106786|FG001|Overall Study|Subject withdrawn-Other|4|||
46885055|NCT02741596|83106785|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
46885056|NCT02741596|83106786|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
46885057|NCT03147248|83106798|FG000|Overall Study|Adverse Event|0|||
46885058|NCT03147248|83106799|FG001|Overall Study|Adverse Event|2|||
46885059|NCT03147248|83106800|FG002|Overall Study|Adverse Event|2|||
46885060|NCT03147248|83106801|FG003|Overall Study|Adverse Event|2|||
46885061|NCT03147248|83106802|FG004|Overall Study|Adverse Event|6|||
46885062|NCT03147248|83106803|FG005|Overall Study|Adverse Event|11|||
46885063|NCT03147248|83106798|FG000|Overall Study|Disease progression|1|||
46885064|NCT03147248|83106799|FG001|Overall Study|Disease progression|0|||
46885065|NCT03147248|83106800|FG002|Overall Study|Disease progression|0|||
46885066|NCT03147248|83106801|FG003|Overall Study|Disease progression|0|||
46885067|NCT03147248|83106802|FG004|Overall Study|Disease progression|0|||
46885068|NCT03147248|83106803|FG005|Overall Study|Disease progression|2|||
46885069|NCT03147248|83106798|FG000|Overall Study|Withdrawal by Subject|0|||
46885070|NCT03147248|83106799|FG001|Overall Study|Withdrawal by Subject|0|||
46885071|NCT03147248|83106800|FG002|Overall Study|Withdrawal by Subject|0|||
46885072|NCT03147248|83106801|FG003|Overall Study|Withdrawal by Subject|0|||
46885073|NCT03147248|83106802|FG004|Overall Study|Withdrawal by Subject|12|||
46885074|NCT03147248|83106803|FG005|Overall Study|Withdrawal by Subject|9|||
46885075|NCT03147248|83106798|FG000|Overall Study|Protocol Violation|0|||
46885076|NCT03147248|83106799|FG001|Overall Study|Protocol Violation|0|||
46885077|NCT03147248|83106800|FG002|Overall Study|Protocol Violation|0|||
46885078|NCT03147248|83106801|FG003|Overall Study|Protocol Violation|0|||
46885079|NCT03147248|83106802|FG004|Overall Study|Protocol Violation|2|||
46885080|NCT03147248|83106803|FG005|Overall Study|Protocol Violation|0|||
46885081|NCT03147248|83106798|FG000|Overall Study|Lost to Follow-up|0|||
46885082|NCT03147248|83106799|FG001|Overall Study|Lost to Follow-up|0|||
46885083|NCT03147248|83106800|FG002|Overall Study|Lost to Follow-up|0|||
46885084|NCT03147248|83106801|FG003|Overall Study|Lost to Follow-up|0|||
46885085|NCT03147248|83106802|FG004|Overall Study|Lost to Follow-up|2|||
46885086|NCT03147248|83106803|FG005|Overall Study|Lost to Follow-up|0|||
46885087|NCT03147248|83106798|FG000|Overall Study|Pregnancy|0|||
46885088|NCT03147248|83106799|FG001|Overall Study|Pregnancy|0|||
46885089|NCT03147248|83106800|FG002|Overall Study|Pregnancy|0|||
46885090|NCT03147248|83106801|FG003|Overall Study|Pregnancy|0|||
46885091|NCT03147248|83106802|FG004|Overall Study|Pregnancy|1|||
46885092|NCT03147248|83106803|FG005|Overall Study|Pregnancy|0|||
46885093|NCT03147248|83106798|FG000|Overall Study|Death|0|||
46885094|NCT03147248|83106799|FG001|Overall Study|Death|0|||
46885095|NCT03147248|83106800|FG002|Overall Study|Death|0|||
46885096|NCT03147248|83106801|FG003|Overall Study|Death|0|||
46885097|NCT03147248|83106802|FG004|Overall Study|Death|0|||
46885098|NCT03147248|83106803|FG005|Overall Study|Death|4|||
46885099|NCT03147248|83106798|FG000|Overall Study|Physician Decision|0|||
46885100|NCT03147248|83106799|FG001|Overall Study|Physician Decision|0|||
46885101|NCT03147248|83106800|FG002|Overall Study|Physician Decision|0|||
46885102|NCT03147248|83106801|FG003|Overall Study|Physician Decision|0|||
46885103|NCT03147248|83106802|FG004|Overall Study|Physician Decision|2|||
46885104|NCT03147248|83106803|FG005|Overall Study|Physician Decision|4|||
46885105|NCT03147248|83106798|FG000|Overall Study|Prolonged Dosing Interval|0|||
46885106|NCT03147248|83106799|FG001|Overall Study|Prolonged Dosing Interval|0|||
46885107|NCT03147248|83106800|FG002|Overall Study|Prolonged Dosing Interval|0|||
46885108|NCT03147248|83106801|FG003|Overall Study|Prolonged Dosing Interval|0|||
46885109|NCT03147248|83106802|FG004|Overall Study|Prolonged Dosing Interval|1|||
46885110|NCT03147248|83106803|FG005|Overall Study|Prolonged Dosing Interval|1|||
46885111|NCT03796039|83106819|FG000|Overall Study|Death|2|||
46885112|NCT03796039|83106820|FG001|Overall Study|Death|1|||
46885113|NCT03796039|83106819|FG000|Overall Study|Withdrawal by Subject|7|||
46885114|NCT03796039|83106820|FG001|Overall Study|Withdrawal by Subject|4|||
46885115|NCT03151304|83106826|FG000|Overall Study|Termination of study by Sponsor|23|||
46885116|NCT03151304|83106826|FG000|Overall Study|missing|3|||
46885117|NCT03151304|83106826|FG000|Overall Study|Withdrawal by Subject|8|||
46885118|NCT03151304|83106826|FG000|Overall Study|multiple reasons|30|||
46885119|NCT03152552|83106835|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
46885120|NCT03152552|83106836|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
46885121|NCT03152552|83106837|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
46885122|NCT03152552|83106838|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
46885123|NCT03152552|83106839|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
46885124|NCT03152552|83106835|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
46885125|NCT03152552|83106836|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
46885126|NCT03152552|83106837|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
46885127|NCT03152552|83106838|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
46885128|NCT03152552|83106839|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
46885129|NCT03152552|83106835|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
46885130|NCT03152552|83106836|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
46885131|NCT03152552|83106837|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
46885132|NCT03152552|83106838|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
46885133|NCT03152552|83106839|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
46885134|NCT03152552|83106835|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46885135|NCT03152552|83106836|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46885136|NCT03152552|83106837|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
46885137|NCT03152552|83106838|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46885138|NCT03152552|83106839|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
46885139|NCT03152552|83106835|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
46885140|NCT03152552|83106836|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
46885141|NCT03152552|83106837|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
46885142|NCT03152552|83106838|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
46885143|NCT03152552|83106839|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
46885144|NCT03152552|83106835|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
46885145|NCT03152552|83106836|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
46885146|NCT03152552|83106837|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
46885147|NCT03152552|83106838|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
46885148|NCT03152552|83106839|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
46885149|NCT03152552|83106835|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
46885150|NCT03152552|83106836|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
46885151|NCT03152552|83106837|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
46885152|NCT03152552|83106838|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
46885153|NCT03152552|83106839|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
46885154|NCT03151226|83106852|FG000|Overall Study|Withdrawal by Subject|2|||
46885155|NCT03151226|83106852|FG000|Overall Study|not wear device correctly|1|||
46885156|NCT03151148|83106858|FG000|Overall Study|Lost to Follow-up|1|||
46885157|NCT03151148|83106859|FG001|Overall Study|Lost to Follow-up|0|||
46885158|NCT03151148|83106858|FG000|Overall Study|Withdrawal by Subject|1|||
46885159|NCT03151148|83106859|FG001|Overall Study|Withdrawal by Subject|0|||
46885160|NCT02741518|83106868|FG000|Overall Study|Withdrawal by Subject|1|||
46885161|NCT02741518|83106869|FG001|Overall Study|Withdrawal by Subject|1|||
46885162|NCT03145766|83106880|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
46885163|NCT03145766|83106881|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
46885164|NCT03145766|83106882|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
46885165|NCT03145766|83106883|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
46885166|NCT03145766|83106884|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
46885167|NCT03145766|83106880|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
46885168|NCT03145766|83106881|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
46885169|NCT03145766|83106882|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
46885170|NCT03145766|83106883|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
46885171|NCT03145766|83106884|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
46885172|NCT03145766|83106880|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
46885173|NCT03145766|83106881|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
46885174|NCT03145766|83106882|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
46885175|NCT03145766|83106883|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
46885176|NCT03145766|83106884|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
46885177|NCT03145766|83106880|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
46885178|NCT03145766|83106881|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
46885179|NCT03145766|83106882|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
46885180|NCT03145766|83106883|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
46885181|NCT03145766|83106884|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
46885182|NCT03145766|83106880|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
46885183|NCT03145766|83106881|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
46885184|NCT03145766|83106882|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
46885185|NCT03145766|83106883|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
46885186|NCT03145766|83106884|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
46885187|NCT03145766|83106880|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
46885188|NCT03145766|83106881|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
46885189|NCT03145766|83106882|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
46885190|NCT03145766|83106883|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
46885191|NCT03145766|83106884|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
46885192|NCT03145766|83106880|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
46885193|NCT03145766|83106881|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
46885194|NCT03145766|83106882|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
46885195|NCT03145766|83106883|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
46885196|NCT03145766|83106884|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
46885197|NCT03145064|83106897|FG000|Overall Study|Death|24|||
46885198|NCT03145064|83106897|FG000|Overall Study|Lost to Follow-up|3|||
46885199|NCT03145064|83106897|FG000|Overall Study|Withdrawal by Subject|6|||
46885200|NCT03145064|83106897|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
46885201|NCT03145064|83106897|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
46885202|NCT03787615|83106922|FG000|Overall Study|Withdrawal by Subject|2|||
46885203|NCT03787615|83106922|FG000|Overall Study|Lost to Follow-up|2|||
46885204|NCT03784963|83106931|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
46885205|NCT03784963|83106932|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
46885206|NCT03784963|83106933|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
46885207|NCT03784963|83106934|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
46885208|NCT03787303|83106944|FG000|Overall Study|Death|1|||
46885209|NCT03787303|83106944|FG000|Overall Study|Premature Termination of Study|1|||
46885210|NCT04170296|83106950|FG000|Overall Study|Adverse Event|1|||
46885211|NCT04170296|83106951|FG001|Overall Study|Adverse Event|0|||
46885212|NCT04170296|83106950|FG000|Overall Study|Withdrawal by Subject|3|||
46885213|NCT04170296|83106951|FG001|Overall Study|Withdrawal by Subject|2|||
46885214|NCT04170296|83106950|FG000|Overall Study|Lost to Follow-up|4|||
46885215|NCT04170296|83106951|FG001|Overall Study|Lost to Follow-up|2|||
46885216|NCT04686266|83106965|FG000|Overall Study|Withdrawal by Subject|0|||
46885217|NCT04686266|83106966|FG001|Overall Study|Withdrawal by Subject|1|||
46885218|NCT03141788|83106996|FG000|Overall Study|Lost to Follow-up|1|||
46885219|NCT03141788|83106996|FG000|Overall Study|Protocol Violation|3|||
46885220|NCT03141788|83106996|FG000|Overall Study|Withdrawal by Subject|4|||
46885221|NCT03781375|83107005|FG000|Double-blind Phase|Adverse Event|0|||
46885222|NCT03781375|83107006|FG001|Double-blind Phase|Adverse Event|1|||
46885223|NCT03781375|83107005|FG000|Double-blind Phase|Lack of Response|6|||
46885224|NCT03781375|83107006|FG001|Double-blind Phase|Lack of Response|2|||
46885225|NCT03781375|83107005|FG000|Double-blind Phase|Other|1|||
46885226|NCT03781375|83107006|FG001|Double-blind Phase|Other|3|||
46885227|NCT03781375|83107005|FG000|Open-label Phase|Protocol Issues|0|||
46885228|NCT03781375|83107006|FG001|Open-label Phase|Protocol Issues|1|||
46885229|NCT03781375|83107005|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
46885230|NCT03781375|83107006|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
46885231|NCT03781375|83107005|FG000|Open-label Phase|Other|2|||
46885232|NCT03781375|83107006|FG001|Open-label Phase|Other|2|||
46885233|NCT03779503|83107013|FG000|First Intervention|Adverse Event|0|||
46885234|NCT03779503|83107014|FG001|First Intervention|Adverse Event|1|||
46885235|NCT03779503|83107013|FG000|First Intervention|Withdrawal by Subject|1|||
46885236|NCT03779503|83107014|FG001|First Intervention|Withdrawal by Subject|0|||
46885237|NCT03150056|83107026|FG000|Overall Study|Withdrawal by Subject|0|||
46885238|NCT03150056|83107027|FG001|Overall Study|Withdrawal by Subject|0|||
46885239|NCT03150056|83107028|FG002|Overall Study|Withdrawal by Subject|0|||
46885240|NCT03150056|83107029|FG003|Overall Study|Withdrawal by Subject|0|||
46885241|NCT03150056|83107030|FG004|Overall Study|Withdrawal by Subject|0|||
46885242|NCT03150056|83107031|FG005|Overall Study|Withdrawal by Subject|2|||
46885243|NCT03150056|83107026|FG000|Overall Study|Study terminated by Sponsor|1|||
46885244|NCT03150056|83107027|FG001|Overall Study|Study terminated by Sponsor|3|||
46705263|NCT00938860|82920117|FG000|Overall Study|Protocol Violation|3|||
46885245|NCT03150056|83107028|FG002|Overall Study|Study terminated by Sponsor|1|||
46885246|NCT03150056|83107029|FG003|Overall Study|Study terminated by Sponsor|1|||
46885247|NCT03150056|83107030|FG004|Overall Study|Study terminated by Sponsor|5|||
46885248|NCT03150056|83107031|FG005|Overall Study|Study terminated by Sponsor|6|||
46885249|NCT03150056|83107026|FG000|Overall Study|Death|9|||
46885250|NCT03150056|83107027|FG001|Overall Study|Death|2|||
46885251|NCT03150056|83107028|FG002|Overall Study|Death|2|||
46885252|NCT03150056|83107029|FG003|Overall Study|Death|7|||
46885253|NCT03150056|83107030|FG004|Overall Study|Death|8|||
46885254|NCT03150056|83107031|FG005|Overall Study|Death|10|||
46885255|NCT02640664|83107051|FG000|Epoch 1|Withdrawal of informed consent|1|||
46885256|NCT02640664|83107052|FG001|Epoch 1|Withdrawal of informed consent|0|||
46885257|NCT02640664|83107053|FG002|Epoch 1|Withdrawal of informed consent|0|||
46885258|NCT02640664|83107051|FG000|Epoch 1|Death|0|||
46885259|NCT02640664|83107052|FG001|Epoch 1|Death|0|||
46885260|NCT02640664|83107053|FG002|Epoch 1|Death|1|||
46885261|NCT02640664|83107051|FG000|Epoch 2|Withdrawal of informed consent|3|||
46885262|NCT02640664|83107052|FG001|Epoch 2|Withdrawal of informed consent|4|||
46885263|NCT02640664|83107053|FG002|Epoch 2|Withdrawal of informed consent|2|||
46885264|NCT02640664|83107051|FG000|Epoch 2|Subject/guardian decision|0|||
46885265|NCT02640664|83107052|FG001|Epoch 2|Subject/guardian decision|2|||
46885266|NCT02640664|83107053|FG002|Epoch 2|Subject/guardian decision|2|||
46885267|NCT02640664|83107051|FG000|Epoch 2|Lost to Follow-up|3|||
46885268|NCT02640664|83107052|FG001|Epoch 2|Lost to Follow-up|4|||
46885269|NCT02640664|83107053|FG002|Epoch 2|Lost to Follow-up|1|||
46885270|NCT02640664|83107051|FG000|Epoch 2|Death|0|||
46885271|NCT02640664|83107052|FG001|Epoch 2|Death|0|||
46885272|NCT02640664|83107053|FG002|Epoch 2|Death|1|||
46885273|NCT00812006|83107065|FG000|Overall Study|Lost to Follow-up|0|||
46885274|NCT00812006|83107066|FG001|Overall Study|Lost to Follow-up|0|||
46885275|NCT00812006|83107067|FG002|Overall Study|Lost to Follow-up|2|||
46885276|NCT00812006|83107065|FG000|Overall Study|Physician Decision|0|||
46885277|NCT00812006|83107066|FG001|Overall Study|Physician Decision|0|||
46885278|NCT00812006|83107067|FG002|Overall Study|Physician Decision|1|||
46885279|NCT00812006|83107065|FG000|Overall Study|Withdrawal by Subject|2|||
46885280|NCT00812006|83107066|FG001|Overall Study|Withdrawal by Subject|1|||
46885281|NCT00812006|83107067|FG002|Overall Study|Withdrawal by Subject|1|||
46885282|NCT00812006|83107065|FG000|Overall Study|Lack of Qualifying Event|4|||
46885283|NCT00812006|83107066|FG001|Overall Study|Lack of Qualifying Event|2|||
46885284|NCT00812006|83107067|FG002|Overall Study|Lack of Qualifying Event|2|||
46885285|NCT04988308|83107101|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
46885286|NCT04988308|83107102|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
46885287|NCT04988308|83107103|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
46885288|NCT04988308|83107104|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
46885289|NCT04988308|83107105|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
46897423|NCT02963766|83123113|FG001|Double-Blind Period|Adverse Event|0|||
46885290|NCT04988308|83107106|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
46885291|NCT04988308|83107101|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
46885292|NCT04988308|83107102|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
46885293|NCT04988308|83107103|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
46885294|NCT04988308|83107104|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
46885295|NCT04988308|83107105|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
46885296|NCT04988308|83107106|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
46885297|NCT04988308|83107101|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
46885298|NCT04988308|83107102|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
46885299|NCT04988308|83107103|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
46885300|NCT04988308|83107104|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
46885301|NCT04988308|83107105|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
46885302|NCT04988308|83107106|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
46885303|NCT04988308|83107101|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
46885304|NCT04988308|83107102|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
46885305|NCT04988308|83107103|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
46885306|NCT04988308|83107104|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
46885307|NCT04988308|83107105|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
46885308|NCT04988308|83107106|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
46885309|NCT04988308|83107101|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
46885310|NCT04988308|83107102|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
46705264|NCT00938860|82920118|FG001|Overall Study|Protocol Violation|1|||
46885311|NCT04988308|83107103|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
46885312|NCT04988308|83107104|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
46885313|NCT04988308|83107105|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
46885314|NCT04988308|83107106|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
46885315|NCT04988308|83107101|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
46885316|NCT04988308|83107102|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
46885317|NCT04988308|83107103|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
46885318|NCT04988308|83107104|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
46885319|NCT04988308|83107105|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
46885320|NCT04988308|83107106|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
46885321|NCT04988308|83107101|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
46885322|NCT04988308|83107102|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
46885323|NCT04988308|83107103|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
46885324|NCT04988308|83107104|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
46885325|NCT04988308|83107105|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
46885326|NCT04988308|83107106|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
46885327|NCT04988308|83107101|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
46885328|NCT04988308|83107102|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
46885329|NCT04988308|83107103|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
46885330|NCT04988308|83107104|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
46885331|NCT04988308|83107105|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
46885332|NCT04988308|83107106|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
46885333|NCT04988308|83107101|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
46885334|NCT04988308|83107102|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
46885335|NCT04988308|83107103|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
46885336|NCT04988308|83107104|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
46885337|NCT04988308|83107105|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
46885338|NCT04988308|83107106|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
46885339|NCT04737109|83107119|FG000|Study Treatment|Disease Progression|5|||
46885340|NCT04737109|83107120|FG001|Study Treatment|Disease Progression|0|||
46885341|NCT04737109|83107121|FG002|Study Treatment|Disease Progression|0|||
46885342|NCT04737109|83107122|FG003|Study Treatment|Disease Progression|0|||
46885343|NCT04737109|83107119|FG000|Study Treatment|Death on study|1|||
46885344|NCT04737109|83107120|FG001|Study Treatment|Death on study|0|||
46885345|NCT04737109|83107121|FG002|Study Treatment|Death on study|0|||
46885346|NCT04737109|83107122|FG003|Study Treatment|Death on study|0|||
46885347|NCT04582669|83107140|FG000|Overall Study|Subject missed appointment(s).|1|||
46885348|NCT04582669|83107141|FG001|Overall Study|Subject missed appointment(s).|0|||
46885349|NCT04582669|83107142|FG002|Overall Study|Subject missed appointment(s).|1|||
46885350|NCT04582669|83107143|FG003|Overall Study|Subject missed appointment(s).|2|||
46885351|NCT04582669|83107140|FG000|Overall Study|Protocol Violation|0|||
46885352|NCT04582669|83107141|FG001|Overall Study|Protocol Violation|1|||
46885353|NCT04582669|83107142|FG002|Overall Study|Protocol Violation|1|||
46885354|NCT04582669|83107143|FG003|Overall Study|Protocol Violation|0|||
46885355|NCT04560309|83107155|FG000|Overall Study|Meet drop out criteria|1|||
46885356|NCT04560309|83107156|FG001|Overall Study|Meet drop out criteria|1|||
46885357|NCT04535986|83107164|FG000|Overall Study|Death|4|||
46885358|NCT04535986|83107165|FG001|Overall Study|Death|5|||
46885359|NCT04535986|83107164|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
46885360|NCT04535986|83107165|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
46885361|NCT04535986|83107164|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
46885362|NCT04535986|83107165|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
46885363|NCT04535986|83107164|FG000|Overall Study|Adverse Event|10|||
46885364|NCT04535986|83107165|FG001|Overall Study|Adverse Event|1|||
46885365|NCT04535986|83107164|FG000|Overall Study|Lack of Efficacy|3|||
46885366|NCT04535986|83107165|FG001|Overall Study|Lack of Efficacy|2|||
46885367|NCT04535986|83107164|FG000|Overall Study|Investigator discretion|3|||
46885368|NCT04535986|83107165|FG001|Overall Study|Investigator discretion|0|||
46885369|NCT04535986|83107164|FG000|Overall Study|Withdrawal by Subject|32|||
46885370|NCT04535986|83107165|FG001|Overall Study|Withdrawal by Subject|14|||
46885371|NCT04535986|83107164|FG000|Overall Study|Lost to Follow-up|5|||
46885372|NCT04535986|83107165|FG001|Overall Study|Lost to Follow-up|3|||
46885373|NCT04535986|83107164|FG000|Overall Study|Other|7|||
46885374|NCT04535986|83107165|FG001|Overall Study|Other|3|||
46885375|NCT04187196|83107175|FG000|Overall Study|Screen Failure|2|||
46885376|NCT04187196|83107176|FG001|Overall Study|Screen Failure|0|||
46885377|NCT04091971|83107182|FG000|Overall Study|Withdrawal by Subject|1|||
46705265|NCT00938470|82920126|FG000|Overall Study|Disease Progression|3|||
46885378|NCT04091971|83107182|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
46885379|NCT04091971|83107182|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
46885380|NCT03902613|83107211|FG000|Overall Study|Physician Decision|1|||
46885381|NCT03299842|83107259|FG000|Overall Study|Caregiver withdrew consent|2|||
46885382|NCT03299842|83107259|FG000|Overall Study|Child would not keep the watch on|3|||
46885383|NCT03237611|83107263|FG000|Overall Study|Withdrawal by Subject|1|||
46885384|NCT03237611|83107263|FG000|Overall Study|Ineligible|1|||
46885385|NCT03104374|83107270|FG000|Overall Study|Adverse Event|7|||
46885386|NCT03104374|83107271|FG001|Overall Study|Adverse Event|6|||
46885387|NCT03104374|83107272|FG002|Overall Study|Adverse Event|12|||
46885388|NCT03104374|83107273|FG003|Overall Study|Adverse Event|15|||
46885389|NCT03104374|83107270|FG000|Overall Study|Withdrawal by Subject|18|||
46885390|NCT03104374|83107271|FG001|Overall Study|Withdrawal by Subject|10|||
46885391|NCT03104374|83107272|FG002|Overall Study|Withdrawal by Subject|10|||
46885392|NCT03104374|83107273|FG003|Overall Study|Withdrawal by Subject|17|||
46885393|NCT03104374|83107270|FG000|Overall Study|Lost to Follow-up|4|||
46885394|NCT03104374|83107271|FG001|Overall Study|Lost to Follow-up|4|||
46885395|NCT03104374|83107272|FG002|Overall Study|Lost to Follow-up|6|||
46885396|NCT03104374|83107273|FG003|Overall Study|Lost to Follow-up|8|||
46885397|NCT03104374|83107270|FG000|Overall Study|Lack of Efficacy|6|||
46885398|NCT03104374|83107271|FG001|Overall Study|Lack of Efficacy|7|||
46885399|NCT03104374|83107272|FG002|Overall Study|Lack of Efficacy|12|||
46885400|NCT03104374|83107273|FG003|Overall Study|Lack of Efficacy|6|||
46885401|NCT03104374|83107270|FG000|Overall Study|Other|2|||
46885402|NCT03104374|83107271|FG001|Overall Study|Other|2|||
46885403|NCT03104374|83107272|FG002|Overall Study|Other|4|||
46885404|NCT03104374|83107273|FG003|Overall Study|Other|7|||
46885405|NCT03043313|83107306|FG000|Overall Study|Withdrawal by Subject|4|||
46885406|NCT03043313|83107307|FG001|Overall Study|Withdrawal by Subject|1|||
46885407|NCT03043313|83107308|FG002|Overall Study|Withdrawal by Subject|1|||
46885408|NCT03043313|83107306|FG000|Overall Study|Lost to Follow-up|1|||
46885409|NCT03043313|83107307|FG001|Overall Study|Lost to Follow-up|0|||
46885410|NCT03043313|83107308|FG002|Overall Study|Lost to Follow-up|0|||
46885411|NCT03043313|83107306|FG000|Overall Study|Death|26|||
46885412|NCT03043313|83107307|FG001|Overall Study|Death|13|||
46885413|NCT03043313|83107308|FG002|Overall Study|Death|8|||
46885414|NCT03043313|83107306|FG000|Overall Study|On Treatment|7|||
46885415|NCT03043313|83107307|FG001|Overall Study|On Treatment|12|||
46885416|NCT03043313|83107308|FG002|Overall Study|On Treatment|11|||
46885417|NCT03043313|83107306|FG000|Overall Study|In follow up|7|||
46885418|NCT03043313|83107307|FG001|Overall Study|In follow up|15|||
46885419|NCT03043313|83107308|FG002|Overall Study|In follow up|11|||
46885420|NCT02834780|83107328|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
46885421|NCT02834780|83107329|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
46885422|NCT02834780|83107330|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
46885423|NCT02834780|83107331|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
46885424|NCT02834780|83107332|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
46885425|NCT02834780|83107333|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
46885426|NCT02834780|83107334|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
46885427|NCT02834780|83107335|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
46885428|NCT02834780|83107336|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
46885429|NCT02834780|83107337|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
46885430|NCT02834780|83107338|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
46885431|NCT02834780|83107339|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
46885432|NCT02834780|83107340|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
46885433|NCT02834780|83107328|FG000|Overall Study|Withdrawal by Subject|0|||
46885434|NCT02834780|83107329|FG001|Overall Study|Withdrawal by Subject|0|||
46885435|NCT02834780|83107330|FG002|Overall Study|Withdrawal by Subject|1|||
46885436|NCT02834780|83107331|FG003|Overall Study|Withdrawal by Subject|0|||
46885437|NCT02834780|83107332|FG004|Overall Study|Withdrawal by Subject|0|||
46885438|NCT02834780|83107333|FG005|Overall Study|Withdrawal by Subject|0|||
46885439|NCT02834780|83107334|FG006|Overall Study|Withdrawal by Subject|0|||
46885440|NCT02834780|83107335|FG007|Overall Study|Withdrawal by Subject|0|||
46885441|NCT02834780|83107336|FG008|Overall Study|Withdrawal by Subject|0|||
46885442|NCT02834780|83107337|FG009|Overall Study|Withdrawal by Subject|0|||
46885443|NCT02834780|83107338|FG010|Overall Study|Withdrawal by Subject|1|||
46885444|NCT02834780|83107339|FG011|Overall Study|Withdrawal by Subject|0|||
46885445|NCT02834780|83107340|FG012|Overall Study|Withdrawal by Subject|0|||
46885446|NCT02834780|83107328|FG000|Overall Study|Adverse Event|0|||
46885447|NCT02834780|83107329|FG001|Overall Study|Adverse Event|0|||
46885448|NCT02834780|83107330|FG002|Overall Study|Adverse Event|0|||
46885449|NCT02834780|83107331|FG003|Overall Study|Adverse Event|0|||
46885450|NCT02834780|83107332|FG004|Overall Study|Adverse Event|1|||
46885451|NCT02834780|83107333|FG005|Overall Study|Adverse Event|0|||
46885452|NCT02834780|83107334|FG006|Overall Study|Adverse Event|1|||
46885453|NCT02834780|83107335|FG007|Overall Study|Adverse Event|1|||
46885454|NCT02834780|83107336|FG008|Overall Study|Adverse Event|0|||
46885455|NCT02834780|83107337|FG009|Overall Study|Adverse Event|2|||
46885456|NCT02834780|83107338|FG010|Overall Study|Adverse Event|0|||
46885457|NCT02834780|83107339|FG011|Overall Study|Adverse Event|3|||
46885458|NCT02834780|83107340|FG012|Overall Study|Adverse Event|2|||
46885459|NCT02834780|83107328|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
46885460|NCT02834780|83107329|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
46885461|NCT02834780|83107330|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
46885462|NCT02834780|83107331|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
46885463|NCT02834780|83107332|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
46885464|NCT02834780|83107333|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
46885465|NCT02834780|83107334|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
46885466|NCT02834780|83107335|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
46885467|NCT02834780|83107336|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
46885468|NCT02834780|83107337|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
46885469|NCT02834780|83107338|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
46885470|NCT02834780|83107339|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
46885471|NCT02834780|83107340|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
46885472|NCT02834780|83107328|FG000|Overall Study|Other|1|||
46885473|NCT02834780|83107329|FG001|Overall Study|Other|0|||
46885474|NCT02834780|83107330|FG002|Overall Study|Other|1|||
46885475|NCT02834780|83107331|FG003|Overall Study|Other|2|||
46885476|NCT02834780|83107332|FG004|Overall Study|Other|0|||
46885477|NCT02834780|83107333|FG005|Overall Study|Other|0|||
46885478|NCT02834780|83107334|FG006|Overall Study|Other|0|||
46885479|NCT02834780|83107335|FG007|Overall Study|Other|0|||
46885480|NCT02834780|83107336|FG008|Overall Study|Other|0|||
46885481|NCT02834780|83107337|FG009|Overall Study|Other|0|||
46885482|NCT02834780|83107338|FG010|Overall Study|Other|0|||
46885483|NCT02834780|83107339|FG011|Overall Study|Other|0|||
46885484|NCT02834780|83107340|FG012|Overall Study|Other|1|||
46885485|NCT02829957|83107376|FG000|Overall Study|Lost to Follow-up|2|||
46885486|NCT02829957|83107377|FG001|Overall Study|Lost to Follow-up|1|||
46885487|NCT01984346|83107396|FG000|Overall Study|Physician Decision|4|||
46885488|NCT01984346|83107397|FG001|Overall Study|Physician Decision|2|||
46885489|NCT01984346|83107396|FG000|Overall Study|Withdrawal by Subject|2|||
46885490|NCT01984346|83107397|FG001|Overall Study|Withdrawal by Subject|2|||
46885491|NCT01984346|83107396|FG000|Overall Study|Enrollment Closed|8|||
46885492|NCT01984346|83107397|FG001|Overall Study|Enrollment Closed|1|||
46885493|NCT01984346|83107396|FG000|Overall Study|Insurance Coverage|1|||
46885494|NCT01984346|83107397|FG001|Overall Study|Insurance Coverage|0|||
46885495|NCT01984346|83107396|FG000|Overall Study|Intra-operative Exclusion|2|||
46885496|NCT01984346|83107397|FG001|Overall Study|Intra-operative Exclusion|0|||
46885497|NCT03772327|83107435|FG000|Overall Study|Lost to Follow-up|3|||
46885498|NCT03772327|83107436|FG001|Overall Study|Lost to Follow-up|4|||
46885499|NCT03772327|83107435|FG000|Overall Study|Withdrawal by Subject|2|||
46885500|NCT03772327|83107436|FG001|Overall Study|Withdrawal by Subject|3|||
46885501|NCT04364763|83107479|FG000|Overall Study|Death|1|||
46885502|NCT04364763|83107480|FG001|Overall Study|Death|2|||
46885503|NCT04364763|83107479|FG000|Overall Study|Lost to Follow-up|1|||
46885504|NCT04364763|83107480|FG001|Overall Study|Lost to Follow-up|0|||
46885505|NCT04247815|83107497|FG000|Overall Study|Adverse Event|1|||
46885506|NCT04247815|83107498|FG001|Overall Study|Adverse Event|0|||
46885507|NCT04247815|83107497|FG000|Overall Study|Withdrawal by Subject|1|||
46885508|NCT04247815|83107498|FG001|Overall Study|Withdrawal by Subject|0|||
46705266|NCT00938470|82920127|FG001|Overall Study|Disease Progression|0|||
46885509|NCT04247815|83107497|FG000|Overall Study|Protocol Violation|0|||
46885510|NCT04247815|83107498|FG001|Overall Study|Protocol Violation|1|||
46885511|NCT03432819|83107533|FG000|Overall Study|Lost to Follow-up|2|||
46885512|NCT03432819|83107534|FG001|Overall Study|Lost to Follow-up|2|||
46885513|NCT03432819|83107533|FG000|Overall Study|Withdrawal by Subject|5|||
46885514|NCT03432819|83107534|FG001|Overall Study|Withdrawal by Subject|3|||
46885515|NCT03272347|83107562|FG000|Overall Study|Death|0|||
46885516|NCT03272347|83107563|FG001|Overall Study|Death|0|||
46885517|NCT03272347|83107564|FG002|Overall Study|Death|0|||
46885518|NCT03272347|83107565|FG003|Overall Study|Death|1|||
46885519|NCT03272347|83107562|FG000|Overall Study|Lost to Follow-up|1|||
46885520|NCT03272347|83107563|FG001|Overall Study|Lost to Follow-up|3|||
46885521|NCT03272347|83107564|FG002|Overall Study|Lost to Follow-up|5|||
46885522|NCT03272347|83107565|FG003|Overall Study|Lost to Follow-up|1|||
46885523|NCT03272347|83107562|FG000|Overall Study|Physician Decision|4|||
46885524|NCT03272347|83107563|FG001|Overall Study|Physician Decision|2|||
46885525|NCT03272347|83107564|FG002|Overall Study|Physician Decision|5|||
46885526|NCT03272347|83107565|FG003|Overall Study|Physician Decision|4|||
46885527|NCT03272347|83107562|FG000|Overall Study|Screen Failure|1|||
46885528|NCT03272347|83107563|FG001|Overall Study|Screen Failure|0|||
46885529|NCT03272347|83107564|FG002|Overall Study|Screen Failure|0|||
46885530|NCT03272347|83107565|FG003|Overall Study|Screen Failure|0|||
46885531|NCT03272347|83107562|FG000|Overall Study|Withdrawal by Subject|5|||
46885532|NCT03272347|83107563|FG001|Overall Study|Withdrawal by Subject|1|||
46885533|NCT03272347|83107564|FG002|Overall Study|Withdrawal by Subject|2|||
46885534|NCT03272347|83107565|FG003|Overall Study|Withdrawal by Subject|1|||
46885535|NCT03259568|83107587|FG000|Overall Study|Participant performance was low|3|||
46885536|NCT03167723|83107599|FG000|Overall Study|Protocol Violation|4|||
46885537|NCT03167723|83107600|FG001|Overall Study|Protocol Violation|6|||
46885538|NCT03103152|83107612|FG000|Overall Study|Physician Decision|5|||
46885539|NCT03103152|83107613|FG001|Overall Study|Physician Decision|2|||
46885540|NCT03103152|83107614|FG002|Overall Study|Physician Decision|6|||
46885541|NCT03103152|83107615|FG003|Overall Study|Physician Decision|3|||
46885542|NCT03103152|83107616|FG004|Overall Study|Physician Decision|3|||
46885543|NCT03103152|83107617|FG005|Overall Study|Physician Decision|1|||
46885544|NCT03103152|83107612|FG000|Overall Study|Protocol Violation|2|||
46885545|NCT03103152|83107613|FG001|Overall Study|Protocol Violation|2|||
46885546|NCT03103152|83107614|FG002|Overall Study|Protocol Violation|1|||
46885547|NCT03103152|83107615|FG003|Overall Study|Protocol Violation|2|||
46885548|NCT03103152|83107616|FG004|Overall Study|Protocol Violation|1|||
46885549|NCT03103152|83107617|FG005|Overall Study|Protocol Violation|1|||
46885550|NCT03103152|83107612|FG000|Overall Study|Inter-current illness|0|||
46885551|NCT03103152|83107613|FG001|Overall Study|Inter-current illness|0|||
46885552|NCT03103152|83107614|FG002|Overall Study|Inter-current illness|1|||
46885553|NCT03103152|83107615|FG003|Overall Study|Inter-current illness|0|||
46885554|NCT03103152|83107616|FG004|Overall Study|Inter-current illness|0|||
46885555|NCT03103152|83107617|FG005|Overall Study|Inter-current illness|0|||
46885556|NCT03103152|83107612|FG000|Overall Study|Death|0|||
46885557|NCT03103152|83107613|FG001|Overall Study|Death|1|||
46885558|NCT03103152|83107614|FG002|Overall Study|Death|0|||
46885559|NCT03103152|83107615|FG003|Overall Study|Death|0|||
46885560|NCT03103152|83107616|FG004|Overall Study|Death|0|||
46885561|NCT03103152|83107617|FG005|Overall Study|Death|0|||
46885562|NCT03103152|83107612|FG000|Overall Study|Adverse Event|0|||
46885563|NCT03103152|83107613|FG001|Overall Study|Adverse Event|0|||
46885564|NCT03103152|83107614|FG002|Overall Study|Adverse Event|1|||
46885565|NCT03103152|83107615|FG003|Overall Study|Adverse Event|0|||
46885566|NCT03103152|83107616|FG004|Overall Study|Adverse Event|0|||
46885567|NCT03103152|83107617|FG005|Overall Study|Adverse Event|1|||
46885568|NCT03103152|83107612|FG000|Overall Study|Withdrawal by Subject|1|||
46885569|NCT03103152|83107613|FG001|Overall Study|Withdrawal by Subject|0|||
46885570|NCT03103152|83107614|FG002|Overall Study|Withdrawal by Subject|1|||
46885571|NCT03103152|83107615|FG003|Overall Study|Withdrawal by Subject|1|||
46885572|NCT03103152|83107616|FG004|Overall Study|Withdrawal by Subject|1|||
46885573|NCT03103152|83107617|FG005|Overall Study|Withdrawal by Subject|1|||
46885574|NCT03103152|83107612|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
46885575|NCT03103152|83107613|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
46885576|NCT03103152|83107614|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
46885577|NCT03103152|83107615|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
46885578|NCT03103152|83107616|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
46991235|NCT02187471|83238190|FG003|Overall Study|Lack of Efficacy|11|||
46885579|NCT03103152|83107617|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
46885580|NCT03103152|83107612|FG000|Overall Study|Unacceptable side effects|0|||
46885581|NCT03103152|83107613|FG001|Overall Study|Unacceptable side effects|0|||
46885582|NCT03103152|83107614|FG002|Overall Study|Unacceptable side effects|0|||
46885583|NCT03103152|83107615|FG003|Overall Study|Unacceptable side effects|0|||
46885584|NCT03103152|83107616|FG004|Overall Study|Unacceptable side effects|0|||
46885585|NCT03103152|83107617|FG005|Overall Study|Unacceptable side effects|1|||
46885586|NCT03103152|83107612|FG000|Overall Study|Lost to Follow-up|0|||
46885587|NCT03103152|83107613|FG001|Overall Study|Lost to Follow-up|1|||
46885588|NCT03103152|83107614|FG002|Overall Study|Lost to Follow-up|0|||
46885589|NCT03103152|83107615|FG003|Overall Study|Lost to Follow-up|1|||
46885590|NCT03103152|83107616|FG004|Overall Study|Lost to Follow-up|0|||
46885591|NCT03103152|83107617|FG005|Overall Study|Lost to Follow-up|1|||
46885592|NCT03103152|83107612|FG000|Overall Study|Testicular pain|0|||
46885593|NCT03103152|83107613|FG001|Overall Study|Testicular pain|0|||
46885594|NCT03103152|83107614|FG002|Overall Study|Testicular pain|0|||
46885595|NCT03103152|83107615|FG003|Overall Study|Testicular pain|1|||
46991236|NCT02187471|83238187|FG000|Overall Study|Adverse Event|24|||
46885596|NCT03103152|83107616|FG004|Overall Study|Testicular pain|0|||
46885597|NCT03103152|83107617|FG005|Overall Study|Testicular pain|0|||
46885598|NCT03033901|83107631|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
46885599|NCT03033901|83107631|FG000|Overall Study|Refused PSG|23|||
46885600|NCT03033901|83107631|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
46885601|NCT03033901|83107631|FG000|Overall Study|Missing Oximetry Data|3|||
46885602|NCT02315196|83107674|FG000|Overall Study|Withdrew consent|9|||
46885603|NCT02059005|83107680|FG000|Overall Study|Death|1|||
46885604|NCT02059005|83107681|FG001|Overall Study|Death|3|||
46885605|NCT02059005|83107680|FG000|Overall Study|Lost to Follow-up|19|||
46885606|NCT02059005|83107681|FG001|Overall Study|Lost to Follow-up|19|||
46885607|NCT02059005|83107680|FG000|Overall Study|Incarceration|0|||
46885608|NCT02059005|83107681|FG001|Overall Study|Incarceration|1|||
46885609|NCT02059005|83107680|FG000|Overall Study|Inpatient|0|||
46885610|NCT02059005|83107681|FG001|Overall Study|Inpatient|1|||
46885611|NCT01393821|83107691|FG000|Overall Study|Cancel|1|||
46885612|NCT01393821|83107692|FG001|Overall Study|Cancel|1|||
46885613|NCT01393821|83107691|FG000|Overall Study|not evaluable for primary endpoint|4|||
46885614|NCT01393821|83107692|FG001|Overall Study|not evaluable for primary endpoint|2|||
46885615|NCT00496873|83107704|FG000|Overall Study|Ineligible|2|||
46885616|NCT00496873|83107704|FG000|Overall Study|Death|2|||
46885617|NCT00496873|83107704|FG000|Overall Study|Withdrawal by Subject|3|||
46885618|NCT00492778|83107710|FG000|Overall Study|Ineligible by Pathology Review|8|||
46885619|NCT00492778|83107711|FG001|Overall Study|Ineligible by Pathology Review|1|||
46885620|NCT03775681|83107745|FG000|Overall Study|Physician Decision|3|||
46885621|NCT03774823|83107751|FG000|Overall Study|Withdrawal by Subject|1|||
46885622|NCT03774823|83107752|FG001|Overall Study|Withdrawal by Subject|1|||
46885623|NCT03149042|83107758|FG000|Overall Study|Invasive FFR not performed|21|||
46885624|NCT03149042|83107758|FG000|Overall Study|Poor CT Image Quality|1|||
46885625|NCT03149042|83107758|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
46885626|NCT03496012|83107766|FG000|Overall Study|Withdrawal by Subject|2|||
46885627|NCT03496012|83107767|FG001|Overall Study|Withdrawal by Subject|0|||
46885628|NCT03496012|83107768|FG002|Overall Study|Withdrawal by Subject|2|||
46885629|NCT03496012|83107766|FG000|Overall Study|Adverse Event|0|||
46885630|NCT03496012|83107767|FG001|Overall Study|Adverse Event|0|||
46885631|NCT03496012|83107768|FG002|Overall Study|Adverse Event|1|||
46885632|NCT03496012|83107766|FG000|Overall Study|Reason Not Specified|2|||
46885633|NCT03496012|83107767|FG001|Overall Study|Reason Not Specified|0|||
46885634|NCT03496012|83107768|FG002|Overall Study|Reason Not Specified|1|||
46885635|NCT03774433|83107776|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
46885636|NCT05061992|83107791|FG000|Overall Study|Excess bowel movements|1|||
46885637|NCT05061992|83107792|FG001|Overall Study|Excess bowel movements|0|||
46885638|NCT05061992|83107791|FG000|Overall Study|Complications of Medical Care|1|||
46885639|NCT05061992|83107792|FG001|Overall Study|Complications of Medical Care|0|||
46885640|NCT05061992|83107791|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
46885641|NCT05061992|83107792|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
46885642|NCT05061992|83107791|FG000|Overall Study|Withdrawal by Subject|0|||
46885643|NCT05061992|83107792|FG001|Overall Study|Withdrawal by Subject|1|||
46885644|NCT04814823|83107807|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
46885645|NCT04625972|83107826|FG000|Overall Study|Death|3|||
46885646|NCT04625972|83107827|FG001|Overall Study|Death|2|||
46885647|NCT04625972|83107826|FG000|Overall Study|Lost to Follow-up|82|||
46885648|NCT04625972|83107827|FG001|Overall Study|Lost to Follow-up|38|||
46885649|NCT04625972|83107826|FG000|Overall Study|Physician Decision|2|||
46885650|NCT04625972|83107827|FG001|Overall Study|Physician Decision|0|||
46885651|NCT04625972|83107826|FG000|Overall Study|Protocol Violation|0|||
46885652|NCT04625972|83107827|FG001|Overall Study|Protocol Violation|1|||
46885653|NCT04625972|83107826|FG000|Overall Study|Withdrawal by Subject|37|||
46885654|NCT04625972|83107827|FG001|Overall Study|Withdrawal by Subject|24|||
46885655|NCT04625972|83107826|FG000|Overall Study|Not specified elsewhere|8|||
46885656|NCT04625972|83107827|FG001|Overall Study|Not specified elsewhere|6|||
46885657|NCT04482647|83107833|FG000|Overall Study|Time constraints|2|||
46885658|NCT04482647|83107833|FG000|Overall Study|Health issues|1|||
46885659|NCT04482647|83107833|FG000|Overall Study|Death in the family|1|||
46885660|NCT04482647|83107833|FG000|Overall Study|Disliked the intervention|1|||
46885661|NCT04482647|83107833|FG000|Overall Study|No reasons specified|7|||
46885662|NCT04429503|83107840|FG000|Overall Study|Non-compliance with protocol by the subject|1|||
46885663|NCT04429503|83107841|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
46885664|NCT04429503|83107842|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
46885665|NCT04429503|83107840|FG000|Overall Study|Adverse Event|0|||
46885666|NCT04429503|83107841|FG001|Overall Study|Adverse Event|4|||
46885667|NCT04429503|83107842|FG002|Overall Study|Adverse Event|2|||
46885668|NCT04429503|83107840|FG000|Overall Study|Decision by the investigator/sponsor|0|||
46885669|NCT04429503|83107841|FG001|Overall Study|Decision by the investigator/sponsor|6|||
46885670|NCT04429503|83107842|FG002|Overall Study|Decision by the investigator/sponsor|2|||
46885671|NCT04429503|83107840|FG000|Overall Study|Withdrawal by Subject|4|||
46885672|NCT04429503|83107841|FG001|Overall Study|Withdrawal by Subject|12|||
46885673|NCT04429503|83107842|FG002|Overall Study|Withdrawal by Subject|2|||
46885674|NCT04429503|83107840|FG000|Overall Study|Lost to Follow-up|2|||
46885675|NCT04429503|83107841|FG001|Overall Study|Lost to Follow-up|8|||
46885676|NCT04429503|83107842|FG002|Overall Study|Lost to Follow-up|2|||
46885677|NCT04429503|83107840|FG000|Overall Study|Death|5|||
46885678|NCT04429503|83107841|FG001|Overall Study|Death|9|||
46885679|NCT04429503|83107842|FG002|Overall Study|Death|4|||
46885680|NCT04408924|83107850|FG000|Overall Study|On Study Treatment|3|||
46885681|NCT04408924|83107850|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
46885682|NCT04408924|83107850|FG000|Overall Study|Lost to Follow-up|1|||
46885683|NCT04408924|83107850|FG000|Overall Study|Withdrawal by Subject|7|||
46885684|NCT04400487|83107854|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
46885685|NCT04400487|83107854|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
46885686|NCT04400487|83107854|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
46885687|NCT04258254|83107862|FG000|Overall Study|Withdrawal by Subject|0|||
46885688|NCT04258254|83107863|FG001|Overall Study|Withdrawal by Subject|1|||
46885689|NCT04258254|83107864|FG002|Overall Study|Withdrawal by Subject|0|||
46885690|NCT04247594|83107872|FG000|Overall Study|Withdrawal by Subject|4|||
46885691|NCT03954704|83107919|FG000|Overall Study|Death|1|||
46885692|NCT03954704|83107920|FG001|Overall Study|Death|1|||
46885693|NCT03954704|83107921|FG002|Overall Study|Death|1|||
46885694|NCT03954704|83107922|FG003|Overall Study|Death|3|||
46885695|NCT03954704|83107923|FG004|Overall Study|Death|2|||
46885696|NCT03954704|83107924|FG005|Overall Study|Death|2|||
46885697|NCT03954704|83107925|FG006|Overall Study|Death|0|||
46885698|NCT03954704|83107919|FG000|Overall Study|Withdrew Consent|0|||
46885699|NCT03954704|83107920|FG001|Overall Study|Withdrew Consent|0|||
46885700|NCT03954704|83107921|FG002|Overall Study|Withdrew Consent|1|||
46885701|NCT03954704|83107922|FG003|Overall Study|Withdrew Consent|0|||
46885702|NCT03954704|83107923|FG004|Overall Study|Withdrew Consent|0|||
46885703|NCT03954704|83107924|FG005|Overall Study|Withdrew Consent|1|||
46885704|NCT03954704|83107925|FG006|Overall Study|Withdrew Consent|0|||
46885705|NCT03954704|83107919|FG000|Overall Study|Lost to Follow-up|0|||
46885706|NCT03954704|83107920|FG001|Overall Study|Lost to Follow-up|0|||
46885707|NCT03954704|83107921|FG002|Overall Study|Lost to Follow-up|0|||
46885708|NCT03954704|83107922|FG003|Overall Study|Lost to Follow-up|0|||
46885709|NCT03954704|83107923|FG004|Overall Study|Lost to Follow-up|0|||
46885710|NCT03954704|83107924|FG005|Overall Study|Lost to Follow-up|0|||
46885711|NCT03954704|83107925|FG006|Overall Study|Lost to Follow-up|1|||
46885712|NCT03954704|83107919|FG000|Overall Study|Study Terminated by Sponsor|0|||
46885713|NCT03954704|83107920|FG001|Overall Study|Study Terminated by Sponsor|0|||
46885714|NCT03954704|83107921|FG002|Overall Study|Study Terminated by Sponsor|1|||
46885715|NCT03954704|83107922|FG003|Overall Study|Study Terminated by Sponsor|0|||
46885716|NCT03954704|83107923|FG004|Overall Study|Study Terminated by Sponsor|1|||
46885717|NCT03954704|83107924|FG005|Overall Study|Study Terminated by Sponsor|4|||
46885718|NCT03954704|83107925|FG006|Overall Study|Study Terminated by Sponsor|2|||
46885719|NCT03954704|83107919|FG000|Overall Study|Enrolled but not Treated|0|||
46885720|NCT03954704|83107920|FG001|Overall Study|Enrolled but not Treated|0|||
46885721|NCT03954704|83107921|FG002|Overall Study|Enrolled but not Treated|0|||
46885722|NCT03954704|83107922|FG003|Overall Study|Enrolled but not Treated|0|||
46885723|NCT03954704|83107923|FG004|Overall Study|Enrolled but not Treated|0|||
46885724|NCT03954704|83107924|FG005|Overall Study|Enrolled but not Treated|1|||
46885725|NCT03954704|83107925|FG006|Overall Study|Enrolled but not Treated|0|||
46885726|NCT03653390|83107966|FG000|Overall Study|Lost to Follow-up|12|||
46885727|NCT03653390|83107967|FG001|Overall Study|Lost to Follow-up|8|||
46885728|NCT03653390|83107968|FG002|Overall Study|Lost to Follow-up|7|||
46885729|NCT03653390|83107966|FG000|Overall Study|Withdrawal by Subject|6|||
46885730|NCT03653390|83107967|FG001|Overall Study|Withdrawal by Subject|1|||
46885731|NCT03653390|83107968|FG002|Overall Study|Withdrawal by Subject|1|||
46885732|NCT03653390|83107966|FG000|Overall Study|Death|1|||
46885733|NCT03653390|83107967|FG001|Overall Study|Death|0|||
46885734|NCT03653390|83107968|FG002|Overall Study|Death|0|||
46885735|NCT03653390|83107966|FG000|Overall Study|Paper Survey Lost|1|||
46885736|NCT03653390|83107967|FG001|Overall Study|Paper Survey Lost|0|||
46885737|NCT03653390|83107968|FG002|Overall Study|Paper Survey Lost|0|||
46885738|NCT03366844|83107976|FG000|Overall Study|Physician Decision|1|||
46885739|NCT03366844|83107976|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
46885740|NCT02739035|83108002|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
46885741|NCT02739035|83108003|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
46885742|NCT02739035|83108002|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
46885743|NCT02739035|83108003|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
46885744|NCT02739035|83108002|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
46885745|NCT02739035|83108003|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
46885746|NCT02739035|83108002|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
46885747|NCT02739035|83108003|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
46885748|NCT02657434|83108023|FG000|Overall Study|Study Terminated By Sponsor|64|||
46885749|NCT02657434|83108024|FG001|Overall Study|Study Terminated By Sponsor|82|||
46885750|NCT02657434|83108023|FG000|Overall Study|Death|189|||
46885751|NCT02657434|83108024|FG001|Overall Study|Death|190|||
46885752|NCT02657434|83108023|FG000|Overall Study|Lost to Follow-up|2|||
46885753|NCT02657434|83108024|FG001|Overall Study|Lost to Follow-up|2|||
46885754|NCT02657434|83108023|FG000|Overall Study|Randomization by Error|2|||
46885755|NCT02657434|83108024|FG001|Overall Study|Randomization by Error|0|||
46885756|NCT02657434|83108023|FG000|Overall Study|Withdrawal by Subject|28|||
46885757|NCT02657434|83108024|FG001|Overall Study|Withdrawal by Subject|17|||
46885758|NCT02657434|83108023|FG000|Overall Study|Protocol Violation|1|||
46885759|NCT02657434|83108024|FG001|Overall Study|Protocol Violation|0|||
46885760|NCT02657434|83108023|FG000|Overall Study|Physician Decision|0|||
46885761|NCT02657434|83108024|FG001|Overall Study|Physician Decision|1|||
46885762|NCT02656290|83108031|FG000|Overall Study|Lost to Follow-up|1|||
46885763|NCT02656290|83108031|FG000|Overall Study|Reintervention|3|||
46885764|NCT02255149|83108043|FG000|Overall Study|Lost to Follow-up|2|||
46885765|NCT02255149|83108043|FG000|Overall Study|Withdrawal by Subject|1|||
46885766|NCT02255149|83108043|FG000|Overall Study|Withdrawal by PI|1|||
46885767|NCT02255149|83108043|FG000|Overall Study|Implant Failure|1|||
46885768|NCT01193842|83108064|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
46885769|NCT01193842|83108065|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
46885770|NCT01193842|83108066|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
46885771|NCT01193842|83108067|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
46885772|NCT01193842|83108068|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
46885773|NCT01193842|83108064|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
46885774|NCT01193842|83108065|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
46885775|NCT01193842|83108066|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
46885776|NCT01193842|83108067|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
46885777|NCT01193842|83108068|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
46885778|NCT01193842|83108064|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
46885779|NCT01193842|83108065|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
46885780|NCT01193842|83108066|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
46885781|NCT01193842|83108067|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
46885782|NCT01193842|83108068|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
46885783|NCT01193842|83108064|FG000|Phase II: Randomized Groups|Death|0|||
46885784|NCT01193842|83108065|FG001|Phase II: Randomized Groups|Death|0|||
46885785|NCT01193842|83108066|FG002|Phase II: Randomized Groups|Death|0|||
46885786|NCT01193842|83108067|FG003|Phase II: Randomized Groups|Death|1|||
46885787|NCT01193842|83108068|FG004|Phase II: Randomized Groups|Death|1|||
46885788|NCT01193842|83108064|FG000|Phase II: Randomized Groups|Adverse Event|0|||
46885789|NCT01193842|83108065|FG001|Phase II: Randomized Groups|Adverse Event|0|||
46885790|NCT01193842|83108066|FG002|Phase II: Randomized Groups|Adverse Event|0|||
46885791|NCT01193842|83108067|FG003|Phase II: Randomized Groups|Adverse Event|5|||
46885792|NCT01193842|83108068|FG004|Phase II: Randomized Groups|Adverse Event|3|||
46885793|NCT01193842|83108064|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
46885794|NCT01193842|83108065|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
46885795|NCT01193842|83108066|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
46885796|NCT01193842|83108067|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
46885797|NCT01193842|83108068|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
46885798|NCT01193842|83108064|FG000|Phase II: Randomized Groups|Ineligible|0|||
46885799|NCT01193842|83108065|FG001|Phase II: Randomized Groups|Ineligible|0|||
46885800|NCT01193842|83108066|FG002|Phase II: Randomized Groups|Ineligible|0|||
46885801|NCT01193842|83108067|FG003|Phase II: Randomized Groups|Ineligible|0|||
46885802|NCT01193842|83108068|FG004|Phase II: Randomized Groups|Ineligible|1|||
46885803|NCT01193842|83108064|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
46885804|NCT01193842|83108065|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
46885805|NCT01193842|83108066|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
46885806|NCT01193842|83108067|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
46885807|NCT01193842|83108068|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
46885808|NCT00855465|83108092|FG000|Treatment Period|Adverse Event|4|||
46885809|NCT00855465|83108093|FG001|Treatment Period|Adverse Event|2|||
46885810|NCT00855465|83108092|FG000|Treatment Period|Death|2|||
46885811|NCT00855465|83108093|FG001|Treatment Period|Death|2|||
46885812|NCT00855465|83108092|FG000|Treatment Period|Lack of Efficacy|2|||
46885813|NCT00855465|83108093|FG001|Treatment Period|Lack of Efficacy|1|||
46885814|NCT00855465|83108092|FG000|Treatment Period|Non-compliance|1|||
46885815|NCT00855465|83108093|FG001|Treatment Period|Non-compliance|0|||
46885816|NCT00855465|83108092|FG000|Treatment Period|Protocol Violation|2|||
46885817|NCT00855465|83108093|FG001|Treatment Period|Protocol Violation|0|||
46885818|NCT00855465|83108092|FG000|Treatment Period|Withdrawal by Subject|2|||
46885819|NCT00855465|83108093|FG001|Treatment Period|Withdrawal by Subject|0|||
46885820|NCT00855465|83108092|FG000|Treatment Period|Not treated|1|||
46885821|NCT00855465|83108093|FG001|Treatment Period|Not treated|0|||
46885822|NCT00855465|83108092|FG000|Follow-up Period (FUP)|Adverse Event|0|||
46885823|NCT00855465|83108093|FG001|Follow-up Period (FUP)|Adverse Event|1|||
46885824|NCT00855465|83108092|FG000|Follow-up Period (FUP)|Death|0|||
46885825|NCT00855465|83108093|FG001|Follow-up Period (FUP)|Death|1|||
46885826|NCT00855465|83108092|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
46885827|NCT00855465|83108093|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
46885828|NCT00855465|83108092|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
46885829|NCT00855465|83108093|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
46885830|NCT00855465|83108092|FG000|Follow-up Period (FUP)|Missing|1|||
46885831|NCT00855465|83108093|FG001|Follow-up Period (FUP)|Missing|0|||
46885832|NCT00098475|83108101|FG000|Step 1|Progressive disease|33|||
46885833|NCT00098475|83108102|FG001|Step 1|Progressive disease|35|||
46885834|NCT00098475|83108103|FG002|Step 1|Progressive disease|2|||
46885835|NCT00098475|83108104|FG003|Step 1|Progressive disease|1|||
46885836|NCT00098475|83108101|FG000|Step 1|Adverse Event|56|||
46885837|NCT00098475|83108102|FG001|Step 1|Adverse Event|37|||
46885838|NCT00098475|83108103|FG002|Step 1|Adverse Event|0|||
46885839|NCT00098475|83108104|FG003|Step 1|Adverse Event|1|||
46885840|NCT00098475|83108101|FG000|Step 1|Death|8|||
46885841|NCT00098475|83108102|FG001|Step 1|Death|5|||
46885842|NCT00098475|83108103|FG002|Step 1|Death|0|||
46885843|NCT00098475|83108104|FG003|Step 1|Death|1|||
46885844|NCT00098475|83108101|FG000|Step 1|Withdrawal by Subject|14|||
46885845|NCT00098475|83108102|FG001|Step 1|Withdrawal by Subject|11|||
46885846|NCT00098475|83108103|FG002|Step 1|Withdrawal by Subject|0|||
46885847|NCT00098475|83108104|FG003|Step 1|Withdrawal by Subject|0|||
46885848|NCT00098475|83108101|FG000|Step 1|Physician Decision|5|||
46885849|NCT00098475|83108102|FG001|Step 1|Physician Decision|2|||
46885850|NCT00098475|83108103|FG002|Step 1|Physician Decision|0|||
46885851|NCT00098475|83108104|FG003|Step 1|Physician Decision|0|||
46885852|NCT00098475|83108101|FG000|Step 1|Alternative therapy|31|||
46885853|NCT00098475|83108102|FG001|Step 1|Alternative therapy|43|||
46885854|NCT00098475|83108103|FG002|Step 1|Alternative therapy|1|||
46885855|NCT00098475|83108104|FG003|Step 1|Alternative therapy|0|||
46885856|NCT00098475|83108101|FG000|Step 1|Other disease|2|||
46885857|NCT00098475|83108102|FG001|Step 1|Other disease|1|||
46885858|NCT00098475|83108103|FG002|Step 1|Other disease|1|||
46885859|NCT00098475|83108104|FG003|Step 1|Other disease|0|||
46885860|NCT00098475|83108101|FG000|Step 1|Never started treatment|0|||
46885861|NCT00098475|83108102|FG001|Step 1|Never started treatment|2|||
46885862|NCT00098475|83108103|FG002|Step 1|Never started treatment|0|||
46885863|NCT00098475|83108104|FG003|Step 1|Never started treatment|0|||
46885864|NCT00098475|83108101|FG000|Step 1|Still on treatment as of this analysis|14|||
46885865|NCT00098475|83108102|FG001|Step 1|Still on treatment as of this analysis|27|||
46885866|NCT00098475|83108103|FG002|Step 1|Still on treatment as of this analysis|0|||
46885867|NCT00098475|83108104|FG003|Step 1|Still on treatment as of this analysis|0|||
46885868|NCT00098475|83108101|FG000|Step 1|Knee surgery|1|||
46885869|NCT00098475|83108102|FG001|Step 1|Knee surgery|0|||
46991237|NCT02187471|83238188|FG001|Overall Study|Adverse Event|34|||
46885870|NCT00098475|83108103|FG002|Step 1|Knee surgery|0|||
46885871|NCT00098475|83108104|FG003|Step 1|Knee surgery|0|||
46885872|NCT00098475|83108101|FG000|Step 1|Complications|1|||
46885873|NCT00098475|83108102|FG001|Step 1|Complications|0|||
46885874|NCT00098475|83108103|FG002|Step 1|Complications|0|||
46991238|NCT02187471|83238189|FG002|Overall Study|Adverse Event|44|||
46885875|NCT00098475|83108104|FG003|Step 1|Complications|0|||
46885876|NCT00098475|83108101|FG000|Step 1|Cannot comply due to other tx|0|||
46705267|NCT00938470|82920126|FG000|Overall Study|Alternate Treatment|1|||
46885877|NCT00098475|83108102|FG001|Step 1|Cannot comply due to other tx|1|||
46885878|NCT00098475|83108103|FG002|Step 1|Cannot comply due to other tx|0|||
46705268|NCT00938470|82920127|FG001|Overall Study|Alternate Treatment|0|||
46705269|NCT00938470|82920126|FG000|Overall Study|Death|3|||
46705270|NCT00938470|82920127|FG001|Overall Study|Death|2|||
46705271|NCT00938470|82920126|FG000|Overall Study|Other Reason|0|||
46705272|NCT00938470|82920127|FG001|Overall Study|Other Reason|1|||
46705273|NCT00938392|82920135|FG000|Overall Study|Adverse Event|0|||
46705274|NCT00938392|82920136|FG001|Overall Study|Adverse Event|1|||
46705275|NCT00938392|82920135|FG000|Overall Study|Withdrawal by Subject|0|||
46705276|NCT00938392|82920136|FG001|Overall Study|Withdrawal by Subject|1|||
46705277|NCT00938392|82920135|FG000|Overall Study|Lost to Follow-up|2|||
46705278|NCT00938392|82920136|FG001|Overall Study|Lost to Follow-up|2|||
46705279|NCT01022853|82920147|FG000|Overall Study|Progressive disease|2|||
46705280|NCT01022853|82920148|FG001|Overall Study|Progressive disease|3|||
46705281|NCT01022853|82920149|FG002|Overall Study|Progressive disease|11|||
46705282|NCT01022853|82920150|FG003|Overall Study|Progressive disease|7|||
46705283|NCT01022853|82920151|FG004|Overall Study|Progressive disease|1|||
46705284|NCT01022853|82920147|FG000|Overall Study|Dose-limiting toxicity|0|||
46705285|NCT01022853|82920148|FG001|Overall Study|Dose-limiting toxicity|0|||
46705286|NCT01022853|82920149|FG002|Overall Study|Dose-limiting toxicity|0|||
46705287|NCT01022853|82920150|FG003|Overall Study|Dose-limiting toxicity|0|||
46705288|NCT01022853|82920151|FG004|Overall Study|Dose-limiting toxicity|1|||
46705289|NCT01022853|82920147|FG000|Overall Study|Withdrawal by Subject|0|||
46705290|NCT01022853|82920148|FG001|Overall Study|Withdrawal by Subject|1|||
46705291|NCT01022853|82920149|FG002|Overall Study|Withdrawal by Subject|1|||
46705292|NCT01022853|82920150|FG003|Overall Study|Withdrawal by Subject|1|||
46705293|NCT01022853|82920151|FG004|Overall Study|Withdrawal by Subject|0|||
46705294|NCT01022853|82920147|FG000|Overall Study|Other not stated above|1|||
46705295|NCT01022853|82920148|FG001|Overall Study|Other not stated above|0|||
46705296|NCT01022853|82920149|FG002|Overall Study|Other not stated above|1|||
46705297|NCT01022853|82920150|FG003|Overall Study|Other not stated above|0|||
46705298|NCT01022853|82920151|FG004|Overall Study|Other not stated above|0|||
46705299|NCT01034709|82920168|FG000|Overall Study|Protocol Violation|9|||
46705300|NCT01034709|82920169|FG001|Overall Study|Protocol Violation|16|||
46705301|NCT00937768|82920177|FG000|Overall Study|Refused Further Treatment|3|||
46705302|NCT00937768|82920178|FG001|Overall Study|Refused Further Treatment|2|||
46705303|NCT00937768|82920177|FG000|Overall Study|Disease Progression|1|||
46705304|NCT00937768|82920178|FG001|Overall Study|Disease Progression|1|||
46705305|NCT00937768|82920177|FG000|Overall Study|Alternate Treatment|0|||
46705306|NCT00937768|82920178|FG001|Overall Study|Alternate Treatment|1|||
46705307|NCT00937768|82920177|FG000|Overall Study|No Further Funding|4|||
46705308|NCT00937768|82920178|FG001|Overall Study|No Further Funding|4|||
46705309|NCT00940888|82920184|FG000|Overall Study|Unsuccessful Implant|4|||
46705310|NCT00940888|82920184|FG000|Overall Study|Death|461|||
46991239|NCT02187471|83238190|FG003|Overall Study|Adverse Event|36|||
46705311|NCT00940888|82920184|FG000|Overall Study|Withdrawn - Non-Death|364|||
46705312|NCT00940888|82920184|FG000|Overall Study|Lost to Follow-up|6|||
46705313|NCT01189266|82920191|FG000|Overall Study|Adverse Event|1|||
46705314|NCT01189266|82920192|FG001|Overall Study|Adverse Event|0|||
46705315|NCT01189266|82920193|FG002|Overall Study|Adverse Event|5|||
46705316|NCT01189266|82920191|FG000|Overall Study|Death|0|||
46991240|NCT02187471|83238187|FG000|Overall Study|Withdrawal by Subject|23|||
46991241|NCT02187471|83238188|FG001|Overall Study|Withdrawal by Subject|29|||
46991242|NCT02187471|83238189|FG002|Overall Study|Withdrawal by Subject|22|||
46991243|NCT02187471|83238190|FG003|Overall Study|Withdrawal by Subject|24|||
46991244|NCT02187471|83238187|FG000|Overall Study|Other|7|||
46991245|NCT02187471|83238188|FG001|Overall Study|Other|5|||
46991246|NCT02187471|83238189|FG002|Overall Study|Other|3|||
46991247|NCT02187471|83238190|FG003|Overall Study|Other|4|||
46991248|NCT02525471|83238201|FG000|Overall Study|Screen Failure|6|||
46991249|NCT02525471|83238201|FG000|Overall Study|Withdrawal by Subject|4|||
46991250|NCT02525471|83238201|FG000|Overall Study|Death|1|||
46991251|NCT01658735|83238209|FG000|Overall Study|Lack of Efficacy|1|||
46991252|NCT01658735|83238210|FG001|Overall Study|Lack of Efficacy|0|||
46991253|NCT01658735|83238211|FG002|Overall Study|Lack of Efficacy|1|||
46991254|NCT01658735|83238209|FG000|Overall Study|Lost to Follow-up|1|||
46991255|NCT01658735|83238210|FG001|Overall Study|Lost to Follow-up|1|||
46991256|NCT01658735|83238211|FG002|Overall Study|Lost to Follow-up|0|||
46991257|NCT01658735|83238209|FG000|Overall Study|Protocol Violation|0|||
46991258|NCT01658735|83238210|FG001|Overall Study|Protocol Violation|1|||
46991259|NCT01658735|83238211|FG002|Overall Study|Protocol Violation|0|||
46991260|NCT01658735|83238209|FG000|Overall Study|Withdrawal by Subject|3|||
46991261|NCT01658735|83238210|FG001|Overall Study|Withdrawal by Subject|5|||
46705317|NCT01189266|82920192|FG001|Overall Study|Death|0|||
46991262|NCT01658735|83238211|FG002|Overall Study|Withdrawal by Subject|3|||
46705318|NCT01189266|82920193|FG002|Overall Study|Death|5|||
46705319|NCT01189266|82920191|FG000|Overall Study|Lack of Efficacy|4|||
46705320|NCT01189266|82920192|FG001|Overall Study|Lack of Efficacy|5|||
46705321|NCT01189266|82920193|FG002|Overall Study|Lack of Efficacy|44|||
46705322|NCT01189266|82920191|FG000|Overall Study|Physician Decision|0|||
46705323|NCT01189266|82920192|FG001|Overall Study|Physician Decision|0|||
46705324|NCT01189266|82920193|FG002|Overall Study|Physician Decision|1|||
46705325|NCT01189266|82920191|FG000|Overall Study|Protocol Violation|0|||
46705326|NCT01189266|82920192|FG001|Overall Study|Protocol Violation|1|||
46885879|NCT00098475|83108104|FG003|Step 1|Cannot comply due to other tx|0|||
46885880|NCT00098475|83108101|FG000|Step 1|Both patient and physician's decision|2|||
46705327|NCT01189266|82920193|FG002|Overall Study|Protocol Violation|1|||
46705328|NCT01189266|82920191|FG000|Overall Study|Withdrawal by Subject|0|||
46705329|NCT01189266|82920192|FG001|Overall Study|Withdrawal by Subject|0|||
46705330|NCT01189266|82920193|FG002|Overall Study|Withdrawal by Subject|1|||
46705331|NCT01189266|82920191|FG000|Overall Study|Patient refuses further therapy|1|||
46705332|NCT01189266|82920192|FG001|Overall Study|Patient refuses further therapy|0|||
46705333|NCT01189266|82920193|FG002|Overall Study|Patient refuses further therapy|7|||
46705334|NCT01189266|82920191|FG000|Overall Study|No treatment|0|||
46705335|NCT01189266|82920192|FG001|Overall Study|No treatment|0|||
46705336|NCT01189266|82920193|FG002|Overall Study|No treatment|1|||
46705337|NCT01189032|82920205|FG000|Overall Study|Adverse Event|1|||
46705338|NCT01189032|82920206|FG001|Overall Study|Adverse Event|3|||
46705339|NCT01189032|82920207|FG002|Overall Study|Adverse Event|4|||
46705340|NCT01189032|82920205|FG000|Overall Study|Lack of Efficacy|2|||
46705341|NCT01189032|82920206|FG001|Overall Study|Lack of Efficacy|3|||
46705342|NCT01189032|82920207|FG002|Overall Study|Lack of Efficacy|0|||
46705343|NCT01189032|82920205|FG000|Overall Study|Withdrawal by Subject|1|||
46705344|NCT01189032|82920206|FG001|Overall Study|Withdrawal by Subject|0|||
46705345|NCT01189032|82920207|FG002|Overall Study|Withdrawal by Subject|1|||
46705346|NCT01189032|82920205|FG000|Overall Study|Protocol Violation|1|||
46705347|NCT01189032|82920206|FG001|Overall Study|Protocol Violation|1|||
46705348|NCT01189032|82920207|FG002|Overall Study|Protocol Violation|1|||
46705349|NCT01188798|82920217|FG000|Overall Study|Death|0|||
46705350|NCT01188798|82920218|FG001|Overall Study|Death|1|||
46705351|NCT01188798|82920217|FG000|Overall Study|Required additional transplant|1|||
46705352|NCT01188798|82920218|FG001|Overall Study|Required additional transplant|1|||
46705353|NCT01188798|82920217|FG000|Overall Study|Protocol closure|1|||
46885881|NCT00098475|83108102|FG001|Step 1|Both patient and physician's decision|1|||
46991263|NCT02523599|83238221|FG000|Overall Study|Adverse Event|1|||
46705354|NCT01188798|82920218|FG001|Overall Study|Protocol closure|1|||
46705355|NCT01183104|82920227|FG000|Overall Study|Adverse Event|8|||
46705356|NCT01183104|82920228|FG001|Overall Study|Adverse Event|6|||
46705357|NCT01183104|82920227|FG000|Overall Study|Death|0|||
46705358|NCT01183104|82920228|FG001|Overall Study|Death|1|||
46705359|NCT01183104|82920227|FG000|Overall Study|Lost to Follow-up|14|||
46705360|NCT01183104|82920228|FG001|Overall Study|Lost to Follow-up|7|||
46885882|NCT00098475|83108103|FG002|Step 1|Both patient and physician's decision|0|||
46885883|NCT00098475|83108104|FG003|Step 1|Both patient and physician's decision|0|||
46885884|NCT00098475|83108101|FG000|Step 1|Incorrect disease assessment|2|||
46885885|NCT00098475|83108102|FG001|Step 1|Incorrect disease assessment|0|||
46885886|NCT00098475|83108103|FG002|Step 1|Incorrect disease assessment|0|||
46885887|NCT00098475|83108104|FG003|Step 1|Incorrect disease assessment|0|||
46885888|NCT00098475|83108101|FG000|Step 1|Off treatment for > specified timeframe|1|||
46885889|NCT00098475|83108102|FG001|Step 1|Off treatment for > specified timeframe|1|||
46885890|NCT00098475|83108103|FG002|Step 1|Off treatment for > specified timeframe|0|||
46705361|NCT01183104|82920227|FG000|Overall Study|Physician Decision|5|||
46705362|NCT01183104|82920228|FG001|Overall Study|Physician Decision|8|||
46705363|NCT01183104|82920227|FG000|Overall Study|Withdrawal by Subject|6|||
46705364|NCT01183104|82920228|FG001|Overall Study|Withdrawal by Subject|11|||
46705365|NCT01183104|82920227|FG000|Overall Study|Nonparticipation in Extension Study|39|||
46991264|NCT02523599|83238222|FG001|Overall Study|Adverse Event|0|||
46991265|NCT02523599|83238221|FG000|Overall Study|Physician Decision|1|||
46991266|NCT02523599|83238222|FG001|Overall Study|Physician Decision|0|||
46991267|NCT02523599|83238221|FG000|Overall Study|Lost to Follow-up|4|||
46991268|NCT02523599|83238222|FG001|Overall Study|Lost to Follow-up|1|||
46991269|NCT02523599|83238221|FG000|Overall Study|Did not return for Day 30 visit|2|||
46991270|NCT02523599|83238222|FG001|Overall Study|Did not return for Day 30 visit|0|||
46991271|NCT02187159|83238232|FG000|Overall Study|Protocol Violation|4|||
46991272|NCT02187159|83238233|FG001|Overall Study|Protocol Violation|6|||
46705366|NCT01183104|82920228|FG001|Overall Study|Nonparticipation in Extension Study|50|||
46705367|NCT01183104|82920227|FG000|Overall Study|Did not receive study drug|5|||
46705368|NCT01183104|82920228|FG001|Overall Study|Did not receive study drug|9|||
46705369|NCT01163292|82920236|FG000|Overall Study|Lack of Efficacy|9|||
46705370|NCT01163292|82920237|FG001|Overall Study|Lack of Efficacy|0|||
46705371|NCT01163292|82920236|FG000|Overall Study|Adverse Event|6|||
46705372|NCT01163292|82920237|FG001|Overall Study|Adverse Event|0|||
46705373|NCT01163292|82920236|FG000|Overall Study|Initiation of biological therapy|0|||
46705374|NCT01163292|82920237|FG001|Overall Study|Initiation of biological therapy|15|||
46705375|NCT01163292|82920236|FG000|Overall Study|Sufficient response to adalimumab|8|||
46705376|NCT01163292|82920237|FG001|Overall Study|Sufficient response to adalimumab|0|||
46705377|NCT01163292|82920236|FG000|Overall Study|Refusal to receive adalimumab|7|||
46705378|NCT01163292|82920237|FG001|Overall Study|Refusal to receive adalimumab|0|||
46705379|NCT01163292|82920236|FG000|Overall Study|Economic reasons|6|||
46705380|NCT01163292|82920237|FG001|Overall Study|Economic reasons|0|||
46705381|NCT01163292|82920236|FG000|Overall Study|No further visits|5|||
46705382|NCT01163292|82920237|FG001|Overall Study|No further visits|7|||
46705383|NCT00950248|82920245|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
46705384|NCT00950248|82920246|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
46705385|NCT00950248|82920247|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
46705386|NCT00950248|82920245|FG000|Year 1: Baseline|worsening of symptoms|2|||
46705387|NCT00950248|82920246|FG001|Year 1: Baseline|worsening of symptoms|0|||
46705388|NCT00950248|82920247|FG002|Year 1: Baseline|worsening of symptoms|0|||
46705389|NCT00950248|82920245|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
46705390|NCT00950248|82920246|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
46705391|NCT00950248|82920247|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
46705392|NCT00950248|82920245|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
46705393|NCT00950248|82920246|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
46705394|NCT00950248|82920247|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
46705395|NCT00950248|82920245|FG000|Year 2&3 Treatment Randomization|Death|0|||
46705396|NCT00950248|82920246|FG001|Year 2&3 Treatment Randomization|Death|0|||
46705397|NCT00950248|82920247|FG002|Year 2&3 Treatment Randomization|Death|1|||
46705398|NCT00950248|82920245|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
46705399|NCT00950248|82920246|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
46705400|NCT00950248|82920247|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
46705401|NCT00950170|82920254|FG000|Overall Study|Parent/Legal Guardian Request|1|||
46705402|NCT00950170|82920254|FG000|Overall Study|Adverse Event|2|||
46705403|NCT00950170|82920254|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
46705404|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
46705405|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
46705406|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
46705407|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
46705408|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
46705409|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
46705410|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
46705411|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
46705412|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
46705413|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
46705414|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
46705415|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
46705416|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
46705417|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
46705418|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
46705419|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
46705420|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
46705421|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
46705422|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
46705423|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
46705424|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
46705425|NCT01227824|82920278|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
46705426|NCT01227824|82920279|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
46705427|NCT01227824|82920280|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
46705428|NCT01227824|82920278|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
46705429|NCT01227824|82920279|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
46705430|NCT01227824|82920280|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
46705431|NCT01227824|82920278|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
46705432|NCT01227824|82920279|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
46705433|NCT01227824|82920280|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
46705434|NCT01227824|82920278|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
46705435|NCT01227824|82920279|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
46705436|NCT01227824|82920280|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
46705437|NCT01227824|82920278|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
46705438|NCT01227824|82920279|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
46705439|NCT01227824|82920280|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
46705440|NCT01227824|82920278|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
46705441|NCT01227824|82920279|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
46705442|NCT01227824|82920280|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
46705443|NCT01227824|82920278|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
46705444|NCT01227824|82920279|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
46705445|NCT01227824|82920280|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
46705446|NCT01227824|82920278|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
46705447|NCT01227824|82920279|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
46705448|NCT01227824|82920280|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
46705449|NCT00949702|82920287|FG000|Overall Study|Death|40|||
46705450|NCT00949702|82920287|FG000|Overall Study|Disease progression|7|||
46705451|NCT00949702|82920287|FG000|Overall Study|Withdrawal of consent|1|||
46705452|NCT01034631|82920294|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
46705453|NCT01034631|82920295|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
46705454|NCT01034631|82920296|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
46705455|NCT01034631|82920294|FG000|Phase II|Not Evaluable per protocol|0|||
46705456|NCT01034631|82920295|FG001|Phase II|Not Evaluable per protocol|0|||
46705457|NCT01034631|82920296|FG002|Phase II|Not Evaluable per protocol|2|||
46705458|NCT01034631|82920294|FG000|Phase II|Determined Ineligible per protocol|0|||
46705459|NCT01034631|82920295|FG001|Phase II|Determined Ineligible per protocol|1|||
46705460|NCT01034631|82920296|FG002|Phase II|Determined Ineligible per protocol|0|||
46705461|NCT01227668|82920308|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
46705462|NCT01227668|82920309|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
46705463|NCT01227668|82920308|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
46705464|NCT01227668|82920309|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
46705465|NCT01227668|82920308|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
46705466|NCT01227668|82920309|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
46705467|NCT01227668|82920308|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
46705468|NCT01227668|82920309|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
46705469|NCT01227668|82920308|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
46705470|NCT01227668|82920309|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
46705471|NCT01227668|82920308|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
46705472|NCT01227668|82920309|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
46705473|NCT01227668|82920308|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
46705474|NCT01227668|82920309|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
46705475|NCT01227668|82920308|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
46705476|NCT01227668|82920309|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
46705477|NCT01227668|82920308|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
46705478|NCT01227668|82920309|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
46705479|NCT01227668|82920308|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
46705480|NCT01227668|82920309|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
46705481|NCT01227668|82920308|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
46705482|NCT01227668|82920309|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
46705483|NCT01227668|82920308|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
46705484|NCT01227668|82920309|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
46705485|NCT01227512|82920321|FG000|Overall Study|Physician Decision|6|||
46705486|NCT01227512|82920322|FG001|Overall Study|Physician Decision|6|||
46705487|NCT01227512|82920321|FG000|Overall Study|Adverse Event|4|||
46885891|NCT00098475|83108104|FG003|Step 1|Off treatment for > specified timeframe|0|||
46885892|NCT00098475|83108101|FG000|Step 1|Declining performance status|0|||
46885893|NCT00098475|83108102|FG001|Step 1|Declining performance status|1|||
46885894|NCT00098475|83108103|FG002|Step 1|Declining performance status|0|||
46885895|NCT00098475|83108104|FG003|Step 1|Declining performance status|0|||
46885896|NCT00098475|83108101|FG000|Step 1|Insurance issue|0|||
46885897|NCT00098475|83108102|FG001|Step 1|Insurance issue|1|||
46885898|NCT00098475|83108103|FG002|Step 1|Insurance issue|0|||
46885899|NCT00098475|83108104|FG003|Step 1|Insurance issue|0|||
46885900|NCT00098475|83108101|FG000|Step 1|Rising paraprotein|0|||
46885901|NCT00098475|83108102|FG001|Step 1|Rising paraprotein|1|||
46885902|NCT00098475|83108103|FG002|Step 1|Rising paraprotein|0|||
46885903|NCT00098475|83108104|FG003|Step 1|Rising paraprotein|0|||
46885904|NCT00098475|83108101|FG000|Step 1|Referred to other physicians|0|||
46885905|NCT00098475|83108102|FG001|Step 1|Referred to other physicians|1|||
46885906|NCT00098475|83108103|FG002|Step 1|Referred to other physicians|0|||
46885907|NCT00098475|83108104|FG003|Step 1|Referred to other physicians|0|||
46885908|NCT00098475|83108101|FG000|Step 1|Criteria to continue treatment not met|0|||
46885909|NCT00098475|83108102|FG001|Step 1|Criteria to continue treatment not met|1|||
46885910|NCT00098475|83108103|FG002|Step 1|Criteria to continue treatment not met|0|||
46885911|NCT00098475|83108104|FG003|Step 1|Criteria to continue treatment not met|0|||
46885912|NCT00098475|83108101|FG000|Step 1|Misinterpretation of lab data|0|||
46885913|NCT00098475|83108102|FG001|Step 1|Misinterpretation of lab data|1|||
46885914|NCT00098475|83108103|FG002|Step 1|Misinterpretation of lab data|0|||
46885915|NCT00098475|83108104|FG003|Step 1|Misinterpretation of lab data|0|||
46885916|NCT00098475|83108101|FG000|Step 1|Patient fell with fracture|1|||
46885917|NCT00098475|83108102|FG001|Step 1|Patient fell with fracture|0|||
46885918|NCT00098475|83108103|FG002|Step 1|Patient fell with fracture|0|||
46885919|NCT00098475|83108104|FG003|Step 1|Patient fell with fracture|0|||
46885920|NCT00098475|83108101|FG000|Step 1|Not documented|0|||
46885921|NCT00098475|83108102|FG001|Step 1|Not documented|1|||
46885922|NCT00098475|83108103|FG002|Step 1|Not documented|0|||
46885923|NCT00098475|83108104|FG003|Step 1|Not documented|0|||
46885924|NCT00098475|83108101|FG000|Step 2|Disease progression|1|||
46885925|NCT00098475|83108102|FG001|Step 2|Disease progression|4|||
46885926|NCT00098475|83108103|FG002|Step 2|Disease progression|0|||
46885927|NCT00098475|83108104|FG003|Step 2|Disease progression|0|||
46885928|NCT00098475|83108101|FG000|Step 2|Adverse Event|2|||
46885929|NCT00098475|83108102|FG001|Step 2|Adverse Event|0|||
46885930|NCT00098475|83108103|FG002|Step 2|Adverse Event|0|||
46885931|NCT00098475|83108104|FG003|Step 2|Adverse Event|0|||
46885932|NCT00098475|83108101|FG000|Step 2|Withdrawal by Subject|0|||
46885933|NCT00098475|83108102|FG001|Step 2|Withdrawal by Subject|2|||
46885934|NCT00098475|83108103|FG002|Step 2|Withdrawal by Subject|0|||
46885935|NCT00098475|83108104|FG003|Step 2|Withdrawal by Subject|0|||
46885936|NCT00098475|83108101|FG000|Step 2|Physician Decision|0|||
46885937|NCT00098475|83108102|FG001|Step 2|Physician Decision|1|||
46885938|NCT00098475|83108103|FG002|Step 2|Physician Decision|0|||
46885939|NCT00098475|83108104|FG003|Step 2|Physician Decision|0|||
46885940|NCT00098475|83108101|FG000|Step 2|Alternative therapy|1|||
46885941|NCT00098475|83108102|FG001|Step 2|Alternative therapy|2|||
46885942|NCT00098475|83108103|FG002|Step 2|Alternative therapy|0|||
46885943|NCT00098475|83108104|FG003|Step 2|Alternative therapy|0|||
46885944|NCT00098475|83108101|FG000|Step 2|Never started treatment|1|||
46885945|NCT00098475|83108102|FG001|Step 2|Never started treatment|1|||
46885946|NCT00098475|83108103|FG002|Step 2|Never started treatment|0|||
46885947|NCT00098475|83108104|FG003|Step 2|Never started treatment|0|||
46885948|NCT03136484|83108120|FG000|Overall Study|Withdrawal by Subject|19|||
46885949|NCT03136484|83108121|FG001|Overall Study|Withdrawal by Subject|14|||
46885950|NCT03136484|83108120|FG000|Overall Study|Lost to Follow-up|7|||
46705488|NCT01227512|82920322|FG001|Overall Study|Adverse Event|3|||
46705489|NCT01227512|82920321|FG000|Overall Study|Withdrawal by Subject|3|||
46705490|NCT01227512|82920322|FG001|Overall Study|Withdrawal by Subject|0|||
46705491|NCT01227512|82920321|FG000|Overall Study|Participant met withdrawal criteria|0|||
46885951|NCT03136484|83108121|FG001|Overall Study|Lost to Follow-up|8|||
46885952|NCT03136484|83108120|FG000|Overall Study|Death|1|||
46885953|NCT03136484|83108121|FG001|Overall Study|Death|0|||
46885954|NCT03922711|83108130|FG000|Overall Study|Adverse Event|3|||
46885955|NCT03922711|83108131|FG001|Overall Study|Adverse Event|2|||
46885956|NCT03922711|83108132|FG002|Overall Study|Adverse Event|2|||
46885957|NCT03922711|83108130|FG000|Overall Study|Protocol Violation|1|||
46885958|NCT03922711|83108131|FG001|Overall Study|Protocol Violation|0|||
46885959|NCT03922711|83108132|FG002|Overall Study|Protocol Violation|0|||
46885960|NCT03922711|83108130|FG000|Overall Study|Withdrawal by Subject|0|||
46885961|NCT03922711|83108131|FG001|Overall Study|Withdrawal by Subject|3|||
46885962|NCT03922711|83108132|FG002|Overall Study|Withdrawal by Subject|1|||
46885963|NCT03922711|83108130|FG000|Overall Study|Not further specified|0|||
46885964|NCT03922711|83108131|FG001|Overall Study|Not further specified|0|||
46885965|NCT03922711|83108132|FG002|Overall Study|Not further specified|1|||
46885966|NCT02877680|83108141|FG000|Overall Study|Lost to Follow-up|1|||
46885967|NCT02877680|83108142|FG001|Overall Study|Lost to Follow-up|1|||
46885968|NCT03141086|83108154|FG000|Overall Study|Study Terminated By Sponsor|1|||
46885969|NCT03141086|83108155|FG001|Overall Study|Study Terminated By Sponsor|1|||
46885970|NCT03141086|83108154|FG000|Overall Study|Withdrawal by Subject|0|||
46885971|NCT03141086|83108155|FG001|Overall Study|Withdrawal by Subject|1|||
46885972|NCT03141086|83108154|FG000|Overall Study|Protocol Violation|0|||
46885973|NCT03141086|83108155|FG001|Overall Study|Protocol Violation|1|||
46885974|NCT03141086|83108154|FG000|Overall Study|Adverse Event|0|||
46885975|NCT03141086|83108155|FG001|Overall Study|Adverse Event|2|||
46885976|NCT03135548|83108164|FG000|Overall Study|Lost to Follow-up|3|||
46885977|NCT03135548|83108165|FG001|Overall Study|Lost to Follow-up|0|||
46885978|NCT03135548|83108166|FG002|Overall Study|Lost to Follow-up|0|||
46885979|NCT03135548|83108164|FG000|Overall Study|Withdrawal by Subject|2|||
46885980|NCT03135548|83108165|FG001|Overall Study|Withdrawal by Subject|2|||
46885981|NCT03135548|83108166|FG002|Overall Study|Withdrawal by Subject|1|||
46885982|NCT03135548|83108164|FG000|Overall Study|Other than listed|0|||
46885983|NCT03135548|83108165|FG001|Overall Study|Other than listed|2|||
46885984|NCT03135548|83108166|FG002|Overall Study|Other than listed|2|||
46885985|NCT03134222|83108177|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
46885986|NCT03134222|83108178|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
46885987|NCT03134222|83108179|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
46885988|NCT03134222|83108180|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
46885989|NCT03134222|83108181|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
46885990|NCT03134222|83108177|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
46885991|NCT03134222|83108178|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
46885992|NCT03134222|83108179|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
46885993|NCT03134222|83108180|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
46885994|NCT03134222|83108181|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
46885995|NCT03134222|83108177|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
46885996|NCT03134222|83108178|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
46885997|NCT03134222|83108179|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
46885998|NCT03134222|83108180|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
46885999|NCT03134222|83108181|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
46886000|NCT03134222|83108177|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
46886001|NCT03134222|83108178|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
46886002|NCT03134222|83108179|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
46886003|NCT03134222|83108180|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
46886004|NCT03134222|83108181|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
46886005|NCT03134222|83108177|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
46886006|NCT03134222|83108178|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
46886007|NCT03134222|83108179|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
46886008|NCT03134222|83108180|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
46886009|NCT03134222|83108181|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
46886010|NCT03134222|83108177|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
46886011|NCT03134222|83108178|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
46886012|NCT03134222|83108179|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
46886013|NCT03134222|83108180|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
46886014|NCT03134222|83108181|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
46886015|NCT03134222|83108177|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
46886016|NCT03134222|83108178|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
46886017|NCT03134222|83108179|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
46886018|NCT03134222|83108180|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
46886019|NCT03134222|83108181|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
46886020|NCT03134222|83108177|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
46886021|NCT03134222|83108178|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
46886022|NCT03134222|83108179|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
46886023|NCT03134222|83108180|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
46886024|NCT03134222|83108181|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
46886025|NCT03769753|83108191|FG000|Overall Study|Not Treated|6|||
46886026|NCT03769753|83108191|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
46886027|NCT03263923|83108255|FG000|Overall Study|Withdrawal by Subject|10|||
46886028|NCT03263923|83108256|FG001|Overall Study|Withdrawal by Subject|8|||
46886029|NCT03263923|83108255|FG000|Overall Study|Lost to Follow-up|15|||
46886030|NCT03263923|83108256|FG001|Overall Study|Lost to Follow-up|13|||
46991273|NCT02187159|83238234|FG002|Overall Study|Protocol Violation|3|||
46886031|NCT03139604|83108266|FG000|Overall Study|Other|7|||
46886032|NCT03139604|83108267|FG001|Overall Study|Other|3|||
46991274|NCT02187159|83238235|FG003|Overall Study|Protocol Violation|4|||
46991275|NCT02187159|83238232|FG000|Overall Study|Lack of Efficacy|10|||
46991276|NCT02187159|83238233|FG001|Overall Study|Lack of Efficacy|5|||
46991277|NCT02187159|83238234|FG002|Overall Study|Lack of Efficacy|4|||
46991278|NCT02187159|83238235|FG003|Overall Study|Lack of Efficacy|7|||
46991279|NCT02187159|83238232|FG000|Overall Study|Adverse Event|28|||
46991280|NCT02187159|83238233|FG001|Overall Study|Adverse Event|33|||
46991281|NCT02187159|83238234|FG002|Overall Study|Adverse Event|42|||
46991282|NCT02187159|83238235|FG003|Overall Study|Adverse Event|50|||
46991283|NCT02187159|83238232|FG000|Overall Study|Withdrawal by Subject|24|||
46991284|NCT02187159|83238233|FG001|Overall Study|Withdrawal by Subject|28|||
46991285|NCT02187159|83238234|FG002|Overall Study|Withdrawal by Subject|25|||
46991286|NCT02187159|83238235|FG003|Overall Study|Withdrawal by Subject|26|||
46991287|NCT02187159|83238232|FG000|Overall Study|Other|3|||
46991288|NCT02187159|83238233|FG001|Overall Study|Other|7|||
46991289|NCT02187159|83238234|FG002|Overall Study|Other|3|||
46991290|NCT02187159|83238235|FG003|Overall Study|Other|9|||
46991291|NCT02335411|83238248|FG000|Overall Study|Death|223|||
46991292|NCT02335411|83238249|FG001|Overall Study|Death|22|||
46991293|NCT02335411|83238250|FG002|Overall Study|Death|26|||
46991294|NCT02335411|83238248|FG000|Overall Study|Physician Decision|3|||
46991295|NCT02335411|83238249|FG001|Overall Study|Physician Decision|0|||
46991296|NCT02335411|83238250|FG002|Overall Study|Physician Decision|0|||
46991297|NCT02335411|83238248|FG000|Overall Study|Protocol Violation|1|||
46991298|NCT02335411|83238249|FG001|Overall Study|Protocol Violation|0|||
46991299|NCT02335411|83238250|FG002|Overall Study|Protocol Violation|0|||
46991300|NCT02335411|83238248|FG000|Overall Study|Withdrawal by Subject|11|||
46991301|NCT02335411|83238249|FG001|Overall Study|Withdrawal by Subject|0|||
46991302|NCT02335411|83238250|FG002|Overall Study|Withdrawal by Subject|3|||
46991303|NCT02335411|83238248|FG000|Overall Study|Sponsor Decision|12|||
46991304|NCT02335411|83238249|FG001|Overall Study|Sponsor Decision|3|||
46991305|NCT02335411|83238250|FG002|Overall Study|Sponsor Decision|2|||
46991306|NCT02335411|83238248|FG000|Overall Study|Adverse Event|9|||
46991307|NCT02335411|83238249|FG001|Overall Study|Adverse Event|0|||
46991308|NCT02335411|83238250|FG002|Overall Study|Adverse Event|0|||
46991309|NCT02186301|83238264|FG000|Overall Study|Progressive Disease|7|||
46991310|NCT02186301|83238265|FG001|Overall Study|Progressive Disease|22|||
46991311|NCT02186301|83238266|FG002|Overall Study|Progressive Disease|27|||
46991312|NCT02186301|83238264|FG000|Overall Study|Adverse Event|5|||
46991313|NCT02186301|83238265|FG001|Overall Study|Adverse Event|5|||
46991314|NCT02186301|83238266|FG002|Overall Study|Adverse Event|5|||
46886033|NCT03139604|83108266|FG000|Overall Study|Withdrawal by Subject|16|||
46886034|NCT03139604|83108267|FG001|Overall Study|Withdrawal by Subject|17|||
46886035|NCT03139604|83108266|FG000|Overall Study|Physician Decision|1|||
46886036|NCT03139604|83108267|FG001|Overall Study|Physician Decision|2|||
46886037|NCT03139604|83108266|FG000|Overall Study|Lost to Follow-up|3|||
46886038|NCT03139604|83108267|FG001|Overall Study|Lost to Follow-up|1|||
46886039|NCT03139604|83108266|FG000|Overall Study|Death|65|||
46886040|NCT03139604|83108267|FG001|Overall Study|Death|67|||
46886041|NCT03139604|83108266|FG000|Overall Study|Study Terminated by Sponsor|122|||
46886042|NCT03139604|83108267|FG001|Overall Study|Study Terminated by Sponsor|127|||
46886043|NCT03139604|83108266|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
46886044|NCT03139604|83108267|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
46886045|NCT03139448|83108276|FG000|Overall Study|Lack of Efficacy|6|||
46886046|NCT03139448|83108277|FG001|Overall Study|Lack of Efficacy|7|||
46886047|NCT03139448|83108276|FG000|Overall Study|Location of procedure changed|2|||
46886048|NCT03139448|83108277|FG001|Overall Study|Location of procedure changed|8|||
46886049|NCT03139448|83108276|FG000|Overall Study|Withdrawal by Subject|3|||
46886050|NCT03139448|83108277|FG001|Overall Study|Withdrawal by Subject|6|||
46886051|NCT03139448|83108276|FG000|Overall Study|Screen fail|1|||
46886052|NCT03139448|83108277|FG001|Overall Study|Screen fail|3|||
46886053|NCT03139448|83108276|FG000|Overall Study|Physician Decision|0|||
46886054|NCT03139448|83108277|FG001|Overall Study|Physician Decision|2|||
46886055|NCT02875340|83108283|FG000|Overall Study|Death|2|||
46886056|NCT02875340|83108283|FG000|Overall Study|Withdrawal by Subject|2|||
46886057|NCT02875340|83108283|FG000|Overall Study|Physician Decision|3|||
46886058|NCT02875340|83108283|FG000|Overall Study|Adverse Event|1|||
46886059|NCT03237325|83108295|FG000|Overall Study|Lost to Follow-up|3|||
46886060|NCT03237325|83108296|FG001|Overall Study|Lost to Follow-up|5|||
46886061|NCT03237325|83108295|FG000|Overall Study|Physician Decision|2|||
46886062|NCT03237325|83108296|FG001|Overall Study|Physician Decision|4|||
46886063|NCT03237325|83108295|FG000|Overall Study|Withdrawal by Subject|9|||
46886064|NCT03237325|83108296|FG001|Overall Study|Withdrawal by Subject|12|||
46886065|NCT03237325|83108295|FG000|Overall Study|Noncompliance with Study Procedures|1|||
46886066|NCT03237325|83108296|FG001|Overall Study|Noncompliance with Study Procedures|1|||
46886067|NCT03237325|83108295|FG000|Overall Study|Termination by Sponsor|0|||
46886068|NCT03237325|83108296|FG001|Overall Study|Termination by Sponsor|1|||
46886069|NCT03237325|83108295|FG000|Overall Study|Reason other than described|0|||
46886070|NCT03237325|83108296|FG001|Overall Study|Reason other than described|2|||
46886071|NCT03113383|83108302|FG000|Overall Study|Death|4|||
46886072|NCT03113383|83108303|FG001|Overall Study|Death|0|||
46886073|NCT03131960|83108324|FG000|Overall Study|Adverse Event|0|||
46886074|NCT03131960|83108325|FG001|Overall Study|Adverse Event|1|||
46886075|NCT03225170|83108334|FG000|Overall Study|Lost to Follow-up|4|||
46886076|NCT03225170|83108335|FG001|Overall Study|Lost to Follow-up|4|||
46886077|NCT03225170|83108336|FG002|Overall Study|Lost to Follow-up|0|||
46991315|NCT02186301|83238264|FG000|Overall Study|Death|1|||
46991316|NCT02186301|83238265|FG001|Overall Study|Death|0|||
46991317|NCT02186301|83238266|FG002|Overall Study|Death|0|||
46991318|NCT02186301|83238264|FG000|Overall Study|Withdrawal by Subject|5|||
46991319|NCT02186301|83238265|FG001|Overall Study|Withdrawal by Subject|1|||
46991320|NCT02186301|83238266|FG002|Overall Study|Withdrawal by Subject|3|||
46886078|NCT03225170|83108334|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
46886079|NCT03225170|83108335|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
46886080|NCT03225170|83108336|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
46886081|NCT02115139|83108342|FG000|Overall Study|Protocol Violation|1|||
46705492|NCT01227512|82920322|FG001|Overall Study|Participant met withdrawal criteria|1|||
46705493|NCT01227278|82920332|FG000|Overall Study|Withdrawal by Subject|4|||
46991321|NCT02186301|83238264|FG000|Overall Study|Physician Decision|1|||
46991322|NCT02186301|83238265|FG001|Overall Study|Physician Decision|0|||
46705494|NCT01227278|82920333|FG001|Overall Study|Withdrawal by Subject|4|||
46705495|NCT01227278|82920332|FG000|Overall Study|Death|0|||
46991323|NCT02186301|83238266|FG002|Overall Study|Physician Decision|1|||
46991324|NCT02186301|83238264|FG000|Overall Study|Study Terminated by Sponsor|1|||
46991325|NCT02186301|83238265|FG001|Overall Study|Study Terminated by Sponsor|0|||
46991326|NCT02186301|83238266|FG002|Overall Study|Study Terminated by Sponsor|11|||
46991327|NCT02186301|83238264|FG000|Overall Study|Protocol Deviation|0|||
46991328|NCT02186301|83238265|FG001|Overall Study|Protocol Deviation|2|||
46991329|NCT02186301|83238266|FG002|Overall Study|Protocol Deviation|0|||
46991330|NCT02186301|83238264|FG000|Overall Study|Missing|0|||
46991331|NCT02186301|83238265|FG001|Overall Study|Missing|0|||
46991332|NCT02186301|83238266|FG002|Overall Study|Missing|2|||
46991333|NCT02186301|83238264|FG000|Overall Study|Other|0|||
46991334|NCT02186301|83238265|FG001|Overall Study|Other|0|||
46991335|NCT02186301|83238266|FG002|Overall Study|Other|1|||
46991336|NCT02186223|83238276|FG000|Overall Study|Not eligible for device placement|6|||
46991337|NCT02186223|83238276|FG000|Overall Study|Unable to obtain femoral access|3|||
46991338|NCT02186223|83238276|FG000|Overall Study|Death|3|||
46991339|NCT02186223|83238276|FG000|Overall Study|Device in place less than 48 hours|9|||
46991340|NCT02163057|83238283|FG000|Overall Study|Participant Refusal to Continue|2|||
46991341|NCT02163057|83238284|FG001|Overall Study|Participant Refusal to Continue|2|||
46991342|NCT02163057|83238283|FG000|Overall Study|Participant Significant Noncompliance|0|||
46991343|NCT02163057|83238284|FG001|Overall Study|Participant Significant Noncompliance|1|||
46991344|NCT02163057|83238283|FG000|Overall Study|Progression of Disease|1|||
46991345|NCT02163057|83238284|FG001|Overall Study|Progression of Disease|2|||
46991346|NCT02185521|83238292|FG000|Overall Study|Withdrawal by Subject|1|||
46991347|NCT02185521|83238292|FG000|Overall Study|Protocol Violation|1|||
46991348|NCT01599585|83238299|FG000|Overall Study|Withdrawal by Subject|16|||
46991349|NCT01599585|83238300|FG001|Overall Study|Withdrawal by Subject|9|||
46991350|NCT01599585|83238299|FG000|Overall Study|Lost to Follow-up|3|||
46991351|NCT01599585|83238300|FG001|Overall Study|Lost to Follow-up|5|||
46991352|NCT01599585|83238299|FG000|Overall Study|randomized did not start treatment|3|||
46991353|NCT01599585|83238300|FG001|Overall Study|randomized did not start treatment|3|||
46991354|NCT02185053|83238306|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
46991355|NCT02185053|83238307|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
46991356|NCT02185053|83238308|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
46991357|NCT02185053|83238306|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
46991358|NCT02185053|83238307|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
46991359|NCT02185053|83238308|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
46991360|NCT02185053|83238306|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
46991361|NCT02185053|83238307|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
46991362|NCT02185053|83238308|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
46991363|NCT02185053|83238306|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
46991364|NCT02185053|83238307|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
46991365|NCT02185053|83238308|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
46991366|NCT02185053|83238306|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
46991367|NCT02185053|83238307|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
46991368|NCT02185053|83238308|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
46991369|NCT02185053|83238306|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
46991370|NCT02185053|83238307|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
46991371|NCT02185053|83238308|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
46991372|NCT02185053|83238306|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
46991373|NCT02185053|83238307|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
46991374|NCT02185053|83238308|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
46991375|NCT02185053|83238306|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
46991376|NCT02185053|83238307|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
46991377|NCT02185053|83238308|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
46991378|NCT02161731|83238317|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
46991379|NCT02161731|83238318|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
46991380|NCT02161731|83238317|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
46991381|NCT02161731|83238318|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
46991382|NCT02124759|83238328|FG000|Overall Study|Withdrawal by Subject|3|||
46991383|NCT02124759|83238329|FG001|Overall Study|Withdrawal by Subject|1|||
46991384|NCT02124759|83238330|FG002|Overall Study|Withdrawal by Subject|1|||
46991385|NCT02124759|83238328|FG000|Overall Study|Screen Fail|2|||
46991386|NCT02124759|83238329|FG001|Overall Study|Screen Fail|2|||
46991387|NCT02124759|83238330|FG002|Overall Study|Screen Fail|3|||
46991388|NCT02302339|83238347|FG000|Overall Study|Lost to Follow-up|1|||
46991389|NCT02302339|83238348|FG001|Overall Study|Lost to Follow-up|0|||
46991390|NCT02302339|83238349|FG002|Overall Study|Lost to Follow-up|0|||
46991391|NCT02302339|83238350|FG003|Overall Study|Lost to Follow-up|0|||
46991392|NCT02302339|83238347|FG000|Overall Study|Withdrawal by Subject|0|||
46991393|NCT02302339|83238348|FG001|Overall Study|Withdrawal by Subject|2|||
46991394|NCT02302339|83238349|FG002|Overall Study|Withdrawal by Subject|1|||
46991395|NCT02302339|83238350|FG003|Overall Study|Withdrawal by Subject|0|||
46991396|NCT02161575|83238361|FG000|Overall Study|Protocol Violation|8|||
46886082|NCT02115139|83108342|FG000|Overall Study|treatment discontinuation|6|||
46886083|NCT01763827|83108390|FG000|Overall Study|Withdrawal by Subject|1|||
46886084|NCT01763827|83108391|FG001|Overall Study|Withdrawal by Subject|0|||
46886085|NCT01763827|83108392|FG002|Overall Study|Withdrawal by Subject|0|||
46886086|NCT01763827|83108393|FG003|Overall Study|Withdrawal by Subject|0|||
46886087|NCT01763827|83108394|FG004|Overall Study|Withdrawal by Subject|2|||
46886088|NCT01763827|83108395|FG005|Overall Study|Withdrawal by Subject|0|||
46886089|NCT01763827|83108390|FG000|Overall Study|Decision by sponsor|2|||
46886090|NCT01763827|83108391|FG001|Overall Study|Decision by sponsor|0|||
46886091|NCT01763827|83108392|FG002|Overall Study|Decision by sponsor|3|||
46991397|NCT02161575|83238361|FG000|Overall Study|Lack of Efficacy|1|||
46886092|NCT01763827|83108393|FG003|Overall Study|Decision by sponsor|0|||
46886093|NCT01763827|83108394|FG004|Overall Study|Decision by sponsor|2|||
46705496|NCT01227278|82920333|FG001|Overall Study|Death|2|||
46705497|NCT01227278|82920332|FG000|Overall Study|Other|1|||
46886094|NCT01763827|83108395|FG005|Overall Study|Decision by sponsor|1|||
46991398|NCT02161575|83238361|FG000|Overall Study|Adverse Event|2|||
46705498|NCT01227278|82920333|FG001|Overall Study|Other|2|||
46705499|NCT01034397|82920341|FG000|Overall Study|Lack of compliance|0|||
46705500|NCT01034397|82920342|FG001|Overall Study|Lack of compliance|1|||
46705501|NCT01034397|82920341|FG000|Overall Study|Lack of Efficacy|3|||
46705502|NCT01034397|82920342|FG001|Overall Study|Lack of Efficacy|0|||
46705503|NCT01034397|82920341|FG000|Overall Study|Adverse Event|4|||
46705504|NCT01034397|82920342|FG001|Overall Study|Adverse Event|0|||
46705505|NCT01034397|82920341|FG000|Overall Study|Other|0|||
46705506|NCT01034397|82920342|FG001|Overall Study|Other|1|||
46705507|NCT01227044|82920359|FG000|Overall Study|Lost to Follow-up|5|||
46705508|NCT01227044|82920360|FG001|Overall Study|Lost to Follow-up|7|||
46705509|NCT01227044|82920359|FG000|Overall Study|Discontinued Intervention|1|||
46705510|NCT01227044|82920360|FG001|Overall Study|Discontinued Intervention|2|||
46705511|NCT01225952|82920369|FG000|Overall Study|Lost to Follow-up|1|||
46705512|NCT01225952|82920370|FG001|Overall Study|Lost to Follow-up|0|||
46705513|NCT01225952|82920371|FG002|Overall Study|Lost to Follow-up|0|||
46705514|NCT01225952|82920369|FG000|Overall Study|Study Eye Explanted|0|||
46705515|NCT01225952|82920370|FG001|Overall Study|Study Eye Explanted|0|||
46705516|NCT01225952|82920371|FG002|Overall Study|Study Eye Explanted|1|||
46705517|NCT01225952|82920369|FG000|Overall Study|Withdrawal by Subject|4|||
46705518|NCT01225952|82920370|FG001|Overall Study|Withdrawal by Subject|4|||
46705519|NCT01225952|82920371|FG002|Overall Study|Withdrawal by Subject|5|||
46705520|NCT01225952|82920369|FG000|Overall Study|Surgical complications|1|||
46705521|NCT01225952|82920370|FG001|Overall Study|Surgical complications|0|||
46705522|NCT01225952|82920371|FG002|Overall Study|Surgical complications|0|||
46705523|NCT01034163|82920381|FG000|Overall Study|Treatment completed as per protocol|8|||
46705524|NCT01034163|82920382|FG001|Overall Study|Treatment completed as per protocol|7|||
46705525|NCT01034163|82920381|FG000|Overall Study|Withdrawal by Subject|8|||
46705526|NCT01034163|82920382|FG001|Overall Study|Withdrawal by Subject|2|||
46886095|NCT01763827|83108390|FG000|Overall Study|Lost to Follow-up|0|||
46705527|NCT01034163|82920381|FG000|Overall Study|Protocol deviation|1|||
46705528|NCT01034163|82920382|FG001|Overall Study|Protocol deviation|0|||
46705529|NCT01034163|82920381|FG000|Overall Study|Disease progression|3|||
46705530|NCT01034163|82920382|FG001|Overall Study|Disease progression|4|||
46705531|NCT01034163|82920381|FG000|Overall Study|Adverse Event|6|||
46705532|NCT01034163|82920382|FG001|Overall Study|Adverse Event|0|||
46705533|NCT01034163|82920381|FG000|Overall Study|Administrative problems|0|||
46705534|NCT01034163|82920382|FG001|Overall Study|Administrative problems|1|||
46705535|NCT01034163|82920381|FG000|Overall Study|Abnormal laboratory value|1|||
46705536|NCT01034163|82920382|FG001|Overall Study|Abnormal laboratory value|0|||
46705537|NCT01033851|82920390|FG000|Overall Study|Withdrawal by Subject|3|||
46705538|NCT01033851|82920391|FG001|Overall Study|Withdrawal by Subject|7|||
46705539|NCT01162122|82920399|FG000|Overall Study|Withdrawal by Subject|52|||
46705540|NCT01162122|82920400|FG001|Overall Study|Withdrawal by Subject|43|||
46705541|NCT01162122|82920399|FG000|Overall Study|Lost to Follow-up|73|||
46705542|NCT01162122|82920400|FG001|Overall Study|Lost to Follow-up|91|||
46705543|NCT01162122|82920399|FG000|Overall Study|Adverse Event|3|||
46705544|NCT01162122|82920400|FG001|Overall Study|Adverse Event|2|||
46705545|NCT01162122|82920399|FG000|Overall Study|Death|51|||
46705546|NCT01162122|82920400|FG001|Overall Study|Death|46|||
46705547|NCT01162122|82920399|FG000|Overall Study|Protocol Violation|2|||
46705548|NCT01162122|82920400|FG001|Overall Study|Protocol Violation|2|||
46705549|NCT01162122|82920399|FG000|Overall Study|Inappropriate enrollment|5|||
46705550|NCT01162122|82920400|FG001|Overall Study|Inappropriate enrollment|4|||
46705551|NCT01162122|82920399|FG000|Overall Study|Administrative reason|1|||
46705552|NCT01162122|82920400|FG001|Overall Study|Administrative reason|1|||
46705553|NCT01162122|82920399|FG000|Overall Study|Unable to classify|3|||
46705554|NCT01162122|82920400|FG001|Overall Study|Unable to classify|7|||
46705555|NCT01162122|82920399|FG000|Overall Study|Missing primary reason|1|||
46705556|NCT01162122|82920400|FG001|Overall Study|Missing primary reason|0|||
46705557|NCT01033071|82920412|FG000|Overall Study|Adverse Event|28|||
46705558|NCT01033071|82920413|FG001|Overall Study|Adverse Event|51|||
46705559|NCT01033071|82920414|FG002|Overall Study|Adverse Event|26|||
46705560|NCT01033071|82920412|FG000|Overall Study|Protocol Violation|0|||
46705561|NCT01033071|82920413|FG001|Overall Study|Protocol Violation|2|||
46705562|NCT01033071|82920414|FG002|Overall Study|Protocol Violation|1|||
46705563|NCT01033071|82920412|FG000|Overall Study|Lost to Follow-up|4|||
46705564|NCT01033071|82920413|FG001|Overall Study|Lost to Follow-up|5|||
46886096|NCT01763827|83108391|FG001|Overall Study|Lost to Follow-up|1|||
46886097|NCT01763827|83108392|FG002|Overall Study|Lost to Follow-up|1|||
46886098|NCT01763827|83108393|FG003|Overall Study|Lost to Follow-up|1|||
46886099|NCT01763827|83108394|FG004|Overall Study|Lost to Follow-up|2|||
46886100|NCT01763827|83108395|FG005|Overall Study|Lost to Follow-up|1|||
46886101|NCT01732783|83108448|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
46886102|NCT01732783|83108449|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
46886103|NCT01732783|83108450|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
46886104|NCT01732783|83108448|FG000|Overall Study|Death|13|||
46886105|NCT01732783|83108449|FG001|Overall Study|Death|4|||
46886106|NCT01732783|83108450|FG002|Overall Study|Death|1|||
46886107|NCT01732783|83108448|FG000|Overall Study|Lost to Follow-up|7|||
46886108|NCT01732783|83108449|FG001|Overall Study|Lost to Follow-up|1|||
46886109|NCT01732783|83108450|FG002|Overall Study|Lost to Follow-up|1|||
46886110|NCT01732783|83108448|FG000|Overall Study|Administrative Decision|8|||
46886111|NCT01732783|83108449|FG001|Overall Study|Administrative Decision|2|||
46886112|NCT01732783|83108450|FG002|Overall Study|Administrative Decision|1|||
46886113|NCT01732783|83108448|FG000|Overall Study|Withdrawal by Subject|1|||
46886114|NCT01732783|83108449|FG001|Overall Study|Withdrawal by Subject|0|||
46886115|NCT01732783|83108450|FG002|Overall Study|Withdrawal by Subject|0|||
46991399|NCT02370121|83238367|FG000|Overall Study|Lost to Follow-up|1|||
46705565|NCT01033071|82920414|FG002|Overall Study|Lost to Follow-up|5|||
46705566|NCT01033071|82920412|FG000|Overall Study|Withdrawal by Subject|17|||
46886116|NCT02787850|83108477|FG000|Overall Study|Withdrawal by Subject|0|||
46886117|NCT02787850|83108478|FG001|Overall Study|Withdrawal by Subject|1|||
46886118|NCT01375777|83108502|FG000|Overall Study|Withdrawal by Subject|0|||
46886119|NCT01375777|83108503|FG001|Overall Study|Withdrawal by Subject|2|||
46705567|NCT01033071|82920413|FG001|Overall Study|Withdrawal by Subject|14|||
46705568|NCT01033071|82920414|FG002|Overall Study|Withdrawal by Subject|11|||
46705569|NCT01033071|82920412|FG000|Overall Study|Lack of Efficacy|0|||
46705570|NCT01033071|82920413|FG001|Overall Study|Lack of Efficacy|1|||
46705571|NCT01033071|82920414|FG002|Overall Study|Lack of Efficacy|1|||
46705572|NCT01033071|82920412|FG000|Overall Study|Other|6|||
46705573|NCT01033071|82920413|FG001|Overall Study|Other|4|||
46705574|NCT01033071|82920414|FG002|Overall Study|Other|3|||
46705575|NCT01032915|82920426|FG000|Overall Study|Adverse Event|2|||
46705576|NCT01032915|82920427|FG001|Overall Study|Adverse Event|2|||
46705577|NCT01032915|82920428|FG002|Overall Study|Adverse Event|1|||
46705578|NCT01032915|82920429|FG003|Overall Study|Adverse Event|1|||
46886120|NCT01375777|83108504|FG002|Overall Study|Withdrawal by Subject|1|||
46886121|NCT01375777|83108505|FG003|Overall Study|Withdrawal by Subject|0|||
46886122|NCT01375777|83108506|FG004|Overall Study|Withdrawal by Subject|1|||
46886123|NCT01375777|83108507|FG005|Overall Study|Withdrawal by Subject|1|||
46886124|NCT01375777|83108508|FG006|Overall Study|Withdrawal by Subject|1|||
46886125|NCT01375777|83108509|FG007|Overall Study|Withdrawal by Subject|2|||
46886126|NCT01375777|83108510|FG008|Overall Study|Withdrawal by Subject|1|||
46886127|NCT01375777|83108502|FG000|Overall Study|Lost to Follow-up|1|||
46886128|NCT01375777|83108503|FG001|Overall Study|Lost to Follow-up|0|||
46886129|NCT01375777|83108504|FG002|Overall Study|Lost to Follow-up|0|||
46886130|NCT01375777|83108505|FG003|Overall Study|Lost to Follow-up|0|||
46886131|NCT01375777|83108506|FG004|Overall Study|Lost to Follow-up|0|||
46886132|NCT01375777|83108507|FG005|Overall Study|Lost to Follow-up|0|||
46886133|NCT01375777|83108508|FG006|Overall Study|Lost to Follow-up|1|||
46886134|NCT01375777|83108509|FG007|Overall Study|Lost to Follow-up|0|||
46886135|NCT01375777|83108510|FG008|Overall Study|Lost to Follow-up|0|||
46886136|NCT01375777|83108502|FG000|Overall Study|Other|1|||
46886137|NCT01375777|83108503|FG001|Overall Study|Other|1|||
46886138|NCT01375777|83108504|FG002|Overall Study|Other|0|||
46886139|NCT01375777|83108505|FG003|Overall Study|Other|0|||
46886140|NCT01375777|83108506|FG004|Overall Study|Other|0|||
46886141|NCT01375777|83108507|FG005|Overall Study|Other|0|||
46886142|NCT01375777|83108508|FG006|Overall Study|Other|0|||
46886143|NCT01375777|83108509|FG007|Overall Study|Other|0|||
46886144|NCT01375777|83108510|FG008|Overall Study|Other|1|||
46886145|NCT02431702|83108530|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
46886146|NCT02431702|83108531|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
46886147|NCT02431702|83108532|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
46705579|NCT01032915|82920426|FG000|Overall Study|Abnormal test procedure result|0|||
46705580|NCT01032915|82920427|FG001|Overall Study|Abnormal test procedure result|0|||
46705581|NCT01032915|82920428|FG002|Overall Study|Abnormal test procedure result|1|||
46705582|NCT01032915|82920429|FG003|Overall Study|Abnormal test procedure result|0|||
46705583|NCT01032915|82920426|FG000|Overall Study|Withdrawal by Subject|0|||
46705584|NCT01032915|82920427|FG001|Overall Study|Withdrawal by Subject|3|||
46705585|NCT01032915|82920428|FG002|Overall Study|Withdrawal by Subject|1|||
46705586|NCT01032915|82920429|FG003|Overall Study|Withdrawal by Subject|1|||
46705587|NCT01032915|82920426|FG000|Overall Study|Administrative reasons|5|||
46705588|NCT01032915|82920427|FG001|Overall Study|Administrative reasons|6|||
46705589|NCT01032915|82920428|FG002|Overall Study|Administrative reasons|4|||
46705590|NCT01032915|82920429|FG003|Overall Study|Administrative reasons|4|||
46705591|NCT01032915|82920426|FG000|Overall Study|Protocol Violation|1|||
46705592|NCT01032915|82920427|FG001|Overall Study|Protocol Violation|0|||
46705593|NCT01032915|82920428|FG002|Overall Study|Protocol Violation|0|||
46705594|NCT01032915|82920429|FG003|Overall Study|Protocol Violation|1|||
46705595|NCT01161498|82920441|FG000|Overall Study|Disease Progression|0|||
46705596|NCT01161498|82920442|FG001|Overall Study|Disease Progression|1|||
46705597|NCT01180998|82920451|FG000|Overall Study|Poor Vision|0|||
46705598|NCT01180998|82920452|FG001|Overall Study|Poor Vision|2|||
46705599|NCT01180998|82920453|FG002|Overall Study|Poor Vision|2|||
46705600|NCT01180998|82920451|FG000|Overall Study|Lost to Follow-up|0|||
46705601|NCT01180998|82920452|FG001|Overall Study|Lost to Follow-up|0|||
46705602|NCT01180998|82920453|FG002|Overall Study|Lost to Follow-up|1|||
46705603|NCT01180998|82920451|FG000|Overall Study|Protocol Violation|1|||
46705604|NCT01180998|82920452|FG001|Overall Study|Protocol Violation|2|||
46705605|NCT01180998|82920453|FG002|Overall Study|Protocol Violation|0|||
46705606|NCT01180998|82920451|FG000|Overall Study|Withdrawal by Subject|0|||
46705607|NCT01180998|82920452|FG001|Overall Study|Withdrawal by Subject|0|||
46705608|NCT01180998|82920453|FG002|Overall Study|Withdrawal by Subject|1|||
46705609|NCT01180998|82920451|FG000|Overall Study|Poor comfort|3|||
46705610|NCT01180998|82920452|FG001|Overall Study|Poor comfort|0|||
46705611|NCT01180998|82920453|FG002|Overall Study|Poor comfort|4|||
46705612|NCT01180998|82920451|FG000|Overall Study|Poor lens handling|0|||
46705613|NCT01180998|82920452|FG001|Overall Study|Poor lens handling|0|||
46705614|NCT01180998|82920453|FG002|Overall Study|Poor lens handling|2|||
46705615|NCT01029795|82920464|FG000|Overall Study|Entry Criteria Not Met|2|||
46705616|NCT01029795|82920465|FG001|Overall Study|Entry Criteria Not Met|1|||
46705617|NCT01029795|82920464|FG000|Overall Study|Physician Decision|2|||
46886148|NCT02431702|83108533|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
46705618|NCT01029795|82920465|FG001|Overall Study|Physician Decision|1|||
46886149|NCT02431702|83108534|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
46886150|NCT02431702|83108535|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
46886151|NCT02431702|83108536|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
46886152|NCT02431702|83108530|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
46705619|NCT01029795|82920464|FG000|Overall Study|Sponsor Decision|11|||
46705620|NCT01029795|82920465|FG001|Overall Study|Sponsor Decision|17|||
46705621|NCT01029795|82920464|FG000|Overall Study|Withdrawal by Subject|1|||
46705622|NCT01029795|82920465|FG001|Overall Study|Withdrawal by Subject|3|||
46705623|NCT01032837|82920475|FG000|Overall Study|Adverse event/internal illness|0|||
46886153|NCT02431702|83108531|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
46886154|NCT02431702|83108532|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
46886155|NCT02431702|83108533|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
46886156|NCT02431702|83108534|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
46886157|NCT02431702|83108535|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
46886158|NCT02431702|83108536|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
46886159|NCT02431702|83108530|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
46886160|NCT02431702|83108531|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
46886161|NCT02431702|83108532|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
46886162|NCT02431702|83108533|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
46886163|NCT02431702|83108534|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
46886164|NCT02431702|83108535|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
46886165|NCT02431702|83108536|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
46886166|NCT02431702|83108530|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
46886167|NCT02431702|83108531|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
46886168|NCT02431702|83108532|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
46886169|NCT02431702|83108533|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
46886170|NCT02431702|83108534|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
46886171|NCT02431702|83108535|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
46886172|NCT02431702|83108536|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
46886173|NCT02431702|83108530|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
46886174|NCT02431702|83108531|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
46886175|NCT02431702|83108532|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
46886176|NCT02431702|83108533|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
46886177|NCT02431702|83108534|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
46886178|NCT02431702|83108535|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
46886179|NCT02431702|83108536|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
46886180|NCT02431702|83108530|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
46886181|NCT02431702|83108531|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
46886182|NCT02431702|83108532|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
46886183|NCT02431702|83108533|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
46886184|NCT02431702|83108534|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
46886185|NCT02431702|83108535|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
46886186|NCT02431702|83108536|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
46886187|NCT02431702|83108530|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
46886188|NCT02431702|83108531|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
46886189|NCT02431702|83108532|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
46886190|NCT02431702|83108533|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
46886191|NCT02431702|83108534|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
46886192|NCT02431702|83108535|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
46886193|NCT02431702|83108536|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
46886194|NCT02431702|83108530|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
46886195|NCT02431702|83108531|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
46886196|NCT02431702|83108532|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
46886197|NCT02431702|83108533|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
46886198|NCT02431702|83108534|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
46705624|NCT01032837|82920476|FG001|Overall Study|Adverse event/internal illness|1|||
46705625|NCT01032837|82920477|FG002|Overall Study|Adverse event/internal illness|0|||
46705626|NCT01032837|82920478|FG003|Overall Study|Adverse event/internal illness|1|||
46705627|NCT01032837|82920475|FG000|Overall Study|Withdrew consent|0|||
46705628|NCT01032837|82920476|FG001|Overall Study|Withdrew consent|2|||
46705629|NCT01032837|82920477|FG002|Overall Study|Withdrew consent|0|||
46705630|NCT01032837|82920478|FG003|Overall Study|Withdrew consent|1|||
46705631|NCT01032837|82920475|FG000|Overall Study|Failed to return|0|||
46705632|NCT01032837|82920476|FG001|Overall Study|Failed to return|0|||
46705633|NCT01032837|82920477|FG002|Overall Study|Failed to return|1|||
46705634|NCT01032837|82920478|FG003|Overall Study|Failed to return|0|||
46705635|NCT01032837|82920475|FG000|Overall Study|Refused treatment|0|||
46705636|NCT01032837|82920476|FG001|Overall Study|Refused treatment|0|||
46705637|NCT01032837|82920477|FG002|Overall Study|Refused treatment|0|||
46705638|NCT01032837|82920478|FG003|Overall Study|Refused treatment|1|||
46705639|NCT01180296|82920490|FG000|Overall Study|Protocol Violation|1|||
46705640|NCT01180296|82920491|FG001|Overall Study|Protocol Violation|2|||
46705641|NCT01160640|82920501|FG000|Overall Study|Physician Decision|3|||
46705642|NCT01160640|82920502|FG001|Overall Study|Physician Decision|3|||
46886199|NCT02431702|83108535|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
46705643|NCT01160640|82920501|FG000|Overall Study|Incarceration|1|||
46705644|NCT01160640|82920502|FG001|Overall Study|Incarceration|0|||
46705645|NCT01160640|82920501|FG000|Overall Study|Withdrawal by Subject|0|||
46705646|NCT01160640|82920502|FG001|Overall Study|Withdrawal by Subject|3|||
46886200|NCT02431702|83108536|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
46886201|NCT02431702|83108530|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
46886202|NCT02431702|83108531|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
46886203|NCT02431702|83108532|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
46886204|NCT02431702|83108533|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
46886205|NCT02431702|83108534|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
46886206|NCT02431702|83108535|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
46886207|NCT02431702|83108536|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
46886208|NCT02431702|83108530|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
46886209|NCT02431702|83108531|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
46886210|NCT02431702|83108532|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
46886211|NCT02431702|83108533|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
46886212|NCT02431702|83108534|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
46886213|NCT02431702|83108535|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
46886214|NCT02431702|83108536|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
46886215|NCT02431702|83108530|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
46886216|NCT02431702|83108531|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
46886217|NCT02431702|83108532|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
46886218|NCT02431702|83108533|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
46886219|NCT02431702|83108534|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
46886220|NCT02431702|83108535|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
46886221|NCT02431702|83108536|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
46886222|NCT02431702|83108530|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
46886223|NCT02431702|83108531|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
46886224|NCT02431702|83108532|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
46886225|NCT02431702|83108533|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
46886226|NCT02431702|83108534|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
46886227|NCT02431702|83108535|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
46886228|NCT02431702|83108536|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
46886229|NCT02431702|83108530|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
46886230|NCT02431702|83108531|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
46886231|NCT02431702|83108532|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
46886232|NCT02431702|83108533|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
46886233|NCT02431702|83108534|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
46886234|NCT02431702|83108535|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
46886235|NCT02431702|83108536|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
46886236|NCT02431702|83108530|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
46886237|NCT02431702|83108531|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
46886238|NCT02431702|83108532|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
46886239|NCT02431702|83108533|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
46886240|NCT02431702|83108534|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
46886241|NCT02431702|83108535|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
46886242|NCT02431702|83108536|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
46886243|NCT02431702|83108530|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
46886244|NCT02431702|83108531|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
46886245|NCT02431702|83108532|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
46886246|NCT02431702|83108533|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
46886247|NCT02431702|83108534|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
46886248|NCT02431702|83108535|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
46886249|NCT02431702|83108536|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
46886250|NCT02086552|83108552|FG000|Overall Study|Withdrawal by Subject|1|||
46886251|NCT03131570|83108597|FG000|Overall Study|Adverse Event|1|||
46886252|NCT03131570|83108598|FG001|Overall Study|Adverse Event|0|||
46886253|NCT02930018|83108608|FG000|Overall Study|Lost to Follow-up|1|||
46886254|NCT02930018|83108609|FG001|Overall Study|Lost to Follow-up|1|||
46886255|NCT02930018|83108608|FG000|Overall Study|Withdrawal by Subject|5|||
46886256|NCT02930018|83108609|FG001|Overall Study|Withdrawal by Subject|2|||
46886257|NCT02875028|83108617|FG000|Washout Period|Withdrawal by Subject|0|||
46886258|NCT02875028|83108618|FG001|Washout Period|Withdrawal by Subject|1|||
46886259|NCT00943618|83108629|FG000|Overall Study|Lost to Follow-up|38|||
46886260|NCT00943618|83108630|FG001|Overall Study|Lost to Follow-up|48|||
46886261|NCT00943618|83108631|FG002|Overall Study|Lost to Follow-up|20|||
46886262|NCT00943618|83108629|FG000|Overall Study|Discontinued Medication|17|||
46886263|NCT00943618|83108630|FG001|Overall Study|Discontinued Medication|29|||
46886264|NCT00943618|83108631|FG002|Overall Study|Discontinued Medication|11|||
46991400|NCT02370121|83238368|FG001|Overall Study|Lost to Follow-up|1|||
46886265|NCT02710084|83108641|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
46886266|NCT02710084|83108642|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
46886267|NCT02849990|83108649|FG000|Overall Study|Adverse Event|1|||
46886268|NCT02849990|83108649|FG000|Overall Study|Withdrawal by Subject|1|||
46886269|NCT02017964|83108653|FG000|Overall Study|Patient deemed ineligible|1|||
46886270|NCT01956110|83108659|FG000|Overall Study|Protocol Violation|25|||
46886271|NCT01956110|83108660|FG001|Overall Study|Protocol Violation|11|||
46886272|NCT01956110|83108659|FG000|Overall Study|Adverse Event|9|||
46886273|NCT01956110|83108660|FG001|Overall Study|Adverse Event|10|||
46886274|NCT01956110|83108659|FG000|Overall Study|Personal reasons|1|||
46886275|NCT01956110|83108660|FG001|Overall Study|Personal reasons|1|||
46886276|NCT03116828|83108691|FG000|Overall Study|Adverse Event|1|||
46886277|NCT03116828|83108692|FG001|Overall Study|Adverse Event|10|||
46886278|NCT03116828|83108691|FG000|Overall Study|Withdrawal by Subject|4|||
46886279|NCT03116828|83108692|FG001|Overall Study|Withdrawal by Subject|8|||
46886280|NCT03116828|83108691|FG000|Overall Study|OTHER|3|||
46886281|NCT03116828|83108692|FG001|Overall Study|OTHER|3|||
46886282|NCT03938272|83108700|FG000|Overall Study|Withdrawal by Subject|1|||
46886283|NCT03938272|83108701|FG001|Overall Study|Withdrawal by Subject|0|||
46886284|NCT03938272|83108700|FG000|Overall Study|Physician Decision|0|||
46886285|NCT03938272|83108701|FG001|Overall Study|Physician Decision|2|||
46886286|NCT03938272|83108700|FG000|Overall Study|Study termination by sponsor|10|||
46886287|NCT03938272|83108701|FG001|Overall Study|Study termination by sponsor|8|||
46886288|NCT03126344|83108719|FG000|Overall Study|Lost to Follow-up|0|||
46886289|NCT03126344|83108720|FG001|Overall Study|Lost to Follow-up|0|||
46886290|NCT03126344|83108721|FG002|Overall Study|Lost to Follow-up|5|||
46886291|NCT03115112|83108742|FG000|Overall Study|Adverse Event|5|||
46886292|NCT03115112|83108743|FG001|Overall Study|Adverse Event|1|||
46886293|NCT03115112|83108742|FG000|Overall Study|Withdrawal by Subject|4|||
46886294|NCT03115112|83108743|FG001|Overall Study|Withdrawal by Subject|2|||
46886295|NCT03115112|83108742|FG000|Overall Study|Lost to Follow-up|0|||
46886296|NCT03115112|83108743|FG001|Overall Study|Lost to Follow-up|1|||
46886297|NCT03115112|83108742|FG000|Overall Study|Death|1|||
46886298|NCT03115112|83108743|FG001|Overall Study|Death|0|||
46886299|NCT03115112|83108742|FG000|Overall Study|Pregnancy|1|||
46886300|NCT03115112|83108743|FG001|Overall Study|Pregnancy|0|||
46886301|NCT03115112|83108742|FG000|Overall Study|Site closure|1|||
46886302|NCT03115112|83108743|FG001|Overall Study|Site closure|1|||
46886303|NCT03556358|83108762|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
46886304|NCT03556358|83108763|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
46886305|NCT03556358|83108762|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
46886306|NCT03556358|83108763|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
46886307|NCT03556358|83108762|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
46886308|NCT03556358|83108763|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
46886309|NCT03556358|83108762|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
46886310|NCT03556358|83108763|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
46886311|NCT03556358|83108762|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
46886312|NCT03556358|83108763|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
46886313|NCT03556358|83108762|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
46886314|NCT03556358|83108763|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
46886315|NCT03556358|83108762|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
46886316|NCT03556358|83108763|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
46886317|NCT03118934|83108790|FG000|Overall Study|Adverse Event|0|||
46886318|NCT03118934|83108791|FG001|Overall Study|Adverse Event|0|||
46886319|NCT03118934|83108792|FG002|Overall Study|Adverse Event|0|||
46886320|NCT03118934|83108793|FG003|Overall Study|Adverse Event|0|||
46886321|NCT03118934|83108794|FG004|Overall Study|Adverse Event|0|||
46886322|NCT03118934|83108795|FG005|Overall Study|Adverse Event|1|||
46886323|NCT03118934|83108790|FG000|Overall Study|Physician Decision|0|||
46886324|NCT03118934|83108791|FG001|Overall Study|Physician Decision|0|||
46886325|NCT03118934|83108792|FG002|Overall Study|Physician Decision|0|||
46886326|NCT03118934|83108793|FG003|Overall Study|Physician Decision|0|||
46886327|NCT03118934|83108794|FG004|Overall Study|Physician Decision|0|||
46886328|NCT03118934|83108795|FG005|Overall Study|Physician Decision|1|||
46886329|NCT03118934|83108790|FG000|Overall Study|Discontinued prior to exposure|0|||
46886330|NCT03118934|83108791|FG001|Overall Study|Discontinued prior to exposure|1|||
46886331|NCT03118934|83108792|FG002|Overall Study|Discontinued prior to exposure|1|||
46886332|NCT03118934|83108793|FG003|Overall Study|Discontinued prior to exposure|1|||
46886333|NCT03118934|83108794|FG004|Overall Study|Discontinued prior to exposure|2|||
46886334|NCT03118934|83108795|FG005|Overall Study|Discontinued prior to exposure|0|||
46886335|NCT03114488|83108805|FG000|Time Period 2|Withdrawal by Subject|1|||
46886336|NCT03114488|83108806|FG001|Time Period 2|Withdrawal by Subject|3|||
46886337|NCT03135262|83108825|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
46886338|NCT03135262|83108826|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
46886339|NCT03135262|83108827|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
46886340|NCT03135262|83108828|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
46886341|NCT03135262|83108829|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
46886342|NCT03135262|83108825|FG000|Overall Study|Progression of disease|0|||
46886343|NCT03135262|83108826|FG001|Overall Study|Progression of disease|0|||
46886344|NCT03135262|83108827|FG002|Overall Study|Progression of disease|0|||
46886345|NCT03135262|83108828|FG003|Overall Study|Progression of disease|1|||
46886346|NCT03135262|83108829|FG004|Overall Study|Progression of disease|0|||
46886347|NCT03135262|83108825|FG000|Overall Study|Death|6|||
46886348|NCT03135262|83108826|FG001|Overall Study|Death|2|||
46886349|NCT03135262|83108827|FG002|Overall Study|Death|2|||
46886350|NCT03135262|83108828|FG003|Overall Study|Death|2|||
46886351|NCT03135262|83108829|FG004|Overall Study|Death|0|||
46886352|NCT03135262|83108825|FG000|Overall Study|Withdrawal by Subject|0|||
46886353|NCT03135262|83108826|FG001|Overall Study|Withdrawal by Subject|0|||
46886354|NCT03135262|83108827|FG002|Overall Study|Withdrawal by Subject|1|||
46886355|NCT03135262|83108828|FG003|Overall Study|Withdrawal by Subject|0|||
46886356|NCT03135262|83108829|FG004|Overall Study|Withdrawal by Subject|1|||
46886357|NCT03135262|83108825|FG000|Overall Study|Study terminated by sponsor|2|||
46886358|NCT03135262|83108826|FG001|Overall Study|Study terminated by sponsor|4|||
46886359|NCT03135262|83108827|FG002|Overall Study|Study terminated by sponsor|4|||
46886360|NCT03135262|83108828|FG003|Overall Study|Study terminated by sponsor|3|||
46886361|NCT03135262|83108829|FG004|Overall Study|Study terminated by sponsor|0|||
46886362|NCT03535194|83108864|FG000|Induction Period|Adverse Event|2|||
46886363|NCT03535194|83108865|FG001|Induction Period|Adverse Event|2|||
46886364|NCT03535194|83108866|FG002|Induction Period|Adverse Event|1|||
46886365|NCT03535194|83108867|FG003|Induction Period|Adverse Event|3|||
46886366|NCT03535194|83108868|FG004|Induction Period|Adverse Event|0|||
46886367|NCT03535194|83108864|FG000|Induction Period|Death|0|||
46886368|NCT03535194|83108865|FG001|Induction Period|Death|1|||
46886369|NCT03535194|83108866|FG002|Induction Period|Death|0|||
46886370|NCT03535194|83108867|FG003|Induction Period|Death|0|||
46886371|NCT03535194|83108868|FG004|Induction Period|Death|0|||
46886372|NCT03535194|83108864|FG000|Induction Period|Lack of Efficacy|1|||
46886373|NCT03535194|83108865|FG001|Induction Period|Lack of Efficacy|3|||
46886374|NCT03535194|83108866|FG002|Induction Period|Lack of Efficacy|2|||
46886375|NCT03535194|83108867|FG003|Induction Period|Lack of Efficacy|2|||
46886376|NCT03535194|83108868|FG004|Induction Period|Lack of Efficacy|0|||
46886377|NCT03535194|83108864|FG000|Induction Period|Lost to Follow-up|3|||
46886378|NCT03535194|83108865|FG001|Induction Period|Lost to Follow-up|5|||
46886379|NCT03535194|83108866|FG002|Induction Period|Lost to Follow-up|2|||
46886380|NCT03535194|83108867|FG003|Induction Period|Lost to Follow-up|3|||
46886381|NCT03535194|83108868|FG004|Induction Period|Lost to Follow-up|0|||
46886382|NCT03535194|83108864|FG000|Induction Period|Physician Decision|1|||
46886383|NCT03535194|83108865|FG001|Induction Period|Physician Decision|1|||
46886384|NCT03535194|83108866|FG002|Induction Period|Physician Decision|0|||
46886385|NCT03535194|83108867|FG003|Induction Period|Physician Decision|0|||
46886386|NCT03535194|83108868|FG004|Induction Period|Physician Decision|0|||
46886387|NCT03535194|83108864|FG000|Induction Period|Protocol Violation|1|||
46886388|NCT03535194|83108865|FG001|Induction Period|Protocol Violation|0|||
46886389|NCT03535194|83108866|FG002|Induction Period|Protocol Violation|0|||
46886390|NCT03535194|83108867|FG003|Induction Period|Protocol Violation|1|||
46886391|NCT03535194|83108868|FG004|Induction Period|Protocol Violation|0|||
46886392|NCT03535194|83108864|FG000|Induction Period|Screen Failure|0|||
46886393|NCT03535194|83108865|FG001|Induction Period|Screen Failure|1|||
46886394|NCT03535194|83108866|FG002|Induction Period|Screen Failure|0|||
46886395|NCT03535194|83108867|FG003|Induction Period|Screen Failure|0|||
46886396|NCT03535194|83108868|FG004|Induction Period|Screen Failure|0|||
46886397|NCT03535194|83108864|FG000|Induction Period|Withdrawal by Subject|3|||
46886398|NCT03535194|83108865|FG001|Induction Period|Withdrawal by Subject|4|||
46886399|NCT03535194|83108866|FG002|Induction Period|Withdrawal by Subject|3|||
46886400|NCT03535194|83108867|FG003|Induction Period|Withdrawal by Subject|2|||
46886401|NCT03535194|83108868|FG004|Induction Period|Withdrawal by Subject|0|||
46886402|NCT03535194|83108864|FG000|Maintenance Period|Adverse Event|6|||
46886403|NCT03535194|83108865|FG001|Maintenance Period|Adverse Event|5|||
46886404|NCT03535194|83108866|FG002|Maintenance Period|Adverse Event|1|||
46886405|NCT03535194|83108867|FG003|Maintenance Period|Adverse Event|11|||
46886406|NCT03535194|83108868|FG004|Maintenance Period|Adverse Event|4|||
46886407|NCT03535194|83108864|FG000|Maintenance Period|Lack of Efficacy|3|||
46886408|NCT03535194|83108865|FG001|Maintenance Period|Lack of Efficacy|2|||
46886409|NCT03535194|83108866|FG002|Maintenance Period|Lack of Efficacy|5|||
46886410|NCT03535194|83108867|FG003|Maintenance Period|Lack of Efficacy|9|||
46886411|NCT03535194|83108868|FG004|Maintenance Period|Lack of Efficacy|0|||
46886412|NCT03535194|83108864|FG000|Maintenance Period|Lost to Follow-up|4|||
46886413|NCT03535194|83108865|FG001|Maintenance Period|Lost to Follow-up|2|||
46886414|NCT03535194|83108866|FG002|Maintenance Period|Lost to Follow-up|1|||
46886415|NCT03535194|83108867|FG003|Maintenance Period|Lost to Follow-up|5|||
46886416|NCT03535194|83108868|FG004|Maintenance Period|Lost to Follow-up|2|||
46886417|NCT03535194|83108864|FG000|Maintenance Period|Other|1|||
46886418|NCT03535194|83108865|FG001|Maintenance Period|Other|2|||
46886419|NCT03535194|83108866|FG002|Maintenance Period|Other|0|||
46886420|NCT03535194|83108867|FG003|Maintenance Period|Other|0|||
46886421|NCT03535194|83108868|FG004|Maintenance Period|Other|0|||
46886422|NCT03535194|83108864|FG000|Maintenance Period|Physician Decision|1|||
46886423|NCT03535194|83108865|FG001|Maintenance Period|Physician Decision|2|||
46886424|NCT03535194|83108866|FG002|Maintenance Period|Physician Decision|0|||
46886425|NCT03535194|83108867|FG003|Maintenance Period|Physician Decision|2|||
46886426|NCT03535194|83108868|FG004|Maintenance Period|Physician Decision|0|||
46886427|NCT03535194|83108864|FG000|Maintenance Period|Pregnancy|0|||
46886428|NCT03535194|83108865|FG001|Maintenance Period|Pregnancy|0|||
46886429|NCT03535194|83108866|FG002|Maintenance Period|Pregnancy|0|||
46886430|NCT03535194|83108867|FG003|Maintenance Period|Pregnancy|2|||
46886431|NCT03535194|83108868|FG004|Maintenance Period|Pregnancy|0|||
46886432|NCT03535194|83108864|FG000|Maintenance Period|Protocol Violation|0|||
46886433|NCT03535194|83108865|FG001|Maintenance Period|Protocol Violation|1|||
46886434|NCT03535194|83108866|FG002|Maintenance Period|Protocol Violation|0|||
46886435|NCT03535194|83108867|FG003|Maintenance Period|Protocol Violation|0|||
46886436|NCT03535194|83108868|FG004|Maintenance Period|Protocol Violation|0|||
46886437|NCT03535194|83108864|FG000|Maintenance Period|Withdrawal by Subject|7|||
46886438|NCT03535194|83108865|FG001|Maintenance Period|Withdrawal by Subject|2|||
46886439|NCT03535194|83108866|FG002|Maintenance Period|Withdrawal by Subject|1|||
46886440|NCT03535194|83108867|FG003|Maintenance Period|Withdrawal by Subject|8|||
46886441|NCT03535194|83108868|FG004|Maintenance Period|Withdrawal by Subject|0|||
46886442|NCT03535194|83108864|FG000|Post-Treatment Followup Period|Adverse Event|4|||
46886443|NCT03535194|83108865|FG001|Post-Treatment Followup Period|Adverse Event|5|||
46886444|NCT03535194|83108866|FG002|Post-Treatment Followup Period|Adverse Event|1|||
46886445|NCT03535194|83108867|FG003|Post-Treatment Followup Period|Adverse Event|8|||
46886446|NCT03535194|83108868|FG004|Post-Treatment Followup Period|Adverse Event|0|||
46886447|NCT03535194|83108864|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
46886448|NCT03535194|83108865|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
46886449|NCT03535194|83108866|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
46886450|NCT03535194|83108867|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
46886451|NCT03535194|83108868|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
46886452|NCT03535194|83108864|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
46886453|NCT03535194|83108865|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
46886454|NCT03535194|83108866|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
46886455|NCT03535194|83108867|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
46886456|NCT03535194|83108868|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
46886457|NCT03535194|83108864|FG000|Post-Treatment Followup Period|Other|1|||
46886458|NCT03535194|83108865|FG001|Post-Treatment Followup Period|Other|0|||
46886459|NCT03535194|83108866|FG002|Post-Treatment Followup Period|Other|0|||
46886460|NCT03535194|83108867|FG003|Post-Treatment Followup Period|Other|5|||
46886461|NCT03535194|83108868|FG004|Post-Treatment Followup Period|Other|0|||
46886462|NCT03535194|83108864|FG000|Post-Treatment Followup Period|Physician Decision|0|||
46886463|NCT03535194|83108865|FG001|Post-Treatment Followup Period|Physician Decision|2|||
46886464|NCT03535194|83108866|FG002|Post-Treatment Followup Period|Physician Decision|1|||
46886465|NCT03535194|83108867|FG003|Post-Treatment Followup Period|Physician Decision|1|||
46886466|NCT03535194|83108868|FG004|Post-Treatment Followup Period|Physician Decision|0|||
46886467|NCT03535194|83108864|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
46886468|NCT03535194|83108865|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
46886469|NCT03535194|83108866|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
46886470|NCT03535194|83108867|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
46886471|NCT03535194|83108868|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
46886472|NCT03559530|83108892|FG000|Overall Study|non-location of medical records|44|||
46886473|NCT03559530|83108893|FG001|Overall Study|non-location of medical records|0|||
46886474|NCT03559530|83108892|FG000|Overall Study|culture results not considered for treat|29|||
46886475|NCT03559530|83108893|FG001|Overall Study|culture results not considered for treat|0|||
46886476|NCT03559530|83108892|FG000|Overall Study|duplicate cases|8|||
46886477|NCT03559530|83108893|FG001|Overall Study|duplicate cases|0|||
46886478|NCT03559530|83108892|FG000|Overall Study|other species of Acinetobacte|7|||
46886479|NCT03559530|83108893|FG001|Overall Study|other species of Acinetobacte|0|||
46886480|NCT03559530|83108892|FG000|Overall Study|contamination / colonization|3|||
46886481|NCT03559530|83108893|FG001|Overall Study|contamination / colonization|0|||
46886482|NCT03124784|83108921|FG000|Overall Study|Adverse Event|1|||
46886483|NCT03124784|83108921|FG000|Overall Study|Computer/Equip Malfunction|1|||
46886484|NCT03531840|83108929|FG000|Overall Study|Death on study|3|||
46886485|NCT03531840|83108930|FG001|Overall Study|Death on study|2|||
46886486|NCT03531840|83108931|FG002|Overall Study|Death on study|1|||
46705647|NCT01160484|82920510|FG000|Overall Study|Lack of Efficacy|9|||
46886487|NCT03531840|83108932|FG003|Overall Study|Death on study|2|||
46886488|NCT03531840|83108929|FG000|Overall Study|Death during follow up|2|||
46886489|NCT03531840|83108930|FG001|Overall Study|Death during follow up|3|||
46886490|NCT03531840|83108931|FG002|Overall Study|Death during follow up|4|||
46886491|NCT03531840|83108932|FG003|Overall Study|Death during follow up|1|||
46886492|NCT03110900|83108949|FG000|Overall Study|Sponsor withdrew|1|||
46886493|NCT03110900|83108950|FG001|Overall Study|Sponsor withdrew|1|||
46886494|NCT03867734|83108956|FG000|Overall Study|Lost to Follow-up|2|||
46886495|NCT03446456|83108966|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
46886496|NCT03446456|83108967|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
46886497|NCT03446456|83108966|FG000|Overall Study|Lost to Follow-up|1|||
46886498|NCT03446456|83108967|FG001|Overall Study|Lost to Follow-up|3|||
46886499|NCT03446456|83108966|FG000|Overall Study|Participant failed the toxicology test|1|||
46886500|NCT03446456|83108967|FG001|Overall Study|Participant failed the toxicology test|0|||
46886501|NCT03446456|83108966|FG000|Overall Study|Break down of the experimental equipment|1|||
46886502|NCT03446456|83108967|FG001|Overall Study|Break down of the experimental equipment|0|||
46886503|NCT03495102|83108976|FG000|Overall Study|Adverse Event|5|||
46886504|NCT03495102|83108977|FG001|Overall Study|Adverse Event|7|||
46886505|NCT03495102|83108978|FG002|Overall Study|Adverse Event|10|||
46886506|NCT03495102|83108976|FG000|Overall Study|Death|3|||
46886507|NCT03495102|83108977|FG001|Overall Study|Death|4|||
46886508|NCT03495102|83108978|FG002|Overall Study|Death|4|||
46886509|NCT03495102|83108976|FG000|Overall Study|Lost to Follow-up|15|||
46886510|NCT03495102|83108977|FG001|Overall Study|Lost to Follow-up|16|||
46705648|NCT01160484|82920510|FG000|Overall Study|Adverse Event|6|||
46705649|NCT01160484|82920510|FG000|Overall Study|Withdrawal by Subject|2|||
46705650|NCT01160484|82920510|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
46705651|NCT01032291|82920517|FG000|Safety Lead-in|Adverse Event|1|||
46705652|NCT01032291|82920518|FG001|Safety Lead-in|Adverse Event|0|||
46705653|NCT01032291|82920519|FG002|Safety Lead-in|Adverse Event|0|||
46705654|NCT01032291|82920517|FG000|Safety Lead-in|Death|1|||
46705655|NCT01032291|82920518|FG001|Safety Lead-in|Death|0|||
46705656|NCT01032291|82920519|FG002|Safety Lead-in|Death|0|||
46705657|NCT01032291|82920517|FG000|Proof of Concept|Adverse Event|0|||
46705658|NCT01032291|82920518|FG001|Proof of Concept|Adverse Event|5|||
46705659|NCT01032291|82920519|FG002|Proof of Concept|Adverse Event|1|||
46705660|NCT01032291|82920517|FG000|Proof of Concept|Death|0|||
46705661|NCT01032291|82920518|FG001|Proof of Concept|Death|1|||
46705662|NCT01032291|82920519|FG002|Proof of Concept|Death|2|||
46705663|NCT01032291|82920517|FG000|Proof of Concept|Lack of Efficacy|0|||
46705664|NCT01032291|82920518|FG001|Proof of Concept|Lack of Efficacy|1|||
46705665|NCT01032291|82920519|FG002|Proof of Concept|Lack of Efficacy|0|||
46705666|NCT01032291|82920517|FG000|Proof of Concept|Never Received Study Drug|0|||
46705667|NCT01032291|82920518|FG001|Proof of Concept|Never Received Study Drug|1|||
46705668|NCT01032291|82920519|FG002|Proof of Concept|Never Received Study Drug|0|||
46705669|NCT01159938|82920533|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
46705670|NCT01159938|82920534|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
46705671|NCT01159938|82920535|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
46705672|NCT01159938|82920536|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
46705673|NCT01159938|82920537|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
46705674|NCT01029405|82920562|FG000|Overall Study|Withdrawal by Subject|0|||
46705675|NCT01029405|82920563|FG001|Overall Study|Withdrawal by Subject|1|||
46705676|NCT01029405|82920564|FG002|Overall Study|Withdrawal by Subject|2|||
46705677|NCT01029405|82920565|FG003|Overall Study|Withdrawal by Subject|0|||
46705678|NCT01029405|82920562|FG000|Overall Study|Protocol Violation|0|||
46705679|NCT01029405|82920563|FG001|Overall Study|Protocol Violation|0|||
46886511|NCT03495102|83108978|FG002|Overall Study|Lost to Follow-up|17|||
46886512|NCT03495102|83108976|FG000|Overall Study|Physician Decision|2|||
46886513|NCT03495102|83108977|FG001|Overall Study|Physician Decision|0|||
46886514|NCT03495102|83108978|FG002|Overall Study|Physician Decision|2|||
46886515|NCT03495102|83108976|FG000|Overall Study|Withdrawal by Subject|25|||
46886516|NCT03495102|83108977|FG001|Overall Study|Withdrawal by Subject|36|||
46886517|NCT03495102|83108978|FG002|Overall Study|Withdrawal by Subject|18|||
46886518|NCT03495102|83108976|FG000|Overall Study|Protocol Violation|1|||
46886519|NCT03495102|83108977|FG001|Overall Study|Protocol Violation|1|||
46886520|NCT03495102|83108978|FG002|Overall Study|Protocol Violation|0|||
46886521|NCT03495102|83108976|FG000|Overall Study|Site Closure|3|||
46886522|NCT03495102|83108977|FG001|Overall Study|Site Closure|1|||
46705680|NCT01029405|82920564|FG002|Overall Study|Protocol Violation|0|||
46705681|NCT01029405|82920565|FG003|Overall Study|Protocol Violation|1|||
46886523|NCT03495102|83108978|FG002|Overall Study|Site Closure|2|||
46886524|NCT03495102|83108976|FG000|Overall Study|Non-compliance|1|||
46886525|NCT03495102|83108977|FG001|Overall Study|Non-compliance|0|||
46886526|NCT03495102|83108978|FG002|Overall Study|Non-compliance|0|||
46886527|NCT03495102|83108976|FG000|Overall Study|Participant Duplicated at Another Site|0|||
46705682|NCT01029405|82920562|FG000|Overall Study|Adverse Event|0|||
46705683|NCT01029405|82920563|FG001|Overall Study|Adverse Event|0|||
46897424|NCT02963766|83123114|FG002|Double-Blind Period|Adverse Event|1|||
46705684|NCT01029405|82920564|FG002|Overall Study|Adverse Event|1|||
46705685|NCT01029405|82920565|FG003|Overall Study|Adverse Event|1|||
46705686|NCT01029405|82920562|FG000|Overall Study|Lost to Follow-up|2|||
46705687|NCT01029405|82920563|FG001|Overall Study|Lost to Follow-up|1|||
46705688|NCT01029405|82920564|FG002|Overall Study|Lost to Follow-up|1|||
46705689|NCT01029405|82920565|FG003|Overall Study|Lost to Follow-up|2|||
46705690|NCT01029405|82920562|FG000|Overall Study|Other|0|||
46705691|NCT01029405|82920563|FG001|Overall Study|Other|1|||
46705692|NCT01029405|82920564|FG002|Overall Study|Other|0|||
46705693|NCT01029405|82920565|FG003|Overall Study|Other|1|||
46705694|NCT01021683|82920575|FG000|Overall Study|Lack of Efficacy|12|||
46705695|NCT01021683|82920575|FG000|Overall Study|Recovery of neutrophil count|51|||
46705696|NCT01021683|82920575|FG000|Overall Study|Other|8|||
46705697|NCT01021293|82920581|FG000|Overall Study|Serious Adverse Event|2|||
46705698|NCT01021293|82920582|FG001|Overall Study|Serious Adverse Event|1|||
46705699|NCT01021293|82920581|FG000|Overall Study|Adverse Event|2|||
46705700|NCT01021293|82920582|FG001|Overall Study|Adverse Event|1|||
46705701|NCT01021293|82920581|FG000|Overall Study|Withdrawal by Subject|1|||
46705702|NCT01021293|82920582|FG001|Overall Study|Withdrawal by Subject|3|||
46705703|NCT01021293|82920581|FG000|Overall Study|Migrated/moved from study area|6|||
46705704|NCT01021293|82920582|FG001|Overall Study|Migrated/moved from study area|18|||
46705705|NCT01021293|82920581|FG000|Overall Study|Lost to Follow-up|1|||
46705706|NCT01021293|82920582|FG001|Overall Study|Lost to Follow-up|1|||
46705707|NCT04625725|82920591|FG000|Overall Study|Death|4|||
46705708|NCT04625725|82920592|FG001|Overall Study|Death|4|||
46705709|NCT04625725|82920591|FG000|Overall Study|Lost to Follow-up|11|||
46705710|NCT04625725|82920592|FG001|Overall Study|Lost to Follow-up|8|||
46705711|NCT04625725|82920591|FG000|Overall Study|Physician Decision|1|||
46705712|NCT04625725|82920592|FG001|Overall Study|Physician Decision|0|||
46705713|NCT04625725|82920591|FG000|Overall Study|Withdrawal by Subject|56|||
46705714|NCT04625725|82920592|FG001|Overall Study|Withdrawal by Subject|32|||
46705715|NCT04625725|82920591|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
46705716|NCT04625725|82920592|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
46705717|NCT04625725|82920591|FG000|Overall Study|Ongoing in study|3409|||
46705718|NCT04625725|82920592|FG001|Overall Study|Ongoing in study|1700|||
46705719|NCT04625725|82920591|FG000|Overall Study|Protocol Deviation|1|||
46705720|NCT04625725|82920592|FG001|Overall Study|Protocol Deviation|0|||
46705721|NCT01021215|82920600|FG000|Overall Study|Lost to Follow-up|3|||
46705722|NCT01021215|82920601|FG001|Overall Study|Lost to Follow-up|0|||
46705723|NCT01021137|82920611|FG000|Overall Study|Lost to Follow-up|9|||
46705724|NCT01021137|82920612|FG001|Overall Study|Lost to Follow-up|4|||
46705725|NCT01021137|82920613|FG002|Overall Study|Lost to Follow-up|2|||
46705726|NCT01021137|82920614|FG003|Overall Study|Lost to Follow-up|6|||
46705727|NCT01021137|82920611|FG000|Overall Study|Withdrawal by Subject|1|||
46705728|NCT01021137|82920612|FG001|Overall Study|Withdrawal by Subject|0|||
46705729|NCT01021137|82920613|FG002|Overall Study|Withdrawal by Subject|0|||
46705730|NCT01021137|82920614|FG003|Overall Study|Withdrawal by Subject|3|||
46705731|NCT01020981|82920627|FG000|Overall Study|Did not return mailed survey|74|||
46705732|NCT01020981|82920628|FG001|Overall Study|Did not return mailed survey|58|||
46705733|NCT01020981|82920627|FG000|Overall Study|Survey returned undeliverable|8|||
46705734|NCT01020981|82920628|FG001|Overall Study|Survey returned undeliverable|32|||
46705735|NCT01020981|82920627|FG000|Overall Study|Participant declined to complete survey|2|||
46705736|NCT01020981|82920628|FG001|Overall Study|Participant declined to complete survey|0|||
46705737|NCT01020747|82920636|FG000|Overall Study|Withdrawal by Subject|1|||
46705738|NCT01020435|82920643|FG000|Overall Study|Lost to Follow-up|0|||
46705739|NCT01020435|82920644|FG001|Overall Study|Lost to Follow-up|1|||
46705740|NCT01031979|82920653|FG000|Overall Study|Lost to Follow-up|5|||
46705741|NCT01031979|82920654|FG001|Overall Study|Lost to Follow-up|4|||
46705742|NCT01020123|82920667|FG000|Main Period|Withdrawal by Subject|6|||
46705743|NCT01020123|82920668|FG001|Main Period|Withdrawal by Subject|5|||
46705744|NCT01020123|82920669|FG002|Main Period|Withdrawal by Subject|3|||
46705745|NCT01020123|82920670|FG003|Main Period|Withdrawal by Subject|1|||
46705746|NCT01020123|82920671|FG004|Main Period|Withdrawal by Subject|6|||
46705747|NCT01020123|82920672|FG005|Main Period|Withdrawal by Subject|3|||
46705748|NCT01020123|82920673|FG006|Main Period|Withdrawal by Subject|2|||
46705749|NCT01020123|82920667|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
46705750|NCT01020123|82920668|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
46705751|NCT01020123|82920669|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
46705752|NCT01020123|82920670|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
46705753|NCT01020123|82920671|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
46705754|NCT01020123|82920672|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
46705755|NCT01020123|82920673|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
46705756|NCT01020123|82920667|FG000|Main Period|Adverse Event|5|||
46705757|NCT01020123|82920668|FG001|Main Period|Adverse Event|2|||
46705758|NCT01020123|82920669|FG002|Main Period|Adverse Event|2|||
46705759|NCT01020123|82920670|FG003|Main Period|Adverse Event|1|||
46705760|NCT01020123|82920671|FG004|Main Period|Adverse Event|1|||
46705761|NCT01020123|82920672|FG005|Main Period|Adverse Event|2|||
46705762|NCT01020123|82920673|FG006|Main Period|Adverse Event|1|||
46705763|NCT01020123|82920667|FG000|Main Period|Protocol Violation|4|||
46705764|NCT01020123|82920668|FG001|Main Period|Protocol Violation|4|||
46705765|NCT01020123|82920669|FG002|Main Period|Protocol Violation|2|||
46705766|NCT01020123|82920670|FG003|Main Period|Protocol Violation|5|||
46705767|NCT01020123|82920671|FG004|Main Period|Protocol Violation|2|||
46705768|NCT01020123|82920672|FG005|Main Period|Protocol Violation|3|||
46705769|NCT01020123|82920673|FG006|Main Period|Protocol Violation|2|||
46705770|NCT01020123|82920667|FG000|Main Period|Lost to Follow-up|0|||
46705771|NCT01020123|82920668|FG001|Main Period|Lost to Follow-up|2|||
46705772|NCT01020123|82920669|FG002|Main Period|Lost to Follow-up|0|||
46705773|NCT01020123|82920670|FG003|Main Period|Lost to Follow-up|0|||
46705774|NCT01020123|82920671|FG004|Main Period|Lost to Follow-up|0|||
46705775|NCT01020123|82920672|FG005|Main Period|Lost to Follow-up|0|||
46705776|NCT01020123|82920673|FG006|Main Period|Lost to Follow-up|0|||
46705777|NCT01020123|82920667|FG000|Main Period|Unclasified|2|||
46705778|NCT01020123|82920668|FG001|Main Period|Unclasified|0|||
46705779|NCT01020123|82920669|FG002|Main Period|Unclasified|1|||
46705780|NCT01020123|82920670|FG003|Main Period|Unclasified|0|||
46705781|NCT01020123|82920671|FG004|Main Period|Unclasified|1|||
46705782|NCT01020123|82920672|FG005|Main Period|Unclasified|3|||
46705783|NCT01020123|82920673|FG006|Main Period|Unclasified|6|||
46705784|NCT01020123|82920667|FG000|Extention Period|Withdrawal by Subject|2|||
46705785|NCT01020123|82920668|FG001|Extention Period|Withdrawal by Subject|1|||
46705786|NCT01020123|82920669|FG002|Extention Period|Withdrawal by Subject|1|||
46705787|NCT01020123|82920670|FG003|Extention Period|Withdrawal by Subject|0|||
46705788|NCT01020123|82920671|FG004|Extention Period|Withdrawal by Subject|0|||
46705789|NCT01020123|82920672|FG005|Extention Period|Withdrawal by Subject|0|||
46705790|NCT01020123|82920673|FG006|Extention Period|Withdrawal by Subject|0|||
46705791|NCT01020123|82920667|FG000|Extention Period|Adverse Event|0|||
46705792|NCT01020123|82920668|FG001|Extention Period|Adverse Event|0|||
46705793|NCT01020123|82920669|FG002|Extention Period|Adverse Event|0|||
46705794|NCT01020123|82920670|FG003|Extention Period|Adverse Event|1|||
46705795|NCT01020123|82920671|FG004|Extention Period|Adverse Event|0|||
46705796|NCT01020123|82920672|FG005|Extention Period|Adverse Event|0|||
46705797|NCT01020123|82920673|FG006|Extention Period|Adverse Event|0|||
46705798|NCT01020123|82920667|FG000|Extention Period|Protocol Violation|1|||
46705799|NCT01020123|82920668|FG001|Extention Period|Protocol Violation|1|||
46705800|NCT01020123|82920669|FG002|Extention Period|Protocol Violation|1|||
46705801|NCT01020123|82920670|FG003|Extention Period|Protocol Violation|0|||
46705802|NCT01020123|82920671|FG004|Extention Period|Protocol Violation|0|||
46705803|NCT01020123|82920672|FG005|Extention Period|Protocol Violation|0|||
46705804|NCT01020123|82920673|FG006|Extention Period|Protocol Violation|1|||
46705805|NCT01020123|82920667|FG000|Extention Period|Lost to Follow-up|0|||
46705806|NCT01020123|82920668|FG001|Extention Period|Lost to Follow-up|0|||
46705807|NCT01020123|82920669|FG002|Extention Period|Lost to Follow-up|0|||
46705808|NCT01020123|82920670|FG003|Extention Period|Lost to Follow-up|0|||
46705809|NCT01020123|82920671|FG004|Extention Period|Lost to Follow-up|0|||
46705810|NCT01020123|82920672|FG005|Extention Period|Lost to Follow-up|2|||
46705811|NCT01020123|82920673|FG006|Extention Period|Lost to Follow-up|0|||
46705812|NCT01028391|82920714|FG000|Overall Study|Adverse Event|4|||
46705813|NCT01028391|82920715|FG001|Overall Study|Adverse Event|0|||
46705814|NCT01028391|82920714|FG000|Overall Study|Lack of Efficacy|0|||
46705815|NCT01028391|82920715|FG001|Overall Study|Lack of Efficacy|2|||
46705816|NCT01028391|82920714|FG000|Overall Study|Lost to Follow-up|3|||
46705817|NCT01028391|82920715|FG001|Overall Study|Lost to Follow-up|4|||
46705818|NCT01028391|82920714|FG000|Overall Study|Physician Decision|0|||
46705819|NCT01028391|82920715|FG001|Overall Study|Physician Decision|1|||
46705820|NCT01028391|82920714|FG000|Overall Study|Withdrawal by Subject|6|||
46705821|NCT01028391|82920715|FG001|Overall Study|Withdrawal by Subject|3|||
46705822|NCT01028391|82920714|FG000|Overall Study|Needed excluded medication|1|||
46705823|NCT01028391|82920715|FG001|Overall Study|Needed excluded medication|1|||
46705824|NCT01179672|82920723|FG000|Overall Study|Adverse Event|17|||
46705825|NCT01179672|82920724|FG001|Overall Study|Adverse Event|8|||
46705826|NCT01179672|82920723|FG000|Overall Study|Withdrawal by Subject|10|||
46705827|NCT01179672|82920724|FG001|Overall Study|Withdrawal by Subject|12|||
46705828|NCT01179672|82920723|FG000|Overall Study|Entry Criteria Not Met|0|||
46705829|NCT01179672|82920724|FG001|Overall Study|Entry Criteria Not Met|2|||
46705830|NCT01179672|82920723|FG000|Overall Study|Lost to Follow-up|0|||
46705831|NCT01179672|82920724|FG001|Overall Study|Lost to Follow-up|1|||
46705832|NCT01179672|82920723|FG000|Overall Study|Protocol Violation|2|||
46705833|NCT01179672|82920724|FG001|Overall Study|Protocol Violation|2|||
46705834|NCT01179672|82920723|FG000|Overall Study|Physician Decision|1|||
46705835|NCT01179672|82920724|FG001|Overall Study|Physician Decision|1|||
46705836|NCT01030965|82920738|FG000|Overall Study|Lack of Efficacy|3|||
46705837|NCT01030965|82920739|FG001|Overall Study|Lack of Efficacy|2|||
46705838|NCT01030965|82920740|FG002|Overall Study|Lack of Efficacy|0|||
46705839|NCT01030965|82920741|FG003|Overall Study|Lack of Efficacy|3|||
46705840|NCT01030965|82920738|FG000|Overall Study|Protocol Violation|1|||
46705841|NCT01030965|82920739|FG001|Overall Study|Protocol Violation|1|||
46705842|NCT01030965|82920740|FG002|Overall Study|Protocol Violation|1|||
46705843|NCT01030965|82920741|FG003|Overall Study|Protocol Violation|1|||
46705844|NCT01030965|82920738|FG000|Overall Study|Adverse Event|0|||
46705845|NCT01030965|82920739|FG001|Overall Study|Adverse Event|1|||
46705846|NCT01030965|82920740|FG002|Overall Study|Adverse Event|2|||
46705847|NCT01030965|82920741|FG003|Overall Study|Adverse Event|1|||
46705848|NCT01030965|82920738|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
46705849|NCT01030965|82920739|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
46886528|NCT03495102|83108977|FG001|Overall Study|Participant Duplicated at Another Site|0|||
46886529|NCT03495102|83108978|FG002|Overall Study|Participant Duplicated at Another Site|1|||
46886530|NCT03495102|83108976|FG000|Overall Study|Primary Care Physician Recommendation|0|||
46886531|NCT03495102|83108977|FG001|Overall Study|Primary Care Physician Recommendation|1|||
46886532|NCT03495102|83108978|FG002|Overall Study|Primary Care Physician Recommendation|0|||
46886533|NCT03495102|83108976|FG000|Overall Study|Relocated to Another Country|0|||
46886534|NCT03495102|83108977|FG001|Overall Study|Relocated to Another Country|1|||
46886535|NCT03495102|83108978|FG002|Overall Study|Relocated to Another Country|0|||
46886536|NCT03495102|83108976|FG000|Overall Study|Participant was in Rehabilitation|1|||
46886537|NCT03495102|83108977|FG001|Overall Study|Participant was in Rehabilitation|0|||
46886538|NCT03495102|83108978|FG002|Overall Study|Participant was in Rehabilitation|0|||
46886539|NCT03105362|83108986|FG000|Overall Study|Withdrawal by Subject|1|||
46886540|NCT03105362|83108986|FG000|Overall Study|Lost to Follow-up|1|||
46886541|NCT03559218|83108995|FG000|Overall Study|Withdrawal by Subject|1|||
46886542|NCT03559218|83108996|FG001|Overall Study|Withdrawal by Subject|0|||
46886543|NCT03104816|83109005|FG000|Overall Study|Lack of Efficacy|0|||
46886544|NCT03104816|83109006|FG001|Overall Study|Lack of Efficacy|2|||
46886545|NCT03104816|83109007|FG002|Overall Study|Lack of Efficacy|0|||
46886546|NCT03104816|83109005|FG000|Overall Study|Protocol Violation|2|||
46886547|NCT03104816|83109006|FG001|Overall Study|Protocol Violation|0|||
46886548|NCT03104816|83109007|FG002|Overall Study|Protocol Violation|2|||
46886549|NCT03559062|83109018|FG000|Overall Study|Other|0|||
46886550|NCT03559062|83109019|FG001|Overall Study|Other|1|||
46886551|NCT03559062|83109020|FG002|Overall Study|Other|0|||
46886552|NCT00089791|83109031|FG000|Overall Study|Physician Decision|6|||
46886553|NCT00089791|83109032|FG001|Overall Study|Physician Decision|3|||
46886554|NCT00089791|83109031|FG000|Overall Study|Adverse Event|81|||
46886555|NCT00089791|83109032|FG001|Overall Study|Adverse Event|93|||
46886556|NCT00089791|83109031|FG000|Overall Study|Withdrawal by Subject|403|||
46886557|NCT00089791|83109032|FG001|Overall Study|Withdrawal by Subject|344|||
46886558|NCT00089791|83109031|FG000|Overall Study|Death|78|||
46886559|NCT00089791|83109032|FG001|Overall Study|Death|62|||
46886560|NCT00089791|83109031|FG000|Overall Study|Disease progression|7|||
46886561|NCT00089791|83109032|FG001|Overall Study|Disease progression|3|||
46886562|NCT00089791|83109031|FG000|Overall Study|Ineligibility determined|12|||
46886563|NCT00089791|83109032|FG001|Overall Study|Ineligibility determined|9|||
46886564|NCT00089791|83109031|FG000|Overall Study|Lost to Follow-up|57|||
46886565|NCT00089791|83109032|FG001|Overall Study|Lost to Follow-up|57|||
46886566|NCT00089791|83109031|FG000|Overall Study|Noncompliance|17|||
46886567|NCT00089791|83109032|FG001|Overall Study|Noncompliance|13|||
46886568|NCT00089791|83109031|FG000|Overall Study|Other|20|||
46886569|NCT00089791|83109032|FG001|Overall Study|Other|32|||
46886570|NCT00089791|83109031|FG000|Overall Study|Protocol deviation|12|||
46886571|NCT00089791|83109032|FG001|Overall Study|Protocol deviation|10|||
46886572|NCT00089791|83109031|FG000|Overall Study|Requirement for alternative therapy|7|||
46886573|NCT00089791|83109032|FG001|Overall Study|Requirement for alternative therapy|4|||
46886574|NCT03558672|83109038|FG000|Overall Study|Study Early Termination|10|||
46886575|NCT03558516|83109044|FG000|Overall Study|Protocol Violation|2|||
46886576|NCT03558516|83109045|FG001|Overall Study|Protocol Violation|2|||
46886577|NCT03557970|83109053|FG000|Overall Study|Study closure|1|||
46886578|NCT03557970|83109054|FG001|Overall Study|Study closure|0|||
46886579|NCT03557970|83109053|FG000|Overall Study|Physician Decision|0|||
46886580|NCT03557970|83109054|FG001|Overall Study|Physician Decision|1|||
46886581|NCT03557970|83109053|FG000|Overall Study|Death|0|||
46886582|NCT03557970|83109054|FG001|Overall Study|Death|1|||
46886583|NCT02815280|83109062|FG000|Double-Blind Phase|Adverse Event|1|||
46886584|NCT02815280|83109063|FG001|Double-Blind Phase|Adverse Event|1|||
46886585|NCT02815280|83109062|FG000|Double-Blind Phase|Lost to Follow-up|10|||
46886586|NCT02815280|83109063|FG001|Double-Blind Phase|Lost to Follow-up|9|||
46705850|NCT01030965|82920740|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
46705851|NCT01030965|82920741|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
46886587|NCT02815280|83109062|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
46886588|NCT02815280|83109063|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
46886589|NCT02815280|83109062|FG000|Double-Blind Phase|Protocol Violation|2|||
46886590|NCT02815280|83109063|FG001|Double-Blind Phase|Protocol Violation|2|||
46886591|NCT02815280|83109062|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
46886592|NCT02815280|83109063|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
46886593|NCT02815280|83109062|FG000|Open-Label Phase|Adverse Event|2|||
46886594|NCT02815280|83109063|FG001|Open-Label Phase|Adverse Event|3|||
46886595|NCT02815280|83109062|FG000|Open-Label Phase|Lost to Follow-up|18|||
46886596|NCT02815280|83109063|FG001|Open-Label Phase|Lost to Follow-up|9|||
46886597|NCT02815280|83109062|FG000|Open-Label Phase|Withdrawal by Subject|33|||
46886598|NCT02815280|83109063|FG001|Open-Label Phase|Withdrawal by Subject|18|||
46886599|NCT02815280|83109062|FG000|Open-Label Phase|Protocol Violation|3|||
46886600|NCT02815280|83109063|FG001|Open-Label Phase|Protocol Violation|0|||
46886601|NCT02815280|83109062|FG000|Open-Label Phase|Administrative|26|||
46886602|NCT02815280|83109063|FG001|Open-Label Phase|Administrative|12|||
46886603|NCT02815280|83109062|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
46886604|NCT02815280|83109063|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
46886605|NCT02737930|83109075|FG000|Overall Study|Withdrawal by Subject|0|||
46886606|NCT02737930|83109076|FG001|Overall Study|Withdrawal by Subject|1|||
46886607|NCT03493698|83109082|FG000|Treatment Period C|Adverse Event|1|||
46886608|NCT03493698|83109082|FG000|Treatment Period C|Withdrawal by Subject|1|||
46886609|NCT02737852|83109096|FG000|Overall Study|Withdrawal by Subject|2|||
46886610|NCT03528174|83109100|FG000|Overall Study|Adverse Event|1|||
46886611|NCT03528174|83109100|FG000|Overall Study|sensors dislodged|1|||
46886612|NCT03109184|83109110|FG000|Overall Study|Lost to Follow-up|6|||
46886613|NCT03109184|83109111|FG001|Overall Study|Lost to Follow-up|6|||
46886614|NCT03109184|83109110|FG000|Overall Study|Withdrawal by Subject|1|||
46886615|NCT03109184|83109111|FG001|Overall Study|Withdrawal by Subject|1|||
46886616|NCT03493386|83109129|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46886617|NCT03493386|83109130|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
46886618|NCT03493386|83109131|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46886619|NCT03493386|83109132|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
46886620|NCT03478644|83109151|FG000|Phase 2|Withdrawal by Subject|2|||
46886621|NCT03478644|83109152|FG001|Phase 2|Withdrawal by Subject|1|||
46886622|NCT03478644|83109151|FG000|Phase 2|Lost to Follow-up|1|||
46886623|NCT03478644|83109152|FG001|Phase 2|Lost to Follow-up|0|||
46886624|NCT03527550|83109160|FG000|Overall Study|Lost to Follow-up|4|||
46886625|NCT03527550|83109161|FG001|Overall Study|Lost to Follow-up|2|||
46886626|NCT03527550|83109160|FG000|Overall Study|Withdrawal by Subject|4|||
46886627|NCT03527550|83109161|FG001|Overall Study|Withdrawal by Subject|1|||
46886628|NCT03527550|83109160|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
46886629|NCT03527550|83109161|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
46886630|NCT03475056|83109171|FG000|Overall Study|Lost to Follow-up|0|||
46886631|NCT03475056|83109172|FG001|Overall Study|Lost to Follow-up|1|||
46886632|NCT03475056|83109171|FG000|Overall Study|Moved from Area|0|||
46886633|NCT03475056|83109172|FG001|Overall Study|Moved from Area|2|||
46886634|NCT00938912|83109179|FG000|Overall Study|Withdrawal by Subject|28|||
46886635|NCT00938912|83109179|FG000|Overall Study|Lost to Follow-up|4|||
46886636|NCT00938912|83109179|FG000|Overall Study|Lack of Efficacy|43|||
46886637|NCT00938912|83109179|FG000|Overall Study|Adverse event, non-fatal|24|||
46886638|NCT00938912|83109179|FG000|Overall Study|Adverse event, fatal|1|||
46886639|NCT00938912|83109179|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
46886640|NCT00938912|83109179|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
46886641|NCT00938912|83109179|FG000|Overall Study|Participant needed prohibit medication|1|||
46886642|NCT00938912|83109179|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
46886643|NCT00938912|83109179|FG000|Overall Study|Did not meet Eligibility criteria|1|||
46886644|NCT00938912|83109179|FG000|Overall Study|Participant relocated not related to AE|1|||
46886645|NCT00938912|83109179|FG000|Overall Study|Participant moved to another city|1|||
46886646|NCT00938912|83109179|FG000|Overall Study|Participant experienced break through seizures|1|||
46886647|NCT00938912|83109179|FG000|Overall Study|No longer wished to participate in the study|1|||
46886648|NCT00938912|83109179|FG000|Overall Study|Protocol Deviation|2|||
46886649|NCT03473808|83109186|FG000|Overall Study|Withdrawal by Subject|1|||
46886650|NCT03473340|83109192|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
46886651|NCT03473340|83109193|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
46886652|NCT03473340|83109192|FG000|Overall Study|Withdrawal by Subject|1|||
46886653|NCT03473340|83109193|FG001|Overall Study|Withdrawal by Subject|0|||
46886654|NCT03473340|83109192|FG000|Overall Study|Lost to Follow-up|1|||
46886655|NCT03473340|83109193|FG001|Overall Study|Lost to Follow-up|2|||
46705852|NCT01030965|82920738|FG000|Overall Study|Withdrawal by Subject|0|||
46705853|NCT01030965|82920739|FG001|Overall Study|Withdrawal by Subject|1|||
46886656|NCT03490032|83109202|FG000|Overall Study|family issue (child custody)|1|||
46886657|NCT03490032|83109203|FG001|Overall Study|family issue (child custody)|0|||
46886658|NCT03490032|83109204|FG002|Overall Study|family issue (child custody)|0|||
46886659|NCT03489720|83109224|FG000|Overall Study|Withdrawal by Subject|2|||
46886660|NCT03489720|83109225|FG001|Overall Study|Withdrawal by Subject|0|||
46886661|NCT03527160|83109237|FG000|Overall Study|No urine collected|13|||
46886662|NCT03527160|83109237|FG000|Overall Study|No clinical serum creatinine collected|6|||
46886663|NCT03527160|83109237|FG000|Overall Study|Did not meet inclusion|2|||
46886664|NCT03739138|83109247|FG000|Overall Study|Death|0|||
46886665|NCT03739138|83109248|FG001|Overall Study|Death|7|||
46886666|NCT03739138|83109249|FG002|Overall Study|Death|4|||
46886667|NCT03739138|83109250|FG003|Overall Study|Death|13|||
46886668|NCT03739138|83109251|FG004|Overall Study|Death|0|||
46886669|NCT03739138|83109247|FG000|Overall Study|Lost to Follow-up|0|||
46886670|NCT03739138|83109248|FG001|Overall Study|Lost to Follow-up|0|||
46886671|NCT03739138|83109249|FG002|Overall Study|Lost to Follow-up|1|||
46886672|NCT03739138|83109250|FG003|Overall Study|Lost to Follow-up|0|||
46886673|NCT03739138|83109251|FG004|Overall Study|Lost to Follow-up|0|||
46886674|NCT03739138|83109247|FG000|Overall Study|Study Terminated By Sponsor|0|||
46886675|NCT03739138|83109248|FG001|Overall Study|Study Terminated By Sponsor|0|||
46886676|NCT03739138|83109249|FG002|Overall Study|Study Terminated By Sponsor|0|||
46886677|NCT03739138|83109250|FG003|Overall Study|Study Terminated By Sponsor|4|||
46886678|NCT03739138|83109251|FG004|Overall Study|Study Terminated By Sponsor|0|||
46886679|NCT03739138|83109247|FG000|Overall Study|Withdrawal by Subject|0|||
46886680|NCT03739138|83109248|FG001|Overall Study|Withdrawal by Subject|0|||
46886681|NCT03739138|83109249|FG002|Overall Study|Withdrawal by Subject|0|||
46886682|NCT03739138|83109250|FG003|Overall Study|Withdrawal by Subject|1|||
46886683|NCT03739138|83109251|FG004|Overall Study|Withdrawal by Subject|0|||
46886684|NCT03472326|83109261|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
46886685|NCT03472326|83109262|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
46886686|NCT03472326|83109263|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
46886687|NCT03472326|83109264|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
46886688|NCT03472326|83109261|FG000|Part 2: Combination Therapy|Pregnancy|0|||
46886689|NCT03472326|83109262|FG001|Part 2: Combination Therapy|Pregnancy|0|||
46886690|NCT03472326|83109263|FG002|Part 2: Combination Therapy|Pregnancy|0|||
46886691|NCT03472326|83109264|FG003|Part 2: Combination Therapy|Pregnancy|1|||
46886692|NCT02737618|83109273|FG000|Overall Study|Withdrawal by Subject|9|||
46886693|NCT03472014|83109277|FG000|Overall Study|Lost to Follow-up|4|||
46886694|NCT03526458|83109283|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
46886695|NCT03526458|83109284|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
46886696|NCT03526458|83109283|FG000|Overall Study|Stone passed, surgery cancelled|2|||
46886697|NCT03526458|83109284|FG001|Overall Study|Stone passed, surgery cancelled|1|||
46886698|NCT03526458|83109283|FG000|Overall Study|Withdrawal by Subject|1|||
46886699|NCT03526458|83109284|FG001|Overall Study|Withdrawal by Subject|0|||
46886700|NCT03526458|83109283|FG000|Overall Study|Physician Decision|2|||
46886701|NCT03526458|83109284|FG001|Overall Study|Physician Decision|1|||
46886702|NCT03526458|83109283|FG000|Overall Study|Lack of equipment|1|||
46886703|NCT03526458|83109284|FG001|Overall Study|Lack of equipment|1|||
46886704|NCT03488238|83109290|FG000|Overall Study|Equipment malfunction|1|||
46886705|NCT03488238|83109290|FG000|Overall Study|Adverse Event|1|||
46886706|NCT03525834|83109294|FG000|Overall Study|Progressive disease|1|||
46886707|NCT03525444|83109336|FG000|Overall Study|Adverse Event|0|||
46886708|NCT03525444|83109337|FG001|Overall Study|Adverse Event|1|||
46886709|NCT03525444|83109336|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
46886710|NCT03525444|83109337|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
46886711|NCT03525444|83109336|FG000|Overall Study|Other|0|||
46886712|NCT03525444|83109337|FG001|Overall Study|Other|1|||
46886713|NCT03487848|83109344|FG000|Overall Study|Lost to Follow-up|1|||
46886714|NCT03524664|83109350|FG000|Overall Study|Withdrawal by Subject|1|||
46897653|NCT00706030|83123369|FG002|Overall Study|Not recorded|2|||
46886715|NCT03524664|83109351|FG001|Overall Study|Withdrawal by Subject|2|||
46886716|NCT03524664|83109350|FG000|Overall Study|Lost to Follow-up|4|||
46886717|NCT03524664|83109351|FG001|Overall Study|Lost to Follow-up|13|||
46886718|NCT04377620|83109360|FG000|Overall Study|Death|42|||
46886719|NCT04377620|83109361|FG001|Overall Study|Death|48|||
46886720|NCT04377620|83109362|FG002|Overall Study|Death|36|||
46886721|NCT04377620|83109360|FG000|Overall Study|Withdrawal by Subject|0|||
46886722|NCT04377620|83109361|FG001|Overall Study|Withdrawal by Subject|2|||
46886723|NCT04377620|83109362|FG002|Overall Study|Withdrawal by Subject|0|||
46886724|NCT03522948|83109371|FG000|Overall Study|Lost to Follow-up|1|||
46886725|NCT03406078|83109377|FG000|Overall Study|Death|1|||
46886726|NCT03406078|83109378|FG001|Overall Study|Death|0|||
46886727|NCT03406078|83109377|FG000|Overall Study|Lost to Follow-up|0|||
46886728|NCT03406078|83109378|FG001|Overall Study|Lost to Follow-up|1|||
46886729|NCT03406078|83109377|FG000|Overall Study|Withdrawal by Subject|5|||
46886730|NCT03406078|83109378|FG001|Overall Study|Withdrawal by Subject|2|||
46886731|NCT03634033|83109391|FG000|Overall Study|Did not have a post-assessment|384|||
46886732|NCT03634033|83109392|FG001|Overall Study|Did not have a post-assessment|291|||
46886733|NCT03634033|83109393|FG002|Overall Study|Did not have a post-assessment|114|||
46886734|NCT03634033|83109394|FG003|Overall Study|Did not have a post-assessment|161|||
46886735|NCT03634033|83109395|FG004|Overall Study|Did not have a post-assessment|5|||
46886736|NCT03634033|83109396|FG005|Overall Study|Did not have a post-assessment|0|||
46886737|NCT03634033|83109397|FG006|Overall Study|Did not have a post-assessment|0|||
46886738|NCT03634033|83109391|FG000|Overall Study|Death|0|||
46886739|NCT03634033|83109392|FG001|Overall Study|Death|0|||
46886740|NCT03634033|83109393|FG002|Overall Study|Death|0|||
46886741|NCT03634033|83109394|FG003|Overall Study|Death|0|||
46886742|NCT03634033|83109395|FG004|Overall Study|Death|0|||
46886743|NCT03634033|83109396|FG005|Overall Study|Death|7|||
46886744|NCT03634033|83109397|FG006|Overall Study|Death|7|||
46886745|NCT03634033|83109391|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
46886746|NCT03634033|83109392|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
46886747|NCT03634033|83109393|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
46886748|NCT03634033|83109394|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
46886749|NCT03634033|83109395|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
46886750|NCT03634033|83109396|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
46886751|NCT03634033|83109397|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
46886752|NCT03634033|83109391|FG000|Overall Study|Lost to Follow-up|0|||
46886753|NCT03634033|83109392|FG001|Overall Study|Lost to Follow-up|0|||
46886754|NCT03634033|83109393|FG002|Overall Study|Lost to Follow-up|0|||
46886755|NCT03634033|83109394|FG003|Overall Study|Lost to Follow-up|0|||
46886756|NCT03634033|83109395|FG004|Overall Study|Lost to Follow-up|0|||
46886757|NCT03634033|83109396|FG005|Overall Study|Lost to Follow-up|1|||
46886758|NCT03634033|83109397|FG006|Overall Study|Lost to Follow-up|2|||
46886759|NCT03634033|83109391|FG000|Overall Study|Withdrawal by Subject|0|||
46886760|NCT03634033|83109392|FG001|Overall Study|Withdrawal by Subject|0|||
46886761|NCT03634033|83109393|FG002|Overall Study|Withdrawal by Subject|0|||
46886762|NCT03634033|83109394|FG003|Overall Study|Withdrawal by Subject|0|||
46886763|NCT03634033|83109395|FG004|Overall Study|Withdrawal by Subject|0|||
46886764|NCT03634033|83109396|FG005|Overall Study|Withdrawal by Subject|0|||
46886765|NCT03634033|83109397|FG006|Overall Study|Withdrawal by Subject|1|||
46886766|NCT03103100|83109431|FG000|Overall Study|Adverse Event|1|||
46886767|NCT03103100|83109432|FG001|Overall Study|Adverse Event|0|||
46886768|NCT03103100|83109433|FG002|Overall Study|Adverse Event|0|||
46886769|NCT03103100|83109431|FG000|Overall Study|Physician Decision|1|||
46886770|NCT03103100|83109432|FG001|Overall Study|Physician Decision|0|||
46886771|NCT03103100|83109433|FG002|Overall Study|Physician Decision|2|||
46886772|NCT03438006|83109441|FG000|Overall Study|Adverse Event|1|||
46886773|NCT03438006|83109441|FG000|Overall Study|Lost to Follow-up|67|||
46886774|NCT03438006|83109441|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
46886775|NCT03438006|83109441|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
46886776|NCT04206020|83109447|FG000|Overall Study|Adverse Event|1|||
46886777|NCT04206020|83109448|FG001|Overall Study|Adverse Event|4|||
46886778|NCT04206020|83109447|FG000|Overall Study|Protocol Violation|2|||
46886779|NCT04206020|83109448|FG001|Overall Study|Protocol Violation|0|||
46886780|NCT04206020|83109447|FG000|Overall Study|Withdrawal by Subject|2|||
46886781|NCT04206020|83109448|FG001|Overall Study|Withdrawal by Subject|0|||
46886782|NCT04206020|83109447|FG000|Overall Study|Lost to Follow-up|2|||
46886783|NCT04206020|83109448|FG001|Overall Study|Lost to Follow-up|0|||
46886784|NCT04206020|83109447|FG000|Overall Study|Pregnancy|0|||
46886785|NCT04206020|83109448|FG001|Overall Study|Pregnancy|1|||
46886786|NCT04206020|83109447|FG000|Overall Study|Unable to attend visits|1|||
46886787|NCT04206020|83109448|FG001|Overall Study|Unable to attend visits|2|||
46886788|NCT03466086|83109454|FG000|Period 1|Sponsor decision due to study timeline|1|||
46886789|NCT03466086|83109455|FG001|Period 1|Sponsor decision due to study timeline|0|||
46886790|NCT03466086|83109454|FG000|Period 1|Withdrawal by Subject|1|||
46886791|NCT03466086|83109455|FG001|Period 1|Withdrawal by Subject|0|||
46886792|NCT03101462|83109463|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
46886793|NCT03101462|83109464|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
46886794|NCT02873936|83109473|FG000|Overall Study|Withdrew Consent|4|||
46886795|NCT02873936|83109474|FG001|Overall Study|Withdrew Consent|11|||
46886796|NCT02873936|83109475|FG002|Overall Study|Withdrew Consent|20|||
46886797|NCT02873936|83109473|FG000|Overall Study|Investigator's Discretion|3|||
46886798|NCT02873936|83109474|FG001|Overall Study|Investigator's Discretion|5|||
46886799|NCT02873936|83109475|FG002|Overall Study|Investigator's Discretion|4|||
46886800|NCT02873936|83109473|FG000|Overall Study|Adverse Event|3|||
46886801|NCT02873936|83109474|FG001|Overall Study|Adverse Event|5|||
46886802|NCT02873936|83109475|FG002|Overall Study|Adverse Event|3|||
46886803|NCT02873936|83109473|FG000|Overall Study|Protocol Violation|0|||
46886804|NCT02873936|83109474|FG001|Overall Study|Protocol Violation|1|||
46886805|NCT02873936|83109475|FG002|Overall Study|Protocol Violation|3|||
46886806|NCT02873936|83109473|FG000|Overall Study|Lost to Follow-up|1|||
46886807|NCT02873936|83109474|FG001|Overall Study|Lost to Follow-up|1|||
46886808|NCT02873936|83109475|FG002|Overall Study|Lost to Follow-up|1|||
46886809|NCT02873936|83109473|FG000|Overall Study|Non-compliance With Study Drug|1|||
46886810|NCT02873936|83109474|FG001|Overall Study|Non-compliance With Study Drug|0|||
46886811|NCT02873936|83109475|FG002|Overall Study|Non-compliance With Study Drug|1|||
46886812|NCT02873936|83109473|FG000|Overall Study|Randomized but not Dosed|1|||
46886813|NCT02873936|83109474|FG001|Overall Study|Randomized but not Dosed|0|||
46886814|NCT02873936|83109475|FG002|Overall Study|Randomized but not Dosed|0|||
46886815|NCT02874794|83109485|FG000|Overall Study|Physician Decision|3|||
46886816|NCT02874794|83109486|FG001|Overall Study|Physician Decision|2|||
46886817|NCT02874794|83109485|FG000|Overall Study|Withdrawal by Subject|2|||
46886818|NCT02874794|83109486|FG001|Overall Study|Withdrawal by Subject|8|||
46886819|NCT02874794|83109485|FG000|Overall Study|Death|2|||
46886820|NCT02874794|83109486|FG001|Overall Study|Death|1|||
46886821|NCT03102710|83109498|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
46886822|NCT03102710|83109499|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
46886823|NCT03102710|83109500|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
46886824|NCT03102710|83109498|FG000|Overall Study|Technical issues during final MRI scan|0|||
46886825|NCT03102710|83109499|FG001|Overall Study|Technical issues during final MRI scan|1|||
46886826|NCT03102710|83109500|FG002|Overall Study|Technical issues during final MRI scan|0|||
46886827|NCT03102710|83109498|FG000|Overall Study|Nausea during MRI scan|0|||
46886828|NCT03102710|83109499|FG001|Overall Study|Nausea during MRI scan|1|||
46886829|NCT03102710|83109500|FG002|Overall Study|Nausea during MRI scan|0|||
46886830|NCT03102710|83109498|FG000|Overall Study|Subject unable to attend final session|0|||
46886831|NCT03102710|83109499|FG001|Overall Study|Subject unable to attend final session|1|||
46886832|NCT03102710|83109500|FG002|Overall Study|Subject unable to attend final session|0|||
46886833|NCT03101150|83109510|FG000|Overall Study|Lost to Follow-up|2|||
46886834|NCT03101150|83109511|FG001|Overall Study|Lost to Follow-up|4|||
46886835|NCT03101150|83109510|FG000|Overall Study|Miscarriage|3|||
46886836|NCT03101150|83109511|FG001|Overall Study|Miscarriage|6|||
46886837|NCT03101930|83109520|FG000|Overall Study|Withdrawal by Subject|2|||
46886838|NCT03101930|83109521|FG001|Overall Study|Withdrawal by Subject|1|||
46886839|NCT03101930|83109522|FG002|Overall Study|Withdrawal by Subject|2|||
46886840|NCT02928848|83109532|FG000|Arm 2|Withdrawal by Subject|1|||
46886841|NCT02928848|83109533|FG001|Arm 2|Withdrawal by Subject|0|||
46886842|NCT02928770|83109541|FG000|Overall Study|Withdrawal by Subject|2|||
46886843|NCT03100838|83109545|FG000|Overall Study|Adverse Event|1|||
46886844|NCT03100838|83109546|FG001|Overall Study|Adverse Event|0|||
46886845|NCT03100838|83109547|FG002|Overall Study|Adverse Event|0|||
46886846|NCT03100838|83109548|FG003|Overall Study|Adverse Event|0|||
46886847|NCT03100838|83109545|FG000|Overall Study|Physician Decision|1|||
46886848|NCT03100838|83109546|FG001|Overall Study|Physician Decision|1|||
46886849|NCT03100838|83109547|FG002|Overall Study|Physician Decision|1|||
46886850|NCT03100838|83109548|FG003|Overall Study|Physician Decision|1|||
46886851|NCT03100838|83109545|FG000|Overall Study|Pregnancy|0|||
46886852|NCT03100838|83109546|FG001|Overall Study|Pregnancy|1|||
46886853|NCT03100838|83109547|FG002|Overall Study|Pregnancy|0|||
46886854|NCT03100838|83109548|FG003|Overall Study|Pregnancy|0|||
46886855|NCT03100838|83109545|FG000|Overall Study|Lost to Follow-up|0|||
46886856|NCT03100838|83109546|FG001|Overall Study|Lost to Follow-up|0|||
46886857|NCT03100838|83109547|FG002|Overall Study|Lost to Follow-up|1|||
46886858|NCT03100838|83109548|FG003|Overall Study|Lost to Follow-up|0|||
46886859|NCT03480750|83109564|FG000|Overall Study|Withdrawal by Subject|0|||
46886860|NCT03480750|83109565|FG001|Overall Study|Withdrawal by Subject|1|||
46886861|NCT03480750|83109566|FG002|Overall Study|Withdrawal by Subject|0|||
46886862|NCT03480750|83109567|FG003|Overall Study|Withdrawal by Subject|0|||
46886863|NCT03480750|83109568|FG004|Overall Study|Withdrawal by Subject|0|||
46886864|NCT03480750|83109569|FG005|Overall Study|Withdrawal by Subject|0|||
46886865|NCT03480750|83109564|FG000|Overall Study|The interruption in Trientine shippment|0|||
46886866|NCT03480750|83109565|FG001|Overall Study|The interruption in Trientine shippment|0|||
46886867|NCT03480750|83109566|FG002|Overall Study|The interruption in Trientine shippment|0|||
46886868|NCT03480750|83109567|FG003|Overall Study|The interruption in Trientine shippment|0|||
46886869|NCT03480750|83109568|FG004|Overall Study|The interruption in Trientine shippment|0|||
46886870|NCT03480750|83109569|FG005|Overall Study|The interruption in Trientine shippment|1|||
46886871|NCT03412734|83109594|FG000|Overall Study|Incorrect labeling of samples|2|||
46886872|NCT03412734|83109595|FG001|Overall Study|Incorrect labeling of samples|0|||
46886873|NCT03412734|83109594|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
46886874|NCT03412734|83109595|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
46886875|NCT02374814|83109607|FG000|Overall Study|Lost to Follow-up|1|||
46886876|NCT02374814|83109608|FG001|Overall Study|Lost to Follow-up|1|||
46886877|NCT02374814|83109609|FG002|Overall Study|Lost to Follow-up|0|||
46886878|NCT02374814|83109610|FG003|Overall Study|Lost to Follow-up|1|||
46886879|NCT02374814|83109611|FG004|Overall Study|Lost to Follow-up|0|||
46886880|NCT02374814|83109612|FG005|Overall Study|Lost to Follow-up|0|||
46886881|NCT02374814|83109607|FG000|Overall Study|Withdrawal by Subject|0|||
46886882|NCT02374814|83109608|FG001|Overall Study|Withdrawal by Subject|0|||
46886883|NCT02374814|83109609|FG002|Overall Study|Withdrawal by Subject|1|||
46886884|NCT02374814|83109610|FG003|Overall Study|Withdrawal by Subject|1|||
46886885|NCT02374814|83109611|FG004|Overall Study|Withdrawal by Subject|0|||
46886886|NCT02374814|83109612|FG005|Overall Study|Withdrawal by Subject|0|||
46886887|NCT04608344|83109636|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
46886888|NCT04608344|83109637|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
46886889|NCT04608344|83109636|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
46886890|NCT04608344|83109637|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
46886891|NCT03433482|83109655|FG000|Overall Study|Lost to Follow-up|1|||
46886892|NCT03433482|83109656|FG001|Overall Study|Lost to Follow-up|0|||
46886893|NCT03433482|83109657|FG002|Overall Study|Lost to Follow-up|1|||
46886894|NCT03433482|83109658|FG003|Overall Study|Lost to Follow-up|1|||
46886895|NCT03433482|83109655|FG000|Overall Study|Withdrawal by Subject|0|||
46886896|NCT03433482|83109656|FG001|Overall Study|Withdrawal by Subject|0|||
46886897|NCT03433482|83109657|FG002|Overall Study|Withdrawal by Subject|1|||
46886898|NCT03433482|83109658|FG003|Overall Study|Withdrawal by Subject|0|||
46886899|NCT03433482|83109655|FG000|Overall Study|Unknown reason|0|||
46886900|NCT03433482|83109656|FG001|Overall Study|Unknown reason|0|||
46886901|NCT03433482|83109657|FG002|Overall Study|Unknown reason|2|||
46886902|NCT03433482|83109658|FG003|Overall Study|Unknown reason|0|||
46886903|NCT03432858|83109671|FG000|Overall Study|Protocol Violation|2|||
46886904|NCT03432858|83109672|FG001|Overall Study|Protocol Violation|1|||
46886905|NCT03432858|83109673|FG002|Overall Study|Protocol Violation|9|||
46886906|NCT03432858|83109671|FG000|Overall Study|Withdrawal by Subject|0|||
46886907|NCT03432858|83109672|FG001|Overall Study|Withdrawal by Subject|1|||
46886908|NCT03432858|83109673|FG002|Overall Study|Withdrawal by Subject|1|||
46886909|NCT03432858|83109671|FG000|Overall Study|Procedure canceled/rescheduled|0|||
46886910|NCT03432858|83109672|FG001|Overall Study|Procedure canceled/rescheduled|9|||
46886911|NCT03432858|83109673|FG002|Overall Study|Procedure canceled/rescheduled|6|||
46886912|NCT03432858|83109671|FG000|Overall Study|Required postop mobilization with splinting|0|||
46886913|NCT03432858|83109672|FG001|Overall Study|Required postop mobilization with splinting|0|||
46886914|NCT03432858|83109673|FG002|Overall Study|Required postop mobilization with splinting|1|||
46886915|NCT03432390|83109683|FG000|Apnea Period|Protocol Violation|2|||
46886916|NCT03432390|83109684|FG001|Apnea Period|Protocol Violation|2|||
46886917|NCT03456960|83109696|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
46886918|NCT03456960|83109697|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
46886919|NCT03456960|83109698|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
46886920|NCT03456960|83109699|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
46886921|NCT03456960|83109700|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
46886922|NCT03456960|83109701|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
46886923|NCT03456960|83109696|FG000|Period 2 (1 Day)|Adverse Event|1|||
46991401|NCT02161185|83238374|FG000|Treatment Phase|Administrative/Other|7|||
46991402|NCT02159469|83238378|FG000|Overall Study|Missing Completion status|1|||
46991403|NCT02159469|83238378|FG000|Overall Study|Adverse Event|5|||
46991404|NCT02159469|83238378|FG000|Overall Study|Non-compliance|2|||
46991405|NCT02159469|83238378|FG000|Overall Study|Withdrawal by Subject|9|||
46886924|NCT03456960|83109697|FG001|Period 2 (1 Day)|Adverse Event|0|||
46991406|NCT02159469|83238378|FG000|Overall Study|Lost to Follow-up|1|||
46991407|NCT02159469|83238378|FG000|Overall Study|Sponsor's request|2|||
46991408|NCT02159469|83238378|FG000|Overall Study|Met Stopping Criteria|3|||
46991409|NCT02159469|83238378|FG000|Overall Study|Other|1|||
46991410|NCT02159469|83238378|FG000|Overall Study|Multiple|29|||
46991411|NCT02123511|83238385|FG000|Overall Study|Cancelled treatment|1|||
46991412|NCT02123511|83238386|FG001|Overall Study|Cancelled treatment|0|||
46991413|NCT02123511|83238385|FG000|Overall Study|Incomplete data|1|||
46991414|NCT02123511|83238386|FG001|Overall Study|Incomplete data|3|||
46991415|NCT02123511|83238385|FG000|Overall Study|Ineligible|0|||
46991416|NCT02123511|83238386|FG001|Overall Study|Ineligible|1|||
46991417|NCT02122887|83238394|FG000|Overall Study|Withdrawal by Subject|20|||
46991418|NCT02122887|83238395|FG001|Overall Study|Withdrawal by Subject|2|||
46991419|NCT02182947|83238401|FG000|Overall Study|Withdrawal by Subject|7|||
46991420|NCT02182947|83238401|FG000|Overall Study|Lost to Follow-up|3|||
46991421|NCT02182947|83238401|FG000|Overall Study|Failed screening activities|8|||
46991422|NCT02370043|83238405|FG000|Overall Study|Withdrawal by Subject|0|||
46991423|NCT02370043|83238406|FG001|Overall Study|Withdrawal by Subject|0|||
46991424|NCT02370043|83238407|FG002|Overall Study|Withdrawal by Subject|0|||
46991425|NCT02370043|83238408|FG003|Overall Study|Withdrawal by Subject|0|||
46991426|NCT02370043|83238409|FG004|Overall Study|Withdrawal by Subject|1|||
46991427|NCT02370043|83238410|FG005|Overall Study|Withdrawal by Subject|1|||
46886925|NCT03456960|83109698|FG002|Period 2 (1 Day)|Adverse Event|0|||
46886926|NCT03456960|83109699|FG003|Period 2 (1 Day)|Adverse Event|1|||
46886927|NCT03456960|83109700|FG004|Period 2 (1 Day)|Adverse Event|0|||
46886928|NCT03456960|83109701|FG005|Period 2 (1 Day)|Adverse Event|0|||
46886929|NCT03430986|83109719|FG000|24-week Control Period|Adverse Event|1|||
46886930|NCT03430986|83109720|FG001|24-week Control Period|Adverse Event|0|||
46886931|NCT03430986|83109719|FG000|24-week Control Period|Lost to Follow-up|2|||
46886932|NCT03430986|83109720|FG001|24-week Control Period|Lost to Follow-up|2|||
46886933|NCT03430986|83109719|FG000|24-week Control Period|Withdrawal by Participant|5|||
46886934|NCT03430986|83109720|FG001|24-week Control Period|Withdrawal by Participant|0|||
46886935|NCT03430986|83109719|FG000|24-week Control Period|Protocol Deviation|0|||
46886936|NCT03430986|83109720|FG001|24-week Control Period|Protocol Deviation|2|||
46886937|NCT03430986|83109719|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
46886938|NCT03430986|83109720|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
46886939|NCT03430986|83109719|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
46886940|NCT03430986|83109720|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
46886941|NCT03448536|83109731|FG000|Overall Study|Protocol Violation|2|||
46886942|NCT03448536|83109732|FG001|Overall Study|Protocol Violation|0|||
46802952|NCT00684203|83022198|FG003|Overall Study|Adverse Event|0|||
46802953|NCT00684203|83022199|FG004|Overall Study|Adverse Event|0|||
46802954|NCT00684203|83022200|FG005|Overall Study|Adverse Event|0|||
46802955|NCT00684203|83022195|FG000|Overall Study|Protocol-defined clinical event|3|||
46802956|NCT00684203|83022196|FG001|Overall Study|Protocol-defined clinical event|1|||
46802957|NCT00684203|83022197|FG002|Overall Study|Protocol-defined clinical event|0|||
46802958|NCT00684203|83022198|FG003|Overall Study|Protocol-defined clinical event|0|||
46802959|NCT00684203|83022199|FG004|Overall Study|Protocol-defined clinical event|0|||
46802960|NCT00684203|83022200|FG005|Overall Study|Protocol-defined clinical event|0|||
46802961|NCT00684203|83022195|FG000|Overall Study|Withdrawal by Subject|0|||
46802962|NCT00684203|83022196|FG001|Overall Study|Withdrawal by Subject|2|||
46802963|NCT00684203|83022197|FG002|Overall Study|Withdrawal by Subject|1|||
46802964|NCT00684203|83022198|FG003|Overall Study|Withdrawal by Subject|0|||
46802965|NCT00684203|83022199|FG004|Overall Study|Withdrawal by Subject|0|||
46802966|NCT00684203|83022200|FG005|Overall Study|Withdrawal by Subject|0|||
46886943|NCT03448536|83109731|FG000|Overall Study|Pregnancy|1|||
46886944|NCT03448536|83109732|FG001|Overall Study|Pregnancy|0|||
46886945|NCT03448536|83109731|FG000|Overall Study|Withdrawal by Subject|1|||
46886946|NCT03448536|83109732|FG001|Overall Study|Withdrawal by Subject|2|||
46886947|NCT03448536|83109731|FG000|Overall Study|Lost to Follow-up|3|||
46886948|NCT03448536|83109732|FG001|Overall Study|Lost to Follow-up|2|||
46886949|NCT03448536|83109731|FG000|Overall Study|Inadequate pain reporter|1|||
46886950|NCT03448536|83109732|FG001|Overall Study|Inadequate pain reporter|0|||
46886951|NCT03448536|83109731|FG000|Overall Study|Other|3|||
46886952|NCT03448536|83109732|FG001|Overall Study|Other|0|||
46886953|NCT03448536|83109731|FG000|Overall Study|Physician Decision|1|||
46886954|NCT03448536|83109732|FG001|Overall Study|Physician Decision|0|||
46886955|NCT03448224|83109740|FG000|Overall Study|Provided same answer to every question|1|||
46886956|NCT03448224|83109741|FG001|Overall Study|Provided same answer to every question|0|||
46886957|NCT03424044|83109747|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886958|NCT03424044|83109748|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886959|NCT03424044|83109749|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
46886960|NCT03424044|83109750|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886961|NCT03424044|83109751|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886962|NCT03424044|83109752|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886963|NCT03424044|83109753|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886964|NCT03424044|83109754|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886965|NCT03424044|83109755|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
46886966|NCT03424044|83109747|FG000|First Intervention (76 Hours)|Adverse Event|0|||
46886967|NCT03424044|83109748|FG001|First Intervention (76 Hours)|Adverse Event|0|||
46886968|NCT03424044|83109749|FG002|First Intervention (76 Hours)|Adverse Event|0|||
46886969|NCT03424044|83109750|FG003|First Intervention (76 Hours)|Adverse Event|0|||
46886970|NCT03424044|83109751|FG004|First Intervention (76 Hours)|Adverse Event|1|||
46705854|NCT01030965|82920740|FG002|Overall Study|Withdrawal by Subject|0|||
46886971|NCT03424044|83109752|FG005|First Intervention (76 Hours)|Adverse Event|0|||
46886972|NCT03424044|83109753|FG006|First Intervention (76 Hours)|Adverse Event|0|||
46886973|NCT03424044|83109754|FG007|First Intervention (76 Hours)|Adverse Event|0|||
46886974|NCT03424044|83109755|FG008|First Intervention (76 Hours)|Adverse Event|0|||
46886975|NCT03424044|83109747|FG000|First Intervention (76 Hours)|device issues|0|||
46886976|NCT03424044|83109748|FG001|First Intervention (76 Hours)|device issues|0|||
46886977|NCT03424044|83109749|FG002|First Intervention (76 Hours)|device issues|0|||
46886978|NCT03424044|83109750|FG003|First Intervention (76 Hours)|device issues|0|||
46886979|NCT03424044|83109751|FG004|First Intervention (76 Hours)|device issues|0|||
46886980|NCT03424044|83109752|FG005|First Intervention (76 Hours)|device issues|0|||
46886981|NCT03424044|83109753|FG006|First Intervention (76 Hours)|device issues|1|||
46886982|NCT03424044|83109754|FG007|First Intervention (76 Hours)|device issues|1|||
46886983|NCT03424044|83109755|FG008|First Intervention (76 Hours)|device issues|1|||
46886984|NCT03424044|83109747|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
46886985|NCT03424044|83109748|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
46886986|NCT03424044|83109749|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
46886987|NCT03424044|83109750|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
46886988|NCT03424044|83109751|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
46886989|NCT03424044|83109752|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
46886990|NCT03424044|83109753|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
46886991|NCT03424044|83109754|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
46886992|NCT03424044|83109755|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
46886993|NCT03424044|83109747|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46886994|NCT03424044|83109748|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46886995|NCT03424044|83109749|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46886996|NCT03424044|83109750|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
46886997|NCT03424044|83109751|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46886998|NCT03424044|83109752|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46886999|NCT03424044|83109753|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46887000|NCT03424044|83109754|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46887001|NCT03424044|83109755|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
46887002|NCT03422250|83109769|FG000|Intervention|Adverse Event|0|||
46887003|NCT03422250|83109770|FG001|Intervention|Adverse Event|1|||
46887004|NCT03422250|83109771|FG002|Intervention|Adverse Event|0|||
46887005|NCT03422250|83109772|FG003|Intervention|Adverse Event|1|||
46887006|NCT03422250|83109769|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
46887007|NCT03422250|83109770|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
46705855|NCT01030965|82920741|FG003|Overall Study|Withdrawal by Subject|2|||
46705856|NCT01179516|82920754|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
46705857|NCT01179516|82920755|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
46705858|NCT01179516|82920756|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
46705859|NCT01179516|82920754|FG000|Overall Study|Lack of Efficacy|4|||
46705860|NCT01179516|82920755|FG001|Overall Study|Lack of Efficacy|2|||
46705861|NCT01179516|82920756|FG002|Overall Study|Lack of Efficacy|0|||
46705862|NCT01179516|82920754|FG000|Overall Study|Noncompliance with Study Drug|2|||
46705863|NCT01179516|82920755|FG001|Overall Study|Noncompliance with Study Drug|0|||
46705864|NCT01179516|82920756|FG002|Overall Study|Noncompliance with Study Drug|1|||
46705865|NCT01179516|82920754|FG000|Overall Study|Protocol Deviations|4|||
46705866|NCT01179516|82920755|FG001|Overall Study|Protocol Deviations|3|||
46705867|NCT01179516|82920756|FG002|Overall Study|Protocol Deviations|3|||
46705868|NCT01179516|82920754|FG000|Overall Study|Withdrawal of Consent|2|||
46705869|NCT01179516|82920755|FG001|Overall Study|Withdrawal of Consent|6|||
46705870|NCT01179516|82920756|FG002|Overall Study|Withdrawal of Consent|10|||
46705871|NCT01179516|82920754|FG000|Overall Study|Lost to Follow-up|7|||
46705872|NCT01179516|82920755|FG001|Overall Study|Lost to Follow-up|7|||
46705873|NCT01179516|82920756|FG002|Overall Study|Lost to Follow-up|3|||
46705874|NCT01179516|82920754|FG000|Overall Study|Other|2|||
46705875|NCT01179516|82920755|FG001|Overall Study|Other|0|||
46705876|NCT01179516|82920756|FG002|Overall Study|Other|2|||
46705877|NCT01018953|82920764|FG000|Overall Study|Adverse Event|2|||
46705878|NCT01018953|82920764|FG000|Overall Study|Withdrawal by Subject|1|||
46705879|NCT01018953|82920764|FG000|Overall Study|Study termination by sponsor|5|||
46705880|NCT01158924|82920771|FG000|Overall Study|Withdrawal by Subject|1|||
46705881|NCT01158924|82920772|FG001|Overall Study|Withdrawal by Subject|2|||
46705882|NCT01158924|82920771|FG000|Overall Study|Lost to Follow-up|0|||
46705883|NCT01158924|82920772|FG001|Overall Study|Lost to Follow-up|1|||
46705884|NCT01027845|82920780|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
46705885|NCT01027845|82920781|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
46887008|NCT03422250|83109771|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
46887009|NCT03422250|83109772|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
46887010|NCT03422250|83109769|FG000|Follow-up|Withdrawal by Subject|0|||
46887011|NCT03422250|83109770|FG001|Follow-up|Withdrawal by Subject|0|||
46887012|NCT03422250|83109771|FG002|Follow-up|Withdrawal by Subject|0|||
46887013|NCT03422250|83109772|FG003|Follow-up|Withdrawal by Subject|1|||
46887014|NCT03422250|83109769|FG000|Follow-up|Adverse Event|0|||
46887015|NCT03422250|83109770|FG001|Follow-up|Adverse Event|0|||
46887016|NCT03422250|83109771|FG002|Follow-up|Adverse Event|0|||
46887017|NCT03422250|83109772|FG003|Follow-up|Adverse Event|1|||
46887018|NCT01266031|83109787|FG000|Overall Study|Not treated|0|||
46887019|NCT01266031|83109788|FG001|Overall Study|Not treated|3|||
46887020|NCT01266031|83109789|FG002|Overall Study|Not treated|2|||
46887021|NCT00075725|83109820|FG000|Overall Study|Adverse Event|6|||
46887022|NCT00075725|83109821|FG001|Overall Study|Adverse Event|6|||
46887023|NCT00075725|83109822|FG002|Overall Study|Adverse Event|20|||
46887024|NCT00075725|83109823|FG003|Overall Study|Adverse Event|8|||
46887025|NCT00075725|83109824|FG004|Overall Study|Adverse Event|4|||
46887026|NCT00075725|83109825|FG005|Overall Study|Adverse Event|38|||
46887027|NCT00075725|83109826|FG006|Overall Study|Adverse Event|3|||
46887028|NCT00075725|83109827|FG007|Overall Study|Adverse Event|51|||
46887029|NCT00075725|83109828|FG008|Overall Study|Adverse Event|15|||
46887030|NCT00075725|83109829|FG009|Overall Study|Adverse Event|4|||
46887031|NCT00075725|83109830|FG010|Overall Study|Adverse Event|2|||
46887032|NCT00075725|83109831|FG011|Overall Study|Adverse Event|2|||
46887033|NCT00075725|83109820|FG000|Overall Study|Death|3|||
46887034|NCT00075725|83109821|FG001|Overall Study|Death|5|||
46887035|NCT00075725|83109822|FG002|Overall Study|Death|10|||
46887036|NCT00075725|83109823|FG003|Overall Study|Death|2|||
46887037|NCT00075725|83109824|FG004|Overall Study|Death|3|||
46887038|NCT00075725|83109825|FG005|Overall Study|Death|25|||
46887039|NCT00075725|83109826|FG006|Overall Study|Death|4|||
46887040|NCT00075725|83109827|FG007|Overall Study|Death|22|||
46887041|NCT00075725|83109828|FG008|Overall Study|Death|14|||
46887042|NCT00075725|83109829|FG009|Overall Study|Death|4|||
46887043|NCT00075725|83109830|FG010|Overall Study|Death|3|||
46887044|NCT00075725|83109831|FG011|Overall Study|Death|0|||
46887045|NCT00075725|83109820|FG000|Overall Study|Lost to Follow-up|1|||
46887046|NCT00075725|83109821|FG001|Overall Study|Lost to Follow-up|1|||
46887047|NCT00075725|83109822|FG002|Overall Study|Lost to Follow-up|4|||
46887048|NCT00075725|83109823|FG003|Overall Study|Lost to Follow-up|1|||
46887049|NCT00075725|83109824|FG004|Overall Study|Lost to Follow-up|0|||
46887050|NCT00075725|83109825|FG005|Overall Study|Lost to Follow-up|13|||
46887051|NCT00075725|83109826|FG006|Overall Study|Lost to Follow-up|2|||
46887052|NCT00075725|83109827|FG007|Overall Study|Lost to Follow-up|4|||
46887053|NCT00075725|83109828|FG008|Overall Study|Lost to Follow-up|1|||
46887054|NCT00075725|83109829|FG009|Overall Study|Lost to Follow-up|0|||
46887055|NCT00075725|83109830|FG010|Overall Study|Lost to Follow-up|0|||
46887056|NCT00075725|83109831|FG011|Overall Study|Lost to Follow-up|0|||
46887057|NCT00075725|83109820|FG000|Overall Study|Physician Decision|2|||
46887058|NCT00075725|83109821|FG001|Overall Study|Physician Decision|6|||
46887059|NCT00075725|83109822|FG002|Overall Study|Physician Decision|5|||
46887060|NCT00075725|83109823|FG003|Overall Study|Physician Decision|8|||
46887061|NCT00075725|83109824|FG004|Overall Study|Physician Decision|4|||
46887062|NCT00075725|83109825|FG005|Overall Study|Physician Decision|19|||
46705886|NCT01027845|82920782|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
46887063|NCT00075725|83109826|FG006|Overall Study|Physician Decision|3|||
46887064|NCT00075725|83109827|FG007|Overall Study|Physician Decision|17|||
46887065|NCT00075725|83109828|FG008|Overall Study|Physician Decision|5|||
46887066|NCT00075725|83109829|FG009|Overall Study|Physician Decision|0|||
46887067|NCT00075725|83109830|FG010|Overall Study|Physician Decision|1|||
46887068|NCT00075725|83109831|FG011|Overall Study|Physician Decision|0|||
46887069|NCT00075725|83109820|FG000|Overall Study|Pregnancy|0|||
46887070|NCT00075725|83109821|FG001|Overall Study|Pregnancy|0|||
46705887|NCT01027845|82920783|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
46705888|NCT01027845|82920780|FG000|Primary Vaccination Phase|Adverse Event|1|||
46705889|NCT01027845|82920781|FG001|Primary Vaccination Phase|Adverse Event|0|||
46887071|NCT00075725|83109822|FG002|Overall Study|Pregnancy|0|||
46887072|NCT00075725|83109823|FG003|Overall Study|Pregnancy|0|||
46887073|NCT00075725|83109824|FG004|Overall Study|Pregnancy|0|||
46887074|NCT00075725|83109825|FG005|Overall Study|Pregnancy|1|||
46887075|NCT00075725|83109826|FG006|Overall Study|Pregnancy|0|||
46887076|NCT00075725|83109827|FG007|Overall Study|Pregnancy|1|||
46887077|NCT00075725|83109828|FG008|Overall Study|Pregnancy|0|||
46887078|NCT00075725|83109829|FG009|Overall Study|Pregnancy|0|||
46887079|NCT00075725|83109830|FG010|Overall Study|Pregnancy|0|||
46887080|NCT00075725|83109831|FG011|Overall Study|Pregnancy|0|||
46887081|NCT00075725|83109820|FG000|Overall Study|Protocol Violation|1|||
46887082|NCT00075725|83109821|FG001|Overall Study|Protocol Violation|1|||
46887083|NCT00075725|83109822|FG002|Overall Study|Protocol Violation|0|||
46887084|NCT00075725|83109823|FG003|Overall Study|Protocol Violation|3|||
46887085|NCT00075725|83109824|FG004|Overall Study|Protocol Violation|3|||
46887086|NCT00075725|83109825|FG005|Overall Study|Protocol Violation|2|||
46887087|NCT00075725|83109826|FG006|Overall Study|Protocol Violation|1|||
46887088|NCT00075725|83109827|FG007|Overall Study|Protocol Violation|2|||
46887089|NCT00075725|83109828|FG008|Overall Study|Protocol Violation|3|||
46887090|NCT00075725|83109829|FG009|Overall Study|Protocol Violation|0|||
46887091|NCT00075725|83109830|FG010|Overall Study|Protocol Violation|0|||
46887092|NCT00075725|83109831|FG011|Overall Study|Protocol Violation|1|||
46887093|NCT00075725|83109820|FG000|Overall Study|Withdrawal by Subject|12|||
46887094|NCT00075725|83109821|FG001|Overall Study|Withdrawal by Subject|3|||
46887095|NCT00075725|83109822|FG002|Overall Study|Withdrawal by Subject|6|||
46887096|NCT00075725|83109823|FG003|Overall Study|Withdrawal by Subject|10|||
46887097|NCT00075725|83109824|FG004|Overall Study|Withdrawal by Subject|6|||
46887098|NCT00075725|83109825|FG005|Overall Study|Withdrawal by Subject|27|||
46887099|NCT00075725|83109826|FG006|Overall Study|Withdrawal by Subject|7|||
46887100|NCT00075725|83109827|FG007|Overall Study|Withdrawal by Subject|31|||
46887101|NCT00075725|83109828|FG008|Overall Study|Withdrawal by Subject|10|||
46887102|NCT00075725|83109829|FG009|Overall Study|Withdrawal by Subject|2|||
46887103|NCT00075725|83109830|FG010|Overall Study|Withdrawal by Subject|0|||
46887104|NCT00075725|83109831|FG011|Overall Study|Withdrawal by Subject|0|||
46887105|NCT00075725|83109820|FG000|Overall Study|Disease Progression, all other reasons|17|||
46887106|NCT00075725|83109821|FG001|Overall Study|Disease Progression, all other reasons|5|||
46887107|NCT00075725|83109822|FG002|Overall Study|Disease Progression, all other reasons|33|||
46887108|NCT00075725|83109823|FG003|Overall Study|Disease Progression, all other reasons|6|||
46887109|NCT00075725|83109824|FG004|Overall Study|Disease Progression, all other reasons|21|||
46887110|NCT00075725|83109825|FG005|Overall Study|Disease Progression, all other reasons|59|||
46887111|NCT00075725|83109826|FG006|Overall Study|Disease Progression, all other reasons|20|||
46887112|NCT00075725|83109827|FG007|Overall Study|Disease Progression, all other reasons|46|||
46887113|NCT00075725|83109828|FG008|Overall Study|Disease Progression, all other reasons|21|||
46887114|NCT00075725|83109829|FG009|Overall Study|Disease Progression, all other reasons|4|||
46887115|NCT00075725|83109830|FG010|Overall Study|Disease Progression, all other reasons|0|||
46887116|NCT00075725|83109831|FG011|Overall Study|Disease Progression, all other reasons|5|||
46887117|NCT00075725|83109820|FG000|Overall Study|Patient off treatment|0|||
46887118|NCT00075725|83109821|FG001|Overall Study|Patient off treatment|0|||
46887119|NCT00075725|83109822|FG002|Overall Study|Patient off treatment|1|||
46887120|NCT00075725|83109823|FG003|Overall Study|Patient off treatment|2|||
46887121|NCT00075725|83109824|FG004|Overall Study|Patient off treatment|1|||
46887122|NCT00075725|83109825|FG005|Overall Study|Patient off treatment|0|||
46887123|NCT00075725|83109826|FG006|Overall Study|Patient off treatment|0|||
46887124|NCT00075725|83109827|FG007|Overall Study|Patient off treatment|2|||
46887125|NCT00075725|83109828|FG008|Overall Study|Patient off treatment|1|||
46887126|NCT00075725|83109829|FG009|Overall Study|Patient off treatment|0|||
46887127|NCT00075725|83109830|FG010|Overall Study|Patient off treatment|0|||
46887128|NCT00075725|83109831|FG011|Overall Study|Patient off treatment|0|||
46887129|NCT00075725|83109820|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
46887130|NCT00075725|83109821|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
46887131|NCT00075725|83109822|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
46887132|NCT00075725|83109823|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
46887133|NCT00075725|83109824|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
46887134|NCT00075725|83109825|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
46887135|NCT00075725|83109826|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
46887136|NCT00075725|83109827|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
46887137|NCT00075725|83109828|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
46887138|NCT00075725|83109829|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
46887139|NCT00075725|83109830|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
46887140|NCT00075725|83109831|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
46887141|NCT00075725|83109820|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
46887142|NCT00075725|83109821|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
46887143|NCT00075725|83109822|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
46887144|NCT00075725|83109823|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
46887145|NCT00075725|83109824|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
46887146|NCT00075725|83109825|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
46887147|NCT00075725|83109826|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
46887148|NCT00075725|83109827|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
46887149|NCT00075725|83109828|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
46887150|NCT00075725|83109829|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
46887151|NCT00075725|83109830|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
46887152|NCT00075725|83109831|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
46887153|NCT00075725|83109820|FG000|Overall Study|Pt non compliant with therapy|2|||
46887154|NCT00075725|83109821|FG001|Overall Study|Pt non compliant with therapy|1|||
46887155|NCT00075725|83109822|FG002|Overall Study|Pt non compliant with therapy|1|||
46887156|NCT00075725|83109823|FG003|Overall Study|Pt non compliant with therapy|0|||
46887157|NCT00075725|83109824|FG004|Overall Study|Pt non compliant with therapy|2|||
46887158|NCT00075725|83109825|FG005|Overall Study|Pt non compliant with therapy|14|||
46887159|NCT00075725|83109826|FG006|Overall Study|Pt non compliant with therapy|2|||
46887160|NCT00075725|83109827|FG007|Overall Study|Pt non compliant with therapy|5|||
46887161|NCT00075725|83109828|FG008|Overall Study|Pt non compliant with therapy|3|||
46887162|NCT00075725|83109829|FG009|Overall Study|Pt non compliant with therapy|0|||
46887163|NCT00075725|83109830|FG010|Overall Study|Pt non compliant with therapy|0|||
46887164|NCT00075725|83109831|FG011|Overall Study|Pt non compliant with therapy|0|||
46887165|NCT00075725|83109820|FG000|Overall Study|Pt age out of range for treatment|0|||
46887166|NCT00075725|83109821|FG001|Overall Study|Pt age out of range for treatment|1|||
46887167|NCT00075725|83109822|FG002|Overall Study|Pt age out of range for treatment|0|||
46887168|NCT00075725|83109823|FG003|Overall Study|Pt age out of range for treatment|0|||
46887169|NCT00075725|83109824|FG004|Overall Study|Pt age out of range for treatment|0|||
46887170|NCT00075725|83109825|FG005|Overall Study|Pt age out of range for treatment|1|||
46887171|NCT00075725|83109826|FG006|Overall Study|Pt age out of range for treatment|0|||
46887172|NCT00075725|83109827|FG007|Overall Study|Pt age out of range for treatment|1|||
46887173|NCT00075725|83109828|FG008|Overall Study|Pt age out of range for treatment|0|||
46887174|NCT00075725|83109829|FG009|Overall Study|Pt age out of range for treatment|0|||
46887175|NCT00075725|83109830|FG010|Overall Study|Pt age out of range for treatment|0|||
46887176|NCT00075725|83109831|FG011|Overall Study|Pt age out of range for treatment|0|||
46887177|NCT00075725|83109820|FG000|Overall Study|Insurance issues|0|||
46887178|NCT00075725|83109821|FG001|Overall Study|Insurance issues|1|||
46887179|NCT00075725|83109822|FG002|Overall Study|Insurance issues|0|||
46887180|NCT00075725|83109823|FG003|Overall Study|Insurance issues|1|||
46887181|NCT00075725|83109824|FG004|Overall Study|Insurance issues|1|||
46887182|NCT00075725|83109825|FG005|Overall Study|Insurance issues|1|||
46887183|NCT00075725|83109826|FG006|Overall Study|Insurance issues|0|||
46887184|NCT00075725|83109827|FG007|Overall Study|Insurance issues|1|||
46887185|NCT00075725|83109828|FG008|Overall Study|Insurance issues|0|||
46887186|NCT00075725|83109829|FG009|Overall Study|Insurance issues|0|||
46887187|NCT00075725|83109830|FG010|Overall Study|Insurance issues|0|||
46887188|NCT00075725|83109831|FG011|Overall Study|Insurance issues|0|||
46887189|NCT00075725|83109820|FG000|Overall Study|MRD positive after extended ind|0|||
46887190|NCT00075725|83109821|FG001|Overall Study|MRD positive after extended ind|1|||
46887191|NCT00075725|83109822|FG002|Overall Study|MRD positive after extended ind|1|||
46887192|NCT00075725|83109823|FG003|Overall Study|MRD positive after extended ind|0|||
46887193|NCT00075725|83109824|FG004|Overall Study|MRD positive after extended ind|1|||
46887194|NCT00075725|83109825|FG005|Overall Study|MRD positive after extended ind|2|||
46887195|NCT00075725|83109826|FG006|Overall Study|MRD positive after extended ind|0|||
46887196|NCT00075725|83109827|FG007|Overall Study|MRD positive after extended ind|1|||
46887197|NCT00075725|83109828|FG008|Overall Study|MRD positive after extended ind|0|||
46887198|NCT00075725|83109829|FG009|Overall Study|MRD positive after extended ind|0|||
46887199|NCT00075725|83109830|FG010|Overall Study|MRD positive after extended ind|0|||
46887200|NCT00075725|83109831|FG011|Overall Study|MRD positive after extended ind|0|||
46887201|NCT00075725|83109820|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
46887202|NCT00075725|83109821|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
46887203|NCT00075725|83109822|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
46887204|NCT00075725|83109823|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
46887205|NCT00075725|83109824|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
46887206|NCT00075725|83109825|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
46887207|NCT00075725|83109826|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
46887208|NCT00075725|83109827|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
46887209|NCT00075725|83109828|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
46887210|NCT00075725|83109829|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
46887211|NCT00075725|83109830|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
46887212|NCT00075725|83109831|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
46887213|NCT00075725|83109820|FG000|Overall Study|Inevaluable|1|||
46887214|NCT00075725|83109821|FG001|Overall Study|Inevaluable|1|||
46887215|NCT00075725|83109822|FG002|Overall Study|Inevaluable|4|||
46887216|NCT00075725|83109823|FG003|Overall Study|Inevaluable|2|||
46887217|NCT00075725|83109824|FG004|Overall Study|Inevaluable|2|||
46887218|NCT00075725|83109825|FG005|Overall Study|Inevaluable|9|||
46887219|NCT00075725|83109826|FG006|Overall Study|Inevaluable|1|||
46887220|NCT00075725|83109827|FG007|Overall Study|Inevaluable|11|||
46887221|NCT00075725|83109828|FG008|Overall Study|Inevaluable|2|||
46887222|NCT00075725|83109829|FG009|Overall Study|Inevaluable|0|||
46887223|NCT00075725|83109830|FG010|Overall Study|Inevaluable|1|||
46887224|NCT00075725|83109831|FG011|Overall Study|Inevaluable|0|||
46887225|NCT00075725|83109820|FG000|Overall Study|Other|4|||
46887226|NCT00075725|83109821|FG001|Overall Study|Other|2|||
46887227|NCT00075725|83109822|FG002|Overall Study|Other|1|||
46887228|NCT00075725|83109823|FG003|Overall Study|Other|1|||
46887229|NCT00075725|83109824|FG004|Overall Study|Other|1|||
46887230|NCT00075725|83109825|FG005|Overall Study|Other|4|||
46887231|NCT00075725|83109826|FG006|Overall Study|Other|2|||
46887232|NCT00075725|83109827|FG007|Overall Study|Other|9|||
46887233|NCT00075725|83109828|FG008|Overall Study|Other|2|||
46887234|NCT00075725|83109829|FG009|Overall Study|Other|1|||
46887235|NCT00075725|83109830|FG010|Overall Study|Other|0|||
46887236|NCT00075725|83109831|FG011|Overall Study|Other|3|||
46887237|NCT00075725|83109820|FG000|Overall Study|Pt trying to find a BM donor|0|||
46887238|NCT00075725|83109821|FG001|Overall Study|Pt trying to find a BM donor|1|||
46887239|NCT00075725|83109822|FG002|Overall Study|Pt trying to find a BM donor|0|||
46887240|NCT00075725|83109823|FG003|Overall Study|Pt trying to find a BM donor|0|||
46887241|NCT00075725|83109824|FG004|Overall Study|Pt trying to find a BM donor|0|||
46887242|NCT00075725|83109825|FG005|Overall Study|Pt trying to find a BM donor|0|||
46887243|NCT00075725|83109826|FG006|Overall Study|Pt trying to find a BM donor|0|||
46887244|NCT00075725|83109827|FG007|Overall Study|Pt trying to find a BM donor|0|||
46887245|NCT00075725|83109828|FG008|Overall Study|Pt trying to find a BM donor|0|||
46887246|NCT00075725|83109829|FG009|Overall Study|Pt trying to find a BM donor|0|||
46887247|NCT00075725|83109830|FG010|Overall Study|Pt trying to find a BM donor|0|||
46887248|NCT00075725|83109831|FG011|Overall Study|Pt trying to find a BM donor|0|||
46887249|NCT00075725|83109820|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
46887250|NCT00075725|83109821|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
46887251|NCT00075725|83109822|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
46887252|NCT00075725|83109823|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
46887253|NCT00075725|83109824|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
46887254|NCT00075725|83109825|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
46887255|NCT00075725|83109826|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
46887256|NCT00075725|83109827|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
46887257|NCT00075725|83109828|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
46887258|NCT00075725|83109829|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
46887259|NCT00075725|83109830|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
46887260|NCT00075725|83109831|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
46887261|NCT00075725|83109820|FG000|Overall Study|Unsuccessful institutional transfer|0|||
46887262|NCT00075725|83109821|FG001|Overall Study|Unsuccessful institutional transfer|0|||
46887263|NCT00075725|83109822|FG002|Overall Study|Unsuccessful institutional transfer|2|||
46887264|NCT00075725|83109823|FG003|Overall Study|Unsuccessful institutional transfer|0|||
46887265|NCT00075725|83109824|FG004|Overall Study|Unsuccessful institutional transfer|0|||
46887266|NCT00075725|83109825|FG005|Overall Study|Unsuccessful institutional transfer|0|||
46887267|NCT00075725|83109826|FG006|Overall Study|Unsuccessful institutional transfer|0|||
46887268|NCT00075725|83109827|FG007|Overall Study|Unsuccessful institutional transfer|0|||
46887269|NCT00075725|83109828|FG008|Overall Study|Unsuccessful institutional transfer|0|||
46887270|NCT00075725|83109829|FG009|Overall Study|Unsuccessful institutional transfer|1|||
46887271|NCT00075725|83109830|FG010|Overall Study|Unsuccessful institutional transfer|0|||
46887272|NCT00075725|83109831|FG011|Overall Study|Unsuccessful institutional transfer|0|||
46887273|NCT00075725|83109820|FG000|Overall Study|specimen(s) not submitted|0|||
46887274|NCT00075725|83109821|FG001|Overall Study|specimen(s) not submitted|0|||
46887275|NCT00075725|83109822|FG002|Overall Study|specimen(s) not submitted|2|||
46887276|NCT00075725|83109823|FG003|Overall Study|specimen(s) not submitted|0|||
46887277|NCT00075725|83109824|FG004|Overall Study|specimen(s) not submitted|0|||
46887278|NCT00075725|83109825|FG005|Overall Study|specimen(s) not submitted|0|||
46887279|NCT00075725|83109826|FG006|Overall Study|specimen(s) not submitted|0|||
46887280|NCT00075725|83109827|FG007|Overall Study|specimen(s) not submitted|0|||
46887281|NCT00075725|83109828|FG008|Overall Study|specimen(s) not submitted|0|||
46887282|NCT00075725|83109829|FG009|Overall Study|specimen(s) not submitted|0|||
46887283|NCT00075725|83109830|FG010|Overall Study|specimen(s) not submitted|0|||
46887284|NCT00075725|83109831|FG011|Overall Study|specimen(s) not submitted|0|||
46887285|NCT00075725|83109820|FG000|Overall Study|Pt went to transplant|0|||
46887286|NCT00075725|83109821|FG001|Overall Study|Pt went to transplant|0|||
46887287|NCT00075725|83109822|FG002|Overall Study|Pt went to transplant|0|||
46887288|NCT00075725|83109823|FG003|Overall Study|Pt went to transplant|1|||
46887289|NCT00075725|83109824|FG004|Overall Study|Pt went to transplant|0|||
46887290|NCT00075725|83109825|FG005|Overall Study|Pt went to transplant|1|||
46887291|NCT00075725|83109826|FG006|Overall Study|Pt went to transplant|0|||
46887292|NCT00075725|83109827|FG007|Overall Study|Pt went to transplant|0|||
46887293|NCT00075725|83109828|FG008|Overall Study|Pt went to transplant|0|||
46887294|NCT00075725|83109829|FG009|Overall Study|Pt went to transplant|0|||
46887295|NCT00075725|83109830|FG010|Overall Study|Pt went to transplant|0|||
46887296|NCT00075725|83109831|FG011|Overall Study|Pt went to transplant|0|||
46887297|NCT00075725|83109820|FG000|Overall Study|Pt received additional steroids|0|||
46887298|NCT00075725|83109821|FG001|Overall Study|Pt received additional steroids|0|||
46887299|NCT00075725|83109822|FG002|Overall Study|Pt received additional steroids|0|||
46887300|NCT00075725|83109823|FG003|Overall Study|Pt received additional steroids|1|||
46887301|NCT00075725|83109824|FG004|Overall Study|Pt received additional steroids|0|||
46887302|NCT00075725|83109825|FG005|Overall Study|Pt received additional steroids|0|||
46887303|NCT00075725|83109826|FG006|Overall Study|Pt received additional steroids|0|||
46887304|NCT00075725|83109827|FG007|Overall Study|Pt received additional steroids|0|||
46887305|NCT00075725|83109828|FG008|Overall Study|Pt received additional steroids|0|||
46887306|NCT00075725|83109829|FG009|Overall Study|Pt received additional steroids|0|||
46887307|NCT00075725|83109830|FG010|Overall Study|Pt received additional steroids|0|||
46887308|NCT00075725|83109831|FG011|Overall Study|Pt received additional steroids|0|||
46887309|NCT00075725|83109820|FG000|Overall Study|Pt relocated|0|||
46887310|NCT00075725|83109821|FG001|Overall Study|Pt relocated|0|||
46887311|NCT00075725|83109822|FG002|Overall Study|Pt relocated|0|||
46887312|NCT00075725|83109823|FG003|Overall Study|Pt relocated|2|||
46887313|NCT00075725|83109824|FG004|Overall Study|Pt relocated|0|||
46887314|NCT00075725|83109825|FG005|Overall Study|Pt relocated|1|||
46887315|NCT00075725|83109826|FG006|Overall Study|Pt relocated|1|||
46887316|NCT00075725|83109827|FG007|Overall Study|Pt relocated|2|||
46887317|NCT00075725|83109828|FG008|Overall Study|Pt relocated|1|||
46887318|NCT00075725|83109829|FG009|Overall Study|Pt relocated|0|||
46887319|NCT00075725|83109830|FG010|Overall Study|Pt relocated|0|||
46887320|NCT00075725|83109831|FG011|Overall Study|Pt relocated|0|||
46887321|NCT00075725|83109820|FG000|Overall Study|Institution Terminated|0|||
46887322|NCT00075725|83109821|FG001|Overall Study|Institution Terminated|0|||
46887323|NCT00075725|83109822|FG002|Overall Study|Institution Terminated|0|||
46887324|NCT00075725|83109823|FG003|Overall Study|Institution Terminated|0|||
46887325|NCT00075725|83109824|FG004|Overall Study|Institution Terminated|1|||
46887326|NCT00075725|83109825|FG005|Overall Study|Institution Terminated|0|||
46887327|NCT00075725|83109826|FG006|Overall Study|Institution Terminated|0|||
46887328|NCT00075725|83109827|FG007|Overall Study|Institution Terminated|3|||
46887329|NCT00075725|83109828|FG008|Overall Study|Institution Terminated|0|||
46887330|NCT00075725|83109829|FG009|Overall Study|Institution Terminated|0|||
46887331|NCT00075725|83109830|FG010|Overall Study|Institution Terminated|0|||
46887332|NCT00075725|83109831|FG011|Overall Study|Institution Terminated|0|||
46887333|NCT00075725|83109820|FG000|Overall Study|Study Closure|1|||
46887334|NCT00075725|83109821|FG001|Overall Study|Study Closure|0|||
46887335|NCT00075725|83109822|FG002|Overall Study|Study Closure|0|||
46887336|NCT00075725|83109823|FG003|Overall Study|Study Closure|0|||
46887337|NCT00075725|83109824|FG004|Overall Study|Study Closure|1|||
46887338|NCT00075725|83109825|FG005|Overall Study|Study Closure|3|||
46887339|NCT00075725|83109826|FG006|Overall Study|Study Closure|0|||
46887340|NCT00075725|83109827|FG007|Overall Study|Study Closure|1|||
46887341|NCT00075725|83109828|FG008|Overall Study|Study Closure|0|||
46887342|NCT00075725|83109829|FG009|Overall Study|Study Closure|0|||
46887343|NCT00075725|83109830|FG010|Overall Study|Study Closure|0|||
46887344|NCT00075725|83109831|FG011|Overall Study|Study Closure|0|||
46887345|NCT00075725|83109820|FG000|Overall Study|Other complications|0|||
46887346|NCT00075725|83109821|FG001|Overall Study|Other complications|0|||
46887347|NCT00075725|83109822|FG002|Overall Study|Other complications|0|||
46887348|NCT00075725|83109823|FG003|Overall Study|Other complications|0|||
46887349|NCT00075725|83109824|FG004|Overall Study|Other complications|0|||
46887350|NCT00075725|83109825|FG005|Overall Study|Other complications|1|||
46887351|NCT00075725|83109826|FG006|Overall Study|Other complications|0|||
46887352|NCT00075725|83109827|FG007|Overall Study|Other complications|0|||
46887353|NCT00075725|83109828|FG008|Overall Study|Other complications|0|||
46887354|NCT00075725|83109829|FG009|Overall Study|Other complications|0|||
46887355|NCT00075725|83109830|FG010|Overall Study|Other complications|0|||
46887356|NCT00075725|83109831|FG011|Overall Study|Other complications|0|||
46887357|NCT00075725|83109820|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
46887358|NCT00075725|83109821|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
46887359|NCT00075725|83109822|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
46887360|NCT00075725|83109823|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
46887361|NCT00075725|83109824|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
46887362|NCT00075725|83109825|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
46887363|NCT00075725|83109826|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
46887364|NCT00075725|83109827|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
46887365|NCT00075725|83109828|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
46887366|NCT00075725|83109829|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
46887367|NCT00075725|83109830|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
46887368|NCT00075725|83109831|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
46887369|NCT00075725|83109820|FG000|Overall Study|Pt incarcerated|0|||
46887370|NCT00075725|83109821|FG001|Overall Study|Pt incarcerated|0|||
46887371|NCT00075725|83109822|FG002|Overall Study|Pt incarcerated|0|||
46887372|NCT00075725|83109823|FG003|Overall Study|Pt incarcerated|0|||
46887373|NCT00075725|83109824|FG004|Overall Study|Pt incarcerated|0|||
46887374|NCT00075725|83109825|FG005|Overall Study|Pt incarcerated|0|||
46887375|NCT00075725|83109826|FG006|Overall Study|Pt incarcerated|0|||
46887376|NCT00075725|83109827|FG007|Overall Study|Pt incarcerated|1|||
46887377|NCT00075725|83109828|FG008|Overall Study|Pt incarcerated|0|||
46887378|NCT00075725|83109829|FG009|Overall Study|Pt incarcerated|0|||
46887379|NCT00075725|83109830|FG010|Overall Study|Pt incarcerated|0|||
46887380|NCT00075725|83109831|FG011|Overall Study|Pt incarcerated|0|||
46887381|NCT02953782|83109870|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
46887382|NCT02953782|83109871|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
46887383|NCT02953782|83109872|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
46887384|NCT02953782|83109873|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
46887385|NCT02953782|83109874|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
46887386|NCT02953782|83109875|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
46887387|NCT02953782|83109876|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
46887388|NCT02953782|83109877|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
46887389|NCT02953782|83109870|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
46887390|NCT02953782|83109871|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
46887391|NCT02953782|83109872|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
46887392|NCT02953782|83109873|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
46887393|NCT02953782|83109874|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
46887394|NCT02953782|83109875|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
46887395|NCT02953782|83109876|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
46887396|NCT02953782|83109877|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
46887397|NCT02953782|83109870|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
46887398|NCT02953782|83109871|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
46887399|NCT02953782|83109872|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
46887400|NCT02953782|83109873|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
46887401|NCT02953782|83109874|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
46887402|NCT02953782|83109875|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
46887403|NCT02953782|83109876|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
46887404|NCT02953782|83109877|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
46887405|NCT02953782|83109870|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
46887406|NCT02953782|83109871|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
46887407|NCT02953782|83109872|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
46887408|NCT02953782|83109873|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
46887409|NCT02953782|83109874|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
46887410|NCT02953782|83109875|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
46887411|NCT02953782|83109876|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
46991428|NCT02301403|83238440|FG000|Overall Study|Withdrawal by Subject|28|||
46887412|NCT02953782|83109877|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
46887413|NCT02953782|83109870|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
46887414|NCT02953782|83109871|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
46887415|NCT02953782|83109872|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
46887416|NCT02953782|83109873|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
46887417|NCT02953782|83109874|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
46887418|NCT02953782|83109875|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
46887419|NCT02953782|83109876|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
46887420|NCT02953782|83109877|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
46887421|NCT02953782|83109870|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
46887422|NCT02953782|83109871|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
46887423|NCT02953782|83109872|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
46887424|NCT02953782|83109873|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
46887425|NCT02953782|83109874|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
46887426|NCT02953782|83109875|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
46887427|NCT02953782|83109876|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
46887428|NCT02953782|83109877|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
46887429|NCT02953782|83109870|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
46887430|NCT02953782|83109871|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
46887431|NCT02953782|83109872|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
46887432|NCT02953782|83109873|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
46887433|NCT02953782|83109874|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
46887434|NCT02953782|83109875|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
46887435|NCT02953782|83109876|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
46887436|NCT02953782|83109877|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
46887437|NCT02953782|83109870|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
46887438|NCT02953782|83109871|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
46887439|NCT02953782|83109872|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
46887440|NCT02953782|83109873|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
46887441|NCT02953782|83109874|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
46887442|NCT02953782|83109875|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
46887443|NCT02953782|83109876|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
46887444|NCT02953782|83109877|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
46887445|NCT03760081|83109900|FG000|Overall Study|Miscellaneous|0|||
46887446|NCT03760081|83109901|FG001|Overall Study|Miscellaneous|1|||
46887447|NCT03760081|83109900|FG000|Overall Study|Progressive Disease|5|||
46887448|NCT03760081|83109901|FG001|Overall Study|Progressive Disease|10|||
46887449|NCT03760081|83109900|FG000|Overall Study|Death|1|||
46887450|NCT03760081|83109901|FG001|Overall Study|Death|1|||
46887451|NCT03422172|83109909|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
46887452|NCT03422172|83109909|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
46887453|NCT03422172|83109909|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
46887454|NCT00057863|83109918|FG000|Overall Study|Death|1|||
46887455|NCT00057863|83109918|FG000|Overall Study|Withdrawal by Subject|2|||
46887456|NCT00075023|83109924|FG000|Pilot Study|Physician Decision|1|||
46887457|NCT00075023|83109925|FG001|Pilot Study|Physician Decision|2|||
46887458|NCT00075023|83109924|FG000|Pilot Study|Withdrawal by Subject|1|||
46887459|NCT00075023|83109925|FG001|Pilot Study|Withdrawal by Subject|0|||
46887460|NCT00074711|83109934|FG000|Overall Study|Withdrawal by Subject|1|||
46887461|NCT00074711|83109935|FG001|Overall Study|Withdrawal by Subject|1|||
46887462|NCT00074711|83109934|FG000|Overall Study|Lost to Follow-up|10|||
46887463|NCT00074711|83109935|FG001|Overall Study|Lost to Follow-up|8|||
46887464|NCT00074711|83109934|FG000|Overall Study|Participant stopped study drug|4|||
46887465|NCT00074711|83109935|FG001|Overall Study|Participant stopped study drug|6|||
46887466|NCT03420300|83109941|FG000|Overall Study|Death|2|||
46887467|NCT03419598|83109945|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
46887468|NCT03407430|83109953|FG000|Washout|Protocol Violation|1|||
46887469|NCT03407430|83109954|FG001|Washout|Protocol Violation|0|||
46887470|NCT03407118|83109967|FG000|Period 2|Withdrawal by Subject|1|||
46887471|NCT03407118|83109968|FG001|Period 2|Withdrawal by Subject|0|||
46887472|NCT03406962|83109974|FG000|Overall Study|Death|2|||
46887473|NCT03406962|83109974|FG000|Overall Study|Adverse Event|1|||
46887474|NCT03406260|83109985|FG000|Period 1|Adverse Event|0|||
46887475|NCT03406260|83109986|FG001|Period 1|Adverse Event|0|||
46887476|NCT03406260|83109987|FG002|Period 1|Adverse Event|0|||
46887477|NCT03406260|83109988|FG003|Period 1|Adverse Event|0|||
46887478|NCT03406260|83109989|FG004|Period 1|Adverse Event|1|||
46887479|NCT03406260|83109990|FG005|Period 1|Adverse Event|0|||
46887480|NCT03419364|83110003|FG000|Overall Study|Delivery due to maternal condition|2|||
46887481|NCT03419364|83110004|FG001|Overall Study|Delivery due to maternal condition|0|||
46887482|NCT03419364|83110005|FG002|Overall Study|Delivery due to maternal condition|0|||
46887483|NCT02954172|83110015|FG000|Overall Study|Protocol Violation|3|||
46887484|NCT02954172|83110016|FG001|Overall Study|Protocol Violation|0|||
46887485|NCT02954172|83110015|FG000|Overall Study|allergic reaction|2|||
46887486|NCT02954172|83110016|FG001|Overall Study|allergic reaction|1|||
46887487|NCT02954172|83110015|FG000|Overall Study|non-measurable lesions at baseline|1|||
46887488|NCT02954172|83110016|FG001|Overall Study|non-measurable lesions at baseline|2|||
46887489|NCT02953938|83110025|FG000|Overall Study|Adverse Event|0|||
46887490|NCT02953938|83110026|FG001|Overall Study|Adverse Event|1|||
46887491|NCT02953938|83110025|FG000|Overall Study|Withdrawal by Subject|1|||
46887492|NCT02953938|83110026|FG001|Overall Study|Withdrawal by Subject|1|||
46887493|NCT03758443|83110037|FG000|Induction Period|Adverse Event|2|||
46887494|NCT03758443|83110038|FG001|Induction Period|Adverse Event|4|||
46887495|NCT03758443|83110039|FG002|Induction Period|Adverse Event|2|||
46887496|NCT03758443|83110040|FG003|Induction Period|Adverse Event|3|||
46887497|NCT03758443|83110037|FG000|Induction Period|Physician Decision|1|||
46887498|NCT03758443|83110038|FG001|Induction Period|Physician Decision|1|||
46887499|NCT03758443|83110039|FG002|Induction Period|Physician Decision|3|||
46887500|NCT03758443|83110040|FG003|Induction Period|Physician Decision|0|||
46887501|NCT03758443|83110037|FG000|Induction Period|Protocol Violation|0|||
46887502|NCT03758443|83110038|FG001|Induction Period|Protocol Violation|0|||
46887503|NCT03758443|83110039|FG002|Induction Period|Protocol Violation|0|||
46887504|NCT03758443|83110040|FG003|Induction Period|Protocol Violation|1|||
46887505|NCT03758443|83110037|FG000|Induction Period|Withdrawal by Subject|3|||
46887506|NCT03758443|83110038|FG001|Induction Period|Withdrawal by Subject|2|||
46887507|NCT03758443|83110039|FG002|Induction Period|Withdrawal by Subject|2|||
46887508|NCT03758443|83110040|FG003|Induction Period|Withdrawal by Subject|4|||
46887509|NCT03758443|83110037|FG000|Extended Induction Period|Adverse Event|1|||
46887510|NCT03758443|83110038|FG001|Extended Induction Period|Adverse Event|1|||
46887511|NCT03758443|83110039|FG002|Extended Induction Period|Adverse Event|0|||
46887512|NCT03758443|83110040|FG003|Extended Induction Period|Adverse Event|1|||
46887513|NCT03758443|83110037|FG000|Extended Induction Period|Lost to Follow-up|1|||
46887514|NCT03758443|83110038|FG001|Extended Induction Period|Lost to Follow-up|0|||
46887515|NCT03758443|83110039|FG002|Extended Induction Period|Lost to Follow-up|0|||
46887516|NCT03758443|83110040|FG003|Extended Induction Period|Lost to Follow-up|0|||
46887517|NCT03758443|83110037|FG000|Extended Induction Period|Physician Decision|2|||
46887518|NCT03758443|83110038|FG001|Extended Induction Period|Physician Decision|1|||
46887519|NCT03758443|83110039|FG002|Extended Induction Period|Physician Decision|2|||
46887520|NCT03758443|83110040|FG003|Extended Induction Period|Physician Decision|2|||
46887521|NCT03758443|83110037|FG000|Extended Induction Period|Protocol Violation|0|||
46887522|NCT03758443|83110038|FG001|Extended Induction Period|Protocol Violation|0|||
46887523|NCT03758443|83110039|FG002|Extended Induction Period|Protocol Violation|0|||
46887524|NCT03758443|83110040|FG003|Extended Induction Period|Protocol Violation|1|||
46887525|NCT03758443|83110037|FG000|Extended Induction Period|Withdrawal by Subject|8|||
46887526|NCT03758443|83110038|FG001|Extended Induction Period|Withdrawal by Subject|1|||
46887527|NCT03758443|83110039|FG002|Extended Induction Period|Withdrawal by Subject|7|||
46887528|NCT03758443|83110040|FG003|Extended Induction Period|Withdrawal by Subject|3|||
46887529|NCT03758443|83110037|FG000|Extended Induction Period|Miscellaneous|1|||
46887530|NCT03758443|83110038|FG001|Extended Induction Period|Miscellaneous|0|||
46887531|NCT03758443|83110039|FG002|Extended Induction Period|Miscellaneous|0|||
46887532|NCT03758443|83110040|FG003|Extended Induction Period|Miscellaneous|0|||
46887533|NCT03758443|83110037|FG000|Maintenance Period|Adverse Event|1|||
46887534|NCT03758443|83110038|FG001|Maintenance Period|Adverse Event|2|||
46887535|NCT03758443|83110039|FG002|Maintenance Period|Adverse Event|0|||
46887536|NCT03758443|83110040|FG003|Maintenance Period|Adverse Event|0|||
46887537|NCT03758443|83110037|FG000|Maintenance Period|Lost to Follow-up|0|||
46887538|NCT03758443|83110038|FG001|Maintenance Period|Lost to Follow-up|0|||
46887539|NCT03758443|83110039|FG002|Maintenance Period|Lost to Follow-up|0|||
46887540|NCT03758443|83110040|FG003|Maintenance Period|Lost to Follow-up|1|||
46887541|NCT03758443|83110037|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
46887542|NCT03758443|83110038|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
46887543|NCT03758443|83110039|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
46887544|NCT03758443|83110040|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
46887545|NCT03758443|83110037|FG000|Maintenance Period|Protocol Violation|0|||
46887546|NCT03758443|83110038|FG001|Maintenance Period|Protocol Violation|1|||
46887547|NCT03758443|83110039|FG002|Maintenance Period|Protocol Violation|0|||
46887548|NCT03758443|83110040|FG003|Maintenance Period|Protocol Violation|0|||
46887549|NCT03758443|83110037|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
46887550|NCT03758443|83110038|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
46887551|NCT03758443|83110039|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
46887552|NCT03758443|83110040|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
46887553|NCT03758443|83110037|FG000|Maintenance Period|Withdrawal by Subject|1|||
46887554|NCT03758443|83110038|FG001|Maintenance Period|Withdrawal by Subject|0|||
46887555|NCT03758443|83110039|FG002|Maintenance Period|Withdrawal by Subject|1|||
46887556|NCT03758443|83110040|FG003|Maintenance Period|Withdrawal by Subject|1|||
46887557|NCT03758443|83110037|FG000|Maintenance Period|Miscellaneous|0|||
46887558|NCT03758443|83110038|FG001|Maintenance Period|Miscellaneous|0|||
46887559|NCT03758443|83110039|FG002|Maintenance Period|Miscellaneous|1|||
46887560|NCT03758443|83110040|FG003|Maintenance Period|Miscellaneous|0|||
46887561|NCT03442764|83110062|FG000|Overall Study|Adverse Event|1|||
46887562|NCT03442764|83110063|FG001|Overall Study|Adverse Event|0|||
46887563|NCT03442764|83110064|FG002|Overall Study|Adverse Event|0|||
46887564|NCT03442296|83110075|FG000|3 Month Follow-up|Death|3|||
46887565|NCT03442296|83110076|FG001|3 Month Follow-up|Death|1|||
46887566|NCT03442296|83110075|FG000|3 Month Follow-up|Lost to Follow-up|1|||
46887567|NCT03442296|83110076|FG001|3 Month Follow-up|Lost to Follow-up|1|||
46887568|NCT03442296|83110075|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
46887569|NCT03442296|83110076|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
46887570|NCT03442296|83110075|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
46887571|NCT03442296|83110076|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
46887572|NCT03442296|83110075|FG000|12 Month Follow-up|Incomplete measurement|1|||
46887573|NCT03442296|83110076|FG001|12 Month Follow-up|Incomplete measurement|1|||
46887574|NCT03441984|83110084|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887575|NCT03441984|83110085|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887576|NCT03441984|83110086|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
46887577|NCT03441984|83110087|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887578|NCT03441984|83110088|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887579|NCT03441984|83110089|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887580|NCT03441984|83110090|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887581|NCT03441984|83110091|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887582|NCT03441984|83110092|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887583|NCT03441984|83110093|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887584|NCT03441984|83110094|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46887585|NCT03441984|83110095|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
46897654|NCT00706030|83123370|FG003|Overall Study|Not recorded|0|||
46887586|NCT03441360|83110113|FG000|Overall Study|Radiological disease progression|5|||
46887587|NCT03441360|83110114|FG001|Overall Study|Radiological disease progression|6|||
46887588|NCT03441360|83110115|FG002|Overall Study|Radiological disease progression|4|||
46887589|NCT03441360|83110113|FG000|Overall Study|Clinical disease progression|2|||
46887590|NCT03441360|83110114|FG001|Overall Study|Clinical disease progression|2|||
46887591|NCT03441360|83110115|FG002|Overall Study|Clinical disease progression|0|||
46887592|NCT03441360|83110113|FG000|Overall Study|Adverse Event|1|||
46887593|NCT03441360|83110114|FG001|Overall Study|Adverse Event|0|||
46887594|NCT03441360|83110115|FG002|Overall Study|Adverse Event|1|||
46887595|NCT01347840|83110123|FG000|Overall Study|Withdrawal by Subject|1|||
46887596|NCT01347762|83110131|FG000|Overall Study|Lost to Follow-up|0|||
46887597|NCT01347762|83110132|FG001|Overall Study|Lost to Follow-up|1|||
46887598|NCT01347762|83110133|FG002|Overall Study|Lost to Follow-up|6|||
46887599|NCT01347762|83110134|FG003|Overall Study|Lost to Follow-up|5|||
46887600|NCT01347762|83110131|FG000|Overall Study|Withdrawal by Subject|4|||
46887601|NCT01347762|83110132|FG001|Overall Study|Withdrawal by Subject|1|||
46887602|NCT01347762|83110133|FG002|Overall Study|Withdrawal by Subject|3|||
46887603|NCT01347762|83110134|FG003|Overall Study|Withdrawal by Subject|3|||
46887604|NCT03438396|83110144|FG000|Overall Study|Reason Not Specified|9|||
46887605|NCT03438396|83110144|FG000|Overall Study|Withdrawal by Subject|5|||
46887606|NCT03438396|83110144|FG000|Overall Study|Lost to Follow-up|2|||
46887607|NCT03438396|83110144|FG000|Overall Study|Death|85|||
46887608|NCT03438396|83110144|FG000|Overall Study|Not treated|1|||
46887609|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
46887610|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
46887611|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
46887612|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
46887613|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
46887614|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
46887615|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
46887616|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
46887617|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
46887618|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
46887619|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
46887620|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
46887621|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
46887622|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
46887623|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
46887624|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
46887625|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
46887626|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
46887627|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
46887628|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
46887629|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
46887630|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
46887631|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
46887632|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
46887633|NCT00073307|83110150|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
46887634|NCT00073307|83110151|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
46887635|NCT00073307|83110152|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
46887636|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
46887637|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
46887638|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
46887639|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
46887640|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
46887641|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
46887642|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
46887643|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
46887644|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
46887645|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
46887646|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
46887647|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
46887648|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
46887649|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
46887650|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
46887651|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
46887652|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
46887653|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
46887654|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
46887655|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
46887656|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
46887657|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
46887658|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
46887659|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
46887660|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
46887661|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
46887662|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
46887663|NCT00073307|83110150|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
46887664|NCT00073307|83110151|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
46887665|NCT00073307|83110152|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
46887666|NCT03388164|83110163|FG000|Overall Study|Withdrawal by Subject|3|||
46887667|NCT03388164|83110164|FG001|Overall Study|Withdrawal by Subject|1|||
46887668|NCT03403374|83110170|FG000|Overall Study|Lost to Follow-up|1|||
46887669|NCT03387462|83110174|FG000|Overall Study|Lost to Follow-up|1|||
46887670|NCT03756883|83110181|FG000|Overall Study|Adverse Event|2|||
46887671|NCT03756883|83110182|FG001|Overall Study|Adverse Event|2|||
46887672|NCT03756883|83110183|FG002|Overall Study|Adverse Event|2|||
46887673|NCT03756883|83110181|FG000|Overall Study|Lack of Efficacy|0|||
46887674|NCT03756883|83110182|FG001|Overall Study|Lack of Efficacy|1|||
46887675|NCT03756883|83110183|FG002|Overall Study|Lack of Efficacy|2|||
46887676|NCT03756883|83110181|FG000|Overall Study|Lost to Follow-up|3|||
46887677|NCT03756883|83110182|FG001|Overall Study|Lost to Follow-up|3|||
46887678|NCT03756883|83110183|FG002|Overall Study|Lost to Follow-up|0|||
46887679|NCT03756883|83110181|FG000|Overall Study|Protocol Violation|2|||
46887680|NCT03756883|83110182|FG001|Overall Study|Protocol Violation|0|||
46887681|NCT03756883|83110183|FG002|Overall Study|Protocol Violation|1|||
46887682|NCT03756883|83110181|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
46887683|NCT03756883|83110182|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
46887684|NCT03756883|83110183|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
46887685|NCT03756883|83110181|FG000|Overall Study|Withdrawal by Subject|4|||
46887686|NCT03756883|83110182|FG001|Overall Study|Withdrawal by Subject|1|||
46887687|NCT03756883|83110183|FG002|Overall Study|Withdrawal by Subject|0|||
46887688|NCT03756883|83110181|FG000|Overall Study|Other Reasons|2|||
46887689|NCT03756883|83110182|FG001|Overall Study|Other Reasons|4|||
46887690|NCT03756883|83110183|FG002|Overall Study|Other Reasons|0|||
46887691|NCT03386994|83110194|FG000|Overall Study|Lung transplant|1|||
46887692|NCT03386994|83110194|FG000|Overall Study|Adverse Event|14|||
46887693|NCT03386994|83110194|FG000|Overall Study|Lost to Follow-up|4|||
46887694|NCT03386994|83110194|FG000|Overall Study|Withdrawal by Subject|3|||
46887695|NCT03386994|83110194|FG000|Overall Study|Death|16|||
46887696|NCT03756571|83110211|FG000|Overall Study|Lost to Follow-up|1|||
46887697|NCT03756571|83110212|FG001|Overall Study|Lost to Follow-up|1|||
46887698|NCT03386448|83110220|FG000|Overall Study|Adverse Event|0|||
46887699|NCT03386448|83110221|FG001|Overall Study|Adverse Event|2|||
46887700|NCT02951988|83110230|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
46887701|NCT02951988|83110231|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
46887702|NCT02951988|83110232|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
46887703|NCT02951988|83110233|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
46887704|NCT02951988|83110230|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
46887705|NCT02951988|83110231|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
46887706|NCT02951988|83110232|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
46887707|NCT02951988|83110233|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
46887708|NCT02951988|83110230|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
46887709|NCT02951988|83110231|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
46887710|NCT02951988|83110232|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
46887711|NCT02951988|83110233|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
46887712|NCT02951988|83110230|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
46887713|NCT02951988|83110231|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
46887714|NCT02951988|83110232|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
46887715|NCT02951988|83110233|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
46887716|NCT02951988|83110230|FG000|Open-Label Treatment Period|Protocol Violation|22|||
46887717|NCT02951988|83110231|FG001|Open-Label Treatment Period|Protocol Violation|0|||
46887718|NCT02951988|83110232|FG002|Open-Label Treatment Period|Protocol Violation|0|||
46705890|NCT01027845|82920782|FG002|Primary Vaccination Phase|Adverse Event|0|||
46705891|NCT01027845|82920783|FG003|Primary Vaccination Phase|Adverse Event|0|||
46887719|NCT02951988|83110233|FG003|Open-Label Treatment Period|Protocol Violation|0|||
46887720|NCT02951988|83110230|FG000|Open-Label Treatment Period|Pregnancy|2|||
46887721|NCT02951988|83110231|FG001|Open-Label Treatment Period|Pregnancy|0|||
46887722|NCT02951988|83110232|FG002|Open-Label Treatment Period|Pregnancy|0|||
46887723|NCT02951988|83110233|FG003|Open-Label Treatment Period|Pregnancy|0|||
46887724|NCT02951988|83110230|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
46887725|NCT02951988|83110231|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
46887726|NCT02951988|83110232|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
46887727|NCT02951988|83110233|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
46887728|NCT02951988|83110230|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
46887729|NCT02951988|83110231|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
46887730|NCT02951988|83110232|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
46887731|NCT02951988|83110233|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
46887732|NCT02951988|83110230|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
46887733|NCT02951988|83110231|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
46887734|NCT02951988|83110232|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
46887735|NCT02951988|83110233|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
46887736|NCT02951988|83110230|FG000|Open-Label Treatment Period|Adverse Event|45|||
46887737|NCT02951988|83110231|FG001|Open-Label Treatment Period|Adverse Event|0|||
46887738|NCT02951988|83110232|FG002|Open-Label Treatment Period|Adverse Event|0|||
46887739|NCT02951988|83110233|FG003|Open-Label Treatment Period|Adverse Event|0|||
46887740|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
46887741|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
46887742|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
46887743|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
46887744|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
46887745|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
46887746|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
46887747|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
46887748|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
46887749|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
46887750|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
46887751|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
46887752|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
46887753|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
46887754|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
46887755|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
46887756|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Pregnancy|0|||
46887757|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Pregnancy|1|||
46887758|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Pregnancy|1|||
46887759|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Pregnancy|0|||
46887760|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46887761|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
46887762|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
46887763|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
46887764|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
46887765|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
46887766|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
46887767|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
46887768|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Adverse Event|0|||
46887769|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Adverse Event|8|||
46887770|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Adverse Event|3|||
46887771|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Adverse Event|6|||
46887772|NCT02951988|83110230|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
46887773|NCT02951988|83110231|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
46887774|NCT02951988|83110232|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
46887775|NCT02951988|83110233|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
46887776|NCT00009737|83110245|FG000|Overall Study|Adverse Event|112|||
46887777|NCT00009737|83110246|FG001|Overall Study|Adverse Event|75|||
46887778|NCT00009737|83110245|FG000|Overall Study|Death|4|||
46887779|NCT00009737|83110246|FG001|Overall Study|Death|6|||
46887780|NCT00009737|83110245|FG000|Overall Study|Lack of Efficacy|17|||
46887781|NCT00009737|83110246|FG001|Overall Study|Lack of Efficacy|15|||
46887782|NCT00009737|83110245|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
46887783|NCT00009737|83110246|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
46887784|NCT00009737|83110245|FG000|Overall Study|Other Protocol Violation|1|||
46887785|NCT00009737|83110246|FG001|Overall Study|Other Protocol Violation|0|||
46887786|NCT00009737|83110245|FG000|Overall Study|Refused Treatment|15|||
46887787|NCT00009737|83110246|FG001|Overall Study|Refused Treatment|16|||
46887788|NCT00009737|83110245|FG000|Overall Study|Lost to Follow-up|1|||
46887789|NCT00009737|83110246|FG001|Overall Study|Lost to Follow-up|1|||
46887790|NCT00009737|83110245|FG000|Overall Study|Administrative/Other Reasons|7|||
46887791|NCT00009737|83110246|FG001|Overall Study|Administrative/Other Reasons|1|||
46887792|NCT03417102|83110254|FG000|Overall Study|Adverse Event|0|||
46887793|NCT03417102|83110255|FG001|Overall Study|Adverse Event|1|||
46887794|NCT03417102|83110254|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
46887795|NCT03417102|83110255|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
46887796|NCT03417102|83110254|FG000|Overall Study|Other|0|||
46887797|NCT03417102|83110255|FG001|Overall Study|Other|1|||
46705892|NCT01027845|82920780|FG000|Primary Vaccination Phase|Protocol Violation|1|||
46887798|NCT03417024|83110261|FG000|Overall Study|Study Termination prior to follow-up|11|||
46887799|NCT03417024|83110261|FG000|Overall Study|Physician Decision|2|||
46887800|NCT00028769|83110265|FG000|Overall Study|Adverse Event|2|||
46705893|NCT01027845|82920781|FG001|Primary Vaccination Phase|Protocol Violation|0|||
46705894|NCT01027845|82920782|FG002|Primary Vaccination Phase|Protocol Violation|0|||
46991429|NCT02301403|83238441|FG001|Overall Study|Withdrawal by Subject|41|||
46991430|NCT02301169|83238449|FG000|Overall Study|Adverse Event|1|||
46887801|NCT00028769|83110265|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
46887802|NCT00028769|83110265|FG000|Overall Study|Progression or Death|31|||
46887803|NCT00028769|83110265|FG000|Overall Study|Other - Not Protocol Specified|1|||
46887804|NCT00028769|83110265|FG000|Overall Study|Ineligible|5|||
46887805|NCT00028769|83110265|FG000|Overall Study|Not Analyzable|1|||
46887806|NCT02953314|83110271|FG000|Overall Study|Adverse Event|0|||
46887807|NCT02953314|83110272|FG001|Overall Study|Adverse Event|1|||
46887808|NCT02953314|83110271|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
46887809|NCT02953314|83110272|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
46887810|NCT03402750|83110280|FG000|Overall Study|Lost to Follow-up|2|||
46887811|NCT03402750|83110281|FG001|Overall Study|Lost to Follow-up|1|||
46887812|NCT00007475|83110290|FG000|Overall Study|Withdrawal by Subject|1|||
46887813|NCT00007475|83110291|FG001|Overall Study|Withdrawal by Subject|0|||
46887814|NCT00007475|83110292|FG002|Overall Study|Withdrawal by Subject|0|||
46887815|NCT00007475|83110293|FG003|Overall Study|Withdrawal by Subject|0|||
46887816|NCT00007475|83110290|FG000|Overall Study|Adverse Event|3|||
46887817|NCT00007475|83110291|FG001|Overall Study|Adverse Event|0|||
46887818|NCT00007475|83110292|FG002|Overall Study|Adverse Event|0|||
46887819|NCT00007475|83110293|FG003|Overall Study|Adverse Event|0|||
46887820|NCT00025883|83110305|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
46887821|NCT00025883|83110305|FG000|Overall Study|no baseline data|1|||
46705895|NCT01027845|82920783|FG003|Primary Vaccination Phase|Protocol Violation|0|||
46705896|NCT01027845|82920780|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
46705897|NCT01027845|82920781|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
46705898|NCT01027845|82920782|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
46705899|NCT01027845|82920783|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
46705900|NCT01027845|82920780|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
46705901|NCT01027845|82920781|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
46705902|NCT01027845|82920782|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
46705903|NCT01027845|82920783|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
46705904|NCT01027845|82920780|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
46705905|NCT01027845|82920781|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
46705906|NCT01027845|82920782|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
46705907|NCT01027845|82920783|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
46705908|NCT01017549|82920792|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
46705909|NCT01017549|82920792|FG000|One-year Follow-up|Lost to Follow-up|2|||
46705910|NCT01017549|82920792|FG000|One-year Follow-up|Withdrawal by Subject|5|||
46705911|NCT01017549|82920792|FG000|5 Year Follow-up|Lost to Follow-up|9|||
46705912|NCT01017549|82920792|FG000|5 Year Follow-up|Mastectomy|3|||
46705913|NCT01030341|82920796|FG000|Overall Study|Withdrawal by Subject|1|||
46705914|NCT01030341|82920796|FG000|Overall Study|Lost to Follow-up|2|||
46705915|NCT01026831|82920802|FG000|Overall Study|Adverse Event|4|||
46705916|NCT01026831|82920803|FG001|Overall Study|Adverse Event|3|||
46705917|NCT01026831|82920802|FG000|Overall Study|Lost to Follow-up|2|||
46887822|NCT00025883|83110305|FG000|Overall Study|Death|1|||
46705918|NCT01026831|82920803|FG001|Overall Study|Lost to Follow-up|0|||
46887823|NCT00025883|83110305|FG000|Overall Study|Adverse Event|1|||
46705919|NCT01026831|82920802|FG000|Overall Study|Physician Decision|1|||
46705920|NCT01026831|82920803|FG001|Overall Study|Physician Decision|1|||
46705921|NCT01026831|82920802|FG000|Overall Study|Protocol Violation|0|||
46705922|NCT01026831|82920803|FG001|Overall Study|Protocol Violation|2|||
46705923|NCT01026831|82920802|FG000|Overall Study|Withdrawal by Subject|7|||
46887824|NCT00025883|83110305|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
46887825|NCT00072293|83110312|FG000|Overall Study|Lost to Follow-up|1|||
46887826|NCT00072293|83110313|FG001|Overall Study|Lost to Follow-up|1|||
46887827|NCT00072293|83110312|FG000|Overall Study|Withdrawal by Subject|0|||
46991431|NCT02301169|83238450|FG001|Overall Study|Adverse Event|0|||
46991432|NCT02333383|83238456|FG000|Overall Study|Adalimumab discontinuation|21|||
46991433|NCT02333383|83238456|FG000|Overall Study|Lost to Follow-up|15|||
46991434|NCT02333383|83238456|FG000|Overall Study|Withdrawal by Subject|3|||
46897655|NCT00706030|83123367|FG000|Overall Study|Protocol Violation|0|||
46897656|NCT00706030|83123368|FG001|Overall Study|Protocol Violation|0|||
46705924|NCT01026831|82920803|FG001|Overall Study|Withdrawal by Subject|5|||
46991435|NCT02333383|83238456|FG000|Overall Study|Transfer to another hospital|2|||
46991436|NCT02332915|83238462|FG000|Overall Study|Moved out of region|3|||
46991437|NCT02332915|83238463|FG001|Overall Study|Moved out of region|0|||
46991438|NCT02332915|83238462|FG000|Overall Study|Unrelated illness|1|||
46991439|NCT02332915|83238463|FG001|Overall Study|Unrelated illness|1|||
46991440|NCT02332915|83238462|FG000|Overall Study|Travel distance prohibitive|0|||
46705925|NCT01016067|82920811|FG000|Overall Study|Lost to Follow-up|1|||
46705926|NCT01016067|82920812|FG001|Overall Study|Lost to Follow-up|2|||
46705927|NCT01016067|82920811|FG000|Overall Study|Physician Decision|1|||
46705928|NCT01016067|82920812|FG001|Overall Study|Physician Decision|1|||
46705929|NCT01016067|82920811|FG000|Overall Study|Withdrew due to Relocation|0|||
46705930|NCT01016067|82920812|FG001|Overall Study|Withdrew due to Relocation|1|||
46705931|NCT01015833|82920820|FG000|Overall Study|Death|1|||
46705932|NCT01015833|82920821|FG001|Overall Study|Death|0|||
46705933|NCT01015833|82920820|FG000|Overall Study|Withdrawal by Subject|3|||
46705934|NCT01015833|82920821|FG001|Overall Study|Withdrawal by Subject|2|||
46705935|NCT01015833|82920820|FG000|Overall Study|Adverse Event|0|||
46705936|NCT01015833|82920821|FG001|Overall Study|Adverse Event|1|||
46705937|NCT01015833|82920820|FG000|Overall Study|Physician Decision|2|||
46705938|NCT01015833|82920821|FG001|Overall Study|Physician Decision|0|||
46705939|NCT01015833|82920820|FG000|Overall Study|Symptomatic deterioration|0|||
46705940|NCT01015833|82920821|FG001|Overall Study|Symptomatic deterioration|1|||
46705941|NCT01015833|82920820|FG000|Overall Study|Other|5|||
46705942|NCT01015833|82920821|FG001|Overall Study|Other|1|||
46705943|NCT01015833|82920820|FG000|Overall Study|Motor Vehicle Accidents|1|||
46705944|NCT01015833|82920821|FG001|Overall Study|Motor Vehicle Accidents|0|||
46705945|NCT01015833|82920820|FG000|Overall Study|Did not start treatment|1|||
46705946|NCT01015833|82920821|FG001|Overall Study|Did not start treatment|0|||
46705947|NCT01015677|82920839|FG000|Overall Study|Adverse Event|0|||
46705948|NCT01015677|82920840|FG001|Overall Study|Adverse Event|1|||
46705949|NCT01015677|82920841|FG002|Overall Study|Adverse Event|0|||
46705950|NCT01015677|82920839|FG000|Overall Study|Lack of Efficacy|0|||
46705951|NCT01015677|82920840|FG001|Overall Study|Lack of Efficacy|1|||
46705952|NCT01015677|82920841|FG002|Overall Study|Lack of Efficacy|0|||
46705953|NCT01015677|82920839|FG000|Overall Study|Protocol Violation|0|||
46705954|NCT01015677|82920840|FG001|Overall Study|Protocol Violation|1|||
46705955|NCT01015677|82920841|FG002|Overall Study|Protocol Violation|0|||
46705956|NCT01015677|82920839|FG000|Overall Study|Withdrawal by Subject|1|||
46705957|NCT01015677|82920840|FG001|Overall Study|Withdrawal by Subject|1|||
46705958|NCT01015677|82920841|FG002|Overall Study|Withdrawal by Subject|0|||
46705959|NCT01225211|82920881|FG000|Overall Study|Adverse Event|0|||
46705960|NCT01225211|82920882|FG001|Overall Study|Adverse Event|0|||
46705961|NCT01225211|82920883|FG002|Overall Study|Adverse Event|1|||
46705962|NCT01225211|82920884|FG003|Overall Study|Adverse Event|0|||
46705963|NCT01225211|82920885|FG004|Overall Study|Adverse Event|0|||
46705964|NCT01225211|82920886|FG005|Overall Study|Adverse Event|0|||
46705965|NCT01225211|82920887|FG006|Overall Study|Adverse Event|0|||
46705966|NCT01225211|82920888|FG007|Overall Study|Adverse Event|0|||
46705967|NCT01225211|82920889|FG008|Overall Study|Adverse Event|0|||
46705968|NCT01225211|82920890|FG009|Overall Study|Adverse Event|1|||
46705969|NCT01225211|82920881|FG000|Overall Study|Withdrawal by Subject|0|||
46705970|NCT01225211|82920882|FG001|Overall Study|Withdrawal by Subject|0|||
46705971|NCT01225211|82920883|FG002|Overall Study|Withdrawal by Subject|0|||
46705972|NCT01225211|82920884|FG003|Overall Study|Withdrawal by Subject|0|||
46705973|NCT01225211|82920885|FG004|Overall Study|Withdrawal by Subject|0|||
46705974|NCT01225211|82920886|FG005|Overall Study|Withdrawal by Subject|0|||
46705975|NCT01225211|82920887|FG006|Overall Study|Withdrawal by Subject|1|||
46705976|NCT01225211|82920888|FG007|Overall Study|Withdrawal by Subject|0|||
46705977|NCT01225211|82920889|FG008|Overall Study|Withdrawal by Subject|1|||
46705978|NCT01225211|82920890|FG009|Overall Study|Withdrawal by Subject|3|||
46705979|NCT01225211|82920881|FG000|Overall Study|Other|0|||
46705980|NCT01225211|82920882|FG001|Overall Study|Other|0|||
46705981|NCT01225211|82920883|FG002|Overall Study|Other|0|||
46705982|NCT01225211|82920884|FG003|Overall Study|Other|0|||
46705983|NCT01225211|82920885|FG004|Overall Study|Other|0|||
46705984|NCT01225211|82920886|FG005|Overall Study|Other|0|||
46705985|NCT01225211|82920887|FG006|Overall Study|Other|0|||
46705986|NCT01225211|82920888|FG007|Overall Study|Other|0|||
46705987|NCT01225211|82920889|FG008|Overall Study|Other|0|||
46705988|NCT01225211|82920890|FG009|Overall Study|Other|1|||
46705989|NCT01224821|82920973|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
46705990|NCT01224821|82920973|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
46705991|NCT01224821|82920973|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
46705992|NCT01224821|82920973|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
46705993|NCT01224821|82920973|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
46705994|NCT01224821|82920973|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
46705995|NCT01224821|82920973|FG000|Long-Term Follow-Up|Death|2|||
46705996|NCT01224821|82920973|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
46705997|NCT01224431|82920990|FG000|Overall Study|not randomized|0|||
46705998|NCT01224431|82920991|FG001|Overall Study|not randomized|4|||
46705999|NCT01224431|82920990|FG000|Overall Study|no video record|0|||
46706000|NCT01224431|82920991|FG001|Overall Study|no video record|1|||
46706001|NCT01223183|82921001|FG000|Imaging Day 1|Physician Decision|0|||
46706002|NCT01223183|82921002|FG001|Imaging Day 1|Physician Decision|1|||
46706003|NCT01223183|82921001|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
46706004|NCT01223183|82921002|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
46706005|NCT01223183|82921001|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
46706006|NCT01223183|82921002|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
46706007|NCT01223027|82921011|FG000|Overall Study|Adverse Event|20|||
46706008|NCT01223027|82921012|FG001|Overall Study|Adverse Event|10|||
46706009|NCT01223027|82921011|FG000|Overall Study|Death|42|||
46706010|NCT01223027|82921012|FG001|Overall Study|Death|42|||
46706011|NCT01223027|82921011|FG000|Overall Study|Lost to Follow-up|2|||
46706012|NCT01223027|82921012|FG001|Overall Study|Lost to Follow-up|1|||
46706013|NCT01223027|82921011|FG000|Overall Study|Physician Decision|4|||
46706014|NCT01223027|82921012|FG001|Overall Study|Physician Decision|8|||
46706015|NCT01223027|82921011|FG000|Overall Study|Progressive Disease|167|||
46706016|NCT01223027|82921012|FG001|Overall Study|Progressive Disease|183|||
46706017|NCT01223027|82921011|FG000|Overall Study|Protocol Violation|2|||
46706018|NCT01223027|82921012|FG001|Overall Study|Protocol Violation|1|||
46706019|NCT01223027|82921011|FG000|Overall Study|Subject/guardian decicion|18|||
46706020|NCT01223027|82921012|FG001|Overall Study|Subject/guardian decicion|16|||
46706021|NCT01223027|82921011|FG000|Overall Study|New therapy for study indication|17|||
46706022|NCT01223027|82921012|FG001|Overall Study|New therapy for study indication|8|||
46706023|NCT01223027|82921011|FG000|Overall Study|Study terminated by sponsor|2|||
46706024|NCT01223027|82921012|FG001|Overall Study|Study terminated by sponsor|8|||
46706025|NCT01015287|82921020|FG000|Overall Study|Death|21|||
46706026|NCT01015287|82921021|FG001|Overall Study|Death|16|||
46706027|NCT01015287|82921020|FG000|Overall Study|Adverse Event|1|||
46706028|NCT01015287|82921021|FG001|Overall Study|Adverse Event|0|||
46706029|NCT01015287|82921020|FG000|Overall Study|Sponsor Decision|3|||
46706030|NCT01015287|82921021|FG001|Overall Study|Sponsor Decision|7|||
46706031|NCT01015287|82921020|FG000|Overall Study|Physician Decision|19|||
46706032|NCT01015287|82921021|FG001|Overall Study|Physician Decision|21|||
46706033|NCT01015287|82921020|FG000|Overall Study|Withdrawal by Subject|14|||
46706034|NCT01015287|82921021|FG001|Overall Study|Withdrawal by Subject|19|||
46706035|NCT01015287|82921020|FG000|Overall Study|Entry Criteria not Met|11|||
46706036|NCT01015287|82921021|FG001|Overall Study|Entry Criteria not Met|14|||
46706037|NCT01015287|82921020|FG000|Overall Study|Lost to Follow-up|2|||
46706038|NCT01015287|82921021|FG001|Overall Study|Lost to Follow-up|1|||
46706039|NCT01015287|82921020|FG000|Overall Study|Protocol Violation|1|||
46706040|NCT01015287|82921021|FG001|Overall Study|Protocol Violation|1|||
46706041|NCT01015131|82921029|FG000|Overall Study|Physician Decision|1|||
46706042|NCT01015131|82921029|FG000|Overall Study|Protocol Violation|1|||
46706043|NCT01015131|82921029|FG000|Overall Study|Withdrawal by Subject|2|||
46706044|NCT01015131|82921029|FG000|Overall Study|Other Protocol Specified Criteria|4|||
46706045|NCT01222715|82921035|FG000|Overall Study|Adverse Event|0|||
46706046|NCT01222715|82921036|FG001|Overall Study|Adverse Event|4|||
46887828|NCT00072293|83110313|FG001|Overall Study|Withdrawal by Subject|1|||
46887829|NCT03753763|83110321|FG000|Overall Study|Adverse Event|2|||
46887830|NCT03753763|83110322|FG001|Overall Study|Adverse Event|0|||
46887831|NCT03753763|83110321|FG000|Overall Study|Withdrawal by Subject|3|||
46887832|NCT03753763|83110322|FG001|Overall Study|Withdrawal by Subject|1|||
46706047|NCT01222715|82921035|FG000|Overall Study|Death|0|||
46991441|NCT02332915|83238463|FG001|Overall Study|Travel distance prohibitive|1|||
46887833|NCT03753763|83110321|FG000|Overall Study|clinical deterioration|1|||
46706048|NCT01222715|82921036|FG001|Overall Study|Death|1|||
46706049|NCT01222715|82921035|FG000|Overall Study|Lack of Efficacy|22|||
46706050|NCT01222715|82921036|FG001|Overall Study|Lack of Efficacy|14|||
46706051|NCT01222715|82921035|FG000|Overall Study|Physician Decision|12|||
46706052|NCT01222715|82921036|FG001|Overall Study|Physician Decision|2|||
46706053|NCT01222715|82921035|FG000|Overall Study|Refusal of further protocol therapy|0|||
46706054|NCT01222715|82921036|FG001|Overall Study|Refusal of further protocol therapy|4|||
46706055|NCT01222715|82921035|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
46706056|NCT01222715|82921036|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
46706057|NCT01222715|82921035|FG000|Overall Study|Ineligible|0|||
46706058|NCT01222715|82921036|FG001|Overall Study|Ineligible|1|||
46706059|NCT01222715|82921035|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
46706060|NCT01222715|82921036|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
46706061|NCT01222403|82921044|FG000|Overall Study|Inappropriate enrollment|0|||
46706062|NCT01222403|82921045|FG001|Overall Study|Inappropriate enrollment|2|||
46706063|NCT01222247|82921053|FG000|Overall Study|Lost to Follow-up|2|||
46706064|NCT01222247|82921054|FG001|Overall Study|Lost to Follow-up|2|||
46706065|NCT01014975|82921060|FG000|Overall Study|Withdrawal by Subject|1|||
46706066|NCT01014975|82921061|FG001|Overall Study|Withdrawal by Subject|0|||
46706067|NCT01014975|82921062|FG002|Overall Study|Withdrawal by Subject|1|||
46887834|NCT03753763|83110322|FG001|Overall Study|clinical deterioration|0|||
46887835|NCT03384966|83110331|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
46887836|NCT03384966|83110332|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
46887837|NCT03384966|83110333|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
46887838|NCT03384966|83110331|FG000|Follow-up Period|Adverse Event|1|||
46887839|NCT03384966|83110332|FG001|Follow-up Period|Adverse Event|0|||
46887840|NCT03384966|83110333|FG002|Follow-up Period|Adverse Event|0|||
46887841|NCT03402126|83110350|FG000|Overall Study|Lost to Follow-up|6|||
46887842|NCT03402126|83110350|FG000|Overall Study|Protocol Violation|10|||
46887843|NCT03402126|83110350|FG000|Overall Study|Sponsor request/Study termination|29|||
46887844|NCT03402126|83110350|FG000|Overall Study|Study product no longer in use|1|||
46887845|NCT03402126|83110350|FG000|Overall Study|Technical problems|1|||
46887846|NCT03402126|83110350|FG000|Overall Study|Withdrawal by Subject|6|||
46887847|NCT03402126|83110350|FG000|Overall Study|Physician Decision|2|||
46887848|NCT03402126|83110350|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
46887849|NCT03402126|83110350|FG000|Overall Study|Death|4|||
46887850|NCT03355326|83110356|FG000|Overall Study|Protocol Violation|3|||
46887851|NCT03355326|83110357|FG001|Overall Study|Protocol Violation|3|||
46887852|NCT03751657|83110365|FG000|Overall Study|Physician Decision|0|||
46887853|NCT03751657|83110366|FG001|Overall Study|Physician Decision|1|||
46887854|NCT03751657|83110365|FG000|Overall Study|Withdrawal by Subject|1|||
46887855|NCT03751657|83110366|FG001|Overall Study|Withdrawal by Subject|1|||
46887856|NCT03751657|83110365|FG000|Overall Study|Lost to Follow-up|2|||
46887857|NCT03751657|83110366|FG001|Overall Study|Lost to Follow-up|1|||
46887858|NCT00025259|83110379|FG000|Overall Study|Death|1|||
46887859|NCT00025259|83110380|FG001|Overall Study|Death|3|||
46887860|NCT00025259|83110381|FG002|Overall Study|Death|0|||
46887861|NCT00025259|83110382|FG003|Overall Study|Death|3|||
46887862|NCT00025259|83110383|FG004|Overall Study|Death|0|||
46887863|NCT00025259|83110384|FG005|Overall Study|Death|1|||
46887864|NCT00025259|83110385|FG006|Overall Study|Death|2|||
46887865|NCT00025259|83110379|FG000|Overall Study|Lack of Efficacy|2|||
46887866|NCT00025259|83110380|FG001|Overall Study|Lack of Efficacy|46|||
46887867|NCT00025259|83110381|FG002|Overall Study|Lack of Efficacy|60|||
46887868|NCT00025259|83110382|FG003|Overall Study|Lack of Efficacy|78|||
46706068|NCT01014975|82921060|FG000|Overall Study|Death|3|||
46706069|NCT01014975|82921061|FG001|Overall Study|Death|3|||
46887869|NCT00025259|83110383|FG004|Overall Study|Lack of Efficacy|11|||
46887870|NCT00025259|83110384|FG005|Overall Study|Lack of Efficacy|30|||
46887871|NCT00025259|83110385|FG006|Overall Study|Lack of Efficacy|38|||
46887872|NCT00025259|83110379|FG000|Overall Study|Lost to Follow-up|2|||
46887873|NCT00025259|83110380|FG001|Overall Study|Lost to Follow-up|9|||
46706070|NCT01014975|82921062|FG002|Overall Study|Death|4|||
46706071|NCT01014975|82921060|FG000|Overall Study|Lost to Follow-up|0|||
46706072|NCT01014975|82921061|FG001|Overall Study|Lost to Follow-up|0|||
46706073|NCT01014975|82921062|FG002|Overall Study|Lost to Follow-up|1|||
46887874|NCT00025259|83110381|FG002|Overall Study|Lost to Follow-up|13|||
46887875|NCT00025259|83110382|FG003|Overall Study|Lost to Follow-up|13|||
46887876|NCT00025259|83110383|FG004|Overall Study|Lost to Follow-up|1|||
46887877|NCT00025259|83110384|FG005|Overall Study|Lost to Follow-up|3|||
46887878|NCT00025259|83110385|FG006|Overall Study|Lost to Follow-up|1|||
46887879|NCT00025259|83110379|FG000|Overall Study|Physician Decision|12|||
46887880|NCT00025259|83110380|FG001|Overall Study|Physician Decision|1|||
46887881|NCT00025259|83110381|FG002|Overall Study|Physician Decision|0|||
46887882|NCT00025259|83110382|FG003|Overall Study|Physician Decision|5|||
46887883|NCT00025259|83110383|FG004|Overall Study|Physician Decision|4|||
46887884|NCT00025259|83110384|FG005|Overall Study|Physician Decision|2|||
46887885|NCT00025259|83110385|FG006|Overall Study|Physician Decision|1|||
46887886|NCT00025259|83110379|FG000|Overall Study|Protocol Violation|3|||
46887887|NCT00025259|83110380|FG001|Overall Study|Protocol Violation|2|||
46887888|NCT00025259|83110381|FG002|Overall Study|Protocol Violation|2|||
46887889|NCT00025259|83110382|FG003|Overall Study|Protocol Violation|1|||
46887890|NCT00025259|83110383|FG004|Overall Study|Protocol Violation|2|||
46887891|NCT00025259|83110384|FG005|Overall Study|Protocol Violation|1|||
46887892|NCT00025259|83110385|FG006|Overall Study|Protocol Violation|3|||
46887893|NCT00025259|83110379|FG000|Overall Study|Withdrawal by Subject|9|||
46887894|NCT00025259|83110380|FG001|Overall Study|Withdrawal by Subject|27|||
46887895|NCT00025259|83110381|FG002|Overall Study|Withdrawal by Subject|6|||
46887896|NCT00025259|83110382|FG003|Overall Study|Withdrawal by Subject|14|||
46887897|NCT00025259|83110383|FG004|Overall Study|Withdrawal by Subject|11|||
46887898|NCT00025259|83110384|FG005|Overall Study|Withdrawal by Subject|8|||
46887899|NCT00025259|83110385|FG006|Overall Study|Withdrawal by Subject|3|||
46887900|NCT00025259|83110379|FG000|Overall Study|Ineligible|14|||
46887901|NCT00025259|83110380|FG001|Overall Study|Ineligible|1|||
46887902|NCT00025259|83110381|FG002|Overall Study|Ineligible|0|||
46887903|NCT00025259|83110382|FG003|Overall Study|Ineligible|0|||
46887904|NCT00025259|83110383|FG004|Overall Study|Ineligible|6|||
46887905|NCT00025259|83110384|FG005|Overall Study|Ineligible|0|||
46887906|NCT00025259|83110385|FG006|Overall Study|Ineligible|1|||
46887907|NCT00025259|83110379|FG000|Overall Study|Randomization error|1|||
46887908|NCT00025259|83110380|FG001|Overall Study|Randomization error|0|||
46887909|NCT00025259|83110381|FG002|Overall Study|Randomization error|0|||
46887910|NCT00025259|83110382|FG003|Overall Study|Randomization error|0|||
46887911|NCT00025259|83110383|FG004|Overall Study|Randomization error|1|||
46887912|NCT00025259|83110384|FG005|Overall Study|Randomization error|7|||
46887913|NCT00025259|83110385|FG006|Overall Study|Randomization error|2|||
46887914|NCT00025259|83110379|FG000|Overall Study|Adverse Event|1|||
46887915|NCT00025259|83110380|FG001|Overall Study|Adverse Event|0|||
46887916|NCT00025259|83110381|FG002|Overall Study|Adverse Event|0|||
46887917|NCT00025259|83110382|FG003|Overall Study|Adverse Event|0|||
46887918|NCT00025259|83110383|FG004|Overall Study|Adverse Event|0|||
46887919|NCT00025259|83110384|FG005|Overall Study|Adverse Event|0|||
46887920|NCT00025259|83110385|FG006|Overall Study|Adverse Event|0|||
46887921|NCT03351738|83110410|FG000|Overall Study|Withdrawal by Subject|0|||
46887922|NCT03351738|83110411|FG001|Overall Study|Withdrawal by Subject|1|||
46887923|NCT03351738|83110412|FG002|Overall Study|Withdrawal by Subject|0|||
46887924|NCT03351738|83110413|FG003|Overall Study|Withdrawal by Subject|1|||
46887925|NCT03351738|83110414|FG004|Overall Study|Withdrawal by Subject|0|||
46887926|NCT03351738|83110415|FG005|Overall Study|Withdrawal by Subject|0|||
46887927|NCT03351114|83110434|FG000|Overall Study|Withdrawal by Subject|1|||
46887928|NCT03350256|83110438|FG000|Overall Study|Inclusion/exclusion violation|4|||
46887929|NCT03350256|83110438|FG000|Overall Study|Recommended for other therapies|2|||
46887930|NCT03350256|83110438|FG000|Overall Study|Protocol Violation|3|||
46887931|NCT03350256|83110438|FG000|Overall Study|Non compliance|2|||
46887932|NCT03350256|83110438|FG000|Overall Study|Denial by insurance|1|||
46887933|NCT03350256|83110438|FG000|Overall Study|Adverse Event|2|||
46887934|NCT03350256|83110438|FG000|Overall Study|Trial failure|12|||
46887935|NCT03350256|83110438|FG000|Overall Study|Did not proceed to permanent implant|3|||
46887936|NCT03350256|83110438|FG000|Overall Study|Withdrawal by Subject|3|||
46887937|NCT03350256|83110438|FG000|Overall Study|Subject moving out of state|1|||
46887938|NCT03350256|83110438|FG000|Overall Study|Lost to Follow-up|1|||
46887939|NCT03350256|83110438|FG000|Overall Study|Lack of Efficacy|2|||
46887940|NCT00024167|83110445|FG000|Overall Study|Death|53|||
46887941|NCT00024167|83110446|FG001|Overall Study|Death|47|||
46887942|NCT00022763|83110455|FG000|Overall Study|Adverse Event|1|||
46887943|NCT00022763|83110456|FG001|Overall Study|Adverse Event|2|||
46887944|NCT00022763|83110455|FG000|Overall Study|Injection Site Reactions|0|||
46887945|NCT00022763|83110456|FG001|Overall Study|Injection Site Reactions|2|||
46887946|NCT00022763|83110455|FG000|Overall Study|Death|0|||
46887947|NCT00022763|83110456|FG001|Overall Study|Death|1|||
46887948|NCT00022763|83110455|FG000|Overall Study|Lost to Follow-up|0|||
46887949|NCT00022763|83110456|FG001|Overall Study|Lost to Follow-up|3|||
46887950|NCT00022763|83110455|FG000|Overall Study|Withdrawal by Subject|4|||
46887951|NCT00022763|83110456|FG001|Overall Study|Withdrawal by Subject|7|||
46887952|NCT00022763|83110455|FG000|Overall Study|Insufficient Therapy|1|||
46887953|NCT00022763|83110456|FG001|Overall Study|Insufficient Therapy|0|||
46887954|NCT00022763|83110455|FG000|Overall Study|Admin|3|||
46887955|NCT00022763|83110456|FG001|Overall Study|Admin|2|||
46887956|NCT00071513|83110463|FG000|Intervention Component|Withdrawal by Subject|2|||
46887957|NCT00071513|83110464|FG001|Intervention Component|Withdrawal by Subject|3|||
46887958|NCT00071513|83110463|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
46887959|NCT00071513|83110464|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
46887960|NCT00006389|83110472|FG000|Overall Study|Adverse Event|1|||
46887961|NCT00006305|83110481|FG000|Overall Study|Withdrawal by Subject|17|||
46887962|NCT00006305|83110482|FG001|Overall Study|Withdrawal by Subject|10|||
46887963|NCT00006305|83110483|FG002|Overall Study|Withdrawal by Subject|15|||
46887964|NCT00006305|83110484|FG003|Overall Study|Withdrawal by Subject|14|||
46887965|NCT03529773|83110534|FG000|Overall Study|Adverse Event|0|||
46887966|NCT03529773|83110535|FG001|Overall Study|Adverse Event|0|||
46887967|NCT03529773|83110536|FG002|Overall Study|Adverse Event|0|||
46887968|NCT03529773|83110537|FG003|Overall Study|Adverse Event|0|||
46887969|NCT03529773|83110538|FG004|Overall Study|Adverse Event|0|||
46887970|NCT03529773|83110539|FG005|Overall Study|Adverse Event|0|||
46887971|NCT03529773|83110540|FG006|Overall Study|Adverse Event|0|||
46887972|NCT03529773|83110541|FG007|Overall Study|Adverse Event|0|||
46887973|NCT03529773|83110542|FG008|Overall Study|Adverse Event|0|||
46887974|NCT03529773|83110543|FG009|Overall Study|Adverse Event|0|||
46887975|NCT03529773|83110544|FG010|Overall Study|Adverse Event|0|||
46887976|NCT03529773|83110545|FG011|Overall Study|Adverse Event|0|||
46887977|NCT03529773|83110546|FG012|Overall Study|Adverse Event|0|||
46887978|NCT03529773|83110547|FG013|Overall Study|Adverse Event|0|||
46887979|NCT03529773|83110548|FG014|Overall Study|Adverse Event|0|||
46887980|NCT03529773|83110549|FG015|Overall Study|Adverse Event|0|||
46887981|NCT03529773|83110550|FG016|Overall Study|Adverse Event|0|||
46887982|NCT03529773|83110551|FG017|Overall Study|Adverse Event|0|||
46887983|NCT03529773|83110552|FG018|Overall Study|Adverse Event|0|||
46887984|NCT03529773|83110553|FG019|Overall Study|Adverse Event|0|||
46887985|NCT03529773|83110554|FG020|Overall Study|Adverse Event|0|||
46887986|NCT03529773|83110555|FG021|Overall Study|Adverse Event|0|||
46991442|NCT02332915|83238462|FG000|Overall Study|did not meet inclusion criteria|2|||
46991443|NCT02332915|83238463|FG001|Overall Study|did not meet inclusion criteria|4|||
46887987|NCT03529773|83110556|FG022|Overall Study|Adverse Event|0|||
46887988|NCT03529773|83110557|FG023|Overall Study|Adverse Event|0|||
46887989|NCT03529773|83110558|FG024|Overall Study|Adverse Event|0|||
46887990|NCT03529773|83110559|FG025|Overall Study|Adverse Event|0|||
46887991|NCT03529773|83110560|FG026|Overall Study|Adverse Event|0|||
46887992|NCT03529773|83110561|FG027|Overall Study|Adverse Event|0|||
46887993|NCT03529773|83110562|FG028|Overall Study|Adverse Event|0|||
46887994|NCT03529773|83110563|FG029|Overall Study|Adverse Event|0|||
46887995|NCT03529773|83110564|FG030|Overall Study|Adverse Event|1|||
46887996|NCT03529773|83110565|FG031|Overall Study|Adverse Event|0|||
46887997|NCT03529773|83110566|FG032|Overall Study|Adverse Event|0|||
46887998|NCT03529773|83110567|FG033|Overall Study|Adverse Event|0|||
46887999|NCT03529773|83110568|FG034|Overall Study|Adverse Event|0|||
46888000|NCT03529773|83110569|FG035|Overall Study|Adverse Event|1|||
46888001|NCT03529773|83110570|FG036|Overall Study|Adverse Event|0|||
46888002|NCT03529773|83110571|FG037|Overall Study|Adverse Event|0|||
46888003|NCT03529773|83110572|FG038|Overall Study|Adverse Event|1|||
46888004|NCT03529773|83110573|FG039|Overall Study|Adverse Event|1|||
46888005|NCT03529773|83110534|FG000|Overall Study|Death|0|||
46888006|NCT03529773|83110535|FG001|Overall Study|Death|0|||
46888007|NCT03529773|83110536|FG002|Overall Study|Death|0|||
46888008|NCT03529773|83110537|FG003|Overall Study|Death|0|||
46888009|NCT03529773|83110538|FG004|Overall Study|Death|0|||
46888010|NCT03529773|83110539|FG005|Overall Study|Death|0|||
46888011|NCT03529773|83110540|FG006|Overall Study|Death|0|||
46888012|NCT03529773|83110541|FG007|Overall Study|Death|0|||
46888013|NCT03529773|83110542|FG008|Overall Study|Death|0|||
46888014|NCT03529773|83110543|FG009|Overall Study|Death|0|||
46888015|NCT03529773|83110544|FG010|Overall Study|Death|0|||
46888016|NCT03529773|83110545|FG011|Overall Study|Death|0|||
46888017|NCT03529773|83110546|FG012|Overall Study|Death|1|||
46888018|NCT03529773|83110547|FG013|Overall Study|Death|0|||
46888019|NCT03529773|83110548|FG014|Overall Study|Death|0|||
46888020|NCT03529773|83110549|FG015|Overall Study|Death|0|||
46888021|NCT03529773|83110550|FG016|Overall Study|Death|0|||
46888022|NCT03529773|83110551|FG017|Overall Study|Death|0|||
46888023|NCT03529773|83110552|FG018|Overall Study|Death|0|||
46888024|NCT03529773|83110553|FG019|Overall Study|Death|1|||
46888025|NCT03529773|83110554|FG020|Overall Study|Death|0|||
46888026|NCT03529773|83110555|FG021|Overall Study|Death|0|||
46888027|NCT03529773|83110556|FG022|Overall Study|Death|1|||
46888028|NCT03529773|83110557|FG023|Overall Study|Death|0|||
46888029|NCT03529773|83110558|FG024|Overall Study|Death|0|||
46888030|NCT03529773|83110559|FG025|Overall Study|Death|0|||
46888031|NCT03529773|83110560|FG026|Overall Study|Death|0|||
46888032|NCT03529773|83110561|FG027|Overall Study|Death|0|||
46888033|NCT03529773|83110562|FG028|Overall Study|Death|0|||
46888034|NCT03529773|83110563|FG029|Overall Study|Death|0|||
46888035|NCT03529773|83110564|FG030|Overall Study|Death|0|||
46888036|NCT03529773|83110565|FG031|Overall Study|Death|0|||
46888037|NCT03529773|83110566|FG032|Overall Study|Death|0|||
46888038|NCT03529773|83110567|FG033|Overall Study|Death|1|||
46888039|NCT03529773|83110568|FG034|Overall Study|Death|1|||
46888040|NCT03529773|83110569|FG035|Overall Study|Death|0|||
46888041|NCT03529773|83110570|FG036|Overall Study|Death|1|||
46888042|NCT03529773|83110571|FG037|Overall Study|Death|0|||
46888043|NCT03529773|83110572|FG038|Overall Study|Death|0|||
46888044|NCT03529773|83110573|FG039|Overall Study|Death|0|||
46888045|NCT03529773|83110534|FG000|Overall Study|Lost to Follow-up|0|||
46888046|NCT03529773|83110535|FG001|Overall Study|Lost to Follow-up|0|||
46888047|NCT03529773|83110536|FG002|Overall Study|Lost to Follow-up|1|||
46888048|NCT03529773|83110537|FG003|Overall Study|Lost to Follow-up|0|||
46888049|NCT03529773|83110538|FG004|Overall Study|Lost to Follow-up|1|||
46888050|NCT03529773|83110539|FG005|Overall Study|Lost to Follow-up|1|||
46888051|NCT03529773|83110540|FG006|Overall Study|Lost to Follow-up|0|||
46888052|NCT03529773|83110541|FG007|Overall Study|Lost to Follow-up|0|||
46888053|NCT03529773|83110542|FG008|Overall Study|Lost to Follow-up|0|||
46888054|NCT03529773|83110543|FG009|Overall Study|Lost to Follow-up|0|||
46888055|NCT03529773|83110544|FG010|Overall Study|Lost to Follow-up|0|||
46888056|NCT03529773|83110545|FG011|Overall Study|Lost to Follow-up|0|||
46888057|NCT03529773|83110546|FG012|Overall Study|Lost to Follow-up|0|||
46888058|NCT03529773|83110547|FG013|Overall Study|Lost to Follow-up|1|||
46888059|NCT03529773|83110548|FG014|Overall Study|Lost to Follow-up|4|||
46888060|NCT03529773|83110549|FG015|Overall Study|Lost to Follow-up|1|||
46888061|NCT03529773|83110550|FG016|Overall Study|Lost to Follow-up|1|||
46888062|NCT03529773|83110551|FG017|Overall Study|Lost to Follow-up|0|||
46888063|NCT03529773|83110552|FG018|Overall Study|Lost to Follow-up|1|||
46888064|NCT03529773|83110553|FG019|Overall Study|Lost to Follow-up|1|||
46888065|NCT03529773|83110554|FG020|Overall Study|Lost to Follow-up|2|||
46888066|NCT03529773|83110555|FG021|Overall Study|Lost to Follow-up|4|||
46706074|NCT01221623|82921072|FG000|Overall Study|Withdrawal by Subject|19|||
46888067|NCT03529773|83110556|FG022|Overall Study|Lost to Follow-up|3|||
46888068|NCT03529773|83110557|FG023|Overall Study|Lost to Follow-up|4|||
46888069|NCT03529773|83110558|FG024|Overall Study|Lost to Follow-up|3|||
46888070|NCT03529773|83110559|FG025|Overall Study|Lost to Follow-up|5|||
46888071|NCT03529773|83110560|FG026|Overall Study|Lost to Follow-up|5|||
46888072|NCT03529773|83110561|FG027|Overall Study|Lost to Follow-up|0|||
46888073|NCT03529773|83110562|FG028|Overall Study|Lost to Follow-up|0|||
46888074|NCT03529773|83110563|FG029|Overall Study|Lost to Follow-up|0|||
46888075|NCT03529773|83110564|FG030|Overall Study|Lost to Follow-up|1|||
46888076|NCT03529773|83110565|FG031|Overall Study|Lost to Follow-up|0|||
46888077|NCT03529773|83110566|FG032|Overall Study|Lost to Follow-up|0|||
46888078|NCT03529773|83110567|FG033|Overall Study|Lost to Follow-up|1|||
46888079|NCT03529773|83110568|FG034|Overall Study|Lost to Follow-up|1|||
46888080|NCT03529773|83110569|FG035|Overall Study|Lost to Follow-up|0|||
46888081|NCT03529773|83110570|FG036|Overall Study|Lost to Follow-up|0|||
46888082|NCT03529773|83110571|FG037|Overall Study|Lost to Follow-up|3|||
46888083|NCT03529773|83110572|FG038|Overall Study|Lost to Follow-up|1|||
46888084|NCT03529773|83110573|FG039|Overall Study|Lost to Follow-up|1|||
46888085|NCT03529773|83110534|FG000|Overall Study|No longer meets eligibility criteria|0|||
46888086|NCT03529773|83110535|FG001|Overall Study|No longer meets eligibility criteria|0|||
46888087|NCT03529773|83110536|FG002|Overall Study|No longer meets eligibility criteria|0|||
46888088|NCT03529773|83110537|FG003|Overall Study|No longer meets eligibility criteria|0|||
46888089|NCT03529773|83110538|FG004|Overall Study|No longer meets eligibility criteria|0|||
46888090|NCT03529773|83110539|FG005|Overall Study|No longer meets eligibility criteria|0|||
46888091|NCT03529773|83110540|FG006|Overall Study|No longer meets eligibility criteria|0|||
46888092|NCT03529773|83110541|FG007|Overall Study|No longer meets eligibility criteria|0|||
46888093|NCT03529773|83110542|FG008|Overall Study|No longer meets eligibility criteria|0|||
46888094|NCT03529773|83110543|FG009|Overall Study|No longer meets eligibility criteria|0|||
46888095|NCT03529773|83110544|FG010|Overall Study|No longer meets eligibility criteria|0|||
46888096|NCT03529773|83110545|FG011|Overall Study|No longer meets eligibility criteria|0|||
46888097|NCT03529773|83110546|FG012|Overall Study|No longer meets eligibility criteria|0|||
46888098|NCT03529773|83110547|FG013|Overall Study|No longer meets eligibility criteria|0|||
46888099|NCT03529773|83110548|FG014|Overall Study|No longer meets eligibility criteria|0|||
46888100|NCT03529773|83110549|FG015|Overall Study|No longer meets eligibility criteria|0|||
46888101|NCT03529773|83110550|FG016|Overall Study|No longer meets eligibility criteria|0|||
46888102|NCT03529773|83110551|FG017|Overall Study|No longer meets eligibility criteria|0|||
46888103|NCT03529773|83110552|FG018|Overall Study|No longer meets eligibility criteria|0|||
46888104|NCT03529773|83110553|FG019|Overall Study|No longer meets eligibility criteria|0|||
46888105|NCT03529773|83110554|FG020|Overall Study|No longer meets eligibility criteria|0|||
46888106|NCT03529773|83110555|FG021|Overall Study|No longer meets eligibility criteria|0|||
46888107|NCT03529773|83110556|FG022|Overall Study|No longer meets eligibility criteria|1|||
46888108|NCT03529773|83110557|FG023|Overall Study|No longer meets eligibility criteria|0|||
46888109|NCT03529773|83110558|FG024|Overall Study|No longer meets eligibility criteria|0|||
46888110|NCT03529773|83110559|FG025|Overall Study|No longer meets eligibility criteria|0|||
46888111|NCT03529773|83110560|FG026|Overall Study|No longer meets eligibility criteria|0|||
46888112|NCT03529773|83110561|FG027|Overall Study|No longer meets eligibility criteria|0|||
46888113|NCT03529773|83110562|FG028|Overall Study|No longer meets eligibility criteria|0|||
46888114|NCT03529773|83110563|FG029|Overall Study|No longer meets eligibility criteria|0|||
46888115|NCT03529773|83110564|FG030|Overall Study|No longer meets eligibility criteria|0|||
46888116|NCT03529773|83110565|FG031|Overall Study|No longer meets eligibility criteria|0|||
46888117|NCT03529773|83110566|FG032|Overall Study|No longer meets eligibility criteria|0|||
46888118|NCT03529773|83110567|FG033|Overall Study|No longer meets eligibility criteria|0|||
46888119|NCT03529773|83110568|FG034|Overall Study|No longer meets eligibility criteria|0|||
46888120|NCT03529773|83110569|FG035|Overall Study|No longer meets eligibility criteria|0|||
46888121|NCT03529773|83110570|FG036|Overall Study|No longer meets eligibility criteria|0|||
46888122|NCT03529773|83110571|FG037|Overall Study|No longer meets eligibility criteria|0|||
46888123|NCT03529773|83110572|FG038|Overall Study|No longer meets eligibility criteria|1|||
46888124|NCT03529773|83110573|FG039|Overall Study|No longer meets eligibility criteria|0|||
46888125|NCT03529773|83110534|FG000|Overall Study|Other|0|||
46888126|NCT03529773|83110535|FG001|Overall Study|Other|0|||
46888127|NCT03529773|83110536|FG002|Overall Study|Other|0|||
46888128|NCT03529773|83110537|FG003|Overall Study|Other|0|||
46888129|NCT03529773|83110538|FG004|Overall Study|Other|0|||
46888130|NCT03529773|83110539|FG005|Overall Study|Other|0|||
46888131|NCT03529773|83110540|FG006|Overall Study|Other|0|||
46888132|NCT03529773|83110541|FG007|Overall Study|Other|0|||
46888133|NCT03529773|83110542|FG008|Overall Study|Other|0|||
46888134|NCT03529773|83110543|FG009|Overall Study|Other|0|||
46888135|NCT03529773|83110544|FG010|Overall Study|Other|0|||
46888136|NCT03529773|83110545|FG011|Overall Study|Other|0|||
46888137|NCT03529773|83110546|FG012|Overall Study|Other|1|||
46888138|NCT03529773|83110547|FG013|Overall Study|Other|0|||
46888139|NCT03529773|83110548|FG014|Overall Study|Other|2|||
46888140|NCT03529773|83110549|FG015|Overall Study|Other|0|||
46888141|NCT03529773|83110550|FG016|Overall Study|Other|0|||
46888142|NCT03529773|83110551|FG017|Overall Study|Other|3|||
46888143|NCT03529773|83110552|FG018|Overall Study|Other|0|||
46888144|NCT03529773|83110553|FG019|Overall Study|Other|0|||
46888145|NCT03529773|83110554|FG020|Overall Study|Other|1|||
46888146|NCT03529773|83110555|FG021|Overall Study|Other|0|||
46888147|NCT03529773|83110556|FG022|Overall Study|Other|1|||
46888148|NCT03529773|83110557|FG023|Overall Study|Other|0|||
46888149|NCT03529773|83110558|FG024|Overall Study|Other|3|||
46888150|NCT03529773|83110559|FG025|Overall Study|Other|2|||
46888151|NCT03529773|83110560|FG026|Overall Study|Other|2|||
46888152|NCT03529773|83110561|FG027|Overall Study|Other|0|||
46888153|NCT03529773|83110562|FG028|Overall Study|Other|0|||
46888154|NCT03529773|83110563|FG029|Overall Study|Other|0|||
46888155|NCT03529773|83110564|FG030|Overall Study|Other|0|||
46888156|NCT03529773|83110565|FG031|Overall Study|Other|0|||
46888157|NCT03529773|83110566|FG032|Overall Study|Other|0|||
46888158|NCT03529773|83110567|FG033|Overall Study|Other|0|||
46888159|NCT03529773|83110568|FG034|Overall Study|Other|1|||
46888160|NCT03529773|83110569|FG035|Overall Study|Other|1|||
46888161|NCT03529773|83110570|FG036|Overall Study|Other|0|||
46888162|NCT03529773|83110571|FG037|Overall Study|Other|0|||
46888163|NCT03529773|83110572|FG038|Overall Study|Other|0|||
46888164|NCT03529773|83110573|FG039|Overall Study|Other|0|||
46888165|NCT03529773|83110534|FG000|Overall Study|Physician Decision|0|||
46888166|NCT03529773|83110535|FG001|Overall Study|Physician Decision|0|||
46888167|NCT03529773|83110536|FG002|Overall Study|Physician Decision|0|||
46888168|NCT03529773|83110537|FG003|Overall Study|Physician Decision|0|||
46888169|NCT03529773|83110538|FG004|Overall Study|Physician Decision|0|||
46888170|NCT03529773|83110539|FG005|Overall Study|Physician Decision|0|||
46888171|NCT03529773|83110540|FG006|Overall Study|Physician Decision|0|||
46888172|NCT03529773|83110541|FG007|Overall Study|Physician Decision|0|||
46888173|NCT03529773|83110542|FG008|Overall Study|Physician Decision|0|||
46888174|NCT03529773|83110543|FG009|Overall Study|Physician Decision|0|||
46888175|NCT03529773|83110544|FG010|Overall Study|Physician Decision|0|||
46888176|NCT03529773|83110545|FG011|Overall Study|Physician Decision|0|||
46888177|NCT03529773|83110546|FG012|Overall Study|Physician Decision|0|||
46888178|NCT03529773|83110547|FG013|Overall Study|Physician Decision|0|||
46888179|NCT03529773|83110548|FG014|Overall Study|Physician Decision|0|||
46888180|NCT03529773|83110549|FG015|Overall Study|Physician Decision|0|||
46888181|NCT03529773|83110550|FG016|Overall Study|Physician Decision|0|||
46888182|NCT03529773|83110551|FG017|Overall Study|Physician Decision|0|||
46888183|NCT03529773|83110552|FG018|Overall Study|Physician Decision|0|||
46888184|NCT03529773|83110553|FG019|Overall Study|Physician Decision|1|||
46888185|NCT03529773|83110554|FG020|Overall Study|Physician Decision|1|||
46888186|NCT03529773|83110555|FG021|Overall Study|Physician Decision|0|||
46888187|NCT03529773|83110556|FG022|Overall Study|Physician Decision|0|||
46888188|NCT03529773|83110557|FG023|Overall Study|Physician Decision|0|||
46888189|NCT03529773|83110558|FG024|Overall Study|Physician Decision|0|||
46888190|NCT03529773|83110559|FG025|Overall Study|Physician Decision|0|||
46888191|NCT03529773|83110560|FG026|Overall Study|Physician Decision|0|||
46888192|NCT03529773|83110561|FG027|Overall Study|Physician Decision|0|||
46888193|NCT03529773|83110562|FG028|Overall Study|Physician Decision|0|||
46888194|NCT03529773|83110563|FG029|Overall Study|Physician Decision|0|||
46888195|NCT03529773|83110564|FG030|Overall Study|Physician Decision|0|||
46888196|NCT03529773|83110565|FG031|Overall Study|Physician Decision|0|||
46888197|NCT03529773|83110566|FG032|Overall Study|Physician Decision|0|||
46888198|NCT03529773|83110567|FG033|Overall Study|Physician Decision|0|||
46888199|NCT03529773|83110568|FG034|Overall Study|Physician Decision|0|||
46888200|NCT03529773|83110569|FG035|Overall Study|Physician Decision|0|||
46888201|NCT03529773|83110570|FG036|Overall Study|Physician Decision|0|||
46888202|NCT03529773|83110571|FG037|Overall Study|Physician Decision|0|||
46888203|NCT03529773|83110572|FG038|Overall Study|Physician Decision|0|||
46888204|NCT03529773|83110573|FG039|Overall Study|Physician Decision|0|||
46888205|NCT03529773|83110534|FG000|Overall Study|Protocol Violation|0|||
46888206|NCT03529773|83110535|FG001|Overall Study|Protocol Violation|0|||
46888207|NCT03529773|83110536|FG002|Overall Study|Protocol Violation|0|||
46888208|NCT03529773|83110537|FG003|Overall Study|Protocol Violation|0|||
46888209|NCT03529773|83110538|FG004|Overall Study|Protocol Violation|0|||
46888210|NCT03529773|83110539|FG005|Overall Study|Protocol Violation|0|||
46888211|NCT03529773|83110540|FG006|Overall Study|Protocol Violation|0|||
46888212|NCT03529773|83110541|FG007|Overall Study|Protocol Violation|0|||
46888213|NCT03529773|83110542|FG008|Overall Study|Protocol Violation|0|||
46888214|NCT03529773|83110543|FG009|Overall Study|Protocol Violation|0|||
46888215|NCT03529773|83110544|FG010|Overall Study|Protocol Violation|0|||
46888216|NCT03529773|83110545|FG011|Overall Study|Protocol Violation|0|||
46888217|NCT03529773|83110546|FG012|Overall Study|Protocol Violation|0|||
46888218|NCT03529773|83110547|FG013|Overall Study|Protocol Violation|0|||
46888219|NCT03529773|83110548|FG014|Overall Study|Protocol Violation|0|||
46888220|NCT03529773|83110549|FG015|Overall Study|Protocol Violation|0|||
46888221|NCT03529773|83110550|FG016|Overall Study|Protocol Violation|0|||
46888222|NCT03529773|83110551|FG017|Overall Study|Protocol Violation|0|||
46888223|NCT03529773|83110552|FG018|Overall Study|Protocol Violation|0|||
46888224|NCT03529773|83110553|FG019|Overall Study|Protocol Violation|0|||
46888225|NCT03529773|83110554|FG020|Overall Study|Protocol Violation|0|||
46888226|NCT03529773|83110555|FG021|Overall Study|Protocol Violation|0|||
46888227|NCT03529773|83110556|FG022|Overall Study|Protocol Violation|0|||
46888228|NCT03529773|83110557|FG023|Overall Study|Protocol Violation|0|||
46888229|NCT03529773|83110558|FG024|Overall Study|Protocol Violation|0|||
46888230|NCT03529773|83110559|FG025|Overall Study|Protocol Violation|0|||
46888231|NCT03529773|83110560|FG026|Overall Study|Protocol Violation|0|||
46888232|NCT03529773|83110561|FG027|Overall Study|Protocol Violation|0|||
46888233|NCT03529773|83110562|FG028|Overall Study|Protocol Violation|0|||
46888234|NCT03529773|83110563|FG029|Overall Study|Protocol Violation|0|||
46888235|NCT03529773|83110564|FG030|Overall Study|Protocol Violation|1|||
46888236|NCT03529773|83110565|FG031|Overall Study|Protocol Violation|0|||
46888237|NCT03529773|83110566|FG032|Overall Study|Protocol Violation|0|||
46888238|NCT03529773|83110567|FG033|Overall Study|Protocol Violation|0|||
46888239|NCT03529773|83110568|FG034|Overall Study|Protocol Violation|0|||
46888240|NCT03529773|83110569|FG035|Overall Study|Protocol Violation|0|||
46888241|NCT03529773|83110570|FG036|Overall Study|Protocol Violation|0|||
46888242|NCT03529773|83110571|FG037|Overall Study|Protocol Violation|0|||
46888243|NCT03529773|83110572|FG038|Overall Study|Protocol Violation|0|||
46888244|NCT03529773|83110573|FG039|Overall Study|Protocol Violation|0|||
46888245|NCT03529773|83110534|FG000|Overall Study|Withdrawal by Subject|0|||
46888246|NCT03529773|83110535|FG001|Overall Study|Withdrawal by Subject|0|||
46888247|NCT03529773|83110536|FG002|Overall Study|Withdrawal by Subject|0|||
46888248|NCT03529773|83110537|FG003|Overall Study|Withdrawal by Subject|0|||
46888249|NCT03529773|83110538|FG004|Overall Study|Withdrawal by Subject|0|||
46888250|NCT03529773|83110539|FG005|Overall Study|Withdrawal by Subject|0|||
46888251|NCT03529773|83110540|FG006|Overall Study|Withdrawal by Subject|0|||
46888252|NCT03529773|83110541|FG007|Overall Study|Withdrawal by Subject|1|||
46888253|NCT03529773|83110542|FG008|Overall Study|Withdrawal by Subject|0|||
46888254|NCT03529773|83110543|FG009|Overall Study|Withdrawal by Subject|1|||
46888255|NCT03529773|83110544|FG010|Overall Study|Withdrawal by Subject|1|||
46888256|NCT03529773|83110545|FG011|Overall Study|Withdrawal by Subject|0|||
46888257|NCT03529773|83110546|FG012|Overall Study|Withdrawal by Subject|0|||
46888258|NCT03529773|83110547|FG013|Overall Study|Withdrawal by Subject|0|||
46888259|NCT03529773|83110548|FG014|Overall Study|Withdrawal by Subject|0|||
46888260|NCT03529773|83110549|FG015|Overall Study|Withdrawal by Subject|3|||
46888261|NCT03529773|83110550|FG016|Overall Study|Withdrawal by Subject|0|||
46888262|NCT03529773|83110551|FG017|Overall Study|Withdrawal by Subject|2|||
46888263|NCT03529773|83110552|FG018|Overall Study|Withdrawal by Subject|3|||
46888264|NCT03529773|83110553|FG019|Overall Study|Withdrawal by Subject|1|||
46888265|NCT03529773|83110554|FG020|Overall Study|Withdrawal by Subject|3|||
46888266|NCT03529773|83110555|FG021|Overall Study|Withdrawal by Subject|1|||
46888267|NCT03529773|83110556|FG022|Overall Study|Withdrawal by Subject|1|||
46888268|NCT03529773|83110557|FG023|Overall Study|Withdrawal by Subject|2|||
46888269|NCT03529773|83110558|FG024|Overall Study|Withdrawal by Subject|2|||
46888270|NCT03529773|83110559|FG025|Overall Study|Withdrawal by Subject|4|||
46888271|NCT03529773|83110560|FG026|Overall Study|Withdrawal by Subject|2|||
46888272|NCT03529773|83110561|FG027|Overall Study|Withdrawal by Subject|1|||
46888273|NCT03529773|83110562|FG028|Overall Study|Withdrawal by Subject|1|||
46888274|NCT03529773|83110563|FG029|Overall Study|Withdrawal by Subject|0|||
46888275|NCT03529773|83110564|FG030|Overall Study|Withdrawal by Subject|0|||
46888276|NCT03529773|83110565|FG031|Overall Study|Withdrawal by Subject|0|||
46888277|NCT03529773|83110566|FG032|Overall Study|Withdrawal by Subject|0|||
46888278|NCT03529773|83110567|FG033|Overall Study|Withdrawal by Subject|0|||
46888279|NCT03529773|83110568|FG034|Overall Study|Withdrawal by Subject|1|||
46888280|NCT03529773|83110569|FG035|Overall Study|Withdrawal by Subject|2|||
46888281|NCT03529773|83110570|FG036|Overall Study|Withdrawal by Subject|0|||
46888282|NCT03529773|83110571|FG037|Overall Study|Withdrawal by Subject|2|||
46888283|NCT03529773|83110572|FG038|Overall Study|Withdrawal by Subject|1|||
46888284|NCT03529773|83110573|FG039|Overall Study|Withdrawal by Subject|1|||
46888285|NCT03529773|83110534|FG000|Overall Study|Screen Failure|0|||
46888286|NCT03529773|83110535|FG001|Overall Study|Screen Failure|0|||
46888287|NCT03529773|83110536|FG002|Overall Study|Screen Failure|0|||
46888288|NCT03529773|83110537|FG003|Overall Study|Screen Failure|0|||
46888289|NCT03529773|83110538|FG004|Overall Study|Screen Failure|0|||
46888290|NCT03529773|83110539|FG005|Overall Study|Screen Failure|0|||
46888291|NCT03529773|83110540|FG006|Overall Study|Screen Failure|0|||
46888292|NCT03529773|83110541|FG007|Overall Study|Screen Failure|0|||
46888293|NCT03529773|83110542|FG008|Overall Study|Screen Failure|0|||
46888294|NCT03529773|83110543|FG009|Overall Study|Screen Failure|0|||
46888295|NCT03529773|83110544|FG010|Overall Study|Screen Failure|0|||
46888296|NCT03529773|83110545|FG011|Overall Study|Screen Failure|0|||
46888297|NCT03529773|83110546|FG012|Overall Study|Screen Failure|0|||
46888298|NCT03529773|83110547|FG013|Overall Study|Screen Failure|0|||
46888299|NCT03529773|83110548|FG014|Overall Study|Screen Failure|0|||
46888300|NCT03529773|83110549|FG015|Overall Study|Screen Failure|0|||
46888301|NCT03529773|83110550|FG016|Overall Study|Screen Failure|0|||
46888302|NCT03529773|83110551|FG017|Overall Study|Screen Failure|0|||
46888303|NCT03529773|83110552|FG018|Overall Study|Screen Failure|0|||
46888304|NCT03529773|83110553|FG019|Overall Study|Screen Failure|0|||
46888305|NCT03529773|83110554|FG020|Overall Study|Screen Failure|0|||
46888306|NCT03529773|83110555|FG021|Overall Study|Screen Failure|0|||
46888307|NCT03529773|83110556|FG022|Overall Study|Screen Failure|0|||
46888308|NCT03529773|83110557|FG023|Overall Study|Screen Failure|0|||
46888309|NCT03529773|83110558|FG024|Overall Study|Screen Failure|0|||
46888310|NCT03529773|83110559|FG025|Overall Study|Screen Failure|0|||
46888311|NCT03529773|83110560|FG026|Overall Study|Screen Failure|0|||
46888312|NCT03529773|83110561|FG027|Overall Study|Screen Failure|0|||
46888313|NCT03529773|83110562|FG028|Overall Study|Screen Failure|0|||
46888314|NCT03529773|83110563|FG029|Overall Study|Screen Failure|0|||
46888315|NCT03529773|83110564|FG030|Overall Study|Screen Failure|0|||
46888316|NCT03529773|83110565|FG031|Overall Study|Screen Failure|0|||
46888317|NCT03529773|83110566|FG032|Overall Study|Screen Failure|0|||
46888318|NCT03529773|83110567|FG033|Overall Study|Screen Failure|0|||
46888319|NCT03529773|83110568|FG034|Overall Study|Screen Failure|0|||
46888320|NCT03529773|83110569|FG035|Overall Study|Screen Failure|0|||
46888321|NCT03529773|83110570|FG036|Overall Study|Screen Failure|1|||
46888322|NCT03529773|83110571|FG037|Overall Study|Screen Failure|1|||
46888323|NCT03529773|83110572|FG038|Overall Study|Screen Failure|0|||
46888324|NCT03529773|83110573|FG039|Overall Study|Screen Failure|1|||
46888325|NCT03529773|83110534|FG000|Overall Study|Randomized but not vaccinated|0|||
46888326|NCT03529773|83110535|FG001|Overall Study|Randomized but not vaccinated|0|||
46888327|NCT03529773|83110536|FG002|Overall Study|Randomized but not vaccinated|0|||
46888328|NCT03529773|83110537|FG003|Overall Study|Randomized but not vaccinated|0|||
46888329|NCT03529773|83110538|FG004|Overall Study|Randomized but not vaccinated|0|||
46888330|NCT03529773|83110539|FG005|Overall Study|Randomized but not vaccinated|0|||
46888331|NCT03529773|83110540|FG006|Overall Study|Randomized but not vaccinated|0|||
46888332|NCT03529773|83110541|FG007|Overall Study|Randomized but not vaccinated|0|||
46888333|NCT03529773|83110542|FG008|Overall Study|Randomized but not vaccinated|0|||
46888334|NCT03529773|83110543|FG009|Overall Study|Randomized but not vaccinated|0|||
46888335|NCT03529773|83110544|FG010|Overall Study|Randomized but not vaccinated|0|||
46888336|NCT03529773|83110545|FG011|Overall Study|Randomized but not vaccinated|0|||
46888337|NCT03529773|83110546|FG012|Overall Study|Randomized but not vaccinated|0|||
46888338|NCT03529773|83110547|FG013|Overall Study|Randomized but not vaccinated|0|||
46888339|NCT03529773|83110548|FG014|Overall Study|Randomized but not vaccinated|0|||
46888340|NCT03529773|83110549|FG015|Overall Study|Randomized but not vaccinated|0|||
46888341|NCT03529773|83110550|FG016|Overall Study|Randomized but not vaccinated|0|||
46888342|NCT03529773|83110551|FG017|Overall Study|Randomized but not vaccinated|1|||
46888343|NCT03529773|83110552|FG018|Overall Study|Randomized but not vaccinated|0|||
46888344|NCT03529773|83110553|FG019|Overall Study|Randomized but not vaccinated|0|||
46888345|NCT03529773|83110554|FG020|Overall Study|Randomized but not vaccinated|0|||
46888346|NCT03529773|83110555|FG021|Overall Study|Randomized but not vaccinated|0|||
46888347|NCT03529773|83110556|FG022|Overall Study|Randomized but not vaccinated|0|||
46888348|NCT03529773|83110557|FG023|Overall Study|Randomized but not vaccinated|0|||
46888349|NCT03529773|83110558|FG024|Overall Study|Randomized but not vaccinated|0|||
46888350|NCT03529773|83110559|FG025|Overall Study|Randomized but not vaccinated|0|||
46888351|NCT03529773|83110560|FG026|Overall Study|Randomized but not vaccinated|0|||
46888352|NCT03529773|83110561|FG027|Overall Study|Randomized but not vaccinated|1|||
46888353|NCT03529773|83110562|FG028|Overall Study|Randomized but not vaccinated|0|||
46888354|NCT03529773|83110563|FG029|Overall Study|Randomized but not vaccinated|0|||
46888355|NCT03529773|83110564|FG030|Overall Study|Randomized but not vaccinated|0|||
46888356|NCT03529773|83110565|FG031|Overall Study|Randomized but not vaccinated|0|||
46888357|NCT03529773|83110566|FG032|Overall Study|Randomized but not vaccinated|0|||
46888358|NCT03529773|83110567|FG033|Overall Study|Randomized but not vaccinated|0|||
46888359|NCT03529773|83110568|FG034|Overall Study|Randomized but not vaccinated|0|||
46888360|NCT03529773|83110569|FG035|Overall Study|Randomized but not vaccinated|0|||
46888361|NCT03529773|83110570|FG036|Overall Study|Randomized but not vaccinated|0|||
46888362|NCT03529773|83110571|FG037|Overall Study|Randomized but not vaccinated|0|||
46888363|NCT03529773|83110572|FG038|Overall Study|Randomized but not vaccinated|0|||
46888364|NCT03529773|83110573|FG039|Overall Study|Randomized but not vaccinated|0|||
46888365|NCT03799211|83110678|FG000|Overall Study|Lost to Follow-up|2|||
46888366|NCT03799211|83110679|FG001|Overall Study|Lost to Follow-up|13|||
46888367|NCT03799211|83110678|FG000|Overall Study|Withdrawal by Subject|2|||
46888368|NCT03799211|83110679|FG001|Overall Study|Withdrawal by Subject|0|||
46888369|NCT03349710|83110691|FG000|Treatment Period|Death|0|||
46888370|NCT03349710|83110692|FG001|Treatment Period|Death|0|||
46888371|NCT03349710|83110693|FG002|Treatment Period|Death|1|||
46888372|NCT03349710|83110694|FG003|Treatment Period|Death|0|||
46888373|NCT03349710|83110691|FG000|Treatment Period|Disease Progression|0|||
46888374|NCT03349710|83110692|FG001|Treatment Period|Disease Progression|2|||
46888375|NCT03349710|83110693|FG002|Treatment Period|Disease Progression|0|||
46888376|NCT03349710|83110694|FG003|Treatment Period|Disease Progression|1|||
46888377|NCT03349710|83110691|FG000|Treatment Period|Study Drug Toxicity|1|||
46888378|NCT03349710|83110692|FG001|Treatment Period|Study Drug Toxicity|0|||
46888379|NCT03349710|83110693|FG002|Treatment Period|Study Drug Toxicity|1|||
46888380|NCT03349710|83110694|FG003|Treatment Period|Study Drug Toxicity|1|||
46888381|NCT03349710|83110691|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
46888382|NCT03349710|83110692|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
46888383|NCT03349710|83110693|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
46888384|NCT03349710|83110694|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
46888385|NCT03349710|83110691|FG000|Treatment Period|admin reason by sponsor|0|||
46888386|NCT03349710|83110692|FG001|Treatment Period|admin reason by sponsor|7|||
46888387|NCT03349710|83110693|FG002|Treatment Period|admin reason by sponsor|0|||
46888388|NCT03349710|83110694|FG003|Treatment Period|admin reason by sponsor|19|||
46888389|NCT03349710|83110691|FG000|Treatment Period|Other Reason|2|||
46888390|NCT03349710|83110692|FG001|Treatment Period|Other Reason|0|||
46888391|NCT03349710|83110693|FG002|Treatment Period|Other Reason|2|||
46888392|NCT03349710|83110694|FG003|Treatment Period|Other Reason|1|||
46888393|NCT03349710|83110691|FG000|Treatment Period|completed|6|||
46888394|NCT03349710|83110692|FG001|Treatment Period|completed|0|||
46888395|NCT03349710|83110693|FG002|Treatment Period|completed|18|||
46888396|NCT03349710|83110694|FG003|Treatment Period|completed|1|||
46888397|NCT03349710|83110691|FG000|Treatment Period|participant request to discontinue|0|||
46888398|NCT03349710|83110692|FG001|Treatment Period|participant request to discontinue|0|||
46888399|NCT03349710|83110693|FG002|Treatment Period|participant request to discontinue|4|||
46888400|NCT03349710|83110694|FG003|Treatment Period|participant request to discontinue|0|||
46888401|NCT03349710|83110691|FG000|Treatment Period|participant withdrew consent|1|||
46888402|NCT03349710|83110692|FG001|Treatment Period|participant withdrew consent|0|||
46888403|NCT03349710|83110693|FG002|Treatment Period|participant withdrew consent|0|||
46888404|NCT03349710|83110694|FG003|Treatment Period|participant withdrew consent|0|||
46888405|NCT03511053|83110704|FG000|Overall Study|Withdrawal by Subject|1|||
46888406|NCT03377634|83110710|FG000|Study Period|Adverse Event|1|||
46888407|NCT03377634|83110711|FG001|Study Period|Adverse Event|0|||
46888408|NCT03377634|83110710|FG000|Study Period|Withdrawal by Subject|1|||
46888409|NCT03377634|83110711|FG001|Study Period|Withdrawal by Subject|0|||
46888410|NCT00006011|83110720|FG000|Overall Study|Disease progression|13|||
46888411|NCT00006011|83110721|FG001|Overall Study|Disease progression|6|||
46888412|NCT00006011|83110722|FG002|Overall Study|Disease progression|26|||
46888413|NCT00006011|83110720|FG000|Overall Study|Refused further treatment|15|||
46888414|NCT00006011|83110721|FG001|Overall Study|Refused further treatment|13|||
46888415|NCT00006011|83110722|FG002|Overall Study|Refused further treatment|26|||
46888416|NCT00006011|83110720|FG000|Overall Study|Adverse Event|15|||
46888417|NCT00006011|83110721|FG001|Overall Study|Adverse Event|39|||
46888418|NCT00006011|83110722|FG002|Overall Study|Adverse Event|5|||
46888419|NCT00006011|83110720|FG000|Overall Study|Death|0|||
46888420|NCT00006011|83110721|FG001|Overall Study|Death|1|||
46888421|NCT00006011|83110722|FG002|Overall Study|Death|2|||
46888422|NCT00006011|83110720|FG000|Overall Study|Other|4|||
46888423|NCT00006011|83110721|FG001|Overall Study|Other|2|||
46888424|NCT00006011|83110722|FG002|Overall Study|Other|5|||
46888425|NCT00006011|83110720|FG000|Overall Study|Ineligible|18|||
46888426|NCT00006011|83110721|FG001|Overall Study|Ineligible|16|||
46888427|NCT00006011|83110722|FG002|Overall Study|Ineligible|9|||
46888428|NCT03377556|83110728|FG000|Overall Study|Adverse Event|5|||
46888429|NCT03377556|83110728|FG000|Overall Study|Refusal unrelated to adverse events|1|||
46888430|NCT03377556|83110728|FG000|Overall Study|Progression/relapse|38|||
46888431|NCT03377556|83110728|FG000|Overall Study|Death|3|||
46888432|NCT03750955|83110734|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
46888433|NCT03750955|83110735|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
46888434|NCT03750955|83110734|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
46888435|NCT03750955|83110735|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
46888436|NCT00005879|83110745|FG000|Overall Study|Withdrawal by Subject|8|||
46888437|NCT00005879|83110746|FG001|Overall Study|Withdrawal by Subject|10|||
46888438|NCT03510663|83110760|FG000|Overall Study|Withdrawal by Subject|0|||
46888439|NCT03510663|83110761|FG001|Overall Study|Withdrawal by Subject|1|||
46888440|NCT03510663|83110762|FG002|Overall Study|Withdrawal by Subject|0|||
46888441|NCT03510663|83110763|FG003|Overall Study|Withdrawal by Subject|0|||
46888442|NCT03510663|83110764|FG004|Overall Study|Withdrawal by Subject|0|||
46888443|NCT03510663|83110765|FG005|Overall Study|Withdrawal by Subject|0|||
46888444|NCT03510663|83110766|FG006|Overall Study|Withdrawal by Subject|0|||
46888445|NCT03510663|83110767|FG007|Overall Study|Withdrawal by Subject|0|||
46888446|NCT03510273|83110777|FG000|Overall Study|Withdrawal by Subject|2|||
46888447|NCT03510273|83110777|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
46888448|NCT03510273|83110777|FG000|Overall Study|Moved away from study area|4|||
46888449|NCT03582813|83110787|FG000|Overall Study|Lost to Follow-up|18|||
46888450|NCT03582813|83110788|FG001|Overall Study|Lost to Follow-up|21|||
46888451|NCT03582813|83110787|FG000|Overall Study|Withdrawal by Subject|1|||
46888452|NCT03582813|83110788|FG001|Overall Study|Withdrawal by Subject|0|||
46888453|NCT03480009|83110798|FG000|Overall Study|Lost to Follow-up|4|||
46888454|NCT03480009|83110799|FG001|Overall Study|Lost to Follow-up|5|||
46888455|NCT03480009|83110800|FG002|Overall Study|Lost to Follow-up|4|||
46888456|NCT03480009|83110801|FG003|Overall Study|Lost to Follow-up|0|||
46888457|NCT03399786|83110816|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
46888458|NCT03399786|83110817|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46888459|NCT03399786|83110818|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46888460|NCT03399786|83110819|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
46888461|NCT03399786|83110816|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
46888462|NCT03399786|83110817|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
46897657|NCT00706030|83123369|FG002|Overall Study|Protocol Violation|1|||
46888463|NCT03399786|83110818|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
46888464|NCT03399786|83110819|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
46888465|NCT03399786|83110816|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
46888466|NCT03399786|83110817|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
46888467|NCT03399786|83110818|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
46888468|NCT03399786|83110819|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
46888469|NCT03505593|83110827|FG000|Overall Study|Withdrawal by Subject|1|||
46888470|NCT03505593|83110827|FG000|Overall Study|Died before procedure|1|||
46888471|NCT03505593|83110827|FG000|Overall Study|Anatomical abnormality|1|||
46888472|NCT03505593|83110827|FG000|Overall Study|Unable to pass through esophagus|1|||
46888473|NCT03505593|83110827|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
46888474|NCT03504189|83110831|FG000|Overall Study|Withdrawal by Subject|1|||
46888475|NCT03504189|83110831|FG000|Overall Study|Screening Failure|1|||
46888476|NCT03504189|83110831|FG000|Overall Study|Device Failure|2|||
46888477|NCT03374358|83110842|FG000|Overall Study|Withdrawal by Subject|0|||
46888478|NCT03374358|83110843|FG001|Overall Study|Withdrawal by Subject|2|||
46888479|NCT03372096|83110849|FG000|Overall Study|Study Closed|8|||
46888480|NCT00004859|83110858|FG000|Overall Study|Lack of Efficacy|43|||
46888481|NCT00004859|83110859|FG001|Overall Study|Lack of Efficacy|113|||
46888482|NCT00004859|83110858|FG000|Overall Study|Adverse Event|31|||
46888483|NCT00004859|83110859|FG001|Overall Study|Adverse Event|93|||
46888484|NCT00004859|83110858|FG000|Overall Study|Death|5|||
46888485|NCT00004859|83110859|FG001|Overall Study|Death|5|||
46888486|NCT00004859|83110858|FG000|Overall Study|Withdrawal by Subject|7|||
46888487|NCT00004859|83110859|FG001|Overall Study|Withdrawal by Subject|33|||
46888488|NCT00004859|83110858|FG000|Overall Study|Protocol Violation|2|||
46888489|NCT00004859|83110859|FG001|Overall Study|Protocol Violation|2|||
46888490|NCT00004859|83110858|FG000|Overall Study|other disease|0|||
46888491|NCT00004859|83110859|FG001|Overall Study|other disease|3|||
46888492|NCT00004859|83110858|FG000|Overall Study|error|3|||
46888493|NCT00004859|83110859|FG001|Overall Study|error|1|||
46888494|NCT00004859|83110858|FG000|Overall Study|missing data|14|||
46888495|NCT00004859|83110859|FG001|Overall Study|missing data|11|||
46888496|NCT00004859|83110858|FG000|Overall Study|Other|13|||
46888497|NCT00004859|83110859|FG001|Overall Study|Other|21|||
46888498|NCT03500679|83110869|FG000|Overall Study|Lost to Follow-up|6|||
46888499|NCT03500679|83110870|FG001|Overall Study|Lost to Follow-up|3|||
46888500|NCT03500679|83110869|FG000|Overall Study|Withdrawal by Subject|3|||
46888501|NCT03500679|83110870|FG001|Overall Study|Withdrawal by Subject|0|||
46888502|NCT03348930|83110876|FG000|Washout (1 Week)|Lost to Follow-up|1|||
46888503|NCT03348930|83110877|FG001|Washout (1 Week)|Lost to Follow-up|1|||
46888504|NCT03500211|83110885|FG000|Overall Study|Withdrawal by Subject|1|||
46888505|NCT03500211|83110886|FG001|Overall Study|Withdrawal by Subject|1|||
46888506|NCT03478683|83110894|FG000|Overall Study|Adverse Event|5|||
46888507|NCT03478683|83110895|FG001|Overall Study|Adverse Event|3|||
46888508|NCT03478683|83110894|FG000|Overall Study|Lost to Follow-up|0|||
46888509|NCT03478683|83110895|FG001|Overall Study|Lost to Follow-up|5|||
46888510|NCT03478683|83110894|FG000|Overall Study|Physician Decision|1|||
46888511|NCT03478683|83110895|FG001|Overall Study|Physician Decision|3|||
46888512|NCT03478683|83110894|FG000|Overall Study|Withdrawal by Subject|7|||
46888513|NCT03478683|83110895|FG001|Overall Study|Withdrawal by Subject|7|||
46888514|NCT03478371|83110901|FG000|Overall Study|non-compliance|1|||
46888515|NCT03478371|83110901|FG000|Overall Study|Lost to Follow-up|4|||
46888516|NCT03477903|83110911|FG000|Overall Study|Study Terminated by Sponsor|1|||
46888517|NCT03475875|83110915|FG000|Period 1|Lost to Follow-up|1|||
46888518|NCT03475875|83110916|FG001|Period 1|Lost to Follow-up|0|||
46888519|NCT03475875|83110915|FG000|Period 1|Adverse Event|2|||
46888520|NCT03475875|83110916|FG001|Period 1|Adverse Event|1|||
46888521|NCT03475875|83110915|FG000|Period 2|Adverse Event|3|||
46888522|NCT03475875|83110916|FG001|Period 2|Adverse Event|0|||
46888523|NCT03475875|83110915|FG000|Period 2|Protocol Violation|0|||
46888524|NCT03475875|83110916|FG001|Period 2|Protocol Violation|1|||
46888525|NCT03474081|83110924|FG000|Overall Study|Adverse Event|6|||
46888526|NCT03474081|83110925|FG001|Overall Study|Adverse Event|3|||
46888527|NCT03474081|83110924|FG000|Overall Study|Lost to Follow-up|2|||
46888528|NCT03474081|83110925|FG001|Overall Study|Lost to Follow-up|1|||
46888529|NCT03474081|83110924|FG000|Overall Study|Physician Decision|3|||
46888530|NCT03474081|83110925|FG001|Overall Study|Physician Decision|2|||
46888531|NCT03474081|83110924|FG000|Overall Study|Withdrawal by Subject|5|||
46888532|NCT03474081|83110925|FG001|Overall Study|Withdrawal by Subject|7|||
46888533|NCT03474081|83110924|FG000|Overall Study|Investigator site closed|1|||
46888534|NCT03474081|83110925|FG001|Overall Study|Investigator site closed|0|||
46888535|NCT03346434|83110937|FG000|Overall Study|Randomized in Error|0|||
46888536|NCT03346434|83110938|FG001|Overall Study|Randomized in Error|0|||
46888537|NCT03346434|83110939|FG002|Overall Study|Randomized in Error|0|||
46888538|NCT03346434|83110940|FG003|Overall Study|Randomized in Error|0|||
46888539|NCT03346434|83110941|FG004|Overall Study|Randomized in Error|1|||
46888540|NCT03346434|83110942|FG005|Overall Study|Randomized in Error|0|||
46888541|NCT03346434|83110937|FG000|Overall Study|Withdrawal by Subject|0|||
46888542|NCT03346434|83110938|FG001|Overall Study|Withdrawal by Subject|0|||
46888543|NCT03346434|83110939|FG002|Overall Study|Withdrawal by Subject|1|||
46888544|NCT03346434|83110940|FG003|Overall Study|Withdrawal by Subject|0|||
46888545|NCT03346434|83110941|FG004|Overall Study|Withdrawal by Subject|1|||
46888546|NCT03346434|83110942|FG005|Overall Study|Withdrawal by Subject|0|||
46888547|NCT03346434|83110937|FG000|Overall Study|Lost to Follow-up|0|||
46888548|NCT03346434|83110938|FG001|Overall Study|Lost to Follow-up|0|||
46888549|NCT03346434|83110939|FG002|Overall Study|Lost to Follow-up|0|||
46888550|NCT03346434|83110940|FG003|Overall Study|Lost to Follow-up|0|||
46888551|NCT03346434|83110941|FG004|Overall Study|Lost to Follow-up|1|||
46888552|NCT03346434|83110942|FG005|Overall Study|Lost to Follow-up|1|||
46888553|NCT03346434|83110937|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
46888554|NCT03346434|83110938|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
46888555|NCT03346434|83110939|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
46888556|NCT03346434|83110940|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
46888557|NCT03346434|83110941|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
46888558|NCT03346434|83110942|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
46888559|NCT03393000|83110960|FG000|Overall Study|Death|11|||
46888560|NCT03393000|83110960|FG000|Overall Study|Withdrawal by Subject|2|||
46888561|NCT03393000|83110960|FG000|Overall Study|Physician Decision|1|||
46888562|NCT03370770|83110964|FG000|Overall Study|Patient was followed in another hospital center|1|||
46888563|NCT03370770|83110964|FG000|Overall Study|Progressive Disease|98|||
46888564|NCT03370770|83110964|FG000|Overall Study|Adverse Event|2|||
46888565|NCT03370770|83110964|FG000|Overall Study|Death|5|||
46888566|NCT03473301|83110971|FG000|Overall Study|Protocol Violation|4|||
46888567|NCT03473301|83110972|FG001|Overall Study|Protocol Violation|0|||
46888568|NCT03473301|83110973|FG002|Overall Study|Protocol Violation|0|||
46888569|NCT03473301|83110971|FG000|Overall Study|Withdrawal by Subject|0|||
46888570|NCT03473301|83110972|FG001|Overall Study|Withdrawal by Subject|1|||
46888571|NCT03473301|83110973|FG002|Overall Study|Withdrawal by Subject|0|||
46888572|NCT03473301|83110971|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
46888573|NCT03473301|83110972|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
46888574|NCT03473301|83110973|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
46888575|NCT03390426|83110985|FG000|Overall Study|Protocol Violation|0|||
46888576|NCT03390426|83110986|FG001|Overall Study|Protocol Violation|1|||
46888577|NCT03472521|83110994|FG000|Overall Study|Lost to Follow-up|3|||
46888578|NCT03472521|83110995|FG001|Overall Study|Lost to Follow-up|2|||
46888579|NCT03472521|83110994|FG000|Overall Study|Discontinued intervention|3|||
46888580|NCT03472521|83110995|FG001|Overall Study|Discontinued intervention|1|||
46888581|NCT02906020|83111011|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
46888582|NCT02906020|83111012|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
46888583|NCT02906020|83111013|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
46888584|NCT02906020|83111014|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
46888585|NCT02906020|83111015|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
46888586|NCT02906020|83111016|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
46888587|NCT02906020|83111017|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
46888588|NCT02906020|83111018|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
46888589|NCT02906020|83111019|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
46888590|NCT02906020|83111020|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
46888591|NCT02906020|83111021|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
46888592|NCT02906020|83111022|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
46888593|NCT02906020|83111023|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
46888594|NCT02906020|83111024|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
46888595|NCT02906020|83111025|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
46888596|NCT02906020|83111026|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
46888597|NCT02906020|83111011|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888598|NCT02906020|83111012|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888599|NCT02906020|83111013|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888600|NCT02906020|83111014|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888601|NCT02906020|83111015|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888602|NCT02906020|83111016|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888603|NCT02906020|83111017|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888604|NCT02906020|83111018|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888605|NCT02906020|83111019|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
46888606|NCT02906020|83111020|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
46888607|NCT02906020|83111021|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888608|NCT02906020|83111022|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888609|NCT02906020|83111023|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888610|NCT02906020|83111024|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888611|NCT02906020|83111025|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888612|NCT02906020|83111026|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
46888613|NCT02906020|83111011|FG000|Part 2: Double-blind Treatment Period|Other|0|||
46888614|NCT02906020|83111012|FG001|Part 2: Double-blind Treatment Period|Other|0|||
46888615|NCT02906020|83111013|FG002|Part 2: Double-blind Treatment Period|Other|0|||
46888616|NCT02906020|83111014|FG003|Part 2: Double-blind Treatment Period|Other|0|||
46888617|NCT02906020|83111015|FG004|Part 2: Double-blind Treatment Period|Other|0|||
46888618|NCT02906020|83111016|FG005|Part 2: Double-blind Treatment Period|Other|0|||
46888619|NCT02906020|83111017|FG006|Part 2: Double-blind Treatment Period|Other|0|||
46888620|NCT02906020|83111018|FG007|Part 2: Double-blind Treatment Period|Other|0|||
46888621|NCT02906020|83111019|FG008|Part 2: Double-blind Treatment Period|Other|6|||
46888622|NCT02906020|83111020|FG009|Part 2: Double-blind Treatment Period|Other|10|||
46888623|NCT02906020|83111021|FG010|Part 2: Double-blind Treatment Period|Other|0|||
46888624|NCT02906020|83111022|FG011|Part 2: Double-blind Treatment Period|Other|0|||
46888625|NCT02906020|83111023|FG012|Part 2: Double-blind Treatment Period|Other|0|||
46888626|NCT02906020|83111024|FG013|Part 2: Double-blind Treatment Period|Other|0|||
46888627|NCT02906020|83111025|FG014|Part 2: Double-blind Treatment Period|Other|0|||
46888628|NCT02906020|83111026|FG015|Part 2: Double-blind Treatment Period|Other|0|||
46888629|NCT02906020|83111011|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888630|NCT02906020|83111012|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888631|NCT02906020|83111013|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888632|NCT02906020|83111014|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888633|NCT02906020|83111015|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888634|NCT02906020|83111016|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888635|NCT02906020|83111017|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888636|NCT02906020|83111018|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888637|NCT02906020|83111019|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888638|NCT02906020|83111020|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888639|NCT02906020|83111021|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888640|NCT02906020|83111022|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888641|NCT02906020|83111023|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
46888642|NCT02906020|83111024|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
46888643|NCT02906020|83111025|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888644|NCT02906020|83111026|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
46888645|NCT02906020|83111011|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888646|NCT02906020|83111012|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888647|NCT02906020|83111013|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888648|NCT02906020|83111014|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888649|NCT02906020|83111015|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888650|NCT02906020|83111016|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888651|NCT02906020|83111017|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888652|NCT02906020|83111018|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888653|NCT02906020|83111019|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888654|NCT02906020|83111020|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888655|NCT02906020|83111021|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888656|NCT02906020|83111022|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888657|NCT02906020|83111023|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
46888658|NCT02906020|83111024|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
46888659|NCT02906020|83111025|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
46888660|NCT02906020|83111026|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
46888661|NCT02906020|83111011|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888662|NCT02906020|83111012|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888663|NCT02906020|83111013|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888664|NCT02906020|83111014|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888665|NCT02906020|83111015|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888666|NCT02906020|83111016|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888667|NCT02906020|83111017|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888668|NCT02906020|83111018|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888669|NCT02906020|83111019|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888670|NCT02906020|83111020|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888671|NCT02906020|83111021|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888672|NCT02906020|83111022|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888673|NCT02906020|83111023|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
46888674|NCT02906020|83111024|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
46888675|NCT02906020|83111025|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888676|NCT02906020|83111026|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
46888677|NCT02906020|83111011|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46897658|NCT00706030|83123370|FG003|Overall Study|Protocol Violation|1|||
46888678|NCT02906020|83111012|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888679|NCT02906020|83111013|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888680|NCT02906020|83111014|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888681|NCT02906020|83111015|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888682|NCT02906020|83111016|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888683|NCT02906020|83111017|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888684|NCT02906020|83111018|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888685|NCT02906020|83111019|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888686|NCT02906020|83111020|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888687|NCT02906020|83111021|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888688|NCT02906020|83111022|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888689|NCT02906020|83111023|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
46888690|NCT02906020|83111024|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
46888691|NCT02906020|83111025|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888692|NCT02906020|83111026|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
46888693|NCT02906020|83111011|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888694|NCT02906020|83111012|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888695|NCT02906020|83111013|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888696|NCT02906020|83111014|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888697|NCT02906020|83111015|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888698|NCT02906020|83111016|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888699|NCT02906020|83111017|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888700|NCT02906020|83111018|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888701|NCT02906020|83111019|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888702|NCT02906020|83111020|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888703|NCT02906020|83111021|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888704|NCT02906020|83111022|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
46888705|NCT02906020|83111023|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
46888706|NCT02906020|83111024|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
46888707|NCT02906020|83111025|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
46888708|NCT02906020|83111026|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
46888709|NCT02906020|83111011|FG000|Part 2: Long-term Follow-up Period|Other|0|||
46888710|NCT02906020|83111012|FG001|Part 2: Long-term Follow-up Period|Other|0|||
46888711|NCT02906020|83111013|FG002|Part 2: Long-term Follow-up Period|Other|0|||
46888712|NCT02906020|83111014|FG003|Part 2: Long-term Follow-up Period|Other|0|||
46888713|NCT02906020|83111015|FG004|Part 2: Long-term Follow-up Period|Other|0|||
46888714|NCT02906020|83111016|FG005|Part 2: Long-term Follow-up Period|Other|0|||
46888715|NCT02906020|83111017|FG006|Part 2: Long-term Follow-up Period|Other|0|||
46888716|NCT02906020|83111018|FG007|Part 2: Long-term Follow-up Period|Other|0|||
46888717|NCT02906020|83111019|FG008|Part 2: Long-term Follow-up Period|Other|0|||
46888718|NCT02906020|83111020|FG009|Part 2: Long-term Follow-up Period|Other|0|||
46888719|NCT02906020|83111021|FG010|Part 2: Long-term Follow-up Period|Other|0|||
46888720|NCT02906020|83111022|FG011|Part 2: Long-term Follow-up Period|Other|0|||
46888721|NCT02906020|83111023|FG012|Part 2: Long-term Follow-up Period|Other|13|||
46888722|NCT02906020|83111024|FG013|Part 2: Long-term Follow-up Period|Other|8|||
46888723|NCT02906020|83111025|FG014|Part 2: Long-term Follow-up Period|Other|3|||
46888724|NCT02906020|83111026|FG015|Part 2: Long-term Follow-up Period|Other|2|||
46888725|NCT03499353|83111054|FG000|Treatment|Adverse Event|3|||
46888726|NCT03499353|83111054|FG000|Treatment|Progressive Disease|10|||
46888727|NCT03499353|83111054|FG000|Treatment|Other|1|||
46888728|NCT03499353|83111054|FG000|Treatment|Withdrawal by Subject|2|||
46888729|NCT03499353|83111054|FG000|Long-Term Follow-up|Death|2|||
46888730|NCT03499353|83111054|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
46888731|NCT03499353|83111054|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
46888732|NCT00004259|83111062|FG000|Overall Study|Protocol Violation|1|||
46888733|NCT00004259|83111063|FG001|Overall Study|Protocol Violation|2|||
46888734|NCT00004259|83111064|FG002|Overall Study|Protocol Violation|0|||
46888735|NCT00004259|83111065|FG003|Overall Study|Protocol Violation|0|||
46888736|NCT00004259|83111062|FG000|Overall Study|Withdrawal by Subject|0|||
46888737|NCT00004259|83111063|FG001|Overall Study|Withdrawal by Subject|2|||
46888738|NCT00004259|83111064|FG002|Overall Study|Withdrawal by Subject|0|||
46888739|NCT00004259|83111065|FG003|Overall Study|Withdrawal by Subject|0|||
46888740|NCT03365934|83111089|FG000|Overall Study|Adverse Event|1|||
46888741|NCT03365934|83111089|FG000|Overall Study|Withdrawal by Subject|1|||
46888742|NCT03468855|83111098|FG000|Overall Study|Adverse Event|2|||
46888743|NCT03468855|83111098|FG000|Overall Study|Lost to Follow-up|5|||
46888744|NCT03468855|83111098|FG000|Overall Study|Withdrawal by Subject|3|||
46888745|NCT03468855|83111098|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
46888746|NCT03738865|83111104|FG000|Overall Study|Withdrawal by Subject|3|||
46888747|NCT03738865|83111105|FG001|Overall Study|Withdrawal by Subject|3|||
46888748|NCT03738865|83111104|FG000|Overall Study|Adverse Event|2|||
46888749|NCT03738865|83111105|FG001|Overall Study|Adverse Event|0|||
46888750|NCT03738865|83111104|FG000|Overall Study|Physician Decision|0|||
46888751|NCT03738865|83111105|FG001|Overall Study|Physician Decision|1|||
46888752|NCT03524157|83111114|FG000|Overall Study|cytology not readable|0|||
46888753|NCT03524157|83111115|FG001|Overall Study|cytology not readable|0|||
46888754|NCT03524157|83111116|FG002|Overall Study|cytology not readable|1|||
46888755|NCT03437733|83111130|FG000|Overall Study|Eligibility criteria not met|0|||
46888756|NCT03437733|83111131|FG001|Overall Study|Eligibility criteria not met|3|||
46888757|NCT03468543|83111139|FG000|Overall Study|Protocol stopping rules met|3|||
46888758|NCT03467763|83111143|FG000|Overall Study|Lost to Follow-up|1|||
46888759|NCT03467763|83111143|FG000|Overall Study|Protocol Violation|2|||
46888760|NCT00004031|83111151|FG000|Overall Study|Adverse Event|5|||
46888761|NCT00004031|83111152|FG001|Overall Study|Adverse Event|0|||
46888762|NCT00004031|83111151|FG000|Overall Study|Refusal unrelated to adverse events|2|||
46888763|NCT00004031|83111152|FG001|Overall Study|Refusal unrelated to adverse events|11|||
46888764|NCT00004031|83111151|FG000|Overall Study|Progression/relapse|9|||
46888765|NCT00004031|83111152|FG001|Overall Study|Progression/relapse|4|||
46888766|NCT00004031|83111151|FG000|Overall Study|Death|3|||
46888767|NCT00004031|83111152|FG001|Overall Study|Death|1|||
46888768|NCT00004031|83111151|FG000|Overall Study|Other- not protocol specified|3|||
46888769|NCT00004031|83111152|FG001|Overall Study|Other- not protocol specified|3|||
46888770|NCT00004031|83111151|FG000|Overall Study|Reason under review|3|||
46888771|NCT00004031|83111152|FG001|Overall Study|Reason under review|2|||
46888772|NCT03467217|83111162|FG000|Overall Study|Trial stopped early|5|||
46888773|NCT03467217|83111163|FG001|Overall Study|Trial stopped early|2|||
46888774|NCT03467217|83111162|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
46888775|NCT03467217|83111163|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
46888776|NCT03467217|83111162|FG000|Overall Study|Lost to Follow-up|0|||
46888777|NCT03467217|83111163|FG001|Overall Study|Lost to Follow-up|2|||
46888778|NCT00003875|83111169|FG000|Overall Study|Screen Failed|1|||
46888779|NCT03364686|83111173|FG000|Overall Study|Physician Decision|2|||
46888780|NCT03437577|83111180|FG000|Pre-Randomization|Withdrawal by Subject|0|||
46888781|NCT03437577|83111181|FG001|Pre-Randomization|Withdrawal by Subject|0|||
46888782|NCT03437577|83111182|FG002|Pre-Randomization|Withdrawal by Subject|10|||
46888783|NCT03437577|83111180|FG000|Post-Randomization|Physician Decision|0|||
46888784|NCT03437577|83111181|FG001|Post-Randomization|Physician Decision|2|||
46888785|NCT03437577|83111182|FG002|Post-Randomization|Physician Decision|0|||
46888786|NCT03336528|83111190|FG000|Overall Study|Protocol Violation|1|||
46888787|NCT03336528|83111191|FG001|Overall Study|Protocol Violation|1|||
46888788|NCT03336528|83111190|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
46888789|NCT03336528|83111191|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
46888790|NCT03336528|83111190|FG000|Overall Study|Did not receive study medication|1|||
46888791|NCT03336528|83111191|FG001|Overall Study|Did not receive study medication|2|||
46888792|NCT03364608|83111199|FG000|Overall Study|Withdrawal by Subject|4|||
46888793|NCT03364608|83111199|FG000|Overall Study|Protocol Violation|2|||
46888794|NCT03364608|83111199|FG000|Overall Study|Lost to Follow-up|2|||
46888795|NCT00003869|83111213|FG000|Overall Study|Adverse Event|14|||
46888796|NCT00003869|83111214|FG001|Overall Study|Adverse Event|3|||
46888797|NCT00003869|83111213|FG000|Overall Study|Withdrawal by Subject|21|||
46888798|NCT00003869|83111214|FG001|Overall Study|Withdrawal by Subject|3|||
46888799|NCT00003869|83111213|FG000|Overall Study|Death|1|||
46888800|NCT00003869|83111214|FG001|Overall Study|Death|2|||
46888801|NCT00003869|83111213|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
46888802|NCT00003869|83111214|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
46888803|NCT03344640|83111222|FG000|Overall Study|Adverse Event|1|||
46888804|NCT03344640|83111223|FG001|Overall Study|Adverse Event|0|||
46888805|NCT03344640|83111222|FG000|Overall Study|Physician Decision|1|||
46888806|NCT03344640|83111223|FG001|Overall Study|Physician Decision|1|||
46888807|NCT03344640|83111222|FG000|Overall Study|Withdrawal by Subject|1|||
46888808|NCT03344640|83111223|FG001|Overall Study|Withdrawal by Subject|2|||
46888809|NCT03344640|83111222|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
46888810|NCT03344640|83111223|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
46888811|NCT03344562|83111231|FG000|Overall Study|Withdrawal by Subject|2|||
46888812|NCT03344562|83111232|FG001|Overall Study|Withdrawal by Subject|0|||
46888813|NCT00003659|83111238|FG000|Overall Study|Withdrawal by Subject|3|||
46888814|NCT03494985|83111246|FG000|Overall Study|Adverse Event|3|||
46888815|NCT03494985|83111247|FG001|Overall Study|Adverse Event|2|||
46888816|NCT03494985|83111248|FG002|Overall Study|Adverse Event|3|||
46888817|NCT03494985|83111249|FG003|Overall Study|Adverse Event|0|||
46888818|NCT03494985|83111246|FG000|Overall Study|Other (Withdrawal of consent)|2|||
46888819|NCT03494985|83111247|FG001|Overall Study|Other (Withdrawal of consent)|3|||
46888820|NCT03494985|83111248|FG002|Overall Study|Other (Withdrawal of consent)|2|||
46888821|NCT03494985|83111249|FG003|Overall Study|Other (Withdrawal of consent)|5|||
46888822|NCT03494985|83111246|FG000|Overall Study|Other (Not specified)|0|||
46888823|NCT03494985|83111247|FG001|Overall Study|Other (Not specified)|1|||
46888824|NCT03494985|83111248|FG002|Overall Study|Other (Not specified)|1|||
46888825|NCT03494985|83111249|FG003|Overall Study|Other (Not specified)|0|||
46888826|NCT00003509|83111259|FG000|Overall Study|Not evaluable|5|||
46888827|NCT03344172|83111265|FG000|Overall Study|Received <1 dose of treatment|1|||
46888828|NCT03344172|83111266|FG001|Overall Study|Received <1 dose of treatment|0|||
46888829|NCT03465891|83111274|FG000|Overall Study|Withdrawal by Subject|0|||
46888830|NCT03465891|83111275|FG001|Overall Study|Withdrawal by Subject|1|||
46888831|NCT03465891|83111274|FG000|Overall Study|Disease progression|1|||
46888832|NCT03465891|83111275|FG001|Overall Study|Disease progression|0|||
46888833|NCT03363906|83111281|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
46888834|NCT03363906|83111282|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
46888835|NCT03363906|83111281|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
46888836|NCT03363906|83111282|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
46888837|NCT03363906|83111281|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
46888838|NCT03363906|83111282|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
46888839|NCT03363906|83111281|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
46888840|NCT03363906|83111282|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
46888841|NCT00003473|83111288|FG000|Overall Study|Three patients were not evaluable.|3|||
46888842|NCT03343626|83111300|FG000|Overall Study|Lost to Follow-up|4|||
46888843|NCT03343626|83111301|FG001|Overall Study|Lost to Follow-up|3|||
46888844|NCT03343626|83111302|FG002|Overall Study|Lost to Follow-up|2|||
46888845|NCT03343626|83111303|FG003|Overall Study|Lost to Follow-up|5|||
46888846|NCT03343626|83111304|FG004|Overall Study|Lost to Follow-up|4|||
46888847|NCT03343626|83111305|FG005|Overall Study|Lost to Follow-up|4|||
46888848|NCT03343626|83111306|FG006|Overall Study|Lost to Follow-up|4|||
46888849|NCT03343626|83111307|FG007|Overall Study|Lost to Follow-up|7|||
46888850|NCT03343626|83111300|FG000|Overall Study|Withdrawal of Consent|2|||
46888851|NCT03343626|83111301|FG001|Overall Study|Withdrawal of Consent|1|||
46888852|NCT03343626|83111302|FG002|Overall Study|Withdrawal of Consent|0|||
46888853|NCT03343626|83111303|FG003|Overall Study|Withdrawal of Consent|3|||
46888854|NCT03343626|83111304|FG004|Overall Study|Withdrawal of Consent|3|||
46888855|NCT03343626|83111305|FG005|Overall Study|Withdrawal of Consent|1|||
46888856|NCT03343626|83111306|FG006|Overall Study|Withdrawal of Consent|1|||
46888857|NCT03343626|83111307|FG007|Overall Study|Withdrawal of Consent|2|||
46888858|NCT03343626|83111300|FG000|Overall Study|Reason not Specified|0|||
46888859|NCT03343626|83111301|FG001|Overall Study|Reason not Specified|1|||
46888860|NCT03343626|83111302|FG002|Overall Study|Reason not Specified|0|||
46888861|NCT03343626|83111303|FG003|Overall Study|Reason not Specified|0|||
46888862|NCT03343626|83111304|FG004|Overall Study|Reason not Specified|0|||
46888863|NCT03343626|83111305|FG005|Overall Study|Reason not Specified|0|||
46888864|NCT03343626|83111306|FG006|Overall Study|Reason not Specified|0|||
46888865|NCT03343626|83111307|FG007|Overall Study|Reason not Specified|1|||
46888866|NCT03343626|83111300|FG000|Overall Study|Data Entry Error|0|||
46888867|NCT03343626|83111301|FG001|Overall Study|Data Entry Error|0|||
46888868|NCT03343626|83111302|FG002|Overall Study|Data Entry Error|0|||
46888869|NCT03343626|83111303|FG003|Overall Study|Data Entry Error|0|||
46888870|NCT03343626|83111304|FG004|Overall Study|Data Entry Error|0|||
46888871|NCT03343626|83111305|FG005|Overall Study|Data Entry Error|0|||
46888872|NCT03343626|83111306|FG006|Overall Study|Data Entry Error|0|||
46888873|NCT03343626|83111307|FG007|Overall Study|Data Entry Error|1|||
46888874|NCT03334422|83111332|FG000|Overall Study|Adverse Event|1|||
46888875|NCT03334422|83111333|FG001|Overall Study|Adverse Event|3|||
46888876|NCT03334422|83111334|FG002|Overall Study|Adverse Event|2|||
46888877|NCT03334422|83111335|FG003|Overall Study|Adverse Event|2|||
46888878|NCT03334422|83111332|FG000|Overall Study|Lack of Efficacy|10|||
46888879|NCT03334422|83111333|FG001|Overall Study|Lack of Efficacy|2|||
46888880|NCT03334422|83111334|FG002|Overall Study|Lack of Efficacy|7|||
46888881|NCT03334422|83111335|FG003|Overall Study|Lack of Efficacy|3|||
46888882|NCT03334422|83111332|FG000|Overall Study|Withdrawal by Subject|8|||
46888883|NCT03334422|83111333|FG001|Overall Study|Withdrawal by Subject|3|||
46888884|NCT03334422|83111334|FG002|Overall Study|Withdrawal by Subject|1|||
46888885|NCT03334422|83111335|FG003|Overall Study|Withdrawal by Subject|0|||
46888886|NCT03334422|83111332|FG000|Overall Study|Lost to Follow-up|0|||
46888887|NCT03334422|83111333|FG001|Overall Study|Lost to Follow-up|0|||
46888888|NCT03334422|83111334|FG002|Overall Study|Lost to Follow-up|0|||
46888889|NCT03334422|83111335|FG003|Overall Study|Lost to Follow-up|1|||
46888890|NCT03334422|83111332|FG000|Overall Study|Inability to obtain laboratory samples|0|||
46888891|NCT03334422|83111333|FG001|Overall Study|Inability to obtain laboratory samples|1|||
46888892|NCT03334422|83111334|FG002|Overall Study|Inability to obtain laboratory samples|0|||
46888893|NCT03334422|83111335|FG003|Overall Study|Inability to obtain laboratory samples|0|||
46888894|NCT03334422|83111332|FG000|Overall Study|Pregnancy|0|||
46888895|NCT03334422|83111333|FG001|Overall Study|Pregnancy|1|||
46888896|NCT03334422|83111334|FG002|Overall Study|Pregnancy|0|||
46888897|NCT03334422|83111335|FG003|Overall Study|Pregnancy|0|||
46888898|NCT02323126|83111353|FG000|Overall Study|Patient / guardian decision|0|||
46888899|NCT02323126|83111354|FG001|Overall Study|Patient / guardian decision|1|||
46888900|NCT02323126|83111355|FG002|Overall Study|Patient / guardian decision|2|||
46888901|NCT02323126|83111353|FG000|Overall Study|Progressive disease|14|||
46888902|NCT02323126|83111354|FG001|Overall Study|Progressive disease|8|||
46888903|NCT02323126|83111355|FG002|Overall Study|Progressive disease|14|||
46888904|NCT02323126|83111353|FG000|Overall Study|Physician Decision|0|||
46888905|NCT02323126|83111354|FG001|Overall Study|Physician Decision|1|||
46888906|NCT02323126|83111355|FG002|Overall Study|Physician Decision|3|||
46888907|NCT02323126|83111353|FG000|Overall Study|Death|1|||
46888908|NCT02323126|83111354|FG001|Overall Study|Death|1|||
46888909|NCT02323126|83111355|FG002|Overall Study|Death|4|||
46888910|NCT02323126|83111353|FG000|Overall Study|Adverse Event|3|||
46888911|NCT02323126|83111354|FG001|Overall Study|Adverse Event|5|||
46888912|NCT02323126|83111355|FG002|Overall Study|Adverse Event|7|||
46888913|NCT03491553|83111372|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
46888914|NCT03491553|83111373|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
46888915|NCT03491553|83111374|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
46888916|NCT03491553|83111375|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
46888917|NCT03491553|83111376|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
46888918|NCT03491553|83111377|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
46888919|NCT03491553|83111372|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
46888920|NCT03491553|83111373|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
46888921|NCT03491553|83111374|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
46888922|NCT03491553|83111375|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
46888923|NCT03491553|83111376|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
46888924|NCT03491553|83111377|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
46888925|NCT00003377|83111398|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
46888926|NCT00003377|83111399|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
46888927|NCT00003377|83111400|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
46888928|NCT00003377|83111401|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
46888929|NCT00003377|83111402|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
46888930|NCT00003377|83111398|FG000|Period II|Ureteral stent complications|0|||
46888931|NCT00003377|83111399|FG001|Period II|Ureteral stent complications|0|||
46888932|NCT00003377|83111400|FG002|Period II|Ureteral stent complications|0|||
46888933|NCT00003377|83111401|FG003|Period II|Ureteral stent complications|0|||
46888934|NCT00003377|83111402|FG004|Period II|Ureteral stent complications|1|||
46888935|NCT00651742|83111415|FG000|Overall Study|Objective Disease Progression|22|||
46888936|NCT00651742|83111415|FG000|Overall Study|Toxicity|3|||
46888937|NCT00651742|83111415|FG000|Overall Study|Investigator Judgment|1|||
46888938|NCT00651742|83111415|FG000|Overall Study|Withdrawal of Consent|1|||
46888939|NCT00651742|83111415|FG000|Overall Study|Enrolled but not treated|1|||
46888940|NCT00002651|83111421|FG000|Induction|Adverse Event|44|||
46888941|NCT00002651|83111422|FG001|Induction|Adverse Event|0|||
46888942|NCT00002651|83111423|FG002|Induction|Adverse Event|0|||
46888943|NCT00002651|83111421|FG000|Induction|Refusal unrelated to adverse event|50|||
46888944|NCT00002651|83111422|FG001|Induction|Refusal unrelated to adverse event|0|||
46888945|NCT00002651|83111423|FG002|Induction|Refusal unrelated to adverse event|0|||
46888946|NCT00002651|83111421|FG000|Induction|Progression/relapse|274|||
46888947|NCT00002651|83111422|FG001|Induction|Progression/relapse|0|||
46888948|NCT00002651|83111423|FG002|Induction|Progression/relapse|0|||
46888949|NCT00002651|83111421|FG000|Induction|Death|62|||
46888950|NCT00002651|83111422|FG001|Induction|Death|0|||
46888951|NCT00002651|83111423|FG002|Induction|Death|0|||
46888952|NCT00002651|83111421|FG000|Induction|Other|823|||
46888953|NCT00002651|83111422|FG001|Induction|Other|0|||
46888954|NCT00002651|83111423|FG002|Induction|Other|0|||
46888955|NCT00002651|83111421|FG000|Induction|not eligible|90|||
46888956|NCT00002651|83111422|FG001|Induction|not eligible|0|||
46888957|NCT00002651|83111423|FG002|Induction|not eligible|0|||
46888958|NCT00002651|83111421|FG000|Consolidation and Randomization|Adverse Event|0|||
46888959|NCT00002651|83111422|FG001|Consolidation and Randomization|Adverse Event|36|||
46888960|NCT00002651|83111423|FG002|Consolidation and Randomization|Adverse Event|14|||
46888961|NCT00002651|83111421|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
46888962|NCT00002651|83111422|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
46888963|NCT00002651|83111423|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
46888964|NCT00002651|83111421|FG000|Consolidation and Randomization|Progression/relapse|0|||
46888965|NCT00002651|83111422|FG001|Consolidation and Randomization|Progression/relapse|295|||
46888966|NCT00002651|83111423|FG002|Consolidation and Randomization|Progression/relapse|298|||
46888967|NCT00002651|83111421|FG000|Consolidation and Randomization|Death|0|||
46888968|NCT00002651|83111422|FG001|Consolidation and Randomization|Death|38|||
46888969|NCT00002651|83111423|FG002|Consolidation and Randomization|Death|48|||
46888970|NCT00002651|83111421|FG000|Consolidation and Randomization|Other|0|||
46888971|NCT00002651|83111422|FG001|Consolidation and Randomization|Other|314|||
46888972|NCT00002651|83111423|FG002|Consolidation and Randomization|Other|313|||
46888973|NCT00002651|83111421|FG000|Consolidation and Randomization|not eligible|0|||
46888974|NCT00002651|83111422|FG001|Consolidation and Randomization|not eligible|102|||
46888975|NCT00002651|83111423|FG002|Consolidation and Randomization|not eligible|112|||
46888976|NCT00002597|83111433|FG000|Overall Study|Protocol Violation|19|||
46888977|NCT00002597|83111434|FG001|Overall Study|Protocol Violation|17|||
46888978|NCT00002597|83111433|FG000|Overall Study|Withdrawal by Subject|7|||
46888979|NCT00002597|83111434|FG001|Overall Study|Withdrawal by Subject|6|||
46888980|NCT03435081|83111443|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
46888981|NCT03435081|83111444|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
46888982|NCT03435081|83111445|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
46888983|NCT03435081|83111443|FG000|Week 0 to Week 16|Adverse Event|2|||
46888984|NCT03435081|83111444|FG001|Week 0 to Week 16|Adverse Event|2|||
46888985|NCT03435081|83111445|FG002|Week 0 to Week 16|Adverse Event|2|||
46888986|NCT03435081|83111443|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
46888987|NCT03435081|83111444|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
46888988|NCT03435081|83111445|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
46888989|NCT03435081|83111443|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
46888990|NCT03435081|83111444|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
46888991|NCT03435081|83111445|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
46888992|NCT03435081|83111443|FG000|Week 0 to Week 16|Pregnancy|1|||
46888993|NCT03435081|83111444|FG001|Week 0 to Week 16|Pregnancy|0|||
46888994|NCT03435081|83111445|FG002|Week 0 to Week 16|Pregnancy|0|||
46888995|NCT03435081|83111443|FG000|Week 0 to Week 16|Non-compliance|1|||
46888996|NCT03435081|83111444|FG001|Week 0 to Week 16|Non-compliance|0|||
46888997|NCT03435081|83111445|FG002|Week 0 to Week 16|Non-compliance|2|||
46888998|NCT03435081|83111443|FG000|Week 0 to Week 16|Inadequate Response|0|||
46888999|NCT03435081|83111444|FG001|Week 0 to Week 16|Inadequate Response|1|||
46889000|NCT03435081|83111445|FG002|Week 0 to Week 16|Inadequate Response|0|||
46889001|NCT03435081|83111443|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
46889002|NCT03435081|83111444|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
46889003|NCT03435081|83111445|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
46889004|NCT03435081|83111443|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
46889005|NCT03435081|83111444|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
46889006|NCT03435081|83111445|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
46889007|NCT03435081|83111443|FG000|Week 16 to Week 104|Adverse Event|1|||
46889008|NCT03435081|83111444|FG001|Week 16 to Week 104|Adverse Event|0|||
46889009|NCT03435081|83111445|FG002|Week 16 to Week 104|Adverse Event|2|||
46889010|NCT03435081|83111443|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
46889011|NCT03435081|83111444|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
46889012|NCT03435081|83111445|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
46889013|NCT03435081|83111443|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
46889014|NCT03435081|83111444|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
46889015|NCT03435081|83111445|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
46889016|NCT03435081|83111443|FG000|Week 16 to Week 104|Non--Compliance|0|||
46889017|NCT03435081|83111444|FG001|Week 16 to Week 104|Non--Compliance|0|||
46889018|NCT03435081|83111445|FG002|Week 16 to Week 104|Non--Compliance|1|||
46889019|NCT02738008|83111460|FG000|Overall Study|Study Terminated by Sponsor|1|||
46889020|NCT02738008|83111461|FG001|Overall Study|Study Terminated by Sponsor|5|||
46889021|NCT02738008|83111462|FG002|Overall Study|Study Terminated by Sponsor|3|||
46889022|NCT02738008|83111460|FG000|Overall Study|Adverse Event|0|||
46889023|NCT02738008|83111461|FG001|Overall Study|Adverse Event|1|||
46889024|NCT02738008|83111462|FG002|Overall Study|Adverse Event|2|||
46889025|NCT03489369|83111474|FG000|Overall Study|Documented Progressive Disease|3|||
46889026|NCT03489369|83111475|FG001|Overall Study|Documented Progressive Disease|2|||
46889027|NCT03489369|83111476|FG002|Overall Study|Documented Progressive Disease|3|||
46889028|NCT03489369|83111477|FG003|Overall Study|Documented Progressive Disease|6|||
46889029|NCT03489369|83111474|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
46889030|NCT03489369|83111475|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
46889031|NCT03489369|83111476|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
46889032|NCT03489369|83111477|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
46889033|NCT03257254|83111487|FG000|Overall Study|Withdrawal by Subject|7|||
46889034|NCT03257254|83111487|FG000|Overall Study|Lost to Follow-up|9|||
46889035|NCT03257254|83111487|FG000|Overall Study|Study discontinued by sponsor|5|||
46889036|NCT03738475|83111493|FG000|Overall Study|Participant Non-Compliance|1|||
46889037|NCT03738475|83111494|FG001|Overall Study|Participant Non-Compliance|0|||
46889038|NCT03084718|83111505|FG000|Overall Study|Withdrawal by Subject|4|||
46889039|NCT03084718|83111506|FG001|Overall Study|Withdrawal by Subject|3|||
46889040|NCT03084718|83111507|FG002|Overall Study|Withdrawal by Subject|4|||
46889041|NCT03084718|83111508|FG003|Overall Study|Withdrawal by Subject|0|||
46889042|NCT03084718|83111509|FG004|Overall Study|Withdrawal by Subject|0|||
46991444|NCT02369341|83238476|FG000|Overall Study|Migrated/moved from study area|1|||
46991445|NCT02369341|83238477|FG001|Overall Study|Migrated/moved from study area|0|||
46991446|NCT02121795|83238489|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
46991447|NCT02121795|83238490|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
46991448|NCT02121795|83238489|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
46889043|NCT03084718|83111505|FG000|Overall Study|Physician Decision|1|||
46889044|NCT03084718|83111506|FG001|Overall Study|Physician Decision|0|||
46889045|NCT03084718|83111507|FG002|Overall Study|Physician Decision|0|||
46889046|NCT03084718|83111508|FG003|Overall Study|Physician Decision|0|||
46889047|NCT03084718|83111509|FG004|Overall Study|Physician Decision|0|||
46889048|NCT03084718|83111505|FG000|Overall Study|Adverse Event|3|||
46889049|NCT03084718|83111506|FG001|Overall Study|Adverse Event|5|||
46889050|NCT03084718|83111507|FG002|Overall Study|Adverse Event|5|||
46889051|NCT03084718|83111508|FG003|Overall Study|Adverse Event|8|||
46889052|NCT03084718|83111509|FG004|Overall Study|Adverse Event|2|||
46889053|NCT03084718|83111505|FG000|Overall Study|Lack of Efficacy|2|||
46889054|NCT03084718|83111506|FG001|Overall Study|Lack of Efficacy|0|||
46889055|NCT03084718|83111507|FG002|Overall Study|Lack of Efficacy|1|||
46889056|NCT03084718|83111508|FG003|Overall Study|Lack of Efficacy|4|||
46889057|NCT03084718|83111509|FG004|Overall Study|Lack of Efficacy|0|||
46889058|NCT03084718|83111505|FG000|Overall Study|Lost to Follow-up|0|||
46889059|NCT03084718|83111506|FG001|Overall Study|Lost to Follow-up|1|||
46889060|NCT03084718|83111507|FG002|Overall Study|Lost to Follow-up|0|||
46889061|NCT03084718|83111508|FG003|Overall Study|Lost to Follow-up|0|||
46889062|NCT03084718|83111509|FG004|Overall Study|Lost to Follow-up|2|||
46889063|NCT03084718|83111505|FG000|Overall Study|Protocol Violation|0|||
46889064|NCT03084718|83111506|FG001|Overall Study|Protocol Violation|0|||
46889065|NCT03084718|83111507|FG002|Overall Study|Protocol Violation|1|||
46889066|NCT03084718|83111508|FG003|Overall Study|Protocol Violation|0|||
46889067|NCT03084718|83111509|FG004|Overall Study|Protocol Violation|0|||
46889068|NCT03084718|83111505|FG000|Overall Study|Death|0|||
46889069|NCT03084718|83111506|FG001|Overall Study|Death|1|||
46889070|NCT03084718|83111507|FG002|Overall Study|Death|0|||
46889071|NCT03084718|83111508|FG003|Overall Study|Death|0|||
46889072|NCT03084718|83111509|FG004|Overall Study|Death|0|||
46889073|NCT03084718|83111505|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
46889074|NCT03084718|83111506|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
46889075|NCT03084718|83111507|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
46889076|NCT03084718|83111508|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
46889077|NCT03084718|83111509|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
46889078|NCT04321252|83111533|FG000|Overall Study|Withdrawal by Subject|0|||
46889079|NCT04321252|83111534|FG001|Overall Study|Withdrawal by Subject|0|||
46889080|NCT04321252|83111535|FG002|Overall Study|Withdrawal by Subject|0|||
46889081|NCT04321252|83111536|FG003|Overall Study|Withdrawal by Subject|0|||
46889082|NCT04321252|83111537|FG004|Overall Study|Withdrawal by Subject|0|||
46889083|NCT04321252|83111538|FG005|Overall Study|Withdrawal by Subject|1|||
46889084|NCT04321252|83111539|FG006|Overall Study|Withdrawal by Subject|0|||
46889085|NCT04321252|83111540|FG007|Overall Study|Withdrawal by Subject|0|||
46889086|NCT04321252|83111541|FG008|Overall Study|Withdrawal by Subject|0|||
46889087|NCT03433677|83111573|FG000|Period 1|Protocol Violation|1|||
46889088|NCT03433677|83111574|FG001|Period 1|Protocol Violation|0|||
46889089|NCT03433677|83111573|FG000|Period 2|Withdrawal by Subject|1|||
46889090|NCT03433677|83111574|FG001|Period 2|Withdrawal by Subject|1|||
46889091|NCT02492711|83111584|FG000|Overall Study|Adverse Event|9|||
46889092|NCT02492711|83111585|FG001|Overall Study|Adverse Event|9|||
46889093|NCT02492711|83111586|FG002|Overall Study|Adverse Event|2|||
46889094|NCT02492711|83111584|FG000|Overall Study|Death|3|||
46889095|NCT02492711|83111585|FG001|Overall Study|Death|3|||
46889096|NCT02492711|83111586|FG002|Overall Study|Death|0|||
46889097|NCT02492711|83111584|FG000|Overall Study|Withdrawal by Subject|10|||
46889098|NCT02492711|83111585|FG001|Overall Study|Withdrawal by Subject|16|||
46889099|NCT02492711|83111586|FG002|Overall Study|Withdrawal by Subject|5|||
46889100|NCT02492711|83111584|FG000|Overall Study|Physician Decision|10|||
46889101|NCT02492711|83111585|FG001|Overall Study|Physician Decision|6|||
46889102|NCT02492711|83111586|FG002|Overall Study|Physician Decision|4|||
46889103|NCT02492711|83111584|FG000|Overall Study|Lost to Follow-up|0|||
46889104|NCT02492711|83111585|FG001|Overall Study|Lost to Follow-up|0|||
46889105|NCT02492711|83111586|FG002|Overall Study|Lost to Follow-up|1|||
46889106|NCT02492711|83111584|FG000|Overall Study|study treatment delay|2|||
46889107|NCT02492711|83111585|FG001|Overall Study|study treatment delay|1|||
46889108|NCT02492711|83111586|FG002|Overall Study|study treatment delay|0|||
46889109|NCT02492711|83111584|FG000|Overall Study|change in chemotherapy|0|||
46889110|NCT02492711|83111585|FG001|Overall Study|change in chemotherapy|1|||
46889111|NCT02492711|83111586|FG002|Overall Study|change in chemotherapy|0|||
46889112|NCT02492711|83111584|FG000|Overall Study|never treated|2|||
46889113|NCT02492711|83111585|FG001|Overall Study|never treated|4|||
46889114|NCT02492711|83111586|FG002|Overall Study|never treated|0|||
46889115|NCT02492711|83111584|FG000|Overall Study|Other|0|||
46889116|NCT02492711|83111585|FG001|Overall Study|Other|0|||
46889117|NCT02492711|83111586|FG002|Overall Study|Other|1|||
46889118|NCT01147822|83111601|FG000|Overall Study|Death|66|||
46889119|NCT01147822|83111602|FG001|Overall Study|Death|59|||
46889120|NCT01147822|83111601|FG000|Overall Study|Protocol Violation|0|||
46889121|NCT01147822|83111602|FG001|Overall Study|Protocol Violation|1|||
46889122|NCT01147822|83111601|FG000|Overall Study|Lost to Follow-up|3|||
46889123|NCT01147822|83111602|FG001|Overall Study|Lost to Follow-up|2|||
46889124|NCT01147822|83111601|FG000|Overall Study|Physician Decision|0|||
46889125|NCT01147822|83111602|FG001|Overall Study|Physician Decision|2|||
46889126|NCT01147822|83111601|FG000|Overall Study|Withdrawal by Subject|8|||
46889127|NCT01147822|83111602|FG001|Overall Study|Withdrawal by Subject|13|||
46889128|NCT01147822|83111601|FG000|Overall Study|Not Completed/Ongoing|111|||
46889129|NCT01147822|83111602|FG001|Overall Study|Not Completed/Ongoing|102|||
46889130|NCT03431337|83111610|FG000|Overall Study|Lost to Follow-up|21|||
46889131|NCT03431337|83111611|FG001|Overall Study|Lost to Follow-up|19|||
46889132|NCT03431337|83111610|FG000|Overall Study|Withdrawal by Subject|8|||
46889133|NCT03431337|83111611|FG001|Overall Study|Withdrawal by Subject|3|||
46889134|NCT03738241|83111631|FG000|Overall Study|Withdrawal by Subject|0|||
46889135|NCT03738241|83111632|FG001|Overall Study|Withdrawal by Subject|0|||
46889136|NCT03738241|83111633|FG002|Overall Study|Withdrawal by Subject|0|||
46889137|NCT03738241|83111634|FG003|Overall Study|Withdrawal by Subject|0|||
46889138|NCT03738241|83111635|FG004|Overall Study|Withdrawal by Subject|0|||
46889139|NCT03738241|83111636|FG005|Overall Study|Withdrawal by Subject|0|||
46889140|NCT03738241|83111637|FG006|Overall Study|Withdrawal by Subject|0|||
46889141|NCT03738241|83111638|FG007|Overall Study|Withdrawal by Subject|0|||
46889142|NCT03738241|83111639|FG008|Overall Study|Withdrawal by Subject|0|||
46889143|NCT03738241|83111640|FG009|Overall Study|Withdrawal by Subject|1|||
46889144|NCT03738241|83111631|FG000|Overall Study|Physician Decision|0|||
46889145|NCT03738241|83111632|FG001|Overall Study|Physician Decision|0|||
46889146|NCT03738241|83111633|FG002|Overall Study|Physician Decision|0|||
46889147|NCT03738241|83111634|FG003|Overall Study|Physician Decision|0|||
46889148|NCT03738241|83111635|FG004|Overall Study|Physician Decision|0|||
46889149|NCT03738241|83111636|FG005|Overall Study|Physician Decision|0|||
46889150|NCT03738241|83111637|FG006|Overall Study|Physician Decision|0|||
46889151|NCT03738241|83111638|FG007|Overall Study|Physician Decision|0|||
46889152|NCT03738241|83111639|FG008|Overall Study|Physician Decision|1|||
46889153|NCT03738241|83111640|FG009|Overall Study|Physician Decision|0|||
46889154|NCT03738241|83111631|FG000|Overall Study|Adverse Event|1|||
46889155|NCT03738241|83111632|FG001|Overall Study|Adverse Event|0|||
46889156|NCT03738241|83111633|FG002|Overall Study|Adverse Event|0|||
46889157|NCT03738241|83111634|FG003|Overall Study|Adverse Event|0|||
46889158|NCT03738241|83111635|FG004|Overall Study|Adverse Event|0|||
46889159|NCT03738241|83111636|FG005|Overall Study|Adverse Event|0|||
46889160|NCT03738241|83111637|FG006|Overall Study|Adverse Event|0|||
46889161|NCT03738241|83111638|FG007|Overall Study|Adverse Event|0|||
46889162|NCT03738241|83111639|FG008|Overall Study|Adverse Event|0|||
46889163|NCT03738241|83111640|FG009|Overall Study|Adverse Event|0|||
46889164|NCT03430245|83111662|FG000|Overall Study|Withdrawal by Subject|6|||
46889165|NCT03430245|83111662|FG000|Overall Study|Lost to Follow-up|1|||
46889166|NCT03461289|83111666|FG000|Overall Study|Death|1|||
46889167|NCT03452943|83111672|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
46889168|NCT03452943|83111673|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
46889169|NCT03452943|83111672|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
46889170|NCT03452943|83111673|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
46889171|NCT03452943|83111672|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
46889172|NCT03452943|83111673|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
46889173|NCT03452943|83111672|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
46889174|NCT03452943|83111673|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
46889175|NCT03452943|83111672|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
46889176|NCT03452943|83111673|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
46889177|NCT03452943|83111672|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
46889178|NCT03452943|83111673|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
46889179|NCT03481725|83111681|FG000|Overall Study|Withdrawal by Subject|1|||
46889180|NCT03481725|83111682|FG001|Overall Study|Withdrawal by Subject|0|||
46889181|NCT03480243|83111690|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
46889182|NCT03480243|83111690|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
46889183|NCT03426345|83111705|FG000|Overall Study|Adverse Event|4|||
46889184|NCT03426345|83111706|FG001|Overall Study|Adverse Event|4|||
46889185|NCT03426345|83111705|FG000|Overall Study|Lack of Efficacy|1|||
46889186|NCT03426345|83111706|FG001|Overall Study|Lack of Efficacy|0|||
46889187|NCT03426345|83111705|FG000|Overall Study|Withdrawal by Subject|5|||
46889188|NCT03426345|83111706|FG001|Overall Study|Withdrawal by Subject|6|||
46889189|NCT03426345|83111705|FG000|Overall Study|Lost to Follow-up|3|||
46889190|NCT03426345|83111706|FG001|Overall Study|Lost to Follow-up|1|||
46889191|NCT03426345|83111705|FG000|Overall Study|Protocol Deviation|3|||
46889192|NCT03426345|83111706|FG001|Overall Study|Protocol Deviation|4|||
46889193|NCT03426345|83111705|FG000|Overall Study|Reason Not Specified|1|||
46889194|NCT03426345|83111706|FG001|Overall Study|Reason Not Specified|2|||
46889195|NCT03426345|83111705|FG000|Overall Study|Missing Completion Status|1|||
46889196|NCT03426345|83111706|FG001|Overall Study|Missing Completion Status|0|||
46889197|NCT03426267|83111715|FG000|Overall Study|Physician Decision|1|||
46889198|NCT03426267|83111716|FG001|Overall Study|Physician Decision|4|||
46889199|NCT03426267|83111715|FG000|Overall Study|Lost to Follow-up|1|||
46889200|NCT03426267|83111716|FG001|Overall Study|Lost to Follow-up|0|||
46889201|NCT03426267|83111715|FG000|Overall Study|Withdrawal by Subject|4|||
46889202|NCT03426267|83111716|FG001|Overall Study|Withdrawal by Subject|10|||
46889203|NCT03426267|83111715|FG000|Overall Study|Protocol Violation|1|||
46889204|NCT03426267|83111716|FG001|Overall Study|Protocol Violation|3|||
46889205|NCT03426267|83111715|FG000|Overall Study|Adverse Event|9|||
46889206|NCT03426267|83111716|FG001|Overall Study|Adverse Event|27|||
46889207|NCT03426267|83111715|FG000|Overall Study|Prohibited Treatment Intake|2|||
46889208|NCT03426267|83111716|FG001|Overall Study|Prohibited Treatment Intake|3|||
46889209|NCT03426267|83111715|FG000|Overall Study|Lack of Efficacy|0|||
46889210|NCT03426267|83111716|FG001|Overall Study|Lack of Efficacy|25|||
46889211|NCT03426267|83111715|FG000|Overall Study|other|3|||
46889212|NCT03426267|83111716|FG001|Overall Study|other|0|||
46889213|NCT03412929|83111722|FG000|Overall Study|Protocol Violation|3|||
46889214|NCT03451773|83111728|FG000|Overall Study|Death on study|1|||
46889215|NCT03451773|83111729|FG001|Overall Study|Death on study|5|||
46889216|NCT03451773|83111728|FG000|Overall Study|Death during follow-up period|0|||
46889217|NCT03451773|83111729|FG001|Overall Study|Death during follow-up period|1|||
46889218|NCT03425253|83111736|FG000|Overall Study|Adverse Event|2|||
46889219|NCT03425253|83111736|FG000|Overall Study|Lost to Follow-up|3|||
46889220|NCT03425253|83111736|FG000|Overall Study|Withdrew Consent|6|||
46889221|NCT03425253|83111736|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
46889222|NCT03424239|83111741|FG000|Overall Study|Withdrawal by Subject|2|||
46889223|NCT03451071|83111745|FG000|First Vaccine|Withdrawal by Subject|1|||
46889224|NCT03451071|83111745|FG000|Second Vaccine|Lost to Follow-up|19|||
46889225|NCT03451071|83111745|FG000|Third Vaccine|Lost to Follow-up|22|||
46889226|NCT03451071|83111745|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
46889227|NCT03449979|83111753|FG000|Overall Study|Technical difficulty|0|||
46889228|NCT03449979|83111754|FG001|Overall Study|Technical difficulty|0|||
46889229|NCT03449979|83111755|FG002|Overall Study|Technical difficulty|0|||
46889230|NCT03449979|83111756|FG003|Overall Study|Technical difficulty|1|||
46889231|NCT03449199|83111769|FG000|Overall Study|Lost to Follow-up|1|||
46889232|NCT03449199|83111770|FG001|Overall Study|Lost to Follow-up|1|||
46889233|NCT03449199|83111771|FG002|Overall Study|Lost to Follow-up|0|||
46889234|NCT03449199|83111769|FG000|Overall Study|Protocol Deviation|0|||
46889235|NCT03449199|83111770|FG001|Overall Study|Protocol Deviation|0|||
46889236|NCT03449199|83111771|FG002|Overall Study|Protocol Deviation|1|||
46889237|NCT03449199|83111769|FG000|Overall Study|Withdrawal by Subject|0|||
46889238|NCT03449199|83111770|FG001|Overall Study|Withdrawal by Subject|0|||
46889239|NCT03449199|83111771|FG002|Overall Study|Withdrawal by Subject|1|||
46889240|NCT03421431|83111785|FG000|Overall Study|Adverse Event|2|||
46889241|NCT03421431|83111786|FG001|Overall Study|Adverse Event|1|||
46889242|NCT03421431|83111787|FG002|Overall Study|Adverse Event|12|||
46889243|NCT03421431|83111785|FG000|Overall Study|Lost to Follow-up|1|||
46889244|NCT03421431|83111786|FG001|Overall Study|Lost to Follow-up|1|||
46889245|NCT03421431|83111787|FG002|Overall Study|Lost to Follow-up|1|||
46889246|NCT03421431|83111785|FG000|Overall Study|Withdrawal by Subject|3|||
46889247|NCT03421431|83111786|FG001|Overall Study|Withdrawal by Subject|2|||
46889248|NCT03421431|83111787|FG002|Overall Study|Withdrawal by Subject|1|||
46889249|NCT03421431|83111785|FG000|Overall Study|Protocol Violation|0|||
46889250|NCT03421431|83111786|FG001|Overall Study|Protocol Violation|1|||
46889251|NCT03421431|83111787|FG002|Overall Study|Protocol Violation|0|||
46889252|NCT03421431|83111785|FG000|Overall Study|Participant met Stopping Rules|0|||
46889253|NCT03421431|83111786|FG001|Overall Study|Participant met Stopping Rules|1|||
46889254|NCT03421431|83111787|FG002|Overall Study|Participant met Stopping Rules|0|||
46889255|NCT03448419|83111799|FG000|Overall Study|Adverse Event|10|||
46889256|NCT03448419|83111800|FG001|Overall Study|Adverse Event|9|||
46889257|NCT03448419|83111799|FG000|Overall Study|Lost to Follow-up|0|||
46889258|NCT03448419|83111800|FG001|Overall Study|Lost to Follow-up|2|||
46889259|NCT03448419|83111799|FG000|Overall Study|Withdrawal by Subject|3|||
46889260|NCT03448419|83111800|FG001|Overall Study|Withdrawal by Subject|1|||
46889261|NCT03448419|83111799|FG000|Overall Study|Not treated|0|||
46889262|NCT03448419|83111800|FG001|Overall Study|Not treated|1|||
46889263|NCT03448419|83111799|FG000|Overall Study|Patient did not attend all visits|0|||
46889264|NCT03448419|83111800|FG001|Overall Study|Patient did not attend all visits|2|||
46889265|NCT03448419|83111799|FG000|Overall Study|Withdrawn by Sponsor|0|||
46889266|NCT03448419|83111800|FG001|Overall Study|Withdrawn by Sponsor|1|||
46889267|NCT04816214|83111817|FG000|Overall Study|Progressive Disease|4|||
46889268|NCT04816214|83111818|FG001|Overall Study|Progressive Disease|0|||
46889269|NCT04816214|83111819|FG002|Overall Study|Progressive Disease|0|||
46889270|NCT04816214|83111817|FG000|Overall Study|Death|1|||
46889271|NCT04816214|83111818|FG001|Overall Study|Death|0|||
46889272|NCT04816214|83111819|FG002|Overall Study|Death|0|||
46889273|NCT04816214|83111817|FG000|Overall Study|Study Terminated by Sponsor|1|||
46889274|NCT04816214|83111818|FG001|Overall Study|Study Terminated by Sponsor|0|||
46889275|NCT04816214|83111819|FG002|Overall Study|Study Terminated by Sponsor|0|||
46889276|NCT04350827|83111864|FG000|Overall Study|Lost to Follow-up|1|||
46889277|NCT04350827|83111865|FG001|Overall Study|Lost to Follow-up|2|||
46889278|NCT04303000|83111873|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
46889279|NCT04303000|83111874|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
46889280|NCT04303000|83111875|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
46889281|NCT04212650|83111896|FG000|Overall Study|Withdrawal by Subject|1|||
46889282|NCT04212650|83111897|FG001|Overall Study|Withdrawal by Subject|0|||
46889283|NCT03992196|83111943|FG000|Enrollment|lost to follow-up prior dosing|1|||
46889284|NCT03992196|83111944|FG001|Enrollment|lost to follow-up prior dosing|0|||
46889285|NCT03992196|83111945|FG002|Enrollment|lost to follow-up prior dosing|0|||
46889286|NCT03992196|83111943|FG000|Treatment|Protocol Violation|0|||
46889287|NCT03992196|83111944|FG001|Treatment|Protocol Violation|0|||
46889288|NCT03992196|83111945|FG002|Treatment|Protocol Violation|1|||
46889289|NCT03992196|83111943|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
46889290|NCT03992196|83111944|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
46889291|NCT03992196|83111945|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
46889292|NCT03992196|83111943|FG000|Treatment|Withdrawal due to non-compliance|0|||
46889293|NCT03992196|83111944|FG001|Treatment|Withdrawal due to non-compliance|0|||
46889294|NCT03992196|83111945|FG002|Treatment|Withdrawal due to non-compliance|1|||
46889295|NCT03992196|83111943|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
46889296|NCT03992196|83111944|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
46889297|NCT03992196|83111945|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
46889298|NCT03992196|83111943|FG000|Treatment|Withdrawal by parent/guardian|0|||
46889299|NCT03992196|83111944|FG001|Treatment|Withdrawal by parent/guardian|0|||
46889300|NCT03992196|83111945|FG002|Treatment|Withdrawal by parent/guardian|2|||
46889301|NCT03970200|83111954|FG000|Overall Study|Death|2|||
46889302|NCT03970200|83111955|FG001|Overall Study|Death|2|||
46889303|NCT03970200|83111956|FG002|Overall Study|Death|1|||
46889304|NCT03970200|83111954|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
46889305|NCT03970200|83111955|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
46889306|NCT03970200|83111956|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
46889307|NCT03840200|83111968|FG000|Overall Study|Death|6|||
46889308|NCT03840200|83111969|FG001|Overall Study|Death|3|||
46889309|NCT03840200|83111970|FG002|Overall Study|Death|6|||
46889310|NCT03840200|83111971|FG003|Overall Study|Death|10|||
46889311|NCT03840200|83111968|FG000|Overall Study|Reason Not Specified|2|||
46889312|NCT03840200|83111969|FG001|Overall Study|Reason Not Specified|2|||
46889313|NCT03840200|83111970|FG002|Overall Study|Reason Not Specified|1|||
46889314|NCT03840200|83111971|FG003|Overall Study|Reason Not Specified|15|||
46889315|NCT03840200|83111968|FG000|Overall Study|Physician Decision|0|||
46889316|NCT03840200|83111969|FG001|Overall Study|Physician Decision|0|||
46889317|NCT03840200|83111970|FG002|Overall Study|Physician Decision|0|||
46889318|NCT03840200|83111971|FG003|Overall Study|Physician Decision|2|||
46889319|NCT03840200|83111968|FG000|Overall Study|Progressive Disease|0|||
46889320|NCT03840200|83111969|FG001|Overall Study|Progressive Disease|0|||
46889321|NCT03840200|83111970|FG002|Overall Study|Progressive Disease|0|||
46889322|NCT03840200|83111971|FG003|Overall Study|Progressive Disease|1|||
46889323|NCT03840200|83111968|FG000|Overall Study|Withdrawal by Subject|0|||
46889324|NCT03840200|83111969|FG001|Overall Study|Withdrawal by Subject|1|||
46889325|NCT03840200|83111970|FG002|Overall Study|Withdrawal by Subject|0|||
46991449|NCT02121795|83238490|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
46991450|NCT02121795|83238489|FG000|Double-Blind Phase|Lost to Follow-up|7|||
46889326|NCT03840200|83111971|FG003|Overall Study|Withdrawal by Subject|2|||
46889327|NCT03334851|83112004|FG000|Overall Study|Other|0|||
46889328|NCT03334851|83112005|FG001|Overall Study|Other|0|||
46889329|NCT03334851|83112006|FG002|Overall Study|Other|0|||
46889330|NCT03334851|83112007|FG003|Overall Study|Other|0|||
46889331|NCT03334851|83112008|FG004|Overall Study|Other|0|||
46889332|NCT03334851|83112009|FG005|Overall Study|Other|0|||
46889333|NCT03334851|83112010|FG006|Overall Study|Other|0|||
46889334|NCT03334851|83112011|FG007|Overall Study|Other|1|||
46889335|NCT03334851|83112012|FG008|Overall Study|Other|0|||
46991451|NCT02121795|83238490|FG001|Double-Blind Phase|Lost to Follow-up|4|||
46889336|NCT03334851|83112013|FG009|Overall Study|Other|0|||
46889337|NCT03334851|83112014|FG010|Overall Study|Other|0|||
46889338|NCT03334851|83112015|FG011|Overall Study|Other|0|||
46889339|NCT03334851|83112016|FG012|Overall Study|Other|0|||
46889340|NCT03334851|83112004|FG000|Overall Study|Adverse Event|0|||
46889341|NCT03334851|83112005|FG001|Overall Study|Adverse Event|0|||
46889342|NCT03334851|83112006|FG002|Overall Study|Adverse Event|0|||
46889343|NCT03334851|83112007|FG003|Overall Study|Adverse Event|0|||
46889344|NCT03334851|83112008|FG004|Overall Study|Adverse Event|0|||
46889345|NCT03334851|83112009|FG005|Overall Study|Adverse Event|0|||
46889346|NCT03334851|83112010|FG006|Overall Study|Adverse Event|0|||
46889347|NCT03334851|83112011|FG007|Overall Study|Adverse Event|1|||
46889348|NCT03334851|83112012|FG008|Overall Study|Adverse Event|0|||
46889349|NCT03334851|83112013|FG009|Overall Study|Adverse Event|0|||
46889350|NCT03334851|83112014|FG010|Overall Study|Adverse Event|0|||
46889351|NCT03334851|83112015|FG011|Overall Study|Adverse Event|0|||
46889352|NCT03334851|83112016|FG012|Overall Study|Adverse Event|0|||
46889353|NCT03334851|83112004|FG000|Overall Study|Withdrawal by Subject|0|||
46889354|NCT03334851|83112005|FG001|Overall Study|Withdrawal by Subject|0|||
46889355|NCT03334851|83112006|FG002|Overall Study|Withdrawal by Subject|0|||
46889356|NCT03334851|83112007|FG003|Overall Study|Withdrawal by Subject|0|||
46889357|NCT03334851|83112008|FG004|Overall Study|Withdrawal by Subject|0|||
46889358|NCT03334851|83112009|FG005|Overall Study|Withdrawal by Subject|0|||
46889359|NCT03334851|83112010|FG006|Overall Study|Withdrawal by Subject|0|||
46889360|NCT03334851|83112011|FG007|Overall Study|Withdrawal by Subject|0|||
46889361|NCT03334851|83112012|FG008|Overall Study|Withdrawal by Subject|0|||
46889362|NCT03334851|83112013|FG009|Overall Study|Withdrawal by Subject|0|||
46889363|NCT03334851|83112014|FG010|Overall Study|Withdrawal by Subject|1|||
46889364|NCT03334851|83112015|FG011|Overall Study|Withdrawal by Subject|0|||
46889365|NCT03334851|83112016|FG012|Overall Study|Withdrawal by Subject|1|||
46889366|NCT03334851|83112004|FG000|Overall Study|Lost to Follow-up|0|||
46889367|NCT03334851|83112005|FG001|Overall Study|Lost to Follow-up|0|||
46889368|NCT03334851|83112006|FG002|Overall Study|Lost to Follow-up|0|||
46889369|NCT03334851|83112007|FG003|Overall Study|Lost to Follow-up|0|||
46889370|NCT03334851|83112008|FG004|Overall Study|Lost to Follow-up|0|||
46889371|NCT03334851|83112009|FG005|Overall Study|Lost to Follow-up|0|||
46889372|NCT03334851|83112010|FG006|Overall Study|Lost to Follow-up|0|||
46889373|NCT03334851|83112011|FG007|Overall Study|Lost to Follow-up|0|||
46889374|NCT03334851|83112012|FG008|Overall Study|Lost to Follow-up|0|||
46889375|NCT03334851|83112013|FG009|Overall Study|Lost to Follow-up|0|||
46889376|NCT03334851|83112014|FG010|Overall Study|Lost to Follow-up|2|||
46889377|NCT03334851|83112015|FG011|Overall Study|Lost to Follow-up|1|||
46889378|NCT03334851|83112016|FG012|Overall Study|Lost to Follow-up|0|||
46889379|NCT02717507|83112078|FG000|Overall Study|Lost to Follow-up|5|||
46889380|NCT02717507|83112079|FG001|Overall Study|Lost to Follow-up|8|||
46889381|NCT02717507|83112078|FG000|Overall Study|Pregnancy|1|||
46889382|NCT02717507|83112079|FG001|Overall Study|Pregnancy|1|||
46889383|NCT02717507|83112078|FG000|Overall Study|Protocol Violation|2|||
46889384|NCT02717507|83112079|FG001|Overall Study|Protocol Violation|2|||
46889385|NCT02717507|83112078|FG000|Overall Study|Withdrawal by Subject|20|||
46889386|NCT02717507|83112079|FG001|Overall Study|Withdrawal by Subject|20|||
46889387|NCT02717507|83112078|FG000|Overall Study|Relapse|1|||
46889388|NCT02717507|83112079|FG001|Overall Study|Relapse|1|||
46889389|NCT02717507|83112078|FG000|Overall Study|Cardiac Event|2|||
46889390|NCT02717507|83112079|FG001|Overall Study|Cardiac Event|6|||
46889391|NCT02470585|83112102|FG000|Overall Study|Death|82|||
46889392|NCT02470585|83112103|FG001|Overall Study|Death|87|||
46889393|NCT02470585|83112104|FG002|Overall Study|Death|86|||
46889394|NCT02470585|83112102|FG000|Overall Study|Withdrawal by Subject|19|||
46889395|NCT02470585|83112103|FG001|Overall Study|Withdrawal by Subject|21|||
46889396|NCT02470585|83112104|FG002|Overall Study|Withdrawal by Subject|29|||
46889397|NCT02470585|83112102|FG000|Overall Study|Lost to Follow-up|2|||
46889398|NCT02470585|83112103|FG001|Overall Study|Lost to Follow-up|5|||
46889399|NCT02470585|83112104|FG002|Overall Study|Lost to Follow-up|4|||
46889400|NCT02470585|83112102|FG000|Overall Study|Other|4|||
46889401|NCT02470585|83112103|FG001|Overall Study|Other|4|||
46889402|NCT02470585|83112104|FG002|Overall Study|Other|6|||
46889403|NCT02199080|83112129|FG000|Overall Study|Protocol Violation|12|||
46889404|NCT02173379|83112137|FG000|Overall Study|Lost to Follow-up|89|||
46889405|NCT02173379|83112138|FG001|Overall Study|Lost to Follow-up|81|||
46889406|NCT02173379|83112137|FG000|Overall Study|Withdrawal by Subject|24|||
46889407|NCT02173379|83112138|FG001|Overall Study|Withdrawal by Subject|29|||
46889408|NCT02173379|83112137|FG000|Overall Study|Physician Decision|8|||
46889409|NCT02173379|83112138|FG001|Overall Study|Physician Decision|8|||
46889410|NCT02173379|83112137|FG000|Overall Study|Death|75|||
46889411|NCT02173379|83112138|FG001|Overall Study|Death|72|||
46889412|NCT02173379|83112137|FG000|Overall Study|Other Reason|1|||
46889413|NCT02173379|83112138|FG001|Overall Study|Other Reason|0|||
46889414|NCT02134925|83112149|FG000|Overall Study|Withdrawal by Subject|1|||
46889415|NCT02134925|83112150|FG001|Overall Study|Withdrawal by Subject|0|||
46889416|NCT02134925|83112149|FG000|Overall Study|Cancel|1|||
46889417|NCT02134925|83112150|FG001|Overall Study|Cancel|6|||
46889418|NCT01849874|83112158|FG000|Overall Study|Death|89|||
46889419|NCT01849874|83112159|FG001|Overall Study|Death|42|||
46889420|NCT01849874|83112158|FG000|Overall Study|Withdrawal by Subject|17|||
46889421|NCT01849874|83112159|FG001|Overall Study|Withdrawal by Subject|16|||
46889422|NCT01849874|83112158|FG000|Overall Study|Lost to Follow-up|3|||
46889423|NCT01849874|83112159|FG001|Overall Study|Lost to Follow-up|2|||
46889424|NCT01849874|83112158|FG000|Overall Study|Study Termination By Sponsor|93|||
46889425|NCT01849874|83112159|FG001|Overall Study|Study Termination By Sponsor|48|||
46889426|NCT01849874|83112158|FG000|Overall Study|Completed as per protocol amendment 6|3|||
46889427|NCT01849874|83112159|FG001|Overall Study|Completed as per protocol amendment 6|0|||
46889428|NCT01849874|83112158|FG000|Overall Study|Physician Decision|7|||
46889429|NCT01849874|83112159|FG001|Overall Study|Physician Decision|1|||
46889430|NCT01849874|83112158|FG000|Overall Study|Other|16|||
46889431|NCT01849874|83112159|FG001|Overall Study|Other|4|||
46889432|NCT01771107|83112172|FG000|Overall Study|Adverse Event|1|||
46889433|NCT01771107|83112173|FG001|Overall Study|Adverse Event|3|||
46889434|NCT01771107|83112172|FG000|Overall Study|Withdrawal by Subject|0|||
46889435|NCT01771107|83112173|FG001|Overall Study|Withdrawal by Subject|2|||
46889436|NCT01771107|83112172|FG000|Overall Study|Lost to Follow-up|0|||
46889437|NCT01771107|83112173|FG001|Overall Study|Lost to Follow-up|1|||
46889438|NCT01771107|83112172|FG000|Overall Study|participant moved|0|||
46889439|NCT01771107|83112173|FG001|Overall Study|participant moved|1|||
46889440|NCT01771107|83112172|FG000|Overall Study|Other|0|||
46889441|NCT01771107|83112173|FG001|Overall Study|Other|1|||
46889442|NCT01375114|83112184|FG000|Overall Study|Lost to Follow-up|1|||
46889443|NCT01375114|83112185|FG001|Overall Study|Lost to Follow-up|0|||
46889444|NCT01375114|83112186|FG002|Overall Study|Lost to Follow-up|1|||
46889445|NCT01375114|83112184|FG000|Overall Study|Disease Progression|3|||
46889446|NCT01375114|83112185|FG001|Overall Study|Disease Progression|2|||
46889447|NCT01375114|83112186|FG002|Overall Study|Disease Progression|2|||
46889448|NCT01375114|83112184|FG000|Overall Study|Patient Changed Mind|0|||
46889449|NCT01375114|83112185|FG001|Overall Study|Patient Changed Mind|0|||
46889450|NCT01375114|83112186|FG002|Overall Study|Patient Changed Mind|2|||
46889451|NCT01375114|83112184|FG000|Overall Study|Pruritus|0|||
46889452|NCT01375114|83112185|FG001|Overall Study|Pruritus|0|||
46889453|NCT01375114|83112186|FG002|Overall Study|Pruritus|1|||
46889454|NCT01375114|83112184|FG000|Overall Study|Restlessness|0|||
46889455|NCT01375114|83112185|FG001|Overall Study|Restlessness|0|||
46889456|NCT01375114|83112186|FG002|Overall Study|Restlessness|1|||
46889457|NCT01375114|83112184|FG000|Overall Study|Diarrhea|0|||
46889458|NCT01375114|83112185|FG001|Overall Study|Diarrhea|0|||
46889459|NCT01375114|83112186|FG002|Overall Study|Diarrhea|1|||
46889460|NCT01375114|83112184|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
46889461|NCT01375114|83112185|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
46889462|NCT01375114|83112186|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
46889463|NCT01375114|83112184|FG000|Overall Study|Nausea|0|||
46889464|NCT01375114|83112185|FG001|Overall Study|Nausea|1|||
46889465|NCT01375114|83112186|FG002|Overall Study|Nausea|0|||
46889466|NCT01375114|83112184|FG000|Overall Study|Increased AST/ALT|0|||
46889467|NCT01375114|83112185|FG001|Overall Study|Increased AST/ALT|1|||
46889468|NCT01375114|83112186|FG002|Overall Study|Increased AST/ALT|0|||
46889469|NCT01375114|83112184|FG000|Overall Study|Vaginal Hemorrhage|0|||
46889470|NCT01375114|83112185|FG001|Overall Study|Vaginal Hemorrhage|1|||
46889471|NCT01375114|83112186|FG002|Overall Study|Vaginal Hemorrhage|0|||
46889472|NCT01375114|83112184|FG000|Overall Study|Family problem|0|||
46889473|NCT01375114|83112185|FG001|Overall Study|Family problem|1|||
46889474|NCT01375114|83112186|FG002|Overall Study|Family problem|0|||
46889475|NCT01375114|83112184|FG000|Overall Study|Protocol Violation|2|||
46889476|NCT01375114|83112185|FG001|Overall Study|Protocol Violation|0|||
46889477|NCT01375114|83112186|FG002|Overall Study|Protocol Violation|0|||
46889478|NCT01009645|83112200|FG000|Overall Study|Lost to Follow-up|2|||
46889479|NCT01009645|83112201|FG001|Overall Study|Lost to Follow-up|8|||
46889480|NCT01009645|83112202|FG002|Overall Study|Lost to Follow-up|4|||
46889481|NCT01009645|83112203|FG003|Overall Study|Lost to Follow-up|5|||
46889482|NCT00950846|83112213|FG000|Overall Study|Death|6|||
46889483|NCT00950846|83112213|FG000|Overall Study|Lost to Follow-up|3|||
46889484|NCT00950846|83112213|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
46889485|NCT03419403|83112220|FG000|Overall Study|Withdrawal by Subject|5|||
46889486|NCT03419403|83112221|FG001|Overall Study|Withdrawal by Subject|2|||
46889487|NCT03419403|83112222|FG002|Overall Study|Withdrawal by Subject|5|||
46889488|NCT03419403|83112223|FG003|Overall Study|Withdrawal by Subject|1|||
46889489|NCT03419403|83112220|FG000|Overall Study|Progressive disease (per protocol)|0|||
46889490|NCT03419403|83112221|FG001|Overall Study|Progressive disease (per protocol)|2|||
46889491|NCT03419403|83112222|FG002|Overall Study|Progressive disease (per protocol)|2|||
46889492|NCT03419403|83112223|FG003|Overall Study|Progressive disease (per protocol)|0|||
46889493|NCT03419403|83112220|FG000|Overall Study|Other, not specified|6|||
46889494|NCT03419403|83112221|FG001|Overall Study|Other, not specified|4|||
46889495|NCT03419403|83112222|FG002|Overall Study|Other, not specified|5|||
46889496|NCT03419403|83112223|FG003|Overall Study|Other, not specified|1|||
46889497|NCT03419403|83112220|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
46889498|NCT03419403|83112221|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
46889499|NCT03419403|83112222|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
46889500|NCT03419403|83112223|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
46889501|NCT03447249|83112233|FG000|Overall Study|Adverse Event|1|||
46889502|NCT03447249|83112234|FG001|Overall Study|Adverse Event|0|||
46889503|NCT03447249|83112233|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
46889504|NCT03447249|83112234|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
46889505|NCT03447249|83112233|FG000|Overall Study|Other|3|||
46889506|NCT03447249|83112234|FG001|Overall Study|Other|0|||
46889507|NCT03418545|83112244|FG000|Overall Study|Withdrawal by Participant|2|||
46889508|NCT03418545|83112245|FG001|Overall Study|Withdrawal by Participant|4|||
46889509|NCT03418545|83112244|FG000|Overall Study|Lost to Follow-up|3|||
46889510|NCT03418545|83112245|FG001|Overall Study|Lost to Follow-up|5|||
46889511|NCT03418545|83112244|FG000|Overall Study|Reason Not Specified|0|||
46889512|NCT03418545|83112245|FG001|Overall Study|Reason Not Specified|1|||
46889513|NCT03418545|83112244|FG000|Overall Study|Missing Completion Status|0|||
46889514|NCT03418545|83112245|FG001|Overall Study|Missing Completion Status|1|||
46889515|NCT03446781|83112256|FG000|Overall Study|Lost to Follow-up|11|||
46889516|NCT03446781|83112257|FG001|Overall Study|Lost to Follow-up|5|||
46889517|NCT03446781|83112256|FG000|Overall Study|Withdrawal by Subject|9|||
46889518|NCT03446781|83112257|FG001|Overall Study|Withdrawal by Subject|7|||
46889519|NCT03446781|83112256|FG000|Overall Study|Adverse Event|8|||
46889520|NCT03446781|83112257|FG001|Overall Study|Adverse Event|2|||
46889521|NCT03446781|83112256|FG000|Overall Study|Protocol Violation|0|||
46889522|NCT03446781|83112257|FG001|Overall Study|Protocol Violation|3|||
46889523|NCT03445065|83112289|FG000|Overall Study|Withdrawal by Subject|3|||
46889524|NCT03445065|83112290|FG001|Overall Study|Withdrawal by Subject|6|||
46889525|NCT03445065|83112291|FG002|Overall Study|Withdrawal by Subject|2|||
46889526|NCT03445065|83112292|FG003|Overall Study|Withdrawal by Subject|2|||
46889527|NCT03445065|83112289|FG000|Overall Study|Other|4|||
46889528|NCT03445065|83112290|FG001|Overall Study|Other|3|||
46889529|NCT03445065|83112291|FG002|Overall Study|Other|3|||
46889530|NCT03445065|83112292|FG003|Overall Study|Other|1|||
46889531|NCT01224106|83112317|FG000|Double-Blind Treatment Phase|Death|3|||
46889532|NCT01224106|83112318|FG001|Double-Blind Treatment Phase|Death|0|||
46889533|NCT01224106|83112319|FG002|Double-Blind Treatment Phase|Death|0|||
46889534|NCT01224106|83112320|FG003|Double-Blind Treatment Phase|Death|0|||
46889535|NCT01224106|83112321|FG004|Double-Blind Treatment Phase|Death|0|||
46889536|NCT01224106|83112317|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
46889537|NCT01224106|83112318|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
46889538|NCT01224106|83112319|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
46889539|NCT01224106|83112320|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
46889540|NCT01224106|83112321|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
46889541|NCT01224106|83112317|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
46889542|NCT01224106|83112318|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
46889543|NCT01224106|83112319|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
46889544|NCT01224106|83112320|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
46889545|NCT01224106|83112321|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
46889546|NCT01224106|83112317|FG000|Double-Blind Treatment Phase|Other|0|||
46889547|NCT01224106|83112318|FG001|Double-Blind Treatment Phase|Other|0|||
46889548|NCT01224106|83112319|FG002|Double-Blind Treatment Phase|Other|1|||
46889549|NCT01224106|83112320|FG003|Double-Blind Treatment Phase|Other|0|||
46889550|NCT01224106|83112321|FG004|Double-Blind Treatment Phase|Other|0|||
46889551|NCT01224106|83112317|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
46889552|NCT01224106|83112318|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
46889553|NCT01224106|83112319|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
46889554|NCT01224106|83112320|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
46889555|NCT01224106|83112321|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
46889556|NCT01224106|83112317|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
46889557|NCT01224106|83112318|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
46889558|NCT01224106|83112319|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
46889559|NCT01224106|83112320|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
46889560|NCT01224106|83112321|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
46889561|NCT01224106|83112317|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
46889562|NCT01224106|83112318|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46889563|NCT01224106|83112319|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
46889564|NCT01224106|83112320|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46991452|NCT02121795|83238489|FG000|Double-Blind Phase|Physician Decision|2|||
46897659|NCT00706030|83123367|FG000|Overall Study|Failed to return|0|||
46889565|NCT01224106|83112321|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
46889566|NCT01224106|83112317|FG000|Open-Label Extension (OLE) Phase|Death|0|||
46889567|NCT01224106|83112318|FG001|Open-Label Extension (OLE) Phase|Death|0|||
46889568|NCT01224106|83112319|FG002|Open-Label Extension (OLE) Phase|Death|0|||
46889569|NCT01224106|83112320|FG003|Open-Label Extension (OLE) Phase|Death|1|||
46889570|NCT01224106|83112321|FG004|Open-Label Extension (OLE) Phase|Death|3|||
46889571|NCT01224106|83112317|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
46889572|NCT01224106|83112318|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
46889573|NCT01224106|83112319|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
46889574|NCT01224106|83112320|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
46889575|NCT01224106|83112321|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
46889576|NCT01224106|83112317|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
46889577|NCT01224106|83112318|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
46889578|NCT01224106|83112319|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
46889579|NCT01224106|83112320|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
46889580|NCT01224106|83112321|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
46889581|NCT01224106|83112317|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
46889582|NCT01224106|83112318|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
46889583|NCT01224106|83112319|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
46889584|NCT01224106|83112320|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
46889585|NCT01224106|83112321|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
46889586|NCT01224106|83112317|FG000|Open-Label Extension (OLE) Phase|Other|0|||
46889587|NCT01224106|83112318|FG001|Open-Label Extension (OLE) Phase|Other|0|||
46889588|NCT01224106|83112319|FG002|Open-Label Extension (OLE) Phase|Other|0|||
46889589|NCT01224106|83112320|FG003|Open-Label Extension (OLE) Phase|Other|5|||
46889590|NCT01224106|83112321|FG004|Open-Label Extension (OLE) Phase|Other|3|||
46889591|NCT03409107|83112341|FG000|Overall Study|Withdrawal by Subject|4|||
46889592|NCT03409107|83112342|FG001|Overall Study|Withdrawal by Subject|2|||
46889593|NCT03409107|83112341|FG000|Overall Study|Physician Decision|1|||
46889594|NCT03409107|83112342|FG001|Overall Study|Physician Decision|0|||
46889595|NCT03409107|83112341|FG000|Overall Study|Lost to Follow-up|7|||
46889596|NCT03409107|83112342|FG001|Overall Study|Lost to Follow-up|2|||
46889597|NCT03409107|83112341|FG000|Overall Study|Adverse Event|5|||
46889598|NCT03409107|83112342|FG001|Overall Study|Adverse Event|3|||
46889599|NCT03408873|83112356|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
46889600|NCT03408873|83112356|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
46889601|NCT03408873|83112356|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
46889602|NCT03408873|83112356|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
46889603|NCT03408873|83112356|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
46889604|NCT03408873|83112356|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
46889605|NCT03780959|83112363|FG000|Part 1|Adverse Event|1|||
46889606|NCT03780959|83112364|FG001|Part 1|Adverse Event|0|||
46889607|NCT03780959|83112365|FG002|Part 1|Adverse Event|0|||
46889608|NCT03780959|83112363|FG000|Part 1|Withdrawal by Subject|1|||
46889609|NCT03780959|83112364|FG001|Part 1|Withdrawal by Subject|0|||
46889610|NCT03780959|83112365|FG002|Part 1|Withdrawal by Subject|0|||
46889611|NCT03780959|83112363|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
46889612|NCT03780959|83112364|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
46889613|NCT03780959|83112365|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
46889614|NCT03780959|83112363|FG000|Part 1|Response Status|2|||
46889615|NCT03780959|83112364|FG001|Part 1|Response Status|0|||
46889616|NCT03780959|83112365|FG002|Part 1|Response Status|0|||
46889617|NCT03780959|83112363|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
46889618|NCT03780959|83112364|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
46889619|NCT03780959|83112365|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
46889620|NCT03780959|83112363|FG000|Part 2|Response Status|0|||
46889621|NCT03780959|83112364|FG001|Part 2|Response Status|18|||
46889622|NCT03780959|83112365|FG002|Part 2|Response Status|6|||
46889623|NCT03408639|83112377|FG000|Overall Study|Death|5|||
46889624|NCT03408639|83112378|FG001|Overall Study|Death|5|||
46889625|NCT03408639|83112377|FG000|Overall Study|Lost to Follow-up|1|||
46889626|NCT03408639|83112378|FG001|Overall Study|Lost to Follow-up|4|||
46889627|NCT03408639|83112377|FG000|Overall Study|Withdrawal by Subject|2|||
46889628|NCT03408639|83112378|FG001|Overall Study|Withdrawal by Subject|7|||
46889629|NCT03408639|83112377|FG000|Overall Study|Physician Decision|3|||
46889630|NCT03408639|83112378|FG001|Overall Study|Physician Decision|6|||
46889631|NCT03810235|83112386|FG000|Overall Study|Withdrawal by Subject|2|||
46889632|NCT03810235|83112387|FG001|Overall Study|Withdrawal by Subject|0|||
46889633|NCT03408483|83112396|FG000|Overall Study|Physician Decision|3|||
46889634|NCT03408483|83112397|FG001|Overall Study|Physician Decision|3|||
46889635|NCT03408483|83112396|FG000|Overall Study|Lost to Follow-up|3|||
46889636|NCT03408483|83112397|FG001|Overall Study|Lost to Follow-up|0|||
46889637|NCT03777059|83112407|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
46889638|NCT03777059|83112408|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
46889639|NCT03777059|83112409|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
46889640|NCT03777059|83112410|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
46889641|NCT03777059|83112407|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
46889642|NCT03777059|83112408|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
46889643|NCT03777059|83112409|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
46889644|NCT03777059|83112410|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
46889645|NCT03777059|83112407|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
46889646|NCT03777059|83112408|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
46889647|NCT03777059|83112409|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
46889648|NCT03777059|83112410|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
46889649|NCT03777059|83112407|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
46889650|NCT03777059|83112408|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
46889651|NCT03777059|83112409|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
46889652|NCT03777059|83112410|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
46889653|NCT03777059|83112407|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
46889654|NCT03777059|83112408|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
46889655|NCT03777059|83112409|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
46889656|NCT03777059|83112410|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
46889657|NCT03777059|83112407|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
46889658|NCT03777059|83112408|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
46889659|NCT03777059|83112409|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
46889660|NCT03777059|83112410|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
46889661|NCT03777059|83112407|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
46889662|NCT03777059|83112408|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
46889663|NCT03777059|83112409|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
46889664|NCT03777059|83112410|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
46889665|NCT03777059|83112407|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
46889666|NCT03777059|83112408|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
46889667|NCT03777059|83112409|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
46889668|NCT03777059|83112410|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
46889669|NCT03777059|83112407|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
46889670|NCT03777059|83112408|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
46889671|NCT03777059|83112409|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
46889672|NCT03777059|83112410|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
46889673|NCT03777059|83112407|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
46889674|NCT03777059|83112408|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
46889675|NCT03777059|83112409|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
46889676|NCT03777059|83112410|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
46889677|NCT03777059|83112407|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
46889678|NCT03777059|83112408|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
46889679|NCT03777059|83112409|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
46889680|NCT03777059|83112410|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
46889681|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
46889682|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
46889683|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
46889684|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
46889685|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
46889686|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
46889687|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
46889688|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
46889689|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
46889690|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
46889691|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
46889692|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
46889693|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
46889694|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
46889695|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
46889696|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
46889697|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
46889698|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
46889699|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
46889700|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
46889701|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
46889702|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
46889703|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
46889704|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
46889705|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
46889706|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
46897660|NCT00706030|83123368|FG001|Overall Study|Failed to return|0|||
46889707|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889708|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
46889709|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
46889710|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889711|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889712|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
46889713|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
46889714|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889715|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889716|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889717|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889718|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889719|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
46889720|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889721|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
46889722|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
46889723|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889724|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889725|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889726|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
46889727|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889728|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
46889729|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889730|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889731|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889732|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
46889733|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889734|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889735|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889736|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
46889737|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889738|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889739|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889740|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
46889741|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889742|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889743|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889744|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889745|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
46889746|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889747|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889748|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889749|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
46889750|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889751|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889752|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
46889753|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889754|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889755|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889756|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889757|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889758|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
46889759|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889760|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
46889761|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889762|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889763|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889764|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889765|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889766|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889767|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889768|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889769|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46889770|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46991453|NCT02121795|83238490|FG001|Double-Blind Phase|Physician Decision|5|||
46889771|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
46991454|NCT02121795|83238489|FG000|Double-Blind Phase|Adverse Event|5|||
46889772|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
46889773|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889774|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889775|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889776|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889777|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889778|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889779|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889780|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889781|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889782|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889783|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889784|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
46889785|NCT03100058|83112429|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889786|NCT03100058|83112430|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889787|NCT03100058|83112431|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889788|NCT03100058|83112432|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889789|NCT03100058|83112433|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889790|NCT03100058|83112434|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889791|NCT03100058|83112435|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
46889792|NCT03100058|83112436|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889793|NCT03100058|83112437|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889794|NCT03100058|83112438|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889795|NCT03100058|83112439|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889796|NCT03100058|83112440|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889797|NCT03100058|83112441|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
46889798|NCT03100058|83112429|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889799|NCT03100058|83112430|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889800|NCT03100058|83112431|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889801|NCT03100058|83112432|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889802|NCT03100058|83112433|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889803|NCT03100058|83112434|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889804|NCT03100058|83112435|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889805|NCT03100058|83112436|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889806|NCT03100058|83112437|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889807|NCT03100058|83112438|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
46889808|NCT03100058|83112439|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
46889809|NCT03100058|83112440|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
46889810|NCT03100058|83112441|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
46889811|NCT03100058|83112429|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889812|NCT03100058|83112430|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889813|NCT03100058|83112431|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889814|NCT03100058|83112432|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889815|NCT03100058|83112433|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889816|NCT03100058|83112434|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889817|NCT03100058|83112435|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889818|NCT03100058|83112436|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889819|NCT03100058|83112437|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889820|NCT03100058|83112438|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889821|NCT03100058|83112439|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
46889822|NCT03100058|83112440|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
46889823|NCT03100058|83112441|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
46889824|NCT03100058|83112429|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889825|NCT03100058|83112430|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889826|NCT03100058|83112431|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889827|NCT03100058|83112432|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889828|NCT03100058|83112433|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889829|NCT03100058|83112434|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889830|NCT03100058|83112435|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889831|NCT03100058|83112436|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889832|NCT03100058|83112437|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889833|NCT03100058|83112438|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
46889834|NCT03100058|83112439|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
46889835|NCT03100058|83112440|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
46889836|NCT03100058|83112441|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
46889837|NCT03100058|83112429|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46897661|NCT00706030|83123369|FG002|Overall Study|Failed to return|1|||
46889838|NCT03100058|83112430|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889839|NCT03100058|83112431|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889840|NCT03100058|83112432|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889841|NCT03100058|83112433|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889842|NCT03100058|83112434|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889843|NCT03100058|83112435|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889844|NCT03100058|83112436|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889845|NCT03100058|83112437|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889846|NCT03100058|83112438|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889847|NCT03100058|83112439|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
46889848|NCT03100058|83112440|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889849|NCT03100058|83112441|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
46889850|NCT03100058|83112429|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889851|NCT03100058|83112430|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889852|NCT03100058|83112431|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889853|NCT03100058|83112432|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889854|NCT03100058|83112433|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889855|NCT03100058|83112434|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889856|NCT03100058|83112435|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889857|NCT03100058|83112436|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889858|NCT03100058|83112437|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889859|NCT03100058|83112438|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889860|NCT03100058|83112439|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889861|NCT03100058|83112440|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
46889862|NCT03100058|83112441|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
46889863|NCT03100058|83112429|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889864|NCT03100058|83112430|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889865|NCT03100058|83112431|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889866|NCT03100058|83112432|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889867|NCT03100058|83112433|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889868|NCT03100058|83112434|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889869|NCT03100058|83112435|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889870|NCT03100058|83112436|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889871|NCT03100058|83112437|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889872|NCT03100058|83112438|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
46889873|NCT03100058|83112439|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889874|NCT03100058|83112440|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889875|NCT03100058|83112441|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
46889876|NCT02871778|83112487|FG000|Part A: Treatment Period 1|Adverse Event|1|||
46889877|NCT02871778|83112488|FG001|Part A: Treatment Period 1|Adverse Event|1|||
46889878|NCT02871778|83112489|FG002|Part A: Treatment Period 1|Adverse Event|1|||
46889879|NCT02871778|83112490|FG003|Part A: Treatment Period 1|Adverse Event|0|||
46889880|NCT02871778|83112491|FG004|Part A: Treatment Period 1|Adverse Event|0|||
46889881|NCT02871778|83112492|FG005|Part A: Treatment Period 1|Adverse Event|0|||
46889882|NCT02871778|83112493|FG006|Part A: Treatment Period 1|Adverse Event|0|||
46889883|NCT02871778|83112494|FG007|Part A: Treatment Period 1|Adverse Event|0|||
46889884|NCT02871778|83112487|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
46889885|NCT02871778|83112488|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
46889886|NCT02871778|83112489|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
46889887|NCT02871778|83112490|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
46889888|NCT02871778|83112491|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
46889889|NCT02871778|83112492|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
46889890|NCT02871778|83112493|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
46889891|NCT02871778|83112494|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
46889892|NCT02871778|83112487|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
46889893|NCT02871778|83112488|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
46889894|NCT02871778|83112489|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
46889895|NCT02871778|83112490|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
46889896|NCT02871778|83112491|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
46889897|NCT02871778|83112492|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
46889898|NCT02871778|83112493|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
46889899|NCT02871778|83112494|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
46889900|NCT02871778|83112487|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
46889901|NCT02871778|83112488|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
46889902|NCT02871778|83112489|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
46889903|NCT02871778|83112490|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
46889904|NCT02871778|83112491|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
46889905|NCT02871778|83112492|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
46889906|NCT02871778|83112493|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
46889907|NCT02871778|83112494|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
46889908|NCT02871778|83112487|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
46889909|NCT02871778|83112488|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
46889910|NCT02871778|83112489|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
46889911|NCT02871778|83112490|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
46889912|NCT02871778|83112491|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
46889913|NCT02871778|83112492|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
46889914|NCT02871778|83112493|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
46889915|NCT02871778|83112494|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
46889916|NCT02871778|83112487|FG000|Part A: Treatment Period 2|Adverse Event|2|||
46889917|NCT02871778|83112488|FG001|Part A: Treatment Period 2|Adverse Event|2|||
46889918|NCT02871778|83112489|FG002|Part A: Treatment Period 2|Adverse Event|0|||
46889919|NCT02871778|83112490|FG003|Part A: Treatment Period 2|Adverse Event|0|||
46889920|NCT02871778|83112491|FG004|Part A: Treatment Period 2|Adverse Event|0|||
46889921|NCT02871778|83112492|FG005|Part A: Treatment Period 2|Adverse Event|0|||
46889922|NCT02871778|83112493|FG006|Part A: Treatment Period 2|Adverse Event|0|||
46889923|NCT02871778|83112494|FG007|Part A: Treatment Period 2|Adverse Event|0|||
46889924|NCT02871778|83112487|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
46889925|NCT02871778|83112488|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
46889926|NCT02871778|83112489|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
46889927|NCT02871778|83112490|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
46889928|NCT02871778|83112491|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
46889929|NCT02871778|83112492|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
46889930|NCT02871778|83112493|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
46889931|NCT02871778|83112494|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
46889932|NCT02871778|83112487|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
46889933|NCT02871778|83112488|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
46889934|NCT02871778|83112489|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
46889935|NCT02871778|83112490|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
46889936|NCT02871778|83112491|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
46889937|NCT02871778|83112492|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
46889938|NCT02871778|83112493|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
46889939|NCT02871778|83112494|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
46889940|NCT02871778|83112487|FG000|Part B: Treatment Period 3|Adverse Event|0|||
46889941|NCT02871778|83112488|FG001|Part B: Treatment Period 3|Adverse Event|0|||
46889942|NCT02871778|83112489|FG002|Part B: Treatment Period 3|Adverse Event|0|||
46889943|NCT02871778|83112490|FG003|Part B: Treatment Period 3|Adverse Event|0|||
46889944|NCT02871778|83112491|FG004|Part B: Treatment Period 3|Adverse Event|1|||
46889945|NCT02871778|83112492|FG005|Part B: Treatment Period 3|Adverse Event|1|||
46889946|NCT02871778|83112493|FG006|Part B: Treatment Period 3|Adverse Event|1|||
46889947|NCT02871778|83112494|FG007|Part B: Treatment Period 3|Adverse Event|0|||
46889948|NCT01471444|83112527|FG000|Overall Study|Physician Decision|3|||
46889949|NCT01471444|83112528|FG001|Overall Study|Physician Decision|2|||
46889950|NCT01471444|83112527|FG000|Overall Study|Withdrawal by Subject|0|||
46889951|NCT01471444|83112528|FG001|Overall Study|Withdrawal by Subject|1|||
46889952|NCT03443427|83112546|FG000|Overall Study|Adverse Event|2|||
46889953|NCT03443427|83112547|FG001|Overall Study|Adverse Event|3|||
46889954|NCT03443427|83112546|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
46889955|NCT03443427|83112547|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
46889956|NCT03443427|83112546|FG000|Overall Study|Other|4|||
46889957|NCT03443427|83112547|FG001|Overall Study|Other|6|||
46889958|NCT03417219|83112555|FG000|Overall Study|Lost to Follow-up|0|||
46889959|NCT03417219|83112556|FG001|Overall Study|Lost to Follow-up|3|||
46889960|NCT02953821|83112564|FG000|Overall Study|Adverse Event|0|||
46889961|NCT02953821|83112565|FG001|Overall Study|Adverse Event|4|||
46889962|NCT02953821|83112564|FG000|Overall Study|Death|1|||
46889963|NCT02953821|83112565|FG001|Overall Study|Death|0|||
46889964|NCT02953821|83112564|FG000|Overall Study|Progressive Disease|5|||
46889965|NCT02953821|83112565|FG001|Overall Study|Progressive Disease|1|||
46889966|NCT02953821|83112564|FG000|Overall Study|Lost to Follow-up|2|||
46889967|NCT02953821|83112565|FG001|Overall Study|Lost to Follow-up|0|||
46889968|NCT02953821|83112564|FG000|Overall Study|Physician Decision|1|||
46889969|NCT02953821|83112565|FG001|Overall Study|Physician Decision|1|||
46889970|NCT02953821|83112564|FG000|Overall Study|Withdrawal by Subject|3|||
46889971|NCT02953821|83112565|FG001|Overall Study|Withdrawal by Subject|3|||
46889972|NCT02953821|83112564|FG000|Overall Study|Change of address|0|||
46889973|NCT02953821|83112565|FG001|Overall Study|Change of address|1|||
46889974|NCT02953821|83112564|FG000|Overall Study|Lack of Efficacy|1|||
46889975|NCT02953821|83112565|FG001|Overall Study|Lack of Efficacy|0|||
46889976|NCT02953821|83112564|FG000|Overall Study|Out of state for indeterminate time|0|||
46889977|NCT02953821|83112565|FG001|Overall Study|Out of state for indeterminate time|1|||
46889978|NCT02953821|83112564|FG000|Overall Study|No improvement|0|||
46889979|NCT02953821|83112565|FG001|Overall Study|No improvement|1|||
46889980|NCT02953821|83112564|FG000|Overall Study|Refused follow-up visit|2|||
46889981|NCT02953821|83112565|FG001|Overall Study|Refused follow-up visit|1|||
46889982|NCT03783923|83112575|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
46889983|NCT03783923|83112576|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
46889984|NCT03783923|83112575|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
46889985|NCT03783923|83112576|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
46889986|NCT03783923|83112575|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
46889987|NCT03783923|83112576|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
46889988|NCT03783923|83112575|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
46889989|NCT03783923|83112576|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
46889990|NCT03783923|83112575|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
46889991|NCT03783923|83112576|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
46889992|NCT03417141|83112580|FG000|Overall Study|Withdrawal by Subject|1|||
46889993|NCT03417141|83112580|FG000|Overall Study|Protocol Violation|3|||
46889994|NCT03724981|83112588|FG000|First Device|Protocol Violation|1|||
46889995|NCT03724981|83112589|FG001|First Device|Protocol Violation|1|||
46889996|NCT01347879|83112599|FG000|Overall Study|Adverse Event|0|||
46889997|NCT01347879|83112600|FG001|Overall Study|Adverse Event|12|||
46889998|NCT01347879|83112599|FG000|Overall Study|Lost to Follow-up|2|||
46889999|NCT01347879|83112600|FG001|Overall Study|Lost to Follow-up|0|||
46890000|NCT01347879|83112599|FG000|Overall Study|Withdrawal by Subject|3|||
46890001|NCT01347879|83112600|FG001|Overall Study|Withdrawal by Subject|2|||
46890002|NCT01347879|83112599|FG000|Overall Study|Other|2|||
46890003|NCT01347879|83112600|FG001|Overall Study|Other|3|||
46890004|NCT03441789|83112617|FG000|Overall Study|Withdrawal by Subject|1|||
46991455|NCT02121795|83238490|FG001|Double-Blind Phase|Adverse Event|0|||
46991456|NCT02121795|83238489|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
46991457|NCT02121795|83238490|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
46991458|NCT02121795|83238489|FG000|Double-Blind Phase|Protocol Violation|0|||
46991459|NCT02121795|83238490|FG001|Double-Blind Phase|Protocol Violation|3|||
46991460|NCT02121795|83238489|FG000|Double-Blind Phase|Death|1|||
46991461|NCT02121795|83238490|FG001|Double-Blind Phase|Death|1|||
46991462|NCT02121795|83238489|FG000|Open-Label Phase|Physician Decision|8|||
46991463|NCT02121795|83238490|FG001|Open-Label Phase|Physician Decision|8|||
46991464|NCT02121795|83238489|FG000|Open-Label Phase|Withdrawal by Subject|3|||
46991465|NCT02121795|83238490|FG001|Open-Label Phase|Withdrawal by Subject|2|||
46991466|NCT02121795|83238489|FG000|Open-Label Phase|Lost to Follow-up|1|||
46991467|NCT02121795|83238490|FG001|Open-Label Phase|Lost to Follow-up|0|||
46991468|NCT02158533|83238501|FG000|Stage 1|Adverse Event|6|||
46991469|NCT02158533|83238502|FG001|Stage 1|Adverse Event|4|||
46991470|NCT02158533|83238503|FG002|Stage 1|Adverse Event|7|||
46991471|NCT02158533|83238504|FG003|Stage 1|Adverse Event|0|||
46991472|NCT02158533|83238505|FG004|Stage 1|Adverse Event|0|||
46991473|NCT02158533|83238506|FG005|Stage 1|Adverse Event|0|||
46991474|NCT02158533|83238501|FG000|Stage 1|Withdrawal by Subject|3|||
46991475|NCT02158533|83238502|FG001|Stage 1|Withdrawal by Subject|2|||
46991476|NCT02158533|83238503|FG002|Stage 1|Withdrawal by Subject|1|||
46991477|NCT02158533|83238504|FG003|Stage 1|Withdrawal by Subject|0|||
46991478|NCT02158533|83238505|FG004|Stage 1|Withdrawal by Subject|0|||
46991479|NCT02158533|83238506|FG005|Stage 1|Withdrawal by Subject|0|||
46991480|NCT02158533|83238501|FG000|Stage 1|Lack of Efficacy|1|||
46991481|NCT02158533|83238502|FG001|Stage 1|Lack of Efficacy|0|||
46991482|NCT02158533|83238503|FG002|Stage 1|Lack of Efficacy|0|||
46991483|NCT02158533|83238504|FG003|Stage 1|Lack of Efficacy|0|||
46991484|NCT02158533|83238505|FG004|Stage 1|Lack of Efficacy|0|||
46991485|NCT02158533|83238506|FG005|Stage 1|Lack of Efficacy|0|||
46991486|NCT02158533|83238501|FG000|Stage 1|Lost to Follow-up|3|||
46991487|NCT02158533|83238502|FG001|Stage 1|Lost to Follow-up|1|||
46991488|NCT02158533|83238503|FG002|Stage 1|Lost to Follow-up|0|||
46991489|NCT02158533|83238504|FG003|Stage 1|Lost to Follow-up|0|||
46991490|NCT02158533|83238505|FG004|Stage 1|Lost to Follow-up|0|||
46991491|NCT02158533|83238506|FG005|Stage 1|Lost to Follow-up|0|||
46991492|NCT02158533|83238501|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
46991493|NCT02158533|83238502|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
46991494|NCT02158533|83238503|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
46991495|NCT02158533|83238504|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
46991496|NCT02158533|83238505|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
46890005|NCT03441789|83112618|FG001|Overall Study|Withdrawal by Subject|1|||
46890006|NCT03441789|83112617|FG000|Overall Study|Adverse Event|0|||
46890007|NCT03441789|83112618|FG001|Overall Study|Adverse Event|1|||
46890008|NCT03441789|83112617|FG000|Overall Study|Protocol Violation|0|||
46890009|NCT03441789|83112618|FG001|Overall Study|Protocol Violation|1|||
46991497|NCT02158533|83238506|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
46991498|NCT02158533|83238501|FG000|Stage 1|Non-compliance with study visits|1|||
46991499|NCT02158533|83238502|FG001|Stage 1|Non-compliance with study visits|0|||
46991500|NCT02158533|83238503|FG002|Stage 1|Non-compliance with study visits|0|||
46991501|NCT02158533|83238504|FG003|Stage 1|Non-compliance with study visits|0|||
46991502|NCT02158533|83238505|FG004|Stage 1|Non-compliance with study visits|0|||
46991503|NCT02158533|83238506|FG005|Stage 1|Non-compliance with study visits|0|||
46991504|NCT02158533|83238501|FG000|Stage 2|Adverse Event|0|||
46991505|NCT02158533|83238502|FG001|Stage 2|Adverse Event|0|||
46991506|NCT02158533|83238503|FG002|Stage 2|Adverse Event|0|||
46991507|NCT02158533|83238504|FG003|Stage 2|Adverse Event|0|||
46991508|NCT02158533|83238505|FG004|Stage 2|Adverse Event|0|||
46991509|NCT02158533|83238506|FG005|Stage 2|Adverse Event|1|||
46991510|NCT02158533|83238501|FG000|Stage 2|Lack of Efficacy|0|||
46991511|NCT02158533|83238502|FG001|Stage 2|Lack of Efficacy|0|||
46991512|NCT02158533|83238503|FG002|Stage 2|Lack of Efficacy|0|||
46991513|NCT02158533|83238504|FG003|Stage 2|Lack of Efficacy|0|||
46991514|NCT02158533|83238505|FG004|Stage 2|Lack of Efficacy|1|||
46991515|NCT02158533|83238506|FG005|Stage 2|Lack of Efficacy|0|||
46991516|NCT02158533|83238501|FG000|Stage 2|Lost to Follow-up|0|||
46991517|NCT02158533|83238502|FG001|Stage 2|Lost to Follow-up|0|||
46991518|NCT02158533|83238503|FG002|Stage 2|Lost to Follow-up|0|||
46991519|NCT02158533|83238504|FG003|Stage 2|Lost to Follow-up|1|||
46991520|NCT02158533|83238505|FG004|Stage 2|Lost to Follow-up|1|||
46991521|NCT02158533|83238506|FG005|Stage 2|Lost to Follow-up|2|||
46991522|NCT02158533|83238501|FG000|Stage 2|Withdrawal by Subject|0|||
46991523|NCT02158533|83238502|FG001|Stage 2|Withdrawal by Subject|0|||
46991524|NCT02158533|83238503|FG002|Stage 2|Withdrawal by Subject|0|||
46991525|NCT02158533|83238504|FG003|Stage 2|Withdrawal by Subject|0|||
46991526|NCT02158533|83238505|FG004|Stage 2|Withdrawal by Subject|1|||
46991527|NCT02158533|83238506|FG005|Stage 2|Withdrawal by Subject|2|||
46991528|NCT02158533|83238501|FG000|Stage 2|Physician Decision|0|||
46991529|NCT02158533|83238502|FG001|Stage 2|Physician Decision|0|||
46991530|NCT02158533|83238503|FG002|Stage 2|Physician Decision|0|||
46991531|NCT02158533|83238504|FG003|Stage 2|Physician Decision|0|||
46991532|NCT02158533|83238505|FG004|Stage 2|Physician Decision|1|||
46991533|NCT02158533|83238506|FG005|Stage 2|Physician Decision|0|||
46991534|NCT02158533|83238501|FG000|Stage 2|Pregnancy|0|||
46991535|NCT02158533|83238502|FG001|Stage 2|Pregnancy|0|||
46991536|NCT02158533|83238503|FG002|Stage 2|Pregnancy|0|||
46991537|NCT02158533|83238504|FG003|Stage 2|Pregnancy|1|||
46991538|NCT02158533|83238505|FG004|Stage 2|Pregnancy|0|||
46991539|NCT02158533|83238506|FG005|Stage 2|Pregnancy|0|||
46890010|NCT03441789|83112617|FG000|Overall Study|Lost to Follow-up|0|||
46706075|NCT01221623|82921073|FG001|Overall Study|Withdrawal by Subject|8|||
46706076|NCT01221623|82921072|FG000|Overall Study|Lost to Follow-up|7|||
46706077|NCT01221623|82921073|FG001|Overall Study|Lost to Follow-up|1|||
46706078|NCT01221623|82921072|FG000|Overall Study|Adverse Event|6|||
46706079|NCT01221623|82921073|FG001|Overall Study|Adverse Event|3|||
46706080|NCT01221623|82921072|FG000|Overall Study|Death|1|||
46706081|NCT01221623|82921073|FG001|Overall Study|Death|0|||
46706082|NCT01221623|82921072|FG000|Overall Study|Other|5|||
46706083|NCT01221623|82921073|FG001|Overall Study|Other|2|||
46706084|NCT01014585|82921083|FG000|Overall Study|Adverse Event|0|||
46706085|NCT01014585|82921084|FG001|Overall Study|Adverse Event|2|||
46706086|NCT01014585|82921085|FG002|Overall Study|Adverse Event|0|||
46706087|NCT01014585|82921086|FG003|Overall Study|Adverse Event|3|||
46706088|NCT01014585|82921083|FG000|Overall Study|Withdrawal by Subject|2|||
46706089|NCT01014585|82921084|FG001|Overall Study|Withdrawal by Subject|0|||
46706090|NCT01014585|82921085|FG002|Overall Study|Withdrawal by Subject|1|||
46706091|NCT01014585|82921086|FG003|Overall Study|Withdrawal by Subject|3|||
46706092|NCT01014585|82921083|FG000|Overall Study|Lost to Follow-up|0|||
46706093|NCT01014585|82921084|FG001|Overall Study|Lost to Follow-up|0|||
46706094|NCT01014585|82921085|FG002|Overall Study|Lost to Follow-up|0|||
46706095|NCT01014585|82921086|FG003|Overall Study|Lost to Follow-up|2|||
46706096|NCT01014585|82921083|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
46706097|NCT01014585|82921084|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
46706098|NCT01014585|82921085|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
46706099|NCT01014585|82921086|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
46706100|NCT01221233|82921098|FG000|Overall Study|Withdrawal by Subject|3|||
46706101|NCT01221233|82921099|FG001|Overall Study|Withdrawal by Subject|1|||
46706102|NCT01220609|82921105|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
46706103|NCT01220609|82921105|FG000|Overall Study|Ineligible- Wrong cell type|1|||
46706104|NCT01220609|82921105|FG000|Overall Study|Ineligible-Never treated|1|||
46706105|NCT01220297|82921117|FG000|Overall Study|Death|2|||
46706106|NCT01220297|82921117|FG000|Overall Study|Lost to Follow-up|1|||
46706107|NCT01219985|82921123|FG000|Overall Study|Physician Decision|20|||
46706108|NCT01218659|82921131|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
46706109|NCT01218659|82921132|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
46706110|NCT01218659|82921133|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
46706111|NCT01218659|82921131|FG000|18-Month Randomized Period|Did not receive study drug|0|||
46706112|NCT01218659|82921132|FG001|18-Month Randomized Period|Did not receive study drug|3|||
46706113|NCT01218659|82921133|FG002|18-Month Randomized Period|Did not receive study drug|0|||
46706114|NCT01218659|82921131|FG000|12-Month OLE|Withdrawal by Subject|0|||
46706115|NCT01218659|82921132|FG001|12-Month OLE|Withdrawal by Subject|0|||
46706116|NCT01218659|82921133|FG002|12-Month OLE|Withdrawal by Subject|2|||
46706117|NCT01218659|82921131|FG000|12-Month OLE|Physician Decision|0|||
46706118|NCT01218659|82921132|FG001|12-Month OLE|Physician Decision|0|||
46706119|NCT01218659|82921133|FG002|12-Month OLE|Physician Decision|1|||
46706120|NCT01218659|82921131|FG000|12-Month OLE|Lost to Follow-up|0|||
46706121|NCT01218659|82921132|FG001|12-Month OLE|Lost to Follow-up|0|||
46706122|NCT01218659|82921133|FG002|12-Month OLE|Lost to Follow-up|1|||
46706123|NCT01218659|82921131|FG000|12-Month OLE|Pregnancy|0|||
46706124|NCT01218659|82921132|FG001|12-Month OLE|Pregnancy|0|||
46706125|NCT01218659|82921133|FG002|12-Month OLE|Pregnancy|1|||
46706126|NCT01218659|82921131|FG000|12-Month OLE|Lack of Efficacy|0|||
46706127|NCT01218659|82921132|FG001|12-Month OLE|Lack of Efficacy|0|||
46706128|NCT01218659|82921133|FG002|12-Month OLE|Lack of Efficacy|1|||
46706129|NCT01218659|82921131|FG000|12-Month OLE|Declined to participate in the OLE|0|||
46706130|NCT01218659|82921132|FG001|12-Month OLE|Declined to participate in the OLE|0|||
46706131|NCT01218659|82921133|FG002|12-Month OLE|Declined to participate in the OLE|4|||
46706132|NCT00940498|82921148|FG000|Overall Study|Death|2|||
46706133|NCT00940498|82921149|FG001|Overall Study|Death|0|||
46706134|NCT00940498|82921150|FG002|Overall Study|Death|0|||
46706135|NCT00940498|82921151|FG003|Overall Study|Death|1|||
46706136|NCT00940498|82921152|FG004|Overall Study|Death|5|||
46706137|NCT00940498|82921153|FG005|Overall Study|Death|0|||
46706138|NCT00940498|82921154|FG006|Overall Study|Death|1|||
46706139|NCT00940498|82921155|FG007|Overall Study|Death|0|||
46706140|NCT00940498|82921148|FG000|Overall Study|Lost to Follow-up|1|||
46706141|NCT00940498|82921149|FG001|Overall Study|Lost to Follow-up|1|||
46706142|NCT00940498|82921150|FG002|Overall Study|Lost to Follow-up|2|||
46706143|NCT00940498|82921151|FG003|Overall Study|Lost to Follow-up|0|||
46706144|NCT00940498|82921152|FG004|Overall Study|Lost to Follow-up|1|||
46706145|NCT00940498|82921153|FG005|Overall Study|Lost to Follow-up|0|||
46706146|NCT00940498|82921154|FG006|Overall Study|Lost to Follow-up|0|||
46706147|NCT00940498|82921155|FG007|Overall Study|Lost to Follow-up|1|||
46706148|NCT00940498|82921148|FG000|Overall Study|Disease Progression|0|||
46706149|NCT00940498|82921149|FG001|Overall Study|Disease Progression|0|||
46706150|NCT00940498|82921150|FG002|Overall Study|Disease Progression|1|||
46706151|NCT00940498|82921151|FG003|Overall Study|Disease Progression|1|||
46706152|NCT00940498|82921152|FG004|Overall Study|Disease Progression|0|||
46706153|NCT00940498|82921153|FG005|Overall Study|Disease Progression|1|||
46706154|NCT00940498|82921154|FG006|Overall Study|Disease Progression|0|||
46706155|NCT00940498|82921155|FG007|Overall Study|Disease Progression|0|||
46706156|NCT00940498|82921148|FG000|Overall Study|Physician Decision|0|||
46706157|NCT00940498|82921149|FG001|Overall Study|Physician Decision|0|||
46706158|NCT00940498|82921150|FG002|Overall Study|Physician Decision|0|||
46706159|NCT00940498|82921151|FG003|Overall Study|Physician Decision|0|||
46706160|NCT00940498|82921152|FG004|Overall Study|Physician Decision|2|||
46706161|NCT00940498|82921153|FG005|Overall Study|Physician Decision|0|||
46706162|NCT00940498|82921154|FG006|Overall Study|Physician Decision|0|||
46706163|NCT00940498|82921155|FG007|Overall Study|Physician Decision|0|||
46706164|NCT00940498|82921148|FG000|Overall Study|Not treated due to disease related pain|0|||
46706165|NCT00940498|82921149|FG001|Overall Study|Not treated due to disease related pain|0|||
46706166|NCT00940498|82921150|FG002|Overall Study|Not treated due to disease related pain|0|||
46706167|NCT00940498|82921151|FG003|Overall Study|Not treated due to disease related pain|0|||
46706168|NCT00940498|82921152|FG004|Overall Study|Not treated due to disease related pain|1|||
46706169|NCT00940498|82921153|FG005|Overall Study|Not treated due to disease related pain|0|||
46706170|NCT00940498|82921154|FG006|Overall Study|Not treated due to disease related pain|0|||
46706171|NCT00940498|82921155|FG007|Overall Study|Not treated due to disease related pain|0|||
46706172|NCT00940342|82921182|FG000|Overall Study|Adverse Event|0|||
46706173|NCT00940342|82921183|FG001|Overall Study|Adverse Event|2|||
46706174|NCT00940342|82921184|FG002|Overall Study|Adverse Event|1|||
46706175|NCT00936910|82921192|FG000|Overall Study|Lack of Efficacy|3|||
46706176|NCT00940108|82921201|FG000|Overall Study|Adverse Event|2|||
46706177|NCT00940108|82921202|FG001|Overall Study|Adverse Event|4|||
46706178|NCT00940108|82921203|FG002|Overall Study|Adverse Event|0|||
46706179|NCT00940108|82921204|FG003|Overall Study|Adverse Event|2|||
46706180|NCT00940108|82921201|FG000|Overall Study|Withdrew Consent|2|||
46706181|NCT00940108|82921202|FG001|Overall Study|Withdrew Consent|1|||
46706182|NCT00940108|82921203|FG002|Overall Study|Withdrew Consent|0|||
46706183|NCT00940108|82921204|FG003|Overall Study|Withdrew Consent|1|||
46706184|NCT00940108|82921201|FG000|Overall Study|Dose 2 contraindicated|1|||
46706185|NCT00940108|82921202|FG001|Overall Study|Dose 2 contraindicated|1|||
46706186|NCT00940108|82921203|FG002|Overall Study|Dose 2 contraindicated|0|||
46706187|NCT00940108|82921204|FG003|Overall Study|Dose 2 contraindicated|1|||
46706188|NCT00940108|82921201|FG000|Overall Study|Declined further vaccination|0|||
46706189|NCT00940108|82921202|FG001|Overall Study|Declined further vaccination|1|||
46706190|NCT00940108|82921203|FG002|Overall Study|Declined further vaccination|3|||
46706191|NCT00940108|82921204|FG003|Overall Study|Declined further vaccination|0|||
46706192|NCT00940108|82921201|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
46706193|NCT00940108|82921202|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
46706194|NCT00940108|82921203|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
46706195|NCT00940108|82921204|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
46706196|NCT00940108|82921201|FG000|Overall Study|Viral illness after Dose 1|0|||
46706197|NCT00940108|82921202|FG001|Overall Study|Viral illness after Dose 1|1|||
46706198|NCT00940108|82921203|FG002|Overall Study|Viral illness after Dose 1|0|||
46706199|NCT00940108|82921204|FG003|Overall Study|Viral illness after Dose 1|0|||
46706200|NCT00940108|82921201|FG000|Overall Study|Diagnosed with H1N1|0|||
46706201|NCT00940108|82921202|FG001|Overall Study|Diagnosed with H1N1|0|||
46706202|NCT00940108|82921203|FG002|Overall Study|Diagnosed with H1N1|0|||
46706203|NCT00940108|82921204|FG003|Overall Study|Diagnosed with H1N1|1|||
46706204|NCT00936598|82921216|FG000|Overall Study|Withdrawal by Subject|1|||
46706205|NCT00936598|82921217|FG001|Overall Study|Withdrawal by Subject|0|||
46706206|NCT00936598|82921216|FG000|Overall Study|Ineligible after consent|1|||
46706207|NCT00936598|82921217|FG001|Overall Study|Ineligible after consent|0|||
46706208|NCT01025817|82921225|FG000|Completed Study Medication|Adverse Event|66|||
46706209|NCT01025817|82921226|FG001|Completed Study Medication|Adverse Event|39|||
46706210|NCT01025817|82921225|FG000|Completed Study Medication|Protocol Deviation|9|||
46706211|NCT01025817|82921226|FG001|Completed Study Medication|Protocol Deviation|8|||
46706212|NCT01025817|82921225|FG000|Completed Study Medication|Withdrawal by Subject|8|||
46706213|NCT01025817|82921226|FG001|Completed Study Medication|Withdrawal by Subject|9|||
46706214|NCT01025817|82921225|FG000|Completed Study Medication|Administrative problems|7|||
46706215|NCT01025817|82921226|FG001|Completed Study Medication|Administrative problems|5|||
46706216|NCT01025817|82921225|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
46706217|NCT01025817|82921226|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
46706218|NCT01025817|82921225|FG000|Completed Study Medication|Abnormal test procedure|4|||
46706219|NCT01025817|82921226|FG001|Completed Study Medication|Abnormal test procedure|0|||
46706220|NCT01025817|82921225|FG000|Completed Study Medication|Graft loss|2|||
46706221|NCT01025817|82921226|FG001|Completed Study Medication|Graft loss|5|||
46706222|NCT01025817|82921225|FG000|Completed Study Medication|Death|2|||
46706223|NCT01025817|82921226|FG001|Completed Study Medication|Death|2|||
46706224|NCT01025817|82921225|FG000|Completed Study Medication|Abnormal lab values|0|||
46706225|NCT01025817|82921226|FG001|Completed Study Medication|Abnormal lab values|2|||
46706226|NCT01025817|82921225|FG000|Completed Study Medication|Subject no longer required study drug|0|||
46706227|NCT01025817|82921226|FG001|Completed Study Medication|Subject no longer required study drug|1|||
46706228|NCT01025817|82921225|FG000|Completed Study Medication|Lost to Follow-up|0|||
46706229|NCT01025817|82921226|FG001|Completed Study Medication|Lost to Follow-up|1|||
46706230|NCT01025817|82921225|FG000|Completed Study|Withdrawal by Subject|8|||
46706231|NCT01025817|82921226|FG001|Completed Study|Withdrawal by Subject|16|||
46706232|NCT01025817|82921225|FG000|Completed Study|Death|6|||
46706233|NCT01025817|82921226|FG001|Completed Study|Death|5|||
46706234|NCT01025817|82921225|FG000|Completed Study|Missing|2|||
46706235|NCT01025817|82921226|FG001|Completed Study|Missing|0|||
46706236|NCT01025817|82921225|FG000|Completed Study|Lost to Follow-up|0|||
46706237|NCT01025817|82921226|FG001|Completed Study|Lost to Follow-up|1|||
46706238|NCT00939640|82921232|FG000|Overall Study|Physician Decision|1|||
46706239|NCT01218113|82921244|FG000|Overall Study|Withdrawal by Subject|1|||
46706240|NCT01218113|82921245|FG001|Overall Study|Withdrawal by Subject|0|||
46706241|NCT01218113|82921246|FG002|Overall Study|Withdrawal by Subject|1|||
46706242|NCT01218113|82921244|FG000|Overall Study|Lost to Follow-up|4|||
46706243|NCT01218113|82921245|FG001|Overall Study|Lost to Follow-up|1|||
46706244|NCT01218113|82921246|FG002|Overall Study|Lost to Follow-up|4|||
46706245|NCT01218113|82921244|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
46706246|NCT01218113|82921245|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
46706247|NCT01218113|82921246|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
46706248|NCT03873493|82921261|FG000|Overall Study|Withdrawal by Subject|1|||
46706249|NCT03873493|82921261|FG000|Overall Study|Death|9|||
46706250|NCT03873493|82921261|FG000|Overall Study|Lost to Follow-up|1|||
46706251|NCT03873493|82921261|FG000|Overall Study|Study Terminated by Sponsor|1|||
46706252|NCT03873493|82921261|FG000|Overall Study|Other|2|||
46706253|NCT00939484|82921281|FG000|Overall Study|Progression/Relapse|8|||
46706254|NCT00939484|82921282|FG001|Overall Study|Progression/Relapse|20|||
46706255|NCT00939484|82921283|FG002|Overall Study|Progression/Relapse|3|||
46706256|NCT01010217|82921298|FG000|Overall Study|Lost to Follow-up|4|||
46706257|NCT01010217|82921299|FG001|Overall Study|Lost to Follow-up|5|||
46706258|NCT01010217|82921300|FG002|Overall Study|Lost to Follow-up|1|||
46706259|NCT01010217|82921301|FG003|Overall Study|Lost to Follow-up|0|||
46706260|NCT01010217|82921302|FG004|Overall Study|Lost to Follow-up|0|||
46706261|NCT01010217|82921298|FG000|Overall Study|Withdrawal by Subject|1|||
46706262|NCT01010217|82921299|FG001|Overall Study|Withdrawal by Subject|0|||
46706263|NCT01010217|82921300|FG002|Overall Study|Withdrawal by Subject|0|||
46706264|NCT01010217|82921301|FG003|Overall Study|Withdrawal by Subject|0|||
46706265|NCT01010217|82921302|FG004|Overall Study|Withdrawal by Subject|0|||
46706266|NCT01010217|82921298|FG000|Overall Study|Physician Decision|0|||
46706267|NCT01010217|82921299|FG001|Overall Study|Physician Decision|0|||
46706268|NCT01010217|82921300|FG002|Overall Study|Physician Decision|0|||
46706269|NCT01010217|82921301|FG003|Overall Study|Physician Decision|6|||
46706270|NCT01010217|82921302|FG004|Overall Study|Physician Decision|3|||
46706271|NCT01217957|82921319|FG000|Phase 1|Withdrawal by Patient|1|||
46706272|NCT01217957|82921320|FG001|Phase 1|Withdrawal by Patient|0|||
46706273|NCT01217957|82921321|FG002|Phase 1|Withdrawal by Patient|1|||
46706274|NCT01217957|82921322|FG003|Phase 1|Withdrawal by Patient|1|||
46706275|NCT01217957|82921323|FG004|Phase 1|Withdrawal by Patient|0|||
46706276|NCT01217957|82921319|FG000|Phase 2|Withdrawal by Patient|0|||
46706277|NCT01217957|82921320|FG001|Phase 2|Withdrawal by Patient|0|||
46706278|NCT01217957|82921321|FG002|Phase 2|Withdrawal by Patient|0|||
46706279|NCT01217957|82921322|FG003|Phase 2|Withdrawal by Patient|0|||
46706280|NCT01217957|82921323|FG004|Phase 2|Withdrawal by Patient|1|||
46706281|NCT00939094|82921346|FG000|Overall Study|Adverse Event|9|||
46706282|NCT00939094|82921347|FG001|Overall Study|Adverse Event|0|||
46706283|NCT00939094|82921346|FG000|Overall Study|Withdrawal by Subject|1|||
46706284|NCT00939094|82921347|FG001|Overall Study|Withdrawal by Subject|6|||
46706285|NCT00939094|82921346|FG000|Overall Study|Lost to Follow-up|1|||
46706286|NCT00939094|82921347|FG001|Overall Study|Lost to Follow-up|1|||
46706287|NCT00939094|82921346|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
46706288|NCT00939094|82921347|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46706289|NCT00939094|82921346|FG000|Overall Study|Severe non-compliance to protocol|0|||
46890011|NCT03441789|83112618|FG001|Overall Study|Lost to Follow-up|1|||
46890012|NCT03387735|83112630|FG000|Overall Study|Lost to Follow-up|4|||
46706290|NCT00939094|82921347|FG001|Overall Study|Severe non-compliance to protocol|1|||
46706291|NCT00939094|82921346|FG000|Overall Study|Study stopped by sponsor|0|||
46706292|NCT00939094|82921347|FG001|Overall Study|Study stopped by sponsor|2|||
46706293|NCT00939094|82921346|FG000|Overall Study|Abnormal ECG findings|1|||
46706294|NCT00939094|82921347|FG001|Overall Study|Abnormal ECG findings|0|||
46706295|NCT01217801|82921355|FG000|Period 1|Protocol Violation|1|||
46706296|NCT01217801|82921356|FG001|Period 1|Protocol Violation|1|||
46706297|NCT01217801|82921355|FG000|Period 1|Withdrawal by Subject|0|||
46706298|NCT01217801|82921356|FG001|Period 1|Withdrawal by Subject|1|||
46706299|NCT00935818|82921364|FG000|Overall Study|Withdrawal by Subject|45|||
46706300|NCT00935818|82921365|FG001|Overall Study|Withdrawal by Subject|50|||
46706301|NCT00935818|82921364|FG000|Overall Study|Lost to Follow-up|40|||
46706302|NCT00935818|82921365|FG001|Overall Study|Lost to Follow-up|42|||
46706303|NCT00935818|82921364|FG000|Overall Study|Adverse Event|6|||
46706304|NCT00935818|82921365|FG001|Overall Study|Adverse Event|7|||
46706305|NCT00935818|82921364|FG000|Overall Study|Physician Decision|0|||
46706306|NCT00935818|82921365|FG001|Overall Study|Physician Decision|1|||
46706307|NCT01216319|82921371|FG000|Overall Study|Lost to Follow-up|2|||
46706308|NCT01216319|82921371|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
46706309|NCT00936208|82921377|FG000|Overall Study|Protocol Violation|37|||
46706310|NCT00936208|82921378|FG001|Overall Study|Protocol Violation|22|||
46706311|NCT01216163|82921387|FG000|Overall Study|Withdrawal by Subject|1|||
46706312|NCT01216163|82921388|FG001|Overall Study|Withdrawal by Subject|1|||
46706313|NCT01216163|82921389|FG002|Overall Study|Withdrawal by Subject|0|||
46706314|NCT00933244|82921400|FG000|Overall Study|Withdrawal by Subject|5|||
46706315|NCT00933244|82921401|FG001|Overall Study|Withdrawal by Subject|1|||
46706316|NCT00933244|82921402|FG002|Overall Study|Withdrawal by Subject|3|||
46706317|NCT00930046|82921412|FG000|Overall Study|Wound catheter malfunctioned|1|||
46706318|NCT00930046|82921413|FG001|Overall Study|Wound catheter malfunctioned|2|||
46706319|NCT00935584|82921421|FG000|Overall Study|Withdrawal by Subject|9|||
46706320|NCT00935584|82921422|FG001|Overall Study|Withdrawal by Subject|0|||
46706321|NCT00935584|82921421|FG000|Overall Study|Death|3|||
46706322|NCT00935584|82921422|FG001|Overall Study|Death|0|||
46706323|NCT00935584|82921421|FG000|Overall Study|Lost to Follow-up|8|||
46706324|NCT00935584|82921422|FG001|Overall Study|Lost to Follow-up|0|||
46706325|NCT00935584|82921421|FG000|Overall Study|No show|9|||
46706326|NCT00935584|82921422|FG001|Overall Study|No show|0|||
46706327|NCT00935584|82921421|FG000|Overall Study|Relocated|3|||
46706328|NCT00935584|82921422|FG001|Overall Study|Relocated|0|||
46706329|NCT00935584|82921421|FG000|Overall Study|Patient changed provider|3|||
46706330|NCT00935584|82921422|FG001|Overall Study|Patient changed provider|0|||
46706331|NCT00935584|82921421|FG000|Overall Study|Provider dropped out of study|14|||
46706332|NCT00935584|82921422|FG001|Overall Study|Provider dropped out of study|4|||
46706333|NCT01215851|82921432|FG000|Treatment Period|Adverse Event|1|||
46706334|NCT01215851|82921433|FG001|Treatment Period|Adverse Event|1|||
46706335|NCT01215851|82921434|FG002|Treatment Period|Adverse Event|1|||
46706336|NCT01215851|82921435|FG003|Treatment Period|Adverse Event|3|||
46706337|NCT01215851|82921436|FG004|Treatment Period|Adverse Event|0|||
46706338|NCT01215851|82921437|FG005|Treatment Period|Adverse Event|1|||
46706339|NCT01215851|82921432|FG000|Follow up Period|Lost to Follow-up|0|||
46706340|NCT01215851|82921433|FG001|Follow up Period|Lost to Follow-up|0|||
46706341|NCT01215851|82921434|FG002|Follow up Period|Lost to Follow-up|0|||
46706342|NCT01215851|82921435|FG003|Follow up Period|Lost to Follow-up|0|||
46706343|NCT01215851|82921436|FG004|Follow up Period|Lost to Follow-up|0|||
46706344|NCT01215851|82921437|FG005|Follow up Period|Lost to Follow-up|1|||
46706345|NCT00933166|82921452|FG000|Overall Study|Lost to Follow-up|4|||
46706346|NCT00933166|82921452|FG000|Overall Study|Lack of Efficacy|9|||
46706347|NCT00933166|82921452|FG000|Overall Study|Unavailable|4|||
46706348|NCT00933166|82921452|FG000|Overall Study|Withdrawal by Subject|1|||
46706349|NCT00935272|82921458|FG000|Overall Study|Lost to Follow-up|10|||
46706350|NCT00935272|82921459|FG001|Overall Study|Lost to Follow-up|3|||
46706351|NCT00935272|82921458|FG000|Overall Study|Withdrawal by Subject|8|||
46706352|NCT00935272|82921459|FG001|Overall Study|Withdrawal by Subject|2|||
46706353|NCT00935272|82921458|FG000|Overall Study|Physician Decision|1|||
46706354|NCT00935272|82921459|FG001|Overall Study|Physician Decision|0|||
46706355|NCT00935272|82921458|FG000|Overall Study|Protocol Violation|0|||
46706356|NCT00935272|82921459|FG001|Overall Study|Protocol Violation|1|||
46706357|NCT01010061|82921468|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
46706358|NCT01010061|82921469|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
46706359|NCT01010061|82921468|FG000|Overall Study|Disease Progression|2|||
46706360|NCT01010061|82921469|FG001|Overall Study|Disease Progression|8|||
46706361|NCT01010061|82921468|FG000|Overall Study|Withdrew Consent|5|||
46706362|NCT01010061|82921469|FG001|Overall Study|Withdrew Consent|1|||
46706363|NCT01010061|82921468|FG000|Overall Study|Death|3|||
46706364|NCT01010061|82921469|FG001|Overall Study|Death|6|||
46706365|NCT01010061|82921468|FG000|Overall Study|Administrative/Other|0|||
46706366|NCT01010061|82921469|FG001|Overall Study|Administrative/Other|1|||
46706367|NCT01010061|82921468|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
46706368|NCT01010061|82921469|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
46706369|NCT01010061|82921468|FG000|Overall Study|Insufficient Therapeutic Response|1|||
46706370|NCT01010061|82921469|FG001|Overall Study|Insufficient Therapeutic Response|5|||
46706371|NCT01010061|82921468|FG000|Overall Study|Violation of Selection Criteria|0|||
46706372|NCT01010061|82921469|FG001|Overall Study|Violation of Selection Criteria|1|||
46706373|NCT01010061|82921468|FG000|Overall Study|Did Not Receive Treatment|2|||
46706374|NCT01010061|82921469|FG001|Overall Study|Did Not Receive Treatment|2|||
46706375|NCT00929734|82921489|FG000|Overall Study|Lost to Follow-up|2|||
46706376|NCT00929734|82921490|FG001|Overall Study|Lost to Follow-up|1|||
46706377|NCT00929734|82921489|FG000|Overall Study|Withdrawal by Subject|0|||
46706378|NCT00929734|82921490|FG001|Overall Study|Withdrawal by Subject|2|||
46706379|NCT01013883|82921498|FG000|Overall Study|Lost to Follow-up|2|||
46706380|NCT01013883|82921499|FG001|Overall Study|Lost to Follow-up|2|||
46706381|NCT01009983|82921505|FG000|Overall Study|necessary scans not completed|1|||
46706382|NCT01215227|82921519|FG000|Overall Study|Adverse Event|11|||
46706383|NCT01215227|82921520|FG001|Overall Study|Adverse Event|11|||
46706384|NCT01215227|82921521|FG002|Overall Study|Adverse Event|4|||
46706385|NCT01215227|82921522|FG003|Overall Study|Adverse Event|8|||
46706386|NCT01215227|82921523|FG004|Overall Study|Adverse Event|7|||
46706387|NCT01215227|82921524|FG005|Overall Study|Adverse Event|6|||
46706388|NCT01215227|82921519|FG000|Overall Study|Treatment Failure|8|||
46706389|NCT01215227|82921520|FG001|Overall Study|Treatment Failure|4|||
46706390|NCT01215227|82921521|FG002|Overall Study|Treatment Failure|1|||
46706391|NCT01215227|82921522|FG003|Overall Study|Treatment Failure|5|||
46706392|NCT01215227|82921523|FG004|Overall Study|Treatment Failure|1|||
46706393|NCT01215227|82921524|FG005|Overall Study|Treatment Failure|1|||
46706394|NCT01215227|82921519|FG000|Overall Study|Lost to Follow-up|1|||
46706395|NCT01215227|82921520|FG001|Overall Study|Lost to Follow-up|4|||
46706396|NCT01215227|82921521|FG002|Overall Study|Lost to Follow-up|1|||
46706397|NCT01215227|82921522|FG003|Overall Study|Lost to Follow-up|1|||
46706398|NCT01215227|82921523|FG004|Overall Study|Lost to Follow-up|1|||
46706399|NCT01215227|82921524|FG005|Overall Study|Lost to Follow-up|2|||
46706400|NCT01215227|82921519|FG000|Overall Study|Subject Withdrew Consent|16|||
46706401|NCT01215227|82921520|FG001|Overall Study|Subject Withdrew Consent|20|||
46706402|NCT01215227|82921521|FG002|Overall Study|Subject Withdrew Consent|7|||
46706403|NCT01215227|82921522|FG003|Overall Study|Subject Withdrew Consent|10|||
46706404|NCT01215227|82921523|FG004|Overall Study|Subject Withdrew Consent|11|||
46706405|NCT01215227|82921524|FG005|Overall Study|Subject Withdrew Consent|8|||
46706406|NCT01215227|82921519|FG000|Overall Study|Non-Compliance With Protocol|2|||
46706407|NCT01215227|82921520|FG001|Overall Study|Non-Compliance With Protocol|6|||
46706408|NCT01215227|82921521|FG002|Overall Study|Non-Compliance With Protocol|1|||
46706409|NCT01215227|82921522|FG003|Overall Study|Non-Compliance With Protocol|0|||
46706410|NCT01215227|82921523|FG004|Overall Study|Non-Compliance With Protocol|0|||
46706411|NCT01215227|82921524|FG005|Overall Study|Non-Compliance With Protocol|0|||
46706412|NCT01215227|82921519|FG000|Overall Study|Administrative|83|||
46706413|NCT01215227|82921520|FG001|Overall Study|Administrative|73|||
46706414|NCT01215227|82921521|FG002|Overall Study|Administrative|42|||
46706415|NCT01215227|82921522|FG003|Overall Study|Administrative|24|||
46706416|NCT01215227|82921523|FG004|Overall Study|Administrative|28|||
46706417|NCT01215227|82921524|FG005|Overall Study|Administrative|40|||
46706418|NCT01215227|82921519|FG000|Overall Study|Missing Status|0|||
46706419|NCT01215227|82921520|FG001|Overall Study|Missing Status|1|||
46706420|NCT01215227|82921521|FG002|Overall Study|Missing Status|0|||
46706421|NCT01215227|82921522|FG003|Overall Study|Missing Status|0|||
46706422|NCT01215227|82921523|FG004|Overall Study|Missing Status|0|||
46706423|NCT01215227|82921524|FG005|Overall Study|Missing Status|0|||
46706424|NCT01215227|82921519|FG000|Overall Study|Randomized but not treated|0|||
46706425|NCT01215227|82921520|FG001|Overall Study|Randomized but not treated|0|||
46706426|NCT01215227|82921521|FG002|Overall Study|Randomized but not treated|1|||
46706427|NCT01215227|82921522|FG003|Overall Study|Randomized but not treated|1|||
46706428|NCT01215227|82921523|FG004|Overall Study|Randomized but not treated|0|||
46706429|NCT01215227|82921524|FG005|Overall Study|Randomized but not treated|1|||
46706430|NCT01009515|82921538|FG000|Overall Study|Withdrawal by Subject|3|||
46706431|NCT01214915|82921542|FG000|Overall Study|Adverse Event|8|||
46706432|NCT01214915|82921542|FG000|Overall Study|Lack of Efficacy|3|||
46706433|NCT01009281|82921546|FG000|Overall Study|Administrative problems|7|||
46706434|NCT01009203|82921550|FG000|Overall Study|Withdrawal by Subject|1|||
46706435|NCT01009203|82921550|FG000|Overall Study|Adverse Event|5|||
46706436|NCT01009203|82921550|FG000|Overall Study|Treatment-unrelated death|1|||
46706437|NCT01009047|82921556|FG000|Overall Study|Adverse Event|5|||
46706438|NCT01009047|82921557|FG001|Overall Study|Adverse Event|0|||
46706439|NCT01009047|82921556|FG000|Overall Study|Lost to Follow-up|0|||
46706440|NCT01009047|82921557|FG001|Overall Study|Lost to Follow-up|2|||
46706441|NCT01009047|82921556|FG000|Overall Study|Lack of Efficacy|4|||
46706442|NCT01009047|82921557|FG001|Overall Study|Lack of Efficacy|11|||
46706443|NCT01009047|82921556|FG000|Overall Study|Withdrawal by consent|16|||
46706444|NCT01009047|82921557|FG001|Overall Study|Withdrawal by consent|11|||
46706445|NCT01009047|82921556|FG000|Overall Study|Other|3|||
46706446|NCT01009047|82921557|FG001|Overall Study|Other|2|||
46706447|NCT01025193|82921563|FG000|Overall Study|Protocol Violation|1|||
46706448|NCT01025193|82921563|FG000|Overall Study|Adverse Event|3|||
46706449|NCT01025037|82921571|FG000|Overall Study|Adverse Event|3|||
46706450|NCT01025037|82921571|FG000|Overall Study|Lost to Follow-up|7|||
46706451|NCT01025037|82921571|FG000|Overall Study|Withdrawal by Subject|1|||
46706452|NCT01214837|82921578|FG000|Overall Study|Death|0|||
46706453|NCT01214837|82921579|FG001|Overall Study|Death|0|||
46706454|NCT01214837|82921580|FG002|Overall Study|Death|1|||
46706455|NCT01214837|82921578|FG000|Overall Study|Adverse Event|1|||
46706456|NCT01214837|82921579|FG001|Overall Study|Adverse Event|2|||
46706457|NCT01214837|82921580|FG002|Overall Study|Adverse Event|1|||
46706458|NCT01214837|82921578|FG000|Overall Study|Withdrawal by Subject|27|||
46706459|NCT01214837|82921579|FG001|Overall Study|Withdrawal by Subject|36|||
46706460|NCT01214837|82921580|FG002|Overall Study|Withdrawal by Subject|28|||
46706461|NCT01214837|82921578|FG000|Overall Study|Lost to Follow-up|20|||
46706462|NCT01214837|82921579|FG001|Overall Study|Lost to Follow-up|15|||
46706463|NCT01214837|82921580|FG002|Overall Study|Lost to Follow-up|21|||
46706464|NCT01214837|82921578|FG000|Overall Study|Inappropriate Enrolment|0|||
46706465|NCT01214837|82921579|FG001|Overall Study|Inappropriate Enrolment|1|||
46706466|NCT01214837|82921580|FG002|Overall Study|Inappropriate Enrolment|2|||
46706467|NCT01214837|82921578|FG000|Overall Study|Administrative Reason|2|||
46706468|NCT01214837|82921579|FG001|Overall Study|Administrative Reason|6|||
46706469|NCT01214837|82921580|FG002|Overall Study|Administrative Reason|4|||
46706470|NCT01214837|82921578|FG000|Overall Study|Protocol Violation|3|||
46706471|NCT01214837|82921579|FG001|Overall Study|Protocol Violation|1|||
46706472|NCT01214837|82921580|FG002|Overall Study|Protocol Violation|5|||
46706473|NCT01214837|82921578|FG000|Overall Study|Unable to Classify|1|||
46706474|NCT01214837|82921579|FG001|Overall Study|Unable to Classify|3|||
46706475|NCT01214837|82921580|FG002|Overall Study|Unable to Classify|0|||
46706476|NCT01024959|82921589|FG000|Overall Study|ineligible|12|||
46706477|NCT01024959|82921589|FG000|Overall Study|results not evaluable|12|||
46706478|NCT01024959|82921589|FG000|Overall Study|missing results required for analysis|17|||
46706479|NCT01008423|82921600|FG000|Overall Study|Adverse Event|13|||
46706480|NCT01008423|82921601|FG001|Overall Study|Adverse Event|6|||
46706481|NCT01008423|82921600|FG000|Overall Study|Withdrawal by Subject|4|||
46706482|NCT01008423|82921601|FG001|Overall Study|Withdrawal by Subject|7|||
46706483|NCT01008423|82921600|FG000|Overall Study|Lost to Follow-up|0|||
46706484|NCT01008423|82921601|FG001|Overall Study|Lost to Follow-up|2|||
46706485|NCT01008423|82921600|FG000|Overall Study|Low Cortisol|0|||
46706486|NCT01008423|82921601|FG001|Overall Study|Low Cortisol|1|||
46706487|NCT01008423|82921600|FG000|Overall Study|Lack of Efficacy|0|||
46706488|NCT01008423|82921601|FG001|Overall Study|Lack of Efficacy|5|||
46706489|NCT01008423|82921600|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
46706490|NCT01008423|82921601|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
46706491|NCT01008423|82921600|FG000|Overall Study|Personal Conflict|1|||
46706492|NCT01008423|82921601|FG001|Overall Study|Personal Conflict|0|||
46706493|NCT01008423|82921600|FG000|Overall Study|Other|0|||
46706494|NCT01008423|82921601|FG001|Overall Study|Other|1|||
46706495|NCT01012947|82921612|FG000|Overall Study|Lost to Follow-up|131|||
46706496|NCT01012947|82921613|FG001|Overall Study|Lost to Follow-up|135|||
46706497|NCT01012947|82921614|FG002|Overall Study|Lost to Follow-up|130|||
46706498|NCT01012947|82921615|FG003|Overall Study|Lost to Follow-up|118|||
46706499|NCT01012947|82921616|FG004|Overall Study|Lost to Follow-up|142|||
46706500|NCT01214603|82921648|FG000|Overall Study|Adverse Event|0|||
46706501|NCT01214603|82921649|FG001|Overall Study|Adverse Event|0|||
46706502|NCT01214603|82921650|FG002|Overall Study|Adverse Event|1|||
46706503|NCT01214603|82921648|FG000|Overall Study|Death|1|||
46706504|NCT01214603|82921649|FG001|Overall Study|Death|0|||
46706505|NCT01214603|82921650|FG002|Overall Study|Death|0|||
46706506|NCT01214603|82921648|FG000|Overall Study|Progressive Disease|4|||
46706507|NCT01214603|82921649|FG001|Overall Study|Progressive Disease|1|||
46706508|NCT01214603|82921650|FG002|Overall Study|Progressive Disease|3|||
46706509|NCT01212185|82921661|FG000|Overall Study|Protocol Violation|2|||
46706510|NCT01212185|82921662|FG001|Overall Study|Protocol Violation|1|||
46706511|NCT01995175|82921668|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
46706512|NCT01995175|82921668|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
46706513|NCT01995175|82921668|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
46706514|NCT01995175|82921668|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
46706515|NCT01995175|82921668|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
46706516|NCT01995175|82921668|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
46706517|NCT01995175|82921668|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
46706518|NCT01995175|82921668|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
46706519|NCT01995175|82921668|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
46706520|NCT01752907|82921757|FG000|Overall Study|Withdrawal by Subject|4|||
46706521|NCT01752907|82921758|FG001|Overall Study|Withdrawal by Subject|10|||
46706522|NCT01752907|82921757|FG000|Overall Study|Lost to Follow-up|2|||
46706523|NCT01752907|82921758|FG001|Overall Study|Lost to Follow-up|1|||
46706524|NCT01752907|82921757|FG000|Overall Study|Decision by Sponsor|6|||
46706525|NCT01752907|82921758|FG001|Overall Study|Decision by Sponsor|9|||
46706526|NCT03439189|82921764|FG000|Overall Study|Protocol Violation|19|||
46706527|NCT03439189|82921764|FG000|Overall Study|Lack of Efficacy|63|||
46706528|NCT01211483|82921773|FG000|Phase 1b|Death|6|||
46706529|NCT01211483|82921774|FG001|Phase 1b|Death|0|||
46706530|NCT01211483|82921775|FG002|Phase 1b|Death|0|||
46706531|NCT01211483|82921776|FG003|Phase 1b|Death|0|||
46706532|NCT01211483|82921773|FG000|Phase 1b|Withdrawal by Subject|1|||
46706533|NCT01211483|82921774|FG001|Phase 1b|Withdrawal by Subject|0|||
46706534|NCT01211483|82921775|FG002|Phase 1b|Withdrawal by Subject|0|||
46706535|NCT01211483|82921776|FG003|Phase 1b|Withdrawal by Subject|0|||
46706536|NCT01211483|82921773|FG000|Phase 2|Lost to Follow-up|0|||
46706537|NCT01211483|82921774|FG001|Phase 2|Lost to Follow-up|1|||
46890013|NCT03387735|83112631|FG001|Overall Study|Lost to Follow-up|8|||
46890014|NCT03387735|83112630|FG000|Overall Study|Death|4|||
46890015|NCT03387735|83112631|FG001|Overall Study|Death|8|||
46890016|NCT04055090|83112639|FG000|Overall Study|screen failure|1|||
46890017|NCT04055090|83112640|FG001|Overall Study|screen failure|0|||
46890018|NCT04055090|83112639|FG000|Overall Study|Withdrawal by Subject|1|||
46890019|NCT04055090|83112640|FG001|Overall Study|Withdrawal by Subject|0|||
46890020|NCT03403413|83112663|FG000|Overall Study|Lack of Efficacy|2|||
46890021|NCT03721705|83112680|FG000|Overall Study|Adverse Event|2|||
46890022|NCT03721705|83112681|FG001|Overall Study|Adverse Event|0|||
46890023|NCT03721705|83112680|FG000|Overall Study|Withdrawal by Subject|4|||
46890024|NCT03721705|83112681|FG001|Overall Study|Withdrawal by Subject|10|||
46890025|NCT03721705|83112680|FG000|Overall Study|No Suitable Study Partner|1|||
46890026|NCT03721705|83112681|FG001|Overall Study|No Suitable Study Partner|0|||
46890027|NCT03721705|83112680|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
46890028|NCT03721705|83112681|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
46890029|NCT03721705|83112680|FG000|Overall Study|Death|0|||
46890030|NCT03721705|83112681|FG001|Overall Study|Death|1|||
46890031|NCT03720847|83112687|FG000|Washout|Physician Decision|1|||
46890032|NCT03720847|83112688|FG001|Washout|Physician Decision|2|||
46890033|NCT02631070|83112697|FG000|Overall Study|Withdrawal by Subject|35|||
46890034|NCT02631070|83112698|FG001|Overall Study|Withdrawal by Subject|13|||
46890035|NCT02631070|83112697|FG000|Overall Study|Death|45|||
46890036|NCT02631070|83112698|FG001|Overall Study|Death|24|||
46890037|NCT02631070|83112697|FG000|Overall Study|Lost to Follow-up|5|||
46890038|NCT02631070|83112698|FG001|Overall Study|Lost to Follow-up|1|||
46890039|NCT02631070|83112697|FG000|Overall Study|Transition to rollover protocol|52|||
46890040|NCT02631070|83112698|FG001|Overall Study|Transition to rollover protocol|21|||
46890041|NCT02631070|83112697|FG000|Overall Study|Other reasons|12|||
46890042|NCT02631070|83112698|FG001|Overall Study|Other reasons|5|||
46890043|NCT00741988|83112706|FG000|Overall Study|Adverse Event|2|||
46890044|NCT00741988|83112707|FG001|Overall Study|Adverse Event|4|||
46890045|NCT00741988|83112706|FG000|Overall Study|Lack of Efficacy|2|||
46890046|NCT00741988|83112707|FG001|Overall Study|Lack of Efficacy|0|||
46890047|NCT03354429|83112715|FG000|Overall Study|Withdrawal by Subject|8|||
46890048|NCT03354429|83112716|FG001|Overall Study|Withdrawal by Subject|7|||
46890049|NCT03354429|83112715|FG000|Overall Study|Lost to Follow-up|1|||
46890050|NCT03354429|83112716|FG001|Overall Study|Lost to Follow-up|0|||
46890051|NCT03352713|83112722|FG000|Overall Study|Lost to Follow-up|8|||
46890052|NCT03352713|83112722|FG000|Overall Study|Withdrawn by investigator|5|||
46890053|NCT03352713|83112722|FG000|Overall Study|Completed 0 EMAs|8|||
46890054|NCT03352713|83112722|FG000|Overall Study|Device incompatible/stolen|5|||
46890055|NCT03901144|83112726|FG000|Overall Study|Lost to Follow-up|1|||
46890056|NCT03901144|83112727|FG001|Overall Study|Lost to Follow-up|1|||
46890057|NCT03901144|83112728|FG002|Overall Study|Lost to Follow-up|1|||
46890058|NCT03901144|83112729|FG003|Overall Study|Lost to Follow-up|1|||
46890059|NCT02952261|83112741|FG000|Overall Study|Withdrawal by Subject|4|||
46890060|NCT02952261|83112742|FG001|Overall Study|Withdrawal by Subject|5|||
46890061|NCT02952261|83112741|FG000|Overall Study|Protocol Violation|1|||
46890062|NCT02952261|83112742|FG001|Overall Study|Protocol Violation|0|||
46890063|NCT03384693|83112748|FG000|Overall Study|Adverse Event|3|||
46890064|NCT03718429|83112760|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
46890065|NCT03718429|83112761|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
46890066|NCT03718429|83112762|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
46890067|NCT03718429|83112763|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
46706538|NCT01211483|82921775|FG002|Phase 2|Lost to Follow-up|1|||
46706539|NCT01211483|82921776|FG003|Phase 2|Lost to Follow-up|2|||
46706540|NCT01211483|82921773|FG000|Phase 2|Death|0|||
46706541|NCT01211483|82921774|FG001|Phase 2|Death|64|||
46706542|NCT01211483|82921775|FG002|Phase 2|Death|53|||
46706543|NCT01211483|82921776|FG003|Phase 2|Death|53|||
46706544|NCT01211483|82921773|FG000|Phase 2|Withdrawal by Subject|0|||
46706545|NCT01211483|82921774|FG001|Phase 2|Withdrawal by Subject|1|||
46706546|NCT01211483|82921775|FG002|Phase 2|Withdrawal by Subject|10|||
46890068|NCT01285102|83112783|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
46890069|NCT03382899|83112817|FG000|Overall Study|Ineligibility Determined|0|||
46890070|NCT03382899|83112818|FG001|Overall Study|Ineligibility Determined|1|||
46890071|NCT03382899|83112817|FG000|Overall Study|Lost to Follow-up|0|||
46890072|NCT03382899|83112818|FG001|Overall Study|Lost to Follow-up|1|||
46890073|NCT03382899|83112817|FG000|Overall Study|Sponsor's decision|31|||
46890074|NCT03382899|83112818|FG001|Overall Study|Sponsor's decision|28|||
46890075|NCT03382899|83112817|FG000|Overall Study|Withdrawal by Subject|0|||
46890076|NCT03382899|83112818|FG001|Overall Study|Withdrawal by Subject|5|||
46890077|NCT00709852|83112824|FG000|Period 1|Adverse Event|2|||
46890078|NCT00709852|83112825|FG001|Period 1|Adverse Event|0|||
46706547|NCT01211483|82921776|FG003|Phase 2|Withdrawal by Subject|5|||
46706548|NCT01211483|82921773|FG000|Phase 2|Study terminated by Sponsor|0|||
46890079|NCT00709852|83112824|FG000|Period 1|Withdrawal by Subject|4|||
46890080|NCT00709852|83112825|FG001|Period 1|Withdrawal by Subject|2|||
46890081|NCT00709852|83112824|FG000|Period 1|Protocol Violation|1|||
46890082|NCT00709852|83112825|FG001|Period 1|Protocol Violation|0|||
46890083|NCT00709852|83112824|FG000|Period 1|Defective scanner|0|||
46890084|NCT00709852|83112825|FG001|Period 1|Defective scanner|1|||
46890085|NCT00709852|83112824|FG000|Period 1|Lost to Follow-up|1|||
46890086|NCT00709852|83112825|FG001|Period 1|Lost to Follow-up|0|||
46890087|NCT00709852|83112824|FG000|Period 2|Protocol Violation|4|||
46890088|NCT00709852|83112825|FG001|Period 2|Protocol Violation|1|||
46890089|NCT00709852|83112824|FG000|Period 2|Adverse Event|1|||
46890090|NCT00709852|83112825|FG001|Period 2|Adverse Event|1|||
46890091|NCT00709852|83112824|FG000|Period 2|Lost to Follow-up|1|||
46890092|NCT00709852|83112825|FG001|Period 2|Lost to Follow-up|0|||
46890093|NCT00709852|83112824|FG000|Period 2|No 72-hour follow-up|3|||
46890094|NCT00709852|83112825|FG001|Period 2|No 72-hour follow-up|0|||
46890095|NCT03382041|83112842|FG000|Overall Study|Consent Form Lost|2|||
46890096|NCT03382041|83112843|FG001|Overall Study|Consent Form Lost|1|||
46890097|NCT03382041|83112842|FG000|Overall Study|Withdrawal by Subject|1|||
46890098|NCT03382041|83112843|FG001|Overall Study|Withdrawal by Subject|4|||
46890099|NCT03382041|83112842|FG000|Overall Study|Lost to Follow-up|1|||
46890100|NCT03382041|83112843|FG001|Overall Study|Lost to Follow-up|4|||
46890101|NCT03351231|83112849|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
46890102|NCT03351231|83112849|FG000|Combination Therapy Period|Disease progression|2|||
46890103|NCT03351231|83112849|FG000|Combination Therapy Period|Study drug toxicity|1|||
46890104|NCT03351231|83112849|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
46890105|NCT03351231|83112849|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
46890106|NCT03351231|83112849|FG000|Safety Follow-Up Period|Other reason|2|||
46890107|NCT03381339|83112855|FG000|Overall Study|Protocol Violation|4|||
46890108|NCT03381339|83112856|FG001|Overall Study|Protocol Violation|3|||
46890109|NCT03381339|83112855|FG000|Overall Study|Lost to Follow-up|0|||
46890110|NCT03381339|83112856|FG001|Overall Study|Lost to Follow-up|1|||
46890111|NCT03401229|83112864|FG000|Overall Study|Lost to Follow-up|2|||
46890112|NCT03401229|83112865|FG001|Overall Study|Lost to Follow-up|1|||
46890113|NCT03401229|83112864|FG000|Overall Study|Other|1|||
46890114|NCT03401229|83112865|FG001|Overall Study|Other|3|||
46890115|NCT03401229|83112864|FG000|Overall Study|Adverse Event|8|||
46890116|NCT03401229|83112865|FG001|Overall Study|Adverse Event|6|||
46890117|NCT03401229|83112864|FG000|Overall Study|Withdrawal by Subject|29|||
46890118|NCT03401229|83112865|FG001|Overall Study|Withdrawal by Subject|26|||
46890119|NCT03401229|83112864|FG000|Overall Study|COVID-19|0|||
46890120|NCT03401229|83112865|FG001|Overall Study|COVID-19|1|||
46890121|NCT03349515|83112873|FG000|Overall Study|Lack of Efficacy|2|||
46890122|NCT03349515|83112874|FG001|Overall Study|Lack of Efficacy|0|||
46890123|NCT03349515|83112873|FG000|Overall Study|Physician Decision|3|||
46890124|NCT03349515|83112874|FG001|Overall Study|Physician Decision|1|||
46890125|NCT03349437|83112880|FG000|Screening|Screen Fail|4|||
46890126|NCT03349437|83112881|FG001|Screening|Screen Fail|0|||
46890127|NCT03349437|83112882|FG002|Screening|Screen Fail|0|||
46890128|NCT03349437|83112880|FG000|Screening|Withdrawn|1|||
46890129|NCT03349437|83112881|FG001|Screening|Withdrawn|0|||
46890130|NCT03349437|83112882|FG002|Screening|Withdrawn|0|||
46890131|NCT03380091|83112891|FG000|Overall Study|Withdrawal by Subject|2|||
46890132|NCT03380091|83112892|FG001|Overall Study|Withdrawal by Subject|1|||
46890133|NCT03379233|83112902|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
46890134|NCT03379233|83112903|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
46890135|NCT01377922|83112911|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
46890136|NCT01377922|83112912|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
46890137|NCT03372603|83112918|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
46890138|NCT03372603|83112919|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
46890139|NCT03372603|83112918|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
46890140|NCT03372603|83112919|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
46890141|NCT01377844|83112927|FG000|Overall Study|Withdrawal by Subject|25|||
46890142|NCT01377844|83112928|FG001|Overall Study|Withdrawal by Subject|28|||
46890143|NCT01377844|83112927|FG000|Overall Study|Protocol Violation|2|||
46890144|NCT01377844|83112928|FG001|Overall Study|Protocol Violation|3|||
46890145|NCT01377844|83112927|FG000|Overall Study|Adverse Event|3|||
46890146|NCT01377844|83112928|FG001|Overall Study|Adverse Event|0|||
46890147|NCT01377844|83112927|FG000|Overall Study|Physician Decision|6|||
46890148|NCT01377844|83112928|FG001|Overall Study|Physician Decision|3|||
46890149|NCT01377844|83112927|FG000|Overall Study|Study terminated by Sponsor|0|||
46890150|NCT01377844|83112928|FG001|Overall Study|Study terminated by Sponsor|1|||
46890151|NCT03372369|83112937|FG000|Qualification Period|Withdrawal by Subject|16|||
46890152|NCT03372369|83112938|FG001|Qualification Period|Withdrawal by Subject|13|||
46890153|NCT03372369|83112937|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
46890154|NCT03372369|83112938|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
46890155|NCT03372369|83112937|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
46890156|NCT03372369|83112938|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
46890157|NCT03371355|83112948|FG000|Overall Study|Investigator judgment|0|||
46890158|NCT03371355|83112949|FG001|Overall Study|Investigator judgment|0|||
46890159|NCT03371355|83112950|FG002|Overall Study|Investigator judgment|1|||
46890160|NCT03371355|83112951|FG003|Overall Study|Investigator judgment|1|||
46890161|NCT03371355|83112948|FG000|Overall Study|Voluntary withdrawal|1|||
46890162|NCT03371355|83112949|FG001|Overall Study|Voluntary withdrawal|0|||
46890163|NCT03371355|83112950|FG002|Overall Study|Voluntary withdrawal|1|||
46890164|NCT03371355|83112951|FG003|Overall Study|Voluntary withdrawal|2|||
46890165|NCT03371355|83112948|FG000|Overall Study|Adverse Event|0|||
46890166|NCT03371355|83112949|FG001|Overall Study|Adverse Event|1|||
46890167|NCT03371355|83112950|FG002|Overall Study|Adverse Event|2|||
46890168|NCT03371355|83112951|FG003|Overall Study|Adverse Event|3|||
46890169|NCT03371355|83112948|FG000|Overall Study|Reason not Specified|0|||
46890170|NCT03371355|83112949|FG001|Overall Study|Reason not Specified|1|||
46890171|NCT03371355|83112950|FG002|Overall Study|Reason not Specified|0|||
46890172|NCT03371355|83112951|FG003|Overall Study|Reason not Specified|1|||
46890173|NCT03370419|83112965|FG000|Overall Study|Lost to Follow-up|16|||
46890174|NCT03369951|83112973|FG000|Overall Study|Withdrawal by Subject|3|||
46890175|NCT03369951|83112973|FG000|Overall Study|Death|1|||
46890176|NCT03369951|83112973|FG000|Overall Study|Lost to Follow-up|1|||
46890177|NCT03369951|83112973|FG000|Overall Study|Protocol Violation|1|||
46890178|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
46890179|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
46890180|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
46890181|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
46890182|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
46890183|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
46890184|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
46890185|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
46890186|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
46890187|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
46890188|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
46890189|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
46890190|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
46890191|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
46890192|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
46890193|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
46890194|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
46890195|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
46890196|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
46890197|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
46890198|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
46890199|NCT04040192|83112977|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
46890200|NCT04040192|83112978|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
46890201|NCT04040192|83112979|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
46890202|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
46890203|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
46890204|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
46890205|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
46890206|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
46890207|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
46890208|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
46890209|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
46890210|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
46890211|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
46890212|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
46890213|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
46890214|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
46890215|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
46890216|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
46890217|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
46890218|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
46890219|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
46890220|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
46890221|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
46991540|NCT02158533|83238501|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
46890222|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
46890223|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
46890224|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
46890225|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
46890226|NCT04040192|83112977|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
46890227|NCT04040192|83112978|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
46890228|NCT04040192|83112979|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
46890229|NCT03368859|83113003|FG000|Overall Study|Withdrew Consent|5|||
46890230|NCT03368859|83113004|FG001|Overall Study|Withdrew Consent|4|||
46890231|NCT03368859|83113003|FG000|Overall Study|Death|12|||
46890232|NCT03368859|83113004|FG001|Overall Study|Death|6|||
46890233|NCT03368859|83113003|FG000|Overall Study|Study terminated by Sponsor|18|||
46890234|NCT03368859|83113004|FG001|Overall Study|Study terminated by Sponsor|23|||
46890235|NCT03368859|83113003|FG000|Overall Study|Other|1|||
46890236|NCT03368859|83113004|FG001|Overall Study|Other|1|||
46890237|NCT03096314|83113018|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
46890238|NCT03096314|83113019|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
46890239|NCT03335163|83113025|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
46890240|NCT03335163|83113025|FG000|Overall Study|Withdrawal by Subject|18|||
46890241|NCT03364335|83113051|FG000|Overall Study|Adverse Event|3|||
46890242|NCT03364335|83113052|FG001|Overall Study|Adverse Event|4|||
46890243|NCT03364335|83113053|FG002|Overall Study|Adverse Event|1|||
46890244|NCT03364335|83113054|FG003|Overall Study|Adverse Event|2|||
46890245|NCT03364335|83113055|FG004|Overall Study|Adverse Event|0|||
46890246|NCT03364335|83113051|FG000|Overall Study|Lost to Follow-up|7|||
46890247|NCT03364335|83113052|FG001|Overall Study|Lost to Follow-up|7|||
46890248|NCT03364335|83113053|FG002|Overall Study|Lost to Follow-up|10|||
46890249|NCT03364335|83113054|FG003|Overall Study|Lost to Follow-up|11|||
46890250|NCT03364335|83113055|FG004|Overall Study|Lost to Follow-up|11|||
46890251|NCT03334695|83113078|FG000|Overall Study|Lost to Follow-up|3|||
46890252|NCT03334695|83113079|FG001|Overall Study|Lost to Follow-up|3|||
46890253|NCT03334695|83113078|FG000|Overall Study|Physician Decision|1|||
46890254|NCT03334695|83113079|FG001|Overall Study|Physician Decision|2|||
46890255|NCT03334695|83113078|FG000|Overall Study|Protocol Violation|0|||
46890256|NCT03334695|83113079|FG001|Overall Study|Protocol Violation|1|||
46890257|NCT03364023|83113087|FG000|Overall Study|Lost to Follow-up|3|||
46890258|NCT03364023|83113087|FG000|Overall Study|Death|14|||
46890259|NCT03764813|83113111|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
46890260|NCT03764813|83113112|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
46890261|NCT03764813|83113113|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
46890262|NCT03764813|83113114|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
46890263|NCT03363321|83113135|FG000|Overall Study|Withdrawal by Subject|0|||
46890264|NCT03363321|83113136|FG001|Overall Study|Withdrawal by Subject|1|||
46890265|NCT03363321|83113137|FG002|Overall Study|Withdrawal by Subject|0|||
46890266|NCT03363321|83113138|FG003|Overall Study|Withdrawal by Subject|1|||
46890267|NCT03363321|83113139|FG004|Overall Study|Withdrawal by Subject|0|||
46890268|NCT03361605|83113152|FG000|Overall Study|Analyzable data not available|3|||
46890269|NCT03829046|83113158|FG000|Overall Study|Withdrawal by Subject|1|||
46890270|NCT03829046|83113159|FG001|Overall Study|Withdrawal by Subject|0|||
46890271|NCT03361293|83113167|FG000|Overall Study|Lost to Follow-up|0|||
46890272|NCT03361293|83113168|FG001|Overall Study|Lost to Follow-up|2|||
46890273|NCT03361293|83113167|FG000|Overall Study|Withdrawal by Subject|1|||
46890274|NCT03361293|83113168|FG001|Overall Study|Withdrawal by Subject|3|||
46890275|NCT03361137|83113179|FG000|Overall Study|Reason not specified|1|||
46890276|NCT03361137|83113180|FG001|Overall Study|Reason not specified|0|||
46890277|NCT03361137|83113181|FG002|Overall Study|Reason not specified|0|||
46890278|NCT03361137|83113182|FG003|Overall Study|Reason not specified|0|||
46890279|NCT03361137|83113183|FG004|Overall Study|Reason not specified|0|||
46890280|NCT03360747|83113197|FG000|Overall Study|Voluntary Withdrawal|1|||
46890281|NCT03359811|83113203|FG000|Overall Study|Protocol Violation|2|||
46890282|NCT03359811|83113204|FG001|Overall Study|Protocol Violation|0|||
46890283|NCT03728426|83113211|FG000|Overall Study|Death|3|||
46890284|NCT02095678|83113217|FG000|Overall Study|Withdrawal by Subject|0|||
46890285|NCT02095678|83113218|FG001|Overall Study|Withdrawal by Subject|1|||
46890286|NCT02095678|83113217|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
46890287|NCT02095678|83113218|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
46890288|NCT02095678|83113217|FG000|Overall Study|lesion impacted by previous treatment|1|||
46890289|NCT02095678|83113218|FG001|Overall Study|lesion impacted by previous treatment|1|||
46890290|NCT02095678|83113217|FG000|Overall Study|No Confirmed Diagnosis|0|||
46890291|NCT02095678|83113218|FG001|Overall Study|No Confirmed Diagnosis|3|||
46890292|NCT02095678|83113217|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
46890293|NCT02095678|83113218|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
46890294|NCT02095678|83113217|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
46890295|NCT02095678|83113218|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
46890296|NCT03763877|83113231|FG000|Overall Study|Withdrawal by Subject|3|||
46890297|NCT03763877|83113232|FG001|Overall Study|Withdrawal by Subject|1|||
46890298|NCT03763877|83113233|FG002|Overall Study|Withdrawal by Subject|3|||
46890299|NCT03763877|83113234|FG003|Overall Study|Withdrawal by Subject|4|||
46890300|NCT03763877|83113231|FG000|Overall Study|Adverse Event|1|||
46890301|NCT03763877|83113232|FG001|Overall Study|Adverse Event|1|||
46890302|NCT03763877|83113233|FG002|Overall Study|Adverse Event|3|||
46890303|NCT03763877|83113234|FG003|Overall Study|Adverse Event|1|||
46890304|NCT03763877|83113231|FG000|Overall Study|Protocol Violation|1|||
46890305|NCT03763877|83113232|FG001|Overall Study|Protocol Violation|1|||
46890306|NCT03763877|83113233|FG002|Overall Study|Protocol Violation|0|||
46890307|NCT03763877|83113234|FG003|Overall Study|Protocol Violation|0|||
46890308|NCT03763877|83113231|FG000|Overall Study|Lost to Follow-up|0|||
46890309|NCT03763877|83113232|FG001|Overall Study|Lost to Follow-up|1|||
46890310|NCT03763877|83113233|FG002|Overall Study|Lost to Follow-up|1|||
46890311|NCT03763877|83113234|FG003|Overall Study|Lost to Follow-up|0|||
46890312|NCT03358407|83113267|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890313|NCT03358407|83113268|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890314|NCT03358407|83113269|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
46890315|NCT03358407|83113270|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890316|NCT03358407|83113271|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890317|NCT03358407|83113272|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890318|NCT03358407|83113273|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890319|NCT03358407|83113274|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890320|NCT03358407|83113275|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890321|NCT03358407|83113276|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
46890322|NCT03358407|83113267|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890323|NCT03358407|83113268|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890324|NCT03358407|83113269|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890325|NCT03358407|83113270|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890326|NCT03358407|83113271|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
46890327|NCT03358407|83113272|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890328|NCT03358407|83113273|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890329|NCT03358407|83113274|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890330|NCT03358407|83113275|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890331|NCT03358407|83113276|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890332|NCT03358407|83113267|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890333|NCT03358407|83113268|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890334|NCT03358407|83113269|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890335|NCT03358407|83113270|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890336|NCT03358407|83113271|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890337|NCT03358407|83113272|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
46890338|NCT03358407|83113273|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890339|NCT03358407|83113274|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
46890340|NCT03358407|83113275|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890341|NCT03358407|83113276|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
46890342|NCT03358407|83113267|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890343|NCT03358407|83113268|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890344|NCT03358407|83113269|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890345|NCT03358407|83113270|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890346|NCT03358407|83113271|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890347|NCT03358407|83113272|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
46890348|NCT03358407|83113273|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890349|NCT03358407|83113274|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
46890350|NCT03358407|83113275|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890351|NCT03358407|83113276|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
46890352|NCT03358407|83113267|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890353|NCT03358407|83113268|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890354|NCT03358407|83113269|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890355|NCT03358407|83113270|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890356|NCT03358407|83113271|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890357|NCT03358407|83113272|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
46890358|NCT03358407|83113273|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
46890359|NCT03358407|83113274|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890360|NCT03358407|83113275|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890361|NCT03358407|83113276|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
46890362|NCT03358407|83113267|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
46890363|NCT03358407|83113268|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
46890364|NCT03358407|83113269|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
46890365|NCT03358407|83113270|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
46890366|NCT03358407|83113271|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
46890367|NCT03358407|83113272|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
46890368|NCT03358407|83113273|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
46890369|NCT03358407|83113274|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
46890370|NCT03358407|83113275|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
46890371|NCT03358407|83113276|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
46890372|NCT02950545|83113318|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
46890373|NCT02950545|83113319|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
46890374|NCT02950545|83113320|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
46890375|NCT02950545|83113321|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
46890376|NCT02950545|83113322|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
46890377|NCT02950545|83113323|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
46890378|NCT02950545|83113318|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
46890379|NCT02950545|83113319|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
46890380|NCT02950545|83113320|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
46890381|NCT02950545|83113321|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
46890382|NCT02950545|83113322|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
46890383|NCT02950545|83113323|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
46890384|NCT02950545|83113318|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
46890385|NCT02950545|83113319|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
46890386|NCT02950545|83113320|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
46890387|NCT02950545|83113321|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
46890388|NCT02950545|83113322|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
46890389|NCT02950545|83113323|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
46890390|NCT02950545|83113318|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
46890391|NCT02950545|83113319|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
46890392|NCT02950545|83113320|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
46890393|NCT02950545|83113321|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
46890394|NCT02950545|83113322|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
46890395|NCT02950545|83113323|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
46890396|NCT02950545|83113318|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
46890397|NCT02950545|83113319|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
46890398|NCT02950545|83113320|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
46890399|NCT02950545|83113321|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
46890400|NCT02950545|83113322|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
46890401|NCT02950545|83113323|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
46890402|NCT03358329|83113329|FG000|Overall Study|Lost to Follow-up|2|||
46890403|NCT03358329|83113329|FG000|Overall Study|Withdrawal by Subject|2|||
46890404|NCT03357471|83113345|FG000|Overall Study|Adverse Event|1|||
46890405|NCT03357471|83113346|FG001|Overall Study|Adverse Event|0|||
46890406|NCT03357471|83113345|FG000|Overall Study|Lost to Follow-up|1|||
46890407|NCT03357471|83113346|FG001|Overall Study|Lost to Follow-up|0|||
46890408|NCT03342963|83113356|FG000|Overall Study|Adverse Event|1|||
46890409|NCT03342963|83113357|FG001|Overall Study|Adverse Event|2|||
46890410|NCT03342963|83113358|FG002|Overall Study|Adverse Event|0|||
46890411|NCT03342963|83113359|FG003|Overall Study|Adverse Event|0|||
46890412|NCT03342963|83113356|FG000|Overall Study|Withdrawal by Subject|1|||
46890413|NCT03342963|83113357|FG001|Overall Study|Withdrawal by Subject|0|||
46890414|NCT03342963|83113358|FG002|Overall Study|Withdrawal by Subject|0|||
46890415|NCT03342963|83113359|FG003|Overall Study|Withdrawal by Subject|0|||
46890416|NCT03361956|83113374|FG000|Overall Study|Adverse Event|1|||
46890417|NCT03361956|83113375|FG001|Overall Study|Adverse Event|0|||
46890418|NCT03361956|83113376|FG002|Overall Study|Adverse Event|1|||
46890419|NCT03361956|83113377|FG003|Overall Study|Adverse Event|1|||
46890420|NCT03361956|83113378|FG004|Overall Study|Adverse Event|0|||
46890421|NCT03361956|83113374|FG000|Overall Study|Other|0|||
46890422|NCT03361956|83113375|FG001|Overall Study|Other|0|||
46890423|NCT03361956|83113376|FG002|Overall Study|Other|0|||
46890424|NCT03361956|83113377|FG003|Overall Study|Other|1|||
46890425|NCT03361956|83113378|FG004|Overall Study|Other|0|||
46890426|NCT03361956|83113374|FG000|Overall Study|Withdrawal by Subject|2|||
46890427|NCT03361956|83113375|FG001|Overall Study|Withdrawal by Subject|2|||
46890428|NCT03361956|83113376|FG002|Overall Study|Withdrawal by Subject|2|||
46890429|NCT03361956|83113377|FG003|Overall Study|Withdrawal by Subject|0|||
46890430|NCT03361956|83113378|FG004|Overall Study|Withdrawal by Subject|3|||
46890431|NCT03361956|83113374|FG000|Overall Study|Disease Relapse|0|||
46890432|NCT03361956|83113375|FG001|Overall Study|Disease Relapse|0|||
46890433|NCT03361956|83113376|FG002|Overall Study|Disease Relapse|1|||
46890434|NCT03361956|83113377|FG003|Overall Study|Disease Relapse|0|||
46890435|NCT03361956|83113378|FG004|Overall Study|Disease Relapse|0|||
46890436|NCT03361956|83113374|FG000|Overall Study|Physician Decision|0|||
46890437|NCT03361956|83113375|FG001|Overall Study|Physician Decision|2|||
46890438|NCT03361956|83113376|FG002|Overall Study|Physician Decision|0|||
46890439|NCT03361956|83113377|FG003|Overall Study|Physician Decision|1|||
46890440|NCT03361956|83113378|FG004|Overall Study|Physician Decision|0|||
46890441|NCT03361956|83113374|FG000|Overall Study|Lost to Follow-up|0|||
46890442|NCT03361956|83113375|FG001|Overall Study|Lost to Follow-up|0|||
46890443|NCT03361956|83113376|FG002|Overall Study|Lost to Follow-up|1|||
46890444|NCT03361956|83113377|FG003|Overall Study|Lost to Follow-up|1|||
46890445|NCT03361956|83113378|FG004|Overall Study|Lost to Follow-up|2|||
46890446|NCT03361176|83113449|FG000|Overall Study|Lost to Follow-up|1|||
46890447|NCT03361176|83113450|FG001|Overall Study|Lost to Follow-up|2|||
46890448|NCT03361176|83113449|FG000|Overall Study|Adverse Event|0|||
46890449|NCT03361176|83113450|FG001|Overall Study|Adverse Event|2|||
46890450|NCT03361176|83113449|FG000|Overall Study|Withdrawal by Subject|0|||
46890451|NCT03361176|83113450|FG001|Overall Study|Withdrawal by Subject|1|||
46890452|NCT05283499|83113458|FG000|Overall Study|Did not receive intervention|1|||
46890453|NCT05283499|83113459|FG001|Overall Study|Did not receive intervention|2|||
46890454|NCT05271175|83113468|FG000|One Week Follow up|Lost to Follow-up|10|||
46890455|NCT05271175|83113469|FG001|One Week Follow up|Lost to Follow-up|7|||
46890456|NCT05271175|83113470|FG002|One Week Follow up|Lost to Follow-up|5|||
46890457|NCT05271175|83113468|FG000|One Month Follow up|Lost to Follow-up|12|||
46890458|NCT05271175|83113469|FG001|One Month Follow up|Lost to Follow-up|7|||
46890459|NCT05271175|83113470|FG002|One Month Follow up|Lost to Follow-up|9|||
46890460|NCT05271175|83113468|FG000|Six Months Follow up|Lost to Follow-up|8|||
46890461|NCT05271175|83113469|FG001|Six Months Follow up|Lost to Follow-up|2|||
46890462|NCT05271175|83113470|FG002|Six Months Follow up|Lost to Follow-up|2|||
46890463|NCT03098030|83113482|FG000|Overall Study|Death|10|||
46890464|NCT03098030|83113483|FG001|Overall Study|Death|156|||
46890465|NCT03098030|83113484|FG002|Overall Study|Death|156|||
46890466|NCT03098030|83113485|FG003|Overall Study|Death|82|||
46890467|NCT03098030|83113482|FG000|Overall Study|Withdrawal by Subject|0|||
46890468|NCT03098030|83113483|FG001|Overall Study|Withdrawal by Subject|7|||
46890469|NCT03098030|83113484|FG002|Overall Study|Withdrawal by Subject|8|||
46890470|NCT03098030|83113485|FG003|Overall Study|Withdrawal by Subject|2|||
46890471|NCT03098030|83113482|FG000|Overall Study|Lost to Follow-up|0|||
46890472|NCT03098030|83113483|FG001|Overall Study|Lost to Follow-up|0|||
46890473|NCT03098030|83113484|FG002|Overall Study|Lost to Follow-up|2|||
46890474|NCT03098030|83113485|FG003|Overall Study|Lost to Follow-up|1|||
46890475|NCT03341637|83113496|FG000|Overall Study|Lost to Follow-up|1|||
46890476|NCT03341637|83113497|FG001|Overall Study|Lost to Follow-up|0|||
46890477|NCT03341637|83113496|FG000|Overall Study|Withdrawal by Subject|3|||
46890478|NCT03341637|83113497|FG001|Overall Study|Withdrawal by Subject|3|||
46890479|NCT03341637|83113496|FG000|Overall Study|Reason not Specified|1|||
46890480|NCT03341637|83113497|FG001|Overall Study|Reason not Specified|1|||
46890481|NCT01378858|83113505|FG000|Overall Study|Withdrawal by Subject|4|||
46890482|NCT01378858|83113506|FG001|Overall Study|Withdrawal by Subject|4|||
46890483|NCT02891850|83113514|FG000|Overall Study|Adverse Event|3|||
46890484|NCT02891850|83113515|FG001|Overall Study|Adverse Event|0|||
46890485|NCT02891850|83113514|FG000|Overall Study|Death|0|||
46890486|NCT02891850|83113515|FG001|Overall Study|Death|4|||
46890487|NCT02891850|83113514|FG000|Overall Study|Physician Decision|1|||
46890488|NCT02891850|83113515|FG001|Overall Study|Physician Decision|0|||
46890489|NCT02891850|83113514|FG000|Overall Study|Pregnancy|1|||
46890490|NCT02891850|83113515|FG001|Overall Study|Pregnancy|0|||
46890491|NCT02891850|83113514|FG000|Overall Study|Withdrawal by Subject|2|||
46890492|NCT02891850|83113515|FG001|Overall Study|Withdrawal by Subject|3|||
46890493|NCT05594173|83113521|FG000|Overall Study|Adverse Event|1|||
46890494|NCT05594173|83113521|FG000|Overall Study|COVID-19 Pandemic|2|||
46890495|NCT03339999|83113534|FG000|Overall Study|Adverse Event|1|||
46890496|NCT03339999|83113535|FG001|Overall Study|Adverse Event|2|||
46890497|NCT03339999|83113536|FG002|Overall Study|Adverse Event|2|||
46890498|NCT03339999|83113537|FG003|Overall Study|Adverse Event|1|||
46890499|NCT03339999|83113534|FG000|Overall Study|Lack of Efficacy|0|||
46890500|NCT03339999|83113535|FG001|Overall Study|Lack of Efficacy|1|||
46890501|NCT03339999|83113536|FG002|Overall Study|Lack of Efficacy|0|||
46890502|NCT03339999|83113537|FG003|Overall Study|Lack of Efficacy|0|||
46890503|NCT03339999|83113534|FG000|Overall Study|Lost to Follow-up|0|||
46890504|NCT03339999|83113535|FG001|Overall Study|Lost to Follow-up|0|||
46890505|NCT03339999|83113536|FG002|Overall Study|Lost to Follow-up|0|||
46890506|NCT03339999|83113537|FG003|Overall Study|Lost to Follow-up|1|||
46890507|NCT03339999|83113534|FG000|Overall Study|Study Terminated by Sponsor|6|||
46890508|NCT03339999|83113535|FG001|Overall Study|Study Terminated by Sponsor|3|||
46890509|NCT03339999|83113536|FG002|Overall Study|Study Terminated by Sponsor|4|||
46890510|NCT03339999|83113537|FG003|Overall Study|Study Terminated by Sponsor|3|||
46890511|NCT03339453|83113550|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
46890512|NCT03339453|83113551|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
46890513|NCT03359850|83113595|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
46890514|NCT03359850|83113596|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
46890515|NCT03359850|83113595|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
46890516|NCT03359850|83113596|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
46890517|NCT03359850|83113595|FG000|Extension Phase (Up to 28 Months)|Death|2|||
46890518|NCT03359850|83113596|FG001|Extension Phase (Up to 28 Months)|Death|4|||
46890519|NCT03359850|83113595|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
46890520|NCT03359850|83113596|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
46890521|NCT03359850|83113595|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
46890522|NCT03359850|83113596|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
46890523|NCT00114140|83113615|FG000|Overall Study|Protocol Violation|7|||
46890524|NCT03712345|83113629|FG000|Overall Study|Failure to meet randomization criteria|0|||
46890525|NCT03712345|83113630|FG001|Overall Study|Failure to meet randomization criteria|0|||
46890526|NCT03712345|83113631|FG002|Overall Study|Failure to meet randomization criteria|1|||
46890527|NCT03358290|83113644|FG000|Overall Study|Study discontinued by Sponsor|0|||
46890528|NCT03358290|83113645|FG001|Overall Study|Study discontinued by Sponsor|1|||
46890529|NCT03358290|83113646|FG002|Overall Study|Study discontinued by Sponsor|1|||
46890530|NCT03358290|83113647|FG003|Overall Study|Study discontinued by Sponsor|0|||
46890531|NCT03358290|83113648|FG004|Overall Study|Study discontinued by Sponsor|0|||
46890532|NCT03358290|83113644|FG000|Overall Study|Adverse Event|0|||
46890533|NCT03358290|83113645|FG001|Overall Study|Adverse Event|0|||
46890534|NCT03358290|83113646|FG002|Overall Study|Adverse Event|1|||
46890535|NCT03358290|83113647|FG003|Overall Study|Adverse Event|2|||
46890536|NCT03358290|83113648|FG004|Overall Study|Adverse Event|0|||
46890537|NCT03358290|83113644|FG000|Overall Study|Withdrawal by Subject|0|||
46890538|NCT03358290|83113645|FG001|Overall Study|Withdrawal by Subject|0|||
46890539|NCT03358290|83113646|FG002|Overall Study|Withdrawal by Subject|0|||
46890540|NCT03358290|83113647|FG003|Overall Study|Withdrawal by Subject|0|||
46890541|NCT03358290|83113648|FG004|Overall Study|Withdrawal by Subject|1|||
46890542|NCT03089216|83113664|FG000|Overall Study|Adverse Event|0|||
46890543|NCT03089216|83113665|FG001|Overall Study|Adverse Event|0|||
46890544|NCT03089216|83113666|FG002|Overall Study|Adverse Event|0|||
46890545|NCT03089216|83113667|FG003|Overall Study|Adverse Event|1|||
46890546|NCT03339726|83113684|FG000|Overall Study|Withdrawal by Subject|1|||
46897662|NCT00706030|83123370|FG003|Overall Study|Failed to return|0|||
46609761|NCT00985088|82698500|FG000|Overall Study|Serious Adverse Event|1|||
46609762|NCT00985088|82698501|FG001|Overall Study|Serious Adverse Event|1|||
46609763|NCT00985088|82698502|FG002|Overall Study|Serious Adverse Event|0|||
46609764|NCT00985088|82698503|FG003|Overall Study|Serious Adverse Event|0|||
46609765|NCT00985088|82698504|FG004|Overall Study|Serious Adverse Event|0|||
46609766|NCT00985088|82698505|FG005|Overall Study|Serious Adverse Event|0|||
46609767|NCT00985088|82698506|FG006|Overall Study|Serious Adverse Event|0|||
46609768|NCT00985088|82698507|FG007|Overall Study|Serious Adverse Event|1|||
46609769|NCT00985088|82698500|FG000|Overall Study|Adverse Event|0|||
46609770|NCT00985088|82698501|FG001|Overall Study|Adverse Event|0|||
46609771|NCT00985088|82698502|FG002|Overall Study|Adverse Event|1|||
46609772|NCT00985088|82698503|FG003|Overall Study|Adverse Event|0|||
46609773|NCT00985088|82698504|FG004|Overall Study|Adverse Event|0|||
46609774|NCT00985088|82698505|FG005|Overall Study|Adverse Event|0|||
46609775|NCT00985088|82698506|FG006|Overall Study|Adverse Event|0|||
46609776|NCT00985088|82698507|FG007|Overall Study|Adverse Event|0|||
46609777|NCT00985088|82698500|FG000|Overall Study|Withdrawal by Subject|4|||
46609778|NCT00985088|82698501|FG001|Overall Study|Withdrawal by Subject|0|||
46609779|NCT00985088|82698502|FG002|Overall Study|Withdrawal by Subject|0|||
46609780|NCT00985088|82698503|FG003|Overall Study|Withdrawal by Subject|1|||
46609781|NCT00985088|82698504|FG004|Overall Study|Withdrawal by Subject|3|||
46609782|NCT00985088|82698505|FG005|Overall Study|Withdrawal by Subject|2|||
46609783|NCT00985088|82698506|FG006|Overall Study|Withdrawal by Subject|1|||
46609784|NCT00985088|82698507|FG007|Overall Study|Withdrawal by Subject|2|||
46609785|NCT00985088|82698500|FG000|Overall Study|Migrated/moved from study area|0|||
46609786|NCT00985088|82698501|FG001|Overall Study|Migrated/moved from study area|0|||
46609787|NCT00985088|82698502|FG002|Overall Study|Migrated/moved from study area|1|||
46609788|NCT00985088|82698503|FG003|Overall Study|Migrated/moved from study area|0|||
46609789|NCT00985088|82698504|FG004|Overall Study|Migrated/moved from study area|0|||
46609790|NCT00985088|82698505|FG005|Overall Study|Migrated/moved from study area|0|||
46609791|NCT00985088|82698506|FG006|Overall Study|Migrated/moved from study area|0|||
46609792|NCT00985088|82698507|FG007|Overall Study|Migrated/moved from study area|1|||
46609793|NCT00985088|82698500|FG000|Overall Study|Lost to Follow-up|6|||
46609794|NCT00985088|82698501|FG001|Overall Study|Lost to Follow-up|1|||
46609795|NCT00985088|82698502|FG002|Overall Study|Lost to Follow-up|2|||
46609796|NCT00985088|82698503|FG003|Overall Study|Lost to Follow-up|6|||
46609797|NCT00985088|82698504|FG004|Overall Study|Lost to Follow-up|6|||
46609798|NCT00985088|82698505|FG005|Overall Study|Lost to Follow-up|5|||
46609799|NCT00985088|82698506|FG006|Overall Study|Lost to Follow-up|3|||
46609800|NCT00985088|82698507|FG007|Overall Study|Lost to Follow-up|2|||
46609801|NCT00984542|82698553|FG000|Overall Study|disease progression|19|||
46609802|NCT00984542|82698553|FG000|Overall Study|toxicity|7|||
46609803|NCT00984542|82698553|FG000|Overall Study|Death|7|||
46609804|NCT00984542|82698553|FG000|Overall Study|complicating disease|3|||
46609805|NCT00984542|82698553|FG000|Overall Study|Withdrawal by Subject|3|||
46609806|NCT00984542|82698553|FG000|Overall Study|clinical deterioration|2|||
46609807|NCT00983918|82698562|FG000|Overall Study|conversion to open cholecystectomy|0|||
46609808|NCT00983918|82698563|FG001|Overall Study|conversion to open cholecystectomy|2|||
46609809|NCT00983918|82698564|FG002|Overall Study|conversion to open cholecystectomy|2|||
46609810|NCT00983918|82698565|FG003|Overall Study|conversion to open cholecystectomy|2|||
46609811|NCT00983528|82698575|FG000|Overall Study|Death|4|||
46609812|NCT00983528|82698575|FG000|Overall Study|Lost to Follow-up|1|||
46609813|NCT00983528|82698575|FG000|Overall Study|Study Terminated|1|||
46609814|NCT00983372|82698579|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
46609815|NCT00983372|82698579|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
46609816|NCT00983372|82698579|FG000|Diltiazem ER Alone|Adverse Event|1|||
46609817|NCT00983294|82698611|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
46609818|NCT00983294|82698611|FG000|Colchicine With Azithromycin|Adverse Event|1|||
46609819|NCT00982280|82698627|FG000|Observation Period|Not eligible to be dosed|19|||
46609820|NCT00982280|82698627|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
46609821|NCT00982280|82698627|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
46609822|NCT00982280|82698627|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
46609823|NCT00982280|82698627|FG000|Maintenance Period|Adverse Event|1|||
46609824|NCT00981578|82698645|FG000|Overall Study|Death|1|||
46609825|NCT00981578|82698645|FG000|Overall Study|Withdrawal by Subject|2|||
46609826|NCT00980798|82698668|FG000|Overall Study|Adverse Event|7|||
46609827|NCT00980798|82698669|FG001|Overall Study|Adverse Event|36|||
46609828|NCT00980798|82698668|FG000|Overall Study|Lack of Efficacy|16|||
46609829|NCT00980798|82698669|FG001|Overall Study|Lack of Efficacy|5|||
46609830|NCT00980798|82698668|FG000|Overall Study|Lost to Follow-up|0|||
46609831|NCT00980798|82698669|FG001|Overall Study|Lost to Follow-up|1|||
46609832|NCT00980798|82698668|FG000|Overall Study|Physician Decision|2|||
46609833|NCT00980798|82698669|FG001|Overall Study|Physician Decision|1|||
46609834|NCT00980798|82698668|FG000|Overall Study|Withdrawal by Subject|8|||
46609835|NCT00980798|82698669|FG001|Overall Study|Withdrawal by Subject|11|||
46609836|NCT00980798|82698668|FG000|Overall Study|Other|0|||
46609837|NCT00980798|82698669|FG001|Overall Study|Other|1|||
46609838|NCT00980330|82698814|FG000|Overall Study|Adverse Event|0|||
46609839|NCT00980330|82698815|FG001|Overall Study|Adverse Event|0|||
46609840|NCT00980330|82698816|FG002|Overall Study|Adverse Event|0|||
46609841|NCT00980330|82698817|FG003|Overall Study|Adverse Event|1|||
46609842|NCT00980330|82698818|FG004|Overall Study|Adverse Event|0|||
46609843|NCT00980330|82698819|FG005|Overall Study|Adverse Event|0|||
46609844|NCT00980330|82698820|FG006|Overall Study|Adverse Event|0|||
46609845|NCT00980330|82698814|FG000|Overall Study|Lost to Follow-up|1|||
46609846|NCT00980330|82698815|FG001|Overall Study|Lost to Follow-up|1|||
46609847|NCT00980330|82698816|FG002|Overall Study|Lost to Follow-up|4|||
46890547|NCT03339726|83113685|FG001|Overall Study|Withdrawal by Subject|0|||
46890548|NCT03339726|83113686|FG002|Overall Study|Withdrawal by Subject|0|||
46609848|NCT00980330|82698817|FG003|Overall Study|Lost to Follow-up|2|||
46609849|NCT00980330|82698818|FG004|Overall Study|Lost to Follow-up|1|||
46609850|NCT00980330|82698819|FG005|Overall Study|Lost to Follow-up|1|||
46609851|NCT00980330|82698820|FG006|Overall Study|Lost to Follow-up|2|||
46609852|NCT00980330|82698814|FG000|Overall Study|Withdrawal by Subject|2|||
46609853|NCT00980330|82698815|FG001|Overall Study|Withdrawal by Subject|4|||
46609854|NCT00980330|82698816|FG002|Overall Study|Withdrawal by Subject|4|||
46609855|NCT00980330|82698817|FG003|Overall Study|Withdrawal by Subject|1|||
46609856|NCT00980330|82698818|FG004|Overall Study|Withdrawal by Subject|3|||
46609857|NCT00980330|82698819|FG005|Overall Study|Withdrawal by Subject|2|||
46609858|NCT00980330|82698820|FG006|Overall Study|Withdrawal by Subject|5|||
46609859|NCT00980330|82698814|FG000|Overall Study|(not specified)|2|||
46609860|NCT00980330|82698815|FG001|Overall Study|(not specified)|0|||
46609861|NCT00980330|82698816|FG002|Overall Study|(not specified)|0|||
46609862|NCT00980330|82698817|FG003|Overall Study|(not specified)|1|||
46609863|NCT00980330|82698818|FG004|Overall Study|(not specified)|1|||
46609864|NCT00980330|82698819|FG005|Overall Study|(not specified)|1|||
46609865|NCT00980330|82698820|FG006|Overall Study|(not specified)|0|||
46609866|NCT00980174|82698864|FG000|Overall Study|Withdrawal by Subject|1|||
46609867|NCT00980174|82698865|FG001|Overall Study|Withdrawal by Subject|4|||
46609868|NCT00980174|82698864|FG000|Overall Study|Adverse Event|0|||
46609869|NCT00980174|82698865|FG001|Overall Study|Adverse Event|3|||
46890549|NCT03339726|83113684|FG000|Overall Study|Lost to Follow-up|0|||
46609870|NCT00980174|82698864|FG000|Overall Study|Ineligibility determined|2|||
46609871|NCT00980174|82698865|FG001|Overall Study|Ineligibility determined|1|||
46609872|NCT00980174|82698864|FG000|Overall Study|Death|1|||
46609873|NCT00980174|82698865|FG001|Overall Study|Death|1|||
46890550|NCT03339726|83113685|FG001|Overall Study|Lost to Follow-up|1|||
46890551|NCT03339726|83113686|FG002|Overall Study|Lost to Follow-up|0|||
46890552|NCT03339297|83113696|FG000|Overall Study|Relapse of Hematologic Disease|1|||
46890553|NCT03339297|83113697|FG001|Overall Study|Relapse of Hematologic Disease|0|||
46890554|NCT03339297|83113696|FG000|Overall Study|Death|10|||
46890555|NCT03339297|83113697|FG001|Overall Study|Death|7|||
46890556|NCT03339297|83113696|FG000|Overall Study|Hepatic Candidosis|1|||
46890557|NCT03339297|83113697|FG001|Overall Study|Hepatic Candidosis|0|||
46890558|NCT03339297|83113696|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
46890559|NCT03339297|83113697|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
46890560|NCT03339297|83113696|FG000|Overall Study|Consent Withdrawn by Participant|3|||
46890561|NCT03339297|83113697|FG001|Overall Study|Consent Withdrawn by Participant|3|||
46890562|NCT03339297|83113696|FG000|Overall Study|Disease Relapse|2|||
46890563|NCT03339297|83113697|FG001|Overall Study|Disease Relapse|0|||
46890564|NCT03339297|83113696|FG000|Overall Study|Physician Decision|1|||
46890565|NCT03339297|83113697|FG001|Overall Study|Physician Decision|1|||
46890566|NCT03339297|83113696|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
46890567|NCT03339297|83113697|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
46890568|NCT03339297|83113696|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
46890569|NCT03339297|83113697|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
46890570|NCT03339297|83113696|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
46890571|NCT03339297|83113697|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
46890572|NCT03339297|83113696|FG000|Overall Study|Adverse Event, Non-fatal|1|||
46890573|NCT03339297|83113697|FG001|Overall Study|Adverse Event, Non-fatal|0|||
46890574|NCT03339297|83113696|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
46890575|NCT03339297|83113697|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
46890576|NCT03339297|83113696|FG000|Overall Study|Patient Was Not Eligible|1|||
46890577|NCT03339297|83113697|FG001|Overall Study|Patient Was Not Eligible|0|||
46890578|NCT03713281|83113723|FG000|Overall Study|Lens handling difficuluties|2|||
46890579|NCT03713281|83113723|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
46890580|NCT03339219|83113727|FG000|Overall Study|Death|12|||
46890581|NCT03339219|83113727|FG000|Overall Study|Site Terminated by Sponsor|22|||
46890582|NCT03339219|83113727|FG000|Overall Study|Withdrawal by Subject|1|||
46890583|NCT03338673|83113733|FG000|Overall Study|Lost to Follow-up|1|||
46890584|NCT03338673|83113734|FG001|Overall Study|Lost to Follow-up|1|||
46890585|NCT02949024|83113742|FG000|Overall Study|Withdrawal by Subject|0|||
46890586|NCT02949024|83113743|FG001|Overall Study|Withdrawal by Subject|1|||
46890587|NCT03093428|83113753|FG000|Overall Study|Not eligible for treatment|2|||
46890588|NCT03093428|83113754|FG001|Overall Study|Not eligible for treatment|1|||
46890589|NCT03093428|83113753|FG000|Overall Study|Progression|14|||
46890590|NCT03093428|83113754|FG001|Overall Study|Progression|4|||
46890591|NCT03093428|83113753|FG000|Overall Study|Death|1|||
46890592|NCT03093428|83113754|FG001|Overall Study|Death|0|||
46890593|NCT03093428|83113753|FG000|Overall Study|Adverse Event|1|||
46890594|NCT03093428|83113754|FG001|Overall Study|Adverse Event|0|||
46890595|NCT03093428|83113753|FG000|Overall Study|Withdrawal by Subject|1|||
46890596|NCT03093428|83113754|FG001|Overall Study|Withdrawal by Subject|1|||
46890597|NCT02735980|83113763|FG000|Overall Study|Adverse Event|0|||
46890598|NCT02735980|83113764|FG001|Overall Study|Adverse Event|4|||
46890599|NCT02735980|83113765|FG002|Overall Study|Adverse Event|1|||
46890600|NCT02735980|83113763|FG000|Overall Study|Death|5|||
46890601|NCT02735980|83113764|FG001|Overall Study|Death|4|||
46890602|NCT02735980|83113765|FG002|Overall Study|Death|0|||
46890603|NCT02735980|83113763|FG000|Overall Study|Physician Decision|3|||
46890604|NCT02735980|83113764|FG001|Overall Study|Physician Decision|1|||
46890605|NCT02735980|83113765|FG002|Overall Study|Physician Decision|0|||
46890606|NCT02735980|83113763|FG000|Overall Study|Screen failure|1|||
46890607|NCT02735980|83113764|FG001|Overall Study|Screen failure|0|||
46890608|NCT02735980|83113765|FG002|Overall Study|Screen failure|0|||
46890609|NCT02735980|83113763|FG000|Overall Study|Withdrawal by Subject|1|||
46890610|NCT02735980|83113764|FG001|Overall Study|Withdrawal by Subject|2|||
46890611|NCT02735980|83113765|FG002|Overall Study|Withdrawal by Subject|0|||
46890612|NCT03338400|83113780|FG000|Overall Study|Lost to Follow-up|1|||
46890613|NCT03338400|83113781|FG001|Overall Study|Lost to Follow-up|2|||
46890614|NCT03337113|83113799|FG000|Overall Study|Adverse Event|1|||
46890615|NCT03337113|83113800|FG001|Overall Study|Adverse Event|1|||
46890616|NCT03337113|83113801|FG002|Overall Study|Adverse Event|0|||
46890617|NCT03337113|83113802|FG003|Overall Study|Adverse Event|1|||
46890618|NCT03337113|83113799|FG000|Overall Study|Physician Decision|0|||
46890619|NCT03337113|83113800|FG001|Overall Study|Physician Decision|2|||
46890620|NCT03337113|83113801|FG002|Overall Study|Physician Decision|0|||
46890621|NCT03337113|83113802|FG003|Overall Study|Physician Decision|1|||
46890622|NCT03337113|83113799|FG000|Overall Study|Withdrawal by Subject|0|||
46890623|NCT03337113|83113800|FG001|Overall Study|Withdrawal by Subject|0|||
46890624|NCT03337113|83113801|FG002|Overall Study|Withdrawal by Subject|1|||
46890625|NCT03337113|83113802|FG003|Overall Study|Withdrawal by Subject|0|||
46890626|NCT03092726|83113814|FG000|Overall Study|Adverse Event|3|||
46890627|NCT03092726|83113815|FG001|Overall Study|Adverse Event|10|||
46890628|NCT03092726|83113814|FG000|Overall Study|Lack of Efficacy|0|||
46890629|NCT03092726|83113815|FG001|Overall Study|Lack of Efficacy|1|||
46890630|NCT03092726|83113814|FG000|Overall Study|Lost to Follow-up|1|||
46890631|NCT03092726|83113815|FG001|Overall Study|Lost to Follow-up|0|||
46890632|NCT03092726|83113814|FG000|Overall Study|Withdrawal by Subject|5|||
46890633|NCT03092726|83113815|FG001|Overall Study|Withdrawal by Subject|3|||
46890634|NCT03338010|83113823|FG000|Overall Study|Withdrawal by Subject|14|||
46890635|NCT03338010|83113824|FG001|Overall Study|Withdrawal by Subject|8|||
46890636|NCT03338010|83113823|FG000|Overall Study|Lost to Follow-up|4|||
46890637|NCT03338010|83113824|FG001|Overall Study|Lost to Follow-up|2|||
46890638|NCT03338010|83113823|FG000|Overall Study|Adverse Event|3|||
46890639|NCT03338010|83113824|FG001|Overall Study|Adverse Event|2|||
46890640|NCT03338010|83113823|FG000|Overall Study|Physician Decision|2|||
46890641|NCT03338010|83113824|FG001|Overall Study|Physician Decision|2|||
46890642|NCT03338010|83113823|FG000|Overall Study|Non-Compliance with Study Drug|0|||
46890643|NCT03338010|83113824|FG001|Overall Study|Non-Compliance with Study Drug|3|||
46890644|NCT03338010|83113823|FG000|Overall Study|Protocol Violation|0|||
46890645|NCT03338010|83113824|FG001|Overall Study|Protocol Violation|1|||
46890646|NCT03337542|83113830|FG000|Overall Study|Withdrew Consent|17|||
46890647|NCT03337542|83113830|FG000|Overall Study|Allergic Adverse Event|1|||
46890648|NCT03337542|83113830|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
46890649|NCT03337542|83113830|FG000|Overall Study|Lost to Follow-up|1|||
46890650|NCT03337542|83113830|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
46890651|NCT01328548|83113837|FG000|Overall Study|Death|3|||
46890652|NCT01328548|83113838|FG001|Overall Study|Death|0|||
46890653|NCT01328548|83113837|FG000|Overall Study|Protocol Violation|1|||
46890654|NCT01328548|83113838|FG001|Overall Study|Protocol Violation|0|||
46890655|NCT03337308|83113876|FG000|Overall Study|Adverse Event|2|||
46890656|NCT03337308|83113877|FG001|Overall Study|Adverse Event|3|||
46890657|NCT03337308|83113878|FG002|Overall Study|Adverse Event|3|||
46890658|NCT03337308|83113879|FG003|Overall Study|Adverse Event|1|||
46890659|NCT03337308|83113876|FG000|Overall Study|Lost to Follow-up|1|||
46890660|NCT03337308|83113877|FG001|Overall Study|Lost to Follow-up|2|||
46890661|NCT03337308|83113878|FG002|Overall Study|Lost to Follow-up|0|||
46890662|NCT03337308|83113879|FG003|Overall Study|Lost to Follow-up|0|||
46890663|NCT03337308|83113876|FG000|Overall Study|Withdrawal by Subject|2|||
46890664|NCT03337308|83113877|FG001|Overall Study|Withdrawal by Subject|1|||
46890665|NCT03337308|83113878|FG002|Overall Study|Withdrawal by Subject|2|||
46890666|NCT03337308|83113879|FG003|Overall Study|Withdrawal by Subject|1|||
46890667|NCT03337308|83113876|FG000|Overall Study|Protocol Violation|0|||
46890668|NCT03337308|83113877|FG001|Overall Study|Protocol Violation|1|||
46890669|NCT03337308|83113878|FG002|Overall Study|Protocol Violation|0|||
46890670|NCT03337308|83113879|FG003|Overall Study|Protocol Violation|0|||
46890671|NCT03337152|83113891|FG000|Overall Study|Physician Decision|1|||
46890672|NCT03337152|83113892|FG001|Overall Study|Physician Decision|0|||
46890673|NCT03337152|83113891|FG000|Overall Study|Lost to Follow-up|1|||
46890674|NCT03337152|83113892|FG001|Overall Study|Lost to Follow-up|3|||
46890675|NCT03337152|83113891|FG000|Overall Study|Adverse Event|3|||
46890676|NCT03337152|83113892|FG001|Overall Study|Adverse Event|1|||
46890677|NCT03337152|83113891|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
46890678|NCT03337152|83113892|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
46890679|NCT03091400|83113906|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
46890680|NCT03091400|83113907|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
46890681|NCT01318993|83113913|FG000|Overall Study|Adverse Event|53|||
46890682|NCT01318993|83113913|FG000|Overall Study|Lack of Efficacy|121|||
46890683|NCT01318993|83113913|FG000|Overall Study|Protocol Violation|3|||
46890684|NCT01318993|83113913|FG000|Overall Study|Protocol based stopping criteria|6|||
46890685|NCT01318993|83113913|FG000|Overall Study|Study closed or terminated|174|||
46890686|NCT01318993|83113913|FG000|Overall Study|Lost to Follow-up|4|||
46890687|NCT01318993|83113913|FG000|Overall Study|Physician Decision|13|||
46890688|NCT01318993|83113913|FG000|Overall Study|Withdrawal by Subject|24|||
46890689|NCT03090152|83113920|FG000|Overall Study|Withdrawal by Subject|0|||
46890690|NCT03090152|83113921|FG001|Overall Study|Withdrawal by Subject|2|||
46890691|NCT03090152|83113922|FG002|Overall Study|Withdrawal by Subject|1|||
46890692|NCT03090152|83113920|FG000|Overall Study|Surgery Canceled|1|||
46890693|NCT03090152|83113921|FG001|Overall Study|Surgery Canceled|0|||
46890694|NCT03090152|83113922|FG002|Overall Study|Surgery Canceled|0|||
46890695|NCT03090152|83113920|FG000|Overall Study|Epidural catheter could not be placed|0|||
46890696|NCT03090152|83113921|FG001|Overall Study|Epidural catheter could not be placed|2|||
46890697|NCT03090152|83113922|FG002|Overall Study|Epidural catheter could not be placed|0|||
46890698|NCT04252287|83113932|FG000|Overall Study|Death|5|||
46890699|NCT04252287|83113933|FG001|Overall Study|Death|3|||
46890700|NCT04252287|83113932|FG000|Overall Study|Lost to Follow-up|4|||
46890701|NCT04252287|83113933|FG001|Overall Study|Lost to Follow-up|6|||
46890702|NCT04252287|83113932|FG000|Overall Study|Withdrawal by Subject|19|||
46890703|NCT04252287|83113933|FG001|Overall Study|Withdrawal by Subject|16|||
46890704|NCT04252287|83113932|FG000|Overall Study|Protocol Violation|3|||
46890705|NCT04252287|83113933|FG001|Overall Study|Protocol Violation|4|||
46890706|NCT02735200|83113945|FG000|Overall Study|Lost to Follow-up|0|||
46890707|NCT02735200|83113946|FG001|Overall Study|Lost to Follow-up|5|||
46890708|NCT02735200|83113945|FG000|Overall Study|Withdrawal by Subject|8|||
46890709|NCT02735200|83113946|FG001|Overall Study|Withdrawal by Subject|0|||
46991541|NCT02158533|83238502|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
46991542|NCT02158533|83238503|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
46991543|NCT02158533|83238504|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
46991544|NCT02158533|83238505|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
46991545|NCT02158533|83238506|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
46991546|NCT02158533|83238501|FG000|Stage 2|Non-adherence with study visits|0|||
46991547|NCT02158533|83238502|FG001|Stage 2|Non-adherence with study visits|0|||
46991548|NCT02158533|83238503|FG002|Stage 2|Non-adherence with study visits|0|||
46991549|NCT02158533|83238504|FG003|Stage 2|Non-adherence with study visits|0|||
46991550|NCT02158533|83238505|FG004|Stage 2|Non-adherence with study visits|0|||
46991551|NCT02158533|83238506|FG005|Stage 2|Non-adherence with study visits|1|||
46991552|NCT02120781|83238522|FG000|Overall Study|Physician Decision|2|||
46991553|NCT02120781|83238523|FG001|Overall Study|Physician Decision|0|||
46991554|NCT02120781|83238522|FG000|Overall Study|Completion not documented|2|||
46991555|NCT02120781|83238523|FG001|Overall Study|Completion not documented|1|||
46991556|NCT02120625|83238529|FG000|Overall Study|Physician Decision|2|||
46991557|NCT02120469|83238536|FG000|Overall Study|HER-2/neu-amplified|1|||
46991558|NCT02120469|83238537|FG001|Overall Study|HER-2/neu-amplified|0|||
46991559|NCT02120469|83238538|FG002|Overall Study|HER-2/neu-amplified|1|||
46991560|NCT02157519|83238551|FG000|Overall Study|Death|3|||
46991561|NCT02157519|83238552|FG001|Overall Study|Death|1|||
46991562|NCT02157519|83238551|FG000|Overall Study|Withdrawal by Subject|7|||
46991563|NCT02157519|83238552|FG001|Overall Study|Withdrawal by Subject|0|||
46991564|NCT02157519|83238551|FG000|Overall Study|Lost to Follow-up|1|||
46991565|NCT02157519|83238552|FG001|Overall Study|Lost to Follow-up|0|||
46991566|NCT02180061|83238560|FG000|Overall Study|Adverse Event|4|||
46991567|NCT02180061|83238561|FG001|Overall Study|Adverse Event|2|||
46991568|NCT02180061|83238560|FG000|Overall Study|Clinical Progression|5|||
46991569|NCT02180061|83238561|FG001|Overall Study|Clinical Progression|1|||
46991570|NCT02180061|83238560|FG000|Overall Study|Progressive Disease|15|||
46991571|NCT02180061|83238561|FG001|Overall Study|Progressive Disease|5|||
46991572|NCT02180061|83238560|FG000|Overall Study|Physician Decision|1|||
46991573|NCT02180061|83238561|FG001|Overall Study|Physician Decision|0|||
46991574|NCT02179515|83238570|FG000|Overall Study|switched to alternative treatment|0|||
46991575|NCT02179515|83238571|FG001|Overall Study|switched to alternative treatment|1|||
46991576|NCT02179515|83238572|FG002|Overall Study|switched to alternative treatment|1|||
46991577|NCT02179515|83238570|FG000|Overall Study|Death|0|||
46991578|NCT02179515|83238571|FG001|Overall Study|Death|1|||
46991579|NCT02179515|83238572|FG002|Overall Study|Death|1|||
46991580|NCT02179515|83238570|FG000|Overall Study|refused further treatment|0|||
46991581|NCT02179515|83238571|FG001|Overall Study|refused further treatment|3|||
46991582|NCT02179515|83238572|FG002|Overall Study|refused further treatment|4|||
46991583|NCT02179515|83238570|FG000|Overall Study|Disease progression on study|2|||
46991584|NCT02179515|83238571|FG001|Overall Study|Disease progression on study|11|||
46991585|NCT02179515|83238572|FG002|Overall Study|Disease progression on study|8|||
46991586|NCT02120157|83238584|FG000|Overall Study|Death|8|||
46991587|NCT02119299|83238590|FG000|Overall Study|Withdrawal by Subject|7|||
46991588|NCT02119299|83238590|FG000|Overall Study|Lack of Efficacy|1|||
46991589|NCT02119299|83238590|FG000|Overall Study|Pregnancy|1|||
46991590|NCT02156271|83238596|FG000|Overall Study|Physician Decision|4|||
46991591|NCT02156271|83238597|FG001|Overall Study|Physician Decision|3|||
46991592|NCT01365455|83238606|FG000|Induction Period|Adverse Event|5|||
46991593|NCT01365455|83238607|FG001|Induction Period|Adverse Event|3|||
46991594|NCT01365455|83238608|FG002|Induction Period|Adverse Event|4|||
46991595|NCT01365455|83238609|FG003|Induction Period|Adverse Event|0|||
46890710|NCT02946918|83113954|FG000|Overall Study|Patient unblinded himself|1|||
46890711|NCT02946918|83113955|FG001|Overall Study|Patient unblinded himself|0|||
46890712|NCT02946918|83113954|FG000|Overall Study|Physician Decision|0|||
46890713|NCT02946918|83113955|FG001|Overall Study|Physician Decision|2|||
46890714|NCT02946918|83113954|FG000|Overall Study|Ran out of study medication|0|||
46991596|NCT01365455|83238610|FG004|Induction Period|Adverse Event|0|||
46991597|NCT01365455|83238606|FG000|Induction Period|Lack of Efficacy|1|||
46991598|NCT01365455|83238607|FG001|Induction Period|Lack of Efficacy|1|||
46991599|NCT01365455|83238608|FG002|Induction Period|Lack of Efficacy|0|||
46991600|NCT01365455|83238609|FG003|Induction Period|Lack of Efficacy|0|||
46890715|NCT02946918|83113955|FG001|Overall Study|Ran out of study medication|1|||
46890716|NCT02734810|83113976|FG000|Overall Study|Adverse Event|1|||
46991601|NCT01365455|83238610|FG004|Induction Period|Lack of Efficacy|0|||
46991602|NCT01365455|83238606|FG000|Induction Period|Pregnancy|0|||
46991603|NCT01365455|83238607|FG001|Induction Period|Pregnancy|1|||
46991604|NCT01365455|83238608|FG002|Induction Period|Pregnancy|0|||
46991605|NCT01365455|83238609|FG003|Induction Period|Pregnancy|0|||
46991606|NCT01365455|83238610|FG004|Induction Period|Pregnancy|0|||
46991607|NCT01365455|83238606|FG000|Induction Period|Protocol deviation|0|||
46991608|NCT01365455|83238607|FG001|Induction Period|Protocol deviation|1|||
46991609|NCT01365455|83238608|FG002|Induction Period|Protocol deviation|1|||
46991610|NCT01365455|83238609|FG003|Induction Period|Protocol deviation|0|||
46991611|NCT01365455|83238610|FG004|Induction Period|Protocol deviation|0|||
46991612|NCT01365455|83238606|FG000|Induction Period|Subject/guardian decision|9|||
46991613|NCT01365455|83238607|FG001|Induction Period|Subject/guardian decision|1|||
46991614|NCT01365455|83238608|FG002|Induction Period|Subject/guardian decision|8|||
46991615|NCT01365455|83238609|FG003|Induction Period|Subject/guardian decision|0|||
46991616|NCT01365455|83238610|FG004|Induction Period|Subject/guardian decision|0|||
46991617|NCT01365455|83238606|FG000|Induction Period|Lost to Follow-up|0|||
46991618|NCT01365455|83238607|FG001|Induction Period|Lost to Follow-up|0|||
46991619|NCT01365455|83238608|FG002|Induction Period|Lost to Follow-up|3|||
46991620|NCT01365455|83238609|FG003|Induction Period|Lost to Follow-up|0|||
46991621|NCT01365455|83238610|FG004|Induction Period|Lost to Follow-up|0|||
46991622|NCT01365455|83238606|FG000|Maintenance Period|Adverse Event|12|||
46991623|NCT01365455|83238607|FG001|Maintenance Period|Adverse Event|5|||
46991624|NCT01365455|83238608|FG002|Maintenance Period|Adverse Event|1|||
46991625|NCT01365455|83238609|FG003|Maintenance Period|Adverse Event|2|||
46991626|NCT01365455|83238610|FG004|Maintenance Period|Adverse Event|4|||
46991627|NCT01365455|83238606|FG000|Maintenance Period|Lack of Efficacy|10|||
46991628|NCT01365455|83238607|FG001|Maintenance Period|Lack of Efficacy|2|||
46991629|NCT01365455|83238608|FG002|Maintenance Period|Lack of Efficacy|0|||
46991630|NCT01365455|83238609|FG003|Maintenance Period|Lack of Efficacy|2|||
46991631|NCT01365455|83238610|FG004|Maintenance Period|Lack of Efficacy|2|||
46991632|NCT01365455|83238606|FG000|Maintenance Period|Lost to Follow-up|2|||
46991633|NCT01365455|83238607|FG001|Maintenance Period|Lost to Follow-up|4|||
46991634|NCT01365455|83238608|FG002|Maintenance Period|Lost to Follow-up|0|||
46991635|NCT01365455|83238609|FG003|Maintenance Period|Lost to Follow-up|0|||
46991636|NCT01365455|83238610|FG004|Maintenance Period|Lost to Follow-up|3|||
46991637|NCT01365455|83238606|FG000|Maintenance Period|Non-compliance with study treatment|0|||
46991638|NCT01365455|83238607|FG001|Maintenance Period|Non-compliance with study treatment|0|||
46991639|NCT01365455|83238608|FG002|Maintenance Period|Non-compliance with study treatment|0|||
46991640|NCT01365455|83238609|FG003|Maintenance Period|Non-compliance with study treatment|1|||
46991641|NCT01365455|83238610|FG004|Maintenance Period|Non-compliance with study treatment|0|||
46991642|NCT01365455|83238606|FG000|Maintenance Period|Physician Decision|0|||
46991643|NCT01365455|83238607|FG001|Maintenance Period|Physician Decision|1|||
46991644|NCT01365455|83238608|FG002|Maintenance Period|Physician Decision|0|||
46991645|NCT01365455|83238609|FG003|Maintenance Period|Physician Decision|0|||
46991646|NCT01365455|83238610|FG004|Maintenance Period|Physician Decision|1|||
46991647|NCT01365455|83238606|FG000|Maintenance Period|Pregnancy|0|||
46991648|NCT01365455|83238607|FG001|Maintenance Period|Pregnancy|4|||
46991649|NCT01365455|83238608|FG002|Maintenance Period|Pregnancy|0|||
46991650|NCT01365455|83238609|FG003|Maintenance Period|Pregnancy|0|||
46991651|NCT01365455|83238610|FG004|Maintenance Period|Pregnancy|2|||
46991652|NCT01365455|83238606|FG000|Maintenance Period|Protocol deviation|1|||
46991653|NCT01365455|83238607|FG001|Maintenance Period|Protocol deviation|1|||
46991654|NCT01365455|83238608|FG002|Maintenance Period|Protocol deviation|0|||
46991655|NCT01365455|83238609|FG003|Maintenance Period|Protocol deviation|0|||
46991656|NCT01365455|83238610|FG004|Maintenance Period|Protocol deviation|0|||
46991657|NCT01365455|83238606|FG000|Maintenance Period|Subject/guardian decision|4|||
46991658|NCT01365455|83238607|FG001|Maintenance Period|Subject/guardian decision|6|||
46991659|NCT01365455|83238608|FG002|Maintenance Period|Subject/guardian decision|2|||
46991660|NCT01365455|83238609|FG003|Maintenance Period|Subject/guardian decision|4|||
46991661|NCT01365455|83238610|FG004|Maintenance Period|Subject/guardian decision|1|||
46991662|NCT02155881|83238630|FG000|Overall Study|Withdrawal by Subject|0|||
46991663|NCT02155881|83238631|FG001|Overall Study|Withdrawal by Subject|2|||
46991664|NCT02155881|83238630|FG000|Overall Study|Inappropriately randomized|2|||
46991665|NCT02155881|83238631|FG001|Overall Study|Inappropriately randomized|2|||
46991666|NCT01658579|83238641|FG000|Treatment Period A|Other|0|||
46991667|NCT01658579|83238642|FG001|Treatment Period A|Other|0|||
46991668|NCT01658579|83238643|FG002|Treatment Period A|Other|1|||
46991669|NCT01658579|83238644|FG003|Treatment Period A|Other|1|||
46991670|NCT01658579|83238641|FG000|Treatment Period A|Adverse Event|1|||
46991671|NCT01658579|83238642|FG001|Treatment Period A|Adverse Event|0|||
46991672|NCT01658579|83238643|FG002|Treatment Period A|Adverse Event|0|||
46991673|NCT01658579|83238644|FG003|Treatment Period A|Adverse Event|0|||
46991674|NCT01658579|83238641|FG000|Treatment Period B|Other|0|||
46991675|NCT01658579|83238642|FG001|Treatment Period B|Other|0|||
46991676|NCT01658579|83238643|FG002|Treatment Period B|Other|0|||
46991677|NCT01658579|83238644|FG003|Treatment Period B|Other|1|||
46991678|NCT02154087|83238650|FG000|Overall Study|Study Termination|1|||
46991679|NCT02118597|83238654|FG000|Overall Study|Sponsor terminated the study|14|||
46991680|NCT02118597|83238654|FG000|Overall Study|Serious Adverse Event|1|||
46991681|NCT02118597|83238654|FG000|Overall Study|Investigator's decision|1|||
46991682|NCT01659125|83238658|FG000|Overall Study|Withdrawal by Subject|2|||
46991683|NCT01659125|83238658|FG000|Overall Study|Lost to Follow-up|7|||
46991684|NCT01659125|83238658|FG000|Overall Study|Technical Problem|1|||
46991685|NCT01659125|83238658|FG000|Overall Study|Time Constraints|2|||
46991686|NCT01659125|83238658|FG000|Overall Study|Failed to Start Treatment|2|||
46991687|NCT01657253|83238664|FG000|Overall Study|Lost to Follow-up|6|||
46991688|NCT01657253|83238665|FG001|Overall Study|Lost to Follow-up|5|||
46991689|NCT01657253|83238664|FG000|Overall Study|Withdrawal by Subject|11|||
46991690|NCT01657253|83238665|FG001|Overall Study|Withdrawal by Subject|12|||
46991691|NCT01657253|83238664|FG000|Overall Study|Adverse Event|0|||
46991692|NCT01657253|83238665|FG001|Overall Study|Adverse Event|1|||
46991693|NCT02117427|83238674|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
46991694|NCT02117427|83238675|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
46991695|NCT02117427|83238676|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
46991696|NCT02117427|83238674|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
46991697|NCT02117427|83238675|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
46991698|NCT02117427|83238676|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
46991699|NCT02117427|83238674|FG000|Overall Study|Physician Decision|0|||
46991700|NCT02117427|83238675|FG001|Overall Study|Physician Decision|2|||
46991701|NCT02117427|83238676|FG002|Overall Study|Physician Decision|0|||
46991702|NCT02117427|83238674|FG000|Overall Study|No longer meets inclusion criteria|0|||
46991703|NCT02117427|83238675|FG001|Overall Study|No longer meets inclusion criteria|1|||
46991704|NCT02117427|83238676|FG002|Overall Study|No longer meets inclusion criteria|0|||
46991705|NCT02117427|83238674|FG000|Overall Study|Death|0|||
46991706|NCT02117427|83238675|FG001|Overall Study|Death|1|||
46991707|NCT02117427|83238676|FG002|Overall Study|Death|0|||
46991708|NCT02117349|83238684|FG000|Overall Study|Withdrawal by Subject|1|||
46991709|NCT02117349|83238685|FG001|Overall Study|Withdrawal by Subject|0|||
46991710|NCT02117349|83238684|FG000|Overall Study|Lost to Follow-up|1|||
46991711|NCT02117349|83238685|FG001|Overall Study|Lost to Follow-up|1|||
46991712|NCT02117349|83238684|FG000|Overall Study|Death|1|||
46991713|NCT02117349|83238685|FG001|Overall Study|Death|0|||
46991714|NCT01626495|83238691|FG000|Overall Study|Adverse Event|3|||
46991715|NCT01626495|83238691|FG000|Overall Study|Disease progression|27|||
46991716|NCT01626495|83238691|FG000|Overall Study|Withdrawal by Subject|1|||
46609874|NCT00980174|82698864|FG000|Overall Study|Other|0|||
46609875|NCT00980174|82698865|FG001|Overall Study|Other|1|||
46609876|NCT00980018|82698893|FG000|Overall Study|Adverse Event|8|||
46609877|NCT00980018|82698893|FG000|Overall Study|Patient withdrew consent|3|||
46609878|NCT00980018|82698893|FG000|Overall Study|Lost to Follow-up|1|||
46609879|NCT00988052|82698911|FG000|Overall Study|Missing|1|||
46609880|NCT00988052|82698912|FG001|Overall Study|Missing|0|||
46609881|NCT00988052|82698911|FG000|Overall Study|Teva requested subject withdrawal|3|||
46609882|NCT00988052|82698912|FG001|Overall Study|Teva requested subject withdrawal|1|||
46609883|NCT00988052|82698911|FG000|Overall Study|Death|1|||
46609884|NCT00988052|82698912|FG001|Overall Study|Death|3|||
46609885|NCT00988052|82698911|FG000|Overall Study|Protocol Violation|6|||
46609886|NCT00988052|82698912|FG001|Overall Study|Protocol Violation|5|||
46609887|NCT00988052|82698911|FG000|Overall Study|Pregnancy|6|||
46609888|NCT00988052|82698912|FG001|Overall Study|Pregnancy|6|||
46609889|NCT00988052|82698911|FG000|Overall Study|Lack of Efficacy|8|||
46609890|NCT00988052|82698912|FG001|Overall Study|Lack of Efficacy|7|||
46609891|NCT00988052|82698911|FG000|Overall Study|Lost to Follow-up|6|||
46991717|NCT01626495|83238691|FG000|Overall Study|Administrative problem|1|||
46991718|NCT01626495|83238691|FG000|Overall Study|Death|2|||
46991719|NCT01626495|83238691|FG000|Overall Study|Physician Decision|1|||
46609892|NCT00988052|82698912|FG001|Overall Study|Lost to Follow-up|11|||
46609893|NCT00988052|82698911|FG000|Overall Study|Physician Decision|27|||
46609894|NCT00988052|82698912|FG001|Overall Study|Physician Decision|28|||
46609895|NCT00988052|82698911|FG000|Overall Study|Adverse Event|35|||
46991720|NCT01626495|83238691|FG000|Overall Study|New cancer therapy|16|||
46991721|NCT01626495|83238691|FG000|Overall Study|Manufacturing failure|1|||
46991722|NCT02177175|83238697|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
46609896|NCT00988052|82698912|FG001|Overall Study|Adverse Event|28|||
46609897|NCT00988052|82698911|FG000|Overall Study|Withdrawal by Subject|90|||
46609898|NCT00988052|82698912|FG001|Overall Study|Withdrawal by Subject|91|||
46609899|NCT00988052|82698911|FG000|Overall Study|Study terminated by sponsor|240|||
46609900|NCT00988052|82698912|FG001|Overall Study|Study terminated by sponsor|236|||
46609901|NCT02569710|82699013|FG000|Overall Study|Adverse Event|1|||
46609902|NCT02569710|82699014|FG001|Overall Study|Adverse Event|0|||
46609903|NCT02569710|82699015|FG002|Overall Study|Adverse Event|0|||
46609904|NCT02569710|82699016|FG003|Overall Study|Adverse Event|0|||
46609905|NCT02569710|82699017|FG004|Overall Study|Adverse Event|0|||
46609906|NCT02569710|82699018|FG005|Overall Study|Adverse Event|0|||
46609907|NCT02569710|82699019|FG006|Overall Study|Adverse Event|0|||
46609908|NCT02569710|82699020|FG007|Overall Study|Adverse Event|0|||
46609909|NCT02569710|82699021|FG008|Overall Study|Adverse Event|0|||
46609910|NCT02569710|82699022|FG009|Overall Study|Adverse Event|0|||
46609911|NCT02569710|82699013|FG000|Overall Study|Lost to Follow-up|0|||
46609912|NCT02569710|82699014|FG001|Overall Study|Lost to Follow-up|0|||
46609913|NCT02569710|82699015|FG002|Overall Study|Lost to Follow-up|0|||
46609914|NCT02569710|82699016|FG003|Overall Study|Lost to Follow-up|0|||
46609915|NCT02569710|82699017|FG004|Overall Study|Lost to Follow-up|0|||
46609916|NCT02569710|82699018|FG005|Overall Study|Lost to Follow-up|0|||
46609917|NCT02569710|82699019|FG006|Overall Study|Lost to Follow-up|1|||
46609918|NCT02569710|82699020|FG007|Overall Study|Lost to Follow-up|0|||
46609919|NCT02569710|82699021|FG008|Overall Study|Lost to Follow-up|1|||
46609920|NCT02569710|82699022|FG009|Overall Study|Lost to Follow-up|0|||
46609921|NCT02569710|82699013|FG000|Overall Study|Virologic failure|0|||
46609922|NCT02569710|82699014|FG001|Overall Study|Virologic failure|0|||
46609923|NCT02569710|82699015|FG002|Overall Study|Virologic failure|0|||
46609924|NCT02569710|82699016|FG003|Overall Study|Virologic failure|0|||
46609925|NCT02569710|82699017|FG004|Overall Study|Virologic failure|1|||
46609926|NCT02569710|82699018|FG005|Overall Study|Virologic failure|0|||
46609927|NCT02569710|82699019|FG006|Overall Study|Virologic failure|1|||
46609928|NCT02569710|82699020|FG007|Overall Study|Virologic failure|0|||
46609929|NCT02569710|82699021|FG008|Overall Study|Virologic failure|0|||
46609930|NCT02569710|82699022|FG009|Overall Study|Virologic failure|0|||
46609931|NCT02569710|82699013|FG000|Overall Study|Withdrawal by Subject|0|||
46609932|NCT02569710|82699014|FG001|Overall Study|Withdrawal by Subject|0|||
46609933|NCT02569710|82699015|FG002|Overall Study|Withdrawal by Subject|0|||
46609934|NCT02569710|82699016|FG003|Overall Study|Withdrawal by Subject|0|||
46609935|NCT02569710|82699017|FG004|Overall Study|Withdrawal by Subject|0|||
46609936|NCT02569710|82699018|FG005|Overall Study|Withdrawal by Subject|1|||
46609937|NCT02569710|82699019|FG006|Overall Study|Withdrawal by Subject|0|||
46609938|NCT02569710|82699020|FG007|Overall Study|Withdrawal by Subject|0|||
46609939|NCT02569710|82699021|FG008|Overall Study|Withdrawal by Subject|0|||
46609940|NCT02569710|82699022|FG009|Overall Study|Withdrawal by Subject|0|||
46609941|NCT02569476|82699124|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
46609942|NCT02569476|82699124|FG000|Overall Study|Death|33|||
46609943|NCT02569476|82699124|FG000|Overall Study|Withdrawal by Subject|9|||
46609944|NCT02569476|82699124|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
46609945|NCT02569476|82699124|FG000|Overall Study|Palliative care|1|||
46609946|NCT02569476|82699124|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
46609947|NCT02569476|82699124|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
46609948|NCT02565576|82699196|FG000|Overall Study|abnormal lab value|2|||
46609949|NCT02565576|82699197|FG001|Overall Study|abnormal lab value|0|||
46609950|NCT02565576|82699196|FG000|Overall Study|subject / guardian decision|1|||
46609951|NCT02565576|82699197|FG001|Overall Study|subject / guardian decision|3|||
46609952|NCT02565576|82699196|FG000|Overall Study|Lost to Follow-up|1|||
46609953|NCT02565576|82699197|FG001|Overall Study|Lost to Follow-up|0|||
46609954|NCT02565576|82699196|FG000|Overall Study|Death|0|||
46609955|NCT02565576|82699197|FG001|Overall Study|Death|2|||
46609956|NCT02565576|82699196|FG000|Overall Study|Adverse Event|1|||
46609957|NCT02565576|82699197|FG001|Overall Study|Adverse Event|0|||
46609958|NCT02569398|82699228|FG000|Overall Study|Adverse Event|0|||
46609959|NCT02569398|82699229|FG001|Overall Study|Adverse Event|1|||
46609960|NCT02569398|82699230|FG002|Overall Study|Adverse Event|6|||
46609961|NCT02569398|82699228|FG000|Overall Study|Withdrawal by Subject|43|||
46609962|NCT02569398|82699229|FG001|Overall Study|Withdrawal by Subject|43|||
46609963|NCT02569398|82699230|FG002|Overall Study|Withdrawal by Subject|30|||
46609964|NCT02569398|82699228|FG000|Overall Study|Study terminated by sponsor|130|||
46609965|NCT02569398|82699229|FG001|Overall Study|Study terminated by sponsor|131|||
46609966|NCT02569398|82699230|FG002|Overall Study|Study terminated by sponsor|134|||
46609967|NCT02569398|82699228|FG000|Overall Study|Other|12|||
46609968|NCT02569398|82699229|FG001|Overall Study|Other|14|||
46609969|NCT02569398|82699230|FG002|Overall Study|Other|13|||
46609970|NCT02569242|82699261|FG000|Overall Study|Death|1|||
46609971|NCT02569242|82699262|FG001|Overall Study|Death|0|||
46609972|NCT02569242|82699261|FG000|Overall Study|Withdrawal by Subject|0|||
46609973|NCT02569242|82699262|FG001|Overall Study|Withdrawal by Subject|1|||
46609974|NCT01663740|82699330|FG000|Overall Study|Lost to Follow-up|1|||
46609975|NCT01663740|82699331|FG001|Overall Study|Lost to Follow-up|4|||
46609976|NCT01663740|82699330|FG000|Overall Study|Other|9|||
46609977|NCT01663740|82699331|FG001|Overall Study|Other|2|||
46609978|NCT01663740|82699330|FG000|Overall Study|Inclusion/Exclusion not met|1|||
46609979|NCT01663740|82699331|FG001|Overall Study|Inclusion/Exclusion not met|0|||
46609980|NCT01663740|82699330|FG000|Overall Study|Death|0|||
46609981|NCT01663740|82699331|FG001|Overall Study|Death|1|||
46609982|NCT01663740|82699330|FG000|Overall Study|Withdrawal by Subject|2|||
46609983|NCT01663740|82699331|FG001|Overall Study|Withdrawal by Subject|1|||
46609984|NCT01663740|82699330|FG000|Overall Study|No end of study status|3|||
46609985|NCT01663740|82699331|FG001|Overall Study|No end of study status|0|||
46609986|NCT01663506|82699447|FG000|Overall Study|Lack of Efficacy|3|||
46609987|NCT01663506|82699447|FG000|Overall Study|Consent Withdrawal by Subject|1|||
46609988|NCT01663506|82699447|FG000|Overall Study|Lost to Follow-up|1|||
46609989|NCT01663506|82699447|FG000|Overall Study|Adverse Event|1|||
46609990|NCT01663506|82699447|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
46609991|NCT02568384|82699451|FG000|Overall Study|Mobile devices incompatible with App|2|||
46609992|NCT02965976|82699558|FG000|Overall Study|Withdrawal by Subject|2|||
46609993|NCT02965976|82699559|FG001|Overall Study|Withdrawal by Subject|0|||
46609994|NCT04125680|82699577|FG000|Overall Study|Lost to Follow-up|15|||
46609995|NCT02565186|82699601|FG000|Overall Study|Adverse Event|113|||
46609996|NCT02565186|82699602|FG001|Overall Study|Adverse Event|148|||
46609997|NCT02565186|82699601|FG000|Overall Study|Lost to Follow-up|102|||
46609998|NCT02565186|82699602|FG001|Overall Study|Lost to Follow-up|93|||
46609999|NCT02565186|82699601|FG000|Overall Study|Non-Compliance|57|||
46610000|NCT02565186|82699602|FG001|Overall Study|Non-Compliance|55|||
46610001|NCT02565186|82699601|FG000|Overall Study|Withdrawal by Subject|229|||
46610002|NCT02565186|82699602|FG001|Overall Study|Withdrawal by Subject|214|||
46610003|NCT02565186|82699601|FG000|Overall Study|Physician Decision|18|||
46610004|NCT02565186|82699602|FG001|Overall Study|Physician Decision|16|||
46610005|NCT02565186|82699601|FG000|Overall Study|Sponsor Request|5|||
46610006|NCT02565186|82699602|FG001|Overall Study|Sponsor Request|9|||
46610007|NCT02565186|82699601|FG000|Overall Study|Missing|1|||
46610008|NCT02565186|82699602|FG001|Overall Study|Missing|0|||
46610009|NCT02565186|82699601|FG000|Overall Study|Did Not Receive Study Drug|55|||
46610010|NCT02565186|82699602|FG001|Overall Study|Did Not Receive Study Drug|86|||
46610011|NCT02568072|82699608|FG000|Overall Study|Unavailable for appointment|23|||
46610012|NCT02568072|82699608|FG000|Overall Study|Unable to contact|3|||
46610013|NCT02568072|82699608|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
46610014|NCT02568072|82699608|FG000|Overall Study|Withdrawal by Subject|1|||
46610015|NCT02568072|82699608|FG000|Overall Study|Sustained injury, marathon not run|24|||
46610016|NCT02565108|82699615|FG000|Overall Study|Adverse Event|1|||
46610017|NCT02565108|82699616|FG001|Overall Study|Adverse Event|0|||
46610018|NCT02565108|82699615|FG000|Overall Study|Withdrew Consent|1|||
46610019|NCT02565108|82699616|FG001|Overall Study|Withdrew Consent|0|||
46610020|NCT02564952|82699622|FG000|Overall Study|Adverse Event|6|||
46610021|NCT02564952|82699622|FG000|Overall Study|Lost to Follow-up|1|||
46610022|NCT02564952|82699622|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
46610023|NCT02564952|82699622|FG000|Overall Study|Withdrawal by Subject|1|||
46610024|NCT02564952|82699622|FG000|Overall Study|Low Efficacy|1|||
46610025|NCT02564952|82699622|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
46610026|NCT02566902|82699628|FG000|Overall Study|Protocol Violation|2|||
46610027|NCT02566902|82699629|FG001|Overall Study|Protocol Violation|1|||
46610028|NCT02564796|82699637|FG000|Overall Study|Physician Decision|2|||
46610029|NCT02564796|82699638|FG001|Overall Study|Physician Decision|2|||
46610030|NCT02564718|82699646|FG000|Overall Study|Withdrew from treatment|0|||
46610031|NCT02564718|82699647|FG001|Overall Study|Withdrew from treatment|1|||
46610032|NCT01453946|82699653|FG000|Overall Study|Did not receive drug for the taper phase|1|||
46610033|NCT01453946|82699653|FG000|Overall Study|Protocol Violation|2|||
46610034|NCT01453946|82699653|FG000|Overall Study|Lack of Efficacy|3|||
46610035|NCT01453946|82699653|FG000|Overall Study|Adverse Event|3|||
46610036|NCT02563548|82699775|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
46610037|NCT02563548|82699776|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
46610038|NCT02563548|82699777|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
46610039|NCT02563548|82699778|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
46610040|NCT02563548|82699779|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
46610041|NCT02563548|82699780|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
46610042|NCT02563548|82699775|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
46610043|NCT02563548|82699776|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
46610044|NCT02563548|82699777|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
46610045|NCT02563548|82699778|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
46610046|NCT02563548|82699779|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
46610047|NCT02563548|82699780|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
46610048|NCT02563548|82699775|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
46610049|NCT02563548|82699776|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
46610050|NCT02563548|82699777|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
46610051|NCT02563548|82699778|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
46610052|NCT02563548|82699779|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
46610053|NCT02563548|82699780|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
46610054|NCT02563548|82699775|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
46610055|NCT02563548|82699776|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
46610056|NCT02563548|82699777|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
46610057|NCT02563548|82699778|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
46610058|NCT02563548|82699779|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
46610059|NCT02563548|82699780|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
46610060|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
46610061|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
46610062|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
46610063|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
46610064|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
46610065|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
46610066|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
46610067|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
46610068|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
46610069|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
46610070|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
46610071|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
46610072|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
46610073|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
46610074|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
46610075|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
46610076|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
46610077|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
46610078|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
46610079|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
46610080|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
46610081|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
46610082|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
46610083|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
46610084|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
46610085|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
46610086|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
46610087|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
46610088|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
46610089|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
46610090|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
46610091|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
46610092|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
46610093|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
46610094|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
46610095|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
46610096|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
46610097|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
46610098|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
46610099|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
46610100|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
46610101|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
46610102|NCT02563548|82699775|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
46610103|NCT02563548|82699776|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
46610104|NCT02563548|82699777|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
46610105|NCT02563548|82699778|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
46610106|NCT02563548|82699779|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
46610107|NCT02563548|82699780|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
46610108|NCT02559570|82699861|FG000|Overall Study|Adverse Event|0|||
46610109|NCT02559570|82699862|FG001|Overall Study|Adverse Event|2|||
46610110|NCT02559570|82699863|FG002|Overall Study|Adverse Event|0|||
46610111|NCT02559570|82699864|FG003|Overall Study|Adverse Event|1|||
46610112|NCT02559570|82699865|FG004|Overall Study|Adverse Event|0|||
46610113|NCT02559570|82699861|FG000|Overall Study|Withdrawal of Consent|0|||
46610114|NCT02559570|82699862|FG001|Overall Study|Withdrawal of Consent|0|||
46610115|NCT02559570|82699863|FG002|Overall Study|Withdrawal of Consent|1|||
46610116|NCT02559570|82699864|FG003|Overall Study|Withdrawal of Consent|2|||
46610117|NCT02559570|82699865|FG004|Overall Study|Withdrawal of Consent|1|||
46610118|NCT02559570|82699861|FG000|Overall Study|Lost to Follow-up|1|||
46610119|NCT02559570|82699862|FG001|Overall Study|Lost to Follow-up|0|||
46610120|NCT02559570|82699863|FG002|Overall Study|Lost to Follow-up|0|||
46610121|NCT02559570|82699864|FG003|Overall Study|Lost to Follow-up|0|||
46610122|NCT02559570|82699865|FG004|Overall Study|Lost to Follow-up|0|||
46610123|NCT02559570|82699861|FG000|Overall Study|Protocol Violation|1|||
46610124|NCT02559570|82699862|FG001|Overall Study|Protocol Violation|0|||
46610125|NCT02559570|82699863|FG002|Overall Study|Protocol Violation|0|||
46610126|NCT02559570|82699864|FG003|Overall Study|Protocol Violation|0|||
46610127|NCT02559570|82699865|FG004|Overall Study|Protocol Violation|1|||
46610128|NCT02559570|82699861|FG000|Overall Study|Other Miscellaneous Reasons|0|||
46610129|NCT02559570|82699862|FG001|Overall Study|Other Miscellaneous Reasons|0|||
46610130|NCT02559570|82699863|FG002|Overall Study|Other Miscellaneous Reasons|1|||
46610131|NCT02559570|82699864|FG003|Overall Study|Other Miscellaneous Reasons|0|||
46610132|NCT02559570|82699865|FG004|Overall Study|Other Miscellaneous Reasons|0|||
46610133|NCT02559414|82700220|FG000|Overall Study|Lost to Follow-up|0|||
46610134|NCT02559414|82700221|FG001|Overall Study|Lost to Follow-up|1|||
46610135|NCT02559414|82700222|FG002|Overall Study|Lost to Follow-up|0|||
46610136|NCT02559414|82700220|FG000|Overall Study|Withdrawal by Subject|1|||
46610137|NCT02559414|82700221|FG001|Overall Study|Withdrawal by Subject|0|||
46610138|NCT02559414|82700222|FG002|Overall Study|Withdrawal by Subject|1|||
46610139|NCT02559414|82700220|FG000|Overall Study|Other|0|||
46610140|NCT02559414|82700221|FG001|Overall Study|Other|1|||
46610141|NCT02559414|82700222|FG002|Overall Study|Other|1|||
46610142|NCT02558790|82700297|FG000|Overall Study|Lost to Follow-up|2|||
46610143|NCT02558790|82700297|FG000|Overall Study|Physician Decision|1|||
46610144|NCT02558790|82700297|FG000|Overall Study|Withdrawal by Subject|1|||
46610145|NCT02558790|82700297|FG000|Overall Study|Screen Fail|3|||
46610146|NCT02556138|82700323|FG000|Overall Study|Withdrawal by Subject|1|||
46610147|NCT02558400|82700406|FG000|Overall Study|Adverse Event|47|||
46610148|NCT02558400|82700407|FG001|Overall Study|Adverse Event|53|||
46610149|NCT02558400|82700408|FG002|Overall Study|Adverse Event|4|||
46610150|NCT02558400|82700406|FG000|Overall Study|Withdrawal by Subject|13|||
46610151|NCT02558400|82700407|FG001|Overall Study|Withdrawal by Subject|9|||
46610152|NCT02558400|82700408|FG002|Overall Study|Withdrawal by Subject|8|||
46610153|NCT02558400|82700406|FG000|Overall Study|Non-Compliant|0|||
46610154|NCT02558400|82700407|FG001|Overall Study|Non-Compliant|1|||
46610155|NCT02558400|82700408|FG002|Overall Study|Non-Compliant|3|||
46610156|NCT02558400|82700406|FG000|Overall Study|Lost to Follow-up|5|||
46610157|NCT02558400|82700407|FG001|Overall Study|Lost to Follow-up|5|||
46610158|NCT02558400|82700408|FG002|Overall Study|Lost to Follow-up|4|||
46610159|NCT02558400|82700406|FG000|Overall Study|Lack of Efficacy|0|||
46610160|NCT02558400|82700407|FG001|Overall Study|Lack of Efficacy|13|||
46610161|NCT02558400|82700408|FG002|Overall Study|Lack of Efficacy|1|||
46610162|NCT02558400|82700406|FG000|Overall Study|Disallowed Concurrent Medication|6|||
46610163|NCT02558400|82700407|FG001|Overall Study|Disallowed Concurrent Medication|7|||
46610164|NCT02558400|82700408|FG002|Overall Study|Disallowed Concurrent Medication|5|||
46610165|NCT02558400|82700406|FG000|Overall Study|Physician Decision|2|||
46610166|NCT02558400|82700407|FG001|Overall Study|Physician Decision|2|||
46610167|NCT02558400|82700408|FG002|Overall Study|Physician Decision|0|||
46610168|NCT02558400|82700406|FG000|Overall Study|Protocol Violation|6|||
46610169|NCT02558400|82700407|FG001|Overall Study|Protocol Violation|3|||
46610170|NCT02558400|82700408|FG002|Overall Study|Protocol Violation|8|||
46610171|NCT02558400|82700406|FG000|Overall Study|Death|0|||
46610172|NCT02558400|82700407|FG001|Overall Study|Death|1|||
46610173|NCT02558400|82700408|FG002|Overall Study|Death|0|||
46610174|NCT02558400|82700406|FG000|Overall Study|Ineligible for the study|0|||
46706549|NCT01211483|82921774|FG001|Phase 2|Study terminated by Sponsor|6|||
46610175|NCT02558400|82700407|FG001|Overall Study|Ineligible for the study|2|||
46610176|NCT02558400|82700408|FG002|Overall Study|Ineligible for the study|0|||
46610177|NCT05021978|82700489|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
46610178|NCT05021978|82700490|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
46610179|NCT05021978|82700491|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
46610180|NCT05021978|82700492|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
46610181|NCT05021978|82700489|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
46610182|NCT05021978|82700490|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
46610183|NCT05021978|82700491|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
46610184|NCT05021978|82700492|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
46610185|NCT01662648|82700556|FG000|Overall Study|Death|1|||
46610186|NCT01662648|82700557|FG001|Overall Study|Death|3|||
46610187|NCT01662648|82700556|FG000|Overall Study|Adverse Event|40|||
46610188|NCT01662648|82700557|FG001|Overall Study|Adverse Event|37|||
46610189|NCT01662648|82700556|FG000|Overall Study|Lack of Efficacy|17|||
46610190|NCT01662648|82700557|FG001|Overall Study|Lack of Efficacy|16|||
46610191|NCT01662648|82700556|FG000|Overall Study|Participant ineligible to continue trial|1|||
46610192|NCT01662648|82700557|FG001|Overall Study|Participant ineligible to continue trial|1|||
46610193|NCT01662648|82700556|FG000|Overall Study|Lost to Follow-up|24|||
46610194|NCT01662648|82700557|FG001|Overall Study|Lost to Follow-up|36|||
46610195|NCT01662648|82700556|FG000|Overall Study|Withdrawal by Subject|36|||
46610196|NCT01662648|82700557|FG001|Overall Study|Withdrawal by Subject|53|||
46610197|NCT01662648|82700556|FG000|Overall Study|Participant non-compliant|16|||
46610198|NCT01662648|82700557|FG001|Overall Study|Participant non-compliant|20|||
46610199|NCT01662648|82700556|FG000|Overall Study|Other|8|||
46610200|NCT01662648|82700557|FG001|Overall Study|Other|11|||
46610201|NCT01662648|82700556|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
46610202|NCT01662648|82700557|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
46610203|NCT01662648|82700556|FG000|Overall Study|LOE and other reason unspecified|1|||
46610204|NCT01662648|82700557|FG001|Overall Study|LOE and other reason unspecified|0|||
46610205|NCT01662648|82700556|FG000|Overall Study|LOE and Participant non-compliant|0|||
46610206|NCT01662648|82700557|FG001|Overall Study|LOE and Participant non-compliant|1|||
46610207|NCT02556918|82700622|FG000|Overall Study|Protocol Violation|5|||
46610208|NCT02556918|82700623|FG001|Overall Study|Protocol Violation|6|||
46610209|NCT02556918|82700622|FG000|Overall Study|Withdrawal by Subject|4|||
46610210|NCT02556918|82700623|FG001|Overall Study|Withdrawal by Subject|4|||
46610211|NCT01662492|82700739|FG000|Overall Study|Other miscellaneous reasons.|1|||
46610212|NCT01662492|82700740|FG001|Overall Study|Other miscellaneous reasons.|0|||
46610213|NCT01662492|82700741|FG002|Overall Study|Other miscellaneous reasons.|1|||
46610214|NCT01662492|82700739|FG000|Overall Study|Withdrawal by Subject|0|||
46610215|NCT01662492|82700740|FG001|Overall Study|Withdrawal by Subject|0|||
46610216|NCT01662492|82700741|FG002|Overall Study|Withdrawal by Subject|1|||
46610217|NCT01662492|82700739|FG000|Overall Study|Protocol Violation|1|||
46610218|NCT01662492|82700740|FG001|Overall Study|Protocol Violation|0|||
46610219|NCT01662492|82700741|FG002|Overall Study|Protocol Violation|0|||
46610220|NCT01662492|82700739|FG000|Overall Study|Lost to Follow-up|0|||
46610221|NCT01662492|82700740|FG001|Overall Study|Lost to Follow-up|0|||
46610222|NCT01662492|82700741|FG002|Overall Study|Lost to Follow-up|2|||
46610223|NCT01662492|82700739|FG000|Overall Study|Lack of Efficacy|1|||
46610224|NCT01662492|82700740|FG001|Overall Study|Lack of Efficacy|1|||
46610225|NCT01662492|82700741|FG002|Overall Study|Lack of Efficacy|2|||
46610226|NCT02552238|82700911|FG000|Overall Study|Withdrawal by Subject|2|||
46610227|NCT02552238|82700911|FG000|Overall Study|Adverse Event|2|||
46610228|NCT01662102|82701124|FG000|Overall Study|Sponsor's decision|1|||
46610229|NCT01662102|82701125|FG001|Overall Study|Sponsor's decision|0|||
46610230|NCT02554656|82701165|FG000|Overall Study|Protocol Violation|3|||
46610231|NCT04053868|82701213|FG000|Overall Study|Withdrawal by Subject|1|||
46610232|NCT04053868|82701214|FG001|Overall Study|Withdrawal by Subject|0|||
46610233|NCT02551692|82701389|FG000|Overall Study|Lost to Follow-up|0|||
46610234|NCT02551692|82701390|FG001|Overall Study|Lost to Follow-up|1|||
46610235|NCT02551692|82701391|FG002|Overall Study|Lost to Follow-up|4|||
46610236|NCT02551692|82701389|FG000|Overall Study|Withdrawal by Subject|1|||
46610237|NCT02551692|82701390|FG001|Overall Study|Withdrawal by Subject|0|||
46610238|NCT02551692|82701391|FG002|Overall Study|Withdrawal by Subject|1|||
46610239|NCT02553330|82701478|FG000|Overall Study|Study Terminated by Sponsor|2|||
46610240|NCT02553330|82701479|FG001|Overall Study|Study Terminated by Sponsor|13|||
46610241|NCT02553330|82701480|FG002|Overall Study|Study Terminated by Sponsor|12|||
46610242|NCT02553330|82701478|FG000|Overall Study|Withdrawal by Subject|3|||
46610243|NCT02553330|82701479|FG001|Overall Study|Withdrawal by Subject|19|||
46610244|NCT02553330|82701480|FG002|Overall Study|Withdrawal by Subject|21|||
46610245|NCT02553330|82701478|FG000|Overall Study|Other|0|||
46610246|NCT02553330|82701479|FG001|Overall Study|Other|1|||
46610247|NCT02553330|82701480|FG002|Overall Study|Other|0|||
46890717|NCT02734810|83113977|FG001|Overall Study|Adverse Event|0|||
46890718|NCT02734810|83113976|FG000|Overall Study|Lack of Efficacy|1|||
46610248|NCT02553330|82701478|FG000|Overall Study|Non compliance to study treatment|0|||
46610249|NCT02553330|82701479|FG001|Overall Study|Non compliance to study treatment|1|||
46610250|NCT02553330|82701480|FG002|Overall Study|Non compliance to study treatment|0|||
46610251|NCT02553330|82701478|FG000|Overall Study|Adverse Event|0|||
46610252|NCT02553330|82701479|FG001|Overall Study|Adverse Event|1|||
46610253|NCT02553330|82701480|FG002|Overall Study|Adverse Event|0|||
46610254|NCT02553330|82701478|FG000|Overall Study|Lost to Follow-up|0|||
46610255|NCT02553330|82701479|FG001|Overall Study|Lost to Follow-up|4|||
46610256|NCT02553330|82701480|FG002|Overall Study|Lost to Follow-up|4|||
46610257|NCT02550288|82701522|FG000|Overall Study|Adverse Event|0|||
46610258|NCT02550288|82701523|FG001|Overall Study|Adverse Event|1|||
46610259|NCT02550288|82701524|FG002|Overall Study|Adverse Event|0|||
46610260|NCT02550288|82701525|FG003|Overall Study|Adverse Event|0|||
46610261|NCT02550288|82701526|FG004|Overall Study|Adverse Event|0|||
46610262|NCT02550288|82701522|FG000|Overall Study|Physician Decision|0|||
46610263|NCT02550288|82701523|FG001|Overall Study|Physician Decision|0|||
46610264|NCT02550288|82701524|FG002|Overall Study|Physician Decision|0|||
46610265|NCT02550288|82701525|FG003|Overall Study|Physician Decision|1|||
46610266|NCT02550288|82701526|FG004|Overall Study|Physician Decision|0|||
46610267|NCT02550288|82701522|FG000|Overall Study|Protocol Violation|2|||
46610268|NCT02550288|82701523|FG001|Overall Study|Protocol Violation|2|||
46610269|NCT02550288|82701524|FG002|Overall Study|Protocol Violation|1|||
46610270|NCT02550288|82701525|FG003|Overall Study|Protocol Violation|0|||
46610271|NCT02550288|82701526|FG004|Overall Study|Protocol Violation|3|||
46610272|NCT02550288|82701522|FG000|Overall Study|Participant moved|0|||
46610273|NCT02550288|82701523|FG001|Overall Study|Participant moved|0|||
46610274|NCT02550288|82701524|FG002|Overall Study|Participant moved|0|||
46610275|NCT02550288|82701525|FG003|Overall Study|Participant moved|1|||
46610276|NCT02550288|82701526|FG004|Overall Study|Participant moved|0|||
46610277|NCT02550288|82701522|FG000|Overall Study|Withdrawal by Subject|0|||
46610278|NCT02550288|82701523|FG001|Overall Study|Withdrawal by Subject|0|||
46610279|NCT02550288|82701524|FG002|Overall Study|Withdrawal by Subject|0|||
46610280|NCT02550288|82701525|FG003|Overall Study|Withdrawal by Subject|1|||
46610281|NCT02550288|82701526|FG004|Overall Study|Withdrawal by Subject|0|||
46610282|NCT01662336|82701587|FG000|Overall Study|Adverse Event|1|||
46610283|NCT01662336|82701587|FG000|Overall Study|No longer on LPV/r|30|||
46610284|NCT01662336|82701587|FG000|Overall Study|Other|29|||
46610285|NCT01662336|82701587|FG000|Overall Study|Withdrawal by Subject|6|||
46610286|NCT02549352|82701606|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
46610287|NCT02549352|82701607|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
46610288|NCT02549352|82701606|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
46610289|NCT02549352|82701607|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
46610290|NCT02549352|82701606|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
46610291|NCT02549352|82701607|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
46610292|NCT02549352|82701606|FG000|12-month Follow-up|Withdrawal by Subject|4|||
46610293|NCT02549352|82701607|FG001|12-month Follow-up|Withdrawal by Subject|5|||
46610294|NCT02549352|82701606|FG000|12-month Follow-up|Lost to Follow-up|3|||
46610295|NCT02549352|82701607|FG001|12-month Follow-up|Lost to Follow-up|2|||
46610296|NCT02549352|82701606|FG000|12-month Follow-up|Death|0|||
46610297|NCT02549352|82701607|FG001|12-month Follow-up|Death|1|||
46610298|NCT02549352|82701606|FG000|12-month Follow-up|Protocol Violation|0|||
46610299|NCT02549352|82701607|FG001|12-month Follow-up|Protocol Violation|1|||
46610300|NCT02549352|82701606|FG000|12-month Follow-up|Other|1|||
46610301|NCT02549352|82701607|FG001|12-month Follow-up|Other|3|||
46610302|NCT02554890|82701784|FG000|Double-blind|Adverse Event|45|||
46610303|NCT02554890|82701785|FG001|Double-blind|Adverse Event|51|||
46610304|NCT02554890|82701784|FG000|Double-blind|Death|6|||
46610305|NCT02554890|82701785|FG001|Double-blind|Death|4|||
46610306|NCT02554890|82701784|FG000|Double-blind|Protocol Violation|1|||
46610307|NCT02554890|82701785|FG001|Double-blind|Protocol Violation|1|||
46610308|NCT02554890|82701784|FG000|Double-blind|Physician Decision|4|||
46610309|NCT02554890|82701785|FG001|Double-blind|Physician Decision|3|||
46610310|NCT02554890|82701784|FG000|Double-blind|Subject/Guardian decision|21|||
46610311|NCT02554890|82701785|FG001|Double-blind|Subject/Guardian decision|16|||
46610312|NCT02554890|82701784|FG000|Double-blind|Lost to Follow-up|7|||
46610313|NCT02554890|82701785|FG001|Double-blind|Lost to Follow-up|5|||
46610314|NCT02554890|82701784|FG000|Double-blind|Technical problems|1|||
46610315|NCT02554890|82701785|FG001|Double-blind|Technical problems|0|||
46610316|NCT02554890|82701784|FG000|Double-blind|Withdrawal by Subject|5|||
46610317|NCT02554890|82701785|FG001|Double-blind|Withdrawal by Subject|6|||
46610318|NCT02554890|82701784|FG000|Double-blind|Noncompliance with study treatment|6|||
46610319|NCT02554890|82701785|FG001|Double-blind|Noncompliance with study treatment|5|||
46610320|NCT02554890|82701784|FG000|Open-label|Adverse Event|0|||
46610321|NCT02554890|82701785|FG001|Open-label|Adverse Event|30|||
46610322|NCT02554890|82701784|FG000|Open-label|Death|0|||
46610323|NCT02554890|82701785|FG001|Open-label|Death|1|||
46610324|NCT02554890|82701784|FG000|Open-label|Physician Decision|0|||
46610325|NCT02554890|82701785|FG001|Open-label|Physician Decision|1|||
46610326|NCT02554890|82701784|FG000|Open-label|Subject/Guardian decision|0|||
46610327|NCT02554890|82701785|FG001|Open-label|Subject/Guardian decision|11|||
46610328|NCT02554890|82701784|FG000|Open-label|Lost to Follow-up|0|||
46610329|NCT02554890|82701785|FG001|Open-label|Lost to Follow-up|7|||
46610330|NCT02554890|82701784|FG000|Open-label|Technical problems|0|||
46610331|NCT02554890|82701785|FG001|Open-label|Technical problems|1|||
46610332|NCT02554890|82701784|FG000|Open-label|Withdrawal by Subject|0|||
46610333|NCT02554890|82701785|FG001|Open-label|Withdrawal by Subject|1|||
46610334|NCT02552316|82701802|FG000|Overall Study|Withdrawal by Subject|1|||
46610335|NCT02552316|82701802|FG000|Overall Study|Withdrawal due to non-compliance|1|||
46610336|NCT02543346|82701850|FG000|Second Priming Visit|Withdrawal by Subject|0|||
46610337|NCT02543346|82701851|FG001|Second Priming Visit|Withdrawal by Subject|2|||
46610338|NCT02543346|82701852|FG002|Second Priming Visit|Withdrawal by Subject|2|||
46610339|NCT02543346|82701853|FG003|Second Priming Visit|Withdrawal by Subject|2|||
46610340|NCT02543346|82701850|FG000|Second Priming Visit|Adverse Event|1|||
46610341|NCT02543346|82701851|FG001|Second Priming Visit|Adverse Event|0|||
46610342|NCT02543346|82701852|FG002|Second Priming Visit|Adverse Event|0|||
46610343|NCT02543346|82701853|FG003|Second Priming Visit|Adverse Event|0|||
46610344|NCT02549196|82701867|FG000|Overall Study|Protocol Violation|0|||
46610345|NCT02549196|82701868|FG001|Overall Study|Protocol Violation|0|||
46610346|NCT02549196|82701869|FG002|Overall Study|Protocol Violation|0|||
46610347|NCT02549196|82701870|FG003|Overall Study|Protocol Violation|1|||
46610348|NCT02549196|82701867|FG000|Overall Study|Withdrawal by Subject|1|||
46610349|NCT02549196|82701868|FG001|Overall Study|Withdrawal by Subject|0|||
46610350|NCT02549196|82701869|FG002|Overall Study|Withdrawal by Subject|1|||
46610351|NCT02549196|82701870|FG003|Overall Study|Withdrawal by Subject|0|||
46610352|NCT02904954|82701882|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
46610353|NCT02904954|82701883|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
46610354|NCT02904954|82701882|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
46610355|NCT02904954|82701883|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
46610356|NCT02904954|82701882|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
46610357|NCT02904954|82701883|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
46610358|NCT02904954|82701882|FG000|Adjuvant Durvalumab|Recurrence|2|||
46610359|NCT02904954|82701883|FG001|Adjuvant Durvalumab|Recurrence|0|||
46610360|NCT02904954|82701882|FG000|Adjuvant Durvalumab|Adverse Event|2|||
46610361|NCT02904954|82701883|FG001|Adjuvant Durvalumab|Adverse Event|6|||
46610362|NCT02904954|82701882|FG000|Adjuvant Durvalumab|Participant wishes|12|||
46610363|NCT02904954|82701883|FG001|Adjuvant Durvalumab|Participant wishes|7|||
46610364|NCT02904954|82701882|FG000|Adjuvant Durvalumab|Physician Decision|2|||
46610365|NCT02904954|82701883|FG001|Adjuvant Durvalumab|Physician Decision|1|||
46610366|NCT02904954|82701882|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
46610367|NCT02904954|82701883|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
46610368|NCT02904954|82701882|FG000|Adjuvant Durvalumab|Death|0|||
46610369|NCT02904954|82701883|FG001|Adjuvant Durvalumab|Death|1|||
46610370|NCT02904954|82701882|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
46610371|NCT02904954|82701883|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
46610372|NCT02548962|82701999|FG000|Overall Study|Withdrawal by Subject|1|||
46610373|NCT02548962|82702000|FG001|Overall Study|Withdrawal by Subject|0|||
46706550|NCT01211483|82921775|FG002|Phase 2|Study terminated by Sponsor|8|||
46706551|NCT01211483|82921776|FG003|Phase 2|Study terminated by Sponsor|11|||
46706552|NCT01210001|82921793|FG000|Overall Study|Not treated|1|||
46706553|NCT01210001|82921794|FG001|Overall Study|Not treated|0|||
46706554|NCT01210001|82921795|FG002|Overall Study|Not treated|0|||
46706555|NCT01210001|82921793|FG000|Overall Study|Adverse Event|4|||
46706556|NCT01210001|82921794|FG001|Overall Study|Adverse Event|2|||
46706557|NCT01210001|82921795|FG002|Overall Study|Adverse Event|5|||
46706558|NCT01210001|82921793|FG000|Overall Study|Non compliant with protocol|2|||
46706559|NCT01210001|82921794|FG001|Overall Study|Non compliant with protocol|2|||
46706560|NCT01210001|82921795|FG002|Overall Study|Non compliant with protocol|3|||
46706561|NCT01210001|82921793|FG000|Overall Study|Lost to Follow-up|4|||
46706562|NCT01210001|82921794|FG001|Overall Study|Lost to Follow-up|3|||
46706563|NCT01210001|82921795|FG002|Overall Study|Lost to Follow-up|2|||
46706564|NCT01210001|82921793|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
46706565|NCT01210001|82921794|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
46706566|NCT01210001|82921795|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
46706567|NCT01210001|82921793|FG000|Overall Study|Other reason not defined above|2|||
46706568|NCT01210001|82921794|FG001|Overall Study|Other reason not defined above|2|||
46706569|NCT01210001|82921795|FG002|Overall Study|Other reason not defined above|1|||
46706570|NCT01209689|82921836|FG000|Overall Study|Insufficient Therapeutic Response|7|||
46706571|NCT01209689|82921837|FG001|Overall Study|Insufficient Therapeutic Response|2|||
46706572|NCT01209689|82921836|FG000|Overall Study|Refused Treatment|8|||
46706573|NCT01209689|82921837|FG001|Overall Study|Refused Treatment|3|||
46706574|NCT01209689|82921836|FG000|Overall Study|Adverse Event|4|||
46706575|NCT01209689|82921837|FG001|Overall Study|Adverse Event|0|||
46706576|NCT01209689|82921836|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
46706577|NCT01209689|82921837|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
46706578|NCT01209689|82921836|FG000|Overall Study|Failure to Return|3|||
46706579|NCT01209689|82921837|FG001|Overall Study|Failure to Return|0|||
46706580|NCT01209689|82921836|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
46706581|NCT01209689|82921837|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
46706582|NCT01209143|82921845|FG000|Overall Study|Adverse Event|2|||
46706583|NCT01209143|82921846|FG001|Overall Study|Adverse Event|1|||
46706584|NCT01209143|82921845|FG000|Overall Study|Death|0|||
46706585|NCT01209143|82921846|FG001|Overall Study|Death|1|||
46706586|NCT01209143|82921845|FG000|Overall Study|Physician Decision|3|||
46706587|NCT01209143|82921846|FG001|Overall Study|Physician Decision|1|||
46706588|NCT01209143|82921845|FG000|Overall Study|Lost to Follow-up|1|||
46706589|NCT01209143|82921846|FG001|Overall Study|Lost to Follow-up|0|||
46706590|NCT01209143|82921845|FG000|Overall Study|Withdrawal by Subject|2|||
46706591|NCT01209143|82921846|FG001|Overall Study|Withdrawal by Subject|1|||
46706592|NCT01209143|82921845|FG000|Overall Study|Disease progression|11|||
46610374|NCT02548650|82702027|FG000|Triple Therapy|Adverse Event|1|||
46610375|NCT02548650|82702028|FG001|Triple Therapy|Adverse Event|0|||
46706593|NCT01209143|82921846|FG001|Overall Study|Disease progression|16|||
46610376|NCT02548650|82702027|FG000|Triple Therapy|Withdrawal by Subject|0|||
46706594|NCT01023789|82921852|FG000|3 - Year Visit|Death|29|||
46706595|NCT01023789|82921852|FG000|3 - Year Visit|Withdrawal of consent|1|||
46706596|NCT01023789|82921852|FG000|3 - Year Visit|Lost to Follow-up|13|||
46706597|NCT01208207|82921859|FG000|Part I|Adverse Event|19|||
46706598|NCT01208207|82921860|FG001|Part I|Adverse Event|2|||
46706599|NCT01208207|82921861|FG002|Part I|Adverse Event|6|||
46706600|NCT01208207|82921862|FG003|Part I|Adverse Event|0|||
46706601|NCT01208207|82921863|FG004|Part I|Adverse Event|0|||
46706602|NCT01208207|82921864|FG005|Part I|Adverse Event|0|||
46706603|NCT01208207|82921865|FG006|Part I|Adverse Event|0|||
46706604|NCT01208207|82921859|FG000|Part I|Lack of Efficacy|21|||
46706605|NCT01208207|82921860|FG001|Part I|Lack of Efficacy|3|||
46706606|NCT01208207|82921861|FG002|Part I|Lack of Efficacy|2|||
46706607|NCT01208207|82921862|FG003|Part I|Lack of Efficacy|0|||
46706608|NCT01208207|82921863|FG004|Part I|Lack of Efficacy|0|||
46706609|NCT01208207|82921864|FG005|Part I|Lack of Efficacy|0|||
46706610|NCT01208207|82921865|FG006|Part I|Lack of Efficacy|0|||
46706611|NCT01208207|82921859|FG000|Part I|Lost to Follow-up|6|||
46706612|NCT01208207|82921860|FG001|Part I|Lost to Follow-up|1|||
46706613|NCT01208207|82921861|FG002|Part I|Lost to Follow-up|0|||
46706614|NCT01208207|82921862|FG003|Part I|Lost to Follow-up|0|||
46706615|NCT01208207|82921863|FG004|Part I|Lost to Follow-up|0|||
46706616|NCT01208207|82921864|FG005|Part I|Lost to Follow-up|0|||
46706617|NCT01208207|82921865|FG006|Part I|Lost to Follow-up|0|||
46706618|NCT01208207|82921859|FG000|Part I|Non-Compliance With Study Drug|1|||
46706619|NCT01208207|82921860|FG001|Part I|Non-Compliance With Study Drug|0|||
46706620|NCT01208207|82921861|FG002|Part I|Non-Compliance With Study Drug|1|||
46706621|NCT01208207|82921862|FG003|Part I|Non-Compliance With Study Drug|0|||
46706622|NCT01208207|82921863|FG004|Part I|Non-Compliance With Study Drug|0|||
46890719|NCT02734810|83113977|FG001|Overall Study|Lack of Efficacy|0|||
46890720|NCT03656068|83114002|FG000|Overall Study|Withdrawal by Subject|4|||
46890721|NCT03656068|83114002|FG000|Overall Study|Adverse Event|1|||
46890722|NCT02944383|83114009|FG000|Overall Study|Lost to Follow-up|0|||
46890723|NCT02944383|83114010|FG001|Overall Study|Lost to Follow-up|0|||
46890724|NCT02944383|83114011|FG002|Overall Study|Lost to Follow-up|1|||
46890725|NCT02944383|83114009|FG000|Overall Study|Withdrawal by Subject|1|||
46890726|NCT02944383|83114010|FG001|Overall Study|Withdrawal by Subject|0|||
46890727|NCT02944383|83114011|FG002|Overall Study|Withdrawal by Subject|0|||
46890728|NCT03768089|83114039|FG000|Part A|Lost to Follow-up|0|||
46890729|NCT03768089|83114040|FG001|Part A|Lost to Follow-up|0|||
46890730|NCT03768089|83114041|FG002|Part A|Lost to Follow-up|0|||
46890731|NCT03768089|83114042|FG003|Part A|Lost to Follow-up|0|||
46890732|NCT03768089|83114043|FG004|Part A|Lost to Follow-up|1|||
46890733|NCT03768089|83114044|FG005|Part A|Lost to Follow-up|0|||
46890734|NCT03768089|83114045|FG006|Part A|Lost to Follow-up|0|||
46890735|NCT03768089|83114046|FG007|Part A|Lost to Follow-up|0|||
46890736|NCT03768089|83114047|FG008|Part A|Lost to Follow-up|0|||
46890737|NCT03768089|83114048|FG009|Part A|Lost to Follow-up|0|||
46890738|NCT03768089|83114049|FG010|Part A|Lost to Follow-up|0|||
46890739|NCT03768089|83114050|FG011|Part A|Lost to Follow-up|0|||
46890740|NCT03768089|83114051|FG012|Part A|Lost to Follow-up|0|||
46890741|NCT03768089|83114052|FG013|Part A|Lost to Follow-up|0|||
46890742|NCT03768089|83114053|FG014|Part A|Lost to Follow-up|0|||
46890743|NCT03768089|83114054|FG015|Part A|Lost to Follow-up|0|||
46890744|NCT03768089|83114055|FG016|Part A|Lost to Follow-up|0|||
46890745|NCT03768089|83114056|FG017|Part A|Lost to Follow-up|0|||
46890746|NCT03768089|83114039|FG000|Part C|Randomized, Never Dosed|0|||
46890747|NCT03768089|83114040|FG001|Part C|Randomized, Never Dosed|0|||
46890748|NCT03768089|83114041|FG002|Part C|Randomized, Never Dosed|0|||
46890749|NCT03768089|83114042|FG003|Part C|Randomized, Never Dosed|0|||
46890750|NCT03768089|83114043|FG004|Part C|Randomized, Never Dosed|0|||
46890751|NCT03768089|83114044|FG005|Part C|Randomized, Never Dosed|0|||
46890752|NCT03768089|83114045|FG006|Part C|Randomized, Never Dosed|0|||
46890753|NCT03768089|83114046|FG007|Part C|Randomized, Never Dosed|0|||
46890754|NCT03768089|83114047|FG008|Part C|Randomized, Never Dosed|0|||
46890755|NCT03768089|83114048|FG009|Part C|Randomized, Never Dosed|0|||
46706623|NCT01208207|82921864|FG005|Part I|Non-Compliance With Study Drug|0|||
46706624|NCT01208207|82921865|FG006|Part I|Non-Compliance With Study Drug|0|||
46706625|NCT01208207|82921859|FG000|Part I|Physician Decision|0|||
46890756|NCT03768089|83114049|FG010|Part C|Randomized, Never Dosed|0|||
46890757|NCT03768089|83114050|FG011|Part C|Randomized, Never Dosed|0|||
46890758|NCT03768089|83114051|FG012|Part C|Randomized, Never Dosed|0|||
46890759|NCT03768089|83114052|FG013|Part C|Randomized, Never Dosed|0|||
46890760|NCT03768089|83114053|FG014|Part C|Randomized, Never Dosed|1|||
46890761|NCT03768089|83114054|FG015|Part C|Randomized, Never Dosed|0|||
46890762|NCT03768089|83114055|FG016|Part C|Randomized, Never Dosed|0|||
46890763|NCT03768089|83114056|FG017|Part C|Randomized, Never Dosed|0|||
46706626|NCT01208207|82921860|FG001|Part I|Physician Decision|1|||
46706627|NCT01208207|82921861|FG002|Part I|Physician Decision|0|||
46706628|NCT01208207|82921862|FG003|Part I|Physician Decision|0|||
46706629|NCT01208207|82921863|FG004|Part I|Physician Decision|0|||
46706630|NCT01208207|82921864|FG005|Part I|Physician Decision|0|||
46706631|NCT01208207|82921865|FG006|Part I|Physician Decision|0|||
46706632|NCT01208207|82921859|FG000|Part I|Progressive Disease|1|||
46890764|NCT03548584|83114114|FG000|Overall Study|Lost to Follow-up|0|||
46890765|NCT03548584|83114115|FG001|Overall Study|Lost to Follow-up|0|||
46890766|NCT03548584|83114116|FG002|Overall Study|Lost to Follow-up|1|||
46890767|NCT03548584|83114114|FG000|Overall Study|Adverse Event|1|||
46890768|NCT03548584|83114115|FG001|Overall Study|Adverse Event|11|||
46890769|NCT03548584|83114116|FG002|Overall Study|Adverse Event|5|||
46890770|NCT03548584|83114114|FG000|Overall Study|Site Terminated by Sponsor|1|||
46890771|NCT03548584|83114115|FG001|Overall Study|Site Terminated by Sponsor|3|||
46890772|NCT03548584|83114116|FG002|Overall Study|Site Terminated by Sponsor|2|||
46890773|NCT03548584|83114114|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
46890774|NCT03548584|83114115|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
46890775|NCT03548584|83114116|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
46890776|NCT03548584|83114114|FG000|Overall Study|Lack of Efficacy|0|||
46890777|NCT03548584|83114115|FG001|Overall Study|Lack of Efficacy|1|||
46890778|NCT03548584|83114116|FG002|Overall Study|Lack of Efficacy|0|||
46890779|NCT03548584|83114114|FG000|Overall Study|Non-compliance with Study Drug|0|||
46890780|NCT03548584|83114115|FG001|Overall Study|Non-compliance with Study Drug|1|||
46890781|NCT03548584|83114116|FG002|Overall Study|Non-compliance with Study Drug|0|||
46890782|NCT03548584|83114114|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
46890783|NCT03548584|83114115|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
46890784|NCT03548584|83114116|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
46890785|NCT03086330|83114129|FG000|Overall Study|Withdrawal by Subject|3|||
46890786|NCT03086330|83114130|FG001|Overall Study|Withdrawal by Subject|2|||
46890787|NCT03086330|83114129|FG000|Overall Study|Lost to Follow-up|1|||
46890788|NCT03086330|83114130|FG001|Overall Study|Lost to Follow-up|2|||
46890789|NCT02943993|83114162|FG000|Overall Study|Withdrawal by Subject|52|||
46890790|NCT02943993|83114162|FG000|Overall Study|Transfer to another institution|6|||
46890791|NCT02943993|83114162|FG000|Overall Study|Lost to Follow-up|135|||
46890792|NCT02943993|83114162|FG000|Overall Study|Death|98|||
46890793|NCT02943993|83114162|FG000|Overall Study|Other reason for premature termination|32|||
46890794|NCT02943993|83114162|FG000|Overall Study|Missing reason for termination|7|||
46890795|NCT02943447|83114186|FG000|Blinded Study Phase|Withdrew Consent|1|||
46890796|NCT02943447|83114187|FG001|Blinded Study Phase|Withdrew Consent|2|||
46890797|NCT02943447|83114188|FG002|Blinded Study Phase|Withdrew Consent|1|||
46890798|NCT02943447|83114186|FG000|Blinded Study Phase|Adverse Event|3|||
46890799|NCT02943447|83114187|FG001|Blinded Study Phase|Adverse Event|0|||
46890800|NCT02943447|83114188|FG002|Blinded Study Phase|Adverse Event|0|||
46890801|NCT02943447|83114186|FG000|Blinded Study Phase|Investigator's discretion|1|||
46890802|NCT02943447|83114187|FG001|Blinded Study Phase|Investigator's discretion|0|||
46890803|NCT02943447|83114188|FG002|Blinded Study Phase|Investigator's discretion|0|||
46890804|NCT02943447|83114186|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
46890805|NCT02943447|83114187|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
46890806|NCT02943447|83114188|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
46890807|NCT02943447|83114186|FG000|Open-Label Extension Phase|Adverse Event|4|||
46890808|NCT02943447|83114187|FG001|Open-Label Extension Phase|Adverse Event|7|||
46890809|NCT02943447|83114188|FG002|Open-Label Extension Phase|Adverse Event|3|||
46890810|NCT02943447|83114186|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
46890811|NCT02943447|83114187|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
46890812|NCT02943447|83114188|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
46890813|NCT02943447|83114186|FG000|Open-Label Extension Phase|Withdrew consent|1|||
46890814|NCT02943447|83114187|FG001|Open-Label Extension Phase|Withdrew consent|1|||
46890815|NCT02943447|83114188|FG002|Open-Label Extension Phase|Withdrew consent|1|||
46890816|NCT02943447|83114186|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
46890817|NCT02943447|83114187|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
46890818|NCT02943447|83114188|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
46890819|NCT02844777|83114217|FG000|Overall Study|Withdrawal by Subject|2|||
46890820|NCT02844777|83114218|FG001|Overall Study|Withdrawal by Subject|0|||
46890821|NCT02844777|83114219|FG002|Overall Study|Withdrawal by Subject|0|||
46890822|NCT02612337|83114229|FG000|Overall Study|Lack of Efficacy|1|||
46890823|NCT02612337|83114230|FG001|Overall Study|Lack of Efficacy|0|||
46890824|NCT02612337|83114229|FG000|Overall Study|Withdrawal by Subject|2|||
46890825|NCT02612337|83114230|FG001|Overall Study|Withdrawal by Subject|2|||
46890826|NCT02612337|83114229|FG000|Overall Study|Did not receive study drug|0|||
46890827|NCT02612337|83114230|FG001|Overall Study|Did not receive study drug|1|||
46890828|NCT03532451|83114244|FG000|Overall Study|Withdrawal by Subject|0|||
46890829|NCT03532451|83114245|FG001|Overall Study|Withdrawal by Subject|1|||
46890830|NCT03532451|83114244|FG000|Overall Study|Progression prior to the surgery|1|||
46890831|NCT03532451|83114245|FG001|Overall Study|Progression prior to the surgery|0|||
46890832|NCT03085238|83114251|FG000|Overall Study|Adverse Event|2|||
46890833|NCT03085238|83114251|FG000|Overall Study|Death|2|||
46890834|NCT03383666|83114273|FG000|Overall Study|Withdrawal by Subject|2|||
46890835|NCT03383666|83114273|FG000|Overall Study|Lost to Follow-up|2|||
46890836|NCT03086018|83114277|FG000|Final Testing for End of Trial|Adverse Event|1|||
46890837|NCT03086018|83114277|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
46890838|NCT03319953|83114287|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
46890839|NCT03319953|83114288|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
46890840|NCT03319953|83114289|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
46890841|NCT03319953|83114290|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
46890842|NCT03319953|83114287|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
46890843|NCT03319953|83114288|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
46890844|NCT03319953|83114289|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
46890845|NCT03319953|83114290|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
46890846|NCT02927834|83114301|FG000|Overall Study|Lost to Follow-up|1|||
46890847|NCT02927834|83114302|FG001|Overall Study|Lost to Follow-up|2|||
46890848|NCT02927834|83114303|FG002|Overall Study|Lost to Follow-up|2|||
46890849|NCT01964547|83114317|FG000|Overall Study|Adverse Event|8|||
46890850|NCT01964547|83114318|FG001|Overall Study|Adverse Event|2|||
46890851|NCT01964547|83114317|FG000|Overall Study|Withdrawal by Subject|4|||
46890852|NCT01964547|83114318|FG001|Overall Study|Withdrawal by Subject|7|||
46890853|NCT01964547|83114317|FG000|Overall Study|Lost to Follow-up|0|||
46890854|NCT01964547|83114318|FG001|Overall Study|Lost to Follow-up|1|||
46890855|NCT01964547|83114317|FG000|Overall Study|Withdrawal by Investigator|0|||
46890856|NCT01964547|83114318|FG001|Overall Study|Withdrawal by Investigator|1|||
46890857|NCT03319719|83114324|FG000|Overall Study|Lost to Follow-up|1|||
46890858|NCT03318783|83114332|FG000|Overall Study|Withdrawal by Subject|0|||
46890859|NCT03318783|83114333|FG001|Overall Study|Withdrawal by Subject|1|||
46890860|NCT03318783|83114332|FG000|Overall Study|Death|0|||
46890861|NCT03318783|83114333|FG001|Overall Study|Death|1|||
46890862|NCT01313689|83114344|FG000|24-Week Randomization 1|Adverse Event|10|||
46890863|NCT01313689|83114345|FG001|24-Week Randomization 1|Adverse Event|5|||
46890864|NCT01313689|83114346|FG002|24-Week Randomization 1|Adverse Event|0|||
46890865|NCT01313689|83114347|FG003|24-Week Randomization 1|Adverse Event|0|||
46890866|NCT01313689|83114348|FG004|24-Week Randomization 1|Adverse Event|0|||
46890867|NCT01313689|83114344|FG000|24-Week Randomization 1|Physician Decision|4|||
46890868|NCT01313689|83114345|FG001|24-Week Randomization 1|Physician Decision|5|||
46890869|NCT01313689|83114346|FG002|24-Week Randomization 1|Physician Decision|0|||
46890870|NCT01313689|83114347|FG003|24-Week Randomization 1|Physician Decision|0|||
46890871|NCT01313689|83114348|FG004|24-Week Randomization 1|Physician Decision|0|||
46890872|NCT01313689|83114344|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
46890873|NCT01313689|83114345|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
46890874|NCT01313689|83114346|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
46890875|NCT01313689|83114347|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
46890876|NCT01313689|83114348|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
46890877|NCT01313689|83114344|FG000|24-Week Randomization 2|Adverse Event|0|||
46890878|NCT01313689|83114345|FG001|24-Week Randomization 2|Adverse Event|0|||
46890879|NCT01313689|83114346|FG002|24-Week Randomization 2|Adverse Event|2|||
46890880|NCT01313689|83114347|FG003|24-Week Randomization 2|Adverse Event|0|||
46890881|NCT01313689|83114348|FG004|24-Week Randomization 2|Adverse Event|8|||
46890882|NCT01313689|83114344|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
46890883|NCT01313689|83114345|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
46890884|NCT01313689|83114346|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
46890885|NCT01313689|83114347|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
46890886|NCT01313689|83114348|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
46890887|NCT01313689|83114344|FG000|24-Week Randomization 2|Physician Decision|0|||
46890888|NCT01313689|83114345|FG001|24-Week Randomization 2|Physician Decision|0|||
46890889|NCT01313689|83114346|FG002|24-Week Randomization 2|Physician Decision|0|||
46890890|NCT01313689|83114347|FG003|24-Week Randomization 2|Physician Decision|0|||
46890891|NCT01313689|83114348|FG004|24-Week Randomization 2|Physician Decision|4|||
46890892|NCT03318315|83114370|FG000|Overall Study|Lost to Follow-up|3|||
46890893|NCT03318315|83114371|FG001|Overall Study|Lost to Follow-up|2|||
46890894|NCT03318315|83114372|FG002|Overall Study|Lost to Follow-up|1|||
46890895|NCT03318315|83114370|FG000|Overall Study|Protocol Violation|1|||
46890896|NCT03318315|83114371|FG001|Overall Study|Protocol Violation|1|||
46890897|NCT03318315|83114372|FG002|Overall Study|Protocol Violation|1|||
46890898|NCT03318315|83114370|FG000|Overall Study|Withdrawal by Subject|0|||
46890899|NCT03318315|83114371|FG001|Overall Study|Withdrawal by Subject|0|||
46890900|NCT03318315|83114372|FG002|Overall Study|Withdrawal by Subject|2|||
46890901|NCT04460183|83114383|FG000|Overall Study|Lost to Follow-up|3|||
46890902|NCT04460183|83114384|FG001|Overall Study|Lost to Follow-up|1|||
46890903|NCT04460183|83114383|FG000|Overall Study|Withdrawal by Subject|1|||
46890904|NCT04460183|83114384|FG001|Overall Study|Withdrawal by Subject|0|||
46890905|NCT03710083|83114390|FG000|Overall Study|Withdrawal by Subject|2|||
46890906|NCT03710083|83114390|FG000|Overall Study|Unsuccessful Procedure|1|||
46890907|NCT03318003|83114396|FG000|Overall Study|Withdrawal by Subject|1|||
46890908|NCT03318003|83114397|FG001|Overall Study|Withdrawal by Subject|1|||
46890909|NCT03318003|83114396|FG000|Overall Study|fetal loss|0|||
46890910|NCT03318003|83114397|FG001|Overall Study|fetal loss|1|||
46890911|NCT03317379|83114406|FG000|Overall Study|Lost to Follow-up|0|||
46890912|NCT03317379|83114407|FG001|Overall Study|Lost to Follow-up|3|||
46890913|NCT03317379|83114408|FG002|Overall Study|Lost to Follow-up|2|||
46890914|NCT03316911|83114418|FG000|Overall Study|Lost to Follow-up|33|||
46890915|NCT03316911|83114419|FG001|Overall Study|Lost to Follow-up|29|||
46890916|NCT01106391|83114425|FG000|Overall Study|Death|12|||
46890917|NCT01106391|83114425|FG000|Overall Study|Withdrawal by Subject|7|||
46890918|NCT03316131|83114429|FG000|Treatment Period 2|Protocol deviation|1|||
46890919|NCT03316131|83114430|FG001|Treatment Period 2|Protocol deviation|0|||
46890920|NCT03301415|83114436|FG000|Overall Study|Lost to Follow-up|2|||
46890921|NCT03301415|83114436|FG000|Overall Study|Unable to comply with visit schedule|2|||
46890922|NCT02732938|83114442|FG000|Overall Study|Death|0|||
46890923|NCT02732938|83114443|FG001|Overall Study|Death|11|||
46890924|NCT02732938|83114444|FG002|Overall Study|Death|0|||
46890925|NCT02732938|83114442|FG000|Overall Study|Randomized but did not receive treatment|0|||
46890926|NCT02732938|83114443|FG001|Overall Study|Randomized but did not receive treatment|1|||
46890927|NCT02732938|83114444|FG002|Overall Study|Randomized but did not receive treatment|0|||
46890928|NCT02732938|83114442|FG000|Overall Study|Refused further follow-up|1|||
46890929|NCT02732938|83114443|FG001|Overall Study|Refused further follow-up|0|||
46890930|NCT02732938|83114444|FG002|Overall Study|Refused further follow-up|0|||
46890931|NCT02732938|83114442|FG000|Overall Study|Study terminated by sponsor|3|||
46890932|NCT02732938|83114443|FG001|Overall Study|Study terminated by sponsor|6|||
46890933|NCT02732938|83114444|FG002|Overall Study|Study terminated by sponsor|0|||
46890934|NCT04647721|83114452|FG000|Overall Study|Withdrawal by Subject|0|||
46890935|NCT04647721|83114453|FG001|Overall Study|Withdrawal by Subject|2|||
46890936|NCT04647721|83114452|FG000|Overall Study|Lost to Follow-up|2|||
46890937|NCT04647721|83114453|FG001|Overall Study|Lost to Follow-up|0|||
46890938|NCT03718000|83114474|FG000|Overall Study|Relocation|2|||
46890939|NCT03718000|83114475|FG001|Overall Study|Relocation|4|||
46890940|NCT03718000|83114474|FG000|Overall Study|Pregnancy|0|||
46890941|NCT03718000|83114475|FG001|Overall Study|Pregnancy|1|||
46890942|NCT03063203|83114482|FG000|Overall Study|Chose alternative therapy|3|||
46890943|NCT03063203|83114482|FG000|Overall Study|Death|2|||
46890944|NCT03063203|83114482|FG000|Overall Study|Disease progression|4|||
46890945|NCT03063203|83114482|FG000|Overall Study|Physician Decision|5|||
46890946|NCT02891226|83114501|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
46890947|NCT02891226|83114502|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
46890948|NCT02891226|83114503|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
46890949|NCT02891226|83114504|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890950|NCT02891226|83114505|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890951|NCT02891226|83114506|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890952|NCT02891226|83114507|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890953|NCT02891226|83114508|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890954|NCT02891226|83114509|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890955|NCT02891226|83114510|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890956|NCT02891226|83114511|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890957|NCT02891226|83114512|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890958|NCT02891226|83114513|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890959|NCT02891226|83114514|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890960|NCT02891226|83114515|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890961|NCT02891226|83114516|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
46890962|NCT02891226|83114501|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
46890963|NCT02891226|83114502|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
46890964|NCT02891226|83114503|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890965|NCT02891226|83114504|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890966|NCT02891226|83114505|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890967|NCT02891226|83114506|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890968|NCT02891226|83114507|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890969|NCT02891226|83114508|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890970|NCT02891226|83114509|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890971|NCT02891226|83114510|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890972|NCT02891226|83114511|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890973|NCT02891226|83114512|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890974|NCT02891226|83114513|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890975|NCT02891226|83114514|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890976|NCT02891226|83114515|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890977|NCT02891226|83114516|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46890978|NCT02891226|83114501|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890979|NCT02891226|83114502|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890980|NCT02891226|83114503|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890981|NCT02891226|83114504|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
46890982|NCT02891226|83114505|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890983|NCT02891226|83114506|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890984|NCT02891226|83114507|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890985|NCT02891226|83114508|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890986|NCT02891226|83114509|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890987|NCT02891226|83114510|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890988|NCT02891226|83114511|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890989|NCT02891226|83114512|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890990|NCT02891226|83114513|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890991|NCT02891226|83114514|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890992|NCT02891226|83114515|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890993|NCT02891226|83114516|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46890994|NCT02891226|83114501|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46890995|NCT02891226|83114502|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46890996|NCT02891226|83114503|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
46890997|NCT02891226|83114504|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46890998|NCT02891226|83114505|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46890999|NCT02891226|83114506|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891000|NCT02891226|83114507|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891001|NCT02891226|83114508|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891002|NCT02891226|83114509|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891003|NCT02891226|83114510|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891004|NCT02891226|83114511|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891005|NCT02891226|83114512|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891006|NCT02891226|83114513|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891007|NCT02891226|83114514|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891008|NCT02891226|83114515|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891009|NCT02891226|83114516|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
46891010|NCT02891226|83114501|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891011|NCT02891226|83114502|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891012|NCT02891226|83114503|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891013|NCT02891226|83114504|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
46891014|NCT02891226|83114505|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891015|NCT02891226|83114506|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891016|NCT02891226|83114507|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891017|NCT02891226|83114508|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891018|NCT02891226|83114509|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891019|NCT02891226|83114510|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891020|NCT02891226|83114511|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891021|NCT02891226|83114512|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891022|NCT02891226|83114513|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891023|NCT02891226|83114514|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891024|NCT02891226|83114515|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891025|NCT02891226|83114516|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
46891026|NCT02891226|83114501|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891027|NCT02891226|83114502|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891028|NCT02891226|83114503|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891029|NCT02891226|83114504|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
46891030|NCT02891226|83114505|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891031|NCT02891226|83114506|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891032|NCT02891226|83114507|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891033|NCT02891226|83114508|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891034|NCT02891226|83114509|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891035|NCT02891226|83114510|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891036|NCT02891226|83114511|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891037|NCT02891226|83114512|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891038|NCT02891226|83114513|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891039|NCT02891226|83114514|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891040|NCT02891226|83114515|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891041|NCT02891226|83114516|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
46891042|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891043|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891044|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891045|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891046|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891047|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891048|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
46891049|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
46891050|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
46891051|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
46891052|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891053|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891054|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891055|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891056|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891057|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
46891058|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891059|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891060|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891061|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891062|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891063|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
46891064|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891065|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891066|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891067|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
46891068|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891069|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891070|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891071|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891072|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891073|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
46891074|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891075|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891076|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891077|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891078|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891079|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891080|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
46891081|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
46891082|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
46891083|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
46891084|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891085|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891086|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891087|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891088|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891089|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
46891090|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891091|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891092|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891093|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891094|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
46891095|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891096|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891097|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891098|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891099|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891100|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891101|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891102|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891103|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891104|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891105|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
46891106|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891107|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891108|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891109|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891110|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891111|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891112|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
46891113|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891114|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891115|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891116|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891117|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891118|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891119|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891120|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891121|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
46891122|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891123|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891124|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891125|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891126|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891127|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891128|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891129|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
46891130|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
46891131|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
46891132|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891133|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891134|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891135|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891136|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891137|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
46891138|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891139|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891140|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891141|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891142|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891143|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891144|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891145|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
46891146|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891147|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891148|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891149|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891150|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891151|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891152|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891153|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
46891154|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891155|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891156|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891157|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891158|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891159|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891160|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891161|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891162|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
46891163|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891164|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891165|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891166|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891167|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891168|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891169|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
46891170|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891171|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891172|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891173|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891174|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891175|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891176|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891177|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891178|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891179|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
46891180|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891181|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891182|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891183|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891184|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46891185|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
46991723|NCT02177175|83238698|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
46891186|NCT02891226|83114501|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891187|NCT02891226|83114502|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891188|NCT02891226|83114503|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891189|NCT02891226|83114504|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891190|NCT02891226|83114505|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891191|NCT02891226|83114506|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891192|NCT02891226|83114507|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891193|NCT02891226|83114508|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891194|NCT02891226|83114509|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891195|NCT02891226|83114510|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
46891196|NCT02891226|83114511|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891197|NCT02891226|83114512|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891198|NCT02891226|83114513|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891199|NCT02891226|83114514|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891200|NCT02891226|83114515|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891201|NCT02891226|83114516|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
46891202|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891203|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891204|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891205|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891206|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891207|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891208|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891209|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891210|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891211|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891212|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
46891213|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891214|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891215|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891216|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891217|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
46891218|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891219|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891220|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891221|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891222|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891223|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891224|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891225|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46610377|NCT02548650|82702028|FG001|Triple Therapy|Withdrawal by Subject|4|||
46610378|NCT02548650|82702027|FG000|Double Therapy|Adverse Event|1|||
46610379|NCT02548650|82702028|FG001|Double Therapy|Adverse Event|1|||
46610380|NCT02548650|82702027|FG000|Double Therapy|Withdrawal by Subject|0|||
46610381|NCT02548650|82702028|FG001|Double Therapy|Withdrawal by Subject|1|||
46610382|NCT02535000|82702094|FG000|Overall Study|Cancellation of surgery.|1|||
46610383|NCT02535000|82702095|FG001|Overall Study|Cancellation of surgery.|2|||
46610384|NCT03110562|82702224|FG000|Overall Study|Withdrawal by Subject|37|||
46610385|NCT03110562|82702225|FG001|Overall Study|Withdrawal by Subject|35|||
46610386|NCT03110562|82702224|FG000|Overall Study|Death|47|||
46610387|NCT03110562|82702225|FG001|Overall Study|Death|61|||
46610388|NCT03110562|82702224|FG000|Overall Study|Lost to Follow-up|7|||
46610389|NCT03110562|82702225|FG001|Overall Study|Lost to Follow-up|6|||
46610390|NCT03110562|82702224|FG000|Overall Study|Other|2|||
46610391|NCT03110562|82702225|FG001|Overall Study|Other|1|||
46610392|NCT03110562|82702224|FG000|Overall Study|Randomized but never treated|0|||
46610393|NCT03110562|82702225|FG001|Overall Study|Randomized but never treated|3|||
46610394|NCT03110562|82702224|FG000|Overall Study|Ongoing|102|||
46610395|NCT03110562|82702225|FG001|Overall Study|Ongoing|101|||
46610396|NCT02546856|82702268|FG000|4 Months Evaluation|Death|2|||
46610397|NCT02546856|82702269|FG001|4 Months Evaluation|Death|3|||
46610398|NCT02546856|82702268|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
46610399|NCT02546856|82702269|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
46891226|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891227|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891228|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
46891229|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891230|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46610400|NCT02546856|82702268|FG000|4 Months Evaluation|Lost to Follow-up|3|||
46891231|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46610401|NCT02546856|82702269|FG001|4 Months Evaluation|Lost to Follow-up|3|||
46610402|NCT02546856|82702268|FG000|4 Months Evaluation|Physician Decision|3|||
46610403|NCT02546856|82702269|FG001|4 Months Evaluation|Physician Decision|0|||
46610404|NCT02546856|82702268|FG000|4 Months Evaluation|Working or living abroad|5|||
46891232|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891233|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
46891234|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891235|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891236|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891237|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891238|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891239|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891240|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891241|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891242|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891243|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891244|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
46891245|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891246|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891247|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891248|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891249|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
46891250|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891251|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891252|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891253|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46610405|NCT02546856|82702269|FG001|4 Months Evaluation|Working or living abroad|1|||
46610406|NCT02546856|82702268|FG000|4 Months Evaluation|reasons not due to titration|4|||
46610407|NCT02546856|82702269|FG001|4 Months Evaluation|reasons not due to titration|1|||
46610408|NCT02546856|82702268|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
46610409|NCT02546856|82702269|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
46610410|NCT02546856|82702268|FG000|6 Months Evaluation|Death|1|||
46610411|NCT02546856|82702269|FG001|6 Months Evaluation|Death|1|||
46610412|NCT02546856|82702268|FG000|6 Months Evaluation|Lost to Follow-up|1|||
46610413|NCT02546856|82702269|FG001|6 Months Evaluation|Lost to Follow-up|1|||
46610414|NCT02546856|82702268|FG000|6 Months Evaluation|Working or living abroad|6|||
46610415|NCT02546856|82702269|FG001|6 Months Evaluation|Working or living abroad|4|||
46610416|NCT02546856|82702268|FG000|6 Months Evaluation|reasons not due to titration|0|||
46610417|NCT02546856|82702269|FG001|6 Months Evaluation|reasons not due to titration|1|||
46610418|NCT02696616|82702394|FG000|Overall Study|Adverse Event|0|||
46610419|NCT02696616|82702395|FG001|Overall Study|Adverse Event|1|||
46610420|NCT02696616|82702396|FG002|Overall Study|Adverse Event|0|||
46610421|NCT02696616|82702397|FG003|Overall Study|Adverse Event|0|||
46610422|NCT02696616|82702398|FG004|Overall Study|Adverse Event|0|||
46610423|NCT02696616|82702399|FG005|Overall Study|Adverse Event|0|||
46610424|NCT02696616|82702400|FG006|Overall Study|Adverse Event|0|||
46610425|NCT01661790|82702443|FG000|Overall Study|Lost to Follow-up|0|||
46610426|NCT01661790|82702444|FG001|Overall Study|Lost to Follow-up|2|||
46610427|NCT02546544|82702464|FG000|Overall Study|Disease Progression|14|||
46610428|NCT02546544|82702464|FG000|Overall Study|Adverse Event|1|||
46610429|NCT02546544|82702464|FG000|Overall Study|Withdrawal by Subject|1|||
46610430|NCT05593211|82702755|FG000|Overall Study|Withdrawal by Subject|1|||
46610431|NCT02533674|82703094|FG000|Dose Level I|Progressive disease|1|||
46610432|NCT02533674|82703095|FG001|Dose Level I|Progressive disease|0|||
46610433|NCT02533674|82703096|FG002|Dose Level I|Progressive disease|0|||
46610434|NCT02533674|82703097|FG003|Dose Level I|Progressive disease|0|||
46610435|NCT02533674|82703098|FG004|Dose Level I|Progressive disease|0|||
46610436|NCT02533674|82703099|FG005|Dose Level I|Progressive disease|0|||
46610437|NCT02533674|82703100|FG006|Dose Level I|Progressive disease|0|||
46610438|NCT02533674|82703101|FG007|Dose Level I|Progressive disease|0|||
46610439|NCT02533674|82703094|FG000|Dose Level I|Withdrawal by Subject|1|||
46610440|NCT02533674|82703095|FG001|Dose Level I|Withdrawal by Subject|0|||
46610441|NCT02533674|82703096|FG002|Dose Level I|Withdrawal by Subject|0|||
46610442|NCT02533674|82703097|FG003|Dose Level I|Withdrawal by Subject|0|||
46610443|NCT02533674|82703098|FG004|Dose Level I|Withdrawal by Subject|0|||
46610444|NCT02533674|82703099|FG005|Dose Level I|Withdrawal by Subject|0|||
46610445|NCT02533674|82703100|FG006|Dose Level I|Withdrawal by Subject|0|||
46610446|NCT02533674|82703101|FG007|Dose Level I|Withdrawal by Subject|0|||
46610447|NCT02533674|82703094|FG000|Dose Level I|Physician Decision|1|||
46610448|NCT02533674|82703095|FG001|Dose Level I|Physician Decision|0|||
46610449|NCT02533674|82703096|FG002|Dose Level I|Physician Decision|0|||
46891254|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891255|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891256|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46610450|NCT02533674|82703097|FG003|Dose Level I|Physician Decision|0|||
46610451|NCT02533674|82703098|FG004|Dose Level I|Physician Decision|0|||
46610452|NCT02533674|82703099|FG005|Dose Level I|Physician Decision|0|||
46610453|NCT02533674|82703100|FG006|Dose Level I|Physician Decision|0|||
46610454|NCT02533674|82703101|FG007|Dose Level I|Physician Decision|0|||
46610455|NCT02533674|82703094|FG000|Dose Level I|Death|1|||
46610456|NCT02533674|82703095|FG001|Dose Level I|Death|0|||
46610457|NCT02533674|82703096|FG002|Dose Level I|Death|0|||
46610458|NCT02533674|82703097|FG003|Dose Level I|Death|0|||
46610459|NCT02533674|82703098|FG004|Dose Level I|Death|0|||
46610460|NCT02533674|82703099|FG005|Dose Level I|Death|0|||
46610461|NCT02533674|82703100|FG006|Dose Level I|Death|0|||
46610462|NCT02533674|82703101|FG007|Dose Level I|Death|0|||
46610463|NCT02533674|82703094|FG000|Dose Level I|Never Treated|1|||
46610464|NCT02533674|82703095|FG001|Dose Level I|Never Treated|0|||
46610465|NCT02533674|82703096|FG002|Dose Level I|Never Treated|0|||
46610466|NCT02533674|82703097|FG003|Dose Level I|Never Treated|0|||
46610467|NCT02533674|82703098|FG004|Dose Level I|Never Treated|0|||
46610468|NCT02533674|82703099|FG005|Dose Level I|Never Treated|0|||
46610469|NCT02533674|82703100|FG006|Dose Level I|Never Treated|0|||
46610470|NCT02533674|82703101|FG007|Dose Level I|Never Treated|0|||
46610471|NCT02533674|82703094|FG000|Dose Level II|Progressive disease|0|||
46610472|NCT02533674|82703095|FG001|Dose Level II|Progressive disease|3|||
46610473|NCT02533674|82703096|FG002|Dose Level II|Progressive disease|0|||
46610474|NCT02533674|82703097|FG003|Dose Level II|Progressive disease|0|||
46610475|NCT02533674|82703098|FG004|Dose Level II|Progressive disease|0|||
46610476|NCT02533674|82703099|FG005|Dose Level II|Progressive disease|0|||
46610477|NCT02533674|82703100|FG006|Dose Level II|Progressive disease|0|||
46610478|NCT02533674|82703101|FG007|Dose Level II|Progressive disease|0|||
46610479|NCT02533674|82703094|FG000|Dose Level II|Withdrawal by Subject|0|||
46610480|NCT02533674|82703095|FG001|Dose Level II|Withdrawal by Subject|1|||
46610481|NCT02533674|82703096|FG002|Dose Level II|Withdrawal by Subject|0|||
46610482|NCT02533674|82703097|FG003|Dose Level II|Withdrawal by Subject|0|||
46610483|NCT02533674|82703098|FG004|Dose Level II|Withdrawal by Subject|0|||
46610484|NCT02533674|82703099|FG005|Dose Level II|Withdrawal by Subject|0|||
46610485|NCT02533674|82703100|FG006|Dose Level II|Withdrawal by Subject|0|||
46610486|NCT02533674|82703101|FG007|Dose Level II|Withdrawal by Subject|0|||
46610487|NCT02533674|82703094|FG000|Dose Level II|Treatment-related AE|0|||
46610488|NCT02533674|82703095|FG001|Dose Level II|Treatment-related AE|1|||
46610489|NCT02533674|82703096|FG002|Dose Level II|Treatment-related AE|0|||
46610490|NCT02533674|82703097|FG003|Dose Level II|Treatment-related AE|0|||
46610491|NCT02533674|82703098|FG004|Dose Level II|Treatment-related AE|0|||
46610492|NCT02533674|82703099|FG005|Dose Level II|Treatment-related AE|0|||
46610493|NCT02533674|82703100|FG006|Dose Level II|Treatment-related AE|0|||
46610494|NCT02533674|82703101|FG007|Dose Level II|Treatment-related AE|0|||
46610495|NCT02533674|82703094|FG000|Dose Level II|Physician Decision|0|||
46610496|NCT02533674|82703095|FG001|Dose Level II|Physician Decision|1|||
46610497|NCT02533674|82703096|FG002|Dose Level II|Physician Decision|0|||
46610498|NCT02533674|82703097|FG003|Dose Level II|Physician Decision|0|||
46610499|NCT02533674|82703098|FG004|Dose Level II|Physician Decision|0|||
46610500|NCT02533674|82703099|FG005|Dose Level II|Physician Decision|0|||
46610501|NCT02533674|82703100|FG006|Dose Level II|Physician Decision|0|||
46610502|NCT02533674|82703101|FG007|Dose Level II|Physician Decision|0|||
46610503|NCT02533674|82703094|FG000|Dose Level II|Non-treatment-related AE|0|||
46610504|NCT02533674|82703095|FG001|Dose Level II|Non-treatment-related AE|1|||
46610505|NCT02533674|82703096|FG002|Dose Level II|Non-treatment-related AE|0|||
46610506|NCT02533674|82703097|FG003|Dose Level II|Non-treatment-related AE|0|||
46610507|NCT02533674|82703098|FG004|Dose Level II|Non-treatment-related AE|0|||
46610508|NCT02533674|82703099|FG005|Dose Level II|Non-treatment-related AE|0|||
46610509|NCT02533674|82703100|FG006|Dose Level II|Non-treatment-related AE|0|||
46610510|NCT02533674|82703101|FG007|Dose Level II|Non-treatment-related AE|0|||
46610511|NCT02533674|82703094|FG000|Dose Level III|Progressive disease|0|||
46610512|NCT02533674|82703095|FG001|Dose Level III|Progressive disease|0|||
46610513|NCT02533674|82703096|FG002|Dose Level III|Progressive disease|2|||
46610514|NCT02533674|82703097|FG003|Dose Level III|Progressive disease|0|||
46610515|NCT02533674|82703098|FG004|Dose Level III|Progressive disease|0|||
46610516|NCT02533674|82703099|FG005|Dose Level III|Progressive disease|0|||
46706633|NCT01208207|82921860|FG001|Part I|Progressive Disease|0|||
46610517|NCT02533674|82703100|FG006|Dose Level III|Progressive disease|0|||
46610518|NCT02533674|82703101|FG007|Dose Level III|Progressive disease|0|||
46610519|NCT02533674|82703094|FG000|Dose Level III|Withdrawal by Subject|0|||
46610520|NCT02533674|82703095|FG001|Dose Level III|Withdrawal by Subject|0|||
46610521|NCT02533674|82703096|FG002|Dose Level III|Withdrawal by Subject|1|||
46610522|NCT02533674|82703097|FG003|Dose Level III|Withdrawal by Subject|0|||
46610523|NCT02533674|82703098|FG004|Dose Level III|Withdrawal by Subject|0|||
46610524|NCT02533674|82703099|FG005|Dose Level III|Withdrawal by Subject|0|||
46610525|NCT02533674|82703100|FG006|Dose Level III|Withdrawal by Subject|0|||
46610526|NCT02533674|82703101|FG007|Dose Level III|Withdrawal by Subject|0|||
46610527|NCT02533674|82703094|FG000|Dose Level III|Treatment-related AE|0|||
46610528|NCT02533674|82703095|FG001|Dose Level III|Treatment-related AE|0|||
46610529|NCT02533674|82703096|FG002|Dose Level III|Treatment-related AE|1|||
46610530|NCT02533674|82703097|FG003|Dose Level III|Treatment-related AE|0|||
46610531|NCT02533674|82703098|FG004|Dose Level III|Treatment-related AE|0|||
46610532|NCT02533674|82703099|FG005|Dose Level III|Treatment-related AE|0|||
46610533|NCT02533674|82703100|FG006|Dose Level III|Treatment-related AE|0|||
46610534|NCT02533674|82703101|FG007|Dose Level III|Treatment-related AE|0|||
46610535|NCT02533674|82703094|FG000|Dose Level IV|Progressive disease|0|||
46610536|NCT02533674|82703095|FG001|Dose Level IV|Progressive disease|0|||
46610537|NCT02533674|82703096|FG002|Dose Level IV|Progressive disease|0|||
46610538|NCT02533674|82703097|FG003|Dose Level IV|Progressive disease|3|||
46610539|NCT02533674|82703098|FG004|Dose Level IV|Progressive disease|0|||
46610540|NCT02533674|82703099|FG005|Dose Level IV|Progressive disease|0|||
46610541|NCT02533674|82703100|FG006|Dose Level IV|Progressive disease|0|||
46610542|NCT02533674|82703101|FG007|Dose Level IV|Progressive disease|0|||
46610543|NCT02533674|82703094|FG000|Dose Level IV|Withdrawal by Subject|0|||
46610544|NCT02533674|82703095|FG001|Dose Level IV|Withdrawal by Subject|0|||
46610545|NCT02533674|82703096|FG002|Dose Level IV|Withdrawal by Subject|0|||
46610546|NCT02533674|82703097|FG003|Dose Level IV|Withdrawal by Subject|1|||
46610547|NCT02533674|82703098|FG004|Dose Level IV|Withdrawal by Subject|0|||
46610548|NCT02533674|82703099|FG005|Dose Level IV|Withdrawal by Subject|0|||
46610549|NCT02533674|82703100|FG006|Dose Level IV|Withdrawal by Subject|0|||
46610550|NCT02533674|82703101|FG007|Dose Level IV|Withdrawal by Subject|0|||
46610551|NCT02533674|82703094|FG000|Dose Level IV|Physician Decision|0|||
46610552|NCT02533674|82703095|FG001|Dose Level IV|Physician Decision|0|||
46610553|NCT02533674|82703096|FG002|Dose Level IV|Physician Decision|0|||
46610554|NCT02533674|82703097|FG003|Dose Level IV|Physician Decision|1|||
46610555|NCT02533674|82703098|FG004|Dose Level IV|Physician Decision|0|||
46610556|NCT02533674|82703099|FG005|Dose Level IV|Physician Decision|0|||
46610557|NCT02533674|82703100|FG006|Dose Level IV|Physician Decision|0|||
46610558|NCT02533674|82703101|FG007|Dose Level IV|Physician Decision|0|||
46610559|NCT02533674|82703094|FG000|Dose Level V|Progressive disease|0|||
46610560|NCT02533674|82703095|FG001|Dose Level V|Progressive disease|0|||
46610561|NCT02533674|82703096|FG002|Dose Level V|Progressive disease|0|||
46610562|NCT02533674|82703097|FG003|Dose Level V|Progressive disease|0|||
46610563|NCT02533674|82703098|FG004|Dose Level V|Progressive disease|3|||
46610564|NCT02533674|82703099|FG005|Dose Level V|Progressive disease|0|||
46610565|NCT02533674|82703100|FG006|Dose Level V|Progressive disease|0|||
46610566|NCT02533674|82703101|FG007|Dose Level V|Progressive disease|0|||
46610567|NCT02533674|82703094|FG000|Dose Level V|Withdrawal by Subject|0|||
46610568|NCT02533674|82703095|FG001|Dose Level V|Withdrawal by Subject|0|||
46610569|NCT02533674|82703096|FG002|Dose Level V|Withdrawal by Subject|0|||
46610570|NCT02533674|82703097|FG003|Dose Level V|Withdrawal by Subject|0|||
46610571|NCT02533674|82703098|FG004|Dose Level V|Withdrawal by Subject|1|||
46610572|NCT02533674|82703099|FG005|Dose Level V|Withdrawal by Subject|0|||
46610573|NCT02533674|82703100|FG006|Dose Level V|Withdrawal by Subject|0|||
46610574|NCT02533674|82703101|FG007|Dose Level V|Withdrawal by Subject|0|||
46610575|NCT02533674|82703094|FG000|Dose Level V|Physician Decision|0|||
46610576|NCT02533674|82703095|FG001|Dose Level V|Physician Decision|0|||
46610577|NCT02533674|82703096|FG002|Dose Level V|Physician Decision|0|||
46610578|NCT02533674|82703097|FG003|Dose Level V|Physician Decision|0|||
46610579|NCT02533674|82703098|FG004|Dose Level V|Physician Decision|1|||
46610580|NCT02533674|82703099|FG005|Dose Level V|Physician Decision|0|||
46610581|NCT02533674|82703100|FG006|Dose Level V|Physician Decision|0|||
46610582|NCT02533674|82703101|FG007|Dose Level V|Physician Decision|0|||
46610583|NCT02533674|82703094|FG000|Dose Level VI|Progressive disease|0|||
46610584|NCT02533674|82703095|FG001|Dose Level VI|Progressive disease|0|||
46610585|NCT02533674|82703096|FG002|Dose Level VI|Progressive disease|0|||
46610586|NCT02533674|82703097|FG003|Dose Level VI|Progressive disease|0|||
46610587|NCT02533674|82703098|FG004|Dose Level VI|Progressive disease|0|||
46610588|NCT02533674|82703099|FG005|Dose Level VI|Progressive disease|7|||
46610589|NCT02533674|82703100|FG006|Dose Level VI|Progressive disease|0|||
46610590|NCT02533674|82703101|FG007|Dose Level VI|Progressive disease|0|||
46610591|NCT02533674|82703094|FG000|Dose Level VI|Withdrawal by Subject|0|||
46610592|NCT02533674|82703095|FG001|Dose Level VI|Withdrawal by Subject|0|||
46610593|NCT02533674|82703096|FG002|Dose Level VI|Withdrawal by Subject|0|||
46610594|NCT02533674|82703097|FG003|Dose Level VI|Withdrawal by Subject|0|||
46610595|NCT02533674|82703098|FG004|Dose Level VI|Withdrawal by Subject|0|||
46610596|NCT02533674|82703099|FG005|Dose Level VI|Withdrawal by Subject|1|||
46610597|NCT02533674|82703100|FG006|Dose Level VI|Withdrawal by Subject|0|||
46610598|NCT02533674|82703101|FG007|Dose Level VI|Withdrawal by Subject|0|||
46610599|NCT02533674|82703094|FG000|Dose Level VI|Treatment-related AE|0|||
46610600|NCT02533674|82703095|FG001|Dose Level VI|Treatment-related AE|0|||
46610601|NCT02533674|82703096|FG002|Dose Level VI|Treatment-related AE|0|||
46610602|NCT02533674|82703097|FG003|Dose Level VI|Treatment-related AE|0|||
46610603|NCT02533674|82703098|FG004|Dose Level VI|Treatment-related AE|0|||
46610604|NCT02533674|82703099|FG005|Dose Level VI|Treatment-related AE|1|||
46610605|NCT02533674|82703100|FG006|Dose Level VI|Treatment-related AE|0|||
46610606|NCT02533674|82703101|FG007|Dose Level VI|Treatment-related AE|0|||
46610607|NCT02533674|82703094|FG000|Dose Level VII|Progressive disease|0|||
46610608|NCT02533674|82703095|FG001|Dose Level VII|Progressive disease|0|||
46610609|NCT02533674|82703096|FG002|Dose Level VII|Progressive disease|0|||
46610610|NCT02533674|82703097|FG003|Dose Level VII|Progressive disease|0|||
46610611|NCT02533674|82703098|FG004|Dose Level VII|Progressive disease|0|||
46610612|NCT02533674|82703099|FG005|Dose Level VII|Progressive disease|0|||
46610613|NCT02533674|82703100|FG006|Dose Level VII|Progressive disease|10|||
46610614|NCT02533674|82703101|FG007|Dose Level VII|Progressive disease|0|||
46610615|NCT02533674|82703094|FG000|Dose Level VII|Withdrawal by Subject|0|||
46610616|NCT02533674|82703095|FG001|Dose Level VII|Withdrawal by Subject|0|||
46610617|NCT02533674|82703096|FG002|Dose Level VII|Withdrawal by Subject|0|||
46610618|NCT02533674|82703097|FG003|Dose Level VII|Withdrawal by Subject|0|||
46610619|NCT02533674|82703098|FG004|Dose Level VII|Withdrawal by Subject|0|||
46610620|NCT02533674|82703099|FG005|Dose Level VII|Withdrawal by Subject|0|||
46610621|NCT02533674|82703100|FG006|Dose Level VII|Withdrawal by Subject|3|||
46610622|NCT02533674|82703101|FG007|Dose Level VII|Withdrawal by Subject|0|||
46610623|NCT02533674|82703094|FG000|Dose Level VII|Treatment-related AE|0|||
46610624|NCT02533674|82703095|FG001|Dose Level VII|Treatment-related AE|0|||
46706634|NCT01208207|82921861|FG002|Part I|Progressive Disease|0|||
46706635|NCT01208207|82921862|FG003|Part I|Progressive Disease|0|||
46706636|NCT01208207|82921863|FG004|Part I|Progressive Disease|0|||
46706637|NCT01208207|82921864|FG005|Part I|Progressive Disease|0|||
46706638|NCT01208207|82921865|FG006|Part I|Progressive Disease|0|||
46706639|NCT01208207|82921859|FG000|Part I|Protocol Violation|8|||
46706640|NCT01208207|82921860|FG001|Part I|Protocol Violation|0|||
46706641|NCT01208207|82921861|FG002|Part I|Protocol Violation|2|||
46706642|NCT01208207|82921862|FG003|Part I|Protocol Violation|0|||
46706643|NCT01208207|82921863|FG004|Part I|Protocol Violation|0|||
46706644|NCT01208207|82921864|FG005|Part I|Protocol Violation|0|||
46706645|NCT01208207|82921865|FG006|Part I|Protocol Violation|0|||
46706646|NCT01208207|82921859|FG000|Part I|Withdrawal by Subject|14|||
46706647|NCT01208207|82921860|FG001|Part I|Withdrawal by Subject|4|||
46706648|NCT01208207|82921861|FG002|Part I|Withdrawal by Subject|4|||
46706649|NCT01208207|82921862|FG003|Part I|Withdrawal by Subject|0|||
46706650|NCT01208207|82921863|FG004|Part I|Withdrawal by Subject|0|||
46706651|NCT01208207|82921864|FG005|Part I|Withdrawal by Subject|0|||
46706652|NCT01208207|82921865|FG006|Part I|Withdrawal by Subject|0|||
46706653|NCT01208207|82921859|FG000|Part II|Withdrawal by Subject|0|||
46706654|NCT01208207|82921860|FG001|Part II|Withdrawal by Subject|0|||
46610625|NCT02533674|82703096|FG002|Dose Level VII|Treatment-related AE|0|||
46610626|NCT02533674|82703097|FG003|Dose Level VII|Treatment-related AE|0|||
46610627|NCT02533674|82703098|FG004|Dose Level VII|Treatment-related AE|0|||
46610628|NCT02533674|82703099|FG005|Dose Level VII|Treatment-related AE|0|||
46610629|NCT02533674|82703100|FG006|Dose Level VII|Treatment-related AE|1|||
46610630|NCT02533674|82703101|FG007|Dose Level VII|Treatment-related AE|0|||
46610631|NCT02533674|82703094|FG000|Dose Level VII|Death|0|||
46610632|NCT02533674|82703095|FG001|Dose Level VII|Death|0|||
46610633|NCT02533674|82703096|FG002|Dose Level VII|Death|0|||
46610634|NCT02533674|82703097|FG003|Dose Level VII|Death|0|||
46610635|NCT02533674|82703098|FG004|Dose Level VII|Death|0|||
46610636|NCT02533674|82703099|FG005|Dose Level VII|Death|0|||
46610637|NCT02533674|82703100|FG006|Dose Level VII|Death|2|||
46610638|NCT02533674|82703101|FG007|Dose Level VII|Death|0|||
46610639|NCT02533674|82703094|FG000|Dose Level VIII|Progressive disease|0|||
46610640|NCT02533674|82703095|FG001|Dose Level VIII|Progressive disease|0|||
46610641|NCT02533674|82703096|FG002|Dose Level VIII|Progressive disease|0|||
46610642|NCT02533674|82703097|FG003|Dose Level VIII|Progressive disease|0|||
46610643|NCT02533674|82703098|FG004|Dose Level VIII|Progressive disease|0|||
46610644|NCT02533674|82703099|FG005|Dose Level VIII|Progressive disease|0|||
46610645|NCT02533674|82703100|FG006|Dose Level VIII|Progressive disease|0|||
46610646|NCT02533674|82703101|FG007|Dose Level VIII|Progressive disease|3|||
46610647|NCT02533674|82703094|FG000|Dose Level VIII|Withdrawal by Subject|0|||
46610648|NCT02533674|82703095|FG001|Dose Level VIII|Withdrawal by Subject|0|||
46610649|NCT02533674|82703096|FG002|Dose Level VIII|Withdrawal by Subject|0|||
46610650|NCT02533674|82703097|FG003|Dose Level VIII|Withdrawal by Subject|0|||
46610651|NCT02533674|82703098|FG004|Dose Level VIII|Withdrawal by Subject|0|||
46610652|NCT02533674|82703099|FG005|Dose Level VIII|Withdrawal by Subject|0|||
46610653|NCT02533674|82703100|FG006|Dose Level VIII|Withdrawal by Subject|0|||
46610654|NCT02533674|82703101|FG007|Dose Level VIII|Withdrawal by Subject|1|||
46610655|NCT02533674|82703094|FG000|Dose Level VIII|Treatment-related AE|0|||
46610656|NCT02533674|82703095|FG001|Dose Level VIII|Treatment-related AE|0|||
46610657|NCT02533674|82703096|FG002|Dose Level VIII|Treatment-related AE|0|||
46610658|NCT02533674|82703097|FG003|Dose Level VIII|Treatment-related AE|0|||
46610659|NCT02533674|82703098|FG004|Dose Level VIII|Treatment-related AE|0|||
46610660|NCT02533674|82703099|FG005|Dose Level VIII|Treatment-related AE|0|||
46610661|NCT02533674|82703100|FG006|Dose Level VIII|Treatment-related AE|0|||
46610662|NCT02533674|82703101|FG007|Dose Level VIII|Treatment-related AE|1|||
46706655|NCT01208207|82921861|FG002|Part II|Withdrawal by Subject|0|||
46610663|NCT02533674|82703094|FG000|Dose Level VIII|Never treated|0|||
46610664|NCT02533674|82703095|FG001|Dose Level VIII|Never treated|0|||
46706656|NCT01208207|82921862|FG003|Part II|Withdrawal by Subject|10|||
46706657|NCT01208207|82921863|FG004|Part II|Withdrawal by Subject|9|||
46706658|NCT01208207|82921864|FG005|Part II|Withdrawal by Subject|3|||
46706659|NCT01208207|82921865|FG006|Part II|Withdrawal by Subject|5|||
46706660|NCT01208207|82921859|FG000|Part II|Adverse Event|0|||
46706661|NCT01208207|82921860|FG001|Part II|Adverse Event|0|||
46706662|NCT01208207|82921861|FG002|Part II|Adverse Event|0|||
46706663|NCT01208207|82921862|FG003|Part II|Adverse Event|5|||
46706664|NCT01208207|82921863|FG004|Part II|Adverse Event|9|||
46706665|NCT01208207|82921864|FG005|Part II|Adverse Event|4|||
46706666|NCT01208207|82921865|FG006|Part II|Adverse Event|2|||
46706667|NCT01208207|82921859|FG000|Part II|Lack of Efficacy|0|||
46706668|NCT01208207|82921860|FG001|Part II|Lack of Efficacy|0|||
46706669|NCT01208207|82921861|FG002|Part II|Lack of Efficacy|0|||
46706670|NCT01208207|82921862|FG003|Part II|Lack of Efficacy|6|||
46706671|NCT01208207|82921863|FG004|Part II|Lack of Efficacy|4|||
46706672|NCT01208207|82921864|FG005|Part II|Lack of Efficacy|3|||
46706673|NCT01208207|82921865|FG006|Part II|Lack of Efficacy|3|||
46706674|NCT01208207|82921859|FG000|Part II|Lost to Follow-up|0|||
46706675|NCT01208207|82921860|FG001|Part II|Lost to Follow-up|0|||
46706676|NCT01208207|82921861|FG002|Part II|Lost to Follow-up|0|||
46706677|NCT01208207|82921862|FG003|Part II|Lost to Follow-up|4|||
46706678|NCT01208207|82921863|FG004|Part II|Lost to Follow-up|0|||
46706679|NCT01208207|82921864|FG005|Part II|Lost to Follow-up|2|||
46706680|NCT01208207|82921865|FG006|Part II|Lost to Follow-up|1|||
46706681|NCT01208207|82921859|FG000|Part II|Non-Compliance With Study Drug|0|||
46706682|NCT01208207|82921860|FG001|Part II|Non-Compliance With Study Drug|0|||
46706683|NCT01208207|82921861|FG002|Part II|Non-Compliance With Study Drug|0|||
46706684|NCT01208207|82921862|FG003|Part II|Non-Compliance With Study Drug|4|||
46706685|NCT01208207|82921863|FG004|Part II|Non-Compliance With Study Drug|1|||
46706686|NCT01208207|82921864|FG005|Part II|Non-Compliance With Study Drug|1|||
46706687|NCT01208207|82921865|FG006|Part II|Non-Compliance With Study Drug|0|||
46802967|NCT00684203|83022195|FG000|Overall Study|Did not meet protocol eligibility|0|||
46802968|NCT00684203|83022196|FG001|Overall Study|Did not meet protocol eligibility|1|||
46802969|NCT00684203|83022197|FG002|Overall Study|Did not meet protocol eligibility|0|||
46802970|NCT00684203|83022198|FG003|Overall Study|Did not meet protocol eligibility|0|||
46802971|NCT00684203|83022199|FG004|Overall Study|Did not meet protocol eligibility|0|||
46802972|NCT00684203|83022200|FG005|Overall Study|Did not meet protocol eligibility|0|||
46802973|NCT00423592|83022221|FG000|Overall Study|Adverse Event (through Week 12)|2|||
46802974|NCT00423592|83022221|FG000|Overall Study|Adverse Event (post Week 12)|5|||
46802975|NCT00683657|83022227|FG000|Overall Study|Adverse Event|0|||
46802976|NCT00683657|83022228|FG001|Overall Study|Adverse Event|1|||
46802977|NCT00683657|83022227|FG000|Overall Study|Subject Withdrew Consent|1|||
46802978|NCT00683657|83022228|FG001|Overall Study|Subject Withdrew Consent|0|||
46891257|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891258|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891259|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891260|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
46891261|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891262|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891263|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891264|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891265|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
46891266|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891267|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891268|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891269|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891270|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891271|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891272|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891273|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891274|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891275|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891276|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
46891277|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891278|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46706688|NCT01208207|82921859|FG000|Part II|Physician Decision|0|||
46706689|NCT01208207|82921860|FG001|Part II|Physician Decision|0|||
46706690|NCT01208207|82921861|FG002|Part II|Physician Decision|0|||
46706691|NCT01208207|82921862|FG003|Part II|Physician Decision|1|||
46706692|NCT01208207|82921863|FG004|Part II|Physician Decision|0|||
46706693|NCT01208207|82921864|FG005|Part II|Physician Decision|2|||
46706694|NCT01208207|82921865|FG006|Part II|Physician Decision|0|||
46891279|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891280|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891281|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
46891282|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891283|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891284|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891285|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891286|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891287|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891288|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891289|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891290|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891291|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891292|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
46891293|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891294|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891295|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891296|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891297|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
46891298|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891299|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891300|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891301|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891302|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891303|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891304|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891305|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891306|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891307|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891308|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
46891309|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891310|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891311|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891312|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891313|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
46891314|NCT02891226|83114501|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891315|NCT02891226|83114502|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891316|NCT02891226|83114503|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891317|NCT02891226|83114504|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891318|NCT02891226|83114505|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891319|NCT02891226|83114506|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891320|NCT02891226|83114507|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891321|NCT02891226|83114508|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891322|NCT02891226|83114509|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891323|NCT02891226|83114510|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891324|NCT02891226|83114511|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
46891325|NCT02891226|83114512|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891326|NCT02891226|83114513|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891327|NCT02891226|83114514|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891328|NCT02891226|83114515|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891329|NCT02891226|83114516|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
46891330|NCT02891226|83114501|FG000|Follow-up Period|Withdrawal by Subject|0|||
46891331|NCT02891226|83114502|FG001|Follow-up Period|Withdrawal by Subject|0|||
46891332|NCT02891226|83114503|FG002|Follow-up Period|Withdrawal by Subject|0|||
46891333|NCT02891226|83114504|FG003|Follow-up Period|Withdrawal by Subject|0|||
46891334|NCT02891226|83114505|FG004|Follow-up Period|Withdrawal by Subject|0|||
46891335|NCT02891226|83114506|FG005|Follow-up Period|Withdrawal by Subject|0|||
46891336|NCT02891226|83114507|FG006|Follow-up Period|Withdrawal by Subject|0|||
46891337|NCT02891226|83114508|FG007|Follow-up Period|Withdrawal by Subject|0|||
46891338|NCT02891226|83114509|FG008|Follow-up Period|Withdrawal by Subject|0|||
46891339|NCT02891226|83114510|FG009|Follow-up Period|Withdrawal by Subject|0|||
46891340|NCT02891226|83114511|FG010|Follow-up Period|Withdrawal by Subject|0|||
46891341|NCT02891226|83114512|FG011|Follow-up Period|Withdrawal by Subject|1|||
46891342|NCT02891226|83114513|FG012|Follow-up Period|Withdrawal by Subject|0|||
46891343|NCT02891226|83114514|FG013|Follow-up Period|Withdrawal by Subject|0|||
46891344|NCT02891226|83114515|FG014|Follow-up Period|Withdrawal by Subject|1|||
46891345|NCT02891226|83114516|FG015|Follow-up Period|Withdrawal by Subject|1|||
46891346|NCT03333837|83114545|FG000|Overall Study|Adverse Event|2|||
46891347|NCT03333837|83114546|FG001|Overall Study|Adverse Event|1|||
46891348|NCT03333837|83114547|FG002|Overall Study|Adverse Event|1|||
46891349|NCT03333837|83114548|FG003|Overall Study|Adverse Event|1|||
46891350|NCT03333837|83114549|FG004|Overall Study|Adverse Event|0|||
46891351|NCT03333837|83114545|FG000|Overall Study|Caregiver withdrew|0|||
46891352|NCT03333837|83114546|FG001|Overall Study|Caregiver withdrew|2|||
46891353|NCT03333837|83114547|FG002|Overall Study|Caregiver withdrew|1|||
46891354|NCT03333837|83114548|FG003|Overall Study|Caregiver withdrew|0|||
46891355|NCT03333837|83114549|FG004|Overall Study|Caregiver withdrew|0|||
46891356|NCT03333837|83114545|FG000|Overall Study|Withdrawal by Subject|0|||
46891357|NCT03333837|83114546|FG001|Overall Study|Withdrawal by Subject|0|||
46891358|NCT03333837|83114547|FG002|Overall Study|Withdrawal by Subject|1|||
46891359|NCT03333837|83114548|FG003|Overall Study|Withdrawal by Subject|1|||
46891360|NCT03333837|83114549|FG004|Overall Study|Withdrawal by Subject|3|||
46891361|NCT03333837|83114545|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
46891362|NCT03333837|83114546|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
46891363|NCT03333837|83114547|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
46891364|NCT03333837|83114548|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
46891365|NCT03333837|83114549|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
46891366|NCT03708211|83114567|FG000|Overall Study|Progressive Disease|10|||
46891367|NCT03708211|83114568|FG001|Overall Study|Progressive Disease|7|||
46891368|NCT03708211|83114567|FG000|Overall Study|Withdrawal by Subject|0|||
46891369|NCT03708211|83114568|FG001|Overall Study|Withdrawal by Subject|1|||
46891370|NCT03708211|83114567|FG000|Overall Study|Other|2|||
46891371|NCT03708211|83114568|FG001|Overall Study|Other|0|||
46891372|NCT02948634|83114578|FG000|Overall Study|Lack of efficacy and study suspended|10|||
46891373|NCT02948634|83114579|FG001|Overall Study|Lack of efficacy and study suspended|2|||
46891374|NCT02945046|83114588|FG000|Overall Study|Adverse Event|1|||
46891375|NCT02945046|83114589|FG001|Overall Study|Adverse Event|0|||
46891376|NCT02945046|83114590|FG002|Overall Study|Adverse Event|2|||
46891377|NCT02945046|83114588|FG000|Overall Study|Withdrawal by Subject|3|||
46891378|NCT02945046|83114589|FG001|Overall Study|Withdrawal by Subject|3|||
46891379|NCT02945046|83114590|FG002|Overall Study|Withdrawal by Subject|3|||
46891380|NCT02945046|83114588|FG000|Overall Study|Protocol Violation|2|||
46891381|NCT02945046|83114589|FG001|Overall Study|Protocol Violation|3|||
46891382|NCT02945046|83114590|FG002|Overall Study|Protocol Violation|2|||
46891383|NCT02945046|83114588|FG000|Overall Study|Lost to Follow-up|1|||
46891384|NCT02945046|83114589|FG001|Overall Study|Lost to Follow-up|1|||
46891385|NCT02945046|83114590|FG002|Overall Study|Lost to Follow-up|0|||
46891386|NCT02945046|83114588|FG000|Overall Study|Lack of Efficacy|1|||
46891387|NCT02945046|83114589|FG001|Overall Study|Lack of Efficacy|2|||
46891388|NCT02945046|83114590|FG002|Overall Study|Lack of Efficacy|1|||
46891389|NCT02945046|83114588|FG000|Overall Study|Other than specified|5|||
46891390|NCT02945046|83114589|FG001|Overall Study|Other than specified|4|||
46891391|NCT02945046|83114590|FG002|Overall Study|Other than specified|7|||
46891392|NCT03705793|83114600|FG000|Overall Study|Lost to Follow-up|3|||
46891393|NCT03705793|83114601|FG001|Overall Study|Lost to Follow-up|4|||
46891394|NCT03705793|83114600|FG000|Overall Study|Withdrawal by Subject|2|||
46891395|NCT03705793|83114601|FG001|Overall Study|Withdrawal by Subject|1|||
46891396|NCT02944968|83114620|FG000|Overall Study|Subject excluded before study procedure|1|||
46891397|NCT02944968|83114620|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
46891398|NCT03761797|83114624|FG000|Overall Study|Changing hospital|11|||
46891399|NCT03761797|83114624|FG000|Overall Study|Improvement/remission|6|||
46891400|NCT03761797|83114624|FG000|Overall Study|Withdrawal by Subject|19|||
46891401|NCT03761797|83114624|FG000|Overall Study|Lost to Follow-up|33|||
46891402|NCT03761797|83114624|FG000|Overall Study|Adverse Event|37|||
46891403|NCT03761797|83114624|FG000|Overall Study|Case report form (CRF) not collected|5|||
46891404|NCT03761797|83114624|FG000|Overall Study|No patient visit after entry|13|||
46891405|NCT03761797|83114624|FG000|Overall Study|Switch to other diabetes medication|10|||
46891406|NCT03761797|83114624|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
46891407|NCT03761797|83114624|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
46891408|NCT03761797|83114624|FG000|Overall Study|Insufficient effectives|2|||
46891409|NCT03761797|83114624|FG000|Overall Study|Excessive alcohol intake|1|||
46891410|NCT02944656|83114630|FG000|Overall Study|No longer eligible|3|||
46891411|NCT02944656|83114631|FG001|Overall Study|No longer eligible|0|||
46891412|NCT02944656|83114630|FG000|Overall Study|Lost to Follow-up|7|||
46891413|NCT02944656|83114631|FG001|Overall Study|Lost to Follow-up|10|||
46891414|NCT02713529|83114644|FG000|Overall Study|Withdrawal by Subject|3|||
46891415|NCT02713529|83114645|FG001|Overall Study|Withdrawal by Subject|1|||
46891416|NCT02713529|83114646|FG002|Overall Study|Withdrawal by Subject|4|||
46891417|NCT02713529|83114647|FG003|Overall Study|Withdrawal by Subject|2|||
46891418|NCT02713529|83114648|FG004|Overall Study|Withdrawal by Subject|0|||
46891419|NCT02713529|83114649|FG005|Overall Study|Withdrawal by Subject|1|||
46891420|NCT02713529|83114650|FG006|Overall Study|Withdrawal by Subject|1|||
46891421|NCT02713529|83114644|FG000|Overall Study|Lost to Follow-up|1|||
46891422|NCT02713529|83114645|FG001|Overall Study|Lost to Follow-up|0|||
46891423|NCT02713529|83114646|FG002|Overall Study|Lost to Follow-up|1|||
46891424|NCT02713529|83114647|FG003|Overall Study|Lost to Follow-up|0|||
46891425|NCT02713529|83114648|FG004|Overall Study|Lost to Follow-up|0|||
46891426|NCT02713529|83114649|FG005|Overall Study|Lost to Follow-up|0|||
46891427|NCT02713529|83114650|FG006|Overall Study|Lost to Follow-up|0|||
46891428|NCT02713529|83114644|FG000|Overall Study|Death|3|||
46891429|NCT02713529|83114645|FG001|Overall Study|Death|3|||
46891430|NCT02713529|83114646|FG002|Overall Study|Death|26|||
46891431|NCT02713529|83114647|FG003|Overall Study|Death|27|||
46891432|NCT02713529|83114648|FG004|Overall Study|Death|3|||
46891433|NCT02713529|83114649|FG005|Overall Study|Death|13|||
46891434|NCT02713529|83114650|FG006|Overall Study|Death|3|||
46891435|NCT03707821|83114676|FG000|Overall Study|Protocol Violation|0|||
46891436|NCT03707821|83114677|FG001|Overall Study|Protocol Violation|1|||
46891437|NCT03707821|83114676|FG000|Overall Study|Unsatisfactory Visual Response|1|||
46891438|NCT03707821|83114677|FG001|Overall Study|Unsatisfactory Visual Response|0|||
46891439|NCT03707821|83114676|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
46891440|NCT03707821|83114677|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
46891441|NCT04546581|83114685|FG000|Overall Study|Adverse Event|9|||
46891442|NCT04546581|83114686|FG001|Overall Study|Adverse Event|3|||
46891443|NCT04546581|83114685|FG000|Overall Study|Physician Decision|0|||
46891444|NCT04546581|83114686|FG001|Overall Study|Physician Decision|1|||
46891445|NCT04546581|83114685|FG000|Overall Study|Protocol Violation|1|||
46891446|NCT04546581|83114686|FG001|Overall Study|Protocol Violation|2|||
46891447|NCT04546581|83114685|FG000|Overall Study|Withdrawal by Subject|3|||
46891448|NCT04546581|83114686|FG001|Overall Study|Withdrawal by Subject|7|||
46891449|NCT03707587|83114694|FG000|Overall Study|Death|0|||
46891450|NCT03707587|83114695|FG001|Overall Study|Death|1|||
46891451|NCT03312933|83114705|FG000|Overall Study|Protocol Violation|15|||
46891452|NCT03312933|83114705|FG000|Overall Study|Lost to Follow-up|36|||
46891453|NCT03312933|83114705|FG000|Overall Study|Withdrawal by Subject|3|||
46891454|NCT03312543|83114711|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
46891455|NCT03312543|83114712|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
46891456|NCT03312543|83114711|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
46891457|NCT03312543|83114712|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
46891458|NCT03312543|83114711|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
46891459|NCT03312543|83114712|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
46891460|NCT03312543|83114711|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
46891461|NCT03312543|83114712|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
46891462|NCT03312543|83114711|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
46891463|NCT03312543|83114712|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
46891464|NCT03312543|83114711|FG000|Regression (Week 12 to Week 24)|Death|0|||
46891465|NCT03312543|83114712|FG001|Regression (Week 12 to Week 24)|Death|1|||
46891466|NCT02392559|83114741|FG000|Overall Study|Withdrawal by Subject|0|||
46891467|NCT02392559|83114742|FG001|Overall Study|Withdrawal by Subject|1|||
46891468|NCT03332589|83114756|FG000|Overall Study|Lack of Efficacy|2|||
46891469|NCT03332589|83114757|FG001|Overall Study|Lack of Efficacy|0|||
46891470|NCT03332589|83114758|FG002|Overall Study|Lack of Efficacy|0|||
46891471|NCT03332589|83114756|FG000|Overall Study|Adverse Event|1|||
46891472|NCT03332589|83114757|FG001|Overall Study|Adverse Event|0|||
46891473|NCT03332589|83114758|FG002|Overall Study|Adverse Event|0|||
46891474|NCT03332589|83114756|FG000|Overall Study|Death|1|||
46891475|NCT03332589|83114757|FG001|Overall Study|Death|0|||
46891476|NCT03332589|83114758|FG002|Overall Study|Death|0|||
46891477|NCT00458003|83114768|FG000|Overall Study|Non protocol spinal anesthesia|1|||
46891478|NCT00458003|83114769|FG001|Overall Study|Non protocol spinal anesthesia|1|||
46891479|NCT02061293|83114779|FG000|Overall Study|Elevated Blood Pressure|1|||
46891480|NCT02061293|83114780|FG001|Overall Study|Elevated Blood Pressure|1|||
46891481|NCT03323736|83114789|FG000|Overall Study|Screen Failure|14|||
46891482|NCT03323736|83114790|FG001|Overall Study|Screen Failure|9|||
46891483|NCT03323736|83114791|FG002|Overall Study|Screen Failure|1|||
46891484|NCT03323736|83114789|FG000|Overall Study|Withdrawal Before Treatment|3|||
46891485|NCT03323736|83114790|FG001|Overall Study|Withdrawal Before Treatment|1|||
46891486|NCT03323736|83114791|FG002|Overall Study|Withdrawal Before Treatment|1|||
46891487|NCT03323736|83114789|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
46891488|NCT03323736|83114790|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
46891489|NCT03323736|83114791|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
46891490|NCT03311841|83114806|FG000|14-day Wash-out|Adverse Event|0|||
46891491|NCT03311841|83114807|FG001|14-day Wash-out|Adverse Event|1|||
46891492|NCT03311841|83114808|FG002|14-day Wash-out|Adverse Event|0|||
46891493|NCT03311841|83114809|FG003|14-day Wash-out|Adverse Event|0|||
46891494|NCT03311841|83114810|FG004|14-day Wash-out|Adverse Event|0|||
46891495|NCT03311841|83114806|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
46891496|NCT03311841|83114807|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
46891497|NCT03311841|83114808|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
46891498|NCT03311841|83114809|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
46891499|NCT03311841|83114810|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
46891500|NCT03311373|83114843|FG000|Overall Study|Adverse Event|1|||
46891501|NCT03311373|83114843|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
46891502|NCT03311373|83114843|FG000|Overall Study|Lost to Follow-up|1|||
46891503|NCT03311373|83114843|FG000|Overall Study|Physician Decision|1|||
46891504|NCT03311373|83114843|FG000|Overall Study|Withdrawal by Subject|3|||
46891505|NCT01155375|83114855|FG000|Overall Study|Adverse Event|1|||
46891506|NCT01155375|83114856|FG001|Overall Study|Adverse Event|0|||
46891507|NCT00628095|83114874|FG000|Overall Study|Adverse Event|5|||
46891508|NCT00628095|83114875|FG001|Overall Study|Adverse Event|3|||
46891509|NCT00628095|83114874|FG000|Overall Study|Lack of Efficacy|0|||
46891510|NCT00628095|83114875|FG001|Overall Study|Lack of Efficacy|3|||
46891511|NCT00628095|83114874|FG000|Overall Study|Withdrawal by Subject|2|||
46891512|NCT00628095|83114875|FG001|Overall Study|Withdrawal by Subject|0|||
46891513|NCT00628095|83114874|FG000|Overall Study|Other|0|||
46891514|NCT00628095|83114875|FG001|Overall Study|Other|1|||
46891515|NCT02889861|83114883|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
46891516|NCT03325881|83114894|FG000|Overall Study|Protocol Violation|0|||
46891517|NCT03325881|83114895|FG001|Overall Study|Protocol Violation|1|||
46891518|NCT03325881|83114894|FG000|Overall Study|Withdrawal by Subject|0|||
46891519|NCT03325881|83114895|FG001|Overall Study|Withdrawal by Subject|2|||
46891520|NCT03325881|83114894|FG000|Overall Study|Lack of Efficacy|2|||
46891521|NCT03325881|83114895|FG001|Overall Study|Lack of Efficacy|0|||
46891522|NCT03325881|83114894|FG000|Overall Study|Not treated|1|||
46891523|NCT03325881|83114895|FG001|Overall Study|Not treated|0|||
46891524|NCT02887989|83114905|FG000|Overall Study|Withdrawal by Subject|8|||
46891525|NCT02887989|83114906|FG001|Overall Study|Withdrawal by Subject|11|||
46891526|NCT02887989|83114905|FG000|Overall Study|Death|1|||
46891527|NCT02887989|83114906|FG001|Overall Study|Death|0|||
46891528|NCT02887521|83114914|FG000|Overall Study|Withdrawal by Subject|0|||
46891529|NCT02887521|83114915|FG001|Overall Study|Withdrawal by Subject|3|||
46891530|NCT03305055|83114923|FG000|Overall Study|Withdrawal by Subject|0|||
46891531|NCT03305055|83114924|FG001|Overall Study|Withdrawal by Subject|1|||
46891532|NCT03305055|83114923|FG000|Overall Study|Adverse Event|1|||
46891533|NCT03305055|83114924|FG001|Overall Study|Adverse Event|1|||
46891534|NCT02763189|83114932|FG000|Overall Study|Device failure|0|||
46891535|NCT02763189|83114933|FG001|Overall Study|Device failure|2|||
46891536|NCT03273387|83114941|FG000|Overall Study|Death|2|||
46891537|NCT03273387|83114942|FG001|Overall Study|Death|2|||
46891538|NCT03273387|83114941|FG000|Overall Study|Withdrawal by Subject|1|||
46891539|NCT03273387|83114942|FG001|Overall Study|Withdrawal by Subject|1|||
46891540|NCT01328080|83114948|FG000|Overall Study|Lost to Follow-up|5|||
46891541|NCT02649946|83114967|FG000|Overall Study|Withdrawal by Subject|1|||
46891542|NCT02649946|83114968|FG001|Overall Study|Withdrawal by Subject|1|||
46891543|NCT02649946|83114967|FG000|Overall Study|Death|7|||
46891544|NCT02649946|83114968|FG001|Overall Study|Death|9|||
46891545|NCT02649946|83114967|FG000|Overall Study|Physician Decision|1|||
46891546|NCT02649946|83114968|FG001|Overall Study|Physician Decision|0|||
46891547|NCT02649946|83114967|FG000|Overall Study|Lost to Follow-up|2|||
46891548|NCT02649946|83114968|FG001|Overall Study|Lost to Follow-up|1|||
46891549|NCT02649946|83114967|FG000|Overall Study|Erroneously enrolled|1|||
46891550|NCT02649946|83114968|FG001|Overall Study|Erroneously enrolled|0|||
46891551|NCT02649946|83114967|FG000|Overall Study|Missed 6-month follow-up visit|0|||
46891552|NCT02649946|83114968|FG001|Overall Study|Missed 6-month follow-up visit|4|||
46891553|NCT03273153|83114976|FG000|Overall Study|Adverse Event|1|||
46891554|NCT03273153|83114977|FG001|Overall Study|Adverse Event|2|||
46891555|NCT03273153|83114976|FG000|Overall Study|Missing|0|||
46891556|NCT03273153|83114977|FG001|Overall Study|Missing|2|||
46891557|NCT03273153|83114976|FG000|Overall Study|Other|3|||
46891558|NCT03273153|83114977|FG001|Overall Study|Other|2|||
46891559|NCT03273153|83114976|FG000|Overall Study|Symptomatic Deterioration|0|||
46891560|NCT03273153|83114977|FG001|Overall Study|Symptomatic Deterioration|1|||
46891561|NCT03273153|83114976|FG000|Overall Study|Progressive Disease|6|||
46891562|NCT03273153|83114977|FG001|Overall Study|Progressive Disease|5|||
46891563|NCT03273153|83114976|FG000|Overall Study|Physician Decision|1|||
46891564|NCT03273153|83114977|FG001|Overall Study|Physician Decision|3|||
46891565|NCT03273153|83114976|FG000|Overall Study|Study Terminated by Sponsor|112|||
46891566|NCT03273153|83114977|FG001|Overall Study|Study Terminated by Sponsor|102|||
46891567|NCT03273153|83114976|FG000|Overall Study|Withdrawal by Subject|26|||
46891568|NCT03273153|83114977|FG001|Overall Study|Withdrawal by Subject|25|||
46891569|NCT03273153|83114976|FG000|Overall Study|Protocol Deviation|3|||
46891570|NCT03273153|83114977|FG001|Overall Study|Protocol Deviation|0|||
46891571|NCT03273153|83114976|FG000|Overall Study|Lost to Follow-up|6|||
46891572|NCT03273153|83114977|FG001|Overall Study|Lost to Follow-up|11|||
46891573|NCT03273153|83114976|FG000|Overall Study|Death|66|||
46891574|NCT03273153|83114977|FG001|Overall Study|Death|69|||
46891575|NCT03270657|83115002|FG000|Overall Study|Withdrawal by Subject|1|||
46891576|NCT03303417|83115006|FG000|Overall Study|Withdrawal by Subject|1|||
46891577|NCT03303417|83115007|FG001|Overall Study|Withdrawal by Subject|1|||
46891578|NCT02943564|83115025|FG000|Overall Study|Miscellaneous Reasons|0|||
46891579|NCT02943564|83115026|FG001|Overall Study|Miscellaneous Reasons|0|||
46891580|NCT02943564|83115027|FG002|Overall Study|Miscellaneous Reasons|3|||
46891581|NCT02943564|83115025|FG000|Overall Study|Site terminated by sponsor|0|||
46891582|NCT02943564|83115026|FG001|Overall Study|Site terminated by sponsor|1|||
46891583|NCT02943564|83115027|FG002|Overall Study|Site terminated by sponsor|0|||
46891584|NCT02943564|83115025|FG000|Overall Study|Non-compliance with study drug|0|||
46891585|NCT02943564|83115026|FG001|Overall Study|Non-compliance with study drug|1|||
46891586|NCT02943564|83115027|FG002|Overall Study|Non-compliance with study drug|0|||
46891587|NCT02943564|83115025|FG000|Overall Study|Pregnancy|0|||
46891588|NCT02943564|83115026|FG001|Overall Study|Pregnancy|1|||
46891589|NCT02943564|83115027|FG002|Overall Study|Pregnancy|1|||
46891590|NCT02943564|83115025|FG000|Overall Study|Protocol Violation|2|||
46891591|NCT02943564|83115026|FG001|Overall Study|Protocol Violation|2|||
46891592|NCT02943564|83115027|FG002|Overall Study|Protocol Violation|2|||
46891593|NCT02943564|83115025|FG000|Overall Study|Lost to Follow-up|1|||
46891594|NCT02943564|83115026|FG001|Overall Study|Lost to Follow-up|0|||
46891595|NCT02943564|83115027|FG002|Overall Study|Lost to Follow-up|0|||
46891596|NCT02943564|83115025|FG000|Overall Study|Withdrawal by Subject|6|||
46891597|NCT02943564|83115026|FG001|Overall Study|Withdrawal by Subject|5|||
46891598|NCT02943564|83115027|FG002|Overall Study|Withdrawal by Subject|2|||
46891599|NCT02943564|83115025|FG000|Overall Study|Adverse Event|1|||
46891600|NCT02943564|83115026|FG001|Overall Study|Adverse Event|2|||
46891601|NCT02943564|83115027|FG002|Overall Study|Adverse Event|1|||
46891602|NCT02943564|83115025|FG000|Overall Study|Lack of Efficacy|0|||
46891603|NCT02943564|83115026|FG001|Overall Study|Lack of Efficacy|1|||
46891604|NCT02943564|83115027|FG002|Overall Study|Lack of Efficacy|0|||
46891605|NCT03268941|83115039|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
46891606|NCT03268941|83115040|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
46891607|NCT03268941|83115041|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
46891608|NCT03268941|83115042|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
46891609|NCT03268941|83115043|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
46891610|NCT03268941|83115044|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
46891611|NCT03268941|83115045|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
46891612|NCT03268941|83115039|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
46891613|NCT03268941|83115040|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
46891614|NCT03268941|83115041|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
46891615|NCT03268941|83115042|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
46891616|NCT03268941|83115043|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
46891617|NCT03268941|83115044|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
46891618|NCT03268941|83115045|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
46891619|NCT03268941|83115039|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
46891620|NCT03268941|83115040|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
46891621|NCT03268941|83115041|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
46891622|NCT03268941|83115042|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
46891623|NCT03268941|83115043|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
46891624|NCT03268941|83115044|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
46891625|NCT03268941|83115045|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
46891626|NCT03268941|83115039|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
46891627|NCT03268941|83115040|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
46891628|NCT03268941|83115041|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
46891629|NCT03268941|83115042|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
46891630|NCT03268941|83115043|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
46891631|NCT03268941|83115044|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
46891632|NCT03268941|83115045|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
46891633|NCT03268941|83115039|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
46891634|NCT03268941|83115040|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
46891635|NCT03268941|83115041|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
46891636|NCT03268941|83115042|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
46891637|NCT03268941|83115043|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
46891638|NCT03268941|83115044|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
46891639|NCT03268941|83115045|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
46891640|NCT03245619|83115122|FG000|Part A (Up to Day 22)|Physician Decision|4|||
46891641|NCT03245619|83115123|FG001|Part A (Up to Day 22)|Physician Decision|6|||
46891642|NCT03245619|83115124|FG002|Part A (Up to Day 22)|Physician Decision|6|||
46891643|NCT03245619|83115125|FG003|Part A (Up to Day 22)|Physician Decision|0|||
46891644|NCT03245619|83115126|FG004|Part A (Up to Day 22)|Physician Decision|0|||
46891645|NCT03245619|83115127|FG005|Part A (Up to Day 22)|Physician Decision|0|||
46891646|NCT03245619|83115128|FG006|Part A (Up to Day 22)|Physician Decision|0|||
46891647|NCT03245619|83115129|FG007|Part A (Up to Day 22)|Physician Decision|0|||
46891648|NCT03245619|83115130|FG008|Part A (Up to Day 22)|Physician Decision|0|||
46891649|NCT03245619|83115131|FG009|Part A (Up to Day 22)|Physician Decision|0|||
46891650|NCT03245619|83115132|FG010|Part A (Up to Day 22)|Physician Decision|0|||
46891651|NCT03245619|83115133|FG011|Part A (Up to Day 22)|Physician Decision|0|||
46891652|NCT03245619|83115134|FG012|Part A (Up to Day 22)|Physician Decision|0|||
46891653|NCT03245619|83115135|FG013|Part A (Up to Day 22)|Physician Decision|0|||
46891654|NCT03245619|83115136|FG014|Part A (Up to Day 22)|Physician Decision|0|||
46891655|NCT03245619|83115137|FG015|Part A (Up to Day 22)|Physician Decision|0|||
46891656|NCT03245619|83115138|FG016|Part A (Up to Day 22)|Physician Decision|0|||
46891657|NCT04472650|83115199|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
46891658|NCT04472650|83115200|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
46891659|NCT02606461|83115212|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
46891660|NCT02606461|83115213|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
46891661|NCT02606461|83115214|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
46891662|NCT02606461|83115215|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
46891663|NCT02606461|83115216|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
46891664|NCT02606461|83115217|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
46891665|NCT03321396|83115232|FG000|Overall Study|Physician Decision|1|||
46891666|NCT03244917|83115238|FG000|Overall Study|Lost to Follow-up|2|||
46891667|NCT03244917|83115239|FG001|Overall Study|Lost to Follow-up|2|||
46891668|NCT03321006|83115247|FG000|Overall Study|Death|1|||
46891669|NCT03321006|83115248|FG001|Overall Study|Death|0|||
46891670|NCT03321006|83115247|FG000|Overall Study|Lack of Efficacy|1|||
46891671|NCT03321006|83115248|FG001|Overall Study|Lack of Efficacy|0|||
46891672|NCT02593123|83115265|FG000|Overall Study|Physician Decision|2|||
46891673|NCT02593123|83115266|FG001|Overall Study|Physician Decision|1|||
46891674|NCT02593123|83115265|FG000|Overall Study|Relapse|1|||
46891675|NCT02593123|83115266|FG001|Overall Study|Relapse|1|||
46891676|NCT03302559|83115274|FG000|Overall Study|Adverse Event|2|||
46891677|NCT03302559|83115274|FG000|Overall Study|Lost to Follow-up|1|||
46891678|NCT03302559|83115274|FG000|Overall Study|Withdrew Consent|3|||
46891679|NCT03302247|83115278|FG000|Overall Study|the study has closed prematurely|2|||
46891680|NCT03302247|83115278|FG000|Overall Study|Death|1|||
46891681|NCT04993339|83115284|FG000|Overall Study|Lost to Follow-up|0|||
46891682|NCT04993339|83115285|FG001|Overall Study|Lost to Follow-up|1|||
46891683|NCT04993339|83115284|FG000|Overall Study|no MRI scan|3|||
46891684|NCT04993339|83115285|FG001|Overall Study|no MRI scan|1|||
46891685|NCT04974697|83115293|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
46891686|NCT04974697|83115293|FG000|Overall Study|Lens discomfort|1|||
46891687|NCT03265119|83115301|FG000|Overall Study|Adverse Event|2|||
46891688|NCT03265119|83115302|FG001|Overall Study|Adverse Event|1|||
46891689|NCT03265119|83115301|FG000|Overall Study|Lack of Efficacy|3|||
46891690|NCT03265119|83115302|FG001|Overall Study|Lack of Efficacy|0|||
46891691|NCT03265119|83115301|FG000|Overall Study|Protocol Violation|1|||
46891692|NCT03265119|83115302|FG001|Overall Study|Protocol Violation|2|||
46891693|NCT03265119|83115301|FG000|Overall Study|Withdrawal by Subject|2|||
46891694|NCT03265119|83115302|FG001|Overall Study|Withdrawal by Subject|4|||
46891695|NCT03265119|83115301|FG000|Overall Study|Lost to Follow-up|1|||
46891696|NCT03265119|83115302|FG001|Overall Study|Lost to Follow-up|0|||
46891697|NCT03265119|83115301|FG000|Overall Study|Lack of Compliance|1|||
46891698|NCT03265119|83115302|FG001|Overall Study|Lack of Compliance|0|||
46891699|NCT04952701|83115308|FG000|Control Lens|Physician Decision|4|||
46891700|NCT04952701|83115308|FG000|Test Lens|Physician Decision|1|||
46891701|NCT04723173|83115314|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
46891702|NCT04919161|83115328|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
46891703|NCT04919161|83115329|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
46891704|NCT04919161|83115328|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
46891705|NCT04919161|83115329|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
46891706|NCT04919161|83115328|FG000|Overall Study|Acute ankle sprain after session 1|0|||
46891707|NCT04919161|83115329|FG001|Overall Study|Acute ankle sprain after session 1|1|||
46891708|NCT03262389|83115357|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
46891709|NCT03262389|83115357|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
46891710|NCT03262389|83115357|FG000|Overall Study|opted out of PET/MR|1|||
46891711|NCT03262233|83115365|FG000|Overall Study|Withdrawal by Subject|12|||
46891712|NCT03262233|83115366|FG001|Overall Study|Withdrawal by Subject|8|||
46891713|NCT03262233|83115367|FG002|Overall Study|Withdrawal by Subject|21|||
46891714|NCT03262233|83115368|FG003|Overall Study|Withdrawal by Subject|13|||
46891715|NCT03262233|83115365|FG000|Overall Study|Declined due to shock|1|||
46891716|NCT03262233|83115366|FG001|Overall Study|Declined due to shock|2|||
46891717|NCT03262233|83115367|FG002|Overall Study|Declined due to shock|2|||
46891718|NCT03262233|83115368|FG003|Overall Study|Declined due to shock|3|||
46891719|NCT03262233|83115365|FG000|Overall Study|Protocol Violation|5|||
46891720|NCT03262233|83115366|FG001|Overall Study|Protocol Violation|10|||
46891721|NCT03262233|83115367|FG002|Overall Study|Protocol Violation|2|||
46891722|NCT03262233|83115368|FG003|Overall Study|Protocol Violation|13|||
46891723|NCT03262233|83115365|FG000|Overall Study|data collection artifact|0|||
46891724|NCT03262233|83115366|FG001|Overall Study|data collection artifact|1|||
46891725|NCT03262233|83115367|FG002|Overall Study|data collection artifact|0|||
46891726|NCT03262233|83115368|FG003|Overall Study|data collection artifact|0|||
46891727|NCT03261531|83115379|FG000|Overall Study|Withdrawal by Subject|4|||
46891728|NCT04151290|83115383|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
46891729|NCT03260205|83115402|FG000|Overall Study|Adverse Event|2|||
46891730|NCT03260205|83115403|FG001|Overall Study|Adverse Event|0|||
46891731|NCT03260205|83115404|FG002|Overall Study|Adverse Event|2|||
46891732|NCT03260205|83115405|FG003|Overall Study|Adverse Event|2|||
46891733|NCT03260205|83115406|FG004|Overall Study|Adverse Event|4|||
46891734|NCT03260205|83115402|FG000|Overall Study|Lost to Follow-up|2|||
46891735|NCT03260205|83115403|FG001|Overall Study|Lost to Follow-up|2|||
46891736|NCT03260205|83115404|FG002|Overall Study|Lost to Follow-up|1|||
46891737|NCT03260205|83115405|FG003|Overall Study|Lost to Follow-up|1|||
46891738|NCT03260205|83115406|FG004|Overall Study|Lost to Follow-up|5|||
46891739|NCT03260205|83115402|FG000|Overall Study|Protocol Violation|0|||
46891740|NCT03260205|83115403|FG001|Overall Study|Protocol Violation|0|||
46891741|NCT03260205|83115404|FG002|Overall Study|Protocol Violation|2|||
46891742|NCT03260205|83115405|FG003|Overall Study|Protocol Violation|0|||
46891743|NCT03260205|83115406|FG004|Overall Study|Protocol Violation|1|||
46891744|NCT03260205|83115402|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
46891745|NCT03260205|83115403|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
46891746|NCT03260205|83115404|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
46891747|NCT03260205|83115405|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
46891748|NCT03260205|83115406|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
46891749|NCT03260205|83115402|FG000|Overall Study|Other: Unspecified|0|||
46891750|NCT03260205|83115403|FG001|Overall Study|Other: Unspecified|0|||
46891751|NCT03260205|83115404|FG002|Overall Study|Other: Unspecified|3|||
46891752|NCT03260205|83115405|FG003|Overall Study|Other: Unspecified|1|||
46891753|NCT03260205|83115406|FG004|Overall Study|Other: Unspecified|1|||
46891754|NCT03260205|83115402|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
46891755|NCT03260205|83115403|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
46891756|NCT03260205|83115404|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
46891757|NCT03260205|83115405|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
46891758|NCT03260205|83115406|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
46891759|NCT04666441|83115431|FG000|Overall Study|Lost to Follow-up|1|||
46891760|NCT04666441|83115432|FG001|Overall Study|Lost to Follow-up|4|||
46891761|NCT04666441|83115433|FG002|Overall Study|Lost to Follow-up|1|||
46891762|NCT04666441|83115434|FG003|Overall Study|Lost to Follow-up|3|||
46891763|NCT04666441|83115435|FG004|Overall Study|Lost to Follow-up|0|||
46891764|NCT04666441|83115436|FG005|Overall Study|Lost to Follow-up|2|||
46891765|NCT04666441|83115437|FG006|Overall Study|Lost to Follow-up|2|||
46891766|NCT04666441|83115438|FG007|Overall Study|Lost to Follow-up|2|||
46891767|NCT04666441|83115431|FG000|Overall Study|Subject Decision|1|||
46891768|NCT04666441|83115432|FG001|Overall Study|Subject Decision|1|||
46891769|NCT04666441|83115433|FG002|Overall Study|Subject Decision|3|||
46891770|NCT04666441|83115434|FG003|Overall Study|Subject Decision|1|||
46891771|NCT04666441|83115435|FG004|Overall Study|Subject Decision|0|||
46891772|NCT04666441|83115436|FG005|Overall Study|Subject Decision|1|||
46891773|NCT04666441|83115437|FG006|Overall Study|Subject Decision|3|||
46891774|NCT04666441|83115438|FG007|Overall Study|Subject Decision|2|||
46891775|NCT03320850|83115475|FG000|Overall Study|Lost to Follow-up|0|||
46891776|NCT03320850|83115476|FG001|Overall Study|Lost to Follow-up|0|||
46891777|NCT03320850|83115477|FG002|Overall Study|Lost to Follow-up|0|||
46891778|NCT03320850|83115478|FG003|Overall Study|Lost to Follow-up|0|||
46891779|NCT03320850|83115479|FG004|Overall Study|Lost to Follow-up|1|||
46891780|NCT03320850|83115480|FG005|Overall Study|Lost to Follow-up|2|||
46891781|NCT03320850|83115481|FG006|Overall Study|Lost to Follow-up|2|||
46891782|NCT03320850|83115482|FG007|Overall Study|Lost to Follow-up|0|||
46991724|NCT02153073|83238704|FG000|Overall Study|Case Report Forms Uncollected|230|||
46891783|NCT03320850|83115483|FG008|Overall Study|Lost to Follow-up|6|||
46891784|NCT03320850|83115484|FG009|Overall Study|Lost to Follow-up|4|||
46891785|NCT03320850|83115475|FG000|Overall Study|Withdrawal by Subject|0|||
46891786|NCT03320850|83115476|FG001|Overall Study|Withdrawal by Subject|0|||
46991725|NCT02153073|83238704|FG000|Overall Study|Protocol Deviation|68|||
46891787|NCT03320850|83115477|FG002|Overall Study|Withdrawal by Subject|0|||
46891788|NCT03320850|83115478|FG003|Overall Study|Withdrawal by Subject|0|||
46891789|NCT03320850|83115479|FG004|Overall Study|Withdrawal by Subject|1|||
46891790|NCT03320850|83115480|FG005|Overall Study|Withdrawal by Subject|2|||
46891791|NCT03320850|83115481|FG006|Overall Study|Withdrawal by Subject|4|||
46891792|NCT03320850|83115482|FG007|Overall Study|Withdrawal by Subject|5|||
46891793|NCT03320850|83115483|FG008|Overall Study|Withdrawal by Subject|2|||
46891794|NCT03320850|83115484|FG009|Overall Study|Withdrawal by Subject|1|||
46891795|NCT03320850|83115475|FG000|Overall Study|Lack of Efficacy|0|||
46891796|NCT03320850|83115476|FG001|Overall Study|Lack of Efficacy|0|||
46891797|NCT03320850|83115477|FG002|Overall Study|Lack of Efficacy|0|||
46891798|NCT03320850|83115478|FG003|Overall Study|Lack of Efficacy|1|||
46891799|NCT03320850|83115479|FG004|Overall Study|Lack of Efficacy|0|||
46891800|NCT03320850|83115480|FG005|Overall Study|Lack of Efficacy|1|||
46891801|NCT03320850|83115481|FG006|Overall Study|Lack of Efficacy|0|||
46891802|NCT03320850|83115482|FG007|Overall Study|Lack of Efficacy|2|||
46891803|NCT03320850|83115483|FG008|Overall Study|Lack of Efficacy|0|||
46891804|NCT03320850|83115484|FG009|Overall Study|Lack of Efficacy|3|||
46891805|NCT03320850|83115475|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
46891806|NCT03320850|83115476|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
46891807|NCT03320850|83115477|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
46891808|NCT03320850|83115478|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
46891809|NCT03320850|83115479|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
46891810|NCT03320850|83115480|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
46891811|NCT03320850|83115481|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
46891812|NCT03320850|83115482|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
46891813|NCT03320850|83115483|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
46891814|NCT03320850|83115484|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
46891815|NCT03320850|83115475|FG000|Overall Study|Adverse Event|0|||
46891816|NCT03320850|83115476|FG001|Overall Study|Adverse Event|0|||
46891817|NCT03320850|83115477|FG002|Overall Study|Adverse Event|0|||
46891818|NCT03320850|83115478|FG003|Overall Study|Adverse Event|0|||
46891819|NCT03320850|83115479|FG004|Overall Study|Adverse Event|0|||
46891820|NCT03320850|83115480|FG005|Overall Study|Adverse Event|2|||
46891821|NCT03320850|83115481|FG006|Overall Study|Adverse Event|1|||
46891822|NCT03320850|83115482|FG007|Overall Study|Adverse Event|0|||
46891823|NCT03320850|83115483|FG008|Overall Study|Adverse Event|2|||
46891824|NCT03320850|83115484|FG009|Overall Study|Adverse Event|0|||
46891825|NCT03320850|83115475|FG000|Overall Study|Reason Not Specified|0|||
46891826|NCT03320850|83115476|FG001|Overall Study|Reason Not Specified|0|||
46891827|NCT03320850|83115477|FG002|Overall Study|Reason Not Specified|0|||
46891828|NCT03320850|83115478|FG003|Overall Study|Reason Not Specified|0|||
46891829|NCT03320850|83115479|FG004|Overall Study|Reason Not Specified|0|||
46891830|NCT03320850|83115480|FG005|Overall Study|Reason Not Specified|1|||
46891831|NCT03320850|83115481|FG006|Overall Study|Reason Not Specified|0|||
46891832|NCT03320850|83115482|FG007|Overall Study|Reason Not Specified|0|||
46891833|NCT03320850|83115483|FG008|Overall Study|Reason Not Specified|0|||
46891834|NCT03320850|83115484|FG009|Overall Study|Reason Not Specified|1|||
46891835|NCT03301623|83115513|FG000|Overall Study|Death|3|||
46891836|NCT03301623|83115514|FG001|Overall Study|Death|1|||
46891837|NCT03301623|83115513|FG000|Overall Study|Withdrawal by Subject|11|||
46891838|NCT03301623|83115514|FG001|Overall Study|Withdrawal by Subject|13|||
46891839|NCT03301623|83115513|FG000|Overall Study|Lost to Follow-up|3|||
46891840|NCT03301623|83115514|FG001|Overall Study|Lost to Follow-up|1|||
46891841|NCT03319212|83115522|FG000|Overall Study|Discontinued as moving out of local area|0|||
46891842|NCT03319212|83115523|FG001|Overall Study|Discontinued as moving out of local area|1|||
46891843|NCT03319212|83115522|FG000|Overall Study|Adverse Event|2|||
46891844|NCT03319212|83115523|FG001|Overall Study|Adverse Event|2|||
46891845|NCT03319212|83115522|FG000|Overall Study|Withdrawal by Subject|0|||
46891846|NCT03319212|83115523|FG001|Overall Study|Withdrawal by Subject|1|||
46891847|NCT03319212|83115522|FG000|Overall Study|Lost to Follow-up|0|||
46891848|NCT03319212|83115523|FG001|Overall Study|Lost to Follow-up|1|||
46891849|NCT03319212|83115522|FG000|Overall Study|Physician Decision|1|||
46891850|NCT03319212|83115523|FG001|Overall Study|Physician Decision|0|||
46891851|NCT04656691|83115528|FG000|Overall Study|Adverse Event|1|||
46891852|NCT03301155|83115534|FG000|Overall Study|Сompliance with exclusion criteria|8|||
46891853|NCT03301155|83115535|FG001|Overall Study|Сompliance with exclusion criteria|7|||
46891854|NCT01952730|83115541|FG000|Overall Study|FDA shut down core lab used by study|1|||
46891855|NCT03316170|83115547|FG000|Overall Study|Death|1|||
46891856|NCT03316170|83115548|FG001|Overall Study|Death|0|||
46891857|NCT03316170|83115547|FG000|Overall Study|Lost to Follow-up|6|||
46891858|NCT03316170|83115548|FG001|Overall Study|Lost to Follow-up|7|||
46891859|NCT03257865|83115557|FG000|Overall Study|Adverse Event|4|||
46891860|NCT03257865|83115558|FG001|Overall Study|Adverse Event|8|||
46891861|NCT03257865|83115557|FG000|Overall Study|Lack of Efficacy|1|||
46891862|NCT03257865|83115558|FG001|Overall Study|Lack of Efficacy|2|||
46891863|NCT03257865|83115557|FG000|Overall Study|Non-compliance with Study Drug|0|||
46891864|NCT03257865|83115558|FG001|Overall Study|Non-compliance with Study Drug|2|||
46891865|NCT03257865|83115557|FG000|Overall Study|Withdrawal by Subject|23|||
46891866|NCT03257865|83115558|FG001|Overall Study|Withdrawal by Subject|17|||
46891867|NCT03257865|83115557|FG000|Overall Study|Physician Decision|3|||
46891868|NCT03257865|83115558|FG001|Overall Study|Physician Decision|1|||
46891869|NCT03257865|83115557|FG000|Overall Study|Other|0|||
46891870|NCT03257865|83115558|FG001|Overall Study|Other|1|||
46891871|NCT03257865|83115557|FG000|Overall Study|Lost to Follow-up|4|||
46891872|NCT03257865|83115558|FG001|Overall Study|Lost to Follow-up|4|||
46891873|NCT04617847|83115566|FG000|Overall Study|Withdrawal by Subject|1|||
46891874|NCT04617847|83115567|FG001|Overall Study|Withdrawal by Subject|0|||
46891875|NCT04617847|83115566|FG000|Overall Study|Adverse Event|0|||
46891876|NCT04617847|83115567|FG001|Overall Study|Adverse Event|2|||
46891877|NCT04617847|83115566|FG000|Overall Study|Death|0|||
46891878|NCT04617847|83115567|FG001|Overall Study|Death|1|||
46891879|NCT04617847|83115566|FG000|Overall Study|Termination of Study by Sponsor|2|||
46891880|NCT04617847|83115567|FG001|Overall Study|Termination of Study by Sponsor|21|||
46891881|NCT04615507|83115577|FG000|Period 1|Covid-19 exposure|2|||
46891882|NCT04615507|83115578|FG001|Period 1|Covid-19 exposure|1|||
46891883|NCT04615507|83115577|FG000|Period 2|Covid-19 exposure|0|||
46891884|NCT04615507|83115578|FG001|Period 2|Covid-19 exposure|1|||
46891885|NCT04615507|83115577|FG000|Period 2|Protocol Violation|1|||
46891886|NCT04615507|83115578|FG001|Period 2|Protocol Violation|0|||
46891887|NCT04615507|83115577|FG000|Period 2|Withdrawal by Subject|1|||
46891888|NCT04615507|83115578|FG001|Period 2|Withdrawal by Subject|0|||
46891889|NCT04615507|83115577|FG000|Period 2|Adverse Event|0|||
46891890|NCT04615507|83115578|FG001|Period 2|Adverse Event|1|||
46891891|NCT04615507|83115577|FG000|Period 3|Covid-19 exposure|0|||
46891892|NCT04615507|83115578|FG001|Period 3|Covid-19 exposure|1|||
46891893|NCT04120233|83115590|FG000|Overall Study|Adverse Event|0|||
46891894|NCT04120233|83115591|FG001|Overall Study|Adverse Event|0|||
46891895|NCT04120233|83115592|FG002|Overall Study|Adverse Event|0|||
46891896|NCT04120233|83115593|FG003|Overall Study|Adverse Event|0|||
46891897|NCT04120233|83115594|FG004|Overall Study|Adverse Event|1|||
46891898|NCT04120233|83115595|FG005|Overall Study|Adverse Event|0|||
46891899|NCT01610700|83115611|FG000|Overall Study|Adverse Event|3|||
46891900|NCT01610700|83115612|FG001|Overall Study|Adverse Event|1|||
46891901|NCT01610700|83115611|FG000|Overall Study|Withdrawal by Subject|0|||
46891902|NCT01610700|83115612|FG001|Overall Study|Withdrawal by Subject|1|||
46891903|NCT01610700|83115611|FG000|Overall Study|subject took one dose of street cannabis|0|||
46891904|NCT01610700|83115612|FG001|Overall Study|subject took one dose of street cannabis|1|||
46891905|NCT03256851|83115621|FG000|Overall Study|Withdrawal by Subject|1|||
46891906|NCT03256851|83115622|FG001|Overall Study|Withdrawal by Subject|0|||
46891907|NCT04837807|83115628|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
46891908|NCT04837807|83115629|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
46891909|NCT03256695|83115635|FG000|Overall Study|Adverse Event|8|||
46891910|NCT03256695|83115635|FG000|Overall Study|Death|2|||
46891911|NCT03256695|83115635|FG000|Overall Study|Withdrawal by Subject|14|||
46891912|NCT03256695|83115635|FG000|Overall Study|Non-compliance with study drug|1|||
46891913|NCT03256695|83115635|FG000|Overall Study|Lost to Follow-up|3|||
46891914|NCT03256695|83115635|FG000|Overall Study|Lack of Efficacy|3|||
46891915|NCT03256695|83115635|FG000|Overall Study|Protocol Violation|5|||
46891916|NCT03256695|83115635|FG000|Overall Study|Other than specified|3|||
46891917|NCT03305016|83115639|FG000|Overall Study|Withdrawal by Subject|2|||
46891918|NCT03297021|83115646|FG000|Overall Study|Incomplete/illegible data sheet|4|||
46891919|NCT03297021|83115647|FG001|Overall Study|Incomplete/illegible data sheet|2|||
46891920|NCT03297021|83115648|FG002|Overall Study|Incomplete/illegible data sheet|3|||
46891921|NCT03297021|83115646|FG000|Overall Study|Missing Post-Op Data|1|||
46891922|NCT03297021|83115647|FG001|Overall Study|Missing Post-Op Data|2|||
46891923|NCT03297021|83115648|FG002|Overall Study|Missing Post-Op Data|1|||
46610665|NCT02533674|82703096|FG002|Dose Level VIII|Never treated|0|||
46610666|NCT02533674|82703097|FG003|Dose Level VIII|Never treated|0|||
46610667|NCT02533674|82703098|FG004|Dose Level VIII|Never treated|0|||
46610668|NCT02533674|82703099|FG005|Dose Level VIII|Never treated|0|||
46610669|NCT02533674|82703100|FG006|Dose Level VIII|Never treated|0|||
46610670|NCT02533674|82703101|FG007|Dose Level VIII|Never treated|1|||
46610671|NCT02540850|82703122|FG000|Overall Study|Lost to Follow-up|69|||
46610672|NCT02540850|82703123|FG001|Overall Study|Lost to Follow-up|66|||
46610673|NCT02540850|82703124|FG002|Overall Study|Lost to Follow-up|34|||
46610674|NCT01662024|82703132|FG000|Overall Study|Pregnancy|2|||
46610675|NCT01662024|82703132|FG000|Overall Study|Withdrawal by Subject|3|||
46610676|NCT02544750|82703201|FG000|Overall Study|Physician Decision|3|||
46610677|NCT02544750|82703202|FG001|Overall Study|Physician Decision|1|||
46610678|NCT02544750|82703201|FG000|Overall Study|Other reasons|69|||
46610679|NCT02544750|82703202|FG001|Overall Study|Other reasons|39|||
46610680|NCT02544750|82703201|FG000|Overall Study|Met withdrawal criteria|2|||
46891924|NCT04820491|83115658|FG000|Overall Study|Withdrawal by Subject|1|||
46891925|NCT04820491|83115659|FG001|Overall Study|Withdrawal by Subject|0|||
46891926|NCT01988571|83115667|FG000|Overall Study|Death|3|||
46891927|NCT01988571|83115668|FG001|Overall Study|Death|1|||
46891928|NCT01988571|83115667|FG000|Overall Study|Physician Decision|2|||
46891929|NCT01988571|83115668|FG001|Overall Study|Physician Decision|1|||
46891930|NCT01988571|83115667|FG000|Overall Study|Lost to Follow-up|3|||
46610681|NCT02544750|82703202|FG001|Overall Study|Met withdrawal criteria|2|||
46610682|NCT02544750|82703201|FG000|Overall Study|Transition To Commercial Product|1|||
46891931|NCT01988571|83115668|FG001|Overall Study|Lost to Follow-up|0|||
46891932|NCT01988571|83115667|FG000|Overall Study|Withdrawal by Subject|31|||
46891933|NCT01988571|83115668|FG001|Overall Study|Withdrawal by Subject|33|||
46891934|NCT04794751|83115674|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
46891935|NCT04794751|83115675|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
46891936|NCT04794751|83115674|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
46891937|NCT04794751|83115675|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
46891938|NCT04794751|83115674|FG000|Period 1|Protocol Violation|0|||
46891939|NCT04794751|83115675|FG001|Period 1|Protocol Violation|2|||
46891940|NCT04794751|83115674|FG000|Period 1|Withdrawal by Subject|0|||
46891941|NCT04794751|83115675|FG001|Period 1|Withdrawal by Subject|1|||
46891942|NCT04794751|83115674|FG000|Period 2|Withdrawal by Subject|0|||
46891943|NCT04794751|83115675|FG001|Period 2|Withdrawal by Subject|1|||
46891944|NCT04794751|83115674|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
46891945|NCT04794751|83115675|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
46891946|NCT04794751|83115674|FG000|Period 2|Protocol Violation|1|||
46891947|NCT04794751|83115675|FG001|Period 2|Protocol Violation|0|||
46891948|NCT04578457|83115681|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
46891949|NCT04578457|83115681|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
46891950|NCT04578457|83115681|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
46891951|NCT04578457|83115681|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
46891952|NCT03334188|83115691|FG000|Overall Study|Withdrawal by Subject|0|||
46891953|NCT03334188|83115692|FG001|Overall Study|Withdrawal by Subject|1|||
46891954|NCT03334188|83115691|FG000|Overall Study|Death|1|||
46891955|NCT03334188|83115692|FG001|Overall Study|Death|0|||
46891956|NCT03334188|83115691|FG000|Overall Study|Never had qualifying clinic visit|7|||
46891957|NCT03334188|83115692|FG001|Overall Study|Never had qualifying clinic visit|7|||
46891958|NCT03333876|83115701|FG000|Screening Period|Screen Failure|4|||
46891959|NCT03333876|83115701|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
46891960|NCT03333876|83115701|FG000|Mandibular Advancement|Adverse Event|2|||
46891961|NCT03333876|83115701|FG000|Mandibular Advancement|Product Damage|2|||
46891962|NCT03294681|83115714|FG000|Overall Study|Withdrawal by Subject|1|||
46891963|NCT01140867|83115718|FG000|Overall Study|Adverse Event|22|||
46891964|NCT01140867|83115718|FG000|Overall Study|Lack of Efficacy|3|||
46891965|NCT01140867|83115718|FG000|Overall Study|Lost to Follow-up|2|||
46891966|NCT01140867|83115718|FG000|Overall Study|Withdrawal by Subject|1|||
46891967|NCT01140867|83115718|FG000|Overall Study|Protocol Violation|1|||
46891968|NCT01140867|83115718|FG000|Overall Study|Uncooperative patient|2|||
46891969|NCT01140867|83115718|FG000|Overall Study|Medication Noncompliance|2|||
46891970|NCT04572997|83115722|FG000|Overall Study|Adverse Event|1|||
46891971|NCT02943096|83115732|FG000|Overall Study|Lack of Efficacy|0|||
46891972|NCT02943096|83115733|FG001|Overall Study|Lack of Efficacy|1|||
46891973|NCT04571515|83115744|FG000|Overall Study|Physician Decision|0|||
46891974|NCT04571515|83115745|FG001|Overall Study|Physician Decision|0|||
46891975|NCT04571515|83115746|FG002|Overall Study|Physician Decision|0|||
46891976|NCT04571515|83115747|FG003|Overall Study|Physician Decision|0|||
46891977|NCT04571515|83115748|FG004|Overall Study|Physician Decision|1|||
46891978|NCT04571515|83115744|FG000|Overall Study|Withdrawal by Subject|0|||
46891979|NCT04571515|83115745|FG001|Overall Study|Withdrawal by Subject|0|||
46891980|NCT04571515|83115746|FG002|Overall Study|Withdrawal by Subject|0|||
46891981|NCT04571515|83115747|FG003|Overall Study|Withdrawal by Subject|0|||
46891982|NCT04571515|83115748|FG004|Overall Study|Withdrawal by Subject|1|||
46891983|NCT04571515|83115744|FG000|Overall Study|insufficient pain|1|||
46891984|NCT04571515|83115745|FG001|Overall Study|insufficient pain|0|||
46891985|NCT04571515|83115746|FG002|Overall Study|insufficient pain|0|||
46891986|NCT04571515|83115747|FG003|Overall Study|insufficient pain|0|||
46891987|NCT04571515|83115748|FG004|Overall Study|insufficient pain|1|||
46891988|NCT03292653|83115763|FG000|Overall Study|Adverse Event|0|||
46891989|NCT03292653|83115764|FG001|Overall Study|Adverse Event|0|||
46891990|NCT03292653|83115765|FG002|Overall Study|Adverse Event|1|||
46891991|NCT03292653|83115763|FG000|Overall Study|Did not Receive Treatment|1|||
46891992|NCT03292653|83115764|FG001|Overall Study|Did not Receive Treatment|0|||
46891993|NCT03292653|83115765|FG002|Overall Study|Did not Receive Treatment|0|||
46891994|NCT03858634|83115776|FG000|Overall Study|Withdrawal by Subject|1|||
46891995|NCT03858634|83115777|FG001|Overall Study|Withdrawal by Subject|0|||
46891996|NCT03858634|83115776|FG000|Overall Study|Adverse Event|1|||
46891997|NCT03858634|83115777|FG001|Overall Study|Adverse Event|0|||
46891998|NCT03858634|83115776|FG000|Overall Study|Lost to Follow-up|0|||
46891999|NCT03858634|83115777|FG001|Overall Study|Lost to Follow-up|1|||
46892000|NCT03858634|83115776|FG000|Overall Study|Other, Not Specified|1|||
46892001|NCT03858634|83115777|FG001|Overall Study|Other, Not Specified|1|||
46892002|NCT02891070|83115793|FG000|Overall Study|Adverse Event|1|||
46892003|NCT02891070|83115794|FG001|Overall Study|Adverse Event|0|||
46892004|NCT02891070|83115793|FG000|Overall Study|Physician Decision|0|||
46892005|NCT02891070|83115794|FG001|Overall Study|Physician Decision|1|||
46892006|NCT02891070|83115793|FG000|Overall Study|Lost to Follow-up|4|||
46892007|NCT02891070|83115794|FG001|Overall Study|Lost to Follow-up|4|||
46892008|NCT02891070|83115793|FG000|Overall Study|Other|1|||
46706695|NCT01208207|82921859|FG000|Part II|Protocol Violation|0|||
46892009|NCT02891070|83115794|FG001|Overall Study|Other|0|||
46892010|NCT02891070|83115793|FG000|Overall Study|Protocol Violation|0|||
46892011|NCT02891070|83115794|FG001|Overall Study|Protocol Violation|1|||
46892012|NCT02891070|83115793|FG000|Overall Study|Withdrawal by Subject|1|||
46892013|NCT02891070|83115794|FG001|Overall Study|Withdrawal by Subject|2|||
46892014|NCT02891070|83115793|FG000|Overall Study|Death|3|||
46892015|NCT02891070|83115794|FG001|Overall Study|Death|0|||
46892016|NCT03255291|83115806|FG000|Overall Study|Determined to be ineligible|10|||
46892017|NCT03255291|83115807|FG001|Overall Study|Determined to be ineligible|12|||
46892018|NCT03255291|83115808|FG002|Overall Study|Determined to be ineligible|6|||
46892019|NCT03255291|83115809|FG003|Overall Study|Determined to be ineligible|6|||
46892020|NCT03255291|83115810|FG004|Overall Study|Determined to be ineligible|5|||
46892021|NCT03255291|83115811|FG005|Overall Study|Determined to be ineligible|10|||
46892022|NCT03255291|83115806|FG000|Overall Study|Baseline data collection issues|3|||
46892023|NCT03255291|83115807|FG001|Overall Study|Baseline data collection issues|0|||
46892024|NCT03255291|83115808|FG002|Overall Study|Baseline data collection issues|0|||
46892025|NCT03255291|83115809|FG003|Overall Study|Baseline data collection issues|0|||
46892026|NCT03255291|83115810|FG004|Overall Study|Baseline data collection issues|2|||
46892027|NCT03255291|83115811|FG005|Overall Study|Baseline data collection issues|0|||
46892028|NCT00381381|83115829|FG000|Overall Study|Adverse Event|3|||
46892029|NCT00381381|83115829|FG000|Overall Study|Lost to Follow-up|52|||
46892030|NCT00381381|83115829|FG000|Overall Study|Withdrawal by Subject|9|||
46892031|NCT02939937|83115835|FG000|Overall Study|Adverse Event|5|||
46892032|NCT02939937|83115836|FG001|Overall Study|Adverse Event|0|||
46892033|NCT02939937|83115835|FG000|Overall Study|Lost to Follow-up|1|||
46892034|NCT02939937|83115836|FG001|Overall Study|Lost to Follow-up|3|||
46892035|NCT02939079|83115844|FG000|Overall Study|Adverse Event|2|||
46892036|NCT02939079|83115845|FG001|Overall Study|Adverse Event|1|||
46892037|NCT02939079|83115844|FG000|Overall Study|Lost to Follow-up|0|||
46892038|NCT02939079|83115845|FG001|Overall Study|Lost to Follow-up|2|||
46892039|NCT02939079|83115844|FG000|Overall Study|Protocol Violation|1|||
46892040|NCT02939079|83115845|FG001|Overall Study|Protocol Violation|0|||
46892041|NCT02939079|83115844|FG000|Overall Study|Withdrawal by Subject|0|||
46892042|NCT02939079|83115845|FG001|Overall Study|Withdrawal by Subject|1|||
46892043|NCT02939079|83115844|FG000|Overall Study|relapse during the study|1|||
46892044|NCT02939079|83115845|FG001|Overall Study|relapse during the study|1|||
46892045|NCT04562155|83115855|FG000|Overall Study|COVID-19 pandemic|0|||
46892046|NCT04562155|83115856|FG001|Overall Study|COVID-19 pandemic|0|||
46892047|NCT04562155|83115857|FG002|Overall Study|COVID-19 pandemic|0|||
46892048|NCT04562155|83115858|FG003|Overall Study|COVID-19 pandemic|1|||
46892049|NCT04562155|83115855|FG000|Overall Study|Adverse Event|7|||
46892050|NCT04562155|83115856|FG001|Overall Study|Adverse Event|3|||
46892051|NCT04562155|83115857|FG002|Overall Study|Adverse Event|8|||
46892052|NCT04562155|83115858|FG003|Overall Study|Adverse Event|1|||
46892053|NCT04562155|83115855|FG000|Overall Study|Withdrawal by Subject|3|||
46892054|NCT04562155|83115856|FG001|Overall Study|Withdrawal by Subject|6|||
46892055|NCT04562155|83115857|FG002|Overall Study|Withdrawal by Subject|3|||
46892056|NCT04562155|83115858|FG003|Overall Study|Withdrawal by Subject|3|||
46892057|NCT04562155|83115855|FG000|Overall Study|Participant personal reason|1|||
46892058|NCT04562155|83115856|FG001|Overall Study|Participant personal reason|0|||
46892059|NCT04562155|83115857|FG002|Overall Study|Participant personal reason|2|||
46892060|NCT04562155|83115858|FG003|Overall Study|Participant personal reason|1|||
46892061|NCT03313050|83115872|FG000|Stage 2: 12 Months|Adverse Event|0|||
46892062|NCT03313050|83115873|FG001|Stage 2: 12 Months|Adverse Event|0|||
46892063|NCT03313050|83115874|FG002|Stage 2: 12 Months|Adverse Event|0|||
46892064|NCT03313050|83115875|FG003|Stage 2: 12 Months|Adverse Event|1|||
46892065|NCT03313050|83115872|FG000|Stage 2: 12 Months|Death|0|||
46892066|NCT03313050|83115873|FG001|Stage 2: 12 Months|Death|0|||
46610683|NCT02544750|82703202|FG001|Overall Study|Transition To Commercial Product|0|||
46610684|NCT02544750|82703201|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
46610685|NCT02544750|82703202|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
46610686|NCT02544750|82703201|FG000|Overall Study|Adverse Event|8|||
46610687|NCT02544750|82703202|FG001|Overall Study|Adverse Event|10|||
46610688|NCT02544750|82703201|FG000|Overall Study|Withdrawal by Subject|10|||
46610689|NCT02544750|82703202|FG001|Overall Study|Withdrawal by Subject|4|||
46610690|NCT02544750|82703201|FG000|Overall Study|Lost to Follow-up|1|||
46610691|NCT02544750|82703202|FG001|Overall Study|Lost to Follow-up|0|||
46610692|NCT02540538|82703248|FG000|Overall Study|Pregnancy|0|||
46610693|NCT02540538|82703249|FG001|Overall Study|Pregnancy|1|||
46610694|NCT02540538|82703250|FG002|Overall Study|Pregnancy|0|||
46610695|NCT04697056|82703283|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
46892067|NCT03313050|83115874|FG002|Stage 2: 12 Months|Death|3|||
46892068|NCT03313050|83115875|FG003|Stage 2: 12 Months|Death|0|||
46892069|NCT03313050|83115872|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
46892070|NCT03313050|83115873|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
46892071|NCT03313050|83115874|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
46892072|NCT03313050|83115875|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
46892073|NCT03313050|83115872|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
46892074|NCT03313050|83115873|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
46892075|NCT03313050|83115874|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
46892076|NCT03313050|83115875|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
46892077|NCT03313050|83115872|FG000|Stage 2: 12 Months|Protocol deviation|0|||
46892078|NCT03313050|83115873|FG001|Stage 2: 12 Months|Protocol deviation|0|||
46892079|NCT03313050|83115874|FG002|Stage 2: 12 Months|Protocol deviation|7|||
46892080|NCT03313050|83115875|FG003|Stage 2: 12 Months|Protocol deviation|7|||
46892081|NCT03313050|83115872|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
46892082|NCT03313050|83115873|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
46892083|NCT03313050|83115874|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
46892084|NCT03313050|83115875|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
46892085|NCT03313050|83115872|FG000|Stage 2: 12 Months|Other|0|||
46892086|NCT03313050|83115873|FG001|Stage 2: 12 Months|Other|0|||
46892087|NCT03313050|83115874|FG002|Stage 2: 12 Months|Other|0|||
46892088|NCT03313050|83115875|FG003|Stage 2: 12 Months|Other|1|||
46892089|NCT04755595|83115894|FG000|Overall Study|Lost to Follow-up|1|||
46892090|NCT04749745|83115899|FG000|Overall Study|Withdrawal by Subject|1|||
46892091|NCT04749745|83115900|FG001|Overall Study|Withdrawal by Subject|0|||
46892092|NCT03257436|83115906|FG000|Overall Study|Withdrawal by Subject|76|||
46892093|NCT03257436|83115906|FG000|Overall Study|Death|19|||
46892094|NCT04748341|83115912|FG000|Overall Study|Lost to Follow-up|1|||
46892095|NCT04748341|83115913|FG001|Overall Study|Lost to Follow-up|1|||
46892096|NCT01328002|83115919|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
46892097|NCT01328002|83115920|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
46892098|NCT01328002|83115919|FG000|Open-Label Period|Adverse Event|8|||
46892099|NCT01328002|83115920|FG001|Open-Label Period|Adverse Event|0|||
46892100|NCT01328002|83115919|FG000|Open-Label Period|Lack of Efficacy|3|||
46892101|NCT01328002|83115920|FG001|Open-Label Period|Lack of Efficacy|0|||
46892102|NCT01328002|83115919|FG000|Open-Label Period|Protocol Violation|2|||
46892103|NCT01328002|83115920|FG001|Open-Label Period|Protocol Violation|0|||
46892104|NCT01328002|83115919|FG000|Open-Label Period|Withdrawal by Subject|9|||
46892105|NCT01328002|83115920|FG001|Open-Label Period|Withdrawal by Subject|0|||
46892106|NCT01328002|83115919|FG000|Open-Label Period|Lost to Follow-up|6|||
46892107|NCT01328002|83115920|FG001|Open-Label Period|Lost to Follow-up|0|||
46892108|NCT01328002|83115919|FG000|Open-Label Period|Other Reason|2|||
46892109|NCT01328002|83115920|FG001|Open-Label Period|Other Reason|0|||
46892110|NCT01328002|83115919|FG000|Double-Blind Period|Adverse Event|1|||
46892111|NCT01328002|83115920|FG001|Double-Blind Period|Adverse Event|0|||
46892112|NCT01328002|83115919|FG000|Double-Blind Period|Lack of Efficacy|1|||
46892113|NCT01328002|83115920|FG001|Double-Blind Period|Lack of Efficacy|0|||
46892114|NCT02579265|83115929|FG000|Overall Study|Weaned off earlier than 28 days|44|||
46892115|NCT02579265|83115930|FG001|Overall Study|Weaned off earlier than 28 days|43|||
46892116|NCT02579265|83115929|FG000|Overall Study|Adverse Event|2|||
46892117|NCT02579265|83115930|FG001|Overall Study|Adverse Event|0|||
46892118|NCT02579265|83115929|FG000|Overall Study|Any other reason not specified|0|||
46892119|NCT02579265|83115930|FG001|Overall Study|Any other reason not specified|2|||
46892120|NCT02579265|83115929|FG000|Overall Study|Withdrawal by Subject|2|||
46892121|NCT02579265|83115930|FG001|Overall Study|Withdrawal by Subject|0|||
46892122|NCT02579265|83115929|FG000|Overall Study|Physician Decision|1|||
46892123|NCT02579265|83115930|FG001|Overall Study|Physician Decision|0|||
46892124|NCT02579265|83115929|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
46892125|NCT02579265|83115930|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
46892126|NCT03289533|83115936|FG000|Overall Study|Death|12|||
46892127|NCT03289533|83115936|FG000|Overall Study|Terminated from study by sponsor|10|||
46892128|NCT04727749|83115942|FG000|Overall Study|Lost to Follow-up|10|||
46610696|NCT04697056|82703284|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
46610697|NCT02532972|82703422|FG000|Overall Study|Withdrawal by Subject|1|||
46610698|NCT03187834|82703475|FG000|Overall Study|Lost to Follow-up|0|||
46610699|NCT03187834|82703476|FG001|Overall Study|Lost to Follow-up|1|||
46610700|NCT03187834|82703477|FG002|Overall Study|Lost to Follow-up|2|||
46610701|NCT03187834|82703478|FG003|Overall Study|Lost to Follow-up|2|||
46610702|NCT03187834|82703475|FG000|Overall Study|Had invalid anthropometric measurements|5|||
46610703|NCT03187834|82703476|FG001|Overall Study|Had invalid anthropometric measurements|3|||
46610704|NCT03187834|82703477|FG002|Overall Study|Had invalid anthropometric measurements|4|||
46610705|NCT03187834|82703478|FG003|Overall Study|Had invalid anthropometric measurements|2|||
46610706|NCT03713944|82703631|FG000|Study Treatment|Patient non-compliance|1|||
46610707|NCT03713944|82703631|FG000|Study Treatment|Alternative Cancer Therapy|3|||
46610708|NCT03713944|82703631|FG000|Study Treatment|Disease Progression|18|||
46610709|NCT03713944|82703631|FG000|Study Treatment|AE/Side Effects/Complications|2|||
46610710|NCT03713944|82703631|FG000|Study Treatment|Death|2|||
46610711|NCT03713944|82703631|FG000|Study Treatment|Withdrawal by Subject|1|||
46610712|NCT03713944|82703631|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
46892129|NCT04727749|83115943|FG001|Overall Study|Lost to Follow-up|3|||
46892130|NCT04547023|83115953|FG000|Overall Study|Did Not Receive Intervention|3|||
46892131|NCT04547023|83115954|FG001|Overall Study|Did Not Receive Intervention|2|||
46892132|NCT04547023|83115953|FG000|Overall Study|Lost to Follow-up|1|||
46892133|NCT04547023|83115954|FG001|Overall Study|Lost to Follow-up|1|||
46892134|NCT03697993|83115964|FG000|Overall Study|Became Ineligible after Enrollment|1|||
46892135|NCT03697993|83115965|FG001|Overall Study|Became Ineligible after Enrollment|3|||
46892136|NCT03697993|83115964|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
46892137|NCT03697993|83115965|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
46892138|NCT03697993|83115964|FG000|Overall Study|Lost to Follow-up|3|||
46892139|NCT03697993|83115965|FG001|Overall Study|Lost to Follow-up|0|||
46892140|NCT03697993|83115964|FG000|Overall Study|Physician Decision|4|||
46892141|NCT03697993|83115965|FG001|Overall Study|Physician Decision|0|||
46892142|NCT03697993|83115964|FG000|Overall Study|Initial Urine Culture Negative|0|||
46892143|NCT03697993|83115965|FG001|Overall Study|Initial Urine Culture Negative|1|||
46892144|NCT03289455|83115975|FG000|Overall Study|Death|1|||
46892145|NCT03289455|83115976|FG001|Overall Study|Death|0|||
46892146|NCT03289455|83115977|FG002|Overall Study|Death|0|||
46892147|NCT03289455|83115975|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
46892148|NCT03289455|83115976|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
46892149|NCT03289455|83115977|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
46892150|NCT03289455|83115975|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
46892151|NCT03289455|83115976|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
46892152|NCT03289455|83115977|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
46892153|NCT03289455|83115975|FG000|Overall Study|Progressive disease|3|||
46892154|NCT03289455|83115976|FG001|Overall Study|Progressive disease|4|||
46892155|NCT03289455|83115977|FG002|Overall Study|Progressive disease|5|||
46892156|NCT04484857|83115986|FG000|Overall Study|Adverse Event|2|||
46892157|NCT04484857|83115986|FG000|Overall Study|Death|10|||
46892158|NCT04484857|83115986|FG000|Overall Study|Withdrawal by Subject|3|||
46892159|NCT04484857|83115986|FG000|Overall Study|Transferred/Relocation|5|||
46892160|NCT04484857|83115986|FG000|Overall Study|Kidney Transplant|7|||
46892161|NCT04484857|83115986|FG000|Overall Study|Other than specified|4|||
46892162|NCT04484857|83115986|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
46892163|NCT04095793|83115990|FG000|Overall Study|Adverse Event|3|||
46892164|NCT04095793|83115990|FG000|Overall Study|Study Terminated by Sponsor|103|||
46892165|NCT04095793|83115990|FG000|Overall Study|Withdrawal by Subject|4|||
46892166|NCT04482439|83115994|FG000|Overall Study|Lost to Follow-up|1|||
46892167|NCT04482439|83115994|FG000|Overall Study|Unrelated illness|1|||
46892168|NCT04535947|83116001|FG000|Overall Study|Adverse Event|1|||
46892169|NCT04535947|83116002|FG001|Overall Study|Adverse Event|4|||
46892170|NCT04535947|83116001|FG000|Overall Study|Other reasons not specified|2|||
46892171|NCT04535947|83116002|FG001|Overall Study|Other reasons not specified|0|||
46892172|NCT04535947|83116001|FG000|Overall Study|Withdrawal by Subject|1|||
46892173|NCT04535947|83116002|FG001|Overall Study|Withdrawal by Subject|1|||
46892174|NCT04474405|83116014|FG000|Overall Study|Withdrawal by Subject|0|||
46892175|NCT04474405|83116015|FG001|Overall Study|Withdrawal by Subject|0|||
46892176|NCT04474405|83116016|FG002|Overall Study|Withdrawal by Subject|1|||
46892177|NCT04474405|83116017|FG003|Overall Study|Withdrawal by Subject|0|||
46892178|NCT04474405|83116018|FG004|Overall Study|Withdrawal by Subject|1|||
46892179|NCT04474405|83116019|FG005|Overall Study|Withdrawal by Subject|0|||
46892180|NCT04474405|83116014|FG000|Overall Study|Other|0|||
46892181|NCT04474405|83116015|FG001|Overall Study|Other|0|||
46892182|NCT04474405|83116016|FG002|Overall Study|Other|0|||
46892183|NCT04474405|83116017|FG003|Overall Study|Other|0|||
46892184|NCT04474405|83116018|FG004|Overall Study|Other|3|||
46892185|NCT04474405|83116019|FG005|Overall Study|Other|0|||
46892186|NCT04531813|83116033|FG000|Overall Study|Protocol Violation|1|||
46892187|NCT04531813|83116033|FG000|Overall Study|Withdrawal by Subject|1|||
46892188|NCT03538444|83116039|FG000|Overall Study|opioid withdrawal|1|||
46892189|NCT03538444|83116040|FG001|Overall Study|opioid withdrawal|0|||
46892190|NCT01199302|83116050|FG000|Overall Study|Adverse Event|1|||
46892191|NCT01199302|83116051|FG001|Overall Study|Adverse Event|1|||
46892192|NCT01199302|83116052|FG002|Overall Study|Adverse Event|2|||
46892193|NCT01199302|83116053|FG003|Overall Study|Adverse Event|0|||
46892194|NCT01199302|83116050|FG000|Overall Study|Withdrawal by Subject|2|||
46892195|NCT01199302|83116051|FG001|Overall Study|Withdrawal by Subject|2|||
46892196|NCT01199302|83116052|FG002|Overall Study|Withdrawal by Subject|3|||
46892197|NCT01199302|83116053|FG003|Overall Study|Withdrawal by Subject|0|||
46892198|NCT01199302|83116050|FG000|Overall Study|Disease Progression|3|||
46892199|NCT01199302|83116051|FG001|Overall Study|Disease Progression|4|||
46892200|NCT01199302|83116052|FG002|Overall Study|Disease Progression|4|||
46892201|NCT01199302|83116053|FG003|Overall Study|Disease Progression|2|||
46892202|NCT01199302|83116050|FG000|Overall Study|Study Termination|13|||
46892203|NCT01199302|83116051|FG001|Overall Study|Study Termination|8|||
46892204|NCT01199302|83116052|FG002|Overall Study|Study Termination|11|||
46892205|NCT01199302|83116053|FG003|Overall Study|Study Termination|9|||
46892206|NCT01199302|83116050|FG000|Overall Study|Lost to Follow-up|0|||
46892207|NCT01199302|83116051|FG001|Overall Study|Lost to Follow-up|1|||
46892208|NCT01199302|83116052|FG002|Overall Study|Lost to Follow-up|0|||
46892209|NCT01199302|83116053|FG003|Overall Study|Lost to Follow-up|0|||
46892210|NCT01199302|83116050|FG000|Overall Study|Other|1|||
46892211|NCT01199302|83116051|FG001|Overall Study|Other|0|||
46892212|NCT01199302|83116052|FG002|Overall Study|Other|0|||
46892213|NCT01199302|83116053|FG003|Overall Study|Other|0|||
46892214|NCT03332784|83116080|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892215|NCT03332784|83116081|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
46892216|NCT03332784|83116082|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892217|NCT03332784|83116083|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892218|NCT03332784|83116084|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892219|NCT03332784|83116085|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892220|NCT03332784|83116086|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892221|NCT03332784|83116087|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892222|NCT03332784|83116088|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892223|NCT03332784|83116089|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892224|NCT03332784|83116090|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892225|NCT03332784|83116091|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892226|NCT03332784|83116092|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892227|NCT03332784|83116093|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892228|NCT03332784|83116094|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
46892229|NCT03332784|83116095|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892230|NCT03332784|83116096|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892231|NCT03332784|83116097|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892232|NCT03332784|83116098|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892233|NCT03332784|83116099|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
46892234|NCT04465357|83116163|FG000|Overall Study|Adverse Event|2|||
46892235|NCT04465357|83116163|FG000|Overall Study|Lack of Efficacy|1|||
46892236|NCT04465357|83116163|FG000|Overall Study|Lost to Follow-up|2|||
46892237|NCT04465357|83116163|FG000|Overall Study|Withdrawal by Subject|6|||
46892238|NCT04465357|83116163|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
46892239|NCT03332628|83116167|FG000|Overall Study|Physician Decision|2|||
46892240|NCT04516759|83116174|FG000|Overall Study|Withdrawal by Subject|1|||
46892241|NCT04516759|83116175|FG001|Overall Study|Withdrawal by Subject|1|||
46892242|NCT04516759|83116174|FG000|Overall Study|Other|0|||
46892243|NCT04516759|83116175|FG001|Overall Study|Other|1|||
46892244|NCT03332160|83116183|FG000|Overall Study|Withdrawal by Subject|1|||
46892245|NCT03332160|83116184|FG001|Overall Study|Withdrawal by Subject|1|||
46892246|NCT03332160|83116183|FG000|Overall Study|Adverse Event|0|||
46892247|NCT03332160|83116184|FG001|Overall Study|Adverse Event|1|||
46892248|NCT03332160|83116183|FG000|Overall Study|Developed Exclusion Criteria|0|||
46892249|NCT03332160|83116184|FG001|Overall Study|Developed Exclusion Criteria|1|||
46892250|NCT03332160|83116183|FG000|Overall Study|Non-adherence to treatment|0|||
46892251|NCT03332160|83116184|FG001|Overall Study|Non-adherence to treatment|2|||
46892252|NCT03312114|83116191|FG000|Overall Study|All the five enrolled dropped out of the|5|||
46892253|NCT03694327|83116198|FG000|Overall Study|Lost to Follow-up|13|||
46892254|NCT03694327|83116199|FG001|Overall Study|Lost to Follow-up|23|||
46892255|NCT03330288|83116207|FG000|Overall Study|Other reason|1|||
46892256|NCT03330288|83116208|FG001|Overall Study|Other reason|1|||
46892257|NCT03330288|83116207|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
46892258|NCT03330288|83116208|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
46892259|NCT03330288|83116207|FG000|Overall Study|Adverse Event|1|||
46892260|NCT03330288|83116208|FG001|Overall Study|Adverse Event|0|||
46892261|NCT03330288|83116207|FG000|Overall Study|Withdrawal by Subject|1|||
46892262|NCT03330288|83116208|FG001|Overall Study|Withdrawal by Subject|0|||
46892263|NCT03330288|83116207|FG000|Overall Study|Lost to Follow-up|26|||
46892264|NCT03330288|83116208|FG001|Overall Study|Lost to Follow-up|7|||
46892265|NCT03084536|83116217|FG000|Overall Study|Determined to be ineligible|0|||
46892266|NCT03084536|83116218|FG001|Overall Study|Determined to be ineligible|0|||
46892267|NCT03084536|83116219|FG002|Overall Study|Determined to be ineligible|16|||
46892268|NCT03084536|83116217|FG000|Overall Study|Withdrawal by Subject|0|||
46892269|NCT03084536|83116218|FG001|Overall Study|Withdrawal by Subject|0|||
46892270|NCT03084536|83116219|FG002|Overall Study|Withdrawal by Subject|4|||
46706696|NCT01208207|82921860|FG001|Part II|Protocol Violation|0|||
46706697|NCT01208207|82921861|FG002|Part II|Protocol Violation|0|||
46706698|NCT01208207|82921862|FG003|Part II|Protocol Violation|1|||
46706699|NCT01208207|82921863|FG004|Part II|Protocol Violation|0|||
46706700|NCT01208207|82921864|FG005|Part II|Protocol Violation|0|||
46706701|NCT01208207|82921865|FG006|Part II|Protocol Violation|0|||
46706702|NCT01208207|82921859|FG000|Part II|Technical Problems|0|||
46706703|NCT01208207|82921860|FG001|Part II|Technical Problems|0|||
46706704|NCT01208207|82921861|FG002|Part II|Technical Problems|0|||
46706705|NCT01208207|82921862|FG003|Part II|Technical Problems|1|||
46706706|NCT01208207|82921863|FG004|Part II|Technical Problems|0|||
46892271|NCT03084536|83116217|FG000|Overall Study|Physician Decision|0|||
46892272|NCT03084536|83116218|FG001|Overall Study|Physician Decision|0|||
46892273|NCT03084536|83116219|FG002|Overall Study|Physician Decision|3|||
46892274|NCT03084536|83116217|FG000|Overall Study|Death|0|||
46892275|NCT03084536|83116218|FG001|Overall Study|Death|0|||
46892276|NCT03084536|83116219|FG002|Overall Study|Death|1|||
46892277|NCT03084536|83116217|FG000|Overall Study|Lost to Follow-up|0|||
46892278|NCT03084536|83116218|FG001|Overall Study|Lost to Follow-up|0|||
46892279|NCT03084536|83116219|FG002|Overall Study|Lost to Follow-up|1|||
46892280|NCT03084536|83116217|FG000|Overall Study|Protocol Violation|0|||
46892281|NCT03084536|83116218|FG001|Overall Study|Protocol Violation|0|||
46892282|NCT03084536|83116219|FG002|Overall Study|Protocol Violation|1|||
46892283|NCT03084536|83116217|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
46892284|NCT03084536|83116218|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
46892285|NCT03084536|83116219|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
46892286|NCT05291936|83116226|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
46892287|NCT05291936|83116227|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
46892288|NCT05291936|83116226|FG000|Period 1|Withdrew Consent during study|1|||
46706707|NCT01208207|82921864|FG005|Part II|Technical Problems|1|||
46706708|NCT01208207|82921865|FG006|Part II|Technical Problems|0|||
46706709|NCT01012713|82921896|FG000|Overall Study|Lack of Efficacy|3|||
46706710|NCT01007253|82921901|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
46706711|NCT01007253|82921902|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
46706712|NCT01007253|82921903|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
46706713|NCT01007253|82921904|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
46706714|NCT01006707|82921914|FG000|Study Session 1|Lost to Follow-up|2|||
46706715|NCT01006707|82921915|FG001|Study Session 1|Lost to Follow-up|0|||
46706716|NCT01006707|82921916|FG002|Study Session 1|Lost to Follow-up|0|||
46706717|NCT01006707|82921914|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
46706718|NCT01006707|82921915|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
46706719|NCT01006707|82921916|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
46706720|NCT01006629|82921924|FG000|Overall Study|Adverse Event|1|||
46706721|NCT01006629|82921924|FG000|Overall Study|Parent refused to continue participation|1|||
46706722|NCT01006629|82921924|FG000|Overall Study|Parent unable to perform site visit|4|||
46706723|NCT01012323|82921928|FG000|Overall Study|Investigator Judgment|1|||
46706724|NCT01011933|82921932|FG000|Overall Study|Wrong cell type|1|||
46706725|NCT01011933|82921932|FG000|Overall Study|Improper pre-protocol Rx|1|||
46706726|NCT01011933|82921932|FG000|Overall Study|Inadequate pathology|1|||
46706727|NCT01011933|82921932|FG000|Overall Study|Never treated|1|||
46706728|NCT01011465|82921954|FG000|Overall Study|Withdrawal by Subject|2|||
46706729|NCT01011465|82921955|FG001|Overall Study|Withdrawal by Subject|1|||
46706730|NCT01011465|82921956|FG002|Overall Study|Withdrawal by Subject|0|||
46706731|NCT01011465|82921957|FG003|Overall Study|Withdrawal by Subject|0|||
46706732|NCT01011465|82921958|FG004|Overall Study|Withdrawal by Subject|1|||
46706733|NCT01011465|82921959|FG005|Overall Study|Withdrawal by Subject|0|||
46706734|NCT01011465|82921960|FG006|Overall Study|Withdrawal by Subject|1|||
46706735|NCT01011465|82921961|FG007|Overall Study|Withdrawal by Subject|0|||
46706736|NCT01011387|82921986|FG000|Overall Study|Withdrawal by Subject|3|||
46706737|NCT01011387|82921986|FG000|Overall Study|Adverse Event|2|||
46706738|NCT01011387|82921986|FG000|Overall Study|Protocol Violation|1|||
46706739|NCT01011309|82921993|FG000|Overall Study|Adverse Event|2|||
46706740|NCT01011309|82921994|FG001|Overall Study|Adverse Event|1|||
46706741|NCT01011309|82921995|FG002|Overall Study|Adverse Event|2|||
46706742|NCT01011309|82921993|FG000|Overall Study|Lack of Efficacy|0|||
46706743|NCT01011309|82921994|FG001|Overall Study|Lack of Efficacy|1|||
46706744|NCT01011309|82921995|FG002|Overall Study|Lack of Efficacy|0|||
46706745|NCT01011309|82921993|FG000|Overall Study|Protocol Violation|0|||
46706746|NCT01011309|82921994|FG001|Overall Study|Protocol Violation|1|||
46706747|NCT01011309|82921995|FG002|Overall Study|Protocol Violation|3|||
46706748|NCT01011153|82922006|FG000|Overall Study|Less than 78 cases completed|8|||
46706749|NCT01011153|82922007|FG001|Overall Study|Less than 78 cases completed|11|||
46706750|NCT01011153|82922008|FG002|Overall Study|Less than 78 cases completed|9|||
46706751|NCT00997893|82922040|FG000|Overall Study|Adverse Event|1|||
46706752|NCT00997893|82922041|FG001|Overall Study|Adverse Event|0|||
46706753|NCT00997893|82922042|FG002|Overall Study|Adverse Event|0|||
46706754|NCT00997893|82922040|FG000|Overall Study|Unable to meet study timelines|1|||
46706755|NCT00997893|82922041|FG001|Overall Study|Unable to meet study timelines|0|||
46706756|NCT00997893|82922042|FG002|Overall Study|Unable to meet study timelines|0|||
46706757|NCT00997893|82922040|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
46706758|NCT00997893|82922041|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
46706759|NCT00997893|82922042|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
46706760|NCT02905825|82922059|FG000|Overall Study|Protocol Violation|11|||
46706761|NCT02905825|82922059|FG000|Overall Study|Device Malfunction|1|||
46706762|NCT01208051|82922068|FG000|Total Enrollment|Withdrawal by Subject|0|||
46706763|NCT01208051|82922069|FG001|Total Enrollment|Withdrawal by Subject|1|||
46892289|NCT05291936|83116227|FG001|Period 1|Withdrew Consent during study|0|||
46892290|NCT05291936|83116226|FG000|Period 2|Adverse Event|0|||
46892291|NCT05291936|83116227|FG001|Period 2|Adverse Event|1|||
46892292|NCT05291936|83116226|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
46892293|NCT05291936|83116227|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
46892294|NCT03289143|83116237|FG000|Overall Study|Caregiver Unavailability|1|||
46892295|NCT03289143|83116238|FG001|Overall Study|Caregiver Unavailability|1|||
46892296|NCT03289143|83116239|FG002|Overall Study|Caregiver Unavailability|0|||
46892297|NCT03289143|83116240|FG003|Overall Study|Caregiver Unavailability|0|||
46892298|NCT03289143|83116237|FG000|Overall Study|Research Department Closure|0|||
46892299|NCT03289143|83116238|FG001|Overall Study|Research Department Closure|0|||
46892300|NCT03289143|83116239|FG002|Overall Study|Research Department Closure|1|||
46892301|NCT03289143|83116240|FG003|Overall Study|Research Department Closure|0|||
46892302|NCT03289143|83116237|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
46892303|NCT03289143|83116238|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
46892304|NCT03289143|83116239|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
46892305|NCT03289143|83116240|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
46892306|NCT03289143|83116237|FG000|Overall Study|Medical Monitor Decision|1|||
46892307|NCT03289143|83116238|FG001|Overall Study|Medical Monitor Decision|0|||
46892308|NCT03289143|83116239|FG002|Overall Study|Medical Monitor Decision|0|||
46892309|NCT03289143|83116240|FG003|Overall Study|Medical Monitor Decision|0|||
46892310|NCT03289143|83116237|FG000|Overall Study|Participant Non-Compliance|0|||
46892311|NCT03289143|83116238|FG001|Overall Study|Participant Non-Compliance|0|||
46892312|NCT03289143|83116239|FG002|Overall Study|Participant Non-Compliance|1|||
46892313|NCT03289143|83116240|FG003|Overall Study|Participant Non-Compliance|0|||
46892314|NCT03289143|83116237|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
46892315|NCT03289143|83116238|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
46892316|NCT03289143|83116239|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
46892317|NCT03289143|83116240|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
46892318|NCT03289143|83116237|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
46892319|NCT03289143|83116238|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
46892320|NCT03289143|83116239|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
46892321|NCT03289143|83116240|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
46892322|NCT03289143|83116237|FG000|Overall Study|Caregiver Passed Away|1|||
46892323|NCT03289143|83116238|FG001|Overall Study|Caregiver Passed Away|0|||
46892324|NCT03289143|83116239|FG002|Overall Study|Caregiver Passed Away|0|||
46892325|NCT03289143|83116240|FG003|Overall Study|Caregiver Passed Away|0|||
46892326|NCT03289143|83116237|FG000|Overall Study|Physician Decision|0|||
46892327|NCT03289143|83116238|FG001|Overall Study|Physician Decision|2|||
46892328|NCT03289143|83116239|FG002|Overall Study|Physician Decision|2|||
46892329|NCT03289143|83116240|FG003|Overall Study|Physician Decision|2|||
46892330|NCT03289143|83116237|FG000|Overall Study|Protocol Deviation|2|||
46892331|NCT03289143|83116238|FG001|Overall Study|Protocol Deviation|1|||
46892332|NCT03289143|83116239|FG002|Overall Study|Protocol Deviation|3|||
46892333|NCT03289143|83116240|FG003|Overall Study|Protocol Deviation|1|||
46892334|NCT03289143|83116237|FG000|Overall Study|Study Terminated By Sponsor|101|||
46892335|NCT03289143|83116238|FG001|Overall Study|Study Terminated By Sponsor|75|||
46892336|NCT03289143|83116239|FG002|Overall Study|Study Terminated By Sponsor|100|||
46892337|NCT03289143|83116240|FG003|Overall Study|Study Terminated By Sponsor|69|||
46892338|NCT03289143|83116237|FG000|Overall Study|Withdrawal by Subject|14|||
46892339|NCT03289143|83116238|FG001|Overall Study|Withdrawal by Subject|6|||
46892340|NCT03289143|83116239|FG002|Overall Study|Withdrawal by Subject|14|||
46892341|NCT03289143|83116240|FG003|Overall Study|Withdrawal by Subject|12|||
46892342|NCT03289143|83116237|FG000|Overall Study|Adverse Event|10|||
46892343|NCT03289143|83116238|FG001|Overall Study|Adverse Event|7|||
46892344|NCT03289143|83116239|FG002|Overall Study|Adverse Event|6|||
46892345|NCT03289143|83116240|FG003|Overall Study|Adverse Event|5|||
46892346|NCT03289143|83116237|FG000|Overall Study|Death|2|||
46892347|NCT03289143|83116238|FG001|Overall Study|Death|0|||
46892348|NCT03289143|83116239|FG002|Overall Study|Death|2|||
46892349|NCT03289143|83116240|FG003|Overall Study|Death|1|||
46892350|NCT03289143|83116237|FG000|Overall Study|Lost to Follow-up|2|||
46892351|NCT03289143|83116238|FG001|Overall Study|Lost to Follow-up|1|||
46892352|NCT03289143|83116239|FG002|Overall Study|Lost to Follow-up|1|||
46892353|NCT03289143|83116240|FG003|Overall Study|Lost to Follow-up|0|||
46892354|NCT03289143|83116237|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
46892355|NCT03289143|83116238|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
46892356|NCT03289143|83116239|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
46892357|NCT03289143|83116240|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
46892358|NCT03289143|83116237|FG000|Overall Study|Withdrawal by Caregiver|0|||
46892359|NCT03289143|83116238|FG001|Overall Study|Withdrawal by Caregiver|1|||
46892360|NCT03289143|83116239|FG002|Overall Study|Withdrawal by Caregiver|0|||
46892361|NCT03289143|83116240|FG003|Overall Study|Withdrawal by Caregiver|0|||
46892362|NCT03289143|83116237|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
46892363|NCT03289143|83116238|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
46892364|NCT03289143|83116239|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
46892365|NCT03289143|83116240|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
46892366|NCT03289143|83116237|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
46892367|NCT03289143|83116238|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
46892368|NCT03289143|83116239|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
46892369|NCT03289143|83116240|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
46892370|NCT03311724|83116259|FG000|Overall Study|Physician Decision|0|||
46892371|NCT03311724|83116260|FG001|Overall Study|Physician Decision|0|||
46892372|NCT03311724|83116261|FG002|Overall Study|Physician Decision|0|||
46892373|NCT03311724|83116262|FG003|Overall Study|Physician Decision|1|||
46892374|NCT03311724|83116259|FG000|Overall Study|Protocol Violation|1|||
46892375|NCT03311724|83116260|FG001|Overall Study|Protocol Violation|0|||
46892376|NCT03311724|83116261|FG002|Overall Study|Protocol Violation|1|||
46892377|NCT03311724|83116262|FG003|Overall Study|Protocol Violation|0|||
46892378|NCT03311724|83116259|FG000|Overall Study|Withdrawal by Subject|1|||
46892379|NCT03311724|83116260|FG001|Overall Study|Withdrawal by Subject|1|||
46892380|NCT03311724|83116261|FG002|Overall Study|Withdrawal by Subject|0|||
46892381|NCT03311724|83116262|FG003|Overall Study|Withdrawal by Subject|0|||
46892382|NCT03311724|83116259|FG000|Overall Study|Lost to Follow-up|1|||
46892383|NCT03311724|83116260|FG001|Overall Study|Lost to Follow-up|0|||
46892384|NCT03311724|83116261|FG002|Overall Study|Lost to Follow-up|0|||
46892385|NCT03311724|83116262|FG003|Overall Study|Lost to Follow-up|0|||
46892386|NCT03311724|83116259|FG000|Overall Study|Sponsor Decision|0|||
46892387|NCT03311724|83116260|FG001|Overall Study|Sponsor Decision|0|||
46892388|NCT03311724|83116261|FG002|Overall Study|Sponsor Decision|1|||
46892389|NCT03311724|83116262|FG003|Overall Study|Sponsor Decision|0|||
46892390|NCT03311646|83116284|FG000|Overall Study|Physician Decision|1|||
46892391|NCT03311646|83116284|FG000|Overall Study|Withdrawal by Subject|5|||
46892392|NCT03311646|83116284|FG000|Overall Study|Lost to Follow-up|5|||
46892393|NCT03311646|83116284|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
46892394|NCT01672892|83116291|FG000|Overall Study|Protocol Violation|7|||
46892395|NCT01672892|83116292|FG001|Overall Study|Protocol Violation|3|||
46892396|NCT03288987|83116303|FG000|Overall Study|Protocol Violation|10|||
46892397|NCT03288987|83116304|FG001|Overall Study|Protocol Violation|4|||
46892398|NCT02939781|83116310|FG000|Overall Study|Protocol Violation|8|||
46892399|NCT02939781|83116310|FG000|Overall Study|Withdrawal by Subject|1|||
46892400|NCT03083990|83116326|FG000|Overall Study|Adverse Event|1|||
46892401|NCT03083990|83116327|FG001|Overall Study|Adverse Event|0|||
46892402|NCT03252015|83116345|FG000|Overall Study|Withdrawal by Subject|0|||
46892403|NCT03252015|83116346|FG001|Overall Study|Withdrawal by Subject|1|||
46892404|NCT03252015|83116347|FG002|Overall Study|Withdrawal by Subject|1|||
46892405|NCT03252015|83116348|FG003|Overall Study|Withdrawal by Subject|0|||
46892406|NCT03252015|83116345|FG000|Overall Study|Adverse Event|1|||
46892407|NCT03252015|83116346|FG001|Overall Study|Adverse Event|0|||
46892408|NCT03252015|83116347|FG002|Overall Study|Adverse Event|0|||
46892409|NCT03252015|83116348|FG003|Overall Study|Adverse Event|1|||
46892410|NCT03083132|83116374|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
46892411|NCT03083132|83116375|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
46892412|NCT03083132|83116374|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
46892413|NCT03083132|83116375|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
46892414|NCT03083132|83116374|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
46892415|NCT03083132|83116375|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
46892416|NCT03683823|83116383|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
46892417|NCT03683823|83116384|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
46892418|NCT03683823|83116383|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
46892419|NCT03683823|83116384|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
46892420|NCT03683823|83116383|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
46892421|NCT03683823|83116384|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
46892422|NCT03285711|83116392|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
46892423|NCT03285711|83116393|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
46892424|NCT03285711|83116394|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
46892425|NCT03285711|83116395|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
46892426|NCT03285711|83116392|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
46892427|NCT03285711|83116393|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
46892428|NCT03285711|83116394|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
46892429|NCT03285711|83116395|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
46892430|NCT03285711|83116392|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
46892431|NCT03285711|83116393|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
46892432|NCT03285711|83116394|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
46892433|NCT03285711|83116395|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
46892434|NCT03285711|83116392|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
46892435|NCT03285711|83116393|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
46892436|NCT03285711|83116394|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
46892437|NCT03285711|83116395|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
46892438|NCT02927366|83116407|FG000|Overall Study|Adverse Event|1|||
46892439|NCT02927366|83116408|FG001|Overall Study|Adverse Event|0|||
46892440|NCT02927366|83116407|FG000|Overall Study|Patient schedule|1|||
46892441|NCT02927366|83116408|FG001|Overall Study|Patient schedule|0|||
46892442|NCT03249909|83116417|FG000|Overall Study|Withdrawal by Subject|3|||
46892443|NCT03249909|83116418|FG001|Overall Study|Withdrawal by Subject|0|||
46892444|NCT03249909|83116419|FG002|Overall Study|Withdrawal by Subject|0|||
46892445|NCT03249909|83116417|FG000|Overall Study|Adverse Event|3|||
46892446|NCT03249909|83116418|FG001|Overall Study|Adverse Event|0|||
46892447|NCT03249909|83116419|FG002|Overall Study|Adverse Event|0|||
46892448|NCT03249909|83116417|FG000|Overall Study|Lost to Follow-up|0|||
46892449|NCT03249909|83116418|FG001|Overall Study|Lost to Follow-up|1|||
46892450|NCT03249909|83116419|FG002|Overall Study|Lost to Follow-up|0|||
46892451|NCT03081884|83116430|FG000|Overall Study|deferred prostate cancer treatment|1|||
46892452|NCT03081884|83116430|FG000|Overall Study|metastasis managed with systemic therapy|3|||
46892453|NCT03077438|83116437|FG000|Overall Study|Protocol Violation|3|||
46892454|NCT03077438|83116438|FG001|Overall Study|Protocol Violation|5|||
46892455|NCT03077438|83116437|FG000|Overall Study|Withdrawal by Subject|3|||
46892456|NCT03077438|83116438|FG001|Overall Study|Withdrawal by Subject|6|||
46892457|NCT03077438|83116437|FG000|Overall Study|Lost to Follow-up|6|||
46892458|NCT03077438|83116438|FG001|Overall Study|Lost to Follow-up|3|||
46892459|NCT03076970|83116448|FG000|Washout Period 2|Adverse Event|0|||
46892460|NCT03076970|83116449|FG001|Washout Period 2|Adverse Event|0|||
46892461|NCT03076970|83116450|FG002|Washout Period 2|Adverse Event|0|||
46892462|NCT03076970|83116451|FG003|Washout Period 2|Adverse Event|0|||
46892463|NCT03076970|83116452|FG004|Washout Period 2|Adverse Event|1|||
46892464|NCT03076970|83116453|FG005|Washout Period 2|Adverse Event|0|||
46892465|NCT03076970|83116448|FG000|Period 3|Withdrawal by Subject|0|||
46892466|NCT03076970|83116449|FG001|Period 3|Withdrawal by Subject|0|||
46892467|NCT03076970|83116450|FG002|Period 3|Withdrawal by Subject|0|||
46892468|NCT03076970|83116451|FG003|Period 3|Withdrawal by Subject|0|||
46892469|NCT03076970|83116452|FG004|Period 3|Withdrawal by Subject|0|||
46892470|NCT03076970|83116453|FG005|Period 3|Withdrawal by Subject|1|||
46892471|NCT03076970|83116448|FG000|Period 3|Failure to meet I/E criteria|0|||
46892472|NCT03076970|83116449|FG001|Period 3|Failure to meet I/E criteria|0|||
46892473|NCT03076970|83116450|FG002|Period 3|Failure to meet I/E criteria|0|||
46892474|NCT03076970|83116451|FG003|Period 3|Failure to meet I/E criteria|0|||
46892475|NCT03076970|83116452|FG004|Period 3|Failure to meet I/E criteria|1|||
46892476|NCT03076970|83116453|FG005|Period 3|Failure to meet I/E criteria|0|||
46892477|NCT00726596|83116466|FG000|Overall Study|Adverse Event|2|||
46892478|NCT00726596|83116467|FG001|Overall Study|Adverse Event|1|||
46892479|NCT00726596|83116466|FG000|Overall Study|Withdrawal by Subject|3|||
46892480|NCT00726596|83116467|FG001|Overall Study|Withdrawal by Subject|3|||
46892481|NCT02890992|83116490|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
46892482|NCT02890992|83116491|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
46892483|NCT02890992|83116492|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
46892484|NCT02890992|83116493|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
46892485|NCT02890992|83116494|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
46892486|NCT02890992|83116495|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
46892487|NCT02890992|83116496|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
46892488|NCT02890992|83116497|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
46892489|NCT02890992|83116490|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
46892490|NCT02890992|83116491|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
46892491|NCT02890992|83116492|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
46892492|NCT02890992|83116493|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
46892493|NCT02890992|83116494|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
46892494|NCT02890992|83116495|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
46892495|NCT02890992|83116496|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
46892496|NCT02890992|83116497|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
46892497|NCT02890992|83116490|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
46892498|NCT02890992|83116491|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
46892499|NCT02890992|83116492|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
46892500|NCT02890992|83116493|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
46892501|NCT02890992|83116494|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
46892502|NCT02890992|83116495|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
46892503|NCT02890992|83116496|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
46892504|NCT02890992|83116497|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
46892505|NCT03076190|83116542|FG000|Overall Study|Lost to Follow-up|9|||
46892506|NCT03076190|83116543|FG001|Overall Study|Lost to Follow-up|34|||
46892507|NCT03076190|83116542|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
46892508|NCT03076190|83116543|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
46892509|NCT03328182|83116552|FG000|Overall Study|Withdrawal by Subject|1|||
46892510|NCT03328182|83116552|FG000|Overall Study|Protocol Violation|2|||
46892511|NCT03328182|83116552|FG000|Overall Study|No Product Evaluated|1|||
46892512|NCT03327402|83116556|FG000|Overall Study|Withdrawal by Subject|1|||
46892513|NCT03327402|83116556|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
46892514|NCT03075878|83116560|FG000|Overall Study|Physician Decision|1|||
46892515|NCT03326856|83116569|FG000|Overall Study|Lost to Follow-up|1|||
46892516|NCT03326856|83116570|FG001|Overall Study|Lost to Follow-up|1|||
46892517|NCT03326856|83116571|FG002|Overall Study|Lost to Follow-up|0|||
46892518|NCT03326856|83116572|FG003|Overall Study|Lost to Follow-up|0|||
46892519|NCT03326856|83116573|FG004|Overall Study|Lost to Follow-up|0|||
46892520|NCT03309696|83116587|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
46892521|NCT03309696|83116588|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
46892522|NCT03309696|83116589|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
46892523|NCT03309696|83116590|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
46892524|NCT03075644|83116604|FG000|Overall Study|Withdrawal by Subject|1|||
46892525|NCT03075644|83116605|FG001|Overall Study|Withdrawal by Subject|1|||
46892526|NCT03075410|83116621|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
46892527|NCT03075410|83116622|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
46892528|NCT03075410|83116623|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
46892529|NCT03075410|83116624|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
46892530|NCT03075410|83116625|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
46892531|NCT03075410|83116626|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
46892532|NCT03075410|83116627|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
46892533|NCT03075410|83116628|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
46892534|NCT03075410|83116629|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
46892535|NCT03075410|83116621|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
46892536|NCT03075410|83116622|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892537|NCT03075410|83116623|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892538|NCT03075410|83116624|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892539|NCT03075410|83116625|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892540|NCT03075410|83116626|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892541|NCT03075410|83116627|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892542|NCT03075410|83116628|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892543|NCT03075410|83116629|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
46892544|NCT03071276|83116671|FG000|Overall Study|Adverse Event|1|||
46892545|NCT03071276|83116671|FG000|Overall Study|Lack of Efficacy|14|||
46892546|NCT03074162|83116681|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
46892547|NCT03074162|83116682|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
46892548|NCT03074162|83116683|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
46892549|NCT03074162|83116684|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
46892550|NCT03074162|83116685|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
46892551|NCT03074162|83116686|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
46892552|NCT03074162|83116681|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
46892553|NCT03074162|83116682|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
46892554|NCT03074162|83116683|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
46892555|NCT03074162|83116684|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
46892556|NCT03074162|83116685|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
46892557|NCT03074162|83116686|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
46892558|NCT03074162|83116681|FG000|Period 3|Withdrawal by Subject|1|||
46892559|NCT03074162|83116682|FG001|Period 3|Withdrawal by Subject|0|||
46892560|NCT03074162|83116683|FG002|Period 3|Withdrawal by Subject|0|||
46892561|NCT03074162|83116684|FG003|Period 3|Withdrawal by Subject|0|||
46892562|NCT03074162|83116685|FG004|Period 3|Withdrawal by Subject|1|||
46892563|NCT03074162|83116686|FG005|Period 3|Withdrawal by Subject|0|||
46892564|NCT03070964|83116694|FG000|Overall Study|Progressive disease|8|||
46892565|NCT03070964|83116694|FG000|Overall Study|Treatment-unrelated adverse event|2|||
46892566|NCT03070964|83116694|FG000|Overall Study|Never treated|1|||
46892567|NCT03070964|83116694|FG000|Overall Study|Physician Decision|1|||
46892568|NCT03070964|83116694|FG000|Overall Study|Withdrawal by Subject|1|||
46892569|NCT03070964|83116694|FG000|Overall Study|Adverse Event|1|||
46892570|NCT02888106|83116704|FG000|Overall Study|Withdrawal by Subject|1|||
46892571|NCT02888106|83116705|FG001|Overall Study|Withdrawal by Subject|2|||
46892572|NCT02888106|83116706|FG002|Overall Study|Withdrawal by Subject|0|||
46892573|NCT02888106|83116707|FG003|Overall Study|Withdrawal by Subject|1|||
46892574|NCT02888106|83116708|FG004|Overall Study|Withdrawal by Subject|0|||
46892575|NCT02888106|83116709|FG005|Overall Study|Withdrawal by Subject|0|||
46892576|NCT02888106|83116704|FG000|Overall Study|Lost to Follow-up|1|||
46892577|NCT02888106|83116705|FG001|Overall Study|Lost to Follow-up|0|||
46892578|NCT02888106|83116706|FG002|Overall Study|Lost to Follow-up|0|||
46892579|NCT02888106|83116707|FG003|Overall Study|Lost to Follow-up|1|||
46892580|NCT02888106|83116708|FG004|Overall Study|Lost to Follow-up|0|||
46892581|NCT02888106|83116709|FG005|Overall Study|Lost to Follow-up|1|||
46892582|NCT02888106|83116704|FG000|Overall Study|Adverse Event|2|||
46892583|NCT02888106|83116705|FG001|Overall Study|Adverse Event|0|||
46892584|NCT02888106|83116706|FG002|Overall Study|Adverse Event|0|||
46892585|NCT02888106|83116707|FG003|Overall Study|Adverse Event|0|||
46892586|NCT02888106|83116708|FG004|Overall Study|Adverse Event|0|||
46892587|NCT02888106|83116709|FG005|Overall Study|Adverse Event|0|||
46892588|NCT02888106|83116704|FG000|Overall Study|Withdrawal of consent|0|||
46892589|NCT02888106|83116705|FG001|Overall Study|Withdrawal of consent|0|||
46892590|NCT02888106|83116706|FG002|Overall Study|Withdrawal of consent|0|||
46892591|NCT02888106|83116707|FG003|Overall Study|Withdrawal of consent|0|||
46892592|NCT02888106|83116708|FG004|Overall Study|Withdrawal of consent|1|||
46892593|NCT02888106|83116709|FG005|Overall Study|Withdrawal of consent|0|||
46892594|NCT02888106|83116704|FG000|Overall Study|Pregnancy|1|||
46892595|NCT02888106|83116705|FG001|Overall Study|Pregnancy|0|||
46892596|NCT02888106|83116706|FG002|Overall Study|Pregnancy|0|||
46892597|NCT02888106|83116707|FG003|Overall Study|Pregnancy|0|||
46892598|NCT02888106|83116708|FG004|Overall Study|Pregnancy|0|||
46892599|NCT02888106|83116709|FG005|Overall Study|Pregnancy|0|||
46892600|NCT03304626|83116731|FG000|Overall Study|Adverse Event|1|||
46892601|NCT03304626|83116732|FG001|Overall Study|Adverse Event|0|||
46892602|NCT03304626|83116731|FG000|Overall Study|Lack of Efficacy|1|||
46892603|NCT03304626|83116732|FG001|Overall Study|Lack of Efficacy|1|||
46892604|NCT03274986|83116741|FG000|Overall Study|Withdrawal by Subject|0|||
46892605|NCT03274986|83116742|FG001|Overall Study|Withdrawal by Subject|1|||
46892606|NCT03274986|83116741|FG000|Overall Study|Lost to Follow-up|0|||
46892607|NCT03274986|83116742|FG001|Overall Study|Lost to Follow-up|1|||
46892608|NCT02919306|83116757|FG000|Overall Study|Withdrawal by Subject|1|||
46892609|NCT02919306|83116758|FG001|Overall Study|Withdrawal by Subject|0|||
46892610|NCT02919306|83116757|FG000|Overall Study|Protocol Violation|1|||
46892611|NCT02919306|83116758|FG001|Overall Study|Protocol Violation|0|||
46892612|NCT03274440|83116764|FG000|Overall Study|Time commitment too great|1|||
46892613|NCT03274440|83116765|FG001|Overall Study|Time commitment too great|0|||
46892614|NCT03274440|83116766|FG002|Overall Study|Time commitment too great|0|||
46892615|NCT03274440|83116767|FG003|Overall Study|Time commitment too great|1|||
46892616|NCT03274440|83116768|FG004|Overall Study|Time commitment too great|0|||
46892617|NCT03274440|83116769|FG005|Overall Study|Time commitment too great|0|||
46892618|NCT03268746|83116777|FG000|Overall Study|Withdrawal by Subject|1|||
46892619|NCT03268590|83116788|FG000|Overall Study|Previously unknown exclusion criteria|1|||
46892620|NCT03267576|83116797|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
46892621|NCT03267576|83116798|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
46892622|NCT03267576|83116797|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
46892623|NCT03267576|83116798|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
46892624|NCT03267264|83116808|FG000|Overall Study|Withdrawal by Subject|1|||
46892625|NCT03267264|83116809|FG001|Overall Study|Withdrawal by Subject|0|||
46892626|NCT03267264|83116810|FG002|Overall Study|Withdrawal by Subject|2|||
46892627|NCT03267264|83116811|FG003|Overall Study|Withdrawal by Subject|4|||
46892628|NCT03244800|83116828|FG000|Overall Study|Adverse Event|0|||
46892629|NCT03244800|83116829|FG001|Overall Study|Adverse Event|1|||
46892630|NCT03244800|83116830|FG002|Overall Study|Adverse Event|0|||
46892631|NCT03244800|83116831|FG003|Overall Study|Adverse Event|1|||
46892632|NCT03244800|83116828|FG000|Overall Study|Withdrew treatment|0|||
46892633|NCT03244800|83116829|FG001|Overall Study|Withdrew treatment|0|||
46892634|NCT03244800|83116830|FG002|Overall Study|Withdrew treatment|0|||
46892635|NCT03244800|83116831|FG003|Overall Study|Withdrew treatment|1|||
46892636|NCT04516291|83116852|FG000|Treatment Period (24 Weeks)|Other|1|||
46892637|NCT04516291|83116853|FG001|Treatment Period (24 Weeks)|Other|0|||
46892638|NCT04516291|83116854|FG002|Treatment Period (24 Weeks)|Other|0|||
46892639|NCT04516291|83116855|FG003|Treatment Period (24 Weeks)|Other|2|||
46892640|NCT04516291|83116856|FG004|Treatment Period (24 Weeks)|Other|2|||
46892641|NCT04516291|83116857|FG005|Treatment Period (24 Weeks)|Other|4|||
46892642|NCT04516291|83116858|FG006|Treatment Period (24 Weeks)|Other|2|||
46892643|NCT04516291|83116859|FG007|Treatment Period (24 Weeks)|Other|0|||
46892644|NCT04516291|83116852|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46892645|NCT04516291|83116853|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
46892646|NCT04516291|83116854|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
46892647|NCT04516291|83116855|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46892648|NCT04516291|83116856|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
46892649|NCT04516291|83116857|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46892650|NCT04516291|83116858|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46892651|NCT04516291|83116859|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
46892652|NCT04516291|83116852|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
46892653|NCT04516291|83116853|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
46892654|NCT04516291|83116854|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
46892655|NCT04516291|83116855|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
46892656|NCT04516291|83116856|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
46892657|NCT04516291|83116857|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
46892658|NCT04516291|83116858|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
46892659|NCT04516291|83116859|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
46892660|NCT04516291|83116852|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46892661|NCT04516291|83116853|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
46892662|NCT04516291|83116854|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46892663|NCT04516291|83116855|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46892664|NCT04516291|83116856|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46892665|NCT04516291|83116857|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46892666|NCT04516291|83116858|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46892667|NCT04516291|83116859|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
46892668|NCT04516291|83116852|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
46892669|NCT04516291|83116853|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
46892670|NCT04516291|83116854|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
46892671|NCT04516291|83116855|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
46892672|NCT04516291|83116856|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
46892673|NCT04516291|83116857|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
46892674|NCT04516291|83116858|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
46892675|NCT04516291|83116859|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
46892676|NCT04516291|83116852|FG000|Follow-up Period (12 Weeks)|Other|0|||
46892677|NCT04516291|83116853|FG001|Follow-up Period (12 Weeks)|Other|1|||
46892678|NCT04516291|83116854|FG002|Follow-up Period (12 Weeks)|Other|0|||
46892679|NCT04516291|83116855|FG003|Follow-up Period (12 Weeks)|Other|2|||
46892680|NCT04516291|83116856|FG004|Follow-up Period (12 Weeks)|Other|0|||
46892681|NCT04516291|83116857|FG005|Follow-up Period (12 Weeks)|Other|0|||
46892682|NCT04516291|83116858|FG006|Follow-up Period (12 Weeks)|Other|0|||
46892683|NCT04516291|83116859|FG007|Follow-up Period (12 Weeks)|Other|0|||
46892684|NCT04516291|83116852|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46892685|NCT04516291|83116853|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46892686|NCT04516291|83116854|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46892687|NCT04516291|83116855|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46892688|NCT04516291|83116856|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
46892689|NCT04516291|83116857|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46892690|NCT04516291|83116858|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46892691|NCT04516291|83116859|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
46892692|NCT04516291|83116852|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
46892693|NCT04516291|83116853|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
46892694|NCT04516291|83116854|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
46892695|NCT04516291|83116855|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
46892696|NCT04516291|83116856|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
46892697|NCT04516291|83116857|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
46892698|NCT04516291|83116858|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
46892699|NCT04516291|83116859|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
46892700|NCT03243630|83116877|FG000|Overall Study|Protocol Violation|1|||
46892701|NCT03243630|83116877|FG000|Overall Study|Physician Decision|1|||
46892702|NCT04450381|83116885|FG000|Overall Study|Protocol Violation|4|||
46892703|NCT04450381|83116885|FG000|Overall Study|Wrong device setting|2|||
46892704|NCT03068468|83116891|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
46892705|NCT03068468|83116892|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
46892706|NCT03068468|83116893|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
46892707|NCT03068468|83116894|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
46892708|NCT03068468|83116891|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
46892709|NCT03068468|83116892|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
46892710|NCT03068468|83116893|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
46892711|NCT03068468|83116894|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
46892712|NCT03068468|83116891|FG000|Placebo-Controlled Period|Adverse Event|16|||
46892713|NCT03068468|83116892|FG001|Placebo-Controlled Period|Adverse Event|21|||
46892714|NCT03068468|83116893|FG002|Placebo-Controlled Period|Adverse Event|0|||
46892715|NCT03068468|83116894|FG003|Placebo-Controlled Period|Adverse Event|0|||
46892716|NCT03068468|83116891|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
46892717|NCT03068468|83116892|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
46892718|NCT03068468|83116893|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
46892719|NCT03068468|83116894|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
46892720|NCT03068468|83116891|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
46892721|NCT03068468|83116892|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
46892722|NCT03068468|83116893|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46892723|NCT03068468|83116894|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
46892724|NCT03068468|83116891|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
46892725|NCT03068468|83116892|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
46892726|NCT03068468|83116893|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
46892727|NCT03068468|83116894|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
46892728|NCT03068468|83116891|FG000|Placebo-Controlled Period|Death|0|||
46892729|NCT03068468|83116892|FG001|Placebo-Controlled Period|Death|1|||
46892730|NCT03068468|83116893|FG002|Placebo-Controlled Period|Death|0|||
46892731|NCT03068468|83116894|FG003|Placebo-Controlled Period|Death|0|||
46892732|NCT03068468|83116891|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
46892733|NCT03068468|83116892|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
46892734|NCT03068468|83116893|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
46892735|NCT03068468|83116894|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
46892736|NCT03068468|83116891|FG000|Open-Label Extension Period|Adverse Event|0|||
46892737|NCT03068468|83116892|FG001|Open-Label Extension Period|Adverse Event|0|||
46892738|NCT03068468|83116893|FG002|Open-Label Extension Period|Adverse Event|13|||
46892739|NCT03068468|83116894|FG003|Open-Label Extension Period|Adverse Event|17|||
46892740|NCT03068468|83116891|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
46892741|NCT03068468|83116892|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
46892742|NCT03068468|83116893|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
46892743|NCT03068468|83116894|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
46892744|NCT03068468|83116891|FG000|Open-Label Extension Period|Death|0|||
46892745|NCT03068468|83116892|FG001|Open-Label Extension Period|Death|0|||
46892746|NCT03068468|83116893|FG002|Open-Label Extension Period|Death|0|||
46892747|NCT03068468|83116894|FG003|Open-Label Extension Period|Death|1|||
46892748|NCT03068468|83116891|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
46892749|NCT03068468|83116892|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
46892750|NCT03068468|83116893|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
46892751|NCT03068468|83116894|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
46892752|NCT03068468|83116891|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
46892753|NCT03068468|83116892|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
46892754|NCT03068468|83116893|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
46892755|NCT03068468|83116894|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
46892756|NCT03068468|83116891|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
46892757|NCT03068468|83116892|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
46892758|NCT03068468|83116893|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
46892759|NCT03068468|83116894|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
46892760|NCT03068468|83116891|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
46892761|NCT03068468|83116892|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
46892762|NCT03068468|83116893|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
46892763|NCT03068468|83116894|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
46892764|NCT03068468|83116891|FG000|Open-Label Extension Period|Reason not Specified|0|||
46892765|NCT03068468|83116892|FG001|Open-Label Extension Period|Reason not Specified|0|||
46892766|NCT03068468|83116893|FG002|Open-Label Extension Period|Reason not Specified|1|||
46892767|NCT03068468|83116894|FG003|Open-Label Extension Period|Reason not Specified|4|||
46892768|NCT04512001|83116904|FG000|Week 0 to Week 24|Adverse Event|14|||
46892769|NCT04512001|83116905|FG001|Week 0 to Week 24|Adverse Event|10|||
46892770|NCT04512001|83116906|FG002|Week 0 to Week 24|Adverse Event|0|||
46892771|NCT04512001|83116907|FG003|Week 0 to Week 24|Adverse Event|0|||
46892772|NCT04512001|83116908|FG004|Week 0 to Week 24|Adverse Event|0|||
46892773|NCT04512001|83116904|FG000|Week 0 to Week 24|Death|0|||
46892774|NCT04512001|83116905|FG001|Week 0 to Week 24|Death|2|||
46892775|NCT04512001|83116906|FG002|Week 0 to Week 24|Death|0|||
46892776|NCT04512001|83116907|FG003|Week 0 to Week 24|Death|0|||
46892777|NCT04512001|83116908|FG004|Week 0 to Week 24|Death|0|||
46892778|NCT04512001|83116904|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
46892779|NCT04512001|83116905|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
46892780|NCT04512001|83116906|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
46892781|NCT04512001|83116907|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
46892782|NCT04512001|83116908|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
46892783|NCT04512001|83116904|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
46892784|NCT04512001|83116905|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
46892785|NCT04512001|83116906|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
46892786|NCT04512001|83116907|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
46892787|NCT04512001|83116908|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
46892788|NCT04512001|83116904|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
46892789|NCT04512001|83116905|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
46892790|NCT04512001|83116906|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
46892791|NCT04512001|83116907|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
46892792|NCT04512001|83116908|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
46892793|NCT04512001|83116904|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
46892794|NCT04512001|83116905|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
46610713|NCT03713944|82703631|FG000|Study Treatment|Symptomatic Deterioration|2|||
46610714|NCT03713944|82703631|FG000|Follow up|Withdrawal by Subject|2|||
46610715|NCT03713944|82703631|FG000|Follow up|Death|11|||
46892795|NCT04512001|83116906|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
46892796|NCT04512001|83116907|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
46892797|NCT04512001|83116908|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
46892798|NCT04512001|83116904|FG000|Week 24 to Week 63|Adverse Event|0|||
46892799|NCT04512001|83116905|FG001|Week 24 to Week 63|Adverse Event|0|||
46892800|NCT04512001|83116906|FG002|Week 24 to Week 63|Adverse Event|13|||
46892801|NCT04512001|83116907|FG003|Week 24 to Week 63|Adverse Event|8|||
46892802|NCT04512001|83116908|FG004|Week 24 to Week 63|Adverse Event|6|||
46892803|NCT04512001|83116904|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
46892804|NCT04512001|83116905|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
46892805|NCT04512001|83116906|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
46892806|NCT04512001|83116907|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
46892807|NCT04512001|83116908|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
46892808|NCT04512001|83116904|FG000|Week 24 to Week 63|Death|0|||
46892809|NCT04512001|83116905|FG001|Week 24 to Week 63|Death|0|||
46892810|NCT04512001|83116906|FG002|Week 24 to Week 63|Death|0|||
46892811|NCT04512001|83116907|FG003|Week 24 to Week 63|Death|1|||
46892812|NCT04512001|83116908|FG004|Week 24 to Week 63|Death|1|||
46892813|NCT04512001|83116904|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
46892814|NCT04512001|83116905|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
46892815|NCT04512001|83116906|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
46892816|NCT04512001|83116907|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
46892817|NCT04512001|83116908|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
46892818|NCT04512001|83116904|FG000|Week 24 to Week 63|Miscellaneous|0|||
46892819|NCT04512001|83116905|FG001|Week 24 to Week 63|Miscellaneous|0|||
46892820|NCT04512001|83116906|FG002|Week 24 to Week 63|Miscellaneous|3|||
46892821|NCT04512001|83116907|FG003|Week 24 to Week 63|Miscellaneous|2|||
46892822|NCT04512001|83116908|FG004|Week 24 to Week 63|Miscellaneous|1|||
46892823|NCT04447417|83116923|FG000|Overall Study|Withdrawal by Subject|1|||
46892824|NCT04447417|83116924|FG001|Overall Study|Withdrawal by Subject|0|||
46892825|NCT04447417|83116923|FG000|Overall Study|Failure to meet inclusion criteria|1|||
46892826|NCT04447417|83116924|FG001|Overall Study|Failure to meet inclusion criteria|0|||
46892827|NCT04447417|83116923|FG000|Overall Study|Lost to Follow-up|1|||
46892828|NCT04447417|83116924|FG001|Overall Study|Lost to Follow-up|0|||
46892829|NCT02787044|83116932|FG000|Overall Study|Lost to Follow-up|15|||
46892830|NCT02787044|83116933|FG001|Overall Study|Lost to Follow-up|19|||
46892831|NCT01345019|83116945|FG000|Blinded Treatment Phase|Death|147|||
46892832|NCT01345019|83116946|FG001|Blinded Treatment Phase|Death|137|||
46892833|NCT01345019|83116945|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
46892834|NCT01345019|83116946|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
46892835|NCT01345019|83116945|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
46892836|NCT01345019|83116946|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
46892837|NCT01345019|83116945|FG000|Blinded Treatment Phase|Disease Progression|12|||
46892838|NCT01345019|83116946|FG001|Blinded Treatment Phase|Disease Progression|10|||
46892839|NCT01345019|83116945|FG000|Blinded Treatment Phase|Adverse Event|6|||
46892840|NCT01345019|83116946|FG001|Blinded Treatment Phase|Adverse Event|13|||
46892841|NCT01345019|83116945|FG000|Blinded Treatment Phase|Administrative Decision|10|||
46892842|NCT01345019|83116946|FG001|Blinded Treatment Phase|Administrative Decision|8|||
46892843|NCT01345019|83116945|FG000|Blinded Treatment Phase|Noncompliance|5|||
46892844|NCT01345019|83116946|FG001|Blinded Treatment Phase|Noncompliance|3|||
46892845|NCT01345019|83116945|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
46892846|NCT01345019|83116946|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
46892847|NCT01345019|83116945|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
46892848|NCT01345019|83116946|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
46892849|NCT01345019|83116945|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
46892850|NCT01345019|83116946|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
46892851|NCT01345019|83116945|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
46892852|NCT01345019|83116946|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
46892853|NCT01345019|83116945|FG000|Open Label Treatment Phase|Death|49|||
46892854|NCT01345019|83116946|FG001|Open Label Treatment Phase|Death|48|||
46892855|NCT01345019|83116945|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
46892856|NCT01345019|83116946|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
46892857|NCT01345019|83116945|FG000|Open Label Treatment Phase|Adverse Event|30|||
46892858|NCT01345019|83116946|FG001|Open Label Treatment Phase|Adverse Event|51|||
46892859|NCT01345019|83116945|FG000|Open Label Treatment Phase|Administrative Decision|30|||
46892860|NCT01345019|83116946|FG001|Open Label Treatment Phase|Administrative Decision|15|||
46892861|NCT01345019|83116945|FG000|Open Label Treatment Phase|Disease Progression|17|||
46892862|NCT01345019|83116946|FG001|Open Label Treatment Phase|Disease Progression|18|||
46892863|NCT01345019|83116945|FG000|Open Label Treatment Phase|Noncompliance|5|||
46892864|NCT01345019|83116946|FG001|Open Label Treatment Phase|Noncompliance|4|||
46991726|NCT01657877|83238708|FG000|Overall Study|Withdrawal by Subject|4|||
46892865|NCT01345019|83116945|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
46892866|NCT01345019|83116946|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
46892867|NCT01345019|83116945|FG000|Open Label Treatment Phase|Pregnancy|1|||
46892868|NCT01345019|83116946|FG001|Open Label Treatment Phase|Pregnancy|0|||
46892869|NCT01345019|83116945|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
46892870|NCT01345019|83116946|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
46892871|NCT01345019|83116945|FG000|Open Label Treatment Phase|Protocol Violation|0|||
46892872|NCT01345019|83116946|FG001|Open Label Treatment Phase|Protocol Violation|1|||
46892873|NCT04507867|83116956|FG000|Overall Study|Death|7|||
46892874|NCT04507867|83116957|FG001|Overall Study|Death|1|||
46892875|NCT03069716|83116981|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
46892876|NCT03069716|83116982|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
46892877|NCT03069716|83116983|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
46892878|NCT03069716|83116981|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
46892879|NCT03069716|83116982|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
46892880|NCT03069716|83116983|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
46892881|NCT03069716|83116981|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
46892882|NCT03069716|83116982|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
46892883|NCT03069716|83116983|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
46892884|NCT03069716|83116981|FG000|Randomized Treatment|Withdrawal by Subject|0|||
46892885|NCT03069716|83116982|FG001|Randomized Treatment|Withdrawal by Subject|2|||
46892886|NCT03069716|83116983|FG002|Randomized Treatment|Withdrawal by Subject|0|||
46892887|NCT03693625|83116996|FG000|Overall Study|Adverse Event|2|||
46892888|NCT03693625|83116997|FG001|Overall Study|Adverse Event|0|||
46892889|NCT03693625|83116996|FG000|Overall Study|Study Terminated By Sponsor|20|||
46892890|NCT03693625|83116997|FG001|Overall Study|Study Terminated By Sponsor|7|||
46892891|NCT03693625|83116996|FG000|Overall Study|Withdrawal by Subject|1|||
46892892|NCT03693625|83116997|FG001|Overall Study|Withdrawal by Subject|1|||
46892893|NCT01265537|83117005|FG000|Overall Study|Adverse Event|2|||
46892894|NCT01265537|83117006|FG001|Overall Study|Adverse Event|1|||
46892895|NCT01265537|83117005|FG000|Overall Study|Physician Decision|0|||
46892896|NCT01265537|83117006|FG001|Overall Study|Physician Decision|1|||
46892897|NCT04396639|83117012|FG000|Overall Study|Withdrawal by Subject|1|||
46892898|NCT04396639|83117012|FG000|Overall Study|Other|1|||
46892899|NCT04432298|83117018|FG000|Overall Study|Other than specified|1|||
46892900|NCT04432298|83117019|FG001|Overall Study|Other than specified|0|||
46892901|NCT04432298|83117018|FG000|Overall Study|Lost to Follow-up|0|||
46892902|NCT04432298|83117019|FG001|Overall Study|Lost to Follow-up|1|||
46892903|NCT04432298|83117018|FG000|Overall Study|Death|3|||
46892904|NCT04432298|83117019|FG001|Overall Study|Death|2|||
46892905|NCT04432298|83117018|FG000|Overall Study|Withdrawal by Subject|2|||
46892906|NCT04432298|83117019|FG001|Overall Study|Withdrawal by Subject|0|||
46892907|NCT04167085|83117027|FG000|Baseline|Withdrawal by Subject|2|||
46892908|NCT04167085|83117028|FG001|Baseline|Withdrawal by Subject|1|||
46892909|NCT04167085|83117027|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
46892910|NCT04167085|83117028|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
46892911|NCT04162795|83117034|FG000|Overall Study|Other|16|||
46892912|NCT04162795|83117034|FG000|Overall Study|Screen failures|10|||
46892913|NCT03069482|83117040|FG000|Overall Study|Lost to Follow-up|0|||
46892914|NCT03069482|83117041|FG001|Overall Study|Lost to Follow-up|1|||
46892915|NCT03069482|83117040|FG000|Overall Study|Physician Decision|1|||
46892916|NCT03069482|83117041|FG001|Overall Study|Physician Decision|0|||
46892917|NCT03266172|83117053|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
46892918|NCT03266172|83117054|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
46892919|NCT03266172|83117055|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
46892920|NCT03266172|83117053|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
46892921|NCT03266172|83117054|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
46892922|NCT03266172|83117055|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
46892923|NCT03266172|83117053|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
46892924|NCT03266172|83117054|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
46892925|NCT03266172|83117055|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
46892926|NCT03266172|83117053|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
46892927|NCT03266172|83117054|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
46892928|NCT03266172|83117055|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
46892929|NCT03266172|83117053|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
46892930|NCT03266172|83117054|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
46892931|NCT03266172|83117055|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
46892932|NCT03266172|83117053|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
46892933|NCT03266172|83117054|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
46892934|NCT03266172|83117055|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
46892935|NCT04356937|83117107|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
46892936|NCT04356937|83117108|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
46892937|NCT03301740|83117120|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
46892938|NCT03301740|83117121|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
46892939|NCT03301740|83117120|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
46610716|NCT03713944|82703631|FG000|Follow up|Study Terminated|3|||
46892940|NCT03301740|83117121|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
46892941|NCT04355767|83117129|FG000|Overall Study|Withdrawal by Subject|2|||
46892942|NCT04355767|83117130|FG001|Overall Study|Withdrawal by Subject|2|||
46892943|NCT04355767|83117129|FG000|Overall Study|Death|5|||
46892944|NCT04355767|83117130|FG001|Overall Study|Death|1|||
46892945|NCT00882050|83117139|FG000|Overall Study|Physician Decision|1|||
46892946|NCT00882050|83117140|FG001|Overall Study|Physician Decision|0|||
46892947|NCT00882050|83117141|FG002|Overall Study|Physician Decision|0|||
46892948|NCT03266094|83117149|FG000|Overall Study|Lost to Follow-up|1|||
46892949|NCT03266094|83117149|FG000|Overall Study|Withdrawal by Subject|1|||
46892950|NCT04161079|83117155|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
46892951|NCT03243084|83117165|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
46892952|NCT03243084|83117166|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
46892953|NCT04353817|83117175|FG000|Overall Study|Adverse Event|0|||
46892954|NCT04353817|83117176|FG001|Overall Study|Adverse Event|1|||
46892955|NCT00159588|83117185|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
46892956|NCT00159588|83117186|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
46892957|NCT00159588|83117187|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
46892958|NCT03265938|83117198|FG000|Overall Study|Withdrawal by Subject|1|||
46892959|NCT03265938|83117198|FG000|Overall Study|Physician Decision|1|||
46892960|NCT03265938|83117198|FG000|Overall Study|friable mass|6|||
46892961|NCT04353037|83117207|FG000|Overall Study|Lost to Follow-up|0|||
46892962|NCT04353037|83117208|FG001|Overall Study|Lost to Follow-up|1|||
46892963|NCT04353037|83117209|FG002|Overall Study|Lost to Follow-up|2|||
46892964|NCT04353037|83117210|FG003|Overall Study|Lost to Follow-up|3|||
46892965|NCT04353037|83117207|FG000|Overall Study|Withdrawal by Subject|0|||
46892966|NCT04353037|83117208|FG001|Overall Study|Withdrawal by Subject|2|||
46892967|NCT04353037|83117209|FG002|Overall Study|Withdrawal by Subject|3|||
46892968|NCT04353037|83117210|FG003|Overall Study|Withdrawal by Subject|5|||
46892969|NCT04353037|83117207|FG000|Overall Study|Adverse Event|0|||
46892970|NCT04353037|83117208|FG001|Overall Study|Adverse Event|0|||
46892971|NCT04353037|83117209|FG002|Overall Study|Adverse Event|2|||
46892972|NCT04353037|83117210|FG003|Overall Study|Adverse Event|0|||
46892973|NCT04353037|83117207|FG000|Overall Study|Exposure Change|0|||
46892974|NCT04353037|83117208|FG001|Overall Study|Exposure Change|0|||
46892975|NCT04353037|83117209|FG002|Overall Study|Exposure Change|0|||
46892976|NCT04353037|83117210|FG003|Overall Study|Exposure Change|2|||
46892977|NCT04349917|83117224|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
46892978|NCT04349917|83117225|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
46892979|NCT04349917|83117224|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
46892980|NCT04349917|83117225|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
46892981|NCT04156399|83117232|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
46892982|NCT04156399|83117232|FG000|Overall Study|study suspension due to COVID pandemic|3|||
46892983|NCT03300570|83117238|FG000|Overall Study|Adverse Event|0|||
46892984|NCT03300570|83117239|FG001|Overall Study|Adverse Event|1|||
46892985|NCT03300570|83117238|FG000|Overall Study|Withdrawal by Subject|1|||
46892986|NCT03300570|83117239|FG001|Overall Study|Withdrawal by Subject|0|||
46892987|NCT03300570|83117238|FG000|Overall Study|Inadequate bowel prep|1|||
46892988|NCT03300570|83117239|FG001|Overall Study|Inadequate bowel prep|0|||
46892989|NCT04154605|83117248|FG000|Overall Study|Procedure Canceled|1|||
46892990|NCT04154605|83117249|FG001|Overall Study|Procedure Canceled|1|||
46892991|NCT04154605|83117248|FG000|Overall Study|Missed follow up|1|||
46892992|NCT04154605|83117249|FG001|Overall Study|Missed follow up|1|||
46892993|NCT04154605|83117248|FG000|Overall Study|Withdrawal by Subject|1|||
46892994|NCT04154605|83117249|FG001|Overall Study|Withdrawal by Subject|0|||
46892995|NCT03264456|83117255|FG000|Overall Study|Withdrawal by Subject|3|||
46892996|NCT03264456|83117255|FG000|Overall Study|Lost to Follow-up|1|||
46892997|NCT03853694|83117262|FG000|Overall Study|Protocol Violation|3|||
46892998|NCT03853694|83117263|FG001|Overall Study|Protocol Violation|5|||
46892999|NCT03853694|83117264|FG002|Overall Study|Protocol Violation|3|||
46893000|NCT03853694|83117262|FG000|Overall Study|Delivered early|0|||
46893001|NCT03853694|83117263|FG001|Overall Study|Delivered early|1|||
46893002|NCT03853694|83117264|FG002|Overall Study|Delivered early|0|||
46893003|NCT03853694|83117262|FG000|Overall Study|not suitable to proceed|0|||
46893004|NCT03853694|83117263|FG001|Overall Study|not suitable to proceed|1|||
46893005|NCT03853694|83117264|FG002|Overall Study|not suitable to proceed|0|||
46893006|NCT03853694|83117262|FG000|Overall Study|difficult surgery|0|||
46893007|NCT03853694|83117263|FG001|Overall Study|difficult surgery|0|||
46893008|NCT03853694|83117264|FG002|Overall Study|difficult surgery|1|||
46893009|NCT03853694|83117262|FG000|Overall Study|Lost to Follow-up|0|||
46893010|NCT03853694|83117263|FG001|Overall Study|Lost to Follow-up|1|||
46893011|NCT03853694|83117264|FG002|Overall Study|Lost to Follow-up|0|||
46893012|NCT03853694|83117262|FG000|Overall Study|Withdrawal by Subject|0|||
46893013|NCT03853694|83117263|FG001|Overall Study|Withdrawal by Subject|1|||
46893014|NCT03853694|83117264|FG002|Overall Study|Withdrawal by Subject|0|||
46893015|NCT04154293|83117275|FG000|Overall Study|Withdrawal by Subject|2|||
46991727|NCT01657877|83238708|FG000|Overall Study|Protocol Violation|6|||
46893016|NCT04154293|83117276|FG001|Overall Study|Withdrawal by Subject|3|||
46893017|NCT04154293|83117277|FG002|Overall Study|Withdrawal by Subject|1|||
46893018|NCT04154293|83117275|FG000|Overall Study|Physician Decision|0|||
46893019|NCT04154293|83117276|FG001|Overall Study|Physician Decision|0|||
46893020|NCT04154293|83117277|FG002|Overall Study|Physician Decision|1|||
46893021|NCT04342897|83117287|FG000|Overall Study|Death|7|||
46893022|NCT04342897|83117288|FG001|Overall Study|Death|4|||
46893023|NCT04342897|83117287|FG000|Overall Study|Lost to Follow-up|6|||
46893024|NCT04342897|83117288|FG001|Overall Study|Lost to Follow-up|6|||
46893025|NCT04342897|83117287|FG000|Overall Study|Withdrawal by Subject|1|||
46893026|NCT04342897|83117288|FG001|Overall Study|Withdrawal by Subject|2|||
46893027|NCT04340557|83117296|FG000|Overall Study|Transferred to ICU and/or death|1|||
46893028|NCT04340557|83117297|FG001|Overall Study|Transferred to ICU and/or death|2|||
46893029|NCT04382053|83117305|FG000|Overall Study|Death|6|||
46893030|NCT04382053|83117306|FG001|Overall Study|Death|8|||
46893031|NCT04382053|83117305|FG000|Overall Study|Lost to Follow-up|0|||
46893032|NCT04382053|83117306|FG001|Overall Study|Lost to Follow-up|2|||
46893033|NCT04382053|83117305|FG000|Overall Study|Protocol Deviation|1|||
46893034|NCT04382053|83117306|FG001|Overall Study|Protocol Deviation|2|||
46893035|NCT04382053|83117305|FG000|Overall Study|Withdrawal by Subject|2|||
46893036|NCT04382053|83117306|FG001|Overall Study|Withdrawal by Subject|1|||
46610717|NCT01572662|82703709|FG000|Overall Study|Withdrawal by Subject|1|||
46610718|NCT01572662|82703710|FG001|Overall Study|Withdrawal by Subject|0|||
46610719|NCT01572662|82703709|FG000|Overall Study|Physician Decision|0|||
46610720|NCT01572662|82703710|FG001|Overall Study|Physician Decision|1|||
46610721|NCT02325154|82703740|FG000|Overall Study|Physician Decision|1|||
46610722|NCT00493870|82703867|FG000|Overall Study|Lost to Follow-up|12|||
46610723|NCT00493870|82703868|FG001|Overall Study|Lost to Follow-up|15|||
46610724|NCT03951753|82704137|FG000|Overall Study|Adverse Event|1|||
46610725|NCT03951753|82704138|FG001|Overall Study|Adverse Event|0|||
46610726|NCT03951753|82704139|FG002|Overall Study|Adverse Event|3|||
46610727|NCT03951753|82704137|FG000|Overall Study|Withdrawal by Subject|3|||
46610728|NCT03951753|82704138|FG001|Overall Study|Withdrawal by Subject|1|||
46610729|NCT03951753|82704139|FG002|Overall Study|Withdrawal by Subject|0|||
46610730|NCT03951753|82704137|FG000|Overall Study|Lost to Follow-up|0|||
46610731|NCT03951753|82704138|FG001|Overall Study|Lost to Follow-up|0|||
46610732|NCT03951753|82704139|FG002|Overall Study|Lost to Follow-up|1|||
46610733|NCT03941964|82704149|FG000|Overall Study|Adverse Event|1|||
46610734|NCT03941964|82704150|FG001|Overall Study|Adverse Event|8|||
46610735|NCT03941964|82704149|FG000|Overall Study|Progressive disease|7|||
46610736|NCT03941964|82704150|FG001|Overall Study|Progressive disease|3|||
46610737|NCT03941964|82704149|FG000|Overall Study|Lack of Efficacy|0|||
46610738|NCT03941964|82704150|FG001|Overall Study|Lack of Efficacy|1|||
46610739|NCT03941964|82704149|FG000|Overall Study|Death|3|||
46610740|NCT03941964|82704150|FG001|Overall Study|Death|1|||
46610741|NCT03941964|82704149|FG000|Overall Study|Withdrew consent|1|||
46610742|NCT03941964|82704150|FG001|Overall Study|Withdrew consent|3|||
46610743|NCT03941964|82704149|FG000|Overall Study|Physician Decision|9|||
46610744|NCT03941964|82704150|FG001|Overall Study|Physician Decision|2|||
46610745|NCT03941964|82704149|FG000|Overall Study|Other, not specified|2|||
46610746|NCT03941964|82704150|FG001|Overall Study|Other, not specified|1|||
46610747|NCT03837509|82704171|FG000|Phase 1|Death|5|||
46610748|NCT03837509|82704172|FG001|Phase 1|Death|2|||
46610749|NCT03837509|82704173|FG002|Phase 1|Death|0|||
46610750|NCT03837509|82704174|FG003|Phase 1|Death|0|||
46610751|NCT03837509|82704175|FG004|Phase 1|Death|0|||
46610752|NCT03837509|82704171|FG000|Phase 2|Death|0|||
46610753|NCT03837509|82704172|FG001|Phase 2|Death|0|||
46610754|NCT03837509|82704173|FG002|Phase 2|Death|0|||
46610755|NCT03837509|82704174|FG003|Phase 2|Death|1|||
46610756|NCT03837509|82704175|FG004|Phase 2|Death|1|||
46610757|NCT03822117|82704195|FG000|Overall Study|Death|18|||
46610758|NCT03822117|82704196|FG001|Overall Study|Death|17|||
46610759|NCT03822117|82704197|FG002|Overall Study|Death|12|||
46610760|NCT03822117|82704198|FG003|Overall Study|Death|4|||
46610761|NCT03822117|82704195|FG000|Overall Study|Lost to Follow-up|1|||
46610762|NCT03822117|82704196|FG001|Overall Study|Lost to Follow-up|2|||
46610763|NCT03822117|82704197|FG002|Overall Study|Lost to Follow-up|3|||
46610764|NCT03822117|82704198|FG003|Overall Study|Lost to Follow-up|0|||
46610765|NCT03822117|82704195|FG000|Overall Study|Study Terminated by Sponsor|25|||
46610766|NCT03822117|82704196|FG001|Overall Study|Study Terminated by Sponsor|11|||
46893037|NCT03066830|83117315|FG000|Overall Study|At the Participant's own Request|16|||
46610767|NCT03822117|82704197|FG002|Overall Study|Study Terminated by Sponsor|6|||
46610768|NCT03822117|82704198|FG003|Overall Study|Study Terminated by Sponsor|0|||
46610769|NCT03822117|82704195|FG000|Overall Study|Withdrawal by Subject|4|||
46610770|NCT03822117|82704196|FG001|Overall Study|Withdrawal by Subject|0|||
46610771|NCT03822117|82704197|FG002|Overall Study|Withdrawal by Subject|3|||
46610772|NCT03822117|82704198|FG003|Overall Study|Withdrawal by Subject|0|||
46610773|NCT03822117|82704195|FG000|Overall Study|Disease Progression|1|||
46610774|NCT03822117|82704196|FG001|Overall Study|Disease Progression|2|||
46893038|NCT03066830|83117316|FG001|Overall Study|At the Participant's own Request|17|||
46610775|NCT03822117|82704197|FG002|Overall Study|Disease Progression|1|||
46610776|NCT03822117|82704198|FG003|Overall Study|Disease Progression|0|||
46610777|NCT03822117|82704195|FG000|Overall Study|Never Returned to Hospital|0|||
46610778|NCT03822117|82704196|FG001|Overall Study|Never Returned to Hospital|0|||
46610779|NCT03822117|82704197|FG002|Overall Study|Never Returned to Hospital|1|||
46610780|NCT03822117|82704198|FG003|Overall Study|Never Returned to Hospital|0|||
46610781|NCT03497897|82704212|FG000|Overall Study|Adverse Event|1|||
46610782|NCT03497897|82704213|FG001|Overall Study|Adverse Event|1|||
46610783|NCT03497897|82704214|FG002|Overall Study|Adverse Event|1|||
46610784|NCT03497897|82704212|FG000|Overall Study|Lost to Follow-up|2|||
46610785|NCT03497897|82704213|FG001|Overall Study|Lost to Follow-up|0|||
46610786|NCT03497897|82704214|FG002|Overall Study|Lost to Follow-up|2|||
46610787|NCT03497897|82704212|FG000|Overall Study|Physician Decision|1|||
46610788|NCT03497897|82704213|FG001|Overall Study|Physician Decision|0|||
46610789|NCT03497897|82704214|FG002|Overall Study|Physician Decision|0|||
46610790|NCT03497897|82704212|FG000|Overall Study|Subject/Guardian Decision|2|||
46610791|NCT03497897|82704213|FG001|Overall Study|Subject/Guardian Decision|1|||
46610792|NCT03497897|82704214|FG002|Overall Study|Subject/Guardian Decision|3|||
46610793|NCT03428217|82704225|FG000|Overall Study|Death|89|||
46610794|NCT03428217|82704226|FG001|Overall Study|Death|93|||
46610795|NCT03428217|82704225|FG000|Overall Study|Withdrawal by Subject|8|||
46610796|NCT03428217|82704226|FG001|Overall Study|Withdrawal by Subject|7|||
46610797|NCT03428217|82704225|FG000|Overall Study|Lost to Follow-up|1|||
46610798|NCT03428217|82704226|FG001|Overall Study|Lost to Follow-up|3|||
46610799|NCT03428217|82704225|FG000|Overall Study|Study terminated by sponsor|124|||
46610800|NCT03428217|82704226|FG001|Overall Study|Study terminated by sponsor|118|||
46610801|NCT03428217|82704225|FG000|Overall Study|Other, Not Specified|1|||
46610802|NCT03428217|82704226|FG001|Overall Study|Other, Not Specified|0|||
46610803|NCT03189719|82704236|FG000|Overall Study|Death|260|||
46610804|NCT03189719|82704237|FG001|Overall Study|Death|308|||
46610805|NCT03189719|82704236|FG000|Overall Study|Withdrawal by Subject|5|||
46610806|NCT03189719|82704237|FG001|Overall Study|Withdrawal by Subject|3|||
46610807|NCT03189719|82704236|FG000|Overall Study|Ongoing in Study|108|||
46610808|NCT03189719|82704237|FG001|Overall Study|Ongoing in Study|65|||
46610809|NCT02969525|82704248|FG000|Double-Blind Period|Adverse Event|0|||
46610810|NCT02969525|82704249|FG001|Double-Blind Period|Adverse Event|0|||
46610811|NCT02969525|82704250|FG002|Double-Blind Period|Adverse Event|1|||
46610812|NCT02969525|82704251|FG003|Double-Blind Period|Adverse Event|1|||
46610813|NCT02969525|82704252|FG004|Double-Blind Period|Adverse Event|0|||
46610814|NCT02969525|82704253|FG005|Double-Blind Period|Adverse Event|0|||
46610815|NCT02969525|82704254|FG006|Double-Blind Period|Adverse Event|0|||
46610816|NCT02969525|82704255|FG007|Double-Blind Period|Adverse Event|0|||
46610817|NCT02969525|82704256|FG008|Double-Blind Period|Adverse Event|0|||
46610818|NCT02969525|82704257|FG009|Double-Blind Period|Adverse Event|0|||
46610819|NCT02969525|82704258|FG010|Double-Blind Period|Adverse Event|0|||
46610820|NCT02969525|82704259|FG011|Double-Blind Period|Adverse Event|0|||
46610821|NCT02969525|82704248|FG000|Double-Blind Period|LOW EGFR|0|||
46610822|NCT02969525|82704249|FG001|Double-Blind Period|LOW EGFR|0|||
46610823|NCT02969525|82704250|FG002|Double-Blind Period|LOW EGFR|0|||
46610824|NCT02969525|82704251|FG003|Double-Blind Period|LOW EGFR|1|||
46610825|NCT02969525|82704252|FG004|Double-Blind Period|LOW EGFR|0|||
46610826|NCT02969525|82704253|FG005|Double-Blind Period|LOW EGFR|0|||
46610827|NCT02969525|82704254|FG006|Double-Blind Period|LOW EGFR|0|||
46610828|NCT02969525|82704255|FG007|Double-Blind Period|LOW EGFR|0|||
46610829|NCT02969525|82704256|FG008|Double-Blind Period|LOW EGFR|0|||
46610830|NCT02969525|82704257|FG009|Double-Blind Period|LOW EGFR|0|||
46610831|NCT02969525|82704258|FG010|Double-Blind Period|LOW EGFR|0|||
46610832|NCT02969525|82704259|FG011|Double-Blind Period|LOW EGFR|0|||
46610833|NCT02969525|82704248|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
46610834|NCT02969525|82704249|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610835|NCT02969525|82704250|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610836|NCT02969525|82704251|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
46610837|NCT02969525|82704252|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610838|NCT02969525|82704253|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610839|NCT02969525|82704254|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610840|NCT02969525|82704255|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610841|NCT02969525|82704256|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610842|NCT02969525|82704257|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610843|NCT02969525|82704258|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610844|NCT02969525|82704259|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
46610845|NCT02969525|82704248|FG000|Dose-Blind Period|Adverse Event|0|||
46610846|NCT02969525|82704249|FG001|Dose-Blind Period|Adverse Event|0|||
46610847|NCT02969525|82704250|FG002|Dose-Blind Period|Adverse Event|0|||
46610848|NCT02969525|82704251|FG003|Dose-Blind Period|Adverse Event|0|||
46610849|NCT02969525|82704252|FG004|Dose-Blind Period|Adverse Event|0|||
46610850|NCT02969525|82704253|FG005|Dose-Blind Period|Adverse Event|0|||
46610851|NCT02969525|82704254|FG006|Dose-Blind Period|Adverse Event|0|||
46610852|NCT02969525|82704255|FG007|Dose-Blind Period|Adverse Event|0|||
46610853|NCT02969525|82704256|FG008|Dose-Blind Period|Adverse Event|0|||
46610854|NCT02969525|82704257|FG009|Dose-Blind Period|Adverse Event|1|||
46610855|NCT02969525|82704258|FG010|Dose-Blind Period|Adverse Event|1|||
46610856|NCT02969525|82704259|FG011|Dose-Blind Period|Adverse Event|1|||
46610857|NCT02969525|82704248|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
46610858|NCT02969525|82704249|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
46610859|NCT02969525|82704250|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
46610860|NCT02969525|82704251|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
46610861|NCT02969525|82704252|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
46610862|NCT02969525|82704253|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
46610863|NCT02969525|82704254|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
46610864|NCT02969525|82704255|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
46610865|NCT02969525|82704256|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
46610866|NCT02969525|82704257|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
46610867|NCT02969525|82704258|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
46610868|NCT02969525|82704259|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
46610869|NCT02969525|82704248|FG000|Dose-Blind Period|Non-cooperating patient|0|||
46610870|NCT02969525|82704249|FG001|Dose-Blind Period|Non-cooperating patient|0|||
46610871|NCT02969525|82704250|FG002|Dose-Blind Period|Non-cooperating patient|0|||
46610872|NCT02969525|82704251|FG003|Dose-Blind Period|Non-cooperating patient|0|||
46610873|NCT02969525|82704252|FG004|Dose-Blind Period|Non-cooperating patient|0|||
46610874|NCT02969525|82704253|FG005|Dose-Blind Period|Non-cooperating patient|0|||
46610875|NCT02969525|82704254|FG006|Dose-Blind Period|Non-cooperating patient|0|||
46610876|NCT02969525|82704255|FG007|Dose-Blind Period|Non-cooperating patient|0|||
46610877|NCT02969525|82704256|FG008|Dose-Blind Period|Non-cooperating patient|0|||
46610878|NCT02969525|82704257|FG009|Dose-Blind Period|Non-cooperating patient|0|||
46610879|NCT02969525|82704258|FG010|Dose-Blind Period|Non-cooperating patient|0|||
46610880|NCT02969525|82704259|FG011|Dose-Blind Period|Non-cooperating patient|1|||
46610881|NCT02969525|82704248|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610882|NCT02969525|82704249|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610883|NCT02969525|82704250|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610884|NCT02969525|82704251|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610885|NCT02969525|82704252|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610886|NCT02969525|82704253|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610887|NCT02969525|82704254|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610888|NCT02969525|82704255|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610889|NCT02969525|82704256|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610890|NCT02969525|82704257|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610891|NCT02969525|82704258|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
46610892|NCT02969525|82704259|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
46610893|NCT04232215|82704290|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
46610894|NCT04232215|82704291|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
46610895|NCT02399813|82704306|FG000|Overall Study|Progressive Disease-Radiographic|2|||
46610896|NCT02399813|82704306|FG000|Overall Study|Death|20|||
46610897|NCT02399813|82704306|FG000|Overall Study|Withdrawal by Subject|3|||
46610898|NCT02399813|82704306|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
46610899|NCT02399813|82704306|FG000|Overall Study|Lost to Follow-up|2|||
46610900|NCT02399813|82704306|FG000|Overall Study|Other than specified|5|||
46610901|NCT02291055|82704315|FG000|Overall Study|Death|2|||
46610902|NCT02291055|82704316|FG001|Overall Study|Death|2|||
46610903|NCT02291055|82704317|FG002|Overall Study|Death|5|||
46610904|NCT02291055|82704318|FG003|Overall Study|Death|8|||
46610905|NCT02291055|82704319|FG004|Overall Study|Death|12|||
46610906|NCT02291055|82704315|FG000|Overall Study|Lost to Follow-up|0|||
46610907|NCT02291055|82704316|FG001|Overall Study|Lost to Follow-up|0|||
46610908|NCT02291055|82704317|FG002|Overall Study|Lost to Follow-up|0|||
46610909|NCT02291055|82704318|FG003|Overall Study|Lost to Follow-up|1|||
46610910|NCT02291055|82704319|FG004|Overall Study|Lost to Follow-up|2|||
46610911|NCT02291055|82704315|FG000|Overall Study|Withdrawal by Subject|3|||
46610912|NCT02291055|82704316|FG001|Overall Study|Withdrawal by Subject|1|||
46610913|NCT02291055|82704317|FG002|Overall Study|Withdrawal by Subject|1|||
46610914|NCT02291055|82704318|FG003|Overall Study|Withdrawal by Subject|5|||
46610915|NCT02291055|82704319|FG004|Overall Study|Withdrawal by Subject|10|||
46610916|NCT02291055|82704315|FG000|Overall Study|Progressive Disease|0|||
46610917|NCT02291055|82704316|FG001|Overall Study|Progressive Disease|0|||
46610918|NCT02291055|82704317|FG002|Overall Study|Progressive Disease|1|||
46610919|NCT02291055|82704318|FG003|Overall Study|Progressive Disease|4|||
46610920|NCT02291055|82704319|FG004|Overall Study|Progressive Disease|2|||
46610921|NCT02291055|82704315|FG000|Overall Study|Study Terminated by Sponsor|0|||
46610922|NCT02291055|82704316|FG001|Overall Study|Study Terminated by Sponsor|0|||
46610923|NCT02291055|82704317|FG002|Overall Study|Study Terminated by Sponsor|0|||
46610924|NCT02291055|82704318|FG003|Overall Study|Study Terminated by Sponsor|5|||
46610925|NCT02291055|82704319|FG004|Overall Study|Study Terminated by Sponsor|1|||
46610926|NCT02291055|82704315|FG000|Overall Study|Other|0|||
46610927|NCT02291055|82704316|FG001|Overall Study|Other|2|||
46610928|NCT02291055|82704317|FG002|Overall Study|Other|1|||
46610929|NCT02291055|82704318|FG003|Overall Study|Other|4|||
46610930|NCT02291055|82704319|FG004|Overall Study|Other|0|||
46610931|NCT00723697|82704335|FG000|Overall Study|Physician questionnaires not received|2|||
46610932|NCT00723697|82704335|FG000|Overall Study|Missing Informed Consent Form|10|||
46610933|NCT00723697|82704335|FG000|Overall Study|Other exclusion criteria applied|6|||
46610934|NCT00684073|82704342|FG000|Selection|Selection/non-selection criteria|3|||
46610935|NCT00684073|82704342|FG000|Selection|Death|1|||
46610936|NCT00684073|82704342|FG000|Selection|noncompliance|1|||
46610937|NCT00684073|82704342|FG000|Selection|Lost to Follow-up|1|||
46610938|NCT00684073|82704342|FG000|Selection|request of the sponsor|1|||
46610939|NCT00684073|82704342|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
46610940|NCT02539368|82706283|FG000|Overall Study|Death|4|||
46610941|NCT02539368|82706284|FG001|Overall Study|Death|2|||
46610942|NCT02539368|82706285|FG002|Overall Study|Death|1|||
46610943|NCT02539368|82706286|FG003|Overall Study|Death|0|||
46610944|NCT02539368|82706287|FG004|Overall Study|Death|0|||
46610945|NCT02539368|82706283|FG000|Overall Study|Withdrawal by Subject|44|||
46610946|NCT02539368|82706284|FG001|Overall Study|Withdrawal by Subject|35|||
46610947|NCT02539368|82706285|FG002|Overall Study|Withdrawal by Subject|9|||
46610948|NCT02539368|82706286|FG003|Overall Study|Withdrawal by Subject|1|||
46610949|NCT02539368|82706287|FG004|Overall Study|Withdrawal by Subject|3|||
46610950|NCT02539368|82706283|FG000|Overall Study|Physician Decision|49|||
46610951|NCT02539368|82706284|FG001|Overall Study|Physician Decision|15|||
46610952|NCT02539368|82706285|FG002|Overall Study|Physician Decision|7|||
46610953|NCT02539368|82706286|FG003|Overall Study|Physician Decision|0|||
46610954|NCT02539368|82706287|FG004|Overall Study|Physician Decision|2|||
46610955|NCT02539368|82706283|FG000|Overall Study|Lost to Follow-up|96|||
46610956|NCT02539368|82706284|FG001|Overall Study|Lost to Follow-up|21|||
46610957|NCT02539368|82706285|FG002|Overall Study|Lost to Follow-up|16|||
46610958|NCT02539368|82706286|FG003|Overall Study|Lost to Follow-up|4|||
46610959|NCT02539368|82706287|FG004|Overall Study|Lost to Follow-up|3|||
46610960|NCT02539368|82706283|FG000|Overall Study|Adverse Event|44|||
46610961|NCT02539368|82706284|FG001|Overall Study|Adverse Event|5|||
46610962|NCT02539368|82706285|FG002|Overall Study|Adverse Event|9|||
46610963|NCT02539368|82706286|FG003|Overall Study|Adverse Event|0|||
46610964|NCT02539368|82706287|FG004|Overall Study|Adverse Event|3|||
46610965|NCT02539368|82706283|FG000|Overall Study|Participant Non-compliant|13|||
46610966|NCT02539368|82706284|FG001|Overall Study|Participant Non-compliant|2|||
46610967|NCT02539368|82706285|FG002|Overall Study|Participant Non-compliant|1|||
46610968|NCT02539368|82706286|FG003|Overall Study|Participant Non-compliant|1|||
46610969|NCT02539368|82706287|FG004|Overall Study|Participant Non-compliant|0|||
46610970|NCT02539368|82706283|FG000|Overall Study|Other|145|||
46610971|NCT02539368|82706284|FG001|Overall Study|Other|18|||
46610972|NCT02539368|82706285|FG002|Overall Study|Other|24|||
46610973|NCT02539368|82706286|FG003|Overall Study|Other|1|||
46610974|NCT02539368|82706287|FG004|Overall Study|Other|3|||
46610975|NCT02539368|82706283|FG000|Overall Study|Missing|10|||
46610976|NCT02539368|82706284|FG001|Overall Study|Missing|3|||
46610977|NCT02539368|82706285|FG002|Overall Study|Missing|0|||
46610978|NCT02539368|82706286|FG003|Overall Study|Missing|0|||
46610979|NCT02539368|82706287|FG004|Overall Study|Missing|0|||
46610980|NCT02539134|82706440|FG000|Overall Study|Lost to Follow-up|1|||
46610981|NCT02539134|82706441|FG001|Overall Study|Lost to Follow-up|0|||
46610982|NCT02539134|82706442|FG002|Overall Study|Lost to Follow-up|0|||
46610983|NCT02539134|82706443|FG003|Overall Study|Lost to Follow-up|0|||
46610984|NCT02539134|82706444|FG004|Overall Study|Lost to Follow-up|0|||
46610985|NCT02539134|82706445|FG005|Overall Study|Lost to Follow-up|0|||
46610986|NCT02538900|82706549|FG000|Overall Study|Death|2|||
46610987|NCT02538900|82706550|FG001|Overall Study|Death|2|||
46610988|NCT02538900|82706551|FG002|Overall Study|Death|2|||
46610989|NCT02538900|82706549|FG000|Overall Study|Withdrawal by Subject|18|||
46610990|NCT02538900|82706550|FG001|Overall Study|Withdrawal by Subject|16|||
46610991|NCT02538900|82706551|FG002|Overall Study|Withdrawal by Subject|15|||
46610992|NCT01986348|82707031|FG000|Overall Study|Death|8|||
46610993|NCT01986348|82707032|FG001|Overall Study|Death|22|||
46610994|NCT01986348|82707033|FG002|Overall Study|Death|10|||
46610995|NCT01986348|82707034|FG003|Overall Study|Death|21|||
46610996|NCT01986348|82707031|FG000|Overall Study|Lost to Follow-up|0|||
46610997|NCT01986348|82707032|FG001|Overall Study|Lost to Follow-up|0|||
46610998|NCT01986348|82707033|FG002|Overall Study|Lost to Follow-up|0|||
46610999|NCT01986348|82707034|FG003|Overall Study|Lost to Follow-up|2|||
46611000|NCT01986348|82707031|FG000|Overall Study|Physician Decision|0|||
46611001|NCT01986348|82707032|FG001|Overall Study|Physician Decision|0|||
46611002|NCT01986348|82707033|FG002|Overall Study|Physician Decision|0|||
46611003|NCT01986348|82707034|FG003|Overall Study|Physician Decision|1|||
46611004|NCT01986348|82707031|FG000|Overall Study|Progressive Disease|0|||
46611005|NCT01986348|82707032|FG001|Overall Study|Progressive Disease|0|||
46611006|NCT01986348|82707033|FG002|Overall Study|Progressive Disease|2|||
46611007|NCT01986348|82707034|FG003|Overall Study|Progressive Disease|0|||
46611008|NCT01986348|82707031|FG000|Overall Study|Withdrawal by Participant|0|||
46611009|NCT01986348|82707032|FG001|Overall Study|Withdrawal by Participant|1|||
46611010|NCT01986348|82707033|FG002|Overall Study|Withdrawal by Participant|2|||
46611011|NCT01986348|82707034|FG003|Overall Study|Withdrawal by Participant|1|||
46611012|NCT01986348|82707031|FG000|Overall Study|Study Terminated by Sponsor|0|||
46611013|NCT01986348|82707032|FG001|Overall Study|Study Terminated by Sponsor|0|||
46611014|NCT01986348|82707033|FG002|Overall Study|Study Terminated by Sponsor|0|||
46611015|NCT01986348|82707034|FG003|Overall Study|Study Terminated by Sponsor|3|||
46611016|NCT01986348|82707031|FG000|Overall Study|Other-unspecified|0|||
46611017|NCT01986348|82707032|FG001|Overall Study|Other-unspecified|1|||
46611018|NCT01986348|82707033|FG002|Overall Study|Other-unspecified|0|||
46611019|NCT01986348|82707034|FG003|Overall Study|Other-unspecified|2|||
46611020|NCT02543892|82707607|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
46611021|NCT02543892|82707608|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
46611022|NCT02543892|82707609|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
46611023|NCT02543892|82707610|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
46611024|NCT02543892|82707611|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
46611025|NCT02543892|82707612|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
46611026|NCT02543892|82707613|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
46611027|NCT02543892|82707614|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
46611028|NCT02543892|82707607|FG000|Received Vaccination 2|Physician Decision|0|||
46611029|NCT02543892|82707608|FG001|Received Vaccination 2|Physician Decision|0|||
46611030|NCT02543892|82707609|FG002|Received Vaccination 2|Physician Decision|0|||
46611031|NCT02543892|82707610|FG003|Received Vaccination 2|Physician Decision|0|||
46611032|NCT02543892|82707611|FG004|Received Vaccination 2|Physician Decision|0|||
46611033|NCT02543892|82707612|FG005|Received Vaccination 2|Physician Decision|1|||
46611034|NCT02543892|82707613|FG006|Received Vaccination 2|Physician Decision|0|||
46611035|NCT02543892|82707614|FG007|Received Vaccination 2|Physician Decision|0|||
46611036|NCT02543892|82707607|FG000|Received Vaccination 2|Adverse Event|0|||
46611037|NCT02543892|82707608|FG001|Received Vaccination 2|Adverse Event|1|||
46611038|NCT02543892|82707609|FG002|Received Vaccination 2|Adverse Event|0|||
46611039|NCT02543892|82707610|FG003|Received Vaccination 2|Adverse Event|0|||
46611040|NCT02543892|82707611|FG004|Received Vaccination 2|Adverse Event|0|||
46611041|NCT02543892|82707612|FG005|Received Vaccination 2|Adverse Event|0|||
46611042|NCT02543892|82707613|FG006|Received Vaccination 2|Adverse Event|0|||
46611043|NCT02543892|82707614|FG007|Received Vaccination 2|Adverse Event|0|||
46611044|NCT02543892|82707607|FG000|Had Immunology Data|Withdrawal by Subject|0|||
46611045|NCT02543892|82707608|FG001|Had Immunology Data|Withdrawal by Subject|0|||
46611046|NCT02543892|82707609|FG002|Had Immunology Data|Withdrawal by Subject|0|||
46611047|NCT02543892|82707610|FG003|Had Immunology Data|Withdrawal by Subject|0|||
46611048|NCT02543892|82707611|FG004|Had Immunology Data|Withdrawal by Subject|0|||
46611049|NCT02543892|82707612|FG005|Had Immunology Data|Withdrawal by Subject|0|||
46611050|NCT02543892|82707613|FG006|Had Immunology Data|Withdrawal by Subject|1|||
46611051|NCT02543892|82707614|FG007|Had Immunology Data|Withdrawal by Subject|0|||
46611052|NCT02543658|82707695|FG000|Overall Study|Lack of Efficacy|0|||
46611053|NCT02543658|82707696|FG001|Overall Study|Lack of Efficacy|4|||
46611054|NCT01607892|82708451|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
46611055|NCT01607892|82708452|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
46611056|NCT01607892|82708453|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
46611057|NCT01607892|82708454|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
46611058|NCT01607892|82708455|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
46611059|NCT01607892|82708451|FG000|Overall Study|Death|4|||
46611060|NCT01607892|82708452|FG001|Overall Study|Death|2|||
46611061|NCT01607892|82708453|FG002|Overall Study|Death|8|||
46611062|NCT01607892|82708454|FG003|Overall Study|Death|10|||
46611063|NCT01607892|82708455|FG004|Overall Study|Death|3|||
46611064|NCT01607892|82708451|FG000|Overall Study|Investigator discretion|2|||
46611065|NCT01607892|82708452|FG001|Overall Study|Investigator discretion|4|||
46611066|NCT01607892|82708453|FG002|Overall Study|Investigator discretion|4|||
46611067|NCT01607892|82708454|FG003|Overall Study|Investigator discretion|8|||
46611068|NCT01607892|82708455|FG004|Overall Study|Investigator discretion|0|||
46611069|NCT01607892|82708451|FG000|Overall Study|Other treatments became available|1|||
46611070|NCT01607892|82708452|FG001|Overall Study|Other treatments became available|1|||
46611071|NCT01607892|82708453|FG002|Overall Study|Other treatments became available|0|||
46611072|NCT01607892|82708454|FG003|Overall Study|Other treatments became available|0|||
46611073|NCT01607892|82708455|FG004|Overall Study|Other treatments became available|2|||
46611074|NCT01607892|82708451|FG000|Overall Study|Intercurrent illness|1|||
46611075|NCT01607892|82708452|FG001|Overall Study|Intercurrent illness|0|||
46611076|NCT01607892|82708453|FG002|Overall Study|Intercurrent illness|0|||
46611077|NCT01607892|82708454|FG003|Overall Study|Intercurrent illness|3|||
46611078|NCT01607892|82708455|FG004|Overall Study|Intercurrent illness|0|||
46611079|NCT01607892|82708451|FG000|Overall Study|Non-Compliance with study procedures|0|||
46611080|NCT01607892|82708452|FG001|Overall Study|Non-Compliance with study procedures|0|||
46611081|NCT01607892|82708453|FG002|Overall Study|Non-Compliance with study procedures|1|||
46611082|NCT01607892|82708454|FG003|Overall Study|Non-Compliance with study procedures|0|||
46611083|NCT01607892|82708455|FG004|Overall Study|Non-Compliance with study procedures|0|||
46611084|NCT01607892|82708451|FG000|Overall Study|Consent withdrawn by participant|9|||
46611085|NCT01607892|82708452|FG001|Overall Study|Consent withdrawn by participant|4|||
46611086|NCT01607892|82708453|FG002|Overall Study|Consent withdrawn by participant|24|||
46611087|NCT01607892|82708454|FG003|Overall Study|Consent withdrawn by participant|14|||
46611088|NCT01607892|82708455|FG004|Overall Study|Consent withdrawn by participant|4|||
46611089|NCT01607892|82708451|FG000|Overall Study|Disease progression|38|||
46611090|NCT01607892|82708452|FG001|Overall Study|Disease progression|13|||
46611091|NCT01607892|82708453|FG002|Overall Study|Disease progression|37|||
46611092|NCT01607892|82708454|FG003|Overall Study|Disease progression|57|||
46611093|NCT01607892|82708455|FG004|Overall Study|Disease progression|9|||
46611094|NCT01607892|82708451|FG000|Overall Study|Incidence or severity of Adverse events|3|||
46611095|NCT01607892|82708452|FG001|Overall Study|Incidence or severity of Adverse events|3|||
46611096|NCT01607892|82708453|FG002|Overall Study|Incidence or severity of Adverse events|7|||
46611097|NCT01607892|82708454|FG003|Overall Study|Incidence or severity of Adverse events|2|||
46611098|NCT01607892|82708455|FG004|Overall Study|Incidence or severity of Adverse events|6|||
46611099|NCT02530242|82708501|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
46611100|NCT02530242|82708502|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
46706764|NCT01208051|82922070|FG002|Total Enrollment|Withdrawal by Subject|0|||
46706765|NCT01208051|82922071|FG003|Total Enrollment|Withdrawal by Subject|0|||
46706766|NCT01208051|82922072|FG004|Total Enrollment|Withdrawal by Subject|2|||
46706767|NCT01208051|82922068|FG000|Total Enrollment|Brain metastases|0|||
46706768|NCT01208051|82922069|FG001|Total Enrollment|Brain metastases|0|||
46706769|NCT01208051|82922070|FG002|Total Enrollment|Brain metastases|1|||
46706770|NCT01208051|82922071|FG003|Total Enrollment|Brain metastases|0|||
46706771|NCT01208051|82922072|FG004|Total Enrollment|Brain metastases|0|||
46706772|NCT01207583|82922091|FG000|Overall Study|Withdrawal by Subject|0|||
46706773|NCT01207583|82922092|FG001|Overall Study|Withdrawal by Subject|3|||
46706774|NCT01207583|82922093|FG002|Overall Study|Withdrawal by Subject|1|||
46706775|NCT01207583|82922091|FG000|Overall Study|Participant failed to return|1|||
46706776|NCT01207583|82922092|FG001|Overall Study|Participant failed to return|0|||
46706777|NCT01207583|82922093|FG002|Overall Study|Participant failed to return|0|||
46706778|NCT01207583|82922091|FG000|Overall Study|Lost to Follow-up|0|||
46706779|NCT01207583|82922092|FG001|Overall Study|Lost to Follow-up|2|||
46706780|NCT01207583|82922093|FG002|Overall Study|Lost to Follow-up|0|||
46706781|NCT01207427|82922117|FG000|Double-blind Treatment Period|Adverse Event|0|||
46706782|NCT01207427|82922118|FG001|Double-blind Treatment Period|Adverse Event|1|||
46706783|NCT01207427|82922119|FG002|Double-blind Treatment Period|Adverse Event|0|||
46706784|NCT01207427|82922117|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
46706785|NCT01207427|82922118|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
46706786|NCT01207427|82922119|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
46706787|NCT01207427|82922117|FG000|Double-blind Treatment Period|Protocol Violation|2|||
46706788|NCT01207427|82922118|FG001|Double-blind Treatment Period|Protocol Violation|1|||
46706789|NCT01207427|82922119|FG002|Double-blind Treatment Period|Protocol Violation|1|||
46706790|NCT01207427|82922117|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
46706791|NCT01207427|82922118|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
46706792|NCT01207427|82922119|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46706793|NCT04713553|82922132|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
46706794|NCT04713553|82922133|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
46706795|NCT04713553|82922134|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
46706796|NCT04713553|82922135|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
46706797|NCT04713553|82922136|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
46706798|NCT04713553|82922137|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
46706799|NCT04713553|82922138|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
46706800|NCT04713553|82922132|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
46706801|NCT04713553|82922133|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
46706802|NCT04713553|82922134|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
46706803|NCT04713553|82922135|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
46706804|NCT04713553|82922136|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
46706805|NCT04713553|82922137|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
46706806|NCT04713553|82922138|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
46706807|NCT04713553|82922132|FG000|Primary Study (2 Months)|Other|1|||
46706808|NCT04713553|82922133|FG001|Primary Study (2 Months)|Other|2|||
46706809|NCT04713553|82922134|FG002|Primary Study (2 Months)|Other|0|||
46706810|NCT04713553|82922135|FG003|Primary Study (2 Months)|Other|0|||
46706811|NCT04713553|82922136|FG004|Primary Study (2 Months)|Other|1|||
46706812|NCT04713553|82922137|FG005|Primary Study (2 Months)|Other|0|||
46706813|NCT04713553|82922138|FG006|Primary Study (2 Months)|Other|0|||
46706814|NCT04713553|82922132|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
46991728|NCT01657877|83238708|FG000|Overall Study|Adverse Event|2|||
46706815|NCT04713553|82922133|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
46611101|NCT02537574|82708526|FG000|Overall Study|Adverse Event|1|||
46611102|NCT02537574|82708527|FG001|Overall Study|Adverse Event|3|||
46611103|NCT02537574|82708528|FG002|Overall Study|Adverse Event|2|||
46611104|NCT02537574|82708526|FG000|Overall Study|Lost to Follow-up|40|||
46611105|NCT02537574|82708527|FG001|Overall Study|Lost to Follow-up|51|||
46611106|NCT02537574|82708528|FG002|Overall Study|Lost to Follow-up|55|||
46611107|NCT02537574|82708526|FG000|Overall Study|Noncompliance with study drug|0|||
46611108|NCT02537574|82708527|FG001|Overall Study|Noncompliance with study drug|1|||
46611109|NCT02537574|82708528|FG002|Overall Study|Noncompliance with study drug|1|||
46611110|NCT02537574|82708526|FG000|Overall Study|Physician Decision|2|||
46611111|NCT02537574|82708527|FG001|Overall Study|Physician Decision|0|||
46611112|NCT02537574|82708528|FG002|Overall Study|Physician Decision|0|||
46611113|NCT02537574|82708526|FG000|Overall Study|Protocol Violation|4|||
46611114|NCT02537574|82708527|FG001|Overall Study|Protocol Violation|2|||
46611115|NCT02537574|82708528|FG002|Overall Study|Protocol Violation|3|||
46611116|NCT02537574|82708526|FG000|Overall Study|Withdrawal by Subject|37|||
46611117|NCT02537574|82708527|FG001|Overall Study|Withdrawal by Subject|27|||
46611118|NCT02537574|82708528|FG002|Overall Study|Withdrawal by Subject|29|||
46611119|NCT02537574|82708526|FG000|Overall Study|Lack of Efficacy|14|||
46611120|NCT02537574|82708527|FG001|Overall Study|Lack of Efficacy|16|||
46611121|NCT02537574|82708528|FG002|Overall Study|Lack of Efficacy|15|||
46611122|NCT02537574|82708526|FG000|Overall Study|Duplicate Patient|1|||
46611123|NCT02537574|82708527|FG001|Overall Study|Duplicate Patient|0|||
46611124|NCT02537574|82708528|FG002|Overall Study|Duplicate Patient|0|||
46611125|NCT02537574|82708526|FG000|Overall Study|Patient not Stable|0|||
46611126|NCT02537574|82708527|FG001|Overall Study|Patient not Stable|1|||
46611127|NCT02537574|82708528|FG002|Overall Study|Patient not Stable|0|||
46611128|NCT02537574|82708526|FG000|Overall Study|Incarceration|0|||
46611129|NCT02537574|82708527|FG001|Overall Study|Incarceration|1|||
46611130|NCT02537574|82708528|FG002|Overall Study|Incarceration|0|||
46611131|NCT02537574|82708526|FG000|Overall Study|Failed Naloxone Challenge|0|||
46611132|NCT02537574|82708527|FG001|Overall Study|Failed Naloxone Challenge|1|||
46611133|NCT02537574|82708528|FG002|Overall Study|Failed Naloxone Challenge|0|||
46611134|NCT02537574|82708526|FG000|Overall Study|Transportation Issues|0|||
46611135|NCT02537574|82708527|FG001|Overall Study|Transportation Issues|0|||
46611136|NCT02537574|82708528|FG002|Overall Study|Transportation Issues|1|||
46611137|NCT02537574|82708526|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
46611138|NCT02537574|82708527|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
46611139|NCT02537574|82708528|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
46611140|NCT02537574|82708526|FG000|Overall Study|Noncompliance with Protocol|0|||
46611141|NCT02537574|82708527|FG001|Overall Study|Noncompliance with Protocol|0|||
46611142|NCT02537574|82708528|FG002|Overall Study|Noncompliance with Protocol|1|||
46611143|NCT02531802|82709180|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
46611144|NCT02531802|82709181|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
46611145|NCT02531802|82709182|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
46611146|NCT02531802|82709183|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
46611147|NCT02531802|82709184|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
46611148|NCT02531802|82709185|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
46611149|NCT02531802|82709186|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
46611150|NCT02531802|82709187|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
46611151|NCT02531802|82709188|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
46611152|NCT02531802|82709189|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
46611153|NCT02531802|82709190|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
46611154|NCT02531802|82709191|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
46611155|NCT02531802|82709192|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
46611156|NCT02531802|82709193|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
46611157|NCT02531802|82709194|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
46611158|NCT02531802|82709195|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
46611159|NCT02531802|82709196|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
46611160|NCT02531802|82709197|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
46611161|NCT02531802|82709198|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
46611162|NCT02531802|82709199|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
46611163|NCT02531802|82709200|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
46611164|NCT02531802|82709180|FG000|Received Vaccination 2|Physician Decision|0|||
46611165|NCT02531802|82709181|FG001|Received Vaccination 2|Physician Decision|0|||
46893039|NCT03066830|83117315|FG000|Overall Study|Other|3|||
46611166|NCT02531802|82709182|FG002|Received Vaccination 2|Physician Decision|0|||
46611167|NCT02531802|82709183|FG003|Received Vaccination 2|Physician Decision|0|||
46611168|NCT02531802|82709184|FG004|Received Vaccination 2|Physician Decision|0|||
46611169|NCT02531802|82709185|FG005|Received Vaccination 2|Physician Decision|1|||
46611170|NCT02531802|82709186|FG006|Received Vaccination 2|Physician Decision|0|||
46611171|NCT02531802|82709187|FG007|Received Vaccination 2|Physician Decision|0|||
46611172|NCT02531802|82709188|FG008|Received Vaccination 2|Physician Decision|0|||
46611173|NCT02531802|82709189|FG009|Received Vaccination 2|Physician Decision|2|||
46611174|NCT02531802|82709190|FG010|Received Vaccination 2|Physician Decision|0|||
46611175|NCT02531802|82709191|FG011|Received Vaccination 2|Physician Decision|0|||
46611176|NCT02531802|82709192|FG012|Received Vaccination 2|Physician Decision|0|||
46611177|NCT02531802|82709193|FG013|Received Vaccination 2|Physician Decision|1|||
46611178|NCT02531802|82709194|FG014|Received Vaccination 2|Physician Decision|0|||
46611179|NCT02531802|82709195|FG015|Received Vaccination 2|Physician Decision|0|||
46611180|NCT02531802|82709196|FG016|Received Vaccination 2|Physician Decision|0|||
46611181|NCT02531802|82709197|FG017|Received Vaccination 2|Physician Decision|1|||
46611182|NCT02531802|82709198|FG018|Received Vaccination 2|Physician Decision|0|||
46611183|NCT02531802|82709199|FG019|Received Vaccination 2|Physician Decision|0|||
46611184|NCT02531802|82709200|FG020|Received Vaccination 2|Physician Decision|0|||
46611185|NCT02531802|82709180|FG000|Received Vaccination 2|Adverse Event|0|||
46611186|NCT02531802|82709181|FG001|Received Vaccination 2|Adverse Event|0|||
46611187|NCT02531802|82709182|FG002|Received Vaccination 2|Adverse Event|0|||
46611188|NCT02531802|82709183|FG003|Received Vaccination 2|Adverse Event|0|||
46611189|NCT02531802|82709184|FG004|Received Vaccination 2|Adverse Event|0|||
46611190|NCT02531802|82709185|FG005|Received Vaccination 2|Adverse Event|2|||
46611191|NCT02531802|82709186|FG006|Received Vaccination 2|Adverse Event|0|||
46611192|NCT02531802|82709187|FG007|Received Vaccination 2|Adverse Event|0|||
46611193|NCT02531802|82709188|FG008|Received Vaccination 2|Adverse Event|0|||
46611194|NCT02531802|82709189|FG009|Received Vaccination 2|Adverse Event|0|||
46611195|NCT02531802|82709190|FG010|Received Vaccination 2|Adverse Event|0|||
46611196|NCT02531802|82709191|FG011|Received Vaccination 2|Adverse Event|0|||
46611197|NCT02531802|82709192|FG012|Received Vaccination 2|Adverse Event|0|||
46611198|NCT02531802|82709193|FG013|Received Vaccination 2|Adverse Event|0|||
46611199|NCT02531802|82709194|FG014|Received Vaccination 2|Adverse Event|0|||
46611200|NCT02531802|82709195|FG015|Received Vaccination 2|Adverse Event|0|||
46611201|NCT02531802|82709196|FG016|Received Vaccination 2|Adverse Event|0|||
46611202|NCT02531802|82709197|FG017|Received Vaccination 2|Adverse Event|2|||
46611203|NCT02531802|82709198|FG018|Received Vaccination 2|Adverse Event|1|||
46611204|NCT02531802|82709199|FG019|Received Vaccination 2|Adverse Event|0|||
46611205|NCT02531802|82709200|FG020|Received Vaccination 2|Adverse Event|1|||
46611206|NCT02531802|82709180|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
46611207|NCT02531802|82709181|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
46611208|NCT02531802|82709182|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
46611209|NCT02531802|82709183|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
46611210|NCT02531802|82709184|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
46611211|NCT02531802|82709185|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
46611212|NCT02531802|82709186|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
46611213|NCT02531802|82709187|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
46611214|NCT02531802|82709188|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
46611215|NCT02531802|82709189|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
46611216|NCT02531802|82709190|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
46611217|NCT02531802|82709191|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
46611218|NCT02531802|82709192|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
46611219|NCT02531802|82709193|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
46611220|NCT02531802|82709194|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
46611221|NCT02531802|82709195|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
46611222|NCT02531802|82709196|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
46611223|NCT02531802|82709197|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
46611224|NCT02531802|82709198|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
46611225|NCT02531802|82709199|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
46611226|NCT02531802|82709200|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
46611227|NCT02531646|82709304|FG000|Overall Study|equip. image processing issue|5|||
46611228|NCT02531646|82709305|FG001|Overall Study|equip. image processing issue|1|||
46611229|NCT02531646|82709306|FG002|Overall Study|equip. image processing issue|0|||
46611230|NCT02536404|82709371|FG000|Overall Study|Adverse Event|5|||
46611231|NCT02536404|82709372|FG001|Overall Study|Adverse Event|0|||
46611232|NCT02536404|82709371|FG000|Overall Study|Withdrawal by Subject|4|||
46611233|NCT02536404|82709372|FG001|Overall Study|Withdrawal by Subject|1|||
46611234|NCT02536404|82709371|FG000|Overall Study|Physician Decision|10|||
46611235|NCT02536404|82709372|FG001|Overall Study|Physician Decision|0|||
46611236|NCT02536404|82709371|FG000|Overall Study|Sponsor decision|1|||
46611237|NCT02536404|82709372|FG001|Overall Study|Sponsor decision|0|||
46611238|NCT01659996|82710332|FG000|Overall Study|Protocol Violation|3|||
46611239|NCT01659996|82710333|FG001|Overall Study|Protocol Violation|3|||
46611240|NCT01659996|82710334|FG002|Overall Study|Protocol Violation|3|||
46611241|NCT01659996|82710332|FG000|Overall Study|Lost to Follow-up|1|||
46611242|NCT01659996|82710333|FG001|Overall Study|Lost to Follow-up|3|||
46611243|NCT01659996|82710334|FG002|Overall Study|Lost to Follow-up|2|||
46611244|NCT01659996|82710332|FG000|Overall Study|Adverse Event|0|||
46611245|NCT01659996|82710333|FG001|Overall Study|Adverse Event|0|||
46611246|NCT01659996|82710334|FG002|Overall Study|Adverse Event|1|||
46611247|NCT01659996|82710332|FG000|Overall Study|Withdrawal by Subject|4|||
46611248|NCT01659996|82710333|FG001|Overall Study|Withdrawal by Subject|1|||
46611249|NCT01659996|82710334|FG002|Overall Study|Withdrawal by Subject|5|||
46611250|NCT02525874|82710693|FG000|Overall Study|Other|1|||
46611251|NCT02525874|82710693|FG000|Overall Study|Investigator Decision|1|||
46611252|NCT02525874|82710693|FG000|Overall Study|Consent withdrawn|22|||
46611253|NCT02525874|82710693|FG000|Overall Study|Non-compliance with study drug|3|||
46611254|NCT02525874|82710693|FG000|Overall Study|Adverse Event|17|||
46611255|NCT02525874|82710693|FG000|Overall Study|Lost to Follow-up|7|||
46611256|NCT02525874|82710693|FG000|Overall Study|Disease progression, defined by protocol|2|||
46611257|NCT02525874|82710693|FG000|Overall Study|Disease relapse|4|||
46611258|NCT02525874|82710693|FG000|Overall Study|Alternative Treatment for MS|2|||
46611259|NCT02525874|82710693|FG000|Overall Study|New lesions in Brain|1|||
46611260|NCT02528214|82710703|FG000|Overall Study|Protocol Violation|0|||
46611261|NCT02528214|82710704|FG001|Overall Study|Protocol Violation|1|||
46611262|NCT02528214|82710703|FG000|Overall Study|Adverse Event|0|||
46611263|NCT02528214|82710704|FG001|Overall Study|Adverse Event|1|||
46611264|NCT02528214|82710703|FG000|Overall Study|Other than specified above|0|||
46611265|NCT02528214|82710704|FG001|Overall Study|Other than specified above|1|||
46611266|NCT05348681|82710748|FG000|Overall Study|Study terminated by Sponsor|8|||
46611267|NCT05348681|82710749|FG001|Overall Study|Study terminated by Sponsor|3|||
46611268|NCT05348681|82710748|FG000|Overall Study|Withdrawal by Subject|1|||
46611269|NCT05348681|82710749|FG001|Overall Study|Withdrawal by Subject|1|||
46611270|NCT05348681|82710748|FG000|Overall Study|Lost to Follow-up|1|||
46611271|NCT05348681|82710749|FG001|Overall Study|Lost to Follow-up|1|||
46611272|NCT05348681|82710748|FG000|Overall Study|Adverse Event|1|||
46611273|NCT05348681|82710749|FG001|Overall Study|Adverse Event|0|||
46611274|NCT05348681|82710748|FG000|Overall Study|Other|2|||
46611275|NCT05348681|82710749|FG001|Overall Study|Other|1|||
46611276|NCT04423757|82710775|FG000|Overall Study|Adverse Event|2|||
46611277|NCT04423757|82710776|FG001|Overall Study|Adverse Event|0|||
46611278|NCT04423757|82710775|FG000|Overall Study|Not treated|1|||
46611279|NCT04423757|82710776|FG001|Overall Study|Not treated|1|||
46611280|NCT04379713|82710784|FG000|Overall Study|Adverse Event|2|||
46611281|NCT04379713|82710785|FG001|Overall Study|Adverse Event|0|||
46611282|NCT04379713|82710784|FG000|Overall Study|Physician Decision|2|||
46611283|NCT04379713|82710785|FG001|Overall Study|Physician Decision|1|||
46611284|NCT04379713|82710784|FG000|Overall Study|Protocol Violation|11|||
46611285|NCT04379713|82710785|FG001|Overall Study|Protocol Violation|6|||
46611286|NCT04379713|82710784|FG000|Overall Study|No longer met eligibility criteria|14|||
46611287|NCT04379713|82710785|FG001|Overall Study|No longer met eligibility criteria|11|||
46611288|NCT04379713|82710784|FG000|Overall Study|Withdrawal by parent/guardian|36|||
46611289|NCT04379713|82710785|FG001|Overall Study|Withdrawal by parent/guardian|15|||
46611290|NCT04379713|82710784|FG000|Overall Study|Lost to Follow-up|31|||
46611291|NCT04379713|82710785|FG001|Overall Study|Lost to Follow-up|21|||
46611292|NCT04085328|82710793|FG000|Overall Study|Witihdrew Consent|16|||
46611293|NCT04085328|82710794|FG001|Overall Study|Witihdrew Consent|16|||
46611294|NCT04085328|82710793|FG000|Overall Study|Adverse Event|8|||
46611295|NCT04085328|82710794|FG001|Overall Study|Adverse Event|7|||
46611296|NCT04085328|82710793|FG000|Overall Study|Lost to Follow-up|7|||
46611297|NCT04085328|82710794|FG001|Overall Study|Lost to Follow-up|2|||
46611298|NCT04085328|82710793|FG000|Overall Study|Physician Decision|0|||
46611299|NCT04085328|82710794|FG001|Overall Study|Physician Decision|1|||
46611300|NCT04085328|82710793|FG000|Overall Study|Pregnancy|0|||
46611301|NCT04085328|82710794|FG001|Overall Study|Pregnancy|1|||
46611302|NCT04085328|82710793|FG000|Overall Study|Reasons Related to COVID-19|5|||
46611303|NCT04085328|82710794|FG001|Overall Study|Reasons Related to COVID-19|8|||
46611304|NCT04085328|82710793|FG000|Overall Study|Did not meet inclusion criteria|1|||
46611305|NCT04085328|82710794|FG001|Overall Study|Did not meet inclusion criteria|1|||
46611306|NCT04085328|82710793|FG000|Overall Study|Early termination|1|||
46611307|NCT04085328|82710794|FG001|Overall Study|Early termination|0|||
46611308|NCT03074474|82710825|FG000|Overall Study|Lost to Follow-up|10|||
46611309|NCT03074474|82710825|FG000|Overall Study|Withdrawal by Subject|10|||
46611310|NCT03074474|82710825|FG000|Overall Study|Death|4|||
46611311|NCT03074474|82710825|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
46611312|NCT02744391|82710834|FG000|Overall Study|Lost to Follow-up|9|||
46611313|NCT02744391|82710834|FG000|Overall Study|Physician Decision|2|||
46611314|NCT02744391|82710834|FG000|Overall Study|Withdrawal by Subject|3|||
46611315|NCT02462837|82710840|FG000|Overall Study|pt developed hives|1|||
46611316|NCT02462837|82710841|FG001|Overall Study|pt developed hives|0|||
46611317|NCT02462837|82710840|FG000|Overall Study|Withdrawal by Subject|1|||
46611318|NCT02462837|82710841|FG001|Overall Study|Withdrawal by Subject|0|||
46611319|NCT02346201|82710849|FG000|Overall Study|Adverse Event|3|||
46611320|NCT02346201|82710850|FG001|Overall Study|Adverse Event|2|||
46611321|NCT02346201|82710849|FG000|Overall Study|Lost to Follow-up|1|||
46611322|NCT02346201|82710850|FG001|Overall Study|Lost to Follow-up|0|||
46611323|NCT02346201|82710849|FG000|Overall Study|Withdrawal by Subject|6|||
46611324|NCT02346201|82710850|FG001|Overall Study|Withdrawal by Subject|3|||
46611325|NCT02346201|82710849|FG000|Overall Study|Unavailable for future follow-up|0|||
46611326|NCT02346201|82710850|FG001|Overall Study|Unavailable for future follow-up|1|||
46611327|NCT02346201|82710849|FG000|Overall Study|Physician Decision|0|||
46611328|NCT02346201|82710850|FG001|Overall Study|Physician Decision|1|||
46611329|NCT02346201|82710849|FG000|Overall Study|Missed final visit|0|||
46611330|NCT02346201|82710850|FG001|Overall Study|Missed final visit|2|||
46611331|NCT01866930|82710870|FG000|Treatment Period|Other|1|||
46611332|NCT01866930|82710871|FG001|Treatment Period|Other|0|||
46611333|NCT01866930|82710870|FG000|Treatment Period|Death|0|||
46611334|NCT01866930|82710871|FG001|Treatment Period|Death|2|||
46611335|NCT01866930|82710870|FG000|Treatment Period|Poor/non compliance|0|||
46611336|NCT01866930|82710871|FG001|Treatment Period|Poor/non compliance|2|||
46611337|NCT01866930|82710870|FG000|Treatment Period|No longer meets study criteria|0|||
46611338|NCT01866930|82710871|FG001|Treatment Period|No longer meets study criteria|1|||
46611339|NCT01866930|82710870|FG000|Treatment Period|Withdrawal by Subject|2|||
46611340|NCT01866930|82710871|FG001|Treatment Period|Withdrawal by Subject|8|||
46611341|NCT01866930|82710870|FG000|Treatment Period|Lack of Efficacy|1|||
46611342|NCT01866930|82710871|FG001|Treatment Period|Lack of Efficacy|9|||
46611343|NCT01866930|82710870|FG000|Treatment Period|Adverse Event|4|||
46611344|NCT01866930|82710871|FG001|Treatment Period|Adverse Event|12|||
46611345|NCT01866930|82710870|FG000|Treatment Period|Lost to Follow-up|1|||
46611346|NCT01866930|82710871|FG001|Treatment Period|Lost to Follow-up|1|||
46611347|NCT01866930|82710870|FG000|Follow-up Period|Lost to Follow-up|1|||
46611348|NCT01866930|82710871|FG001|Follow-up Period|Lost to Follow-up|1|||
46611349|NCT01866930|82710870|FG000|Follow-up Period|Other|1|||
46611350|NCT01866930|82710871|FG001|Follow-up Period|Other|5|||
46611351|NCT01866930|82710870|FG000|Follow-up Period|No longer required per protocol|1|||
46611352|NCT01866930|82710871|FG001|Follow-up Period|No longer required per protocol|0|||
46611353|NCT01866930|82710870|FG000|Follow-up Period|Withdrawal by Subject|3|||
46611354|NCT01866930|82710871|FG001|Follow-up Period|Withdrawal by Subject|3|||
46611355|NCT01621568|82710879|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
46611356|NCT01621568|82710880|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
46611357|NCT01621568|82710879|FG000|Week 5-6 No Treatment|Death|1|||
46611358|NCT01621568|82710880|FG001|Week 5-6 No Treatment|Death|0|||
46611359|NCT00813293|82710900|FG000|Overall Study|Intercurrent illness|1|||
46611360|NCT00813293|82710901|FG001|Overall Study|Intercurrent illness|0|||
46611361|NCT00813293|82710900|FG000|Overall Study|Adverse Event|0|||
46611362|NCT00813293|82710901|FG001|Overall Study|Adverse Event|1|||
46611363|NCT00481091|82710917|FG000|Overall Study|Withdrawal by Subject|0|||
46611364|NCT00481091|82710918|FG001|Overall Study|Withdrawal by Subject|1|||
46611365|NCT00481091|82710919|FG002|Overall Study|Withdrawal by Subject|1|||
46611366|NCT00481091|82710920|FG003|Overall Study|Withdrawal by Subject|0|||
46611367|NCT00481091|82710921|FG004|Overall Study|Withdrawal by Subject|0|||
46611368|NCT00481091|82710922|FG005|Overall Study|Withdrawal by Subject|0|||
46611369|NCT00481091|82710923|FG006|Overall Study|Withdrawal by Subject|0|||
46611370|NCT00481091|82710924|FG007|Overall Study|Withdrawal by Subject|0|||
46611371|NCT00481091|82710925|FG008|Overall Study|Withdrawal by Subject|1|||
46611372|NCT00481091|82710926|FG009|Overall Study|Withdrawal by Subject|6|||
46611373|NCT00481091|82710917|FG000|Overall Study|Other, Not Specified|0|||
46611374|NCT00481091|82710918|FG001|Overall Study|Other, Not Specified|1|||
46611375|NCT00481091|82710919|FG002|Overall Study|Other, Not Specified|1|||
46611376|NCT00481091|82710920|FG003|Overall Study|Other, Not Specified|0|||
46611377|NCT00481091|82710921|FG004|Overall Study|Other, Not Specified|0|||
46611378|NCT00481091|82710922|FG005|Overall Study|Other, Not Specified|1|||
46611379|NCT00481091|82710923|FG006|Overall Study|Other, Not Specified|0|||
46611380|NCT00481091|82710924|FG007|Overall Study|Other, Not Specified|0|||
46611381|NCT00481091|82710925|FG008|Overall Study|Other, Not Specified|0|||
46611382|NCT00481091|82710926|FG009|Overall Study|Other, Not Specified|4|||
46611383|NCT00481091|82710917|FG000|Overall Study|Adverse Event|1|||
46611384|NCT00481091|82710918|FG001|Overall Study|Adverse Event|2|||
46611385|NCT00481091|82710919|FG002|Overall Study|Adverse Event|0|||
46611386|NCT00481091|82710920|FG003|Overall Study|Adverse Event|1|||
46611387|NCT00481091|82710921|FG004|Overall Study|Adverse Event|1|||
46611388|NCT00481091|82710922|FG005|Overall Study|Adverse Event|1|||
46611389|NCT00481091|82710923|FG006|Overall Study|Adverse Event|2|||
46611390|NCT00481091|82710924|FG007|Overall Study|Adverse Event|1|||
46611391|NCT00481091|82710925|FG008|Overall Study|Adverse Event|1|||
46611392|NCT00481091|82710926|FG009|Overall Study|Adverse Event|6|||
46611393|NCT00481091|82710917|FG000|Overall Study|Progressive disease clinical|0|||
46611394|NCT00481091|82710918|FG001|Overall Study|Progressive disease clinical|0|||
46611395|NCT00481091|82710919|FG002|Overall Study|Progressive disease clinical|0|||
46611396|NCT00481091|82710920|FG003|Overall Study|Progressive disease clinical|0|||
46611397|NCT00481091|82710921|FG004|Overall Study|Progressive disease clinical|0|||
46611398|NCT00481091|82710922|FG005|Overall Study|Progressive disease clinical|0|||
46611399|NCT00481091|82710923|FG006|Overall Study|Progressive disease clinical|0|||
46611400|NCT00481091|82710924|FG007|Overall Study|Progressive disease clinical|0|||
46611401|NCT00481091|82710925|FG008|Overall Study|Progressive disease clinical|1|||
46611402|NCT00481091|82710926|FG009|Overall Study|Progressive disease clinical|7|||
46611403|NCT00481091|82710917|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
46611404|NCT00481091|82710918|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
46611405|NCT00481091|82710919|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
46611406|NCT00481091|82710920|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
46611407|NCT00481091|82710921|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
46611408|NCT00481091|82710922|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
46611409|NCT00481091|82710923|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
46611410|NCT00481091|82710924|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
46611411|NCT00481091|82710925|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
46611412|NCT00481091|82710926|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
46611413|NCT00481091|82710917|FG000|Overall Study|Progressive disease other|1|||
46611414|NCT00481091|82710918|FG001|Overall Study|Progressive disease other|1|||
46611415|NCT00481091|82710919|FG002|Overall Study|Progressive disease other|0|||
46893040|NCT03066830|83117316|FG001|Overall Study|Other|0|||
46893041|NCT03066830|83117315|FG000|Overall Study|Poor Compliance to Protocol|1|||
46893042|NCT03066830|83117316|FG001|Overall Study|Poor Compliance to Protocol|0|||
46893043|NCT03066830|83117315|FG000|Overall Study|Adverse Event|2|||
46893044|NCT03066830|83117316|FG001|Overall Study|Adverse Event|2|||
46893045|NCT03066830|83117315|FG000|Overall Study|Lost to Follow-up|11|||
46893046|NCT03066830|83117316|FG001|Overall Study|Lost to Follow-up|3|||
46893047|NCT04380961|83117325|FG000|Overall Study|Lost to Follow-up|17|||
46893048|NCT04380961|83117326|FG001|Overall Study|Lost to Follow-up|11|||
46893049|NCT04380961|83117325|FG000|Overall Study|Withdrawal by Subject|3|||
46893050|NCT04380961|83117326|FG001|Overall Study|Withdrawal by Subject|0|||
46893051|NCT04380961|83117325|FG000|Overall Study|Death|22|||
46893052|NCT04380961|83117326|FG001|Overall Study|Death|16|||
46893053|NCT04380961|83117325|FG000|Overall Study|Other|1|||
46893054|NCT04380961|83117326|FG001|Overall Study|Other|0|||
46893055|NCT04380961|83117325|FG000|Overall Study|Randomized but Not Treated|1|||
46893056|NCT04380961|83117326|FG001|Overall Study|Randomized but Not Treated|2|||
46893057|NCT04331899|83117336|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
46893058|NCT04331899|83117337|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
46893059|NCT04328467|83117346|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
46893060|NCT04328467|83117347|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
46893061|NCT04328467|83117348|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
46893062|NCT04328077|83117360|FG000|Overall Study|Lost to Follow-up|0|||
46893063|NCT04328077|83117361|FG001|Overall Study|Lost to Follow-up|1|||
46893064|NCT04328077|83117362|FG002|Overall Study|Lost to Follow-up|0|||
46893065|NCT04328077|83117363|FG003|Overall Study|Lost to Follow-up|0|||
46893066|NCT04328077|83117360|FG000|Overall Study|Withdrawal by Subject|0|||
46893067|NCT04328077|83117361|FG001|Overall Study|Withdrawal by Subject|1|||
46893068|NCT04328077|83117362|FG002|Overall Study|Withdrawal by Subject|1|||
46893069|NCT04328077|83117363|FG003|Overall Study|Withdrawal by Subject|3|||
46893070|NCT03691831|83117381|FG000|Overall Study|Lost to Follow-up|16|||
46893071|NCT03691831|83117382|FG001|Overall Study|Lost to Follow-up|12|||
46893072|NCT03691831|83117381|FG000|Overall Study|Withdrawal by Subject|9|||
46893073|NCT03691831|83117382|FG001|Overall Study|Withdrawal by Subject|17|||
46893074|NCT03691831|83117381|FG000|Overall Study|Investigator Decision|2|||
46893075|NCT03691831|83117382|FG001|Overall Study|Investigator Decision|2|||
46893076|NCT04320745|83117399|FG000|Overall Study|Adverse Event|26|||
46893077|NCT04320745|83117399|FG000|Overall Study|Withdrawal by Subject|4|||
46893078|NCT04320745|83117399|FG000|Overall Study|Lost to Follow-up|12|||
46893079|NCT04320745|83117399|FG000|Overall Study|Protocol Deviation|2|||
46893080|NCT04320745|83117399|FG000|Overall Study|Non-compliance With Study Drug|2|||
46893081|NCT04320745|83117399|FG000|Overall Study|Reason Not Specified|1|||
46893082|NCT03063086|83117403|FG000|Overall Study|technical problems|1|||
46893083|NCT03063086|83117404|FG001|Overall Study|technical problems|0|||
46893084|NCT03063086|83117405|FG002|Overall Study|technical problems|0|||
46893085|NCT03063086|83117406|FG003|Overall Study|technical problems|0|||
46893086|NCT03063086|83117407|FG004|Overall Study|technical problems|0|||
46893087|NCT03063086|83117408|FG005|Overall Study|technical problems|0|||
46893088|NCT03063086|83117403|FG000|Overall Study|Adverse Event|1|||
46893089|NCT03063086|83117404|FG001|Overall Study|Adverse Event|1|||
46893090|NCT03063086|83117405|FG002|Overall Study|Adverse Event|1|||
46893091|NCT03063086|83117406|FG003|Overall Study|Adverse Event|1|||
46893092|NCT03063086|83117407|FG004|Overall Study|Adverse Event|0|||
46893093|NCT03063086|83117408|FG005|Overall Study|Adverse Event|0|||
46893094|NCT03063086|83117403|FG000|Overall Study|subject/guardian decision|1|||
46893095|NCT03063086|83117404|FG001|Overall Study|subject/guardian decision|0|||
46893096|NCT03063086|83117405|FG002|Overall Study|subject/guardian decision|0|||
46893097|NCT03063086|83117406|FG003|Overall Study|subject/guardian decision|0|||
46893098|NCT03063086|83117407|FG004|Overall Study|subject/guardian decision|0|||
46893099|NCT03063086|83117408|FG005|Overall Study|subject/guardian decision|0|||
46893100|NCT03063086|83117403|FG000|Overall Study|Non-compliance with study treatment|0|||
46893101|NCT03063086|83117404|FG001|Overall Study|Non-compliance with study treatment|0|||
46893102|NCT03063086|83117405|FG002|Overall Study|Non-compliance with study treatment|0|||
46893103|NCT03063086|83117406|FG003|Overall Study|Non-compliance with study treatment|1|||
46893104|NCT03063086|83117407|FG004|Overall Study|Non-compliance with study treatment|0|||
46893105|NCT03063086|83117408|FG005|Overall Study|Non-compliance with study treatment|1|||
46893106|NCT03063086|83117403|FG000|Overall Study|Physician Decision|0|||
46893107|NCT03063086|83117404|FG001|Overall Study|Physician Decision|0|||
46893108|NCT03063086|83117405|FG002|Overall Study|Physician Decision|0|||
46893109|NCT03063086|83117406|FG003|Overall Study|Physician Decision|1|||
46893110|NCT03063086|83117407|FG004|Overall Study|Physician Decision|0|||
46893111|NCT03063086|83117408|FG005|Overall Study|Physician Decision|0|||
46893112|NCT04128007|83117419|FG000|Overall Study|Withdrawal by Subject|9|||
46893113|NCT04128007|83117420|FG001|Overall Study|Withdrawal by Subject|6|||
46893114|NCT04128007|83117419|FG000|Overall Study|Protocol Violation|1|||
46893115|NCT04128007|83117420|FG001|Overall Study|Protocol Violation|0|||
46893116|NCT04128007|83117419|FG000|Overall Study|Lost to Follow-up|8|||
46893117|NCT04128007|83117420|FG001|Overall Study|Lost to Follow-up|7|||
46893118|NCT04128007|83117419|FG000|Overall Study|Adverse Event|5|||
46893119|NCT04128007|83117420|FG001|Overall Study|Adverse Event|2|||
46893120|NCT04128007|83117419|FG000|Overall Study|Not reported|0|||
46893121|NCT04128007|83117420|FG001|Overall Study|Not reported|2|||
46893122|NCT04318093|83117428|FG000|Overall Study|Adverse Event|2|||
46893123|NCT04318093|83117429|FG001|Overall Study|Adverse Event|2|||
46893124|NCT04318093|83117428|FG000|Overall Study|Participant withdrew consent|1|||
46893125|NCT04318093|83117429|FG001|Overall Study|Participant withdrew consent|0|||
46893126|NCT04318093|83117428|FG000|Overall Study|Other reasons|0|||
46893127|NCT04318093|83117429|FG001|Overall Study|Other reasons|1|||
46893128|NCT04123405|83117440|FG000|Overall Study|Adverse Event|1|||
46893129|NCT04123405|83117441|FG001|Overall Study|Adverse Event|2|||
46893130|NCT04123405|83117442|FG002|Overall Study|Adverse Event|3|||
46893131|NCT04123405|83117443|FG003|Overall Study|Adverse Event|3|||
46893132|NCT04123405|83117440|FG000|Overall Study|Exclusion criteria met|1|||
46893133|NCT04123405|83117441|FG001|Overall Study|Exclusion criteria met|2|||
46893134|NCT04123405|83117442|FG002|Overall Study|Exclusion criteria met|0|||
46893135|NCT04123405|83117443|FG003|Overall Study|Exclusion criteria met|2|||
46893136|NCT04123405|83117440|FG000|Overall Study|Withdrawal by Subject|1|||
46893137|NCT04123405|83117441|FG001|Overall Study|Withdrawal by Subject|3|||
46893138|NCT04123405|83117442|FG002|Overall Study|Withdrawal by Subject|0|||
46893139|NCT04123405|83117443|FG003|Overall Study|Withdrawal by Subject|2|||
46893140|NCT04123405|83117440|FG000|Overall Study|Contact to subject lost|0|||
46893141|NCT04123405|83117441|FG001|Overall Study|Contact to subject lost|0|||
46893142|NCT04123405|83117442|FG002|Overall Study|Contact to subject lost|0|||
46893143|NCT04123405|83117443|FG003|Overall Study|Contact to subject lost|1|||
46893144|NCT04123405|83117440|FG000|Overall Study|screening failure|1|||
46893145|NCT04123405|83117441|FG001|Overall Study|screening failure|0|||
46893146|NCT04123405|83117442|FG002|Overall Study|screening failure|0|||
46893147|NCT04123405|83117443|FG003|Overall Study|screening failure|0|||
46893148|NCT04314037|83117472|FG000|Treatment Period 2|Adverse Event|1|||
46893149|NCT04314037|83117473|FG001|Treatment Period 2|Adverse Event|0|||
46893150|NCT04314037|83117472|FG000|Treatment Period 3|Protocol Violation|1|||
46893151|NCT04314037|83117473|FG001|Treatment Period 3|Protocol Violation|0|||
46893152|NCT04314037|83117472|FG000|Treatment Period 3|Adverse Event|0|||
46893153|NCT04314037|83117473|FG001|Treatment Period 3|Adverse Event|1|||
46893154|NCT03056300|83117489|FG000|Overall Study|Surgical reason per study protocol|3|||
46893155|NCT03061214|83117496|FG000|Overall Study|Withdrawal by Subject|21|||
46893156|NCT03061214|83117497|FG001|Overall Study|Withdrawal by Subject|26|||
46893157|NCT03061214|83117498|FG002|Overall Study|Withdrawal by Subject|9|||
46893158|NCT03061214|83117496|FG000|Overall Study|Lost to Follow-up|3|||
46893159|NCT03061214|83117497|FG001|Overall Study|Lost to Follow-up|1|||
46893160|NCT03061214|83117498|FG002|Overall Study|Lost to Follow-up|1|||
46893161|NCT03061214|83117496|FG000|Overall Study|Death|1|||
46893162|NCT03061214|83117497|FG001|Overall Study|Death|1|||
46893163|NCT03061214|83117498|FG002|Overall Study|Death|0|||
46893164|NCT04115839|83117509|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
46893165|NCT04115839|83117510|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
46893166|NCT04115839|83117511|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
46893167|NCT04115839|83117512|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
46893168|NCT04115839|83117513|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
46893169|NCT04115839|83117514|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
46893170|NCT04115839|83117515|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
46893171|NCT04115839|83117509|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
46893172|NCT04115839|83117510|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
46893173|NCT04115839|83117511|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
46893174|NCT04115839|83117512|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
46893175|NCT04115839|83117513|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
46893176|NCT04115839|83117514|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
46893177|NCT04115839|83117515|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
46893178|NCT04115839|83117509|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
46893179|NCT04115839|83117510|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
46893180|NCT04115839|83117511|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
46893181|NCT04115839|83117512|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
46893182|NCT04115839|83117513|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
46893183|NCT04115839|83117514|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
46893184|NCT04115839|83117515|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
46893185|NCT04115839|83117509|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
46893186|NCT04115839|83117510|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
46893187|NCT04115839|83117511|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
46893188|NCT04115839|83117512|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
46893189|NCT04115839|83117513|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
46893190|NCT04115839|83117514|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
46893191|NCT04115839|83117515|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
46893192|NCT04115839|83117509|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
46893193|NCT04115839|83117510|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
46893194|NCT04115839|83117511|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
46893195|NCT04115839|83117512|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
46893196|NCT04115839|83117513|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
46893197|NCT04115839|83117514|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
46893198|NCT04115839|83117515|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
46893199|NCT04115839|83117509|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
46893200|NCT04115839|83117510|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
46893201|NCT04115839|83117511|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
46893202|NCT04115839|83117512|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
46893203|NCT04115839|83117513|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
46893204|NCT04115839|83117514|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
46893205|NCT04115839|83117515|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
46893206|NCT01561430|83117544|FG000|Overall Study|Adverse Event|0|||
46893207|NCT01561430|83117545|FG001|Overall Study|Adverse Event|0|||
46893208|NCT01561430|83117546|FG002|Overall Study|Adverse Event|3|||
46893209|NCT01561430|83117547|FG003|Overall Study|Adverse Event|1|||
46893210|NCT01561430|83117544|FG000|Overall Study|Withdrawal by Subject|0|||
46893211|NCT01561430|83117545|FG001|Overall Study|Withdrawal by Subject|0|||
46893212|NCT01561430|83117546|FG002|Overall Study|Withdrawal by Subject|1|||
46893213|NCT01561430|83117547|FG003|Overall Study|Withdrawal by Subject|0|||
46893214|NCT01561430|83117544|FG000|Overall Study|Physician Decision|0|||
46893215|NCT01561430|83117545|FG001|Overall Study|Physician Decision|1|||
46893216|NCT01561430|83117546|FG002|Overall Study|Physician Decision|0|||
46893217|NCT01561430|83117547|FG003|Overall Study|Physician Decision|0|||
46893218|NCT01561430|83117544|FG000|Overall Study|Sponsor Decision|1|||
46893219|NCT01561430|83117545|FG001|Overall Study|Sponsor Decision|14|||
46893220|NCT01561430|83117546|FG002|Overall Study|Sponsor Decision|13|||
46893221|NCT01561430|83117547|FG003|Overall Study|Sponsor Decision|12|||
46893222|NCT03060512|83117582|FG000|Overall Study|Adverse Event|4|||
46893223|NCT03060512|83117583|FG001|Overall Study|Adverse Event|6|||
46893224|NCT03060512|83117582|FG000|Overall Study|Lost to Follow-up|1|||
46893225|NCT03060512|83117583|FG001|Overall Study|Lost to Follow-up|1|||
46893226|NCT03060512|83117582|FG000|Overall Study|Withdrawal by Subject|1|||
46893227|NCT03060512|83117583|FG001|Overall Study|Withdrawal by Subject|0|||
46893228|NCT03060512|83117582|FG000|Overall Study|Non-compliance with study medication|1|||
46893229|NCT03060512|83117583|FG001|Overall Study|Non-compliance with study medication|2|||
46893230|NCT02539160|83117671|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
46893231|NCT02539160|83117672|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
46893232|NCT02539160|83117673|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
46893233|NCT02539160|83117674|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
46893234|NCT02539160|83117671|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
46893235|NCT02539160|83117672|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
46893236|NCT02539160|83117673|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
46893237|NCT02539160|83117674|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
46893238|NCT02539160|83117671|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
46893239|NCT02539160|83117672|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
46893240|NCT02539160|83117673|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
46893241|NCT02539160|83117674|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
46893242|NCT04292899|83117688|FG000|Overall Study|Death|21|||
46893243|NCT04292899|83117689|FG001|Overall Study|Death|28|||
46893244|NCT04292899|83117690|FG002|Overall Study|Death|188|||
46893245|NCT04292899|83117691|FG003|Overall Study|Death|371|||
46893246|NCT04292899|83117688|FG000|Overall Study|Lost to Follow-up|8|||
46893247|NCT04292899|83117689|FG001|Overall Study|Lost to Follow-up|4|||
46893248|NCT04292899|83117690|FG002|Overall Study|Lost to Follow-up|22|||
46893249|NCT04292899|83117691|FG003|Overall Study|Lost to Follow-up|235|||
46893250|NCT04292899|83117688|FG000|Overall Study|Withdrew consent|1|||
46893251|NCT04292899|83117689|FG001|Overall Study|Withdrew consent|0|||
46893252|NCT04292899|83117690|FG002|Overall Study|Withdrew consent|11|||
46893253|NCT04292899|83117691|FG003|Overall Study|Withdrew consent|32|||
46893254|NCT04292899|83117688|FG000|Overall Study|Adverse Event|2|||
46893255|NCT04292899|83117689|FG001|Overall Study|Adverse Event|1|||
46893256|NCT04292899|83117690|FG002|Overall Study|Adverse Event|2|||
46893257|NCT04292899|83117691|FG003|Overall Study|Adverse Event|2|||
46893258|NCT04292899|83117688|FG000|Overall Study|Investigator's Discretion|0|||
46893259|NCT04292899|83117689|FG001|Overall Study|Investigator's Discretion|0|||
46893260|NCT04292899|83117690|FG002|Overall Study|Investigator's Discretion|0|||
46893261|NCT04292899|83117691|FG003|Overall Study|Investigator's Discretion|3|||
46893262|NCT04292899|83117688|FG000|Overall Study|Non-compliance With Study Drug|0|||
46893263|NCT04292899|83117689|FG001|Overall Study|Non-compliance With Study Drug|0|||
46893264|NCT04292899|83117690|FG002|Overall Study|Non-compliance With Study Drug|0|||
46893265|NCT04292899|83117691|FG003|Overall Study|Non-compliance With Study Drug|1|||
46893266|NCT04292899|83117688|FG000|Overall Study|Protocol Violation|0|||
46893267|NCT04292899|83117689|FG001|Overall Study|Protocol Violation|0|||
46893268|NCT04292899|83117690|FG002|Overall Study|Protocol Violation|0|||
46893269|NCT04292899|83117691|FG003|Overall Study|Protocol Violation|1|||
46893270|NCT03241173|83117710|FG000|Overall Study|Death|3|||
46893271|NCT03241173|83117711|FG001|Overall Study|Death|2|||
46893272|NCT03241173|83117712|FG002|Overall Study|Death|4|||
46893273|NCT03241173|83117713|FG003|Overall Study|Death|4|||
46893274|NCT03241173|83117714|FG004|Overall Study|Death|2|||
46893275|NCT03241173|83117715|FG005|Overall Study|Death|2|||
46893276|NCT03241173|83117716|FG006|Overall Study|Death|3|||
46893277|NCT03241173|83117717|FG007|Overall Study|Death|1|||
46893278|NCT03241173|83117718|FG008|Overall Study|Death|0|||
46893279|NCT03241173|83117719|FG009|Overall Study|Death|5|||
46893280|NCT03241173|83117720|FG010|Overall Study|Death|4|||
46893281|NCT03241173|83117721|FG011|Overall Study|Death|3|||
46893282|NCT03241173|83117722|FG012|Overall Study|Death|0|||
46893283|NCT03241173|83117723|FG013|Overall Study|Death|0|||
46893284|NCT03241173|83117724|FG014|Overall Study|Death|0|||
46893285|NCT03241173|83117710|FG000|Overall Study|Withdrawal by Subject|0|||
46893286|NCT03241173|83117711|FG001|Overall Study|Withdrawal by Subject|0|||
46893287|NCT03241173|83117712|FG002|Overall Study|Withdrawal by Subject|1|||
46893288|NCT03241173|83117713|FG003|Overall Study|Withdrawal by Subject|0|||
46893289|NCT03241173|83117714|FG004|Overall Study|Withdrawal by Subject|0|||
46893290|NCT03241173|83117715|FG005|Overall Study|Withdrawal by Subject|1|||
46893291|NCT03241173|83117716|FG006|Overall Study|Withdrawal by Subject|0|||
46893292|NCT03241173|83117717|FG007|Overall Study|Withdrawal by Subject|0|||
46893293|NCT03241173|83117718|FG008|Overall Study|Withdrawal by Subject|0|||
46893294|NCT03241173|83117719|FG009|Overall Study|Withdrawal by Subject|0|||
46893295|NCT03241173|83117720|FG010|Overall Study|Withdrawal by Subject|0|||
46893296|NCT03241173|83117721|FG011|Overall Study|Withdrawal by Subject|0|||
46893297|NCT03241173|83117722|FG012|Overall Study|Withdrawal by Subject|0|||
46893298|NCT03241173|83117723|FG013|Overall Study|Withdrawal by Subject|0|||
46893299|NCT03241173|83117724|FG014|Overall Study|Withdrawal by Subject|0|||
46893300|NCT03241173|83117710|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
46893301|NCT03241173|83117711|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
46893302|NCT03241173|83117712|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
46893303|NCT03241173|83117713|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
46893304|NCT03241173|83117714|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
46893305|NCT03241173|83117715|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
46893306|NCT03241173|83117716|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
46893307|NCT03241173|83117717|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
46893308|NCT03241173|83117718|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
46893309|NCT03241173|83117719|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
46893310|NCT03241173|83117720|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
46893311|NCT03241173|83117721|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
46893312|NCT03241173|83117722|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
46893313|NCT03241173|83117723|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
46893314|NCT03241173|83117724|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
46893315|NCT03241173|83117710|FG000|Overall Study|Lost to Follow-up|0|||
46893316|NCT03241173|83117711|FG001|Overall Study|Lost to Follow-up|0|||
46893317|NCT03241173|83117712|FG002|Overall Study|Lost to Follow-up|0|||
46893318|NCT03241173|83117713|FG003|Overall Study|Lost to Follow-up|0|||
46893319|NCT03241173|83117714|FG004|Overall Study|Lost to Follow-up|1|||
46893320|NCT03241173|83117715|FG005|Overall Study|Lost to Follow-up|0|||
46893321|NCT03241173|83117716|FG006|Overall Study|Lost to Follow-up|0|||
46893322|NCT03241173|83117717|FG007|Overall Study|Lost to Follow-up|0|||
46893323|NCT03241173|83117718|FG008|Overall Study|Lost to Follow-up|0|||
46893324|NCT03241173|83117719|FG009|Overall Study|Lost to Follow-up|1|||
46893325|NCT03241173|83117720|FG010|Overall Study|Lost to Follow-up|0|||
46893326|NCT03241173|83117721|FG011|Overall Study|Lost to Follow-up|0|||
46893327|NCT03241173|83117722|FG012|Overall Study|Lost to Follow-up|0|||
46893328|NCT03241173|83117723|FG013|Overall Study|Lost to Follow-up|0|||
46893329|NCT03241173|83117724|FG014|Overall Study|Lost to Follow-up|0|||
46893330|NCT03264066|83117758|FG000|Overall Study|Adverse Event|1|||
46893331|NCT03264066|83117759|FG001|Overall Study|Adverse Event|1|||
46893332|NCT03264066|83117760|FG002|Overall Study|Adverse Event|0|||
46893333|NCT03264066|83117761|FG003|Overall Study|Adverse Event|0|||
46893334|NCT03264066|83117762|FG004|Overall Study|Adverse Event|0|||
46893335|NCT03264066|83117763|FG005|Overall Study|Adverse Event|0|||
46893336|NCT03264066|83117758|FG000|Overall Study|Death|12|||
46893337|NCT03264066|83117759|FG001|Overall Study|Death|12|||
46893338|NCT03264066|83117760|FG002|Overall Study|Death|8|||
46893339|NCT03264066|83117761|FG003|Overall Study|Death|10|||
46893340|NCT03264066|83117762|FG004|Overall Study|Death|6|||
46893341|NCT03264066|83117763|FG005|Overall Study|Death|1|||
46893342|NCT03264066|83117758|FG000|Overall Study|Lost to Follow-up|1|||
46893343|NCT03264066|83117759|FG001|Overall Study|Lost to Follow-up|0|||
46893344|NCT03264066|83117760|FG002|Overall Study|Lost to Follow-up|0|||
46893345|NCT03264066|83117761|FG003|Overall Study|Lost to Follow-up|0|||
46893346|NCT03264066|83117762|FG004|Overall Study|Lost to Follow-up|0|||
46893347|NCT03264066|83117763|FG005|Overall Study|Lost to Follow-up|0|||
46893348|NCT03264066|83117758|FG000|Overall Study|Progressive Disease|0|||
46893349|NCT03264066|83117759|FG001|Overall Study|Progressive Disease|2|||
46893350|NCT03264066|83117760|FG002|Overall Study|Progressive Disease|1|||
46893351|NCT03264066|83117761|FG003|Overall Study|Progressive Disease|0|||
46893352|NCT03264066|83117762|FG004|Overall Study|Progressive Disease|0|||
46893353|NCT03264066|83117763|FG005|Overall Study|Progressive Disease|0|||
46893354|NCT03264066|83117758|FG000|Overall Study|Study Terminated by Sponsor|5|||
46893355|NCT03264066|83117759|FG001|Overall Study|Study Terminated by Sponsor|5|||
46893356|NCT03264066|83117760|FG002|Overall Study|Study Terminated by Sponsor|8|||
46893357|NCT03264066|83117761|FG003|Overall Study|Study Terminated by Sponsor|5|||
46893358|NCT03264066|83117762|FG004|Overall Study|Study Terminated by Sponsor|1|||
46893359|NCT03264066|83117763|FG005|Overall Study|Study Terminated by Sponsor|2|||
46893360|NCT03264066|83117758|FG000|Overall Study|Withdrawal by Subject|1|||
46893361|NCT03264066|83117759|FG001|Overall Study|Withdrawal by Subject|0|||
46893362|NCT03264066|83117760|FG002|Overall Study|Withdrawal by Subject|0|||
46893363|NCT03264066|83117761|FG003|Overall Study|Withdrawal by Subject|5|||
46893364|NCT03264066|83117762|FG004|Overall Study|Withdrawal by Subject|0|||
46893365|NCT03264066|83117763|FG005|Overall Study|Withdrawal by Subject|0|||
46893366|NCT03759041|83117781|FG000|Overall Study|Withdrawal by Subject|4|||
46893367|NCT03759041|83117782|FG001|Overall Study|Withdrawal by Subject|10|||
46893368|NCT03759041|83117783|FG002|Overall Study|Withdrawal by Subject|10|||
46893369|NCT03759041|83117781|FG000|Overall Study|Adverse Event|1|||
46893370|NCT03759041|83117782|FG001|Overall Study|Adverse Event|3|||
46893371|NCT03759041|83117783|FG002|Overall Study|Adverse Event|4|||
46893372|NCT03759041|83117781|FG000|Overall Study|Lack of Efficacy|0|||
46893373|NCT03759041|83117782|FG001|Overall Study|Lack of Efficacy|0|||
46893374|NCT03759041|83117783|FG002|Overall Study|Lack of Efficacy|1|||
46893375|NCT03759041|83117781|FG000|Overall Study|Study Terminated by Sponsor|15|||
46893376|NCT03759041|83117782|FG001|Overall Study|Study Terminated by Sponsor|16|||
46893377|NCT03759041|83117783|FG002|Overall Study|Study Terminated by Sponsor|10|||
46893378|NCT03759041|83117781|FG000|Overall Study|Other reason for discontinuation|0|||
46893379|NCT03759041|83117782|FG001|Overall Study|Other reason for discontinuation|2|||
46893380|NCT03759041|83117783|FG002|Overall Study|Other reason for discontinuation|1|||
46893381|NCT03759041|83117781|FG000|Overall Study|Lost to Follow-up|7|||
46893382|NCT03759041|83117782|FG001|Overall Study|Lost to Follow-up|2|||
46893383|NCT03759041|83117783|FG002|Overall Study|Lost to Follow-up|2|||
46893384|NCT03759041|83117781|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
46893385|NCT03759041|83117782|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
46893386|NCT03759041|83117783|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
46893387|NCT04110145|83117796|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
46893388|NCT04110145|83117797|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
46893389|NCT04110145|83117798|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
46893390|NCT04110145|83117799|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
46893391|NCT04110145|83117800|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
46611416|NCT00481091|82710920|FG003|Overall Study|Progressive disease other|1|||
46893392|NCT02477618|83117814|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
46893393|NCT02477618|83117815|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
46893394|NCT02477618|83117814|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
46893395|NCT02477618|83117815|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
46893396|NCT02477618|83117814|FG000|Overall Study|Adverse Event|1|||
46893397|NCT02477618|83117815|FG001|Overall Study|Adverse Event|1|||
46893398|NCT02477618|83117814|FG000|Overall Study|Transferred Away from Study Site|1|||
46893399|NCT02477618|83117815|FG001|Overall Study|Transferred Away from Study Site|0|||
46893400|NCT02477618|83117814|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
46893401|NCT02477618|83117815|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
46893402|NCT04102501|83117823|FG000|Overall Study|Withdrawal by Subject|7|||
46893403|NCT04102501|83117824|FG001|Overall Study|Withdrawal by Subject|9|||
46893404|NCT04102501|83117823|FG000|Overall Study|Adverse Event|1|||
46893405|NCT04102501|83117824|FG001|Overall Study|Adverse Event|3|||
46893406|NCT03285477|83117834|FG000|Treatment and Response Assessment Period|Death|1|||
46893407|NCT03285477|83117835|FG001|Treatment and Response Assessment Period|Death|0|||
46893408|NCT03285477|83117834|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
46893409|NCT03285477|83117835|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
46893410|NCT03285477|83117834|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
46893411|NCT03285477|83117835|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
46893412|NCT03285477|83117834|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
46893413|NCT03285477|83117835|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
46893414|NCT03285477|83117834|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
46893415|NCT03285477|83117835|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
46893416|NCT04289623|83117852|FG000|Wave 1 Emails|Email was not delivered|268|||
46893417|NCT04289623|83117853|FG001|Wave 1 Emails|Email was not delivered|257|||
46893418|NCT04289623|83117854|FG002|Wave 1 Emails|Email was not delivered|0|||
46893419|NCT04289623|83117855|FG003|Wave 1 Emails|Email was not delivered|0|||
46893420|NCT04289623|83117856|FG004|Wave 1 Emails|Email was not delivered|0|||
46893421|NCT04289623|83117857|FG005|Wave 1 Emails|Email was not delivered|0|||
46893422|NCT03248037|83117873|FG000|Overall Study|Withdrawal by Subject|6|||
46893423|NCT03248037|83117874|FG001|Overall Study|Withdrawal by Subject|9|||
46893424|NCT03248037|83117873|FG000|Overall Study|Adverse Event|15|||
46893425|NCT03248037|83117874|FG001|Overall Study|Adverse Event|0|||
46893426|NCT04287517|83117889|FG000|Overall Study|Withdrawal by Subject|1|||
46893427|NCT04287517|83117890|FG001|Overall Study|Withdrawal by Subject|1|||
46893428|NCT03284229|83117896|FG000|Overall Study|Lost to Follow-up|3|||
46893429|NCT03242928|83117903|FG000|Overall Study|Adverse Event|2|||
46893430|NCT03242928|83117904|FG001|Overall Study|Adverse Event|1|||
46893431|NCT03242928|83117903|FG000|Overall Study|Lost to Follow-up|2|||
46893432|NCT03242928|83117904|FG001|Overall Study|Lost to Follow-up|0|||
46893433|NCT03242928|83117903|FG000|Overall Study|Physician Decision|0|||
46893434|NCT03242928|83117904|FG001|Overall Study|Physician Decision|1|||
46893435|NCT03242928|83117903|FG000|Overall Study|Withdrawal by Subject|5|||
46893436|NCT03242928|83117904|FG001|Overall Study|Withdrawal by Subject|3|||
46893437|NCT03300024|83117912|FG000|Overall Study|Physician Decision|4|||
46893438|NCT03300024|83117913|FG001|Overall Study|Physician Decision|6|||
46893439|NCT04276207|83117921|FG000|Period 1|Withdrawal by Subject|0|||
46893440|NCT04276207|83117922|FG001|Period 1|Withdrawal by Subject|1|||
46893441|NCT03282357|83117928|FG000|Overall Study|Lost to Follow-up|3|||
46893442|NCT03282357|83117928|FG000|Overall Study|Withdrawal by Subject|4|||
46893443|NCT03282357|83117928|FG000|Overall Study|Adverse Event|1|||
46893444|NCT03282357|83117928|FG000|Overall Study|Other|9|||
46893445|NCT04272775|83117935|FG000|Overall Study|Study Terminated by Sponsor|1|||
46893446|NCT04272775|83117936|FG001|Overall Study|Study Terminated by Sponsor|0|||
46893447|NCT04272775|83117935|FG000|Overall Study|Protocol Violation|0|||
46893448|NCT04272775|83117936|FG001|Overall Study|Protocol Violation|1|||
46893449|NCT04272775|83117935|FG000|Overall Study|Symptomatic Deterioration|1|||
46893450|NCT04272775|83117936|FG001|Overall Study|Symptomatic Deterioration|1|||
46893451|NCT04272775|83117935|FG000|Overall Study|Withdrawal by Subject|1|||
46893452|NCT04272775|83117936|FG001|Overall Study|Withdrawal by Subject|2|||
46893453|NCT04272775|83117935|FG000|Overall Study|Adverse Event|1|||
46893454|NCT04272775|83117936|FG001|Overall Study|Adverse Event|2|||
46893455|NCT04272775|83117935|FG000|Overall Study|Progressive Disease|3|||
46893456|NCT04272775|83117936|FG001|Overall Study|Progressive Disease|1|||
46893457|NCT03232983|83117942|FG000|Period 1|Physician Decision|0|||
46893458|NCT03232983|83117943|FG001|Period 1|Physician Decision|0|||
46893459|NCT03232983|83117944|FG002|Period 1|Physician Decision|1|||
46893460|NCT03232983|83117945|FG003|Period 1|Physician Decision|0|||
46893461|NCT03232983|83117942|FG000|Washout Period 2|Physician Decision|0|||
46893462|NCT03232983|83117943|FG001|Washout Period 2|Physician Decision|0|||
46893463|NCT03232983|83117944|FG002|Washout Period 2|Physician Decision|1|||
46893464|NCT03232983|83117945|FG003|Washout Period 2|Physician Decision|0|||
46893465|NCT03232983|83117942|FG000|Washout Period 2|Withdrawal by Subject|0|||
46893466|NCT03232983|83117943|FG001|Washout Period 2|Withdrawal by Subject|0|||
46893467|NCT03232983|83117944|FG002|Washout Period 2|Withdrawal by Subject|0|||
46893468|NCT03232983|83117945|FG003|Washout Period 2|Withdrawal by Subject|1|||
46893469|NCT03232983|83117942|FG000|Period 4|Withdrawal by Subject|1|||
46893470|NCT03232983|83117943|FG001|Period 4|Withdrawal by Subject|0|||
46893471|NCT03232983|83117944|FG002|Period 4|Withdrawal by Subject|0|||
46893472|NCT03232983|83117945|FG003|Period 4|Withdrawal by Subject|0|||
46893473|NCT04102345|83117959|FG000|Overall Study|Withdrawal by Subject|1|||
46893474|NCT04102345|83117960|FG001|Overall Study|Withdrawal by Subject|0|||
46893475|NCT04271605|83117966|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
46893476|NCT03299244|83117972|FG000|Overall Study|Withdrawal by Subject|34|||
46893477|NCT03299244|83117973|FG001|Overall Study|Withdrawal by Subject|29|||
46893478|NCT03299244|83117972|FG000|Overall Study|Decision by Sponsor|4|||
46893479|NCT03299244|83117973|FG001|Overall Study|Decision by Sponsor|5|||
46893480|NCT03299244|83117972|FG000|Overall Study|Death|9|||
46893481|NCT03299244|83117973|FG001|Overall Study|Death|4|||
46893482|NCT03757715|83117982|FG000|Overall Study|Lost to Follow-up|4|||
46893483|NCT03757715|83117983|FG001|Overall Study|Lost to Follow-up|9|||
46893484|NCT03757715|83117982|FG000|Overall Study|Withdrawal by Subject|1|||
46893485|NCT03757715|83117983|FG001|Overall Study|Withdrawal by Subject|1|||
46893486|NCT03281577|83117993|FG000|Overall Study|Adverse Event|0|||
46893487|NCT03281577|83117994|FG001|Overall Study|Adverse Event|0|||
46893488|NCT03281577|83117995|FG002|Overall Study|Adverse Event|0|||
46893489|NCT03281577|83117996|FG003|Overall Study|Adverse Event|1|||
46893490|NCT03281577|83117993|FG000|Overall Study|Withdrawal by Subject|1|||
46893491|NCT03281577|83117994|FG001|Overall Study|Withdrawal by Subject|0|||
46893492|NCT03281577|83117995|FG002|Overall Study|Withdrawal by Subject|0|||
46893493|NCT03281577|83117996|FG003|Overall Study|Withdrawal by Subject|0|||
46893494|NCT04098367|83118012|FG000|Overall Study|Adverse Event|0|||
46893495|NCT04098367|83118013|FG001|Overall Study|Adverse Event|0|||
46893496|NCT04098367|83118014|FG002|Overall Study|Adverse Event|1|||
46893497|NCT04098367|83118012|FG000|Overall Study|Lost to Follow-up|1|||
46893498|NCT04098367|83118013|FG001|Overall Study|Lost to Follow-up|5|||
46893499|NCT04098367|83118014|FG002|Overall Study|Lost to Follow-up|2|||
46893500|NCT04098367|83118012|FG000|Overall Study|Withdrawal by Subject|0|||
46893501|NCT04098367|83118013|FG001|Overall Study|Withdrawal by Subject|0|||
46893502|NCT04098367|83118014|FG002|Overall Study|Withdrawal by Subject|1|||
46893503|NCT04098367|83118012|FG000|Overall Study|Sick . Could not attend visit|1|||
46893504|NCT04098367|83118013|FG001|Overall Study|Sick . Could not attend visit|0|||
46893505|NCT04098367|83118014|FG002|Overall Study|Sick . Could not attend visit|0|||
46893506|NCT04091659|83118031|FG000|Overall Study|Protocol Violation|3|||
46893507|NCT04091659|83118032|FG001|Overall Study|Protocol Violation|0|||
46893508|NCT04091659|83118031|FG000|Overall Study|Lost to Follow-up|0|||
46893509|NCT04091659|83118032|FG001|Overall Study|Lost to Follow-up|1|||
46893510|NCT04256785|83118069|FG000|Overall Study|Adverse Event|8|||
46893511|NCT04256785|83118070|FG001|Overall Study|Adverse Event|6|||
46893512|NCT04256785|83118069|FG000|Overall Study|Lack of Efficacy|3|||
46893513|NCT04256785|83118070|FG001|Overall Study|Lack of Efficacy|4|||
46893514|NCT04256785|83118069|FG000|Overall Study|Lost to Follow-up|7|||
46893515|NCT04256785|83118070|FG001|Overall Study|Lost to Follow-up|7|||
46893516|NCT04256785|83118069|FG000|Overall Study|Protocol Violation|1|||
46893517|NCT04256785|83118070|FG001|Overall Study|Protocol Violation|0|||
46893518|NCT04256785|83118069|FG000|Overall Study|Withdrawal by Subject|4|||
46893519|NCT04256785|83118070|FG001|Overall Study|Withdrawal by Subject|1|||
46893520|NCT04256785|83118069|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
46893521|NCT04256785|83118070|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
46991729|NCT01657877|83238708|FG000|Overall Study|Other Reason|2|||
46991730|NCT02175771|83238733|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
46991731|NCT02175771|83238734|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991732|NCT02175771|83238735|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991733|NCT02175771|83238736|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991734|NCT02175771|83238737|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991735|NCT02175771|83238738|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991736|NCT02175771|83238739|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991737|NCT02175771|83238740|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991738|NCT02175771|83238741|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
46991739|NCT02175771|83238733|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
46991740|NCT02175771|83238734|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46991741|NCT02175771|83238735|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46991742|NCT02175771|83238736|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46991743|NCT02175771|83238737|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46991744|NCT02175771|83238738|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46991745|NCT02175771|83238739|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46893522|NCT02959918|83118092|FG000|Overall Study|Adverse Event|1|||
46893523|NCT02959918|83118093|FG001|Overall Study|Adverse Event|1|||
46893524|NCT02959918|83118094|FG002|Overall Study|Adverse Event|2|||
46893525|NCT02959918|83118095|FG003|Overall Study|Adverse Event|0|||
46991746|NCT02175771|83238740|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46991747|NCT02175771|83238741|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
46991748|NCT02175771|83238733|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
46991749|NCT02175771|83238734|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991750|NCT02175771|83238735|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991751|NCT02175771|83238736|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991752|NCT02175771|83238737|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991753|NCT02175771|83238738|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991754|NCT02175771|83238739|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991755|NCT02175771|83238740|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991756|NCT02175771|83238741|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
46991757|NCT02175771|83238733|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
46991758|NCT02175771|83238734|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991759|NCT02175771|83238735|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991760|NCT02175771|83238736|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991761|NCT02175771|83238737|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991762|NCT02175771|83238738|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991763|NCT02175771|83238739|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991764|NCT02175771|83238740|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991765|NCT02175771|83238741|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
46991766|NCT02175771|83238733|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
46991767|NCT02175771|83238734|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991768|NCT02175771|83238735|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991769|NCT02175771|83238736|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991770|NCT02175771|83238737|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991771|NCT02175771|83238738|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991772|NCT02175771|83238739|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991773|NCT02175771|83238740|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991774|NCT02175771|83238741|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
46991775|NCT02175771|83238733|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
46991776|NCT02175771|83238734|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991777|NCT02175771|83238735|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991778|NCT02175771|83238736|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991779|NCT02175771|83238737|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991780|NCT02175771|83238738|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991781|NCT02175771|83238739|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991782|NCT02175771|83238740|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991783|NCT02175771|83238741|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
46991784|NCT02175771|83238733|FG000|Run-In Period (Pre-assignment)|Other|8|||
46991785|NCT02175771|83238734|FG001|Run-In Period (Pre-assignment)|Other|0|||
46991786|NCT02175771|83238735|FG002|Run-In Period (Pre-assignment)|Other|0|||
46991787|NCT02175771|83238736|FG003|Run-In Period (Pre-assignment)|Other|0|||
46991788|NCT02175771|83238737|FG004|Run-In Period (Pre-assignment)|Other|0|||
46991789|NCT02175771|83238738|FG005|Run-In Period (Pre-assignment)|Other|0|||
46991790|NCT02175771|83238739|FG006|Run-In Period (Pre-assignment)|Other|0|||
46991791|NCT02175771|83238740|FG007|Run-In Period (Pre-assignment)|Other|0|||
46991792|NCT02175771|83238741|FG008|Run-In Period (Pre-assignment)|Other|0|||
46991793|NCT02175771|83238733|FG000|Treatment Period|Adverse Event|0|||
46991794|NCT02175771|83238734|FG001|Treatment Period|Adverse Event|2|||
46991795|NCT02175771|83238735|FG002|Treatment Period|Adverse Event|1|||
46991796|NCT02175771|83238736|FG003|Treatment Period|Adverse Event|1|||
46991797|NCT02175771|83238737|FG004|Treatment Period|Adverse Event|1|||
46991798|NCT02175771|83238738|FG005|Treatment Period|Adverse Event|3|||
46991799|NCT02175771|83238739|FG006|Treatment Period|Adverse Event|2|||
46991800|NCT02175771|83238740|FG007|Treatment Period|Adverse Event|0|||
46991801|NCT02175771|83238741|FG008|Treatment Period|Adverse Event|1|||
46991802|NCT02175771|83238733|FG000|Treatment Period|Withdrawal by Subject|0|||
46991803|NCT02175771|83238734|FG001|Treatment Period|Withdrawal by Subject|9|||
46893526|NCT02959918|83118096|FG004|Overall Study|Adverse Event|0|||
46893527|NCT02959918|83118097|FG005|Overall Study|Adverse Event|2|||
46893528|NCT02959918|83118098|FG006|Overall Study|Adverse Event|2|||
46893529|NCT02959918|83118099|FG007|Overall Study|Adverse Event|1|||
46893530|NCT02959918|83118100|FG008|Overall Study|Adverse Event|2|||
46893531|NCT02959918|83118101|FG009|Overall Study|Adverse Event|1|||
46893532|NCT02959918|83118102|FG010|Overall Study|Adverse Event|1|||
46893533|NCT02959918|83118103|FG011|Overall Study|Adverse Event|3|||
46893534|NCT02959918|83118104|FG012|Overall Study|Adverse Event|2|||
46893535|NCT02959918|83118105|FG013|Overall Study|Adverse Event|4|||
46893536|NCT02959918|83118092|FG000|Overall Study|Lost to Follow-up|0|||
46991804|NCT02175771|83238735|FG002|Treatment Period|Withdrawal by Subject|3|||
46991805|NCT02175771|83238736|FG003|Treatment Period|Withdrawal by Subject|6|||
46991806|NCT02175771|83238737|FG004|Treatment Period|Withdrawal by Subject|2|||
46991807|NCT02175771|83238738|FG005|Treatment Period|Withdrawal by Subject|4|||
46991808|NCT02175771|83238739|FG006|Treatment Period|Withdrawal by Subject|2|||
46991809|NCT02175771|83238740|FG007|Treatment Period|Withdrawal by Subject|9|||
46991810|NCT02175771|83238741|FG008|Treatment Period|Withdrawal by Subject|2|||
46991811|NCT02175771|83238733|FG000|Treatment Period|Noncompliance|0|||
46991812|NCT02175771|83238734|FG001|Treatment Period|Noncompliance|1|||
46991813|NCT02175771|83238735|FG002|Treatment Period|Noncompliance|2|||
46991814|NCT02175771|83238736|FG003|Treatment Period|Noncompliance|0|||
46991815|NCT02175771|83238737|FG004|Treatment Period|Noncompliance|0|||
46991816|NCT02175771|83238738|FG005|Treatment Period|Noncompliance|0|||
46991817|NCT02175771|83238739|FG006|Treatment Period|Noncompliance|0|||
46991818|NCT02175771|83238740|FG007|Treatment Period|Noncompliance|0|||
46991819|NCT02175771|83238741|FG008|Treatment Period|Noncompliance|1|||
46991820|NCT02175771|83238733|FG000|Treatment Period|Protocol Violation|0|||
46991821|NCT02175771|83238734|FG001|Treatment Period|Protocol Violation|0|||
46991822|NCT02175771|83238735|FG002|Treatment Period|Protocol Violation|0|||
46991823|NCT02175771|83238736|FG003|Treatment Period|Protocol Violation|0|||
46991824|NCT02175771|83238737|FG004|Treatment Period|Protocol Violation|0|||
46991825|NCT02175771|83238738|FG005|Treatment Period|Protocol Violation|0|||
46991826|NCT02175771|83238739|FG006|Treatment Period|Protocol Violation|0|||
46991827|NCT02175771|83238740|FG007|Treatment Period|Protocol Violation|1|||
46991828|NCT02175771|83238741|FG008|Treatment Period|Protocol Violation|0|||
46991829|NCT02175771|83238733|FG000|Treatment Period|Disease progression|0|||
46991830|NCT02175771|83238734|FG001|Treatment Period|Disease progression|0|||
46991831|NCT02175771|83238735|FG002|Treatment Period|Disease progression|0|||
46991832|NCT02175771|83238736|FG003|Treatment Period|Disease progression|0|||
46991833|NCT02175771|83238737|FG004|Treatment Period|Disease progression|0|||
46991834|NCT02175771|83238738|FG005|Treatment Period|Disease progression|0|||
46991835|NCT02175771|83238739|FG006|Treatment Period|Disease progression|0|||
46991836|NCT02175771|83238740|FG007|Treatment Period|Disease progression|2|||
46991837|NCT02175771|83238741|FG008|Treatment Period|Disease progression|0|||
46991838|NCT02175771|83238733|FG000|Treatment Period|Lost to Follow-up|0|||
46991839|NCT02175771|83238734|FG001|Treatment Period|Lost to Follow-up|3|||
46991840|NCT02175771|83238735|FG002|Treatment Period|Lost to Follow-up|1|||
46991841|NCT02175771|83238736|FG003|Treatment Period|Lost to Follow-up|3|||
46991842|NCT02175771|83238737|FG004|Treatment Period|Lost to Follow-up|1|||
46991843|NCT02175771|83238738|FG005|Treatment Period|Lost to Follow-up|2|||
46991844|NCT02175771|83238739|FG006|Treatment Period|Lost to Follow-up|1|||
46611417|NCT00481091|82710921|FG004|Overall Study|Progressive disease other|1|||
46611418|NCT00481091|82710922|FG005|Overall Study|Progressive disease other|1|||
46611419|NCT00481091|82710923|FG006|Overall Study|Progressive disease other|0|||
46611420|NCT00481091|82710924|FG007|Overall Study|Progressive disease other|2|||
46611421|NCT00481091|82710925|FG008|Overall Study|Progressive disease other|0|||
46611422|NCT00481091|82710926|FG009|Overall Study|Progressive disease other|0|||
46611423|NCT00481091|82710917|FG000|Overall Study|No reason given|0|||
46611424|NCT00481091|82710918|FG001|Overall Study|No reason given|0|||
46611425|NCT00481091|82710919|FG002|Overall Study|No reason given|1|||
46611426|NCT00481091|82710920|FG003|Overall Study|No reason given|1|||
46611427|NCT00481091|82710921|FG004|Overall Study|No reason given|1|||
46611428|NCT00481091|82710922|FG005|Overall Study|No reason given|0|||
46611429|NCT00481091|82710923|FG006|Overall Study|No reason given|1|||
46611430|NCT00481091|82710924|FG007|Overall Study|No reason given|1|||
46611431|NCT00481091|82710925|FG008|Overall Study|No reason given|1|||
46611432|NCT00481091|82710926|FG009|Overall Study|No reason given|4|||
46611433|NCT00003641|82710957|FG000|Overall Study|Withdrawal by Subject|0|||
46611434|NCT00003641|82710958|FG001|Overall Study|Withdrawal by Subject|100|||
46611435|NCT00003641|82710957|FG000|Overall Study|Adverse Event|0|||
46611436|NCT00003641|82710958|FG001|Overall Study|Adverse Event|38|||
46611437|NCT00003641|82710957|FG000|Overall Study|Disease progression|0|||
46611438|NCT00003641|82710958|FG001|Overall Study|Disease progression|2|||
46611439|NCT00003641|82710957|FG000|Overall Study|Unknown/missing|0|||
46611440|NCT00003641|82710958|FG001|Overall Study|Unknown/missing|22|||
46611441|NCT00003641|82710957|FG000|Overall Study|Should not receive interferon therapy|2|||
46611442|NCT00003641|82710958|FG001|Overall Study|Should not receive interferon therapy|0|||
46611443|NCT00003641|82710957|FG000|Overall Study|Never started interferon|567|||
46611444|NCT00003641|82710958|FG001|Overall Study|Never started interferon|12|||
46611445|NCT02524158|82710988|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
46611446|NCT02524158|82710989|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
46611447|NCT02524158|82710988|FG000|12-weeks Assessment|Lost to Follow-up|18|||
46611448|NCT02524158|82710989|FG001|12-weeks Assessment|Lost to Follow-up|12|||
46611449|NCT02524158|82710988|FG000|6-month Assessment|Withdrawal by Subject|1|||
46611450|NCT02524158|82710989|FG001|6-month Assessment|Withdrawal by Subject|1|||
46611451|NCT02524158|82710988|FG000|6-month Assessment|Lost to Follow-up|21|||
46611452|NCT02524158|82710989|FG001|6-month Assessment|Lost to Follow-up|20|||
46611453|NCT02525094|82711009|FG000|Overall Study|Lost to Follow-up|2|||
46611454|NCT02525094|82711010|FG001|Overall Study|Lost to Follow-up|1|||
46611455|NCT02525094|82711009|FG000|Overall Study|Withdrawal by Subject|5|||
46611456|NCT02525094|82711010|FG001|Overall Study|Withdrawal by Subject|6|||
46611457|NCT02525094|82711009|FG000|Overall Study|Not Treated|1|||
46611458|NCT02525094|82711010|FG001|Overall Study|Not Treated|1|||
46611459|NCT01657266|82711167|FG000|Overall Study|Lost to Follow-up|2|||
46611460|NCT01657266|82711168|FG001|Overall Study|Lost to Follow-up|2|||
46611461|NCT01657266|82711167|FG000|Overall Study|Adverse Event|2|||
46611462|NCT01657266|82711168|FG001|Overall Study|Adverse Event|3|||
46611463|NCT01657032|82711217|FG000|Overall Study|Lost to Follow-up|0|||
46611464|NCT01657032|82711218|FG001|Overall Study|Lost to Follow-up|7|||
46611465|NCT01657500|82711321|FG000|Overall Study|set impropperly matched|3|||
46611466|NCT01657500|82711322|FG001|Overall Study|set impropperly matched|3|||
46611467|NCT01657500|82711321|FG000|Overall Study|Lost to Follow-up|2|||
46611468|NCT01657500|82711322|FG001|Overall Study|Lost to Follow-up|2|||
46611469|NCT01658904|82711335|FG000|Overall Study|Principal Investigator discretion|2|||
46611470|NCT01658904|82711336|FG001|Overall Study|Principal Investigator discretion|0|||
46611471|NCT01658904|82711337|FG002|Overall Study|Principal Investigator discretion|0|||
46893537|NCT02959918|83118093|FG001|Overall Study|Lost to Follow-up|0|||
46893538|NCT02959918|83118094|FG002|Overall Study|Lost to Follow-up|0|||
46611472|NCT01658514|82711521|FG000|Overall Study|Protocol Violation|1|||
46611473|NCT01658514|82711522|FG001|Overall Study|Protocol Violation|0|||
46611474|NCT01658514|82711523|FG002|Overall Study|Protocol Violation|2|||
46611475|NCT01658436|82711544|FG000|Overall Study|Adverse Event|6|||
46611476|NCT01658436|82711545|FG001|Overall Study|Adverse Event|5|||
46611477|NCT01658436|82711544|FG000|Overall Study|Physician Decision|1|||
46611478|NCT01658436|82711545|FG001|Overall Study|Physician Decision|0|||
46611479|NCT01658436|82711544|FG000|Overall Study|Progressive disease|12|||
46611480|NCT01658436|82711545|FG001|Overall Study|Progressive disease|4|||
46611481|NCT01658436|82711544|FG000|Overall Study|Study terminated by sponsor|0|||
46893539|NCT02959918|83118095|FG003|Overall Study|Lost to Follow-up|0|||
46893540|NCT02959918|83118096|FG004|Overall Study|Lost to Follow-up|0|||
46611482|NCT01658436|82711545|FG001|Overall Study|Study terminated by sponsor|1|||
46611483|NCT01658436|82711544|FG000|Overall Study|Subject/guardian decision|0|||
46611484|NCT01658436|82711545|FG001|Overall Study|Subject/guardian decision|1|||
46611485|NCT01658436|82711544|FG000|Overall Study|Death|1|||
46611486|NCT01658436|82711545|FG001|Overall Study|Death|0|||
46611487|NCT00550862|82712044|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
46611488|NCT00550862|82712045|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
46611489|NCT00550862|82712046|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
46611490|NCT00550862|82712047|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
46611491|NCT00550862|82712048|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
46611492|NCT00550862|82712044|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
46611493|NCT00550862|82712045|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
46611494|NCT00550862|82712046|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
46611495|NCT00550862|82712047|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
46611496|NCT00550862|82712048|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
46611497|NCT00550862|82712044|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
46611498|NCT00550862|82712045|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
46611499|NCT00550862|82712046|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
46611500|NCT00550862|82712047|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
46611501|NCT00550862|82712048|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
46611502|NCT00550862|82712044|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
46611503|NCT00550862|82712045|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
46611504|NCT00550862|82712046|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
46611505|NCT00550862|82712047|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
46611506|NCT00550862|82712048|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
46611507|NCT00550862|82712044|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
46611508|NCT00550862|82712045|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
46611509|NCT00550862|82712046|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
46611510|NCT00550862|82712047|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
46611511|NCT00550862|82712048|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
46611512|NCT00550862|82712044|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
46611513|NCT00550862|82712045|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
46611514|NCT00550862|82712046|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
46611515|NCT00550862|82712047|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
46611516|NCT00550862|82712048|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
46611517|NCT00550862|82712044|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
46611518|NCT00550862|82712045|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
46611519|NCT00550862|82712046|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
46611520|NCT00550862|82712047|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
46611521|NCT00550862|82712048|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
46611522|NCT00550862|82712044|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
46611523|NCT00550862|82712045|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
46611524|NCT00550862|82712046|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
46611525|NCT00550862|82712047|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
46611526|NCT00550862|82712048|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
46611527|NCT00550862|82712044|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
46611528|NCT00550862|82712045|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
46611529|NCT00550862|82712046|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
46611530|NCT00550862|82712047|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
46611531|NCT00550862|82712048|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
46611532|NCT00550862|82712044|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
46611533|NCT00550862|82712045|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
46611534|NCT00550862|82712046|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
46611535|NCT00550862|82712047|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
46611536|NCT00550862|82712048|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
46611537|NCT01656408|82712110|FG000|Overall Study|Adverse Event|0|||
46611538|NCT01656408|82712111|FG001|Overall Study|Adverse Event|0|||
46611539|NCT01656408|82712112|FG002|Overall Study|Adverse Event|1|||
46611540|NCT01656408|82712113|FG003|Overall Study|Adverse Event|0|||
46611541|NCT01656408|82712114|FG004|Overall Study|Adverse Event|0|||
46611542|NCT01656408|82712115|FG005|Overall Study|Adverse Event|1|||
46611543|NCT01656408|82712116|FG006|Overall Study|Adverse Event|1|||
46611544|NCT01656408|82712117|FG007|Overall Study|Adverse Event|0|||
46611545|NCT01656408|82712118|FG008|Overall Study|Adverse Event|1|||
46611546|NCT01656408|82712119|FG009|Overall Study|Adverse Event|0|||
46611547|NCT01656408|82712110|FG000|Overall Study|Physician Decision|1|||
46611548|NCT01656408|82712111|FG001|Overall Study|Physician Decision|0|||
46611549|NCT01656408|82712112|FG002|Overall Study|Physician Decision|1|||
46611550|NCT01656408|82712113|FG003|Overall Study|Physician Decision|0|||
46611551|NCT01656408|82712114|FG004|Overall Study|Physician Decision|1|||
46611552|NCT01656408|82712115|FG005|Overall Study|Physician Decision|1|||
46611553|NCT01656408|82712116|FG006|Overall Study|Physician Decision|0|||
46611554|NCT01656408|82712117|FG007|Overall Study|Physician Decision|1|||
46611555|NCT01656408|82712118|FG008|Overall Study|Physician Decision|1|||
46611556|NCT01656408|82712119|FG009|Overall Study|Physician Decision|3|||
46611557|NCT01364298|82712542|FG000|Overall Study|Adverse Event|3|||
46611558|NCT01364298|82712543|FG001|Overall Study|Adverse Event|4|||
46611559|NCT01364298|82712542|FG000|Overall Study|Lack of adherence to treatment|1|||
46611560|NCT01364298|82712543|FG001|Overall Study|Lack of adherence to treatment|3|||
46611561|NCT01364298|82712542|FG000|Overall Study|Lack of Efficacy|1|||
46611562|NCT01364298|82712543|FG001|Overall Study|Lack of Efficacy|0|||
46611563|NCT01364298|82712542|FG000|Overall Study|Lost to Follow-up|5|||
46611564|NCT01364298|82712543|FG001|Overall Study|Lost to Follow-up|10|||
46611565|NCT01364298|82712542|FG000|Overall Study|Withdrawal by Subject|3|||
46611566|NCT01364298|82712543|FG001|Overall Study|Withdrawal by Subject|3|||
46611567|NCT01364298|82712542|FG000|Overall Study|Other|1|||
46611568|NCT01364298|82712543|FG001|Overall Study|Other|3|||
46611569|NCT01364922|82712602|FG000|Open-label (OL) Period|Adverse Event|7|||
46611570|NCT01364922|82712603|FG001|Open-label (OL) Period|Adverse Event|0|||
46611571|NCT01364922|82712604|FG002|Open-label (OL) Period|Adverse Event|0|||
46611572|NCT01364922|82712602|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
46611573|NCT01364922|82712603|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
46611574|NCT01364922|82712604|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
46611575|NCT01364922|82712602|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
46611576|NCT01364922|82712603|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
46611577|NCT01364922|82712604|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
46611578|NCT01364922|82712602|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
46611579|NCT01364922|82712603|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
46611580|NCT01364922|82712604|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
46611581|NCT01364922|82712602|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
46611582|NCT01364922|82712603|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
46611583|NCT01364922|82712604|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
46611584|NCT01364922|82712602|FG000|Open-label (OL) Period|Other, Unspecified|1|||
46611585|NCT01364922|82712603|FG001|Open-label (OL) Period|Other, Unspecified|0|||
46611586|NCT01364922|82712604|FG002|Open-label (OL) Period|Other, Unspecified|0|||
46611587|NCT01364922|82712602|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
46611588|NCT01364922|82712603|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
46611589|NCT01364922|82712604|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
46611590|NCT01364922|82712602|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
46611591|NCT01364922|82712603|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
46611592|NCT01364922|82712604|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
46611593|NCT01364922|82712602|FG000|Double-Blind (DB) Period|Adverse Event|0|||
46611594|NCT01364922|82712603|FG001|Double-Blind (DB) Period|Adverse Event|0|||
46611595|NCT01364922|82712604|FG002|Double-Blind (DB) Period|Adverse Event|1|||
46611596|NCT01364922|82712602|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
46611597|NCT01364922|82712603|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
46611598|NCT01364922|82712604|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
46611599|NCT02522286|82712778|FG000|Overall Study|Withdrawal by Subject|3|||
46611600|NCT02522286|82712779|FG001|Overall Study|Withdrawal by Subject|0|||
46611601|NCT02522286|82712780|FG002|Overall Study|Withdrawal by Subject|0|||
46611602|NCT02522286|82712781|FG003|Overall Study|Withdrawal by Subject|3|||
46611603|NCT02520726|82712802|FG000|Overall Study|Lost to Follow-up|3|||
46611604|NCT02520726|82712803|FG001|Overall Study|Lost to Follow-up|2|||
46611605|NCT02519712|82712826|FG000|Overall Study|Disease Relapse|1|||
46611606|NCT02519712|82712826|FG000|Overall Study|Disease Progression|1|||
46611607|NCT02519712|82712826|FG000|Overall Study|Accruals are donors|2|||
46611608|NCT02516202|82713069|FG000|Overall Study|Withdrawal by Subject|1|||
46611609|NCT02516202|82713070|FG001|Overall Study|Withdrawal by Subject|0|||
46611610|NCT02516202|82713071|FG002|Overall Study|Withdrawal by Subject|1|||
46611611|NCT02516202|82713069|FG000|Overall Study|Lost to Follow-up|1|||
46611612|NCT02516202|82713070|FG001|Overall Study|Lost to Follow-up|1|||
46611613|NCT02516202|82713071|FG002|Overall Study|Lost to Follow-up|1|||
46611614|NCT02516202|82713069|FG000|Overall Study|Stopped Follow-up|0|||
46611615|NCT02516202|82713070|FG001|Overall Study|Stopped Follow-up|0|||
46611616|NCT02516202|82713071|FG002|Overall Study|Stopped Follow-up|1|||
46611617|NCT02518620|82713268|FG000|Overall Study|Adverse Event|23|||
46611618|NCT02518620|82713269|FG001|Overall Study|Adverse Event|11|||
46611619|NCT02518620|82713268|FG000|Overall Study|Lack of Efficacy|2|||
46611620|NCT02518620|82713269|FG001|Overall Study|Lack of Efficacy|0|||
46611621|NCT02518620|82713268|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46611622|NCT02518620|82713269|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46611623|NCT02518620|82713268|FG000|Overall Study|Physician Decision|1|||
46611624|NCT02518620|82713269|FG001|Overall Study|Physician Decision|1|||
46611625|NCT02518620|82713268|FG000|Overall Study|Sponsor's Decision|0|||
46611626|NCT02518620|82713269|FG001|Overall Study|Sponsor's Decision|3|||
46611627|NCT02518620|82713268|FG000|Overall Study|Lost to Follow-up|1|||
46611628|NCT02518620|82713269|FG001|Overall Study|Lost to Follow-up|1|||
46611629|NCT02518620|82713268|FG000|Overall Study|Withdrawal by Subject|17|||
46611630|NCT02518620|82713269|FG001|Overall Study|Withdrawal by Subject|9|||
46611631|NCT02518620|82713268|FG000|Overall Study|Death|1|||
46611632|NCT02518620|82713269|FG001|Overall Study|Death|0|||
46611633|NCT02518620|82713268|FG000|Overall Study|Pregnancy Wish|3|||
46611634|NCT02518620|82713269|FG001|Overall Study|Pregnancy Wish|0|||
46611635|NCT02518620|82713268|FG000|Overall Study|Pregnancy|1|||
46611636|NCT02518620|82713269|FG001|Overall Study|Pregnancy|0|||
46611637|NCT02518620|82713268|FG000|Overall Study|Relocation|2|||
46611638|NCT02518620|82713269|FG001|Overall Study|Relocation|1|||
46611639|NCT01653912|82713448|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
46611640|NCT01653912|82713449|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
46611641|NCT01653912|82713450|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
46611642|NCT01653912|82713451|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
46611643|NCT01653912|82713452|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
46611644|NCT01653912|82713453|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
46611645|NCT01653912|82713448|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
46611646|NCT01653912|82713449|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
46611647|NCT01653912|82713450|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
46611648|NCT01653912|82713451|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
46611649|NCT01653912|82713452|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
46611650|NCT01653912|82713453|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
46611651|NCT01653912|82713448|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
46611652|NCT01653912|82713449|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
46611653|NCT01653912|82713450|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
46611654|NCT01653912|82713451|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
46611655|NCT01653912|82713452|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
46611656|NCT01653912|82713453|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
46611657|NCT01653912|82713448|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611658|NCT01653912|82713449|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611659|NCT01653912|82713450|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611660|NCT01653912|82713451|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
46611661|NCT01653912|82713452|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611662|NCT01653912|82713453|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611663|NCT01653912|82713448|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
46611664|NCT01653912|82713449|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
46611665|NCT01653912|82713450|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
46611666|NCT01653912|82713451|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
46611667|NCT01653912|82713452|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
46611668|NCT01653912|82713453|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
46611669|NCT01653912|82713448|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
46611670|NCT01653912|82713449|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
46611671|NCT01653912|82713450|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
46611672|NCT01653912|82713451|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
46611673|NCT01653912|82713452|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
46611674|NCT01653912|82713453|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
46611675|NCT01653912|82713448|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611676|NCT01653912|82713449|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611677|NCT01653912|82713450|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611678|NCT01653912|82713451|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611679|NCT01653912|82713452|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
46611680|NCT01653912|82713453|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
46611681|NCT02483520|82713479|FG000|Overall Study|Lost to Follow-up|3|||
46611682|NCT02483520|82713480|FG001|Overall Study|Lost to Follow-up|4|||
46611683|NCT02483520|82713479|FG000|Overall Study|Withdrawal by Subject|4|||
46611684|NCT02483520|82713480|FG001|Overall Study|Withdrawal by Subject|14|||
46611685|NCT02483520|82713479|FG000|Overall Study|Hospitalized|2|||
46611686|NCT02483520|82713480|FG001|Overall Study|Hospitalized|3|||
46611687|NCT02483520|82713479|FG000|Overall Study|Moved to LTC|2|||
46611688|NCT02483520|82713480|FG001|Overall Study|Moved to LTC|3|||
46611689|NCT02514174|82713486|FG000|Overall Study|Patient refused to continue medication|1|||
46611690|NCT02514174|82713486|FG000|Overall Study|Adverse Event|2|||
46611691|NCT02514174|82713486|FG000|Overall Study|Study closed by sponsor|9|||
46611692|NCT02514174|82713486|FG000|Overall Study|Progressive disease|11|||
46611693|NCT02514174|82713486|FG000|Overall Study|Treatment change|1|||
46611694|NCT02514174|82713486|FG000|Overall Study|Treated off study with Afatinib.|1|||
46611695|NCT02482428|82713546|FG000|Overall Study|Lost to Follow-up|4|||
46611696|NCT02482428|82713547|FG001|Overall Study|Lost to Follow-up|9|||
46611697|NCT02482428|82713548|FG002|Overall Study|Lost to Follow-up|1|||
46611698|NCT02482428|82713549|FG003|Overall Study|Lost to Follow-up|2|||
46611699|NCT02482428|82713550|FG004|Overall Study|Lost to Follow-up|4|||
46611700|NCT02482428|82713546|FG000|Overall Study|Physician Decision|0|||
46611701|NCT02482428|82713547|FG001|Overall Study|Physician Decision|0|||
46611702|NCT02482428|82713548|FG002|Overall Study|Physician Decision|0|||
46611703|NCT02482428|82713549|FG003|Overall Study|Physician Decision|0|||
46611704|NCT02482428|82713550|FG004|Overall Study|Physician Decision|1|||
46611705|NCT02482428|82713546|FG000|Overall Study|protocol deviation|1|||
46611706|NCT02482428|82713547|FG001|Overall Study|protocol deviation|1|||
46611707|NCT02482428|82713548|FG002|Overall Study|protocol deviation|0|||
46611708|NCT02482428|82713549|FG003|Overall Study|protocol deviation|0|||
46611709|NCT02482428|82713550|FG004|Overall Study|protocol deviation|0|||
46611710|NCT02482428|82713546|FG000|Overall Study|subject/guardian decision|4|||
46611711|NCT02482428|82713547|FG001|Overall Study|subject/guardian decision|2|||
46611712|NCT02482428|82713548|FG002|Overall Study|subject/guardian decision|0|||
46611713|NCT02482428|82713549|FG003|Overall Study|subject/guardian decision|0|||
46611714|NCT02482428|82713550|FG004|Overall Study|subject/guardian decision|2|||
46611715|NCT02480712|82713589|FG000|Overall Study|Enrolled but Never Treated|1|||
46611716|NCT02480712|82713589|FG000|Overall Study|Lost to Follow-up|5|||
46611717|NCT02480712|82713589|FG000|Overall Study|Withdrew Consent|3|||
46611718|NCT02480712|82713589|FG000|Overall Study|Death|1|||
46611719|NCT02480712|82713589|FG000|Overall Study|Lack of Efficacy|1|||
46611720|NCT02513550|82714858|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
46611721|NCT02513550|82714859|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
46611722|NCT02513550|82714860|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
46611723|NCT02513550|82714861|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
46611724|NCT02513550|82714862|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
46611725|NCT02513550|82714863|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
46611726|NCT02513550|82714858|FG000|Double Blind Treatment Period|Adverse Event|5|||
46611727|NCT02513550|82714859|FG001|Double Blind Treatment Period|Adverse Event|13|||
46611728|NCT02513550|82714860|FG002|Double Blind Treatment Period|Adverse Event|17|||
46611729|NCT02513550|82714861|FG003|Double Blind Treatment Period|Adverse Event|0|||
46611730|NCT02513550|82714862|FG004|Double Blind Treatment Period|Adverse Event|1|||
46611731|NCT02513550|82714863|FG005|Double Blind Treatment Period|Adverse Event|0|||
46611732|NCT02513550|82714858|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
46611733|NCT02513550|82714859|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
46611734|NCT02513550|82714860|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
46611735|NCT02513550|82714861|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
46611736|NCT02513550|82714862|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
46611737|NCT02513550|82714863|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
46611738|NCT02513550|82714858|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
46611739|NCT02513550|82714859|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
46611740|NCT02513550|82714860|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
46611741|NCT02513550|82714861|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
46611742|NCT02513550|82714862|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
46611743|NCT02513550|82714863|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
46611744|NCT02513550|82714858|FG000|Double Blind Treatment Period|Protocol Violation|1|||
46611745|NCT02513550|82714859|FG001|Double Blind Treatment Period|Protocol Violation|1|||
46611746|NCT02513550|82714860|FG002|Double Blind Treatment Period|Protocol Violation|4|||
46611747|NCT02513550|82714861|FG003|Double Blind Treatment Period|Protocol Violation|0|||
46611748|NCT02513550|82714862|FG004|Double Blind Treatment Period|Protocol Violation|0|||
46611749|NCT02513550|82714863|FG005|Double Blind Treatment Period|Protocol Violation|0|||
46611750|NCT02513550|82714858|FG000|Double Blind Treatment Period|Physician Decision|2|||
46611751|NCT02513550|82714859|FG001|Double Blind Treatment Period|Physician Decision|0|||
46611752|NCT02513550|82714860|FG002|Double Blind Treatment Period|Physician Decision|4|||
46611753|NCT02513550|82714861|FG003|Double Blind Treatment Period|Physician Decision|0|||
46611754|NCT02513550|82714862|FG004|Double Blind Treatment Period|Physician Decision|0|||
46611755|NCT02513550|82714863|FG005|Double Blind Treatment Period|Physician Decision|0|||
46611756|NCT02513550|82714858|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
46611757|NCT02513550|82714859|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
46611758|NCT02513550|82714860|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
46611759|NCT02513550|82714861|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
46611760|NCT02513550|82714862|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
46611761|NCT02513550|82714863|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
46611762|NCT02513550|82714858|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
46611763|NCT02513550|82714859|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
46611764|NCT02513550|82714860|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
46611765|NCT02513550|82714861|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
46893541|NCT02959918|83118097|FG005|Overall Study|Lost to Follow-up|0|||
46611766|NCT02513550|82714862|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
46611767|NCT02513550|82714863|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
46611768|NCT02513550|82714858|FG000|Double Blind Treatment Period|Due to personal business|2|||
46611769|NCT02513550|82714859|FG001|Double Blind Treatment Period|Due to personal business|0|||
46611770|NCT02513550|82714860|FG002|Double Blind Treatment Period|Due to personal business|1|||
46611771|NCT02513550|82714861|FG003|Double Blind Treatment Period|Due to personal business|0|||
46611772|NCT02513550|82714862|FG004|Double Blind Treatment Period|Due to personal business|0|||
46611773|NCT02513550|82714863|FG005|Double Blind Treatment Period|Due to personal business|0|||
46611774|NCT02513550|82714858|FG000|Double Blind Treatment Period|Death|1|||
46611775|NCT02513550|82714859|FG001|Double Blind Treatment Period|Death|0|||
46611776|NCT02513550|82714860|FG002|Double Blind Treatment Period|Death|2|||
46611777|NCT02513550|82714861|FG003|Double Blind Treatment Period|Death|0|||
46611778|NCT02513550|82714862|FG004|Double Blind Treatment Period|Death|0|||
46611779|NCT02513550|82714863|FG005|Double Blind Treatment Period|Death|0|||
46611780|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
46611781|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
46611782|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
46611783|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46611784|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46611785|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
46611786|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
46611787|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
46611788|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
46611789|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
46611790|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
46611791|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
46611792|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
46611793|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
46611794|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
46611795|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46611796|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46611797|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
46611798|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
46611799|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
46611800|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
46611801|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
46611802|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
46611803|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
46611804|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
46611805|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
46611806|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
46611807|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
46611808|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
46611809|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
46611810|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Death|0|||
46611811|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Death|0|||
46611812|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Death|1|||
46611813|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Death|0|||
46611814|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Death|0|||
46611815|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Death|0|||
46611816|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
46611817|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
46611818|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
46611819|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
46611820|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
46611821|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
46611822|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
46611823|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
46611824|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
46611825|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
46611826|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
46611827|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
46611828|NCT02513550|82714858|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
46611829|NCT02513550|82714859|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
46611830|NCT02513550|82714860|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
46611831|NCT02513550|82714861|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
46611832|NCT02513550|82714862|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
46611833|NCT02513550|82714863|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
46611834|NCT02513472|82715197|FG000|Overall Study|Radiological Disease Progression|45|||
46611835|NCT02513472|82715198|FG001|Overall Study|Radiological Disease Progression|57|||
46611836|NCT02513472|82715197|FG000|Overall Study|Clinical Disease Progression|5|||
46611837|NCT02513472|82715198|FG001|Overall Study|Clinical Disease Progression|13|||
46611838|NCT02513472|82715197|FG000|Overall Study|Adverse Event|8|||
46611839|NCT02513472|82715198|FG001|Overall Study|Adverse Event|11|||
46611840|NCT02513472|82715197|FG000|Overall Study|Withdrawal by Subject|0|||
46611841|NCT02513472|82715198|FG001|Overall Study|Withdrawal by Subject|4|||
46611842|NCT02513472|82715197|FG000|Overall Study|Subject Choice|2|||
46611843|NCT02513472|82715198|FG001|Overall Study|Subject Choice|7|||
46611844|NCT02513472|82715197|FG000|Overall Study|Treatment Completed as per Protocol|3|||
46611845|NCT02513472|82715198|FG001|Overall Study|Treatment Completed as per Protocol|3|||
46611846|NCT02513472|82715197|FG000|Overall Study|Other|3|||
46611847|NCT02513472|82715198|FG001|Overall Study|Other|6|||
46611848|NCT04490395|82715418|FG000|Overall Study|Lost to Follow-up|0|||
46611849|NCT04490395|82715419|FG001|Overall Study|Lost to Follow-up|1|||
46611850|NCT03843541|82715862|FG000|Overall Study|Adverse Event|4|||
46611851|NCT03843541|82715863|FG001|Overall Study|Adverse Event|2|||
46611852|NCT03843541|82715864|FG002|Overall Study|Adverse Event|3|||
46611853|NCT03843541|82715862|FG000|Overall Study|Death|1|||
46611854|NCT03843541|82715863|FG001|Overall Study|Death|0|||
46611855|NCT03843541|82715864|FG002|Overall Study|Death|0|||
46611856|NCT03843541|82715862|FG000|Overall Study|Lack of adherence to study medication|0|||
46611857|NCT03843541|82715863|FG001|Overall Study|Lack of adherence to study medication|0|||
46611858|NCT03843541|82715864|FG002|Overall Study|Lack of adherence to study medication|1|||
46611859|NCT03843541|82715862|FG000|Overall Study|Physician Decision|1|||
46611860|NCT03843541|82715863|FG001|Overall Study|Physician Decision|2|||
46611861|NCT03843541|82715864|FG002|Overall Study|Physician Decision|2|||
46611862|NCT03843541|82715862|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
46611863|NCT03843541|82715863|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
46611864|NCT03843541|82715864|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
46611865|NCT03843541|82715862|FG000|Overall Study|Withdrawal by Subject|6|||
46611866|NCT03843541|82715863|FG001|Overall Study|Withdrawal by Subject|9|||
46611867|NCT03843541|82715864|FG002|Overall Study|Withdrawal by Subject|7|||
46611868|NCT03843541|82715862|FG000|Overall Study|Administration of rescue mucolytic|0|||
46611869|NCT03843541|82715863|FG001|Overall Study|Administration of rescue mucolytic|0|||
46611870|NCT03843541|82715864|FG002|Overall Study|Administration of rescue mucolytic|1|||
46611871|NCT03843541|82715862|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
46611872|NCT03843541|82715863|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
46611873|NCT03843541|82715864|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
46611874|NCT02992418|82717127|FG000|Overall Study|Withdrawal by Subject|11|||
46611875|NCT02992418|82717128|FG001|Overall Study|Withdrawal by Subject|12|||
46611876|NCT02992418|82717127|FG000|Overall Study|Non-compliance with the protocol|308|||
46611877|NCT02992418|82717128|FG001|Overall Study|Non-compliance with the protocol|308|||
46611878|NCT02992418|82717127|FG000|Overall Study|Lost to Follow-up|27|||
46611879|NCT02992418|82717128|FG001|Overall Study|Lost to Follow-up|22|||
46611880|NCT01276106|82717370|FG000|Overall Study|Adverse Event|3|||
46611881|NCT01276106|82717371|FG001|Overall Study|Adverse Event|3|||
46611882|NCT01276106|82717372|FG002|Overall Study|Adverse Event|11|||
46611883|NCT01276106|82717373|FG003|Overall Study|Adverse Event|3|||
46611884|NCT01276106|82717370|FG000|Overall Study|Withdrawal by Subject|6|||
46611885|NCT01276106|82717371|FG001|Overall Study|Withdrawal by Subject|3|||
46611886|NCT01276106|82717372|FG002|Overall Study|Withdrawal by Subject|1|||
46611887|NCT01276106|82717373|FG003|Overall Study|Withdrawal by Subject|6|||
46611888|NCT01276106|82717370|FG000|Overall Study|Lack of Efficacy|0|||
46611889|NCT01276106|82717371|FG001|Overall Study|Lack of Efficacy|1|||
46611890|NCT01276106|82717372|FG002|Overall Study|Lack of Efficacy|0|||
46611891|NCT01276106|82717373|FG003|Overall Study|Lack of Efficacy|1|||
46611892|NCT01276106|82717370|FG000|Overall Study|Lost to Follow-up|2|||
46611893|NCT01276106|82717371|FG001|Overall Study|Lost to Follow-up|1|||
46611894|NCT01276106|82717372|FG002|Overall Study|Lost to Follow-up|1|||
46611895|NCT01276106|82717373|FG003|Overall Study|Lost to Follow-up|0|||
46611896|NCT01276106|82717370|FG000|Overall Study|Physician Decision|0|||
46611897|NCT01276106|82717371|FG001|Overall Study|Physician Decision|0|||
46611898|NCT01276106|82717372|FG002|Overall Study|Physician Decision|1|||
46611899|NCT01276106|82717373|FG003|Overall Study|Physician Decision|1|||
46611900|NCT01276106|82717370|FG000|Overall Study|Protocol Violation|1|||
46611901|NCT01276106|82717371|FG001|Overall Study|Protocol Violation|1|||
46611902|NCT01276106|82717372|FG002|Overall Study|Protocol Violation|0|||
46611903|NCT01276106|82717373|FG003|Overall Study|Protocol Violation|2|||
46611904|NCT01276106|82717370|FG000|Overall Study|Insufficient therapeutic effects|0|||
46611905|NCT01276106|82717371|FG001|Overall Study|Insufficient therapeutic effects|0|||
46611906|NCT01276106|82717372|FG002|Overall Study|Insufficient therapeutic effects|2|||
46611907|NCT01276106|82717373|FG003|Overall Study|Insufficient therapeutic effects|0|||
46611908|NCT01275170|82717391|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
46611909|NCT01275170|82717392|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
46611910|NCT01275170|82717393|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
46611911|NCT01275170|82717394|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
46611912|NCT01275170|82717395|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
46611913|NCT01275170|82717396|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
46893542|NCT02959918|83118098|FG006|Overall Study|Lost to Follow-up|0|||
46893543|NCT02959918|83118099|FG007|Overall Study|Lost to Follow-up|0|||
46893544|NCT02959918|83118100|FG008|Overall Study|Lost to Follow-up|0|||
46893545|NCT02959918|83118101|FG009|Overall Study|Lost to Follow-up|1|||
46893546|NCT02959918|83118102|FG010|Overall Study|Lost to Follow-up|0|||
46893547|NCT02959918|83118103|FG011|Overall Study|Lost to Follow-up|0|||
46893548|NCT02959918|83118104|FG012|Overall Study|Lost to Follow-up|1|||
46893549|NCT02959918|83118105|FG013|Overall Study|Lost to Follow-up|0|||
46893550|NCT02959918|83118092|FG000|Overall Study|Withdrawal by Subject|0|||
46893551|NCT02959918|83118093|FG001|Overall Study|Withdrawal by Subject|0|||
46893552|NCT02959918|83118094|FG002|Overall Study|Withdrawal by Subject|1|||
46893553|NCT02959918|83118095|FG003|Overall Study|Withdrawal by Subject|2|||
46893554|NCT02959918|83118096|FG004|Overall Study|Withdrawal by Subject|0|||
46893555|NCT02959918|83118097|FG005|Overall Study|Withdrawal by Subject|0|||
46893556|NCT02959918|83118098|FG006|Overall Study|Withdrawal by Subject|1|||
46893557|NCT02959918|83118099|FG007|Overall Study|Withdrawal by Subject|0|||
46893558|NCT02959918|83118100|FG008|Overall Study|Withdrawal by Subject|1|||
46893559|NCT02959918|83118101|FG009|Overall Study|Withdrawal by Subject|1|||
46893560|NCT02959918|83118102|FG010|Overall Study|Withdrawal by Subject|2|||
46893561|NCT02959918|83118103|FG011|Overall Study|Withdrawal by Subject|3|||
46893562|NCT02959918|83118104|FG012|Overall Study|Withdrawal by Subject|1|||
46893563|NCT02959918|83118105|FG013|Overall Study|Withdrawal by Subject|1|||
46893564|NCT02959918|83118092|FG000|Overall Study|Protocol Violation|0|||
46893565|NCT02959918|83118093|FG001|Overall Study|Protocol Violation|0|||
46893566|NCT02959918|83118094|FG002|Overall Study|Protocol Violation|1|||
46893567|NCT02959918|83118095|FG003|Overall Study|Protocol Violation|0|||
46893568|NCT02959918|83118096|FG004|Overall Study|Protocol Violation|0|||
46893569|NCT02959918|83118097|FG005|Overall Study|Protocol Violation|1|||
46893570|NCT02959918|83118098|FG006|Overall Study|Protocol Violation|0|||
46893571|NCT02959918|83118099|FG007|Overall Study|Protocol Violation|0|||
46893572|NCT02959918|83118100|FG008|Overall Study|Protocol Violation|2|||
46893573|NCT02959918|83118101|FG009|Overall Study|Protocol Violation|1|||
46893574|NCT02959918|83118102|FG010|Overall Study|Protocol Violation|0|||
46893575|NCT02959918|83118103|FG011|Overall Study|Protocol Violation|1|||
46893576|NCT02959918|83118104|FG012|Overall Study|Protocol Violation|1|||
46893577|NCT02959918|83118105|FG013|Overall Study|Protocol Violation|0|||
46893578|NCT02959918|83118092|FG000|Overall Study|Stopping Rule Met|1|||
46893579|NCT02959918|83118093|FG001|Overall Study|Stopping Rule Met|0|||
46893580|NCT02959918|83118094|FG002|Overall Study|Stopping Rule Met|3|||
46893581|NCT02959918|83118095|FG003|Overall Study|Stopping Rule Met|4|||
46893582|NCT02959918|83118096|FG004|Overall Study|Stopping Rule Met|5|||
46893583|NCT02959918|83118097|FG005|Overall Study|Stopping Rule Met|3|||
46893584|NCT02959918|83118098|FG006|Overall Study|Stopping Rule Met|2|||
46893585|NCT02959918|83118099|FG007|Overall Study|Stopping Rule Met|4|||
46893586|NCT02959918|83118100|FG008|Overall Study|Stopping Rule Met|1|||
46893587|NCT02959918|83118101|FG009|Overall Study|Stopping Rule Met|1|||
46893588|NCT02959918|83118102|FG010|Overall Study|Stopping Rule Met|3|||
46893589|NCT02959918|83118103|FG011|Overall Study|Stopping Rule Met|5|||
46893590|NCT02959918|83118104|FG012|Overall Study|Stopping Rule Met|2|||
46893591|NCT02959918|83118105|FG013|Overall Study|Stopping Rule Met|1|||
46893592|NCT02959918|83118092|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
46893593|NCT02959918|83118093|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
46893594|NCT02959918|83118094|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
46893595|NCT02959918|83118095|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
46893596|NCT02959918|83118096|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893597|NCT02959918|83118097|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893598|NCT02959918|83118098|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893599|NCT02959918|83118099|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893600|NCT02959918|83118100|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893601|NCT02959918|83118101|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893602|NCT02959918|83118102|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893603|NCT02959918|83118103|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893604|NCT02959918|83118104|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893605|NCT02959918|83118105|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
46893606|NCT02959918|83118092|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893607|NCT02959918|83118093|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893608|NCT02959918|83118094|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893609|NCT02959918|83118095|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893610|NCT02959918|83118096|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893611|NCT02959918|83118097|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893612|NCT02959918|83118098|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893613|NCT02959918|83118099|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
46893614|NCT02959918|83118100|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893615|NCT02959918|83118101|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893616|NCT02959918|83118102|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893617|NCT02959918|83118103|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893618|NCT02959918|83118104|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893619|NCT02959918|83118105|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
46893620|NCT02959918|83118092|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893621|NCT02959918|83118093|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893622|NCT02959918|83118094|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893623|NCT02959918|83118095|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893624|NCT02959918|83118096|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893625|NCT02959918|83118097|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893626|NCT02959918|83118098|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893627|NCT02959918|83118099|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893628|NCT02959918|83118100|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
46893629|NCT02959918|83118101|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893630|NCT02959918|83118102|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893631|NCT02959918|83118103|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893632|NCT02959918|83118104|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893633|NCT02959918|83118105|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
46893634|NCT02959918|83118092|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893635|NCT02959918|83118093|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893636|NCT02959918|83118094|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893637|NCT02959918|83118095|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893638|NCT02959918|83118096|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893639|NCT02959918|83118097|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893640|NCT02959918|83118098|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893641|NCT02959918|83118099|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893642|NCT02959918|83118100|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893643|NCT02959918|83118101|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
46893644|NCT02959918|83118102|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893645|NCT02959918|83118103|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893646|NCT02959918|83118104|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893647|NCT02959918|83118105|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
46893648|NCT03263442|83118140|FG000|Inpatient Phase|Death|1|||
46893649|NCT03263442|83118141|FG001|Inpatient Phase|Death|0|||
46893650|NCT03263442|83118140|FG000|Inpatient Phase|Withdrawal by Subject|1|||
46893651|NCT03263442|83118141|FG001|Inpatient Phase|Withdrawal by Subject|0|||
46893652|NCT03263442|83118140|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
46893653|NCT03263442|83118141|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
46893654|NCT03263442|83118140|FG000|1-month Follow-Up|Lost to Follow-up|1|||
46893655|NCT03263442|83118141|FG001|1-month Follow-Up|Lost to Follow-up|0|||
46893656|NCT03263442|83118140|FG000|3-month Follow-Up|Lost to Follow-up|1|||
46893657|NCT03263442|83118141|FG001|3-month Follow-Up|Lost to Follow-up|3|||
46893658|NCT03263442|83118140|FG000|6-month Follow-Up|Lost to Follow-up|2|||
46893659|NCT03263442|83118141|FG001|6-month Follow-Up|Lost to Follow-up|2|||
46893660|NCT04245709|83118149|FG000|Overall Study|Adverse Event|13|||
46893661|NCT04245709|83118149|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
46893662|NCT04091581|83118155|FG000|Overall Study|Lost to Follow-up|0|||
46893663|NCT04091581|83118156|FG001|Overall Study|Lost to Follow-up|1|||
46893664|NCT02940522|83118164|FG000|Overall Study|Lost to Follow-up|1|||
46893665|NCT02940522|83118165|FG001|Overall Study|Lost to Follow-up|2|||
46893666|NCT02940522|83118164|FG000|Overall Study|Withdrawal by Subject|1|||
46893667|NCT02940522|83118165|FG001|Overall Study|Withdrawal by Subject|0|||
46893668|NCT03262038|83118173|FG000|Overall Study|Withdrawal by Subject|0|||
46893669|NCT03262038|83118174|FG001|Overall Study|Withdrawal by Subject|1|||
46893670|NCT02472964|83118182|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
46893671|NCT02472964|83118183|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
46893672|NCT02472964|83118182|FG000|Part 1 (up to Week 24)|disease progression|58|||
46893673|NCT02472964|83118183|FG001|Part 1 (up to Week 24)|disease progression|47|||
46893674|NCT02472964|83118182|FG000|Part 1 (up to Week 24)|Death|3|||
46893675|NCT02472964|83118183|FG001|Part 1 (up to Week 24)|Death|6|||
46893676|NCT02472964|83118182|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
46893677|NCT02472964|83118183|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
46893678|NCT02472964|83118182|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
46893679|NCT02472964|83118183|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
46893680|NCT02472964|83118182|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
46893681|NCT02472964|83118183|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
46893682|NCT02472964|83118182|FG000|Part 1 (up to Week 24)|Other|2|||
46893683|NCT02472964|83118183|FG001|Part 1 (up to Week 24)|Other|1|||
46893684|NCT02472964|83118182|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
46893685|NCT02472964|83118183|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
46893686|NCT02472964|83118182|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
46893687|NCT02472964|83118183|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
46893688|NCT02472964|83118182|FG000|Part 2 (Week 24-week 48)|Death|0|||
46893689|NCT02472964|83118183|FG001|Part 2 (Week 24-week 48)|Death|1|||
46893690|NCT02472964|83118182|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
46893691|NCT02472964|83118183|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
46893692|NCT02472964|83118182|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
46893693|NCT02472964|83118183|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
46893694|NCT02472964|83118182|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
46893695|NCT02472964|83118183|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
46893696|NCT02472964|83118182|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
46893697|NCT02472964|83118183|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
46893698|NCT04079803|83118196|FG000|Overall Study|Withdrawal by Subject|0|||
46893699|NCT04079803|83118197|FG001|Overall Study|Withdrawal by Subject|0|||
46893700|NCT04079803|83118198|FG002|Overall Study|Withdrawal by Subject|1|||
46893701|NCT03278613|83118226|FG000|Overall Study|Lost to Follow-up|3|||
46893702|NCT03278613|83118227|FG001|Overall Study|Lost to Follow-up|1|||
46893703|NCT03761147|83118235|FG000|Overall Study|Withdrawal by Subject|6|||
46893704|NCT03761147|83118236|FG001|Overall Study|Withdrawal by Subject|1|||
46893705|NCT03761147|83118235|FG000|Overall Study|Adverse Event|1|||
46893706|NCT03761147|83118236|FG001|Overall Study|Adverse Event|3|||
46893707|NCT04076917|83118242|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
46893708|NCT04076917|83118242|FG000|Overall Study|Study closure|13|||
46893709|NCT04076917|83118242|FG000|Overall Study|Physician Decision|3|||
46893710|NCT04076917|83118242|FG000|Overall Study|Death|1|||
46893711|NCT04076917|83118242|FG000|Overall Study|Lost to Follow-up|1|||
46893712|NCT04076917|83118242|FG000|Overall Study|Withdrawal by Subject|1|||
46893713|NCT04076917|83118242|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
46893714|NCT04222699|83118246|FG000|Overall Study|Lost to Follow-up|2|||
46893715|NCT02731690|83118259|FG000|Overall Study|Adverse Event|1|||
46893716|NCT02731690|83118259|FG000|Overall Study|Withdrawal by Subject|3|||
46893717|NCT02731690|83118259|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
46893718|NCT04075513|83118265|FG000|Overall Study|Withdrawal by Subject|2|||
46893719|NCT04075513|83118266|FG001|Overall Study|Withdrawal by Subject|2|||
46893720|NCT04075513|83118265|FG000|Overall Study|Lack of Efficacy|1|||
46893721|NCT04075513|83118266|FG001|Overall Study|Lack of Efficacy|0|||
46893722|NCT04075513|83118265|FG000|Overall Study|Lost to Follow-up|4|||
46893723|NCT04075513|83118266|FG001|Overall Study|Lost to Follow-up|2|||
46893724|NCT04075513|83118265|FG000|Overall Study|Switch to insulin pump|1|||
46893725|NCT04075513|83118266|FG001|Overall Study|Switch to insulin pump|0|||
46893726|NCT04073407|83118274|FG000|Part 1|Withdrawal by Subject|1|||
46893727|NCT04073407|83118275|FG001|Part 1|Withdrawal by Subject|0|||
46893728|NCT04073407|83118274|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
46893729|NCT04073407|83118275|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
46893730|NCT04073407|83118274|FG000|Part 2|Withdrawal by Subject|0|||
46893731|NCT04073407|83118275|FG001|Part 2|Withdrawal by Subject|1|||
46893732|NCT02778204|83118285|FG000|Overall Study|Adverse Event|1|||
46893733|NCT02778204|83118286|FG001|Overall Study|Adverse Event|0|||
46893734|NCT02778204|83118287|FG002|Overall Study|Adverse Event|0|||
46893735|NCT02778204|83118288|FG003|Overall Study|Adverse Event|0|||
46893736|NCT02778204|83118285|FG000|Overall Study|Withdrawal by Subject|0|||
46893737|NCT02778204|83118286|FG001|Overall Study|Withdrawal by Subject|0|||
46893738|NCT02778204|83118287|FG002|Overall Study|Withdrawal by Subject|1|||
46893739|NCT02778204|83118288|FG003|Overall Study|Withdrawal by Subject|2|||
46893740|NCT02778204|83118285|FG000|Overall Study|Lost to Follow-up|1|||
46893741|NCT02778204|83118286|FG001|Overall Study|Lost to Follow-up|0|||
46893742|NCT02778204|83118287|FG002|Overall Study|Lost to Follow-up|2|||
46893743|NCT02778204|83118288|FG003|Overall Study|Lost to Follow-up|1|||
46893744|NCT02778204|83118285|FG000|Overall Study|Protocol Violation|0|||
46893745|NCT02778204|83118286|FG001|Overall Study|Protocol Violation|0|||
46893746|NCT02778204|83118287|FG002|Overall Study|Protocol Violation|1|||
46893747|NCT02778204|83118288|FG003|Overall Study|Protocol Violation|0|||
46893748|NCT02778204|83118285|FG000|Overall Study|Eligibility Violation|0|||
46893749|NCT02778204|83118286|FG001|Overall Study|Eligibility Violation|0|||
46893750|NCT02778204|83118287|FG002|Overall Study|Eligibility Violation|0|||
46893751|NCT02778204|83118288|FG003|Overall Study|Eligibility Violation|1|||
46893752|NCT04072159|83118302|FG000|Overall Study|Lost to Follow-up|6|||
46893753|NCT04072159|83118303|FG001|Overall Study|Lost to Follow-up|6|||
46893754|NCT04072159|83118302|FG000|Overall Study|Withdrawal by Subject|2|||
46893755|NCT04072159|83118303|FG001|Overall Study|Withdrawal by Subject|0|||
46893756|NCT03232281|83118312|FG000|Overall Study|Adverse Event|1|||
46893757|NCT03232281|83118313|FG001|Overall Study|Adverse Event|1|||
46893758|NCT03232281|83118312|FG000|Overall Study|Withdrawal by Subject|5|||
46893759|NCT03232281|83118313|FG001|Overall Study|Withdrawal by Subject|4|||
46893760|NCT03232281|83118312|FG000|Overall Study|Protocol Deviation|1|||
46893761|NCT03232281|83118313|FG001|Overall Study|Protocol Deviation|1|||
46893762|NCT04071301|83118319|FG000|Overall Study|Withdrawal by Subject|6|||
46893763|NCT04071301|83118319|FG000|Overall Study|Death|1|||
46893764|NCT03261336|83118323|FG000|Overall Study|Adverse Event|1|||
46893765|NCT00462748|83118330|FG000|Overall Study|Adverse Event|7|||
46893766|NCT00462748|83118331|FG001|Overall Study|Adverse Event|5|||
46893767|NCT00462748|83118332|FG002|Overall Study|Adverse Event|9|||
46893768|NCT00462748|83118330|FG000|Overall Study|Protocol Violation|0|||
46893769|NCT00462748|83118331|FG001|Overall Study|Protocol Violation|2|||
46893770|NCT00462748|83118332|FG002|Overall Study|Protocol Violation|1|||
46893771|NCT00462748|83118330|FG000|Overall Study|Withdrew consent|3|||
46893772|NCT00462748|83118331|FG001|Overall Study|Withdrew consent|3|||
46893773|NCT00462748|83118332|FG002|Overall Study|Withdrew consent|0|||
46893774|NCT00462748|83118330|FG000|Overall Study|Lost to Follow-up|1|||
46893775|NCT00462748|83118331|FG001|Overall Study|Lost to Follow-up|1|||
46893776|NCT00462748|83118332|FG002|Overall Study|Lost to Follow-up|1|||
46893777|NCT00462748|83118330|FG000|Overall Study|Discontinued after 41 days Rx|1|||
46893778|NCT00462748|83118331|FG001|Overall Study|Discontinued after 41 days Rx|0|||
46893779|NCT00462748|83118332|FG002|Overall Study|Discontinued after 41 days Rx|0|||
46893780|NCT04206085|83118343|FG000|Overall Study|Lost to Follow-up|0|||
46893781|NCT04206085|83118344|FG001|Overall Study|Lost to Follow-up|1|||
46893782|NCT04206085|83118345|FG002|Overall Study|Lost to Follow-up|0|||
46893783|NCT04206085|83118343|FG000|Overall Study|Lost to Follow-up|0|||
46893784|NCT04206085|83118344|FG001|Overall Study|Lost to Follow-up|0|||
46893785|NCT04206085|83118345|FG002|Overall Study|Lost to Follow-up|1|||
46893786|NCT04202497|83118353|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
46893787|NCT04202497|83118354|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
46893788|NCT04202497|83118355|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
46893789|NCT04202497|83118356|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
46893790|NCT03297294|83118372|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
46893791|NCT03297294|83118373|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
46893792|NCT03297294|83118374|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46893793|NCT03297294|83118375|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46893794|NCT03297294|83118376|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
46893795|NCT03297294|83118372|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
46893796|NCT03297294|83118373|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
46893797|NCT03297294|83118374|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46893798|NCT03297294|83118375|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46893799|NCT03297294|83118376|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
46893800|NCT03297294|83118372|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
46893801|NCT03297294|83118373|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
46893802|NCT03297294|83118374|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46893803|NCT03297294|83118375|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46893804|NCT03297294|83118376|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
46893805|NCT03297294|83118372|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
46893806|NCT03297294|83118373|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
46893807|NCT03297294|83118374|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46893808|NCT03297294|83118375|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46893809|NCT03297294|83118376|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
46893810|NCT03297294|83118372|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
46893811|NCT03297294|83118373|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
46893812|NCT03297294|83118374|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
46893813|NCT03297294|83118375|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
46893814|NCT03297294|83118376|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
46893815|NCT03238911|83118390|FG000|Overall Study|Withdrawal by Subject|1|||
46893816|NCT03238911|83118391|FG001|Overall Study|Withdrawal by Subject|2|||
46893817|NCT03238911|83118390|FG000|Overall Study|Lost to Follow-up|2|||
46893818|NCT03238911|83118391|FG001|Overall Study|Lost to Follow-up|1|||
46893819|NCT00418834|83118400|FG000|Overall Study|Adverse Event|16|||
46893820|NCT00418834|83118401|FG001|Overall Study|Adverse Event|9|||
46893821|NCT00418834|83118400|FG000|Overall Study|Lost to Follow-up|0|||
46893822|NCT00418834|83118401|FG001|Overall Study|Lost to Follow-up|1|||
46893823|NCT00418834|83118400|FG000|Overall Study|Protocol Violation|4|||
46893824|NCT00418834|83118401|FG001|Overall Study|Protocol Violation|3|||
46893825|NCT00418834|83118400|FG000|Overall Study|Withdrawal by Subject|3|||
46893826|NCT00418834|83118401|FG001|Overall Study|Withdrawal by Subject|7|||
46893827|NCT03276975|83118409|FG000|Overall Study|Withdrawal by Subject|1|||
46893828|NCT03276975|83118410|FG001|Overall Study|Withdrawal by Subject|0|||
46893829|NCT03297216|83118418|FG000|Overall Study|Death|0|||
46893830|NCT03297216|83118419|FG001|Overall Study|Death|1|||
46893831|NCT03297216|83118418|FG000|Overall Study|Miscarriage|0|||
46893832|NCT03297216|83118419|FG001|Overall Study|Miscarriage|2|||
46893833|NCT03297216|83118418|FG000|Overall Study|Lost to Follow-up|3|||
46893834|NCT03297216|83118419|FG001|Overall Study|Lost to Follow-up|2|||
46893835|NCT03260868|83118434|FG000|Overall Study|Poor Compliance to Protocol|0|||
46893836|NCT03260868|83118435|FG001|Overall Study|Poor Compliance to Protocol|2|||
46893837|NCT03260868|83118434|FG000|Overall Study|Study Terminated By Sponsor|2|||
46893838|NCT03260868|83118435|FG001|Overall Study|Study Terminated By Sponsor|1|||
46893839|NCT03260868|83118434|FG000|Overall Study|Other than specified above|1|||
46893840|NCT03260868|83118435|FG001|Overall Study|Other than specified above|0|||
46893841|NCT03293394|83118443|FG000|Follow-up (6 Months)|Adverse Event|4|||
46893842|NCT03293394|83118444|FG001|Follow-up (6 Months)|Adverse Event|2|||
46893843|NCT03259308|83118453|FG000|Overall Study|Adverse Event|5|||
46893844|NCT03259308|83118454|FG001|Overall Study|Adverse Event|4|||
46893845|NCT03259308|83118455|FG002|Overall Study|Adverse Event|1|||
46893846|NCT03259308|83118453|FG000|Overall Study|Withdrawal by Subject|2|||
46893847|NCT03259308|83118454|FG001|Overall Study|Withdrawal by Subject|1|||
46893848|NCT03259308|83118455|FG002|Overall Study|Withdrawal by Subject|3|||
46893849|NCT03259308|83118453|FG000|Overall Study|Lost to Follow-up|0|||
46893850|NCT03259308|83118454|FG001|Overall Study|Lost to Follow-up|0|||
46893851|NCT03259308|83118455|FG002|Overall Study|Lost to Follow-up|1|||
46893852|NCT03259308|83118453|FG000|Overall Study|Pregnancy|0|||
46893853|NCT03259308|83118454|FG001|Overall Study|Pregnancy|0|||
46893854|NCT03259308|83118455|FG002|Overall Study|Pregnancy|1|||
46893855|NCT03259308|83118453|FG000|Overall Study|Protocol Deviation|0|||
46893856|NCT03259308|83118454|FG001|Overall Study|Protocol Deviation|3|||
46893857|NCT03259308|83118455|FG002|Overall Study|Protocol Deviation|0|||
46893858|NCT03259308|83118453|FG000|Overall Study|Lack of Efficacy|0|||
46893859|NCT03259308|83118454|FG001|Overall Study|Lack of Efficacy|0|||
46893860|NCT03259308|83118455|FG002|Overall Study|Lack of Efficacy|1|||
46893861|NCT03258762|83118465|FG000|Overall Study|Lost to Follow-up|0|||
46893862|NCT03258762|83118466|FG001|Overall Study|Lost to Follow-up|1|||
46893863|NCT04502589|83118475|FG000|Overall Study|Physician Decision|1|||
46893864|NCT04502589|83118476|FG001|Overall Study|Physician Decision|0|||
46893865|NCT03291288|83118482|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
46893866|NCT03291288|83118483|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
46893867|NCT03291288|83118482|FG000|Drug-drug Interaction Phase|Disease progression|1|||
46893868|NCT03291288|83118483|FG001|Drug-drug Interaction Phase|Disease progression|0|||
46893869|NCT03291288|83118482|FG000|Drug-drug Interaction Phase|Other|3|||
46893870|NCT03291288|83118483|FG001|Drug-drug Interaction Phase|Other|0|||
46893871|NCT03291288|83118482|FG000|Pexidartinib Only|Ongoing|0|||
46893872|NCT03291288|83118483|FG001|Pexidartinib Only|Ongoing|2|||
46893873|NCT03257358|83118508|FG000|Overall Study|Adverse Event|25|||
46893874|NCT03257358|83118509|FG001|Overall Study|Adverse Event|12|||
46893875|NCT03257358|83118508|FG000|Overall Study|Lack of Efficacy|1|||
46893876|NCT03257358|83118509|FG001|Overall Study|Lack of Efficacy|1|||
46893877|NCT03257358|83118508|FG000|Overall Study|Lost to Follow-up|12|||
46893878|NCT03257358|83118509|FG001|Overall Study|Lost to Follow-up|4|||
46893879|NCT03257358|83118508|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
46893880|NCT03257358|83118509|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
46893881|NCT03257358|83118508|FG000|Overall Study|Physician Decision|2|||
46893882|NCT03257358|83118509|FG001|Overall Study|Physician Decision|2|||
46893883|NCT03257358|83118508|FG000|Overall Study|Protocol Violation|5|||
46893884|NCT03257358|83118509|FG001|Overall Study|Protocol Violation|3|||
46893885|NCT03257358|83118508|FG000|Overall Study|Technical problems|4|||
46893886|NCT03257358|83118509|FG001|Overall Study|Technical problems|1|||
46893887|NCT03257358|83118508|FG000|Overall Study|Withdrawal by Subject|8|||
46893888|NCT03257358|83118509|FG001|Overall Study|Withdrawal by Subject|3|||
46611914|NCT01275170|82717397|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
46706816|NCT04713553|82922134|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
46893889|NCT03257358|83118508|FG000|Overall Study|Withdrawal of informed consent|9|||
46893890|NCT03257358|83118509|FG001|Overall Study|Withdrawal of informed consent|5|||
46893891|NCT03257358|83118508|FG000|Overall Study|New therapy for study indication|1|||
46893892|NCT03257358|83118509|FG001|Overall Study|New therapy for study indication|0|||
46893893|NCT03257358|83118508|FG000|Overall Study|No longer requires treatment|0|||
46893894|NCT03257358|83118509|FG001|Overall Study|No longer requires treatment|1|||
46893895|NCT02936037|83118517|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
46893896|NCT02936037|83118518|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
46893897|NCT02936037|83118517|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
46893898|NCT02936037|83118518|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
46893899|NCT02936037|83118517|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
46893900|NCT02936037|83118518|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
46893901|NCT02936037|83118517|FG000|Double-Blind Treatment Period|Death|0|||
46893902|NCT02936037|83118518|FG001|Double-Blind Treatment Period|Death|1|||
46893903|NCT02936037|83118517|FG000|Double-Blind Treatment Period|Adverse Event|11|||
46893904|NCT02936037|83118518|FG001|Double-Blind Treatment Period|Adverse Event|11|||
46893905|NCT02936037|83118517|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
46893906|NCT02936037|83118518|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
46893907|NCT02936037|83118517|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
46893908|NCT02936037|83118518|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
46893909|NCT02936037|83118517|FG000|Open Label Extension|Adverse Event|0|||
46893910|NCT02936037|83118518|FG001|Open Label Extension|Adverse Event|3|||
46893911|NCT02936037|83118517|FG000|Open Label Extension|Other|0|||
46893912|NCT02936037|83118518|FG001|Open Label Extension|Other|3|||
46893913|NCT02936037|83118517|FG000|Open Label Extension|Withdrawal by Subject|0|||
46893914|NCT02936037|83118518|FG001|Open Label Extension|Withdrawal by Subject|4|||
46893915|NCT03288714|83118526|FG000|Overall Study|Lost to Follow-up|2|||
46893916|NCT03288714|83118527|FG001|Overall Study|Lost to Follow-up|1|||
46893917|NCT03288714|83118526|FG000|Overall Study|Non-compliance with study schedule|2|||
46893918|NCT03288714|83118527|FG001|Overall Study|Non-compliance with study schedule|0|||
46893919|NCT03288714|83118526|FG000|Overall Study|Withdrawal by Subject|3|||
46893920|NCT03288714|83118527|FG001|Overall Study|Withdrawal by Subject|1|||
46893921|NCT03288714|83118526|FG000|Overall Study|Clinical Worsening|2|||
46893922|NCT03288714|83118527|FG001|Overall Study|Clinical Worsening|1|||
46893923|NCT03288714|83118526|FG000|Overall Study|Adverse Event|1|||
46893924|NCT03288714|83118527|FG001|Overall Study|Adverse Event|0|||
46893925|NCT03256578|83118537|FG000|Overall Study|Excluded Post Randomization|66|||
46893926|NCT03256578|83118538|FG001|Overall Study|Excluded Post Randomization|56|||
46893927|NCT03227445|83118544|FG000|Period 1 (28 Days)|Adverse Event|1|||
46893928|NCT03227445|83118545|FG001|Period 1 (28 Days)|Adverse Event|2|||
46893929|NCT03227445|83118546|FG002|Period 1 (28 Days)|Adverse Event|0|||
46893930|NCT03227445|83118547|FG003|Period 1 (28 Days)|Adverse Event|1|||
46893931|NCT03227445|83118544|FG000|Period 1 (28 Days)|Protocol Violation|1|||
46893932|NCT03227445|83118545|FG001|Period 1 (28 Days)|Protocol Violation|0|||
46893933|NCT03227445|83118546|FG002|Period 1 (28 Days)|Protocol Violation|0|||
46893934|NCT03227445|83118547|FG003|Period 1 (28 Days)|Protocol Violation|0|||
46893935|NCT03227445|83118544|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
46893936|NCT03227445|83118545|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
46893937|NCT03227445|83118546|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
46893938|NCT03227445|83118547|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
46893939|NCT03227445|83118544|FG000|Period 2 (28 Days)|Adverse Event|1|||
46893940|NCT03227445|83118545|FG001|Period 2 (28 Days)|Adverse Event|0|||
46893941|NCT03227445|83118546|FG002|Period 2 (28 Days)|Adverse Event|2|||
46893942|NCT03227445|83118547|FG003|Period 2 (28 Days)|Adverse Event|1|||
46893943|NCT03227445|83118544|FG000|Period 2 (28 Days)|Protocol Violation|0|||
46893944|NCT03227445|83118545|FG001|Period 2 (28 Days)|Protocol Violation|0|||
46893945|NCT03227445|83118546|FG002|Period 2 (28 Days)|Protocol Violation|0|||
46893946|NCT03227445|83118547|FG003|Period 2 (28 Days)|Protocol Violation|1|||
46893947|NCT03227445|83118544|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
46893948|NCT03227445|83118545|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
46893949|NCT03227445|83118546|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
46893950|NCT03227445|83118547|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
46893951|NCT04067401|83118558|FG000|Overall Study|Withdrawal by Subject|7|||
46893952|NCT04067401|83118559|FG001|Overall Study|Withdrawal by Subject|0|||
46893953|NCT04067401|83118558|FG000|Overall Study|no data provided|1|||
46893954|NCT04067401|83118559|FG001|Overall Study|no data provided|0|||
46893955|NCT04194151|83118571|FG000|Overall Study|Physician Decision|1|||
46893956|NCT04194151|83118572|FG001|Overall Study|Physician Decision|1|||
46893957|NCT04194151|83118573|FG002|Overall Study|Physician Decision|1|||
46893958|NCT04194151|83118574|FG003|Overall Study|Physician Decision|1|||
46893959|NCT04194151|83118575|FG004|Overall Study|Physician Decision|0|||
46893960|NCT04194151|83118576|FG005|Overall Study|Physician Decision|1|||
46893961|NCT04194151|83118571|FG000|Overall Study|Monitorization problem|0|||
46893962|NCT04194151|83118572|FG001|Overall Study|Monitorization problem|1|||
46893963|NCT04194151|83118573|FG002|Overall Study|Monitorization problem|0|||
46893964|NCT04194151|83118574|FG003|Overall Study|Monitorization problem|0|||
46893965|NCT04194151|83118575|FG004|Overall Study|Monitorization problem|0|||
46893966|NCT04194151|83118576|FG005|Overall Study|Monitorization problem|0|||
46893967|NCT03820323|83118592|FG000|Overall Study|Lost to Follow-up|2|||
46893968|NCT03820323|83118593|FG001|Overall Study|Lost to Follow-up|1|||
46893969|NCT03820323|83118592|FG000|Overall Study|Missed 12-month visit|22|||
46893970|NCT03820323|83118593|FG001|Overall Study|Missed 12-month visit|14|||
46893971|NCT03820323|83118592|FG000|Overall Study|Death|2|||
46893972|NCT03820323|83118593|FG001|Overall Study|Death|1|||
46893973|NCT03820323|83118592|FG000|Overall Study|Transferred out|13|||
46893974|NCT03820323|83118593|FG001|Overall Study|Transferred out|11|||
46893975|NCT03820323|83118592|FG000|Overall Study|Terminated|0|||
46893976|NCT03820323|83118593|FG001|Overall Study|Terminated|3|||
46893977|NCT03820323|83118592|FG000|Overall Study|Withdrawal by Subject|1|||
46893978|NCT03820323|83118593|FG001|Overall Study|Withdrawal by Subject|6|||
46893979|NCT03287622|83118608|FG000|Overall Study|Withdrawal by Subject|1|||
46893980|NCT03287622|83118609|FG001|Overall Study|Withdrawal by Subject|0|||
46893981|NCT03287622|83118608|FG000|Overall Study|Lost to Follow-up|27|||
46893982|NCT03287622|83118609|FG001|Overall Study|Lost to Follow-up|15|||
46893983|NCT03287622|83118608|FG000|Overall Study|No prescripion after surgery|28|||
46893984|NCT03287622|83118609|FG001|Overall Study|No prescripion after surgery|31|||
46893985|NCT03287622|83118608|FG000|Overall Study|prolonged Length of stay|2|||
46893986|NCT03287622|83118609|FG001|Overall Study|prolonged Length of stay|0|||
46893987|NCT03287622|83118608|FG000|Overall Study|surgery related|0|||
46893988|NCT03287622|83118609|FG001|Overall Study|surgery related|2|||
46893989|NCT04063657|83118624|FG000|Overall Study|Lost to Follow-up|1|||
46893990|NCT04063657|83118625|FG001|Overall Study|Lost to Follow-up|0|||
46893991|NCT04058353|83118642|FG000|Overall Study|Adverse Event|2|||
46893992|NCT04058353|83118643|FG001|Overall Study|Adverse Event|1|||
46893993|NCT04058353|83118642|FG000|Overall Study|Physician Decision|1|||
46893994|NCT04058353|83118643|FG001|Overall Study|Physician Decision|0|||
46893995|NCT04058353|83118642|FG000|Overall Study|Other|1|||
46893996|NCT04058353|83118643|FG001|Overall Study|Other|0|||
46893997|NCT03226353|83118650|FG000|Overall Study|Withdrawal by Subject|1|||
46893998|NCT03226353|83118650|FG000|Overall Study|Screen Failure|5|||
46893999|NCT02730598|83118659|FG000|Overall Study|Withdrawal by Subject|3|||
46894000|NCT02730598|83118660|FG001|Overall Study|Withdrawal by Subject|3|||
46894001|NCT02730598|83118659|FG000|Overall Study|Protocol Violation|0|||
46894002|NCT02730598|83118660|FG001|Overall Study|Protocol Violation|1|||
46894003|NCT02730598|83118659|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
46894004|NCT02730598|83118660|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
46894005|NCT03226275|83118670|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
46894006|NCT03226275|83118671|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
46611915|NCT01275170|82717398|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
46611916|NCT01273064|82717445|FG000|Overall Study|Adverse Event|5|||
46611917|NCT01273064|82717446|FG001|Overall Study|Adverse Event|1|||
46611918|NCT01273064|82717447|FG002|Overall Study|Adverse Event|3|||
46611919|NCT01273064|82717448|FG003|Overall Study|Adverse Event|2|||
46611920|NCT01273064|82717449|FG004|Overall Study|Adverse Event|1|||
46611921|NCT01273064|82717445|FG000|Overall Study|Withdrawal by Subject|4|||
46611922|NCT01273064|82717446|FG001|Overall Study|Withdrawal by Subject|2|||
46611923|NCT01273064|82717447|FG002|Overall Study|Withdrawal by Subject|2|||
46611924|NCT01273064|82717448|FG003|Overall Study|Withdrawal by Subject|2|||
46611925|NCT01273064|82717449|FG004|Overall Study|Withdrawal by Subject|0|||
46611926|NCT01273064|82717445|FG000|Overall Study|Study Termination|13|||
46611927|NCT01273064|82717446|FG001|Overall Study|Study Termination|27|||
46611928|NCT01273064|82717447|FG002|Overall Study|Study Termination|26|||
46611929|NCT01273064|82717448|FG003|Overall Study|Study Termination|16|||
46611930|NCT01273064|82717449|FG004|Overall Study|Study Termination|8|||
46611931|NCT01273064|82717445|FG000|Overall Study|Lost to Follow-up|1|||
46611932|NCT01273064|82717446|FG001|Overall Study|Lost to Follow-up|0|||
46611933|NCT01273064|82717447|FG002|Overall Study|Lost to Follow-up|0|||
46611934|NCT01273064|82717448|FG003|Overall Study|Lost to Follow-up|0|||
46611935|NCT01273064|82717449|FG004|Overall Study|Lost to Follow-up|0|||
46611936|NCT01273064|82717445|FG000|Overall Study|Physician Decision|0|||
46611937|NCT01273064|82717446|FG001|Overall Study|Physician Decision|0|||
46611938|NCT01273064|82717447|FG002|Overall Study|Physician Decision|0|||
46611939|NCT01273064|82717448|FG003|Overall Study|Physician Decision|0|||
46611940|NCT01273064|82717449|FG004|Overall Study|Physician Decision|1|||
46611941|NCT01272908|82717461|FG000|Initial Treatment Period|Adverse Event|1|||
46611942|NCT01272908|82717461|FG000|Initial Treatment Period|Lack of Efficacy|5|||
46611943|NCT01272908|82717461|FG000|Initial Treatment Period|Protocol Violation|1|||
46611944|NCT01272908|82717461|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
46611945|NCT01272908|82717461|FG000|Re-Treatment Period|Adverse Event|2|||
46611946|NCT01272908|82717461|FG000|Re-Treatment Period|Lack of Efficacy|3|||
46611947|NCT01272908|82717461|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
46894007|NCT03226275|83118672|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
46894008|NCT03226275|83118673|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
46894009|NCT03226275|83118670|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
46894010|NCT03226275|83118671|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
46894011|NCT03226275|83118672|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
46611948|NCT01271504|82717471|FG000|Overall Study|Death|7|||
46611949|NCT01271504|82717472|FG001|Overall Study|Death|6|||
46894012|NCT03226275|83118673|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
46611950|NCT01271504|82717473|FG002|Overall Study|Death|32|||
46611951|NCT01271504|82717474|FG003|Overall Study|Death|32|||
46611952|NCT01271504|82717471|FG000|Overall Study|Lost to Follow-up|0|||
46611953|NCT01271504|82717472|FG001|Overall Study|Lost to Follow-up|1|||
46611954|NCT01271504|82717473|FG002|Overall Study|Lost to Follow-up|3|||
46611955|NCT01271504|82717474|FG003|Overall Study|Lost to Follow-up|1|||
46611956|NCT01271504|82717471|FG000|Overall Study|Protocol Violation|0|||
46611957|NCT01271504|82717472|FG001|Overall Study|Protocol Violation|0|||
46611958|NCT01271504|82717473|FG002|Overall Study|Protocol Violation|0|||
46611959|NCT01271504|82717474|FG003|Overall Study|Protocol Violation|2|||
46611960|NCT01271504|82717471|FG000|Overall Study|Administrative Reasons|0|||
46611961|NCT01271504|82717472|FG001|Overall Study|Administrative Reasons|0|||
46611962|NCT01271504|82717473|FG002|Overall Study|Administrative Reasons|6|||
46611963|NCT01271504|82717474|FG003|Overall Study|Administrative Reasons|5|||
46611964|NCT01271504|82717471|FG000|Overall Study|Withdrawal by Subject|0|||
46611965|NCT01271504|82717472|FG001|Overall Study|Withdrawal by Subject|0|||
46611966|NCT01271504|82717473|FG002|Overall Study|Withdrawal by Subject|1|||
46611967|NCT01271504|82717474|FG003|Overall Study|Withdrawal by Subject|3|||
46611968|NCT01271504|82717471|FG000|Overall Study|Other|0|||
46611969|NCT01271504|82717472|FG001|Overall Study|Other|1|||
46611970|NCT01271504|82717473|FG002|Overall Study|Other|2|||
46611971|NCT01271504|82717474|FG003|Overall Study|Other|0|||
46611972|NCT01270958|82717517|FG000|Overall Study|Lost to Follow-up|2|||
46611973|NCT01270958|82717517|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
46611974|NCT01270880|82717521|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
46611975|NCT01270802|82717527|FG000|Overall Study|Withdrawal by Subject|1|||
46611976|NCT01270802|82717528|FG001|Overall Study|Withdrawal by Subject|0|||
46611977|NCT01270802|82717527|FG000|Overall Study|Adverse Event|1|||
46611978|NCT01270802|82717528|FG001|Overall Study|Adverse Event|0|||
46611979|NCT01270802|82717527|FG000|Overall Study|Lost to Follow-up|0|||
46611980|NCT01270802|82717528|FG001|Overall Study|Lost to Follow-up|1|||
46611981|NCT01270256|82717537|FG000|Overall Study|Withdrawal by Subject|1|||
46611982|NCT01270256|82717538|FG001|Overall Study|Withdrawal by Subject|0|||
46611983|NCT01279616|82717608|FG000|Overall Study|donor could not be located|5|||
46611984|NCT01279616|82717608|FG000|Overall Study|no signs of sickle cell disease|2|||
46611985|NCT01279070|82717619|FG000|Overall Study|Withdrawal by Subject|2|||
46611986|NCT01279070|82717620|FG001|Overall Study|Withdrawal by Subject|3|||
46611987|NCT01279070|82717619|FG000|Overall Study|Acute exacerbation|3|||
46611988|NCT01279070|82717620|FG001|Overall Study|Acute exacerbation|1|||
46611989|NCT01277744|82717630|FG000|Overall Study|Physician Decision|2|||
46611990|NCT01277822|82717636|FG000|Overall Study|Adverse Event|2|||
46611991|NCT01277822|82717637|FG001|Overall Study|Adverse Event|1|||
46611992|NCT01277822|82717636|FG000|Overall Study|Withdrawal by Subject|6|||
46611993|NCT01277822|82717637|FG001|Overall Study|Withdrawal by Subject|7|||
46611994|NCT01277822|82717636|FG000|Overall Study|Physician Decision|1|||
46611995|NCT01277822|82717637|FG001|Overall Study|Physician Decision|1|||
46611996|NCT01277822|82717636|FG000|Overall Study|Protocol Violation|1|||
46611997|NCT01277822|82717637|FG001|Overall Study|Protocol Violation|0|||
46611998|NCT01277822|82717636|FG000|Overall Study|Lost to Follow-up|2|||
46611999|NCT01277822|82717637|FG001|Overall Study|Lost to Follow-up|1|||
46612000|NCT01277822|82717636|FG000|Overall Study|Contraindicated medication used|2|||
46612001|NCT01277822|82717637|FG001|Overall Study|Contraindicated medication used|1|||
46612002|NCT01277822|82717636|FG000|Overall Study|Participant moved|1|||
46612003|NCT01277822|82717637|FG001|Overall Study|Participant moved|0|||
46612004|NCT01277666|82717646|FG000|Overall Study|Adverse Event|26|||
46612005|NCT01277666|82717647|FG001|Overall Study|Adverse Event|25|||
46612006|NCT01277666|82717648|FG002|Overall Study|Adverse Event|20|||
46612007|NCT01277666|82717646|FG000|Overall Study|Lack of Efficacy|8|||
46612008|NCT01277666|82717647|FG001|Overall Study|Lack of Efficacy|20|||
46612009|NCT01277666|82717648|FG002|Overall Study|Lack of Efficacy|12|||
46612010|NCT01277666|82717646|FG000|Overall Study|Protocol Violation|2|||
46612011|NCT01277666|82717647|FG001|Overall Study|Protocol Violation|3|||
46612012|NCT01277666|82717648|FG002|Overall Study|Protocol Violation|2|||
46612013|NCT01277666|82717646|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
46612014|NCT01277666|82717647|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
46612015|NCT01277666|82717648|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
46612016|NCT01277666|82717646|FG000|Overall Study|Lost to Follow-up|1|||
46612017|NCT01277666|82717647|FG001|Overall Study|Lost to Follow-up|1|||
46612018|NCT01277666|82717648|FG002|Overall Study|Lost to Follow-up|2|||
46612019|NCT01277666|82717646|FG000|Overall Study|Withdrawal by Subject|7|||
46612020|NCT01277666|82717647|FG001|Overall Study|Withdrawal by Subject|8|||
46612021|NCT01277666|82717648|FG002|Overall Study|Withdrawal by Subject|6|||
46612022|NCT01277666|82717646|FG000|Overall Study|Death|0|||
46612023|NCT01277666|82717647|FG001|Overall Study|Death|0|||
46612024|NCT01277666|82717648|FG002|Overall Study|Death|1|||
46612025|NCT00249002|82717656|FG000|Overall Study|Adverse Event|2|||
46612026|NCT00249002|82717656|FG000|Overall Study|Study cancellation|3|||
46612027|NCT00249002|82717656|FG000|Overall Study|Other|2|||
46612028|NCT01277042|82717662|FG000|Overall Study|Adverse Event|4|||
46612029|NCT01277042|82717663|FG001|Overall Study|Adverse Event|3|||
46612030|NCT01277042|82717662|FG000|Overall Study|Lost to Follow-up|2|||
46612031|NCT01277042|82717663|FG001|Overall Study|Lost to Follow-up|2|||
46612032|NCT01277042|82717662|FG000|Overall Study|Withdrawal by Subject|2|||
46612033|NCT01277042|82717663|FG001|Overall Study|Withdrawal by Subject|0|||
46612034|NCT00246740|82717703|FG000|Initial Enrollment|Death|1|||
46612035|NCT00246740|82717704|FG001|Initial Enrollment|Death|0|||
46612036|NCT00246740|82717703|FG000|Initial Enrollment|Additional surgery scheduled|0|||
46612037|NCT00246740|82717704|FG001|Initial Enrollment|Additional surgery scheduled|2|||
46612038|NCT00246740|82717703|FG000|Initial Enrollment|Surgery schedule change|4|||
46612039|NCT00246740|82717704|FG001|Initial Enrollment|Surgery schedule change|4|||
46612040|NCT00246740|82717703|FG000|Initial Enrollment|Other|1|||
46612041|NCT00246740|82717704|FG001|Initial Enrollment|Other|2|||
46612042|NCT00245102|82717749|FG000|Overall Study|Not Treated|1|||
46612043|NCT00245102|82717750|FG001|Overall Study|Not Treated|0|||
46612044|NCT00245102|82717751|FG002|Overall Study|Not Treated|1|||
46612045|NCT00245102|82717752|FG003|Overall Study|Not Treated|0|||
46612046|NCT00245102|82717753|FG004|Overall Study|Not Treated|0|||
46612047|NCT00245102|82717754|FG005|Overall Study|Not Treated|0|||
46612048|NCT00245102|82717749|FG000|Overall Study|Protocol Violation|1|||
46612049|NCT00245102|82717750|FG001|Overall Study|Protocol Violation|0|||
46612050|NCT00245102|82717751|FG002|Overall Study|Protocol Violation|0|||
46612051|NCT00245102|82717752|FG003|Overall Study|Protocol Violation|0|||
46612052|NCT00245102|82717753|FG004|Overall Study|Protocol Violation|0|||
46612053|NCT00245102|82717754|FG005|Overall Study|Protocol Violation|0|||
46612054|NCT00245102|82717749|FG000|Overall Study|Death|0|||
46612055|NCT00245102|82717750|FG001|Overall Study|Death|0|||
46612056|NCT00245102|82717751|FG002|Overall Study|Death|0|||
46612057|NCT00245102|82717752|FG003|Overall Study|Death|1|||
46612058|NCT00245102|82717753|FG004|Overall Study|Death|0|||
46612059|NCT00245102|82717754|FG005|Overall Study|Death|0|||
46612060|NCT00245102|82717749|FG000|Overall Study|Adverse Event|4|||
46612061|NCT00245102|82717750|FG001|Overall Study|Adverse Event|2|||
46612062|NCT00245102|82717751|FG002|Overall Study|Adverse Event|5|||
46612063|NCT00245102|82717752|FG003|Overall Study|Adverse Event|1|||
46612064|NCT00245102|82717753|FG004|Overall Study|Adverse Event|0|||
46612065|NCT00245102|82717754|FG005|Overall Study|Adverse Event|2|||
46612066|NCT00245102|82717749|FG000|Overall Study|Decline in performance|0|||
46612067|NCT00245102|82717750|FG001|Overall Study|Decline in performance|2|||
46612068|NCT00245102|82717751|FG002|Overall Study|Decline in performance|0|||
46612069|NCT00245102|82717752|FG003|Overall Study|Decline in performance|1|||
46612070|NCT00245102|82717753|FG004|Overall Study|Decline in performance|0|||
46612071|NCT00245102|82717754|FG005|Overall Study|Decline in performance|2|||
46612072|NCT00245102|82717749|FG000|Overall Study|Participant needed surgery|0|||
46612073|NCT00245102|82717750|FG001|Overall Study|Participant needed surgery|0|||
46612074|NCT00245102|82717751|FG002|Overall Study|Participant needed surgery|1|||
46612075|NCT00245102|82717752|FG003|Overall Study|Participant needed surgery|0|||
46612076|NCT00245102|82717753|FG004|Overall Study|Participant needed surgery|0|||
46612077|NCT00245102|82717754|FG005|Overall Study|Participant needed surgery|0|||
46612078|NCT00245102|82717749|FG000|Overall Study|Clinical progression|1|||
46612079|NCT00245102|82717750|FG001|Overall Study|Clinical progression|0|||
46612080|NCT00245102|82717751|FG002|Overall Study|Clinical progression|0|||
46612081|NCT00245102|82717752|FG003|Overall Study|Clinical progression|0|||
46612082|NCT00245102|82717753|FG004|Overall Study|Clinical progression|0|||
46612083|NCT00245102|82717754|FG005|Overall Study|Clinical progression|0|||
46612084|NCT00244712|82717799|FG000|Overall Study|Adverse Event|20|||
46612085|NCT00244712|82717800|FG001|Overall Study|Adverse Event|21|||
46612086|NCT00244712|82717799|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
46612087|NCT00244712|82717800|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
46612088|NCT00244712|82717799|FG000|Overall Study|Lack of Compliance|10|||
46612089|NCT00244712|82717800|FG001|Overall Study|Lack of Compliance|11|||
46612090|NCT00244712|82717799|FG000|Overall Study|Lost to Follow-up|45|||
46612091|NCT00244712|82717800|FG001|Overall Study|Lost to Follow-up|52|||
46612092|NCT00244712|82717799|FG000|Overall Study|Withdrawal by Subject|13|||
46612093|NCT00244712|82717800|FG001|Overall Study|Withdrawal by Subject|23|||
46612094|NCT00244712|82717799|FG000|Overall Study|Protocol Violation, disease progression|13|||
46612095|NCT00244712|82717800|FG001|Overall Study|Protocol Violation, disease progression|11|||
46706817|NCT04713553|82922135|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
46612096|NCT00243932|82717818|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
46612097|NCT00243932|82717819|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
46612098|NCT00243932|82717820|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
46612099|NCT00243386|82717828|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
46612100|NCT00243386|82717829|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
46612101|NCT00243386|82717830|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
46612102|NCT00243386|82717828|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
46612103|NCT00243386|82717829|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
46612104|NCT00243386|82717830|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
46612105|NCT00243386|82717828|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
46612106|NCT00243386|82717829|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
46612107|NCT00243386|82717830|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
46612108|NCT00243386|82717828|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
46612109|NCT00243386|82717829|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
46612110|NCT00243386|82717830|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
46612111|NCT00243386|82717828|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
46612112|NCT00243386|82717829|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
46612113|NCT00243386|82717830|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
46612114|NCT00243386|82717828|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
46612115|NCT00243386|82717829|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
46612116|NCT00243386|82717830|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
46612117|NCT00243386|82717828|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
46612118|NCT00243386|82717829|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
46612119|NCT00243386|82717830|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
46612120|NCT00243386|82717828|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
46612121|NCT00243386|82717829|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
46612122|NCT00243386|82717830|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
46612123|NCT00243230|82717889|FG000|Double-Blind Period|Adverse Event|0|||
46612124|NCT00243230|82717890|FG001|Double-Blind Period|Adverse Event|2|||
46612125|NCT00243230|82717891|FG002|Double-Blind Period|Adverse Event|2|||
46612126|NCT00243230|82717892|FG003|Double-Blind Period|Adverse Event|0|||
46612127|NCT00243230|82717889|FG000|Double-Blind Period|Withdrawal by Subject|1|||
46612128|NCT00243230|82717890|FG001|Double-Blind Period|Withdrawal by Subject|0|||
46612129|NCT00243230|82717891|FG002|Double-Blind Period|Withdrawal by Subject|0|||
46612130|NCT00243230|82717892|FG003|Double-Blind Period|Withdrawal by Subject|0|||
46612131|NCT00243230|82717889|FG000|Double-Blind Period|Protocol Violation|0|||
46612132|NCT00243230|82717890|FG001|Double-Blind Period|Protocol Violation|0|||
46612133|NCT00243230|82717891|FG002|Double-Blind Period|Protocol Violation|1|||
46612134|NCT00243230|82717892|FG003|Double-Blind Period|Protocol Violation|0|||
46612135|NCT00243230|82717889|FG000|Double-Blind Period|Randomized but Not Treated|0|||
46612136|NCT00243230|82717890|FG001|Double-Blind Period|Randomized but Not Treated|0|||
46612137|NCT00243230|82717891|FG002|Double-Blind Period|Randomized but Not Treated|2|||
46612138|NCT00243230|82717892|FG003|Double-Blind Period|Randomized but Not Treated|0|||
46612139|NCT00243230|82717889|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
46612140|NCT00243230|82717890|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
46612141|NCT00243230|82717891|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
46612142|NCT00243230|82717892|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
46612143|NCT00243230|82717889|FG000|Open Label Period|Adverse Event|0|||
46612144|NCT00243230|82717890|FG001|Open Label Period|Adverse Event|0|||
46612145|NCT00243230|82717891|FG002|Open Label Period|Adverse Event|0|||
46612146|NCT00243230|82717892|FG003|Open Label Period|Adverse Event|2|||
46612147|NCT00243230|82717889|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
46612148|NCT00243230|82717890|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
46612149|NCT00243230|82717891|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
46612150|NCT00243230|82717892|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
46612151|NCT00243230|82717889|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
46612152|NCT00243230|82717890|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
46612153|NCT00243230|82717891|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
46612154|NCT00243230|82717892|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
46612155|NCT00243230|82717889|FG000|Open Label Period|Lost to Follow-up|0|||
46612156|NCT00243230|82717890|FG001|Open Label Period|Lost to Follow-up|0|||
46612157|NCT00243230|82717891|FG002|Open Label Period|Lost to Follow-up|0|||
46612158|NCT00243230|82717892|FG003|Open Label Period|Lost to Follow-up|2|||
46612159|NCT00243230|82717889|FG000|Open Label Period|Withdrawal by Subject|0|||
46612160|NCT00243230|82717890|FG001|Open Label Period|Withdrawal by Subject|0|||
46612161|NCT00243230|82717891|FG002|Open Label Period|Withdrawal by Subject|0|||
46612162|NCT00243230|82717892|FG003|Open Label Period|Withdrawal by Subject|2|||
46612163|NCT00243230|82717889|FG000|Open Label Period|Protocol Violation|0|||
46612164|NCT00243230|82717890|FG001|Open Label Period|Protocol Violation|0|||
46612165|NCT00243230|82717891|FG002|Open Label Period|Protocol Violation|0|||
46612166|NCT00243230|82717892|FG003|Open Label Period|Protocol Violation|2|||
46612167|NCT00243230|82717889|FG000|Open Label Period|Administrative Reason|0|||
46612168|NCT00243230|82717890|FG001|Open Label Period|Administrative Reason|0|||
46612169|NCT00243230|82717891|FG002|Open Label Period|Administrative Reason|0|||
46612170|NCT00243230|82717892|FG003|Open Label Period|Administrative Reason|63|||
46612171|NCT00243074|82717902|FG000|Overall Study|Ineligible|6|||
46612172|NCT00243074|82717902|FG000|Overall Study|Adverse Event|6|||
46612173|NCT00243074|82717902|FG000|Overall Study|Withdrawal by Subject|2|||
46612174|NCT00243074|82717902|FG000|Overall Study|Lack of Efficacy|36|||
46612175|NCT00243074|82717902|FG000|Overall Study|Death|2|||
46612176|NCT00243074|82717902|FG000|Overall Study|not protocol specified|1|||
46612177|NCT00243074|82717902|FG000|Overall Study|Did not receive any treatment|1|||
46612178|NCT00241358|82717910|FG000|Overall Study|Determined to be not ineligible|0|||
46612179|NCT00241358|82717911|FG001|Overall Study|Determined to be not ineligible|1|||
46612180|NCT00241358|82717912|FG002|Overall Study|Determined to be not ineligible|1|||
46612181|NCT00241280|82717921|FG000|Overall Study|Adverse Event|2|||
46612182|NCT00241280|82717922|FG001|Overall Study|Adverse Event|6|||
46612183|NCT00241280|82717921|FG000|Overall Study|Discomfort|11|||
46612184|NCT00241280|82717922|FG001|Overall Study|Discomfort|16|||
46612185|NCT00241280|82717921|FG000|Overall Study|Pregnancy|1|||
46612186|NCT00241280|82717922|FG001|Overall Study|Pregnancy|5|||
46612187|NCT00241280|82717921|FG000|Overall Study|Lost to Follow-up|5|||
46612188|NCT00241280|82717922|FG001|Overall Study|Lost to Follow-up|8|||
46612189|NCT00241280|82717921|FG000|Overall Study|Withdrawal by Subject|7|||
46612190|NCT00241280|82717922|FG001|Overall Study|Withdrawal by Subject|4|||
46612191|NCT00241280|82717921|FG000|Overall Study|Protocol Violation|4|||
46612192|NCT00241280|82717922|FG001|Overall Study|Protocol Violation|10|||
46612193|NCT00241280|82717921|FG000|Overall Study|Relocation|4|||
46612194|NCT00241280|82717922|FG001|Overall Study|Relocation|4|||
46612195|NCT00241280|82717921|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
46612196|NCT00241280|82717922|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
46612197|NCT00241280|82717921|FG000|Overall Study|Unsatisfactory Visual Response|1|||
46612198|NCT00241280|82717922|FG001|Overall Study|Unsatisfactory Visual Response|1|||
46612199|NCT00241280|82717921|FG000|Overall Study|Diabetic|1|||
46612200|NCT00241280|82717922|FG001|Overall Study|Diabetic|0|||
46612201|NCT00241280|82717921|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
46612202|NCT00241280|82717922|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
46612203|NCT00241280|82717921|FG000|Overall Study|Dispensed incorrect test article|1|||
46612204|NCT00241280|82717922|FG001|Overall Study|Dispensed incorrect test article|2|||
46612205|NCT00241280|82717921|FG000|Overall Study|Unacceptable Fit|0|||
46612206|NCT00241280|82717922|FG001|Overall Study|Unacceptable Fit|1|||
46612207|NCT00241280|82717921|FG000|Overall Study|Scheduling Conflict|0|||
46612208|NCT00241280|82717922|FG001|Overall Study|Scheduling Conflict|2|||
46612209|NCT00241280|82717921|FG000|Overall Study|History of Ocular Surgery|0|||
46612210|NCT00241280|82717922|FG001|Overall Study|History of Ocular Surgery|1|||
46612211|NCT00241280|82717921|FG000|Overall Study|Coating on Lens|1|||
46612212|NCT00241280|82717922|FG001|Overall Study|Coating on Lens|0|||
46612213|NCT00241280|82717921|FG000|Overall Study|Excessive Dryness|0|||
46612214|NCT00241280|82717922|FG001|Overall Study|Excessive Dryness|1|||
46612215|NCT04278872|82718490|FG000|Overall Study|Adverse Event|1|||
46612216|NCT04278872|82718491|FG001|Overall Study|Adverse Event|0|||
46612217|NCT04278872|82718490|FG000|Overall Study|Protocol Violation|0|||
46612218|NCT04278872|82718491|FG001|Overall Study|Protocol Violation|1|||
46612219|NCT04278872|82718490|FG000|Overall Study|Study Termination|2|||
46612220|NCT04278872|82718491|FG001|Overall Study|Study Termination|0|||
46612221|NCT05497557|82719198|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
46612222|NCT05497557|82719199|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
46612223|NCT05497557|82719200|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
46612224|NCT05024032|82719212|FG000|Overall Study|Withdrawal by Subject|0|||
46894013|NCT04189081|83118686|FG000|Overall Study|Lost to Follow-up|1|||
46894014|NCT04189081|83118687|FG001|Overall Study|Lost to Follow-up|0|||
46894015|NCT04189081|83118688|FG002|Overall Study|Lost to Follow-up|0|||
46894016|NCT04189081|83118686|FG000|Overall Study|Withdrawal by Subject|0|||
46894017|NCT04189081|83118687|FG001|Overall Study|Withdrawal by Subject|0|||
46894018|NCT04189081|83118688|FG002|Overall Study|Withdrawal by Subject|1|||
46894019|NCT04187989|83118698|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
46894020|NCT04187989|83118699|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
46612225|NCT05024032|82719213|FG001|Overall Study|Withdrawal by Subject|3|||
46612226|NCT05024032|82719214|FG002|Overall Study|Withdrawal by Subject|4|||
46612227|NCT05024032|82719212|FG000|Overall Study|Adverse Event|0|||
46612228|NCT05024032|82719213|FG001|Overall Study|Adverse Event|1|||
46612229|NCT05024032|82719214|FG002|Overall Study|Adverse Event|0|||
46612230|NCT05024032|82719212|FG000|Overall Study|Protocol Deviation|1|||
46612231|NCT05024032|82719213|FG001|Overall Study|Protocol Deviation|0|||
46612232|NCT05024032|82719214|FG002|Overall Study|Protocol Deviation|0|||
46612233|NCT04432376|82719227|FG000|Double-blind Treatment Period|Adverse Event|2|||
46894021|NCT04187989|83118698|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
46894022|NCT04187989|83118699|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
46612234|NCT04432376|82719228|FG001|Double-blind Treatment Period|Adverse Event|6|||
46612235|NCT04432376|82719229|FG002|Double-blind Treatment Period|Adverse Event|0|||
46612236|NCT04432376|82719227|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
46612237|NCT04432376|82719228|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
46612238|NCT04432376|82719229|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
46612239|NCT04432376|82719227|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
46612240|NCT04432376|82719228|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
46612241|NCT04432376|82719229|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
46612242|NCT04432376|82719227|FG000|Double-blind Treatment Period|Protocol Violation|0|||
46612243|NCT04432376|82719228|FG001|Double-blind Treatment Period|Protocol Violation|1|||
46612244|NCT04432376|82719229|FG002|Double-blind Treatment Period|Protocol Violation|0|||
46612245|NCT04432376|82719227|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
46612246|NCT04432376|82719228|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
46612247|NCT04432376|82719229|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
46612248|NCT04409834|82719238|FG000|Overall Study|Death|55|||
46612249|NCT04409834|82719239|FG001|Overall Study|Death|62|||
46612250|NCT04320849|82719251|FG000|Overall Study|Withdrawal by Subject|4|||
46612251|NCT04320849|82719251|FG000|Overall Study|Imaging data unavailable|2|||
46612252|NCT04320849|82719251|FG000|Overall Study|Incomplete imaging|2|||
46612253|NCT03750838|82719272|FG000|Overall Study|Lost to Follow-up|10|||
46612254|NCT03750838|82719273|FG001|Overall Study|Lost to Follow-up|6|||
46612255|NCT02726386|82719344|FG000|Overall Study|Adverse Event|17|||
46612256|NCT02726386|82719345|FG001|Overall Study|Adverse Event|20|||
46612257|NCT02726386|82719344|FG000|Overall Study|Withdrawal by Subject|14|||
46612258|NCT02726386|82719345|FG001|Overall Study|Withdrawal by Subject|28|||
46612259|NCT02726386|82719344|FG000|Overall Study|Other reasons|7|||
46612260|NCT02726386|82719345|FG001|Overall Study|Other reasons|8|||
46612261|NCT02203799|82719351|FG000|Overall Study|Withdrawal by Subject|3|||
46612262|NCT02180724|82719358|FG000|Overall Study|Death|26|||
46612263|NCT02180724|82719359|FG001|Overall Study|Death|1|||
46612264|NCT02180724|82719358|FG000|Overall Study|Lost to Follow-up|3|||
46612265|NCT02180724|82719359|FG001|Overall Study|Lost to Follow-up|1|||
46612266|NCT02180724|82719358|FG000|Overall Study|Withdrawal by Subject|4|||
46612267|NCT02180724|82719359|FG001|Overall Study|Withdrawal by Subject|2|||
46612268|NCT02180724|82719358|FG000|Overall Study|PI Decision|5|||
46612269|NCT02180724|82719359|FG001|Overall Study|PI Decision|2|||
46612270|NCT02180724|82719358|FG000|Overall Study|Study terminated by sponsor|54|||
46612271|NCT02180724|82719359|FG001|Overall Study|Study terminated by sponsor|8|||
46612272|NCT01853748|82719382|FG000|Allocation|Withdrawal by Subject|1|||
46612273|NCT01853748|82719383|FG001|Allocation|Withdrawal by Subject|13|||
46612274|NCT01853748|82719382|FG000|Allocation|not sufficient to receive intervention|0|||
46612275|NCT01853748|82719383|FG001|Allocation|not sufficient to receive intervention|1|||
46612276|NCT01853748|82719382|FG000|Follow-Up|Withdrawal by Subject|7|||
46612277|NCT01853748|82719383|FG001|Follow-Up|Withdrawal by Subject|6|||
46612278|NCT01853748|82719382|FG000|Follow-Up|Adverse Event|67|||
46612279|NCT01853748|82719383|FG001|Follow-Up|Adverse Event|7|||
46612280|NCT01853748|82719382|FG000|Follow-Up|not available for data collection|16|||
46612281|NCT01853748|82719383|FG001|Follow-Up|not available for data collection|4|||
46612282|NCT01843374|82719400|FG000|Overall Study|Death|155|||
46612283|NCT01843374|82719401|FG001|Overall Study|Death|313|||
46612284|NCT01843374|82719400|FG000|Overall Study|Withdrawal by Subject|14|||
46612285|NCT01843374|82719401|FG001|Overall Study|Withdrawal by Subject|20|||
46612286|NCT01843374|82719400|FG000|Overall Study|Withdrawing due to Other reason|20|||
46612287|NCT01843374|82719401|FG001|Overall Study|Withdrawing due to Other reason|46|||
46612288|NCT01773733|82719412|FG000|Overall Study|Adverse Event|3286|||
46612289|NCT01773733|82719413|FG001|Overall Study|Adverse Event|540|||
46612290|NCT01773733|82719412|FG000|Overall Study|Pregnancy|28|||
46612291|NCT01773733|82719413|FG001|Overall Study|Pregnancy|0|||
46612292|NCT01773733|82719412|FG000|Overall Study|Other different categories of not compl|55415|||
46612293|NCT01773733|82719413|FG001|Overall Study|Other different categories of not compl|7781|||
46612294|NCT01757535|82719423|FG000|Overall Study|Disease Relapse|143|||
46612295|NCT01757535|82719424|FG001|Overall Study|Disease Relapse|180|||
46612296|NCT01757535|82719423|FG000|Overall Study|Adverse Event|29|||
46612297|NCT01757535|82719424|FG001|Overall Study|Adverse Event|11|||
46612298|NCT01757535|82719423|FG000|Overall Study|Withdrawal by Subject|9|||
46612299|NCT01757535|82719424|FG001|Overall Study|Withdrawal by Subject|13|||
46612300|NCT01757535|82719423|FG000|Overall Study|Miscellaneous|5|||
46612301|NCT01757535|82719424|FG001|Overall Study|Miscellaneous|2|||
46612302|NCT01757535|82719423|FG000|Overall Study|Physician Decision|6|||
46612303|NCT01757535|82719424|FG001|Overall Study|Physician Decision|0|||
46612304|NCT01757535|82719423|FG000|Overall Study|Death|1|||
46612305|NCT01757535|82719424|FG001|Overall Study|Death|2|||
46612306|NCT01110005|82719452|FG000|Overall Study|ineligible|1|||
46612307|NCT01110005|82719453|FG001|Overall Study|ineligible|2|||
46612308|NCT01110005|82719452|FG000|Overall Study|missing consent|3|||
46612309|NCT01110005|82719453|FG001|Overall Study|missing consent|2|||
46612310|NCT01110005|82719452|FG000|Overall Study|Withdrawal by Subject|0|||
46612311|NCT01110005|82719453|FG001|Overall Study|Withdrawal by Subject|1|||
46612312|NCT00840801|82719461|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
46612313|NCT00840801|82719462|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
46612314|NCT00840801|82719463|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
46612315|NCT00840801|82719461|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
46612316|NCT00840801|82719462|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
46612317|NCT00840801|82719463|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
46612318|NCT00840801|82719461|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
46612319|NCT00840801|82719462|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
46612320|NCT00840801|82719463|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
46612321|NCT00840801|82719461|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
46612322|NCT00840801|82719462|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
46612323|NCT00840801|82719463|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
46612324|NCT00494234|82719497|FG000|Overall Study|Withdrawal by Subject|1|||
46612325|NCT00494234|82719498|FG001|Overall Study|Withdrawal by Subject|0|||
46612326|NCT00494234|82719497|FG000|Overall Study|Disease progression|11|||
46612327|NCT00494234|82719498|FG001|Overall Study|Disease progression|8|||
46612328|NCT00494234|82719497|FG000|Overall Study|Death|2|||
46612329|NCT00494234|82719498|FG001|Overall Study|Death|1|||
46612330|NCT02513160|82721269|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
46612331|NCT02513160|82721270|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
46612332|NCT02513160|82721271|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
46612333|NCT02513160|82721272|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
46612334|NCT02513160|82721269|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
46612335|NCT02513160|82721270|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
46612336|NCT02513160|82721271|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
46612337|NCT02513160|82721272|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
46612338|NCT02513160|82721269|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
46612339|NCT02513160|82721270|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
46612340|NCT02513160|82721271|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
46612341|NCT02513160|82721272|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
46612342|NCT02513160|82721269|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
46612343|NCT02513160|82721270|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
46612344|NCT02513160|82721271|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
46612345|NCT02513160|82721272|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
46612346|NCT02513160|82721269|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
46612347|NCT02513160|82721270|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
46612348|NCT02513160|82721271|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
46612349|NCT02513160|82721272|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
46612350|NCT02513160|82721269|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
46612351|NCT02513160|82721270|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
46612352|NCT02513160|82721271|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
46612353|NCT02513160|82721272|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
46612354|NCT02513160|82721269|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
46612355|NCT02513160|82721270|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
46612356|NCT02513160|82721271|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
46612357|NCT02513160|82721272|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
46612358|NCT02513160|82721269|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
46612359|NCT02513160|82721270|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
46612360|NCT02513160|82721271|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
46612361|NCT02513160|82721272|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
46612362|NCT02513160|82721269|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
46612363|NCT02513160|82721270|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
46612364|NCT02513160|82721271|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
46612365|NCT02513160|82721272|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
46612366|NCT02513160|82721269|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
46612367|NCT02513160|82721270|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
46612368|NCT02513160|82721271|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
46612369|NCT02513160|82721272|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
46612370|NCT02513160|82721269|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
46612371|NCT02513160|82721270|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
46612372|NCT02513160|82721271|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
46612373|NCT02513160|82721272|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
46612374|NCT02513160|82721269|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
46612375|NCT02513160|82721270|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
46612376|NCT02513160|82721271|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
46612377|NCT02513160|82721272|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
46612378|NCT02480010|82721307|FG000|Overall Study|Adverse Event|3|||
46612379|NCT02480010|82721308|FG001|Overall Study|Adverse Event|1|||
46612380|NCT02480010|82721307|FG000|Overall Study|Death|1|||
46612381|NCT02480010|82721308|FG001|Overall Study|Death|0|||
46612382|NCT02480010|82721307|FG000|Overall Study|Insufficient therapeutic response|31|||
46612383|NCT02480010|82721308|FG001|Overall Study|Insufficient therapeutic response|29|||
46612384|NCT02480010|82721307|FG000|Overall Study|Refused Treatment|0|||
46612385|NCT02480010|82721308|FG001|Overall Study|Refused Treatment|3|||
46612386|NCT02512302|82721336|FG000|Period 1|Adverse Event|0|||
46612387|NCT02512302|82721337|FG001|Period 1|Adverse Event|1|||
46612388|NCT02512302|82721338|FG002|Period 1|Adverse Event|0|||
46612389|NCT02512302|82721339|FG003|Period 1|Adverse Event|0|||
46612390|NCT02512302|82721340|FG004|Period 1|Adverse Event|0|||
46612391|NCT02512302|82721341|FG005|Period 1|Adverse Event|0|||
46612392|NCT02512302|82721342|FG006|Period 1|Adverse Event|0|||
46612393|NCT02512302|82721343|FG007|Period 1|Adverse Event|0|||
46612394|NCT02512302|82721344|FG008|Period 1|Adverse Event|0|||
46612395|NCT02512302|82721345|FG009|Period 1|Adverse Event|0|||
46612396|NCT02512302|82721336|FG000|Period 2|Adverse Event|0|||
46612397|NCT02512302|82721337|FG001|Period 2|Adverse Event|0|||
46612398|NCT02512302|82721338|FG002|Period 2|Adverse Event|0|||
46612399|NCT02512302|82721339|FG003|Period 2|Adverse Event|0|||
46612400|NCT02512302|82721340|FG004|Period 2|Adverse Event|0|||
46612401|NCT02512302|82721341|FG005|Period 2|Adverse Event|0|||
46612402|NCT02512302|82721342|FG006|Period 2|Adverse Event|0|||
46612403|NCT02512302|82721343|FG007|Period 2|Adverse Event|0|||
46612404|NCT02512302|82721344|FG008|Period 2|Adverse Event|0|||
46612405|NCT02512302|82721345|FG009|Period 2|Adverse Event|1|||
46612406|NCT02512302|82721336|FG000|Period 3|Lost to Follow-up|0|||
46612407|NCT02512302|82721337|FG001|Period 3|Lost to Follow-up|0|||
46612408|NCT02512302|82721338|FG002|Period 3|Lost to Follow-up|1|||
46612409|NCT02512302|82721339|FG003|Period 3|Lost to Follow-up|0|||
46612410|NCT02512302|82721340|FG004|Period 3|Lost to Follow-up|0|||
46612411|NCT02512302|82721341|FG005|Period 3|Lost to Follow-up|0|||
46612412|NCT02512302|82721342|FG006|Period 3|Lost to Follow-up|0|||
46612413|NCT02512302|82721343|FG007|Period 3|Lost to Follow-up|0|||
46612414|NCT02512302|82721344|FG008|Period 3|Lost to Follow-up|0|||
46612415|NCT02512302|82721345|FG009|Period 3|Lost to Follow-up|0|||
46612416|NCT02512302|82721336|FG000|Period 4|Adverse Event|0|||
46612417|NCT02512302|82721337|FG001|Period 4|Adverse Event|0|||
46612418|NCT02512302|82721338|FG002|Period 4|Adverse Event|0|||
46612419|NCT02512302|82721339|FG003|Period 4|Adverse Event|0|||
46612420|NCT02512302|82721340|FG004|Period 4|Adverse Event|0|||
46612421|NCT02512302|82721341|FG005|Period 4|Adverse Event|0|||
46612422|NCT02512302|82721342|FG006|Period 4|Adverse Event|1|||
46612423|NCT02512302|82721343|FG007|Period 4|Adverse Event|0|||
46612424|NCT02512302|82721344|FG008|Period 4|Adverse Event|0|||
46612425|NCT02512302|82721345|FG009|Period 4|Adverse Event|0|||
46612426|NCT02511678|82721460|FG000|Overall Study|Withdrawal by Subject|2|||
46612427|NCT02511678|82721460|FG000|Overall Study|Lost to Follow-up|4|||
46612428|NCT02511678|82721460|FG000|Overall Study|Death|19|||
46612429|NCT02511678|82721460|FG000|Overall Study|Adverse Event|1|||
46706818|NCT04713553|82922136|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
46706819|NCT04713553|82922137|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
46706820|NCT04713553|82922138|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
46706821|NCT04713553|82922132|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
46706822|NCT04713553|82922133|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
46706823|NCT04713553|82922134|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
46706824|NCT04713553|82922135|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
46706825|NCT04713553|82922136|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
46706826|NCT04713553|82922137|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
46706827|NCT04713553|82922138|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
46706828|NCT01206101|82922161|FG000|Overall Study|Adverse Event|1|||
46706829|NCT01206101|82922162|FG001|Overall Study|Adverse Event|0|||
46706830|NCT01206101|82922161|FG000|Overall Study|Physician Decision|0|||
46706831|NCT01206101|82922162|FG001|Overall Study|Physician Decision|1|||
46706832|NCT01206101|82922161|FG000|Overall Study|Unclassified|1|||
46706833|NCT01206101|82922162|FG001|Overall Study|Unclassified|0|||
46706834|NCT01205165|82922168|FG000|Overall Study|Lost to Follow-up|2|||
46706835|NCT00997503|82922173|FG000|Overall Study|Death|53|||
46706836|NCT00997503|82922173|FG000|Overall Study|Withdrawal by Subject|76|||
46706837|NCT00997503|82922173|FG000|Overall Study|Lost to Follow-up|33|||
46706838|NCT00997503|82922173|FG000|Overall Study|Adverse Event|3|||
46706839|NCT00997503|82922173|FG000|Overall Study|Physician Decision|10|||
46706840|NCT00997503|82922173|FG000|Overall Study|Missed 12-month follow-up|85|||
46706841|NCT00997503|82922173|FG000|Overall Study|Other reason|13|||
46706842|NCT01204775|82922182|FG000|Overall Study|Poor/non-compliance|0|||
46612430|NCT02511678|82721460|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
46612431|NCT02511678|82721460|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
46612432|NCT02511678|82721460|FG000|Overall Study|Required Radiofrequency Ablation|1|||
46612433|NCT02511678|82721460|FG000|Overall Study|Biopsy was Negative|1|||
46612434|NCT02511678|82721460|FG000|Overall Study|Protocol Violation|1|||
46612435|NCT02511678|82721460|FG000|Overall Study|Received Radiation Treatment|1|||
46706843|NCT01204775|82922183|FG001|Overall Study|Poor/non-compliance|1|||
46706844|NCT01204775|82922182|FG000|Overall Study|Withdrawal by Subject|1|||
46706845|NCT01204775|82922183|FG001|Overall Study|Withdrawal by Subject|0|||
46706846|NCT00997035|82922191|FG000|3-week Followup Visit|Lost to Follow-up|9|||
46706847|NCT00997035|82922192|FG001|3-week Followup Visit|Lost to Follow-up|6|||
46706848|NCT00997035|82922191|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
46706849|NCT00997035|82922192|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
46706850|NCT01204697|82922210|FG000|Overall Study|Death|26|||
46706851|NCT01204697|82922211|FG001|Overall Study|Death|27|||
46706852|NCT01204697|82922210|FG000|Overall Study|Lost to Follow-up|3|||
46706853|NCT01204697|82922211|FG001|Overall Study|Lost to Follow-up|4|||
46706854|NCT01204697|82922210|FG000|Overall Study|Withdrawal by Subject|2|||
46706855|NCT01204697|82922211|FG001|Overall Study|Withdrawal by Subject|4|||
46706856|NCT01204697|82922210|FG000|Overall Study|Randomized, but not treated|0|||
46706857|NCT01204697|82922211|FG001|Overall Study|Randomized, but not treated|1|||
46706858|NCT01001325|82922219|FG000|Overall Study|Lost to Follow-up|16|||
46706859|NCT01001325|82922220|FG001|Overall Study|Lost to Follow-up|10|||
46706860|NCT01001325|82922219|FG000|Overall Study|Protocol Violation|2|||
46706861|NCT01001325|82922220|FG001|Overall Study|Protocol Violation|0|||
46706862|NCT01203917|82922226|FG000|Overall Study|Death|29|||
46706863|NCT01203917|82922226|FG000|Overall Study|Lost to Follow-up|2|||
46706864|NCT01203917|82922226|FG000|Overall Study|Withdrawal by Subject|3|||
46706865|NCT01203917|82922226|FG000|Overall Study|Due to objective disease progression|1|||
46894023|NCT01150890|83118709|FG000|Overall Study|Other|0|||
46894024|NCT01150890|83118710|FG001|Overall Study|Other|1|||
46894025|NCT01150890|83118711|FG002|Overall Study|Other|0|||
46894026|NCT01150890|83118712|FG003|Overall Study|Other|2|||
46894027|NCT01150890|83118709|FG000|Overall Study|Pregnancy|0|||
46894028|NCT01150890|83118710|FG001|Overall Study|Pregnancy|0|||
46894029|NCT01150890|83118711|FG002|Overall Study|Pregnancy|0|||
46894030|NCT01150890|83118712|FG003|Overall Study|Pregnancy|1|||
46894031|NCT01150890|83118709|FG000|Overall Study|Administrative Decision|4|||
46894032|NCT01150890|83118710|FG001|Overall Study|Administrative Decision|4|||
46894033|NCT01150890|83118711|FG002|Overall Study|Administrative Decision|5|||
46894034|NCT01150890|83118712|FG003|Overall Study|Administrative Decision|6|||
46894035|NCT01150890|83118709|FG000|Overall Study|Ineligibility determined|0|||
46894036|NCT01150890|83118710|FG001|Overall Study|Ineligibility determined|1|||
46894037|NCT01150890|83118711|FG002|Overall Study|Ineligibility determined|0|||
46894038|NCT01150890|83118712|FG003|Overall Study|Ineligibility determined|0|||
46894039|NCT01150890|83118709|FG000|Overall Study|Adverse Event|0|||
46894040|NCT01150890|83118710|FG001|Overall Study|Adverse Event|0|||
46894041|NCT01150890|83118711|FG002|Overall Study|Adverse Event|2|||
46894042|NCT01150890|83118712|FG003|Overall Study|Adverse Event|0|||
46894043|NCT01150890|83118709|FG000|Overall Study|Withdrawal by Subject|0|||
46894044|NCT01150890|83118710|FG001|Overall Study|Withdrawal by Subject|0|||
46894045|NCT01150890|83118711|FG002|Overall Study|Withdrawal by Subject|2|||
46894046|NCT01150890|83118712|FG003|Overall Study|Withdrawal by Subject|1|||
46894047|NCT01150890|83118709|FG000|Overall Study|Disease progression|0|||
46894048|NCT01150890|83118710|FG001|Overall Study|Disease progression|7|||
46894049|NCT01150890|83118711|FG002|Overall Study|Disease progression|3|||
46894050|NCT01150890|83118712|FG003|Overall Study|Disease progression|7|||
46894051|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Adverse Event|2|||
46894052|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Adverse Event|0|||
46894053|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Adverse Event|0|||
46894054|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Adverse Event|0|||
46894055|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
46894056|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
46894057|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
46894058|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
46894059|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
46894060|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
46894061|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
46894062|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
46894063|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Physician Decision|1|||
46894064|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Physician Decision|0|||
46894065|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Physician Decision|0|||
46894066|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Physician Decision|0|||
46894067|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Pregnancy|1|||
46894068|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Pregnancy|0|||
46894069|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Pregnancy|0|||
46894070|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Pregnancy|0|||
46894071|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
46894072|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
46894073|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
46706866|NCT01203917|82922226|FG000|Overall Study|Due to EGFR M+I patient|1|||
46706867|NCT01202903|82922232|FG000|Overall Study|Administrative Probelms|1|||
46706868|NCT01202903|82922233|FG001|Overall Study|Administrative Probelms|4|||
46706869|NCT01202903|82922232|FG000|Overall Study|Protocol Violation|0|||
46894074|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
46894075|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
46894076|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
46894077|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
46894078|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
46894079|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
46894080|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
46894081|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
46894082|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
46894083|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
46894084|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
46894085|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
46894086|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
46894087|NCT04057573|83118727|FG000|24-Week Double-Blind Period|Not Treated|1|||
46894088|NCT04057573|83118728|FG001|24-Week Double-Blind Period|Not Treated|0|||
46894089|NCT04057573|83118729|FG002|24-Week Double-Blind Period|Not Treated|0|||
46894090|NCT04057573|83118730|FG003|24-Week Double-Blind Period|Not Treated|0|||
46894091|NCT04057573|83118727|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
46894092|NCT04057573|83118728|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
46894093|NCT04057573|83118729|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
46894094|NCT04057573|83118730|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
46894095|NCT04057573|83118727|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
46894096|NCT04057573|83118728|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
46894097|NCT04057573|83118729|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
46894098|NCT04057573|83118730|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
46894099|NCT04057573|83118727|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
46894100|NCT04057573|83118728|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
46894101|NCT04057573|83118729|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
46894102|NCT04057573|83118730|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
46894103|NCT04057573|83118727|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
46894104|NCT04057573|83118728|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
46894105|NCT04057573|83118729|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
46894106|NCT04057573|83118730|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
46894107|NCT04057573|83118727|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
46894108|NCT04057573|83118728|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
46894109|NCT04057573|83118729|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
46894110|NCT04057573|83118730|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
46894111|NCT04054765|83118743|FG000|Baseline|Withdrawal by Subject|5|||
46894112|NCT04054765|83118744|FG001|Baseline|Withdrawal by Subject|3|||
46894113|NCT04054765|83118743|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
46894114|NCT04054765|83118744|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
46894115|NCT04054765|83118743|FG000|3-month Follow up|Withdrawal by Subject|0|||
46894116|NCT04054765|83118744|FG001|3-month Follow up|Withdrawal by Subject|3|||
46894117|NCT04054765|83118743|FG000|6-month Follow up|Lost to Follow-up|32|||
46894118|NCT04054765|83118744|FG001|6-month Follow up|Lost to Follow-up|32|||
46894119|NCT04179721|83118752|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
46894120|NCT04179721|83118753|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
46894121|NCT04179721|83118752|FG000|Overall Study|Lost to Follow-up|0|||
46894122|NCT04179721|83118753|FG001|Overall Study|Lost to Follow-up|1|||
46894123|NCT03286218|83118759|FG000|Qualification Phase Period 1|Adverse Event|1|||
46894124|NCT03286218|83118760|FG001|Qualification Phase Period 1|Adverse Event|0|||
46894125|NCT03286218|83118761|FG002|Qualification Phase Period 1|Adverse Event|0|||
46894126|NCT03286218|83118762|FG003|Qualification Phase Period 1|Adverse Event|0|||
46894127|NCT03286218|83118763|FG004|Qualification Phase Period 1|Adverse Event|0|||
46894128|NCT03286218|83118764|FG005|Qualification Phase Period 1|Adverse Event|0|||
46894129|NCT03286218|83118765|FG006|Qualification Phase Period 1|Adverse Event|0|||
46894130|NCT03286218|83118766|FG007|Qualification Phase Period 1|Adverse Event|0|||
46894131|NCT03286218|83118767|FG008|Qualification Phase Period 1|Adverse Event|0|||
46894132|NCT03286218|83118768|FG009|Qualification Phase Period 1|Adverse Event|0|||
46894133|NCT03286218|83118769|FG010|Qualification Phase Period 1|Adverse Event|0|||
46894134|NCT03286218|83118770|FG011|Qualification Phase Period 1|Adverse Event|0|||
46894135|NCT03286218|83118759|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894136|NCT03286218|83118760|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
46894137|NCT03286218|83118761|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894138|NCT03286218|83118762|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894139|NCT03286218|83118763|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894140|NCT03286218|83118764|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894141|NCT03286218|83118765|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894142|NCT03286218|83118766|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894143|NCT03286218|83118767|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894144|NCT03286218|83118768|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894145|NCT03286218|83118769|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894146|NCT03286218|83118770|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
46894147|NCT03286218|83118759|FG000|Qualification Phase Period 2|Adverse Event|0|||
46894148|NCT03286218|83118760|FG001|Qualification Phase Period 2|Adverse Event|1|||
46894149|NCT03286218|83118761|FG002|Qualification Phase Period 2|Adverse Event|0|||
46894150|NCT03286218|83118762|FG003|Qualification Phase Period 2|Adverse Event|0|||
46894151|NCT03286218|83118763|FG004|Qualification Phase Period 2|Adverse Event|0|||
46894152|NCT03286218|83118764|FG005|Qualification Phase Period 2|Adverse Event|0|||
46894153|NCT03286218|83118765|FG006|Qualification Phase Period 2|Adverse Event|0|||
46894154|NCT03286218|83118766|FG007|Qualification Phase Period 2|Adverse Event|0|||
46894155|NCT03286218|83118767|FG008|Qualification Phase Period 2|Adverse Event|0|||
46894156|NCT03286218|83118768|FG009|Qualification Phase Period 2|Adverse Event|0|||
46894157|NCT03286218|83118769|FG010|Qualification Phase Period 2|Adverse Event|0|||
46894158|NCT03286218|83118770|FG011|Qualification Phase Period 2|Adverse Event|0|||
46894159|NCT03286218|83118759|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
46894160|NCT03286218|83118760|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
46894161|NCT03286218|83118761|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894162|NCT03286218|83118762|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894163|NCT03286218|83118763|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894164|NCT03286218|83118764|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894165|NCT03286218|83118765|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894166|NCT03286218|83118766|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894167|NCT03286218|83118767|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894168|NCT03286218|83118768|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894169|NCT03286218|83118769|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894170|NCT03286218|83118770|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
46894171|NCT03286218|83118759|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
46894172|NCT03286218|83118760|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
46894173|NCT03286218|83118761|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
46894174|NCT03286218|83118762|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
46894175|NCT03286218|83118763|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
46894176|NCT03286218|83118764|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
46894177|NCT03286218|83118765|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
46894178|NCT03286218|83118766|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
46894179|NCT03286218|83118767|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
46894180|NCT03286218|83118768|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
46894181|NCT03286218|83118769|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
46894182|NCT03286218|83118770|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
46894183|NCT03286218|83118759|FG000|Qualification Phase Period 2|Protocol Violation|2|||
46894184|NCT03286218|83118760|FG001|Qualification Phase Period 2|Protocol Violation|0|||
46894185|NCT03286218|83118761|FG002|Qualification Phase Period 2|Protocol Violation|0|||
46894186|NCT03286218|83118762|FG003|Qualification Phase Period 2|Protocol Violation|0|||
46894187|NCT03286218|83118763|FG004|Qualification Phase Period 2|Protocol Violation|0|||
46894188|NCT03286218|83118764|FG005|Qualification Phase Period 2|Protocol Violation|0|||
46894189|NCT03286218|83118765|FG006|Qualification Phase Period 2|Protocol Violation|0|||
46894190|NCT03286218|83118766|FG007|Qualification Phase Period 2|Protocol Violation|0|||
46894191|NCT03286218|83118767|FG008|Qualification Phase Period 2|Protocol Violation|0|||
46894192|NCT03286218|83118768|FG009|Qualification Phase Period 2|Protocol Violation|0|||
46706870|NCT01202903|82922233|FG001|Overall Study|Protocol Violation|1|||
46706871|NCT01202903|82922232|FG000|Overall Study|Death|1|||
46894193|NCT03286218|83118769|FG010|Qualification Phase Period 2|Protocol Violation|0|||
46894194|NCT03286218|83118770|FG011|Qualification Phase Period 2|Protocol Violation|0|||
46894195|NCT03286218|83118759|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
46894196|NCT03286218|83118760|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
46894197|NCT03286218|83118761|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894198|NCT03286218|83118762|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894199|NCT03286218|83118763|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894200|NCT03286218|83118764|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894201|NCT03286218|83118765|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894202|NCT03286218|83118766|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894203|NCT03286218|83118767|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894204|NCT03286218|83118768|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894205|NCT03286218|83118769|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894206|NCT03286218|83118770|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
46894207|NCT03286218|83118759|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894208|NCT03286218|83118760|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894209|NCT03286218|83118761|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
46894210|NCT03286218|83118762|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
46894211|NCT03286218|83118763|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894212|NCT03286218|83118764|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
46894213|NCT03286218|83118765|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894214|NCT03286218|83118766|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894215|NCT03286218|83118767|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894216|NCT03286218|83118768|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894217|NCT03286218|83118769|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
46894218|NCT03286218|83118770|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
46894219|NCT03286218|83118759|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894220|NCT03286218|83118760|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894221|NCT03286218|83118761|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894222|NCT03286218|83118762|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894223|NCT03286218|83118763|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894224|NCT03286218|83118764|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894225|NCT03286218|83118765|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894226|NCT03286218|83118766|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894227|NCT03286218|83118767|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894228|NCT03286218|83118768|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894229|NCT03286218|83118769|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
46894230|NCT03286218|83118770|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
46894231|NCT03224325|83118804|FG000|Overall Study|Adverse Event|1|||
46894232|NCT03224325|83118805|FG001|Overall Study|Adverse Event|0|||
46894233|NCT03224325|83118806|FG002|Overall Study|Adverse Event|0|||
46894234|NCT03224325|83118807|FG003|Overall Study|Adverse Event|0|||
46894235|NCT03224325|83118808|FG004|Overall Study|Adverse Event|0|||
46894236|NCT03224325|83118809|FG005|Overall Study|Adverse Event|0|||
46894237|NCT03224325|83118810|FG006|Overall Study|Adverse Event|1|||
46894238|NCT03224325|83118804|FG000|Overall Study|Withdrawal by Subject|0|||
46894239|NCT03224325|83118805|FG001|Overall Study|Withdrawal by Subject|0|||
46894240|NCT03224325|83118806|FG002|Overall Study|Withdrawal by Subject|0|||
46894241|NCT03224325|83118807|FG003|Overall Study|Withdrawal by Subject|1|||
46894242|NCT03224325|83118808|FG004|Overall Study|Withdrawal by Subject|0|||
46894243|NCT03224325|83118809|FG005|Overall Study|Withdrawal by Subject|0|||
46894244|NCT03224325|83118810|FG006|Overall Study|Withdrawal by Subject|0|||
46894245|NCT04016779|83118834|FG000|Overall Study|Adverse Event|9|||
46894246|NCT04016779|83118835|FG001|Overall Study|Adverse Event|17|||
46894247|NCT04016779|83118834|FG000|Overall Study|Lack of Efficacy|4|||
46894248|NCT04016779|83118835|FG001|Overall Study|Lack of Efficacy|1|||
46894249|NCT04016779|83118834|FG000|Overall Study|Lost to Follow-up|5|||
46894250|NCT04016779|83118835|FG001|Overall Study|Lost to Follow-up|14|||
46894251|NCT04016779|83118834|FG000|Overall Study|Physician Decision|1|||
46894252|NCT04016779|83118835|FG001|Overall Study|Physician Decision|3|||
46894253|NCT04016779|83118834|FG000|Overall Study|Withdrawal by Subject|6|||
46894254|NCT04016779|83118835|FG001|Overall Study|Withdrawal by Subject|8|||
46894255|NCT04016779|83118834|FG000|Overall Study|Non-compliance with Study Drug|2|||
46894256|NCT04016779|83118835|FG001|Overall Study|Non-compliance with Study Drug|3|||
46894257|NCT04016779|83118834|FG000|Overall Study|Other, Multiple categories|17|||
46894258|NCT04016779|83118835|FG001|Overall Study|Other, Multiple categories|17|||
46894259|NCT02857426|83118845|FG000|Overall Study|Disease progression|34|||
46894260|NCT02857426|83118846|FG001|Overall Study|Disease progression|13|||
46894261|NCT02857426|83118845|FG000|Overall Study|Study drug toxicity|4|||
46894262|NCT02857426|83118846|FG001|Overall Study|Study drug toxicity|1|||
46894263|NCT02857426|83118845|FG000|Overall Study|Death|1|||
46894264|NCT02857426|83118846|FG001|Overall Study|Death|0|||
46894265|NCT02857426|83118845|FG000|Overall Study|Adverse event unrelated to study drug|6|||
46894266|NCT02857426|83118846|FG001|Overall Study|Adverse event unrelated to study drug|2|||
46894267|NCT02857426|83118845|FG000|Overall Study|Participant withdrew consent|1|||
46894268|NCT02857426|83118846|FG001|Overall Study|Participant withdrew consent|1|||
46894269|NCT02857426|83118845|FG000|Overall Study|Maximum clinical benefit|1|||
46894270|NCT02857426|83118846|FG001|Overall Study|Maximum clinical benefit|0|||
46894271|NCT02857426|83118845|FG000|Overall Study|Completed treatment|0|||
46894272|NCT02857426|83118846|FG001|Overall Study|Completed treatment|2|||
46894273|NCT01127256|83118854|FG000|Overall Study|Adverse Event|13|||
46706872|NCT01202903|82922233|FG001|Overall Study|Death|0|||
46706873|NCT01202903|82922232|FG000|Overall Study|Lost to Follow-up|1|||
46706874|NCT01202903|82922233|FG001|Overall Study|Lost to Follow-up|1|||
46706875|NCT01202903|82922232|FG000|Overall Study|Lack of Efficacy|1|||
46706876|NCT01202903|82922233|FG001|Overall Study|Lack of Efficacy|3|||
46894274|NCT01127256|83118855|FG001|Overall Study|Adverse Event|13|||
46706877|NCT01202903|82922232|FG000|Overall Study|Adverse Event|3|||
46706878|NCT01202903|82922233|FG001|Overall Study|Adverse Event|3|||
46706879|NCT01202903|82922232|FG000|Overall Study|Withdrawal by Subject|4|||
46706880|NCT01202903|82922233|FG001|Overall Study|Withdrawal by Subject|4|||
46706881|NCT01001169|82922241|FG000|Overall Study|Withdrawal by Subject|2|||
46706882|NCT01001169|82922242|FG001|Overall Study|Withdrawal by Subject|1|||
46706883|NCT01202747|82922256|FG000|Overall Study|Withdrawal by Subject|1|||
46706884|NCT00996801|82922266|FG000|Overall Study|Adverse Event|6|||
46706885|NCT00996801|82922267|FG001|Overall Study|Adverse Event|4|||
46706886|NCT00996801|82922268|FG002|Overall Study|Adverse Event|12|||
46706887|NCT00996801|82922269|FG003|Overall Study|Adverse Event|17|||
46706888|NCT00996801|82922270|FG004|Overall Study|Adverse Event|31|||
46706889|NCT00996801|82922271|FG005|Overall Study|Adverse Event|3|||
46706890|NCT00996801|82922266|FG000|Overall Study|Lack of Efficacy|3|||
46706891|NCT00996801|82922267|FG001|Overall Study|Lack of Efficacy|0|||
46706892|NCT00996801|82922268|FG002|Overall Study|Lack of Efficacy|1|||
46706893|NCT00996801|82922269|FG003|Overall Study|Lack of Efficacy|3|||
46706894|NCT00996801|82922270|FG004|Overall Study|Lack of Efficacy|0|||
46706895|NCT00996801|82922271|FG005|Overall Study|Lack of Efficacy|1|||
46706896|NCT00996801|82922266|FG000|Overall Study|Lost to Follow-up|0|||
46706897|NCT00996801|82922267|FG001|Overall Study|Lost to Follow-up|0|||
46706898|NCT00996801|82922268|FG002|Overall Study|Lost to Follow-up|0|||
46706899|NCT00996801|82922269|FG003|Overall Study|Lost to Follow-up|3|||
46706900|NCT00996801|82922270|FG004|Overall Study|Lost to Follow-up|3|||
46706901|NCT00996801|82922271|FG005|Overall Study|Lost to Follow-up|2|||
46706902|NCT00996801|82922266|FG000|Overall Study|Physician Decision|0|||
46706903|NCT00996801|82922267|FG001|Overall Study|Physician Decision|0|||
46706904|NCT00996801|82922268|FG002|Overall Study|Physician Decision|0|||
46706905|NCT00996801|82922269|FG003|Overall Study|Physician Decision|1|||
46706906|NCT00996801|82922270|FG004|Overall Study|Physician Decision|0|||
46706907|NCT00996801|82922271|FG005|Overall Study|Physician Decision|0|||
46706908|NCT00996801|82922266|FG000|Overall Study|Progressive Disease|0|||
46706909|NCT00996801|82922267|FG001|Overall Study|Progressive Disease|1|||
46706910|NCT00996801|82922268|FG002|Overall Study|Progressive Disease|0|||
46706911|NCT00996801|82922269|FG003|Overall Study|Progressive Disease|0|||
46706912|NCT00996801|82922270|FG004|Overall Study|Progressive Disease|0|||
46706913|NCT00996801|82922271|FG005|Overall Study|Progressive Disease|0|||
46706914|NCT00996801|82922266|FG000|Overall Study|Protocol Violation|3|||
46706915|NCT00996801|82922267|FG001|Overall Study|Protocol Violation|4|||
46706916|NCT00996801|82922268|FG002|Overall Study|Protocol Violation|1|||
46706917|NCT00996801|82922269|FG003|Overall Study|Protocol Violation|2|||
46706918|NCT00996801|82922270|FG004|Overall Study|Protocol Violation|3|||
46706919|NCT00996801|82922271|FG005|Overall Study|Protocol Violation|4|||
46706920|NCT00996801|82922266|FG000|Overall Study|Study Terminated by Sponsor|0|||
46706921|NCT00996801|82922267|FG001|Overall Study|Study Terminated by Sponsor|1|||
46706922|NCT00996801|82922268|FG002|Overall Study|Study Terminated by Sponsor|0|||
46706923|NCT00996801|82922269|FG003|Overall Study|Study Terminated by Sponsor|0|||
46706924|NCT00996801|82922270|FG004|Overall Study|Study Terminated by Sponsor|46|||
46706925|NCT00996801|82922271|FG005|Overall Study|Study Terminated by Sponsor|0|||
46706926|NCT00996801|82922266|FG000|Overall Study|Withdrawal by Subject|8|||
46706927|NCT00996801|82922267|FG001|Overall Study|Withdrawal by Subject|6|||
46706928|NCT00996801|82922268|FG002|Overall Study|Withdrawal by Subject|9|||
46706929|NCT00996801|82922269|FG003|Overall Study|Withdrawal by Subject|5|||
46706930|NCT00996801|82922270|FG004|Overall Study|Withdrawal by Subject|5|||
46706931|NCT00996801|82922271|FG005|Overall Study|Withdrawal by Subject|9|||
46706932|NCT00996489|82922287|FG000|Overall Study|Device failure|45|||
46706933|NCT00996489|82922287|FG000|Overall Study|Discontinued|116|||
46706934|NCT01000311|82922293|FG000|Overall Study|Adverse Event|2|||
46706935|NCT01000311|82922294|FG001|Overall Study|Adverse Event|5|||
46706936|NCT01000311|82922293|FG000|Overall Study|Withdrawal by Subject|16|||
46706937|NCT01000311|82922294|FG001|Overall Study|Withdrawal by Subject|24|||
46706938|NCT01000311|82922293|FG000|Overall Study|Lost to Follow-up|15|||
46706939|NCT01000311|82922294|FG001|Overall Study|Lost to Follow-up|24|||
46706940|NCT01000311|82922293|FG000|Overall Study|Protocol Violation|1|||
46706941|NCT01000311|82922294|FG001|Overall Study|Protocol Violation|2|||
46706942|NCT01000311|82922293|FG000|Overall Study|Inappropriate enrollment|2|||
46706943|NCT01000311|82922294|FG001|Overall Study|Inappropriate enrollment|0|||
46706944|NCT01000311|82922293|FG000|Overall Study|Administrative reason|9|||
46706945|NCT01000311|82922294|FG001|Overall Study|Administrative reason|15|||
46706946|NCT01003899|82922300|FG000|Overall Study|Other Adverse Event|8|||
46706947|NCT01003899|82922300|FG000|Overall Study|Not entered|4|||
46706948|NCT01003899|82922300|FG000|Overall Study|Not treated|1|||
46706949|NCT01003899|82922300|FG000|Overall Study|Progressive disease|34|||
46706950|NCT01000155|82922304|FG000|Overall Study|Withdrawal by Subject|1|||
46706951|NCT01000155|82922304|FG000|Overall Study|Adverse Event|1|||
46706952|NCT00999921|82922310|FG000|Overall Study|Lost to Follow-up|10|||
46706953|NCT00999921|82922311|FG001|Overall Study|Lost to Follow-up|19|||
46706954|NCT01002573|82922322|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
46706955|NCT01002573|82922323|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
46706956|NCT00999687|82922329|FG000|First Intervention|Withdrawal by Subject|1|||
46706957|NCT00999687|82922329|FG000|Second Intervention|Withdrawal by Subject|2|||
46706958|NCT00999687|82922329|FG000|Second Intervention|Lack of Efficacy|1|||
46706959|NCT00996333|82922335|FG000|Overall Study|Screen failure|1|||
46706960|NCT00996333|82922335|FG000|Overall Study|Withdrawal by Subject|1|||
46706961|NCT00996333|82922335|FG000|Overall Study|Death|4|||
46706962|NCT00996333|82922335|FG000|Overall Study|Adverse Event|1|||
46706963|NCT00996333|82922335|FG000|Overall Study|Physician Decision|1|||
46706964|NCT00996333|82922335|FG000|Overall Study|Other|5|||
46706965|NCT00995865|82922342|FG000|Overall Study|Protocol Violation|2|||
46706966|NCT00995865|82922343|FG001|Overall Study|Protocol Violation|0|||
46706967|NCT00995865|82922344|FG002|Overall Study|Protocol Violation|0|||
46706968|NCT00995865|82922342|FG000|Overall Study|Lost to Follow-up|0|||
46706969|NCT00995865|82922343|FG001|Overall Study|Lost to Follow-up|0|||
46706970|NCT00995865|82922344|FG002|Overall Study|Lost to Follow-up|1|||
46706971|NCT00995709|82922360|FG000|Overall Study|Adverse Event|4|||
46706972|NCT00995709|82922361|FG001|Overall Study|Adverse Event|2|||
46706973|NCT00995709|82922362|FG002|Overall Study|Adverse Event|0|||
46706974|NCT00995709|82922360|FG000|Overall Study|Lack of Efficacy|0|||
46706975|NCT00995709|82922361|FG001|Overall Study|Lack of Efficacy|1|||
46706976|NCT00995709|82922362|FG002|Overall Study|Lack of Efficacy|4|||
46706977|NCT00995709|82922360|FG000|Overall Study|Withdrawal by Subject|0|||
46706978|NCT00995709|82922361|FG001|Overall Study|Withdrawal by Subject|4|||
46706979|NCT00995709|82922362|FG002|Overall Study|Withdrawal by Subject|1|||
46706980|NCT00995709|82922360|FG000|Overall Study|Lost to Follow-up|1|||
46706981|NCT00995709|82922361|FG001|Overall Study|Lost to Follow-up|0|||
46706982|NCT00995709|82922362|FG002|Overall Study|Lost to Follow-up|0|||
46706983|NCT00995709|82922360|FG000|Overall Study|Death|0|||
46706984|NCT00995709|82922361|FG001|Overall Study|Death|1|||
46706985|NCT00995709|82922362|FG002|Overall Study|Death|0|||
46706986|NCT00995709|82922360|FG000|Overall Study|Protocol Violation|2|||
46706987|NCT00995709|82922361|FG001|Overall Study|Protocol Violation|1|||
46706988|NCT00995709|82922362|FG002|Overall Study|Protocol Violation|0|||
46706989|NCT00998985|82922384|FG000|Overall Study|Withdrawal by Subject|0|||
46706990|NCT00998985|82922385|FG001|Overall Study|Withdrawal by Subject|0|||
46706991|NCT00998985|82922386|FG002|Overall Study|Withdrawal by Subject|0|||
46706992|NCT00998985|82922387|FG003|Overall Study|Withdrawal by Subject|0|||
46706993|NCT00998985|82922388|FG004|Overall Study|Withdrawal by Subject|0|||
46706994|NCT00998985|82922389|FG005|Overall Study|Withdrawal by Subject|0|||
46706995|NCT00998985|82922390|FG006|Overall Study|Withdrawal by Subject|0|||
46706996|NCT00998985|82922391|FG007|Overall Study|Withdrawal by Subject|0|||
46706997|NCT00998985|82922392|FG008|Overall Study|Withdrawal by Subject|1|||
46706998|NCT00998985|82922393|FG009|Overall Study|Withdrawal by Subject|0|||
46706999|NCT00998985|82922394|FG010|Overall Study|Withdrawal by Subject|0|||
46707000|NCT00998985|82922395|FG011|Overall Study|Withdrawal by Subject|0|||
46707001|NCT00998985|82922396|FG012|Overall Study|Withdrawal by Subject|0|||
46707002|NCT00998985|82922397|FG013|Overall Study|Withdrawal by Subject|0|||
46707003|NCT00998985|82922384|FG000|Overall Study|Protocol Violation|0|||
46707004|NCT00998985|82922385|FG001|Overall Study|Protocol Violation|0|||
46707005|NCT00998985|82922386|FG002|Overall Study|Protocol Violation|0|||
46707006|NCT00998985|82922387|FG003|Overall Study|Protocol Violation|0|||
46707007|NCT00998985|82922388|FG004|Overall Study|Protocol Violation|0|||
46707008|NCT00998985|82922389|FG005|Overall Study|Protocol Violation|1|||
46707009|NCT00998985|82922390|FG006|Overall Study|Protocol Violation|0|||
46707010|NCT00998985|82922391|FG007|Overall Study|Protocol Violation|0|||
46707011|NCT00998985|82922392|FG008|Overall Study|Protocol Violation|0|||
46707012|NCT00998985|82922393|FG009|Overall Study|Protocol Violation|0|||
46707013|NCT00998985|82922394|FG010|Overall Study|Protocol Violation|0|||
46707014|NCT00998985|82922395|FG011|Overall Study|Protocol Violation|0|||
46707015|NCT00998985|82922396|FG012|Overall Study|Protocol Violation|0|||
46707016|NCT00998985|82922397|FG013|Overall Study|Protocol Violation|0|||
46707017|NCT00995553|82922444|FG000|Overall Study|Withdrawal by Subject|2|||
46707018|NCT00995553|82922445|FG001|Overall Study|Withdrawal by Subject|6|||
46707019|NCT00991887|82922453|FG000|Overall Study|Lost to Follow-up|2|||
46707020|NCT00991887|82922454|FG001|Overall Study|Lost to Follow-up|1|||
46707021|NCT01002339|82922463|FG000|Overall Study|Withdrawal by Subject|0|||
46707022|NCT01002339|82922464|FG001|Overall Study|Withdrawal by Subject|1|||
46707023|NCT01002339|82922465|FG002|Overall Study|Withdrawal by Subject|0|||
46707024|NCT01002339|82922463|FG000|Overall Study|Incorrect treatment assignment|0|||
46707025|NCT01002339|82922464|FG001|Overall Study|Incorrect treatment assignment|0|||
46707026|NCT01002339|82922465|FG002|Overall Study|Incorrect treatment assignment|1|||
46707027|NCT01002339|82922463|FG000|Overall Study|Protocol Violation|0|||
46707028|NCT01002339|82922464|FG001|Overall Study|Protocol Violation|0|||
46707029|NCT01002339|82922465|FG002|Overall Study|Protocol Violation|2|||
46707030|NCT01002339|82922463|FG000|Overall Study|Lung cancer detected before transplant|0|||
46707031|NCT01002339|82922464|FG001|Overall Study|Lung cancer detected before transplant|0|||
46707032|NCT01002339|82922465|FG002|Overall Study|Lung cancer detected before transplant|1|||
46707033|NCT01002339|82922463|FG000|Overall Study|Randomized. Not transplanted|0|||
46707034|NCT01002339|82922464|FG001|Overall Study|Randomized. Not transplanted|0|||
46707035|NCT01002339|82922465|FG002|Overall Study|Randomized. Not transplanted|1|||
46707036|NCT01002105|82922475|FG000|Overall Study|Lost to Follow-up|10|||
46707037|NCT01002105|82922476|FG001|Overall Study|Lost to Follow-up|16|||
46707038|NCT01002105|82922475|FG000|Overall Study|non compliance|5|||
46707039|NCT01002105|82922476|FG001|Overall Study|non compliance|3|||
46707040|NCT01002105|82922475|FG000|Overall Study|condition worsened|4|||
46707041|NCT01002105|82922476|FG001|Overall Study|condition worsened|2|||
46707042|NCT02605993|82922489|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
46707043|NCT02605993|82922490|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
46707044|NCT02605993|82922491|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
46707045|NCT02605993|82922492|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
46707046|NCT00995085|82922502|FG000|Overall Study|Withdrawal by Subject|5|||
46707047|NCT00603733|82922508|FG000|Active Phase ITT|Adverse Event|8|||
46707048|NCT00603733|82922509|FG001|Active Phase ITT|Adverse Event|7|||
46894275|NCT01127256|83118854|FG000|Overall Study|Lack of Efficacy|4|||
46894276|NCT01127256|83118855|FG001|Overall Study|Lack of Efficacy|0|||
46894277|NCT01127256|83118854|FG000|Overall Study|Lost to Follow-up|16|||
46894278|NCT01127256|83118855|FG001|Overall Study|Lost to Follow-up|17|||
46894279|NCT01127256|83118854|FG000|Overall Study|Withdrawal by Subject|5|||
46894280|NCT01127256|83118855|FG001|Overall Study|Withdrawal by Subject|9|||
46894281|NCT01127256|83118854|FG000|Overall Study|Protocol Violation|1|||
46894282|NCT01127256|83118855|FG001|Overall Study|Protocol Violation|0|||
46894283|NCT04016311|83118863|FG000|Overall Study|Withdrawal by Subject|1|||
46894284|NCT04016311|83118864|FG001|Overall Study|Withdrawal by Subject|0|||
46894285|NCT04052425|83118874|FG000|24-Week Double-blind Period|Adverse Event|0|||
46894286|NCT04052425|83118875|FG001|24-Week Double-blind Period|Adverse Event|1|||
46894287|NCT04052425|83118876|FG002|24-Week Double-blind Period|Adverse Event|0|||
46894288|NCT04052425|83118877|FG003|24-Week Double-blind Period|Adverse Event|0|||
46894289|NCT04052425|83118874|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
46894290|NCT04052425|83118875|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
46894291|NCT04052425|83118876|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
46894292|NCT04052425|83118877|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
46894293|NCT04052425|83118874|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
46894294|NCT04052425|83118875|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
46894295|NCT04052425|83118876|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
46894296|NCT04052425|83118877|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
46894297|NCT04052425|83118874|FG000|24-Week Double-blind Period|Physician Decision|1|||
46894298|NCT04052425|83118875|FG001|24-Week Double-blind Period|Physician Decision|0|||
46894299|NCT04052425|83118876|FG002|24-Week Double-blind Period|Physician Decision|0|||
46894300|NCT04052425|83118877|FG003|24-Week Double-blind Period|Physician Decision|0|||
46894301|NCT04052425|83118874|FG000|24-Week Double-blind Period|Protocol Violation|1|||
46894302|NCT04052425|83118875|FG001|24-Week Double-blind Period|Protocol Violation|0|||
46894303|NCT04052425|83118876|FG002|24-Week Double-blind Period|Protocol Violation|0|||
46894304|NCT04052425|83118877|FG003|24-Week Double-blind Period|Protocol Violation|0|||
46894305|NCT04052425|83118874|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
46894306|NCT04052425|83118875|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
46894307|NCT04052425|83118876|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
46894308|NCT04052425|83118877|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
46894309|NCT04052425|83118874|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
46894310|NCT04052425|83118875|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
46894311|NCT04052425|83118876|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
46894312|NCT04052425|83118877|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
46894313|NCT04052425|83118874|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
46894314|NCT04052425|83118875|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
46894315|NCT04052425|83118876|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
46894316|NCT04052425|83118877|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
46894317|NCT04052425|83118874|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
46894318|NCT04052425|83118875|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
46894319|NCT04052425|83118876|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
46894320|NCT04052425|83118877|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
46894321|NCT04052425|83118874|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
46894322|NCT04052425|83118875|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
46894323|NCT04052425|83118876|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
46894324|NCT04052425|83118877|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
46894325|NCT04052425|83118874|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
46894326|NCT04052425|83118875|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
46894327|NCT04052425|83118876|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
46894328|NCT04052425|83118877|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
46894329|NCT04052425|83118874|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
46894330|NCT04052425|83118875|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
46894331|NCT04052425|83118876|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
46894332|NCT04052425|83118877|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
46894333|NCT04052425|83118874|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
46894334|NCT04052425|83118875|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
46894335|NCT04052425|83118876|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
46894336|NCT04052425|83118877|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
46894337|NCT04052425|83118874|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
46894338|NCT04052425|83118875|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
46894339|NCT04052425|83118876|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
46894340|NCT04052425|83118877|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
46894341|NCT03235089|83118887|FG000|Overall Study|Lost to Follow-up|1|||
46894342|NCT03235089|83118888|FG001|Overall Study|Lost to Follow-up|1|||
46894343|NCT03235089|83118887|FG000|Overall Study|Physician Decision|2|||
46894344|NCT03235089|83118888|FG001|Overall Study|Physician Decision|2|||
46894345|NCT04013191|83118897|FG000|Overall Study|Adverse Event|1|||
46894346|NCT04013191|83118898|FG001|Overall Study|Adverse Event|0|||
46894347|NCT03285594|83118911|FG000|Overall Study|At the Participant's Own Request|10|||
46894348|NCT03285594|83118912|FG001|Overall Study|At the Participant's Own Request|5|||
46894349|NCT03285594|83118913|FG002|Overall Study|At the Participant's Own Request|21|||
46894350|NCT03285594|83118911|FG000|Overall Study|Adverse Event|2|||
46894351|NCT03285594|83118912|FG001|Overall Study|Adverse Event|2|||
46894352|NCT03285594|83118913|FG002|Overall Study|Adverse Event|6|||
46894353|NCT03285594|83118911|FG000|Overall Study|Poor Compliance to Protocol|0|||
46894354|NCT03285594|83118912|FG001|Overall Study|Poor Compliance to Protocol|0|||
46894355|NCT03285594|83118913|FG002|Overall Study|Poor Compliance to Protocol|1|||
46894356|NCT03285594|83118911|FG000|Overall Study|Lost to Follow-up|0|||
46894357|NCT03285594|83118912|FG001|Overall Study|Lost to Follow-up|0|||
46894358|NCT03285594|83118913|FG002|Overall Study|Lost to Follow-up|1|||
46894359|NCT03285594|83118911|FG000|Overall Study|Reason Not Specified|3|||
46894360|NCT03285594|83118912|FG001|Overall Study|Reason Not Specified|4|||
46894361|NCT03285594|83118913|FG002|Overall Study|Reason Not Specified|8|||
46894362|NCT03234465|83118924|FG000|Overall Study|Adverse Event|4|||
46894363|NCT03234465|83118925|FG001|Overall Study|Adverse Event|2|||
46894364|NCT03234465|83118924|FG000|Overall Study|Death|0|||
46894365|NCT03234465|83118925|FG001|Overall Study|Death|1|||
46894366|NCT03234465|83118924|FG000|Overall Study|Lost to Follow-up|1|||
46894367|NCT03234465|83118925|FG001|Overall Study|Lost to Follow-up|1|||
46894368|NCT03234465|83118924|FG000|Overall Study|Withdrawal by Subject|12|||
46894369|NCT03234465|83118925|FG001|Overall Study|Withdrawal by Subject|27|||
46894370|NCT03234465|83118924|FG000|Overall Study|Symptomatic deterioration|0|||
46894371|NCT03234465|83118925|FG001|Overall Study|Symptomatic deterioration|1|||
46894372|NCT03234465|83118924|FG000|Overall Study|Non-compliance|2|||
46894373|NCT03234465|83118925|FG001|Overall Study|Non-compliance|0|||
46894374|NCT03234465|83118924|FG000|Overall Study|Other|14|||
46894375|NCT03234465|83118925|FG001|Overall Study|Other|8|||
46894376|NCT03290131|83118934|FG000|Overall Study|Adverse Event|22|||
46894377|NCT03290131|83118935|FG001|Overall Study|Adverse Event|57|||
46894378|NCT03290131|83118936|FG002|Overall Study|Adverse Event|11|||
46894379|NCT03290131|83118934|FG000|Overall Study|Withdrawal by Subject|18|||
46894380|NCT03290131|83118935|FG001|Overall Study|Withdrawal by Subject|13|||
46894381|NCT03290131|83118936|FG002|Overall Study|Withdrawal by Subject|8|||
46894382|NCT03290131|83118934|FG000|Overall Study|MS Relapse|2|||
46894383|NCT03290131|83118935|FG001|Overall Study|MS Relapse|1|||
46894384|NCT03290131|83118936|FG002|Overall Study|MS Relapse|0|||
46894385|NCT03290131|83118934|FG000|Overall Study|Unknown reason|0|||
46894386|NCT03290131|83118935|FG001|Overall Study|Unknown reason|1|||
46894387|NCT03290131|83118936|FG002|Overall Study|Unknown reason|0|||
46894388|NCT04050865|83118947|FG000|Overall Study|Adverse Event|1|||
46894389|NCT04050865|83118948|FG001|Overall Study|Adverse Event|0|||
46894390|NCT04050865|83118947|FG000|Overall Study|no insert|1|||
46894391|NCT04050865|83118948|FG001|Overall Study|no insert|0|||
46894392|NCT04050865|83118947|FG000|Overall Study|Only 1 insert|2|||
46894393|NCT04050865|83118948|FG001|Overall Study|Only 1 insert|3|||
46894394|NCT04050865|83118947|FG000|Overall Study|Physician Decision|0|||
46894395|NCT04050865|83118948|FG001|Overall Study|Physician Decision|1|||
46894396|NCT04050865|83118947|FG000|Overall Study|Withdrawal by Subject|0|||
46894397|NCT04050865|83118948|FG001|Overall Study|Withdrawal by Subject|1|||
46894398|NCT03283566|83118956|FG000|Overall Study|Lost to Follow-up|1|||
46894399|NCT03283566|83118957|FG001|Overall Study|Lost to Follow-up|2|||
46894400|NCT03210519|83118965|FG000|Overall Study|Adverse Event|2|||
46894401|NCT03210519|83118966|FG001|Overall Study|Adverse Event|0|||
46894402|NCT04048681|83118972|FG000|Overall Study|family emergency|0|||
46894403|NCT04048681|83118973|FG001|Overall Study|family emergency|0|||
46894404|NCT04048681|83118974|FG002|Overall Study|family emergency|0|||
46894405|NCT04048681|83118975|FG003|Overall Study|family emergency|1|||
46894406|NCT04048681|83118976|FG004|Overall Study|family emergency|0|||
46894407|NCT04007107|83118984|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
46894408|NCT04007107|83118985|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
46894409|NCT04007107|83118986|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
46894410|NCT04007107|83118987|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
46894411|NCT04046341|83118992|FG000|Overall Study|Lost to Follow-up|2|||
46894412|NCT04046341|83118992|FG000|Overall Study|Withdrawal by Subject|1|||
46894413|NCT03233529|83118996|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
46894414|NCT03233529|83118996|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
46894415|NCT04006171|83119006|FG000|Overall Study|Withdrawal by Subject|8|||
46894416|NCT04006171|83119007|FG001|Overall Study|Withdrawal by Subject|7|||
46894417|NCT04006171|83119006|FG000|Overall Study|missing serum samples|2|||
46894418|NCT04006171|83119007|FG001|Overall Study|missing serum samples|2|||
46894419|NCT04006171|83119006|FG000|Overall Study|insufficient sample volume|2|||
46894420|NCT04006171|83119007|FG001|Overall Study|insufficient sample volume|3|||
46894421|NCT04043143|83119020|FG000|Overall Study|Lost to Follow-up|5|||
46894422|NCT04043143|83119021|FG001|Overall Study|Lost to Follow-up|5|||
46894423|NCT04043143|83119020|FG000|Overall Study|screen failure|1|||
46894424|NCT04043143|83119021|FG001|Overall Study|screen failure|0|||
46894425|NCT03283098|83119029|FG000|Overall Study|Withdrawal by Subject|0|||
46894426|NCT03283098|83119030|FG001|Overall Study|Withdrawal by Subject|1|||
46894427|NCT03655951|83119038|FG000|Overall Study|Lost to Follow-up|39|||
46894428|NCT03655951|83119039|FG001|Overall Study|Lost to Follow-up|20|||
46894429|NCT03655951|83119038|FG000|Overall Study|Withdrawal by Subject|0|||
46894430|NCT03655951|83119039|FG001|Overall Study|Withdrawal by Subject|1|||
46894431|NCT02527798|83119051|FG000|Overall Study|Physician Decision|1|||
46894432|NCT02527798|83119052|FG001|Overall Study|Physician Decision|0|||
46894433|NCT02527798|83119053|FG002|Overall Study|Physician Decision|1|||
46894434|NCT02527798|83119054|FG003|Overall Study|Physician Decision|1|||
46894435|NCT02527798|83119055|FG004|Overall Study|Physician Decision|0|||
46894436|NCT02527798|83119056|FG005|Overall Study|Physician Decision|0|||
46894437|NCT02527798|83119051|FG000|Overall Study|Death|0|||
46894438|NCT02527798|83119052|FG001|Overall Study|Death|0|||
46894439|NCT02527798|83119053|FG002|Overall Study|Death|1|||
46894440|NCT02527798|83119054|FG003|Overall Study|Death|0|||
46894441|NCT02527798|83119055|FG004|Overall Study|Death|0|||
46894442|NCT02527798|83119056|FG005|Overall Study|Death|0|||
46894443|NCT02527798|83119051|FG000|Overall Study|Withdrawal by Subject|0|||
46894444|NCT02527798|83119052|FG001|Overall Study|Withdrawal by Subject|1|||
46894445|NCT02527798|83119053|FG002|Overall Study|Withdrawal by Subject|2|||
46894446|NCT02527798|83119054|FG003|Overall Study|Withdrawal by Subject|0|||
46894447|NCT02527798|83119055|FG004|Overall Study|Withdrawal by Subject|0|||
46707049|NCT00603733|82922508|FG000|Active Phase ITT|Withdrawal by Subject|0|||
46707050|NCT00603733|82922509|FG001|Active Phase ITT|Withdrawal by Subject|3|||
46707051|NCT00603733|82922508|FG000|Active Phase ITT|Lost to Follow-up|0|||
46707052|NCT00603733|82922509|FG001|Active Phase ITT|Lost to Follow-up|1|||
46707053|NCT00603733|82922508|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
46707054|NCT00603733|82922509|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
46707055|NCT00603733|82922508|FG000|Active Phase ITT|Lack of Efficacy|1|||
46707056|NCT00603733|82922509|FG001|Active Phase ITT|Lack of Efficacy|2|||
46707057|NCT00603733|82922508|FG000|Active Phase ITT|Subject moved, site closed|1|||
46707058|NCT00603733|82922509|FG001|Active Phase ITT|Subject moved, site closed|1|||
46707059|NCT00603733|82922508|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
46707060|NCT00603733|82922509|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
46707061|NCT00603733|82922508|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
46707062|NCT00603733|82922509|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
46707063|NCT00603733|82922508|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
46707064|NCT00603733|82922509|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
46707065|NCT00603733|82922508|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
46707066|NCT00603733|82922509|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
46707067|NCT00603733|82922508|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
46707068|NCT00603733|82922509|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
46707069|NCT00603733|82922508|FG000|Maintenance Phase ITT|Adverse Event|3|||
46707070|NCT00603733|82922509|FG001|Maintenance Phase ITT|Adverse Event|6|||
46707071|NCT00603733|82922508|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
46707072|NCT00603733|82922509|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
46707073|NCT00603733|82922508|FG000|Maintenance Phase ITT|Protocol Violation|1|||
46707074|NCT00603733|82922509|FG001|Maintenance Phase ITT|Protocol Violation|1|||
46707075|NCT00603733|82922508|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
46707076|NCT00603733|82922509|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
46707077|NCT00603733|82922508|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
46707078|NCT00603733|82922509|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
46707079|NCT00603733|82922508|FG000|Maintenance Phase ITT|Physician Decision|0|||
46707080|NCT00603733|82922509|FG001|Maintenance Phase ITT|Physician Decision|1|||
46707081|NCT00603733|82922508|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
46707082|NCT00603733|82922509|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
46707083|NCT04631107|82922515|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
46707084|NCT04631107|82922515|FG000|Second Intervention (1 Night)|Adverse Event|1|||
46707085|NCT04631107|82922515|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
46707086|NCT04631107|82922515|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
46707087|NCT00995007|82922525|FG000|Overall Study|Withdrew consent|1|||
46707088|NCT00995007|82922526|FG001|Overall Study|Withdrew consent|0|||
46707089|NCT00995007|82922525|FG000|Overall Study|Refused further treatment|8|||
46707090|NCT00995007|82922526|FG001|Overall Study|Refused further treatment|2|||
46707091|NCT00995007|82922525|FG000|Overall Study|Toxicity|8|||
46707092|NCT00995007|82922526|FG001|Overall Study|Toxicity|0|||
46707093|NCT00994461|82922544|FG000|Overall Study|Adverse Event|2|||
46707094|NCT00994461|82922545|FG001|Overall Study|Adverse Event|1|||
46707095|NCT00994461|82922546|FG002|Overall Study|Adverse Event|0|||
46707096|NCT00993915|82922554|FG000|Overall Study|Insufficient clinical response|3|||
46707097|NCT00993915|82922554|FG000|Overall Study|Withdrawal by Subject|2|||
46707098|NCT00993915|82922554|FG000|Overall Study|Other|1|||
46707099|NCT00993915|82922554|FG000|Overall Study|Ongoing|3|||
46707100|NCT01202591|82922564|FG000|Overall Study|Adverse Event|2|||
46707101|NCT01202591|82922565|FG001|Overall Study|Adverse Event|1|||
46707102|NCT01202591|82922566|FG002|Overall Study|Adverse Event|4|||
46707103|NCT01202591|82922567|FG003|Overall Study|Adverse Event|4|||
46707104|NCT01202591|82922568|FG004|Overall Study|Adverse Event|0|||
46707105|NCT01202591|82922569|FG005|Overall Study|Adverse Event|0|||
46707106|NCT01202591|82922564|FG000|Overall Study|Other reason as per investigator|3|||
46707107|NCT01202591|82922565|FG001|Overall Study|Other reason as per investigator|4|||
46707108|NCT01202591|82922566|FG002|Overall Study|Other reason as per investigator|7|||
46707109|NCT01202591|82922567|FG003|Overall Study|Other reason as per investigator|3|||
46707110|NCT01202591|82922568|FG004|Overall Study|Other reason as per investigator|1|||
46707111|NCT01202591|82922569|FG005|Overall Study|Other reason as per investigator|3|||
46707112|NCT01202591|82922564|FG000|Overall Study|Withdrawal by Subject|0|||
46707113|NCT01202591|82922565|FG001|Overall Study|Withdrawal by Subject|0|||
46707114|NCT01202591|82922566|FG002|Overall Study|Withdrawal by Subject|0|||
46707115|NCT01202591|82922567|FG003|Overall Study|Withdrawal by Subject|0|||
46707116|NCT01202591|82922568|FG004|Overall Study|Withdrawal by Subject|2|||
46707117|NCT01202591|82922569|FG005|Overall Study|Withdrawal by Subject|1|||
46707118|NCT01202591|82922564|FG000|Overall Study|Objective Disease Progression|0|||
46707119|NCT01202591|82922565|FG001|Overall Study|Objective Disease Progression|0|||
46707120|NCT01202591|82922566|FG002|Overall Study|Objective Disease Progression|0|||
46707121|NCT01202591|82922567|FG003|Overall Study|Objective Disease Progression|0|||
46707122|NCT01202591|82922568|FG004|Overall Study|Objective Disease Progression|2|||
46707123|NCT01202591|82922569|FG005|Overall Study|Objective Disease Progression|0|||
46707124|NCT01202279|82922585|FG000|Overall Study|Adverse Event|8|||
46707125|NCT01202279|82922586|FG001|Overall Study|Adverse Event|6|||
46707126|NCT01202279|82922585|FG000|Overall Study|Withdrawal by Subject|13|||
46707127|NCT01202279|82922586|FG001|Overall Study|Withdrawal by Subject|10|||
46707128|NCT01202279|82922585|FG000|Overall Study|Physician Decision|0|||
46707129|NCT01202279|82922586|FG001|Overall Study|Physician Decision|1|||
46707130|NCT01202279|82922585|FG000|Overall Study|Lost to Follow-up|10|||
46707131|NCT01202279|82922586|FG001|Overall Study|Lost to Follow-up|7|||
46707132|NCT01202279|82922585|FG000|Overall Study|Protocol Violation|1|||
46707133|NCT01202279|82922586|FG001|Overall Study|Protocol Violation|1|||
46707134|NCT01202279|82922585|FG000|Overall Study|study compliance|5|||
46707135|NCT01202279|82922586|FG001|Overall Study|study compliance|2|||
46707136|NCT01201967|82922594|FG000|Overall Study|Lost to Follow-up|6|||
46707137|NCT01201967|82922595|FG001|Overall Study|Lost to Follow-up|5|||
46707138|NCT01201811|82922611|FG000|Overall Study|Adverse Event|6|||
46707139|NCT01201811|82922611|FG000|Overall Study|Disease progression|3|||
46707140|NCT01201811|82922611|FG000|Overall Study|Withdrawal by Subject|3|||
46707141|NCT01201811|82922611|FG000|Overall Study|Death|4|||
46707142|NCT01201811|82922611|FG000|Overall Study|Treatment Failure|2|||
46707143|NCT01201811|82922611|FG000|Overall Study|Physician Decision|1|||
46707144|NCT01201343|82922615|FG000|Overall Study|Adverse Event|6|||
46707145|NCT01201343|82922615|FG000|Overall Study|Withdrawal by Subject|5|||
46707146|NCT01201343|82922615|FG000|Overall Study|Lost to Follow-up|2|||
46707147|NCT01201343|82922615|FG000|Overall Study|Lack of Efficacy|2|||
46707148|NCT01201343|82922615|FG000|Overall Study|Participant wrongly included in trial|1|||
46707149|NCT01201343|82922615|FG000|Overall Study|Randomized, not treated|3|||
46707150|NCT01201265|82922619|FG000|Overall Study|Death|14|||
46707151|NCT01201265|82922619|FG000|Overall Study|Insufficient Therapeutic Response|3|||
46707152|NCT01201265|82922619|FG000|Overall Study|Lost to Follow-up|10|||
46707153|NCT01201265|82922619|FG000|Overall Study|Withdrawal by Subject|7|||
46707154|NCT01201265|82922619|FG000|Overall Study|Disease Progression|4|||
46707155|NCT04246801|82922625|FG000|Overall Study|Adverse Event|1|||
46707156|NCT04246801|82922626|FG001|Overall Study|Adverse Event|1|||
46707157|NCT04246801|82922625|FG000|Overall Study|Protocol Violation|1|||
46707158|NCT04246801|82922626|FG001|Overall Study|Protocol Violation|1|||
46707159|NCT04246801|82922625|FG000|Overall Study|Lack of Efficacy|0|||
46707160|NCT04246801|82922626|FG001|Overall Study|Lack of Efficacy|2|||
46707161|NCT04246801|82922625|FG000|Overall Study|Lost to Follow-up|1|||
46707162|NCT04246801|82922626|FG001|Overall Study|Lost to Follow-up|1|||
46707163|NCT04246801|82922625|FG000|Overall Study|Withdrawal by Subject|2|||
46707164|NCT04246801|82922626|FG001|Overall Study|Withdrawal by Subject|1|||
46707165|NCT01200797|82922632|FG000|Overall Study|symptomatic deterioration|2|||
46707166|NCT01200797|82922632|FG000|Overall Study|Adverse Event|4|||
46707167|NCT01200797|82922632|FG000|Overall Study|Disease Progression|13|||
46707168|NCT01200485|82922637|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
46707169|NCT01200485|82922638|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
46707170|NCT01200485|82922639|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
46707171|NCT01200485|82922637|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
46707172|NCT01200485|82922638|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
46707173|NCT01200485|82922639|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
46707174|NCT01200407|82922646|FG000|Overall Study|Lost to Follow-up|56|||
46707175|NCT01200407|82922646|FG000|Overall Study|Adverse Event|3|||
46707176|NCT01200407|82922646|FG000|Overall Study|Withdrawal by Subject|4|||
46707177|NCT01200407|82922646|FG000|Overall Study|Other|19|||
46707178|NCT01200329|82922650|FG000|Overall Study|Lack of financial coverage|2|||
46707179|NCT01200329|82922650|FG000|Overall Study|Progressive disease|1|||
46707180|NCT01199939|82922654|FG000|Overall Study|Adverse Event|4|||
46707181|NCT01199939|82922654|FG000|Overall Study|Protocol Violation|3|||
46707182|NCT01199939|82922654|FG000|Overall Study|Lost to Follow-up|2|||
46707183|NCT01199939|82922654|FG000|Overall Study|Reached a virologic endpoint|4|||
46707184|NCT01199861|82922660|FG000|Overall Study|Administrative problems|1|||
46707185|NCT01199861|82922661|FG001|Overall Study|Administrative problems|0|||
46707186|NCT01199861|82922660|FG000|Overall Study|Adverse Event|1|||
46707187|NCT01199861|82922661|FG001|Overall Study|Adverse Event|0|||
46707188|NCT01199705|82922681|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
46707189|NCT01199471|82922696|FG000|Overall Study|Protocol Violation|4|||
46707190|NCT01199471|82922696|FG000|Overall Study|Withdrawal by Subject|1|||
46707191|NCT01199471|82922696|FG000|Overall Study|Physician Decision|1|||
46707192|NCT01198145|82922703|FG000|Overall Study|Withdrawal by Subject|1|||
46707193|NCT01198145|82922704|FG001|Overall Study|Withdrawal by Subject|1|||
46707194|NCT01197911|82922714|FG000|Overall Study|Adverse Event|0|||
46707195|NCT01197911|82922715|FG001|Overall Study|Adverse Event|0|||
46707196|NCT01197911|82922716|FG002|Overall Study|Adverse Event|1|||
46707197|NCT01197755|82922728|FG000|Overall Study|Adverse Event|8|||
46707198|NCT01197755|82922729|FG001|Overall Study|Adverse Event|10|||
46707199|NCT01197755|82922730|FG002|Overall Study|Adverse Event|10|||
46707200|NCT01197755|82922728|FG000|Overall Study|Study-specific discontinuation criteria|2|||
46707201|NCT01197755|82922729|FG001|Overall Study|Study-specific discontinuation criteria|1|||
46707202|NCT01197755|82922730|FG002|Overall Study|Study-specific discontinuation criteria|0|||
46707203|NCT01197755|82922728|FG000|Overall Study|Entered the long-term extension study|18|||
46707204|NCT01197755|82922729|FG001|Overall Study|Entered the long-term extension study|21|||
46707205|NCT01197755|82922730|FG002|Overall Study|Entered the long-term extension study|35|||
46707206|NCT01197755|82922728|FG000|Overall Study|Lack of therapeutic response|0|||
46707207|NCT01197755|82922729|FG001|Overall Study|Lack of therapeutic response|7|||
46707208|NCT01197755|82922730|FG002|Overall Study|Lack of therapeutic response|4|||
46707209|NCT01197755|82922728|FG000|Overall Study|Severe non-compliance to the protocol|2|||
46707210|NCT01197755|82922729|FG001|Overall Study|Severe non-compliance to the protocol|1|||
46707211|NCT01197755|82922730|FG002|Overall Study|Severe non-compliance to the protocol|2|||
46707212|NCT01197755|82922728|FG000|Overall Study|Withdrawal by Subject|1|||
46707213|NCT01197755|82922729|FG001|Overall Study|Withdrawal by Subject|0|||
46707214|NCT01197755|82922730|FG002|Overall Study|Withdrawal by Subject|0|||
46894448|NCT02527798|83119056|FG005|Overall Study|Withdrawal by Subject|0|||
46707215|NCT01197755|82922728|FG000|Overall Study|Lost to Follow-up|0|||
46707216|NCT01197755|82922729|FG001|Overall Study|Lost to Follow-up|0|||
46707217|NCT01197755|82922730|FG002|Overall Study|Lost to Follow-up|1|||
46707218|NCT01197755|82922728|FG000|Overall Study|eg, change in circumstances|7|||
46707219|NCT01197755|82922729|FG001|Overall Study|eg, change in circumstances|3|||
46707220|NCT01197755|82922730|FG002|Overall Study|eg, change in circumstances|2|||
46707221|NCT01179048|82922742|FG000|Overall Study|Withdrawn - does not allow contact|4|||
46707222|NCT01179048|82922743|FG001|Overall Study|Withdrawn - does not allow contact|8|||
46707223|NCT01179048|82922742|FG000|Overall Study|Lost to Follow-up|8|||
46707224|NCT01179048|82922743|FG001|Overall Study|Lost to Follow-up|9|||
46707225|NCT01179048|82922742|FG000|Overall Study|Alive|127|||
46707226|NCT01179048|82922743|FG001|Overall Study|Alive|142|||
46707227|NCT00603265|82922752|FG000|Overall Study|Adverse Event|2|||
46707228|NCT00603265|82922753|FG001|Overall Study|Adverse Event|11|||
46707229|NCT00603265|82922754|FG002|Overall Study|Adverse Event|1|||
46707230|NCT00603265|82922752|FG000|Overall Study|Withdrawal by Subject|1|||
46707231|NCT00603265|82922753|FG001|Overall Study|Withdrawal by Subject|2|||
46707232|NCT00603265|82922754|FG002|Overall Study|Withdrawal by Subject|1|||
46707233|NCT00603265|82922752|FG000|Overall Study|Lack of Efficacy|3|||
46707234|NCT00603265|82922753|FG001|Overall Study|Lack of Efficacy|0|||
46707235|NCT00603265|82922754|FG002|Overall Study|Lack of Efficacy|3|||
46707236|NCT00603265|82922752|FG000|Overall Study|Lost to Follow-up|0|||
46707237|NCT00603265|82922753|FG001|Overall Study|Lost to Follow-up|1|||
46707238|NCT00603265|82922754|FG002|Overall Study|Lost to Follow-up|0|||
46707239|NCT00603265|82922752|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
46707240|NCT00603265|82922753|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
46707241|NCT00603265|82922754|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
46707242|NCT00603265|82922752|FG000|Overall Study|Participant Left Country, No Responses|0|||
46707243|NCT00603265|82922753|FG001|Overall Study|Participant Left Country, No Responses|1|||
46707244|NCT00603265|82922754|FG002|Overall Study|Participant Left Country, No Responses|0|||
46707245|NCT00603265|82922752|FG000|Overall Study|Protocol Violation|1|||
46707246|NCT00603265|82922753|FG001|Overall Study|Protocol Violation|0|||
46707247|NCT00603265|82922754|FG002|Overall Study|Protocol Violation|0|||
46707248|NCT04010227|82922764|FG000|Overall Study|Death|1|||
46707249|NCT04010227|82922765|FG001|Overall Study|Death|2|||
46707250|NCT04010227|82922764|FG000|Overall Study|Medical Reasons|4|||
46707251|NCT04010227|82922765|FG001|Overall Study|Medical Reasons|3|||
46707252|NCT04010227|82922764|FG000|Overall Study|Withdrawal by Subject|2|||
46707253|NCT04010227|82922765|FG001|Overall Study|Withdrawal by Subject|0|||
46707254|NCT04010227|82922764|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
46707255|NCT04010227|82922765|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
46707256|NCT01158534|82922772|FG000|Overall Study|Withdrawal by Subject|1|||
46707257|NCT01158534|82922772|FG000|Overall Study|Death|1|||
46707258|NCT01158534|82922772|FG000|Overall Study|Other|1|||
46894449|NCT02527798|83119051|FG000|Overall Study|Reason undisclosed|1|||
46894450|NCT02527798|83119052|FG001|Overall Study|Reason undisclosed|0|||
46894451|NCT02527798|83119053|FG002|Overall Study|Reason undisclosed|1|||
46894452|NCT02527798|83119054|FG003|Overall Study|Reason undisclosed|0|||
46894453|NCT02527798|83119055|FG004|Overall Study|Reason undisclosed|0|||
46894454|NCT02527798|83119056|FG005|Overall Study|Reason undisclosed|0|||
46894455|NCT02527798|83119051|FG000|Overall Study|Did not receive intervention|1|||
46894456|NCT02527798|83119052|FG001|Overall Study|Did not receive intervention|1|||
46894457|NCT02527798|83119053|FG002|Overall Study|Did not receive intervention|0|||
46894458|NCT02527798|83119054|FG003|Overall Study|Did not receive intervention|0|||
46894459|NCT02527798|83119055|FG004|Overall Study|Did not receive intervention|0|||
46894460|NCT02527798|83119056|FG005|Overall Study|Did not receive intervention|0|||
46894461|NCT03188991|83119087|FG000|Overall Study|Withdrawal by Subject|0|||
46894462|NCT03188991|83119088|FG001|Overall Study|Withdrawal by Subject|0|||
46894463|NCT03188991|83119089|FG002|Overall Study|Withdrawal by Subject|0|||
46894464|NCT03188991|83119090|FG003|Overall Study|Withdrawal by Subject|1|||
46894465|NCT03857542|83119102|FG000|Overall Study|Adverse Event|1|||
46894466|NCT03857542|83119103|FG001|Overall Study|Adverse Event|3|||
46894467|NCT03857542|83119102|FG000|Overall Study|Withdrawal by Subject|2|||
46894468|NCT03857542|83119103|FG001|Overall Study|Withdrawal by Subject|1|||
46894469|NCT03857542|83119102|FG000|Overall Study|Lost to Follow-up|2|||
46894470|NCT03857542|83119103|FG001|Overall Study|Lost to Follow-up|1|||
46894471|NCT03857542|83119102|FG000|Overall Study|Reason not Specified|1|||
46894472|NCT03857542|83119103|FG001|Overall Study|Reason not Specified|0|||
46894473|NCT03209973|83119110|FG000|Overall Study|Withdrawal by Subject|7|||
46894474|NCT03209973|83119110|FG000|Overall Study|Lost to Follow-up|2|||
46894475|NCT03209973|83119110|FG000|Overall Study|Death|8|||
46894476|NCT03209973|83119110|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
46894477|NCT03209973|83119110|FG000|Overall Study|Sponsor Decision|18|||
46894478|NCT03209973|83119110|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
46894479|NCT03209973|83119110|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
46894480|NCT03751631|83119116|FG000|Overall Study|Withdrawal by Subject|0|||
46894481|NCT03751631|83119117|FG001|Overall Study|Withdrawal by Subject|0|||
46894482|NCT03751631|83119118|FG002|Overall Study|Withdrawal by Subject|1|||
46894483|NCT03751631|83119119|FG003|Overall Study|Withdrawal by Subject|1|||
46894484|NCT03751631|83119120|FG004|Overall Study|Withdrawal by Subject|0|||
46894485|NCT03751631|83119121|FG005|Overall Study|Withdrawal by Subject|0|||
46894486|NCT03688711|83119134|FG000|Overall Study|Withdrawal by Subject|0|||
46894487|NCT03688711|83119135|FG001|Overall Study|Withdrawal by Subject|1|||
46894488|NCT03188055|83119143|FG000|Overall Study|Unavailable for training|0|||
46894489|NCT03188055|83119144|FG001|Overall Study|Unavailable for training|0|||
46894490|NCT03188055|83119145|FG002|Overall Study|Unavailable for training|19|||
46894491|NCT03188055|83119146|FG003|Overall Study|Unavailable for training|0|||
46894492|NCT03188055|83119147|FG004|Overall Study|Unavailable for training|0|||
46894493|NCT03188055|83119148|FG005|Overall Study|Unavailable for training||||
46894494|NCT03188055|83119143|FG000|Overall Study|Lost to Follow-up|0|||
46894495|NCT03188055|83119144|FG001|Overall Study|Lost to Follow-up|18|||
46894496|NCT03188055|83119145|FG002|Overall Study|Lost to Follow-up|0|||
46894497|NCT03188055|83119146|FG003|Overall Study|Lost to Follow-up|11|||
46894498|NCT03188055|83119147|FG004|Overall Study|Lost to Follow-up|0|||
46894499|NCT03188055|83119148|FG005|Overall Study|Lost to Follow-up||||
46894500|NCT03188055|83119143|FG000|Overall Study|Withdrawal by Subject|0|||
46894501|NCT03188055|83119144|FG001|Overall Study|Withdrawal by Subject|1|||
46894502|NCT03188055|83119145|FG002|Overall Study|Withdrawal by Subject|0|||
46894503|NCT03188055|83119146|FG003|Overall Study|Withdrawal by Subject|1|||
46894504|NCT03188055|83119147|FG004|Overall Study|Withdrawal by Subject|0|||
46894505|NCT03188055|83119148|FG005|Overall Study|Withdrawal by Subject||||
46894506|NCT04035577|83119159|FG000|Overall Study|Lost to Follow-up|1|||
46894507|NCT04035577|83119159|FG000|Overall Study|Withdrawal by Subject|1|||
46894508|NCT03655717|83119187|FG000|Overall Study|Withdrawal by Subject|4|||
46894509|NCT03655717|83119188|FG001|Overall Study|Withdrawal by Subject|8|||
46894510|NCT03655717|83119189|FG002|Overall Study|Withdrawal by Subject|1|||
46894511|NCT03655717|83119190|FG003|Overall Study|Withdrawal by Subject|0|||
46894512|NCT03655717|83119191|FG004|Overall Study|Withdrawal by Subject|0|||
46894513|NCT03655717|83119192|FG005|Overall Study|Withdrawal by Subject|1|||
46894514|NCT03655717|83119193|FG006|Overall Study|Withdrawal by Subject|3|||
46894515|NCT03655717|83119194|FG007|Overall Study|Withdrawal by Subject|1|||
46894516|NCT03655717|83119195|FG008|Overall Study|Withdrawal by Subject|2|||
46894517|NCT03655717|83119196|FG009|Overall Study|Withdrawal by Subject|0|||
46894518|NCT03655717|83119197|FG010|Overall Study|Withdrawal by Subject|0|||
46894519|NCT03655717|83119198|FG011|Overall Study|Withdrawal by Subject|1|||
46894520|NCT03655717|83119199|FG012|Overall Study|Withdrawal by Subject|0|||
46894521|NCT03655717|83119200|FG013|Overall Study|Withdrawal by Subject|3|||
46894522|NCT03655717|83119201|FG014|Overall Study|Withdrawal by Subject|0|||
46894523|NCT03655717|83119202|FG015|Overall Study|Withdrawal by Subject|1|||
46894524|NCT03655717|83119203|FG016|Overall Study|Withdrawal by Subject|0|||
46894525|NCT03655717|83119204|FG017|Overall Study|Withdrawal by Subject|0|||
46894526|NCT03655717|83119205|FG018|Overall Study|Withdrawal by Subject|1|||
46894527|NCT03655717|83119206|FG019|Overall Study|Withdrawal by Subject|0|||
46894528|NCT03655717|83119207|FG020|Overall Study|Withdrawal by Subject|0|||
46894529|NCT03655717|83119208|FG021|Overall Study|Withdrawal by Subject|1|||
46894530|NCT03655717|83119209|FG022|Overall Study|Withdrawal by Subject|2|||
46894531|NCT03655717|83119210|FG023|Overall Study|Withdrawal by Subject|1|||
46894532|NCT03655717|83119211|FG024|Overall Study|Withdrawal by Subject|1|||
46894533|NCT03655717|83119212|FG025|Overall Study|Withdrawal by Subject|0|||
46894534|NCT03655717|83119187|FG000|Overall Study|Physician Decision|3|||
46894535|NCT03655717|83119188|FG001|Overall Study|Physician Decision|3|||
46894536|NCT03655717|83119189|FG002|Overall Study|Physician Decision|0|||
46894537|NCT03655717|83119190|FG003|Overall Study|Physician Decision|0|||
46894538|NCT03655717|83119191|FG004|Overall Study|Physician Decision|0|||
46894539|NCT03655717|83119192|FG005|Overall Study|Physician Decision|0|||
46894540|NCT03655717|83119193|FG006|Overall Study|Physician Decision|0|||
46894541|NCT03655717|83119194|FG007|Overall Study|Physician Decision|0|||
46894542|NCT03655717|83119195|FG008|Overall Study|Physician Decision|0|||
46894543|NCT03655717|83119196|FG009|Overall Study|Physician Decision|1|||
46894544|NCT03655717|83119197|FG010|Overall Study|Physician Decision|0|||
46894545|NCT03655717|83119198|FG011|Overall Study|Physician Decision|0|||
46894546|NCT03655717|83119199|FG012|Overall Study|Physician Decision|0|||
46894547|NCT03655717|83119200|FG013|Overall Study|Physician Decision|0|||
46894548|NCT03655717|83119201|FG014|Overall Study|Physician Decision|0|||
46894549|NCT03655717|83119202|FG015|Overall Study|Physician Decision|0|||
46894550|NCT03655717|83119203|FG016|Overall Study|Physician Decision|0|||
46894551|NCT03655717|83119204|FG017|Overall Study|Physician Decision|0|||
46894552|NCT03655717|83119205|FG018|Overall Study|Physician Decision|0|||
46894553|NCT03655717|83119206|FG019|Overall Study|Physician Decision|1|||
46894554|NCT03655717|83119207|FG020|Overall Study|Physician Decision|0|||
46894555|NCT03655717|83119208|FG021|Overall Study|Physician Decision|0|||
46894556|NCT03655717|83119209|FG022|Overall Study|Physician Decision|0|||
46894557|NCT03655717|83119210|FG023|Overall Study|Physician Decision|1|||
46894558|NCT03655717|83119211|FG024|Overall Study|Physician Decision|0|||
46894559|NCT03655717|83119212|FG025|Overall Study|Physician Decision|0|||
46894560|NCT03655717|83119187|FG000|Overall Study|Lost to Follow-up|3|||
46894561|NCT03655717|83119188|FG001|Overall Study|Lost to Follow-up|1|||
46894562|NCT03655717|83119189|FG002|Overall Study|Lost to Follow-up|0|||
46894563|NCT03655717|83119190|FG003|Overall Study|Lost to Follow-up|1|||
46894564|NCT03655717|83119191|FG004|Overall Study|Lost to Follow-up|0|||
46894565|NCT03655717|83119192|FG005|Overall Study|Lost to Follow-up|1|||
46894566|NCT03655717|83119193|FG006|Overall Study|Lost to Follow-up|0|||
46894567|NCT03655717|83119194|FG007|Overall Study|Lost to Follow-up|0|||
46894568|NCT03655717|83119195|FG008|Overall Study|Lost to Follow-up|0|||
46894569|NCT03655717|83119196|FG009|Overall Study|Lost to Follow-up|0|||
46894570|NCT03655717|83119197|FG010|Overall Study|Lost to Follow-up|0|||
46894571|NCT03655717|83119198|FG011|Overall Study|Lost to Follow-up|1|||
46894572|NCT03655717|83119199|FG012|Overall Study|Lost to Follow-up|0|||
46894573|NCT03655717|83119200|FG013|Overall Study|Lost to Follow-up|0|||
46894574|NCT03655717|83119201|FG014|Overall Study|Lost to Follow-up|0|||
46894575|NCT03655717|83119202|FG015|Overall Study|Lost to Follow-up|0|||
46894576|NCT03655717|83119203|FG016|Overall Study|Lost to Follow-up|0|||
46894577|NCT03655717|83119204|FG017|Overall Study|Lost to Follow-up|0|||
46894578|NCT03655717|83119205|FG018|Overall Study|Lost to Follow-up|0|||
46894579|NCT03655717|83119206|FG019|Overall Study|Lost to Follow-up|0|||
46894580|NCT03655717|83119207|FG020|Overall Study|Lost to Follow-up|0|||
46894581|NCT03655717|83119208|FG021|Overall Study|Lost to Follow-up|0|||
46894582|NCT03655717|83119209|FG022|Overall Study|Lost to Follow-up|0|||
46894583|NCT03655717|83119210|FG023|Overall Study|Lost to Follow-up|0|||
46894584|NCT03655717|83119211|FG024|Overall Study|Lost to Follow-up|0|||
46894585|NCT03655717|83119212|FG025|Overall Study|Lost to Follow-up|0|||
46894586|NCT04032613|83119228|FG000|Overall Study|Did not complete post-program assessment|5|||
46894587|NCT04032613|83119229|FG001|Overall Study|Did not complete post-program assessment|2|||
46894588|NCT04000165|83119235|FG000|Overall Study|Physician Decision|1|||
46894589|NCT04000165|83119235|FG000|Overall Study|Withdrawal by Subject|1|||
46894590|NCT03187197|83119242|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
46894591|NCT03187197|83119243|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
46894592|NCT03187197|83119244|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
46894593|NCT03187197|83119242|FG000|Overall Study|Withdrawal by Subject|8|||
46894594|NCT03187197|83119243|FG001|Overall Study|Withdrawal by Subject|63|||
46894595|NCT03187197|83119244|FG002|Overall Study|Withdrawal by Subject|4|||
46894596|NCT03187197|83119242|FG000|Overall Study|Lost to Follow-up|1|||
46894597|NCT03187197|83119243|FG001|Overall Study|Lost to Follow-up|60|||
46894598|NCT03187197|83119244|FG002|Overall Study|Lost to Follow-up|7|||
46894599|NCT03187197|83119242|FG000|Overall Study|Adverse Event|6|||
46894600|NCT03187197|83119243|FG001|Overall Study|Adverse Event|29|||
46894601|NCT03187197|83119244|FG002|Overall Study|Adverse Event|0|||
46894602|NCT03187197|83119242|FG000|Overall Study|Death|0|||
46894603|NCT03187197|83119243|FG001|Overall Study|Death|11|||
46894604|NCT03187197|83119244|FG002|Overall Study|Death|0|||
46894605|NCT03187197|83119242|FG000|Overall Study|Administrative problem|1|||
46894606|NCT03187197|83119243|FG001|Overall Study|Administrative problem|1|||
46894607|NCT03187197|83119244|FG002|Overall Study|Administrative problem|0|||
46894608|NCT03187197|83119242|FG000|Overall Study|Reason not listed|2|||
46894609|NCT03187197|83119243|FG001|Overall Study|Reason not listed|54|||
46894610|NCT03187197|83119244|FG002|Overall Study|Reason not listed|1|||
46894611|NCT03187197|83119242|FG000|Overall Study|Missing|1|||
46894612|NCT03187197|83119243|FG001|Overall Study|Missing|32|||
46894613|NCT03187197|83119244|FG002|Overall Study|Missing|3|||
46894614|NCT03187197|83119242|FG000|Overall Study|Status missing|2|||
46894615|NCT03187197|83119243|FG001|Overall Study|Status missing|33|||
46894616|NCT03187197|83119244|FG002|Overall Study|Status missing|3|||
46894617|NCT03187197|83119242|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
46894618|NCT03187197|83119243|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
46894619|NCT03187197|83119244|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
46894620|NCT04000009|83119252|FG000|Overall Study|Adverse Event|13|||
46894621|NCT04000009|83119252|FG000|Overall Study|Lack of Efficacy|7|||
46894622|NCT04000009|83119252|FG000|Overall Study|Lost to Follow-up|8|||
46894623|NCT04000009|83119252|FG000|Overall Study|Noncompliance with study drug|4|||
46894624|NCT04000009|83119252|FG000|Overall Study|Physician Decision|1|||
46894625|NCT04000009|83119252|FG000|Overall Study|Use of prohibited medication|3|||
46894626|NCT04000009|83119252|FG000|Overall Study|Pregnancy|1|||
46894627|NCT04000009|83119252|FG000|Overall Study|Withdrawal by Subject|22|||
46894628|NCT04000009|83119252|FG000|Overall Study|Study terminated by sponsor|98|||
46894629|NCT04000009|83119252|FG000|Overall Study|Not further specified|8|||
46894630|NCT03282240|83119259|FG000|Overall Study|Adverse Event|2|||
46894631|NCT03282240|83119260|FG001|Overall Study|Adverse Event|2|||
46894632|NCT03282240|83119261|FG002|Overall Study|Adverse Event|0|||
46894633|NCT03282240|83119259|FG000|Overall Study|Lost to Follow-up|3|||
46894634|NCT03282240|83119260|FG001|Overall Study|Lost to Follow-up|0|||
46894635|NCT03282240|83119261|FG002|Overall Study|Lost to Follow-up|0|||
46894636|NCT03282240|83119259|FG000|Overall Study|Protocol Deviation|4|||
46894637|NCT03282240|83119260|FG001|Overall Study|Protocol Deviation|1|||
46894638|NCT03282240|83119261|FG002|Overall Study|Protocol Deviation|2|||
46894639|NCT03282240|83119259|FG000|Overall Study|Withdrawal by Subject|1|||
46894640|NCT03282240|83119260|FG001|Overall Study|Withdrawal by Subject|0|||
46894641|NCT03282240|83119261|FG002|Overall Study|Withdrawal by Subject|1|||
46894642|NCT03185949|83119274|FG000|ITT Analysis|Withdrawal by Subject|4|||
46894643|NCT03185949|83119275|FG001|ITT Analysis|Withdrawal by Subject|3|||
46894644|NCT03185949|83119274|FG000|PP Analysis|Protocol Violation|2|||
46894645|NCT03185949|83119275|FG001|PP Analysis|Protocol Violation|2|||
46894646|NCT03185949|83119274|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
46894647|NCT03185949|83119275|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
46894648|NCT03655405|83119285|FG000|Overall Study|Death after initial data collection|4|||
46894649|NCT03655405|83119286|FG001|Overall Study|Death after initial data collection|2|||
46894650|NCT03655405|83119285|FG000|Overall Study|Died before initial data collection|1|||
46894651|NCT03655405|83119286|FG001|Overall Study|Died before initial data collection|2|||
46894652|NCT03655405|83119285|FG000|Overall Study|Protocol Violation|0|||
46894653|NCT03655405|83119286|FG001|Overall Study|Protocol Violation|1|||
46894654|NCT03510598|83119292|FG000|Overall Study|Withdrawal by Subject|1|||
46894655|NCT03222141|83119296|FG000|Overall Study|Death|15|||
46894656|NCT03222141|83119296|FG000|Overall Study|Lost to Follow-up|3|||
46894657|NCT04029961|83119303|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
46894658|NCT04029961|83119304|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
46894659|NCT04029961|83119303|FG000|Overall Study|Change in Treatment Course|0|||
46894660|NCT04029961|83119304|FG001|Overall Study|Change in Treatment Course|1|||
46894661|NCT03997825|83119310|FG000|Overall Study|Death|3|||
46894662|NCT03997825|83119310|FG000|Overall Study|Lost to Follow-up|10|||
46894663|NCT03997825|83119310|FG000|Overall Study|Withdrawal by Subject|3|||
46894664|NCT03997825|83119310|FG000|Overall Study|Refused participation|1|||
46894665|NCT04024891|83119316|FG000|Overall Study|Pregnancy|0|||
46894666|NCT04024891|83119317|FG001|Overall Study|Pregnancy|1|||
46894667|NCT03250182|83119323|FG000|Overall Study|Withdrawal by Subject|1|||
46894668|NCT03993379|83119331|FG000|Overall Study|The study was terminated early due to business decision.|0|||
46894669|NCT03993379|83119332|FG001|Overall Study|The study was terminated early due to business decision.|2|||
46894670|NCT03993379|83119333|FG002|Overall Study|The study was terminated early due to business decision.|0|||
46894671|NCT03993379|83119334|FG003|Overall Study|The study was terminated early due to business decision.|0|||
46894672|NCT03993379|83119331|FG000|Overall Study|Withdrawal by Subject|0|||
46894673|NCT03993379|83119332|FG001|Overall Study|Withdrawal by Subject|1|||
46894674|NCT03993379|83119333|FG002|Overall Study|Withdrawal by Subject|0|||
46894675|NCT03993379|83119334|FG003|Overall Study|Withdrawal by Subject|0|||
46894676|NCT03370120|83119344|FG000|Overall Study|Adverse event, non-fatal|24|||
46894677|NCT03370120|83119344|FG000|Overall Study|Withdrawal by Subject|6|||
46894678|NCT03370120|83119344|FG000|Overall Study|Lost to Follow-up|1|||
46894679|NCT03370120|83119344|FG000|Overall Study|Lack of Efficacy|37|||
46894680|NCT03370120|83119344|FG000|Overall Study|Per sponsor's instructions|1|||
46894681|NCT03370120|83119344|FG000|Overall Study|Study was terminated by parent company UCB|2|||
46894682|NCT03370120|83119344|FG000|Overall Study|The study was ended by the promoter|3|||
46894683|NCT03370120|83119344|FG000|Overall Study|Discontinuation of drug development|3|||
46894684|NCT03370120|83119344|FG000|Overall Study|End of project|2|||
46894685|NCT03370120|83119344|FG000|Overall Study|Premature study closure|2|||
46894686|NCT03370120|83119344|FG000|Overall Study|Premature program termination|1|||
46894687|NCT03370120|83119344|FG000|Overall Study|Premature study termination|7|||
46894688|NCT03370120|83119344|FG000|Overall Study|Trial terminated by sponsor|2|||
46894689|NCT03370120|83119344|FG000|Overall Study|Trial discontinued by sponsor|2|||
46894690|NCT03370120|83119344|FG000|Overall Study|Study ended|15|||
46894691|NCT03370120|83119344|FG000|Overall Study|Clinical trial has been cancelled|1|||
46894692|NCT03370120|83119344|FG000|Overall Study|End of study per sponsor decision|2|||
46894693|NCT03370120|83119344|FG000|Overall Study|Promoter's decision|2|||
46894694|NCT03370120|83119344|FG000|Overall Study|The trial has been suspended|3|||
46894695|NCT03370120|83119344|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
46894696|NCT03370120|83119344|FG000|Overall Study|Early termination by order of sponsor|2|||
46894697|NCT03370120|83119344|FG000|Overall Study|Discontinuation of the study|5|||
46894698|NCT03370120|83119344|FG000|Overall Study|End of clinical trial discontinuation|1|||
46894699|NCT03370120|83119344|FG000|Overall Study|Because the clinical trial ended halfway|4|||
46894700|NCT03370120|83119344|FG000|Overall Study|Development discontinued|5|||
46894701|NCT03370120|83119344|FG000|Overall Study|Padsenovil program closed|3|||
46894702|NCT03370120|83119344|FG000|Overall Study|End of project|2|||
46894703|NCT03370120|83119344|FG000|Overall Study|Termination of project|1|||
46894704|NCT03370120|83119344|FG000|Overall Study|The study was interrupted by sponsor|4|||
46894705|NCT03370120|83119344|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
46894706|NCT03370120|83119344|FG000|Overall Study|End of sponsor decision|1|||
46894707|NCT03370120|83119344|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
46894708|NCT03370120|83119344|FG000|Overall Study|Early termination of studies|5|||
46894709|NCT03370120|83119344|FG000|Overall Study|This study is ended early|1|||
46894710|NCT03370120|83119344|FG000|Overall Study|End of padsevonil program|2|||
46894711|NCT03370120|83119344|FG000|Overall Study|Decision of sponsor|6|||
46894712|NCT03370120|83119344|FG000|Overall Study|Asked by the sponsor|3|||
46894713|NCT03370120|83119344|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
46894714|NCT03370120|83119344|FG000|Overall Study|PI decision poor compliance from participant|1|||
46894715|NCT03370120|83119344|FG000|Overall Study|Promoter ended the study|3|||
46894716|NCT03370120|83119344|FG000|Overall Study|Premature study close by sponsor's decision|4|||
46894717|NCT03370120|83119344|FG000|Overall Study|Study terminated by sponsor|33|||
46894718|NCT03370120|83119344|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
46894719|NCT03370120|83119344|FG000|Overall Study|Sponsor decision to terminate study|63|||
46894720|NCT03370120|83119344|FG000|Overall Study|Program closure|3|||
46894721|NCT03370120|83119344|FG000|Overall Study|Study ended prematurely|1|||
46894722|NCT03370120|83119344|FG000|Overall Study|Study stopped by sponsor|2|||
46894723|NCT03370120|83119344|FG000|Overall Study|Program termination|55|||
46894724|NCT03370120|83119344|FG000|Overall Study|Sponsor decision|62|||
46894725|NCT03370120|83119344|FG000|Overall Study|Sponsor study closure|10|||
46894726|NCT03247686|83119352|FG000|Overall Study|Withdrawal by Subject|1|||
46894727|NCT03247686|83119353|FG001|Overall Study|Withdrawal by Subject|2|||
46894728|NCT03990649|83119364|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
46894729|NCT03990649|83119365|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
46894730|NCT03990649|83119366|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
46894731|NCT03990649|83119364|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
46894732|NCT03990649|83119365|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
46894733|NCT03990649|83119366|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
46894734|NCT03990649|83119364|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
46894735|NCT03990649|83119365|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
46894736|NCT03990649|83119366|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
46894737|NCT03990649|83119364|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
46894738|NCT03990649|83119365|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
46894739|NCT03990649|83119366|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
46894740|NCT03990649|83119364|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
46894741|NCT03990649|83119365|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
46894742|NCT03990649|83119366|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
46894743|NCT03990649|83119364|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
46894744|NCT03990649|83119365|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
46894745|NCT03990649|83119366|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
46894746|NCT03990649|83119364|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
46894747|NCT03990649|83119365|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
46894748|NCT03990649|83119366|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
46894749|NCT03185481|83119373|FG000|Overall Study|Adverse Event|1|||
46894750|NCT03185481|83119373|FG000|Overall Study|Study Terminated by Sponsor|4|||
46894751|NCT03652675|83119379|FG000|Overall Study|Lost to Follow-up|4|||
46894752|NCT03652675|83119380|FG001|Overall Study|Lost to Follow-up|4|||
46894753|NCT03241368|83119386|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
46894754|NCT03241368|83119386|FG000|Overall Study|Lost to Follow-up|1|||
46894755|NCT03241368|83119386|FG000|Overall Study|Physician Decision|6|||
46894756|NCT03241368|83119386|FG000|Overall Study|Withdrawal by Subject|6|||
46894757|NCT03241368|83119386|FG000|Overall Study|Protocol Violation|1|||
46894758|NCT03220581|83119393|FG000|Overall Study|Withdrawal by Subject|0|||
46894759|NCT03220581|83119394|FG001|Overall Study|Withdrawal by Subject|1|||
46894760|NCT03220581|83119393|FG000|Overall Study|Lost to Follow-up|3|||
46894761|NCT03220581|83119394|FG001|Overall Study|Lost to Follow-up|6|||
46894762|NCT02954575|83119402|FG000|Overall Study|Withdrawal by Subject|2|||
46894763|NCT02954575|83119402|FG000|Overall Study|Adverse Event|1|||
46894764|NCT03184701|83119410|FG000|Overall Study|Death|3|||
46894765|NCT03184701|83119410|FG000|Overall Study|Physician Decision|3|||
46894766|NCT03184701|83119410|FG000|Overall Study|Withdrawal by Subject|6|||
46894767|NCT03184701|83119410|FG000|Overall Study|Lost to Follow-up|5|||
46894768|NCT03247530|83119417|FG000|Overall Study|Withdrawal by caregiver|19|||
46894769|NCT03247530|83119418|FG001|Overall Study|Withdrawal by caregiver|8|||
46894770|NCT03247530|83119419|FG002|Overall Study|Withdrawal by caregiver|10|||
46894771|NCT03247530|83119417|FG000|Overall Study|Lost to Follow-up|3|||
46894772|NCT03247530|83119418|FG001|Overall Study|Lost to Follow-up|9|||
46894773|NCT03247530|83119419|FG002|Overall Study|Lost to Follow-up|6|||
46894774|NCT03247530|83119417|FG000|Overall Study|Adverse Event|2|||
46894775|NCT03247530|83119418|FG001|Overall Study|Adverse Event|5|||
46894776|NCT03247530|83119419|FG002|Overall Study|Adverse Event|2|||
46894777|NCT03247530|83119417|FG000|Overall Study|Failure to follow procedure|1|||
46894778|NCT03247530|83119418|FG001|Overall Study|Failure to follow procedure|1|||
46894779|NCT03247530|83119419|FG002|Overall Study|Failure to follow procedure|1|||
46894780|NCT03247530|83119417|FG000|Overall Study|Withdrawal by Subject|1|||
46894781|NCT03247530|83119418|FG001|Overall Study|Withdrawal by Subject|1|||
46894782|NCT03247530|83119419|FG002|Overall Study|Withdrawal by Subject|0|||
46894783|NCT03247530|83119417|FG000|Overall Study|Study medication misuse|0|||
46894784|NCT03247530|83119418|FG001|Overall Study|Study medication misuse|1|||
46894785|NCT03247530|83119419|FG002|Overall Study|Study medication misuse|0|||
46894786|NCT03247530|83119417|FG000|Overall Study|Other, multiple categories|1|||
46894787|NCT03247530|83119418|FG001|Overall Study|Other, multiple categories|3|||
46894788|NCT03247530|83119419|FG002|Overall Study|Other, multiple categories|1|||
46894789|NCT03246672|83119430|FG000|Overall Study|Lost to Follow-up|2|||
46894790|NCT03983317|83119434|FG000|Overall Study|Physician Decision|5|||
46894791|NCT03207243|83119440|FG000|Overall Study|Adverse Event|2|||
46894792|NCT03207243|83119441|FG001|Overall Study|Adverse Event|2|||
46894793|NCT03207243|83119440|FG000|Overall Study|Loss of Asthma Control|47|||
46894794|NCT03207243|83119441|FG001|Overall Study|Loss of Asthma Control|31|||
46894795|NCT03207243|83119440|FG000|Overall Study|Withdrawal by Subject|2|||
46894796|NCT03207243|83119441|FG001|Overall Study|Withdrawal by Subject|4|||
46894797|NCT03207243|83119440|FG000|Overall Study|Physician Decision|1|||
46894798|NCT03207243|83119441|FG001|Overall Study|Physician Decision|1|||
46894799|NCT03207243|83119440|FG000|Overall Study|Lost to Follow-up|0|||
46894800|NCT03207243|83119441|FG001|Overall Study|Lost to Follow-up|1|||
46894801|NCT03207243|83119440|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
46894802|NCT03207243|83119441|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
46894803|NCT03207243|83119440|FG000|Overall Study|Protocol Violation|0|||
46894804|NCT03207243|83119441|FG001|Overall Study|Protocol Violation|3|||
46894805|NCT03982069|83119452|FG000|Overall Study|Lost to Follow-up|5|||
46894806|NCT03982069|83119453|FG001|Overall Study|Lost to Follow-up|5|||
46894807|NCT03982069|83119454|FG002|Overall Study|Lost to Follow-up|3|||
46894808|NCT03982069|83119455|FG003|Overall Study|Lost to Follow-up|5|||
46894809|NCT03982069|83119452|FG000|Overall Study|Physician Decision|0|||
46894810|NCT03982069|83119453|FG001|Overall Study|Physician Decision|1|||
46894811|NCT03982069|83119454|FG002|Overall Study|Physician Decision|0|||
46894812|NCT03982069|83119455|FG003|Overall Study|Physician Decision|0|||
46894813|NCT03982069|83119452|FG000|Overall Study|Withdrawal by Subject|2|||
46894814|NCT03982069|83119453|FG001|Overall Study|Withdrawal by Subject|1|||
46894815|NCT03982069|83119454|FG002|Overall Study|Withdrawal by Subject|5|||
46894816|NCT03982069|83119455|FG003|Overall Study|Withdrawal by Subject|2|||
46894817|NCT03982069|83119452|FG000|Overall Study|Specimen loss|3|||
46894818|NCT03982069|83119453|FG001|Overall Study|Specimen loss|3|||
46894819|NCT03982069|83119454|FG002|Overall Study|Specimen loss|1|||
46894820|NCT03982069|83119455|FG003|Overall Study|Specimen loss|1|||
46894821|NCT02937870|83119463|FG000|Overall Study|Adverse Event|1|||
46894822|NCT02937870|83119463|FG000|Overall Study|Protocol Deviation|2|||
46894823|NCT03629041|83119477|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
46894824|NCT03629041|83119478|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
46894825|NCT03629041|83119479|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
46894826|NCT03629041|83119480|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
46894827|NCT03219723|83119498|FG000|Overall Study|Case Report Forms Uncollected|6|||
46894828|NCT03219723|83119498|FG000|Overall Study|Protocol Deviation|4|||
46894829|NCT03628417|83119502|FG000|Overall Study|Death|1|||
46894830|NCT03628417|83119503|FG001|Overall Study|Death|1|||
46894831|NCT03184077|83119515|FG000|Overall Study|Lost to Follow-up|21|||
46894832|NCT03184077|83119516|FG001|Overall Study|Lost to Follow-up|21|||
46894833|NCT03245736|83119522|FG000|Overall Study|Adverse Event|1|||
46894834|NCT03245736|83119522|FG000|Overall Study|Progressive Disease|4|||
46894835|NCT02954887|83119526|FG000|Overall Study|Withdrawal by Subject|3|||
46894836|NCT02954887|83119526|FG000|Overall Study|Lack of Efficacy|3|||
46894837|NCT02954887|83119526|FG000|Overall Study|Other|1|||
46894838|NCT03183063|83119533|FG000|Overall Study|Withdrawal by Subject|2|||
46894839|NCT03183063|83119534|FG001|Overall Study|Withdrawal by Subject|0|||
46894840|NCT03183063|83119535|FG002|Overall Study|Withdrawal by Subject|0|||
46894841|NCT03183063|83119533|FG000|Overall Study|Physician Decision|3|||
46894842|NCT03183063|83119534|FG001|Overall Study|Physician Decision|4|||
46894843|NCT03183063|83119535|FG002|Overall Study|Physician Decision|4|||
46894844|NCT03182829|83119551|FG000|Overall Study|Protocol Violation|12|||
46894845|NCT03182829|83119552|FG001|Overall Study|Protocol Violation|12|||
46894846|NCT03182829|83119551|FG000|Overall Study|Other|4|||
46894847|NCT03182829|83119552|FG001|Overall Study|Other|3|||
46894848|NCT03278028|83119560|FG000|Overall Study|Lost to Follow-up|1|||
46894849|NCT03278028|83119561|FG001|Overall Study|Lost to Follow-up|0|||
46894850|NCT03278028|83119560|FG000|Overall Study|Withdrawal by Subject|3|||
46894851|NCT03278028|83119561|FG001|Overall Study|Withdrawal by Subject|1|||
46894852|NCT03278028|83119560|FG000|Overall Study|Pregnancy|0|||
46894853|NCT03278028|83119561|FG001|Overall Study|Pregnancy|1|||
46894854|NCT03181503|83119569|FG000|Overall Study|Adverse Event|2|||
46894855|NCT03181503|83119570|FG001|Overall Study|Adverse Event|2|||
46894856|NCT03181503|83119569|FG000|Overall Study|Protocol Violation|1|||
46894857|NCT03181503|83119570|FG001|Overall Study|Protocol Violation|0|||
46894858|NCT03181503|83119569|FG000|Overall Study|Withdrawal by Subject|3|||
46894859|NCT03181503|83119570|FG001|Overall Study|Withdrawal by Subject|0|||
46894860|NCT03181503|83119569|FG000|Overall Study|Lost to Follow-up|1|||
46894861|NCT03181503|83119570|FG001|Overall Study|Lost to Follow-up|1|||
46894862|NCT03277794|83119581|FG000|Overall Study|Lost to Follow-up|2|||
46894863|NCT03277794|83119582|FG001|Overall Study|Lost to Follow-up|4|||
46894864|NCT03277794|83119581|FG000|Overall Study|Withdrew due to high acuity|1|||
46894865|NCT03277794|83119582|FG001|Overall Study|Withdrew due to high acuity|0|||
46894866|NCT03276078|83119589|FG000|Overall Study|Adverse Event|1|||
46894867|NCT03180801|83119596|FG000|Overall Study|Physician Decision|3|||
46894868|NCT03180801|83119597|FG001|Overall Study|Physician Decision|3|||
46894869|NCT03180801|83119598|FG002|Overall Study|Physician Decision|1|||
46894870|NCT03180801|83119596|FG000|Overall Study|Non-compliance|1|||
46894871|NCT03180801|83119597|FG001|Overall Study|Non-compliance|4|||
46894872|NCT03180801|83119598|FG002|Overall Study|Non-compliance|0|||
46894873|NCT03180801|83119596|FG000|Overall Study|Inoculation Target Reached|1|||
46894874|NCT03180801|83119597|FG001|Overall Study|Inoculation Target Reached|1|||
46894875|NCT03180801|83119598|FG002|Overall Study|Inoculation Target Reached|3|||
46894876|NCT03180801|83119596|FG000|Overall Study|Adverse Event|1|||
46894877|NCT03180801|83119597|FG001|Overall Study|Adverse Event|0|||
46894878|NCT03180801|83119598|FG002|Overall Study|Adverse Event|2|||
46894879|NCT03180801|83119596|FG000|Overall Study|Withdrawal by Subject|2|||
46894880|NCT03180801|83119597|FG001|Overall Study|Withdrawal by Subject|2|||
46894881|NCT03180801|83119598|FG002|Overall Study|Withdrawal by Subject|1|||
46894882|NCT03180801|83119596|FG000|Overall Study|Lost to Follow-up|0|||
46894883|NCT03180801|83119597|FG001|Overall Study|Lost to Follow-up|2|||
46894884|NCT03180801|83119598|FG002|Overall Study|Lost to Follow-up|3|||
46894885|NCT03742271|83119609|FG000|Overall Study|Unsatisfactory Visual Response|1|||
46894886|NCT03742271|83119609|FG000|Overall Study|Withdrawal by Subject|3|||
46894887|NCT03742271|83119609|FG000|Overall Study|Lost to Follow-up|4|||
46894888|NCT03742271|83119609|FG000|Overall Study|Failed Insertion & removal|3|||
46894889|NCT03742271|83119609|FG000|Overall Study|Protocol Violation|1|||
46894890|NCT03214224|83119613|FG000|Overall Study|Protocol Violation|1|||
46894891|NCT03214224|83119613|FG000|Overall Study|Withdrawal by Subject|2|||
46894892|NCT03214224|83119613|FG000|Overall Study|Practice controls or therapists|6|||
46894893|NCT03180645|83119620|FG000|Overall Study|Adverse Event|0|||
46894894|NCT03180645|83119621|FG001|Overall Study|Adverse Event|1|||
46894895|NCT03180645|83119622|FG002|Overall Study|Adverse Event|2|||
46894896|NCT03750695|83119634|FG000|Overall Study|Lost to Follow-up|0|||
46894897|NCT03750695|83119635|FG001|Overall Study|Lost to Follow-up|1|||
46894898|NCT03231228|83119648|FG000|Overall Study|Lost to Follow-up|2|||
46894899|NCT03231228|83119649|FG001|Overall Study|Lost to Follow-up|0|||
46894900|NCT03231228|83119648|FG000|Overall Study|Physician Decision|1|||
46894901|NCT03231228|83119649|FG001|Overall Study|Physician Decision|0|||
46894902|NCT03213366|83119657|FG000|Overall Study|Lost to Follow-up|9|||
46894903|NCT03213366|83119658|FG001|Overall Study|Lost to Follow-up|4|||
46894904|NCT03213210|83119664|FG000|Overall Study|Lost to Follow-up|2|||
46894905|NCT03213210|83119664|FG000|Overall Study|Study termination|3|||
46894906|NCT02932878|83119670|FG000|Overall Study|Due to Lab Results|2|||
46894907|NCT02932878|83119671|FG001|Overall Study|Due to Lab Results|1|||
46894908|NCT03230292|83119677|FG000|Overall Study|Adverse Event|1|||
46894909|NCT03230292|83119677|FG000|Overall Study|Protocol Violation|1|||
46894910|NCT03230292|83119677|FG000|Overall Study|Lost to Follow-up|1|||
46894911|NCT03230292|83119677|FG000|Overall Study|Withdrawal by Subject|3|||
46894912|NCT03228420|83119685|FG000|Overall Study|Lost to Follow-up|5|||
46894913|NCT03228420|83119686|FG001|Overall Study|Lost to Follow-up|3|||
46894914|NCT03228420|83119685|FG000|Overall Study|Withdrawal by Subject|10|||
46894915|NCT03228420|83119686|FG001|Overall Study|Withdrawal by Subject|0|||
46894916|NCT03228420|83119685|FG000|Overall Study|Adverse Event|5|||
46894917|NCT03228420|83119686|FG001|Overall Study|Adverse Event|2|||
46894918|NCT03746483|83119694|FG000|Overall Study|Adverse Event|0|||
46894919|NCT03746483|83119695|FG001|Overall Study|Adverse Event|1|||
46894920|NCT03746483|83119694|FG000|Overall Study|Lack of Efficacy|3|||
46894921|NCT03746483|83119695|FG001|Overall Study|Lack of Efficacy|2|||
46894922|NCT03746483|83119694|FG000|Overall Study|Lost to Follow-up|1|||
46894923|NCT03746483|83119695|FG001|Overall Study|Lost to Follow-up|0|||
46894924|NCT03746483|83119694|FG000|Overall Study|Protocol Violation|2|||
46894925|NCT03746483|83119695|FG001|Overall Study|Protocol Violation|0|||
46894926|NCT03746405|83119705|FG000|Overall Study|Withdrawal by Subject|3|||
46894927|NCT03746405|83119706|FG001|Overall Study|Withdrawal by Subject|0|||
46894928|NCT03746405|83119705|FG000|Overall Study|technical difficulties|0|||
46894929|NCT03746405|83119706|FG001|Overall Study|technical difficulties|2|||
46894930|NCT03226392|83119714|FG000|Overall Study|Protocol Deviation|1|||
46894931|NCT03226392|83119715|FG001|Overall Study|Protocol Deviation|0|||
46894932|NCT03226392|83119714|FG000|Overall Study|Physician Decision|1|||
46894933|NCT03226392|83119715|FG001|Overall Study|Physician Decision|0|||
46894934|NCT03226392|83119714|FG000|Overall Study|Lost to Follow-up|1|||
46894935|NCT03226392|83119715|FG001|Overall Study|Lost to Follow-up|0|||
46894936|NCT03226392|83119714|FG000|Overall Study|Adverse Event|1|||
46894937|NCT03226392|83119715|FG001|Overall Study|Adverse Event|0|||
46894938|NCT03226392|83119714|FG000|Overall Study|Technical Problems|0|||
46894939|NCT03226392|83119715|FG001|Overall Study|Technical Problems|2|||
46894940|NCT03226392|83119714|FG000|Overall Study|Subject/Guardian Decision|7|||
46894941|NCT03226392|83119715|FG001|Overall Study|Subject/Guardian Decision|6|||
46894942|NCT03205371|83119733|FG000|Overall Study|Withdrawal by Subject|4|||
46894943|NCT03205371|83119734|FG001|Overall Study|Withdrawal by Subject|1|||
46894944|NCT03205371|83119735|FG002|Overall Study|Withdrawal by Subject|0|||
46894945|NCT03205371|83119736|FG003|Overall Study|Withdrawal by Subject|0|||
46894946|NCT03205371|83119737|FG004|Overall Study|Withdrawal by Subject|0|||
46894947|NCT03205371|83119738|FG005|Overall Study|Withdrawal by Subject|0|||
46894948|NCT03205371|83119739|FG006|Overall Study|Withdrawal by Subject|4|||
46894949|NCT03205371|83119740|FG007|Overall Study|Withdrawal by Subject|0|||
46894950|NCT03205371|83119741|FG008|Overall Study|Withdrawal by Subject|2|||
46894951|NCT03205371|83119742|FG009|Overall Study|Withdrawal by Subject|0|||
46894952|NCT03205371|83119743|FG010|Overall Study|Withdrawal by Subject|0|||
46894953|NCT03205371|83119744|FG011|Overall Study|Withdrawal by Subject|1|||
46894954|NCT03205371|83119733|FG000|Overall Study|Lost to Follow-up|0|||
46894955|NCT03205371|83119734|FG001|Overall Study|Lost to Follow-up|0|||
46894956|NCT03205371|83119735|FG002|Overall Study|Lost to Follow-up|0|||
46894957|NCT03205371|83119736|FG003|Overall Study|Lost to Follow-up|0|||
46894958|NCT03205371|83119737|FG004|Overall Study|Lost to Follow-up|0|||
46894959|NCT03205371|83119738|FG005|Overall Study|Lost to Follow-up|0|||
46894960|NCT03205371|83119739|FG006|Overall Study|Lost to Follow-up|5|||
46894961|NCT03205371|83119740|FG007|Overall Study|Lost to Follow-up|2|||
46894962|NCT03205371|83119741|FG008|Overall Study|Lost to Follow-up|3|||
46894963|NCT03205371|83119742|FG009|Overall Study|Lost to Follow-up|0|||
46894964|NCT03205371|83119743|FG010|Overall Study|Lost to Follow-up|0|||
46894965|NCT03205371|83119744|FG011|Overall Study|Lost to Follow-up|0|||
46894966|NCT03205371|83119733|FG000|Overall Study|Protocol Violation|0|||
46894967|NCT03205371|83119734|FG001|Overall Study|Protocol Violation|0|||
46894968|NCT03205371|83119735|FG002|Overall Study|Protocol Violation|0|||
46894969|NCT03205371|83119736|FG003|Overall Study|Protocol Violation|0|||
46894970|NCT03205371|83119737|FG004|Overall Study|Protocol Violation|0|||
46894971|NCT03205371|83119738|FG005|Overall Study|Protocol Violation|0|||
46894972|NCT03205371|83119739|FG006|Overall Study|Protocol Violation|1|||
46894973|NCT03205371|83119740|FG007|Overall Study|Protocol Violation|0|||
46894974|NCT03205371|83119741|FG008|Overall Study|Protocol Violation|0|||
46894975|NCT03205371|83119742|FG009|Overall Study|Protocol Violation|0|||
46894976|NCT03205371|83119743|FG010|Overall Study|Protocol Violation|0|||
46894977|NCT03205371|83119744|FG011|Overall Study|Protocol Violation|0|||
46894978|NCT03205371|83119733|FG000|Overall Study|Adverse Event|0|||
46894979|NCT03205371|83119734|FG001|Overall Study|Adverse Event|0|||
46894980|NCT03205371|83119735|FG002|Overall Study|Adverse Event|0|||
46894981|NCT03205371|83119736|FG003|Overall Study|Adverse Event|0|||
46894982|NCT03205371|83119737|FG004|Overall Study|Adverse Event|0|||
46894983|NCT03205371|83119738|FG005|Overall Study|Adverse Event|0|||
46894984|NCT03205371|83119739|FG006|Overall Study|Adverse Event|0|||
46894985|NCT03205371|83119740|FG007|Overall Study|Adverse Event|1|||
46894986|NCT03205371|83119741|FG008|Overall Study|Adverse Event|0|||
46894987|NCT03205371|83119742|FG009|Overall Study|Adverse Event|0|||
46894988|NCT03205371|83119743|FG010|Overall Study|Adverse Event|0|||
46894989|NCT03205371|83119744|FG011|Overall Study|Adverse Event|0|||
46894990|NCT03367858|83119792|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
46894991|NCT03367858|83119793|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
46894992|NCT03367858|83119792|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
46894993|NCT03367858|83119793|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
46894994|NCT03367858|83119792|FG000|3 Month Follow Up|Lost to Follow-up|8|||
46894995|NCT03367858|83119793|FG001|3 Month Follow Up|Lost to Follow-up|3|||
46894996|NCT03367858|83119792|FG000|3 Month Follow Up|Moved out of study area|2|||
46894997|NCT03367858|83119793|FG001|3 Month Follow Up|Moved out of study area|6|||
46894998|NCT03367858|83119792|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
46894999|NCT03367858|83119793|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
46895000|NCT03367858|83119792|FG000|3 Month Follow Up|MRI contraindication|2|||
46895001|NCT03367858|83119793|FG001|3 Month Follow Up|MRI contraindication|1|||
46895002|NCT03367858|83119792|FG000|3 Month Follow Up|Incarcerated|0|||
46895003|NCT03367858|83119793|FG001|3 Month Follow Up|Incarcerated|1|||
46895004|NCT03367858|83119792|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
46895005|NCT03367858|83119793|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
46895006|NCT03367858|83119792|FG000|6 Month Follow Up|Lost to Follow-up|5|||
46895007|NCT03367858|83119793|FG001|6 Month Follow Up|Lost to Follow-up|2|||
46895008|NCT03367858|83119792|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
46895009|NCT03367858|83119793|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
46895010|NCT03367858|83119792|FG000|12 Month Follow Up|Lost to Follow-up|3|||
46895011|NCT03367858|83119793|FG001|12 Month Follow Up|Lost to Follow-up|3|||
46895012|NCT03367858|83119792|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
46895013|NCT03367858|83119793|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
46895014|NCT03682705|83119805|FG000|Overall Study|Adverse Event|1|||
46895015|NCT03682705|83119806|FG001|Overall Study|Adverse Event|1|||
46895016|NCT03682705|83119807|FG002|Overall Study|Adverse Event|1|||
46895017|NCT03682705|83119808|FG003|Overall Study|Adverse Event|0|||
46895018|NCT03682705|83119809|FG004|Overall Study|Adverse Event|1|||
46895019|NCT03682705|83119810|FG005|Overall Study|Adverse Event|1|||
46895020|NCT03682705|83119805|FG000|Overall Study|Withdrawal by Subject|1|||
46895021|NCT03682705|83119806|FG001|Overall Study|Withdrawal by Subject|3|||
46895022|NCT03682705|83119807|FG002|Overall Study|Withdrawal by Subject|2|||
46895023|NCT03682705|83119808|FG003|Overall Study|Withdrawal by Subject|4|||
46895024|NCT03682705|83119809|FG004|Overall Study|Withdrawal by Subject|0|||
46895025|NCT03682705|83119810|FG005|Overall Study|Withdrawal by Subject|1|||
46895026|NCT03682705|83119805|FG000|Overall Study|Other, not specified|0|||
46895027|NCT03682705|83119806|FG001|Overall Study|Other, not specified|0|||
46895028|NCT03682705|83119807|FG002|Overall Study|Other, not specified|0|||
46895029|NCT03682705|83119808|FG003|Overall Study|Other, not specified|1|||
46895030|NCT03682705|83119809|FG004|Overall Study|Other, not specified|2|||
46895031|NCT03682705|83119810|FG005|Overall Study|Other, not specified|0|||
46895032|NCT03682705|83119805|FG000|Overall Study|Lost to Follow-up|0|||
46895033|NCT03682705|83119806|FG001|Overall Study|Lost to Follow-up|0|||
46895034|NCT03682705|83119807|FG002|Overall Study|Lost to Follow-up|0|||
46895035|NCT03682705|83119808|FG003|Overall Study|Lost to Follow-up|0|||
46895036|NCT03682705|83119809|FG004|Overall Study|Lost to Follow-up|3|||
46895037|NCT03682705|83119810|FG005|Overall Study|Lost to Follow-up|0|||
46895038|NCT03179787|83119824|FG000|Overall Study|Lost to Follow-up|15|||
46895039|NCT03179787|83119824|FG000|Overall Study|Case report failures|2|||
46895040|NCT03179787|83119824|FG000|Overall Study|Treatment not administered|1|||
46895041|NCT03745937|83119832|FG000|Overall Study|Withdrawal by Subject|0|||
46895042|NCT03745937|83119833|FG001|Overall Study|Withdrawal by Subject|0|||
46895043|NCT03745937|83119834|FG002|Overall Study|Withdrawal by Subject|0|||
46895044|NCT03745937|83119835|FG003|Overall Study|Withdrawal by Subject|1|||
46895045|NCT03745937|83119832|FG000|Overall Study|Not-specifed|0|||
46895046|NCT03745937|83119833|FG001|Overall Study|Not-specifed|1|||
46895047|NCT03745937|83119834|FG002|Overall Study|Not-specifed|0|||
46895048|NCT03745937|83119835|FG003|Overall Study|Not-specifed|1|||
46895049|NCT02956057|83119852|FG000|Overall Study|Discontinued intervention|14|||
46895050|NCT02956057|83119853|FG001|Overall Study|Discontinued intervention|10|||
46895051|NCT02956057|83119854|FG002|Overall Study|Discontinued intervention|7|||
46895052|NCT02956057|83119855|FG003|Overall Study|Discontinued intervention|14|||
46895053|NCT02956057|83119856|FG004|Overall Study|Discontinued intervention|4|||
46895054|NCT02956057|83119857|FG005|Overall Study|Discontinued intervention|17|||
46895055|NCT02956057|83119852|FG000|Overall Study|Lost to Follow-up|0|||
46895056|NCT02956057|83119853|FG001|Overall Study|Lost to Follow-up|2|||
46895057|NCT02956057|83119854|FG002|Overall Study|Lost to Follow-up|1|||
46895058|NCT02956057|83119855|FG003|Overall Study|Lost to Follow-up|1|||
46895059|NCT02956057|83119856|FG004|Overall Study|Lost to Follow-up|1|||
46895060|NCT02956057|83119857|FG005|Overall Study|Lost to Follow-up|0|||
46895061|NCT03179319|83119873|FG000|Overall Study|Lost to Follow-up|6|||
46895062|NCT03179319|83119874|FG001|Overall Study|Lost to Follow-up|0|||
46895063|NCT03627091|83119883|FG000|Overall Study|Adverse Event|0|||
46895064|NCT03627091|83119884|FG001|Overall Study|Adverse Event|0|||
46895065|NCT03627091|83119885|FG002|Overall Study|Adverse Event|2|||
46895066|NCT03627091|83119883|FG000|Overall Study|Withdrawal by Subject|2|||
46895067|NCT03627091|83119884|FG001|Overall Study|Withdrawal by Subject|0|||
46895068|NCT03627091|83119885|FG002|Overall Study|Withdrawal by Subject|2|||
46895069|NCT03627091|83119883|FG000|Overall Study|Physician Decision|2|||
46895070|NCT03627091|83119884|FG001|Overall Study|Physician Decision|0|||
46895071|NCT03627091|83119885|FG002|Overall Study|Physician Decision|0|||
46895072|NCT03627091|83119883|FG000|Overall Study|Site terminated by sponsor|0|||
46612436|NCT02518464|82721487|FG000|Overall Study|Adverse Event|2|||
46612437|NCT02510820|82721491|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
46612438|NCT02510820|82721492|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
46612439|NCT02510820|82721491|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
46612440|NCT02510820|82721492|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
46612441|NCT02510664|82721502|FG000|Overall Study|Transferred Care|9|||
46612442|NCT02510664|82721503|FG001|Overall Study|Transferred Care|9|||
46612443|NCT02510664|82721504|FG002|Overall Study|Transferred Care|0|||
46612444|NCT02510664|82721502|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
46612445|NCT02510664|82721503|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
46612446|NCT02510664|82721504|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
46612447|NCT02510664|82721502|FG000|Overall Study|Time Constraints|1|||
46612448|NCT02510664|82721503|FG001|Overall Study|Time Constraints|1|||
46612449|NCT02510664|82721504|FG002|Overall Study|Time Constraints|0|||
46612450|NCT01363986|82721535|FG000|Overall Study|Disease progression|1|||
46612451|NCT02478372|82721569|FG000|Overall Study|Protocol Violation|12|||
46612452|NCT02478372|82721570|FG001|Overall Study|Protocol Violation|8|||
46612453|NCT02478372|82721569|FG000|Overall Study|Lost to Follow-up|1|||
46612454|NCT02478372|82721570|FG001|Overall Study|Lost to Follow-up|4|||
46612455|NCT02478372|82721569|FG000|Overall Study|Death|0|||
46612456|NCT02478372|82721570|FG001|Overall Study|Death|2|||
46612457|NCT01654536|82721582|FG000|Overall Study|Lost to Follow-up|5|||
46612458|NCT01654536|82721583|FG001|Overall Study|Lost to Follow-up|5|||
46612459|NCT01654536|82721582|FG000|Overall Study|Physician Decision|12|||
46612460|NCT01654536|82721583|FG001|Overall Study|Physician Decision|8|||
46612461|NCT01654536|82721582|FG000|Overall Study|Withdrawal by Subject|27|||
46612462|NCT01654536|82721583|FG001|Overall Study|Withdrawal by Subject|25|||
46612463|NCT01654380|82721592|FG000|Part B, Period 1|Physician Decision|0|||
46612464|NCT01654380|82721593|FG001|Part B, Period 1|Physician Decision|0|||
46612465|NCT01654380|82721594|FG002|Part B, Period 1|Physician Decision|1|||
46612466|NCT01654380|82721595|FG003|Part B, Period 1|Physician Decision|0|||
46612467|NCT02477670|82721614|FG000|Stage 1|Adverse Event|2|||
46612468|NCT02477670|82721615|FG001|Stage 1|Adverse Event|7|||
46612469|NCT02477670|82721616|FG002|Stage 1|Adverse Event|0|||
46612470|NCT02477670|82721617|FG003|Stage 1|Adverse Event|0|||
46612471|NCT02477670|82721618|FG004|Stage 1|Adverse Event|0|||
46612472|NCT02477670|82721619|FG005|Stage 1|Adverse Event|0|||
46612473|NCT02477670|82721620|FG006|Stage 1|Adverse Event|0|||
46612474|NCT02477670|82721614|FG000|Stage 1|Lost to Follow-up|0|||
46612475|NCT02477670|82721615|FG001|Stage 1|Lost to Follow-up|2|||
46612476|NCT02477670|82721616|FG002|Stage 1|Lost to Follow-up|0|||
46612477|NCT02477670|82721617|FG003|Stage 1|Lost to Follow-up|0|||
46612478|NCT02477670|82721618|FG004|Stage 1|Lost to Follow-up|0|||
46612479|NCT02477670|82721619|FG005|Stage 1|Lost to Follow-up|0|||
46612480|NCT02477670|82721620|FG006|Stage 1|Lost to Follow-up|0|||
46612481|NCT02477670|82721614|FG000|Stage 1|Withdrawal by Subject|1|||
46612482|NCT02477670|82721615|FG001|Stage 1|Withdrawal by Subject|2|||
46612483|NCT02477670|82721616|FG002|Stage 1|Withdrawal by Subject|0|||
46612484|NCT02477670|82721617|FG003|Stage 1|Withdrawal by Subject|0|||
46612485|NCT02477670|82721618|FG004|Stage 1|Withdrawal by Subject|0|||
46612486|NCT02477670|82721619|FG005|Stage 1|Withdrawal by Subject|0|||
46612487|NCT02477670|82721620|FG006|Stage 1|Withdrawal by Subject|0|||
46612488|NCT02477670|82721614|FG000|Stage 1|Non-compliance with Study Drug|1|||
46612489|NCT02477670|82721615|FG001|Stage 1|Non-compliance with Study Drug|2|||
46612490|NCT02477670|82721616|FG002|Stage 1|Non-compliance with Study Drug|0|||
46612491|NCT02477670|82721617|FG003|Stage 1|Non-compliance with Study Drug|0|||
46612492|NCT02477670|82721618|FG004|Stage 1|Non-compliance with Study Drug|0|||
46612493|NCT02477670|82721619|FG005|Stage 1|Non-compliance with Study Drug|0|||
46612494|NCT02477670|82721620|FG006|Stage 1|Non-compliance with Study Drug|0|||
46612495|NCT02477670|82721614|FG000|Stage 2|Adverse Event|0|||
46612496|NCT02477670|82721615|FG001|Stage 2|Adverse Event|0|||
46612497|NCT02477670|82721616|FG002|Stage 2|Adverse Event|1|||
46612498|NCT02477670|82721617|FG003|Stage 2|Adverse Event|0|||
46612499|NCT02477670|82721618|FG004|Stage 2|Adverse Event|0|||
46612500|NCT02477670|82721619|FG005|Stage 2|Adverse Event|0|||
46612501|NCT02477670|82721620|FG006|Stage 2|Adverse Event|0|||
46612502|NCT02477670|82721614|FG000|Stage 2|Antipsychotic Medication Changed|0|||
46612503|NCT02477670|82721615|FG001|Stage 2|Antipsychotic Medication Changed|0|||
46612504|NCT02477670|82721616|FG002|Stage 2|Antipsychotic Medication Changed|1|||
46612505|NCT02477670|82721617|FG003|Stage 2|Antipsychotic Medication Changed|0|||
46612506|NCT02477670|82721618|FG004|Stage 2|Antipsychotic Medication Changed|0|||
46612507|NCT02477670|82721619|FG005|Stage 2|Antipsychotic Medication Changed|0|||
46612508|NCT02477670|82721620|FG006|Stage 2|Antipsychotic Medication Changed|0|||
46612509|NCT02477670|82721614|FG000|Stage 2|Withdrawal by Subject|0|||
46612510|NCT02477670|82721615|FG001|Stage 2|Withdrawal by Subject|0|||
46612511|NCT02477670|82721616|FG002|Stage 2|Withdrawal by Subject|0|||
46612512|NCT02477670|82721617|FG003|Stage 2|Withdrawal by Subject|1|||
46612513|NCT02477670|82721618|FG004|Stage 2|Withdrawal by Subject|0|||
46612514|NCT02477670|82721619|FG005|Stage 2|Withdrawal by Subject|0|||
46612515|NCT02477670|82721620|FG006|Stage 2|Withdrawal by Subject|0|||
46612516|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
46612517|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
46612518|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
46612519|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
46612520|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Other|2|||
46612521|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
46612522|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
46612523|NCT02509026|82721631|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
46612524|NCT02509026|82721631|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
46612525|NCT02509026|82721631|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
46612526|NCT02509026|82721631|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
46612527|NCT02509026|82721631|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
46612528|NCT02509026|82721631|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
46612529|NCT02476968|82722005|FG000|Overall Study|Other|0|||
46612530|NCT02476968|82722006|FG001|Overall Study|Other|2|||
46612531|NCT02476968|82722007|FG002|Overall Study|Other|0|||
46612532|NCT02476968|82722005|FG000|Overall Study|Lost to Follow-up|10|||
46612533|NCT02476968|82722006|FG001|Overall Study|Lost to Follow-up|0|||
46612534|NCT02476968|82722007|FG002|Overall Study|Lost to Follow-up|1|||
46612535|NCT02476968|82722005|FG000|Overall Study|Death|48|||
46612536|NCT02476968|82722006|FG001|Overall Study|Death|8|||
46612537|NCT02476968|82722007|FG002|Overall Study|Death|1|||
46612538|NCT02476968|82722005|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
46612539|NCT02476968|82722006|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
46612540|NCT02476968|82722007|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
46612541|NCT02476968|82722005|FG000|Overall Study|Patient decision|37|||
46612542|NCT02476968|82722006|FG001|Overall Study|Patient decision|8|||
46895073|NCT03627091|83119884|FG001|Overall Study|Site terminated by sponsor|1|||
46895074|NCT03627091|83119885|FG002|Overall Study|Site terminated by sponsor|0|||
46895075|NCT03627091|83119883|FG000|Overall Study|Disease relapse|7|||
46895076|NCT03627091|83119884|FG001|Overall Study|Disease relapse|5|||
46895077|NCT03627091|83119885|FG002|Overall Study|Disease relapse|1|||
46895078|NCT03627091|83119883|FG000|Overall Study|Other|1|||
46895079|NCT03627091|83119884|FG001|Overall Study|Other|0|||
46895080|NCT03627091|83119885|FG002|Overall Study|Other|0|||
46612543|NCT02476968|82722007|FG002|Overall Study|Patient decision|0|||
46895081|NCT04237584|83119898|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
46895082|NCT04237584|83119899|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
46612544|NCT02476578|82722028|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
46612545|NCT02476578|82722029|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
46612546|NCT02476578|82722028|FG000|Overall Study|Lost to Follow-up|6|||
46612547|NCT02476578|82722029|FG001|Overall Study|Lost to Follow-up|13|||
46612548|NCT02504892|82722047|FG000|Overall Study|Adverse event-pneumonitis|2|||
46612549|NCT02504502|82722053|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
46612550|NCT02504502|82722054|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
46612551|NCT02504502|82722053|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
46612552|NCT02504502|82722054|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
46612553|NCT03772717|82722091|FG000|Overall Study|Withdrawal by Subject|2|||
46612554|NCT03770403|82722095|FG000|Overall Study|Adverse Event|8|||
46612555|NCT03770403|82722095|FG000|Overall Study|Death|5|||
46612556|NCT03770403|82722095|FG000|Overall Study|Physician Decision|1|||
46612557|NCT03770403|82722095|FG000|Overall Study|Sponsor decision|1|||
46612558|NCT03770403|82722095|FG000|Overall Study|Study terminated by Sponsor|1|||
46612559|NCT03770403|82722095|FG000|Overall Study|Withdrawal by Subject|13|||
46612560|NCT03770403|82722095|FG000|Overall Study|Other|88|||
46612561|NCT03740100|82722099|FG000|Overall Study|Adverse Event|1|||
46612562|NCT03740100|82722099|FG000|Overall Study|Death|1|||
46612563|NCT03499795|82722103|FG000|Overall Study|Adverse Event|1|||
46612564|NCT03499795|82722103|FG000|Overall Study|Lost to Follow-up|1|||
46612565|NCT03456700|82722120|FG000|Overall Study|Withdrawal by Subject|1|||
46612566|NCT03401450|82722126|FG000|Overall Study|Lost to Follow-up|4|||
46612567|NCT03401450|82722127|FG001|Overall Study|Lost to Follow-up|6|||
46612568|NCT03401450|82722126|FG000|Overall Study|Anesthesia plan changed|2|||
46612569|NCT03401450|82722127|FG001|Overall Study|Anesthesia plan changed|2|||
46612570|NCT03401450|82722126|FG000|Overall Study|Did not complete medication diary|4|||
46612571|NCT03401450|82722127|FG001|Overall Study|Did not complete medication diary|2|||
46612572|NCT03401450|82722126|FG000|Overall Study|post surgery medication change|2|||
46612573|NCT03401450|82722127|FG001|Overall Study|post surgery medication change|1|||
46612574|NCT03401450|82722126|FG000|Overall Study|Cancelled surgery|0|||
46612575|NCT03401450|82722127|FG001|Overall Study|Cancelled surgery|2|||
46612576|NCT03326063|82722135|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
46612577|NCT03326063|82722136|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
46612578|NCT02764762|82722155|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
46612579|NCT02764762|82722155|FG000|Overall Study|Lost to Follow-up|4|||
46612580|NCT02764762|82722155|FG000|Overall Study|Voluntary Withdrawal|8|||
46612581|NCT02764762|82722155|FG000|Overall Study|Site Termination|1|||
46612582|NCT02764762|82722155|FG000|Overall Study|Lack of Efficacy|16|||
46612583|NCT02764762|82722155|FG000|Overall Study|Reason not Specified|1|||
46612584|NCT02340962|82722165|FG000|Overall Study|Lost to Follow-up|1|||
46612585|NCT02340962|82722166|FG001|Overall Study|Lost to Follow-up|0|||
46612586|NCT02272634|82722186|FG000|Overall Study|Adverse Event|1|||
46612587|NCT02272634|82722187|FG001|Overall Study|Adverse Event|0|||
46612588|NCT02272634|82722188|FG002|Overall Study|Adverse Event|0|||
46612589|NCT02272634|82722186|FG000|Overall Study|Protocol Violation|0|||
46612590|NCT02272634|82722187|FG001|Overall Study|Protocol Violation|0|||
46612591|NCT02272634|82722188|FG002|Overall Study|Protocol Violation|1|||
46612592|NCT02272634|82722186|FG000|Overall Study|Withdrawal by Subject|0|||
46612593|NCT02272634|82722187|FG001|Overall Study|Withdrawal by Subject|1|||
46612594|NCT02272634|82722188|FG002|Overall Study|Withdrawal by Subject|0|||
46612595|NCT00788125|82722199|FG000|Overall Study|Death|6|||
46612596|NCT02504424|82722212|FG000|Overall Study|Withdrawal by Subject|2|||
46612597|NCT02548832|82722538|FG000|Overall Study|Lost to Follow-up|2|||
46612598|NCT02548832|82722539|FG001|Overall Study|Lost to Follow-up|2|||
46612599|NCT02548832|82722540|FG002|Overall Study|Lost to Follow-up|2|||
46612600|NCT03215264|82722729|FG000|Dose Level 2|Adverse Event|0|||
46612601|NCT03215264|82722730|FG001|Dose Level 2|Adverse Event|1|||
46612602|NCT03215264|82722731|FG002|Dose Level 2|Adverse Event|0|||
46612603|NCT03215264|82722729|FG000|Dose Level 3|Withdrawal by Subject|0|||
46612604|NCT03215264|82722730|FG001|Dose Level 3|Withdrawal by Subject|0|||
46612605|NCT03215264|82722731|FG002|Dose Level 3|Withdrawal by Subject|1|||
46612606|NCT02504268|82722802|FG000|Overall Study|Adverse Event|18|||
46612607|NCT02504268|82722803|FG001|Overall Study|Adverse Event|8|||
46612608|NCT02504268|82722804|FG002|Overall Study|Adverse Event|14|||
46612609|NCT02504268|82722805|FG003|Overall Study|Adverse Event|0|||
46612610|NCT02504268|82722806|FG004|Overall Study|Adverse Event|0|||
46612611|NCT02504268|82722807|FG005|Overall Study|Adverse Event|0|||
46612612|NCT02504268|82722808|FG006|Overall Study|Adverse Event|0|||
46612613|NCT02504268|82722809|FG007|Overall Study|Adverse Event|0|||
46612614|NCT02504268|82722810|FG008|Overall Study|Adverse Event|0|||
46612615|NCT02504268|82722802|FG000|Overall Study|Withdrawal of Consent|11|||
46612616|NCT02504268|82722803|FG001|Overall Study|Withdrawal of Consent|10|||
46612617|NCT02504268|82722804|FG002|Overall Study|Withdrawal of Consent|3|||
46612618|NCT02504268|82722805|FG003|Overall Study|Withdrawal of Consent|0|||
46612619|NCT02504268|82722806|FG004|Overall Study|Withdrawal of Consent|0|||
46612620|NCT02504268|82722807|FG005|Overall Study|Withdrawal of Consent|0|||
46612621|NCT02504268|82722808|FG006|Overall Study|Withdrawal of Consent|0|||
46612622|NCT02504268|82722809|FG007|Overall Study|Withdrawal of Consent|0|||
46612623|NCT02504268|82722810|FG008|Overall Study|Withdrawal of Consent|0|||
46612624|NCT02504268|82722802|FG000|Overall Study|Pregnancy|2|||
46612625|NCT02504268|82722803|FG001|Overall Study|Pregnancy|0|||
46612626|NCT02504268|82722804|FG002|Overall Study|Pregnancy|0|||
46612627|NCT02504268|82722805|FG003|Overall Study|Pregnancy|0|||
46612628|NCT02504268|82722806|FG004|Overall Study|Pregnancy|0|||
46612629|NCT02504268|82722807|FG005|Overall Study|Pregnancy|0|||
46612630|NCT02504268|82722808|FG006|Overall Study|Pregnancy|0|||
46612631|NCT02504268|82722809|FG007|Overall Study|Pregnancy|0|||
46612632|NCT02504268|82722810|FG008|Overall Study|Pregnancy|0|||
46612633|NCT02504268|82722802|FG000|Overall Study|Lost to Follow-up|3|||
46612634|NCT02504268|82722803|FG001|Overall Study|Lost to Follow-up|6|||
46612635|NCT02504268|82722804|FG002|Overall Study|Lost to Follow-up|4|||
46612636|NCT02504268|82722805|FG003|Overall Study|Lost to Follow-up|0|||
46612637|NCT02504268|82722806|FG004|Overall Study|Lost to Follow-up|0|||
46612638|NCT02504268|82722807|FG005|Overall Study|Lost to Follow-up|0|||
46612639|NCT02504268|82722808|FG006|Overall Study|Lost to Follow-up|0|||
46612640|NCT02504268|82722809|FG007|Overall Study|Lost to Follow-up|0|||
46612641|NCT02504268|82722810|FG008|Overall Study|Lost to Follow-up|0|||
46612642|NCT02504268|82722802|FG000|Overall Study|Death|1|||
46612643|NCT02504268|82722803|FG001|Overall Study|Death|1|||
46612644|NCT02504268|82722804|FG002|Overall Study|Death|0|||
46612645|NCT02504268|82722805|FG003|Overall Study|Death|0|||
46612646|NCT02504268|82722806|FG004|Overall Study|Death|0|||
46612647|NCT02504268|82722807|FG005|Overall Study|Death|0|||
46612648|NCT02504268|82722808|FG006|Overall Study|Death|0|||
46612649|NCT02504268|82722809|FG007|Overall Study|Death|0|||
46612650|NCT02504268|82722810|FG008|Overall Study|Death|0|||
46612651|NCT02504268|82722802|FG000|Overall Study|Subject Request to Discontinue|11|||
46612652|NCT02504268|82722803|FG001|Overall Study|Subject Request to Discontinue|3|||
46612653|NCT02504268|82722804|FG002|Overall Study|Subject Request to Discontinue|6|||
46612654|NCT02504268|82722805|FG003|Overall Study|Subject Request to Discontinue|0|||
46612655|NCT02504268|82722806|FG004|Overall Study|Subject Request to Discontinue|0|||
46612656|NCT02504268|82722807|FG005|Overall Study|Subject Request to Discontinue|0|||
46612657|NCT02504268|82722808|FG006|Overall Study|Subject Request to Discontinue|0|||
46612658|NCT02504268|82722809|FG007|Overall Study|Subject Request to Discontinue|0|||
46612659|NCT02504268|82722810|FG008|Overall Study|Subject Request to Discontinue|0|||
46612660|NCT02504268|82722802|FG000|Overall Study|No Longer Meets Study Criteria|2|||
46612661|NCT02504268|82722803|FG001|Overall Study|No Longer Meets Study Criteria|3|||
46612662|NCT02504268|82722804|FG002|Overall Study|No Longer Meets Study Criteria|0|||
46612663|NCT02504268|82722805|FG003|Overall Study|No Longer Meets Study Criteria|0|||
46612664|NCT02504268|82722806|FG004|Overall Study|No Longer Meets Study Criteria|0|||
46612665|NCT02504268|82722807|FG005|Overall Study|No Longer Meets Study Criteria|0|||
46612666|NCT02504268|82722808|FG006|Overall Study|No Longer Meets Study Criteria|0|||
46612667|NCT02504268|82722809|FG007|Overall Study|No Longer Meets Study Criteria|0|||
46612668|NCT02504268|82722810|FG008|Overall Study|No Longer Meets Study Criteria|0|||
46612669|NCT02504268|82722802|FG000|Overall Study|Lack of Efficacy|11|||
46612670|NCT02504268|82722803|FG001|Overall Study|Lack of Efficacy|35|||
46612671|NCT02504268|82722804|FG002|Overall Study|Lack of Efficacy|9|||
46612672|NCT02504268|82722805|FG003|Overall Study|Lack of Efficacy|0|||
46612673|NCT02504268|82722806|FG004|Overall Study|Lack of Efficacy|0|||
46612674|NCT02504268|82722807|FG005|Overall Study|Lack of Efficacy|0|||
46612675|NCT02504268|82722808|FG006|Overall Study|Lack of Efficacy|0|||
46612676|NCT02504268|82722809|FG007|Overall Study|Lack of Efficacy|0|||
46612677|NCT02504268|82722810|FG008|Overall Study|Lack of Efficacy|0|||
46612678|NCT02504268|82722802|FG000|Overall Study|Poor/Non-Compliance|3|||
46612679|NCT02504268|82722803|FG001|Overall Study|Poor/Non-Compliance|2|||
46612680|NCT02504268|82722804|FG002|Overall Study|Poor/Non-Compliance|3|||
46612681|NCT02504268|82722805|FG003|Overall Study|Poor/Non-Compliance|0|||
46612682|NCT02504268|82722806|FG004|Overall Study|Poor/Non-Compliance|0|||
46612683|NCT02504268|82722807|FG005|Overall Study|Poor/Non-Compliance|0|||
46612684|NCT02504268|82722808|FG006|Overall Study|Poor/Non-Compliance|0|||
46612685|NCT02504268|82722809|FG007|Overall Study|Poor/Non-Compliance|0|||
46612686|NCT02504268|82722810|FG008|Overall Study|Poor/Non-Compliance|0|||
46612687|NCT02504268|82722802|FG000|Overall Study|Not Disclosed|1|||
46612688|NCT02504268|82722803|FG001|Overall Study|Not Disclosed|0|||
46612689|NCT02504268|82722804|FG002|Overall Study|Not Disclosed|2|||
46612690|NCT02504268|82722805|FG003|Overall Study|Not Disclosed|0|||
46612691|NCT02504268|82722806|FG004|Overall Study|Not Disclosed|0|||
46612692|NCT02504268|82722807|FG005|Overall Study|Not Disclosed|0|||
46612693|NCT02504268|82722808|FG006|Overall Study|Not Disclosed|0|||
46612694|NCT02504268|82722809|FG007|Overall Study|Not Disclosed|0|||
46612695|NCT02504268|82722810|FG008|Overall Study|Not Disclosed|0|||
46612696|NCT01654302|82722854|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
46612697|NCT01654302|82722855|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
46612698|NCT02476422|82722871|FG000|Overall Study|Subject/guardian decision|0|||
46612699|NCT02476422|82722872|FG001|Overall Study|Subject/guardian decision|1|||
46612700|NCT02475564|82722902|FG000|Overall Study|Withdrawal by Subject|1|||
46612701|NCT02475564|82722903|FG001|Overall Study|Withdrawal by Subject|0|||
46612702|NCT02475564|82722902|FG000|Overall Study|Lost to Follow-up|2|||
46612703|NCT02475564|82722903|FG001|Overall Study|Lost to Follow-up|1|||
46612704|NCT02475564|82722902|FG000|Overall Study|Intense Menstrual bleeding|1|||
46612705|NCT02475564|82722903|FG001|Overall Study|Intense Menstrual bleeding|0|||
46612706|NCT02503332|82723191|FG000|Overall Study|Adverse Event|17|||
46612707|NCT02503332|82723192|FG001|Overall Study|Adverse Event|5|||
46612708|NCT02503332|82723193|FG002|Overall Study|Adverse Event|3|||
46612709|NCT02503332|82723194|FG003|Overall Study|Adverse Event|1|||
46612710|NCT02503332|82723191|FG000|Overall Study|Investigator's Decision|5|||
46612711|NCT02503332|82723192|FG001|Overall Study|Investigator's Decision|1|||
46612712|NCT02503332|82723193|FG002|Overall Study|Investigator's Decision|0|||
46612713|NCT02503332|82723194|FG003|Overall Study|Investigator's Decision|0|||
46612714|NCT02503332|82723191|FG000|Overall Study|Sponsor's Decision|1|||
46612715|NCT02503332|82723192|FG001|Overall Study|Sponsor's Decision|0|||
46612716|NCT02503332|82723193|FG002|Overall Study|Sponsor's Decision|0|||
46612717|NCT02503332|82723194|FG003|Overall Study|Sponsor's Decision|1|||
46612718|NCT02503332|82723191|FG000|Overall Study|Subject Request|6|||
46612719|NCT02503332|82723192|FG001|Overall Study|Subject Request|5|||
46612720|NCT02503332|82723193|FG002|Overall Study|Subject Request|2|||
46612721|NCT02503332|82723194|FG003|Overall Study|Subject Request|1|||
46612722|NCT02503332|82723191|FG000|Overall Study|Death|0|||
46612723|NCT02503332|82723192|FG001|Overall Study|Death|2|||
46612724|NCT02503332|82723193|FG002|Overall Study|Death|2|||
46612725|NCT02503332|82723194|FG003|Overall Study|Death|0|||
46612726|NCT02503332|82723191|FG000|Overall Study|Other|5|||
46612727|NCT02503332|82723192|FG001|Overall Study|Other|6|||
46612728|NCT02503332|82723193|FG002|Overall Study|Other|1|||
46612729|NCT02503332|82723194|FG003|Overall Study|Other|1|||
46612730|NCT02502864|82723212|FG000|Overall Study|Withdrawal by Subject|1|||
46612731|NCT02474082|82723246|FG000|Overall Study|Adverse Event|2|||
46612732|NCT02474082|82723247|FG001|Overall Study|Adverse Event|32|||
46612733|NCT02474082|82723246|FG000|Overall Study|Withdrawal of informed consent|1|||
46612734|NCT02474082|82723247|FG001|Overall Study|Withdrawal of informed consent|11|||
46612735|NCT02474082|82723246|FG000|Overall Study|Lost to Follow-up|2|||
46612736|NCT02474082|82723247|FG001|Overall Study|Lost to Follow-up|2|||
46612737|NCT02474082|82723246|FG000|Overall Study|Dose tapering not achieved|0|||
46612738|NCT02474082|82723247|FG001|Overall Study|Dose tapering not achieved|4|||
46612739|NCT02474082|82723246|FG000|Overall Study|Participant/guardian decision|1|||
46612740|NCT02474082|82723247|FG001|Overall Study|Participant/guardian decision|2|||
46612741|NCT02474082|82723246|FG000|Overall Study|Non-compliance with study treatment|0|||
46612742|NCT02474082|82723247|FG001|Overall Study|Non-compliance with study treatment|2|||
46612743|NCT02474082|82723246|FG000|Overall Study|Protocol deviation|0|||
46612744|NCT02474082|82723247|FG001|Overall Study|Protocol deviation|1|||
46612745|NCT02501928|82723357|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
46612746|NCT02501928|82723358|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
46612747|NCT02501928|82723359|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
46612748|NCT02501928|82723360|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
46612749|NCT02501928|82723361|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
46612750|NCT02501928|82723362|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
46612751|NCT02473614|82723426|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
46612752|NCT02473614|82723427|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
46612753|NCT02500758|82723449|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
46612754|NCT02500758|82723450|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
46612755|NCT02500758|82723449|FG000|Washout (1 Week)|Lost to Follow-up|2|||
46612756|NCT02500758|82723450|FG001|Washout (1 Week)|Lost to Follow-up|2|||
46612757|NCT02500758|82723449|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
46612758|NCT02500758|82723450|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
46612759|NCT02500758|82723449|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
46612760|NCT02500758|82723450|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
46612761|NCT02500758|82723449|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
46612762|NCT02500758|82723450|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
46612763|NCT02500056|82723464|FG000|Overall Study|Lost to Follow-up|3|||
46612764|NCT02500056|82723465|FG001|Overall Study|Lost to Follow-up|7|||
46612765|NCT02500056|82723464|FG000|Overall Study|Recurrence|1|||
46612766|NCT02500056|82723465|FG001|Overall Study|Recurrence|0|||
46612767|NCT02500056|82723464|FG000|Overall Study|Death|3|||
46612768|NCT02500056|82723465|FG001|Overall Study|Death|1|||
46612769|NCT02472756|82723514|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
46612770|NCT02472756|82723514|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
46612771|NCT02472756|82723514|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
46612772|NCT02472756|82723514|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
46612773|NCT02472756|82723514|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
46612774|NCT02498652|82723524|FG000|Overall Study|Protocol Violation|0|||
46612775|NCT02498652|82723525|FG001|Overall Study|Protocol Violation|1|||
46612776|NCT03213158|82723549|FG000|Overall Study|Withdrawal by Subject|1|||
46612777|NCT03213158|82723549|FG000|Overall Study|Physician Decision|2|||
46612778|NCT02498418|82723556|FG000|Overall Study|Lack of Efficacy|0|||
46612779|NCT02498418|82723557|FG001|Overall Study|Lack of Efficacy|0|||
46612780|NCT02498418|82723558|FG002|Overall Study|Lack of Efficacy|1|||
46612781|NCT02498418|82723556|FG000|Overall Study|Withdrawal by Subject|2|||
46612782|NCT02498418|82723557|FG001|Overall Study|Withdrawal by Subject|0|||
46612783|NCT02498418|82723558|FG002|Overall Study|Withdrawal by Subject|3|||
46612784|NCT02498418|82723556|FG000|Overall Study|Lost to Follow-up|0|||
46612785|NCT02498418|82723557|FG001|Overall Study|Lost to Follow-up|1|||
46612786|NCT02498418|82723558|FG002|Overall Study|Lost to Follow-up|1|||
46612787|NCT02498418|82723556|FG000|Overall Study|Participant taken prohibited medication|0|||
46612788|NCT02498418|82723557|FG001|Overall Study|Participant taken prohibited medication|1|||
46612789|NCT02498418|82723558|FG002|Overall Study|Participant taken prohibited medication|1|||
46612790|NCT02472366|82723576|FG000|Overall Study|Lost to Follow-up|1|||
46612791|NCT02472366|82723577|FG001|Overall Study|Lost to Follow-up|0|||
46612792|NCT03219164|82723585|FG000|Overall Study|Study Terminated by Sponsor|16|||
46612793|NCT03219164|82723586|FG001|Overall Study|Study Terminated by Sponsor|12|||
46612794|NCT03219164|82723585|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
46612795|NCT03219164|82723586|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
46612796|NCT03219164|82723585|FG000|Overall Study|Lost to Follow-up|1|||
46612797|NCT03219164|82723586|FG001|Overall Study|Lost to Follow-up|1|||
46612798|NCT03219164|82723585|FG000|Overall Study|Adverse Event|1|||
46612799|NCT03219164|82723586|FG001|Overall Study|Adverse Event|0|||
46612800|NCT03219164|82723585|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46612801|NCT03219164|82723586|FG001|Overall Study|Non-Compliance with Study Drug|0|||
46612802|NCT03219164|82723585|FG000|Overall Study|Protocol Violation|0|||
46612803|NCT03219164|82723586|FG001|Overall Study|Protocol Violation|1|||
46612804|NCT03219164|82723585|FG000|Overall Study|Withdrew Assent|1|||
46612805|NCT03219164|82723586|FG001|Overall Study|Withdrew Assent|0|||
46612806|NCT02471586|82723604|FG000|Overall Study|Lost to Follow-up|3|||
46612807|NCT02471586|82723605|FG001|Overall Study|Lost to Follow-up|8|||
46612808|NCT02471586|82723606|FG002|Overall Study|Lost to Follow-up|4|||
46612809|NCT02471586|82723604|FG000|Overall Study|Death|2|||
46612810|NCT02471586|82723605|FG001|Overall Study|Death|2|||
46612811|NCT02471586|82723606|FG002|Overall Study|Death|0|||
46895083|NCT04237584|83119900|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
46895084|NCT04237584|83119901|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
46895085|NCT04237584|83119898|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
46895086|NCT04237584|83119899|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
46895087|NCT04237584|83119900|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
46895088|NCT04237584|83119901|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
46895089|NCT04237584|83119898|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
46895090|NCT04237584|83119899|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
46895091|NCT04237584|83119900|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
46895092|NCT04237584|83119901|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
46895093|NCT04237584|83119898|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
46895094|NCT04237584|83119899|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
46895095|NCT04237584|83119900|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
46895096|NCT04237584|83119901|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
46895097|NCT04237584|83119898|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
46895098|NCT04237584|83119899|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
46895099|NCT04237584|83119900|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
46895100|NCT04237584|83119901|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
46895101|NCT03224598|83119918|FG000|Overall Study|Lost to Follow-up|0|||
46895102|NCT03224598|83119919|FG001|Overall Study|Lost to Follow-up|2|||
46895103|NCT03224598|83119920|FG002|Overall Study|Lost to Follow-up|0|||
46895104|NCT03224598|83119918|FG000|Overall Study|Other|0|||
46895105|NCT03224598|83119919|FG001|Overall Study|Other|1|||
46895106|NCT03224598|83119920|FG002|Overall Study|Other|0|||
46895107|NCT03681691|83119930|FG000|Overall Study|COVID|1|||
46895108|NCT03681691|83119931|FG001|Overall Study|COVID|0|||
46895109|NCT03681691|83119930|FG000|Overall Study|prolonged bleeding|1|||
46895110|NCT03681691|83119931|FG001|Overall Study|prolonged bleeding|0|||
46895111|NCT03681691|83119930|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
46612812|NCT02470806|82723753|FG000|Overall Study|Lost to Follow-up|1|||
46612813|NCT02470806|82723754|FG001|Overall Study|Lost to Follow-up|1|||
46612814|NCT02470806|82723753|FG000|Overall Study|Adverse Event|5|||
46612815|NCT02470806|82723754|FG001|Overall Study|Adverse Event|2|||
46612816|NCT02470806|82723753|FG000|Overall Study|Protocol Violation|4|||
46895112|NCT03681691|83119931|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
46895113|NCT02935842|83119943|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
46895114|NCT02935842|83119944|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
46895115|NCT02935842|83119945|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
46895116|NCT02935842|83119946|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
46895117|NCT02935842|83119943|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
46895118|NCT02935842|83119944|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
46895119|NCT02935842|83119945|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
46895120|NCT02935842|83119946|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
46895121|NCT02935842|83119943|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
46895122|NCT02935842|83119944|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
46895123|NCT02935842|83119945|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
46895124|NCT02935842|83119946|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
46895125|NCT02935842|83119943|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
46895126|NCT02935842|83119944|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
46895127|NCT02935842|83119945|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
46895128|NCT02935842|83119946|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
46895129|NCT02935842|83119943|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
46895130|NCT02935842|83119944|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
46895131|NCT02935842|83119945|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
46895132|NCT02935842|83119946|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
46895133|NCT03680911|83119965|FG000|At Home Treatment|Study Termination|3|||
46895134|NCT03680911|83119966|FG001|At Home Treatment|Study Termination|0|||
46895135|NCT03680911|83119965|FG000|At Home Treatment|Lost to Follow-up|0|||
46895136|NCT03680911|83119966|FG001|At Home Treatment|Lost to Follow-up|1|||
46895137|NCT03680911|83119965|FG000|At Home Treatment|Withdrawal by Subject|0|||
46895138|NCT03680911|83119966|FG001|At Home Treatment|Withdrawal by Subject|2|||
46895139|NCT03680911|83119965|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
46895140|NCT03680911|83119966|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
46895141|NCT03224130|83119974|FG000|Overall Study|consent issue|0|||
46895142|NCT03224130|83119975|FG001|Overall Study|consent issue|1|||
46895143|NCT03679741|83119981|FG000|Period 1|No longer meet eligibility criteria|1|||
46895144|NCT03679741|83119982|FG001|Period 1|No longer meet eligibility criteria|0|||
46895145|NCT03679741|83119981|FG000|Period 1|Lost to Follow-up|0|||
46895146|NCT03679741|83119982|FG001|Period 1|Lost to Follow-up|1|||
46895147|NCT03679741|83119981|FG000|Period 1|Adverse Event|1|||
46895148|NCT03679741|83119982|FG001|Period 1|Adverse Event|1|||
46895149|NCT03679741|83119981|FG000|Period 1|Withdrawal by Subject|0|||
46895150|NCT03679741|83119982|FG001|Period 1|Withdrawal by Subject|1|||
46895151|NCT03679741|83119981|FG000|Period 2|Adverse Event|2|||
46895152|NCT03679741|83119982|FG001|Period 2|Adverse Event|1|||
46895153|NCT03679741|83119981|FG000|Period 2|Withdrawal by Subject|1|||
46895154|NCT03679741|83119982|FG001|Period 2|Withdrawal by Subject|1|||
46895155|NCT03678103|83119988|FG000|Overall Study|Withdrawn prior to completion|4|||
46895156|NCT03649477|83119995|FG000|Overall Study|Adverse Event|2|||
46895157|NCT03649477|83119996|FG001|Overall Study|Adverse Event|0|||
46895158|NCT03649477|83119997|FG002|Overall Study|Adverse Event|0|||
46895159|NCT03677869|83120005|FG000|Overall Study|Withdrawal by Subject|1|||
46895160|NCT03677401|83120011|FG000|Overall Study|Adverse Event|4|||
46895161|NCT03677401|83120012|FG001|Overall Study|Adverse Event|14|||
46895162|NCT03677401|83120011|FG000|Overall Study|Lack of Efficacy|3|||
46895163|NCT03677401|83120012|FG001|Overall Study|Lack of Efficacy|1|||
46895164|NCT03677401|83120011|FG000|Overall Study|Withdrawal by Subject|2|||
46895165|NCT03677401|83120012|FG001|Overall Study|Withdrawal by Subject|2|||
46895166|NCT03677401|83120011|FG000|Overall Study|Sponsor decision|0|||
46895167|NCT03677401|83120012|FG001|Overall Study|Sponsor decision|1|||
46895168|NCT03677401|83120011|FG000|Overall Study|Reason Unspecified|1|||
46895169|NCT03677401|83120012|FG001|Overall Study|Reason Unspecified|0|||
46895170|NCT03218787|83120018|FG000|Overall Study|Lost to Follow-up|12|||
46895171|NCT03218787|83120018|FG000|Overall Study|Withdrawal by Subject|72|||
46895172|NCT03218787|83120018|FG000|Overall Study|Physician Decision|11|||
46895173|NCT03218787|83120018|FG000|Overall Study|Death|111|||
46895174|NCT01348087|83120022|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
46895175|NCT01348087|83120022|FG000|Overall Study|Administrative problems|79|||
46895176|NCT01348087|83120022|FG000|Overall Study|protocol deviation|1|||
46895177|NCT01348087|83120022|FG000|Overall Study|Lost to Follow-up|1|||
46895178|NCT01348087|83120022|FG000|Overall Study|Subject withdrew consent|7|||
46895179|NCT01348087|83120022|FG000|Overall Study|Adverse Event|25|||
46895180|NCT01347931|83120036|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
46895181|NCT03645421|83120046|FG000|Overall Study|Adverse Event|0|||
46895182|NCT03645421|83120047|FG001|Overall Study|Adverse Event|0|||
46895183|NCT03645421|83120048|FG002|Overall Study|Adverse Event|4|||
46895184|NCT03645421|83120049|FG003|Overall Study|Adverse Event|1|||
46895185|NCT03645421|83120046|FG000|Overall Study|Withdrawal by patient|0|||
46895186|NCT03645421|83120047|FG001|Overall Study|Withdrawal by patient|0|||
46895187|NCT03645421|83120048|FG002|Overall Study|Withdrawal by patient|0|||
46895188|NCT03645421|83120049|FG003|Overall Study|Withdrawal by patient|3|||
46895189|NCT03645421|83120046|FG000|Overall Study|Study specific withdrawal criteria|0|||
46895190|NCT03645421|83120047|FG001|Overall Study|Study specific withdrawal criteria|0|||
46895191|NCT03645421|83120048|FG002|Overall Study|Study specific withdrawal criteria|1|||
46895192|NCT03645421|83120049|FG003|Overall Study|Study specific withdrawal criteria|0|||
46895193|NCT03207750|83120064|FG000|Overall Study|Adverse Event|3|||
46895194|NCT03207750|83120065|FG001|Overall Study|Adverse Event|2|||
46895195|NCT03207750|83120064|FG000|Overall Study|Lost to Follow-up|21|||
46895196|NCT03207750|83120065|FG001|Overall Study|Lost to Follow-up|29|||
46895197|NCT03207750|83120064|FG000|Overall Study|Protocol Violation|0|||
46895198|NCT03207750|83120065|FG001|Overall Study|Protocol Violation|1|||
46895199|NCT03207750|83120064|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
46895200|NCT03207750|83120065|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
46895201|NCT03207750|83120064|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
46895202|NCT03207750|83120065|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
46895203|NCT03207750|83120064|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
46895204|NCT03207750|83120065|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
46895205|NCT03207750|83120064|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
46895206|NCT03207750|83120065|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
46895207|NCT03207750|83120064|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
46895208|NCT03207750|83120065|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
46895209|NCT03674281|83120074|FG000|Overall Study|screen failure|2|||
46895210|NCT03674281|83120075|FG001|Overall Study|screen failure|0|||
46895211|NCT03674281|83120076|FG002|Overall Study|screen failure|0|||
46895212|NCT03674281|83120074|FG000|Overall Study|Withdrawal by Subject|1|||
46895213|NCT03674281|83120075|FG001|Overall Study|Withdrawal by Subject|3|||
46895214|NCT03674281|83120076|FG002|Overall Study|Withdrawal by Subject|3|||
46895215|NCT03673345|83120100|FG000|Overall Study|Lost to Follow-up|1|||
46895216|NCT03673345|83120101|FG001|Overall Study|Lost to Follow-up|0|||
46895217|NCT03673345|83120102|FG002|Overall Study|Lost to Follow-up|3|||
46895218|NCT03673345|83120103|FG003|Overall Study|Lost to Follow-up|3|||
46895219|NCT03673345|83120104|FG004|Overall Study|Lost to Follow-up|2|||
46895220|NCT03673345|83120105|FG005|Overall Study|Lost to Follow-up|1|||
46895221|NCT03673345|83120106|FG006|Overall Study|Lost to Follow-up|0|||
46895222|NCT03673345|83120107|FG007|Overall Study|Lost to Follow-up|0|||
46895223|NCT03673345|83120100|FG000|Overall Study|Withdrawal by Subject|1|||
46895224|NCT03673345|83120101|FG001|Overall Study|Withdrawal by Subject|0|||
46895225|NCT03673345|83120102|FG002|Overall Study|Withdrawal by Subject|4|||
46895226|NCT03673345|83120103|FG003|Overall Study|Withdrawal by Subject|2|||
46895227|NCT03673345|83120104|FG004|Overall Study|Withdrawal by Subject|0|||
46895228|NCT03673345|83120105|FG005|Overall Study|Withdrawal by Subject|0|||
46895229|NCT03673345|83120106|FG006|Overall Study|Withdrawal by Subject|0|||
46895230|NCT03673345|83120107|FG007|Overall Study|Withdrawal by Subject|0|||
46895231|NCT03673345|83120100|FG000|Overall Study|Physician Decision|0|||
46895232|NCT03673345|83120101|FG001|Overall Study|Physician Decision|0|||
46895233|NCT03673345|83120102|FG002|Overall Study|Physician Decision|2|||
46895234|NCT03673345|83120103|FG003|Overall Study|Physician Decision|0|||
46895235|NCT03673345|83120104|FG004|Overall Study|Physician Decision|0|||
46895236|NCT03673345|83120105|FG005|Overall Study|Physician Decision|0|||
46895237|NCT03673345|83120106|FG006|Overall Study|Physician Decision|0|||
46895238|NCT03673345|83120107|FG007|Overall Study|Physician Decision|0|||
46895239|NCT03223662|83120125|FG000|Overall Study|Physician Decision|1|||
46895240|NCT03223662|83120125|FG000|Overall Study|Study closure|1|||
46895241|NCT03672097|83120129|FG000|Period 1|Withdrawal by Subject|2|||
46895242|NCT03672097|83120129|FG000|Period 1|Adverse Event|1|||
46895243|NCT03672097|83120129|FG000|Period 1|Did not receive treatment|1|||
46895244|NCT03672097|83120129|FG000|Period 2|Withdrawal by Subject|3|||
46895245|NCT03672097|83120129|FG000|Period 2|Other|1|||
46895246|NCT03847896|83120138|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
46895247|NCT03847896|83120139|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
46895248|NCT03847896|83120140|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
46895249|NCT03847896|83120141|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
46895250|NCT03847896|83120142|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
46895251|NCT03847896|83120138|FG000|Overall Study|Withdrawal by Subject|2|||
46895252|NCT03847896|83120139|FG001|Overall Study|Withdrawal by Subject|10|||
46895253|NCT03847896|83120140|FG002|Overall Study|Withdrawal by Subject|5|||
46895254|NCT03847896|83120141|FG003|Overall Study|Withdrawal by Subject|9|||
46895255|NCT03847896|83120142|FG004|Overall Study|Withdrawal by Subject|8|||
46895256|NCT03847896|83120138|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46895257|NCT03847896|83120139|FG001|Overall Study|Withdrawal by parent/guardian|0|||
46895258|NCT03847896|83120140|FG002|Overall Study|Withdrawal by parent/guardian|1|||
46895259|NCT03847896|83120141|FG003|Overall Study|Withdrawal by parent/guardian|0|||
46895260|NCT03847896|83120142|FG004|Overall Study|Withdrawal by parent/guardian|0|||
46895261|NCT03847896|83120138|FG000|Overall Study|Adverse Event|2|||
46895262|NCT03847896|83120139|FG001|Overall Study|Adverse Event|1|||
46895263|NCT03847896|83120140|FG002|Overall Study|Adverse Event|3|||
46895264|NCT03847896|83120141|FG003|Overall Study|Adverse Event|2|||
46895265|NCT03847896|83120142|FG004|Overall Study|Adverse Event|4|||
46895266|NCT03847896|83120138|FG000|Overall Study|A severe exacerbation event|0|||
46895267|NCT03847896|83120139|FG001|Overall Study|A severe exacerbation event|0|||
46895268|NCT03847896|83120140|FG002|Overall Study|A severe exacerbation event|0|||
46895269|NCT03847896|83120141|FG003|Overall Study|A severe exacerbation event|0|||
46895270|NCT03847896|83120142|FG004|Overall Study|A severe exacerbation event|3|||
46895271|NCT03847896|83120138|FG000|Overall Study|Protocol Violation|0|||
46895272|NCT03847896|83120139|FG001|Overall Study|Protocol Violation|2|||
46895273|NCT03847896|83120140|FG002|Overall Study|Protocol Violation|1|||
46895274|NCT03847896|83120141|FG003|Overall Study|Protocol Violation|0|||
46895275|NCT03847896|83120142|FG004|Overall Study|Protocol Violation|2|||
46895276|NCT03847896|83120138|FG000|Overall Study|Lost to Follow-up|0|||
46895277|NCT03847896|83120139|FG001|Overall Study|Lost to Follow-up|0|||
46895278|NCT03847896|83120140|FG002|Overall Study|Lost to Follow-up|0|||
46895279|NCT03847896|83120141|FG003|Overall Study|Lost to Follow-up|1|||
46895280|NCT03847896|83120142|FG004|Overall Study|Lost to Follow-up|0|||
46895281|NCT03847896|83120138|FG000|Overall Study|Condition under investigation worsened|0|||
46895282|NCT03847896|83120139|FG001|Overall Study|Condition under investigation worsened|0|||
46895283|NCT03847896|83120140|FG002|Overall Study|Condition under investigation worsened|0|||
46895284|NCT03847896|83120141|FG003|Overall Study|Condition under investigation worsened|1|||
46895285|NCT03847896|83120142|FG004|Overall Study|Condition under investigation worsened|1|||
46895286|NCT03847896|83120138|FG000|Overall Study|Lack of Efficacy|0|||
46895287|NCT03847896|83120139|FG001|Overall Study|Lack of Efficacy|0|||
46895288|NCT03847896|83120140|FG002|Overall Study|Lack of Efficacy|0|||
46895289|NCT03847896|83120141|FG003|Overall Study|Lack of Efficacy|2|||
46895290|NCT03847896|83120142|FG004|Overall Study|Lack of Efficacy|2|||
46895291|NCT03847896|83120138|FG000|Overall Study|Other reasons|3|||
46895292|NCT03847896|83120139|FG001|Overall Study|Other reasons|3|||
46895293|NCT03847896|83120140|FG002|Overall Study|Other reasons|1|||
46895294|NCT03847896|83120141|FG003|Overall Study|Other reasons|2|||
46895295|NCT03847896|83120142|FG004|Overall Study|Other reasons|1|||
46895296|NCT03670537|83120154|FG000|Overall Study|Protocol Violation|1|||
46895297|NCT03619837|83120158|FG000|Screening|received organs from HCV-negative donors|47|||
46895298|NCT03619837|83120158|FG000|Screening|died on the wait-list|2|||
46895299|NCT03619837|83120158|FG000|Screening|remained on the wait list|40|||
46895300|NCT03619837|83120158|FG000|Screening|didn't meet eligibility criteria|3|||
46895301|NCT03619837|83120158|FG000|Screening|withdrew consent|2|||
46895302|NCT03619837|83120158|FG000|Screening|never listed for HCV-viremic donor|1|||
46895303|NCT03619837|83120158|FG000|Screening|developed exclusion criteria|2|||
46895304|NCT03619837|83120158|FG000|Screening|excluded by the investigator due to non-compliance|1|||
46895305|NCT03206970|83120162|FG000|Overall Study|Death|21|||
46895306|NCT03206970|83120162|FG000|Overall Study|Withdrawal by Subject|13|||
46895307|NCT03206970|83120162|FG000|Overall Study|Lost to Follow-up|3|||
46895308|NCT03206970|83120162|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
46895309|NCT03644173|83120166|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
46895310|NCT03644173|83120166|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
46895311|NCT03644173|83120166|FG000|Participants at the 1-month Follow up|Death|2|||
46895312|NCT03644173|83120166|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
46895313|NCT03178851|83120174|FG000|Overall Study|Death|48|||
46895314|NCT03178851|83120175|FG001|Overall Study|Death|2|||
46895315|NCT03178851|83120176|FG002|Overall Study|Death|25|||
46895316|NCT03178851|83120174|FG000|Overall Study|Withdrawal by Subject|8|||
46895317|NCT03178851|83120175|FG001|Overall Study|Withdrawal by Subject|0|||
46895318|NCT03178851|83120176|FG002|Overall Study|Withdrawal by Subject|0|||
46895319|NCT03178851|83120174|FG000|Overall Study|Lost to Follow-up|5|||
46895320|NCT03178851|83120175|FG001|Overall Study|Lost to Follow-up|2|||
46895321|NCT03178851|83120176|FG002|Overall Study|Lost to Follow-up|0|||
46895322|NCT03178851|83120174|FG000|Overall Study|Adverse Event|0|||
46895323|NCT03178851|83120175|FG001|Overall Study|Adverse Event|0|||
46895324|NCT03178851|83120176|FG002|Overall Study|Adverse Event|1|||
46895325|NCT03178851|83120174|FG000|Overall Study|Study Termination by Sponsor|31|||
46895326|NCT03178851|83120175|FG001|Overall Study|Study Termination by Sponsor|7|||
46895327|NCT03178851|83120176|FG002|Overall Study|Study Termination by Sponsor|26|||
46895328|NCT03643159|83120187|FG000|Overall Study|Adverse Event|1|||
46895329|NCT03643159|83120187|FG000|Overall Study|Withdrawal by Subject|1|||
46895330|NCT03205566|83120194|FG000|Phase 1|Protocol Violation|1|||
46895331|NCT03205566|83120195|FG001|Phase 1|Protocol Violation|1|||
46895332|NCT02935452|83120207|FG000|Overall Study|work and life commintment|3|||
46895333|NCT02935452|83120208|FG001|Overall Study|work and life commintment|1|||
46895334|NCT03178773|83120216|FG000|Overall Study|Death|0|||
46895335|NCT03178773|83120217|FG001|Overall Study|Death|1|||
46895336|NCT03178773|83120216|FG000|Overall Study|Lost to Follow-up|29|||
46895337|NCT03178773|83120217|FG001|Overall Study|Lost to Follow-up|25|||
46895338|NCT03178773|83120216|FG000|Overall Study|Withdrawal by Subject|10|||
46895339|NCT03178773|83120217|FG001|Overall Study|Withdrawal by Subject|14|||
46895340|NCT03218397|83120226|FG000|Overall Study|Prior positive blood culture|8|||
46895341|NCT03218397|83120227|FG001|Overall Study|Prior positive blood culture|13|||
46895342|NCT03218397|83120226|FG000|Overall Study|Comfort care|8|||
46895343|NCT03218397|83120227|FG001|Overall Study|Comfort care|5|||
46895344|NCT03218397|83120226|FG000|Overall Study|Comfort care and positive blood culture|1|||
46895345|NCT03218397|83120227|FG001|Overall Study|Comfort care and positive blood culture|0|||
46895346|NCT03218397|83120226|FG000|Overall Study|Comfort care and mixed culture|0|||
46895347|NCT03218397|83120227|FG001|Overall Study|Comfort care and mixed culture|1|||
46895348|NCT03218397|83120226|FG000|Overall Study|Mixed culture|2|||
46895349|NCT03218397|83120227|FG001|Overall Study|Mixed culture|2|||
46895350|NCT03218397|83120226|FG000|Overall Study|Inaccessible hospital records|2|||
46895351|NCT03218397|83120227|FG001|Overall Study|Inaccessible hospital records|5|||
46895352|NCT03218397|83120226|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
46895353|NCT03218397|83120227|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
46895354|NCT03218397|83120226|FG000|Overall Study|Randomized during laboratory off hours|2|||
46895355|NCT03218397|83120227|FG001|Overall Study|Randomized during laboratory off hours|1|||
46895356|NCT03618823|83120235|FG000|Overall Study|Lost to Follow-up|63|||
46895357|NCT03618823|83120236|FG001|Overall Study|Lost to Follow-up|61|||
46895358|NCT03640507|83120248|FG000|Overall Study|Withdrawal by Subject|0|||
46895359|NCT03640507|83120249|FG001|Overall Study|Withdrawal by Subject|0|||
46895360|NCT03640507|83120250|FG002|Overall Study|Withdrawal by Subject|1|||
46895361|NCT02937636|83120260|FG000|Overall Study|Other (Not specified)|3|||
46895362|NCT02937636|83120261|FG001|Overall Study|Other (Not specified)|2|||
46895363|NCT03638635|83120270|FG000|Initial Hospitalization|Study terminated prematurely|0|||
46895364|NCT03638635|83120271|FG001|Initial Hospitalization|Study terminated prematurely|1|||
46895365|NCT03638635|83120270|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
46895366|NCT03638635|83120271|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
46895367|NCT03638635|83120270|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
46895368|NCT03638635|83120271|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
46895369|NCT03204981|83120277|FG000|Overall Study|Physician Decision|2|||
46895370|NCT03204981|83120277|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
46895371|NCT03205488|83120286|FG000|Overall Study|Adverse Event|1|||
46895372|NCT03205488|83120287|FG001|Overall Study|Adverse Event|2|||
46895373|NCT03205488|83120288|FG002|Overall Study|Adverse Event|4|||
46895374|NCT03205488|83120286|FG000|Overall Study|Protocol Violation|0|||
46895375|NCT03205488|83120287|FG001|Overall Study|Protocol Violation|0|||
46895376|NCT03205488|83120288|FG002|Overall Study|Protocol Violation|1|||
46895377|NCT03204279|83120302|FG000|Overall Study|Withdrawal by Subject|0|||
46895378|NCT03204279|83120303|FG001|Overall Study|Withdrawal by Subject|1|||
46895379|NCT03173547|83120312|FG000|Overall Study|Adverse Event|2|||
46895380|NCT03173547|83120313|FG001|Overall Study|Adverse Event|0|||
46895381|NCT03173547|83120312|FG000|Overall Study|Withdrawal by Subject|2|||
46895382|NCT03173547|83120313|FG001|Overall Study|Withdrawal by Subject|2|||
46895383|NCT02954653|83120321|FG000|Overall Study|Death|3|||
46895384|NCT02954653|83120322|FG001|Overall Study|Death|1|||
46895385|NCT02954653|83120323|FG002|Overall Study|Death|0|||
46895386|NCT02954653|83120324|FG003|Overall Study|Death|0|||
46895387|NCT02954653|83120325|FG004|Overall Study|Death|0|||
46895388|NCT02954653|83120326|FG005|Overall Study|Death|0|||
46895389|NCT02954653|83120327|FG006|Overall Study|Death|0|||
46895390|NCT02954653|83120328|FG007|Overall Study|Death|0|||
46895391|NCT02954653|83120329|FG008|Overall Study|Death|0|||
46895392|NCT02954653|83120321|FG000|Overall Study|Randomized but did not receive treatment|1|||
46895393|NCT02954653|83120322|FG001|Overall Study|Randomized but did not receive treatment|0|||
46895394|NCT02954653|83120323|FG002|Overall Study|Randomized but did not receive treatment|0|||
46895395|NCT02954653|83120324|FG003|Overall Study|Randomized but did not receive treatment|0|||
46895396|NCT02954653|83120325|FG004|Overall Study|Randomized but did not receive treatment|0|||
46895397|NCT02954653|83120326|FG005|Overall Study|Randomized but did not receive treatment|0|||
46895398|NCT02954653|83120327|FG006|Overall Study|Randomized but did not receive treatment|0|||
46895399|NCT02954653|83120328|FG007|Overall Study|Randomized but did not receive treatment|0|||
46895400|NCT02954653|83120329|FG008|Overall Study|Randomized but did not receive treatment|0|||
46895401|NCT02954653|83120321|FG000|Overall Study|Started another anti-cancer therapy|0|||
46895402|NCT02954653|83120322|FG001|Overall Study|Started another anti-cancer therapy|1|||
46895403|NCT02954653|83120323|FG002|Overall Study|Started another anti-cancer therapy|0|||
46895404|NCT02954653|83120324|FG003|Overall Study|Started another anti-cancer therapy|0|||
46895405|NCT02954653|83120325|FG004|Overall Study|Started another anti-cancer therapy|0|||
46895406|NCT02954653|83120326|FG005|Overall Study|Started another anti-cancer therapy|0|||
46895407|NCT02954653|83120327|FG006|Overall Study|Started another anti-cancer therapy|0|||
46895408|NCT02954653|83120328|FG007|Overall Study|Started another anti-cancer therapy|0|||
46895409|NCT02954653|83120329|FG008|Overall Study|Started another anti-cancer therapy|0|||
46895410|NCT02954653|83120321|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
46895411|NCT02954653|83120322|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
46895412|NCT02954653|83120323|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
46895413|NCT02954653|83120324|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
46895414|NCT02954653|83120325|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
46895415|NCT02954653|83120326|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
46895416|NCT02954653|83120327|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
46895417|NCT02954653|83120328|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
46895418|NCT02954653|83120329|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
46895419|NCT03173313|83120343|FG000|Overall Study|Lost to Follow-up|2|||
46895420|NCT03173313|83120344|FG001|Overall Study|Lost to Follow-up|3|||
46895421|NCT03173313|83120343|FG000|Overall Study|Withdrawal by Subject|0|||
46895422|NCT03173313|83120344|FG001|Overall Study|Withdrawal by Subject|1|||
46895423|NCT03173313|83120343|FG000|Overall Study|Death|5|||
46895424|NCT03173313|83120344|FG001|Overall Study|Death|0|||
46895425|NCT03173313|83120343|FG000|Overall Study|Physician Decision|1|||
46895426|NCT03173313|83120344|FG001|Overall Study|Physician Decision|0|||
46895427|NCT03173313|83120343|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
46895428|NCT03173313|83120344|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
46895429|NCT03173313|83120343|FG000|Overall Study|Bone Fracture|1|||
46895430|NCT03173313|83120344|FG001|Overall Study|Bone Fracture|0|||
46895431|NCT03215667|83120350|FG000|Overall Study|Physician Decision|4|||
46895432|NCT03634579|83120354|FG000|Overall Study|study termination|9|||
46895433|NCT02730208|83120360|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
46895434|NCT02730208|83120361|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
46895435|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
46895436|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
46895437|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
46895438|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
46895439|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
46895440|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
46895441|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
46895442|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
46895443|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
46895444|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
46895445|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
46895446|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
46895447|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
46895448|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
46895449|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
46895450|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
46895451|NCT01291511|83120369|FG000|Cross-Titration and Stabilization Phase|Death|1|||
46895452|NCT01291511|83120370|FG001|Cross-Titration and Stabilization Phase|Death|0|||
46895453|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
46895454|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
46895455|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
46895456|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
46895457|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
46895458|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
46895459|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
46895460|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
46895461|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
46895462|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
46895463|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
46895464|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
46895465|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
46895466|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
46895467|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
46895468|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
46895469|NCT01291511|83120369|FG000|Double-blind Relapse Prevention Phase|Death|1|||
46895470|NCT01291511|83120370|FG001|Double-blind Relapse Prevention Phase|Death|0|||
46895471|NCT03201900|83120377|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
46895472|NCT03201900|83120377|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
46895473|NCT03201900|83120377|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
46895474|NCT03201900|83120377|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
46895475|NCT03201900|83120377|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
46895476|NCT03201900|83120377|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
46895477|NCT03201900|83120377|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
46895478|NCT03201900|83120377|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
46895479|NCT03201900|83120377|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
46895480|NCT03201900|83120377|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
46895481|NCT03201900|83120377|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
46895482|NCT03201900|83120377|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
46895483|NCT03201900|83120377|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
46895484|NCT03170271|83120392|FG000|Overall Study|Adverse Event|7|||
46895485|NCT03170271|83120393|FG001|Overall Study|Adverse Event|2|||
46895486|NCT03170271|83120392|FG000|Overall Study|Lost to Follow-up|0|||
46895487|NCT03170271|83120393|FG001|Overall Study|Lost to Follow-up|1|||
46895488|NCT03170271|83120392|FG000|Overall Study|Physician Decision|1|||
46895489|NCT03170271|83120393|FG001|Overall Study|Physician Decision|0|||
46895490|NCT03170271|83120392|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
46895491|NCT03170271|83120393|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
46895492|NCT03170271|83120392|FG000|Overall Study|Withdrawal by Subject|17|||
46895493|NCT03170271|83120393|FG001|Overall Study|Withdrawal by Subject|5|||
46895494|NCT03170271|83120392|FG000|Overall Study|Other|2|||
46895495|NCT03170271|83120393|FG001|Overall Study|Other|2|||
46895496|NCT03170271|83120392|FG000|Overall Study|Randomized in error|4|||
46895497|NCT03170271|83120393|FG001|Overall Study|Randomized in error|0|||
46895498|NCT03613129|83120403|FG000|Pre-treatment Assessment|Protocol Violation|2|||
46895499|NCT03613129|83120404|FG001|Pre-treatment Assessment|Protocol Violation|0|||
46895500|NCT03613129|83120405|FG002|Pre-treatment Assessment|Protocol Violation|0|||
46895501|NCT03613129|83120406|FG003|Pre-treatment Assessment|Protocol Violation|0|||
46895502|NCT03613129|83120407|FG004|Pre-treatment Assessment|Protocol Violation|0|||
46895503|NCT03613129|83120403|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
46895504|NCT03613129|83120404|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
46895505|NCT03613129|83120405|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
46895506|NCT03613129|83120406|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
46895507|NCT03613129|83120407|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
46895508|NCT03235284|83120422|FG000|Overall Study|Adverse Event|1|||
46895509|NCT03235284|83120423|FG001|Overall Study|Adverse Event|2|||
46895510|NCT03235284|83120424|FG002|Overall Study|Adverse Event|1|||
46895511|NCT03170193|83120439|FG000|Overall Study|Withdrawal by Subject|0|||
46895512|NCT03170193|83120440|FG001|Overall Study|Withdrawal by Subject|0|||
46895513|NCT03170193|83120441|FG002|Overall Study|Withdrawal by Subject|0|||
46895514|NCT03170193|83120442|FG003|Overall Study|Withdrawal by Subject|1|||
46895515|NCT03170193|83120443|FG004|Overall Study|Withdrawal by Subject|0|||
46895516|NCT03170193|83120444|FG005|Overall Study|Withdrawal by Subject|0|||
46895517|NCT03170193|83120445|FG006|Overall Study|Withdrawal by Subject|0|||
46895518|NCT03170193|83120439|FG000|Overall Study|Lost to Follow-up|1|||
46895519|NCT03170193|83120440|FG001|Overall Study|Lost to Follow-up|1|||
46895520|NCT03170193|83120441|FG002|Overall Study|Lost to Follow-up|0|||
46895521|NCT03170193|83120442|FG003|Overall Study|Lost to Follow-up|0|||
46895522|NCT03170193|83120443|FG004|Overall Study|Lost to Follow-up|0|||
46895523|NCT03170193|83120444|FG005|Overall Study|Lost to Follow-up|0|||
46895524|NCT03170193|83120445|FG006|Overall Study|Lost to Follow-up|0|||
46895525|NCT03633331|83120467|FG000|Overall Study|Withdrawal by Subject|1|||
46895526|NCT03201003|83120473|FG000|Overall Study|Adverse Event|14|||
46895527|NCT03201003|83120474|FG001|Overall Study|Adverse Event|1|||
46895528|NCT03201003|83120473|FG000|Overall Study|Other reasons|5|||
46895529|NCT03201003|83120474|FG001|Overall Study|Other reasons|1|||
46895530|NCT03201003|83120473|FG000|Overall Study|Withdrawal by Subject|4|||
46895531|NCT03201003|83120474|FG001|Overall Study|Withdrawal by Subject|1|||
46895532|NCT03201003|83120473|FG000|Overall Study|Lost to Follow-up|2|||
46895533|NCT03201003|83120474|FG001|Overall Study|Lost to Follow-up|0|||
46895534|NCT03201003|83120473|FG000|Overall Study|Protocol Violation|1|||
46895535|NCT03201003|83120474|FG001|Overall Study|Protocol Violation|0|||
46895536|NCT03166215|83120482|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
46895537|NCT03166215|83120483|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
46895538|NCT03166215|83120484|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
46895539|NCT03166215|83120482|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
46895540|NCT03166215|83120483|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
46895541|NCT03166215|83120484|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
46895542|NCT03168711|83120506|FG000|Overall Study|Adverse Event|2|||
46895543|NCT03168711|83120507|FG001|Overall Study|Adverse Event|0|||
46895544|NCT03168711|83120506|FG000|Overall Study|Withdrawal by Subject|0|||
46895545|NCT03168711|83120507|FG001|Overall Study|Withdrawal by Subject|1|||
46895546|NCT03168711|83120506|FG000|Overall Study|Death|0|||
46895547|NCT03168711|83120507|FG001|Overall Study|Death|1|||
46895548|NCT03738215|83120516|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
46895549|NCT03738215|83120517|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
46895550|NCT03738215|83120518|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
46895551|NCT03738215|83120516|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
46895552|NCT03738215|83120517|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
46895553|NCT03738215|83120518|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
46895554|NCT03738215|83120516|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
46895555|NCT03738215|83120517|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
46895556|NCT03738215|83120518|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
46895557|NCT03738215|83120516|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
46895558|NCT03738215|83120517|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
46895559|NCT03738215|83120518|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
46895560|NCT03738215|83120516|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
46895561|NCT03738215|83120517|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
46895562|NCT03738215|83120518|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
46895563|NCT03738215|83120516|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
46895564|NCT03738215|83120517|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
46895565|NCT03738215|83120518|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
46895566|NCT03738215|83120516|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
46895567|NCT03738215|83120517|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
46895568|NCT03738215|83120518|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
46895569|NCT03738215|83120516|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
46895570|NCT03738215|83120517|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
46895571|NCT03738215|83120518|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
46895572|NCT03738215|83120516|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
46895573|NCT03738215|83120517|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
46895574|NCT03738215|83120518|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
46895575|NCT03738215|83120516|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
46895576|NCT03738215|83120517|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
46895577|NCT03738215|83120518|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
46895578|NCT03199911|83120528|FG000|Overall Study|Lost to Follow-up|5|||
46895579|NCT03199911|83120529|FG001|Overall Study|Lost to Follow-up|5|||
46895580|NCT03199911|83120528|FG000|Overall Study|Did not proceed with surgery|2|||
46895581|NCT03199911|83120529|FG001|Overall Study|Did not proceed with surgery|1|||
46895582|NCT03736967|83120539|FG000|Overall Study|Withdrawal by Subject|26|||
46895583|NCT03736967|83120540|FG001|Overall Study|Withdrawal by Subject|25|||
46895584|NCT03736967|83120541|FG002|Overall Study|Withdrawal by Subject|23|||
46895585|NCT03736967|83120542|FG003|Overall Study|Withdrawal by Subject|26|||
46895586|NCT03736967|83120539|FG000|Overall Study|Lost to Follow-up|3|||
46895587|NCT03736967|83120540|FG001|Overall Study|Lost to Follow-up|2|||
46895588|NCT03736967|83120541|FG002|Overall Study|Lost to Follow-up|1|||
46895589|NCT03736967|83120542|FG003|Overall Study|Lost to Follow-up|1|||
46895590|NCT03736967|83120539|FG000|Overall Study|Physician Decision|1|||
46895591|NCT03736967|83120540|FG001|Overall Study|Physician Decision|0|||
46895592|NCT03736967|83120541|FG002|Overall Study|Physician Decision|0|||
46895593|NCT03736967|83120542|FG003|Overall Study|Physician Decision|1|||
46895594|NCT03736967|83120539|FG000|Overall Study|Adverse Event|0|||
46895595|NCT03736967|83120540|FG001|Overall Study|Adverse Event|1|||
46895596|NCT03736967|83120541|FG002|Overall Study|Adverse Event|0|||
46895597|NCT03736967|83120542|FG003|Overall Study|Adverse Event|1|||
46895598|NCT03736967|83120539|FG000|Overall Study|Death|0|||
46895599|NCT03736967|83120540|FG001|Overall Study|Death|0|||
46895600|NCT03736967|83120541|FG002|Overall Study|Death|0|||
46895601|NCT03736967|83120542|FG003|Overall Study|Death|1|||
46895602|NCT03736967|83120539|FG000|Overall Study|Randomized but never treated|1|||
46895603|NCT03736967|83120540|FG001|Overall Study|Randomized but never treated|0|||
46895604|NCT03736967|83120541|FG002|Overall Study|Randomized but never treated|0|||
46895605|NCT03736967|83120542|FG003|Overall Study|Randomized but never treated|0|||
46895606|NCT03168555|83120555|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
46895607|NCT03168555|83120555|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
46895608|NCT03168555|83120555|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
46895609|NCT03168555|83120555|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
46895610|NCT03235050|83120567|FG000|Overall Study|Adverse Event|0|||
46895611|NCT03235050|83120568|FG001|Overall Study|Adverse Event|0|||
46895612|NCT03235050|83120569|FG002|Overall Study|Adverse Event|1|||
46895613|NCT03235050|83120570|FG003|Overall Study|Adverse Event|4|||
46895614|NCT03235050|83120571|FG004|Overall Study|Adverse Event|1|||
46895615|NCT03235050|83120567|FG000|Overall Study|Death|0|||
46895616|NCT03235050|83120568|FG001|Overall Study|Death|0|||
46895617|NCT03235050|83120569|FG002|Overall Study|Death|0|||
46895618|NCT03235050|83120570|FG003|Overall Study|Death|2|||
46895619|NCT03235050|83120571|FG004|Overall Study|Death|1|||
46895620|NCT03235050|83120567|FG000|Overall Study|Lost to Follow-up|1|||
46895621|NCT03235050|83120568|FG001|Overall Study|Lost to Follow-up|2|||
46612817|NCT02470806|82723754|FG001|Overall Study|Protocol Violation|11|||
46895622|NCT03235050|83120569|FG002|Overall Study|Lost to Follow-up|1|||
46895623|NCT03235050|83120570|FG003|Overall Study|Lost to Follow-up|2|||
46895624|NCT03235050|83120571|FG004|Overall Study|Lost to Follow-up|0|||
46895625|NCT03235050|83120567|FG000|Overall Study|Withdrawal by Subject|3|||
46895626|NCT03235050|83120568|FG001|Overall Study|Withdrawal by Subject|2|||
46895627|NCT03235050|83120569|FG002|Overall Study|Withdrawal by Subject|2|||
46895628|NCT03235050|83120570|FG003|Overall Study|Withdrawal by Subject|5|||
46895629|NCT03235050|83120571|FG004|Overall Study|Withdrawal by Subject|7|||
46895630|NCT03235050|83120567|FG000|Overall Study|Other reasons|0|||
46895631|NCT03235050|83120568|FG001|Overall Study|Other reasons|1|||
46895632|NCT03235050|83120569|FG002|Overall Study|Other reasons|0|||
46895633|NCT03235050|83120570|FG003|Overall Study|Other reasons|1|||
46895634|NCT03235050|83120571|FG004|Overall Study|Other reasons|2|||
46895635|NCT04502212|83120600|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
46895636|NCT04502212|83120600|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
46895637|NCT03167619|83120607|FG000|Overall Study|Death|11|||
46895638|NCT03167619|83120608|FG001|Overall Study|Death|8|||
46895639|NCT03167619|83120607|FG000|Overall Study|Withdrawal by Subject|1|||
46895640|NCT03167619|83120608|FG001|Overall Study|Withdrawal by Subject|2|||
46895641|NCT03167619|83120607|FG000|Overall Study|Physician Decision|0|||
46895642|NCT03167619|83120608|FG001|Overall Study|Physician Decision|1|||
46895643|NCT03578809|83120618|FG000|Overall Study|Death|0|||
46895644|NCT03578809|83120619|FG001|Overall Study|Death|2|||
46895645|NCT03578809|83120620|FG002|Overall Study|Death|0|||
46895646|NCT03578809|83120621|FG003|Overall Study|Death|1|||
46895647|NCT03578809|83120618|FG000|Overall Study|Lost to Follow-up|0|||
46895648|NCT03578809|83120619|FG001|Overall Study|Lost to Follow-up|1|||
46895649|NCT03578809|83120620|FG002|Overall Study|Lost to Follow-up|0|||
46895650|NCT03578809|83120621|FG003|Overall Study|Lost to Follow-up|0|||
46895651|NCT03578809|83120618|FG000|Overall Study|Withdrawal by Subject|3|||
46895652|NCT03578809|83120619|FG001|Overall Study|Withdrawal by Subject|5|||
46895653|NCT03578809|83120620|FG002|Overall Study|Withdrawal by Subject|2|||
46895654|NCT03578809|83120621|FG003|Overall Study|Withdrawal by Subject|0|||
46895655|NCT03578809|83120618|FG000|Overall Study|Other|3|||
46895656|NCT03578809|83120619|FG001|Overall Study|Other|6|||
46895657|NCT03578809|83120620|FG002|Overall Study|Other|2|||
46895658|NCT03578809|83120621|FG003|Overall Study|Other|8|||
46895659|NCT03198507|83120636|FG000|Overall Study|Withdrawal by Subject|1|||
46895660|NCT03198507|83120637|FG001|Overall Study|Withdrawal by Subject|0|||
46895661|NCT03610165|83120645|FG000|Overall Study|Device didn't work|0|||
46895662|NCT03610165|83120646|FG001|Overall Study|Device didn't work|1|||
46895663|NCT03609619|83120654|FG000|Overall Study|Adverse Event|1|||
46895664|NCT03609619|83120655|FG001|Overall Study|Adverse Event|0|||
46895665|NCT03609619|83120654|FG000|Overall Study|Lack of Efficacy|1|||
46895666|NCT03609619|83120655|FG001|Overall Study|Lack of Efficacy|2|||
46895667|NCT03609619|83120654|FG000|Overall Study|Protocol Violation|5|||
46895668|NCT03609619|83120655|FG001|Overall Study|Protocol Violation|0|||
46895669|NCT03609619|83120654|FG000|Overall Study|Withdrawal by Subject|2|||
46895670|NCT03609619|83120655|FG001|Overall Study|Withdrawal by Subject|3|||
46895671|NCT03609619|83120654|FG000|Overall Study|Lost to Follow-up|1|||
46895672|NCT03609619|83120655|FG001|Overall Study|Lost to Follow-up|1|||
46895673|NCT03167151|83120664|FG000|Overall Study|Withdrawal by Subject|1|||
46895674|NCT03167151|83120665|FG001|Overall Study|Withdrawal by Subject|0|||
46895675|NCT03167151|83120666|FG002|Overall Study|Withdrawal by Subject|0|||
46895676|NCT03167151|83120664|FG000|Overall Study|No evidence of tumour at surgery|0|||
46895677|NCT03167151|83120665|FG001|Overall Study|No evidence of tumour at surgery|1|||
46895678|NCT03167151|83120666|FG002|Overall Study|No evidence of tumour at surgery|1|||
46895679|NCT03660943|83120676|FG000|Overall Study|Adverse Event|5|||
46895680|NCT03660943|83120677|FG001|Overall Study|Adverse Event|3|||
46895681|NCT03660943|83120676|FG000|Overall Study|Death|0|||
46895682|NCT03660943|83120677|FG001|Overall Study|Death|2|||
46895683|NCT03660943|83120676|FG000|Overall Study|Lost to Follow-up|7|||
46895684|NCT03660943|83120677|FG001|Overall Study|Lost to Follow-up|3|||
46895685|NCT03660943|83120676|FG000|Overall Study|Protocol Violation|3|||
46895686|NCT03660943|83120677|FG001|Overall Study|Protocol Violation|5|||
46895687|NCT03660943|83120676|FG000|Overall Study|Withdrawal by Subject|8|||
46895688|NCT03660943|83120677|FG001|Overall Study|Withdrawal by Subject|15|||
46895689|NCT03660943|83120676|FG000|Overall Study|Lack of Efficacy|9|||
46895690|NCT03660943|83120677|FG001|Overall Study|Lack of Efficacy|12|||
46895691|NCT03660943|83120676|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
46895692|NCT03660943|83120677|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
46895693|NCT03167073|83120685|FG000|Overall Study|Stillbirth|1|||
46895694|NCT03167073|83120686|FG001|Overall Study|Stillbirth|0|||
46895695|NCT03657277|83120692|FG000|Overall Study|Physician Decision|2|||
46895696|NCT03657277|83120692|FG000|Overall Study|Lost to Follow-up|1|||
46895697|NCT03657277|83120692|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
46895698|NCT03197883|83120698|FG000|Overall Study|Adverse Event|1|||
46895699|NCT03197883|83120699|FG001|Overall Study|Adverse Event|1|||
46895700|NCT03197883|83120698|FG000|Overall Study|Lost to Follow-up|1|||
46895701|NCT03197883|83120699|FG001|Overall Study|Lost to Follow-up|0|||
46895702|NCT03197883|83120698|FG000|Overall Study|Protocol Violation|1|||
46895703|NCT03197883|83120699|FG001|Overall Study|Protocol Violation|0|||
46895704|NCT03197883|83120698|FG000|Overall Study|Other (Not Specified)|0|||
46895705|NCT03197883|83120699|FG001|Overall Study|Other (Not Specified)|5|||
46895706|NCT03234036|83120708|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
46895707|NCT03234036|83120709|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
46895708|NCT03234036|83120710|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
46895709|NCT03234036|83120711|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
46895710|NCT03606109|83120729|FG000|Overall Study|Lost to Follow-up|2|||
46895711|NCT03606109|83120730|FG001|Overall Study|Lost to Follow-up|1|||
46895712|NCT02729896|83120739|FG000|Overall Study|Death|0|||
46895713|NCT02729896|83120740|FG001|Overall Study|Death|2|||
46895714|NCT02729896|83120741|FG002|Overall Study|Death|13|||
46895715|NCT02729896|83120739|FG000|Overall Study|Lost to Follow-up|0|||
46895716|NCT02729896|83120740|FG001|Overall Study|Lost to Follow-up|2|||
46895717|NCT02729896|83120741|FG002|Overall Study|Lost to Follow-up|3|||
46895718|NCT02729896|83120739|FG000|Overall Study|Other|0|||
46895719|NCT02729896|83120740|FG001|Overall Study|Other|2|||
46895720|NCT02729896|83120741|FG002|Overall Study|Other|0|||
46895721|NCT02729896|83120739|FG000|Overall Study|Physician Decision|1|||
46895722|NCT02729896|83120740|FG001|Overall Study|Physician Decision|2|||
46895723|NCT02729896|83120741|FG002|Overall Study|Physician Decision|3|||
46895724|NCT02729896|83120739|FG000|Overall Study|Progressive Disease|0|||
46895725|NCT02729896|83120740|FG001|Overall Study|Progressive Disease|1|||
46895726|NCT02729896|83120741|FG002|Overall Study|Progressive Disease|0|||
46895727|NCT02729896|83120739|FG000|Overall Study|Withdrawal by Subject|1|||
46895728|NCT02729896|83120740|FG001|Overall Study|Withdrawal by Subject|0|||
46895729|NCT02729896|83120741|FG002|Overall Study|Withdrawal by Subject|3|||
46895730|NCT03575065|83120752|FG000|Overall Study|Death|31|||
46895731|NCT03575065|83120753|FG001|Overall Study|Death|12|||
46895732|NCT03575065|83120752|FG000|Overall Study|Sponsor's Decision|28|||
46895733|NCT03575065|83120753|FG001|Overall Study|Sponsor's Decision|13|||
46895734|NCT03575065|83120752|FG000|Overall Study|Withdrawal by Subject|2|||
46895735|NCT03575065|83120753|FG001|Overall Study|Withdrawal by Subject|1|||
46895736|NCT03575065|83120752|FG000|Overall Study|Lost to Follow-up|1|||
46895737|NCT03575065|83120753|FG001|Overall Study|Lost to Follow-up|0|||
46895738|NCT03514134|83120762|FG000|Overall Study|Lost to Follow-up|0|||
46895739|NCT03514134|83120763|FG001|Overall Study|Lost to Follow-up|1|||
46895740|NCT03188718|83120769|FG000|Overall Study|Participant noncompliance|4|||
46895741|NCT03188718|83120769|FG000|Overall Study|Withdrawal by Subject|1|||
46895742|NCT03188718|83120769|FG000|Overall Study|Device failure|3|||
46895743|NCT03574753|83120773|FG000|Overall Study|Adverse Event|3|||
46895744|NCT03574753|83120773|FG000|Overall Study|Progression/relapse|19|||
46895745|NCT03574753|83120773|FG000|Overall Study|Death|1|||
46895746|NCT03573505|83120780|FG000|Overall Study|Adverse Event|1|||
46895747|NCT03573505|83120781|FG001|Overall Study|Adverse Event|1|||
46895748|NCT03573505|83120780|FG000|Overall Study|Consent withdrawn|0|||
46895749|NCT03573505|83120781|FG001|Overall Study|Consent withdrawn|1|||
46895750|NCT03573505|83120780|FG000|Overall Study|Disease progression|0|||
46895751|NCT03573505|83120781|FG001|Overall Study|Disease progression|1|||
46895752|NCT03573505|83120780|FG000|Overall Study|Site Terminated by Sponsor|1|||
46895753|NCT03573505|83120781|FG001|Overall Study|Site Terminated by Sponsor|1|||
46895754|NCT03573505|83120780|FG000|Overall Study|Study terminated by sponsor|50|||
46895755|NCT03573505|83120781|FG001|Overall Study|Study terminated by sponsor|45|||
46895756|NCT03573505|83120780|FG000|Overall Study|Reason not specified|0|||
46895757|NCT03573505|83120781|FG001|Overall Study|Reason not specified|1|||
46895758|NCT03573505|83120780|FG000|Overall Study|Death|0|||
46895759|NCT03573505|83120781|FG001|Overall Study|Death|4|||
46895760|NCT01376908|83120790|FG000|Overall Study|Protocol Violation|1|||
46895761|NCT01376908|83120791|FG001|Overall Study|Protocol Violation|1|||
46895762|NCT01376908|83120790|FG000|Overall Study|Withdrawal by Subject|1|||
46895763|NCT01376908|83120791|FG001|Overall Study|Withdrawal by Subject|2|||
46895764|NCT03736031|83120806|FG000|Overall Study|Death|2|||
46895765|NCT03736031|83120807|FG001|Overall Study|Death|4|||
46895766|NCT03736031|83120806|FG000|Overall Study|Lost to Follow-up|21|||
46895767|NCT03736031|83120807|FG001|Overall Study|Lost to Follow-up|2|||
46895768|NCT03736031|83120806|FG000|Overall Study|Withdrawal by Subject|9|||
46895769|NCT03736031|83120807|FG001|Overall Study|Withdrawal by Subject|0|||
46895770|NCT03602053|83120816|FG000|Overall Study|Withdrawal by Subject|7|||
46895771|NCT03602053|83120817|FG001|Overall Study|Withdrawal by Subject|9|||
46895772|NCT03602053|83120818|FG002|Overall Study|Withdrawal by Subject|7|||
46895773|NCT03602053|83120816|FG000|Overall Study|Lost to Follow-up|5|||
46895774|NCT03602053|83120817|FG001|Overall Study|Lost to Follow-up|6|||
46895775|NCT03602053|83120818|FG002|Overall Study|Lost to Follow-up|0|||
46895776|NCT03602053|83120816|FG000|Overall Study|Protocol Violation|3|||
46895777|NCT03602053|83120817|FG001|Overall Study|Protocol Violation|0|||
46895778|NCT03602053|83120818|FG002|Overall Study|Protocol Violation|4|||
46895779|NCT03602053|83120816|FG000|Overall Study|Physician Decision|1|||
46895780|NCT03602053|83120817|FG001|Overall Study|Physician Decision|0|||
46895781|NCT03602053|83120818|FG002|Overall Study|Physician Decision|0|||
46895782|NCT03602053|83120816|FG000|Overall Study|migration|2|||
46895783|NCT03602053|83120817|FG001|Overall Study|migration|3|||
46895784|NCT03602053|83120818|FG002|Overall Study|migration|0|||
46895785|NCT03602053|83120816|FG000|Overall Study|Other|1|||
46895786|NCT03602053|83120817|FG001|Overall Study|Other|0|||
46895787|NCT03602053|83120818|FG002|Overall Study|Other|0|||
46895788|NCT04831515|83120830|FG000|First Intervention|Adverse Event|0|||
46895789|NCT04831515|83120831|FG001|First Intervention|Adverse Event|1|||
46895790|NCT03554629|83120837|FG000|Overall Study|Inadequate data|6|||
46895791|NCT03196791|83120867|FG000|Overall Study|Protocol Violation|7|||
46895792|NCT03196791|83120868|FG001|Overall Study|Protocol Violation|3|||
46895793|NCT03196791|83120867|FG000|Overall Study|Withdrawal by Subject|3|||
46895794|NCT03196791|83120868|FG001|Overall Study|Withdrawal by Subject|2|||
46895795|NCT03196635|83120874|FG000|Overall Study|Withdrawal by Subject|1|||
46895796|NCT03194217|83120896|FG000|Overall Study|Adverse Event|0|||
46895797|NCT03194217|83120897|FG001|Overall Study|Adverse Event|2|||
46895798|NCT03194217|83120898|FG002|Overall Study|Adverse Event|3|||
46895799|NCT03194217|83120899|FG003|Overall Study|Adverse Event|3|||
46895800|NCT03194217|83120896|FG000|Overall Study|Failure to meet randomisation criteria|0|||
46895801|NCT03194217|83120897|FG001|Overall Study|Failure to meet randomisation criteria|0|||
46895802|NCT03194217|83120898|FG002|Overall Study|Failure to meet randomisation criteria|0|||
46895803|NCT03194217|83120899|FG003|Overall Study|Failure to meet randomisation criteria|1|||
46895804|NCT03194217|83120896|FG000|Overall Study|Other|0|||
46895805|NCT03194217|83120897|FG001|Overall Study|Other|1|||
46895806|NCT03194217|83120898|FG002|Overall Study|Other|1|||
46895807|NCT03194217|83120899|FG003|Overall Study|Other|0|||
46895808|NCT00709618|83120909|FG000|Overall Study|Withdrawal by Subject|4|||
46895809|NCT00709618|83120909|FG000|Overall Study|Lost to Follow-up|1|||
46895810|NCT00709618|83120909|FG000|Overall Study|Study Closed/Terminated|25|||
46895811|NCT03193047|83120915|FG000|Overall Study|Physician Decision|1|||
46895812|NCT03193047|83120916|FG001|Overall Study|Physician Decision|0|||
46895813|NCT03193047|83120915|FG000|Overall Study|Participant Left State|1|||
46895814|NCT03193047|83120916|FG001|Overall Study|Participant Left State|0|||
46895815|NCT02918019|83120928|FG000|Overall Study|Death|0|||
46895816|NCT02918019|83120929|FG001|Overall Study|Death|0|||
46895817|NCT02918019|83120930|FG002|Overall Study|Death|1|||
46895818|NCT02918019|83120931|FG003|Overall Study|Death|0|||
46895819|NCT02918019|83120928|FG000|Overall Study|Lost to Follow-up|1|||
46895820|NCT02918019|83120929|FG001|Overall Study|Lost to Follow-up|1|||
46895821|NCT02918019|83120930|FG002|Overall Study|Lost to Follow-up|0|||
46895822|NCT02918019|83120931|FG003|Overall Study|Lost to Follow-up|1|||
46895823|NCT02918019|83120928|FG000|Overall Study|Principal investigator request|0|||
46895824|NCT02918019|83120929|FG001|Overall Study|Principal investigator request|0|||
46895825|NCT02918019|83120930|FG002|Overall Study|Principal investigator request|0|||
46895826|NCT02918019|83120931|FG003|Overall Study|Principal investigator request|1|||
46895827|NCT02918019|83120928|FG000|Overall Study|Physician Decision|1|||
46895828|NCT02918019|83120929|FG001|Overall Study|Physician Decision|3|||
46895829|NCT02918019|83120930|FG002|Overall Study|Physician Decision|2|||
46895830|NCT02918019|83120931|FG003|Overall Study|Physician Decision|0|||
46895831|NCT02918019|83120928|FG000|Overall Study|Protocol deviation|1|||
46895832|NCT02918019|83120929|FG001|Overall Study|Protocol deviation|1|||
46895833|NCT02918019|83120930|FG002|Overall Study|Protocol deviation|0|||
46895834|NCT02918019|83120931|FG003|Overall Study|Protocol deviation|2|||
46895835|NCT02918019|83120928|FG000|Overall Study|Withdrawal by Subject|3|||
46895836|NCT02918019|83120929|FG001|Overall Study|Withdrawal by Subject|4|||
46895837|NCT02918019|83120930|FG002|Overall Study|Withdrawal by Subject|6|||
46895838|NCT02918019|83120931|FG003|Overall Study|Withdrawal by Subject|4|||
46895839|NCT02918019|83120928|FG000|Overall Study|Adverse Event|0|||
46895840|NCT02918019|83120929|FG001|Overall Study|Adverse Event|1|||
46895841|NCT02918019|83120930|FG002|Overall Study|Adverse Event|0|||
46895842|NCT02918019|83120931|FG003|Overall Study|Adverse Event|1|||
46895843|NCT03055988|83120949|FG000|Period 1|Adverse Event|0|||
46895844|NCT03055988|83120950|FG001|Period 1|Adverse Event|1|||
46895845|NCT03055988|83120949|FG000|Period 1|Lost to Follow-up|1|||
46895846|NCT03055988|83120950|FG001|Period 1|Lost to Follow-up|0|||
46895847|NCT03055988|83120949|FG000|Period 1|Withdrawal by Subject|0|||
46895848|NCT03055988|83120950|FG001|Period 1|Withdrawal by Subject|4|||
46895849|NCT03055988|83120949|FG000|Period 2|Adverse Event|0|||
46895850|NCT03055988|83120950|FG001|Period 2|Adverse Event|1|||
46895851|NCT03055988|83120949|FG000|Period 2|Other than listed|1|||
46895852|NCT03055988|83120950|FG001|Period 2|Other than listed|1|||
46895853|NCT01250912|83120956|FG000|Overall Study|Lost to Follow-up|1|||
46895854|NCT03733301|83120966|FG000|Overall Study|Screen Fail|1|||
46895855|NCT03733301|83120967|FG001|Overall Study|Screen Fail|0|||
46895856|NCT03733301|83120968|FG002|Overall Study|Screen Fail|0|||
46895857|NCT03733301|83120966|FG000|Overall Study|Non-compliance|1|||
46895858|NCT03733301|83120967|FG001|Overall Study|Non-compliance|0|||
46895859|NCT03733301|83120968|FG002|Overall Study|Non-compliance|0|||
46895860|NCT03733301|83120966|FG000|Overall Study|Lack of Efficacy|2|||
46895861|NCT03733301|83120967|FG001|Overall Study|Lack of Efficacy|3|||
46895862|NCT03733301|83120968|FG002|Overall Study|Lack of Efficacy|0|||
46895863|NCT03733301|83120966|FG000|Overall Study|Adverse Event|0|||
46895864|NCT03733301|83120967|FG001|Overall Study|Adverse Event|1|||
46895865|NCT03733301|83120968|FG002|Overall Study|Adverse Event|3|||
46895866|NCT03733301|83120966|FG000|Overall Study|Withdrawal by Subject|3|||
46895867|NCT03733301|83120967|FG001|Overall Study|Withdrawal by Subject|5|||
46895868|NCT03733301|83120968|FG002|Overall Study|Withdrawal by Subject|1|||
46895869|NCT02871297|83120977|FG000|Overall Study|Adverse Event|34|||
46895870|NCT02871297|83120977|FG000|Overall Study|Lack of Efficacy|10|||
46895871|NCT02871297|83120977|FG000|Overall Study|Non-compliance with study drug|15|||
46895872|NCT02871297|83120977|FG000|Overall Study|Protocol Violation|3|||
46895873|NCT02871297|83120977|FG000|Overall Study|Withdrawal by Subject|20|||
46895874|NCT02871297|83120977|FG000|Overall Study|Lost to Follow-up|13|||
46895875|NCT02871297|83120977|FG000|Overall Study|Rolled over to 13546A|2|||
46895876|NCT02871297|83120977|FG000|Overall Study|Other than specified|39|||
46895877|NCT03554005|83120987|FG000|Overall Study|Not in participant's best interest|0|||
46895878|NCT03554005|83120988|FG001|Overall Study|Not in participant's best interest|0|||
46895879|NCT03554005|83120989|FG002|Overall Study|Not in participant's best interest|0|||
46895880|NCT03554005|83120990|FG003|Overall Study|Not in participant's best interest|0|||
46895881|NCT03554005|83120991|FG004|Overall Study|Not in participant's best interest|0|||
46895882|NCT03554005|83120992|FG005|Overall Study|Not in participant's best interest|1|||
46895883|NCT03554005|83120987|FG000|Overall Study|Disease Progression|1|||
46895884|NCT03554005|83120988|FG001|Overall Study|Disease Progression|1|||
46895885|NCT03554005|83120989|FG002|Overall Study|Disease Progression|1|||
46895886|NCT03554005|83120990|FG003|Overall Study|Disease Progression|1|||
46895887|NCT03554005|83120991|FG004|Overall Study|Disease Progression|5|||
46895888|NCT03554005|83120992|FG005|Overall Study|Disease Progression|6|||
46895889|NCT03554005|83120987|FG000|Overall Study|Adverse Event|0|||
46895890|NCT03554005|83120988|FG001|Overall Study|Adverse Event|0|||
46895891|NCT03554005|83120989|FG002|Overall Study|Adverse Event|0|||
46895892|NCT03554005|83120990|FG003|Overall Study|Adverse Event|0|||
46895893|NCT03554005|83120991|FG004|Overall Study|Adverse Event|0|||
46895894|NCT03554005|83120992|FG005|Overall Study|Adverse Event|3|||
46895895|NCT03554005|83120987|FG000|Overall Study|Physician Decision|0|||
46895896|NCT03554005|83120988|FG001|Overall Study|Physician Decision|0|||
46895897|NCT03554005|83120989|FG002|Overall Study|Physician Decision|0|||
46895898|NCT03554005|83120990|FG003|Overall Study|Physician Decision|0|||
46895899|NCT03554005|83120991|FG004|Overall Study|Physician Decision|1|||
46895900|NCT03554005|83120992|FG005|Overall Study|Physician Decision|0|||
46895901|NCT03554005|83120987|FG000|Overall Study|Other|0|||
46895902|NCT03554005|83120988|FG001|Overall Study|Other|0|||
46895903|NCT03554005|83120989|FG002|Overall Study|Other|0|||
46895904|NCT03554005|83120990|FG003|Overall Study|Other|0|||
46895905|NCT03554005|83120991|FG004|Overall Study|Other|0|||
46895906|NCT03554005|83120992|FG005|Overall Study|Other|1|||
46895907|NCT00709228|83121006|FG000|Overall Study|Not treated|14|||
46895908|NCT00709228|83121006|FG000|Overall Study|Eligibility criteria not met|281|||
46895909|NCT00709228|83121006|FG000|Overall Study|Adverse events|2|||
46895910|NCT00709228|83121006|FG000|Overall Study|Discontinued treatment|14|||
46895911|NCT00709228|83121006|FG000|Overall Study|Did not enter follow-up|4|||
46895912|NCT00709228|83121006|FG000|Overall Study|Discontinued follow-up|5|||
46895913|NCT00709228|83121006|FG000|Overall Study|Disease progression|1|||
46895914|NCT00709228|83121006|FG000|Overall Study|Lost to Follow-up|6|||
46895915|NCT00709228|83121006|FG000|Overall Study|Non-compliance|5|||
46895916|NCT03219372|83121012|FG000|Overall Study|Withdrawal by Subject|1|||
46895917|NCT03219372|83121013|FG001|Overall Study|Withdrawal by Subject|0|||
46895918|NCT03056690|83121028|FG000|Overall Study|Adverse Event|3|||
46895919|NCT03056690|83121029|FG001|Overall Study|Adverse Event|2|||
46895920|NCT03056690|83121028|FG000|Overall Study|Lack of Efficacy|1|||
46895921|NCT03056690|83121029|FG001|Overall Study|Lack of Efficacy|2|||
46895922|NCT03056690|83121028|FG000|Overall Study|Lost to Follow-up|3|||
46895923|NCT03056690|83121029|FG001|Overall Study|Lost to Follow-up|2|||
46612818|NCT02470806|82723753|FG000|Overall Study|Physician Decision|0|||
46895924|NCT03056690|83121028|FG000|Overall Study|Protocol Violation|2|||
46895925|NCT03056690|83121029|FG001|Overall Study|Protocol Violation|2|||
46895926|NCT03056690|83121028|FG000|Overall Study|Withdrawal by Subject|3|||
46895927|NCT03056690|83121029|FG001|Overall Study|Withdrawal by Subject|6|||
46895928|NCT03056690|83121028|FG000|Overall Study|Non-compliance with Study Drug|1|||
46895929|NCT03056690|83121029|FG001|Overall Study|Non-compliance with Study Drug|0|||
46895930|NCT03056690|83121028|FG000|Overall Study|Miscellaneous|1|||
46895931|NCT03056690|83121029|FG001|Overall Study|Miscellaneous|2|||
46895932|NCT03191799|83121035|FG000|Overall Study|Withdrawal by Subject|4|||
46895933|NCT03191799|83121035|FG000|Overall Study|Physician Decision|2|||
46895934|NCT03191799|83121035|FG000|Overall Study|Lost to Follow-up|1|||
46895935|NCT03191799|83121035|FG000|Overall Study|Death|2|||
46895936|NCT00708916|83121039|FG000|Overall Study|Subject Noncompliance|2|||
46895937|NCT00708916|83121039|FG000|Overall Study|Adverse Event|2|||
46895938|NCT02352753|83121044|FG000|6-Month Dosing Period|Decision by sponsor|2|||
46895939|NCT02352753|83121044|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
46895940|NCT02352753|83121044|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
46895941|NCT02352753|83121044|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
46895942|NCT02352753|83121044|FG000|3-Month Dosing Period|Decision by sponsor|14|||
46895943|NCT02352753|83121044|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
46895944|NCT04532294|83121055|FG000|Overall Study|Withdrawal by Subject|0|||
46895945|NCT04532294|83121056|FG001|Overall Study|Withdrawal by Subject|0|||
46895946|NCT04532294|83121057|FG002|Overall Study|Withdrawal by Subject|1|||
46895947|NCT04532294|83121055|FG000|Overall Study|Participants Not Dosed|0|||
46895948|NCT04532294|83121056|FG001|Overall Study|Participants Not Dosed|0|||
46895949|NCT04532294|83121057|FG002|Overall Study|Participants Not Dosed|2|||
46895950|NCT03197766|83121069|FG000|Overall Study|Withdrawal by Subject|2|||
46895951|NCT03197766|83121070|FG001|Overall Study|Withdrawal by Subject|0|||
46895952|NCT03738332|83121076|FG000|Overall Study|Withdrawal by Subject|1|||
46895953|NCT03173456|83121086|FG000|Baseline|Medication dispensing system malfunction'|0|||
46895954|NCT03173456|83121087|FG001|Baseline|Medication dispensing system malfunction'|1|||
46895955|NCT03173456|83121088|FG002|Baseline|Medication dispensing system malfunction'|0|||
46895956|NCT03173456|83121089|FG003|Baseline|Medication dispensing system malfunction'|0|||
46895957|NCT03173456|83121090|FG004|Baseline|Medication dispensing system malfunction'|2|||
46895958|NCT03173456|83121086|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
46895959|NCT03173456|83121087|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
46895960|NCT03173456|83121088|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
46895961|NCT03173456|83121089|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
46895962|NCT03173456|83121090|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
46895963|NCT03197376|83121113|FG000|Primary and Booster Phase|Adverse Event|0|||
46895964|NCT03197376|83121114|FG001|Primary and Booster Phase|Adverse Event|0|||
46895965|NCT03197376|83121115|FG002|Primary and Booster Phase|Adverse Event|0|||
46895966|NCT03197376|83121116|FG003|Primary and Booster Phase|Adverse Event|1|||
46895967|NCT03197376|83121113|FG000|Primary and Booster Phase|Death|1|||
46895968|NCT03197376|83121114|FG001|Primary and Booster Phase|Death|0|||
46895969|NCT03197376|83121115|FG002|Primary and Booster Phase|Death|0|||
46895970|NCT03197376|83121116|FG003|Primary and Booster Phase|Death|2|||
46895971|NCT03197376|83121113|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
46895972|NCT03197376|83121114|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
46895973|NCT03197376|83121115|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
46895974|NCT03197376|83121116|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
46895975|NCT03197376|83121113|FG000|Primary and Booster Phase|Physician Decision|1|||
46895976|NCT03197376|83121114|FG001|Primary and Booster Phase|Physician Decision|0|||
46895977|NCT03197376|83121115|FG002|Primary and Booster Phase|Physician Decision|1|||
46895978|NCT03197376|83121116|FG003|Primary and Booster Phase|Physician Decision|3|||
46895979|NCT03197376|83121113|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
46895980|NCT03197376|83121114|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
46895981|NCT03197376|83121115|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
46895982|NCT03197376|83121116|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
46895983|NCT03197376|83121113|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
46895984|NCT03197376|83121114|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
46895985|NCT03197376|83121115|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
46895986|NCT03197376|83121116|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
46895987|NCT03197376|83121113|FG000|Primary and Booster Phase|Not vaccine related|1|||
46895988|NCT03197376|83121114|FG001|Primary and Booster Phase|Not vaccine related|2|||
46895989|NCT03197376|83121115|FG002|Primary and Booster Phase|Not vaccine related|0|||
46895990|NCT03197376|83121116|FG003|Primary and Booster Phase|Not vaccine related|6|||
46895991|NCT03197376|83121113|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
46895992|NCT03197376|83121114|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
46895993|NCT03197376|83121115|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
46895994|NCT03197376|83121116|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
46895995|NCT03197376|83121113|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
46895996|NCT03197376|83121114|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
46895997|NCT03197376|83121115|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
46895998|NCT03197376|83121116|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
46895999|NCT03197376|83121113|FG000|Immune Persistence Phase|Not vaccine related|1|||
46896000|NCT03197376|83121114|FG001|Immune Persistence Phase|Not vaccine related|0|||
46896001|NCT03197376|83121115|FG002|Immune Persistence Phase|Not vaccine related|1|||
46896002|NCT03197376|83121116|FG003|Immune Persistence Phase|Not vaccine related|1|||
46896003|NCT03600805|83121153|FG000|Overall Study|Adverse Event|2|||
46896004|NCT03600805|83121154|FG001|Overall Study|Adverse Event|1|||
46896005|NCT03600805|83121155|FG002|Overall Study|Adverse Event|1|||
46896006|NCT03600805|83121156|FG003|Overall Study|Adverse Event|7|||
46896007|NCT03600805|83121153|FG000|Overall Study|Lack of Efficacy|2|||
46896008|NCT03600805|83121154|FG001|Overall Study|Lack of Efficacy|1|||
46896009|NCT03600805|83121155|FG002|Overall Study|Lack of Efficacy|0|||
46896010|NCT03600805|83121156|FG003|Overall Study|Lack of Efficacy|0|||
46896011|NCT03600805|83121153|FG000|Overall Study|Withdrawal by Subject|1|||
46896012|NCT03600805|83121154|FG001|Overall Study|Withdrawal by Subject|0|||
46896013|NCT03600805|83121155|FG002|Overall Study|Withdrawal by Subject|0|||
46896014|NCT03600805|83121156|FG003|Overall Study|Withdrawal by Subject|1|||
46896015|NCT03600805|83121153|FG000|Overall Study|Other unspecified|14|||
46896016|NCT03600805|83121154|FG001|Overall Study|Other unspecified|6|||
46896017|NCT03600805|83121155|FG002|Overall Study|Other unspecified|7|||
46896018|NCT03600805|83121156|FG003|Overall Study|Other unspecified|11|||
46896019|NCT02729740|83121168|FG000|Overall Study|Early Termination|130|||
46896020|NCT02729740|83121168|FG000|Overall Study|Other|1|||
46896021|NCT03196284|83121178|FG000|Main Part|Withdrawal by Subject|0|||
46896022|NCT03196284|83121179|FG001|Main Part|Withdrawal by Subject|1|||
46896023|NCT03196284|83121180|FG002|Main Part|Withdrawal by Subject|0|||
46896024|NCT03196284|83121178|FG000|Extension Part|Lack of Efficacy|0|||
46896025|NCT03196284|83121179|FG001|Extension Part|Lack of Efficacy|0|||
46896026|NCT03196284|83121180|FG002|Extension Part|Lack of Efficacy|1|||
46896027|NCT03196284|83121178|FG000|Extension Part|Withdrawal by Subject|0|||
46896028|NCT03196284|83121179|FG001|Extension Part|Withdrawal by Subject|0|||
46896029|NCT03196284|83121180|FG002|Extension Part|Withdrawal by Subject|1|||
46896030|NCT03196284|83121178|FG000|Extension Part|Physician Decision|0|||
46896031|NCT03196284|83121179|FG001|Extension Part|Physician Decision|0|||
46896032|NCT03196284|83121180|FG002|Extension Part|Physician Decision|1|||
46896033|NCT03730961|83121202|FG000|Overall Study|Adverse Event|0|||
46896034|NCT03730961|83121203|FG001|Overall Study|Adverse Event|1|||
46896035|NCT01078454|83121211|FG000|Overall Study|Adverse Event|1|||
46896036|NCT01078454|83121212|FG001|Overall Study|Adverse Event|1|||
46896037|NCT01078454|83121211|FG000|Overall Study|Death|0|||
46896038|NCT01078454|83121212|FG001|Overall Study|Death|1|||
46896039|NCT03345004|83121229|FG000|Overall Study|Physician Decision|1|||
46896040|NCT03345004|83121230|FG001|Overall Study|Physician Decision|0|||
46896041|NCT03345004|83121229|FG000|Overall Study|Withdrawal by Subject|0|||
46896042|NCT03345004|83121230|FG001|Overall Study|Withdrawal by Subject|1|||
46896043|NCT03552757|83121241|FG000|Overall Study|Withdrawal by Subject|10|||
46896044|NCT03552757|83121242|FG001|Overall Study|Withdrawal by Subject|5|||
46896045|NCT03552757|83121243|FG002|Overall Study|Withdrawal by Subject|12|||
46896046|NCT03552757|83121241|FG000|Overall Study|Lost to Follow-up|2|||
46896047|NCT03552757|83121242|FG001|Overall Study|Lost to Follow-up|7|||
46896048|NCT03552757|83121243|FG002|Overall Study|Lost to Follow-up|7|||
46896049|NCT03552757|83121241|FG000|Overall Study|Death|1|||
46896050|NCT03552757|83121242|FG001|Overall Study|Death|1|||
46896051|NCT03552757|83121243|FG002|Overall Study|Death|1|||
46896052|NCT03730103|83121256|FG000|Overall Study|Did not meet inclusion criteria|0|||
46896053|NCT03730103|83121257|FG001|Overall Study|Did not meet inclusion criteria|5|||
46896054|NCT03727841|83121265|FG000|Overall Study|Physician Decision|3|||
46896055|NCT03727841|83121266|FG001|Overall Study|Physician Decision|1|||
46896056|NCT03552523|83121272|FG000|Overall Study|Withdrawal by Subject|1|||
46896057|NCT03552523|83121273|FG001|Overall Study|Withdrawal by Subject|1|||
46896058|NCT03345550|83121281|FG000|Overall Study|Withdrawal by Subject|1|||
46896059|NCT03345550|83121282|FG001|Overall Study|Withdrawal by Subject|0|||
46896060|NCT03345550|83121281|FG000|Overall Study|Lost to Follow-up|4|||
46896061|NCT03345550|83121282|FG001|Overall Study|Lost to Follow-up|5|||
46896062|NCT03186378|83121290|FG000|Overall Study|Lost to Follow-up|1|||
46896063|NCT03186378|83121291|FG001|Overall Study|Lost to Follow-up|0|||
46896064|NCT00687596|83121299|FG000|Overall Study|Adverse Event (AE)|10|||
46896065|NCT00687596|83121300|FG001|Overall Study|Adverse Event (AE)|3|||
46896066|NCT00687596|83121299|FG000|Overall Study|Radiological Disease Progression|6|||
46896067|NCT00687596|83121300|FG001|Overall Study|Radiological Disease Progression|2|||
46896068|NCT00687596|83121299|FG000|Overall Study|Clinical Disease Progression|1|||
46896069|NCT00687596|83121300|FG001|Overall Study|Clinical Disease Progression|3|||
46896070|NCT00687596|83121299|FG000|Overall Study|Investigator Discretion|3|||
46896071|NCT00687596|83121300|FG001|Overall Study|Investigator Discretion|1|||
46896072|NCT00687596|83121299|FG000|Overall Study|Sponsor Terminated Study|6|||
46896073|NCT00687596|83121300|FG001|Overall Study|Sponsor Terminated Study|17|||
46896074|NCT02892409|83121308|FG000|Overall Study|Adverse Event|1|||
46896075|NCT02892409|83121309|FG001|Overall Study|Adverse Event|0|||
46896076|NCT02892409|83121308|FG000|Overall Study|Withdrawal by Subject|2|||
46896077|NCT02892409|83121309|FG001|Overall Study|Withdrawal by Subject|1|||
46896078|NCT03219216|83121317|FG000|Overall Study|Lost to Follow-up|0|||
46896079|NCT03219216|83121318|FG001|Overall Study|Lost to Follow-up|1|||
46896080|NCT03195660|83121332|FG000|Overall Study|The study was terminated|2|||
46896081|NCT03194490|83121338|FG000|Overall Study|Lost to Follow-up|1|||
46896082|NCT03194490|83121339|FG001|Overall Study|Lost to Follow-up|3|||
46896083|NCT03194490|83121338|FG000|Overall Study|participant developed specific neck pain|1|||
46896084|NCT03194490|83121339|FG001|Overall Study|participant developed specific neck pain|0|||
46896085|NCT03217968|83121346|FG000|Overall Study|Withdrawal by Subject|4|||
46896086|NCT03217968|83121346|FG000|Overall Study|Lost to Follow-up|1|||
46896087|NCT03217968|83121346|FG000|Overall Study|Protocol Violation|6|||
46896088|NCT03192306|83121352|FG000|Overall Study|Did not treat cold sore during study|149|||
46896089|NCT03192306|83121353|FG001|Overall Study|Did not treat cold sore during study|143|||
46896090|NCT03192306|83121352|FG000|Overall Study|Withdrawal by Subject|1|||
46896091|NCT03192306|83121353|FG001|Overall Study|Withdrawal by Subject|1|||
46896092|NCT03192306|83121352|FG000|Overall Study|Lost to Follow-up|1|||
46896093|NCT03192306|83121353|FG001|Overall Study|Lost to Follow-up|0|||
46896094|NCT03192306|83121352|FG000|Overall Study|Protocol Violation|1|||
46896095|NCT03192306|83121353|FG001|Overall Study|Protocol Violation|1|||
46896096|NCT03216954|83121376|FG000|Overall Study|Adverse Event|0|||
46896097|NCT03216954|83121377|FG001|Overall Study|Adverse Event|0|||
46896098|NCT03216954|83121378|FG002|Overall Study|Adverse Event|1|||
46896099|NCT03216954|83121379|FG003|Overall Study|Adverse Event|0|||
46896100|NCT03216954|83121380|FG004|Overall Study|Adverse Event|1|||
46896101|NCT03216954|83121376|FG000|Overall Study|Withdrawal by Subject|2|||
46896102|NCT03216954|83121377|FG001|Overall Study|Withdrawal by Subject|0|||
46896103|NCT03216954|83121378|FG002|Overall Study|Withdrawal by Subject|0|||
46896104|NCT03216954|83121379|FG003|Overall Study|Withdrawal by Subject|0|||
46896105|NCT03216954|83121380|FG004|Overall Study|Withdrawal by Subject|0|||
46896106|NCT03216954|83121376|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
46896107|NCT03216954|83121377|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
46896108|NCT03216954|83121378|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
46896109|NCT03216954|83121379|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
46896110|NCT03216954|83121380|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
46896111|NCT03599089|83121392|FG000|Overall Study|Lost to Follow-up|1|||
46896112|NCT03599089|83121393|FG001|Overall Study|Lost to Follow-up|0|||
46896113|NCT03599089|83121394|FG002|Overall Study|Lost to Follow-up|0|||
46896114|NCT03599089|83121395|FG003|Overall Study|Lost to Follow-up|0|||
46896115|NCT03599089|83121392|FG000|Overall Study|Withdrawal by Subject|2|||
46896116|NCT03599089|83121393|FG001|Overall Study|Withdrawal by Subject|1|||
46896117|NCT03599089|83121394|FG002|Overall Study|Withdrawal by Subject|0|||
46896118|NCT03599089|83121395|FG003|Overall Study|Withdrawal by Subject|0|||
46896119|NCT03599089|83121392|FG000|Overall Study|Lack of Efficacy|0|||
46896120|NCT03599089|83121393|FG001|Overall Study|Lack of Efficacy|0|||
46896121|NCT03599089|83121394|FG002|Overall Study|Lack of Efficacy|1|||
46896122|NCT03599089|83121395|FG003|Overall Study|Lack of Efficacy|2|||
46896123|NCT03192150|83121407|FG000|Overall Study|Adverse Event|14|||
46896124|NCT03192150|83121408|FG001|Overall Study|Adverse Event|12|||
46896125|NCT03192150|83121407|FG000|Overall Study|Lack of Efficacy|23|||
46896126|NCT03192150|83121408|FG001|Overall Study|Lack of Efficacy|30|||
46896127|NCT03192150|83121407|FG000|Overall Study|Lost to Follow-up|1|||
46896128|NCT03192150|83121408|FG001|Overall Study|Lost to Follow-up|1|||
46896129|NCT03192150|83121407|FG000|Overall Study|Withdrawal by Subject|4|||
46896130|NCT03192150|83121408|FG001|Overall Study|Withdrawal by Subject|2|||
46896131|NCT03192150|83121407|FG000|Overall Study|Protocol Violation|5|||
46896132|NCT03192150|83121408|FG001|Overall Study|Protocol Violation|2|||
46896133|NCT03192150|83121407|FG000|Overall Study|Surgery Canceled|6|||
46896134|NCT03192150|83121408|FG001|Overall Study|Surgery Canceled|2|||
46896135|NCT03192150|83121407|FG000|Overall Study|Other-Various Administrative Reasons|2|||
46896136|NCT03192150|83121408|FG001|Overall Study|Other-Various Administrative Reasons|5|||
46896137|NCT03597529|83121416|FG000|Overall Study|Lost to Follow-up|10|||
46896138|NCT03597529|83121417|FG001|Overall Study|Lost to Follow-up|12|||
46896139|NCT03597529|83121416|FG000|Overall Study|Physician Decision|3|||
46896140|NCT03597529|83121417|FG001|Overall Study|Physician Decision|1|||
46896141|NCT03597529|83121416|FG000|Overall Study|Withdrawal by Subject|6|||
46896142|NCT03597529|83121417|FG001|Overall Study|Withdrawal by Subject|3|||
46896143|NCT03597529|83121416|FG000|Overall Study|Non-compliant with study activities|1|||
46896144|NCT03597529|83121417|FG001|Overall Study|Non-compliant with study activities|2|||
46896145|NCT03180528|83121423|FG000|Overall Study|Adverse Event|1|||
46896146|NCT03180528|83121423|FG000|Overall Study|Withdrawal by Subject|1|||
46896147|NCT03180528|83121423|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
46896148|NCT03597295|83121427|FG000|Overall Study|Death|70|||
46896149|NCT03597295|83121427|FG000|Overall Study|Lost to Follow-up|7|||
46896150|NCT03180138|83121434|FG000|Overall Study|Mobile-phone could not be verified|2|||
46896151|NCT03180138|83121435|FG001|Overall Study|Mobile-phone could not be verified|13|||
46896152|NCT03180138|83121436|FG002|Overall Study|Mobile-phone could not be verified|15|||
46896153|NCT03180138|83121434|FG000|Overall Study|No prior immunization records|17|||
46896154|NCT03180138|83121435|FG001|Overall Study|No prior immunization records|0|||
46896155|NCT03180138|83121436|FG002|Overall Study|No prior immunization records|6|||
46896156|NCT03180138|83121434|FG000|Overall Study|Found to be >24 mon after randomization|3|||
46896157|NCT03180138|83121435|FG001|Overall Study|Found to be >24 mon after randomization|0|||
46896158|NCT03180138|83121436|FG002|Overall Study|Found to be >24 mon after randomization|3|||
46896159|NCT03597139|83121446|FG000|Overall Study|Adverse Event|3|||
46896160|NCT03597139|83121447|FG001|Overall Study|Adverse Event|0|||
46896161|NCT03597139|83121446|FG000|Overall Study|Protocol Non-compliance|1|||
46896162|NCT03597139|83121447|FG001|Overall Study|Protocol Non-compliance|0|||
46896163|NCT03179202|83121453|FG000|Overall Study|Screen Failure|67|||
46896164|NCT03179202|83121453|FG000|Overall Study|Subject Lost to Follow Up|12|||
46896165|NCT03179202|83121453|FG000|Overall Study|Withdrawal by Subject|7|||
46896166|NCT03179202|83121453|FG000|Overall Study|Adverse Event|3|||
46896167|NCT03179202|83121453|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
46896168|NCT03179202|83121453|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
46896169|NCT00708214|83121462|FG000|Overall Study|Other Adverse Event|3|||
46896170|NCT00708214|83121463|FG001|Overall Study|Other Adverse Event|6|||
46896171|NCT00708214|83121464|FG002|Overall Study|Other Adverse Event|2|||
46896172|NCT00708214|83121462|FG000|Overall Study|Other|0|||
46896173|NCT00708214|83121463|FG001|Overall Study|Other|1|||
46896174|NCT00708214|83121464|FG002|Overall Study|Other|1|||
46896175|NCT00708214|83121462|FG000|Overall Study|Progressive Disease|4|||
46896176|NCT00708214|83121463|FG001|Overall Study|Progressive Disease|6|||
46896177|NCT00708214|83121464|FG002|Overall Study|Progressive Disease|5|||
46896178|NCT03570697|83121479|FG000|Overall Study|Lost to Follow-up|0|||
46896179|NCT03570697|83121480|FG001|Overall Study|Lost to Follow-up|1|||
46896180|NCT03570697|83121479|FG000|Overall Study|Death|2|||
46896181|NCT03570697|83121480|FG001|Overall Study|Death|0|||
46896182|NCT03570697|83121479|FG000|Overall Study|Withdrawal by Subject|4|||
46896183|NCT03570697|83121480|FG001|Overall Study|Withdrawal by Subject|2|||
46896184|NCT03569371|83121497|FG000|Overall Study|Lack of Efficacy|1|||
46896185|NCT03569371|83121497|FG000|Overall Study|Lost to Follow-up|1|||
46896186|NCT03569371|83121497|FG000|Overall Study|Adverse Event|1|||
46896187|NCT01318070|83121504|FG000|Overall Study|Adverse Event|1|||
46896188|NCT01318070|83121505|FG001|Overall Study|Adverse Event|1|||
46896189|NCT01318070|83121506|FG002|Overall Study|Adverse Event|5|||
46896190|NCT01318070|83121504|FG000|Overall Study|Withdrawal by Subject|0|||
46896191|NCT01318070|83121505|FG001|Overall Study|Withdrawal by Subject|1|||
46896192|NCT01318070|83121506|FG002|Overall Study|Withdrawal by Subject|1|||
46896193|NCT01318070|83121504|FG000|Overall Study|Lack of Efficacy|0|||
46896194|NCT01318070|83121505|FG001|Overall Study|Lack of Efficacy|0|||
46896195|NCT01318070|83121506|FG002|Overall Study|Lack of Efficacy|1|||
46896196|NCT01318070|83121504|FG000|Overall Study|Principal Investigator Discretion|1|||
46896197|NCT01318070|83121505|FG001|Overall Study|Principal Investigator Discretion|0|||
46896198|NCT01318070|83121506|FG002|Overall Study|Principal Investigator Discretion|0|||
46896199|NCT02895295|83121517|FG000|Overall Study|Survey Non-response|71|||
46896200|NCT02895295|83121518|FG001|Overall Study|Survey Non-response|94|||
46896201|NCT02895295|83121519|FG002|Overall Study|Survey Non-response|92|||
46896202|NCT00245960|83121529|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
46896203|NCT00245960|83121530|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
46896204|NCT00245960|83121529|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
46896205|NCT00245960|83121530|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
46896206|NCT00245960|83121529|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
46896207|NCT00245960|83121530|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
46896208|NCT00245960|83121529|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
46896209|NCT00245960|83121530|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
46896210|NCT00245960|83121529|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
46896211|NCT00245960|83121530|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
46896212|NCT00245960|83121529|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
46896213|NCT00245960|83121530|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
46896214|NCT00245960|83121529|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
46896215|NCT00245960|83121530|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
46896216|NCT00245960|83121529|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
46896217|NCT00245960|83121530|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
46896218|NCT00245960|83121529|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
46896219|NCT00245960|83121530|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
46896220|NCT00245960|83121529|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
46896221|NCT00245960|83121530|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
46896222|NCT00245960|83121529|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
46896223|NCT00245960|83121530|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
46896224|NCT00245960|83121529|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
46896225|NCT00245960|83121530|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
46896226|NCT02729194|83121536|FG000|Overall Study|Withdrawal by Subject|3|||
46896227|NCT03178266|83121542|FG000|Overall Study|Death|0|||
46896228|NCT03178266|83121543|FG001|Overall Study|Death|1|||
46896229|NCT03178266|83121542|FG000|Overall Study|Disont. Early|0|||
46896230|NCT03178266|83121543|FG001|Overall Study|Disont. Early|1|||
46896231|NCT03178266|83121542|FG000|Overall Study|Withdrawal by Subject|0|||
46896232|NCT03178266|83121543|FG001|Overall Study|Withdrawal by Subject|2|||
46896233|NCT03548935|83121551|FG000|Overall Study|Withdrawal by Subject|26|||
46896234|NCT03548935|83121552|FG001|Overall Study|Withdrawal by Subject|17|||
46896235|NCT03548935|83121551|FG000|Overall Study|Lost to Follow-up|39|||
46896236|NCT03548935|83121552|FG001|Overall Study|Lost to Follow-up|28|||
46896237|NCT03548935|83121551|FG000|Overall Study|Death|1|||
46896238|NCT03548935|83121552|FG001|Overall Study|Death|1|||
46896239|NCT03547687|83121558|FG000|Overall Study|Withdrawal by Subject|1|||
46896240|NCT03547687|83121558|FG000|Overall Study|Death|1|||
46896241|NCT03547531|83121564|FG000|Overall Study|not coming in data collection : sick|2|||
46896242|NCT03547531|83121565|FG001|Overall Study|not coming in data collection : sick|2|||
46896243|NCT03547531|83121564|FG000|Overall Study|having family occasion|0|||
46896244|NCT03547531|83121565|FG001|Overall Study|having family occasion|2|||
46896245|NCT03566485|83121573|FG000|Overall Study|Disease progression|5|||
46896246|NCT03566485|83121574|FG001|Overall Study|Disease progression|4|||
46896247|NCT03566485|83121573|FG000|Overall Study|Clinical progression|0|||
46896248|NCT03566485|83121574|FG001|Overall Study|Clinical progression|1|||
46896249|NCT03566485|83121573|FG000|Overall Study|Toxicity|0|||
46896250|NCT03566485|83121574|FG001|Overall Study|Toxicity|2|||
46896251|NCT03176238|83121582|FG000|Overall Study|Unacceptable AEs|15|||
46896252|NCT03176238|83121583|FG001|Overall Study|Unacceptable AEs|8|||
46896253|NCT03176238|83121582|FG000|Overall Study|Abnormal lab value(s)|2|||
46896254|NCT03176238|83121583|FG001|Overall Study|Abnormal lab value(s)|0|||
46896255|NCT03176238|83121582|FG000|Overall Study|Inter-current illness|0|||
46896256|NCT03176238|83121583|FG001|Overall Study|Inter-current illness|1|||
46896257|NCT03176238|83121582|FG000|Overall Study|Consent withdrawal|14|||
46896258|NCT03176238|83121583|FG001|Overall Study|Consent withdrawal|2|||
46896259|NCT03176238|83121582|FG000|Overall Study|Lost to Follow-up|3|||
46896260|NCT03176238|83121583|FG001|Overall Study|Lost to Follow-up|0|||
46896261|NCT03176238|83121582|FG000|Overall Study|Administrative problems|1|||
46896262|NCT03176238|83121583|FG001|Overall Study|Administrative problems|0|||
46896263|NCT03176238|83121582|FG000|Overall Study|Death|3|||
46896264|NCT03176238|83121583|FG001|Overall Study|Death|0|||
46896265|NCT03176238|83121582|FG000|Overall Study|Disease Progression|133|||
46896266|NCT03176238|83121583|FG001|Overall Study|Disease Progression|22|||
46896267|NCT03176238|83121582|FG000|Overall Study|Tx duration completed per EAP|0|||
46896268|NCT03176238|83121583|FG001|Overall Study|Tx duration completed per EAP|1|||
46896269|NCT03176238|83121582|FG000|Overall Study|Patient is switched to commercial drug|16|||
46896270|NCT03176238|83121583|FG001|Overall Study|Patient is switched to commercial drug|1|||
46896271|NCT03176238|83121582|FG000|Overall Study|Protocol Violation|1|||
46896272|NCT03176238|83121583|FG001|Overall Study|Protocol Violation|0|||
46896273|NCT03176238|83121582|FG000|Overall Study|Changes in the patient's condition|2|||
46896274|NCT03176238|83121583|FG001|Overall Study|Changes in the patient's condition|1|||
46896275|NCT03176238|83121582|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
46896276|NCT03176238|83121583|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
46896277|NCT03565315|83121597|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
46896278|NCT03565315|83121598|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
46896279|NCT03565315|83121599|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
46896280|NCT03565315|83121600|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
46896281|NCT03565237|83121623|FG000|Overall Study|Non-compliance of Investigational Product|1|||
46896282|NCT03565237|83121623|FG000|Overall Study|Physician Decision|1|||
46896283|NCT01345682|83121629|FG000|Overall Study|Progressive disease per RECIST|226|||
46896284|NCT01345682|83121630|FG001|Overall Study|Progressive disease per RECIST|93|||
46896285|NCT01345682|83121629|FG000|Overall Study|Worsening of underlying cancer disease|23|||
46896286|NCT01345682|83121630|FG001|Overall Study|Worsening of underlying cancer disease|12|||
46896287|NCT01345682|83121629|FG000|Overall Study|Adverse Event|51|||
46896288|NCT01345682|83121630|FG001|Overall Study|Adverse Event|41|||
46896289|NCT01345682|83121629|FG000|Overall Study|Non-compliance with protocol|0|||
46896290|NCT01345682|83121630|FG001|Overall Study|Non-compliance with protocol|1|||
46896291|NCT01345682|83121629|FG000|Overall Study|Lost to Follow-up|0|||
46896292|NCT01345682|83121630|FG001|Overall Study|Lost to Follow-up|1|||
46896293|NCT01345682|83121629|FG000|Overall Study|Refused to continue trial medication|16|||
46896294|NCT01345682|83121630|FG001|Overall Study|Refused to continue trial medication|9|||
46896295|NCT01345682|83121629|FG000|Overall Study|Not treated|2|||
46896296|NCT01345682|83121630|FG001|Overall Study|Not treated|1|||
46896297|NCT01345682|83121629|FG000|Overall Study|Reason other than those specified above|4|||
46896298|NCT01345682|83121630|FG001|Overall Study|Reason other than those specified above|3|||
46896299|NCT03562117|83121639|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
46896300|NCT03562117|83121640|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
46896301|NCT03562117|83121641|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
46896302|NCT03561883|83121651|FG000|Overall Study|Adverse Event|10|||
46896303|NCT03561883|83121652|FG001|Overall Study|Adverse Event|13|||
46896304|NCT03561883|83121651|FG000|Overall Study|Non-Compliance With Study Drug|1|||
46896305|NCT03561883|83121652|FG001|Overall Study|Non-Compliance With Study Drug|2|||
46896306|NCT03561883|83121651|FG000|Overall Study|Protocol Violation|2|||
46896307|NCT03561883|83121652|FG001|Overall Study|Protocol Violation|3|||
46896308|NCT03561883|83121651|FG000|Overall Study|Withdrawal by Subject|14|||
46896309|NCT03561883|83121652|FG001|Overall Study|Withdrawal by Subject|6|||
46896310|NCT03561883|83121651|FG000|Overall Study|Lost to Follow-up|2|||
46896311|NCT03561883|83121652|FG001|Overall Study|Lost to Follow-up|6|||
46896312|NCT03561883|83121651|FG000|Overall Study|Study Terminated by Sponsor|12|||
46896313|NCT03561883|83121652|FG001|Overall Study|Study Terminated by Sponsor|11|||
46896314|NCT03561883|83121651|FG000|Overall Study|Physician Decision|1|||
46896315|NCT03561883|83121652|FG001|Overall Study|Physician Decision|0|||
46896316|NCT03561883|83121651|FG000|Overall Study|Randomized by Mistake|1|||
46896317|NCT03561883|83121652|FG001|Overall Study|Randomized by Mistake|0|||
46896318|NCT03561883|83121651|FG000|Overall Study|Other, Not Specified|3|||
46896319|NCT03561883|83121652|FG001|Overall Study|Other, Not Specified|2|||
46896320|NCT03546907|83121660|FG000|Overall Study|Lack of Efficacy|1|||
46896321|NCT03546907|83121661|FG001|Overall Study|Lack of Efficacy|1|||
46896322|NCT03546907|83121660|FG000|Overall Study|Withdrawal by Subject|8|||
46896323|NCT03546907|83121661|FG001|Overall Study|Withdrawal by Subject|9|||
46896324|NCT03546907|83121660|FG000|Overall Study|Adverse events (AEs)|7|||
46896325|NCT03546907|83121661|FG001|Overall Study|Adverse events (AEs)|10|||
46896326|NCT03546907|83121660|FG000|Overall Study|Other-unspecified|1|||
46896327|NCT03546907|83121661|FG001|Overall Study|Other-unspecified|1|||
46896328|NCT01318382|83121667|FG000|Overall Study|Physician Decision|2|||
46896329|NCT01318382|83121667|FG000|Overall Study|Device Malfunction|10|||
46896330|NCT01318382|83121667|FG000|Overall Study|Protocol Violation|1|||
46896331|NCT03053180|83121685|FG000|Overall Study|Failure to Return|1|||
46896332|NCT03560869|83121689|FG000|Overall Study|Withdrawal by Subject|3|||
46896333|NCT03560869|83121690|FG001|Overall Study|Withdrawal by Subject|4|||
46896334|NCT03560869|83121689|FG000|Overall Study|Screening failure|4|||
46896335|NCT03560869|83121690|FG001|Overall Study|Screening failure|4|||
46896336|NCT03560869|83121689|FG000|Overall Study|Withdrawal by PI|0|||
46896337|NCT03560869|83121690|FG001|Overall Study|Withdrawal by PI|1|||
46896338|NCT03590743|83121698|FG000|Overall Study|Withdrawal by Subject|0|||
46896339|NCT03590743|83121699|FG001|Overall Study|Withdrawal by Subject|1|||
46896340|NCT03053102|83121705|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
46896341|NCT03053102|83121705|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
46896342|NCT03589885|83121713|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
46896343|NCT03589885|83121714|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
46896344|NCT03589885|83121715|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
46896345|NCT03589885|83121716|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
46896346|NCT03589885|83121717|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
46896347|NCT03589885|83121713|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
46896348|NCT03589885|83121714|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
46896349|NCT03589885|83121715|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
46896350|NCT03589885|83121716|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
46896351|NCT03589885|83121717|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
46896352|NCT03589885|83121713|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
46896353|NCT03589885|83121714|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
46896354|NCT03589885|83121715|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
46896355|NCT03589885|83121716|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
46896356|NCT03589885|83121717|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
46896357|NCT03589885|83121713|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
46896358|NCT03589885|83121714|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
46896359|NCT03589885|83121715|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
46896360|NCT03589885|83121716|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
46896361|NCT03589885|83121717|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
46896362|NCT03589885|83121713|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
46896363|NCT03589885|83121714|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
46896364|NCT03589885|83121715|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
46896365|NCT03589885|83121716|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
46896366|NCT03589885|83121717|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
46896367|NCT03589885|83121713|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
46896368|NCT03589885|83121714|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
46896369|NCT03589885|83121715|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
46896370|NCT03589885|83121716|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
46896371|NCT03589885|83121717|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
46896372|NCT03589885|83121713|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
46896373|NCT03589885|83121714|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
46896374|NCT03589885|83121715|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
46896375|NCT03589885|83121716|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
46896376|NCT03589885|83121717|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
46896377|NCT03589885|83121713|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
46896378|NCT03589885|83121714|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
46896379|NCT03589885|83121715|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
46612819|NCT02470806|82723754|FG001|Overall Study|Physician Decision|3|||
46896380|NCT03589885|83121716|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
46896381|NCT03589885|83121717|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
46896382|NCT03545503|83121737|FG000|Overall Study|Protocol Violation|14|||
46896383|NCT03545503|83121738|FG001|Overall Study|Protocol Violation|16|||
46896384|NCT03545113|83121746|FG000|Overall Study|Surgery Cancelled|1|||
46896385|NCT03545113|83121747|FG001|Overall Study|Surgery Cancelled|0|||
46896386|NCT03545113|83121746|FG000|Overall Study|Death|1|||
46896387|NCT03545113|83121747|FG001|Overall Study|Death|0|||
46896388|NCT03545113|83121746|FG000|Overall Study|Adverse Event|2|||
46896389|NCT03545113|83121747|FG001|Overall Study|Adverse Event|0|||
46896390|NCT03545113|83121746|FG000|Overall Study|Received different surgery|1|||
46896391|NCT03545113|83121747|FG001|Overall Study|Received different surgery|0|||
46896392|NCT03214380|83121759|FG000|Lead-in|Adverse Event|3|||
46896393|NCT03214380|83121760|FG001|Lead-in|Adverse Event|0|||
46896394|NCT03214380|83121761|FG002|Lead-in|Adverse Event|0|||
46896395|NCT03214380|83121762|FG003|Lead-in|Adverse Event|1|||
46896396|NCT03214380|83121763|FG004|Lead-in|Adverse Event|0|||
46896397|NCT03214380|83121764|FG005|Lead-in|Adverse Event|0|||
46896398|NCT03214380|83121759|FG000|Lead-in|Lost to Follow-up|4|||
46896399|NCT03214380|83121760|FG001|Lead-in|Lost to Follow-up|0|||
46896400|NCT03214380|83121761|FG002|Lead-in|Lost to Follow-up|0|||
46896401|NCT03214380|83121762|FG003|Lead-in|Lost to Follow-up|1|||
46896402|NCT03214380|83121763|FG004|Lead-in|Lost to Follow-up|0|||
46896403|NCT03214380|83121764|FG005|Lead-in|Lost to Follow-up|0|||
46896404|NCT03214380|83121759|FG000|Lead-in|Eligibility Criteria|3|||
46896405|NCT03214380|83121760|FG001|Lead-in|Eligibility Criteria|0|||
46896406|NCT03214380|83121761|FG002|Lead-in|Eligibility Criteria|0|||
46896407|NCT03214380|83121762|FG003|Lead-in|Eligibility Criteria|0|||
46896408|NCT03214380|83121763|FG004|Lead-in|Eligibility Criteria|0|||
46896409|NCT03214380|83121764|FG005|Lead-in|Eligibility Criteria|0|||
46896410|NCT03214380|83121759|FG000|Lead-in|Physician Decision|6|||
46896411|NCT03214380|83121760|FG001|Lead-in|Physician Decision|0|||
46896412|NCT03214380|83121761|FG002|Lead-in|Physician Decision|0|||
46896413|NCT03214380|83121762|FG003|Lead-in|Physician Decision|0|||
46896414|NCT03214380|83121763|FG004|Lead-in|Physician Decision|0|||
46896415|NCT03214380|83121764|FG005|Lead-in|Physician Decision|0|||
46896416|NCT03214380|83121759|FG000|Lead-in|Protocol Deviation|7|||
46896417|NCT03214380|83121760|FG001|Lead-in|Protocol Deviation|0|||
46896418|NCT03214380|83121761|FG002|Lead-in|Protocol Deviation|0|||
46896419|NCT03214380|83121762|FG003|Lead-in|Protocol Deviation|3|||
46896420|NCT03214380|83121763|FG004|Lead-in|Protocol Deviation|0|||
46896421|NCT03214380|83121764|FG005|Lead-in|Protocol Deviation|0|||
46896422|NCT03214380|83121759|FG000|Lead-in|Withdrawal by Subject|41|||
46896423|NCT03214380|83121760|FG001|Lead-in|Withdrawal by Subject|0|||
46896424|NCT03214380|83121761|FG002|Lead-in|Withdrawal by Subject|0|||
46896425|NCT03214380|83121762|FG003|Lead-in|Withdrawal by Subject|14|||
46896426|NCT03214380|83121763|FG004|Lead-in|Withdrawal by Subject|0|||
46896427|NCT03214380|83121764|FG005|Lead-in|Withdrawal by Subject|0|||
46896428|NCT03214380|83121759|FG000|Lead-in|Family Emergency|1|||
46896429|NCT03214380|83121760|FG001|Lead-in|Family Emergency|0|||
46896430|NCT03214380|83121761|FG002|Lead-in|Family Emergency|0|||
46896431|NCT03214380|83121762|FG003|Lead-in|Family Emergency|0|||
46896432|NCT03214380|83121763|FG004|Lead-in|Family Emergency|0|||
46896433|NCT03214380|83121764|FG005|Lead-in|Family Emergency|0|||
46896434|NCT03214380|83121759|FG000|Lead-in|Natural Disaster|9|||
46896435|NCT03214380|83121760|FG001|Lead-in|Natural Disaster|0|||
46896436|NCT03214380|83121761|FG002|Lead-in|Natural Disaster|0|||
46896437|NCT03214380|83121762|FG003|Lead-in|Natural Disaster|0|||
46896438|NCT03214380|83121763|FG004|Lead-in|Natural Disaster|0|||
46896439|NCT03214380|83121764|FG005|Lead-in|Natural Disaster|0|||
46896440|NCT03214380|83121759|FG000|Lead-in|Non Compliance|1|||
46896441|NCT03214380|83121760|FG001|Lead-in|Non Compliance|0|||
46896442|NCT03214380|83121761|FG002|Lead-in|Non Compliance|0|||
46896443|NCT03214380|83121762|FG003|Lead-in|Non Compliance|0|||
46896444|NCT03214380|83121763|FG004|Lead-in|Non Compliance|0|||
46896445|NCT03214380|83121764|FG005|Lead-in|Non Compliance|0|||
46896446|NCT03214380|83121759|FG000|Lead-in|Participant Schedule|2|||
46896447|NCT03214380|83121760|FG001|Lead-in|Participant Schedule|0|||
46896448|NCT03214380|83121761|FG002|Lead-in|Participant Schedule|0|||
46896449|NCT03214380|83121762|FG003|Lead-in|Participant Schedule|0|||
46896450|NCT03214380|83121763|FG004|Lead-in|Participant Schedule|0|||
46896451|NCT03214380|83121764|FG005|Lead-in|Participant Schedule|0|||
46896452|NCT03214380|83121759|FG000|Treatment Period|Adverse Event|0|||
46896453|NCT03214380|83121760|FG001|Treatment Period|Adverse Event|1|||
46896454|NCT03214380|83121761|FG002|Treatment Period|Adverse Event|1|||
46896455|NCT03214380|83121762|FG003|Treatment Period|Adverse Event|0|||
46896456|NCT03214380|83121763|FG004|Treatment Period|Adverse Event|1|||
46896457|NCT03214380|83121764|FG005|Treatment Period|Adverse Event|0|||
46896458|NCT03214380|83121759|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
46896459|NCT03214380|83121760|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
46896460|NCT03214380|83121761|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
46896461|NCT03214380|83121762|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
46896462|NCT03214380|83121763|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
46896463|NCT03214380|83121764|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
46896464|NCT03214380|83121759|FG000|Treatment Period|Withdrawal by Subject|0|||
46896465|NCT03214380|83121760|FG001|Treatment Period|Withdrawal by Subject|10|||
46896466|NCT03214380|83121761|FG002|Treatment Period|Withdrawal by Subject|8|||
46896467|NCT03214380|83121762|FG003|Treatment Period|Withdrawal by Subject|0|||
46896468|NCT03214380|83121763|FG004|Treatment Period|Withdrawal by Subject|7|||
46896469|NCT03214380|83121764|FG005|Treatment Period|Withdrawal by Subject|11|||
46896470|NCT03214380|83121759|FG000|Treatment Period|Death|0|||
46896471|NCT03214380|83121760|FG001|Treatment Period|Death|1|||
46896472|NCT03214380|83121761|FG002|Treatment Period|Death|2|||
46896473|NCT03214380|83121762|FG003|Treatment Period|Death|0|||
46896474|NCT03214380|83121763|FG004|Treatment Period|Death|0|||
46896475|NCT03214380|83121764|FG005|Treatment Period|Death|0|||
46896476|NCT03214380|83121759|FG000|Treatment Period|Lost to Follow-up|0|||
46896477|NCT03214380|83121760|FG001|Treatment Period|Lost to Follow-up|6|||
46896478|NCT03214380|83121761|FG002|Treatment Period|Lost to Follow-up|3|||
46896479|NCT03214380|83121762|FG003|Treatment Period|Lost to Follow-up|0|||
46896480|NCT03214380|83121763|FG004|Treatment Period|Lost to Follow-up|0|||
46896481|NCT03214380|83121764|FG005|Treatment Period|Lost to Follow-up|0|||
46896482|NCT03214380|83121759|FG000|Treatment Period|Participant schedule|0|||
46896483|NCT03214380|83121760|FG001|Treatment Period|Participant schedule|0|||
46896484|NCT03214380|83121761|FG002|Treatment Period|Participant schedule|1|||
46896485|NCT03214380|83121762|FG003|Treatment Period|Participant schedule|0|||
46896486|NCT03214380|83121763|FG004|Treatment Period|Participant schedule|0|||
46896487|NCT03214380|83121764|FG005|Treatment Period|Participant schedule|0|||
46896488|NCT03214380|83121759|FG000|Treatment Period|Treatment Interruption|0|||
46896489|NCT03214380|83121760|FG001|Treatment Period|Treatment Interruption|0|||
46896490|NCT03214380|83121761|FG002|Treatment Period|Treatment Interruption|1|||
46896491|NCT03214380|83121762|FG003|Treatment Period|Treatment Interruption|0|||
46896492|NCT03214380|83121763|FG004|Treatment Period|Treatment Interruption|0|||
46896493|NCT03214380|83121764|FG005|Treatment Period|Treatment Interruption|0|||
46897067|NCT03471871|83122646|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
46897068|NCT03471871|83122647|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
46897069|NCT03471871|83122648|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
46897070|NCT03471871|83122649|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
46897071|NCT03471871|83122650|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
46897072|NCT03471871|83122646|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
46897073|NCT03471871|83122647|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
46897074|NCT03471871|83122648|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
46897075|NCT03471871|83122649|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
46897076|NCT03471871|83122650|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
46897077|NCT03471871|83122646|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
46897078|NCT03471871|83122647|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
46897079|NCT03471871|83122648|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
46897080|NCT03471871|83122649|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
46897081|NCT03471871|83122650|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
46897082|NCT03471871|83122646|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
46897083|NCT03471871|83122647|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
46897084|NCT03471871|83122648|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
46897085|NCT03471871|83122649|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
46897086|NCT03471871|83122650|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
46897087|NCT03471871|83122646|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
46897088|NCT03471871|83122647|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
46897089|NCT03471871|83122648|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
46897090|NCT03471871|83122649|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
46897091|NCT03471871|83122650|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
46897092|NCT01957176|83122668|FG000|Overall Study|Adverse Event|2|||
46897093|NCT01957176|83122669|FG001|Overall Study|Adverse Event|0|||
46897094|NCT01957176|83122668|FG000|Overall Study|Physician Decision|2|||
46897095|NCT01957176|83122669|FG001|Overall Study|Physician Decision|1|||
46897096|NCT01957176|83122668|FG000|Overall Study|Withdrawal by Subject|1|||
46897097|NCT01957176|83122669|FG001|Overall Study|Withdrawal by Subject|0|||
46897098|NCT03527173|83122678|FG000|Overall Study|Lost to Follow-up|4|||
46897099|NCT03527173|83122679|FG001|Overall Study|Lost to Follow-up|2|||
46897100|NCT03527173|83122678|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
46897101|NCT03527173|83122679|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
46897102|NCT03527173|83122678|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
46897103|NCT03527173|83122679|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
46897104|NCT03527173|83122678|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
46896494|NCT02674464|83121778|FG000|Overall Study|Death|10|||
46896495|NCT02674464|83121779|FG001|Overall Study|Death|21|||
46896496|NCT02674464|83121778|FG000|Overall Study|Withdrawal by Subject|24|||
46896497|NCT02674464|83121779|FG001|Overall Study|Withdrawal by Subject|44|||
46896498|NCT02674464|83121778|FG000|Overall Study|Lost to Follow-up|97|||
46896499|NCT02674464|83121779|FG001|Overall Study|Lost to Follow-up|92|||
46896500|NCT02674464|83121778|FG000|Overall Study|Outside survey window|6|||
46896501|NCT02674464|83121779|FG001|Overall Study|Outside survey window|3|||
46896502|NCT03172026|83121787|FG000|Overall Study|Withdrawal by Subject|1|||
46896503|NCT03172026|83121788|FG001|Overall Study|Withdrawal by Subject|0|||
46896504|NCT03172026|83121787|FG000|Overall Study|COVID restrictions|1|||
46896505|NCT03172026|83121788|FG001|Overall Study|COVID restrictions|0|||
46896506|NCT01343888|83121798|FG000|Overall Study|Adverse Event|12|||
46896507|NCT01343888|83121799|FG001|Overall Study|Adverse Event|22|||
46896508|NCT01343888|83121800|FG002|Overall Study|Adverse Event|5|||
46896509|NCT01343888|83121798|FG000|Overall Study|Lack of Efficacy|9|||
46896510|NCT01343888|83121799|FG001|Overall Study|Lack of Efficacy|9|||
46896511|NCT01343888|83121800|FG002|Overall Study|Lack of Efficacy|13|||
46896512|NCT01343888|83121798|FG000|Overall Study|Lost to Follow-up|0|||
46896513|NCT01343888|83121799|FG001|Overall Study|Lost to Follow-up|2|||
46896514|NCT01343888|83121800|FG002|Overall Study|Lost to Follow-up|1|||
46896515|NCT01343888|83121798|FG000|Overall Study|Protocol Violation|0|||
46896516|NCT01343888|83121799|FG001|Overall Study|Protocol Violation|2|||
46896517|NCT01343888|83121800|FG002|Overall Study|Protocol Violation|0|||
46896518|NCT01343888|83121798|FG000|Overall Study|Withdrawal by Subject|4|||
46896519|NCT01343888|83121799|FG001|Overall Study|Withdrawal by Subject|4|||
46896520|NCT01343888|83121800|FG002|Overall Study|Withdrawal by Subject|2|||
46896521|NCT01343888|83121798|FG000|Overall Study|other than stated above|0|||
46896522|NCT01343888|83121799|FG001|Overall Study|other than stated above|0|||
46896523|NCT01343888|83121800|FG002|Overall Study|other than stated above|1|||
46896524|NCT03589807|83121814|FG000|Overall Study|Lost to Follow-up|0|||
46896525|NCT03589807|83121815|FG001|Overall Study|Lost to Follow-up|2|||
46896526|NCT03589807|83121816|FG002|Overall Study|Lost to Follow-up|2|||
46896527|NCT03589807|83121817|FG003|Overall Study|Lost to Follow-up|3|||
46896528|NCT03589807|83121818|FG004|Overall Study|Lost to Follow-up|1|||
46896529|NCT03589807|83121819|FG005|Overall Study|Lost to Follow-up|1|||
46896530|NCT03589807|83121814|FG000|Overall Study|Withdrawal by Subject|0|||
46896531|NCT03589807|83121815|FG001|Overall Study|Withdrawal by Subject|5|||
46896532|NCT03589807|83121816|FG002|Overall Study|Withdrawal by Subject|0|||
46896533|NCT03589807|83121817|FG003|Overall Study|Withdrawal by Subject|0|||
46896534|NCT03589807|83121818|FG004|Overall Study|Withdrawal by Subject|0|||
46896535|NCT03589807|83121819|FG005|Overall Study|Withdrawal by Subject|0|||
46896536|NCT03589807|83121814|FG000|Overall Study|Protocol Violation|0|||
46896537|NCT03589807|83121815|FG001|Overall Study|Protocol Violation|0|||
46896538|NCT03589807|83121816|FG002|Overall Study|Protocol Violation|0|||
46896539|NCT03589807|83121817|FG003|Overall Study|Protocol Violation|1|||
46896540|NCT03589807|83121818|FG004|Overall Study|Protocol Violation|0|||
46896541|NCT03589807|83121819|FG005|Overall Study|Protocol Violation|0|||
46896542|NCT03589807|83121814|FG000|Overall Study|Enrolled but treatment not administered|0|||
46896543|NCT03589807|83121815|FG001|Overall Study|Enrolled but treatment not administered|0|||
46896544|NCT03589807|83121816|FG002|Overall Study|Enrolled but treatment not administered|0|||
46896545|NCT03589807|83121817|FG003|Overall Study|Enrolled but treatment not administered|0|||
46896546|NCT03589807|83121818|FG004|Overall Study|Enrolled but treatment not administered|1|||
46896547|NCT03589807|83121819|FG005|Overall Study|Enrolled but treatment not administered|0|||
46896548|NCT03544333|83121838|FG000|Overall Study|Withdrawal by Subject|1|||
46896549|NCT03544333|83121839|FG001|Overall Study|Withdrawal by Subject|0|||
46896550|NCT03560245|83121847|FG000|Overall Study|Withdrawal by Subject|3|||
46896551|NCT03560245|83121848|FG001|Overall Study|Withdrawal by Subject|2|||
46896552|NCT03560245|83121847|FG000|Overall Study|Adverse Event|1|||
46896553|NCT03560245|83121848|FG001|Overall Study|Adverse Event|1|||
46896554|NCT03560245|83121847|FG000|Overall Study|Protocol Violation|1|||
46896555|NCT03560245|83121848|FG001|Overall Study|Protocol Violation|0|||
46896556|NCT03560245|83121847|FG000|Overall Study|Death|0|||
46896557|NCT03560245|83121848|FG001|Overall Study|Death|1|||
46896558|NCT03560245|83121847|FG000|Overall Study|Lost to Follow-up|0|||
46896559|NCT03560245|83121848|FG001|Overall Study|Lost to Follow-up|1|||
46896560|NCT03560245|83121847|FG000|Overall Study|Physician Decision|0|||
46896561|NCT03560245|83121848|FG001|Overall Study|Physician Decision|1|||
46896562|NCT03560245|83121847|FG000|Overall Study|Other|0|||
46896563|NCT03560245|83121848|FG001|Overall Study|Other|1|||
46896564|NCT00707434|83121856|FG000|Overall Study|Adverse Event|1|||
46896565|NCT03054428|83121863|FG000|Overall Study|Physician Decision|0|||
46896566|NCT03054428|83121864|FG001|Overall Study|Physician Decision|1|||
46896567|NCT03054428|83121865|FG002|Overall Study|Physician Decision|1|||
46896568|NCT03054428|83121863|FG000|Overall Study|Lack of Efficacy|3|||
46896569|NCT03054428|83121864|FG001|Overall Study|Lack of Efficacy|1|||
46896570|NCT03054428|83121865|FG002|Overall Study|Lack of Efficacy|0|||
46896571|NCT03054428|83121863|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
46896572|NCT03054428|83121864|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
46896573|NCT03054428|83121865|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
46896574|NCT03054428|83121863|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
46896575|NCT03054428|83121864|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
46896576|NCT03054428|83121865|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
46896577|NCT03054428|83121863|FG000|Overall Study|Transitioned to OLE study|76|||
46896578|NCT03054428|83121864|FG001|Overall Study|Transitioned to OLE study|76|||
46896579|NCT03054428|83121865|FG002|Overall Study|Transitioned to OLE study|73|||
46896580|NCT03054428|83121863|FG000|Overall Study|Withdrawal by Subject|3|||
46896581|NCT03054428|83121864|FG001|Overall Study|Withdrawal by Subject|2|||
46896582|NCT03054428|83121865|FG002|Overall Study|Withdrawal by Subject|3|||
46896583|NCT03054428|83121863|FG000|Overall Study|Lost to Follow-up|0|||
46896584|NCT03054428|83121864|FG001|Overall Study|Lost to Follow-up|0|||
46896585|NCT03054428|83121865|FG002|Overall Study|Lost to Follow-up|1|||
46896586|NCT03558997|83121877|FG000|Overall Study|Adverse Event|0|||
46896587|NCT03558997|83121878|FG001|Overall Study|Adverse Event|2|||
46896588|NCT03558997|83121879|FG002|Overall Study|Adverse Event|5|||
46896589|NCT03558997|83121880|FG003|Overall Study|Adverse Event|1|||
46896590|NCT03558997|83121877|FG000|Overall Study|Physician Decision|0|||
46896591|NCT03558997|83121878|FG001|Overall Study|Physician Decision|0|||
46896592|NCT03558997|83121879|FG002|Overall Study|Physician Decision|1|||
46896593|NCT03558997|83121880|FG003|Overall Study|Physician Decision|0|||
46896594|NCT03558997|83121877|FG000|Overall Study|Withdrawal by Subject|1|||
46896595|NCT03558997|83121878|FG001|Overall Study|Withdrawal by Subject|0|||
46896596|NCT03558997|83121879|FG002|Overall Study|Withdrawal by Subject|1|||
46896597|NCT03558997|83121880|FG003|Overall Study|Withdrawal by Subject|1|||
46896598|NCT03558997|83121877|FG000|Overall Study|Lost to Follow-up|0|||
46896599|NCT03558997|83121878|FG001|Overall Study|Lost to Follow-up|0|||
46896600|NCT03558997|83121879|FG002|Overall Study|Lost to Follow-up|1|||
46896601|NCT03558997|83121880|FG003|Overall Study|Lost to Follow-up|0|||
46896602|NCT03052400|83121895|FG000|Overall Study|Lost to Follow-up|1|||
46896603|NCT03052400|83121896|FG001|Overall Study|Lost to Follow-up|0|||
46896604|NCT03052400|83121895|FG000|Overall Study|Withdrawal by Subject|0|||
46896605|NCT03052400|83121896|FG001|Overall Study|Withdrawal by Subject|1|||
46896606|NCT03538951|83121904|FG000|Overall Study|Withdrawal by Subject|1|||
46896607|NCT03538951|83121905|FG001|Overall Study|Withdrawal by Subject|2|||
46896608|NCT03052322|83121913|FG000|Overall Study|Other un-specified|1|||
46896609|NCT03052322|83121914|FG001|Overall Study|Other un-specified|2|||
46896610|NCT03052322|83121913|FG000|Overall Study|Withdrawal by Subject|10|||
46896611|NCT03052322|83121914|FG001|Overall Study|Withdrawal by Subject|9|||
46896612|NCT03052322|83121913|FG000|Overall Study|Death|0|||
46896613|NCT03052322|83121914|FG001|Overall Study|Death|2|||
46896614|NCT03052322|83121913|FG000|Overall Study|Lack of Efficacy|1|||
46896615|NCT03052322|83121914|FG001|Overall Study|Lack of Efficacy|2|||
46896616|NCT03052322|83121913|FG000|Overall Study|Protocol Violation|1|||
46896617|NCT03052322|83121914|FG001|Overall Study|Protocol Violation|0|||
46896618|NCT03052322|83121913|FG000|Overall Study|Lost to Follow-up|2|||
46896619|NCT03052322|83121914|FG001|Overall Study|Lost to Follow-up|4|||
46896620|NCT03052322|83121913|FG000|Overall Study|Adverse Event|6|||
46896621|NCT03052322|83121914|FG001|Overall Study|Adverse Event|13|||
46896622|NCT03521791|83121922|FG000|Overall Study|Protocol Violation|7|||
46896623|NCT03521791|83121923|FG001|Overall Study|Protocol Violation|17|||
46896624|NCT03521635|83121931|FG000|Overall Study|Adverse Event|1|||
46896625|NCT03521635|83121932|FG001|Overall Study|Adverse Event|1|||
46896626|NCT03521635|83121931|FG000|Overall Study|Refused to complete study visit|1|||
46896627|NCT03521635|83121932|FG001|Overall Study|Refused to complete study visit|0|||
46896628|NCT03521635|83121931|FG000|Overall Study|Refused to continue trial medication|2|||
46896629|NCT03521635|83121932|FG001|Overall Study|Refused to continue trial medication|2|||
46896630|NCT03521635|83121931|FG000|Overall Study|Lost to Follow-up|0|||
46896631|NCT03521635|83121932|FG001|Overall Study|Lost to Follow-up|1|||
46896632|NCT03521635|83121931|FG000|Overall Study|Meet exclusion criteria|0|||
46896633|NCT03521635|83121932|FG001|Overall Study|Meet exclusion criteria|1|||
46896634|NCT03521635|83121931|FG000|Overall Study|Patient not taken study medicine|0|||
46896635|NCT03521635|83121932|FG001|Overall Study|Patient not taken study medicine|1|||
46896636|NCT03170544|83121950|FG000|Part 1|Lost to Follow-up|1|||
46896637|NCT03170544|83121951|FG001|Part 1|Lost to Follow-up|0|||
46896638|NCT03170544|83121952|FG002|Part 1|Lost to Follow-up|0|||
46896639|NCT03170544|83121953|FG003|Part 1|Lost to Follow-up|0|||
46896640|NCT03170544|83121954|FG004|Part 1|Lost to Follow-up|0|||
46896641|NCT03170544|83121955|FG005|Part 1|Lost to Follow-up|0|||
46896642|NCT03170544|83121956|FG006|Part 1|Lost to Follow-up|0|||
46896643|NCT03170544|83121957|FG007|Part 1|Lost to Follow-up|0|||
46896644|NCT03170544|83121958|FG008|Part 1|Lost to Follow-up|0|||
46896645|NCT03170544|83121959|FG009|Part 1|Lost to Follow-up|0|||
46896646|NCT03170544|83121960|FG010|Part 1|Lost to Follow-up|0|||
46896647|NCT03170544|83121961|FG011|Part 1|Lost to Follow-up|0|||
46896648|NCT03170544|83121950|FG000|Part 1|Not treated|0|||
46896649|NCT03170544|83121951|FG001|Part 1|Not treated|0|||
46896650|NCT03170544|83121952|FG002|Part 1|Not treated|0|||
46896651|NCT03170544|83121953|FG003|Part 1|Not treated|1|||
46896652|NCT03170544|83121954|FG004|Part 1|Not treated|0|||
46896653|NCT03170544|83121955|FG005|Part 1|Not treated|0|||
46896654|NCT03170544|83121956|FG006|Part 1|Not treated|0|||
46896655|NCT03170544|83121957|FG007|Part 1|Not treated|0|||
46896656|NCT03170544|83121958|FG008|Part 1|Not treated|0|||
46896657|NCT03170544|83121959|FG009|Part 1|Not treated|0|||
46896658|NCT03170544|83121960|FG010|Part 1|Not treated|0|||
46896659|NCT03170544|83121961|FG011|Part 1|Not treated|0|||
46896660|NCT03582943|83122046|FG000|Allocated to Groups|Withdrawal by Subject|1|||
46896661|NCT03582943|83122047|FG001|Allocated to Groups|Withdrawal by Subject|1|||
46896662|NCT03582943|83122046|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
46896663|NCT03582943|83122047|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
46896664|NCT03582943|83122046|FG000|Analyzed|Protocol Violation|4|||
46896665|NCT03582943|83122047|FG001|Analyzed|Protocol Violation|1|||
46896666|NCT03532009|83122055|FG000|Overall Study|Other|1|||
46896667|NCT03532009|83122056|FG001|Overall Study|Other|1|||
46896668|NCT03532009|83122055|FG000|Overall Study|Death|1|||
46896669|NCT03532009|83122056|FG001|Overall Study|Death|1|||
46896670|NCT03532009|83122055|FG000|Overall Study|Withdrawal by Patient|0|||
46896671|NCT03532009|83122056|FG001|Overall Study|Withdrawal by Patient|2|||
46896672|NCT03520387|83122067|FG000|Pre-Randomization|Withdrawal by Subject|1|||
46896673|NCT03520387|83122068|FG001|Pre-Randomization|Withdrawal by Subject|0|||
46896674|NCT03520387|83122069|FG002|Pre-Randomization|Withdrawal by Subject|0|||
46896675|NCT03520387|83122070|FG003|Pre-Randomization|Withdrawal by Subject|0|||
46896676|NCT03520387|83122071|FG004|Pre-Randomization|Withdrawal by Subject|0|||
46896677|NCT03520387|83122067|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
46896678|NCT03520387|83122068|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
46896679|NCT03520387|83122069|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
46896680|NCT03520387|83122070|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
46896681|NCT03520387|83122071|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
46896682|NCT03170232|83122084|FG000|Overall Study|Adverse Event|0|||
46896683|NCT03170232|83122085|FG001|Overall Study|Adverse Event|1|||
46896684|NCT03170232|83122084|FG000|Overall Study|Protocol Violation|0|||
46896685|NCT03170232|83122085|FG001|Overall Study|Protocol Violation|1|||
46896686|NCT03170232|83122084|FG000|Overall Study|Lack of Efficacy|0|||
46896687|NCT03170232|83122085|FG001|Overall Study|Lack of Efficacy|1|||
46896688|NCT03170232|83122084|FG000|Overall Study|Study closed/terminated|26|||
46896689|NCT03170232|83122085|FG001|Overall Study|Study closed/terminated|23|||
46896690|NCT03170232|83122084|FG000|Overall Study|Lost to Follow-up|1|||
46896691|NCT03170232|83122085|FG001|Overall Study|Lost to Follow-up|0|||
46896692|NCT03170232|83122084|FG000|Overall Study|Withdrawal by Subject|0|||
46896693|NCT03170232|83122085|FG001|Overall Study|Withdrawal by Subject|1|||
46896694|NCT03519919|83122091|FG000|Overall Study|Withdrawal by Subject|1|||
46896695|NCT03519919|83122091|FG000|Overall Study|Lack of Efficacy|1|||
46896696|NCT03519919|83122091|FG000|Overall Study|Screen Failure|1|||
46896697|NCT03478969|83122124|FG000|Overall Study|Withdrawal by Subject|4|||
46896698|NCT03478969|83122125|FG001|Overall Study|Withdrawal by Subject|7|||
46896699|NCT03478969|83122126|FG002|Overall Study|Withdrawal by Subject|6|||
46896700|NCT03478969|83122124|FG000|Overall Study|Adverse Event|2|||
46896701|NCT03478969|83122125|FG001|Overall Study|Adverse Event|0|||
46896702|NCT03478969|83122126|FG002|Overall Study|Adverse Event|1|||
46896703|NCT03478969|83122124|FG000|Overall Study|Pregnancy|1|||
46896704|NCT03478969|83122125|FG001|Overall Study|Pregnancy|0|||
46896705|NCT03478969|83122126|FG002|Overall Study|Pregnancy|0|||
46896706|NCT03478969|83122124|FG000|Overall Study|Personal Reasons|1|||
46896707|NCT03478969|83122125|FG001|Overall Study|Personal Reasons|0|||
46896708|NCT03478969|83122126|FG002|Overall Study|Personal Reasons|1|||
46896709|NCT03478969|83122124|FG000|Overall Study|Covid-19|1|||
46896710|NCT03478969|83122125|FG001|Overall Study|Covid-19|4|||
46896711|NCT03478969|83122126|FG002|Overall Study|Covid-19|3|||
46896712|NCT03478969|83122124|FG000|Overall Study|Multiple Reasons|0|||
46896713|NCT03478969|83122125|FG001|Overall Study|Multiple Reasons|1|||
46896714|NCT03478969|83122126|FG002|Overall Study|Multiple Reasons|1|||
46896715|NCT03478969|83122124|FG000|Overall Study|Eligibility Criteria|0|||
46896716|NCT03478969|83122125|FG001|Overall Study|Eligibility Criteria|0|||
46896717|NCT03478969|83122126|FG002|Overall Study|Eligibility Criteria|5|||
46896718|NCT03478969|83122124|FG000|Overall Study|Lost to Follow-up|0|||
46896719|NCT03478969|83122125|FG001|Overall Study|Lost to Follow-up|0|||
46896720|NCT03478969|83122126|FG002|Overall Study|Lost to Follow-up|1|||
46896721|NCT04823949|83122157|FG000|Overall Study|Withdrawal by Subject|0|||
46896722|NCT04823949|83122158|FG001|Overall Study|Withdrawal by Subject|4|||
46896723|NCT04823949|83122157|FG000|Overall Study|Physician Decision|0|||
46896724|NCT04823949|83122158|FG001|Overall Study|Physician Decision|1|||
46896725|NCT04499482|83122173|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
46896726|NCT04408794|83122192|FG000|Overall Study|Adverse Event|43|||
46896727|NCT04408794|83122192|FG000|Overall Study|Infrequent study drug usage|43|||
46896728|NCT04408794|83122192|FG000|Overall Study|Lack of Efficacy|61|||
46896729|NCT04408794|83122192|FG000|Overall Study|Lost to Follow-up|33|||
46896730|NCT04408794|83122192|FG000|Overall Study|Non-compliance|6|||
46896731|NCT04408794|83122192|FG000|Overall Study|Physician Decision|1|||
46896732|NCT04408794|83122192|FG000|Overall Study|Pregnancy|6|||
46896733|NCT04408794|83122192|FG000|Overall Study|Protocol Deviation|9|||
46896734|NCT04408794|83122192|FG000|Overall Study|Sheehan-STS Result|1|||
46896735|NCT04408794|83122192|FG000|Overall Study|Withdrawal by Subject|57|||
46896736|NCT04408794|83122192|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
46896737|NCT04408794|83122192|FG000|Overall Study|Never Treated Migraine|5|||
46896738|NCT04354168|83122225|FG000|Overall Study|Lost to Follow-up|22|||
46896739|NCT04305405|83122231|FG000|Overall Study|Withdrawal by parent/guardian|0|||
46896740|NCT04305405|83122232|FG001|Overall Study|Withdrawal by parent/guardian|1|||
46896741|NCT03543410|83122250|FG000|Overall Study|Adverse Event|10|||
46896742|NCT03543410|83122251|FG001|Overall Study|Adverse Event|8|||
46896743|NCT03543410|83122252|FG002|Overall Study|Adverse Event|2|||
46896744|NCT03543410|83122250|FG000|Overall Study|Lack of Efficacy|0|||
46896745|NCT03543410|83122251|FG001|Overall Study|Lack of Efficacy|1|||
46896746|NCT03543410|83122252|FG002|Overall Study|Lack of Efficacy|0|||
46896747|NCT03543410|83122250|FG000|Overall Study|Lost to Follow-up|0|||
46896748|NCT03543410|83122251|FG001|Overall Study|Lost to Follow-up|1|||
46896749|NCT03543410|83122252|FG002|Overall Study|Lost to Follow-up|0|||
46896750|NCT03543410|83122250|FG000|Overall Study|Withdrawal by Subject|5|||
46896751|NCT03543410|83122251|FG001|Overall Study|Withdrawal by Subject|2|||
46896752|NCT03543410|83122252|FG002|Overall Study|Withdrawal by Subject|8|||
46896753|NCT03543410|83122250|FG000|Overall Study|Protocol Violation|0|||
46896754|NCT03543410|83122251|FG001|Overall Study|Protocol Violation|1|||
46896755|NCT03543410|83122252|FG002|Overall Study|Protocol Violation|0|||
46896756|NCT03543410|83122250|FG000|Overall Study|Due to COVID-19|4|||
46896757|NCT03543410|83122251|FG001|Overall Study|Due to COVID-19|0|||
46896758|NCT03543410|83122252|FG002|Overall Study|Due to COVID-19|2|||
46896759|NCT03543410|83122250|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
46896760|NCT03543410|83122251|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
46896761|NCT03543410|83122252|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
46896762|NCT03543410|83122250|FG000|Overall Study|Not Due to COVID-19|2|||
46896763|NCT03543410|83122251|FG001|Overall Study|Not Due to COVID-19|0|||
46896764|NCT03543410|83122252|FG002|Overall Study|Not Due to COVID-19|1|||
46896765|NCT02908074|83122266|FG000|Overall Study|sponsor/ICON decision|0|||
46896766|NCT02908074|83122267|FG001|Overall Study|sponsor/ICON decision|0|||
46896767|NCT02908074|83122268|FG002|Overall Study|sponsor/ICON decision|1|||
46896768|NCT02908074|83122269|FG003|Overall Study|sponsor/ICON decision|0|||
46896769|NCT02908074|83122270|FG004|Overall Study|sponsor/ICON decision|0|||
46896770|NCT02908074|83122271|FG005|Overall Study|sponsor/ICON decision|0|||
46896771|NCT02908074|83122266|FG000|Overall Study|Protocol Violation|0|||
46896772|NCT02908074|83122267|FG001|Overall Study|Protocol Violation|1|||
46896773|NCT02908074|83122268|FG002|Overall Study|Protocol Violation|0|||
46896774|NCT02908074|83122269|FG003|Overall Study|Protocol Violation|0|||
46896775|NCT02908074|83122270|FG004|Overall Study|Protocol Violation|0|||
46896776|NCT02908074|83122271|FG005|Overall Study|Protocol Violation|0|||
46896777|NCT02908074|83122266|FG000|Overall Study|Adverse Event|5|||
46896778|NCT02908074|83122267|FG001|Overall Study|Adverse Event|2|||
46896779|NCT02908074|83122268|FG002|Overall Study|Adverse Event|0|||
46896780|NCT02908074|83122269|FG003|Overall Study|Adverse Event|0|||
46896781|NCT02908074|83122270|FG004|Overall Study|Adverse Event|1|||
46896782|NCT02908074|83122271|FG005|Overall Study|Adverse Event|0|||
46896783|NCT02908074|83122266|FG000|Overall Study|AESI|1|||
46612820|NCT02470806|82723753|FG000|Overall Study|Withdrawal by Subject|3|||
46612821|NCT02470806|82723754|FG001|Overall Study|Withdrawal by Subject|10|||
46612822|NCT02470806|82723753|FG000|Overall Study|Lack of Efficacy|5|||
46612823|NCT02470806|82723754|FG001|Overall Study|Lack of Efficacy|15|||
46612824|NCT01363908|82723796|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
46612825|NCT01363908|82723797|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
46612826|NCT01363908|82723796|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
46612827|NCT01363908|82723797|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
46612828|NCT01363908|82723796|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
46612829|NCT01363908|82723797|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
46612830|NCT01363908|82723796|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
46612831|NCT01363908|82723797|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
46612832|NCT02497404|82723835|FG000|Overall Study|Adverse Event|1|||
46612833|NCT02496702|82723868|FG000|Overall Study|Lost to Follow-up|8|||
46612834|NCT02496702|82723869|FG001|Overall Study|Lost to Follow-up|6|||
46612835|NCT02496702|82723868|FG000|Overall Study|Only partially tested|0|||
46612836|NCT02496702|82723869|FG001|Overall Study|Only partially tested|2|||
46612837|NCT02469246|82723945|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
46612838|NCT02469246|82723946|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
46612839|NCT02469246|82723945|FG000|Double-Blind Phase|Adverse Event|12|||
46612840|NCT02469246|82723946|FG001|Double-Blind Phase|Adverse Event|9|||
46612841|NCT02469246|82723945|FG000|Double-Blind Phase|Death|2|||
46612842|NCT02469246|82723946|FG001|Double-Blind Phase|Death|0|||
46612843|NCT02469246|82723945|FG000|Double-Blind Phase|Lack of Efficacy|2|||
46612844|NCT02469246|82723946|FG001|Double-Blind Phase|Lack of Efficacy|1|||
46612845|NCT02469246|82723945|FG000|Double-Blind Phase|Investigator's Discretion|8|||
46612846|NCT02469246|82723946|FG001|Double-Blind Phase|Investigator's Discretion|8|||
46612847|NCT02469246|82723945|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
46612848|NCT02469246|82723946|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
46612849|NCT02469246|82723945|FG000|Double-Blind Phase|Protocol Violation|1|||
46612850|NCT02469246|82723946|FG001|Double-Blind Phase|Protocol Violation|1|||
46612851|NCT02469246|82723945|FG000|Double-Blind Phase|Withdrew Consent|25|||
46612852|NCT02469246|82723946|FG001|Double-Blind Phase|Withdrew Consent|25|||
46612853|NCT02469246|82723945|FG000|Double-Blind Phase|Lost to Follow-up|9|||
46612854|NCT02469246|82723946|FG001|Double-Blind Phase|Lost to Follow-up|5|||
46612855|NCT02469168|82723965|FG000|Overall Study|Trial closed|1|||
46612856|NCT02469168|82723966|FG001|Overall Study|Trial closed|0|||
46612857|NCT02469090|82723974|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
46612858|NCT02469090|82723975|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
46612859|NCT02469090|82723976|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
46612860|NCT02469090|82723974|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
46612861|NCT02469090|82723975|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
46612862|NCT02469090|82723976|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
46612863|NCT02469090|82723974|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
46612864|NCT02469090|82723975|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
46612865|NCT02469090|82723976|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
46612866|NCT02469090|82723974|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
46612867|NCT02469090|82723975|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
46612868|NCT02469090|82723976|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
46612869|NCT02469090|82723974|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
46612870|NCT02469090|82723975|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
46612871|NCT02469090|82723976|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
46612872|NCT02469090|82723974|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
46612873|NCT02469090|82723975|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
46612874|NCT02469090|82723976|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
46612875|NCT02469090|82723974|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
46612876|NCT02469090|82723975|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
46612877|NCT02469090|82723976|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
46612878|NCT02469090|82723974|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
46612879|NCT02469090|82723975|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
46612880|NCT02469090|82723976|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
46612881|NCT02496000|82723986|FG000|Overall Study|Withdrawal by Subject|1|||
46612882|NCT02496000|82723987|FG001|Overall Study|Withdrawal by Subject|2|||
46612883|NCT02496000|82723988|FG002|Overall Study|Withdrawal by Subject|0|||
46612884|NCT02496000|82723986|FG000|Overall Study|Lost to Follow-up|1|||
46612885|NCT02496000|82723987|FG001|Overall Study|Lost to Follow-up|0|||
46612886|NCT02496000|82723988|FG002|Overall Study|Lost to Follow-up|1|||
46612887|NCT02496000|82723986|FG000|Overall Study|Protocol Violation|0|||
46612888|NCT02496000|82723987|FG001|Overall Study|Protocol Violation|0|||
46612889|NCT02496000|82723988|FG002|Overall Study|Protocol Violation|1|||
46612890|NCT02496000|82723986|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
46612891|NCT02496000|82723987|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
46612892|NCT02496000|82723988|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
46612893|NCT02496000|82723986|FG000|Overall Study|undetermined|0|||
46612894|NCT02496000|82723987|FG001|Overall Study|undetermined|1|||
46612895|NCT02496000|82723988|FG002|Overall Study|undetermined|0|||
46612896|NCT02468934|82723997|FG000|Overall Study|Withdrawal by Subject|4|||
46612897|NCT02468934|82723997|FG000|Overall Study|Screen Failure|3|||
46612898|NCT02517528|82724003|FG000|Overall Study|Withdrawal by Subject|1|||
46612899|NCT02495844|82724009|FG000|Overall Study|Lack of Efficacy|1|||
46612900|NCT02495844|82724010|FG001|Overall Study|Lack of Efficacy|2|||
46612901|NCT02495844|82724009|FG000|Overall Study|AE, non-fatal|0|||
46612902|NCT02495844|82724010|FG001|Overall Study|AE, non-fatal|1|||
46612903|NCT02495844|82724009|FG000|Overall Study|Hepatitis Positivity|0|||
46612904|NCT02495844|82724010|FG001|Overall Study|Hepatitis Positivity|1|||
46612905|NCT02468778|82724021|FG000|Overall Study|Death|2|||
46612906|NCT02468778|82724022|FG001|Overall Study|Death|1|||
46612907|NCT02468778|82724023|FG002|Overall Study|Death|0|||
46612908|NCT02468778|82724021|FG000|Overall Study|Lost to Follow-up|1|||
46612909|NCT02468778|82724022|FG001|Overall Study|Lost to Follow-up|2|||
46612910|NCT02468778|82724023|FG002|Overall Study|Lost to Follow-up|2|||
46612911|NCT02468778|82724021|FG000|Overall Study|Withdrawal by Subject|0|||
46612912|NCT02468778|82724022|FG001|Overall Study|Withdrawal by Subject|1|||
46612913|NCT02468778|82724023|FG002|Overall Study|Withdrawal by Subject|1|||
46612914|NCT01727336|82724037|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
46612915|NCT01727336|82724038|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
46612916|NCT01727336|82724039|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
46612917|NCT01727336|82724040|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
46612918|NCT01727336|82724041|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
46612919|NCT01727336|82724042|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
46612920|NCT01727336|82724037|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
46612921|NCT01727336|82724038|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
46612922|NCT01727336|82724039|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
46612923|NCT01727336|82724040|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
46612924|NCT01727336|82724041|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
46612925|NCT01727336|82724042|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
46612926|NCT01727336|82724037|FG000|Part 2 Blinded|Death|0|||
46612927|NCT01727336|82724038|FG001|Part 2 Blinded|Death|0|||
46612928|NCT01727336|82724039|FG002|Part 2 Blinded|Death|0|||
46612929|NCT01727336|82724040|FG003|Part 2 Blinded|Death|0|||
46612930|NCT01727336|82724041|FG004|Part 2 Blinded|Death|20|||
46612931|NCT01727336|82724042|FG005|Part 2 Blinded|Death|16|||
46612932|NCT01727336|82724037|FG000|Part 2 Blinded|Lack of Efficacy|0|||
46612933|NCT01727336|82724038|FG001|Part 2 Blinded|Lack of Efficacy|0|||
46612934|NCT01727336|82724039|FG002|Part 2 Blinded|Lack of Efficacy|0|||
46612935|NCT01727336|82724040|FG003|Part 2 Blinded|Lack of Efficacy|0|||
46612936|NCT01727336|82724041|FG004|Part 2 Blinded|Lack of Efficacy|42|||
46612937|NCT01727336|82724042|FG005|Part 2 Blinded|Lack of Efficacy|44|||
46612938|NCT01727336|82724037|FG000|Part 2 Blinded|Lost to Follow-up|0|||
46612939|NCT01727336|82724038|FG001|Part 2 Blinded|Lost to Follow-up|0|||
46612940|NCT01727336|82724039|FG002|Part 2 Blinded|Lost to Follow-up|0|||
46612941|NCT01727336|82724040|FG003|Part 2 Blinded|Lost to Follow-up|0|||
46612942|NCT01727336|82724041|FG004|Part 2 Blinded|Lost to Follow-up|0|||
46612943|NCT01727336|82724042|FG005|Part 2 Blinded|Lost to Follow-up|1|||
46612944|NCT01727336|82724037|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
46612945|NCT01727336|82724038|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
46612946|NCT01727336|82724039|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
46612947|NCT01727336|82724040|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
46612948|NCT01727336|82724041|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
46612949|NCT01727336|82724042|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
46612950|NCT01727336|82724037|FG000|Part 2 Blinded|use of prohibited medications|0|||
46612951|NCT01727336|82724038|FG001|Part 2 Blinded|use of prohibited medications|0|||
46612952|NCT01727336|82724039|FG002|Part 2 Blinded|use of prohibited medications|0|||
46612953|NCT01727336|82724040|FG003|Part 2 Blinded|use of prohibited medications|0|||
46612954|NCT01727336|82724041|FG004|Part 2 Blinded|use of prohibited medications|1|||
46612955|NCT01727336|82724042|FG005|Part 2 Blinded|use of prohibited medications|3|||
46612956|NCT02466516|82724076|FG000|Overall Study|Adverse Event|1|||
46612957|NCT02466516|82724077|FG001|Overall Study|Adverse Event|1|||
46612958|NCT02466516|82724078|FG002|Overall Study|Adverse Event|0|||
46612959|NCT02466516|82724079|FG003|Overall Study|Adverse Event|0|||
46612960|NCT02466516|82724080|FG004|Overall Study|Adverse Event|0|||
46612961|NCT02466516|82724076|FG000|Overall Study|Withdrew Consent|1|||
46612962|NCT02466516|82724077|FG001|Overall Study|Withdrew Consent|0|||
46612963|NCT02466516|82724078|FG002|Overall Study|Withdrew Consent|0|||
46612964|NCT02466516|82724079|FG003|Overall Study|Withdrew Consent|0|||
46612965|NCT02466516|82724080|FG004|Overall Study|Withdrew Consent|0|||
46612966|NCT02466516|82724076|FG000|Overall Study|Lost to Follow-up|2|||
46612967|NCT02466516|82724077|FG001|Overall Study|Lost to Follow-up|0|||
46612968|NCT02466516|82724078|FG002|Overall Study|Lost to Follow-up|1|||
46612969|NCT02466516|82724079|FG003|Overall Study|Lost to Follow-up|0|||
46612970|NCT02466516|82724080|FG004|Overall Study|Lost to Follow-up|0|||
46612971|NCT01725152|82724094|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
46612972|NCT01725152|82724095|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
46612973|NCT01725152|82724094|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
46612974|NCT01725152|82724095|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
46612975|NCT01725152|82724094|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
46612976|NCT01725152|82724095|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
46612977|NCT01725152|82724094|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
46612978|NCT01725152|82724095|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
46612979|NCT01049984|82724111|FG000|Overall Study|Withdrawal by Subject|1|||
46612980|NCT01049984|82724112|FG001|Overall Study|Withdrawal by Subject|5|||
46612981|NCT01049984|82724111|FG000|Overall Study|Protocol Violation|3|||
46612982|NCT01049984|82724112|FG001|Overall Study|Protocol Violation|4|||
46612983|NCT01049984|82724111|FG000|Overall Study|Lost to Follow-up|2|||
46612984|NCT01049984|82724112|FG001|Overall Study|Lost to Follow-up|1|||
46612985|NCT01049984|82724111|FG000|Overall Study|Adverse Event|13|||
46612986|NCT01049984|82724112|FG001|Overall Study|Adverse Event|7|||
46612987|NCT01049984|82724111|FG000|Overall Study|Treatment failure|0|||
46612988|NCT01049984|82724112|FG001|Overall Study|Treatment failure|2|||
46612989|NCT01049360|82724118|FG000|Period 1|Adverse Event|0|||
46612990|NCT01049360|82724119|FG001|Period 1|Adverse Event|1|||
46612991|NCT01049360|82724120|FG002|Period 1|Adverse Event|0|||
46612992|NCT01049360|82724121|FG003|Period 1|Adverse Event|1|||
46612993|NCT01049360|82724122|FG004|Period 1|Adverse Event|0|||
46612994|NCT01049360|82724123|FG005|Period 1|Adverse Event|0|||
46612995|NCT01049360|82724124|FG006|Period 1|Adverse Event|0|||
46612996|NCT01049360|82724125|FG007|Period 1|Adverse Event|1|||
46612997|NCT01049360|82724126|FG008|Period 1|Adverse Event|0|||
46612998|NCT01049360|82724127|FG009|Period 1|Adverse Event|0|||
46612999|NCT01049360|82724128|FG010|Period 1|Adverse Event|0|||
46613000|NCT01049360|82724129|FG011|Period 1|Adverse Event|0|||
46613001|NCT01049360|82724130|FG012|Period 1|Adverse Event|1|||
46613002|NCT01049360|82724131|FG013|Period 1|Adverse Event|1|||
46613003|NCT01049360|82724132|FG014|Period 1|Adverse Event|0|||
46613004|NCT01049360|82724133|FG015|Period 1|Adverse Event|0|||
46613005|NCT01049360|82724134|FG016|Period 1|Adverse Event|1|||
46613006|NCT01049360|82724135|FG017|Period 1|Adverse Event|0|||
46613007|NCT01049360|82724136|FG018|Period 1|Adverse Event|1|||
46613008|NCT01049360|82724137|FG019|Period 1|Adverse Event|0|||
46613009|NCT01049360|82724118|FG000|Period 1|Did not meet inc/exc criteria|0|||
46613010|NCT01049360|82724119|FG001|Period 1|Did not meet inc/exc criteria|0|||
46613011|NCT01049360|82724120|FG002|Period 1|Did not meet inc/exc criteria|0|||
46613012|NCT01049360|82724121|FG003|Period 1|Did not meet inc/exc criteria|0|||
46613013|NCT01049360|82724122|FG004|Period 1|Did not meet inc/exc criteria|0|||
46613014|NCT01049360|82724123|FG005|Period 1|Did not meet inc/exc criteria|0|||
46613015|NCT01049360|82724124|FG006|Period 1|Did not meet inc/exc criteria|0|||
46613016|NCT01049360|82724125|FG007|Period 1|Did not meet inc/exc criteria|1|||
46613017|NCT01049360|82724126|FG008|Period 1|Did not meet inc/exc criteria|1|||
46613018|NCT01049360|82724127|FG009|Period 1|Did not meet inc/exc criteria|0|||
46613019|NCT01049360|82724128|FG010|Period 1|Did not meet inc/exc criteria|0|||
46613020|NCT01049360|82724129|FG011|Period 1|Did not meet inc/exc criteria|0|||
46613021|NCT01049360|82724130|FG012|Period 1|Did not meet inc/exc criteria|0|||
46613022|NCT01049360|82724131|FG013|Period 1|Did not meet inc/exc criteria|0|||
46613023|NCT01049360|82724132|FG014|Period 1|Did not meet inc/exc criteria|0|||
46613024|NCT01049360|82724133|FG015|Period 1|Did not meet inc/exc criteria|0|||
46613025|NCT01049360|82724134|FG016|Period 1|Did not meet inc/exc criteria|0|||
46613026|NCT01049360|82724135|FG017|Period 1|Did not meet inc/exc criteria|0|||
46613027|NCT01049360|82724136|FG018|Period 1|Did not meet inc/exc criteria|0|||
46613028|NCT01049360|82724137|FG019|Period 1|Did not meet inc/exc criteria|0|||
46613029|NCT01049360|82724118|FG000|Period 1|Withdrawal by Subject|0|||
46613030|NCT01049360|82724119|FG001|Period 1|Withdrawal by Subject|0|||
46613031|NCT01049360|82724120|FG002|Period 1|Withdrawal by Subject|0|||
46613032|NCT01049360|82724121|FG003|Period 1|Withdrawal by Subject|0|||
46613033|NCT01049360|82724122|FG004|Period 1|Withdrawal by Subject|0|||
46613034|NCT01049360|82724123|FG005|Period 1|Withdrawal by Subject|0|||
46613035|NCT01049360|82724124|FG006|Period 1|Withdrawal by Subject|0|||
46613036|NCT01049360|82724125|FG007|Period 1|Withdrawal by Subject|0|||
46613037|NCT01049360|82724126|FG008|Period 1|Withdrawal by Subject|1|||
46613038|NCT01049360|82724127|FG009|Period 1|Withdrawal by Subject|0|||
46613039|NCT01049360|82724128|FG010|Period 1|Withdrawal by Subject|1|||
46613040|NCT01049360|82724129|FG011|Period 1|Withdrawal by Subject|0|||
46613041|NCT01049360|82724130|FG012|Period 1|Withdrawal by Subject|1|||
46613042|NCT01049360|82724131|FG013|Period 1|Withdrawal by Subject|0|||
46613043|NCT01049360|82724132|FG014|Period 1|Withdrawal by Subject|0|||
46613044|NCT01049360|82724133|FG015|Period 1|Withdrawal by Subject|0|||
46613045|NCT01049360|82724134|FG016|Period 1|Withdrawal by Subject|0|||
46613046|NCT01049360|82724135|FG017|Period 1|Withdrawal by Subject|0|||
46613047|NCT01049360|82724136|FG018|Period 1|Withdrawal by Subject|0|||
46613048|NCT01049360|82724137|FG019|Period 1|Withdrawal by Subject|0|||
46613049|NCT01049360|82724118|FG000|Period 2|Protocol Violation|0|||
46613050|NCT01049360|82724119|FG001|Period 2|Protocol Violation|0|||
46613051|NCT01049360|82724120|FG002|Period 2|Protocol Violation|0|||
46613052|NCT01049360|82724121|FG003|Period 2|Protocol Violation|1|||
46613053|NCT01049360|82724122|FG004|Period 2|Protocol Violation|0|||
46613054|NCT01049360|82724123|FG005|Period 2|Protocol Violation|0|||
46613055|NCT01049360|82724124|FG006|Period 2|Protocol Violation|0|||
46613056|NCT01049360|82724125|FG007|Period 2|Protocol Violation|0|||
46613057|NCT01049360|82724126|FG008|Period 2|Protocol Violation|0|||
46613058|NCT01049360|82724127|FG009|Period 2|Protocol Violation|0|||
46613059|NCT01049360|82724128|FG010|Period 2|Protocol Violation|0|||
46613060|NCT01049360|82724129|FG011|Period 2|Protocol Violation|0|||
46613061|NCT01049360|82724130|FG012|Period 2|Protocol Violation|0|||
46613062|NCT01049360|82724131|FG013|Period 2|Protocol Violation|0|||
46613063|NCT01049360|82724132|FG014|Period 2|Protocol Violation|1|||
46613064|NCT01049360|82724133|FG015|Period 2|Protocol Violation|1|||
46613065|NCT01049360|82724134|FG016|Period 2|Protocol Violation|0|||
46613066|NCT01049360|82724135|FG017|Period 2|Protocol Violation|0|||
46613067|NCT01049360|82724136|FG018|Period 2|Protocol Violation|0|||
46613068|NCT01049360|82724137|FG019|Period 2|Protocol Violation|0|||
46613069|NCT01049360|82724118|FG000|Period 2|Adverse Event|0|||
46613070|NCT01049360|82724119|FG001|Period 2|Adverse Event|1|||
46613071|NCT01049360|82724120|FG002|Period 2|Adverse Event|0|||
46613072|NCT01049360|82724121|FG003|Period 2|Adverse Event|0|||
46613073|NCT01049360|82724122|FG004|Period 2|Adverse Event|0|||
46613074|NCT01049360|82724123|FG005|Period 2|Adverse Event|0|||
46613075|NCT01049360|82724124|FG006|Period 2|Adverse Event|0|||
46613076|NCT01049360|82724125|FG007|Period 2|Adverse Event|0|||
46613077|NCT01049360|82724126|FG008|Period 2|Adverse Event|1|||
46613078|NCT01049360|82724127|FG009|Period 2|Adverse Event|0|||
46613079|NCT01049360|82724128|FG010|Period 2|Adverse Event|0|||
46613080|NCT01049360|82724129|FG011|Period 2|Adverse Event|0|||
46613081|NCT01049360|82724130|FG012|Period 2|Adverse Event|0|||
46613082|NCT01049360|82724131|FG013|Period 2|Adverse Event|0|||
46613083|NCT01049360|82724132|FG014|Period 2|Adverse Event|0|||
46613084|NCT01049360|82724133|FG015|Period 2|Adverse Event|0|||
46613085|NCT01049360|82724134|FG016|Period 2|Adverse Event|0|||
46613086|NCT01049360|82724135|FG017|Period 2|Adverse Event|0|||
46613087|NCT01049360|82724136|FG018|Period 2|Adverse Event|0|||
46613088|NCT01049360|82724137|FG019|Period 2|Adverse Event|1|||
46613089|NCT01049360|82724118|FG000|Period 2|Withdrawal by Subject|0|||
46613090|NCT01049360|82724119|FG001|Period 2|Withdrawal by Subject|0|||
46613091|NCT01049360|82724120|FG002|Period 2|Withdrawal by Subject|0|||
46613092|NCT01049360|82724121|FG003|Period 2|Withdrawal by Subject|1|||
46613093|NCT01049360|82724122|FG004|Period 2|Withdrawal by Subject|0|||
46613094|NCT01049360|82724123|FG005|Period 2|Withdrawal by Subject|0|||
46613095|NCT01049360|82724124|FG006|Period 2|Withdrawal by Subject|0|||
46613096|NCT01049360|82724125|FG007|Period 2|Withdrawal by Subject|0|||
46613097|NCT01049360|82724126|FG008|Period 2|Withdrawal by Subject|0|||
46613098|NCT01049360|82724127|FG009|Period 2|Withdrawal by Subject|0|||
46613099|NCT01049360|82724128|FG010|Period 2|Withdrawal by Subject|0|||
46613100|NCT01049360|82724129|FG011|Period 2|Withdrawal by Subject|0|||
46613101|NCT01049360|82724130|FG012|Period 2|Withdrawal by Subject|0|||
46613102|NCT01049360|82724131|FG013|Period 2|Withdrawal by Subject|0|||
46613103|NCT01049360|82724132|FG014|Period 2|Withdrawal by Subject|1|||
46613104|NCT01049360|82724133|FG015|Period 2|Withdrawal by Subject|0|||
46613105|NCT01049360|82724134|FG016|Period 2|Withdrawal by Subject|0|||
46613106|NCT01049360|82724135|FG017|Period 2|Withdrawal by Subject|0|||
46613107|NCT01049360|82724136|FG018|Period 2|Withdrawal by Subject|0|||
46613108|NCT01049360|82724137|FG019|Period 2|Withdrawal by Subject|1|||
46613109|NCT01049360|82724118|FG000|Period 2|Lack of Efficacy|0|||
46613110|NCT01049360|82724119|FG001|Period 2|Lack of Efficacy|0|||
46613111|NCT01049360|82724120|FG002|Period 2|Lack of Efficacy|0|||
46613112|NCT01049360|82724121|FG003|Period 2|Lack of Efficacy|0|||
46613113|NCT01049360|82724122|FG004|Period 2|Lack of Efficacy|0|||
46613114|NCT01049360|82724123|FG005|Period 2|Lack of Efficacy|1|||
46613115|NCT01049360|82724124|FG006|Period 2|Lack of Efficacy|0|||
46613116|NCT01049360|82724125|FG007|Period 2|Lack of Efficacy|0|||
46613117|NCT01049360|82724126|FG008|Period 2|Lack of Efficacy|0|||
46613118|NCT01049360|82724127|FG009|Period 2|Lack of Efficacy|0|||
46613119|NCT01049360|82724128|FG010|Period 2|Lack of Efficacy|0|||
46613120|NCT01049360|82724129|FG011|Period 2|Lack of Efficacy|0|||
46613121|NCT01049360|82724130|FG012|Period 2|Lack of Efficacy|0|||
46613122|NCT01049360|82724131|FG013|Period 2|Lack of Efficacy|0|||
46613123|NCT01049360|82724132|FG014|Period 2|Lack of Efficacy|0|||
46613124|NCT01049360|82724133|FG015|Period 2|Lack of Efficacy|0|||
46613125|NCT01049360|82724134|FG016|Period 2|Lack of Efficacy|0|||
46613126|NCT01049360|82724135|FG017|Period 2|Lack of Efficacy|0|||
46613127|NCT01049360|82724136|FG018|Period 2|Lack of Efficacy|0|||
46613128|NCT01049360|82724137|FG019|Period 2|Lack of Efficacy|0|||
46613129|NCT01049360|82724118|FG000|Period 4|Protocol Violation|0|||
46613130|NCT01049360|82724119|FG001|Period 4|Protocol Violation|0|||
46613131|NCT01049360|82724120|FG002|Period 4|Protocol Violation|0|||
46613132|NCT01049360|82724121|FG003|Period 4|Protocol Violation|0|||
46613133|NCT01049360|82724122|FG004|Period 4|Protocol Violation|0|||
46613134|NCT01049360|82724123|FG005|Period 4|Protocol Violation|0|||
46613135|NCT01049360|82724124|FG006|Period 4|Protocol Violation|0|||
46613136|NCT01049360|82724125|FG007|Period 4|Protocol Violation|0|||
46613137|NCT01049360|82724126|FG008|Period 4|Protocol Violation|0|||
46613138|NCT01049360|82724127|FG009|Period 4|Protocol Violation|0|||
46613139|NCT01049360|82724128|FG010|Period 4|Protocol Violation|0|||
46613140|NCT01049360|82724129|FG011|Period 4|Protocol Violation|0|||
46613141|NCT01049360|82724130|FG012|Period 4|Protocol Violation|0|||
46613142|NCT01049360|82724131|FG013|Period 4|Protocol Violation|0|||
46613143|NCT01049360|82724132|FG014|Period 4|Protocol Violation|0|||
46613144|NCT01049360|82724133|FG015|Period 4|Protocol Violation|0|||
46613145|NCT01049360|82724134|FG016|Period 4|Protocol Violation|0|||
46613146|NCT01049360|82724135|FG017|Period 4|Protocol Violation|1|||
46613147|NCT01049360|82724136|FG018|Period 4|Protocol Violation|0|||
46613148|NCT01049360|82724137|FG019|Period 4|Protocol Violation|0|||
46613149|NCT01049360|82724118|FG000|Period 4|Withdrawal by Subject|0|||
46613150|NCT01049360|82724119|FG001|Period 4|Withdrawal by Subject|0|||
46613151|NCT01049360|82724120|FG002|Period 4|Withdrawal by Subject|0|||
46613152|NCT01049360|82724121|FG003|Period 4|Withdrawal by Subject|1|||
46613153|NCT01049360|82724122|FG004|Period 4|Withdrawal by Subject|0|||
46613154|NCT01049360|82724123|FG005|Period 4|Withdrawal by Subject|0|||
46613155|NCT01049360|82724124|FG006|Period 4|Withdrawal by Subject|0|||
46613156|NCT01049360|82724125|FG007|Period 4|Withdrawal by Subject|0|||
46613157|NCT01049360|82724126|FG008|Period 4|Withdrawal by Subject|0|||
46613158|NCT01049360|82724127|FG009|Period 4|Withdrawal by Subject|0|||
46613159|NCT01049360|82724128|FG010|Period 4|Withdrawal by Subject|0|||
46613160|NCT01049360|82724129|FG011|Period 4|Withdrawal by Subject|0|||
46613161|NCT01049360|82724130|FG012|Period 4|Withdrawal by Subject|0|||
46613162|NCT01049360|82724131|FG013|Period 4|Withdrawal by Subject|0|||
46613163|NCT01049360|82724132|FG014|Period 4|Withdrawal by Subject|0|||
46613164|NCT01049360|82724133|FG015|Period 4|Withdrawal by Subject|0|||
46613165|NCT01049360|82724134|FG016|Period 4|Withdrawal by Subject|0|||
46613166|NCT01049360|82724135|FG017|Period 4|Withdrawal by Subject|0|||
46613167|NCT01049360|82724136|FG018|Period 4|Withdrawal by Subject|0|||
46613168|NCT01049360|82724137|FG019|Period 4|Withdrawal by Subject|0|||
46613169|NCT02494596|82724149|FG000|Overall Study|Insufficient Therapeutic Response|3|||
46613170|NCT02494596|82724150|FG001|Overall Study|Insufficient Therapeutic Response|3|||
46613171|NCT02494596|82724151|FG002|Overall Study|Insufficient Therapeutic Response|1|||
46613172|NCT02494596|82724149|FG000|Overall Study|Adverse Event|0|||
46613173|NCT02494596|82724150|FG001|Overall Study|Adverse Event|1|||
46613174|NCT02494596|82724151|FG002|Overall Study|Adverse Event|0|||
46613175|NCT02494596|82724149|FG000|Overall Study|Refused Treatment|0|||
46613176|NCT02494596|82724150|FG001|Overall Study|Refused Treatment|1|||
46613177|NCT02494596|82724151|FG002|Overall Study|Refused Treatment|0|||
46613178|NCT02494206|82724170|FG000|Overall Study|Adverse Event|1|||
46613179|NCT02494206|82724170|FG000|Overall Study|Disease Progression|1|||
46613180|NCT01048502|82724187|FG000|Overall Study|Lost to Follow-up|2|||
46613181|NCT01048502|82724188|FG001|Overall Study|Lost to Follow-up|0|||
46613182|NCT01048502|82724189|FG002|Overall Study|Lost to Follow-up|0|||
46613183|NCT01048502|82724190|FG003|Overall Study|Lost to Follow-up|0|||
46613184|NCT01048502|82724187|FG000|Overall Study|Adverse Event|1|||
46613185|NCT01048502|82724188|FG001|Overall Study|Adverse Event|0|||
46613186|NCT01048502|82724189|FG002|Overall Study|Adverse Event|0|||
46613187|NCT01048502|82724190|FG003|Overall Study|Adverse Event|0|||
46613188|NCT01048502|82724187|FG000|Overall Study|Withdrawal by Subject|1|||
46613189|NCT01048502|82724188|FG001|Overall Study|Withdrawal by Subject|4|||
46613190|NCT01048502|82724189|FG002|Overall Study|Withdrawal by Subject|5|||
46613191|NCT01048502|82724190|FG003|Overall Study|Withdrawal by Subject|3|||
46613192|NCT01048502|82724187|FG000|Overall Study|Physician Decision|0|||
46613193|NCT01048502|82724188|FG001|Overall Study|Physician Decision|3|||
46613194|NCT01048502|82724189|FG002|Overall Study|Physician Decision|0|||
46613195|NCT01048502|82724190|FG003|Overall Study|Physician Decision|1|||
46613196|NCT02465034|82724203|FG000|Overall Study|Withdrawal by Subject|1|||
46613197|NCT02465034|82724204|FG001|Overall Study|Withdrawal by Subject|1|||
46613198|NCT02465034|82724203|FG000|Overall Study|Screen fail|2|||
46613199|NCT02465034|82724204|FG001|Overall Study|Screen fail|0|||
46613200|NCT02465034|82724203|FG000|Overall Study|Could not be scheduled for study visit|0|||
46613201|NCT02465034|82724204|FG001|Overall Study|Could not be scheduled for study visit|5|||
46613202|NCT02516982|82724231|FG000|Overall Study|Called in to antenatal appointment|32|||
46613203|NCT02516982|82724232|FG001|Overall Study|Called in to antenatal appointment|35|||
46613204|NCT02516982|82724233|FG002|Overall Study|Called in to antenatal appointment|0|||
46613205|NCT02516982|82724234|FG003|Overall Study|Called in to antenatal appointment|0|||
46613206|NCT02516982|82724231|FG000|Overall Study|Withdrawal by Subject|0|||
46613207|NCT02516982|82724232|FG001|Overall Study|Withdrawal by Subject|0|||
46613208|NCT02516982|82724233|FG002|Overall Study|Withdrawal by Subject|1|||
46613209|NCT02516982|82724234|FG003|Overall Study|Withdrawal by Subject|2|||
46613210|NCT02516982|82724231|FG000|Overall Study|Protocol Violation|0|||
46613211|NCT02516982|82724232|FG001|Overall Study|Protocol Violation|0|||
46613212|NCT02516982|82724233|FG002|Overall Study|Protocol Violation|1|||
46613213|NCT02516982|82724234|FG003|Overall Study|Protocol Violation|1|||
46613214|NCT02516982|82724231|FG000|Overall Study|Did not install the app|0|||
46613215|NCT02516982|82724232|FG001|Overall Study|Did not install the app|0|||
46613216|NCT02516982|82724233|FG002|Overall Study|Did not install the app|46|||
46613217|NCT02516982|82724234|FG003|Overall Study|Did not install the app|47|||
46613218|NCT02464410|82724279|FG000|Overall Study|Death|3|||
46613219|NCT02464410|82724280|FG001|Overall Study|Death|4|||
46613220|NCT02464410|82724279|FG000|Overall Study|Lost to Follow-up|7|||
46613221|NCT02464410|82724280|FG001|Overall Study|Lost to Follow-up|9|||
46613222|NCT02464410|82724279|FG000|Overall Study|Withdrawal by Subject|12|||
46613223|NCT02464410|82724280|FG001|Overall Study|Withdrawal by Subject|3|||
46613224|NCT01047332|82724288|FG000|Overall Study|SEMS Obstruction|11|||
46613225|NCT01047332|82724289|FG001|Overall Study|SEMS Obstruction|20|||
46613226|NCT01047332|82724288|FG000|Overall Study|Died Unobstructed|38|||
46613227|NCT01047332|82724289|FG001|Overall Study|Died Unobstructed|41|||
46613228|NCT01047332|82724288|FG000|Overall Study|Lost to Follow-up|8|||
46613229|NCT01047332|82724289|FG001|Overall Study|Lost to Follow-up|3|||
46613230|NCT01046396|82724295|FG000|Overall Study|Withdrawal by Subject|5|||
46613231|NCT01046084|82724321|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
46613232|NCT01046084|82724322|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
46613233|NCT01045694|82724341|FG000|Overall Study|Withdrawal by Subject|2|||
46613234|NCT01044290|82724401|FG000|Follow-up 1|Death|3|||
46613235|NCT01044290|82724402|FG001|Follow-up 1|Death|3|||
46613236|NCT01044290|82724403|FG002|Follow-up 1|Death|1|||
46613237|NCT01044290|82724401|FG000|Follow-up 1|Withdrawal by Subject|2|||
46613238|NCT01044290|82724402|FG001|Follow-up 1|Withdrawal by Subject|2|||
46613239|NCT01044290|82724403|FG002|Follow-up 1|Withdrawal by Subject|0|||
46613240|NCT01044290|82724401|FG000|Follow-Up 2|Death|0|||
46613241|NCT01044290|82724402|FG001|Follow-Up 2|Death|1|||
46613242|NCT01044290|82724403|FG002|Follow-Up 2|Death|1|||
46613243|NCT01044290|82724401|FG000|Follow-Up 2|Withdrawal by Subject|0|||
46613244|NCT01044290|82724402|FG001|Follow-Up 2|Withdrawal by Subject|1|||
46613245|NCT01044290|82724403|FG002|Follow-Up 2|Withdrawal by Subject|1|||
46613246|NCT01041638|82724484|FG000|Overall Study|Adverse Event|4|||
46613247|NCT01041638|82724484|FG000|Overall Study|Death|1|||
46613248|NCT01041638|82724484|FG000|Overall Study|Lack of Efficacy|7|||
46613249|NCT01041638|82724484|FG000|Overall Study|Physician Decision|4|||
46613250|NCT01041638|82724484|FG000|Overall Study|Withdrawal by Subject|11|||
46613251|NCT01045460|82724508|FG000|Overall Study|Physician Decision|3|||
46613252|NCT01045460|82724509|FG001|Overall Study|Physician Decision|2|||
46613253|NCT01045460|82724508|FG000|Overall Study|Lost to Follow-up|0|||
46613254|NCT01045460|82724509|FG001|Overall Study|Lost to Follow-up|1|||
46613255|NCT01045460|82724508|FG000|Overall Study|Lack of Efficacy|3|||
46613256|NCT01045460|82724509|FG001|Overall Study|Lack of Efficacy|0|||
46613257|NCT05014919|82724520|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
46613258|NCT05014919|82724521|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
46613259|NCT05014919|82724522|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
46613260|NCT05014919|82724520|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
46613261|NCT05014919|82724521|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
46613262|NCT05014919|82724522|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
46613263|NCT05014919|82724520|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
46613264|NCT05014919|82724521|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
46613265|NCT05014919|82724522|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
46613266|NCT05014919|82724520|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
46613267|NCT05014919|82724521|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
46613268|NCT05014919|82724522|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
46613269|NCT05014919|82724520|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
46613270|NCT05014919|82724521|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
46613271|NCT05014919|82724522|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
46613272|NCT05014919|82724520|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
46613273|NCT05014919|82724521|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
46613274|NCT05014919|82724522|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
46613275|NCT05014919|82724520|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
46613276|NCT05014919|82724521|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
46613277|NCT05014919|82724522|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
46613278|NCT05014919|82724520|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
46613279|NCT05014919|82724521|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
46613280|NCT05014919|82724522|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
46707259|NCT01158378|82922778|FG000|Overall Study|Death|4|||
46707260|NCT01158378|82922779|FG001|Overall Study|Death|5|||
46707261|NCT01158378|82922778|FG000|Overall Study|Lost to Follow-up|2|||
46707262|NCT01158378|82922779|FG001|Overall Study|Lost to Follow-up|4|||
46707263|NCT01158378|82922778|FG000|Overall Study|Withdrawal by Subject|4|||
46707264|NCT01158378|82922779|FG001|Overall Study|Withdrawal by Subject|0|||
46707265|NCT01158222|82922786|FG000|Overall Study|Not eligible for intermediate phase|17|||
46707266|NCT01197521|82922793|FG000|Overall Study|Not reported|24|||
46707267|NCT01197521|82922794|FG001|Overall Study|Not reported|25|||
46707268|NCT01197521|82922795|FG002|Overall Study|Not reported|21|||
46707269|NCT01197521|82922793|FG000|Overall Study|Enrolment in long term extension|42|||
46707270|NCT01197521|82922794|FG001|Overall Study|Enrolment in long term extension|36|||
46707271|NCT01197521|82922795|FG002|Overall Study|Enrolment in long term extension|87|||
46707272|NCT01197521|82922793|FG000|Overall Study|Severe non-compliance to protocol|1|||
46707273|NCT01197521|82922794|FG001|Overall Study|Severe non-compliance to protocol|3|||
46707274|NCT01197521|82922795|FG002|Overall Study|Severe non-compliance to protocol|3|||
46707275|NCT01197521|82922793|FG000|Overall Study|Lack of therapeutic response|2|||
46707276|NCT01197521|82922794|FG001|Overall Study|Lack of therapeutic response|3|||
46707277|NCT01197521|82922795|FG002|Overall Study|Lack of therapeutic response|4|||
46707278|NCT01197521|82922793|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
46707279|NCT01197521|82922794|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
46707280|NCT01197521|82922795|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
46707281|NCT01197521|82922793|FG000|Overall Study|Lost to Follow-up|3|||
46707282|NCT01197521|82922794|FG001|Overall Study|Lost to Follow-up|2|||
46707283|NCT01197521|82922795|FG002|Overall Study|Lost to Follow-up|2|||
46707284|NCT01197521|82922793|FG000|Overall Study|Adverse Event|25|||
46707285|NCT01197521|82922794|FG001|Overall Study|Adverse Event|28|||
46707286|NCT01197521|82922795|FG002|Overall Study|Adverse Event|24|||
46707287|NCT01157676|82922808|FG000|Randomization|Death|1|||
46707288|NCT01157676|82922809|FG001|Randomization|Death|1|||
46707289|NCT01157676|82922808|FG000|Randomization|unresectable|2|||
46707290|NCT01157676|82922809|FG001|Randomization|unresectable|3|||
46707291|NCT01157676|82922808|FG000|Randomization|Withdrawal by Subject|17|||
46707292|NCT01157676|82922809|FG001|Randomization|Withdrawal by Subject|13|||
46707293|NCT01157676|82922808|FG000|Randomization|Physician Decision|1|||
46707294|NCT01157676|82922809|FG001|Randomization|Physician Decision|0|||
46707295|NCT01157676|82922808|FG000|Surgery|underwent open cystectomy|0|||
46707296|NCT01157676|82922809|FG001|Surgery|underwent open cystectomy|4|||
46707297|NCT01157676|82922808|FG000|Surgery|converted to open procedure|0|||
46707298|NCT01157676|82922809|FG001|Surgery|converted to open procedure|5|||
46707299|NCT01157676|82922808|FG000|Surgery|underwent robotic cystectomy|1|||
46707300|NCT01157676|82922809|FG001|Surgery|underwent robotic cystectomy|0|||
46707301|NCT00991341|82922823|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
46707302|NCT00991341|82922824|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
46707303|NCT00991341|82922823|FG000|Overall Study|Death|3|||
46707304|NCT00991341|82922824|FG001|Overall Study|Death|0|||
46707305|NCT00991341|82922823|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
46896784|NCT02908074|83122267|FG001|Overall Study|AESI|0|||
46707306|NCT00991341|82922824|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
46707307|NCT00991341|82922823|FG000|Overall Study|Physician Decision|1|||
46707308|NCT00991341|82922824|FG001|Overall Study|Physician Decision|2|||
46707309|NCT00991341|82922823|FG000|Overall Study|Withdrawal by Subject|3|||
46707310|NCT00991341|82922824|FG001|Overall Study|Withdrawal by Subject|4|||
46707311|NCT00990249|82922830|FG000|Overall Study|Disease Progression|8|||
46707312|NCT00990249|82922830|FG000|Overall Study|Non-Compliance|1|||
46707313|NCT00990249|82922830|FG000|Overall Study|Death|2|||
46707314|NCT00990249|82922830|FG000|Overall Study|Not treated|2|||
46707315|NCT02846545|82922836|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
46707316|NCT02846545|82922837|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
46707317|NCT02846545|82922836|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
46707318|NCT02846545|82922837|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
46707319|NCT02846545|82922836|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
46707320|NCT02846545|82922837|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
46707321|NCT02846545|82922836|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
46707322|NCT02846545|82922837|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
46707323|NCT02846545|82922836|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
46707324|NCT02846545|82922837|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
46707325|NCT00990093|82922847|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
46707326|NCT00990093|82922848|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
46707327|NCT00990093|82922847|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
46707328|NCT00990093|82922848|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
46707329|NCT00990093|82922847|FG000|Test Period 1 (1-14 Days)|Other|1|||
46707330|NCT00990093|82922848|FG001|Test Period 1 (1-14 Days)|Other|0|||
46707331|NCT00990093|82922847|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
46707332|NCT00990093|82922848|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
46707333|NCT00990093|82922847|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
46707334|NCT00990093|82922848|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
46707335|NCT00990093|82922847|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
46707336|NCT00990093|82922848|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
46707337|NCT00990093|82922847|FG000|Test Period 2 (15-28 Days)|Other|0|||
46707338|NCT00990093|82922848|FG001|Test Period 2 (15-28 Days)|Other|1|||
46707339|NCT00984165|82922858|FG000|Overall Study|Death on study|2|||
46707340|NCT00984165|82922859|FG001|Overall Study|Death on study|0|||
46707341|NCT00984165|82922860|FG002|Overall Study|Death on study|0|||
46707342|NCT00984165|82922861|FG003|Overall Study|Death on study|0|||
46707343|NCT00984165|82922858|FG000|Overall Study|Disease progression on study|5|||
46707344|NCT00984165|82922859|FG001|Overall Study|Disease progression on study|1|||
46707345|NCT00984165|82922860|FG002|Overall Study|Disease progression on study|0|||
46707346|NCT00984165|82922861|FG003|Overall Study|Disease progression on study|0|||
46707347|NCT00984165|82922858|FG000|Overall Study|Death of recipient|0|||
46707348|NCT00984165|82922859|FG001|Overall Study|Death of recipient|0|||
46707349|NCT00984165|82922860|FG002|Overall Study|Death of recipient|0|||
46707350|NCT00984165|82922861|FG003|Overall Study|Death of recipient|1|||
46707351|NCT00984165|82922858|FG000|Overall Study|New protocol|0|||
46707352|NCT00984165|82922859|FG001|Overall Study|New protocol|0|||
46707353|NCT00984165|82922860|FG002|Overall Study|New protocol|0|||
46707354|NCT00984165|82922861|FG003|Overall Study|New protocol|1|||
46707355|NCT00984165|82922858|FG000|Overall Study|P+/donor pair removed from protocol|0|||
46707356|NCT00984165|82922859|FG001|Overall Study|P+/donor pair removed from protocol|0|||
46707357|NCT00984165|82922860|FG002|Overall Study|P+/donor pair removed from protocol|0|||
46707358|NCT00984165|82922861|FG003|Overall Study|P+/donor pair removed from protocol|1|||
46896785|NCT02908074|83122268|FG002|Overall Study|AESI|1|||
46896786|NCT02908074|83122269|FG003|Overall Study|AESI|0|||
46896787|NCT02908074|83122270|FG004|Overall Study|AESI|1|||
46896788|NCT02908074|83122271|FG005|Overall Study|AESI|0|||
46896789|NCT02908074|83122266|FG000|Overall Study|Discontinuation criteria per protocol|0|||
46896790|NCT02908074|83122267|FG001|Overall Study|Discontinuation criteria per protocol|0|||
46896791|NCT02908074|83122268|FG002|Overall Study|Discontinuation criteria per protocol|1|||
46896792|NCT02908074|83122269|FG003|Overall Study|Discontinuation criteria per protocol|0|||
46896793|NCT02908074|83122270|FG004|Overall Study|Discontinuation criteria per protocol|0|||
46896794|NCT02908074|83122271|FG005|Overall Study|Discontinuation criteria per protocol|1|||
46896795|NCT02908074|83122266|FG000|Overall Study|Withdrawal by Subject|3|||
46896796|NCT02908074|83122267|FG001|Overall Study|Withdrawal by Subject|2|||
46896797|NCT02908074|83122268|FG002|Overall Study|Withdrawal by Subject|2|||
46896798|NCT02908074|83122269|FG003|Overall Study|Withdrawal by Subject|2|||
46896799|NCT02908074|83122270|FG004|Overall Study|Withdrawal by Subject|2|||
46896800|NCT02908074|83122271|FG005|Overall Study|Withdrawal by Subject|2|||
46896801|NCT02908074|83122266|FG000|Overall Study|Lost to Follow-up|0|||
46896802|NCT02908074|83122267|FG001|Overall Study|Lost to Follow-up|1|||
46896803|NCT02908074|83122268|FG002|Overall Study|Lost to Follow-up|1|||
46896804|NCT02908074|83122269|FG003|Overall Study|Lost to Follow-up|1|||
46896805|NCT02908074|83122270|FG004|Overall Study|Lost to Follow-up|0|||
46896806|NCT02908074|83122271|FG005|Overall Study|Lost to Follow-up|1|||
46896807|NCT02907359|83122290|FG000|Overall Study|Death|234|||
46896808|NCT02907359|83122291|FG001|Overall Study|Death|117|||
46896809|NCT02907359|83122290|FG000|Overall Study|Withdrawal by Subject|6|||
46896810|NCT02907359|83122291|FG001|Overall Study|Withdrawal by Subject|11|||
46896811|NCT02907359|83122290|FG000|Overall Study|Lost to Follow-up|1|||
46896812|NCT02907359|83122291|FG001|Overall Study|Lost to Follow-up|0|||
46896813|NCT02714205|83122299|FG000|Overall Study|Cannot tolerate medication|1|||
46896814|NCT02714205|83122300|FG001|Overall Study|Cannot tolerate medication|0|||
46896815|NCT02714205|83122299|FG000|Overall Study|Adverse Event|2|||
46896816|NCT02714205|83122300|FG001|Overall Study|Adverse Event|0|||
46896817|NCT02714205|83122299|FG000|Overall Study|Too busy|1|||
46896818|NCT02714205|83122300|FG001|Overall Study|Too busy|0|||
46896819|NCT02714205|83122299|FG000|Overall Study|Incomplete outcome data|0|||
46896820|NCT02714205|83122300|FG001|Overall Study|Incomplete outcome data|1|||
46896821|NCT00583752|83122324|FG000|Overall Study|Lost to Follow-up|5|||
46896822|NCT00583752|83122325|FG001|Overall Study|Lost to Follow-up|5|||
46896823|NCT03170154|83122343|FG000|Overall Study|Lost to Follow-up|4|||
46896824|NCT03170154|83122343|FG000|Overall Study|Death|2|||
46896825|NCT03170154|83122343|FG000|Overall Study|Withdrawal by Subject|2|||
46896826|NCT03518125|83122358|FG000|Overall Study|Lost to Follow-up|0|||
46896827|NCT03518125|83122359|FG001|Overall Study|Lost to Follow-up|2|||
46896828|NCT03518125|83122360|FG002|Overall Study|Lost to Follow-up|0|||
46896829|NCT03518125|83122361|FG003|Overall Study|Lost to Follow-up|0|||
46896830|NCT03518125|83122362|FG004|Overall Study|Lost to Follow-up|3|||
46896831|NCT03518125|83122363|FG005|Overall Study|Lost to Follow-up|5|||
46896832|NCT03518125|83122358|FG000|Overall Study|Physician Decision|0|||
46896833|NCT03518125|83122359|FG001|Overall Study|Physician Decision|1|||
46896834|NCT03518125|83122360|FG002|Overall Study|Physician Decision|0|||
46896835|NCT03518125|83122361|FG003|Overall Study|Physician Decision|0|||
46896836|NCT03518125|83122362|FG004|Overall Study|Physician Decision|0|||
46896837|NCT03518125|83122363|FG005|Overall Study|Physician Decision|0|||
46896838|NCT03518125|83122358|FG000|Overall Study|Withdrawal by Subject|1|||
46896839|NCT03518125|83122359|FG001|Overall Study|Withdrawal by Subject|1|||
46896840|NCT03518125|83122360|FG002|Overall Study|Withdrawal by Subject|0|||
46896841|NCT03518125|83122361|FG003|Overall Study|Withdrawal by Subject|1|||
46896842|NCT03518125|83122362|FG004|Overall Study|Withdrawal by Subject|1|||
46896843|NCT03518125|83122363|FG005|Overall Study|Withdrawal by Subject|3|||
46896844|NCT03518125|83122358|FG000|Overall Study|Missed Day 394 Visit|1|||
46896845|NCT03518125|83122359|FG001|Overall Study|Missed Day 394 Visit|0|||
46896846|NCT03518125|83122360|FG002|Overall Study|Missed Day 394 Visit|0|||
46896847|NCT03518125|83122361|FG003|Overall Study|Missed Day 394 Visit|0|||
46896848|NCT03518125|83122362|FG004|Overall Study|Missed Day 394 Visit|0|||
46896849|NCT03518125|83122363|FG005|Overall Study|Missed Day 394 Visit|0|||
46896850|NCT03169530|83122380|FG000|Overall Study|Study ended by NIH|15|||
46896851|NCT03169530|83122381|FG001|Overall Study|Study ended by NIH|17|||
46896852|NCT03478891|83122399|FG000|Overall Study|Enrolled, but product never administered|0|||
46896853|NCT03478891|83122400|FG001|Overall Study|Enrolled, but product never administered|0|||
46896854|NCT03478891|83122401|FG002|Overall Study|Enrolled, but product never administered|1|||
46896855|NCT03478891|83122399|FG000|Overall Study|Moved from area|0|||
46896856|NCT03478891|83122400|FG001|Overall Study|Moved from area|0|||
46896857|NCT03478891|83122401|FG002|Overall Study|Moved from area|1|||
46896858|NCT03478891|83122399|FG000|Overall Study|Lost to Follow-up|1|||
46896859|NCT03478891|83122400|FG001|Overall Study|Lost to Follow-up|0|||
46896860|NCT03478891|83122401|FG002|Overall Study|Lost to Follow-up|1|||
46896861|NCT01585103|83122413|FG000|Overall Study|Unable to swallow Cytosponge|6|||
46896862|NCT03168906|83122419|FG000|Overall Study|Lack of Efficacy|6|||
46896863|NCT03168906|83122420|FG001|Overall Study|Lack of Efficacy|6|||
46896864|NCT00706966|83122427|FG000|Overall Study|Adverse Event|1|||
46896865|NCT03478657|83122461|FG000|Overall Study|Withdrawal by Subject|0|||
46896866|NCT03478657|83122462|FG001|Overall Study|Withdrawal by Subject|1|||
46896867|NCT03018288|83122472|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
46896868|NCT03018288|83122473|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
46896869|NCT03018288|83122474|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
46896870|NCT03018288|83122475|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
46896871|NCT03018288|83122472|FG000|Overall Study|Participant withdrew consent.|0|||
46896872|NCT03018288|83122473|FG001|Overall Study|Participant withdrew consent.|0|||
46896873|NCT03018288|83122474|FG002|Overall Study|Participant withdrew consent.|1|||
46896874|NCT03018288|83122475|FG003|Overall Study|Participant withdrew consent.|0|||
46896875|NCT03018288|83122472|FG000|Overall Study|Switched to alternative treatment.|0|||
46896876|NCT03018288|83122473|FG001|Overall Study|Switched to alternative treatment.|0|||
46896877|NCT03018288|83122474|FG002|Overall Study|Switched to alternative treatment.|1|||
46896878|NCT03018288|83122475|FG003|Overall Study|Switched to alternative treatment.|0|||
46896879|NCT03018288|83122472|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
46896880|NCT03018288|83122473|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
46896881|NCT03018288|83122474|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
46896882|NCT03018288|83122475|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
46896883|NCT03018288|83122472|FG000|Overall Study|Screen failures|0|||
46896884|NCT03018288|83122473|FG001|Overall Study|Screen failures|0|||
46896885|NCT03018288|83122474|FG002|Overall Study|Screen failures|0|||
46896886|NCT03018288|83122475|FG003|Overall Study|Screen failures|51|||
46896887|NCT03018288|83122472|FG000|Overall Study|Chose treatment outside of UNC|0|||
46896888|NCT03018288|83122473|FG001|Overall Study|Chose treatment outside of UNC|0|||
46896889|NCT03018288|83122474|FG002|Overall Study|Chose treatment outside of UNC|0|||
46896890|NCT03018288|83122475|FG003|Overall Study|Chose treatment outside of UNC|1|||
46896891|NCT03018288|83122472|FG000|Overall Study|Unable to comply with protocol requirements|1|||
46896892|NCT03018288|83122473|FG001|Overall Study|Unable to comply with protocol requirements|1|||
46896893|NCT03018288|83122474|FG002|Overall Study|Unable to comply with protocol requirements|0|||
46896894|NCT03018288|83122475|FG003|Overall Study|Unable to comply with protocol requirements|1|||
46896895|NCT03018288|83122472|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
46896896|NCT03018288|83122473|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
46896897|NCT03018288|83122474|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
46896898|NCT03018288|83122475|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
46896899|NCT03018288|83122472|FG000|Overall Study|Physician Decision|0|||
46896900|NCT03018288|83122473|FG001|Overall Study|Physician Decision|0|||
46896901|NCT03018288|83122474|FG002|Overall Study|Physician Decision|0|||
46896902|NCT03018288|83122475|FG003|Overall Study|Physician Decision|1|||
46896903|NCT03515941|83122492|FG000|Overall Study|Adverse Event|1|||
46896904|NCT03515941|83122493|FG001|Overall Study|Adverse Event|0|||
46896905|NCT03011034|83122501|FG000|Overall Study|Adverse Event|1|||
46896906|NCT03011034|83122502|FG001|Overall Study|Adverse Event|0|||
46896907|NCT03515629|83122510|FG000|Overall Study|Death|0|||
46896908|NCT03515629|83122511|FG001|Overall Study|Death|1|||
46896909|NCT03515629|83122512|FG002|Overall Study|Death|1|||
46896910|NCT03515629|83122510|FG000|Overall Study|Progressive disease|0|||
46896911|NCT03515629|83122511|FG001|Overall Study|Progressive disease|1|||
46896912|NCT03515629|83122512|FG002|Overall Study|Progressive disease|0|||
46896913|NCT03512353|83122521|FG000|Overall Study|Sponsor Decision|3|||
46896914|NCT03512353|83122521|FG000|Overall Study|Death|1|||
46896915|NCT03512275|83122529|FG000|Overall Study|Withdrawal by Subject|1|||
46896916|NCT03512275|83122530|FG001|Overall Study|Withdrawal by Subject|3|||
46896917|NCT03512275|83122529|FG000|Overall Study|Physician Decision|0|||
46896918|NCT03512275|83122530|FG001|Overall Study|Physician Decision|1|||
46896919|NCT03512275|83122529|FG000|Overall Study|Lost to Follow-up|0|||
46896920|NCT03512275|83122530|FG001|Overall Study|Lost to Follow-up|3|||
46896921|NCT03512275|83122529|FG000|Overall Study|Other|1|||
46896922|NCT03512275|83122530|FG001|Overall Study|Other|0|||
46896923|NCT03473197|83122536|FG000|Overall Study|Adverse Event|4|||
46896924|NCT03473197|83122536|FG000|Overall Study|Lost to Follow-up|1|||
46896925|NCT03473197|83122536|FG000|Overall Study|Withdrawal by Subject|5|||
46896926|NCT03511105|83122542|FG000|Overall Study|Adverse Event|1|||
46896927|NCT03511105|83122543|FG001|Overall Study|Adverse Event|0|||
46896928|NCT03511105|83122542|FG000|Overall Study|Withdrew consent|1|||
46896929|NCT03511105|83122543|FG001|Overall Study|Withdrew consent|0|||
46896930|NCT03510715|83122563|FG000|Overall Study|Adverse Event|1|||
46896931|NCT03510715|83122564|FG001|Overall Study|Adverse Event|0|||
46896932|NCT03508843|83122571|FG000|Overall Study|Withdrawal by Subject|1|||
46896933|NCT03508843|83122571|FG000|Overall Study|technical difficulties|2|||
46896934|NCT03508609|83122575|FG000|Overall Study|Withdrawal by Subject|1|||
46896935|NCT03054350|83122585|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
46896936|NCT03054350|83122586|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
46896937|NCT03054350|83122587|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
46896938|NCT03054350|83122588|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
46896939|NCT03054350|83122589|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
46896940|NCT03054350|83122590|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
46896941|NCT03054350|83122585|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
46896942|NCT03054350|83122586|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
46896943|NCT03054350|83122587|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
46896944|NCT03054350|83122588|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
46896945|NCT03054350|83122589|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
46896946|NCT03054350|83122590|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
46896947|NCT03054350|83122585|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
46896948|NCT03054350|83122586|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
46896949|NCT03054350|83122587|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
46896950|NCT03054350|83122588|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
46896951|NCT03054350|83122589|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
46896952|NCT03054350|83122590|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
46896953|NCT03054350|83122585|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
46896954|NCT03054350|83122586|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
46896955|NCT03054350|83122587|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
46896956|NCT03054350|83122588|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
46896957|NCT03054350|83122589|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
46991845|NCT02175771|83238740|FG007|Treatment Period|Lost to Follow-up|2|||
46991846|NCT02175771|83238741|FG008|Treatment Period|Lost to Follow-up|2|||
46991847|NCT02175771|83238733|FG000|Treatment Period|Lack of Efficacy|0|||
46991848|NCT02175771|83238734|FG001|Treatment Period|Lack of Efficacy|0|||
46991849|NCT02175771|83238735|FG002|Treatment Period|Lack of Efficacy|0|||
46991850|NCT02175771|83238736|FG003|Treatment Period|Lack of Efficacy|0|||
46991851|NCT02175771|83238737|FG004|Treatment Period|Lack of Efficacy|0|||
46991852|NCT02175771|83238738|FG005|Treatment Period|Lack of Efficacy|1|||
46991853|NCT02175771|83238739|FG006|Treatment Period|Lack of Efficacy|0|||
46991854|NCT02175771|83238740|FG007|Treatment Period|Lack of Efficacy|1|||
46991855|NCT02175771|83238741|FG008|Treatment Period|Lack of Efficacy|0|||
46991856|NCT02175771|83238733|FG000|Treatment Period|Other|0|||
46991857|NCT02175771|83238734|FG001|Treatment Period|Other|1|||
46991858|NCT02175771|83238735|FG002|Treatment Period|Other|0|||
46991859|NCT02175771|83238736|FG003|Treatment Period|Other|3|||
46991860|NCT02175771|83238737|FG004|Treatment Period|Other|1|||
46991861|NCT02175771|83238738|FG005|Treatment Period|Other|0|||
46991862|NCT02175771|83238739|FG006|Treatment Period|Other|0|||
46991863|NCT02175771|83238740|FG007|Treatment Period|Other|2|||
46991864|NCT02175771|83238741|FG008|Treatment Period|Other|0|||
46991865|NCT01657799|83238762|FG000|Overall Study|Adverse Event Related to progression|6|||
46991866|NCT01657799|83238763|FG001|Overall Study|Adverse Event Related to progression|8|||
46991867|NCT01657799|83238764|FG002|Overall Study|Adverse Event Related to progression|12|||
46991868|NCT01657799|83238762|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
46991869|NCT01657799|83238763|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
46991870|NCT01657799|83238764|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
46991871|NCT01657799|83238762|FG000|Overall Study|Withdrawal by Subject|13|||
46991872|NCT01657799|83238763|FG001|Overall Study|Withdrawal by Subject|10|||
46991873|NCT01657799|83238764|FG002|Overall Study|Withdrawal by Subject|10|||
46991874|NCT01657799|83238762|FG000|Overall Study|Lost to Follow-up|1|||
46991875|NCT01657799|83238763|FG001|Overall Study|Lost to Follow-up|0|||
46991876|NCT01657799|83238764|FG002|Overall Study|Lost to Follow-up|1|||
46991877|NCT01657799|83238762|FG000|Overall Study|Disease Progression|2|||
46991878|NCT01657799|83238763|FG001|Overall Study|Disease Progression|4|||
46991879|NCT01657799|83238764|FG002|Overall Study|Disease Progression|4|||
46991880|NCT01657799|83238762|FG000|Overall Study|Progressive Disease Clinical|7|||
46991881|NCT01657799|83238763|FG001|Overall Study|Progressive Disease Clinical|4|||
46991882|NCT01657799|83238764|FG002|Overall Study|Progressive Disease Clinical|7|||
46991883|NCT01657799|83238762|FG000|Overall Study|Radiographic & Clinical Progression|16|||
46991884|NCT01657799|83238763|FG001|Overall Study|Radiographic & Clinical Progression|11|||
46991885|NCT01657799|83238764|FG002|Overall Study|Radiographic & Clinical Progression|15|||
46991886|NCT01657799|83238762|FG000|Overall Study|Other|52|||
46991887|NCT01657799|83238763|FG001|Overall Study|Other|62|||
46991888|NCT01657799|83238764|FG002|Overall Study|Other|49|||
46991889|NCT02116803|83238774|FG000|Overall Study|Adverse Event|2|||
46991890|NCT02116803|83238775|FG001|Overall Study|Adverse Event|1|||
46991891|NCT02116803|83238774|FG000|Overall Study|Physician Decision|1|||
46991892|NCT02116803|83238775|FG001|Overall Study|Physician Decision|0|||
46991893|NCT02116803|83238774|FG000|Overall Study|Progressive disease|4|||
46991894|NCT02116803|83238775|FG001|Overall Study|Progressive disease|0|||
46991895|NCT02116803|83238774|FG000|Overall Study|Study terminated by sponsor|2|||
46991896|NCT02116803|83238775|FG001|Overall Study|Study terminated by sponsor|1|||
46991897|NCT02116803|83238774|FG000|Overall Study|Death|1|||
46991898|NCT02116803|83238775|FG001|Overall Study|Death|0|||
46991899|NCT02115321|83238783|FG000|Overall Study|Death|1|||
46991900|NCT02115321|83238784|FG001|Overall Study|Death|0|||
46991901|NCT02367781|83238792|FG000|Overall Study|Withdrawal by Subject|20|||
46991902|NCT02367781|83238793|FG001|Overall Study|Withdrawal by Subject|13|||
46991903|NCT02367781|83238792|FG000|Overall Study|Protocol Violation|0|||
46991904|NCT02367781|83238793|FG001|Overall Study|Protocol Violation|1|||
46991905|NCT02367781|83238792|FG000|Overall Study|Physician Decision|7|||
46991906|NCT02367781|83238793|FG001|Overall Study|Physician Decision|0|||
46991907|NCT02367781|83238792|FG000|Overall Study|Randomized in Error|5|||
46991908|NCT02367781|83238793|FG001|Overall Study|Randomized in Error|4|||
46991909|NCT02367781|83238792|FG000|Overall Study|Non-Compliance|1|||
46991910|NCT02367781|83238793|FG001|Overall Study|Non-Compliance|0|||
46896958|NCT03054350|83122590|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
46896959|NCT03528577|83122621|FG000|Sequence 1|Failed Spirometry|1|||
46896960|NCT03528577|83122621|FG000|Sequence 1|Restricted medication|1|||
46896961|NCT03528577|83122621|FG000|Sequence 2|Adverse Event|1|||
46896962|NCT03528577|83122621|FG000|Sequence 2|Withdrawal by Subject|1|||
46896963|NCT03528577|83122621|FG000|Sequence 2|Failed Spirometry|1|||
46896964|NCT03528577|83122621|FG000|Sequence 3|Failed Spirometry|1|||
46896965|NCT03528577|83122621|FG000|Sequence 4|Failed Spirometry|2|||
46991911|NCT02367781|83238792|FG000|Overall Study|Lost to Follow-up|1|||
46991912|NCT02367781|83238793|FG001|Overall Study|Lost to Follow-up|2|||
46991913|NCT02367781|83238792|FG000|Overall Study|Death|330|||
46991914|NCT02367781|83238793|FG001|Overall Study|Death|176|||
46991915|NCT02367781|83238792|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
46991916|NCT02367781|83238793|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
46991917|NCT02367781|83238792|FG000|Overall Study|Prolonged Hospitalization|1|||
46991918|NCT02367781|83238793|FG001|Overall Study|Prolonged Hospitalization|0|||
46991919|NCT02367781|83238792|FG000|Overall Study|Death Prior First Dose|1|||
46991920|NCT02367781|83238793|FG001|Overall Study|Death Prior First Dose|0|||
46991921|NCT02367781|83238792|FG000|Overall Study|Administrative-Change Facility|1|||
46991922|NCT02367781|83238793|FG001|Overall Study|Administrative-Change Facility|0|||
46991923|NCT02367781|83238792|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
46991924|NCT02367781|83238793|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
46991925|NCT02367781|83238792|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
46991926|NCT02367781|83238793|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
46991927|NCT02367781|83238792|FG000|Overall Study|Study Terminated by Sponsor|3|||
46991928|NCT02367781|83238793|FG001|Overall Study|Study Terminated by Sponsor|1|||
46991929|NCT02367781|83238792|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
46991930|NCT02367781|83238793|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
46991931|NCT02367781|83238792|FG000|Overall Study|Sponsor Decision|2|||
46991932|NCT02367781|83238793|FG001|Overall Study|Sponsor Decision|0|||
46991933|NCT02367781|83238792|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
46991934|NCT02367781|83238793|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
46991935|NCT02152761|83238805|FG000|Epoch: Treatment Epoch|Technical problems|0|||
46991936|NCT02152761|83238806|FG001|Epoch: Treatment Epoch|Technical problems|0|||
46991937|NCT02152761|83238807|FG002|Epoch: Treatment Epoch|Technical problems|0|||
46991938|NCT02152761|83238808|FG003|Epoch: Treatment Epoch|Technical problems|1|||
46991939|NCT02152761|83238805|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
46991940|NCT02152761|83238806|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
46991941|NCT02152761|83238807|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
46991942|NCT02152761|83238808|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
46991943|NCT02152761|83238805|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
46991944|NCT02152761|83238806|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
46991945|NCT02152761|83238807|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
46991946|NCT02152761|83238808|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
46991947|NCT02152761|83238805|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
46991948|NCT02152761|83238806|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
46991949|NCT02152761|83238807|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
46991950|NCT02152761|83238808|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
46991951|NCT02152761|83238805|FG000|Epoch: Treatment Epoch|Death|0|||
46991952|NCT02152761|83238806|FG001|Epoch: Treatment Epoch|Death|3|||
46991953|NCT02152761|83238807|FG002|Epoch: Treatment Epoch|Death|1|||
46991954|NCT02152761|83238808|FG003|Epoch: Treatment Epoch|Death|0|||
46991955|NCT02152761|83238805|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
46991956|NCT02152761|83238806|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
46991957|NCT02152761|83238807|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
46991958|NCT02152761|83238808|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
46991959|NCT02152761|83238805|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
46991960|NCT02152761|83238806|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
46991961|NCT02152761|83238807|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
46991962|NCT02152761|83238808|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
46991963|NCT02152761|83238805|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
46991964|NCT02152761|83238806|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
46991965|NCT02152761|83238807|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
46991966|NCT02152761|83238808|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
46991967|NCT02152761|83238805|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
46991968|NCT02152761|83238806|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
46991969|NCT02152761|83238807|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
46991970|NCT02152761|83238808|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
46991971|NCT02152761|83238805|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
46991972|NCT02152761|83238806|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
46991973|NCT02152761|83238807|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
46991974|NCT02152761|83238808|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
46991975|NCT02152605|83238830|FG000|Overall Study|Adverse Event|6|||
46991976|NCT02152605|83238831|FG001|Overall Study|Adverse Event|8|||
46991977|NCT02152605|83238830|FG000|Overall Study|Lack of Efficacy|7|||
46991978|NCT02152605|83238831|FG001|Overall Study|Lack of Efficacy|4|||
46991979|NCT02152605|83238830|FG000|Overall Study|Protocol deviation|1|||
46991980|NCT02152605|83238831|FG001|Overall Study|Protocol deviation|4|||
46991981|NCT02152605|83238830|FG000|Overall Study|Lost to Follow-up|1|||
46991982|NCT02152605|83238831|FG001|Overall Study|Lost to Follow-up|0|||
46991983|NCT02152605|83238830|FG000|Overall Study|Withdrew consent|4|||
46991984|NCT02152605|83238831|FG001|Overall Study|Withdrew consent|2|||
46991985|NCT02152371|83238840|FG000|Overall Study|Adverse Event|6|||
46991986|NCT02152371|83238841|FG001|Overall Study|Adverse Event|2|||
46991987|NCT02152371|83238840|FG000|Overall Study|Withdrawal by Subject|3|||
46991988|NCT02152371|83238841|FG001|Overall Study|Withdrawal by Subject|7|||
46991989|NCT02152371|83238840|FG000|Overall Study|Protocol Violation|2|||
46991990|NCT02152371|83238841|FG001|Overall Study|Protocol Violation|3|||
46991991|NCT02152371|83238840|FG000|Overall Study|Lost to Follow-up|1|||
46991992|NCT02152371|83238841|FG001|Overall Study|Lost to Follow-up|0|||
46991993|NCT02152371|83238840|FG000|Overall Study|Lack of Efficacy|0|||
46991994|NCT02152371|83238841|FG001|Overall Study|Lack of Efficacy|1|||
46991995|NCT02152371|83238840|FG000|Overall Study|Physician Decision|0|||
46991996|NCT02152371|83238841|FG001|Overall Study|Physician Decision|2|||
46991997|NCT02152371|83238840|FG000|Overall Study|Reason Not Given|0|||
46991998|NCT02152371|83238841|FG001|Overall Study|Reason Not Given|1|||
46991999|NCT02332291|83238849|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
46992000|NCT02332291|83238850|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
46992001|NCT02332291|83238849|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
46992002|NCT02332291|83238850|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
46992003|NCT02332291|83238849|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
46992004|NCT02332291|83238850|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
46992005|NCT02332291|83238849|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
46992006|NCT02332291|83238850|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
46992007|NCT02332291|83238849|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
46992008|NCT02332291|83238850|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
46992009|NCT02332291|83238849|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
46992010|NCT02332291|83238850|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
46992011|NCT01656395|83238866|FG000|Overall Study|Adverse Event|1|||
46992012|NCT01656395|83238867|FG001|Overall Study|Adverse Event|14|||
46992013|NCT01656395|83238868|FG002|Overall Study|Adverse Event|5|||
46992014|NCT01656395|83238869|FG003|Overall Study|Adverse Event|4|||
46992015|NCT01656395|83238870|FG004|Overall Study|Adverse Event|5|||
46992016|NCT01656395|83238871|FG005|Overall Study|Adverse Event|7|||
46992017|NCT01656395|83238872|FG006|Overall Study|Adverse Event|0|||
46992018|NCT01656395|83238873|FG007|Overall Study|Adverse Event|0|||
46992019|NCT01656395|83238866|FG000|Overall Study|Lack of Efficacy|1|||
46992020|NCT01656395|83238867|FG001|Overall Study|Lack of Efficacy|8|||
46992021|NCT01656395|83238868|FG002|Overall Study|Lack of Efficacy|6|||
46992022|NCT01656395|83238869|FG003|Overall Study|Lack of Efficacy|1|||
46992023|NCT01656395|83238870|FG004|Overall Study|Lack of Efficacy|1|||
46992024|NCT01656395|83238871|FG005|Overall Study|Lack of Efficacy|6|||
46992025|NCT01656395|83238872|FG006|Overall Study|Lack of Efficacy|0|||
46992026|NCT01656395|83238873|FG007|Overall Study|Lack of Efficacy|0|||
46992027|NCT01656395|83238866|FG000|Overall Study|Lost to Follow-up|1|||
46992028|NCT01656395|83238867|FG001|Overall Study|Lost to Follow-up|0|||
46992029|NCT01656395|83238868|FG002|Overall Study|Lost to Follow-up|0|||
46992030|NCT01656395|83238869|FG003|Overall Study|Lost to Follow-up|0|||
46992031|NCT01656395|83238870|FG004|Overall Study|Lost to Follow-up|0|||
46992032|NCT01656395|83238871|FG005|Overall Study|Lost to Follow-up|0|||
46992033|NCT01656395|83238872|FG006|Overall Study|Lost to Follow-up|0|||
46992034|NCT01656395|83238873|FG007|Overall Study|Lost to Follow-up|0|||
46992035|NCT01656395|83238866|FG000|Overall Study|Non-Compliance with Study Drug|1|||
46992036|NCT01656395|83238867|FG001|Overall Study|Non-Compliance with Study Drug|1|||
46992037|NCT01656395|83238868|FG002|Overall Study|Non-Compliance with Study Drug|0|||
46992038|NCT01656395|83238869|FG003|Overall Study|Non-Compliance with Study Drug|0|||
46992039|NCT01656395|83238870|FG004|Overall Study|Non-Compliance with Study Drug|1|||
46992040|NCT01656395|83238871|FG005|Overall Study|Non-Compliance with Study Drug|1|||
46992041|NCT01656395|83238872|FG006|Overall Study|Non-Compliance with Study Drug|0|||
46992042|NCT01656395|83238873|FG007|Overall Study|Non-Compliance with Study Drug|0|||
46992043|NCT01656395|83238866|FG000|Overall Study|Other|0|||
46992044|NCT01656395|83238867|FG001|Overall Study|Other|0|||
46992045|NCT01656395|83238868|FG002|Overall Study|Other|1|||
46992046|NCT01656395|83238869|FG003|Overall Study|Other|0|||
46992047|NCT01656395|83238870|FG004|Overall Study|Other|0|||
46992048|NCT01656395|83238871|FG005|Overall Study|Other|1|||
46992049|NCT01656395|83238872|FG006|Overall Study|Other|0|||
46992050|NCT01656395|83238873|FG007|Overall Study|Other|0|||
46992051|NCT01656395|83238866|FG000|Overall Study|Physician Decision|2|||
46992052|NCT01656395|83238867|FG001|Overall Study|Physician Decision|3|||
46992053|NCT01656395|83238868|FG002|Overall Study|Physician Decision|3|||
46992054|NCT01656395|83238869|FG003|Overall Study|Physician Decision|2|||
46992055|NCT01656395|83238870|FG004|Overall Study|Physician Decision|3|||
46992056|NCT01656395|83238871|FG005|Overall Study|Physician Decision|3|||
46992057|NCT01656395|83238872|FG006|Overall Study|Physician Decision|0|||
46992058|NCT01656395|83238873|FG007|Overall Study|Physician Decision|0|||
46992059|NCT01656395|83238866|FG000|Overall Study|Pregnancy|0|||
46992060|NCT01656395|83238867|FG001|Overall Study|Pregnancy|0|||
46992061|NCT01656395|83238868|FG002|Overall Study|Pregnancy|1|||
46992062|NCT01656395|83238869|FG003|Overall Study|Pregnancy|0|||
46992063|NCT01656395|83238870|FG004|Overall Study|Pregnancy|0|||
46992064|NCT01656395|83238871|FG005|Overall Study|Pregnancy|0|||
46992065|NCT01656395|83238872|FG006|Overall Study|Pregnancy|0|||
46992066|NCT01656395|83238873|FG007|Overall Study|Pregnancy|0|||
46992067|NCT01656395|83238866|FG000|Overall Study|Progressive Disease|0|||
46992068|NCT01656395|83238867|FG001|Overall Study|Progressive Disease|0|||
46992069|NCT01656395|83238868|FG002|Overall Study|Progressive Disease|0|||
46992070|NCT01656395|83238869|FG003|Overall Study|Progressive Disease|0|||
46992071|NCT01656395|83238870|FG004|Overall Study|Progressive Disease|0|||
46992072|NCT01656395|83238871|FG005|Overall Study|Progressive Disease|1|||
46992073|NCT01656395|83238872|FG006|Overall Study|Progressive Disease|0|||
46992074|NCT01656395|83238873|FG007|Overall Study|Progressive Disease|0|||
46992075|NCT01656395|83238866|FG000|Overall Study|Protocol Violation|6|||
46992076|NCT01656395|83238867|FG001|Overall Study|Protocol Violation|6|||
46992077|NCT01656395|83238868|FG002|Overall Study|Protocol Violation|9|||
46992078|NCT01656395|83238869|FG003|Overall Study|Protocol Violation|2|||
46992079|NCT01656395|83238870|FG004|Overall Study|Protocol Violation|4|||
46992080|NCT01656395|83238871|FG005|Overall Study|Protocol Violation|10|||
46992081|NCT01656395|83238872|FG006|Overall Study|Protocol Violation|0|||
46992082|NCT01656395|83238873|FG007|Overall Study|Protocol Violation|0|||
46992083|NCT01656395|83238866|FG000|Overall Study|Screen Failure|2|||
46992084|NCT01656395|83238867|FG001|Overall Study|Screen Failure|1|||
46992085|NCT01656395|83238868|FG002|Overall Study|Screen Failure|7|||
46992086|NCT01656395|83238869|FG003|Overall Study|Screen Failure|1|||
46992087|NCT01656395|83238870|FG004|Overall Study|Screen Failure|0|||
46992088|NCT01656395|83238871|FG005|Overall Study|Screen Failure|8|||
46992089|NCT01656395|83238872|FG006|Overall Study|Screen Failure|0|||
46992090|NCT01656395|83238873|FG007|Overall Study|Screen Failure|0|||
46992091|NCT01656395|83238866|FG000|Overall Study|Withdrawal by Subject|3|||
46992092|NCT01656395|83238867|FG001|Overall Study|Withdrawal by Subject|1|||
46992093|NCT01656395|83238868|FG002|Overall Study|Withdrawal by Subject|4|||
46992094|NCT01656395|83238869|FG003|Overall Study|Withdrawal by Subject|2|||
46992095|NCT01656395|83238870|FG004|Overall Study|Withdrawal by Subject|0|||
46992096|NCT01656395|83238871|FG005|Overall Study|Withdrawal by Subject|3|||
46992097|NCT01656395|83238872|FG006|Overall Study|Withdrawal by Subject|0|||
46992098|NCT01656395|83238873|FG007|Overall Study|Withdrawal by Subject|0|||
46992099|NCT02114931|83238889|FG000|Overall Study|Withdrawal by Subject|15|||
46992100|NCT02114931|83238890|FG001|Overall Study|Withdrawal by Subject|18|||
46992101|NCT02114931|83238889|FG000|Overall Study|Adverse Event|4|||
46992102|NCT02114931|83238890|FG001|Overall Study|Adverse Event|6|||
46992103|NCT02114931|83238889|FG000|Overall Study|Lost to Follow-up|3|||
46992104|NCT02114931|83238890|FG001|Overall Study|Lost to Follow-up|3|||
46992105|NCT02114931|83238889|FG000|Overall Study|Physician Decision|1|||
46992106|NCT02114931|83238890|FG001|Overall Study|Physician Decision|2|||
46992107|NCT02114931|83238889|FG000|Overall Study|Other|2|||
46992108|NCT02114931|83238890|FG001|Overall Study|Other|1|||
46992109|NCT01657019|83238896|FG000|Overall Study|Withdrawal by Subject|65|||
46992110|NCT01657019|83238896|FG000|Overall Study|Adverse Event|55|||
46992111|NCT01657019|83238896|FG000|Overall Study|Lost to Follow-up|48|||
46992112|NCT01657019|83238896|FG000|Overall Study|Protocol Violation|6|||
46992113|NCT01657019|83238896|FG000|Overall Study|Lack of Efficacy|3|||
46992114|NCT01657019|83238896|FG000|Overall Study|Other|58|||
46992115|NCT02329327|83238902|FG000|Overall Study|Death|78|||
46992116|NCT02329327|83238903|FG001|Overall Study|Death|0|||
46992117|NCT02329327|83238902|FG000|Overall Study|Withdrawal by Subject|3|||
46992118|NCT02329327|83238903|FG001|Overall Study|Withdrawal by Subject|0|||
46992119|NCT02329327|83238902|FG000|Overall Study|Lost to Follow-up|4|||
46992120|NCT02329327|83238903|FG001|Overall Study|Lost to Follow-up|0|||
46992121|NCT02328937|83238922|FG000|Period 1|Lost to Follow-up|0|||
46992122|NCT02328937|83238923|FG001|Period 1|Lost to Follow-up|0|||
46992123|NCT02328937|83238924|FG002|Period 1|Lost to Follow-up|0|||
46992124|NCT02328937|83238925|FG003|Period 1|Lost to Follow-up|1|||
46992125|NCT02328937|83238926|FG004|Period 1|Lost to Follow-up|0|||
46992126|NCT02328937|83238927|FG005|Period 1|Lost to Follow-up|0|||
46992127|NCT02328937|83238922|FG000|Period 2|Adverse Event|0|||
46992128|NCT02328937|83238923|FG001|Period 2|Adverse Event|0|||
46992129|NCT02328937|83238924|FG002|Period 2|Adverse Event|1|||
46992130|NCT02328937|83238925|FG003|Period 2|Adverse Event|0|||
46992131|NCT02328937|83238926|FG004|Period 2|Adverse Event|0|||
46992132|NCT02328937|83238927|FG005|Period 2|Adverse Event|0|||
46992133|NCT02328547|83238937|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
46992134|NCT02328547|83238938|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
46992135|NCT02328547|83238937|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
46992136|NCT02328547|83238938|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
46992137|NCT02300311|83238952|FG000|Overall Study|Other than the reason specified|1|||
46992138|NCT02300311|83238953|FG001|Overall Study|Other than the reason specified|0|||
46992139|NCT02300311|83238952|FG000|Overall Study|Refused to continue taking medication|18|||
46992140|NCT02300311|83238953|FG001|Overall Study|Refused to continue taking medication|0|||
46992141|NCT02300233|83238966|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
46992142|NCT02300233|83238967|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
46992143|NCT02300233|83238968|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
46992144|NCT02300233|83238966|FG000|Overall Study|Withdrawal by Subject|1|||
46992145|NCT02300233|83238967|FG001|Overall Study|Withdrawal by Subject|0|||
46992146|NCT02300233|83238968|FG002|Overall Study|Withdrawal by Subject|3|||
46992147|NCT02300233|83238966|FG000|Overall Study|Investigator Judgement|0|||
46992148|NCT02300233|83238967|FG001|Overall Study|Investigator Judgement|0|||
46992149|NCT02300233|83238968|FG002|Overall Study|Investigator Judgement|1|||
46992150|NCT02300233|83238966|FG000|Overall Study|Reason Not Specified|0|||
46992151|NCT02300233|83238967|FG001|Overall Study|Reason Not Specified|0|||
46992152|NCT02300233|83238968|FG002|Overall Study|Reason Not Specified|5|||
46992153|NCT02175225|83238979|FG000|Overall Study|Withdrawal by Subject|1|||
46992154|NCT02175225|83238980|FG001|Overall Study|Withdrawal by Subject|2|||
46992155|NCT02175225|83238979|FG000|Overall Study|Lost to Follow-up|6|||
46992156|NCT02175225|83238980|FG001|Overall Study|Lost to Follow-up|7|||
46992157|NCT02175225|83238979|FG000|Overall Study|Study drug not administered|1|||
46992158|NCT02175225|83238980|FG001|Overall Study|Study drug not administered|2|||
46992159|NCT02299375|83238988|FG000|Overall Study|Adverse Event, serious fatal|1|||
46992160|NCT02299375|83238989|FG001|Overall Study|Adverse Event, serious fatal|3|||
46992161|NCT02299375|83238988|FG000|Overall Study|Adverse Event, non-fatal|8|||
46992162|NCT02299375|83238989|FG001|Overall Study|Adverse Event, non-fatal|9|||
46992163|NCT02299375|83238988|FG000|Overall Study|Lack of Efficacy|1|||
46992164|NCT02299375|83238989|FG001|Overall Study|Lack of Efficacy|3|||
46992165|NCT02299375|83238988|FG000|Overall Study|Protocol Violation|1|||
46992166|NCT02299375|83238989|FG001|Overall Study|Protocol Violation|3|||
46992167|NCT02299375|83238988|FG000|Overall Study|Other: Met stopping criteria|1|||
46992168|NCT02299375|83238989|FG001|Overall Study|Other: Met stopping criteria|0|||
46992169|NCT02299375|83238988|FG000|Overall Study|Other: Study closed/terminated|66|||
46992170|NCT02299375|83238989|FG001|Overall Study|Other: Study closed/terminated|55|||
46992171|NCT02299375|83238988|FG000|Overall Study|Lost to Follow-up|0|||
46992172|NCT02299375|83238989|FG001|Overall Study|Lost to Follow-up|2|||
46992173|NCT02299375|83238988|FG000|Overall Study|Physician Decision|1|||
46992174|NCT02299375|83238989|FG001|Overall Study|Physician Decision|1|||
46992175|NCT02299375|83238988|FG000|Overall Study|Withdrawal by Subject|1|||
46992176|NCT02299375|83238989|FG001|Overall Study|Withdrawal by Subject|4|||
46992177|NCT02151903|83238998|FG000|Overall Study|Withdrawal by Subject|1|||
46992178|NCT02151903|83238999|FG001|Overall Study|Withdrawal by Subject|0|||
46992179|NCT02151903|83238998|FG000|Overall Study|Progressive disease|2|||
46992180|NCT02151903|83238999|FG001|Overall Study|Progressive disease|1|||
46992181|NCT02151591|83239007|FG000|Overall Study|Lost to Follow-up|6|||
46992182|NCT02151591|83239008|FG001|Overall Study|Lost to Follow-up|3|||
46992183|NCT02174523|83239016|FG000|Overall Study|Withdrawal by Subject|1|||
46992184|NCT02174523|83239017|FG001|Overall Study|Withdrawal by Subject|0|||
46992185|NCT02297815|83239024|FG000|Overall Study|Lost to Follow-up|236|||
46992186|NCT02297815|83239025|FG001|Overall Study|Lost to Follow-up|140|||
46992187|NCT02114385|83239035|FG000|Overall Study|Withdrawal by Subject|3|||
46992188|NCT02114385|83239036|FG001|Overall Study|Withdrawal by Subject|2|||
46992189|NCT02114385|83239035|FG000|Overall Study|Lost to Follow-up|0|||
46992190|NCT02114385|83239036|FG001|Overall Study|Lost to Follow-up|6|||
46992191|NCT02114151|83239042|FG000|Overall Study|Death|1|||
46992192|NCT02114151|83239042|FG000|Overall Study|Lost to Follow-up|1|||
46992193|NCT02114151|83239042|FG000|Overall Study|Withdrawal by Subject|5|||
46992194|NCT02297503|83239048|FG000|Overall Study|Withdrawal by Subject|1|||
46992195|NCT02297503|83239049|FG001|Overall Study|Withdrawal by Subject|1|||
46992196|NCT02297503|83239048|FG000|Overall Study|Protocol Violation|1|||
46992197|NCT02297503|83239049|FG001|Overall Study|Protocol Violation|0|||
46992198|NCT02297503|83239048|FG000|Overall Study|Pregnancy|0|||
46992199|NCT02297503|83239049|FG001|Overall Study|Pregnancy|1|||
46896966|NCT03528577|83122621|FG000|Sequence 4|Adverse Event|1|||
46896967|NCT00706654|83122631|FG000|Conversion Phase|Lost to Follow-up|4|||
46896968|NCT00706654|83122632|FG001|Conversion Phase|Lost to Follow-up|0|||
46896969|NCT00706654|83122633|FG002|Conversion Phase|Lost to Follow-up|0|||
46896970|NCT00706654|83122634|FG003|Conversion Phase|Lost to Follow-up|0|||
46896971|NCT00706654|83122631|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
46896972|NCT00706654|83122632|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
46896973|NCT00706654|83122633|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
46896974|NCT00706654|83122634|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
46896975|NCT00706654|83122631|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
46896976|NCT00706654|83122632|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
46896977|NCT00706654|83122633|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
46896978|NCT00706654|83122634|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
46896979|NCT00706654|83122631|FG000|Conversion Phase|Withdrawn by Investigator|14|||
46992200|NCT02297503|83239048|FG000|Overall Study|Lost to Follow-up|0|||
46992201|NCT02297503|83239049|FG001|Overall Study|Lost to Follow-up|1|||
46992202|NCT02297503|83239048|FG000|Overall Study|Medical reason|0|||
46992203|NCT02297503|83239049|FG001|Overall Study|Medical reason|1|||
46992204|NCT02113449|83239064|FG000|Overall Study|Adverse Event|4|||
46992205|NCT02366923|83239072|FG000|Overall Study|Withdrawal by Subject|1|||
46992206|NCT02366923|83239072|FG000|Overall Study|Positive Slit Lamp Findings|2|||
46992207|NCT02366923|83239072|FG000|Overall Study|High Astigmatism|3|||
46992208|NCT02326597|83239079|FG000|Overall Study|Lost to Follow-up|42|||
46992209|NCT02326597|83239080|FG001|Overall Study|Lost to Follow-up|32|||
46992210|NCT02366767|83239090|FG000|Overall Study|left for home after 1 day at camp|1|||
46992211|NCT02366767|83239091|FG001|Overall Study|left for home after 1 day at camp|0|||
46992212|NCT02150343|83239101|FG000|Overall Study|Adverse Event|2|||
46992213|NCT02150343|83239102|FG001|Overall Study|Adverse Event|0|||
46992214|NCT02150343|83239103|FG002|Overall Study|Adverse Event|1|||
46992215|NCT02150343|83239104|FG003|Overall Study|Adverse Event|1|||
46992216|NCT02150343|83239101|FG000|Overall Study|Withdrawal by Subject|13|||
46992217|NCT02150343|83239102|FG001|Overall Study|Withdrawal by Subject|10|||
46992218|NCT02150343|83239103|FG002|Overall Study|Withdrawal by Subject|9|||
46992219|NCT02150343|83239104|FG003|Overall Study|Withdrawal by Subject|4|||
46992220|NCT02150343|83239101|FG000|Overall Study|Lost to Follow-up|4|||
46992221|NCT02150343|83239102|FG001|Overall Study|Lost to Follow-up|4|||
46992222|NCT02150343|83239103|FG002|Overall Study|Lost to Follow-up|2|||
46992223|NCT02150343|83239104|FG003|Overall Study|Lost to Follow-up|3|||
46992224|NCT02150343|83239101|FG000|Overall Study|Other|2|||
46992225|NCT02150343|83239102|FG001|Overall Study|Other|6|||
46992226|NCT02150343|83239103|FG002|Overall Study|Other|0|||
46992227|NCT02150343|83239104|FG003|Overall Study|Other|2|||
46992228|NCT02149875|83239117|FG000|Overall Study|Lost to Follow-up|3|||
46992229|NCT02149875|83239118|FG001|Overall Study|Lost to Follow-up|4|||
46992230|NCT02149875|83239119|FG002|Overall Study|Lost to Follow-up|5|||
46992231|NCT02149875|83239117|FG000|Overall Study|Withdrawal by Subject|3|||
46992232|NCT02149875|83239118|FG001|Overall Study|Withdrawal by Subject|2|||
46992233|NCT02149875|83239119|FG002|Overall Study|Withdrawal by Subject|2|||
46992234|NCT02149875|83239117|FG000|Overall Study|Physician Decision|1|||
46992235|NCT02149875|83239118|FG001|Overall Study|Physician Decision|2|||
46992236|NCT02149875|83239119|FG002|Overall Study|Physician Decision|2|||
46992237|NCT02112045|83239129|FG000|Overall Study|Withdrawal by Subject|1|||
46992238|NCT02112045|83239130|FG001|Overall Study|Withdrawal by Subject|0|||
46992239|NCT01629693|83239138|FG000|Overall Study|Lost to Follow-up|2|||
46992240|NCT01629693|83239139|FG001|Overall Study|Lost to Follow-up|4|||
46992241|NCT01629693|83239138|FG000|Overall Study|Withdrawal by Subject|2|||
46992242|NCT01629693|83239139|FG001|Overall Study|Withdrawal by Subject|2|||
46992243|NCT01629693|83239138|FG000|Overall Study|Adverse Event|1|||
46992244|NCT01629693|83239139|FG001|Overall Study|Adverse Event|0|||
46992245|NCT01629693|83239138|FG000|Overall Study|Investigator decision|0|||
46992246|NCT01629693|83239139|FG001|Overall Study|Investigator decision|1|||
46992247|NCT01629693|83239138|FG000|Overall Study|Poor comfort of study lenses|0|||
46992248|NCT01629693|83239139|FG001|Overall Study|Poor comfort of study lenses|2|||
46992249|NCT01629693|83239138|FG000|Overall Study|Subject decision unrelated to AE|0|||
46992250|NCT01629693|83239139|FG001|Overall Study|Subject decision unrelated to AE|1|||
46992251|NCT02147691|83239147|FG000|Overall Study|Withdrawal by Subject|2|||
46992252|NCT02147691|83239148|FG001|Overall Study|Withdrawal by Subject|0|||
46992253|NCT02147691|83239147|FG000|Overall Study|Adverse Event|2|||
46992254|NCT02147691|83239148|FG001|Overall Study|Adverse Event|0|||
46992255|NCT02147691|83239147|FG000|Overall Study|Lost to Follow-up|0|||
46992256|NCT02147691|83239148|FG001|Overall Study|Lost to Follow-up|1|||
46992257|NCT02111811|83239156|FG000|Treatment Phase|Lost to Follow-up|22|||
46992258|NCT02111811|83239157|FG001|Treatment Phase|Lost to Follow-up|18|||
46992259|NCT02111811|83239156|FG000|Treatment Phase|Death|2|||
46992260|NCT02111811|83239157|FG001|Treatment Phase|Death|0|||
46992261|NCT02111811|83239156|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
46992262|NCT02111811|83239157|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
46992263|NCT02111811|83239156|FG000|Follow up Period (Aim 2)|Death|2|||
46992264|NCT02111811|83239157|FG001|Follow up Period (Aim 2)|Death|0|||
46992265|NCT01655693|83239166|FG000|Overall Study|Progression of Disease|92|||
46992266|NCT01655693|83239167|FG001|Overall Study|Progression of Disease|76|||
46992267|NCT01655693|83239168|FG002|Overall Study|Progression of Disease|58|||
46992268|NCT01655693|83239166|FG000|Overall Study|Death|8|||
46992269|NCT01655693|83239167|FG001|Overall Study|Death|9|||
46992270|NCT01655693|83239168|FG002|Overall Study|Death|12|||
46992271|NCT01655693|83239166|FG000|Overall Study|Serious Adverse Event|3|||
46992272|NCT01655693|83239167|FG001|Overall Study|Serious Adverse Event|15|||
46992273|NCT01655693|83239168|FG002|Overall Study|Serious Adverse Event|11|||
46992274|NCT01655693|83239166|FG000|Overall Study|Withdrawal by Subject|3|||
46992275|NCT01655693|83239167|FG001|Overall Study|Withdrawal by Subject|2|||
46992276|NCT01655693|83239168|FG002|Overall Study|Withdrawal by Subject|20|||
46992277|NCT01655693|83239166|FG000|Overall Study|Adverse Event|3|||
46992278|NCT01655693|83239167|FG001|Overall Study|Adverse Event|11|||
46992279|NCT01655693|83239168|FG002|Overall Study|Adverse Event|3|||
46992280|NCT01655693|83239166|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
46992281|NCT01655693|83239167|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
46992282|NCT01655693|83239168|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
46992283|NCT01655693|83239166|FG000|Overall Study|Non-Compliance|0|||
46992284|NCT01655693|83239167|FG001|Overall Study|Non-Compliance|0|||
46992285|NCT01655693|83239168|FG002|Overall Study|Non-Compliance|7|||
46992286|NCT01655693|83239166|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
46992287|NCT01655693|83239167|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
46992288|NCT01655693|83239168|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
46992289|NCT01655693|83239166|FG000|Overall Study|Protocol Violation|1|||
46992290|NCT01655693|83239167|FG001|Overall Study|Protocol Violation|0|||
46992291|NCT01655693|83239168|FG002|Overall Study|Protocol Violation|3|||
46992292|NCT01655693|83239166|FG000|Overall Study|Lost to Follow-up|1|||
46992293|NCT01655693|83239167|FG001|Overall Study|Lost to Follow-up|0|||
46992294|NCT01655693|83239168|FG002|Overall Study|Lost to Follow-up|1|||
46992295|NCT01655693|83239166|FG000|Overall Study|Screening Failure|1|||
46992296|NCT01655693|83239167|FG001|Overall Study|Screening Failure|0|||
46992297|NCT01655693|83239168|FG002|Overall Study|Screening Failure|0|||
46992298|NCT01655693|83239166|FG000|Overall Study|Other|8|||
46992299|NCT01655693|83239167|FG001|Overall Study|Other|6|||
46992300|NCT01655693|83239168|FG002|Overall Study|Other|15|||
46992301|NCT01655381|83239186|FG000|Overall Study|Investigator Decision|1|||
46992302|NCT01655381|83239186|FG000|Overall Study|Moved to Another City|1|||
46992303|NCT01655381|83239186|FG000|Overall Study|Insufficient Treatment Response|1|||
46992304|NCT01656161|83239191|FG000|Overall Study|Death|3|||
46992305|NCT01656161|83239191|FG000|Overall Study|Adverse Event|2|||
46992306|NCT01656161|83239191|FG000|Overall Study|Protocol Violation|1|||
46992307|NCT01656161|83239191|FG000|Overall Study|Withdrawal by Subject|1|||
46992308|NCT02111577|83239200|FG000|Overall Study|Protocol Violation|2|||
46992309|NCT02111577|83239201|FG001|Overall Study|Protocol Violation|0|||
46992310|NCT02111577|83239200|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
46992311|NCT02111577|83239201|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
46992312|NCT02111577|83239200|FG000|Overall Study|Failure to produce study treatment|6|||
46992313|NCT02111577|83239201|FG001|Overall Study|Failure to produce study treatment|0|||
46992314|NCT02111577|83239200|FG000|Overall Study|Death|518|||
46992315|NCT02111577|83239201|FG001|Overall Study|Death|254|||
46992316|NCT02111577|83239200|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
46992317|NCT02111577|83239201|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
46992318|NCT02111577|83239200|FG000|Overall Study|Adverse Event|1|||
46992319|NCT02111577|83239201|FG001|Overall Study|Adverse Event|1|||
46992320|NCT02111577|83239200|FG000|Overall Study|Withdrawal by Subject|51|||
46992321|NCT02111577|83239201|FG001|Overall Study|Withdrawal by Subject|23|||
46992322|NCT02111577|83239200|FG000|Overall Study|Disease progression|0|||
46992323|NCT02111577|83239201|FG001|Overall Study|Disease progression|1|||
46992324|NCT02111577|83239200|FG000|Overall Study|Lost to Follow-up|19|||
46992325|NCT02111577|83239201|FG001|Overall Study|Lost to Follow-up|10|||
46992326|NCT02170779|83239211|FG000|Overall Study|Withdrawal by Subject|1|||
46992327|NCT02170779|83239212|FG001|Overall Study|Withdrawal by Subject|0|||
46992328|NCT02170779|83239211|FG000|Overall Study|Lost to Follow-up|0|||
46992329|NCT02170779|83239212|FG001|Overall Study|Lost to Follow-up|1|||
46992330|NCT02147067|83239220|FG000|Overall Study|Withdrawal by Subject|2|||
46992331|NCT02147067|83239221|FG001|Overall Study|Withdrawal by Subject|2|||
46992332|NCT02170389|83239227|FG000|Overall Study|Study terminated prior to start of treat|1|||
46992333|NCT02146599|83239231|FG000|Overall Study|Failed to meet inclusion criteria|5|||
46992334|NCT02146365|83239241|FG000|Overall Study|Lost to Follow-up|2|||
46992335|NCT02146365|83239242|FG001|Overall Study|Lost to Follow-up|1|||
46992336|NCT02146365|83239243|FG002|Overall Study|Lost to Follow-up|3|||
46992337|NCT02146365|83239244|FG003|Overall Study|Lost to Follow-up|3|||
46992338|NCT02146365|83239245|FG004|Overall Study|Lost to Follow-up|1|||
46992339|NCT02146365|83239246|FG005|Overall Study|Lost to Follow-up|1|||
46992340|NCT02146365|83239247|FG006|Overall Study|Lost to Follow-up|0|||
46992341|NCT02146365|83239248|FG007|Overall Study|Lost to Follow-up|1|||
46992342|NCT02146365|83239241|FG000|Overall Study|Withdrawal by Subject|1|||
46992343|NCT02146365|83239242|FG001|Overall Study|Withdrawal by Subject|2|||
46992344|NCT02146365|83239243|FG002|Overall Study|Withdrawal by Subject|1|||
46992345|NCT02146365|83239244|FG003|Overall Study|Withdrawal by Subject|5|||
46992346|NCT02146365|83239245|FG004|Overall Study|Withdrawal by Subject|1|||
46992347|NCT02146365|83239246|FG005|Overall Study|Withdrawal by Subject|0|||
46992348|NCT02146365|83239247|FG006|Overall Study|Withdrawal by Subject|0|||
46992349|NCT02146365|83239248|FG007|Overall Study|Withdrawal by Subject|0|||
46992350|NCT02146365|83239241|FG000|Overall Study|Unable to Comply with Protocol|0|||
46992351|NCT02146365|83239242|FG001|Overall Study|Unable to Comply with Protocol|1|||
46992352|NCT02146365|83239243|FG002|Overall Study|Unable to Comply with Protocol|1|||
46992353|NCT02146365|83239244|FG003|Overall Study|Unable to Comply with Protocol|0|||
46992354|NCT02146365|83239245|FG004|Overall Study|Unable to Comply with Protocol|0|||
46992355|NCT02146365|83239246|FG005|Overall Study|Unable to Comply with Protocol|0|||
46992356|NCT02146365|83239247|FG006|Overall Study|Unable to Comply with Protocol|0|||
46992357|NCT02146365|83239248|FG007|Overall Study|Unable to Comply with Protocol|0|||
46992358|NCT02146365|83239241|FG000|Overall Study|Other|1|||
46992359|NCT02146365|83239242|FG001|Overall Study|Other|0|||
46992360|NCT02146365|83239243|FG002|Overall Study|Other|2|||
46992361|NCT02146365|83239244|FG003|Overall Study|Other|1|||
46992362|NCT02146365|83239245|FG004|Overall Study|Other|0|||
46992363|NCT02146365|83239246|FG005|Overall Study|Other|0|||
46992364|NCT02146365|83239247|FG006|Overall Study|Other|0|||
46992365|NCT02146365|83239248|FG007|Overall Study|Other|0|||
46992366|NCT02146131|83239268|FG000|Overall Study|Physician Decision|61|||
46992367|NCT02146131|83239269|FG001|Overall Study|Physician Decision|56|||
46992368|NCT02107131|83239277|FG000|Overall Study|Lost to Follow-up|4|||
46992369|NCT02107131|83239278|FG001|Overall Study|Lost to Follow-up|4|||
46992370|NCT02107131|83239277|FG000|Overall Study|Physician Decision|1|||
46992371|NCT02107131|83239278|FG001|Overall Study|Physician Decision|0|||
46992372|NCT02107131|83239277|FG000|Overall Study|Withdrawal by Subject|2|||
46992373|NCT02107131|83239278|FG001|Overall Study|Withdrawal by Subject|0|||
46992374|NCT02107131|83239277|FG000|Overall Study|mental instability|1|||
46992375|NCT02107131|83239278|FG001|Overall Study|mental instability|0|||
46992376|NCT02107131|83239277|FG000|Overall Study|Death|0|||
46992377|NCT02107131|83239278|FG001|Overall Study|Death|1|||
46992378|NCT02107131|83239277|FG000|Overall Study|Protocol Violation|0|||
46992379|NCT02107131|83239278|FG001|Overall Study|Protocol Violation|4|||
46992380|NCT02106975|83239288|FG000|Overall Study|Death|25|||
46992381|NCT02106975|83239289|FG001|Overall Study|Death|39|||
46992382|NCT02145429|83239297|FG000|Overall Study|Death|4|||
46992383|NCT02145429|83239298|FG001|Overall Study|Death|5|||
46992384|NCT02145429|83239297|FG000|Overall Study|Lost to Follow-up|4|||
46992385|NCT02145429|83239298|FG001|Overall Study|Lost to Follow-up|3|||
46992386|NCT02145429|83239297|FG000|Overall Study|Withdrawal by Subject|8|||
46992387|NCT02145429|83239298|FG001|Overall Study|Withdrawal by Subject|3|||
46992388|NCT02144337|83239306|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
46992389|NCT02144337|83239307|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
46992390|NCT02144337|83239306|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
46992391|NCT02144337|83239307|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
46992392|NCT02144337|83239306|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
46992393|NCT02144337|83239307|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
46992394|NCT02144337|83239306|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
46992395|NCT02144337|83239307|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
46992396|NCT02144337|83239306|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
46992397|NCT02144337|83239307|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
46992398|NCT02520011|83239317|FG000|Overall Study|Adverse Event|0|||
46992399|NCT02520011|83239318|FG001|Overall Study|Adverse Event|1|||
46992400|NCT02520011|83239319|FG002|Overall Study|Adverse Event|2|||
46992401|NCT02520011|83239317|FG000|Overall Study|Death|0|||
46992402|NCT02520011|83239318|FG001|Overall Study|Death|8|||
46992403|NCT02520011|83239319|FG002|Overall Study|Death|1|||
46992404|NCT02520011|83239317|FG000|Overall Study|Lack of Efficacy|4|||
46992405|NCT02520011|83239318|FG001|Overall Study|Lack of Efficacy|26|||
46992406|NCT02520011|83239319|FG002|Overall Study|Lack of Efficacy|4|||
46992407|NCT02520011|83239317|FG000|Overall Study|Physician Decision|0|||
46992408|NCT02520011|83239318|FG001|Overall Study|Physician Decision|2|||
46992409|NCT02520011|83239319|FG002|Overall Study|Physician Decision|0|||
46992410|NCT02520011|83239317|FG000|Overall Study|Withdrawal by Subject|1|||
46992411|NCT02520011|83239318|FG001|Overall Study|Withdrawal by Subject|3|||
46992412|NCT02520011|83239319|FG002|Overall Study|Withdrawal by Subject|0|||
46992413|NCT02520011|83239317|FG000|Overall Study|Protocol Deviation|0|||
46992414|NCT02520011|83239318|FG001|Overall Study|Protocol Deviation|1|||
46992415|NCT02520011|83239319|FG002|Overall Study|Protocol Deviation|0|||
46992416|NCT02520011|83239317|FG000|Overall Study|Patient went to hospice|0|||
46992417|NCT02520011|83239318|FG001|Overall Study|Patient went to hospice|1|||
46992418|NCT02520011|83239319|FG002|Overall Study|Patient went to hospice|0|||
46992419|NCT02520011|83239317|FG000|Overall Study|Progressive disease following response|0|||
46992420|NCT02520011|83239318|FG001|Overall Study|Progressive disease following response|4|||
46992421|NCT02520011|83239319|FG002|Overall Study|Progressive disease following response|2|||
46992422|NCT02519231|83239334|FG000|Overall Study|Lost to Follow-up|2|||
46992423|NCT02519231|83239335|FG001|Overall Study|Lost to Follow-up|5|||
46992424|NCT02519231|83239334|FG000|Overall Study|Withdrawal by Subject|0|||
46992425|NCT02519231|83239335|FG001|Overall Study|Withdrawal by Subject|1|||
46992426|NCT02106351|83239346|FG000|Treatment Cycle 1|Adverse Event|2|||
46992427|NCT02106351|83239347|FG001|Treatment Cycle 1|Adverse Event|0|||
46992428|NCT02106351|83239348|FG002|Treatment Cycle 1|Adverse Event|0|||
46992429|NCT02106351|83239346|FG000|Treatment Cycle 1|Consent withdrawn|1|||
46992430|NCT02106351|83239347|FG001|Treatment Cycle 1|Consent withdrawn|0|||
46992431|NCT02106351|83239348|FG002|Treatment Cycle 1|Consent withdrawn|2|||
46992432|NCT02106351|83239346|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
46992433|NCT02106351|83239347|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
46992434|NCT02106351|83239348|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
46992435|NCT02106351|83239346|FG000|Treatment Cycle 1|Other|0|||
46992436|NCT02106351|83239347|FG001|Treatment Cycle 1|Other|3|||
46992437|NCT02106351|83239348|FG002|Treatment Cycle 1|Other|1|||
46992438|NCT02106351|83239346|FG000|Treatment Cycle 1|Randomised but not treated|1|||
46992439|NCT02106351|83239347|FG001|Treatment Cycle 1|Randomised but not treated|0|||
46992440|NCT02106351|83239348|FG002|Treatment Cycle 1|Randomised but not treated|1|||
46992441|NCT02106351|83239346|FG000|Treatment Cycle 2|Adverse Event|0|||
46992442|NCT02106351|83239347|FG001|Treatment Cycle 2|Adverse Event|2|||
46992443|NCT02106351|83239348|FG002|Treatment Cycle 2|Adverse Event|0|||
46992444|NCT02106351|83239346|FG000|Treatment Cycle 2|Consent withdrawn|0|||
46992445|NCT02106351|83239347|FG001|Treatment Cycle 2|Consent withdrawn|1|||
46992446|NCT02106351|83239348|FG002|Treatment Cycle 2|Consent withdrawn|1|||
46992447|NCT02106351|83239346|FG000|Treatment Cycle 2|Other|0|||
46992448|NCT02106351|83239347|FG001|Treatment Cycle 2|Other|2|||
46992449|NCT02106351|83239348|FG002|Treatment Cycle 2|Other|2|||
46992450|NCT02106351|83239346|FG000|Treatment Cycle 3|Adverse Event|0|||
46992451|NCT02106351|83239347|FG001|Treatment Cycle 3|Adverse Event|1|||
46992452|NCT02106351|83239348|FG002|Treatment Cycle 3|Adverse Event|0|||
46992453|NCT02106351|83239346|FG000|Treatment Cycle 3|Consent withdrawn|0|||
46992454|NCT02106351|83239347|FG001|Treatment Cycle 3|Consent withdrawn|0|||
46992455|NCT02106351|83239348|FG002|Treatment Cycle 3|Consent withdrawn|2|||
46992456|NCT02106351|83239346|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
46992457|NCT02106351|83239347|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
46992458|NCT02106351|83239348|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
46992459|NCT02106351|83239346|FG000|Treatment Cycle 3|Other|0|||
46992460|NCT02106351|83239347|FG001|Treatment Cycle 3|Other|2|||
46992461|NCT02106351|83239348|FG002|Treatment Cycle 3|Other|3|||
46992462|NCT02106351|83239346|FG000|Treatment Cycle 4|Consent withdrawn|0|||
46992463|NCT02106351|83239347|FG001|Treatment Cycle 4|Consent withdrawn|0|||
46992464|NCT02106351|83239348|FG002|Treatment Cycle 4|Consent withdrawn|2|||
46992465|NCT02106351|83239346|FG000|Treatment Cycle 4|Other|0|||
46992466|NCT02106351|83239347|FG001|Treatment Cycle 4|Other|1|||
46992467|NCT02106351|83239348|FG002|Treatment Cycle 4|Other|0|||
46992468|NCT02143947|83239364|FG000|Overall Study|Lost to Follow-up|4|||
46992469|NCT02143947|83239365|FG001|Overall Study|Lost to Follow-up|2|||
46992470|NCT02075073|83239376|FG000|Overall Study|Withdrawal by Subject|0|||
46992471|NCT02075073|83239377|FG001|Overall Study|Withdrawal by Subject|1|||
46992472|NCT02075073|83239378|FG002|Overall Study|Withdrawal by Subject|0|||
46992473|NCT02074059|83239392|FG000|Overall Study|Death|0|||
46992474|NCT02074059|83239393|FG001|Overall Study|Death|0|||
46992475|NCT02074059|83239394|FG002|Overall Study|Death|0|||
46992476|NCT02074059|83239395|FG003|Overall Study|Death|0|||
46992477|NCT02074059|83239396|FG004|Overall Study|Death|1|||
46992478|NCT02074059|83239397|FG005|Overall Study|Death|1|||
46992479|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
46992480|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
46992481|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
46992482|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
46992483|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Adverse Event|7|||
46992484|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Adverse Event|8|||
46992485|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Adverse Event|8|||
46992486|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Adverse Event|9|||
46992487|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
46992488|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
46992489|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
46992490|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
46992491|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
46992492|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
46992493|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
46992494|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
46992495|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Pregnancy|0|||
46992496|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Pregnancy|2|||
46992497|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Pregnancy|2|||
46992498|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Pregnancy|0|||
46992499|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Non-compliance|1|||
46992500|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Non-compliance|0|||
46992501|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Non-compliance|0|||
46992502|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Non-compliance|3|||
46992503|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Other|3|||
46992504|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Other|0|||
46992505|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Other|3|||
46992506|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Other|2|||
46992507|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
46992508|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
46992509|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
46992510|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
46992511|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
46992512|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
46992513|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
46992514|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
46992515|NCT02143713|83239416|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
46992516|NCT02143713|83239417|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
46992517|NCT02143713|83239418|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
46992518|NCT02143713|83239419|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
46992519|NCT02143713|83239416|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
46992520|NCT02143713|83239417|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
46992521|NCT02143713|83239418|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
46992522|NCT02143713|83239419|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
46992523|NCT02143713|83239416|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
46992524|NCT02143713|83239417|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
46992525|NCT02143713|83239418|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
46992526|NCT02143713|83239419|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
46992527|NCT02143713|83239416|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
46992528|NCT02143713|83239417|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
46992529|NCT02143713|83239418|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
46992530|NCT02143713|83239419|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
46992531|NCT02143713|83239416|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
46992532|NCT02143713|83239417|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
46992533|NCT02143713|83239418|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
46992534|NCT02143713|83239419|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
46992535|NCT02143713|83239416|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
46992536|NCT02143713|83239417|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
46992537|NCT02143713|83239418|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
46992538|NCT02143713|83239419|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
46992539|NCT02143713|83239416|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
46992540|NCT02143713|83239417|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
46992541|NCT02143713|83239418|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
46992542|NCT02143713|83239419|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
46992543|NCT02519855|83239432|FG000|Overall Study|Adverse Event|0|||
46992544|NCT02519855|83239433|FG001|Overall Study|Adverse Event|1|||
46992545|NCT02519855|83239432|FG000|Overall Study|Lost to Follow-up|3|||
46992546|NCT02519855|83239433|FG001|Overall Study|Lost to Follow-up|3|||
46992547|NCT02142387|83239441|FG000|Overall Study|<19 years old|49|||
46992548|NCT02142387|83239442|FG001|Overall Study|<19 years old|326|||
46992549|NCT02142387|83239441|FG000|Overall Study|non-cardiac etiology|504|||
46992550|NCT02142387|83239442|FG001|Overall Study|non-cardiac etiology|3431|||
46992551|NCT02142387|83239441|FG000|Overall Study|CPR not performed|74|||
46992552|NCT02142387|83239442|FG001|Overall Study|CPR not performed|473|||
46992553|NCT02142387|83239441|FG000|Overall Study|witnessed by paramedic|139|||
46992554|NCT02142387|83239442|FG001|Overall Study|witnessed by paramedic|917|||
46992555|NCT02142387|83239441|FG000|Overall Study|incomplete data|1|||
46992556|NCT02142387|83239442|FG001|Overall Study|incomplete data|9|||
46992557|NCT02142387|83239441|FG000|Overall Study|occurred not at home|298|||
46992558|NCT02142387|83239442|FG001|Overall Study|occurred not at home|2474|||
46992559|NCT02518919|83239451|FG000|Overall Study|Protocol Violation|1|||
46992560|NCT02518919|83239452|FG001|Overall Study|Protocol Violation|1|||
46992561|NCT02518919|83239453|FG002|Overall Study|Protocol Violation|2|||
46707359|NCT00984165|82922858|FG000|Overall Study|removed with a pair recipient|0|||
46707360|NCT00984165|82922859|FG001|Overall Study|removed with a pair recipient|0|||
46707361|NCT00984165|82922860|FG002|Overall Study|removed with a pair recipient|0|||
46707362|NCT00984165|82922861|FG003|Overall Study|removed with a pair recipient|1|||
46707363|NCT00993291|82922872|FG000|Overall Study|Withdrawal by Subject|1|||
46707364|NCT01196975|82922881|FG000|Overall Study|Adverse Event|2|||
46707365|NCT01196975|82922882|FG001|Overall Study|Adverse Event|2|||
46707366|NCT01196975|82922883|FG002|Overall Study|Adverse Event|0|||
46707367|NCT01196975|82922884|FG003|Overall Study|Adverse Event|0|||
46707368|NCT01196975|82922885|FG004|Overall Study|Adverse Event|2|||
46707369|NCT01196975|82922881|FG000|Overall Study|Withdrawal by Subject|2|||
46707370|NCT01196975|82922882|FG001|Overall Study|Withdrawal by Subject|1|||
46707371|NCT01196975|82922883|FG002|Overall Study|Withdrawal by Subject|0|||
46707372|NCT01196975|82922884|FG003|Overall Study|Withdrawal by Subject|1|||
46707373|NCT01196975|82922885|FG004|Overall Study|Withdrawal by Subject|0|||
46707374|NCT01196975|82922881|FG000|Overall Study|Lost to Follow-up|11|||
46707375|NCT01196975|82922882|FG001|Overall Study|Lost to Follow-up|6|||
46707376|NCT01196975|82922883|FG002|Overall Study|Lost to Follow-up|5|||
46707377|NCT01196975|82922884|FG003|Overall Study|Lost to Follow-up|5|||
46707378|NCT01196975|82922885|FG004|Overall Study|Lost to Follow-up|11|||
46707379|NCT00992589|82922920|FG000|Open-Label Phase|Adverse Event|4|||
46707380|NCT00992589|82922921|FG001|Open-Label Phase|Adverse Event|0|||
46707381|NCT00992589|82922922|FG002|Open-Label Phase|Adverse Event|0|||
46707382|NCT00992589|82922923|FG003|Open-Label Phase|Adverse Event|0|||
46707383|NCT00992589|82922920|FG000|Open-Label Phase|Withdrawal by Subject|20|||
46707384|NCT00992589|82922921|FG001|Open-Label Phase|Withdrawal by Subject|0|||
46707385|NCT00992589|82922922|FG002|Open-Label Phase|Withdrawal by Subject|0|||
46707386|NCT00992589|82922923|FG003|Open-Label Phase|Withdrawal by Subject|0|||
46707387|NCT00992589|82922920|FG000|Open-Label Phase|Lost to Follow-up|1|||
46707388|NCT00992589|82922921|FG001|Open-Label Phase|Lost to Follow-up|0|||
46707389|NCT00992589|82922922|FG002|Open-Label Phase|Lost to Follow-up|0|||
46707390|NCT00992589|82922923|FG003|Open-Label Phase|Lost to Follow-up|0|||
46707391|NCT00992589|82922920|FG000|Open-Label Phase|Protocol Violation|3|||
46707392|NCT00992589|82922921|FG001|Open-Label Phase|Protocol Violation|0|||
46707393|NCT00992589|82922922|FG002|Open-Label Phase|Protocol Violation|0|||
46707394|NCT00992589|82922923|FG003|Open-Label Phase|Protocol Violation|0|||
46707395|NCT00992589|82922920|FG000|Open-Label Phase|Physician Decision|4|||
46707396|NCT00992589|82922921|FG001|Open-Label Phase|Physician Decision|0|||
46707397|NCT00992589|82922922|FG002|Open-Label Phase|Physician Decision|0|||
46707398|NCT00992589|82922923|FG003|Open-Label Phase|Physician Decision|0|||
46707399|NCT00992589|82922920|FG000|Open-Label Phase|Other|45|||
46707400|NCT00992589|82922921|FG001|Open-Label Phase|Other|0|||
46707401|NCT00992589|82922922|FG002|Open-Label Phase|Other|0|||
46707402|NCT00992589|82922923|FG003|Open-Label Phase|Other|0|||
46707403|NCT00992589|82922920|FG000|Double-Blind Phase|Adverse Event|0|||
46707404|NCT00992589|82922921|FG001|Double-Blind Phase|Adverse Event|6|||
46707405|NCT00992589|82922922|FG002|Double-Blind Phase|Adverse Event|2|||
46707406|NCT00992589|82922923|FG003|Double-Blind Phase|Adverse Event|3|||
46707407|NCT00992589|82922920|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
46707408|NCT00992589|82922921|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
46707409|NCT00992589|82922922|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
46707410|NCT00992589|82922923|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
46707411|NCT00992589|82922920|FG000|Double-Blind Phase|Lost to Follow-up|0|||
46707412|NCT00992589|82922921|FG001|Double-Blind Phase|Lost to Follow-up|0|||
46707413|NCT00992589|82922922|FG002|Double-Blind Phase|Lost to Follow-up|0|||
46707414|NCT00992589|82922923|FG003|Double-Blind Phase|Lost to Follow-up|2|||
46707415|NCT00992589|82922920|FG000|Double-Blind Phase|Other|0|||
46707416|NCT00992589|82922921|FG001|Double-Blind Phase|Other|1|||
46707417|NCT00992589|82922922|FG002|Double-Blind Phase|Other|6|||
46707418|NCT00992589|82922923|FG003|Double-Blind Phase|Other|3|||
46707419|NCT01196741|82922943|FG000|Overall Study|Disease progression|34|||
46707420|NCT01196741|82922944|FG001|Overall Study|Disease progression|14|||
46707421|NCT01196741|82922943|FG000|Overall Study|Adverse Event|10|||
46707422|NCT01196741|82922944|FG001|Overall Study|Adverse Event|6|||
46707423|NCT01196741|82922943|FG000|Overall Study|Serious Adverse Event|3|||
46707424|NCT01196741|82922944|FG001|Overall Study|Serious Adverse Event|1|||
46707425|NCT01196741|82922943|FG000|Overall Study|Dose limiting Adverse Event|2|||
46707574|NCT00988221|82923145|FG000|Part I|Insufficient Therapeutic Response|4|||
46707575|NCT00988221|82923146|FG001|Part I|Insufficient Therapeutic Response|6|||
46707576|NCT00988221|82923147|FG002|Part I|Insufficient Therapeutic Response|5|||
46707577|NCT00988221|82923148|FG003|Part I|Insufficient Therapeutic Response|0|||
46707578|NCT00988221|82923145|FG000|Part I|Refused Treatment|0|||
46707579|NCT00988221|82923146|FG001|Part I|Refused Treatment|2|||
46707580|NCT00988221|82923147|FG002|Part I|Refused Treatment|1|||
46707581|NCT00988221|82923148|FG003|Part I|Refused Treatment|0|||
46707582|NCT00988221|82923145|FG000|Part I|Lost to Follow-up|0|||
46707583|NCT00988221|82923146|FG001|Part I|Lost to Follow-up|1|||
46707584|NCT00988221|82923147|FG002|Part I|Lost to Follow-up|0|||
46707585|NCT00988221|82923148|FG003|Part I|Lost to Follow-up|0|||
46707586|NCT00988221|82923145|FG000|Part II|Adverse Event|1|||
46707587|NCT00988221|82923146|FG001|Part II|Adverse Event|0|||
46707588|NCT00988221|82923147|FG002|Part II|Adverse Event|0|||
46707589|NCT00988221|82923148|FG003|Part II|Adverse Event|1|||
46707590|NCT00988221|82923145|FG000|Part II|Withdrawal by Subject|0|||
46707591|NCT00988221|82923146|FG001|Part II|Withdrawal by Subject|0|||
46707592|NCT00988221|82923147|FG002|Part II|Withdrawal by Subject|2|||
46707593|NCT00988221|82923148|FG003|Part II|Withdrawal by Subject|2|||
46707594|NCT00988221|82923145|FG000|Part II|Reason not Specified|0|||
46707595|NCT00988221|82923146|FG001|Part II|Reason not Specified|0|||
46707596|NCT00988221|82923147|FG002|Part II|Reason not Specified|1|||
46707597|NCT00988221|82923148|FG003|Part II|Reason not Specified|0|||
46707598|NCT00988221|82923145|FG000|Part III|Adverse Event|1|||
46707599|NCT00988221|82923146|FG001|Part III|Adverse Event|0|||
46707600|NCT00988221|82923147|FG002|Part III|Adverse Event|1|||
46707601|NCT00988221|82923148|FG003|Part III|Adverse Event|0|||
46707602|NCT00988221|82923145|FG000|Part III|Insufficient Therapeutic Response|0|||
46707603|NCT00988221|82923146|FG001|Part III|Insufficient Therapeutic Response|1|||
46707604|NCT00988221|82923147|FG002|Part III|Insufficient Therapeutic Response|1|||
46707605|NCT00988221|82923148|FG003|Part III|Insufficient Therapeutic Response|0|||
46707606|NCT00988221|82923145|FG000|Part III|Refused Treatment|0|||
46707607|NCT00988221|82923146|FG001|Part III|Refused Treatment|0|||
46707608|NCT00988221|82923147|FG002|Part III|Refused Treatment|1|||
46707609|NCT00988221|82923148|FG003|Part III|Refused Treatment|0|||
46707610|NCT01149096|82923169|FG000|Overall Study|Lost to Follow-up|0|||
46707611|NCT01149096|82923170|FG001|Overall Study|Lost to Follow-up|1|||
46707612|NCT01175382|82923180|FG000|Overall Study|Lost to Follow-up|4|||
46707613|NCT01175382|82923181|FG001|Overall Study|Lost to Follow-up|3|||
46707614|NCT01175382|82923182|FG002|Overall Study|Lost to Follow-up|1|||
46707615|NCT01175382|82923180|FG000|Overall Study|Physician Decision|0|||
46707616|NCT01175382|82923181|FG001|Overall Study|Physician Decision|1|||
46707617|NCT01175382|82923182|FG002|Overall Study|Physician Decision|0|||
46707618|NCT01175382|82923180|FG000|Overall Study|Withdrawal by Subject|0|||
46707619|NCT01175382|82923181|FG001|Overall Study|Withdrawal by Subject|0|||
46707620|NCT01175382|82923182|FG002|Overall Study|Withdrawal by Subject|1|||
46707621|NCT01175382|82923180|FG000|Overall Study|No longer having problem|1|||
46707622|NCT01175382|82923181|FG001|Overall Study|No longer having problem|0|||
46707623|NCT01175382|82923182|FG002|Overall Study|No longer having problem|1|||
46707624|NCT01175382|82923180|FG000|Overall Study|Unable/unwilling to attend visits|3|||
46707625|NCT01175382|82923181|FG001|Overall Study|Unable/unwilling to attend visits|1|||
46707626|NCT01175382|82923182|FG002|Overall Study|Unable/unwilling to attend visits|2|||
46707627|NCT01175382|82923180|FG000|Overall Study|Unwilling to follow protocol|0|||
46707628|NCT01175382|82923181|FG001|Overall Study|Unwilling to follow protocol|1|||
46707629|NCT01175382|82923182|FG002|Overall Study|Unwilling to follow protocol|0|||
46707630|NCT01175382|82923180|FG000|Overall Study|Unable to tolerate study meds|0|||
46707631|NCT01175382|82923181|FG001|Overall Study|Unable to tolerate study meds|1|||
46707632|NCT01175382|82923182|FG002|Overall Study|Unable to tolerate study meds|1|||
46707633|NCT01194245|82923195|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
46707634|NCT01194245|82923196|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
46707635|NCT01194245|82923197|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
46707636|NCT01194245|82923198|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
46707637|NCT01194245|82923199|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
46707638|NCT01194245|82923195|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
46707639|NCT01194245|82923196|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
46707640|NCT01194245|82923197|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
46707641|NCT01194245|82923198|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
46707642|NCT01194245|82923199|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
46707643|NCT01194245|82923195|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
46707644|NCT01194245|82923196|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
46707645|NCT01194245|82923197|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
46707646|NCT01194245|82923198|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
46707647|NCT01194245|82923199|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
46707648|NCT01194245|82923195|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
46707649|NCT01194245|82923196|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
46707650|NCT01194245|82923197|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
46707651|NCT01194245|82923198|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
46707652|NCT01194245|82923199|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
46707653|NCT01194245|82923195|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46707654|NCT01194245|82923196|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46707655|NCT01194245|82923197|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46707656|NCT01194245|82923198|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
46707657|NCT01194245|82923199|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
46707658|NCT01194245|82923195|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46707659|NCT01194245|82923196|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
46707660|NCT01194245|82923197|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
46707661|NCT01194245|82923198|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
46707662|NCT01194245|82923199|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
46707663|NCT00979407|82923210|FG000|Overall Study|Withdrawal by Subject|3|||
46707664|NCT00979407|82923211|FG001|Overall Study|Withdrawal by Subject|4|||
46707665|NCT00979407|82923210|FG000|Overall Study|Lost to Follow-up|3|||
46707666|NCT00979407|82923211|FG001|Overall Study|Lost to Follow-up|3|||
46707667|NCT01148862|82923219|FG000|Second Intervention|Withdrawal by Subject|0|||
46707668|NCT01148862|82923220|FG001|Second Intervention|Withdrawal by Subject|2|||
46707669|NCT00975975|82923226|FG000|Overall Study|Death|6|||
46707670|NCT01193153|82923230|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
46707671|NCT01193153|82923231|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
46707672|NCT01193153|82923230|FG000|Open-label Lead in Period|Pregnancy|1|||
46707673|NCT01193153|82923231|FG001|Open-label Lead in Period|Pregnancy|0|||
46707674|NCT01193153|82923230|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
46707675|NCT01193153|82923231|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
46707676|NCT01193153|82923230|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
46707677|NCT01193153|82923231|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
46707678|NCT01193153|82923230|FG000|Open-label Lead in Period|Other|14|||
46707679|NCT01193153|82923231|FG001|Open-label Lead in Period|Other|0|||
46707680|NCT01193153|82923230|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
46707681|NCT01193153|82923231|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
46707682|NCT01193153|82923230|FG000|Open-label Lead in Period|Adverse Event|41|||
46707683|NCT01193153|82923231|FG001|Open-label Lead in Period|Adverse Event|0|||
46707684|NCT01193153|82923230|FG000|Open-label Lead in Period|Death|1|||
46707685|NCT01193153|82923231|FG001|Open-label Lead in Period|Death|0|||
46707686|NCT01193153|82923230|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
46707687|NCT01193153|82923231|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
46707688|NCT01193153|82923230|FG000|Open-label Stabilization Period|Adverse Event|9|||
46707689|NCT01193153|82923231|FG001|Open-label Stabilization Period|Adverse Event|0|||
46707690|NCT01193153|82923230|FG000|Open-label Stabilization Period|Death|2|||
46707691|NCT01193153|82923231|FG001|Open-label Stabilization Period|Death|0|||
46707692|NCT01193153|82923230|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
46707693|NCT01193153|82923231|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
46707694|NCT01193153|82923230|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
46707695|NCT01193153|82923231|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
46707696|NCT01193153|82923230|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
46707697|NCT01193153|82923231|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
46707698|NCT01193153|82923230|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
46707699|NCT01193153|82923231|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
46707700|NCT01193153|82923230|FG000|Open-label Stabilization Period|Other|8|||
46707701|NCT01193153|82923231|FG001|Open-label Stabilization Period|Other|0|||
46707702|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|Other|2|||
46707703|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|Other|3|||
46707704|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
46707705|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
46707706|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|Death|2|||
46707707|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|Death|0|||
46707708|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
46707709|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
46707710|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
46707711|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
46707712|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
46707713|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
46707714|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
46707715|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
46707716|NCT01193153|82923230|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
46707717|NCT01193153|82923231|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
46707757|NCT01174446|82923277|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
46707758|NCT01174446|82923278|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
46707759|NCT01174446|82923275|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
46707760|NCT01174446|82923276|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
46707761|NCT01174446|82923277|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
46707762|NCT01174446|82923278|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
46707763|NCT01174446|82923275|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
46707764|NCT01174446|82923276|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
46707765|NCT01174446|82923277|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
46707766|NCT01174446|82923278|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
46707767|NCT00932698|82923336|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
46707768|NCT00932698|82923337|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
46707769|NCT00932698|82923338|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
46707770|NCT00932698|82923339|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
46707771|NCT00932698|82923340|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
46707772|NCT00932698|82923341|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
46707773|NCT00932698|82923342|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
46707774|NCT00932698|82923343|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
46707775|NCT00932698|82923344|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
46707776|NCT00932698|82923345|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
46707777|NCT00932698|82923346|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
46707778|NCT00932698|82923336|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
46707779|NCT00932698|82923337|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
46707780|NCT00932698|82923338|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
46707781|NCT00932698|82923339|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
46707782|NCT00932698|82923340|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
46707783|NCT00932698|82923341|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
46707784|NCT00932698|82923342|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
46707785|NCT00932698|82923343|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
46707786|NCT00932698|82923344|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
46707787|NCT00932698|82923345|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
46707788|NCT00932698|82923346|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
46707789|NCT00932698|82923336|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
46707790|NCT00932698|82923337|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
46707791|NCT00932698|82923338|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
46707792|NCT00932698|82923339|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
46707793|NCT00932698|82923340|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
46707794|NCT00932698|82923341|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
46707795|NCT00932698|82923342|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
46707796|NCT00932698|82923343|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
46707797|NCT00932698|82923344|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
46707798|NCT00932698|82923345|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
46707799|NCT00932698|82923346|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
46707800|NCT00932698|82923336|FG000|Part 1 (Dose Escalation)|Other|0|||
46707801|NCT00932698|82923337|FG001|Part 1 (Dose Escalation)|Other|0|||
46707802|NCT00932698|82923338|FG002|Part 1 (Dose Escalation)|Other|1|||
46707803|NCT00932698|82923339|FG003|Part 1 (Dose Escalation)|Other|0|||
46707804|NCT00932698|82923340|FG004|Part 1 (Dose Escalation)|Other|0|||
46707805|NCT00932698|82923341|FG005|Part 1 (Dose Escalation)|Other|0|||
46707806|NCT00932698|82923342|FG006|Part 1 (Dose Escalation)|Other|1|||
46707807|NCT00932698|82923343|FG007|Part 1 (Dose Escalation)|Other|0|||
46707808|NCT00932698|82923344|FG008|Part 1 (Dose Escalation)|Other|0|||
46707809|NCT00932698|82923345|FG009|Part 1 (Dose Escalation)|Other|0|||
46707810|NCT00932698|82923346|FG010|Part 1 (Dose Escalation)|Other|0|||
46707811|NCT00932698|82923336|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
46707812|NCT00932698|82923337|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
46707813|NCT00932698|82923338|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
46707814|NCT00932698|82923339|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
46707815|NCT00932698|82923340|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
46707816|NCT00932698|82923341|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
46707817|NCT00932698|82923342|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
46707818|NCT00932698|82923343|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
46707819|NCT00932698|82923344|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
46707820|NCT00932698|82923345|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
46707821|NCT00932698|82923346|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
46707822|NCT00932698|82923336|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707823|NCT00932698|82923337|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707824|NCT00932698|82923338|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707825|NCT00932698|82923339|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707826|NCT00932698|82923340|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707827|NCT00932698|82923341|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707828|NCT00932698|82923342|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707829|NCT00932698|82923343|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
46707830|NCT00932698|82923344|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
46707831|NCT00932698|82923345|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
46707832|NCT00932698|82923346|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
46707833|NCT00932698|82923336|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
46707834|NCT00932698|82923337|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
46707835|NCT00932698|82923338|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
46707836|NCT00932698|82923339|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
46707837|NCT00932698|82923340|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
46707838|NCT00932698|82923341|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
46707839|NCT00932698|82923342|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
46707840|NCT00932698|82923343|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
46707841|NCT00932698|82923344|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
46707842|NCT00932698|82923345|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
46707843|NCT00932698|82923346|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
46707844|NCT00978627|82923374|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
46707845|NCT00978627|82923375|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
46707846|NCT00978627|82923374|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
46707847|NCT00978627|82923375|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
46707848|NCT00978627|82923374|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
46707849|NCT00978627|82923375|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
46707850|NCT00978627|82923374|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
46707851|NCT00978627|82923375|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
46707852|NCT00978627|82923374|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
46707853|NCT00978627|82923375|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
46707854|NCT00978627|82923374|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
46707855|NCT00978627|82923375|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
46707856|NCT00978627|82923374|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
46707857|NCT00978627|82923375|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
46707858|NCT00978627|82923374|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
46707859|NCT00978627|82923375|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
46707860|NCT00978627|82923374|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
46707861|NCT00978627|82923375|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
46707862|NCT01181609|82923381|FG000|Overall Study|Adverse Event|1|||
46707863|NCT01181609|82923381|FG000|Overall Study|Withdrawal by Subject|1|||
46707864|NCT01181609|82923381|FG000|Overall Study|Lost to Follow-up|1|||
46707865|NCT01181609|82923381|FG000|Overall Study|Death|50|||
46707866|NCT01154010|82923387|FG000|Overall Study|Lost to Follow-up|0|||
46707867|NCT01154010|82923388|FG001|Overall Study|Lost to Follow-up|1|||
46707868|NCT01174368|82923394|FG000|Overall Study|Withdrawal by Subject|1|||
46707869|NCT01147926|82923400|FG000|Overall Study|Subject Withdrew Consent|9|||
46707870|NCT01147926|82923401|FG001|Overall Study|Subject Withdrew Consent|10|||
46707871|NCT01147926|82923400|FG000|Overall Study|Adverse Event|7|||
46707872|NCT01147926|82923401|FG001|Overall Study|Adverse Event|6|||
46707873|NCT01147926|82923400|FG000|Overall Study|Subject Non-Compliant|5|||
46707874|NCT01147926|82923401|FG001|Overall Study|Subject Non-Compliant|4|||
46707875|NCT01147926|82923400|FG000|Overall Study|Principal investigator left hospital|1|||
46707876|NCT01147926|82923401|FG001|Overall Study|Principal investigator left hospital|3|||
46707877|NCT01147926|82923400|FG000|Overall Study|Selection criteria not met|3|||
46707878|NCT01147926|82923401|FG001|Overall Study|Selection criteria not met|1|||
46707879|NCT01147926|82923400|FG000|Overall Study|Lost to Follow-up|0|||
46707880|NCT01147926|82923401|FG001|Overall Study|Lost to Follow-up|2|||
46707881|NCT01147926|82923400|FG000|Overall Study|Sponsor's Decision|0|||
46707882|NCT01147926|82923401|FG001|Overall Study|Sponsor's Decision|1|||
46707883|NCT01147926|82923400|FG000|Overall Study|Lack of Efficacy|1|||
46707884|NCT01147926|82923401|FG001|Overall Study|Lack of Efficacy|0|||
46707885|NCT01147926|82923400|FG000|Overall Study|Too busy, no time for study|1|||
46707886|NCT01147926|82923401|FG001|Overall Study|Too busy, no time for study|0|||
46707887|NCT01147926|82923400|FG000|Overall Study|Went on holiday|0|||
46707888|NCT01147926|82923401|FG001|Overall Study|Went on holiday|1|||
46707889|NCT01147926|82923400|FG000|Overall Study|Colonoscopy result|0|||
46707890|NCT01147926|82923401|FG001|Overall Study|Colonoscopy result|1|||
46707891|NCT00975507|82923409|FG000|Overall Study|Adverse Event|1|||
46707892|NCT00975507|82923410|FG001|Overall Study|Adverse Event|0|||
46707893|NCT00975507|82923409|FG000|Overall Study|Lost to Follow-up|7|||
46707894|NCT00975507|82923410|FG001|Overall Study|Lost to Follow-up|1|||
46707895|NCT00975507|82923409|FG000|Overall Study|Protocol Violation|2|||
46707896|NCT00975507|82923410|FG001|Overall Study|Protocol Violation|0|||
46707897|NCT00975507|82923409|FG000|Overall Study|Withdrawal by Subject|10|||
46707898|NCT00975507|82923410|FG001|Overall Study|Withdrawal by Subject|3|||
46707899|NCT01147848|82923420|FG000|Run-in Period|Screen Failure|623|||
46707900|NCT01147848|82923421|FG001|Run-in Period|Screen Failure|0|||
46707911|NCT01147848|82923420|FG000|Randomized Phase|Protocol Violation|0|||
46707912|NCT01147848|82923421|FG001|Randomized Phase|Protocol Violation|7|||
46707913|NCT01147848|82923422|FG002|Randomized Phase|Protocol Violation|10|||
46707914|NCT01147848|82923420|FG000|Randomized Phase|Lost to Follow-up|0|||
46707915|NCT01147848|82923421|FG001|Randomized Phase|Lost to Follow-up|5|||
46707916|NCT01147848|82923422|FG002|Randomized Phase|Lost to Follow-up|7|||
46707917|NCT01147848|82923420|FG000|Randomized Phase|Physician Decision|0|||
46707918|NCT01147848|82923421|FG001|Randomized Phase|Physician Decision|0|||
46707919|NCT01147848|82923422|FG002|Randomized Phase|Physician Decision|1|||
46707920|NCT01147848|82923420|FG000|Randomized Phase|Withdrawal by Subject|0|||
46707921|NCT01147848|82923421|FG001|Randomized Phase|Withdrawal by Subject|7|||
46707922|NCT01147848|82923422|FG002|Randomized Phase|Withdrawal by Subject|9|||
46707923|NCT00929656|82923431|FG000|Overall Study|Lost to Follow-up|0|||
46707924|NCT00929656|82923432|FG001|Overall Study|Lost to Follow-up|1|||
46707925|NCT00977613|82923438|FG000|Overall Study|Lost to Follow-up|16|||
46707926|NCT01152996|82923442|FG000|Overall Study|Withdrawal by Subject|142|||
46707927|NCT01152996|82923442|FG000|Overall Study|Adverse Event|115|||
46707928|NCT01152996|82923442|FG000|Overall Study|Lost to Follow-up|112|||
46707929|NCT01152996|82923442|FG000|Overall Study|Lack of Efficacy|68|||
46707930|NCT01152996|82923442|FG000|Overall Study|Noncompliance|41|||
46707931|NCT01152996|82923442|FG000|Overall Study|Other|36|||
46707932|NCT01152996|82923442|FG000|Overall Study|Protocol Violation|22|||
46707933|NCT01152996|82923442|FG000|Overall Study|Elevated liver enzymes|1|||
46707934|NCT00979953|82923450|FG000|Overall Study|Adverse Event|5|||
46707935|NCT00979953|82923451|FG001|Overall Study|Adverse Event|2|||
46707936|NCT00979953|82923452|FG002|Overall Study|Adverse Event|17|||
46707937|NCT00979953|82923453|FG003|Overall Study|Adverse Event|4|||
46707938|NCT00979953|82923450|FG000|Overall Study|Lack of Efficacy|1|||
46707939|NCT00979953|82923451|FG001|Overall Study|Lack of Efficacy|2|||
46707940|NCT00979953|82923452|FG002|Overall Study|Lack of Efficacy|0|||
46707941|NCT00979953|82923453|FG003|Overall Study|Lack of Efficacy|0|||
46707942|NCT00979953|82923450|FG000|Overall Study|Lost to Follow-up|1|||
46707943|NCT00979953|82923451|FG001|Overall Study|Lost to Follow-up|1|||
46707944|NCT00979953|82923452|FG002|Overall Study|Lost to Follow-up|1|||
46707945|NCT00979953|82923453|FG003|Overall Study|Lost to Follow-up|0|||
46707946|NCT00979953|82923450|FG000|Overall Study|Withdrawal by Subject|0|||
46707947|NCT00979953|82923451|FG001|Overall Study|Withdrawal by Subject|0|||
46707948|NCT00979953|82923452|FG002|Overall Study|Withdrawal by Subject|2|||
46707949|NCT00979953|82923453|FG003|Overall Study|Withdrawal by Subject|1|||
46707950|NCT00979953|82923450|FG000|Overall Study|Protocol Violation|1|||
46707951|NCT00979953|82923451|FG001|Overall Study|Protocol Violation|0|||
46707952|NCT00979953|82923452|FG002|Overall Study|Protocol Violation|2|||
46707953|NCT00979953|82923453|FG003|Overall Study|Protocol Violation|2|||
46707954|NCT01181531|82923465|FG000|Overall Study|Other|17|||
46707955|NCT01181531|82923466|FG001|Overall Study|Other|12|||
46707956|NCT01181531|82923465|FG000|Overall Study|Partial consent by subject withdrawn|0|||
46707957|NCT01181531|82923466|FG001|Overall Study|Partial consent by subject withdrawn|1|||
46707958|NCT01181531|82923465|FG000|Overall Study|Physician Decision|3|||
46707959|NCT01181531|82923466|FG001|Overall Study|Physician Decision|1|||
46707960|NCT01181531|82923465|FG000|Overall Study|Noncompliance|2|||
46707961|NCT01181531|82923466|FG001|Overall Study|Noncompliance|2|||
46707962|NCT01181531|82923465|FG000|Overall Study|Ineligibility determined|1|||
46707963|NCT01181531|82923466|FG001|Overall Study|Ineligibility determined|2|||
46707964|NCT01181531|82923465|FG000|Overall Study|Protocol Specified Criteria|15|||
46707965|NCT01181531|82923466|FG001|Overall Study|Protocol Specified Criteria|8|||
46707966|NCT01181531|82923465|FG000|Overall Study|Pregnancy|0|||
46707967|NCT01181531|82923466|FG001|Overall Study|Pregnancy|1|||
46707968|NCT01181531|82923465|FG000|Overall Study|Withdrawal by Subject|8|||
46707969|NCT01181531|82923466|FG001|Overall Study|Withdrawal by Subject|7|||
46707970|NCT01181531|82923465|FG000|Overall Study|Protocol Violation|6|||
46707971|NCT01181531|82923466|FG001|Overall Study|Protocol Violation|6|||
46707972|NCT01181531|82923465|FG000|Overall Study|Death|9|||
46707973|NCT01181531|82923466|FG001|Overall Study|Death|12|||
46707974|NCT01181531|82923465|FG000|Overall Study|Adverse Event|0|||
46707975|NCT01181531|82923466|FG001|Overall Study|Adverse Event|1|||
46707976|NCT01152450|82923472|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
46707977|NCT01152450|82923473|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
46707978|NCT01152450|82923474|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
46707979|NCT01152450|82923475|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
46707980|NCT01152450|82923476|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
46707981|NCT01152450|82923477|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
46707982|NCT01152450|82923472|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
46707983|NCT01152450|82923473|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
46707984|NCT01152450|82923474|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
46707985|NCT01152450|82923475|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
46707986|NCT01152450|82923476|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
46707987|NCT01152450|82923477|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
46707988|NCT01152450|82923472|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46707989|NCT01152450|82923473|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
46707990|NCT01152450|82923474|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
46707991|NCT01152450|82923475|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46707992|NCT01152450|82923476|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46707993|NCT01152450|82923477|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
46707994|NCT01181141|82923487|FG000|Overall Study|Adverse Event|2|||
46707995|NCT01181141|82923488|FG001|Overall Study|Adverse Event|1|||
46707996|NCT01181141|82923487|FG000|Overall Study|Lack of Efficacy|1|||
46707997|NCT01181141|82923488|FG001|Overall Study|Lack of Efficacy|0|||
46707998|NCT01181141|82923487|FG000|Overall Study|Lost to Follow-up|1|||
46707999|NCT01181141|82923488|FG001|Overall Study|Lost to Follow-up|1|||
46708000|NCT01181141|82923487|FG000|Overall Study|Physician Decision|2|||
46708001|NCT01181141|82923488|FG001|Overall Study|Physician Decision|0|||
46708002|NCT01181141|82923487|FG000|Overall Study|Protocol Violation|3|||
46708003|NCT01181141|82923488|FG001|Overall Study|Protocol Violation|1|||
46708004|NCT01181141|82923487|FG000|Overall Study|Withdrawal by Subject|3|||
46708005|NCT01181141|82923488|FG001|Overall Study|Withdrawal by Subject|1|||
46708006|NCT01173120|82923494|FG000|Overall Study|Lack of Efficacy|2|||
46708007|NCT01173120|82923494|FG000|Overall Study|Lost to Follow-up|1|||
46708008|NCT01173120|82923494|FG000|Overall Study|Participant Decision|2|||
46708009|NCT01173120|82923494|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
46708010|NCT01173120|82923494|FG000|Overall Study|Switch-Participant Decision|12|||
46708011|NCT01173120|82923494|FG000|Overall Study|Switch-Difficulty With Device|12|||
46708012|NCT00977379|82923502|FG000|Overall Study|Withdrawal by Subject|1|||
46708013|NCT00977379|82923503|FG001|Overall Study|Withdrawal by Subject|1|||
46708014|NCT00977379|82923502|FG000|Overall Study|Death|7|||
46708015|NCT00977379|82923503|FG001|Overall Study|Death|9|||
46708016|NCT00977379|82923502|FG000|Overall Study|Premature Study Termination|4|||
46708017|NCT00977379|82923503|FG001|Overall Study|Premature Study Termination|0|||
46708018|NCT00977379|82923502|FG000|Overall Study|Participant Moving House|0|||
46708019|NCT00977379|82923503|FG001|Overall Study|Participant Moving House|1|||
46708020|NCT00977379|82923502|FG000|Overall Study|Randomization Error|0|||
46708021|NCT00977379|82923503|FG001|Overall Study|Randomization Error|1|||
46708022|NCT01180985|82923509|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
46708023|NCT01180985|82923510|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
46708024|NCT01147536|82923517|FG000|Overall Study|Administrative study close|2|||
46708025|NCT01147536|82923517|FG000|Overall Study|Death|1|||
46708026|NCT01154088|82923524|FG000|Overall Study|Lost to Follow-up|4|||
46708027|NCT01154088|82923525|FG001|Overall Study|Lost to Follow-up|6|||
46708028|NCT01154088|82923526|FG002|Overall Study|Lost to Follow-up|7|||
46708029|NCT01180049|82923537|FG000|Overall Study|Other|9|||
46708030|NCT01180049|82923538|FG001|Overall Study|Other|7|||
46708031|NCT01180049|82923537|FG000|Overall Study|Lost to Follow-up|8|||
46708032|NCT01180049|82923538|FG001|Overall Study|Lost to Follow-up|6|||
46708033|NCT01180049|82923537|FG000|Overall Study|Death|36|||
46708034|NCT01180049|82923538|FG001|Overall Study|Death|35|||
46708035|NCT01147458|82923544|FG000|First Intervention|Study terminated by sponsor|8|||
46708036|NCT01147458|82923545|FG001|First Intervention|Study terminated by sponsor|8|||
46708037|NCT01147458|82923546|FG002|First Intervention|Study terminated by sponsor|7|||
46708038|NCT01147458|82923547|FG003|First Intervention|Study terminated by sponsor|8|||
46708039|NCT01147458|82923544|FG000|First Intervention|Protocol Violation|2|||
46708040|NCT01147458|82923545|FG001|First Intervention|Protocol Violation|3|||
46708041|NCT01147458|82923546|FG002|First Intervention|Protocol Violation|2|||
46708042|NCT01147458|82923547|FG003|First Intervention|Protocol Violation|3|||
46708043|NCT01147458|82923544|FG000|First Intervention|Withdrawal by Subject|3|||
46708044|NCT01147458|82923545|FG001|First Intervention|Withdrawal by Subject|0|||
46708045|NCT01147458|82923546|FG002|First Intervention|Withdrawal by Subject|1|||
46708046|NCT01147458|82923547|FG003|First Intervention|Withdrawal by Subject|0|||
46708047|NCT01147458|82923544|FG000|First Intervention|Adverse Event|0|||
46708048|NCT01147458|82923545|FG001|First Intervention|Adverse Event|3|||
46708049|NCT01147458|82923546|FG002|First Intervention|Adverse Event|2|||
46708050|NCT01147458|82923547|FG003|First Intervention|Adverse Event|3|||
46708051|NCT01147458|82923544|FG000|First Intervention|Other|1|||
46708052|NCT01147458|82923545|FG001|First Intervention|Other|2|||
46708053|NCT01147458|82923546|FG002|First Intervention|Other|0|||
46708054|NCT01147458|82923547|FG003|First Intervention|Other|0|||
46708055|NCT01147458|82923544|FG000|Second Intervention|Study terminated by sponsor|7|||
46708056|NCT01147458|82923545|FG001|Second Intervention|Study terminated by sponsor|5|||
46708057|NCT01147458|82923546|FG002|Second Intervention|Study terminated by sponsor|5|||
46708058|NCT01147458|82923547|FG003|Second Intervention|Study terminated by sponsor|3|||
46708059|NCT01147458|82923544|FG000|Second Intervention|Protocol Violation|0|||
46708060|NCT01147458|82923545|FG001|Second Intervention|Protocol Violation|1|||
46708061|NCT01147458|82923546|FG002|Second Intervention|Protocol Violation|1|||
46708062|NCT01147458|82923547|FG003|Second Intervention|Protocol Violation|0|||
46708063|NCT01147458|82923544|FG000|Second Intervention|Withdrawal by Subject|0|||
46708064|NCT01147458|82923545|FG001|Second Intervention|Withdrawal by Subject|1|||
46708065|NCT01147458|82923546|FG002|Second Intervention|Withdrawal by Subject|0|||
46708066|NCT01147458|82923547|FG003|Second Intervention|Withdrawal by Subject|0|||
46708067|NCT01147458|82923544|FG000|Second Intervention|Adverse Event|2|||
46708091|NCT01172808|82923563|FG000|Overall Study|Withdrawal by Subject|4|||
46708092|NCT01172808|82923564|FG001|Overall Study|Withdrawal by Subject|1|||
46708093|NCT01172808|82923565|FG002|Overall Study|Withdrawal by Subject|3|||
46708094|NCT01172808|82923566|FG003|Overall Study|Withdrawal by Subject|2|||
46708095|NCT01172808|82923563|FG000|Overall Study|Other|6|||
46708096|NCT01172808|82923564|FG001|Overall Study|Other|5|||
46708097|NCT01172808|82923565|FG002|Overall Study|Other|9|||
46708098|NCT01172808|82923566|FG003|Overall Study|Other|7|||
46708099|NCT01151280|82923576|FG000|Overall Study|Adverse Event|1|||
46708100|NCT01151280|82923576|FG000|Overall Study|Lack of Efficacy|3|||
46708101|NCT01149486|82923582|FG000|First Intervention|Adverse Event|0|||
46708102|NCT01149486|82923583|FG001|First Intervention|Adverse Event|1|||
46708103|NCT00601705|82923589|FG000|Overall Study|Withdrawal by Subject|1|||
46708104|NCT01179737|82923598|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
46708105|NCT01179737|82923599|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
46708106|NCT01179737|82923600|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
46708107|NCT01179737|82923601|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
46708108|NCT01179737|82923598|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
46708109|NCT01179737|82923599|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
46708110|NCT01179737|82923600|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
46708111|NCT01179737|82923601|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
46708112|NCT01179737|82923598|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
46708113|NCT01179737|82923599|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
46708114|NCT01179737|82923600|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
46708115|NCT01179737|82923601|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
46708116|NCT01179737|82923598|FG000|Cohort 1 & Cohort 2|Death|0|||
46708117|NCT01179737|82923599|FG001|Cohort 1 & Cohort 2|Death|0|||
46708118|NCT01179737|82923600|FG002|Cohort 1 & Cohort 2|Death|1|||
46708119|NCT01179737|82923601|FG003|Cohort 1 & Cohort 2|Death|0|||
46708120|NCT01179737|82923598|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
46708121|NCT01179737|82923599|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
46708122|NCT01179737|82923600|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
46708123|NCT01179737|82923601|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
46708124|NCT01179737|82923598|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
46708125|NCT01179737|82923599|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
46708126|NCT01179737|82923600|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
46708127|NCT01179737|82923601|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
46708128|NCT01179737|82923598|FG000|Extension|The study was terminated|3|||
46708129|NCT01179737|82923599|FG001|Extension|The study was terminated|0|||
46708130|NCT01179737|82923600|FG002|Extension|The study was terminated|0|||
46708131|NCT01179737|82923601|FG003|Extension|The study was terminated|0|||
46708132|NCT00929110|82923613|FG000|Overall Study|Adverse Event|40|||
46708133|NCT00929110|82923614|FG001|Overall Study|Adverse Event|29|||
46708134|NCT00929110|82923615|FG002|Overall Study|Adverse Event|18|||
46708135|NCT00929110|82923613|FG000|Overall Study|Subject withdrew consent|40|||
46708136|NCT00929110|82923614|FG001|Overall Study|Subject withdrew consent|23|||
46708137|NCT00929110|82923615|FG002|Overall Study|Subject withdrew consent|26|||
46708138|NCT00929110|82923613|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
46708139|NCT00929110|82923614|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
46708140|NCT00929110|82923615|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
46708141|NCT00929110|82923613|FG000|Overall Study|Lost to Follow-up|7|||
46708142|NCT00929110|82923614|FG001|Overall Study|Lost to Follow-up|7|||
46708143|NCT00929110|82923615|FG002|Overall Study|Lost to Follow-up|3|||
46708144|NCT00929110|82923613|FG000|Overall Study|Protocol deviation|5|||
46708145|NCT00929110|82923614|FG001|Overall Study|Protocol deviation|2|||
46708146|NCT00929110|82923615|FG002|Overall Study|Protocol deviation|4|||
46708147|NCT00929110|82923613|FG000|Overall Study|Administrative problems|4|||
46708148|NCT00929110|82923614|FG001|Overall Study|Administrative problems|1|||
46708149|NCT00929110|82923615|FG002|Overall Study|Administrative problems|2|||
46708150|NCT00929110|82923613|FG000|Overall Study|Death|2|||
46708151|NCT00929110|82923614|FG001|Overall Study|Death|2|||
46708152|NCT00929110|82923615|FG002|Overall Study|Death|2|||
46708153|NCT00929110|82923613|FG000|Overall Study|Abnormal laboratory value(s)|0|||
46708154|NCT00929110|82923614|FG001|Overall Study|Abnormal laboratory value(s)|1|||
46708155|NCT00929110|82923615|FG002|Overall Study|Abnormal laboratory value(s)|0|||
46708156|NCT00929110|82923613|FG000|Overall Study|Abnormal test procedure result(s)|0|||
46708157|NCT00929110|82923614|FG001|Overall Study|Abnormal test procedure result(s)|1|||
46708158|NCT00929110|82923615|FG002|Overall Study|Abnormal test procedure result(s)|1|||
46708159|NCT00929110|82923613|FG000|Overall Study|Patient inability to use the device|0|||
46708160|NCT00929110|82923614|FG001|Overall Study|Patient inability to use the device|1|||
46708161|NCT00929110|82923615|FG002|Overall Study|Patient inability to use the device|0|||
46708162|NCT01147068|82923630|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
46708163|NCT01147068|82923631|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
46708164|NCT01147068|82923632|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
46708165|NCT01147068|82923633|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
46708166|NCT01147068|82923634|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
46708167|NCT01147068|82923635|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
46708168|NCT01147068|82923636|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
46708169|NCT01147068|82923630|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
46708170|NCT01147068|82923631|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
46708171|NCT01147068|82923632|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
46708172|NCT01147068|82923633|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
46708173|NCT01147068|82923634|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
46708174|NCT01147068|82923635|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
46708175|NCT01147068|82923636|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
46708176|NCT01147068|82923630|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
46708177|NCT01147068|82923631|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
46708178|NCT01147068|82923632|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
46708179|NCT01147068|82923633|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
46708180|NCT01147068|82923634|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
46708181|NCT01147068|82923635|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
46708182|NCT01147068|82923636|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
46708183|NCT01147068|82923630|FG000|Subjects That Received 2nd Dose|Other|0|||
46708184|NCT01147068|82923631|FG001|Subjects That Received 2nd Dose|Other|3|||
46708185|NCT01147068|82923632|FG002|Subjects That Received 2nd Dose|Other|3|||
46708186|NCT01147068|82923633|FG003|Subjects That Received 2nd Dose|Other|0|||
46708187|NCT01147068|82923634|FG004|Subjects That Received 2nd Dose|Other|1|||
46708188|NCT01147068|82923635|FG005|Subjects That Received 2nd Dose|Other|0|||
46708189|NCT01147068|82923636|FG006|Subjects That Received 2nd Dose|Other|0|||
46708190|NCT01147068|82923630|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
46708191|NCT01147068|82923631|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
46708192|NCT01147068|82923632|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
46708193|NCT01147068|82923633|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
46708194|NCT01147068|82923634|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
46708195|NCT01147068|82923635|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
46708196|NCT01147068|82923636|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
46708197|NCT01147068|82923630|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
46708198|NCT01147068|82923631|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
46708199|NCT01147068|82923632|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
46708200|NCT01147068|82923633|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
46708201|NCT01147068|82923634|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
46708202|NCT01147068|82923635|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
46708203|NCT01147068|82923636|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
46708204|NCT01147068|82923630|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
46708205|NCT01147068|82923631|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
46708206|NCT01147068|82923632|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
46708207|NCT01147068|82923633|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
46708208|NCT01147068|82923634|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
46708209|NCT01147068|82923635|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
46708210|NCT01147068|82923636|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
46708211|NCT01146912|82923659|FG000|Overall Study|Already received influenza vaccination|817|||
46708212|NCT01146912|82923660|FG001|Overall Study|Already received influenza vaccination|822|||
46708213|NCT01146912|82923661|FG002|Overall Study|Already received influenza vaccination|13|||
46708214|NCT01146912|82923662|FG003|Overall Study|Already received influenza vaccination|15|||
46708215|NCT01146912|82923663|FG004|Overall Study|Already received influenza vaccination|41|||
46708216|NCT01146912|82923664|FG005|Overall Study|Already received influenza vaccination|61|||
46708217|NCT01146912|82923665|FG006|Overall Study|Already received influenza vaccination|56|||
46708218|NCT01146912|82923666|FG007|Overall Study|Already received influenza vaccination|0|||
46708219|NCT01146912|82923659|FG000|Overall Study|< 14 weeks gestational age|0|||
46708220|NCT01146912|82923660|FG001|Overall Study|< 14 weeks gestational age|0|||
46708221|NCT01146912|82923661|FG002|Overall Study|< 14 weeks gestational age|3|||
46708222|NCT01146912|82923662|FG003|Overall Study|< 14 weeks gestational age|2|||
46708223|NCT01146912|82923663|FG004|Overall Study|< 14 weeks gestational age|0|||
46708224|NCT01146912|82923664|FG005|Overall Study|< 14 weeks gestational age|0|||
46708225|NCT01146912|82923665|FG006|Overall Study|< 14 weeks gestational age|0|||
46708226|NCT01146912|82923666|FG007|Overall Study|< 14 weeks gestational age|0|||
46708227|NCT01146912|82923659|FG000|Overall Study|Duplicate patient|0|||
46708228|NCT01146912|82923660|FG001|Overall Study|Duplicate patient|0|||
46708229|NCT01146912|82923661|FG002|Overall Study|Duplicate patient|1|||
46708230|NCT01146912|82923662|FG003|Overall Study|Duplicate patient|0|||
46708231|NCT01146912|82923663|FG004|Overall Study|Duplicate patient|0|||
46708232|NCT01146912|82923664|FG005|Overall Study|Duplicate patient|0|||
46708233|NCT01146912|82923665|FG006|Overall Study|Duplicate patient|0|||
46708234|NCT01146912|82923666|FG007|Overall Study|Duplicate patient|0|||
46708256|NCT01179347|82923702|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
46708257|NCT01179347|82923701|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
46708258|NCT01179347|82923702|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
46708259|NCT01179347|82923701|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
46708260|NCT01179347|82923702|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
46708261|NCT01179347|82923701|FG000|Double-blind Period (12 Weeks)|Other|2|||
46708262|NCT01179347|82923702|FG001|Double-blind Period (12 Weeks)|Other|4|||
46708263|NCT01179347|82923701|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
46708264|NCT01179347|82923702|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
46708265|NCT01179347|82923701|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
46708266|NCT01179347|82923702|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
46708267|NCT01179347|82923701|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
46708268|NCT01179347|82923702|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
46708269|NCT01179347|82923701|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
46708270|NCT01179347|82923702|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
46708271|NCT01179347|82923701|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
46708272|NCT01179347|82923702|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
46708273|NCT01179347|82923701|FG000|Open-label Period (12 Weeks)|Other|7|||
46708274|NCT01179347|82923702|FG001|Open-label Period (12 Weeks)|Other|4|||
46708275|NCT01146288|82923712|FG000|First Intervention(1 Day)|Adverse Event|0|||
46708276|NCT01146288|82923713|FG001|First Intervention(1 Day)|Adverse Event|1|||
46708277|NCT01146054|82923720|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
46708278|NCT01146054|82923720|FG000|Overall Study|Rapid tumor progression|2|||
46708279|NCT01146054|82923720|FG000|Overall Study|Other illness precluded treatment|2|||
46708280|NCT01146054|82923720|FG000|Overall Study|Lost to Follow-up|1|||
46708281|NCT01145898|82923726|FG000|3-year Treatment|medication change by treating physician|3|||
46708282|NCT01145898|82923727|FG001|3-year Treatment|medication change by treating physician|16|||
46708283|NCT01133418|82923734|FG000|Overall Study|Lost to Follow-up|5|||
46708284|NCT01133418|82923735|FG001|Overall Study|Lost to Follow-up|6|||
46708285|NCT00931918|82923743|FG000|Overall Study|Adverse Event|4|||
46708286|NCT00931918|82923744|FG001|Overall Study|Adverse Event|6|||
46708287|NCT00931918|82923743|FG000|Overall Study|Progressive Disease|2|||
46708288|NCT00931918|82923744|FG001|Overall Study|Progressive Disease|1|||
46708289|NCT00931918|82923743|FG000|Overall Study|Symptomatic Deterioration|1|||
46708290|NCT00931918|82923744|FG001|Overall Study|Symptomatic Deterioration|0|||
46708291|NCT00931918|82923743|FG000|Overall Study|Withdrawal by Patient|3|||
46708292|NCT00931918|82923744|FG001|Overall Study|Withdrawal by Patient|4|||
46708293|NCT00931918|82923743|FG000|Overall Study|Other Reason not Specified|4|||
46708294|NCT00931918|82923744|FG001|Overall Study|Other Reason not Specified|4|||
46708295|NCT00931918|82923743|FG000|Overall Study|Did not receive study drug|3|||
46708296|NCT00931918|82923744|FG001|Overall Study|Did not receive study drug|2|||
46896980|NCT00706654|83122632|FG001|Conversion Phase|Withdrawn by Investigator|0|||
46896981|NCT00706654|83122633|FG002|Conversion Phase|Withdrawn by Investigator|0|||
46896982|NCT00706654|83122634|FG003|Conversion Phase|Withdrawn by Investigator|0|||
46896983|NCT00706654|83122631|FG000|Conversion Phase|Withdrew Consent|38|||
46896984|NCT00706654|83122632|FG001|Conversion Phase|Withdrew Consent|0|||
46896985|NCT00706654|83122633|FG002|Conversion Phase|Withdrew Consent|0|||
46896986|NCT00706654|83122634|FG003|Conversion Phase|Withdrew Consent|0|||
46896987|NCT00706654|83122631|FG000|Conversion Phase|Adverse Event|18|||
46896988|NCT00706654|83122632|FG001|Conversion Phase|Adverse Event|0|||
46896989|NCT00706654|83122633|FG002|Conversion Phase|Adverse Event|0|||
46896990|NCT00706654|83122634|FG003|Conversion Phase|Adverse Event|0|||
46896991|NCT00706654|83122631|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
46896992|NCT00706654|83122632|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
46896993|NCT00706654|83122633|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
46896994|NCT00706654|83122634|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
46896995|NCT00706654|83122631|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
46896996|NCT00706654|83122632|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
46896997|NCT00706654|83122633|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
46896998|NCT00706654|83122634|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
46896999|NCT00706654|83122631|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
46897000|NCT00706654|83122632|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
46897001|NCT00706654|83122633|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
46897002|NCT00706654|83122634|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
46897003|NCT00706654|83122631|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
46897004|NCT00706654|83122632|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
46897005|NCT00706654|83122633|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
46897006|NCT00706654|83122634|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
46897007|NCT00706654|83122631|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
46897008|NCT00706654|83122632|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
46897009|NCT00706654|83122633|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
46897010|NCT00706654|83122634|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
46897108|NCT00707980|83122685|FG000|Overall Study|Non-Compliance with Study Drug|28|||
46897109|NCT00707980|83122685|FG000|Overall Study|Protocol Deviations|19|||
46897110|NCT00707980|83122685|FG000|Overall Study|Withdrawal of Consent|81|||
46897111|NCT00707980|83122685|FG000|Overall Study|Lost to Follow-up|59|||
46897112|NCT00707980|83122685|FG000|Overall Study|Other|39|||
46897113|NCT03506425|83122692|FG000|Overall Study|Adverse Event|1|||
46897114|NCT03506425|83122693|FG001|Overall Study|Adverse Event|3|||
46897115|NCT03506425|83122694|FG002|Overall Study|Adverse Event|0|||
46897116|NCT03506425|83122692|FG000|Overall Study|Death|1|||
46897117|NCT03506425|83122693|FG001|Overall Study|Death|0|||
46897118|NCT03506425|83122694|FG002|Overall Study|Death|0|||
46897119|NCT03506425|83122692|FG000|Overall Study|Withdrawal by Subject|0|||
46897120|NCT03506425|83122693|FG001|Overall Study|Withdrawal by Subject|0|||
46897121|NCT03506425|83122694|FG002|Overall Study|Withdrawal by Subject|1|||
46897122|NCT03051620|83122703|FG000|Overall Study|Lost to Follow-up|6|||
46897123|NCT03051620|83122703|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
46897124|NCT03053492|83122709|FG000|Overall Study|Adverse Event|1|||
46897125|NCT03053492|83122710|FG001|Overall Study|Adverse Event|1|||
46897126|NCT03053492|83122709|FG000|Overall Study|Withdrawal by Subject|7|||
46897127|NCT03053492|83122710|FG001|Overall Study|Withdrawal by Subject|5|||
46897128|NCT03801707|83122716|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
46897129|NCT04239872|83122720|FG000|Overall Study|Lost to Follow-up|0|||
46897130|NCT04239872|83122721|FG001|Overall Study|Lost to Follow-up|1|||
46897131|NCT03164772|83122729|FG000|Overall Study|Death|4|||
46897132|NCT03164772|83122730|FG001|Overall Study|Death|2|||
46897133|NCT03164772|83122729|FG000|Overall Study|Adverse Event|1|||
46897134|NCT03164772|83122730|FG001|Overall Study|Adverse Event|4|||
46897135|NCT03164772|83122729|FG000|Overall Study|Progressive Disease|11|||
46897136|NCT03164772|83122730|FG001|Overall Study|Progressive Disease|21|||
46897137|NCT03164772|83122729|FG000|Overall Study|Physician Decision|2|||
46897138|NCT03164772|83122730|FG001|Overall Study|Physician Decision|0|||
46897139|NCT03164772|83122729|FG000|Overall Study|Withdrawal by Subject|0|||
46897140|NCT03164772|83122730|FG001|Overall Study|Withdrawal by Subject|4|||
46897141|NCT03050450|83122753|FG000|Overall Study|Physician Decision|1|||
46897142|NCT03050450|83122754|FG001|Overall Study|Physician Decision|0|||
46897143|NCT03050450|83122755|FG002|Overall Study|Physician Decision|0|||
46897144|NCT03050450|83122756|FG003|Overall Study|Physician Decision|0|||
46897145|NCT03050450|83122757|FG004|Overall Study|Physician Decision|0|||
46897146|NCT03505021|83122771|FG000|Overall Study|Protocol Violation|1|||
46897147|NCT03505021|83122772|FG001|Overall Study|Protocol Violation|0|||
46897148|NCT03505021|83122771|FG000|Overall Study|Death|9|||
46897149|NCT03505021|83122772|FG001|Overall Study|Death|8|||
46897150|NCT03505021|83122771|FG000|Overall Study|Consent withdrawn by subject|6|||
46897151|NCT03505021|83122772|FG001|Overall Study|Consent withdrawn by subject|1|||
46897152|NCT03505021|83122771|FG000|Overall Study|Lost to Follow-up|5|||
46897153|NCT03505021|83122772|FG001|Overall Study|Lost to Follow-up|3|||
46897154|NCT03505021|83122771|FG000|Overall Study|Adverse Event|26|||
46897155|NCT03505021|83122772|FG001|Overall Study|Adverse Event|9|||
46897156|NCT03505021|83122771|FG000|Overall Study|Disease progression|33|||
46897157|NCT03505021|83122772|FG001|Overall Study|Disease progression|17|||
46897158|NCT03505021|83122771|FG000|Overall Study|Other|11|||
46897159|NCT03505021|83122772|FG001|Overall Study|Other|5|||
46897160|NCT03505021|83122771|FG000|Overall Study|Personal reason|21|||
46897161|NCT03505021|83122772|FG001|Overall Study|Personal reason|12|||
46897162|NCT03050372|83122778|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
46897163|NCT03050372|83122779|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
46897164|NCT03050372|83122778|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
46897165|NCT03050372|83122779|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
46897166|NCT03470545|83122786|FG000|Overall Study|Death|0|||
46897167|NCT03470545|83122787|FG001|Overall Study|Death|1|||
46897168|NCT03470545|83122786|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
46897169|NCT03470545|83122787|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
46897170|NCT03470545|83122786|FG000|Overall Study|Adverse Event|2|||
46897171|NCT03470545|83122787|FG001|Overall Study|Adverse Event|0|||
46897172|NCT03470545|83122786|FG000|Overall Study|Withdrawal by Subject|1|||
46897173|NCT03470545|83122787|FG001|Overall Study|Withdrawal by Subject|1|||
46897174|NCT03470545|83122786|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
46897175|NCT03470545|83122787|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
46897176|NCT03163446|83122796|FG000|Overall Study|Unable to return for Day 180 visit|2|||
46897177|NCT03163446|83122797|FG001|Overall Study|Unable to return for Day 180 visit|0|||
46897178|NCT03163446|83122796|FG000|Overall Study|Withdrawal by Subject|2|||
46897179|NCT03163446|83122797|FG001|Overall Study|Withdrawal by Subject|6|||
46897180|NCT03163446|83122796|FG000|Overall Study|Death|16|||
46897181|NCT03163446|83122797|FG001|Overall Study|Death|5|||
46897182|NCT03163446|83122796|FG000|Overall Study|Lost to Follow-up|6|||
46897183|NCT03163446|83122797|FG001|Overall Study|Lost to Follow-up|5|||
46897195|NCT03722485|83122812|FG001|Overall Study|eligibility criteria not met|0|||
46897196|NCT03047720|83122846|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
46897197|NCT03047720|83122847|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
46897198|NCT03626168|83122872|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
46897199|NCT03626168|83122873|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
46897200|NCT03626168|83122872|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
46897201|NCT03626168|83122873|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
46897202|NCT03626168|83122872|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
46897203|NCT03626168|83122873|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
46897204|NCT02966873|83122881|FG000|Overall Study|Lost to Follow-up|16|||
46897205|NCT02966873|83122882|FG001|Overall Study|Lost to Follow-up|15|||
46897206|NCT01389024|83122890|FG000|Overall Study|Withdrawal by Subject|0|||
46897207|NCT01389024|83122891|FG001|Overall Study|Withdrawal by Subject|1|||
46897208|NCT01389024|83122890|FG000|Overall Study|Lost to Follow-up|1|||
46897209|NCT01389024|83122891|FG001|Overall Study|Lost to Follow-up|0|||
46897210|NCT03050060|83122901|FG000|Overall Study|Adverse Event|7|||
46897211|NCT03050060|83122901|FG000|Overall Study|Withdrawal by Subject|1|||
46897212|NCT03050060|83122901|FG000|Overall Study|Progression|7|||
46897213|NCT00706342|83122914|FG000|Overall Study|Adverse Event|3|||
46897214|NCT00706342|83122914|FG000|Overall Study|Not responding to treatment|2|||
46897215|NCT00706342|83122914|FG000|Overall Study|Withdrawn due to failure to respond|1|||
46897216|NCT00706342|83122914|FG000|Overall Study|Death|1|||
46897217|NCT00706342|83122914|FG000|Overall Study|Withdrew from the study on his own.|1|||
46897218|NCT00706342|83122914|FG000|Overall Study|Investigator discretion|2|||
46897219|NCT00706342|83122914|FG000|Overall Study|Non-responder Week 12|1|||
46897220|NCT00706342|83122914|FG000|Overall Study|Ongoing|6|||
46897221|NCT00706342|83122914|FG000|Overall Study|WIthdrawal of consent|1|||
46897222|NCT03049748|83122920|FG000|Overall Study|Lost to Follow-up|1|||
46897223|NCT03049748|83122921|FG001|Overall Study|Lost to Follow-up|0|||
46897224|NCT03049748|83122920|FG000|Overall Study|Death|3|||
46897225|NCT03049748|83122921|FG001|Overall Study|Death|0|||
46897226|NCT03049748|83122920|FG000|Overall Study|Withdrawal by Subject|0|||
46897227|NCT03049748|83122921|FG001|Overall Study|Withdrawal by Subject|3|||
46897228|NCT03049748|83122920|FG000|Overall Study|Protocol Violation|0|||
46897229|NCT03049748|83122921|FG001|Overall Study|Protocol Violation|2|||
46897230|NCT03049748|83122920|FG000|Overall Study|Moved out of state (relocation)|0|||
46897231|NCT03049748|83122921|FG001|Overall Study|Moved out of state (relocation)|1|||
46897232|NCT03501277|83122935|FG000|Intervention Period 1 (4 Days)|Other|0|||
46897233|NCT03501277|83122936|FG001|Intervention Period 1 (4 Days)|Other|0|||
46897234|NCT03501277|83122937|FG002|Intervention Period 1 (4 Days)|Other|1|||
46897235|NCT03501277|83122938|FG003|Intervention Period 1 (4 Days)|Other|0|||
46897236|NCT03501277|83122935|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
46897237|NCT03501277|83122936|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
46897238|NCT03501277|83122937|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
46897239|NCT03501277|83122938|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
46897240|NCT03501277|83122935|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
46897241|NCT03501277|83122936|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
46897242|NCT03501277|83122937|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
46897243|NCT03501277|83122938|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
46897244|NCT03501277|83122935|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
46897245|NCT03501277|83122936|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
46897246|NCT03501277|83122937|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
46897247|NCT03501277|83122938|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
46897248|NCT03500419|83122950|FG000|Overall Study|Withdrawal by Subject|2|||
46897249|NCT03500419|83122951|FG001|Overall Study|Withdrawal by Subject|25|||
46897250|NCT03500341|83122957|FG000|Overall Study|Withdrawn prior to Completion|2|||
46897251|NCT01316900|83122978|FG000|Overall Study|Adverse Event|10|||
46897252|NCT01316900|83122979|FG001|Overall Study|Adverse Event|10|||
46897253|NCT01316900|83122980|FG002|Overall Study|Adverse Event|15|||
46897254|NCT01316900|83122981|FG003|Overall Study|Adverse Event|9|||
46897255|NCT01316900|83122978|FG000|Overall Study|Lack of Efficacy|17|||
46897256|NCT01316900|83122979|FG001|Overall Study|Lack of Efficacy|9|||
46897257|NCT01316900|83122980|FG002|Overall Study|Lack of Efficacy|5|||
46897258|NCT01316900|83122981|FG003|Overall Study|Lack of Efficacy|7|||
46897259|NCT01316900|83122978|FG000|Overall Study|Protocol Violation|7|||
46897260|NCT01316900|83122979|FG001|Overall Study|Protocol Violation|1|||
46897261|NCT01316900|83122980|FG002|Overall Study|Protocol Violation|4|||
46897262|NCT01316900|83122981|FG003|Overall Study|Protocol Violation|0|||
46897263|NCT01316900|83122978|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
46897264|NCT01316900|83122979|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
46897265|NCT01316900|83122980|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
46897266|NCT01316900|83122981|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
46897267|NCT01316900|83122978|FG000|Overall Study|Lost to Follow-up|1|||
46897268|NCT01316900|83122979|FG001|Overall Study|Lost to Follow-up|0|||
46897271|NCT01316900|83122978|FG000|Overall Study|Withdrawal by Subject|7|||
46897272|NCT01316900|83122979|FG001|Overall Study|Withdrawal by Subject|8|||
46897273|NCT01316900|83122980|FG002|Overall Study|Withdrawal by Subject|6|||
46897274|NCT01316900|83122981|FG003|Overall Study|Withdrawal by Subject|9|||
46897275|NCT03499873|83122994|FG000|Overall Study|Withdrawal by Subject|4|||
46897276|NCT03499873|83122995|FG001|Overall Study|Withdrawal by Subject|6|||
46897277|NCT03499873|83122996|FG002|Overall Study|Withdrawal by Subject|1|||
46897278|NCT03499873|83122994|FG000|Overall Study|Subjects condition worsened|0|||
46897279|NCT03499873|83122995|FG001|Overall Study|Subjects condition worsened|3|||
46897280|NCT03499873|83122996|FG002|Overall Study|Subjects condition worsened|11|||
46897281|NCT03499873|83122994|FG000|Overall Study|Adverse Event|8|||
46897282|NCT03499873|83122995|FG001|Overall Study|Adverse Event|3|||
46897283|NCT03499873|83122996|FG002|Overall Study|Adverse Event|6|||
46897284|NCT03499873|83122994|FG000|Overall Study|Physician Decision|1|||
46897285|NCT03499873|83122995|FG001|Overall Study|Physician Decision|0|||
46897286|NCT03499873|83122996|FG002|Overall Study|Physician Decision|0|||
46897287|NCT03499873|83122994|FG000|Overall Study|Administrative reasons|0|||
46897288|NCT03499873|83122995|FG001|Overall Study|Administrative reasons|1|||
46897289|NCT03499873|83122996|FG002|Overall Study|Administrative reasons|0|||
46897290|NCT03499873|83122994|FG000|Overall Study|Concomitant therapy|5|||
46897291|NCT03499873|83122995|FG001|Overall Study|Concomitant therapy|4|||
46897292|NCT03499873|83122996|FG002|Overall Study|Concomitant therapy|7|||
46897293|NCT03499873|83122994|FG000|Overall Study|Miscellaneous|1|||
46897294|NCT03499873|83122995|FG001|Overall Study|Miscellaneous|2|||
46897295|NCT03499873|83122996|FG002|Overall Study|Miscellaneous|2|||
46897296|NCT03499873|83122994|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
46897297|NCT03499873|83122995|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
46897298|NCT03499873|83122996|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
46897299|NCT03467971|83123006|FG000|Treatment Period 2|Withdrawal by Subject|0|||
46897300|NCT03467971|83123007|FG001|Treatment Period 2|Withdrawal by Subject|1|||
46897301|NCT03049280|83123023|FG000|Overall Study|Physician Decision|1|||
46897302|NCT03048500|83123029|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
46897303|NCT03048500|83123029|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
46897304|NCT03048500|83123029|FG000|Reached 1st Response/Continued Treatment|Death|1|||
46897305|NCT03048500|83123029|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
46897306|NCT03048500|83123029|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
46897307|NCT03048500|83123029|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
46897308|NCT03048500|83123029|FG000|Follow up for 3 Years|Death|12|||
46897309|NCT00908076|83123035|FG000|Overall Study|Lack of Efficacy|1|||
46897310|NCT00908076|83123036|FG001|Overall Study|Lack of Efficacy|1|||
46897311|NCT03467425|83123044|FG000|Overall Study|Adverse Event|9|||
46897312|NCT03467425|83123045|FG001|Overall Study|Adverse Event|9|||
46897313|NCT03467425|83123044|FG000|Overall Study|Lack of Efficacy|3|||
46897314|NCT03467425|83123045|FG001|Overall Study|Lack of Efficacy|1|||
46897315|NCT03467425|83123044|FG000|Overall Study|Protocol Violation|0|||
46897316|NCT03467425|83123045|FG001|Overall Study|Protocol Violation|1|||
46897317|NCT03467425|83123044|FG000|Overall Study|Lost to Follow-up|18|||
46897318|NCT03467425|83123045|FG001|Overall Study|Lost to Follow-up|25|||
46897319|NCT03467425|83123044|FG000|Overall Study|Physician Decision|2|||
46897320|NCT03467425|83123045|FG001|Overall Study|Physician Decision|1|||
46897321|NCT03467425|83123044|FG000|Overall Study|Withdrawal by Subject|15|||
46897322|NCT03467425|83123045|FG001|Overall Study|Withdrawal by Subject|17|||
46897323|NCT02886702|83123054|FG000|Overall Study|Other|4|||
46897324|NCT02886702|83123055|FG001|Overall Study|Other|3|||
46897325|NCT02886702|83123056|FG002|Overall Study|Other|9|||
46897326|NCT02886702|83123054|FG000|Overall Study|Withdrawal by Subject|24|||
46897327|NCT02886702|83123055|FG001|Overall Study|Withdrawal by Subject|18|||
46897328|NCT02886702|83123056|FG002|Overall Study|Withdrawal by Subject|22|||
46897329|NCT02886702|83123054|FG000|Overall Study|Significant Worsening of Condition|0|||
46897330|NCT02886702|83123055|FG001|Overall Study|Significant Worsening of Condition|1|||
46897331|NCT02886702|83123056|FG002|Overall Study|Significant Worsening of Condition|0|||
46897332|NCT02886702|83123054|FG000|Overall Study|Protocol Violation|2|||
46897333|NCT02886702|83123055|FG001|Overall Study|Protocol Violation|2|||
46897334|NCT02886702|83123056|FG002|Overall Study|Protocol Violation|1|||
46897335|NCT02886702|83123054|FG000|Overall Study|Non-Compliance With Study Drug|0|||
46897336|NCT02886702|83123055|FG001|Overall Study|Non-Compliance With Study Drug|1|||
46897337|NCT02886702|83123056|FG002|Overall Study|Non-Compliance With Study Drug|4|||
46897338|NCT02886702|83123054|FG000|Overall Study|Lost to Follow-up|11|||
46897339|NCT02886702|83123055|FG001|Overall Study|Lost to Follow-up|13|||
46897340|NCT02886702|83123056|FG002|Overall Study|Lost to Follow-up|8|||
46897341|NCT02886702|83123054|FG000|Overall Study|Lack of Efficacy|3|||
46897342|NCT02886702|83123055|FG001|Overall Study|Lack of Efficacy|4|||
46897343|NCT02886702|83123056|FG002|Overall Study|Lack of Efficacy|5|||
46897344|NCT02886702|83123054|FG000|Overall Study|Adverse Event|4|||
46897345|NCT02886702|83123055|FG001|Overall Study|Adverse Event|9|||
46897346|NCT02886702|83123056|FG002|Overall Study|Adverse Event|3|||
46897347|NCT02886702|83123054|FG000|Overall Study|Administrative Reasons|0|||
46897348|NCT02886702|83123055|FG001|Overall Study|Administrative Reasons|0|||
46897349|NCT02886702|83123056|FG002|Overall Study|Administrative Reasons|1|||
46897350|NCT03498313|83123070|FG000|Experimental Period 1|Adverse Event|1|||
46897351|NCT03498313|83123071|FG001|Experimental Period 1|Adverse Event|0|||
46897352|NCT03498313|83123072|FG002|Experimental Period 1|Adverse Event|0|||
46897353|NCT03498313|83123073|FG003|Experimental Period 1|Adverse Event|1|||
46897354|NCT03498313|83123074|FG004|Experimental Period 1|Adverse Event|0|||
46897355|NCT03498313|83123075|FG005|Experimental Period 1|Adverse Event|0|||
46897356|NCT03498313|83123070|FG000|Experimental Period 1|Withdrawal by Subject|0|||
46897357|NCT03498313|83123071|FG001|Experimental Period 1|Withdrawal by Subject|1|||
46897358|NCT03498313|83123072|FG002|Experimental Period 1|Withdrawal by Subject|0|||
46897359|NCT03498313|83123073|FG003|Experimental Period 1|Withdrawal by Subject|0|||
46897360|NCT03498313|83123074|FG004|Experimental Period 1|Withdrawal by Subject|0|||
46897361|NCT03498313|83123075|FG005|Experimental Period 1|Withdrawal by Subject|0|||
46897362|NCT03498313|83123070|FG000|Washout Period 1|Anovulation|1|||
46897363|NCT03498313|83123071|FG001|Washout Period 1|Anovulation|0|||
46897364|NCT03498313|83123072|FG002|Washout Period 1|Anovulation|0|||
46897365|NCT03498313|83123073|FG003|Washout Period 1|Anovulation|0|||
46897366|NCT03498313|83123074|FG004|Washout Period 1|Anovulation|0|||
46897367|NCT03498313|83123075|FG005|Washout Period 1|Anovulation|0|||
46897368|NCT03498313|83123070|FG000|Washout Period 1|Withdrawal by Subject|0|||
46897369|NCT03498313|83123071|FG001|Washout Period 1|Withdrawal by Subject|3|||
46897370|NCT03498313|83123072|FG002|Washout Period 1|Withdrawal by Subject|0|||
46897371|NCT03498313|83123073|FG003|Washout Period 1|Withdrawal by Subject|1|||
46897372|NCT03498313|83123074|FG004|Washout Period 1|Withdrawal by Subject|0|||
46897373|NCT03498313|83123075|FG005|Washout Period 1|Withdrawal by Subject|1|||
46897374|NCT03498313|83123070|FG000|Experimental Period 2|Adverse Event|0|||
46897375|NCT03498313|83123071|FG001|Experimental Period 2|Adverse Event|0|||
46897376|NCT03498313|83123072|FG002|Experimental Period 2|Adverse Event|0|||
46897377|NCT03498313|83123073|FG003|Experimental Period 2|Adverse Event|0|||
46897378|NCT03498313|83123074|FG004|Experimental Period 2|Adverse Event|1|||
46897379|NCT03498313|83123075|FG005|Experimental Period 2|Adverse Event|2|||
46897380|NCT03498313|83123070|FG000|Washout Period 2|Physician Decision|1|||
46897381|NCT03498313|83123071|FG001|Washout Period 2|Physician Decision|0|||
46897382|NCT03498313|83123072|FG002|Washout Period 2|Physician Decision|0|||
46897383|NCT03498313|83123073|FG003|Washout Period 2|Physician Decision|1|||
46897384|NCT03498313|83123074|FG004|Washout Period 2|Physician Decision|0|||
46897385|NCT03498313|83123075|FG005|Washout Period 2|Physician Decision|1|||
46897386|NCT03498313|83123070|FG000|Washout Period 2|Withdrawal by Subject|3|||
46897387|NCT03498313|83123071|FG001|Washout Period 2|Withdrawal by Subject|2|||
46897388|NCT03498313|83123072|FG002|Washout Period 2|Withdrawal by Subject|0|||
46897389|NCT03498313|83123073|FG003|Washout Period 2|Withdrawal by Subject|0|||
46897390|NCT03498313|83123074|FG004|Washout Period 2|Withdrawal by Subject|2|||
46897391|NCT03498313|83123075|FG005|Washout Period 2|Withdrawal by Subject|0|||
46897392|NCT03498313|83123070|FG000|Washout Period 2|Anovulation|0|||
46897393|NCT03498313|83123071|FG001|Washout Period 2|Anovulation|0|||
46897394|NCT03498313|83123072|FG002|Washout Period 2|Anovulation|0|||
46897395|NCT03498313|83123073|FG003|Washout Period 2|Anovulation|0|||
46897396|NCT03498313|83123074|FG004|Washout Period 2|Anovulation|0|||
46897397|NCT03498313|83123075|FG005|Washout Period 2|Anovulation|1|||
46897398|NCT02601014|83123085|FG000|Overall Study|Adverse Event|3|||
46897399|NCT02601014|83123086|FG001|Overall Study|Adverse Event|3|||
46897400|NCT02601014|83123085|FG000|Overall Study|Death|3|||
46897401|NCT02601014|83123086|FG001|Overall Study|Death|1|||
46897402|NCT02601014|83123085|FG000|Overall Study|Disease progression|4|||
46897403|NCT02601014|83123086|FG001|Overall Study|Disease progression|8|||
46897404|NCT01307046|83123094|FG000|Overall Study|Adverse Event|3|||
46897405|NCT01307046|83123095|FG001|Overall Study|Adverse Event|3|||
46897406|NCT01307046|83123094|FG000|Overall Study|Lack of Efficacy|0|||
46897407|NCT01307046|83123095|FG001|Overall Study|Lack of Efficacy|2|||
46897408|NCT01307046|83123094|FG000|Overall Study|Physician Decision|2|||
46897409|NCT01307046|83123095|FG001|Overall Study|Physician Decision|0|||
46897410|NCT01307046|83123094|FG000|Overall Study|Withdrawal by Subject|1|||
46897411|NCT01307046|83123095|FG001|Overall Study|Withdrawal by Subject|1|||
46897412|NCT01307046|83123094|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
46897413|NCT01307046|83123095|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
46897414|NCT01307046|83123094|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
46897415|NCT01307046|83123095|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
46897416|NCT03495817|83123101|FG000|26 Week Open Label|Adverse Event|3|||
46897417|NCT03495817|83123101|FG000|26 Week Open Label|Withdrawal by Subject|4|||
46897418|NCT03495817|83123101|FG000|26 Week Open Label|Lost to Follow-up|1|||
46897419|NCT03495817|83123101|FG000|26 Week Extension|Lost to Follow-up|2|||
46897420|NCT02886624|83123105|FG000|12-week Post Treatment Follow-up|Death|1|||
46897421|NCT02886624|83123105|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
46897422|NCT02963766|83123112|FG000|Double-Blind Period|Adverse Event|1|||
46897425|NCT02963766|83123112|FG000|Double-Blind Period|Physician Decision|1|||
46897426|NCT02963766|83123113|FG001|Double-Blind Period|Physician Decision|0|||
46897427|NCT02963766|83123114|FG002|Double-Blind Period|Physician Decision|0|||
46897428|NCT02963766|83123112|FG000|Double-Blind Period|Withdrawal by Subject|1|||
46897429|NCT02963766|83123113|FG001|Double-Blind Period|Withdrawal by Subject|1|||
46897430|NCT02963766|83123114|FG002|Double-Blind Period|Withdrawal by Subject|0|||
46897431|NCT02963766|83123112|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
46897432|NCT02963766|83123113|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
46897433|NCT02963766|83123114|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
46897434|NCT02963766|83123112|FG000|Double-Blind Period|Protocol Violation|1|||
46897435|NCT02963766|83123113|FG001|Double-Blind Period|Protocol Violation|0|||
46897436|NCT02963766|83123114|FG002|Double-Blind Period|Protocol Violation|0|||
46897437|NCT02963766|83123112|FG000|Double-Blind Period|Lost to Follow-up|0|||
46897438|NCT02963766|83123113|FG001|Double-Blind Period|Lost to Follow-up|1|||
46897439|NCT02963766|83123114|FG002|Double-Blind Period|Lost to Follow-up|0|||
46897440|NCT02963766|83123112|FG000|Open Label Extension (OLE)|Physician Decision|1|||
46897441|NCT02963766|83123113|FG001|Open Label Extension (OLE)|Physician Decision|2|||
46897442|NCT02963766|83123114|FG002|Open Label Extension (OLE)|Physician Decision|2|||
46897443|NCT02963766|83123112|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
46897444|NCT02963766|83123113|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
46897445|NCT02963766|83123114|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
46897446|NCT04839965|83123134|FG000|Overall Study|Death|6|||
46897447|NCT04839965|83123135|FG001|Overall Study|Death|6|||
46897448|NCT04839965|83123134|FG000|Overall Study|Lost to Follow-up|1|||
46897449|NCT04839965|83123135|FG001|Overall Study|Lost to Follow-up|0|||
46897450|NCT03466099|83123144|FG000|Overall Study|Adverse Event|1|||
46897451|NCT03466099|83123145|FG001|Overall Study|Adverse Event|1|||
46897452|NCT03466099|83123146|FG002|Overall Study|Adverse Event|1|||
46897453|NCT03466099|83123144|FG000|Overall Study|Withdrawal by Subject|2|||
46897454|NCT03466099|83123145|FG001|Overall Study|Withdrawal by Subject|3|||
46897455|NCT03466099|83123146|FG002|Overall Study|Withdrawal by Subject|1|||
46897456|NCT03466099|83123144|FG000|Overall Study|Use of rescue medication|8|||
46897457|NCT03466099|83123145|FG001|Overall Study|Use of rescue medication|9|||
46897458|NCT03466099|83123146|FG002|Overall Study|Use of rescue medication|13|||
46897459|NCT03466099|83123144|FG000|Overall Study|Rescued without meeting criteria|4|||
46897460|NCT03466099|83123145|FG001|Overall Study|Rescued without meeting criteria|1|||
46897461|NCT03466099|83123146|FG002|Overall Study|Rescued without meeting criteria|1|||
46897462|NCT03466099|83123144|FG000|Overall Study|Subject compliance|2|||
46897463|NCT03466099|83123145|FG001|Overall Study|Subject compliance|0|||
46897464|NCT03466099|83123146|FG002|Overall Study|Subject compliance|0|||
46897465|NCT03466099|83123144|FG000|Overall Study|Worsening disease|0|||
46897466|NCT03466099|83123145|FG001|Overall Study|Worsening disease|0|||
46897467|NCT03466099|83123146|FG002|Overall Study|Worsening disease|1|||
46897468|NCT00739674|83123156|FG000|Overall Study|Screening failures|19|||
46897469|NCT00739674|83123157|FG001|Overall Study|Screening failures|17|||
46897470|NCT00739674|83123156|FG000|Overall Study|Site 212 removal|19|||
46897471|NCT00739674|83123157|FG001|Overall Study|Site 212 removal|13|||
46897472|NCT00739674|83123156|FG000|Overall Study|No follow-up data|33|||
46897473|NCT00739674|83123157|FG001|Overall Study|No follow-up data|18|||
46897474|NCT00739674|83123156|FG000|Overall Study|Dietician consultation >30 days|1|||
46897475|NCT00739674|83123157|FG001|Overall Study|Dietician consultation >30 days|9|||
46897476|NCT00739674|83123156|FG000|Overall Study|Adverse Event|22|||
46897477|NCT00739674|83123157|FG001|Overall Study|Adverse Event|13|||
46897478|NCT00739674|83123156|FG000|Overall Study|Death|1|||
46897479|NCT00739674|83123157|FG001|Overall Study|Death|0|||
46897480|NCT00739674|83123156|FG000|Overall Study|Lack of Efficacy|1|||
46897481|NCT00739674|83123157|FG001|Overall Study|Lack of Efficacy|0|||
46897482|NCT00739674|83123156|FG000|Overall Study|Lost to Follow-up|52|||
46897483|NCT00739674|83123157|FG001|Overall Study|Lost to Follow-up|30|||
46897484|NCT00739674|83123156|FG000|Overall Study|Protocol Violation|5|||
46897485|NCT00739674|83123157|FG001|Overall Study|Protocol Violation|5|||
46897486|NCT00739674|83123156|FG000|Overall Study|Withdrawal by Subject|9|||
46897487|NCT00739674|83123157|FG001|Overall Study|Withdrawal by Subject|9|||
46897488|NCT00739674|83123156|FG000|Overall Study|Reason missing|2|||
46897489|NCT00739674|83123157|FG001|Overall Study|Reason missing|0|||
46897490|NCT00739674|83123156|FG000|Overall Study|Clinic closed|6|||
46897491|NCT00739674|83123157|FG001|Overall Study|Clinic closed|4|||
46897492|NCT00739674|83123156|FG000|Overall Study|Patient moved|3|||
46897493|NCT00739674|83123157|FG001|Overall Study|Patient moved|2|||
46897494|NCT00739674|83123156|FG000|Overall Study|Non compliant|4|||
46897495|NCT00739674|83123157|FG001|Overall Study|Non compliant|0|||
46897496|NCT00739674|83123156|FG000|Overall Study|Unable to attend visit|3|||
46897497|NCT00739674|83123157|FG001|Overall Study|Unable to attend visit|1|||
46897498|NCT00739674|83123156|FG000|Overall Study|Home monitoring off meds|1|||
46897499|NCT00739674|83123157|FG001|Overall Study|Home monitoring off meds|0|||
46897500|NCT00739674|83123156|FG000|Overall Study|Erectile dysfunction|0|||
46897501|NCT00739674|83123157|FG001|Overall Study|Erectile dysfunction|1|||
46897502|NCT03494725|83123165|FG000|Overall Study|Withdrawal by Subject|0|||
46897503|NCT03494725|83123166|FG001|Overall Study|Withdrawal by Subject|2|||
46897504|NCT03494725|83123165|FG000|Overall Study|Antibiotic use|1|||
46897505|NCT03494725|83123166|FG001|Overall Study|Antibiotic use|0|||
46897506|NCT00705718|83123180|FG000|Overall Study|Death|6|||
46897507|NCT00705718|83123181|FG001|Overall Study|Death|6|||
46897508|NCT00705718|83123180|FG000|Overall Study|Not due for Visit|0|||
46897509|NCT00705718|83123181|FG001|Overall Study|Not due for Visit|12|||
46897510|NCT00705718|83123180|FG000|Overall Study|Follow up not done|1|||
46897511|NCT00705718|83123181|FG001|Overall Study|Follow up not done|4|||
46897512|NCT03435211|83123187|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
46897513|NCT03465709|83123200|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
46897514|NCT03465709|83123200|FG000|Overall Study|Withdrawal by Subject|3|||
46897515|NCT03435055|83123206|FG000|Screening|Physician Decision|2|||
46897516|NCT03435055|83123206|FG000|Received Intervention|Did not complete nitrous administration|3|||
46897517|NCT03434977|83123219|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
46897518|NCT03434977|83123220|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
46897519|NCT03434119|83123228|FG000|Overall Study|Randomized but not treated|1|||
46897520|NCT03434119|83123229|FG001|Overall Study|Randomized but not treated|0|||
46897521|NCT03434119|83123228|FG000|Overall Study|Adverse Event|1|||
46897522|NCT03434119|83123229|FG001|Overall Study|Adverse Event|0|||
46897523|NCT03434119|83123228|FG000|Overall Study|Poor Compliance to Protocol|0|||
46897524|NCT03434119|83123229|FG001|Overall Study|Poor Compliance to Protocol|1|||
46897525|NCT03434119|83123228|FG000|Overall Study|Study Terminated by Sponsor|91|||
46897526|NCT03434119|83123229|FG001|Overall Study|Study Terminated by Sponsor|102|||
46897527|NCT03434119|83123228|FG000|Overall Study|Withdrawal by Subject|7|||
46897528|NCT03434119|83123229|FG001|Overall Study|Withdrawal by Subject|5|||
46897529|NCT03434119|83123228|FG000|Overall Study|Other than specified|7|||
46897530|NCT03434119|83123229|FG001|Overall Study|Other than specified|5|||
46897531|NCT00378378|83123238|FG000|Overall Study|Withdrawal by Subject|0|||
46897532|NCT00378378|83123239|FG001|Overall Study|Withdrawal by Subject|1|||
46897533|NCT00378378|83123240|FG002|Overall Study|Withdrawal by Subject|0|||
46897534|NCT00378378|83123238|FG000|Overall Study|Treatment Failure|0|||
46897535|NCT00378378|83123239|FG001|Overall Study|Treatment Failure|0|||
46897536|NCT00378378|83123240|FG002|Overall Study|Treatment Failure|1|||
46897537|NCT00378378|83123238|FG000|Overall Study|Non-compliance with protocol|0|||
46897538|NCT00378378|83123239|FG001|Overall Study|Non-compliance with protocol|0|||
46897539|NCT00378378|83123240|FG002|Overall Study|Non-compliance with protocol|1|||
46897540|NCT03490981|83123250|FG000|Overall Study|Lost to Follow-up|1|||
46897541|NCT03490981|83123251|FG001|Overall Study|Lost to Follow-up|2|||
46897542|NCT03160716|83123257|FG000|Overall Study|Lost to Follow-up|1|||
46897543|NCT03713021|83123261|FG000|Overall Study|Did not have CT sim scan available|6|||
46897544|NCT03713021|83123261|FG000|Overall Study|Not eligible|4|||
46897545|NCT03713021|83123261|FG000|Overall Study|Issues with TraceIT markers|5|||
46897546|NCT03160560|83123269|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
46897547|NCT03160560|83123270|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46897548|NCT03160560|83123271|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
46897549|NCT03160560|83123272|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
46897550|NCT03160560|83123269|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
46897551|NCT03160560|83123270|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
46897552|NCT03160560|83123271|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
46897553|NCT03160560|83123272|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
46897554|NCT03489343|83123289|FG000|Overall Study|Documented progressive disease|1|||
46897555|NCT03489343|83123290|FG001|Overall Study|Documented progressive disease|0|||
46897556|NCT03489343|83123291|FG002|Overall Study|Documented progressive disease|3|||
46897557|NCT03489343|83123292|FG003|Overall Study|Documented progressive disease|1|||
46897558|NCT03489343|83123293|FG004|Overall Study|Documented progressive disease|3|||
46897559|NCT03489343|83123294|FG005|Overall Study|Documented progressive disease|5|||
46897560|NCT03489343|83123295|FG006|Overall Study|Documented progressive disease|4|||
46897561|NCT03489343|83123289|FG000|Overall Study|Adverse Event|0|||
46897562|NCT03489343|83123290|FG001|Overall Study|Adverse Event|1|||
46897563|NCT03489343|83123291|FG002|Overall Study|Adverse Event|0|||
46897564|NCT03489343|83123292|FG003|Overall Study|Adverse Event|0|||
46897565|NCT03489343|83123293|FG004|Overall Study|Adverse Event|0|||
46897566|NCT03489343|83123294|FG005|Overall Study|Adverse Event|1|||
46897567|NCT03489343|83123295|FG006|Overall Study|Adverse Event|0|||
46897568|NCT03489343|83123289|FG000|Overall Study|Withdrawal by Subject|0|||
46897569|NCT03489343|83123290|FG001|Overall Study|Withdrawal by Subject|0|||
46897570|NCT03489343|83123291|FG002|Overall Study|Withdrawal by Subject|0|||
46897571|NCT03489343|83123292|FG003|Overall Study|Withdrawal by Subject|1|||
46897572|NCT03489343|83123293|FG004|Overall Study|Withdrawal by Subject|0|||
46897573|NCT03489343|83123294|FG005|Overall Study|Withdrawal by Subject|1|||
46897574|NCT03489343|83123295|FG006|Overall Study|Withdrawal by Subject|1|||
46897575|NCT03489343|83123289|FG000|Overall Study|Clinical progression|0|||
46897576|NCT03489343|83123290|FG001|Overall Study|Clinical progression|0|||
46897577|NCT03489343|83123291|FG002|Overall Study|Clinical progression|0|||
46897578|NCT03489343|83123292|FG003|Overall Study|Clinical progression|1|||
46897579|NCT03489343|83123293|FG004|Overall Study|Clinical progression|0|||
46897580|NCT03489343|83123294|FG005|Overall Study|Clinical progression|0|||
46897581|NCT03489343|83123295|FG006|Overall Study|Clinical progression|1|||
46897582|NCT03489109|83123313|FG000|Overall Study|Lost to Follow-up|1|||
46897583|NCT03489109|83123314|FG001|Overall Study|Lost to Follow-up|2|||
46897584|NCT03709823|83123326|FG000|Overall Study|Adverse Event|0|||
46897585|NCT03709823|83123327|FG001|Overall Study|Adverse Event|0|||
46897586|NCT03709823|83123328|FG002|Overall Study|Adverse Event|1|||
46897587|NCT03709823|83123329|FG003|Overall Study|Adverse Event|0|||
46897588|NCT03709823|83123330|FG004|Overall Study|Adverse Event|0|||
46897589|NCT03709823|83123331|FG005|Overall Study|Adverse Event|0|||
46897590|NCT03709823|83123326|FG000|Overall Study|Lost to Follow-up|2|||
46897591|NCT03709823|83123327|FG001|Overall Study|Lost to Follow-up|2|||
46897592|NCT03709823|83123328|FG002|Overall Study|Lost to Follow-up|2|||
46897593|NCT03709823|83123329|FG003|Overall Study|Lost to Follow-up|1|||
46897594|NCT03709823|83123330|FG004|Overall Study|Lost to Follow-up|1|||
46897595|NCT03709823|83123331|FG005|Overall Study|Lost to Follow-up|0|||
46897596|NCT03709823|83123326|FG000|Overall Study|Withdrawal by Subject|1|||
46897597|NCT03709823|83123327|FG001|Overall Study|Withdrawal by Subject|3|||
46897598|NCT03709823|83123328|FG002|Overall Study|Withdrawal by Subject|0|||
46897599|NCT03709823|83123329|FG003|Overall Study|Withdrawal by Subject|0|||
46897600|NCT03709823|83123330|FG004|Overall Study|Withdrawal by Subject|0|||
46897601|NCT03709823|83123331|FG005|Overall Study|Withdrawal by Subject|0|||
46897602|NCT03709823|83123326|FG000|Overall Study|Other, Not Specified|0|||
46897603|NCT03709823|83123327|FG001|Overall Study|Other, Not Specified|0|||
46897604|NCT03709823|83123328|FG002|Overall Study|Other, Not Specified|0|||
46897605|NCT03709823|83123329|FG003|Overall Study|Other, Not Specified|1|||
46897606|NCT03709823|83123330|FG004|Overall Study|Other, Not Specified|0|||
46897607|NCT03709823|83123331|FG005|Overall Study|Other, Not Specified|0|||
46897608|NCT03488563|83123351|FG000|Overall Study|Lost to Follow-up|7|||
46897609|NCT03488563|83123352|FG001|Overall Study|Lost to Follow-up|6|||
46897610|NCT03488563|83123353|FG002|Overall Study|Lost to Follow-up|7|||
46897611|NCT03488563|83123351|FG000|Overall Study|Withdrawal by Subject|8|||
46897612|NCT03488563|83123352|FG001|Overall Study|Withdrawal by Subject|7|||
46897613|NCT03488563|83123353|FG002|Overall Study|Withdrawal by Subject|7|||
46897614|NCT03488563|83123351|FG000|Overall Study|Physician Decision|0|||
46897615|NCT03488563|83123352|FG001|Overall Study|Physician Decision|0|||
46897616|NCT03488563|83123353|FG002|Overall Study|Physician Decision|1|||
46897617|NCT03488563|83123351|FG000|Overall Study|Protocol Violation|3|||
46897618|NCT03488563|83123352|FG001|Overall Study|Protocol Violation|2|||
46897619|NCT03488563|83123353|FG002|Overall Study|Protocol Violation|6|||
46897620|NCT03488563|83123351|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
46897621|NCT03488563|83123352|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
46897622|NCT03488563|83123353|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
46897623|NCT03488563|83123351|FG000|Overall Study|Use of prohibited medication|2|||
46897624|NCT03488563|83123352|FG001|Overall Study|Use of prohibited medication|0|||
46897625|NCT03488563|83123353|FG002|Overall Study|Use of prohibited medication|0|||
46897626|NCT03488563|83123351|FG000|Overall Study|Adverse Event|1|||
46897627|NCT03488563|83123352|FG001|Overall Study|Adverse Event|0|||
46897628|NCT03488563|83123353|FG002|Overall Study|Adverse Event|1|||
46897629|NCT03488563|83123351|FG000|Overall Study|Subject returned for ET visit|0|||
46897630|NCT03488563|83123352|FG001|Overall Study|Subject returned for ET visit|1|||
46897631|NCT03488563|83123353|FG002|Overall Study|Subject returned for ET visit|0|||
46897632|NCT03488563|83123351|FG000|Overall Study|Sponsor's decision|0|||
46897633|NCT03488563|83123352|FG001|Overall Study|Sponsor's decision|0|||
46897634|NCT03488563|83123353|FG002|Overall Study|Sponsor's decision|1|||
46897635|NCT00706030|83123367|FG000|Overall Study|Disease Progression|4|||
46897636|NCT00706030|83123368|FG001|Overall Study|Disease Progression|6|||
46897637|NCT00706030|83123369|FG002|Overall Study|Disease Progression|46|||
46897638|NCT00706030|83123370|FG003|Overall Study|Disease Progression|12|||
46897639|NCT00706030|83123367|FG000|Overall Study|Adverse Event|1|||
46897640|NCT00706030|83123368|FG001|Overall Study|Adverse Event|0|||
46897641|NCT00706030|83123369|FG002|Overall Study|Adverse Event|4|||
46897642|NCT00706030|83123370|FG003|Overall Study|Adverse Event|2|||
46897643|NCT00706030|83123367|FG000|Overall Study|Withdrawal by Subject|1|||
46897644|NCT00706030|83123368|FG001|Overall Study|Withdrawal by Subject|0|||
46897645|NCT00706030|83123369|FG002|Overall Study|Withdrawal by Subject|2|||
46897646|NCT00706030|83123370|FG003|Overall Study|Withdrawal by Subject|0|||
46897647|NCT00706030|83123367|FG000|Overall Study|Physician Decision|0|||
46897648|NCT00706030|83123368|FG001|Overall Study|Physician Decision|0|||
46897649|NCT00706030|83123369|FG002|Overall Study|Physician Decision|2|||
46897650|NCT00706030|83123370|FG003|Overall Study|Physician Decision|0|||
46897651|NCT00706030|83123367|FG000|Overall Study|Not recorded|0|||
46897652|NCT00706030|83123368|FG001|Overall Study|Not recorded|0|||
46897663|NCT00706030|83123367|FG000|Overall Study|Symptomatic Deterioration|0|||
46897664|NCT00706030|83123368|FG001|Overall Study|Symptomatic Deterioration|0|||
46897665|NCT00706030|83123369|FG002|Overall Study|Symptomatic Deterioration|1|||
46897666|NCT00706030|83123370|FG003|Overall Study|Symptomatic Deterioration|0|||
46897667|NCT00706030|83123367|FG000|Overall Study|No treatment received|0|||
46897668|NCT00706030|83123368|FG001|Overall Study|No treatment received|0|||
46897669|NCT00706030|83123369|FG002|Overall Study|No treatment received|0|||
46897670|NCT00706030|83123370|FG003|Overall Study|No treatment received|1|||
46897671|NCT00706030|83123367|FG000|Overall Study|Death|0|||
46897672|NCT00706030|83123368|FG001|Overall Study|Death|0|||
46897673|NCT00706030|83123369|FG002|Overall Study|Death|1|||
46897674|NCT00706030|83123370|FG003|Overall Study|Death|0|||
46897675|NCT03488251|83123385|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
46897676|NCT03488251|83123386|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
46897677|NCT03488251|83123387|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
46897678|NCT03488251|83123388|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
46897679|NCT03488251|83123385|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
46897680|NCT03488251|83123386|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
46897681|NCT03488251|83123387|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
46897682|NCT03488251|83123388|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
46897683|NCT03488251|83123385|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
46897684|NCT03488251|83123386|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
46897685|NCT03488251|83123387|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
46897686|NCT03488251|83123388|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
46897687|NCT03488251|83123385|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
46897688|NCT03488251|83123386|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
46897689|NCT03488251|83123387|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
46897690|NCT03488251|83123388|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
46897691|NCT03488251|83123385|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
46897692|NCT03488251|83123386|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
46897693|NCT03488251|83123387|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
46897694|NCT03488251|83123388|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
46897695|NCT02727322|83123401|FG000|Overall Study|Withdrawal by Subject|1|||
46897696|NCT02727322|83123402|FG001|Overall Study|Withdrawal by Subject|1|||
46897697|NCT02727322|83123401|FG000|Overall Study|Protocol Violation|1|||
46897698|NCT02727322|83123402|FG001|Overall Study|Protocol Violation|0|||
46897699|NCT03431857|83123412|FG000|Overall Study|Death|6|||
46897700|NCT03431857|83123412|FG000|Overall Study|Lost to Follow-up|41|||
46897701|NCT03431857|83123412|FG000|Overall Study|Adverse Event|6|||
46897702|NCT03431857|83123412|FG000|Overall Study|Withdrawal by Subject|1|||
46897703|NCT03487549|83123418|FG000|Overall Study|Protocol Violation|0|||
46897704|NCT03487549|83123419|FG001|Overall Study|Protocol Violation|1|||
46897705|NCT03487549|83123418|FG000|Overall Study|Lost to Follow-up|2|||
46897706|NCT03487549|83123419|FG001|Overall Study|Lost to Follow-up|1|||
46897707|NCT03487549|83123418|FG000|Overall Study|Withdrawal by Subject|2|||
46897708|NCT03487549|83123419|FG001|Overall Study|Withdrawal by Subject|0|||
46897709|NCT03464383|83123428|FG000|Overall Study|Lost to Follow-up|1|||
46897710|NCT03464383|83123429|FG001|Overall Study|Lost to Follow-up|0|||
46897711|NCT03464383|83123430|FG002|Overall Study|Lost to Follow-up|0|||
46897712|NCT03464383|83123428|FG000|Overall Study|Withdrawal by Subject|0|||
46897713|NCT03464383|83123429|FG001|Overall Study|Withdrawal by Subject|1|||
46897714|NCT03464383|83123430|FG002|Overall Study|Withdrawal by Subject|0|||
46897715|NCT01444092|83123439|FG000|Overall Study|Adverse Event|8|||
46897716|NCT01444092|83123439|FG000|Overall Study|Protocol Violation|1|||
46897717|NCT01444092|83123439|FG000|Overall Study|Withdrawal by Subject|1|||
46897718|NCT01444092|83123439|FG000|Overall Study|Other Eligibility criteria|7|||
46897719|NCT01265784|83123446|FG000|Overall Study|Lost to Follow-up|5|||
46897720|NCT01265784|83123447|FG001|Overall Study|Lost to Follow-up|3|||
46897721|NCT01265784|83123448|FG002|Overall Study|Lost to Follow-up|2|||
46897722|NCT01265784|83123446|FG000|Overall Study|Withdrawal by Subject|0|||
46897723|NCT01265784|83123447|FG001|Overall Study|Withdrawal by Subject|5|||
46897724|NCT01265784|83123448|FG002|Overall Study|Withdrawal by Subject|0|||
46897725|NCT01265784|83123446|FG000|Overall Study|Physician Decision|1|||
46897726|NCT01265784|83123447|FG001|Overall Study|Physician Decision|0|||
46897727|NCT01265784|83123448|FG002|Overall Study|Physician Decision|1|||
46897728|NCT01265784|83123446|FG000|Overall Study|Adverse Event|1|||
46897729|NCT01265784|83123447|FG001|Overall Study|Adverse Event|0|||
46897730|NCT01265784|83123448|FG002|Overall Study|Adverse Event|0|||
46897731|NCT01265784|83123446|FG000|Overall Study|Death|3|||
46897732|NCT01265784|83123447|FG001|Overall Study|Death|0|||
46897733|NCT01265784|83123448|FG002|Overall Study|Death|0|||
46897734|NCT01265784|83123446|FG000|Overall Study|Protocol Violation|2|||
46897735|NCT01265784|83123447|FG001|Overall Study|Protocol Violation|0|||
46897736|NCT01265784|83123448|FG002|Overall Study|Protocol Violation|0|||
46897737|NCT01265784|83123446|FG000|Overall Study|Incorrectly Randomized|0|||
46897738|NCT01265784|83123447|FG001|Overall Study|Incorrectly Randomized|0|||
46897739|NCT01265784|83123448|FG002|Overall Study|Incorrectly Randomized|1|||
